Publication Type,Authors,Book Authors,Book Editors,Book Group Authors,Author Full Names,Book Author Full Names,Group Authors,Title,Source Title,Book Series Title,Book Series Subtitle,Language,Document Type,Conference Title,Conference Date,Conference Location,Conference Sponsor,Conference Host,Author Keywords,Keywords Plus,Abstract,Addresses,Affiliations,Reprint Addresses,Email Addresses,Researcher Ids,ORCIDs,Funding Orgs,Funding Name Preferred,Funding Text,Cited References,Cited Reference Count,"Times Cited, WoS Core","Times Cited, All Databases",180 Day Usage Count,Since 2013 Usage Count,Publisher,Publisher City,Publisher Address,ISSN,eISSN,ISBN,Journal Abbreviation,Journal ISO Abbreviation,Publication Date,Publication Year,Volume,Issue,Part Number,Supplement,Special Issue,Meeting Abstract,Start Page,End Page,Article Number,DOI,DOI Link,Book DOI,Early Access Date,Number of Pages,WoS Categories,Web of Science Index,Research Areas,IDS Number,Pubmed Id,Open Access Designations,Highly Cited Status,Hot Paper Status,Date of Export,UT (Unique WOS ID),Web of Science Record
J,"Yu, T; Zheng, YP; Tan, JC; Xiong, WJ; Wang, Y; Lin, L",,,,"Yu, Ting; Zheng, Yong-Ping; Tan, Jia-Cheng; Xiong, Wen-Jie; Wang, Yu; Lin, Lin",,,Effects of Prebiotics and Synbiotics on Functional Constipation,AMERICAN JOURNAL OF THE MEDICAL SCIENCES,,,English,Review,,,,,,Functional constipation; Fructo-oligosaccharides; Galacto-oligosaccharides; Prebiotics; Synbiotics,CHRONIC IDIOPATHIC CONSTIPATION; IRRITABLE-BOWEL-SYNDROME; DOUBLE-BLIND; PROBIOTICS; METAANALYSIS; MICROBIOTA; TRANSIT; PREVALENCE; SYMPTOMS; EFFICACY,"The objective was to determine the effects of prebiotics and synbiotics on adults with functional constipation (FC). Medline, Embase and the Cochrane Library were searched for literature published up to February 2015. We selected randomized controlled trials (RCTs) that reported administration of prebiotics or synbiotics to adults with FC. The end points included stool frequency, stool consistency and other symptoms related to constipation. Mean differences (MD) or standard mean differences (SMD) were used for continuous outcomes and risk ratios for discontinuous outcomes using a random-effects model. The Cochrane Risk of Bias Tool was used to determine the quality of the trials. Funnel plots and Egger's test were used to analyze for publication bias. We included 5 RCTs involving 199 patients who were administered prebiotics and 8 RCTs involving 825 patients who were administered synbiotics. Prebiotics increased weekly stool frequency (MD: 1.01 bowel movements/week, 95% CI: 0.04-1.99) and improved stool consistency (SMD: -0.59, 95% CI: -1.16 to -0.02). Subgroup analysis showed specific effects for galacto-oligosaccharides on stool frequency, consistency, ease of defecation and abdominal pain. Synbiotics significantly improved stool frequency (MD: 1.15 bowel movements/week, 95% CI: 0.58-1.71), consistency (SMD: 0.63, 95% CI: 0.33-0.92) and reduced whole-gut transit time (MD: 13.52, 95% CI: -26.56 to -0.49) in patients with FC. Subgroup analysis showed specific effects for fructo-oligosaccharides and probiotic combinations on stool frequency, consistency, straining defecation and bloating. Galacto-oligosaccharides and synbiotics made up of fructo-oligosaccharides with probiotic combinations may improve stool frequency, consistency and some other symptoms related to constipation.","[Yu, Ting; Zheng, Yong-Ping; Xiong, Wen-Jie; Wang, Yu; Lin, Lin] Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing 210029, Jiangsu, Peoples R China; [Tan, Jia-Cheng] Southeast Univ, Dept Gastroenterol, Zhongda Hosp, Nanjing, Jiangsu, Peoples R China",Nanjing Medical University; Southeast University - China,"Lin, L (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing 210029, Jiangsu, Peoples R China.",ling9100@aliyun.com,"huang, libo/JMB-4345-2023; Xi, Yang/KEH-5204-2024; li, xiao/GSN-6181-2022",,"National Science Foundation of China, China [81270462]","National Science Foundation of China, China(National Natural Science Foundation of China (NSFC))","This study was supported by a grant from National Science Foundation of China, China (81270462).",,43,42,47,5,61,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",0002-9629,1538-2990,,AM J MED SCI,Am. J. Med. Sci.,MAR,2017,353,3,,,,,282,292,,10.1016/j.amjms.2016.09.014,http://dx.doi.org/10.1016/j.amjms.2016.09.014,,,11,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,EO9WG,28262216,hybrid,,,2024-06-04,WOS:000397038200014,View Full Record in Web of Science
J,"Erhardt, R; Harnett, JE; Steels, E; Steadman, KJ",,,,"Erhardt, Rene; Harnett, Joanna E.; Steels, Elizabeth; Steadman, Kathryn J.",,,Functional constipation and the effect of prebiotics on the gut microbiota: a review,BRITISH JOURNAL OF NUTRITION,,,English,Review,,,,,,Functional constipation; Prebiotics; Microbiota; Dietary fibre,CHRONIC IDIOPATHIC CONSTIPATION; HYDROLYZED GUAR GUM; BRAIN AXIS; ENTERIC MICROBIOTA; FIBER; DIETARY; HEALTH; IMPACT; INULIN; SUPPLEMENTATION,"Functional constipation is a significant health issue impacting the lives of an estimated 14 % of the global population. Non-pharmaceutical treatment advice for cases with no underlying medical conditions focuses on exercise, hydration and an increase in dietary fibre intake. An alteration in the composition of the gut microbiota is thought to play a role in constipation. Prebiotics are non-digestible food ingredients that selectively stimulate the growth of a limited number of bacteria in the colon with a benefit for host health. Various types of dietary fibre, though not all, can act as a prebiotic. Short-chain fatty acids produced by these microbes play a critical role as signalling molecules in a range of metabolic and physiological processes including laxation, although details are unclear. Prebiotics have a history of safe use in the food industry spanning several decades and are increasingly used as supplements to alleviate constipation. Most scientific research on the effects of prebiotics and gut microbiota has focussed on inflammatory bowel disease rather than functional constipation. Very few clinical studies evaluated the efficacy of prebiotics in the management of constipation and their effect on the microbiota, with highly variable designs and conflicting results. Despite this, broad health claims are made by manufacturers of prebiotic supplements. This narrative review provides an overview of the literature on the interaction of prebiotics with the gut microbiota and their potential clinical role in the alleviation of functional constipation.","[Erhardt, Rene; Steels, Elizabeth; Steadman, Kathryn J.] Univ Queensland, Sch Pharm, Brisbane, Qld 4102, Australia; [Harnett, Joanna E.] Univ Sydney, Sch Pharm, Camperdown, NSW 2006, Australia; [Steels, Elizabeth] Evidence Sci, 3-884 Brunswick St, New Farm, Qld 4005, Australia",University of Queensland; University of Sydney,"Erhardt, R (corresponding author), Univ Queensland, Sch Pharm, Brisbane, Qld 4102, Australia.",r.erhardt@uq.edu.au,"Harnett, Joanna E/L-1214-2018; Steadman, Kathryn/C-3401-2008","Harnett, Joanna E/0000-0001-9904-2144; Steadman, Kathryn/0000-0001-7357-330X; Erhardt, Rene/0000-0002-1961-135X",Postgraduate Research Scholarship from The University of Queensland,Postgraduate Research Scholarship from The University of Queensland,"R Erhardt is supported by a Postgraduate Research Scholarship from The University of Queensland. E. R. contributed to the conception, design and interpretation of the research. All authors contributed to the drafting of the manuscript. All authors critically revised the manuscript, agree to be fully accountable for ensuring the integrity and accuracy of the work and read and approved the final manuscript. There are no conflicts of interest.",,72,5,5,18,47,CAMBRIDGE UNIV PRESS,CAMBRIDGE,"EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND",0007-1145,1475-2662,,BRIT J NUTR,Br. J. Nutr.,SEP 28,2023,130,6,,,,,1015,1023,PII S0007114522003853,10.1017/S0007114522003853,http://dx.doi.org/10.1017/S0007114522003853,,DEC 2022,9,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,FP0W1,36458339,"hybrid, Green Published",,,2024-06-04,WOS:000939912400001,View Full Record in Web of Science
J,"Naseer, M; Poola, S; Uraz, S; Tahan, V",,,,"Naseer, Maliha; Poola, Shiva; Uraz, Suleyman; Tahan, Veysel",,,Therapeutic Effects of Prebiotics on Constipation: A Schematic Review,CURRENT CLINICAL PHARMACOLOGY,,,English,Review,,,,,,Prebiotic; idiopathic constipation; dysbiosis; galactan; fructan; gastrointestinal microbiome,CHAIN FATTY-ACIDS; CHRONIC IDIOPATHIC CONSTIPATION; GERMINATED BARLEY FOODSTUFF; IRRITABLE-BOWEL-SYNDROME; GALACTO-OLIGOSACCHARIDES; FECAL MICROFLORA; DOUBLE-BLIND; FERMENTATION PROPERTIES; COLONIC TRANSIT; RISK-FACTORS,"Constipation is a highly prevalent functional gastrointestinal disorder that may significantly affect the quality of life and health care costs. Treatment for constipation has been broadly reviewed by cognitive therapies, medications, and surgical interventions. Gut microbiota such as Bifidobacterium, Clostridium, Bacteroidetes, and Lactobacilli have been demonstrated in functional gastrointestinal disorders and prebiotics to play a role in augmenting their presence. Prebiotics are ingredients in foods that remain undigested, stimulating the bacteria. There are a variety of prebiotics; however, there exists only a handful of studies that describe their efficacy for chronic constipation. The purpose of this study is to review the available literature on the utility of different commercially available prebiotics in patients with functional and chronic idiopathic constipation. To fulfil the objectives of the study, published articles in the English language on databases such as Pubmed, Ovid Medline, and EMBASE were searched. The terms prebiotics, constipation, chronic constipation, functional constipation were used. We reviewed and included 21 randomized controlled trials exploring the role of prebiotics in constipated adults. Prebiotics are effective treatments for chronic idiopathic constipation and showed improvement in the stool consistency, number of bowel moments and bloating. Although which prebiotic formulary would promote improved symptoms of constipation is still not clear.","[Naseer, Maliha] East Carolina Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Greenville, NC 27834 USA; [Poola, Shiva] East Carolina Univ, Dept Internal & Pediat Med, Greenville, NC 27834 USA; [Uraz, Suleyman; Tahan, Veysel] Univ Missouri, Dept Internal Med, Div Gastroenterol & Hepatol, Columbia, MO 65211 USA",University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of Missouri System; University of Missouri Columbia,"Tahan, V (corresponding author), Univ Missouri, Dept Internal Med, Div Gastroenterol & Hepatol, Columbia, MO 65211 USA.",tahanv@health.missouri.edu,,"Uraz, Suleyman/0000-0002-0389-2599; Tahan, Veysel/0000-0001-6796-9359; Poola, Shiva/0000-0002-8447-2149",,,,,74,19,21,5,61,BENTHAM SCIENCE PUBL LTD,SHARJAH,"EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES",1574-8847,2212-3938,,CURR CLIN PHARMACOL,Curr. Clin. Pharmacol.,,2020,15,3,,,,,207,215,,10.2174/1574884715666200212125035,http://dx.doi.org/10.2174/1574884715666200212125035,,,9,Pharmacology & Pharmacy,Emerging Sources Citation Index (ESCI),Pharmacology & Pharmacy,PH7ZQ,32048977,,,,2024-06-04,WOS:000600626100005,View Full Record in Web of Science
J,"Malaguarnera, M; Vacante, M; Condorelli, G; Leggio, F; Di Rosa, M; Motta, M; Malaguarnera, G; Alessandria, I; Rampello, L; Chisari, G",,,,"Malaguarnera, Michele; Vacante, Marco; Condorelli, Giovanni; Leggio, Federico; Di Rosa, Michelino; Motta, Massimo; Malaguarnera, Giulia; Alessandria, Innocenza; Rampello, Liborio; Chisari, Giuseppe",,,PROBIOTICS AND PREBIOTICS IN THE MANAGEMENT OF CONSTIPATION IN THE ELDERLY,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Probiotics; Constipation; Bifidobacterium; Prebiotics; Elderly,BIFIDOBACTERIUM-LONGUM; LACTOBACILLUS-ACIDOPHILUS; FUNCTIONAL CONSTIPATION; FRUCTO-OLIGOSACCHARIDE; HEPATIC-ENCEPHALOPATHY; TYPHIMURIUM INFECTION; IMMUNE PARAMETERS; CELL-CULTURE; DOUBLE-BLIND; LARGE-BOWEL,"The prevalence of constipation and its impact on quality of life are high among elderly people, with a incidence of 26% in men and 34% in women aged 65 or more. The current standard treatment consists of laxatives administration, lifestyle modifications such as regular physical activity and increased fluids and fibers intake. Several studies have demonstrated that modifications in the intestinal microflora of elderly could alter the metabolic environment of the colon with important changes in the concentration of physiologically active substances that may alter the motor and secretory functions of the bowel. Probiotics are live microorganisms (such as Bifidobacteria and Lactobacilli), which, when administered in adequate amounts, confer a health benefit to the host. Studies examining the effects of probiotics on constipation in elderly are limited, and different strains have been used so far. The aim of this review is to summarize the best available data and indications regarding probiotics as a tool for the management of constipation in the elderly.","[Malaguarnera, Michele; Malaguarnera, Giulia] Univ Catania, Int PhD Programme Neuropharmacol, I-95124 Catania, Italy; [Vacante, Marco; Condorelli, Giovanni; Leggio, Federico; Motta, Massimo; Alessandria, Innocenza] Univ Catania, Res Ctr La Grande Senescenza, I-95124 Catania, Italy; [Di Rosa, Michelino; Chisari, Giuseppe] Univ Catania, Dept Biomed Sci, Ctr Ocular Microbiol, I-95124 Catania, Italy; [Rampello, Liborio] Univ Catania, Dept Neurosci, I-95124 Catania, Italy",University of Catania; University of Catania; University of Catania; University of Catania,"Chisari, G (corresponding author), Azienda Osped Univ Policlin Catania, Ctr Microbiol Superficie Oculare, Via S Sofia 78, I-95123 Catania, Italy.",,"Malaguarnera, Giulia/ABD-4968-2020; Malaguarnera, Michele/A-1376-2019; Michelino, Di Rosa/B-5807-2013; Vacante, Marco/S-4377-2019","Malaguarnera, Giulia/0000-0003-3655-4307; Malaguarnera, Michele/0000-0002-7145-6377; Michelino, Di Rosa/0000-0002-1837-9325; CHISARI, Giuseppe/0000-0002-0492-2171; Vacante, Marco/0000-0002-6815-5012",,,,,72,19,19,1,27,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2013,29,4,,,,,791,798,,,,,,8,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,295YB,,,,,2024-06-04,WOS:000330151200032,View Full Record in Web of Science
J,"Haz, YM; Dos Santos, R; Márquez, JL; Cuevas, ZO",,,,"Michelle Haz, Yanine; Dos Santos, Rosanna; Leonardo Marquez, Juan; Ostojich Cuevas, Zoitza",,,Elaboration of bread with prebiotics and its effect on the gastrointestinal transit in person with constipation,MEDULA,,,Spanish,Article,,,,,,Prebiotics; constipation; bread; dietary fiber,,"The aim of this study was to create bread with prebiotics (Inulin and FOS), analyze its proximate composition, evaluate its acceptance through sensorial affective tests, and evaluate its effect on the gastrointestinal transit in constipated people. In order to do this, a daily 50 g portion of bread was given for 21 days to 17 people diagnosed with constipation and without pharmacological treatment. Additionally, data were collected about their eating, physical activity and water intake habits. It was found that most of them ingest less than 20 g Fiber per day and 7 glasses of water/day, as well as doing little physical activity, habits that could favor the constipation. At the end of the study, there was an increase in the participant's evacuation frequency (to 11-14 times per week), a decrease in pain when evacuating, and in the incomplete evacuation sensation and in evacuation with blood in the participants who presented these symptoms. From the proximate analysis it was found that contribution of total dietary fiber (6.02g) in a bread portion contributes to the 20% of the Daily Intake Recommendations of this nutrient. Affective tests results show bread has a 90% of acceptability and a global liking in the Like category.","[Michelle Haz, Yanine; Dos Santos, Rosanna; Leonardo Marquez, Juan; Ostojich Cuevas, Zoitza] Univ Los Andes, Fac Med, Escuela Nutr & Dietet, Dept Nutr & Alimentac, Merida, Venezuela",University of Los Andes Venezuela,"Márquez, JL (corresponding author), Fac Med, Av Don Tulio Febres Cordero,Edif Sede Sur Piso 1, Merida, Venezuela.",marquez_juanleo@yahoo.com; zoitzaula@gmail.com,,,,,,,33,0,0,1,2,UNIV LOS ANDES,MERIDA,"AP POSTAL 870, MERIDA, 5101-A, VENEZUELA",0798-3166,,,MEDULA,MedULA,JUL-DEC,2019,28,2,,,,,,,,,,,,9,"Medicine, General & Internal",Emerging Sources Citation Index (ESCI),General & Internal Medicine,JX7AK,,,,,2024-06-04,WOS:000503882900004,View Full Record in Web of Science
J,"Li, YN; Zong, YH; Qi, JS; Liu, K",,,,"Li, Yanning; Zong, Yanhong; Qi, Jinsheng; Liu, Kun",,,Prebiotics and Oxidative Stress in Constipated Rats,JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION,,,English,Article,,,,,,constipation; malondialdehyde; prebiotics; secretory immunoglobulin A; superoxide dismutase,IRRITABLE-BOWEL-SYNDROME; IMMUNE ACTIVATION; GUT HEALTH; HUMAN-MILK; INULIN; OLIGOSACCHARIDE; MICROBIOTA; DAMAGE; BIFIDOBACTERIA; OLIGOFRUCTOSE,"Objectives: Constipation can adversely affect children's health, with disorders of host immunity and enhanced oxidative stress. As nondigestible carbohydrates, prebiotics can affect the host with constipation; however, whether the prebiotics have effects on the content of intestinal secretory immunoglobulin A (sIgA) and the contents of superoxide dismutase (SOD) and malondialdehyde (MDA) in constipation has not been fully clarified. Methods: In the present study, constipation was induced in female Sprague-Dawley rats by diphenoxylate, and the prebiotics dissolved in milk were used as an intervention. The indicators of intestinal peristalsis, including the time of passing black stool initially, the grains of black stool in 24 hours, and the advance rate of ponceau, were measured. The content of intestinal sIgA was detected by enzyme-linked immunosorbent assay. The contents of SOD and MDA in serum and intestinal tissue were analyzed by their detection kits. Results: The changes in intestinal peristalsis show obvious constipation. The content of intestinal sIgA decreases, the content of SOD decreases, but the content of MDA increases in constipated rats. Prebiotics can attenuate the constipation-caused abnormal indicators significantly. Conclusions: Prebiotics can attenuate decreased intestinal immunity and enhanced oxidative stress, in addition to reduced intestinal peristalsis and of the constipated rats.","[Zong, Yanhong; Qi, Jinsheng; Liu, Kun] Hebei Med Univ, Dept Biochem, Shijiazhuang 050017, Hebei Province, Peoples R China; [Li, Yanning] Hebei Med Univ, Hebei Key Lab Lab Anim, Dept Mol Biol, Shijiazhuang 050017, Hebei Province, Peoples R China",Hebei Medical University; Hebei Medical University,"Qi, JS (corresponding author), Hebei Med Univ, Dept Biochem, 361 E Zhongshan Rd, Shijiazhuang 050017, Hebei Province, Peoples R China.",qijinsheng777@163.com,,,Hebei Natural Science Foundation [C2009001092],Hebei Natural Science Foundation(Natural Science Foundation of Hebei Province),This study was funded by the Hebei Natural Science Foundation (C2009001092).,,35,19,20,1,25,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA",0277-2116,,,J PEDIATR GASTR NUTR,J. Pediatr. Gastroenterol. Nutr.,OCT,2011,53,4,,,,,447,452,,10.1097/MPG.0b013e3182leed83,http://dx.doi.org/10.1097/MPG.0b013e3182leed83,,,6,Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,826HA,21505362,,,,2024-06-04,WOS:000295344000020,View Full Record in Web of Science
J,"Huang, LS; Zhu, Q; Qu, X; Qin, HL",,,,"Huang, Linsheng; Zhu, Qi; Qu, Xiao; Qin, Huanlong",,,Microbial treatment in chronic constipation,SCIENCE CHINA-LIFE SCIENCES,,,English,Review,,,,,,constipation; probiotics; prebiotics; synbiotics; FMT,CLOSTRIDIUM-DIFFICILE INFECTION; PLACEBO-CONTROLLED TRIAL; IRRITABLE-BOWEL-SYNDROME; COLONIC TRANSIT-TIME; CHRONIC FUNCTIONAL CONSTIPATION; RANDOMIZED CLINICAL-TRIAL; HUMAN GUT MICROBIOTA; LACTIS DN-173 010; DOUBLE-BLIND; FERMENTED MILK,"Chronic functional constipation is a kind of common intestinal disease that occurs in children, adults and elderly people. This disease not only causes great influence to physiological function, but also results in varying degrees of psychological barriers. At present, constipation treatments continue to rely on traditional methods such as purgative therapy and surgery. However, these approaches can disrupt intestinal function. Recent research between intestinal diseases and gut microbiota has gradually revealed a connection between constipation and intestinal flora disturbance, providing a theoretical basis for microbial treatment in chronic constipation. Microbial treatment mainly includes probiotic preparations such as probiotics, prebiotics, synbiotics and fecal microbiota transplantation (FMT). Due to its safety, convenience and curative effect, probiotic preparations have been widely accepted, especially gradually developed FMT with higher curative effects. Microbial treatment improves clinical symptoms, promotes the recovery of intestinal flora, and has no complications during the treatment process. Compared with traditional treatments, microbial treatment in chronic constipation has advantages, and is worthy of further promotion from clinical research to clinical application.","[Huang, Linsheng; Zhu, Qi; Qu, Xiao; Qin, Huanlong] Tongji Univ, Shanghai Peoples Hosp 10, Dept Gen Surg, Shanghai 200072, Peoples R China; [Huang, Linsheng; Qin, Huanlong] Anhui Med Univ, Shanghai Peoples Hosp 10, Clin Med Coll, Shanghai 200072, Peoples R China",Tongji University; Anhui Medical University,"Qin, HL (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Dept Gen Surg, Shanghai 200072, Peoples R China.;Qin, HL (corresponding author), Anhui Med Univ, Shanghai Peoples Hosp 10, Clin Med Coll, Shanghai 200072, Peoples R China.",huanlong_qin@live.cn,"huanlong, Qin/B-3844-2015",,"National Natural Science Foundation of China [81230057, 81200264, 81372615, 81472262]; Emerging Cutting-Edge Technology Joint Research Projects of Shanghai [SHDC12012106]; Tongji University Subject Pilot Program [162385]",National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Emerging Cutting-Edge Technology Joint Research Projects of Shanghai; Tongji University Subject Pilot Program,"This work was supported by the National Natural Science Foundation of China (81230057, 81200264, 81372615, 81472262), the Emerging Cutting-Edge Technology Joint Research Projects of Shanghai (SHDC12012106) and the Tongji University Subject Pilot Program (162385).",,98,44,60,10,83,SCIENCE PRESS,BEIJING,"16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA",1674-7305,1869-1889,,SCI CHINA LIFE SCI,Sci. China-Life Sci.,JUL,2018,61,7,,,,,744,752,,10.1007/s11427-017-9220-7,http://dx.doi.org/10.1007/s11427-017-9220-7,,,9,Biology,Science Citation Index Expanded (SCI-EXPANDED),Life Sciences & Biomedicine - Other Topics,GM8HS,29388040,,,,2024-06-04,WOS:000438465700002,View Full Record in Web of Science
J,"Kim, MG; Jo, K; Cho, K; Park, SS; Suh, HJ; Hong, KB",,,,"Kim, Min Guk; Jo, Kyungae; Cho, Kyoungwon; Park, Sung Sun; Suh, Hyung Joo; Hong, Ki-Bae",,,Prebiotics/Probiotics Mixture Induced Changes in Cecal Microbiome and Intestinal Morphology Alleviated the Loperamide-Induced Constipation in Rat,FOOD SCIENCE OF ANIMAL RESOURCES,,,English,Article,,,,,,constipation; multi-strain probiotics; loperamide; microbiota,IRRITABLE-BOWEL-SYNDROME; CHILDHOOD CONSTIPATION; DOUBLE-BLIND; FUNCTIONAL CONSTIPATION; INTERSTITIAL-CELLS; DIETARY FIBER; COLONIC MUCUS; FATTY-ACIDS; LACTOBACILLUS; CAJAL,"The aim of this study was to investigate the effect of a mixture of multi-strain probiotics and prebiotics on loperamide-induced constipation in Sprague-Dawley rats. A multi-strain probiotics alone (loperamide-induced group with multi-strain probiotics mixture group; Lop-Pro) and a mixture of multi-strain probiotics and prebiotics (loperamide-induced group with multi-strain probiotics and prebiotics mixture group; Lop-Pro/Pre) were administered orally after inducing constipation. The fecal water content was significantly higher (by 42%) in the Lop-Pro/Pre group (33.5%) than in the loperamide-induced group (Lop) (23.7%) (p<0.05). The intestinal mucosal thickness, crypt cell area, and interstitial cells of Cajal area were significantly higher in the Lop-Pro/Pre group compared to the Lop group by 16.4%, 20.6%, and 42.3%, respectively. Additionally, the total short-chain fatty acid content was significantly increased in the Lop-Pro and Lop-Pro/Pre groups by 56.4% and 54.2%, respectively, compared with the Lop group. The Lop-Pro and Lop-Pro/Pre groups recovered loperamide-induced alteration in Bacteroidetes and Verrucomicrobia abundance among intestinal microbiota, whereas the Lop-Pro/Pre group recovered Akkermansia, Lactobacillus, Clostridium, Bacteroides, and Oscillibacter abundance. Moreover, the relative abundance of Oscillibacter and Clostridium was significantly different in the Lop-Pro/Pre group compared to the Lop group. Collectively, administration of synbiotics rather than multi-strain probiotics alone is effective in alleviating constipation.","[Kim, Min Guk; Jo, Kyungae; Suh, Hyung Joo] Korea Univ, Grad Sch, Dept Integrated Biomed & Life Sci, Seoul 02841, South Korea; [Cho, Kyoungwon; Park, Sung Sun] Chong Kun Dang Healthcare Co, Seoul 04300, South Korea; [Suh, Hyung Joo] Korea Univ, Grad Sch, Dept Healthcare Sci, Transdisciplinary Major Learning Hlth Syst, Seoul 02841, South Korea; [Hong, Ki-Bae] Jeju Natl Univ, Dept Food Sci & Nutr, Jeju 63243, South Korea",Korea University; Korea University; Jeju National University,"Suh, HJ (corresponding author), Korea Univ, Grad Sch, Dept Integrated Biomed & Life Sci, Seoul 02841, South Korea.;Hong, KB (corresponding author), Jeju Natl Univ, Dept Food Sci & Nutr, Jeju 63243, South Korea.",suh1960@korea.ac.kr; kbhong@jejunu.ac.kr,,"Jo, Kyungae/0000-0003-4056-6706; gim, mingug/0000-0001-8625-4957; Hong, Ki-Bae/0000-0001-5199-2685; Cho, Kyoungwon/0000-0002-3693-2817; Suh, Hyung Joo/0000-0001-8869-3929",,,,,51,10,10,9,33,KOREAN SOC FOOD SCIENCE ANIMAL RESOURCES,SEOUL,"806, HANGANG HYUNDAI HYEL, 213-12, SAECHANG-RO, YONGSAN-GU, SEOUL, 04376, SOUTH KOREA",2636-0772,2636-0780,,FOOD SCI ANIM RESOUR,Food Sci. Anim. Resour.,,2021,41,3,,,,,527,541,,10.5851/kosfa.2021.e17,http://dx.doi.org/10.5851/kosfa.2021.e17,,,15,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,SE9BA,34017959,"Green Published, gold",,,2024-06-04,WOS:000652361400013,View Full Record in Web of Science
J,"Araújo, MM; Botelho, PB",,,,"Araujo, Maisa Miranda; Botelho, Patricia Borges",,,"Probiotics, prebiotics, and synbiotics in chronic constipation: Outstanding aspects to be considered for the current evidence",FRONTIERS IN NUTRITION,,,English,Review,,,,,,probiotic; constipation; gastrointestinal symptoms; defecation frequency; prebiotic; synbiotic; review,INTERNATIONAL SCIENTIFIC ASSOCIATION; DIPHENOXYLATE-INDUCED CONSTIPATION; SEROTONIN TRANSPORTER EXPRESSION; CHRONIC IDIOPATHIC CONSTIPATION; LOPERAMIDE-INDUCED CONSTIPATION; RANDOMIZED DOUBLE-BLIND; FUNCTIONAL CONSTIPATION; FERMENTED MILK; TRANSIT-TIME; GASTROINTESTINAL SYMPTOMS,"This integrative aimed to evaluate the effects and the potential mechanism of action of prebiotics, probiotics, and synbiotics on constipation-associated gastrointestinal symptoms and to identify issues that still need to be answered. A literature search was performed in the PubMed database. Animal models (n = 23) and clinical trials (n = 39) were included. In animal studies, prebiotic, probiotic, and synbiotic supplementation showed a decreased colonic transit time (CTT) and an increase in the number and water content of feces. In humans, inulin is shown to be the most promising prebiotic, while B. lactis and L. casei Shirota probiotics were shown to increase defecation frequency, the latter strain being more effective in improving stool consistency and constipation symptoms. Overall, synbiotics seem to reduce CTT, increase defecation frequency, and improve stool consistency with a controversial effect on the improvement of constipation symptoms. Moreover, some aspects of probiotic use in constipation-related outcomes remain unanswered, such as the best dose, duration, time of consumption (before, during, or after meals), and matrices, as well as their effect and mechanisms on the regulation of inflammation in patients with constipation, on polymorphisms associated with constipation, and on the management of constipation via 5-HT. Thus, more high-quality randomized control trials (RCTs) evaluating these lacking aspects are necessary to provide safe conclusions about their effectiveness in managing intestinal constipation.","[Araujo, Maisa Miranda; Botelho, Patricia Borges] Univ Brasilia, Fac Hlth Sci, Dept Nutr, Brasilia, DF, Brazil",Universidade de Brasilia,"Botelho, PB (corresponding author), Univ Brasilia, Fac Hlth Sci, Dept Nutr, Brasilia, DF, Brazil.",patriciabotelho@unb.br,"Araújo, Maísa Miranda/ABX-5307-2022; Botelho, Patrícia Borges/AAL-7977-2020; Araújo, Maísa Miranda/AHD-3728-2022","Araújo, Maísa Miranda/0000-0001-8232-7653; Botelho, Patrícia Borges/0000-0001-8909-3757; Araújo, Maísa Miranda/0000-0001-8232-7653",,,,,124,11,12,21,38,FRONTIERS MEDIA SA,LAUSANNE,"AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND",2296-861X,,,FRONT NUTR,Front. Nutr.,DEC 8,2022,9,,,,,,,,935830,10.3389/fnut.2022.935830,http://dx.doi.org/10.3389/fnut.2022.935830,,,12,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,7F6XL,36570175,"gold, Green Published",,,2024-06-04,WOS:000901987800001,View Full Record in Web of Science
J,"Yuan, XY; Chen, YS; Liu, Z",,,,"Yuan, Xin-Yang; Chen, Yu-Sen; Liu, Zhou",,,"Relationship among Parkinson's disease, constipation, microbes, and microbiological therapy",WORLD JOURNAL OF GASTROENTEROLOGY,,,English,Review,,,,,,Parkinson disease; Constipation; Gut microbiota; Prebiotics; Probiotics; Fecal microbiota transplantation,CHAIN FATTY-ACIDS; INTERNATIONAL SCIENTIFIC ASSOCIATION; ALPHA-SYNUCLEIN; GUT MICROBIOTA; GASTROINTESTINAL SYMPTOMS; INTESTINAL PERMEABILITY; CONSENSUS STATEMENT; NONMOTOR FEATURES; HYDROGEN-SULFIDE; POTENTIAL ROLE,"This comprehensive review elucidates the complex interplay between gut microbiota and constipation in Parkinson's disease (PD), a prevalent non-motor symptom contributing significantly to patients' morbidity. A marked alteration in the gut microbiota, predominantly an increase in the abundance of Proteobacteria and Bacteroidetes, is observed in PD-related constipation. Conventional treatments, although safe, have failed to effectively alleviate symptoms, thereby necessitating the development of novel therapeutic strategies. Microbiological interventions such as prebiotics, probiotics, and fecal microbiota transplantation (FMT) hold therapeutic potential. While prebiotics improve bowel movements, probiotics are effective in enhancing stool consistency and alleviating abdominal discomfort. FMT shows potential for significantly alleviating constipation symptoms by restoring gut microbiota balance in patients with PD. Despite promising developments, the causal relationship between changes in gut microbiota and PD-related constipation remains elusive, highlighting the need for further research in this expanding field.","[Yuan, Xin-Yang; Chen, Yu-Sen; Liu, Zhou] Guangdong Med Univ, Dept Neurol, Affiliated Hosp, Zhanjiang 524000, Guangdong, Peoples R China; [Yuan, Xin-Yang; Chen, Yu-Sen; Liu, Zhou] Inst Neurol, Guangdong Key Lab Age Related Cardiac & Cerebral D, Zhanjiang 524000, Guangdong, Peoples R China; [Liu, Zhou] Guangdong Med Univ, Affiliated Hosp, Inst Neurol, 57 Peoples Ave South, Zhanjiang 524000, Guangdong, Peoples R China",Guangdong Medical University; Guangdong Medical University,"Liu, Z (corresponding author), Guangdong Med Univ, Affiliated Hosp, Inst Neurol, 57 Peoples Ave South, Zhanjiang 524000, Guangdong, Peoples R China.",liuzhou@gdmu.edu.cn,,,Science and Technology Planning Project of Zhanjiang [2021A05071],Science and Technology Planning Project of Zhanjiang,"Supported by the Science and Technology Planning Project of Zhanjiang, No. 2021A05071.",,145,0,0,7,7,BAISHIDENG PUBLISHING GROUP INC,PLEASANTON,"7041 Koll Center Parkway, Suite 160, PLEASANTON, CA, UNITED STATES",1007-9327,2219-2840,,WORLD J GASTROENTERO,World J. Gastroenterol.,JAN 21,2024,30,3,,,,,,,,10.3748/wjg.v30.i3.225,http://dx.doi.org/10.3748/wjg.v30.i3.225,,,14,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,HA7S0,38314132,"hybrid, Green Published",,,2024-06-04,WOS:001156836700008,View Full Record in Web of Science
J,"Deng, XX; Liang, C; Zhou, LY; Shang, X; Hui, X; Hou, LY; Wang, YS; Liu, WD; Liang, SS; Yao, L; Yang, KH; Li, XX",,,,"Deng, Xinxin; Liang, Cui; Zhou, Liying; Shang, Xue; Hui, Xu; Hou, Liangying; Wang, Yongsheng; Liu, Wendi; Liang, Shanshan; Yao, Liang; Yang, Kehu; Li, Xiuxia",,,"Network meta-analysis of probiotics, prebiotics, and synbiotics for the treatment of chronic constipation in adults",EUROPEAN JOURNAL OF NUTRITION,,,English,Review; Early Access,,,,,,Constipation; Probiotic; Prebiotic; Synbiotic; Network meta-analysis; Systematic review; Adults,IRRITABLE-BOWEL-SYNDROME; QUALITY-OF-LIFE; SYSTEMATIC REVIEWS; TRANSIT-TIME; DIARRHEA; EPIDEMIOLOGY; MICROBIOTA; TRIAL; NEEDS; RISK,"ObjectiveTo compare the outcomes associated with the use of probiotics, prebiotics, and synbiotics for the treatment of chronic constipation in adults.MethodsWe searched eight electronic databases from database inception to July 11, 2023, to identify randomized controlled trials (RCTs) that report efficacy and safety for the treatment of chronic constipation. The risk of bias in the included RCTs was evaluated according to the Cochrane tool, and the certainty of the evidence was assessed using the Confidence in Network Meta-Analysis framework. The analysis was conducted using R version 4.3.0.ResultsOut of the 37 RCTs, a total of 21 different types of interventions were reported, involving 3,903 patients. This NMA demonstrated that both prebiotics and synbiotics resulted in an increase in frequency of stool movements per week. Compared to placebo, lactulose (Mean difference [MD] = 3.39, 95% Confdence interval [CI] [1.13, 5.65], moderate certainty), mix2 (consisting of Lactulose and Bacillus coagulans) (MD = 3.63, 95% CI [1.37, 5.89], moderate certainty), mix6 (consisting of Lactulose and Bifidobacterium coagulans) (MD = 4.30, 95% CI [1.04, 7.54], low certainty), and mix7 (consisting of Lactulose, Bifidobacterium subtilis, and Enterococcus faecium) (MD = 4.58, 95% CI [1.35, 7.78], moderate certainty) exhibited a significant effect. Notably, mix7 demonstrated the highest probability of being the most effective intervention (94.8%). Furthermore, when compared to L. plantarum, four probiotics and two synbiotics showed significant advantages in the Patient Assessment of Constipation Symptoms (PAC-SYM) score. L. reuteri (MD = -13.74, 95% CI [-22.20, -4.66], very low certainty) exhibited a significant effect in improving the Patient Assessment of Constipation Quality of Life (PAC-QoL) score. In terms of safety, there were no statistically significant differences between the intervention and control groups in all adverse event analyses.ConclusionsModerate to very low evidence supports the use of lactulose and synbiotics to increase the number of weekly stool movements in patients, particularly highlighting the significant impact of synbiotics in increasing the number of weekly stool movements in patients with constipation. The use of L. paracasei showed improvements in PAC-SYM scores, while L. reuteri demonstrated enhancements in PAC-QoL scores.","[Deng, Xinxin; Liang, Cui; Zhou, Liying; Wang, Yongsheng; Liu, Wendi; Liang, Shanshan; Li, Xiuxia] Lanzhou Univ, Hlth Technol Assessment Ctr, Evidence Based Social Sci Res Ctr, Sch Publ Hlth, 199 Donggang West Rd, Lanzhou 730000, Peoples R China; [Deng, Xinxin; Liang, Cui; Zhou, Liying; Hui, Xu; Hou, Liangying; Wang, Yongsheng; Liu, Wendi; Liang, Shanshan; Yang, Kehu; Li, Xiuxia] Lanzhou Univ, Evidence Based Med Ctr, Sch Basic Med Sci, 199 Donggang West Rd, Lanzhou 730000, Peoples R China; [Deng, Xinxin; Liang, Cui; Zhou, Liying; Hui, Xu; Hou, Liangying; Wang, Yongsheng; Liu, Wendi; Liang, Shanshan; Yang, Kehu; Li, Xiuxia] Key Lab Evidence Based Med & Knowledge Translat Ga, Lanzhou 730000, Peoples R China; [Shang, Xue] Southern Univ Sci & Technol, Sch Publ Hlth & Emergency Management, Shenzhen, Peoples R China; [Yao, Liang] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada",Lanzhou University; Lanzhou University; Southern University of Science & Technology; McMaster University,"Li, XX (corresponding author), Lanzhou Univ, Hlth Technol Assessment Ctr, Evidence Based Social Sci Res Ctr, Sch Publ Hlth, 199 Donggang West Rd, Lanzhou 730000, Peoples R China.;Yang, KH; Li, XX (corresponding author), Lanzhou Univ, Evidence Based Med Ctr, Sch Basic Med Sci, 199 Donggang West Rd, Lanzhou 730000, Peoples R China.;Yang, KH; Li, XX (corresponding author), Key Lab Evidence Based Med & Knowledge Translat Ga, Lanzhou 730000, Peoples R China.",yangkh-ebm@lzu.edu.cn; lixiuxia@lzu.edu.cn,"Li, xiuxia/IWV-4235-2023",,Fundamental Research Funds for the Central Universities,Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities),None.,,49,0,0,1,1,SPRINGER HEIDELBERG,HEIDELBERG,"TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY",1436-6207,1436-6215,,EUR J NUTR,Eur. J. Nutr.,2024 MAY 2,2024,,,,,,,,,,10.1007/s00394-024-03410-1,http://dx.doi.org/10.1007/s00394-024-03410-1,,MAY 2024,12,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,PV2N3,38693449,,,,2024-06-04,WOS:001216793600002,View Full Record in Web of Science
J,"Ohkusa, T; Koido, S; Nishikawa, Y; Sato, N",,,,"Ohkusa, Toshifumi; Koido, Shigeo; Nishikawa, Yuriko; Sato, Nobuhiro",,,Gut Microbiota and Chronic Constipation: A Review and Update,FRONTIERS IN MEDICINE,,,English,Review,,,,,,chronic constipation; functional constipation; irritable bowel syndrome with constipation; gut microbiota; probiotics; synbiotics; antibiotics; FMT,IRRITABLE-BOWEL-SYNDROME; CASEI-RHAMNOSUS LCR35; DOUBLE-BLIND; FUNCTIONAL CONSTIPATION; FERMENTED MILK; GASTROINTESTINAL SYMPTOMS; CHILDHOOD CONSTIPATION; COLONIC TRANSIT; FLORA; CHILDREN,"Background: Chronic constipation, including functional constipation and constipation-type irritable bowel syndrome, is a prevalent, multifactorial gastrointestinal disorder, and its etiology and pathophysiology remain poorly understood. Recently studies using 16S rRNA-based microbiota profiling have demonstrated dysbiosis of gut microbiota in chronic constipation. Aims: To provide an overview of recent studies formicrobiota in chronic constipation and treatments for chronic constipation using probiotics, prebiotics, synbiotics, antibiotics and fecal microbiota transplantation (FMT). Methods: PubMed searches were performed up to 1 August 2018 using keywords: IBS, IBS-C, irritable bowel syndrome, irritable bowel syndrome with constipation, functional constipation, chronic constipation in combination with gut microbiota, dysbiosis, gut microflora for microbiota in chronic constipation, and in combination with probiotics, prebiotics, synbiotics, antibiotics, and fecal microbiota transplantation. Results: The findings of gut microbiota in functional constipation are inconsistent, and currently no consensus exists. Although no clear consensus exists, compared with healthy subjects, IBS-C patients have a lower level of Actinobacteria, including Bifidobacteria, in their fecal samples and a higher level of Bacteroidetes in their mucosa. In most randomized controlled and parallel-group trials, probiotics, prebiotics, synbiotics, antibiotics, and FMT therapy for chronic constipation were effective with few side effects. However, there are many studies in a small number and the types of probiotics are different, it is difficult to evaluate the effect. Conclusions: Evidence indicates that dysbiosis of gut microbiota may contribute to functional constipation and constipation-type irritable bowel syndrome. Targeting treatments for the dysbiosis of constipation by probiotics, prebiotics, synbiotics, antibiotics, and FMT may be a new option, especially for refractory constipation to conventional therapies.","[Ohkusa, Toshifumi; Nishikawa, Yuriko; Sato, Nobuhiro] Juntendo Univ, Grad Sch Med, Dept Microbiota Res, Tokyo, Japan; [Ohkusa, Toshifumi; Koido, Shigeo] Jikei Univ, Kashiwa Hosp, Dept Gastroenterol & Hepatol, Kashiwa, Chiba, Japan",Juntendo University; Jikei University,"Ohkusa, T (corresponding author), Juntendo Univ, Grad Sch Med, Dept Microbiota Res, Tokyo, Japan.;Ohkusa, T (corresponding author), Jikei Univ, Kashiwa Hosp, Dept Gastroenterol & Hepatol, Kashiwa, Chiba, Japan.",ohkusa@juntendo.ac.jp,"大草, 敏史/HGD-2376-2022",,,,,,47,173,188,52,289,FRONTIERS MEDIA SA,LAUSANNE,"AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND",,2296-858X,,FRONT MED-LAUSANNE,Front. Med.,FEB 12,2019,6,,,,,,,,19,10.3389/fmed.2019.00019,http://dx.doi.org/10.3389/fmed.2019.00019,,,9,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,HL3IF,30809523,"Green Published, gold",Y,N,2024-06-04,WOS:000458606400002,View Full Record in Web of Science
J,"Koppen, IJN; Benninga, MA; Tabbers, MM",,,,"Koppen, Ilan J. N.; Benninga, Marc A.; Tabbers, Merit M.",,,"Is There A Role for Pre-, Pro- and Synbiotics in the Treatment of Functional Constipation in Children? A Systematic Review",JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION,,,English,Article; Proceedings Paper,"8th Meeting on Probiotics, Prebiotics and New Foods","SEP 13-15, 2015","Rome, ITALY",,,children; constipation; fiber; microbiota; prebiotics; probiotics; synbiotics,DIETARY FIBER MIXTURE; CHILDHOOD CONSTIPATION; DOUBLE-BLIND; LACTULOSE; MICROBIOME; PROBIOTICS,"Purpose of review: To investigate the efficacy and safety of pre-, pro- and synbiotics in the treatment of pediatric functional constipation (FC). Recent findings: A recent study reported that the gut microbiota in obese children with FC differs from that of obese children without FC. The gut microbiota may be involved in the pathophysiology of FC. Pre- and probiotics have been suggested as potential treatment modalities for FC in children. Summary: PubMed and Cochrane databases were searched from inception to February 2016. We found 6 RCTs on prebiotics, 6 RCTs on probiotics and 1 RCT concerning synbiotics. Overall, most studies were at high risk of bias. The majority of studies were unable to demonstrate a significant effect of pre-, pro- or synbiotics on predefined outcome measures such as defecation frequency, fecal incontinence and painful or difficult defecation. Pre-, pro and synbiotics were not associated with significant adverse effects. In conclusion, there is insufficient evidence to recommend pre-, pro- or synbiotics in the treatment of children with functional constipation. High-quality randomized controlled trials are warranted to further explore these treatment modalities.","[Koppen, Ilan J. N.; Benninga, Marc A.; Tabbers, Merit M.] Emma Childrens Hosp, Acad Med Ctr, Dept Pediat Gastroenterol & Nutr, NL-1100 DD Amsterdam, Netherlands",University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital,"Koppen, IJN (corresponding author), Emma Childrens Hosp, Acad Med Ctr, POB 22700, NL-1100 DD Amsterdam, Netherlands.",i.j.koppen@amc.nl,"Koppen, Ilan J.N./AAA-6800-2020","Koppen, Ilan J.N./0000-0002-1856-0968",,,,,32,26,31,4,30,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0277-2116,1536-4801,,J PEDIATR GASTR NUTR,J. Pediatr. Gastroenterol. Nutr.,JUL,2016,63,,,1,,,S27,S35,,,,,,9,Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,DP8OZ,27380596,,,,2024-06-04,WOS:000378758800010,View Full Record in Web of Science
J,"Chu, JR; Kang, SY; Kim, SE; Lee, SJ; Lee, YC; Sung, MK",,,,"Chu, Jae Ryang; Kang, Saem-Yi; Kim, Sung-Eun; Lee, Sol-Ji; Lee, Young-Chul; Sung, Mi-Kyung",,,Prebiotic UG1601 mitigates constipation-related events in association with gut microbiota: A randomized placebo-controlled intervention study,WORLD JOURNAL OF GASTROENTEROLOGY,,,English,Article,,,,,,Prebiotics; Constipation; Gut microbiota; Endotoxemia; Short-chain fatty acids,IRRITABLE-BOWEL-SYNDROME; CHAIN FATTY-ACIDS; ALOE-VERA; DOUBLE-BLIND; GALACTO-OLIGOSACCHARIDES; IDIOPATHIC CONSTIPATION; FUNCTIONAL CONSTIPATION; COLONIC FLORA; IN-VITRO; SYNBIOTICS,"BACKGROUND Constipation is a common functional gastrointestinal disorder and its etiology is multifactorial. Growing evidence suggests that intestinal dysbiosis is associated with the development of constipation. Prebiotics are subjected to bacterial fermentation in the gut to produce short-chain fatty acids (SCFAs), which can help relieve constipation symptoms. The prebiotic UG1601 consists of inulin, lactitol, and aloe vera gel, which are known laxatives, but randomized, controlled clinical trials that examine the effects of this supplement on gut microbiota composition are lacking. AIM To assess the efficacy of the prebiotic UG1601 in suppressing constipation-related adverse events in subjects with mild constipation. METHODS Adults with a stool frequency of less than thrice a week were randomized to receive either prebiotics or a placebo supplement for 4 wk. All participants provided their fecal and blood samples at baseline and at the end of intervention. Gastrointestinal symptoms and stool frequency were evaluated. The concentrations of serum endotoxemia markers and fecal SCFAs were determined. The relative abundance of SCFA-producing bacteria and the gut microbial community in the responders and non-responders in the prebiotics supplementation group were evaluated. RESULTS There were no significant differences in gastrointestinal symptoms between groups, although the prebiotic group showed greater symptom improvement. However, after prebiotic usage, serum cluster of differentiation (CD) 14 and lipopolysaccharide (LPS) concentrations were significantly decreased (CD14, P = 0.012; LPS, P < 0.001). The change in LPS concentration was significantly larger in the prebiotic group than in the placebo group (P < 0.001). Fecal SCFAs concentrations did not differ between groups, while the relative abundance of Roseburia hominis, a major butyrate producer, was significantly increased in the prebiotic group (P = 0.045). The abundances of the phylum Firmicutes and the family Lachnospiraceae (phylum Firmicutes, class Clostridia) (P = 0.009) were decreased in the responders within the prebiotic group. In addition, the proportions of the phylum Firmicutes, the class Clostridia, and the order Clostridiales were inversely correlated with several fecal SCFAs (P < 0.05). CONCLUSION Alterations in gut microbiota composition, including a decrease in the phylum Firmicutes and an increase in butyrate-producing bacteria, following prebiotic UG1601 supplementation might help alleviate symptom scores and endotoxemia.","[Chu, Jae Ryang; Kang, Saem-Yi; Kim, Sung-Eun; Lee, Sol-Ji; Sung, Mi-Kyung] Sookmyung Womens Univ, Dept Food & Nutr, 100 Cheongpa Ro 47 Gil, Seoul 04310, South Korea; [Lee, Young-Chul] Unigen Inc, Cheonan 31257, South Korea",Sookmyung Women's University,"Sung, MK (corresponding author), Sookmyung Womens Univ, Dept Food & Nutr, 100 Cheongpa Ro 47 Gil, Seoul 04310, South Korea.",mksung@sookmyung.ac.kr,,,"Unigen, Inc.; Mid-Career Research Program of the National Research Foundation of Korea [2015R1A2A2A01004607]; Basic Science Research Program of the National Research Foundation of Korea [NRF-2016R1A6A3A11934151]","Unigen, Inc.; Mid-Career Research Program of the National Research Foundation of Korea(National Research Foundation of Korea); Basic Science Research Program of the National Research Foundation of Korea(National Research Foundation of Korea)","Supported by the Unigen, Inc.; the Mid-Career Research Program of the National Research Foundation of Korea, No. 2015R1A2A2A01004607; the Basic Science Research Program of the National Research Foundation of Korea, No. NRF-2016R1A6A3A11934151.",,59,42,45,1,27,BAISHIDENG PUBLISHING GROUP INC,PLEASANTON,"7041 Koll Center Parkway, Suite 160, PLEASANTON, CA, UNITED STATES",1007-9327,2219-2840,,WORLD J GASTROENTERO,World J. Gastroenterol.,OCT 28,2019,25,40,,,,,6129,6144,,10.3748/wjg.v25.i40.6129,http://dx.doi.org/10.3748/wjg.v25.i40.6129,,,16,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,KI5TB,31686768,"Green Published, hybrid",,,2024-06-04,WOS:000511411600008,View Full Record in Web of Science
J,"Khodadad, A; Sabbaghian, M",,,,"Khodadad, Ahmad; Sabbaghian, Mozhgan",,,Role of Synbiotics in the Treatment of Childhood Constipation: A Double-Blind Randomized Placebo Controlled Trial,IRANIAN JOURNAL OF PEDIATRICS,,,English,Article,,,,,,Constipation; Synbiotic; Probiotics; Prebiotics; Paraffin oil,FUNCTIONAL CONSTIPATION; PROBIOTICS; CHILDREN; LACTULOSE; ARTICLE; MIXTURE,"Objective: Constipation is a common problem in children. There is some clinical evidence for the role of probiotics and prebiotics in the treatment of constipated children. This is the first study on the therapeutic effect of synbiotics (combination of probiotics and prebiotic) in treatment of childhood constipation. Methods: In a double-blind randomized placebo controlled study 102 children aged 4-12 years with functional constipation were assessed according to Rome III criteria for 4 weeks. They were divided into 3 groups: Group A, received 1.5 ml/kg/day oral liquid paraffin plus placebo, group B, 1 sachet synbiotic per day plus placebo and group C, 1.5 ml/kg/day oral liquid paraffin plus 1 sachet synbiotic per day. Frequency of bowel movements (BMs), stool consistency, number of fecal incontinence episodes, abdominal pain, painful defecation per week, success of treatment and side effects were determined in each group before and after treatment. Findings: The frequency of BMs per week increased in all groups (P<0.001), but it differed between groups and was higher in group C (P=0.03). Stool consistency increased and number of fecal incontinence episodes, abdominal pain and painful defecation per week decreased in all groups similarly and there was statistically no difference between them. No side effects were reported in group B; the main side effect in group A and C was seepage of oil (P<0.001). Treatment success was similar in all groups without any significant difference between them (P=0.6). Conclusion: This study showed that synbiotics have positive effects on symptoms of childhood constipation without any side effects.","[Khodadad, Ahmad] Univ Tehran Med Sci, Dept Pediat, Tehran, Iran; [Khodadad, Ahmad; Sabbaghian, Mozhgan] Pediat Ctr Excellence, Childrens Med Ctr, Tehran, Iran",Tehran University of Medical Sciences,"Sabbaghian, M (corresponding author), Univ Tehran Med Sci, Dept Gastroenterol, Childrens Med Ctr Hosp, Tehran, Iran.",mozhgan_sabbaghian@yahoo.com,,,,,,,21,32,33,1,7,KOWSAR CORP,TEHRAN,"PO BOX 14155-3651, TEHRAN, 14155, IRAN",2008-2142,2008-2150,,IRAN J PEDIATR,Iran. J. Pediatr.,DEC,2010,20,4,,,,,387,392,,,,,,6,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,705YF,23056736,,,,2024-06-04,WOS:000286175900001,View Full Record in Web of Science
J,"Vandenplas, Y; De Greef, E; Devreker, T; Veereman-Wauters, G; Hauser, B",,,,"Vandenplas, Y.; De Greef, E.; Devreker, T.; Veereman-Wauters, G.; Hauser, B.",,,Probiotics and Prebiotics in Infants and Children,CURRENT INFECTIOUS DISEASE REPORTS,,,English,Article,,,,,,Probiotics; Prebiotics; Synbiotics; Children; Gastrointestinal flora; Antibiotics; Diarrhea,RANDOMIZED CLINICAL-TRIAL; REUTERI DSM 17938; ANTIBIOTIC-ASSOCIATED DIARRHEA; RESPIRATORY-TRACT INFECTIONS; HELICOBACTER-PYLORI INFECTION; DOUBLE-BLIND; NECROTIZING ENTEROCOLITIS; LACTOBACILLUS-PARACASEI; SACCHAROMYCES-BOULARDII; CHILDHOOD CONSTIPATION,"Probiotics and prebiotics have a major influence on gastrointestinal flora composition. This review analyses the relationship between this change in flora composition and health benefits in children. Literature databases were searched for relevant articles. Despite exhaustive research on the subject in different indications, such as prevention and treatment of acute gastroenteritis, antibiotic associated diarrhea (AAD), traveler's diarrhea, inflammatory bowel disease, irritable bowel syndrome, Helicobacter pylori, necrotizing enterocolitis, constipation, allergy and atopic dermatitis, colic and extraintestinal infections, reports of clear benefits for the use of prebiotics and probiotics in pediatric disorders remain scarce. The best evidence has been provided for the use of probiotics in acute gastroenteritis and in prevention of AAD. However, AAD in children is in general mild, and only seldom necessitates additional interventions. Overall, the duration of acute infectious diarrhea is reduced by approximately 24 hours. Evidence for clinically relevant benefit in all other indications (inflammatory bowel disease, irritable bowel syndrome, constipation, allergy) is weak to nonexistent. Selected probiotic strains given during late pregnancy and early infancy decrease atopic dermatitis. Adverse effects have very seldom been reported. Since the risk seems minimal to nonexistent, prebiotics and probiotics may be helpful in the prevention and treatment of some disorders in children, although the evidence for benefit is limited. The best evidence has been accumulated for some lactobacilli strains and for Saccharomyces boulardii in the reduction of the duration of acute diarrhea due to gastroenteritis and prevention of AAD.","[Vandenplas, Y.; De Greef, E.; Devreker, T.; Veereman-Wauters, G.; Hauser, B.] Vrije Univ Brussel, UZ Brussel, B-1090 Brussels, Belgium",Vrije Universiteit Brussel,"Vandenplas, Y (corresponding author), Vrije Univ Brussel, UZ Brussel, Laarbeeklaan 101, B-1090 Brussels, Belgium.",yvan.vandenplas@uzbrussel.be,"De Greef, Elisabeth/AAA-8186-2020","Hauser, Bruno/0000-0002-8431-1556",,,,,115,22,27,0,37,SPRINGER,NEW YORK,"ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES",1523-3847,1534-3146,,CURR INFECT DIS REP,Curr. Infect. Dis. Rep.,JUN,2013,15,3,,,,,251,262,,10.1007/s11908-013-0334-4,http://dx.doi.org/10.1007/s11908-013-0334-4,,,12,Infectious Diseases,Science Citation Index Expanded (SCI-EXPANDED),Infectious Diseases,AK2YQ,23640127,,,,2024-06-04,WOS:000338286900009,View Full Record in Web of Science
J,"Kim, MC; Lee, S; Park, JK; Park, J; Lee, D; Park, J; Kim, BY; Cho, MS; Kim, TY; Park, H; Park, JH; Bok, MK; Lim, H",,,,"Kim, Min Cheol; Lee, Sunghee; Park, Jin Kyung; Park, Jongmi; Lee, Donghun; Park, Jaewan; Kim, Byung-Yong; Cho, Min Seok; Kim, Tae-Yoon; Park, Ha Young; Park, Ju Hyun; Bok, Min Kyung; Lim, Hyunjung",,,"Effects of ID-HWS1000 on the Perception of Bowel Activity and Microbiome in Subjects with Functional Constipation: A Randomized, Double-Blind Placebo-Controlled Study",JOURNAL OF MEDICINAL FOOD,,,English,Article,,,,,,bowel movements; functional constipation; gut microbiome; prebiotics; probiotics,CHRONIC IDIOPATHIC CONSTIPATION; GUT MICROBIOME; PROBIOTICS; PREBIOTICS; SYMPTOMS; SEARCH,"During constipation, indigestible foods, such as probiotics, prebiotics, and dietary fiber, may improve the bowel environment and activity. In this randomized, double-blind, and placebo-controlled study, the effects of ID-HWS1000, composed of Lactobacillus and Bifidobacterium species, xylooligosaccharide, and dietary fiber, were evaluated to determine whether it improves the perception of bowel activity or cause changes in the gut microbiome. Thirty Korean adults with functional constipation according to the Rome III criteria were randomly assigned to the following groups: 20 in the ID-HWS1000 group and 10 in the placebo group. ID-HWS1000 or the placebo was consumed by the participants for 4 weeks. To assess the changes in the perception of bowel activity, clinical data and gut microbiome analyses were conducted before and after the experiment. There were significant differences between the groups in the response to 9 of the 12 survey questions (the number and duration of bowel movements, amount of feces, number of irritant bowel movements, number of times bowel movements felt incomplete, shape of the feces, amount of gas in the gut, discomfort after defecation, and discomfort owing to constipation) (P < .05). There was a decrease in the proportion of Firmicutes (Ruminococcaceae and Lachnospiraceae) and an increase in Bacteroidetes (Bacteroidaceae) (P < .05). Moreover, ID-HWS1000 directly improved the discomfort associated with bowel movements, decreased the proportion of Lachnospiraceae, and increased the proportion of Bacteroidaceae. These results confirmed that ID-HWS1000 improves the perception of bowel activity and exerts positive changes in individuals with functional constipation.","[Kim, Min Cheol; Park, Jin Kyung; Park, Jongmi; Park, Ha Young] ILDONG Pharmaceut Co Ltd, Hwaseong, South Korea; [Lee, Sunghee; Lee, Donghun; Park, Jaewan; Kim, Tae-Yoon] ILDONG Pharmaceut Co Ltd, Res Lab, Hwaseong, South Korea; [Kim, Byung-Yong; Cho, Min Seok] ChunLab Inc, Microbiome Res Ctr, Seoul, South Korea; [Park, Ju Hyun; Bok, Min Kyung; Lim, Hyunjung] Kyung Hee Univ, Grad Sch East West Med Sci, Dept Med Nutr, Yongin 17104, South Korea; [Park, Ju Hyun; Bok, Min Kyung; Lim, Hyunjung] Kyung Hee Univ, Res Inst Med Nutr, Yongin, South Korea",Kyung Hee University; Kyung Hee University,"Lim, H (corresponding author), Kyung Hee Univ, Grad Sch East West Med Sci, Dept Med Nutr, Yongin 17104, South Korea.",hjlim@khu.ac.kr,", BYUNGYONG KIM/JLL-7806-2023; LEE, Sunghee/HCH-4510-2022; PARK, JIN-KYUNG/I-8716-2017","Park, Ju Hyun/0000-0002-4700-4960; Kim, Byung-Yong/0000-0002-4229-8859; Lee, Dong-Hoon/0000-0001-7976-1862; Tak, jihye/0000-0001-9914-0086",,,,,42,10,10,5,13,"MARY ANN LIEBERT, INC",NEW ROCHELLE,"140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA",1096-620X,1557-7600,,J MED FOOD,J. Med. Food,AUG 1,2021,24,8,,,,,883,893,,10.1089/jmf.2020.4746,http://dx.doi.org/10.1089/jmf.2020.4746,,,11,"Chemistry, Medicinal; Food Science & Technology; Nutrition & Dietetics",Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy; Food Science & Technology; Nutrition & Dietetics,UB5GK,34406877,,,,2024-06-04,WOS:000685874100012,View Full Record in Web of Science
J,"Marteau, P; Boutron-Ruault, MC",,,,"Marteau, P; Boutron-Ruault, MC",,,Nutritional advantages of probiotics and prebiotics,BRITISH JOURNAL OF NUTRITION,,,English,Article; Proceedings Paper,Conference on Recent Scientific Research on Inulin and Oligofructose,"FEB, 2001","LONDON, ENGLAND",ORAFTL,,probiotics; prebiotics; disease prevention by food,INFLAMMATORY-BOWEL-DISEASE; ESCHERICHIA-COLI; SACCHAROMYCES-BOULARDII; LACTOBACILLUS GG; MAINTENANCE TREATMENT; DOUBLE-BLIND; PREVENTION; LACTULOSE; DIARRHEA; THERAPY,"The potential 'nutritional advantages' of probiotics and prebiotics consist of preventive, and sometimes curative, effects against certain diseases. The evidence supporting such advantages, which requires randomised controlled trials and consistency of results from study to study, is rapidly increasing. This article summarizes the effects against diseases of intestinal origin. There is a high level of evidence for positive effects of some prebiotics to alleviate constipation and treat hepatic encephalopathy. Interesting aspects, but with a lower level of evidence at the present time, include prevention of colon cancer, intestinal infection, and recurrence of inflammatory bowel disease. There is a high level of evidence for positive effects of some probiotics in the alleviation of lactose intolerance, antibiotic-associated intestinal disorders and gastroenteritis. Evidence is rapidly growing regarding the prevention of recurrence of inflammatory bowel diseases. Positive trials have suggested preventive effects against intestinal colonization with specific gut pathogens including Clostridium difficile and Helicobacter pylori.","Assistance Publ Hop Paris, Hop Europeen Georges Pompidou, Dept Gastroenterol, Serv Hepatogastroenterol, F-75908 Paris 15, France; Assistance Publ Hop Paris, Hop Europeen Georges Pompidou, ISTNA, INSERM,U557,INRA U1125,EA CNAM 3200, F-75908 Paris 15, France; Univ Paris 05, F-75270 Paris 06, France",Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Saint-Louis - APHP; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Saint-Louis - APHP; INRAE; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Hopital Universitaire Europeen Georges-Pompidou - APHP; Universite Paris Cite,"Assistance Publ Hop Paris, Hop Europeen Georges Pompidou, Dept Gastroenterol, Serv Hepatogastroenterol, 20 Rue Leblanc, F-75908 Paris 15, France.",philippe.marteau@egp.ap-hop-paris.fr,"Boutron-Ruault, Marie-Christine/H-3936-2014",,,,,,45,75,92,1,18,CAMBRIDGE UNIV PRESS,CAMBRIDGE,"EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND",0007-1145,1475-2662,,BRIT J NUTR,Br. J. Nutr.,MAY,2002,87,,,2,,,S153,S157,,10.1079/BJN2002531,http://dx.doi.org/10.1079/BJN2002531,,,5,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Nutrition & Dietetics,567DG,12088512,Bronze,,,2024-06-04,WOS:000176469700003,View Full Record in Web of Science
J,"Guo, YA; Song, LQ; Huang, YM; Li, XP; Xiao, YC; Wang, ZH; Ren, ZH",,,,"Guo, Yanan; Song, Liqiong; Huang, Yuanming; Li, Xianping; Xiao, Yuchun; Wang, Zhihuan; Ren, Zhihong",,,"Latilactobacillus sakei Furu2019 and stachyose as probiotics, prebiotics, and synbiotics alleviate constipation in mice",FRONTIERS IN NUTRITION,,,English,Article,,,,,,slow transit constipation; Latilactobacillus sakei; stachyose; synbiotics; intestinal flora,CHAIN FATTY-ACIDS; QUALITY-OF-LIFE; GUT MICROBIOTA; METABOLISM; MANAGEMENT; DISORDERS; SEROTONIN; CHILDREN; MOTILITY; COLITIS,"IntroductionSlow transit constipation (STC) is a common disorder in the digestive system. This study aimed to evaluate the effects of stachyose (ST) and Latilactobacillus sakei Furu 2019 (L. sakei) alone or combined on diphenoxylate-induced constipation and explore the underlying mechanisms using a mouse model. MethodsICR mice were randomly divided into five groups. The normal and constipation model groups were intragastrically administrated with PBS. The ST, L. sakei, and synbiotic groups were intragastrically administrated with ST (1.5 g/kg body weight), alive L. sakei (3 x 10(9) CFU/mouse), or ST + L. sakei (1.5 g/kg plus 3 x 10(9) CFU/mouse), respectively. After 21 days of intervention, all mice except the normal mice were intragastrically administrated with diphenoxylate (10 mg/kg body weight). Defecation indexes, constipation-related intestinal factors, serum neurotransmitters, hormone levels, short-chain fatty acids (SCFAs), and intestinal microbiota were measured. ResultsOur results showed that three interventions with ST, L. sakei, and synbiotic combination (ST + L. sakei) all alleviated constipation, and synbiotic intervention was superior to ST or L. sakei alone in some defecation indicators. The RT-PCR and immunohistochemical experiment showed that all three interventions relieved constipation by affecting aquaporins (AQP4 and AQP8), interstitial cells of Cajal (SCF and c-Kit), glial cell-derived neurotrophic factor (GDNF), and Nitric Oxide Synthase (NOS). The three interventions exhibited a different ability to increase the serum excitatory neurotransmitters and hormones (5-hydroxytryptamine, substance P, motilin), and reduce the serum inhibitory neurotransmitters (vasoactive intestinal peptide, endothelin). The result of 16S rDNA sequencing of feces showed that synbiotic intervention significantly increased the relative abundance of beneficial bacteria such as Akkermansia, and regulated the gut microbes of STC mice. In conclusion, oral administration of ST or L. sakei alone or combined are all effective to relieve constipation and the symbiotic use may have a promising preventive effect on STC.","[Guo, Yanan; Song, Liqiong; Huang, Yuanming; Li, Xianping; Xiao, Yuchun; Wang, Zhihuan; Ren, Zhihong] Chinese Acad Med Sci, Natl Inst Communicable Dis Control & Prevent, Res Units Discovery Unknown Bacteria & Funct 2018, Chinese Ctr Dis Control & Prevent,State Key Lab In, Beijing, Peoples R China","Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention","Ren, ZH (corresponding author), Chinese Acad Med Sci, Natl Inst Communicable Dis Control & Prevent, Res Units Discovery Unknown Bacteria & Funct 2018, Chinese Ctr Dis Control & Prevent,State Key Lab In, Beijing, Peoples R China.",renzhihong@icdc.cn,"ren, jing/JXN-8411-2024",,National Natural Science Foundation of China [81371761]; Ministry of Science and Technology of China [2018ZX10305409-003-001],"National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)","Funding This work was supported by grants from the National Natural Science Foundation of China (No. 81371761 to ZR), and the Ministry of Science and Technology of China (Grant No. 2018ZX10305409-003-001 to ZR).",,59,5,5,13,28,FRONTIERS MEDIA SA,LAUSANNE,"AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND",2296-861X,,,FRONT NUTR,Front. Nutr.,JAN 5,2023,9,,,,,,,,1039403,10.3389/fnut.2022.1039403,http://dx.doi.org/10.3389/fnut.2022.1039403,,,16,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,7X3DV,36687730,"gold, Green Published",,,2024-06-04,WOS:000914082800001,View Full Record in Web of Science
J,"Sant'Anna, MDL; Rodrigues, VC; Araújo, TF; Oliveira, TT; Peluzio, MDG; Ferreira, CLDF",,,,"Lima Sant'Anna, Monica de Souza; Rodrigues, Vivian Carolina; Araujo, Tatiane Ferreira; de Oliveira, Tania Toledo; Gouveia Peluzio, Maria do Carmo; de Luces Fortes Ferreira, Celia Lucia",,,Yacon-Based Product in the Modulation of Intestinal Constipation,JOURNAL OF MEDICINAL FOOD,,,English,Article,,,,,,yacon; constipation; prebiotics; functional food,DOUBLE-BLIND; SMALLANTHUS-SONCHIFOLIUS; FECAL BIFIDOBACTERIA; INULIN; OLIGOFRUCTOSE; MICROBIOTA; SUPPLEMENTATION,"This study aimed to assess the effects of a yacon-based product (YBP) on constipation in adults, including the elderly. Forty-eight individuals were recruited and divided into equal intervention groups named the test and control groups. The YBP (test) and the control (maltodextrin) were dissolved in commercial orange juice. The volunteers for the YBP/test group consumed, on a daily basis, orange juice containing 10 g fructooligosaccharide (FOS)/inulin per day. The control group consumed, on a daily basis, orange juice containing 25 g of maltodextrin. The study had a span of 30 days. We evaluated the participants' frequency of evacuation, consistency of the feces, constipation score, abdominal symptoms (flatulence, pain, and abdominal strain), and effects upon the microbiota, pH, lactate, and short-chain fatty acids (SCFAs) of the feces. The study showed an increased number of evacuations after the consumption of the YBP as well as an improvement in the consistency of the feces and a reduction in the constipation score. After 30 days of intervention, the group that consumed the YBP showed higher counts of Bifidobacterium, lower Clostridium and enterobacteria counts, and lower fecal pH. In relation to SCFAs, no significant change was found after the intervention. However, the lactate concentration was higher in the test group when compared to the post-treatment control group. The YBP was effective in improving constipation symptoms; not only was its functional characteristic in reducing constipation symptoms evident but it also demonstrated usefulness as a potential therapy.","[Lima Sant'Anna, Monica de Souza] Fed Univ Sergipe UFS, Dept Nutr, BR-49100000 Sao Cristovao, Sergipe, Brazil; [Rodrigues, Vivian Carolina; Araujo, Tatiane Ferreira; de Luces Fortes Ferreira, Celia Lucia] Fed Univ Vicosa UFV, Dept Food Technol, Vicosa, MG, Brazil; [de Oliveira, Tania Toledo] Fed Univ Vicosa UFV, Dept Agr Biochem, Vicosa, MG, Brazil; [Gouveia Peluzio, Maria do Carmo] Fed Univ Vicosa UFV, Dept Nutr & Hlth, Vicosa, MG, Brazil",Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Vicosa,"Sant'Anna, MDL (corresponding author), Fed Univ Sergipe UFS, Dept Nutr, Ave Marechal Rondon S-N, BR-49100000 Sao Cristovao, Sergipe, Brazil.",monicaslsantana@gmail.com,,"PELUZIO, MARIA DO CARMO GOUVEIA/0000-0003-4665-7043",,,,,45,10,11,2,25,"MARY ANN LIEBERT, INC",NEW ROCHELLE,"140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA",1096-620X,1557-7600,,J MED FOOD,J. Med. Food,SEP 1,2015,18,9,,,,,980,986,,10.1089/jmf.2014.0115,http://dx.doi.org/10.1089/jmf.2014.0115,,,7,"Chemistry, Medicinal; Food Science & Technology; Nutrition & Dietetics",Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy; Food Science & Technology; Nutrition & Dietetics,CQ9XG,25692980,,,,2024-06-04,WOS:000360968100005,View Full Record in Web of Science
J,"Marteau, P",,,,"Marteau, P",,,Prebiotics and probiotics for gastrointestinal health,CLINICAL NUTRITION,,,English,Article; Proceedings Paper,11th Nutricia Symposium on Recent Developments in Clinical Nutrition,"MAY 04-06, 2000","SELSDON PARK, ENGLAND",,,probiotics; prebiotics; human health; gastroenteritis; antibiotic associated diarrhoea; inflammatory bowel disease,DOUBLE-BLIND; SACCHAROMYCES-BOULARDII; POLYETHYLENE-GLYCOL; ESCHERICHIA-COLI; LACTULOSE; DIARRHEA; PREVENTION; INGESTION; MULTICENTER; MESALAZINE,"Accumulating research evidence suggests that probiotics and prebiotics, which both influence the endogenous flora, may have a role in human therapies, especially in the prevention of digestive diseases. This article summarises the current knowledge on their fate in the gastrointestinal tract (survival, adherence, colonization, or metabolism), mechanisms of action, potential adverse effects and proven effects, It presents and comments on the results of randomized controlled trials using various probiotics to treat lactose intolerance, antibiotic associated diarrhoea, gastroenteritis, intestinal infections and colonization by pathogenic bacteria, and inflammatory bowel disease. Finally, the results of randomized controlled trials that used prebiotics to treat constipation and hepatic encephalopathy are also discussed, as well as potential applications, especially colon cancer prevention. (C) 2001 Harcourt Publishers Ltd.","Hop Europeen Georges Pompidou, Serv Gastroenterol, Gastroenterol Unit, AP HP, F-75015 Paris, France; Univ Paris 05, Paris, France",Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Europeen Georges-Pompidou - APHP; Universite Paris Cite,"Hop Europeen Georges Pompidou, Serv Gastroenterol, Gastroenterol Unit, AP HP, 25 Rue Leblanc, F-75015 Paris, France.",,,,,,,,43,21,24,1,12,CHURCHILL LIVINGSTONE,EDINBURGH,"JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND",0261-5614,1532-1983,,CLIN NUTR,Clin. Nutr.,JUN,2001,20,,,1,,,41,45,,10.1054/clnu.2001.0403,http://dx.doi.org/10.1054/clnu.2001.0403,,,5,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Nutrition & Dietetics,456LA,,,,,2024-06-04,WOS:000170082900005,View Full Record in Web of Science
J,"Patel, S; Goyal, A",,,,"Patel, Seema; Goyal, Arun",,,The current trends and future perspectives of prebiotics research: a review,3 BIOTECH,,,English,Review,,,,,,Prebiotics; Oligosaccharides; Anticancer; Colitis prevention; Cholesterol reduction,HUMAN COLONIC MICROBIOTA; IN-VITRO; GALACTO-OLIGOSACCHARIDES; ENZYMATIC-HYDROLYSIS; DIETARY MODULATION; ALPHA-GLUCOSIDASE; GUT MICROBIOTA; HEALTHY-MEN; RESPONSES; FRUCTOOLIGOSACCHARIDES,"Prebiotics are non-digestible food ingredients that stimulate the growth of bifidogenic and lactic acid bacteria in the gastro-intestinal tract. Typically, the prebiotics consist of dietary fibers and oligosaccharides. Prebiotics exert a plethora of health-promoting effects, owing to which multi million food and pharma industries have been established. Prebiotics are being implicated in starter culture formulation, gut health maintenance, colitis prevention, cancer inhibition, immunopotentiaton, cholesterol removal, reduction of cardiovascular disease, prevention of obesity and constipation, bacteriocin production, use in fishery, poultry, pig, cattle feed and pet food. Looking at the ever-increasing demand of prebiotics, in this review, recent trends in prebiotic production from new novel sources, from food industrial wastes, prebiotic supplementation in food, commercially available prebiotic agents, prebiotic production by various techniques and future perspectives has been discussed. The critical insight into this hot research area aims to stimulate further ponderance.","[Patel, Seema] Lovely Profess Univ, Dept Biotechnol, Jalandhar 144402, Punjab, India; [Goyal, Arun] Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati 781039, Assam, India",Lovely Professional University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati,"Patel, S (corresponding author), Lovely Profess Univ, Dept Biotechnol, Jalandhar 144402, Punjab, India.",seemabiotech83@gmail.com; arungoyl@iitg.ernet.in,,,,,,,97,137,158,6,52,SPRINGER HEIDELBERG,HEIDELBERG,"TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY",2190-572X,2190-5738,,3 BIOTECH,3 Biotech,JUN,2012,2,2,,,,,115,125,,10.1007/s13205-012-0044-x,http://dx.doi.org/10.1007/s13205-012-0044-x,,,11,Biotechnology & Applied Microbiology,Science Citation Index Expanded (SCI-EXPANDED),Biotechnology & Applied Microbiology,V39WV,,"Green Published, hybrid",,,2024-06-04,WOS:000209442000002,View Full Record in Web of Science
J,"Li, ZH; Dong, M; Wang, ZF",,,,"Li, Zheng-Hong; Dong, Mei; Wang, Zhi-Feng",,,Functional constipation in children: investigation and management of anorectal motility,WORLD JOURNAL OF PEDIATRICS,,,English,Article,,,,,,constipation; manometry; motility; rectum,CHILDHOOD CONSTIPATION,"Background. Constipation is a common disease in children. Despite many causes, constipation is most often functional. This study was undertaken to investigate the anorectal motility in children with functional constipation as compared with healthy children and to determine the efficacy of management based on the results of anorectal manometry. Methods: A multi-functional manometry was used to detect the anorectal manometry indexes of 8 patients with functional constipation (11.44 +/- 4.8 years) as well as those of 10 healthy children (10.5 +/- 3.5 years) from May 2004 to June 2005. The patients received a combined treatment regimen including probiotics (bifid triple viable bacterial tablet), prebiotics (lactulose) and regular defecation according to the results of anorectal manometry. The efficacy of these conservative measures was estimated during the course of treatment. Results: No statistical difference was found in the indexes of effective length of the anal sphincter, anal tract maximal systolic pressure and the duration of more than 50% maximal systolic pressure between the two groups. But minimal sensitivity and maximal tolerated volume between the two groups were different significantly. Seven of the eight patients got better with the conservative treatment. Conclusions: Abnormalities exist in the anorectal motility of the children with functional constipation. Conservative treatment regimen based on the results of anorectal manometry is significantly effective.","[Li, Zheng-Hong; Dong, Mei] Chinese Acad Med Sci, Peking Union Med Coll, PUMC Hosp, Dept Pediat, Beijing 100730, Peoples R China; [Wang, Zhi-Feng] Chinese Acad Med Sci, Peking Union Med Coll, PUMC Hosp, Dept Gastroenterol, Beijing, Peoples R China",Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Peking Union Medical College,"Dong, M (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, PUMC Hosp, Dept Pediat, Beijing 100730, Peoples R China.",worldlizhengh@yahoo.com.cn,"zhang, zan/JGL-7665-2023",,,,,,21,13,14,1,3,ZHEJIANG UNIV SCH MEDICINE,HANGZHOU,"CHILDRENS HOSPITAL, 57 ZHUGAN XIANG, HANGZHOU, 310003, PEOPLES R CHINA",1708-8569,1867-0687,,WORLD J PEDIATR,World Journal of Pediatrics,FEB,2008,4,1,,,,,45,48,,10.1007/s12519-008-0009-7,http://dx.doi.org/10.1007/s12519-008-0009-7,,,4,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,283QY,18402252,,,,2024-06-04,WOS:000254652800009,View Full Record in Web of Science
J,"Santucci, NR; Chogle, A; Leiby, A; Mascarenhas, M; Borlack, RE; Lee, A; Perez, M; Russell, A; Yeh, AM",,,,"Santucci, Neha R.; Chogle, Ashish; Leiby, Alycia; Mascarenhas, Maria; Borlack, Rachel E.; Lee, Amanda; Perez, Maria; Russell, Alexandra; Yeh, Ann Ming",,,Non-pharmacologic approach to pediatric constipation,COMPLEMENTARY THERAPIES IN MEDICINE,,,English,Article,,,,,,Functional constipation; Treatment; Integrative medicine; Fiber,TRANSABDOMINAL ELECTRICAL-STIMULATION; SLOW-TRANSIT CONSTIPATION; RANDOMIZED CLINICAL-TRIAL; FUNCTIONAL CONSTIPATION; DOUBLE-BLIND; BIOFEEDBACK THERAPY; DIETARY FIBER; CHILDHOOD CONSTIPATION; POLYETHYLENE-GLYCOL; CASSIA-FISTULA,"Functional constipation (FC) is a pervasive problem in pediatrics. Although pharmaceuticals are commonly used for FC, parents and patients show reluctance or find dissatisfaction with available medications at times. Further, patients often have interest in utilizing nutraceutical supplements and botanicals that are available over the counter. This literature review aims to summarize research studies performed on non-pharmacologic approaches to constipation and to evaluate the safety and efficacy of these modalities. Overall data on non-pharmacologic treatments for childhood constipation were sparse, and though some studies were available for adult populations, pediatrics studies were generally limited, lacking or flawed. Certain supplements, such as prebiotics, probiotics and fiber, are safe and are without significant side effects. Though fiber supplements such as glucomannan, green banana mass, cocao husk and various fiber blends have emerging evidence in children, evidence for psyllium, cellulose and flaxseed only have supportive studies in adults. Other than senna, studies of botanicals indicate significant safety concerns (in particular with Aloe vera with aloin and Cascara sagrada) and insufficient evidence. For patients with a significant behavioral or anxiety component to their FC and exhibit dyssynergia, mind-body interventions (e.g. diaphragmatic breathing, biofeedback, cognitive behavioral therapy, and behavioral modifications) are certainly safe and effective. Finally, movement and manipulative interventions such as abdominal massage, reflexology, acupuncture and transcutaneous nerve stimulation show promise in the field of pediatric constipation, and data is accumulating for efficacy. These modalities require further study to determine mechanisms of action and which populations may benefit the most from these therapies.","[Santucci, Neha R.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati Childrens Hosp Med Ctr,Div Gastroenter, Cincinnati, OH 45221 USA; [Chogle, Ashish] Childrens Hosp Orange Cty, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Orange, CA 92668 USA; [Mascarenhas, Maria] Childrens Hosp Philadelphia, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; [Leiby, Alycia; Perez, Maria] Thomas Jefferson Univ, Div Gastroenterol Hepatol & Nutr, Goryeb Childrens Hosp, Atlantic Hlth Syst,Dept Pediat,Sidney Kimmel Med, Philadelphia, PA 19107 USA; [Borlack, Rachel E.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Div Gastroenterol & Nutr, Buffalo, NY USA; [Lee, Amanda] Oregon Hlth & Sci Univ, Div Gastroenterol Hepatol & Nutr, Dept Pediat, Portland, OR 97201 USA; [Russell, Alexandra] Vanderbilt Univ, Sch Med, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37212 USA; [Yeh, Ann Ming] Stanford Univ, Sch Med, Div Gastroenterol Hepatol & Nutr, Dept Pediat, 730 Welch Rd,Suite 116, Palo Alto, CA 94304 USA",Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Childrens Hospital of Orange County; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Jefferson University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Oregon Health & Science University; Vanderbilt University; Stanford University,"Yeh, AM (corresponding author), Stanford Univ, Sch Med, Div Gastroenterol Hepatol & Nutr, Dept Pediat, 730 Welch Rd,Suite 116, Palo Alto, CA 94304 USA.",Annming@stanford.edu,,"Chogle, Ashish/0000-0001-9028-0584; Santucci, Neha/0000-0002-0896-079X; Yeh, Ann Ming/0000-0003-2293-6849; Leiby, Alycia/0000-0003-3402-1523",,,,,135,7,9,0,20,CHURCHILL LIVINGSTONE,EDINBURGH,"JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND",0965-2299,1873-6963,,COMPLEMENT THER MED,Complement. Ther. Med.,JUN,2021,59,,,,,,,,102711,10.1016/j.ctim.2021.102711,http://dx.doi.org/10.1016/j.ctim.2021.102711,,,10,Integrative & Complementary Medicine,Science Citation Index Expanded (SCI-EXPANDED),Integrative & Complementary Medicine,SR7YT,33737146,gold,,,2024-06-04,WOS:000661263100001,View Full Record in Web of Science
J,"Ferreira, VC; Barroso, TLCT; Castro, LEN; da Rosa, RG; Oliveira, LD",,,,"Ferreira, Vanessa Cosme; Barroso, Tiago Linhares Cruz Tabosa; Castro, Luiz Eduardo Nochi; da Rosa, Rafael Gabriel; Oliveira, Luciana de Siqueira",,,An overview of prebiotics and their applications in the food industry,EUROPEAN FOOD RESEARCH AND TECHNOLOGY,,,English,Review,,,,,,Functional foods; Prebiotics; Bioactive compounds; Bibliometric,FUNCTIONAL FOOD; BIOTECHNOLOGICAL PRODUCTION; PHYSICOCHEMICAL PROPERTIES; BETA-GALACTOSIDASE; IMMUNE PARAMETERS; RECENT INSIGHTS; GUT MICROBIOTA; FATTY-ACIDS; INULIN; OLIGOSACCHARIDES,"Prebiotics are bioactive compounds added to or naturally found in some foods that serve as substrates for specific host microorganisms of the gastrointestinal tract, conferring health benefits. The objective of this work was to demonstrate, through an updated bibliographic survey, the importance of prebiotics, considering their performance in food technology, as well as their benefits in the health of their consumers. The definition of functional foods and prebiotics was presented, which are classified into three main classes: polyols, oligosaccharides, and dietary fibers. Prebiotics are widely used in the production of beverages, bakery, dairy products, and meats, both for their health benefits and for their technological properties. They are also added along with probiotics in symbiotic foods, promoting increased viability, growth, and development of probiotic bacteria during processing and digestion. Benefits such as improved lipid metabolism, constipation relief, reduced risk of gastrointestinal diseases, increased absorption of vitamins and minerals, prevention of type II diabetes, help in controlling blood glucose, weight loss, and stimulation of the immune system have already been proven through in vivo and in vitro studies. These studies demonstrate that prebiotics present countless benefits to health, and these benefits vary according to the type of prebiotic consumed. For this reason, it is of the utmost importance to know the functional foods supplemented with prebiotics, as well as their functionality. Along with the studies of new prebiotics, new health benefits will emerge, making it increasingly necessary to have a functional diet through diets with the inclusion of prebiotics.","[Ferreira, Vanessa Cosme; Barroso, Tiago Linhares Cruz Tabosa; Castro, Luiz Eduardo Nochi; da Rosa, Rafael Gabriel] Univ Estadual Campinas, Sch Food Engn FEA, UNICAMP, BR-13083862 Campinas, Brazil; [Oliveira, Luciana de Siqueira] Fed Univ Ceara UFC, Dept Food Engn, BR-60455760 Fortaleza, CE, Brazil",Universidade Estadual de Campinas,"Ferreira, VC; Barroso, TLCT (corresponding author), Univ Estadual Campinas, Sch Food Engn FEA, UNICAMP, BR-13083862 Campinas, Brazil.",v183882@dac.unicamp.br; t234201@dac.unicamp.br,"Barroso, Tiago Linhares Cruz Tabosa/JXX-3834-2024; Castro, Luiz Eduardo Nochi/JAC-5049-2023; de Siqueira Oliveira, Luciana/E-1344-2019","Barroso, Tiago Linhares Cruz Tabosa/0000-0002-0133-2969; Castro, Luiz Eduardo Nochi/0000-0002-5968-8968; de Siqueira Oliveira, Luciana/0000-0003-3047-9211; da Rosa, Rafael Gabriel/0000-0001-9885-6197","Brazilian Science and Research Foundation (CNPq, Brazil) [308482/2022-0]","Brazilian Science and Research Foundation (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))","AcknowledgementsThis work was supported by the Brazilian Science and Research Foundation (CNPq, Brazil) (productivity grant 308482/2022-0).",,199,2,2,27,49,SPRINGER,NEW YORK,"ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES",1438-2377,1438-2385,,EUR FOOD RES TECHNOL,Eur. Food Res. Technol.,NOV,2023,249,11,,,,,2957,2976,,10.1007/s00217-023-04341-7,http://dx.doi.org/10.1007/s00217-023-04341-7,,AUG 2023,20,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,S1FY7,,,,,2024-06-04,WOS:001041348000001,View Full Record in Web of Science
J,"Zhang, S; Han, F; Wang, Q; Fan, F",,,,"Zhang, Si; Han, Fei; Wang, Qiong; Fan, Fei",,,Probiotics and Prebiotics in the Treatment of Autism Spectrum Disorder: A Narrative Review,JOURNAL OF INTEGRATIVE NEUROSCIENCE,,,English,Review,,,,,,autism spectrum disorder; probiotics; prebiotics; gut microbiome,GUT-BRAIN AXIS; INTERNATIONAL SCIENTIFIC ASSOCIATION; CONSENSUS STATEMENT; MICROBIOTA; CHILDREN; HEALTH; CELLS; SCOPE,"More than half of the patients with autism spectrum disorder (ASD) have gastrointestinal (GI) comorbidities, such as constipation, indigestion, abdominal pain, and diarrhea. Recent studies suggest prescribing probiotics and prebiotics in ASD could relieve GI disturbances and behavioral issues. This narrative review generalizes the research progress on probiotic and prebiotic therapies for ASD over the past 5 years and further discusses the underlying mechanisms of interaction between probiotics and prebiotics with ASD. Preliminary evidence has demonstrated the beneficial effects of probiotics and prebiotics on GI problems, autism-related behavioral disorders, and gut microbiome composition; the mechanism of probiotics and prebiotics in the treatment of ASD is mediated through inflammatory signaling pathways, metabolic pathways, neuronal signaling pathways, and the involvement of the vagus nerve. However, the results are inconclusive and mainly generated by animal experiments. Overall, the present review recommends further standardization of clinical studies to draw more robust evidence for prescribing probiotics and prebiotics in ASD.","[Zhang, Si; Han, Fei; Fan, Fei] China Acad Chinese Med Sci, Guanganmen Hosp, Dept Paediat, Beijing 100053, Peoples R China; [Wang, Qiong] Beijing Univ Chinese Med, Clin Med Sch, Beijing 100029, Peoples R China","China Academy of Chinese Medical Sciences; Guang'anmen Hospital, CACMS; Beijing University of Chinese Medicine","Fan, F (corresponding author), China Acad Chinese Med Sci, Guanganmen Hosp, Dept Paediat, Beijing 100053, Peoples R China.",fanfansofia@hotmail.com,,"Fan, Fei/0000-0002-3831-2646","China Academy of Chinese Medical Sciences, Beijing, China","China Academy of Chinese Medical Sciences, Beijing, China","Acknowledgment The authors gratefully would like to acknowledge the China Academy of Chinese Medical Sciences, Beijing, China.",,89,1,1,10,10,IMR PRESS,ROBINSON,"112 ROBINSON RD, ROBINSON, SINGAPORE",0219-6352,1757-448X,,J INTEGR NEUROSCI,J. Integr. Neurosci.,JAN 10,2024,23,1,,,,,,,20,10.31083/j.jin2301020,http://dx.doi.org/10.31083/j.jin2301020,,,11,Neurosciences,Science Citation Index Expanded (SCI-EXPANDED),Neurosciences & Neurology,GW6I3,38287844,gold,,,2024-06-04,WOS:001155745900006,View Full Record in Web of Science
J,"Fernández-Bañares, F",,,,"Fernandez-Banares, Fernando",,,Nutritional care of the patient with constipation,BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY,,,English,Article,,,,,,chronic constipation; irritable bowel syndrome; dietary fibre; bulking agents; probiotics; prebiotics,IRRITABLE-BOWEL-SYNDROME; DOUBLE-BLIND; DIETARY FIBER; WHEAT BRAN; LACTOBACILLUS-GG; LACTULOSE SYRUP; TRANSIT-TIME; PROBIOTICS; EFFICACY; BIFIDOBACTERIUM,"Chronic constipation is defined as a symptom-based disorder based on the presence for at least 3 months in the last year of unsatisfactory defecation characterized by infrequent stools, difficult stool passage, or both. On the other hand, the presence of clinically important abdominal discomfort or pain associated with constipation defines irritable bowel syndrome (IBS) with constipation. Intake of dietary fibre and bulking agents (psyllium) may be effective in alleviating chronic constipation in patients without slow colonic transit or disordered constipation. On the other hand, fibre may improve stool consistency in patients with IBS with constipation, but it is considered to be not effective in improving abdominal pain, distension or bloating. Probiotics may be effective in relieving constipation; however, the effect of lactic acid bacteria ingestion may be dependent on the bacterial strain used and the population being studied. Lactulose, which is a substrate for lactic acid bacteria (prebiotic), is effective to treat patients with chronic constipation.","Hosp Univ Mutua Terrassa, Dept Gastroenterol, Barcelona 08221, Spain",Hospital Universitario Mutua Terrassa,"Fernández-Bañares, F (corresponding author), Hosp Univ Mutua Terrassa, Dept Gastroenterol, Plaza Dr Robert 5, Barcelona 08221, Spain.",digestiu@mutuaterrassa.es,,"Fernandez-Banares, Fernando/0000-0002-1489-504X",,,,,53,34,46,0,21,ELSEVIER SCI LTD,OXFORD,"THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND",1521-6918,1532-1916,,BEST PRACT RES CL GA,Best Pract. Res. Clin. Gastroenterol.,,2006,20,3,,,,,575,587,,10.1016/j.bpg.2005.11.002,http://dx.doi.org/10.1016/j.bpg.2005.11.002,,,13,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,063LI,16782530,,,,2024-06-04,WOS:000239019300010,View Full Record in Web of Science
J,"Cavagnari, MAV; Ribas, BA; Medino, IC; Vieira, RDFA; Schiessel, DL; Melhem, ARD; Kuhl, M",,,,"Cavagnari, Mariana Abe Vicente; Ribas, Brenda Alana; Medino, Isabela Cristina; Fernandes Almeida Vieira, Rafaely de Fatima; Schiessel, Dalton Luiz; de Freitas Melhem, Rocha Angelica; Kuhl, Masiero Adriana",,,Action of prebiotics and symbiotic on constipation bowel in individuals with cerebral paralysis,NUTRICION CLINICA Y DIETETICA HOSPITALARIA,,,Portuguese,Article,,,,,,Gastrointestinal Microbiome; Lactobacillus; Nutritional Status; Nutrition; Oligosaccharides,CHILDREN; PALSY; PROBIOTICS; DISEASE,"Introduction: The addition of symbiotics in dietary formulas is evidenced as an option to improve immunity and reduce gastrointestinal disorders such as intestinal constipation in individuals with cerebral palsy. Objetive: To assess the bowel function of individuals with cerebral palsy who received nutritional intervention through supplementation symbiotic and prebiotics food consumption. Methods: The study was conducted with children and adolescents of Parents and Friends of Exceptional Guarapuava-PR. Short communication study was characterized by two groups: Group with synbiotic supplementation, which was in- structed to daily supplementation colony 4x10(9) Bifidobacterium infantis, Bifidobacterium longum, Lactobacillus casei, Lactobacillus plantarum, Lactobacillus rhamnosus and 2g Fructooligosaccharides, shaped sachet and Nutritional counseling group focusing on consumer prebiotic foods, which received nutritional guidelines with the aim of daily consumption of food with prebiotics. Data collection was performed by means of two questionnaires and anthropometric assessment at the beginning of nutritional interventions and 2 months after the intervention. Results: Through anthropometric assessment identified an increase in weight of the symbiotic group and nutritional counseling. There was significant improvement in stool consistency after 2 months of evaluation in the symbiotic group (p=0.002) and nutritional counseling group (p=0.005). Conclusion: The supplementation with both symbiotic as nutritional counseling assisted in increased frequency of bowel movements and improved stool consistency in these individuals.","[Cavagnari, Mariana Abe Vicente; Ribas, Brenda Alana; Medino, Isabela Cristina; Fernandes Almeida Vieira, Rafaely de Fatima; Schiessel, Dalton Luiz; de Freitas Melhem, Rocha Angelica; Kuhl, Masiero Adriana] Univ Estadual Ctr Oeste UNICTR Parana, Guarapuava, Brazil",,"Cavagnari, MAV (corresponding author), Univ Estadual Ctr Oeste UNICTR Parana, Guarapuava, Brazil.",marianaav@hotmail.com,"Schiessel, Dalton Luiz/FTD-1164-2022","Schiessel, Dalton/0000-0002-0998-8161",,,,,30,0,0,0,5,SOC ESPANOLA DIETETICA & CIENCIAS ALIMENTACION-SEDCA,MADRID,"APARTADO 60055, MADRID, 28080, SPAIN",0211-6057,1989-208X,,NUTR CLIN DIET HOSP,Nutr. Clin. Diet. Hosp.,,2019,39,1,,,,,46,55,,10.12873/391cavagnari,http://dx.doi.org/10.12873/391cavagnari,,,10,Nutrition & Dietetics,Emerging Sources Citation Index (ESCI),Nutrition & Dietetics,IA0XQ,,,,,2024-06-04,WOS:000469283500009,View Full Record in Web of Science
J,"Francavilla, R; Cristofori, F; Indrio, F",,,,"Francavilla, Ruggiero; Cristofori, Fernanda; Indrio, Flavia",,,Indications and Recommendations by Societies and Institutions fore the Use of Probiotics and Prebiotics in Paediatric Functional Intestinal Disorders,JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION,,,English,Article; Proceedings Paper,"8th Meeting on Probiotics, Prebiotics and New Foods","SEP 13-15, 2015","Rome, ITALY",,,Functional Intestinal Disorders; Guidelines; Prebiotics; Probiotics,,"Purpose of review: To report the indications and/or recommendations by Societies and Institutions for the use of probiotics and prebiotics in functional intestinal disorders in childhood. Recent findings: A position by Societies and Institutions is available only for infant colic, irritable bowel syndrome and constipation. Supplementation with the probiotic L reuteri DSM 17938 in breastfed term infants with colic appears to be effective in reducing crying, while still debated is its role in the prevention of colic. Irritable bowel syndrome is a common disorder in children and at present no specific treatments are available; existing data show that although high-quality studies are still needed, some evidence support the efficacy of LGG and VSL#3 in paediatric IBS. At present there is no evidence for the use of pre- or probiotics in childhood constipation. Summary: Probiotics in a near future may have a definite role is some FGIDs of infants and children. The main limitations for the recommendation by Societies and Institutions are the methodological issues that limit the quality of the evidence and the heterogeneity of treatments (probiotic strain and dose, mode, dose and duration of supplementation, primary outcomes, etc). Some specific strains are promising for infant colic (L. reuteri DSM 17938) and irritable bowel syndrome (LGG) while at present there is no indication for their use in the treatment of childhood constipation.","[Francavilla, Ruggiero; Cristofori, Fernanda; Indrio, Flavia] Univ Bari, Interdisciplinary Dept Med, I-70121 Bari, Italy",Universita degli Studi di Bari Aldo Moro,"Francavilla, R (corresponding author), Osped Giovanni 23, Clin Pediat B Trambusti, Via Amendola 207, Bari, Italy.",ruggiero.francavilla@uniba.it,"cristofori, fernanda/IQR-6099-2023; FRANCAVILLA, RUGGIERO/S-1391-2019","FRANCAVILLA, RUGGIERO/0000-0002-4603-974X",,,,,7,10,12,0,9,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0277-2116,1536-4801,,J PEDIATR GASTR NUTR,J. Pediatr. Gastroenterol. Nutr.,JUL,2016,63,,,1,,,S36,S37,,,,,,2,Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,DP8OZ,27380598,,,,2024-06-04,WOS:000378758800011,View Full Record in Web of Science
J,"Rau, S; Gregg, A; Yaceczko, S; Limketkai, B",,,,"Rau, Sameeha; Gregg, Andrew; Yaceczko, Shelby; Limketkai, Berkeley",,,Prebiotics and Probiotics for Gastrointestinal Disorders,NUTRIENTS,,,English,Review,,,,,,prebiotics; probiotics; gut microbiome; dietary supplements; short-chain fatty acids; constipation; diarrhea; irritable bowel syndrome; inflammatory bowel disease,INTESTINAL BACTERIAL OVERGROWTH; ANTIBIOTIC-ASSOCIATED DIARRHEA; GERMINATED BARLEY FOODSTUFF; LACTOBACILLUS-RHAMNOSUS GG; PYLORI ERADICATION THERAPY; RANDOMIZED CLINICAL-TRIAL; DOUBLE-BLIND; ULCERATIVE-COLITIS; FECAL MICROBIOTA; GUT MICROBIOTA,"The complex role of the gut microbiome in the pathogenesis of gastrointestinal (GI) disorders is an emerging area of research, and there is considerable interest in understanding how diet can alter the composition and function of the microbiome. Prebiotics and probiotics have been shown to beneficially modulate the gut microbiome, which underlies their potential for benefit in GI conditions. Formulating specific recommendations for the public regarding these dietary supplements has been difficult due to the significant heterogeneity between strains, doses, and duration of treatment investigated across studies, as well as safety concerns with administering live organisms. This review aims to summarize the existing evidence for the use of prebiotics and probiotics in various GI disorders, paying special attention to strain-specific effects that emerged and any adverse effects noted.","[Rau, Sameeha; Gregg, Andrew; Yaceczko, Shelby; Limketkai, Berkeley] Univ Calif Los Angeles, David Geffen Sch Med, Vatche & Tamar Manoukian Div Digest Dis, Los Angeles, CA 90095 USA",University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA,"Limketkai, B (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Vatche & Tamar Manoukian Div Digest Dis, Los Angeles, CA 90095 USA.",rau.sameeha@gmail.com; agregg@mednet.ucla.edu; shelby.yaceczko@gmail.com; berkeley.limketkai@gmail.com,,,,,,,181,0,0,5,5,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,MAR,2024,16,6,,,,,,,778,10.3390/nu16060778,http://dx.doi.org/10.3390/nu16060778,,,22,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,MH0G5,38542689,"Green Published, gold",,,2024-06-04,WOS:001192610300001,View Full Record in Web of Science
J,"Li, YL; Yu, Y; Wu, XL; Liu, B; Ma, HM; Zhao, XJ; Cao, S; Ding, SY; Li, TT; Wang, XL; Wang, P; Xu, XZ; Zhao, JY; Liu, YP; Lan, CH; Wang, J; Chen, LJ; Zeng, Q",,,,"Li, Yongli; Yu, Ying; Wu, Xiaoling; Liu, Bin; Ma, Huimin; Zhao, Xiaojuan; Cao, Shan; Ding, Suying; Li, Tiantian; Wang, Xiaolu; Wang, Pin; Xu, Xizhan; Zhao, Junying; Liu, Yanpin; Lan, Canhui; Wang, Jun; Chen, Lijun; Zeng, Qiang",,,Applied nutritional investigation Specially designed yogurt supplemented with combination of pro- and prebiotics relieved constipation in mice and humans,NUTRITION,,,English,Article,,,,,,Functional constipation; Gut microbiota; Clinical treatment; Yogurt; Metagenomics; Patient assessment scores,QUALITY-OF-LIFE; INULIN-TYPE FRUCTANS; COLONIC TRANSIT; LACTOBACILLUS; PROBIOTICS; MICROBIOTA; SYMPTOMS; PERMEABILITY; VALIDATION; ACTIVATION,"Objective: Functional constipation is a gastrointestinal disorder that affects millions of people and is correlated with gut microbiome dysbiosis. The currently available treatments are ineffective; therefore, novel treatment schemes targeting the gut microbiome are desired. The aim of this study was to assess the effects of yogurt supplemented with seven probiotic strains and six types of dietary fibers on functional constipation.Methods: In the mouse study, mice with induced constipation were administered the yogurt once a day for 1 wk, with fecal parameters and intestinal transit rate measured. In the clinical study, participants with constipation (N = 86) were given the yogurt once daily (200 g) for 4 wk. Fecal and blood samples along with Patient Assessment of Constipation-symptoms and Patient Assessment of Constipation-Quality of Life Scale questionnaires were collected to evaluate the safety and efficacy of the yogurt. Shotgun metagenomic sequencing was performed to analyze fecal samples of both mice and humans.Results: We found that constipated mice had different gut microbiomes compared with those in healthy controls; yogurt treatment significantly relieved constipation-related symptoms and resulted in shifts in the microbiome. Yogurt also relieved symptoms of antibiotic-induced constipation in mice and restored the gut microbiome to a certain extent. In the clinical trial with 86 patients, yogurt administration significantly improved constipation symptoms and showed no serious adverse effects (was generally considered safe). However, subsequent metagenomic profiling of the gut microbiome did not reveal significant changes in the microbial composition, in contrast to the results in mice. We hypothesize that the differences in dosage between mice and humans may attribute to such discrepancies, and microbiome changes may not be necessary for improvements of constipation symptoms in humans.","[Li, Yongli; Ma, Huimin; Zhao, Xiaojuan; Cao, Shan] Henan Prov Peoples Hosp, Dept Hlth Management Ctr, Zhengzhou, Peoples R China; [Li, Yongli; Wu, Xiaoling; Ma, Huimin; Zhao, Xiaojuan; Cao, Shan] Zhengzhou Univ, Peoples Hosp, Zhengzhou, Peoples R China; [Yu, Ying; Xu, Xizhan; Wang, Jun] Chinese Acad Sci, Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing, Peoples R China; [Wu, Xiaoling] Henan Prov Peoples Hosp, Dept Nucl Med, Zhengzhou, Peoples R China; [Liu, Bin; Zhao, Junying; Liu, Yanpin; Chen, Lijun] Beijing Sanyuan Foods Co Ltd, Natl Engn Ctr Dairy Maternal & Child Hlth, Beijing, Peoples R China; [Ding, Suying; Li, Tiantian] Zhengzhou Univ, Hlth Management Ctr, Affiliated Hosp 1, Zhengzhou, Peoples R China; [Wang, Xiaolu; Wang, Pin] Hosp Zhengzhou YiHe, Hlth Management Ctr, Zhengzhou, Peoples R China; [Lan, Canhui] Beijing Rexinchang Biotechnol Res Inst Co Ltd, Beijing, Peoples R China; [Zeng, Qiang] Chinese Peoples Liberat Army Gen Hosp, Hlth Management Inst, Med Ctr 2, Beijing, Peoples R China; [Zeng, Qiang] Chinese Peoples Liberat Army Gen Hosp, Natl Clin Res Ctr Geriatr Dis, Beijing, Peoples R China","Zhengzhou University; Zhengzhou University; Chinese Academy of Sciences; Institute of Microbiology, CAS; Zhengzhou University; Zhengzhou University; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital","Chen, LJ (corresponding author), Beijing Sanyuan Foods Co Ltd, Natl Engn Ctr Dairy Maternal & Child Hlth, Beijing, Peoples R China.;Zeng, Q (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Hlth Management Inst, Med Ctr 2, Beijing, Peoples R China.;Zeng, Q (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Natl Clin Res Ctr Geriatr Dis, Beijing, Peoples R China.",chenlijun@sanyuan.com.cn; zq301@126.com,"Lan, Canhui/JTU-3162-2023; Xu, Xizhan/C-4259-2018; qin, cheng/KHC-3344-2024; Cao, Shan/JOZ-2892-2023; 马, 会民/AAM-8054-2021; CAO, ying/KFA-2972-2024","Lan, Canhui/0000-0001-6052-1041; 马, 会民/0000-0001-6155-9076; Yu, Ying/0000-0002-7009-5901",National Natural Science Foundation of China [81872920]; Beijing Science and Technology Plan [Z201100008020005],National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Science and Technology Plan,"This work was supported by the National Natural Science Foundation of China (grant no. 32072191) ; Beijing Science and Technology Plan (grant no. Z201100008020005) ; and National Natural Science Foundation of China (grant no. 81872920) . YL, YY, XW, and BL contributed to the work equally and should be regarded as co-first authors.",,42,1,1,9,35,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",0899-9007,1873-1244,,NUTRITION,Nutrition,NOV-DEC,2022,103-104,,,,,,,,111802,10.1016/j.nut.2022.111802,http://dx.doi.org/10.1016/j.nut.2022.111802,,SEP 2022,8,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,4W9IQ,36063723,hybrid,,,2024-06-04,WOS:000860468800006,View Full Record in Web of Science
J,"Tabbers, MM; Boluyt, N; Berger, MY; Benninga, MA",,,,"Tabbers, Merit M.; Boluyt, Nicole; Berger, Marjolein Y.; Benninga, Marc A.",,,Nonpharmacologic Treatments for Childhood Constipation: Systematic Review,PEDIATRICS,,,English,Review,,,,,,childhood constipation; systematic review; nonpharmacologic treatments; complementary treatment; alternative treatment,DOUBLE-BLIND; ALTERNATIVE MEDICINE; DIETARY FIBER; CHILDREN; MANAGEMENT; COMPLEMENTARY; DISORDERS; LACTULOSE; PROGNOSIS; TRIAL,"OBJECTIVE: To summarize the evidence and assess the reported quality of studies concerning nonpharmacologic treatments for childhood constipation, including fiber, fluid, physical movement, prebiotics, probiotics, behavioral therapy, multidisciplinary treatment, and forms of alternative medicine. METHODS: We systematically searched 3 major electronic databases and reference lists of existing reviews. We included systematic reviews and randomized controlled trials (RCTs) that reported on nonpharmacologic treatments. Two reviewers rated the methodologic quality independently. RESULTS: We included 9 studies with 640 children. Considerable heterogeneity across studies precluded meta-analysis. We found no RCTs for physical movement, multidisciplinary treatment, or alternative medicine. Some evidence shows that fiber may be more effective than placebo in improving both the frequency and consistency of stools and in reducing abdominal pain. Compared with normal fluid intake, we found no evidence that water intake increases or that hyperosmolar fluid treatment is more effective in increasing stool frequency or decreasing difficulty in passing stools. We found no evidence to recommend the use of prebiotics or probiotics. Behavioral therapy with laxatives is not more effective than laxatives alone. CONCLUSIONS: There is some evidence that fiber supplements are more effective than placebo. No evidence for any effect was found for fluid supplements, prebiotics, probiotics, or behavioral intervention. There is a lack of well-designed RCTs of high quality concerning nonpharmacologic treatments for children with functional constipation. Pediatrics 2011;128:753-761","[Tabbers, Merit M.; Benninga, Marc A.] Emma Childrens Hospital, Acad Med Ctr, Dept Pediat Gastroenterol & Nutr, NL-1100 DD Amsterdam, Netherlands; [Boluyt, Nicole] Emma Childrens Hospital, Acad Med Ctr, Dept Pediat, NL-1100 DD Amsterdam, Netherlands; [Berger, Marjolein Y.] Univ Groningen Hosp, Dept Gen Practice, Groningen, Netherlands",University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; University of Groningen,"Tabbers, MM (corresponding author), Emma Childrens Hospital, Acad Med Ctr, Dept Pediat Gastroenterol & Nutr, H7-250,POB 22700, NL-1100 DD Amsterdam, Netherlands.",m.m.tabbers@amc.nl,,"Tabbers, Merit/0000-0001-9744-7308",,,,,25,59,72,0,21,AMER ACAD PEDIATRICS,ELK GROVE VILLAGE,"141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA",0031-4005,1098-4275,,PEDIATRICS,Pediatrics,OCT,2011,128,4,,,,,753,761,,10.1542/peds.2011-0179,http://dx.doi.org/10.1542/peds.2011-0179,,,9,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,827DH,21949142,"Green Published, Bronze",,,2024-06-04,WOS:000295406800052,View Full Record in Web of Science
J,"Abbasalizadeh, S; Ebrahimi, B; Azizi, A; Dargahi, R; Tayebali, M; Ghadim, ST; Foroumandi, E; Aliasghari, F; Javadi, M; Izadi, A; Banifatemeh, L; Pourjafar, H; Khalili, L; Ghalichi, F; Houshmandi, S; Rad, AH",,,,"Abbasalizadeh, Shamsi; Ebrahimi, Behzad; Azizi, Aslan; Dargahi, Rogaye; Tayebali, Maryam; Ghadim, Sepideh T.; Foroumandi, Elaheh; Aliasghari, Fereshteh; Javadi, Mina; Izadi, Azimeh; Banifatemeh, Leila; Pourjafar, Hadi; Khalili, Leila; Ghalichi, Faezeh; Houshmandi, Sousan; Rad, Aziz H.",,,Review of Constipation Treatment Methods with Emphasis on Laxative Foods,CURRENT NUTRITION & FOOD SCIENCE,,,English,Review,,,,,,Constipation; defecation; dietary fiber; food ingredients; laxative; treatment,IRRITABLE-BOWEL-SYNDROME; PLACEBO-CONTROLLED TRIAL; DIETARY FIBER INTAKE; DOUBLE-BLIND TRIAL; TRANSIT-TIME; WHEAT BRAN; GASTROINTESTINAL TRANSIT; FUNCTIONAL CONSTIPATION; STOOL FREQUENCY; COLONIC TRANSIT,"Constipation is a common public health concern experienced by all individuals during their life affecting the quality of life. In this paper, we aimed to provide an overview of the existing evidence regarding the role of food ingredients, including bran, prune, fig, kiwifruit, and flax-seed in constipation treatment. We searched Scopus, Pub Med, and Science Direct by using the keywords, laxative foods and constipation, for searching studies assessing laxative food ingredients and their beneficial effects on constipation treatment and/or control. Lifestyle modifications such as increasing dietary fiber and fluid intake and daily exercise are the proposed first line treatments for constipation. Optimizing 'diet' as an efficient lifestyle factor may contribute to the well-being of patients. The use of laxative food ingredients including bran, prune, fig, kiwifruit, flax-seed, probiotics, and prebiotics is a convenient alternative to cope with constipation. According to previous findings, laxative food ingredients could be considered as effective treatments for subjects suffering from constipation. Many studies have assessed the pharmacological and non-pharmacological roles of these ingredients in treating constipation, however, their importance has not been thoroughly investigated.","[Abbasalizadeh, Shamsi; Ghadim, Sepideh T.] Tabriz Univ Med Sci, Womens Reprod Hlth Res Ctr, Tabriz, Iran; [Ebrahimi, Behzad] Maragheh Univ Med Sci, Dept Food Sci & Technol, Maragheh, Iran; [Azizi, Aslan] Minist Jihad Agr, Agr Engn Res Inst, Karaj, Iran; [Dargahi, Rogaye] Ardabil Univ Med Sci, Obstet & Gynecol, Ardebil, Iran; [Tayebali, Maryam] Dept Taras Shevchenko Natl Univ Kyiv, Kiev, Ukraine; [Foroumandi, Elaheh] Tabriz Univ Med Sci, Nutr Res Ctr, Sch Nutr, Tabriz, Iran; [Aliasghari, Fereshteh; Javadi, Mina; Izadi, Azimeh; Khalili, Leila; Ghalichi, Faezeh] Tabriz Univ Med Sci, Fac Nutr & Food Sci, Dept Nutr, Tabriz, Iran; [Banifatemeh, Leila; Rad, Aziz H.] Tabriz Univ Med Sci, Fac Nutr & Food Sci, Dept Food Sci & Technol, Tabriz, Iran; [Pourjafar, Hadi] Maragheh Univ Med Sci, Dept Publ Hlth, Maragheh, Iran; [Houshmandi, Sousan] Ardabil Univ Med Sci, Fac Midwifery, Ardebil, Iran",Tabriz University of Medical Science; Ardabil University of Medical Sciences; Ministry of Education & Science of Ukraine; Taras Shevchenko National University of Kyiv; Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science; Ardabil University of Medical Sciences,"Azizi, A (corresponding author), Minist Jihad Agr, Agr Engn Res Inst, Karaj, Iran.;Rad, AH (corresponding author), Tabriz Univ Med Sci, Fac Nutr & Food Sci, Dept Food Sci & Technol, Tabriz, Iran.",aslan_azizi@yahoo.com; homayounia@tbzmed.ac.ir,"Foroumandi, Elaheh/AAC-6700-2021; Homayouni, Aziz/L-1508-2017; Bbrahimi, Behzad/ABF-7380-2021; abbasalizadeh, shamsi/M-2858-2017; ebrahimi, Behzad/AAG-2196-2021","Foroumandi, Elaheh/0000-0003-1600-747X; Homayouni, Aziz/0000-0001-6766-0108; Ebrahimi, Behzad/0000-0002-5278-0841; Aliasghari, Fereshteh/0000-0002-9191-1592",Aras Functional Company (SHAFA),Aras Functional Company (SHAFA),The authors sincerely acknowledge the Aras Functional Company (SHAFA) for supporting the present study.,,168,0,0,4,26,BENTHAM SCIENCE PUBL LTD,SHARJAH,"EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES",1573-4013,2212-3881,,CURR NUTR FOOD SCI,Curr. Nutr. Food Sci.,,2020,16,5,,,,,675,688,,10.2174/1573401315666191002164336,http://dx.doi.org/10.2174/1573401315666191002164336,,,14,Nutrition & Dietetics,Emerging Sources Citation Index (ESCI),Nutrition & Dietetics,MN9VM,,,,,2024-06-04,WOS:000551187200005,View Full Record in Web of Science
J,"Nath, A; Haktanirlar, G; Varga, A; Molnár, MA; Albert, K; Galambos, I; Koris, A; Vatai, G",,,,"Nath, Arijit; Haktanirlar, Gokce; Varga, Aron; Molnar, Mate Andras; Albert, Krisztina; Galambos, Ildiko; Koris, Andras; Vatai, Gyula",,,Biological Activities of Lactose-Derived Prebiotics and Symbiotic with Probiotics on Gastrointestinal System,MEDICINA-LITHUANIA,,,English,Review,,,,,,lactose-derived prebiotics; probiotics; biological activities; gastrointestinal health,CHAIN FATTY-ACIDS; INFLAMMATORY-BOWEL-DISEASE; CHRONIC HEPATIC-ENCEPHALOPATHY; ENTEROPATHOGENIC ESCHERICHIA-COLI; INTESTINAL EPITHELIAL-CELLS; RANDOMIZED CONTROLLED-TRIAL; IN-VITRO BINDING; DOUBLE-BLIND; CIRRHOTIC-PATIENTS; OXIDATIVE STRESS,"Lactose-derived prebiotics provide wide ranges of gastrointestinal comforts. In this review article, the probable biochemical mechanisms through which lactose-derived prebiotics offer positive gastrointestinal health are reported along with the up-to-date results of clinical investigations; this might be the first review article of its kind, to the best of our knowledge. Lactose-derived prebiotics have unique biological and functional values, and they are confirmed as 'safe' by the Food and Drug Administration federal agency. Medical practitioners frequently recommend them as therapeutics as a pure form or combined with dairy-based products (yoghurt, milk and infant formulas) or fruit juices. The biological activities of lactose-derived prebiotics are expressed in the presence of gut microflora, mainly probiotics (Lactobacillus spp. in the small intestine and Bifidobacterium spp. in the large intestine). Clinical investigations reveal that galacto-oligosaccharide reduces the risks of several types of diarrhea (traveler's diarrhea, osmotic diarrhea and Clostridium difficile associated relapsing diarrhea). Lactulose and lactosucrose prevent inflammatory bowel diseases (Crohn's disease and ulcerative colitis). Lactulose and lactitol reduce the risk of hepatic encephalopathy. Furthermore, lactulose, galacto-oligosaccharide and lactitol prevent constipation in individuals of all ages. It is expected that the present review article will receive great attention from medical practitioners and food technologists.","[Nath, Arijit; Haktanirlar, Gokce; Varga, Aron; Molnar, Mate Andras; Albert, Krisztina; Koris, Andras; Vatai, Gyula] Szent Istvan Univ, Fac Food Sci, Dept Food Engn, Menesi St 44, H-1118 Budapest, Hungary; [Nath, Arijit; Galambos, Ildiko] Univ Pannonia, Fac Engn, Soos Erno Water Technol Res Ctr, Zrinyi M U 18, H-8800 Nagykanizsa, Hungary",Hungarian University of Agriculture & Life Sciences,"Nath, A; Vatai, G (corresponding author), Szent Istvan Univ, Fac Food Sci, Dept Food Engn, Menesi St 44, H-1118 Budapest, Hungary.;Nath, A (corresponding author), Univ Pannonia, Fac Engn, Soos Erno Water Technol Res Ctr, Zrinyi M U 18, H-8800 Nagykanizsa, Hungary.",arijit0410@gmail.com; gokcehaktanirlar@gmail.com; mr.aron.varga@gmail.com; molnar.a.mate@gmail.com; krisztina.albert1986@gmail.com; galambos.i@sooswrc.hu; Koris.Andras@etk.szie.hu; Vatai.Gyula@etk.szie.hu,"Koris, Andras/CAH-3465-2022","Nath, Arijit/0000-0003-2146-4309; Galambos, Ildiko/0000-0003-0080-9953; VATAI, Gyula/0000-0002-8672-7256; Koris, Andras/0000-0002-2284-8139","Hungarian State Board Post-doctoral Research Fellowship; project 'Szechenyi 2020' [EFOP-3.6.1-16-2016-00015]; Ministry of Human Capacities, Hungary [UNKP-17-III, UNKP-16-III]","Hungarian State Board Post-doctoral Research Fellowship; project 'Szechenyi 2020'; Ministry of Human Capacities, Hungary","The first author acknowledges the Hungarian State Board Post-doctoral Research Fellowship and the project 'Szechenyi 2020' (grant agreement no. EFOP-3.6.1-16-2016-00015). Aron Varga acknowledges the research fund 'New National Excellence Program' (UNKP-17-III), provided by the Ministry of Human Capacities, Hungary. Krisztina Albert acknowledges the research fund 'New National Excellence Program' (UNKP-16-III), provided by the Ministry of Human Capacities, Hungary. The authors also acknowledge Szent Istvan University, Doctoral School of Food Science, Hungary.",,211,17,18,1,30,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",1010-660X,1648-9144,,MEDICINA-LITHUANIA,Med. Lith.,MAY,2018,54,2,,,,,,,18,10.3390/medicina54020018,http://dx.doi.org/10.3390/medicina54020018,,,28,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,GN4OV,30344249,"gold, Green Published, Green Submitted",,,2024-06-04,WOS:000439008700008,View Full Record in Web of Science
J,"Bellini, M; Tonarelli, S; Barracca, F; Rettura, F; Pancetti, A; Ceccarelli, L; Ricchiuti, A; Costa, F; de Bortoli, N; Marchi, S; Rossi, A",,,,"Bellini, Massimo; Tonarelli, Sara; Barracca, Federico; Rettura, Francesco; Pancetti, Andrea; Ceccarelli, Linda; Ricchiuti, Angelo; Costa, Francesco; de Bortoli, Nicola; Marchi, Santino; Rossi, Alessandra",,,Chronic Constipation: Is a Nutritional Approach Reasonable?,NUTRIENTS,,,English,Review,,,,,,chronic constipation; food; fiber; water; diet; nutrition,IRRITABLE-BOWEL-SYNDROME; PLACEBO-CONTROLLED TRIAL; FICUS-CARICA PASTE; DIETARY FIBER; MINERAL-WATER; DOUBLE-BLIND; FUNCTIONAL CONSTIPATION; FERMENTED MILK; FATTY-ACIDS; MANAGEMENT,"Chronic constipation (CC) is one of the most common gastroenterological diagnoses in clinical practice. Treatment includes several steps, depending on the severity of symptoms. Lifestyle modifications and increased intake of fiber and water are suggested by most health professionals. Unfortunately, the recommendations in this regard are the most varied, often conflicting with each other and not always based on solid scientific arguments. This paper aims to clarify this topic by providing practical indications for the management of these patients in every day clinical practice. The literature available on this topic is scarce, and dietary studies have important methodological biases. However, fiber, mainly by binding water and acting as bulking agents and/or as prebiotics for the intestinal microbiota, and mineral water, especially if rich in magnesium and/or bicarbonate, are useful tools. An adequate, well-designed diet should be a cornerstone of any effective treatment for chronic constipation. High-quality studies on larger samples are mandatory to give scientific validity to the role of the food in CC therapy and to enable professionals to choose the best approach for their patients, combining nutritional and pharmacological agents.","[Bellini, Massimo; Tonarelli, Sara; Barracca, Federico; Rettura, Francesco; Pancetti, Andrea; Ceccarelli, Linda; Ricchiuti, Angelo; Costa, Francesco; de Bortoli, Nicola; Marchi, Santino] Univ Pisa, Dept Translat Sci & New Technol Med & Surg, Gastrointestinal Unit, I-56124 Pisa, Italy; [Rossi, Alessandra] Univ Pisa, Clin & Expt Med Rheumatol Unit, I-56100 Pisa, Italy",University of Pisa; University of Pisa,"Tonarelli, S (corresponding author), Univ Pisa, Dept Translat Sci & New Technol Med & Surg, Gastrointestinal Unit, I-56124 Pisa, Italy.",massimo.bellini@med.unipi.it; satonarelli@gmail.com; barracca.federico@gmail.com; rettura.fra@gmail.com; pancio10@alice.it; l.ceccarelli@ao-pisa.toscana.it; a.ricchiuti@int.med.unipi.it; fcosta@med.unipi.it; nicola.debortoli@unipi.it; santino.marchi@unipi.it; alessandra.rossi@unipi.it,,"Tonarelli, Sara/0000-0002-2010-4304; DE BORTOLI, NICOLA/0000-0003-1995-1060; bellini, massimo/0000-0002-6387-6443; Rettura, Francesco/0000-0003-3455-1794",,,,,71,16,17,0,10,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,OCT,2021,13,10,,,,,,,3386,10.3390/nu13103386,http://dx.doi.org/10.3390/nu13103386,,,13,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,XI8KY,34684388,"Green Published, gold",,,2024-06-04,WOS:000726354400001,View Full Record in Web of Science
J,"Olveira, G; González-Molero, I",,,,"Olveira, Gabriel; Gonzalez-Molero, Inmaculada",,,"An update on probiotics, prebiotics and symbiotics in clinical nutrition",ENDOCRINOLOGIA Y NUTRICION,,,Spanish,Review,,,,,,Probiotics; Prebiotics; Symbiotics; Clinical nutrition,HYDROLYZED GUAR GUM; CRITICALLY-ILL PATIENTS; DOUBLE-BLIND; METAANALYSIS; PREVENTION; MANAGEMENT; INFECTION; DIARRHEA; INULIN; SYNBIOTICS,"The concept of prebiotics, probiotics, and symbiotics and their use in different situations of daily clinical practice related to clinical nutrition is reviewed, as well as their role in the treatment/prevention of diarrhea (acute, induced by antibiotics, secondary to radiotherapy), inflammatory bowel disease (ulcerative colitis and pouchitis), in colonic health (constipation, irritable bowel), in liver disease (steatosis and minimum encephalopathy), and in intensive care, surgical, and liver transplantation. While their effectiveness for preventing antibiotic-induced diarrhea and pouchitis in ulcerative colitis appears to be shown, additional studies are needed to establish recommendations in most clinical settings. The risk of infection associated to use of probiotics is relatively low; however, there are selected groups of patients in whom they should be used with caution (as jejunum infusion). (C) 2016 SEEN. Published by Elsevier Espana, S.L.U. All rights reserved.","[Olveira, Gabriel; Gonzalez-Molero, Inmaculada] Univ Malaga, UGC Endocrinol & Nutr, Inst Invest Biomed Malaga, Hosp Reg Univ Malaga, Malaga, Spain; [Olveira, Gabriel; Gonzalez-Molero, Inmaculada] Inst Salud Carlos III, CIBERDEM, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain",Universidad de Malaga; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM,"Olveira, G (corresponding author), Univ Malaga, UGC Endocrinol & Nutr, Inst Invest Biomed Malaga, Hosp Reg Univ Malaga, Malaga, Spain.;Olveira, G (corresponding author), Inst Salud Carlos III, CIBERDEM, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain.",gabrielm.olveira.sspa@juntadeandalucia.es,"OLVEIRA, GABRIEL/K-8778-2012","OLVEIRA, GABRIEL/0000-0002-7646-2899",,,,,60,61,77,0,49,ELSEVIER ESPANA SLU,BARCELONA,"AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN",1575-0922,1579-2021,,ENDOCRINOL NUTR,Endocrinol. Nutr.,NOV,2016,63,9,,,,,482,494,,10.1016/j.endonu.2016.07.006,http://dx.doi.org/10.1016/j.endonu.2016.07.006,,,13,Endocrinology & Metabolism; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Endocrinology & Metabolism; Nutrition & Dietetics,EA3WC,27633133,,,,2024-06-04,WOS:000386539000007,View Full Record in Web of Science
J,"Wegh, CAM; Schoterman, MHC; Vaughan, EE; Belzer, C; Benninga, MA",,,,"Wegh, Carrie A. M.; Schoterman, Margriet H. C.; Vaughan, Elaine E.; Belzer, Clara; Benninga, Marc A.",,,The effect of fiber and prebiotics on children's gastrointestinal disorders and microbiome,EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY,,,English,Review,,,,,,Gut microbiota; children; dietary fiber; functional gastrointestinal disorders; prebiotics; oligosaccharides,IRRITABLE-BOWEL-SYNDROME; FUNCTIONAL ABDOMINAL-PAIN; HYDROLYZED GUAR GUM; QUALITY-OF-LIFE; DIETARY FIBER; DOUBLE-BLIND; PEDIATRIC-PATIENTS; CHILDHOOD CONSTIPATION; GALACTO-OLIGOSACCHARIDES; FRUCTO-OLIGOSACCHARIDES,"Introduction: The bacteria received upon birth are the start of colonization of the approximately 10(14) bacteria that are present in the mature human gastrointestinal tract, better known as the microbiota. The gut microbiota is implicated in gastrointestinal health, nutrient metabolism and benefits such as prevention of infection. Dietary fiber, including prebiotics, escape digestion in the small intestine and reach the colon intact, where they are partially or completely fermented by the gut microbiota.Areas covered: The possible interactions between dietary fiber, prebiotics and microbiota are discussed as well as how this relates to functional gastrointestinal disorders. During the first years of life the microbiota have not yet reached a stable state and is sensitive to disturbance by environmental factors. An imbalance in the microbiota early in life is found to be associated with several functional gastrointestinal disorders such as colic, functional abdominal pain, irritable bowel syndrome and constipation.Expert commentary: A better understanding of how gut microbial changes in early-life can impact gastrointestinal health might lead to new treatments or disease prevention. Nutritional strategies with fiber or prebiotics may support health due to modification of colonic microbiota composition and metabolic activity, for example by growth stimulation of Bifidobacterium and Lactobacillus.","[Wegh, Carrie A. M.; Belzer, Clara] Wageningen Univ & Res, Microbiol Lab, Wageningen, Netherlands; [Wegh, Carrie A. M.; Benninga, Marc A.] Emmas Childrens Hosp, Dept Pediat Gastroenterol & Nutr, Acad Med Ctr, Amsterdam, Netherlands; [Schoterman, Margriet H. C.] FrieslandCampina, Amersfoort, Netherlands; [Vaughan, Elaine E.] Sensus BV Royal Consun, Roosendaal, Netherlands",Wageningen University & Research; University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital,"Wegh, CAM (corresponding author), Wageningen Univ & Res Ctr, Microbiol, NL-6700 HB Wageningen, Netherlands.",carrie.wegh@wur.nl,"; Belzer, Clara/P-6500-2018","Wegh, Carrie A.M./0000-0001-7963-7634; Belzer, Clara/0000-0001-6922-836X",,,,,108,41,49,5,36,TAYLOR & FRANCIS LTD,ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND",1747-4124,1747-4132,,EXPERT REV GASTROENT,Expert Rev. Gastroenterol. Hepatol.,,2017,11,11,,,,,1031,1045,,10.1080/17474124.2017.1359539,http://dx.doi.org/10.1080/17474124.2017.1359539,,,15,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Gastroenterology & Hepatology,FM3VR,28737484,hybrid,,,2024-06-04,WOS:000414938300005,View Full Record in Web of Science
J,"Shahramian, I; Kalvandi, G; Javaherizadeh, H; Khalili, M; Noori, NM; Delaramnasab, M; Bazi, A",,,,"Shahramian, Iraj; Kalvandi, Gholamreza; Javaherizadeh, Hazhir; Khalili, Manijeh; Noori, Noor Mohammad; Delaramnasab, Mojtaba; Bazi, Ali",,,"The effects of prebiotic supplementation on weight gain, diarrhoea, constipation, fever and respiratory tract infections in the first year of life",JOURNAL OF PAEDIATRICS AND CHILD HEALTH,,,English,Article,,,,,,constipation; diarrhoea; neonate; prebiotics; respiratory tract infection,HUMAN-MILK OLIGOSACCHARIDES; GALACTO-OLIGOSACCHARIDES; PRETERM INFANTS; DOUBLE-BLIND; FORMULA; MICROBIOTA; MANAGEMENT; PROBIOTICS; TOLERANCE; CHILDREN,"AimThis study was conducted to evaluate the effect of prebiotics on some common clinical ailments in healthy term infants. MethodsSixty healthy-term, breastfed (BF) infants were included. Along with these infants, 120 healthy-term formula-fed infants were randomly assigned to either the prebiotic formula (PF, n = 60) or regular formula (RF, n = 60) groups. Ready-to-use prebiotic-supplemented formula containing galacto-oligosaccharides and polydextrose (ratio 1:1) was used. ResultsAt 2 months of age, PF infants demonstrated significantly higher weight gain than BF and RF. At 6 months of age, bodyweight was significantly higher in the RF group compared to BF and PF groups (P < 0.05). Similar results were seen at 8, 10 and 12 months of age. At 10 months of age, the duration of diarrhoea was significantly shorter in PF-fed compared to the RF (P = 0.03) group. A significant difference was found between PF and RF (P < 0.0001) and BF and RF groups (P = 0.002) for diarrhoea duration. Means of constipation episodes per year were 0.03 0.18, 0.433 +/- 0.77 and 0.1 +/- 0.30 for the BF, RF and PF groups, respectively, with significant difference found between BF and RF (P = 0.006) and PF and RF (P = 0.02). The means of episodes of respiratory tract infections per year for BF, RF and PF groups were 1 +/- 0.69, 1.6 +/- 0.88 and 1 +/- 0.58, respectively (P = 0.01). ConclusionPrebiotic-supplemented and regular formula were similar to breast milk regarding prophylactic effects for diarrhoea, constipation and respiratory tract infections in the first year of life. Prebiotic-supplemented formula may be an appropriate substitution for breast milk when breast milk in unavailable.","[Shahramian, Iraj; Bazi, Ali] Zabol Univ Med Sci, Pediat Digest & Hepat Res Ctr, Zabol, Iran; [Delaramnasab, Mojtaba; Bazi, Ali] Zabol Univ Med Sci, Clin Res Dev Unit, Amir Al Momenin Hosp, Zabol 9861615881, Iran; [Kalvandi, Gholamreza] Ilam Univ Med Sci, Dept Pediat, Ilam, Iran; [Javaherizadeh, Hazhir] Ahvaz Jundishapur Univ Med Sci, Abuzar Childrens Hosp, Dept Pediat Gastroenterol, Ahvaz, Iran; [Khalili, Manijeh; Noori, Noor Mohammad] Zahedan Univ Med Sci, Children & Adolescent Hlth Res Ctr, Zahedan, Iran",Ahvaz Jundishapur University of Medical Sciences (AJUMS); Zahedan University of Medical Sciences,"Bazi, A (corresponding author), Zabol Univ Med Sci, Clin Res Dev Unit, Amir Al Momenin Hosp, Zabol 9861615881, Iran.",m.baziali@gmail.com,"shahramian, iraj/K-9772-2017; khalili, Manijeh/Z-5526-2019; Javaherizadeh, Hazhir/E-6045-2011; Bazi, Ali/D-1440-2017","shahramian, iraj/0000-0002-3760-7717; Javaherizadeh, Hazhir/0000-0001-7898-4589; delaramnasab, mojtaba/0000-0002-2958-3671; shahramian, iraj/0000-0002-4134-1405; Bazi, Ali/0000-0003-4872-1352",,,,,36,26,27,0,19,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1034-4810,1440-1754,,J PAEDIATR CHILD H,J. Paediatr. Child Health,AUG,2018,54,8,,,,,875,880,,10.1111/jpc.13906,http://dx.doi.org/10.1111/jpc.13906,,,6,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,GP9PL,29579345,,,,2024-06-04,WOS:000441248800012,View Full Record in Web of Science
J,"Roman, JL; Gonzálvez, ABM; Luque, A; Miñano, JAP; Acosta, AV; Iglesias, R; Henández, M; Villegas, JA",,,,"Roman, J. Lopez; Gonzalvez, A. B. Martinez; Luque, A.; Minano, J. A. Pons; Acosta, A. Vargas; Iglesias, R.; Henandez, M.; Villegas, J. A.",,,The effect of a fibre enriched dietary milk product in chronic primary idiopatic constipation,NUTRICION HOSPITALARIA,,,Spanish,Article,,,,,,constipation; dietary fibre; inulin; glucose polymers; prebiotics,ASSOCIATION; INULIN,"Background: fibre is effective in some types of constipation. Our objective was to determine if the administration of an enriched dairy preparation with a supplement of soluble fibre (Naturfibra)(R) [inulin and digestion resistant maltodextrin (Fibersol2 (R))], improves primary chronic constipation. Methods: Prospective, randomized, double blind clinical trial randomized with dietary intervention in 32 subjects with constipation according to the Rome H criteria. Thirty two subjects (men 4; women 28) with an average age of 47 15 years were randomly divided in two homogeneous groups. A type of milk (A or B) was assigned to each group. Group A received fibre enriched semi-skimmed milk; Group B received semi skimmed milk. The subjects drank half a litre of milk per day during 20 days, meaning that those who drank the enriched milk ingested 20 grams of fibre a day. Results: The subjects that presented straining at defecation (p < 0,001), sensation of incomplete evacuation (p < 0,001), sensation of obstruction in the evacuation (p < 0,001) and days between bowel movements, diminished significantly after the intake of milk supplemented with fibre. Conclusion: The intake of a dairy preparation with a supplement of fibre containing 20 grams of soluble fibre (inulin and digestion resistant maltodextrin), improves the situation of idiopathic primary chronic constipation based on the Rome H criteria.","[Roman, J. Lopez; Gonzalvez, A. B. Martinez; Luque, A.; Villegas, J. A.] UCAM, Catedra Fisol, Murcia 30107, Spain; [Minano, J. A. Pons] Hosp Univ Virgen Arrixaca, Serv Med Aparato Digestivo, Murcia, Spain; [Acosta, A. Vargas] Especialista & Med Aparato Digestivo, Asturias, Spain; [Iglesias, R.; Henandez, M.] Corp Alimentaria Penasanta CAPSA, Asturias, Spain",Universidad Catolica de Murcia; Hospital Clinico Universitario Virgen de la Arrixaca,"Villegas, JA (corresponding author), UCAM, Catedra Fisol, Campus Los Jeronimos,Carretera Guadalupe S-N, Murcia 30107, Spain.",javillegas@pdi.ucam.edu,"Miñano, Jose Antonio Pons/S-4644-2019","Miñano, Jose Antonio Pons/0000-0001-5017-7240",,,,,20,30,31,0,13,"ARAN EDICIONES, S L",MADRID,"C/ CASTELLO, 128, 1O, MADRID, 28006, SPAIN",0212-1611,1699-5198,,NUTR HOSP,Nutr. Hosp.,JAN-FEB,2008,23,1,,,,,12,19,,,,,,8,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,259PD,18372941,,,,2024-06-04,WOS:000252950300003,View Full Record in Web of Science
J,"Ouyang, Q; Xu, YJ; Ban, YJ; Li, JJ; Cai, YJ; Wu, B; Hao, YQ; Sun, ZZ; Zhang, M; Wang, MQ; Wang, WT; Zhao, YK",,,,"Ouyang, Qian; Xu, Yajuan; Ban, Yanjie; Li, Jingjing; Cai, Yanjun; Wu, Bo; Hao, Yingqi; Sun, Zongzong; Zhang, Miao; Wang, Mengqi; Wang, Wentao; Zhao, Yinkai",,,Probiotics and Prebiotics in Subclinical Hypothyroidism of Pregnancy with Small Intestinal Bacterial Overgrowth,PROBIOTICS AND ANTIMICROBIAL PROTEINS,,,English,Article,,,,,,Subclinical hypothyroidism during pregnancy; Small intestinal bacterial overgrowth; Probiotics; Prebiotics; Treatment,GUT MICROBIOTA; ASSOCIATION; WOMEN; SYNBIOTICS; FEATURES; DISEASE,"Evaluating efficacy of probiotics combined with prebiotics in small intestinal bacterial overgrowth (SIBO) in subclinical hypothyroidism (SCH) in the second trimester. We collected data from 78 pregnant women with SCH (SCH group) and 74 normal pregnant women (control group) in second trimester, compare the differences in high sensitivity C-reactive protein (hsCRP), result of lactulose methane-hydrogen breath test and gastrointestinal symptoms assessed by GSRS scale between two groups. In SCH group, 32 patients with SIBO were selected as intervention group. Treatment with probiotics + prebiotics for 21 days; The differences of lipid metabolism, hsCRP, thyroid function level, methane-hydrogen breath test results and GSRS scores before and after treatment were compared to evaluate the therapeutic effect. (1) The positive rate of SIBO and methane, hsCRP levels in SCH group were higher than those in control group (P < 0.05), the total score of GSRS scale, mean score of indigestion syndrome, and constipation syndrome in SCH group were higher (P < 0.05). (2) The mean abundance of hydrogen and methane were higher in SCH group. (3) After treatment, serum levels of thyrotropin(TSH), total cholesterol(TC), triglyceride(TG), low-density lipoprotein (LDL), and hsCRP in intervention group were decreased, and high-density lipoprotein (HDL) was increased compared with before treatment (P < 0.05). (4) After treatment, methane positive rate, total score of GSRS scale, mean score of diarrhea syndrome, dyspepsia syndrome, and constipation syndrome were decreased (P < 0.05). (5) The average abundance of methane and hydrogen were lower. Probiotics combined with prebiotics are effective in the treatment of SIBO in pregnant SCH patients.Clinical Trial Registration Number: ChiCTR1900026326.","[Ouyang, Qian; Xu, Yajuan; Ban, Yanjie; Li, Jingjing; Cai, Yanjun; Wu, Bo; Hao, Yingqi; Sun, Zongzong; Zhang, Miao; Wang, Mengqi; Wang, Wentao; Zhao, Yinkai] Zhengzhou Univ, Affiliated Hosp 3, Dept Obstet & Gynecol, Zhengzhou, Peoples R China",Zhengzhou University,"Xu, YJ (corresponding author), Zhengzhou Univ, Affiliated Hosp 3, Dept Obstet & Gynecol, Zhengzhou, Peoples R China.",cnzzzsl@163.com,,,,,,,45,0,0,8,11,SPRINGER,NEW YORK,"ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES",1867-1306,1867-1314,,PROBIOTICS ANTIMICRO,Probiotics Antimicrob. Proteins,APR,2024,16,2,,,,,579,588,,10.1007/s12602-023-10068-4,http://dx.doi.org/10.1007/s12602-023-10068-4,,APR 2023,10,Biotechnology & Applied Microbiology; Microbiology,Science Citation Index Expanded (SCI-EXPANDED),Biotechnology & Applied Microbiology; Microbiology,MX5M6,37032411,"hybrid, Green Published, Green Submitted",,,2024-06-04,WOS:000965012000001,View Full Record in Web of Science
J,"Hamilton-Miller, JMT",,,,"Hamilton-Miller, JMT",,,Probiotics and prebiotics in the elderly,POSTGRADUATE MEDICAL JOURNAL,,,English,Review,,,,,,,LACTOBACILLUS-CASEI PREPARATION; CONSTIPATION; MALNUTRITION; SUPPLEMENTATION; CONSUMPTION; MICROFLORA; RECURRENCE; PREVENTION; LACTULOSE; BACTERIA,"Probiotics ( usually lactobacilli and bifidobacteria) and prebiotics (non-digestible oligosaccharides) have been shown to be useful in preventing certain disease conditions as well as possibly promoting specific aspects of health. In the present review, the evidence from clinical trials for benefits from probiotics and prebiotics to elderly populations is presented and discussed, specifically in respect of three common conditions found in the elderly. Both probiotics and prebiotics may be helpful in malnutrition, particularly in lactose intolerance and calcium absorption, and in constipation. Probiotics have been shown clearly to boost immunity in the elderly, but the clinical significance of this remains to be clarified. These results are encouraging, and further large scale studies seem justified to establish the place of probiotic and prebiotic supplements in elderly subjects.","UCL Royal Free & Univ Coll Med Sch, Dept Med Microbiol, London NW3 2PF, England",University of London; University College London; UCL Medical School,"UCL Royal Free & Univ Coll Med Sch, Dept Med Microbiol, Rowland Hill St, London NW3 2PF, England.",j.hamilton-miller@rfc.ucl.ac.uk,,,,,,,60,70,92,1,25,BMJ PUBLISHING GROUP,LONDON,"BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND",0032-5473,1469-0756,,POSTGRAD MED J,Postgrad. Med. J.,AUG,2004,80,946,,,,,447,451,,10.1136/pgmj.2003.015339,http://dx.doi.org/10.1136/pgmj.2003.015339,,,5,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,844FM,15299153,"Green Published, Bronze",,,2024-06-04,WOS:000223143000005,View Full Record in Web of Science
J,"Ford, AC; Quigley, EMM; Lacy, BE; Lembo, AJ; Saito, YA; Schiller, LR; Soffer, EE; Spiegel, BMR; Moayyedi, P",,,,"Ford, Alexander C.; Quigley, Eamonn M. M.; Lacy, Brian E.; Lembo, Anthony J.; Saito, Yuri A.; Schiller, Lawrence R.; Soffer, Edy E.; Spiegel, Brennan M. R.; Moayyedi, Paul",,,"Efficacy of Prebiotics, Probiotics, and Synbiotics in Irritable Bowel Syndrome and Chronic Idiopathic Constipation: Systematic Review and Meta-analysis",AMERICAN JOURNAL OF GASTROENTEROLOGY,,,English,Review,,,,,,,RANDOMIZED CONTROLLED-TRIAL; LACTOBACILLUS-PLANTARUM 299V; SIGNIFICANTLY REDUCES SYMPTOMS; QUALITY-OF-LIFE; DOUBLE-BLIND; CLINICAL-TRIAL; FERMENTED MILK; FECAL MICROBIOTA; PRIMARY-CARE; RISK-FACTORS,"OBJECTIVES: Irritable bowel syndrome (IBS) and chronic idiopathic constipation (CIC) are functional bowel disorders. Evidence suggests that disturbance in the gastrointestinal microbiota may be implicated in both conditions. We performed a systematic review and meta-analysis to examine the efficacy of prebiotics, probiotics, and synbiotics in IBS and CIC. METHODS: MEDLINE, EMBASE, and the Cochrane Controlled Trials Register were searched (up to December 2013). Randomized controlled trials (RCTs) recruiting adults with IBS or CIC, which compared prebiotics, probiotics, or synbiotics with placebo or no therapy, were eligible. Dichotomous symptom data were pooled to obtain a relative risk (RR) of remaining symptomatic after therapy, with a 95% confidence interval (CI). Continuous data were pooled using a standardized or weighted mean difference with a 95% CI. RESULTS: The search strategy identified 3,216 citations. Forty-three RCTs were eligible for inclusion. The RR of IBS symptoms persisting with probiotics vs. placebo was 0.79 (95% CI 0.70-0.89). Probiotics had beneficial effects on global IBS, abdominal pain, bloating, and flatulence scores. Data for prebiotics and synbiotics in IBS were sparse. Probiotics appeared to have beneficial effects in CIC (mean increase in number of stools per week = 1.49; 95% CI = 1.02-1.96), but there were only two RCTs. Synbiotics also appeared beneficial (RR of failure to respond to therapy = 0.78; 95% CI 0.67-0.92). Again, trials for prebiotics were few in number, and no definite conclusions could be drawn. CONCLUSIONS: Probiotics are effective treatments for IBS, although which individual species and strains are the most beneficial remains unclear. Further evidence is required before the role of prebiotics or synbiotics in IBS is known. The efficacy of all three therapies in CIC is also uncertain.","[Ford, Alexander C.] St James Univ Hosp, Leeds Gastroenterol Inst, Leeds LS9 7TF, W Yorkshire, England; [Ford, Alexander C.] Univ Leeds, Leeds Inst Biomed & Clin Sci, Leeds, W Yorkshire, England; [Quigley, Eamonn M. M.] Houston Methodist Hosp, Dept Med, Div Gastroenterol & Hepatol, Houston, TX USA; [Lacy, Brian E.] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA; [Lembo, Anthony J.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Saito, Yuri A.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA; [Schiller, Lawrence R.] Baylor Univ, Med Ctr, Digest Hlth Associates Texas, Dallas, TX USA; [Soffer, Edy E.] Univ So Calif, Div Gastroenterol Cedars Sinai, Los Angeles, CA USA; [Spiegel, Brennan M. R.] VA Greater Los Angeles Healthcare Syst, Dept Gastroenterol, Los Angeles, CA USA; [Moayyedi, Paul] McMaster Univ, Hlth Sci Ctr, Div Gastroenterol, Hamilton, ON, Canada",Saint James's University Hospital; University of Leeds; The Methodist Hospital System; The Methodist Hospital - Houston; Dartmouth College; Harvard University; Beth Israel Deaconess Medical Center; Mayo Clinic; Baylor University Medical Center; Baylor University; University of Southern California; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; McMaster University,"Ford, AC (corresponding author), St James Univ Hosp, Leeds Gastroenterol Inst, Room 125,4th Floor,Bexley Wing,Beckett St, Leeds LS9 7TF, W Yorkshire, England.",alexf12399@yahoo.com,"Ford, Alexander/K-5491-2012; Moayyedi, Paul/M-6178-2014","Ford, Alexander/0000-0001-6371-4359; Moayyedi, Paul/0000-0002-3616-9292",American College of Gastroenterology,American College of Gastroenterology,This work was supported by American College of Gastroenterology.,,72,491,549,11,231,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0002-9270,1572-0241,,AM J GASTROENTEROL,Am. J. Gastroenterol.,OCT,2014,109,10,,,,,1547,1561,,10.1038/ajg.2014.202,http://dx.doi.org/10.1038/ajg.2014.202,,,15,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,AS7UM,25070051,,Y,N,2024-06-04,WOS:000344460100007,View Full Record in Web of Science
J,"Shen, F; Wang, QQ; Zhong, H; Pan, Y; Zhang, JH; Wang, J; Chen, M; Feng, FQ; Zhao, MJ",,,,"Shen, Fei; Wang, Qianqian; Zhong, Hao; Pan, Ya; Zhang, Junhui; Wang, Jing; Chen, Ming; Feng, Fengqin; Zhao, Mingjie",,,"Combination of galacto-oligosaccharides and wheat peptides synergistically relieved constipation via regulating water transport, gut barrier, inflammation and gut microbiota",FOOD BIOSCIENCE,,,English,Article,,,,,,Galacto-oligosaccharides; Wheat peptides; Constipation; Gut microbiota,CAJAL,"Constipation is a common gastrointestinal problem. This study aimed to identify a combination of prebiotics and wheat peptides (WP) to promote intestinal peristalsis and explore the underlying mechanism. First, we screened four prebiotics (galacto-oligosaccharides (GOS), fructose oligosaccharides (FOS), inulin (IN), and resistant dextrin (RD)) using a zebrafish model and found that GOS was the most synergistic with WP. We then tested the GOS-WP combination in a mouse model of loperamide (Lop)-induced constipation and found that it significantly improved constipation symptoms. Specifically, GOS-WP shortened the first black stool time, increased the number of defecation particles, accelerated small intestinal propulsion rate, and increased fecal water content. GOS-WP also normalized the colonic water transport system by inhibiting colonic AQP4/8 expression. Additionally, GOS-WP reversed Lop-induced morphological damage in the ileum and colon, increased colonic barrier, and reduced inflammation in mice. Furthermore, 16S rRNA gene sequence analysis showed that GOS-WP reversed the gut microbiota structure changes induced by Lop. GOS-WP significantly increased butyric acid and decreased BCFA levels, indicating improved gut health. Our findings suggest that the GOS-WP combination has potential as a novel intervention for constipation relief. This study highlights the potential of combining prebiotics and WP as a therapeutic strategy for constipation.","[Shen, Fei; Wang, Qianqian; Pan, Ya; Zhang, Junhui; Feng, Fengqin; Zhao, Mingjie] Zhejiang Univ, Coll Biosyst Engn & Food Sci, Natl Local Joint Engn Lab Intelligent Food Technol, Zhejiang Key Lab Agrofood Proc, Hangzhou 310058, Peoples R China; [Feng, Fengqin] Zhejiang Univ, Ningbo Res Inst, Ningbo 315100, Peoples R China; [Zhong, Hao; Feng, Fengqin] Zhejiang Univ, ZhongYuan Inst, Zhengzhou 450001, Peoples R China; [Wang, Jing] Zhejiang Univ, Ningbo Inst, Ningbo 315100, Peoples R China; [Chen, Ming] Hangzhou Kangyuan Food Sci & Technol Co Ltd, Hangzhou 310012, Peoples R China",Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University,"Zhao, MJ (corresponding author), Zhejiang Univ, Coll Biosyst Engn & Food Sci, Natl Local Joint Engn Lab Intelligent Food Technol, Zhejiang Key Lab Agrofood Proc, Hangzhou 310058, Peoples R China.",minjiezhao@zju.edu.cn,"Wang, Jing/ABB-5658-2021; Wang, Yuhan/KGL-5855-2024; feng, feng/KBR-1814-2024; Wang, Fei/KEH-6292-2024; WANG, SHIHAO/KHC-8263-2024; Wang, Yibin/KEZ-9645-2024","Wang, Jing/0000-0002-6394-5357; Zhao, Minjie/0000-0002-5429-9824; Zhong, Hao/0009-0005-9206-3715","Hangzhou Kangyuan Food Science Technology Co.; National Natural Science Foundation of China [32072224]; Natural Science Foundation of Zhejiang Province [32001693, LQ23C200011, LQ21C200007]",Hangzhou Kangyuan Food Science Technology Co.; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province),"We thank Hangzhou Kangyuan Food Science & Technology Co. for providing financial support. We thank Yingniang Li from the Core Facilities, Zhejiang University School of Medicine for their technical support. This research was funded by the National Natural Science Foundation of China, grant numbers 32072224. Research was also funded by the Natural Science Foundation of Zhejiang Province, grant numbers 32001693, LQ23C200011 and LQ21C200007.",,47,0,0,28,32,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",2212-4292,2212-4306,,FOOD BIOSCI,Food Biosci.,DEC,2023,56,,,,,,,,103208,10.1016/j.fbio.2023.103208,http://dx.doi.org/10.1016/j.fbio.2023.103208,,OCT 2023,13,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,U8IA2,,,,,2024-06-04,WOS:001087170900001,View Full Record in Web of Science
J,"Orel, R; Rebersak, LV",,,,"Orel, Rok; Rebersak, Lea Vodusek",,,Clinical Effects of Prebiotics in Pediatric Population,INDIAN PEDIATRICS,,,English,Review,,,,,,Conetipation; Eczema; Nutrition; Prevention,ORAL REHYDRATION SOLUTION; DOUBLE-BLIND; PROBIOTIC SUPPLEMENTATION; GALACTO-OLIGOSACCHARIDES; ACIDIC OLIGOSACCHARIDES; INTESTINAL MICROBIOTA; STOOL CHARACTERISTICS; CALCIUM-ABSORPTION; ATOPIC-DERMATITIS; PRETERM INFANTS,"Context: Prebiotics are non-digestible components of food that in a selective manner trigger the expansion of microbes in the gut with valuable effects for the health of the host. In our document, current literature pertaining to the clinical effects of the use of prebiotics for the treatment and prevention of some common pediatric pathology such as infantile colic, constipation, absorption of minerals, weight gain, diarrhea, respiratory infections, and eczema is reviewed. Evidence: Data was collected through search of the MEDLINE, PubMed, UpToDate, Cochrane Database of Systemic Reviews, and the Cochrane Controlled Trials Register database as well as through references from relevant articles, all until September 201.5. However, only the results of publications with adequate methodological quality were included. Results: Prebiotics seem to be very appealing in treatment of many clinical conditions, explicitly in the fight against constipation, poor weight gain in preterm infants, and eczema in atopic children. In contrast to probiotics, the evidence of true clinical efficacy of prebiotics, supported with exact type and dose information are rather sparse, and there are a limited number of randomized controlled trials concerning prebiotics in children, especially beyond the age of infancy. Conclusion: Large well-designed, controlled, confirmatory clinical trials are required, using commercially available products, to help healthcare providers in making an appropriate decision concerning the appropriate use of prebiotics in different conditions.","[Orel, Rok; Rebersak, Lea Vodusek] Univ Childrens Hosp, Univ Med Ctr, Ljubljana, Slovenia",University Medical Centre Ljubljana,"Orel, R (corresponding author), Univ Childrens Hosp, Bohoriceva 20, Ljubljana 1000, Slovenia.",rok.orel@kclj.si,,,,,,,59,5,5,0,15,SPRINGER INDIA,NEW DELHI,"7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA",0019-6061,0974-7559,,INDIAN PEDIATR,Indian Pediatrics,DEC,2016,53,12,,,,,1083,1089,,,,,,7,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,EG3VK,28064261,,,,2024-06-04,WOS:000390972600008,View Full Record in Web of Science
J,"Ceresola, ER; Ferrarese, R; Preti, A; Canducci, F",,,,"Ceresola, E. R.; Ferrarese, R.; Preti, A.; Canducci, F.",,,Targeting patients' microbiota with probiotics and natural fibers in adults and children with constipation,EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES,,,English,Article,,,,,,Microbiota; Probiotics; Natural fibers; Constipation,FUNCTIONAL GASTROINTESTINAL SYMPTOMS; INTERNATIONAL SCIENTIFIC ASSOCIATION; RANDOMIZED CLINICAL-TRIAL; DOUBLE-BLIND; DIETARY FIBER; FERMENTED MILK; CONSENSUS STATEMENT; METHANOGENIC FLORA; HEALTHY-VOLUNTEERS; GUT MICROBIOME,"OBJECTIVE: Functional constipation (FC) is a common condition in which the gut microbiota composition plays a fundamental role. The increasing knowledge on the role of gut microbes in the regulation of gut motility and stool consistency has allowed reconsidering, with a new scientific-based approach, the possibility to target the composition of intestinal bacterial populations for FC treatment. In this review, we evaluate recent attempts that used prebiotics, natural fibers or probiotics to treat FC, with a deep microbiome-based focus. MATERIALS AND METHODS: This is a literature review of articles published in Medline, Web of Science, and the Cochrane Library. Studies on FC in adults and children were identified using the following terms: constipation AND probiotics OR prebiotics OR synbiotics PR fibers OR microbiome OR microbiota. Selected animal studies were also considered if showing mechanistic observations. RESULTS: FC is associated with alteration in microbiome composition. Motility and fecal consistency are affected with different efficacy by the type of fiber, prebiotic or probiotic strain used in patients. CONCLUSIONS: Selected bacterial strains, mainly belonging to the Bifidobacterium genus, and some poorly or non-fermented natural fibers, such as Psyllium, may significantly improve FC and may represent the basis for an effective supplementation.","[Ceresola, E. R.; Preti, A.; Canducci, F.] Univ Insubria, Microbiol Unit, Varese, Italy; [Ferrarese, R.] Univ Vita Salute San Raffaele, Microbiol Unit, Milan, Italy; [Canducci, F.] Osped San Raffaele, Microbiol Unit, Milan, Italy",University of Insubria; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele,"Canducci, F (corresponding author), Univ Insubria, Microbiol Unit, Varese, Italy.;Canducci, F (corresponding author), Osped San Raffaele, Microbiol Unit, Milan, Italy.",canducci.filippo@gmail.com,"Ferrarese, Roberto/AAC-2671-2022","Ferrarese, Roberto/0000-0002-8232-5786",Italian Ministry of University and Research; Italian Ministry of Health [GR-2011-02347170],"Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health(Ministry of Health, Italy)",This study was partially funded by the Italian Ministry of University and Research and by the Italian Ministry of Health (grant GR-2011-02347170).,,85,19,20,2,25,VERDUCI PUBLISHER,ROME,"VIA GREGORIO VII, ROME, 186-00165, ITALY",1128-3602,,,EUR REV MED PHARMACO,Eur. Rev. Med. Pharmacol. Sci.,OCT,2018,22,20,,,,,7045,7057,,,,,,13,Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy,GZ5XR,30402873,,,,2024-06-04,WOS:000449504500047,View Full Record in Web of Science
J,"Khangwal, I; Shukla, P",,,,"Khangwal, Ishu; Shukla, Pratyoosh",,,"Prospecting prebiotics, innovative evaluation methods, and their health applications: a review",3 BIOTECH,,,English,Review,,,,,,Prebiotics; Gut microbiota; Gastrointestinal tract; Oligosaccharides; Human health,IRRITABLE-BOWEL-SYNDROME; IN-VITRO EVALUATION; DOUBLE-BLIND; GROWTH-PERFORMANCE; GUT MICROBIOTA; PROBIOTICS; OLIGOSACCHARIDES; CONSTIPATION; TRIAL; SYNBIOTICS,"Prebiotics are necessary natural and synthetic food ingredients that help in the growth and development of gut microflora. There is a complex relationship between gut dysbiosis and microbes, so alteration in both probiotics and prebiotics can reduce illness of gut, which further plays a decisive role in human health. The prebiotic efficiency can be validated using various in vitro and in vivo experiments, and this gives an important insight to this field. This review focuses on these aspects including the standardized assessment of prebiotics and its metabolic products for customary applications. This review has also summarized the mechanism of their beneficial actions such as immunomodulation, nutrient absorption, pathogen inhibition, etc., and its significance in human nutrition. In addition to this, some fascinating applications of prebiotics in health-related disorders have also discussed, with current challenges in this facet.","[Khangwal, Ishu; Shukla, Pratyoosh] Maharshi Dayanand Univ, Enzyme Technol & Prot Bioinformat Lab, Dept Microbiol, Rohtak 124001, Haryana, India",Maharshi Dayanand University,"Shukla, P (corresponding author), Maharshi Dayanand Univ, Enzyme Technol & Prot Bioinformat Lab, Dept Microbiol, Rohtak 124001, Haryana, India.",pratyoosh.shukla@gmail.com,"Shukla, Pratyoosh/N-8039-2013","Shukla, Pratyoosh/0000-0002-9307-4126","M.D. University, Rohtak, India [RS/R-15/19/1868]; Department of Science and Technology, New Delhi, Govt. of India, FIST grant [1196 SR/FST/LS-I/ 2017/4]; Department of Biotechnology, Government of India [BT/PR27437/BCE/8/1433/2018]","M.D. University, Rohtak, India; Department of Science and Technology, New Delhi, Govt. of India, FIST grant; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)","The authors acknowledge Maharshi Dayanand University, Rohtak, India, for providing infrastructure facility. IK acknowledges the support as University Research Scholarship by M.D. University, Rohtak, India (Grant No. R&S/R-15/19/1868). PS acknowledges the infrastructural support from Department of Science and Technology, New Delhi, Govt. of India, FIST grant (Grant No. 1196 SR/FST/LS-I/ 2017/4) and Department of Biotechnology, Government of India (Grant No. BT/PR27437/BCE/8/1433/2018). PS also acknowledges Department of Microbiology, Barkatullah University, Bhopal, India, for their infrastructural support for D.Sc. work.",,66,21,21,2,30,SPRINGER HEIDELBERG,HEIDELBERG,"TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY",2190-572X,2190-5738,,3 BIOTECH,3 Biotech,MAY,2019,9,5,,,,,,,187,10.1007/s13205-019-1716-6,http://dx.doi.org/10.1007/s13205-019-1716-6,,,7,Biotechnology & Applied Microbiology,Science Citation Index Expanded (SCI-EXPANDED),Biotechnology & Applied Microbiology,HV6QR,31065487,"Green Published, Bronze",,,2024-06-04,WOS:000466108400001,View Full Record in Web of Science
J,"Erhardt, R; Steels, E; Harnett, JE; Taing, MW; Steadman, KJ",,,,"Erhardt, Rene; Steels, Elizabeth; Harnett, Joanna E.; Taing, Meng-Wong; Steadman, Kathryn J.",,,Effects of a prebiotic formulation on the composition of the faecal microbiota of people with functional constipation,EUROPEAN JOURNAL OF NUTRITION,,,English,Article,,,,,,Functional constipation; Prebiotics; Gut microbiota; Species richness; Shannon diversity; Functional richness; Functional diversity; RCT; LMER models,ADULTS,"PurposePrebiotics are defined as substances which selectively promote beneficial gut microbes leading to a health benefit for the host. Limited trials have been carried out investigating their effect on the microbiota composition of individuals afflicted by functional constipation with equivocal outcomes. In a 21-day randomised, controlled clinical trial involving 61 adults with functional constipation, a prebiotic formulation with partially hydrolysed guar gum and acacia gum as its main ingredients, significantly increased complete spontaneous bowel motions in the treatment group. This follow-up exploratory analysis investigated whether the prebiotic was associated with changes to the composition, richness, and diversity of the faecal microbiota.MethodsParticipants provided a faecal specimen at baseline and on day 21 of the intervention period. Whole genome metagenomic shotgun sequencing comprehensively assessed taxonomic and functional composition of the microbiota.ResultsLinear mixed effects regression models adjusted for potential confounders showed a significant reduction in species richness of 28.15 species (95% CI - 49.86, - 6.43) and Shannon diversity of 0.29 units (95% CI - 0.56, - 0.02) over the trial period in the prebiotic group. These changes were not observed in the control group, and functional composition was unchanged in both groups.ConclusionIn adults with functional constipation, the intake of a prebiotic formulation was associated with a decline of species richness and Shannon diversity. Further research regarding the associations between prebiotics and the composition and function of the gut microbiota is warranted.","[Erhardt, Rene; Steels, Elizabeth; Taing, Meng-Wong; Steadman, Kathryn J.] Univ Queensland, Sch Pharm, Brisbane, Australia; [Steels, Elizabeth] Evidence Sci Pty Ltd, New Farm, Australia; [Harnett, Joanna E.] Univ Sydney, Sch Pharm, Sydney, Australia; [Erhardt, Rene] Univ Queensland, Sch Pharm, 20 Cornwall St, Woolloongabba, Qld 4102, Australia",University of Queensland; University of Sydney; University of Queensland,"Erhardt, R (corresponding author), Univ Queensland, Sch Pharm, Brisbane, Australia.;Erhardt, R (corresponding author), Univ Queensland, Sch Pharm, 20 Cornwall St, Woolloongabba, Qld 4102, Australia.",r.erhardt@uq.edu.au,"Harnett, Joanna E/L-1214-2018; Steadman, Kathryn/C-3401-2008","Harnett, Joanna E/0000-0001-9904-2144; Steadman, Kathryn/0000-0001-7357-330X; Erhardt, Rene/0000-0002-1961-135X",University of Queensland,University of Queensland(University of Queensland),Rene Erhardt was supported by a postgraduate scholarship of the University of Queensland.,,32,0,0,9,9,SPRINGER HEIDELBERG,HEIDELBERG,"TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY",1436-6207,1436-6215,,EUR J NUTR,Eur. J. Nutr.,APR,2024,63,3,,,,,777,784,,10.1007/s00394-023-03292-9,http://dx.doi.org/10.1007/s00394-023-03292-9,,JAN 2024,8,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,LI9F8,38165420,,,,2024-06-04,WOS:001132796800001,View Full Record in Web of Science
B,"Frokiær, H; Metzdorff, SB; Venema, K",,"Venema, K; DoCarmo, AP",,"Frokiaer, Hanne; Metzdorff, Stine B.; Venema, Koen",,,Immunomodulating Effects of Prebiotics and Fibres,PROBIOTICS AND PREBIOTICS: CURRENT RESEARCH AND FUTURE TRENDS,,,English,Article; Book Chapter,,,,,,,CHAIN FATTY-ACIDS; PATTERN-RECOGNITION RECEPTOR; INNATE IMMUNE-RESPONSES; BETA-GLUCAN RECEPTOR; TOLL-LIKE RECEPTORS; MANNOSE RECEPTOR; DOUBLE-BLIND; DC-SIGN; FRUCTO-OLIGOSACCHARIDES; INTESTINAL HOMEOSTASIS,"The beneficial effects of fibres have long been attributed to their bulking effect, reducing the transit time of chyme through the gastrointestinal (GI) tract, thereby, for example, reducing the contact of potential toxic compounds with the gastrointestinal epithelium and preventing constipation. Lately however, it has been recognized that fibres may have prebiotics effects by modulating the activity of the gut microbiota, and even direct effects on the immune system. This chapter highlights the effects of fibres on the immune system. Mostly direct interactions with the host are discussed, although effects of microbial fermentation products [the so-called short-chain fatty acids (SCFA)] on the immune system is also briefly mentioned.","[Frokiaer, Hanne; Metzdorff, Stine B.] Univ Copenhagen, Dept Vet Dis Biol, Sect Expt Anim Models, Copenhagen, Denmark; [Venema, Koen] Beneficial Microbes Consultancy, Wageningen, Netherlands",University of Copenhagen,"Frokiær, H (corresponding author), Univ Copenhagen, Dept Vet Dis Biol, Sect Expt Anim Models, Copenhagen, Denmark.",hafr@sund.ku.dk; broeng@sund.ku.dk; koen.venema@outlook.com,"Venema, Koen/A-6775-2011",,,,,,138,0,0,0,0,CAISTER ACADEMIC PRESS,WYMONDHAM,"32 HEWITTS LANE, WYMONDHAM NR 18 0JA, ENGLAND",,,978-1-910190-09-8,,,,2015,,,,,,,315,329,,,,,,15,Biotechnology & Applied Microbiology; Microbiology,Book Citation Index – Science (BKCI-S),Biotechnology & Applied Microbiology; Microbiology,BG3MQ,,,,,2024-06-04,WOS:000388049800021,View Full Record in Web of Science
J,"van der Schoot, A; Drysdale, C; Whelan, K; Dimidi, E",,,,"van der Schoot, Alice; Drysdale, Candice; Whelan, Kevin; Dimidi, Eirini",,,The Effect of Fiber Supplementation on Chronic Constipation in Adults: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials,AMERICAN JOURNAL OF CLINICAL NUTRITION,,,English,Review,,,,,,constipation; fiber; prebiotics; systematic review; meta-analysis,CHRONIC IDIOPATHIC CONSTIPATION; IRRITABLE-BOWEL-SYNDROME; QUALITY-OF-LIFE; DOUBLE-BLIND; GALACTO-OLIGOSACCHARIDES; MICROBIOTA; INULIN; ASSOCIATION; FREQUENCY; TRANSIT,"Background Chronic constipation is a prevalent disorder that remains challenging to treat. Studies suggest increasing fiber intake may improve symptoms, although recommendations on the fiber type, dose, and treatment duration are unclear. Objectives We investigated the effects of fiber supplementation on stool output, gut transit time, symptoms, and quality of life in adults with chronic constipation via a systematic review and meta-analysis of randomized controlled trials (RCTs). Methods Studies were identified using electronic databases, backward citation, and hand searches of abstracts. RCTs reporting administration of fiber supplementation in adults with chronic constipation were included. Risks of bias (RoB) was assessed with the Cochrane RoB 2.0 tool. Results were synthesized using risk ratios (RRs), mean differences, or standardized mean differences (SMDs) and 95% CIs using a random-effects model. Results Sixteen RCTs with 1251 participants were included. Overall, 311 of 473 (66%) participants responded to fiber treatment and 134 of 329 (41%) responded to control treatment [RR: 1.48 (95% CI: 1.17, 1.88; P = 0.001); I-2 = 57% (P = 0.007)], with psyllium and pectin having significant effects. A higher response to treatment was apparent in fiber groups compared to control groups irrespective of the treatment duration, but only with higher fiber doses (>10 g/d). Fiber increased stool frequency [SMD: 0.72 (95% CI: 0.36, 1.08; P = 0.0001); I-2 = 86% (P < 0.00001)]; psyllium and pectin had significant effects, and improvement was apparent only with higher fiber doses and greater treatment durations (>= 4 weeks). Fiber improved stool consistency (SMD: 0.32; 95% CI: 0.18, 0.46; P < 0.0001), particularly with higher fiber doses. Flatulence was higher in fiber groups compared to control groups(SMD: 0.80; 95% CI: 0.47, 1.13; P < 0.00001). Conclusions Fiber supplementation is effective at improving constipation. Particularly, psyllium, doses >10 g/d and treatment durations of at least 4 weeks appear optimal, though caution is needed when interpreting the results due to considerable heterogeneity. These findings provide promising evidence on the optimal type and regime of fiber supplementation, which could be used to standardize recommendations to patients. The protocol for this review is registered at PROSPERO as CRD42020191404.","[van der Schoot, Alice; Drysdale, Candice; Whelan, Kevin; Dimidi, Eirini] Kings Coll London, Dept Nutr Sci, London, England",University of London; King's College London,"Dimidi, E (corresponding author), Kings Coll London, Dept Nutr Sci, London, England.",Eirini.dimidi@kcl.ac.uk,,"Dimidi, Eirini/0000-0003-0140-0199; Drysdale, Candice/0000-0002-7362-3933; van der Schoot, Alice/0000-0002-2889-7900",,,,,51,15,15,2,15,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",0002-9165,1938-3207,,AM J CLIN NUTR,Am. J. Clin. Nutr.,OCT 6,2022,116,4,,,,,953,969,,10.1093/ajcn/nqac184,http://dx.doi.org/10.1093/ajcn/nqac184,,JUL 2022,17,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,5C6JV,35816465,"hybrid, Green Published",,,2024-06-04,WOS:000849031700001,View Full Record in Web of Science
J,"Ikee, R; Yano, K; Tsuru, T",,,,"Ikee, Ryota; Yano, Kazuhiro; Tsuru, Tomomi",,,Constipation in chronic kidney disease: it is time to reconsider,RENAL REPLACEMENT THERAPY,,,English,Review,,,,,,Constipation; Chronic kidney disease; Dialysis; Uremic toxins; Intestinal motility; Gut microbiota; Gut dysbiosis; Chronic inflammation,IRRITABLE-BOWEL-SYNDROME; PERITONEAL-DIALYSIS PATIENTS; STAGE RENAL-DISEASE; GASTROINTESTINAL SYMPTOMS; FUNCTIONAL CONSTIPATION; CARDIOVASCULAR-DISEASE; SEVELAMER HYDROCHLORIDE; HEMODIALYSIS-PATIENTS; DIABETES-MELLITUS; COLORECTAL-CANCER,"Constipation is highly prevalent in patients with chronic kidney disease (CKD) and is primarily characterized by decreased intestinal motility. This chronic disorder affects the quality of life of patients. However, nephrologist and dialysis clinicians have long had a disproportionately limited understanding of constipation. Accumulating evidence has revealed a relationship between constipation and cardiovascular disease and CKD. The pathogenesis of constipation in CKD patients is multifactorial: decreased physical activity, comorbidities affecting bowel movement, such as diabetes mellitus, cerebrovascular disease, and hyperparathyroidism, a restricted dietary intake of plant-based fiber-rich foods, and multiple medications, including phosphate binders and potassium-binding resins, have all been implicated. CKD is associated with alterations in the composition and function of the gut microbiota, so-called gut dysbiosis. Recent studies showed that CKD-related gut dysbiosis decreased intestinal motility via intestinal inflammation or the increased generation of gut-derived uremic toxins, such as indoxyl sulfate and p-cresyl sulfate. Furthermore, the gastrointestinal secretion of mucin was found to be decreased in CKD animal models, which may delay colonic transit by diminished lubrication in the alimentary tract. Thus, CKD-related gut dysbiosis may play a role in constipation, but limited information is currently available. Since constipation is often intractable, particularly in CKD patients, every available means needs to be employed in its treatment. The effects of probiotics, prebiotics, and synbiotics on the composition of the gut microbiota and gut-derived uremic toxins have been increasingly reported. However, their effects on stool consistency or frequency in CKD patients remain unclear. Some laxatives may be beneficial for improving not only bowel habits but also gut dysbiosis. Further studies are required to elucidate the CKD-specific pathogenesis of constipation and develop novel effective treatment options.","[Ikee, Ryota; Yano, Kazuhiro] Med Co LTA PS Clin, Dialysis Vasc Access Ctr, Hakata Ku, 6-18 Tenyamachi, Fukuoka, Fukuoka 8120025, Japan; [Tsuru, Tomomi] Med Co LTA PS Clin, Dept Rheumatol, Hakata Ku, 6-18 Tenyamachi, Fukuoka, Fukuoka 8120025, Japan",,"Ikee, R (corresponding author), Med Co LTA PS Clin, Dialysis Vasc Access Ctr, Hakata Ku, 6-18 Tenyamachi, Fukuoka, Fukuoka 8120025, Japan.",ryota.ikee@gmail.com,,"Ikee, Ryota/0000-0002-3683-5363",,,,,99,14,14,0,5,BMC,LONDON,"CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND",,2059-1381,,RENAL REPLACE THER,Renal Replace. Ther.,DEC 12,2019,5,1,,,,,,,51,10.1186/s41100-019-0246-3,http://dx.doi.org/10.1186/s41100-019-0246-3,,,10,Urology & Nephrology,Emerging Sources Citation Index (ESCI),Urology & Nephrology,WE0TG,,gold,,,2024-06-04,WOS:000705341700001,View Full Record in Web of Science
J,"Quigley, EMM",,,,"Quigley, E. M. M.",,,The enteric microbiota in the pathogenesis and management of constipation,BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY,,,English,Article,,,,,,Constipation; Fiber; Prebiotic; Probiotic; Microbiota; Flora; Bran; Guar; Pectin; Ispaghula; Methane; Bifidobacteria; Lactobacilli,IRRITABLE-BOWEL-SYNDROME; INTESTINAL BACTERIAL OVERGROWTH; DOUBLE-BLIND; FERMENTED MILK; FECAL MICROBIOTA; COLONIC TRANSIT; CLINICAL-TRIAL; PROBIOTICS; BIFIDOBACTERIUM; LACTOBACILLUS,"For centuries, fiber has been recommended on an empirical basis for the management of constipation: it has only been in recent decades that the mechanisms whereby fiber and related products may influence colonic function have begun to be elucidated. The interaction between fiber and the microbiota of the human colon appears to play a major role in generating the beneficial effects of fiber. The microbiota is also the target for the other therapeutic interventions discussed in this chapter: prebiotics and probiotics. While a scientific basis for a role for these approaches in the management of constipation continues to develop, evidence from high-quality clinical trials to support their use in daily practice continues to lag far behind. While benefits for fiber and, perhaps, for certain prebiotic and probiotic preparations in constipation appear to be extant there is a real need for large well-conducted clinical trials in this important area of human medicine. (C) 2011 Elsevier Ltd. All rights reserved.","Cork Univ Hosp, Dept Med, Alimentary Pharmabiot Ctr, Cork, Ireland",University College Cork,"Quigley, EMM (corresponding author), Cork Univ Hosp, Dept Med, Alimentary Pharmabiot Ctr, Clin Sci Bldg, Cork, Ireland.",e.quigley@ucc.ie,,,Procter and Gamble,Procter and Gamble(Procter & Gamble),"Eamonn M.M. Quigley is a non-executive director of a multi-departmental university campus company (Alimentary Health), which investigates host-flora interactions and the therapeutic manipulation of these interactions in various human and animal disorders and holds patents in these areas. Dr Quigley has also received honoraria for speaking engagements from Procter and Gamble, Danone, Yakult and Yakult, Korea and research support from Procter and Gamble.",,70,74,89,1,37,ELSEVIER SCI LTD,OXFORD,"THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND",1521-6918,1532-1916,,BEST PRACT RES CL GA,Best Pract. Res. Clin. Gastroenterol.,FEB,2011,25,1,,,,,119,126,,10.1016/j.bpg.2011.01.003,http://dx.doi.org/10.1016/j.bpg.2011.01.003,,,8,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,743KV,21382583,,,,2024-06-04,WOS:000289018100010,View Full Record in Web of Science
J,"Han, SH; Hong, KB; Kim, EY; Ahn, SH; Suh, HJ",,,,"Han, Sung Hee; Hong, Ki Bae; Kim, Eun Young; Ahn, So Hyun; Suh, Hyung Joo",,,Effect of dual-type oligosaccharides on constipation in loperamide-treated rats,NUTRITION RESEARCH AND PRACTICE,,,English,Article,,,,,,Oligosaccharides; constipation; loperamide; gastrointestinal transit; Alcian Blue,FATTY-ACIDS; MANAGEMENT; HEALTH,"BACKGROUND/OBJECTIVE: Constipation is a condition that can result from intestinal deformation. Because humans have an upright posture, the effects of gravity can cause this shape deformation. Oligosaccharides are common prebiotics and their effects on bowel health are well known. However, studies of the physiological functionality of a product that contains both lactulose and galactooligosaccharides are insufficient. We investigated the constipation reduction effect of a dual-type oligosaccharide, Dual-Oligo, in loperamide-treated rats. MATERIALS/METHODS: Dual-Oligo consists of galactooligosaccharides (15.80%) and lactulose (51.67%). Animals were randomly divided into four groups, the normal group (normal), control group (control), low concentration of Dual-Oligo (LDO) group, and high concentration of Dual-Oligo (HDO) group. After 7 days of oral administration, fecal pellet amount, fecal weight, water content of fecal were measured. Blood chemistry, short-chain fatty acid (SCFA), gastrointestinal transit ratio and length and intestinal mucosa were analyzed. RESULTS: Dual-Oligo increased the fecal weight, and water content of feces in rats with loperamide-induced constipation. Gastrointestinal transit ratio and length and area of intestinal mucosa significantly increased after treatment with Dual-Oligo in loperamide-induced rats. A high concentration of Dual-Oligo tended to produce more acetic acid than that observed for the control group, and Dual-Oligo affected the production of total SCFA. Bifidobacteria concentration of cecal contents in the high-concentration oligosaccharide (HDO) and low-concentration oligosaccharide (LDO) groups was similar to the result of the normal group. CONCLUSIONS: These results showed that Dual-Oligo is a functional material that is derived from a natural food product and is effective in ameliorating constipation.","[Han, Sung Hee] Korea Univ, Coll Hlth Sci, Bk21Plus, Seoul 02841, South Korea; [Hong, Ki Bae] Korea Univ, Inst Biomat, Seoul 02841, South Korea; [Kim, Eun Young; Ahn, So Hyun; Suh, Hyung Joo] Korea Univ, Grad Sch, Dept Publ Hlth Sci, 145 Anam Ro, Seoul 02841, South Korea",Korea University; Korea University; Korea University,"Suh, HJ (corresponding author), Korea Univ, Grad Sch, Dept Publ Hlth Sci, 145 Anam Ro, Seoul 02841, South Korea.",suh1960@korea.ac.kr,,,"High Value-Added Food Technology Development Program, Ministry of Agriculture, Food and Rural Affairs, Sejong, Korea","High Value-Added Food Technology Development Program, Ministry of Agriculture, Food and Rural Affairs, Sejong, Korea","This research was supported by High Value-Added Food Technology Development Program, Ministry of Agriculture, Food and Rural Affairs, Sejong, Korea.",,31,11,15,1,11,KOREAN NUTRITION SOC,SEOUL,"804 KST CTR, 635-4 YEOGSAM-SONG KANGNAM-KU, SEOUL, 135-703, SOUTH KOREA",1976-1457,2005-6168,,NUTR RES PRACT,Nutr. Res. Pract.,DEC,2016,10,6,,,,,583,589,,10.4162/nrp.2016.10.6.583,http://dx.doi.org/10.4162/nrp.2016.10.6.583,,,7,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,ED9CU,27909555,"Green Published, Green Submitted",,,2024-06-04,WOS:000389168600003,View Full Record in Web of Science
J,"Eghbali, A; Ghaffari, K; Khalilpour, A; Afzal, RR; Eghbali, A; Ghasemi, A",,,,"Eghbali, Aziz; Ghaffari, Kazem; Khalilpour, Atefeh; Afzal, Roghayeh Rahimi; Eghbali, Aygin; Ghasemi, Ali",,,"The effects of LactoCare synbiotic administration on chemotherapy-induced nausea, vomiting, diarrhea, and constipation in children with ALL: A double-blind randomized clinical trial",PEDIATRIC BLOOD & CANCER,,,English,Article,,,,,,chemotherapy; constipation; diarrhea; LactoCare; nausea; vomiting,PROBIOTICS; CANCER; SUPPLEMENTATION; METAANALYSIS; PREVENTION; PREBIOTICS; EFFICACY; SAFETY,"BackgroundSynbiotics are supplements containing probiotics and prebiotics and potentially have a stronger effect in modulating the gut microbiota than probiotics or prebiotics alone. The aim of this study was to determine the effects of LactoCare synbiotic administration on chemotherapy-induced diarrhea (CID), nausea, vomiting, and constipation in children with acute lymphoblastic leukemia (ALL) who receiving maintenance chemotherapy. MethodsThis double-blind clinical trial was performed on 113 children with ALL. The patients were randomly assigned into two groups to receive either 5 x 10(9) CFU LactoCare synbiotic administration or placebo (58 patients in the LactoCare-treatment group and 55 patients in the placebo group), twice a day for 7 days. The number of times CID, vomiting, nausea, and constipation were recorded in the first week after the beginning of receiving LactoCare and the placebo. ResultsIn the LactoCare-treatment group, CID was present in 3.7% and 1.8% of patients on the first and second days, respectively, and no CID was observed on the third to seventh days (p < .05). While in the placebo group, the rate of patients with CID on the second, third, and fourth days was 11.5%, 13.5%, and 11.5%, respectively, and less than 10% on the first, fifth, sixth, and seventh days. It was observed that the rate of constipation in the LactoCare-treatment group was significantly lower than in the placebo group. The difference between the groups was about 14% on the third day, which increased to about 20% on the sixth day (p < .05). ConclusionThe use of synbiotic supplements in this study reduced CID in patients. This study supports the concept that the use of synbiotic supplements will be an easy and effective way to reduce CID in ALL patients.","[Eghbali, Aziz] Iran Univ Med Sci, Clin Res Dev Ctr, Aliasghar Hosp, Tehran, Iran; [Ghaffari, Kazem] Khomein Univ Med Sci, Dept Basic & Lab Sci, Khomein, Iran; [Khalilpour, Atefeh; Afzal, Roghayeh Rahimi] Arak Univ Med Sci, Amir Kabir Hosp, Pediat Dept, Arak, Iran; [Eghbali, Aygin] Iran Univ Med Sci, Sch Med, Tehran, Iran; [Ghasemi, Ali] Semnan Univ Med Sci, Fac Med, Dept Biochem & Hematol, Semnan, Iran",Iran University of Medical Sciences; Iran University of Medical Sciences; Semnan University of Medical Sciences,"Ghasemi, A (corresponding author), Semnan Univ Med Sci, Fac Med, Dept Biochem & Hematol, Semnan, Iran.",a.qasemi2012@yahoo.com,"ghasemi, Ali/AAM-5775-2020; ghaffari, kazem/D-9158-2016","ghasemi, Ali/0000-0002-4996-7656; ghaffari, kazem/0000-0002-6077-3123",Arak University of Medical Sciences [2873],Arak University of Medical Sciences,"Arak University of Medical Sciences, Grant/Award Number:2873",,38,3,3,3,6,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1545-5009,1545-5017,,PEDIATR BLOOD CANCER,Pediatr. Blood Cancer,JUN,2023,70,6,,,,,,,,10.1002/pbc.30328,http://dx.doi.org/10.1002/pbc.30328,,MAR 2023,7,Oncology; Hematology; Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Oncology; Hematology; Pediatrics,D8WE3,36975174,,,,2024-06-04,WOS:000956793800001,View Full Record in Web of Science
J,"Zhang, SS; Wang, RX; Li, DY; Zhao, LQ; Zhu, LX",,,,"Zhang, Shengsheng; Wang, Ruixin; Li, Danyan; Zhao, Luqing; Zhu, Lixin",,,Role of gut microbiota in functional constipation,GASTROENTEROLOGY REPORT,,,English,Review,,,,,,gut microbiota; functional constipation; bile acids; SCFA; serotonin; traditional Chinese medicine,CHAIN FATTY-ACIDS; IRRITABLE-BOWEL-SYNDROME; BILE-ACIDS; COLONIC TRANSIT; GASTROINTESTINAL DISORDERS; DOUBLE-BLIND; TRANSPORTER INHIBITOR; INTESTINAL TRANSIT; LAXATIVE USE; ADULTS,"Functional constipation (FC) is common, yet the etiology is not clear. Accumulating evidence suggests an association between FC and abnormal gut microbiota. The relationship between the gut microbiota and the gut transit is likely bidirectional. This review summarizes the current evidence regarding the impact of gut microbiota on the pathogenesis of FC. By modulating the colonic motility, secretion, and absorption, gut microbiota may contribute to the development of FC through microbial metabolic activities involving bile acids, short-chain fatty acids, 5-hydroxytryptamine, and methane. In support of the key roles of the gut microbiota in FC, treatment with probiotics, prebiotics, synbiotics, and traditional Chinese medicine often result in compositional and functional changes in the gut microbiota. Further studies on the pathogenesis of FC and the therapeutic mechanism of microecological agents will provide a knowledge base for better management of FC.","[Zhang, Shengsheng; Wang, Ruixin; Li, Danyan; Zhao, Luqing] Capital Med Univ, Beijing Hosp Tradit Chinese Med, Digest Dis Ctr, 23 Meishuguan Back St, Beijing 100010, Peoples R China; [Zhu, Lixin] Sun Yat Sen Univ, Guangdong Inst Gastroenterol, Dept Colorectal Surg,Affiliated Hosp 6, Guangdong Prov Key Lab Colorectal & Pelv Floor Di, 26 Yuancun Erheng Rd, Guangzhou 510655, Guangdong, Peoples R China",Capital Medical University; Sun Yat Sen University,"Zhao, LQ (corresponding author), Capital Med Univ, Beijing Hosp Tradit Chinese Med, Digest Dis Ctr, 23 Meishuguan Back St, Beijing 100010, Peoples R China.;Zhu, LX (corresponding author), Sun Yat Sen Univ, Guangdong Inst Gastroenterol, Dept Colorectal Surg,Affiliated Hosp 6, Guangdong Prov Key Lab Colorectal & Pelv Floor Di, 26 Yuancun Erheng Rd, Guangzhou 510655, Guangdong, Peoples R China.",zhaoluqing@bjzhongyi.com; zhulx6@mail.sysu.edu.cn,"Zhu, Lixin/ACE-1496-2022; Liu, Zhiyu/JNR-8043-2023; Huang, Liancheng/KDN-5718-2024; Wang, Ruixin/JJC-8035-2023","Zhu, Lixin/0000-0001-7904-1769; Liu, Zhiyu/0000-0001-8351-1268; Wang, Ruixin/0000-0002-4395-8492",Clinical Medicine Development Project of Beijing Municipal Administration of Hospitals [ZYLX201411]; Beijing Municipal Science & Technology Commission [Z201100006820119]; Beijing Science and technology project [z181100001718218]; Guangdong Province 'Pearl River Talent Plan' Innovation and Entrepreneurship Team Project [2019ZT08Y464]; National Key Clinical Discipline of China,Clinical Medicine Development Project of Beijing Municipal Administration of Hospitals; Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); Beijing Science and technology project; Guangdong Province 'Pearl River Talent Plan' Innovation and Entrepreneurship Team Project; National Key Clinical Discipline of China,"This work was supported by the Clinical Medicine Development Project of Beijing Municipal Administration of Hospitals [ZYLX201411], the Beijing Nova Program [Z201100006820119] from Beijing Municipal Science & Technology Commission, the Beijing Science and technology project [z181100001718218], the National Natural Science Foundation of China [81770571], the Guangdong Province 'Pearl River Talent Plan' Innovation and Entrepreneurship Team Project [2019ZT08Y464], and the National Key Clinical Discipline of China.",,104,49,55,13,79,OXFORD UNIV PRESS,OXFORD,"GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND",2052-0034,,,GASTROENTEROL REP,Gastroenterol. Rep.,OCT,2021,9,5,,,,,392,401,,10.1093/gastro/goab035,http://dx.doi.org/10.1093/gastro/goab035,,AUG 2021,10,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,WV8WQ,34733524,"Green Published, gold",,,2024-06-04,WOS:000717511400003,View Full Record in Web of Science
J,"Zawadzka, K; Kaluzinska, K; Swierz, MJ; Sawiec, Z; Antonowicz, E; Leonczyk-Spórna, M; Abadi, AK; Trofimiuk-Müldner, M; Bala, MM",,,,"Zawadzka, Karolina; Kaluzinska, Klaudia; Swierz, Mateusz J.; Sawiec, Zuzanna; Antonowicz, Ewa; Leonczyk-Sporna, Monika; Abadi, Ahmad Kamal; Trofimiuk-Mueldner, Malgorzata; Bala, Malgorzata M.",,,"Are probiotics, prebiotics, and synbiotics beneficial in primary thyroid diseases? A systematic review with meta-analysis",ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE,,,English,Review,,,,,,thyroid; probiotics; hypothyroidism; prebiotics; synbiotics,INTERNATIONAL SCIENTIFIC ASSOCIATION; CONSENSUS STATEMENT; GUT MICROBIOTA; GUIDELINES; VALIDITY; QUALITY; GRADE; SCOPE,"Introduction and Objective. A number of studies indicate the presence of a thyroid-gut axis and the important influence of the gut microbiota on thyroid function. As prebiotics, probiotics and synbiotics show therapeutic potential in the treatment of intestinal dysbiosis, the aim of this review is to evaluate the efficacy of their supplementation in primary thyroid diseases. Review Methods. Electronic databases (Ovid MEDLINE, Embase, CENTRAL), registers of clinical trials, and grey literature up to 6 October 2022 were searched for randomised controlled trials (RCTs) meeting pre-specified inclusion criteria. The protocol was registered in PROSPERO (CRD42021235054). Brief description of the state of knowledge. After screening 1,721 references, two RCTs were identified, which included 136 hypothyroid participants in total. Meta-analysis of the results after eight weeks of supplementation with predominantly Lactobacillus and Bifidobacterium strains indicated a clinically and statistically nonsignificant decrease in TSH (MD -0.19 mIU/L; 95% CI -0.43 to 0.06; I2 = 0%), and no effect on fT3 levels (MD 0.01 pg/mL; 95% CI-0.16 to 0.18; I2 = 0%). Data from single studies indicated no significant change in the levels of fT4, thyroid auto-antibodies, BMI, levothyroxine doses, and severity of symptoms measured with validated scales. Only constipation scores showed significant improvement (MD -8.71 points in the Faecal Incontinence Questionnaire; 95% CI -15.85 to -1.57; I2 = 0%). Summary. Low-certainty evidence from two randomised trials, suggests that routine administration of probiotics, prebiotics or synbiotics may result in little to no benefit in patients with primary hypothyroidism.","[Zawadzka, Karolina; Kaluzinska, Klaudia; Sawiec, Zuzanna; Antonowicz, Ewa; Leonczyk-Sporna, Monika] Jagiellonian Univ Med Coll, Fac Med, Students Sci Res Grp Systemat Reviews, Krakow, Poland; [Zawadzka, Karolina] Jagiellonian Univ Med Coll, Doctoral Sch Med & Hlth Sci, Krakow, Poland; [Swierz, Mateusz J.; Bala, Malgorzata M.] Jagiellonian Univ Med Coll, Fac Med, Chair Epidemiol & Prevent Med, Dept Hyg & Dietet, Krakow, Poland; [Abadi, Ahmad Kamal] Univ Arak, Fac Engn, Dept Comp Engn, Arak, Iran; [Trofimiuk-Mueldner, Malgorzata] Jagiellonian Univ Med Coll, Fac Med, Chair & Dept Endocrinol, Krakow, Poland",Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University,"Bala, MM (corresponding author), Jagiellonian Univ Med Coll, Fac Med, Chair Epidemiol & Prevent Med, Dept Hyg & Dietet, Krakow, Poland.",malgorzata.1.bala@uj.edu.pl,"; Bala, Malgorzata M/A-3723-2014","Zawadzka, Karolina/0000-0002-6918-4683; Trofimiuk-Muldner, Malgorzata,/0000-0001-5247-9760; Kamal Abadi, Ahmad/0000-0002-6689-3898; Leonczyk-Sporna, Monika/0000-0003-4858-8846; Swierz, Mateusz Jan/0000-0002-5269-664X; Sawiec, Zuzanna/0000-0002-3237-4029; Bala, Malgorzata M/0000-0003-1978-7264",,,,,38,3,3,1,1,"Inst Rural Health Lublin, Poland",LUBLIN,"JACZEWSKIEGO 2, PO BOX 185, 20-950 LUBLIN, POLAND",1232-1966,1898-2263,,ANN AGR ENV MED,Ann. Agr. Env. Med.,,2023,30,2,,,,,217,223,,10.26444/aaem/162732,http://dx.doi.org/10.26444/aaem/162732,,,7,"Environmental Sciences; Public, Environmental & Occupational Health",Science Citation Index Expanded (SCI-EXPANDED),"Environmental Sciences & Ecology; Public, Environmental & Occupational Health",M5HH5,37387369,gold,,,2024-06-04,WOS:001030521000002,View Full Record in Web of Science
J,"Vitetta, L; Briskey, D; Alford, H; Hall, S; Coulson, S",,,,"Vitetta, Luis; Briskey, David; Alford, Hollie; Hall, Sean; Coulson, Samantha",,,"Probiotics, prebiotics and the gastrointestinal tract in health and disease",INFLAMMOPHARMACOLOGY,,,English,Review,,,,,,Microbiome; Clinical trials; Reactive oxygen species; Probiotics; Lactobacillus; Bifidobacteria; Prebiotics; Gastrointestinal tract; Inflammation; Internal environment; Nutrition,IRRITABLE-BOWEL-SYNDROME; ANTIBIOTIC-ASSOCIATED DIARRHEA; RANDOMIZED CONTROLLED-TRIAL; LACTOBACILLUS-PLANTARUM 299V; PLACEBO-CONTROLLED TRIAL; PREVENT NECROTIZING ENTEROCOLITIS; BIFIDOBACTERIA-FERMENTED MILK; WEIGHT PRETERM INFANTS; TOLL-LIKE RECEPTORS; RAT COLONIC MUCOSA,"The microbiome located in the human gastrointestinal tract (GIT) comprises the largest community (diverse and dense) of bacteria, and in conjunction with a conducive internal milieu, promotes the development of regulated pro- and anti-inflammatory signals within the GIT that promotes immunological and metabolic tolerance. In addition, host-microbial interactions govern GIT inflammation and provide cues for upholding metabolic regulation in both the host and microbes. Failure to regulate inflammatory responses can increase the risk of developing inflammatory conditions in the GIT. Here, we review clinical studies regarding the efficacy of probiotics/prebiotics and the role they may have in restoring host metabolic homeostasis by rescuing the inflammatory response. The clinical studies reviewed included functional constipation, antibiotic-associated diarrhoea, Clostridium difficile diarrhoea, infectious diarrhoea/gastroenteritis, irritable bowel syndrome, inflammatory bowel diseases and necrotizing enterocolitis. We have demonstrated that there was an overall reduction in risk when probiotics were administered over placebo in the majority of GIT inflammatory conditions. The effect size of a cumulative reduction in relative risk for the GIT conditions/diseases investigated was 0.65 (0.61-0.70) (z = 13.3); p < 0.0001 that is an average reduction in risk of 35 % in favour of probiotics. We also progress a hypothesis that the GIT comprises numerous micro-axes (e.g. mucus secretion, Th1/Th2 balance) that are in operational homeostasis; hence probiotics and prebiotics may have a significant pharmacobiotic regulatory role in maintaining host GIT homeostasis in disease states partially through reactive oxygen species signalling.","[Vitetta, Luis; Alford, Hollie; Hall, Sean] Medlab, Sydney, NSW 2015, Australia; [Vitetta, Luis; Briskey, David; Coulson, Samantha] Univ Queensland, Sch Med, Brisbane, Qld, Australia",University of Queensland,"Vitetta, L (corresponding author), Medlab, 66 McCauley St, Sydney, NSW 2015, Australia.",l.vitetta@uq.edu.au,"Vitetta, Luis/F-4206-2010; coulson, samantha m/L-7716-2016; Briskey, David R/J-7111-2016","Vitetta, Luis/0000-0002-7490-9298; Hall, Sean/0000-0003-0090-7895",National Institute of Complementary Medicine; National Health and Medical Research Council of Australia,National Institute of Complementary Medicine; National Health and Medical Research Council of Australia(National Health & Medical Research Council (NHMRC) of Australia),Luis Vitetta has received National Institute of Complementary Medicine and National Health and Medical Research Council of Australia competitive funding and Industry support for research into probiotics.,,128,39,42,1,135,SPRINGER BASEL AG,BASEL,"PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND",0925-4692,1568-5608,,INFLAMMOPHARMACOLOGY,Inflammopharmacology,JUN,2014,22,3,,,,,135,154,,10.1007/s10787-014-0201-4,http://dx.doi.org/10.1007/s10787-014-0201-4,,,20,Immunology; Pharmacology & Pharmacy; Toxicology,Science Citation Index Expanded (SCI-EXPANDED),Immunology; Pharmacology & Pharmacy; Toxicology,AH8NH,24633989,,,,2024-06-04,WOS:000336394200001,View Full Record in Web of Science
J,"Koebnick, C; Wagner, I; Leitzmann, P; Stern, U; Zunft, HJF",,,,"Koebnick, C; Wagner, I; Leitzmann, P; Stern, U; Zunft, HJF",,,Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation,CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,,,English,Article,,,,,,constipation; gastrointestinal disorders; probiotics,CHRONIC FUNCTIONAL CONSTIPATION; DIETARY FIBER INTAKE; QUALITY-OF-LIFE; GENERAL-POPULATION; STRAIN SHIROTA; DIARRHEA; RISK; PREBIOTICS; FREQUENCY; DISEASES,"BACKGROUND: The aim of the present study was to investigate the effect of a probiotic beverage on gastrointestinal symptoms in patients with chronic constipation. METHODS: A double-blind, placebo-controlled, randomized study was conducted over a four-week period in patients with symptoms of chronic constipation (n=70). To all patients, 65 mL/day of a probiotic beverage containing Lactobacillus casei Shirota (LcS) or a sensorially identical placebo was administered. Patients completed a questionnaire on gastrointestinal symptoms, well-being and stool habits and underwent a medical examination weekly. Severity of constipation, flatulence and bloating was summarized into four categories (severe, moderately severe, mild and no symptoms). RESULTS: The consumption of LcS resulted in a significant improvement in self-reported severity of constipation and stool consistency, starting in the second week of the intervention phase (P<0.0001). Severe and moderately severe constipation was observed less in the LcS group. The occurrence and degree of flatulence or bloating sensation did not change. In the final examination, 89% of the LcS group and 56% of the placebo group showed a positive effect of their beverage on constipation (P=0.003). No adverse reactions were reported. CONCLUSIONS: The results indicate a beneficial effect on gastrointestinal symptoms of patients with chronic constipation. The administration of probiotic foodstuffs may be recommended as an adjunctive therapy of chronic constipation.","German Inst Human Nutr, Dept Intervent Studies, D-14558 Bergholz Rehbrucke, Germany; Yakult Deutschland GmbH, Neuss, Germany; Univ Giessen, Inst Nutrit Sci, D-35390 Giessen, Germany",Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Justus Liebig University Giessen,"German Inst Human Nutr, Dept Intervent Studies, Arthur Scheunert Allee 114-116, D-14558 Bergholz Rehbrucke, Germany.",Koebnick@mail.dife.de,,,,,,,46,199,220,2,45,HINDAWI LTD,LONDON,"ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND",2291-2797,,,CAN J GASTROENTEROL,Can. J. Gastroenterol. Hepatol.,NOV,2003,17,11,,,,,655,659,,10.1155/2003/654907,http://dx.doi.org/10.1155/2003/654907,,,5,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,744JZ,14631461,"Green Submitted, gold",,,2024-06-04,WOS:000186626900004,View Full Record in Web of Science
J,"Alshehri, DB; Sindi, HH; AlMusalami, IM; Rozi, IH; Shagrani, M; Kamal, NM; Alahmadi, NS; Alfuraikh, SS; Vandenplas, Y",,,,"Alshehri, Dhafer B.; Sindi, Haifa Hasan; AlMusalami, Ibrahim Mohamod; Rozi, Ibrahim Hosamuddin; Shagrani, Mohamed; Kamal, Naglaa M.; Alahmadi, Najat Saeid; Alfuraikh, Samia Saud; Vandenplas, Yvan",,,Saudi Experts Consensus on Diagnosis and Management of Pediatric Functional Constipation,PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION,,,English,Article,,,,,,Constipation; Gastrointestinal diseases; Saudi Arabia; Consensus; Feeding,NATURAL MINERAL-WATER; GASTROINTESTINAL DISORDERS; INFANT FORMULA; COWS MILK; MAGNESIUM-SULFATE; DOUBLE-BLIND; PALM OIL; PREVALENCE; RICH; EPIDEMIOLOGY,"Although functional gastrointestinal disorders (FGIDs) are very common in pediatric patients, there is a scarcity of published epidemiologic data, characteristics, and management patterns from Saudi Arabia, which is the 2nd largest Arabic country in terms of area and the 6th largest Arabic country in terms of population, with 10% of its population aged <5 years. Functional constipation (FC) is an FGID that has shown a rising prevalence among Saudi infants and children in the last few years, which urges us to update our clinical practices. Nine pediatric consultants attended two advisory board meetings to discuss and address current challenges, provide solutions, and reach a Saudi national consensus for the management of pediatric constipation. The pediatric consultants agreed that pediatricians should pay attention to any alarming signs (red flags) found during history taking or physical examinations. They also agreed that the Rome IV criteria are the gold standard for the diagnosis of pediatric FC. Different therapeutic options are available for pediatric patients with FC. Dietary treatment is recommended for infants with constipation for up to six months of age. When non-pharmacological interventions fail to improve FC symptoms, pharmacological treatment with laxatives is indicated. First, the treatment is aimed at disimpaction to remove fecal masses. This is achieved by administering a high dose of oral polyethylene glycol (PEG) or lactulose for a few days. Subsequently, maintenance therapy with PEG should be initiated to prevent the re-accumulation of feces. In addition to PEG, several other options may be used, such as Mg-rich formulas or stimulant laxatives. However, rectal enemas and suppositories are usually reserved for cases that require acute pain relief. In contrast, infant formulas that contain prebiotics or probiotics have not been shown to be effective in infant constipation, while the use of partially hydrolyzed formula is inconclusive. These clinical practice recommendations are intended to be adopted by pediatricians and primary care physicians across Saudi Arabia.","[Alshehri, Dhafer B.] Najran Univ, Fac Med, Dept Pediat, Najran, Saudi Arabia; [Sindi, Haifa Hasan] Royal Commiss Med Ctr, Yanbu, Saudi Arabia; [AlMusalami, Ibrahim Mohamod] Matern & Childrens Hosp, Pediat Dept, Dammam, Saudi Arabia; [Rozi, Ibrahim Hosamuddin] King Fahd Armed Forces Hosp, Dept Pediat, Jeddah, Saudi Arabia; [Shagrani, Mohamed] King Faisal Specialist Hosp & Res Ctr, Pediat Gastroenterol, Riyadh, Saudi Arabia; [Kamal, Naglaa M.] Cairo Univ, Kasr Alainy Fac Med, Pediat Dept, Cairo, Egypt; [Kamal, Naglaa M.] Alhada Armed Forces Hosp, Gastroenterol & Nutr, Pediat Hepatol, At Taif, Saudi Arabia; [Alahmadi, Najat Saeid] Minist Hlth, King Salman Med City, Pediat Dept, Almadinah Almonawarah, Saudi Arabia; [Alfuraikh, Samia Saud] Minist Natl Guard Hlth Affairs, King Abdul Aziz Hosp, Eastern Region, Saudi Arabia; [Vandenplas, Yvan] Vrije Univ Brussel, KidZ Hlth Castle, UZ Brussel, Laarbeeklaan 101, B-1090 Brussels, Belgium",Najran University; King Fahd Armed Forces Hospital; King Faisal Specialist Hospital & Research Center; Egyptian Knowledge Bank (EKB); Cairo University; Al Hada Armed Forces Hospital; King Saud Bin Abdulaziz University for Health Sciences; Ministry of National Guard - Health Affairs; University Hospital Brussels; Vrije Universiteit Brussel,"Vandenplas, Y (corresponding author), Vrije Univ Brussel, KidZ Hlth Castle, UZ Brussel, Laarbeeklaan 101, B-1090 Brussels, Belgium.",yvan.vandenplas@uzbrussel.be,,"Sindi, Haifa/0000-0002-7583-2691; SHAGRANI, MOHAMMAD/0000-0001-7325-9441; Mohamed Kamal, Naglaa/0000-0002-8535-3838; alahmadi, najat/0000-0003-4839-2747; Alshehri, Dhafer/0000-0002-7382-3337; Rozi, Ibrahim/0000-0002-0132-7641",,,,,80,4,4,0,3,KOREAN SOC PEDIATRIC GASTROENTEROLOGY & NUTRITION,SEOUL,"301 DONGSUNG-DONG 25-I, JONGNO-GU, SEOUL, 301 DONGSUNG, SOUTH KOREA",2234-8646,2234-8840,,PEDIATR GASTROENTERO,Pediatr. Gastroenterol. Hepatol. Nutr.,MAY,2022,25,3,,,,,163,179,,10.5223/pghn.2022.25.3.163,http://dx.doi.org/10.5223/pghn.2022.25.3.163,,,17,Pediatrics,Emerging Sources Citation Index (ESCI),Pediatrics,1M6FP,35611377,"gold, Green Published",,,2024-06-04,WOS:000800063200001,View Full Record in Web of Science
J,"Wilson, B; Rossi, M; Dimidi, E; Whelan, K",,,,"Wilson, Bridgette; Rossi, Megan; Dimidi, Eirini; Whelan, Kevin",,,Prebiotics in irritable bowel syndrome and other functional bowel disorders in adults: a systematic review and meta-analysis of randomized controlled trials,AMERICAN JOURNAL OF CLINICAL NUTRITION,,,English,Review,,,,,,Prebiotics; IBS; FBD; inulin-type fructans; galactooligosaccharides,CHRONIC IDIOPATHIC CONSTIPATION; GUT MICROBIOTA; SYMPTOMS; PROBIOTICS; DIET; OLIGOSACCHARIDES; MONOSACCHARIDES; RESTRICTION; DEFINITION; MANAGEMENT,"Background: Irritable bowel syndrome (IBS) and other functional bowel disorders (FBDs) are prevalent disorders with altered microbiota. Prebiotics positively augment gut microbiota and may offer therapeutic potential. Objectives: The aim of this study was to investigate the effect of prebiotics compared with placebo on global response, gastrointestinal symptoms, quality of life (QoL), and gut microbiota, via systematic review and meta-analysis of randomized controlled trials (RCTs) in adults with IBS and other FBDs. Methods: Studies were identified using electronic databases, back-searching reference lists, and hand-searching abstracts. RCTs that compared prebiotics to placebo in adults with IBS or other FBDs were included. Two reviewers independently performed screening, data extraction, and bias assessment. Outcome data were synthesized as ORs, weighted mean differences (WMDs) or standardized mean differences (SMDs) with the use of a random-effects model. Subanalyses were performed for type of FBD and dose, type, and duration of prebiotic. Results: Searches identified 2332 records, and 11 RCTs were eligible (729 patients). The numbers responding were 52/97 (54%) for prebiotic and 59/94 (63%) for placebo, with no difference between groups (OR: 0.62; 95% CI: 0.07, 5.69; P = 0.67). Similarly, no differences were found for severity of abdominal pain, bloating and flatulence, and QoL score between prebiotics and placebo. However, flatulence severity was improved by prebiotics at doses <= 6 g/d (SMD: -0.35; 95% CI: -0.71, 0.00; P = 0.05) and by non-inulin-type fructan prebiotics (SMD: -0.34; 95% CI: -0.66, -0.01; P = 0.04), while inulin-type fructans worsened flatulence (SMD: 0.85; 95% CI: 0.23, 1.47; P = 0.007). Prebiotics increased absolute abundance of bifidobacteria (WMD: 1.16 log(10) copies of the 16S ribosomal RNA gene; 95% CI: 0.06, 2.26; P = 0.04). No studies were at low risk of bias across all bias categories. Conclusions: Prebiotics do not improve gastrointestinal symptoms or QoL in patients with IBS or other FBDs, but they do increase bifidobacteria. Variations in prebiotic type and dose impacted symptom improvement or exacerbation. This review was registered at PROSPERO as CRD42017074072.","[Wilson, Bridgette; Rossi, Megan; Dimidi, Eirini; Whelan, Kevin] Kings Coll London, Dept Nutr Sci, London, England",University of London; King's College London,"Whelan, K (corresponding author), Kings Coll London, Dept Nutr Sci, London, England.",kevin.whelan@kcl.ac.uk,"Whelan, Kevin/ABD-5154-2021; Whelan, Kevin/ABD-5350-2021","Whelan, Kevin/0000-0001-5414-2950; Dimidi, Eirini/0000-0003-0140-0199",Clasado Biosciences Ltd; National Institute of Health Research; Medical Research Council; Crohn's and Colitis UK; ForCrohns; Helmsley Charitable Trust; Kenneth Rainin Foundation; Almond Board of California; Clasado Biosciences; International Nut and Dried Fruit Council Foundation; Nestle,Clasado Biosciences Ltd; National Institute of Health Research(National Institutes of Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Crohn's and Colitis UK(Crohn's & Colitis Foundation of America); ForCrohns; Helmsley Charitable Trust; Kenneth Rainin Foundation; Almond Board of California; Clasado Biosciences; International Nut and Dried Fruit Council Foundation; Nestle(Nestle SA),"This systematic review was part of a doctoral fellowship funded by Clasado Biosciences Ltd, a dietary supplement company that produce prebiotics. Clasado Biosciences Ltd played no role in the decision to undertake this systematic review, nor any role in its design, implementation, analysis, or interpretation.; The authors received research funding from government bodies including National Institute of Health Research (KW) and Medical Research Council (KW, MR), charities including Crohn's and Colitis UK (KW, BW), ForCrohns (MR, KW), Helmsley Charitable Trust (KW, MR), and Kenneth Rainin Foundation (KW), and industry bodies including Almond Board of California (KW, MR, ED), Clasado Biosciences (KW, BW), International Nut and Dried Fruit Council Foundation (KW, ED, MR), and Nestle (KW, ED).",,57,67,71,9,34,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",0002-9165,1938-3207,,AM J CLIN NUTR,Am. J. Clin. Nutr.,APR,2019,109,4,,,,,1098,1111,,10.1093/ajcn/nqy376,http://dx.doi.org/10.1093/ajcn/nqy376,,,14,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,IM5WM,30949662,"hybrid, Green Submitted",,,2024-06-04,WOS:000478064700009,View Full Record in Web of Science
J,"Barboi, OB; Chirila, I; Ciortescu, I; Anton, C; Drug, VL",,,,"Barboi, Oana-Bogdana; Chirila, Ioan; Ciortescu, Irina; Anton, Carmen; Drug, Vasile-Liviu",,,"Inulin, Choline and Silymarin in the Treatment of Irritable Bowel Syndrome with Constipation-Randomized Case-Control Study",JOURNAL OF CLINICAL MEDICINE,,,English,Article,,,,,,irritable bowel syndrome; constipation; inulin; choline; silymarin,CHICORY INULIN; FECAL MICROBIOTA; CONSUMPTION; THERAPY,"(1) Background: Irritable bowel syndrome (IBS) is a common disease, with multiple pathophysiological mechanisms involved. A single treatment for all the patients with IBS is not possible. Prebiotics may have a beneficial effect on IBS patients with constipation. (2) Methods: A randomized cross-over case-control study was conducted, including patients with IBS and constipation (IBS-C), who were randomized into two groups receiving a specific constipation diet with or without a food supplement containing inulin, choline and silymarin (Stoptoxin (R), Fiterman Pharma, Iasi, Romania). Patients were evaluated at baseline, after four and eight weeks, using a questionnaire to assess IBS symptoms. (3) Results: 51 IBS-C patients were included, of which 47 patients finished the trial (33 women, mean age 52.82 years). Adding Stoptoxin (R) to a diet for constipation brought extra benefits. Abdominal pain severity improved by 68.3% after the diet and Stoptoxin (R) (p = 0.004) and abdominal bloating severity parameter improved by 34.8% (p = 0.040). The stool number per week and the stool consistency according to the Bristol scale were improved, but without statistical significance between groups (p > 0.05). (4) Conclusions: The combination of inulin, choline and silymarin associated with a specific-constipation diet had obvious clinical beneficial effects on IBS-C patients in terms of bowel movement, abdominal pain and bloating.","[Barboi, Oana-Bogdana; Ciortescu, Irina; Anton, Carmen; Drug, Vasile-Liviu] Grigore T PopaUniv Med & Pharm, Dept Gastroenterol, Iasi 700115, Romania; [Barboi, Oana-Bogdana; Ciortescu, Irina; Anton, Carmen; Drug, Vasile-Liviu] St Spiridon Hosp, Inst Gastroenterol & Hepatol, Iasi 700111, Romania; [Chirila, Ioan] Natl Inst Publ Hlth RCoPH, Environm Hlth Dept, Iasi 700465, Romania",Grigore T Popa University of Medicine & Pharmacy; Grigore T Popa University of Medicine & Pharmacy,"Ciortescu, I (corresponding author), Grigore T PopaUniv Med & Pharm, Dept Gastroenterol, Iasi 700115, Romania.;Ciortescu, I (corresponding author), St Spiridon Hosp, Inst Gastroenterol & Hepatol, Iasi 700111, Romania.",oany_leo@yahoo.com; chirilaioan@gmail.com; irinaciortescu@yahoo.com; carmen_ro2008@yahoo.com; vasidrug@email.com,"ciortescu, irina/AFJ-8114-2022",,"SC Fiterman Pharma SRL, Romania [692/14.12.2015, NCT03174561]","SC Fiterman Pharma SRL, Romania","This research was funded by SC Fiterman Pharma SRL, Romania, with Clinical Study Identifier, NCT03174561 and funding number 692/14.12.2015.",,23,4,4,4,9,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2077-0383,,J CLIN MED,J. Clin. Med.,APR,2022,11,8,,,,,,,2248,10.3390/jcm11082248,http://dx.doi.org/10.3390/jcm11082248,,,11,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,0U9AK,35456341,"Green Published, gold",,,2024-06-04,WOS:000787938500001,View Full Record in Web of Science
J,"Cardile, S; Alterio, T; Arrigo, T; Salpietro, C",,,,"Cardile, Sabrina; Alterio, Tommaso; Arrigo, Teresa; Salpietro, Carmelo",,,Role of prebiotics and probiotics in pediatric diseases,MINERVA PEDIATRICA,,,English,Review,,,,,,Probiotics; Prebiotics; Gastrointestinal microbiome; Therapy; Children,IRRITABLE-BOWEL-SYNDROME; INTESTINAL MICROFLORA; GUT MICROBIOTA; DOUBLE-BLIND; CHILDREN; PREVENTION; INFANTS; HEALTH; FLORA; CONSTIPATION,"The increasing knowledge about the composition and activities of the microflora has shown the close link between the bacteria and the health of the human organism. For this reason it has focused attention on the possibility of modulating the gut flora. The use of probiotics and prebiotics has increased enormously in recent years, more for real beneficial effects demonstrated in patients than for their safety profiles. However, it is recorded an indiscriminate use also in conditions in which there are no scientific evidence to support. Their use in case of immunocompromised patients or with severe and debilitating chronic diseases should be very prudent, because of the risk of complications including sepsis. The use of a probiotic cannot ignore the knowledge of the genus and species of the strain and in pediatric patients has been demonstrated their role for treating acute viral gastroenteritis and preventing antibiotic-associated diarrhea in healthy children. Moreover probiotics are considered as an option for recurrent and relapsing antibiotic sensitive pouchitis and in select patients with mild ulcerative colitis. Further studies are needed to evaluate clinical conditions that may require their use and to define the optimal doses and intake durations.","[Cardile, Sabrina; Alterio, Tommaso; Arrigo, Teresa; Salpietro, Carmelo] Univ Messina, Dept Pediat Sci, Messina, Italy",University of Messina,"Alterio, T (corresponding author), Univ Messina, Gaetano Martino Univ Policlin, Dept Pediat Sci, Via Consolare Valeria 1, I-98125 Messina, Italy.",t.alterio@gmail.com,"Damiano, Carmelo Salpietro/AAL-2945-2020; Alterio, Tommaso/AAB-7657-2019","Damiano, Carmelo Salpietro/0000-0001-8794-2292; Alterio, Tommaso/0000-0002-3082-855X",,,,,80,5,7,0,14,EDIZIONI MINERVA MEDICA,TURIN,"CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY",0026-4946,1827-1715,,MINERVA PEDIATR,Minerva Pediat.,DEC,2016,68,6,,,,,487,497,,,,,,11,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,EL4YY,25926157,,,,2024-06-04,WOS:000394629500012,View Full Record in Web of Science
B,"Boler, BMV; Fahey, GC",,"Callaway, TR; Ricke, SC",,"Boler, Brittany M. Vester; Fahey, George C., Jr.",,,Prebiotics of Plant and Microbial Origin,DIRECT-FED MICROBIALS AND PREBIOTICS FOR ANIMALS: SCIENCE AND MECHANISMS OF ACTION,,,English,Article; Book Chapter,,,,,,,CHAIN FATTY-ACIDS; HUMAN COLONIC MICROBIOTA; NONDIGESTIBLE OLIGOSACCHARIDES; PUTREFACTIVE PRODUCTS; FECAL BIFIDOBACTERIA; DIETARY MODULATION; IMMUNE FUNCTIONS; INULIN; OLIGOFRUCTOSE; FERMENTATION,"The food industry is constantly shifting focus based on what is most important to the consumer. Products are marketed currently that are believed to provide health benefits to the consumer such as beneficial effects on health or as disease preventatives. Much of the focus is on oligosaccharides as health-promoting substrates. Many oligosaccharides are resistant to digestion and absorption by mammalian enzymes and, therefore, reach the large bowel where they may be fermented by the resident bacteria. Beyond their potential as substrates for fermentation, oligosaccharides are popular food additives due in large part to their low caloric value and their ability to enhance mineral absorption. Health benefits include alleviation of constipation, reduced risk of infection and diarrhea, and improved immune response. Many oligosaccharides modulate microbiota of the large bowel by increasing bifidobacteria and lactobacilli populations and decreasing clostridia populations. This review will describe the manufacturing processes for select non-digestible oligosaccharides and other food ingredients currently classified as prebiotics and those with prebiotic potential.","[Boler, Brittany M. Vester; Fahey, George C., Jr.] Univ Illinois, Dept Anim Sci, Anim Sci Lab 132, Urbana, IL 61801 USA",University of Illinois System; University of Illinois Urbana-Champaign,"Fahey, GC (corresponding author), Univ Illinois, Dept Anim Sci, Anim Sci Lab 132, 328 Mumford Hall, Urbana, IL 61801 USA.",gcfahey@illinois.edu,,,,,,,80,14,16,0,5,SPRINGER,NEW YORK,"233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES",,,978-1-4614-1310-3,,,,2012,,,,,,,13,26,,10.1007/978-1-4614-1311-0_2,http://dx.doi.org/10.1007/978-1-4614-1311-0_2,10.1007/978-1-4614-1311-0,,14,Food Science & Technology; Microbiology,Book Citation Index – Science (BKCI-S),Food Science & Technology; Microbiology,BBG95,,,,,2024-06-04,WOS:000306815400003,View Full Record in Web of Science
J,"Xie, CY; Gao, W; Liang, XD; Chye, FY",,,,"Xie, Chanyuan; Gao, Wei; Liang, Xingdi; Chye, Fook Yee",,,Effects of garlic-derived fructan and oligofructose mixtures on intestinal health and constipation relief in mice,JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE,,,English,Article; Early Access,,,,,,constipation; garlic polysaccharides; intestinal barrier; neurotransmitters; short-chain fatty acids,,"BACKGROUNDGarlic polysaccharides (GPs) constitute over 75% of the dry weight of garlic. They are characterized by fructan with a 2,1-beta-d-Fruf backbone and 2,6-beta-d-Fruf branches. Studies have suggested a role for GPs in regulating gut microbiota but whether they possess a comprehensive function in maintaining intestinal well-being and can serve as effective prebiotics remains unknown. To explore this, varied doses of GPs (1.25-5.0 g kg-1 body weight) and inulin (as a positive control) were administered to Kunming mice via gavage, and their effects on the intestinal epithelial, chemical, and biological barriers were assessed. A constipation model was also established using loperamide to investigate the potential effects of GPs on the relief of constipation.RESULTSAdministration of GPs significantly upregulated expression of tight-junction proteins and mucins in Kunming mouse small-intestine tissue. Garlic polysaccharides elevated cecal butyric acid content, reduced the abundance of Desulfobacterota, and decreased the ratio of Firmicutes to Bacteroidetes (the F/B ratio). Garlic polysaccharides also promoted the growth of Bacteroides acidifaciens and Clostridium saccharogumia. Tax4Fun functional predictions suggested the potential of GPs to prevent human diseases, reducing the risk of insulin resistance, infectious diseases, and drug resistance. Garlic polysaccharides also exhibited a beneficial effect in alleviating loperamide-induced constipation symptoms by enhancing small intestinal transit, softening stool consistency, accelerating bowel movements, and promoting the release of excitatory neurotransmitters.CONCLUSIONSThese findings highlight the important role of GPs in maintaining gut fitness by enhancing intestinal barrier function and peristalsis. Garlic polysaccharides are promising prebiotics, potentially contributing to overall intestinal well-being and health. (c) 2024 Society of Chemical Industry.","[Xie, Chanyuan; Chye, Fook Yee] Univ Malaysia Sabah, Fac Food Sci & Nutr, Food Secur Res Lab, Kota Kinabalu 88400, Sabah, Malaysia; [Xie, Chanyuan] Hebei Univ Engn, Sch Life Sci & Food Engn, Handan, Peoples R China; [Xie, Chanyuan] Hebei Univ Engn, Sch Life Sci & Food Engn, Key Lab Nat Prod & Funct Food Dev Handan City, Handan, Peoples R China; [Gao, Wei; Liang, Xingdi] Chenguang Biotech Grp Co Ltd, Key Lab Comprehens Utilizat Plant Resources Hebei, Handan, Peoples R China; [Gao, Wei] Chenguang Biotech Grp Co Ltd, Handan 057250, Hebei, Peoples R China",Universiti Malaysia Sabah; Hebei University of Engineering; Hebei University of Engineering,"Chye, FY (corresponding author), Univ Malaysia Sabah, Fac Food Sci & Nutr, Food Secur Res Lab, Kota Kinabalu 88400, Sabah, Malaysia.;Gao, W (corresponding author), Chenguang Biotech Grp Co Ltd, Handan 057250, Hebei, Peoples R China.",gaowei2003425@163.com; fychye@ums.edu.my,,,Hebei Province Major Scientific and Technological Achievements Transformation Special Project; Hebei Provincial Department of Science and Technology; [215A2801D],Hebei Province Major Scientific and Technological Achievements Transformation Special Project; Hebei Provincial Department of Science and Technology;,"This work was supported by the Hebei Province Major Scientific and Technological Achievements Transformation Special Project (grant number: 215A2801D), funded by the Hebei Provincial Department of Science and Technology.",,37,0,0,0,0,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0022-5142,1097-0010,,J SCI FOOD AGR,J. Sci. Food Agric.,2024 MAY 14,2024,,,,,,,,,,10.1002/jsfa.13567,http://dx.doi.org/10.1002/jsfa.13567,,MAY 2024,12,"Agriculture, Multidisciplinary; Chemistry, Applied; Food Science & Technology",Science Citation Index Expanded (SCI-EXPANDED),Agriculture; Chemistry; Food Science & Technology,QM3Z4,38742546,,,,2024-06-04,WOS:001221264500001,View Full Record in Web of Science
J,"Dey, K; Sheth, M; Anand, S; Archana, G; Raval, S",,,,"Dey, Kankona; Sheth, Mini; Anand, Shankar; Archana, G.; Raval, Shivani",,,"Daily consumption of galactooligosaccharide gummies ameliorates constipation symptoms, gut dysbiosis, degree of depression and quality of life among sedentary university teaching staff: A double-blind randomized placebo control clinical trial",INDIAN JOURNAL OF GASTROENTEROLOGY,,,English,Article,,,,,,BDI; Chronic constipation; Depression; Galactooligosaccharide; Gut dysbiosis; Idiopathic constipation; Prebiotics; QOL; Real-time PCR; SCFA; Sedentary lifestyle,FUNCTIONAL CONSTIPATION; INTESTINAL MICROBIOTA; PROBIOTICS; ASSOCIATION; ADULTS,"BackgroundFunctional constipation affects approximately 10% of the Indian population and may reduce the quality of life (QOL) and increase gut dysbiosis.Purpose of studyThe study aimed at assessing the impact of galactooligosaccharide (GOS) gummy supplementation on gut health, depression status and QOL of constipated subjects.MethodsA double-blind placebo control clinical trial (CTRI/2021/10/037474) was conducted on sedentary constipated adults (n = 35), who were split into an experimental group (n = 17) and a control group (n = 18), supplemented with 10 g GOS and sugar gummies, respectively, for 30 days. Relative abundance of fecal gut microbes, including Bifidobacterium, Lactobacillus, Clostridium and Bacteroides and phyla Bacteroidetes and Firmicutes using real-time polymerase chain reaction and short-chain fatty acids, was analyzed pre and post supplementation. Constipation profile was studied using Rome IV criteria and the Bristol stool chart. Depression status was studied using the Becks Depression Inventory. The QOL was assessed using patient assessment of constipation.ResultsGOS gummy supplementation increased Bifidobacterium and Lactobacillus by 1230% and 322%, respectively, (p < 0.001; p < 0.01) with reduced Clostridium by 63%, phylum Firmicutes by 73% and Bacteroidetes by 85% (p < 0.01). The GOS-supplemented group demonstrated a higher F/B ratio (4.2) indicating improved gut health (p < 0.01) with reduced gut dysbiosis and constipation severity. GOS gummies enhanced acetic acid and butyric acid levels compared to the control group (p < 0.01; p < 0.001). Post supplementation, there was 40% reduction in depression (p < 0.01) and 22% improvement in QOL (p < 0.05).ConclusionsThis research validates the predicted beneficial benefits of short-term GOS consumption on constipation profile, gut microflora, depression status and quality of life of constipated subjects.{GRAPHIACAL ABSTRACT}","[Dey, Kankona; Sheth, Mini] Maharaja Sayajirao Univ Baroda, Dept Food & Nutr, Vadodara 390 002, India; [Anand, Shankar] Syri Res Private Ltd, Vadodara 391740, India; [Archana, G.; Raval, Shivani] Maharaja Sayajirao Univ Baroda, Dept Microbiol & Biotechnol Ctr, Vadodara 390002, India",Maharaja Sayajirao University Baroda; Maharaja Sayajirao University Baroda,"Dey, K (corresponding author), Maharaja Sayajirao Univ Baroda, Dept Food & Nutr, Vadodara 390 002, India.",deykankona@gmail.com,,"Anand, Shankar/0000-0003-1359-6416; Dey, Kankona/0000-0002-5195-2461","The authors acknowledge Department of Food and Nutrition, The Maharaja Sayajirao University of Baroda, for the support of work related to this research article and Tata Chemicals Pvt. Ltd. for supply of GOS for research purpose.; Department of Food and Nutrition, The Maharaja Sayajirao University of Baroda","The authors acknowledge Department of Food and Nutrition, The Maharaja Sayajirao University of Baroda, for the support of work related to this research article and Tata Chemicals Pvt. Ltd. for supply of GOS for research purpose.; Department of Food and Nutrition, The Maharaja Sayajirao University of Baroda","The authors acknowledge Department of Food and Nutrition, The Maharaja Sayajirao University of Baroda, for the support of work related to this research article and Tata Chemicals Pvt. Ltd. for supply of GOS for research purpose.",,30,1,1,6,7,SPRINGER INDIA,NEW DELHI,"7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA",0254-8860,0975-0711,,INDIAN J GASTROENTER,Indian J. Gastroenterol.,DEC,2023,42,6,,,,,839,848,,10.1007/s12664-023-01435-8,http://dx.doi.org/10.1007/s12664-023-01435-8,,SEP 2023,10,Gastroenterology & Hepatology,Emerging Sources Citation Index (ESCI),Gastroenterology & Hepatology,AO6B2,37751049,,,,2024-06-04,WOS:001072245400001,View Full Record in Web of Science
J,"Macfarlane, S; Macfarlane, GT; Cummings, JH",,,,"Macfarlane, S.; Macfarlane, G. T.; Cummings, J. H.",,,Review article: prebiotics in the gastrointestinal tract,ALIMENTARY PHARMACOLOGY & THERAPEUTICS,,,English,Review,,,,,,,INULIN-TYPE FRUCTANS; HUMAN COLONIC MICROBIOTA; CALCIUM-ABSORPTION; NONDIGESTIBLE OLIGOSACCHARIDES; BACTERIAL FERMENTATION; BONE MINERALIZATION; SHORT-CHAIN; GALACTO-OLIGOSACCHARIDES; ULCERATIVE-COLITIS; DIETARY MODULATION,"Prebiotics are short-chain carbohydrates that alter the composition, or metabolism, of the gut microbiota in a beneficial manner. It is therefore expected that prebiotics will improve health in a way similar to probiotics, whilst at the same time being cheaper, and carrying less risk and being easier to incorporate into the diet than probiotics. To review published evidence for prebiotic effects on gut function and human health. We searched the Science Citation Index with the terms prebiotic, microbiota, gut bacteria, large intestine, mucosa, bowel habit, constipation, diarrhoea, inflammatory bowel disease, Crohn's disease, ulcerative colitis, pouchitis, calcium and cancer, focussing principally on studies in humans and reports in the English language. Search of the Cochrane Library did not identify any clinical study or meta-analysis on this topic. Three prebiotics, oligofructose, galacto-oligosaccharides and lactulose, clearly alter the balance of the large bowel microbiota by increasing bifidobacteria and Lactobacillus numbers. These carbohydrates are fermented and give rise to short-chain fatty acid and intestinal gas; however, effects on bowel habit are relatively small. Randomized-controlled trials of their effect in a clinical context are few, although animal studies show anti-inflammatory effects in inflammatory bowel disease, while calcium absorption is increased. It is still early days for prebiotics, but they offer the potential to modify the gut microbial balance in such a way as to bring direct health benefits cheaply and safely.","Univ Dundee, Ninewells Hosp & Med Sch, Gut Grp, Div Pathol & Neurosci, Dundee DD1 9SY, Scotland",University of Dundee,"Macfarlane, S (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Gut Grp, Div Pathol & Neurosci, Dundee DD1 9SY, Scotland.",s.macfarlane@dundee.ac.uk,"Cummings, John H/H-3538-2011; Cummings, John/AAC-2007-2019",,,,,,101,440,523,1,189,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0269-2813,1365-2036,,ALIMENT PHARM THER,Aliment. Pharmacol. Ther.,SEP 1,2006,24,5,,,,,701,714,,10.1111/j.1365-2036.2006.03042.x,http://dx.doi.org/10.1111/j.1365-2036.2006.03042.x,,,14,Gastroenterology & Hepatology; Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Pharmacology & Pharmacy,074GD,16918875,Bronze,,,2024-06-04,WOS:000239799800001,View Full Record in Web of Science
J,"Camacho-Díaz, BH; Arenas-Ocampo, ML; Osorio-Díaz, P; Jiménez-Aparicio, AR; Alvarado-Jasso, GM; Saavedra-Briones, EV; Valdovinos-Díaz, MA; Gómez-Reyes, E",,,,"Camacho-Diaz, Brenda Hildeliza; Arenas-Ocampo, Martha Lucia; Osorio-Diaz, Perla; Jimenez-Aparicio, Antonio Ruperto; Alvarado-Jasso, Guadalupe Monserrat; Saavedra-Briones, Eden Valfre; Valdovinos-Diaz, Miguel angel; Gomez-Reyes, Elisa",,,"The Effects of Agave Fructans in a Functional Food Consumed by Patients with Irritable Bowel Syndrome with Constipation: A Randomized, Double-Blind, Placebo-Controlled Trial",NUTRIENTS,,,English,Article,,,,,,IBS; constipation; prebiotic jelly; agave fructans; functional foods; prebiotics; fiber intake; intestinal movements,QUALITY-OF-LIFE; MEXICAN CONSENSUS; GUT MICROBIOTA; DIETARY FIBER; DEPRESSION; IBS; VALIDATION; ANXIETY; ALTERS,"Irritable bowel syndrome displays three different subtypes: constipation (IBS-C), diarrhea (IBS-D), and mixed (IBS-M). Treatment with dietary fiber is used, with consideration given both to the chemical composition of the fiber and to the different subtypes of IBS. The IBS-D subtype is usually treated with a low-FODMAPs diet, whereas the IBS-C subtype suggests prebiotics and probiotics to promote microbiota restoration. The aim of this study was to assess the effects of employing agave fructans as the soluble fiber of a jelly (Gelyfun (R) gastro) containing 8 g per serving in the IBS-C group (n = 50), using a randomized, double-blind, time-limited trial for four weeks. We evaluated changes in the frequency and types of bowel movements through the Bristol scale, and the improvement of the condition was evaluated using quality of life (IBS-QOL) and anxiety-depression (HADS) scales. The main results were that the number of bowel movements increased by more than 80%, with at least one stool per day from fifteen days onwards, without a laxative effect for the group treated. Finally, the quality of life with the prebiotic jelly was significantly improved compared to the placebo in all specific domains, in addition to significantly reducing anxiety and depression.","[Camacho-Diaz, Brenda Hildeliza; Arenas-Ocampo, Martha Lucia; Osorio-Diaz, Perla; Jimenez-Aparicio, Antonio Ruperto] Inst Politecn Nacl, Ctr Desarrollo Prod Biot, Yautepec 62731, Morelos, Mexico; [Alvarado-Jasso, Guadalupe Monserrat] Ctr Nacl Tecnol & Seguridad Alimentaria CNTA, Ctra NA-134 Km 53, San Adrian 31570, Navarra, Spain; [Saavedra-Briones, Eden Valfre] Univ Autonoma Estado Morelos, Fac Nutr, Cuernavaca 62290, Morelos, Mexico; [Valdovinos-Diaz, Miguel angel] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Gastrointestinal Motilidad Lab, Dept Gastroenterol, Ciudad De Mexico 14080, Mexico; [Gomez-Reyes, Elisa] Tecnol Monterrey, Escuela Med & Ciencias Salud, Campus Ciudad Mexico,Calle Puente 222, Ciudad De Mexico 14380, Mexico",Instituto Politecnico Nacional - Mexico; Universidad Autonoma del Estado de Morelos; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Tecnologico de Monterrey,"Camacho-Díaz, BH (corresponding author), Inst Politecn Nacl, Ctr Desarrollo Prod Biot, Yautepec 62731, Morelos, Mexico.;Gómez-Reyes, E (corresponding author), Tecnol Monterrey, Escuela Med & Ciencias Salud, Campus Ciudad Mexico,Calle Puente 222, Ciudad De Mexico 14380, Mexico.",bcamacho@ipn.mx; mlarenas@ipn.mx; posorio@ipn.mx; aaparici@ipn.mx; gpemonserratjasso@gmail.com; eden.saavedra@uaem.edu.mx; miguelvaldovinosd@gmail.com; elisa.gomez@tec.mx,,,Fundacion MAPFRE; Ignacio H. Larramendi; Secretaria de Investigacion y Posgrado del Instituto Politecnico Nacional [SIP 20131913]; Instituto Morelense para el Financiamiento del Sector Productivo,Fundacion MAPFRE; Ignacio H. Larramendi; Secretaria de Investigacion y Posgrado del Instituto Politecnico Nacional; Instituto Morelense para el Financiamiento del Sector Productivo,"This research was funded by Fundacion MAPFRE with the Ignacio H. Larramendi grant; by a research project from Secretaria de Investigacion y Posgrado del Instituto Politecnico Nacional with grant number SIP 20131913; and by Instituto Morelense para el Financiamiento del Sector Productivo, FM/fortalece12/052/2023.",,50,0,0,2,2,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,AUG,2023,15,16,,,,,,,3526,10.3390/nu15163526,http://dx.doi.org/10.3390/nu15163526,,,15,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,Q4QQ6,37630717,"gold, Green Published",,,2024-06-04,WOS:001057387100001,View Full Record in Web of Science
J,"de Milliano, I; Tabbers, MM; van der Post, JA; Benninga, MA",,,,"de Milliano, Inge; Tabbers, Merit M.; van der Post, Joris A.; Benninga, Marc A.",,,Is a multispecies probiotic mixture effective in constipation during pregnancy? 'A pilot study',NUTRITION JOURNAL,,,English,Article,,,,,,Probiotics; Constipation; Pregnancy,INULIN-TYPE PREBIOTICS; DOUBLE-BLIND; GASTROINTESTINAL DISORDERS; LACTOBACILLUS-GG; MANAGEMENT; SYMPTOMS; DIARRHEA; IMPACT; HARD,"Background: Constipation during pregnancy is a common problem. Nowadays only few effective interventions are published preventing or treating constipation during pregnancy. However, their use is limited due to side-effects. This uncontrolled intervention study was performed to determine if a mixture of probiotics in the treatment of constipation during pregnancy is effective. Methods: Women aged >= 18 years with functional constipation were included at the Obstetrical outpatient clinic and midwife practices. Patients received during four weeks a daily dose of Ecologic (R) Relief (Bifidobacterium bifidum W23, Bifidobacterium lactis W52, Bifidobacterium longum W108, Lactobacillus casei W79, Lactobacillus plantarum W62 and Lactobacillus rhamnosus W71 (total 4*10(9) CFU)). For all analyses, the non-parametric paired Wilcoxon test was used. Primary outcome measure was change in defecation frequency. Secondary outcome measures were stool consistency, sensation of incomplete evacuation, sensation of anorectal obstruction, manual manoeuvres to facilitate defecation, abdominal pain, adverse effects, presence of reflux episodes and intake of Bisacodyl. Results: 20 women were included. Defecation frequency significantly increased from 3.1 at baseline to 6.7 in week four (p < 0.01). Compared to baseline, a significant decrease in 1) sensation of anorectal obstruction from 90.0% to 45.0% (p < 0.01), 2) sensation of incomplete evacuation from 90.0% to 40.0% (p < 0.01), 3) straining during defecation from 100% to 65% (p = 0.01), 4) episodes of abdominal pain from 60% to 20% (p = 0.01) and 5) the presence of reflux episodes from 60% to 20% in week four (p = 0.01) was found. Other secondary outcomes did not decrease significantly. No side effects were reported. Conclusions: Ecologic (R) Relief is effective in the treatment of constipation during pregnancy. A randomised placebo controlled trial is required to confirm these data.","[de Milliano, Inge; Tabbers, Merit M.; Benninga, Marc A.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Paediat Gastroenterol & Nutr, NL-1105 AZ Amsterdam, Netherlands; [van der Post, Joris A.] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynaecol, NL-1105 AZ Amsterdam, Netherlands",Emma Children's Hospital; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam,"Tabbers, MM (corresponding author), Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Paediat Gastroenterol & Nutr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.",M.M.Tabbers@amc.uva.nl,"van der Post, Joris A M/A-8991-2008","van der Post, Joris/0000-0003-3311-2116; Tabbers, Merit/0000-0001-9744-7308",Winclove Bio Industries B.V. (The Netherlands),Winclove Bio Industries B.V. (The Netherlands)(Netherlands Government),"The authors wish to thank Winclove Bio Industries B.V. (The Netherlands), sponsor of the study.",,36,23,27,0,27,BMC,LONDON,"CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND",,1475-2891,,NUTR J,Nutr. J.,OCT 4,2012,11,,,,,,,,80,10.1186/1475-2891-11-80,http://dx.doi.org/10.1186/1475-2891-11-80,,,6,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,041UW,23035837,"Green Published, gold",,,2024-06-04,WOS:000311427700001,View Full Record in Web of Science
J,"Barboi, OB; Ciortescu, I; Chirila, I; Anton, C; Drug, V",,,,"Barboi, Oana-Bogdana; Ciortescu, Irina; Chirila, Ioan; Anton, Carmen; Drug, Vasile",,,Effect of inulin in the treatment of irritable bowel syndrome with constipation (Review),EXPERIMENTAL AND THERAPEUTIC MEDICINE,,,English,Review,,,,,,inulin; irritable bowel syndrome; constipation; gut microbiota; prebiotic; probiotic,CHICORY INULIN; JERUSALEM-ARTICHOKE; FECAL MICROBIOTA; CONSUMPTION,"At present, irritable bowel syndrome (IBS) is a common medical problem all over the world that implies considerable social burden and high costs. Considering the different pathophysiological pathways, unitary management for IBS is not possible. Of the therapeutic approaches that have been proposed so far, only a few have been demonstrated to have beneficial effects in IBS patients. The implication of gut microbiota in IBS is obvious, similarly to the therapeutic effect of pro-/prebiotics, which is reflected by the latest publications. The intake of inulin seems to regulate the bowel peristalsis and colonic transit, the consistency and frequency of the stools, as it changes the composition of gut microbiota. The beneficial effect of inulin in patients with IBS-constipation form (IBS-C) is obvious, but still, more randomized controlled clinical trials involving large samples of patients are needed in order to provide more evidence.","[Barboi, Oana-Bogdana; Ciortescu, Irina; Anton, Carmen; Drug, Vasile] Grigore T Popa Univ Med & Pharm, Dept Gastroenterol, 16 Univ St, Iasi 700115, Romania; [Barboi, Oana-Bogdana; Ciortescu, Irina; Anton, Carmen; Drug, Vasile] St Spiridon Hosp, Inst Gastroenterol & Hepatol, Iasi 700111, Romania; [Chirila, Ioan] Natl Inst Publ Hlth, Hlth Related Environm Dept, Iasi 700506, Romania",Grigore T Popa University of Medicine & Pharmacy; Grigore T Popa University of Medicine & Pharmacy,"Anton, C (corresponding author), Grigore T Popa Univ Med & Pharm, Dept Gastroenterol, 16 Univ St, Iasi 700115, Romania.",carmen_ro2008@yahoo.com,"ciortescu, irina/AAF-4983-2022; ciortescu, irina/AFJ-8114-2022",,,,,,19,4,6,4,26,SPANDIDOS PUBL LTD,ATHENS,"POB 18179, ATHENS, 116 10, GREECE",1792-0981,1792-1015,,EXP THER MED,Exp. Ther. Med.,DEC,2020,20,6,,,,,,,185,10.3892/etm.2020.9315,http://dx.doi.org/10.3892/etm.2020.9315,,,3,"Medicine, Research & Experimental",Science Citation Index Expanded (SCI-EXPANDED),Research & Experimental Medicine,OZ9VS,33101475,"Green Published, gold",,,2024-06-04,WOS:000595267100062,View Full Record in Web of Science
J,"Yurrita, LC; Martín, IS; Ciudad-Cabañas, MJ; Calle-Purón, ME; Cabria, MH",,,,"Collado Yurrita, Luis; San Mauro Martin, Ismael; Jose Ciudad-Cabanas, Maria; Elisa Calle-Puron, Maria; Hernandez Cabria, Marta",,,Effectiveness of inulin intake on indicators of chronic constipation; a meta-analysis of controlled randomized clinical trials,NUTRICION HOSPITALARIA,,,English,Review,,,,,,Inulin; Constipation; Bowel function; Randomized controlled clinical trial; Meta-analysis,QUALITY-OF-LIFE; COLORECTAL-CANCER; FERMENTED MILK; ADULTS; POPULATION; EFFICACY; RISK,"Background: Constipation is an intestinal dysfunction. Prebiotics, such as inulin, can improve bowel function by positively influencing intestinal biota. Aim: To analyze the scientific evidence for the role of inulin in improving bowel function in patients with chronic constipation. Methods: A meta-analysis of randomized controlled clinical trials was conducted, grounded on a literature search for the period 1995-2013 (descriptors: inulin & constipation) on PubMed, ScieLo and Central Trials Register Cochrane databases. A total of 24 articles were found, 5 of them were selected for this meta-analysis, involving 252 subjects (experimental group: n = 144, control group: n = 108). The quality of the studies was assessed using the Jadad scale. Results: We found a significant overall effect of inulin on stool frequency (DEM = 0.69, 95 % CI: 0.04, 1.34), stool consistency (Bristol scale) (DEM = 1.07, 95% CI: 0.70, 1.45), transit time (DEM = -0.57, 95% CI: -0.99, -0.15) and hardness of stool (RR = 0.42, 95% CI: 0.26, 0.70). Pain and bloating do not improve with inulin intake. Conclusions: inulin intake has a positive effect on bowel function.","[Collado Yurrita, Luis; San Mauro Martin, Ismael; Jose Ciudad-Cabanas, Maria] Univ Complutense Madrid, Dept Med, E-28040 Madrid, Spain; [San Mauro Martin, Ismael] Univ Complutense Madrid, Dept Med, Res Ctr Nutr, CINUSA Grp, E-28040 Madrid, Spain; [San Mauro Martin, Ismael] Univ Complutense Madrid, Dept Med, Res Ctr Hlth, CINUSA Grp, E-28040 Madrid, Spain; [Elisa Calle-Puron, Maria] Univ Complutense Madrid, Dept Prevent Med & Publ Hlth, E-28040 Madrid, Spain; [Hernandez Cabria, Marta] Corp Alimentaria Penasanta SA Spain, Dept Nutr, Siero, Spain",Complutense University of Madrid; Complutense University of Madrid; Complutense University of Madrid; Complutense University of Madrid,"Yurrita, LC (corresponding author), Univ Complutense Madrid, Dept Med, Plaza Ramon y Cajal S-N, E-28040 Madrid, Spain.",lcollado@ucm.es,,,,,,,26,40,44,2,17,"ARAN EDICIONES, S L",MADRID,"C/ CASTELLO, 128, 1O, MADRID, 28006, SPAIN",0212-1611,1699-5198,,NUTR HOSP,Nutr. Hosp.,AUG,2014,30,2,,,,,244,252,,10.3305/nh.2014.30.2.7565,http://dx.doi.org/10.3305/nh.2014.30.2.7565,,,9,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,AP7QW,25208775,,,,2024-06-04,WOS:000342272800003,View Full Record in Web of Science
J,"Turan, I; Dedeli, Ö; Bor, S; Ilter, T",,,,"Turan, Ilker; Dedeli, Ozden; Bor, Serhat; Ilter, Tankut",,,"Effects of a kefir supplement on symptoms, colonic transit, and bowel satisfaction score in patients with chronic constipation: A pilot study",TURKISH JOURNAL OF GASTROENTEROLOGY,,,English,Article; Proceedings Paper,1st International Probiotics Prebiotics and Functional Food Congress,"APR 11-14, 2013","Antalya, TURKEY",,,Kefir; probiotic; constipation; therapy; gastrointestinal transit,FUNCTIONAL CONSTIPATION; FERMENTED MILK; CLINICAL-TRIAL; UNITED-STATES; PROBIOTICS; EPIDEMIOLOGY; EFFICACY; PERSPECTIVE; DISORDERS; GRAINS,"Background/Aims: Although probiotics have been extensively studied in irritable bowel syndrome, data on the impact of probiotics on chronic constipation are scarce. We aimed to evaluate the effects of kefir, which is a probiotic fermented milk product, on the symptoms, colonic transit, and bowel satisfaction scores of patients with chronic constipation. Materials and Methods: Twenty consecutive patients with functional constipation according to the Rome II criteria were divided into two groups based on their colon transit studies: 1. The normal transit (NT) group (n=10); and 2. The slow transit (ST) group (n=10). After a baseline period, 500 mL/day of a probiotic kefir beverage was administered to all patients for 4 weeks. Defecation parameters (stool frequency, stool consistency, degree of straining, laxative consumption) were recorded in diaries daily by the patients. Bowel satisfaction scores were assessed using a visual analog scale. The colon transit study was repeated in the ST group at the end of the study. Results: At the end of the study, the patients showed an increased stool frequency (p<0.001), improved stool consistency (p=0.014), and decreased laxative consumption (p=0.031). The degree of straining during evacuation showed a tendency to improve after kefir administration; however, this was not statistically significant (p=0.18). A repeat transit study showed an acceleration of colonic transit in the ST group (p=0.013). Bowel satisfaction scores also improved (p<0.001). Conclusion: This pilot study shows that kefir has positive effects on the symptoms of constipation. Our results also suggest that kefir improves bowel satisfaction scores and accelerates colonic transit. Controlled trials are warranted to confirm these findings.","[Turan, Ilker; Bor, Serhat; Ilter, Tankut] Ege Univ, Dept Gastroenterol, Fac Med, Izmir, Turkey; [Dedeli, Ozden] Celal Bayar Univ, Dept Internal Med, Sch Hlth, Manisa, Turkey",Ege University; Celal Bayar University,"Turan, I (corresponding author), Ege Univ, Dept Gastroenterol, Fac Med, Izmir, Turkey.",ilkerturan@gmail.com,"Turan, Ilker/A-7076-2017; Bor, Serhat/AAC-8287-2020","Bor, Serhat/0000-0001-5766-9598",,,,,32,31,37,1,23,AVES,SISLI,"BUYUKDERE CAD 105-9, MECIDIYEKOY, SISLI, ISTANBUL 34096, TURKEY",1300-4948,,,TURK J GASTROENTEROL,Turk. J. Gastroenterol.,DEC,2014,25,6,,,,,650,656,,10.5152/tjg.2014.6990,http://dx.doi.org/10.5152/tjg.2014.6990,,,7,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Gastroenterology & Hepatology,CA7EQ,25599776,,,,2024-06-04,WOS:000349080900010,View Full Record in Web of Science
J,"Roberfroid, MB",,,,"Roberfroid, MB",,,Prebiotics and probiotics: are they functional foods?,AMERICAN JOURNAL OF CLINICAL NUTRITION,,,English,Article; Proceedings Paper,17th Ross Research Conference on Medical Issues,"FEB 22-24, 1998","SAN DIEGO, CA","Ross Prod Div, Abbott Lab Inc",,probiotic; prebiotic; synbiotic; lactobacilli; bifidobacteria; inulin,HUMAN LACTOBACILLUS STRAIN; LACTIC-ACID BACTERIA; DIETARY OLIGOFRUCTOSE; INULIN; HEALTH; ABSORPTION; PRODUCTS; DIARRHEA; IMMUNOMODULATION; CHOLESTEROL,"A probiotic is a viable microbial dietary supplement that beneficially affects the host through its effects in the intestinal tract. Probiotics are widely used to prepare fermented dairy products such as yogurt or freeze-dried cultures. In the future, they may also be found in fermented vegetables and meats. Several health-related effects associated with the intake of probiotics, including alleviation of lactose intolerance and immune enhancement, have been reported in human studies. Some evidence suggests a role for probiotics in reducing the risk of rotavirus-induced diarrhea and colon cancer. Prebiotics are nondigestible food ingredients that benefit the host by selectively stimulating the growth or activity of one or a limited number of bacteria in the colon. Work with prebiotics has been limited, and only studies involving the inulin-type fructans have generated sufficient data for thorough evaluation regarding their possible use as functional food ingredients. At present, claims about reduction of disease risk are only tentative and further research is needed. Among the claims are constipation relief, suppression of diarrhea, and reduction of the risks of osteoporosis, atherosclerotic cardiovascular disease associated with dyslipidemia and insulin resistance, obesity, and possibly type 2 diabetes. The combination of probiotics and prebiotics in a synbiotic has not been studied. This combination might improve the survival of the bacteria crossing the upper part of the gastrointestinal tract, thereby enhancing their effects in the large bowel. In addition, their effects might be additive or even synergistic.","Catholic Univ Louvain, Dept Pharmaceut Sci, B-1200 Brussels, Belgium",Universite Catholique Louvain,"Catholic Univ Louvain, Dept Pharmaceut Sci, Ave Mounier 73, B-1200 Brussels, Belgium.",roberfroid@pmnt.ucl.ac.be,,,,,,,47,419,492,1,101,OXFORD UNIV PRESS,OXFORD,"GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND",0002-9165,1938-3207,,AM J CLIN NUTR,Am. J. Clin. Nutr.,JUN,2000,71,6,,S,,,1682S,1687S,,,,,,6,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Nutrition & Dietetics,321NW,10837317,,,,2024-06-04,WOS:000087462400009,View Full Record in Web of Science
J,"Botelho, PB; Ferreira, MVR; Araújo, AD; Mendes, MM; Nakano, EY",,,,"Botelho, Patricia Borges; Rodrigues Ferreira, Marcus Vinicius; Araujo, Ananda de Mesquita; Mendes, Marcela Moraes; Nakano, Eduardo Yoshio",,,"Effect of multispecies probiotic on gut microbiota composition in individuals with intestinal constipation: A double-blind, placebo- controlled randomized trial",NUTRITION,,,English,Article,,,,,,Microbiota; Probiotics; Constipation,FUNCTIONAL CONSTIPATION; BIFIDOBACTERIUM-ANIMALIS; FERMENTED MILK; METAANALYSIS; MECHANISMS; ADULTS; CONSUMPTION; PREBIOTICS; FREQUENCY; FLORA,"Objective: The aim of this study was to evaluate the effect of a multispecies probiotic on gut microbiota com-position and constipation symptoms. Methods: A randomized, double-blind, placebo-controlled clinical trial was conducted with 35 individuals with constipation for 30 days. The individuals were randomized into two groups: the control capsule (CC) and the probiotic capsule (PC) groups. Constipation symptoms were evaluated by the ROME IV criteria and by evacuation diaries. Fecal microbiota was analyzed by 16 S rRNA gene sequencing. Results: The majority of participants were women (85.7%). There was a significant reduction in the percent of participants who had incomplete defecation (P = 0.034), blockage sensation (P = 0.025), and rarely present liquid stools without the aid of laxatives (P = 0.046) only within the PC group (but no significant difference between groups). There was a significant increase in the relative abundance percentage of Blautia faecis and Ruminococcus torques in the CC group (P = 0.003 and P = 0.011, respectively), although there was no signifi-cant change in the PC group (P = 0.794 and P = 0.958, respectively), with a significant difference between groups (P = 0.029 and P 0.013, respectively), suggesting that probiotic treatment prevented the increase of percent relative abundance of these two species. Conclusion: These results suggest that multispecies probiotics in capsule form may modulate gut microbiota by reducing the bacteria that are commonly increased in patients with constipation, contributing to the balance of microbiota and, consequently, to the well-being of the individual. Future studies with larger numbers of patients are required. (C) 2020 Elsevier Inc. All rights reserved.","[Botelho, Patricia Borges; Rodrigues Ferreira, Marcus Vinicius; Araujo, Ananda de Mesquita; Mendes, Marcela Moraes] Univ Brasilia, Fac Hlth Sci, Dept Nutr, Brasilia, DF, Brazil; [Nakano, Eduardo Yoshio] Univ Brasilia, Stat Dept, Brasilia, DF, Brazil",Universidade de Brasilia; Universidade de Brasilia,"Botelho, PB (corresponding author), Univ Brasilia, Fac Ciencias Saude Asa Norte, BR-70910900 Brasilia, DF, Brazil.",patriciabotelho@unb.br,"FERREIRA, MARCUS V L/M-4625-2016; Botelho, Patrícia Borges/AAL-7977-2020; Mendes, Marcela Moraes/K-1032-2019; Nakano, Eduardo/G-1660-2011","Botelho, Patrícia Borges/0000-0001-8909-3757; Mendes, Marcela Moraes/0000-0001-9853-4198; Nakano, Eduardo/0000-0002-9071-8512; Araujo, Ananda/0000-0002-1496-4527",Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES),Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)),The authors acknowledge the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for the scholarship.,,45,21,21,5,27,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",0899-9007,1873-1244,,NUTRITION,Nutrition,OCT,2020,78,,,,,,,,110890,10.1016/j.nut.2020.110890,http://dx.doi.org/10.1016/j.nut.2020.110890,,,9,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,NT9XS,32738573,,,,2024-06-04,WOS:000573295600031,View Full Record in Web of Science
J,"Bastürk, A; Artan, R; Atalay, A; Yilmaz, A",,,,"Basturk, Ahmet; Artan, Reha; Atalay, Atike; Yilmaz, Aygen",,,Investigation of the efficacy of synbiotics in the treatment of functional constipation in children: a randomized double-blind placebo-controlled study,TURKISH JOURNAL OF GASTROENTEROLOGY,,,English,Article,,,,,,Child; functional constipation; synbiotic,TRIAL,"Background/Aims: The aim of this study was to demonstrate the efficacy of synbiotic (Lactobacillus casei, L. rhamnosus, L. plantarum, and Bifidobacterium lactis and prebiotics [fiber, polydextrose, fructo-oligosaccharides, and galacto-oligosaccharides]) treatment in children with functional constipation. Materials and Methods: This study was performed in patients aged 4-18 years, and the patients were diagnosed to have functional constipation according to the Roma III diagnostic criteria. In this prospective study, the first group received synbiotic and the second group received a placebo. At the end of 4 weeks, patients were questioned about the initial symptoms. Patients who showed improvement in the initial symptoms at the end of the 4-week treatment period were considered to completely benefit from the treatment and those with some improvement in initial symptom were considered to partially benefit from the treatment. Results: The synbiotic and placebo groups comprised 72 and 74 patients, respectively. The mean age in the whole study group was 9.18 +/- 3.48 years with a male: female ratio of 1.21. After 4 weeks of treatment, significant improvement was not observed in any of the findings in the placebo group. Conversely, a significant improvement was observed in the weekly number of defecations, abdominal pain, painful defecation, and pediatric Bristol scale (p <= 0.001) in the synbiotic group. Complete benefit from the treatment was achieved in 48 (66.7%) and 21 (28.3%) patients in the synbiotic and placebo groups, respectively, and a significant difference was observed between the groups (p <= 0.001). Conclusion: Our studies have shown that the use of synbiotics in the treatment of functional constipation in children is beneficial.","[Basturk, Ahmet; Artan, Reha; Atalay, Atike; Yilmaz, Aygen] Akdeniz Univ, Sch Med, Dept Pediat Gastroenterol, Antalya, Turkey",Akdeniz University,"Bastürk, A (corresponding author), Akdeniz Univ, Sch Med, Dept Pediat Gastroenterol, Antalya, Turkey.",drahmetbasturk@hotmail.com,"artan, reha/AAI-8259-2020; Atalay, Atike/HKF-7210-2023; artan, reha/I-6332-2015; Basturk, Ahmet/V-9914-2017","artan, reha/0000-0001-6114-9210;",Scientific Research Fund of Akdeniz University [2015/323],Scientific Research Fund of Akdeniz University(Akdeniz University),This study was supported by the Scientific Research Fund of Akdeniz University (Project No: 2015/323).,,19,20,22,0,11,AVES,SISLI,"BUYUKDERE CAD 105-9, MECIDIYEKOY, SISLI, ISTANBUL 34394, TURKEY",1300-4948,2148-5607,,TURK J GASTROENTEROL,Turk. J. Gastroenterol.,SEP,2017,28,5,,,,,388,393,,10.5152/tjg.2017.17097,http://dx.doi.org/10.5152/tjg.2017.17097,,,6,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,FH8RR,28705786,,,,2024-06-04,WOS:000411468300011,View Full Record in Web of Science
J,"Liang, YX; Wen, P; Wang, Y; OuYang, DM; Wang, D; Chen, YZ; Song, Y; Deng, J; Sun, YM; Wang, H",,,,"Liang, Yu-Xuan; Wen, Peng; Wang, Yu; OuYang, Dong-Mei; Wang, Da; Chen, Yu-Zhong; Song, Ya; Deng, Jie; Sun, Yuan-Ming; Wang, Hong",,,The Constipation-Relieving Property of d-Tagatose by Modulating the Composition of Gut Microbiota,INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,,,English,Article,,,,,,d-tagatose; prebiotic; constipation; gut microbiota; 16S rRNA; neurotransmitter,LOPERAMIDE-INDUCED CONSTIPATION; BUTYRATE-PRODUCING BACTERIA; CHAIN FATTY-ACIDS; DIETARY FIBER; IDENTIFICATION; BACTEROIDES; PREBIOTICS; DIVERSITY; TRANSIT; MICE,"d-tagatose, a monosaccharide as well as a dietary supplement, has been reported as having a wide range of applicability in the food industry, however, the prebiotic activity, anticonstipation effects, and related mechanisms are still unclear. In this study, using the loperamide-induced constipation Kunming mice as the animal model, the effects of d-tagatose for the prevention of constipation were evaluated by gastrointestinal transit experiment and defecation experiment. Furthermore, the underlying mechanism was clarified by evaluating the change of the biochemical indicators and analyzing 16S rRNA amplicon of gut microbiota among the different mice groups. The results showed that the gastrointestinal transit rate, fecal number, and weight in six hours were significantly enhanced after the administration of d-tagatose. In addition, d-tagatose significantly increased the serum levels of acetylcholine (Ach) and substance P (SP), whereas the serum levels of nitric oxide (NO) were significantly decreased. Moreover, the 16S rRNA sequencing analysis revealed that the changes in the gut microbiota caused by constipation were restored by d-tagatose treatment. In conclusion, this study indicated that the administration of d-tagatose as a dietary supplement can effectively prevent and relieve constipation in Kunming mice, and it is a promising prebiotic candidate with constipation-relieving properties.","[Liang, Yu-Xuan; Wen, Peng; OuYang, Dong-Mei; Wang, Da; Song, Ya; Deng, Jie; Sun, Yuan-Ming; Wang, Hong] South China Agr Univ, Coll Food Sci, Guangdong Prov Key Lab Food Qual & Safety, Guangzhou 510642, Guangdong, Peoples R China; [Wang, Yu; Chen, Yu-Zhong] Guangzhou Inst Food Inspect, Guangzhou 511400, Guangdong, Peoples R China",South China Agricultural University,"Sun, YM; Wang, H (corresponding author), South China Agr Univ, Coll Food Sci, Guangdong Prov Key Lab Food Qual & Safety, Guangzhou 510642, Guangdong, Peoples R China.",l402972616@163.com; wenpeng100@163.com; xxwangyu@163.com; ouydm2019@163.com; wangda134@foxmail.com; Kittychenyuzhong@gmail.com; songya_1990@163.com; scaudengjie@163.com; ymsun@scau.edu.cn; gzwhongd@163.com,"LI, Xiang-Yang/JZE-0275-2024; Liu, Chenyu/KBQ-8899-2024; li, jing/KHY-5337-2024",,Key Realm R&D Program of GuangDong Province [2019B020211002]; National Natural Science Foundation of China [31972157]; Science and Technology Planning Project of Guangzhou City [201804020077]; International Cooperation Program of SCAU [2019SCAUGH03]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme,Key Realm R&D Program of GuangDong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangzhou City; International Cooperation Program of SCAU; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme,"This research was funded by Key Realm R&D Program of GuangDong Province (No. 2019B020211002), National Natural Science Foundation of China (No. 31972157), Science and Technology Planning Project of Guangzhou City (201804020077), International Cooperation Program of SCAU (2019SCAUGH03) and Project Supported by Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2017).",,59,20,21,4,29,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,1422-0067,,INT J MOL SCI,Int. J. Mol. Sci.,NOV,2019,20,22,,,,,,,5721,10.3390/ijms20225721,http://dx.doi.org/10.3390/ijms20225721,,,17,"Biochemistry & Molecular Biology; Chemistry, Multidisciplinary",Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Chemistry,JW0YW,31739640,"Green Published, gold",,,2024-06-04,WOS:000502786800203,View Full Record in Web of Science
J,"Cherbut, C",,,,"Cherbut, Christine",,,Gastro-intestinal effects of probiotics and prebiotics: where do we stand?,AGRO FOOD INDUSTRY HI-TECH,,,English,Article,,,,,,,HELICOBACTER-PYLORI COLONIZATION; LACTOBACILLUS-JOHNSONII LA1; ACUTE INFECTIOUS DIARRHEA; IRRITABLE-BOWEL-SYNDROME; DOUBLE-BLIND; FRUCTO-OLIGOSACCHARIDE; PREVENTION; BIFIDOBACTERIUM; CHILDREN; THERAPY,"Whereas there is an overwhelming load of publications about probiotics and prebiotics, only few randomised, double-blind placebo-controlled human trials are available. However, the composite of information is encouraging and indicate that there is a significant role for probiotics and prebiotics in prevention and treatment of certain gastrointestinal diseases. Among probiotic applications, reduction of diarrhea is probably the best documented effect Also capability of some strains to reduce intestinal inflammation could be useful as adjuvant-therapy in several diseases. However, so far, clear benefits have been demonstrated only for H. pylori-associated gastritis and pouchitis. Though they would need to be confirmed, recent results indicate that probiotics may benefit patients with irritable bowel syndrome. Prebiotics appear to favour stool output and alleviate slight constipation. A few studies indicate that inulin-type fructans may also have a role in prevention of infectious diseases and relief of intestinal inflammation.","Nestle Res Ctr, CH-1000 Lausanne 6, Switzerland",Nestle SA,"Cherbut, C (corresponding author), Nestle Res Ctr, Vers Chez Blanc, CH-1000 Lausanne 6, Switzerland.",,,,,,,,40,1,1,0,7,TEKNOSCIENZE PUBL,MILANO,"VIALE BRIANZA 22, 20127 MILANO, ITALY",1722-6996,2035-4606,,AGRO FOOD IND HI TEC,Agro Food Ind. Hi-Tech,MAR-APR,2006,17,2,,,,,18,20,,,,,,3,Biotechnology & Applied Microbiology; Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Biotechnology & Applied Microbiology; Food Science & Technology,058JK,,,,,2024-06-04,WOS:000238661100007,View Full Record in Web of Science
J,"Wang, Y; Zeng, T; Wang, SE; Li, F; Guo, XY; Jin, J; Yu, HX",,,,"Wang, Yu; Zeng, Tao; Wang, Shu-e; Li, Fang; Guo, Xiao-Yan; Jin, Jin; Yu, Hong-Xia",,,LAXATIVE EFFECT OF FRUCTOOLIGOSACCHARIDE IN MICE AND HUMANS,CURRENT TOPICS IN NUTRACEUTICAL RESEARCH,,,English,Article,,,,,,Constipation; Fructooligosaccharides; Human trial; Laxative effect; Prebiotics,CHAIN FRUCTO-OLIGOSACCHARIDES; HUMAN COLONIC MICROBIOTA; DIETARY MODULATION; FOOD-SCIENCE; BIFIDOBACTERIA; OLIGOFRUCTOSE; FERMENTATION; CONSUMPTION; METABOLISM; HEALTH,"Constipation is a prevalent, symptom-based disorder. There is evidence supporting the fact that the intake of prebiotics can affect bowel habit and is mildly laxative. Fructooligosaccharides (FOS) are referred to as prebiotics because they are capable of selectively stimulating the growth of beneficial bacteria such as bifidobacteria and enhancing their survival in vivo. Thus, the present study tests the laxative effect of FOS on the constipated mice and constipated adults. In the animal experiment, 100 Kun-Ming mice were randomized into 10 groups with 10 in each, among which 5 groups (control group, constipation group, and low, medium, high dose of FOS groups) were for small intestine movement experiment, the other 5 groups (the same as above) were for defecating experiment. The animals were treated with different doses of FOS (0.4, 0.8, and 2.5 g/kg bw) for 10 days, and then subjected to the small intestine movement experiment (reflected by ink propellant rate) and defecating experiment (reflected by the time of the first black feces excretion and the number and the weight of mice feces within 5 hrs). In the human study, a total of 100 constipated adults were enrolled on the basis of inclusion and excluded criteria in a randomized, double-blind study with the consumption of 5 g/d I FOS for 10 days. The stool frequency, stool shape, straining effort and evacuation were used to define the efficacy of FOS. In the animal study, compared to constipation group, FOS effectively boosted the ink propellant rate, shortened the time of the first black feces excretion, and increased the number, fecal weight and the level of SCFA in the mice. In the human study, FOS significantly increased the bowel evacuation rate, reduced perception of straining effort and pain, and improved the quality of stools. These data indicate that FOS effectively enhanced the bowel movement and showed a significant improvement in the parameters related with bowel evacuation, and thus FOS could serve as a useful and safe tool for ameliorating constipation.","[Wang, Yu; Li, Fang; Guo, Xiao-Yan; Jin, Jin] Shandong Ctr TB Control, Jinan, Shandong, Peoples R China; [Zeng, Tao] Shandong Univ, Inst Toxicol, Jinan 250100, Shandong, Peoples R China; [Wang, Shu-e; Yu, Hong-Xia] Shandong Univ, Inst Nutr & Food Hyg, Jinan 250100, Shandong, Peoples R China",Shandong University; Shandong University,"Yu, HX (corresponding author), Shandong Univ, Inst Nutr & Food Hyg, Jinan 250100, Shandong, Peoples R China.",wy001617@163.com,,,,,,,45,15,15,0,28,"NEW CENTURY HEALTH PUBLISHERS, LLC",COPPELL,"PO BOX 175, COPPELL, TX 75019 USA",1540-7535,2641-452X,,CURR TOP NUTRACEUT R,Curr. Top. Nutraceutical Res.,FEB-MAR,2013,11,1-2,,,,,1,8,,,,,,8,Nutrition & Dietetics; Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics; Pharmacology & Pharmacy,AF3ZC,,,,,2024-06-04,WOS:000334650200001,View Full Record in Web of Science
J,"Zhao, YM; Liu, QJ; Hou, YM; Zhao, YQ",,,,"Zhao, Yueming; Liu, Qingjing; Hou, Yanmei; Zhao, Yiqing",,,Alleviating effects of gut micro-ecologically regulatory treatments on mice with constipation,FRONTIERS IN MICROBIOLOGY,,,English,Article,,,,,,constipation; probiotics; postbiotics; synbiotics; gut microbial regulation; short-chain fatty acids,PROBIOTICS; PATHOPHYSIOLOGY; SYNBIOTICS; PREBIOTICS; ADULTS,"Treatments targeted for gut microbial regulation are newly developed strategies in constipation management. In this study, the alleviating effects of gut micro-ecologically regulatory treatments on constipation in mice were investigated. Male BALB/c mice were treated with loperamide to induce constipation, and then the corresponding intervention was administered in each group, respectively. The results showed that administration of mixed probiotics (MP), a 5-fold dose of postbiotics (P5), both synbiotics (S and S2), as well as mixed probiotics and postbiotics (MPP) blend for 8 days shortened the time to the first black stool, raised fecal water content, promoted intestinal motility, and increased serum motilin level in loperamide-treated mice. Furthermore, these treatments altered gut microbial composition and metabolism of short-chain fatty acids (SCFA). Based on linear regression analysis, SCFA was positively correlated with serum motilin except for isobutyrate. It suggested gut microbial metabolites affected secretion of motilin to increase gastrointestinal movement and transportation function and thus improved pathological symptoms of mice with constipation. In conclusion, the alteration of gut micro-ecology is closely associated with gastrointestinal function, and it is an effective way to improve constipation via probiotic, prebiotic, and postbiotic treatment.","[Zhao, Yueming] Northeast Agr Univ, Dept Food Sci, Key Lab Dairy Sci, Minist Educ, Harbin, Peoples R China; [Zhao, Yueming; Liu, Qingjing; Hou, Yanmei; Zhao, Yiqing] Hyproca Nutr Co Ltd, Changsha, Peoples R China; [Hou, Yanmei] Hunan Prov Key Lab Food Sci & Biotechnol, Changsha, Peoples R China",Northeast Agricultural University - China,"Zhao, YQ (corresponding author), Hyproca Nutr Co Ltd, Changsha, Peoples R China.",yiqing.zhao@hyproca.com,"Zhao, Yiqing/AEL-5533-2022","Zhao, Yiqing/0000-0003-2874-8136",,,,,42,6,7,15,38,FRONTIERS MEDIA SA,LAUSANNE,"AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND",,1664-302X,,FRONT MICROBIOL,Front. Microbiol.,AUG 9,2022,13,,,,,,,,956438,10.3389/fmicb.2022.956438,http://dx.doi.org/10.3389/fmicb.2022.956438,,,12,Microbiology,Science Citation Index Expanded (SCI-EXPANDED),Microbiology,3Y5VP,36016793,"Green Published, gold",,,2024-06-04,WOS:000843793200001,View Full Record in Web of Science
J,"Carrasco, AJP; Timmermann, L; Pedrosa, DJ",,,,"Carrasco, Anna J. Pedrosa; Timmermann, Lars; Pedrosa, David J.",,,Management of constipation in patients with Parkinson's disease,NPJ PARKINSONS DISEASE,,,English,Review,,,,,,,DEEP BRAIN-STIMULATION; OUTLET OBSTRUCTION CONSTIPATION; CHRONIC IDIOPATHIC CONSTIPATION; SACRAL NERVE-STIMULATION; DAI-KENCHU-TO; TOXIN TYPE-A; BOTULINUM TOXIN; NONMOTOR SYMPTOMS; ABDOMINAL MASSAGE; GASTROINTESTINAL DYSFUNCTION,"A considerable body of research has recently emerged around nonmotor symptoms in Parkinson's disease (PD) and their substantial impact on patients' well-being. A prominent example is constipation which occurs in up to two thirds of all PD-patients thereby effecting psychological and social distress and consequently reducing quality of life. Despite the significant clinical relevance of constipation, unfortunately little knowledge exists on effective treatments. Therefore this systematic review aims at providing a synopsis on clinical effects and safety of available treatment options for constipation in PD. For this purpose, three electronic databases (MEDLINE, EMBASE, PsycINFO) were searched for experimental and quasi-experimental studies investigating the efficacy/effectiveness of interventions in the management of PD-associated constipation. Besides, adverse events were analyzed as secondary outcome. In total, 18 publications were identified involving 15 different interventions, of which none can be attributed sufficient evidence to derive strong recommendations. Nevertheless, some evidence indicates that dietetic interventions with probiotics and prebiotics may reduce symptom burden while providing a very favorable side-effects profile. Furthermore, the use of lubiprostone, macrogol and in the specific case of isolated or prominent outlet obstruction constipation injections of botulinum neurotoxin A into the puborectal muscles may as well be moderately supported. In summary, too little attention has been paid to treatment options for constipation in PD leaving abundant room for further research addressing this topic.","[Carrasco, Anna J. Pedrosa] Oxford Univ Hosp, Sir Michael Sobell House, Oxford, England; [Carrasco, Anna J. Pedrosa] Kings Coll London, Cicely Saunders Inst, Dept Palliat Care Policy & Rehabil, London, England; [Carrasco, Anna J. Pedrosa] Univ Hosp Giessen & Marburg, Dept Internal Med 5, Giessen, Germany; [Timmermann, Lars; Pedrosa, David J.] Univ Hosp Giessen & Marburg, Dept Neurol, Marburg, Germany; [Pedrosa, David J.] Univ Hosp Giessen & Marburg, Dept Psychiat, Marburg, Germany",University of Oxford; University of London; King's College London; University Hospital of Giessen & Marburg; University Hospital of Giessen & Marburg; University Hospital of Giessen & Marburg,"Carrasco, AJP (corresponding author), Oxford Univ Hosp, Sir Michael Sobell House, Oxford, England.;Carrasco, AJP (corresponding author), Kings Coll London, Cicely Saunders Inst, Dept Palliat Care Policy & Rehabil, London, England.;Carrasco, AJP (corresponding author), Univ Hosp Giessen & Marburg, Dept Internal Med 5, Giessen, Germany.",Anna.Pedrosa@innere.med.uni-giessen.de,"Pedrosa, David J./HJP-5325-2023; Pedrosa Carrasco, Anna/HOH-8086-2023","Pedrosa, David J./0000-0002-5403-1959; Pedrosa Carrasco, Anna/0000-0002-4757-9019; Timmermann, Lars/0000-0002-5301-3580","German Research Foundation [PE2291-1]; German Research Foundation; German Ministry of Education and Research; Manfred und Ursula Muller Foundation; Kluh Foundation, Hoffnungsbaum; Neurodegeneration With Brain Iron Accumulation Disorders Society; Koln Fortune Foundation; zur Rose Pharma; Deutsche Parkinson Vereinigung","German Research Foundation(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG)); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Manfred und Ursula Muller Foundation; Kluh Foundation, Hoffnungsbaum; Neurodegeneration With Brain Iron Accumulation Disorders Society; Koln Fortune Foundation; zur Rose Pharma; Deutsche Parkinson Vereinigung","D.P. reports a grant from the German Research Foundation (PE2291-1). L.T. received grants from the German Research Foundation, the German Ministry of Education and Research, the Manfred und Ursula Muller Foundation, the Kluh Foundation, Hoffnungsbaum, the Neurodegeneration With Brain Iron Accumulation Disorders Society, the Koln Fortune Foundation, Deutsche Parkinson Vereinigung, and zur Rose Pharma.",,89,41,45,3,25,NATURE PUBLISHING GROUP,LONDON,"MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND",,2373-8057,,NPJ PARKINSON DIS,npj Parkinsons Dis.,MAR 16,2018,4,,,,,,,,6,10.1038/s41531-018-0042-8,http://dx.doi.org/10.1038/s41531-018-0042-8,,,10,Neurosciences,Science Citation Index Expanded (SCI-EXPANDED),Neurosciences & Neurology,GE2MC,29560414,"gold, Green Published",,,2024-06-04,WOS:000431048300001,View Full Record in Web of Science
J,"Kwon, JI; Park, Y; Noh, DO; Suh, HJ; Han, SH",,,,"Kwon, Jung Il; Park, Yooheon; Noh, Dong Ouk; Suh, Hyung Joo; Han, Sung Hee",,,Complex-oligosaccharide composed of galacto-oligosaccharide and lactulose ameliorates loperamide-induced constipation in rats,FOOD SCIENCE AND BIOTECHNOLOGY,,,English,Article,,,,,,GOS; Lactulose; Oligosaccharides; Constipation; Short-chain fatty acids; Crypt cell,SLOW-TRANSIT CONSTIPATION; CHAIN FATTY-ACIDS; INTERSTITIAL-CELLS; FECAL MICROFLORA; PREBIOTICS; FIBER; CAJAL; FERMENTATION; MEGACOLON; HEALTH,"The purpose of this study was to compare the beneficial effects of galactooligosaccharide (GOS), lactulose, and a complex-oligosaccharide composed with GOS and lactulose (Com-oligo) on loperamide-induced constipation in SD rats. Rats were randomly divided into the following eight groups: the normal group (Nor); constipation control group (Con); and 6 constipation groups fed low and high doses of GOS, lactulose (Lac), and Com-oligo, respectively. Com-oligo increased intestinal transit ratio and relieved constipation in loperamide-treated rats. The group receiving a high dose of Com-oligo favorably regulated gastrointestinal functions such as pellet number, weight, moisture content, short chain fatty acid, intestinal transit ratio, and bifidobacterium number in constipated rats. In addition, Com-oligo restored peristalsis of the small intestine, morphology of colon, and increased interstitial cells of Cajal area. Thus, providing Com-oligo as an oligosaccharide ingredient in nutritional formulas could benefit the health of the gastrointestinal tract.","[Kwon, Jung Il] Maeil Darilies Co Ltd, Human Milk R&D Team, Seoul, South Korea; [Park, Yooheon] Dongguk Univ, Res Inst Biotechnol, Goyang 10326, South Korea; [Noh, Dong Ouk] Kaya Univ, Dept Food Serv & Nutr, Gimhae 50830, South Korea; [Suh, Hyung Joo; Han, Sung Hee] Korea Univ, Coll Hlth Sci, BK21Plus, Seoul 02841, South Korea",Dongguk University; Korea University,"Suh, HJ; Han, SH (corresponding author), Korea Univ, Coll Hlth Sci, BK21Plus, Seoul 02841, South Korea.",suh1960@korea.ac.kr; sungheeh3@gmail.com,"Park, Yooheon/AAF-6504-2019","Han, Sung Hee/0000-0003-0825-6687; Suh, Hyung Joo/0000-0001-8869-3929","High Valueadded Food Technology Development Program, Ministry of Agriculture, Food and Rural Affairs","High Valueadded Food Technology Development Program, Ministry of Agriculture, Food and Rural Affairs(Ministry of Food & Drug Safety (MFDS), Republic of Korea)","This research was supported by the High Value-added Food Technology Development Program, Ministry of Agriculture, Food and Rural Affairs.",,32,11,13,4,48,KOREAN SOCIETY FOOD SCIENCE & TECHNOLOGY-KOSFOST,SEOUL,"#605, KOREA SCI TECHNOL CENT, 635-4 YEOKSAM-DONG, KANGNAM-GU, SEOUL, 135-703, SOUTH KOREA",1226-7708,2092-6456,,FOOD SCI BIOTECHNOL,Food Sci. Biotechnol.,JUN,2018,27,3,,,,,781,788,,10.1007/s10068-017-0300-2,http://dx.doi.org/10.1007/s10068-017-0300-2,,,8,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,GI9NJ,30263804,Green Published,,,2024-06-04,WOS:000434851600018,View Full Record in Web of Science
J,"Jang, YJ; Moon, JS; Kim, JE; Kim, D; Choi, HS; Oh, I",,,,"Jang, Ye-Ji; Moon, Jin Seok; Kim, Ji Eun; Kim, Dayoung; Choi, Han Sol; Oh, Ikhoon",,,Blending Three Probiotics Alleviates Loperamide- Induced Constipation in Sprague-Dawley (SD)-Rats,FOOD SCIENCE OF ANIMAL RESOURCES,,,English,Article,,,,,,constipation; probiotics; BIOVITA 3 bacterial species; gut microbiota,CHAIN FATTY-ACIDS; PREBIOTICS; MICROBIOTA,"BIOVITA 3 bacterial species (BIOVITA 3), a probiotic blend powder containing Clostridium butyricum IDCC 1301, Weizmannia coagulans IDCC 1201, and Bacillus subtilis IDCC 1101, has been used as a food ingredient for gut health. However, its efficacy in improving constipation has not been reported. Therefore, we aimed to investigate the functional effects of oral administration of BIOVITA 3 as well as its component strains alone (at 1.0x109 CFU/day) in Sprague-Dawley (SD) rats with loperamide-induced constipation. The study included fecal analysis, gastrointestinal transit ratio, histopathological analysis, short chain fatty acids (SCFAs), and metagenome analysis. As results, the BIOVITA 3 group showed significant improvements in fecal number, water content, gastrointestinal transit ratio, and thickening of the mucosal layer. In the SCFAs analysis, all probiotic-treated groups showed an increase in total SCFAs compared to the loperamide-constipated group. Changes in microbial abundance and the diversity index of three groups (normal, constipated, and BIOVITA 3) were also defined. Of these, the BIOVITA 3 showed a significant improvement in loperamide-constipated SD-rats. This study suggests the possibility that BIOVITA 3 can be applied as an ingredient in functional foods to relieve constipation.","[Jang, Ye-Ji; Moon, Jin Seok; Kim, Ji Eun; Kim, Dayoung; Choi, Han Sol; Oh, Ikhoon] ILDONG Pharmaceut Co Ltd, Res Labs, Hwaseong 18449, South Korea",,"Oh, I (corresponding author), ILDONG Pharmaceut Co Ltd, Res Labs, Hwaseong 18449, South Korea.",oih52@ildong.com,,"Oh, Ikhoon/0009-0007-3112-8727; Moon, Jin Seok/0000-0003-0375-7175",Ministry of Education (MOE) [2021RIS-001],"Ministry of Education (MOE)(Ministry of Education, Singapore)","This research was supported by Regional Innovation Strategy (RIS) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (MOE) (2021RIS-001). We would deeply be thankful to Ildong Bioscience Co., Ltd. for providing the BIOVITA 3 and its three strains used as experimental materials for this study.(NRF) funded by the Ministry of Education (MOE) (2021RIS-001) . We would deeply be thankful to Ildong Bioscience Co., Ltd. for providing the BIOVITA 3 and its three strains used as experimental materials for this study.r (NRF) funded by the Ministry of Education (MOE) (2021RIS-001) . We would deeply be thankful to Ildong Bioscience Co., Ltd. for providing the BIOVITA 3 and its three strains used as experimental materials for this study.",,35,0,0,6,6,KOREAN SOC FOOD SCIENCE ANIMAL RESOURCES,SEOUL,"806, HANGANG HYUNDAI HYEL, 213-12, SAECHANG-RO, YONGSAN-GU, SEOUL, 04376, SOUTH KOREA",2636-0772,2636-0780,,FOOD SCI ANIM RESOUR,Food Sci. Anim. Resour.,,2024,44,1,,,,,119,131,,10.5851/kosfa.2023.e61,http://dx.doi.org/10.5851/kosfa.2023.e61,,,13,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,IK1N9,38229852,"gold, Green Published",,,2024-06-04,WOS:001166128600014,View Full Record in Web of Science
J,"Steels, E; Erhardt, R; Harnett, JE; Vigar, V; Steadman, KJ",,,,"Steels, Elizabeth; Erhardt, Rene; Harnett, Joanna E.; Vigar, Vanessa; Steadman, Kathryn J.",,,Efficacy of a prebiotic formulation for treatment of functional constipation and associated gastrointestinal symptoms in adults: A randomised controlled trial,ADVANCES IN INTEGRATIVE MEDICINE,,,English,Article,,,,,,Prebiotic; Polyphenols; Constipation; PAC-SYM; PAC-QoL,HYDROLYZED GUAR GUM; OF-LIFE QUESTIONNAIRE; PATIENT ASSESSMENT; CLINICAL-TRIAL; TRANSIT; INULIN; FIBER; SUPPLEMENTATION; METAANALYSIS; ANTIOXIDANT,"Objectives: Functional constipation is the result of a complex interplay between the gastrointestinal tract, the gut microbiome, the nervous system, along with diet and lifestyle factors. This study aimed to evaluate the efficacy of a prebiotic formulation containing plant-based extracts rich in dietary fibre and polyphenols in the management of functional constipation and associated gastrointestinal symptoms.Design: This 3-week randomised controlled study assessed the effect of a prebiotic formulation (6 g powder taken in water twice daily), by comparison with a capsule designed to have minimal effect on gastrointestinal function, on indicators of bowel health in healthy adults with low fibre intake and meeting the Rome IV criteria for functional constipation.Methods: Participants were informed that they may receive one of two products, either a powder or a capsule, both of which contained prebiotics. The primary outcome was change in frequency of complete spontaneous bowel movements. Secondary outcomes assessed were gastrointestinal symptoms, quality of life and mood using the PAC-SYM, PAC-QoL, and DASS-21. Safety and tolerability were also assessed.Results: There was a significant improvement in bowel movements (p < 0.001) and improved stool consistency (p < 0.01) in participants taking the prebiotic powder formulation compared to those taking the capsule. Accompanying this was a significant reduction in overall gastrointestinal symptoms (p < 0.001) including abdominal (p < 0.001), rectal (p = 0.004) and stool (p = 0.002) symptoms, and a significant improvement in quality of life (p 0.001). There was a significant reduction in mean score for depression, anxiety, and stress for participants in both groups, which indicated a significant improvement in mood during the study that was un-related to bowel function.Conclusions: The results showed that the prebiotic powder formulation taken twice per day for 21 days was effective in reducing clinical symptoms of functional constipation in individuals reporting a low fibre intake.","[Steels, Elizabeth; Erhardt, Rene; Steadman, Kathryn J.] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia; [Steels, Elizabeth] Evidence Sci, New Farm, Qld, Australia; [Harnett, Joanna E.] Univ Sydney, Fac Med & Hlth, Sch Pharm, Sydney, NSW, Australia; [Vigar, Vanessa] Integria Healthcare, Eight Mile Plains, Qld, Australia",University of Queensland; University of Sydney,"Steels, E (corresponding author), Univ Queensland, Sch Pharm, Brisbane, Qld, Australia.;Steels, E (corresponding author), Evidence Sci, New Farm, Qld, Australia.",e.steels@uq.edu.au,"Steels, Elizabeth L/B-9366-2012; Harnett, Joanna E/L-1214-2018; Steadman, Kathryn/C-3401-2008","Harnett, Joanna E/0000-0001-9904-2144; Steadman, Kathryn/0000-0001-7357-330X; Erhardt, Rene/0000-0002-1961-135X",,,,,57,1,1,4,9,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",2212-9588,2212-9596,,ADV INTEGR MED,Adv. Integr. Med.,MAY,2023,10,2,,,,,43,50,,10.1016/j.aimed.2023.05.001,http://dx.doi.org/10.1016/j.aimed.2023.05.001,,JUN 2023,8,Integrative & Complementary Medicine,Emerging Sources Citation Index (ESCI),Integrative & Complementary Medicine,K7KR2,,hybrid,,,2024-06-04,WOS:001018196200001,View Full Record in Web of Science
J,"Barichella, M; Pacchetti, C; Bolliri, C; Cassani, E; Iorio, L; Pusani, C; Pinelli, G; Privitera, G; Cesari, I; Faierman, SA; Caccialanza, R; Pezzoli, G; Cereda, E",,,,"Barichella, Michela; Pacchetti, Claudio; Bolliri, Carlotta; Cassani, Erica; Iorio, Laura; Pusani, Chiara; Pinelli, Giovanna; Privitera, Giulia; Cesari, Ilaria; Faierman, Samanta Andrea; Caccialanza, Riccardo; Pezzoli, Gianni; Cereda, Emanuele",,,Probiotics and prebiotic fiber for constipation associated with Parkinson disease: An RCT,NEUROLOGY,,,English,Article,,,,,,,FUNCTIONAL GASTROINTESTINAL DISORDERS; IRRITABLE-BOWEL-SYNDROME; METAANALYSIS; MANAGEMENT; TRIALS,"Objectives:Our objective was to evaluate the efficacy of probiotics and prebiotics in patients with Parkinson disease (PD) and constipation.Methods:We conducted a tertiary setting, randomized, double-blind, placebo-controlled trial in patients with PD with Rome III-confirmed constipation based on 2-week stool diary data at baseline. Patients (n = 120) were randomly assigned (2:1) to either a fermented milk, containing multiple probiotic strains and prebiotic fiber, or placebo, once daily for 4 weeks. The primary efficacy endpoint was the increase in the number of complete bowel movements (CBMs) per week. The key secondary endpoints were 3 or more CBMs and an increase by one or more CBMs per week during weeks 3 and 4.Results:For the primary endpoint, the consumption of a fermented milk containing probiotics and prebiotics resulted in a higher increase in the number of CBMs (mean 1.2, 95% confidence interval [CI] 0.8-1.6) than placebo (0.1, 95% CI -0.4% to 0.6%) (mean difference 1.1, 95% CI 0.4-1.8; p = 0.002). For the key secondary endpoints, a higher number of patients in the probiotics-prebiotics group vs the placebo group reported 3 or more CBMs (p = 0.030; 58.8% vs 37.5%; odds ratio = 2.4, 95% CI 1.1-5.2) and an increase by one or more CBMs (p = 0.004; 53.8% vs 25.0%; odds ratio = 3.5, 95% CI 1.8-8.1) during weeks 3 and 4.Conclusions:The consumption of a fermented milk containing multiple probiotic strains and prebiotic fiber was superior to placebo in improving constipation in patients with PD.ClinicalTrials.gov identifier:NCT02459717.Classification of evidence:This study provides Class I evidence that for patients with PD who have constipation, fermented milk containing probiotics and prebiotics increases the frequency of CBMs.","[Barichella, Michela; Bolliri, Carlotta; Cassani, Erica; Iorio, Laura; Pusani, Chiara; Pinelli, Giovanna; Privitera, Giulia; Cesari, Ilaria; Faierman, Samanta Andrea; Pezzoli, Gianni] Ex ICP, ASST G Pini CTO, Parkinson Inst, Milan, Italy; [Pacchetti, Claudio] IRCCS Ist Neurol Mondino, Parkinson & Movement Disorders Unit, Pavia, Italy; [Caccialanza, Riccardo; Cereda, Emanuele] Fdn IRCCS Policlin San Matteo, Nutr & Dietet Serv, Pavia, Italy",IRCCS Fondazione Casimiro Mondino; IRCCS Fondazione San Matteo,"Cereda, E (corresponding author), Fdn IRCCS Policlin San Matteo, Nutr & Dietet Serv, Pavia, Italy.",e.cereda@smatteo.pv.it,"pacchetti, claudio/AAA-5033-2020; Cereda, Emanuele/AAA-2247-2019; Caccialanza, Riccardo/J-1904-2015","Cereda, Emanuele/0000-0002-0747-1951; Caccialanza, Riccardo/0000-0002-9379-3569; Pezzoli, Gianni/0000-0003-4665-6710",Fondazione Grigioni per il Morbo di Parkinson; Brain and Malnutrition in Chronic Diseases Association-ONLUS,Fondazione Grigioni per il Morbo di Parkinson; Brain and Malnutrition in Chronic Diseases Association-ONLUS,"The study was funded by the Fondazione Grigioni per il Morbo di Parkinson, and Brain and Malnutrition in Chronic Diseases Association-ONLUS. The funding sources are nonprofit organizations that actively contributed to the design and conduct of the study, to the analysis and interpretation of the data, and to the preparation, review, and approval of the manuscript.",,27,224,247,7,81,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0028-3878,1526-632X,,NEUROLOGY,Neurology,SEP 20,2016,87,12,,,,,1274,1280,,10.1212/WNL.0000000000003127,http://dx.doi.org/10.1212/WNL.0000000000003127,,,7,Clinical Neurology,Science Citation Index Expanded (SCI-EXPANDED),Neurosciences & Neurology,DX5ZE,27543643,,,,2024-06-04,WOS:000384460500018,View Full Record in Web of Science
J,"Li, T; Lu, XS; Yang, XB",,,,"Li, Ting; Lu, Xinshan; Yang, Xingbin",,,Stachyose-Enriched α-Galacto-oligosaccharides Regulate Gut Microbiota and Relieve Constipation in Mice,JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY,,,English,Article,,,,,,oligosaccharides; gut microbiota; bifidobacteria; lactobacilli; constipation,DOUBLE-BLIND; INTESTINAL MICROBIOTA; FECAL BIFIDOBACTERIA; HEALTHY HUMANS; PREBIOTICS; FERMENTATION; MODULATION; DISEASE; FLORA,"This study probed the effects of Deshipu stachyose granules (DSG), a novel oligosaccharide preparation (55.3% stachyose, 25.8% raffinose, and 9.7% verbascose), on gut microbiota and constipation in mice. Mice were administered intragastrically without or with DSG (0.42, 0.83, and 2.49 g/kg bw), and feces were collected after 14 days of treatment and subjected to classical microbiological assays. Selective index (SI) and prebiotic index (PI) were incorporated to evaluate the prebiotic effect. DSG at 0.83 g/kg bw scored the highest SI and PI scores, thus supporting a strong prebiotic role. In addition, the impact of DSG (0.42, 0.83, and 1.68 g/kg bw) on defecation function of constipated mice was determined. Ink propulsion rate in the small intestine was significantly improved by DSG treatment. DSG supplementation also distinctly increased the weight and number of black feces within 5 h and evidently shortened the defecating time of first black feces, as compared with the constipation control mice. All of these findings indicate that DSG may promote the growth of beneficial intestinal bacteria and inhibit pathogenic bacteria and also facilitate intestinal peristalsis and fecal excretion, thereby enhancing intestinal health and relieving constipation.","[Li, Ting; Lu, Xinshan; Yang, Xingbin] Shaanxi Normal Univ, Coll Food Engn & Nutr Sci, Key Lab Minist Educ Med Resource & Nat Pharmaceut, Xian 710062, Peoples R China",Shaanxi Normal University,"Yang, XB (corresponding author), Shaanxi Normal Univ, Coll Food Engn & Nutr Sci, Key Lab Minist Educ Med Resource & Nat Pharmaceut, Xian 710062, Peoples R China.",xbyang@snnu.edu.cn,"Ting, Zhang/KGM-5479-2024; Li, Tingting/HKE-0812-2023",,"National Natural Science Foundation of China [C31171678]; Fundamental Research Funds for the Central Universities of Shaanxi Normal University, China [GK201103004]","National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of Shaanxi Normal University, China","This study was supported by grants from the National Natural Science Foundation of China (C31171678) and the Fundamental Research Funds for the Central Universities of Shaanxi Normal University, China (GK201103004).",,33,70,79,4,116,AMER CHEMICAL SOC,WASHINGTON,"1155 16TH ST, NW, WASHINGTON, DC 20036 USA",0021-8561,1520-5118,,J AGR FOOD CHEM,J. Agric. Food Chem.,DEC 4,2013,61,48,,,,,11825,11831,,10.1021/jf404160e,http://dx.doi.org/10.1021/jf404160e,,,7,"Agriculture, Multidisciplinary; Chemistry, Applied; Food Science & Technology",Science Citation Index Expanded (SCI-EXPANDED),Agriculture; Chemistry; Food Science & Technology,267LW,24245736,,,,2024-06-04,WOS:000328100300016,View Full Record in Web of Science
J,"Whelan, K",,,,"Whelan, Kevin",,,The Importance of Systematic Reviews and Meta-Analyses of Probiotics and Prebiotics,AMERICAN JOURNAL OF GASTROENTEROLOGY,,,English,Editorial Material,,,,,,,IRRITABLE-BOWEL-SYNDROME; CHRONIC CONSTIPATION; RISK-FACTORS; PREVALENCE; MANAGEMENT; DISEASE,"Irritable bowel syndrome (IBS) and chronic idiopathic constipation are prevalent and burdensome gastrointestinal disorders. A systematic review and meta-analysis of the evidence for probiotics, prebiotics, and synbiotics in IBS and chronic idiopathic constipation has recently been performed. By far, the most convincing evidence was for the use of probiotics in IBS, which reported that overall probiotics reduced the risk of symptom persistence by 21%. However, only a minority of the trials were at a low risk of bias, and some used small sample sizes. Meta-analysis is a powerful tool to combine individual small trials to improve the power to detect the direction, size, and consistency of an effect, but it can do little to overcome the poor design of individual trials. Many debate the use of meta-analysis to combine data from different probiotic species, strains, or combinations. It is recommended that all future meta-analyses of probiotics, in any clinical setting, perform subgroup analysis on specific species/strains and specific combinations. It is hoped that the current meta-analysis will empower clinicians in making evidence-based decisions regarding whether probiotics should be recommended for IBS, whichspecies/strain(s) to use, and for which symptoms.","Kings Coll London, Sch Med, Diabet & Nut Sci Div, London SE1 9NH, England",University of London; King's College London,"Whelan, K (corresponding author), Kings Coll London, Sch Med, Diabet & Nut Sci Div, London SE1 9NH, England.",kevin.whelan@kcl.ac.uk,"Whelan, Kevin/ABD-5154-2021; Whelan, Kevin/ABD-5350-2021","Whelan, Kevin/0000-0001-5414-2950",,,,,18,25,26,0,18,NATURE PUBLISHING GROUP,NEW YORK,"75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA",0002-9270,1572-0241,,AM J GASTROENTEROL,Am. J. Gastroenterol.,OCT,2014,109,10,,,,,1563,1565,,10.1038/ajg.2014.258,http://dx.doi.org/10.1038/ajg.2014.258,,,3,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,AS7UM,25287086,,,,2024-06-04,WOS:000344460100009,View Full Record in Web of Science
J,"Toporovski, MS; de Morais, MB; Abuhab, A; Crippa, MA",,,,"Toporovski, Mauro Sergio; de Morais, Mauro Batista; Abuhab, Abrao; Crippa Junior, Mauro Acir",,,Effect of Polydextrose/Fructooligosaccharide Mixture on Constipation Symptoms in Children Aged 4 to 8 Years,NUTRIENTS,,,English,Article,,,,,,constipation; dietary fiber; clinical trial,FUNCTIONAL GASTROINTESTINAL DISORDERS; DOUBLE-BLIND; PEDIATRIC-PATIENTS; GASTROENTEROLOGY; POLYDEXTROSE; SYNBIOTICS; PREBIOTICS; FIBER,"Constipation is a frequent problem in children. We evaluated the effect of a mixture (polydextrose [PDX] and fructooligosaccharide [FOS]) in children with constipation. We performed a prospective interventional study with a mixture (PDX 4.17 g and FOS 0.45 g) in a daily dose of food supplement. The intervention lasted 45 days, with visits at 15, 30, and 45 days after administration. The sample comprised 105 patients, of whom 77 completed the intervention. A statistically significant reduction in the frequency of symptoms was observed at the end of the study. The frequency of children with fewer than three bowel movements per week dropped from 59.7% to 11.7%, and there was a decrease in the frequency of Bristol type 1 and 2 dry stools (68.8% to 7.8%), pain on defecation (79.2% to 10.4%), and fear of defecation (68.8% to 3.9%). The proportion of children with abdominal pain symptoms decreased from 84.2% to 2.6% at the end of the study. A relevant limitation of the present study was the lack of a control group treated with placebo. The administration of the PDX/FOS mixture was accompanied by a significant reduction in the frequency of constipation symptoms of the children evaluated. The tolerability was very good, and the rate of adverse effects was low.","[Toporovski, Mauro Sergio] Fac Ciencias Med Santa Casa Sao Paulo, Responsavel Disciplina Gastroenterol Pediat, BR-01234001 Sao Paulo, Brazil; [de Morais, Mauro Batista] Univ Fed Sao Paulo UNIFESP, Escola Paulista Med EPM, Disciplina Gastroenterol Pediat, BR-04023062 Sao Paulo, Brazil; [Abuhab, Abrao] Hypera Pharma, BR-05676120 Sao Paulo, Brazil; [Crippa Junior, Mauro Acir] Allergisa Contract Res Org, BR-13084791 Campinas, Brazil",Faculdade de Ciencias Medicas Santa Casa de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP),"Toporovski, MS (corresponding author), Fac Ciencias Med Santa Casa Sao Paulo, Responsavel Disciplina Gastroenterol Pediat, BR-01234001 Sao Paulo, Brazil.",mstoporovski@gmail.com; maurobmorais@gmail.com; abrao.abuhab@hypera.com.br; mauro.crippa@grupoinvestiga.com.br,"MORAIS, MAURO B/I-7995-2014","TOPOROVSKI, MAURO SERGIO/0000-0003-1525-7581",Hypera Pharma Brazil,Hypera Pharma Brazil,This study was funded by Hypera Pharma Brazil.,,25,6,6,2,12,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,MAY,2021,13,5,,,,,,,1634,10.3390/nu13051634,http://dx.doi.org/10.3390/nu13051634,,,10,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,ST4TI,34067961,"Green Published, gold",,,2024-06-04,WOS:000662437500001,View Full Record in Web of Science
J,"Bellaiche, M; Tounian, P; Oozeer, R; Rocher, E; Vandenplas, Y",,,,"Bellaiche, Marc; Tounian, Patrick; Oozeer, Raish; Rocher, Emilie; Vandenplas, Yvan",,,"Digestive Tolerance and Safety of an Anti-Regurgitation Formula Containing Locust Bean Gum, Prebiotics and Postbiotics: A Real-World Study",PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION,,,English,Article,,,,,,Locust bean gum; Quality of life; Infant well-being; Nutritional support; Colic; Diarrhea; Crying; Defecation; Digestive tolerance; Infant formula; Constipation; Gastroesophageal reflux; Infant health,CHAIN GALACTO-OLIGOSACCHARIDES; GASTROINTESTINAL SYMPTOMS; FRUCTO-OLIGOSACCHARIDES; INFANT FORMULA; HEALTH; EFFICACY; CHILDREN; TRIAL,"Purpose: Infant regurgitation is associated with other functional gastrointestinal disorders and signs and symptoms that have a major impact on the quality of life of infants and their families. This study evaluated the safety, tolerance, and real-world effectiveness of an anti-regurgitation formula containing locust bean gum (LBG), prebiotics, and postbiotics to alleviate digestive symptoms beyond regurgitation. Methods: This 3-month study involved infants with regurgitation requiring the prescription of an anti-regurgitation formula according to usual clinical practice. Outcomes included evaluation of the evolution of stool consistency and frequency; occurrence of colic, constipation, and diarrhea; and assessment of regurgitation severity. Infant crying, parental assessment of infant well-being, and parental satisfaction with the stool consistency were also evaluated. Results: In total, 190 infants (average age: 1.9 +/- 1.1 months) were included. After three months, stool frequency and consistency remained within the normal physiological range, with 82.7% of infants passing one or two stools per day and 90.4% passing loose or formed stools. There was no significant increase in the number of infants with diarrhea, whereas a decrease was observed in the number of infants with constipation after 1 month (p = 0.001) and with colic after both 1 and 3 months (p< 0.001). Regurgitation severity and crying decreased and parental satisfaction with stool consistency, formula acceptability, infant well-being, and sleep quality increased. Monitoring of adverse events did not reveal any safety concerns. Conclusion: Formulas containing LBG, prebiotics, and postbiotics were well tolerated and provided an effective strategy for managing infant regurgitation and gastrointestinal discomfort.","[Bellaiche, Marc] Hosp Robert Debre, AP HP, Dept Gastroenterol & Pediat Nutr, 48 Boulevard Serurier, F-75019 Paris, France; [Tounian, Patrick] Sorbonne Univ, Trousseau Hosp, AP HP, Dept Pediat Nutr & Gastroenterol, Paris, France; [Oozeer, Raish; Rocher, Emilie] Danone Nutr Res, Utrecht, Netherlands; [Vandenplas, Yvan] Vrije Univ Brussel, UZ Brussel, KidZ Hlth Castle, Brussels, Belgium",Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Robert-Debre - APHP; Assistance Publique Hopitaux Paris (APHP); Sorbonne Universite; Hopital Universitaire Armand-Trousseau - APHP; Danone Nutricia; University Hospital Brussels; Vrije Universiteit Brussel,"Bellaiche, M (corresponding author), Hosp Robert Debre, AP HP, Dept Gastroenterol & Pediat Nutr, 48 Boulevard Serurier, F-75019 Paris, France.",marc.bellaiche@aphp.fr,,"Rocher, Emilie/0000-0002-7614-8875","Danone Nutricia Research, the Netherlands","Danone Nutricia Research, the Netherlands(Danone Nutricia)","This study and medical writing assistance were funded by Danone Nutricia Research, the Netherlands.",,40,1,1,0,2,KOREAN SOC PEDIATRIC GASTROENTEROLOGY & NUTRITION,SEOUL,"301 DONGSUNG-DONG 25-I, JONGNO-GU, SEOUL, 301 DONGSUNG, SOUTH KOREA",2234-8646,2234-8840,,PEDIATR GASTROENTERO,Pediatr. Gastroenterol. Hepatol. Nutr.,SEP,2023,26,5,,,,,249,265,,10.5223/pghn.2023.26.5.249,http://dx.doi.org/10.5223/pghn.2023.26.5.249,,,17,Pediatrics,Emerging Sources Citation Index (ESCI),Pediatrics,S8HG4,37736220,"gold, Green Published",,,2024-06-04,WOS:001073516500003,View Full Record in Web of Science
J,"Xu, ZY; Liu, TH; Zhou, QL; Chen, J; Yuan, JL; Yang, ZS",,,,"Xu, Zhenyuan; Liu, Tianhao; Zhou, Qingli; Chen, Jing; Yuan, Jiali; Yang, Zhongshan",,,Roles of Chinese Medicine and Gut Microbiota in Chronic Constipation,EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE,,,English,Review,,,,,,,FECAL MICROBIOTA,"Chronic constipation is a common gastrointestinal dysfunction, but its aetiology and pathogenesis are still unclear. Interestingly, the compositions of the gut microbiota in constipation patients and healthy controls are different. Various studies reported the different gut microbiota alterations in constipation patients, but most studies indicated that constipation patients showed the decreased beneficial bacteria and the reduced species richness of gut bacteria. Besides, the alterations in the gut microbiota may lead to constipation and constipation-related symptoms and the regulation of gut microbiota has a positive effect on gut functional diseases such as constipation. Microbial treatment methods, such as probiotics, prebiotics, synbiotics, and fecal microbiota transplantation, can be used to regulate gut microbiota. Increasing evidences have suggested that Chinese medicine (CM) has a good therapeutic effect on chronic constipation. Chinese medicine is well known for its multitarget and multimode effects on diseases as well as less side effects. In previous studies, after the treatment of constipation with CM, the gut microbiota was restored, indicating that the gut microbiota might be the target or important way for CM to exert its efficacy. In this review, we summarized the effects of microbial treatment and CM on the gut microbiota of constipation patients and discussed the relationship between CM and gut microbiota.","[Xu, Zhenyuan; Zhou, Qingli; Chen, Jing; Yang, Zhongshan] Yunnan Univ Chinese Med, Coll Basic Med Sci, Kunming 650500, Yunnan, Peoples R China; [Xu, Zhenyuan; Chen, Jing; Yuan, Jiali; Yang, Zhongshan] Yunnan Key Lab Mol Biol Chinese Med, Kunming 650500, Yunnan, Peoples R China; [Liu, Tianhao] Jinan Univ, Coll Chinese Med, Guangzhou 510632, Guangdong, Peoples R China",Yunnan University of Chinese Medicine; Jinan University,"Yang, ZS (corresponding author), Yunnan Univ Chinese Med, Coll Basic Med Sci, Kunming 650500, Yunnan, Peoples R China.;Yuan, JL; Yang, ZS (corresponding author), Yunnan Key Lab Mol Biol Chinese Med, Kunming 650500, Yunnan, Peoples R China.",yjl20182018@126.com; yangzhongshan@ynutcm.edu.cn,"Chen, Jing/HOF-4754-2023; Liu, Tianhao/HNI-3749-2023","Chen, Jing/0000-0002-1088-0019; Liu, Tianhao/0000-0002-3997-756X; Xu, Zhenyuan/0000-0002-6124-2543; Yang, ZhongShan/0000-0002-5270-0119; yuan, jiali/0000-0003-2236-0827","National Natural Science Foundation of China [81760819, 81860646]",National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)),This study was supported by grants from the National Natural Science Foundation of China (81760819 and 81860646). The authors thank the scholars who have provided the guidance for the paper.,,68,20,24,4,39,HINDAWI LTD,LONDON,"ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND",1741-427X,1741-4288,,EVID-BASED COMPL ALT,Evid.-based Complement Altern. Med.,,2019,2019,,,,,,,,9372563,10.1155/2019/9372563,http://dx.doi.org/10.1155/2019/9372563,,,11,Integrative & Complementary Medicine,Science Citation Index Expanded (SCI-EXPANDED),Integrative & Complementary Medicine,IB3MD,31239866,"Green Published, Green Submitted, gold",,,2024-06-04,WOS:000470170700001,View Full Record in Web of Science
S,"Horvath, A; Szajewska, H",,"Szajewska, H; Shamir, R",,"Horvath, Andrea; Szajewska, Hania",,,"Probiotics, Prebiotics, and Dietary Fiber in the Management of Functional Gastrointestinal Disorders",EVIDENCE-BASED RESEARCH IN PEDIATRIC NUTRITION,World Review of Nutrition and Dietetics,,English,Article; Book Chapter,,,,,,,REUTERI DSM 17938; DOUBLE-BLIND; CHILDHOOD CONSTIPATION; CHILDREN; GLUCOMANNAN; LACTULOSE; MOTILITY; GG,"At best, currently available therapies provide symptomatic relief from functional gastrointestinal disorders (FGD). No existing therapy, however, can influence the natural course of any of these disorders, prompting interest in new and safe treatment options. This paper summarizes the clinical evidence from randomized controlled trials (RCTs) and their meta-analyses of the effectiveness of probiotics, prebiotics, and dietary fiber in the treatment of FGD in the pediatric population. While it is too soon to recommend the routine use of any probiotics for treating FGD, some of these therapeutic options can provide a health benefit to patients, and therefore can be discussed with patients and/or caregivers. Lactobacillus reuteri DSM 17938 has consistently improved symptoms of infantile colic. The use of Lactobacillus GG moderately increased treatment success in children with abdominal pain-related FGD, particularly among children with irritable bowel syndrome. Also, data from one trial suggest that VSL# 3 seems to be effective in ameliorating symptoms and improving the quality of life of children affected by irritable bowel syndrome. L. reuteri DSM 17938 may help infants with constipation. Limited evidence suggests that administration of a fiber supplement is more effective than placebo for the treatment of childhood constipation. Copyright (C) 2013 S. Karger AG, Basel","[Horvath, Andrea; Szajewska, Hania] Med Univ Warsaw, Dept Paediat, Dzialdowska 1, PL-01184 Warsaw, Poland",Medical University of Warsaw,"Horvath, A (corresponding author), Med Univ Warsaw, Dept Paediat, Dzialdowska 1, PL-01184 Warsaw, Poland.",andrea.hania@gmail.com,"Szajewska, Hania/M-4141-2018; Horvath, Andrea/S-5069-2018","Szajewska, Hania/0000-0002-4596-2874; Horvath, Andrea/0000-0001-9940-0001",,,,,27,10,15,2,20,KARGER,BASEL,"POSTFACH, CH-4009 BASEL, SWITZERLAND",0084-2230,1662-3975,978-3-318-02457-9; 978-3-318-02456-2,WORLD REV NUTR DIET,World Rev.Nutr.Diet.,,2013,108,,,,,,40,48,,10.1159/000351483,http://dx.doi.org/10.1159/000351483,10.1159/isbn.978-3-318-02457-9,,9,Nutrition & Dietetics; Pediatrics,Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics; Pediatrics,BE8RK,24029785,,,,2024-06-04,WOS:000376929700006,View Full Record in Web of Science
J,"Lan, JH; Wang, KL; Chen, GY; Cao, GT; Yang, CM",,,,"Lan, Junhong; Wang, Kangli; Chen, Guangyong; Cao, Guangtian; Yang, Caimei",,,"Effects of inulin and isomalto-oligosaccharide on diphenoxylate-induced constipation, gastrointestinal motility-related hormones, short-chain fatty acids, and the intestinal flora in rats",FOOD & FUNCTION,,,English,Article,,,,,,,LOPERAMIDE-INDUCED CONSTIPATION; GUT MICROBIOTA; LACTOBACILLUS-PLANTARUM; IMMUNE ACTIVATION; CHICORY INULIN; DOUBLE-BLIND; SUPPLEMENTATION; PERFORMANCE; DYSBACTERIOSIS; CONSUMPTION,"The prebiotics inulin (INU) and isomalto-oligosaccharide (IMO) influence intestinal health and immunity, but their effects on constipation are not clearly established. We evaluated the effects of INU and IMO in a rat model of diphenoxylate-induced constipation. Twenty-four male rats were divided into four groups: basal diet (Con), 40 mg kg(-1)diphenoxylate (PCon), 20 g kg(-1)INU and treated with 40 mg kg(-1)diphenoxylate, and 20 g kg(-1)IMO and treated with 40 mg kg(-1)diphenoxylate. INU and IMO increased the number, weight, and water content of fecal pellets, and decreased the time to the first black stool in rats with constipation. Serum levels of the gastrointestinal motility-related hormones adrenocorticotropic hormone (ACTH), motilin (MTL), and Substance P (SP) were higher and corticosterone (CORT), vasoactive intestinal peptide (VIP), and calcitonin gene-related peptide (CGRP) were lower in rats treated with prebiotics than in untreated rats. Colon tissue levels of MTL and SP were increased, and VIP and CGRP were decreased by prebiotics. Furthermore, in rats with constipation, INU and IMO increased the colonic contents of short-chain fatty acids. The relative abundance of Bacteroidetes was lower in the prebiotics groups than in the Con and PCon groups.Lactobacilluswas more abundant in the INU and IMO groups than in PCon rats.Lactobacillus reuteriandLactobacillus intestinaliswere more abundant in the IMO group than in the PCon group (P< 0.01), andL. intestinaliswas more abundant in the INU group than in the PCon group (P< 0.01). In summary, INU and IMO improved constipation and altered the intestinal microbiota in a rat model of constipation.","[Lan, Junhong; Wang, Kangli; Chen, Guangyong; Yang, Caimei] Zhejiang A&F Univ, Coll Anim Sci & Technol, Key Lab Appl Technol Green Ecohlth Anim Husb Zhej, Zhejiang Prov Engn Lab Anim Hlth & Internet Techn, Hangzhou 311300, Peoples R China; [Cao, Guangtian] China Jiliang Univ, Coll Standardisat, Hangzhou 310018, Peoples R China",Zhejiang A&F University; China Jiliang University,"Yang, CM (corresponding author), Zhejiang A&F Univ, Coll Anim Sci & Technol, Key Lab Appl Technol Green Ecohlth Anim Husb Zhej, Zhejiang Prov Engn Lab Anim Hlth & Internet Techn, Hangzhou 311300, Peoples R China.",yangcaimei2012@163.com,,,"Zhejiang Provincial Key Research and Development Program [2017C02005, 2019C02051]; National key research and development program of China [2018YFE0112700]",Zhejiang Provincial Key Research and Development Program; National key research and development program of China,"The present research was supported by the Zhejiang Provincial Key Research and Development Program (No. 2017C02005 and No.2019C02051) and the National key research and development program of China (2018YFE0112700). We also acknowledge Vegamax Biotechnology Co. Ltd (Anji, Zhejiang, China) for providing inulin and isomalto-oligosaccharide.",,75,42,43,16,88,ROYAL SOC CHEMISTRY,CAMBRIDGE,"THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND",2042-6496,2042-650X,,FOOD FUNCT,Food Funct.,OCT 1,2020,11,10,,,,,9216,9225,,10.1039/d0fo00865f,http://dx.doi.org/10.1039/d0fo00865f,,,10,Biochemistry & Molecular Biology; Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Food Science & Technology,OE6VW,33030479,,,,2024-06-04,WOS:000580667100063,View Full Record in Web of Science
J,"Vandenplas, Y; Veereman-Wauters, G; De Greef, E; Peeters, S; Casteels, A; Mahler, T; Devreker, T; Hauser, B",,,,"Vandenplas, Yvan; Veereman-Wauters, Genevieve; De Greef, Elisabeth; Peeters, Stefaan; Casteels, Ann; Mahler, Tania; Devreker, Thierry; Hauser, Bruno",,,Probiotics and prebiotics in prevention and treatment of diseases in infants and children,JORNAL DE PEDIATRIA,,,English,Review,,,,,,,ANTIBIOTIC-ASSOCIATED DIARRHEA; RANDOMIZED-CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; LACTOBACILLUS-RHAMNOSUS GG; FORMULA-FED INFANTS; 1ST 6 MONTHS; ACUTE INFECTIOUS DIARRHEA; BIRTH-WEIGHT INFANTS; REAL-TIME PCR; SACCHAROMYCES-BOULARDII,"Objective: To evaluate the impact of probiotics and prebiotics on the health of children. Sources: MEDLINE and LILACS were searched for relevant English and French-language articles. Summary of the findings: Human milk is rich in prebiotic oligosaccharides and may contain some probiotics. No data suggest that addition of probiotics to infant formula may be harmful, but evidence of its efficacy is insufficient for its recommendation. Since data suggest that addition of specific prebiotic oligosaccharides may reduce infections and atopy in healthy infants, their addition to infant formula seems reasonable. Long-term health benefits of pro- and prebiotics on the developing immune system remain to be proven. Selected probiotics reduce the duration of infectious diarrhea by 1 day, but evidence in prevention is lacking, except in antibiotic-associated diarrhea. Some specific probiotics prevent necrotizing enterocolitis, and other microorganisms may be beneficial in Helicobacter pylori gastritis and in infantile colic. Evidence is insufficient to recommend probiotics in prevention and treatment of atopic dermatitis. The use of probiotics in constipation, irritable bowel syndrome, inflammatory bowel disease, and extra-intestinal infections requires more studies. Conclusions: Duration of administration, microbial dosage, and species used need further validation for both pro- and prebiotics. Unjustified health claims are a major threat for the pro- and prebiotic concept.","[Vandenplas, Yvan; Veereman-Wauters, Genevieve; De Greef, Elisabeth; Mahler, Tania; Devreker, Thierry; Hauser, Bruno] Vrije Univ Brussel, Univ KinderZiekenhuis Brussel, B-1090 Brussels, Belgium; [Peeters, Stefaan] Aalsters Stedelijk Ziekenhuis, Aalst, Belgium; [Casteels, Ann] Portaels Ziekenhuis, Vilvoorde, Belgium; [Mahler, Tania] Univ Ziekenhuis Antwerpen, Antwerp, Belgium",Vrije Universiteit Brussel; University of Antwerp,"Vandenplas, Y (corresponding author), Vrije Univ Brussel, Univ KinderZiekenhuis Brussel, Laarbeeklaan 101, B-1090 Brussels, Belgium.",yvan.vandenplas@uzbrussel.be,"De Greef, Elisabeth/AAA-8186-2020","Hauser, Bruno/0000-0002-8431-1556",,,,,105,40,41,1,56,SOC BRASIL PEDIATRIA,"RIO DE JANEIRO, RJ","RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL",0021-7557,1678-4782,,J PEDIAT-BRAZIL,J. Pediatr.,JUL-AUG,2011,87,4,,,,,292,300,,10.2223/JPED.2103,http://dx.doi.org/10.2223/JPED.2103,,,9,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,816AW,21769417,,,,2024-06-04,WOS:000294572100004,View Full Record in Web of Science
J,"Yu, XR; Fu, CS; Cui, ZC; Chen, GY; Xu, YL; Yang, CM",,,,"Yu, Xiaorong; Fu, Chunsheng; Cui, Zhenchuan; Chen, Guangyong; Xu, Yinglei; Yang, Caimei",,,"Inulin and isomalto-oligosaccharide alleviate constipation and improve reproductive performance by modulating motility-related hormones, short-chain fatty acids, and feces microflora in pregnant sows",JOURNAL OF ANIMAL SCIENCE,,,English,Article,,,,,,constipation alleviation; inulin; isomalto-oligosaccharide; reproductive performance; sows,DIPHENOXYLATE-INDUCED CONSTIPATION; CARBON-INDUCED CONSTIPATION; GUT MICROBIOTA; PREBIOTICS; FUNGI; FLORA; DIET; PIGS,"Constipation in gestating and lactating sows is common and the inclusion of dietary fiber may help to alleviate this problem. We investigated the effects of inulin (INU) and isomalto-oligosaccharide (IMO), two sources of soluble dietary fiber, on gastrointestinal motility-related hormones, short-chain fatty acids (SCFA), fecal microflora, and reproductive performance in pregnant sows. On day 64 of gestation, 30 sows were randomly divided into three groups and fed as follows: a basal diet, a basal diet with 0.5% INU, and a basal diet with 0.5% IMO. We found that INU and IMO significantly modulated the levels of gastrointestinal motility-related hormones, as evidenced by an increase in substance P (P < 0.05), and a decrease in the vasoactive intestinal peptide concentrations (P < 0.05), indicating the capacity of INU and IMO to alleviate constipation. Furthermore, IMO enhanced the concentrations of acetic, propionic, isobutyric, butyric, isovaleric, and valeric acids in the feces (P < 0.05). High-throughput sequencing showed that IMO and INU increased the fecal microflora alpha- and beta-diversity (P < 0.05). Methanobrevibacter was more abundant (P < 0.05), whereas the richness of Turicibacter was lower in the INU and IMO groups than in the control group (P < 0.05). In addition, IMO significantly increased litter size (P < 0.05). Overall, our findings indicate that INU and IMO can relieve constipation, optimize intestinal flora, and promote reproductive performance in pregnant sows.","[Yu, Xiaorong; Fu, Chunsheng; Cui, Zhenchuan; Chen, Guangyong; Xu, Yinglei; Yang, Caimei] Zhejiang A&F Univ, Coll Anim Sci & Technol,Coll Vet Med, Key Lab Appl Technol Green Ecohlth Anim Husb Zhej, Zhejiang Prov Engn Lab Anim Hlth & Internet Techn, Hangzhou 311300, Peoples R China",Zhejiang A&F University,"Yang, CM (corresponding author), Zhejiang A&F Univ, Coll Anim Sci & Technol,Coll Vet Med, Key Lab Appl Technol Green Ecohlth Anim Husb Zhej, Zhejiang Prov Engn Lab Anim Hlth & Internet Techn, Hangzhou 311300, Peoples R China.",yangcaimei2012@163.com,,,"Zhejiang Provincial Key Research and Development Program [2019C02051, 2020C02032]; Zhejiang Provincial Leading Innovation Team Project [2020R01015]; National key research and development program of China [2018YFE0112700]",Zhejiang Provincial Key Research and Development Program; Zhejiang Provincial Leading Innovation Team Project; National key research and development program of China,"The present research was supported by the Zhejiang Provincial Key Research and Development Program (No. 2019C02051 and No.2020C02032), Zhejiang Provincial Leading Innovation Team Project (No.2020R01015), and the National key research and development program of China (2018YFE0112700).",,60,11,11,3,43,OXFORD UNIV PRESS INC,CARY,"JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA",0021-8812,1525-3163,,J ANIM SCI,J. Anim. Sci.,OCT,2021,99,10,,,,,,,,10.1093/jas/skab257,http://dx.doi.org/10.1093/jas/skab257,,SEP 2021,9,"Agriculture, Dairy & Animal Science",Science Citation Index Expanded (SCI-EXPANDED),Agriculture,YJ8HB,34487146,Green Published,,,2024-06-04,WOS:000744768100005,View Full Record in Web of Science
J,"Di Rosa, C; Altomare, A; Terrigno, V; Carbone, F; Tack, J; Cicala, M; Guarino, MPL",,,,"Di Rosa, Claudia; Altomare, Annamaria; Terrigno, Vittoria; Carbone, Florencia; Tack, Jan; Cicala, Michele; Guarino, Michele Pier Luca",,,Constipation-Predominant Irritable Bowel Syndrome (IBS-C): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms,NUTRIENTS,,,English,Review,,,,,,irritable bowel syndrome and diet; irritable bowel syndrome with constipation; IBS and diet; IBS and microbiota,MUCOSA-ASSOCIATED MICROBIOTA; CHAIN FATTY-ACIDS; GUT MICROBIOTA; DIETARY FIBER; COLONIC MICROBIOTA; CONTROLLED TRIAL; FERMENTED MILK; CLINICAL-TRIAL; DOUBLE-BLIND; BIFIDOBACTERIUM,"Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal disorder characterized by abdominal pain associated with defecation or a change in bowel habits. The pathogenesis of IBS is not completely clear, but it is known to be multifactorial and complex. Endogenous and exogenous factors such as abnormal GI motility, low-grade inflammation, increased epithelial permeability and visceral hypersensitivity, but diet and psychosocial aspects are also recognized as important actors. Furthermore, the interaction between diet and gut microbiota has gained interest as a potential contributor to the pathophysiology of IBS. To date, there is no specific diet for IBS with constipation (IBS-C); however, many studies show that fiber intake, especially soluble fiber such as inulin, could have a positive effect on symptoms. This review aims to evaluate the effects of some nutritional components such as fibers but also functional foods, prebiotics, probiotics and symbiotics on symptoms and microbiota in IBS-C subjects.","[Di Rosa, Claudia; Terrigno, Vittoria] Univ Campus Biomed Roma, Dept Sci & Technol Humans & Environm, Res Unit Food Sci & Human Nutr, Via Alvaro del Portillo 21, I-00128 Rome, Italy; [Altomare, Annamaria; Cicala, Michele; Guarino, Michele Pier Luca] Univ Campus Biomed Roma, Res Unit Gastroenterol, Via Alvaro del Portillo 21, I-00128 Rome, Italy; [Altomare, Annamaria; Cicala, Michele; Guarino, Michele Pier Luca] Fdn Policlin Univ Campus Biomed, Operat Res Unit Gastroenterol, Via Alvaro del Portillo 200, I-00128 Rome, Italy; [Carbone, Florencia; Tack, Jan] Univ Hosp Leuven, Dept Gastroenterol & Hepatol, B-3000 Leuven, Belgium",University Campus Bio-Medico - Rome Italy; University Campus Bio-Medico - Rome Italy; Fondazione Policlinico Universitario Campus Bio-Medico; KU Leuven; University Hospital Leuven,"Altomare, A (corresponding author), Univ Campus Biomed Roma, Res Unit Gastroenterol, Via Alvaro del Portillo 21, I-00128 Rome, Italy.;Altomare, A (corresponding author), Fdn Policlin Univ Campus Biomed, Operat Res Unit Gastroenterol, Via Alvaro del Portillo 200, I-00128 Rome, Italy.",c.dirosa@unicampus.it; a.altomare@unicampus.it,"Guarino, Michele Pier Luca/IQT-3994-2023","Guarino, Michele Pier Luca/0000-0003-3325-9425; Di Rosa, Claudia/0000-0002-5465-5657; Terrigno, Vittoria/0009-0006-1093-1628; Altomare, Annamaria/0000-0001-8630-7836; Tack, Jan/0000-0002-3206-6704; Carbone, Florencia/0000-0003-1790-7904",,,,,105,9,9,5,23,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,APR,2023,15,7,,,,,,,1647,10.3390/nu15071647,http://dx.doi.org/10.3390/nu15071647,,,17,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,D6OY1,37049488,"gold, Green Published",,,2024-06-04,WOS:000969915600001,View Full Record in Web of Science
J,"Ghalandari, N; Assarzadegan, F; Habibi, SAH; Esmaily, H; Malekpour, H",,,,"Ghalandari, Nasibeh; Assarzadegan, Farhad; Habibi, Seyed Amir Hassan; Esmaily, Hadi; Malekpour, Habib",,,Efficacy of Probiotics in Improving Motor Function and Alleviating Constipation in Parkinson's Disease: A Randomized Controlled Trial,IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH,,,English,Article,,,,,,Parkinson's Disease; Bristol Stool Scale; Constipation; Probiotics; UPDRS,GUT MICROBIOTA; DOUBLE-BLIND; PREBIOTICS; CHILDREN; ADULTS,"Background: Parkinson's disease (PD) is one of the common neurodegenerative diseases, and there has been an increasing interest in the potential role of intestinal dysbiosis in its pathogenesis and related gastrointestinal complications such as constipation.Objectives: This study aims to evaluate the effects of multi-strain probiotics on constipation and motor function in PD patients. Methods: This study was a blinded, randomized controlled trial (RCT) that involved 27 PD patients who were diagnosed with constipation according to the ROME IV criteria for functional constipation. The primary outcome measured before and after the intervention in both the placebo and probiotic groups was the frequency of defecation. Secondary outcomes evaluated were laxative use, sense of complete evacuation, Bristol Stool Scale for consistency, and Unified Parkinson's Disease Rating Scale (UPDRS) scale. The study lasted for eight weeks. Both groups also were educated about lifestyle modification.Results: Of 30 included patients (15 in each group), 13 were women, and 17 were men. Three patients dropped out of the study. Between-group analysis showed that the frequency of bowel movements significantly increased in the probiotic group 4 [3 -5] in comparison with 2 [2 -3] in placebo (P = 0.02). Stool consistency also improved in the probiotic group (P = 0.04). However, there were no significant differences in other outcomes. The within-group analysis showed improvement in stool consistency in both probiotics and placebo groups (P = 0.01 and P = 0.007, respectively), while stool frequency and sense of complete evacuation significantly improved only in the probiotic group (P < 0.05).Conclusions: This study demonstrated that multi-strain probiotics could improve frequency, consistency, and sense of complete evacuation in PD patients, while there was no significant effect on motor functions in 8 weeks. It is suggested that additional studies be conducted on longer-term effects.","[Ghalandari, Nasibeh; Esmaily, Hadi] Shahid Beheshti Univ Med Sci, Sch Pharm, Dept Clin Pharm, Tehran, Iran; [Assarzadegan, Farhad] Shahid Beheshti Univ Med Sci, Sch Med, Dept Neurol, Tehran, Iran; [Habibi, Seyed Amir Hassan; Malekpour, Habib] Iran Univ Med Sci, Sch Med, Dept Gastroenterol & Liver Dis, Tehran, Iran; [Esmaily, Hadi] Shahid Beheshti Univ Med Sci, Dept Clin Pharm, Sch Pharm, Vali e Asr Ave,POB 1991953381, Tehran, Iran",Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Iran University of Medical Sciences; Shahid Beheshti University Medical Sciences,"Esmaily, H (corresponding author), Shahid Beheshti Univ Med Sci, Dept Clin Pharm, Sch Pharm, Vali e Asr Ave,POB 1991953381, Tehran, Iran.",hadi@sbmu.ac.ir,"Ghalandari, Nasibeh/KBB-4129-2024","Esmaily, Hadi/0000-0001-6915-6028; Ghalandari, Nasibeh/0000-0002-0651-5545",Shahid Beheshti University of Medical Sciences [30366],Shahid Beheshti University of Medical Sciences,Funding/Support: This work was supported by the Shahid Beheshti University of Medical Sciences (grant number: 30366) .,,30,0,0,6,6,BRIEFLAND,Shertogenbosch,"25 Derde Morgen, Shertogenbosch, NETHERLANDS",1735-0328,1726-6890,,IRAN J PHARM RES,Iran. J. Pharm. Res.,DEC,2023,22,1,,,,,,,e137840,10.5812/ijpr-137840,http://dx.doi.org/10.5812/ijpr-137840,,,9,Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy,Z2VX1,38116573,"hybrid, Green Published",,,2024-06-04,WOS:001110714900001,View Full Record in Web of Science
J,"Van Laar, T; Boertien, JM; Herranz, AH",,,,"Van Laar, T.; Boertien, J. M.; Herranz, A. Horta",,,"Faecal Transplantation, Pro- and Prebiotics in Parkinson's Disease; Hope or Hype?",JOURNAL OF PARKINSONS DISEASE,,,English,Review,,,,,,Parkinson's disease; faecal microbiome transplantation; prebiotics; probiotics,GUT-MICROBIOTA; MULTIPLE-SCLEROSIS; BUTYRATE ENEMAS; COLONIC-MUCOSA; DOUBLE-BLIND; INFLAMMATION; MUCUS; PROTECTION; PROBIOTICS; THERAPY,"Faecal microbiome transplantation (FMT) is an attractive technique, because the administration is relatively simple and in general has a mild adverse effect pattern. Moreover, FMT consists of a broad mixture, which could be beneficial, because at this moment it is not known what type of changes in the microbiome are needed. However, except from a few cases no clinical data in Parkinson's disease (PD) is available yet. There is some indication that FMT might be beneficial in severe constipated PD patients, but the clinical data to support this are very scarce. So, actually there are no good data in the public domain to support FMT at this moment in PD patients. FMT at this moment is a black box with too many unanswered questions, also with respect to safety concerns. Only the administration of species of Lactobacillus and Bifidobacterium over a time period of four to twelve weeks has repeatedly proven to be effective in treating constipation in PD. Also, no solid clinical data are available about the possible effects of probiotic treatment on motor symptoms or progression of PD. Therefore, also probiotic treatments in PD should wait until better clinical data become available, in order to select the right target populations and to have good estimates of the clinical effects to be expected.","[Van Laar, T.; Boertien, J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Herranz, A. Horta] Univ Groningen, Behav & Cognit Neurosci, Groningen, Netherlands",University of Groningen; University of Groningen,"Van Laar, T (corresponding author), Hanzepl 1, NL-9713 GZ Groningen, Netherlands.",t.van.laar@umcg.nl,"van Laar, Teus/AAO-3906-2021",,,,,,77,24,25,0,14,IOS PRESS,AMSTERDAM,"NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS",1877-7171,1877-718X,,J PARKINSON DIS,J. Parkinsons Dis.,,2019,9,,,2,,,S371,S379,,10.3233/JPD-191802,http://dx.doi.org/10.3233/JPD-191802,,,9,Neurosciences,Science Citation Index Expanded (SCI-EXPANDED),Neurosciences & Neurology,JJ7LY,31609702,"Green Published, hybrid",,,2024-06-04,WOS:000494336100009,View Full Record in Web of Science
J,"Valerio, F; Russo, F; de Candia, S; Riezzo, G; Orlando, A; Lonigro, SL; Lavermicocca, P",,,,"Valerio, Francesca; Russo, Francesco; de Candia, Silvia; Riezzo, Giuseppe; Orlando, Antonella; Lonigro, Stella Lisa; Lavermicocca, Paola",,,Effects of Probiotic Lactobacillus paracasei-enriched Artichokes on Constipated Patients A Pilot Study,JOURNAL OF CLINICAL GASTROENTEROLOGY,,,English,Article,,,,,,short-chain fatty acids; fecal enzymatic activity; microbiota; constipation; prebiotics,FECAL MICROFLORA; IN-VITRO; INULIN; BIFIDOBACTERIA; OLIGOFRUCTOSE; PROFILES; SURVIVAL; STRAINS; ENZYMES; SCALE,"Goals: To determine whether the consumption of artichokes enriched with a probiotic Lactobacillus paracasei strain affects fecal microbiota composition, fecal enzyme activity, and short-chain fatty acids production and symptom profile in patients suffering from constipation. Background: Constipation is a common gastrointestinal disorder often related to the food diet. The beneficial effects of probiotics and prebiotics on human health are under investigation. Moreover, recent studies assessed the suitability of some vegetables, particularly olives and artichokes, to vehicle probiotic strains into the gastrointestinal tract. Study: For 15 days, 8 volunteers (3M/5F age 40 +/- 14 y) integrated their normal diet with artichokes (180 gr) enriched with 20 billions of L. paracasei LMGP22043. Faecal samples were subjected to microbiologic and biochemical analyses. Besides, investigations on symptom profile of the volunteers and stool consistency were carried out by using a validated questionnaire (Gastrointestinal Symptom Rating Scale) and the Bristol stool form chart. Results: The gut of all volunteers resulted to be colonized by the probiotic strain after 15 days feeding. No significant differences in the microbiological counts throughout the experimental period were registered, whereas a significant increase of butyric and valeric acids with a concomitant decrease of lactic acid was registered. At the same time, the fecal beta-glucuronidase activity was significantly reduced. Finally, the analysis of symptom profile indicated a marked reduction in abdominal distension and feeling of incomplete evacuation. Conclusions: These preliminary data suggest that novel approaches for treating constipation can come through ingestion of probiotic vegetable products that, acting as symbiotics, can ameliorate this common disorder.","[Lavermicocca, Paola] CNR, Inst Sci Food Prod, ISPA, I-70126 Bari, Italy; [Russo, Francesco; Orlando, Antonella] Natl Inst Digest Dis, IRCCS Saverio de Bellis, Lab Expt Biochem, San Giovanni Rotondo, Italy; [Riezzo, Giuseppe] Natl Inst Digest Dis, IRCCS Saverio de Bellis, Lab Expt Pathophysiol, San Giovanni Rotondo, Italy",Consiglio Nazionale delle Ricerche (CNR); Istituto Scienze delle Produzioni Alimentari (ISPA-CNR); IRCCS Saverio de Bellis; IRCCS Saverio de Bellis,"Lavermicocca, P (corresponding author), CNR, Inst Sci Food Prod, ISPA, Via Amendola 122-O, I-70126 Bari, Italy.",paola.lavermicocca@ispa.cnr.it,"Russo, Francesco/H-1738-2016; Lavermicocca, Paola/B-6925-2015; Riezzo, Giuseppe/AAC-1753-2022; Valerio, Francesca/P-5551-2015","Lavermicocca, Paola/0000-0002-6808-0532; Riezzo, Giuseppe/0000-0002-1800-4830; Valerio, Francesca/0000-0001-7270-1808",Italian Ministry for University and Research [D. M. 28830],"Italian Ministry for University and Research(Ministry of Education, Universities and Research (MIUR))",This work was supported by the Italian Ministry for University and Research (art. 12 D. M. 593/2000-D.D. 3300-22 December 2005-tema 2) Project Ortobiotici pugliesi'' (D. M. 28830).,,35,33,35,0,15,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0192-0790,1539-2031,,J CLIN GASTROENTEROL,J. Clin. Gastroenterol.,SEP,2010,44,,,1,,,S49,S53,,10.1097/MCG.0b013e3181d2dca4,http://dx.doi.org/10.1097/MCG.0b013e3181d2dca4,,,5,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,641UM,20495470,,,,2024-06-04,WOS:000281155300013,View Full Record in Web of Science
J,"Kubota, M; Ito, K; Tomimoto, K; Kanazaki, M; Tsukiyama, K; Kubota, A; Kuroki, H; Fujita, M; Vandenplas, Y",,,,"Kubota, Megumi; Ito, Kazuya; Tomimoto, Kazuhiko; Kanazaki, Mitsuharu; Tsukiyama, Kei; Kubota, Akio; Kuroki, Haruo; Fujita, Mitsugu; Vandenplas, Yvan",,,Lactobacillus reuteri DSM 17938 and Magnesium Oxide in Children with Functional Chronic Constipation: A Double-Blind and Randomized Clinical Trial,NUTRIENTS,,,English,Article,,,,,,constipation; Dialister; functional gastrointestinal disorder; Lactobacillus; magnesium oxide; microbiome; Bristol stool scale,CASEI-RHAMNOSUS LCR35; MOTILITY; MANAGEMENT; PROBIOTICS; PREBIOTICS,"Objective: Chronic functional constipation is a frequent condition. The aim of the study was to evaluate the efficacy of the probiotic Lactobacillus (L.) reuteri DSM 17938 and magnesium oxide (MgO) for relieving chronic functional constipation in children. Study design: A prospective, double-blind, placebo-controlled, randomized, and parallel-group trial was conducted in five pediatric outpatient clinics in Japan. Sixty patients who were more than six months old and under six years of age with a diagnosis of functional constipation according to Rome IV criteria were randomly divided into three groups: group A (n = 20) received L. reuteri DSM 17938 and lactose hydrate as a placebo of MgO; group B (n = 19) received L. reuteri DSM 17938 and MgO; and group C (n = 21) received a placebo of L. reuteri DSM 17938 and MgO. Results: All three groups exhibited significant improvement in defecation frequency in the fourth week compared with the baseline condition (group A: p < 0.05; group B: p < 0.05; group C: p < 0.05). The MgO group and combination group showed a significant decrease in stool consistency, but the L. reuteri DSM 17938 group did not (group A: p = 0.079; group B: p < 0.05; group C: p < 0.05). MgO significantly suppressed the presence of the genus Dialister. Defecation frequency negatively correlated with the frequency of Clostridiales-belonging bacteria among the gut microbiome. Conclusions: L. rueteri DSM 17938 and MgO were both effective in the management of functional constipation in young children. MgO caused an imbalance in the gastrointestinal microbiome, which was not the case in the probiotic group.","[Kubota, Megumi] Kubota Childrens Clin, Ikuno Ku, 2-6-18 Katsuyamakita, Osaka 5440033, Japan; [Kubota, Megumi; Ito, Kazuya] Osaka City Univ, Grad Sch Med, Dept Publ Hlth, Abeno Ku, 1-4-3 Asahimachi, Osaka 5450051, Japan; [Tomimoto, Kazuhiko] Tomimoto Pediat Clin, 6-6-20 Minatotakadai, Hachinohe, Aomori 0310823, Japan; [Kanazaki, Mitsuharu] Kanazaki Childrens Clin, Naka Ku, 3323 Dotocho, Sakai, Osaka 5998234, Japan; [Tsukiyama, Kei; Kubota, Akio] Tsukiyama Child Care Clin, 484 Akizuki, Wakayama 6408322, Japan; [Kuroki, Haruo] Sotobo Childrens Clin, 1880-4 Izumi Misakicho, Isumi 2994503, Japan; [Fujita, Mitsugu] Kindai Univ, Fac Med, Dept Microbiol, 377-2 Ohnohigashi, Osakasayama 5898511, Japan; [Vandenplas, Yvan] Vrije Univ Brussel, UZ Brussel, KidZ Hlth Castle, B-1090 Brussels, Belgium",Osaka Metropolitan University; Vrije Universiteit Brussel; University Hospital Brussels,"Kubota, M (corresponding author), Kubota Childrens Clin, Ikuno Ku, 2-6-18 Katsuyamakita, Osaka 5440033, Japan.;Kubota, M (corresponding author), Osaka City Univ, Grad Sch Med, Dept Publ Hlth, Abeno Ku, 1-4-3 Asahimachi, Osaka 5450051, Japan.",meg@ki.rim.or.jp; ito.kazuya@med.osaka-cu.ac.jp; ito.kazuya@med.osaka-cu.ac.jp; mitkanazaki@icloud.com; tsukiyama@mikazukikai.jp; akioyuki0628@yahoo.co.jp; sotobo-child@healthcarenet.jp; mfujita47@med.kindai.ac.jp; Yvan.Vandenplas@uzbrussel.be,"Kubota, Megumi/AAJ-9788-2020; Fujita, Mitsugu/A-6690-2009","Fujita, Mitsugu/0000-0002-0000-9879; Kubota, Megumi/0000-0002-1169-623X",BioGaia AB Sweden supplied products of Lactobacillus reuteri DSM [17938],BioGaia AB Sweden supplied products of Lactobacillus reuteri DSM,"This study was funded through scholarships. Additionally, BioGaia AB Sweden supplied products of Lactobacillus reuteri DSM 17938 and KENEI Pharmaceutical Co., Ltd., supplied the placebo and magnesium oxide.",,27,33,38,1,20,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,JAN,2020,12,1,,,,,,,225,10.3390/nu12010225,http://dx.doi.org/10.3390/nu12010225,,,12,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,KQ3KN,31952280,"Green Published, gold",,,2024-06-04,WOS:000516825500225,View Full Record in Web of Science
J,"Ale, EC; Binetti, AG",,,,"Ale, Elisa C.; Binetti, Ana G.",,,"Role of Probiotics, Prebiotics, and Synbiotics in the Elderly: Insights Into Their Applications",FRONTIERS IN MICROBIOLOGY,,,English,Review,,,,,,microbiota; elderly; probiotic; prebiotic; synbiotic; health,,"Elderly people are an important part of the global population who suffer from the natural processes of senescence, which lead to changes in the gut microbiota composition. These modifications have a great impact on their quality of life, bringing a general putrefactive and inflammatory status as a consequence. Some of the most frequent conditions related to this status are constipation, undernutrition, neurodegenerative diseases, susceptibility to opportunistic pathogens, and metabolic disbalance, among others. For these reasons, there is an increasing interest in improving their quality of life by non-invasive treatments such as the consumption of probiotics, prebiotics, and synbiotics. The aim of the present mini-review is to describe the benefits of these functional supplements/food according to the most recent clinical and pre-clinical studies published during the last decade. In addition, insights into several aspects we consider relevant to improve the quality of future studies are provided.","[Ale, Elisa C.; Binetti, Ana G.] Fac Ingn Quim UNL, Inst Lactol Ind CONICET UNL, Santa Fe, Argentina",National University of the Littoral,"Binetti, AG (corresponding author), Fac Ingn Quim UNL, Inst Lactol Ind CONICET UNL, Santa Fe, Argentina.",anabinetti@fiq.unl.edu.ar,"Ale, Elisa/AAY-7131-2021",,Agencia Nacional de Promocion Cientifica y Tecnologica; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Litoral (UNL),Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyTSpanish Government); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Nacional del Litoral (UNL),"This work was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica, Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), and Universidad Nacional del Litoral (UNL).",,106,21,21,5,35,FRONTIERS MEDIA SA,LAUSANNE,"AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND",1664-302X,,,FRONT MICROBIOL,Front. Microbiol.,JAN 28,2021,12,,,,,,,,631254,10.3389/fmicb.2021.631254,http://dx.doi.org/10.3389/fmicb.2021.631254,,,9,Microbiology,Science Citation Index Expanded (SCI-EXPANDED),Microbiology,QF2BB,33584631,"Green Published, gold",,,2024-06-04,WOS:000616703300001,View Full Record in Web of Science
J,"Hao, YQ; Xu, YJ; Ban, YJ; Li, JJ; Wu, B; Ouyang, Q; Sun, ZZ; Zhang, M; Cai, YJ; Wang, MQ; Wang, WT",,,,"Hao, Yingqi; Xu, Yajuan; Ban, Yanjie; Li, Jingjing; Wu, Bo; Ouyang, Qian; Sun, Zongzong; Zhang, Miao; Cai, Yanjun; Wang, Mengqi; Wang, Wentao",,,Efficacy evaluation of probiotics combined with prebiotics in patients with clinical hypothyroidism complicated with small intestinal bacterial overgrowth during the second trimester of pregnancy,FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY,,,English,Article,,,,,,breath test; hypothyroidism; intestine; pregnancy; therapy,ASSOCIATION; MICROBIOTA,"ObjectiveTo explore the effect of probiotics combined with prebiotics on clinical hypothyroidism during pregnancy combined with small intestinal bacterial overgrowth. Methods(1) In total, 441 pregnant women were included in this study. A total of 231 patients with clinical hypothyroidism during the second trimester of pregnancy and 210 normal pregnant women were enrolled in the lactulose methane-hydrogen breath test. The positive rate of intestinal bacterial overgrowth (SIBO), gastrointestinal symptoms, thyroid function and inflammatory factors were compared between the two groups by chi-square test and two independent sample t-test. (2) SIBO-positive patients in the clinical hypothyroidism group during pregnancy (n=112) were treated with probiotics combined with prebiotics based on conventional levothyroxine sodium tablets treatment. The changes in the methane-hydrogen breath test, gastrointestinal symptoms, thyroid function and inflammatory factors were compared before treatment (G0) and 21 days after treatment (G21) by chi-square test and paired sample t test. Results(1) The positive rates of SIBO in pregnant women in the clinical hypothyroidism group and control group were 48.5% and 24.8%, respectively. (2) The incidence of abdominal distention and constipation in the clinical hypothyroidism group was significantly higher than that in the control group, and the risk of abdominal distention and constipation in SIBO-positive pregnant women was higher than that in SIBO-negative pregnant women. (3) The serum levels of hypersensitive C-reactive protein (hsCRP), IL-10, IL-6, TNF-alpha, low-density lipoprotein (LDL), total cholesterol (TC), free fatty acids (FFAs) and apolipoprotein B (ApoB) in the hypothyroidism group during pregnancy were higher than those in the control group. (4) After 21 days of probiotics combined with prebiotics, the incidence of pure methane positivity in the methane-hydrogen breath test in the G21 group was significantly reduced, and the average abundance of hydrogen and methane at each time point in the G21 group was lower than that in the G0 group. (5) The incidence of constipation in the G21 group was significantly lower than before treatment. (6) The levels of serum TSH, hsCRP, IL-6, TNF-alpha, TC and LDL in pregnant women after probiotics combined with prebiotics were lower than those before treatment. ConclusionProbiotics combined with prebiotics are effective in the treatment of pregnant patients with clinical hypothyroidism complicated with SIBO, providing a new idea to treat pregnant patients with clinical hypothyroidism complicated with SIBO.","[Hao, Yingqi; Xu, Yajuan; Ban, Yanjie; Li, Jingjing; Wu, Bo; Ouyang, Qian; Sun, Zongzong; Zhang, Miao; Cai, Yanjun; Wang, Mengqi; Wang, Wentao] Zhengzhou Univ, Dept Obstet & Gynecol, Affiliated Hosp 3, Zhengzhou, Peoples R China",Zhengzhou University,"Xu, YJ (corresponding author), Zhengzhou Univ, Dept Obstet & Gynecol, Affiliated Hosp 3, Zhengzhou, Peoples R China.",cnzzzsl@163.com,,,Henan provincial science and technology research and development special funds; [182102410020],Henan provincial science and technology research and development special funds;,Funding This research was funded by Henan provincial science and technology research and development special funds #182102410020 (YX).,,38,1,1,4,6,FRONTIERS MEDIA SA,LAUSANNE,"AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND",2235-2988,,,FRONT CELL INFECT MI,Front. Cell. Infect. Microbiol.,OCT 6,2022,12,,,,,,,,983027,10.3389/fcimb.2022.983027,http://dx.doi.org/10.3389/fcimb.2022.983027,,,10,Immunology; Microbiology,Science Citation Index Expanded (SCI-EXPANDED),Immunology; Microbiology,6Q0ZR,36275023,"gold, Green Published",,,2024-06-04,WOS:000891350100001,View Full Record in Web of Science
J,"Wojtyniak, K; Szajewska, H",,,,"Wojtyniak, Katarzyna; Szajewska, Hania",,,Systematic review: probiotics for functional constipation in children,EUROPEAN JOURNAL OF PEDIATRICS,,,English,Review,,,,,,Probiotics; RCT; Microbiota; Functional gastrointestinal disorders,CASEI-RHAMNOSUS LCR35; GASTROINTESTINAL DISORDERS; DOUBLE-BLIND; CHILDHOOD CONSTIPATION; FOLLOW-UP; PREBIOTICS; ADULTS; FLORA,"We updated our 2010 systematic review on the efficacy of probiotics in the treatment of constipation in children. The MEDLINE, EMBASE, and Cochrane Library databases; clinical trial registries; and reference lists of included studies were searched to February 2017 for randomized controlled trials (RCTs) performed in children, with no language restriction. The primary outcome measure was treatment success, as defined by the investigators. We included seven RCTs with a total of 515 participants. Included trials were heterogeneous with respect to study population, probiotic strains, dosages, study duration, and follow-up. Pooled results of two RCTs showed no significant difference between the Lactobacillus rhamnosus casei Lcr35 and placebo groups with respect to treatment success. Other probiotics were studied in single trials only. There was no significant difference between the probiotic and control groups with respect to treatment success. While some probiotic strains showed some effects on defecation frequency, none of the probiotics had beneficial effects on frequency of fecal incontinence or frequency of abdominal pain. Adverse events were rare and not serious. Conclusion: Limited evidence does not support the use of any of currently evaluated probiotics in the treatment of functional constipation in children. What is Known: Conventional treatment for functional constipation in children does not always provide satisfying improvement. Probiotics have been suggested as potential treatment modalities for this condition. What is New: Probiotics are ineffective for the management of functional constipation in children in terms of treatment success, frequency of fecal incontinence, and frequency of abdominal pain.","[Wojtyniak, Katarzyna; Szajewska, Hania] Med Univ Warsaw, Dept Paediat, Zwirki & Wigury 63A, PL-02091 Warsaw, Poland",Medical University of Warsaw,"Szajewska, H (corresponding author), Med Univ Warsaw, Dept Paediat, Zwirki & Wigury 63A, PL-02091 Warsaw, Poland.",wojtyniakkasia@gmail.com; hania@ipgate.pl,"Szajewska, Hania/M-4141-2018","Szajewska, Hania/0000-0002-4596-2874",,,,,32,53,62,1,31,SPRINGER,NEW YORK,"ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES",0340-6199,1432-1076,,EUR J PEDIATR,Eur. J. Pediatr.,SEP,2017,176,9,,,,,1155,1162,,10.1007/s00431-017-2972-2,http://dx.doi.org/10.1007/s00431-017-2972-2,,,8,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,FE1TL,28762070,"Green Published, hybrid",,,2024-06-04,WOS:000408000400002,View Full Record in Web of Science
J,"Ribiero, T; Scalabrin, D; Pontes, M; de Mattos, A; Harris, C; Stolz, S; Strong, P; Almeida, I; Godoy, C; Gatto, S; Leal, V; Cabral, G; Ribeiro, H",,,,"Ribiero, Tereza; Scalabrin, Deolinda; Pontes, Mariana; de Mattos, Angela; Harris, Cheryl; Stolz, Suzanne; Strong, Paul; Almeida, Indhira; Godoy, Carolina; Gatto, Sara; Leal, Vivian; Cabral, G.; Ribeiro, Hugo",,,Effect of a follow-up formula containing prebiotics on constipation in young children,FASEB JOURNAL,,,English,Meeting Abstract,,,,,,,,,"[Ribiero, Tereza; Pontes, Mariana; de Mattos, Angela; Almeida, Indhira; Godoy, Carolina; Gatto, Sara; Leal, Vivian; Cabral, G.; Ribeiro, Hugo] Univ Fed Bahia, Salvador, BA, Brazil; [Scalabrin, Deolinda; Harris, Cheryl; Stolz, Suzanne; Strong, Paul] Mead Johnson Pediat Nutr Inst, Evansville, IN USA",Universidade Federal da Bahia,,,,,,,,,0,0,0,0,1,FEDERATION AMER SOC EXP BIOL,BETHESDA,"9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA",0892-6638,1530-6860,,FASEB J,Faseb J.,APR,2014,28,1,,S,,LB348,,,,,,,,2,Biochemistry & Molecular Biology; Biology; Cell Biology,Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology,AX0OG,,,,,2024-06-04,WOS:000346651004359,View Full Record in Web of Science
J,"Hayeeawaema, F; Wichienchot, S; Khuituan, P",,,,"Hayeeawaema, Fittree; Wichienchot, Santad; Khuituan, Pissared",,,Amelioration of gut dysbiosis and gastrointestinal motility by konjac oligo-glucomannan on loperamide-induced constipation in mice,NUTRITION,,,English,Article,,,,,,Colonic motility; Colonic smooth muscle; Gut microbiota; Gut transit time; Prebiotics; Laxative,,"Objective: Konjac oligo-glucomannan (KOG) is a non-digestible dietary fiber that is resistant to digestion and absorption in gastrointestinal (GI) tract. Thus, it might be used as an alternative management for constipation. The aim of this study was to evaluate the effects of KOG on gut motility and microbiota to relieve constipation in mice. Methods: Mice received Bifidobacterium animalis, lactulose, konjac glucomannan (KGM), or KOG for 14 d. Constipation was induced by 5 mg/kg loperamide days 12 through 14 in all groups except the control. Defecation frequency, small intestinal transit, and total gut transit time were indicated by counting the number of feces, and using charcoal meal and Evans blue as markers, respectively. Smooth muscle (SM) contraction and gut motility were evaluated by organ bath and GI motility monitor system. Gut microbiota were measured by fluorescence in situ hybridization technique. Results: KOG significantly (P < 0.01) increased defecation frequency and small intestinal transit but decreased total gut transit time when compared with the constipation-without-treatment group. These results were similar to the effects of Bifidobacterium animalis, lactulose, and KGM. KOG ameliorated the effect of loperamide on contraction frequency of distal colonic circular SM. The motility patterns were changed in the KOG group from non-propagation to propagation contraction. KOG significantly inhibited the effects of loperamide on gut microbiota by increasing the numbers of Bifidobacterium spp. and decreasing the numbers of Clostridium spp. and Bacteroides spp. Conclusion: These results suggest that KOG acts as a prebiotic and stimulant laxative for relief and prevention of constipation. (C) 2019 Elsevier Inc. All rights reserved.","[Hayeeawaema, Fittree; Khuituan, Pissared] Prince Songkla Univ, Gut Biol & Microbiota Res Unit, Hat Yai, Thailand; [Hayeeawaema, Fittree; Khuituan, Pissared] Prince Songkla Univ, Fac Sci, Dept Physiol, Hat Yai, Thailand; [Wichienchot, Santad] Prince Songkla Univ, Interdisciplinary Grad Sch Nutraceut & Funct Food, Hat Yai, Thailand",Prince of Songkla University; Prince of Songkla University; Prince of Songkla University,"Khuituan, P (corresponding author), Prince Songkla Univ, Gut Biol & Microbiota Res Unit, Hat Yai, Thailand.;Khuituan, P (corresponding author), Prince Songkla Univ, Fac Sci, Dept Physiol, Hat Yai, Thailand.",pissared.k@psu.ac.th,"Wichienchot, Santad/AAR-6845-2021; Khuituan, Pissared/GNW-5846-2022","Khuituan, Pissared/0000-0003-1376-3253",Prince of Songkla University [SCI610513S],Prince of Songkla University,This work was supported by a grant from Prince of Songkla University (grant no. SCI610513S). The authors have no conflicts of interest to declare.,,24,28,29,4,67,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",0899-9007,1873-1244,,NUTRITION,Nutrition,MAY,2020,73,,,,,,,,110715,10.1016/j.nut.2019.110715,http://dx.doi.org/10.1016/j.nut.2019.110715,,,11,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,LN2UI,32135415,,,,2024-06-04,WOS:000532798500011,View Full Record in Web of Science
J,"Silva, ATD; Cavalcanti, IDL; Fernandes, MAD; Coimbra, CGD; Lima, GMD",,,,"de Aguiar Silva, Andreza Tallyne; Lima Cavalcanti, Iago Dillion; de Lima Fernandes, Maria Ayanny; de Oliveira Coimbra, Cynthia Gisele; de Souza Lima, Glaucia Manoella",,,Effect of zymomonas mobilis probiotic on cholesterol and its lipoprotein fractions and the intestinal regulation,CLINICAL NUTRITION,,,English,Article,,,,,,Constipation; Prebiotics; Probiotics; Zymomonas,MECHANISMS; PREBIOTICS; MICROBIOTA; STATE,"Zymomonas mobilis have characteristics that classify it as probiotic. Thus, this study aimed to evaluate the effect of regular consumption of fermented broth of this strain on the intestinal function of individuals with changes in intestinal transit. This is a randomized, descriptive and quantitative clinical trial, a sample composed of undergraduate students from a university center in Caruaru. After screening for individuals with constipation according to the inclusion and exclusion criteria, only 13 agreed to participate in the study. They were divided into groups: group 1 received Zymomonas mobilis fermented broth once a day; group 2 also received the fermented broth in the same concentration cells being twice a day; group 3 received cell-free fermented broth once daily; and group 4, placebo, received saline once daily, all groups drank for fifteen days, and laboratory tests were performed to check lipid profile before and after that period. Observed an increase in evacuation days in all groups averaged in media 7.0-10.5 days. Groups 1 and 2 showed an increase in total cholesterol (0.5% and 5.0%, respectively), HDL cholesterol (4.1% and 24.1%), LDL cholesterol (4.9% and 8.4%), VLDL cholesterol (17.9% and 11.2%) and triglycerides (19.1% and 27.9%). In group 3, there was a reduction of total cholesterol (-2.4%), LDL cholesterol (-11.2%), VLDL cholesterol (-15.9%), triglycerides (-27.7%) and increase in HDL cholesterol (25.7%). Thus, the broth fermented with Zymomonas mobilis regulated the intestinal transit, but did not improve the lipid profile, while the without cells broth showed a better lipid profile. (C) 2020 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","[de Aguiar Silva, Andreza Tallyne; Lima Cavalcanti, Iago Dillion; de Lima Fernandes, Maria Ayanny] Univ Ctr Tabosa Almeida ASCES UNITA, Lato Sensu Multiprofess Residence Program Canc At, Caruaru, PE, Brazil; [de Oliveira Coimbra, Cynthia Gisele] Univ Ctr Tabosa Almeida ASCES UNITA, Caruaru, PE, Brazil; [de Souza Lima, Glaucia Manoella] Univ Fed Pernambuco, Dept Antibiot, Recife, PE, Brazil",Universidade Federal de Pernambuco,"Silva, ATD (corresponding author), Univ Ctr Tabosa Almeida ASCES UNITA, Lato Sensu Multiprofess Residence Program Canc At, Caruaru, PE, Brazil.",andrezathallyne@hotmail.com,"Lima, Gláucia/Q-9733-2019; Cavalcanti, Iago/AAK-2587-2021; Lima Gomes, Glaucia/ADP-4337-2022","Cavalcanti, Iago/0000-0001-6625-8395; Lima Gomes, Glaucia/0000-0002-1941-8912; TALLYNE DE AGUIAR SILVA, ANDREZA/0009-0002-5182-8353",,,,,38,7,7,0,11,CHURCHILL LIVINGSTONE,EDINBURGH,"JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND",0261-5614,1532-1983,,CLIN NUTR,Clin. Nutr.,DEC,2020,39,12,,,,,3750,3755,,10.1016/j.clnu.2020.04.002,http://dx.doi.org/10.1016/j.clnu.2020.04.002,,,6,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,PH6YQ,32471645,,,,2024-06-04,WOS:000600555900023,View Full Record in Web of Science
J,"Gan, D; Chen, JL; Tang, X; Xiao, LY; Martoni, CJ; Leyer, G; Huang, GX; Li, W",,,,"Gan, Dan; Chen, Jialun; Tang, Xin; Xiao, Luyao; Martoni, Christopher J.; Leyer, Gregory; Huang, Guixia; Li, Wei",,,Impact of a probiotic chewable tablet on stool habits and microbial profile in children with functional constipation: A randomized controlled clinical trial,FRONTIERS IN MICROBIOLOGY,,,English,Article,,,,,,functional constipation; microbiome; probiotic chewable; children; clinical trial,IRRITABLE-BOWEL-SYNDROME; COLONIC TRANSIT; GUT MICROBIOTA; LUBIPROSTONE; PREBIOTICS; SYMPTOMS; TIME,"Constipation is a common and typically multifactorial childhood complaint, and the clinical management of childhood functional constipation (FC) is challenging. A randomized, single-blind, placebo-controlled, multi-center clinical trial was conducted in 92 children (47 from Beijing, China and 45 from Shanghai, China) aged 4-12 with FC according to Rome III criteria. Children were assigned to receive a probiotic chewable tablet (5 x 10(9) CFU/day, n = 47), consisting of Lactobacillus acidophilus DDS-1 (R) and Bifidobacterium animalis subsp. lactis UABla-12 (TM) or placebo (n = 45), twice daily for 4 weeks, followed by a week follow-up period. Results suggested that the probiotic group showed a faster and more pronounced normalization of stool frequency over the intervention period (3.15 vs. 1.83) when compared to placebo group (2.51 vs. 1.87). Meanwhile, the percentage of subjects with hard defecation decreased from 43 to 14% in the probiotic group, while the percentage of subjects with normal defecation increased from 56 to 80% in the probiotic group, further confirming the normalization of stools habits. This randomized controlled trial demonstrated the potential of a probiotic chewable tablet containing L. acidophilus DDS-1 (R) and B. Lactis UABla-12 (TM) as a daily probiotic dosage form for children with FC.","[Gan, Dan; Chen, Jialun; Tang, Xin; Huang, Guixia] Sirio Pharm Co Ltd, Shantou, Peoples R China; [Xiao, Luyao; Li, Wei] Nanjing Agr Univ, Coll Food Sci & Technol, Nanjing, Peoples R China; [Martoni, Christopher J.; Leyer, Gregory] Chr Hansen, Windsor, WI USA",Nanjing Agricultural University,"Gan, D (corresponding author), Sirio Pharm Co Ltd, Shantou, Peoples R China.;Li, W (corresponding author), Nanjing Agr Univ, Coll Food Sci & Technol, Nanjing, Peoples R China.",dan.gan@siriopharma.com; lw1981@njau.edu.cn,,,Qing Lan Project of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD),Qing Lan Project of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD),Funding This work was co-financed by Qing Lan Project of Jiangsu Province and Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).,,33,5,5,6,18,FRONTIERS MEDIA SA,LAUSANNE,"AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND",,1664-302X,,FRONT MICROBIOL,Front. Microbiol.,AUG 22,2022,13,,,,,,,,985308,10.3389/fmicb.2022.985308,http://dx.doi.org/10.3389/fmicb.2022.985308,,,10,Microbiology,Science Citation Index Expanded (SCI-EXPANDED),Microbiology,4J6PH,36071965,"gold, Green Published",,,2024-06-04,WOS:000851386500001,View Full Record in Web of Science
J,"Guevara-Gonzaléz, J; Guevara-Campos, J; González, L; Cauli, O",,,,"Guevara-Gonzalez, Jose; Guevara-Campos, Jose; Gonzalez, Lucia; Cauli, Omar",,,The Effects of Probiotics and Prebiotics on Gastrointestinal and Behavioural Symptoms in Autism Spectrum Disorder,CURRENT REVIEWS IN CLINICAL AND EXPERIMENTAL PHARMACOLOGY,,,English,Review,,,,,,Nutraceuticals; behavior; constipation; probiotic; fungi; gut-brain axis; prebiotic; bifidobacteria,SEROTONIN LEVELS; UNITED-STATES; CHILDREN; BRAIN; HERITABILITY; MICROBIOME; PREVALENCE,"Background: Autism Spectrum Disorders (ASDs) are a group of prevalent neuropsychiatric disorders. They present a complex and unknown etiology, which in most cases includes significant peripheral alterations outside the brain such as in the composition of gut microbiota. Because the gut microbiota is involved in modulating the gut-brain axis, several studies have suggested that the microbiome in the gut can modify metabolites which are able to cross the blood-brain barrier and modulate brain function. Methods: We reviewed the current evidence regarding microbiota alterations in patients with ASD and the effects of the administration of probiotics and prebiotics in these patients, both in terms of gastrointestinal and behavioural symptoms. Results: Administration of a probiotic formulation containing different strains of Lactobacillus (L. acidophilus, L. rhamnosus, and others) and Bifidobacteria had beneficial effects upon these aforementioned symptoms and their use is recommended in a subgroup of ASD patients that present gastrointestinal disturbances. Nonetheless, the types of gastrointestinal disturbances that most benefit from such interventions remain to be elucidated in order to personalize the medical approaches. Conclusion: Recent clinical studies have shown that probiotic treatments can regulate the gut microbiota and may result in improvements in some behavioral abnormalities associated with ASD. Trials using prebiotic fibers or synbiotics preparations are still lacking and necessary in order to deep in such therapeutic strategies in ASD with comorbid gastrointestinal disrturbances.","[Guevara-Gonzalez, Jose] Hosp Miguel Perez Carreno, Neuropediat Serv, Caracas, Venezuela; [Guevara-Campos, Jose] Hosp Felipe Guevara Rojas, Pediat Serv, El Tigre, Anzoategui, Venezuela; [Gonzalez, Lucia] Felipe Guevara Rojas Hosp, Epilepsy & Encephalog Unit, El Tigre Anzoategui 6034, Venezuela; [Cauli, Omar] Univ Valencia, Nursing Dept, Valencia, Spain",University of Valencia,"Cauli, O (corresponding author), Univ Valencia, Nursing Dept, Valencia, Spain.",Omar.Cauli@uv.es,"Cauli, Omar/L-6063-2014","Cauli, Omar/0000-0001-5669-4943",,,,,61,1,1,5,17,BENTHAM SCIENCE PUBL LTD,SHARJAH,"EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES",2772-4328,2772-4336,,CURR REV CLIN EXP PH,Curr. Rev. Clin. Exper. Pharmacol.,,2022,17,3,,,,,166,173,,10.2174/2772432816666210805141257,http://dx.doi.org/10.2174/2772432816666210805141257,,,8,Pharmacology & Pharmacy,Emerging Sources Citation Index (ESCI),Pharmacology & Pharmacy,3O6TB,34455945,,,,2024-06-04,WOS:000836966400002,View Full Record in Web of Science
J,"Lim, YJ; Jamaluddin, R; Hazizi, A; Chieng, JY",,,,"Lim, Ying Jye; Jamaluddin, Rosita; Hazizi, Abu Saad; Chieng, Jin Yu",,,"Effects of Synbiotics among Constipated Adults in Serdang, Selangor, Malaysia-A Randomised, Double-Blind, Placebo-Controlled Trial",NUTRIENTS,,,English,Article,,,,,,functional constipation; Rome III criteria; Bristol Stool Form Scale; defecation frequency; synbiotics; probiotics; prebiotics; Lactobacillus plantarum LP01; Bifidobacterium lactis BB12; randomised controlled trial (RCT),LACTIC-ACID BACTERIA; QUALITY-OF-LIFE; FUNCTIONAL CONSTIPATION; PROBIOTIC BACTERIA; TRANSIT-TIME; BIFIDOBACTERIA; SYMPTOMS; EPIDEMIOLOGY; MODULATION; MICROBIOTA,"Synbiotics approach complementarily and synergistically toward the balance of gastrointestinal microbiota and improvement in bowel functions. A randomised, double-blind, placebo-controlled study was conducted to examine the effects of a synbiotics supplement among constipated adults. A total of 85 constipated adults, diagnosed by Rome III criteria for functional constipation were randomised to receive either synbiotics (n = 43) or placebo (n = 42) once daily (2.5 g) in the morning for 12 weeks. Eight times of follow-up was conducted every fortnightly with treatment response based on a questionnaire that included a record of evacuation (stool frequency, stool type according to Bristol Stool Form Scale), Patients Assessment on Constipation Symptoms (PAC-SYM), and Patients Assessment on Constipation Quality of Life (PAC-QOL). There were no significant differences in stool evacuation, but defecation frequency and stool type in treatment group were improved tremendously than in placebo group. While the treatment group was reported to have higher reduction in severity of functional constipation symptoms, the differences were not statistically significant. Dietary supplementation of synbiotics in this study suggested that the combination of probiotics and prebiotics improved the functional constipation symptoms and quality of life although not significant. This was due to the high placebo effect which synbiotics failed to demonstrate benefit over the controls.","[Lim, Ying Jye; Jamaluddin, Rosita; Hazizi, Abu Saad] Univ Putra Malaysia, Dept Nutr & Dietet, Fac Med & Hlth Sci, Upm Serdang 43400, Selangor, Malaysia; [Chieng, Jin Yu] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Med, Gastroenterol & Hepatol Unit, Upm Serdang 43400, Selangor, Malaysia",Universiti Putra Malaysia; Universiti Putra Malaysia,"Jamaluddin, R (corresponding author), Univ Putra Malaysia, Dept Nutr & Dietet, Fac Med & Hlth Sci, Upm Serdang 43400, Selangor, Malaysia.",yingjye806@gmail.com; rositaj@upm.edu.my; hazizi@upm.edu.my; cjy511@yahoo.com,"AS, Hazizi/AAV-5090-2021","AS, Hazizi/0000-0002-0614-6700; Jamaluddin, Rosita/0000-0003-1229-0845",,,,,73,20,21,1,9,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",2072-6643,,,NUTRIENTS,Nutrients,JUL,2018,10,7,,,,,,,824,10.3390/nu10070824,http://dx.doi.org/10.3390/nu10070824,,,14,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,GX2JK,29949873,"Green Published, gold, Green Submitted, Green Accepted",,,2024-06-04,WOS:000447544900027,View Full Record in Web of Science
J,"Janssenduijghuijsen, L; van den Belt, M; Rijnaarts, I; Vos, P; Guillemet, D; Witteman, B; de Wit, N",,,,"Janssenduijghuijsen, Lonneke; van den Belt, Maartje; Rijnaarts, Iris; Vos, Paul; Guillemet, Damien; Witteman, Ben; de Wit, Nicole",,,Acacia fiber or probiotic supplements to relieve gastrointestinal complaints in patients with constipation-predominant IBS: a 4-week randomized double-blinded placebo-controlled intervention trial,EUROPEAN JOURNAL OF NUTRITION,,,English,Article; Early Access,,,,,,Irritable bowel syndrome; Constipation; Fiber; Probiotics; Stool frequency; IBS symptoms,IRRITABLE-BOWEL-SYNDROME; QUALITY-OF-LIFE; FERMENTED MILK; CLINICAL-TRIAL; SEVERITY; VALIDATION; TRANSIT; RISK; SYNBIOTICS; PREBIOTICS,"Purpose To date, no adequate treatment for irritable bowel syndrome with predominant constipation complaints (IBS-C) is available. Fibers with prebiotic properties and probiotic compounds have shown promise in relieving IBS-C-related complaints. We aimed to determine the effects of a 4-week intervention with either an Acacia fiber (AF) with prebiotic properties or a probiotic Bifidobacterium Lactis (BLa80) supplement, compared to a control supplement, on stool pattern, IBS symptoms and Quality of Life (QoL), in IBS-C individuals. Methods A parallel, double-blind, randomized controlled trial involving 180 subjects meeting the ROME IV criteria for IBS-C was conducted. Following a 4-week observation period, subjects received either AF (10 g), Probiotic BLa80 (4 g; 2 x 10(11) CFU/g) or a maltodextrin placebo (10 g) daily for 4 weeks. Subjects reported daily information on stool pattern and gastrointestinal complaints. Before and after each 4-week period, questionnaires on symptom severity, constipation symptoms, anxiety and depression and QoL were completed. Stool mass was measured for 5-days before and after the intervention. Results Stool frequency significantly improved in the AF and Probiotic BLa80 groups compared to placebo (P < 0.001, P = 0.02, respectively). Probiotic BLa80 showed a significant reduction in IBS symptom severity (P = 0.03), for AF a trend towards decreased constipation symptoms (PAC-SYM, P = 0.10) was observed. No significant changes in stool consistency, stool mass or QoL measures were observed between the AF and Probiotic BLa80 compared to placebo. Conclusion Daily dietary supplementation with Acacia fiber and probiotic supplements might help IBS-C patients by relieving IBS-related complaints compared to a placebo supplement. Registration number of clinical trial The trial is registered at ClinicalTrials.gov: NCT04798417: Study Details | Nutrition to Relieve IBS Constipation | ClinicalTrials.gov.","[Janssenduijghuijsen, Lonneke; van den Belt, Maartje; Vos, Paul; de Wit, Nicole] Wageningen Univ & Res, Wageningen Food & Biobased Res, Wageningen, Netherlands; [Rijnaarts, Iris; Witteman, Ben] Wageningen Univ & Res, Div Human Nutr & Hlth, Wageningen, Netherlands; [Witteman, Ben] Hosp Gelderse Vallei, Gastroenterol & Hepatol Dept, Ede, Netherlands; [Guillemet, Damien] Nexira, Rouen, France",Wageningen University & Research; Wageningen University & Research; Gelderse Vallei Hospital,"van den Belt, M (corresponding author), Wageningen Univ & Res, Wageningen Food & Biobased Res, Wageningen, Netherlands.",maartje.vandenbelt@wur.nl,,"Guillemet, Damien/0000-0002-6638-0531",Ministerie van Buitenlandse Zaken,Ministerie van Buitenlandse Zaken,"We thank Els Oosterink, Juliette Hooghiemstra, Niels Klaassen, Saskia Meijboom, and Odette Paling for their help in study logistics and data collection. We thank Joao Paulo and Geertje van Bergen for their support with the statistical analyses, and Nicole de Roos for her support during data interpretation and writing of the manuscript.",,49,0,0,0,0,SPRINGER HEIDELBERG,HEIDELBERG,"TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY",1436-6207,1436-6215,,EUR J NUTR,Eur. J. Nutr.,2024 APR 23,2024,,,,,,,,,,10.1007/s00394-024-03398-8,http://dx.doi.org/10.1007/s00394-024-03398-8,,APR 2024,12,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,OK4W9,38653808,hybrid,,,2024-06-04,WOS:001207161800001,View Full Record in Web of Science
J,"Inatomi, T; Honma, M",,,,"Inatomi, Takio; Honma, Mihoko",,,Effects of probiotics on loperamide-induced constipation in rats,SCIENTIFIC REPORTS,,,English,Article,,,,,,,CHAIN FATTY-ACIDS; IN-SITU HYBRIDIZATION; LIPID-METABOLISM; BACTERIA; MOTILITY; PREBIOTICS; STRAINS; GROWTH; PROBES; DRUG,"The role of probiotics in mitigating constipation, gut immunity, and gut microbiota has not been well studied. We aimed to evaluate the effects of probiotics on loperamide (LP)-induced constipation in Sprague-Dawley rats. Altogether, 150 male Sprague-Dawley rats (age 8 weeks) were used in the experiments following a 12-day acclimatisation period and were randomly divided into three treatment groups (groups 1, 2, and 3). Spastic constipation was induced via oral LP administration (3 mg/kg) for 6 days, 1 h before administering each test compound in groups 1 and 2. A probiotic solution (4 mL/kg body weight) was orally administered once a day for 6 days in group 2. In group 1, a phosphate buffer solution was orally administered once a day for 6 days, 1 h after each LP administration. In group 3, a phosphate buffer solution was orally administered once a day for 6 days. In the probiotic group, faecal parameters improved; faecal n-butyric acid, acetic acid, and IgA concentrations were increased; intestinal transit time was shortened; and disturbance of intestinal microbiota was inhibited. Our findings suggest that this probiotic was useful in improving various symptoms caused by constipation.","[Inatomi, Takio] Inat Anim Hosp, Ota Ku, 1-1-24 Denenchofu, Tokyo 1450071, Japan; [Honma, Mihoko] Kusama Anim Hlth Lab, 2240 Tsunehiro, Kashima, Saga 8491301, Japan",,"Inatomi, T (corresponding author), Inat Anim Hosp, Ota Ku, 1-1-24 Denenchofu, Tokyo 1450071, Japan.",takato.inatomi@gmail.com,,,,,,,67,10,11,2,18,NATURE PORTFOLIO,BERLIN,"HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY",2045-2322,,,SCI REP-UK,Sci Rep,DEC 16,2021,11,1,,,,,,,24098,10.1038/s41598-021-02931-7,http://dx.doi.org/10.1038/s41598-021-02931-7,,,9,Multidisciplinary Sciences,Science Citation Index Expanded (SCI-EXPANDED),Science & Technology - Other Topics,XP8GQ,34916548,"gold, Green Submitted, Green Published",,,2024-06-04,WOS:000731098600053,View Full Record in Web of Science
J,"Zhang, Q; Zhao, W; Zhao, YY; Duan, SF; Liu, WH; Zhang, C; Sun, SY; Wang, TT; Wang, X; Hung, WL; Wang, R",,,,"Zhang, Qi; Zhao, Wen; Zhao, Yuyang; Duan, Sufang; Liu, Wei-Hsien; Zhang, Chao; Sun, Siyuan; Wang, Tingting; Wang, Xin; Hung, Wei-Lian; Wang, Ran",,,In vitro Study of Bifidobacterium lactis BL-99 With Fructooligosaccharide Synbiotics Effected on the Intestinal Microbiota,FRONTIERS IN NUTRITION,,,English,Article,,,,,,Bifidobacterium lactis BL-99; fructooligosaccharide; constipation; intestinal microbiota; in vitro fermentation,PROBIOTICS; PREBIOTICS; LIFE,"Probiotics and prebiotics relieve constipation by altering the composition of the intestinal microbiota. However, their synergistic mechanism of action remains unclear. Herein, an in vitro fermentation model was constructed to examine the synergistic effects of Bifidobacterium lactis BL-99 and fructooligosaccharide (FOS) on the regulation of intestinal microbiota from a population with constipation. The utilization of FOS was promoted by BL-99, and the increase rate being 22.33%. Relative to the BL-99 and the FOS groups, the BL-99_FOS group showed a highly significant increase in acetic acid content (P < 0.01) and a marked decrease in CO2 and H2S contents (P < 0.01) in the fermentation broth. In addition, the BL-99_FOS combination significantly changed the structure of the intestinal microbiota, enhanced the relative abundances of beneficial bacteria that relieved constipation, including Bifidobacterium, Fecalibacterium, Lactobacillus, Subdoligranulum, and Blautia, and decreased those of the harmful bacteria, including Bilophila and Escherichia-Shigella. These findings suggested that BL-99 and FOS synergistically regulated the composition and structure of the intestinal microbiota from the population with constipation and increased acetic acid and decreased CO2 and H2S levels, thereby providing a theoretical basis for the application of synbiotics.","[Zhang, Qi; Zhao, Wen; Zhang, Chao; Sun, Siyuan; Wang, Ran] China Agr Univ, Dept Nutr & Hlth, Key Lab Funct Dairy, Coconstructed Minist Educ & Beijing Govt, Beijing, Peoples R China; [Zhao, Yuyang] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing Lab Food Qual & Safety, Beijing, Peoples R China; [Duan, Sufang; Liu, Wei-Hsien; Hung, Wei-Lian] Inner Mongolia Dairy Technol Res Inst Co Ltd, Hohhot, Peoples R China; [Duan, Sufang; Liu, Wei-Hsien; Hung, Wei-Lian] Inner Mongolia Yili Ind Grp Co Ltd, Yili Innovat Ctr, Hohhot, Peoples R China; [Wang, Tingting] Hangzhou Hailu Med Technol Co Ltd, Hangzhou, Peoples R China; [Wang, Xin] Zhejiang Acad Agr Sci, Inst Food Sci, Hangzhou, Peoples R China",China Agricultural University; China Agricultural University; Inner Mongolia Yili Industrial Group Co Ltd; Zhejiang Academy of Agricultural Sciences,"Wang, R (corresponding author), China Agr Univ, Dept Nutr & Hlth, Key Lab Funct Dairy, Coconstructed Minist Educ & Beijing Govt, Beijing, Peoples R China.;Hung, WL (corresponding author), Inner Mongolia Dairy Technol Res Inst Co Ltd, Hohhot, Peoples R China.;Hung, WL (corresponding author), Inner Mongolia Yili Ind Grp Co Ltd, Yili Innovat Ctr, Hohhot, Peoples R China.",Hongweilian@yili.com; wangran@cau.edu.cn,"Liu, Wei-Hsien/HTS-9107-2023; guo, caiping/IYS-5296-2023; li, yang/IQV-3559-2023; Sun, Siyuan/ITV-0582-2023; LI, XIAO/IQV-9318-2023; Zhang, Qi/GWC-9220-2022","Liu, Wei-Hsien/0000-0001-8432-7294; Zhang, Chao/0009-0007-8631-2476; Zhang, Qi/0000-0002-9021-3960; DUAN, SuFang/0000-0003-3093-291X",,,,,44,8,9,21,59,FRONTIERS MEDIA SA,LAUSANNE,"AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND",2296-861X,,,FRONT NUTR,Front. Nutr.,APR 28,2022,9,,,,,,,,890316,10.3389/fnut.2022.890316,http://dx.doi.org/10.3389/fnut.2022.890316,,,10,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,1E3IR,35571919,"Green Published, gold",,,2024-06-04,WOS:000794387300001,View Full Record in Web of Science
J,"Puccio, G; Cajozzo, C; Meli, F; Rochat, F; Grathwohl, D; Steenhout, P",,,,"Puccio, Giuseppe; Cajozzo, Cinzia; Meli, Ferdinando; Rochat, Florence; Grathwohl, Dominik; Steenhout, Philippe",,,Clinical evaluation of a new starter formula for infants containing live Bifidobacterium longum BL999 and prebiotics,NUTRITION,,,English,Article,,,,,,Bifidobacterium longum; probiotics; galacto-oligosaccharides/fructo-oligosaccharides; prebiotics; infants; formula; safety,INTESTINAL MICROFLORA; SYNBIOTIC THERAPY; PROBIOTICS; OLIGOSACCHARIDES; BOWEL; FLORA; PREVENTION; MILK,"Objectives: The larger number of bifidobacteria in the intestine of breast-fed infants has been associated with their better health compared with formula-fed infants. We assessed the safety and tolerability of an experimental formula containing 2 X 10(7) colony-forming units of Bifidobacterium longum BL999 and 4 g/L of a prebiotic mixture containing 90% galacto-oligosaccharides and 10% fructo-oligosacchari des. Methods: A 7-mo prospective, randomized, reference-controlled, double-blinded trial was performed in infants who were not breast fed after the 14th day of birth. One hundred thirty-eight infants were enrolled and assigned to receive the control or experimental formula until they were 112 d old. Mean weight gain (primary outcome) and recumbent length, head circumference, tolerability (gastrointestinal symptoms), and overall morbidity (secondary outcomes) were measured at 14, 28, 56, 84, and 112 d of age. Results: Equivalence in mean weight gain between the two groups was shown. The treatment difference in the intention-to-treat and per-protocol populations were within the predefined equivalence boundaries of +/- 3.9 g/d. No statistically significant difference in recumbent length, head circumference, or incidence of adverse events was found between the two groups. Infants in the experimental group had fewer incidences of constipation and had stool characteristics that suggest that the experimental formula was tolerated well. Furthermore, these infants showed a trend toward fewer respiratory tract infections. Conclusions: The starter formula containing BL999 and galacto-oligosaccharides/fructooligosaccharides is safe and well-tolerated. (c) 2007 Elsevier Inc. All rights reserved.","Univ Palermo, Inst Obstet & Gynaecol, Palermo, Italy; Nestle Res Ctr, CH-1000 Lausanne, Switzerland; Nestec Ltd, Nestle Nutr, Vevey, Switzerland",University of Palermo; Nestle SA; Nestle SA,"Puccio, G (corresponding author), Univ Palermo, Inst Obstet & Gynaecol, Palermo, Italy.",gpuccio@neomedia.it,,,,,,,37,89,107,1,18,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",0899-9007,1873-1244,,NUTRITION,Nutrition,JAN,2007,23,1,,,,,1,8,,10.1016/j.nut.2006.09.007,http://dx.doi.org/10.1016/j.nut.2006.09.007,,,8,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,126XN,17189085,,,,2024-06-04,WOS:000243549000001,View Full Record in Web of Science
J,"Hosoda, S; Nishimoto, Y; Yamauchi, Y; Yamada, T; Hamada, M",,,,"Hosoda, Shion; Nishimoto, Yuichiro; Yamauchi, Yohsuke; Yamada, Takuji; Hamada, Michiaki",,,Probiotic responder identification in cross-over trials for constipation using a Bayesian statistical model considering lags between intake and effect periods,COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL,,,English,Article,,,,,,Probiotics; Bayesian statistical model; Microbiome; Defecation frequency,FUNCTIONAL CONSTIPATION,"Recent advances in microbiome research have led to the further development of microbial interventions, such as probiotics and prebiotics, which are potential treatments for constipation. However, the effects of probiotics vary from person to person; therefore, the effectiveness of probiotics needs to be verified for each individual. Individuals showing significant effects of the target probiotic are called responders. A statistical model for the evaluation of responders was proposed in a previous study. However, the previous model does not consider the lag between intake and effect periods of the probiotic. It is expected that the lag exists when probiotics are administered and when they are effective. In this study, we propose a Bayesian statistical model to estimate the probability that a subject is a responder, by considering the lag between intake and effect periods. In synthetic dataset experiments, the proposed model was found to outperform the base model, which did not factor in the lag. Further, we found that the proposed model could distinguish responders showing large uncertainty in terms of the lag between intake and effect periods.","[Hosoda, Shion; Hamada, Michiaki] Waseda Univ, Grad Sch Adv Sci & Engn, Dept Elect Engn & Biosci, Tokyo, Japan; [Hosoda, Shion; Hamada, Michiaki] AIST Waseda Univ, Computat Bio Big Data Open Innovat Lab, Tokyo, Japan; [Nishimoto, Yuichiro; Yamauchi, Yohsuke; Yamada, Takuji] Metagen Inc, Yamagata, Japan; [Yamada, Takuji] Tokyo Inst Technol, Dept Life Sci & Technol, Tokyo, Japan; [Hamada, Michiaki] Nippon Med Sch, Grad Sch Med, Tokyo, Japan",Waseda University; Waseda University; Tokyo Institute of Technology; Nippon Medical School,"Hosoda, S; Hamada, M (corresponding author), Waseda Univ, Grad Sch Adv Sci & Engn, Dept Elect Engn & Biosci, Tokyo, Japan.",shion_hosoda@asagi.waseda.jp; mhamada@waseda.jp,"Hamada, Michiaki/L-9371-2018","Hamada, Michiaki/0000-0001-9466-1034","JSPS/MEXT KAKENHI [JP19J20117, JP20H00624, JP19H01152, JP18KT0016]","JSPS/MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))","Funding This work was supported by JSPS/MEXT KAKENHI (Grant Num-ber JP19J20117 to SH, JP20H00624, JP19H01152, and JP18KT0016 to MH) .",,22,0,0,0,0,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",2001-0370,,,COMPUT STRUCT BIOTEC,Comp. Struct. Biotechnol. J..,,2023,21,,,,,,5350,5357,,10.1016/j.csbj.2023.10.047,http://dx.doi.org/10.1016/j.csbj.2023.10.047,,OCT 2023,8,Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology,Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology,Y3KL4,37954146,"Green Published, gold",,,2024-06-04,WOS:001104290100001,View Full Record in Web of Science
J,"Sengkhim, R; Peerakietkhajorn, S; Jeanmard, N; Pongparadon, S; Khuituan, P; Thitiphatphuvanon, T; Surinlert, P; Tipbunjong, C",,,,"Sengkhim, Rattanaporn; Peerakietkhajorn, Saranya; Jeanmard, Nilobon; Pongparadon, Supattra; Khuituan, Pissared; Thitiphatphuvanon, Thanvarin; Surinlert, Piyaporn; Tipbunjong, Chittipong",,,Effects of Sargassum plagiophyllum extract pretreatment on tissue histology of constipated mice,TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH,,,English,Article,,,,,,Sargassum plagiophyllum; Constipation; Prebiotics; Seaweed; Antioxidant,ANTIOXIDANT,"Purpose: To evaluate the toxicity of the dried seaweed, Sargassum plagiophyllum, extract (SPE) pretreatment in constipated mice. Methods: The dried seaweed powder was mixed with distilled water and extracted by autoclave at 121 degrees C. Antioxidant activity of the extract was determined by 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay. Human normal colon cells were pretreated with SPE at 0 - 100 mu g/mL for 24 h before challenging them with 100 mu M hydrogen peroxide (H2O2). Intracellular reactive oxygen species (ROS) were quantified using 2',7'-dichlorodihydrofluorescein diacetate (H(2)DCFDA). Male ICR mice were pretreated for 14 consecutive days with SPE at 100, 500 and 1,000 mg/kg or lactulose at 500 mg/kg. Body weight and food intake were recorded daily. Constipation was induced with loperamide on days 12, 13 and 14 and fecal pellets evacuated over a 4-hr period. The ileum, liver, kidney, and spleen were collected for histopathological examination. Results: The IC50 for the radical scavenging capacity of SPE was 343.90 +/- 4.21 pg/mL compared to 14.14 +/- 0.71 mu g/mL for ascorbic acid. Pretreatment with SPE was significantly reduced ROS production in human normal colon cells. Oral administration of all doses of SPE and lactulose for 14 consecutive days had no effect on food intake or body weight when compared to the normal control group. Defecation was significantly more frequent in mice pretreated with SPE at 100 mg/kg than in the constipation control group. Histopathological examination of the ileum, liver, kidney and spleen of pretreated constipated mice revealed no toxic effect from either SPE or lactulose. On the other hand, the loss of mucus-producing cells in the ileum of constipated mice was significantly lower in mice pretreated with SPE. Conclusions: These findings support the safety of SPE supplementation and may broaden its application in clinical fields as an alternative drug or supplement for constipation management.","[Sengkhim, Rattanaporn; Peerakietkhajorn, Saranya; Jeanmard, Nilobon] Prince Songkla Univ, Fac Sci, Dept Biol, Div Biol Sci, Hat Yai 90110, Thailand; [Peerakietkhajorn, Saranya; Khuituan, Pissared; Tipbunjong, Chittipong] Prince Songkla Univ, Fac Sci, Gut Biol & Microbiota Res Unit, Hat Yai 90110, Thailand; [Pongparadon, Supattra] Prince Songkla Univ, Fac Sci, Excellence Ctr Biodivers Peninsular Thailand, Hat Yai 90110, Thailand; [Khuituan, Pissared] Prince Songkla Univ, Fac Sci, Dept Physiol, Div Hlth & Appl Sci, Hat Yai 90110, Thailand; [Thitiphatphuvanon, Thanvarin] Siam Univ, Fac Med, Bangkok 10160, Thailand; [Surinlert, Piyaporn] Thammasat Univ, Chulabhorn Int Coll Med, Pathum Thani 12120, Thailand; [Tipbunjong, Chittipong] Prince Songkla Univ, Fac Sci, Dept Anat, Div Hlth & Appl Sci, Hat Yai 90110, Thailand",Prince of Songkla University; Prince of Songkla University; Prince of Songkla University; Prince of Songkla University; Thammasat University; Chulabhorn Research Institute; Prince of Songkla University,"Tipbunjong, C (corresponding author), Prince Songkla Univ, Fac Sci, Gut Biol & Microbiota Res Unit, Hat Yai 90110, Thailand.;Tipbunjong, C (corresponding author), Prince Songkla Univ, Fac Sci, Dept Anat, Div Hlth & Appl Sci, Hat Yai 90110, Thailand.",chittipong.t@psu.ac.th,"Peerakietkhajorn, Saranya/AAC-5602-2019; Khuituan, Pissared/GNW-5846-2022","Peerakietkhajorn, Saranya/0000-0002-1233-9488; Khuituan, Pissared/0000-0003-1376-3253; Thitiphatphuvanon, Thanvarin/0000-0003-0965-3705","National Science, Research and Innovation Fund (NSRF); Prince of Songkla University [SCI6405072S]; Thammasat University Research Unit in Synthesis and Applications of Graphene","National Science, Research and Innovation Fund (NSRF); Prince of Songkla University; Thammasat University Research Unit in Synthesis and Applications of Graphene","This research was supported by National Science, Research and Innovation Fund (NSRF) and Prince of Songkla University (Grant No. SCI6405072S) . This work was supported by Thammasat University Research Unit in Synthesis and Applications of Graphene. The authors would like to thank Mr Thomas Duncan Coyne for English proofreading of the manuscript.",,17,4,4,2,5,PHARMACOTHERAPY GROUP,BENIN CITY,"UNIV BENIN, FACULTY PHARMACY, BENIN CITY, 00000, NIGERIA",1596-5996,,,TROP J PHARM RES,Trop. J. Pharm. Res.,NOV,2021,20,11,,,,,2339,2346,,10.4314/tjpr.v20i11.16,http://dx.doi.org/10.4314/tjpr.v20i11.16,,,8,Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy,XI8HK,,gold,,,2024-06-04,WOS:000726345100016,View Full Record in Web of Science
J,"Bousdouni, P; Kandyliari, A; Koutelidakis, AE",,,,"Bousdouni, Panoraia; Kandyliari, Aikaterini; Koutelidakis, Antonios E.",,,"Probiotics and Phytochemicals: Role on Gut Microbiota and Efficacy on Irritable Bowel Syndrome, Functional Dyspepsia, and Functional Constipation",GASTROINTESTINAL DISORDERS,,,English,Article,,,,,,irritable bowel syndrome; functional dyspepsia; functional constipation; probiotics; phytochemicals; functional foods,DOUBLE-BLIND; GASTROINTESTINAL DISORDERS; FECAL MICROBIOTA; BRAIN AXIS; G-POEM; DIET; PATHOGENESIS; MANAGEMENT; PREBIOTICS; DIAGNOSIS,"Functional gastrointestinal disorders (FGIDs), such as irritable bowel syndrome, functional constipation, and functional dyspepsia, have had a high prevalence over the past few years. Recent evidence suggests that functional foods and bioactive compounds, such as probiotics and phytochemicals, may have a positive effect in treating the symptoms of the above diseases. In this systematic review study, 32 published studies were selected with the use of comprehensive scientific databases, according to PRISMA guidelines, with emphasis on recent interventional studies that reflect the effect of probiotics and selected phytochemicals on the improvement of FGID symptoms. The bioactive compounds in the selected studies were administered to patients either in capsule form or in enriched food products (yogurt, juice, etc.). According to the results, there is a correlation between the consumption of probiotics and phytochemicals, such as polyphenols, and the relief of symptoms in selected gastrointestinal disorders. Enriching foods that are regularly consumed by the population, such as fruit juices, yogurt, and cheese, with ingredients that may have a positive effect on gastrointestinal disorders, could be a possible novel goal for the management of these diseases. However, further evidence is required for the role of probiotics and phytochemicals in FGIDs to be fully understood.","[Bousdouni, Panoraia; Kandyliari, Aikaterini; Koutelidakis, Antonios E.] Univ Aegean, Dept Food Sci & Nutr, Myrina 81400, Lemnos, Greece",,"Koutelidakis, AE (corresponding author), Univ Aegean, Dept Food Sci & Nutr, Myrina 81400, Lemnos, Greece.",p.bousdouni@gmail.com; kandyliari@aegean.gr; akoutel@aegean.gr,,"Kandyliari, Aikaterini/0000-0002-0883-7409; KOUTELIDAKIS, ANTONIOS/0000-0001-5137-0499; Bousdouni, Panoraia/0000-0001-9760-1483",European Regional Development Fund (ERDF),European Regional Development Fund (ERDF)(European Union (EU)),"This research is part of the project, Infrastructure of Microbiome Applications in Food Systems-FoodBiomes, which is co-funded by the European Regional Development Fund (ERDF), under the Operational Program Competitiveness, Entrepreneurship and Innovation-EPANEK 2014-2020, Call 111 Support for Regional Excellence",,79,4,4,0,7,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2624-5647,,GASTROINTEST DISORD,Gastrointest. Disord.,MAR,2022,4,1,,,,,30,48,,10.3390/gidisord4010005,http://dx.doi.org/10.3390/gidisord4010005,,,19,Gastroenterology & Hepatology,Emerging Sources Citation Index (ESCI),Gastroenterology & Hepatology,0C4FB,,gold,,,2024-06-04,WOS:000775269900001,View Full Record in Web of Science
J,"Palamutoglu, MI; Köse, G; Bas, M",,,,"Palamutoglu, Merve Ince; Kose, Gizem; Bas, Murat",,,Probiotics and Prebiotics Affecting Mental and Gut Health,HEALTHCARE,,,English,Article,,,,,,probiotic; prebiotic; gastrointestinal system; depression; anxiety; stress,TURKISH VERSION; BRAIN AXIS; RELIABILITY; DEPRESSION; VALIDITY; ANXIETY; SCALE; DIARRHEA,"The effects of the gut microbiota on mental and intestinal health are an area of great interest. This study aimed to reveal the relationship between the intake of probiotic and prebiotic foods and mental and gut health. Data were obtained using an online survey from young adults (n = 538) enrolled at Afyonkarahisar Health Sciences University who agreed to participate in this study in the 2022-2023 academic year. This study included 538 participants, mostly (85.5%) females. Participants who never consumed yogurt had 7.614 times higher Gastrointestinal Symptom Rating Scale scores than those who consumed yogurt daily (p < 0.01). Similarly, the frequency of ayran consumption had a statistically significant effect on Bristol Stool Scale scores (p < 0.05). The ratio of normal defecation to constipation was 68.7% lower in participants who consumed ayran daily, whereas the ratio of diarrhea to constipation was 76.4% lower in participants who never consumed ayran. However, the frequency of prebiotic consumption did not have a significant effect on Bristol Stool Scale scores (p > 0.05). The consumption of probiotic and prebiotic foods exerted a significant effect on GSRS total scores and subfactors of the Depression Anxiety Stress Scale-42, namely depression, anxiety, and stress.","[Palamutoglu, Merve Ince] Acibadem Mehmet Ali Aydinlar Univ, Inst Hlth Sci, Dept Nutr & Dietet, TR-34752 Istanbul, Turkiye; [Palamutoglu, Merve Ince] Afyonkarahisar Hlth Sci Univ, Fac Hlth Sci, Dept Nutr & Dietet, TR-03030 Afyonkarahisar, Turkiye; [Kose, Gizem; Bas, Murat] Acibadem Mehmet Ali Aydinlar Univ, Fac Hlth Sci, Dept Nutr & Dietet, TR-34752 Istanbul, Turkiye",Acibadem University; Afyonkarahisar Health Sciences University; Acibadem University,"Palamutoglu, MI (corresponding author), Acibadem Mehmet Ali Aydinlar Univ, Inst Hlth Sci, Dept Nutr & Dietet, TR-34752 Istanbul, Turkiye.;Palamutoglu, MI (corresponding author), Afyonkarahisar Hlth Sci Univ, Fac Hlth Sci, Dept Nutr & Dietet, TR-03030 Afyonkarahisar, Turkiye.",merve.palamutoglu@live.acibadem.edu.tr; gizem.kose@acibadem.edu.tr; murat.bas@acibadem.edu.tr,"; INCE PALAMUTOGLU, MERVE/P-4177-2018","Kose, Gizem/0000-0001-6612-6253; INCE PALAMUTOGLU, MERVE/0000-0002-7953-742X; Bas, Murat/0000-0002-0494-301X",,,,,41,0,0,3,3,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2227-9032,,HEALTHCARE-BASEL,Healthcare,MAR,2024,12,5,,,,,,,510,10.3390/healthcare12050510,http://dx.doi.org/10.3390/healthcare12050510,,,18,Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Health Care Sciences & Services,KX5J4,38470623,"gold, Green Published",,,2024-06-04,WOS:001183275200001,View Full Record in Web of Science
J,"Tan, AH; Lim, SY; Chong, KK; Manap, MAAA; Hor, JW; Lim, JL; Low, SC; Chong, CW; Mahadeva, S; Lang, AE",,,,"Tan, Ai Huey; Lim, Shen-Yang; Chong, Kah Kian; Manap, Mohammad Addin Azhan A.; Hor, Jia Wei; Lim, Jia Lun; Low, Soon Chai; Chong, Chun Wie; Mahadeva, Sanjiv; Lang, Anthony E.",,,Probiotics for Constipation in Parkinson Disease A Randomized Placebo-Controlled Study,NEUROLOGY,,,English,Article,,,,,,,CONTROLLED-TRIAL; SYMPTOMS; INFLAMMATION; ENTEROCOCCUS; MICROBIOME; PREBIOTICS; LEVODOPA; MARKERS; SAFETY,"Objective To determine whether probiotics are effective for constipation, a common and often difficultto-treat problem, in Parkinson disease (PD). Methods In this double-blind, randomized, placebo-controlled, single-center trial, 280 patients with PD were screened, and 72 eligible patients were block-randomized (1:1) to receive either multistrain probiotics capsules (n = 34) or identical-appearing placebo (n = 38), for 4 weeks. The primary endpoint was the change in the average number of spontaneous bowel movements (SBM) per week during the last 2 weeks of intervention compared with the 2-week preintervention phase, recorded by daily stool diary. Secondary outcome measures included changes in stool consistency, constipation severity score, and quality of life related to constipation. Satisfaction with intervention received was assessed. Change in levels of fecal calprotectin, a marker of intestinal inflammation, was an exploratory outcome. Results SBM increased by 1.0 +/- 1.2 per week after treatment with probiotics and decreased by 0.3 +/- 1.0 per week in the placebo group (mean difference 1.3, 95% confidence interval 0.8-1.8, p < 0.001). Significant improvements were also seen for secondary outcomes after correction for multiple comparisons, including stool consistency (p = 0.009) and quality of life related to constipation (p = 0.001). In the treatment group, 65.6% reported satisfaction with the intervention vs only 21.6% in the placebo group (p < 0.001). One patient (2.9%) in the treatment group withdrew due to a nonserious adverse event. Fecal calprotectin did not change significantly during the study. Conclusions Multistrain probiotics treatment was effective for constipation in PD. Further studies are needed to investigate the long-term efficacy and safety of probiotics in PD, as well as their mechanisms of action. Classification of Evidence This study provides Class I evidence that, for people with PD, multistrain probiotics significantly increased the average number of SBM per week.","[Tan, Ai Huey; Lim, Shen-Yang; Chong, Kah Kian; Manap, Mohammad Addin Azhan A.; Hor, Jia Wei; Lim, Jia Lun; Low, Soon Chai] Univ Malaya, Fac Med, Div Neurol, Kuala Lumpur, Malaysia; [Tan, Ai Huey; Lim, Shen-Yang; Chong, Kah Kian; Manap, Mohammad Addin Azhan A.; Hor, Jia Wei; Lim, Jia Lun; Low, Soon Chai] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia; [Tan, Ai Huey; Lim, Shen-Yang; Chong, Kah Kian; Manap, Mohammad Addin Azhan A.; Hor, Jia Wei; Lim, Jia Lun; Low, Soon Chai] Univ Malaya, Fac Med, Mah Pooi Soo & Tan Chin Nam Ctr Parkinsons & Rela, Kuala Lumpur, Malaysia; [Chong, Chun Wie] Monash Univ Malaysia, Sch Pharm, Subang Jaya, Selangor, Malaysia; [Mahadeva, Sanjiv] Univ Malaya, Fac Med, Dept Med, Div Gastroenterol, Kuala Lumpur, Malaysia; [Lang, Anthony E.] Toronto Western Hosp, Safra Program Parkinsons Dis, Toronto, ON, Canada; [Lang, Anthony E.] Toronto Western Hosp, Morton & Gloria Shulman Movement Disorders Clin, Toronto, ON, Canada",Universiti Malaya; Universiti Malaya; Universiti Malaya; Monash University; Monash University Malaysia; Universiti Malaya; University of Toronto; University Health Network Toronto; University of Toronto; University Health Network Toronto,"Tan, AH (corresponding author), Univ Malaya, Fac Med, Div Neurol, Kuala Lumpur, Malaysia.;Tan, AH (corresponding author), Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia.;Tan, AH (corresponding author), Univ Malaya, Fac Med, Mah Pooi Soo & Tan Chin Nam Ctr Parkinsons & Rela, Kuala Lumpur, Malaysia.",aihuey.tan@gmail.com,"Low, Soon Chai/AAU-9560-2020; Lang, Anthony/ABF-8114-2021; Lim, Shen-Yang/E-5099-2010; Chong, Chun Wie/ABG-7676-2020; Tan, Ai Huey/G-5264-2016; Mahadeva, Sanjiv/E-1711-2011","Lim, Shen-Yang/0000-0002-6942-2522; Chong, Chun Wie/0000-0002-6881-8883; Tan, Ai Huey/0000-0002-2979-3839; Mahadeva, Sanjiv/0000-0001-5824-0590; Hor, Jia Wei/0000-0002-8306-5453; Lang, Anthony/0000-0003-1229-3667","Ministry of Education, Malaysia Fundamental Research Grant Scheme [FRGS/1/2018/SKK02/UM/02/1]","Ministry of Education, Malaysia Fundamental Research Grant Scheme","This study was supported by the Ministry of Education, Malaysia Fundamental Research Grant Scheme FRGS/1/2018/SKK02/UM/02/1 (to A.H.T.).",,54,109,114,20,105,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0028-3878,1526-632X,,NEUROLOGY,Neurology,FEB 2,2021,96,5,,,,,E772,E782,,10.1212/WNL.0000000000010998,http://dx.doi.org/10.1212/WNL.0000000000010998,,,11,Clinical Neurology,Science Citation Index Expanded (SCI-EXPANDED),Neurosciences & Neurology,SL0WO,33046607,,Y,N,2024-06-04,WOS:000656637200024,View Full Record in Web of Science
J,"Guandalini, S; Cernat, E; Moscoso, D",,,,"Guandalini, S.; Cernat, E.; Moscoso, D.",,,Prebiotics and probiotics in irritable bowel syndrome and inflammatory bowel disease in children,BENEFICIAL MICROBES,,,English,Article; Proceedings Paper,2nd State of Art Congress,2014,"Antalya, TURKEY",,,irritable bowel syndrome; functional gastrointestinal disorders; inflammatory bowel disease; Crohn's disease; ulcerative colitis,GERMINATED BARLEY FOODSTUFF; FUNCTIONAL GASTROINTESTINAL DISORDERS; RANDOMIZED CONTROLLED-TRIAL; DOUBLE-BLIND; ULCERATIVE-COLITIS; LACTOBACILLUS-GG; CROHNS-DISEASE; CLINICAL-TRIAL; SACCHAROMYCES-BOULARDII; FECAL MICROBIOTA,"Underlying pathophysiological mechanisms of irritable bowel syndrome (IBS), a common disorder characterized by abdominal pain associated to a change in stool consistency or frequency, include low-grade inflammation and intestinal microbiota changes. Few and disappointing data are available for prebiotics. A few controlled trials (RCTs) of probiotics are instead available with favourable effects, although most are limited by suboptimal design and small sample size. A recent report from the Rome foundation group included 32 RCTs of probiotics, most of which showed an overall modest improvement in symptoms, with the patients most benefitting from probiotics being those with predominant diarrhoea and those having a post-infectious IBS. A review focusing only on children with functional gastrointestinal disorders concluded that probiotics are more effective than placebo in the treatment of patients with abdominal pain-related functional gastrointestinal disorders, although no effect on constipation was evident. The role for probiotics in inflammatory bowel disease (IBD) appears logical: the endogenous intestinal microbiota plays a central role in their development, and various probiotics have been found effective in animal models of IBD. However, research in humans has been overall quite limited, and it would seem that after a phase of intense research in the first decade of this century, the pace has slowed down, with fewer clinical trials been published in the past 2-3 years. To summarize current evidence: no probiotic has proven successful in Crohn's disease. In ulcerative colitis, on the other hand, data are more promising, and a very recent meta-analysis, that included 23 randomized controlled trials, concluded that there is evidence of efficacy for the probiotic mixture VSL#3 in helping inducing and maintaining remission, as well as in maintaining remission in patients with pouchitis. It is fair to state that for both IBD and IBS, more well-designed, rigorous, randomized clinical trials must be performed.","[Guandalini, S.; Cernat, E.; Moscoso, D.] Univ Chicago, Sect Gastroenterol Hepatol & Nutr, Dept Pediat, Chicago, IL 60637 USA",University of Chicago,"Guandalini, S (corresponding author), Univ Chicago, Sect Gastroenterol Hepatol & Nutr, Dept Pediat, 5841 S Maryland Ave,MC 4065, Chicago, IL 60637 USA.",sguandalini@peds.bsd.uchicago.edu,"Guandalini, Stefano/G-8084-2011",,,,,,85,17,21,0,48,WAGENINGEN ACADEMIC PUBLISHERS,WAGENINGEN,"PO BOX 220, WAGENINGEN, 6700 AE, NETHERLANDS",1876-2883,1876-2891,,BENEF MICROBES,Benef. Microbes,,2015,6,2,,,SI,,209,217,,10.3920/BM2014.0067,http://dx.doi.org/10.3920/BM2014.0067,,,9,Microbiology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Microbiology; Nutrition & Dietetics,CI3FT,25391345,,,,2024-06-04,WOS:000354633700010,View Full Record in Web of Science
J,"de Menezes, CR; Durrant, LR",,,,"de Menezes, Cristiano Ragagnin; Durrant, Lucia Regina",,,"Xylooligosaccharides: production, applications and effects on human health",CIENCIA RURAL,,,Portuguese,Review,,,,,,xylooligosacccharides; prebiotics; health benefits,BY-PRODUCTS; ASPERGILLUS-AWAMORI; XYLANASE PRODUCTION; BETA-XYLOSIDASE; AUTOHYDROLYSIS; OLIGOSACCHARIDES; FOOD; BIFIDOBACTERIUM; FERMENTATION; MICROBIOTA,"Xylooligosaccharides are non-conventional sugars (sugar oligomers made of xylose units), non-calorics and non-digestible by humans. They are recognyzed as prebiotics once there are non digestible food ingredient that stimulate selectively probiotic growth like Lactobacillus sp. and Bifidobacterium bifidum, promoting several benefices to the human health as the reduction of the gut constipation, the increase of the digestion and nutrient absorption, prevention of gastrointestinal infections, and the inhibition of pathogenic microorganisms. This article reviews the production of xylooligosaccharides front lignocellulosic materials (by chemical or enzymatic methods) and its end products, as well (is their application as food ingredients, with special attention to the beneficial effects caused on health by these types of compounds.","[de Menezes, Cristiano Ragagnin] Univ Estadual Campinas, Lab Sistemat & Fisiol Microbiana, DCA, FEA, BR-13083970 Campinas, SP, Brazil",Universidade Estadual de Campinas,"de Menezes, CR (corresponding author), Univ Estadual Campinas, Lab Sistemat & Fisiol Microbiana, DCA, FEA, CP 6121, BR-13083970 Campinas, SP, Brazil.",ragagnin@fea.unicamp.br,"Durrant, Lucia Regina/AAA-3580-2019; Durrant, Lucia R/I-7971-2012; MENEZES, CRISTIANO/T-5665-2019","GROSSMAN, Lucia/0000-0002-0804-517X",,,,,58,13,13,3,62,UNIV FEDERAL SANTA MARIA,SANTA MARIA,"CIDADE UNIV, BAIRRO CAMOBI, SANTA MARIA, RS 97105-900, BRAZIL",0103-8478,1678-4596,,CIENC RURAL,Cienc. Rural,MAR-APR,2008,38,2,,,,,587,592,,10.1590/S0103-84782008000200050,http://dx.doi.org/10.1590/S0103-84782008000200050,,,6,Agronomy,Science Citation Index Expanded (SCI-EXPANDED),Agriculture,299TE,,"Green Submitted, gold",,,2024-06-04,WOS:000255777100050,View Full Record in Web of Science
J,"Harris, RG; Neale, EP; Ferreira, I",,,,"Harris, Rebecca G.; Neale, Elizabeth P.; Ferreira, Isabel",,,When poorly conducted systematic reviews and meta-analyses can mislead: a critical appraisal and update of systematic reviews and meta-analyses examining the effects of probiotics in the treatment of functional constipation in children,AMERICAN JOURNAL OF CLINICAL NUTRITION,,,English,Review,,,,,,children; critical appraisal; functional constipation; meta-analysis; probiotics; randomized controlled trials; risk of bias; systematic review,CASEI-RHAMNOSUS LCR35; DOUBLE-BLIND; CHILDHOOD CONSTIPATION; PUBLICATION BIAS; SYNBIOTICS; PLACEBO; CONSENSUS; COCHRANE; MANAGEMENT; PREBIOTICS,"Background: Recent systematic reviews and meta-analyses on the efficacy of probiotics in the treatment of functional constipation in children have yielded conflicting results. Objectives: The aim of this study was to critically review and update the evidence in this field by mapping all the steps involved against those reported in previous reviews, in an attempt to understand the nature of their conflicting results. Methods: Four literature databases, trial registries, and citations were searched through December 1, 2018. We included randomized controlled trials (RCTs) that assessed the effects of probiotics compared with placebo or treatment as usual on defecation frequency [bowel movements (BMs)/wk] or treatment success rates in children with functional constipation. Independent reviewers extracted the data and assessed risk of bias in each RCT. Data were pooled with (inverse variance) random-effects models. Results: We identified 17 RCTs, of which 14 and 11 provided sufficient data to enable meta-analysis of the effects of probiotics compared with control on defecation frequency (n = 965) or treatment success (n = 835), respectively. When compared to (any) control intervention, probiotics did not significantly increase defecation frequency [weighted mean difference (WMD): 0.28 BMs/wk; 95% CI:-0.12, 0.69; P = 0.165] but were more efficacious in achieving treatment success (RR: 1.24; 95% CI: 1.03, 1.50; P = 0.024). These effects did not differ by type of control (i.e., active or inactive) intervention. However, in analyses confined to the RCTs that were free of high risk of bias (only 5), probiotics did not confer any beneficial effects on defecation frequency (WMD: -0.55 BMs/wk; 95% CI: -1.37, 0.26; P = 0.185) and achievement of treatment success (RR: 1.01; 95% CI: 0.90, 1.13; P = 0.873), compared with control interventions. Conclusions: The current evidence thus does not support the use of probiotics as a single or coadjuvant therapy for treatment of functional constipation in children and refutes recently published reviews reporting favorable effects of probiotics. Conflicting findings of previous reviews resulted from methodologic errors, highlighting the susceptibility of evidence synthesis to oversights in study selection, quality assessments, and data extraction and collation. This review was registered at PROSPERO as CRD42019119109.","[Harris, Rebecca G.; Neale, Elizabeth P.; Ferreira, Isabel] Univ Wollongong, Fac Sci Med & Hlth, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Harris, Rebecca G.; Neale, Elizabeth P.; Ferreira, Isabel] Univ Wollongong, Fac Sci Med & Hlth, Sch Med, Wollongong, NSW, Australia",Illawarra Health & Medical Research Institute; University of Wollongong; University of Wollongong,"Ferreira, I (corresponding author), Univ Wollongong, Fac Sci Med & Hlth, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia.",isabelf@uow.edu.au,"Ferreira, Isabel/B-6033-2008","Ferreira, Isabel/0000-0003-1434-0607; Harris, Rebecca/0000-0003-2460-4522; Neale, Elizabeth/0000-0002-6373-8622",,,,,70,17,18,0,14,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",0002-9165,1938-3207,,AM J CLIN NUTR,Am. J. Clin. Nutr.,JUL,2019,110,1,,,,,177,195,,10.1093/ajcn/nqz071,http://dx.doi.org/10.1093/ajcn/nqz071,,,19,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,IM5YP,31127810,hybrid,,,2024-06-04,WOS:000478070200022,View Full Record in Web of Science
J,"Rasmussen, HE; Hamaker, B; Rajan, KB; Mutlu, E; Green, SJ; Brown, M; Kaur, A; Keshavarzian, A",,,,"Rasmussen, Heather E.; Hamaker, Bruce; Rajan, Kumar B.; Mutlu, Ece; Green, Stefan J.; Brown, Michael; Kaur, Amandeep; Keshavarzian, Ali",,,"Starch-entrapped microsphere fibers improve bowel habit but do not exhibit prebiotic capacity in those with unsatisfactory bowel habits: a phase I, randomized, double-blind, controlled human trial",NUTRITION RESEARCH,,,English,Article,,,,,,Prebiotics; Dietary fiber; Microbiota; Constipation; Clinical trial,DIETARY FIBER; FERMENTATION; CONSTIPATION; PSYLLIUM; HEALTH; MICROBIOME; BACTERIAL; TRANSIT,"Approximately one-third of individuals in the United States experience unsatisfactory bowel habits, and dietary intake, especially one low in fiber, could be partly responsible. We hypothesized that intake of a fermentable fiber (starch-entrapped microspheres, SM) that has a delayed, slow fermentation profile in vitro would improve bowel habit while exhibiting prebiotic capacity in those with self -described unsatisfactory bowel habits, all with minimal adverse effects. A total of 43 healthy volunteers completed a 3-month, double-blind, parallel-aim randomized clinical trial to assess the ability of a daily dose (9 or 12 g) of SM vs psyllium (12 g) to improve bowel habit, including stool consistency and frequency, and modify gut milieu through changes in stool microbiota and short-chain fatty acids while remaining tolerable through minimal gastrointestinal symptoms. All outcomes were compared before and after fiber treatment. Stool frequency significantly improved (P = .0003) in all groups after 3 months, but stool consistency improved only in both SM groups compared with psyllium. In addition, all groups self-reported a similar improvement in overall bowel habit with fiber intake. Both SM and psyllium resulted in minimal changes in microbiota composition and short chain fatty acid concentrations. The present study suggests that supplementation with a delayed and slow-fermenting fiber in vitro may improve bowel habit in those with constipation, but further investigation is warranted to determine capacity to alter microbiota and fermentation profiles in humans. (C) 2017 Elsevier Inc. All rights reserved.","[Rasmussen, Heather E.] Rush Univ, Med Ctr, Dept Clin Nutr, 1700 W VanBuren St Ste 425, Chicago, IL 60612 USA; [Hamaker, Bruce; Kaur, Amandeep] Purdue Univ, Dept Food Sci, 745 Agr Mall Dr, W Lafayette, IN 47907 USA; [Rajan, Kumar B.] Rush Univ, Med Ctr, Dept Internal Med, Rush Inst Hlth Aging, 1653 W Congress Pkwy, Chicago, IL 60612 USA; [Mutlu, Ece; Brown, Michael; Keshavarzian, Ali] Rush Univ, Med Ctr, Dept Internal Med, Div Digest Dis & Nutr, 1725 W Harrison St Ste 206, Chicago, IL 60612 USA; [Green, Stefan J.] Univ Illinois, DNA Serv Facil, Res Resources Ctr, 35 S Wolcott Ave STE E102, Chicago, IL 60612 USA",Rush University; Purdue University System; Purdue University; Rush University; Rush University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital,"Rasmussen, HE (corresponding author), Rush Univ, Med Ctr, 1700 W Van Buren St Ste 425, Chicago, IL 60612 USA.",Heather_Rasmussen@rush.edu; hamakerb@purdue.edu; Kumar_Rajan@rush.edu; Ece_Mutlu@rush.edu; greendna@uic.edu; Michael_Brown@rush.edu; kaur1@purdue.edu; Ali_Keshavarzian@rush.edu,"Kaur, Amandeep/IYJ-2622-2023; Green, Stefan J/C-8980-2011","Kaur, Amandeep/0000-0002-9825-4951; Green, Stefan/0000-0003-2781-359X","National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; Small Business Innovation Research grant [DK088525-01]","National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Small Business Innovation Research grant","This work was supported by the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, and Small Business Innovation Research grant (DK088525-01). Ali Keshavarzian and Bruce Hamaker are holders of the patent for the starch-entrapped microspheres (patent is pending) and are part owners of Nutrabiotix LLC, the company that has the sole right of license of the product. Ali Keshavarzian and Bruce Hamaker were involved in study design and preparation and submission of the application for the Small Business Innovation Research grant but did not participate in participant assessment or data analysis. Both Ali Keshavarzian and Bruce Hamaker participated in preparation of the manuscript after the data were analyzed and finalized.",,38,9,10,3,23,PERGAMON-ELSEVIER SCIENCE LTD,OXFORD,"THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND",0271-5317,1879-0739,,NUTR RES,Nutr. Res.,AUG,2017,44,,,,,,27,37,,10.1016/j.nutres.2017.05.015,http://dx.doi.org/10.1016/j.nutres.2017.05.015,,,11,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,FG4SA,28821315,"Green Accepted, hybrid, Green Published",,,2024-06-04,WOS:000410254600004,View Full Record in Web of Science
J,"de Souza, SS; Pierezan, MD; Hassemer, GD; Lima, CMG; Lindner, JD; Miotto, M; Verruck, S",,,,"de Souza, Sofia Steinmetz; Pierezan, Milena Dutra; Hassemer, Guilherme de Souza; Lima, Clara Mariana Goncalves; Lindner, Juliano De Dea; Miotto, Marilia; Verruck, Silvani",,,Effect of Prebiotics and Synbiotics Carried by Food over Irritable Bowel Syndrome Symptoms: A Systematic Review,DAIRY,,,English,Review,,,,,,irritable bowel syndrome; mucous colitis; Lactobacillus; Bifidobacterium; dairy products; yogurt,INTERNATIONAL SCIENTIFIC ASSOCIATION; CONSENSUS STATEMENT; PROBIOTICS; CONSTIPATION; DEFINITION; PREVALENCE; SCOPE,"Irritable bowel syndrome (IBS) is a chronic condition that affects 11.2% of the world's population. The management of gut microbiota using probiotic and synbiotic agents might be a valid alternative to assist in the treatment of IBS. The focus of this study was to evaluate the effects of prebiotic and synbiotic compounds carried by different foods on major symptoms of IBS through a systematic literature review. MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and LILACS were accessed during July 2021. The studies included in this review were the ones that tested volunteers older than 16 years of age and were conducted using a randomized, controlled clinical trial. The risk of bias was assessed by using the Cochrane risk-of-bias tool for randomized trials (RoB2). Furthermore, the data found were qualitatively evaluated due to the studies' differences. Two papers were able to fit the criteria, with a total sample size of 280 participants. No datum was found regarding the use of prebiotics in the treatment of IBS. Synbiotic agents, however, had a positive effect on gastrointestinal symptoms and the participants' overall bowel satisfaction; however, it was not possible to reach a consensus on which effects. Further studies regarding the use of synbiotics and prebiotics must be carried out to determine which effects are the most significant in the treatment of IBS.","[de Souza, Sofia Steinmetz] Univ Fed Santa Catarina, Dept Hlth Sci, BR-88040900 Florianopolis, Brazil; [Pierezan, Milena Dutra; Lindner, Juliano De Dea; Miotto, Marilia; Verruck, Silvani] Univ Fed Santa Catarina, Dept Food Sci & Technol, BR-88040900 Florianopolis, Brazil; [Hassemer, Guilherme de Souza] Univ Reg Integrada Alto Uruguai & Missoes, Dept Food Engn, BR-99700000 Erechim, Brazil; [Lima, Clara Mariana Goncalves] Univ Fed Lavras, Dept Food Sci, BR-37200000 Lavras, Brazil",Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC); Universidade Regional Integrada do Alto Uruguai e das Missoes (URI); Universidade Federal de Lavras,"Verruck, S (corresponding author), Univ Fed Santa Catarina, Dept Food Sci & Technol, BR-88040900 Florianopolis, Brazil.",sofiasteinmetz97@gmail.com; mdutra.cta@gmail.com; guilherme.hassemer@hotmail.com; claramarianalima@gmail.com; juliano.lindner@gmail.com; marilia.miotto@ufsc.br; silvani.verruck@ufsc.br,"De Dea Lindner, Juliano/L-7802-2014; Lima, Clara Mariana Gonçalves/AAN-6177-2021; Verruck, Silvani/V-4786-2018","De Dea Lindner, Juliano/0000-0002-6191-8910; Lima, Clara Mariana Gonçalves/0000-0002-3150-9139; Verruck, Silvani/0000-0003-0266-5885",,,,,35,2,2,2,2,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2624-862X,,DAIRY-BASEL,Dairy,MAR,2022,3,1,,,,,148,162,,10.3390/dairy3010012,http://dx.doi.org/10.3390/dairy3010012,,,15,"Agriculture, Dairy & Animal Science",Emerging Sources Citation Index (ESCI),Agriculture,KE8Q8,,gold,,,2024-06-04,WOS:001178377200001,View Full Record in Web of Science
J,"Su, H; Chen, JH; Miao, S; Deng, KB; Liu, JW; Zeng, SX; Zheng, BD; Lu, X",,,,"Su, Han; Chen, Jinghao; Miao, Song; Deng, Kaibo; Liu, Jiawen; Zeng, Shaoxiao; Zheng, Baodong; Lu, Xu",,,Lotus seed oligosaccharides at various dosages with prebiotic activity regulate gut microbiota and relieve constipation in mice,FOOD AND CHEMICAL TOXICOLOGY,,,English,Article; Proceedings Paper,10th International Symposium on Natural Products Chemistry and Applications (ISNPCA),2019,"Chillan, CHILE",,,Lotus seeds; Oligosaccharides; Resistant starch; Gut microbiota; Short-chain fatty acids; Prebiotics,CHAIN FATTY-ACIDS; RESISTANT STARCH; INTESTINAL MICROBIOTA; HUMAN-MILK; HEALTHY; DIET; OPTIMIZATION; OSCILLOSPIRA; OBESITY; TRACT,"The aim of this study was to evaluate the effects of lotus seed oligosaccharides (formulation consisting of LSO2, LSO3-1, LSO3-2 and LSO4; relative ratios are 1.107:0.554:0.183:0.443, m/m/m/m) at dosages of 0.42, 0.83 g/d/kg bw and 2.49 g/d/kg bw on the microbiota composition and the propulsion of intestinal contents in the gut of mice. The results showed that fecal water content increased in treated mice; there was less gut microbiota diversity than in other groups; and there was a large number of fauna in the cecum of the mice. At the same time, the number of short-chain fatty acid (SCFA) bacterial producers increased after feeding with oligosaccharides; Lotus seed oligosaccharides (LOS) also enhanced the concentration of SCFAs in the intestine, which also increased the concentration of cytokines in the serum of mice. In conclusion, these findings suggest that LOS or combination with resistant starch has a better effect on relieving constipation.","[Su, Han; Chen, Jinghao; Miao, Song; Deng, Kaibo; Liu, Jiawen; Zeng, Shaoxiao; Zheng, Baodong; Lu, Xu] Fujian Agr & Forestry Univ, Coll Food Sci, 15 Shangxiadian Rd, Fuzhou 350002, Peoples R China; [Miao, Song; Deng, Kaibo; Lu, Xu] TEAGASC, Food Res Ctr, Food Chem & Technol Dept, Moorepk, Fermoy, Cork, Ireland; [Deng, Kaibo; Zeng, Shaoxiao; Zheng, Baodong; Lu, Xu] Fujian Agr & Forestry Univ, Inst Food Sci & Technol, 18 Simon Pit Rd, Fuzhou 350002, Peoples R China; [Su, Han; Chen, Jinghao; Miao, Song; Deng, Kaibo; Zeng, Shaoxiao; Zheng, Baodong; Lu, Xu] Fujian Agr & Forestry Univ, China Ireland Int Cooperat Ctr Food Mat Sci & Str, Fuzhou 350002, Peoples R China; [Su, Han; Chen, Jinghao; Deng, Kaibo; Zeng, Shaoxiao; Zheng, Baodong; Lu, Xu] Fujian Agr & Forestry Univ, Fujian Prov Key Lab Qual Sci & Proc Technol Speci, Fuzhou 350002, Peoples R China","Fujian Agriculture & Forestry University; Teagasc; Chinese Academy of Agricultural Sciences; Institute of Food Science & Technology, CAAS; Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University","Zeng, SX; Lu, X (corresponding author), Fujian Agr & Forestry Univ, Coll Food Sci, 15 Shangxiadian Rd, Fuzhou 350002, Peoples R China.",zsxfst@163.com; lxvfst@yeah.net,"Gu, b/JNS-4761-2023; Lu, Xu/JVN-1408-2024; MIAO, SONG/C-3919-2018; Liu, Jiawen/AAQ-4168-2020","Lu, Xu/0000-0003-4892-5240; MIAO, SONG/0000-0002-8385-3513; Liu, Jiawen/0000-0002-1733-3501",Research Fund for the China-Ireland International Cooperation Centre for Food Material Science and Structure Design [KXGH17001]; National Natural Science Foundation of China [31601473]; FAFU Funds for Distinguished Young Scientists [xjg201811]; Research Fund for the Doctoral Program of Higher Education of China [108/c41mke02a]; Department of Education of Fujian [JK2015012]; Science and Technology Major Project of Fujian Province [2018NZ0003-1]; Natural Science Foundation of Fujian Province of China [2018J01697]; Projects for Scientific and Technological Development of Fujian Agriculture and Forestry University [CXZX2018069],Research Fund for the China-Ireland International Cooperation Centre for Food Material Science and Structure Design; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); FAFU Funds for Distinguished Young Scientists; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Department of Education of Fujian; Science and Technology Major Project of Fujian Province; Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province); Projects for Scientific and Technological Development of Fujian Agriculture and Forestry University,"This study was financially supported by the Research Fund for the China-Ireland International Cooperation Centre for Food Material Science and Structure Design (No. KXGH17001), the National Natural Science Foundation of China (No. 31601473), the FAFU Funds for Distinguished Young Scientists (xjg201811), the Research Fund for the Doctoral Program of Higher Education of China (108/c41mke02a), Provincial Universities Special Funded by the Department of Education of Fujian (JK2015012), the Science and Technology Major Project of Fujian Province (No. 2018NZ0003-1), the Natural Science Foundation of Fujian Province of China (No. 2018J01697), Projects for Scientific and Technological Development of Fujian Agriculture and Forestry University (CXZX2018069).",,48,37,38,4,84,PERGAMON-ELSEVIER SCIENCE LTD,OXFORD,"THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND",0278-6915,1873-6351,,FOOD CHEM TOXICOL,Food Chem. Toxicol.,DEC,2019,134,,,,,,,,110838,10.1016/j.fct.2019.110838,http://dx.doi.org/10.1016/j.fct.2019.110838,,,12,Food Science & Technology; Toxicology,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Food Science & Technology; Toxicology,JN3ZZ,31568850,Green Published,,,2024-06-04,WOS:000496839500029,View Full Record in Web of Science
J,"Meng, X; Zhang, G; Cao, H; Yu, D; Fang, X; de Vos, WM; Wu, H",,,,"Meng, X.; Zhang, G.; Cao, H.; Yu, D.; Fang, X.; de Vos, W. M.; Wu, H.",,,Gut dysbacteriosis and intestinal disease: mechanism and treatment,JOURNAL OF APPLIED MICROBIOLOGY,,,English,Review,,,,,,gut microbiome; immune response; intestinal diseases; prebiotics; probiotics,FECAL MICROBIOTA TRANSPLANTATION; IRRITABLE-BOWEL-SYNDROME; STRUCTURAL MODULATION; CHRONIC CONSTIPATION; ULCERATIVE-COLITIS; FATTY-ACIDS; BACTERIA; CELLS; METABOLITES; PREBIOTICS,"The gut microbiome functions like an endocrine organ, generating bioactive metabolites, enzymes or small molecules that can impact host physiology. Gut dysbacteriosis is associated with many intestinal diseases including (but not limited to) inflammatory bowel disease, primary sclerosing cholangitis-IBD, irritable bowel syndrome, chronic constipation, osmotic diarrhoea and colorectal cancer. The potential pathogenic mechanism of gut dysbacteriosis associated with intestinal diseases includes the alteration of composition of gut microbiota as well as the gut microbiota-derived signalling molecules. The many correlations between the latter and the susceptibility for intestinal diseases has placed a spotlight on the gut microbiome as a potential novel target for therapeutics. Currently, faecal microbial transplantation, dietary interventions, use of probiotics, prebiotics and drugs are the major therapeutic tools utilized to impact dysbacteriosis and associated intestinal diseases. In this review, we systematically summarized the role of intestinal microbiome in the occurrence and development of intestinal diseases. The potential mechanism of the complex interplay between gut dysbacteriosis and intestinal diseases, and the treatment methods are also highlighted.","[Meng, X.; Zhang, G.; Yu, D.; Fang, X.] Jilin Univ, Coll Life Sci, Minist Educ, Key Lab Mol Enzymol & Engn, 2699 Qianjin St, Changchun 130012, Peoples R China; [Cao, H.] InnovHope Inc, Framingham, MA USA; [de Vos, W. M.] Wageningen Univ, Lab Microbiol, Stippeneng 4, NL-6708 WE Wageningen, Netherlands; [de Vos, W. M.] Univ Helsinki, Fac Med, Human Microbiome Res Program, POB 00014, Helsinki, Finland; [Wu, H.] Boston Childrens Hosp, Dept Surg, Vasc Biol Program, Boston, MA 02115 USA; [Wu, H.] Harvard Med Sch, Boston, MA 02115 USA",Jilin University; Wageningen University & Research; University of Helsinki; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School,"Yu, D; Fang, X (corresponding author), Jilin Univ, Coll Life Sci, Minist Educ, Key Lab Mol Enzymol & Engn, 2699 Qianjin St, Changchun 130012, Peoples R China.;de Vos, WM (corresponding author), Wageningen Univ, Lab Microbiol, Stippeneng 4, NL-6708 WE Wageningen, Netherlands.;de Vos, WM (corresponding author), Univ Helsinki, Fac Med, Human Microbiome Res Program, POB 00014, Helsinki, Finland.;Wu, H (corresponding author), Boston Childrens Hosp, Dept Surg, Vasc Biol Program, Boston, MA 02115 USA.;Wu, H (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.",yudahai@jlu.edu.cn; fangxx@jlu.edu.cn; willem.devos@wur.nl; hao.wu3@childrens.harvard.edu,,,National Natural Science Foundation of China [31670796]; AHA SDG [17SDG33410868],National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); AHA SDG(American Heart Association),"This work was supported by general financial grant from the National Natural Science Foundation of China (no. 31670796) to D.Y. and X.F.; and the AHA SDG, Grant/Award (no. 17SDG33410868) to H.W.",,135,50,62,8,84,OXFORD UNIV PRESS,OXFORD,"GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND",1364-5072,1365-2672,,J APPL MICROBIOL,J. Appl. Microbiol.,OCT,2020,129,4,,,,,787,805,,10.1111/jam.14661,http://dx.doi.org/10.1111/jam.14661,,MAY 2020,19,Biotechnology & Applied Microbiology; Microbiology,Science Citation Index Expanded (SCI-EXPANDED),Biotechnology & Applied Microbiology; Microbiology,NR5QC,32277534,Bronze,,,2024-06-04,WOS:000533670400001,View Full Record in Web of Science
J,"Swennen, K; Courtin, CM; Delcour, JA",,,,"Swennen, Katrien; Courtin, Christophe M.; Delcour, Jan A.",,,Non-digestible oligosaccharides with prebiotic properties,CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION,,,English,Review,,,,,,non-digestible oligosaccharides; prebiotics; dietary fiber; production; characterization; health,ANION-EXCHANGE CHROMATOGRAPHY; FUNCTIONAL FOOD CONCEPT; XYLO-OLIGOSACCHARIDES; MASS-SPECTROMETRY; STRUCTURAL-CHARACTERIZATION; DIETARY OLIGOSACCHARIDES; INTESTINAL MICROFLORA; H-1-NMR SPECTROSCOPY; ENZYMATIC PRODUCTION; MOLECULAR-WEIGHT,"The search for functional foods or functional food ingredients, i.e. foods or food ingredients that can enhance health, is beyond any doubt one of the leading trends in today's food industry. In this context, probiotics, i.e. living microbial food supplements, and prebiotics, i.e. non-digestible food ingredients, receive much attention. Both popular concepts target the gastrointestinal microbiota. While in the Western world, intake of probiotics has been recommended for long, prebiotics in general, and non-digestible oligosaccharides in particular, have only recently received attention. This review deals with production and characterization of non-digestible oligosaccharides and focuses on their role in promoting health and treating diseases. Attention is paid to the effects of non- digestible oligosaccharides on constipation, mineral absorption, lipid metabolism, cancer prevention, hepatic encephalopathy, glycemia/insulinemia, and immunomodulation.","Katholieke Univ Leuven, Food Chem Lab, B-3001 Louvain, Belgium",KU Leuven,"Swennen, K (corresponding author), Kasteelpk Arenberg 20, B-3001 Louvain, Belgium.",katrien.swennen@agr.kuleuven.ac.be,"DELCOUR, Jan A/P-4182-2017; Courtin, Christophe M/Q-1916-2016","DELCOUR, Jan A/0000-0003-2954-1022; Courtin, Christophe M/0000-0002-1203-9063",,,,,196,246,282,4,145,TAYLOR & FRANCIS INC,PHILADELPHIA,"530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA",1040-8398,1549-7852,,CRIT REV FOOD SCI,Crit. Rev. Food Sci. Nutr.,SEP,2006,46,6,,,,,459,471,,10.1080/10408390500215746,http://dx.doi.org/10.1080/10408390500215746,,,13,Food Science & Technology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Nutrition & Dietetics,073XS,16864139,,,,2024-06-04,WOS:000239776600002,View Full Record in Web of Science
J,"Jalanka, J; Major, G; Murray, K; Singh, G; Nowak, A; Kurtz, C; Silos-Santiago, I; Johnston, JM; de Vos, WM; Spiller, R",,,,"Jalanka, Jonna; Major, Giles; Murray, Kathryn; Singh, Gulzar; Nowak, Adam; Kurtz, Caroline; Silos-Santiago, Inmaculada; Johnston, Jeffrey M.; de Vos, Willem M.; Spiller, Robin",,,The Effect of Psyllium Husk on Intestinal Microbiota in Constipated Patients and Healthy Controls,INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,,,English,Article,,,,,,prebiotics; microbiome; ispaghula; constipation; transit,HYDROGEN-SULFIDE; DIETARY FIBER; FERMENTATION; TIME; DIVERSITY; BACTERIAL; TRANSIT; GENE; BRAN,"Psyllium is a widely used treatment for constipation. It traps water in the intestine increasing stool water, easing defaecation and altering the colonic environment. We aimed to assess the impact of psyllium on faecal microbiota, whose key role in gut physiology is being increasingly recognised. We performed two randomised, placebo-controlled, double-blinded trials comparing 7 days of psyllium with a placebo (maltodextrin) in 8 healthy volunteers and 16 constipated patients respectively. We measured the patients' gastrointestnal (GI) transit, faecal water content, short-chain fatty acid (SCFA) and the stool microbiota composition. While psyllium supplement had a small but significant effect on the microbial composition of healthy adults (increasing Veillonella and decreasing Subdoligranulum), in constipated subjects there were greater effects on the microbial composition (increased Lachnospira, Faecalibacterium, Phascolarctobacterium, Veillonella and Sutterella and decreased uncultured Coriobacteria and Christensenella) and alterations in the levels of acetate and propionate. We found several taxa to be associated with altered GI transit, SCFAs and faecal water content in these patients. Significant increases in three genera known to produce butyrate, Lachnospira, Roseburia and Faecalibacterium, correlated with increased faecal water. In summary, psyllium supplementation increased stool water and this was associated with significant changes in microbiota, most marked in constipated patients.","[Jalanka, Jonna] Univ Helsinki, Fac Med, Immunobiol Res Program, Hy Helsinki 00014, Finland; [Jalanka, Jonna] Univ Helsinki, Fac Med, Dept Bacteriol & Immunol, Hy Helsinki 00014, Finland; [Jalanka, Jonna; Major, Giles; Murray, Kathryn; Singh, Gulzar; Spiller, Robin] Univ Nottingham, Nottingham Univ Hosp NHS Trust, Nottingham Digest Dis Ctr, Notts NG7 2UH, England; [Jalanka, Jonna; Major, Giles; Murray, Kathryn; Singh, Gulzar; Spiller, Robin] Univ Nottingham, Nottingham Univ Hosp NHS Trust, NIHR Nottingham Biomed Res Ctr, Notts NG7 2UH, England; [Nowak, Adam] Univ Nottingham, Nottingham Univ Hosp NHS Trust, Nottingham NG5 1PB, Notts, England; [Kurtz, Caroline] Synl Therapeut, Cambridge, MA 02142 USA; [Silos-Santiago, Inmaculada] Decibel Therapeut Inc, Boston, MA 02215 USA; [Johnston, Jeffrey M.] Neurogastrx Inc, Woburn, MA 01801 USA; [de Vos, Willem M.] Wageningen Univ, Lab Microbiol, NL-6708WE Wageningen, Netherlands",University of Helsinki; University of Helsinki; Nottingham University Hospital NHS Trust; University of Nottingham; University of Nottingham; Nottingham University Hospital NHS Trust; University of Nottingham; Nottingham University Hospital NHS Trust; Wageningen University & Research,"Spiller, R (corresponding author), Univ Nottingham, Nottingham Univ Hosp NHS Trust, Nottingham Digest Dis Ctr, Notts NG7 2UH, England.;Spiller, R (corresponding author), Univ Nottingham, Nottingham Univ Hosp NHS Trust, NIHR Nottingham Biomed Res Ctr, Notts NG7 2UH, England.",Jonna.Jalanka@helsinki.fi; giles.major1@nottingham.ac.uk; Kathryn.Murray@nottingham.ac.uk; Gulzar.Singh@nottingham.ac.uk; adam.nowak@nhs.net; carolinebkurtz@gmail.com; asilos@decibeltx.com; jjohnston@neurogastrx.com; willem.devos@wur.nl; Robin.Spiller@Nottingham.ac.uk,"spiller, robin/ABE-6690-2021; Major, Giles/AAF-4207-2019","spiller, robin/0000-0001-6371-4500; Major, Giles/0000-0001-7944-3709; De Vos, Willem M/0000-0002-0273-3166; jalanka, jonna/0000-0002-3847-8136","Finnish Academy [0313471-7]; Ironwood Pharmaceuticals Inc., Cambridge, MA, USA","Finnish Academy(Research Council of Finland); Ironwood Pharmaceuticals Inc., Cambridge, MA, USA","This research was funded by the Finnish Academy (grant no. 0313471-7 for J.J.). The clinical trials were collaborative studies undertaken by the Nottingham Digestive Diseases Centre and NIHR Nottingham Biomedical Research Centre at Nottingham University Hospitals NHS Trust, the University of Nottingham, funded by Ironwood Pharmaceuticals Inc., Cambridge, MA, USA.",,40,96,106,6,52,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",1422-0067,,,INT J MOL SCI,Int. J. Mol. Sci.,JAN 2,2019,20,2,,,,,,,433,10.3390/ijms20020433,http://dx.doi.org/10.3390/ijms20020433,,,12,"Biochemistry & Molecular Biology; Chemistry, Multidisciplinary",Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Chemistry,HM8QS,30669509,"Green Published, gold, Green Submitted",,,2024-06-04,WOS:000459746500201,View Full Record in Web of Science
J,"Glibowski, P; Skrzypek, M; Cwiklinska, M; Drozd, M; Kowalska, A",,,,"Glibowski, Pawel; Skrzypek, Michal; Cwiklinska, Magdalena; Drozd, Monika; Kowalska, Aleksandra",,,Chemical stability of fructans in apple beverages and their influence on chronic constipation,FOOD & FUNCTION,,,English,Article,,,,,,,CHICORY INULIN; DOUBLE-BLIND; LOW-FAT; OLIGOFRUCTOSE; JUICES; PREBIOTICS; MILK,"The aim of this study was to analyse the concentration of reducing sugars in beverages based on apple juice with the addition of 2 and 4% of native and high polymerized inulin as well as oligofructose. Moreover, the effect of the consumption of this potentially prebiotic beverage containing highly polymerized inulin (12 g per 300 mL) on constipation was analysed. Pasteurization of the studied beverages followed by 120-day storage at ambient temperature, carried out in three independent trials, did not cause the hydrolysis of fructans into reducing sugars. Sensory analysis showed that the presence of fructans in beverages based on apple juice did not change the colour, clarity, odour, flavour, sweetness and acidity in comparison to apple juice. A placebo-controlled, randomized study involving 20 volunteers of age 20-29 with symptoms related to chronic constipation showed that the consumption of juice enriched with highly polymerized inulin significantly (p <= 0.05) increased the frequency of bowel movements and facilitated defecation. The final conclusion is that fructans in beverages based on apple juice are chemically stable, do not affect sensory sensation and can help those with chronic constipation.","[Glibowski, Pawel; Drozd, Monika; Kowalska, Aleksandra] Univ Life Sci Lublin, Dept Biotechnol Microbiol & Human Nutr, Skromna St 8, PL-20704 Lublin, Poland; [Skrzypek, Michal] Med Univ Lublin, Fac Hlth Sci, Dept Clin Dietet, Chodzki St 1, PL-20093 Lublin, Poland; [Cwiklinska, Magdalena] Univ Life Sci Lublin, Fac Prod Engn, Dept Appl Math & Informat, Lublin, Poland",University of Life Sciences in Lublin; Medical University of Lublin; University of Life Sciences in Lublin,"Glibowski, P (corresponding author), Univ Life Sci Lublin, Dept Biotechnol Microbiol & Human Nutr, Skromna St 8, PL-20704 Lublin, Poland.",pawel.glibowski@up.lublin.pl,"Skrzypek, Michal/IZD-4545-2023","Skrzypek, Michal/0000-0002-7498-8248; Cwiklinska, Magdalena/0000-0001-7497-7314; Glibowski, Pawel/0000-0003-1774-6899",,,,,44,13,13,6,27,ROYAL SOC CHEMISTRY,CAMBRIDGE,"THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND",2042-6496,2042-650X,,FOOD FUNCT,Food Funct.,MAY 1,2020,11,5,,,,,3860,3866,,10.1039/c9fo02596k,http://dx.doi.org/10.1039/c9fo02596k,,,7,Biochemistry & Molecular Biology; Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Food Science & Technology,LU9BG,32319465,,,,2024-06-04,WOS:000538041500005,View Full Record in Web of Science
J,"Rao, TP; Quartarone, G",,,,"Rao, Theertham Pradyumna; Quartarone, Giuseppina",,,Role of guar fiber in improving digestive health and function,NUTRITION,,,English,Review,,,,,,Constipation; Diarrhea; Guar fiber; IBD; IBS; PHGG; Prebiotics; Probiotics,IRRITABLE-BOWEL-SYNDROME; CHAIN FATTY-ACID; ORAL REHYDRATION SOLUTION; COLONIC TRANSIT-TIME; ENTERAL NUTRITION; DIETARY FIBER; SOLUBLE FIBER; DOUBLE-BLIND; GASTROINTESTINAL SYMPTOMS; BLOOD-PRESSURE,"Digestive health plays key role in our active daily life; but maintaining proper bowel movements, i.e., being free from constipation, diarrhea, irritable bowel syndrome, inflammatory bowel disease, flatulence, bloating, and abdominal pain, is complex. Dietary fibers often are recommended to maintain proper digestive health, but none seems to provide a single comprehensive solution for overall maintanance of proper digestive health. Guar fiber, however, has emerged as a credible candidate for just such a solution. This review focused on summarizing the clinically observed effects of guar fiber on digestive health. Several clinical studies suggest the guar fiber normalizes both constipation and diarrheal conditions. Also, it was effective in alleviating the symptoms associated with irritable bowel syndrome. The studies suggest that a regular intake of 5 to 10 gid guar fiber is effective to treat most of the morbidities associated with digestive health. Guar fiber is all natural. It may offer potential protection and promotion of digestive health both alone and when combined with probiotics as a synbiotic formula. (C) 2018 Elsevier Inc. All rights reserved.","[Rao, Theertham Pradyumna] Taiyo Kagaku Co Ltd, Yokaichi, Japan; [Quartarone, Giuseppina] GSK Italy, Origgio, Varese, Italy","TAIYO KAGAKU CO., LTD.","Rao, TP (corresponding author), Taiyo Kagaku Co Ltd, Yokaichi, Japan.",tprao@taiyokagaku.co.jp,,,,,,,119,16,16,1,29,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",0899-9007,1873-1244,,NUTRITION,Nutrition,MAR,2019,59,,,,,,158,169,,10.1016/j.nut.2018.07.109,http://dx.doi.org/10.1016/j.nut.2018.07.109,,,12,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,HK6MU,30496956,,,,2024-06-04,WOS:000458095600023,View Full Record in Web of Science
J,"Granata, M; Brandi, G; Borsari, A; Gasbarri, R; Di Gioia, D",,,,"Granata, M.; Brandi, G.; Borsari, A.; Gasbarri, R.; Di Gioia, D.",,,Synbiotic yogurt consumption by healthy adults and the elderly: the fate of bifidobacteria and LGG probiotic strain,INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION,,,English,Article,,,,,,fructooligosaccharides; Lactobacillus rhamnosus GG; prebiotics; constipation; synbiotic dietary supplements,LACTOBACILLUS-RHAMNOSUS GG; STREPTOCOCCUS-THERMOPHILUS; BACTERIAL-POPULATIONS; TEMPORAL STABILITY; IMMUNE FUNCTION; HUMAN FECES; PCR; IDENTIFICATION; COLONIZATION; VOLUNTEERS,"Synbiotic dietary supplements are used to modulate the intestinal microbiota in adults; however, studies regarding elderly people are limited. The aim of this work is to determine the effect of regular consumption of yogurt containing Lactobacillus rhamnosus GG (LGG) and the fructooligosaccharide (FOS) Actilight (R) both in healthy adults and the elderly suffering from constipation. Yogurt was administered daily for 4 weeks; faecal samples were collected before starting, after 4-week administration and a 15-day wash out period, and analyzed for LGG and bifidobacteria counts. Constipation status in the elderly was recorded by a standardized questionnaire. Bifidobacteria did not increase in either groups; at the end of the intervention trial, LGG was detected in significantly different amount in the faeces of the elderly and adults, being higher in adults (95% vs. 30%). An increased evacuation number in the elderly was evidenced, probably due to the presence of FOS in yogurt.","[Granata, M.; Gasbarri, R.; Di Gioia, D.] Alma Mater Studiorum Univ Bologna, Microbiol Area, Dept Agroenvironm Sci & Technol, I-40127 Bologna, Italy; [Brandi, G.] Alma Mater Studiorum Univ Bologna, Inst Haematol & Med Oncol, I-40127 Bologna, Italy; [Borsari, A.] Granarolo SpA, Bologna, Italy",University of Bologna; University of Bologna,"Di Gioia, D (corresponding author), Alma Mater Studiorum Univ Bologna, Microbiol Area, Dept Agroenvironm Sci & Technol, Viale Fanin 42, I-40127 Bologna, Italy.",diana.digioia@unibo.it,"Brandi, Giovanni/AAD-6327-2021","Brandi, Giovanni/0000-0003-0013-2858","Granarolo SpA; University of Bologna, RFO Programme","Granarolo SpA; University of Bologna, RFO Programme","The product used in the study is a commercial product provided by Granarolo SpA, Bologna, Italy. The study was funded by Granarolo SpA and by the University of Bologna, RFO Programme. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.",,39,31,33,2,51,TAYLOR & FRANCIS LTD,ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND",0963-7486,1465-3478,,INT J FOOD SCI NUTR,Int. J. Food Sci. Nutr.,MAR,2013,64,2,,,,,162,168,,10.3109/09637486.2012.718742,http://dx.doi.org/10.3109/09637486.2012.718742,,,7,Food Science & Technology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Nutrition & Dietetics,083OQ,22946635,,,,2024-06-04,WOS:000314474800005,View Full Record in Web of Science
J,"Closa-Monasterolo, R; Ferré, N; Castillejo-DeVillasante, G; Luque, V; Gispert-Llaurado, M; Zaragoza-Jordana, M; Theis, S; Escribano, J",,,,"Closa-Monasterolo, Ricardo; Ferre, Natalia; Castillejo-DeVillasante, Gemma; Luque, Veronica; Gispert-Llaurado, Mariona; Zaragoza-Jordana, Marta; Theis, Stephan; Escribano, Joaquin",,,The use of inulin-type fructans improves stool consistency in constipated children. A randomised clinical trial: pilot study,INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION,,,English,Article,,,,,,Constipation; prebiotics; inulin; stool consistency; non-pharmacological treatment; children,DIETARY FIBER INTAKE; CHILDHOOD CONSTIPATION; OLIGOFRUCTOSE; HEALTH; EPIDEMIOLOGY; PROGNOSIS; VALIDITY; ADULTS,"Background: Constipation is a common disorder in children.Objective: The objective of this study is to assess the beneficial effects of a daily supplementation with Orafti((R)) inulin-type fructans in 2-5 year old constipated children.Methods: Double-blind, randomised, placebo-controlled parallel group trial where constipated children received two doses of 2g Orafti((R)) inulin-type fructans (OF:IN) or placebo (maltodextrin) for 6 weeks. Primary outcome was stool consistency. Secondary outcomes were stool frequency and gastrointestinal symptoms.Results: Twenty-two children were included, 17 completed the study protocol (nine and eight for the control and the OF:IN group, respectively). Results showed that Orafti((R)) inulin-type fructans supplemented children had softer stools (p=.003). The longitudinal analysis showed no significant changes in controls, whereas supplemented children increased their stool consistency from 2.2 to 2.6 on the modified Bristol scale for children (five items instead of seven) (p=.040).Conclusions: Prebiotic inulin-type fructans supplementation improves stool consistency in constipated 2-5-year old children.Clinicaltrials.gov, with number NCT02863848.","[Closa-Monasterolo, Ricardo; Luque, Veronica] Hosp Univ Joan XXIII Tarragona, Neonatal Unit, Tarragona, Spain; [Closa-Monasterolo, Ricardo; Ferre, Natalia; Castillejo-DeVillasante, Gemma; Luque, Veronica; Gispert-Llaurado, Mariona; Zaragoza-Jordana, Marta; Escribano, Joaquin] Univ Rovira & Virgili, Paediat Res Unit, IISPV, St Llorenc 21, Reus 43201, Spain; [Theis, Stephan; Escribano, Joaquin] Beneo GmbH Obrigheim, Nutr Sci, Mannheim, Germany; [Castillejo-DeVillasante, Gemma] Hosp Univ St Joan Reus, Paediat Unit, Reus, Spain",Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV),"Escribano, J (corresponding author), Univ Rovira & Virgili, Paediat Res Unit, IISPV, St Llorenc 21, Reus 43201, Spain.",jescribano@grupsagessa.com,"Gispert-Llaurado, Mariona/AAL-1143-2020; Zaragoza-Jordana, Marta/AAL-1342-2020; Ferré, Natalia/ABE-5700-2020; Escribano, Joaquin/ABD-6604-2020; Luque, Veronica/AAC-9002-2019; Ferre, Natalia/AGA-5684-2022","Gispert-Llaurado, Mariona/0000-0002-4586-8079; Zaragoza-Jordana, Marta/0000-0001-9704-6950; Luque, Veronica/0000-0003-2615-8175; Ferre, Natalia/0000-0002-2838-1525; Escribano, Joaquin/0000-0002-5041-459X",BeneoGmbH,BeneoGmbH,BeneoGmbH.,,30,43,51,1,30,TAYLOR & FRANCIS LTD,ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND",0963-7486,1465-3478,,INT J FOOD SCI NUTR,Int. J. Food Sci. Nutr.,,2017,68,5,,,,,587,594,,10.1080/09637486.2016.1263605,http://dx.doi.org/10.1080/09637486.2016.1263605,,,8,Food Science & Technology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Nutrition & Dietetics,EV9CH,27931142,"hybrid, Green Submitted",,,2024-06-04,WOS:000402081600009,View Full Record in Web of Science
J,"Shang, X; Fen-Fen, E; Guo, KL; Li, YF; Zhao, HL; Wang, Y; Chen, N; Nian, T; Yang, CQ; Yang, KH; Li, XX",,,,"Shang, Xue; Fen-Fen, E.; Guo, Kang-Le; Li, Yan-Fei; Zhao, Hong-Lin; Wang, Yan; Chen, Nan; Nian, Tao; Yang, Chao-Qun; Yang, Ke-Hu; Li, Xiu-Xia",,,Effectiveness and Safety of Probiotics for Patients with Constipation-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of 10 Randomized Controlled Trials,NUTRIENTS,,,English,Review,,,,,,irritable bowel syndrome; constipation; probiotics; meta-analysis; systematic review,FUNCTIONAL GASTROINTESTINAL DISORDERS; DOUBLE-BLIND; FECAL MICROBIOTA; INTESTINAL MICROBIOTA; GUT MICROBIOTA; EFFICACY; SYMPTOMS; PLACEBO; PREBIOTICS; QUALITY,"To perform a systematic review and meta-analysis to evaluate the effectiveness and safety of probiotics in the treatment of constipation-predominant irritable bowel syndrome (IBS-C), we searched for randomized controlled trials (RCTs) comparing probiotic care versus placebos for patients with IBS-C in five comprehensive databases (March 2022). The risk of bias was assessed using the Cochrane Collaboration Risk of Bias Tool. RevMan 5.3 was used to perform a meta-analysis on stool consistency, abdominal pain, bloating, quality of life (QoL), fecal Bifidobacterium and Lactobacillus counts, and adverse events. The GRADE approach was used to evaluate the certainty of the evidence. Ten RCTs involving 757 patients were included. Only three studies were rated as having a low risk of bias. The meta-analysis results show that, compared to the placebo, probiotics significantly improved stool consistency (MD = 0.72, 95% CI (0.18, 1.26), p < 0.05, low quality) and increased the number of fecal Bifidobacteria (MD = 1.75, 95% CI (1.51, 2.00), p < 0.05, low quality) and Lactobacillus (MD = 1.69, 95% CI (1.48, 1.89), p < 0.05, low quality), while no significant differences were found in abdominal pain scores, bloating scores, QoL scores, or the incidence of adverse events (p > 0.05). The low-to-very low certainty evidence suggests that probiotics might improve the stool consistency of patients with IBS-C and increase the number of Bifidobacteria and Lactobacilli in feces with good safety. However, more high-quality studies with large samples are needed to verify the findings.","[Shang, Xue; Fen-Fen, E.; Guo, Kang-Le; Wang, Yan; Chen, Nan; Nian, Tao; Yang, Chao-Qun; Yang, Ke-Hu; Li, Xiu-Xia] Lanzhou Univ, Sch Publ Hlth, Hlth Technol Assessment Ctr, Evidence Based Social Sci Res Ctr, Lanzhou 730000, Peoples R China; [Shang, Xue; Fen-Fen, E.; Guo, Kang-Le; Li, Yan-Fei; Wang, Yan; Chen, Nan; Nian, Tao; Yang, Chao-Qun; Yang, Ke-Hu; Li, Xiu-Xia] Lanzhou Univ, Sch Basic Med Sci, Evidence Based Med Ctr, Lanzhou 730000, Peoples R China; [Shang, Xue; Fen-Fen, E.; Guo, Kang-Le; Li, Yan-Fei; Wang, Yan; Chen, Nan; Nian, Tao; Yang, Chao-Qun; Yang, Ke-Hu; Li, Xiu-Xia] Key Lab Evidence Based Med & Knowledge Translat G, Lanzhou 730000, Peoples R China; [Zhao, Hong-Lin] Lanzhou Univ, Inst Social Med & Hlth Management, Sch Publ Hlth, Lanzhou 730000, Peoples R China",Lanzhou University; Lanzhou University; Lanzhou University,"Yang, KH; Li, XX (corresponding author), Lanzhou Univ, Sch Publ Hlth, Hlth Technol Assessment Ctr, Evidence Based Social Sci Res Ctr, Lanzhou 730000, Peoples R China.;Yang, KH; Li, XX (corresponding author), Lanzhou Univ, Sch Basic Med Sci, Evidence Based Med Ctr, Lanzhou 730000, Peoples R China.;Yang, KH; Li, XX (corresponding author), Key Lab Evidence Based Med & Knowledge Translat G, Lanzhou 730000, Peoples R China.",shangx20@lzu.edu.cn; eff20@lzu.edu.cn; guokl19@lzu.edu.cn; yfli2021@lzu.edu.cn; zhaohl20@lzu.edu.cn; ywang2020@lzu.edu.cn; chenn19@lzu.edu.cn; niant21@lzu.edu.cn; yangchq2020@lzu.edu.cn; yangkh-ebm@lzu.edu.cn; lixiuxia@lzu.edu.cn,"chen, jiayi/KHV-5520-2024; Zhao, ZiHao/KHT-4413-2024; Wang, Xin/AAN-8435-2021; zhen, wang/KBA-3844-2024; Yin, Jing/KDO-6274-2024","Wang, Xin/0000-0002-4457-7376; Yang, Hehu/0000-0001-7864-3012","National Natural Science Foundation of China [72074103]; Gansu Special Project of Soft Science [20CX9ZA109]; Fundamental Research Funds for the Central Universities [lzujbky-2021-ct06, lzujbky-2021-kb22]",National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Gansu Special Project of Soft Science; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities),"This research is supported by the National Natural Science Foundation of China (Project No. 72074103); the Gansu Special Project of Soft Science (20CX9ZA109); the Fundamental Research Funds for the Central Universities: lzujbky-2021-ct06, lzujbky-2021-kb22.",,62,12,12,0,17,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,JUN,2022,14,12,,,,,,,2482,10.3390/nu14122482,http://dx.doi.org/10.3390/nu14122482,,,17,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,2M1AL,35745212,"gold, Green Published",,,2024-06-04,WOS:000817441400001,View Full Record in Web of Science
J,"Sheyholislami, H; Connor, KL",,,,"Sheyholislami, Hauna; Connor, Kristin L.",,,Are Probiotics and Prebiotics Safe for Use during Pregnancy and Lactation? A Systematic Review and Meta-Analysis,NUTRIENTS,,,English,Review,,,,,,pregnancy; infant; probiotics; prebiotics; synbiotics; safety; adverse effects,INTERNATIONAL SCIENTIFIC ASSOCIATION; IRRITABLE-BOWEL-SYNDROME; CONSENSUS STATEMENT; INFECTIOUS MASTITIS; GASTROENTEROLOGISTS; SUPPLEMENTATION; CONSTIPATION; PREVENTION; YOGURT; WOMEN,"Probiotic and prebiotic products have shown potential health benefits, including for the prevention of adverse pregnancy outcomes. The incidence of adverse effects in pregnant people and their infants associated with probiotic/prebiotic/synbiotic intake, however, remains unclear. The objectives of this study were to evaluate the evidence on adverse effects of maternal probiotic, prebiotic, and/or synbiotic supplementation during pregnancy and lactation and interpret the findings to help inform clinical decision-making and care of this population. A systematic review was conducted following PRISMA guidelines. Scientific databases were searched using pre-determined terms, and risk of bias assessments were conducted to determine study quality. Inclusion criteria were English language studies, human studies, access to full-text, and probiotic/prebiotic/synbiotic supplementation to the mother and not the infant. In total, 11/100 eligible studies reported adverse effects and were eligible for inclusion in quantitative analysis, and data were visualised in a GOfER diagram. Probiotic and prebiotic products are safe for use during pregnancy and lactation. One study reported increased risk of vaginal discharge and changes in stool consistency (relative risk [95% CI]: 3.67 [1.04, 13.0]) when administering Lactobacillus rhamnosus and L. reuteri. Adverse effects associated with probiotic and prebiotic use do not pose any serious health concerns to mother or infant. Our findings and knowledge translation visualisations provide healthcare professionals and consumers with information to make evidence-informed decisions about the use of pre- and probiotics.","[Sheyholislami, Hauna; Connor, Kristin L.] Carleton Univ, Dept Hlth Sci, Ottawa, ON K1S 5B6, Canada",Carleton University,"Connor, KL (corresponding author), Carleton Univ, Dept Hlth Sci, Ottawa, ON K1S 5B6, Canada.",haunasheyholislami3@cmail.carleton.ca; kristin.connor@carleton.ca,"tacchella, giulia/JMC-4431-2023",,,,,,66,25,27,1,9,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,JUL,2021,13,7,,,,,,,2382,10.3390/nu13072382,http://dx.doi.org/10.3390/nu13072382,,,16,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,TN6VG,34371892,"Green Submitted, Green Published, gold",,,2024-06-04,WOS:000676369500001,View Full Record in Web of Science
J,"Takahashi, M; Kadota, Y; Shiko, Y; Kawasaki, Y; Sakurai, K; Mori, C; Shimojo, N",,,,"Takahashi, Mayuko; Kadota, Yoshihiro; Shiko, Yuki; Kawasaki, Yohei; Sakurai, Kenichi; Mori, Chisato; Shimojo, Naoki",,,"A Double-Blind, Randomized, Placebo-Controlled Trial of the Effect of 1-Kestose on Defecation Habits in Constipated Kindergarten Children: A Pilot Study",NUTRIENTS,,,English,Article,,,,,,constipation; prebiotic; 1-kestose; Intestinibacter; gut microbiota; short-chain fatty acid,GUT MICROBIOTA; FERMENTATION; METABOLISM; INULIN; GOS,"Constipation is common in children and can significantly affect quality of life. Prebiotics are reportedly helpful for constipation in adults, but few studies have examined their use in young children. In this study, the effect of 1-kestose (kestose), which has excellent bifidobacterial growth properties, on constipation in kindergarten children (n = 11) was compared with that of maltose (n = 12) in a randomized, double-blind study. Three grams of kestose per day for 8 weeks did not affect stool properties, but significantly increased the number of defecations per week (Median; 3 & RARR; 4 times/week, p = 0.017, effect size = 0.53). A significant decrease in Intestinibacter, a trend toward increased bifidobacteria, and a trend toward decreased Clostridium sensu stricto were observed after kestose ingestion, while concentrations of short-chain fatty acids in stools were unchanged.","[Takahashi, Mayuko; Kadota, Yoshihiro] B Food Sci Co Ltd, Chita, Aichi 4780046, Japan; [Shiko, Yuki] Chiba Univ Hosp, Clin Res Ctr, Chiba, Chiba 2608677, Japan; [Kawasaki, Yohei] Japanese Red Cross Coll Nursing, Shibuya, Tokyo 1500012, Japan; [Sakurai, Kenichi; Mori, Chisato; Shimojo, Naoki] Chiba Univ, Ctr Prevent Med Sci, Chiba, Chiba 2608670, Japan",Chiba University; Chiba University,"Shimojo, N (corresponding author), Chiba Univ, Ctr Prevent Med Sci, Chiba, Chiba 2608670, Japan.",m-takahashi@bfsci.co.jp; y-kadota@bfsci.co.jp; shiko_yuki@chiba-u.jp; ykawasaki@chiba-u.jp; sakuraik@faculty.chiba-u.jp; cmori@faculty.chiba-u.jp; shimojo@faculty.chiba-u.jp,,"Mori, Chisato/0000-0002-1144-8316; Shiko, Yuki/0000-0002-3959-9343; Kawasaki, Yohei/0000-0002-7474-7647",,,,,29,0,0,2,3,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,JUL,2023,15,14,,,,,,,3276,10.3390/nu15143276,http://dx.doi.org/10.3390/nu15143276,,,8,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,N5SD8,37513693,"Green Published, gold",,,2024-06-04,WOS:001037599800001,View Full Record in Web of Science
J,"Pakneshan, S; Shah, A; Fairlie, T; Morrison, M; Holtmann, G",,,,"Pakneshan, S.; Shah, A.; Fairlie, T.; Morrison, M.; Holtmann, G.",,,"Effect of prebiotics, probiotics, and synbiotics on fecal microbiome in adult patients with constipation-predominant irritable bowel syndrome and functional constipation, and links with symptom relief: A systematic review",JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,,,English,Meeting Abstract,,,,,,,,,"[Pakneshan, S.; Shah, A.; Fairlie, T.; Holtmann, G.] Univ Queensland, Princess Alexandra Hosp, Dept Gastroenterol & Hepatol, Woolloongabba, Qld, Australia; [Shah, A.; Morrison, M.; Holtmann, G.] Univ Queensland, Fac Hlth & Behav Sci, Fac Med, Brisbane, Qld, Australia; [Morrison, M.] Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia",Princess Alexandra Hospital; University of Queensland; University of Queensland; University of Queensland,,,"Holtmann, G.J./I-5341-2014",,,,,,0,0,0,0,1,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0815-9319,1440-1746,,J GASTROEN HEPATOL,J. Gastroenterol. Hepatol.,SEP,2021,36,,,3,SI,240,154,154,,,,,,1,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,UM5NQ,,,,,2024-06-04,WOS:000693377800243,View Full Record in Web of Science
B,"Rowland, I",,"Versalovic, J; Wilson, M",,"Rowland, Ian",,,Prebiotics in Human Medicine,THERAPEUTIC MICROBIOLOGY: PROBIOTICS AND RELATED STRATEGIES,,,English,Article; Book Chapter,,,,,,,RISK-FACTORS; BIFIDOBACTERIUM-LACTIS; MYOELECTRIC ACTIVITY; COLORECTAL-CANCER; CONSTIPATION; OLIGOFRUCTOSE; MICROFLORA; OLIGOSACCHARIDES; EPIDEMIOLOGY; DEFINITION,,"Univ Reading, Dept Food Biosci, Reading RG6 6AP, Berks, England",University of Reading,"Rowland, I (corresponding author), Univ Reading, Dept Food Biosci, POB 226, Reading RG6 6AP, Berks, England.",,,,,,,,51,3,3,0,0,AMER SOC MICROBIOLOGY,WASHINGTON,"1752 N STREET NW, WASHINGTON, DC 20036-2904 USA",,,978-1-55581-403-8,,,,2008,,,,,,,299,306,,,,,,8,Gastroenterology & Hepatology; Microbiology,Book Citation Index – Science (BKCI-S),Gastroenterology & Hepatology; Microbiology,BOY03,,,,,2024-06-04,WOS:000277999300024,View Full Record in Web of Science
J,"Lee, Y; Yoshitsugu, R; Kikuchi, K; Joe, GH; Tsuji, M; Nose, T; Shimizu, H; Hara, H; Minamida, K; Miwa, K; Ishizuka, S",,,,"Lee, Yeonmi; Yoshitsugu, Reika; Kikuchi, Keidai; Joe, Ga-Hyun; Tsuji, Misaki; Nose, Takuma; Shimizu, Hidehisa; Hara, Hiroshi; Minamida, Kimiko; Miwa, Kazunori; Ishizuka, Satoshi",,,Combination of soya pulp and Bacillus coagulans lilac-01 improves intestinal bile acid metabolism without impairing the effects of prebiotics in rats fed a cholic acid-supplemented diet,BRITISH JOURNAL OF NUTRITION,,,English,Article,,,,,,Bile acids; Soya pulp; Bacillus coagulans lilac-01; Synbiotics; Gut permeability,SALT HYDROLASE ACTIVITY; EPITHELIAL PROLIFERATION; CHOLESTEROL; PURIFICATION; FAT; DECONJUGATION; LACTOBACILLUS; PERMEABILITY; MICROBIOTA; BACTERIA,"Intestinal bacteria are involved in bile acid (BA) deconjugation and/ or dehydroxylation and are responsible for the production of secondary BA. However, an increase in the production of secondary BA modulates the intestinal microbiota due to the bactericidal effects and promotes cancer risk in the liver and colon. The ingestion of Bacillus coagulans improves constipation via the activation of bowel movement to promote defaecation in humans, which may alter BA metabolism in the intestinal contents. BA secretion is promoted with high-fat diet consumption, and the ratio of cholic acid (CA): chenodeoxycholic acid in primary BA increases with ageing. The dietary supplementation of CA mimics the BA environment in diet-induced obesity and ageing. We investigated whether B. coagulans lilac-01 and soya pulp influence both BA metabolism and the maintenance of host health in CA-supplemented diet-fed rats. In CA-fed rats, soya pulp significantly increased the production of secondary BA such as deoxycholic acid and omega-muricholic acids, and soya pulp ingestion alleviated problems related to plasma adiponectin and gut permeability in rats fed the CA diet. The combination of B. coagulans and soya pulp successfully suppressed the increased production of secondary BA in CA-fed rats compared with soya pulp itself, without impairing the beneficial effects of soya pulp ingestion. In conclusion, it is possible that a combination of prebiotics and probiotics can be used to avoid an unnecessary increase in the production of secondary BA in the large intestine without impairing the beneficial functions of prebiotics.","[Lee, Yeonmi; Yoshitsugu, Reika; Kikuchi, Keidai; Joe, Ga-Hyun; Tsuji, Misaki; Nose, Takuma; Shimizu, Hidehisa; Hara, Hiroshi; Ishizuka, Satoshi] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan; [Shimizu, Hidehisa] Shimane Univ, Fac Life & Environm Sci, Matsue, Shimane 6908504, Japan; [Minamida, Kimiko; Miwa, Kazunori] Arterio Bio Co Ltd, Otaru, Hokkaido 0470261, Japan",Hokkaido University; Shimane University,"Ishizuka, S (corresponding author), Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan.",zuka@chem.agr.hokudai.ac.jp,"Ishizuka, Satoshi/A-4322-2012; Shimizu, Hidehisa/AFQ-7985-2022; HARA, HIROSHI/A-4581-2012","Ishizuka, Satoshi/0000-0003-2445-8238; Shimizu, Hidehisa/0000-0002-0939-0098; HARA, HIROSHI/0000-0001-5925-5751","Regional Innovation Strategy Support Program of the MEXT (Ministry of Education, Culture, Sports, Science and Technology) from the Japanese Government; Grants-in-Aid for Scientific Research [16K14917] Funding Source: KAKEN","Regional Innovation Strategy Support Program of the MEXT (Ministry of Education, Culture, Sports, Science and Technology) from the Japanese Government; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))","This study was supported by the Regional Innovation Strategy Support Program of the MEXT (Ministry of Education, Culture, Sports, Science and Technology) from the Japanese Government.",,39,28,31,2,34,CAMBRIDGE UNIV PRESS,CAMBRIDGE,"EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND",0007-1145,1475-2662,,BRIT J NUTR,Br. J. Nutr.,AUG 28,2016,116,4,,,,,603,610,,10.1017/S0007114516002270,http://dx.doi.org/10.1017/S0007114516002270,,,8,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,DS6RA,27464459,"Bronze, Green Submitted",,,2024-06-04,WOS:000380908600005,View Full Record in Web of Science
J,"Savino, F; Maccario, S; Castagno, E; Cresi, F; Cavallo, F; Dalmasso, P; Fanaro, S; Oggero, R; Silvestro, L",,,,"Savino, F; Maccario, S; Castagno, E; Cresi, F; Cavallo, F; Dalmasso, P; Fanaro, S; Oggero, R; Silvestro, L",,,Advances in the management of digestive problems during the first months of life,ACTA PAEDIATRICA,,,English,Article; Proceedings Paper,Symposium on Infant Nutrition,"DEC 11-12, 2003","Milan, ITALY",,,constipation; milk formula; prebiotics; regurgitation; stool frequency,PALMITIC ACID; DOUBLE-BLIND; FORMULA; OLIGOSACCHARIDES; FAT,"A study was carried out on 168 full-term infants with digestive problems such as regurgitation and/or constipation to evaluate the efficacy of new infant formulas containing partially hydrolysed whey protein, modified vegetable oil with a high P-palmitic acid content, prebiotic oligosaccharides and starch. Infants receiving the new formulas had an increase in stool frequency of 0.60 between day 1 and day 7 (95% CI 0.19-1.01; p = 0.004) and 0.53 (95% CI 0.11-0.90; p = 0.015) between day 7 and day 14. A reduction of 1.06 in the number of regurgitation episodes was reported between day 1 and day 7 (95% CI 0.24-1.88-3 p = 0.012) and 1.31 (95% CI 0.42-2.21; p = 0.005) between day 7 and day 14. Conclusion: A prebiotic mixture of galacto-/fructo-oligosaccharides with a high beta-palmitic acid content may reduce digestive problems and improve intestinal tolerance in infants during the first months of life.","Univ Turin, Osped Infantile Regina Margherita, Dept Paediat, Turin, Italy; Univ Turin, Dept Microbiol & Publ Hlth, Turin, Italy; Univ Ferrara, Dept Paediat, Neonatal Intens Care Unit, I-44100 Ferrara, Italy",University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; University of Ferrara,"Osped Infantile Regina Margherita, Dipartimento Sci Pediat & Adolescenza, Piazza Polonia 94, I-10126 Turin, Italy.",francesco.savino@unito.it,"cresi, francesco/R-3118-2017; Castagno, Emanuele/AAU-2634-2021; Savino, Francesco/J-6935-2019; fanaro, silvia/B-1189-2016; Dalmasso, Paola/F-8555-2013","Castagno, Emanuele/0000-0001-7756-5075; Savino, Francesco/0000-0001-9163-1016; Cresi, Francesco/0000-0002-2139-6855; Dalmasso, Paola/0000-0001-6081-6966; SILVESTRO, LEANDRA/0000-0002-5564-1580",,,,,20,25,33,0,4,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0803-5253,1651-2227,,ACTA PAEDIATR,Acta Paediatr.,OCT,2005,94,,,449,,,120,124,,10.1080/08035320510043673,http://dx.doi.org/10.1080/08035320510043673,,,5,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Pediatrics,980KF,16214778,,,,2024-06-04,WOS:000233016700022,View Full Record in Web of Science
J,"Guarner, F",,,,"Guarner, Francisco",,,Prebiotics and mucosal barrier function,JOURNAL OF NUTRITION,,,English,Letter,,,,,,,LOPERAMIDE-INDUCED CONSTIPATION; RAT COLONIC-MUCOSA; MUCIN SECRETION; SURFACE HYDROPHOBICITY; MUCUS,,"Univ Hosp Vall Hebron, Digest Syst Res Unit, Barcelona 08035, Spain",Hospital Universitari Vall d'Hebron,"Guarner, F (corresponding author), Univ Hosp Vall Hebron, Digest Syst Res Unit, P Vall Hebron 119-129, Barcelona 08035, Spain.",fguarner@vhebron.net,"Guarner, Francisco/ABF-1192-2020","Guarner, Francisco/0000-0002-4051-0836",,,,,12,4,4,0,10,AMER SOCIETY NUTRITIONAL SCIENCE,BETHESDA,"9650 ROCKVILLE PIKE, RM L-2407A, BETHESDA, MD 20814 USA",0022-3166,,,J NUTR,J. Nutr.,AUG,2006,136,8,,,,,2269,2269,,10.1093/jn/136.8.2269,http://dx.doi.org/10.1093/jn/136.8.2269,,,1,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,068IG,16857852,hybrid,,,2024-06-04,WOS:000239366300025,View Full Record in Web of Science
J,"D'Onofrio, V; Del Chierico, F; Belci, P; Vernocchi, P; Quagliariello, A; Reddel, S; Conta, G; Mancino, MV; Fadda, M; Scigliano, MC; Morelli, R; De Francesco, A; Guagnini, F; Fassio, F; Galletti, R; Putignani, L",,,,"D'Onofrio, Valentina; Del Chierico, Federica; Belci, Paola; Vernocchi, Pamela; Quagliariello, Andrea; Reddel, Sofia; Conta, Giorgia; Mancino, Maria Vittoria; Fadda, Maurizio; Scigliano, Maria Carmine; Morelli, Roberta; De Francesco, Antonella; Guagnini, Fabio; Fassio, Filippo; Galletti, Rosalba; Putignani, Lorenza",,,Effects of a Synbiotic Formula on Functional Bowel Disorders and Gut Microbiota Profile during Long-Term Home Enteral Nutrition (LTHEN): A Pilot Study,NUTRIENTS,,,English,Article,,,,,,bedridden patients; long-term home enteral nutrition (LTHEN); synbiotics; constipation; diarrhoea; gut microbiota; dysbiosis,FECAL MICROBIOTA; DIVERSITY; MODULATION; PROBIOTICS; SYSTEM; FIBER,"Long-term enteral nutrition (LTEN) can induce gut microbiota (GM) dysbiosis and gastrointestinal related symptoms, such as constipation or diarrhoea. To date, the treatment of constipation is based on the use of laxatives and prebiotics. Only recently have probiotics and synbiotics been considered, the latter modulating the GM and regulating intestinal functions. This randomized open-label intervention study evaluated the effects of synbiotic treatment on the GM profile, its functional activity and on intestinal functions in long-term home EN (LTHEN) patients. Twenty LTHEN patients were recruited to take enteral formula plus one sachet/day of synbiotic (intervention group, IG) or enteral formula (control group, CG) for four months and evaluated for constipation, stool consistency, and GM and metabolite profiles. In IG patients, statistically significant reduction of constipation and increase of stool consistency were observed after four months (T-1), compared to CG subjects. GM ecology analyses revealed a decrease in the microbial diversity of both IC and CG groups. Biodiversity increased at T-1 for 5/11 IG patients and Methanobrevibacter was identified as the biomarker correlated to the richness increase. Moreover, the increase of short chain fatty acids and the reduction of harmful molecules have been correlated to synbiotic administration. Synbiotics improve constipation symptoms and influences Methanobrevibacter growth in LTHEN patients.","[D'Onofrio, Valentina; Belci, Paola; Mancino, Maria Vittoria; Fadda, Maurizio; Scigliano, Maria Carmine; Morelli, Roberta; De Francesco, Antonella; Galletti, Rosalba] AOU Citta Salute & Sci Torino, SC Dietet & Nutr Clin, I-10126 Turin, Italy; [Del Chierico, Federica; Vernocchi, Pamela; Quagliariello, Andrea; Reddel, Sofia] Bambino Gesu Pediat Hosp, Unit Human Microbiome, Multimodal Lab, IRCCS,Med Res Area, I-00165 Rome, Italy; [Conta, Giorgia] Sapienza Univ Rome, Dept Chem, I-00185 Rome, Italy; [Conta, Giorgia] Sapienza Univ Rome, NMR Based Metab Lab, I-00185 Rome, Italy; [Guagnini, Fabio] Allergy Therapeut Italia, Milan, Italy; [Guagnini, Fabio] GE Healthcare, I-20019 Milan, Italy; [Fassio, Filippo] San Giovanni di Dio Hosp, Azienda USL Toscana Ctr, Allergy & Clin Immunol Unit, I-50143 Florence, Italy; [Putignani, Lorenza] IRCCS, Bambino Gesu Childrens Hosp, Dept Diagnost & Lab Med, Unit Parasitol, I-00147 Rome, Italy; [Putignani, Lorenza] IRCCS, Bambino Gesu Childrens Hosp, Multimodal Lab, Unit Human Microbiome,Med Res Area, I-00147 Rome, Italy",A.O.U. Citta della Salute e della Scienza di Torino; IRCCS Bambino Gesu; Sapienza University Rome; Sapienza University Rome; General Electric; IRCCS Bambino Gesu; IRCCS Bambino Gesu,"Putignani, L (corresponding author), IRCCS, Bambino Gesu Childrens Hosp, Dept Diagnost & Lab Med, Unit Parasitol, I-00147 Rome, Italy.;Putignani, L (corresponding author), IRCCS, Bambino Gesu Childrens Hosp, Multimodal Lab, Unit Human Microbiome,Med Res Area, I-00147 Rome, Italy.",donofriovalentina.vdo@gmail.com; federica.delchierico@opbg.net; paola.belci@gmail.com; pamela.vernocchi@opbg.net; andrea.quagliariello@opbg.net; sofia.reddel@opbg.net; giorgia.conta@uniroma1.it; mmancino@cittadellasalute.to.it; mfadda@cittadellasalute.to.it; mscigliano@cittadellasalute.to.it; rmorelli2@cittadellasalute.to.it; adefrancesco@cittadellasalute.to.it; fabio.guagnini@allergytherapeutics.com; fassio.filippo@gmail.com; rgalletti@cittadellasalute.to.it; lorenza.putignani@opbg.net,"Del Chierico, Federica/J-4373-2016; Putignani, Lorenza/K-3409-2016; Quagliariello, Andrea/K-4955-2018; Conta, Giorgia/GOV-5057-2022; Fadda, Maurizio/K-3091-2016","Del Chierico, Federica/0000-0002-4204-4736; Putignani, Lorenza/0000-0003-0134-2830; Quagliariello, Andrea/0000-0002-3941-3684; Fadda, Maurizio/0000-0001-9205-8450; Fassio, Filippo/0000-0002-0732-9090",Allergy Therapeutics Italia [RC 201905_Genetica_Putignani],Allergy Therapeutics Italia,"This research was funded by Lorenza Putignani, Grant number RC 201905_Genetica_Putignani, and by Allergy Therapeutics Italia, which provided the synbiotics preparation and paid the article processing charge and for English language revision costs.",,63,4,4,2,14,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,JAN,2021,13,1,,,,,,,87,10.3390/nu13010087,http://dx.doi.org/10.3390/nu13010087,,,14,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,PW4EZ,33383954,"Green Published, gold",,,2024-06-04,WOS:000610625700001,View Full Record in Web of Science
B,"Benninga, MA; Vink, M; Akkermans, LMA",,"Browne, PD; Claassen, E; Cabana, MD",,"Benninga, M. A.; Vink, M.; Akkermans, L. M. A.",,,Intestinal microbiota and its role in the development of paediatric gastrointestinal disorders,MICROBIOTA IN HEALTH AND DISEASE: FROM PREGNANCY TO CHILDHOOD,,,English,Article; Book Chapter,,,,,,children; gastrointestinal infections; obesity; abdominal pain; constipation; prebiotics; probiotics,IRRITABLE-BOWEL-SYNDROME; CLOSTRIDIUM-DIFFICILE INFECTION; HELICOBACTER-PYLORI INFECTION; FUNCTIONAL ABDOMINAL-PAIN; QUALITY-OF-LIFE; GUT MICROBIOTA; DOUBLE-BLIND; ESCHERICHIA-COLI; HEALTHY-CHILDREN; PLACEBO,"The human gut microbiota play an essential role in health and disease because of its influence on metabolism, digestion, nutrient absorption, immune system modulation and prevention of enteric pathogen colonisation. In this chapter, the role and interaction of the gut microbiota and probiotics in infectious diseases, functional gastrointestinal disorders, such as functional abdominal pain (FAP) and functional constipation (FC), and obesity amongst children are discussed. Infectious diseases caused by Escherichia coli, Clostridium difficile, Helicobacter pylori, and Shigella, pose a great disease burden in both developed and underdeveloped countries. The administration of probiotics, either as single treatment or as an adjuvant agent, provides significant benefits, yet, additional studies determining optimal dose and strains per disease are required. The role of gut microbiota in FAP is less clear, although alterations of the gut microbiota are suggested to negatively influence symptom generation. Probiotics appear to improve treatment success, mainly in children with irritable bowel syndrome. Dysbiosis of the gut is assumed to play a role in FC as well. Current evidence, however is insufficient to support the use of specific strains as a treatment in children with constipation. Children with obesity have a distinct gut microbial composition in comparison to lean children. Studies that specifically look at the effect of perinatal probiotics on childhood overweight and obesity are rather disappointing with regard to long-term effectiveness. The positive short-term effects on gut microbiota modulation and consequently weight of perinatal probiotic supplementation, however, indicate that it is relevant to examine the effects of continuous supplementation. Probiotics are suggested to be beneficial for infectious diseases, functional gastrointestinal disorders, and obesity. There is, however, a definite need to determine which species, specific strains and combinations of strains of probiotics are most efficacious.","[Benninga, M. A.] Emma Childrens Hosp, Dept Paediat Gastroenterol & Nutr, Acad Med Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Vink, M.; Akkermans, L. M. A.] Amsterdam Univ Coll AUC, Sci Pk 113, NL-1098 XG Amsterdam, Netherlands; [Akkermans, L. M. A.] Univ Med Ctr Utrecht, Dept Surg, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands",University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; Utrecht University; Utrecht University Medical Center,"Benninga, MA (corresponding author), Emma Childrens Hosp, Dept Paediat Gastroenterol & Nutr, Acad Med Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.",m.a.benninga@amc.uva.nl,,,,,,,76,1,1,0,3,WAGENINGEN ACAD PUBL,WAGENINGEN,"POSTBUS 220, 6700 AE WAGENINGEN, NETHERLANDS",,,978-90-8686-839-1; 978-90-8686-294-8,,,,2017,,,,,,,197,216,,10.3920/978-90-8686-839-1_11,http://dx.doi.org/10.3920/978-90-8686-839-1_11,10.3920/978-90-8686-839-1,,20,Microbiology; Pediatrics,Book Citation Index – Science (BKCI-S),Microbiology; Pediatrics,BM6WB,,,,,2024-06-04,WOS:000467403000011,View Full Record in Web of Science
J,"Quigley, EMM",,,,"Quigley, Eamonn M. M.",,,Probiotics in the Management of Functional Bowel Disorders Promise Fulfilled?,GASTROENTEROLOGY CLINICS OF NORTH AMERICA,,,English,Article,,,,,,Irritable bowel syndrome; Constipation; Bloating; Functional bowel disorders; Microbiota; Probiotics,PLACEBO-CONTROLLED-TRIAL; INTESTINAL BACTERIAL OVERGROWTH; BIFIDOBACTERIUM-INFANTIS 35624; QUALITY-OF-LIFE; NURSING-HOME RESIDENTS; LACTIC-ACID BACTERIA; A-DOUBLE-BLIND; FERMENTED MILK; VISCERAL HYPERSENSITIVITY; COLONIC FERMENTATION,"Irritable bowel syndrome (IBS) and chronic constipation (CC) are common problems worldwide and are associated with significant impact on activities of daily living and quality of life. Recent interest, in IBS in particular, has focused on the potential roles of the microbiota and its interaction with the host's immune system. Recently, high-quality clinical trials have been performed on prebiotics and probiotics in IBS or CC. Although strategies that seek to modify the microbiota, such as the use of probiotics, offer much promise in IBS and CC, more high-quality trials and, studies of longer duration are required.","[Quigley, Eamonn M. M.] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Dept Med, Cork, Ireland",University College Cork,"Quigley, EMM (corresponding author), Cork Univ Hosp, Dept Med, Clin Sci Bldg, Cork, Ireland.",e.quigley@ucc.ie,,,Science Foundation Ireland,Science Foundation Ireland(Science Foundation Ireland),"Supported, in part, by a grant from Science Foundation Ireland to the Alimentary Pharmabiotic Center.",,140,12,12,0,28,W B SAUNDERS CO-ELSEVIER INC,PHILADELPHIA,"1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA",0889-8553,1558-1942,,GASTROENTEROL CLIN N,Gastroenterol. Clin. North Am.,DEC,2012,41,4,,,,,805,+,,10.1016/j.gtc.2012.08.005,http://dx.doi.org/10.1016/j.gtc.2012.08.005,,,16,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,047TI,23101688,,,,2024-06-04,WOS:000311864000007,View Full Record in Web of Science
J,"Bonetto, S; Fagoonee, S; Battaglia, E; Grassini, M; Saracco, GM; Pellicano, R",,,,"Bonetto, Silvia; Fagoonee, Sharmila; Battaglia, Edda; Grassini, Mario; Saracco, Giorgio Maria; Pellicano, Rinaldo",,,Recent advances in the treatment of irritable bowel syndrome,POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ,,,English,Review,,,,,,abdominal pain; constipation; diarrhea; irritable bowel syndrome; probiotics,FECAL MICROBIOTA TRANSPLANTATION; PLACEBO-CONTROLLED TRIAL; DIARRHEA-PREDOMINANT; CLINICAL-TRIAL; 5-HT4 AGONISTS; DOUBLE-BLIND; CONSTIPATION; PREVALENCE; EFFICACY; LINACLOTIDE,"Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal disorder which presents with abdominal pain and altered bowel habits. It affects about 20% of the general population, mainly women, and has a considerable impact on the quality of life and health care costs. Four different entities of IBS have been identified: IBS with constipation (IBS -C), IBS with diarrhea (IBS -D), IBS with a mixed pattern of constipation and diarrhea, and unclassified IBS. Although the precise pathogenesis of IBS remains unclear, its multifactorial nature is evident and includes environmental and host factors. Management of patients with this disease is challenging and a personalized approach is required. A strong, reassuring physician -patient relationship is crucial, followed by patient education, dietary advice, and stress reduction. For nonresponding patients, the therapeutic approach may include nonpharmacological therapies and / or pharmacotherapy. The choice of pharmacological treatment is based on the predominant symptom and a prespecified time point should be planned for effectiveness evaluation and dose adjustment. In patients with IBS -D, the therapeutic options include mainly antibiotics, such as rifaximin, peripheral opioid agonists, mixed opioid agonists / antagonists, bile acid sequestrants, and antagonists of serotonin 5 -hydroxytryptamine type 3 receptors. Bulking agents and osmotic laxatives represent the first -line therapy for IBS -C, while lubiprostone and linaclotide should be reserved for difficult -to -treat patients. The involvement of gastrointestinal microbiota constitutes a fascinating field of exploration as it offers the potential to be modulated by the use of probiotics, prebiotics, synbiotics as well as fecal microbiota transplantation. This review offers an updated overview on the recent advances in the treatment of IBS.","[Bonetto, Silvia; Saracco, Giorgio Maria] Univ Turin, Dept Med Sci, Turin, Italy; [Bonetto, Silvia; Pellicano, Rinaldo] Mol Biotechnol Ctr, Natl Res Council, Inst Biostruct & Bioimaging, Turin, Italy; [Battaglia, Edda; Grassini, Mario] Cardinal Massaia Hosp, Gastroenterol & Endoscopy Unit, Asti, Italy; [Saracco, Giorgio Maria; Pellicano, Rinaldo] Molinette SGAS Hosp, Gastroenterol Unit, Via Cavour 31, I-10126 Turin, Italy",University of Turin; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette,"Pellicano, R (corresponding author), Molinette SGAS Hosp, Gastroenterol Unit, Via Cavour 31, I-10126 Turin, Italy.",rinaldo_pellican@hotmail.com,"Fagoonee, Sharmila/L-1940-2019; Pellicano, Rinaldo/K-2575-2016","Fagoonee, Sharmila/0000-0001-6070-6716;",,,,,62,37,43,6,30,MEDYCYNA PRAKTYCZNA SP K SP ZOO,KRAKOW,"REJTANA 2, KRAKOW, 30-510 AP, POLAND",0032-3772,1897-9483,,POL ARCH INTERN MED,Pol. Intern. Med.,AUG 30,2021,131,7-8,,,,,709,715,,10.20452/pamw.16067,http://dx.doi.org/10.20452/pamw.16067,,,7,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,UX5ME,34463082,,,,2024-06-04,WOS:000700888500015,View Full Record in Web of Science
C,"Olaru, RA; Diaconescu, S; Gimiga, N; Burlea, M; Olaru, C",,"Dumitrascu, DL",,"Olaru, Radian Alexandru; Diaconescu, Smaranda; Gimiga, Nicoleta; Burlea, Marin; Olaru, Claudia",,,Benefits of synbiotic treatment in constipated children,"XXXVI NATIONAL CONGRESS OF GASTROENTEROLOGY, HEPATOLOGY AND DIGESTIVE ENDOSCOPY",,,English,Proceedings Paper,"36th Romanian National Congress of Gastroenterology, Hepatology and Digestive Endoscopy","JUN 08-11, 2016","Cluj Napoca, ROMANIA","Soc Gastroenterologie Hepatologie,RSCP,APPR,Ging,Ueg,UMF",,Constipation; Probiotic/synbiotic therapy; Child,MYOELECTRIC ACTIVITY; GUT MICROBIOTA; TRANSIT; FLORA; MOTILITY; COMPLEX; RAT,"Background: It is hypothesized that prebiotic oligosaccharides affects stool characteristics in constipated infants. We aimed to compare the efficiency of additional treatment with to probiotic/synbiotic therapy to conventional treatment alone in constipated children. Methods: 57 constipated infants, aged 6-15 years, were included and randomized to probiotic/synbiotic therapy and conventional treatment (n=30) or conventional treatment alone (n=27) in period 1 and crossed-over after 3 weeks to treatment period 2. Constipation was defined by at least one of the following symptoms: 1) defecation frequency <3/week; 2) painful defecation; 3) abdominal or rectal palpable mass. Results: Period 1 was completed by all the children. A significant increase in defecation frequency (3.5 pre versus 5.6/week post treatment; 3.6 pre versus 4.9/week post treatment) was found in both groups, but was not significantly different (p=0.36). Improvement of hard stool consistency to soft stool consistency was found more often with prebiotics than conventional treatment alone, but did not reach statistical significance (90% versus 50%; RR, 1.8; 95% CI, 0.9-3.5; p=0.14). No difference was found in painful defecation or the presence of an abdominal or rectal mass between the two groups. Fifty-four children completed period 2. Only stool consistency was significantly different between the two treatments (17% had soft stools on prebiotic treatment; no child had soft stools on conventional treatment). Conclusion: The addition of prebiotic oligosaccharides resulted in a strong tendency of softer stools in constipated children, but not in a difference in defecation frequency. Prebiotics may be considered as treatment in constipated children with hard stools.","[Olaru, Radian Alexandru] Gr T Popa Univ Med & Pharm, Psychiat, Iasi, Romania; Gr T Popa Univ Med & Pharm, Pediat, Iasi, Romania",Grigore T Popa University of Medicine & Pharmacy; Grigore T Popa University of Medicine & Pharmacy,"Olaru, RA (corresponding author), Gr T Popa Univ Med & Pharm, Psychiat, Iasi, Romania.",arosoft99@yahoo.com; turti23@yahoo.com; chiti_nico@yahoo.com; mburlea@yahoo.com; moa_clau@yahoo.com,"Diaconescu, Smaranda/J-8753-2015; GIMIGA, NICOLETA G/U-6335-2017","Diaconescu, Smaranda/0000-0001-8018-7191;",,,,,15,0,0,0,4,FILODIRITTO PUBLISHER,BOLOGNA,"INFOROMATICA SRL, VIA CASTIGLIONE, 81, BOLOGNA, 40124, ITALY",,,978-88-95922-72-0,,,,2016,,,,,,,290,294,,,,,,5,Gastroenterology & Hepatology,Conference Proceedings Citation Index - Science (CPCI-S),Gastroenterology & Hepatology,BG7FA,,,,,2024-06-04,WOS:000391251900048,View Full Record in Web of Science
J,"Wang, LL; Hu, LJ; Yan, S; Jiang, T; Fang, SG; Wang, G; Zhao, JX; Zhang, H; Chen, W",,,,"Wang, Linlin; Hu, Lujun; Yan, Shuang; Jiang, Tian; Fang, Shuguang; Wang, Gang; Zhao, Jianxin; Zhang, Hao; Chen, Wei",,,Effects of different oligosaccharides at various dosages on the composition of gut microbiota and short-chain fatty acids in mice with constipation,FOOD & FUNCTION,,,English,Article,,,,,,,GALACTO-OLIGOSACCHARIDES; INTESTINAL MICROBIOTA; RATS; HEALTH; PREBIOTICS; BUTYRATE; INULIN; FRUCTOOLIGOSACCHARIDE; OLIGOFRUCTOSE; METABOLISM,"The aim of this study was to evaluate the effects of three different kinds of oligosaccharides (a fructooligosaccharide (FOS) formulation consisting of 95% FOS (FOS95); a galacto-oligosaccharide (GOS) formulation consisting of 90% GOS (GOS90) and an isomalto-oligosaccharide (IMO) formulation consisting of 90% IMO (IMO90)) at dosages of 0.8, 4 g per d per kg bw and 8 g per d per kg bw on the composition and activity of the microbiota in the gut of mice with constipation induced by loperamide. Oligosaccharides were intragastrically administered to specific pathogen-free BALB/c mice once per day for 17 days. Feces were collected during a feeding trial and subjected to 16S rDNA amplicon analysis. Constipation indices, changes in gut microbiota and metabolic activity were measured to evaluate the effects of the oligosaccharides. The results show that oligosaccharides treated constipation by increasing both the water content of the feces and the small intestinal transit rate. The dosage required to treat constipation was different for different oligosaccharides. High-dose GOS90 was the most effective in relieving constipation, followed by medium-dose FOS95 and IMO90. The fecal samples were investigated after the oligosaccharide treatment. All three oligosaccharides increased the ratio of acetic acid and decreased the ratio of propionic and butyric acids in the feces. The increase in the ratio of acetic acid and the concentration of butyric acid were found to have relatively larger effects on constipation. After treatment with oligosaccharides, the gut microbiotas of the mice were dominated by Firmicutes, Bacteroidetes and Actinobacteria. At the genus level, oligosaccharide treatment increased the levels of Lactobacillus and Bifidobacterium and decreased the levels of Odoribacter, Alistipes and Bacteroides. In conclusion, our results demonstrate that oligosaccharides administered as a dietary supplement increase the water content of feces, reduce intestinal transit time, modulate the composition of the gut microbiota and increase the concentration of short-chain fatty acids in the feces of mice with constipation.","[Wang, Linlin; Hu, Lujun; Yan, Shuang; Wang, Gang; Zhao, Jianxin; Zhang, Hao; Chen, Wei] Jiangnan Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Technol, Wuxi 214122, Peoples R China; [Wang, Linlin; Hu, Lujun; Yan, Shuang; Wang, Gang; Zhao, Jianxin; Zhang, Hao; Chen, Wei] Jiangnan Univ, Int Joint Res Lab Probiot, Wuxi 214122, Peoples R China; [Jiang, Tian; Fang, Shuguang] Jiangsu Wecare Biotechnol Co Ltd, Wujiang 215200, Peoples R China; [Chen, Wei] BTBU, Beijing Innovat Ctr Food Nutr & Human Hlth, Beijing 100048, Peoples R China",Jiangnan University; Jiangnan University; Beijing Technology & Business University,"Wang, G (corresponding author), Jiangnan Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Technol, Wuxi 214122, Peoples R China.;Wang, G (corresponding author), Jiangnan Univ, Int Joint Res Lab Probiot, Wuxi 214122, Peoples R China.",wanggang@jiangnan.edu.cn,"Chen, Wei/GZK-7348-2022; Zhang, Hao/HHM-1940-2022; Wang, Gang/AEO-7822-2022; Wang, Ling/AGR-4917-2022","Wang, Ling/0000-0003-0272-2974; /0009-0006-1337-808X; Hu, Lujun/0000-0002-4467-079X; Wang, Gang/0000-0003-2007-2143",National Natural Science Foundation of China [31671839]; Program of Introducing Talents of Discipline to Universities [B07029]; Fundamental Research Funds for the Central Universities [JUSRP51501]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Program of Collaborative Innovation Centre of Food Safety and Quality Control in Jiangsu Province,"National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Priority Academic Program Development of Jiangsu Higher Education Institutions; Program of Collaborative Innovation Centre of Food Safety and Quality Control in Jiangsu Province","This work was supported by the National Natural Science Foundation of China (No. 31671839), the Program of Introducing Talents of Discipline to Universities (B07029), the Fundamental Research Funds for the Central Universities (JUSRP51501), a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions and the Program of Collaborative Innovation Centre of Food Safety and Quality Control in Jiangsu Province.",,53,112,128,10,205,ROYAL SOC CHEMISTRY,CAMBRIDGE,"THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND",2042-6496,2042-650X,,FOOD FUNCT,Food Funct.,MAY 1,2017,8,5,,,,,1966,1978,,10.1039/c7fo00031f,http://dx.doi.org/10.1039/c7fo00031f,,,13,Biochemistry & Molecular Biology; Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Food Science & Technology,EV8QI,28475191,,,,2024-06-04,WOS:000402046800024,View Full Record in Web of Science
J,"Wegh, CAM; Benninga, MA; Tabbers, MM",,,,"Wegh, Carrie A. M.; Benninga, Marc A.; Tabbers, Merit M.",,,Effectiveness of Probiotics in Children With Functional Abdominal Pain Disorders and Functional Constipation A Systematic Review,JOURNAL OF CLINICAL GASTROENTEROLOGY,,,English,Article; Proceedings Paper,"9th Meeting on Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition and Human and Microbiota","SEP 10-12, 2017","Rome, ITALY",,,probiotics; gut microbiota; children; functional gastrointestinal disorders,IRRITABLE-BOWEL-SYNDROME; REUTERI DSM 17938; DOUBLE-BLIND; GASTROINTESTINAL DISORDERS; CHILDHOOD CONSTIPATION; LACTOBACILLUS-GG; CLINICAL-TRIALS; PLACEBO; METAANALYSIS; MULTICENTER,"Objective: The objective of this study was to investigate the effect of probiotics on functional abdominal pain disorders (FAPD) and functional constipation (FC). Methods: A systematic review was conducted, searching PubMed and Cochrane databases from inception to January 2018 for randomized controlled trials (RCTs) investigating the efficacy of probiotics in children aged 4 to 18 years with FAPD or children aged 0 to 18 years with FC. Results: A total of 657 citations were identified. Finally, 11 RCTs for FAPD and 6 RCTs for FC were included. Some evidence exists for Lactobacillus rhamnosus GG (n = 3) in reducing frequency and intensity of abdominal pain in children with irritable bowel syndrome. There is no evidence to recommend L. reuteri DSM 17938 (n = 5), a mix of Bifidobacterium infantis, Bifidobacterium breve and Bifidobacterium longum (n = 1), Bifidobacterium lactis (n = 1) or VSL#3 (n = 1) for children with FAPD. No evidence exists to support the use of Lactobacillus casei rhamnosus LCR35 (n = 1), B. lactis DN173 010 (n = 1), B. longum (n = 1), L. reuteri DSM 17938 (n = 1), a mix of B. infantis, B. breve and B. longum (n = 1), or Protexin mix (n = 1) for children with FC. In general, studies had an unclear or high risk of bias. Conclusions: Insufficient evidence exists for the use of probiotics in FAPD and FC, only L. rhamnosus GG seems to reduce frequency and intensity of abdominal pain but only in children with irritable bowel syndrome. A better understanding of differences in gut microbiota in health and disease might lead to better probiotic strategies to treat disease.","[Wegh, Carrie A. M.] Wageningen Univ & Res, Lab Microbiol, Wageningen, Netherlands; [Benninga, Marc A.; Tabbers, Merit M.] Emmas Childrens Hosp, Acad Med Ctr, Dept Pediat Gastroenterol & Nutr, Amsterdam, Netherlands",Wageningen University & Research; University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital,"Wegh, CAM (corresponding author), 0031614212564,Postbus 8033, NL-6700 EH Wageningen, Netherlands.",carrie.wegh@wur.nl,,"Tabbers, Merit/0000-0001-9744-7308; Wegh, Carrie A.M./0000-0001-7963-7634",,,,,64,24,26,1,19,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0192-0790,1539-2031,,J CLIN GASTROENTEROL,J. Clin. Gastroenterol.,NOV-DEC,2018,52,,,1,,,S10,S26,,10.1097/MCG.0000000000001054,http://dx.doi.org/10.1097/MCG.0000000000001054,,,17,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Gastroenterology & Hepatology,HD6OA,29782469,,,,2024-06-04,WOS:000452658900005,View Full Record in Web of Science
J,"Hong, CT; Chen, JH; Huang, TW",,,,"Hong, Chien -Tai; Chen, Jia-Hung; Huang, Tsai-Wei",,,Probiotics treatment for Parkinson disease: a systematic review and meta-analysis of clinical trials,AGING-US,,,English,Review,,,,,,Parkinson disease; probiotics; constipation; meta-analysis,GUT MICROBIOTA; CONSTIPATION; SYNBIOTICS; MECHANISMS; PREBIOTICS; VAGOTOMY; RISK,"Background and aims: People with Parkinson disease (PwP) exhibit gut dysbiosis and considerable gastrointestinal (GI) symptoms. Probiotics, beneficial strains of microorganisms, supplement and optimize the intestinal environment and alleviate GI symptoms among elderly people. We conducted a systematic review and meta -analysis of clinical trials to investigate the effects of probiotics on PwP. Methods: We searched the PubMed, Embase, and Cochrane Library databases. Major outcomes were the effects on GI symptoms, including bowel movement and stool characteristics. This study was registered with PROSPERO (CRD42021262036). Results: Six randomized controlled trials (RCTs) and two open-label studies were included. Most of the probiotic regimens were based on Lactobacillus and Bifidobacterium. Six studies investigated the benefit of probiotics for GI symptoms, especially for PwP with functional constipation, and two RCTs assessed probiotics' effect on systematic metabolism and inflammation. In the meta-analysis, probiotic treatment significantly increased the frequency of bowel movements among PwP (mean difference [MD]: 1.06 /week, 95% confidence interval [CI]: 0.61 to 1.51, p < 0.001, I-2 = 40%). Additionally, probiotic treatment significantly normalized stool consistency (standard MD: 0.61, 95% CI = 0.31 to 0.91, p < 0.001, I-2 = 0%). Conclusions: Although the probiotic compositions varied, probiotic treatment significantly attenuated constipation for PwP and exhibited possible systematic effects on inflammation and metabolism. Given the tolerability of probiotics, the present meta-analysis may provide more consolidated evidence of the benefit of probiotics on constipation in PwP and a possible new therapeutic approach for disease modification.","[Hong, Chien -Tai; Chen, Jia-Hung] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, New Taipei, Taiwan; [Hong, Chien -Tai] Taipei Med Univ, Coll Med, Sch Med, Dept Neurol, Taipei, Taiwan; [Huang, Tsai-Wei] Taipei Med Univ, Coll Nursing, Sch Nursing, Taipei, Taiwan; [Huang, Tsai-Wei] Taipei Med Univ, Wan Fang Hosp, Dept Nursing, Taipei, Taiwan; [Huang, Tsai-Wei] Taipei Med Univ, Wan Fang Hosp, Ctr Nursing & Healthcare Res Clin Practice Applica, Taipei, Taiwan; [Huang, Tsai-Wei] Taipei Med Univ, Cochrane Taiwan, Taipei, Taiwan",Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University,"Huang, TW (corresponding author), Taipei Med Univ, Coll Nursing, Sch Nursing, Taipei, Taiwan.;Huang, TW (corresponding author), Taipei Med Univ, Wan Fang Hosp, Dept Nursing, Taipei, Taiwan.;Huang, TW (corresponding author), Taipei Med Univ, Wan Fang Hosp, Ctr Nursing & Healthcare Res Clin Practice Applica, Taipei, Taiwan.;Huang, TW (corresponding author), Taipei Med Univ, Cochrane Taiwan, Taipei, Taiwan.",tsaiwei@tmu.edu.tw,"Huang, Tsai-Wei/K-9600-2018","Huang, Tsai-Wei/0000-0002-6722-1153",,,,,64,5,5,1,15,IMPACT JOURNALS LLC,ORCHARD PARK,"6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA",1945-4589,,,AGING-US,Aging-US,SEP 14,2022,14,17,,,,,7014,7025,,,,,,12,Cell Biology; Geriatrics & Gerontology,Science Citation Index Expanded (SCI-EXPANDED),Cell Biology; Geriatrics & Gerontology,5F3NZ,36084951,"Green Published, gold",,,2024-06-04,WOS:000866227100012,View Full Record in Web of Science
J,"Haiden, N; Savino, F; Hill, S; Kivelae, L; De Koning, B; Köglmeier, J; Luque, V; Moltu, SJ; Norsa, L; De Pipaon, MS; Verduci, E; Bronsky, J",,,,"Haiden, Nadja; Savino, Francesco; Hill, Susan; Kivelae, Laura; De Koning, Barbara; Koglmeier, Jutta; Luque, Veronica; Moltu, Sissel J.; Norsa, Lorenzo; De Pipaon, Miguel Saenz; Verduci, Elvira; Bronsky, Jiri",,,Infant formulas for the treatment of functional gastrointestinal disorders: A position paper of the ESPGHAN Nutrition Committee,JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION,,,English,Article; Early Access,,,,,,constipation; FGID; infant colic; regurgitation,REUTERI DSM 17938; DOUBLE-BLIND; PEDIATRIC GASTROENTEROLOGY; GASTROESOPHAGEAL-REFLUX; EUROPEAN-SOCIETY; NECROTIZING ENTEROCOLITIS; HYDROLYZED FORMULA; THICKENED FORMULA; LACTOSE; MILK,"Functional gastrointestinal disorders (FGID), such as infant regurgitation, infant colic, and functional constipation, are common and typically physiological phenomena during the early months of an infant's life and account for frequent consultations with pediatricians. Various infant formulas are marketed for their management and are frequently given by parents to infants before a medical consultation. However, the evidence supporting their effectiveness is limited and some have altered nutritional compositions when compared to standard formulas. Thus, these products should only be used under medical supervision and upon medical advice. Marketing and over-the-counter sales do not ensure proper medical guidance and supervision. The aim of this position paper is to review the current evidence regarding the safety and efficacy of formulas specifically formulated for addressing regurgitation, colic, and constipation, recognized as FGID. The objective is to provide guidance for clinical management based on the highest quality of available evidence. A wide search using Pubmed, MEDLINE, EMBASE and Cochrane Database of Systematic Reviews was performed including the MESH terms infant formula, colic, constipation, regurgitation, reflux, palmitate, lactase, lactose, magnesium, hydrolyzed protein, prebiotics or probiotics. 752 papers were identified and screened. Finally, 72 papers were included in the paper. In the absence of evidence, recommendations reflect the authors' combined expert opinion. Final consensus was obtained by multiple e-mail exchange and meetings of the Nutrition Committee. (1) For breastfed infants experiencing FGID such as regurgitation, colic, or constipation, transitioning from breastfeeding to commercial formulas is not recommended. (2) In general, whether an infant is breastfed or formula-fed, it's crucial to reassure parents that FGIDs are normal and typically do not necessitate treatment or change to a special formula. (3) Thickened formulas, often termed anti-reflux formulas, may be considered in specific cases of regurgitation. (4) The usage of specialized formulas for infants with colic is not advised due to a lack of clinical evidence. (5) In the case of constipation in infants, the use of formulas enriched with high beta-palmitate and increased magnesium content may be considered to soften the stool. Generally, there is limited evidence supporting the use of specialized formulas for FGID. Breastfeeding should never be discontinued in favor of formula feeding. What is Known Functional gastrointestinal disorders, such as infant regurgitation, infant colic, and functional constipation, are common and typically physiological phenomena during the early months of an infant's life. The infant food industry provides a wide range of formulas designed for managing these mild functional gastrointestinal disorders. Despite the widespread use of these formulas, their effectiveness in treating mild functional gastrointestinal disorders remains uncertain.What is New Weaning from breastfeeding is not advised for infants experiencing any or several functional gastrointestinal disorders. In majority of formula-fed infants, no specific formulas are indicated. In breastfed infants with regurgitation, breast milk can be expressed and supplemented with thickening agents and in formula fed infants, industrially thickened infant formulas often referred to as anti-reflux formulas, or formulas with appropriately added thickeners can be considered in special cases under medical guidance. Special anti-colic formulas do not usually benefit infants with colic. In cases of infant constipation, considering formulas with high beta-palmitate and an elevated magnesium content may be an option to soften stool consistency. It is generally not recommended to use formulas for combined functional gastrointestinal disorders.","[Haiden, Nadja] Kepler Univ Hosp, Dept Neonatol, Krankenhausstr 26-30, A-4020 Linz, Austria; [Savino, Francesco] Azienda Osped Univ Citta Salute & Sci Torino, Regina Margher Regina Margher Children Hosp, Dept Patol & cura bambino, Turin, Italy; [Hill, Susan] Great Ormond St Hosp Children NHS Fdn Trust, Gastroenterol Dept, Nutr & Intestinal Failure Div, London, England; [Kivelae, Laura] Tampere Univ, Celiac Dis Res Ctr, Tampere, Finland; [Kivelae, Laura] Tampere Univ Hosp, Dept Pediat, Tampere, Finland; [Kivelae, Laura] Helsinki Univ Hosp, Childrens Hosp, Helsinki, Finland; [Kivelae, Laura] Univ Oslo, Res Inst, Oslo, Norway; [De Koning, Barbara] Erasmus MC Sophia Childrens Hosp, Dept Pediat Gastroenterol, Rotterdam, Netherlands; [Koglmeier, Jutta] Great Ormond St Hosp Children NHS Fdn Trust, Dept Paediat Gastroenterol, Unit Nutr & Intestinal Failure Rehabil, London, England; [Luque, Veronica] Univ Rovira & Virgili IISPV, Paediat Nutr & Dev Res Unit, Tarragona, Spain; [Moltu, Sissel J.] Oslo Univ Hosp, Dept Neonatal Intens Care, Norway Pediat, Oslo, Norway; [Norsa, Lorenzo] ASST Papa Giovanni XXIII, Pediat Hepatol Gastroenterol & Transplantat Unit, Bergamo, Italy; [De Pipaon, Miguel Saenz] Univ Autonoma Madrid, Neonatol Hosp La Paz Inst Hlth Res IdiPAZ, Madrid, Spain; [Verduci, Elvira] Univ Milan, Vittore Buzzi Hosp, Dept Pediat, Metab Dis Unit, Milan, Italy; [Bronsky, Jiri] Univ Hosp Motol, Dept Paediat, Prague, Czech Republic",Kepler University Hospital; A.O.U. Citta della Salute e della Scienza di Torino; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Tampere University; Tampere University; Tampere University Hospital; University of Helsinki; Helsinki University Central Hospital; University of Oslo; Erasmus University Rotterdam; Erasmus MC; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); University of Oslo; ASST Papa Giovanni XXIII; Autonomous University of Madrid; University of Milan; Motol University Hospital,"Haiden, N (corresponding author), Kepler Univ Hosp, Dept Neonatol, Krankenhausstr 26-30, A-4020 Linz, Austria.",nadja.haiden@kepleruniklinikum.at,,,None,None,No funding was obtained for this study.,,76,0,0,1,1,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0277-2116,1536-4801,,J PEDIATR GASTR NUTR,J. Pediatr. Gastroenterol. Nutr.,2024 MAY 20,2024,,,,,,,,,,10.1002/jpn3.12240,http://dx.doi.org/10.1002/jpn3.12240,,MAY 2024,13,Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,RI1F9,38766683,,,,2024-06-04,WOS:001226937200001,View Full Record in Web of Science
J,"Sumida, K; Lau, WL; Kovesdy, CP; Kalantar-Zadeh, K; Kalantar-Zadeh, K",,,,"Sumida, Keiichi; Lau, Wei Ling; Kovesdy, Csaba P.; Kalantar-Zadeh, Kamyar; Kalantar-Zadeh, Kourosh",,,Microbiome modulation as a novel therapeutic approach in chronic kidney disease,CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION,,,English,Review,,,,,,chronic kidney disease; constipation; microbiome; nanotechnology; plant-based diet,,"Purpose of review Gut dysbiosis has been implicated in the pathogenesis of chronic kidney disease (CKD). Interventions aimed at restoring gut microbiota have emerged as a potential therapeutic option in CKD. This review summarizes the current evidence on gut microbiota-targeted strategies in patients with CKD. Recent findings A growing number of studies have shown that plant-based diets, low-protein diets, prebiotic, probiotic, and synbiotic supplementation, and constipation treatment may lead to favorable alterations in the gut microbiota. Current evidence suggests that the implementation of both plant-based and low-protein diets has potential benefits for the primary prevention of CKD, and for slowing CKD progression, with minimal risk of hyperkalemia and/or cachexia. The use of prebiotics, probiotics, and synbiotics and laxatives may have beneficial effects on uremic toxin generation, but their evidence is limited for the prevention and treatment of CKD. Recent advances in diagnostic technologies (e.g., high-throughput sequencing and nanotechnology) could enhance rapid diagnosis, monitoring, and design of effective therapeutic strategies for mitigating gut dysbiosis in CKD. Plant-based and low-protein diets, prebiotic, probiotic, and synbiotic supplementation, and constipation treatment represent novel gut microbiota-targeted strategies in the conservative management of CKD, which could improve clinical outcomes in CKD.","[Sumida, Keiichi; Kovesdy, Csaba P.] Univ Tennessee, Ctr Hlth Sci, Dept Med, Div Nephrol, Memphis, TN 38163 USA; [Lau, Wei Ling; Kalantar-Zadeh, Kamyar] Univ Calif Irvine, Dept Med, Div Nephrol & Hypertens, Orange, CA 92668 USA; [Kovesdy, Csaba P.] Memphis VA Med Ctr, Nephrol Sect, Memphis, TN USA; [Kalantar-Zadeh, Kourosh] Univ New South Wales, Sch Chem Engn, Kensington, NSW 2052, Australia",University of Tennessee System; University of Tennessee Health Science Center; University of California System; University of California Irvine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University of New South Wales Sydney,"Kalantar-Zadeh, K (corresponding author), Univ New South Wales, Sch Chem Engn, Kensington, NSW 2052, Australia.",k.kalantar-zadeh@unsw.edu.au,"Kalantar-Zadeh, Kamyar/Q-4734-2018; Kalantar-zadeh, Kourosh/O-3868-2018","Kalantar-Zadeh, Kamyar/0000-0002-8666-0725; Kalantar-zadeh, Kourosh/0000-0001-6109-132X","US Department of Veterans affairs; National Health and Medical Research Council (NHMRC), Australia [APP1154969]; NIH NINDS [R01-NS113337]; NIH [K24-DK091419, R01-DK125586]","US Department of Veterans affairs(US Department of Veterans Affairs); National Health and Medical Research Council (NHMRC), Australia(National Health & Medical Research Council (NHMRC) of Australia); NIH NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)","C.P.K. is an employee of the US Department of Veterans affairs. The interpretation and reporting of these data are the responsibility of the authors and in no way should be seen as official policy or interpretation of the Department of Veterans Affairs or the US government. The results of this article have not been published previously in whole or part. Kourosh K.-Z. would like to thank the National Health and Medical Research Council (NHMRC), Australia for financial support (APP1154969). W.L.L. acknowledges funding from NIH NINDS R01-NS113337, Kamyar K.-Z. acknowledges funding from NIH K24-DK091419 and K.S. acknowledges funding from NIH R01-DK125586.",,130,24,24,1,27,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",1062-4821,1473-6543,,CURR OPIN NEPHROL HY,Curr. Opin. Nephrol. Hypertens.,JAN,2021,30,1,,,,,75,84,,10.1097/MNH.0000000000000661,http://dx.doi.org/10.1097/MNH.0000000000000661,,,10,Urology & Nephrology; Peripheral Vascular Disease,Science Citation Index Expanded (SCI-EXPANDED),Urology & Nephrology; Cardiovascular System & Cardiology,PE2WS,33148949,Green Published,,,2024-06-04,WOS:000598229800009,View Full Record in Web of Science
J,"Freitas, KD; Amancio, OMS; de Morais, MB",,,,"Freitas, Karine de Cassia; Silverio Amancio, Olga Maria; de Morais, Mauro Batista",,,High-performance inulin and oligofructose prebiotics increase the intestinal absorption of iron in rats with iron deficiency anaemia during the growth phase,BRITISH JOURNAL OF NUTRITION,,,English,Article,,,,,,Dietary fibre; Inulin; Intestinal absorption; Iron deficiency anaemia; Rats,PREVENT POSTGASTRECTOMY ANEMIA; CHAIN FATTY-ACIDS; DIETARY FIBER; NONHEME-IRON; NONDIGESTIBLE OLIGOSACCHARIDES; FRUCTO-OLIGOSACCHARIDES; CHRONIC CONSTIPATION; APPARENT ABSORPTION; CELL-PROLIFERATION; GROWING RATS,"Considering the high frequency of anaemia due to Fe deficiency, it is important to evaluate the effects of prebiotics on the absorption of Fe. The aim of the present study was to evaluate the effects of high-performance (HP) inulin, oligofructose and synergy1 during recovery from anaemia in rats through the intestinal absorption of Fe, food intake, body growth, caecal pH and weight of the intestine. Wistar rats (n 47) were fed with rations of AIN93-G with no Fe to induce Fe deficiency anaemia. At 36 d of life, anaemic rats were divided into four groups: (1) the HP inulin group; (2) the synergy1 group; and (3) the oligofructose group, all with 100 g of the respective prebiotic per kg of ration; and (4) a control group, in which the prebiotic was replaced by maize starch. Then, 25 mg of elemental Fe/kg of ration was added to all rations to allow recovery from anaemia. The final values of Hb in the HP inulin, synergy1, oligofructose and control groups were, respectively: 98 (94-99); 83 (81-92); 100 (90-114); 77 (72-81) g/l, with a statistically significant difference (P <= 0.001) between the oligofructose and control groups and the HP inulin and control groups. The four groups had an increase in weight and body length and had similar consumption of rations. The intestinal weight and caecal pH were significantly different between the groups that consumed prebiotics and the control group. HP inulin and oligofructose increased the intestinal absorption of Fe in rats.","[Silverio Amancio, Olga Maria; de Morais, Mauro Batista] Univ Fed Sao Paulo, Dept Pediat, Res Lab, Nutrol Discipline, BR-04039031 Sao Paulo, Brazil; [Freitas, Karine de Cassia] Fed Univ Grande Dourados, Dourados, MS, Brazil",Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal da Grande Dourados,"de Morais, MB (corresponding author), Univ Fed Sao Paulo, Dept Pediat, Res Lab, Nutrol Discipline, Rua Pedro de Toledo 441, BR-04039031 Sao Paulo, Brazil.",mbmorais@osite.com.br,"MORAIS, MAURO B/I-7995-2014","Batista de Morais, Mauro/0000-0003-4014-5549","'Coordination of Improvement of Higher Education' - CAPES; 'Sao Paulo Research Foundation' - FAPESP, Brazil","'Coordination of Improvement of Higher Education' - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); 'Sao Paulo Research Foundation' - FAPESP, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))","The present research was supported by 'Coordination of Improvement of Higher Education' - CAPES and the 'Sao Paulo Research Foundation' - FAPESP, Brazil. The authors' contributions were as follows: K. d. C. F., M. B. d. M. and O. M. S. A. were instrumental in the conception and design of the study. K. d. C. F. and M. B. d. M. were responsible for the generation of the study. K. d. C. F. and M. B. d. M. performed the assembly, analysis and interpretation of the data (statistical analysis). K. d. C. F., M. B. d. M. and O. M. S. A. contributed to the revision of the manuscript. None of the authors had any personal or financial interest in any organisation sponsoring this research or any conflict of interest related to their participation in this study.",,53,30,34,0,27,CAMBRIDGE UNIV PRESS,CAMBRIDGE,"EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND",0007-1145,1475-2662,,BRIT J NUTR,Br. J. Nutr.,SEP 28,2012,108,6,,,,,1008,1016,,10.1017/S0007114511006301,http://dx.doi.org/10.1017/S0007114511006301,,,9,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,003BO,22172251,Bronze,,,2024-06-04,WOS:000308583400008,View Full Record in Web of Science
J,"Bush, JR; Baisley, J; Harding, SV; Alfa, MJ",,,,"Bush, Jason R.; Baisley, Joshua; Harding, Scott V.; Alfa, Michelle J.",,,"Consumption of Solnul™ Resistant Potato Starch Produces a Prebiotic Effect in a Randomized, Placebo-Controlled Clinical Trial",NUTRIENTS,,,English,Article,,,,,,prebiotic; constipation; diarrhea; potato; resistant starch; Bifidobacterium; Akkermansia; microbiome,GUT MICROBIOTA COMPOSITION; INSULIN SENSITIVITY; DIETARY FIBER; IN-VITRO; SUPPLEMENTATION; FERMENTATION; HEMODIALYSIS; MODULATION; OVERWEIGHT; WEIGHT,"The effects of resistant starch at high doses have been well-characterized, but the potential prebiotic effects of resistant starch at doses comparable to oligosaccharide prebiotics have not been evaluated. A three-arm randomized, double-blind, placebo-controlled clinical trial was conducted to evaluate the effect of 3.5 g and 7 g daily doses of Solnul((TM)) resistant potato starch (RPS) on beneficial populations of gut bacteria and stool consistency after a 4-week period. The relative abundance of Bifidobacterium and Akkermansia was determined by employing 16Sv4 sequencing of stool samples. To assess the effect of RPS on laxation and bowel movements, stools were recorded and scored using the Bristol Stool Form Scale. Participants consuming 3.5 g/day of RPS experienced significantly greater changes in Bifidobacterium and Akkermansia compared to the placebo after 4 weeks. The number of diarrhea- and constipation-associated bowel movements were both significantly lower in the 3.5 g RPS arm compared to the placebo group. Participants consuming 7 g of RPS responded similarly to those in the 3.5 g arm. Our analyses demonstrate that Solnul((TM)) RPS has a prebiotic effect when consumed for 4 weeks at the 3.5 g per day dose, stimulating increases in beneficial health-associated bacteria and reducing diarrhea- and constipation-associated bowel movements when compared to the placebo group.","[Bush, Jason R.] MSP Starch Prod Inc, Carberry, MB R0K 0H0, Canada; [Baisley, Joshua] Nutrasource Pharmaceut & Nutraceut Serv, Guelph, ON N1G 0B4, Canada; [Harding, Scott V.] Mem Univ Newfoundland, Fac Sci, Dept Biochem, St John, NF A1C 5S7, Canada; [Alfa, Michelle J.] AlfaMed Consulting, Winnipeg, MB R2M 5M3, Canada",Memorial University Newfoundland,"Bush, JR (corresponding author), MSP Starch Prod Inc, Carberry, MB R0K 0H0, Canada.",jbush@solnul.com,,,MSP Starch Products Inc.,MSP Starch Products Inc.,This research and the APC were funded by MSP Starch Products Inc.,,59,1,1,6,12,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,APR,2023,15,7,,,,,,,1582,10.3390/nu15071582,http://dx.doi.org/10.3390/nu15071582,,,16,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,D6XP9,37049425,"gold, Green Published",,,2024-06-04,WOS:000970141900001,View Full Record in Web of Science
J,"Tokunaga, T",,,,"Tokunaga, T",,,Novel physiological function of fructooligosaccharides,BIOFACTORS,,,English,Article; Proceedings Paper,3rd International Conference on Food Factors (ICoFF-3),"DEC 01-04, 2003","Tokyo, JAPAN",,,fructooligosaccharides; prebiotics; Bifidobacteria; short chain fatty acids; isoflavone,DIETARY FRUCTOOLIGOSACCHARIDES; RATS; EXCRETION,"Two key properties of short chain fructooligosacchari des (sc-FOS) which lead to physiological functions are indigestibility in the small intestine and fermentability in the colon. Sc-FOS is converted into short chain fatty acids (SCFAs) by intestinal bacteria in the colon and absorbed. Through the metabolic pathway, sc-FOS improves gastrointestinal (GI) condition such as relief from constipation, formation of preferable intestinal microflora and intestinal immunomodulation those are known as prebiotics' function. Besides improvement of GI condition, dietary sc-FOS influences on calcium and magnesium absorption in the colon. A major mineral absorption site is the small intestine, but the colon also works as a Ca and Mg absorption site with an aid of SCFAs made from sc-FOS. Furthermore dietary sc-FOS influences on bioavailability of soy-isoflavones. Plasma and urinal concentration of Genistein and Daidzein, aglycones of Daidzin and Genistin, are higher in the rat fed with sc-FOS than the control rat. An additive effect of dietary isoflavone and sc-FOS was observed on the bone mineral density in OVX mice and moreover sc-FOS increased ceacal beta-glycosidase activity and equol production. These results suggest that FOS increase the bioavailability of isoflavones.","Meiji Seika Kaisha Ltd, Hlth & Biosci Labs, Sakado, Saitama 3500289, Japan","Meiji Holdings Co., Ltd.","Tokunaga, T (corresponding author), Meiji Seika Kaisha Ltd, Hlth & Biosci Labs, 5-3-1 Chiyoda, Sakado, Saitama 3500289, Japan.",takahisa_tokunaga@meiji.co.jp,,,,,,,15,30,40,1,16,IOS PRESS,AMSTERDAM,"NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS",0951-6433,,,BIOFACTORS,Biofactors,,2004,21,1-4,,,SI,,89,94,,10.1002/biof.552210117,http://dx.doi.org/10.1002/biof.552210117,,,6,Biochemistry & Molecular Biology; Endocrinology & Metabolism,Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Endocrinology & Metabolism,901UF,15630176,,,,2024-06-04,WOS:000227306700017,View Full Record in Web of Science
J,"Waitzberg, DL; Logullo, LC; Bittencourt, AE; Torrinhas, RS; Shiroma, GM; Paulino, NP; Teixeira-da-Silva, ML",,,,"Waitzberg, Dan L.; Logullo, Luciana C.; Bittencourt, Amanda E.; Torrinhas, Raquel S.; Shiroma, Glaucia M.; Paulino, Natalia P.; Teixeira-da-Silva, Maria L.",,,"Effect of synbiotic in constipated adult women - A randomized, double-blind, placebo-controlled study of clinical response",CLINICAL NUTRITION,,,English,Article,,,,,,Synbiotic; Fructooligosaccharides; Lactobacillus; Bifidobacteria; Constipation; Probiotic,LACTOBACILLUS-ACIDOPHILUS; GASTROINTESTINAL SYMPTOMS; PROBIOTIC BACTERIA; FECAL MICROBIOTA; CONTROLLED-TRIAL; TRANSIT-TIME; BIFIDOBACTERIUM; SUPPLEMENTATION; PREBIOTICS; SURVIVAL,"Background & aims: Synbiotic intake may selectively change microbiota composition, restore microbial balance in the gut and improve gastrointestinal functions. We have assessed the clinical response of chronically constipated women to a commercially available synbiotic, combining fructooligosaccharides with Lactobacillus and Bifidobacterium strains (LACTOFOS (R)). Methods: Following 1 week of non-interventional clinical observation, 100 constipated adult women, diagnosed by ROME III criteria, were randomized to receive two daily doses (6 g) of synbiotic or maltodextrin (placebo group), for 30 days. Treatment response was evaluated by patient's daily record of evacuation (stool frequency, consistency and shape, according to Bristol scale), abdominal symptoms (abdominal pain, bloating and flatulence) and constipation intensity (Constipation Scoring System AGACHAN). Results: Patients treated with synbiotic had increased frequency of evacuation, as well as stool consistency and shape nearer normal parameters than the placebo group, with significant benefits starting during the second and third weeks, respectively (interaction group/time, P < 0.0001). There were no significant differences in abdominal symptoms, but AGACHAN score was better in the synbiotic than in the placebo group. Conclusions: Dietary supplementation with a synbiotic composed of fructooligosaccharides with Lactobacillus and Bifidobacterium improved evacuation parameters and constipation intensity of chronically constipated women, without influencing abdominal symptoms. NCT01286376 (C) 2012 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","[Waitzberg, Dan L.; Torrinhas, Raquel S.] Univ Sao Paulo Scholl Med, Dept Gastroenterol, Surg Gastroenterol Discipline LIM 35, Sao Paulo, Brazil; [Waitzberg, Dan L.; Logullo, Luciana C.; Bittencourt, Amanda E.; Shiroma, Glaucia M.; Paulino, Natalia P.; Teixeira-da-Silva, Maria L.] GANEP Nutr Humana, Sao Paulo, Brazil",,"Torrinhas, RS (corresponding author), Univ Sao Paulo, Fac Med, Lab Nutr & Cirurgia Metab Aparelho Digest, LIM 35, Av Dr Arnaldo,455 2 Andar,Sala 2108, BR-01246903 Sao Paulo, Brazil.",torrinhas@uol.com.br,"Duarte, Graziela Biude Silva/Q-7728-2016; Torrinhas, Raquel Susana/AAH-4722-2019","Torrinhas, Raquel Susana/0000-0003-0874-3995",SKL Functional Nutrition,SKL Functional Nutrition,"The authors thank the statisticians Prof. Julio Cesar Rodrigues Pereira and Joao Italo Dias Franca for the statistical discussion. Statement of Authorship: DLW conceived the study, and participated in its design and coordination and helped to interpret the data and to draft the manuscript; LCL performed the enrollment, assignment and clinical evaluation of patients and participated in data analysis; AFB performed the database relating to abdominal symptoms and constipation intensity and participated in the analysis and interpretation of these data; RST participated in data analysis and interpretation and helped to write the manuscript; GMS performed the database relating to stool frequency, consistency and shape and participated in the analysis and interpretation of these data; NPP monitored the patients weekly, by phone calls, and participated in overall organization of data; MLT participated in the study design and conception, oriented the data collection and revised the manuscript critically. All authors read and approved the final manuscript. Funding sources: This study was supported by SKL Functional Nutrition that kindly provided the synbiotic LACTOFOS (R).",,32,60,72,0,35,CHURCHILL LIVINGSTONE,EDINBURGH,"JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND",0261-5614,1532-1983,,CLIN NUTR,Clin. Nutr.,FEB,2013,32,1,,,,,27,33,,10.1016/j.clnu.2012.08.010,http://dx.doi.org/10.1016/j.clnu.2012.08.010,,,7,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,094GS,22959620,Bronze,,,2024-06-04,WOS:000315251600004,View Full Record in Web of Science
J,"Waitzberg, DL; Pereira, CCA; Logullo, L; Jacintho, TM; Almeida, D; da Silva, MDT; Torrinhas, RSMD",,,,"Linetzky Waitzberg, D.; Alves Pereira, C. C.; Logullo, L.; Manzoni Jacintho, T.; Almeida, D.; Teixeira da Silva, Ma. de L.; de Miranda Torrinhas, R. S. Matos",,,Microbiota benefits after inulin and partially hydrolized guar gum supplementation - a randomized clinical trial in constipated women,NUTRICION HOSPITALARIA,,,English,Article,,,,,,Guar gum; Inulin; Gut microbiota; Short-chain fatty acids; Constipation,CLOSTRIDIUM-PERFRINGENS; DIETARY FIBER; UNITED-STATES; FATTY-ACIDS; BIFIDOBACTERIA; EPIDEMIOLOGY; TRANSIT,"Introduction: Prebiotics positively affect gut microbiota composition, thus improving gut function. These properties may be useful for the treatment of constipation. Objectives: This study assessed the tolerance and effectiveness of a prebiotic inulin/partially hydrolyzed guar gum mixture (I-PHGG) for the treatment of constipation in females, as well as its influence on the composition of intestinal microbiota and production of short chain fatty acids. Methods: Our study enrolled 60 constipated female health worker volunteers. Participants reported less than 3 bowel movements per week. Volunteers were randomized to treatment with prebiotic or placebo. Treatment consisted of 3 weeks supplementation with 15 g/d I-PHGG (fiber group) or maltodextrin (placebo group). Abdominal discomfort, flatulence, stool consistency, and bowel movements were evaluated by a recorded daily questionnaire and a weekly interview. Changes in fecal bacterial population and short chain fatty acids were assessed by real-time PCR and gas chromatography, respectively. Results: There was an increased frequency of weekly bowel movements and patient satisfaction in both the fiber and placebo groups with no significant differences. Total Clostridium sp significantly decreased in the fiber group (p = 0.046) and increased in the placebo group (p = 0.047). There were no changes in fecal short chain fatty acid profile. Conclusions: Consumption of I-PHGG produced clinical results comparable to placebo in constipated females, but had additional protective effects on gut rnicrobiota by decreasing the amount of pathological bacteria of the Clostridium genera.","[Linetzky Waitzberg, D.] Univ Sao Paulo, Fac Med, Sch Med, Dept Gastroenterol,Surg Gastroenterol Discipline, BR-01246903 Sao Paulo, Brazil; [Alves Pereira, C. C.] Univ Fed Sao Paulo, Dept Biociences, Santos, Brazil; [Linetzky Waitzberg, D.; Logullo, L.; Teixeira da Silva, Ma. de L.] GANEP Nutr Humana, Sao Paulo, Brazil",Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP),"Waitzberg, DL (corresponding author), Univ Sao Paulo, Fac Med, Sch Med, Dept Gastroenterol,Surg Gastroenterol Discipline, Avda Dr Arnaldo 455,2 Andar,Sala 2108, BR-01246903 Sao Paulo, Brazil.",dan.waitzberg@gmail.com,"Torrinhas, Raquel Susana/AAH-4722-2019","Torrinhas, Raquel Susana/0000-0003-0874-3995",Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (Fapesp) [07/58600-2],Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (Fapesp)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)),This study was funded by a grant from the Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (Fapesp project 07/58600-2).,,33,55,60,0,39,"ARAN EDICIONES, S L",MADRID,"C/ CASTELLO, 128, 1O, MADRID, 28006, SPAIN",0212-1611,1699-5198,,NUTR HOSP,Nutr. Hosp.,JAN-FEB,2012,27,1,,,,,123,129,,10.3305/nh.2012.27.1.5445,http://dx.doi.org/10.3305/nh.2012.27.1.5445,,,7,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,888WW,22566311,,,,2024-06-04,WOS:000300036300014,View Full Record in Web of Science
J,"Nakabayashi, I; Nakamura, M; Kawakami, K; Ohta, T; Kato, I; Uchida, K; Yoshida, M",,,,"Nakabayashi, Iwao; Nakamura, Motonobu; Kawakami, Koji; Ohta, Toshihisa; Kato, Ikuo; Uchida, Kazumi; Yoshida, Masaharu",,,Effects of synbiotic treatment on serum level of p-cresol in haemodialysis patients: a preliminary study,NEPHROLOGY DIALYSIS TRANSPLANTATION,,,English,Article,,,,,,constipation; haemodialysis; p-cresol; p-cresyl sulphate; synbiotic,LIQUID-CHROMATOGRAPHY; INDOXYL SULFATE; UREMIC TOXINS; METABOLISM; ACCUMULATION; PROBIOTICS; SYMPTOMS; TIME,"Background. para-Cresol, which is present in the blood mainly as p-cresyl sulphate, is a protein-bound uraemic toxin that is produced in the intestine by certain intestinal bacteria, and its production is affected by various intestinal environmental factors. Patients with end-stage renal disease who are undergoing haemodialysis (HD) often have defective bowel function leading to abnormal defecation. Since treatment with synbiotics (SYN), which are a combination of probiotics and prebiotics, is reported to improve bowel habit, we examined the effects of SYN on the serum p-cresol level in HD patients. Methods. Nine HD patients received SYN (Lactobacillus casei strain Shirota and Bifidobacterium breve strain Yakult as probiotics and galacto-oligosaccharides as prebiotics) three times a day for 2 weeks. The duration of the study was 4 weeks (2 weeks of pretreatment observation and 2 weeks of treatment). The subjects were asked to complete a questionnaire about their bowel habits (defecation frequency, stool quantity, stool form and ease of defecation) during the study period. Serum p-cresol levels before and after SYN treatment were determined. Results. According to the questionnaire conducted during the pretreatment observation period, HD patients with a high serum p-cresol level tended to have hard stools with difficulty in defecation. With SYN treatment, stool quantity increased significantly and hard, muddy or soft stools tended to be replaced by normal ones. The serum p-cresol level also decreased significantly. Conclusions. It was found that uraemic toxin, p-cresol, was associated with constipation and that SYN treatment resulted in normalization of bowel habits and a decrease of serum p-cresol levels in HD patients. Therefore, SYN treatment may be anticipated to reduce the toxic effect of p-cresol in HD patients.","[Kawakami, Koji; Ohta, Toshihisa; Kato, Ikuo; Uchida, Kazumi] Yakult Cent Inst Microbiol Res, Kunitachi, Tokyo 1868650, Japan; [Nakabayashi, Iwao; Nakamura, Motonobu; Yoshida, Masaharu] Tokyo Med Univ, Hachioji Med Ctr, Dept Renal, Unit Internal Med, Hachioji, Tokyo 1930998, Japan; [Nakabayashi, Iwao; Nakamura, Motonobu] Tojinkai Med Corp, Toyoda Clin, Hino, Tokyo 1910062, Japan","Yakult Honsha Company, Limited; Tokyo Medical University","Kawakami, K (corresponding author), Yakult Cent Inst Microbiol Res, 1796 Yaho, Kunitachi, Tokyo 1868650, Japan.",koji-kawakami@yakult.co.jp,,,,,,,24,153,164,0,19,OXFORD UNIV PRESS,OXFORD,"GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND",0931-0509,1460-2385,,NEPHROL DIAL TRANSPL,Nephrol. Dial. Transplant.,MAR,2011,26,3,,,,,1094,1098,,10.1093/ndt/gfq624,http://dx.doi.org/10.1093/ndt/gfq624,,,5,Transplantation; Urology & Nephrology,Science Citation Index Expanded (SCI-EXPANDED),Transplantation; Urology & Nephrology,726SN,20929916,Bronze,,,2024-06-04,WOS:000287746500049,View Full Record in Web of Science
J,"Marteau, P; Jacobs, H; Cazaubiel, M; Signoret, C; Prevel, JM; Housez, B",,,,"Marteau, Philippe; Jacobs, Heidi; Cazaubiel, Murielle; Signoret, Cathy; Prevel, Jean-Michel; Housez, Beatrice",,,Effects of chicory inulin in constipated elderly people: a double-blind controlled trial,INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION,,,English,Article,,,,,,Inulin; prebiotic; bifidobacteria; constipation; elderly,BIFIDOBACTERIUM-LACTIS; FECAL BIFIDOBACTERIA; INFANT FORMULA; HEALTHY HUMANS; DIETARY FIBER; PREBIOTICS; OLIGOFRUCTOSE; MICROBIOTA; OLIGOSACCHARIDES; PROBIOTICS,"The impact of the daily consumption of 15 g chicory native inulin on fecal levels of bifidobacteria, stool parameters and quality of life of elderly constipated volunteers was investigated in a randomized, double-blind, controlled versus placebo clinical trial. The impact of supplementation on constipation was assessed with questionnaires on bowel motor function parameters, visual analogue scales on bowel symptoms and quality of life. Fecal bacteria counts were determined at the beginning and at the end of the supplementation. Inulin supplementation led to a significant increase in total fecal bacteria (P < 0.01) and bifidobacteria (P < 0.001) concentrations after 28 days of consumption. Volunteers (n = 25) in the inulin group reported increased satisfaction about digestion (P < 0.01) and reduced defecation difficulties (P < 0.001) during the supplementation. Slight gastrointestinal symptoms (flatulence) were reported but did not lead to discontinuation. Daily supplementation with 15 g inulin improves constipation and quality of life in an elderly population with constipation.","[Jacobs, Heidi; Signoret, Cathy] Cosucra Grp Warcoing, B-7740 Warcoing, Belgium; [Marteau, Philippe] Lariboisiere Hosp, AP HP, Medicosurg Dept Digest Dis, Paris, France; [Marteau, Philippe] Univ Paris 07, Paris, France; [Cazaubiel, Murielle; Prevel, Jean-Michel; Housez, Beatrice] Biofortis, Nantes, France",Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Universite Paris Cite,"Signoret, C (corresponding author), Cosucra Grp Warcoing, Rue Sucrerie 1, B-7740 Warcoing, Belgium.",csignoret@cosucra.com,,"philippe, marteau/0000-0002-7621-6719",,,,,45,59,68,8,33,TAYLOR & FRANCIS LTD,ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND",0963-7486,1465-3478,,INT J FOOD SCI NUTR,Int. J. Food Sci. Nutr.,MAR,2011,62,2,,,,,164,170,,10.3109/09637486.2010.527323,http://dx.doi.org/10.3109/09637486.2010.527323,,,7,Food Science & Technology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Nutrition & Dietetics,733BJ,21091293,,,,2024-06-04,WOS:000288235100011,View Full Record in Web of Science
J,"Leylabadlo, HE; Heravi, FS; Soltani, E; Abbasi, A; Kafil, HS; Parsaei, M; Sanaie, S; Ahmadian, Z; Ghotaslou, R",,,,"Leylabadlo, Hamed Ebrahimzadeh; Heravi, Fatemah Sadeghpour; Soltani, Elghar; Abbasi, Amin; Kafil, Hossein Samadi; Parsaei, Mahdi; Sanaie, Sarvin; Ahmadian, Zainab; Ghotaslou, Reza",,,The role of gut microbiota in the treatment of irritable bowel syndrome,REVIEWS AND RESEARCH IN MEDICAL MICROBIOLOGY,,,English,Article,,,,,,irritable bowel syndrome; microbiome; microbiota; prebiotics; probiotics,LACTOBACILLUS-PLANTARUM 299V; RANDOMIZED CLINICAL-TRIAL; CHAIN FATTY-ACIDS; QUALITY-OF-LIFE; DOUBLE-BLIND; FECAL MICROBIOTA; INTESTINAL MICROBIOTA; SACCHAROMYCES-CEREVISIAE; ENTEROENDOCRINE CELLS; BACTERIAL OVERGROWTH,"Irritable bowel syndrome (IBS) is known as a functional gastrointestinal disorder that has different effects on the large intestine and caused malfunction of bowel and colon tissues, which leads to chronic diarrhea, constipation, abdominal pain, cramps, and bloating. Genetic pre determinants and environmental factors including; stress, age, diet, geographical features, use of antibiotics, and more importantly gut microbiota (GM) are implicated in the development of IBS. In the present review, by using free search engines providing biomedical and clinical literature (Science Direct, PubMed, and Google Scholar) we have evaluated the association of GM and IBS and the role of human interventions such as probiotics, synbiotic, prebiotics, and the fecal microbiota transplantation (FMT) as potential therapeutic methods within the treatment of IBS. Current advances in molecular approaches have broadened our understanding of GM and the significant impact of microbial communities on human wellbeing. The imbalanced distribution of microbial communities resides in the human intestine (intestinal dysbiosis) has been associated with IBS development. Due to current challenges in the treatment of IBS, various manipulation of the GM as a new approach for IBS remedy has attracted much attention in recent years. Hence, scientific literature confirms that the manipulation of GM with prebiotic, probiotic, and synbiotic interventions as well as FMT can significantly improve the GM composition/balances and prevent negative effects of dysbiosis GM in patients with symptoms of IBS. Copyright (C) 2021 Wolters Kluwer Health, Inc. All rights reserved.","[Leylabadlo, Hamed Ebrahimzadeh; Ghotaslou, Reza] Tabriz Univ Med Sci, Liver & Gastrointestinal Dis Res Ctr, Tabriz, Iran; [Leylabadlo, Hamed Ebrahimzadeh] Tabriz Univ Med Sci, Student Res Comm, Tabriz, Iran; [Heravi, Fatemah Sadeghpour] Pasteur Inst Iran, Dept Microbiol, Tehran, Iran; [Soltani, Elghar; Ghotaslou, Reza] Tabriz Univ Med Sci, Dept Bacteriol & Virol, Fac Med, Tabriz, Iran; [Abbasi, Amin] Tabriz Univ Med Sci, Dept Food Sci & Technol, Nutr Res Ctr, Tabriz, Iran; [Kafil, Hossein Samadi] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran; [Parsaei, Mahdi] Tabriz Univ Med Sci, Dept Parasitol & Mycol, Fac Med, Tabriz, Iran; [Sanaie, Sarvin] Tabriz Univ Med Sci, Neurosci Res Ctr, Aging Res Inst, Tabriz, Iran; [Ahmadian, Zainab] Zanjan Univ Med Sci, Sch Pharm, Dept Pharmaceut, Zanjan, Iran",Tabriz University of Medical Science; Tabriz University of Medical Science; Pasteur Network; Pasteur Institute of Iran; Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science,"Ghotaslou, R (corresponding author), Tabriz Univ Med Sci, Liver & Gastrointestinal Dis Res Ctr, Tabriz, Iran.",rzgottaslo@yahoo.com,"ahmadian, zainab/ABI-5141-2020; Ebrahimzadeh Leylabadlo, Hamed/AER-9974-2022; Samadi Kafil, Hossein/AAX-2888-2021; Abbasi, Amin/ACB-8198-2022","Samadi Kafil, Hossein/0000-0001-6026-8795; Abbasi, Amin/0000-0001-5957-0540",,,,,159,9,9,1,23,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",2770-3150,2770-3169,,REV RES MED MICROBIO,Rev. Res. Med. Microbiol.,JAN,2022,33,1,,,,,E89,E104,,10.1097/MRM.0000000000000284,http://dx.doi.org/10.1097/MRM.0000000000000284,,,16,Microbiology,Emerging Sources Citation Index (ESCI),Microbiology,XS3ST,,,,,2024-06-04,WOS:000732833800023,View Full Record in Web of Science
J,"Arrari, F; Jabri, MA; Hammami, I; Sebai, H",,,,"Arrari, Fatma; Jabri, Mohamed-Amine; Hammami, Imen; Sebai, Hichem",,,Extraction of Pectin from Orange Peel and Study of Its Protective Effect Against Loperamide-Induced Impaired Gastrointestinal Motor Functions and Oxidative Stress in Rats,JOURNAL OF MEDICINAL FOOD,,,English,Article,,,,,,constipation; gastrointestinal motility; LOP; oxidative stress; pectin,INDUCED CONSTIPATION; IN-VITRO; AQUEOUS EXTRACT; NERVOUS-SYSTEM; DIETARY FIBER; ANTIDIARRHEAL; PREBIOTICS; SECRETION; CELLULOSE; RISK,"Pectin is a polysaccharide attached to carbohydrates. These are substances exclusively of plant origin. The aim of the present study is to evaluate the laxative effects of orange peel pectin extract (OPPE) against constipation induced by loperamide (LOP) in rats. Rats were equally divided into six groups and treated daily 1 week as follows: Control, LOP (3 mg/kg, body weight [b.w.], Per Os [p.o.]), LOP+yohimbine (2 mg/kg, b.w., i.p.), and LOP+OPPE (6.25, 12.5, and 25 mg/kg, b.w., p.o.). At the end of the experiment, the effects of OPPE were assessed by fecal parameters (numbers, weight, and water content), gastrointestinal transit, gastric emptying, serum metabolic parameter changes, intestinal and colon mucosa oxidative stress, and the histological examination. The defecation test showed that administration of LOP (3 mg/kg, b.w., p.o.) leads to the production of remarkable constipation. Indeed, the number and water content of stools decreased (25.50 [n/24 h] and 29.86%) significantly (P < .05).Acute pretreatment with OPPE significantly and dose dependently accelerated the stool moistening and allowed an increase of stool weight (2.85, 3.61, 3.93 [g/24 h/rat]) as well as the frequency of defecation (47.36, 54.54, and 56.26 [n/24 h]). OPPE also significantly (P < .05) and dose dependently increased the intestinal motility (70.78%, 73.33%, and 75.01%) and gastric emptying. LOP-induced reduction (P < .05) of intestinal secretion was accompanied by a colonic and small bowel oxidative stress status and histological changes, which was attenuated by OPPE treatment. The findings of this study indicate that OPPE possesses an important role in the gastrointestinal motility regulation, and thus lend pharmacological credence to the suggested use of the natural pectin for the treatment, management, and/or control of constipation.","[Arrari, Fatma; Jabri, Mohamed-Amine; Sebai, Hichem] Univ Jendouba, Higher Inst Biotechnol Beja, Unit Funct Physiol & Valorizat Bioresources, BP 382, Beja 9000, Tunisia; [Hammami, Imen] Tunis El Manar Univ, Fac Med, Res Unit 17 ES 13, Tunis, Tunisia",Universite de Jendouba; Universite de Tunis-El-Manar; Faculte de Medecine de Tunis (FMT),"Jabri, MA (corresponding author), Univ Jendouba, Higher Inst Biotechnol Beja, Unit Funct Physiol & Valorizat Bioresources, BP 382, Beja 9000, Tunisia.",jabri.amino@gmail.com,"Arrari, Fatma/KIJ-4885-2024","Arrari, Fatma/0000-0002-6207-4641",,,,,66,1,1,6,25,"MARY ANN LIEBERT, INC",NEW ROCHELLE,"140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA",1096-620X,1557-7600,,J MED FOOD,J. Med. Food,SEP 1,2022,25,9,,,,,892,901,,10.1089/jmf.2021.0091,http://dx.doi.org/10.1089/jmf.2021.0091,,FEB 2022,10,"Chemistry, Medicinal; Food Science & Technology; Nutrition & Dietetics",Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy; Food Science & Technology; Nutrition & Dietetics,4O9YB,35143346,,,,2024-06-04,WOS:000753739000001,View Full Record in Web of Science
J,"Stachowska, E; Maciejewska, D; Palma, J; Jamiol-Milc, D; Szczuko, M; Marlicz, W; Wunsch, E; Skonieczna-Zydecka, K",,,,"Stachowska, Ewa; Maciejewska, Dominika; Palma, Joanna; Jamiol-Milc, Dominika; Szczuko, Malgorzata; Marlicz, Wojciech; Wunsch, Ewa; Skonieczna-Zydecka, Karolina",,,Improvement of bowel movements among people with a sedentary lifestyle after prebiotic snack supply - preliminary study,GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY,,,English,Article,,,,,,prebiotics; dietary fibre; microbiota; constipation; clinical trial,GUT MICROBIAL COMPOSITION; CHAIN FATTY-ACIDS; CONSTIPATION; HEALTH; FIBER,"Introduction: Dietary fiber is one of the most important components of food. Fulfilling regulatory and nutritional functions for the intestinal microbiota, it appears to be an essential ingredient for people with a sedentary lifestyle. Aim: We hypothesized that regular intake of a snack containing high amounts of soluble fibre in parallel to a regular diet may rapidly improve bowel habits with simultaneous elevation of synthesis of short-chain fatty acids (SCFA). Material and methods: A total of 20 healthy volunteers, with a stool frequency of less than 3 spontaneous bowel movements per week, completed a 14-day double-blind, parallel-arm, randomized clinical trial with the intervention comprising daily intake of 2 doses (9.99% per 100 g or 13.91% per 100 g) of fibre. Food consumption was evaluated via 72-hour recall diaries at baseline and after 14 days of intervention. Gastrointestinal symptoms (abdominal comfort, distension, bloating, flatulence, stomach rumbling, number of bowel movements) were monitored via the IBS/VAS scale every day. Results: We found that the elevated fibre intake improved bowel habits significantly (defecation frequency increased from 0.28 to 0.87 times/day; p = 0.0002) in both study arms. After 14 days of the trial, an increase in SCFA concentration (for whole study group: acetic p < 0.036, propionic p < 0.019, and butyric acid p < 0.0012 compared to baseline parameters) with no adverse gastrointestinal symptoms was reported. Conclusions: Short-term, regular intake of a snack containing soluble fibre improves the SCFA synthesis and bowel habits in healthy people living a sedentary lifestyle. The exact mechanism behind this observation requires further investigation.","[Stachowska, Ewa; Maciejewska, Dominika; Palma, Joanna; Jamiol-Milc, Dominika; Szczuko, Malgorzata; Skonieczna-Zydecka, Karolina] Pomeranian Med Univ, Dept Human Nutr & Metabol, Szczecin, Poland; [Marlicz, Wojciech] Pomeranian Med Univ, Dept Gastroenterol, Szczecin, Poland; [Wunsch, Ewa] Pomeranian Med Univ, Translat Med Grp, Szczecin, Poland",Pomeranian Medical University; Pomeranian Medical University; Pomeranian Medical University,"Stachowska, E (corresponding author), Pomeranian Med Univ, Dept Human Nutr & Metabol, Szczecin, Poland.",ewast@pum.edu.pl,"stachowska, Ewa/G-9521-2017; Marlicz, Wojciech/G-5007-2013; Skonieczna-Żydecka, Karolina/K-7252-2014; Szczuko, Malgorzata MS/A-9501-2015; Palma, Joanna/AAE-7293-2020; Wunsch, Ewa/A-8487-2015; Jamioł-Milc, Dominika/ABA-4267-2020","Marlicz, Wojciech/0000-0002-2649-5967; Skonieczna-Żydecka, Karolina/0000-0002-3430-9079; Szczuko, Malgorzata MS/0000-0001-9808-0624; Palma, Joanna/0000-0003-0620-3776; Jamioł-Milc, Dominika/0000-0003-0203-1823",Ministry of Science and Higher Education; EU funds (ERDF),"Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); EU funds (ERDF)(European Union (EU))",Inkubator Innowacyjnoci + project of the Maremed consortium (Pomeranian Medical Universi-ty Technology Transfer Centre and Innovation Centre of the Maritime University Ltd.) with financial support from the Ministry of Science and Higher Education and EU funds (ERDF) .,,29,3,3,0,3,TERMEDIA PUBLISHING HOUSE LTD,POZNAN,"KLEEBERGA ST 2, POZNAN, 61-615, POLAND",1895-5770,1897-4317,,GASTROENTEROL REV,Gastroenterol. Rev.,,2022,17,1,,,,,73,80,,10.5114/pg.2021.108985,http://dx.doi.org/10.5114/pg.2021.108985,,,8,Gastroenterology & Hepatology,Emerging Sources Citation Index (ESCI),Gastroenterology & Hepatology,ZZ6HE,35371359,"gold, Green Published",,,2024-06-04,WOS:000773366600012,View Full Record in Web of Science
J,"Yu, JP; Ye, M; Li, KD; Wang, F; Shi, XX; Pan, C; Yang, XB; Gao, XD; Liu, W",,,,"Yu, Juping; Ye, Meng; Li, Kaidong; Wang, Feng; Shi, Xuexia; Pan, Chun; Yang, Xiaobing; Gao, Xiangdong; Liu, Wei",,,Fragments of a pectin from Arctium lappa L: Molecular properties and intestinal regulation activity,JOURNAL OF FUNCTIONAL FOODS,,,English,Article,,,,,,Pectin; Acid hydrolysis; Enzymatic hydrolysis; Anti-constipation; Gut microbiota; Arctium lappa L.,RHEOLOGICAL PROPERTIES; GUT MICROBIOTA; POLYSACCHARIDE; ROOTS; PROBIOTICS; RESIDUE,"Pectin is the most studied compound. However, recently, more attention has been paid to the health care of pectin oligosaccharides, especially the potential of prebiotics. In order to obtain lower molecular weight molecules with improved bioactivities, the pectin (ALP2) was partially degraded by acid and enzymatic hydrolysis. The molecular weights of acid hydrolyzed fragment (ALP2-A) and enzymatic hydrolyzed fragment (ALP2-E) were 2.4 x 10(4) Da and 5.8 x 10(3) Da, respectively. ALP2-A was composed of rhamnose and galacturonic acid while ALP2-E contained rhamnose, glucuronic acid, galacturonic acid, galactose, and arabinose. Rheological experiments showed that ALP2-A and ALP2-E solutions had lower viscosity than that of ALP2 solution, exhibited shear thinning behavior and belonged to pseudoplastic fluids. ALP2-A could alleviate the constipation symptoms of mice while ALP2-A and ALP2-E had better intestinal flora regulation activity than that of ALP2. Therefore, the results indicated that ALP2-A and ALP2-E could be recommended as potential prebiotic or functional food that could benefit the host by regulating human gut microbiota.","[Yu, Juping; Ye, Meng; Li, Kaidong; Gao, Xiangdong; Liu, Wei] China Pharmaceut Univ, Sch Life Sci & Technol, State Key Lab Nat Med, Jiangsu Key Lab Druggabil Biopharmaceut, Nanjing 210009, Peoples R China; [Wang, Feng] Simcere Pharmaceut Grp Ltd, Nanjing 210042, Peoples R China; [Shi, Xuexia; Liu, Wei] Qinghai Univ, Affiliated Hosp, Dept Clin Pharm, Xining, Peoples R China; [Pan, Chun] Southeast Univ, Zhongda Hosp, Dept Crit Care Med, Nanjing 210009, Peoples R China; [Yang, Xiaobing] Jiangsu Ind Technol Res Inst, Biol & Med Dept, Nanjing 210031, Peoples R China",China Pharmaceutical University; Qinghai University; Southeast University - China,"Gao, XD; Liu, W (corresponding author), China Pharmaceut Univ, Sch Life Sci & Technol, State Key Lab Nat Med, Jiangsu Key Lab Druggabil Biopharmaceut, Nanjing 210009, Peoples R China.",xdgao@cpu.edu.cn; liuwei@cpu.edu.cn,"Gao, Xiang/HDO-3543-2022","ye, meng/0000-0002-4558-8384","National Key Research and Development Program of China [2018YFA0902000]; National Natural Science Foundation of China [81673589, 81872850]; Natural Science Foundation of Jiangsu Province [BK20191317, CPU 2018GF08]; PAPD; (Priority Academic Program Development of Jiangsu Higher Education Institutions)",National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); PAPD; (Priority Academic Program Development of Jiangsu Higher Education Institutions),"This study was supported by the National Key Research and Development Program of China (2018YFA0902000), National Natural Science Foundation of China (No. 81673589, 81872850), Natural Science Foundation of Jiangsu Province (BK20191317), Double First-Class University Project (CPU 2018GF08), and PAPD (A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions).",,22,9,9,6,31,ELSEVIER,AMSTERDAM,"RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS",1756-4646,2214-9414,,J FUNCT FOODS,J. Funct. Food.,JAN,2022,88,,,,,,,,104900,10.1016/j.jff.2021.104900,http://dx.doi.org/10.1016/j.jff.2021.104900,,,12,Food Science & Technology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Nutrition & Dietetics,ZY5LD,,gold,,,2024-06-04,WOS:000772627000003,View Full Record in Web of Science
J,"Mohajeri, MH; Brummer, RJM; Rastall, RA; Weersma, RK; Harmsen, HJM; Faas, M; Eggersdorfer, M",,,,"Mohajeri, M. Hasan; Brummer, Robert J. M.; Rastall, Robert A.; Weersma, Rinse K.; Harmsen, Hermie J. M.; Faas, Marijke; Eggersdorfer, Manfred",,,The role of the microbiome for human health: from basic science to clinical applications,EUROPEAN JOURNAL OF NUTRITION,,,English,Article,,,,,,Microbiota; Gut; Prebiotics; Probiotics; Vitamins; Colonic fermentation; Inflammatory bowel disease; Irritable bowel syndrome; Gut-brain axis; Obesity,IRRITABLE-BOWEL-SYNDROME; 1ST 6 MONTHS; GUT MICROBIOTA; DOUBLE-BLIND; FAECALIBACTERIUM-PRAUSNITZII; GALACTO-OLIGOSACCHARIDES; INTESTINAL PERMEABILITY; CALCIUM-ABSORPTION; SHORT-CHAIN; IN-VIVO,"The 2017 annual symposium organized by the University Medical Center Groningen in The Netherlands focused on the role of the gut microbiome in human health and disease. Experts from academia and industry examined interactions of prebiotics, probiotics, or vitamins with the gut microbiome in health and disease, the development of the microbiome in early-life and the role of the microbiome on the gut-brain axis. The gut microbiota changes dramatically during pregnancy and intrinsic factors (such as stress), in addition to extrinsic factors (such as diet, and drugs) influence the composition and activity of the gut microbiome throughout life. Microbial metabolites, e.g. short-chain fatty acids affect gut-brain signaling and the immune response. The gut microbiota has a regulatory role on anxiety, mood, cognition and pain which is exerted via the gut-brain axis. Ingestion of prebiotics or probiotics has been used to treat a range of conditions including constipation, allergic reactions and infections in infancy, and IBS. Fecal microbiota transplantation (FMT) highly effective for treating recurrent Clostridium difficile infections. The gut microbiome affects virtually all aspects of human health, but the degree of scientific evidence, the models and technologies and the understanding of mechanisms of action vary considerably from one benefit area to the other. For a clinical practice to be broadly accepted, the mode of action, the therapeutic window, and potential side effects need to thoroughly be investigated. This calls for further coordinated state-of-the art research to better understand and document the human gut microbiome's effects on human health.","[Mohajeri, M. Hasan; Eggersdorfer, Manfred] DSM Nutr Prod Ltd, Kaiseraugst, Switzerland; [Mohajeri, M. Hasan] Univ Zurich, Zurich, Switzerland; [Brummer, Robert J. M.] Orebro Univ, Sch Med Sci, Orebro, Sweden; [Rastall, Robert A.] Univ Reading, Dept Food & Nutr Sci, Reading, Berks, England; [Weersma, Rinse K.] Univ Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [Weersma, Rinse K.] Univ Med Ctr Groningen, Groningen, Netherlands; [Harmsen, Hermie J. M.] Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [Faas, Marijke] Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands",DSM NV; University of Zurich; Orebro University; University of Reading; University of Groningen; University of Groningen; University of Groningen; University of Groningen,"Mohajeri, MH (corresponding author), DSM Nutr Prod Ltd, Kaiseraugst, Switzerland.;Mohajeri, MH (corresponding author), Univ Zurich, Zurich, Switzerland.",mhasan.mohajeri@uzh.ch,"Weersma, Rinse/ABE-3807-2021; Brummer, Robert JM/A-3137-2009","Rastall, Robert/0000-0003-1775-5226",Netherlands Organization for Scientific Research (NWO) [016.136.308],Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)),RKW is supported by a VIDI grant (016.136.308) from the Netherlands Organization for Scientific Research (NWO).,,114,225,264,8,118,SPRINGER HEIDELBERG,HEIDELBERG,"TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY",1436-6207,1436-6215,,EUR J NUTR,Eur. J. Nutr.,MAY,2018,57,,,1,,,S1,S14,,10.1007/s00394-018-1703-4,http://dx.doi.org/10.1007/s00394-018-1703-4,,,14,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,GJ8VL,29748817,"Green Published, hybrid",Y,N,2024-06-04,WOS:000435669400001,View Full Record in Web of Science
J,"Abe, A; Morishima, S; Kapoor, MP; Inoue, R; Tsukahara, T; Naito, Y; Ozeki, M",,,,"Abe, Aya; Morishima, So; Kapoor, Mahendra P.; Inoue, Ryo; Tsukahara, Takamitsu; Naito, Yuji; Ozeki, Makoto",,,"Partially hydrolyzed guar gum is associated with improvement in gut health, sleep, and motivation among healthy subjects",JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION,,,English,Article,,,,,,partially hydrolyzed guar gum; constipation; mucolytic bacteria; sleep; motivation,DIETARY FIBER; SP-NOV.; SOLUBLE FIBER; GEN. NOV.; MICROBIOME; BACTERIA; CONSTIPATION; PREVALENCE; PREBIOTICS; NUTRITION,"Partially hydrolyzed guar gum dietary fiber is well recognized for a number of health benefits. In the present study, we aim to investigate the effects of partially hydrolyzed guar gum on constipation, intestinal microbiota as well as mental health in healthy subjects. In the randomized, parallel, double-blind, and placebo-controlled study the enrolled healthy men and women volunteers took either 3 g/day (T3) or 5 g/day (T5) of dietary fiber intakes for eight consecutive weeks compared to placebo (T0). The fecal characteristics, fecal microbiota, defecation characteristics, and quality of life (QOL) questionnaire were investigated. The results revealed a significant suppression in fecal potent harmful mucolytic bacteria in the T3 and T5 groups compared to the T0 group. The defecation frequency, excretory feeling, and scores of sleep and motivation questionnaire were also improved in the dietary fiber intake groups, showing a significant difference in the T5 group compared to the T0 group. In summary, the consumption of partially hydrolyzed guar gum dietary fiber is found effective in suppressing the potent harmful mucolytic bacteria that could be associated with the improvement of constipation-related symptoms including mental health in terms of sleep and motivation among the healthy subjects.","[Abe, Aya; Morishima, So; Kapoor, Mahendra P.; Ozeki, Makoto] Taiyo Kagaku Co Ltd, Nutr Div, 1-3 Takaramachi, Yokaichi, Mie 5100844, Japan; [Inoue, Ryo] Setsunan Univ, Dept Appl Biol Sci, Lab Anim Sci, Fac Agr, Nagatoge Cho 45-1, Hirakata, Osaka 5730101, Japan; [Tsukahara, Takamitsu] Kyoto Inst Nutr & Pathol, Ujitawara, Kyoto 6100231, Japan; [Naito, Yuji] Kyoto Prefectural Univ Med, Dept Human Immunol & Nutr Sci, 465 Kajii Cho,Kamigyo Ku, Kyoto 6028566, Japan","TAIYO KAGAKU CO., LTD.; Setsunan University; Kyoto Prefectural University of Medicine","Abe, A (corresponding author), Taiyo Kagaku Co Ltd, Nutr Div, 1-3 Takaramachi, Yokaichi, Mie 5100844, Japan.",aabe@taiyokagaku.co.jp,,,,,,,82,2,2,0,3,JOURNAL CLINICAL BIOCHEMISTRY & NUTRITION,KYOTO,"KYOTO PREFECTURAL UNIV MED, GRAD SCH MEDICAL SCIENCE, DEPT MOLECULAR GASTROENTEROLOGY & HEPATOLOGY, KYOTO, 602-8566, JAPAN",0912-0009,1880-5086,,J CLIN BIOCHEM NUTR,J. Clin. Biochem. Nutr.,,2023,72,2,,,,,189,197,,10.3164/jcbn.22-75,http://dx.doi.org/10.3164/jcbn.22-75,,,9,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,Q7AK2,36936875,"Green Published, gold",,,2024-06-04,WOS:001059010300013,View Full Record in Web of Science
J,"Ding, F; Hu, MY; Ding, YF; Meng, YY; Zhao, YC",,,,"Ding, Fei; Hu, Mengyang; Ding, Yifei; Meng, Yingying; Zhao, Yanchao",,,Efficacy in bowel movement and change of gut microbiota on adult functional constipation patients treated with probiotics-containing products: a systematic review and meta-analysis,BMJ OPEN,,,English,Article,,,,,,Functional bowel disorders; MICROBIOLOGY; Motility disorders; Systematic Review,DOUBLE-BLIND; INTESTINAL TRANSIT; FERMENTED MILK; PREBIOTICS; SUPPLEMENTATION; SYNBIOTICS,"Objectives This study aimed to pool the efficacy in bowel movement and explore the change of gut microbiota on adult functional constipated patients after probiotics-containing products treatment.Design Systematic review and meta-analysis.Data sources PubMed, Cochrane Library for published studies and ClinicalTrials.gov for 'grey' researches were independently investigated for randomised controlled trials up to November 2022.Eligibility criteria, data extraction and synthesis The intervention was probiotics-containing product, either probiotics or synbiotics, while the control was placebo. The risk of bias was conducted. The efficacy in bowel movement was indicated by stool frequency, stool consistency and Patient Assessment of Constipation Symptom (PAC-SYM), while the change of gut microbiota was reviewed through alpha diversity, beta diversity, change/difference in relative abundance and so on. The subgroup analysis, sensitivity analysis and random-effect meta-regression were conducted to explore the heterogeneity. The Grading of Recommendations Assessment Development and Evaluation was conducted to grade the quality of evidence.Results 17 studies, comprising 1256 participants, were included with perfect agreements between two researchers (kappa statistic=0.797). Compared with placebo, probiotics-containing products significantly increased the stool frequency (weighted mean difference, WMD 0.93, 95% CI 0.47 to 1.40, p=0.000, I-2=84.5%, 'low'), improved the stool consistency (WMD 0.38, 95% CI 0.05 to 0.70, p=0.023, I-2=81.6%, 'very low') and reduced the PAC-SYM (WMD -0.28, 95% CI: -0.45 to -0.11, p=0.001, I-2=55.7%, 'very low'). In subgroup analysis, synbiotics was superior to probiotics to increase stool frequency. Probiotics-containing products might not affect alpha or beta diversity, but would increase the relative abundance of specific strain.Conclusions Probiotics-containing products, significantly increased stool frequency, improved stool consistency, and alleviated functional constipation symptoms. They increased the relative abundance of specific strain. More high-quality head-to-head randomised controlled trials are needed.","[Ding, Fei] Yancheng Third Peoples Hosp, Dept Gastroenterol, Yancheng, Jiangsu, Peoples R China; [Hu, Mengyang] Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Ding, Yifei; Meng, Yingying; Zhao, Yanchao] Xuzhou Med Univ, Affiliated Hosp, Dept Gastroenterol, Xuzhou, Jiangsu, Peoples R China",Huazhong University of Science & Technology; Xuzhou Medical University,"Meng, YY; Zhao, YC (corresponding author), Xuzhou Med Univ, Affiliated Hosp, Dept Gastroenterol, Xuzhou, Jiangsu, Peoples R China.",1043512210@qq.com; 6181191@qq.com,"DING, FEI/KLD-8925-2024",,,,,,51,0,0,5,5,BMJ PUBLISHING GROUP,LONDON,"BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND",2044-6055,,,BMJ OPEN,BMJ Open,JAN,2024,14,1,,,,,,,e074557,10.1136/bmjopen-2023-074557,http://dx.doi.org/10.1136/bmjopen-2023-074557,,,11,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,GS9X7,38238054,gold,,,2024-06-04,WOS:001154790300021,View Full Record in Web of Science
J,"Mafra, D; Baptista, BA; Sahiun, E; Abuznada, S; Leal, VO; Borges, NA",,,,"Mafra, D.; Baptista, B. A.; Sahiun, E.; Abuznada, S.; Leal, V. O.; Borges, N. A.",,,May polydextrose potentially improve gut health in patients with chronic kidney disease?,CLINICAL NUTRITION ESPEN,,,English,Review,,,,,,Polydextrose; Dietary fibre; Constipation; Chronic kidney disease,GLUCAGON-LIKE PEPTIDE-1; SOLUBLE MAIZE FIBER; CHAIN FATTY-ACIDS; DIETARY FIBER; ENERGY-INTAKE; CONSTIPATION; SUPPLEMENTATION; FERMENTATION; PREBIOTICS; MICROBIOTA,"Polydextrose (PDX) is a non-digestible oligosaccharide with a complex structure widely used in the food industry. Studies have shown many health benefits of polydextrose, including modulating the gut microbiota, improving the immune system, altering the lipid profile, and stimulating bowel function. Patients with chronic kidney disease (CKD) report gut dysbiosis, inflammation, dyslipidemia and con-stipation. These are major concerns that affect the quality of life. In this context, PDX can promote beneficial effects. However, little is known about PDX in CKD. This review discusses the possible bene-ficial effects of PDX on gut health for patients with CKD, particularly its impact on constipation.(c) 2022 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.","[Mafra, D.] Fed Univ Rio De Janeiro UFRJ, Grad Program Biol Sci Physiol, Rio De Janeiro, RJ, Brazil; [Mafra, D.; Baptista, B. A.] Fed Fluminense Univ UFF, Grad Program Med Sci, Niteroi, RJ, Brazil; [Mafra, D.] Fed Fluminense Univ UFF, Grad Program Nutr Sci, Niteroi, RJ, Brazil; [Sahiun, E.; Borges, N. A.] State Univ Rio De Janeiro UERJ, Inst Nutr, Rio De Janeiro, RJ, Brazil; [Abuznada, S.] Univ Glasgow, Glasgow, Scotland; [Abuznada, S.] Saudi Elect Univ, Coll Hlth Sci, Publ Hlth Dept, Jeddah, Saudi Arabia; [Leal, V. O.] Rio De Janeiro State Univ UERJ, Pedro Ernesto Univ Hosp, Nutr Div, Rio De Janeiro, Brazil; [Mafra, D.] Clin Res Unit, Rua Marques Parana,303, Niteroi, RJ, Brazil",Universidade Federal Fluminense; Universidade Federal Fluminense; Universidade do Estado do Rio de Janeiro; University of Glasgow; Saudi Electronic University; Universidade do Estado do Rio de Janeiro,"Mafra, D (corresponding author), Clin Res Unit, Rua Marques Parana,303, Niteroi, RJ, Brazil.",dm@id.uff.br,"Mafra, Denise/D-4923-2015","Mafra, Denise/0000-0001-6752-6056; Baptista, Beatriz/0000-0002-5029-8584",Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ),Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)),"Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) support Denise Mafra's research.",,102,1,2,1,5,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",2405-4577,,,CLIN NUTR ESPEN,Clin. Nutr. ESPEN,OCT,2022,51,,,,,,7,16,,10.1016/j.clnesp.2022.08.025,http://dx.doi.org/10.1016/j.clnesp.2022.08.025,,SEP 2022,10,Nutrition & Dietetics,Emerging Sources Citation Index (ESCI),Nutrition & Dietetics,7V9XA,36184250,,,,2024-06-04,WOS:000913165600002,View Full Record in Web of Science
J,"Ito, D; Yamamoto, Y; Maekita, T; Yamagishi, N; Kawashima, S; Yoshikawa, T; Tanioka, K; Yoshida, T; Iguchi, M; Kunitatsu, K; Kanai, Y; Kato, S; Kitano, M",,,,"Ito, Daisaku; Yamamoto, Yuta; Maekita, Takao; Yamagishi, Naoko; Kawashima, Shuji; Yoshikawa, Takanori; Tanioka, Kensuke; Yoshida, Takeichi; Iguchi, Mikitaka; Kunitatsu, Kosei; Kanai, Yoshimitsu; Kato, Seiya; Kitano, Masayuki",,,"Do synbiotics really enhance beneficial synbiotics effect on defecation symptoms in healthy adults? Randomized, double-blind, placebo-controlled trial",MEDICINE,,,English,Article,,,,,,BDHQ; Bifidobacterium longum NT strain; PAC-SYM; probiotics; synbiotics,ANIMALIS SUBSP LACTIS; GALACTO-OLIGOSACCHARIDES; FUNCTIONAL CONSTIPATION; INTESTINAL TRANSIT; BOWEL MOVEMENT; PARALLEL-GROUP; DIETARY FIBER; FREQUENCY; SUPPLEMENTATION; BIFIDOBACTERIA,"Goals: We examined whether synbiotics enhance improvement by probiotics. Background: Probiotics, which are beneficial microbacteria, are a nutritional intervention for treatment of functional constipation or its tendency. Prebiotics, meanwhile, can promote the proliferation of probiotics in the gastrointestinal tract and enhance their beneficial effects. Synbiotics, a combination of probiotics and prebiotics, may be superior to probiotics in the treatment of defecation-related symptoms, but this requires elucidation. Study: This randomized, double-blind, placebo-controlled study enrolled 69 healthy adults with constipation tendency. Participants were allocated to either control, probiotics, or synbiotics groups and they recorded details of their defecations and their condition. The first 2 weeks were the observation period and the latter 2 weeks were the intervention period, in which participants took test foods. Probiotic foods included Bifidobacterium longum NT strain (10(10) CFU/day), synbiotic foods included the NT strain (10(10) CFU/day) and galactooligosaccharide (1 g/day). Placebo foods contained the vehicle only. Participants answered questionnaires (Patient Assessment on Constipation Symptoms [PAC-SYM], and one on dietary history) on the last day of each period. Results: Nine participants withdrew consent, and 2 of the remaining 60 had missing data. Age, body mass index, and sex were not significantly different between the 3 groups. Frequency of bowel movements in the fourth week, the primary endpoint, was not increased in the probiotics or synbiotics groups compared with the control group, and the frequency of bowel movements and days with defecation were not changed by probiotics or synbiotics during the intervention period. Probiotics and synbiotics did not improve stool conditions, although incomplete defecation was improved by probiotics but not by synbiotics compared with placebo. PAC-SYM indicated that stool condition and total scores were improved by probiotics but not by synbiotics during the intervention compared with placebo. Conclusion: The probiotic strain Bifidobacterium longum NT can improve constipation symptoms, especially stool condition, but it does not increase bowel movement frequency in healthy adults with constipation tendency. Synbiotics treatment seemed to diminish this improvement of constipation induced by probiotics. This study indicates the possibility of attenuation of beneficial effects from probiotics by the use of synbiotics, contrary to synbiotics theory.","[Ito, Daisaku; Maekita, Takao; Yoshida, Takeichi; Iguchi, Mikitaka; Kitano, Masayuki] Wakayama Med Univ, Dept Internal Med 2, Kimiidera 811-1, Wakayama, Japan; [Yamamoto, Yuta; Yamagishi, Naoko; Kanai, Yoshimitsu] Wakayama Med Univ, Dept Anat & Cell Biol, Kimiidera 811-1, Wakayama 6418509, Japan; [Kawashima, Shuji; Kunitatsu, Kosei; Kato, Seiya] Wakayama Med Univ, Dept Emergency & Crit Care Med, Kimiidera 811-1, Wakayama, Japan; [Yoshikawa, Takanori; Tanioka, Kensuke] Wakayama Med Univ, Clin Study Support Ctr, Kimiidera 811-1, Wakayama, Japan",Wakayama Medical University; Wakayama Medical University; Wakayama Medical University; Wakayama Medical University,"Yamamoto, Y (corresponding author), Wakayama Med Univ, Dept Anat & Cell Biol, Kimiidera 811-1, Wakayama 6418509, Japan.",yuta-y@wakayama-med.ac.jp,"Yamamoto, Yuta/R-1143-2019; Kanai, Yoshimitsu/W-3486-2019","Yamamoto, Yuta/0000-0001-5225-6989; Kanai, Yoshimitsu/0000-0002-0375-6853",Noster Inc.,Noster Inc.,This study was supported by funding from Noster Inc. The funder had no role in data collection or data analysis.,,32,4,4,5,18,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0025-7974,1536-5964,,MEDICINE,Medicine (Baltimore),FEB 25,2022,101,8,,,,,,,e28858,10.1097/MD.0000000000028858,http://dx.doi.org/10.1097/MD.0000000000028858,,,9,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,ZH4YB,35212286,"gold, Green Published",,,2024-06-04,WOS:000760945400028,View Full Record in Web of Science
J,"Settanni, CR; Bibbò, S; Ianiro, G; Rinninella, E; Cintoni, M; Mele, MC; Cammarota, G; Gasbarrini, A",,,,"Settanni, Carlo Romano; Bibbo, Stefano; Ianiro, Gianluca; Rinninella, Emanuele; Cintoni, Marco; Mele, Maria Cristina; Cammarota, Giovanni; Gasbarrini, Antonio",,,Gastrointestinal involvement of autism spectrum disorder: focus on gut microbiota,EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY,,,English,Review,,,,,,Autism spectrum disorder; gastrointestinal Symptoms; gut Microbiota; gut-Brain Axis; probiotics; prebiotics; fecal Microbiota Transplantation; diet,SOCIAL-BEHAVIOR; PROPIONIC-ACID; FREE DIET; CHILDREN; SYMPTOMS; ABNORMALITIES; ASSOCIATION; MICROFLORA; METABOLISM; SEROTONIN,"Introduction Autism spectrum disorder (ASD) is a neurodevelopmental disorder typical of early age, characterized by impaired communication, social interaction, and repetitive behaviors. ASD patients frequently suffer from gastrointestinal (GI) symptoms. Neuro-psychological functions, intestinal homeostasis, and functional GI disturbances are modulated by the gut microbiota through the so-called 'microbiota-gut-brain axis'. Areas covered Literature regarding GI symptoms among the ASD community as well as the involvement and modulation of the gut microbiota in GI disturbances of ASD patients was searched. Constipation, diarrhea, reflux, abdominal bloating, pain, and discomfort are reported with variable prevalence. ASD is characterized by a reduction of Bacteroidetes/Firmicutes, of the abundance of Bacteroidetes and other imbalances. ASD patients with GI symptoms present microbial changes with plausible relation with deficiency of digestive enzymes, carbohydrate malabsorption, selective eating, bacterial toxins, serotonin metabolism, and inflammation. The strategies to mitigate the GI distress through the gut microbiota modulation comprise antimicrobials, probiotics, prebiotics, fecal microbiota transplantation, and dietary intervention. Expert opinion The modulation of the gut microbiota in ASD individuals with GI disturbances seems a promising target for the future medicine. A standardization of the research strategies for large-scale studies together with a focus on poorly explored fields is necessary to strengthen this hypothesis.","[Settanni, Carlo Romano; Bibbo, Stefano; Ianiro, Gianluca; Cammarota, Giovanni; Gasbarrini, Antonio] Univ Cattolica Sacro Cuore, Fdn Policlin Univ Agostino Gemelli IRCCS, Digest Dis Ctr, Dipartimento Sci Med & Chirurg, Rome, Italy; [Rinninella, Emanuele; Mele, Maria Cristina] Fdn Policlin Univ A Gemelli IRCCS, Endocrino Metab E Nefro Urolog, Dipartimento Sci Gastroenterolog, UOC Nutr Clin, Rome, Italy; [Cintoni, Marco] Univ Roma Tor Vergata, Scuola Specializzaz Sci Alimentaz, Rome, Italy; [Cammarota, Giovanni; Gasbarrini, Antonio] Univ Cattolica Sacro Cuore, Ist Patol Speciale Med, Milan, Italy",Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Rome Tor Vergata; Catholic University of the Sacred Heart,"Gasbarrini, A (corresponding author), Univ Cattolica Sacro Cuore, Fdn Policlin Univ Agostino Gemelli IRCCS, Digest Dis Ctr, Rome, Italy.",antonio.gasbarrini@unicatt.it,"Gasbarrini, Antonio/AAB-8487-2019; Rinninella, Emanuele/I-9385-2019; Cammarota, Giovanni/AAD-1732-2022; Bibbo, Stefano/AAA-9851-2019; Settanni, Carlo Romano/AAA-9308-2022; Ianiro, Gianluca/K-5578-2016","Rinninella, Emanuele/0000-0002-9165-2367; Cammarota, Giovanni/0000-0002-3626-6148; Bibbo, Stefano/0000-0002-8043-4807; Settanni, Carlo Romano/0000-0001-5339-1947; Cintoni, Marco/0000-0002-9610-0748; Gasbarrini, Antonio/0000-0002-6230-1779; Ianiro, Gianluca/0000-0002-8318-0515; Gasbarrini, Antonio/0000-0003-4863-6924",,,,,177,38,42,3,45,TAYLOR & FRANCIS LTD,ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND",1747-4124,1747-4132,,EXPERT REV GASTROENT,Expert Rev. Gastroenterol. Hepatol.,JUN 3,2021,15,6,,,,,599,622,,10.1080/17474124.2021.1869938,http://dx.doi.org/10.1080/17474124.2021.1869938,,JAN 2021,24,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Gastroenterology & Hepatology,SM9LN,33356668,,,,2024-06-04,WOS:000604695100001,View Full Record in Web of Science
J,"Palumbo, VD; Tutino, R; Messina, M; Santarelli, M; Nigro, C; Lo Secco, G; Piceni, C; Montanari, E; Barletta, G; Venturelli, P; Geraci, G; Bonventre, S; Lo Monte, AI",,,,"Palumbo, Vincenzo Davide; Tutino, Roberta; Messina, Marianna; Santarelli, Mauro; Nigro, Casimiro; Lo Secco, Giacomo; Piceni, Chiara; Montanari, Elena; Barletta, Gabriele; Venturelli, Paolina; Geraci, Girolamo; Bonventre, Sebastiano; Lo Monte, Attilio Ignazio",,,Altered Gut Microbic Flora and Haemorrhoids: Could They Have a Possible Relationship?,JOURNAL OF CLINICAL MEDICINE,,,English,Article,,,,,,microbiota; haemorrhoids; slow transit constipation,IRRITABLE-BOWEL-SYNDROME; RECTAL MOTOR-ACTIVITY; ANAL-SPHINCTER; DOUBLE-BLIND; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL CONSTIPATION; CHILDHOOD CONSTIPATION; STOOL CHARACTERISTICS; ULCERATIVE-COLITIS; METHANE PRODUCTION,"To date, the exact pathophysiology of haemorrhoids is poorly understood. The different philosophies on haemorrhoids aetiology may lead to different approaches of treatment. A pathogenic theory involving a correlation between altered anal canal microflora, local inflammation, and muscular dyssynergia is proposed through an extensive review of the literature. Since the middle of the twentieth century, three main theories exist: (1) the varicose vein theory, (2) the vascular hyperplasia theory, and (3) the concept of a sliding anal lining. These phenomena determine changes in the connective tissue (linked to inflammation), including loss of organization, muscular hypertrophy, fragmentation of the anal subepithelial muscle and the elastin component, and vascular changes, including abnormal venous dilatation and vascular thrombosis. Recent studies have reported a possible involvement of gut microbiota in gut motility alteration. Furthermore, dysbiosis seems to represent the leading cause of bowel mucosa inflammation in any intestinal district. The alteration of the gut microbioma in the anorectal district could be responsible for haemorrhoids and other anorectal disorders. A deeper knowledge of the gut microbiota in anorectal disorders lays the basis for unveiling the roles of these various gut microbiota components in anorectal disorder pathogenesis and being conductive to instructing future therapeutics. The therapeutic strategy of antibiotics, prebiotics, probiotics, and fecal microbiota transplantation will benefit the effective application of precision microbiome manipulation in anorectal disorders.","[Palumbo, Vincenzo Davide] Euro Mediterranean Inst Sci & Technol, I-90139 Palermo, Italy; [Tutino, Roberta; Santarelli, Mauro; Piceni, Chiara; Montanari, Elena] Univ Hosp Citta Salute & Sci Torino, Molinette Hosp, Gen Surg 3 OU, I-10126 Turin, Italy; [Messina, Marianna] Univ Palermo, Dept Biomed Neurosci & Adv Diagnost, I-90129 Palermo, Italy; [Nigro, Casimiro] Univ Roma Tor Vergata, Dept Surg, I-00173 Rome, Italy; [Lo Secco, Giacomo] Univ Torino, Dept Surg Sci, I-10126 Turin, Italy; [Barletta, Gabriele; Venturelli, Paolina; Geraci, Girolamo; Bonventre, Sebastiano; Lo Monte, Attilio Ignazio] Univ Palermo, Dept Surg Oncol & Oral Sci, I-90127 Palermo, Italy",A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Palermo; University of Rome Tor Vergata; University of Turin; University of Palermo,"Palumbo, VD (corresponding author), Euro Mediterranean Inst Sci & Technol, I-90139 Palermo, Italy.",vincenzopalumbo@iemest.eu; dr.messinam@gmail.com; girolamo.geraci@unipa.it,,"Piceni, Chiara/0000-0001-7754-1022; tutino, roberta/0000-0002-0891-4689; Barletta, Gabriele/0000-0002-5554-684X; Geraci, Girolamo/0000-0002-8239-9830",,,,,107,7,7,0,13,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2077-0383,,J CLIN MED,J. Clin. Med.,MAR,2023,12,6,,,,,,,2198,10.3390/jcm12062198,http://dx.doi.org/10.3390/jcm12062198,,,12,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,A4XF0,36983199,"Green Published, gold",,,2024-06-04,WOS:000955163300001,View Full Record in Web of Science
J,"Naito, Y",,,,"Naito, Yuji",,,Gut Frailty: Its Concept and Pathogenesis,DIGESTION,,,English,Review,,,,,,Aging; Gut frailty; Izumo Scale; Longevity; Well-being,CARDIOVASCULAR-DISEASE; RISK; CONSTIPATION; MICROBIOME; HEALTH,"Background: There is still a considerable gap between average life expectancy and healthy life expectancy in Japan. Recent research has revealed that gut frailty may be a worsening factor for various diseases, a cause of chronic inflammation, and a precursor to frailty. Summary: Among self-reported symptoms, constipation is particularly significant as one of the key symptoms of gut frailty. Studies have demonstrated that individuals with constipation have significantly lower survival rates and are also at a higher risk of developing various diseases such as chronic kidney disease, cardiovascular diseases, and neurodegenerative disorders like Parkinson's disease. Various molecular mechanisms could contribute to gut frailty, and the decrease in mucus secretion is an extremely early-stage pathology. Dysbiosis of gut microbiota has a major impact on many conditions associated with gut frailty. Prebiotics, probiotics, post-biotics, and fecal microbiota transplantation are under investigation as a treatment option for gut frailty. Key Message: Although the concept of gut frailty has not yet gained widespread recognition, we hope to propose more practical screening methods, diagnostic approaches, and specific interventions in the future.","[Naito, Yuji] Kyoto Prefectural Univ Med, Human Immunol & Nutr Sci, Kyoto, Japan",Kyoto Prefectural University of Medicine,"Naito, Y (corresponding author), Kyoto Prefectural Univ Med, Human Immunol & Nutr Sci, Kyoto, Japan.",ynaito@koto.kpu-m.ac.jP,,,"MAFF Commissioned project [JPJ009842]; COI-NEXT, JST [JPMJPF2210]","MAFF Commissioned project; COI-NEXT, JST","This work was partly supported by MAFF Commissioned project study on Project for the realization of foods and dietary habits to extend healthy life expectancy allotted to Y.N. (Grant No. JPJ009842), and partly supported by COI-NEXT, JST Grant No. JPMJPF2210.",,32,2,2,5,5,KARGER,BASEL,"ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND",0012-2823,1421-9867,,DIGESTION,Digestion,JAN,2024,105,1,,,,,49,57,,10.1159/000534733,http://dx.doi.org/10.1159/000534733,,,9,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,ER8B3,37967548,"Green Published, hybrid",,,2024-06-04,WOS:001140730700006,View Full Record in Web of Science
J,"Scholtens, PAMJ; Goossens, DAM; Staiano, A",,,,"Scholtens, Petra A. M. J.; Goossens, Dominique A. M.; Staiano, Annamaria",,,Stool characteristics of infants receiving short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides: A review,WORLD JOURNAL OF GASTROENTEROLOGY,,,English,Review,,,,,,Short-chain galactooligosaccharides; Long-chain fructooligosaccharides; Stool consistency; Stool frequency; Infants,GASTROINTESTINAL TRANSIT-TIME; PREBIOTIC OLIGOSACCHARIDES; FATTY-ACIDS; CHILDHOOD CONSTIPATION; DIETARY MODULATION; HUMAN-MILK; FORMULA; INULIN; HEALTH; COLON,"Human milk is considered to be the optimal source of infant nutrition. Some of the benefits of breastfeeding have been ascribed to human milk oligosaccharides (HMO). For instance, HMO can affect faecal characteristics such as stool consistency and stool frequency. Such effects on stool characteristics can be beneficial for young infants as hard stools and even constipation is common in that age group. Prebiotics in infant milk formulas have been introduced to exert similar functionalities. A specific mixture of prebiotics consists of a combination of short chain galacto-oligosaccharides and long-chain fructo-oligosaccharides (scGOS/lcFOS) in a ratio of 9:1. This specific mixture has been developed to closely resemble the molecular size composition of HMO. Many studies have been done with scGOS/lcFOS, and indicators for digestive comfort have often been included as secondary outcomes. This review summarizes the effects of scGOS/lcFOS (9:1) on stool consistency, stool frequency and transit time in healthy term and preterm infants. In several of the studies with scGOS/lcFOS in a ratio of 9:1 in infant milk formulas, positive effects of this mixture on stool characteristics such as stool consistency and stool frequency were observed. As stool consistency was shown to be correlated to whole gut transit time, scGOS/lcFOS can be hypothesised to have a role in reducing the risk of constipation. (C) 2014 Baishideng Publishing Group Inc. All rights reserved.","[Scholtens, Petra A. M. J.; Goossens, Dominique A. M.] Nutr Res, NL-3508 TC Utrecht, Netherlands; [Staiano, Annamaria] Univ Naples Federico II, Dept Translat Med Sci, Sect Pediat, I-80138 Naples, Italy",University of Naples Federico II,"Scholtens, PAMJ (corresponding author), Nutr Res, POB 80141, NL-3508 TC Utrecht, Netherlands.",petra.scholtens@danone.com,"Staiano, Annamaria/H-3026-2011","Staiano, Annamaria/0000-0003-0586-1339",,,,,50,50,54,1,45,BAISHIDENG PUBLISHING GROUP INC,PLEASANTON,"7041 Koll Center Parkway, Suite 160, PLEASANTON, CA, UNITED STATES",1007-9327,2219-2840,,WORLD J GASTROENTERO,World J. Gastroenterol.,OCT 7,2014,20,37,,,,,13446,13452,,10.3748/wjg.v20.i37.13446,http://dx.doi.org/10.3748/wjg.v20.i37.13446,,,7,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,AR9GN,25309075,"Green Published, hybrid",,,2024-06-04,WOS:000343881200019,View Full Record in Web of Science
J,"Liu, Y; Liu, B; Li, D; Hu, YL; Zhao, L; Zhang, M; Ge, SY; Pang, J; Li, YX; Wang, R; Wang, PJ; Huang, YT; Huang, J; Bai, J; Ren, FZ; Li, Y",,,,"Liu, Ying; Liu, Bin; Li, Dan; Hu, Yulin; Zhao, Liang; Zhang, Ming; Ge, Shaoyang; Pang, Jie; Li, Yixuan; Wang, Ran; Wang, Pengjie; Huang, Yutao; Huang, Jing; Bai, Jie; Ren, Fazheng; Li, Yuan",,,Improved Gastric Acid Resistance and Adhesive Colonization of Probiotics by Mucoadhesive and Intestinal Targeted Konjac Glucomannan Microspheres,ADVANCED FUNCTIONAL MATERIALS,,,English,Article,,,,,,constipation alleviation; gastric acid resistance; mucoadhesion; oxidized konjac glucomannan; probiotics,THIOLATED POLYMERS; GUT MICROBIOTA; MICROENCAPSULATION; PREBIOTICS; ALGINATE; DELIVERY; ACIDOPHILUS; SURVIVAL; BACTERIA; CHITOSAN,"The low survival rate in harsh stomach conditions and short retention in intestine of probiotics greatly limit their health benefits. To solve this problem, thiolated oxidized konjac glucomannan (sOKGM) microspheres is designed with pH responsive and mucoadhesive properties. First, an increased survival rate of probiotics by sOKGM microspheres encapsulation in simulated gastric fluid (SGF) is discovered in contrast to the zero-survival rate of naked probiotics. sOKGM/probiotics even show a higher survival rate in SGF compared with commercial Bb12 formulation. Further, an enhanced mucoadhesion of probiotics to intestinal mucus by mediated interactions with sOKGM is confirmed by isotherm titration calorimetry, rheology, and tensile measurements. The in vivo intestinal transition experiment indicates a prolonged retention of probiotics at intestine by sOKGM encapsulation. Moreover, in vivo evaluation of enhanced colonization and proliferation by sOKGM/probiotics is demonstrated by the fecal and intestinal bacteria copy number via quantitative polymerase chain reaction (qPCR) detection. Further investigation of the alleviation of constipation by sOKGM containingBifidobacterium animalissubsp.lactisA6 suggests that sOKGM increases the abundance ofBifidobacterium, balanced intestinal flora, and alleviated constipation in mice compared with other formulations. sOKGM with both enhanced gastric acid resistance and adhesion colonization at intestine can effectively improve the function of probiotics.","[Liu, Ying; Liu, Bin; Li, Dan; Hu, Yulin; Zhao, Liang; Li, Yixuan; Wang, Ran; Wang, Pengjie; Huang, Yutao; Huang, Jing; Bai, Jie; Ren, Fazheng; Li, Yuan] China Agr Univ, Coll Food Sci & Nutr Engn, Key Lab Precis Nutr & Food Qual, Key Lab Funct Dairy,Minist Educ, Beijing 100083, Peoples R China; [Zhang, Ming] Beijing Technol & Business Univ, Sch Food & Hlth, Beijing 100048, Peoples R China; [Ge, Shaoyang; Wang, Ran] China Agr Univ, Res Ctr Probiot, Baoding 065201, Hebei, Peoples R China; [Pang, Jie] Fujian Agr & Forestry Univ, Coll Food Sci, Fuzhou 350002, Peoples R China",China Agricultural University; Beijing Technology & Business University; China Agricultural University; Fujian Agriculture & Forestry University,"Ren, FZ; Li, Y (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Key Lab Precis Nutr & Food Qual, Key Lab Funct Dairy,Minist Educ, Beijing 100083, Peoples R China.",renfazheng@cau.edu.cn; yuanli@cau.edu.cn,"Wang, Pengjie/AAR-4864-2020","Wang, Pengjie/0000-0002-1427-6599; Liu, Bin/0000-0003-3969-3484; Zhao, Liang/0000-0001-9244-3121; Wang, Pengjie/0000-0001-9975-6737; Zhang, Ming/0000-0003-1175-4636","National Natural Science Foundation of China [NSFC 31471577, 31772014, 31972202]; Beijing Nova Program [Z181100006218071]",National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Nova Program(Beijing Municipal Science & Technology Commission),"This work was supported by the National Natural Science Foundation of China (NSFC 31471577, 31772014, 31972202) and the Beijing Nova Program (No. Z181100006218071). Special thanks to Prof. Hao Yanling for providing NZ9000 and WCFS1 for this study.",,50,66,70,69,571,WILEY-V C H VERLAG GMBH,WEINHEIM,"POSTFACH 101161, 69451 WEINHEIM, GERMANY",1616-301X,1616-3028,,ADV FUNCT MATER,Adv. Funct. Mater.,AUG 26,2020,30,35,,,,,,,2001157,10.1002/adfm.202001157,http://dx.doi.org/10.1002/adfm.202001157,,JUL 2020,11,"Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter",Science Citation Index Expanded (SCI-EXPANDED),Chemistry; Science & Technology - Other Topics; Materials Science; Physics,PF0CI,,,,,2024-06-04,WOS:000545403200001,View Full Record in Web of Science
J,"Floch, MH; Narayan, R",,,,"Floch, MH; Narayan, R",,,Diet in the irritable bowel syndrome,JOURNAL OF CLINICAL GASTROENTEROLOGY,,,English,Article; Proceedings Paper,Workshop on Irritable Bowel Syndrome,"SEP 26, 2001","YALE UNIV, NEW HAVEN, CT",,YALE UNIV,,FOOD INTOLERANCE; CELIAC-DISEASE; WHEAT BRAN; MAST-CELLS; FIBER; HYPERSENSITIVITY; REDUCTION; DIARRHEA; ALLERGY,"Patients with irritable bowel syndrome (IBS) often request dietary recommendations. They must eat, and they want to know what to eat. Present national guidelines recommend dietary treatment with fiber for IBS patients with constipation. Diet recommendations are made based on symptoms. There may be different dietary recommendations for constipation, diarrhea, and pain or bloating. This article reviews the relationship of foods to IBS and issues of food intolerances and hypersensitivities, and recommendations for diet therapy. The role of dietary fiber, both soluble and insoluble, is reviewed. Although there are few studies to substantiate exact diets, broad dietary plans are recommended for the different symptoms of IBS. In addition, the recent literature on probiotics and prebiotics pertinent to IBS is reviewed.","Yale Univ, Sch Med, Norwalk, CT 06856 USA; Norwalk Hosp, Gastroenterol & Nutr Sect, Norwalk, CT 06856 USA",Yale University,"Yale Univ, Sch Med, 30 Stevens St,Suite E, Norwalk, CT 06856 USA.",martinfloch@snet.net,,,,,,,55,32,36,0,11,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0192-0790,1539-2031,,J CLIN GASTROENTEROL,J. Clin. Gastroenterol.,JUL,2002,35,1,,S,,,S45,S52,,10.1097/00004836-200207001-00009,http://dx.doi.org/10.1097/00004836-200207001-00009,,,8,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Gastroenterology & Hepatology,566QH,12184139,,,,2024-06-04,WOS:000176439400009,View Full Record in Web of Science
C,"Domellöf, M; West, C",,"Agostoni, C; Brunser, O",,"Domellof, Magnus; West, Christina",,,Processed infant cereals as vehicles of functional components,ISSUES IN COMPLEMENTARY FEEDING,Nestle Nutrition Institute Workshop Series,,English,Proceedings Paper,60th Nestle Nutrition Workshop,"OCT 22-26, 2006","Manaus, BRAZIL",,,,DIETARY NUCLEOTIDE SUPPLEMENTATION; RECOMBINANT HUMAN LACTOFERRIN; LACTOBACILLUS GG; ACUTE DIARRHEA; PREBIOTIC OLIGOSACCHARIDES; MICRONUTRIENT STATUS; ESPGHAN COMMITTEE; DIETETIC PRODUCTS; ATOPIC-DERMATITIS; YOUNG-CHILDREN,"Cereals are the most common complementary foods all over the world and there is now a novel possibility to add functional components to target health problems that are not caused by a simple nutritional deficiency. So far there have been very few published trials on the addition of functional components to infant cereals. A single trial has suggested that infant cereals containing a combination of probiotics, prebiotics and zinc are an effective adjunct to oral rehydration solution in the treatment of acute gastroenteritis. Up to now there has been no evidence that infant cereals supplemented with probiotics or prebiotics have a preventive effect on diarrhea but a recent study has suggested that a milk fat globule membrane (MFGM) protein fraction added to an infant cereal reduces the risk of diarrhea in a developing country. There are some promising results suggesting that infant cereals supplemented with probiotics or prebiotics may prevent atopic eczema. The addition of prebiotic oligosaccharides to infant cereals may lead to softer stools, likely to benefit those infants who are suffering from constipation. More studies are needed to verify these results and to assess the effects of other functional components - especially probiotics, prebiotics, nucleotides, novel protein fractions and recombinant human milk proteins - added to infant cereals. Copyright (c) 2007 Nestec Ltd., Vevey/S. Karger AG, Basel.","[Domellof, Magnus; West, Christina] Umea Univ, Dept Clin Sci, Pediat, Umea, Sweden",Umea University,"Domellöf, M (corresponding author), Umea Univ, Dept Clin Sci, Pediat, Umea, Sweden.",,"Domellöf, Magnus/E-5307-2011; Domellöf, Magnus/AAP-9542-2021","Domellöf, Magnus/0000-0002-0726-7029; West, Christina/0000-0001-9599-2580",,,,,70,0,0,0,12,KARGER,BASEL,"POSTFACH, CH-4009 BASEL, SWITZERLAND",1664-2147,1664-2155,978-3-8055-8283-4,NESTLE NUTR WORKS SE,,,2007,60,,,,,,107,+,,10.1159/000106364,http://dx.doi.org/10.1159/000106364,,,5,Nutrition & Dietetics; Pediatrics,Conference Proceedings Citation Index - Science (CPCI-S),Nutrition & Dietetics; Pediatrics,BGT31,17664900,,,,2024-06-04,WOS:000250405300008,View Full Record in Web of Science
J,"Vera, C; Ubilla, C; Guerrero, C; López, J; Flórez-Méndez, J; Bustos, R",,,,"Vera, Carlos; Ubilla, Claudia; Guerrero, Cecilia; Lopez, Jessica; Florez-Mendez, Jennyfer; Bustos, Ruben",,,Non-digestible oligosaccharides and polysaccharides: a source of health for older people,REVISTA CHILENA DE NUTRICION,,,Spanish,Review,,,,,,Functional ingredient; Non-digestible oligosaccharides; Non-digestible polysaccharides; Prebiotics,INTESTINAL BACTERIAL OVERGROWTH; CHAIN FATTY-ACIDS; MIXTURE B-GOS; CALCIUM-ABSORPTION; PROTEIN FERMENTATION; FECAL MICROFLORA; GUT MICROBIOTA; FUNCTIONAL FOOD; PREBIOTICS; PROBIOTICS,"Since aging naturally leads to an imbalance in the diversity and quantity of microorganisms present in the intestine, older people are particularly vulnerable to diseases associated with the gastrointestinal tract. Thus, supplementing the diet of elderly persons with non-digestible oligosaccharides and polysaccharides (OPND) has gained scientific relevance. Supplementation aims to prevent and (partially) revert the negative changes in intestinal microbiota due to aging. It has been observed that OPND supplementation in older adults provides several benefits, including an improvement in the immune system, increased calcium absorption, a reduction in the incidence of allergies, a reduction in constipation and a decrease in blood levels of cholesterol and glucose. Because the effects of OPND supplementation in older adults has been scarcely discussed in the scientific literature in the Spanish language, the purpose of this review is to address the issue with emphasis on the Chilean and Latin-American reality. The article promotes the incorporation of OPND in processed food and feeding programs specifically designed for older people in Latin America.","[Vera, Carlos] Univ Santiago Chile, Dept Biol, Fac Quim & Biol, Av Libertador Bernardo OHiggins 3363, Santiago, Chile; [Ubilla, Claudia; Guerrero, Cecilia] Pontificia Univ Catolica Valparaiso, Escuela Ingn Bioquim, Fac Ingn, Valparaiso, Chile; [Lopez, Jessica] Pontificia Univ Catolica Valparaiso, Escuela Alimentos, Fac Ciencias Agronom & Alimentos, Valparaiso, Chile; [Florez-Mendez, Jennyfer] Univ Santiago Chile, Ctr Estudios Univ Santiago CEUS Llanquihue, Llanquihue, Region De Los L, Chile; [Bustos, Ruben] Univ Santiago Chile, Dept Ingn Quim, Fac Ingn, Santiago, Chile",Universidad de Santiago de Chile; Pontificia Universidad Catolica de Valparaiso; Pontificia Universidad Catolica de Valparaiso; Universidad de Santiago de Chile,"Vera, C (corresponding author), Univ Santiago Chile, Dept Biol, Fac Quim & Biol, Av Libertador Bernardo OHiggins 3363, Santiago, Chile.;Flórez-Méndez, J (corresponding author), Univ Santiago Chile, Ctr Estudios Univ Santiago CEUS Llanquihue, Llanquihue, Region De Los L, Chile.",carlos.vera.v@usach.cl; jennyfer.florez@usach.cl,"vera, Carlos Felipe/G-5240-2019; Lopez, Jessica/IQT-7114-2023","Bustos, Ruben/0000-0003-0183-0324; Vera Vera, Carlos Felipe/0000-0003-2179-9467; Florez Mendez, Jennyfer/0000-0003-1515-6262",,,,,103,0,1,1,20,"SOC CHILENA NUTRICION, BROMATOLOGIA & TOXICOLOGIA",SANTIAGO,"CONCEPCION 81, OFICINA 1307, PROVIDENCIA, SANTIAGO, 00000, CHILE",0717-7518,,,REV CHIL NUTR,Rev. Chil. Nutr.,SEP,2020,47,5,,,,,848,864,,10.4067/S0717-75182020000500848,http://dx.doi.org/10.4067/S0717-75182020000500848,,,17,Nutrition & Dietetics,Emerging Sources Citation Index (ESCI),Nutrition & Dietetics,OF3GU,,gold,,,2024-06-04,WOS:000581101500016,View Full Record in Web of Science
J,"Sharma, S; Awasthi, A; Singh, S",,,,"Sharma, Shakshi; Awasthi, Anupam; Singh, Shamsher",,,Altered gut microbiota and intestinal permeability in Parkinson's disease: Pathological highlight to management,NEUROSCIENCE LETTERS,,,English,Article,,,,,,Parkinson's disease; Gut-brain axis; Gut-Microbiota; Probiotics; Prebiotics; Vagotomy,ENTERIC NERVOUS-SYSTEM; CHAIN FATTY-ACIDS; ALPHA-SYNUCLEIN; BRAIN AXIS; RISK; SUSCEPTIBILITY; CONSTIPATION; MUTATIONS; VAGOTOMY; MODELS,"Parkinson's disease (PD) is a multifactorial neurodegenerative disorder, affecting 3.7% of the population over 65 years of age. PD involves degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNPC) with deficiency of dopamine. Genetic factors like SNCA, PARK-2, PARK-7, PINK-1 and LRRK-2 as well as environmental toxins enhance alpha-synuclein, amyloid beta (beta) and tau (tau) proteins aggregation. Moreover, oxidative stress, mitochondria] dysfunctioning, neuroinfiammation, prion like phenomena, excitotoxicity, mutations etc are known to cause pathological insult in PD. Recently, facts indicates strong correlation between gut-brain axis and PD. The communication between the gastrointestinal system (GIT) and central nervous system is bidirectional and it is hypothesized that PD arises in the gut and spreads to brain via vagus nerve that helps to propagate the alpha-synuclein that target brain. The Lewy bodies are found in olfactory bulb, dorsal motor vagal nerve and the ENS of the gut indicate peripheral and central correlation. The alteration of gut microbial flora leads to GIT disturbance which cause neuroinflammation by prion alpha-synuclein expression and produces PD like symptoms. Persistent gut inflammation with spontaneous neuroinflammation is yet need to confirm but increased intestinal permeability and disrupt function of GIT is known to produce non-motor symptoms of PD. The present review is aimed to explore mechanistic approach for gut associated PD symptoms as well as use of probiotics and prebiotics as therapeutic approach to retain gut microbial flora and prevent PD like symptoms.","[Sharma, Shakshi; Awasthi, Anupam; Singh, Shamsher] ISF Coll Pharm, Dept Pharmacol, Neurosci Div, Moga 142001, Punjab, India",ISF College of Pharmacy,"Singh, S (corresponding author), ISF Coll Pharm, Dept Pharmacol, Neurosci Div, Moga 142001, Punjab, India.",shamshersinghbajwa@gmail.com,"Shamsher Singh, M.Pharm/AAC-6598-2021","Shamsher Singh, M.Pharm/0000-0002-2780-6632; Awasthi, Anupam/0000-0002-0475-0031",,,,,73,30,34,7,49,ELSEVIER IRELAND LTD,CLARE,"ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND",0304-3940,1872-7972,,NEUROSCI LETT,Neurosci. Lett.,NOV 1,2019,712,,,,,,,,134516,10.1016/j.neulet.2019.134516,http://dx.doi.org/10.1016/j.neulet.2019.134516,,,8,Neurosciences,Science Citation Index Expanded (SCI-EXPANDED),Neurosciences & Neurology,JN0PQ,31560998,,,,2024-06-04,WOS:000496606900034,View Full Record in Web of Science
J,"Ruszkowski, J; Witkowski, JM",,,,"Ruszkowski, Jakub; Witkowski, Jacek M.",,,Lactulose: Patient- and dose-dependent prebiotic properties in humans,ANAEROBE,,,English,Review,,,,,,Lactulose; Gastrointestinal microbiome; Prebiotics; Metabolomics; Chronic kidney disease,INCREASES SERUM PROPIONATE; IN-VITRO FERMENTATION; CHAIN FATTY-ACIDS; L-RHAMNOSE; HEPATIC-ENCEPHALOPATHY; COLONIC FERMENTATION; NITROGEN-METABOLISM; AMMONIA PRODUCTION; DEOXYCHOLIC-ACID; OXIDATIVE STRESS,"Lactulose is a disaccharide used in clinical practice since 1957 and has since been tested in the treatment of many human disorders, including chronic constipation, hepatic encephalopathy, and chronic kidney disease. Its mode of action is based on the lactulose fermentation by intestinal microbiota. Based on in silico, in vitro and in vivo studies we comprehensively review here the impact of lactulose on human gut/fecal and vaginal microbiota composition and both fecal and blood metabolomes. However, both in vitro and in vivo studies summarized in this review have revealed that the effects of lactulose on human microbiota composition are both patient- and dose-dependent. This highlights the need of heterogeneity indication in clinical trials. (C) 2019 Elsevier Ltd. All rights reserved.","[Ruszkowski, Jakub; Witkowski, Jacek M.] Med Acad Gdansk, Dept Pathophysiol, Fac Med, Ul Debinki 7, PL-80211 Gdansk, Poland",Fahrenheit Universities; Medical University Gdansk,"Ruszkowski, J (corresponding author), Med Acad Gdansk, Dept Pathophysiol, Fac Med, Ul Debinki 7, PL-80211 Gdansk, Poland.",jakub.ruszkowski@gumed.edu.pl,"Ruszkowski, Jakub/AAK-3436-2021","Ruszkowski, Jakub/0000-0002-9666-9627; Witkowski, Jacek M./0000-0003-2906-1109",,,,,79,28,36,4,26,ELSEVIER SCI LTD,OXFORD,"THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND",1075-9964,1095-8274,,ANAEROBE,Anaerobe,OCT,2019,59,,,,,,100,106,,10.1016/j.anaerobe.2019.06.002,http://dx.doi.org/10.1016/j.anaerobe.2019.06.002,,,7,Microbiology,Science Citation Index Expanded (SCI-EXPANDED),Microbiology,KL0ZP,31176002,,,,2024-06-04,WOS:000513161600015,View Full Record in Web of Science
J,"Salem, AE; Singh, R; Ayoub, YK; Khairy, AM; Mullin, GE",,,,"Salem, Ahmed E.; Singh, Rajdeep; Ayoub, Younan K.; Khairy, Ahmed M.; Mullin, Gerard E.",,,The gut microbiome and irritable bowel syndrome: State of art review,ARAB JOURNAL OF GASTROENTEROLOGY,,,English,Review,,,,,,Irritable bowel syndrome IBS; Gut microbiota; Gut microbiome; Probiotics; Prebiotics; Dysbiosis; SIBO; Enterotype,CHAIN FATTY-ACIDS; RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; INTESTINAL MICROBIOTA; FECAL MICROBIOTA; DOUBLE-BLIND; GASTROINTESTINAL MICROBIOTA; CONSTIPATION-PREDOMINANT; PROBIOTIC BACTERIA; CLINICAL-TRIAL,"Irritable bowel syndrome (IBS) is a functional disorder of the gastrointestinal tract, the physiology of which is not very well understood. There are multiple factors and pathways involved in pathogenesis of this entity. Among all, dysmotility, dysregulation of the brain-gut axis, altered intestinal microbiota and visceral hypersensitivity play a major role. Over the last years, research has shown that the type of gut microbiome present in an individual plays a significant role in the pathophysiology of IBS. Multiple studies have consistently shown that subjects diagnosed with IBS have disruption in gut microbiota balance. It has been established that host immune system and its interaction with metabolic products of gut microbiota play an important role in the gastrointestinal tract. Therefore, probiotics, prebiotics and antibiotics have shown some promising results in managing IBS symptoms via modulating the interaction between the above. This paper discusses the various factors involved in pathophysiology of IBS, especially gut microbiota. (C) 2018 Pan-Arab Association of Gastroenterology. Published by Elsevier B.V. All rights reserved.","[Salem, Ahmed E.] Johns Hopkins Univ, Sch Med, Div Gastroenterol, Div Gastroenterol & Hepatol, Baltimore, MD 21287 USA; [Singh, Rajdeep] Sinai Hosp, Dept Med, 2401 W Belvedere Ave, Baltimore, MD 21215 USA; [Ayoub, Younan K.; Khairy, Ahmed M.] Cairo Univ, Dept Endem Med, Sch Med, Cairo, Egypt; [Mullin, Gerard E.] Johns Hopkins Univ, Sch Med, Div Gastroenterol & Hepatol, Baltimore, MD 21287 USA",Johns Hopkins University; Sinai Hospital of Baltimore; Egyptian Knowledge Bank (EKB); Cairo University; Johns Hopkins University,"Salem, AE (corresponding author), Johns Hopkins Univ, Sch Med, Div Gastroenterol, Div Gastroenterol & Hepatol, Baltimore, MD 21287 USA.",asalem@uab.edu,"Salem, Ahmed/AAW-2678-2021; Mullin, Gerry/H-5294-2019","Mullin, Gerry/0000-0001-5317-6788; Salem, Ahmed/0000-0001-8204-8451; Khairy, Ahmed/0000-0003-2848-6885",,,,,115,25,28,0,32,ELSEVIER SCIENCE BV,AMSTERDAM,"PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",1687-1979,2090-2387,,ARAB J GASTROENTEROL,Arab J. Gastroenterol.,SEP,2018,19,3,,,,,136,141,,10.1016/j.ajg.2018.02.008,http://dx.doi.org/10.1016/j.ajg.2018.02.008,,,6,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,GW8AL,29935865,,,,2024-06-04,WOS:000447194800008,View Full Record in Web of Science
J,"Klosterbuer, A; Roughead, ZF; Slavin, J",,,,"Klosterbuer, Abby; Roughead, Zamzam Fariba; Slavin, Joanne",,,Benefits of Dietary Fiber in Clinical Nutrition,NUTRITION IN CLINICAL PRACTICE,,,English,Article,,,,,,"dietary fiber; enteral nutrition; prebiotics; diarrhea; constipation; fatty acids, volatile",HYDROLYZED GUAR GUM; CHAIN FATTY-ACIDS; INULIN-TYPE FRUCTANS; CRITICALLY-ILL PATIENTS; TOTAL ENTERAL NUTRITION; TUBE-FED PATIENTS; RESISTANT STARCH; BOWEL FUNCTION; SOY-POLYSACCHARIDE; SOLUBLE FIBER,"Dietary fiber is widely recognized as an important part of a healthy diet and is a common addition to enteral nutrition (EN) formulas. Fiber sources differ in characteristics such as solubility, fermentability, and viscosity, and it is now well known that different types of fiber exert varying physiological effects in the body. Clinical studies suggest fiber can exert a wide range of benefits in areas such as bowel function, gut health, immunity, blood glucose control, and serum lipid levels. Although early clinical nutrition products contained fiber from a single source, it is now thought that blends of fiber from multiple sources more closely resemble a regular diet and may provide a greater range of benefits for the patient. Current recommendations support the use of dietary fiber in clinical nutrition when no contraindications exist, but little information exists about which types and combinations of fibers provide the relevant benefit in certain patient populations. This article summarizes the different types of fiber commonly added to EN products and reviews the current literature on the use of fiber blends in clinical nutrition. (Nutr Clin Pract. 2011; 26:625-635)","[Klosterbuer, Abby; Slavin, Joanne] Univ Minnesota, St Paul, MN 55108 USA; [Roughead, Zamzam Fariba] Nestle HealthCare Nutr, Minnetonka, MN USA",University of Minnesota System; University of Minnesota Twin Cities,"Slavin, J (corresponding author), Univ Minnesota, 1334 Eckles Ave, St Paul, MN 55108 USA.",jslavin@umn.edu,"Slavin, Joanne/GOJ-9874-2022","Slavin, Joanne/0000-0003-0720-5300",,,,,118,51,59,1,62,SAGE PUBLICATIONS INC,THOUSAND OAKS,"2455 TELLER RD, THOUSAND OAKS, CA 91320 USA",0884-5336,1941-2452,,NUTR CLIN PRACT,Nutr. Clin. Pract.,OCT,2011,26,5,,,,,625,635,,10.1177/0884533611416126,http://dx.doi.org/10.1177/0884533611416126,,,11,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,824SQ,21947646,,,,2024-06-04,WOS:000295222800015,View Full Record in Web of Science
J,"Patsenko, MB; Ardatskaya, MD; Anuchkin, AA; Butorova, LI; Gaivoronsky, IN; Konkova, LA; Levin, VI; Nugaeva, NR; Pavlov, AI; Topchiy, TB; Patsenko, OY",,,,"Patsenko, Mikhail B.; Ardatskaya, Maria D.; Anuchkin, Aleksandr A.; Butorova, Ludmila I.; Gaivoronsky, Ivan N.; Konkova, Larisa A.; Levin, Vladimir I.; Nugaeva, Nelli R.; Pavlov, Alexandr I.; Topchiy, Tatiana B.; Patsenko, Oksana Yu.",,,The value and advanced features of pre- and metabiotics in the treatment of symptomatic uncomplicated diverticular colon disease,TERAPEVTICHESKII ARKHIV,,,Russian,Article,,,,,,symptomatic uncomplicated diverticular disease; microbiota; prebiotics; metabiotics; butyric acid,,"Background. Symptomatic uncomplicated diverticular colon disease (SNDCD) is a common condition that significantly affects the quality of life of patients. One of the main therapeutic targets in SNDCD is the microbiota. Aim. To evaluate the efficacy and safety of microbiocenosis-based therapy (prebiotic Mucofalk + metabiotic Zakofalk) in relieving symptoms of SNDCD and maintaining asymptomatic remission. Materials and methods. The study included 60 patients with clinically apparent SNDCD. For 3 months, they were treated with Mukofalk and Zakofalk and then followed up for another 3 months. Parameters such as treatment efficacy, satisfaction and compliance were evaluated, as well as change of short -chain fatty acids in feces using gas -liquid chromatography was measured. Results. A statistically significant improvement of all assessed symptoms (abdominal pain, constipation, diarrhea, flatulence, tenesmus) was observed after 3 months of therapy. Relapse of abdominal pain and bowel movement disorders (constipation) after completion of therapy were observed in 7 (11.6%) subjects. The compliance study showed that more than 80% of the required number of sachets/tablets was taken by more than 80% of patients. At the end of follow-up, 49 (81.7%) patients rated their outcomes as excellent and 11 (18.3%) as good. During treatment, there was a significant tendency to increase the absolute content of butyric acid in feces. Conclusion. Microbiocenosis-based therapy with the prebiotic Mukofalk and the metabiotic Zakofalk is effective and safe for treating SNDCD and preventing the recurrence of symptoms and disease complications. The therapy is associated with excellent and good satisfaction and a high compliance to treatment. Therapy with Mukofalk and Zakofalk resulted in the normalization of the intestinal microbiota.","[Patsenko, Mikhail B.; Anuchkin, Aleksandr A.; Butorova, Ludmila I.; Gaivoronsky, Ivan N.; Konkova, Larisa A.; Levin, Vladimir I.; Nugaeva, Nelli R.] Kirov Mil Med Acad branch Moscow, Moscow, Russia; [Ardatskaya, Maria D.; Topchiy, Tatiana B.] Cent State Med Acad President Russian Federat, Moscow, Russia; [Pavlov, Alexandr I.] Vishnevsky Cent Mil Clin Hosp, Natl Med Res Ctr High Med Technol, Moscow, Russia; [Pavlov, Alexandr I.] Russian Biotechnol Univ, Moscow, Russia; [Patsenko, Oksana Yu.] Vishnevsky Cent Mil Clin Hosp, Branch 1 Natl Med Res Ctr High Med Technol, Moscow, Russia",Russian Biotechnological University (ROSBIOTECH),"Butorova, LI (corresponding author), Kirov Mil Med Acad branch Moscow, Moscow, Russia.",ludmilabutorova@mail.ru,,,,,,,21,0,0,0,0,CJSC CONSILIUM MEDICUM,MOSCOW,"NOVIY ZIKOVSKIY PROEZD, D 3, 40, MOSCOW, 125167, RUSSIA",0040-3660,2309-5342,,TERAPEVT ARKH,Ter. Arkhiv,,2024,96,2,,,,,135,142,,10.26442/00403660.2024.02.202610,http://dx.doi.org/10.26442/00403660.2024.02.202610,,,8,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,MT9Z4,,gold,,,2024-06-04,WOS:001196018100009,View Full Record in Web of Science
J,"Eddins, C; Gray, M",,,,"Eddins, Carolyn; Gray, Mike",,,Do Probiotic or synbiotic preparations alleviate symptoms associated with constipation or irritable bowel syndrome?,JOURNAL OF WOUND OSTOMY AND CONTINENCE NURSING,,,English,Editorial Material,,,,,,,DOUBLE-BLIND; LACTOBACILLUS; PREBIOTICS; PLACEBO; COMBINATION; EFFICACY; TRIAL,,"Univ Virginia, Hlth Sci Ctr, Dept Urol, Charlottesville, VA 22908 USA; Univ Virginia, Hlth Care Ctr, Wound Care Team, Charlottesville, VA USA",University of Virginia; University of Virginia,"Gray, M (corresponding author), Univ Virginia, Hlth Sci Ctr, Dept Urol, POB 80042, Charlottesville, VA 22908 USA.",mg5k@virginia.edu,,,,,,,41,6,9,0,12,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",1071-5754,1528-3976,,J WOUND OSTOMY CONT,J. Wound Ostomy Cont. Nurs.,NOV-DEC,2007,34,6,,,,,615,624,,10.1097/01.WON.0000299811.00910.f0,http://dx.doi.org/10.1097/01.WON.0000299811.00910.f0,,,10,Nursing,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Nursing,235HH,18030100,,,,2024-06-04,WOS:000251223800006,View Full Record in Web of Science
J,"Harris, LA; Baffy, N",,,,"Harris, Lucinda A.; Baffy, Noemi",,,Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome,POSTGRADUATE MEDICINE,,,English,Review,,,,,,Antibiotic; constipation; diarrhea; diet; irritable bowel syndrome; microbiota; prebiotic; probiotic; rifaximin,RANDOMIZED CONTROLLED-TRIAL; LACTIS DN-173 010; GLUTEN-FREE DIET; PROBIOTIC-PREBIOTIC TREATMENT; QUALITY-OF-LIFE; FECAL MICROBIOTA; DOUBLE-BLIND; CLINICAL-TRIAL; FERMENTED MILK; INTESTINAL MICROBIOTA,"Irritable bowel syndrome (IBS), which is characterized by recurrent abdominal pain and disordered bowel habits, is one of the most common functional bowel disorders. IBS is a substantial burden on both patient health-related quality of life and healthcare costs. Several pathophysiologic mechanisms have been postulated for the occurrence of IBS, including altered gastrointestinal motility, visceral hypersensitivity, changes in gut permeability, immune activation, gut-brain dysregulation, central nervous system dysfunction, and changes in the gut microbiota. Of note, both qualitative and quantitative differences have been observed in the gut microbiota of a population with IBS versus a healthy population. Because of the substantial interest in the gut microbiota and its role as a therapeutic target in IBS, this article provides an overview of specific interventions with the potential to modulate the gut microbiota in IBS, including elimination diets, prebiotics, probiotics, synbiotics, and nonsystemic antibiotics. Although probiotics and synbiotics are generally well tolerated, differences in the composition and concentration of different bacterial species and inclusion or exclusion of prebiotic components varies widely across studies and has prevented strong recommendations on their use in IBS. For nonsystemic antibiotics, rifaximin is indicated in the United States for the treatment of IBS with diarrhea in adults and has been shown to be efficacious and well tolerated in well-designed clinical trials. Overall, more consistent evidence is needed regarding the efficacy and safety of elimination diets, prebiotics, probiotics, and synbiotics for the treatment of patients with IBS. Furthermore, additional well-designed studies are needed that examine alterations in the gut microbiota that occur with these interventions and their potential associations with clinical symptoms of IBS.","[Harris, Lucinda A.; Baffy, Noemi] Mayo Clin, Div Gastroenterol & Hepatol, 13400 East Shea Blvd, Scottsdale, AZ 85259 USA",Mayo Clinic; Mayo Clinic Phoenix,"Harris, LA (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, 13400 East Shea Blvd, Scottsdale, AZ 85259 USA.",Harris.Lucinda@mayo.edu,,,Salix Pharmaceuticals,Salix Pharmaceuticals,"The authors did not receive any compensation for development of this manuscript. Salix Pharmaceuticals provided funding for editorial support. Salix, the study sponsor, did not actively contribute to the content or have a role in the decision to submit, but reviewed the article for scientific accuracy.",,127,50,60,1,17,TAYLOR & FRANCIS LTD,ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND",0032-5481,1941-9260,,POSTGRAD MED,Postgrad. Med.,,2017,129,8,,,,,872,888,,10.1080/00325481.2017.1383819,http://dx.doi.org/10.1080/00325481.2017.1383819,,,17,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,FQ8FQ,28936910,Bronze,,,2024-06-04,WOS:000418598700012,View Full Record in Web of Science
J,"Roberfroid, MB",,,,"Roberfroid, MB",,,Functional foods: concepts and application to inulin and oligofructose,BRITISH JOURNAL OF NUTRITION,,,English,Editorial Material,,,,,,functional foods; health claims; prebiotics,FRUCTO-OLIGOSACCHARIDES; COLON; BIFIDOBACTERIA; HYDROLYSIS; EXCRETION,"A food can be regarded as functional if it is satisfactorily demonstrated to affect beneficially one or more target functions in the body, beyond adequate nutritional effects, in a way which is relevant to either the state of well-being and health or the reduction of the risk of a disease. Health claims are expected to be authorized for functional foods based either on enhanced function (type A claim) or disease risk reduction (type B claim). Their development is a unique opportunity to contribute to the improvement of the quality of the food offered to consumer's choice for the benefit of his well-being and health. But only a rigorous scientific approach producing sound data will garantee its success. The functional food components that are discussed in the proceedings of the 3rd ORAFTI Research Conference are the inulin-type fructans, natural food components found in miscellaneous edible plants. They are non-digestible oligosaccharides that are classified as dietary fiber. The targets for their functional effects are the colonic microflora that use them as selective 'fertilizers'; the gastrointestinal physiology; the immune functions; the bioavailability of minerals; and the metabolism of lipids. Potential health benefits may also concern reduction of the risk of some diseases like intestinal infections, constipation, non-insulin dependent diabetes, obesity, osteoporosis or colon cancer. The present proceedings review the scientific data available and, by reference to the concepts in functional food science, they assess the scientific evidence which will be used to substantiate health claims.","Catholic Univ Louvain, B-1200 Brussels, Belgium",Universite Catholique Louvain,"Catholic Univ Louvain, B-1200 Brussels, Belgium.",roberfroid@pmnt.ucl.ac.be,,,,,,,30,148,171,1,40,CAMBRIDGE UNIV PRESS,CAMBRIDGE,"EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND",0007-1145,1475-2662,,BRIT J NUTR,Br. J. Nutr.,MAY,2002,87,,,2,,,S139,S143,,10.1079/BJN/2002529,http://dx.doi.org/10.1079/BJN/2002529,,,5,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,567DG,12088510,Bronze,,,2024-06-04,WOS:000176469700001,View Full Record in Web of Science
J,"Stern, EK; Brenner, DM",,,,"Stern, Emily K.; Brenner, Darren M.",,,Gut Microbiota-Based Therapies for Irritable Bowel Syndrome,CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY,,,English,Review,,,,,,,INTESTINAL BACTERIAL OVERGROWTH; FUNCTIONAL GASTROINTESTINAL DISORDERS; CHRONIC IDIOPATHIC CONSTIPATION; RANDOMIZED CONTROLLED-TRIAL; DOUBLE-BLIND; FECAL MICROBIOTA; IBS PATIENTS; BOVINE IMMUNOGLOBULIN; REDUCES SYMPTOMS; RISK-FACTORS,"Irritable bowel syndrome (IBS) is a common, heterogeneous disorder characterized by abdominal pain associated with changes in bowel habits. The pathogenesis of IBS is multifactorial and may relate to alterations in the gut microbiota, changes in visceral sensation and motility, and genetic and environmental factors. Administration of systemic antibiotics may increase the risk of IBS by altering gastrointestinal homeostasis. Therapeutic interventions for IBS with diarrhea that are thought to target alterations in the gut microbiota include the nonsystemic antibiotic rifaximin, the medical food serum-derived bovine immunoglobulin, prebiotics, probiotics, and dietary modification. SYN-010 is a modified-release statin formulation that reduces methane production by Methanobrevibacter smithii and is currently in development for the treatment of patients with constipation-predominant IBS. Use of these interventions in the management of patients with IBS may function to restore a healthy gut microbiota and ameliorate symptoms of IBS.","[Stern, Emily K.; Brenner, Darren M.] Northwestern Univ, Feinberg Sch Med, Div Gastroenterol, 676 North St Clair Ave,Suite 1400, Chicago, IL 60611 USA",Northwestern University; Feinberg School of Medicine,"Brenner, DM (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Gastroenterol, 676 North St Clair Ave,Suite 1400, Chicago, IL 60611 USA.",darren-brenner@northwestern.edu,,,"Salix Pharmaceuticals, Bridgewater, NJ, USA","Salix Pharmaceuticals, Bridgewater, NJ, USA","Technical editorial and medical writing assistance were provided by Mary Beth Moncrief, PhD, and Sophie Bolick, PhD, for Synchrony Medical Communications, LLC, West Chester, PA, USA, under the direction of the authors. Funding for this support was provided by Salix Pharmaceuticals, Bridgewater, NJ, USA. No remuneration for the development of the article was received.",,91,30,34,1,21,NATURE PUBLISHING GROUP,NEW YORK,"75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA",2155-384X,,,CLIN TRANSL GASTROEN,Clin. Transl. Gastroenterol.,FEB 15,2018,9,,,,,,,,e134,10.1038/ctg.2018.2,http://dx.doi.org/10.1038/ctg.2018.2,,,7,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,FY0GG,29446765,"Green Published, gold",,,2024-06-04,WOS:000426488000002,View Full Record in Web of Science
J,"Rahim, MA; Saeed, F; Khalid, W; Hussain, M; Anjum, FM",,,,"Rahim, Muhammad Abdul; Saeed, Farhan; Khalid, Waseem; Hussain, Muzzamal; Anjum, Faqir M.",,,Functional and nutraceutical properties of fructo-oligosaccharides derivatives: a review,INTERNATIONAL JOURNAL OF FOOD PROPERTIES,,,English,Review,,,,,,Prebiotic; Fructo-oligosaccharides; Extraction methods; Health benefits,DIETARY FIBER; FRUCTOOLIGOSACCHARIDES; PREBIOTICS; INULIN; PROBIOTICS; FRUCTOSYLTRANSFERASE; OPTIMIZATION; METABOLISM; EXTRACTION; PROFILE,"Prebiotics are good source of dietary fiber or a group of nutrients or non-digestible short chain carbohydrates which human body cannot digest and it stimulates the growth and activity of some friendly bacteria in your intestinal tract. Prebiotics fibers are linked to beta-(2 -> 1) fructosyl units and are universally agreed to be fructooligosaccharides (FOS) or oligofructose or oligosaccharide or inulin. FOS are oligosaccharides that occur naturally in a variety of plants such as garlic and onions, wheat, rye, chicory roots, jerusalem artichokes, nectarine, seaweed, sugar cane bagasse, cassava waste, rice bran, rice straw, apple pomace, papaya, beet root peels, flaxseed, cereals, and banana peels among many others. These are extracted from fruits, vegetables, seeds and cereals using the various novel techniques such as membrane ultra-filtration method, microwave extraction, Ultrasonic Microwave Assisted Extraction, and high-pressure solvent extraction method. FOS are non-digestible carbohydrates with low-calorie that improve the taste and texture of food products while immunity booster, nutraceutical properties, bone health, microbial properties and its prebiotic activity in digestive track are the limelight of current review article. In addition, the main beneficial physiological effects of FOS such as low carcinogenicity, improved mineral absorption in gut and a reduction in serum cholesterol levels, triacylglycerols and phospholipids are the major part of this review. Moreover, FOS is beneficial for long-term blood glucose and its sensitivity to insulin due to the higher contents of plasma-free fatty acids using low tissue glucose. Conclusively, FOS improves intestinal flora, with subsequent relief of constipation, reduce the risk of heart diseases and certain cancers, improved blood lipids in hyperlipidemia, suppressed the production of intestinal putrefactive-substances and make your digestive work better.","[Rahim, Muhammad Abdul; Saeed, Farhan; Khalid, Waseem; Hussain, Muzzamal] Govt Coll Univ, Dept Food Sci, Faisalabad, Pakistan; [Anjum, Faqir M.] Univ Gambia, Adm Dept, Banjul, Gambia",Government College University Faisalabad; University of the Gambia,"Saeed, F (corresponding author), Govt Coll Univ, Dept Food Sci, Faisalabad, Pakistan.;Anjum, FM (corresponding author), Univ Gambia, Adm Dept, Banjul, Gambia.",f.saeed@gcuf.edu.pk; dranjum@utg.edu.gm,"Khalid, Waseem/IXN-2782-2023; ANJUM, FAQIR/AAW-9311-2020; Saeed, Farhan/ABD-2112-2021; Hussain, Muzzamal/AAC-1261-2022; Rahim, Muhammad Abdul/JVD-7113-2023; rahim, muhammad Sadiq/KFT-2740-2024","Saeed, Farhan/0000-0001-5340-4015; Hussain, Muzzamal/0000-0001-6508-1962;",,,,,102,36,37,14,85,TAYLOR & FRANCIS INC,PHILADELPHIA,"530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA",1094-2912,1532-2386,,INT J FOOD PROP,Int. J. Food Prop.,JAN 1,2021,24,1,,,,,1588,1602,,10.1080/10942912.2021.1986520,http://dx.doi.org/10.1080/10942912.2021.1986520,,,15,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,WC5NV,,gold,,,2024-06-04,WOS:000704304900001,View Full Record in Web of Science
J,"Gómez-Gallego, C; El-Nezami, H",,,,"Gomez-Gallego, Carlos; El-Nezami, Hani",,,Editorial: Novel developments for promoting health through microbiota modulation,FRONTIERS IN NUTRITION,,,English,Editorial Material,,,,,,probiotics; prebiotics; synbiotics; fecal transplants; obesity; type 2 diabetes; hyperuricemia; constipation,,,"[Gomez-Gallego, Carlos; El-Nezami, Hani] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Fac Hlth Sci, Sch Med, Kuopio, Finland; [El-Nezami, Hani] Univ Hong Kong, Fac Sci, Sch Biol Sci, Hong Kong, Peoples R China",University of Eastern Finland; University of Hong Kong,"Gómez-Gallego, C; El-Nezami, H (corresponding author), Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Fac Hlth Sci, Sch Med, Kuopio, Finland.;El-Nezami, H (corresponding author), Univ Hong Kong, Fac Sci, Sch Biol Sci, Hong Kong, Peoples R China.",carlos.gomezgallego@uef.fi; hani.el-nezami@uef.fi,,"Gomez Gallego, Carlos/0000-0003-0219-1827",,,,,2,0,0,3,3,FRONTIERS MEDIA SA,LAUSANNE,"AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND",2296-861X,,,FRONT NUTR,Front. Nutr.,NOV 17,2023,10,,,,,,,,1331665,10.3389/fnut.2023.1331665,http://dx.doi.org/10.3389/fnut.2023.1331665,,,3,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,Z5AA3,38045814,"gold, Green Published",,,2024-06-04,WOS:001112189200001,View Full Record in Web of Science
J,"Salvatore, S; Battigaglia, MS; Murone, E; Dozio, E; Pensabene, L; Agosti, M",,,,"Salvatore, Silvia; Battigaglia, Maria Serena; Murone, Elena; Dozio, Eugenia; Pensabene, Licia; Agosti, Massimo",,,Dietary Fibers in Healthy Children and in Pediatric Gastrointestinal Disorders: A Practical Guide,NUTRIENTS,,,English,Review,,,,,,dietary fiber; children; prebiotics; fermentation; microbiota; SCFAs; functional gastrointestinal disorders; inflammatory bowel disease; diet,IRRITABLE-BOWEL-SYNDROME; HYDROLYZED GUAR GUM; WHOLE-GRAIN INTAKE; DOUBLE-BLIND; FUNCTIONAL CONSTIPATION; ABDOMINAL-PAIN; GALACTO-OLIGOSACCHARIDE; CHILDHOOD CONSTIPATION; INFANT FORMULA; PSYLLIUM FIBER,"Dietary fibers include non-digestible plant carbohydrates, lignin and resistant starch. Dietary fibers provide immune, cardiovascular, metabolic and intestinal beneficial effects in humans. Fibers naturally present in foods (fruits, vegetables, legumes, cereals) or used as supplements have different physical, chemical and functional profiles. This narrative review provides an update to the knowledge on the effects of dietary fibers in healthy subjects and in children with gastrointestinal disorders. Soluble fibers are digested by gut bacteria, producing short-chain fatty acids and energy for colonocytes, and may exert prebiotic effects that promote the growth of bifidobacteria and lactobacilli. Non-soluble fibers are bulking agents and may improve intestinal transit. The exact amount and characteristics of the fiber requirement in infants and children need to be further established. There are limited data evaluating fibers in children with gastrointestinal disorders. The low intake of fibers has been associated with constipation, but the intake of excessive fibers is not recommended as it may cause flatulence and abdominal discomfort. Certain fibers (particularly psyllium in irritable bowel syndrome) have shown beneficial effects in children with gastrointestinal disorders, but the limited and heterogenous data do not currently allow a specific recommendation.","[Salvatore, Silvia; Agosti, Massimo] Univ Insubria, Hosp F Ponte, Pediat Dept, Via F Ponte 19, I-21100 Varese, Italy; [Battigaglia, Maria Serena; Murone, Elena; Pensabene, Licia] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Pediat Unit, Viale Europa, I-88100 Catanzaro, Italy; [Dozio, Eugenia] Univ Insubria, Dipartimento Med & Chirurg, I-21100 Varese, Italy",University of Insubria; Magna Graecia University of Catanzaro; University of Insubria,"Salvatore, S (corresponding author), Univ Insubria, Hosp F Ponte, Pediat Dept, Via F Ponte 19, I-21100 Varese, Italy.",silvia.salvatore@uninsubria.it; mariaserena.battigaglia@studenti.unicz.it; elenamurone@gmail.com; eugenia.dozio@uninsubria.it; pensabene@unicz.it; massimo.agosti@uninsubria.it,,,,,,,84,10,10,7,21,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,MAY 6,2023,15,9,,,,,,,2208,10.3390/nu15092208,http://dx.doi.org/10.3390/nu15092208,,,17,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,G2NN9,37432354,"Green Published, gold",,,2024-06-04,WOS:000987588800001,View Full Record in Web of Science
J,"Wan, XH; Guo, H; Liang, YY; Zhou, CZ; Liu, ZH; Li, KW; Niu, FJ; Zhai, X; Wang, LZ",,,,"Wan, Xinhuan; Guo, Hao; Liang, Yiyu; Zhou, Changzheng; Liu, Zihao; Li, Kunwei; Niu, Fengju; Zhai, Xin; Wang, Lizhu",,,The physiological functions and pharmaceutical applications of inulin: A review,CARBOHYDRATE POLYMERS,,,English,Review,,,,,,Inulin; Physiological functions; Pharmaceutical applications; Prebiotics; Stabilizer; Drug delivery,HUMAN COLONIC MICROBIOTA; SUBUNIT VACCINE POWDER; ABERRANT CRYPT FOCI; CYNARA-SCOLYMUS L.; CHAIN FATTY-ACIDS; JERUSALEM-ARTICHOKE; DIETARY OLIGOFRUCTOSE; IN-VITRO; CALCIUM-ABSORPTION; STORAGE STABILITY,"Inulin (IN), a fructan-type plant polysaccharide, is widely found in nature. The major plant sources of IN include chicory, Jerusalem artichoke, dahlia etc. Studies have found that IN possessed a wide array of biological activities, e.g. as a prebiotic to improve the intestinal microbe environment, regulating blood sugar, regulating blood lipids, antioxidant, anticancer, immune regulation and so on. Currently, IN is widely used in the food and pharmaceutical industries. IN can be used as thickener, fat replacer, sweetener and water retaining agent in the food industry. IN also can be applied in the pharmaceutics as stabilizer, drug carrier, and auxiliary therapeutic agent for certain diseases such as constipation and diabetes. This paper reviews the physiological functions of IN and its applications in the field of pharmaceutics, analyzes its present research status and future research di-rection. This review will serve as a one-in-all resource for the researchers who are interested to work on IN.","[Wan, Xinhuan; Guo, Hao; Liang, Yiyu; Zhou, Changzheng; Liu, Zihao; Li, Kunwei] Shandong Univ Tradit Chinese Med, Sch Pharm, Jinan, Peoples R China; [Niu, Fengju] Shandong Inst Tradit Chinese Med, Jinan, Peoples R China; [Zhai, Xin] Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA; [Wang, Lizhu] Shandong Univ Tradit Chinese Med, Clin Coll 1, Jingshi Rd, Jinan 16369, Peoples R China",Shandong University of Traditional Chinese Medicine; Shandong University of Traditional Chinese Medicine; University of Chicago; Shandong University of Traditional Chinese Medicine,"Wang, LZ (corresponding author), Shandong Univ Tradit Chinese Med, Clin Coll 1, Jingshi Rd, Jinan 16369, Peoples R China.",wlz_0511@sina.com,"Liang, Yiyu/D-5579-2013","Li, Kunwei/0000-0002-8520-5907",,,,,214,78,84,23,157,ELSEVIER SCI LTD,OXFORD,"THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND",0144-8617,1879-1344,,CARBOHYD POLYM,Carbohydr. Polym.,OCT 15,2020,246,,,,,,,,116589,10.1016/j.carbpol.2020.116589,http://dx.doi.org/10.1016/j.carbpol.2020.116589,,,15,"Chemistry, Applied; Chemistry, Organic; Polymer Science",Science Citation Index Expanded (SCI-EXPANDED),Chemistry; Polymer Science,MT3ZR,32747248,,,,2024-06-04,WOS:000554907700013,View Full Record in Web of Science
S,"Hojsak, I",,"Koletzko, B; Bhatia, J; Bhutta, ZA; Cooper, P; Makrides, M; Uauy, R; Wang, W",,"Hojsak, Iva",,,Digestible and Non-Digestible Carbohydrates,"PEDIATRIC NUTRITION IN PRACTICE, 2ND EDITION",World Review of Nutrition and Dietetics,,English,Article; Book Chapter,,,,,,Carbohydrate; Fibre; Glycaemic carbohydrate; Prebiotics,ESPGHAN COMMITTEE; DIETARY FIBER; CHILDREN; CONSTIPATION; PREBIOTICS; OBESITY; HEALTH; FOOD,,"Childrens Hosp Zagreb, Referral Ctr Paediat Gastroenterol & Nutr, HR-10000 Zagreb, Croatia",University of Zagreb,"Hojsak, I (corresponding author), Childrens Hosp Zagreb, Referral Ctr Paediat Gastroenterol & Nutr, Klaiceva 16, HR-10000 Zagreb, Croatia.",ivahojsak@gmail.com,"Hojsak, Iva/AAI-8937-2020","Hojsak, Iva/0000-0003-3262-5964",,,,,18,1,1,2,17,KARGER,BASEL,"POSTFACH, CH-4009 BASEL, SWITZERLAND",0084-2230,1662-3975,978-3-318-02691-7; 978-3-318-02690-0,WORLD REV NUTR DIET,World Rev.Nutr.Diet.,,2015,113,,,,,,46,50,,10.1159/000360316,http://dx.doi.org/10.1159/000360316,10.1159/isbn.978-3-318-02691-7,,5,Nutrition & Dietetics; Pediatrics,Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics; Pediatrics,BD3CI,25906855,,,,2024-06-04,WOS:000359469200010,View Full Record in Web of Science
J,"Lee, S; You, H; Lee, Y; Baik, H; Paik, J; Lee, H; Park, S; Shim, J; Lee, J; Hyun, S",,,,"Lee, Songhee; You, Heesang; Lee, Yeongju; Baik, Haingwoon; Paik, Jeankyung; Lee, Hayera; Park, Soodong; Shim, Jaejung; Lee, Junglyoul; Hyun, Sunghee",,,Intake of MPRO3 over 4 Weeks Reduces Glucose Levels and Improves Gastrointestinal Health and Metabolism,MICROORGANISMS,,,English,Article,,,,,,gut microbiota; 16S rRNA; probiotics; prebiotics; synbiotics,STOOL FORM SCALE; BIFIDOBACTERIUM-ANIMALIS; INSULIN-RESISTANCE; GUT MICROBIOME; HIGH-FAT; PATHWAY; ADULTS; OLIGOFRUCTOSE; FERMENTATION; METAGENOME,"Human gut microbiota are involved in different metabolic processes, such as digestion and nutrient synthesis, among others. For the elderly, supplements are a major means of maintaining health and improving intestinal homeostasis. In this study, 51 elderly women were administered MPRO3 (n = 17), a placebo (n = 16), or both (MPRO3: 1 week, placebo: 3 weeks; n = 18) for 4 weeks. The fecal microbiota were analyzed by sequencing the 16S rRNA gene V3-V4 super-variable region. The dietary fiber intake increased, and glucose levels decreased with 4-week MPRO3 intake. Reflux, indigestion, and diarrhea syndromes gradually improved with MPRO3 intake, whereas constipation was maintained. The stool shape also improved. Bifidobacterium animalis, B. pseudolongum, Lactobacillus plantarum, and L. paracasei were relatively more abundant after 4 weeks of MPRO3 intake than in those subjects after a 1-week intake. Bifidobacterium and B. longum abundances increased after 1 week of MPRO3 intake but decreased when the intake was discontinued. Among different modules and pathways, all 10 modules analyzed showed a relatively high association with 4-week MPRO3 intake. The mineral absorption pathway and cortisol biosynthesis and secretion pathways correlated with the B. animalis and B. pseudolongum abundances at 4 weeks. Therefore, 4-week MPRO3 intake decreased the fasting blood glucose level and improved intestinal health and metabolism.","[Lee, Songhee; Lee, Yeongju; Hyun, Sunghee] Eulji Univ, Grad Sch, Dept Biomed Lab Sci, 712,Dongil ro, Uijongbu 11759, South Korea; [You, Heesang; Hyun, Sunghee] Eulji Univ, Grad Sch, Dept Senior Hlthcare, 712,Dongil ro, Uijongbu 11759, South Korea; [Baik, Haingwoon] Eulji Univ, Sch Med, Grad Sch, Dept Biochem & Mol Biol, Daejeon 34824, South Korea; [Paik, Jeankyung] Eulji Univ, Grad Sch, Dept Food & Nutr, Seongnam 13135, South Korea; [Lee, Hayera; Park, Soodong; Shim, Jaejung; Lee, Junglyoul] R&BD Ctr hy Co Ltd, 22,Giheungdanji ro 24beon gil, Yongin 17086, South Korea",Eulji University; Eulji University; Eulji University; Eulji University,"Hyun, S (corresponding author), Eulji Univ, Grad Sch, Dept Biomed Lab Sci, 712,Dongil ro, Uijongbu 11759, South Korea.;Hyun, S (corresponding author), Eulji Univ, Grad Sch, Dept Senior Hlthcare, 712,Dongil ro, Uijongbu 11759, South Korea.",song-1107@naver.com; yhs1532@nate.com; dlddwn1@gmail.com; baikhw@eulji.ac.kr; jkpaik@eulji.ac.kr; yera@hy.co.kr; soodpark@hy.co.kr; jjshim@hy.co.kr; jlleesk@hy.co.kr; hyunsh@eulji.ac.kr,,"LEE, yeongju/0000-0003-0820-2275; Paik, Jean Kyung/0000-0003-0393-0353; Hyun, Sung Hee/0000-0002-8980-1036; Lee, Hayera/0000-0002-0446-5441; songhee, Lee/0000-0001-5235-8686",,,,,75,4,4,0,7,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2076-2607,,MICROORGANISMS,Microorganisms,JAN,2022,10,1,,,,,,,88,10.3390/microorganisms10010088,http://dx.doi.org/10.3390/microorganisms10010088,,,20,Microbiology,Science Citation Index Expanded (SCI-EXPANDED),Microbiology,ZC0YN,35056536,"gold, Green Published",,,2024-06-04,WOS:000757256600001,View Full Record in Web of Science
J,"Saulnier, DM; Kolida, S; Gibson, GR",,,,"Saulnier, Delphine M.; Kolida, Sofia; Gibson, Glenn R.",,,Microbiology of the Human Intestinal Tract and Approaches for Its Dietary Modulation,CURRENT PHARMACEUTICAL DESIGN,,,English,Review,,,,,,,16S RIBOSOMAL-RNA; ANTIBIOTIC-ASSOCIATED DIARRHEA; LACTOBACILLUS-RHAMNOSUS GR-1; IRRITABLE-BOWEL-SYNDROME; HUMAN COLONIC MICROBIOTA; HUMAN FECAL MICROBIOTA; GROUP-SPECIFIC PRIMERS; IN-SITU HYBRIDIZATION; ACID-INDUCED COLITIS; INULIN-TYPE FRUCTANS,"Gut bacteria can be categorised as being either beneficial or potentially pathogenic due to their metabolic activities and fermentation end-products. Health-promoting effects of the microflora may include immunostimulation, improved digestion and absorption, vitamin synthesis, inhibition of the growth of potential pathogens and lowering of gas distension. Detrimental effects are carcinogen production, intestinal putrefaction, toxin production, diarrhoea/constipation and intestinal infections. Certain indigenous bacteria such as bifidobacteria and lactobacilli are considered to be examples of health-promoting constituents of the microflora. They may aid digestion of lactose in lactose-intolerant individuals, reduce diarrhoea, help resist infections and assist in inflammatory conditions. Probiotics, prebiotics and synbiotics are functional foods that fortify the lactate producing microflora of the human or animal gut.","[Saulnier, Delphine M.; Kolida, Sofia; Gibson, Glenn R.] Univ Reading, Dept Food Biosci, Reading RG6 6AP, Berks, England",University of Reading,"Gibson, GR (corresponding author), Univ Reading, Dept Food Biosci, Reading RG6 6AP, Berks, England.",g.r.gibson@reading.ac.uk,"Gibson, Glenn R/A-9595-2009; SAULNIER, Delphine DM/C-1307-2013",,,,,,120,65,71,1,33,BENTHAM SCIENCE PUBL LTD,SHARJAH,"EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES",1381-6128,1873-4286,,CURR PHARM DESIGN,Curr. Pharm. Design,MAY,2009,15,13,,,,,1403,1414,,10.2174/138161209788168128,http://dx.doi.org/10.2174/138161209788168128,,,12,Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy,441SE,19442165,,,,2024-06-04,WOS:000265790000002,View Full Record in Web of Science
J,"Sawicka, B; Skiba, D; Pszczólkowski, P; Aslan, I; Sharifi-Rad, J; Krochmal-Marczak, B",,,,"Sawicka, Barbara; Skiba, Dominika; Pszczolkowski, Piotr; Aslan, Imran; Sharifi-Rad, Javad; Krochmal-Marczak, Barbara",,,Jerusalem artichoke (Helianthus tuberosus L.) as a medicinal plant and its natural products,CELLULAR AND MOLECULAR BIOLOGY,,,English,Review,,,,,,Jerusalem artichoke; Bioactive ingredients; Medicinal use; Pharmaceutical use; Probiotics; Prebiotics; Functional food,WATER-SOLUBLE EXTRACT; AMINO-ACIDS; FRUCTANS; PROTEIN; INULIN; LIPIDS; FERTILIZATION; PERFORMANCE; NUTRIENT; PROFILE,"Identifying the nutritional and health properties of Helianthus tuberosus , and learning more about this valuable species. It is believed that increased consumption of Jerusalem artichoke (JA) products is related to low blood pressure. One of many questions to answer is whether supplementation of inulin and inulin derivatives obtained from Helianthus tuberosus tubers and aerial parts can be used as antidiabetic, anti-carcinogenic, anti-fungistatic, anti-constipation, body mass-reducing, metabolism-improving agents. We ran a search in Medline, Web of Science, Scopus, Agricola, EBSCO-Food Science Source, Europe PMC, PBL, Cochrane Central Register of Controlled Trials until March 2020. We also browsed reference lists of articles and previous reviews. No language limitations were applied. Jerusalem artichoke (JA) has multiple applications thanks to its rich chemical composition, resistance to biotic and abiotic factors, as: functional food, bio-active ingredient, raw material for the production of ethanol and butanol, succinic, citric and lactic acid. It can be used in medicine and the pharmaceutical industry, because it contains anti-fungistatic, anti-carcinogenic and antioxidant components, and the production of the raw material is easy and inexpensive. It also lowers high cholesterol, triglycerides and high glucose levels; facilitates weight loss; detoxes the organism (e.g. alcohol, heavy metals, radionuclides); lowers uric acid levels; has immunostimulating properties; protects the gastric mucosa, prevents constipation; prevents acne; improves metabolism in lipid disorders; reduces body mass; has cytotoxic properties in breast cancer. It also helps in cardiovascular diseases, chronic infectious diseases; chronic fatigue syndrome; gut flora disorders; immune system disorders. A number of Jerusalem artichoke-derived products were discussed.","[Sawicka, Barbara; Skiba, Dominika] Univ Life Sci, Dept Plant Prod Teclmol & Commod Sci, Akad 15 Str, PL-20950 Lublin, Poland; [Pszczolkowski, Piotr] Expt Stn Cultivar Assessment Cent Crop Res Ctr, PL-21211 Debowa Kloda, Poland; [Aslan, Imran] Bingol Univ, Dept Occupat Hlth & Safety, Healthcare Fac, Bingol, Turkey; [Sharifi-Rad, Javad] Shahid Beheshti Univ Med Sci, Phytochem Res Ctr, Tehran, Iran; [Krochmal-Marczak, Barbara] Stanislaw Pigonia State Higher Vocat Sch Krosno, Dept Plant Prod & Food Safety, Dmochowskiego 12 Str, PL-38400 Krosno, Poland",Bingol University; Shahid Beheshti University Medical Sciences,"Krochmal-Marczak, B (corresponding author), Stanislaw Pigonia State Higher Vocat Sch Krosno, Dept Plant Prod & Food Safety, Dmochowskiego 12 Str, PL-38400 Krosno, Poland.",barbara.marczak@pwsz.krosno.pl,"Krochmal-Marczak, Barbara/AFS-1923-2022; Sawicka, Barbara/I-7614-2019; Aslan, İmran/B-1079-2016; Ertan, Asli/AAE-6201-2021; Sawicka, Barbara/E-7200-2016; KROCHMAL-MARCZAK, BARBARA/HTR-1181-2023; Sharifi-Rad, Javad/D-5747-2016; Marczak, Barbara/ABG-2463-2020","Krochmal-Marczak, Barbara/0000-0001-8619-3031; Sawicka, Barbara/0000-0002-8183-7624; Sawicka, Barbara/0000-0002-8183-7624; Sharifi-Rad, Javad/0000-0002-7301-8151; ASLAN, IMRAN/0000-0001-5307-4474",,,,,125,19,22,2,48,C M B ASSOC,POITIERS,"34 BOULEVARD SOLFERINO, 86000 POITIERS, FRANCE",0145-5680,1165-158X,,CELL MOL BIOL,Cell. Mol. Biol.,,2020,66,4,,,,,160,177,,10.14715/cmb/2020.66.4.20,http://dx.doi.org/10.14715/cmb/2020.66.4.20,,,18,Biochemistry & Molecular Biology; Cell Biology,Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Cell Biology,NR4AY,32583794,hybrid,,,2024-06-04,WOS:000571506200020,View Full Record in Web of Science
J,"Currò, D; Ianiro, G; Pecere, S; Bibbò, S; Cammarota, G",,,,"Curro, Diego; Ianiro, Gianluca; Pecere, Silvia; Bibbo, Stefano; Cammarota, Giovanni",,,"Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders",BRITISH JOURNAL OF PHARMACOLOGY,,,English,Review,,,,,,,RANDOMIZED CLINICAL-TRIAL; GERMINATED BARLEY FOODSTUFF; ACTIVE ULCERATIVE-COLITIS; INDUCED VISCERAL HYPERSENSITIVITY; CHRONIC IDIOPATHIC CONSTIPATION; BIFIDOBACTERIA-FERMENTED MILK; PLACEBO-CONTROLLED TRIAL; EVIDENCE-BASED CONSENSUS; PEPPERMINT-OIL CAPSULES; ACID-INDUCED COLITIS,"Functional bowel disorders (FBD), mainly irritable bowel syndrome (IBS) and functional constipation (FC, also called chronic idiopathic constipation), are very common worldwide. Inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease, although less common, has a strong impact on patients' quality of life, as well as being highly expensive for our healthcare. A definite cure for those disorders is still yet to come. Over the years, several therapeutic approaches complementary or alternative to traditional pharmacological treatments, including probiotics, prebiotics, synbiotics, fibre and herbal medicinal products, have been investigated for the management of both groups of diseases. However, most available studies are biased by several drawbacks, including small samples and poor methodological quality. Probiotics, in particular Saccharomyces boulardii and Lactobacilli (among which Lactobacillus rhamnosus), synbiotics, psyllium, and some herbal medicinal products, primarily peppermint oil, seem to be effective in ameliorating IBS symptoms. Synbiotics and fibre seem to be beneficial in FC patients. The probiotic combination VSL#3 may be effective in inducing remission in patients with mild-to-moderate ulcerative colitis, in whom Escherichia coli Nissle 1917 seems to be as effective as mesalamine in maintaining remission. No definite conclusions can be drawn as to the efficacy of fibre and herbal medicinal products in IBD patients due to the low number of studies and the lack of randomized controlled trials that replicate the results obtained in the individual studies conducted so far. Thus, further, well-designed studies are needed to address the real role of these therapeutic options in the management of both FBD and IBD.","[Curro, Diego] Univ Cattolica Sacro Cuore, Sch Med, Inst Pharmacol, Lgo F Vito 1, I-00168 Rome, Italy; [Ianiro, Gianluca; Pecere, Silvia; Cammarota, Giovanni] Univ Cattolica Sacro Cuore, Sch Med, Dept Internal Med, Lgo F Vito 1, I-00168 Rome, Italy; [Bibbo, Stefano] Univ Sassari, Dept Clin & Expt Med, Vle S Pietro 8, I-07100 Sassari, Italy",Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Sassari,"Currò, D (corresponding author), Univ Cattolica Sacro Cuore, Sch Med, Inst Pharmacol, Lgo F Vito 1, I-00168 Rome, Italy.",diego.curro@unicatt.it,"Bibbo, Stefano/AAA-9851-2019; Cammarota, Giovanni/AAD-1732-2022; Curro', Diego/F-1430-2016; pecere, silvia/M-2541-2018; Andrew, Ruth/C-2727-2008; Ianiro, Gianluca/K-5578-2016","Bibbo, Stefano/0000-0002-8043-4807; Cammarota, Giovanni/0000-0002-3626-6148; Curro', Diego/0000-0001-6726-6872; pecere, silvia/0000-0002-4401-7344; Andrew, Ruth/0000-0002-6916-2994; Ianiro, Gianluca/0000-0002-8318-0515",,,,,222,115,125,2,74,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0007-1188,1476-5381,,BRIT J PHARMACOL,Br. J. Pharmacol.,JUN,2017,174,11,,,,,1426,1449,,10.1111/bph.13632,http://dx.doi.org/10.1111/bph.13632,,,24,Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy,EU7SY,27696378,"Green Published, Bronze",,,2024-06-04,WOS:000401236200014,View Full Record in Web of Science
J,"Hengst, C; Ptok, S; Roessler, A; Fechner, A; Jahreis, G",,,,"Hengst, Christin; Ptok, Sebastian; Roessler, Andrea; Fechner, Anita; Jahreis, Gerhard",,,Effects of polydextrose supplementation on different faecal parameters in healthy volunteers,INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION,,,English,Article,,,,,,polydextrose; prebiotics; orofaecal transit time; microbiota; short-chain fatty acids,GASTROINTESTINAL-TRACT; RESISTANT STARCH; COLON-CANCER; FERMENTATION; CHOLESTEROL; BACTERIA; COPROSTANOL; MICROBIOTA; LACTITOL; STEROLS,"Polydextrose (PDX) is a non-digestible polysaccharide providing beneficial effects on bowel health. The aim of the study was to show prebiotic effects of PDX. A placebo-controlled, randomized intervention study with PDX supplementation (8 g/day) was conducted in 45 healthy subjects. The effects of PDX on stool weight, orofaecal transit time, consistency of stool (Bristol stool form scale), short-chain fatty acid production, pH value, neutral sterol and bile acid excretion and faecal microbiota were evaluated. It was found that supplementation of PDX shortened the orofaecal transit time significantly. Furthermore, ingestion of PDX resulted in a decreased pH value and in significant changes in bile acid and neutral sterol excretion. PDX had no effects on stool weight, concentrations of the abundant short-chain fatty acids (acetate, propionate) and faecal contents of Lactobacillus acidophilus and Bifidobacterium lactis. In conclusion, PDX is able to shorten the orofaecal transit time and to improve stool consistency in subjects suffering from constipation.","[Hengst, Christin; Ptok, Sebastian; Roessler, Andrea; Fechner, Anita; Jahreis, Gerhard] Univ Jena, Inst Nutr, Dept Nutr Physiol, D-07743 Jena, Germany",Friedrich Schiller University of Jena,"Jahreis, G (corresponding author), Univ Jena, Inst Nutr, Dept Nutr Physiol, Dornburger Str 24, D-07743 Jena, Germany.",b6jage@uni-jena.de,,,"Zott GmbH & Co KG, Merntingen, Germany","Zott GmbH & Co KG, Merntingen, Germany","The present study was supported by Zott GmbH & Co KG, Merntingen, Germany. The authors thank all volunteers for participation.",,31,39,45,0,10,TAYLOR & FRANCIS LTD,ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND",0963-7486,1465-3478,,INT J FOOD SCI NUTR,Int. J. Food Sci. Nutr.,,2009,60,,,5,,,96,105,,10.1080/09637480802526760,http://dx.doi.org/10.1080/09637480802526760,,,10,Food Science & Technology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Nutrition & Dietetics,535BW,19107626,,,,2024-06-04,WOS:000272942600011,View Full Record in Web of Science
J,"Uyar, GÖ; Yildiran, H",,,,"Uyar, Gizem Ozata; Yildiran, Hilal",,,A nutritional approach to microbiota in Parkinson's disease,BIOSCIENCE OF MICROBIOTA FOOD AND HEALTH,,,English,Review,,,,,,Parkinson's disease; alpha-synuclein; microbiota; nutrition; probiotics; gut-brain axis,GUT-BRAIN AXIS; HELICOBACTER-PYLORI; INTESTINAL PERMEABILITY; STRUCTURAL-CHANGES; DIETARY PATTERNS; DOUBLE-BLIND; POLYPHENOLS; PROBIOTICS; FIBER; PREBIOTICS,"Parkinson's disease (PD) is a neurodegenerative disease characterized by motor impairment and the accumulation of alpha-synucleinopathy (alpha-syn), which can affect different levels of the brain-gut axis. There is a two-way communication between the gastrointestinal tract, and brain that includes the gut microbiota. This bidirectional communication between the gut microbiota and the brain includes many pathways, such as immune mechanisms, the vagus nerve, and microbial neurometabolite production. The common cause of constipation in PD is thought to be the accumulation of alpha-syn proteins in the enteric nervous system. Recent studies have focused on changes in microbial metabolites and gut microbiota dysbiosis. Microbiota dysbiosis is associated with increased intestinal permeability, intestinal inflammation, and neuroinflammation. Many factors, such as unbalanced nutrition, antibiotic use, age, and infection, result in alteration of microbial metabolites, triggering alpha-syn accumulation in the intestinal mucosa cells. Increased evidence indicates that the amount, type, and balance of dietary macronutrients (carbohydrates, proteins, and fats); high consumption of vegetables, fruits, and omega-3 fatty acids; and healthy diet patterns such as the Mediterranean diet may have a great protective impact on PD. This review focuses on the potential benefits of prebiotics, probiotics, and synbiotics to regulate microbiota dysbiosis along with the effect of diet on the gut microbiota in PD.","[Uyar, Gizem Ozata; Yildiran, Hilal] Gazi Univ, Fac Hlth Sci, Dept Nutr & Dietet, Ankara, Turkey",Gazi University,"Uyar, GÖ (corresponding author), Gazi Univ, Fac Hlth Sci, Dept Nutr & Dietet, Ankara, Turkey.",gizemozata91@gmail.com,"YILDIRAN, HİLAL/AID-4577-2022; ÖZATA UYAR, Gizem/AED-0847-2022","ÖZATA UYAR, Gizem/0000-0002-9022-6956",,,,,142,25,26,2,18,BMFH PRESS,TOKYO,"ATTN-BMFH, EDITORIAL OFF IPEC INC, 1-24-12 SUGAMO,TOSHIMA-KU, TOKYO, 170-0002, JAPAN",2186-6953,2186-3342,,BIOSCI MICROB FOOD H,Biosci. Microbiota Food Health,,2019,38,4,,,,,115,127,,10.12938/bmfh.19-002,http://dx.doi.org/10.12938/bmfh.19-002,,,13,Microbiology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Microbiology; Nutrition & Dietetics,JI5YS,31763115,"Green Published, gold",,,2024-06-04,WOS:000493544100001,View Full Record in Web of Science
J,"Alvarez-Calatayud, G; Pérez-Moreno, J; Tolín, M; Sánchez, C",,,,"Alvarez-Calatayud, Guillermo; Perez-Moreno, Jimena; Tolin, Mar; Sanchez, Cesar",,,CLINICAL APPLICATIONS OF THE USE OF PROBIOTICS IN PEDIATRICS,NUTRICION HOSPITALARIA,,,Spanish,Article,,,,,,Gut microbiota; Probiotics; Children,ANTIBIOTIC-ASSOCIATED DIARRHEA; EVIDENCE-BASED GUIDELINES; IRRITABLE-BOWEL-SYNDROME; TREATING ACUTE DIARRHEA; REUTERI DSM 17938; DOUBLE-BLIND; HELICOBACTER-PYLORI; LACTOBACILLUS-GG; SACCHAROMYCES-BOULARDII; CYSTIC-FIBROSIS,"Introduction: The use of probiotics supposes a novel advance in the field of Pediatrics since they can be useful in the prevention and treatment of many gastrointestinal pathologies, constituting one more element in our therapeutic arsenal. Objective: This article presents an updated review of the scientific literature on the use of probiotics in paediatrics, mainly in gastrointestinal problems with alteration in the intestinal microbiota describing the main applications of the use of probiotics and prebiotics in childhood and reviewing the future lines of research. Results and conclusions: Although there enough scientific evidence in various pathologies, the use of probiotics is not entirely incorporated into the clinical practice of pediatricians. It is used in the context of the gastrointestinal diseases (acute infectious diarrhea, diarrhea associated with antibiotics, bacterial overcast) and, more recently, in chronic inflammatory processes such as inflammatory bowel disease or functional disorders as colic infant or constipation. Also have been assessed their beneficial effect in extraintestinal alterations, such as the allergies (atopic dermatitis) or the effects on respiratory or urogenital mucosae and, in recent years, in the prevention of pathology of the preterm newborn and in the H. pylori infection. In addition there are several lines of research open in nutritional supplementation with probiotics. and prebiotics. Each strain probiotics should be studied individually and extensively to determine its efficacy and safety in all situations in which their employment may be advisable.","[Alvarez-Calatayud, Guillermo; Perez-Moreno, Jimena; Tolin, Mar; Sanchez, Cesar] Hosp Gen Univ Gregorio Maranon, Secc Gastroenterol & Nutr Pediat, Madrid 28007, Spain",General University Gregorio Maranon Hospital,"Alvarez-Calatayud, G (corresponding author), Hosp Gen Univ Gregorio Maranon, Secc Gastroenterol & Nutr Pediat, C ODonnell 48, Madrid 28007, Spain.",galvarezcalatayud@gmail.com,"Alvarez Calatayud, Guillermo/KAL-8818-2024","Perez moreno, Jimena/0000-0002-7360-7319",,,,,99,4,8,0,60,"ARAN EDICIONES, S L",MADRID,"C/ CASTELLO, 128, 1O, MADRID, 28006, SPAIN",0212-1611,1699-5198,,NUTR HOSP,Nutr. Hosp.,MAY-JUN,2013,28,3,,,,,564,574,,10.3305/nh.2013.28.3.6603,http://dx.doi.org/10.3305/nh.2013.28.3.6603,,,11,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,140PD,23848073,,,,2024-06-04,WOS:000318666500003,View Full Record in Web of Science
J,"Barnes, D; Yeh, AM",,,,"Barnes, Danielle; Yeh, Ann Ming",,,Bugs and Guts: Practical Applications of Probiotics for Gastrointestinal Disorders in Children,NUTRITION IN CLINICAL PRACTICE,,,English,Review,,,,,,probiotics; pediatrics; microbiota; prebiotics; gastroenteritis; inflammatory bowel diseases; irritable bowel syndrome; diarrhea,ANTIBIOTIC-ASSOCIATED DIARRHEA; PLACEBO-CONTROLLED TRIAL; LACTOBACILLUS-RHAMNOSUS GG; CLOSTRIDIUM-DIFFICILE INFECTION; TREATING ACUTE GASTROENTERITIS; BIFIDOBACTERIA-FERMENTED MILK; RANDOMIZED CONTROLLED-TRIAL; IRRITABLE-BOWEL-SYNDROME; LONG-TERM CONSUMPTION; REUTERI DSM 17938,"Probiotics are foods or products that contain live microorganisms that benefit the host when administered. In this clinical review, we evaluate the literature associated with using probiotics in common pediatric gastrointestinal disorders, focusing specifically on antibiotic-associated diarrhea, acute gastroenteritis, Clostridium difficile infection (CDI), colic, inflammatory bowel disease, and functional gastrointestinal diseases. Meta-analysis of several randomized controlled trials have confirmed benefit for the administration of Lactobacillus rhamnosus GG and Saccharomyces boulardii to prevent antibiotic-associated diarrhea and to treat acute infectious diarrhea. Individual studies have also suggested benefit of probiotics to prevent acute gastroenteritis and serve as an adjunct in ulcerative colitis, pouchitis, antibiotic-associated diarrhea, CDI, functional abdominal pain, irritable bowel syndrome, and colic in breastfed babies. Although promising, larger well-designed studies need to confirm these findings. There is currently insufficient evidence to recommend probiotics for the treatment of constipation-predominant irritable bowel syndrome or Crohn's disease.","[Barnes, Danielle; Yeh, Ann Ming] Stanford Univ, Stanford Childrens Hlth, Dept Pediat, Div Pediat Gastroenterol Hepatol & Nutr, Palo Alto, CA 94304 USA",Stanford University,"Yeh, AM (corresponding author), Stanford Univ, Sch Med, 750 Welch Rd,Suite 116, Palo Alto, CA 94304 USA.",annming@stanford.edu,,,Tashia and John Morgridge Endowed Postdoctoral Fellowship; Child Health Research Institute; Stanford NIH Clinical and Translational Science Award [UL1 TR001085],Tashia and John Morgridge Endowed Postdoctoral Fellowship; Child Health Research Institute; Stanford NIH Clinical and Translational Science Award,"Funding was provided by the Tashia and John Morgridge Endowed Postdoctoral Fellowship, Child Health Research Institute, and Stanford NIH Clinical and Translational Science Award (Grant: UL1 TR001085).",,112,19,26,0,51,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0884-5336,1941-2452,,NUTR CLIN PRACT,Nutr. Clin. Pract.,DEC,2015,30,6,,,,,747,759,,10.1177/0884533615610081,http://dx.doi.org/10.1177/0884533615610081,,,13,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,CV9WE,26538058,,,,2024-06-04,WOS:000364637500003,View Full Record in Web of Science
J,"Hubbard, GP; Atwal, K; Graham, L; Narayanan, S; Cooke, L; Casewell, C; Denton, SA; Gavin, J; Browne, RM; Kinnear, FJ; McHardy, AJ; Evans, D; Vallis, R; Venkataraman, D; Cawood, AL; Donohoe, S; Steele, V; Armstrong, S; Stratton, RJ",,,,"Hubbard, Gary P.; Atwal, Kiranjit; Graham, Lynne; Narayanan, Sankara; Cooke, Lisa; Casewell, Catherine; Denton, Sally-Ann; Gavin, Joan; Browne, Robert M.; Kinnear, Fiona J.; McHardy, Ailsa J.; Evans, Debbie; Vallis, Rachel; Venkataraman, Devasmitha; Cawood, Abbie L.; Donohoe, Sarah; Steele, Victoria; Armstrong, Sonia; Stratton, Rebecca J.",,,"Synbiotic containing extensively hydrolyzed formula improves gastrointestinal and atopic symptom severity, growth, caregiver quality of life, and hospital-related healthcare use in infants with cow's milk allergy",IMMUNITY INFLAMMATION AND DISEASE,,,English,Article,,,,,,cow's milk allergy; dermatitis; prebiotics; probiotics; synbiotics,ACID-BASED FORMULA; 1ST 6 MONTHS; GUT MICROBIOTA; FOOD ALLERGY; INTESTINAL MICROFLORA; ECZEMA/DERMATITIS SYNDROME; PROBIOTIC BACTERIA; DOUBLE-BLIND; DERMATITIS; CHILDREN,"Background: Healthy gut microbiota is important for prognosis in cow's milk allergy (CMA). The application of synbiotics (specific pre- and probiotics) in extensively hydrolyzed formulae (eHFs) is a relatively new concept. Aims: To evaluate a synbiotic-containing, whey-based eHF (SeHF) with galacto-oligosaccharides, fructo-oligosaccharides, and bifidobacterium breve M-16V in infants with CMA. Materials and Methods: A 31-day one-arm pilot study in 29 infants with CMA (mean age 30.8 weeks [SD 11]) was undertaken, with outcomes including gastrointestinal tolerance, atopic dermatitis symptoms, dietary intake, growth, SeHF acceptability, caregiver quality of life, and hospital-related healthcare use. Results: Significant improvements (p < .05) in the severity of abdominal pain (in 57%), burping (in 46%), flatulence (in 79%), constipation (in 14%), rhinitis (41%), and itchy eyes (73%), as well as atopic dermatitis in those with severe baseline symptoms (PO-SCORAD(C) reduction: 34.7-18.2 (p = .003), n = 6) were observed over time. Growth and caregiver quality of life scores significantly increased (+26.7%, p < .05) over time. Hospital visits and medications significantly reduced (-1.61 and -2.23, respectively, p < .005) in the 6 months after SeHF initiation. Discussion: In this small, single-arm, pilot study, the use of SeHF enhanced the management of infants with non-IgE mediated CMA who were already established on eHF. Conclusion: Whilst this study adds to the evidence base for the use of SeHF in CMA, further robust research to explore the longer-term benefits of synbiotics, specifically the blend used in this study, for the clinical management of infants with CMA is warranted.","[Hubbard, Gary P.; Atwal, Kiranjit; Browne, Robert M.; Kinnear, Fiona J.; Cawood, Abbie L.; Stratton, Rebecca J.] Nutricia Ltd, Trowbridge, England; [Graham, Lynne; Narayanan, Sankara] West Hertfordshire Hosp NHS Trust, Watford, England; [Cooke, Lisa] Bristol Royal Hosp Children, Bristol, Avon, England; [Casewell, Catherine] Ashford & St Peters Hosp NHS Fdn Trust, Chertsey, England; [Denton, Sally-Ann; Gavin, Joan; McHardy, Ailsa J.] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England; [Evans, Debbie; Vallis, Rachel] Royal Surrey NHS Fdn Trust, Guildford, Surrey, England; [Venkataraman, Devasmitha; Donohoe, Sarah; Steele, Victoria; Armstrong, Sonia] South Tees Hosp NHS Fdn Trust, James Cook Hosp, Middlesbrough, Cleveland, England; [Stratton, Rebecca J.] Univ Southampton, Fac Med, Southampton, Hants, England",Danone Nutricia; Bristol Royal Hospital For Children; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton,"Hubbard, GP (corresponding author), Nutricia Ltd, Trowbridge, England.",gary.hubbard@nutricia.com,"Atwal, Kiranjit/KJZ-6174-2024","Stratton, Rebecca J/0000-0003-3811-3847; Hubbard, Gary/0000-0001-6029-6446; Atwal, Kiranjit/0000-0003-2265-7321",Nutricia Ltd,Nutricia Ltd(Danone Nutricia),Nutricia Ltd,,86,5,5,1,6,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",,2050-4527,,IMMUN INFLAMM DIS,IMMUN. INFLAMM. DIS.,JUN,2022,10,6,,,,,,,e636,10.1002/iid3.636,http://dx.doi.org/10.1002/iid3.636,,,17,Immunology,Science Citation Index Expanded (SCI-EXPANDED),Immunology,1J0FS,35634950,"Green Published, gold",,,2024-06-04,WOS:000797602400001,View Full Record in Web of Science
J,"Nishimoto, Y; Nomaguchi, T; Mori, Y; Ito, M; Nakamura, Y; Fujishima, M; Murakami, S; Yamada, T; Fukuda, S",,,,"Nishimoto, Yuichiro; Nomaguchi, Tatsuhiro; Mori, Yuka; Ito, Masaki; Nakamura, Yuya; Fujishima, Masaki; Murakami, Shinnosuke; Yamada, Takuji; Fukuda, Shinji",,,The Nutritional Efficacy of Chlorella Supplementation Depends on the Individual Gut Environment: A Randomised Control Study,FRONTIERS IN NUTRITION,,,English,Article,,,,,,prebiotics (sources; MeSH); gut microbiome; gut metabolome; dietary fibre; Chlorella,PROBIOTIC INTERVENTION; GLUCOSE-METABOLISM; OMEGA-OXIDATION; MICROBIOTA; VULGARIS; ACID; MODULATION; PRODUCTS,"Recent studies have accumulated evidence that the intestinal environment is strongly correlated with host diet, which influences host health. A number of dietary products whose mechanisms of influence operate via the gut microbiota have been revealed, but they are still limited. Here, we investigated the dietary influence of Chlorella, a green alga commercially available as a dietary supplement. A randomised, double-blind, placebo-controlled crossover trial including 40 Japanese participants with constipation was performed. In this study, the primary outcome and secondary outcome were set as defecation frequency and blood folate level, respectively. In both outcomes, no significant differences were detected compared to the control intake. Therefore, we analysed the gut microbiome, gut metabolome, and blood parameters in an integrated manner as an exploratory analysis. We revealed that the consumption of Chlorella increased the level of several dicarboxylic acids in faeces. Furthermore, the analysis showed that individuals with low concentrations of faecal propionate showed an increase in propionate concentration upon Chlorella intake. In addition, increasing blood folate levels were negatively correlated with defecation frequency at baseline. Our study suggested that the effect of Chlorella consumption varies among individuals depending on their intestinal environment, which illustrates the importance of stratified dietary management based on the intestinal environment in individuals.","[Nishimoto, Yuichiro; Nomaguchi, Tatsuhiro; Mori, Yuka; Ito, Masaki; Nakamura, Yuya; Murakami, Shinnosuke; Yamada, Takuji; Fukuda, Shinji] Metabologenomics Inc, Tsuruoka, Yamagata, Japan; [Fujishima, Masaki] Sun Chlorella Corp, Kyoko, Japan; [Murakami, Shinnosuke; Fukuda, Shinji] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Yamada, Takuji] Tokyo Inst Technol, Dept Life Sci & Technol, Tokyo, Japan; [Fukuda, Shinji] Kanagawa Inst Ind Sci & Technol, Intestinal Microbiota Project, Kawasaki, Kanagawa, Japan; [Fukuda, Shinji] Univ Tsukuba, Transborder Med Res Ctr, Tsukuba, Ibaraki, Japan",Keio University; Tokyo Institute of Technology; Kanagawa Academy Science & Technology; University of Tsukuba,"Yamada, T; Fukuda, S (corresponding author), Metabologenomics Inc, Tsuruoka, Yamagata, Japan.;Fukuda, S (corresponding author), Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan.;Yamada, T (corresponding author), Tokyo Inst Technol, Dept Life Sci & Technol, Tokyo, Japan.;Fukuda, S (corresponding author), Kanagawa Inst Ind Sci & Technol, Intestinal Microbiota Project, Kawasaki, Kanagawa, Japan.;Fukuda, S (corresponding author), Univ Tsukuba, Transborder Med Res Ctr, Tsukuba, Ibaraki, Japan.",yamada@metagen.co.jp; sfukuda@metagen.co.jp,"Masaki, Fujishima/AAT-6049-2021; Yamada, Takuji/GVS-1079-2022","Masaki, Fujishima/0000-0002-0396-6199; Yamada, Takuji/0000-0002-9622-1849; Murakami, Shinnosuke/0000-0002-1101-9255; Fukuda, Shinji/0000-0001-5161-9880; Nakamura, Yuya/0000-0003-4018-1718","Sun Chlorella Corp.; Metabologenomics, Inc.","Sun Chlorella Corp.; Metabologenomics, Inc.","This study was funded by Sun Chlorella Corp., and Metabologenomics, Inc.",,32,5,5,3,22,FRONTIERS MEDIA SA,LAUSANNE,"AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND",2296-861X,,,FRONT NUTR,Front. Nutr.,MAY 31,2021,8,,,,,,,,648073,10.3389/fnut.2021.648073,http://dx.doi.org/10.3389/fnut.2021.648073,,,10,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,SR5IG,34136514,"Green Published, Green Submitted, gold",,,2024-06-04,WOS:000661074400001,View Full Record in Web of Science
J,"Cuamatzin-García, L; Rodríguez-Rugarcía, P; El-Kassis, EG; Galicía, G; Meza-Jiménez, MD; Baños-Lara, MD; Zaragoza-Maldonado, DS; Pérez-Armendáriz, B",,,,"Cuamatzin-Garcia, Leonel; Rodriguez-Rugarcia, Paola; El-Kassis, Elie Girgis; Galicia, Georgina; Meza-Jimenez Maria, de Lourdes; Banos-Lara Ma., del Rocio; Zaragoza-Maldonado Diego, Salatiel; Perez-Armendariz, Beatriz",,,Traditional Fermented Foods and Beverages from around the World and Their Health Benefits,MICROORGANISMS,,,English,Review,,,,,,traditional fermented foods and beverages; functional food; gut microbiota; prebiotics; probiotics,LACTIC-ACID BACTERIA; AGAVE-TEQUILANA; GUT MICROBIOTA; BODY-COMPOSITION; KOMBUCHA TEA; DOUBLE-BLIND; CONSUMPTION; PROBIOTICS; MILK; INULIN,"Traditional fermented foods and beverages play an important role in a range of human diets, and several experimental studies have shown their potential positive effects on human health. Studies from different continents have revealed strong associations between the microorganisms present in certain fermented foods (e.g., agave fructans, kefir, yeats, kombucha, chungkookjang, cheeses and vegetables, among others) and weight maintenance, reductions in the risk of cardiovascular disease, antidiabetic and constipation benefits, improvement of glucose and lipids levels, stimulation of the immunological system, anticarcinogenic effects and, most importantly, reduced mortality. Accordingly, the aim of this review is to corroborate information reported in experimental studies that comprised interventions involving the consumption of traditional fermented foods or beverages and their association with human health. This work focuses on studies that used fermented food from 2014 to the present. In conclusion, traditional fermented foods or beverages could be important in the promotion of human health. Further studies are needed to understand the mechanisms involved in inflammatory, immune, chronic and gastrointestinal diseases and the roles of fermented traditional foods and beverages in terms of preventing or managing those diseases.","[Cuamatzin-Garcia, Leonel; Rodriguez-Rugarcia, Paola; El-Kassis, Elie Girgis; Perez-Armendariz, Beatriz] Univ Popular Autonoma Estado Puebla, Biol Sci Dept, Puebla 72410, Mexico; [Galicia, Georgina] Pfizer Univ Granada Junta Andalucia, Ctr Genom & Oncol Res GENYO, Granada 18016, Spain; [Meza-Jimenez Maria, de Lourdes] Univ Popular Autonoma Estado Puebla, Sch Nutr, Dept Hlth Sci, Puebla 72410, Mexico; [Banos-Lara Ma., del Rocio; Zaragoza-Maldonado Diego, Salatiel] Univ Popular Autonoma Estado Puebla, Oncol Res Ctr, Una Nueva Esperanza, Puebla 72410, Mexico; [Banos-Lara Ma., del Rocio] Univ Popular Autonoma Estado Puebla, Sch Med, Puebla 72410, Mexico",Universidad Popular Autonoma del Estado de Puebla; Pfizer; University of Granada; Universidad Popular Autonoma del Estado de Puebla; Universidad Popular Autonoma del Estado de Puebla; Universidad Popular Autonoma del Estado de Puebla,"Pérez-Armendáriz, B (corresponding author), Univ Popular Autonoma Estado Puebla, Biol Sci Dept, Puebla 72410, Mexico.",leocuamatzin@gmail.com; paola.rdz.rugarcia@gmail.com; eliegirgis.elkassis@upaep.mx; georgina.galicia@gmail.com; marialourdes.meza@upaep.mx; marocio.banos@upaep.mx; diegozaragoza@unanuevaesperanza.mx; beatriz.perez@upaep.mx,"Pérez-Armendáriz, Beatriz/GSM-7849-2022; Meza Jiménez, María de Lourdes/GQP-9502-2022","Pérez-Armendáriz, Beatriz/0000-0002-2287-8338; El Kassis, Elie Girgis/0000-0002-8397-9482; Banos Lara, Ma. del Rocio/0000-0002-8455-8671; Meza Jimenez, Maria de Lourdes/0000-0001-6560-0929",,,,,104,21,22,6,52,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2076-2607,,MICROORGANISMS,Microorganisms,JUN,2022,10,6,,,,,,,1151,10.3390/microorganisms10061151,http://dx.doi.org/10.3390/microorganisms10061151,,,18,Microbiology,Science Citation Index Expanded (SCI-EXPANDED),Microbiology,2N3FZ,35744669,"Green Published, gold",,,2024-06-04,WOS:000818270600001,View Full Record in Web of Science
J,"Tomas, L",,,,"Tomas, Lily",,,Best breastfeeding and formulas,JOURNAL OF COMPLEMENTARY MEDICINE,,,English,Article,,,,,,,FATTY-ACID-COMPOSITION; RANDOMIZED CONTROLLED-TRIAL; HUMAN-MILK OLIGOSACCHARIDES; FULL-TERM INFANTS; DOCOSAHEXAENOIC ACID; PREGNANCY; LACTATION; PRETERM; OUTCOMES; MOTHERS,"The nature of the protein source is the main criteria for choosing an infant formula Adverse reactions to cow's milk protein may include constipation, diarrhoea, abdominal bloating, excessive burping and/or flatulence, reflux, colic, irritability, excessive crying or difficulty steeping. A different formula should always be trialled The main indication for using soya or goat's milk formulas include cow's milk allergy/intolerance, galactosaemia or ethical considerations. They are not recommended for the prevention of allergy or intolerance in high-risk infants Feeding high-risk infants a hypoallergenic or pure amino-acid formula, combined with avoidance of complementary foods during the first 4-6 months, reduces infant and childhood allergy, atopic dermatitis and infant cow's milk allergy when compared with standard cow's milk formula Antenatal supplementation with DHA is associated with improved mental and visual development, and decreased incidence of allergy, asthma, infection and other auto-immune diseases Breast milk contains natural prebiotics that stimulate bifidobacteria and Lactobacillus growth in the gut, reducing the incidence of allergy. Prebiotics added to infant formulas decrease atopic dermatitis, intestinal and upper airway infections in the first year of life Vitamin D and/or iodine deficiency is very common during pregnancy. Vitamin D deficiency may result in bone disease, dental problems, auto-immune disease, several cancers and even autism. Iodine deficiency is the most common cause of preventable mental impairment worldwide Proper breastfeeding training is comparable to pharmaceutical galactagogues, such as metoclopramide. Fenugreek, goat's rue and fennel are common herbal galactagogues",,,,,,,,,,,34,1,1,0,29,AUSTRALIAN PHARMACEUTICAL PUBLISHING CO LTD,HAWTHORN,"40 BURWOOD ROAD, HAWTHORN, VIC 3122, AUSTRALIA",1446-8263,,,J COMPLEMENT MED,J. Complement. Med.,MAR-APR,2009,8,2,,,,,32,+,,,,,,6,Integrative & Complementary Medicine,Science Citation Index Expanded (SCI-EXPANDED),Integrative & Complementary Medicine,422CR,,,,,2024-06-04,WOS:000264405200017,View Full Record in Web of Science
J,"Vandenplas, Y; Cruchet, S; Faure, C; Lee, HC; Di Lorenzo, C; Staiano, A; Xu, CD; Aw, MM; Gutiérrez-Castrellón, P; Asery, A; Spolidoro, J; Heine, RG; Miqdady, M; Arancibia, ME; Alarcón, P",,,,"Vandenplas, Y.; Cruchet, S.; Faure, C.; Lee, H. C.; Di Lorenzo, C.; Staiano, A.; Xu Chundi; Aw, M. M.; Gutierrez-Castrellon, P.; Asery, A.; Spolidoro, J.; Heine, R. G.; Miqdady, M.; Arancibia, M. E.; Alarcon, P.",,,When should we use partially hydrolysed formulae for frequent gastrointestinal symptoms and allergy prevention?,ACTA PAEDIATRICA,,,English,Article,,,,,,Cow milk (protein) allergy; Extensive hydrolysate; Hydrolysate; Hypo-allergenic formula; partially hydrolysate,REUTERI DSM 17938; INFANT FORMULA; DOUBLE-BLIND; WHEY FORMULA; MILK FORMULA; PROTEIN; DISEASE; CHILDREN; RECOMMENDATIONS; TOLERANCE,"Experts reviewed the literature to determine whether partially whey hydrolysed formulas (HF) offer benefits in the dietary management of frequent gastrointestinal symptoms and allergy prevention. Compared with standard cow's milk-based formulas, partially whey HF confer a limited protective effect against allergic disease in high-risk infants, particularly atopic dermatitis, but not respiratory allergies. No randomised clinical trials have been published on partially whey HF in infants with colicky symptoms. The group did not find sufficient evidence to support the use of partially whey HF in regurgitation, although recent data suggest that a thickened partially whey HF may be more effective. Partially whey HF, fortified with prebiotics and/or probiotics, with high levels of sn-2 palmitate in the fat blend or without palm oil, provide some benefit in functional constipation. Conclusion Overall, partially whey HF may offer a useful alternative to intact protein in the dietary management of common functional gastrointestinal symptoms.","[Vandenplas, Y.] Vrije Univ Brussel, UZ Brussel, Brussels, Belgium; [Cruchet, S.] Univ Chile, INTA, Santiago, Chile; [Faure, C.] Univ Montreal, Dept Pediat, Montreal, PQ H3C 3J7, Canada; [Lee, H. C.] Mackay Mem Hosp, Dept Pediat, Hsinchu, Taiwan; [Lee, H. C.] Taipei Med Univ, Taipei, Taiwan; [Di Lorenzo, C.] Nationwide Childrens Hosp, Dept Pediat, Columbus, OH USA; [Staiano, A.] Univ Naples Federico II, Dept Pediat, Naples, Italy; [Xu Chundi] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Aw, M. M.] Natl Univ Singapore Hosp, Dept Paediat, Khoo Teck Puat Natl Univ Childrens Med Inst, Singapore 117548, Singapore; [Aw, M. M.] Natl Univ Singapore, Dept Paediat, Singapore 117548, Singapore; [Gutierrez-Castrellon, P.] La Salle Univ, Fac Med, Inst Nacl Perinatol, Hosp Gen Dr Manuel Gea Gonzalez, Mexico City, DF, Mexico; [Asery, A.] King Fahad Med City, Dept Pediat, Riyadh, Saudi Arabia; [Spolidoro, J.] Pontificia Univ Catolica Rio Grande do Sul, PUCRS, Porto Alegre, RS, Brazil; [Heine, R. G.] Univ Melbourne, Dept Allergy & Immunol, Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Miqdady, M.] Sheikh Khalifa Med City, Pediat GI, Abu Dhabi, U Arab Emirates; [Arancibia, M. E.] Clin Alemana, Santiago, Chile; [Alarcon, P.] Natl Inst Child Hlth, Lima, Peru",Vrije Universiteit Brussel; Universidad de Chile; Universite de Montreal; Mackay Memorial Hospital; Taipei Medical University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University of Naples Federico II; Shanghai Jiao Tong University; National University of Singapore; National University of Singapore; Universidad Nacional Autonoma de Mexico; King Fahad Medical City; Pontificia Universidade Catolica Do Rio Grande Do Sul; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of Melbourne; Clinica Alemana,"Vandenplas, Y (corresponding author), UZ Brussel, Dept Pediat, Laarbeeklaan 101, B-1090 Brussels, Belgium.",yvan.vandenplas@uzbrussel.be,"Aw, Marion/D-8882-2015; Faure, Christophe/AAD-8425-2019; Gutierrez-Castrellon, Pedro/JDN-2600-2023; Staiano, Annamaria/H-3026-2011","Faure, Christophe/0000-0002-2998-8935; Gutierrez-Castrellon, Pedro/0000-0002-9885-9635; Staiano, Annamaria/0000-0003-0586-1339; Heine, Ralf Gunter/0000-0002-3343-0379; Miqdady, Mohamad/0000-0001-9089-9424",,,,,31,19,22,1,17,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0803-5253,1651-2227,,ACTA PAEDIATR,Acta Paediatr.,JUL,2014,103,7,,,,,689,695,,10.1111/apa.12637,http://dx.doi.org/10.1111/apa.12637,,,7,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,AJ3NF,24654945,,,,2024-06-04,WOS:000337572700014,View Full Record in Web of Science
J,"Serra, J",,,,"Serra, Jordi",,,Management of bloating,NEUROGASTROENTEROLOGY AND MOTILITY,,,English,Review,,,,,,abdominal distension; bloating; intestinal fermentation; intestinal gas; visceral sensitivity,IRRITABLE-BOWEL-SYNDROME; ABDOMINOTHORACIC MUSCULAR-ACTIVITY; BIOFEEDBACK-GUIDED CONTROL; FODMAPS REDUCES SYMPTOMS; INTESTINAL GAS RETENTION; ABDOMINAL DISTENSION; FUNCTIONAL DYSPEPSIA; PHYSICAL-ACTIVITY; DOUBLE-BLIND; DIET LOW,"Abdominal bloating is a subjective sensation of trapped abdominal gas, producing abdominal pressure, fullness sensation, and, in some patients, associated objective abdominal distension. In this month's edition of the journal, a new validated questionnaire to assess the prevalence and impact of gas-related symptoms is presented by Duracinsky et al., showing that gas-related abdominal symptoms are prevalent in patients with irritable bowel syndrome and have a measurable impact on patients daily life. A parallel study by Gardiner et al. assessing the severity of bloating in functional gastrointestinal disorders shows that severe bloating is associated with the severity of abdominal pain, constipation, and somatization, advancing our understanding of the clinical characteristics and relevance of gas-related symptoms in the broad spectrum of functional gastrointestinal disorders. Management of bloating includes non-pharmacological and pharmacological strategies. Dietary interventions to reduce intestinal fermentation and ingestion of food supplements like prebiotics or probiotics can reduce bloating by reducing gas production. The main targets of pharmacological treatments are to improve transit and evacuation with prokinetics, to improve intestinal gas tolerance with antispasmodics and/or neuromodulators, and to modify intestinal microbiota with antibiotics. Secretagogues act by increasing intestinal secretion and decreasing visceral sensitivity and have been reported to be an effective treatment alternative for patients with bloating associated with constipation. Biofeedback therapy addressed to correct abdomino-phrenic dysynergia may be useful for patients with objective abdominal distension, and patients with bloating associated with outlet obstructed defecation may benefit from anorectal biofeedback.","[Serra, Jordi] Univ Hosp Vall dHebron, Digest Syst Res Unit, Barcelona 08035, Spain; [Serra, Jordi] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain",Hospital Universitari Vall d'Hebron; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD,"Serra, J (corresponding author), Univ Hosp Vall dHebron, Digest Syst Res Unit, Barcelona 08035, Spain.",jordiserra.motility@gmail.com,"Serra, Jordi/ABH-6319-2020","Serra, Jordi/0000-0003-2120-6270",,,,,86,2,2,1,18,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1350-1925,1365-2982,,NEUROGASTROENT MOTIL,Neurogastroenterol. Motil.,MAR,2022,34,3,,,,,,,e14333,10.1111/nmo.14333,http://dx.doi.org/10.1111/nmo.14333,,FEB 2022,9,Gastroenterology & Hepatology; Clinical Neurology; Neurosciences,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Neurosciences & Neurology,ZG6VP,35143108,,,,2024-06-04,WOS:000753506800001,View Full Record in Web of Science
J,"Mori, N; Kano, M; Masuoka, N; Konno, T; Suzuki, Y; Miyazaki, K; Ueki, Y",,,,"Mori, Naoko; Kano, Mitsuyoshi; Masuoka, Norie; Konno, Tomoe; Suzuki, Yumiko; Miyazaki, Kouji; Ueki, Yukihide",,,Effect of probiotic and prebiotic fermented milk on skin and intestinal conditions in healthy young female students,BIOSCIENCE OF MICROBIOTA FOOD AND HEALTH,,,English,Article,,,,,,phenols; probiotics; prebiotics; skin condition; Bifidobacterium; skin hydration; defecation,,"Although persistent constipation is considered to be associated with skin problems, the supporting evidence is limited. Hence, this study investigated the effects of probiotic and prebiotic fermented milk on skin and intestinal conditions in an open-label trial. Among the 101 Japanese healthy young female students that participated, the 81 subjects in the intake group consumed a bottle of probiotic and prebiotic fermented milk containing Bifidobacterium breve strain Yakult and galactooligosaccharides daily for 4 weeks after a pre-intake period of 4 weeks, while the 20 subjects in the non-intake group did not consume the test beverage. Defecation patterns, skin conditions including hydration levels in the stratum corneum, and urinary phenol and p-cresol levels were evaluated before (baseline) and after intake. All subjects completed the study. No differences in dietary intake and body mass index were observed between both groups during the trial. In the intake group, hydration levels of the stratum corneum, defecation frequency, and feces quantity significantly increased, and urinary phenol and p-cresol levels significantly decreased after intake compared with the corresponding baseline values. However, they did not significantly change in the non-intake group. A significant difference was observed between the intake group and non-intake group in regard to clearness of the skin as assessed by visual analogue scale. Therefore, consecutive intake of probiotic and prebiotic fermented milk might have beneficial effects on the skin that prevent dryness and beneficial effects on the intestinal conditions that stimulate defecation and decrease phenol production by gut bacteria in healthy young women.","[Mori, Naoko; Konno, Tomoe; Ueki, Yukihide] Seitoku Univ, Fac Human Nutr, Dept Human Nutr, 550 Iwase, Matsudo, Chiba 2718555, Japan; [Kano, Mitsuyoshi; Masuoka, Norie; Miyazaki, Kouji] Yakult Cent Inst, 5-11 Izumi, Kunitachi, Tokyo 1868650, Japan; [Suzuki, Yumiko] Chibaken Yakult Sales Corp, Wakaba Ku, 63 Kasoricho, Chiba, Chiba 2640017, Japan","Yakult Honsha Company, Limited","Mori, N (corresponding author), Seitoku Univ, Fac Human Nutr, Dept Human Nutr, 550 Iwase, Matsudo, Chiba 2718555, Japan.",nkawano@seitoku.ac.jp,,,,,,,24,27,29,1,10,BMFH PRESS,TOKYO,"ATTN-BMFH, EDITORIAL OFF IPEC INC, 1-24-12 SUGAMO,TOSHIMA-KU, TOKYO, 170-0002, JAPAN",2186-6953,2186-3342,,BIOSCI MICROB FOOD H,Biosci. Microbiota Food Health,JUL,2016,35,3,,,,,105,112,,10.12938/bmfh.2015-022,http://dx.doi.org/10.12938/bmfh.2015-022,,,8,Microbiology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Microbiology; Nutrition & Dietetics,VC0OY,27508111,"Green Published, gold",,,2024-06-04,WOS:000426586400001,View Full Record in Web of Science
J,"Herrera-Mejía, J; Ramos-Jiménez, A; Jiménez-Vega, F; Campos-Vega, R; González-Córdova, AF; Wall-Medrano, A",,,,"Herrera-Mejia, Julian; Ramos-Jimenez, Arnulfo; Jimenez-Vega, Florinda; Campos-Vega, Rocio; Gonzalez-Cordova, Aaron F.; Wall-Medrano, Abraham",,,Functional feeding to correct gastrointestinal disorders associated with autism spectrum disorders: a systematic review,NUTRICION HOSPITALARIA,,,Spanish,Review,,,,,,Autism; Gastrointestinal disorders; Intestinal microbiota; Prebiotics; Probiotics; Gluten-free; Casein-free,GUT MICROBIOTA; FREE DIET; CHILDREN; SYMPTOMS; GLUTEN; CASEIN; PROBIOTICS,"Background: gastrointestinal disorders (GIDs) are common comorbidities in patients with autism spectrum disorders (ASD); treatments with gluten- and casein-free (LGLC) diets or prebiotic/probiotic supplements may reduce the severity of GIDs. Objective: to integrate and discuss the evidence on the effectiveness of LGLC diet therapies and prebiotic/probiotic supplements on GIDs in patients with ASD. Methodology: the guidelines for the publication of systematic reviews and meta-analyses (PRISMA) were used. Participant characteristics, dietary interventions, prebiotic/prebiotic supplementation, effects of interventions on GIDs, risk of bias, and safety of treatments were analyzed. Results: fifteen investigations were analyzed; the prevalence of GIDs among patients with ASD was high (58 %; range, 27-83 %). In more than 20 % of the patients managed with LGLC diets or supplements GID severity decreased (mainly constipation, diarrhea, and abdominal pain). Increases in the counts of beneficial bacteria and a decrease in the proportion of pathogenic bacteria were reported after supplement use. However, all these investigations had significant methodological biases. Conclusions: although reductions in the frequency and severity of some GIDs have been found, the effectiveness of these treatments has not been proven yet. Given the methodological differences in the investigations, the design of rigorous studies to evaluate the therapeutic effects of these treatments on gastrointestinal health in patients with ASD is warranted.","[Herrera-Mejia, Julian; Ramos-Jimenez, Arnulfo; Jimenez-Vega, Florinda; Wall-Medrano, Abraham] Univ Autonoma Ciudad Juarez, Inst Ciencias Biomed, Ciudad Juarez, Chihuahua, Mexico; [Campos-Vega, Rocio] Univ Autonoma Queretaro, Fac Quim, Programa Posgrado Alimentos Ctr Repub PROPAC, Santiago De Queretaro, Queretaro, Mexico; [Gonzalez-Cordova, Aaron F.] Ctr Invest Alimentac & Desarrollo AC CIAD, Hermosillo, Sonora, Mexico",Universidad Autonoma de Ciudad Juarez; Universidad Autonoma de Queretaro; CIAD - Centro de Investigacion en Alimentacion y Desarrollo,"Herrera-Mejía, J (corresponding author), Univ Autonoma Ciudad Juarez, Inst Ciencias Biomed, Anillo Envolvente PRONAF & Estocolmo S-N, Ciudad Juarez 32310, Chihuahua, Mexico.",al194425@alumnos.uacj.mx,"Campos-Vega, Rocio/JZC-8641-2024","Campos-Vega, Rocio/0000-0003-4054-1250",,,,,55,1,1,2,10,"ARAN EDICIONES, S L",MADRID,"C/ CASTELLO, 128, 1O, MADRID, 28006, SPAIN",0212-1611,1699-5198,,NUTR HOSP,Nutr. Hosp.,MAY-JUN,2022,39,3,,,,,663,677,,10.20960/nh.03898,http://dx.doi.org/10.20960/nh.03898,,,15,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,6Q4GY,35485378,gold,,,2024-06-04,WOS:000891572900023,View Full Record in Web of Science
J,"Champ, M; Hoebler, C",,,,"Champ, Martine; Hoebler, Christine",,,"Functional food for pregnant, lactating women and in perinatal nutrition: a role for dietary fibres?",CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE,,,English,Article,,,,,,constipation; diabetes; dietary fibre; human milk oligosaccharides; lactation; metabolic imprinting; newborn; pregnancy,CHAIN GALACTO-OLIGOSACCHARIDES; GESTATIONAL DIABETES-MELLITUS; HUMAN-MILK; GUT MICROBIOTA; WEIGHT-GAIN; DOUBLE-BLIND; IMMUNOGLOBULIN-A; FECAL MICROBIOTA; CONTROLLED-TRIAL; IMMUNE-SYSTEM,"Purpose of review If the benefits of dietary fibre in healthy adults have extensively been studied, little information is available on the specific needs of pregnant, lactating women or foetus. As far as infants are concerned, milk oligosaccharides are supposed to be the optimal 'dietary fibre'. The supplementation of infant formula with prebiotic oligosaccharides is still discussed. However, recent studies provide a large amount of information, allowing a new discussion on this topic. Recent findings Most recent findings are linked to the involvement of dietary fibre in occurrence or prevention of obesity. The multiple mechanisms appear more clearly than earlier. This finding will soon allow appropriate counselling for young mothers at risk of obesity and/or postpartum retention weight, gestational diabetes and preeclampsia. Another area which benefits from recent research is the use of prebiotics in formula. Summary Pregnancy is a critical period during which many physiologic changes occurred and is associated with several gut disorders and metabolic diseases. Dietary fibre may be helpful in the prevention and management of these diseases. Lactation and pregnancy are two phases during which food consumption of the mother can interact with the physiology of the baby. Moreover, the use of formula supplemented in oligosaccharides is able to compensate for the lack of some of the complex molecules naturally present in human milk.","[Champ, Martine; Hoebler, Christine] CHU Nantes, INRA, UMR Physiol Adaptat Nutr 1280, CRNH, F-44035 Nantes 01, France",INRAE; Nantes Universite; CHU de Nantes,"Champ, M (corresponding author), CHU Hotel Dieu, HNB1 UMR PhAN, Pl Alexis Ricordeau, F-44093 Nantes 1, France.",Martine.Champ@univ-nantes.fr,,,,,,,92,15,19,0,27,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",1363-1950,1473-6519,,CURR OPIN CLIN NUTR,Curr. Opin. Clin. Nutr. Metab. Care,NOV,2009,12,6,,,,,565,574,,10.1097/MCO.0b013e328331b4aa,http://dx.doi.org/10.1097/MCO.0b013e328331b4aa,,,10,Endocrinology & Metabolism; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Endocrinology & Metabolism; Nutrition & Dietetics,513BI,19741518,,,,2024-06-04,WOS:000271296600002,View Full Record in Web of Science
J,"Bastürk, A; Artan, R; Yilmaz, A",,,,"Basturk, Ahmet; Artan, Reha; Yilmaz, Aygen",,,"Efficacy of synbiotic, probiotic, and prebiotic treatments for irritable bowel syndrome in children: A randomized controlled trial",TURKISH JOURNAL OF GASTROENTEROLOGY,,,English,Article,,,,,,Bifidobacterium lactis B94; irritable bowel syndrome; synbiotic; probiotic; child,PLACEBO-CONTROLLED-TRIAL; B94 PLUS INULIN; CLINICAL-TRIAL; DOUBLE-BLIND; FECAL MICROBIOTA; FERMENTED MILK; SYMPTOMS; BIFIDOBACTERIUM; DIARRHEA; TRANSIT,"Background/Aims: Irritable bowel syndrome (IBS) is an important health problem that presents serious social burdens and high costs. Our study investigated the efficacy of synbiotic (Bifidobacterium lactis B94 with inulin), probiotic (B. lactis B94), and prebiotic (inulin) treatment for IBS in a pediatric age group. Materials and Methods: This study was randomized, double-blind, controlled, and prospective in design and included 71 children between the ages of 4 and 16 years who were diagnosed with IBS according to the Rome III criteria. The first group received synbiotic treatment [5x10(9) colony forming units (CFU) of B. lactis B94 and 900 mg inulin]; the second group received probiotic treatment (5x10(9) CFU B. lactis B94), and the third group received prebiotic treatment (900 mg inulin) twice daily for 4 weeks. Results: Probiotic treatment improved belching-abdominal fullness (p<0.001), bloating after meals (p=0.016), and constipation (p=0.031), and synbiotic treatment improved belching-abdominal fullness (p=<0.001), bloating after meals (p=0.004), constipation (p=0.021), and mucus in the feces (p=0.021). The synbiotic group had a significantly higher percentage of patients with full recovery than the prebiotic group (39.1% vs. 12.5%, p=0.036). Conclusion: Administration of synbiotics and probiotics resulted in significant improvements in initial complaints when compared to prebiotics. Additionally, there was a significantly higher number of patients with full recovery from IBS symptoms in the synbiotic group than in the prebiotic group. Therefore, the twice daily administration of synbiotics is suggested for the treatment of children with IBS.","[Basturk, Ahmet; Artan, Reha; Yilmaz, Aygen] Akdeniz Univ, Dept Pediat Gastroenterol, Sch Med, Antalya, Turkey",Akdeniz University,"Bastürk, A (corresponding author), Akdeniz Univ, Dept Pediat Gastroenterol, Sch Med, Antalya, Turkey.",drahmetbasturk@hotmail.com,"Basturk, Ahmet/V-9914-2017; artan, reha/I-6332-2015; artan, reha/AAI-8259-2020","artan, reha/0000-0001-6114-9210;",,,,,28,43,49,1,43,AVES,SISLI,"BUYUKDERE CAD 105-9, MECIDIYEKOY, SISLI, ISTANBUL 34394, TURKEY",1300-4948,2148-5607,,TURK J GASTROENTEROL,Turk. J. Gastroenterol.,SEP,2016,27,5,,,,,439,443,,10.5152/tjg.2016.16301,http://dx.doi.org/10.5152/tjg.2016.16301,,,5,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,EB1BE,27782892,,,,2024-06-04,WOS:000387080500008,View Full Record in Web of Science
J,"Ribeiro, TCM; Costa-Ribeiro, H; Almeida, PS; Pontes, MV; Leite, MEQ; Filadelfo, LR; Khoury, JC; Bean, JA; Mitmesser, SH; Vanderhoof, JA; Scalabrin, DMF",,,,"Ribeiro, Tereza C. M.; Costa-Ribeiro, Hugo, Jr.; Almeida, Patricia S.; Pontes, Mariana V.; Leite, Maria E. Q.; Filadelfo, Lais R.; Khoury, Jane C.; Bean, Judy A.; Mitmesser, Susan H.; Vanderhoof, Jon A.; Scalabrin, Deolinda M. F.",,,Stool Pattern Changes in Toddlers Consuming a Follow-on Formula Supplemented With Polydextrose and Galactooligosaccharides,JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION,,,English,Article,,,,,,children; follow-on formula; galactooligosaccharides; polydextrose; prebiotics; stool pattern,DIETARY FIBER; FED INFANTS; CHILDREN; OLIGOSACCHARIDES; CONSTIPATION; PREBIOTICS; CHILDHOOD,"Healthy 9- to 48-month-old children (n = 133) were randomized to receive a cow's-milk-based follow-on formula (control) or the same formula with polydextrose and galactooligosaccharides (PDX/GOS) for 108 days. Pediatricians assessed diarrheal disease, stool pattern, acute respiratory infection, systemic antibiotic use, and growth. The 2 groups had similar weight-for-length/height z score and similar odds of having diarrheal disease, acute respiratory infection, and systemic antibiotic use; however, PDX/GOS had greater odds of increased defecation than control (P <= 0.01). Addition of PDX and GOS to a follow-on formula was well tolerated and induced a pattern of more frequent and softer stools in toddlers.","[Ribeiro, Tereza C. M.; Costa-Ribeiro, Hugo, Jr.; Almeida, Patricia S.; Pontes, Mariana V.; Leite, Maria E. Q.; Filadelfo, Lais R.] Univ Fed Bahia, Dept Pediat, Fima Lifshitz Res Ctr, Univ Hosp Complex Prof Edgard Santos, Salvador, BA, Brazil; [Khoury, Jane C.; Bean, Judy A.] Cincinnati Childrens Hosp, Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH USA; [Mitmesser, Susan H.; Vanderhoof, Jon A.; Scalabrin, Deolinda M. F.] Mead Johnson Nutr, Dept Clin Res, Med Affairs, Evansville, IN 47721 USA",Universidade Federal da Bahia; Cincinnati Children's Hospital Medical Center,"Mitmesser, SH (corresponding author), Mead Johnson Nutr, Dept Clin Res, Med Affairs, 2400 W Lloyd Expressway, Evansville, IN 47721 USA.",susan.mitmesser@mjn.com,"Khoury, Jane/O-2068-2015",,Mead Johnson Nutrition,Mead Johnson Nutrition,The present study was supported by Mead Johnson Nutrition.,,17,27,34,1,16,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0277-2116,1536-4801,,J PEDIATR GASTR NUTR,J. Pediatr. Gastroenterol. Nutr.,FEB,2012,54,2,,,,,288,290,,10.1097/MPG.0b013e31823a8a4c,http://dx.doi.org/10.1097/MPG.0b013e31823a8a4c,,,3,Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,882SN,22002482,"Bronze, Green Published",,,2024-06-04,WOS:000299584300024,View Full Record in Web of Science
J,"Liao, WY; Su, MY; Zhang, D",,,,"Liao, Wenyan; Su, Miya; Zhang, Dong",,,A study on the effect of symbiotic fermented milk products on human gastrointestinal health: Double-blind randomized controlled clinical trial,FOOD SCIENCE & NUTRITION,,,English,Article,,,,,,gastrointestinal health; Inulin; L. plantarum ST-III; symbiotics,PLANTARUM ST-III; LACTOBACILLUS-PLANTARUM; GUT MICROBIOTA; IMPACT; HOST,"Several studies have claimed that the consumption of fermented dairy products can improve human gastrointestinal (GI) health. However, the numbers of systematic clinic trials are limited. In this study, a yogurt containing both probiotics and prebiotics was developed and a double-blind randomized controlled clinical trial was carried out to evaluate the effect of the product on human gastrointestinal health in three different aspects: (1) the effect on functional constipation (FC) and functional diarrhea (FD); (2) the effect on gastrointestinal (GI) tract immune system; and (3) the changes in GI tract microbiota. Participants who suffered FC or FD were randomized into three groups (n = 66 each group): the first group was treated with fermented milk with Lactobacillus plantarum ST-III (7 mg/kg) and inulin (1.5%), the second group was treated with L. plantarum ST-III (7 mg/kg) and inulin (1.0%), and the third group (control group) was treated without probiotics and prebiotics. Half of the participants stopped the treatment after 14 days and the rest of the group continued the trial to the full 28 days. The fecal samples of participants were analyzed regarding their short-chain fatty acids (SCFAs), secretory immunoglobulin A (sigA), and microbiota. A survey on GI tract health was conducted and the Bristol stool scale was recorded. The results showed that the consumption of the symbiotic yogurt for 14 days and 28 days can both improve the digestive system, with the continual consumption of product containing L. plantarum ST-III(7 mg/kg) and inulin (1.5%) for 28 days showing the most significance. The consumption of this product may be used as a potential functional food.","[Liao, Wenyan; Su, Miya; Zhang, Dong] Bright Dairy & Food Co Ltd, Shanghai Engn Res Ctr Dairy Biotechnol, Dairy Res Inst, State Key Lab Dairy Biotechnol, Bldg 2,1518,West Jiangchang Rd, Shanghai 200436, Peoples R China",Bright Dairy & Food Co Ltd,"Zhang, D (corresponding author), Bright Dairy & Food Co Ltd, Shanghai Engn Res Ctr Dairy Biotechnol, Dairy Res Inst, State Key Lab Dairy Biotechnol, Bldg 2,1518,West Jiangchang Rd, Shanghai 200436, Peoples R China.",Zhangdong@brightdairy.com,,"Zhang, Dong/0000-0001-8767-3328",Shanghai Engineering Research Center of Dairy Biotechnology [19DZ2281400],Shanghai Engineering Research Center of Dairy Biotechnology,This study was supported by Shanghai Engineering Research Center of Dairy Biotechnology (No. 19DZ2281400).,,24,2,2,7,22,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",2048-7177,,,FOOD SCI NUTR,Food Sci. Nutr.,SEP,2022,10,9,,,,,2947,2955,,10.1002/fsn3.2890,http://dx.doi.org/10.1002/fsn3.2890,,MAY 2022,9,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,7A0GA,36171774,Green Published,,,2024-06-04,WOS:000789757300001,View Full Record in Web of Science
J,"Gearry, RB; Irving, PM; Barrett, JS; Nathan, DM; Shepherd, SJ; Gibson, PR",,,,"Gearry, Richard B.; Irving, Peter M.; Barrett, Jacqueline S.; Nathan, Debbie M.; Shepherd, Sue J.; Gibson, Peter R.",,,Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease-a pilot study,JOURNAL OF CROHNS & COLITIS,,,English,Article,,,,,,Inflammatory bowel diseases; Diet; Crohn's disease; Treatment; Carbohydrates; Prebiotics,CROHNS-DISEASE; FRUCTOSE MALABSORPTION; LACTOSE-MALABSORPTION; BREATH TESTS; OLIGOSACCHARIDES; PREVALENCE; SORBITOL; COLITIS; IMPACT; MOOD,"Objective: Functional gut symptoms are common in patients with inflammatory bowel disease (IBD). Since poorly absorbed, short-chain carbohydrates (FODMAPs) appear to play an important role in the induction of functional gut symptoms, we aimed to determine the effect of their dietary restriction on abdominal symptoms in patients with stable IBD and to examine factors associated with success of and adherence to the diet. Material and method: 52 consecutive patients with Crohn's disease and 20 with ulcerative colitis who received dietary advice at least 3 months prior at a gastrointestinal dietetic service in Victoria, Australia, underwent a retrospective telephone questionnaire. Information gathered included patient demographics, recall of dietary advice, dietary adherence, and change in gastrointestinal symptoms. Results: Up to 70% of patients were adherent to the diet. Approximately one in two patients responded (defined as improvement of at least 5 out of 10 in overall symptoms). Overall abdominal symptoms, abdominal pain, bloating, wind and diarrhoea improved in patients with Crohn's disease and ulcerative colitis (p < 0.02 for all), but constipation did not. For Crohn's disease, efficacy was associated with dietary adherence (p=0.033) and inefficacy with non-adherence (p=0.013). Sustained response was associated with post-secondary education and working 35 h per week or less (P < 0.03). Conclusions: These data suggest that reduction of FODMAP intake offers an efficacious strategy for patients with IBD who have concurrent functional gut symptoms. A controlled dietary intervention trial is indicated. (c) 2008 European Crohn's and Collitis Organisation. Published by Elsevier B.V. All rights reserved.","Box Hill Hosp, Dept Gastroenterol, Box Hill, Vic 3128, Australia; Monash Univ, Dept Med, Box Hill, Vic 3128, Australia",Eastern Health; Box Hill Hospital; Monash University,"Gibson, PR (corresponding author), Box Hill Hosp, Dept Med, Box Hill, Vic 3128, Australia.",gibson@med.monash.edu.au,"Gearry, Richard B/H-3959-2019; Shepherd, Susan J/F-6353-2013; Irving, Peter/AAP-4543-2020","Gearry, Richard B/0000-0002-2298-5141; Irving, Peter/0000-0003-0972-8148",New Zealand Society of Gast roenterotogy / Ferring Fellowship; Pharmatel Fresenius Kabi Inftammatory Bowel Disease Fellowship,New Zealand Society of Gast roenterotogy / Ferring Fellowship; Pharmatel Fresenius Kabi Inftammatory Bowel Disease Fellowship,"At the time this work was performed, Dr. Gearry was the recipient of the New Zealand Society of Gast roenterotogy / Ferring Fellowship and the Pharmatel Fresenius Kabi Inftammatory Bowel Disease Fellowship.",,20,234,251,0,47,OXFORD UNIV PRESS,OXFORD,"GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND",1873-9946,1876-4479,,J CROHNS COLITIS,J. Crohns Colitis,FEB,2009,3,1,,,,,8,14,,10.1016/j.crohns.2008.09.004,http://dx.doi.org/10.1016/j.crohns.2008.09.004,,,7,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,413NK,21172242,Bronze,,,2024-06-04,WOS:000263799600003,View Full Record in Web of Science
J,"Burlina, A; Tims, S; van Spronsen, F; Sperl, W; Burlina, AP; Kuhn, M; Knol, J; Rakhshandehroo, M; Coskun, T; Singh, RH; MacDonald, A",,,,"Burlina, Alberto; Tims, Sebastian; van Spronsen, Francjan; Sperl, Wolfgang; Burlina, Alessandro P.; Kuhn, Mirjam; Knol, Jan; Rakhshandehroo, Maryam; Coskun, Turgay; Singh, Rani H.; MacDonald, Anita",,,The potential role of gut microbiota and its modulators in the management of propionic and methylmalonic acidemia,EXPERT OPINION ON ORPHAN DRUGS,,,English,Article,,,,,,Propionic acid; methylmalonic acid; prebiotic; probiotic; microbiota,BUTYRATE-PRODUCING BACTERIA; PROTEIN TUBE FEEDS; CHAIN FATTY-ACIDS; IN-VITRO; ORGANIC ACIDEMIAS; GALACTO-OLIGOSACCHARIDES; INTESTINAL TRANSPORT; PHENOTYPIC SPECTRUM; CEREAL FRUCTANS; MOUSE MODELS,"Introduction: Propionic and methylmalonic acidemia (PA/MMA) are rare inborn errors of metabolism characterized by accumulation of propionyl CoA and/or methylmalonyl CoA, resulting in potentially serious metabolic crises arid clinical complications. The gut microbiota contributes a significant proportion of total propionate production and provides a potentially modifiable target. Empiric use of oral antibiotics to reduce propionate production is a common approach but is hampered by possible drug resistance, perturbation of normal gut microbiota, and toxicity. Moreover, constipation, associated with low fiber intake, inadequate fluid intake, low gut motility, and other factors, is a chronic problem in this patient population and may influence propionate production. Newer management techniques that reduce the burden of propionate and address these clinical challenges are needed. Areas covered: This paper summarizes the potential contribution of gut-related factors in PA/MMA and considers modifying gut microbiota as a management approach. Expert opinion: Dietary management of PA/MMA may be improved by specific prebiotics that modify gut microbiota to stabilize or possibly reduce PA production.","[Burlina, Alberto] Reference Ctr Expanded Newborn Screening, Div Inherited Metab Dis, Padua, Italy; [Tims, Sebastian; Knol, Jan; MacDonald, Anita] Nutricia Res, Adv Med Nutr, Gut & Microbiol Platform, Utrecht, Netherlands; [van Spronsen, Francjan] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Div Metab Dis, Groningen, Netherlands; [Sperl, Wolfgang] Salzburger Landeskliniken, Salzburg, Austria; [Sperl, Wolfgang] Paracelsus Med Univ Salzburg, Salzburg, Austria; [Burlina, Alessandro P.] St Bassiano Hosp, Neurol Unit, Bassano Del Grappa, Italy; [Kuhn, Mirjam; Rakhshandehroo, Maryam] Nutricia Res, Adv Med Nutr, Res Dept Paediat Care & Metab Control, Utrecht, Netherlands; [Knol, Jan] Wageningen Univ, Lab Microbiol, Wageningen, Netherlands; [Coskun, Turgay] Hacettepe Univ, Fac Med, Dept Pediat, Div Metab & Nutr, Ankara, Turkey; [Singh, Rani H.] Emory Univ, Nutr Sect, Div Med Genet, Atlanta, GA 30322 USA; [MacDonald, Anita] Birmingham Childrens Hosp, Birmingham, W Midlands, England",Danone Nutricia; University of Groningen; Paracelsus Private Medical University; ULSS 7 Pedemontana; Ospedale San Bassiano; Danone Nutricia; Wageningen University & Research; Hacettepe University; Emory University; University of Birmingham,"Burlina, A (corresponding author), Univ Hosp, Reference Ctr Expanded Newborn Screening, Div Inherited Metab Dis, Paediat Dept, Padua, Italy.",alberto.burlina@unipd.it,"burlina, alberto/AHE-6095-2022; Knol, Jan/AAL-6487-2020; Singh, Rani/AAU-8246-2020","Knol, Jan/0000-0002-2103-5961; Singh, Rani/0000-0003-2096-2592",,,,,92,6,7,5,10,TAYLOR & FRANCIS LTD,ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND",2167-8707,,,EXPERT OPIN ORPHAN D,Exp. Opin. Orphan Drugs,,2018,6,11,,,,,683,692,,10.1080/21678707.2018.1536540,http://dx.doi.org/10.1080/21678707.2018.1536540,,,10,Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy,HB9HD,,,,,2024-06-04,WOS:000451401200005,View Full Record in Web of Science
J,"Mälkki, Y",,,,"Mälkki, Y",,,Trends in dietary fibre research and development -: A review,ACTA ALIMENTARIA,,,English,Review,,,,,,dietary fibre; cholesterol; glycemic effects; weight control; cancer risks; antioxidants; lignans; prebiotics; immunological effects,OAT BETA-GLUCAN; ISCHEMIC-HEART-DISEASE; GLYCEMIC INDEX DIET; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; GUAR GUM; PLASMA-GLUCOSE; LIPID PROFILE; SERUM-LIPIDS; RISK-FACTORS,"In the past twenty years, the main interest in increasing dietary fibre intake has been to reduce risk of coronary heart disease. In addition to the reduction of blood cholesterol by soluble viscous dietary fibre, this risk is also reduced by antioxidative and fibrinolytic effects. Attenuating levels and fluctuations of blood glucose and insulin have interest not only for diabetic people, but also for improving endurance in sports or physical work, and because of the multitude of physiological effects of insulin as well. Dietary fibre is also in a key position in weight control due to its effect on satiety. New data on the effects of fibre on the intestinal function have shown advantages of soluble fibre sources, partly due to their ability to support selectively the growth of beneficial bacteria, and partly by alleviating constipation. Both soluble and insoluble fibres have effects which reduce risks of cancers, not only colorectal cancer. In applications, the trend is now towards a more specific use of the different types and sources of dietary fibre.","Cerefi Ltd, FIN-02160 Espoo, Finland",,"Cerefi Ltd, Lyokkiniemi 24, FIN-02160 Espoo, Finland.",yrjo.malkki@kolombus.fi,,,,,,,137,36,41,0,40,AKADEMIAI KIADO ZRT,BUDAPEST,"BUDAFOKI UT 187-189-A-3, H-1117 BUDAPEST, HUNGARY",0139-3006,1588-2535,,ACTA ALIMENT HUNG,Acta Aliment.,MAR,2004,33,1,,,,,39,62,,10.1556/AAlim.33.2004.1.5,http://dx.doi.org/10.1556/AAlim.33.2004.1.5,,,24,Food Science & Technology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Nutrition & Dietetics,846MH,,,,,2024-06-04,WOS:000223319300005,View Full Record in Web of Science
J,"Liu, YY; Tran, DQ; Rhoads, JM",,,,"Liu, Yuying; Tran, Dat Q.; Rhoads, J. Marc",,,Probiotics in Disease Prevention and Treatment,JOURNAL OF CLINICAL PHARMACOLOGY,,,English,Article,,,,,,allergy; diarrhea; immunology; lactobacillus; microbiome; regulatory T cells,IRRITABLE-BOWEL-SYNDROME; TREATING ACUTE GASTROENTERITIS; LACTOBACILLUS-RHAMNOSUS GG; CD103(+) DENDRITIC CELLS; ABUSIVE HEAD TRAUMA; REGULATORY T-CELLS; REUTERI DSM 17938; SACCHAROMYCES-BOULARDII; DOUBLE-BLIND; INTESTINAL MICROBIOTA,"Few treatments for human diseases have received as much investigation in the past 20 years as probiotics. In 2017, English-language meta-analyses totaling 52 studies determined the effect of probiotics on conditions ranging from necrotizing enterocolitis and colic in infants to constipation, irritable bowel syndrome, and hepatic encephalopathy in adults. The strongest evidence in favor of probiotics lies in the prevention or treatment of 5 disorders: necrotizing enterocolitis, acute infectious diarrhea, acute respiratory tract infections, antibiotic-associated diarrhea, and infant colic. Probiotic mechanisms of action include the inhibition of bacterial adhesion; enhanced mucosal barrier function; modulation of the innate and adaptive immune systems (including induction of tolerogenic dendritic cells and regulatory T cells); secretion of bioactive metabolites; and regulation of the enteric and central nervous systems. Future research is needed to identify the optimal probiotic and dose for specific diseases, to address whether the addition of prebiotics (to form synbiotics) would enhance activity, and to determine if defined microbial communities would provide benefit exceeding that of single-species probiotics.","Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Pediat, Div Gastroenterol, Houston, TX 77030 USA; Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Pediat Res Ctr, Houston, TX 77030 USA",University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston,"Rhoads, JM (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, 6431 Fannin St,MSB 3-137, Houston, TX 77030 USA.",J.Marc.Rhoads@uth.tmc.edu,"Rhoads, Jon Marc/AFO-5397-2022; Liu, Yuying/ABB-8417-2021","Rhoads, Jon Marc/0000-0002-6252-9490; Liu, Yuying/0000-0003-3848-9254","BioGaia AB, Sweden","BioGaia AB, Sweden","Research was partially supported by BioGaia AB, Sweden, in addition to federal and state governmental grants.",,142,127,137,1,37,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0091-2700,1552-4604,,J CLIN PHARMACOL,J. Clin. Pharmacol.,OCT,2018,58,10,,S,,,S164,S179,,10.1002/jcph.1121,http://dx.doi.org/10.1002/jcph.1121,,,16,Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy,HD3MZ,30248200,"Bronze, Green Accepted",,,2024-06-04,WOS:000452422500014,View Full Record in Web of Science
J,"Tazi, LA; Benabdesslem, Y; Amara, S; Hachem, K",,,,"Tazi, Lamia Abir; Benabdesslem, Yasmina; Amara, Sabrina; Hachem, Kadda",,,"A survey into the utilization of probiotics and medicinal plants among individuals afflicted with gastrointestinal disorders in healthcare institutions in Saïda, Algeria",LIBYAN JOURNAL OF MEDICINE,,,English,Article,,,,,,Survey; probiotics; prebiotics; medicinal plants; gastrointestinal disorders; patients; Saida,ETHNOBOTANICAL SURVEY; IZMIR PROVINCE; DOUBLE-BLIND; CROSS-OVER; SUPPLEMENTATION; MICROBIOTA; KNOWLEDGE; AWARENESS; PEOPLE; REGION,"Aim: Functional gastrointestinal (GI) disorders are recognized as a major public health concern worldwide. These disorders involve persistent digestive symptoms indicative of digestive tract dysfunction. Materials and Methods: A survey examining the utilisation of probiotics and medicinal plants as supplementary treatments was conducted on 160 patients with GI disorders at healthcare institutions in Saida from March to April 2023 using questionnaires that had been previously adapted and tested for reliability with Cronbach's alpha test. Raw data collected through the questionnaires were transferred to a database and analysed using SPSS software. Results: Overall, 49.38% of participants possessed knowledge of or actively utilised probiotics; such awareness was strongly associated with the participants' educational attainment (p = 0.029). The noteworthy probiotic supplements were Biocharbon (36.09%), Lactocil (15.38%), Smebiocta (13.61%), Ultrabiotic Adult (12.43%), Effidigest (12.43%), and Ultralevure (7.69%). During crisis, individuals tended to consume natural goods rich in probiotics, including yoghurt (13.26%) and fermented milk (8.60%), as well as foods rich in prebiotic fibre, including vegetables (18.99%), fruits (13.26%), wheat (9.67%), bran (7.52%), rye (6.81%), and oat flakes (6.45%). Additionally, 77.56% of patients used medicinal plants during crises, with Mentha spicata (12.2%), Thymus vulgaris (11.3%), Pimpinella anisum (8.5%), Cuminum cyminum (8.0%), Punica granatum (7.8%), Trachyspermum ammi (7.5%), and Senna acutifolia (7.0%) being the more commonly favoured options in phytotherapy. The main focus of these herbs was to alleviate bloating (57%), constipation (30.12%), and diarrhoea (12.87%) (p < 0.001). The most frequently utilised plant parts were leaves (47.30%), seeds (25.21%), and bark (13.21%). Most patients (82.91%) favoured infusion as their preferred consumption method, and approximately 85.43% believed in phytotherapy's ability to extend symptomatic relief. Conclusion: The understanding of probiotics is still in its infancy, whereas phytotherapy is more widely accepted by patients. Nonetheless, patients are open to the exploration of natural alternatives to conventional medicines.","[Tazi, Lamia Abir; Benabdesslem, Yasmina; Hachem, Kadda] Univ Saida Dr Tahar Moulay, Fac Nat & Life Sci, Lab Biotoxicol Pharmacognosy & Biol Valorizat Plan, Saida, Algeria; [Benabdesslem, Yasmina] Univ Djillali Liabes Sidi Bel Abbes, Fac Nat Sci & Life, Lab Nutr Pathol Agrobiotechnol & Hlth LAB NUPABS, Sidi Bel Abbes, Algeria; [Amara, Sabrina] Univ Oran 1, Lab Biol Microorganisms & Biotechnol LBMB, Oran, Algeria; [Hachem, Kadda] Univ Sci & Technol Oran Mohamed Boudiaf, Fac Nat & Life Sci, Lab Prod Plant & Microbial Valorizat LP2VM, Oran, Algeria; [Hachem, Kadda] Univ Saida Dr Moulay Tahar, Fac Nat & Life Sci, Dept Biol, POB 138 City Ennasr, Saida 20000, Algeria",University Djillali Liabes Sidi Bel Abbes; Universite des Sciences et de la Technologie d'Oran Mohamed Boudiaf; Universite de Saida,"Hachem, K (corresponding author), Univ Saida Dr Moulay Tahar, Fac Nat & Life Sci, Dept Biol, POB 138 City Ennasr, Saida 20000, Algeria.",kadda46@hotmail.com,"; hachem, kadda/J-5822-2018","Tz, LaMia AbiR/0009-0005-9685-5883; hachem, kadda/0000-0003-2683-0101",,,,,66,0,0,1,1,TAYLOR & FRANCIS LTD,ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND",1993-2820,1819-6357,,LIBYAN J MED,Libyan J. Med.,DEC 31,2024,19,1,,,,,,,2317492,10.1080/19932820.2024.2317492,http://dx.doi.org/10.1080/19932820.2024.2317492,,,16,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,IL0C1,38369815,"gold, Green Published",,,2024-06-04,WOS:001166352500001,View Full Record in Web of Science
J,"Mai, TT; Thu, PT; Hang, HT; Trang, TTT; Yui, S; Shigehisa, A; Tien, VT; Dung, TV; Nga, PB; Hung, NT; Tuyen, L",,,,"Mai, Truong Tuyet; Thi Thu, Pham; Thi Hang, Hoang; Trang, Tran Thi Thu; Yui, Shintaro; Shigehisa, Akira; Tien, Vu Thuy; Dung, Truong Viet; Nga, Phan Bich; Hung, Nguyen Trong; Tuyen, Le Danh",,,Efficacy of probiotics on digestive disorders and acute respiratory infections: a controlled clinical trial in young Vietnamese children,EUROPEAN JOURNAL OF CLINICAL NUTRITION,,,English,Article,,,,,,,CASEI STRAIN SHIROTA; FERMENTED MILK; FUNCTIONAL CONSTIPATION; INTESTINAL MICROBIOTA; ACUTE DIARRHEA; DOUBLE-BLIND; PREBIOTICS,"Objectives To evaluate the efficacy of fermented milk containingLactobacillus caseistrain Shirota (LcS) on the incidence of constipation, diarrhea, acute respiratory infections (ARI), and nutritional status of young Vietnamese children. Methods A controlled field trial was conducted with 1003 children (3-5 years old) in Thanh Hoa province in Vietnam. The probiotic group (n = 510) consumed fermented milk 65 mL/day containing 10(8)CFU/mL of LcS for the 12-week intervention period, whereas the control group (n = 493) was not given any. The incidence of constipation, diarrhea, ARI, and anthropometry in children was determined at baseline, after 4, 8, and 12-week intervention, and after the 4-week follow-up period. Results Probiotic drink decreased the incidence of constipation after the 12-week intervention period (12.0% vs. 32.0%, OR = 0.28 (95% CI: 0.21-0.40),p < 0.001), tended to decrease the incidence of diarrhea (4.9% vs. 7.9%, OR = 0.60 (95% CI: 0.35-1.01),p = 0.068), and prevented the occurrence of ARI (15.9% vs. 24.5%, OR = 0.58 (95% CI: 0.42-0.79),p < 0.001), when compared with the control group. In contrast, no probiotic effects were observed for the duration of diarrhea or ARI. Weight gain was higher in the probiotic group than in the control group after 4, 8, and 12-week intervention and after the 4-week follow-up period (p < 0.05). Conclusions Daily intake of fermented milk containing LcS strongly prevented the incidence of constipation and ARI in Vietnamese children. This study also revealed the potential effects of the use of a probiotic drink on diarrhea prevention as well as nutritional status improvement.","[Mai, Truong Tuyet; Thi Hang, Hoang; Trang, Tran Thi Thu; Nga, Phan Bich; Hung, Nguyen Trong; Tuyen, Le Danh] Natl Inst Nutr, 48B Tang Bat Ho St, Hanoi, Vietnam; [Thi Thu, Pham] Haiphong Univ Med & Pharm, 72 A, Ngo Quyen, Haiphong, Vietnam; [Yui, Shintaro] Yakult Cent Inst, 5-11 Izumi, Kunitachi, Tokyo 1868650, Japan; [Shigehisa, Akira] Yakult Honsha European Res Ctr Microbiol ESV, Technol Pk 4, B-9052 Zwijnaarde, Belgium; [Tien, Vu Thuy] Yakult Vietnam Co Ltd, 195 Truong Van Bang St,Thanh My Loi Ward Dist 2, Ho Chi Minh, Vietnam; [Dung, Truong Viet] Hanoi Med Univ, 1 Ton That Tung, Hanoi, Vietnam","Hai Phong University Medicine & Pharmacy; Yakult Honsha Company, Limited; Yakult Honsha Company, Limited; Hanoi Medical University","Mai, TT (corresponding author), Natl Inst Nutr, 48B Tang Bat Ho St, Hanoi, Vietnam.",truongtuyetmai@dinhduong.org.vn,"Nguyen, Truong/JXN-9786-2024","Shigehisa, Akira/0000-0002-0939-4494","Yakult Honsha Co., Ltd.","Yakult Honsha Co., Ltd.","This study was sponsored by Yakult Honsha Co., Ltd.",,33,14,14,0,3,SPRINGERNATURE,LONDON,"CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND",0954-3007,1476-5640,,EUR J CLIN NUTR,Eur. J. Clin. Nutr.,MAR,2021,75,3,,,,,513,520,,10.1038/s41430-020-00754-9,http://dx.doi.org/10.1038/s41430-020-00754-9,,SEP 2020,8,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,QU0AE,32981933,"Green Published, hybrid",,,2024-06-04,WOS:000573192200001,View Full Record in Web of Science
J,"François, IEJA; Lescroart, O; Veraverbeke, WS; Marzorati, M; Possemiers, S; Evenepoel, P; Hamer, H; Houben, E; Windey, K; Welling, GW; Delcour, JA; Courtin, CM; Verbeke, K; Broekaert, WF",,,,"Francois, Isabelle E. J. A.; Lescroart, Olivier; Veraverbeke, Wim S.; Marzorati, Massimo; Possemiers, Sam; Evenepoel, Pieter; Hamer, Henrike; Houben, Els; Windey, Karen; Welling, Gjalt W.; Delcour, Jan A.; Courtin, Christophe M.; Verbeke, Kristin; Broekaert, Willem F.",,,"Effects of a wheat bran extract containing arabinoxylan oligosaccharides on gastrointestinal health parameters in healthy adult human volunteers: a double-blind, randomised, placebo-controlled, cross-over trial",BRITISH JOURNAL OF NUTRITION,,,English,Article,,,,,,Wheat bran extract; Prebiotics; Protein fermentation reduction; Colonic SCFA; p-Cresol,16S RIBOSOMAL-RNA; IN-SITU HYBRIDIZATION; CHAIN FATTY-ACIDS; BUTYRATE-PRODUCING BACTERIA; RESISTANT STARCH; CHICORY INULIN; FECAL BIFIDOBACTERIA; DIETARY INCLUSION; GUT BACTERIA; P-CRESOL,"Wheat bran extract (WBE) is a food-grade soluble fibre preparation that is highly enriched in arabinoxylan oligosaccharides. In this placebo-controlled cross-over human intervention trial, tolerance and effects on colonic protein and carbohydrate fermentation were studied. After a 1-week run-in period, sixty-three healthy adult volunteers consumed 3, 10 and 0 g WBE/d for 3 weeks in a random order, with 2 weeks' washout between each treatment period. Fasting blood samples were collected at the end of the run-in period and at the end of each treatment period for analysis of haematological and clinical chemistry parameters. Additionally, subjects collected a stool sample for analysis of microbiota, SCFA and pH. A urine sample, collected over 48 h, was used for analysis of p-cresol and phenol content. Finally, the subjects completed questionnaires scoring occurrence frequency and distress severity of eighteen gastrointestinal symptoms. Urinary p-cresol excretion was significantly decreased after WBE consumption at 10 g/d. Faecal bifidobacteria levels were significantly increased after daily intake of 10 g WBE. Additionally, WBE intake at 10 g/d increased faecal SCFA concentrations and lowered faecal pH, indicating increased colonic fermentation of WBE into desired metabolites. At 10 g/d, WBE caused a mild increase in flatulence occurrence frequency and distress severity and a tendency for a mild decrease in constipation occurrence frequency. In conclusion, WBE is well tolerated at doses up to 10 g/d in healthy adults volunteers. Intake of 10 g WBE/d exerts beneficial effects on gut health parameters.","[Francois, Isabelle E. J. A.; Lescroart, Olivier; Veraverbeke, Wim S.; Broekaert, Willem F.] FUGEIA NV, B-3001 Louvain, Belgium; [Marzorati, Massimo; Possemiers, Sam] Univ Ghent, Lab Microbial Ecol & Technol LabMet, B-9000 Ghent, Belgium; [Evenepoel, Pieter] Univ Hosp UZ Leuven, Div Nephrol, B-3000 Louvain, Belgium; [Hamer, Henrike; Houben, Els; Windey, Karen; Verbeke, Kristin] Univ Hosp UZ Leuven, Leuven Food Sci & Nutr Ctr LFoRCe, B-3000 Louvain, Belgium; [Welling, Gjalt W.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, NL-9713 GZ Groningen, Netherlands; [Delcour, Jan A.; Courtin, Christophe M.] Katholieke Univ Leuven, Lab Food Chem & Biochem, B-3001 Louvain, Belgium; [Delcour, Jan A.; Courtin, Christophe M.] Katholieke Univ Leuven, Leuven Food Sci & Nutr Res Ctr LFoRCe, B-3001 Louvain, Belgium",Ghent University; University of Groningen; KU Leuven; KU Leuven,"François, IEJA (corresponding author), FUGEIA NV, Arenberg Sci Pk,Gaston Geenslaan 1, B-3001 Louvain, Belgium.",isabelle.francois@fugeia.com,"P, Evenepoel/D-9597-2018; Courtin, Christophe M/Q-1916-2016; DELCOUR, Jan A/P-4182-2017; Meijers, Bjorn/D-6169-2018","Courtin, Christophe M/0000-0002-1203-9063; DELCOUR, Jan A/0000-0003-2954-1022; Verbeke, Kristin/0000-0002-5352-7565; Possemiers, Sam/0000-0002-6893-5780; Meijers, Bjorn/0000-0002-2846-2026; Hamer, Henrike/0000-0002-6544-2331",Fugeia NV,Fugeia NV,"The authors thank Jan Wijffels (BNOSAC - the Belgium Network of Open Source Analytical Consultants) for the statistical analysis. The authors are also grateful to Erwin Raangs for technical assistance in analysing the faecal microbiota. The authors' responsibilities were as follows: I. E. J. A. F., O. L., J. A. D., C. M. C., K. V. and W. F. B. conceived of and designed the study; W. S. V. coordinated the production of the study's soft drinks; M. M. and S. P. were responsible for the analysis of ammonia content in stool samples; P. E. was responsible for the analysis of p-cresylsulfate content in serum; H. H., E. H. and K. W. were responsible for the analysis of the percentage moisture in the faecal samples and for the analysis of p-cresol content in urine; G. W. W. was responsible for the analysis of microbiota levels in the faecal samples; I. E. J. A. F. and W. F. B. were responsible for interaction with Jan Wijffels for analysis of the data; I. E. J. A. F. and W. F. B. had full access to all of the data in the study and jointly take responsibility for its integrity; I. E. J. A. F., O. L. and W. F. B. wrote the paper. I. E. J. A. F., O. L., W. S. V. and W. F. B. are presently employed by Fugeia NV, which manufactures the wheat bran extract product and is the sole sponsor source of funding for the studies described in the present paper.",,83,92,100,5,94,CAMBRIDGE UNIV PRESS,CAMBRIDGE,"EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND",0007-1145,1475-2662,,BRIT J NUTR,Br. J. Nutr.,DEC 28,2012,108,12,,,,,2229,2242,,10.1017/S0007114512000372,http://dx.doi.org/10.1017/S0007114512000372,,,14,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,056AM,22370444,"Bronze, Green Submitted, Green Published",,,2024-06-04,WOS:000312459300014,View Full Record in Web of Science
J,"Edwards, CA; Parrett, AM",,,,"Edwards, CA; Parrett, AM",,,Dietary fibre in infancy and childhood,PROCEEDINGS OF THE NUTRITION SOCIETY,,,English,Article; Proceedings Paper,7th International Vahouny Fibre Symposium,"MAY 27-30, 2002","ROYAL COLL PHYS, EDINBURGH, SCOTLAND",,ROYAL COLL PHYS,dietary fibre; childhood; microflora; fermentation,FORMULA-FED INFANTS; 1ST 2 YEARS; BREAST-FED INFANTS; CHAIN FATTY-ACIDS; INTESTINAL MICROFLORA; CHRONIC CONSTIPATION; FECAL FLORA; CHILDREN; STARCH; FERMENTATION,"There is very little evidence for the effects of dietary fibre in young children and current dietary guidelines are based on assumptions and data extrapolated from studies in adults. The first years of life may be critical for the establishment of a healthy colonic microflora, as well as good eating habits. The lack of clear and well-founded guidelines for the intake of dietary fibre in childhood may hinder both factors. The fears that a high-fibre diet in children < 5 years of age will lead to growth faltering and mineral imbalance are not well supported in the literature, especially for children in the developed world. Indeed, with the rising levels of obesity, fibre intake may be of benefit in reducing energy intake. A low-fibre diet may also be implicated in the aetiology of childhood constipation and appendicitis. The latest proposals for the definition of dietary fibre include oligosaccharides, which may act as prebiotics. There are potential health benefits of including oligosaccharides in the diets of infants and children, but more research is needed to consider the long-term effects. The immature intestine of the infant may also result in a greater amount of starch entering the colon during weaning, and this starch would now be considered dietary fibre under the new definitions. Much new research is needed to allow adequate recommendations for the intake of dietary fibre in childhood based on data collected in appropriate age-groups.","Univ Glasgow, Yorkhill Hosp, Dept Human Nutr, Glasgow G3 8SJ, Lanark, Scotland",University of Glasgow,"Univ Glasgow, Yorkhill Hosp, Dept Human Nutr, Glasgow G3 8SJ, Lanark, Scotland.",caeln@clinmed.gla.ac.uk,,"Parrett, Alison/0000-0001-6037-5398",,,,,68,39,56,0,15,CAMBRIDGE UNIV PRESS,CAMBRIDGE,"EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND",0029-6651,1475-2719,,P NUTR SOC,Proc. Nutr. Soc.,FEB,2003,62,1,,,,,17,23,,10.1079/PNS2002231,http://dx.doi.org/10.1079/PNS2002231,,,7,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Nutrition & Dietetics,670EU,12740052,Bronze,,,2024-06-04,WOS:000182395100004,View Full Record in Web of Science
J,"Rebelo, F; Mansur, IR; Miglioli, TC; Meio, MDB; Junior, SG",,,,"Rebelo, Fernanda; Mansur, Isabela Rodrigues; Miglioli, Teresa Cristina; Meio, Maria Dalva Baker; Gomes Junior, Saint Clair",,,Dietary and nutritional interventions in children with cerebral palsy: A systematic literature review,PLOS ONE,,,English,Review,,,,,,,VITAMIN-D; SUPPLEMENTATION,"Background Cerebral palsy is an extremely severe brain injury associated with multiple nutritional and clinical issues, such as underweight, gastroesophageal reflux, constipation, and nutrient deficiency. Evidence-based dietary and nutritional interventions may improve the quality of life of children with cerebral palsy. Aim Systematically review randomized clinical trials evaluating nutritional and dietary interventions in the clinical, nutritional, and neurodevelopmental aspects of children with cerebral palsy. Methods A search was performed in electronic databases (LILACS, Medline, Web of Science, Embase, Scopus, Cochrane Library, ClinicalTrials.gov, Brazilian Digital Library of Theses and Dissertations, ProQuest Dissertations and Theses Database, OpenGrey) using keywords. The search was firstly performed in May 2020 and updated on June 18th, 2021. Eligible studies were randomized clinical trials, that included children between 2 and 12 years old, and evaluated the effect of nutritional or dietetic interventions on clinical, nutritional or neurodevelopmental outcomes. Risk of bias was investigated using the RoB-2 tool. The study was registered on PROSPERO (CRD42020181284). Results Fifteen studies were selected. Positive results included the use of whey-based or pectin-enriched enteral formulas for gastroesophageal reflux (n = 6); 25-hydroxy-vitamin D supplementation for hypovitaminosis D (n = 2); supplementation with lipid mixture or diet with high-density energy for improvements in anthropometric measures (n = 2); supplementation with probiotics, prebiotics, symbiotics or magnesium for constipation (n = 2); nutritional support system for gross motor function (n = 1); lactoferrin and iron hydroxide polymaltose for iron deficiency anemia (n = 1); and educational intervention to improve feeding skills (n = 1). The overall risk of bias was high for 60% of the studies, and some concerns were raised for the remaining 40%. Conclusion Some promising dietary and nutritional interventions may promote important clinical improvements for patients with cerebral palsy. However, evidence is weak, as few clinical trials have been published with many methodological errors, leading to a high risk of bias.","[Rebelo, Fernanda; Mansur, Isabela Rodrigues; Miglioli, Teresa Cristina; Meio, Maria Dalva Baker; Gomes Junior, Saint Clair] Oswaldo Cruz Fdn Fiocuz, Natl Inst Women Children & Adolescents Hlth Ferna, Clin Res Unit, Rio De Janeiro, RJ, Brazil; [Mansur, Isabela Rodrigues] Fluminense Fed Univ UFF, Undergrad Program Nutr, Niteroi, RJ, Brazil; [Miglioli, Teresa Cristina] Iguacu Univ UNIG, Nutr Dept, Nova Iguacu, RJ, Brazil",Universidade Federal Fluminense,"Rebelo, F (corresponding author), Oswaldo Cruz Fdn Fiocuz, Natl Inst Women Children & Adolescents Hlth Ferna, Clin Res Unit, Rio De Janeiro, RJ, Brazil.",frebelos@gmail.com,"Gomes, Clair/F-7579-2012; Rebelo, Fernanda/AAN-5125-2020","Gomes, Clair/0000-0002-1554-943X; Rebelo, Fernanda/0000-0001-6207-5161",National Research Council (CNPq) [442551/2019-3],National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)),"This study was funded by the National Research Council (CNPq, process number 442551/2019-3). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,35,1,1,3,4,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1932-6203,,,PLOS ONE,PLoS One,JUL 21,2022,17,7,,,,,,,e0271993,10.1371/journal.pone.0271993,http://dx.doi.org/10.1371/journal.pone.0271993,,,15,Multidisciplinary Sciences,Science Citation Index Expanded (SCI-EXPANDED),Science & Technology - Other Topics,7T4CW,35867728,"Green Published, gold",,,2024-06-04,WOS:000911392100289,View Full Record in Web of Science
J,"Chen, ZJ; Liang, CY; Yang, LQ; Ren, SM; Xia, YM; Cui, L; Li, XF; Gao, BL",,,,"Chen, Zhao-Ji; Liang, Cheng-Yu; Yang, Li-Qing; Ren, Si-Min; Xia, Yan-Min; Cui, Lei; Li, Xiao-Fang; Gao, Bu-Lang",,,Association of Parkinson's Disease With Microbes and Microbiological Therapy,FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY,,,English,Review,,,,,,Parkinson’ s disease; a-synuclein; microbe; microbiological therapy; pathology,ALTERED GUT MICROBIOTA; ALPHA-SYNUCLEIN; SECRETORY PATHWAY; BRAIN AXIS; BACTERIAL; TRANSMISSION; DYSFUNCTION; PATHOLOGY; SYSTEM; CONSTIPATION,"Parkinson's disease (PD) is the most common movement disorder in the world, affecting 1-2 per 1,000 of the population. The main pathological changes of PD are damage of dopaminergic neurons in substantia nigra of the central nervous system and formation of Lewy bodies. These pathological changes also occur in the intestinal tract and are strongly associated with changes in intestinal flora. By reviewing the research progress in PD and its association with intestinal flora in recent years, this review expounded the mechanism of action between intestinal flora and PD as well as the transmission mode of alpha - synuclein in neurons. In clinical studies, beta diversity of intestinal flora in PD patients was found to change significantly, with Lactobacillusaceae and Verrucomicrobiaceae being significantly increased and Lachnospiraceae and Prevotellaceae being significantly decreased. In addition, a longer PD course was associated with fewer bacteria and probiotics producing short chain fatty acids, but more pathogenic bacteria. Moreover, the motor symptoms of PD patients may be related to Enterobacteriaceae and bacteria. Most importantly, catechol-O-methyltransferase inhibitors and anticholinergic drugs could change the intestinal flora of PD patients and increase the harmful flora, whereas other anti-PD drugs such as levodopa, dopamine agonist, monoamine oxidase inhibitors, and amantadine did not have these effects. Probiotics, prebiotics, and synbiotics treatment had some potential values in improving the constipation of PD patients, promoting the growth of probiotics, and improving the level of intestinal inflammation. At present, there were only a few case studies and small sample studies which have found certain clinical efficacy of fecal microbiome transplants. Further studies are necessary to elaborate the relationship of PD with microbes.","[Chen, Zhao-Ji; Liang, Cheng-Yu; Yang, Li-Qing; Ren, Si-Min; Xia, Yan-Min; Cui, Lei; Li, Xiao-Fang; Gao, Bu-Lang] Hebei Univ, Dept Neurol, Affiliated Hosp, Baoding, Peoples R China",Hebei University,"Li, XF; Gao, BL (corresponding author), Hebei Univ, Dept Neurol, Affiliated Hosp, Baoding, Peoples R China.",lxf2530@163.com; browngao@163.com,"Li, Xiaofang/C-9014-2009",,,,,,113,24,26,3,43,FRONTIERS MEDIA SA,LAUSANNE,"AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND",2235-2988,,,FRONT CELL INFECT MI,Front. Cell. Infect. Microbiol.,MAR 8,2021,11,,,,,,,,619354,10.3389/fcimb.2021.619354,http://dx.doi.org/10.3389/fcimb.2021.619354,,,11,Immunology; Microbiology,Science Citation Index Expanded (SCI-EXPANDED),Immunology; Microbiology,QZ9RF,33763383,"Green Published, gold",,,2024-06-04,WOS:000631056100001,View Full Record in Web of Science
J,"Biagi, E; Candela, M; Turroni, S; Garagnani, P; Franceschi, C; Brigidi, P",,,,"Biagi, Elena; Candela, Marco; Turroni, Silvia; Garagnani, Paolo; Franceschi, Claudio; Brigidi, Patrizia",,,Ageing and gut microbes: Perspectives for health maintenance and longevity,PHARMACOLOGICAL RESEARCH,,,English,Review,,,,,,Intestinal microbiota; Ageing; Immunosenescence; Probiotics; Longevity,NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CLOSTRIDIUM-DIFFICILE INFECTION; LACTOBACILLUS-ACIDOPHILUS NCFM; BUTYRATE-PRODUCING BACTERIA; CHAIN FATTY-ACIDS; FECAL MICROBIOTA; INTESTINAL MICROBIOTA; INFLUENZA VACCINATION; IMMUNE FUNCTION; GASTROINTESTINAL MICROBIOTA,"The ageing process affects the human gut microbiota phylogenetic composition and its interaction with the immune system. Age-related gut microbiota modifications are associated with immunosenescence and inflamm-ageing in a sort of self-sustaining loop, which allows the placement of gut microbiota unbalances among both the causes and the effects of the inflamm-ageing process. Even if, up to now, the link between gut microbiota and the ageing process is only partially understood, the gut ecosystem shows the potential to become a promising target for strategies able to contribute to the health status of older people. In this context, the consumption of pro/prebiotics may be useful in both prevention and treatment of age-related pathophysiological conditions, such as recovery and promotion of immune functions, i.e. adjuvant effect for influenza vaccine, and prevention and/or alleviation of common winter diseases, as well as constipation and Clostridium difficile-associated diarrhoea. Moreover, being involved in different mechanisms which concur in counteracting inflammation, such as down-regulation of inflammation-associated genes and improvement of colonic mucosa conditions, probiotics have the potentiality to be involved in the promotion of longevity. (C) 2012 Elsevier Ltd. All rights reserved.","[Biagi, Elena; Candela, Marco; Turroni, Silvia; Brigidi, Patrizia] Univ Bologna, Dept Pharmaceut Sci, I-40126 Bologna, Italy; [Garagnani, Paolo; Franceschi, Claudio] Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy; [Garagnani, Paolo; Franceschi, Claudio] Univ Bologna, CIG Interdipartimental Ctr L Galvani, I-40126 Bologna, Italy",University of Bologna; University of Bologna; University of Bologna,"Brigidi, P (corresponding author), Univ Bologna, Dept Pharmaceut Sci, Via Belmeloro 6, I-40126 Bologna, Italy.",patrizia.brigidi@unibo.it,"Franceschi, Claudio/L-4484-2017; Turroni, Silvia/J-7195-2016","Turroni, Silvia/0000-0003-2345-9482; Garagnani, Paolo/0000-0002-4161-3626; Brigidi, Patrizia/0000-0001-8375-6150",,,,,122,175,193,3,123,ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD,LONDON,"24-28 OVAL RD, LONDON NW1 7DX, ENGLAND",1043-6618,,,PHARMACOL RES,Pharmacol. Res.,MAR,2013,69,1,,,,,11,20,,10.1016/j.phrs.2012.10.005,http://dx.doi.org/10.1016/j.phrs.2012.10.005,,,10,Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy,102FU,23079287,,,,2024-06-04,WOS:000315831100002,View Full Record in Web of Science
J,"Napolitano, M; Fasulo, E; Ungaro, F; Massimino, L; Sinagra, E; Danese, S; Mandarino, FV",,,,"Napolitano, Maria; Fasulo, Ernesto; Ungaro, Federica; Massimino, Luca; Sinagra, Emanuele; Danese, Silvio; Mandarino, Francesco Vito",,,Gut Dysbiosis in Irritable Bowel Syndrome: A Narrative Review on Correlation with Disease Subtypes and Novel Therapeutic Implications,MICROORGANISMS,,,English,Review,,,,,,irritable bowel syndrome; IBS; microbiota; microflora; gut; subtype IBS-D; subtype IBS-C,FECAL MICROBIOTA TRANSPLANTATION; RANDOMIZED DOUBLE-BLIND; MUCOSAL-ASSOCIATED MICROBIOTA; CEREVISIAE CNCM I-3856; LOW FODMAP DIET; INTESTINAL MICROBIOTA; SACCHAROMYCES-CEREVISIAE; METHANOBREVIBACTER-SMITHII; MOLECULAR ANALYSIS; SYMBIOTIC MIXTURE,"Irritable bowel syndrome (IBS) is a prevalent functional gastrointestinal disorder characterized by chronic abdominal pain and altered bowel habits. It can be subclassified in different subtypes according to the main clinical manifestation: constipation, diarrhea, mixed, and unclassified. Over the past decade, the role of gut microbiota in IBS has garnered significant attention in the scientific community. Emerging research spotlights the intricate involvement of microbiota dysbiosis in IBS pathogenesis. Studies have demonstrated reduced microbial diversity and stability and specific microbial alterations for each disease subgroup. Microbiota-targeted treatments, such as antibiotics, probiotics, prebiotics, synbiotics, fecal microbiota transplantation, and even diet, offer exciting prospects for managing IBS. However, definitive conclusions are hindered by the heterogeneity of these studies. Further research should focus on elucidating the mechanisms, developing microbiome-based diagnostics, and enabling personalized therapies tailored to an individual's microbiome profile. This review takes a deep dive into the microscopic world inhabiting our guts, and its implications for IBS. Our aim is to elucidate the complex interplay between gut microbiota and each IBS subtype, exploring novel microbiota-targeted treatments and providing a comprehensive overview of the current state of knowledge.","[Napolitano, Maria; Fasulo, Ernesto; Ungaro, Federica; Massimino, Luca; Danese, Silvio; Mandarino, Francesco Vito] IRCCS San Raffaele Hosp, Dept Gastroenterol & Gastrointestinal Endoscopy, I-20132 Milan, Italy; [Ungaro, Federica; Massimino, Luca] IRCCS Osped San Raffaele, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy; [Sinagra, Emanuele] Fdn Ist G Giglio, Gastroenterol & Endoscopy Unit, I-90015 Cefalu, Italy; [Danese, Silvio] Univ Vita Salute San Raffaele, Gastroenterol & Endoscopy, I-20132 Milan, Italy",Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University,"Napolitano, M (corresponding author), IRCCS San Raffaele Hosp, Dept Gastroenterol & Gastrointestinal Endoscopy, I-20132 Milan, Italy.",napolitano.maria@hsr.it; fasulo.ernesto@hsr.it; ungaro.federica@hsr.it; massimino.luca@hsr.it; emanuelesinagra83@googlemail.com; danese.silvio@hsr.it; mandarino.francesco@hsr.it,"Mandarino, Francesco Vito/CAH-8556-2022; Massimino, Luca/IAO-1351-2023; Fasulo, Ernesto/JZD-4045-2024; Ungaro, Federica/JCE-1744-2023; Sinagra, Emanuele/C-9336-2014; Massimino, Luca/F-2244-2011","Fasulo, Ernesto/0009-0009-3967-2684; Mandarino, Francesco Vito/0000-0002-9931-7221; Massimino, Luca/0000-0003-3975-9148",All the authors thank the Hospital San Raffaele and Hospital G. Giglio for the support provided to all the authors.; Hospital San Raffaele and Hospital G. Giglio,All the authors thank the Hospital San Raffaele and Hospital G. Giglio for the support provided to all the authors.; Hospital San Raffaele and Hospital G. Giglio,All the authors thank the Hospital San Raffaele and Hospital G. Giglio for the support provided to all the authors.,,198,4,4,13,14,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2076-2607,,MICROORGANISMS,Microorganisms,OCT,2023,11,10,,,,,,,2369,10.3390/microorganisms11102369,http://dx.doi.org/10.3390/microorganisms11102369,,,31,Microbiology,Science Citation Index Expanded (SCI-EXPANDED),Microbiology,W8HJ1,37894027,"Green Published, gold",,,2024-06-04,WOS:001093981000001,View Full Record in Web of Science
J,"Schmulson, M; Bashashati, M",,,,"Schmulson, Max; Bashashati, Mohammad",,,Fecal microbiota transfer for bowel disorders: efficacy or hype?,CURRENT OPINION IN PHARMACOLOGY,,,English,Article,,,,,,,GUT MICROBIOTA; DOUBLE-BLIND; INTESTINAL MICROBIOTA; TRANSPLANTATION; PLACEBO; MODULATION; PATTERNS,"Purpose of review: Dysbiosis has been related to the pathophysiology of disorders of - gut-brain interaction (DGBI) including irritable bowel syndrome (IBS) and functional constipation (FC). Accordingly, modulation of gut microbiota has been proposed as a potential treatment for these disorders. Gut microbiota modulation can be effected by probiotics, prebiotics, symbiotics, postbiotics, antibiotics and fecal transplantation (FMT) or bacteriotherapy. The latter is currently used for recurrent or severe Clostridium difficile colitis and has been the focus of recent research in IBS and FC. Recent findings: Several case series reported promising results for FMT in patients with IBS and FC, which prompted the conduction of randomized controlled trials (RCT) in these DGBI. Summary: Both case series and RCTs are herein discussed. To the best of our knowledge, as of yet, 5 RCTs have been published on IBS and one in FC with slow colonic transit. In IBS, the majority of studies have used the IBS severity scoring system (IBS-SSS) as an outcome measure; however, the selection criteria were different among the trials as well as the route and form of administration of the FMT. Therefore, the results are inconsistent and no conclusion can be drawn. Some studies suggest that the presence of post-infection (PI)-IBS and the baseline microbiota status in the donors could be predictor factors of successful FMT in IBS. In constipation with slow colonic transit, the FMT seems to be more effective, although the data is based on only one RCT. We believe that larger RCTs, controlled with true placebos and considering baseline intestinal microbiota of the study subjects as well as donors' microbiota are still needed before recommending FMT in IBS and/or FC. History of previous GI infection (e.g. PI-IBS) and IBS subtypes should also be taken into account.","[Schmulson, Max] Univ Nacl Autonoma Mexico, Hosp Gen Mexico Dr Eduardo Liceaga, Fac Med, Lab Higado Pancreas & Motilidad HIPAM,Unidad Inve, Mexico City, DF, Mexico; [Bashashati, Mohammad] Texas Tech Univ, Hlth Sci Ctr, Dept Med, Div Gastroenterol, El Paso, TX USA",Universidad Nacional Autonoma de Mexico; Texas Tech University System; Texas Tech University,"Schmulson, M (corresponding author), Univ Nacl Autonoma Mexico, Hosp Gen Mexico Dr Eduardo Liceaga, Fac Med, Lab Higado Pancreas & Motilidad HIPAM,Unidad Inve, Mexico City, DF, Mexico.",maxjulio@prodigy.net.mx,"Schmulson, Max Julio/A-3176-2008","Schmulson, Max Julio/0000-0002-8440-8542",,,,,42,13,14,0,17,ELSEVIER SCI LTD,OXFORD,"THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND",1471-4892,1471-4973,,CURR OPIN PHARMACOL,Curr. Opin. Pharmacol.,DEC,2018,43,,,,,,72,80,,10.1016/j.coph.2018.08.012,http://dx.doi.org/10.1016/j.coph.2018.08.012,,,9,Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy,HG6CD,30218939,,,,2024-06-04,WOS:000455067700013,View Full Record in Web of Science
J,"Vandenplas, Y",,,,"Vandenplas, Yvan",,,Algorithms for Common Gastrointestinal Disorders,JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION,,,English,Article; Proceedings Paper,"8th Meeting on Probiotics, Prebiotics and New Foods","SEP 13-15, 2015","Rome, ITALY",,,colic; constipation; cows' milk allergy; functional disorder; regurgitation,INFANTS; SYMPTOMS,"Regurgitation, infantile colic and, or, constipationare frequent during the first 12 months of life, and although they aremost of the time functional disorders, these conditions can also be related to cow's milk. Practical algorithms for their management are presented. Management consists of exclusion of warning signs for organic disease, parental reassurance and nutritional strategies. The proposed algorithms will assist healthcare providers to manage frequent gastrointestinal and cows' milkrelated symptoms in infants.","[Vandenplas, Yvan] Vrije Univ Brussel, UZ Brussel, Dept Paediat, Brussels, Belgium",Vrije Universiteit Brussel; University Hospital Brussels,"Vandenplas, Y (corresponding author), UZ Brussel, Laarbeeklaan 101, B-1090 Brussels, Belgium.",yvan.vandenplas@uzbrussel.be,,,,,,,10,2,4,0,5,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0277-2116,1536-4801,,J PEDIATR GASTR NUTR,J. Pediatr. Gastroenterol. Nutr.,JUL,2016,63,,,1,,,S38,S40,,,,,,3,Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,DP8OZ,27380599,,,,2024-06-04,WOS:000378758800012,View Full Record in Web of Science
J,"Surdea-Blaga, T; Cozma-Petrut, A; Dumitrascu, DL",,,,"Surdea-Blaga, Teodora; Cozma-Petrut, Anamaria; Dumitrascu, Dan Lucian",,,Dietary interventions and irritable bowel syndrome - what really works?,CURRENT OPINION IN GASTROENTEROLOGY,,,English,Review,,,,,,diet; fermentable oligo-; di-; monosaccharides; and polyols; gluten; irritable bowel syndrome; microbiota modulation,,"Purpose of review The review examines the latest research on the use of dietary interventions in the management of irritable bowel syndrome (IBS) in order to understand what is the evidence supporting the efficacy of a dietary approach in this disorder. Recent findings A general dietary advice should be offered to all IBS patients. Psyllium supplementation is recommended in IBS with both constipation and diarrhea predominance. There is increasing evidence showing the beneficial effects of a low fermentable oligo-, di-, monosaccharides, and polyols (FODMAP) diet (LFD) on IBS symptoms. FODMAPs that are well tolerated should be reintroduced in daily diet, to increase acceptability of the diet, and limit potentially harmful effects. The benefits observed with the gluten-free diet seem determined by the reduction of FODMAPs rather than gluten. Modulation of gut microbiota using probiotics shows promising results, but there are unanswered questions regarding the optimal strains, dose and duration of treatment. Additional evidence is also needed for the role of prebiotics and synbiotics in IBS. Food is both trigger of IBS symptoms and therapeutic tool. Recent studies demonstrated the beneficial effects of LFD on symptom control, as well as the role of probiotics, which seem to contribute to gut health and function.","[Surdea-Blaga, Teodora; Dumitrascu, Dan Lucian] Iuliu Hatieganu Univ Med & Pharm, Dept Med 2, Cluj Napoca, Romania; [Cozma-Petrut, Anamaria] Iuliu Hatieganu Univ Med & Pharm, Dept Bromatol, Hyg, Nutr, 6 Louis Pasteur St, Cluj Napoca 400349, Romania",Iuliu Hatieganu University of Medicine & Pharmacy; Iuliu Hatieganu University of Medicine & Pharmacy,"Cozma-Petrut, A (corresponding author), Iuliu Hatieganu Univ Med & Pharm, Dept Bromatol, Hyg, Nutr, 6 Louis Pasteur St, Cluj Napoca 400349, Romania.",anamaria.cozma@umfcluj.ro,"Dumitrascu, Dan/C-4618-2011; Surdea-Blaga, Teodora/IAM-5919-2023; Cozma-Petrut, Anamaria/HJI-6925-2023","Cozma-Petrut, Anamaria/0000-0003-4381-5544",,,,,53,4,4,0,23,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0267-1379,1531-7056,,CURR OPIN GASTROEN,Curr. Opin. Gastroenterol.,MAR,2021,37,2,,,,,152,157,,10.1097/MOG.0000000000000706,http://dx.doi.org/10.1097/MOG.0000000000000706,,,6,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,PZ6LJ,33332914,,,,2024-06-04,WOS:000612851000013,View Full Record in Web of Science
J,"Singh, S; Singh, G; Arya, SK",,,,"Singh, Saumya; Singh, Gursharan; Arya, Shailendra Kumar",,,Mannans: An overview of properties and application in food products',INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES,,,English,Review,,,,,,Mannans; Mannanases; Food products,LOCUST BEAN GUM; THERMOSTABLE BETA-MANNANASE; CELL-WALL POLYSACCHARIDES; HYDROLYZED GUAR GUM; RHEOLOGICAL PROPERTIES; KONJAC GLUCOMANNAN; PHYSICAL-PROPERTIES; STRUCTURAL-CHARACTERIZATION; PHYSICOCHEMICAL PROPERTIES; CARBOXYMETHYL DERIVATIVES,"This review aims to emphasize the occurrence and abundant presence of mannans in nature, their classification, structural differences and significance in food and feed industry. With rising demand from the consumers' end for novel natural foods, usage of galactomannan and glucomannan has also increased alternatively. Non toxicity of mannans permits their usage in the pharmaceutical, biomedical, cosmetics, and textile industries. In the food industry, mannans have various applications such as edible films/coating, gel formation, stiffeners, viscosity modifiers, stabilizers, texture improvers, water absorbants, as prebiotics in dairy products and bakery, seasonings, diet foods, coffee whiteners etc. Applications and functions of these commonly used commercially available mannans have therefore, been highlighted. Mannans improve the texture and appeal of food products and provide numerous health benefits like controlling obesity and body weight control, prebiotic benefits, constipation alleviaton, prevent occurrence of diarrhea, check inflammation due to gut related diseases, management of diverticular disease management, balance intestinal microbiota, immune system modulator, reduced risk of colorectal cancer etc. Mannan degrading enzymes are the key enzymes involved in degradation and are useful in various industrial processes such as fruit juice clarification, viscosity reduction of coffee extracts etc. besides facilitating the process steps and improving process quality. (C) 2018 Elsevier B.V. All rights reserved.","[Singh, Saumya; Singh, Gursharan; Arya, Shailendra Kumar] Panjab Univ, Univ Inst Engn & Technol, Dept Biotechnol, Chandigarh, India",Panjab University,"Arya, SK (corresponding author), Panjab Univ, Univ Inst Engn & Technol, Sect 25, Chandigarh 160025, India.",skarya@pu.ac.in,,,,,,,162,124,131,22,221,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",0141-8130,1879-0003,,INT J BIOL MACROMOL,Int. J. Biol. Macromol.,NOV,2018,119,,,,,,79,95,,10.1016/j.ijbiomac.2018.07.130,http://dx.doi.org/10.1016/j.ijbiomac.2018.07.130,,,17,"Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science",Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Chemistry; Polymer Science,GX4FD,30048723,,,,2024-06-04,WOS:000447682100011,View Full Record in Web of Science
J,"Neag, MA; Craciun, AE; Inceu, AI; Burlacu, DE; Craciun, CI; Buzoianu, AD",,,,"Neag, Maria-Adriana; Craciun, Anca-Elena; Inceu, Andreea-Ioana; Burlacu, Diana-Elena; Craciun, Cristian-Ioan; Buzoianu, Anca-Dana",,,Short-Chain Fatty Acids as Bacterial Enterocytes and Therapeutic Target in Diabetes Mellitus Type 2,BIOMEDICINES,,,English,Review,,,,,,enteric nervous system; short-chain fatty acids; diabetes mellitus; gut microbiota; glucagon-like peptide 1,GLUCAGON-LIKE PEPTIDE-1; ENTERIC NERVOUS-SYSTEM; TOLL-LIKE RECEPTORS; GUT MICROBIOTA; DOUBLE-BLIND; BRAIN AXIS; PROTEIN; CELLS; NEUROGENESIS; HOMEOSTASIS,"Diabetes mellitus is a disease with multiple gastrointestinal symptoms (diarrhea or constipation, abdominal pain, bloating) whose pathogenesis is multifactorial. The most important of these factors is the enteric nervous system, also known as the second brain; a part of the peripheral nervous system capable of functioning independently of the central nervous system. Modulation of the enteric nervous system can be done by short-chain fatty acids, which are bacterial metabolites of the intestinal microbiota. In addition, these acids provide multiple benefits in diabetes, particularly by stimulating glucagon-like peptide 1 and insulin secretion. However, it is not clear what type of nutraceuticals (probiotics, prebiotics, and alimentary supplements) can be used to increase the amount of short-chain fatty acids and achieve the beneficial effects in diabetes. Thus, even if several studies demonstrate that the gut microbiota modulates the activity of the ENS, and thus, may have a positive effect in diabetes, further studies are needed to underline this effect. This review outlines the most recent data regarding the involvement of SCFAs as a disease modifying agent in diabetes mellitus type 2. For an in-depth understanding of the modulation of gut dysbiosis with SCFAs in diabetes, we provide an overview of the interplay between gut microbiota and ENS.","[Neag, Maria-Adriana; Inceu, Andreea-Ioana; Craciun, Cristian-Ioan; Buzoianu, Anca-Dana] Iuliu Hatieganu Univ Med & Pharm, Dept Pharmacol Toxicol & Clin Pharmacol, Cluj Napoca 400337, Romania; [Craciun, Anca-Elena] Iuliu Hatieganu Univ Med, Dept Diabet & Nutr Dis, Pharm, Cluj Napoca 400006, Romania; [Burlacu, Diana-Elena] Iuliu Hatieganu Univ Med & Pharm, Fac Med, Cluj Napoca 400012, Romania",Iuliu Hatieganu University of Medicine & Pharmacy; Iuliu Hatieganu University of Medicine & Pharmacy; Iuliu Hatieganu University of Medicine & Pharmacy,"Craciun, AE (corresponding author), Iuliu Hatieganu Univ Med, Dept Diabet & Nutr Dis, Pharm, Cluj Napoca 400006, Romania.",anca.craciun@umfcluj.ro,"Inceu, Andreea Ioana/JDC-6177-2023; Buzoianu, Anca Dana/M-1050-2017","Buzoianu, Anca Dana/0000-0002-3511-2788; Inceu, Andreea/0000-0001-8863-2851",,,,,101,0,0,1,8,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2227-9059,,BIOMEDICINES,Biomedicines,JAN,2023,11,1,,,,,,,72,10.3390/biomedicines11010072,http://dx.doi.org/10.3390/biomedicines11010072,,,18,"Biochemistry & Molecular Biology; Medicine, Research & Experimental; Pharmacology & Pharmacy",Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Research & Experimental Medicine; Pharmacology & Pharmacy,7X3KW,36672580,"gold, Green Published",,,2024-06-04,WOS:000914101400001,View Full Record in Web of Science
J,"Umeda, K; Ikeda, A; Uchida, R; Sasahara, I; Mine, T; Murakami, H; Kameyama, K",,,,"Umeda, Kentaro; Ikeda, Atsuko; Uchida, Ryo; Sasahara, Ikuko; Mine, Tomoyuki; Murakami, Hitoshi; Kameyama, Keishi",,,"Combination of poly-γ-glutamic acid and galactooligosaccharide improves intestinal microbiota, defecation status, and relaxed mood in humans: a randomized, double-blind, parallel-group comparison trial",BIOSCIENCE OF MICROBIOTA FOOD AND HEALTH,,,English,Article,,,,,,intestinal regulation; intestinal environment; bifidobacteria; galactooligosaccharide; poly-?-glutamic acid,ESCHERICHIA-COLI K-12; GASTROINTESTINAL-TRACT; SENSING CELLS; TRANSPEPTIDASE; GABA; CONSTIPATION; TRANSFERASE; BIFIDOBACTERIA; TRANSPORTERS; CONSUMPTION,"The genus Bifidobacterium comprises beneficial intestinal bacteria that play a crucial role in the regulation of human health. Traditional prebiotics are known to increase intestinal bifidobacteria by supplying a carbon source necessary for their growth. However, intestinal bifidobacteria need not only a carbon source but also a nitrogen source for growth. Moreover, the growth of bifidobacteria is known to be inhibited in a culture medium that does not contain glutamic acid. Based on these reports, we hypothesized that the combined intake of traditional prebiotics and glutamic acid would be beneficial for growth of bifidobacteria in the gut. In this study, we investigated the effects of the combination of galactooligosaccharide (GOS; traditional prebiotic material) and poly-gamma-glutamic acid (gamma-PGA; source of glutamic acid) and only GOS on the intestinal microbiota and health conditions (including intestinal regulation, mood status, gastrointestinal condition, skin condition, and sleep quality) in a randomized, double-blind, parallel-group comparison trial in healthy subjects. The combined intake of GOS and gamma-PGA significantly increased the prevalence of B. longum compared to the intake of GOS alone. A minimum effective dose of 2.0 g GOS and 0.3 g gamma-PGA improved defecation and mood status. We revealed the combined effects of GOS and gamma-PGA on intestinal microbiota as well as physical condition and concluded that the delivery of glutamic acid to the large intestine with traditional prebiotics is useful as an advanced prebiotic.","[Ikeda, Atsuko; Uchida, Ryo; Sasahara, Ikuko; Murakami, Hitoshi; Kameyama, Keishi] Ajinomoto Co Inc, Inst Food Sci & Technol, 1-1 Suzuki Cho,Kawasaki Ku, Kawasaki 2108681, Japan; [Mine, Tomoyuki] Ajinomoto Co Inc, Res & Business Planning Dept, 1-15-1 Kyobashi,Chuo Ku, Tokyo 1048315, Japan",Ajinomoto Co Inc; Ajinomoto Co Inc,"Kameyama, K (corresponding author), Ajinomoto Co Inc, Inst Food Sci & Technol, 1-1 Suzuki Cho,Kawasaki Ku, Kawasaki 2108681, Japan.",keishi.kameyama.hw4@asv.ajinomoto.com,"Ikeda, Atsuko/A-4105-2012; Murakami, Hitoshi/IWU-8940-2023","Ikeda, Atsuko/0000-0002-3065-262X; Umeda, Kentaro/0000-0001-7761-4703",,,,,79,3,3,3,12,BMFH PRESS,TOKYO,"ATTN-BMFH, EDITORIAL OFF IPEC INC, 1-24-12 SUGAMO,TOSHIMA-KU, TOKYO, 170-0002, JAPAN",2186-6953,2186-3342,,BIOSCI MICROB FOOD H,Biosci. Microbiota Food Health,,2023,42,1,,,,,34,48,,10.12938/bmfh.2021-084,http://dx.doi.org/10.12938/bmfh.2021-084,,,15,Microbiology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Microbiology; Nutrition & Dietetics,7O9RC,36660591,"gold, Green Published",,,2024-06-04,WOS:000908351200006,View Full Record in Web of Science
J,"Menozzi, E; Schapira, AHV",,,,"Menozzi, Elisa; Schapira, Anthony H. V.",,,The Gut Microbiota in Parkinson Disease: Interactions with Drugs and Potential for Therapeutic Applications,CNS DRUGS,,,English,Article,,,,,,,INTESTINAL BACTERIAL OVERGROWTH; HELICOBACTER-PYLORI INFECTION; INTERNATIONAL SCIENTIFIC ASSOCIATION; L-DOPA ABSORPTION; ALPHA-SYNUCLEIN; DOUBLE-BLIND; CONSENSUS STATEMENT; LEVODOPA ABSORPTION; MOTOR FLUCTUATIONS; PROBIOTICS,"The concept of a 'microbiota-gut-brain axis' has recently emerged as an important player in the pathophysiology of Parkinson disease (PD), not least because of the reciprocal interaction between gut bacteria and medications. The gut microbiota can influence levodopa kinetics, and conversely, drugs administered for PD can influence gut microbiota composition. Through a two-step enzymatic pathway, gut microbes can decarboxylate levodopa to dopamine in the small intestine and then dehydroxylate it to m-tyramine, thus reducing availability. Inhibition of bacterial decarboxylation pathways could therefore represent a strategy to increase levodopa absorption. Other bacterial perturbations common in PD, such as small intestinal bacterial overgrowth and Helicobacter pylori infection, can also modulate levodopa metabolism, and eradication therapies may improve levodopa absorption. Interventions targeting the gut microbiota offer a novel opportunity to manage disabling motor complications and dopa-unresponsive symptoms. Mediterranean diet-induced changes in gut microbiota composition might improve a range of non-motor symptoms. Prebiotics can increase levels of short-chain fatty acid-producing bacteria and decrease pro-inflammatory species, with positive effects on clinical symptoms and levodopa kinetics. Different formulations of probiotics showed beneficial outcomes on constipation, with some of them improving dopamine levels; however, the most effective dosage and duration and long-term effects of these treatments remain unknown. Data from faecal microbiota transplantation studies are preliminary, but show encouraging trends towards improvement in both motor and non-motor outcomes.This article summarises the most up-to-date knowledge in pharmacomicrobiomics in PD, and discusses how the manipulation of gut microbiota represents a potential new therapeutic avenue for PD.","[Menozzi, Elisa; Schapira, Anthony H. V.] UCL, Dept Clin & Movement Neurosci, Queen Sq Inst Neurol, London NW3 2PF, England; [Menozzi, Elisa; Schapira, Anthony H. V.] Aligning Sci Parkinsons ASAP Collaborat Res Networ, Chevy Chase, MD 20815 USA",University of London; University College London,"Schapira, AHV (corresponding author), UCL, Dept Clin & Movement Neurosci, Queen Sq Inst Neurol, London NW3 2PF, England.;Schapira, AHV (corresponding author), Aligning Sci Parkinsons ASAP Collaborat Res Networ, Chevy Chase, MD 20815 USA.",a.schapira@ucl.ac.uk,"Schapira, Anthony/A-1245-2010","Schapira, Anthony/0000-0002-3018-3966; Menozzi, Elisa/0000-0003-3565-7910",Aligning Science Across Parkinson's,Aligning Science Across Parkinson's(Aligning Science Across Parkinson's (ASAP)),No Statement Available,,128,0,0,4,4,ADIS INT LTD,NORTHCOTE,"5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND",1172-7047,1179-1934,,CNS DRUGS,CNS Drugs,MAY,2024,38,5,,,,,315,331,,10.1007/s40263-024-01073-4,http://dx.doi.org/10.1007/s40263-024-01073-4,,APR 2024,17,Clinical Neurology; Pharmacology & Pharmacy; Psychiatry,Science Citation Index Expanded (SCI-EXPANDED),Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry,OA5F1,38570412,hybrid,,,2024-06-04,WOS:001196319000001,View Full Record in Web of Science
J,"Talley, NJ; Holtmann, G; Walker, MM",,,,"Talley, Nicholas J.; Holtmann, Gerald; Walker, Marjorie M.",,,Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology,JOURNAL OF GASTROENTEROLOGY,,,English,Review,,,,,,Functional dyspepsia; Irritable bowel syndrome; Therapeutics,UPPER GASTROINTESTINAL-TRACT; PLACEBO-CONTROLLED TRIAL; GROWTH-FACTOR 19; QUALITY-OF-LIFE; HELICOBACTER-PYLORI; DOUBLE-BLIND; SENSORY FUNCTION; GUT MICROBIOTA; RISK-FACTORS; FOLLOW-UP,"Functional gastrointestinal disorders (FGIDs) are common and distressing. They are so named because a defined pathophysiology in terms of structural or biochemical pathways is lacking. Traditionally FGIDs have been conceptualized as brain-gut disorders, with subgroups of patients demonstrating visceral hypersensitivity and motility abnormalities as well as psychological distress. However, it is becoming apparent that there are certain structural or biochemical gut alterations among subsets with the common FGIDs, most notably functional dyspepsia (FD) and irritable bowel syndrome (IBS). For example, a sodium channel mutation has been identified in IBS that may account for 2 % of cases, and subtle intestinal inflammation has been observed in both IBS and FD. Other research has implicated early life events and stress, autoimmune disorders and atopy and infections, the gut microbiome and disordered mucosal immune activation in patients with IBS or FD. Understanding the origin of symptoms in FGIDs will allow therapy to be targeted at the pathophysiological changes, not at merely alleviating symptoms, and holds hope for eventual cure in some cases. For example, there are promising developments in manipulating the microbiome through diet, prebiotics and antibiotics in IBS, and testing and treating patients for Helicobacter pylori infection remains a mainstay of therapy in patients with dyspepsia and this infection. Locally acting drugs such as linaclotide have been an advance in treating the symptoms of constipation-predominant IBS, but do not alter the natural history of the disease. A role for a holistic approach to patients with FGIDs is warranted, as brain-to-gut and gut-to-brain pathways appear to be activated.","[Talley, Nicholas J.] Univ Newcastle, Global Res, New Lambton, NSW 2305, Australia; [Holtmann, Gerald] Univ Queensland, Fac Med & Biomed Sci, Herston, Qld 4029, Australia; [Holtmann, Gerald] Univ Queensland, Fac Hlth & Behav Sci, Herston, Qld 4029, Australia; [Walker, Marjorie M.] Univ Newcastle, Callaghan, NSW 2308, Australia",University of Newcastle; University of Queensland; University of Queensland; University of Newcastle,"Talley, NJ (corresponding author), Univ Newcastle, Global Res, HMRI Bldg,Room 3419, New Lambton, NSW 2305, Australia.",nicholas.talley@newcastle.edu.au,"Holtmann, Gerald/S-4065-2019; Walker, Marjorie Mary/F-6504-2013; Holtmann, Gerald/I-5341-2014","Holtmann, Gerald/0000-0002-0206-2358",,,,,127,46,52,0,22,SPRINGER JAPAN KK,TOKYO,"SHIROYAMA TRUST TOWER 5F, 4-3-1 TORANOMON, MINATO-KU, TOKYO, 105-6005, JAPAN",0944-1174,1435-5922,,J GASTROENTEROL,J. Gastroenterol.,JUN,2015,50,6,,,,,601,613,,10.1007/s00535-015-1076-x,http://dx.doi.org/10.1007/s00535-015-1076-x,,,13,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,CK0YK,25917563,Bronze,,,2024-06-04,WOS:000355931500001,View Full Record in Web of Science
J,"Corsello, A; Scatigno, L; Fiore, G; Baresi, S; Eletti, F; Zuccotti, G; Strisciuglio, C; Dilillo, D; Verduci, E",,,,"Corsello, Antonio; Scatigno, Lorenzo; Fiore, Giulia; Baresi, Stefano; Eletti, Francesca; Zuccotti, Gianvincenzo; Strisciuglio, Caterina; Dilillo, Dario; Verduci, Elvira",,,Nutraceuticals and biotics in pediatric gastrointestinal disorders,EUROPEAN JOURNAL OF CLINICAL NUTRITION,,,English,Review,,,,,,,IRRITABLE-BOWEL-SYNDROME; INTERNATIONAL SCIENTIFIC ASSOCIATION; PROBIOTIC LACTOBACILLUS STRAINS; RANDOMIZED CLINICAL-TRIAL; CASEI-RHAMNOSUS LCR35; DIETARY FIBER MIXTURE; FUNCTIONAL CONSTIPATION; CHILDHOOD CONSTIPATION; ACUTE GASTROENTERITIS; CONSENSUS STATEMENT,"In recent years there has been growing interest in the use of nutraceuticals and biotics in both pediatric and adult clinical practice. The overlapping and often ambiguous symptoms of both functional and organic gastrointestinal disorders have led to a search for alternative therapeutic approaches that avoid the use of synthetic or chemical treatments. However, while nutraceuticals and natural supplements are widely used, their health benefits are often not supported by adequate scientific evidence, and an unregulated use of nutraceuticals can be potentially harmful. The correct use of nutraceuticals, prebiotics, and probiotics can optimize the results of drug therapy in some cases and reduce the risk of side effects. This review aims to provide clinicians with guidance on the use of complementary therapies for pediatric gastrointestinal symptoms and disorders, highlighting the scarcity of studies on the kinetics and dynamics of nutraceuticals and biotics. While it is generally difficult to associate their intakes with adverse events due to the often-coexisting pharmacological treatments, it is essential to avoid the abandonment of traditional drugs with proven efficacy in the treatment of single diseases. Overall, the use of nutraceuticals, prebiotics, and probiotics in pediatric gastroenterological practice requires caution and medical supervision. Further research is needed to determine the effects of alternative therapies on pediatric gastrointestinal symptoms and disorders, and to ensure their safe and effective use in the clinical practice.","[Corsello, Antonio; Scatigno, Lorenzo; Fiore, Giulia; Baresi, Stefano; Eletti, Francesca; Zuccotti, Gianvincenzo; Dilillo, Dario; Verduci, Elvira] Univ Milan, Vittore Buzzi Childrens Hosp, Dept Pediat, Milan, Italy; [Fiore, Giulia; Verduci, Elvira] Univ Milan, Dept Hlth Sci, Milan, Italy; [Zuccotti, Gianvincenzo] Univ Milan, Dept Biomed & Clin Sci, Milan, Italy; [Strisciuglio, Caterina] Univ Campania Luigi Vanvitelli, Dept Woman Child & Gen & Specialized Surg, Naples, Italy",University of Milan; University of Milan; University of Milan; Universita della Campania Vanvitelli,"Strisciuglio, C (corresponding author), Univ Campania Luigi Vanvitelli, Dept Woman Child & Gen & Specialized Surg, Naples, Italy.",caterina.strisciuglio@unicampania.it,"Verduci, Elvira/D-7338-2014; Corsello, Antonio/AAH-7881-2021; Strisciuglio, Caterina/ABD-2466-2020; Zuccotti, Gianvincenzo/H-8572-2017","Corsello, Antonio/0000-0003-4578-0066; Strisciuglio, Caterina/0000-0002-9005-6571; Zuccotti, Gianvincenzo/0000-0002-2795-9874; Baresi, Stefano/0009-0005-2460-2756",,,,,146,1,1,3,3,SPRINGERNATURE,LONDON,"CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND",0954-3007,1476-5640,,EUR J CLIN NUTR,Eur. J. Clin. Nutr.,FEB,2024,78,2,,,,,87,98,,10.1038/s41430-023-01362-z,http://dx.doi.org/10.1038/s41430-023-01362-z,,OCT 2023,12,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,HK0I0,37875612,,,,2024-06-04,WOS:001088156900002,View Full Record in Web of Science
J,"Piirainen, L; Kekkonen, RA; Kajander, K; Ahlroos, T; Tynkkynen, S; Nevala, R; Korpela, R",,,,"Piirainen, Laura; Kekkonen, Riina A.; Kajander, Kajsa; Ahlroos, Terhi; Tynkkynen, Soile; Nevala, Riikka; Korpela, Riitta",,,In school-aged children a combination of galacto-oligosaccharides and Lactobacillus GG increases bifidobacteria more than Lactobacillus GG on its own,ANNALS OF NUTRITION AND METABOLISM,,,English,Article,,,,,,galacto-oligosaccharides; gastrointestinal symptoms; bifidobacteria; Lactobacillus rhamnosus GG; prebiotics; probiotics,MICROFLORA; FORMULA; HEALTHY; CONSTIPATION; MILK,"The aim of this study was to compare a combination of Lactobacillus GG (LGG) and galacto-oligosaccharides (GOS) with LGG on its own, and their effects on the intestinal microbiota in school-aged children. The randomized, double-blinded, crossover study comprised 30 healthy children. There were two 3-week study periods with a 4-week wash-out period in between. The children ingested daily 65 ml of milk-based fruit juice containing either LGG alone (6.5 x 10(9) CFU) or LGG plus 2 g of GOS. Symptom diaries were filled during the study periods. Fecal samples were collected at the beginning and end of both study periods. At the end of both study periods, the amount of bifidobacteria was significantly greater after the ingestion of LGG + GOS compared with LGG alone (geometric mean 9.33 x 10(9) vs. 4.28 x 10(9) CFU/g, p < 0.001). No significant differences were seen in the amount of lactobacilli or LGG, nor did gastrointestinal symptoms, defecation frequency, consistency of stools or ease of defecation differ between the two study periods. Ingestion of LGG combined with 2 g of GOS increased the bifidobacteria more than LGG on its own and thus GOS clearly has a prebiotic effect in children. The children tolerated well a daily intake of 2 g of GOS. Copyright (C) 2008 S. Karger AG, Basel.","[Piirainen, Laura; Kekkonen, Riina A.; Kajander, Kajsa; Nevala, Riikka; Korpela, Riitta] Univ Helsinki, Inst Biomed Pharmacol, Nutraceut Grp, FI-00014 Helsinki, Finland; [Kekkonen, Riina A.; Kajander, Kajsa; Ahlroos, Terhi; Tynkkynen, Soile] R&D, Valio Ltd, Helsinki, Finland; [Korpela, Riitta] Fdn Nutr Res, Helsinki, Finland",University of Helsinki; Valio,"Korpela, R (corresponding author), Univ Helsinki, Inst Biomed Pharmacol, Nutraceut Grp, POB 63, FI-00014 Helsinki, Finland.",riitta.korpela@valio.fi,,"Korpela, Riitta/0000-0003-0337-9186",,,,,23,13,17,0,11,KARGER,BASEL,"ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND",0250-6807,1421-9697,,ANN NUTR METAB,Ann. Nutr. Metab.,,2008,52,3,,,,,204,208,,10.1159/000138124,http://dx.doi.org/10.1159/000138124,,,5,Endocrinology & Metabolism; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Endocrinology & Metabolism; Nutrition & Dietetics,323VV,18544974,,,,2024-06-04,WOS:000257477400005,View Full Record in Web of Science
J,"Li, YY; Liu, M; Liu, H; Wei, XQ; Su, XY; Li, M; Yuan, JL",,,,"Li, Yuyuan; Liu, Man; Liu, He; Wei, Xiaoqing; Su, Xianying; Li, Ming; Yuan, Jieli",,,Oral Supplements of Combined Bacillus licheniformis Zhengchangsheng® and Xylooligosaccharides Improve High-Fat Diet-Induced Obesity and Modulate the Gut Microbiota in Rats,BIOMED RESEARCH INTERNATIONAL,,,English,Article,,,,,,,INSULIN SENSITIVITY; ALLEVIATES OBESITY; SP NOV.; PREBIOTICS; INFLAMMATION; WEIGHT; DISTASONIS; INCREASES; SUCCINATE; CONSTIPATION,"Gut dysbiosis induced by high-fat diet (HFD) may result in low-grade inflammation leading to diverse inflammatory diseases. The beneficial effects of probiotics and prebiotics on obesity have been reported previously. However, their benefits in promoting human health and the underlying mechanisms still need to be further characterized. This study is aimed at understanding how probiotic Bacillus licheniformis Zhengchangsheng (R) (BL) and prebiotic xylooligosaccharides (XOS) influence the health of a rat model with HF (60 kcal %) diet-induced obesity. Five groups of male Sprague Dawley (SD) rats were fed a normal fat diet (CON) or an HFD with or without BL and XOS supplementation for 3 weeks. Lipid profiles, inflammatory biomarkers, and microbiota composition were analyzed at the end of the experiment. Rats fed an HFD exhibited increased body weight and disordered lipid metabolism. In contrast, combined BL and XOS supplementation inhibited body weight gain and returned lipid metabolism to normal. Furthermore, BL and XOS administration changed the gut microbiota composition and modulated specific bacteria such as Prevotellaceae, Desulfovibrionaceae, and Ruminococcaceae. In addition, supplements of combined BL and XOS obviously reduced the serum LPS level, which was significantly related to microbial variations. Our findings suggest that modulation of the gut microbiota as a result of probiotic BL and prebiotic XOS supplementation has a positive effect on HFD-induced obesity in rats.","[Li, Yuyuan] Dalian Med Univ, Adv Inst Med Sci, Dalian, Peoples R China; [Liu, Man; Liu, He; Li, Ming; Yuan, Jieli] Dalian Med Univ, Coll Basic Med Sci, Dept Microecol, Dalian, Peoples R China; [Wei, Xiaoqing] Dalian Med Univ, Core Lab Med Mol Biol Liaoning Prov, Dalian, Peoples R China; [Su, Xianying] Northeastern Pharmaceut Grp NEPG, Res Inst, Shenyang, Peoples R China",Dalian Medical University; Dalian Medical University; Dalian Medical University,"Li, M; Yuan, JL (corresponding author), Dalian Med Univ, Coll Basic Med Sci, Dept Microecol, Dalian, Peoples R China.",vivianmarat@163.com; zgwst@126.com,,"Li, Ming/0000-0002-4923-1964","Natural Science Foundation of Liaoning Province, China [2019030085]; Department of Education of Liaoning Province, China [L2016003]; China Postdoctoral Science Foundation [2016M601317, 2018T110225]; National Natural Science Foundation of China [81502737, 81472891]; Liaoning Provincial Program for Top Discipline of Basic Medical Sciences, China","Natural Science Foundation of Liaoning Province, China(Natural Science Foundation of Liaoning Province); Department of Education of Liaoning Province, China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Liaoning Provincial Program for Top Discipline of Basic Medical Sciences, China","This study was supported by the Natural Science Foundation of Liaoning Province, China (2019030085), the Research Foundation from the Department of Education of Liaoning Province, China (L2016003), the China Postdoctoral Science Foundation (2016M601317, 2018T110225), and the National Natural Science Foundation of China (81502737, 81472891). This work was also supported by Liaoning Provincial Program for Top Discipline of Basic Medical Sciences, China.",,68,22,22,5,36,HINDAWI LTD,LONDON,"ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND",2314-6133,2314-6141,,BIOMED RES INT,Biomed Res. Int.,MAY 18,2020,2020,,,,,,,,9067821,10.1155/2020/9067821,http://dx.doi.org/10.1155/2020/9067821,,,17,"Biotechnology & Applied Microbiology; Medicine, Research & Experimental",Science Citation Index Expanded (SCI-EXPANDED),Biotechnology & Applied Microbiology; Research & Experimental Medicine,LV0DV,32509874,"Green Published, gold",,,2024-06-04,WOS:000538115900006,View Full Record in Web of Science
J,"Uchiyama-Tanaka, Y",,,,"Uchiyama-Tanaka, Yoko",,,Case Study of Homeopathic Bowel Nosode Remedies for Dysbiotic Japanese Patients,JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE,,,English,Article,,,,,,bowel nosodes; dysbiosis; homeopathy,FECAL MICROBIOTA TRANSPLANTATION; GUT,"Background: The composition of intestinal microbiota is very important in human health. Gastrointestinal disturbances are among the symptoms commonly reported by individuals diagnosed with chronic diseases, such as inflammatory bowel disease, autism, and chronic fatigue syndrome. The effects of probiotics and prebiotics for dysbiosis have been reported in many studies. Bowel nosodes are homeopathic remedies made from human gut microbiota. Objective: Bowel nosodes made from the intestinal bacteria of European patients from the 1900s were administered to Japanese patients suffering from gastrointestinal disturbances, such as constipation and diarrhea, to determine their therapeutic efficacy. Methods: Twenty-eight outpatients from Yoko Clinic (11 males, 17 females; age range, 4-72 years) were enrolled in this study. One nosode remedy was selected for each case. Patients took six pills for 2 days. After a month, the effect of each treatment was evaluated using the Glasgow Homeopathic Hospital Outcome Scale (grade +4 to -4). Results: Patient number of each grade was +4 (N = 2), +3 (N = 4), +2 (N = 7), +1 (N = 3), 0 (N = 7), with no negative grades. Of the 23 patients analyzed, 69.6% showed some type of improvement, and no harmful effects from taking bowel nosodes were observed; 26% of patients showed major improvement or were cured. Conclusion: It is difficult to find correct constitutional remedies as they often require high-level techniques and time. Since there are only 11 main bowel nosode remedies, they are easier to choose from and cheaper to use and develop than classical constitutional remedies. Herein, 69.6% of dysbiotic patients taking bowel nosodes showed improvements, and no harmful effects were reported by any patient. These results suggest that the homeopathic bowel nosodes are a useful method for controlling gastrointestinal disturbances.","[Uchiyama-Tanaka, Yoko] Yoko Clin, Kitakyushu, Fukuoka, Japan",,"Uchiyama-Tanaka, Y (corresponding author), Yoko Clin, Yahatahigashi Ku, 3-3-13 Takami, Kitakyushu, Fukuoka 8050016, Japan.",yoko-uchiyama-tanaka@yoko-clinic.net,,"Uchiyama, Yoko/0000-0002-0013-9614",,,,,16,2,2,0,10,"MARY ANN LIEBERT, INC",NEW ROCHELLE,"140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA",1075-5535,1557-7708,,J ALTERN COMPLEM MED,J. Altern. Complement Med.,FEB,2018,24,2,,,,,187,192,,10.1089/acm.2017.0061,http://dx.doi.org/10.1089/acm.2017.0061,,,6,Integrative & Complementary Medicine,Science Citation Index Expanded (SCI-EXPANDED),Integrative & Complementary Medicine,FV7RR,28805460,,,,2024-06-04,WOS:000424783100014,View Full Record in Web of Science
J,"Phan, J; Nair, D; Jain, S; Montagne, T; Flores, DV; Nguyen, A; Dietsche, S; Gombar, S; Cotter, P",,,,"Phan, Joann; Nair, Divya; Jain, Suneer; Montagne, Thibaut; Flores, Demi Valeria; Nguyen, Andre; Dietsche, Summer; Gombar, Saurabh; Cotter, Philip",,,Alterations in Gut Microbiome Composition and Function in Irritable Bowel Syndrome and Increased Probiotic Abundance with Daily Supplementation,MSYSTEMS,,,English,Article,,,,,,irritable bowel syndrome; gut microbiome; metagenomics; probiotics; prebiotics; synbiotics,FAECALIBACTERIUM-PRAUSNITZII; CONTROLLED-TRIAL; DOUBLE-BLIND; CONSTIPATION; RISK; IBS; PREVALENCE; SEVERITY; PATTERNS; EFFICACY,"Irritable bowel syndrome (IBS) is characterized by abdominal discomfort and irregular bowel movements and stool consistency. As such, the gut microbiome has been posited as being influential for the syndrome. However, identifying microbial features associated with IBS symptom heterogeneity is difficult without large cohorts. Our aim was to identify microbial features associated with IBS and IBS subtypes compared to healthy controls and to determine if a synbiotic supplementation intervention could decrease the proportion of those microbial features. Stool samples from 490 individuals with IBS (including all dominant subtypes) and 122 individuals without IBS were analyzed with metagenomic sequencing. One hundred thirty-four IBS subjects were followed over time while receiving daily synbiotic supplementation, the composition of which varied between participants. IBS participants had significantly lower alpha diversity, an enrichment in Gram-negative bacteria, and a reduction in pathways associated with short-chain fatty acid and vitamin synthesis. Shigella species were significantly associated with IBS, while Eubacterium rectale and Faecalibacterium prausnitzii were associated with healthy controls. Random forest identified unique and overlapping microbial features associated with each IBS subtype. Longitudinal assessment of 134 IBS subjects receiving synbiotic supplements demonstrated a significant difference in microbial features and an increase in probiotic abundance across time. We identified microbial features that differentiate healthy and IBS subtypes. Synbiotic supplementation in IBS subjects did not result in alpha diversity change in the microbiome but did demonstrate changes in microbial features. Future work is needed to determine if the observed microbiome changes are associated with IBS symptom improvement. IMPORTANCE An estimated 35 million people in the United States and 11.5% of the population globally are affected by IBS. Immunity, genetics, environment, diet, small intestinal bacterial overgrowth (SIBO), and the gut microbiome are all factors that contribute to the onset or triggers of IBS. With strong supporting evidence that the gut microbiome may influence symptoms associated with IBS, elucidating the important microbes that contribute to the symptoms and severity is important to make decisions for targeted treatment. As probiotics have become more common in treating IBS symptoms, identifying effective probiotics may help inform future studies and treatment.","[Phan, Joann; Nair, Divya; Jain, Suneer; Montagne, Thibaut; Flores, Demi Valeria; Nguyen, Andre; Dietsche, Summer] Sun Genom Inc, San Diego, CA 92122 USA; [Gombar, Saurabh] Atropos Hlth, Palo Alto, CA USA; [Cotter, Philip] ResearchDx Inc, Irvine, CA USA",,"Phan, J (corresponding author), Sun Genom Inc, San Diego, CA 92122 USA.",joann@sungenomics.com,,,,,,,82,10,10,6,17,AMER SOC MICROBIOLOGY,WASHINGTON,"1752 N ST NW, WASHINGTON, DC 20036-2904 USA",2379-5077,,,MSYSTEMS,mSystems,NOV-DEC,2021,6,6,,,,,,,e01215-21,10.1128/mSystems.01215-21,http://dx.doi.org/10.1128/mSystems.01215-21,,,13,Microbiology,Science Citation Index Expanded (SCI-EXPANDED),Microbiology,YB2UE,34726487,"Green Published, Green Submitted",,,2024-06-04,WOS:000738873100003,View Full Record in Web of Science
J,"Cheng, X; Zheng, JP; Lin, AZ; Xia, H; Zhang, ZG; Gao, QH; Lv, WL; Liu, HT",,,,"Cheng, Xue; Zheng, Junping; Lin, Aizhen; Xia, Hui; Zhang, Zhigang; Gao, Qinghua; Lv, Wenliang; Liu, Hongtao",,,A review: Roles of carbohydrates in human diseases through regulation of imbalanced intestinal microbiota,JOURNAL OF FUNCTIONAL FOODS,,,English,Review,,,,,,Carbohydrates; Gut microbiota; Prebiotics; Metabolic disease; Colorectal cancer,INFLAMMATORY-BOWEL-DISEASE; RANDOMIZED CLINICAL-TRIAL; HUMAN GUT MICROBIOME; CHAIN FATTY-ACIDS; RESISTANT STARCH; GALACTO-OLIGOSACCHARIDES; FECAL MICROBIOTA; RELIEVE CONSTIPATION; GUAR GUM; OBESITY,"Gut microbiota plays a key role in the maintenance of human health. In most cases, carbohydrates can be fermented by gut microbiota as substrates. By such degradation reaction, the abundances, activities and metabolite production of gut microbiota will be regulated and thus prevent the occurrence of human diseases such as glycolipid metabolism disorders, enteric abnormality, aging and neurodegeneration, cancers and depression. In this paper, we reviewed the roles of carbohydrates in promoting human health through gut microbial regulation, as well as further studies on the regulatory mechanism and potential application of carbohydrates, which need to be strengthened in the future.","[Cheng, Xue; Zheng, Junping; Xia, Hui; Zhang, Zhigang; Gao, Qinghua; Liu, Hongtao] Hubei Univ Chinese Med, Coll Basic Med, Huangjiahu 16, Wuhan 430065, Peoples R China; [Lin, Aizhen] Hubei Prov Hosp Tradit Chinese Med, Wuhan 430061, Peoples R China; [Lv, Wenliang] Hubei Univ Chinese Med, Clin Coll Tradit Chinese Med, Wuhan 430065, Peoples R China",Hubei University of Chinese Medicine; Hubei University of Chinese Medicine,"Liu, HT (corresponding author), Hubei Univ Chinese Med, Coll Basic Med, Huangjiahu 16, Wuhan 430065, Peoples R China.;Lv, WL (corresponding author), Hubei Univ Chinese Med, Clin Coll Tradit Chinese Med, Wuhan 430065, Peoples R China.",wenliang_lv@hbtcm.edu.cn; hongtaoliu@ipe.ac.cn,"Zheng, Johny/AAX-8898-2020","Zheng, Johny/0000-0002-9134-572X","Science and Technology Commission of Hubei Province of China [2018CFB344, 2018ZYYD017]; National Natural Science Foundation of China [81873098]; Health Commission of Hubei Province of China [ZY2019Q015]",Science and Technology Commission of Hubei Province of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Health Commission of Hubei Province of China,"We are grateful for the support by Science and Technology Commission of Hubei Province of China (No. 2018CFB344 and No. 2018ZYYD017), National Natural Science Foundation of China (No. 81873098) and Health Commission of Hubei Province of China (No. ZY2019Q015).",,157,16,16,9,64,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",1756-4646,2214-9414,,J FUNCT FOODS,J. Funct. Food.,NOV,2020,74,,,,,,,,104197,10.1016/j.jff.2020.104197,http://dx.doi.org/10.1016/j.jff.2020.104197,,,14,Food Science & Technology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Nutrition & Dietetics,NZ2SI,,gold,,,2024-06-04,WOS:000576946100003,View Full Record in Web of Science
J,"Olano, A; Corzo, N",,,,"Olano, Agustin; Corzo, Nieves",,,Lactulose as a food ingredient,JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE,,,English,Review,,,,,,lactulose; synthesis; transgalactosylation; prebiotic,BETA-GALACTOSIDASE; DOUBLE-BLIND; ISOMERIZATION; LACTOSE; OLIGOSACCHARIDES; CONSTIPATION; ABSORPTION; FORMULA; CALCIUM; MIXTURE,"Lactulose is a synthetic ketose disaccharide that can be obtained from lactose by different methods of synthesis. Chemical methods are based on the isomerization of lactose in the presence of basic catalysts and enzymatic methods using lactose as a galactose donor and fructose as an acceptor. The prebiotic properties of lactulose have been known for more than 50 years and numerous studies have confirmed several health benefits of lactulose as a food ingredient, including selective stimulation of intestinal flora, laxative effect and improvement of calcium absorption. Its use in fermented milk manufacture may reduce the incubation period and favour the growth of bifidobacteria. The synthesis of lactulose-derived oligosaccharides may provide a new group of prebiotics with properties complementary to those of native lactulose. (C) 2009 Society of Chemical industry","[Olano, Agustin; Corzo, Nieves] CSIC, Inst Fermentac Ind, E-28006 Madrid, Spain",Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Fermentaciones Industriales (IFI),"Corzo, N (corresponding author), CSIC, Inst Fermentac Ind, Juan Cierva 3, E-28006 Madrid, Spain.",ncorzo@ifi.csic.es,"Corzo, Nieves/F-2137-2013; Olano, Agustín/B-9775-2013",,"Spanish Ministry of Education and Science, project Consolider Ingenio 2010 [CSID 2007-00063]; Comunidad de Madrid, project ALIBIRD [S-0505/AGR/000153]","Spanish Ministry of Education and Science, project Consolider Ingenio 2010(Spanish Government); Comunidad de Madrid, project ALIBIRD(Comunidad de Madrid)","This work has been financed under a R&D program of the Spanish Ministry of Education and Science, project Consolider Ingenio 2010 (FUN-C-FOOD): CSID 2007-00063, and an R&D program of the Comunidad de Madrid, project ALIBIRD S-0505/AGR/000153.",,39,78,86,2,40,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0022-5142,1097-0010,,J SCI FOOD AGR,J. Sci. Food Agric.,SEP,2009,89,12,,,,,1987,1990,,10.1002/jsfa.3694,http://dx.doi.org/10.1002/jsfa.3694,,,4,"Agriculture, Multidisciplinary; Chemistry, Applied; Food Science & Technology",Science Citation Index Expanded (SCI-EXPANDED),Agriculture; Chemistry; Food Science & Technology,488UB,,,,,2024-06-04,WOS:000269374500001,View Full Record in Web of Science
J,"Rosa, D; Zablah, RA; Vazquez-Frias, R",,,,"Rosa, Dimas; Zablah, Roberto Arturo; Vazquez-Frias, Rodrigo",,GICCAMPP,Unraveling the complexity of Disorders of the Gut-Brain Interaction: the gut microbiota connection in children,FRONTIERS IN PEDIATRICS,,,English,Review,,,,,,microbiota; dysbiosis; immunity; inflammatory bowel diseases; probiotics; prebiotics; diversity; microbiome,FUNCTIONAL GASTROINTESTINAL DISORDERS; IRRITABLE-BOWEL-SYNDROME; CASEI-RHAMNOSUS LCR35; DOUBLE-BLIND; CONSTIPATION; MANAGEMENT; MICROFLORA; INFANTS; HEALTH; IMPACT,"Disorders of Gut-Brain Interaction (DGBIs), formerly referred to as Functional Gastrointestinal Disorders (FGIDs), encompass a prevalent array of chronic or recurring gastrointestinal symptoms that notably impact the quality of life for affected children and their families. Recent studies have elucidated the intricate pathophysiology of DGBIs, underscoring their correlation with gut microbiota. This review seeks to explore the present comprehension of the gut microbiota's role in DGBI development. While other factors can contribute to DGBIs, the gut microbiota prominently influences the onset and progression of these conditions. According to the Rome IV diagnostic criteria, DGBI prevalence is approximately 40% worldwide. The Rome Foundation has diligently worked for nearly three decades to refine our comprehension of DGBIs. By centering on the gut microbiota, this review sheds light on potential therapeutic interventions for DGBIs, potentially enhancing the quality of life for pediatric patients and their families.","[Rosa, Dimas; Zablah, Roberto Arturo; Vazquez-Frias, Rodrigo] GICCAMPP, La Romana, Dominican Rep; [Zablah, Roberto Arturo] Hosp Ninos Benjamin Bloom, Serv Gastroenterol & Endoscopia Digest, San Salvador, El Salvador; [Vazquez-Frias, Rodrigo] Inst Nacl Salud Hosp Infantil Mexico Federico Gom, Dept Gastroenterol & Nutr Pediat, Ciudad De Mexico, Mexico",,"Rosa, D (corresponding author), GICCAMPP, La Romana, Dominican Rep.",dimasrosa@gmail.com,,"Zablah, Roberto Arturo/0000-0003-2799-2225","Grupo de Investigacin del Caribe y Centroamrica para la Microbiota, Probiticos y Prebiticos, GICCAMPP","Grupo de Investigacin del Caribe y Centroamrica para la Microbiota, Probiticos y Prebiticos, GICCAMPP","Ricardo Di Domenico took part in both the writing and technical editing processes of the manuscript, for which he received compensation. Marco Luis Herrera reviewed the text for any typographical, spelling, or formatting errors. To Marie Claire Arrieta for his constant advice and guidance.",,50,0,0,1,1,FRONTIERS MEDIA SA,LAUSANNE,"AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND",2296-2360,,,FRONT PEDIATR,Front. Pediatr.,FEB 16,2024,11,,,,,,,,1283389,10.3389/fped.2023.1283389,http://dx.doi.org/10.3389/fped.2023.1283389,,,11,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,JO4D2,38433954,"gold, Green Published",,,2024-06-04,WOS:001174085700001,View Full Record in Web of Science
J,"Niv, E; Halak, A; Tiommny, E; Yanai, H; Strul, H; Naftali, T; Vaisman, N",,,,"Niv, E.; Halak, A.; Tiommny, E.; Yanai, H.; Strul, H.; Naftali, T.; Vaisman, N.",,,Randomized clinical study: Partially hydrolyzed guar gum (PHGG) versus placebo in the treatment of patients with irritable bowel syndrome,NUTRITION & METABOLISM,,,English,Article,,,,,,Irritable bowel syndrome (IBS); Partially hydrolyzed guar gum (PHGG); Prebiotics; Fibers,QUALITY-OF-LIFE; INTESTINAL MICROFLORA; OPEN TRIAL; CONSTIPATION; VALIDATION; FIBER; TRANSLATION; MULTICENTER; DIARRHEA; DIET,"Background: The treatment of Irritable bowel syndrome (IBS) is still challenging. Partially hydrolyzed guar gum (PHGG) is a known prebiotic fiber. To assess the effects of PHGG on clinical symptoms of IBS patients in a prospective randomized double blind placebo-controlled study. Methods: Suitable IBS patients were recruited into an 18-week-long study (2 weeks of run-in, 12 weeks of treatment and 4 weeks of follow-up). They were blindly randomized to receive 6 gr of PHGG or placebo. Treatment efficacy was evaluated by the Francis Severity IBS score, the IBS quality-of-life scores and scored parameters of weekly journal of symptoms. Deltas of changes between the final and baseline scores were compared between two groups. Results: Of 121 patients who underwent randomization, 108 patients (49 in the PHGG group and 59 in the placebo group) had all the data needed for intention-to-treat analysis. A 12-week administration of PHGG led to a significant improvement of journal bloating score in the PHGG group versus placebo (-4.1 +/- 13.4 versus -1.2 +/- 11.9, P=0.03), as well as in bloating+gasses score (-4.3 +/- 10.4 versus -1.12 +/- 10.5, P = 0.035). The effect lasted for at least 4 weeks after the last PHGG administration. PHGG had no effect on other journal reported IBS symptoms or on Severity and Quality of life scores. There were no significant side effects associated with PHGG ingestion. The rate of dropouts was significantly higher among patients in the placebo group compared with the PHGG group (49.15% versus 22.45%, respectively, P = 0.01). Conclusions: The results of this study support the administration of 6 g/day PHGG for IBS patients with bloating.","[Niv, E.; Vaisman, N.] Tel Aviv Univ, Sackler Sch Med, Tel Aviv Sourasky Med Ctr, Unit Clin Nutr, IL-6423906 Tel Aviv, Israel; [Halak, A.; Tiommny, E.; Yanai, H.; Strul, H.] Tel Aviv Univ, Sackler Sch Med, Tel Aviv Sourasky Med Ctr, Dept Gastroenterol, IL-6423906 Tel Aviv, Israel; [Naftali, T.] Sapir Med Ctr, Dept Gastroenterol, Kefar Sava, Israel",Tel Aviv University; Tel Aviv Sourasky Medical Center; Tel Aviv University; Tel Aviv Sourasky Medical Center; Tel Aviv University,"Niv, E (corresponding author), Tel Aviv Univ, Sackler Sch Med, Tel Aviv Sourasky Med Ctr, Unit Clin Nutr, IL-6423906 Tel Aviv, Israel.",niv_em@netvision.net.il,,"Yanai, Henit/0000-0001-5483-5271","Pro Natura company, Bad Vilbel, Germany; Sunwic AB company, Kungsbacka, Sweden","Pro Natura company, Bad Vilbel, Germany; Sunwic AB company, Kungsbacka, Sweden","Declaration of funding interests: Pro Natura company, Bad Vilbel, Germany; Sunwic AB company, Kungsbacka, Sweden were funders but the design and performance of the study were done independently by the Unit of Clinical Nutrition, TASMC, Israel.",,31,42,46,0,32,BIOMED CENTRAL LTD,LONDON,"236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND",1743-7075,,,NUTR METAB,Nutr. Metab.,FEB 6,2016,13,,,,,,,,10,10.1186/s12986-016-0070-5,http://dx.doi.org/10.1186/s12986-016-0070-5,,,7,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,DC7HM,26855665,"gold, Green Published",,,2024-06-04,WOS:000369390500001,View Full Record in Web of Science
J,"Yen, CH; Kuo, YW; Tseng, YH; Lee, MC; Chen, HL",,,,"Yen, Chi-Hua; Kuo, Yi-Wen; Tseng, Yun-Hua; Lee, Meng-Chih; Chen, Hsiao-Ling",,,"Beneficial effects of fructo-oligosaccharides supplementation on fecal bifidobacteria and index of peroxidation status in constipated nursing-home residents-A placebo-controlled, diet-controlled trial",NUTRITION,,,English,Article,,,,,,Fructo-oligosaccharides; Thiobarbituric acid-reactive substances; Constipation; Elderly; Cholesterol; Bifidobacteria,LACTOBACILLUS-ACIDOPHILUS; FERMENTABLE CARBOHYDRATE; ANTIOXIDATIVE CAPACITY; FATTY-ACID; OLIGOFRUCTOSE; CHOLESTEROL; PREBIOTICS; NITROGEN; EXERTS; INULIN,"Objective: This study assessed effects of fructo-oligosaccharides (FOS) supplementation on fecal bifidobacteria, lipid peroxidation index, indices of nutritional status, and whether effects of FOS were sustained after its withdrawal in constipated nursing-home residents. The associations of fecal bifidobacteria and blood measurements were also examined. Methods: Six men and, four women participated in a double-blind, diet-controlled study that consisted of a 4-wk placebo (3 mL of fructose syrup) period, a 4-wk FOS (10 g/d) period, and a 4-wk post-FOS period. Stools were collected during the last week of each period to determine the microflora and fecal weight. Fasting blood was collected at the end of each period and analyzed for thiobarbituric acid-reactive substances (TBARS) and biochemical indices. Results: Fecal counts (log counts/gram of dry feces) and daily fecal output of bifidobacteria significantly increased with FOS compared with placebo. The effect on bifidobacteria output was sustained in the post-FOS period. Plasma TBARS concentration was reduced by 16% and 21% in the FOS and post-FOS periods, respectively, compared with that in the placebo period. The plasma cholesterol level was significantly lowered by 7% in the FOS and post-FOS periods compared with that in the placebo period. The increases in fecal bifidobacteria output during the FOS period (log colony-forming units per day) were associated with decreases in plasma TBARS and plasma cholesterol, respectively. Conclusion: Supplementation of FOS increases the daily output of bifidobacteria and decreases plasma TBARS and cholesterol concentrations in constipated nursing-home elderly residents and these effects remained at the end the post-FOS period. (C) 2011 Elsevier Inc. All rights reserved.","[Kuo, Yi-Wen; Tseng, Yun-Hua; Chen, Hsiao-Ling] Chung Shan Med Univ, Sch Nutr, Taichung, Taiwan; [Yen, Chi-Hua; Lee, Meng-Chih] Chung Shan Med Univ Hosp, Dept Family & Community Med, Taichung, Taiwan; [Yen, Chi-Hua; Lee, Meng-Chih] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Yen, Chi-Hua; Lee, Meng-Chih] Chung Shan Med Univ, Ctr Educ & Res Geriatr & Gerontol, Taichung, Taiwan; [Chen, Hsiao-Ling] Chung Shan Med Univ Hosp, Dept Nutr, Taichung, Taiwan",Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital,"Chen, HL (corresponding author), Chung Shan Med Univ, Sch Nutr, Taichung, Taiwan.",cshy352@csmu.edu.tw,,,"National Science Council, Taiwan, Republic of China [NSC-96-2320-B-040-031-MY3]","National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)","This work was supported in part by grant NSC-96-2320-B-040-031-MY3, National Science Council, Taiwan, Republic of China.",,34,40,46,2,25,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",0899-9007,1873-1244,,NUTRITION,Nutrition,MAR,2011,27,3,,,,,323,328,,10.1016/j.nut.2010.02.009,http://dx.doi.org/10.1016/j.nut.2010.02.009,,,6,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,725ZF,20579847,,,,2024-06-04,WOS:000287684700010,View Full Record in Web of Science
J,"Sahin, Ö; Yesil, A; Senates, E; Akdogan, MF; Konür, S; Erdem, E; Dal, MS; Karakan, T",,,,"Sahin, Onder; Yesil, Atakan; Senates, Ebubekir; Akdogan, Mehmet Fatih; Konur, Sevki; Erdem, Emrullah; Dal, Mehmet Sinan; Karakan, Tarkan",,,SYNBIOTIC THERAPY INCREASES ERADICATION RATE IN HELICOBACTER PYLORI ERADICATION,ACTA MEDICA MEDITERRANEA,,,English,Article,,,,,,Helicobacter pylori; eradication; probiotics; synbiotics; lactobacillus; bifidobacteria,TRIPLE THERAPY; SACCHAROMYCES-BOULARDII; PROBIOTICS; EFFICACY; METAANALYSIS; PREBIOTICS; INFECTION; SAFETY,"Background: Probiotics are used in combinations of H. pylori eradication regimens with variable results. Many strains tested had shown positive effects on side effect profiles. However, a clear effect on eradication rate is studied thoroughly. We aimed to investigate the beneficial effect of a synbiotic combination in clarithromycin-based triple eradication therapy. Methods: Ninety-two patients who were infected with H. pylori (confirmed via endoscopic biopsy) were randomized into two groups: those undergoing standard triple treatment (control group (rabeprozol plus amoksisilin plus clarithromycin bid) n=49) and those receiving symbiotic (triple plus symbiotic bid group n=43). The symbiotic product contained lactobacillus, bifidobacterium and enterococcus. The 13C-breath test was performed at least 6 weeks after completing both therapy regimens. Results: In the synbiotic group, 3 of the patients complained of metallic taste (7.0%). 1 complained of diarrhea (23%), 3 had nausea (7.0%), 2 had gas (4.7%), 3 experienced vomiting (7.0%) and 1 had constipation (23%). In the control group, 3 of the patients experienced a metallic taste (63%), 7 had diarrhea (14.6%), 5 had nausea (10.4%), 3 had intestinal bloating (63%), 3 experienced vomiting (63%) and I had constipation (2.1%). There was no significant difference between the two groups. However, side effect intensity and eradication rates were significant different between the groups (p<0.05). The eradication rate in the synbiotic group was 88.4%, while it was 68.8% in the control group (p<0.05). Conclusion: The addition of synbiotic to triple therapy decreases the rate of antibiotic-related side effects. It also increases H. pylori eradication rates in clarithromycin-based triple therapy.","[Sahin, Onder] Istanbul Univ, Istanbul Fac Med, Neuromuscular Patol Unit, Dept Neurol, Istanbul, Turkey; [Yesil, Atakan; Erdem, Emrullah] Haydarpasa Numune Educ & Res Hosp, Dept Gastroenterol, Istanbul, Turkey; [Senates, Ebubekir] Dicle Univ, Fac Med, Dept Gastroenterol, Diyarbakir, Turkey; [Akdogan, Mehmet Fatih; Konur, Sevki] Haydarpasa Numune Educ & Res Hosp, Dept Internal Med, Istanbul, Turkey; [Dal, Mehmet Sinan] Dicle Univ, Fac Med, Dept Hematol, Diyarbakir, Turkey; [Karakan, Tarkan] Gazi Univ Hosp, Dept Gastroenterol, Ankara, Turkey",Istanbul University; Istanbul Haydarpasa Numune Training & Research Hospital; Dicle University; Istanbul Haydarpasa Numune Training & Research Hospital; Dicle University; Gazi University,"Senates, E (corresponding author), Univ Med Fac, Dept Gastroenterol, Diyarbakir, Turkey.",,"Karakan, Tarkan/A-9875-2016","Karakan, Tarkan/0000-0003-1561-8789",,,,,25,3,3,0,7,CARBONE EDITORE,PALERMO,"VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY",0393-6384,2283-9720,,ACTA MEDICA MEDITERR,Acta Medica Mediterr.,,2013,29,3,,,,,569,573,,,,,,5,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,AJ8BJ,,,,,2024-06-04,WOS:000337927200041,View Full Record in Web of Science
J,"Weingarden, AR; Ko, CW",,,,"Weingarden, Alexa R.; Ko, Cynthia W.",,,Non-prescription Therapeutics,AMERICAN JOURNAL OF GASTROENTEROLOGY,,,English,Article,,,,,,probiotics/therapeutic use; probiotics/adverse effects; synbiotics; prebiotics; postbiotics; fermented foods,IRRITABLE-BOWEL-SYNDROME; CHRONIC IDIOPATHIC CONSTIPATION; DIFFICILE-ASSOCIATED DIARRHEA; ULCERATIVE-COLITIS; DOUBLE-BLIND; FUNCTIONAL DYSPEPSIA; LACTOSE DIGESTION; PRETERM INFANTS; HUMAN-MILK; PROBIOTICS,,"[Weingarden, Alexa R.] Stanford Univ, Dept Med, Div Gastroenterol & Hepatol, Redwood City, CA USA; [Ko, Cynthia W.] Univ Washington, Sch Med, Div Gastroenterol, Seattle, WA 98195 USA",Stanford University; University of Washington; University of Washington Seattle,"Ko, CW (corresponding author), Univ Washington, Sch Med, Div Gastroenterol, Seattle, WA 98195 USA.",aweingar@stanford.edu; cwko@u.washington.edu,,,Life Sciences Research Foundation postdoctoral fellowship; Monograph have been provided to the ACG Institute for Clinical Research and Education from Nestle Health Science and Seres Therapeutics and Ferring Pharmaceuticals Inc.,Life Sciences Research Foundation postdoctoral fellowship; Monograph have been provided to the ACG Institute for Clinical Research and Education from Nestle Health Science and Seres Therapeutics and Ferring Pharmaceuticals Inc.,This article appeared as part of the ACG Monograph on Microbiome Therapeutics. Unrestricted educational grants to support the monograph have been provided to the ACG Institute for Clinical Research and Education from Nestle Health Science and Seres Therapeutics and Ferring Pharmaceuticals Inc. A.R.W. is supported by the Life Sciences Research Foundation postdoctoral fellowship.,,100,0,0,2,2,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0002-9270,1572-0241,,AM J GASTROENTEROL,Am. J. Gastroenterol.,JAN,2024,119,1S,,1,,,S7,S15,,10.14309/ajg.0000000000002578,http://dx.doi.org/10.14309/ajg.0000000000002578,,,9,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,GW9O2,38153220,Bronze,,,2024-06-04,WOS:001155829900004,View Full Record in Web of Science
J,"Mitchell, LK; Davies, PSW",,,,"Mitchell, Leanne K.; Davies, Peter S. W.",,,Pre- and probiotics in the management of children with autism and gut issues: a review of the current evidence,EUROPEAN JOURNAL OF CLINICAL NUTRITION,,,English,Review,,,,,,,HYDROLYZED GUAR GUM; SPECTRUM DISORDER; MICROBIOTA; SYMPTOMS; CONSTIPATION; CHILDHOOD; ANXIETY; RISK,"Manipulation of the gut microbiome offers a promising treatment option for children with autism spectrum disorder (ASD) for whom functional gastrointestinal disorders (FGIDs) are a common comorbidity. Both ASD and FGIDs have been linked to dysfunction of the microbiome-gut-brain (MGB) axis. Dysfunction of this bidirectional network has the ability to impact multiple host processes including gastrointestinal (GI) function, mood and behaviour. Prebiotic and probiotic supplementation aims to produce beneficial shifts within the gut environment, resulting in favourable changes to microbial metabolite production and gastrointestinal function. The aim of this review is to investigate the gut microbiome as a therapeutic target for children with ASD. Evidence for the utility of prebiotics, probiotics or synbiotics (i.e., prebiotic + probiotic) among this cohort is examined. Electronic databases (PubMed, Web of Science, Medline and clinicaltrials.gov) were searched using keywords or phrases to review the literature from 1 January 2010 to 30 October 2020. Findings suggest limited, but preliminary evidence of efficacy in relieving GI distress, improving ASD-associated behaviours, altering microbiota composition, and reducing inflammatory potential.","[Mitchell, Leanne K.; Davies, Peter S. W.] Univ Queensland, Child Hlth Res Ctr, Fac Med, South Brisbane, Qld, Australia",University of Queensland,"Mitchell, LK (corresponding author), Univ Queensland, Child Hlth Res Ctr, Fac Med, South Brisbane, Qld, Australia.",leanne.mitchell@uq.edu.au,"Davies, Peter SW/B-9483-2008","Mitchell, Leanne Katherine/0000-0001-7926-6132",,,,,43,10,10,2,18,SPRINGERNATURE,LONDON,"CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND",0954-3007,1476-5640,,EUR J CLIN NUTR,Eur. J. Clin. Nutr.,JUL,2022,76,7,,,,,913,921,,10.1038/s41430-021-01027-9,http://dx.doi.org/10.1038/s41430-021-01027-9,,OCT 2021,9,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,2T3DM,34675402,,,,2024-06-04,WOS:000709730600005,View Full Record in Web of Science
J,"Tierney, BT; Versalovic, J; Fasano, A; Petrosino, JF; Chumpitazi, BP; Mayer, EA; Boetes, J; Smits, G; Parkar, SG; Voreades, N; Kartal, E; Al-Ghalith, GA; Pane, M; Bron, PA; Reid, G; Dhir, R; Mason, CE",,,,"Tierney, Braden T.; Versalovic, James; Fasano, Alessio; Petrosino, Joseph F.; Chumpitazi, Bruno P.; Mayer, Emeran A.; Boetes, Jared; Smits, Gerard; Parkar, Shanthi G.; Voreades, Noah; Kartal, Ece; Al-Ghalith, Gabriel A.; Pane, Marco; Bron, Peter A.; Reid, Gregor; Dhir, Raja; Mason, Christopher E.",,,Functional response to a microbial synbiotic in the gastrointestinal system of children: a randomized clinical trial,PEDIATRIC RESEARCH,,,English,Article,,,,,,,DIETARY FIBER INTAKE; GUT MICROBIOTA; CONSTIPATION; PROBIOTICS; SUPPLEMENTATION; OLIGOFRUCTOSE; METAANALYSIS; MULTICENTER; PREBIOTICS; OBESITY,"Background Oral microbial therapy has been studied as an intervention for a range of gastrointestinal disorders. Though research suggests that microbial exposure may affect the gastrointestinal system, motility, and host immunity in a pediatric population, data have been inconsistent, with most prior studies being in neither a randomized nor placebo-controlled setting. The aim of this randomized, placebo-controlled study was to evaluate the efficacy of a synbiotic on increasing weekly bowel movements (WBMs) in constipated children. Methods Sixty-four children (3-17 years of age) were randomized to receive a synbiotic (n = 33) comprising mixed-chain length oligosaccharides and nine microbial strains, or placebo (n = 31) for 84 days. Stool microbiota was analyzed on samples collected at baseline and completion. The primary outcome was a change from baseline of WBMs in the treatment group compared to placebo. Results Treatment increased (p < 0.05) the number of WBMs in children with low baseline WBMs, despite broadly distinctive baseline microbiome signatures. Sequencing revealed that low baseline microbial richness in the treatment group significantly anticipated improvements in constipation (p = 0.00074). Conclusions These findings suggest the potential for (i) multi-species-synbiotic interventions to improve digestive health in a pediatric population and (ii) bioinformatics-based methods to predict response to microbial interventions in children. Impact Synbiotic microbial treatment improved the number of spontaneous weekly bowel movements in children compared to placebo. Intervention induced an increased abundance of bifidobacteria in children, compared to placebo. All administered probiotic species were enriched in the gut microbiome of the intervention group compared to placebo. Baseline microbial richness demonstrated potential as a predictive biomarker for response to intervention.","[Tierney, Braden T.; Mason, Christopher E.] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Tierney, Braden T.; Boetes, Jared; Smits, Gerard; Parkar, Shanthi G.; Voreades, Noah; Al-Ghalith, Gabriel A.; Pane, Marco; Bron, Peter A.; Dhir, Raja] Seed Hlth, Venice, CA 90291 USA; [Versalovic, James] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Versalovic, James] Texas Childrens Hosp, Dept Pathol, Houston, TX 77030 USA; [Fasano, Alessio] Massachusetts Gen Hosp Children, Mucosal Immunol & Biol Res Ctr, Ctr Celiac Res & Treatment, Boston, MA USA; [Fasano, Alessio] Massachusetts Gen Hosp Children, Div Pediat Gastroenterol & Nutr, Boston, MA USA; [Petrosino, Joseph F.] Baylor Coll Med, Alkek Ctr Metagen & Microbiome Res, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Chumpitazi, Bruno P.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Chumpitazi, Bruno P.] Texas Childrens Hosp, Neurogastroenterol & Motil Program, Houston, TX 77030 USA; [Mayer, Emeran A.] Univ Calif Los Angeles, David Geffen Sch Med, Vatche & Tamar Manoukian Div Digest Dis, Los Angeles, CA 90095 USA; [Mayer, Emeran A.] G Oppenheimer Ctr Neurobiol Stress & Resilience, Los Angeles, CA USA; [Kartal, Ece] Heidelberg Univ Hosp, Inst Computat Biomed, Heidelberg, Germany; [Reid, Gregor] Lawson Hlth Res Inst, Ctr Human Microbiome & Probiot Res, London, ON, Canada; [Reid, Gregor] Western Univ, Dept Microbiol & Immunol, London, ON, Canada",Cornell University; Weill Cornell Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Ruprecht Karls University Heidelberg; Western University (University of Western Ontario); Western University (University of Western Ontario),"Mason, CE (corresponding author), Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA.;Dhir, R (corresponding author), Seed Hlth, Venice, CA 90291 USA.",raja@seed.com; chm2042@med.cornell.edu,"Petrosino, Joseph F./AAF-1621-2019; Fasano, Alessio/K-5486-2016; Mason, Christopher/HCH-3977-2022","Fasano, Alessio/0000-0002-2134-0261; Boetes, Jared/0000-0002-8277-4784",Seed Health (SH),Seed Health (SH),"DY This work was funded by Seed Health (SH). SH funding contributed towards study design, microbiome sequencing, bioinformatics, and manuscript preparation.",,56,2,2,1,5,SPRINGERNATURE,LONDON,"CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND",0031-3998,1530-0447,,PEDIATR RES,Pediatr. Res.,JUN,2023,93,7,,,,,2005,2013,,10.1038/s41390-022-02289-0,http://dx.doi.org/10.1038/s41390-022-02289-0,,NOV 2022,9,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,L3PZ0,36319696,"hybrid, Green Published",,,2024-06-04,WOS:000877746600001,View Full Record in Web of Science
J,"Koga, J; Ojiro, K; Yanagida, A; Suto, T; Hiki, H; Inoue, Y; Sakai, C; Nakamoto, K; Fujisawa, Y; Orihara, A; Murakami, H; Hirasawa, S; Nakajima, K; Sakazawa, T; Yamane, H",,,,"Koga, Jinichiro; Ojiro, Kota; Yanagida, Ayumi; Suto, Takahisa; Hiki, Hideaki; Inoue, Yuki; Sakai, Chihiro; Nakamoto, Kohei; Fujisawa, Yuta; Orihara, Ayaka; Murakami, Haruka; Hirasawa, Shintaro; Nakajima, Kengo; Sakazawa, Tomoko; Yamane, Hisakazu",,,Ingestion of Indigestible Cacao Proteins Promotes Defecation and Alters the Intestinal Microbiota in Mice,CURRENT DEVELOPMENTS IN NUTRITION,,,English,Article,,,,,,cacao proteins; Theobroma cacao L; defecation; intestinal microbiota; chocolate; prebiotics; Lactococcus; Oscillospira; Mucispirillum; Anaerotruncus,COLONIC TRANSIT; DOUBLE-BLIND; COCOA; POLYPHENOLS; LACTOBACILLUS; BIFIDOBACTERIUM; CONSTIPATION; THEOBROMINE; PROBIOTICS; CAFFEINE,"Background In animals, the health effects of ingested cacao proteins are unknown because the proteins are difficult to extract and purify from cacao beans. Objectives This study aimed to develop an extraction and purification method for cacao proteins and reveal the effect of ingestion of cacao proteins on defecation and intestinal microbiota in mice. Methods Three groups of mice were fed a control diet (AIN-93 G), a cacao lignin diet (AIN-93 G containing 1.22% cacao lignin), or a cacao protein and lignin diet (AIN-93 G containing 1.97% cacao proteins and 1.22% cacao lignin) by pair-feeding for 8 d. Feces were collected as 2 bulked samples from days 1 to 4 and days 5 to 8 on each diet. The collected feces were weighed and the intestinal microbiota was analyzed by next-generation sequencing-based 16S rRNA. Results A new extraction and purification method for cacao proteins has been developed, then found that the proteins are resistant to digestive enzymes. However, the cacao protein powder made by this method contained 34.9% of lignin in addition to 56.4% of proteins. Therefore, to reveal the effect by cacao proteins alone, the fecal weight and intestinal microbiota of mice fed the cacao protein and lignin diet were compared with those of mice fed the cacao lignin diet. The fecal weight of mice fed the cacao protein and lignin diet was significantly greater than of mice fed the cacao lignin diet. The relative abundance of Lactococcus and Mucispirillum species in mice fed the cacao protein and lignin diet was significantly higher than in mice fed the cacao lignin diet, but the relative abundance of Anaerotruncus, Oscillospira, and Roseburia species in mice fed the cacao protein and lignin diet was significantly lower than in mice fed the cacao lignin diet. Conclusions Ingestion of indigestible cacao proteins promoted defecation and altered the intestinal microbiota such as Lactococcus, Mucispirillum, Anaerotruncus, Oscillospira, and Roseburia species in mice.","[Koga, Jinichiro; Ojiro, Kota; Yanagida, Ayumi; Suto, Takahisa; Hiki, Hideaki; Inoue, Yuki; Sakai, Chihiro; Nakamoto, Kohei; Fujisawa, Yuta; Orihara, Ayaka; Murakami, Haruka; Hirasawa, Shintaro; Nakajima, Kengo; Sakazawa, Tomoko; Yamane, Hisakazu] Teikyo Univ, Sch Sci & Engn, Dept Biosci, Utsunomiya, Tochigi, Japan",Teikyo University,"Koga, J (corresponding author), Teikyo Univ, Sch Sci & Engn, Dept Biosci, Utsunomiya, Tochigi, Japan.",jinichiro_koga@nasu.bio.teikyo.u.ac.jp,,"Koga, Jinichiro/0000-0003-2106-9894","Teikyo University, Japan","Teikyo University, Japan","Supported by Teikyo University, Japan, to revitalize educational activities.",,52,0,0,0,9,OXFORD UNIV PRESS INC,CARY,"JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA",2475-2991,,,CURR DEV NUTR,Curr. Dev. Nutr.,OCT 3,2022,6,10,,,,,,,nzac129,10.1093/cdn/nzac129,http://dx.doi.org/10.1093/cdn/nzac129,,,10,Nutrition & Dietetics,Emerging Sources Citation Index (ESCI),Nutrition & Dietetics,5B7HP,36204331,"Green Published, gold",,,2024-06-04,WOS:000863740000006,View Full Record in Web of Science
J,"Chen, T; Ma, YY; Xu, L; Sun, C; Xu, HX; Zhu, JC",,,,"Chen, Ting; Ma, Yuanyuan; Xu, Lei; Sun, Cheng; Xu, Hongxia; Zhu, Jingci",,,Soluble Dietary Fiber Reduces Feeding Intolerance in Severe Acute Pancreatitis: A Randomized Study,JOURNAL OF PARENTERAL AND ENTERAL NUTRITION,,,English,Article,,,,,,enteral nutrition; feeding intolerance; intestinal motility; severe acute pancreatitis; soluble dietary fiber,ENTERAL NUTRITION; CRITICALLY-ILL; INTESTINAL PERMEABILITY; PREBIOTICS; SUPPLEMENTATION; COMPLICATIONS; CONSTIPATION; GUIDELINES; MANAGEMENT; BLIND,"Background Feeding intolerance of enteral nutrition (EN) frequently occurs in patients with severe acute pancreatitis (SAP) because of intestinal motility disorders. Soluble dietary fiber (SDF) modulates the intestinal motility. The present study examined whether SDF can improve intestinal motility and permeability, and thereby reduce feeding intolerance, in patients with SAP. Methods This study was a single-blind, randomized, controlled, single-center trial. Forty-nine patients with SAP were included. The control and SDF groups received the same EN solution via a nasojejunal tube. The SDF group additionally received 20-g/d polydextrose. The primary outcome was the time to reach the energy goal. Follow-up was continued for 28 days after admission or until discharge from the hospital. Results Among 49 randomized patients, 46 patients (n = 22, control group; n = 24, SDF group) were included in the intent-to-treat analysis. The time to reach the energy goal was 7.00 (6.00, 8.25) days and 5.00 (4.25, 6.00) days in the control and SDF groups, respectively (P < 0.001). The rates of feeding intolerance were significantly reduced in the SDF group (59.09% vs 25.00%,P < .05). SDF was associated with decreases in the incidence of abdominal distension (72.73% vs 29.17%,P < .01), diarrhea (40.91% vs 8.33%,P < .05), and constipation (72.73% vs 12.50%,P < .001). The time to first flatus and first defecation were significantly shorter in the SDF group (P < .001). The intestinal mucosal barrier function and levels of gastrointestinal hormone were improved by SDF, as evidenced by significantly reduced blood levels of diamine oxidase, D-lactic acid, endotoxin, and vasoactive intestinal peptide (P < .05). Conclusions SDF shortens the time to reach the energy goal during EN and improves intestinal permeability and motility disorders, thus reducing the incidence of feeding intolerance in SAP patients.","[Chen, Ting] Gen Hosp Western Theater Command, Gen Surg Ctr, Chengdu, Sichuan, Peoples R China; [Chen, Ting; Ma, Yuanyuan; Zhu, Jingci] Third Mil Med Univ, Sch Nursing, Dept Basic Nursing, Army Med Univ, Chongqing, Peoples R China; [Ma, Yuanyuan] 75th Army Grp Hosp, Nursing Dept, Kunming, Yunnan, Peoples R China; [Xu, Lei] 940th Hosp Joint Logist Support Force Chinese Peo, Operating Room, Lanzhou, Peoples R China; [Sun, Cheng] Guangzhou First Peoples Hosp, Dept Cardiol, Guangzhou, Peoples R China; [Xu, Hongxia] Third Mil Med Univ, Daping Hosp, Dept Clin Nutr, Army Med Univ, Chongqing, Peoples R China",Army Medical University; South China University of Technology; Army Medical University,"Zhu, JC (corresponding author), Third Mil Med Univ, Sch Nursing, Dept Basic Nursing, Army Med Univ, Chongqing, Peoples R China.;Xu, HX (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Clin Nutr, Army Med Univ, Chongqing, Peoples R China.",hx_xu1975@126.com; zhujingci2009@163.com,"Xu, Hongxia/AAN-8608-2021; chen, bin/KBQ-8114-2024","chen, bin/0000-0002-3398-1314; xu, hongxia/0000-0001-5215-734X; chen, ting/0000-0001-8414-6346; Zhu, Jingci/0000-0002-7992-8420",,,,,50,21,26,2,16,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0148-6071,1941-2444,,JPEN-PARENTER ENTER,J. Parenter. Enter. Nutr.,JAN,2021,45,1,,,,,125,135,,10.1002/jpen.1816,http://dx.doi.org/10.1002/jpen.1816,,MAR 2020,11,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,PZ4CF,32141126,,,,2024-06-04,WOS:000561147300001,View Full Record in Web of Science
J,"Sakurai, M; Kubota, M; Iguchi, A; Shigematsu, T; Yamaguchi, T; Nakagawa, S; Kurahashi, A; Oguro, Y; Nishiwaki, T; Aihara, K; Sato, S",,,,"Sakurai, Misato; Kubota, Masatoshi; Iguchi, Akinori; Shigematsu, Toru; Yamaguchi, Toshio; Nakagawa, Saori; Kurahashi, Atsushi; Oguro, Yoshifumi; Nishiwaki, Toshikazu; Aihara, Kotaro; Sato, Shinji",,,Effects of Koji amazake and Its Lactic Acid Fermentation Product by Lactobacillus sakei UONUMA on Defecation Status in Healthy Volunteers with Relatively Low Stool Frequency,FOOD SCIENCE AND TECHNOLOGY RESEARCH,,,English,Article,,,,,,amazake; koji; Lactobacillus sakei; lactic acid fermentation; defecation; intestinal microflora; healthy volunteers,BREWING SAKE; SEED MASH; PROBIOTICS; PREBIOTICS; BACTERIA; STRAIN,"To clarify the effects of the koji amazake and its lactic acid fermentation product amazake by Lactobacillus sakei UONUMA (LAF-amazake) on defecation status and intestinal microflora, a double-blind parallel group comparison test in healthy volunteers with relatively low stool frequency was conducted. Subjects ingested koji amazake or LAF-amazake for 1 week one bottle (108 mL, 118 g) once a day every morning. Subjects filled out daily questionnaires concerning their defecation conditions for the entire 3 weeks. First, second and third periods were the pre-test non-intake, the test food intake and the washout periods, respectively. Although there were no significant changes in intestinal microflora, it was found that defecation frequencies in the koji amazake group in the second and third periods were significantly higher when compared with those in the first period. These results indicated that the koji amazake may be a food material with constipation-relieving effects.","[Sakurai, Misato; Kubota, Masatoshi; Iguchi, Akinori; Shigematsu, Toru; Yamaguchi, Toshio; Nakagawa, Saori; Sato, Shinji] Niigata Univ Pharm & Appl Life Sci, Akiha Ku, 265-1 Higashijima, Niigata, Niigata 9568603, Japan; [Kurahashi, Atsushi; Oguro, Yoshifumi] Hakkaisan Brewery Co Ltd, 1051 Nagamori, Niigata 9497112, Japan; [Nishiwaki, Toshikazu; Aihara, Kotaro] Niigata Agr Res Inst, Food Res Ctr, 2-25 Shin Eicho, Niigata 9591381, Japan",Niigata University,"Sato, S (corresponding author), Niigata Univ Pharm & Appl Life Sci, Akiha Ku, 265-1 Higashijima, Niigata, Niigata 9568603, Japan.",sato@nupals.ac.jp,,"Shigematsu, Toru/0000-0002-9589-5921","regional revitalization project of the Cabinet Office, Government of Japan [A3007]","regional revitalization project of the Cabinet Office, Government of Japan","The authors wish to thank the staff of the Niigata Bio-Research Park, Inc., for their support in this study and the registration of the UMIN Clinical Trials Registry. This research was partly supported by the regional revitalization project of the Cabinet Office, Government of Japan (A3007).",,30,3,3,0,18,JAPANESE SOC FOOD SCI & TECHNOLOGY,Tsukuba,"2-1-12 Kannondai, Tsukuba, Ibaraki 305 8642, JAPAN",1344-6606,1881-3984,,FOOD SCI TECHNOL RES,Food Sci. Technol. Res.,NOV,2019,25,6,,,,,853,861,,10.3136/fstr.25.853,http://dx.doi.org/10.3136/fstr.25.853,,,9,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,JR6WI,,,,,2024-06-04,WOS:000499762800012,View Full Record in Web of Science
J,"Ren, XX; Liu, L; Liu, PK; Gamallat, Y; Xin, Y; Shang, D",,,,"Ren, Xinxiu; Liu, Lei; Liu, Pingkun; Gamallat, Yaser; Xin, Yi; Shang, Dong",,,Polysaccharide extracted from Enteromorpha ameliorates Cisplastin-induced small intestine injury in mice,JOURNAL OF FUNCTIONAL FOODS,,,English,Article,,,,,,Cisplatin (DDP); Polysaccharide Extracted from Enteromorpha (PEP); Intestinal microbiota; Escherichia-Shigella,GUT MICROBIOTA; TIGHT JUNCTIONS; CISPLATIN; FERMENTATION; CANCER; MUCIN; NEPHROTOXICITY; PREBIOTICS; COMMENSAL; ENZYMES,"Cisplatin is a commonly used drug against solid tumors. However, it can cause cell death in rapidly dividing intestinal epithelial cells. Enteromorpha (EP), an edible marine alga found in eastern China, and its polysaccharide fraction (PEP), can relieve constipation and modulate the intestinal microbiota. The aim of our study was to investigate the possible role of PEP in preventing cisplatin induced intestinal damage and gut microbiota imbalance in a mouse model. Cisplatin disturbed the intestinal microbiota and damaged the intestinal barriers. PEP treatment prior to cisplatin injection ameliorated these injuries and restored the gut microbial composition. We also analyzed the diversity of the fecal bacterial population by 16S DNA sequencing, and found a high abundance of the Escherichia - Shigella genera in the cisplatin treated mice. In conclusion, our results indicate that PEP is a powerful natural product that can protect against the gastrointestinal side effects of cisplatin.","[Ren, Xinxiu; Liu, Pingkun; Gamallat, Yaser; Xin, Yi] Dalian Med Univ, Dept Biotechnol, Dalian, Peoples R China; [Liu, Lei] Dalian Med Univ, Affiliated Hosp 1, Dept Urol, Dalian, Peoples R China; [Shang, Dong] Dalian Med Univ, Affiliated Hosp 1, Dept Gen Surg, Dalian, Peoples R China",Dalian Medical University; Dalian Medical University; Dalian Medical University,"Xin, Y (corresponding author), Dalian Med Univ, Dept Biotechnol, Dalian, Peoples R China.;Shang, D (corresponding author), Dalian Med Univ, Affiliated Hosp 1, Dept Gen Surg, Dalian, Peoples R China.",jimxin@hotmail.com; shangdong@dmu.edu.cn,,"Xin, Yi/0000-0002-6988-5121",Liaoning Provincial Program for Top Discipline of Basic Medical Sciences,Liaoning Provincial Program for Top Discipline of Basic Medical Sciences,This work was supported by Liaoning Provincial Program for Top Discipline of Basic Medical Sciences.,,43,11,13,0,53,ELSEVIER SCIENCE BV,AMSTERDAM,"PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",1756-4646,,,J FUNCT FOODS,J. Funct. Food.,OCT,2018,49,,,,,,154,161,,10.1016/j.jff.2018.08.023,http://dx.doi.org/10.1016/j.jff.2018.08.023,,,8,Food Science & Technology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Nutrition & Dietetics,GX5VB,,,,,2024-06-04,WOS:000447818000016,View Full Record in Web of Science
J,"Coman, V; Vodnar, DC",,,,"Coman, Vasile; Vodnar, Dan Cristian",,,Gut microbiota and old age: Modulating factors and interventions for healthy longevity,EXPERIMENTAL GERONTOLOGY,,,English,Review,,,,,,Aging; Human gut microbiota; Dietary alterations; Concomitant disease; Therapeutic interventions; Healthy longevity,CLOSTRIDIUM-DIFFICILE INFECTION; CHRONIC IDIOPATHIC CONSTIPATION; LACTOBACILLUS-ACIDOPHILUS NCFM; IRRITABLE-BOWEL-SYNDROME; DIET-INDUCED OBESITY; CHAIN FATTY-ACIDS; FECAL MICROBIOTA; ANTIBIOTIC-RESISTANCE; INTESTINAL MICROBIOTA; CROHNS-DISEASE,"Our gut microbiota is a complex and dynamic ecosystem with a paramount role in shaping our metabolic and immunological functions. Recent research suggests that aging may negatively affect the composition, diversity, and function of our microbiota mainly due to alterations in diet and immunologic reactivity (i.e. immunosenescence), and increased incidence of certain diseases and, therefore, increased exposure to certain medication (e.g. antibiotics, proton pump inhibitors). In turn, this aging-related gut dysbiosis may contribute to the initiation and/or progress of other metabolic diseases, and consequently, to a decrease in healthy longevity. On the positive side, promising therapeutic interventions, such as diet supplementation with prebiotics, probiotics and synbiotics, or fecal microbiota transplantation, aimed to counteract these aging-related deleterious consequences, could improve our health, and extend our healthy lifespan. In this context, the current review aims to assess the latest progress in identifying the key elements affecting the gut microbiota of the older adults and their mechanism of action, and the effectiveness of the therapeutic interventions aimed at restoring the diversity and healthy functions of the gut microbiota in older individuals.","[Coman, Vasile; Vodnar, Dan Cristian] Univ Agr Sci & Vet Med Cluj Napoca, Inst Life Sci, Calea Manastur 3-5, Cluj Napoca 400372, Romania; [Vodnar, Dan Cristian] Univ Agr Sci & Vet Med Cluj Napoca, Fac Food Sci & Technol, Calea Manastur 3-5, Cluj Napoca 400372, Romania",University of Agricultural Sciences & Veterinary Medicine Cluj Napoca; University of Agricultural Sciences & Veterinary Medicine Cluj Napoca,"Vodnar, DC (corresponding author), Univ Agr Sci & Vet Med Cluj Napoca, Inst Life Sci, Calea Manastur 3-5, Cluj Napoca 400372, Romania.",vasile.coman@usamvcluj.ro; dan.vodnar@usamvcluj.ro,"Vodnar, Dan C./K-5634-2019; Coman, Vasile/D-7947-2011; Vodnar, Dan C./B-8423-2011","Coman, Vasile/0000-0001-8685-3394; Vodnar, Dan C./0000-0001-5407-8071","National Research, Development and Innovations Programme for 2015-2020-PNII; UEFISCDI [PN-III-P1-1.2-PCCDI-2017-0056, 2PCCDI]","National Research, Development and Innovations Programme for 2015-2020-PNII; UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI))","This work was supported by the National Research, Development and Innovations Programme for 2015-2020-PNII, developed with the support of UEFISCDI (Project No. PN-III-P1-1.2-PCCDI-2017-0056; 2PCCDI).",,305,54,55,5,40,PERGAMON-ELSEVIER SCIENCE LTD,OXFORD,"THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND",0531-5565,1873-6815,,EXP GERONTOL,Exp. Gerontol.,NOV,2020,141,,,,,,,,111095,10.1016/j.exger.2020.111095,http://dx.doi.org/10.1016/j.exger.2020.111095,,,18,Geriatrics & Gerontology,Science Citation Index Expanded (SCI-EXPANDED),Geriatrics & Gerontology,QX8TK,32979504,Green Published,,,2024-06-04,WOS:000629615700014,View Full Record in Web of Science
J,"Ma, KD; Su, B; Li, FY; Li, JF; Nie, JW; Xiong, WY; Luo, JX; Huang, SB; Zhou, T; Liang, XD; Li, FC; Deng, JP; Tan, CQ",,,,"Ma, Kaidi; Su, Bin; Li, Fuyong; Li, Jinfeng; Nie, Jiawei; Xiong, Wenyu; Luo, Jinxi; Huang, Shuangbo; Zhou, Tong; Liang, Xide; Li, Facai; Deng, Jinping; Tan, Chengquan",,,Maternal or post-weaning dietary fructo-oligosaccharide supplementation reduces stillbirth rate of sows and diarrhea of weaned piglets,ANIMAL NUTRITION,,,English,Article,,,,,,Stillbirth; Diarrhea; Fructo-oligosaccharide; Sow; Weaned piglet,CHAIN FATTY-ACIDS; CHITOSAN OLIGOSACCHARIDE; COLONIC MICROBIOTA; INSULIN-RESISTANCE; PERFORMANCE; FIBER; FRUCTOOLIGOSACCHARIDE; GESTATION; PREGNANCY; BACTERIA,"Fructo-oligosaccharides (FOS) are well-known prebiotics that have the potential to improve sow reproductive performance and increase piglet growth. However, previous studies were observed in sole FOS-supplemented diets of sows or weaned piglets and did not consider the sow-to-piglet transfer effect on the performance and diarrhea rate of weaned piglets. This study explores the effects of dietary FOS supplementation on the reproductive performance of sows, and the effects of FOS supplementation at different stages on the growth performance and diarrhea rate of weaned piglets. A split-plot experimental design was used with sow diet effect in the whole plot and differing piglet diet effect in the subplot. Fifty-two multiparous sows (223.24 +/- 14.77 kg) were randomly divided into 2 groups (0 or 0.2% FOS). The experiment lasted from day 85 of gestation to day 21 of lactation. Reproductive performance, glucose tolerance, placental angiogenesis, and intestinal flora of sows were assessed. At weaning, 192 weaned piglets were grouped in 2 x 2 factorial designs, with the main effects of FOS supplemental level of sow diet (0 and 0.2%), and FOS supplemental level of weaned piglet diet (0 and 0.2%), respectively. The growth performance and diarrhea rate of the weaned piglets were analyzed during a 28-d experiment. Maternal dietary supplementation of FOS was shown to reduce the stillbirth and invalid piglet rates ( P < 0.05), improve the insulin sensitivity ( P < 0.05) and fecal scores ( P < 0.05) of sows, increase the abundance of Akkermansia muciniphila ( P = 0.016), decrease the abundance of Escherichia coli ( P = 0.035), and increase the isovalerate content in feces ( P = 0.086). Meanwhile, the placental angiogenesis marker CD31 expression was increased in sows fed FOS diet ( P < 0.05). Moreover, maternal and post-weaning dietary FOS supplementation reduced the diarrhea rate of weaned piglets ( P < 0.05) and increased the content of short-chain fatty acids in feces ( P < 0.05). Furthermore, only post-weaning dietary FOS supplementation could improve nutrient digestibility of weaned piglets ( P < 0.05). Collectively, FOS supplementation in sows can reduce stillbirth rate, perinatal constipation, and insulin resistance, as well as improve placental vascularization barrier. Additionally, maternal and post-weaning dietary FOS supplementation reduced the diarrhea rate of weaned piglets, but only FOS supplementation in piglets alone at weaning stage could improve their nutrient digestibility. (c) 2024 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","[Ma, Kaidi; Su, Bin; Li, Fuyong; Li, Jinfeng; Nie, Jiawei; Xiong, Wenyu; Luo, Jinxi; Huang, Shuangbo; Deng, Jinping; Tan, Chengquan] South China Agr Univ, Inst Subtrop Anim Nutr & Feed, Natl Engn Res Ctr Breeding Swine Ind, Coll Anim Sci,Guangdong Prov Key Lab Anim Nutr Con, Guangzhou 510642, Peoples R China; [Zhou, Tong] Guangzhou Pucheng Biol Technol Co, Guangzhou 511300, Peoples R China; [Liang, Xide; Li, Facai] Baolingbao Biol Co Ltd, Dezhou 251200, Peoples R China",South China Agricultural University,"Deng, JP; Tan, CQ (corresponding author), South China Agr Univ, Inst Subtrop Anim Nutr & Feed, Natl Engn Res Ctr Breeding Swine Ind, Coll Anim Sci,Guangdong Prov Key Lab Anim Nutr Con, Guangzhou 510642, Peoples R China.",dengjinping@scau.edu.cn; tanchengquan@scau.edu,,,"National Natural Science Foundation China [32172744, 32272895]",National Natural Science Foundation China(National Natural Science Foundation of China (NSFC)),The authors would like to thank the Guangzhou Pucheng Biological Technology Co. for animal management. This project was funded by National Natural Science Foundation China (32172744 or 32272895) .,,63,0,0,0,0,KEAI PUBLISHING LTD,BEIJING,"16 DONGHUANGCHENGGEN NORTH ST, Building 5, Room 411, BEIJING, DONGCHENG DISTRICT 100009, PEOPLES R CHINA",2405-6383,2405-6545,,ANIM NUTR,Anim. Nutr.,JUN,2024,17,,,,,,155,164,,10.1016/j.aninu.2024.04.002,http://dx.doi.org/10.1016/j.aninu.2024.04.002,,,10,"Agriculture, Dairy & Animal Science; Veterinary Sciences",Science Citation Index Expanded (SCI-EXPANDED),Agriculture; Veterinary Sciences,RV3O3,38774024,gold,,,2024-06-04,WOS:001230398300001,View Full Record in Web of Science
J,"Smid, A; Strnisa, L; Bajc, K; Vujic-Podlipec, D; Matijasic, BB; Rogelj, I",,,,"Smid, Alenka; Strnisa, Luka; Bajc, Katarina; Vujic-Podlipec, Dunja; Matijasic, Bojana Bogavic; Rogelj, Irena",,,Randomized clinical trial: The effect of fermented milk with the probiotic cultures Lactobacillus acidophilus La-5® and Bifidobacteriurn BB-12® and Beneo dietary fibres on health-related quality of life and the symptoms of irritable bowel syndrome in adults,JOURNAL OF FUNCTIONAL FOODS,,,English,Article,,,,,,Synbiotic; Irritable bowel syndrome; Quality of life; Randomized clinical trial,GASTROINTESTINAL MICROBIOTA; SYMBIOTIC FORMULATION; FECAL MICROBIOTA; DOUBLE-BLIND; EFFICACY; MANAGEMENT; MULTICENTER; PREBIOTICS; IBS; METAANALYSIS,"Clinical trials evaluating the effects of synbiotics on irritable bowel syndrome (IBS) are lacking. The aim of this study was to assess the effect of a synbiotic fermented milk on health related quality of life (QoL) and IBS symptoms in patients with constipation-predominant IBS. Altogether, 76 patients (test = 33, control = 43) were randomized in this multicentre, double-blind, randomized and placebo-controlled trial. On average, an 18% improvement in total IBS-QoL score was reported and significant improvements in bloating severity, satisfaction with bowel movements and the severity of IBS symptoms' interference with patients' everyday life were observed; however, there were no statistically significant differences between the synbiotic group and the placebo group. Sustained improvements in several IBS symptoms and total IBS-QoL score observed in both groups could suggest there may be derivable benefits from the regular consumption of fermented milk; however, this would need to be confirmed in a separate clinical trial. (c) 2016 Elsevier Ltd. All rights reserved.","[Smid, Alenka] Univ Ljubljana, Fac Pharm, Ljubljana 1000, Slovenia; [Strnisa, Luka] Univ Med Ctr Ljubljana, Dept Gastroenterol, Ljubljana 1000, Slovenia; [Bajc, Katarina; Vujic-Podlipec, Dunja] Clinres Farm Doo, Ljubljana 1000, Slovenia; [Matijasic, Bojana Bogavic; Rogelj, Irena] Univ Ljubljana, Biotech Fac, Inst Dairy Sci & Probiot, Domzale 1230, Slovenia",University of Ljubljana; University Medical Centre Ljubljana; University of Ljubljana,"Smid, A (corresponding author), Univ Ljubljana, Fac Pharm, Ljubljana 1000, Slovenia.",alenka.smid@ffa.uni-li.si,"Matijašić, Bojana Bogovič/ABI-8319-2020; Matijasic, Bojana Bogovic/J-2885-2012","Matijašić, Bojana Bogovič/0000-0003-0666-6981;","European Union (EU) - European Regional Development Fund (ERDF); Ministry of Education, Science and Sport of the Republic of Slovenia","European Union (EU) - European Regional Development Fund (ERDF)(European Union (EU)); Ministry of Education, Science and Sport of the Republic of Slovenia","The European Union (EU) - European Regional Development Fund (ERDF) and the Ministry of Education, Science and Sport of the Republic of Slovenia co-financed the Competence Center for Biotechnological Development and Innovation project (from 2010 to 2013). Within the framework of this project, the study was conducted. We would like to express our gratitude to all the patients, investigators, and other personnel who participated in this clinical trial for their invaluable contribution.",,53,14,19,1,47,ELSEVIER SCIENCE BV,AMSTERDAM,"PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",1756-4646,,,J FUNCT FOODS,J. Funct. Food.,JUN,2016,24,,,,,,549,557,,10.1016/j.jff.2016.04.031,http://dx.doi.org/10.1016/j.jff.2016.04.031,,,9,Food Science & Technology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Nutrition & Dietetics,DP3BJ,,,,,2024-06-04,WOS:000378367100053,View Full Record in Web of Science
J,"Chong, PP; Chin, VK; Looi, CY; Wong, WF; Madhavan, P; Yong, VC",,,,"Chong, Pei Pei; Chin, Voon Kin; Looi, Chung Yeng; Wong, Won Fen; Madhavan, Priya; Yong, Voon Chen",,,"The Microbiome and Irritable Bowel Syndrome - A Review on the Pathophysiology, Current Research and Future Therapy",FRONTIERS IN MICROBIOLOGY,,,English,Review,,,,,,irritable bowel syndrome; microbiome; microbiota dysbiosis; fecal transplant; IBS animal model,FUNCTIONAL GASTROINTESTINAL DISORDERS; GUANYLATE-CYCLASE-C; QUALITY-OF-LIFE; INTESTINAL BACTERIAL OVERGROWTH; CHRONIC IDIOPATHIC CONSTIPATION; NEONATAL MATERNAL SEPARATION; GLUTEN-FREE DIET; FECAL MICROBIOTA; GUT MICROBIOTA; VISCERAL HYPERSENSITIVITY,"Irritable bowel syndrome (IBS) is a functional disorder which affects a large proportion of the population globally. The precise etiology of IBS is still unknown, although consensus understanding proposes IBS to be of multifactorial origin with yet undefined subtypes. Genetic and epigenetic factors, stress-related nervous and endocrine systems, immune dysregulation and the brain-gut axis seem to be contributing factors that predispose individuals to IBS. In addition to food hypersensitivity, toxins and adverse life events, chronic infections and dysbiotic gut microbiota have been suggested to trigger IBS symptoms in tandem with the predisposing factors. This review will summarize the pathophysiology of IBS and the role of gut microbiota in relation to IBS. Current methodologies for microbiome studies in IBS such as genome sequencing, metagenomics, culturomics and animal models will be discussed. The myriad of therapy options such as immunoglobulins (immune-based therapy), probiotics and prebiotics, dietary modifications including FODMAP restriction diet and gluten-free diet, as well as fecal transplantation will be reviewed. Finally this review will highlight future directions in IBS therapy research, including identification of new molecular targets, application of 3-D gut model, gut-on-a-chip and personalized therapy.","[Chong, Pei Pei; Chin, Voon Kin; Looi, Chung Yeng; Yong, Voon Chen] Taylors Univ, Sch Biosci, Subang Jaya, Malaysia; [Wong, Won Fen] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Madhavan, Priya] Taylors Univ, Sch Med, Fac Hlth & Med Sci, Subang Jaya, Malaysia",Taylor's University; Universiti Malaya; Taylor's University,"Chong, PP (corresponding author), Taylors Univ, Sch Biosci, Subang Jaya, Malaysia.;Wong, WF (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.",PeiPei.Chong@taylors.edu.my; wonfen@um.edu.my,"Madhavan, Priya/AAI-4016-2020; Yong, Phelim VC/M-5961-2015; Chong, Pei Pei/AAP-4227-2021; Looi, Chung Yeng/A-2623-2013; Chin, Voon Kin/AAK-9153-2020; wong, won fen/D-3087-2012","Madhavan, Priya/0000-0001-6714-1279; Chong, Pei Pei/0000-0002-8229-3593; wong, won fen/0000-0003-1082-1956","Taylor's Research Grant Scheme (TRGS), Taylor's University, Malaysia [TRGS/MFS/2/2016/SOM/013]","Taylor's Research Grant Scheme (TRGS), Taylor's University, Malaysia","This work was supported by the Taylor's Research Grant Scheme (TRGS), Taylor's University, Malaysia (Award No. TRGS/MFS/2/2016/SOM/013).",,222,166,188,6,46,FRONTIERS MEDIA SA,LAUSANNE,"AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND",,1664-302X,,FRONT MICROBIOL,Front. Microbiol.,JUN 10,2019,10,,,,,,,,1136,10.3389/fmicb.2019.01136,http://dx.doi.org/10.3389/fmicb.2019.01136,,,23,Microbiology,Science Citation Index Expanded (SCI-EXPANDED),Microbiology,IC5AI,31244784,"Green Published, gold",,,2024-06-04,WOS:000470979100001,View Full Record in Web of Science
J,"Sinagra, E; Morreale, GC; Mohammadian, G; Fusco, G; Guarnotta, V; Tomasello, G; Cappello, F; Rossi, F; Amvrosiadis, G; Raimondo, D",,,,"Sinagra, Emanuele; Morreale, Gaetano Cristian; Mohammadian, Ghazaleh; Fusco, Giorgio; Guarnotta, Valentina; Tomasello, Giovanni; Cappello, Francesco; Rossi, Francesca; Amvrosiadis, Georgios; Raimondo, Dario",,,"New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond",WORLD JOURNAL OF GASTROENTEROLOGY,,,English,Review,,,,,,Therapy; Low grade inflammation; Motility; Secretion; Irritable bowel syndrome; Immunoendocrine axis,PLACEBO-CONTROLLED TRIAL; 5-HT4 RECEPTOR AGONIST; GUANYLATE-CYCLASE-C; CHRONIC IDIOPATHIC CONSTIPATION; RANDOMIZED CLINICAL-TRIAL; QUALITY-OF-LIFE; ACID TRANSPORTER INHIBITOR; HIGH INTRINSIC ACTIVITY; CARDIOVASCULAR SAFETY PROFILE; ORAL ALPHA-GALACTOSIDASE,"Irritable bowel syndrome (IBS) is a chronic, recurring, and remitting functional disorder of the gastrointestinal tract characterized by abdominal pain, distention, and changes in bowel habits. Although there are several drugs for IBS, effective and approved treatments for one or more of the symptoms for various IBS subtypes are needed. Improved understanding of pathophysiological mechanisms such as the role of impaired bile acid metabolism, neurohormonal regulation, immune dysfunction, the epithelial barrier and the secretory properties of the gut has led to advancements in the treatment of IBS. With regards to therapies for restoring intestinal permeability, multiple studies with prebiotics and probiotics are ongoing, even if to date their efficacy has been limited. In parallel, much progress has been made in targeting low-grade inflammation, especially through the introduction of drugs such as mesalazine and rifaximin, even if a better knowledge of the mechanisms underlying the low-grade inflammation in IBS may allow the design of clinical trials that test the efficacy and safety of such drugs. This literature review aims to summarize the findings related to new and investigational therapeutic agents for IBS, most recently developed in preclinical as well as Phase 1 and Phase 2 clinical studies.","[Sinagra, Emanuele; Rossi, Francesca; Raimondo, Dario] Fdn Ist Giuseppe Giglio, Gastroenterol & Endoscopy Unit, I-90015 Snc, Cefalu, Italy; [Sinagra, Emanuele; Tomasello, Giovanni; Cappello, Francesco] Euromediterranean Inst Sci & Technol, I-90100 Palermo, Italy; [Sinagra, Emanuele; Tomasello, Giovanni; Cappello, Francesco] Univ Palermo, Dept Expt Biomed & Clin Neurosci, Sect Human Anat, I-90100 Palermo, Italy; [Morreale, Gaetano Cristian; Amvrosiadis, Georgios] Osped Riuniti Villa Sofia Vincenzo Cervello, Unit Gastroenterol, I-90100 Palermo, Italy; [Mohammadian, Ghazaleh] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Div Gastroenterol & Hepatol, S-17176 Stockholm, Sweden; [Fusco, Giorgio] Osped Riuniti Villa Sofia Vincenzo Cervello, Unit Internal Med, I-90100 Palermo, Italy; [Guarnotta, Valentina] Univ Palermo, Sect Cardioresp & Endocrine Metab Dis, Biomed Dept Internal & Specialist Med, I-90127 Palermo, Italy",University of Palermo; Karolinska Institutet; Karolinska University Hospital; University of Palermo,"Sinagra, E (corresponding author), Fdn Ist Giuseppe Giglio, Gastroenterol & Endoscopy Unit, I-90015 Snc, Cefalu, Italy.",emanuelesinagra83@googlemail.com,"Sinagra, Emanuele/C-9336-2014; Cappello, Francesco/F-9153-2012","Cappello, Francesco/0000-0001-9288-1148; TOMASELLO, GIOVANNI/0000-0002-3071-822X",,,,,254,31,36,1,12,BAISHIDENG PUBLISHING GROUP INC,PLEASANTON,"8226 REGENCY DR, PLEASANTON, CA 94588 USA",1007-9327,2219-2840,,WORLD J GASTROENTERO,World J. Gastroenterol.,SEP 28,2017,23,36,,,,,6593,6627,,10.3748/wjg.v23.i36.6593,http://dx.doi.org/10.3748/wjg.v23.i36.6593,,,35,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,FI0IG,29085207,"Green Published, hybrid",,,2024-06-04,WOS:000411606800003,View Full Record in Web of Science
J,"Bazzocchi, G; Gionchetti, P; Almerigi, PF; Amadini, C; Campieri, M",,,,"Bazzocchi, G; Gionchetti, P; Almerigi, PF; Amadini, C; Campieri, M",,,Intestinal microflora and oral bacteriotherapy in irritable bowel syndrome,DIGESTIVE AND LIVER DISEASE,,,English,Article,,,,,,colonic motility; functional gastro-intestinal disorders; intestinal bacterial flora; irritable bowel syndrome; probiotics,MAINTENANCE TREATMENT; FUNCTIONAL DIARRHEA; DOUBLE-BLIND; DISEASE; HEALTH; FLORA; PREBIOTICS; PROBIOTICS; TRANSIT; IMPACT,"On the basis of many clinical and experimental observations, it would appear feasible to hold that the characteristics of the luminal milieu, the relationship, the balance between luminal prokaryotic cells and mucosal eukaryotic cells and the consequent immunological and humoral local and systemic responses take part in the pathophysiology of several diseases and, consequently, bacteriotherapy can play a relevant role in the treatment and prevention of irritable bowel syndrome and more in general, of the intestinal functional disorders. The irritable bowel syndrome is characterised by sudden and unforeseeable changes in the two main symptoms, constipation and diarrhoea, even within a few days. The amount and composition of proximal colon microflora, increasing with regard to the above-mentioned factors, and the time in which this development occurs, are, in our opinion, elements taking part, together with colon dysmotility and alterations of visceral perception, in the onset of the variability in stool frequency typical of these patients. The present open non-controlled trial is the first observation showing a clinical improvement related to changes in the composition of the faecal bacterial flora and in faecal biochemistry and, remarkably, in the colonic motility pattern, all of which induced by administration of probiotics, in patients with functional diarrhoea.","Univ Bologna, Osped Bellaria, Dept Internal Med & Gastroenterol, I-40139 Bologna, Italy",University of Bologna,"Bazzocchi, G (corresponding author), Univ Bologna, Osped Bellaria, Dept Internal Med & Gastroenterol, Via Altura 3, I-40139 Bologna, Italy.",,,"GIONCHETTI, PAOLO/0000-0001-9479-5307; Campieri, Massimo/0000-0001-8782-4245",,,,,24,45,48,1,8,PACINI EDITORE,PISA,"VIA DELLA GHERARDESCA-ZONA INDUSTRIALE OSPEDALETTO, 56121 PISA, ITALY",1590-8658,,,DIGEST LIVER DIS,Dig. Liver Dis.,SEP,2002,34,,,2,,,S48,S53,,10.1016/S1590-8658(02)80164-5,http://dx.doi.org/10.1016/S1590-8658(02)80164-5,,,6,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,602MQ,12408440,,,,2024-06-04,WOS:000178509400011,View Full Record in Web of Science
J,"Omotosho, AO; Tajudeen, YA; Oladipo, HJ; Yusuff, SI; AbdulKadir, M; Muili, AO; Egbewande, OM; Yusuf, RO; Faniran, ZO; Afolabi, AO; El-Sherbini, MS",,,,"Omotosho, Abass Olawale; Tajudeen, Yusuf Amuda; Oladipo, Habeebullah Jayeola; Yusuff, Sodiq Inaolaji; AbdulKadir, Muritala; Muili, Abdulbasit Opeyemi; Egbewande, Oluwaseyi Muyiwa; Yusuf, Rashidat Onyinoyi; Faniran, Zaccheaus Oluwaseun; Afolabi, Abdullateef Opeyemi; El-Sherbini, Mona Said",,,Parkinson's disease: Are gut microbes involved?,BRAIN AND BEHAVIOR,,,English,Review; Early Access,,,,,,Braak's Theory; Gut-brain axis; Gut Microbiome; Parkinson's Disease; Neurologial Disorders,INTESTINAL BACTERIAL OVERGROWTH; CONSTIPATION; PROBIOTICS; SYMPTOMS; PROGRESSION; MOTILITY; COFFEE; METAANALYSIS; ASSOCIATION; DYSFUNCTION,"IntroductionParkinson's disease (PD) is a neurodegenerative disorder that affects more than 10 million individuals worldwide. It is characterized by motor and sensory deficits. Research studies have increasingly demonstrated a correlation between Parkinson's disease and alternations in the composition of the gut microbiota in affected patients. Also, the significant role of prebiotics and probiotics in gastrointestinal and neurological conditions is imperative to understand their relation to Parkinson's disease. MethodTo explore the scientific interaction of the gut-microbiota-brain axis and its association with Parkinson's disease, a comprehensive narrative review of the relevant literature was conducted. Articles were retrieved systematically from reputable sources, including PubMed, Science Direct, World Health Organization (WHO), and Advanced Google Scholar. Key search terms included are Parkinson's Disease, Gut Microbiome, Braak's Theory, Neurological Disorders, and Gut-brain axis. Articles included in our review are published in English and they provide detailed information on the relationship between Parkinson's disease and gut microbiota ResultsThis review highlights the impact of gut microbiota composition and associated factors on the progression of Parkinson's disease. Evidence-based studies highlighting the existing evidence of the relationship between Parkinson's disease and alteration in gut microbiota are discussed. Consequently, the potential mechanisms by which the gut microbiota may affect the composition of the gut microbiota were revealed, with a particular emphasis on the role of the gut-brain axis in this interplay. ConclusionUnderstanding the complex interplay between gut microbiota and Parkinson's disease is a potential implication for the development of novel therapeutics against Parkinson's disease. Following the existing relationship demonstrated by different evidence-based studies on Parkinson's disease and gut microbiota, our review concludes by providing recommendations and suggestions for future research studies with a particular emphasis on the impact of the microbiota-brain axis on Parkinson's disease.","[Omotosho, Abass Olawale] Kwara State Univ, Fac Pure & Appl Sci, Dept Microbiol, Ilorin, Nigeria; [Tajudeen, Yusuf Amuda; Oladipo, Habeebullah Jayeola] Univ Ilorin, Fac Life Sci, Dept Microbiol, Ilorin, Nigeria; [Tajudeen, Yusuf Amuda] Univ Ilorin, Fac Pharmaceut Sci, Ilorin, Nigeria; [Oladipo, Habeebullah Jayeola; AbdulKadir, Muritala; Egbewande, Oluwaseyi Muyiwa; Yusuf, Rashidat Onyinoyi] Univ Ibadan, Coll Med, Fac Publ Hlth, Dept Epidemiol & Med Stat, Ibadan, Nigeria; [Yusuff, Sodiq Inaolaji] Obafemi Awolowo Univ, Fac Clin Sci, Dept Med, Ife, Nigeria; [Muili, Abdulbasit Opeyemi] Ladoke Akintola Univ Technol, Dept Med, Ogbomosho, Nigeria; [Faniran, Zaccheaus Oluwaseun] Univ Ibadan, Fac Sci, Dept Microbiol, Ibadan, Nigeria; [Afolabi, Abdullateef Opeyemi] Kampala Int Univ, Fac Biomed Sci, Dept Microbiol & Immunol, Bushenyi, Uganda; [El-Sherbini, Mona Said] Cairo Univ, Fac Med, Integrated Program Kasr Al Ainy IPKA, Narrat Med & Planetary Hlth, Cairo, Egypt; [El-Sherbini, Mona Said] Nova Inst Hlth, Invited Fac, Baltimore, MD USA; [El-Sherbini, Mona Said] Cairo Univ, Fac Med, Dept Med Parasitol, Cairo, Egypt; [Afolabi, Abdullateef Opeyemi] Kampala Int Univ, Fac Biomed Sci, Dept Microbiol & Immunol, POB 71,Western Campus Ishaka, Bushenyi, Uganda",University of Ilorin; University of Ilorin; University of Ibadan; Obafemi Awolowo University; University of Ibadan; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University,"Afolabi, AO (corresponding author), Kampala Int Univ, Fac Biomed Sci, Dept Microbiol & Immunol, POB 71,Western Campus Ishaka, Bushenyi, Uganda.",O.afolabi@kiu.ac.ug; monas.elsherbini@kasralainy.edu.eg,,"Oladipo, Habeebullah/0000-0002-0146-1349; Afolabi, Abdullateef/0000-0001-6440-1805; Egbewande, Oluwaseyi Muyiwa/0000-0002-9034-7993; Tajudeen, Yusuf/0000-0001-7441-1468",,,,,112,3,3,20,39,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN, NJ 07030 USA",2162-3279,,,BRAIN BEHAV,Brain Behav.,2023 JUN 20,2023,,,,,,,,,,10.1002/brb3.3130,http://dx.doi.org/10.1002/brb3.3130,,JUN 2023,15,Behavioral Sciences; Neurosciences,Science Citation Index Expanded (SCI-EXPANDED),Behavioral Sciences; Neurosciences & Neurology,J7TT1,37340511,"gold, Green Published",,,2024-06-04,WOS:001011616800001,View Full Record in Web of Science
J,"Elford, JD; Becht, N; Garssen, J; Kraneveld, AD; Perez-Pardo, P",,,,"Elford, Joshua D.; Becht, Nanette; Garssen, Johan; Kraneveld, Aletta D.; Perez-Pardo, Paula",,,Buty and the beast: the complex role of butyrate in Parkinson's disease,FRONTIERS IN PHARMACOLOGY,,,English,Review,,,,,,Parkinson's disease; short-chain fatty acid; butyrate; gut-brain axis; microbiome,CHAIN FATTY-ACIDS; GUT-BRAIN AXIS; SODIUM-BUTYRATE; MICROBIOTA; PATHOLOGY; MODEL; CONSTIPATION; PROBIOTICS; ASSOCIATION; IMPAIRMENT,"Parkinson's disease (PD) is a complex neurodegenerative disease which is often associated with gastrointestinal (GI) dysfunction. The GI tract is home to a wide range of microorganisms, among which bacteria, that can influence the host through various mechanisms. Products produced by these bacteria can act in the gut but can also exert effects in the brain via what is now well established to be the microbiota-gut-brain axis. In those with PD the gut-bacteria composition is often found to be different to that of non-PD individuals. In addition to compositional changes, the metabolic activity of the gut-microbiota is also changed in PD. Specifically, it is often reported that key producers of short chain fatty acids (SCFAs) as well as the concentration of SCFAs themselves are altered in the stool and blood of those with PD. These SCFAs, among which butyrate, are essential nutrients for the host and are a major energy source for epithelial cells of the GI tract. Additionally, butyrate plays a key role in regulating various host responses particularly in relation to inflammation. Studies have demonstrated that a reduction in butyrate levels can have a critical role in the onset and progression of PD. Furthermore, it has been shown that restoring butyrate levels in those with PD through methods such as probiotics, prebiotics, sodium butyrate supplementation, and fecal transplantation can have a beneficial effect on both motor and non-motor outcomes of the disease. This review presents an overview of evidence for the altered gut-bacteria composition and corresponding metabolite production in those with PD, with a particular focus on the SCFA butyrate. In addition to presenting current studies regarding SCFA in clinical and preclinical reports, evidence for the possibility to target butyrate production using microbiome based approaches in a therapeutic context is discussed.","[Elford, Joshua D.; Becht, Nanette; Garssen, Johan; Kraneveld, Aletta D.; Perez-Pardo, Paula] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Fac Sci, Div Pharmacol, Utrecht, Netherlands; [Garssen, Johan] Danone Nutr Res, Utrecht, Netherlands; [Kraneveld, Aletta D.] Vrije Univ, Fac Sci, Dept Neurosci, Amsterdam, Netherlands",Utrecht University; Danone Nutricia; Vrije Universiteit Amsterdam,"Perez-Pardo, P (corresponding author), Univ Utrecht, Utrecht Inst Pharmaceut Sci, Fac Sci, Div Pharmacol, Utrecht, Netherlands.",p.perezpardo@uu.nl,"Kraneveld, Aletta/J-3351-2016","Kraneveld, Aletta/0000-0001-9819-383X",Parkinson NL [P2021-17],Parkinson NL,"The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. Part of this work was made possible by funding from Parkinson NL (project number: P2021-17).",,146,0,0,1,1,FRONTIERS MEDIA SA,LAUSANNE,"AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND",,1663-9812,,FRONT PHARMACOL,Front. Pharmacol.,APR 17,2024,15,,,,,,,,1388401,10.3389/fphar.2024.1388401,http://dx.doi.org/10.3389/fphar.2024.1388401,,,16,Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy,OU6T8,38694925,gold,,,2024-06-04,WOS:001209841000001,View Full Record in Web of Science
J,"Chen, YC; Chien, YW; Chang, PJ; Hsieh, WS; Chen, PC",,,,"Chen, Yi-Chun; Chien, Yi-Wen; Chang, Pei-Jen; Hsieh, Wu-Shiun; Chen, Pau-Chung",,,Probiotic Supplement Use among Young Children in Taiwan: A Prospective Cohort Study,PLOS ONE,,,English,Article,,,,,,,NUTRITION EXAMINATION SURVEY; NATIONAL-HEALTH; VITAMIN; MARKETPLACE; ADOLESCENTS; PREVENTION; MANAGEMENT; PREBIOTICS; BACTERIA; GUIDANCE,"Objectives: The objective of this study is to provide details on probiotic supplement use among young children in Taiwan. Participants and Methods: This study is based on the Taiwan Birth Cohort Study database. We used questionnaires to collect information on probiotic supplement use among young children from birth to 18 months of age, while also considering their demographic characteristics and other covariates. Low-birth-weight infants, preterm infants, those with birth defects, and those with caregivers who returned incomplete questionnaires were excluded. The final valid sample comprised 16,991 cases. Results: Approximately half the children received probiotic supplements before the age of 18 months. Only 6.3% of the children received probiotic supplements during the two periods of birth to 6 months and 7 to 18 months. Firstborn children, native mothers, mothers with higher educational levels, higher family income, and parents who lead healthy lifestyles were positively related to probiotic supplement use among children. Young children who were breastfed, with eczema, or with gastrointestinal tract problems were significantly positively associated with probiotic supplement use. Conclusion: The findings show that probiotic supplement usage among young children is associated with a more socially advantaged circumstance and certain child health factors, such as eczema, diarrhea, and constipation. Parents might use probiotic supplements for prevention or treatment of child diseases. The findings of this research could serve as a baseline for future studies, and provide insight into probiotic supplement use behavior for health professionals caring for infants and young children.","[Chen, Yi-Chun; Chien, Yi-Wen] Taipei Med Univ, Sch Nutr & Hlth Sci, Taipei, Taiwan; [Chang, Pei-Jen] Natl Taipei Univ Nursing & Hlth Sci, Dept Nursing, Taipei, Taiwan; [Hsieh, Wu-Shiun] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Taipei 10764, Taiwan; [Hsieh, Wu-Shiun] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Chen, Pau-Chung] Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Coll Publ Hlth, Taipei 10764, Taiwan",Taipei Medical University; National Taipei University of Nursing & Health Science (NTUNHS); National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University,"Chen, YC (corresponding author), Taipei Med Univ, Sch Nutr & Hlth Sci, Taipei, Taiwan.",yichun@tmu.edu.tw,"Chen, Pau-Chung/H-5686-2011","Chen, Pau-Chung/0000-0002-6242-5974; HSIEH, WU-SHIUN/0000-0002-0609-3311","Bureau of Health Promotion, Department of Health, Taiwan","Bureau of Health Promotion, Department of Health, Taiwan","The study was supported by a grant from the Bureau of Health Promotion, Department of Health, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,37,10,10,0,9,PUBLIC LIBRARY SCIENCE,SAN FRANCISCO,"1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA",1932-6203,,,PLOS ONE,PLoS One,SEP 12,2012,7,9,,,,,,,e43885,10.1371/journal.pone.0043885,http://dx.doi.org/10.1371/journal.pone.0043885,,,8,Multidisciplinary Sciences,Science Citation Index Expanded (SCI-EXPANDED),Science & Technology - Other Topics,005GJ,22984450,"Green Published, Green Submitted, gold",,,2024-06-04,WOS:000308738500027,View Full Record in Web of Science
J,"Oh, JH; Jang, YS; Kang, D; Kim, HS; Kim, EJ; Park, SY; Kim, CH; Min, YW; Chang, DK",,,,"Oh, Joo Hyun; Jang, Yeon Sil; Kang, Danbee; Kim, Hong Seog; Kim, Eui-Joong; Park, So-Young; Kim, Cheol-Hyun; Min, Yang Won; Chang, Dong Kyung",,,"Efficacy of a Synbiotic Containing Lactobacillus paracasei DKGF1 and Opuntia humifusa in Elderly Patients with Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial",GUT AND LIVER,,,English,Article,,,,,,Irritable bowel syndrome; Synbiotics; Lactobacillus paracasei; Opuntia humifusa; Aged,GUT MICROBIOTA; IN-VITRO; PROBIOTICS; PREBIOTICS; SYMPTOMS; ASSOCIATION; MUCILAGE; IMPACT; SCALE,"Background/Aims: There is increasing evidence that supplementation with pre- and probiotics appears to have positive effects on irritable bowel syndrome (IBS). The aim of this study was to determine the effects of a new synbiotic formulation on gastrointestinal symptoms in elderly patients with IBS. Methods: Sixty-seven IBS patients aged >= 60 years were randomly assigned to either a placebo group (n=34) or a synbiotic group (n=33). During a 4-week intervention, subjects used a placebo or a synbiotic containing Lactobacillus paracasei DKGF1 and extracts of Opuntia humifusa once a day. Patients were evaluated with the subject global assessment, visual analog scale, and Bristol stool chart. The primary outcome was the overall responder rate and the secondary outcome was the responder rates for abdominal symptom reduction at week 4. Results: Overall, responder rates were significantly higher in the synbiotic group (51.5%) than in the placebo group (23.5%) (p=0.017). Abdominal pain (58.8% vs 81.8%) and psychological well-being (26.4% vs 60.6%) were noticeably improved in the synbiotic group (p=0.038 and p=0.004, respectively). However, there were no significant differences in gas and bloating symptoms (p=0.88 and p=0.88, respectively). In patients with constipation-dominant and diarrhea-dominant IBS (n=16), the synbiotic significantly improved abdominal pain and defecation symptoms (responder rates for the placebo vs the synbiotic: 22.2% vs 85.7%, p=0.04). There were no adverse events in either group. Conclusions: The results indicate that this new synbiotic supplement can potentially relieve abdominal symptoms in elderly IBS patients.","[Oh, Joo Hyun; Jang, Yeon Sil; Min, Yang Won; Chang, Dong Kyung] Sungkyunkwan Univ, Dept Med, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Oh, Joo Hyun] Eulji Univ, Sch Med, Nowon Eulji Med Ctr, Dept Med, Daejeon, South Korea; [Kang, Danbee] Sungkyunkwan Univ, Sch Med, Samsung Adv Inst Hlth Sci & Technol SAIHST, Dept Clin Res Design & Evaluat, Seoul, South Korea; [Kang, Danbee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Clin Epidemiol, Seoul, South Korea; [Kim, Hong Seog] Youdam Co Ltd, Cheonan, South Korea; [Kim, Eui-Joong] Genofocus Inc, Daejeon, South Korea; [Park, So-Young] Dankook Univ, Coll Pharm, Lab Pharmacognosy, Yongin, South Korea; [Park, So-Young; Kim, Cheol-Hyun] Dankook Univ, Coll Biotechnol & Bioengn, Dept Anim Resources Sci, Cheonan, South Korea",Sungkyunkwan University (SKKU); Samsung Medical Center; Eulji University; Samsung; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center; Dankook University; Dankook University,"Min, YW (corresponding author), Sungkyunkwan Univ, Dept Med, Samsung Med Ctr, Sch Med, Seoul, South Korea.",yangwonee@gmail.com,"Kang, Danbee/AAN-5933-2020; min, yang/KEJ-2761-2024","Kang, Danbee/0000-0003-0244-7714; Min, Yang Won/0000-0001-7471-1305; KIM, HONGSEOG/0000-0002-6546-3976; Chang, Dong Kyung/0000-0001-8925-4629","Ministry of Trade, Industry & Energy (MOTIE), Korea Institute for Advancement of Technology (KIAT) through the Encouragement Program for The Industries of Economic Cooperation Region [P0004697]","Ministry of Trade, Industry & Energy (MOTIE), Korea Institute for Advancement of Technology (KIAT) through the Encouragement Program for The Industries of Economic Cooperation Region(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea)","This research was supported by the Ministry of Trade, Industry & Energy (MOTIE), Korea Institute for Advancement of Technology (KIAT) through the Encouragement Program for The Industries of Economic Cooperation Region (P0004697).",,42,5,5,5,9,EDITORIAL OFFICE GUT & LIVER,SEOUL,"305 LOTTE GOLD ROSE II, 890-59, DAECHI 4-DONG, GANGNAM-GU, SEOUL, 135-839, SOUTH KOREA",1976-2283,2005-1212,,GUT LIVER,Gut Liver,JAN,2023,17,1,,,,,100,107,,10.5009/gnl210478,http://dx.doi.org/10.5009/gnl210478,,,8,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,DM5K4,35611667,"Green Published, gold",,,2024-06-04,WOS:001132471400014,View Full Record in Web of Science
J,"Oh, JH; Jang, YS; Kang, D; Kim, HS; Kim, EJ; Park, SY; Kim, CH; Min, YW; Chang, DK",,,,"Oh, Joo Hyun; Jang, Yeon Sil; Kang, Danbee; Kim, Hong Seog; Kim, Eui-Joong; Park, So -Young; Kim, Cheol-Hyun; Min, Yang Won; Chang, Dong Kyung",,,Efficacy of a Synbiotic Containing Lactobacillus paracasei DKGF1 and Opuntia humifusa in Elderly Patients with Irritable Bowel A Placebo-Controlled Trial,GUT AND LIVER,,,English,Article; Early Access,,,,,,Irritable bowel syndrome; Synbiotics; Lactobacillus paracasei; Opuntia humifusa; Aged,GUT MICROBIOTA; IN-VITRO; PROBIOTICS; PREBIOTICS; SYMPTOMS; ASSOCIATION; MUCILAGE; IMPACT; SCALE,"Background/Aims: There is increasing evidence that supplementation with pre-and probiotics appears to have positive effects on irritable bowel syndrome (IBS). The aim of this study was to determine the effects of a new synbiotic formulation on gastrointestinal symptoms in elderly patients with IBS. Methods: Sixty-seven IBS patients aged >= 60 years were randomly assigned to either a placebo group (n=34) or a synbiotic group (n=33). During a 4-week intervention, subjects used a placebo or a synbiotic containing Lactobacillus paracasei DKGF1 and extracts of Opuntia humifusa once a day. Patients were evaluated with the subject global assessment, visual analog scale, and Bris-tol stool chart. The primary outcome was the overall responder rate and the secondary outcome was the responder rates for abdominal symptom reduction at week 4. Results: Overall, responder rates were significantly higher in the synbiotic group (51.5%) than in the placebo group (23.5%) (p=0.017). Abdominal pain (58.8% vs 81.8%) and psychological well-being (26.4% vs 60.6%) were noticeably improved in the synbiotic group (p=0.038 and p=0.004, respectively). However, there were no significant differences in gas and bloating symptoms (p=0.88 and p=0.88, respectively). In patients with constipation-dominant and diarrhea-dominant IBS (n=16), the synbiotic significantly improved abdominal pain and defecation symptoms (re-sponder rates for the placebo vs the synbiotic: 22.2% vs 85.7%, p=0.04). There were no adverse events in either group. Conclusions: The results indicate that this new synbiotic supplement can potentially relieve abdominal symptoms in elderly IBS patients. (Gut Liver, Published online May 25, 2022)","[Oh, Joo Hyun; Jang, Yeon Sil; Min, Yang Won; Chang, Dong Kyung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea; [Oh, Joo Hyun] Eulji Univ, Sch Med, Nowon Eulji Med Ctr, Dept Med, Daejeon, South Korea; [Kang, Danbee] Sungkyunkwan Univ, Sch Med, Samsung Adv Inst Hlth Sci & Technol SAIHST, Dept Clin Res Design & Evaluat, Seoul, South Korea; [Kang, Danbee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Clin Epidemiol, Seoul, South Korea; [Kim, Hong Seog] Youdam Co Ltd, Cheonan, South Korea; [Kim, Eui-Joong] Genofocus Inc, Daejeon, South Korea; [Park, So -Young] Dankook Univ, Coll Pharm, Lab Pharmacognosy, Cheonan, South Korea; [Park, So -Young; Kim, Cheol-Hyun] Dankook Univ, Coll Biotechnol & Bioengn, Dept Anim Resources Sci, Cheonan, South Korea",Sungkyunkwan University (SKKU); Samsung Medical Center; Eulji University; Samsung; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center; Dankook University; Dankook University,"Min, YW (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea.",yangwonee@gmail.com,"Kang, Danbee/AAN-5933-2020; min, yang/KEJ-2761-2024","Kang, Danbee/0000-0003-0244-7714; Min, Yang Won/0000-0001-7471-1305; KIM, HONGSEOG/0000-0002-6546-3976; Chang, Dong Kyung/0000-0001-8925-4629","Ministry of Trade, Industry & Energy (MOTIE), Korea Institute for Advancement of Technology (KIAT) through the Encouragement Program for The Industries of Economic Cooperation Region [P0004697]","Ministry of Trade, Industry & Energy (MOTIE), Korea Institute for Advancement of Technology (KIAT) through the Encouragement Program for The Industries of Economic Cooperation Region","This research was supported by the Ministry of Trade, Industry & Energy (MOTIE), Korea Institute for Advancement of Technology (KIAT) through the Encouragement Program for The Industries of Economic Cooperation Region (P0004697).",,42,5,5,5,9,EDITORIAL OFFICE GUT & LIVER,SEOUL,"305 LOTTE GOLD ROSE II, 890-59, DAECHI 4-DONG, GANGNAM-GU, SEOUL, 135-839, SOUTH KOREA",1976-2283,2005-1212,,GUT LIVER,Gut Liver,2022 MAY 25,2022,,,,,,,,,,10.5009/gnl210478,http://dx.doi.org/10.5009/gnl210478,,MAY 2022,8,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,2G6RT,35611667,"Green Published, gold",,,2024-06-04,WOS:000813720300001,View Full Record in Web of Science
J,"Zhang, X; Yang, JJ; Zhang, C; Chi, HY; Zhang, CW; Zhang, JJ; Li, TT; Liu, LB; Li, AL",,,,"Zhang, Xin; Yang, Jiajie; Zhang, Chao; Chi, Houyu; Zhang, Chongwei; Zhang, Jingjing; Li, Tongtong; Liu, Libo; Li, Aili",,,Effects of Lactobacillus fermentum HY01 on the quality characteristics and storage stability of yak yogurt,JOURNAL OF DAIRY SCIENCE,,,English,Article,,,,,,yak yogurt; L. fermentum HY01; volatiles; rheology; fatty acid profile,CONJUGATED LINOLEIC-ACID; FATTY-ACIDS; RHEOLOGICAL PROPERTIES; VOLATILE COMPOUNDS; MILK; BACTERIA; FLAVOR; PREBIOTICS; IDENTIFICATION; OPTIMIZATION,"Lactobacillus fermentum HY01 is a probiotic strain screened from traditional yak yogurt, which can effectively relieve enteritis and constipation. This study aimed to evaluate the effects of HY01 as an adjunct starter on the quality and storage of yak yogurt. A to-tal of 36 main volatile flavor substances were detected in all samples. In particular, more aldehydes, esters, and alcohols were detected in yak yogurt prepared by mixed fermentation of L. fermentum HY01 and starter MY105 (including Streptococcus thermophilus and Lactobacillus delbrueckii ssp. bulgaricus). The rheological results showed that the yak yogurt prepared by mixed fermentation of L. fermentum HY01 and starter MY105 had higher apparent viscosity and lower tan delta value compared with compared with traditional yak yogurt, yak yogurt with only L. fermentum HY01, and cow yogurt with L. fermentum HY01 and starter MY105. Meanwhile, the conjugated linoleic acid in the yak yogurt prepared by mixed fermentation of L. fermentum HY01 and starter was significantly higher than those in the HY01 group or the yogurt starter group alone. After 28 d of storage at 4 degrees C, the number of HY01 in the yak yogurt prepared by mixed fermentation of L. fermentum HY01 and starter was still higher than 107 cfu/mL, its acidity was lower than 110 degrees T, and its syneresis was the lowest. The results indicated that L. fermentum HY01 could improve the flavor, texture, and storage properties of yak yogurt.","[Zhang, Xin; Yang, Jiajie; Zhang, Chao; Chi, Houyu; Zhang, Chongwei; Zhang, Jingjing; Li, Tongtong; Liu, Libo; Li, Aili] Northeast Agr Univ, Coll Food Sci, Minist Educ, Key Lab Dairy Sci, Harbin 150030, Heilongjiang, Peoples R China; [Li, Aili] Heilongjiang Green Food Res Inst, Harbin 150028, Peoples R China",Northeast Agricultural University - China,"Liu, LB; Li, AL (corresponding author), Northeast Agr Univ, Coll Food Sci, Minist Educ, Key Lab Dairy Sci, Harbin 150030, Heilongjiang, Peoples R China.;Li, AL (corresponding author), Heilongjiang Green Food Res Inst, Harbin 150028, Peoples R China.",liboliu@126.com; ailimail@neau.edu.cn,"羊, 嘉杰/JZD-1458-2024; li, tong/HPC-6702-2023; Zhang, Jing/ISA-6627-2023; Zhang, Chongwei/AAA-2521-2019; li, tong/JYO-7530-2024; Zhang, Jing/HII-4294-2022","羊, 嘉杰/0000-0001-7950-5666; Zhang, Jing/0009-0003-5039-5688; Zhang, Chongwei/0000-0002-0062-4548;","National Key Research and Development Plan [2018YFD0502404]; (Lhasa, China)","National Key Research and Development Plan; (Lhasa, China)","This study was supported by the National Key Research and Development Plan (grant number 2018YFD0502404; Lhasa, China). The authors have not stated any conflicts of interest.",,56,16,16,17,88,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",0022-0302,1525-3198,,J DAIRY SCI,J. Dairy Sci.,MAR,2022,105,3,,,,,2025,2037,,10.3168/jds.2021-20861,http://dx.doi.org/10.3168/jds.2021-20861,,FEB 2022,13,"Agriculture, Dairy & Animal Science; Food Science & Technology",Science Citation Index Expanded (SCI-EXPANDED),Agriculture; Food Science & Technology,ZF2EQ,35033347,gold,,,2024-06-04,WOS:000759385400015,View Full Record in Web of Science
J,"Sabater-Molina, M; Larqué, E; Torrella, F; Zamora, S",,,,"Sabater-Molina, M.; Larque, E.; Torrella, F.; Zamora, S.",,,Dietary fructooligosaccharides and potential benefits on health,JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY,,,English,Review,,,,,,Fructooligosaccharides; Prebiotic; Infant formulas; Human milk,HUMAN-MILK OLIGOSACCHARIDES; BREAST-FED INFANTS; EPITHELIAL-CELL PROLIFERATION; HUMAN COLONIC MICROBIOTA; FRUCTO-OLIGOSACCHARIDES; MINERAL METABOLISM; RATS; OLIGOFRUCTOSE; PREBIOTICS; INULIN,"M. SABATER-MOLINA, E. LARQU, F. TORRELLA and S. ZAMORA. Dietary fructooligosaccharides and potential benefits on health, (minireview). J Physiol Biochem, 65 (3), 315-328, 2009. Fructooligosaccharides (FOS) are oligosaccharides that occur naturally in plants such as onion, chicory, garlic, asparagus, banana, artichoke, among many others. They are composed of linear chains of fructose units, linked by beta (2-1) bonds. The number of fructose units ranges from 2 to 60 and often terminate in a glucose unit. Dietary FOS are not hydrolyzed by small intestinal glycosidases and reach the cecum structurally unchanged. There, they are metabolized by the intestinal microflora to form short-chain carboxylic acids, L -lactate, CO2, hydrogen and other metabolites. FOS have a number of interesting properties, including a low sweetness intensity; they are also caloric free, non-cariogenic and are considered as soluble dietary fibre. Furthermore, FOS have important beneficial physiological effects such as low carcinogenicity, a prebiotic effect, improved mineral absorption and decreased levels of serum cholesterol, triacylglycerols and phospholipids. Currently FOS are increasingly included in food products and infant formulas due to their prebiotic effect stimulate the growth of nonpathogenic intestinal microflora. Their consumption increases fecal bolus and the frequency of depositions, while a dose of 4-15 g/day given to healthy subjects will reduce constipation, considered one of the growing problems of modern society, and newborns during the first months of life.","[Sabater-Molina, M.; Larque, E.; Zamora, S.] Univ Murcia, Dept Physiol, Fac Biol, E-30001 Murcia, Spain; [Torrella, F.] Univ Murcia, Dept Microbiol, Fac Biol, E-30001 Murcia, Spain",University of Murcia; University of Murcia,"Sabater-Molina, M (corresponding author), Univ Murcia, Dept Physiol, Fac Biol, E-30001 Murcia, Spain.",mariasm@um.es,"Larqué Daza, Elvira/HNC-4859-2023; Sabater-Molina, Maria/I-2722-2015; TORRELLA, FRANCISCO/H-9789-2015","Larqué Daza, Elvira/0000-0001-6805-3449; Sabater-Molina, Maria/0000-0003-1352-1748; TORRELLA, FRANCISCO/0000-0001-8157-0440",,,,,69,228,251,3,112,SPRINGER,DORDRECHT,"VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS",1138-7548,1877-8755,,J PHYSIOL BIOCHEM,J. Physiol. Biochem.,SEP,2009,65,3,,,,,315,328,,10.1007/BF03180584,http://dx.doi.org/10.1007/BF03180584,,,14,Biochemistry & Molecular Biology; Physiology,Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Physiology,547AS,20119826,,,,2024-06-04,WOS:000273857700011,View Full Record in Web of Science
J,"Laue, C; Papazova, E; Pannenbeckers, A; Schrezenmeir, J",,,,"Laue, Christiane; Papazova, Ekaterina; Pannenbeckers, Angelika; Schrezenmeir, Juergen",,,"Effect of a Probiotic and a Synbiotic on Body Fat Mass, Body Weight and Traits of Metabolic Syndrome in Individuals with Abdominal Overweight: A Human, Double-Blind, Randomised, Controlled Clinical Study",NUTRIENTS,,,English,Article,,,,,,probiotics; synbiotics; L. fermentum; weight management; body fat mass; metabolic syndrome; NAFLD,TYPE-2 DIABETES-MELLITUS; GASTROINTESTINAL SYMPTOMS; GLUCOSE-METABOLISM; LIVER-DISEASE; RATING-SCALE; METAANALYSIS; IDENTIFICATION; PREBIOTICS; MICROBIOTA; VALIDITY,"L. fermentum strains K7-Lb1, K8-Lb1 and K11-Lb3 were found to suppress Th1 and Th2 response and to enhance defensin release by enterocytes, respectively. Based on these anti-inflammatory actions, we investigated the effect of these strains on traits of metabolic syndrome, which is driven by low-grade inflammation. In a double-blind, randomised, placebo-controlled clinical trial with three parallel arms, 180 individuals with abdominal overweight were administered for 3 months with (1) placebo; (2) probiotic, comprising L. fermentum strains; or (3) synbiotic, comprising the strains + acacia gum (10 g daily). The effects were evaluated using Kruskal-Wallis one-way analysis of variance on ranks and post hoc tests (Holm-Sidak and Dunn's tests). The alteration ( increment ) in body fat mass (kg) (primary parameter) during intervention was significantly (p = 0.039) more pronounced in the Probiotic group (-0.61 & PLUSMN; 1.94; mean & PLUSMN; SD) compared with the Placebo group (+0.13 & PLUSMN; 1.64). Accordingly, differences were found in increment body weight (p = 0.012), BMI (p = 0.011), waist circumference (p = 0.03), waist-to-height ratio (p = 0.033), visceral adipose tissue (SAD) (p < 0.001) and liver steatosis grade (LSG) (p < 0.001), as assessed using sonography. In the Synbiotic group, increment SAD (p = 0.002), increment LSG (p < 0.001) and increment constipation score (p = 0.009) were improved compared with Placebo. The probiotic mixture and the synbiotic improved the parameters associated with overweight.","[Laue, Christiane; Papazova, Ekaterina; Pannenbeckers, Angelika; Schrezenmeir, Juergen] Kiel Ctr Innovat & Technol, Clin Res Ctr Kiel, Schauenburgstr 116, D-24118 Kiel, Germany; [Schrezenmeir, Juergen] Johannes Gutenberg Univ Mainz, Univ Med, D-55131 Mainz, Germany",Johannes Gutenberg University of Mainz,"Schrezenmeir, J (corresponding author), Kiel Ctr Innovat & Technol, Clin Res Ctr Kiel, Schauenburgstr 116, D-24118 Kiel, Germany.;Schrezenmeir, J (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med, D-55131 Mainz, Germany.",c.laue@crc-kiel.de; e.papazova@crc-kiel.de; a.pannenbeckers@crc-kiel.de; j.schrezenmeir@crc-kiel.de,,,,,,,59,3,3,6,11,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,JUL,2023,15,13,,,,,,,3039,10.3390/nu15133039,http://dx.doi.org/10.3390/nu15133039,,,25,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,M2NR5,37447365,"Green Published, gold",,,2024-06-04,WOS:001028605000001,View Full Record in Web of Science
J,"Skrzydlo-Radomanska, B; Prozorow-Krol, B; Kurzeja-Miroslaw, A; Cichoz-Lach, H; Laskowska, K; Majsiak, E; Bierla, JB; Agnieszka, S; Cukrowska, B",,,,"Skrzydlo-Radomanska, Barbara; Prozorow-Krol, Beata; Kurzeja-Miroslaw, Anetta; Cichoz-Lach, Halina; Laskowska, Katarzyna; Majsiak, Emilia; Bierla, Joanna B.; Agnieszka, Sowinska; Cukrowska, Bozena",,,The Efficacy and Safety of Single-Strain Probiotic Formulations Containing Bifidobacterium lactis or Bacillus coagulans in Adult Patients with Irritable Bowel Syndrome-A Randomized Double-Blind Placebo-Controlled Three-Arm Interventional Trial,JOURNAL OF CLINICAL MEDICINE,,,English,Article,,,,,,irritable bowel syndrome; probiotics; Bifidobacterium lactis; Bacillus coagulans; IBS-SSS,INTERNATIONAL SCIENTIFIC ASSOCIATION; INTESTINAL MICROBIOTA; CONSENSUS STATEMENT; PREBIOTICS; SCOPE,"Probiotics offer a potential new therapeutic approach for irritable bowel syndrome (IBS), but current results are still controversial. The aim of this study was to assess the efficacy and safety of single-strain probiotic formulations in adult IBS patients and to compare the effects of Bifidobacterium lactis NORDBIOTIC & TRADE; BI040 (DSM 33812/34614) and Bacillus coagulans NORDBIOTIC & TRADE; BC300 (DSM 33836) in a prospective three-arm interventional randomized double-blind placebo-controlled clinical trial. The study included 123 IBS subjects diagnosed according to the Rome IV criteria. The primary outcomes were changes in symptom severity and symptom improvement as assessed using the IBS Severity Scoring System (IBS-SSS) after 4, 8, and 12 weeks of intervention and after 4 weeks of follow-up. Secondary outcomes included the assessment of individual IBS symptoms and the occurrence of adverse events. During the 12-week intervention, IBS-SSS scores significantly decreased (p-values < 0.001) in the study groups but differences between the interventional and placebo groups did not reach statistical significance. However, at the 16th week of follow-up, a significant improvement in the total IBS-SSS score in comparison to the placebo group (20.5%) was found in 43.8% and 52.9% of the Bifidobacterium lactis (p = 0.038, OR 3.0, [95% CI 1.1-8.6]) and the Bacillus coagulans (p = 0.005, OR 4.6 [95% CI 1.5-12.2]) groups, respectively. Bifidobacterium lactis had a beneficial effect on the intensity and frequency of pain, whereas Bacillus coagulans decreased the bowel dissatisfaction. Both strains increased the percentage of patients with normal stool consistency, but only Bifidobacterium lactis induced a decrease in the number of patients with constipation after 6 weeks of supplementation. Both probiotic strains were well tolerated, without differences in the occurrence of adverse events between groups. In conclusion, single-strain supplementation was safe and efficient in IBS patients but showed a different range of effects. Bifidobacterium lactis BI040 primarily reduced the frequency and intensity of pain, while Bacillus coagulans BC300 increased bowel satisfaction [ClinicalTrials.gov NCT05064930].","[Skrzydlo-Radomanska, Barbara; Prozorow-Krol, Beata; Kurzeja-Miroslaw, Anetta; Cichoz-Lach, Halina; Laskowska, Katarzyna] Med Univ Lublin, Dept Gastroenterol, Jaczewskiego 8, PL-20950 Lublin, Poland; [Majsiak, Emilia] Med Univ Lublin, Fac Hlth Sci, Dept Hlth Promot, Stasz 4-6, PL-20081 Lublin, Poland; [Bierla, Joanna B.; Agnieszka, Sowinska; Cukrowska, Bozena] Childrens Mem Hlth Inst, Dept Pathomorphol, Aleja Dzieci Polskich 20, PL-04730 Warsaw, Poland",Medical University of Lublin; Medical University of Lublin; Children's Memorial Health Institute,"Cukrowska, B (corresponding author), Childrens Mem Hlth Inst, Dept Pathomorphol, Aleja Dzieci Polskich 20, PL-04730 Warsaw, Poland.",barbara.radomanska@gmail.com; prozorow1@wp.pl; anettakm@op.pl; lach.halina@wp.pl; katarzynalaskowska@go2.pl; emiliamajsiak@umlub.pl; j.bierla@ipczd.pl; a.sowinska@ipczd.pl; b.cukrowska@ipczd.pl,"Bierła, Joanna Beata/U-3173-2018; Majsiak, Emilia/GXG-5149-2022","Majsiak, Emilia/0000-0003-3638-9292","Nordic Biotic Sp z o.o., Poland [CT/NB/120/2020/PR-SS]","Nordic Biotic Sp z o.o., Poland","This research was financed by Nordic Biotic Sp z o.o., Poland (grant number CT/NB/120/2020/PR-SS).",,29,2,2,6,7,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2077-0383,,J CLIN MED,J. Clin. Med.,JUL,2023,12,14,,,,,,,4838,10.3390/jcm12144838,http://dx.doi.org/10.3390/jcm12144838,,,19,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,N3IL9,37510953,"Green Published, gold",,,2024-06-04,WOS:001035989700001,View Full Record in Web of Science
J,"Cosier, DJ; Lambert, K; Neale, EP; Probst, Y; Charlton, K",,,,"Cosier, Denelle J.; Lambert, Kelly; Neale, Elizabeth P.; Probst, Yasmine; Charlton, Karen",,,The effect of oral synbiotics on the gut microbiota and inflammatory biomarkers in healthy adults: a systematic review and meta-analysis,NUTRITION REVIEWS,,,English,Review; Early Access,,,,,,gut microbiome; gut microbiota; healthy adult; inflammation; prebiotic; probiotic; symbiotic,RANDOMIZED DOUBLE-BLIND; INTERNATIONAL SCIENTIFIC ASSOCIATION; LACTOBACILLUS-ACIDOPHILUS NCFM; IRRITABLE-BOWEL-SYNDROME; FUNCTIONAL CONSTIPATION; FECAL BIFIDOBACTERIA; CONSENSUS STATEMENT; CLINICAL-TRIAL; PROBIOTICS; CONSUMPTION,"Context: Prior research has explored the effect of synbiotics, the combination of probiotics and prebiotics, on the gut microbiota in clinical populations. However, evidence related to the effect of synbiotics on the gut microbiota in healthy adults has not been reviewed to date. Objective: A systematic review and meta-analysis was conducted to comprehensively investigate the effect of synbiotics on the gut microbiota and inflammatory markers in populations of healthy adults. Data sources: Scopus, PubMed, Web of Science, ScienceDirect, MEDLINE, CINAHL, and The Cochrane Library were systematically searched to retrieve randomized controlled trials examining the primary outcome of gut microbiota or intestinal permeability changes after synbiotic consumption in healthy adults. Secondary outcomes of interest were short-chain fatty acids, inflammatory biomarkers, and gut microbiota diversity. Data extraction: Weighted (WMD) or standardized mean difference (SMD) outcome data were pooled in restricted maximum likelihood models using random effects. Twenty-seven articles reporting on 26 studies met the eligibility criteria (n = 1319). Data analysis: Meta-analyses of 16 studies showed synbiotics resulted in a significant increase in Lactobacillus cell count (SMD, 0.74; 95% confidence interval [CI], 0.15, 1.33; P = 0.01) and propionate concentration (SMD, 0.22; 95% CI, 0.02, 0.43; P = 0.03) compared with controls. A trend for an increase in Bifidobacterium relative abundance (WMD, 0.97; 95% CI, 0.42, 2.52; P = 0.10) and cell count (SMD, 0.82; 95% CI, 0.13, 1.88; P = 0.06) was seen. No significant differences in alpha-diversity, acetate, butyrate, zonulin, IL-6, CRP, or endotoxins were observed. Conclusion: This review demonstrates that synbiotics modulate the gut microbiota by increasing Lactobacillus and propionate across various healthy adult populations, and may result in increased Bifidobacterium. Significant variations in synbiotic type, dose, and duration should be considered as limitations when applying findings to clinical practice.","[Cosier, Denelle J.; Lambert, Kelly; Neale, Elizabeth P.; Probst, Yasmine; Charlton, Karen] Univ Wollongong, Sch Med Indigenous & Hlth Sci, Bldg 41,Northfields Ave, Wollongong, NSW 2522, Australia",University of Wollongong,"Cosier, DJ (corresponding author), Univ Wollongong, Sch Med Indigenous & Hlth Sci, Bldg 41,Northfields Ave, Wollongong, NSW 2522, Australia.",djb983@uowmail.edu.au,"Probst, Yasmine/A-1342-2008; Charlton, Karen/G-5906-2012; Lambert, Kelly/A-3940-2015","Probst, Yasmine/0000-0002-1971-173X; Cosier, Denelle/0000-0002-3469-8123; Charlton, Karen/0000-0002-8044-444X; Lambert, Kelly/0000-0001-5935-7328",Australian Government Research Training Program scholarship,"Australian Government Research Training Program scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)",D.J.C. is supported by an Australian Government Research Training Program scholarship. All other authors have no relevant interests to declare.,,93,0,0,8,8,OXFORD UNIV PRESS INC,CARY,"JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA",0029-6643,1753-4887,,NUTR REV,Nutr. Rev.,2024 FEB 11,2024,,,,,,,,,,10.1093/nutrit/nuae002,http://dx.doi.org/10.1093/nutrit/nuae002,,FEB 2024,21,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,HW7F9,38341803,hybrid,,,2024-06-04,WOS:001162604100001,View Full Record in Web of Science
J,"Wang, J; Ke, H; Liu, KX; Qu, JM",,,,"Wang, Jie; Ke, Hui; Liu, Kai-Xiong; Qu, Jie-Ming",,,Effects of exogenous probiotics on the gut microbiota and clinical outcomes in critically ill patients: a randomized controlled trial,ANNALS OF PALLIATIVE MEDICINE,,,English,Article,,,,,,Gut microbiota; probiotics; Clostridium butyricum; critically ill patients,VENTILATOR-ASSOCIATED PNEUMONIA; EARLY ENTERAL NUTRITION; DOUBLE-BLIND; BACTERIAL OVERGROWTH; SYNBIOTIC THERAPY; INFECTION; COMPLICATIONS; INFLAMMATION; PREBIOTICS; DISEASE,"Background: Gut microbiota play an important role in the inflammation. This study aimed to investigate whether exogenous probiotics could improve the intestinal barrier function effect via attenuating inflammation and immunomodulation to improve the clinical outcomes in critically ill patients. Methods: A single-blind, randomized controlled trial was performed in a respiratory intensive care unit (RICUs). Patients assigned to the intervention group received probiotics Clostridium butyricum until death or discharge. Stool and blood samples were collected on the 1st day and 15th day of administration. Primary clinical outcomes and clinical manifestations were recorded during the follow-up period. Results: There were 61 patients in this study, with 28 patients receiving probiotics. There were no differences in the mortality and hospital stay between intervention group and control group. In addition, the duration of fever (% of hospital stays) was significantly shorter in the intervention group as compared to control group (4.85% vs. 12.94%, P=0.00). The incidence of constipation significantly reduced in the intervention group (17.86% vs. 42.42%, P=0.04). The overall ratio of gastrointestinal adverse effects was comparable between them. Bactericides significantly decreased after probiotic intervention (Delta m=-0.69, P=0.048), while Escherichia coli and Enterococcus tended to decrease in the intervention group (Delta m=-0.65, P=0.08; Delta m=-0.52, P=0.22) on the day 15. No fluctuation was observed in the Bifidobacterium and Lactobacillus after probiotic intervention. Conclusions: Our study fails to show the beneficial effects of probiotics on the primary clinical outcomes in critically ill patients. The intestinal barrier is damaged, and probiotics may reduce the burden of Gm-bacteria from the gut.","[Wang, Jie] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Nephrol Med, Hangzhou, Peoples R China; [Ke, Hui] Tongji Univ, Shanghai Pulm Hosp, Clin & Res Ctr TB, Shanghai Key Lab TB,Sch Med, Shanghai, Peoples R China; [Liu, Kai-Xiong; Qu, Jie-Ming] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Pulm Med, Shanghai 200025, Peoples R China",Zhejiang University; Tongji University; Shanghai Jiao Tong University,"Qu, JM (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Pulm Med, Shanghai 200025, Peoples R China.",jmqu0906@163.com,,,National Basic Research Program (973 Program) in China [2013CB531402],National Basic Research Program (973 Program) in China(National Basic Research Program of China),This work was supported by the National Basic Research Program (973 Program) in China (2013CB531402).,,36,10,10,1,5,AME PUBLISHING COMPANY,SHATIN,"FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG 00000, PEOPLES R CHINA",2224-5820,2224-5839,,ANN PALLIAT MED,Ann. Pallliat. Med.,FEB,2021,10,2,,,,,1180,1190,,10.21037/apm-20-202,http://dx.doi.org/10.21037/apm-20-202,,,11,Health Care Sciences & Services,Science Citation Index Expanded (SCI-EXPANDED),Health Care Sciences & Services,QQ5FV,33040557,gold,,,2024-06-04,WOS:000624549600021,View Full Record in Web of Science
J,"Chen, K; Xin, J; Zhang, G; Xie, H; Luo, L; Yuan, S; Bu, Y; Yang, X; Ge, Y; Liu, C",,,,"Chen, K.; Xin, J.; Zhang, G.; Xie, H.; Luo, L.; Yuan, S.; Bu, Y.; Yang, X.; Ge, Y.; Liu, C.",,,"A combination of three probiotic strains for treatment of acute diarrhoea in hospitalised children: an open label, randomised controlled trial",BENEFICIAL MICROBES,,,English,Article,,,,,,probiotics; diarrhoea; children,LACTOBACILLUS-RHAMNOSUS HN001; SACCHAROMYCES-CEREVISIAE FUNGEMIA; ACUTE GASTROENTERITIS; CLINICAL-TRIAL; PREVENTION; MANAGEMENT; BOULARDII; GUIDELINES; PREBIOTICS; ADHESION,"Acute diarrhoea continues to be a leading cause of morbidity, hospitalisation, and mortality worldwide, and probiotics have been proposed as a complementary therapy in the treatment of acute diarrhoea. The goal of this study is to assess the efficacy and safety of three combined probiotic strains, Bifidobacterium lactis Bi-07, Lactobacillus rhamnosus HN001, and Lactobacillus acidophilus NCFM, as an adjunct to rehydration therapy in treatment of acute watery diarrhoea in hospitalised children. Eligible diarrheal children were randomised into intervention group (IG, n=96, conventional treatment for diarrhoea in combination with probiotics) and control group (CG, n=98, conventional treatment for diarrhoea without probiotics). The primary assessments of this study were duration of diarrhoea and hospital stay and improvement in diarrhoea symptoms. Significantly more children in the IG showed improvements in diarrhoea (defined as a decrease of stool frequency to no more than four times per day and an improved stool consistency within 24-48 h after the treatment) than those in the CG (96.9 vs 79.6%, P<0.05). Children supplemented with the mixed strains had a 22.5 h shorter (121.4 +/- 13.7 h vs 143.9 +/- 19.8 h) mean duration of diarrhoea and 1.2 d shorter hospital stays (5.1 +/- 1.2 d vs 6.3 +/- 1.4 d) than children only receiving the rehydration therapy (P<0.05). The prevalence of constipation of children in the IG (3.1%) was markedly lower (P<0.05) than that of children in the CG (13.3%) after treatment. In conclusion, the mixture of three probiotic strains given to children aged 1-3 years resulted in shorter durations of diarrhoea and hospitalisation and a higher percentage of improved children.","[Chen, K.; Yuan, S.] Univ Elect Sci & Technol China, Chengdu Womens & Childrens Cent Hosp, Sch Med, Dept Nutr, 1617 Riyue Ave, Chengdu 6100131, Sichuan, Peoples R China; [Xin, J.; Ge, Y.] Infinitus China Co Ltd, Hangzhou, Zhejiang, Peoples R China; [Zhang, G.] Univ Elect Sci & Technol China, Chengdu Womens & Childrens Hosp, Sch Med, Dept Pediat Intens Care Unit, Chengdu, Sichuan, Peoples R China; [Xie, H.; Luo, L.; Bu, Y.; Yang, X.] Dayi Maternal & Child Hlth Care Hosp, Dept Pediat, Chengdu, Sichuan, Peoples R China; [Liu, C.] San Diego State Univ, Sch Exercise & Nutr Sci, 5500 Campanile Dr, San Diego, CA 92182 USA",University of Electronic Science & Technology of China; University of Electronic Science & Technology of China; California State University System; San Diego State University,"Chen, K (corresponding author), Univ Elect Sci & Technol China, Chengdu Womens & Childrens Cent Hosp, Sch Med, Dept Nutr, 1617 Riyue Ave, Chengdu 6100131, Sichuan, Peoples R China.",263662086@qq.com,"Chen, Ke/HNP-4600-2023; Liu, Changqi/K-6862-2014","Chen, Ke/0000-0001-7455-0900; Liu, Changqi/0000-0001-6526-5024; Mosaddek, Abu/0000-0002-7682-9187",,,,,35,12,13,1,24,WAGENINGEN ACADEMIC PUBLISHERS,WAGENINGEN,"PO BOX 220, WAGENINGEN, 6700 AE, NETHERLANDS",1876-2883,1876-2891,,BENEF MICROBES,Benef. Mirbobes,,2020,11,4,,,,,339,346,,10.3920/BM2020.0046,http://dx.doi.org/10.3920/BM2020.0046,,,8,Microbiology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Microbiology; Nutrition & Dietetics,ND7LS,32720832,,,,2024-06-04,WOS:000562085000004,View Full Record in Web of Science
J,"Fijan, S; Frauwallner, A; Varga, L; Langerholc, T; Rogelj, I; Lorber, M; Lewis, P; Brzan, PP",,,,"Fijan, Sabina; Frauwallner, Anita; Varga, Laszlo; Langerholc, Tomaz; Rogelj, Irena; Lorber, Mateja; Lewis, Peter; Brzan, Petra Povalej",,,Health Professionals' Knowledge of Probiotics: An International Survey,INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH,,,English,Article,,,,,,probiotics; knowledge; health professionals,SCIENTIFIC ASSOCIATION; CONSENSUS STATEMENT; CARE PROFESSIONALS; PREBIOTICS; PERCEPTIONS; PREVENTION; PRODUCTS; EFFICACY; DIARRHEA; BELIEFS,"The objective of this study was to survey health professionals to investigate their knowledge of probiotics. An online survey was conducted to gather data on the knowledge of health professionals. The online survey was distributed via email and social media platforms using snowball sampling. A total of 1066 health professionals (859; 80.6% female) from 30 countries responded to the survey. Most of the respondents evaluated their knowledge of probiotics as medium (36.4%) or good (36.2%). Only 8.9% of the respondents rated it as excellent. No statistical difference in knowledge was found between male and female health professionals. Over 80% of pharmacists, allied health professionals, medical doctors and dentists, and other health professionals knew the correct definition of probiotics as live microorganisms that, when administered in adequate amounts, confer a health benefit on the host, whereas three quarters of registered nurses and midwives and less than two thirds of psychologists identified the correct definition. Statistically, more female than male health professionals knew the correct definition of probiotics. The most frequently recognized species of bacteria containing probiotic strains were Lactobacillus acidophilus (92%), Bifidobacterium bifidum (82%), and Lactobacillus rhamnosus (62%). The opinions on when it is best to take probiotics were different (chi(2) = 28.375; p < 0.001), with 90.2% of respondents identifying that probiotics have beneficial effects if taken during antibiotic therapy, 83.5% for diarrhea, 70.6% for constipation, 63.3% before traveling abroad, and 60.4% for treating allergies. Almost 79% of health professionals involved in this study have advised their patients to use probiotics and 57.5% of the respondents wanted to learn more about probiotics. All things considered, health professionals have a medium level of knowledge of probiotics, which could be improved by the implementation of targeted learning programs. As probiotics have many beneficial effects in a wide range of health areas, health professionals need to adopt the use of probiotics in clinical practice.","[Fijan, Sabina; Lorber, Mateja] Univ Maribor, Fac Hlth Sci, Zitna Ulica 15, SLO-2000 Maribor, Slovenia; [Frauwallner, Anita] Inst Allergosan Pharmazeut Prod Forsch & Vertrieb, Gmeinstr 13, A-8055 Graz, Austria; [Varga, Laszlo] Szechenyi Istvan Univ, Fac Agr & Food Sci, Dept Food Sci, Lucsony U 15-17, H-9200 Mosonmagyarovar, Hungary; [Langerholc, Tomaz] Univ Maribor, Fac Agr & Life Sci, Dept Microbiol Biochem Mol Biol & Biotechnol, Pivola 10, Hoce 2311, Slovenia; [Rogelj, Irena] Univ Ljubljana, Biotech Fac, Jamnikarjeva 101, Ljubljana 1000, Slovenia; [Lewis, Peter] Univ Western Sydney, Sch Nursing & Midwifery, Locked Bag 1797, Penrith, NSW 2751, Australia; [Brzan, Petra Povalej] Univ Maribor, Fac Med, Taborska Ulica 8, Maribor 2000, Slovenia; [Brzan, Petra Povalej] Univ Maribor, Fac Elect Engn & Comp Sci, Koroska Cesta 46, SLO-2000 Maribor, Slovenia",University of Maribor; University of Maribor; University of Ljubljana; Western Sydney University; University of Maribor; University of Maribor,"Fijan, S (corresponding author), Univ Maribor, Fac Hlth Sci, Zitna Ulica 15, SLO-2000 Maribor, Slovenia.",sabina.fijan@um.si,"Varga, Laszlo/E-4380-2016; Lorber, Mateja/AAJ-7293-2020; Fijan, Sabina/B-9186-2019; Povalej, Petra/R-2277-2017","Varga, Laszlo/0000-0001-7431-852X; Fijan, Sabina/0000-0003-4380-1310; Povalej, Petra/0000-0001-7872-586X; Lorber, Mateja/0000-0001-7200-5204","project Mobility of Higher Education Professors at the University of Maribor (UM); Faculty of Health Sciences, University of Maribor; Government of Hungary; European Union; European Social Fund [EFOP-3.6.1-16-2016-00017]","project Mobility of Higher Education Professors at the University of Maribor (UM); Faculty of Health Sciences, University of Maribor; Government of Hungary; European Union(European Union (EU)); European Social Fund(European Social Fund (ESF))","S.F. and P.P.B. gratefully acknowledge funding support from the project Mobility of Higher Education Professors at the University of Maribor (UM) 2017-2018 implemented within the Framework of the Operational Program for the Implementation of the Cohesion Policy for the period 2014-2020. S.F. also acknowledges funding support from the Faculty of Health Sciences, University of Maribor within the framework of the internal project entitled Methods for Studying Probiotics. L.V. gratefully acknowledges research funding support from the Government of Hungary, the European Union, and the European Social Fund (grant number: EFOP-3.6.1-16-2016-00017).",,63,35,37,0,14,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,1660-4601,,INT J ENV RES PUB HE,Int. J. Environ. Res. Public Health,SEP 1,2019,16,17,,,,,,,3128,10.3390/ijerph16173128,http://dx.doi.org/10.3390/ijerph16173128,,,16,"Environmental Sciences; Public, Environmental & Occupational Health",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),"Environmental Sciences & Ecology; Public, Environmental & Occupational Health",IZ4EQ,31466273,"Green Published, Green Submitted, gold",,,2024-06-04,WOS:000487037500123,View Full Record in Web of Science
B,"Khan, ST; Malik, A",,"Malik, A; Erginkaya, Z; Erten, H",,"Khan, Shams Tabrez; Malik, Abdul",,,Next-Generation Probiotics Their Molecular Taxonomy and Health Benefits,HEALTH AND SAFETY ASPECTS OF FOOD PROCESSING TECHNOLOGIES,,,English,Article; Book Chapter,,,,,,Probiotics; Health benefits; Molecular taxonomy; Microorganisms,LACTIC-ACID BACTERIA; BILE-SALT HYDROLASE; GUT MICROBIOTA; INTESTINAL MICROBIOTA; POPULATION-STRUCTURE; INSULIN-RESISTANCE; IMMUNE-RESPONSES; IN-VITRO; SAFETY; PREBIOTICS,"The concept of probiotics although perceived as new is more than a century old. Since the early studies of the Elie Metchnikoff in 1903, a number of commercial products containing probiotics are in the market. The recent success of converting probiotic products into commercial reality was achieved by the scientists like Minoru Shirota and Kellog. Minoru Shirota is a Japanese scientist who successfully demonstrated the health benefits of probiotics and commercialized the globally known probiotic drink Yakult. This renewed interest in probiotics is spurred by the recent advances made in understanding the human microbiome and its role in human health. The link between the gut microbiome and human health is becoming increasingly clear and is well described. Nevertheless, the gut microbiome is continuously influenced by a number of factors like diet, lifestyle and consumption of antibiotics. A healthy gut microbiome can be retained and maintained by using various probiotics. Moreover, the probiotic microorganisms are no more limited to a few conventionally used bacteria and are being currently represented by more phylogenetically diverse microorganisms than previously thought. These probiotic microorganisms include conventionally used Lactic acid bacteria, like Lactobacillus and recently identified probiotic bacteria like Akkermansia muciniphila, Bifidobacterium infantis, Bacteroides fragilis, Clostridium butyricum, Faecalibacterium prausnitzii and Streptococcus thermophiles etc. Many of these probiotic strains have a shared mechanism of action, while strain specific, species-specific or genus-specific probiotic effects have also been documented. Probiotics are administered as live cultures or as spores, directly or through fermented dairy products, food, and drinks. Probiotics based therapies like fecal microbiota transplant are also being used successfully for treating medical conditions and diseases like diarrhea, constipation, vaginitis, necrotizing enterocolitis, inflammatory bowel disease, Clostridium difficile infection, and others. Reports showing a clear role of probiotics in immunomodulation, prevention of cardiovascular diseases and even cancer are also emerging. Yet, a number of microorganisms in the gut remain uncultured and many candidate probiotic microorganisms remain poorly identified, requiring correct identification and a rigorous evaluation as probiotics. Probiotics may be a century old but require fresh attention keeping in view the recent advances made in understanding the gut microbiome and the role of these microorganisms in human health.","[Khan, Shams Tabrez; Malik, Abdul] Aligarh Muslim Univ, Fac Agr Sci, Dept Agr Microbiol, Aligarh, Uttar Pradesh, India",Aligarh Muslim University,"Khan, ST (corresponding author), Aligarh Muslim Univ, Fac Agr Sci, Dept Agr Microbiol, Aligarh, Uttar Pradesh, India.",,"Khan, Shams/AAM-3333-2020","Khan, Shams/0000-0003-4963-4998",,,,,133,2,2,0,18,SPRINGER INTERNATIONAL PUBLISHING AG,CHAM,"GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND",,,978-3-030-24903-8; 978-3-030-24902-1,,,,2019,,,,,,,471,500,,10.1007/978-3-030-24903-8_16,http://dx.doi.org/10.1007/978-3-030-24903-8_16,10.1007/978-3-030-24903-8,,30,"Food Science & Technology; Public, Environmental & Occupational Health",Book Citation Index – Science (BKCI-S),"Food Science & Technology; Public, Environmental & Occupational Health",BP8SD,,,,,2024-06-04,WOS:000566845200017,View Full Record in Web of Science
J,"Pilipenko, VI; Perova, IB; Kochetkova, AA; Isakov, VA",,,,"Pilipenko, Vladimir I.; Perova, Irina B.; Kochetkova, Alla A.; Isakov, Vasily A.",,,Prospects of dietary fibers food fortification for the treatment and prevention ofgastrointestinal diseases: A review,TERAPEVTICHESKII ARKHIV,,,English,Review,,,,,,dietary fiber; healthy diet; the effectiveness of dietary fiber; enriched food,WEIGHT-LOSS; SUPPLEMENTATION; CONSTIPATION; RISK; PREBIOTICS; BENEFITS; QUALITY,"Epidemiological studies have proven the connection between high consumption of dietary fiber and a reduction in the risk of many diseases. In clinical trials, the possibility of functional regulation of the intestine and intestinal microbiome by dietary fibers has been revealed, which may be significant in certain diseases of the digestive system. This review provides information on the relationship between the physico-chemical properties and functional characteristics of dietary fibers, discusses evidence of the effectiveness of their use in the treatment of diseases of the digestive system, discusses the need to enrich food with dietary fibers.","[Pilipenko, Vladimir I.; Perova, Irina B.; Kochetkova, Alla A.; Isakov, Vasily A.] Fed Res Ctr Nutr Biotechnol & Food Safety, Moscow, Russia","Federal Research Center of Nutrition, Biotechnology & Food Safety","Isakov, VA (corresponding author), Fed Res Ctr Nutr Biotechnol & Food Safety, Moscow, Russia.",vasily.isakov@gmail.com,"Isakov, Vasily/A-4876-2011; Kochetkova, Alla/I-3900-2017","Isakov, Vasily/0000-0002-4417-8076; Pilipenko, Vladimir/0000-0001-5632-1880; Kochetkova, Alla/0000-0001-9821-192X",Russian Science Foundation [19-76-30014-P],Russian Science Foundation(Russian Science Foundation (RSF)),Funding source. Grant of the Russian Science Foundation No ;19-76-30014-P.,,52,0,0,18,21,CJSC CONSILIUM MEDICUM,MOSCOW,"NOVIY ZIKOVSKIY PROEZD, D 3, 40, MOSCOW, 125167, RUSSIA",0040-3660,2309-5342,,TERAPEVT ARKH,Ter. Arkhiv,,2023,95,8,,,,,701,705,,10.26442/00403660.2023.08.202328,http://dx.doi.org/10.26442/00403660.2023.08.202328,,,5,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,U5NP1,38158909,gold,,,2024-06-04,WOS:001085272300009,View Full Record in Web of Science
C,"Kokke, FTM; Taminiau, JAJM; Benninga, MA",,"Hernell, O; Schmitz, J",,"Kokke, FTM; Taminiau, JAJM; Benninga, MA",,,The role of dietary fiber in childhood and its applications in pediatric gastroenterology,FEEDING DURING LATE INFANCY AND EARLY CHILDHOOD: IMPACT ON HEALTH,Nestle Nutrition Institute Workshop Series,,English,Proceedings Paper,56th Nestle Pediatric Nutrition Workshop,"NOV 14-18, 2004","Noordwijk, NETHERLANDS",,,,CHRONIC CONSTIPATION; TRANSIT-TIME; CHILDREN; GLUCOMANNAN; PREBIOTICS; FREQUENCY; BUTYRATE,,"Rijnstate Hosp, Dept Pediat, Arnhem, Netherlands",Rijnstate Hospital,"Rijnstate Hosp, Dept Pediat, Arnhem, Netherlands.",j.a.taminiau@amc.uva.nl; m.a.benninga@amc.uva.nl,,,,,,,40,0,0,0,0,KARGER,BASEL,"POSTFACH, CH-4009 BASEL, SWITZERLAND",1664-2147,1664-2155,3-8055-7906-3,NESTLE NUTR WORKS SE,,,2005,56,,,,,,111,126,,10.1159/000086279,http://dx.doi.org/10.1159/000086279,,,16,Nutrition & Dietetics; Pediatrics,Conference Proceedings Citation Index - Science (CPCI-S),Nutrition & Dietetics; Pediatrics,BDD04,16632948,,,,2024-06-04,WOS:000232792000009,View Full Record in Web of Science
J,"Dai, FJ; Chau, CF",,,,"Dai, Fan-Jhen; Chau, Chi-Fai",,,Classification and regulatory perspectives of dietary fiber,JOURNAL OF FOOD AND DRUG ANALYSIS,,,English,Review,,,,,,classification; definition; degree of polymerization; dietary fiber; oligosaccharide,RESISTANT STARCH; HEALTH-BENEFITS; CRUDE FIBER; DEFINITION; CONSTIPATION; MECHANISMS; PREBIOTICS; FOODS,"This review discusses the history and evolution of the state of dietary fiber (DF) with account of refinements in extraction methods and legal definitions subsequent to the launch of DF hypothesis. For a long time, defining and regulating DFs relied heavily on their chemical compositions and analytical methods. Although chemical compositions and analytical methods still play an important role in the definition of DF, physiological activity has also been taken into consideration. The precise definition of DF is still evolving, particularly whether oligosaccharides degrees of polymerization (DP) 3-9 should be considered as DF or not. Decades of scientific research have initiated the expansion of the term DF to include indigestible oligosaccharides with their DP between 3 and 9; hence responding to the positive health benefits of DF as well as fulfilling the needs in food labeling regulations. Copyright (C) 2016, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan LLC.","[Dai, Fan-Jhen; Chau, Chi-Fai] Natl Chung Hsing Univ, Dept Food Sci & Biotechnol, 250 Kuokuang Rd, Taichung 40227, Taiwan; [Chau, Chi-Fai] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung, Taiwan",National Chung Hsing University; National Chung Hsing University,"Chau, CF (corresponding author), Natl Chung Hsing Univ, Dept Food Sci & Biotechnol, 250 Kuokuang Rd, Taichung 40227, Taiwan.",chaucf@nchu.edu.tw,,"CHAU, Chi-Fai/0000-0002-6761-7932","Ministry of Science and Technology of the Republic of China [MOST 103-2313-B-005-033-MY3]; Ministry of Education, Taiwan, ROC, under the ATU plan","Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, ROC, under the ATU plan(Ministry of Education, Taiwan)","This work was supported by the Ministry of Science and Technology of the Republic of China (MOST 103-2313-B-005-033-MY3) and in part by the Ministry of Education, Taiwan, ROC, under the ATU plan.",,52,114,125,8,95,DIGITAL COMMONS BEPRESS,BERKELEY,"2100 MILVIA ST, STE 300, BERKELEY, CA 94704 USA",1021-9498,,,J FOOD DRUG ANAL,J. Food Drug Anal.,JAN,2017,25,1,,,,,37,42,,10.1016/j.jfda.2016.09.006,http://dx.doi.org/10.1016/j.jfda.2016.09.006,,,6,Food Science & Technology; Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Pharmacology & Pharmacy,EJ4IM,28911542,"hybrid, Green Published",,,2024-06-04,WOS:000393180200005,View Full Record in Web of Science
J,"Moreira-Rosario, A; Marques, C; Pinheiro, H; Norberto, S; Sintra, D; Teixeira, JA; Calhau, C; Azevedo, LF",,,,"Moreira-Rosario, Andre; Marques, Claudia; Pinheiro, Helder; Norberto, Sonia; Sintra, Diana; Teixeira, Jose Antonio; Calhau, Conceicao; Azevedo, Luis Filipe",,,Daily intake of wheat germ-enriched bread may promote a healthy gut bacterial microbiota: a randomised controlled trial,EUROPEAN JOURNAL OF NUTRITION,,,English,Article,,,,,,Gastrointestinal discomfort; Gut microbiota; Bread; Wheat germ; Randomised controlled trial,QUALITY-OF-LIFE; DIETARY FIBER; CONSTIPATION; ASSOCIATION; PREBIOTICS; SYMPTOMS; IMPACT; PRUCALOPRIDE; DIVERSITY; NUTRITION,"Purpose Wheat bran fibre has a beneficial effect on gastrointestinal function, but evidence for wheat germ is scarce. Accordingly, we evaluated the effects of daily intake of wheat germ on gastrointestinal discomfort and gut microbiota by adding wheat germ to refined (white) wheat bread, the most consumed bread type. We hypothesised that an improvement in the composition of refined bread could beneficially affect intestinal health without compromising consumers' acceptance. Methods Fifty-five healthy adults were recruited for a randomised, double-blind, crossover, controlled trial comprising two 4-week intervention periods separated by a 5-week washout stage. During the first 4-week period, one group consumed wheat bread enriched with 6 g of wheat germ and the control group consumed non-enriched wheat bread. Results Wheat germ-enriched bread was well-appreciated and the number of participants that demonstrated minimal gastrointestinal improvements after wheat-germ intake was higher than in the control arm. Importantly, intake of wheat germ-enriched bread decreased the perceived gastrointestinal discomfort-related quality of life (subscale worries and concerns) over refined white bread. The improvements in the gastrointestinal function were accompanied by favourable changes in gut microbiota, increasing the number ofBacteroidesspp. andBifidobacteriumspp. Conclusions Adding wheat germ to industrially made white bread without altering sensory properties may promote a healthy gut bacterial microbiota and the gastrointestinal health.","[Moreira-Rosario, Andre; Marques, Claudia; Norberto, Sonia; Sintra, Diana; Calhau, Conceicao; Azevedo, Luis Filipe] Ctr Hlth Technol & Serv Res CINTESIS, Porto, Portugal; [Moreira-Rosario, Andre; Azevedo, Luis Filipe] Univ Porto, Fac Med, Dept Community Med Informat & Hlth Decis Sci MEDC, Porto, Portugal; [Marques, Claudia; Pinheiro, Helder; Calhau, Conceicao] NOVA Univ Lisbon, NOVA Med Sch, Nutr & Metab, Lisbon, Portugal; [Pinheiro, Helder] Hosp Curry Cabral, Infect Dis Serv, Lisbon, Portugal; [Teixeira, Jose Antonio] Univ Minho, Ctr Biol Engn, Campus Gualtar, Braga, Portugal; [Calhau, Conceicao] Univ Unit Lifestyle Med, Jose de Mello Saude NOVA Med Sch, Lisbon, Portugal",Universidade do Porto; Universidade Nova de Lisboa; Universidade do Minho,"Moreira-Rosario, A (corresponding author), Ctr Hlth Technol & Serv Res CINTESIS, Porto, Portugal.;Moreira-Rosario, A (corresponding author), Univ Porto, Fac Med, Dept Community Med Informat & Hlth Decis Sci MEDC, Porto, Portugal.",andrerosario@med.up.pt,"Azevedo, Luís/J-7819-2012; Teixeira, Diana Marina Silva/GNM-9140-2022; Teixeira, Jose/A-6268-2012; Moreira-Rosario, Andre/L-9893-2014","Azevedo, Luís/0000-0002-8421-2937; Teixeira, Diana Marina Silva/0000-0002-2162-1450; Calhau, Conceicao/0000-0001-9567-3379; Teixeira, Jose/0000-0002-4918-3704; Norberto, Sonia/0000-0002-5388-3682; Marques, Claudia/0000-0002-8365-7934; Moreira-Rosario, Andre/0000-0003-0320-1839; Pinheiro, Helder/0000-0001-6076-2670",Fundação para a Ciência e a Tecnologia [POCI-01-0145-FEDER-007746] Funding Source: Medline,Fundação para a Ciência e a Tecnologia(Fundacao para a Ciencia e a Tecnologia (FCT)),,,49,6,6,3,37,SPRINGER HEIDELBERG,HEIDELBERG,"TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY",1436-6207,1436-6215,,EUR J NUTR,Eur. J. Nutr.,AUG,2020,59,5,,,,,1951,1961,,10.1007/s00394-019-02045-x,http://dx.doi.org/10.1007/s00394-019-02045-x,,,11,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,MH8HM,31325040,Green Published,,,2024-06-04,WOS:000546963100016,View Full Record in Web of Science
J,"MCCLUNG, HJ; BOYNE, L; HEITLINGER, L",,,,"MCCLUNG, HJ; BOYNE, L; HEITLINGER, L",,,CONSTIPATION AND DIETARY FIBER INTAKE IN CHILDREN,PEDIATRICS,,,English,Article; Proceedings Paper,Role of Dietary Fiber in Childhood Conference,"MAY 24, 1994","NEW YORK, NY","Amer Hlth Fdn,Kellogg Co",,DIETARY FIBER; CONSTIPATION; ENCOPRESIS; ENEMA; LAXATIVES,ENCOPRESIS; COLON; BRAN,"Objective. Severe constipation in children is associated with rectal overdistension and insensitivity. Treatment typically involves three phases: disimpaction (days to weeks), laxative use (months), and a high-fiber diet (lifelong). The purpose of this survey is a discussion of therapies that recognize the unique problems that children with severe constipation have. Methods. Four-day diet logs were obtained from children who had no history of chronic bowel disease. Their intake of dietary fiber was determined from the logs and was compared with the dietary fiber ingested by children who had chronic constipation. These data sets were compared in light of our current understanding of the need for dietary fiber. Results. Approximately half of the children from families who were health conscious enough to request dietary evaluation still fell below the age + 5 guidelines for grams of dietary fiber intake per day. The children referred to us with chronic constipation had all been instructed ''to eat a high-fiber diet.'' Those constipated patients were consuming less than one fourth of the recommended fiber intake. Conclusions. This survey underscored the difficulties in beginning and in maintaining high-fiber diets in children. When families receive advice to administer a high-fiber diet, they are unable to accomplish this unless they receive intensive and ongoing dietary counseling. Even among health-conscious families, only half of the children received the recommended amounts of dietary fiber. Further public education in this regard is warranted.",,,"MCCLUNG, HJ (corresponding author), OHIO STATE UNIV,COLUMBUS CHILDRENS HOSP,COLL MED,DEPT PEDIAT,COLUMBUS,OH 43210, USA.",,,,,,,,13,36,40,1,10,AMER ACAD PEDIATRICS,ELK GROVE VILLAGE,"141 NORTH-WEST POINT BLVD, ELK GROVE VILLAGE, IL 60007-1098",0031-4005,,,PEDIATRICS,Pediatrics,NOV,1995,96,5,,S,,,999,1001,,,,,,3,Pediatrics,Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,TE557,7494681,,,,2024-06-04,WOS:A1995TE55700005,View Full Record in Web of Science
J,"Niwa, T; Nakao, M; Hoshi, S; Yamada, K; Inagaki, K; Nishida, M; Nabeshima, T",,,,"Niwa, T; Nakao, M; Hoshi, S; Yamada, K; Inagaki, K; Nishida, M; Nabeshima, T",,,Effect of dietary fiber on morphine-induced constipation in rats,BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY,,,English,Article,,,,,,constipation; dietary fiber; morphine; SC-FAs,CHAIN FATTY-ACIDS; INTESTINAL PROPULSION; CANCER-PATIENTS; TRANSIT; OPIOIDS; INVITRO; ILEUM; TRACT; COLON,"Morphine is used to alleviate chronic cancer pain. However, constipation is a major adverse effect that often detracts from the patient's quality of life. In this study, we investigated the effectiveness of dietary fiber on morphine-induced constipation. Rats were fed on a normal diet or one containing either 10% or 20% apple fiber for two weeks before morphine was administered. In the control diet group, the fecal number and dry weight were decreased by treating with morphine in a dose-dependent manner. Moreover, the motility of the small and large intestines was reduced. The fecal number and weight were increased and the colon motility was promoted by dietary fiber, regardless of whether morphine was being administered. The dietary fiber increased the concentration of short-chain fatty acids (SC-FAs) in the cecum. These results suggest that dietary fiber has a preventative effect on morphine-induced constipation by increasing SCFAs in the cecum, and thereby promoting colon motility in rats.","Nagoya Univ, Grad Sch Med, Dept Neuropsychopharmacol & Hosp Pharm, Showa Ku, Nagoya, Aichi 4668560, Japan; Meiji Milk Prod Co Ltd, Dept Nutr Res, Nutr Sci Inst, Odawara 2500862, Japan; Meijo Univ, Fac Pharm, Dept Clin Pharm, Tempaku Ku, Nagoya, Aichi 4688503, Japan","Nagoya University; Meiji Holdings Co., Ltd.; Meijo University","Nagoya Univ, Grad Sch Med, Dept Neuropsychopharmacol & Hosp Pharm, Showa Ku, 65 Tsuruma Cho, Nagoya, Aichi 4668560, Japan.",tnabeshi@med.nagoya-u.ac.jp,"Sokabe, Masahiro/I-1565-2012; Yamada, Kiyofumi/I-7487-2014",,,,,,26,29,34,2,14,TAYLOR & FRANCIS LTD,ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND",0916-8451,1347-6947,,BIOSCI BIOTECH BIOCH,Biosci. Biotechnol. Biochem.,JUN,2002,66,6,,,,,1233,1240,,10.1271/bbb.66.1233,http://dx.doi.org/10.1271/bbb.66.1233,,,8,"Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology",Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology,569LL,12162543,Bronze,,,2024-06-04,WOS:000176603800007,View Full Record in Web of Science
J,"Ho, KS; Tan, CYM; Daud, MAM; Seow-Choen, F",,,,"Ho, Kok-Sun; Tan, Charmaine You Mei; Daud, Muhd Ashik Mohd; Seow-Choen, Francis",,,Stopping or reducing dietary fiber intake reduces constipation and its associated symptoms,WORLD JOURNAL OF GASTROENTEROLOGY,,,English,Article,,,,,,Dietary fiber; Constipation; Chronic idiopathic constipation; Abdominal bloating,TRANSIT,"AIM: To investigate the effect of reducing dietary fiber on patients with idiopathic constipation. METHODS: Sixty-three cases of idiopathic constipation presenting between May 2008 and May 2010 were enrolled into the study after colonoscopy excluded an organic cause of the constipation. Patients with previous colon surgery or a medical cause of their constipation were excluded. All patients were given an explanation on the role of fiber in the gastrointestinal tract. They were then asked to go on a no fiber diet for 2 wk. Thereafter, they were asked to reduce the amount of dietary fiber intake to a level that they found acceptable. Dietary fiber intake, symptoms of constipation, difficulty in evacuation of stools, anal bleeding, abdominal bloating or abdominal pain were recorded at 1 and 6 mo. RESULTS: The median age of the patients (16 male, 47 female) was 47 years (range, 20-80 years). At 6 mo, 41 patients remained on a no fiber diet, 16 on a reduced fiber diet, and 6 resumed their high fiber diet for religious or personal reasons. Patients who stopped or reduced dietary fiber had significant improvement in their symptoms while those who continued on a high fiber diet had no change. Of those who stopped fiber completely, the bowel frequency increased from one motion in 3.75 d (+/- 1.59 d) to one motion in 1.0 d (+/- 0.0 d) (P < 0.001); those with reduced fiber intake had increased bowel frequency from a mean of one motion per 4.19 d (+/- 2.09 d) to one motion per 1.9 d (+/- 1.21 d) on a reduced fiber diet (P < 0.001); those who remained on a high fiber diet continued to have a mean of one motion per 6.83 d (+/- 1.03 d) before and after consultation. For no fiber, reduced fiber and high fiber groups, respectively, symptoms of bloating were present in 0%, 31.3% and 100% (P < 0.001) and straining to pass stools occurred in 0%, 43.8% and 100% (P < 0.001). CONCLUSION: Idiopathic constipation and its associated symptoms can be effectively reduced by stopping or even lowering the intake of dietary fiber. (C) 2012 Baishideng. All rights reserved.","[Ho, Kok-Sun; Tan, Charmaine You Mei; Daud, Muhd Ashik Mohd; Seow-Choen, Francis] Seow Choen Colorectal Surg PLC, Singapore 238859, Singapore",,"Seow-Choen, F (corresponding author), Seow Choen Colorectal Surg PLC, 290 Orchard Rd,Paragon 06-06, Singapore 238859, Singapore.",seowchoen@colorectalcentre.com,,,,,,,23,36,38,4,33,BAISHIDENG PUBLISHING GROUP INC,PLEASANTON,"8226 REGENCY DR, PLEASANTON, CA 94588 USA",1007-9327,2219-2840,,WORLD J GASTROENTERO,World J. Gastroenterol.,SEP 7,2012,18,33,,,,,4593,4596,,10.3748/wjg.v18.i33.4593,http://dx.doi.org/10.3748/wjg.v18.i33.4593,,,4,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,005WA,22969234,"Green Published, hybrid",,,2024-06-04,WOS:000308779600020,View Full Record in Web of Science
J,"Yang, J; Wang, HP; Zhou, L; Xu, CF",,,,"Yang, Jing; Wang, Hai-Peng; Zhou, Li; Xu, Chun-Fang",,,Effect of dietary fiber on constipation: A meta analysis,WORLD JOURNAL OF GASTROENTEROLOGY,,,English,Article,,,,,,Dietary fiber; Constipation; Meta-analysis; Stool frequency; Stool consistency,CHRONIC IDIOPATHIC CONSTIPATION; DOUBLE-BLIND TRIAL; CHILDHOOD CONSTIPATION; LAXATIVES; CHILDREN; GLUCOMANNAN; LACTULOSE; EFFICACY; TRANSIT; COLON,"AIM: To investigate the effect of dietary fiber intake on constipation by a meta-analysis of randomized controlled trials (RCTs). METHODS: We searched Ovid MEDLINE (from 1946 to October 2011), Cochrane Library (2011), PubMed for articles on dietary fiber intake and constipation using the terms: constipation, fiber, cellulose, plant extracts, cereals, bran, psyllium, or plantago. References of important articles were searched manually for relevant studies. Articles were eligible for the meta-analysis if they were high-quality RCTs and reported data on stool frequency, stool consistency, treatment success, laxative use and gastrointestinal symptoms. The data were extracted independently by two researchers (Yang 3 and Wang HP) according to the described selection criteria. Review manager version 5 software was used for analysis and test. Weighted mean difference with 95%CI was used for quantitative data, odds ratio (OR) with 95%CI was used for dichotomous data. Both I-2 statistic with a cut-off of >= 50% and the chi(2) test with a P value < 0.10 were used to define a significant degree of heterogeneity. RESULTS: We searched 1322 potential relevant articles, 19 of which were retrieved for further assessment, 14 studies were excluded for various reasons, five studies were included in the analysis. Dietary fiber showed significant advantage over placebo in stool frequency (OR = 1.19; 95%CI: 0.58-1.80, P < 0.05). There was no significant difference in stool consistency, treatment success, laxative use and painful defecation between the two groups. Stool frequency were reported by five RCTs, all results showed either a trend or a significant difference in favor of the treatment group, number of stools per week increased in treatment group than in placebo group (OR = 1.19; 95%CI: 0.58-1.80, P < 0.05), with no significant heterogeneity among studies (I-2 = 0, P = 0.77). Four studies evaluated stool consistency, one of them presented outcome in terms of percentage of hard stool, which was different from others, so we included the other three studies for analysis. Two studies reported treatment success. There was significant heterogeneity between the studies (P < 0.1, I-2 > 50%). Three studies reported laxative use, quantitative data was shown in one study, and the pooled analysis of the other two studies showed no significant difference between treatment and placebo groups in laxative use (OR = 1.07; 95%CI 0.51-2.25), and no heterogeneity was found (P = 0.84, I-2 = 0). Three studies evaluated painful defecation: one study presented both quantitative and dichotomous data, the other two studies reported quantitative and dichotomous data separately. We used dichotomous data for analysis. CONCLUSION: Dietary fiber intake can obviously increase stool frequency in patients with constipation. It does not obviously improve stool consistency, treatment success, laxative use and painful defecation. (C) 2012 Baishideng. All rights reserved.","[Yang, Jing; Zhou, Li] Soochow Univ, Dept Clin Nutr, Affiliated Hosp 1, Suzhou 215006, Jiangsu, Peoples R China; [Wang, Hai-Peng] Soochow Univ, Dept Cardiovasc, Affiliated Hosp 1, Suzhou 215006, Jiangsu, Peoples R China; [Xu, Chun-Fang] Soochow Univ, Dept Gastroenterol, Affiliated Hosp 1, Suzhou 215006, Jiangsu, Peoples R China",Soochow University - China; Soochow University - China; Soochow University - China,"Xu, CF (corresponding author), Soochow Univ, Dept Gastroenterol, Affiliated Hosp 1, 188 Shizi Rd, Suzhou 215006, Jiangsu, Peoples R China.",nutritionscience@163.com,"li, zhou/AGZ-7953-2022",,,,,,28,165,186,2,76,BAISHIDENG PUBL GRP CO LTD,WANCHAI,"ROOM 1701, 17-F, HENAN BUILDING, NO. 90, JAFFE RD, WANCHAI, HONG KONG 100025, PEOPLES R CHINA",1007-9327,,,WORLD J GASTROENTERO,World J. Gastroenterol.,DEC 28,2012,18,48,,,,,7378,7383,,10.3748/wjg.v18.i48.7378,http://dx.doi.org/10.3748/wjg.v18.i48.7378,,,6,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,075BH,23326148,"hybrid, Green Submitted, Green Published",,,2024-06-04,WOS:000313858300033,View Full Record in Web of Science
J,"Stewart, ML; Schroeder, NM",,,,"Stewart, Maria L.; Schroeder, Natalia M.",,,Dietary treatments for childhood constipation: efficacy of dietary fiber and whole grains,NUTRITION REVIEWS,,,English,Review,,,,,,children; constipation; fiber; whole grains,FUNCTIONAL GASTROINTESTINAL DISORDERS; PHYSICAL-ACTIVITY; BOWEL HABIT; US CHILDREN; WHEAT BRAN; ADOLESCENTS; NUTRIENT; INFANTS; QUALITY; FOOD,"Constipation in children is defined on the basis of several clusters of symptoms, and these symptoms are likely to persist into adulthood. The aim of this review article is to summarize the current literature on the use of dietary fiber and whole grains as treatments for childhood constipation. Current recommendations for fiber intake in children vary substantially among organizations, suggesting that the function of fiber in children is not fully understood. Additionally, no formal definition of whole grain exists, which further complicates the interpretation of the literature. Few randomized controlled trials have examined the effect of dietary fiber supplementation in children with constipation. Currently, no randomized controlled trials have investigated the efficacy of whole grains in treating childhood constipation. This is an area thatwarrants further attention. Increasing the intake of dietary fiber and/or whole grain has the potential to relieve childhood constipation; however, additional randomized controlled trials are necessary to make a formal recommendation. (C) 2013 International Life Sciences Institute","[Stewart, Maria L.] Univ Hawaii Manoa, Dept Human Nutr Food & Anim Sci, Honolulu, HI 96822 USA; [Schroeder, Natalia M.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA",University of Hawaii System; University of Hawaii Manoa; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health,"Stewart, ML (corresponding author), Univ Hawaii Manoa, Dept Human Nutr Food & Anim Sci, 1955 East West Rd,AgSci 216, Honolulu, HI 96822 USA.",mstew@hawaii.edu,,,,,,,73,25,34,2,62,OXFORD UNIV PRESS INC,CARY,"JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA",0029-6643,1753-4887,,NUTR REV,Nutr. Rev.,FEB,2013,71,2,,,,,98,109,,10.1111/nure.12010,http://dx.doi.org/10.1111/nure.12010,,,12,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,099SM,23356637,Bronze,,,2024-06-04,WOS:000315641800003,View Full Record in Web of Science
J,"Morais, MB; Vítolo, MR; Aguirre, ANC; Fagundes-Neto, U",,,,"Morais, MB; Vítolo, MR; Aguirre, ANC; Fagundes-Neto, U",,,Measurement of low dietary fiber intake as a risk factor for chronic constipation in children,JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION,,,English,Article,,,,,,children; chronic constipation; dietary fiber,,"Background: Scarce information exists regarding dietary fiber intake in children with chronic constipation. The objective of this case-control study was to evaluate the intake of fiber as a risk factor for chronic constipation. Methods: Fifty-two children with a mean age of 6.8 +/- 3.2 years who had chronic constipation were age and gender matched with 52 children with normal intestinal habits. The fiber content of the diet was evaluated with a 24-hour dietary recall. Two tables of fiber composition in foods were used: a Brazilian table, and a table based on the method of the Association of Official Agricultural Chemists (AOAC). Results: According to the Brazilian table, the median intake of fiber (in grams per day) by the constipated and the control groups was 13.8 and 17.3, respectively, for total fiber (p = 0.020), 6.8 and 9.7 for insoluble fiber (p = 0.004), and 6.5 and 7.6 for soluble fiber (p = 0.104). According to the AOAC table, the constipation group (9.7 g/day) also had lower (p = 0.0022) intake of total fiber than the control group (12.6 g/day). The coefficient of correlation between the two tables on fiber content of food was +0.82 (p < 0.001) in the constipation group and +0.86 (p < 0.001) in the control group. The intake of fiber was less than the minimum recommendation (age + 5 g) and statistically associated (p = 0.001) with the constipation group (75.0%) in comparison with the controls (42.5%). The odds ratio was 4.1 (95% confidence limits, 1.64-10.32). Conclusion: Intake of fiber below the minimum recommendation is a risk factor for chronic constipation in children.","Univ Fed Sao Paulo, Escola Paulista Med, Div Pediat Gastroenterol, Sao Paulo, Brazil; Univ Fed Sao Paulo, Escola Paulista Med, Div Nutr & Metab, Sao Paulo, Brazil",Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP),"Rua Araioses 75, BR-05442010 Sao Paulo, Brazil.",,"MORAIS, MAURO B/I-7995-2014","Vitolo, Marcia Regina/0000-0001-9137-3854; Batista de Morais, Mauro/0000-0003-4014-5549",,,,,22,89,112,1,18,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0277-2116,1536-4801,,J PEDIATR GASTR NUTR,J. Pediatr. Gastroenterol. Nutr.,AUG,1999,29,2,,,,,132,135,,10.1097/00005176-199908000-00007,http://dx.doi.org/10.1097/00005176-199908000-00007,,,4,Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,216ZH,10435648,Bronze,,,2024-06-04,WOS:000081474000006,View Full Record in Web of Science
J,"Chan, AOO; Leung, G; Tong, T; Wong, NYH",,,,"Chan, Annie On On; Leung, Gigi; Tong, Teresa; Wong, Nina Y. H.",,,Increasing dietary fiber intake in terms of kiwifruit improves constipation in Chinese patients,WORLD JOURNAL OF GASTROENTEROLOGY,,,English,Article,,,,,,constipation; dietary fiber; kiwifruit; Chinese,TRANSIT-TIME; POPULATION; STOOL; BRAN,"AIM: To investigate if increased dietary fiber, in terms of kiwifruit, is effective in Chinese constipated patients. METHODS: 33 constipated patients and 20 healthy volunteers were recruited for a 4-wk treatment of kiwi fruit twice daily. Response during wk 1-4 was defined as an increase in complete spontaneous bowl, motion (CSBM) >= 1/wk. Secondary efficacy included response during wk 1-4, individual symptoms and scores of bowel habits and constipation. Responses were compared with the baseline run-in period. Colonic transit time and anorectal manometry were performed before and after treatment. RESULTS: Responder rate was 54.5% in the constipated group. The mean CSBM increased after treatment (2.2 +/- 2.6 vs 4.4 +/- 4.6, P = 0.013). There was also improvement in the scores for bothersomeness of constipation (P = 0.02), and satisfaction of bowel habit (P = 0.001), and decreased in days of laxative used (P = 0.003). There was also improvement in transit time (P = 0.003) and rectal sensation (P < 0.05). However, there was no change in the bowel symptoms or anorectal physiology in the healthy subjects. CONCLUSION: Increasing dietary fiber intake is effective in relieving chronic constipation in Chinese population. (C) 2007 WJG. All rights reserved.","Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Peoples R China",University of Hong Kong,"Chan, AOO (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Peoples R China.",aoochan@hku.hk,,,,,,,16,73,78,2,20,BAISHIDENG PUBLISHING GROUP INC,PLEASANTON,"8226 REGENCY DR, PLEASANTON, CA 94588 USA",1007-9327,2219-2840,,WORLD J GASTROENTERO,World J. Gastroenterol.,SEP 21,2007,13,35,,,,,4771,4775,,10.3748/wjg.v13.i35.4771,http://dx.doi.org/10.3748/wjg.v13.i35.4771,,,5,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,207XN,17729399,"Green Published, hybrid",,,2024-06-04,WOS:000249284500013,View Full Record in Web of Science
J,"Tse, PWT; Leung, SSF; Chan, T; Sien, A; Chan, AKH",,,,"Tse, PWT; Leung, SSF; Chan, T; Sien, A; Chan, AKH",,,Dietary fibre intake and constipation in children with severe developmental disabilities,JOURNAL OF PAEDIATRICS AND CHILD HEALTH,,,English,Article,,,,,,constipation; dietary fibre; disabled children,,"Objective: Constipation is a common problem in children with severe developmental disabilities (DD). This study aimed to evaluate fibre intake of severe DD children living in a residential institution, and the possibility of reducing the use of laxatives by increasing their fibre intake. Methodology: A baseline study was performed to evaluate the fibre and macronutrient intake in a group of severe DD children. Nutrients including fibre for a standard serving in each meal were calculated and daily macronutrients and fibre intake were estimated. An intervention study was then carried out to evaluate whether increasing fibre intake could relieve constipation. A total of 20 children aged between 3 and 17 years were assessed over a 4-month period. In a residential unit for severe DD children, laxatives were routinely prescribed if there was no spontaneous bowel motion for two consecutive days. Fibre intake was increased in stages by adding All-Bran (R) (Kellogg Company, Battle Creek, MI, USA) and desserts. The mean number of laxative usage per week per child in the different stages were then compared. Results: The baseline fibre intake was found to be approximately 2 g/day. The mean number of laxatives required per week per child decreased significantly from a baseline value of 1.22 (about 5 laxatives/month) (standard deviation (SD) = 0.36)) to 0.90 (about 3.5 laxatives/month) (SD = 0.75) in the first stage, and 0.71 (about 3 laxatives/month) (SD = 0.40) in the second stage. Using paired t-test, the difference was statistically significant when compared with the baseline: P < 0.05 for the first, and P < 0.01 for the second stage of fibre supplementation. Conclusion: Very low daily intake of fibre of 2 g/day was documented. Relief of constipation and a significant reduction in the usage of laxatives was demonstrated by increasing fibre intake to 17 g/day (stage 1). Increasing fibre intake further to 21 g/day (stage 2), showed a further reduction in the use of laxatives. There was, however, no statistical significance between stage 1 and stage 2 of fibre supplementation. Alternative ways to further relieve constipation in severe DD children require further studies.","Caritas Med Ctr, Dept Paediat, Dev Disabil Unit, 111 Wing Hong St, Kowloon, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Dept Paediat, Hong Kong 100083, Peoples R China",Chinese University of Hong Kong,"Caritas Med Ctr, Dept Paediat, Dev Disabil Unit, 111 Wing Hong St, Kowloon, Hong Kong, Peoples R China.",philotse@netvigator.com,,,,,,,10,40,43,1,5,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1034-4810,1440-1754,,J PAEDIATR CHILD H,J. Paediatr. Child Health,JUN,2000,36,3,,,,,236,239,,10.1046/j.1440-1754.2000.00498.x,http://dx.doi.org/10.1046/j.1440-1754.2000.00498.x,,,4,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,317LQ,10849223,,,,2024-06-04,WOS:000087227200008,View Full Record in Web of Science
J,"Arya, LA; Novi, JM; Shaunik, A; Morgan, MA; Bradley, CS",,,,"Arya, LA; Novi, JM; Shaunik, A; Morgan, MA; Bradley, CS",,,"Pelvic organ prolapse, constipation, and dietary fiber intake in women: A case-control study",AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY,,,English,Article; Proceedings Paper,Joint Annual Meeting of the American-Urogynecologic-Society/Society-of-Gynecologic-Surgeons,"JUL 29-31, 2004","San Diego, CA","Amer Urogynecol Soc,Soc Gynecol Surg",,constipation; fiber; prolapse,VALIDATION; DAMAGE,"Objective: This study was undertaken to determine whether there is an association among pelvic organ prolapse, constipation, and dietary fiber intake. Study design: Sixty consecutive women with prolapse were compared with 30 control women without prolapse. All women completed 2 validated questionnaires to assess constipation and dietary fiber intake. Multivariate analysis was performed. Results: The risk for constipation was greater in women with prolapse than controls (odds ratio 4.03, 95% CI 1.5-11.4). Median insoluble fiber intake was significantly lower in women with prolapse (2.4 g) than controls (5.8 g, P < .01). The increased risk for constipation was reduced but remained significant after controlling for age and insoluble dietary fiber intake (odds ratio 2.9, 95% CI 1.1-13.5). Conclusion: Women with pelvic organ prolapse are at a higher risk for constipation than controls. This increased risk for constipation is partially explained by lower intake of dietary insoluble fiber by women with prolapse than controls. (c) 2005 Elsevier Inc. All rights reserved.","Univ Penn, Div Urogynecol & Reconstruct Pelv Surg, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; Univ Iowa Hosp & Clin, Div Urogynecol, Dept Obstet & Gynecol, Iowa City, IA 52242 USA",University of Pennsylvania; University of Iowa,"Univ Penn, Div Urogynecol & Reconstruct Pelv Surg, Dept Obstet & Gynecol, 5 Penn Tower,3400 Spruce St, Philadelphia, PA 19104 USA.",jnovi@obgyn.upenn.edu,,"Bradley, Catherine/0000-0002-7402-5476",,,,,15,42,45,1,6,MOSBY-ELSEVIER,NEW YORK,"360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA",0002-9378,1097-6868,,AM J OBSTET GYNECOL,Am. J. Obstet. Gynecol.,MAY,2005,192,5,,,,,1687,1691,,10.1016/j.ajog.2004.11.032,http://dx.doi.org/10.1016/j.ajog.2004.11.032,,,5,Obstetrics & Gynecology,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Obstetrics & Gynecology,929ZA,15902178,,,,2024-06-04,WOS:000229384100070,View Full Record in Web of Science
J,"Machado, WM; Capelari, SM",,,,"Machado, Wellington Monteiro; Capelari, Silvia Maria",,,Evaluation of the efficacy and adherence to long-term use of dietary fiber in the treatment of functional intestinal constipation,REVISTA DE NUTRICAO-BRAZILIAN JOURNAL OF NUTRITION,,,Portuguese,Article,,,,,,Dietary fiber; Constipation; Dietary fiber efficacy; Food habits,LOW-FAT; INTERVENTION; REGIMENS; FRUIT; CONSUMPTION; RECURRENCE; INCREASE; RISK; LIFE,"Objective The objective of this study was to evaluate the adherence to and efficacy of dietary fiber in the treatment of functional constipation. Methods This is a longitudinal clinical study involving 59 subjects, 54 women and 5 men, aged 18 to 74 years, mean age of 46 years, with functional constipation. Once the bowel movements became regular with the use of dietary fiber, subjects were instructed to maintain the fiber-rich diet for four months in order to determine if the efficacy continued over time and the degree of adherence to its use. The association between adherence and efficacy was investigated by the Fisher's exact test. Results Although nine individuals abandoned the study, 50 returned. From these, 32 sustained normal bowel movements and 18 had recurrence of the constipation. In the first group, 16 continued consuming the same amount of fiber, four increased, nine reduced and three stopped taking it. In the group with recurrence, three maintained the same amount of fiber, one increased, three reduced and eleven stopped taking it. There was a significant statistical association between adherence and efficacy (p=0.008). Conclusion The long-term efficacy of dietary fiber for the treatment of constipation was moderate (64%) and treatment drop-out rate was high (52%). These results suggest the need of new strategies that promote greater fidelity to fiber therapy, thereby improving the efficacy of constipation treatment.","[Machado, Wellington Monteiro] Univ Estadual Paulista, Fac Med Botucatu, Dept Clin Med, BR-18618000 Botucatu, SP, Brazil; [Capelari, Silvia Maria] Univ Metodista Piracicaba, Curso Nutr, Piracicaba, SP, Brazil",Universidade Estadual Paulista; Universidade Metodista de Piracicaba,"Machado, WM (corresponding author), Univ Estadual Paulista, Fac Med Botucatu, Dept Clin Med, Rubiao Jr S-N, BR-18618000 Botucatu, SP, Brazil.",wmachado@fmb.unesp.br,,,,,,,29,2,4,0,10,PONTIFICIA UNIVERSIDADE CATOLICA CAMPINAS,CAMPINAS,"NUCLEO EDITORACAO SBI-CCV, CAMPUS II AV JOHN BOYD DUNLOP S-N PREDIO ONTOLOGIA JD IPAUSSURAMA, CAMPINAS, SP 13060-904, BRAZIL",1415-5273,,,REV NUTR,Rev. Nutr.,MAR-APR,2010,23,2,,,,,231,238,,10.1590/S1415-52732010000200006,http://dx.doi.org/10.1590/S1415-52732010000200006,,,8,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,634SQ,,"Green Submitted, gold, Green Published",,,2024-06-04,WOS:000280606000006,View Full Record in Web of Science
J,"Shen, L; Huang, C; Lu, X; Xu, X; Jiang, Z; Zhu, C",,,,"Shen, L.; Huang, C.; Lu, X.; Xu, X.; Jiang, Z.; Zhu, C.",,,"Lower dietary fibre intake, but not total water consumption, is associated with constipation: a population-based analysis",JOURNAL OF HUMAN NUTRITION AND DIETETICS,,,English,Article,,,,,,constipation; dietary fibre intake; epidemiology; functional bowel disorders,PHYSICAL-ACTIVITY; NATIONAL-HEALTH; FUNCTIONAL CONSTIPATION; FECAL INCONTINENCE; RISK-FACTORS; NUTRITION; BOWEL; PREVALENCE; SYMPTOMS; HABITS,"Background Associations between constipation and dietary fibre and water intake, as well as various lifestyle factors, have not been fully evaluated. The present study aimed to investigate associations between fibre and water intake and constipation, as well as other possible risk factors for constipation, in a large adult population. Methods Data obtained from 14 024 adults aged >= 20 years from three cycles of the National Health and Nutrition Examination Survey (NHANES) 2005-2010, who had completed a bowel health questionnaire, were included in this cross-sectional population-based study. Variables included demographics, lifestyle and dietary factors, comorbidities and laboratory parameters. Logistic regression analyses were performed to determine associations between potential risk factors and constipation. Results Among 17 132 participants >= 20 years, 2401 (14%) did not complete bowel health questionnaires and were excluded, along with pregnant women (n = 461) and participants without dietary sample weight on day 1 (n = 246), leaving data from 14 024 participants available for analysis. Multivariate analysis revealed that black race/ethnicity [odds ratio (OR) = 1.380, 95% confidence interval (CI) = 1.054-1.809], a lower than 12th grade education (OR = 1.420, 95% CI = 1.154-1.749) or high school education (OR = 1.339, 95% CI = 1.057-1.697), lower income/poverty ratios (1.3-3.49 versus >= 3.5: OR = 1.261, 95% CI = 1.015-1.567), normal weight (OR = 1.913, 95% CI = 1.534-2.386) or overweight (OR = 1.536, 95% CI = 1.207-1.955), depression (OR = 1.610, 95% CI = 1.119-2.315) and poor teeth (OR = 1.441, 95% CI = 1.100-1.888) were associated with an increased risk for constipation. Lower dietary fibre intake was associated with a greater risk of constipation. Total water consumption was significantly associated an with an increased risk of constipation in univariate analysis, but not in multivariate analysis. Conclusions Lower dietary fibre intake, but not poor water consumption, was associated with a greater risk of constipation in US adults.","[Shen, L.; Huang, C.; Lu, X.; Xu, X.; Jiang, Z.; Zhu, C.] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Emergency, 160 Pujian Rd, Shanghai 200127, Peoples R China",Shanghai Jiao Tong University,"Jiang, Z (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Emergency, 160 Pujian Rd, Shanghai 200127, Peoples R China.",fairlight@sohu.com,,,,,,,39,22,23,1,15,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0952-3871,1365-277X,,J HUM NUTR DIET,J. Hum. Nutr. Diet.,AUG,2019,32,4,,,,,422,431,,10.1111/jhn.12589,http://dx.doi.org/10.1111/jhn.12589,,,10,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Nutrition & Dietetics,IJ5ZO,31087475,,,,2024-06-04,WOS:000475982100003,View Full Record in Web of Science
J,"Roman, JL; Gonzálvez, ABM; Luque, A; Miñano, JAP; Acosta, AV; Iglesias, R; Henández, M; Villegas, JA",,,,"Roman, J. Lopez; Gonzalvez, A. B. Martinez; Luque, A.; Minano, J. A. Pons; Acosta, A. Vargas; Iglesias, R.; Henandez, M.; Villegas, J. A.",,,The effect of a fibre enriched dietary milk product in chronic primary idiopatic constipation,NUTRICION HOSPITALARIA,,,Spanish,Article,,,,,,constipation; dietary fibre; inulin; glucose polymers; prebiotics,ASSOCIATION; INULIN,"Background: fibre is effective in some types of constipation. Our objective was to determine if the administration of an enriched dairy preparation with a supplement of soluble fibre (Naturfibra)(R) [inulin and digestion resistant maltodextrin (Fibersol2 (R))], improves primary chronic constipation. Methods: Prospective, randomized, double blind clinical trial randomized with dietary intervention in 32 subjects with constipation according to the Rome H criteria. Thirty two subjects (men 4; women 28) with an average age of 47 15 years were randomly divided in two homogeneous groups. A type of milk (A or B) was assigned to each group. Group A received fibre enriched semi-skimmed milk; Group B received semi skimmed milk. The subjects drank half a litre of milk per day during 20 days, meaning that those who drank the enriched milk ingested 20 grams of fibre a day. Results: The subjects that presented straining at defecation (p < 0,001), sensation of incomplete evacuation (p < 0,001), sensation of obstruction in the evacuation (p < 0,001) and days between bowel movements, diminished significantly after the intake of milk supplemented with fibre. Conclusion: The intake of a dairy preparation with a supplement of fibre containing 20 grams of soluble fibre (inulin and digestion resistant maltodextrin), improves the situation of idiopathic primary chronic constipation based on the Rome H criteria.","[Roman, J. Lopez; Gonzalvez, A. B. Martinez; Luque, A.; Villegas, J. A.] UCAM, Catedra Fisol, Murcia 30107, Spain; [Minano, J. A. Pons] Hosp Univ Virgen Arrixaca, Serv Med Aparato Digestivo, Murcia, Spain; [Acosta, A. Vargas] Especialista & Med Aparato Digestivo, Asturias, Spain; [Iglesias, R.; Henandez, M.] Corp Alimentaria Penasanta CAPSA, Asturias, Spain",Universidad Catolica de Murcia; Hospital Clinico Universitario Virgen de la Arrixaca,"Villegas, JA (corresponding author), UCAM, Catedra Fisol, Campus Los Jeronimos,Carretera Guadalupe S-N, Murcia 30107, Spain.",javillegas@pdi.ucam.edu,"Miñano, Jose Antonio Pons/S-4644-2019","Miñano, Jose Antonio Pons/0000-0001-5017-7240",,,,,20,30,31,0,13,"ARAN EDICIONES, S L",MADRID,"C/ CASTELLO, 128, 1O, MADRID, 28006, SPAIN",0212-1611,1699-5198,,NUTR HOSP,Nutr. Hosp.,JAN-FEB,2008,23,1,,,,,12,19,,,,,,8,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,259PD,18372941,,,,2024-06-04,WOS:000252950300003,View Full Record in Web of Science
J,"ODES, HS; LAZOVSKI, H; STERN, I; MADAR, Z",,,,"ODES, HS; LAZOVSKI, H; STERN, I; MADAR, Z",,,"DOUBLE-BLIND TRIAL OF A HIGH DIETARY FIBER, MIXED GRAIN CEREAL IN PATIENTS WITH CHRONIC CONSTIPATION AND HYPERLIPIDEMIA",NUTRITION RESEARCH,,,English,Article,,,,,,CONSTIPATION; DIETARY FIBER; HYPERLIPIDEMIA,BRAN; TRANSIT; WEIGHT; WHEAT; STOOL,"A high dietary fiber breakfast cereal (Disivit(TM)), prepared from oats, corn, wheat and soybean, was tested for its therapeutic efficacy in patients. suffering from constipation and hyperlipidemia. In a double-blind cross-over trial, a daily dose of 50 grams Disivit(TM) cereal, containing 12.5 grams dietary fiber, was administered to 20 constipated patients for 2 weeks, and to 20 hyperlipidemic patients for 4 weeks, and cereal was alternated with a low fiber placebo given for a similar time period; fiber and placebo were given in random order. In the constipated patients taking fiber cereal, bowel movement frequency and stool consistency improved significantly and laxative intake was reduced. ln the hyperlipidemic patients taking fiber, the serum cholesterol dropped significantly (but also during placebo treatment), the serum triglycerides dropped (but without attaining statistical significance) and the HDL and LDL levels were not altered. In summary, the fiber cereal appears to be a suitable short-term treatment for constipation, although its long-term efficacy requires further study. Regarding hyperlipidemia, the trend of the cereal to lower the serum cholesterol and triglycerides warrants further study, by adding more soluble fiber to the cereal formula or using a longer treatment period.","BEN GURION UNIV NEGEV,IL-84105 BEER SHEVA,ISRAEL; ZAMENHOF CLIN KUPAT HOLIM CLALIT,TEL AVIV,ISRAEL; HEBREW UNIV JERUSALEM,FAC AGR,SCH NUTR,IL-76100 REHOVOT,ISRAEL",Ben Gurion University; Hebrew University of Jerusalem,"ODES, HS (corresponding author), SOROKA MED CTR,INST GASTROENTEROL,POB 151,IL-84101 BEER SHEVA,ISRAEL.",,,,,,,,16,15,16,0,6,PERGAMON-ELSEVIER SCIENCE LTD,OXFORD,"THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB",0271-5317,,,NUTR RES,Nutr. Res.,SEP,1993,13,9,,,,,979,985,,10.1016/S0271-5317(05)80517-2,http://dx.doi.org/10.1016/S0271-5317(05)80517-2,,,7,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,LW006,,,,,2024-06-04,WOS:A1993LW00600001,View Full Record in Web of Science
J,"Li, Y; Tong, WD; Qian, Y",,,,"Li, Yi; Tong, Wei-Dong; Qian, Yang",,,Effect of Physical Activity on the Association Between Dietary Fiber and Constipation: Evidence From the National Health and Nutrition Examination Survey 2005-2010,JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY,,,English,Article,,,,,,Constipation; Dietary fiber; Exercise; Nutrition surveys,CHRONIC IDIOPATHIC CONSTIPATION; QUALITY-OF-LIFE; EPIDEMIOLOGY; PREVALENCE; MANAGEMENT; PROBIOTICS; DISORDERS; EFFICACY; ADULTS,"Background/Aims The effect of physical activity on the relationship between dietary fiber intake and constipation has not been comprehensively studied. This study aims to explore the impact of physical activity. Methods Data were obtained from 3 cycles of the National Health and Nutrition Examination Survey (NHANES) 2005-2010 and included a total of 13 941 participants aged >= 20 years. Multiple logistic regression analysis was used to investigate the independent association between dietary fiber and constipation. Interaction analysis was also performed to analyze the relationship between dietary fiber and constipation in different physical activity groups. Results Among non-active participants, dietary fiber intake did not associate with stool consistency (OR, 1.02; 95% CI, 0.98-1.05; P = 0.407). For physically active participants, 1-gram unit increase in dietary fiber intake reduced the risk of stool consistency by 3% (OR, 0.97; 95% CI, 0.94-0.99; P = 0.020). Moreover, the relationship between dietary fiber intake and stool consistency was significantly different for groups with different levels of physical activity (P interaction = 0.044). However, dietary fiber intake was not related to stool frequency among non-active participants (OR, 0.99; 95% CI, 0.94-1.05; P = 0.767) nor physically active participants (OR, 1.01; 95% CI, 0.97-1.04; P = 0.751). Conclusions Increasing dietary fiber intake was associated with stool consistency-related constipation among physically active participants, but not among non-active participants. However, increasing dietary fiber intake is not significantly associated with stool frequency in different physical activity groups.","[Li, Yi] Yanan Univ, Med Coll, Yanan, Shaanxi, Peoples R China; [Tong, Wei-Dong] Army Med Univ, Daping Hosp, Dept Gen Surg, Gastr & Colorectal Div, 10 Changjiang Zhi Lu, Chongqing 400042, Peoples R China; [Qian, Yang] Shaanxi Prov Peoples Hosp, Operating Room, Xian, Shaanxi, Peoples R China",Yanan University; Army Medical University; Xi'an Medical University,"Tong, WD (corresponding author), Army Med Univ, Daping Hosp, Dept Gen Surg, Gastr & Colorectal Div, 10 Changjiang Zhi Lu, Chongqing 400042, Peoples R China.",vdtong@163.com,"Tong, Weidong/A-2729-2011","Tong, Weidong/0000-0001-6150-9941; Li, Yi/0000-0002-9170-6943","National Natural Science Foundation of China [81570483, 81770541]",National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)),This study was supported by the National Natural Science Foundation of China (Grant No. 81570483 and 81770541).,,36,16,16,5,19,KOREAN SOC NEUROGASTROENTEROLOGY & MOTILITY,GANGNAM-GU,"RM 305, LOTTE GOLD ROSE VILL II, 31 SEOLLEUNG-RO 86-GIL, GANGNAM-GU, SEOUL 135-839, SOUTH KOREA",2093-0879,2093-0887,,J NEUROGASTROENTEROL,J. Neurogastroenterol. Motil.,JAN,2021,27,1,,,,,97,107,,10.5056/jnm20051,http://dx.doi.org/10.5056/jnm20051,,,11,Gastroenterology & Hepatology; Clinical Neurology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Neurosciences & Neurology,PO5SR,33380555,"Green Published, gold",,,2024-06-04,WOS:000605229600013,View Full Record in Web of Science
J,"Rijnaarts, I; de Roos, NM; Wang, TJ; Zoetendal, EG; Top, J; Timmer, M; Hogenelst, K; Bouwman, EP; Witteman, B; de Wit, N",,,,"Rijnaarts, Iris; de Roos, Nicole M.; Wang, Taojun; Zoetendal, Erwin G.; Top, Jan; Timmer, Marielle; Hogenelst, Koen; Bouwman, Emily P.; Witteman, Ben; de Wit, Nicole",,,A high-fibre personalised dietary advice given via a web tool reduces constipation complaints in adults,JOURNAL OF NUTRITIONAL SCIENCE,,,English,Article,,,,,,Constipation; Dietary fibre; Functional bowel disorders; Personalised nutrition; Quality of life,QUALITY-OF-LIFE; CHAIN FATTY-ACIDS; CORONARY-HEART-DISEASE; ROME III CRITERIA; STOOL FREQUENCY; FUNCTIONAL CONSTIPATION; PATIENT ASSESSMENT; COLORECTAL-CANCER; RELATIVE VALIDITY; HEALTHY-SUBJECTS,"Constipation can greatly impact the quality of life (QoL), which can be relieved by dietary fibres; however, preserving a higher fibre intake remains a challenge. We investigated the effects of a personalised dietary advice (PDA) on fibre intake and mild constipation complaints. A total number of twenty-five adults with mild constipation complaints were included in a 4-week observation period followed by a 4-week personalised intervention. The PDA provided high-fibre alternatives via a web tool. In weeks 1, 4 and 8, dietary intake, constipation complaints and QoL were assessed. Furthermore, participants collected a faecal sample at weeks 1, 4 and 8 to determine microbiota diversity and composition, and short-chain fatty acids (SCFA). Participants completed questions daily for 8 weeks regarding abdominal complaints, stool frequency and stool consistency. Fibre intake in week 8 was significantly higher compared to week 1 (Delta = 5.7 +/- 6.7 g, P < 0.001) and week 4 (Delta = 5.2 +/- 6.4 g, P < 0.001). Constipation severity and QoL significantly improved at week 8 compared to the observation period (P < 0.001). A higher fibre intake significantly reduced constipation severity (beta = -0.031 (-0.05; -0.01), P = 0.001) and the QoL (beta = -0.022 (-0.04; -0.01), P = 0.009). Stool consistency (P = 0.040) and abdominal pain (P = 0.030) improved significantly during the intervention period (P = 0.040), but stool frequency did not. Average microbial alpha diversity and composition and SCFA concentrations did not change over time, but indicated individual-specific dynamics. Several SCFAs were associated with constipation complaints. To conclude, a PDA effectively increased fibre intake and subsequently reduced constipation complaints, indicating that guided dietary adjustments are important and feasible in the treatment of mild constipation complaints.","[Rijnaarts, Iris; de Roos, Nicole M.; Witteman, Ben] Wageningen Univ & Res, Div Human Nutr & Hlth, Stippeneng 4, NL-6708 WE Wageningen, Netherlands; [Rijnaarts, Iris; Wang, Taojun; Zoetendal, Erwin G.] Wageningen Univ & Res, Lab Microbiol, Stippeneng 4, NL-6708 WE Wageningen, Netherlands; [Rijnaarts, Iris; Top, Jan; Timmer, Marielle; de Wit, Nicole] Wageningen Univ & Res, Wageningen Food & Biobased Res, Bornse Weilanden 9, NL-6708 PD Wageningen, Netherlands; [Hogenelst, Koen] Wageningen Univ & Res, Wageningen Econ Res, Bornse Weilanden 9, NL-6708 PD Wageningen, Netherlands; [Bouwman, Emily P.] Netherlands Org Appl Sci Res TNO, Dept Human Performance, Kampweg 55, NL-3769 DE Soesterberg, Netherlands; [Witteman, Ben] Hosp Gelderse Vallei, Gastroenterol & Hepatol Dept, Willy Brandtlaan 10, NL-6716 RP Ede, Netherlands",Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Netherlands Organization Applied Science Research; Gelderse Vallei Hospital,"Rijnaarts, I (corresponding author), Wageningen Univ & Res, Div Human Nutr & Hlth, Stippeneng 4, NL-6708 WE Wageningen, Netherlands.;Rijnaarts, I (corresponding author), Wageningen Univ & Res, Lab Microbiol, Stippeneng 4, NL-6708 WE Wageningen, Netherlands.;Rijnaarts, I (corresponding author), Wageningen Univ & Res, Wageningen Food & Biobased Res, Bornse Weilanden 9, NL-6708 PD Wageningen, Netherlands.",iris.rijnaarts@wur.nl,,"Witteman, Ben/0000-0002-1341-8540; Rijnaarts, Iris/0000-0001-7811-6669; Wang, Taojun/0000-0003-1885-3864; Bouwman, Emily/0000-0002-5633-7425; Hogenelst, Koen/0000-0002-7263-0920; de Roos, Nicole/0000-0002-3655-1678",Public Private Partnership Personalized Nutrition and Health program from the Top consortium for Knowledge and Innovation (TKI) Agri Food [TKI-AF-15262]; Dutch Digestive Foundation; China Scholarship Council [201600090211],Public Private Partnership Personalized Nutrition and Health program from the Top consortium for Knowledge and Innovation (TKI) Agri Food; Dutch Digestive Foundation; China Scholarship Council(China Scholarship Council),"This research was supported by the Public Private Partnership Personalized Nutrition and Health program from the Top consortium for Knowledge and Innovation (TKI) Agri & Food (TKI-AF-15262), in collaboration with the Dutch Digestive Foundation and companies. The funding agencies had no role in the collection, analysis and interpretation of data, or in the preparation, review or approval of the manuscript. T.W. was financially supported by the China Scholarship Council (File No. 201600090211).",,93,1,2,4,13,CAMBRIDGE UNIV PRESS,NEW YORK,"32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA",2048-6790,,,J NUTR SCI,J. Nutr. Sci.,APR 28,2022,11,,,,,,,,e31,10.1017/jns.2022.27,http://dx.doi.org/10.1017/jns.2022.27,,,14,Nutrition & Dietetics,Emerging Sources Citation Index (ESCI),Nutrition & Dietetics,1F0SH,35573462,"gold, Green Published",,,2024-06-04,WOS:000794886400001,View Full Record in Web of Science
J,"Abdullah, MMH; Gyles, CL; Marinangeli, CPF; Carlberg, JG; Jones, PJH",,,,"Abdullah, Mohammad M. H.; Gyles, Collin L.; Marinangeli, Christopher P. F.; Carlberg, Jared G.; Jones, Peter J. H.",,,Dietary fibre intakes and reduction in functional constipation rates among Canadian adults: a cost-of-illness analysis,FOOD & NUTRITION RESEARCH,,,English,Article,,,,,,dietary fibre; constipation; healthcare; cost; savings; nutrition economics,HEALTH-CARE SAVINGS; CARDIOVASCULAR-DISEASE; BOWEL FUNCTION; PEDIATRIC-PATIENTS; LIFE-STYLE; RYE BREAD; YOGURT; WOMEN; INFORMATION; CONSUMPTION,"Background: Evidence-based research highlights beneficial impacts of dietary fibre on several aspects of the gut pathophysiology that are accompanied by a considerable financial burden in healthcare services. Recommended intakes of dietary fibre may thus associate with financial benefits at a population level. Objective: We sought to systematically assess the potential annual savings in healthcare costs that would follow the reduction in rates of functional constipation and irregularity with increased dietary fibre intakes among Canadian adults. Design: A cost-of-illness analysis was developed on the basis of current and recommended levels of fibre intake in Canada, constipation reduction per 1 g fibre intake, proportion of adults who are likely to consume fibre-rich diets, and population expected to respond to fibre intake. Sensitivity analyses covering a range of assumptions were further implemented within the economic simulation. Results: Our literature searches assumed a 1.8% reduction in constipation rates with each 1 g/day increase in fibre intake. With intakes corresponding to the Institute of Medicine's adequate levels of 38 g/day for men and 25 g/day for women, among 5 and 100% of the adult populations, anywhere between CAD$1.5 and CAD$31.9 million could be saved on constipation-related healthcare costs annually. Each 1 g/ day increase in dietary fibre was estimated to result in total annual healthcare cost savings that ranged between CAD$0.1 and CAD$2.5 million. Conclusions: The present research suggests an economic value of increasing dietary fibre intake beyond its well-known health benefits. Healthy-eating behaviours consistent with the recommended intakes of dietary fibre by the general public should hence be advocated as a practical approach for reducing costs associated with the management of constipation in Canada.","[Abdullah, Mohammad M. H.; Jones, Peter J. H.] Univ Manitoba, Dept Human Nutr Sci, Winnipeg, MB R3T 6C5, Canada; [Abdullah, Mohammad M. H.; Jones, Peter J. H.] Univ Manitoba, Richardson Ctr Funct Foods & Nutraceut, Winnipeg, MB R3T 6C5, Canada; [Gyles, Collin L.; Carlberg, Jared G.] Univ Manitoba, Dept Agribusiness & Agr Econ, Winnipeg, MB R3T 6C5, Canada; [Marinangeli, Christopher P. F.] Pulse Canada, Winnipeg, MB, Canada",University of Manitoba; University of Manitoba; University of Manitoba,"Jones, PJH (corresponding author), Univ Manitoba, Richardson Ctr Funct Foods & Nutraceut, 196 Innovat Dr,SmartPk, Winnipeg, MB R3T 6C5, Canada.",peter_jones@umanitoba.ca,"Abdullah, Mohammad/HMV-7091-2023; Marinangeli, Christopher/HMD-3619-2023","Abdullah, Mohammad/0000-0003-1804-3044; Marinangeli, Christopher/0000-0002-0881-9921",Kellogg Canada Inc.,Kellogg Canada Inc.,"At the time of the manuscript's inception and submission for publication, CPFM was an employee of Kellogg Canada. Funding from Kellogg Canada Inc. directly supported the efforts of MMHA, CLG, JGC, and PJHJ.",,50,19,22,1,7,TAYLOR & FRANCIS LTD,ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND",1654-6628,1654-661X,,FOOD NUTR RES,Food Nutr. Res.,,2015,59,,,,,,,,28646,10.3402/fnr.v59.28646,http://dx.doi.org/10.3402/fnr.v59.28646,,,8,Food Science & Technology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Nutrition & Dietetics,CY3TR,26652739,"Green Published, Green Submitted, gold",,,2024-06-04,WOS:000366333300001,View Full Record in Web of Science
J,"Speridiao, PGL; Tahan, S; Fagundes-Neto, U; Morais, MB",,,,"Speridiao, PGL; Tahan, S; Fagundes-Neto, U; Morais, MB",,,"Dietary fiber, energy intake and nutritional status during the treatment of children with chronic constipation",BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH,,,English,Article,,,,,,constipation; anthropometry; nutritional status; energy intake; dietary fiber,ENCOPRESIS; MANAGEMENT; INFANTS,"The present prospective study was carried out to determine dietary fiber and energy intake and nutritional status of children during the treatment of chronic constipation. Twenty-five patients aged 2 to 12 years with chronic constipation were submitted to clinical evaluation, assessment of dietary patterns, and anthropometry before and after 45 and 90 days of treatment. The treatment of chronic constipation included rectal disimpaction, ingestion of mineral oil and diet therapy. The standardized diet prescribed consisted of regular food without a fiber supplement and met the nutrient requirements according to the recommended daily allowance. The fiber content was 9.0 to 11.9 g for patients aged less than 6 years and 12.0 to 18.0 g for patients older than 6 years. Sixteen patients completed the 90-day follow-up and all presented clinical improvement. The anthropometric variables did not change, except midarm circumference and triceps skinfold thickness which were significantly increased. Statistically significant increases were also found in percent calorie intake adequacy in terms of recommended daily allowance (55.5 to 76.5% on day 45 and to 68.5% on day 90; P = 0.047). Percent adequacy of minimum recommended daily intake of dietary fiber (age + 5 g) increased during treatment (from 46.8 to 52.8% on day 45 and to 56.3% on day 90; P = 0.009). Food and dietary fiber intake and triceps skinfold thickness increased during follow-up. We conclude that the therapeutic program provided a good clinical outcome.","Univ Fed Sao Paulo, Escola Paulista Med, Programa Posgrad & Nutr, Sao Paulo, Brazil; Univ Fed Sao Paulo, Escola Paulista Med, Dept Pediat, Disciplina Gastroenterol Pediat, Sao Paulo, Brazil",Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP),"Morais, MB (corresponding author), Rua Loefegreen 1596, BR-04040032 Sao Paulo, Brazil.",,"MORAIS, MAURO B/I-7995-2014","Batista de Morais, Mauro/0000-0003-4014-5549",,,,,25,17,22,0,5,ASSOC BRAS DIVULG CIENTIFICA,SAO PAULO,"FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, BRAZIL",0100-879X,,,BRAZ J MED BIOL RES,Brazilian J. Med. Biol. Res.,JUN,2003,36,6,,,,,753,759,,10.1590/S0100-879X2003000600011,http://dx.doi.org/10.1590/S0100-879X2003000600011,,,7,"Biology; Medicine, Research & Experimental",Science Citation Index Expanded (SCI-EXPANDED),Life Sciences & Biomedicine - Other Topics; Research & Experimental Medicine,696BX,12792705,"Green Submitted, gold",,,2024-06-04,WOS:000183866400011,View Full Record in Web of Science
J,"Schmidbaur, W; Wienbeck, M",,,,"Schmidbaur, W; Wienbeck, M",,,Dietary and drug therapy of chronic constipation,ZENTRALBLATT FUR CHIRURGIE,,,German,Article,,,,,,constipation; dietary therapy; drug therapy; dietary fibers,TRANSIT; TRIAL,"Therapy of constipation is complex. It is mainly based on general rules and treatment with dietary fibers. If drugs are necessary they should be applied according to the type of constipation as evidenced by the results of special diagnostic procedures. Some patients may improve with psychotherapeutic procedures. Surgical treatment should be the last choice. The aim of therapy is to relieve the patient from his symptoms and achieve a habit of regular defecation, if possible with only a small amount of laxatives - or better without the application of drugs. Most often a highly individualized therapy is necessary. Many patients consult their doctor only when they have already a grave problem. Therapy then becomes difficult. Information on bowel movements and on how to prevent constipation by the way of living, therefore, should be widely spread in the general population in order to minimize constipation as a medical problem.","Zent Klinikum, Med Klin 3, D-86156 Augsburg, Germany",,"Schmidbaur, W (corresponding author), Zent Klinikum, Med Klin 3, Stenglinstr 2, D-86156 Augsburg, Germany.",,,,,,,,47,2,3,0,0,GEORG THIEME VERLAG KG,STUTTGART,"RUDIGERSTR 14, D-70469 STUTTGART, GERMANY",0044-409X,1438-9592,,ZBL CHIR,Zent.bl. Chir.,,1999,124,9,,,,,825,832,,,,,,8,Surgery,Science Citation Index Expanded (SCI-EXPANDED),Surgery,244JN,10544489,,,,2024-06-04,WOS:000083048200010,View Full Record in Web of Science
J,"Weber, TK; Toporovski, MS; Tahan, S; Neufeld, CB; de Morais, MB",,,,"Weber, Thabata K.; Toporovski, Mauro S.; Tahan, Soraia; Neufeld, Clarice B.; de Morais, Mauro B.",,,Dietary Fiber Mixture in Pediatric Patients With Controlled Chronic Constipation,JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION,,,English,Article,,,,,,child; constipation; fiber; randomized controlled trial,COLONIC TRANSIT; CHILDHOOD CONSTIPATION; CHILDREN; GLUCOMANNAN; INFANTS; TIME,"Objectives:The aim of the study was to test the clinical efficacy and effect on colonic transit time (CTT) of a dietary fiber mixture given to children with controlled chronic constipation (CC) after the withdrawal of stool softeners and enemas.Methods:This randomized, placebo-controlled, double-blind clinical trial involved 54 patients aged 4 to 12 years and had CC that was controlled by the use of low-dose stool softeners. The use of these softeners was discontinued when the patients were admitted to the clinical trial. The patients were randomized into 2 groups for the 4-week study period. One group received a dietary fiber mixture and the other group received a placebo (maltodextrin). The primary outcome was therapeutic failure (oral stool softeners or enemas was required to prescribe during the trial). Secondary outcomes included defecation frequency, stool consistency (measured using the Bristol Stool Form Scale), and CTT.Results:Therapeutic failure was observed in 34.6% (9/26) of the patients in the dietary fiber mixture group and in 35.7% (10/28) in the control group (P=0.933). The mean increase in daily bowel movements was 0.53 in the dietary fiber mixture group and 0.23 in the control group (P=0.014). The patients in the dietary fiber mixture group (60.0%) passed nonhardened stools more frequently than did those in the control group (16.7%, P=0.003). The CTT was similar for both groups.Conclusions:The fiber mixture did not prevent the suspension of stool softeners or lead to reduced CTT; however, the mixture promoted an increased frequency of defecation and an improvement in the stool consistency.","[Weber, Thabata K.; Tahan, Soraia; de Morais, Mauro B.] Univ Fed Sao Paulo, Div Pediat Gastroenterol, Sao Paulo, Brazil; [Toporovski, Mauro S.; Neufeld, Clarice B.] Santa Casa Sao Paulo, Dept Pediat, Sch Med, BR-01234001 Sao Paulo, Brazil",Universidade Federal de Sao Paulo (UNIFESP),"Toporovski, MS (corresponding author), Santa Casa Sao Paulo, Dept Pediat, Sch Med, Ave Pacaembu 1083, BR-01234001 Sao Paulo, Brazil.",toporovski@uol.com.br,"MORAIS, MAURO B/I-7995-2014","WEBER/0000-0001-5588-4235; Batista de Morais, Mauro/0000-0003-4014-5549",Support Produtos Nutricionais,Support Produtos Nutricionais,"The authors are thankful for the support from Support Produtos Nutricionais and for the collaboration of residents in pediatric gastroenterology, namely Cristina Marino, Fernanda Miyamoto Barreto (Santa Casa de Misericordia, de Sao Paulo), Sabrina Bortolin Nery, and Juliana Okamoto (Federal University of Sao Paulo).",,30,37,40,1,23,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0277-2116,1536-4801,,J PEDIATR GASTR NUTR,J. Pediatr. Gastroenterol. Nutr.,MAR,2014,58,3,,,,,297,302,,10.1097/MPG.0000000000000224,http://dx.doi.org/10.1097/MPG.0000000000000224,,,6,Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,AD5MO,24157445,Bronze,,,2024-06-04,WOS:000333297300010,View Full Record in Web of Science
J,"Murakami, K; Sasaki, S; Okubo, H; Takahashi, Y; Hosoi, Y; Itabashi, M",,,,"Murakami, K.; Sasaki, S.; Okubo, H.; Takahashi, Y.; Hosoi, Y.; Itabashi, M.",,Freshmen Dietetic Dourses Study,"Association between dietary fiber, water and magnesium intake and functional constipation among young Japanese women",EUROPEAN JOURNAL OF CLINICAL NUTRITION,,,English,Article,,,,,,dietary fiber intake; water intake; magnesium intake; functional constipation; Japanese women; epidemiology,HISTORY QUESTIONNAIRE; STOOL OUTPUT; FLUID INTAKE; LIFE-STYLE; VOLUNTEERS; FREQUENCY; COMMUNITY; VALIDITY,"Objective: Most research on constipation has focused on dietary fiber intake. Here, we examined the intake of water and magnesium, nutrients possibly associated with constipation, as well as that of dietary fiber in relation to constipation. Design: Cross-sectional study. Subjects: A total of 3835 female Japanese dietetic students aged 18 - 20 years from 53 institutions in Japan.] Methods: Dietary intake was estimated with a validated, self-administered diet history questionnaire. Functional constipation was defined using the Rome I criteria. Results: The prevalence of functional constipation was 26.2%. Neither dietary fiber intake (mean = 6.4 g/4186 kJ) nor intakes of total water and water from fluids were associated with constipation. Conversely, low intake of water from foods was associated with an increasing prevalence of constipation. In comparison with women in the first (lowest) quintile, the multivariate adjusted odds ratio (OR) (95% confidence interval (CI)) for women in the second, third, fourth, and fifth quintiles were 0.72 (0.57, 0.90), 0.78 (0.62, 0.98), 0.71 (0.56, 0.89), and 0.77 (0.61, 0.97), respectively (P for trend = 0.04). Additionally, low magnesium intake was associated with increasing prevalence of constipation. Compared with women in the first quintile, the multivariate adjusted OR (95% CI) for women in the second, third, fourth and fifth quintiles were 0.70 (0.56, 0.88), 0.75 (0.60, 0.95), 0.73 (0.58, 0.92) and 0.79 (0.63, 0.996), respectively (P for trend = 0.09). Conclusions: Low intakes of water from foods and magnesium are independently associated with an increasing prevalence of functional constipation among a population whose dietary fiber intake is relatively low.","Natl Inst Hlth & Nutr, Nutr Epidemiol Program, Shinjuku Ku, Tokyo 1628636, Japan; Kagawa Nutr Univ, Dept Nutr Sci, Kagawa, Saitama, Japan",National Institute of Health & Nutrition - Japan; Kagawa Nutrition University,"Sasaki, S (corresponding author), Natl Inst Hlth & Nutr, Nutr Epidemiol Program, Shinjuku Ku, Toyama 1-23-1, Tokyo 1628636, Japan.",stssasak@nih.go.jp,"Okubo, Hitomi/AAB-7613-2020","Okubo, Hitomi/0000-0002-2305-0719; Murakami, Kentaro/0000-0002-4189-7753",,,,,32,72,75,0,19,NATURE PUBLISHING GROUP,LONDON,"MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND",0954-3007,1476-5640,,EUR J CLIN NUTR,Eur. J. Clin. Nutr.,MAY,2007,61,5,,,,,616,622,,10.1038/sj.ejcn.1602573,http://dx.doi.org/10.1038/sj.ejcn.1602573,,,7,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,163SO,17151587,,,,2024-06-04,WOS:000246183700008,View Full Record in Web of Science
J,"Maffei, HVL; Vicentini, AP",,,,"Leoni Maffei, Helga Verena; Vicentini, Andrea Pereira",,,Prospective Evaluation of Dietary Treatment in Childhood Constipation: High Dietary Fiber and Wheat Bran Intake Are Associated With Constipation Amelioration,JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION,,,English,Article,,,,,,bowel habit; children; constipation; dietary fiber; wheat bran,CONTROLLED-TRIAL; STOOL FREQUENCY; COLONIC TRANSIT; CHILDREN; GLUCOMANNAN,"Objectives: The aim of the study was to evaluate, over 24 months, the intake of dietary fiber (DF) and the bowel habit (BH) of constipated children advised a DF-rich diet containing wheat bran. Patients and Methods: BH and dietary data of 28 children with functional constipation defined by the Boston criteria were obtained at visit 1 (V1, n = 28) and at 4 follow-up visits (V2-V5, n = 80). At each visit the BH was rated BAD (worse/unaltered; improved but still complications) or RECOVERY (REC) (improved, no complications; asymptomatic), and a food intake questionnaire was applied. DF intake was calculated according to age (year)+5 to 10 g/day and bran intake according to international tables. Nonparametric statistics were used. Results: Median age (range) was 7.25 years (0.25-15.6 years); 21 children underwent bowel washout (most before V1/V2), and 14 had the last visit at V3/V4. DF intake, bran intake, and the BH rate significantly increased at V2 and remained higher than at V1 through V2 to V5. At V1, median DF intake was 29.9% below the minimum recommended and at the last visit 49.9% above it. Twenty-four children accepted bran at 60 visits, at which median bran intake was 20 g/day and median proportion of DF due to bran 26.9%. Children had significantly higher DF and higher bran intake at V2 to V5 at which they had REC than at those at which they presented BAD BH. DF intake > age+10 g/day was associated with bran acceptance and REC. At the last visit 21 children presented REC (75%); 20 of them were asymptomatic and 18 were off washout/laxatives. Conclusions: High DF and bran intake are feasible in constipated children and contribute to amelioration of constipation.","[Leoni Maffei, Helga Verena] UNESP Sao Paulo State Univ, Botucatu Med Sch, Dept Pediat, Botucatu, SP, Brazil; [Vicentini, Andrea Pereira] UNESP Sao Paulo State Univ, Botucatu Med Sch, Dept Internal Med, Botucatu, SP, Brazil",Universidade Estadual Paulista; Universidade Estadual Paulista,"Maffei, HVL (corresponding author), Rua Engn Edgar Egidio de Souza 303,Apt 51, BR-01233020 Sao Paulo, Brazil.",vlmaffei@uol.com.br,,,,,,,41,26,33,0,30,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0277-2116,1536-4801,,J PEDIATR GASTR NUTR,J. Pediatr. Gastroenterol. Nutr.,JAN,2011,52,1,,,,,55,59,,10.1097/MPG.0b013e3181e2c6e2,http://dx.doi.org/10.1097/MPG.0b013e3181e2c6e2,,,5,Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,697NO,20975583,Bronze,,,2024-06-04,WOS:000285520500012,View Full Record in Web of Science
J,"de Carvalho, EB; Vitolo, MR; Gama, CM; Lopez, FA; Taddei, JAC; de Morais, MB",,,,"de Carvalho, Erica Bloes; Vitolo, Marcia Regina; Gama, Cintia Mendes; Lopez, Fabio Ancona; Taddei, Jose Augusto C.; de Morais, Mauro Batista",,,"Fiber intake, constipation, and overweight among adolescents living in Sao Paulo city",NUTRITION,,,English,Article,,,,,,dietary fiber; teen health; constipation; overweight,BODY-MASS INDEX; DIETARY FIBER; CHILDREN; FAT; WEIGHT; BRAZIL; CONSUMPTION; PATTERNS; PROTEIN; OBESITY,"Objective: This study evaluated the dietary fiber intake of adolescents in the metropolitan area of Sao Paulo city and any association between low dietary fiber intake. with constipation and overweight. Methods: In total, 716 adolescents were included within the study, of whom 314 attended private school and 402 attended public school. Evaluation of fiber intake was based on a 24-h daily intake record and a frequency questionnaire. Data concerning bowel movements and height and weight measurements were also taken. Results: Fiber consumption, below that recommended (age + 5), was found in 61.8% and 41.4% (P = 0.000) of girls attending private and public schools, respectively, and in 44.1% and 25.6% of boys (P = 0.001). Adolescents who did not eat beans on more than 4 d/wk presented a higher risk of fiber intake below that recommended (age + 5; P < 0.05), with odds ratios ranging from 10.4 to 14.2 according gender and private or public schooling. Dietary fiber intake below that recommended was associated with a greater risk (P < 0.05) toward overweight in students attending public schooling (odds ratios 2.84 and 2.95 for males and females, respectively). Low dietary fiber intake was not associated with constipation. Conclusion: Intake of beans more than four times per week is associated with the appropriate level of fiber intake. Dietary fiber intake below the recommendation was not associated with constipation but was associated with being overweight among those students attending public schooling. (C) 2006 Elsevier Inc. All rights reserved.","Univ Fed Sao Paulo, Pediat Gastroenterol Div, Sao Paulo, Brazil; Univ Fed Sao Paulo, Postgrad Course Nutr, Sao Paulo, Brazil; Fed Fdn, Fac Med Sci, Dept Publ Hlth, Porto Alegre, RS, Brazil; Univ Fed Sao Paulo, Nutr & Metab Div, Sao Paulo, Brazil",Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP),"de Morais, MB (corresponding author), Univ Fed Sao Paulo, Pediat Gastroenterol Div, Sao Paulo, Brazil.",mbmorais@osite.com.br,"MORAIS, MAURO B/I-7995-2014; TADDEI, JOSE AUGUSTO A C/D-8216-2015","Batista de Morais, Mauro/0000-0003-4014-5549; Vitolo, Marcia Regina/0000-0001-9137-3854",,,,,38,25,29,0,9,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",0899-9007,1873-1244,,NUTRITION,Nutrition,JUL-AUG,2006,22,7-8,,,,,744,749,,10.1016/j.nut.2006.05.001,http://dx.doi.org/10.1016/j.nut.2006.05.001,,,6,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,064OM,16815488,,,,2024-06-04,WOS:000239099000007,View Full Record in Web of Science
J,"Kokke, FTM; Scholtens, PAMJ; Alles, MS; Decates, TS; Fiselier, TJW; Tolboom, JJM; Kimpen, JLL; Benninga, MA",,,,"Kokke, Freddy T. M.; Scholtens, Petra A. M. J.; Alles, Martine S.; Decates, Tom S.; Fiselier, Theo J. W.; Tolboom, Jules J. M.; Kimpen, Jan L. L.; Benninga, Marc A.",,,A Dietary Fiber Mixture versus Lactulose in the Treatment of Childhood Constipation: A Double-blind Randomized Controlled Trial,JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION,,,English,Article,,,,,,Dietary fiber; Lactulose; Childhood constipation; Randomized controlled trial,GASTROINTESTINAL TRANSIT; FUNCTIONAL CONSTIPATION; CHILDREN; STOOL; OLIGOSACCHARIDES; GLUCOMANNAN; ENCOPRESIS; INTESTINE; TIME,"Background: Constipation is a common problem in children. As first-line treatment, increased dietary fiber is often advocated. To our knowledge. however, no large Studies evaluating the effect of dietary fibers in childhood constipation have been published. Patients and Methods: A randomized, double-blind, prospective controlled Study was performed. Patients received either a fiber mixture or lactulose in a yogurt drink. After a baseline period of a week, patients were treated for 8 weeks followed by 4 weeks of weaning. Polyethylene glycol 3350 was added if no clinical improvement was observed after 3 weeks. Using a standardized bowel diary. parents recorded defecation frequency during the treatment period. In addition, incontinence frequency. stool consistency. presence of abdominal pain and flatulence. necessity for step-up medication, and dry weight of feces were recorded, as were adverse effects. Results: A total of 147 children were eligible 12 children wished not to participate. Of the remaining children, 65 were randomized to treatment with fiber Mixture and 70 to treatment with lactulose. In ally 97 children completed the study. No difference was found between the groups after the treatment period concerning defecation frequency (P=0.481) and fecal incontinence frequency (P=0.084). However, consistency of stools was softer in the lactulose group (P = 0.01). Abdominal pain and flatulence scores were comparable (P=0.395 and P = 0.739. respectively). The necessity of step-up medication during the treatment period was comparable (P=0.996), as were taste scores (P=0.657). No serious adverse effects were registered. Conclusions: A fluid fiber mixture and lactulose give Comparable results in the treatment of childhood constipation. JPGN 47:592-597, 2008.","[Kokke, Freddy T. M.; Kimpen, Jan L. L.] Univ Med Ctr Utrecht, Wilhelmia Childrens Hosp, Dept Paediat Gastroenterol, NL-3508 AB Utrecht, Netherlands; [Kokke, Freddy T. M.; Kimpen, Jan L. L.] Univ Med Ctr Utrecht, Wilhelmia Childrens Hosp, Dept Paediat, NL-3508 AB Utrecht, Netherlands; [Fiselier, Theo J. W.; Tolboom, Jules J. M.] Catholic Univ Nijmegen, Dept Paediat & Paediat Gastroenterol, Nijmegen, Netherlands; [Decates, Tom S.; Benninga, Marc A.] Univ Amsterdam, Acad Med Ctr, Dept Paediat Gastroenterol, NL-1105 AZ Amsterdam, Netherlands",Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam,"Kokke, FTM (corresponding author), Univ Med Ctr Utrecht, Wilhelmia Childrens Hosp, Dept Paediat Gastroenterol, POB 85090, NL-3508 AB Utrecht, Netherlands.",f.t.m.kokke@umcutrecht.nl,,,The Scientific Research Foundation (Stichting Wetenschappelijk Onderzoek) [SWO 2001]; Business aimed Technological Cooperation [00176]; [9.001],The Scientific Research Foundation (Stichting Wetenschappelijk Onderzoek); Business aimed Technological Cooperation;,"The Scientific Research Foundation (Stichting Wetenschappelijk Onderzoek) project SWO 2001 provided financial support. Dr Kokke received financial support through project no. 9.001, which is a sub-project of Business aimed Technological Cooperation project 00176. Dr Scholtens and Alles arc researchers and employees of, Danone Research BV (formerly Numico Research BV). Drs Decates. Fiselier, Tolboom, Kimpen, and Benninga report no conflicts of interest.",,36,57,64,0,14,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA",0277-2116,,,J PEDIATR GASTR NUTR,J. Pediatr. Gastroenterol. Nutr.,NOV,2008,47,5,,,,,592,597,,10.1097/MPG.0b013e318162c43c,http://dx.doi.org/10.1097/MPG.0b013e318162c43c,,,6,Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,366YL,18979582,Bronze,,,2024-06-04,WOS:000260519400010,View Full Record in Web of Science
J,"Okuda, M; Kunitsugu, I; Yoshitake, N; Sasaki, S",,,,"Okuda, Masayuki; Kunitsugu, Ichiro; Yoshitake, Norikazu; Sasaki, Satoshi",,,The Relationship between Functional Constipation and Dietary Habits in School-Age Japanese Children,JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY,,,English,Article,,,,,,cross-sectional study; dietary fiber; fruits; functional constipation; vegetables,QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; FIBER INTAKE; ROME-II; GASTROINTESTINAL DISORDERS; HISTORY QUESTIONNAIRES; CHILDHOOD CONSTIPATION; DEFECATION DISORDERS; PRESCHOOL-CHILDREN; CELIAC-DISEASE,"Functional constipation negatively affects school-related quality of life for children and adolescents. We investigated the association between functional constipation, defined according to the Rome criteria version III, and dietary habits. The subjects of this cross-sectional study were 1,140 5th graders and 1,054 8th graders attending schools in Shunan City, Japan in 2012. Functional constipation was defined as having two or more symptoms of constipation. Dietary habits were assessed using a brief questionnaire. Self-reported biological, demographic and lifestyle information was obtained. Using multiple logistic models, dose-dependent associations among subgroups stratified with quintiles of nutrient and food intake were examined. The prevalence of functional constipation ranged from 3.7% to 8.3% across the grades. The most prevalent symptom was pain or hard stools. There was a link between higher rates of functional constipation and lower levels of dietary fiber intake, vegetables, and fruits (p(trend) = 0.010-0.030). Associations with vegetables and fruits attenuated when controlling for dietary fiber intake (p(trend) = 0.074-0.150). When 5th and 8th graders were separately analyzed, intake of dietary fiber, water from foods, and vegetables had beneficial effects on functional constipation in 8th graders (p(trend) = 0.005-0.038), and fruit intake had a beneficial effect in 5th graders (p(trend) = 0.012). Modification of dietary habits may have a positive effect in reducing functional constipation in school-age children. Diets rich in fiber, vegetables, and fruits, have the potential to improve functional constipation in Japanese children and adolescents.","[Okuda, Masayuki] Yamaguchi Univ, Grad Sch Sci & Engn Innovat, Ube, Yamaguchi 7558505, Japan; [Kunitsugu, Ichiro] Yamaguchi Univ, Grad Sch Med, Ube, Yamaguchi 7558505, Japan; [Yoshitake, Norikazu; Sasaki, Satoshi] Univ Tokyo, Sch Publ Hlth, Tokyo 1130033, Japan",Yamaguchi University; Yamaguchi University; University of Tokyo,"Okuda, M (corresponding author), Yamaguchi Univ, Grad Sch Sci & Engn Innovat, Ube, Yamaguchi 7558505, Japan.",okuda@yamaguchi-u.ac.jp,"Okuda, Masayuki/N-7049-2018","Okuda, Masayuki/0000-0002-2082-8687",,,,,49,11,15,2,7,CENTER ACADEMIC PUBL JAPAN,TOKYO,"2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN",0301-4800,1881-7742,,J NUTR SCI VITAMINOL,J. Nutr. Sci. Vitaminol.,,2019,65,1,,,,,38,44,,10.3177/jnsv.65.38,http://dx.doi.org/10.3177/jnsv.65.38,,,7,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Nutrition & Dietetics,HQ1YL,30814410,gold,,,2024-06-04,WOS:000462195600006,View Full Record in Web of Science
J,"Guimaraes, EV; Goulart, EMA; Penna, FJ",,,,"Guimaraes, EV; Goulart, EMA; Penna, FJ",,,"Dietary fiber intake, stool frequency and colonic transit time in chronic functional constipation in children",BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH,,,English,Article,,,,,,children; constipation; dietary fiber; colonic transit time,RECALL,"The objective of the present study was to evaluate associations between fiber intake, colonic transit time and stool frequency. Thirty-eight patients aged 4 to 14 years were submitted to alimentary evaluation and to measurement of colonic transit time. The median fiber intake of the total sample was age + 10.3 g/day. Only 18.4% of the subjects presented a daily dietary fiber intake below the levels recommended by the American Health Foundation. In this group, the median left colonic transit time was shorter than in the group with higher dietary fiber intake (11 vs 17 h, P = 0.067). The correlation between stool frequency and colonic transit time was negative and weak for left colon (r = -0.3, P = 0.04), and negative and moderate for rectosigmoid and total colon (r = -0.5, P <0.001 and r = -0.5, P <0.001, respectively). The stool frequency was lower in the group with slow transit time (0.8 vs 2.3 per week, P = 0.014). In conclusion. most patients with chronic functional constipation had adequate dietary fiber intake. The negative correlation between stool frequency and colonic transit time increased progressively from proximal segments to distal segments of the colon. Patients with normal and prolonged colonic transit time differ in terms of stool frequency.","Univ Fed Minas Gerais, Hosp Clin, Dept Pediat, Setor Gastroenterol Pediat, Belo Horizonte, MG, Brazil",Universidade Federal de Minas Gerais,"Rua Julia Nunes Guerra,194,Apartamento 501, BR-30380400 Belo Horizonte, MG, Brazil.",,,,,,,,25,21,27,0,4,ASSOC BRAS DIVULG CIENTIFICA,SAO PAULO,"FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, 00, BRAZIL",0100-879X,1678-4510,,BRAZ J MED BIOL RES,Brazilian J. Med. Biol. Res.,SEP,2001,34,9,,,,,1147,1153,,10.1590/S0100-879X2001000900007,http://dx.doi.org/10.1590/S0100-879X2001000900007,,,7,"Biology; Medicine, Research & Experimental",Science Citation Index Expanded (SCI-EXPANDED),Life Sciences & Biomedicine - Other Topics; Research & Experimental Medicine,474QD,11514838,"gold, Green Submitted, Green Published",,,2024-06-04,WOS:000171117600007,View Full Record in Web of Science
J,"Choi, SC; Kim, BJ; Rhee, PL; Chang, DK; Son, HJ; Kim, JJ; Rhee, JC; Kim, SI; Han, YS; Sim, KH; Park, SN",,,,"Choi, Sung Chul; Kim, Beom Jin; Rhee, Poong-Lyul; Chang, Dong Kyung; Son, Hee Jung; Kim, Jae J.; Rhee, Jong Chul; Kim, Soon Im; Han, Young Sil; Sim, Ki Hyeon; Park, Seok Nam",,,Probiotic Fermented Milk Containing Dietary Fiber Has Additive Effects in IBS with Constipation Compared to Plain Probiotic Fermented Milk,GUT AND LIVER,,,English,Article,,,,,,Constipation; Dietary fiber; Irritable bowel syndrome; Probiotic fermented milk,IRRITABLE-BOWEL-SYNDROME; RANDOMIZED CONTROLLED-TRIAL; DOUBLE-BLIND; CLINICAL-TRIAL; COLONIC FERMENTATION; BARRIER FUNCTION; SYMPTOMS; PLACEBO; LACTOBACILLUS; BIFIDOBACTERIUM,"Background/Aims: Although controversial, probiotics and dietary fiber are commonly used for patients with irritable bowel syndrome (IBS). We evaluated the effects of multistrain probiotics on the symptoms of IBS to determine whether the addition of dietary fiber had an additive effect on constipation-predominant IBS. Methods: A total of 142 participants who met the Rome III criteria were recruited and randomized into a control group or a test group. Participants in the control group received multistrain probiotic fermented milk with Streptococcus thermophilus, Lactobacillus acidophilus and Bifidobacterium infantis; the participants in the test group received the same probiotic fermented milk mixed with dietary fiber such as sea tangle extracts, radish extracts and glasswort extracts. The patients were treated for four weeks. Results: Most of the symptoms of IBS, with the exception of flatulence, stool consistency, and frequency of defecation, significantly improved in both groups. In the analysis of IBS subtypes, especially constipation-predominant IBS, the frequency and duration of defecation and straining at stool were improved more in the test group than in the control group. Conclusions: Dietary fiber had additive benefits for the symptoms of constipation, especially in constipation-predominant IBS. (Gut Liver 2011;5:22-28)","[Choi, Sung Chul; Rhee, Poong-Lyul; Chang, Dong Kyung; Son, Hee Jung; Kim, Jae J.; Rhee, Jong Chul] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul 135710, South Korea; [Kim, Beom Jin] Chung Ang Univ, Coll Med, Dept Internal Med, Seoul 156756, South Korea; [Kim, Soon Im; Han, Young Sil] Sookmyung Womens Univ, Nano Bioresources Ctr, Seoul, South Korea; [Sim, Ki Hyeon] Sookmyung Womens Univ, Dept Food & Nutr, Seoul, South Korea; [Park, Seok Nam] NamYang Dairy Prod Co Ltd, R&D Ctr, Gongju, South Korea",Sungkyunkwan University (SKKU); Samsung Medical Center; Chung Ang University; Chung Ang University Hospital; Sookmyung Women's University; Sookmyung Women's University,"Rhee, PL (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, 50 Irwon Dong, Seoul 135710, South Korea.",plrhee@skku.edu,"Rhee, Poong Lyul/C-9655-2011","Rhee, Poong-Lyul/0000-0003-0495-5296",Seoul Research and Business Development Program [10582],Seoul Research and Business Development Program(Seoul RBD program),The authors were supported by grants from the Seoul Research and Business Development Program (No. 10582).,,29,19,20,1,41,EDITORIAL OFFICE GUT & LIVER,SEOUL,"305 LOTTE GOLD ROSE II, 890-59, DAECHI 4-DONG, GANGNAM-GU, SEOUL, 135-839, SOUTH KOREA",1976-2283,,,GUT LIVER,Gut Liver,MAR,2011,5,1,,,,,22,28,,10.5009/gnl.2011.5.1.22,http://dx.doi.org/10.5009/gnl.2011.5.1.22,,,7,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,737LG,21461068,"Green Published, gold",,,2024-06-04,WOS:000288569700003,View Full Record in Web of Science
J,"Jia, FJ; Yang, SF; Ma, YY; Gong, ZQ; Cui, WJ; Wang, YS; Wang, WL",,,,"Jia, Fengjuan; Yang, Shifa; Ma, Yuyang; Gong, Zhiqing; Cui, Wenjia; Wang, Yansheng; Wang, Wenliang",,,Extraction optimization and constipation-relieving activity of dietary fiber from Auricularia polytricha,FOOD BIOSCIENCE,,,English,Article,,,,,,Auricularia polytricha; Dietary fiber; Constipation-relieving activity; Gastrointestinal hormone,GASTROINTESTINAL HORMONES; HEALTH-BENEFITS; CLASSIFICATION; PRODUCTS; BARLEY,"Auricularia polytricha-derived dietary fiber (DF) is a bio-active health-promoting compound, but limited work has been done on optimization of extraction and constipation-relieving activity. In this study, an enzymatic-chemical method to extract DF was optimized, and the results showed that optimal extraction conditions were ratio of water to A. polytricha powder 41 ml/g, 0.4% a-amylase, 1.0% protamex, and enzymolysis at 66 degrees C, with DF extraction rate of 56 +/- 3%. Then, the constipation-relieving activity of DF was evaluated with a constipated rat model. Sprague - Dawley specific pathogen free rats were randomly divided into 6 groups, namely normal, model, Maren boluses treatment, and three DF treatment groups. Constipated rats fed with 5% A. polytricha-derived DF in place of part of the standard diet resulted in increased wet weight of feces and intestinal propulsive rate, which was associated with the functional properties of DF, including high swelling capacity, water binding capacity, fat adsorption capacity, and glucose adsorption capacity. Moreover, A. polytricha-derived DF had a positive effect on gastrointestinal hormones in rats. The results indicated that the enzymatic-chemical extraction method is effective for extracting DF from A. polytricha and the DF has high constipation-relieving activity.","[Jia, Fengjuan; Ma, Yuyang; Gong, Zhiqing; Cui, Wenjia; Wang, Yansheng; Wang, Wenliang] Shandong Acad Agr Sci, Inst Agrofood Sci & Technol, 202 Gongye North Rd, Jinan 250100, Shandong, Peoples R China; [Jia, Fengjuan; Ma, Yuyang; Gong, Zhiqing; Cui, Wenjia; Wang, Yansheng; Wang, Wenliang] Key Lab Agroprod Proc Technol Shandong Prov, Jinan 250100, Shandong, Peoples R China; [Jia, Fengjuan; Ma, Yuyang; Gong, Zhiqing; Cui, Wenjia; Wang, Yansheng; Wang, Wenliang] Minist Agr & Rural Affairs, Key Lab Novel Food Resources Proc, Jinan 250100, Shandong, Peoples R China; [Yang, Shifa] Shandong Acad Agr Sci, Jinan 250100, Shandong, Peoples R China",Shandong Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Shandong Academy of Agricultural Sciences,"Jia, FJ; Wang, WL (corresponding author), Shandong Acad Agr Sci, Inst Agrofood Sci & Technol, 202 Gongye North Rd, Jinan 250100, Shandong, Peoples R China.",jfj.5566@163.com; cywwl@163.com,"yang, shifa/HLX-5248-2023",,Natural Science Foundation of Shandong Province [ZR2018LC018]; Key Research and Development Plan of Shandong Province [2017GNC13106]; Modern Agricultural Industry Technology System of Shandong Province [SDAIT-07-08]; Key Basic Research Project of Provincial Natural Science Foundation of Shandong [ZR2018ZC0944],Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Key Research and Development Plan of Shandong Province; Modern Agricultural Industry Technology System of Shandong Province; Key Basic Research Project of Provincial Natural Science Foundation of Shandong,"This work was supported by the Natural Science Foundation of Shandong Province (ZR2018LC018), the Key Research and Development Plan of Shandong Province (2017GNC13106), the Modern Agricultural Industry Technology System of Shandong Province (SDAIT-07-08), and the Key Basic Research Project of Provincial Natural Science Foundation of Shandong (ZR2018ZC0944).",,33,14,16,8,53,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",2212-4292,2212-4306,,FOOD BIOSCI,Food Biosci.,FEB,2020,33,,,,,,,,,10.1016/j.fbio.2019.100506,http://dx.doi.org/10.1016/j.fbio.2019.100506,,,9,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,JY6AB,,,,,2024-06-04,WOS:000504494300007,View Full Record in Web of Science
J,"Sullivan, PB; Alder, N; Shrestha, B; Turton, L; Lambert, B",,,,"Sullivan, P. B.; Alder, N.; Shrestha, B.; Turton, L.; Lambert, B.",,,Effectiveness of using a behavioural intervention to improve dietary fibre intakes in children with constipation,JOURNAL OF HUMAN NUTRITION AND DIETETICS,,,English,Article,,,,,,behavioural intervention; children; constipation; diet; fibre,GLUCOMANNAN; ENCOPRESIS; CHILDHOOD; TRIAL,"Background: Functional constipation is common in childhood; diets in affluent industrialised countries may be a significant contributory factor as a result of inadequate fibre content. Only a few intervention studies have been reported where childhood constipation has been treated by increasing dietary fibre. The present study aimed to demonstrate that dietary fibre intakes of children with constipation can be increased using a specifically-designed behaviour modification technique with a self-monitoring and reward system. Methods: Forty-three children, aged 2-14 years, with functional constipation (defined as less than three bowel movements per week with hard stools and difficulty or delay in defecation) were randomised to one of two treatment groups: Control (n = 20), receiving general advice on increasing dietary fibre intake, or Intervention (n = 23), using the intervention tool. Fibre intake, laxative use and stool frequency were assessed at baseline, and at 3, 6 and 12 months, using parent-filled diaries. Results: A behavioural intervention method significantly increases the fibre intakes of children with constipation at 3 months compared to standard dietary treatment (P = 0.005), remaining so after adjusting for baseline fibre intake (P = 0.007). Follow-up at 6 and 12 months showed no further increase. No significant benefit in terms of a reduction in laxative use or increased stool frequency associated with additional fibre intake was demonstrated. Conclusions: The findings confirm the difficulties encountered in beginning and maintaining high-fibre diets in children.","[Sullivan, P. B.; Shrestha, B.; Turton, L.; Lambert, B.] Univ Oxford, John Radcliffe Hosp, Dept Paediat, Childrens Hosp, Oxford OX3 9DU, England; [Alder, N.] Wolfson Coll Annexe, Ctr Stat Med, Oxford, England",University of Oxford; University of Oxford,"Sullivan, PB (corresponding author), Univ Oxford, John Radcliffe Hosp, Dept Paediat, Childrens Hosp, Level 2, Oxford OX3 9DU, England.",peter.sullivan@paediatrics.ox.ac.uk,,,Well Child and Children Nationwide; Sparks Charity [07OXF03] Funding Source: researchfish,Well Child and Children Nationwide; Sparks Charity,The authors declare they have no conflict of interests. Funding for the research time of LS and BL was provided by Well Child and Children Nationwide.,,23,8,10,2,26,WILEY-BLACKWELL,MALDEN,"COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA",0952-3871,,,J HUM NUTR DIET,J. Hum. Nutr. Diet.,FEB,2012,25,1,,,,,33,42,,10.1111/j.1365-277X.2011.01179.x,http://dx.doi.org/10.1111/j.1365-277X.2011.01179.x,,,10,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,877SS,21668531,,,,2024-06-04,WOS:000299203600005,View Full Record in Web of Science
J,"Lai, H; Li, YF; He, YF; Chen, FY; Mi, BB; Li, JQ; Xie, JW; Ma, GQ; Yang, JZ; Xu, K; Liao, X; Yin, Y; Liang, JR; Kong, LY; Wang, XY; Li, ZX; Shen, Y; Dang, SN; Zhang, L; Wu, Q; Zeng, LX; Shi, L; Zhang, XG; Tian, T; Liu, X",,,,"Lai, Hao; Li, Yunfeng; He, Yafang; Chen, Fangyao; Mi, Baibing; Li, Junqi; Xie, Jiawen; Ma, Guoqing; Yang, Jinzhao; Xu, Kun; Liao, Xia; Yin, Yan; Liang, Junrong; Kong, Liyun; Wang, Xinyan; Li, Zhongxia; Shen, Yuan; Dang, Shaonong; Zhang, Lei; Wu, Qian; Zeng, Lingxia; Shi, Lin; Zhang, Xuguang; Tian, Tian; Liu, Xin",,,Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial,GUT MICROBES,,,English,Article,,,,,,Dietary fiber; probiotics; gut microbiota; functional constipation; nutritional intervention,BIFIDOBACTERIA; ADULTS; HEALTH,"Dietary fibers/probiotics may relieve constipation via optimizing gut microbiome, yet with limited trial-based evidences. We aimed to evaluate the effects of formulas with dietary fibers or probiotics on functional constipation symptoms, and to identify modulations of gut microbiota of relevance. We conducted a 4-week double-blinded randomized placebo-controlled trial in 250 adults with functional constipation. Intervention: A: polydextrose; B: psyllium husk; C: wheat bran + psyllium husk; D: Bifidobacterium animalis subsp. lactis HN019 + Lacticaseibacillus rhamnosus HN001; Placebo: maltodextrin. Oligosaccharides were also included in group A to D. 16S rRNA sequencing was used to assess the gut microbiota at weeks 0, 2, and 4. A total of 242 participants completed the study. No time-by-group effect was observed for bowel movement frequency (BMF), Bristol stool scale score (BSS), and degree of defecation straining (DDS), while BSS showed mean increases of 0.95-1.05 in group A to D (all P < 0.05), but not significantly changed in placebo (P = 0.170), and 4-week change of BSS showed similarly superior effects of the interventions as compared placebo. Group D showed a marginal reduction in plasma 5-hydroxytryptamine. Group A resulted in a higher Bifidobacterium abundance than placebo at week 2 and 4. Fourteen genera showed intervention-specific increasing or decreasing trends continuously, among which Anaerostipes showed increasing trends in groups B and C, associated with BMF increase. Random forest models identified specific baseline microbial genera panels predicting intervention responders. In conclusion, we found that the dietary fibers or probiotics may relieve hard stool, with intervention-specific changes in gut microbiota relevant to constipation relief. Baseline gut microbiota may predispose the intervention responsiveness. ClincialTrials.gov number, NCT04667884. Plain Language Summary What is the context? Supplementation of dietary fibers, such as psyllium husk or wheat bran (10 similar to 15 g/day) may relieve constipation symptoms, but bloating and flatulence are major concerns on a high fiber intake. Functional constipation patients had alternated gut microbiota profiles, while meta-analysis suggested that multispecies probiotics may increase bowel movement frequency and relieve hard stool in functional constipation. center dot Dietary fibers or probiotics may lead to before-after changes of gut microbiota in patients with functional constipation, but time-series continued changes of gut microbiota during the intervention are unknown. Elevation of 5-hydroxytryptamine synthesis in enterochromaffin cells may affect bowel movement. And the elevated plasma 5-hydroxytryptamine was observed in functional constipation patients. What is new? Daily supplement of three prebiotic formulas with dietary fibers (polydextrose, psyllium husk, wheat bran, together with oligosaccharides), or a probiotic formula with Bifidobacterium animalis subsp. lactis HN019 + Lacticaseibacillus rhamnosus HN001 effectively relieved hard stool in functional constipation patients after 4 weeks intervention. We identified continued increasing or decreasing gut microbial genera over the intervention. Dietary fiber - gut microbiota (Anaerostipes)-constipation relieve (bowel movement frequency) evidence axis was identified in this human trial. Probiotic supplementation marginally reduced plasma 5-hydroxytryptamine, possibly associated with changes in BMF-related gut microbial genera. Intervention-specific baseline gut microbiota well predicted the responsiveness of constipation symptom relief. What is the impact? We provided references for the dosage and duration of dietary fiber/probiotics recommendations for adults with functional constipation, and advanced the microbial genera evidences of the fibers/probiotics-microbiota-laxation theory in humans.","[Lai, Hao; Li, Yunfeng; He, Yafang; Chen, Fangyao; Mi, Baibing; Li, Junqi; Xie, Jiawen; Ma, Guoqing; Yang, Jinzhao; Xu, Kun; Kong, Liyun; Shen, Yuan; Dang, Shaonong; Zhang, Lei; Wu, Qian; Zeng, Lingxia; Liu, Xin] Xi An Jiao Tong Univ, Global Hlth Inst, Hlth Sci Ctr, Sch Publ Hlth, Xian, Peoples R China; [Liao, Xia] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Nutr, Xian, Peoples R China; [Yin, Yan] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Gastroenterol, Xian, Peoples R China; [Liang, Junrong] Fourth Mil Med Univ, Tangdu Hosp, Dept Gastroenterol, Xian, Peoples R China; [Wang, Xinyan; Li, Zhongxia; Zhang, Xuguang] BYHEALTH Inst Nutr & Hlth, Guangzhou, Peoples R China; [Shi, Lin] Shaanxi Normal Univ, Sch Food Engn & Nutr Sci, Xian, Peoples R China; [Tian, Tian] Xian Daxing Hosp, Dept Nutr, Xian, Peoples R China; [Liu, Xin] Xi An Jiao Tong Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hlth Sci Ctr, 76 West Yanta Rd, Xian 710061, Peoples R China; [Tian, Tian] Xian Daxing Hosp, Dept Nutr, Xian 710016, Peoples R China; [Zhang, Xuguang] BYHEALTH Inst Nutr & Hlth, 3 Kehui 3rd St,99 Kexue Ave Cent, Guangzhou 510663, Peoples R China",Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University; Air Force Military Medical University; Shaanxi Normal University; Xi'an Jiaotong University,"Liu, X (corresponding author), Xi An Jiao Tong Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hlth Sci Ctr, 76 West Yanta Rd, Xian 710061, Peoples R China.;Tian, T (corresponding author), Xian Daxing Hosp, Dept Nutr, Xian 710016, Peoples R China.;Zhang, XG (corresponding author), BYHEALTH Inst Nutr & Hlth, 3 Kehui 3rd St,99 Kexue Ave Cent, Guangzhou 510663, Peoples R China.",zhangxg2@by-health.com; yyktiantian@163.com; xinliu@xjtu.edu.cn,"Wang, Xinyi/KHV-4909-2024; Chen, Jin/KBQ-0163-2024; Zhang, Wenkai/JWO-2030-2024; FENG, X/JPL-4188-2023; zhang, xu/JXX-7692-2024; Li, Zhongxia/JNS-8893-2023; chen, yue/JXW-9556-2024; li, guo/KHU-1749-2024; Zhang, yuxuan/JXM-9935-2024; Wang, YuHan/KGY-2933-2024; yang, liu/JXX-5043-2024; zhang, wen/JXN-0191-2024; Wang, zhenhua/KFA-8731-2024; Liu, Zhiyuan/KDP-2606-2024; yu, hui/KDO-3946-2024; mi, baibing/ABO-1246-2022; yang, yy/KBR-1536-2024; wang, KiKi/JFZ-3334-2023; li, xinyi/KEI-6391-2024; xu, xuan/KHX-8344-2024; he, xi/JXN-3817-2024; feng, yue/KHV-4687-2024; zhao, weiwei/JUU-6585-2023; yang, le/KFB-5420-2024; zhang, can/KHC-5357-2024; Liu, Shaobo/JUU-5767-2023; Li, Wenjuan/KDN-8450-2024; Liu, qi/JZT-5038-2024; Li, Ren/JVZ-9153-2024; lin, yuan/JXL-9592-2024; zhang, ling/JXW-6931-2024; zhang, jiayue/JUF-0129-2023; wang, jiaqi/KHC-5900-2024; wang, jiaqi/JSL-7112-2023; Ma, Wei/JXY-5019-2024; li, lan/KCJ-5061-2024; Liu, Junjie/KHV-6949-2024; Sun, Yue/KHU-8159-2024; Lu, Yi/KEJ-2560-2024; Li, Huizhen/JPX-2563-2023; wang, haoyu/KHY-6295-2024; Yan, Lu/KHW-7015-2024; Liu, Chang/KGL-6678-2024; Wang, Yibin/KEZ-9645-2024; wang, yue/KDO-9209-2024; Jing, Jing/JSK-6237-2023; Zhou, Xinyi/KGM-6689-2024; Zhang, Xiaoyu/JXR-6386-2024; WU, CHUNYAN/HMO-6771-2023","Chen, Jin/0009-0005-5844-635X; mi, baibing/0000-0002-5208-7633; Li, Ren/0000-0002-2579-2580; Ma, Wei/0000-0002-7344-998X; wang, haoyu/0009-0001-2467-5331; WU, CHUNYAN/0000-0002-6531-1219; Lai, Hao/0000-0003-0277-9364",,,,,37,19,19,49,126,TAYLOR & FRANCIS INC,PHILADELPHIA,"530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA",1949-0976,1949-0984,,GUT MICROBES,Gut Microbes,DEC 31,2023,15,1,,,,,,,2197837,10.1080/19490976.2023.2197837,http://dx.doi.org/10.1080/19490976.2023.2197837,,,15,Gastroenterology & Hepatology; Microbiology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Microbiology,D8UB0,37078654,"gold, Green Published",Y,N,2024-06-04,WOS:000971413300001,View Full Record in Web of Science
J,"Schmier, JK; Miller, PE; Levine, JA; Perez, V; Maki, KC; Rains, TM; Devareddy, L; Sanders, LM; Alexander, DD",,,,"Schmier, Jordana K.; Miller, Paige E.; Levine, Jessica A.; Perez, Vanessa; Maki, Kevin C.; Rains, Tia M.; Devareddy, Latha; Sanders, Lisa M.; Alexander, Dominik D.",,,Cost savings of reduced constipation rates attributed to increased dietary fiber intakes: a decision-analytic model,BMC PUBLIC HEALTH,,,English,Article,,,,,,Constipation; Public health; Prevention; Cost-savings; Fiber; Diet; Lifestyle,FUNCTIONAL GASTROINTESTINAL DISORDERS; UNITED-STATES; HEALTH-CARE; DIVERTICULAR-DISEASE; PHYSICAL-ACTIVITY; RISK; CHILDREN; CANCER; METAANALYSIS; ASSOCIATION,"Background: Nearly five percent of Americans suffer from functional constipation, many of whom may benefit from increasing dietary fiber consumption. The annual constipation-related healthcare cost savings associated with increasing intakes may be considerable but have not been examined previously. The objective of the present study was to estimate the economic impact of increased dietary fiber consumption on direct medical costs associated with constipation. Methods: Literature searches were conducted to identify nationally representative input parameters for the U. S. population, which included prevalence of functional constipation; current dietary fiber intakes; proportion of the population meeting recommended intakes; and the percentage that would be expected to respond, in terms of alleviation of constipation, to a change in dietary fiber consumption. A dose-response analysis of published data was conducted to estimate the percent reduction in constipation prevalence per 1 g/day increase in dietary fiber intake. Annual direct medical costs for constipation were derived from the literature and updated to U. S. $ 2012. Sensitivity analyses explored the impact on adult vs. pediatric populations and the robustness of the model to each input parameter. Results: The base case direct medical cost-savings was $ 12.7 billion annually among adults. The base case assumed that 3% of men and 6% of women currently met recommended dietary fiber intakes; each 1 g/day increase in dietary fiber intake would lead to a reduction of 1.9% in constipation prevalence; and all adults would increase their dietary fiber intake to recommended levels (mean increase of 9 g/day). Sensitivity analyses, which explored numerous alternatives, found that even if only 50% of the adult population increased dietary fiber intake by 3 g/day, annual medical costs savings exceeded $ 2 billion. All plausible scenarios resulted in cost savings of at least $ 1 billion. Conclusions: Increasing dietary fiber consumption is associated with considerable cost savings, potentially exceeding $ 12 billion, which is a conservative estimate given the exclusion of lost productivity costs in the model. The finding that $ 12.7 billion in direct medical costs of constipation could be averted through simple, realistic changes in dietary practices is promising and highlights the need for strategies to increase dietary fiber intakes.","[Schmier, Jordana K.; Levine, Jessica A.] Exponent Inc, Alexandria, VA 22314 USA; [Miller, Paige E.; Perez, Vanessa] Exponent Inc, Chicago, IL 60661 USA; [Maki, Kevin C.; Rains, Tia M.] Biofortis Provident Clin Res, Addison, IL 60101 USA; [Devareddy, Latha; Sanders, Lisa M.] Kellogg Co, Battle Creek, MI 49015 USA; [Alexander, Dominik D.] Exponent Inc, Boulder, CO 80303 USA",Exponent; Exponent; Exponent,"Perez, V (corresponding author), Exponent Inc, 525 W Monroe St Suite 1050, Chicago, IL 60661 USA.",vperez@exponent.com,"Sanders, Lisa M./AAC-7105-2020; Schmier, Jordana/I-2994-2019","Sanders, Lisa M./0000-0003-1347-1533; Schmier, Jordana/0000-0002-4662-8800; Perez Patel, Vanessa/0000-0003-0586-3019",Biofortis Provident Clinical Research; Kellogg Company,Biofortis Provident Clinical Research; Kellogg Company,"JKS, PEM, JAL, VP, and DDA were supported by funds from Biofortis Provident Clinical Research, and KCM and TMR were supported by funds from Kellogg Company.",,47,25,32,2,18,BMC,LONDON,"CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND",,1471-2458,,BMC PUBLIC HEALTH,BMC Public Health,APR 17,2014,14,,,,,,,,374,10.1186/1471-2458-14-374,http://dx.doi.org/10.1186/1471-2458-14-374,,,7,"Public, Environmental & Occupational Health",Science Citation Index Expanded (SCI-EXPANDED),"Public, Environmental & Occupational Health",AG5SH,24739472,"Green Published, gold",,,2024-06-04,WOS:000335478300001,View Full Record in Web of Science
J,"HILLEMEIER, C",,,,"HILLEMEIER, C",,,AN OVERVIEW OF THE EFFECTS OF DIETARY FIBER ON GASTROINTESTINAL TRANSIT,PEDIATRICS,,,English,Article; Proceedings Paper,Role of Dietary Fiber in Childhood Conference,"MAY 24, 1994","NEW YORK, NY","Amer Hlth Fdn,Kellogg Co",,DIETARY FIBER; GASTROINTESTINAL TRANSIT; CONSTIPATION,WHEAT BRAN; WEIGHT; STOOL; TIME,"This article is a review of the effects that ingested dietary fiber has on gastrointestinal transit time. The various phases of gastrointestinal motility are considered, and the effect of fiber on these various components is explored. Fiber affects each phase of gastrointestinal motility differently; however, the most dramatic effect on decreased transit time and frequency of bowel movements results from the variations it causes in colonic transit time. The mechanisms of defecation in children and the ways in which fiber affects the frequency of bowel movements are emphasized. All types of fiber do not affect gastrointestinal transit in a similar manner, and different preparations of the same fiber either may delay or may increase the time of intestinal transit. In general, fiber is found to increase the frequency of bowel movements and may prove to be of considerable benefit in treating constipation, a common childhood disorder.",,,"HILLEMEIER, C (corresponding author), UNIV MICHIGAN,CS MOTT CHILDRENS HOSP,MED CTR,DEPT PEDIAT,ANN ARBOR,MI 48109, USA.",,,,,,,,13,56,68,2,15,AMER ACAD PEDIATRICS,ELK GROVE VILLAGE,"141 NORTH-WEST POINT BLVD, ELK GROVE VILLAGE, IL 60007-1098",0031-4005,,,PEDIATRICS,Pediatrics,NOV,1995,96,5,,S,,,997,999,,,,,,3,Pediatrics,Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,TE557,7494680,,,,2024-06-04,WOS:A1995TE55700004,View Full Record in Web of Science
J,"Barbosa, IDJ; da Silva, KCA; de Souza, MLR",,,,"Barbosa, Ivanete de Jesus; Alves da Silva, Kenya Cristina; Ribeiro de Souza, Marcio Leandro",,,Association between fiber consumption and constipation in the elderly in a long-term institution,RBONE-REVISTA BRASILEIRA DE OBESIDADE NUTRICAO E EMAGRECIMENTO,,,Portuguese,Article,,,,,,Intestinal constipation; Elderly; Dietary fiber,,"Brazil, following a global trend, experiences an upward growth in the population of people aged over 60 years. With aging, some clinical conditions start to emerge, among which constipation can be included, which seems to be not only related to aging, but also to inadequate nutrition, with a decrease in the consumption of dietary fiber and a decrease in intake of liquids. This study aimed to investigate the association between fiber consumption and constipation in elderly people living in a long-term institution. For this investigation, a questionnaire was developed regarding demographic, anthropometric, eating habits and bowel function. For anthropometry, weight and height were measured. Food intake of macronutrients and fiber was assessed through the average consumption of three nonconsecutive days, assessed through food records. The diagnosis of constipation was performed using the Rome IV criteria and the type of stool assessed by the Bristol Scale. Thirty-one elderly people with a mean age of 86.2 (6.8) years were evaluated and the prevalence of constipation was 22.6%. The average fiber intake was 20.0 (8.1) grams/day. It was observed that 64.5% did not meet the fiber recommendations and there was an association between inadequate fiber consumption and the diagnosis of constipation according to the Rome IV criteria ( p=0.024). This study showed that inadequate fiber consumption may be associated with constipation in elderly people living in a longterm institution.","[Barbosa, Ivanete de Jesus; Alves da Silva, Kenya Cristina; Ribeiro de Souza, Marcio Leandro] Fac Minas FAMINAS BH, Belo Horizonte, MG, Brazil",,"Barbosa, IDJ (corresponding author), Fac Minas FAMINAS BH, Belo Horizonte, MG, Brazil.",ivatata@hotmail.com; kenyacristina_14_bh@hotmail.com; marcionutricionista@yahoo.com.br,"Souza, Marcio/AAX-1638-2020","Souza, Marcio/0000-0003-1517-4516",,,,,37,0,1,3,3,INST BRASILEIRO PESQUISA & ENSINO FISIOLOGIA EXERCICIO-IBPEFEX,SAO PAULO,"INST BRASILEIRO PESQUISA & ENSINO FISIOLOGIA EXERCICIO-IBPEFEX, SAO PAULO, 00000, BRAZIL",1981-9919,,,RBONE-REV BRAS OBES,RBONE-Rev. Bras. Obes. Nutr. Emagrecimento,SEP-OCT,2021,15,96,,,,,871,882,,,,,,12,Nutrition & Dietetics,Emerging Sources Citation Index (ESCI),Nutrition & Dietetics,VM2PH,,,,,2024-06-04,WOS:000984501500012,View Full Record in Web of Science
J,"Bosaeus, I",,,,"Bosaeus, I",,,"Fibre effects on intestinal functions (diarrhoea, constipation and irritable bowel syndrome)",CLINICAL NUTRITION,,,English,Article; Proceedings Paper,Symposium on New Lipid Emulsions in Parenteral Nutrition,"SEP 12, 2004","Lisbon, PORTUGAL",ESPEN,,dietary fibre; diarrhoea; constipation; irritable bowel syndrome,HYDROLYZED GUAR GUM; ORAL REHYDRATION SOLUTION; BRAN PARTICLE-SIZE; DIETARY FIBER; PLASTIC PARTICLES; TRIAL; CHILDREN; TRANSIT,"The effects of fibre on intestinal functions and diseases have been the area of a large body of research conducted over the past decades. In this presentation, some aspects of its effects on diarrhoea, constipation and its use in the irritable bowel syndrome (IBS) are discussed. Dietary fibre is difficult to define and difficult to analyse. Some studies on bowel function and intestinal disease have used high-fibre diets, while most have used fibre concentrates such as wheat bran or preparations of isolated non-digestible carbohydrates. Different fibre sources in the diet do not have the same qualitative or quantitative effects on intestinal functions, making general recommendations on fibre type and amount extremely difficult. Increased fibre intake will generally increase stool weight. The magnitude of the increase varies with the fibre source. The contributions of this increase from an elevated bacterial mass, faecal water and undigested fibre also vary markedly with the type of fibre. Data on the use of fibre are most convincing regarding constipation. Fibre increase bowel movement frequency modestly in constipation and improves symptoms. However, there is too little evidence to determine if one treatment is better than another, and to determine the best treatment for different types of patients, or what fibre source which is most effective. The use of fibre for the treatment of diarrhoea is poorly documented outside the area of enteral nutrition. Though effects have been shown, especially on the duration of diarrhoea in children, further research is needed for recommendations to be made. Fibre and bulking agents are commonly used in the treatment of IBS, but the benefits seem to remain unproven despite a large number of trials. Some IBS patients may benefit from fibre supplementation, but there are problems of tolerance in many patients. Some fibre products may be better tolerated than others, but data are too sparse for definite recommendations to be made. (c) 2004 Elsevier Ltd. All rights reserved.","Sahlgrens Univ Hosp, Dept Clin Nutr, SE-41345 Gothenburg, Sweden",Sahlgrenska University Hospital,"Bosaeus, I (corresponding author), Sahlgrens Univ Hosp, Dept Clin Nutr, SE-41345 Gothenburg, Sweden.",ingvar.bosaeus@nutrition.gu.se,"Bosaeus, Ingvar/IYJ-5104-2023","Bosaeus, Ingvar/0000-0001-8287-6310",,,,,34,64,79,2,35,CHURCHILL LIVINGSTONE,EDINBURGH,"JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND",0261-5614,,,CLIN NUTR,Clin. Nutr.,,2004,,,,2,,,33,38,,10.1016/j.clnu.2004.09.006,http://dx.doi.org/10.1016/j.clnu.2004.09.006,,,6,Nutrition & Dietetics,Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,973RI,,,,,2024-06-04,WOS:000232539900005,View Full Record in Web of Science
J,"Macêdo, MIP; Albuquerque, MDM; Tahan, S; de Morais, MB",,,,"Macedo, Maria Irisdalva P.; Albuquerque, Maria de Fatima M.; Tahan, Soraia; de Morais, Mauro Batista",,,"Is there any association between overweight, physical activity, fat and fiber intake with functional constipation in adolescents?",SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY,,,English,Article,,,,,,Constipation; overweight; physical activity (motor activity); dietary fiber; dietary fats; adolescent,GASTROINTESTINAL DISORDERS; INCREASED PREVALENCE; INCREASED RISK; DIETARY FIBER; CHILDREN; OBESITY; SYMPTOMS; POPULATION; FREQUENCY,"Objectives: To assess the prevalence of functional constipation and its association with overweight, physical activity and the estimation of fat and fiber intake in adolescents. Methods: In all, 386 adolescents aged 14-19 years from the city of Maceio (Alagoas, Northeast Brazil) were included in this study. Participants responded to standardized questionnaires that assessed bowel habits, physical activity and the estimation of fat and dietary fiber intake. Functional constipation was defined according to the Rome criteria. Weight and height were measured using standard methods. Body mass index (BMI) was used to evaluate whether a participant was overweight. Results: The prevalence of constipation was 24.9%. The median BMI was higher in female adolescents with constipation (22.6) compared with female adolescents without constipation (20.0; p = .001). Physical inactivity (fewer than 300 min of physical activity per week) was more frequent in females (62.7%; 126/201) than in males (42.2%; 78/185; p = .000). No association was observed between physical inactivity and functional constipation. Excessive intake of fat in the diet was found in 45.3% (175/386) of participants, while poor dietary fiber intake was found in 84.2% (325/386) of participants. No association was found between a fat-rich diet and constipation. Low dietary fiber intake was associated with constipation in female adolescents (odds ratio = 3.42, 95% confidence interval: 1.08 and 12.06). Conclusions: The prevalence of constipation was high among this group of adolescents. Constipation was not associated with physical inactivity but was associated with a low dietary fiber intake and higher BMI values in female adolescents.","[Macedo, Maria Irisdalva P.] Univ Fed Sao Paulo, Postgrad Program Pediat, Escola Paulista Med, Rua Pedro de Toledo 781,12th Andar, BR-04039002 Sao Paulo, Brazil; [Albuquerque, Maria de Fatima M.] Univ Fed Alagoas, Maceio, Alagoas, Brazil; [Tahan, Soraia; de Morais, Mauro Batista] Univ Fed Sao Paulo, Div Pediat Gastroenterol, Escola Paulista Med, Sao Paulo, Brazil",Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Alagoas; Universidade Federal de Sao Paulo (UNIFESP),"de Morais, MB (corresponding author), Univ Fed Sao Paulo, Postgrad Program Pediat, Escola Paulista Med, Rua Pedro de Toledo 781,12th Andar, BR-04039002 Sao Paulo, Brazil.",maurobmorais@gmail.com,"MORAIS, MAURO B/I-7995-2014",,,,,,40,12,14,1,12,TAYLOR & FRANCIS LTD,ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND",0036-5521,1502-7708,,SCAND J GASTROENTERO,Scand. J. Gastroenterol.,APR 2,2020,55,4,,,,,414,420,,10.1080/00365521.2020.1749878,http://dx.doi.org/10.1080/00365521.2020.1749878,,APR 2020,7,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,LN3EV,32320314,,,,2024-06-04,WOS:000528364700001,View Full Record in Web of Science
J,"Huang, CF; Lyu, J; Chu, CN; Ge, L; Peng, YP; Yang, ZY; Xiong, SH; Wu, B; Chen, X; Zhang, XW",,,,"Huang, Congfu; Lyu, Jinli; Chu, Chunuo; Ge, Lan; Peng, Yuanping; Yang, Zhenyu; Xiong, Shenghua; Wu, Bin; Chen, Xiao; Zhang, Xiaowei",,,Dietary fiber and probiotics based on gut microbiota targeting for functional constipation in children with cerebral palsy,FRONTIERS IN PEDIATRICS,,,English,Article,,,,,,gut microbiota; dietary fiber; probiotics; cerebral palsy; functional constipation,GASTROINTESTINAL DISORDERS; PSYLLIUM; TRANSIT,"Gastrointestinal (GI) disorders are very common among children with cerebral palsy. Gut microbiota has been confirmed to maintain normal GI physiological function and further contributed to cerebral palsy through the gut-brain axis. Our study was to investigate the effect of dietary fiber combined with probiotics on functional constipated children with cerebral palsy. In total, 35 patient children were enrolled and divided into general diet group (n = 14) and liquid diet group (n = 21). All the participants received Compound Dietary Fiber (CDF) for 1 month and lactic acid-producing and butyric acid-producing probiotics for 6 months. After a 1-month intervention, the frequency of spontaneous and manual defecation, and Bristol score were all significantly improved (P < 0.001). The alpha-diversity of the gut microbiota was significantly increased after a 1-month intervention (P < 0.05), with a higher abundance of butyric acid-producing bacteria and a lower abundance of opportunistic pathogens (P < 0.05, FDR < 0.05). However, the impersistent effect of the 6-month intervention suggested the insufficient impact of intaking probiotics alone and the short duration of CDF intervention. Moreover, although the intervention had affected the constipation symptoms equally in cerebral palsy children with a general diet and liquid diet, the general diet group showed a greater and more durable change in gut microbiota and clinical phenotypes after intervention than the liquid diet group, which indicated that longer intervention time should be considered for liquid diet children. This study not only illustrated that supplementation of dietary fiber combined with probiotics can improve functional constipation in children with cerebral palsy, but also provides guidance for optimal intervention strategy for future studies, which will further benefit cerebral palsy children.","[Huang, Congfu; Xiong, Shenghua; Wu, Bin; Chen, Xiao] Longgang Dist Matern & Child Healthcare Hosp, Dept Pediat, Shenzhen, Peoples R China; [Lyu, Jinli; Zhang, Xiaowei] Peking Univ, Dept Obstet & Gynecol, Shenzhen Hosp, Shenzhen, Peoples R China; [Chu, Chunuo] Shenzhen Middle Sch, Shenzhen, Peoples R China; [Ge, Lan] BGI Nutr Precis Co Ltd, Dept Nutr, Shenzhen, Peoples R China; [Peng, Yuanping] Longgang Dist Social Welf Ctr, Outpatient Dept, Shenzhen, Peoples R China; [Yang, Zhenyu] Shenzhen We Hlth Gene Co Ltd, Shenzhen Childrens Hosp, Joint Lab Micro Ecol & Childrens Hlth, Dept Microbial Res,We Hlth Gene Inst, Shenzhen, Peoples R China",Peking University; Shenzhen Children's Hospital,"Zhang, XW (corresponding author), Peking Univ, Dept Obstet & Gynecol, Shenzhen Hosp, Shenzhen, Peoples R China.",zhangivy726@163.com,"Chu, Chunuo/JCD-6184-2023",,Longgang District Science and Technology Innovation Bureau; National Natural Science Foundation of China; [LGKCYLWS2020104]; [82201793],Longgang District Science and Technology Innovation Bureau; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); ;,Funding This work has been strongly supported by Longgang District Science and Technology Innovation Bureau (LGKCYLWS2020104) and National Natural Science Foundation of China (82201793).,,33,4,4,1,9,FRONTIERS MEDIA SA,LAUSANNE,"AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND",2296-2360,,,FRONT PEDIATR,Front. Pediatr.,OCT 6,2022,10,,,,,,,,1001789,10.3389/fped.2022.1001789,http://dx.doi.org/10.3389/fped.2022.1001789,,,11,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,5V4HB,36313885,"gold, Green Published",,,2024-06-04,WOS:000877190600001,View Full Record in Web of Science
J,"Oshiro, T; Harada, Y; Kubota, K; Sadatomi, D; Sekine, H; Nishiyama, M; Fujitsuka, N",,,,"Oshiro, Taro; Harada, Yumi; Kubota, Kunitsugu; Sadatomi, Daichi; Sekine, Hitomi; Nishiyama, Mitsue; Fujitsuka, Naoki",,,"Associations between intestinal microbiota, fecal properties, and dietary fiber conditions: The Japanese traditional medicine Junchoto ameliorates dietary fiber deficit-induced constipation with F/B ratio alteration in rats",BIOMEDICINE & PHARMACOTHERAPY,,,English,Article,,,,,,Dietary fiber; Constipation; Junchoto; Fecal property; Microbiome,ACTIVATION,"Changes in the intestinal microbiota are known to occur in constipated patients. Dietary fiber restriction presents obstacles to appropriate defecation and affects fecal properties, but the relationship between fecal microbiota and fecal morphological properties remains obscure. Therefore, we examined the influence of fiber diets on the fecal microbiome and properties in rats, and the effectiveness of the Japanese traditional medicine Junchoto (JCT) in rats with fiber deficit-induced constipation. Rats were fed three different fiber diets with varying cellulose contents (0 %, FFD; 5 %, ND; 15 %, HFD), respectively, as follows: study 1: 21 days of feeding; study 2: 14 days of feeding followed by 7 days of ND (fiber normalization in all groups); study 3: FFD for 21 days, followed by JCT administration from 14 days. Fecal properties and 16S rRNA amplicon sequencing results were examined. We observed that the fecal frequency, dry weight, and length were increased, and water ratio were decreased in a cellulose dose-dependent manner. The difference in several kinds of fecal microbiota, but not the alpha-diversity Chao1 index and the Firmicutes/Bacteroidetes ratio (F/B ratio), between groups were observed. The change in fecal property in both the HFD and FFD groups was ameliorated with fiber normalization, accompanied by alteration of the Chao1 index and/or F/B ratio. JCT administration reversed the fecal morphological changes in FFD group, accompanied by F/B ratio increasing. In conclusion, short-term dietary changes modulated microbial homeostasis, which is linked to fecal property. JCT may alter the F/B ratio and improve fecal properties to facilitate easier excretion.","[Oshiro, Taro; Nishiyama, Mitsue] Tsumura & Co, Tsumura Adv Technol Res Labs, Ibaraki, Japan; [Harada, Yumi; Kubota, Kunitsugu; Sadatomi, Daichi; Sekine, Hitomi; Fujitsuka, Naoki] Tsumura & Co, Tsumura Kampo Res Labs, 3586 Yoshiwara Ami machi, Ibaraki 3001192, Japan",Tsumura & Company; Tsumura & Company,"Harada, Y (corresponding author), Tsumura & Co, Tsumura Kampo Res Labs, 3586 Yoshiwara Ami machi, Ibaraki 3001192, Japan.",harada_yumi@mail.tsumura.co.jp,"Nishiyama, Mitsue/ABQ-1118-2022",,,,,,35,6,6,5,15,ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER,ISSY-LES-MOULINEAUX,"65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE",0753-3322,1950-6007,,BIOMED PHARMACOTHER,Biomed. Pharmacother.,AUG,2022,152,,,,,,,,113263,10.1016/j.biopha.2022.113263,http://dx.doi.org/10.1016/j.biopha.2022.113263,,,12,"Medicine, Research & Experimental; Pharmacology & Pharmacy",Science Citation Index Expanded (SCI-EXPANDED),Research & Experimental Medicine; Pharmacology & Pharmacy,2K1SU,35717933,gold,,,2024-06-04,WOS:000816124600006,View Full Record in Web of Science
J,"Ge, XL; Tian, HL; Ding, C; Gu, LL; Wei, Y; Gong, JF; Zhu, WM; Li, N; Li, JS",,,,"Ge, Xiaolong; Tian, Hongliang; Ding, Chao; Gu, Lili; Wei, Yao; Gong, Jianfeng; Zhu, Weiming; Li, Ning; Li, Jieshou",,,Fecal Microbiota Transplantation in Combination with Soluble Dietary Fiber for Treatment of Slow Transit Constipation: A Pilot Study,ARCHIVES OF MEDICAL RESEARCH,,,English,Article,,,,,,Fecal microbiota transplantation; Soluble dietary fiber; Slow transit constipation; Intestinal microbiota,CHRONIC IDIOPATHIC CONSTIPATION; COLONIC-TRANSIT; ENDOCRINE-CELLS; GUT MICROBIOME; BOWEL FUNCTION; DOUBLE-BLIND; EFFICACY; PRUCALOPRIDE; PREVALENCE; PATTERNS,"Background and Aims. Intestinal microbiota and soluble dietary fiber play an important role in intestinal microecology, which is closely related to gut motility. Regulating intestinal microecology comprised of fecal microbiota transplantation (FMT) or fiber supplementation is becoming a novel therapy for functional gastrointestinal disease. We launched this study to evaluate the efficacy and safety of FMT combined with fiber for slow transit constipation (STC). Methods. We performed a study of 21 patients with STC. Participants received FMT (via nasojejunal tubes) on 3 consecutive days. After FMT, they were recommended to receive soluble dietary fiber for 4 weeks (8 g, twice daily). Rate of clinical improvement and remission, constipation-related symptoms (PAC-SYM scores), bowel movements per week, colonic transit time (CTT) and gastrointestinal quality-of-life index (GIQLI) were recorded during the 12-week follow-up. Results. At the study end, clinical improvement and remission of constipated patients reached 66.7 and 42.9%, respectively. The patients showed an increased stool frequency from 1.7 +/- 0.5 per week to 4.8 +/- 2.1 per week (p < 0.05) and an improved stool consistency after FMT combined with fiber. When compared to pre-treatment, PAC-SYM scores improved significantly from 2.0 +/- 0.4 to 1.5 +/- 0.6 after treatment (p < 0.05). Meanwhile, patients showed an acceleration of colonic transit time from 81.9 +/- 9.5 to 53.5 +/- 11.2 h at week 12. During follow-up, patients felt satisfied with improved GIQLI. No serious adverse events were observed. Conclusion. This is a pilot study confirming that FMT combined with fiber may improve symptoms experienced by constipated patients by regulating intestinal microecology, without any serious adverse events. (C) 2016 IMSS. Published by Elsevier Inc.","[Ge, Xiaolong; Tian, Hongliang; Ding, Chao; Gu, Lili; Wei, Yao; Gong, Jianfeng; Zhu, Weiming; Li, Ning; Li, Jieshou] Nanjing Univ, Sch Med, Jinling Hosp, Dept Gen Surg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China",Nanjing University,"Gong, JF; Li, N (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Gen Surg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.",jinlingh_gongjf@163.com; jinlingh_lining@163.com,"Li, jie/GXG-4583-2022; Liu, Liu/JXM-8208-2024; Li, Zexi/KFA-6939-2024",,"Jiangsu Provincial Special Program of Medical Sciences, China [BL2012006]; National Natural Science Foundation of China [81270006]","Jiangsu Provincial Special Program of Medical Sciences, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))","Funding: Financial support was provided by Jiangsu Provincial Special Program of Medical Sciences, China (BL2012006) and National Natural Science Foundation of China (81270006).",,43,35,47,3,43,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",0188-4409,1873-5487,,ARCH MED RES,Arch. Med. Res.,APR,2016,47,3,,,,,236,242,,10.1016/j.arcmed.2016.06.005,http://dx.doi.org/10.1016/j.arcmed.2016.06.005,,,7,"Medicine, Research & Experimental",Science Citation Index Expanded (SCI-EXPANDED),Research & Experimental Medicine,DV1WT,27387020,,,,2024-06-04,WOS:000382713500012,View Full Record in Web of Science
J,"Roma, E; Adamidis, D; Nikolara, R; Constantopoulos, A; Messaritakis, J",,,,"Roma, E; Adamidis, D; Nikolara, R; Constantopoulos, A; Messaritakis, J",,,Diet and chronic constipation in children: The role of fiber,JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION,,,English,Article,,,,,,children; constipation; fiber; nutrition,FOOD-INTAKE; BOWEL FUNCTION; ACCURACY,"Background: Chronic constipation is one of the most common disorders in Western countries and despite numerous clinical, pathophysiologic, and epidemiologic studies its cause is still unclear. Several hypotheses have been proposed and according to experimental studies and clinical observation, fiber intake could play a role in its pathogenesis. The purpose of this case-control study was to examine the possible correlation of idiopathic chronic constipation in children and dietary intake, particularly fiber intake. Methods: A randomized sample of children (291 children with constipation and 1602 controls) aged 2 to 14 years was taken from three of the 52 counties of Greece. Stratification was performed on the basis of urban, rural, or suburban location and socioeconomic status. The nutritional data were obtained from a 3-day dietary record and a dietary history. Statistical analysis was performed with multivariate tests, multivariate analysis of variance, discriminant analysis, and chi-square analysis according to the characteristics of the correlated variables. Results: Constipated children had a lower caloric and nutrient intake (p < 0.001), lower body weight/height (p < 0.001), and higher prevalence of reported anorexia (p < 0.001). Discriminant analysis indicated that dietary fiber alone was independently negatively correlated with chronic constipation, despite the age and the age of onset of constipation. Relative risk also had a negative correlation with fiber intake (p < 0.001). Of the main fiber fractions only cellulose and pentose were independently correlated with chronic constipation. Conclusions: Lack of fiber may play an important role in the etiology of chronic idiopathic constipation in children.","Univ Athens, Dept Paediat 1, Athens, Greece",National & Kapodistrian University of Athens,"Roma, E (corresponding author), Aghia Sofia Childrens Hosp, Athens 11527, Greece.",,,,,,,,37,106,120,0,16,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA",0277-2116,,,J PEDIATR GASTR NUTR,J. Pediatr. Gastroenterol. Nutr.,FEB,1999,28,2,,,,,169,174,,10.1097/00005176-199902000-00015,http://dx.doi.org/10.1097/00005176-199902000-00015,,,6,Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,177TH,9932850,Bronze,,,2024-06-04,WOS:000079226800014,View Full Record in Web of Science
J,"Wisten, A; Messner, T",,,,"Wisten, A; Messner, T",,,Fruit and fibre (Pajala porridge) in the prevention of constipation,SCANDINAVIAN JOURNAL OF CARING SCIENCES,,,English,Article,,,,,,constipation; fibre; geriatric patients; dietary intervention,DIETARY FIBER; BOWEL TRANSIT; POPULATION; MANAGEMENT; STOOL; BRAN,"Background and Aims: Constipation is a common problem in geriatric wards and in the elderly population. Although high-fibre diets can help relieve constipation non-pharmacologically in many patients, traditional laxatives still remain the standard treatment. A fibre supplement in the form of raw bran is not always well tolerated. We wanted to Study the effects of a daily consumption of a fruit- and fibre-rich porridge on stool frequency, perceived wellbeing and the costs for laxatives, when compared With traditional treatment with laxatives, in geriatric patients. Methods: Twenty patients in secondary geriatric wards (hospital rehabilitation wards) were randomized into an intervention group (porridge group) and a control group (standard diet without porridge) for a 1-week run-in and 2-week study, with registration of clinical data, e.g. medical treatment, laxative consumption, stool frequency and perceived well-being. Results: The patients in the porridge group had a daily defaecation without laxatives on average 76% of the time (10.7/14 days) compared with 23% of the time (3.3/14 days) in the non-porridge group (p = 0.003). The discomfort was less in the porridge group (2.5 vs. 6.5 on a 10-degree visual analogue scale, p = 0.008) when compared with the control group. The cost for laxatives was 93% lower in the intervention group (2.5Euro vs. 37.5Euro) for the 2-week Study. Conclusions: A fibre-rich porridge was effective, well liked and tolerated and reduced the need for laxatives in geriatric patients. We conclude that a daily fibre-rich meal Ought to be included in the treatment strategies of constipation in hospital wards.","Sunderby Hosp, Dept Internal Med, Sect Geriatr & Rehabil, SE-97180 Lulea, Sweden; Kiruna Dist Hosp, Dept Internal Med, Kiruna, Sweden; Umea Univ Hosp, Dept Publ Hlth & Clin Med, S-90185 Umea, Sweden",Sunderby Hospital; Umea University,"Wisten, A (corresponding author), Sunderby Hosp, Dept Internal Med, Sect Geriatr & Rehabil, SE-97180 Lulea, Sweden.",aasewisten@hotmail.com,,"Wisten, Aase/0000-0002-2734-1054",,,,,27,27,30,0,11,BLACKWELL PUBLISHING LTD,OXFORD,"9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND",0283-9318,,,SCAND J CARING SCI,Scand. J. Caring Sci.,MAR,2005,19,1,,,,,71,76,,10.1111/j.1471-6712.2004.00308.x,http://dx.doi.org/10.1111/j.1471-6712.2004.00308.x,,,6,Nursing,Social Science Citation Index (SSCI),Nursing,907HU,15737169,,,,2024-06-04,WOS:000227708000012,View Full Record in Web of Science
J,"Sturtzel, B; Elmadfa, I",,,,"Sturtzel, Baerbel; Elmadfa, Ibrahim",,,Intervention with dietary fiber to treat constipation and reduce laxative use in residents of nursing homes,ANNALS OF NUTRITION AND METABOLISM,,,English,Article,,,,,,elderly; constipation; laxatives; dietary fiber; body weight; eating habits,MALNUTRITION; WEIGHT,"Background: Residents of nursing homes have lost their independence. Recent studies reported that nutritional problems arise in nursing homes. These problems are correlated with changed eating habits and geriatric constipation which is predominantly treated with laxatives. These interventions are not always without risk since frequent usage of laxatives may be accompanied by several side effects. Dietary fibers also affect stool weight and transit time. Therefore, oat-bran effectiveness in reducing the need for bowel medication was examined. Aim: To develop diets with the addition of oat bran for reduction of laxatives and to improve the inhabitants' well-being in a long-term-care facility. Methods: A controlled blind parallel intervention trial among 30 frail inhabitants of a geriatric ward aged 57-100 years with laxative use. An intervention and a control group were formed. 15 of them received oat bran for 12 weeks ( fiber group) mixed up in the daily common diet of the ward and 15 served as control ( control group). Laxative use, body weight and the observations concerning the eating habits of the elderly were documented. Results: A cake with the required dietary fibers and the complaisant acceptance of the seniors was developed. Laxatives were successfully discontinued by 59% ( p < 0.001) in the fiber group. Body weight remained constant in the fiber group and decreased in the control group ( p < 0.005). Conclusion: Fiber supplementation in the form of a cake allows discontinuation of laxatives and increases the seniors' well-being in a nursing home. Copyright (C) 2008 S. Karger AG, Basel.","[Sturtzel, Baerbel; Elmadfa, Ibrahim] Univ Vienna, Dept Nutr Sci, AT-1090 Vienna, Austria",University of Vienna,"Elmadfa, I (corresponding author), Univ Vienna, Dept Nutr Sci, Althanstr 14, AT-1090 Vienna, Austria.",ibrahim.elmadfa@univie.ac.at,,,,,,,13,32,37,0,11,KARGER,BASEL,"ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND",0250-6807,,,ANN NUTR METAB,Ann. Nutr. Metab.,,2008,52,,,1,,,54,56,,10.1159/000115351,http://dx.doi.org/10.1159/000115351,,,3,Endocrinology & Metabolism; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Endocrinology & Metabolism; Nutrition & Dietetics,292WW,18382081,,,,2024-06-04,WOS:000255297800014,View Full Record in Web of Science
J,"Zhang, XY; Tian, HL; Gu, LL; Nie, YZ; Ding, C; Ge, XL; Yang, B; Gong, JF; Li, N",,,,"Zhang, Xueying; Tian, Hongliang; Gu, Lili; Nie, Yongzhan; Ding, Chao; Ge, Xiaolong; Yang, Bo; Gong, Jianfeng; Li, Ning",,,Long-term follow-up of the effects of fecal microbiota transplantation in combination with soluble dietary fiber as a therapeutic regimen in slow transit constipation,SCIENCE CHINA-LIFE SCIENCES,,,English,Article,,,,,,fecal microbiota transplantation; soluble dietary fiber; slow transit constipation; long-term efficacy,CHRONIC IDIOPATHIC CONSTIPATION; IRRITABLE-BOWEL-SYNDROME; ACTIVE ULCERATIVE-COLITIS; SACRAL NERVE-STIMULATION; PLACEBO-CONTROLLED TRIAL; FUNCTIONAL CONSTIPATION; COLONIC TRANSIT; DOUBLE-BLIND; EFFICACY; PRUCALOPRIDE,"As some studies have reported that strategies targeting the gut microbiota such as fecal microbiota transplantation (FMT) with or without other microecological therapy might have efficacy in treating slow transit constipation (STC), we conducted a single-center, open-label trial to study the long-term effect of FMT combined with soluble dietary fiber (pectin) on STC. Thirty-one adult patients with STC were enrolled into the trial. Patients received 6-day FMT procedures repeatedly for the first 3 months and soluble dietary fiber (pectin) daily during the follow-up. The rate of clinical remission and improvement, stool consistency, the Wexner constipation scale, and assessment of constipation-related symptoms were evaluated at week 4 and 1 year later. The clinical remission and improvement rates at week 4 were 69.0% (20/29) and 75.9% (22/29), respectively. At the end of the study, 48.3% (14/29) of patients continued to have at least three complete spontaneous bowel movements per week and 58.6% (17/29) of patients showed clinical improvements. Stool consistency, the Wexner constipation scale, and constipation symptoms improved both at short-term and long-term follow-up. The results indicated that FMT in combination with soluble dietary fiber (pectin) had both short-term and long-term efficacy in treating STC.","[Zhang, Xueying; Gu, Lili; Ding, Chao; Ge, Xiaolong; Gong, Jianfeng; Li, Ning] Nanjing Univ, Jinling Hosp, Med Sch, Dept Gen Surg, Nanjing 210093, Jiangsu, Peoples R China; [Tian, Hongliang; Yang, Bo; Li, Ning] Tongji Univ, Shanghai Peoples Hosp 10, Peoples Hosp 10, Shanghai 200072, Peoples R China; [Nie, Yongzhan] Fourth Mil Med Univ, Xi Jing Hosp, Inst Digest Dis, Xian 710032, Shaanxi, Peoples R China; [Ding, Chao] Nanjing Univ, Drum Tower Hosp, Med Sch, Dept Gen Surg, Nanjing 210008, Jiangsu, Peoples R China; [Ge, Xiaolong] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Gen Surg, Hangzhou 310016, Zhejiang, Peoples R China",Nanjing University; Tongji University; Air Force Military Medical University; Nanjing University; Zhejiang University,"Gong, JF; Li, N (corresponding author), Nanjing Univ, Jinling Hosp, Med Sch, Dept Gen Surg, Nanjing 210093, Jiangsu, Peoples R China.;Li, N (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Peoples Hosp 10, Shanghai 200072, Peoples R China.",gongjianfeng@aliyun.com; liningrigsnju@163.com,"Zhang, Yonghui/AGY-9072-2022; li, fang/KDO-8841-2024",,National Natural Science Foundation of China [81670493]; National Gastroenterology Research Project [2015BAI13B07],National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Gastroenterology Research Project,"We would like to thank Yue Hua, Yifan Zhu, Xuelei Zhang, Zhengjin Xie, Yan Zhou, Chunlian Ma and Lingling Huang from Jinling Hospital for their work in the collection of patients' information. This work was supported by the National Natural Science Foundation of China (81670493) (http://www.nsfc.gov.cn/publish/portal1/) and by the National Gastroenterology Research Project (2015BAI13B07). We thank Kate Fox, DPhil, from Liwen Bianji, Edanz Group China (www.liwenbianji.cn/ac), for editing the English text of a draft of this manuscript. The funders had no role in study design, data collection and analysis, the decision to publish, or preparation of the manuscript.",,58,36,44,2,42,SCIENCE PRESS,BEIJING,"16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA",1674-7305,1869-1889,,SCI CHINA LIFE SCI,Sci. China-Life Sci.,JUL,2018,61,7,,,,,779,786,,10.1007/s11427-017-9229-1,http://dx.doi.org/10.1007/s11427-017-9229-1,,,8,Biology,Science Citation Index Expanded (SCI-EXPANDED),Life Sciences & Biomedicine - Other Topics,GM8HS,29441452,,,,2024-06-04,WOS:000438465700006,View Full Record in Web of Science
J,"Trepel, F",,,,"Trepel, F",,,Dietary fibre: More than a matter of dietetics. II. Application in prevention and therapy,WIENER KLINISCHE WOCHENSCHRIFT,,,German,Review,,,,,,dietary fibre; constipation; colorectal carcinoma; diabetes mellitus; metabolic syndrome,IRRITABLE-BOWEL-SYNDROME; CORONARY-HEART-DISEASE; CHAIN FATTY-ACIDS; COLORECTAL-CANCER; WHEAT BRAN; CARDIOVASCULAR-DISEASE; GLYCEMIC INDEX; WHOLE-GRAIN; CHRONIC CONSTIPATION; SOLUBLE FIBER,"A nutrition rich in fibre has a preventive effect against constipation, colon diverticulosis, carcinoma of the large bowel and stomach, type 2-diabetes, metabolic syndrome and cardiovascular disease. In case of constipation, diverticulosis and diabetes this effect solely depends on dietary fibre. Regarding carcinomas and cardiovascular diseases, so far unknown factors integrated in or associated with fibre-rich food may also contribute to the preventive effect. Therapy with dietary fibre is indicated for constipation, colon diverticulosis, diarrhea, diabetes, and hypercholesterinemia. The individual dietary fibres differ substance-specifically. Food-integrated dietary fibre such as whole-grain bread, vegetables and fruit have their place in prevention. Dietary fibre preparations such as wheat bran, flax seed or sugar-beet fibre are useful in the treatment of constipation, colon diverticulosis and adiposity. Oat bran is preferentially used in hypercholesterinemia. Purified dietary fibres such as cellulose, guar, psyllium, and beta-glucan have an anti-diabetic, all viscous fibres an anti-lipaemic effect. The therapeutic dosages of dietary fibre preparations are 2040 g/day and of purified fibres substances 10-20 g/day respectively.",,,"Hohenzollernstr 49, D-76135 Karlsruhe, Germany.",friedrich.trepel@web.de,,,,,,,130,3,3,1,30,SPRINGER WIEN,WIEN,"SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA",0043-5325,1613-7671,,WIEN KLIN WOCHENSCHR,Wien. Klin. Wochen.,AUG 31,2004,116,15-16,,,,,511,522,,10.1007/BF03217703,http://dx.doi.org/10.1007/BF03217703,,,12,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,852PN,15471177,,,,2024-06-04,WOS:000223769000003,View Full Record in Web of Science
J,"Yang, NB; Li, J; Hu, HX; Shi, SL; Li, YH; Sun, WW",,,,"Yang, Ningbo; Li, Jie; Hu, Hongxia; Shi, Shaoli; Li, Yanhong; Sun, Wenwen",,,The synergistic impact of probiotics and dietary fiber on constipation management in chlorpromazine-induced schizophrenia patients: exploring the modulation of intestinal microbiota and neurotrophic factors,INTERNATIONAL JOURNAL OF NEUROSCIENCE,,,English,Article; Early Access,,,,,,Probiotics; dietary fiber; patients with schizophrenia; constipation; intestinal microbiota; efficacy,,"Objective: To explore the improvement effect of probiotics combined with dietary fiber on constipation in patients with schizophrenia. Methods: To compare the improvement scores of constipation, constipation symptoms, quality of life, neurotrophic factors-related indicators, and clinical efficacy between the two groups. Results: There was no statistically significant difference in Cleveland Constipation Scoring System (CCS) scores in the control group before and after treatment (p > 0.05), while the CCS scores in the observation group decreased significantly after treatment (p < 0.05); Patient Assessment of Constipation Symptoms scores significantly decreased in the observation group compared to the control group (p < 0.05), with no significant difference in Patient Assessment of Constipation Quality of Life scores between the two groups pre- and post-treatment; Neuron-specific enolase levels decreased significantly in both groups post-treatment, while brain-derived neurotrophic factor, neuregulin-1, and nerve growth factor levels increased significantly, with a more pronounced rise in the observation group (p < 0.05). Additionally, the total effective rate of clinical treatment in the observation group was higher than that in the control group (p < 0.05). Conclusion: Probiotics combined with dietary fiber can improve constipation symptoms in patients with schizophrenia accompanied by constipation, effectively maintain the balance of intestinal microbiota, and improve the quality of life of patients. Additionally, levels of neurotrophic factors associated with bowel function and neurological health increased significantly, with a higher total effective rate of clinical treatment observed in the probiotics and dietary fiber group. These findings suggest the potential efficacy of probiotics and dietary fiber in managing constipation in this patient population.","[Yang, Ningbo; Sun, Wenwen] Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Psychiat, Luoyang, Peoples R China; [Li, Jie] Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Gen Med, Luoyang, Peoples R China; [Hu, Hongxia] Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Clin Lab Med, Luoyang, Peoples R China; [Shi, Shaoli; Li, Yanhong] Fifth Peoples Hosp Luoyang, Dept Psychiat, Luoyang, Peoples R China",Henan University of Science & Technology; Henan University of Science & Technology; Henan University of Science & Technology,"Yang, NB (corresponding author), Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Psychiat, Luoyang, Peoples R China.",plcu1007@21cn.com,,,National Natural Science Foundation of China [81971250]; Opening Project of Beijing Key laboratory of Mental Disorders [2020JSJB01]; Medical Science and Technology Research Program of Henan Province [LHGJ20200573],National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Opening Project of Beijing Key laboratory of Mental Disorders; Medical Science and Technology Research Program of Henan Province,This work was supported by 1. National Natural Science Foundation of China (Grant No. 81971250); 2. Opening Project of Beijing Key laboratory of Mental Disorders (Grant No. 2020JSJB01); 3. Medical Science and Technology Research Program of Henan Province (Grant No.LHGJ20200573).,,25,0,0,0,0,TAYLOR & FRANCIS LTD,ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND",0020-7454,1563-5279,,INT J NEUROSCI,Int. J. Neurosci.,2024 MAY 6,2024,,,,,,,,,,10.1080/00207454.2024.2352023,http://dx.doi.org/10.1080/00207454.2024.2352023,,MAY 2024,7,Neurosciences,Science Citation Index Expanded (SCI-EXPANDED),Neurosciences & Neurology,QF7I7,38701375,,,,2024-06-04,WOS:001219525400001,View Full Record in Web of Science
J,"Loening-Baucke, V; Miele, E; Staiano, A",,,,"Loening-Baucke, V; Miele, E; Staiano, A",,,Fiber (glucomannan) is beneficial in the treatment of childhood constipation,PEDIATRICS,,,English,Article; Proceedings Paper,36th Annual Meeting of ESPGHAN,"JUN 07, 2003","Prague, CZECH REPUBLIC",ESPGHAN,,fiber; glucomannan; constipation; encopresis; children,SEGMENTAL COLONIC TRANSIT; CHRONIC IDIOPATHIC CONSTIPATION; DIETARY FIBER; WHEAT BRAN; GASTROINTESTINAL TRANSIT; STOOL CHARACTERISTICS; CHILDREN; PSYLLIUM; TIME; ENCOPRESIS,"Objective. Constipation and encopresis are common problems in children. Still today, the role of fiber in the treatment of chronic constipation in childhood is controversial. The aim of our study was to evaluate whether fiber supplementation is beneficial in the treatment of children with functional constipation with or without encopresis. We used glucomannan as the fiber supplement. Methods. We evaluated the effect of fiber (glucomannan, a fiber gel polysaccharide from the tubers of the Japanese Konjac plant) and placebo in children with chronic functional constipation with and without encopresis in a double-blind, randomized, crossover study. After the initial evaluation, the patients were disimpacted with 1 or 2 phosphate enemas if a rectal impaction was felt during rectal examination. Patients continued with their preevaluation laxative. No enemas were given during each treatment period. Fiber and placebo were given as 100 mg/kg body weight daily (maximal 5 g/day) with 50 mL fluid/500 mg for 4 weeks each. Parents were asked to have children sit on the toilet 4 times daily after meals and to keep a stool diary. Age, frequency of bowel movements into the toilet and into the undergarment, presence of abdominal pain, dietary fiber intake, medications, and the presence of an abdominal and/or a rectal fecal mass were recorded on a structured form at the time of recruitment and 4 weeks and 8 weeks later. Children were rated by the physician as successfully treated when they had greater than or equal to3 bowel movements/wk and less than or equal to1 soiling/3 weeks with no abdominal pain in the last 3 weeks of each 4-week treatment period. Parents made a global assessments to whether they believed that the child was better during the first or second treatment period. Results. Forty-six chronically constipated children were recruited into the study, but only 31 children completed the study. These 31 children ( 16 boys and 15 girls) were 4.5 to 11.7 years of age (mean: 7 +/- 2 years). All children had functional constipation; in addition, 18 had encopresis when recruited for the study. No significant side effects were reported during each 4-week treatment period. Significantly fewer children complained of abdominal pain and more children were successfully treated while on fiber (45%) as compared with placebo treatment (13%). Parents rated significantly more children (68%) as being better on fiber versus 13% as being better on placebo. The initial fiber intake was low in 22 (71%) children. There was no difference in the percentage of children with low fiber intake living in the United States (70%) and Italy (71%). Successful treatment (physician rating) and improvement (parent rating) were independent of low or acceptable initial fiber intake. The duration of chronic constipation ranged from 0.6 to 10 years (mean: 4.0 +/- 2.5 years). Duration of constipation did not predict response to fiber treatment. Children with constipation only were significantly more likely to be treated successfully with fiber (69%) than those with constipation and encopresis (28%). Conclusion. We found glucomannan to be beneficial in the treatment of constipation with and without encopresis in children. Symptomatic children who were already on laxatives still benefited from the addition of fiber. Therefore, we suggest that we continue with the recommendation to increase the fiber in the diet of constipated children with and without encopresis.","Univ Iowa, Iowa City, IA USA; Univ Naples Federico II, Naples, Italy",University of Iowa; University of Naples Federico II,"Univ Iowa Hosp & Clin, Dept Pediat, JCP 2555, 200 Hawkins Dr, Iowa City, IA 52242 USA.",vera-loening-baucke@uiowa.edu,"Miele, Erasmo/A-1906-2010; Staiano, Annamaria/H-3026-2011","Staiano, Annamaria/0000-0003-0586-1339",,,,,33,113,121,4,24,AMER ACAD PEDIATRICS,ELK GROVE VILLAGE,"141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA",0031-4005,1098-4275,,PEDIATRICS,Pediatrics,MAR 1,2004,113,3,,,,,E259,E264,,10.1542/peds.113.3.e259,http://dx.doi.org/10.1542/peds.113.3.e259,,,6,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Pediatrics,779ZT,14993586,,,,2024-06-04,WOS:000189344400061,View Full Record in Web of Science
J,"McRae, MP",,,,"McRae, Marc P.",,,"Effectiveness of Fiber Supplementation for Constipation, Weight Loss, and Supporting Gastrointestinal Function: A Narrative Review of Meta-Analyses",JOURNAL OF CHIROPRACTIC MEDICINE,,,English,Review,,,,,,Dietary Fiber; Meta-Analysis; Constipation; Irritable Bowel Syndrome; Weight Loss,IRRITABLE-BOWEL-SYNDROME; DIETARY FIBER; BODY-WEIGHT; OVERWEIGHT; GLUCOMANNAN; HEMORRHOIDS; DIAGNOSIS; OBESITY; DISEASE; ADULTS,"Objective: The purpose of this narrative review is to determine whether published meta-analyses support the use of fiber supplementation in the treatment of constipation, weight loss, and dietary support for gastrointestinal disorders such as irritable bowel syndrome (IBS) and inflammatory bowel disease. Methods: A PubMed search from January 1, 1980, to July 31, 2019, was conducted with the following search strategy: (fiber OR fibre) AND (meta-analysis OR systematic review) AND (constipation OR body weight OR obesity OR irritable bowel syndrome OR inflammatory bowel disease). Meta-analyses that provided quantitative statistical analysis with a measured effect size were retrieved and accepted into this review. The following was extracted and entered into an Excel spreadsheet: number of publications included in the meta-analysis, number of total participants, fiber type and daily dose, pooled treatment effects for clinical endpoints, or summary relative risks. Results: Eighteen meta-analyses support dietary fiber supplementation for patients with constipation, weight loss, and IBS, but the significant heterogeneity and publication bias undermine the support for using dietary fiber supplementation in these conditions. Conclusion: This narrative review of meta-analyses finds some benefits for recommending fiber supplementation to patients with constipation, obesity, and IBS, but significant heterogeneity and publication bias undermine this support.","[McRae, Marc P.] Natl Univ Hlth Sci, Dept Basic Sci, Lombard, IL USA",,"McRae, MP (corresponding author), NUHS, 200 E Roosevelt Rd, Lombard, IL 60148 USA.",mmcrae@nuhs.edu,,,,,,,39,10,11,2,18,ELSEVIER INC,SAN DIEGO,"525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA",0899-3467,1556-3715,,J CHIROPR MED,J. Chiropr. Med.,MAR,2020,19,1,,,,,58,64,,10.1016/j.jcm.2019.10.008,http://dx.doi.org/10.1016/j.jcm.2019.10.008,,,7,Rehabilitation,Emerging Sources Citation Index (ESCI),Rehabilitation,OK0MT,33192192,Green Published,,,2024-06-04,WOS:000584347600007,View Full Record in Web of Science
J,"Anderson, JW; Baird, P; Davis, RH; Ferreri, S; Knudtson, M; Koraym, A; Waters, V; Williams, CL",,,,"Anderson, James W.; Baird, Pat; Davis, Richard H., Jr.; Ferreri, Stefanie; Knudtson, Mary; Koraym, Ashraf; Waters, Valerie; Williams, Christine L.",,,Health benefits of dietary fiber,NUTRITION REVIEWS,,,English,Review,,,,,,coronary heart disease; diabetes; dietary fiber; gastrointestinal disorders; obesity,CORONARY-HEART-DISEASE; WHOLE-GRAIN CONSUMPTION; LIFE-STYLE MODIFICATION; INULIN-TYPE FRUCTANS; HYDROLYZED GUAR GUM; LONG-TERM TREATMENT; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; LOW-FAT; INSULIN SENSITIVITY,"Dietary fiber intake provides many health benefits. However, average fiber intakes for US children and adults are less than half of the recommended levels. Individuals with high intakes of dietary fiber appear to be at significantly lower risk for developing coronary heart disease, stroke, hypertension, diabetes, obesity, and certain gastrointestinal diseases. Increasing fiber intake lowers blood pressure and serum cholesterol levels. Increased intake of soluble fiber improves glycemia and insulin sensitivity in non-diabetic and diabetic individuals. Fiber supplementation in obese individuals significantly enhances weight loss. Increased fiber intake benefits a number of gastrointestinal disorders including the following: gastroesophageal reflux disease, duodenal ulcer, diverticulitis, constipation, and hemorrhoids. Prebiotic fibers appear to enhance immune function. Dietary fiber intake provides similar benefits for children as for adults. The recommended dietary fiber intakes for children and adults are 14 g/1000 kcal. More effective communication and consumer education is required to enhance fiber consumption from foods or supplements.","[Anderson, James W.] Univ Kentucky, Dept Internal Med, Lexington, KY 40502 USA; [Anderson, James W.] Univ Kentucky, Nutr Sci Program, Lexington, KY 40502 USA; [Baird, Pat] Univ Connecticut, Stamford, CT USA; [Baird, Pat] Westchester Community Coll, Valhalla, NY USA; [Davis, Richard H., Jr.] Univ Florida, Dept Med, Gainesville, FL USA; [Ferreri, Stefanie] UNC Eshelman, Sch Pharm, Div Pharm Practice & Experiential Educ, Chapel Hill, NC USA; [Knudtson, Mary] Univ Calif Irvine, Irvine, CA USA; [Koraym, Ashraf] Ohio State Univ, Columbus, OH 43210 USA; [Koraym, Ashraf] Wright State Univ, Dayton, OH 45435 USA; [Williams, Christine L.] Healthy Direct Inc, New York, NY USA",University of Kentucky; University of Kentucky; University of Connecticut; State University of New York (SUNY) System; SUNY Community College; State University System of Florida; University of Florida; University of California System; University of California Irvine; University System of Ohio; Ohio State University; University System of Ohio; Wright State University Dayton,"Anderson, JW (corresponding author), Univ Kentucky, Dept Internal Med, 913 Taborlake Court, Lexington, KY 40502 USA.",jwandersmd@aol.com,"Ayubi, Tazeen/HLH-8767-2023; Ferreri, Stefanie/ABB-4844-2020","Ferreri, Stefanie/0000-0002-1819-9631",National Fiber Council; Procter & Gamble and by the High Carbohydrate; Fiber (HCF) Nutrition Research Foundation,National Fiber Council; Procter & Gamble and by the High Carbohydrate; Fiber (HCF) Nutrition Research Foundation,"Preparation of this manuscript was funded, in part, by the National Fiber Council, which is supported by Procter & Gamble and by the High Carbohydrate, Fiber (HCF) Nutrition Research Foundation.",,146,1305,1527,43,760,OXFORD UNIV PRESS INC,CARY,"JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA",0029-6643,1753-4887,,NUTR REV,Nutr. Rev.,APR,2009,67,4,,,,,188,205,,10.1111/j.1753-4887.2009.00189.x,http://dx.doi.org/10.1111/j.1753-4887.2009.00189.x,,,18,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,424LP,19335713,Green Published,,,2024-06-04,WOS:000264568500002,View Full Record in Web of Science
J,"Appak, YÇ; Karakoyun, M; Koru, NT; Baran, M",,,,"Appak, Yeliz Cagan; Karakoyun, Miray; Koru, Nutritionist Tugce; Baran, Masallah",,,Dietary properties and anthropometric findings of children with functional constipation: a cross-sectional study,ARCHIVOS ARGENTINOS DE PEDIATRIA,,,English,Article,,,,,,constipation; proteins; fats; dietary fiber; anthropometry,GASTROINTESTINAL TRANSIT; CHILDHOOD CONSTIPATION; FIBER; PREVALENCE; EPIDEMIOLOGY; OBESE; TIME; FAT,"Introduction. Functional constipation (FC) is a common problem in childhood. This study intended to investigate the dietary properties and anthropometric findings of children with FC. Population and methods. Patients with FC were defined according to the Rome IV diagnostic criteria. The control group included children who were not diagnosed with FC or any other organic disease. The children who admitted to pediatric gastroenterology outpatient clinic between September 2017-March 2018 were included. Anthropometric measurements of weight, height, and body mass index were recorded. Body mass index z-scores were used to identify for overweight and obese children. Malnutrition was defined according to Waterlow criteria. The three-day nutritional diaries of both FC patients and control subjects were assessed and the daily average of calorie, fiber, carbohydrate, protein and fat intake were calculated by the same nutritionist. Results. Fourty patients with FC and fourty healthy control were included. Twenty-four patients with FC were in the normal height and weight ranges. There was no significant difference in the average daily calorie, carbohydrate, fat and fiber intake between the FC and control groups. Although protein ratios (%) in the diet were found to be significantly lower in children with FC, the amount of protein that taken daily was found to be within normal limits in both groups. Conclusion. Most children with FC were in the normal range for height and weight. There was no significant relationship between FC and carbohydrate, fat and fiber content in the diet, only low protein ratios were found in FC.","[Appak, Yeliz Cagan; Karakoyun, Miray] Tepecik Training & Res Hosp, Dept Pediat Gastroenterol, Izmir, Turkey; [Koru, Nutritionist Tugce] SBU Tepecik Training & Res Hosp, Dept Nutr & Dietet, Izmir, Turkey; [Baran, Masallah] Izmir Katip Celebi Univ, Sch Med, Tepecik Training & Res Hosp, Dept Pediat Gastroenterol, Izmir, Turkey",Izmir Tepecik Training & Research Hospital; Izmir Katip Celebi University; Izmir Tepecik Training & Research Hospital,"Appak, YÇ (corresponding author), Tepecik Training & Res Hosp, Dept Pediat Gastroenterol, Izmir, Turkey.",yelizcagan@yahoo.com,"cagan appak, yeliz/L-2492-2018; Baran, Masallah/ACJ-1208-2022","Baran, Masallah/0000-0003-3827-2039",,,,,29,5,6,0,9,SOC ARGENTINA PEDIATRIA,CAP FED BUENO AIRES,"AV COLONEL DIAZ 1971-75-C1425DQF, CAP FED BUENO AIRES, 00000, ARGENTINA",0325-0075,1668-3501,,ARCH ARGENT PEDIATR,Arch. Argent. Pediatr.,JUN,2019,117,3,,,,,E224,E231,,10.5546/aap.2019.eng.e224,http://dx.doi.org/10.5546/aap.2019.eng.e224,,,8,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,IA2EB,31063305,gold,,,2024-06-04,WOS:000469373200012,View Full Record in Web of Science
J,"Yurtdas, G; Acar-Tek, N; Akbulut, G; Cemali, Ö; Arslan, N; Coskun, AB; Zengin, FH",,,,"Yurtdas, Gamze; Acar-Tek, Nilufer; Akbulut, Gamze; Cemali, Ozge; Arslan, Neslihan; Beyaz Coskun, Ayfer; Zengin, Fatmanur Humeyra",,,Risk Factors for Constipation in Adults: A Cross-Sectional Study,JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION,,,English,Article,,,,,,Dietary fiber intake; fluid intake; constipation; physical activity; water intake,PHYSICAL-ACTIVITY; DIETARY-INTAKE; FUNCTIONAL CONSTIPATION; FIBER; ASSOCIATION; PREVALENCE; QUESTIONNAIRE; FREQUENCY; NUTRITION; SYMPTOMS,"Aim: The objective of this study was to determine associations between physical activity, dietary fiber intake, water and fluid intake, and constipation as well as other possible risk factors for constipation in adults. Method: A cross-sectional study was conducted in 4561 (1812 male and 2749 female) adults, aged between 18-65 years, living in Ankara, Turkey. Participants having three or fewer bowel movements per week were considered constipated. Dietary fiber and fluid intake data were ascertained from a 62-item food frequency questionnaire (FFQ). The International Physical Activity Questionnaire-Short Form (IPAQ-SF) was used to evaluate participant physical activity. Results: Of the total cohort, 16.6% were diagnosed with constipation (13.6% males, 18.5% females). Logistic regression analysis showed a significantly greater risk of constipation in participants with female gender, advancing age, being obese. Participants who were moderately active (OR: 0.77, 95% CI: 0.62-0.91) and active (OR: 0.74, 95% CI: 0.59-0.90) had a decreased likelihood of constipation, when compared with inactive participants (p < 0.05). Participants in the middle upper quartile for water intake (OR: 0.71, 95% CI: 0.57-0.88), had a decreased likelihood of constipation, when compared with participants in the lowest quartile. Participants in the middle upper quartile (OR: 0.74, 95% CI: 0.58-0.92) and the highest quartile for dietary fiber intake (OR: 0.66, 95% CI: 0.52-0.84), had a decreased likelihood of constipation, when compared with participants in the lowest quartile (p < 0.05). Conclusion: Constipation is common in the Turkish adult population. Insufficient physical activity, decreasing fiber and water intake, obesity, advancing age and female gender were associated with increased constipation risks. Combining regular physical activity and increasing fiber and water intake may protect from constipation, and relieve constipation symptoms.","[Yurtdas, Gamze; Acar-Tek, Nilufer; Akbulut, Gamze; Cemali, Ozge; Arslan, Neslihan; Beyaz Coskun, Ayfer] Gazi Univ, Dept Nutr & Dietet, Fac Hlth Sci, Ankara, Turkey; [Yurtdas, Gamze] Izmir Katip Celebi Univ, Dept Nutr & Dietet, Fac Hlth Sci, TR-35620 Izmir, Turkey; [Zengin, Fatmanur Humeyra] Ankara Numune Training & Res Hosp, Dept Nutr & Dietet, Ankara, Turkey",Gazi University; Izmir Katip Celebi University; Ankara Numune Training & Research Hospital,"Yurtdas, G (corresponding author), Izmir Katip Celebi Univ, Dept Nutr & Dietet, Fac Hlth Sci, TR-35620 Izmir, Turkey.",gmzyurtdas@hotmail.com,"arslan, neslihan/AAW-2874-2021; zengin, fatmanur humeyra/HKV-8413-2023; Yurtdaş, Gamze/ACA-1910-2022; Cemali, Özge/AIE-5693-2022; Tek, Nilüfer Acar/AAN-9250-2021","zengin, fatmanur humeyra/0000-0003-1586-5878; Cemali, Özge/0000-0002-9971-8498;",,,,,42,32,34,5,19,"ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD",ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND",0731-5724,1541-1087,,J AM COLL NUTR,J. Am. Coll. Nutr.,NOV 16,2020,39,8,,,,,713,719,,10.1080/07315724.2020.1727380,http://dx.doi.org/10.1080/07315724.2020.1727380,,FEB 2020,7,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,OU3JV,32077808,,,,2024-06-04,WOS:000514985600001,View Full Record in Web of Science
J,"Reijonen, JK; Tihtonen, KMH; Luukkaala, TH; Uotila, JT",,,,"Reijonen, Johanna Kristiina; Tihtonen, Kati Maaria Hannele; Luukkaala, Tiina Hannele; Uotila, Jukka Tapio",,,"Association of dietary fiber, liquid intake and lifestyle characteristics with gastrointestinal symptoms and pregnancy outcome",EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY-X,,,English,Article,,,,,,Heartburn and constipation in pregnancy; Dietary fiber; Pregnancy outcome,CONSTIPATION; RISK; MECHANISMS; PATTERNS; REFLUX; NAUSEA,"Objectives: Heartburn and constipation are common gastrointestinal symptoms during pregnancy. High fiber and liquid intake have beneficial effects on these symptoms in non-pregnant population. Our aim was to evaluate the association of dietary fiber, fluid intake and lifestyle characteristics with constipation, heartburn, and pregnancy outcome.Study design: Two hundred pregnant women were enrolled in this prospective cohort study during the 1st trimester of pregnancy. Participants completed a self-administered questionnaire concerning bowel symptoms, dietary fiber, liquid intake, and lifestyle characteristics before pregnancy, during pregnancy and post-partum. After exclusions 173 pregnant women participated the study and 173, 173, 136, 109 and 91 completed prepregnancy, and 1st, 2nd, and 3rd trimester, and post-partum questionnaires, respectively. Data on deliveries and perinatal outcome (n = 173) were collected from hospital records. In trajectory analysis, the women were clustered in groups based on the intake of fiber and liquids. Generalized linear mixed models and logistic regression analyses were used to find associations of fiber and fluid intake with constipation, heartburn and pregnancy outcome.Results and conclusions: Heartburn increased significantly during pregnancy and the highest prevalence (33%) was during the third trimester. A combination of low fiber and low fluid intake increased the risk of constipation during pregnancy (OR 5.9, 95% CI 2.00-17.4). Low fiber intake increased the risk of combined adverse outcome (cesarean section, premature delivery and/or small for gestational age; OR 3.4, 95% CI 1.2-9.6). Sufficient fiber and liquid intake may be protective against pregnancy-associated constipation and may be associated with improved pregnancy outcome.","[Reijonen, Johanna Kristiina; Tihtonen, Kati Maaria Hannele; Uotila, Jukka Tapio] Tampere Univ Hosp, Dept Obstet & Gynecol, PL 2000, FI-33521 Tampere, Finland; [Luukkaala, Tiina Hannele] Tampere Univ Hosp, Res Dev & Innovat Ctr, Tampere, Finland; [Luukkaala, Tiina Hannele] Tampere Univ, Fac Sci, Hlth Sci, Tampere, Finland",Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; Tampere University,"Reijonen, JK (corresponding author), Tampere Univ Hosp, Dept Obstet & Gynecol, PL 2000, FI-33521 Tampere, Finland.",johanna.reijonen80@gmail.com,,"Luukkaala, Tiina/0000-0003-4636-9586",Competitive State Research Financing of the Expert Responsibility Area of Tampere Uni-versity Hospital,Competitive State Research Financing of the Expert Responsibility Area of Tampere Uni-versity Hospital,This study was financially supported by the Competitive State Research Financing of the Expert Responsibility Area of Tampere Uni-versity Hospital.,,30,3,3,1,3,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",2590-1613,,,EUR J OBST GYN R B-X,Eur. J. Obstet. Gynecol. Reprod. Biol-X,DEC,2022,16,,,,,,,,100168,10.1016/j.eurox.2022.100168,http://dx.doi.org/10.1016/j.eurox.2022.100168,,,8,Obstetrics & Gynecology; Reproductive Biology,Emerging Sources Citation Index (ESCI),Obstetrics & Gynecology; Reproductive Biology,W8EN1,36312325,"gold, Green Published",,,2024-06-04,WOS:001093904500001,View Full Record in Web of Science
J,"Nisar, T; Amjad, A; Javed, A; Natasha, H; Akram, M; Riaz, M; Nazir, W",,,,"Nisar, Tahreem; Amjad, Aniqa; Javed, Amna; Natasha, Hanza; Akram, Mamoona; Riaz, Mehwish; Nazir, Wafa",,,Development of fiber enriched food bars for elderly people suffering from constipation,BIOSCIENCE RESEARCH,,,English,Article,,,,,,Constipation; dietary fibers; oats; dates; flax seeds; honey,,"The prevalence of constipation increases after the age of 65. Low fiber diet had a great influence on causing constipation, so it is important to include high fiber products in older people diet. Fiber enriched food bars were developing to add fiber on the diet of older people. To develop fiber enriched food bars to prevent constipation.4 treatments were made from fiber enriched food bars. Proximate analysis was determined to find out the moisture, ash, fiber, protein, and fat content. A preliminary sensory evaluation was used for assessing the acceptability of the fiber enrich bars using an 9-point hedonic scale Proximate composition revealed that highest crude fiber 14.16 was find in the T-4 followed by T-3 (13.40), T-2 (9.26) and T-1 (4.67). The results for the sensory study reflect highest core for T-3.Fiber enrich bar was prepared by using oats, flex seeds, dates, figs, and honey. T3 (23% dates, 25% figs, 20% flex seeds and 20% 0ats) was better as compared to the other treatments as it was sensory more acceptable and had significant amount of fiber (13.4) which is good to prevent constipation.","[Nisar, Tahreem; Amjad, Aniqa; Javed, Amna; Natasha, Hanza; Akram, Mamoona; Riaz, Mehwish; Nazir, Wafa] Univ Lahore, Lahore, Pakistan",University of Lahore,"Nisar, T (corresponding author), Univ Lahore, Lahore, Pakistan.",tahreemnisar23@gmail.com,,,,,,,25,0,0,1,5,INNOVATIVE SCIENTIFIC INFORMATION & SERVICES NETWORK,FAISALABAD,"INNOVATIVE SCIENTIFIC INFORMATION & SERVICES NETWORK, FAISALABAD, 00000, PAKISTAN",1811-9506,2218-3973,,BIOSCI RES,Biosci. Res.,JUL-SEP,2021,18,3,,,,,2475,2482,,,,,,8,Biology,Emerging Sources Citation Index (ESCI),Life Sciences & Biomedicine - Other Topics,WW6DY,,,,,2024-06-04,WOS:000718005900035,View Full Record in Web of Science
J,"MULLERLISSNER, SA",,,,"MULLERLISSNER, SA",,,CONSTIPATION AND IRRITABLE-BOWEL-SYNDROME,EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY,,,English,Article,,,,,,CONSTIPATION; IRRITABLE BOWEL SYNDROME; (DIETARY) FIBER; COLONIC TRANSIT,,"The assumption that constipation is caused by a diet low in fibre is derived from the effect of bulking agents on the healthy colon. It holds true only for a minority of patients. Dietary fibre does reduce transit times and increase stool weight and frequency, both in controls and in patients with constipation. In the latter, however, the effect is smaller. A favourable response to natural fibre treatment is more likely with constipation than with abdominal complaints such as pain and bloating. A satisfactory effect is unlikely in patients with severe slow transit constipation. All the same, a trial of a high-fibre diet should be part of the basic diagnostic work-up of patients complaining of chronic constipation with or without accompanying abdominal complaints.",,,"MULLERLISSNER, SA (corresponding author), UNIV MUNICH,KLINIKUM INNENSTADT,MED KLIN,W-8000 MUNICH 2,GERMANY.",,,,,,,,0,13,13,0,0,RAPID SCIENCE PUBLISHERS,LONDON,"2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8NH",0954-691X,,,EUR J GASTROEN HEPAT,Eur. J. Gastroenterol. Hepatol.,AUG,1993,5,8,,,,,587,592,,,,,,6,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,LV086,,,,,2024-06-04,WOS:A1993LV08600006,View Full Record in Web of Science
B,"Slavin, J; Jacobs, DR",,"Wilson, T; Temple, NJ; Bray, GA; Struble, MB",,"Slavin, Joanne; Jacobs, David R., Jr.",,,Dietary Fiber: All Fibers Are Not Alike,NUTRITION GUIDE FOR PHYSICIANS,Nutrition and Health Series,,English,Article; Book Chapter,,,,,,Fiber; dietary fiber; whole grain; colon function,BREAST-CANCER; RISK; COLON; WEIGHT,"Dietary fiber intake protects against chronic disease, especially cardiovascular disease. Usual dietary fiber intake is less than half of recommended levels, so most consumers need to increase consumption of high-fiber foods, such as whole grains, legumes, vegetables, and fruits. Fiber may have a role in the prevention and treatment of digestive disorders such as constipation. For more complicated digestive disorders, such as irritable bowel syndrome and ulcerative colitis, fiber may be helpful. While some health benefits of dietary fiber clearly pertain to its physical properties (e.g., colonic bulk), fiber and phytochemicals are almost impossible to separate in epidemiologic studies. Much of the health effect of fiber may be due to the phytochemicals with which it is associated. Therefore, best medical practice is to encourage fiber consumption from foods. Fiber supplements may be recommended for laxation and cholesterol lowering, but whole foods high in dietary fiber also contain phytochemicals that provide additional health benefits.","[Slavin, Joanne] Univ Minnesota, Dept Food & Nutr Sci, Minneapolis, MN 55455 USA; [Jacobs, David R., Jr.] Univ Minnesota, Div Epidemiol, Minneapolis, MN USA",University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities,"Slavin, J (corresponding author), Univ Minnesota, Dept Food & Nutr Sci, Minneapolis, MN 55455 USA.",,"Slavin, Joanne/GOJ-9874-2022","Slavin, Joanne/0000-0003-0720-5300",,,,,32,7,8,1,19,HUMANA PRESS INC,TOTOWA,"999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA",,,978-1-60327-430-2,NUTR HEALTH SER,Nutr. Health Ser.,,2010,,,,,,,13,24,,10.1007/978-1-60327-431-9_2,http://dx.doi.org/10.1007/978-1-60327-431-9_2,10.1007/978-1-60327-431-9,,12,"Geriatrics & Gerontology; Medicine, General & Internal; Nutrition & Dietetics",Book Citation Index – Science (BKCI-S),Geriatrics & Gerontology; General & Internal Medicine; Nutrition & Dietetics,BMR61,,,,,2024-06-04,WOS:000273401400002,View Full Record in Web of Science
J,"García-Contreras, AA; Vásquez-Garibay, EM; Sánchez-Ramírez, CA; Fafutis-Morris, M; Delgado-Rizo, V",,,,"Garcia-Contreras, Andrea A.; Vasquez-Garibay, Edgar M.; Sanchez-Ramirez, Carmen A.; Fafutis-Morris, Mary; Delgado-Rizo, Vidal",,,Factors associated with the stool characteristics of children with cerebral palsy and chronic constipation,REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS,,,English,Article,,,,,,Cerebral palsy; Constipation; Dietary fiber,DIETARY FIBER; DOUBLE-BLIND; PREVALENCE; GLUCOMANNAN,"Background: chronic constipation is a common gastrointestinal problem in children with cerebral palsy and several factors can influence the stool frequency, consistency and pH in these cases. Aim: to identify the association of dietary factors, use of anticonvulsants and family history of constipation with the stool characteristics of children with cerebral palsy and chronic constipation. Methods: an analytical cross-sectional study was performed of 45 children with cerebral palsy and chronic constipation that included 19 females and 26 males, aged 37 +/- 13 months. Dietary factors, the use of anticonvulsants and family history were analyzed. Stool frequency, consistency (Bristol Stool Form Scale) and pH (using a pH-meter) were also determined. Results: there was a positive correlation between stool frequency and the consumption of oilseeds (r = 0.339, p = 0.023).There was a negative correlation between hard stools and fluid intake (r = -0.336, p = 0.042) and between stool pH and the consumption of cereals rich in insoluble fiber, high soluble fiber vegetables, carrots and potatoes (r = -0.339, p = 0.030; r = -0.308, p = 0.044; r = -0.336, p = 0.027; r = -0.307, p = 0.045, respectively). An association was also identified between the use of anticonvulsant polytherapy and hard stools (OR = 14.2 [95% CI 1.16-174], p = 0.038). There was no association between family history and constipation. Conclusions: rich-fiber food consumption, fluids intake and anticonvulsant polytherapy were associated with the stool characteristics of children with cerebral palsy and chronic constipation.","[Garcia-Contreras, Andrea A.; Vasquez-Garibay, Edgar M.] Hosp Civil Guadalajara Dr Juan I Menchaca, Inst Nutr Humana, Guadalajara, Jalisco, Mexico; [Vasquez-Garibay, Edgar M.] Hosp Civil Guadalajara Dr Juan I Menchaca, Guadalajara, Jalisco, Mexico; [Garcia-Contreras, Andrea A.; Sanchez-Ramirez, Carmen A.] Univ Colima, Colima, Mexico; [Vasquez-Garibay, Edgar M.; Fafutis-Morris, Mary; Delgado-Rizo, Vidal] Univ Guadalajara, Guadalajara, Jalisco, Mexico",Universidad de Colima; Universidad de Guadalajara,"Vásquez-Garibay, EM (corresponding author), Hosp Civil Guadalajara Dr Juan I Menchaca, Inst Nutr Humana, Salvador Quevedo & Zubieta, 350 Col Independencia, Guadalajara 44340, Jalisco, Mexico.",vasquez.garibay@gmail.com,"Fafutis-Morris, Mary/AGG-1618-2022; Sánchez, Carmen/GYU-2984-2022; Vazquez Garibay, Edgar Manuel/JPK-6895-2023; Garibay, Edgar Vasquez/AAI-2891-2020","Sanchez-Ramirez, Carmen A/0000-0002-3525-7821; Vasquez-Garibay, Edgar/0000-0002-5576-7263",,,,,35,4,5,3,5,"ARAN EDICIONES, S A",MADRID,"CASTELLO, 128, 28006 MADRID, SPAIN",1130-0108,2340-4167,,REV ESP ENFERM DIG,Rev. Esp. Enferm. Dig.,,2020,112,1,,,,,41,46,,10.17235/reed.2019.6313/2019,http://dx.doi.org/10.17235/reed.2019.6313/2019,,,6,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,KC9AF,31830793,gold,,,2024-06-04,WOS:000507462500009,View Full Record in Web of Science
J,"Voderholzer, WA; Schatke, W; Muhldorfer, BE; Klauser, AG; Birkner, B; MullerLissner, SA",,,,"Voderholzer, WA; Schatke, W; Muhldorfer, BE; Klauser, AG; Birkner, B; MullerLissner, SA",,,Clinical response to dietary fiber treatment of chronic constipation,AMERICAN JOURNAL OF GASTROENTEROLOGY,,,English,Article,,,,,,,IRRITABLE-BOWEL-SYNDROME; COLONIC TRANSIT-TIME; DEFECATION,"Objectives: To determine the clinical outcome of dietary fiber therapy in patients with chronic constipation. Methods: One hundred, forty-nine patients with chronic constipation (age 53 yr, range 18-81 yr, 84% women) at two gastroenterology departments in Munich, Germany, were treated with Plantago ovata seeds, 15-30 g/day, for a period of at least 6 wk. Repeated symptom evaluation, oroanal transit time measurement (radiopaque markers), and functional rectoanal evaluation (proctoscopy, manometry, defecography) were performed. Patients were classified on the basis of the result of dietary fiber treatment: no effect, n = 84; improved, n = 33; and symptom free, n = 32, Results: Eighty percent of patients with slow transit and 63% of patients with a disorder of defecation did not respond to dietary fiber treatment, whereas 85% of patients without a pathological finding improved or became symptom free. Conclusion: Slow GI transit and/or a disorder of defecation may explain a poor outcome of dietary fiber therapy in patients with chronic constipation. A dietary fiber trial should be conducted before technical investigations, which are indicated only if the dietary fiber trial fails.","KLINIKUM BOGENHAUSEN,MED KLIN 2,MUNICH,GERMANY; KRANKENHAUS WEISSENSEE,DEPT INTERNAL MED,BERLIN,GERMANY",University of Hamburg; University Medical Center Hamburg-Eppendorf; Munchen Klinik; University of Munich,"Voderholzer, WA (corresponding author), UNIV MUNICH,KLINIKUM INNENSTADT,MED KLIN,ZIEMSSENSTR 1,D-80336 MUNICH,GERMANY.",,,,,,,,13,186,202,1,14,WILLIAMS & WILKINS,BALTIMORE,"351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436",0002-9270,,,AM J GASTROENTEROL,Am. J. Gastroenterol.,JAN,1997,92,1,,,,,95,98,,,,,,4,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,WB762,8995945,,,,2024-06-04,WOS:A1997WB76200017,View Full Record in Web of Science
J,"Chao, HC; Lai, MW; Kong, MS; Chen, SY; Chen, CC; Chiu, CH",,,,"Chao, Hsun-Chin; Lai, Ming-Wei; Kong, Man-Shan; Chen, Shih-Yen; Chen, Chien-Chang; Chiu, Cheng-Hsun",,,Cutoff volume of dietary fiber to ameliorate constipation in children,JOURNAL OF PEDIATRICS,,,English,Article,,,,,,,PREVALENCE; CHILDHOOD; BRAN,"Objective To evaluate the proper ingested volume of dietary fiber for relieving constipation in children. Study design During a 3-year period, we prospectively evaluated the correlation of intake volume of dietary fiber with improvement of constipation in children. Patients were categorized into younger (3-7 years) and older (8-14 years) children. The evaluation period lasted 12 weeks. A good improvement was defined as the child exhibiting at least 60% relief of die constipation symptoms during the observation period. Freedom from constipation was observed during the last 4 weeks. Results The study population consisted of 422 patients (213 younger, 209 older), with a mean age of 7.89 +/- 4.71 years. Baseline daily dietary fiber intake of the younger and older groups was 5.97 +/- 2.35 g and 9.83 +/- 3.51 g, respectively. 227 cases (53.8 %) showed improvement of constipation, and 49.1 % of the patients had relief of constipation. Greater intake of dietary fiber was positively associated with good improvement of constipation in both groups (P =.002, and P <.001). Cutoff volumes of daily dietary fiber intake in the relief of constipation were 10 g in the younger group and 14.5 g in the older group. Conclusion The cutoff of dietary fiber intake needed to relieve constipation increased with age, achievable in a 12-week intervention.","[Chiu, Cheng-Hsun] Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Dept Pediat,Div Pediat Infect Dis, Tao Yuan 333, Taiwan; [Chao, Hsun-Chin; Lai, Ming-Wei; Kong, Man-Shan; Chen, Shih-Yen; Chen, Chien-Chang] Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Dept Pediat,Div Gastroenterol, Tao Yuan 333, Taiwan",Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University,"Chiu, CH (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Dept Pediat,Div Pediat Infect Dis, 5 Fu Hsing St, Tao Yuan 333, Taiwan.",chchiu@adm.cgmh.org.tw,,,,,,,32,22,27,3,17,MOSBY-ELSEVIER,NEW YORK,"360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA",0022-3476,1097-6833,,J PEDIATR-US,J. Pediatr.,JUL,2008,153,1,,,,,45,49,,10.1016/j.jpeds.2007.12.044,http://dx.doi.org/10.1016/j.jpeds.2007.12.044,,,5,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,319HN,18571534,,,,2024-06-04,WOS:000257154800014,View Full Record in Web of Science
J,"Li, JQ; Ma, GQ; Xie, JW; Xu, K; Lai, H; Li, YF; He, YF; Yu, H; Liao, X; Wang, XY; Li, ZX; Kong, LY; Mi, BB; Shen, Y; Tian, T; Liu, X",,,,"Li, Junqi; Ma, Guoqing; Xie, Jiawen; Xu, Kun; Lai, Hao; Li, Yunfeng; He, Yafang; Yu, Hang; Liao, Xia; Wang, Xinyan; Li, Zhongxia; Kong, Liyun; Mi, Baibing; Shen, Yuan; Tian, Tian; Liu, Xin",,,"Differential Gut Microbiota, Dietary Intakes in Constipation Patients with or without Hypertension",MOLECULAR NUTRITION & FOOD RESEARCH,,,English,Article,,,,,,beans; constipation; dietary pattern; gut microbiota; hypertension,CHAIN FATTY-ACIDS; BLOOD-PRESSURE; HEALTH; ASSOCIATIONS; PREVALENCE; DYSBIOSIS; ADULTS,"Scope: Diet and gut microbiota are involved in blood pressure regulations, but few studies have focused on the constipation patients. The study seeks to identify differences in gut microbiota between hypertensive and normotensive subjects in constipation patients, analyzes the relationship between dietary patterns and blood pressure, and explores mediation effects of gut microbiota. Methods and results: Gut microbial genera and dietary information of 186 functional constipation participants are characterized by 16S rRNA sequencing and a food frequency questionnaire. The hypertensive subjects shows lower. alpha-diversity and.. -diversity of gut microbiota than normotensive (p < 0.05) and 17 differential microbial genera. The dried-beans intake frequency inversely correlated with systolic and diastolic blood pressure after multivariate adjustment (r =-0.273, p-(FDR) < 0.01; r= -0.251, p-(FDR) = 0.026, respectively). Logistic regression indicates that the individuals often consumed dried-beans have a lower hypertension risk than those never consumed [OR = 0.137, 95% CI: (0.022, 0.689), p = 0.022]. A marginal mediating effect of the genus Monoglobus is observed for the association between high-fiber dietary pattern and hypertension. Conclusion: In patients with functional constipation, hypertension-related gut microbial differences are identified. Dried-beans intake is inversely associated with blood pressure, and a genus may potentially mediate the association between high-fiber dietary pattern and hypertension.","[Li, Junqi; Ma, Guoqing; Xie, Jiawen; Xu, Kun; Lai, Hao; Li, Yunfeng; He, Yafang; Kong, Liyun; Mi, Baibing; Shen, Yuan; Liu, Xin] Xi An Jiao Tong Univ, Global Hlth Inst, Hlth Sci Ctr, Sch Publ Hlth,Key Lab Dis Prevent & Control & Hlth, Xian 710061, Peoples R China; [Yu, Hang] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Cardiovasc Med, Xian 710061, Peoples R China; [Liao, Xia] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Nutr, Xian 710061, Peoples R China; [Wang, Xinyan; Li, Zhongxia] BYHEALTH Inst Nutr & Hlth, Guangzhou 510663, Peoples R China; [Tian, Tian] Xian Daxing Hosp, Dept Nutr, Xian 710016, Peoples R China",Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University,"Liu, X (corresponding author), Xi An Jiao Tong Univ, Global Hlth Inst, Hlth Sci Ctr, Sch Publ Hlth,Key Lab Dis Prevent & Control & Hlth, Xian 710061, Peoples R China.;Tian, T (corresponding author), Xian Daxing Hosp, Dept Nutr, Xian 710016, Peoples R China.",yyktiantian@163.com; xinliu@xjtu.edu.cn,"mi, baibing/ABO-1246-2022; Li, Zhongxia/JNS-8893-2023; WU, CHUNYAN/HMO-6771-2023","mi, baibing/0000-0002-5208-7633; WU, CHUNYAN/0000-0002-6531-1219; Lai, Hao/0000-0003-0277-9364","National Natural Science Foundation of China [82173504, 82011530197]; BYHEALTH Nutrition and Health Research Foundation [TY0191118]",National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); BYHEALTH Nutrition and Health Research Foundation,"The authors thank the staff in Xi'an Jiaotong University, Xi'an Daxing Hospital, Yue Cheng and all the members in Xin Liu Laboratory for their work on data collection and analysis. This research was funded by National Natural Science Foundation of China (82173504, 82011530197) and BYHEALTH Nutrition and Health Research Foundation (TY0191118).",,47,2,2,4,11,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1613-4125,1613-4133,,MOL NUTR FOOD RES,Mol. Nutr. Food Res.,NOV,2023,67,22,,,,,,,2300208,10.1002/mnfr.202300208,http://dx.doi.org/10.1002/mnfr.202300208,,SEP 2023,7,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,AM7I0,37712107,,,,2024-06-04,WOS:001067090900001,View Full Record in Web of Science
J,"Erhardt, R; Harnett, JE; Steels, E; Steadman, KJ",,,,"Erhardt, Rene; Harnett, Joanna E.; Steels, Elizabeth; Steadman, Kathryn J.",,,Functional constipation and the effect of prebiotics on the gut microbiota: a review,BRITISH JOURNAL OF NUTRITION,,,English,Review,,,,,,Functional constipation; Prebiotics; Microbiota; Dietary fibre,CHRONIC IDIOPATHIC CONSTIPATION; HYDROLYZED GUAR GUM; BRAIN AXIS; ENTERIC MICROBIOTA; FIBER; DIETARY; HEALTH; IMPACT; INULIN; SUPPLEMENTATION,"Functional constipation is a significant health issue impacting the lives of an estimated 14 % of the global population. Non-pharmaceutical treatment advice for cases with no underlying medical conditions focuses on exercise, hydration and an increase in dietary fibre intake. An alteration in the composition of the gut microbiota is thought to play a role in constipation. Prebiotics are non-digestible food ingredients that selectively stimulate the growth of a limited number of bacteria in the colon with a benefit for host health. Various types of dietary fibre, though not all, can act as a prebiotic. Short-chain fatty acids produced by these microbes play a critical role as signalling molecules in a range of metabolic and physiological processes including laxation, although details are unclear. Prebiotics have a history of safe use in the food industry spanning several decades and are increasingly used as supplements to alleviate constipation. Most scientific research on the effects of prebiotics and gut microbiota has focussed on inflammatory bowel disease rather than functional constipation. Very few clinical studies evaluated the efficacy of prebiotics in the management of constipation and their effect on the microbiota, with highly variable designs and conflicting results. Despite this, broad health claims are made by manufacturers of prebiotic supplements. This narrative review provides an overview of the literature on the interaction of prebiotics with the gut microbiota and their potential clinical role in the alleviation of functional constipation.","[Erhardt, Rene; Steels, Elizabeth; Steadman, Kathryn J.] Univ Queensland, Sch Pharm, Brisbane, Qld 4102, Australia; [Harnett, Joanna E.] Univ Sydney, Sch Pharm, Camperdown, NSW 2006, Australia; [Steels, Elizabeth] Evidence Sci, 3-884 Brunswick St, New Farm, Qld 4005, Australia",University of Queensland; University of Sydney,"Erhardt, R (corresponding author), Univ Queensland, Sch Pharm, Brisbane, Qld 4102, Australia.",r.erhardt@uq.edu.au,"Harnett, Joanna E/L-1214-2018; Steadman, Kathryn/C-3401-2008","Harnett, Joanna E/0000-0001-9904-2144; Steadman, Kathryn/0000-0001-7357-330X; Erhardt, Rene/0000-0002-1961-135X",Postgraduate Research Scholarship from The University of Queensland,Postgraduate Research Scholarship from The University of Queensland,"R Erhardt is supported by a Postgraduate Research Scholarship from The University of Queensland. E. R. contributed to the conception, design and interpretation of the research. All authors contributed to the drafting of the manuscript. All authors critically revised the manuscript, agree to be fully accountable for ensuring the integrity and accuracy of the work and read and approved the final manuscript. There are no conflicts of interest.",,72,5,5,18,47,CAMBRIDGE UNIV PRESS,CAMBRIDGE,"EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND",0007-1145,1475-2662,,BRIT J NUTR,Br. J. Nutr.,SEP 28,2023,130,6,,,,,1015,1023,PII S0007114522003853,10.1017/S0007114522003853,http://dx.doi.org/10.1017/S0007114522003853,,DEC 2022,9,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,FP0W1,36458339,"hybrid, Green Published",,,2024-06-04,WOS:000939912400001,View Full Record in Web of Science
J,"Taylor, CM; Northstone, K; Wernimont, SM; Emmett, PM",,,,"Taylor, Caroline M.; Northstone, Kate; Wernimont, Susan M.; Emmett, Pauline M.",,,Picky eating in preschool children: Associations with dietary fibre intakes and stool hardness,APPETITE,,,English,Article,,,,,,ALSPAC; Dietary fibre; Constipation; Hard stools; Picky eating; Vegetables,SOUTH-WEST; FUNCTIONAL CONSTIPATION; FEEDING DIFFICULTIES; 3-YEAR-OLD CHILDREN; POPULATION-SAMPLE; FOOD NEOPHOBIA; PREVALENCE; PATTERNS; AGE; CHILDHOOD,"It has been suggested that constipation may be associated with picky eating. Constipation is a common condition in childhood and a low intake of dietary fibre may be a risk factor. Differences in fibre intake between picky and non-picky children and its relation to stool consistency is currently not well understood. Children enrolled in the Avon Longitudinal Study of Parents and Children identified as picky eaters (PE) were compared with non-picky eaters (NPE): (1) to determine dietary fibre intake at 38 months; (2) to investigate whether any difference in dietary fibre intake was predictive of usual stool hardness at 42 months. PE was identified from questionnaires at 24 and 38 months. Usual stool hardness was identified from a questionnaire at 42 months. Dietary intake was assessed at 38 months with a food frequency questionnaire. Dietary fibre intake was lower in PE than NPE (mean difference -1.4 (95% CI -1.6, -1.2) g/day, p < 0.001). PE was strongly associated with dietary fibre intake (adjusted regression model; unstandardised B -1.44 (95% CI -1.62, -1.24) g/day, p < 0.001). PE had a lower percentage of fibre from vegetables compared with NPE (8.9% vs 15.7%, respectively, p < 0.001). There was an association between PE and usually having hard stools (adjusted multinomial model; OR 131, 95% CI 1.07, 1.61; p = 0.010). This was attenuated when dietary fibre was included in the model, suggesting that fibre intake mediated the association (OR 1.16, 95% CI 0.94,1.43, p = 0.180). Picky eating in 3-year-old children was associated with an increased prevalence of usually having hard stools. This association was mediated by low dietary fibre intake, particularly from vegetables, in PE. For children with PE, dietary advice aimed at increasing fibre intake may help avoid hard stools. (C) 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license.","[Taylor, Caroline M.; Emmett, Pauline M.] Univ Bristol, Ctr Child & Adolescent Hlth, Sch Social & Community Med, Oakfield House, Bristol BS8 2BN, Avon, England; [Northstone, Kate] Univ Bristol, Sch Social & Community Med, Bristol BS8 2BN, Avon, England; [Wernimont, Susan M.] Nestle Nutr R&D, King Of Prussia, PA USA",University of Bristol; University of Bristol,"Taylor, CM (corresponding author), Univ Bristol, Ctr Child & Adolescent Hlth, Sch Social & Community Med, Oakfield House, Bristol BS8 2BN, Avon, England.",Caroline.m.taylor@bristol.ac.uk,"Wernimont, Sue/AAW-2811-2020; Wernimont, Susan M/KFS-1562-2024; Emmett, Pauline/AAL-6815-2021; Northstone, Kate/A-8165-2011","Wernimont, Susan M/0000-0001-7203-1349; Northstone, Kate/0000-0002-0602-1983; Taylor, Caroline/0000-0001-8347-5092",UK Medical Research Council; Wellcome Trust [102215/2/13/2]; University of Bristol; Nestle Nutrition; Medical Research Council [MC_PC_15018] Funding Source: researchfish,UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); University of Bristol; Nestle Nutrition(Nestle SA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)),The UK Medical Research Council and the Wellcome Trust (Grant ref: 102215/2/13/2) and the University of Bristol provide core support for ALSPAC. This publication is the work of the authors who will serve as guarantors for the contents of this paper. The research reported in this paper was funded by Nestle Nutrition.,,47,34,42,0,35,ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD,LONDON,"24-28 OVAL RD, LONDON NW1 7DX, ENGLAND",0195-6663,1095-8304,,APPETITE,Appetite,MAY 1,2016,100,,,,,,263,271,,10.1016/j.appet.2016.02.021,http://dx.doi.org/10.1016/j.appet.2016.02.021,,,9,Behavioral Sciences; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Behavioral Sciences; Nutrition & Dietetics,DJ0BK,26879221,"hybrid, Green Accepted, Green Published",,,2024-06-04,WOS:000373866200031,View Full Record in Web of Science
J,"DIMSKI, DS",,,,"DIMSKI, DS",,,USING DIETARY FIBER TO MANAGE CONSTIPATION,PRAKTISCHE TIERARZT,,,German,Article,,,,,,,,"Constipation is a frequently encountered problem in small-animal practice. Identifying and treating underlying disorders will prevent recurrence in many cases; however, in many cases an underlying cause cannot be found, and the practitioner's goal is managing the problem. Dietary therapy with insoluble fiber either as a component of an available diet or as a dietary supplement is an excellent way to alter colonic physiology to promote the more frequent passage of bulkier, hydrated stools. Additional laxative therapy may occasionally be needed to promote fecal hydration and lubrication.",,,"DIMSKI, DS (corresponding author), OHIO STATE UNIV,COLL VET MED,DEPT VET CLIN SCI,COLUMBUS,OH 43210, USA.",,,,,,,,0,0,0,0,3,SCHLUTERSCHE VERLAG DRUCKEREI,HANOVER 1,"GEORGSWALL 4, W-3000 HANOVER 1, GERMANY",0032-681X,,,PRAKT TIERARZT,Prakt Tierarzt,JUN 1,1991,72,6,,,,,489,491,,,,,,3,Veterinary Sciences,Science Citation Index Expanded (SCI-EXPANDED),Veterinary Sciences,FQ544,,,,,2024-06-04,WOS:A1991FQ54400002,View Full Record in Web of Science
J,"de Mello, PP; Eifer, DA; de Mello, ED",,,,"de Mello, Patricia Piccoli; Eifer, Diego Andre; de Mello, Elza Daniel",,,Use of fibers in childhood constipation treatment: systematic review with meta-analysis,JORNAL DE PEDIATRIA,,,English,Review,,,,,,Constipation; Fiber; Meta-analysis; Children; Preschool; Adolescent,DIETARY FIBER; FUNCTIONAL CONSTIPATION; CHILDREN; GLUCOMANNAN; LACTULOSE; MIXTURE; TRIALS,"Objective: To gather current evidence on the use of fiber for constipation treatment in pediatric patients. Source of data: Systematic review with meta-analysis of studies identified through Pubmed, Embase, LILACS and Cochrane databases published up to 2016. Inclusion criteria: Randomized controlled trials; patients aged between 1 and 18 years and diagnosed with functional constipation receiving or not drug treatment for constipation; articles published in Portuguese, English, Spanish, French, and German in journals accessible to the researchers. Synthesis of data: A total of 2963 articles were retrieved during the search and, after adequate evaluation, nine articles were considered relevant to the study objective. A total of 680 children were included, of whom 45% were boys. No statistical significance was observed for bowel movement frequency, stool consistency, therapeutic success, fecal incontinence, and abdominal pain with fiber intake in patients with childhood constipation. These results should be interpreted with care due to the high clinical heterogeneity between the studies and the methodological limitation of the articles selected for analysis. Conclusions: There is a scarcity of qualified studies to evaluate fiber supplementation in the treatment of childhood constipation, generating a low degree of confidence in estimating thereal effect of this intervention on this population. Today, according to the current literature, adequate fiber intake should only be recommended for functional constipation, and fiber-supplementation should not be prescribed in the diet of constipated children and adolescents. (C) 2018 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda. This is an openaccess article under the CC BY-NC-ND license.","[de Mello, Patricia Piccoli; de Mello, Elza Daniel] Univ Fed Rio Grande do Sul, Programa Pos Grad Saude Crianca & Adolescente, Porto Alegre, RS, Brazil; [Eifer, Diego Andre] HCPA, Serv Radiol, Porto Alegre, RS, Brazil; [Eifer, Diego Andre] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil",Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul,"de Mello, PP (corresponding author), Univ Fed Rio Grande do Sul, Programa Pos Grad Saude Crianca & Adolescente, Porto Alegre, RS, Brazil.",patriciamellomed@gmail.com,,,,,,,34,25,28,2,6,SOC BRASIL PEDIATRIA,"RIO DE JANEIRO, RJ","RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL",0021-7557,1678-4782,,J PEDIAT-BRAZIL,J. Pediatr.,SEP-OCT,2018,94,5,,,,,460,470,,10.1016/j.jped.2017.10.014,http://dx.doi.org/10.1016/j.jped.2017.10.014,,,11,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,GY5FQ,29474804,"Green Published, gold",,,2024-06-04,WOS:000448597500003,View Full Record in Web of Science
J,"Murakami, K; Okubo, H; Sasaki, S",,,,"Murakami, K; Okubo, H; Sasaki, S",,,Dietary intake in relation to self-reported constipation among Japanese women aged 18-20 years,EUROPEAN JOURNAL OF CLINICAL NUTRITION,,,English,Article,,,,,,dietary intake; constipation; Japanese women,LIFE-STYLE FACTORS; HISTORY QUESTIONNAIRE; BOWEL MOVEMENT; UNITED-STATES; ENERGY-INTAKE; POPULATION; VALIDITY; DEFINITION; PREVALENCE; FREQUENCY,"Objective: Information on modifiable lifestyle factors associated with constipation is limited, especially among non-Western populations. We examined associations between dietary intake and self-reported constipation in young Japanese women. Design: Cross-sectional study. Subjects: A total of 1705 female Japanese dietetic students aged 18-20 years and free of current disease and current dietary counseling. Methods: Dietary intake was estimated over a 1-month period with a validated, self-administered, diet history questionnaire, and lifestyle variables including self-reported constipation were assessed by a second questionnaire designed for this survey. Results: A total of 436 women (26%) reported themselves to be 'constipated'. A multivariate odds ratio (OR) for women in the highest quartile of rice intake was 0.47 (95% confidence interval (CI): 0.33, 0.68) compared with the lowest. Additionally, women in the highest category of coffee intake had a multivariate OR of 0.67 (0.47, 0.94) compared with women in the lowest. Conversely, women in the highest quartile of confectionery intake had a multivariate OR of 1.54 (1.12, 2.13) compared with women in the lowest. Moreover, a multivariate OR for constipation for women in the highest quartile of Japanese and Chinese tea intake was 1.49 (1.09, 2.05) compared with women in the lowest. Neither total dietary fiber intake nor other lifestyle factors examined were associated with constipation. Conclusions: The consumption of rice and coffee was inversely associated with and that of confectioneries and Japanese and Chinese tea was positively associated with a prevalence of self-reported constipation.","Univ Shizuoka, Grad Sch Nutr & Environm Sci, Dept Food & Nutr Sci, Shizuoka 422, Japan; Natl Inst Hlth & Nutr, Tokyo 162, Japan",University of Shizuoka; National Institute of Health & Nutrition - Japan,"Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628636, Japan.",stssasak@nih.go.jp,"Okubo, Hitomi/AAB-7613-2020","Okubo, Hitomi/0000-0002-2305-0719; Murakami, Kentaro/0000-0002-4189-7753",,,,,35,36,39,0,10,NATURE PUBLISHING GROUP,LONDON,"MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND",0954-3007,1476-5640,,EUR J CLIN NUTR,Eur. J. Clin. Nutr.,MAY,2006,60,5,,,,,650,657,,10.1038/sj.ejcn.1602365,http://dx.doi.org/10.1038/sj.ejcn.1602365,,,8,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,039AR,16340942,,,,2024-06-04,WOS:000237272300013,View Full Record in Web of Science
J,"Alvarez, EE; Sánchez, PG",,,,"Escudero Alvarez, E.; Gonzalez Sanchez, P.",,,Dietary fibre,NUTRICION HOSPITALARIA,,,English,Article,,,,,,dietary fibre; colonic flora; fermentation; short chain fatty acids,STIMULATES CALCIUM-ABSORPTION; ULCERATIVE-COLITIS; RAT COLON; BUTYRATE; BIFIDOBACTERIA; OLIGOFRUCTOSE; DISEASE; GROWTH,"Currently and after 30 years of research, dietary fibre is part of what is considered a healthy diet. There is no single definition yet comprising the different components of dietary fibre and its functions. The main factors of fibre are complex carbohydrates and lignin, although new products may be included in the future within the concept of fibre. Dietary fibres reach the large bowel and are attacked by colonic microflora, yielding short chain fatty acids, hydrogen, carbon dioxide, and methane as fermentation products. Short chain fatty acids represent a way of recovering energy and they are also implicated in other beneficial functions for the human organism. Although there are no yet conclusive data on recommendations of different types of fibre, it is still appropriate to indicate a diet providing 20-35 g/day of fibre from different sources. There is a consensus to recommend a mixture of fibres or fibre like soybean polysaccharide for constipation. There are few conclusive data, still, on the benefit of fibre on prevention of colorectal cancer and cardiovascular disease. However, a fibre-rich diet is recommended from early years of life since it is often associated to a lifestyle that in the long term helps controlling other risk factors.","Hosp Fuenfria, Unidad Dietet & Nutr, Madrid 28470, Spain",,"Alvarez, EE (corresponding author), Hosp Fuenfria, Unidad Dietet & Nutr, Ctra Dehesas S-N, Madrid 28470, Spain.",eescudero.hlff@salud.madrid.org,,,,,,,52,87,102,3,27,"ARAN EDICIONES, S L",MADRID,"C/ CASTELLO, 128, 1O, MADRID, 28006, SPAIN",0212-1611,1699-5198,,NUTR HOSP,Nutr. Hosp.,MAY,2006,21,,,2,,,60,71,,,,,,12,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,119QM,16771074,,,,2024-06-04,WOS:000243027800007,View Full Record in Web of Science
J,"Gélinas, P",,,,"Gelinas, Pierre",,,Preventing constipation: a review of the laxative potential of food ingredients,INTERNATIONAL JOURNAL OF FOOD SCIENCE AND TECHNOLOGY,,,English,Review,,,,,,Constipation; dietary fibre; food ingredients; laxative,FECAL STEROID-EXCRETION; WATER-HOLDING CAPACITY; DIETARY FIBER INTAKE; IRRITABLE-BOWEL-SYNDROME; WHEAT BRAN EQUIVALENTS; INCREASE STOOL WEIGHT; GUT TRANSIT-TIME; INTESTINAL TRANSIT; RESISTANT STARCH; COLONIC FUNCTION,"Constipation is a highly prevalent and difficult-to-cure health problem, forcing 1020% of the worldwide population to seek medical care. Efficacy of treatments varies greatly among individuals, and problems are becoming more frequent despite higher consumption of fibre-rich foods, the most popular solution for preventing such gastrointestinal disorders. The evidence that consumption of fibre prevents and relieves constipation is unconvincing or uncertain. The food industry has made great efforts to develop fibre-rich ingredients, especially those from food by-products and wastes. Except for psyllium and wheat bran, most of these ingredients have intermediate or low laxative potential and their efficacy needs to be confirmed by more clinical studies. This review suggests that there are major discrepancies between the proposed fibre-enriched ingredients and the consumers' needs. As a lasting solution to prevent constipation, the true impact of dietary fibre and potent food-grade laxatives might also be limited by overeating.","Agr & Agri Food Canada, Food Res & Dev Ctr, St Hyacinthe, PQ J2S 8E3, Canada",Agriculture & Agri Food Canada,"Gélinas, P (corresponding author), Agr & Agri Food Canada, Food Res & Dev Ctr, 3600 Casavant Blvd W, St Hyacinthe, PQ J2S 8E3, Canada.",pierre.gelinas@agr.gc.ca,,"Gelinas, Pierre/0000-0001-7405-5694",,,,,295,17,18,3,79,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0950-5423,1365-2621,,INT J FOOD SCI TECH,Int. J. Food Sci. Technol.,MAR,2013,48,3,,,,,445,467,,10.1111/j.1365-2621.2012.03207.x,http://dx.doi.org/10.1111/j.1365-2621.2012.03207.x,,,23,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,078OY,,,,,2024-06-04,WOS:000314110100001,View Full Record in Web of Science
J,"Bai, XL; He, Y; Quan, BY; Xia, T; Zhang, XL; Wang, YQ; Zheng, Y; Wang, M",,,,"Bai, Xiaoli; He, Yi; Quan, Bingyan; Xia, Ting; Zhang, Xianglong; Wang, Yongqi; Zheng, Yu; Wang, Min",,,"Physicochemical properties, structure, and ameliorative effects of insoluble dietary fiber from tea on slow transit constipation",FOOD CHEMISTRY-X,,,English,Article,,,,,,Tea; Insoluble dietary fiber; Physicochemical property; Slow transit constipation; In vitro fermentation,NEUTRAL DETERGENT FIBER; CHAIN FATTY-ACIDS; POLYSACCHARIDE; EXTRACTION; ALKALINE; RESIDUE,"Tea residue is a by-product of tea processing and contains similar to 60 % insoluble dietary fiber. We investigated the physicochemical properties and structure of the insoluble dietary fiber of tea (T-IDF), and its defecation function was evaluated. The physical and chemical indexes of the T-IDF, including its water holding, oil holding, swelling, cation exchange, and cholesterol exchange capacities, were measured, while its structure was analyzed by a range of analytical techniques. Furthermore, the related indexes of the animal defecation function were determined, and the in vitro detection of fermented short chain fatty acid was conducted. We found that T-IDF exhibits excellent physical and chemical properties. Moreover, the consumption of T-IDF significantly promoted defecation in slow transit intestinal dyskinesia mice and enhanced the production of short chain fatty acids. Overall, we demonstrated a good correlation between the physicochemical properties and the structure/function of T-IDF.","[Bai, Xiaoli; Quan, Bingyan; Xia, Ting; Zhang, Xianglong; Wang, Yongqi; Zheng, Yu; Wang, Min] Tianjin Univ Sci & Technol, Coll Biotechnol, Key Lab Ind Fermentat Microbiol, State Key Lab Food Nutr & Safety, Tianjin 300457, Peoples R China; [Bai, Xiaoli; He, Yi] Tasly Pharmaceut Grp Co Ltd, State Key Lab Core Technol Innovat Chinese Med, Tianjin 300410, Peoples R China",Tianjin University Science & Technology,"Zheng, Y; Wang, M (corresponding author), Tianjin Univ Sci & Technol, Coll Biotechnol, Key Lab Ind Fermentat Microbiol, State Key Lab Food Nutr & Safety, Tianjin 300457, Peoples R China.",yuzheng@tust.edu.cn; minw@tust.edu.cn,,,National Natural Science Foundation of China [32072203]; Tianjin Synthetic Biotechnology Innovation Capacity Improvement Project [TSBICIP-KJGG-016-03]; Tianjin Science and Technology Commission [21ZYJDJC00030]; Tianjin Municipal Education Commission [TD13-5013],National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Synthetic Biotechnology Innovation Capacity Improvement Project; Tianjin Science and Technology Commission; Tianjin Municipal Education Commission,"Financial supports from National Natural Science Foundation of China (32072203), Tianjin Synthetic Biotechnology Innovation Capacity Improvement Project (TSBICIP-KJGG-016-03), Tianjin Science and Technology Commission (21ZYJDJC00030), and Tianjin Municipal Education Commission (TD13-5013).",,33,13,13,18,104,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",2590-1575,,,FOOD CHEM X,Food Chem. X,JUN 30,2022,14,,,,,,,,100340,10.1016/j.fochx.2022.100340,http://dx.doi.org/10.1016/j.fochx.2022.100340,,MAY 2022,9,"Chemistry, Applied; Food Science & Technology",Science Citation Index Expanded (SCI-EXPANDED),Chemistry; Food Science & Technology,1Y7AV,35663600,"Green Published, gold",,,2024-06-04,WOS:000808293800013,View Full Record in Web of Science
J,"Li, L; Huang, AP; Wang, LQ; Yu, XL",,,,"Li, Li; Huang, Ai-Ping; Wang, Li-Qin; Yu, Xiao-Long",,,"Empirically derived dietary patterns and constipation among a middle-aged population from China, 2016-2018",NUTRITION JOURNAL,,,English,Article,,,,,,Dietary patterns; Constipation; Chinese; Cross-sectional study,TYPE-2 DIABETES-MELLITUS; LIFE-STYLE FACTORS; FUNCTIONAL CONSTIPATION; ASSOCIATION; WOMEN; DETERMINANTS; FIBER,"Background The association of dietary patterns with constipation is not well established, particularly in Chinese population. Therefore, the present study aimed to determine the relationship between dietary patterns and the risk of constipation in a middle-aged Chinese population. Methods A total of 2267 participants aged 45-59 years were recruited in Hangzhou city, the capital of Zhejiang Province, east China from August 2016 to October 2018. Dietary intake was estimated using a semi-quantitative food frequency questionnaire (FFQ) containing 138 food items. Constipation was defined using the Rome II criteria. Multivariate logistic regression was used to examine the association between dietary patterns and the risk of constipation. Results Three major dietary patterns were extracted by factor analysis and labeled as the traditional southern Chinese, Western and grains-vegetables patterns. The prevalence of constipation in our study population was 13.28%. Compared with the participants in the lowest quartile, the participants in the highest quartile of the traditional southern Chinese pattern were associated with reduced odds of constipation (odd ratios (OR) = 0.79; 95%confidence interval (CI): 0.626-0.981; P < 0.05), after adjusting for confounding variables. In contrast, we found no significant associations between the Western and grains-vegetables patterns and the risk of constipation (P > 0.05). Conclusions Our study demonstrated that the traditional southern Chinese pattern was associated with a reduced risk of constipation. Further longitudinal studies are needed to confirm our findings.","[Li, Li] Lanzhou Univ, Grad Off, Hosp 1, Lanzhou 730000, Gansu, Peoples R China; [Huang, Ai-Ping] Blood Ctr Zhejiang Prov, Dept Blood Donat Serv, Hangzhou 310006, Zhejiang, Peoples R China; [Wang, Li-Qin] Gansu Univ Tradit Chinese Med, Dept Rheumatol, Affiliated Hosp, Lanzhou 730000, Gansu, Peoples R China; [Yu, Xiao-Long] Zhejiang Hosp, Dept Nutr, Hangzhou 310013, Zhejiang, Peoples R China",Lanzhou University; Gansu University of Chinese Medicine,"Yu, XL (corresponding author), Zhejiang Hosp, Dept Nutr, Hangzhou 310013, Zhejiang, Peoples R China.",rainboy2018@163.com,"li, tong/JYO-7530-2024; Liu, Yixuan/JFJ-2820-2023",,Natural Science Foundation of Zhejiang [Y17H030008],Natural Science Foundation of Zhejiang(Natural Science Foundation of Zhejiang Province),This research was supported by grants from the Natural Science Foundation of Zhejiang (No. Y17H030008).,,33,8,8,2,12,BMC,LONDON,"CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND",,1475-2891,,NUTR J,Nutr. J.,DEC 26,2019,18,1,,,,,,,88,10.1186/s12937-019-0512-9,http://dx.doi.org/10.1186/s12937-019-0512-9,,,9,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Nutrition & Dietetics,KJ4YS,31878924,"Green Published, gold",,,2024-06-04,WOS:000512066600001,View Full Record in Web of Science
J,"Fernández-Bañares, F",,,,"Fernandez-Banares, Fernando",,,Nutritional care of the patient with constipation,BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY,,,English,Article,,,,,,chronic constipation; irritable bowel syndrome; dietary fibre; bulking agents; probiotics; prebiotics,IRRITABLE-BOWEL-SYNDROME; DOUBLE-BLIND; DIETARY FIBER; WHEAT BRAN; LACTOBACILLUS-GG; LACTULOSE SYRUP; TRANSIT-TIME; PROBIOTICS; EFFICACY; BIFIDOBACTERIUM,"Chronic constipation is defined as a symptom-based disorder based on the presence for at least 3 months in the last year of unsatisfactory defecation characterized by infrequent stools, difficult stool passage, or both. On the other hand, the presence of clinically important abdominal discomfort or pain associated with constipation defines irritable bowel syndrome (IBS) with constipation. Intake of dietary fibre and bulking agents (psyllium) may be effective in alleviating chronic constipation in patients without slow colonic transit or disordered constipation. On the other hand, fibre may improve stool consistency in patients with IBS with constipation, but it is considered to be not effective in improving abdominal pain, distension or bloating. Probiotics may be effective in relieving constipation; however, the effect of lactic acid bacteria ingestion may be dependent on the bacterial strain used and the population being studied. Lactulose, which is a substrate for lactic acid bacteria (prebiotic), is effective to treat patients with chronic constipation.","Hosp Univ Mutua Terrassa, Dept Gastroenterol, Barcelona 08221, Spain",Hospital Universitario Mutua Terrassa,"Fernández-Bañares, F (corresponding author), Hosp Univ Mutua Terrassa, Dept Gastroenterol, Plaza Dr Robert 5, Barcelona 08221, Spain.",digestiu@mutuaterrassa.es,,"Fernandez-Banares, Fernando/0000-0002-1489-504X",,,,,53,34,46,0,21,ELSEVIER SCI LTD,OXFORD,"THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND",1521-6918,1532-1916,,BEST PRACT RES CL GA,Best Pract. Res. Clin. Gastroenterol.,,2006,20,3,,,,,575,587,,10.1016/j.bpg.2005.11.002,http://dx.doi.org/10.1016/j.bpg.2005.11.002,,,13,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,063LI,16782530,,,,2024-06-04,WOS:000239019300010,View Full Record in Web of Science
J,"SPILLER, RC",,,,"SPILLER, RC",,,PHARMACOLOGY OF DIETARY FIBER,PHARMACOLOGY & THERAPEUTICS,,,English,Review,,,,,,FIBER; MOTILITY; CONSTIPATION; GLUCOSE TOLERANCE; HYPOCHOLESTEROLEMIC EFFECT; FERMENTATION,CHAIN FATTY-ACIDS; IRRITABLE BOWEL SYNDROME; FECAL INCUBATION SYSTEM; DIGESTIVE TRANSIT-TIME; BLOOD-GLUCOSE RESPONSE; WHEAT-BRAN; GUAR GUM; COLONIC FERMENTATION; OAT-BRAN; HYPERCHOLESTEROLEMIC MEN,"''Dietary fibre'' includes a range of relatively poorly digested food substances mainly composed of non-starch polysaccharides. Pectins and gums are multi-branched hydrophilic substances, forming viscous solutions that delay gastric emptying and nutrient absorption from the small bowel. They are used to delay gastric emptying and improve glycemic control in diabetes, as well as to alleviate constipation. Other fibres, including cellulose and lignins, are insoluble and have little effect on gastric emptying and small bowel transit. They markedly accelerate colonic transit and are frequently used as laxatives. Other important, less well-characaterised effects of fibre include lowering of blood cholesterol, increase in satiety and possibly reduction in colon neoplasia.",,,"UNIV NOTTINGHAM HOSP, QUEENS MED CTR, NOTTINGHAM NG7 2UH, ENGLAND.",,"spiller, robin/ABE-6690-2021","spiller, robin/0000-0001-6371-4500",,,,,154,78,83,0,22,PERGAMON-ELSEVIER SCIENCE LTD,OXFORD,"THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND",0163-7258,1879-016X,,PHARMACOL THERAPEUT,Pharmacol. Ther.,,1994,62,3,,,,,407,427,,10.1016/0163-7258(94)90052-3,http://dx.doi.org/10.1016/0163-7258(94)90052-3,,,21,Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy,NZ786,7972341,,,,2024-06-04,WOS:A1994NZ78600006,View Full Record in Web of Science
J,"Edwards, CA; Parrett, AM",,,,"Edwards, CA; Parrett, AM",,,Dietary fibre in infancy and childhood,PROCEEDINGS OF THE NUTRITION SOCIETY,,,English,Article; Proceedings Paper,7th International Vahouny Fibre Symposium,"MAY 27-30, 2002","ROYAL COLL PHYS, EDINBURGH, SCOTLAND",,ROYAL COLL PHYS,dietary fibre; childhood; microflora; fermentation,FORMULA-FED INFANTS; 1ST 2 YEARS; BREAST-FED INFANTS; CHAIN FATTY-ACIDS; INTESTINAL MICROFLORA; CHRONIC CONSTIPATION; FECAL FLORA; CHILDREN; STARCH; FERMENTATION,"There is very little evidence for the effects of dietary fibre in young children and current dietary guidelines are based on assumptions and data extrapolated from studies in adults. The first years of life may be critical for the establishment of a healthy colonic microflora, as well as good eating habits. The lack of clear and well-founded guidelines for the intake of dietary fibre in childhood may hinder both factors. The fears that a high-fibre diet in children < 5 years of age will lead to growth faltering and mineral imbalance are not well supported in the literature, especially for children in the developed world. Indeed, with the rising levels of obesity, fibre intake may be of benefit in reducing energy intake. A low-fibre diet may also be implicated in the aetiology of childhood constipation and appendicitis. The latest proposals for the definition of dietary fibre include oligosaccharides, which may act as prebiotics. There are potential health benefits of including oligosaccharides in the diets of infants and children, but more research is needed to consider the long-term effects. The immature intestine of the infant may also result in a greater amount of starch entering the colon during weaning, and this starch would now be considered dietary fibre under the new definitions. Much new research is needed to allow adequate recommendations for the intake of dietary fibre in childhood based on data collected in appropriate age-groups.","Univ Glasgow, Yorkhill Hosp, Dept Human Nutr, Glasgow G3 8SJ, Lanark, Scotland",University of Glasgow,"Univ Glasgow, Yorkhill Hosp, Dept Human Nutr, Glasgow G3 8SJ, Lanark, Scotland.",caeln@clinmed.gla.ac.uk,,"Parrett, Alison/0000-0001-6037-5398",,,,,68,39,56,0,15,CAMBRIDGE UNIV PRESS,CAMBRIDGE,"EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND",0029-6651,1475-2719,,P NUTR SOC,Proc. Nutr. Soc.,FEB,2003,62,1,,,,,17,23,,10.1079/PNS2002231,http://dx.doi.org/10.1079/PNS2002231,,,7,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Nutrition & Dietetics,670EU,12740052,Bronze,,,2024-06-04,WOS:000182395100004,View Full Record in Web of Science
J,"HULL, C; GRECO, RS; BROOKS, DL",,,,"HULL, C; GRECO, RS; BROOKS, DL",,,ALLEVIATION OF CONSTIPATION IN THE ELDERLY BY DIETARY FIBER SUPPLEMENTATION,JOURNAL OF THE AMERICAN GERIATRICS SOCIETY,,,English,Article,,,,,,,,"To alleviate the constipation problem among the elderly residents of Essex County Geriatric Center, New Jersey, USA, a fiber-supplemented dietary regimen was started. Bran was added to the hot breakfast cereal, increasing the crude fiber content of the diet to 6-8 g compared with the former 4-6 g. The total dietary fiber was increased from 25 to 40% by the addition of bran. This amount of fiber was effective in preventing constipation in 60% of the residents even though many of them had previously required laxatives. Additional programs of dietary fiber supplementation were devised for residents who did not respond to the cereal supplementation or who required nasogastric feedings. In the year following initiation of the program at this center, the use of laxatives was virtually eliminated and the institution''s pharmacy reported a saving in expenditures for laxative drugs. Recipes are included for the bran-supplemented hot cereal, a special fiber-prune juice supplement and a fiber-rich liquid for tube-feedings.","COLL MED & DENT NEW JERSEY, SCH ALLIED HLTH PROFESS, PROGRAM DIETET INTERNSHIP, NEWARK, NJ 07103 USA",Rutgers University System; Rutgers University New Brunswick; Rutgers University Biomedical & Health Sciences,,,,,,,,,18,46,49,0,8,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0002-8614,1532-5415,,J AM GERIATR SOC,J. Am. Geriatr. Soc.,,1980,28,9,,,,,410,414,,10.1111/j.1532-5415.1980.tb01108.x,http://dx.doi.org/10.1111/j.1532-5415.1980.tb01108.x,,,5,Geriatrics & Gerontology; Gerontology,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Geriatrics & Gerontology,KH588,6251128,,,,2024-06-04,WOS:A1980KH58800004,View Full Record in Web of Science
J,"Abbasalizadeh, S; Ebrahimi, B; Azizi, A; Dargahi, R; Tayebali, M; Ghadim, ST; Foroumandi, E; Aliasghari, F; Javadi, M; Izadi, A; Banifatemeh, L; Pourjafar, H; Khalili, L; Ghalichi, F; Houshmandi, S; Rad, AH",,,,"Abbasalizadeh, Shamsi; Ebrahimi, Behzad; Azizi, Aslan; Dargahi, Rogaye; Tayebali, Maryam; Ghadim, Sepideh T.; Foroumandi, Elaheh; Aliasghari, Fereshteh; Javadi, Mina; Izadi, Azimeh; Banifatemeh, Leila; Pourjafar, Hadi; Khalili, Leila; Ghalichi, Faezeh; Houshmandi, Sousan; Rad, Aziz H.",,,Review of Constipation Treatment Methods with Emphasis on Laxative Foods,CURRENT NUTRITION & FOOD SCIENCE,,,English,Review,,,,,,Constipation; defecation; dietary fiber; food ingredients; laxative; treatment,IRRITABLE-BOWEL-SYNDROME; PLACEBO-CONTROLLED TRIAL; DIETARY FIBER INTAKE; DOUBLE-BLIND TRIAL; TRANSIT-TIME; WHEAT BRAN; GASTROINTESTINAL TRANSIT; FUNCTIONAL CONSTIPATION; STOOL FREQUENCY; COLONIC TRANSIT,"Constipation is a common public health concern experienced by all individuals during their life affecting the quality of life. In this paper, we aimed to provide an overview of the existing evidence regarding the role of food ingredients, including bran, prune, fig, kiwifruit, and flax-seed in constipation treatment. We searched Scopus, Pub Med, and Science Direct by using the keywords, laxative foods and constipation, for searching studies assessing laxative food ingredients and their beneficial effects on constipation treatment and/or control. Lifestyle modifications such as increasing dietary fiber and fluid intake and daily exercise are the proposed first line treatments for constipation. Optimizing 'diet' as an efficient lifestyle factor may contribute to the well-being of patients. The use of laxative food ingredients including bran, prune, fig, kiwifruit, flax-seed, probiotics, and prebiotics is a convenient alternative to cope with constipation. According to previous findings, laxative food ingredients could be considered as effective treatments for subjects suffering from constipation. Many studies have assessed the pharmacological and non-pharmacological roles of these ingredients in treating constipation, however, their importance has not been thoroughly investigated.","[Abbasalizadeh, Shamsi; Ghadim, Sepideh T.] Tabriz Univ Med Sci, Womens Reprod Hlth Res Ctr, Tabriz, Iran; [Ebrahimi, Behzad] Maragheh Univ Med Sci, Dept Food Sci & Technol, Maragheh, Iran; [Azizi, Aslan] Minist Jihad Agr, Agr Engn Res Inst, Karaj, Iran; [Dargahi, Rogaye] Ardabil Univ Med Sci, Obstet & Gynecol, Ardebil, Iran; [Tayebali, Maryam] Dept Taras Shevchenko Natl Univ Kyiv, Kiev, Ukraine; [Foroumandi, Elaheh] Tabriz Univ Med Sci, Nutr Res Ctr, Sch Nutr, Tabriz, Iran; [Aliasghari, Fereshteh; Javadi, Mina; Izadi, Azimeh; Khalili, Leila; Ghalichi, Faezeh] Tabriz Univ Med Sci, Fac Nutr & Food Sci, Dept Nutr, Tabriz, Iran; [Banifatemeh, Leila; Rad, Aziz H.] Tabriz Univ Med Sci, Fac Nutr & Food Sci, Dept Food Sci & Technol, Tabriz, Iran; [Pourjafar, Hadi] Maragheh Univ Med Sci, Dept Publ Hlth, Maragheh, Iran; [Houshmandi, Sousan] Ardabil Univ Med Sci, Fac Midwifery, Ardebil, Iran",Tabriz University of Medical Science; Ardabil University of Medical Sciences; Ministry of Education & Science of Ukraine; Taras Shevchenko National University of Kyiv; Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science; Ardabil University of Medical Sciences,"Azizi, A (corresponding author), Minist Jihad Agr, Agr Engn Res Inst, Karaj, Iran.;Rad, AH (corresponding author), Tabriz Univ Med Sci, Fac Nutr & Food Sci, Dept Food Sci & Technol, Tabriz, Iran.",aslan_azizi@yahoo.com; homayounia@tbzmed.ac.ir,"Foroumandi, Elaheh/AAC-6700-2021; Homayouni, Aziz/L-1508-2017; Bbrahimi, Behzad/ABF-7380-2021; abbasalizadeh, shamsi/M-2858-2017; ebrahimi, Behzad/AAG-2196-2021","Foroumandi, Elaheh/0000-0003-1600-747X; Homayouni, Aziz/0000-0001-6766-0108; Ebrahimi, Behzad/0000-0002-5278-0841; Aliasghari, Fereshteh/0000-0002-9191-1592",Aras Functional Company (SHAFA),Aras Functional Company (SHAFA),The authors sincerely acknowledge the Aras Functional Company (SHAFA) for supporting the present study.,,168,0,0,4,26,BENTHAM SCIENCE PUBL LTD,SHARJAH,"EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES",1573-4013,2212-3881,,CURR NUTR FOOD SCI,Curr. Nutr. Food Sci.,,2020,16,5,,,,,675,688,,10.2174/1573401315666191002164336,http://dx.doi.org/10.2174/1573401315666191002164336,,,14,Nutrition & Dietetics,Emerging Sources Citation Index (ESCI),Nutrition & Dietetics,MN9VM,,,,,2024-06-04,WOS:000551187200005,View Full Record in Web of Science
J,"Müller-Lissner, S",,,,"Mueller-Lissner, Stefan",,,"The Pathophysiology, Diagnosis, and Treatment of Constipation",DEUTSCHES ARZTEBLATT INTERNATIONAL,,,English,Article,,,,,,constipation; defecation; laxatives; dietary fiber,DIETARY FIBER; TRANSIT; BRAN; BIOFEEDBACK; LACTULOSE; TIME,"Background: Constipation is a common condition about which there are many widespread notions that have no basis in fact. The purpose of this article is to summarize current scientific knowledge on the subject. Methods: Selective review of the literature. Results: Diagnostic evaluation usually fails to reveal the cause of constipation. It is due to medications in some patients, while endocrine disorders are the cause in only a small minority. Abnormal defecation may be due to dysfunction of the pelvic floor. Most patients complain of abdominal fullness and of needing to strain to pass stool; low stool frequency is a rare symptom. The symptoms alone determine the indication for treatment. Constipation usually poses no threat to health. Some patients are helped by a diet rich in fiber, others by laxatives. A number of laxatives with different modes of action are available; all are safe and generally well tolerated. In some patients, dysfunctional defecation may be an indication for proctological surgery. Conclusions: The Rome criteria are useful for establishing a specific diagnosis of constipation. Most patients can be helped with laxatives and patient education.","Charite, Pk Klin Weissensee, D-13086 Berlin, Germany",Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin,"Müller-Lissner, S (corresponding author), Charite, Pk Klin Weissensee, Schonstr 80, D-13086 Berlin, Germany.",muell@park-klinik.com,,,,,,,25,31,33,0,5,DEUTSCHER AERZTE-VERLAG GMBH,COLOGNE,"DIESELSTRABE 2, POSTFACH 400265, D-50859 COLOGNE, GERMANY",1866-0452,,,DTSCH ARZTEBL INT,Dtsch. Arztebl. Int.,JUN 19,2009,106,25,,,,,424,431,,10.3238/arztebl.2009.0424,http://dx.doi.org/10.3238/arztebl.2009.0424,,,8,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,476VZ,19623313,Green Published,,,2024-06-04,WOS:000268475700005,View Full Record in Web of Science
J,"Cong, L; Duan, LW; Su, WP; Hao, SH; Li, DF",,,,"Cong, Liang; Duan, Li-Wei; Su, Wei-Ping; Hao, Shuhong; Li, Dong-Fu",,,Efficacy of High Specific Volume Polysaccharide - A New Type of Dietary Fiber - On Molecular Mechanism of Intestinal Water Metabolism in Rats With Constipation,MEDICAL SCIENCE MONITOR,,,English,Article,,,,,,Aquaporin 3; Constipation; Probiotics; Vasoactive Intestinal Peptide,AQUAPORIN-3,"Background: The aim of this study was to evaluate the effects of a new type of dietary fiber - high specific volume polysaccharide (HSVP) - on fecal properties, serum vasoactive intestinal peptide (VIP) concentration, intestinal flora count, and expression of the VIP-cAMP-PKA-AQP3 signaling pathway. Marerial/Methods: Compound diphenoxylate was used in 48 healthy Wistar rats to establish a constipation model. Rats were divided into a normal control group, a constipation model group, an HSVP low-dose group, an HSVP medium-dose group, an HSVP high-dose group, and a fructose control group. We used colony count method, ELISA, WB, and RT-PCR to determine fecal moisture content, fecal hardness, fecal passage time, serum VIP concentration, number of intestinal bacteria, and VIP-cAMP-PKA-AQP3 signal pathway protein expression. Results: The constipation model was established successfully. HSVP (the medium dose was 10% and the high dose was 15%) improved fecal moisture content, reduced hardness, shortened fecal emptying time, increased intestinal bacteria, reduced serum VIP concentration, downregulated cAMP and PKAm RNA transcription, reduced protein expression, and reduced intestinal AQP3 expression. Conclusions: HSVP improved constipation, increased the number of intestinal bacteria, and elevated expression of the VIP-cAMP-PKA-AQP3 signaling pathway. The mechanism of HSVP in regulating intestinal water metabolism in constipated rats may occur through the VIP-cAMP-PKA-AQP3 signaling pathway, and be closely related to changes in intestinal bacteria. The important role of the brain-gut-microbiome axis in the pathogenesis of constipation has been confirmed in this study.","[Cong, Liang; Duan, Li-Wei; Li, Dong-Fu] Jilin Univ, Hosp 2, Digest Syst Dept, Changchun, Jilin, Peoples R China; [Su, Wei-Ping] Chinese Acad Sci, Key Lab Polymer Ecomat, Changchun, Jilin, Peoples R China; [Hao, Shuhong] Jilin Univ, Hosp 2, Dept Hematol & Oncol, Changchun, Jilin, Peoples R China",Jilin University; Chinese Academy of Sciences; Jilin University,"Li, DF (corresponding author), Jilin Univ, Hosp 2, Digest Syst Dept, Changchun, Jilin, Peoples R China.;Hao, SH (corresponding author), Jilin Univ, Hosp 2, Dept Hematol & Oncol, Changchun, Jilin, Peoples R China.",267311158@qq.com; 317659725@qq.com,"su, wei/GZM-3986-2022",,Industrial Technology Research and Development Fund of Jilin China Province Development and Reform Commission on 'Clinical Application of high specific volume polysaccharide in the treatment of functional constipation and Diabetic complications constipatio [2011007-7],Industrial Technology Research and Development Fund of Jilin China Province Development and Reform Commission on 'Clinical Application of high specific volume polysaccharide in the treatment of functional constipation and Diabetic complications constipatio,"This study was supported by a Project funded by Industrial Technology Research and Development Fund of Jilin China Province Development and Reform Commission (2011007-7), on 'Clinical Application of high specific volume polysaccharide in the treatment of functional constipation and Diabetic complications constipation'",,14,13,15,6,68,"INT SCIENTIFIC INFORMATION, INC",MELVILLE,"150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA",,1643-3750,,MED SCI MONITOR,Med. Sci. Monitor,JUL 7,2019,25,,,,,,5028,5035,,10.12659/MSM.916526,http://dx.doi.org/10.12659/MSM.916526,,,8,"Medicine, Research & Experimental",Science Citation Index Expanded (SCI-EXPANDED),Research & Experimental Medicine,II6MJ,31280283,"Green Published, Green Submitted",,,2024-06-04,WOS:000475307700002,View Full Record in Web of Science
J,"Karagiozoglou-Lampoudi, T; Daskalou, E; Agakidis, C; Savvidou, A; Apostolou, A; Vlahavas, G",,,,"Karagiozoglou-Lampoudi, Thomais; Daskalou, Efstratia; Agakidis, Charalambos; Savvidou, Afroditi; Apostolou, Aggeliki; Vlahavas, Georges",,,"Personalized Diet Management Can Optimize Compliance to a High-Fiber, High-Water Diet in Children with Refractory Functional Constipation",JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS,,,English,Article,,,,,,Functional constipation; High-fiber diet; Mediterranean diet; Compliance; Dietetic management,CHILDHOOD CONSTIPATION,"Diet modification to increase water and fiber consumption is considered an important component in the management of constipation. This prospective randomized study aimed to evaluate the compliance of 86 children with refractory functional constipation (mean age 4.4 years, range 1 to 11 years) to a high-fiber, high-water diet following either physician's dietary advice (PI group) (n=42) or physician's dietary advice plus personalized diet management by a registered dietitian (DM group) (n=44). Dietary intake was assessed by a 24-hour dietary recall at baseline and 1 month later. The changes in water and fiber consumption were used as compliance criteria. DM group had comparable anthropometric measurements; sex distribution; and baseline intakes of energy, macronutrient, water, and dietary fiber compared with the PI group. Comparison of nutrient intakes between the two visits within each group showed a significant increase in fiber consumption in both groups that was more pronounced in the DM group. Water, energy, and carbohydrate consumption increased significantly only in the DM group. Multivariate regression analysis revealed that the intervention group was the only significant independent predictor for the change in fiber and water consumption after controlling for age, sex, and weight-for-age z score. Children receiving personalized diet management for refractory functional constipation achieved better compliance in increasing fiber and water consumption. Acad Nutr Diet. 2012;112:725-729.","[Karagiozoglou-Lampoudi, Thomais; Daskalou, Efstratia; Agakidis, Charalambos; Savvidou, Afroditi; Apostolou, Aggeliki; Vlahavas, Georges] Alexander Technol Educ Inst Thessaloniki, Clin Nutr Lab, Dept Nutr & Dietet, Thessaloniki 54101, Greece",,"Karagiozoglou-Lampoudi, T (corresponding author), Alexander Technol Educ Inst Thessaloniki, Clin Nutr Lab, Dept Nutr & Dietet, Sindos POB 14 561, Thessaloniki 54101, Greece.",clinnutrlab@yahoo.gr,"AGAKIDIS, CHARALAMPOS/GXZ-7865-2022","AGAKIDIS, CHARALAMPOS/0000-0002-2800-6530; Daskalou, Efstratia/0000-0002-1299-604X",,,,,26,16,23,0,13,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",2212-2672,2212-2680,,J ACAD NUTR DIET,J. Acad. Nutr. Diet.,MAY,2012,112,5,,,,,725,729,,10.1016/j.jand.2012.01.021,http://dx.doi.org/10.1016/j.jand.2012.01.021,,,5,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,943NO,22709778,,,,2024-06-04,WOS:000304131200021,View Full Record in Web of Science
J,"Lee, WTK; Ip, KS; Chan, JSH; Lui, NWM; Young, BWY",,,,"Lee, Warren T. K.; Ip, Kin S.; Chan, June S. H.; Lui, Noel W. M.; Young, Betty W. Y.",,,Increased prevalence of constipation in pre-school children is attributable to under-consumption of plant foods: A community-based study,JOURNAL OF PAEDIATRICS AND CHILD HEALTH,,,English,Article,,,,,,children; constipation; dietary fibre; fruits; vegetables,DIETARY FIBER INTAKE; VEGETABLE CONSUMPTION; CHINESE CHILDREN; BONE MASS; FRUIT; CALCIUM; DISEASE; METAANALYSIS; GIRLS; RISK,"To evaluate consumption of foods rich in dietary fibre and its relation to the prevalence of constipation in pre-school children. In total, 368 children aged 3-5 years were randomly selected from kindergartens in Hong Kong. Constipation was confirmed by Rome-criteria. Children with normal bowel habits served as non-constipated controls. Consumption of vegetables, fruits, whole-grain cereals and fluid were determined using a 3-day food record. A total of 28.8% children were reported to have constipation. Median dietary fibre intake of constipated children was significantly lower than non-constipated children (3.4 g/d (inter-quartile range (IQR): 2.3-4.6 g/d) vs. 3.8 g/d (IQR: 2.7-4.9 g/d); P = 0.044) corresponding to 40% reference dietary fibre intake. Constipated children also had significantly lower intakes of vitamin C (P = 0.041), folate (P = 0.043) and magnesium (P = 0.002). Fruit intake and total plant foods intake were significantly lower in the constipated than non-constipated children: (61 g/d (IQR: 23.8-115 g/d) vs. 78 g/d (IQR: 41.7-144.6 g/d); P = 0.047) and (142.5 g/d (IQR: 73.7-214.7 g/d) vs. 161.1 g/d (IQR: 98.3-233.3 g/d); P = 0.034), respectively. Total fluid intake did not differ between groups but milk intake among the constipated children was marginally higher than the non-constipated children (P = 0.055) Insufficient dietary fibre intake is common in Hong Kong pre-school children. Constipated children had significantly lower intakes of dietary fibre and micronutrients including vitamin C, folate and magnesium than non-constipated counterparts which was attributable to under-consumption of plant foods. However, milk intake was marginally higher in the constipated children. More public education is necessary for parents to help develop healthy dietary habit and bowel habit in early life in order to prevent childhood constipation.","[Lee, Warren T. K.] Univ Surrey, Div Nutr Sci, Fac Hlth & Med Sci, Surrey GU2 7XH, England; [Lee, Warren T. K.] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Lui, Noel W. M.] Chinese Univ Hong Kong, Nethersole Sch Nursing, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Ip, Kin S.; Chan, June S. H.; Young, Betty W. Y.] Pamela Youde Nethersole Eastern Hosp, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China",University of Surrey; Chinese University of Hong Kong; Chinese University of Hong Kong; Pamela Youde Nethersole Eastern Hospital,"Lee, WTK (corresponding author), Univ Surrey, Div Nutr Sci, Fac Hlth & Med Sci, Surrey GU2 7XH, England.",w.t.lee@surrey.ac.uk,,,,,,,38,70,81,1,12,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1034-4810,1440-1754,,J PAEDIATR CHILD H,J. Paediatr. Child Health,APR,2008,44,4,,,,,170,175,,10.1111/j.1440-1754.2007.01212.x,http://dx.doi.org/10.1111/j.1440-1754.2007.01212.x,,,6,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,281MG,17854410,,,,2024-06-04,WOS:000254501100004,View Full Record in Web of Science
J,"Shin, JE; Kim, SJ; Cha, R; Kim, JW; Cho, YS; Yim, SK; Kang, SJ; Park, SY",,,,"Shin, J. E.; Kim, S. J.; Cha, R.; Kim, J. W.; Cho, Y. S.; Yim, S. K.; Kang, S. J.; Park, S. Y.",,,Effect of dietary fiber on chronic constipation in adult: Systematic review with meta-analysis,NEUROGASTROENTEROLOGY AND MOTILITY,,,English,Meeting Abstract,,,,,,constipation; dietary fiber,,,"[Shin, J. E.] Dankook Univ, Coll Med, Dept Internal Med, Cheonan, South Korea; [Kim, S. J.] Chosun Univ Hosp, Dept Internal Med, Gwangju, South Korea; [Cha, R.] Gyeongsang Natl Univ, Changwon Hosp, Dept Internal Med, Jinju, South Korea; [Kim, J. W.] Kyung Hee Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Cho, Y. S.] Soonchunhyang Univ, Coll Med, Cheonan Hosp, Dept Internal Med,Univ Coll Med,Cheonan Hosp, Cheonan, South Korea; [Yim, S. K.] Chonbuk Natl Univ Hosp, Dept Internal Med, Jeonju, South Korea; [Kang, S. J.] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Dept Internal Med, Seoul, South Korea; [Park, S. Y.] Chonnam Natl Univ, Sch Med, Dept Internal Med, Gwangju, South Korea",Dankook University; Chosun University; Gyeongsang National University; Kyung Hee University; Soonchunhyang University; Jeonbuk National University; Jeonbuk National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Chonnam National University,,,,,,,,,0,0,0,0,0,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1350-1925,1365-2982,,NEUROGASTROENT MOTIL,Neurogastroenterol. Motil.,SEP,2023,35,,,2,SI,NGS18146-9,,,,,,,,1,Gastroenterology & Hepatology; Clinical Neurology; Neurosciences,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Neurosciences & Neurology,Q6KE8,,,,,2024-06-04,WOS:001058584800132,View Full Record in Web of Science
J,"Salehi, M; Dehghani, M; Imanieh, MH",,,,"Salehi, M.; Dehghani, M.; Imanieh, M. H.",,,Therapy of Chronic Functional Constipation in Children before and after Dietary Education,IRANIAN RED CRESCENT MEDICAL JOURNAL,,,English,Article,,,,,,Constipation; Children; High fiber diet; Southern Iran,FIBER INTAKE; CHILDHOOD,"Background: The prevalence of chronic constipation in children has been reported between 0.3 and 28% This study was conducted in southern Iran to compare the effect of a balanced and high fiber diet in children with chronic functional constipation. Methods: During summer 2007, all children (60) who referred to the Pediatric Department of Mottahari Clinic affiliated to Shiraz University of Medical Sciences and were diagnosed with chronic functional constipation entered this study A questionnaire on the child's routine dietary regime was filled in for each child through face to face interviews with the parents The questionnaire included demographic information, food habits, physical exam, and the para-clinical results of each participant 30 parents were trained to supply a high fiber diet for their children, and its effect on chronic functional constipation was followed after two months. The children of these parents were considered as the case group and the other 30 children were considered as the control group. Results: Before the parents were educated, the amount of fiber intake from fruits and vegetables by the children was 7 6 +/- 2 1 gr in the case group which increased to 24 25 +/- 2 3 gr after 2 months of training The amount of water intake was 280 ml before training which increased to 600 ml afterwards and that of milk and yoghurt intake was 280 and 240 ml which decreased to 60 and 200 ml after training, respectively The amount of beverage and fruit juice intake was 280 and 220 ml while after training it decreased to 100 and 60 ml, respectively In the case group, 10% of the children had 3 to 6 times defecation per week before the intervention while this increased significantly to 56 7% of the children after the training. The stool consistency significantly changed from very firm to normal and soft consistency after training and the times of stool defecation increased significantly, too. The children's nutrition status changed from a poor state to a good status after training. Conclusion: Drug treatment was more effective in children that consumed high-fiber diet It was shown that some of these changes were significant The difference between the two groups was not, of course, significant which might be due to the small sample size.","[Dehghani, M.; Imanieh, M. H.] Shiraz Univ Med Sci, Nemazee Hosp, Gastroenterohepatol Res Ctr, Shiraz, Iran; [Salehi, M.] Shiraz Univ Med Sci, Nemazee Hosp, Dept Nutr, Sch Publ Hlth, Shiraz, Iran",Shiraz University of Medical Science; Shiraz University of Medical Science,"Imanieh, MH (corresponding author), Shiraz Univ Med Sci, Nemazee Hosp, Gastroenterohepatol Res Ctr, Shiraz, Iran.",,"Imanieh, Mohammad Hadi/AAF-7426-2019; Imanieh, Mohammad Hadi/M-7068-2016; Salehi, Mousa/D-8360-2012; Dehghani, Seyed Mohsen/A-9226-2018","Imanieh, Mohammad Hadi/0000-0003-4610-0413; Dehghani, Seyed Mohsen/0000-0001-5930-0110",Shiraz University of Medical Sciences,Shiraz University of Medical Sciences,"This work was supported by a grant from Shiraz University of Medical Sciences student research center. The authors appreciate the excellent technical assistance provided by Mrs Haidari Bani, M. and Ws Moradifar, El.",,13,3,3,0,10,KOWSAR PUBL,HOENSBROEK,"PATERSWEG 22,, HOENSBROEK, LIMBURG 6431 GC, NETHERLANDS",2074-1804,2074-1812,,IRAN RED CRESCENT ME,Iran. Red Crescent Med. J.,MAR,2010,12,2,,,,,118,121,,,,,,4,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,571GX,,,,,2024-06-04,WOS:000275741000005,View Full Record in Web of Science
J,"Depboylu, GY; Tek, NA; Akbulut, G; Günel, Z; Kamanli, B",,,,"Depboylu, Gamze Yurtdas; Tek, Nilufer Acar; Akbulut, Gamze; Gunel, Zerin; Kamanli, Betul",,,Functional Constipation in Elderly and Related Determinant Risk Factors: Malnutrition and Dietary Intake,JOURNAL OF THE AMERICAN NUTRITION ASSOCIATION,,,English,Article,,,,,,Functional constipation; malnutrition; water intake; fiber intake,PHYSICAL-ACTIVITY; MANAGEMENT; CHILDREN; WATER; FIBER; QUESTIONNAIRE; EPIDEMIOLOGY; ASSOCIATION; ADULTS,"Aim The objective of this study was to evaluate the relationship between FC and physical activity, dietary intake and malnutrition in the elderly. Method A cross-sectional study was conducted on 883 adults aged >65 years from nursing homes and community health centers in Turkey. Constipation status was evaluated according to Rome IV criteria and Bristol Stool Form Scale. Dietary intake was assessed using a food consumption record (24-hour food recall). The dietary energy and nutrients were analyzed using the Nutrition Information Systems Package Program. The nutritional status of participants was evaluated using the Mini-Nutritional Assessment (MNA) test. The International Physical Activity Questionnaire (IPAQ, short form) was used to assess physical activity status. Results Among the 883 participants, 29.6% were classified into the FC group (32.2% of females, 25.8% of males). The FC group had significantly lower total energy, fluid, water, protein, carbohydrate, magnesium, zinc, phosphorus, potassium, soluble fiber, insoluble fiber, total fiber, and fiber (g)/1000 kcal intake than the non-FC group (p < 0.05). The multivariate logistic regression analysis showed that total dietary fiber intake was significantly associated with a lower prevalence of FC (OR: 0.98, 95% Cl: 0.96-0.99). According to MNA, participants at risk of malnutrition (OR: 5.21, 95% Cl: 3.09-9.77) and malnourished participants (OR: 3.03, 95% Cl: 1.62-5.68) had a greater likelihood of FC compared with normal participants. Participants in the middle lower quartile of water intake (OR: 0.63, 95% CI: 0.42-0.95) had a decreased likelihood of FC compared with participants in the lowest quartile. Conclusion FC is a common gastrointestinal disorder among the elderly in Turkey. Low dietary fiber intake, low water intake and malnutrition were important risk factors associated with FC in the elderly.","[Depboylu, Gamze Yurtdas] Izmir Katip Celebi Univ, Dept Nutr & Dietet, Izmir, Turkey; [Tek, Nilufer Acar; Akbulut, Gamze] Gazi Univ, Dept Nutr & Dietet, Ankara, Turkey; [Gunel, Zerin; Kamanli, Betul] Mugla Sitki Kocman Univ, Dept Nutr & Dietet, Mugla, Turkey; [Kamanli, Betul] Bozok Univ Res & Applicat Hosp, Dept Nutr & Dietet, Yozgat, Turkey",Izmir Katip Celebi University; Gazi University; Mugla Sitki Kocman University,"Depboylu, GY (corresponding author), Izmir Katip Celebi Univ, Fac Hlth Sci, Dept Nutr & Dietet, Cigli Ana Yerleske Merkezi Ofisler, TR-35620 Cigli Izmir, Turkey.",gmzyurtdas@hotmail.com,"Yurtdaş, Gamze/ACA-1910-2022","Acar Tek, Nilufer/0000-0002-8772-9608",,,,,49,3,3,6,16,"ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD",ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND",2769-7061,2769-707X,,J AM NUTR ASSOC,J. Am. Nutr. Assoc.,AUG 18,2023,42,6,,,,,541,547,,10.1080/27697061.2022.2096150,http://dx.doi.org/10.1080/27697061.2022.2096150,,JUN 2022,7,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,L9NW7,35833672,,,,2024-06-04,WOS:000826302000001,View Full Record in Web of Science
J,"Camilleri, E; Blundell, R; Cuschieri, A",,,,"Camilleri, Emma; Blundell, Renald; Cuschieri, Andrea",,,Deciphering the anti-constipation characteristics of palm dates (Phoenix dactylifera): a review,INTERNATIONAL JOURNAL OF FOOD PROPERTIES,,,English,Review,,,,,,P.dactylifera; date fruit; gastrointestinal motility; dietary fiber; laxative; constipation,GASTROINTESTINAL MOTILITY; FUNCTIONAL CONSTIPATION; DIETARY FIBER; TRANSIT; FRUITS; L.; OLIGOSACCHARIDE; ANTIOXIDANT; MANAGEMENT; MAGNESIUM,"Phoenix dactylifera, commonly known as palm dates, is an inexpensive dietary staple in many countries. It is rich in many nutrients and bioactive chemicals, which are responsible for its health benefits. Folk medicine has suggested that P.dactylifera has potent anti-constipation effects. Although many studies have investigated its physiological mechanisms and phytochemistry against diseases like colon cancer, hypertension and diabetes mellitus, research unraveling this fruit's laxative properties is limited. Studies characterizing the phytochemical, micromolecular and macromolecular composition of Phoenix dactylifera revealed numerous compounds with anti-constipation properties. The flavonoid, phenol, dietary fiber and mineral content were identified as the likely protagonists collectively contributing to Phoenix dactylifera's laxative properties. This review aims to give an updated overview of the safety, laxative and anti-constipation properties of Phoenix dactylifera, by highlighting the main phytochemicals and compounds responsible for this and their underlying mechanisms. C-1: Summarize what is the findings??","[Camilleri, Emma; Blundell, Renald; Cuschieri, Andrea] Univ Malta, Fac Med & Surg, Dept Physiol & Biochem, Imsida, Malta; [Blundell, Renald] Univ Malta, Ctr Mol Med & Biobanking, Msida, Malta; [Blundell, Renald] Univ Malta, Fac Med & Surg, Dept Physiol & Biochem, Imsida 2080, Malta",University of Malta; University of Malta; University of Malta,"Blundell, R (corresponding author), Univ Malta, Fac Med & Surg, Dept Physiol & Biochem, Imsida 2080, Malta.",renaldblundell@gmail.com,"Cuschieri, Andrea/AEN-6058-2022; Blundell, Renald/GQY-8677-2022","Blundell, Renald/0000-0002-1483-0991",,,,,71,0,0,2,27,TAYLOR & FRANCIS INC,PHILADELPHIA,"530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA",1094-2912,1532-2386,,INT J FOOD PROP,Int. J. Food Prop.,DEC 31,2023,26,1,,,,,65,80,,10.1080/10942912.2022.2153865,http://dx.doi.org/10.1080/10942912.2022.2153865,,,16,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,6Z3UA,,gold,,,2024-06-04,WOS:000897704700001,View Full Record in Web of Science
J,"Li, Y; Tong, WD",,,,"Li, Yi; Tong, Wei-Dong",,,Association between dietary protein intake and constipation: Data from the National Health and nutrition examination survey 2005-2010,NEUROGASTROENTEROLOGY AND MOTILITY,,,English,Article; Early Access,,,,,,carbohydrates; constipation; dietary protein; nutrition surveys,STOOL CONSISTENCY; GUT MICROBIOTA; CONSUMPTION; PREVALENCE; FIBER,"BackgroundThe association between dietary protein intake and constipation remains inconclusive. The aim of this study was to investigate whether dietary protein intake is associated with constipation.MethodsThis cross-sectional study included 13,941 adults from the 2005 to 2010 National Health and Nutrition Examination Survey. A weighted logistic regression analysis was used to control for confounding factors. In addition, weighted interaction and stratified analyses were conducted to ascertain the potential modifying factors.ResultsThe prevalence of constipation was 7.5% when constipation was defined by stool consistency and 3.5% when constipation was defined by stool frequency. After adjusting for covariates, an increase in dietary protein intake of 10 g was not associated with constipation, as defined by stool frequency (OR = 0.94, 95% CI = 0.54, 1.62) or stool consistency (OR = 1.02, 95% CI = 0.75, 1.39). Subgroup analyses revealed that dietary protein intake was associated with an increase in constipation defined by stool consistency risk in participants who consumed a low amount of carbohydrates (OR = 1.08, 95% CI = 1.02-1.14 for every 10-g increase in protein intake), but a decrease in risk in participants in the moderate-carbohydrate group (OR = 0.94, 95% CI = 0.89-0.99 for every 10-g increase in protein intake), suggesting a significant interaction (p = 0.001).Conclusion & InferencesDietary protein intake is not associated with stool consistency or frequency-defined constipation. However, the association between dietary protein intake and constipation defined by stool consistency in participants with a low carbohydrate intake differed from that in participants with a moderate carbohydrate intake. The association between dietary protein intake and constipation was not significant, but dietary carbohydrate intake was an effect modifier of this relationship. Among participants who consumed moderate amounts of carbohydrates, increased dietary protein consumption was associated with a reduced risk of constipation (defined by stool consistency); in the low-carbohydrate group, increased dietary protein consumption increased the risk of constipation (defined by stool consistency). However, the association between dietary protein intake and stool frequency-defined constipation among most subgroups was not significant.image","[Li, Yi; Tong, Wei-Dong] Army Med Univ, Daping Hosp, Dept Gen Surg, Gastr & Colorectal Div, 10 Changjiang Zhi Lu, Chongqing, Peoples R China",Army Medical University,"Tong, WD (corresponding author), Army Med Univ, Daping Hosp, Dept Gen Surg, Gastr & Colorectal Div, 10 Changjiang Zhi Lu, Chongqing, Peoples R China.",vdtong@163.com,"Tong, Weidong/A-2729-2011","Tong, Weidong/0000-0001-6150-9941",National Natural Science Foundation of China; Natural Science Foundation of Chongqing [CSTB2023NSCQ-ZDJ0012]; Special Program of Science and Technology Innovation of Army Medical University [2022XLC05]; [82370547],National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Chongqing(Natural Science Foundation of Chongqing); Special Program of Science and Technology Innovation of Army Medical University;,"This work was supported by the National Natural Science Foundation of China (No.82370547), the Natural Science Foundation of Chongqing (No. CSTB2023NSCQ-ZDJ0012) and the Special Program of Science and Technology Innovation of Army Medical University (No.2022XLC05). We thank AJE for editing the English text of the draft of this manuscript.",,31,0,0,0,0,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1350-1925,1365-2982,,NEUROGASTROENT MOTIL,Neurogastroenterol. Motil.,2024 APR 23,2024,,,,,,,,,,10.1111/nmo.14795,http://dx.doi.org/10.1111/nmo.14795,,APR 2024,11,Gastroenterology & Hepatology; Clinical Neurology; Neurosciences,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Neurosciences & Neurology,OG6D6,38651659,,,,2024-06-04,WOS:001206146300001,View Full Record in Web of Science
J,"Asakura, K; Masayasu, S; Sasaki, S",,,,"Asakura, Keiko; Masayasu, Shizuko; Sasaki, Satoshi",,,"Dietary intake, physical activity, and time management are associated with constipation in preschool children in Japan",ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION,,,English,Article,,,,,,constipation; diet; physical activity; time management; Japanese preschool children,CHILDHOOD CONSTIPATION; FUNCTIONAL CONSTIPATION; HISTORY QUESTIONNAIRES; RELATIVE VALIDITY; FIBER,"Background and Objectives: Constipation is a common complaint in children, which is not fatal but can affect quality of life. Several lifestyle-related risk factors for constipation have been reported, particularly dietary factors, but results have been inconsistent. Here, we examined the relationship of dietary and lifestyle factors with constipation in Japanese preschool children using data of a nationwide study. Methods and Study Design: Subjects were 5,309 children aged 5 to 6 years at 380 nursery schools in 44 of 47 prefectures in Japan. Children having three or fewer bowel movements per week were considered constipated. Dietary intake data was collected using a validated brief-type self-administered diet history questionnaire for Japanese preschool children, and information about general lifestyle was collected using a 4-page questionnaire designed for this study. Multivariate adjusted odds ratios for constipation were calculated by logistic regression. Results: Higher dietary fiber intake was significantly associated with a lower prevalence of constipation (adjusted odds ratio: 0.62, p for trend: 0.005), but higher carbohydrate intake was marginally associated with a higher prevalence of constipation. Intake of potatoes, pulses, vegetables, and fruits intake decreased constipation prevalence, whereas higher rice intake was significantly and independently associated with higher prevalence of constipation. Regarding lifestyle factors, high physical activity and sufficient preparation time for breakfast and dinner for guardians were significantly associated with lower prevalence. Prevalence tended to be negatively associated with a higher educational background of the mother. Conclusions: Several lifestyle factors were associated with a lower prevalence of constipation among Japanese preschool children, including dietary fiber intake.","[Asakura, Keiko] Univ Tokyo, Interfac Initiat Informat Studies, Tokyo, Japan; [Asakura, Keiko; Sasaki, Satoshi] Univ Tokyo, Sch Publ Hlth, Dept Social & Prevent Epidemiol, Tokyo, Japan; [Masayasu, Shizuko] Ikurien Naka, Ibaraki, Japan",University of Tokyo; University of Tokyo,"Sasaki, S (corresponding author), Ikurien Naka, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.",stssasak@m.u-tokyo.ac.jp,"Asakura, Keiko/HLG-5315-2023","Asakura, Keiko/0000-0002-2323-1640",Japan Dietetic Association,Japan Dietetic Association,This work was financially supported by the Japan Dietetic Association. The authors declare that they have no conflict of interest.,,33,23,27,0,17,"H E C PRESS, HEALTHY EATING CLUB PTY LTD",MCKINNON,"PO BOX 4121, MCKINNON, VIC 3204, AUSTRALIA",0964-7058,1440-6047,,ASIA PAC J CLIN NUTR,Asia Pac. J. Clin. Nutr.,JAN,2017,26,1,,,,,118,129,,10.6133/apjcn.112015.02,http://dx.doi.org/10.6133/apjcn.112015.02,,,12,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Nutrition & Dietetics,EI1TD,28049271,,,,2024-06-04,WOS:000392259900019,View Full Record in Web of Science
J,"Müller-Lissner, S",,,,"Müller-Lissner, S",,,General geriatrics and gastroenterology:: constipation and faecal incontinence,BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY,,,English,Article,,,,,,constipation; faecal incontinence; ageing; laxatives; dietary fibre; rectal prolapse,COMPLETE RECTAL PROLAPSE; IDIOPATHIC FECAL INCONTINENCE; INTESTINAL TRANSIT-TIME; COLONIC TRANSIT; ULCER SYNDROME; DIETARY FIBER; FUNCTIONAL CONSTIPATION; ANAL ENDOSONOGRAPHY; PARKINSONS-DISEASE; ANORECTAL FUNCTION,"The incidence of constipation increases with age but no consistent changes of colonic or anorectal motility have been shown in elderly people. Instead, neurological diseases, constipating drugs, bedriddenness and weak straining ability may explain this increased prevalence of constipation. The amount of dietary fibre in the diet may be reduced because of poor chewing ability, Parkinson's disease is accompanied by both slow colonic transit and impaired relaxation of the anal sphincter. Drug-induced constipation is particularly likely with anti-parkinsonism drugs (either anti-cholinergic or dopaminergic) and also with tricyclic antidepressants, opiates, iron, anti-convulsants and aluminium- or calcium-containing antacids. The prevalence of faecal incontinence is also increased in elderly people. About half of frail bedridden institutionalized patients are incontinent. Anal sphincter pressures tend to be lower, but variables of sensitivity are not. In bedridden people faecal impaction may occur. The ensuing rectal distension leads to relaxation of the internal sphincter and hence to faecal soiling. The condition is often overlooked though correct diagnosis is rather simple, being made with a digital rectal examination.","Humboldt Univ, Dept Internal Med, Pk Klin Weissensee, D-13086 Berlin, Germany",Humboldt University of Berlin,,,,,,,,,83,32,34,0,9,ELSEVIER SCI LTD,OXFORD,"THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND",1521-6918,1532-1916,,BEST PRACT RES CL GA,Best Pract. Res. Clin. Gastroenterol.,FEB,2002,16,1,,,,,115,133,,10.1053/bega.2002.0269,http://dx.doi.org/10.1053/bega.2002.0269,,,19,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,519VM,11977932,,,,2024-06-04,WOS:000173746200009,View Full Record in Web of Science
J,"Lu, DD; Pi, Y; Ye, H; Wu, YJ; Bai, Y; Lian, S; Han, DD; Ni, DJ; Zou, XH; Zhao, JB; Zhang, S; Kemp, B; Soede, N; Wang, JJ",,,,"Lu, Dongdong; Pi, Yu; Ye, Hao; Wu, Yujun; Bai, Yu; Lian, Shuai; Han, Dandan; Ni, Dongjiao; Zou, Xinhua; Zhao, Jinbiao; Zhang, Shuai; Kemp, Bas; Soede, Nicoline; Wang, Junjun",,,Consumption of Dietary Fiber with Different Physicochemical Properties during Late Pregnancy Alters the Gut Microbiota and Relieves Constipation in Sow Model,NUTRIENTS,,,English,Article,,,,,,defecation frequency; dietary fiber; different physicochemical properties; late pregnancy; intestinal motility; Turicibacter,IN-VITRO FERMENTATION; CHAIN FATTY-ACIDS; COLONIC TRANSIT; KONJAC GLUCOMANNAN; FECAL MICROBIOTA; RESISTANT STARCH; PREVALENCE; SEROTONIN; CONSISTENCY; SYMPTOMS,"Constipation is a common problem in sows and women during late pregnancy. Dietary fiber has potential in the regulation of intestinal microbiota, thereby promoting intestinal motility and reducing constipation. However, the effects of fibers with different physicochemical properties on intestinal microbe and constipation during late pregnancy have not been fully explored. In this study, a total of 80 sows were randomly allocated to control and one of three dietary fiber treatments from day 85 of gestation to delivery: LIG (lignocellulose), PRS (resistant starch), and KON (konjaku flour). Results showed that the defecation frequency and fecal consistency scores were highest in PRS. PRS and KON significantly increased the level of gut motility regulatory factors, 5-hydroxytryptamine (5-HT), motilin (MTL), and acetylcholinesterase (AChE) in serum. Moreover, PRS and KON promoted the IL-10 level and reduced the TNF-alpha level in serum. Furthermore, maternal PRS and KON supplementation significantly reduced the number of stillborn piglets. Microbial sequencing analysis showed that PRS and KON increased short-chain fatty acids (SCFAs)-producing genera Bacteroides and Parabacteroides and decreased the abundance of endotoxin-producing bacteria Desulfovibrio and Oscillibacter in feces. Moreover, the relative abundance of Turicibacter and the fecal butyrate concentration in PRS were the highest. Correlation analysis further revealed that the defecation frequency and serum 5-HT were positively correlated with Turicibacter and butyrate. In conclusion, PRS is the best fiber source for promoting gut motility, which was associated with increased levels of 5-HT under specific bacteria Turicibacter and butyrate stimulation, thereby relieving constipation. Our findings provide a reference for dietary fiber selection to improve intestinal motility in late pregnant mothers.","[Lu, Dongdong; Pi, Yu; Wu, Yujun; Bai, Yu; Lian, Shuai; Han, Dandan; Zhao, Jinbiao; Zhang, Shuai; Wang, Junjun] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing 100193, Peoples R China; [Pi, Yu; Ni, Dongjiao; Zou, Xinhua] Boen Biotechnol Co Ltd, Minist Agr & Rural Affairs, Key Lab Biol Feed, Ganzhou 341000, Peoples R China; [Ye, Hao; Kemp, Bas; Soede, Nicoline] Wageningen Univ, Dept Anim Sci, Adaptat Physiol Grp, NL-6700 AH Wageningen, Netherlands",China Agricultural University; Ministry of Agriculture & Rural Affairs; Wageningen University & Research,"Wang, JJ (corresponding author), China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing 100193, Peoples R China.",dongd.lu@hotmail.com; yzupiyu@163.com; hao.ye@wur.nl; yujun@cau.edu.cn; yubaijlucau@163.com; lianlianshuai@163.com; handandan@cau.edu.cn; nidj@boencorp.com; jeff@bo-en.com; jinbiaozhao@cau.edu.cn; zhangshuail6@cau.edu.cn; bas.kemp@wur.nl; nicoline.soede@wur.nl; wangjj@cau.edu.cn,"zhang, shuai/HDL-8303-2022; Han, Dandan/JVN-3712-2024; Wang, Junjun/G-8893-2011; Pi, Yu/GZM-4565-2022","Han, Dandan/0000-0001-6041-4887; Wang, Junjun/0000-0001-9427-3824; Pi, Yu/0000-0003-1320-0290; Soede, Nicoline/0000-0003-0296-886X; Zhang, Shuai/0000-0001-5435-2640","National Key Research and Development Programof China [2021YDF1300201]; National Natural Science Foundation of China [31972596, 32002189, 31902170]; Key Research and Development Project of Hainan Province [ZDYF2021XDNY177]; 2021 Research Program of Sanya Yazhou Bay Science and Technology City [SYND-2021-25]; earmarked fund for CARS [CARS-35]; Key-Area Research and Development Program of Guangdong Province [2019B020218001]; China Scholarship Council [201913043]; Hainan University; 111 Project [B16044]","National Key Research and Development Programof China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research and Development Project of Hainan Province; 2021 Research Program of Sanya Yazhou Bay Science and Technology City; earmarked fund for CARS; Key-Area Research and Development Program of Guangdong Province; China Scholarship Council(China Scholarship Council); Hainan University; 111 Project(Ministry of Education, China - 111 Project)",This work was financially supported by the National Key Research and Development Programof China (2021YDF1300201); the National Natural Science Foundation of China (31972596); the National Natural Science Foundation of China (32002189); the National Natural Science Foundation of China (31902170); the Key Research and Development Project of Hainan Province (ZDYF2021XDNY177); the 2021 Research Program of Sanya Yazhou Bay Science and Technology City (SYND-2021-25); the earmarked fund for CARS (CARS-35); the Key-Area Research and Development Program of Guangdong Province (2019B020218001); the China Scholarship Council (201913043) and Hainan University; the 111 Project (B16044).,,65,12,13,14,75,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,JUN,2022,14,12,,,,,,,2511,10.3390/nu14122511,http://dx.doi.org/10.3390/nu14122511,,,18,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,2M0TO,35745241,"gold, Green Published",,,2024-06-04,WOS:000817423500001,View Full Record in Web of Science
J,"Agakisiyeva, G; Yildirim, D; Hizarcioglu-Gulsen, H; Gumus, E; Karhan, AN; Karabulut, E; Ozen, H; Demir, H; Saltik-Temizel, IN",,,,"Agakisiyeva, Gulnar; Yildirim, Damla; Hizarcioglu-Gulsen, Hayriye; Gumus, Ersin; Karhan, Asuman N.; Karabulut, Erdem; Ozen, Hasan; Demir, Hulya; Saltik-Temizel, Inci N.",,,Nutritional characteristics of patients with functional constipation aged 4 years and older,MINERVA PEDIATRICS,,,English,Article,,,,,,Constipation; Child nutrition sciences; Diet therapy; Dietary fiber,PHYSICAL-ACTIVITY; PRESCHOOL-CHILDREN; DIETARY-INTAKE; DEFECATION; CONSUMPTION; ADOLESCENTS,"BACKGROUND: Dietary modifications may have role in prevention and treatment of functional constipation. Macronutrient, extrafluid, and fiber intake have been evaluated and the results are conflicting. The aim of our study was to define the nutritional features associated with functional constipation aged 4 years and older. METHODS: This is a cross-sectional descriptive study. Forty-one patients with functional constipation and 55 age-gender matched controls between 4-18 years old were enrolled. Demographic data, duration of breast-feeding, defecation pattern in the first year of life, physical activity, socioeconomic parameters, and anthropometric measurements were noted. Mean daily macronutrient and micronutrient consumption from the 5-day dietary records were calculated by Nutrition Information System - BEBIS 7.2 version. RESULTS: There were no differences between two groups in energy, water, protein, and fiber consumption. However, in 4-7 years old constipated female and male group, the percentage of carbohydrate was higher (P=0.010, P=0.049, respectively) but fat was lower (P=0.011, P=0.032, respectively). All patients except 4-7 years old boys of both groups got less energy than the reference values. The mean daily protein intake was higher than required in the 4-7 years old constipated and control groups. There was no significant difference in fiber consumption between 2 groups. Breastfeeding >18 months was more common in controls (P=0.039). The constipated group used the squatting toilet more frequently (P=0.002). Lower family income (P<0.001) and parental education levels (P<0.001) were associated with FC. CONCLUSIONS: Dietary habits may be a risk factor for functional constipation, especially, in rapid growth period.","[Agakisiyeva, Gulnar] Hacettepe Univ, Fac Med, Dept Pediat, Ankara, Turkey; [Yildirim, Damla] Hacettepe Univ, Unit Nutr & Diet, Ankara, Turkey; [Hizarcioglu-Gulsen, Hayriye; Gumus, Ersin; Karhan, Asuman N.; Ozen, Hasan; Demir, Hulya; Saltik-Temizel, Inci N.] Hacettepe Univ, Fac Med, Dept Pediat, Div Pediat Gastroenterol Hepatol & Nutr, Ankara, Turkey; [Gumus, Ersin] Balikesir Ataturk City Hosp, Div Pediat Gastroenterol Hepatol & Nutr, Balikesir, Turkey; [Karhan, Asuman N.] Mersin Univ, Fac Med, Dept Pediat, Div Pediat Gastroenterol Hepatol & Nutr, Mersin, Turkey; [Karabulut, Erdem] Hacettepe Univ, Fac Med, Dept Biostat, Ankara, Turkey",Hacettepe University; Hacettepe University; Hacettepe University; Mersin University; Hacettepe University,"Hizarcioglu-Gulsen, H (corresponding author), Hacettepe Univ, Fac Med, Dept Pediat, Div Pediat Gastroenterol Hepatol & Nutr, Ankara, Turkey.",hayriyegulsen@hacettepe.edu.ir,"GUMUS, ERSIN/I-9116-2013; KARHAN, ASUMAN NUR/HCH-6789-2022; saltik temizel, inci nur/I-9321-2013","gumus, ersin/0000-0002-2280-9789; saltik temizel, inci nur/0000-0002-5580-5100",,,,,29,1,1,2,9,EDIZIONI MINERVA MEDICA,TURIN,"CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY",2724-5276,2724-5780,,MINERVA PEDIATR,Minerva Pediatr.,AUG,2022,74,4,,,,,468,476,,10.23736/S2724-5276.20.05978-2,http://dx.doi.org/10.23736/S2724-5276.20.05978-2,,,9,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,3O2XV,32960005,,,,2024-06-04,WOS:000836701200011,View Full Record in Web of Science
J,"McCrea, GL; Miaskowski, C; Stotts, NA; Macera, L; Paul, SM; Varma, MG",,,,"McCrea, G. Lindsay; Miaskowski, Christine; Stotts, Nancy A.; Macera, Liz; Paul, Steven M.; Varma, Madhulika G.",,,"Gender Differences in Self-Reported Constipation Characteristics, Symptoms, and Bowel and Dietary Habits Among Patients Attending a Specialty Clinic for Constipation",GENDER MEDICINE,,,English,Article,,,,,,constipation; gender; symptoms; characteristics; comorbid conditions; bowel habits; dietary habits; sex differences,UNITED-STATES; HEALTH; EPIDEMIOLOGY; PREVALENCE; DEMOGRAPHICS; DEFINITION; DISORDERS; ABUSE,"Objectives: This study assessed gender differences in the frequency of various characteristics of constipation, constipation-specific symptoms, and bowel and dietary habits, as well as the effects of independent but associated risk factors. Methods: A cross-sectional Study of patients aged >= 18 years with a primary diagnosis of constipation (ie, constipation, slow-transit constipation, outlet dysfunction constipation) was conducted at a tertiary referral center; patients were excluded if they had a primary diagnosis of fecal incontinence. Patients completed both a clinical questionnaire to obtain information on demographic characteristics and medical history and all unvalidated self-report questionnaire relating to the characteristics zinc] symptoms of constipation as well as various bowel and dietary habits. Likert scales were used to assess 4 characteristics of constipation (frequency of constipation, duration of constipation symptoms of >= 1 month, bowel movement frequency, stool consistency) and the frequency of occurrence of 6 constipation symptoms (abdominal pain, abdominal bloating, incomplete evacuation, unsuccessful attempts at evacuation, pain with evacuation, straining with evacuation). The bowel habits that were evaluated included time spent at each evacuation; frequency of needing to change position to evacuate; use of anal digitation to evacuate; and the use of laxatives, enemas, stool softeners, foods, drinks, or other aids. The dietary habits that were evaluated included use of dietary fiber, use of fiber Supplements, and water intake. Results: Of the 518 patients, the majority were female (79.0%), white (76.3%), and employed (62.0%), with a mean (SD) age of 52.4 (16.5) years (range, 18.6-91.5 years). After controlling for a [lumber of related conditions, women were more likely than men to have infrequent bowel movements (adjusted odds ratio [AOR] = 2.97; 95% CI, 1.67-5.28), abnormal stool consistency (ie, hard or pelletlike stools) (AOR = 3.08; 95% CI, 1.80-5.28), and a longer duration of constipation symptoms (AOR 2.00; 95% CI, 1.05-3.82). In addition, women were more likely to report an increased frequency Of Occurrence of abdominal pain (AOR = 2.22; 95% CI, 1.22-4.05), bloating (AOR = 2.65; 95% CI, 1.50-4.70), unsuccessful attempts at evacuation (AOR = 1.74; 95% CI, 1.01-3.00), and the use of anal digitation to evacuate stool (AOR = 3.37; 95% CI, 1.15-9.90). Conclusions: The women in this specialty-based clinic study experienced a number of constipation symptoms and abnormal bowel habits more frequently than did men. These findings warrant replication in both population- and specialty clinic-based samples. In addition, the physiologic mechanisms that underlie these gender differences warrant investigation. (Gend Med. 2009;6:259-271) (C) 2009 Excerpta Medica Inc.","[McCrea, G. Lindsay] Calif State Univ, Dept Nursing & Hlth Sci, E Bay, CA USA; [Miaskowski, Christine; Stotts, Nancy A.; Macera, Liz; Paul, Steven M.] Univ Calif San Francisco, Dept Physiol Nursing, San Francisco, CA 94143 USA; [Varma, Madhulika G.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA",University of California System; University of California San Francisco; University of California System; University of California San Francisco,"McCrea, GL (corresponding author), 3185 Old Tunnel Rd, Lafayette, CA 94549 USA.",lindsay.mccrea@csueastbay.edu,"Paul, Steve/ABE-5400-2020",,Betty Irene Moore Foundation,Betty Irene Moore Foundation,Dr. McCrea's doctoral studies were funded by the Betty Irene Moore Foundation. Dr. Miaskowski's work is partially funded by grants from the National Institute of Nursing Research and the National Cancer Institute.,,27,48,52,0,12,EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC,BRIDGEWATER,"685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA",1550-8579,1878-7398,,GENDER MED,Gend. Med.,APR,2009,6,1,,,,,259,271,,10.1016/j.genm.2009.04.007,http://dx.doi.org/10.1016/j.genm.2009.04.007,,,13,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,452YM,19467522,,,,2024-06-04,WOS:000266577100003,View Full Record in Web of Science
J,"de Mora, BRRC; Conde, LPO",,,,"Ruiz-Roso Calvo de Mora, Baltasar; Perez-Olleros Conde, Lourdes",,,Preliminary results on dietary fibre intake in Spain and health benefits associated to soluble fiber intake,REVISTA ESPANOLA DE NUTRICION COMUNITARIA-SPANISH JOURNAL OF COMMUNITY NUTRITION,,,Spanish,Article,,,,,,Dietary fiber; Soluble fiber; Insoluble fiber; Chronic diseases,NATURAL CAROB FIBER; CORONARY-HEART-DISEASE; NUTRITIONAL UTILIZATION; RISK,"Background: Many studies have found an association between dietary fiber intake and a protective effect against a number of chronic diseases such as colon cancer, cardiovascular diseases, constipation and obesity, among other. However, fiber intake in western countries are low, distant from recommended values. Methods: In this ecological study, total dietary fiber consumption, soluble and insoluble, in Spanish households has been estimated and its association with morbidity and morbidity data for selected diseases in the period 2004-2008. Results: Average total fiber intake in Spanish households during the study period was 16.24 +/- 0.15 g/day, below recommended intakes for dietary fiber. A negative correlation (p < 0.05) was observed between total fiber and insoluble fiber intake and mortality for ischaemic heart disease (myocardial infarction), cardiac failure and stroke. No significant correlation was found with soluble fiber intake. Conclusions: Consumption of foods rich in fiber is adequate for the prevention of different chronic diseases, particularly foods rich in insoluble dietary fiber, such as cereals and pulses. (C) 2010 SENC. Published by Elsevier Espana, S.L. All rights reserved.","[Ruiz-Roso Calvo de Mora, Baltasar; Perez-Olleros Conde, Lourdes] Univ Complutense Madrid, Fac Farm, Dept Nutr & Bromatol 1, Madrid, Spain",Complutense University of Madrid,"de Mora, BRRC (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Nutr & Bromatol 1, Madrid, Spain.",ruizrojo@farm.ucm.es,"Pérez-Olleros, Lourdes/K-6724-2014","Pérez-Olleros, Lourdes/0000-0003-1345-4231",,,,,28,2,2,1,18,NEXUS MEDICA EDITORES,BARCELONA,"PASSEIG D AMUNT 38, BARCELONA, 08028, SPAIN",1135-3074,,,REV ESP NUTR COMUNIT,Rev. Esp. Nutr. Comunitaria,JUL-SEP,2010,16,3,,,,,147,153,,,,,,7,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,725DK,,,,,2024-06-04,WOS:000287625200005,View Full Record in Web of Science
J,"Akl, EM",,,,"Akl, Engy M.",,,Oilseeds Dietary Fiber and Their Health Benefits,EGYPTIAN JOURNAL OF CHEMISTRY,,,English,Article,,,,,,Dietary fiber; functionality; oilseeds; health benefits,CHEMICAL-COMPOSITION; FLAXSEED; ACID; FRACTIONATION; FUNCTIONALITY; EXTRACTION; GOSSYPOL; MUCILAGE; MEAL; OIL,"Recently, epidemiological studies confirm that dietary fiber intake is linked with a reduced risk of death. So, this review illustrated dietary fiber (DF) composition and classification. It also shows the extraction methods, factors that influence its functionality, and how it affects microbiota. The main components in oilseeds are fatty acids (FA), protein, dietary fiber, and other micronutrients. It also acts as an antioxidant, anti-bacterial, anti-cancer, anti-cholesterol, anti -cardiovascular, and anti-inflammatory agent, in addition to its role in diabetes, diarrhea, constipation, and obesity, as well as their utilization in the field of cosmetics. In this review, the health benefits of some popular oilseeds dietary fiber such as (flaxseed, cotton, sunflower, soybean, sesame, and mustard) were evaluated. Oilseeds DF are of great importance to human health by reducing the risks of some diseases.","[Akl, Engy M.] Natl Res Ctr, Food Ind & Nutr Res Inst, Fats & Oils Dept, Giza 12622, Egypt",Egyptian Knowledge Bank (EKB); National Research Centre (NRC),"Akl, EM (corresponding author), Natl Res Ctr, Food Ind & Nutr Res Inst, Fats & Oils Dept, Giza 12622, Egypt.",engy_akl@yahoo.com,,,,,,,73,1,1,3,3,National Information & Documentation Centre-NIDOC,CAIRO,"NIDOC DOKKI, CAIRO, 00000, EGYPT",0449-2285,2357-0245,,EGYPT J CHEM,Egypt. J. Chem.,SEP,2023,66,9,,,,,459,471,,10.21608/EJCHEM.2023.177503.7243,http://dx.doi.org/10.21608/EJCHEM.2023.177503.7243,,,13,"Chemistry, Multidisciplinary",Emerging Sources Citation Index (ESCI),Chemistry,Y9ZB6,,,,,2024-06-04,WOS:001108759100020,View Full Record in Web of Science
J,"KLAUSER, AG; PEYERL, C; SCHINDLBECK, NE; MULLERLISSNER, SA",,,,"KLAUSER, AG; PEYERL, C; SCHINDLBECK, NE; MULLERLISSNER, SA",,,NUTRITION AND PHYSICAL-ACTIVITY IN CHRONIC CONSTIPATION,EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY,,,English,Article,,,,,,CHRONIC CONSTIPATION; NUTRITION; PHYSICAL ACTIVITY; SLOW TRANSIT; DIETARY FIBER,,"Objective: To test whether patients suffering from chronic constipation eat less dietary fibre, drink less fluid, or are less physically active than healthy controls. Design: Cohort study. Nutrition was assessed by a week's diary, physical activity estimated from a standardized questionnaire. Setting: Outpatient Department of Gastroenterology, Medizinische Klinik, Klinikum Innenstadt of the University of Munich. Participants: Sixty-two consecutive patients who presented with chronic constipation. Patients with additional disease were excluded. One hundred healthy controls with a comparable gender and age distribution, eight of whom were excluded because they took laxatives occasionally. Main outcome measures: Dietary fibre intake, total fluid intake, amount of beverages drunk, and estimated physical activity. For other items and comparisons made between patients with normal and prolonged total colonic marker transit times, descriptive statistics are given. Results: There was no significant difference between controls and patients with respect to fibre intake [mean +/- s.e., 18.8 +/- 0.8 g per day, 95% confidence interval for the difference between controls and patients (-1.7; 3.1)], total fluid [2.00 +/- 0.06 and 2.14 +/- 0.08 l per day, 95% confidence interval (-0.32; 0.05)] and beverages [1.60 +/- 0.06 and 1.70 +/- 06 l per day, 95% confidence interval (-0.26; 0.05)]. Total energy spent as a measure for physical activity was estimated as 8.21 +/- 0.14 and 7.77 +/- 0.17 MJ per day for controls and patients, respectively, [95% confidence interval (-0.01; 0.89)]. The results were similar when only patients with documented slow colonic transit were considered. Conclusion: A lack of dietary fibre, fluid, and physical activity is not the primary cause of constipation in most patients.",,,"KLAUSER, AG (corresponding author), UNIV MUNICH,KLINIKUM INNENSTADT,DEPT GASTROENTEROL,MED KLIN,ZIEMSSENSTR 1,W-8000 MUNICH 2,GERMANY.",,,,,,,,0,36,40,0,7,RAPID SCIENCE PUBLISHERS,LONDON,"2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8NH",0954-691X,,,EUR J GASTROEN HEPAT,Eur. J. Gastroenterol. Hepatol.,MAR,1992,4,3,,,,,227,233,,,,,,7,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,HL231,,,,,2024-06-04,WOS:A1992HL23100010,View Full Record in Web of Science
J,"LENNARDJONES, JE",,,,"LENNARDJONES, JE",,,CLINICAL MANAGEMENT OF CONSTIPATION,PHARMACOLOGY,,,English,Article; Proceedings Paper,2ND INTERNATIONAL SYMP ON SENNA,"APR 23-24, 1993","KONSTANZ, GERMANY",,,CONSTIPATION; FIBER; LAXATIVES; BIOFEEDBACK,IDIOPATHIC CONSTIPATION; BIOFEEDBACK TREATMENT; SURGICAL-TREATMENT; TRANSIT-TIME; POPULATION; LACTULOSE; COLECTOMY; CHILDREN; ANISMUS; WEIGHT,"First, it is important to find out whether the patient is complaining of infrequent defaecation, excessive straining at defaecation, abdominal pain or bloating, a general sense of malaise attributed to constipation, soiling, or a combination of more than one symptom. Second, one must decide if there is a definable abnormality as a cause of the symptom(s). Is the colon apparently normal or is its lumen widened (megacolon)? Is the upper gut normal or is there evidence of neuropathy or myopathy? Is the ano-rectum normal or is there evidence of a weak pelvic floor, mucosal prolapse, major rectocele, an internal intussusception or solitary rectal ulcer? Is there any systemic component such as hypothyroidism, hypercalcaemia, neurological or psychiatric disorder or relevant drug therapy? Choice of treatment will depend on this clinical evaluation. The range of treatments available is: Reassurance and stop current treatment: Patients with a bowel obsession may take laxatives or rectal preparations regularly without need. Increase dietary fibre: Most cases of 'simple' constipation respond to increased dietary fibre, possibly with an added supplement of natural bran. Toilet training and altered routine of life: Young people particularly may need to recognise the call to stool and alter their daily routine to permit and encourage regular defaecation. Medicinal bulking agent: Ispaghula, methyl cellulose, concentrated wheat germ or bran, and similar preparations are useful when patients with a normal colon find it difficult to take adequate dietary fibre. These preparations increase the bulk of stool and soften its consistency. They may be useful for those patients with the constipated form of irritable bowel syndrome. Additional bulk does not help patients with megacolon or severe idiopathic slow transit constipation. Osmotic laxatives or saline perfusion: Preparations of magnesium hydroxide or sulphate, sodium sulphate, or mannitol soften the stool and if taken in sufficient quantity produce a liquid stool. Magnesium hydroxide is a useful mild laxative for use in childhood. Patients with idiopathic megacolon need to keep the stools liquid with an osmotic laxative. Stimulant laxatives: Anthranoid preparations, bisacodyl and its derivatives are used occasionally by many patients and regularly by some patients with severe idiopathic slow transit constipation. Prokinetic drugs: Can be helpful as a supplement to laxatives. Rectal preparations: Useful particularly for emptying the rectum in childhood and elderly patients with rectal impaction and soiling. Biofeedback: Biofeedback training to increase rectal sensitivity to distension, relax the pelvic floor and increase the effectiveness of straining is proving beneficial for some patients with slow transit constipation and many of those with marked paradoxical contraction of the pelvic floor including children with soiling. Psychological: Certain patients, for example those with 'denied bowel actions' or eating disorders need primary psychiatric treatment. Other patients, for example those with a history of sexual abuse, may need it as a supportive measure. Surgery: Surgery is needed for aganglionosis, a few patients with idiopathic megacolon or idiopathic slow transit constipation or pseudoobstruction, and for those with severe rectal mucosal prolapse.","UNIV LONDON,LONDON,ENGLAND; ROYAL LONDON HOSP,LONDON,ENGLAND; ST MARKS HOSP,LONDON EC1V 2PS,ENGLAND",University of London; Barts Health NHS Trust; Royal London Hospital; Imperial College London,,,,,,,,,31,23,25,0,11,KARGER,BASEL,"ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND",0031-7012,,,PHARMACOLOGY,Pharmacology,OCT,1993,47,,,1,,,216,223,,10.1159/000139861,http://dx.doi.org/10.1159/000139861,,,8,Pharmacology & Pharmacy,Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy,MC565,8234432,,,,2024-06-04,WOS:A1993MC56500029,View Full Record in Web of Science
C,"Ozolina, V; Gramatina, I; Kunkulberga, D",,"Treija, S; Skuja, I",,"Ozolina, Vija; Gramatina, Ilze; Kunkulberga, Daiga",,,METHODOLOGY OF DIETARY FIBRE DETERMINATION IN GRAIN PRODUCTS,RESEARCH FOR RURAL DEVELOPMENT 2009,Research for Rural Development,,English,Proceedings Paper,15th Annual International Scientific Conference on Research for Rural Development,"MAY 20-22, 2009","Latvia Univ Agr, Jelgava, LATVIA",,Latvia Univ Agr,dietary fibre; grain products,,"The dietary fibre is edible parts of plants' carbohydrates that are resistant to digestion in human small intestine. Diets naturally rich in dietary fibre support to prevent constipation, improve gastrointestinal health, glucose tolerance and the insulin response, and reduce the risk of colon cancer, hyperlipidemia, hypertension and other coronary heart disease risk factors. About 45% of the dietary fibre intake comes from grains and grain mixtures. In Latvia, there are neither data, nor investigations of the dietary fibre content in grain products during processing and in the end products in which manufacturers and consumers are interested. The aim of this paper was an approval of dietary fibre determination methodology by using analytical equipment the Full option science system (FOS) Analytical Fibertec E 1023. The dietary fibre determination experiments were carried out in the Research Laboratory of the Department of Food Technology at the Latvia University of Agriculture in 2009. The Total Dietary Fibre (TDF) content was analyzed in the samples of rye whole grain flour, rye whole grain bread, and wheat biscuit. Experiments showed that the fibre content in rye whole grain flour is 13.8 g 100 g(-1), in rye whole grain bread -11.6 g 100 g(-1), and in the wheat biscuit -1.9 g 100 g(-1). Reached data are comparable with results of other researchers' data.","[Ozolina, Vija; Gramatina, Ilze; Kunkulberga, Daiga] Latvia Univ Agr, Jelgava, Latvia",Latvia University of Life Sciences & Technologies,"Ozolina, V (corresponding author), Latvia Univ Agr, Jelgava, Latvia.",vro@apollo.lv; IlzeGramatina@inbox.lv.lv; Daiga.Kunkulberga@llu.lv,,"Gramatina, Ilze/0000-0002-1049-0141",,,,,16,2,3,1,4,LATVIA UNIV AGRICULTURE,JELGAVA,"LIELA IELA 2, JELGAVA, LV-3001, LATVIA",1691-4031,,,RES RURAL DEV,,,2009,,,,,,,115,119,,,,,,5,"Agriculture, Multidisciplinary",Conference Proceedings Citation Index - Science (CPCI-S),Agriculture,BJP13,,,,,2024-06-04,WOS:000329454800018,View Full Record in Web of Science
J,"Kiefte-de Jong, JC; de Vries, JH; Escher, JC; Jaddoe, VWV; Hofman, A; Raat, H; Moll, HA",,,,"Kiefte-de Jong, Jessica C.; de Vries, Jeanne H.; Escher, Johanna C.; Jaddoe, Vincent W. V.; Hofman, Albert; Raat, Hein; Moll, Henriette A.",,,"Role of dietary patterns, sedentary behaviour and overweight on the longitudinal development of childhood constipation: the Generation R study",MATERNAL AND CHILD NUTRITION,,,English,Article,,,,,,overweight; dietary patterns; constipation; children,FUNCTIONAL GASTROINTESTINAL DISORDERS; PHYSICAL-ACTIVITY; INCREASED PREVALENCE; MULTIPLE IMPUTATION; CHILDREN; FIBER; ASSOCIATION; ADOLESCENTS; CONSUMPTION; OBESITY,"The influence of childhood nutrition on the development of constipation beyond the period of weaning and breastfeeding is relatively understudied. In addition, eating patterns in childhood can be highly correlated with overweight and sedentary behaviour, which may also have an influence on constipation. The aim of this study was to assess whether common dietary patterns, sedentary behaviour and childhood overweight are associated with constipation in childhood. The study was embedded in a population-based prospective birth cohort. Information on dietary intake was obtained by a food frequency questionnaire at the child's age of 14 months (n=2420). The adherence scores on a Health conscious' and Western-like' diet were extracted from principal component analysis. At the age of 24, 36 and 48 months, information on constipation and sedentary behaviour, and weight and height was obtained by parental-derived questionnaires and from the child health centres, respectively. Adherence to a Western-like' dietary pattern was associated with a higher prevalence of constipation up to 48 months [adjusted odds ratio (aOR); 95% confidence interval (CI): 1.39; 1.02-1.87], which was not mediated by overweight or sedentary behaviour. Adherence to a Health Conscious' dietary pattern was only associated at short term, with a lower prevalence of constipation at 24 months (aOR; 95%CI: 0.65; 0.44-0.96). No association was found between overweight, sedentary behaviour and constipation. Our results suggest that specific dietary patterns in early childhood could be associated with higher or lower risks for constipation, but these effects are time-dependent. Overweight and sedentary behaviour seem to not have a major role on constipation in childhood.","[Kiefte-de Jong, Jessica C.; Jaddoe, Vincent W. V.] Wageningen Univ, Dept Generat Study Grp R, NL-6700 AP Wageningen, Netherlands; [Kiefte-de Jong, Jessica C.; Jaddoe, Vincent W. V.; Moll, Henriette A.] Wageningen Univ, Dept Pediat, NL-6700 AP Wageningen, Netherlands; [Escher, Johanna C.] Wageningen Univ, Dept Pediat Gastroenterol, NL-6700 AP Wageningen, Netherlands; [Jaddoe, Vincent W. V.; Hofman, Albert] Wageningen Univ, Dept Epidemiol, NL-6700 AP Wageningen, Netherlands; [Raat, Hein] Erasmus MC, Dept Publ Hlth, NL-3000 CB Rotterdam, Netherlands; [de Vries, Jeanne H.] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands",Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Erasmus University Rotterdam; Erasmus MC; Wageningen University & Research,"Moll, HA (corresponding author), Erasmus MC, Dept Pediat, POB 2060, NL-3000 CB Rotterdam, Netherlands.",h.a.moll@erasmusmc.nl,"Kiefte-de Jong, Jessica/GLV-3216-2022","Kiefte-de Jong, Jessica/0000-0002-8136-0918",Erasmus Medical Center; Erasmus University Rotterdam; Netherlands Organization for Health Research and Development (Zon Mw); Europe Container terminals B.V,Erasmus Medical Center; Erasmus University Rotterdam; Netherlands Organization for Health Research and Development (Zon Mw)(Netherlands Organization for Health Research and Development); Europe Container terminals B.V,"This phase of the Generation R study was supported by the Erasmus Medical Center, the Erasmus University Rotterdam, the Netherlands Organization for Health Research and Development (Zon Mw) and Europe Container terminals B.V.",,46,19,21,0,20,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1740-8695,1740-8709,,MATERN CHILD NUTR,Matern. Child Nutr.,OCT,2013,9,4,,,,,511,523,,10.1111/j.1740-8709.2011.00395.x,http://dx.doi.org/10.1111/j.1740-8709.2011.00395.x,,,13,Nutrition & Dietetics; Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics; Pediatrics,263PO,22288911,Green Published,,,2024-06-04,WOS:000327820700007,View Full Record in Web of Science
J,"BADIALI, D; CORAZZIARI, E; HABIB, FI; TOMEI, E; BAUSANO, G; MAGRINI, P; ANZINI, F; TORSOLI, A",,,,"BADIALI, D; CORAZZIARI, E; HABIB, FI; TOMEI, E; BAUSANO, G; MAGRINI, P; ANZINI, F; TORSOLI, A",,,EFFECT OF WHEAT BRAN IN TREATMENT OF CHRONIC NONORGANIC CONSTIPATION - A DOUBLE-BLIND CONTROLLED TRIAL,DIGESTIVE DISEASES AND SCIENCES,,,English,Article,,,,,,CONSTIPATION; DIETARY FIBERS,IRRITABLE BOWEL SYNDROME; DIETARY FIBER; DIVERTICULAR-DISEASE; UNPROCESSED BRAN; COLONIC FUNCTION; PARTICLE-SIZE; TRANSIT; CROSSOVER; WEIGHT; STOOL,"After a two-week basal period, 24 patients were randomly allocated to receive, with a crossover double-blind design, for two consecutive four-week periods, bran (20 g/24 hr) or placebo. The daily intake of water and dietary fibers was standardized. Symptomatology, oroanal transit time, bowel frequency, and stool weight were assessed in basal conditions and at week 4 and 8 of the treatment. Oroanal transit time decreased and bowel frequency and stool weight increased significantly during both bran and placebo administration in comparison with basal period. Bran treatment was more effective than placebo in improving bowel frequency and oroanal transit. During bran treatment oroanal transit time became normal only in patients with slow colonic transit and not in those with slow rectal transit. Neither the occurrence nor the severity of the most frequent accompanying symptoms of chronic constipation differed significantly between placebo and bran treatments.","UNIV ROMA LA SAPIENZA,CATTEDRA GASTROENTEROL 1,ROME,ITALY",Sapienza University Rome,,,,,,,,,29,99,105,0,10,PLENUM PUBL CORP,NEW YORK,"233 SPRING ST, NEW YORK, NY 10013",0163-2116,,,DIGEST DIS SCI,Dig. Dis. Sci.,FEB,1995,40,2,,,,,349,356,,10.1007/BF02065421,http://dx.doi.org/10.1007/BF02065421,,,8,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,QK211,7851201,,,,2024-06-04,WOS:A1995QK21100018,View Full Record in Web of Science
J,"Zhuang, ZQ; Chen, M; Niu, JH; Qu, N; Ji, B; Duan, X; Liu, ZD; Liu, XB; Wang, YT; Zhao, BT",,,,"Zhuang, Ziqi; Chen, Min; Niu, Jihan; Qu, Na; Ji, Bing; Duan, Xiang; Liu, Zhande; Liu, Xuebo; Wang, Yutang; Zhao, Beita",,,The Manufacturing Process of Kiwifruit Fruit Powder with High Dietary Fiber and Its Laxative Effect,MOLECULES,,,English,Article,,,,,,kiwifruit; microencapsulate; dietary fiber; ultra-micro kiwifruit powder; constipation; laxative effect,IRRITABLE-BOWEL-SYNDROME; WATER-HOLDING CAPACITY; CONSTIPATION; MICROENCAPSULATION; SPRAY; POLYPHENOLS; EXPRESSION; POMACE,"Kiwifruit is rich in vitamins, minerals, dietary fiber and other functional components, and it has long been used as a functional food to treat intestinal ailments such as constipation. The current research made full use of the kiwifruit, the juice was prepared by microencapsulation, and the dietary fiber in kiwifruit pomace was modified by enzymatic hydrolysis and grinding, then, the two were mixed to obtain an ultra-micro kiwifruit powder (UKP). In addition, the laxative effect of the UKP was verified by a diphenoxylate induced constipated mice model. The results demonstrated that compared with the raw samples, the retention rate of vitamin C, lutein and catechin in UKP were 83.3%, 81.9% and 88.3%, respectively, thus effectively avoiding the loss of functional components during the processing of kiwifruit. Moreover, alpha-amylase, protease and the ball milling process effectively reduced the size of dietary fiber in kiwifruit pomace, and its water-holding capacity (WHC), oil-holding capacity (OHC) and swelling capacity (SWC) were enhanced by 1.26, 1.65 and 1.10 times, respectively. Furthermore, to analyze the laxative effect of the UKP, a constipation mice model was established by diphenoxylate treatment (5 mgkg(-1), i.g.) for the last week, with or without UKP supplementation (2.4 gkg(-1) B.W. per day) for 4 weeks. The results demonstrated that UKP significantly increased feces condition (fecal output and dejecta moisture content, gut transit (the intestinal propulsion rates) and substance P (SP) levels in portal vein plasma, and it decreased the whole gut transit time and mucinogen granules secreted by goblet cell in constipated mice.","[Zhuang, Ziqi; Chen, Min; Niu, Jihan; Ji, Bing; Duan, Xiang; Liu, Xuebo; Wang, Yutang; Zhao, Beita] Northwest A&F Univ, Coll Food Sci & Engn, Yangling 712100, Shaanxi, Peoples R China; [Qu, Na] Patent Examinat Cooperat Jiangsu Ctr, Patent Off, Suzhou 215000, Jiangsu, Peoples R China; [Liu, Zhande] Northwest A&F Univ, Coll Hort, Yangling 712100, Shaanxi, Peoples R China",Northwest A&F University - China; Northwest A&F University - China,"Wang, YT; Zhao, BT (corresponding author), Northwest A&F Univ, Coll Food Sci & Engn, Yangling 712100, Shaanxi, Peoples R China.",906881422@nwafu.edu.cn; 18794419539@163.com; NiuJiHan0716@163.com; japannlhquna@126.com; jjjibing@163.com; duanxiang402@163.com; dezhanliu@vip.sina.com; xueboliu@aliyun.com; wyt991023@nwsuaf.edu.cn; beitazhao@nwafu.edu.cn,"Zhao, Beita/AAF-7526-2021; Zhuang, Ziqi/JVZ-5879-2024",,Shaanxi Keypoint Research and Development Program [2016MSZD-N-1-4]; China Postdoctoral Science Foundation [2019M653768],Shaanxi Keypoint Research and Development Program; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation),"This research was funded by the Shaanxi Keypoint Research and Development Program (No.: 2016MSZD-N-1-4), China Postdoctoral Science Foundation funded project (No.: 2019M653768).",,34,22,24,0,22,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,1420-3049,,MOLECULES,Molecules,NOV,2019,24,21,,,,,,,3813,10.3390/molecules24213813,http://dx.doi.org/10.3390/molecules24213813,,,14,"Biochemistry & Molecular Biology; Chemistry, Multidisciplinary",Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Chemistry,JP1TW,31652679,"Green Published, gold",,,2024-06-04,WOS:000498055500002,View Full Record in Web of Science
J,"Liu, QY; Kang, YL; Yan, J",,,,"Liu, Qingye; Kang, Yulong; Yan, Jin",,,Association between overall dietary quality and constipation in American adults: a cross-sectional study,BMC PUBLIC HEALTH,,,English,Article,,,,,,Healthy eating index; Overall dietary quality; Constipation; Stool consistency; Stool frequency,HEALTHY EATING INDEX; NATIONAL-HEALTH; PATTERNS; FIBER; RISK,"Background Constipation seriously affects people's life quality, and dietary adjustment has been one of the effective methods. Overall dietary quality has been reported to be associated with some diseases, while its association with constipation has not been reported. This study aims to explore the association between overall dietary quality and constipation. Methods A cross-sectional study was designed and data were extracted from National Health and Nutrition Examination Survey (NHANES). Overall dietary quality was assessed by healthy eating index-2015 (HEI-2015), and constipation was defined by either stool consistency or stool frequency. The association between overall dietary quality or components of HEI-2015 and constipation was assessed using logistic regression, with results expressed as odds ratio (OR) and 95% confidence intervals (95%CI). Subgroup analysis was conducted according to age and gender. Results A total of 13,945 participants were eligible, with 1,407 in constipation group and 12,538 in non-constipation group. Results showed that higher adherence to HEI-2015 was associated with reduced odds of constipation (OR: 0.98, 95%CI: 0.98-0.99) after adjusting potential confounders. Further, we found higher intake of total fruits, whole fruits, total vegetables, greens and beans, whole grains, total protein foods, seafood and plant proteins, and higher fatty acids ratio decreased the odds of constipation, while higher intake of sodium increased the odds (all P < 0.05). We also found negative association between HEI-2015 and constipation in participants with male sex, female sex, age >= 65 years, and age < 65 years (all P < 0.05). Conclusion We found higher adherence to HEI-2015 decreased the odds of constipation, suggesting that increasing HEI-2015 adherence may be one of effective methods to alleviate constipation.","[Liu, Qingye] Changzhou Wujin Hosp Tradit Chinese Med, Dept Anus Intestines, Changzhou 213161, Peoples R China; [Kang, Yulong; Yan, Jin] Subei Peoples Hosp Jiangsu Prov, Dept Proctol, 98 Nantong Western Rd, Yangzhou 225001, Jiangsu, Peoples R China",,"Yan, J (corresponding author), Subei Peoples Hosp Jiangsu Prov, Dept Proctol, 98 Nantong Western Rd, Yangzhou 225001, Jiangsu, Peoples R China.",yanjinyz@hotmail.com,,,,,,,46,9,10,2,7,BMC,LONDON,"CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND",,1471-2458,,BMC PUBLIC HEALTH,BMC Public Health,OCT 27,2022,22,1,,,,,,,1971,10.1186/s12889-022-14360-w,http://dx.doi.org/10.1186/s12889-022-14360-w,,,10,"Public, Environmental & Occupational Health",Science Citation Index Expanded (SCI-EXPANDED),"Public, Environmental & Occupational Health",5S0ZL,36303148,"Green Published, gold",,,2024-06-04,WOS:000874929200002,View Full Record in Web of Science
J,"Inoue, R; Sakaue, Y; Kawada, Y; Tamaki, R; Yasukawa, Z; Ozeki, M; Ueba, S; Sawai, C; Nonomura, K; Tsukahara, T; Naito, Y",,,,"Inoue, Ryo; Sakaue, Yuko; Kawada, Yuki; Tamaki, Ryuji; Yasukawa, Zenta; Ozeki, Makoto; Ueba, Satoko; Sawai, Chihiro; Nonomura, Kazuo; Tsukahara, Takamitsu; Naito, Yuji",,,Dietary supplementation with partially hydrolyzed guar gum helps improve constipation and gut dysbiosis symptoms and behavioral irritability in children with autism spectrum disorder,JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION,,,English,Article,,,,,,gut microbiota; autism spectrum disorders; dietary fiber; constipation,MICROBIOTA; POPULATION; MICROFLORA; CHECKLIST; FLORA,"Prebiotic dietary water-soluble fiber obtained from partially hydrolyzed guar gum was added to diets of children with autism spectrum disorders who presented constipation symptoms. Supplementation with partially hydrolyzed guar gum altered gut micro biota and significantly increased the frequency of defecation per week and altered the gut microbiota. In addition, supplementation with partially hydrolyzed guar gum significantly (p<0.05) decreased and tended to decrease (p = 0.07) the concentrations of serum interleukin-1 beta and tumor necrosis factor-alpha, respectively. More importantly, supplementation with partially hydrolyzed guar gum significantly ameliorated behavioral irritability as per the Aberrant Behavior Checklist, Japanese Version. The present study demonstrated that supplementation with partially hydrolyzed guar gum to diets of constipated autism spectrum disorders children helped improve constipation and gut dysbiosis symptoms, which in turn helped attenuate the level of serum inflammation cytokines and behavioral irritability.","[Inoue, Ryo; Kawada, Yuki; Tamaki, Ryuji] Kyoto Prefectural Univ, Dept Agr & Life Sci, Lab Anim Sci, Sakyo Ku, 1-5 Shimogamohangi Cho, Kyoto 6068522, Japan; [Sakaue, Yuko; Sawai, Chihiro] Shiga Univ Med Sci, Dept Pediat, Seta Tsukinowa Cho, Otsu, Shiga 5202192, Japan; [Yasukawa, Zenta; Ozeki, Makoto] Taiyo Kagaku Co Ltd, 1-3 Takaramachi, Yokaichi, Mie 5100844, Japan; [Ueba, Satoko; Nonomura, Kazuo] Moriyama Municipal Hosp, 4-14-1 Moriyama, Shiga 5240022, Japan; [Tsukahara, Takamitsu] Kyoto Inst Nutr & Pathol, Ujitawara, Kyoto 6100231, Japan; [Naito, Yuji] Kyoto Prefectural Univ Med, Dept Mol Gastroenterol & Hepatol, Kamigyo Ku, Kyoto 6028566, Japan","Kyoto Prefectural University; Shiga University of Medical Science; TAIYO KAGAKU CO., LTD.; Kyoto Prefectural University of Medicine","Inoue, R (corresponding author), Kyoto Prefectural Univ, Dept Agr & Life Sci, Lab Anim Sci, Sakyo Ku, 1-5 Shimogamohangi Cho, Kyoto 6068522, Japan.",r-inoue@kpu.ac.jp,"Tsukahara, Takamitsu/Y-7348-2019","Tsukahara, Takamitsu/0000-0002-3902-5956; Tamaki, Ryuji/0009-0009-1231-7893",,,,,28,46,46,0,25,JOURNAL CLINICAL BIOCHEMISTRY & NUTRITION,KYOTO,"KYOTO PREFECTURAL UNIV MED, GRAD SCH MEDICAL SCIENCE, DEPT MOLECULAR GASTROENTEROLOGY & HEPATOLOGY, KYOTO, 602-8566, JAPAN",0912-0009,1880-5086,,J CLIN BIOCHEM NUTR,J. Clin. Biochem. Nutr.,MAY 1,2019,64,3,,,,,217,223,,10.3164/jcbn.18-105,http://dx.doi.org/10.3164/jcbn.18-105,,,7,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Nutrition & Dietetics,HY6SA,31138955,"Green Published, gold, Green Submitted",,,2024-06-04,WOS:000468258800005,View Full Record in Web of Science
J,"NAIR, P; MAYBERRY, JF",,,,"NAIR, P; MAYBERRY, JF",,,"VEGETARIANISM, DIETARY FIBER AND GASTROINTESTINAL-DISEASE",DIGESTIVE DISEASES,,,English,Article,,,,,,VEGETARIANISM; DIETARY FIBER; GASTROINTESTINAL DISEASE,,"Purpose: To review the association between vegetarianism, dietary fibre and gastro-intestinal disease. Data: There is an increasing trend towards vegetarianism in the United Kingdom. Studies have shown a lower than expected death rate in vegetarians with a significant association between meat eating and mortality from all causes in men. Vegetarians were found to have a lower incidence of gastro-intestinal cancer, gallstones, diverticular disease and constipation. Patients treated with vegetarian/high-fibre diets have not experienced significant benefits when diets are used in gastro-intestinal cancer, peptic ulcer disease or inflammatory bowel disease. Conclusion: The benefits of a vegetarian life-style may be conferred to non-vegetarians by eating a carefully planned nonvegetarian diet consisting of increased fruit, vegetables and fibre.",,,"NAIR, P (corresponding author), LEICESTER GEN HOSP,GASTROINTESTINAL RES UNIT,GWENDOLEN RD,LEICESTER LE5 4PW,ENGLAND.",,"Mayberry, John/AAP-2392-2020","Mayberry, John/0000-0002-4117-8740",,,,,0,21,21,1,13,KARGER,BASEL,"ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND",0257-2753,,,DIGEST DIS,Dig. Dis.,MAY-JUN,1994,12,3,,,,,177,185,,10.1159/000171451,http://dx.doi.org/10.1159/000171451,,,9,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,PG716,7988064,,,,2024-06-04,WOS:A1994PG71600006,View Full Record in Web of Science
J,"Klosterbuer, A; Roughead, ZF; Slavin, J",,,,"Klosterbuer, Abby; Roughead, Zamzam Fariba; Slavin, Joanne",,,Benefits of Dietary Fiber in Clinical Nutrition,NUTRITION IN CLINICAL PRACTICE,,,English,Article,,,,,,"dietary fiber; enteral nutrition; prebiotics; diarrhea; constipation; fatty acids, volatile",HYDROLYZED GUAR GUM; CHAIN FATTY-ACIDS; INULIN-TYPE FRUCTANS; CRITICALLY-ILL PATIENTS; TOTAL ENTERAL NUTRITION; TUBE-FED PATIENTS; RESISTANT STARCH; BOWEL FUNCTION; SOY-POLYSACCHARIDE; SOLUBLE FIBER,"Dietary fiber is widely recognized as an important part of a healthy diet and is a common addition to enteral nutrition (EN) formulas. Fiber sources differ in characteristics such as solubility, fermentability, and viscosity, and it is now well known that different types of fiber exert varying physiological effects in the body. Clinical studies suggest fiber can exert a wide range of benefits in areas such as bowel function, gut health, immunity, blood glucose control, and serum lipid levels. Although early clinical nutrition products contained fiber from a single source, it is now thought that blends of fiber from multiple sources more closely resemble a regular diet and may provide a greater range of benefits for the patient. Current recommendations support the use of dietary fiber in clinical nutrition when no contraindications exist, but little information exists about which types and combinations of fibers provide the relevant benefit in certain patient populations. This article summarizes the different types of fiber commonly added to EN products and reviews the current literature on the use of fiber blends in clinical nutrition. (Nutr Clin Pract. 2011; 26:625-635)","[Klosterbuer, Abby; Slavin, Joanne] Univ Minnesota, St Paul, MN 55108 USA; [Roughead, Zamzam Fariba] Nestle HealthCare Nutr, Minnetonka, MN USA",University of Minnesota System; University of Minnesota Twin Cities,"Slavin, J (corresponding author), Univ Minnesota, 1334 Eckles Ave, St Paul, MN 55108 USA.",jslavin@umn.edu,"Slavin, Joanne/GOJ-9874-2022","Slavin, Joanne/0000-0003-0720-5300",,,,,118,51,59,1,62,SAGE PUBLICATIONS INC,THOUSAND OAKS,"2455 TELLER RD, THOUSAND OAKS, CA 91320 USA",0884-5336,1941-2452,,NUTR CLIN PRACT,Nutr. Clin. Pract.,OCT,2011,26,5,,,,,625,635,,10.1177/0884533611416126,http://dx.doi.org/10.1177/0884533611416126,,,11,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,824SQ,21947646,,,,2024-06-04,WOS:000295222800015,View Full Record in Web of Science
J,"Lee, AJ; Evans, CJ; Hau, CM; Fowkes, FGR",,,,"Lee, AJ; Evans, CJ; Hau, CM; Fowkes, FGR",,,"Fiber intake, constipation, and risk of varicose veins in the general population: Edinburgh Vein Study",JOURNAL OF CLINICAL EPIDEMIOLOGY,,,English,Article,,,,,,varicose veins; fiber intake; constipation; epidemiology,CHRONIC VENOUS INSUFFICIENCY; TRANSIT-TIME; EPIDEMIOLOGY; PREVALENCE; DEFECATION; DISEASE,"The purpose of the present study was to determine the relationship between fiber intake, constipation, and clinical venous disease in the general population The Edinburgh Vein Study was comprised of 1566 men and women aged 1864 years who were selected at random from the age-sex registers of 12 general practices. Fiber intake, intestinal transit time, defecation frequency and the prevalence of straining at stool were all found to be significantly different between the sexes. Men who reported that they strained to start passing a motion showed a higher prevalence of mild and severe trunk varices compared to men who did not strain. After adjustment for social class, BMI and mobility at work, this group of men showed a significantly elevated risk of having severe trunk varices (OR 2.76, 95% CI 1.16, 6.58). In contrast, no consistent relationships were seen among women. Overall, within this Western general population, an association between dietary fiber, constipation and the presence or severity of varicose veins was not supported. (C) 2001 Elsevier Science. All rights reserved.","Univ Edinburgh, Dept Publ Hlth Sci, Wolfson Unit Prevent Peripheral Vasc Dis, Edinburgh EH8 9AG, Midlothian, Scotland",University of Edinburgh,"Lee, AJ (corresponding author), Univ Edinburgh, Dept Publ Hlth Sci, Wolfson Unit Prevent Peripheral Vasc Dis, Teviot Pl, Edinburgh EH8 9AG, Midlothian, Scotland.",,"Lee, Andrew/GVU-2817-2022","Lee, Amanda/0000-0002-4865-9061",,,,,26,13,15,0,4,PERGAMON-ELSEVIER SCIENCE LTD,OXFORD,"THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND",0895-4356,,,J CLIN EPIDEMIOL,J. Clin. Epidemiol.,APR,2001,54,4,,,,,423,429,,10.1016/S0895-4356(00)00300-0,http://dx.doi.org/10.1016/S0895-4356(00)00300-0,,,7,"Health Care Sciences & Services; Public, Environmental & Occupational Health",Science Citation Index Expanded (SCI-EXPANDED),"Health Care Sciences & Services; Public, Environmental & Occupational Health",417KX,11297893,,,,2024-06-04,WOS:000167835100014,View Full Record in Web of Science
J,"Cong, L; Ma, JT; Jin, ZJ; Duan, LW; Su, WP; Zheng, J; Zhang, LJ; Xu, J; Li, DF",,,,"Cong, Liang; Ma, Jing-Ting; Jin, Zhen-Jing; Duan, Li-Wei; Su, Wei-Ping; Zheng, Jing; Zhang, Ling-Juan; Xu, Jia; Li, Dong-Fu",,,Efficacy and Safety of High Specific Volume Polysaccharide-A New Type of Dietary Fiber for Treatment of Functional Constipation and IBS-C,JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY,,,English,Article,,,,,,high specific volume polysaccharide; functional constipation; irritable bowel syndrome-constipation (IBS-C); constipation,WHEAT BRAN; TRANSIT,"We investigated the efficacy and safety of a new type of dietary fiber (high specific volume polysaccharide) for use in treating constipation of different etiologies. Functional constipation patients and irritable bowel syndrome-constipation (IBS-C) patients were administrated high specific volume polysaccharide (HSVP) three times daily for a period of 2 wk to relieve their symptoms. Scores on a stool form scale, and patient reports of straining during a bowel movement, having sensations of an incomplete bowel movement or a blocked anorectum, and abnormal defecation intervals were recorded, graded, and scored by a functional constipation sample group. Similarly, a cohort of IBS-C patients reported their occurrence of abdominal discomfort or pain, abnormal stool formation, defecation frequency, and straining during a bowel movement. Additionally, both groups reported any adverse reactions associated with taking HSVP. All patients in both groups returned for follow-up visits, and no adverse reactions to treatment with HSVP were reported. In the functional constipation group, HSVP was effective for treating symptoms of constipation in 81.46% and 93.17% of patients after 7 and 14 d of dosing, respectively (both p<0.05). In the IBS-C group, symptoms of constipation were relieved in 71.67% and 88.34% of patients after 7 and 14 d of dosing, respectively (both p<0.05). High specific volume polysaccharide was shown be effective for treatment of functional constipation and IBS-C, without causing significant adverse events.","[Cong, Liang; Ma, Jing-Ting; Jin, Zhen-Jing; Duan, Li-Wei; Zheng, Jing; Zhang, Ling-Juan; Xu, Jia; Li, Dong-Fu] Jilin Univ, Hosp 2, Digest Syst Dept, Changchun 130023, Jilin, Peoples R China; [Su, Wei-Ping] Chinese Acad Sci, Key Lab Polymer Ecomat, Changchun, Jilin, Peoples R China",Jilin University; Chinese Academy of Sciences,"Cong, L (corresponding author), Jilin Univ, Hosp 2, Digest Syst Dept, Changchun 130023, Jilin, Peoples R China.",jingjingcl1@163.com,"su, wei/GZM-3986-2022",,,,,,12,2,5,0,21,CENTER ACADEMIC PUBL JAPAN,TOKYO,"2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN",0301-4800,1881-7742,,J NUTR SCI VITAMINOL,J. Nutr. Sci. Vitaminol.,AUG,2015,61,4,,,,,326,331,,10.3177/jnsv.61.326,http://dx.doi.org/10.3177/jnsv.61.326,,,6,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,CQ3QU,26440640,gold,,,2024-06-04,WOS:000360518400007,View Full Record in Web of Science
J,"Edwards, CA; Xie, CR; Garcia, AL",,,,"Edwards, Christine A.; Xie, Chengru; Garcia, Ada L.",,,Dietary fibre and health in children and adolescents,PROCEEDINGS OF THE NUTRITION SOCIETY,,,English,Article; Proceedings Paper,Nutrition-Society Summer Meeting / Conference on Carbohydrates in Health - Friends or Foes / Plenary Lecture 4,"JUL 14-17, 2014","Univ Glasgow, Glasgow, SCOTLAND",Nutr Soc,Univ Glasgow,Dietary fibre; Children; Dietary recommendations; Dietary fibre intake,METABOLIC SYNDROME; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; AMSTERDAM GROWTH; YOUNG-CHILDREN; GLYCEMIC INDEX; BLOOD-PRESSURE; BODY-FAT; CONSTIPATION; DISEASE,"The role of dietary fibre in promoting sustained health has been studied for several decades and in adults there is good evidence that diets rich in high-fibre foods reduce the risk of chronic diseases, including CVD and cancer. Research in this area, however, has been hampered by uncertainties about the definition of dietary fibre which has resulted in many studies measuring fibre in different ways. There is also a wide range of properties and actions of different fibres in the human body, depending on their solubility, viscosity and fermentability by the colonic microbiota. This review considers the epidemiological evidence for dietary fibre and health in children and the current dietary recommendations and measured intakes in several countries using national surveys. In children and adolescents, there is a particular lack of relevant research on which to formulate appropriate dietary fibre recommendations and these are often based on extrapolation from adult data. However, children are not little adults and have differing physiology and nutritional needs as they grow. The dietary recommendations in different countries are based on varying premises and daily amounts. Intakes vary from country to country and on the whole do not meet recommendations. Much more research is needed in children to fully understand the impact of dietary fibre on growth and health in the young to allow more appropriate recommendations to be made.","[Edwards, Christine A.; Xie, Chengru; Garcia, Ada L.] Univ Glasgow, Coll Med Vet & Life Sci, Sch Med, Human Nutr, Glasgow, Lanark, Scotland",University of Glasgow,"Edwards, CA (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Sch Med, Human Nutr, Glasgow, Lanark, Scotland.",Christine.edwards@glasgow.ac.uk,"Garcia, Ada L/ACW-5470-2022; Edwards, christine/AGQ-4192-2022","Edwards, Christine/0000-0003-0406-918X; Garcia, Ada/0000-0002-3526-2380",,,,,81,33,36,3,58,CAMBRIDGE UNIV PRESS,CAMBRIDGE,"EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND",0029-6651,1475-2719,,P NUTR SOC,Proc. Nutr. Soc.,AUG,2015,74,3,,,,,292,302,,10.1017/S0029665115002335,http://dx.doi.org/10.1017/S0029665115002335,,,11,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Nutrition & Dietetics,CN2ZK,26186674,"Bronze, Green Accepted",,,2024-06-04,WOS:000358292000014,View Full Record in Web of Science
J,"EWE, K; UEBERSCHAER, B; PRESS, AG",,,,"EWE, K; UEBERSCHAER, B; PRESS, AG",,,"INFLUENCE OF SENNA, FIBER, AND FIBER PLUS SENNA ON COLONIC TRANSIT IN LOPERAMIDE-INDUCED CONSTIPATION",PHARMACOLOGY,,,English,Article,,,,,,SENNA; FIBER; COLONIC TRANSIT; CONSTIPATION,GASTROINTESTINAL TRANSIT; TIME; SENNOSIDES,"Retarded colonic transit and disturbed defecation are the most prominent pathophysiological mechanisms in constipation. Both may be influenced by bulking agents and by laxatives such as senna. Direct measurements of the influence of such substances on colonic transit are rare mainly because of technical problems. We measured gastric emptying, small and large intestinal transit in 24 healthy volunteers by a newly developed method employing a metal detector. Twelve persons taking a normal diet received loperamide in a dose sufficient to double the individual transit time. All subjects measured gastrointestinal transit time under normal conditions and with Sennatin containing purified sennosides 20 mg, Agiocur (30 g) as a fibre product containing 20 g Plantago ovata seeds/husks, or Agiolax (10 g) as a combination of 5.4 g P. ovata seeds/husks + 1.2 g senna pod with a sennoside content of 30 mg. Colonic transit was reduced by Sennatin and by Agiolax from 39 +/- 4 h to 17 +/- 3 h (p < 0.005). Agiocur did not influence colonic transit (39 +/- 3 h). Loperamide prolonged colonic transit from 27 +/- 0.7 to 72 +/- 12 h. This effect was abolished by Sennatin (30 +/- 5 h) and Agiolax (27 +/- 1 h) (p < 0.005), but not by Agiocur (64 +/- 13 h). The same effects were seen when right and left colonic transit were analyzed separately. Neither gastric emptying nor small intestinal transit were affected by either substance. All of the three study drugs increased stool weight significantly (p < 0.05). When stool frequency and consistency were compared, the effects were less clear. Agiolax caused the greatest, Agiocur the least changes of these parameters. Oroanal transit times measured by the metal detector and by the Hinton method using 20 radioopaque markers were similar (43 +/- 6 and 47 +/- 6 h, respectively). Sennosides alone as well as in combination with P. ovata seeds, but not fibre alone, shortened colonic transit time to half of the original value and abolished the effect of loperamide-induced constipation. The effect of bulking agents on colonic transit time is inferior to the efficacy of senna. The combination of both agents is not superior to sennosides alone at least under normal dietary conditions.",,,"JOHANNES GUTENBERG UNIV, MED KLIN & POLIKLIN 1, LANGENBECKSTR 1, D-55131 MAINZ, GERMANY.",,,,,,,,16,14,17,0,4,KARGER,BASEL,"ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND",0031-7012,1423-0313,,PHARMACOLOGY,Pharmacology,OCT,1993,47,,,1,,,242,248,,10.1159/000139864,http://dx.doi.org/10.1159/000139864,,,7,Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy,MC565,8234436,,,,2024-06-04,WOS:A1993MC56500032,View Full Record in Web of Science
J,"Mueller-Lissner, S",,,,"Mueller-Lissner, Stefan",,,The difficult patient with constipation,BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY,,,English,Article,,,,,,constipation; defaecation; colonic transit; laxatives; dietary fibre,IRRITABLE-BOWEL-SYNDROME; SLOW TRANSIT CONSTIPATION; IDIOPATHIC CONSTIPATION; COLONIC TRANSIT; DIETARY FIBER; TIME; BIOFEEDBACK; DISORDERS; DEFECOGRAPHY; METAANALYSIS,"Difficult patients with constipation mostly suffer for years, have consulted more than one physician and have had some experience with laxatives. The first step should be sorting out what exactly the patient's problem is. For this purpose technical investigations may be helpful, but the most important measures are a detailed history, symptom analysis and proctological examination. Rarely, an underlying and treatable cause of the constipation can be identified. In disordered defaecation this may be a large rectocele or an intussusception of the rectum amenable to proctosurgery. In most cases, however, some form of laxative treatment will be required. For this purpose, a detailed knowledge of their pharmacology is mandatory. The type of laxative and the schedule of administration often have to be determined on an individual basis over a number of weeks. In some patients, combination treatment with macrogol and a stimulant laxative may be the solution. Psychological features must also be taken into account in difficult patients, in particular if they ask for colectomy. Total colectomy with ileorectal anastomosis is an effective (although not universally successful) treatment of constipation, which is, however, hampered by a high rate of both early and late complications.","Humboldt Univ, Dept Internal Med, Park Klin Weissensee, D-13086 Berlin, Germany",Humboldt University of Berlin,"Mueller-Lissner, S (corresponding author), Humboldt Univ, Dept Internal Med, Park Klin Weissensee, Schoenstr 80, D-13086 Berlin, Germany.",mueli@park-klinik.com,,,,,,,40,6,6,0,0,ELSEVIER SCI LTD,OXFORD,"THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND",1521-6918,1532-1916,,BEST PRACT RES CL GA,Best Pract. Res. Clin. Gastroenterol.,,2007,21,3,,,,,473,484,,10.1016/j.bpg.2007.01.008,http://dx.doi.org/10.1016/j.bpg.2007.01.008,,,12,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,181UR,17544112,,,,2024-06-04,WOS:000247462100009,View Full Record in Web of Science
J,"Wu, L; Tang, CH; Chen, LL; Zhao, JY",,,,"Wu, Li; Tang, Chunhong; Chen, Linli; Zhao, Jiuyi",,,Modified dietary fiber from soybean dregs by fermentation alleviated constipation in mice,FOOD CHEMISTRY-X,,,English,Article,,,,,,Soybean; Dietary fiber; Intestinal flora; Physicochemical properties,PHYSICOCHEMICAL PROPERTIES; HEALTH-BENEFITS; GUT MICROBIOTA; PRODUCTS; CANCER; IMPACT; OKARA; RISK,"Soybean dregs are the main by-product obtained from the processing of soy products and are good sources of dietary fiber (DF). This study showed that the soluble DF content increased from 4.97% to 18.82%, while the insoluble DF content decreased from 59.37% to 44.89% after soybean dreg fermentation using Trichoderma spp., without any significant change in the total DF content (p > 0.05). Physicochemical property and electron microscopy analysis revealed that the rehydration ratio, dissolution rate, expansion force, and oil holding capacity of DF significantly increased (p < 0.05) with finer microstructure. Additionally, we found that fermented DF could further promote intestinal peristalsis in mice. Furthermore, fermented DF was more effective in balancing and adjusting intestinal flora in mice and promoting the production of short-chain fatty acids. Therefore, this study provides evidence indicating a correlation between the physicochemical properties and functional benefits of DF derived from soybean dregs.","[Wu, Li; Tang, Chunhong; Chen, Linli; Zhao, Jiuyi] Chongqing Technol & Business Univ, Coll Environm & Resources, Chongqing 400067, Peoples R China",Chongqing Technology & Business University,"Wu, L (corresponding author), Chongqing Technol & Business Univ, Coll Environm & Resources, Chongqing 400067, Peoples R China.",wulili1228@163.com,,"Wu, Li/0000-0002-4374-5892",Natural Sci-ence Foundation of Chongqing City [cstc2017shmsA80001],Natural Sci-ence Foundation of Chongqing City(Natural Science Foundation of Chongqing),This work was supported by the funds provided by the Natural Sci-ence Foundation of Chongqing City (Grant No. cstc2017shmsA80001) . We would like to thank Editage ( www.editage.cn) for English lan-guage editing.,,42,3,3,19,30,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",2590-1575,,,FOOD CHEM X,Food Chem. X,OCT 30,2023,19,,,,,,,,100810,10.1016/j.fochx.2023.100810,http://dx.doi.org/10.1016/j.fochx.2023.100810,,AUG 2023,9,"Chemistry, Applied; Food Science & Technology",Science Citation Index Expanded (SCI-EXPANDED),Chemistry; Food Science & Technology,W6WE4,37780347,"gold, Green Published",,,2024-06-04,WOS:001093003800001,View Full Record in Web of Science
J,"Ceresola, ER; Ferrarese, R; Preti, A; Canducci, F",,,,"Ceresola, E. R.; Ferrarese, R.; Preti, A.; Canducci, F.",,,Targeting patients' microbiota with probiotics and natural fibers in adults and children with constipation,EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES,,,English,Article,,,,,,Microbiota; Probiotics; Natural fibers; Constipation,FUNCTIONAL GASTROINTESTINAL SYMPTOMS; INTERNATIONAL SCIENTIFIC ASSOCIATION; RANDOMIZED CLINICAL-TRIAL; DOUBLE-BLIND; DIETARY FIBER; FERMENTED MILK; CONSENSUS STATEMENT; METHANOGENIC FLORA; HEALTHY-VOLUNTEERS; GUT MICROBIOME,"OBJECTIVE: Functional constipation (FC) is a common condition in which the gut microbiota composition plays a fundamental role. The increasing knowledge on the role of gut microbes in the regulation of gut motility and stool consistency has allowed reconsidering, with a new scientific-based approach, the possibility to target the composition of intestinal bacterial populations for FC treatment. In this review, we evaluate recent attempts that used prebiotics, natural fibers or probiotics to treat FC, with a deep microbiome-based focus. MATERIALS AND METHODS: This is a literature review of articles published in Medline, Web of Science, and the Cochrane Library. Studies on FC in adults and children were identified using the following terms: constipation AND probiotics OR prebiotics OR synbiotics PR fibers OR microbiome OR microbiota. Selected animal studies were also considered if showing mechanistic observations. RESULTS: FC is associated with alteration in microbiome composition. Motility and fecal consistency are affected with different efficacy by the type of fiber, prebiotic or probiotic strain used in patients. CONCLUSIONS: Selected bacterial strains, mainly belonging to the Bifidobacterium genus, and some poorly or non-fermented natural fibers, such as Psyllium, may significantly improve FC and may represent the basis for an effective supplementation.","[Ceresola, E. R.; Preti, A.; Canducci, F.] Univ Insubria, Microbiol Unit, Varese, Italy; [Ferrarese, R.] Univ Vita Salute San Raffaele, Microbiol Unit, Milan, Italy; [Canducci, F.] Osped San Raffaele, Microbiol Unit, Milan, Italy",University of Insubria; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele,"Canducci, F (corresponding author), Univ Insubria, Microbiol Unit, Varese, Italy.;Canducci, F (corresponding author), Osped San Raffaele, Microbiol Unit, Milan, Italy.",canducci.filippo@gmail.com,"Ferrarese, Roberto/AAC-2671-2022","Ferrarese, Roberto/0000-0002-8232-5786",Italian Ministry of University and Research; Italian Ministry of Health [GR-2011-02347170],"Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health(Ministry of Health, Italy)",This study was partially funded by the Italian Ministry of University and Research and by the Italian Ministry of Health (grant GR-2011-02347170).,,85,19,20,2,25,VERDUCI PUBLISHER,ROME,"VIA GREGORIO VII, ROME, 186-00165, ITALY",1128-3602,,,EUR REV MED PHARMACO,Eur. Rev. Med. Pharmacol. Sci.,OCT,2018,22,20,,,,,7045,7057,,,,,,13,Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy,GZ5XR,30402873,,,,2024-06-04,WOS:000449504500047,View Full Record in Web of Science
J,"Byun, YJ; Han, DS; Lee, YH; Ro, Y; Kim, SM; Kim, TY; Eun, CS; Yoo, KS; Jeon, YC; Sohn, JH",,,,"Byun, Young Jae; Han, Dong Soo; Lee, Yu Hwa; Ro, Youngouk; Kim, Sun Min; Kim, Tae Yeob; Eun, Chang Soo; Yoo, Kyo-Sang; Jeon, Yong Cheol; Sohn, Joo Hyun",,,Association between functional constipation and intake of dietary fiber: A population-based study,JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,,,English,Meeting Abstract,,,,,,Constipation; Dietary fiber; Overactive bladder; Cohort study,,,"[Byun, Young Jae; Han, Dong Soo; Lee, Yu Hwa; Ro, Youngouk; Kim, Sun Min; Kim, Tae Yeob; Eun, Chang Soo; Yoo, Kyo-Sang; Jeon, Yong Cheol; Sohn, Joo Hyun] Hanyang Univ, Guri Hosp, Seoul, South Korea",Hanyang University,,,"Han, Dong Soo/P-1753-2015; Han, Dong Soo/AHD-6285-2022","Han, Dong Soo/0000-0001-7103-3318",,,,,0,0,0,1,9,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0815-9319,1440-1746,,J GASTROEN HEPATOL,J. Gastroenterol. Hepatol.,OCT,2013,28,,,3,,,348,348,,,,,,1,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,226ER,,,,,2024-06-04,WOS:000325017802266,View Full Record in Web of Science
J,"Grosse, CS; Cope, VC",,,,"Grosse, C. S.; Cope, V. C.",,,Dietary Fibre Intake and Bowel Habits After Bariatric Surgery: a Structured Literature Review,OBESITY SURGERY,,,English,Review,,,,,,Bariatric surgery; Dietary fibre; Bowel habits; Constipation; Diarrhoea,GASTRIC BYPASS; SLEEVE GASTRECTOMY; OBESITY; WEIGHT; WOMEN,"Background Bariatric patients regularly present with insufficient dietary fibre intake. Adequate dietary fibre is essential for gut function and laxation. This review aims to assess the effect of bariatric surgery on dietary fibre intake and bowel habits. Methods This review was conducted using the methodology described by Kable et al. (Nurse Educ Today 8:878-886, 2012) for structured literature reviews. Results Post-surgery, patients consume inadequate dietary fibre when compared to recommendations for healthy populations. Food intolerance to fibre-rich foods, food restriction and discomfort with eating are possible causes. Bowel habit changes are likely to be procedure-specific. Only one study has assessed both dietary fibre intake and bowel habits. Conclusion Understanding changes in dietary fibre types and bowel habits will be useful to address future dietary interventions.","[Grosse, C. S.; Cope, V. C.] Murdoch Univ, Sch Hlth Profess, Perth, WA, Australia",Murdoch University,"Cope, VC (corresponding author), Murdoch Univ, Sch Hlth Profess, Perth, WA, Australia.",Charlene.Grosse@sjog.org.au; v.cope@murdoch.edu.au,,"Cope, Vicki/0000-0002-4528-4268",,,,,22,8,9,9,41,SPRINGER,NEW YORK,"233 SPRING ST, NEW YORK, NY 10013 USA",0960-8923,1708-0428,,OBES SURG,Obes. Surg.,JUL,2019,29,7,,,,,2247,2254,,10.1007/s11695-019-03837-0,http://dx.doi.org/10.1007/s11695-019-03837-0,,,8,Surgery,Science Citation Index Expanded (SCI-EXPANDED),Surgery,IA7WA,30903429,,,,2024-06-04,WOS:000469767700031,View Full Record in Web of Science
J,"Kuczynska, B; Bobkiewicz, A; Studniarek, A; Szmyt, K; Krokowicz, L; Matysiak, K; Szmeja, J; Walkowiak, J; Drews, M; Banasiewicz, T",,,,"Kuczynska, Barbara; Bobkiewicz, Adam; Studniarek, Adam; Szmyt, Krzsztof; Krokowicz, Lukasz; Matysiak, Konrad; Szmeja, Jacek; Walkowiak, Jaroslaw; Drews, Michal; Banasiewicz, Tomasz",,,Conservative Measures for Managing Constipation in Patients Living With a Colostomy,JOURNAL OF WOUND OSTOMY AND CONTINENCE NURSING,,,English,Article,,,,,,Chronic constipation; Colostomy; Diet; Fiber; Ostomy; Stoma,FUNCTIONAL GASTROINTESTINAL DISORDERS; DIETARY FIBER; FLUID INTAKE; EPIDEMIOLOGY; ASSOCIATION,"PURPOSE: The purpose of this study was to determine the effect of a conservative regimen for the treatment of constipation in persons living with a colostomy. DESIGN: Prospective, noncontrolled, single-center study. SUBJECTS AND SETTING: The study sample comprised 35 patients with a colostomy who were diagnosed with constipation. Subjects with morphologic changes causing constipation such as stomal stenosis and neoplastic and inflammatory changes were excluded. The study was conducted in the Proctology and Stoma Outpatient Clinic at Poznan University of Medical Sciences. METHODS: Patients at our Stoma Outpatient Clinic underwent baseline evaluation, and those with symptoms of constipation (prolonged periods between bowel movements, passage of pasty or hardened fecal effluent, and associated symptoms such as abdominal discomfort or bloating, flatulence, and pain with passage of effluent into the stoma) received individualized dietary recommendations that typically included an increase in dietary fiber and fluid intake, along with increased fluid intake. The outcomes of dietary changes were evaluated during a follow-up visit 3 months later. If dietary changes alone did not improve constipation symptoms, we prescribed a psyllium-based bulk-forming agent, an osmotic stool softener, and a probiotic, with or without a prokinetic agent such as metoclopramide taken 3 times daily. RESULTS: Dietary interventions alone were deemed successful in 60% of study subjects (n = 21); the remaining 14 patients required additional treatment. CONCLUSIONS: Dietary modifications alone relieved constipation in more than half of a group of 35 patients with constipation. We therefore recommend a trial of dietary modifications prior to the initiation of pharmacotherapy in patients with a colostomy.","[Kuczynska, Barbara; Bobkiewicz, Adam; Studniarek, Adam; Szmyt, Krzsztof; Krokowicz, Lukasz; Matysiak, Konrad; Szmeja, Jacek; Drews, Michal; Banasiewicz, Tomasz] Poznan Univ Med Sci, Dept Gen Endocrinol Surg & Gastroenterol Oncol, Przybyszewskiego 49, PL-60355 Poznan, Poland; [Kuczynska, Barbara; Matysiak, Konrad] Poznan Univ Med Sci, Ctr Intestinal Failure, Poznan, Poland; [Walkowiak, Jaroslaw] Poznan Univ Med Sci, Dept Pediat Gastroenterol & Metab Dis, Poznan, Poland",Poznan University of Medical Sciences; Poznan University of Medical Sciences; Poznan University of Medical Sciences,"Kuczynska, B (corresponding author), Poznan Univ Med Sci, Dept Gen Endocrinol Surg & Gastroenterol Oncol, Przybyszewskiego 49, PL-60355 Poznan, Poland.",barbarakuczynskaa@gmail.com,,"Matysiak, Konrad/0000-0001-6040-5112; Bobkiewicz, Adam/0000-0002-4657-5788; Walkowiak, Jaroslaw/0000-0001-5813-5707",,,,,27,4,4,0,5,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",1071-5754,1528-3976,,J WOUND OSTOMY CONT,J. Wound Ostomy Cont. Nurs.,MAR-APR,2017,44,2,,,,,160,164,,10.1097/WON.0000000000000318,http://dx.doi.org/10.1097/WON.0000000000000318,,,5,Nursing,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Nursing,EN3ZE,28267123,,,,2024-06-04,WOS:000395945800011,View Full Record in Web of Science
J,"Haz, YM; Dos Santos, R; Márquez, JL; Cuevas, ZO",,,,"Michelle Haz, Yanine; Dos Santos, Rosanna; Leonardo Marquez, Juan; Ostojich Cuevas, Zoitza",,,Elaboration of bread with prebiotics and its effect on the gastrointestinal transit in person with constipation,MEDULA,,,Spanish,Article,,,,,,Prebiotics; constipation; bread; dietary fiber,,"The aim of this study was to create bread with prebiotics (Inulin and FOS), analyze its proximate composition, evaluate its acceptance through sensorial affective tests, and evaluate its effect on the gastrointestinal transit in constipated people. In order to do this, a daily 50 g portion of bread was given for 21 days to 17 people diagnosed with constipation and without pharmacological treatment. Additionally, data were collected about their eating, physical activity and water intake habits. It was found that most of them ingest less than 20 g Fiber per day and 7 glasses of water/day, as well as doing little physical activity, habits that could favor the constipation. At the end of the study, there was an increase in the participant's evacuation frequency (to 11-14 times per week), a decrease in pain when evacuating, and in the incomplete evacuation sensation and in evacuation with blood in the participants who presented these symptoms. From the proximate analysis it was found that contribution of total dietary fiber (6.02g) in a bread portion contributes to the 20% of the Daily Intake Recommendations of this nutrient. Affective tests results show bread has a 90% of acceptability and a global liking in the Like category.","[Michelle Haz, Yanine; Dos Santos, Rosanna; Leonardo Marquez, Juan; Ostojich Cuevas, Zoitza] Univ Los Andes, Fac Med, Escuela Nutr & Dietet, Dept Nutr & Alimentac, Merida, Venezuela",University of Los Andes Venezuela,"Márquez, JL (corresponding author), Fac Med, Av Don Tulio Febres Cordero,Edif Sede Sur Piso 1, Merida, Venezuela.",marquez_juanleo@yahoo.com; zoitzaula@gmail.com,,,,,,,33,0,0,1,2,UNIV LOS ANDES,MERIDA,"AP POSTAL 870, MERIDA, 5101-A, VENEZUELA",0798-3166,,,MEDULA,MedULA,JUL-DEC,2019,28,2,,,,,,,,,,,,9,"Medicine, General & Internal",Emerging Sources Citation Index (ESCI),General & Internal Medicine,JX7AK,,,,,2024-06-04,WOS:000503882900004,View Full Record in Web of Science
J,"Merenkova, SP; Zinina, OV; Stuart, M; Okuskhanova, EK; Androsova, NV",,,,"Merenkova, S. P.; Zinina, O. V.; Stuart, M.; Okuskhanova, E. K.; Androsova, N. V.",,,EFFECTS OF DIETARY FIBER ON HUMAN HEALTH: A REVIEW,HUMAN SPORT MEDICINE,,,English,Review,,,,,,dietary fiber; terminology; classification; essential components of nutrition; physiological effects,GLYCEMIC RESPONSE; IMPACT; PROSTATE; CANCER; GUT,"The aim of this article is to review literature data on the terminology, classification and physiological effects of dietary fibers. Results. The scientific studies on the terminology, classification and characteristics of various types of dietary fiber are presented, the sources of dietary fiber and their positive physiological effects are described. Nowadays no consensus definition has been given to the concept of dietary fibers. The authors point to dietary fibers being related to chemical compounds defined by structure, or functional properties, and/or a combination of both structural and functional properties. The authors noted one commonality in these definitions: each mentioned positive physiological effects. The modern classification system for dietary fibers is wide and diverse and can be based on origin, structure of polymers, solubility, ion exchange, sorption or physiological effect. Many studies have shown that dietary fibers can promote human health and help prevent specific chronic diseases that increase mortality and reduce life expectancy. Numerous healthful effects of the dietary fibers have been documented. These include curative and preventive effects for diseases such as obesity, certain types of cancers, cardiovascular diseases, diabetes, and constipation. Conclusion. Fibers are considered before other nutrients to ensure a healthy nutrition. Research continues to contribute new data on the effect of dietary fiber on the human body.","[Merenkova, S. P.; Zinina, O. V.; Androsova, N. V.] South Ural State Univ, Chelyabinsk, Russia; [Stuart, M.] Canadian Nucl Labs, Chalk River, ON, Canada; [Okuskhanova, E. K.] Shakarim State Univ Semey, Semey, Kazakhstan",South Ural State University; Atomic Energy of Canada Limited; Semey State University Shakarim,"Merenkova, SP (corresponding author), South Ural State Univ, Chelyabinsk, Russia.",merenkovasp@susu.ru; zininaov@susu.ru; marilyne.stuart@cnl.ca; eleonora-okushan@mail.ru; androsovanv@susu.ru,"Zinina, Oksana/ABC-2220-2021; Merenkova, Svetlana/AAL-1863-2021; Zinina, Oksana Vladimirovna/E-8618-2018; Androsova, Natasha/ABA-7257-2021","Merenkova, Svetlana/0000-0002-8795-1065; Zinina, Oksana/0000-0003-4817-1645; Zinina, Oksana/0000-0003-3729-1692",Act 211 Government of the Russian Federation [A03.21.0011],Act 211 Government of the Russian Federation,"The work was supported by Act 211 Government of the Russian Federation, contract. 02.A03.21.0011.",,48,13,15,14,69,"SOUTH URAL STATE UNIV, SCIENTIFIC RESEARCH DEPT",CHELYABINSK,"76, LENIN PROSPECT, CHELYABINSK, 454080, RUSSIA",2500-0209,2500-0195,,HUM SPORT MED,Hum. Sport Med.,,2020,20,1,,,,,106,113,,10.14529/hsm200113,http://dx.doi.org/10.14529/hsm200113,,,8,Sport Sciences,Emerging Sources Citation Index (ESCI),Sport Sciences,MC4WE,,gold,,,2024-06-04,WOS:000543288300001,View Full Record in Web of Science
J,"Ng, HM; Maggo, J; Wall, C; Bayer, S; Roy, NC; Gearry, R",,,,"Ng, H. M.; Maggo, J.; Wall, C.; Bayer, S.; Roy, N. C.; Gearry, R.",,,Dietary fibre intakes of two cohorts of New Zealand adults with and without constipation,PROCEEDINGS OF THE NUTRITION SOCIETY,,,English,Meeting Abstract,,,,,,dietary fibre intake; New Zealand; adults; constipation,,,"[Ng, H. M.; Maggo, J.; Wall, C.; Bayer, S.; Gearry, R.] Univ Otago, Dept Med, Christchurch 8011, New Zealand; [Roy, N. C.] Univ Otago, Dept Human Nutr, Dunedin 9016, New Zealand; [Roy, N. C.] Massey Univ, Riddet Inst, Palmerston North 4410, New Zealand",University of Otago; University of Otago; Massey University,"Ng, HM (corresponding author), Univ Otago, Dept Med, Christchurch 8011, New Zealand.",,,,"High-Value Nutrition National Science Challenge - NewZealand Ministry of Business, Innovation and Employment (MBIE) [UOAX1902]","High-Value Nutrition National Science Challenge - NewZealand Ministry of Business, Innovation and Employment (MBIE)","Funding from the BREAD study had come from the High-Value Nutrition National Science Challenge, which was funded by the NewZealand Ministry of Business, Innovation and Employment (MBIE), contract number (UOAX1902). Goodman Fielder providedapproximately 10 percent of cash co-funding and in-kind contributions. For the KINGS study, funding had also come from the High-Value Nutrition National Science Challenge; and Zespri International Ltd.",,2,0,0,0,0,CAMBRIDGE UNIV PRESS,CAMBRIDGE,"EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND",0029-6651,1475-2719,,P NUTR SOC,Proc. Nutr. Soc.,APR,2024,83,OCE1,,,SI,,,,E72,10.1017/S0029665124000909,http://dx.doi.org/10.1017/S0029665124000909,,,1,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,PP1Q8,,hybrid,,,2024-06-04,WOS:001215194800196,View Full Record in Web of Science
J,"Bellini, M; Tonarelli, S; Barracca, F; Rettura, F; Pancetti, A; Ceccarelli, L; Ricchiuti, A; Costa, F; de Bortoli, N; Marchi, S; Rossi, A",,,,"Bellini, Massimo; Tonarelli, Sara; Barracca, Federico; Rettura, Francesco; Pancetti, Andrea; Ceccarelli, Linda; Ricchiuti, Angelo; Costa, Francesco; de Bortoli, Nicola; Marchi, Santino; Rossi, Alessandra",,,Chronic Constipation: Is a Nutritional Approach Reasonable?,NUTRIENTS,,,English,Review,,,,,,chronic constipation; food; fiber; water; diet; nutrition,IRRITABLE-BOWEL-SYNDROME; PLACEBO-CONTROLLED TRIAL; FICUS-CARICA PASTE; DIETARY FIBER; MINERAL-WATER; DOUBLE-BLIND; FUNCTIONAL CONSTIPATION; FERMENTED MILK; FATTY-ACIDS; MANAGEMENT,"Chronic constipation (CC) is one of the most common gastroenterological diagnoses in clinical practice. Treatment includes several steps, depending on the severity of symptoms. Lifestyle modifications and increased intake of fiber and water are suggested by most health professionals. Unfortunately, the recommendations in this regard are the most varied, often conflicting with each other and not always based on solid scientific arguments. This paper aims to clarify this topic by providing practical indications for the management of these patients in every day clinical practice. The literature available on this topic is scarce, and dietary studies have important methodological biases. However, fiber, mainly by binding water and acting as bulking agents and/or as prebiotics for the intestinal microbiota, and mineral water, especially if rich in magnesium and/or bicarbonate, are useful tools. An adequate, well-designed diet should be a cornerstone of any effective treatment for chronic constipation. High-quality studies on larger samples are mandatory to give scientific validity to the role of the food in CC therapy and to enable professionals to choose the best approach for their patients, combining nutritional and pharmacological agents.","[Bellini, Massimo; Tonarelli, Sara; Barracca, Federico; Rettura, Francesco; Pancetti, Andrea; Ceccarelli, Linda; Ricchiuti, Angelo; Costa, Francesco; de Bortoli, Nicola; Marchi, Santino] Univ Pisa, Dept Translat Sci & New Technol Med & Surg, Gastrointestinal Unit, I-56124 Pisa, Italy; [Rossi, Alessandra] Univ Pisa, Clin & Expt Med Rheumatol Unit, I-56100 Pisa, Italy",University of Pisa; University of Pisa,"Tonarelli, S (corresponding author), Univ Pisa, Dept Translat Sci & New Technol Med & Surg, Gastrointestinal Unit, I-56124 Pisa, Italy.",massimo.bellini@med.unipi.it; satonarelli@gmail.com; barracca.federico@gmail.com; rettura.fra@gmail.com; pancio10@alice.it; l.ceccarelli@ao-pisa.toscana.it; a.ricchiuti@int.med.unipi.it; fcosta@med.unipi.it; nicola.debortoli@unipi.it; santino.marchi@unipi.it; alessandra.rossi@unipi.it,,"Tonarelli, Sara/0000-0002-2010-4304; DE BORTOLI, NICOLA/0000-0003-1995-1060; bellini, massimo/0000-0002-6387-6443; Rettura, Francesco/0000-0003-3455-1794",,,,,71,16,17,0,10,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,OCT,2021,13,10,,,,,,,3386,10.3390/nu13103386,http://dx.doi.org/10.3390/nu13103386,,,13,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,XI8KY,34684388,"Green Published, gold",,,2024-06-04,WOS:000726354400001,View Full Record in Web of Science
J,"Santucci, NR; Chogle, A; Leiby, A; Mascarenhas, M; Borlack, RE; Lee, A; Perez, M; Russell, A; Yeh, AM",,,,"Santucci, Neha R.; Chogle, Ashish; Leiby, Alycia; Mascarenhas, Maria; Borlack, Rachel E.; Lee, Amanda; Perez, Maria; Russell, Alexandra; Yeh, Ann Ming",,,Non-pharmacologic approach to pediatric constipation,COMPLEMENTARY THERAPIES IN MEDICINE,,,English,Article,,,,,,Functional constipation; Treatment; Integrative medicine; Fiber,TRANSABDOMINAL ELECTRICAL-STIMULATION; SLOW-TRANSIT CONSTIPATION; RANDOMIZED CLINICAL-TRIAL; FUNCTIONAL CONSTIPATION; DOUBLE-BLIND; BIOFEEDBACK THERAPY; DIETARY FIBER; CHILDHOOD CONSTIPATION; POLYETHYLENE-GLYCOL; CASSIA-FISTULA,"Functional constipation (FC) is a pervasive problem in pediatrics. Although pharmaceuticals are commonly used for FC, parents and patients show reluctance or find dissatisfaction with available medications at times. Further, patients often have interest in utilizing nutraceutical supplements and botanicals that are available over the counter. This literature review aims to summarize research studies performed on non-pharmacologic approaches to constipation and to evaluate the safety and efficacy of these modalities. Overall data on non-pharmacologic treatments for childhood constipation were sparse, and though some studies were available for adult populations, pediatrics studies were generally limited, lacking or flawed. Certain supplements, such as prebiotics, probiotics and fiber, are safe and are without significant side effects. Though fiber supplements such as glucomannan, green banana mass, cocao husk and various fiber blends have emerging evidence in children, evidence for psyllium, cellulose and flaxseed only have supportive studies in adults. Other than senna, studies of botanicals indicate significant safety concerns (in particular with Aloe vera with aloin and Cascara sagrada) and insufficient evidence. For patients with a significant behavioral or anxiety component to their FC and exhibit dyssynergia, mind-body interventions (e.g. diaphragmatic breathing, biofeedback, cognitive behavioral therapy, and behavioral modifications) are certainly safe and effective. Finally, movement and manipulative interventions such as abdominal massage, reflexology, acupuncture and transcutaneous nerve stimulation show promise in the field of pediatric constipation, and data is accumulating for efficacy. These modalities require further study to determine mechanisms of action and which populations may benefit the most from these therapies.","[Santucci, Neha R.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati Childrens Hosp Med Ctr,Div Gastroenter, Cincinnati, OH 45221 USA; [Chogle, Ashish] Childrens Hosp Orange Cty, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Orange, CA 92668 USA; [Mascarenhas, Maria] Childrens Hosp Philadelphia, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; [Leiby, Alycia; Perez, Maria] Thomas Jefferson Univ, Div Gastroenterol Hepatol & Nutr, Goryeb Childrens Hosp, Atlantic Hlth Syst,Dept Pediat,Sidney Kimmel Med, Philadelphia, PA 19107 USA; [Borlack, Rachel E.] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Div Gastroenterol & Nutr, Buffalo, NY USA; [Lee, Amanda] Oregon Hlth & Sci Univ, Div Gastroenterol Hepatol & Nutr, Dept Pediat, Portland, OR 97201 USA; [Russell, Alexandra] Vanderbilt Univ, Sch Med, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37212 USA; [Yeh, Ann Ming] Stanford Univ, Sch Med, Div Gastroenterol Hepatol & Nutr, Dept Pediat, 730 Welch Rd,Suite 116, Palo Alto, CA 94304 USA",Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Childrens Hospital of Orange County; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Jefferson University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Oregon Health & Science University; Vanderbilt University; Stanford University,"Yeh, AM (corresponding author), Stanford Univ, Sch Med, Div Gastroenterol Hepatol & Nutr, Dept Pediat, 730 Welch Rd,Suite 116, Palo Alto, CA 94304 USA.",Annming@stanford.edu,,"Chogle, Ashish/0000-0001-9028-0584; Santucci, Neha/0000-0002-0896-079X; Yeh, Ann Ming/0000-0003-2293-6849; Leiby, Alycia/0000-0003-3402-1523",,,,,135,7,9,0,20,CHURCHILL LIVINGSTONE,EDINBURGH,"JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND",0965-2299,1873-6963,,COMPLEMENT THER MED,Complement. Ther. Med.,JUN,2021,59,,,,,,,,102711,10.1016/j.ctim.2021.102711,http://dx.doi.org/10.1016/j.ctim.2021.102711,,,10,Integrative & Complementary Medicine,Science Citation Index Expanded (SCI-EXPANDED),Integrative & Complementary Medicine,SR7YT,33737146,gold,,,2024-06-04,WOS:000661263100001,View Full Record in Web of Science
J,"Chowdhury, K; Sinha, S; Kumar, S; Haque, M; Ahmad, R",,,,"Chowdhury, Kona; Sinha, Susmita; Kumar, Santosh; Haque, Mainul; Ahmad, Rahnuma",,,Constipation: A Pristine Universal Pediatric Health Delinquent,CUREUS JOURNAL OF MEDICAL SCIENCE,,,English,Review,,,,,,fast food; fruits; low intake; consumption; issue; public health; global; dietary fiber; constipation; childhood,FUNCTIONAL GASTROINTESTINAL DISORDERS; QUALITY-OF-LIFE; FAST-FOOD CONSUMPTION; DIETARY FIBER INTAKE; PHYSICAL-ACTIVITY; CHILDHOOD CONSTIPATION; MANAGE CONSTIPATION; CONTROLLED-TRIAL; DOUBLE-BLIND; RISK-FACTORS,"Constipation suffered by children is a global public health problem. Functional constipation (FC) brings about deteriorating effects in the children's lives who suffer from it. The risk factors for the development of constipation include the consumption of a diet low in fiber and high in calories (such as the consumption of fast food), a sedentary lifestyle with a lack of exercise, a family history of constipation, and emotional and psychological stress endured by children in their families. It is one of the most common causes of stomachaches in children. FC may lead to fecal incontinence (FI), anal fissures, recurrent urinary tract infections (RUTI), and enuresis in children. Severe constipation may result in stool becoming rock-hard and inflexible in the rectum, which is clinically identified as fecal impaction. It is imperative to perform clinical evaluation and treatment, including pharmacological (the use of stimulant and osmotic laxatives) and non-pharmacological (education, changes in diet, intervention to promote positive behavior and address any emotional issues, toilet training, and physiotherapy for the pelvic floor) interventions. In the case of refractory patients, neuromodulation, the irrigation of the anal canal, and surgical management may be needed. It is essential to lead a healthy, stress-free lifestyle with plenty of exercise and a balanced diet rich in fiber (such as fruits and vegetables) so children can have regular bowel habits and thrive.","[Chowdhury, Kona] Gonoshasthaya Samaj Vittik Med Coll, Dept Pediat, Dhaka, Bangladesh; [Sinha, Susmita] Khulna City Med Coll & Hosp, Dept Physiol, Khulna, Bangladesh; [Kumar, Santosh] Karnavati Univ, Karnavati Sch Dent, Dept Periodontol & Implantol, Gandhinagar, India; [Haque, Mainul] Karnavati Univ, Karnavati Sci Res Ctr KSRC, Karnavati Sch Dent, Gandhinagar, India; [Haque, Mainul] Natl Def Univ Malaysia, Dept Pharmacol & Therapeut, Kuala Lumpur, Malaysia; [Ahmad, Rahnuma] Med Coll Women & Hosp, Dept Physiol, Dhaka, Bangladesh",Universiti Pertahanan Nasional Malaysia,"Haque, M (corresponding author), Karnavati Univ, Karnavati Sci Res Ctr KSRC, Karnavati Sch Dent, Gandhinagar, India.;Haque, M (corresponding author), Natl Def Univ Malaysia, Dept Pharmacol & Therapeut, Kuala Lumpur, Malaysia.",runurono@gmail.com,"Haque, Mainul/ABG-2866-2020; Ahmad, Rahnuma/ABB-3336-2021","Haque, Mainul/0000-0002-6124-7993; Ahmad, Rahnuma/0000-0001-7379-0822",,,,,182,0,0,0,0,SPRINGERNATURE,LONDON,"CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND",,2168-8184,,CUREUS J MED SCIENCE,Cureus J Med Sci,JAN 19,2024,16,1,,,,,,,e52551,10.7759/cureus.52551,http://dx.doi.org/10.7759/cureus.52551,,,16,"Medicine, General & Internal",Emerging Sources Citation Index (ESCI),General & Internal Medicine,GX7Y2,38249647,gold,,,2024-06-04,WOS:001156049800013,View Full Record in Web of Science
J,"Ding, C; Ge, XL; Zhang, XY; Tian, HL; Wang, HK; Gu, LL; Gong, JF; Zhu, WM; Li, N",,,,"Ding, Chao; Ge, Xiaolong; Zhang, Xueying; Tian, Hongliang; Wang, Hongkan; Gu, Lili; Gong, Jianfeng; Zhu, Weiming; Li, Ning",,,Efficacy of Synbiotics in Patients with Slow Transit Constipation: A Prospective Randomized Trial,NUTRIENTS,,,English,Article,,,,,,synbiotic; soluble dietary fiber; slow transit constipation; microbiota,CHRONIC IDIOPATHIC CONSTIPATION; FUNCTIONAL GASTROINTESTINAL DISORDERS; CHAIN FATTY-ACIDS; DIETARY FIBER; COLONIC TRANSIT; CLINICAL-RESPONSE; METAANALYSIS; PRUCALOPRIDE; MANAGEMENT; MICROBIOTA,"Synbiotic intake may efficiently restore the balance of gut microbiota and improve gastrointestinal functions. The aim of the study was to evaluate the efficacy of a synbiotic in patients with slow transit constipation. A total of 100 patients with slow transit constipation were randomized to receive either a synbiotic or placebo twice daily for 12 weeks. The primary efficacy endpoints were the clinical remission and improvement rates at weeks 4 and 12. Stool frequency and consistency, colonic transit time (CTT), evacuation and abdominal symptoms, patient assessment of constipation symptoms, gastrointestinal quality-of-life index scores, satisfaction scores, and adverse events were also monitored. The clinical remission rates reached 37.5% at week 4 and 45.8% at week 12 in the treatment group, compared to 13.3% at week 4 and 16.7% at week 12 in the placebo group (p < 0.01 for both comparisons). Over 12 weeks, 64.6% of the patients who received the synbiotic experienced clinical improvement, compared to 29.2% of the patients in the placebo group (p < 0.01). During the intervention period, patients who were treated with the synbiotic exhibited increased stool frequency, improved stool consistency, decreased CTT, and improved constipation-related symptoms. This randomized, placebo-controlled trial suggested that dietary supplementation with a synbiotic improved evacuation-parameters-associated symptoms and colonic motility in patients with slow transit constipation (STC).","[Ding, Chao; Ge, Xiaolong; Zhang, Xueying; Tian, Hongliang; Gu, Lili; Gong, Jianfeng; Zhu, Weiming; Li, Ning] Nanjing Univ, Sch Med, Dept Gen Surg, Jinling Hosp, Nanjing 210002, Jiangsu, Peoples R China; [Wang, Hongkan] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China",Nanjing University; Zhejiang University,"Gong, JF; Li, N (corresponding author), Nanjing Univ, Sch Med, Dept Gen Surg, Jinling Hosp, Nanjing 210002, Jiangsu, Peoples R China.",jinlingh_dc@163.com; xiaolongge9118@126.com; 15996282291@163.com; kevin_thl@163.com; njumedcy@126.com; njumedgll@126.com; jinlingh_gongjf@163.com; jinlingh_zwm@sina.com; jinlingh_lining@163.com,"Li, Zexi/KFA-6939-2024; Zhang, Xueying/AAK-1725-2021; Liu, Liu/JXM-8208-2024",,National Natural Science Foundation of China [81270006]; National Gastroenterology Research Project [2015BAI13B07],National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Gastroenterology Research Project,This study was funded by the National Natural Science Foundation of China (81270006) and the National Gastroenterology Research Project (2015BAI13B07). The authors thank Huatong Liu from the Australian National University for checking the entire manuscript for grammar and typographical errors.,,37,32,39,2,19,MDPI AG,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",2072-6643,,,NUTRIENTS,Nutrients,OCT,2016,8,10,,,,,,,605,10.3390/nu8100605,http://dx.doi.org/10.3390/nu8100605,,,10,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,ED2HT,27690093,"Green Submitted, Green Published, gold",,,2024-06-04,WOS:000388665300023,View Full Record in Web of Science
J,"McRorie, JW; Fahey, GC; Gibb, RD; Chey, WD",,,,"McRorie, Johnson W., Jr.; Fahey, George C., Jr.; Gibb, Roger D.; Chey, William D.",,,Laxative effects of wheat bran and psyllium: Resolving enduring misconceptions about fiber in treatment guidelines for chronic idiopathic constipation,JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS,,,English,Review,,,,,,Constipation; fiber; laxative; treatment guidelines,FECAL STEROID-EXCRETION; DIETARY FIBER; BOWEL FUNCTION; INTESTINAL TRANSIT; COLONIC FUNCTION; SUPPLEMENTS; ASSOCIATION; ISPAGHULA; HEALTH; LIPIDS,"Background: Treatment guidelines for chronic idiopathic constipation (CIC) recommend an increase in fiber intake as a first-line therapy, but most epidemiologic studies fail to support an association between a high-fiber diet and a reduced risk of constipation. Furthermore, randomized controlled clinical studies show that most isolated fibers (e.g., supplements) are not different from placebo for a laxative effect, and several may be constipating. Objectives: The objective of this review was to compare the effects of two isolated fibers, coarse wheat bran and psyllium, on stool output and stool water content in patients with CIC. This review will also address misconceptions about fiber that are perpetuated by treatment guidelines. Data sources: A comprehensive literature review was conducted with the use of the Scopus, SciFinder, and PubMed scientific databases, limited to the previous 50 years (1968-2018; latest date included, December 31, 2018). Conclusions: In patients with CIC, nonfermented gel-forming psyllium was 3.4 times more effective than insoluble wheat bran for increasing stool output. Both psyllium and coarse wheat bran increased stool water content, a stool-softening effect, but finely ground wheat bran decreased stool water content, a stool-hardening effect.","[McRorie, Johnson W., Jr.; Gibb, Roger D.] Procter & Gamble, Healthcare Res & Dev, 8700 Mason Montgomery Rd, Mason, OH 45040 USA; [Fahey, George C., Jr.] Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA; [Chey, William D.] Univ Michigan Hlth Syst, Ann Arbor, MI USA",Procter & Gamble; University of Illinois System; University of Illinois Urbana-Champaign; University of Michigan System; University of Michigan,"McRorie, JW (corresponding author), Procter & Gamble, Healthcare Res & Dev, 8700 Mason Montgomery Rd, Mason, OH 45040 USA.",mcrorie.jw@pg.com,"Chey, William/AAY-7766-2021",,,,,,64,23,23,11,34,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",2327-6886,2327-6924,,J AM ASSOC NURSE PRA,J. Am. Assoc. Nurs. Pract.,JAN,2020,32,1,,,,,15,23,,10.1097/JXX.0000000000000346,http://dx.doi.org/10.1097/JXX.0000000000000346,,,9,Health Care Sciences & Services; Nursing,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Health Care Sciences & Services; Nursing,LE4DZ,31764399,,,,2024-06-04,WOS:000526671200005,View Full Record in Web of Science
J,"Kranz, S; Brauchla, M; Slavin, JL; Miller, KB",,,,"Kranz, Sibylle; Brauchla, Mary; Slavin, Joanne L.; Miller, Kevin B.",,,"What Do We Know about Dietary Fiber Intake in Children and Health? The Effects of Fiber Intake on Constipation, Obesity, and Diabetes in Children",ADVANCES IN NUTRITION,,,English,Review,,,,,,,CHILDHOOD CONSTIPATION; METABOLIC SYNDROME; GLYCEMIC INDEX; FUNCTIONAL CONSTIPATION; INCREASED PREVALENCE; COLONIC TRANSIT; NATIONAL-HEALTH; NUTRIENT INTAKE; BODY-WEIGHT; IN-VITRO,"The effect of dietary fiber intake on chronic diseases has been explored in adults but is largely unknown in children. This paper summarizes the currently existing evidence on the implications of dietary fiber intake on constipation, obesity, and diabetes in children. Current intake studies suggest that all efforts to increase children's dietary fiber consumption should be encouraged. Available data, predominantly from adult studies, indicate significantly lower risks for obesity, diabetes, and constipation could be expected with higher dietary fiber consumption. However, there is a lack of data from clinical studies in children of various ages consuming different levels of dietary fiber to support such assumptions. The existing fiber recommendations for children are conflicting, a surprising situation, because the health benefits associated with higher dietary fiber intake are well established in adults. Data providing conclusive evidence to either support or refute some, if not all, of the current pediatric fiber intake recommendations are lacking. The opportunity to improve children's health should be a priority, because it also relates to their health later in life. The known health benefits of dietary fiber intake, as summarized in this paper, call for increased awareness of the need to examine the potential benefits to children's health through increased dietary fiber. Adv. Nutr. 3: 47-53, 2012.","[Kranz, Sibylle] Purdue Univ, Dept Nutr Sci, W Lafayette, IN 47907 USA; [Slavin, Joanne L.] Univ Minnesota, Dept Food Sci & Nutr, St Paul, MN USA; [Miller, Kevin B.] WK Kellogg Inst Food & Nutr, Battle Creek, MI USA",Purdue University System; Purdue University; University of Minnesota System; University of Minnesota Twin Cities,"Kranz, S (corresponding author), Purdue Univ, Dept Nutr Sci, W Lafayette, IN 47907 USA.",kranz@purdue.edu,"Slavin, Joanne/GOJ-9874-2022; Kranz, Sibylle/G-1728-2017","Slavin, Joanne/0000-0003-0720-5300; Kranz, Sibylle/0000-0001-5637-1706",,,,,65,100,121,3,58,AMER SOC NUTRITION-ASN,BETHESDA,"9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA",2161-8313,,,ADV NUTR,Adv. Nutr.,JAN,2012,3,1,,,,,47,53,,10.3945/an.111.001362,http://dx.doi.org/10.3945/an.111.001362,,,7,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,066KN,22332100,"Green Published, hybrid",,,2024-06-04,WOS:000313219800005,View Full Record in Web of Science
J,"Bittencourt, AF; Martins, JR; Logullo, L; Shiroma, G; Horie, L; Ortolani, MC; Silva, MDT; Waitzberg, DL",,,,"Bittencourt, Amanda F.; Martins, Juliana R.; Logullo, Luciana; Shiroma, Glaucia; Horie, Lilian; Ortolani, Maria Claudia; Silva, Maria de Lourdes T.; Waitzberg, Dan L.",,,Constipation Is More Frequent Than Diarrhea in Patients Fed Exclusively by Enteral Nutrition: Results of an Observational Study,NUTRITION IN CLINICAL PRACTICE,,,English,Article,,,,,,enteral nutrition; constipation; diarrhea; dietary fiber,FIBER; METAANALYSIS; PROBIOTICS; OUTCOMES,"Background: Digestive complications in enteral nutrition (EN) can negatively affect the nutrition clinical outcome of hospitalized patients. Diarrhea and constipation are intestinal motility disorders associated with pharmacotherapy, hydration, nutrition status, and age. The aim of this study was to analyze the frequency of these intestinal motility disorders in patients receiving EN and assess risk factors associated with diarrhea and constipation in hospitalized patients receiving exclusive EN therapy in a general hospital. Materials and Methods: The authors performed a sequential and observational study of 110 hospitalized adult patients fed exclusively by EN through a feeding tube. Patients were categorized according to the type of intestinal transit disorder as follows: group D (diarrhea, 3 or more watery evacuations in 24 hours), group C (constipation, less than 1 evacuation during 3 days), and group N (absence of diarrhea or constipation). All prescription drugs were recorded, and patients were analyzed according to the type and amount of medication received. The authors also investigated the presence of fiber in the enteral formula. Results: Patients classified in group C represented 70% of the study population; group D comprised 13%, and group N represented 17%. There was an association between group C and orotracheal intubation as the indication for EN (P<.001). Enteral formula without fiber was associated with constipation (logistic regression analysis: P<.001). Conclusion: Constipation is more frequent than diarrhea in patients fed exclusively by EN. Enteral diet with fiber may protect against medication-associated intestinal motility disorders. The addition of prokinetic drugs seems to be useful in preventing constipation. (Nutr Clin Pract. XXXX;xx:xx-xx)","[Bittencourt, Amanda F.; Martins, Juliana R.; Logullo, Luciana; Shiroma, Glaucia; Horie, Lilian; Ortolani, Maria Claudia; Silva, Maria de Lourdes T.; Waitzberg, Dan L.] GANEP Nutr Humana, Sao Paulo, Brazil; [Waitzberg, Dan L.] Univ Sao Paulo, Fac Med, Dept Gastroenterol, Sao Paulo, Brazil",Universidade de Sao Paulo,"Bittencourt, AF (corresponding author), GANEP, Rua Maestro Cardim, BR-01323001 Sao Paulo, Brazil.",a.bittencourt@hotmail.com,"Martins, Juliana/JFB-0803-2023",,,,,,31,22,26,0,14,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0884-5336,1941-2452,,NUTR CLIN PRACT,Nutr. Clin. Pract.,AUG,2012,27,4,,,,,533,539,,10.1177/0884533612449488,http://dx.doi.org/10.1177/0884533612449488,,,7,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,976TS,22730041,,,,2024-06-04,WOS:000306608700009,View Full Record in Web of Science
C,"Jaundzeikare, L; Beitane, I",,"Straumite, E",,"Jaundzeikare, Liene; Beitane, Ilze",,,COMPARISON OF DIETARY FIBRE CONTENT IN DIFFERENT FIBRE SOURCES,9TH BALTIC CONFERENCE ON FOOD SCIENCE AND TECHNOLOGY - FOOD FOR CONSUMER WELL-BEING: FOODBALT 2014,FoodBalt,,English,Proceedings Paper,"9th Baltic Conference on Food Science and Technology - Food for Consumer well-being, (Foodbalt 2014)","MAY 08-09, 2014","Latvia Univ Agr, Jelgava, LATVIA","Latvia Univ Agr, Fac Food Technol",Latvia Univ Agr,bran; flaxseeds; chicory; Jerusalem artichoke; soluble and insoluble fibre,INULIN; OLIGOFRUCTOSE; CEREAL; CONSTIPATION; FLAXSEED; HEALTH,"Dietary fibre is an important component of human's nutrition. It is the common name for all carbohydrate components occurring in foods that are non-digestible in the human small intestine. It is known that deficiency of dietary fibre in food, provoke disturbance of intestinal tract, for example, constipation and that different fibre sources have different composition and quantities of dietary fibre. Therefore the task of research was to investigate the content of total, soluble and insoluble dietary fibre in different fibre sources such as,wheat and rye bran, defatted flaxseeds, chicory and Jerusalem artichoke powder. The results of research showed that total dietary fibre content in different fibre sources ranged between 41.76% and 59.42%, where the lowest TDF content was determined for wheat bran and the highest for Jerusalem artichoke powder. The content of TDF in defatted flaxseeds and Jerusalem artichoke powder was significantly higher comparing with other samples (P<0.05). Whereas dried chicory and Jerusalem artichoke powder were important sources of soluble dietary fibre, which significantly differed from other analysed samples (p<0.05). The significant part of SDF content made inulin, which contain in dried chicory was 94.3% of total SDF and in Jerusalem artichoke powder 97.7%. The significantly higher amount of IDF was determined in wheat and rye bran, defatted flaxseeds (p<0.05) comparing with dried chicory and Jerusalem artichoke powder.","[Jaundzeikare, Liene; Beitane, Ilze] Latvia Univ Agr, Fac Food Technol, Dept Nutr, Jelgava, Latvia",Latvia University of Life Sciences & Technologies,"Jaundzeikare, L (corresponding author), Latvia Univ Agr, Fac Food Technol, Dept Nutr, 2 Liela St, Jelgava, Latvia.",Ilze.Beitane@llu.lv,"Beitane, Ilze/AAE-4093-2020","Beitane, Ilze/0000-0002-7165-8390",,,,,31,1,1,1,12,LATVIA UNIV LIFE SCIENCES & TECHNOLOGIES,JELGAVA,"LIELA IELA 2, JELGAVA, LV-3001, LATVIA",2255-9809,,,FOODBALT,,,2014,,,,,,,90,93,,,,,,4,Agricultural Engineering; Food Science & Technology,Conference Proceedings Citation Index - Science (CPCI-S),Agriculture; Food Science & Technology,BE1QJ,,,,,2024-06-04,WOS:000368384800018,View Full Record in Web of Science
C,"Dohnalek, MH",,"VanderKamp, JW; Asp, NG; Jones, JM; Schaafsma, G",,"Dohnalek, MH",,,The role of fibre in clinical nutrition.,DIETARY FIBRE: BIO-ACTIVE CARBOHYDRATES FOR FOOD AND FEED,,,English,Proceedings Paper,Dietary Fibre 2003 Conference,"MAY 18-21, 2003","Noordwijkerhout, NETHERLANDS",,,soluble fibre; insoluble fibre; fermentable fibre; constipation; diarrhoea; colic; enteral nutrition,FATTY-ACID PRODUCTION; DEFINED-FORMULA DIET; ACUTELY ILL PATIENTS; HUMAN BOWEL FUNCTION; ENTERAL NUTRITION; CLOSTRIDIUM-DIFFICILE; BACTERIAL TRANSLOCATION; MINERAL BALANCE; SOLUBLE FIBER; DIARRHEA,"Dietary fibre can be an important part of clinical nutritional care-The Federation of American Societies for Experimental Biology (FASEB) recommends a fibre intake that is 25% soluble and 75% insoluble, a proportion that represents the types of fibre found in a solid diet containing wide varieties of food. For an enteral nutritional product that is used as the patient's sole source of nutrition, a source of fibre provides a means of normalizing gastrointestinal function. Patients receiving a fibre-containing nutritional product will require less use of laxatives to address constipation, and will have significantly, fewer incidence of diarrhoea. This is especially important in adult patients who require long term tube feeding. By maintaining the integrity of the structure of the gastrointestinal tract, fibre also can provide protection against mucosal atrophy and reduction in risk of infectious complications. Fermentable; fibres further enhance the integrity of the gastrointestinal tract by serving as an energy source for beneficial bacteria that can help control pathogenic corganisms. For infants and young children, fibre-containing products can also play a key role. Dietary fibre has been incorporated into infant feedings that are used to provide nutritional management of diarrhoeal episodes; fibre is also used in infant nutritional products that are intended to help address colicky symptoms. Fibre can be a key component of nutritional products, and provide significant advantages over non-fibre containing products. Overall, the importance of dietary fibre in clinical nutrition has been well established.","Global Nutr Prod, Abbott Labs, Abbott Pk, IL USA",Abbott Laboratories,"Dohnalek, MH (corresponding author), Global Nutr Prod, Abbott Labs, 200 Abbott Pk Rd, Abbott Pk, IL USA.",,,,,,,,55,1,1,0,8,WAGENINGEN ACAD PUBL,WAGENINGEN,"POSTBUS 220, 6700 AE WAGENINGEN, NETHERLANDS",,,90-76998-32-9,,,,2004,,,,,,,271,294,,,,,,24,Food Science & Technology; Nutrition & Dietetics,Conference Proceedings Citation Index - Science (CPCI-S),Food Science & Technology; Nutrition & Dietetics,BBP25,,,,,2024-06-04,WOS:000226861600022,View Full Record in Web of Science
J,"Culetu, A; Mohan, G; Duta, DE",,,,"Culetu, Alma; Mohan, Gabriela; Duta, Denisa Eglantina",,,Rheological Characterization of the Dough with Added Dietary Fiber by Rheometer: A Review,BULLETIN OF UNIVERSITY OF AGRICULTURAL SCIENCES AND VETERINARY MEDICINE CLUJ-NAPOCA-FOOD SCIENCE AND TECHNOLOGY,,,English,Review,,,,,,dietary fiber; dough viscoelastic properties; rheometer,GLUTEN-FREE DOUGH; PHYSICOCHEMICAL PROPERTIES; FLOUR DOUGH; BREAD; QUALITY; ENRICHMENT,"Dietary fibers represent a group of food components approved for use in functional foods as they offer health benefits such as a lower risk for coronary heart disease, type 2 diabetes, obesity and constipation. The enriched bread with different sources of fiber is important in the actual market situation, with an increasing consumer aware of health benefits. This paper reviews recent studies dealing with bread dough rheological characterization by rheometer. The focus is on wheat-based dough and gluten-free dough with added dietary fiber, also. Rheological analysis by rheometer is a useful approach to study the effects of dietary fibers on dough behavior showing that fiber incorporation in bread formulation reduces the elasticity of bread and enhances the mechanical properties of bread.","[Culetu, Alma; Mohan, Gabriela; Duta, Denisa Eglantina] Natl Inst Res & Dev Food Bioresources IBA Buchare, 6 Dinu Vintila, Bucharest 021102, Romania",National Research & Development Institute for Food Bioresources - IBA Bucharest,"Culetu, A (corresponding author), Natl Inst Res & Dev Food Bioresources IBA Buchare, 6 Dinu Vintila, Bucharest 021102, Romania.",alinaculetu@gmail.com,"Duta, Denisa E./C-7057-2017",,"Ministry of Research and Innovation through Program 1 - Development of the National RAMP;D System, Subprogram 1.2 - Institutional Performance - Projects for Excellence Financing in RDI [26 PFE/17.10.2018]","Ministry of Research and Innovation through Program 1 - Development of the National RAMP;D System, Subprogram 1.2 - Institutional Performance - Projects for Excellence Financing in RDI","This work was supported by a grant of the Ministry of Research and Innovation through Program 1 - Development of the National R&D System, Subprogram 1.2 - Institutional Performance - Projects for Excellence Financing in RDI, project no. 26 PFE/17.10.2018.",,32,2,2,7,30,UNIV AGRICULTURAL SCIENCES & VETERINARY MEDICINE CLUJ-NAPOCA,CLUJ-NAPOCA,"STR MANASTUR 3-5, CLUJ-NAPOCA, 400372, ROMANIA",2344-2344,2344-5300,,B UASVM-FOOD SCI TE,Bull. Univ. Agric. Sci. Vet. Med. Cluj-Napoca-Food Sci. Technol.,,2020,77,1,,,,,13,24,,10.15835/buasvmcn-fst:2019.0034,http://dx.doi.org/10.15835/buasvmcn-fst:2019.0034,,,12,Food Science & Technology,Emerging Sources Citation Index (ESCI),Food Science & Technology,LS9VC,,gold,,,2024-06-04,WOS:000536725500002,View Full Record in Web of Science
J,"Sturtzel, B; Dietrich, A; Wagner, KH; Gisinger, C; Elmadfa, I",,,,"Sturtzel, B.; Dietrich, A.; Wagner, K. -H.; Gisinger, C.; Elmadfa, I.",,,"The status of vitamins B6, B12, folate, and of homocysteine in geriatric home residents receiving laxatives or dietary fiber",JOURNAL OF NUTRITION HEALTH & AGING,,,English,Article,,,,,,Elderly; dietary fiber; constipation; vitamin B12; homocysteine,HOSPITALIZED-PATIENTS; RHEUMATOID-ARTHRITIS; CHRONIC CONSTIPATION; PLASMA HOMOCYSTEINE; RISK-FACTOR; FOLIC-ACID; INFLAMMATION; DEMENTIA; METHIONINE; DISEASE,"Vitamin B12 deficiency as a digestive disorder and constipation as a gastro motility disorder are common in the elderly. Laxative treatment is often chosen without regard for gut health. To investigate whether the addition of oat-bran to the common oral diet for 12 weeks is able to reduce constipation and laxative use and improve gut health. It is assumed that this will lead to improved plasma levels of vitamins B6, B12, folate, and of homocysteine in nursing home residents. A controlled, parallel intervention trial. 30 frail patients with multiple chronic diseases, aged 57-98 years, receiving laxative therapy were included. Patients were randomized into a fiber (n=15) and a control group (n=15). The intervention group received 5.2g/d oat-bran for 84 days mixed into the daily common meals. The control group received the ward's habitual diet. Food intake and laxative use were documented and blood samples (on day 01, day 42 and day 84) were collected. Vitamin B12 and folate were analyzed by radioimmunoassay, B6 and homocysteine by RP-HPLC with fluorescence detection, in addition to the routine lab test of albumin and CRP. In the fiber group, the intervention was well tolerated and laxative use decreased significantly (p < 0.001). In the control group, plasma B12 decreased faster (p < 0.05). In both groups, B6 and folate status remained unchanged. Plasma homocysteine decreased in both groups (p < 0.05). General mean energy intake was low (4861.4 kJ/d). Oat-bran helps to improve constipation management and B12 bioavailability in elderly, with multiple chronic diseases who live in nursing homes.","[Sturtzel, B.; Dietrich, A.; Wagner, K. -H.; Elmadfa, I.] Univ Vienna, Dept Nutr Sci, A-1090 Vienna, Austria; [Gisinger, C.] Geriatr Hosp, Vienna, Austria",University of Vienna,"Sturtzel, B (corresponding author), Univ Vienna, Dept Nutr Sci, Althanstr 14, A-1090 Vienna, Austria.",baerbel.sturtzel@univie.ac.at,"Wagner, Karl-Heinz/B-9098-2013","Wagner, Karl-Heinz/0000-0002-1683-7265",,,,,45,26,29,2,13,SPRINGER FRANCE,PARIS,"22 RUE DE PALESTRO, PARIS, 75002, FRANCE",1279-7707,,,J NUTR HEALTH AGING,J. Nutr. Health Aging,MAR,2010,14,3,,,,,219,223,,10.1007/s12603-010-0053-6,http://dx.doi.org/10.1007/s12603-010-0053-6,,,5,Geriatrics & Gerontology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Geriatrics & Gerontology; Nutrition & Dietetics,581MH,20191257,hybrid,,,2024-06-04,WOS:000276527000009,View Full Record in Web of Science
J,"Rajindrajith, S; Devanarayana, NM; Thapar, N; Benninga, MA",,,,"Rajindrajith, Shaman; Devanarayana, Niranga Manjuri; Thapar, Nikhil; Benninga, Marc Alexander",,,Myths and misconceptions about childhood constipation,EUROPEAN JOURNAL OF PEDIATRICS,,,English,Review,,,,,,Constipation; Bowel habits; Epidemiology; Quality of life; Dietary fiber; Physical activity; Laxatives; Prognosis,QUALITY-OF-LIFE; FUNCTIONAL GASTROINTESTINAL DISORDERS; COWS MILK; PEDIATRIC GASTROENTEROLOGY; ABDOMINAL RADIOGRAPHS; RECTAL COMPLIANCE; FECAL IMPACTION; DIETARY FIBER; BOWEL HABITS; CHILDREN,"Many widely held beliefs and assumptions concerning childhood constipation continue to interfere with rational management of childhood constipation. Although many still believe that constipation is not a common disease, about 9.5% of the world's children suffer from chronic constipation. Most of these children live in non-Western countries. There are major misconceptions about the etiology of constipation as a significant proportion of clinicians still believe that constipation is caused by some form an organic pathology, whereas in reality, the majority have functional constipation. Contrary to a commonly held belief that children outgrow constipation without long-term problems, there is evidence that constipation leads to significant bowel and psychological consequences and has a major impact on the quality of life which detrimentally affects future health and education. Finally, ineffective management strategies such as increasing fiber and water in the diet, and short duration of treatment owing to the fear that long-term laxative treatment leads to colonic dysfunction, interfere with effective therapeutic strategies. Conclusions: It is apparent that myths and misconception often lead to wrong assumptions regarding the distribution of the disease, its etiology, pathophysiology, and management leading to ordering incorrect investigations and ineffective therapeutic strategies while spending large sums of public funds unnecessarily. Poorly treated constipation leads to deleterious psychological consequences predisposing children to develop significant psychological damage and bowel dysfunctions. This review aims to challenge these myths about various elements of constipation by exploring the existing literature and encouraging clinicians to have a fresh look at old concepts that could interfere with the well-being of children with constipation.","[Rajindrajith, Shaman] Univ Colombo, Fac Med, Dept Pediat, Colombo 00800, Sri Lanka; [Devanarayana, Niranga Manjuri] Univ Kelaniya, Fac Med, Dept Physiol, Ragama, Western Provinc, Sri Lanka; [Thapar, Nikhil] Queensland Childrens Hosp, Dept Gastroenterol Hepatol & Liver Transplant, Brisbane, Qld, Australia; [Benninga, Marc Alexander] Univ Amsterdam, Emma Childrens Hosp, Dept Pediat Gastroenterol & Nutr, Med Ctr, Amsterdam, Netherlands",University of Colombo; University Kelaniya; Childrens Health Queensland Hospital & Health Service; Queensland Childrens Hospital; Emma Children's Hospital; University of Amsterdam,"Rajindrajith, S (corresponding author), Univ Colombo, Fac Med, Dept Pediat, Colombo 00800, Sri Lanka.",shamanrajindrajith4@gmail.com,"Rajindrajith, Shaman/AAN-8675-2020","Rajindrajith, Shaman/0000-0003-1379-5052; Thapar, Nikhil/0000-0002-0276-9951",,,,,109,1,1,3,8,SPRINGER,NEW YORK,"ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES",0340-6199,1432-1076,,EUR J PEDIATR,Eur. J. Pediatr.,APR,2023,182,4,,,,,1447,1458,,10.1007/s00431-023-04821-8,http://dx.doi.org/10.1007/s00431-023-04821-8,,JAN 2023,12,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,FH1D3,36689003,,,,2024-06-04,WOS:000928187600003,View Full Record in Web of Science
J,"Bell, SJ",,,,"Bell, Stacey J.",,,A Review of Dietary Fiber and Health: Focus on Raisins,JOURNAL OF MEDICINAL FOOD,,,English,Review,,,,,,dietary fiber; fiber and gastrointestinal disease; fiber and type 2 diabetes; fiber and weight loss; raisins,CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; SYSTEMIC INFLAMMATION; COLORECTAL ADENOMA; POOLED ANALYSIS; BREAST-CANCER; BODY-WEIGHT; BILE-ACID; ALL-CAUSE; RISK,"Fibers vary in their physiologic effects. For example, viscous fibers may delay gastric emptying of ingested foods into the small intestine, creating a sensation of fullness; reduce blood glucose concentrations; and potentially benefit insulin sensitivity. They also improve blood cholesterol levels. Insoluble fibers are poorly absorbed and are known to improve fecal bulk and laxation and ameliorate constipation. Despite these numerous benefits, most Americans do not get enough of either kind of fiber in the diet. Some have argued that fiber-rich foods are not appetizing and therefore avoided. Raisins contain both forms of fiber and have a sweet flavor. This review provides support for consuming adequate fiber in the diet and suggests a role for raisins to help increase total dietary fiber.",,,"Bell, SJ (corresponding author), 1 Huntington Ave, Boston, MA 02116 USA.",staceyjbell@yahoo.com,,,,,,,33,15,18,2,37,MARY ANN LIEBERT INC,NEW ROCHELLE,"140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA",1096-620X,,,J MED FOOD,J. Med. Food,SEP,2011,14,9,,,,,877,883,,10.1089/jmf.2010.0215,http://dx.doi.org/10.1089/jmf.2010.0215,,,7,"Chemistry, Medicinal; Food Science & Technology; Nutrition & Dietetics",Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy; Food Science & Technology; Nutrition & Dietetics,810FP,21476884,,,,2024-06-04,WOS:000294111400001,View Full Record in Web of Science
J,"Tramonte, SM; Brand, MB; Mulrow, CD; Amato, MG; OKeefe, ME; Ramirez, G",,,,"Tramonte, SM; Brand, MB; Mulrow, CD; Amato, MG; OKeefe, ME; Ramirez, G",,,The treatment of chronic constipation in adults - A systematic review,JOURNAL OF GENERAL INTERNAL MEDICINE,,,English,Review,,,,,,"constipation, treatment; laxatives; dietary fiber; bowel movement, frequency; meta-analysis",SEEKING HEALTH-CARE; IDIOPATHIC CONSTIPATION; ELDERLY PATIENTS; CISAPRIDE; LACTULOSE; PLACEBO; POPULATION; SENNA; TRIAL; EFFICACY,"OBJECTIVE: To evaluate whether laxatives and fiber therapies improve symptoms and bowel movement frequency in adults with chronic constipation. DATA SOURCES: English language studies were identified from computerized MEDLINE (1966-1995), Biological Abstracts (1990-1995), and Micromedex searches; bibliographies; textbooks: laxative manufacturers; and experts. STUDY SELECTION: Randomized trials of laxative or fiber therapies lasting more than 1 week that evaluated clinical outcomes in adults with chronic constipation. MEASUREMENTS AND MAIN RESULTS: Two independent reviewers appraised each trial's characteristics including methodologic quality. There were 36 trials involving 1,815 persons from a variety of settings including clinics, hospitals and nursing homes. Twenty-three trials were 1 month or less in duration. Several laxative and fiber preparations were evaluated. Twenty trials had a placebo, usual care, or discontinuation of laxative control group, and 16 directly compared different agents. Laxatives and fiber increased bowel movement frequency by an overall weighted average of 1.4 (95% confidence interval [CT] 1.1-1.8) bowel movements per week. Fiber and bulk laxatives decreased abdominal pain and improved stool consistency compared with placebo. Most nonbulk laxative data concerning abdominal pain and stool consistency were inconclusive, though cisapride, lactulose, and lactitol improved consistency. Data concerning superiority of various treatments were inconclusive. No severe side effects for any of the therapies were reported. CONCLUSIONS: Both fiber and laxatives modestly improved bowel movement frequency in adults with chronic constipation. There was inadequate evidence to establish whether fiber was superior to laxatives or one laxative class was superior to another.","METROPOLITAN METHODIST HOSP,SAN ANTONIO,TX",,,,"; Ramirez, Gilbert/D-7410-2018","Amato, Mary/0000-0002-0247-9049; Ramirez, Gilbert/0000-0001-7559-3646",,,,,62,124,137,1,29,BLACKWELL SCIENCE INC,MALDEN,"350 MAIN ST, MALDEN, MA 02148",0884-8734,,,J GEN INTERN MED,J. Gen. Intern. Med.,JAN,1997,12,1,,,,,15,24,,10.1046/j.1525-1497.1997.12103.x,http://dx.doi.org/10.1046/j.1525-1497.1997.12103.x,,,10,"Health Care Sciences & Services; Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),Health Care Sciences & Services; General & Internal Medicine,WG811,9034942,Green Published,,,2024-06-04,WOS:A1997WG81100003,View Full Record in Web of Science
J,"Du, WY; Lu, LC; Liu, YX; Yan, YX; La, R; Wu, Q; Xu, J; Zhou, XJ",,,,"Du, Wenyi; Lu, Lingchen; Liu, Yuxuan; Yan, Yuxin; La, Rui; Wu, Qian; Xu, Jie; Zhou, Xiaojun",,,The association between dietary vitamin B1 intake and constipation: a population-based study,BMC GASTROENTEROLOGY,,,English,Article,,,,,,Constipation; Vitamin B1; National Health and Nutrition Examination Survey; Cross-sectional study,CHRONIC IDIOPATHIC CONSTIPATION; NATIONAL-HEALTH; OXIDATIVE STRESS; RISK-FACTORS; THIAMINE; ADULTS; METABOLISM; FIBER,"Background Numerous researches have indicated a correlation between the intake of dietary micronutrients and the occurrence of constipation. Nevertheless, the correlation between constipation and vitamin B1 remains uninvestigated. The main aim of this research was to examine the association between chronic constipation and the consumption of vitamin B1 in the diet among adult participants of the National Health and Nutrition Examination Survey (NHANES).Methods This study used data from the NHANES, a survey on health and nutrition conducted between 2005 and 2010. The respondents' dietary information was gathered by utilizing the 24-hour dietary records. Various statistical analyses, such as multiple logistic regression, subgroup analysis, and curve-fitting analysis, were employed to investigate the correlation between dietary intake of vitamin B1 and chronic constipation.Results In the trial, there were 10,371 participants, out of which 1,123 individuals (10.8%) were identified as having chronic constipation. Fully adjusted multiple logistic regression analyses showed that increasing dietary intake of vitamin B1 (OR = 0.87, 95% CI: 0.77-0.99) was significantly associated with a reduced risk of constipation. Following adjustment for multiple variables in Model 3, the odds ratio (OR) and 95% confidence interval (CI) for the third tertile, in comparison to the first tertile (reference group), was 0.80 (0.65, 0.99). In addition, subgroup analyses and interaction tests showed a significant inverse association between vitamin B1 intake and the prevalence of constipation, especially among men, non-hypertensive, and non-diabetic individuals (all P-values less than 0.05).Conclusion This research uncovered an inverse correlation between the consumption of vitamin B1 in the diet and the occurrence of chronic constipation. One potential explanation for this phenomenon is that the consumption of vitamin B1 in one's diet is linked to the softening of stools and an augmented occurrence of colonic peristalsis. Additional extensive prospective research is required to thoroughly examine the significance of thiamine in long-term constipation.","[Du, Wenyi; Liu, Yuxuan; Xu, Jie; Zhou, Xiaojun] Soochow Univ, Suzhou Stomatol Hosp, Affiliated Stomatol Hosp, Suzhou, Peoples R China; [Du, Wenyi] Nanjing Med Univ, Wuxi Med Ctr, Dept Gen Surg, Wuxi Peoples Hosp, Wuxi, Jiangsu, Peoples R China; [Lu, Lingchen] Maternal & Child Hlth Care Hosp Kunshan, Dept Pediat Surg, Suzhou, Jiangsu, Peoples R China; [Yan, Yuxin; La, Rui; Wu, Qian] Soochow Univ, Dept Orthoped Surg, Affiliated Hosp 1, Inst Orthoped, Suzhou, Jiangsu, Peoples R China; [Wu, Qian] Jeonbuk Natl Univ, Med Sch, Res Inst Clin Med, Jeonju, South Korea",Soochow University - China; Jiangnan University; Nanjing Medical University; Soochow University - China; Jeonbuk National University,"Xu, J; Zhou, XJ (corresponding author), Soochow Univ, Suzhou Stomatol Hosp, Affiliated Stomatol Hosp, Suzhou, Peoples R China.;Wu, Q (corresponding author), Soochow Univ, Dept Orthoped Surg, Affiliated Hosp 1, Inst Orthoped, Suzhou, Jiangsu, Peoples R China.;Wu, Q (corresponding author), Jeonbuk Natl Univ, Med Sch, Res Inst Clin Med, Jeonju, South Korea.",qianwujoint@163.com; johnson82813@163.com; 714809021@qq.com,,,,,,,51,0,0,0,0,BMC,LONDON,"CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND",,1471-230X,,BMC GASTROENTEROL,BMC Gastroenterol.,MAY 17,2024,24,1,,,,,,,171,10.1186/s12876-024-03255-2,http://dx.doi.org/10.1186/s12876-024-03255-2,,,12,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,RJ2Y6,38760704,gold,,,2024-06-04,WOS:001227242300004,View Full Record in Web of Science
J,"Kreft, D",,,,"Kreft, D",,,Psyllium - a soluble dietary fibre used in the treatment of chronic constipation,ERNAHRUNGS-UMSCHAU,,,German,Article,,,,,,,FIBER; TRIAL,"Chronic constipation is regarded as a typical disease of western countries. It is attributed to the relatively low intake of dietary fibre common to western countries, For the nutritional therapy of constipation, high-Fibre food is usually recommended, but alternative fibre sources may also be used. Wheat bran is the best known source of supplementary fibre. However, its use is limited due to frequent lack of therapeutical success, hard stools or abdominal complaints (flatulence, cramps). Psyllium which is little known in Germany has been widely used in other countries as a source of concentrated fibre. Due to its extraordinary water-binding capacity, the soluble mucilaginous Fibre can absorb water in excess of its own weight. The resulting gelatinous substance is colourless and has a neutral taste. The effect of psyllium as a laxantive is based an a normalization of the digestive process, A significant increase in stool quantity and positive effects an stool frequency and consistency have been reported. Stool softening and lubrication decrease pains. In studies comparing psyllium with other laxantives, psyllium was not only more effective; most patients also found it superior in taste, acceptability and practical application. Its most frequent side effects are allergic reactions. Sensitization is mainly caused by skin contact or inhalation of psyllium dust particles. The allergenic components are located in the inner seed endospore and embryo. Peroral sensitization is rare and can be minimized by purification of the psyllium husks, i.e. by removal of the IgE-binding proteins. Complications after psyllium intake such as esophageal or intestinal obstruction are rare. Undesirable effects Such as sensation of repletion, nausea or abdominal pain were only rarely reported and regarded as of minor degree. Prolonged intake - at least at the usual doses - seems to be of no clinical relevance for nutritional status. Most authors consider psyllium to be a safe and effective laxantive, provided it is taken as prescribed. Because a recent study in colon cancer patients has shown that the recidivism rate among patients who took psyllium was higher than in the placebo group, psyllium should not be regularly applied for longer periods of time as long as the results of further studies are not available.",,,"Kreft, D (corresponding author), Altkonigstr 77, D-61440 Oberursel, Germany.",,,,,,,,10,1,1,0,5,UMSCHAU VERLAG,FRANKFURT AM MAIN,"POSTFACH 11 02 62, D-60037 FRANKFURT AM MAIN, GERMANY",0174-0008,,,ERNAHRUNGS-UMSCHAU,Ernahr.-Umsch.,DEC,2001,48,12,,,,,482,+,,,,,,8,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,523VY,,,,,2024-06-04,WOS:000173979300004,View Full Record in Web of Science
J,"Evans, S; Daly, A; Davies, P; MacDonald, A",,,,"Evans, S.; Daly, A.; Davies, P.; MacDonald, A.",,,Fibre content of enteral feeds for the older child,JOURNAL OF HUMAN NUTRITION AND DIETETICS,,,English,Article,,,,,,constipation; dietary fibre; enteral feeding; laxatives; paediatrics,PLASMA ZINC CONCENTRATIONS; ACUTE-PHASE RESPONSE; DIETARY FIBER; MICRONUTRIENT STATUS; ABSORPTION,"Background: There is currently a lack of clinical data on fibre requirements in UK children. Subsequently, the ideal fibre profile for enteral formulae designed to meet the requirements of older children is unknown. The present study aimed to investigate the effect of fibre supplementation on gastrointestinal function of children aged 7-12 years (or weight 21-45 kg) receiving an age-specific high-energy enteral feed. Methods: In this double-blind randomised crossover study, 25 home enterally tube-fed children with a range of medical conditions (including cystic fibrosis, neurological conditions, liver transplant and bone marrow transplant) were given a 1.5 kcal mL(-1) formula with or without added dietary fibre (1.13 g per 100 mL). Each formula was taken for 6 weeks, followed by 6 months on the second randomly assigned formula. Anthropometry, blood biochemistry, stool characteristics, tolerance and oral dietary intake were assessed. Results: Despite a higher median fibre intake on the fibre-containing formula (84% versus 26% of recommended intake; P = 0.003), most children did not meet existing international recommendations for fibre as a result of small feed volumes (median 800 mL day(-1); 9 g fibre day(-1)). There was some evidence of reduced constipation, laxative reliance and abdominal pain on the fibre-containing formula. Conclusions: Given the poor fibre intakes and absence of adverse effects, the use of fibre-containing formulae should become standard practice for the majority of children on enteral feeds. Larger trials in children are required to further evaluate the effect of amount and blend of fibre in enteral formulae for older children. However, it is likely that current formulae require higher levels of fibre.","[Evans, S.; Daly, A.; MacDonald, A.] Birmingham Childrens Hosp, Dietet Dept, Birmingham B4 6NH, W Midlands, England; [Davies, P.] Univ Birmingham, Inst Child Hlth, Birmingham B15 2TT, W Midlands, England",University of Birmingham; University of Birmingham,"Evans, S (corresponding author), Birmingham Childrens Hosp, Dietet Dept, Steelhouse Lane, Birmingham B4 6NH, W Midlands, England.",evanss21@onetel.com,,"Morris (Evans), Sharon/0000-0002-7654-3621",Nutricia Clinical Care,Nutricia Clinical Care(Danone Nutricia),Nutricia Clinical Care provided funding for this study.,,23,19,20,0,7,"WILEY-BLACKWELL PUBLISHING, INC",MALDEN,"COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA",0952-3871,,,J HUM NUTR DIET,J. Hum. Nutr. Diet.,OCT,2009,22,5,,,,,414,421,,10.1111/j.1365-277X.2009.00991.x,http://dx.doi.org/10.1111/j.1365-277X.2009.00991.x,,,8,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,491MP,19743979,,,,2024-06-04,WOS:000269583400006,View Full Record in Web of Science
J,"Karabudak, E; Koksal, E; Macit, MS",,,,"Karabudak, Efsun; Koksal, Eda; Macit, Melahat Sedanur",,,"The relationship between body weight, fiber and fluid intake status and functional constipation in young adults",NUTRITION & FOOD SCIENCE,,,English,Article,,,,,,Physical activity; Body mass index; Fiber; Beverage; Functional constipation,PHYSICAL-ACTIVITY; DIETARY-INTAKE; ASSOCIATION; RELIABILITY; PREVALENCE; DEFECATION; MANAGEMENT; VALIDITY; CHILDREN; SMOKING,"Purpose The present study aims to determine the relationship between functional constipation and lifestyle patterns, eating habits and nutritional status in young adults. Design/methodology/approach This study was conducted in 825 young adults between the age of 20 and 24 years in Ankara. Constipation was evaluated via self-reports and ROMA III criteria. Food and beverage consumption frequency and fluid intake were surveyed, and anthropometric measurements (weight and height) were evaluated. Physical activity was assessed using the brief physical activity assessment tool. Findings Participants reported themselves as constipated, not constipated and sometimes constipated in 7.8, 39.6 and 53.6 per cent of cases, respectively. These rates differed from those obtained using the ROMA III criteria: constipated 51.3 per cent and not constipated 48.7 per cent. Constipation rates were higher in females (54.4 per cent) than males (44.8 per cent) (p < 0.05). No association was found between daily water, total fluid and fiber intake and constipation (p > 0.05). However, water from foods have lowering effects on constipation (p < 0.05). Increased physical activity seems to have no effect on constipation. According to food frequency records, participants who consumed more whole grains, rice/pasta and vegetables had lower rates of constipation. Conversely, higher consumption of tea was associated with higher constipation rates (p < 0.05). Originality/value Young adults should be encouraged to consume foods rich in water such as fruits and vegetables against constipation, fiber-rich foods and fluids to meet the recommendations for healthy eating. Only a few studies have assessed the relationships between lifestyle, fluid and nutritional status and body mass index.","[Karabudak, Efsun; Koksal, Eda; Macit, Melahat Sedanur] Gazi Univ, Hlth Sci Fac, Dept Nutr & Dietet, Ankara, Turkey",Gazi University,"Macit, MS (corresponding author), Gazi Univ, Hlth Sci Fac, Dept Nutr & Dietet, Ankara, Turkey.",sedanur.macit@gmail.com,"Koksal, Eda/AAW-2900-2021","Koksal, Eda/0000-0002-7930-9910; Macit-Celebi, Melahat Sedanur/0000-0002-7480-1586",,,,,49,5,5,1,15,EMERALD GROUP PUBLISHING LTD,BINGLEY,"HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND",0034-6659,1758-6917,,NUTR FOOD SCI,Nutr. Food Sci.,FEB 11,2019,49,1,,,,,129,140,,10.1108/NFS-03-2018-0083,http://dx.doi.org/10.1108/NFS-03-2018-0083,,,12,Food Science & Technology,Emerging Sources Citation Index (ESCI),Food Science & Technology,HK9KV,,,,,2024-06-04,WOS:000458311200010,View Full Record in Web of Science
J,"READ, NW; CELIK, AF; KATSINELOS, P",,,,"READ, NW; CELIK, AF; KATSINELOS, P",,,CONSTIPATION AND INCONTINENCE IN THE ELDERLY,JOURNAL OF CLINICAL GASTROENTEROLOGY,,,English,Article,,,,,,CONSTIPATION; INCONTINENCE; ELDERLY,ANAL-CANAL PRESSURES; FECAL INCONTINENCE; ANORECTAL FUNCTION; SPHINCTER FUNCTION; NERVE-CONDUCTION; PHOSPHATE ENEMA; DIETARY FIBER; WHEAT BRAN; PREVALENCE; DISEASE,"We summarize the prevalence and causes of constipation and incontinence in an elderly, drawing particular attention to the roles of immobility, dietary fiber, and dehydration. The physiology of fecal impaction is described in detail, and neurological and mechanical causes (rectal prolapse, rectocele, and hemorrhoids) of constipation are discussed. Consideration is also given to constipation associated with diverticular disease and ulcerative colitis. We also discuss the pathogenesis of fecal incontinence in the elderly, paying particular attention to fecal impaction and neurological causes that result in both constipation and incontinence. The importance of previous obstetric trauma and pudendal enuropathy is emphasized. We conclude with detailed guidelines of the clinical assessment and management of an elderly patient with a disorder of defecation.",,,"READ, NW (corresponding author), NO GEN HOSP,CTR HUMAN NUTR,SHEFFIELD S5 7AU,S YORKSHIRE,ENGLAND.",,"celik, Ahmet/IAP-5710-2023",,,,,,76,68,70,0,7,LIPPINCOTT-RAVEN PUBL,PHILADELPHIA,"227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106",0192-0790,,,J CLIN GASTROENTEROL,J. Clin. Gastroenterol.,JAN,1995,20,1,,,,,61,70,,10.1097/00004836-199501000-00016,http://dx.doi.org/10.1097/00004836-199501000-00016,,,10,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,PY345,7884183,,,,2024-06-04,WOS:A1995PY34500015,View Full Record in Web of Science
J,"Dong, LH; Xu, ZH; Huang, GT; Zhang, RF; Deng, M; Huang, F; Su, DX",,,,"Dong, Lihong; Xu, Zhuohui; Huang, Guitao; Zhang, Ruifen; Deng, Mei; Huang, Fei; Su, Dongxiao",,,Lychee Pulp-Derived Dietary Fiber-Bound Phenolic Complex Upregulates the SCFAs-GPRs-ENS Pathway and Aquaporins in Loperamide-Induced Constipated Mice by Reshaping Gut Microbiome,JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY,,,English,Article,,,,,,lychee; constipation; gut microbiota; dietary fiber; bound phenolics,MECHANISMS; EXPRESSION; RECEPTORS,"This study aimed to investigate the effects of the lychee pulp-derived dietary fiber-bound phenolic complex (DF-BPC) on a murine model of loperamide-induced constipation and its molecular mechanism associated with gut microbiota modification. DF-BPC supplementation mitigated loperamide-induced dyschezia, intestinal hypomotility, and colonic impairment, as evidenced by the increased gastro-intestinal transit rate and mucus cell counts. By comparison, short-chain fatty acids (SCFAs) contents and relative abundances of associated genera (Butyricimonas, Clostridium, and Lactobacillus) were effectively upregulated following DF-BPC supplementation. Notably, DF-BPC significantly enhanced expressions of G protein-coupled receptor (GPR) 41 and 43, reaching 1.43- and 1.62-fold increase, respectively. Neurotransmitter secretions were simultaneously altered in DF-BPC-treated mice, suggesting upregulation of the SCFAs-GPRs-enteric nervous system pathway. The overexpression of aquaporins (AQP3, 8, and 9) was stimulated partly through GPRs activation. Mild inflammation associated with constipation was inhibited by suppressing LBP-TLR4-NF-kappa B signaling translocation. These findings suggest that DF-BPC from lychee pulp has the potential to alleviate constipation in mice through modifying the gut microbiome.","[Dong, Lihong; Huang, Guitao; Zhang, Ruifen; Deng, Mei; Huang, Fei] Guangdong Acad Agr Sci, Minist Agr & Rural Affairs, Key Lab Funct Foods, Sericultural & Agrifood Res Inst,Guangdong Key Lab, Guangzhou 510610, Peoples R China; [Xu, Zhuohui; Huang, Guitao; Su, Dongxiao] Guangzhou Univ, Sch Chem & Chem Engn, Guangzhou 510006, Peoples R China",Ministry of Agriculture & Rural Affairs; Guangdong Academy of Agricultural Sciences; Guangzhou University,"Huang, F (corresponding author), Guangdong Acad Agr Sci, Minist Agr & Rural Affairs, Key Lab Funct Foods, Sericultural & Agrifood Res Inst,Guangdong Key Lab, Guangzhou 510610, Peoples R China.;Su, DX (corresponding author), Guangzhou Univ, Sch Chem & Chem Engn, Guangzhou 510006, Peoples R China.",hf1311@163.com; dongxsu@126.com,,"Su, Dongxiao/0000-0002-1928-0810",Guangdong Provincial Key Research and Development Program [2022B0202020004]; Guangdong Basic and Applied Basic Research Foundation [2022A1515010444]; Agricultural Competitive Industry Discipline Team Building Project of Guangdong Academy of Agricultural Sciences [202108TD],Guangdong Provincial Key Research and Development Program; Guangdong Basic and Applied Basic Research Foundation; Agricultural Competitive Industry Discipline Team Building Project of Guangdong Academy of Agricultural Sciences,"This project was supported by the Guangdong Provincial Key Research and Development Program (2022B0202020004), the Guangdong Basic and Applied Basic Research Foundation (2022A1515010444), and the Agricultural Competitive Industry Discipline Team Building Project of Guangdong Academy of Agricultural Sciences (202108TD).",,44,2,2,20,27,AMER CHEMICAL SOC,WASHINGTON,"1155 16TH ST, NW, WASHINGTON, DC 20036 USA",0021-8561,1520-5118,,J AGR FOOD CHEM,J. Agric. Food Chem.,OCT 10,2023,71,41,,,,,15087,15096,,10.1021/acs.jafc.3c03734,http://dx.doi.org/10.1021/acs.jafc.3c03734,,OCT 2023,10,"Agriculture, Multidisciplinary; Chemistry, Applied; Food Science & Technology",Science Citation Index Expanded (SCI-EXPANDED),Agriculture; Chemistry; Food Science & Technology,U7EF8,37814441,,,,2024-06-04,WOS:001082708400001,View Full Record in Web of Science
J,"Gallagher, P; O'Mahony, D",,,,"Gallagher, Paul; O'Mahony, Denis",,,Constipation in old age,BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY,,,English,Article,,,,,,constipation; ageing; clinical assessment; laxatives; faecal impaction,SLOW-TRANSIT CONSTIPATION; PLACEBO-CONTROLLED TRIAL; BALANCED SOLUTION PMF-100; NURSING-HOME RESIDENTS; DOUBLE-BLIND; FECAL INCONTINENCE; IDIOPATHIC CONSTIPATION; PELVIC FLOOR; ELECTROLYTE-SOLUTION; BOWEL DISORDERS,"The prevalence of constipation increases with age. However, constipation is not a physiological consequence of normal ageing. Indeed, the aetiology of constipation in older people is often multifactorial with co-morbid diseases, impaired mobility, reduced dietary fibre intake and prescription medications contributing significantly to constipation in many instances. A detailed clinical history and physical examination including digital rectal examination is usually sufficient to uncover the causes of constipation in older people; more specialized tests of anorectal physiology and colonic transit are rarely required. The scientific evidence base from which to develop specific treatment recommendations for constipation in older people is, for the most part, slim. Constipation can be complicated by faecal impaction and incontinence, particularly in frail older people with reduced mobility and cognitive impairment; preventative strategies are important in those at risk. (C) 2009 Elsevier Ltd. All rights reserved.","[Gallagher, Paul; O'Mahony, Denis] Cork Univ Hosp, Dept Geriatr Med, Cork, Ireland",University College Cork,"Gallagher, P (corresponding author), Cork Univ Hosp, Dept Geriatr Med, Cork, Ireland.",pfgallagher77@eircom.net; denis.omahony@hse.ie,,,,,,,74,99,110,7,35,ELSEVIER SCI LTD,OXFORD,"THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND",1521-6918,1532-1916,,BEST PRACT RES CL GA,Best Pract. Res. Clin. Gastroenterol.,DEC,2009,23,6,,,,,875,887,,10.1016/j.bpg.2009.09.001,http://dx.doi.org/10.1016/j.bpg.2009.09.001,,,13,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,537NZ,19942165,,,,2024-06-04,WOS:000273121000009,View Full Record in Web of Science
J,"Cao, JH; Wang, K; Li, NX; Zhang, LP; Qin, L; He, YY; Wang, JF; Qu, CF; Miao, JL",,,,"Cao, Junhan; Wang, Kai; Li, Nianxu; Zhang, Liping; Qin, Ling; He, Yingying; Wang, Jingfeng; Qu, Changfeng; Miao, Jinlai",,,"Soluble dietary fiber and cellulose from Saccharina japonica by-product ameliorate Loperamide-induced constipation via modulating enteric neurotransmitters, short-chain fatty acids and gut microbiota",INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES,,,English,Article,,,,,,Saccharina japonica; SDF; IDF; Cellulose; Constipation; SCFAs; Gut microbiota,LAMINARIA-JAPONICA; POLYSACCHARIDE; BUTYRATE; PEPTIDE; LIVER; MICE,"The effects of soluble dietary fiber (SDF) and cellulose (IDF) from Saccharina japonica by-product and their differences in improving constipation were further clarified in the present study. We demonstrated that SDF was mainly made up of D-mannuronic acid and D-mannose while IDF consisted of D-glucose , which is different from other reported dietary fibers of terrestrial plants. In this research, both SDF and IDF improved fecal-related in-dicators, gastrointestinal transit rate and histological morphology in Lop-induced mice. Moreover, they could increase the level of antioxidant enzymes (SOD and GSH-Px), restore the expression of enteric neurotransmitters, and maintain the function of ZO-1, JAM-1 as well as Occludin. Interestingly, SDF and IDF had a significant up -regulated effect on the proportion of Muribaculacea, Prevotellaceaen and Lachnospiraceae, which are critical to preserving intestinal immune homeostasis. Besides, they promoted the biosynthesis of short-chain fatty acids (SCFAs). The overall index showed that SDF is more effective for constipation due to its better water retention capacity. Thus, they can be used as a safe dietary supplement for the treatment of chronic or occasional con-stipation in humans.","[Cao, Junhan; Wang, Kai; Wang, Jingfeng] Ocean Univ China, Coll Food Sci & Engn, Qingdao 266003, Peoples R China; [Cao, Junhan; Wang, Kai; Li, Nianxu; Zhang, Liping; Qin, Ling; He, Yingying; Qu, Changfeng; Miao, Jinlai] Minist Nat Resources, Inst Oceanog 1, Key Lab Marine Ecoenvironm Sci & Technol, Qingdao 266061, Peoples R China; [Qu, Changfeng; Miao, Jinlai] Qingdao Pilot Natl Lab Marine Sci & Technol, Lab Marine Drugs & Bioprod, Qingdao 266237, Peoples R China; [Qu, Changfeng; Miao, Jinlai] Qingdao Key Lab, Marine Nat Prod R&D Lab, Qingdao 266061, Peoples R China","Ocean University of China; Ministry of Natural Resources of the People's Republic of China; First Institute of Oceanography, Ministry of Natural Resources; Laoshan Laboratory","Qu, CF; Miao, JL (corresponding author), Minist Nat Resources, Inst Oceanog 1, Key Lab Marine Ecoenvironm Sci & Technol, Qingdao 266061, Peoples R China.",cfqu@fio.org.cn; miaojinlai@fio.org.cn,"LIU, HAO/JBI-9623-2023; Jiang, Yalin/ITV-2565-2023; wang, juan/IUO-6218-2023; zhao, yujie/JLL-1283-2023; liu, liu/JEO-6900-2023; qin, ling/KIB-1029-2024; ZHOU, YUE/IZE-6277-2023; lu, qian/IUN-7445-2023; wang, wenjuan/JGD-0428-2023; zhang, yuyang/IVV-5089-2023; Yang, Yufei/JXX-6325-2024; he, he/JPL-3505-2023; Tang, Tang/KEI-2928-2024; He, Ying Ying/HZL-0137-2023; Wang, Yiping/IZQ-2052-2023; Wang, Chao/JHT-6081-2023; Liu, Ying/ISU-1216-2023","Jiang, Yalin/0009-0003-3726-8828; wang, wenjuan/0000-0002-4220-8817; He, Ying Ying/0000-0002-8759-3157;","Shandong Program of Qingdao Pilot National Laboratory for Marine Science and Technology [2022QNLM030003-1]; Basic Scientific Fund for National Public Research Institutes of China [2022Q10, 2020Q02]; Science and Technology Planning Project of Guangxi [AA21196002]; Natural Science Foundation of China [32000074, 42176130]; Natural Science Foundation of Shandong Province [ZR2021MD044]; Tai Mountain Industry Leading Talent of Shandong [2019TSCYCX-06]; Key Research and Development Program of Shandong Province [2021TZXD008]",Shandong Program of Qingdao Pilot National Laboratory for Marine Science and Technology; Basic Scientific Fund for National Public Research Institutes of China; Science and Technology Planning Project of Guangxi; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Tai Mountain Industry Leading Talent of Shandong; Key Research and Development Program of Shandong Province,"This work was supported by the Shandong Program of Qingdao Pilot National Laboratory for Marine Science and Technology [2022QNLM030003-1]; the Basic Scientific Fund for National Public Research Institutes of China [2022Q10] and [2020Q02]; Science and Technology Planning Project of Guangxi [AA21196002]; Natural Science Foundation of China [32000074] and [42176130]; Natural Science Foundation of Shandong Province [ZR2021MD044]; Tai Mountain Industry Leading Talent of Shandong [2019TSCYCX-06], and Key Research and Development Program of Shandong Province [2021TZXD008]",,52,8,8,17,51,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",0141-8130,1879-0003,,INT J BIOL MACROMOL,Int. J. Biol. Macromol.,JAN 31,2023,226,,,,,,1319,1331,,10.1016/j.ijbiomac.2022.11.243,http://dx.doi.org/10.1016/j.ijbiomac.2022.11.243,,DEC 2022,13,"Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science",Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Chemistry; Polymer Science,8A9EP,36511265,,,,2024-06-04,WOS:000916536700001,View Full Record in Web of Science
J,"Staiano, A; Simeone, D; Del Giudice, E; Miele, E; Tozzi, A; Toraldo, C",,,,"Staiano, A; Simeone, D; Del Giudice, E; Miele, E; Tozzi, A; Toraldo, C",,,Effect of the dietary fiber glucomannan on chronic constipation in neurologically impaired children,JOURNAL OF PEDIATRICS,,,English,Article,,,,,,,BOWEL FUNCTION; TRANSIT; BRAN,"Objective: Inadequate dietary fiber intake is a widely accepted explanation for chronic constipation in children with severe brain damage. The aim of our study was to evaluate the efficacy of glucomannan, a soluble fiber, as a treatment for chronic constipation in these children. Study design: Twenty children with severe brain damage and chronic constipation were randomly assigned to double-blind treatment with either glucomannan (n = 10) or placebo (n = 10) for 12 weeks. Stool habits, total and segmental gastrointestinal transit times, and anorectal motility were evaluated in all children before and after the treatment period. Results: Glucomannan significantly increased (P < .01) stool frequency, whereas the effect of placebo was not significant. Laxative or suppository use was significantly reduced (P <.01) by glucomannan but was not affected by placebo. Clinical scores of stool consistency were significantly improved and episodes of painful defecation per week were significantly reduced by glucomannan (P < .01) but not by placebo. However, neither glucomannan nor placebo had a measurable effect on total and segmental transit times. Conclusions: In neurologically impaired children, glucomannan improves stool frequency but has no effect on colonic motility. (J Pediatr 2000;136: 41-5).","Univ Naples Federico II, Dipartimento Pediat, I-80131 Naples, Italy",University of Naples Federico II,"Staiano, A (corresponding author), Univ Naples Federico II, Dipartimento Pediat, Via S Pansini 5, I-80131 Naples, Italy.",,"Miele, Erasmo/A-1906-2010; Staiano, Annamaria/H-3026-2011; Tozzi, Arturo/M-2174-2014","Staiano, Annamaria/0000-0003-0586-1339; Tozzi, Arturo/0000-0001-8426-4860",,,,,17,64,69,0,4,MOSBY-ELSEVIER,NEW YORK,"360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA",0022-3476,1097-6833,,J PEDIATR-US,J. Pediatr.,JAN,2000,136,1,,,,,41,45,,10.1016/S0022-3476(00)90047-7,http://dx.doi.org/10.1016/S0022-3476(00)90047-7,,,5,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,277AF,10636972,,,,2024-06-04,WOS:000084910000012,View Full Record in Web of Science
J,"Mälkki, Y",,,,"Mälkki, Y",,,Trends in dietary fibre research and development -: A review,ACTA ALIMENTARIA,,,English,Review,,,,,,dietary fibre; cholesterol; glycemic effects; weight control; cancer risks; antioxidants; lignans; prebiotics; immunological effects,OAT BETA-GLUCAN; ISCHEMIC-HEART-DISEASE; GLYCEMIC INDEX DIET; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; GUAR GUM; PLASMA-GLUCOSE; LIPID PROFILE; SERUM-LIPIDS; RISK-FACTORS,"In the past twenty years, the main interest in increasing dietary fibre intake has been to reduce risk of coronary heart disease. In addition to the reduction of blood cholesterol by soluble viscous dietary fibre, this risk is also reduced by antioxidative and fibrinolytic effects. Attenuating levels and fluctuations of blood glucose and insulin have interest not only for diabetic people, but also for improving endurance in sports or physical work, and because of the multitude of physiological effects of insulin as well. Dietary fibre is also in a key position in weight control due to its effect on satiety. New data on the effects of fibre on the intestinal function have shown advantages of soluble fibre sources, partly due to their ability to support selectively the growth of beneficial bacteria, and partly by alleviating constipation. Both soluble and insoluble fibres have effects which reduce risks of cancers, not only colorectal cancer. In applications, the trend is now towards a more specific use of the different types and sources of dietary fibre.","Cerefi Ltd, FIN-02160 Espoo, Finland",,"Cerefi Ltd, Lyokkiniemi 24, FIN-02160 Espoo, Finland.",yrjo.malkki@kolombus.fi,,,,,,,137,36,41,0,40,AKADEMIAI KIADO ZRT,BUDAPEST,"BUDAFOKI UT 187-189-A-3, H-1117 BUDAPEST, HUNGARY",0139-3006,1588-2535,,ACTA ALIMENT HUNG,Acta Aliment.,MAR,2004,33,1,,,,,39,62,,10.1556/AAlim.33.2004.1.5,http://dx.doi.org/10.1556/AAlim.33.2004.1.5,,,24,Food Science & Technology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Nutrition & Dietetics,846MH,,,,,2024-06-04,WOS:000223319300005,View Full Record in Web of Science
J,"Salvatore, S; Battigaglia, MS; Murone, E; Dozio, E; Pensabene, L; Agosti, M",,,,"Salvatore, Silvia; Battigaglia, Maria Serena; Murone, Elena; Dozio, Eugenia; Pensabene, Licia; Agosti, Massimo",,,Dietary Fibers in Healthy Children and in Pediatric Gastrointestinal Disorders: A Practical Guide,NUTRIENTS,,,English,Review,,,,,,dietary fiber; children; prebiotics; fermentation; microbiota; SCFAs; functional gastrointestinal disorders; inflammatory bowel disease; diet,IRRITABLE-BOWEL-SYNDROME; HYDROLYZED GUAR GUM; WHOLE-GRAIN INTAKE; DOUBLE-BLIND; FUNCTIONAL CONSTIPATION; ABDOMINAL-PAIN; GALACTO-OLIGOSACCHARIDE; CHILDHOOD CONSTIPATION; INFANT FORMULA; PSYLLIUM FIBER,"Dietary fibers include non-digestible plant carbohydrates, lignin and resistant starch. Dietary fibers provide immune, cardiovascular, metabolic and intestinal beneficial effects in humans. Fibers naturally present in foods (fruits, vegetables, legumes, cereals) or used as supplements have different physical, chemical and functional profiles. This narrative review provides an update to the knowledge on the effects of dietary fibers in healthy subjects and in children with gastrointestinal disorders. Soluble fibers are digested by gut bacteria, producing short-chain fatty acids and energy for colonocytes, and may exert prebiotic effects that promote the growth of bifidobacteria and lactobacilli. Non-soluble fibers are bulking agents and may improve intestinal transit. The exact amount and characteristics of the fiber requirement in infants and children need to be further established. There are limited data evaluating fibers in children with gastrointestinal disorders. The low intake of fibers has been associated with constipation, but the intake of excessive fibers is not recommended as it may cause flatulence and abdominal discomfort. Certain fibers (particularly psyllium in irritable bowel syndrome) have shown beneficial effects in children with gastrointestinal disorders, but the limited and heterogenous data do not currently allow a specific recommendation.","[Salvatore, Silvia; Agosti, Massimo] Univ Insubria, Hosp F Ponte, Pediat Dept, Via F Ponte 19, I-21100 Varese, Italy; [Battigaglia, Maria Serena; Murone, Elena; Pensabene, Licia] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Pediat Unit, Viale Europa, I-88100 Catanzaro, Italy; [Dozio, Eugenia] Univ Insubria, Dipartimento Med & Chirurg, I-21100 Varese, Italy",University of Insubria; Magna Graecia University of Catanzaro; University of Insubria,"Salvatore, S (corresponding author), Univ Insubria, Hosp F Ponte, Pediat Dept, Via F Ponte 19, I-21100 Varese, Italy.",silvia.salvatore@uninsubria.it; mariaserena.battigaglia@studenti.unicz.it; elenamurone@gmail.com; eugenia.dozio@uninsubria.it; pensabene@unicz.it; massimo.agosti@uninsubria.it,,,,,,,84,10,10,7,21,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,MAY 6,2023,15,9,,,,,,,2208,10.3390/nu15092208,http://dx.doi.org/10.3390/nu15092208,,,17,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,G2NN9,37432354,"Green Published, gold",,,2024-06-04,WOS:000987588800001,View Full Record in Web of Science
J,"Walia, R; Mahajan, L; Steffen, R",,,,"Walia, Ritu; Mahajan, Lori; Steffen, Rita",,,Recent advances in chronic constipation,CURRENT OPINION IN PEDIATRICS,,,English,Review,,,,,,children; constipation; encopresis,PLAIN ABDOMINAL RADIOGRAPHS; ANTEGRADE CONTINENCE ENEMA; CHILDHOOD CONSTIPATION; CHILDREN; PREVALENCE; COMMUNITY; SYMPTOMS; TRANSIT; STOOL,"Purpose of review Chronic constipation remains one of the most frequent complaints in primary and subspecialty pediatric clinics. It is associated with significant emotional and economic burden for both the children and the caregivers. Recently, advances have expanded our understanding of the pathophysiology and treatment options for children with chronic constipation. Here, we review current strategies addressing the cause, diagnostic technologies and treatments of chronic constipation. Recent findings There is some new information presented here on techniques for diagnosis and long-term complications associated with chronic childhood constipation. Comparative data on current laxatives and the development of medications with novel mechanisms of action are reviewed for a glimpse into the horizon of possible new treatments for children with chronic constipation. Studies on effects of growth, quality of life, dietary fiber and symptoms, which may coexist with constipation, are discussed. Summary The recent literature on chronic constipation has provided some new knowledge providing a more evidence-based approach to treating these patients. We review the scope of this problem and the estimated cost of treating constipation. The availability of long-term outcome data enhances our understanding of the natural history of this problem. Newer pharmacological approaches provide optimism for treatment for this common problem.","[Walia, Ritu; Mahajan, Lori; Steffen, Rita] Childrens Hosp, Cleveland Clin, Dept Pediat Gastroenterol & Nutr, Cleveland, OH 44195 USA",Cleveland Clinic Foundation,"Steffen, R (corresponding author), Childrens Hosp, Cleveland Clin, Dept Pediat Gastroenterol & Nutr, 9500 Euclid Ave, Cleveland, OH 44195 USA.",steffer@ccf.org,,,,,,,35,56,58,1,25,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",1040-8703,1531-698X,,CURR OPIN PEDIATR,CURR. OPIN. PEDIATR.,OCT,2009,21,5,,,,,661,666,,10.1097/MOP.0b013e32832ff241,http://dx.doi.org/10.1097/MOP.0b013e32832ff241,,,6,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,502UV,19606041,,,,2024-06-04,WOS:000270486700019,View Full Record in Web of Science
J,"Murakami, K; Sasaki, S; Okubo, H; Takahashi, Y; Hosoi, Y; Itabashi, M",,,,"Murakami, Kentaro; Sasaki, Satoshi; Okubo, Hitomi; Takahashi, Yoshiko; Hosoi, Yoko; Itabashi, Mami",,Freshmen Dietetic Courses Study II,"Food intake and functional constipation: A cross-sectional study of 3,835 Japanese women aged 18-20 years",JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY,,,English,Article,,,,,,dietary fiber; food; rice; functional constipation; epidemiology,DIET HISTORY QUESTIONNAIRE; LIFE-STYLE FACTORS; POPULATION; VALIDITY; FREQUENCY; COMMUNITY,"Although we previously observed significant associations between intakes of several foods and constipation, definition of constipation was completely based on subjective perception assessed by a quite simple and single question: do you often have constipation? In this study, we examined the associations between food intake and functional constipation as defined according to symptom-based criteria (Rome I criteria: straining, hard stools, incomplete evacuation. and infrequency of bowel movement). Subjects were 3,835 female Japanese dietetic students aged 18-20y from 53 institutions in Japan. Dietary intake was estimated with a validated, self-administered diet history questionnaire. The prevalence of functional constipation was 26.2%. Dietary intakes of several foods were significantly associated with functional constipation. A multivariate adjusted odds ratio (95%) confidence interval; p for trend) for women in the highest quintile of dietary intake compared with those in the lowest was 0.59 (0.46-0.75: < 0.0001) for rice, 0.77 (0.61-0.97: 0.003) for pulses, 1.64 (1.30-2.08: < 0.0001) for confectioneries, and 1.41 (1.11-1.78: 0.01) for bread. In conclusion. intake of rice and pulse was negatively and that of confectioneries and bread was positively associated with functional constipation among a population of young Japanese women, which was generally consistent with our previous study where constipation was assessed by a quite simple question.","Natl Inst Hlth & Nutr, Nutr Epidemiol Program, Tokyo 1628636, Japan",National Institute of Health & Nutrition - Japan,"Sasaki, S (corresponding author), Natl Inst Hlth & Nutr, Nutr Epidemiol Program, Tokyo 1628636, Japan.",stssasak@nih.go.jp,"Okubo, Hitomi/AAB-7613-2020","Okubo, Hitomi/0000-0002-2305-0719; Murakami, Kentaro/0000-0002-4189-7753",,,,,30,15,19,1,5,CENTER ACADEMIC PUBL JAPAN,TOKYO,"2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN",0301-4800,1881-7742,,J NUTR SCI VITAMINOL,J. Nutr. Sci. Vitaminol.,FEB,2007,53,1,,,,,30,36,,10.3177/jnsv.53.30,http://dx.doi.org/10.3177/jnsv.53.30,,,7,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,142PY,17484376,gold,,,2024-06-04,WOS:000244663200005,View Full Record in Web of Science
J,"Velio, P; Bassotti, G",,,,"Velio, P; Bassotti, G",,,Chronic idiopathic constipation: Pathophysiology and treatment,JOURNAL OF CLINICAL GASTROENTEROLOGY,,,English,Article,,,,,,chronic constipation; normal transit; slow transit; pathophysiology; treatment,SLOW TRANSIT CONSTIPATION; IRRITABLE-BOWEL-SYNDROME; PELVIC FLOOR DISORDERS; COLONIC MOTILITY; YOUNG-WOMEN; EVACUATION PROCTOGRAPHY; MOTOR-ACTIVITY; DIETARY FIBER; COLECTOMY; ADULTS,"Chronic constipation is common-in the general population, especially in women, in its idiopathic form. However, confusion still surrounds its definition, despite recent efforts to standardize it. Constipation can be divided in two large subgroups - normal transit and slow transit. They have different pathophysiological bases still not completely understood. Most patients respond to simple therapeutic measures aimed at correcting dietary fiber intake and lifestyle. Others, however, need more aggressive treatment, including laxatives, psychological therapy, and biofeedback. In a few patients with intractable constipation, surgery might be indicated to give relief.","UNIV MILAN, OSPED MAGGIORE,IRCCS,IST SCI MED, CATTEDRA GASTROENTEROL, MILAN, ITALY; UNIV PERUGIA, DIPARTIMENTO MED CLIN PATOL & FARMACOL, I-06100 PERUGIA, ITALY; UNIV N CAROLINA, CTR FUNCT GASTROINTESTINAL DIS, CHAPEL HILL, NC USA; UNIV N CAROLINA, DEPT MED, DIV DIGEST DIS & NUTR, CHAPEL HILL, NC USA",IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Perugia; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill,,,,,,,,,91,31,34,0,5,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0192-0790,1539-2031,,J CLIN GASTROENTEROL,J. Clin. Gastroenterol.,APR,1996,22,3,,,,,190,196,,10.1097/00004836-199604000-00008,http://dx.doi.org/10.1097/00004836-199604000-00008,,,7,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,UF813,8724256,,,,2024-06-04,WOS:A1996UF81300008,View Full Record in Web of Science
J,"Venancio, VP; Kim, H; Sirven, MA; Tekwe, CD; Honvoh, G; Talcott, ST; Mertens-Talcott, SU",,,,"Venancio, Vinicius P.; Kim, Hyemee; Sirven, Maritza A.; Tekwe, Carmen D.; Honvoh, Gilson; Talcott, Stephen T.; Mertens-Talcott, Susanne U.",,,Polyphenol-rich Mango (Mangifera indica L.) Ameliorate Functional Constipation Symptoms in Humans beyond Equivalent Amount of Fiber,MOLECULAR NUTRITION & FOOD RESEARCH,,,English,Article,,,,,,chronic constipation; gallotannins; inflammation; mango; polyphenols,HIGH-FAT DIET; DOUBLE-BLIND; STOOL FREQUENCY; GUT MICROBIOTA; QUALITY; TRANSIT; HEALTH; GALLOTANNINS; MECHANISMS; MANAGEMENT,"Scope: Chronic constipation is a common gastrointestinal condition associated with intestinal inflammation and considerably impaired quality of life, affecting about 20% of Americans. Dietary fiber and laxatives aid in its treatment but do not fully address all symptoms, such as intestinal inflammation. Mango (Mangifera indica L.), a fiber- and polyphenol-rich fruit may provide anti-inflammatory effects in constipation. Methods and results: The 4 week consumption of mango fruit (300 g) or the equivalent amount of fiber is investigated in otherwise healthy human volunteers with chronic constipation who are randomly assigned to either group. Blood and fecal samples and digestive wellness questionnaires are collected at the beginning and end of the study. Results show that mango consumption significantly improve constipation status (stool frequency, consistency, and shape) and increase gastrin levels and fecal concentrations of short chain fatty acid (valeric acid) while lowering endotoxin and interleukin 6 concentrations in plasma. Conclusion: In this pilot study, the consumption of mango improves symptoms and associated biomarkers of constipation beyond an equivalent amount of fiber. Larger follow-up studies would need to investigate biomarkers for intestinal inflammation in more detail.","[Venancio, Vinicius P.; Kim, Hyemee; Sirven, Maritza A.; Talcott, Stephen T.; Mertens-Talcott, Susanne U.] Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX 77843 USA; [Tekwe, Carmen D.; Honvoh, Gilson] Texas A&M Univ, Dept Epidemiol & Biostat, College Stn, TX 77843 USA",Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station,"Mertens-Talcott, SU (corresponding author), Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX 77843 USA.",smtalcott@tamu.edu,"Tekwe, Carmen D/W-4737-2017; Venancio, Vinicius/H-8188-2012","Kim, Hyemee/0000-0002-0713-3952; Venancio, Vinicius/0000-0003-3239-6380","National Mango Board (Orlando, FL); [U01-057030]","National Mango Board (Orlando, FL);","The authors would like to thank the National Mango Board (Orlando, FL) for funding for the presented research. C.D.T's research was supported by a diversity supplement to the National Cancer Institute (NCI), grant U01-057030. V.P.V. conducted the clinical trial, analyzed plasma samples and questionnaire entries, and wrote the manuscript. H.K. analyzed samples for short-chain fatty acids and endotoxin. M.A.S. performed the polyphenol composition of mango fruit. C.D.T. and G.H. performed the statistical analyses. S.T.T. and S.U.M.-T. supervised the all steps of the clinical trial and wrote the manuscript.",,55,28,30,3,57,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1613-4125,1613-4133,,MOL NUTR FOOD RES,Mol. Nutr. Food Res.,JUN,2018,62,12,,,,,,,1701034,10.1002/mnfr.201701034,http://dx.doi.org/10.1002/mnfr.201701034,,,8,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,GK2HG,29733520,,,,2024-06-04,WOS:000435947600008,View Full Record in Web of Science
J,"ANDERSON, AS",,,,"ANDERSON, AS",,,DIETARY FACTORS IN THE ETIOLOGY AND TREATMENT OF CONSTIPATION DURING PREGNANCY,BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY,,,English,Article,,,,,,,,"Using a 7-day weighed-intake method, dietary factors implicated in the aetiology of constipation were examined by comparison between the nutrient intakes of nine women with constipation in the third trimester of pregnancy who had not altered their diets, and a matched group of nine women who had not suffered constipation at any time during pregnancy. No significant differences were found for intakes of major nutrients, including dietary fibre, between the constipated and non-constipated groups, including dietary fibre, between the constipated and non-constipated groups, indicating that inappropriate diets do not appear to be the primary cause of constipation during pregnancy. The nutrient intakes of 40 women with constipation in the third trimester of pregnancy were examined to assess dietary changes made in attempts to treat constipation. No difference in intakes of dietary fibre were found between those who claimed to have increased their intakes, and those who had not altered their diets. Both were well below the level of dietary fibre intake known to be successful in treating constipation.","ADDENBROOKES HOSP, OFF REGIUS PROF PHYS, CAMBRIDGE CB2 2QQ, ENGLAND",University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital,,,,"anderson, annie/0000-0002-0047-4500",,,,,13,27,30,0,5,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",0306-5456,,,BRIT J OBSTET GYNAEC,Br. J. Obstet. Gynaecol.,MAR,1986,93,3,,,,,245,249,,10.1111/j.1471-0528.1986.tb07901.x,http://dx.doi.org/10.1111/j.1471-0528.1986.tb07901.x,,,5,Obstetrics & Gynecology,Science Citation Index Expanded (SCI-EXPANDED),Obstetrics & Gynecology,A4964,3008805,,,,2024-06-04,WOS:A1986A496400010,View Full Record in Web of Science
C,"Sezini, AM; Guimaraes, EV",,"FagundesNeto, U; Uauy, R",,"Sezini, A. M.; Guimaraes, E. V.",,,Dietary Aspects in Functional Intestinal Constipation Children,"WCPGHAN 3: WORLD CONGRESS OF PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY AND NUTRITION",,,English,Proceedings Paper,"3rd World Congress of Pediatric Gastroenterology, Hepatology and Nutrition","AUG 16-20, 2008","Iguazu Falls, BRAZIL",Federat Int Soc Pediat Gastroenterol Hepatol & Nutrit,,,CHILDHOOD CONSTIPATION; FIBER,"The study aim was to investigate the correlation between the ingestion of alimentary fibers and the pharmacological treatment of children with chronic functional intestinal constipation that have presented good response to the treatment. The study was performed with 35 children from 4 to 14 years old, of both genders, with clinical diagnosis of constipation. A questionnaire was developed to gather required information, including the time spent on treatment, the intestinal habit and the medication utilized. The daily ingestion of fiber recommended by Williams et al (1995) was adopted for evaluation purposes. The masculine gender represented 51.4% of the total population. The mean age was 95 months. The amount of fibers ingested by 70% of the children was higher than the minimum recommended level. The results did not indicate meaningful correlations between the ingestion of fibers, the dosage and the time required to achieve positive response to the treatment with laxatives.","[Sezini, A. M.; Guimaraes, E. V.] Univ Fed Minas Gerais, Coll Med, Dept Pediat, Belo Horizonte, MG, Brazil",Universidade Federal de Minas Gerais,"Sezini, AM (corresponding author), Univ Fed Minas Gerais, Coll Med, Dept Pediat, Belo Horizonte, MG, Brazil.",,,,,,,,9,0,0,0,3,MEDIMOND S R L,40128 BOLOGNA,"VIA MASERATI 5, 40128 BOLOGNA, 00000, ITALY",,,978-88-7587-486-5,,,,2008,,,,,,,75,78,,,,,,4,Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,Conference Proceedings Citation Index - Science (CPCI-S),Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,BLZ47,,,,,2024-06-04,WOS:000271564000015,View Full Record in Web of Science
J,"Jennings, A; Davies, GJ; Costarelli, V; Dettmar, PW",,,,"Jennings, Amy; Davies, G. Jill; Costarelli, Vassiliki; Dettmar, Peter W.",,,"Dietary fibre, fluids and physical activity in relation to constipation symptoms in pre-adolescent children",JOURNAL OF CHILD HEALTH CARE,,,English,Article,,,,,,childhood; nutrition; child health,COLONIC TRANSIT-TIME; CHILDHOOD CONSTIPATION; STOOL FREQUENCY; CONSUMPTION; ADOLESCENTS; MANAGEMENT; LIFE,"Children with constipation are advised frequently to increase their activity levels, fluids and fibre intake. The aim of this study was to examine the prevalence of constipation symptoms in a group of schoolchildren while concurrently assessing their activity levels and fluid and fibre intakes. Eighty-four pre-adolescent children aged 7-10 years were recruited. All children completed a bowel function diary, an activity diary and a weighed food inventory for seven consecutive days. Of the children, 33 percent were found to experience constipation symptoms. Fluid and fibre intakes were higher in the children who did not experience constipation symptoms, but the results were not significant. Physical activity levels were found to be significantly higher in the children reporting constipation symptoms, with the most active children reporting low water intakes. This study has highlighted that constipation symptoms are a prevalent problem in children not seeking medical treatment.","[Jennings, Amy] Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England; [Davies, G. Jill] S Bank Univ, Acad Sport Phys Act & Wellbeing, London SE1 0AA, England; [Costarelli, Vassiliki] Harokopio Univ, Dept Home Econ & Ecol, Athens, Greece; [Dettmar, Peter W.] Technost Ltd, Kingston Upon Hull, Yorks, England",University of East Anglia; London South Bank University; Harokopio University Athens,"Jennings, A (corresponding author), Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England.",amy.jennings@uea.ac.uk,"Costarelli, Vassiliki/AAM-1210-2020","Costarelli, Vassiliki/0000-0002-3863-838X",,,,,29,40,44,2,28,SAGE PUBLICATIONS LTD,LONDON,"1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND",1367-4935,1741-2889,,J CHILD HEALTH CARE,J. Child Health Care,JUN,2009,13,2,,,,,116,127,,10.1177/1367493509102469,http://dx.doi.org/10.1177/1367493509102469,,,12,Nursing; Pediatrics,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Nursing; Pediatrics,645YX,19458167,,,,2024-06-04,WOS:000281503200004,View Full Record in Web of Science
J,"Haynes, L; Atherton, D; Clayden, G",,,,"Haynes, L; Atherton, D; Clayden, G",,,Constipation in epidermolysis bullosa: Successful treatment with a liquid fiber-containing formula,PEDIATRIC DERMATOLOGY,,,English,Article,,,,,,,DIETARY FIBER; NUTRITION; CHILDREN,"In epidermolysis bullosa (EB), chronic constipation, painful defecation, and fecal impaction frequently contribute to malnutrition and growth failure. Standard treatments for constipation, such as increased intake of conventional dietary fiber and fluids and/or the use of laxatives and stool softeners, are largely unsuccessful. We evaluated by questionnaire the use of a fiber-containing liquid formula (Enrich(R)) in 20 chronically constipated children with dystrophic EB. All derived substantial improvement in constipation when taking 250 to 750 ml Enrich(R) per day. We recommend that such a fiber-containing food be prescribed for chronic constipation in EB. In cases of fecal impaction, this should be preceded by bowel cleansing.","GREAT ORMOND ST HOSP CHILDREN NHS TRUST,DEPT DERMATOL,LONDON WC1N 3JH,ENGLAND",University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust,,,,,,,,,15,10,10,0,2,BLACKWELL SCIENCE INC,MALDEN,"350 MAIN ST, MALDEN, MA 02148",0736-8046,,,PEDIATR DERMATOL,Pediatr. Dermatol.,SEP-OCT,1997,14,5,,,,,393,396,,10.1111/j.1525-1470.1997.tb00991.x,http://dx.doi.org/10.1111/j.1525-1470.1997.tb00991.x,,,4,Dermatology; Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Dermatology; Pediatrics,XZ834,9336815,,,,2024-06-04,WOS:A1997XZ83400016,View Full Record in Web of Science
J,"Jones, JW; Lamont, KL; Stoltenberg, JN; Brannan, GD",,,,"Jones, J. Wesley; Lamont, Katrina L.; Stoltenberg, Jennifer N.; Brannan, Grace D.",,,"A Low Cost, Novel Treatment of Severe Diabetic Gastroparesis Based on Burkitt's Dietary Fiber Hypothesis",CUREUS JOURNAL OF MEDICAL SCIENCE,,,English,Article,,,,,,abdominal distension; treatment; abdominal bloating; constipation; dietary fiber; gastroparesis; intestinal dysmotility; gastric emptying; intestinal transit,ORAL ENDOSCOPIC PYLOROMYOTOMY; TRANSIT-TIMES; ASSOCIATION; DIAGNOSIS; IMPACT,"We report a seven-year follow-up of a 43-year-old Hispanic female with severe diabetic gastroparesis (GP) and a 42.5 kg weight loss (45% of body mass), who required feeding jejunostomy tube placement. The patient had an excellent response to a treatment regime directed at increasing stool bulk, enhancing gut transit, and mobilizing intestinal gas by using dietary fiber supplements and osmotic laxatives with as needed tap water enemas. Hospital cost savings for this patient exceeded $125,000 annually. This case study suggests that constipation may substantially contribute to GP.","[Jones, J. Wesley; Lamont, Katrina L.; Stoltenberg, Jennifer N.] Campbell Univ, Dept Internal Med, Jerry M Wallace Sch Osteopath Med, Buies Creek, NC 27506 USA; [Brannan, Grace D.] McLaren Macomb Hosp, Dept Internal Med, Mt Clemens, MI USA",Campbell University,"Jones, JW (corresponding author), Campbell Univ, Dept Internal Med, Jerry M Wallace Sch Osteopath Med, Buies Creek, NC 27506 USA.",jwesjonesmd@gmail.com,"Brannan, Grace/HTP-7485-2023","Brannan, Grace/0000-0001-6801-0617; Jones, J Wesley/0000-0002-8097-8214",,,,,25,2,2,0,3,SPRINGERNATURE,LONDON,"CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND",,2168-8184,,CUREUS J MED SCIENCE,Cureus J Med Sci,SEP 17,2021,13,9,,,,,,,e18062,10.7759/cureus.18062,http://dx.doi.org/10.7759/cureus.18062,,,6,"Medicine, General & Internal",Emerging Sources Citation Index (ESCI),General & Internal Medicine,UY6YD,34552840,"Green Published, gold",,,2024-06-04,WOS:000701666000007,View Full Record in Web of Science
J,"Markland, AD; Palsson, O; Goode, PS; Burgio, KL; Busby-Whitehead, J; Whitehead, WE",,,,"Markland, Alayne D.; Palsson, Olafur; Goode, Patricia S.; Burgio, Kathryn L.; Busby-Whitehead, Jan; Whitehead, William E.",,,Association of Low Dietary Intake of Fiber and Liquids With Constipation: Evidence From the National Health and Nutrition Examination Survey,AMERICAN JOURNAL OF GASTROENTEROLOGY,,,English,Article,,,,,,,RISK-FACTORS; EPIDEMIOLOGY; POPULATION; CARE,"OBJECTIVES: Epidemiological studies support an association of self-defined constipation with fiber and physical activity, but not liquid intake. The aims of this study were to assess the prevalence and associations of dietary fiber and liquid intake to constipation. METHODS: Analyses were based on data from 10,914 adults (>= 20 years) from the 2005-2008 cycles of the National Health and Nutrition Examination Surveys. Constipation was defined as hard or lumpy stools (Bristol Stool Scale type 1 or 2) as the usual or most common stool type. Dietary fiber and liquid intake from total moisture content were obtained from dietary recall. Co-variables included: age, race, education, poverty income ratio, body mass index, self-reported general health status, chronic illnesses, and physical activity. Prevalence estimates and prevalence odds ratios (POR) were analyzed in adjusted multivariable models using appropriate sampling weights. RESULTS: Overall, 9,373 (85.9%) adults (4,787 women and 4,586 men) had complete stool consistency and dietary data. Constipation rates were 10.2% (95% confidence interval (CI): 9.6, 10.9) for women and 4.0% (95% CI: 3.2, 5.0) for men (P<.001). After multivariable adjustment, low liquid consumption remained a predictor of constipation among women (POR: 1.3, 95% CI: 1.0, 1.6) and men (POR: 2.4, 95% CI: 1.5, 3.9); however, dietary fiber was not a predictor. Among women, African-American race/ethnicity (POR: 1.4, 95% CI: 1.0, 1.9), being obese (POR: 0.7, 95% CI: 0.5,0.9), and having a higher education level (POR: 0.8, 95% CI: 0.7, 0.9) were significantly associated with constipation. CONCLUSIONS: The findings support clinical recommendations to treat constipation with increased liquid, but not fiber or exercise.","[Markland, Alayne D.; Goode, Patricia S.; Burgio, Kathryn L.] Vet Affairs Med Ctr, Dept Vet Affairs Med Ctr, Birmingham Atlanta Geriatr Res Educ & Clin Ctr, Birmingham, AL 35233 USA; [Markland, Alayne D.; Goode, Patricia S.; Burgio, Kathryn L.] Univ Alabama Birmingham, Sch Med, Ctr Aging, Div Gerontol Geriatr & Palliat Care, Birmingham, AL USA; [Palsson, Olafur; Whitehead, William E.] Univ N Carolina, Div Gastroenterol & Hepatol, Ctr Funct Gastrointestinal & Motil Disorders, Chapel Hill, NC USA; [Busby-Whitehead, Jan] Univ N Carolina, Div Geriatr Med, Ctr Aging & Hlth, Chapel Hill, NC USA",Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill,"Markland, AD (corresponding author), Vet Affairs Med Ctr, Dept Vet Affairs Med Ctr, Birmingham Atlanta Geriatr Res Educ & Clin Ctr, GRECC 11G,700 19th St S, Birmingham, AL 35233 USA.",amarkland@aging.uab.edu,,"Palsson, Olafur/0000-0002-4480-3708",Veterans Health Administration Career Development Award; [R01 DK31369],Veterans Health Administration Career Development Award;,is study was supported in part from a Veterans Health Administration Career Development Award (CDA-2) to Dr A. D. Markland and supported in part by R01 DK31369 to Dr W. E. Whitehead.,,23,116,128,0,40,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0002-9270,1572-0241,,AM J GASTROENTEROL,Am. J. Gastroenterol.,MAY,2013,108,5,,,,,796,803,,10.1038/ajg.2013.73,http://dx.doi.org/10.1038/ajg.2013.73,,,8,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,141FE,23567352,Green Accepted,,,2024-06-04,WOS:000318710200018,View Full Record in Web of Science
J,"Sant'Anna, AMGD; Calçado, AC",,,,"Sant'Anna, AMGD; Calçado, AC",,,"Constipation in school-aged children at public schools in Rio de Janeiro, Brazil",JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION,,,English,Article,,,,,,children; fecal soiling; fiber intake; prevalence of constipation,SEEKING HEALTH-CARE; UNITED-STATES; DIETARY FIBER; CHILDHOOD; PATTERNS; MANAGEMENT; POPULATION; ENCOPRESIS; DISORDERS,"Background: Constipation in childhood is a significant problem worldwide; however, understanding of its epidemiology is limited. Some investigators in the United States have estimated the prevalence of constipation to be 1.2% to 8.0% in the general population. Ln Brazil, some have found a prevalence of up to 36%. Methods: This cross-sectional, descriptive, observational prevalence study included 391 pupils (age range, 8-10 years) who were attending three public education centers in Rio de Janeiro. The prevalence of constipation, associated symptoms, and dietary fiber intake were evaluated by questionnaire. A child was considered to be constipated when he or she reported difficulty in defecating two or more times per week. The children were divided into constipated and nonconstipated groups, and the presence of fecal soiling, blood in the feces, and shape of the frees were assessed. Results: Twenty-eight percent of the children were constipated. There was no significant difference between the sexes. Blood in the stools was significantly more frequently reported by the constipated children (p < 0.01). There was no significant difference in the prevalence and frequency of fecal soiling or in the stool shape between the constipated and nonconstipated children (p > 0.1). Fiber content in the diet ranged from 3.4 to 4.8 g per day, which is below the range recommended. Conclusions: The prevalence of constipation in Rio de Janeiro is similar to the rates reported in all of Brazil and in a recent study from the United Kingdom but is much higher than that in the United States. In addition, the school menu was found to contain inadequate dietary fiber content.","Univ Fed Rio de Janeiro, Fac Med, Dept Pediat, Rio De Janeiro, Brazil; Univ Fed Rio de Janeiro, Fac Med, Pediat Gastroenterol Unit, Rio De Janeiro, Brazil",Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro,"Sant'Anna, AMGD (corresponding author), Rua Coelho Neto 70-101 Laranjeiras, BR-22231110 Rio De Janeiro, Brazil.",,,,,,,,27,46,54,0,1,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA",0277-2116,,,J PEDIATR GASTR NUTR,J. Pediatr. Gastroenterol. Nutr.,AUG,1999,29,2,,,,,190,193,,,,,,4,Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,216ZH,10435657,Bronze,,,2024-06-04,WOS:000081474000015,View Full Record in Web of Science
J,"Wang, MZ; Cha, RT; Hao, WS; Du, R; Zhang, P; Hu, YM; Jiang, XY",,,,"Wang, Mingzheng; Cha, Ruitao; Hao, Wenshuai; Du, Ran; Zhang, Pai; Hu, Yingmo; Jiang, Xingyu",,,Nanocrystalline Cellulose Cures Constipation via Gut Microbiota Metabolism,ACS NANO,,,English,Article,,,,,,nanocrystalline cellulose; nanocellulose; constipation; gut microbiota; metabolite,IRRITABLE-BOWEL-SYNDROME; CHAIN FATTY-ACIDS; CHRONIC IDIOPATHIC CONSTIPATION; LACTOBACILLUS-PLANTARUM; DIETARY FIBER; FUNCTIONAL CONSTIPATION; URSODEOXYCHOLIC ACID; BILE-ACIDS; MECHANISMS; MANAGEMENT,"Constipation can seriously affect the quality of life and increase the risk of colorectal cancer. The present strategies for constipation therapy have adverse effects, such as causing irreversible intestinal damage and affecting the absorption of nutrients. Nanocrystalline cellulose (NCC), which is from natural plants, has good biocompatibility and high safety. Herein, we used NCC to treat constipation assessed by the black stool, intestinal tissue sections, and serum biomarkers. We studied the effect of NCC on gut microbiota and discussed the correlation of gut microbiota and metabolites. We evaluated the long-term biosafety of NCC. NCC could effectively treat constipation through gut microbiota metabolism, which required a small dosage and did not affect the organs and intestines. NCC could be used as an alternative to medications and dietary fiber for constipation therapy.","[Wang, Mingzheng; Hao, Wenshuai; Zhang, Pai; Hu, Yingmo] China Univ Geosci Beijing, Sch Mat Sci & Technol, Beijing Key Lab Mat Utilizat Nonmetall Minerals &, Natl Lab Mineral Mat, Beijing 100083, Peoples R China; [Wang, Mingzheng; Cha, Ruitao; Hao, Wenshuai; Zhang, Pai] Natl Ctr Nano Sci & Technol, CAS Key Lab Biomed Effects Nanomat & Nanosafety, Beijing 100190, Peoples R China; [Du, Ran] Chinese Acad Agr Sci, Guangdong Lab Lingnan Modern Agr, Shenzhen Key Lab Agr Synthet Biol, Genome Anal Lab,Minist Agr & Rural Affairs,Shenzh, Shenzhen 518124, Guangdong, Peoples R China; [Jiang, Xingyu] Southern Univ Sci & Technol, Guangdong Prov Key Lab Adv Biomat, Shenzhen Key Lab Smart Healthcare Engn, Dept Biomed Engn, Shenzhen 518055, Guangdong, Peoples R China","China University of Geosciences; Chinese Academy of Sciences; National Center for Nanoscience & Technology, CAS; Guangdong Laboratory for Lingnan Modern Agriculture; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Southern University of Science & Technology","Hu, YM (corresponding author), China Univ Geosci Beijing, Sch Mat Sci & Technol, Beijing Key Lab Mat Utilizat Nonmetall Minerals &, Natl Lab Mineral Mat, Beijing 100083, Peoples R China.;Cha, RT (corresponding author), Natl Ctr Nano Sci & Technol, CAS Key Lab Biomed Effects Nanomat & Nanosafety, Beijing 100190, Peoples R China.;Du, R (corresponding author), Chinese Acad Agr Sci, Guangdong Lab Lingnan Modern Agr, Shenzhen Key Lab Agr Synthet Biol, Genome Anal Lab,Minist Agr & Rural Affairs,Shenzh, Shenzhen 518124, Guangdong, Peoples R China.;Jiang, XY (corresponding author), Southern Univ Sci & Technol, Guangdong Prov Key Lab Adv Biomat, Shenzhen Key Lab Smart Healthcare Engn, Dept Biomed Engn, Shenzhen 518055, Guangdong, Peoples R China.",chart@nanoctr.cn; duran@caas.cn; huyingmo@cugb.edu.cn; jiang@sustech.edu.cn,,"DU, RAN/0000-0002-6647-0780; Cha, Ruitao/0000-0001-6653-7263","National Key RAMP;D Program of China [2021YFF1200100, 2018YFA0902600]; National Natural Science Foundation of China [21875050, 32171397, 81730051]; Natural Science Foundation of Shenzhen [JCYJ20190814163201896]; Shenzhen Science and Technology Program [KQTD20190929172743294]; Guangdong Provincial Key Laboratory of Advanced Biomaterials [2022B1212010003]",National Key RAMP;D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shenzhen; Shenzhen Science and Technology Program; Guangdong Provincial Key Laboratory of Advanced Biomaterials,"We thank the National Key R&D Program of China (2021YFF1200100 and 2018YFA0902600), the National Natural Science Foundation of China (21875050, 32171397, and 81730051), the Natural Science Foundation of Shenzhen (JCYJ20190814163201896), Shenzhen Science and Technology Program (KQTD20190929172743294), and Guangdong Provincial Key Laboratory of Advanced Biomaterials (2022B1212010003) for financial support. We thank the Facility Center of Metabolomics and Lipidomics in Tsinghua University for their help on metabolome detection. We acknowledge the technical support from SUSTech CRF.",,102,12,12,21,97,AMER CHEMICAL SOC,WASHINGTON,"1155 16TH ST, NW, WASHINGTON, DC 20036 USA",1936-0851,1936-086X,,ACS NANO,ACS Nano,OCT 25,2022,16,10,,,,,16481,16496,,10.1021/acsnano.2c05809,http://dx.doi.org/10.1021/acsnano.2c05809,,SEP 2022,16,"Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary",Science Citation Index Expanded (SCI-EXPANDED),Chemistry; Science & Technology - Other Topics; Materials Science,7N5YY,36129390,,,,2024-06-04,WOS:000862658200001,View Full Record in Web of Science
J,"Paulo, AZ; Amancio, OMS; de Morais, MB; Tabacow, KMMD",,,,"Paulo, A. Z.; Amancio, O. M. S.; De Morais, M. B.; Tabacow, K. M. M. D.",,,Low-dietary fiber intake as a risk factor for recurrent abdominal pain in children,EUROPEAN JOURNAL OF CLINICAL NUTRITION,,,English,Article,,,,,,abdominal pain; child; dietary fiber,PEDIATRIC GASTROENTEROLOGY; MOTILITY; CLASSIFICATION; CHILDHOOD,"Objective: To evaluate dietary fiber intake in children with recurrent abdominal pain. Design: Cross-sectional study with control group. Setting: Outpatients of the Pediatric Gastroenterology public health clinic of the Darcy Vargas Children's Hospital, Brazil. Subjects: Forty-one patients with recurrent abdominal pain were evaluated and 41 children, as a control group. Interventions: Macronutrients and fiber intake evaluation by the Daily Food Intake method. Two tables of fiber composition in foods were used. Results: According to the Brazilian table the mean intake of fiber ( g/day) by the children of the recurrent abdominal pain groups with chronic constipation or not, and the control group was, respectively, 18.2, 16.6 and 23.7 for total fiber ( P 0.001), 7.5, 6.9 and 9.5 for soluble fiber ( P 0.001) and 10.7, 9.7 and 14.1 for insoluble fiber ( P 0.002). According to the AOAC table, the recurrent abdominal pain group with chronic constipation or not ( 10.6 and 9.9 g/day) also had lower intake of total fiber than the control group ( 13.4 g/day) ( P 0.008). The intake of fiber was lower than the minimum recommended value ( age+5g) and statistically associated ( P 0.021) with the recurrent abdominal pain group ( 78%) in comparison with the control one ( 51.2%). The odds ratio was 3.39 ( 95% CI, 1.18 - 9.95). Conclusion: fiber intake below the minimum recommended value is a risk factor for recurrent abdominal pain in children.","Univ Fed Sao Paulo, Dept Pediat, Paulista Sch Med, BR-04023062 Sao Paulo, Brazil; Darcy Vargas Childrens Hosp, Sao Paulo, Brazil",Universidade Federal de Sao Paulo (UNIFESP),"Amancio, OMS (corresponding author), Univ Fed Sao Paulo, Dept Pediat, Paulista Sch Med, Rua Botucatu 703, BR-04023062 Sao Paulo, Brazil.",omsamancio.dped@epm.br,"MORAIS, MAURO B/I-7995-2014","Batista de Morais, Mauro/0000-0003-4014-5549",,,,,40,21,23,1,7,NATURE PUBLISHING GROUP,LONDON,"MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND",0954-3007,1476-5640,,EUR J CLIN NUTR,Eur. J. Clin. Nutr.,JUL,2006,60,7,,,,,823,827,,10.1038/sj.ejcn.1602386,http://dx.doi.org/10.1038/sj.ejcn.1602386,,,5,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,059BT,16452916,,,,2024-06-04,WOS:000238709000002,View Full Record in Web of Science
J,"Kanauchi, O; Hitomi, Y; Agata, K; Nakamura, T; Fushiki, T",,,,"Kanauchi, O; Hitomi, Y; Agata, K; Nakamura, T; Fushiki, T",,,Germinated barley foodstuff improves constipation induced by loperamide in rats,BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY,,,English,Article,,,,,,germinated barley; butyrate; constipation; dietary fiber; rat,MUCOSAL PROTEIN-CONTENT; DIETARY FIBER,"The effects of germinated barley foodstuff (GBF) derived from the aleurone and scutellum fractions of germinated barley low-lignified hemicellulose were examined in Sprague-Dawley rats with constipation induced by loperamide by addition to the diet (2 mg/kg body weight). Bowel movements were higher in the GBF-fed rats than in the cellulose-fed rats used as a control. Fecal water content was also higher in the GBF-fed rats. The concentration of short chain fatty acids in cecal content, especially butyrate, was significantly higher in the GBF-fed rats than in the cellulose-fed rats. These findings suggested that GBF helps normalize defecation not only in diarrhea but also constipation.","Kirin Brewery Co Ltd, Corp Res & Dev Div, Appl Biores Ctr, Takasaki, Gumma 3701295, Japan; Kyoto Univ, Fac Agr, Dept Food Sci & Technol, Sakyo Ku, Kyoto 6068502, Japan",Kirin Brewery Company Limited; Kyoto University,"Kirin Brewery Co Ltd, Corp Res & Dev Div, Appl Biores Ctr, Miyaharacho 3, Takasaki, Gumma 3701295, Japan.",,,,,,,,20,12,13,0,2,TAYLOR & FRANCIS LTD,ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND",0916-8451,1347-6947,,BIOSCI BIOTECH BIOCH,Biosci. Biotechnol. Biochem.,SEP,1998,62,9,,,,,1788,1790,,10.1271/bbb.62.1788,http://dx.doi.org/10.1271/bbb.62.1788,,,3,"Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology",Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology,127TW,9805382,,,,2024-06-04,WOS:000076367500028,View Full Record in Web of Science
J,"Dierkes, J; Nwaru, BI; Ramel, A; Arnesen, EK; Thorisdottir, B; Lamberg-Allardt, C; Spielau, U; Söderlund, F; Bärebring, L; Åkesson, A",,,,"Dierkes, Jutta; Nwaru, Bright I.; Ramel, Alfons; Arnesen, Erik Kristoffer; Thorisdottir, Birna; Lamberg-Allardt, Christel; Spielau, Ulrike; Soderlund, Fredrik; Barebring, Linnea; Akesson, Agneta",,,"Dietary fiber and growth, iron status and bowel function in children 0-5 years old: a systematic review",FOOD & NUTRITION RESEARCH,,,English,Review,,,,,,dietary fiber; children; iron; growth,CONSTIPATION; VEGETARIAN; CHILDHOOD; RISK; INFANTS; VEGAN,"Background: While dietary fiber intake is low in many children, the current trend to plant-based diets is associated with higher fiber intake in children raised on these diets. As older reports indicate that diets providing high fiber intake in children 0-5 years may affect growth, iron status and bowel function, we summarized the available evidence in this systematic review. Objective: To identify, critically appraise, and synthesize evidence on the effect of high fiber intake on growth, iron and bowel function in children 0-5 years, with relevance to the Nordic and Baltic countries. Methods: Following a pre-registered protocol, we searched MEDLINE, EMBASE, Cochrane Central of Controlled Trials, and Scopus for clinical trials and prospective cohort studies published until November 2021. Two reviewers independently screened retrieved literature, extracted relevant data, and performed risk of bias assessment. Outcomes were growth, iron metabolism and bowel function in children 0-5 years. We narratively described findings from studies that met inclusion criteria. Results: From 5,644 identified records, five articles met the inclusion criteria. Two RCTs had an overall moderate risk of bias, while the three observational studies had serious risk. Overall, we found no robust association between high intake of dietary fiber and growth. In the RCTs, higher intake of fiber had a positive effect on bowel movements and constipation. No studies on fiber intake and iron status were identified. The certainty of the overall evidence was inconclusive for growth and bowel function, while no assess-ment was made for iron status. Conclusion: We found no clear association between high intake of dietary fiber and growth or bowel func-tion in young children living in affluent countries, albeit with only a limited number of studies. There is a lack of studies investigating health effects of high fiber intake in small children.","[Dierkes, Jutta] Univ Bergen, Ctr Nutr, Dept Clin Med, Bergen, Norway; [Dierkes, Jutta; Spielau, Ulrike] Haukeland Hosp, Dept Lab Med & Pathol, Bergen, Norway; [Nwaru, Bright I.] Univ Gothenburg, Inst Med, Krefting Res Ctr, Gothenburg, Sweden; [Ramel, Alfons] Univ Iceland, Fac Food Sci & Nutr, Reykjavik, Iceland; [Arnesen, Erik Kristoffer] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway; [Thorisdottir, Birna] Univ Iceland, Fac Sociol Anthropol & Folklorist, Reykjavik, Iceland; [Thorisdottir, Birna] Univ Iceland, Hlth Sci Inst, Reykjavik, Iceland; [Lamberg-Allardt, Christel] Univ Helsinki, Dept Food & Nutr, Helsinki, Finland; [Soderlund, Fredrik; Barebring, Linnea] Univ Gothenburg, Inst Med, Sahlgrenska Acad, Dept Internal Med & Clin Nutr, Gothenburg, Sweden; [Akesson, Agneta] Karolinska Inst, Inst Environm Med, Unit Cardiovasc & Nutr Epidemiol, Stockholm, Sweden",University of Bergen; University of Bergen; Haukeland University Hospital; University of Gothenburg; University of Iceland; University of Oslo; University of Iceland; University of Iceland; University of Helsinki; University of Gothenburg; Karolinska Institutet,"Dierkes, J (corresponding author), Univ Bergen, Dept Clin Med, Jonas Lies Vei 68, N-5021 Bergen, Norway.",jutta.dierkes@uib.no,,"Arnesen, Erik/0000-0002-5568-8813; Soderlund, Fredrik/0000-0002-0389-2361; Lamberg-Allardt, Christel/0000-0001-7326-1904",,,,,35,1,1,4,7,SWEDISH NUTRITION FOUNDATION-SNF,LUND,"IDEON SCIENCE PARK, BESOK SCHEELEV 17 BETA 5, 3V, LUND, 223 70, SWEDEN",1654-6628,1654-661X,,FOOD NUTR RES,Food Nutr. Res.,MAR 27,2023,67,,,,,,,,9011,10.29219/fnr.v67.9011,http://dx.doi.org/10.29219/fnr.v67.9011,,,10,Food Science & Technology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Nutrition & Dietetics,C0TV3,37050923,"Green Published, gold",,,2024-06-04,WOS:000959156700001,View Full Record in Web of Science
J,"Séhonou, J; Sokpon, CNM; Kpossou, AR; Azandjeme, C; Cataria, H; Vignon, RK",,,,"Sehonou, Jean; Sokpon, Comlan Ndehougbea Martin; Kpossou, Aboudou Raimi; Azandjeme, Colette; Cataria, Hugues; Vignon, Rodolphe Koffi",,,Functional constipation in the general population of Cotonou (Benin): clinical features and factors influencing dietary behaviours,PAN AFRICAN MEDICAL JOURNAL,,,French,Article,,,,,,Functional constipation; clinical aspects; nutritional factors; Cotonou; Benin; sub-Saharan Africa,HEALTH,"Introduction: constipation is rare in sub-Saharan Africa, due to the high intake of dietary fiber. The purpose of this work was to describe the different clinical features of functional constipation in the general population in Cotonou and to determine the impact of diet on its occurrence. Methods: this study was conducted from July to August 2017. Subjects were considered affected by functional constipation when criteria for Rome IV or Bristol stool scale were completed. Results: in total, 1058 participants were enrolled; (574 men, sex-ratio 1.2; average age 29 years). The prevalence of functional constipation was 24.2% (Rome IV) and 20.4% (Bristol stool scale). Clinical manifestations were dominated by the emission of hard or fragmented stools (90.6%), pushing efforts during defecation (78.9%), and feeling of incomplete evacuation (76.2%). Dietary habits among people affected by constipation were; at breakfast, maize meal + donut/peanuts (39.1%), lunch, corn dough (38.7%), at dinner, corn dough (57.4%), and as a snack banana (35.5%). There was no statistically significant relationship between constipation and morning meal (p=0.09), lunch meal (p=0.901), snack (p=0.09) or dinner (p=0.75) respectively. Conclusion: the emission of hard or fragmented stools was the most common clinical manifestation among people affected by constipation living in Cotonou. Dietary habits do not influence the occurrence of functional constipation in our case series.","[Sehonou, Jean; Sokpon, Comlan Ndehougbea Martin; Kpossou, Aboudou Raimi; Cataria, Hugues; Vignon, Rodolphe Koffi] Ctr Natl Hosp Univ Hubert Koutoukou Maga CNHU HKM, Clin Univ Hepatogastroenterol, Cotonou, Benin; [Azandjeme, Colette] IRSP, Ouidah, Benin",,"Séhonou, J (corresponding author), Ctr Natl Hosp Univ Hubert Koutoukou Maga CNHU HKM, Clin Univ Hepatogastroenterol, Cotonou, Benin.",,,,,,,,19,1,1,0,0,AFRICAN FIELD EPIDEMIOLOGY NETWORK-AFENET,KAMPALA,"PO BOX 12874, KAMPALA, 00000, UGANDA",1937-8688,,,PAN AFR MED J,Pan Afr. Med. J.,DEC 23,2019,34,,,,,,,,210,10.11604/pamj.2019.34.210.16945,http://dx.doi.org/10.11604/pamj.2019.34.210.16945,,,7,"Public, Environmental & Occupational Health",Emerging Sources Citation Index (ESCI),"Public, Environmental & Occupational Health",KK4VQ,32180884,"Green Published, gold",,,2024-06-04,WOS:000512742000001,View Full Record in Web of Science
J,"Yadav, V; Agarwal, V; Shetty, R; Aggarwal, KC; Arora, V",,,,"Yadav, Viratveer; Agarwal, Veenu; Shetty, Rakesh; Aggarwal, K. C.; Arora, Vishwani",,,"DOES EFFECTIVE COMMUNICATION OF DIETARY RECOMMENDATIONS ALONG WITH PRESCRIBED LAXATIVE IN CHILDREN WITH FUNCTIONAL CONSTIPATION, HAVE ADDED THERAPEUTIC BENEFIT",JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS,,,English,Article,,,,,,Functional constipation; Diet; Fibre; fluid intake; behaviour modification; children,CHILDHOOD CONSTIPATION; FIBER; ETIOLOGY; HEALTH,"Introduction: The present study was aimed to know whether the effective communication of dietary recommendations would have added therapeutic benefit in children with functional constipation on laxatives. Material and methods: A total of 106 children of functional constipation, age 1 to18 years who attended general Pediatrics OPD were enrolled. Consecutively enrolled children with odd number were placed in group 1 & rest were placed in group 0. All were advised to take laxative polyethylene glycol (PEG) for 6- 12 months, maintain stool diary & to come for follow up at 10 to15 days,1, 3 & 6 months. Group 0 was attended in usual way in OPD while group 1 was explained the desired changes in diet & toilet schedule in structured format & written handouts were given. Primary outcome was number of stools per week & stool form on BSFS assessed beyond 3 months. Results: Group 1 and 0 were almost same in initial months in terms of cure rates but beyond 3 months the kids in former group were better in terms of softer stools, higher number of stools per week & also subjective improvement reported by many (71 % in group 1 vs 52% in group 0) and fewer relapses (17.8% in former vs 38.9% in later). Conclusion: The effective communication of changes in diet and toilet habits are helpful mainly in long term follow up, associated with higher objective improvement rates &fewer relapses.","[Yadav, Viratveer; Shetty, Rakesh; Arora, Vishwani] Santosh Deemed Be Univ, Dept Pediat, Ghaziabad, UP, India; [Agarwal, Veenu; Aggarwal, K. C.] Santosh Deemed Be Univ, Pediat, Ghaziabad, UP, India",,"Agarwal, V (corresponding author), Santosh Deemed Be Univ, Pediat, Ghaziabad, UP, India.",,"Agarwal, Veenu/HKV-8113-2023","Agarwal, Veenu/0000-0001-9693-0568",,,,,20,0,0,0,1,RESEARCHTRENTZ ACAD PUBL EDUCATION SERVICES,Somerville,"240 Elm Street, 2nd & 3rd Floors, Somerville, MA, UNITED STATES",0976-9234,2229-7723,,J PHARM NEGAT RESULT,J. Pharm. Negat. Results,,2022,13,,,,6,,209,214,,10.47750/pnr.2022.13.S06.031,http://dx.doi.org/10.47750/pnr.2022.13.S06.031,,,6,Pharmacology & Pharmacy,Emerging Sources Citation Index (ESCI),Pharmacology & Pharmacy,6D7CS,,,,,2024-06-04,WOS:000882844400031,View Full Record in Web of Science
J,"Micka, A; Siepelmeyer, A; Holz, A; Theis, S; Schön, C",,,,"Micka, Antje; Siepelmeyer, Anne; Holz, Anja; Theis, Stephan; Schoen, Christiane",,,"Effect of consumption of chicory inulin on bowel function in healthy subjects with constipation: a randomized, double-blind, placebo-controlled trial",INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION,,,English,Article,,,,,,Dietary fiber; inulin; constipation; stool frequency; bowel function,CHAIN FATTY-ACIDS; OLIGOFRUCTOSE; ABSORPTION; FRUCTANS; RELEASE; YY,"Constipation is among the most common health impairments in Western countries. This study aimed to determine the effect of the chicory-derived fermentable dietary fiber Orafti((R)) VR Inulin on stool frequency in healthy subjects with constipation. The study was conducted according to recent guidance documents for investigating bowel function and used a randomized, doubleblind, placebo-controlled, cross-over design with a 2-week wash-out phase. Each study period comprised a run-in phase followed by 4 weeks daily intake of 3 x 4g inulin or maltodextrin (placebo). Forty-four healthy volunteers with constipation documented stool frequency and consistency, gastrointestinal characteristics and quality of life. Consumption of Orafti((R)) VR Inulin significantly increased stool frequency compared to placebo (median 4.0 [IQR 2.5-4.5] versus 3.0 [IQR 2.5-4.0] stools/week, p = 0.038). This was accompanied by a softening of stools and trend toward higher satisfaction versus placebo (p = 0.059). In conclusion, Orafti((R)) VR Inulin was effective in volunteers with chronic constipation and significantly improved bowel function.","[Micka, Antje; Siepelmeyer, Anne; Schoen, Christiane] BioTeSys GmbH, Schelztorstr 54-56, D-73728 Esslingen, Germany; [Holz, Anja; Theis, Stephan] BENEO Inst, Obrigheim Pfalz, Germany",,"Schön, C (corresponding author), BioTeSys GmbH, Schelztorstr 54-56, D-73728 Esslingen, Germany.",c.schoen@biotesys.de,,,"BENEO GmbH, Mannheim, Germany, Sudzucker Group","BENEO GmbH, Mannheim, Germany, Sudzucker Group","The study was funded by BENEO GmbH, Mannheim, Germany, a member of the Sudzucker Group. The study results and data contained in the publication have been developed by and/or for BENEO. BENEO reserves the exclusive right to use the results and data for possible Health Claim requests.",,36,72,80,7,41,TAYLOR & FRANCIS LTD,ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND",0963-7486,1465-3478,,INT J FOOD SCI NUTR,Int. J. Food Sci. Nutr.,,2017,68,1,,,,,82,89,,10.1080/09637486.2016.1212819,http://dx.doi.org/10.1080/09637486.2016.1212819,,,8,Food Science & Technology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Nutrition & Dietetics,EK6JE,27492975,hybrid,,,2024-06-04,WOS:000394030100009,View Full Record in Web of Science
J,"Alfawaz, H; Khan, N; Alhuthayli, H; Wani, K; Aljumah, MA; Khattak, MNK; Alghanim, SA; Al-Daghri, NM",,,,"Alfawaz, Hanan; Khan, Nasiruddin; Alhuthayli, Haya; Wani, Kaiser; Aljumah, Muneerah A.; Khattak, Malak Nawaz Khan; Alghanim, Saad A.; Al-Daghri, Nasser M.",,,Awareness and Knowledge Regarding the Consumption of Dietary Fiber and Its Relation to Self-Reported Health Status in an Adult Arab Population: A Cross-Sectional Study,INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH,,,English,Article,,,,,,dietary fiber; nutrition knowledge; fiber and health; Saudi Arabia,WHOLE-GRAIN; CEREAL FIBER; SAUDI-ARABIA; PREVALENCE; DISEASE; CONSTIPATION; CHOLESTEROL; PRODUCTS; OBESITY; RISK,"The objective of this study was to examine the awareness, knowledge, and habits regarding dietary fiber intake and to analyze its relationship with self-reported health status among Saudi adults. A survey-based study using face-to-face interview was designed, and 1363 apparently healthy adult Saudi males and females participated. Most participants were females (81.2%), aged 25 and above (87.2%), and were educated at least up to the secondary level of education (80.8%). The majority of the participants were aware of the role of fiber-rich foods in health conditions such as obesity (70.5%), cardiovascular diseases (68.9%), and regulation of blood sugar (68.9%), with females significantly having higher nutrition knowledge than males. A disconnect in translating this nutrition knowledge was observed particularly in food choices when eating out, where preferences for white bread (84.4%), fried potatoes (69.9%) and peeled fruits (60.6%) were significantly higher than preferences for cooked vegetables (29.6%) and brown bread (18.1%). The most common reason for this disconnect was due to perception that foods rich in dietary fibers were expensive (72.1%), have less health benefits (56.5%), were not readily available (51.6%), and participants' disliking of the taste (52.8%). Participants in the highest quartile (Q4) for dietary fiber consumption reported a lower prevalence of constipation (odds ratio, 95% confidence interval of 0.40, 0.28-0.57,p< 0.01), high cholesterol (0.43, 0.27-0.68,p< 0.01) and obesity (0.67, 0.44-0.98,p= 0.03) than participants in the lowest quartile (Q1). Dietary fiber intake appears to be protective against constipation, high cholesterol and obesity in Saudi adults. However, a disparity observed between knowledge and attitude towards intake of dietary fibers could limit its health benefits. Further studies including adolescents should be conducted to impart knowledge on the emotional, cognitive and sensory factors related to food choices in order to minimize the gap between nutrition knowledge and the consumption of healthy high-fiber diets.","[Alfawaz, Hanan; Alhuthayli, Haya] King Saud Univ, Coll Food Sci & Agr, Dept Food Sci & Nutr, Riyadh 11495, Saudi Arabia; [Alfawaz, Hanan; Wani, Kaiser; Khattak, Malak Nawaz Khan; Al-Daghri, Nasser M.] King Saud Univ, Biochem Dept, Chair Biomarkers Chron Dis, Riyadh 11451, Saudi Arabia; [Khan, Nasiruddin] A Sharqiyah Univ, Coll Appl & Hlth Sci, Dept Food Sci & Human Nutr, Ibra 400, Oman; [Aljumah, Muneerah A.] Almaarefa Univ, Coll Med Med Student, Riyadh 11597, Saudi Arabia; [Alghanim, Saad A.] King Saud Univ, Hlth & Hosp Adm Program, Coll Business Adm, Dept Hlth Adm, Riyadh 11352, Saudi Arabia",King Saud University; King Saud University; Almaarefa University; King Saud University,"Alfawaz, H (corresponding author), King Saud Univ, Coll Food Sci & Agr, Dept Food Sci & Nutr, Riyadh 11495, Saudi Arabia.;Alfawaz, H (corresponding author), King Saud Univ, Biochem Dept, Chair Biomarkers Chron Dis, Riyadh 11451, Saudi Arabia.",halfawaz@ksu.edu.sa; nasiruddin2006@gmail.com; h.f.h4@hotmail.com; wani.kaiser@gmail.com; aljumahmd@gmail.com; malaknawaz@yahoo.com; sagksu@gmail.com; aldaghri2011@gmail.com,"Khan, Nasiruddin/AAP-3955-2020; ALFAWAZ, HANAN A/E-6913-2018; Alghanim, Saad/E-8336-2011; Al-Daghri, Nasser/G-7736-2011; Al-Daghri, Nasser/A-8360-2011; Khattak, Malak Nawaz Khan/D-2626-2019; Wani, Kaiser/N-9522-2015","Khan, Nasiruddin/0000-0002-1192-5565; ALFAWAZ, HANAN A/0000-0002-4794-1778; Al-Daghri, Nasser/0000-0001-5472-1725; Al-Daghri, Nasser/0000-0001-5472-1725; Khattak, Malak Nawaz Khan/0000-0002-1493-7297; Wani, Kaiser/0000-0001-9568-6516","Chair for Biomarkers of Chronic Diseases (CBCD), King Saud University (KSU), Riyadh, Saudi Arabia","Chair for Biomarkers of Chronic Diseases (CBCD), King Saud University (KSU), Riyadh, Saudi Arabia","This work was supported by the Deanship of Scientific Research, Chair for Biomarkers of Chronic Diseases (CBCD), King Saud University (KSU), Riyadh, Saudi Arabia.",,49,10,10,3,10,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,1660-4601,,INT J ENV RES PUB HE,Int. J. Environ. Res. Public Health,JUN,2020,17,12,,,,,,,4226,10.3390/ijerph17124226,http://dx.doi.org/10.3390/ijerph17124226,,,18,"Environmental Sciences; Public, Environmental & Occupational Health",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),"Environmental Sciences & Ecology; Public, Environmental & Occupational Health",ML6MF,32545755,"Green Published, gold",,,2024-06-04,WOS:000549577000001,View Full Record in Web of Science
J,"KLAUSER, AG; MULLERLISSNER, SA",,,,"KLAUSER, AG; MULLERLISSNER, SA",,,HOW EFFECTIVE IS NONLAXATIVE TREATMENT OF CONSTIPATION,PHARMACOLOGY,,,English,Article; Proceedings Paper,2ND INTERNATIONAL SYMP ON SENNA,"APR 23-24, 1993","KONSTANZ, GERMANY",,,ANISMUS; BIOFEEDBACK; DIETARY FIBER; MASSAGE; PHYSICAL ACTIVITY,PELVIC FLOOR SYNDROME; EXERCISE,"In almost any textbook of medicine so-called simple measures are proposed for treating constipation, such as increasing physical activity, drinking more fluid, triggering the gastrocolonic response by, e.g., drinking a glass of water or a cup of coffee, and bowel training. All of these have not been formally evaluated in constipated patients. Biofeedback training is useful for paradoxical puborectal contraction ('anismus'). Dietary fibre, e.g. in the form of wheat bran, increases stool weight and decreases colonic transit time. So every patient should have an empiric treatment with an adequate amount of fibre. Some patients, especially those with slow transit constipation and those with stasis in the right hemicolon, are not likely to respond to a therapy with bran, however.",,,"KLAUSER, AG (corresponding author), LUDWIG MAXIMILIANS UNIV MUNCHEN,KLINIKUM INNENSTADT,MED KLIN,DEPT GASTROENTEROL,ZIEMSSENSTR 1,D-80336 MUNICH,GERMANY.",,,,,,,,13,7,7,0,3,KARGER,BASEL,"ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND",0031-7012,,,PHARMACOLOGY,Pharmacology,OCT,1993,47,,,1,,,256,260,,10.1159/000139868,http://dx.doi.org/10.1159/000139868,,,5,Pharmacology & Pharmacy,Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy,MC565,8234439,,,,2024-06-04,WOS:A1993MC56500035,View Full Record in Web of Science
J,"Wenk, C",,,,"Wenk, C",,,The role of dietary fibre in the digestive physiology of the pig,ANIMAL FEED SCIENCE AND TECHNOLOGY,,,English,Article,,,,,,dietary fibre; pigs; nutrients; energy; digestion,GROWING-PIGS; ENERGY-UTILIZATION; ADULT SOWS; DIGESTIBILITY; FIBER,"Dietary fibre (DF) is usually defined as the sum of plant polysaccharides and lignin that are not hydrolysed by endogenous enzymes of the mammalian digestive system (non-starch polysaccharides and lignin). The amount and composition of DF varies over a wide range between and within feedstuffs. Furthermore, a precise distinction between dietary fibre and starch is far from easy. Therefore, the analysis as well as the physiological function of DF in the digestive tract of the pig can vary considerably. The age or body mass of the pig also interacts with the digestive processes and there is an adaptation developing in the animal over the time of exposure to fibrous diets. DF is generally considered as a fraction with a low energy content. This diluting effect of the diet is used to increase the feed intake during low performance of animals. DF influences transit time with a reduction in the upper and increase in the lower digestive tract and, therefore, decreases the digestibility of almost all nutrients and energy. On the other hand, it increases the microbial growth in the gastrointestinal tract. This can lead to an increased excretion of nutrients in faeces. Finally, DF beneficially influences well-being and health. Fibrous feedstuffs give pigs the opportunity to chew the feed over a longer time. More short chain fatty acids are produced and eventually undesired micro-organisms are excluded. A regular peristaltic action avoids the possibility of constipation. (C) 2001 Elsevier Science B.V. All rights reserved.","ETH Zurich, Inst Anim Sci, CH-8092 Zurich, Switzerland",Swiss Federal Institutes of Technology Domain; ETH Zurich,"Wenk, C (corresponding author), ETH Zurich, Inst Anim Sci, Univ Str 2, CH-8092 Zurich, Switzerland.",,,,,,,,28,262,335,2,76,ELSEVIER SCIENCE BV,AMSTERDAM,"PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",0377-8401,,,ANIM FEED SCI TECH,Anim. Feed Sci. Technol.,MAR 15,2001,90,1-2,,,SI,,21,33,,10.1016/S0377-8401(01)00194-8,http://dx.doi.org/10.1016/S0377-8401(01)00194-8,,,13,"Agriculture, Dairy & Animal Science",Science Citation Index Expanded (SCI-EXPANDED),Agriculture,432EL,,,,,2024-06-04,WOS:000168679200003,View Full Record in Web of Science
J,"TOWERS, AL; BURGIO, KL; LOCHER, JL; MERKEL, IS; SAFAEIAN, M; WALD, A",,,,"TOWERS, AL; BURGIO, KL; LOCHER, JL; MERKEL, IS; SAFAEIAN, M; WALD, A",,,"CONSTIPATION IN THE ELDERLY - INFLUENCE OF DIETARY, PSYCHOLOGICAL, AND PHYSIOLOGICAL FACTORS",JOURNAL OF THE AMERICAN GERIATRICS SOCIETY,,,English,Article,,,,,,,SEVERE IDIOPATHIC CONSTIPATION; UNITED-STATES; INTESTINAL TRANSIT; POPULATION; PREVALENCE; HOME; TIME,"OBJECTIVE: To identify dietary, psychological, and physiological characteristics of older individuals with chronic constipation, compared with a control group of individuals without constipation, and identify correlates of colonic transit time. DESIGN: Cohort study. SETTING: University hospital and affiliated clinics. PARTICIPANTS: Eighteen constipated and 18 control subjects who were nondemented, ambulatory, community-dwelling outpatients over the age of 60 years. MEASURES: Measures included a 1-week food diary, diet questionnaire, bowel diary, the Hopkins Symptom Checklist (SCL-90R), colonic transit study, and medical history, including queries about activity, medications, medical illnesses, and bowel symptoms. MAIN RESULTS: Constipated subjects reported consuming fewer meals per day compared with control subjects (P < 0.01) and a tendency to consume fewer calories (P = 0.07). There were no differences between groups on fiber or fluid intake or any of the other dietary parameters. However, slow colonic transit was significantly related to low caloric intake (P < 0.0001), higher percent of protein in the diet (P < 0.05), low fluid intake (P < 0.05), and to psychological symptoms of somatization, obsessive-compulsiveness, depression, anxiety, and the global severity index (P < 0.05). Transit times were unrelated to crude or dietary fiber intake, activity level, or age. CONCLUSIONS: The data suggest that constipation in this older population is related to caloric intake rather than fiber consumption or other dietary qualities. Psychological distress is associated with slowed colonic transit and should be investigated further as a possible etiologic factor in constipation.","UNIV ALABAMA,SCH MED,BIRMINGHAM,AL; UNIV ALABAMA,CTR AGING,BIRMINGHAM,AL",University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham,"TOWERS, AL (corresponding author), UNIV PITTSBURGH,SCH MED,PITTSBURGH,PA, USA.",,,"Locher, Julie/0000-0002-2639-6459",NIA NIH HHS [KO4-AG00431] Funding Source: Medline,NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)),,,27,108,117,0,7,WILLIAMS & WILKINS,BALTIMORE,"351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436",0002-8614,,,J AM GERIATR SOC,J. Am. Geriatr. Soc.,JUL,1994,42,7,,,,,701,706,,10.1111/j.1532-5415.1994.tb06527.x,http://dx.doi.org/10.1111/j.1532-5415.1994.tb06527.x,,,6,Geriatrics & Gerontology; Gerontology,Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED),Geriatrics & Gerontology,NW339,8014342,,,,2024-06-04,WOS:A1994NW33900002,View Full Record in Web of Science
J,"Robertson, J; Baines, S; Emerson, E; Hatton, C",,,,"Robertson, Janet; Baines, Susannah; Emerson, Eric; Hatton, Chris",,,Constipation management in people with intellectual disability: A systematic review,JOURNAL OF APPLIED RESEARCH IN INTELLECTUAL DISABILITIES,,,English,Review,,,,,,constipation; intellectual disability; review,CARE SENSITIVE CONDITIONS; HEALTH-PROBLEMS; DIETARY FIBER; DOWN-SYNDROME; COLORECTAL-CANCER; LAXATIVE USE; GLYCOL 3350; ADULTS; CHILDREN; POPULATION,"BackgroundConstipation can lead to serious health issues and death. This systematic review summarizes international research pertaining to the management of constipation in people with intellectual disability. MethodStudies published from 1990 to 2017 were identified using Medline, Cinahl, PsycINFO, Web of Science, email requests and cross-citations. Studies were reviewed narratively in relation to identified themes. ResultsEighteen studies were reviewed in relation to three themes: laxative receipt; interventions (dietary fibre, abdominal massage and macrogol); and staff issues (knowledge and training). Laxative polypharmacy was common. Studies report positive results for dietary fibre and abdominal massage although study quality was limited. ConclusionThe main management response to constipation in people with intellectual disability is laxative use despite limited effectiveness. An improved evidence base is required to support the suggestion that an individualized, integrated bowel management programme may reduce constipation and associated health conditions in people with intellectual disability.","[Robertson, Janet; Baines, Susannah; Emerson, Eric; Hatton, Chris] Univ Lancaster, Fac Hlth & Med, Div Hlth Res, Ctr Disabil Res, Lancaster, England; [Emerson, Eric] Univ Sydney, Ctr Disabil Res & Policy, Sydney, NSW, Australia",Lancaster University; University of Sydney,"Robertson, J (corresponding author), Univ Lancaster, Fac Hlth & Med, Div Hlth Res, Ctr Disabil Res, Lancaster, England.",j.m.robertson@lancaster.ac.uk,"; Hatton, Chris/C-1924-2013","Emerson, Eric/0000-0002-1776-6032; Hatton, Chris/0000-0001-8781-8486; Robertson, Janet Margaret/0000-0002-0519-9077",Public Health England,Public Health England,"This work was supported by Public Health England. However, the findings and views reported in this article are those of the authors and should not be attributed to Public Health England.",,86,12,14,0,13,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1360-2322,1468-3148,,J APPL RES INTELLECT,J. Appl. Res. Intellect. Disabil.,SEP,2018,31,5,,,,,709,724,,10.1111/jar.12426,http://dx.doi.org/10.1111/jar.12426,,,16,"Psychology, Educational; Rehabilitation",Social Science Citation Index (SSCI),Psychology; Rehabilitation,GP5PM,29168259,Green Accepted,,,2024-06-04,WOS:000440925400005,View Full Record in Web of Science
J,"Yang, CL; Hong, Q; Wu, T; Fan, YH; Shen, XB; Dong, XS",,,,"Yang, Chuanli; Hong, Qin; Wu, Teng; Fan, Yunhe; Shen, Xiaobing; Dong, Xiushan",,,Association between Dietary Intake of Live Microbes and Chronic Constipation in Adults,JOURNAL OF NUTRITION,,,English,Article,,,,,,live microbe; chronic constipation; NHANES,NATIONAL-HEALTH; PROBIOTICS; FIBER; SYMPTOMS; INDEX; FRESH,"Background: Chronic constipation (CC) is a common gut health problem, and the role of live dietary microbes in CC is unclear. Objective: This study aimed to investigate the relationship between dietary live microbes consumption and CC. Methods: Using the National Health and Nutrition Examination Survey data (2005-2010), 11,170 adults who completed the 24-h face-toface dietary recall and bowel health questionnaire were identified. CC was defined by the Bristol Stool Form Scale. Dietary live microbes intake was classified as low, medium, and high. Additionally, combined medium and high categories (MedHi) were analyzed. Multivariate regression models were constructed to assess the association between dietary intake of live microbes and CC. Results: In the weighted sample, the age -adjusted CC prevalence was 7.06% (95% confidence interval [CI]: 6.45, 7.67). In multivariate regression models, after controlling for potential confounders race/ethnicity, sex, body mass index, education, poverty, depression, caffeine intake, and alcohol intake, a significant inverse association between dietary live microbes consumption and CC was observed (odds ratio [OR]: 0.77, 95% CI: 0.61, 0.97, P -trend 1/4 0.061). Conclusions: Our findings suggest that a high dietary live microbes consumption may be associated with lower odds of CC. However, further prospective studies are essential to confirm its effectiveness in reducing CC occurrence.","[Yang, Chuanli; Hong, Qin; Shen, Xiaobing] Southeast Univ, Sch Publ Hlth, Key Lab Environm Med Engn, Nanjing, Jiangsu, Peoples R China; [Yang, Chuanli; Hong, Qin; Shen, Xiaobing] Southeast Univ, Educ Minist, Nanjing, Jiangsu, Peoples R China; [Yang, Chuanli; Hong, Qin; Shen, Xiaobing] Southeast Univ, Sch Publ Hlth, Dept Prevent Med, Nanjing, Peoples R China; [Yang, Chuanli; Wu, Teng; Fan, Yunhe; Dong, Xiushan] Shanxi Med Univ, Shanxi Bethune Hosp, Tongji Shanxi Hosp, Shanxi Acad Med Sci,Hosp 3,Dept Gen Surg, Taiyuan, Peoples R China",Southeast University - China; Southeast University - China; Southeast University - China; Shanxi Medical University,"Shen, XB (corresponding author), Southeast Univ, Sch Publ Hlth, Key Lab Environm Med Engn, Nanjing, Jiangsu, Peoples R China.;Shen, XB (corresponding author), Southeast Univ, Educ Minist, Nanjing, Jiangsu, Peoples R China.;Shen, XB (corresponding author), Southeast Univ, Sch Publ Hlth, Dept Prevent Med, Nanjing, Peoples R China.;Dong, XS (corresponding author), Shanxi Med Univ, Shanxi Bethune Hosp, Tongji Shanxi Hosp, Shanxi Acad Med Sci,Hosp 3,Dept Gen Surg, Taiyuan, Peoples R China.",xb.shen@seu.edu.cn; dongxiushan2012@163.com,,,Shanxi Province 136 Revitalization Medical Project Construction Fund; Key R&D Program of Shanxi Province [202102130501015],Shanxi Province 136 Revitalization Medical Project Construction Fund; Key R&D Program of Shanxi Province,The Shanxi Province 136 Revitalization Medical Project Construction Fund and the Key R & D Program of Shanxi Province (202102130501015) provided financial support.,,40,0,0,3,3,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",0022-3166,1541-6100,,J NUTR,J. Nutr.,FEB,2024,154,2,,,,,526,534,,10.1016/j.tjnut.2023.11.032,http://dx.doi.org/10.1016/j.tjnut.2023.11.032,,FEB 2024,9,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,LS4K1,38072155,,,,2024-06-04,WOS:001188776700001,View Full Record in Web of Science
J,"Santacruz, CC; López, MO; García, MV; Pérez, CF; Miguel, JC",,,,"Cerdan Santacruz, Carlos; Ortega Lopez, Mario; Vigara Garcia, Marta; Fernandez Perez, Cristina; Cerdan Miguel, Javier",,,Do bad habits bring a double constipation risk?,TURKISH JOURNAL OF GASTROENTEROLOGY,,,English,Article,,,,,,Chronic constipation; Rome III criteria; prevalence; risk factors,FUNCTIONAL CONSTIPATION; UNITED-STATES; BOWEL DISORDERS; NATIONAL-HEALTH; PREVALENCE; FIBER; POPULATION; METAANALYSIS; ASSOCIATION; SPAIN,"Background/Aims: Good dietary habits, fluid intake, and regular exercise are considered to ease defecation although very few cases of chronic constipation can be managed through these approaches alone. Good defecation habits are recommended to avoid chronic constipation; however, the literature regarding this remains scarce. In this paper, we aimed to assess the association of bad habits concerning defecation, such as postponing, reluctance, or avoiding defecation anywhere but at home, with chronic constipation. Materials and Methods: This was a cross-sectional observational study including subjects from a tertiary hospital task force. In total, 415 of 910 eligible subjects were randomly selected. A cluster of questionnaires easy to understand and fill out was distributed. The questionnaires included queries regarding demographic data; past medical history; the presence of constipation; and dietary, other lifestyle, and defecation habits. The Rome In criteria for chronic constipation were also recorded. Results: In total, 24.3% of the subjects considered themselves constipated, and 26.5% fulfilled the Rome III criteria for constipation. There were obvious differences in constipation prevalence by sex (men 5% vs. women 31%). Fiber-rich diet, fluid intake, and exercise habits were not related to constipation. Defecation habits significantly correlated with the presence or absence of constipation: regular schedule (OR 0.39; CI 95% 0.23-0.67), persistently postponing defecation (OR 1.94; CI 95% 1.13-3.34), or avoiding defecation anywhere but at home (OR 2.38; CI 95% 1.4-4.1). Conclusion: Compared with dietary habits, behavioral aspects surrounding defecation are more related to chronic constipation. Our results indicate that the modification of these bad habits may be the first step in chronic constipation treatment.","[Cerdan Santacruz, Carlos; Cerdan Miguel, Javier] Santa Elena Clin, Dept Colorectal Surg, Madrid, Spain; [Ortega Lopez, Mario] Fdn Jimenez Diaz, Dept Colorectal Surg, Madrid, Spain; [Vigara Garcia, Marta] Hosp Clin Univ San Carlos, Dept Geriatr & Gerontol, Madrid, Spain; [Fernandez Perez, Cristina] Hosp Clin Univ San Carlos, Clin Res & Methodol Unit, Madrid, Spain",,"Santacruz, CC (corresponding author), Santa Elena Clin, Dept Colorectal Surg, Madrid, Spain.",carloscerdansantacruz@hotmail.com,"Santacruz, Carlos Cerdán/N-5595-2018; Fernandez Perez, Cristina/I-2220-2015","Santacruz, Carlos Cerdán/0000-0002-6507-900X; Fernandez Perez, Cristina/0000-0001-9853-6257",,,,,27,2,4,0,5,AVES,SISLI,"BUYUKDERE CAD 105-9, MECIDIYEKOY, SISLI, ISTANBUL 34394, TURKEY",1300-4948,2148-5607,,TURK J GASTROENTEROL,Turk. J. Gastroenterol.,SEP,2018,29,5,,,,,580,587,,10.5152/tjg.2018.17533,http://dx.doi.org/10.5152/tjg.2018.17533,,,8,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,GT6KI,30260781,Green Published,,,2024-06-04,WOS:000444619800010,View Full Record in Web of Science
J,"Tappin, D; Grzeda, M; Joinson, C; Heron, J",,,,"Tappin, David; Grzeda, Mariusz; Joinson, Carol; Heron, Jon",,,Challenging the view that lack of fibre causes childhood constipation,ARCHIVES OF DISEASE IN CHILDHOOD,,,English,Article,,,,,,,DIETARY FIBER; FUNCTIONAL CONSTIPATION; ASSOCIATIONS; PATTERNS; CHILDREN; MIXTURE; GLUCOMANNAN; LACTULOSE; PARENTS,"Objectives To assess evidence supporting the view that 'low fibre causes childhood constipation'. Design Triangulation integrated three approaches: a systematic review NICE guideline CG99 examining effectiveness of increasing fibre; a cohort study, Avon Longitudinal Study of Parents and Children (ALSPAC), to assess if constipation (or hard stools) can precede fibre intake at weaning; and a literature search for twin studies to calculate heredity. Setting CG99 examined the literature regarding the effectiveness of increasing fibre. ALSPAC asked parents about: hard stools at 4 weeks, 6 months and 2.5 years and constipation at age 4-10 years, as well as fibre intake at 2 years. Twin studies and data from ALSPAC were pooled to calculate concordance of constipation comparing monozygotic and dizygous twin pairs. Participants CG99 reported six randomised controlled trials (RCTs). ALSPAC hard stool data from 6796 children at 4 weeks, 9828 at 6 months and 9452 at 2.5 years plus constipation data on 8401 at 4-10 years were compared with fibre intake at 2 years. Twin studies had 338 and 93 twin pairs and ALSPAC added a further 45. Results Increasing fibre did not effectively treat constipation. Hard stools at 4 weeks predated fibre and at 6 months predicted lower fibre intake at 2 years (p=0.003). Heredity explained 59% of constipation. Conclusions RCTs indicate that increasing fibre is not an effective treatment for constipation in children. Hard stools can precede and predict later fibre intake. Genetic inheritance explains most childhood constipation. Extended treatment with stool softeners may improve fibre intake and limit long-term damaging sequelae of constipation.","[Tappin, David] Univ Glasgow, Scottish Cot Death Trust, Glasgow G3 8SJ, Lanark, Scotland; [Grzeda, Mariusz; Joinson, Carol; Heron, Jon] Univ Bristol, Populat Hlth Sci, Bristol, Avon, England; [Joinson, Carol] Univ Bristol, Ctr Child & Adolescent Hlth, Bristol, Avon, England",University of Glasgow; University of Bristol; University of Bristol,"Tappin, D (corresponding author), Univ Glasgow, Scottish Cot Death Trust, Glasgow G3 8SJ, Lanark, Scotland.",david.tappin@glasgow.ac.uk,"Heron, Jon/D-5884-2011","Heron, Jon/0000-0001-6199-5644; Joinson, Carol/0000-0002-5651-097X",NHS Greater Glasgow and Clyde Health Board; MRC [MC_PC_19009] Funding Source: UKRI,NHS Greater Glasgow and Clyde Health Board; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)),This research received grant funding from NHS Greater Glasgow and Clyde Health Board.,,37,6,7,0,5,BMJ PUBLISHING GROUP,LONDON,"BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND",0003-9888,1468-2044,,ARCH DIS CHILD,Arch. Dis. Child.,SEP,2020,105,9,,,,,864,868,,10.1136/archdischild-2019-318082,http://dx.doi.org/10.1136/archdischild-2019-318082,,,5,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,NL4OQ,32156695,"Green Published, hybrid, Green Accepted",,,2024-06-04,WOS:000567397700016,View Full Record in Web of Science
J,"Cañete, NG; D'ardaillon, FP; Johns, PC; Agüero, SD",,,,"Gonzalez Canete, Natalia; Pena D'ardaillon, Francisca; Candia Johns, Priscila; Duran Agueero, Samuel",,,RELATIONSHIP BETWEEN SLEEP AND CONSTIPATION IN THE ELDERLY CHILEANS,NUTRICION HOSPITALARIA,,,Spanish,Article,,,,,,Elderly; Constipation; Sleep,IRRITABLE-BOWEL-SYNDROME; CIRCADIAN-RHYTHMS; DIETARY FIBER; HEALTH; TRACT; POPULATION; MANAGEMENT; DISORDERS; NUTRITION; SYMPTOMS,"Background: There is scarce information about constipation in elderly subjects. Among the variety of factors causing constipation, the sleeping hours are a factor usually not taken into account. Objectives: To determine the association between hours of sleep during the week and weekend, with constipation in older adults. Design: Sleep quality, stool consistency, physical activity (PA) and dietary fiber intake was assessed using various validated surveys in 424 healthy autonomous elderly men and women, living in Santiago, Chile. Results: Half of the participants reported having abnormal stools (constipation and diarrhea). Subjects who had constipation had lower PA and greater difficulty falling asleep than subjects with normal bowel movements. The elderly participants with constipation had a higher amount of sleep during the week and weekend, that subjects with normal bowel movements (9.4 +/- 1.6 vs 8.8 +/- 1.8 hours, p = 0.013). The constipated subjects slept significantly more than those with normal evacuation (9.7 +/- 1.5 vs 9.2 +/- 1.8, p = 0.024). No differences in the nutritional status and fiber intake among patients with different consistencies were found. Conclusions: There is an association between sleep and the consistency of the stools in elderly patients. It would be interesting to evaluate whether long-term improvement of these factors could have a positive impact on the other.","[Gonzalez Canete, Natalia; Pena D'ardaillon, Francisca; Candia Johns, Priscila; Duran Agueero, Samuel] Univ San Sebastian, Fac Ciencias Salud, Providencia, Chile",Universidad San Sebastian,"Agüero, SD (corresponding author), Univ San Sebastian, Fac Ciencias Salud, Lota 2465, Providencia, Chile.",samuel.duran@uss.cl,"Agüero, Samuel Durán/AAZ-6140-2020; wang, shuiling/AAK-2231-2020","Agüero, Samuel Durán/0000-0002-0548-3676;",,,,,33,5,6,2,15,AULA MEDICA EDICIONES,MADRID,"C/ISABEL COLBRAND, 10-12 NAVE 78 S PLANTA CIUDAD INDUSTRIAL VENECIA-EDIFICIO ALFA, MADRID, 28050, SPAIN",0212-1611,1699-5198,,NUTR HOSP,Nutr. Hosp.,JAN,2015,31,1,,,,,357,362,,10.3305/nh.2015.31.1.7976,http://dx.doi.org/10.3305/nh.2015.31.1.7976,,,6,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,AZ5ON,25561130,,,,2024-06-04,WOS:000348270100039,View Full Record in Web of Science
J,"Vitolo, MR; Aguirre, AND; Fagundes-Neto, U; de Morais, M",,,,"Vitolo, MR; Aguirre, AND; Fagundes-Neto, U; de Morais, M",,,Estimated dietary fiber intake by children according to different food composition reference tables.,ARCHIVOS LATINOAMERICANOS DE NUTRICION,,,Spanish,Article,,,,,,dietary fiber; children; food composition tables,,"The importance of dietary fiber intake in the prevention and treatment of adult diseases has been widely emphasized in the literature for several years. Recommendations for fiber intake by children have only recently began to be published. The present study estimated the fiber intake by children with or without constipation according to five food composition tables. We studied 114 children under 12 years of age, of whom 56 were constipated and 58 had normal bowel movements. We used a 24 hour recall questionnaire and fiber consumption was analysed by five food composition tables: 1. Association of Official Agricultural Chemist- AOAC, 2. Southgate, 3. Mendez, 4. Englyst and 5. crude fiber. The statistical analysis showed significant differences between the medians of the estimated fiber consumption calculated using all tables, except the AOAC and Southgate tables. The median value and percentis 25th and 75 th presented between parenthesis were (grams/day): Mendez - 15,4(11,9-19,6); Southgate -10,5(7,8-13,5); AOAC - 10,2(7,3-14,0); Englyst - 4,5 (3,0-6,0) and crude fiber - 2,1 (1,4-2,9). There were statistical significant correlations between all pairs of tables but the best correlation was observed between Mendez and Southgate (r=+0,90), AOAC and Southgate (r=+0,88); and Mendez and AOAC (r=+0,84). Constipated children presented lower estimated fiber intake than those with normal bowel movements, with statistical significance according to all tables. In conclusion, it is important to determine which reference table should be utilized when recommending dietary fiber.","Univ Fed Sao Paulo, Escola Paulista Med, Dept Pediat, Disciplina Nutr & Metab Infantil, Sao Paulo, Brazil",Universidade Federal de Sao Paulo (UNIFESP),"Vitolo, MR (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Pediat, Disciplina Nutr & Metab Infantil, Sao Paulo, Brazil.",,,"Vitolo, Marcia Regina/0000-0001-9137-3854; Batista de Morais, Mauro/0000-0003-4014-5549",,,,,23,5,6,0,0,ARCHIVOS LATINOAMERICANOS NUTRICION,CARACAS,"APARTADO 62778 CHACAO, AVENIDA FRANCISCO MIRANDA, CARACAS 1060, VENEZUELA",0004-0622,,,ARCH LATINOAM NUTR,Arch. Latinoam. Nutr.,JUN,1998,48,2,,,,,141,145,,,,,,5,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,128VZ,9830489,,,,2024-06-04,WOS:000076430200007,View Full Record in Web of Science
J,"Pilipenko, VI; Perova, IB; Kochetkova, AA; Isakov, VA",,,,"Pilipenko, Vladimir I.; Perova, Irina B.; Kochetkova, Alla A.; Isakov, Vasily A.",,,Prospects of dietary fibers food fortification for the treatment and prevention ofgastrointestinal diseases: A review,TERAPEVTICHESKII ARKHIV,,,English,Review,,,,,,dietary fiber; healthy diet; the effectiveness of dietary fiber; enriched food,WEIGHT-LOSS; SUPPLEMENTATION; CONSTIPATION; RISK; PREBIOTICS; BENEFITS; QUALITY,"Epidemiological studies have proven the connection between high consumption of dietary fiber and a reduction in the risk of many diseases. In clinical trials, the possibility of functional regulation of the intestine and intestinal microbiome by dietary fibers has been revealed, which may be significant in certain diseases of the digestive system. This review provides information on the relationship between the physico-chemical properties and functional characteristics of dietary fibers, discusses evidence of the effectiveness of their use in the treatment of diseases of the digestive system, discusses the need to enrich food with dietary fibers.","[Pilipenko, Vladimir I.; Perova, Irina B.; Kochetkova, Alla A.; Isakov, Vasily A.] Fed Res Ctr Nutr Biotechnol & Food Safety, Moscow, Russia","Federal Research Center of Nutrition, Biotechnology & Food Safety","Isakov, VA (corresponding author), Fed Res Ctr Nutr Biotechnol & Food Safety, Moscow, Russia.",vasily.isakov@gmail.com,"Isakov, Vasily/A-4876-2011; Kochetkova, Alla/I-3900-2017","Isakov, Vasily/0000-0002-4417-8076; Pilipenko, Vladimir/0000-0001-5632-1880; Kochetkova, Alla/0000-0001-9821-192X",Russian Science Foundation [19-76-30014-P],Russian Science Foundation(Russian Science Foundation (RSF)),Funding source. Grant of the Russian Science Foundation No ;19-76-30014-P.,,52,0,0,18,21,CJSC CONSILIUM MEDICUM,MOSCOW,"NOVIY ZIKOVSKIY PROEZD, D 3, 40, MOSCOW, 125167, RUSSIA",0040-3660,2309-5342,,TERAPEVT ARKH,Ter. Arkhiv,,2023,95,8,,,,,701,705,,10.26442/00403660.2023.08.202328,http://dx.doi.org/10.26442/00403660.2023.08.202328,,,5,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,U5NP1,38158909,gold,,,2024-06-04,WOS:001085272300009,View Full Record in Web of Science
J,"Deka, RS",,,,"Deka, Rijusmita Sarma",,,CRUDE FIBRE DEFICIENCY IN DOG-A CASE REPORT,VETERINARY PRACTITIONER,,,English,Article,,,,,,Dog; constipation; fibre,MEAN RETENTION TIME; METABOLIZABLE ENERGY; NUTRIENT INTAKE; DIETARY FIBER; DIGESTIBILITY,"A 6-year-old Rotweiller dog was kept on commercial pet food and developed constipation. Role of fibre is often the overlooked ingredient in pet food. Function of fibre is to increases the bulk and water in intestinal contents. Additional fibre in diet is essential to manage problems like obesity, diarrhoea, constipation and diabetes mellitus.","[Deka, Rijusmita Sarma] Apollo Coll Vet Med, Jaipur 203002, Rajasthan, India",,"Deka, RS (corresponding author), Natl Dairy Res Inst, Dairy Cattle Nutr Div, Karnal 132001, Haryana, India.",,,,,,,,8,0,0,0,10,VETERINARY PRACTITIONER,BIKANER,"GAHLOT KUTEER, B-30-A, KARNI NAGAR, NAGNENIJI RD, BIKANER, 334 003, INDIA",0972-4036,,,VET PRACT,Vet. Pract.,DEC,2009,10,2,,,,,183,184,,,,,,2,Veterinary Sciences,Science Citation Index Expanded (SCI-EXPANDED),Veterinary Sciences,568UY,,,,,2024-06-04,WOS:000275550100031,View Full Record in Web of Science
J,"Zhang, L; Du, Z; Li, ZA; Yu, F; Li, LJ",,,,"Zhang, Lei; Du, Zhang; Li, Zhiang; Yu, Fei; Li, Lijun",,,Association of dietary magnesium intake with chronic constipation among US adults: Evidence from the National Health and Nutrition Examination Survey,FOOD SCIENCE & NUTRITION,,,English,Article,,,,,,bowel health; chronic constipation; magnesium; National Health And Nutrition Examination Survey,FUNCTIONAL CONSTIPATION; MINERAL-WATER; DOUBLE-BLIND; SULFATE; BOWEL; SYMPTOMS; FIBER; RICH,"The association of dietary magnesium intake with chronic constipation has not been well-studied in general population. Therefore, the aim of this study was to examine whether increased intake of dietary magnesium is associated with the presence of chronic constipation. Data from the 2007-2010 National Health and Nutrition Examination Survey (NHANES) were used. A total of 9,519 participants (4,814 men and 4,705 women) aged >= 20 years were included. The individual's bowel habits (chronic constipation) were evaluated using the questionnaire on bowel health and two different definitions of constipation (stool consistency and stool frequency) were used. Dietary magnesium intake was obtained from 24-h dietary recall. Participants were categorized based on the quartiles of magnesium intake. Multivariable logistic regressions models were performed controlling for confounding factors. After multi-variable adjustment, dietary magnesium intake was inversely associated with chronic constipation defined by stool frequency, and the ORs (95% CIs) across quartiles 2-4 compared with the lowest quartile were 0.71 (0.51-0.99), 0.78 (0.46-1.31), and 0.39 (0.16-0.95), respectively. In addition, there was a significant trend for the decreased prevalence of chronic constipation by quartiles of magnesium intake only among men (p for trend < .001). However, no statistically significant association between magnesium intake and prevalence of chronic constipation defined by stool consistency was observed. More evidence from longitudinal studies is needed to confirm these findings.","[Zhang, Lei; Du, Zhang; Li, Zhiang; Yu, Fei; Li, Lijun] Dongyang Peoples Hosp, Dept Anorectal Surg, 60 West Wuning Rd, Dongyang 322100, Zhejiang, Peoples R China",,"Li, LJ (corresponding author), Dongyang Peoples Hosp, Dept Anorectal Surg, 60 West Wuning Rd, Dongyang 322100, Zhejiang, Peoples R China.",ljli_dyhos@126.com,"Li, Lijun/AAG-9407-2019","Li, Lijun/0000-0002-7406-6702",,,,,20,5,5,1,7,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",2048-7177,,,FOOD SCI NUTR,Food Sci. Nutr.,DEC,2021,9,12,,,,,6634,6641,,10.1002/fsn3.2611,http://dx.doi.org/10.1002/fsn3.2611,,SEP 2021,8,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,XM1DN,34925793,Green Published,,,2024-06-04,WOS:000701013200001,View Full Record in Web of Science
J,"Bustos, E; Medina, A",,,,"Bustos A, Edson; Medina P, Alexis",,,Recommendations and effects of dietary fiber for children,REVISTA CHILENA DE NUTRICION,,,Spanish,Review,,,,,,Children; Dietary fiber; Gastrointestinal health; Insoluble fiber; Soluble fiber; Whole grains,CHAIN FRUCTO-OLIGOSACCHARIDES; HYDROLYZED GUAR GUM; FUNCTIONAL CONSTIPATION; HEALTH; CONSUMPTION; SUPPLEMENTATION; OVERWEIGHT; EFFICACY; PSYLLIUM; QUALITY,"Among adults, the influence of dietary fiber on mechanical effects at the gastrointestinal level, the composition and modulation of the intestinal microbiota and function in the metabolic and nutritional activity is known. However, in children and adolescents, these effects are less known, generating interesting areas of research and development that could provide additional knowledge at the physiological and pathophysiological level. The aim of this review was to provide updated information about the different classifications of fiber, the principal digestive and metabolic functions, as well as recommendations for daily intake for pediatric populations.","[Bustos A, Edson; Medina P, Alexis] Univ Finis Terrae, Escuela Nutr & Dietet, Fac Med, Ave Pedro de Valdivia 1509, Santiago, Chile",Universidad Finis Terrae,"Bustos, E (corresponding author), Univ Finis Terrae, Escuela Nutr & Dietet, Fac Med, Ave Pedro de Valdivia 1509, Santiago, Chile.",edsonbustos@uft.cl,"Bustos, Edson/AAR-5937-2020","Bustos, Edson/0000-0003-4698-1425",,,,,54,1,1,1,11,"SOC CHILENA NUTRICION, BROMATOLOGIA & TOXICOLOGIA",SANTIAGO,"CONCEPCION 81, OFICINA 1307, PROVIDENCIA, SANTIAGO, 00000, CHILE",0717-7518,,,REV CHIL NUTR,Rev. Chil. Nutr.,JUN,2020,47,3,,,,,457,462,,10.4067/S0717-75182020000300457,http://dx.doi.org/10.4067/S0717-75182020000300457,,,6,Nutrition & Dietetics,Emerging Sources Citation Index (ESCI),Nutrition & Dietetics,MC6FZ,,gold,,,2024-06-04,WOS:000543381600015,View Full Record in Web of Science
J,"Coss-Adame, E; Garcia-Cedillo, MF; Bustillo-Armendariz, G; de la Torre, MF; Delgado-Bautista, MK; Arenas-Martinez, J; Cassis-Nosthas, L",,,,"Coss-Adame, Enrique; Garcia-Cedillo, Maria F.; Bustillo-Armendariz, Gustavo; de la Torre, Maria F.; Delgado-Bautista, Melisa K.; Arenas-Martinez, Josealberto; Cassis-Nosthas, Lorena",,,Agave tequilana Fructans Versus Psyllium plantago for Functional Constipation,JOURNAL OF CLINICAL GASTROENTEROLOGY,,,English,Article,,,,,,functional constipation; randomized clinical trial; fiber; agave fructans,QUALITY-OF-LIFE; FIBER SUPPLEMENTATION; DIETARY FIBER; VS. PSYLLIUM; TRIAL; METAANALYSIS; PRUNES,"Goal: The aim of this study was to evaluate the efficacy of supplementation with Agave tequilana Weber blue variety fructans (Predilife) in the improvement of symptoms in functional constipation. Background: Fiber supplementation is the first-line treatment for constipation. Fibers-like fructans have a known prebiotic effect. Materials and Methods: A randomized, double-blind, study comparing agave fructans (AF) against psyllium plantago (PP). Four groups were randomized. Group 1: AF 5 g (Predilife), group 2: AF 10 g (Predilife), group 3: AF 5 g (Predilife)+10 g maltodextrin (MTDx), and group 4: PP 5 g+10 g MTDx. The fiber was administered once daily for 8 weeks. All fibers were similarly flavored and packaged. Patients kept their usual diet and fiber sources were quantified. Responders were defined as >= 1 complete spontaneous bowel movement from baseline to 8 weeks. Adverse events were reported. The study was registered in Clinicaltrials.gov with registration number NCT04716868. Results: Seventy-nine patients were included (group 1: 21, group 2: 18, group 3: 20, and group 4: 20), of which 62 (78.4%) were women. The responders were similar across groups (73.3%, 71.4%, 70.6%, and 69%, P>0.050). After 8 weeks, all groups significantly increased complete spontaneous bowel movements, showing the greatest increase in spontaneous bowel movements in group 3 (P=0.008). All groups improved in symptoms, stool consistency, and quality of life. Diet and fiber intake were similar between groups. Adverse events were mild and similar between groups. Conclusions: AF (Predilife) are as effective at different doses and combined with MTDx as PP and are a feasible option for the treatment of functional constipation.","[Coss-Adame, Enrique; Garcia-Cedillo, Maria F.; de la Torre, Maria F.; Delgado-Bautista, Melisa K.; Arenas-Martinez, Josealberto] Salvador Zubiran Natl Inst Hlth Sci & Nutr, Dept Gastroenterol, Mexico City, Mexico; [Cassis-Nosthas, Lorena] Salvador Zubiran Natl Inst Hlth Sci & Nutr, Dept Food Sci & Technol, Mexico City, Mexico; [Bustillo-Armendariz, Gustavo] Bustar Alimentos SAPI CV, Guadalajara, Jalisco, Mexico; [Coss-Adame, Enrique] Salvador Zubiran Natl Inst Med Sci & Nutr, Dept Gastroenterol, Motil Lab, Mexico City 14080, Mexico",Tecnologico de Monterrey; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico,"Coss-Adame, E (corresponding author), Salvador Zubiran Natl Inst Med Sci & Nutr, Dept Gastroenterol, Motil Lab, Mexico City 14080, Mexico.",enriquecossmd@gmail.com; lic.nut.fernandagace@gmail.com; gbustilloa@hotmail.com; mhuertadelatorre@gmail.com; meldeb1105@gmail.com; arenas2113@gmail.com; lorena_cassis@yahoo.com.mx,"Arenas, Josealberto/HNB-6038-2023","Arenas, Josealberto/0000-0003-3819-7198; Coss-Adame, Enrique/0000-0002-8569-2792; Garcia Cedillo, Maria Fernanda/0000-0002-3114-1493",National Council on Science and Technology (CONACYT); Bustar Alimentos S.A.P.I. de C.V. Bustar Alimentos S.A.P.I. de C.V.,National Council on Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Bustar Alimentos S.A.P.I. de C.V. Bustar Alimentos S.A.P.I. de C.V.,The study was financed by the National Council on Science and Technology (CONACYT) and Bustar Alimentos S.A.P.I. de C.V. Bustar Alimentos S.A.P.I. de C.V. financed this study and courses and congresses for the presentation of papers related to the study.,,24,0,0,3,3,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0192-0790,1539-2031,,J CLIN GASTROENTEROL,J. Clin. Gastroenterol.,MAY-JUN,2024,58,5,,,,,475,482,,10.1097/MCG.0000000000001888,http://dx.doi.org/10.1097/MCG.0000000000001888,,,8,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,MZ6D3,37389917,,,,2024-06-04,WOS:001197487000016,View Full Record in Web of Science
J,"Bellini, M; Gambaccini, D; Salvadori, S; Tosetti, C; Urbano, MT; Costa, F; Monicelli, P; Mumolo, MG; Ricchiuti, A; De Bortoli, N; Marchi, S",,,,"Bellini, M.; Gambaccini, D.; Salvadori, S.; Tosetti, C.; Urbano, M. T.; Costa, F.; Monicelli, P.; Mumolo, M. G.; Ricchiuti, A.; De Bortoli, N.; Marchi, S.",,,Management of chronic constipation in general practice,TECHNIQUES IN COLOPROCTOLOGY,,,English,Article,,,,,,Chronic constipation; Functional constipation; Irritable bowel syndrome; General practice,IRRITABLE-BOWEL-SYNDROME; STATEMENT AIGO/SICCR DIAGNOSIS; UNITED-STATES; CARE; PERSPECTIVE; DISORDERS; CRITERIA,"Chronic constipation is often diagnosed and treated by general practitioners (GPs). The aim of the study was to evaluate the management of constipation by a cohort of Italian GPs. Over the course of 1 month, 41 GPs recorded tests and therapies suggested to patients complaining of chronic constipation. They were classified according to the Rome III criteria as constipated irritable bowel syndrome (C-IBS), functional constipation (FC), or self-perceived constipation (SPC) (not consistent with the Rome criteria). The most frequently prescribed tests for the 229 patients (147 FC, 50 C-IBS, 32 SPC) were routine blood tests (59.3 %), abdominal ultrasounds (37.2 %), thyroid function (36.7 %), fecal occult blood tests (36.7 %), and tumor markers (35 %). Patient sex and age, GP age, and whether the diagnosis was new influenced the GP's request, but FC, C-IBS, or SPC status did not. Dietary suggestions (81.9 %), fiber supplements (59.7 %), reassurance (50.9 %), and laxatives (30.5 %) were the most frequently prescribed treatments. Antispasmodics were more frequently suggested for C-IBS patients; dietary suggestions, fiber, and enemas were more frequently prescribed in SPC patients. Patient and GP age and whether the diagnosis was new influenced the GP's choice of treatment. The Rome III criteria do not influence diagnostic strategies and only slightly influence therapeutic strategies of GPs. Other factors (age, gender, new or old diagnosis) have more influence on GPs choice of investigations and treatment.","[Bellini, M.; Gambaccini, D.; Urbano, M. T.; Costa, F.; Mumolo, M. G.; Ricchiuti, A.; De Bortoli, N.; Marchi, S.] Univ Pisa, Gastrointestinal Unit, Dept Gastroenterol, I-56100 Pisa, Italy; [Salvadori, S.] CNR, Inst Clin Physiol, I-56124 Pisa, Italy",University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR),"Bellini, M (corresponding author), Univ Pisa, Gastrointestinal Unit, Dept Gastroenterol, Via Paradisa 2, I-56100 Pisa, Italy.",mbellini@med.unipi.it,"SALVADORI, STEFANO/AAL-3217-2021; Tosetti, Cesare/ABF-1789-2021; Gambaccini, Dario/AAC-6716-2022","SALVADORI, STEFANO/0000-0002-1266-3931; Gambaccini, Dario/0000-0002-6506-0253; Tosetti, Cesare/0000-0001-8600-9003; bellini, massimo/0000-0002-6387-6443; DE BORTOLI, NICOLA/0000-0003-1995-1060",,,,,25,15,15,0,14,SPRINGER-VERLAG ITALIA SRL,MILAN,"VIA DECEMBRIO, 28, MILAN, 20137, ITALY",1123-6337,1128-045X,,TECH COLOPROCTOL,Tech. Coloproctology,JUN,2014,18,6,,,,,543,549,,10.1007/s10151-013-1093-9,http://dx.doi.org/10.1007/s10151-013-1093-9,,,7,Gastroenterology & Hepatology; Surgery,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Surgery,AJ0MM,24272606,,,,2024-06-04,WOS:000337347900004,View Full Record in Web of Science
J,"Krokowicz, L; Bobkiewicz, A; Borejsza-Wysocki, M; Kuczynska, B; Lisowska, A; Skowronska-Piekarska, U; Paszkowski, J; Walkowiak, J; Drews, M; Banasiewicz, T",,,,"Krokowicz, Lukasz; Bobkiewicz, Adam; Borejsza-Wysocki, Maciej; Kuczynska, Barbara; Lisowska, Aleksandra; Skowronska-Piekarska, Urszula; Paszkowski, Jacek; Walkowiak, Jaroslaw; Drews, Michal; Banasiewicz, Tomasz",,,"A Prospective, Descriptive Study to Assess the Effect of Dietary and Pharmacological Strategies to Manage Constipation in Patients with a Stoma",OSTOMY WOUND MANAGEMENT,,,English,Article,,,,,,descriptive study; colostomy; constipation; prevalence; diet,QUALITY-OF-LIFE; SURVEILLANCE; RESECTION; BUTYRATE; DISEASE; COLON; FIBER,"The term constipation with regard to patients with a stoma is defined as impaired bowel movements associated with increased stool consistency or long periods without bowel movements that lead to discomfort, flatulence, and abdominal pain. Information about constipation in patients with a stoma is limited. A prospective, descriptive study was conducted among patients attending ostomy and proctology outpatient clinics in Poznan, Poland between January 2011 and December 2014 to assess the role of dietary and pharmacological strategies in the management of constipation in patients with a stoma. Patients were included if they experienced a 3-day period without bowel movements leading to abdominal discomfort and bloating. Patients who were terminally ill from neoplastic disease or could not provide informed consent for study participation were not eligible to participate. Patients underwent 3 evaluations 3 months apart: the first assessed problems with passing stool through the stoma, at which time patients were told to increase fiber and fluid intake. During the next 2 visits, patients were asked if their symptoms had improved. If dietary changes were not successful, first-line pharmacological interventions were suggested (laxatives, osmotic agents, and probiotics). If no improvement was reported during the third assessment, second line pharmacologic therapy (eg, stimulant laxatives) were prescribed. Of the 405 patients initially assessed for participation, 331 met the initial screening criteria and were scheduled for follow-up. Of those, 93 (28%) had constipation; 50 (15%) required a surgical referral for morphological stoma changes and 43 (12.9%) met the study inclusion criteria for dietary recommendations. Almost all (42) had a colostomy and most (28) had a history of stoma creation due to diverticular disease. Twenty-five (25) men and 18 women (average age 55.9 +/- 9.3 years) received dietary recommendations during the first visit. Diet modifications were effective and sufficient to resolve the problem with constipation in more than half (24) of the patients. Among the remaining 19 patients, only 2 did not improve after using first-line or second-line pharmacological management strategies. One patient required emergency surgery due to complicated colonic diverticulosis (perforation). The results of this study suggest constipation among patients with a stoma can be associated with morphological stoma changes and in the absence of morphologic changes the majority of patients respond well to a change in diet. Additional studies are needed to increase understanding about the incidence and optimal management strategies of constipation in persons with a stoma.","[Krokowicz, Lukasz; Bobkiewicz, Adam; Borejsza-Wysocki, Maciej; Kuczynska, Barbara; Skowronska-Piekarska, Urszula; Paszkowski, Jacek; Drews, Michal; Banasiewicz, Tomasz] Poznan Univ Med Sci, Dept Gen Endocrinol Surg & Gastroenterol Oncol, PL-49 Poznan, Poland; [Lisowska, Aleksandra] Poznan Univ Med Sci, Dept Gastroenterol & Metab, Chair Pediat, Poznan, Poland; [Walkowiak, Jaroslaw] Poznan Univ Med Sci, Dept Gastroenterol & Metab, Chair Pediat 1, Poznan, Poland",Poznan University of Medical Sciences; Poznan University of Medical Sciences; Poznan University of Medical Sciences,"Krokowicz, L (corresponding author), Poznan Univ Med Sci, Dept Gen Endocrinol Surg & Gastroenterol Oncol, PL-49 Poznan, Poland.",lkrokowicz@gmail.com,,"Lisowska, Aleksandra/0000-0002-5453-4716; Walkowiak, Jaroslaw/0000-0001-5813-5707; Bobkiewicz, Adam/0000-0002-4657-5788",,,,,30,5,5,0,6,H M P COMMUNICATIONS,MALVERN,"83 GENERAL WARREN BLVD, STE 100, MALVERN, PA 19355 USA",0889-5899,1943-2720,,OSTOMY WOUND MANAG,Ostomy Wound Manag.,DEC,2015,61,12,,,,,14,22,,,,,,8,Surgery,Science Citation Index Expanded (SCI-EXPANDED),Surgery,DD9JB,27763879,,,,2024-06-04,WOS:000370240400004,View Full Record in Web of Science
S,"Sharma, A; Rao, S",,"GreenwoodVanMeerveld, B",,"Sharma, Amol; Rao, Satish",,,Constipation: Pathophysiology and Current Therapeutic Approaches,GASTROINTESTINAL PHARMACOLOGY,Handbook of Experimental Pharmacology,,English,Article; Book Chapter,,,,,,Chronic constipation; Constipation-predominant irritable bowel syndrome (IBS-C); Dyssynergic defecation; Slow-transit constipation,IRRITABLE-BOWEL-SYNDROME; CHRONIC IDIOPATHIC CONSTIPATION; GUANYLATE-CYCLASE-C; INTESTINAL BACTERIAL OVERGROWTH; RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; DYSSYNERGIC DEFECATION; STOOL CHARACTERISTICS; COLONIC TRANSIT; CLINICAL-TRIAL,"Chronic constipation is a common, persistent condition affecting many patients worldwide, presenting significant economic burden and resulting in substantial healthcare utilization. In addition to infrequent bowel movements, the definition of constipation includes excessive straining, a sense of incomplete evacuation, failed or lengthy attempts to defecate, use of digital manoeuvres for evacuation of stool, abdominal bloating, and hard consistency of stools. After excluding secondary causes of constipation, chronic idiopathic or primary constipation can be classified as functional defecation disorder, slow-transit constipation (STC), and constipation-predominant irritable bowel syndrome (IBS-C). These classifications are not mutually exclusive and significant overlap exists. Initial therapeutic approach to primary constipation, regardless of aetiology, consists of diet and lifestyle changes such as encouraging adequate fluid and fibre intake, regular exercise, and dietary modification. Laxatives are the mainstay of pharmacologic treatment for potential long-term therapy in patients who do not respond to lifestyle or dietary modification. After a failed empiric trial of laxatives, diagnostic testing is necessary to understand underlying anorectal and/or colonic pathophysiology. No single test provides a comprehensive assessment for primary constipation; therefore, multiple tests are used to provide complementary information to one another. Dyssynergic defecation, a functional defecation disorder, is an acquired behavioural disorder of defecation present in two-thirds of adult patients, where an inability to coordinate the abdominal, recto-anal, and pelvic floor muscles during attempted defecation exists. Biofeedback therapy is the mainstay treatment for dyssynergic defecation aimed at improving coordination of abdominal and anorectal muscles. A large percentage of patients with dyssynergic defecation also exhibit rectal hyposensitivity and may benefit from the addition of sensory retraining. Our understanding of the pathophysiology of STC is evolving. The advent of high-resolution colonic manometry allows for the improved identification of colonic motor patterns and may provide further insight into pathophysiological mechanisms. In a minority of cases of STC, identification of colonic neuropathy suggests a medically refractory condition, warranting consideration of colectomy. The pathophysiology of IBS-C is poorly understood with multiple etiological factors implicated. Pharmacological advances in the treatment of primary constipation have added therapeutic options to the armamentarium of this disorder. Drug development in the secretagogue, serotonergic prokinetic, and ileal bile acid transporter inhibition pathways has yielded current and futuremedical treatment options for primary chronic constipation.","[Sharma, Amol; Rao, Satish] Augusta Univ, Med Coll Georgia, Div Gastroenterol & Hepatol, Augusta, GA 30912 USA",University System of Georgia; Augusta University,"Sharma, A (corresponding author), Augusta Univ, Med Coll Georgia, Div Gastroenterol & Hepatol, Augusta, GA 30912 USA.",AMOSHARMA@augusta.edu; SRAO@augusta.edu,,"Sharma, Amol/0000-0002-5843-1220",,,,,97,86,90,3,21,SPRINGER-VERLAG BERLIN,BERLIN,"HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY",0171-2004,,978-3-319-56360-2; 978-3-319-56359-6,HANDB EXP PHARMACOL,Handb. Exp. Pharmacol.,,2017,239,,,,,,59,74,,10.1007/164_2016_111,http://dx.doi.org/10.1007/164_2016_111,10.1007/978-3-319-56360-2,,16,Gastroenterology & Hepatology; Pharmacology & Pharmacy,Book Citation Index – Science (BKCI-S),Gastroenterology & Hepatology; Pharmacology & Pharmacy,BL8IM,28185025,,,,2024-06-04,WOS:000456439200005,View Full Record in Web of Science
J,"Rasmussen, HE; Hamaker, B; Rajan, KB; Mutlu, E; Green, SJ; Brown, M; Kaur, A; Keshavarzian, A",,,,"Rasmussen, Heather E.; Hamaker, Bruce; Rajan, Kumar B.; Mutlu, Ece; Green, Stefan J.; Brown, Michael; Kaur, Amandeep; Keshavarzian, Ali",,,"Starch-entrapped microsphere fibers improve bowel habit but do not exhibit prebiotic capacity in those with unsatisfactory bowel habits: a phase I, randomized, double-blind, controlled human trial",NUTRITION RESEARCH,,,English,Article,,,,,,Prebiotics; Dietary fiber; Microbiota; Constipation; Clinical trial,DIETARY FIBER; FERMENTATION; CONSTIPATION; PSYLLIUM; HEALTH; MICROBIOME; BACTERIAL; TRANSIT,"Approximately one-third of individuals in the United States experience unsatisfactory bowel habits, and dietary intake, especially one low in fiber, could be partly responsible. We hypothesized that intake of a fermentable fiber (starch-entrapped microspheres, SM) that has a delayed, slow fermentation profile in vitro would improve bowel habit while exhibiting prebiotic capacity in those with self -described unsatisfactory bowel habits, all with minimal adverse effects. A total of 43 healthy volunteers completed a 3-month, double-blind, parallel-aim randomized clinical trial to assess the ability of a daily dose (9 or 12 g) of SM vs psyllium (12 g) to improve bowel habit, including stool consistency and frequency, and modify gut milieu through changes in stool microbiota and short-chain fatty acids while remaining tolerable through minimal gastrointestinal symptoms. All outcomes were compared before and after fiber treatment. Stool frequency significantly improved (P = .0003) in all groups after 3 months, but stool consistency improved only in both SM groups compared with psyllium. In addition, all groups self-reported a similar improvement in overall bowel habit with fiber intake. Both SM and psyllium resulted in minimal changes in microbiota composition and short chain fatty acid concentrations. The present study suggests that supplementation with a delayed and slow-fermenting fiber in vitro may improve bowel habit in those with constipation, but further investigation is warranted to determine capacity to alter microbiota and fermentation profiles in humans. (C) 2017 Elsevier Inc. All rights reserved.","[Rasmussen, Heather E.] Rush Univ, Med Ctr, Dept Clin Nutr, 1700 W VanBuren St Ste 425, Chicago, IL 60612 USA; [Hamaker, Bruce; Kaur, Amandeep] Purdue Univ, Dept Food Sci, 745 Agr Mall Dr, W Lafayette, IN 47907 USA; [Rajan, Kumar B.] Rush Univ, Med Ctr, Dept Internal Med, Rush Inst Hlth Aging, 1653 W Congress Pkwy, Chicago, IL 60612 USA; [Mutlu, Ece; Brown, Michael; Keshavarzian, Ali] Rush Univ, Med Ctr, Dept Internal Med, Div Digest Dis & Nutr, 1725 W Harrison St Ste 206, Chicago, IL 60612 USA; [Green, Stefan J.] Univ Illinois, DNA Serv Facil, Res Resources Ctr, 35 S Wolcott Ave STE E102, Chicago, IL 60612 USA",Rush University; Purdue University System; Purdue University; Rush University; Rush University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital,"Rasmussen, HE (corresponding author), Rush Univ, Med Ctr, 1700 W Van Buren St Ste 425, Chicago, IL 60612 USA.",Heather_Rasmussen@rush.edu; hamakerb@purdue.edu; Kumar_Rajan@rush.edu; Ece_Mutlu@rush.edu; greendna@uic.edu; Michael_Brown@rush.edu; kaur1@purdue.edu; Ali_Keshavarzian@rush.edu,"Kaur, Amandeep/IYJ-2622-2023; Green, Stefan J/C-8980-2011","Kaur, Amandeep/0000-0002-9825-4951; Green, Stefan/0000-0003-2781-359X","National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; Small Business Innovation Research grant [DK088525-01]","National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Small Business Innovation Research grant","This work was supported by the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, and Small Business Innovation Research grant (DK088525-01). Ali Keshavarzian and Bruce Hamaker are holders of the patent for the starch-entrapped microspheres (patent is pending) and are part owners of Nutrabiotix LLC, the company that has the sole right of license of the product. Ali Keshavarzian and Bruce Hamaker were involved in study design and preparation and submission of the application for the Small Business Innovation Research grant but did not participate in participant assessment or data analysis. Both Ali Keshavarzian and Bruce Hamaker participated in preparation of the manuscript after the data were analyzed and finalized.",,38,9,10,3,23,PERGAMON-ELSEVIER SCIENCE LTD,OXFORD,"THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND",0271-5317,1879-0739,,NUTR RES,Nutr. Res.,AUG,2017,44,,,,,,27,37,,10.1016/j.nutres.2017.05.015,http://dx.doi.org/10.1016/j.nutres.2017.05.015,,,11,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,FG4SA,28821315,"Green Accepted, hybrid, Green Published",,,2024-06-04,WOS:000410254600004,View Full Record in Web of Science
J,"Yasuda, G; Shibata, K; Takizawa, T; Ikeda, Y; Tokita, Y; Umemura, S; Tochikubo, O",,,,"Yasuda, G; Shibata, K; Takizawa, T; Ikeda, Y; Tokita, Y; Umemura, S; Tochikubo, O",,,Prevalence of constipation in continuous ambulatory peritoneal dialysis patients and comparison with hemodialysis patients,AMERICAN JOURNAL OF KIDNEY DISEASES,,,English,Article,,,,,,dietary fiber; nutrition; diabetes mellitus (DM); chronic glomerulonephritis,,"Many hemodialysis patients suffer from constipation. The frequency of constipation has not been rigorously evaluated in continuous ambulatory peritoneal dialysis (CAPD) patients, however. We conducted a survey on constipation in CAPD patients and compared the findings with those in hemodialysis patients through a questionnaire. Daily dietary fiber and potassium intake were calculated from the patients' dietary records. In the questionnaire, patients were asked about bowel frequency, stool consistency, straining, and use of laxatives and resins. The frequency of constipation was 28.9% in 204 CAPD patients and 63.1% in 268 hemodialysis patients. The hemodialysis patients had a 3.14 times higher relative risk of constipation than the CAPD patients. Only 3.4% of CAPD patients needed resin to avoid hyperkalemia. Of hemodialysis patients, 49% needed resin. Among the 261 hemodialysis patients, 205 (78.5%) suppressed an urge to defecate during hemodialysis therapy. Potassium and total dietary fiber intake per day were 1.8 +/- 0.5 g and 11.0 +/- 4.0 g in CAPD patients, which were higher (P < 0.01) than the values in hemodialysis patients-1.3 +/- 0.5 g and 5.9 +/- 2.7 g. The results suggest that constipation occurs less frequently in CAPD patients than in hemodialysis patients. The low rate of constipating drug administration, dialysis modality-based lifestyle, and higher total dietary fiber intake may cause the lower prevalence of constipation in CAPD patients. (C) 2002 by the National Kidney Foundation, Inc.","Yokohama City Univ, Sch Med, Dept Internal Med & Hyg 2,Div Nephrol, Minami Ku, Yokohama, Kanagawa 2320024, Japan; Yokohama Minami Kyousai Hosp, Dept Internal Med 2, Yokohama, Kanagawa, Japan; Fujisawa Municipal Hosp, Div Nephrol, Kanagawa, Japan",Yokohama City University,"Yasuda, G (corresponding author), Yokohama City Univ, Sch Med, Dept Internal Med & Hyg 2,Div Nephrol, Minami Ku, 4-57 Urafune, Yokohama, Kanagawa 2320024, Japan.",,,,,,,,15,79,88,0,8,W B SAUNDERS CO,PHILADELPHIA,"INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA",0272-6386,,,AM J KIDNEY DIS,Am. J. Kidney Dis.,JUN,2002,39,6,,,,,1292,1299,,10.1053/ajkd.2002.33407,http://dx.doi.org/10.1053/ajkd.2002.33407,,,8,Urology & Nephrology,Science Citation Index Expanded (SCI-EXPANDED),Urology & Nephrology,565ZC,12046044,,,,2024-06-04,WOS:000176399600023,View Full Record in Web of Science
J,"Camilleri, M",,,,"Camilleri, M",,,Clinical subgroups of chronic constipation: exploring the potential of polyethylene glycol,ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,,,English,Article,,,,,,colonic inertia; constipation; fibre; laxatives; slow transit,MOTILITY; TRANSIT; COLON; TONE,This brief review has explored the rationale for therapy of polyethylene glycol electrolyte solutions in subgroups of patients with chronic constipation. There appears to be a good rationale for their use in patients with colonic inertia or those with extrinsic denervation. However first-line therapies such as dietary fibre and bulking agents should be tried initially prior to resorting to osmotic agents such as polyethylene glycol electrolyte solutions.,"Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA",Mayo Clinic,"Camilleri, M (corresponding author), Mayo Clin & Mayo Fdn, 200 1st St SW, Rochester, MN 55905 USA.",,,,,,,,12,2,2,0,0,PACINI EDITORE,OSPEDALETTO PISA,"VIA DELLA GHERARDESCA-ZONA INDUSTRIALE, 56014 OSPEDALETTO PISA, ITALY",1125-8055,,,ITAL J GASTROENTEROL,Ital. J. Gastroenterol. Hepatol.,NOV,1999,31,,,3,,,S253,S254,,,,,,2,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,260QZ,10726230,,,,2024-06-04,WOS:000083962500008,View Full Record in Web of Science
J,"Candelli, M; Nista, EC; Zocco, MA; Gasbarrini, A",,,,"Candelli, M; Nista, EC; Zocco, MA; Gasbarrini, A",,,"Idiopathic chronic constipation: Pathophysiology, diagnosis and treatment",HEPATO-GASTROENTEROLOGY,,,English,Review,,,,,,idiopathic chronic constipation; slow transit constipation; pelvic floor disfunction,COLON TRANSIT SCINTIGRAPHY; GASTROINTESTINAL TRANSIT; GUT TRANSIT; BREATH TEST; WOMEN; DYSSYNERGIA; MISOPROSTOL; EXPERIENCE; SPHINCTER; MANOMETRY,"Constipation is one of the most common disease in Western countries. Its prevalence is widely variable (5-30%), depending on criteria utilized for diagnosis. Usually constipated patients have mild-moderate symptoms and are self-treated. Only patients that do not benefit from simple therapy (dietary supplementation of fiber and water, laxatives) need examinations such as blood tests, colonoscopy, radiography with bario-enemas, intestinal transit time and manometry. These tests are able to differentiate idiopathic from secondary constipation. Idiopathic chronic constipation is a collective term that involves different functional disorders. More specific investigations (oro-cecal transit time, manometry, electromyography) allow one to distinguish between two different patterns of idiopathic chronic constipation (slow transit constipation and pelvic floor disease) and to utilize the appropriate treatment of disease. The aims of this paper are to review the recent world literature on chronic constipation and to propose a diagnostic and a therapeutic flow chart for this disorder.","Univ Cattolica Sacro Cuore, Gemelli Hosp, Dept Internal Med, I-00168 Rome, Italy",Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli,"Univ Cattolica Sacro Cuore, Gemelli Hosp, Dept Internal Med, Largo Gemelli 8, I-00168 Rome, Italy.",angiologia@rm.unicatt.it,"Zocco, Maria Assunta/IAS-0337-2023; Candelli, Marcello/W-2375-2019; Gasbarrini, Antonio/AAB-8487-2019","Candelli, Marcello/0000-0001-8443-7880; Gasbarrini, Antonio/0000-0002-6230-1779",,,,,64,23,25,1,8,H G E UPDATE MEDICAL PUBLISHING S A,ATHENS,"PO BOX 17257, ATHENS GR-10024, GREECE",0172-6390,,,HEPATO-GASTROENTEROL,Hepato-Gastroenterol.,JUL-AUG,2001,48,40,,,,,1050,1057,,,,,,8,Gastroenterology & Hepatology; Surgery,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Surgery,458CK,11490798,,,,2024-06-04,WOS:000170175500035,View Full Record in Web of Science
J,"ODES, HS; MADAR, Z; TROP, M; NAMIR, S; GROSS, J; COHEN, T",,,,"ODES, HS; MADAR, Z; TROP, M; NAMIR, S; GROSS, J; COHEN, T",,,PILOT-STUDY OF THE EFFICACY OF SPENT GRAIN DIETARY FIBER IN THE TREATMENT OF CONSTIPATION,ISRAEL JOURNAL OF MEDICAL SCIENCES,,,English,Article,,,,,,,,"Spent grain is the crude fiber obtained by decanting the fermented distillate of barley. The spent grain was processed to yield dietary fiber composed of: cellulose and hemicellulose 65.5% (by weight), lignin 5.2%, pectin 2.2%, protein 10.9% and lipid 8.0%. Biscuits and scones were prepared by 25% substitution of wheat flour by fiber, yielding 7 to 8 g fiber per biscuit/scone. Nineteen ambulatory patients with chronic, laxative-dependent constipation were treated in a pilot study for 4 weeks with 20 to 25 g fiber daily. Fifteen patients (79%) showed improvement in some or all of five factors, while four patients were largely unresponsive to fiber. Specific symptoms improved as follows: bowel movement frequency in 15 patients (79%), flatulence in 12 (63%), abdominal pain in 10 (53%), stool consistency in 8 (42%) and laxative dependence in 14 (74%). A 4-week post-treatment follow-up showed a return to prefiber status in 11 of 13 improved subjects. This preliminary study suggests a role for spent grain fiber in the treatment of constipated patients, and a comparative study with placebo and wheat fiber is now warranted.","BEN GURION UNIV NEGEV, SOROKA MED CTR, DEPT MED, GASTROENTEROL UNIT, POB 151, IL-84101 BEER SHEVA, ISRAEL; BEN GURION UNIV NEGEV, APPL BIOL UNIT, IL-84101 BEER SHEVA, ISRAEL; BEN GURION UNIV NEGEV, HLTH SCI EVALUAT UNIT, IL-84101 BEER SHEVA, ISRAEL; HEBREW UNIV JERUSALEM, FAC AGR, IL-76100 REHOVOT, ISRAEL",,,,,,,,,,14,14,15,0,5,ISRAEL JOURNAL MED SCIENCES,JERUSALEM,"2 ETZEL ST, FRENCH HILL, JERUSALEM 97853, ISRAEL",0021-2180,,,ISRAEL J MED SCI,Isr. J. Med. Sci.,JAN,1986,22,1,,,,,12,15,,,,,,4,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,A0740,3007392,,,,2024-06-04,WOS:A1986A074000003,View Full Record in Web of Science
J,"Korczak, R; Kamil, A; Fleige, L; Donovan, SM; Slavin, JL",,,,"Korczak, Renee; Kamil, Alison; Fleige, Lisa; Donovan, Sharon M.; Slavin, Joanne L.",,,Dietary fiber and digestive health in children,NUTRITION REVIEWS,,,English,Review,,,,,,children; dietary fiber; digestive health; whole grains; stool form scale,FUNCTIONAL GASTROINTESTINAL DISORDERS; HYDROLYZED GUAR GUM; WHOLE-GRAIN; CHILDHOOD CONSTIPATION; PHYSICAL-ACTIVITY; ABDOMINAL-PAIN; DOUBLE-BLIND; WHEAT BRAN; DEFECATION DYNAMICS; BOWEL FREQUENCY,"Digestive health is an expanding area in nutrition research due to the interest in how food components such as fiber affect gastrointestinal tolerance, stool form, defecation frequency, transit time, and gut microbial composition and metabolic activity. In children, however, digestive health studies that intervene with dietary fiber are limited due to legal and ethical concerns. To better understand if fiber improves digestive health in children, a literature review was conducted to answer the following research question: What are the effect(s) of fiber-containing foods and/or supplements on digestive health outcomes in children? A search of the PubMed database identified a total of 12 studies that fit the inclusion criteria established for this review. Most of the evidence in children shows beneficial effects of partially hydrolyzed guar gum, glucomannan, and bran on digestive health outcomes; however, the existing evidence is not conclusive. Furthermore, limited data exists on the effect of whole-grain sources of dietary fiber, such as oats. Additional well-designed intervention trials are needed to determine whether outcomes of digestive health such as stool form, gastrointestinal tolerance, and stool frequency are improved by increasing the fiber content of children's diets with whole-grain sources.","[Korczak, Renee; Slavin, Joanne L.] Univ Minnesota, Dept Food Sci & Nutr, 1334 Eckles Ave,Room 225, St Paul, MN 55108 USA; [Kamil, Alison; Fleige, Lisa] PepsiCo R&D Nutr, Quaker Oats Ctr Excellence, Barrington, IL USA; [Donovan, Sharon M.] Univ Illinois, Dept Food Sci & Nutr, Urbana, IL 61801 USA",University of Minnesota System; University of Minnesota Twin Cities; PepsiCo; University of Illinois System; University of Illinois Urbana-Champaign,"Slavin, JL (corresponding author), Univ Minnesota, Dept Food Sci & Nutr, 1334 Eckles Ave,Room 225, St Paul, MN 55108 USA.",jslavin@umn.edu,"Donovan, Sharon/AAY-6787-2020; Slavin, Joanne/GOJ-9874-2022","Slavin, Joanne/0000-0003-0720-5300","University of Minnesota from PepsiCo R&D Nutrition, Barrington, Illinois, USA","University of Minnesota from PepsiCo R&D Nutrition, Barrington, Illinois, USA","This work was supported by funding provided to JS and the University of Minnesota from PepsiCo R&D Nutrition, Barrington, Illinois, USA. The funder had no role in the design, performance, or approval of the review.",,87,33,37,1,50,OXFORD UNIV PRESS INC,CARY,"JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA",0029-6643,1753-4887,,NUTR REV,Nutr. Rev.,APR,2017,75,4,,,,,241,259,,10.1093/nutrit/nuw068,http://dx.doi.org/10.1093/nutrit/nuw068,,,19,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,ET4SD,28586481,,,,2024-06-04,WOS:000400274200002,View Full Record in Web of Science
J,"Adams, S; Che, DS; Qin, GX; Rui, H; Sello, CT; Jiang, HL",,,,"Adams, Seidu; Che, Dongsheng; Qin, Guixin; Rui, Han; Sello, Cornelius Tlotliso; Jiang Hailong",,,"Interactions of Dietary Fibre with Nutritional Components on Gut Microbial Composition, Function and Health in Monogastrics",CURRENT PROTEIN & PEPTIDE SCIENCE,,,English,Review,,,,,,Dietary fiber; gastrointestinal tract; microbial composition; nutritional components; feeding disorders; VFA,TYPE-2 DIABETES-MELLITUS; HUMAN COLONIC MICROBIOTA; FAT-SOLUBLE VITAMINS; SUGAR-BEET FIBER; RESISTANT STARCH; INSULIN SENSITIVITY; GUAR GUM; PHYSICOCHEMICAL CHARACTERIZATION; INTESTINAL-ABSORPTION; PHYSICAL-PROPERTIES,"The relation between dietary fibre and the well-being of human and other monogastrics has recently became a hot topic as shown by the increasing number of publications of the related research. The aim of this review is to describe - through a logical approach - the scientific suggestion linking possible benefits of dietary fibre on nutritional components and their effect on the gastrointestinal composition in relation to disease conditions in humans and animals. Dietary fibre plays a key role in: influencing blood glucose or insulin concentrations, stool bulkiness, reducing the pH within the digestive tract, synthesising volatile fatty acids (VFA), reducing intestinal transit time, stimulating growth of intestinal microbes, and constructively enhancing various blood parameters. The available literature suggests that fibre influences the bioavailability of nutrients and maintains the host's well-being by controlling disorders and disease prevalent with a Western way of living such as constipation and diarrhoea, diabetes, obesity, gastrointestinal inflammation, atherosclerosis, and colon cancer. Although there are some studies demonstrating that dietary fibre may be effective in the prevention and treatment of these disorders, the mechanisms involved are yet to be understood","[Adams, Seidu; Che, Dongsheng; Qin, Guixin; Rui, Han; Jiang Hailong] Jilin Agr Univ, Coll Anim Sci & Technol, Changchun 130118, Jilin, Peoples R China; [Adams, Seidu; Che, Dongsheng; Qin, Guixin; Rui, Han; Jiang Hailong] Jilin Agr Univ, Jilin Prov Key Lab Anim Nutr & Feed Sci, Changchun 130118, Jilin, Peoples R China; [Che, Dongsheng; Qin, Guixin; Rui, Han; Jiang Hailong] Jilin Agr Univ, Minist Educ, Key Lab Anim Prod Prod Qual & Secur, Changchun 130118, Jilin, Peoples R China; [Sello, Cornelius Tlotliso] Jilin Agr Univ, Anim Breeding & Genet, Changchun 130118, Jilin, Peoples R China",Jilin Agricultural University; Jilin Agricultural University; Jilin Agricultural University; Jilin Agricultural University,"Adams, S; Jiang, HL (corresponding author), Jilin Agr Univ, Dept Anim Sci & Feed Technol, POB 0000-000, Changchun, Jilin, Peoples R China.",adams@jlau.edu.cn; hljiang@jlau.edu.cn,"Adams, Seidu/AAF-6098-2019; rui, han/KGL-0673-2024","ADAMS, SEIDU/0000-0002-9515-1156",state-supporting technology project of the national high technology research and Development program of China [2013AA102503]; National key research and development program [2017YFD0502004]; Major national special projects [2014ZX0800604B]; scientific project of Jilin province [20170309003NY],state-supporting technology project of the national high technology research and Development program of China; National key research and development program; Major national special projects; scientific project of Jilin province,"The financial support from state-supporting technology project of the national high technology research and Development program of China (2013AA102503), the National key research and development program (2017YFD0502004), the Major national special projects (2014ZX0800604B) and the scientific project of Jilin province (20170309003NY) for providing the financial support of publishing this review.",,199,12,13,5,54,BENTHAM SCIENCE PUBL LTD,SHARJAH,"EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES",1389-2037,1875-5550,,CURR PROTEIN PEPT SC,Curr. Protein Pept. Sci.,,2018,19,10,,,,,1011,1023,,10.2174/1389203719666180508111843,http://dx.doi.org/10.2174/1389203719666180508111843,,,13,Biochemistry & Molecular Biology,Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology,GQ7AF,29745332,,,,2024-06-04,WOS:000441884000008,View Full Record in Web of Science
J,"Cullen, G; O'Donoghue, D",,,,"Cullen, Garret; O'Donoghue, Diarmuid",,,Constipation and pregnancy,BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY,,,English,Article,,,,,,constipation; pregnancy,SEVERE IDIOPATHIC CONSTIPATION; GASTROINTESTINAL TRANSIT-TIME; MENSTRUAL-CYCLE; BOWEL FUNCTION; SMOOTH-MUSCLE; DIETARY FIBER; INCONTINENCE; PROGESTERONE; POSTPARTUM; DIARRHEA,"Constipation is a common symptom during pregnancy. The majority of cases are simple constipation that occurs due to a combination of hormonal and mechanical factors affecting normal Gl function. However, a number of women suffer from constipation prior to conception and find their symptoms worsen during pregnancy. Patients with simple constipation can usually be treated by explanation, reassurance and advice. Medications are best avoided but if necessary should be taken under supervision using best available evidence. It is important that all patients be evaluated by detailed history, physical examination and basic investigations to outrule Gl pathology that may be present in a small number of cases. Those whose symptoms predated their pregnancy should be fully evaluated after the puerperiurn.","Union Coll, Dublin, Ireland; St Vincent Univ Hosp, Ctr Colorectal Dis, Dublin, Ireland",University College Dublin; University College Dublin,"Cullen, G (corresponding author), Union Coll, Dublin, Ireland.",garret.cullen@ucd.ie; dodonog@indigo.ie,,,,,,,47,69,78,2,26,ELSEVIER SCI LTD,OXFORD,"THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND",1521-6918,1532-1916,,BEST PRACT RES CL GA,Best Pract. Res. Clin. Gastroenterol.,,2007,21,5,,,,,807,818,,10.1016/j.bpg.2007.05.005,http://dx.doi.org/10.1016/j.bpg.2007.05.005,,,12,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,222NJ,17889809,,,,2024-06-04,WOS:000250303900005,View Full Record in Web of Science
J,"Yang, S; Wu, XL; Wang, SQ; Guo, XL; Guo, FZ; Sun, XF",,,,"Yang, Shuai; Wu, Xiao-Li; Wang, Shou-Qing; Guo, Xiang-Ling; Guo, Fu-Zheng; Sun, Xiao-Feng",,,Association of Dietary Energy Intake With Constipation Among Men and Women: Results From the National Health and Nutrition Examination Survey,FRONTIERS IN NUTRITION,,,English,Article,,,,,,constipation; energy intake; stool consistency; cross-sectional study; NHANES,HIGH-RESOLUTION; FIBER,"BackgroundPrevious studies supported that dietary factor was associated with constipation, but the relationship between dietary energy intake and constipation has not been well-studied. Therefore, we aimed to evaluate the prevalence and correlation between energy intake and constipation among men and women. MethodsThese observational analyses included 12,587 adults (>= 20 years) from the 2005-2010 cycles of the National Health and Nutrition Examination Surveys (NHANES). Constipation was defined as Bristol Stool Scale Type 1 (separate hard lumps, like nuts) or Type 2 (sausage-like but lumpy). Total energy intake was obtained from the two 24-h dietary recalls and averaged. We used the logistic regression model in Generalized Linear Model (GLM) function, controlling demographic, lifestyle, and dietary factors, to estimate the association between energy intake and constipation among men and women. ResultsThe overall weighted incidence of constipation in this research was 7.4%, the incidence in women and men was 10.4 and 4.3%, respectively. After multivariable adjustment, middle energy consumption correlated with decreased risk of constipation in men (OR:0.5, 95% CI:0.29-0.84), and lower-middle energy intake increased the constipation risk in women (OR: 1.56, 95% CI: 1.15-2.13). High energy consumption was not associated with increased or decreased constipation risk. ConclusionsTo our knowledge, this is the first research to investigate the association between energy intake and constipation; the study demonstrates that appropriate energy consumption can help reduce the risk of constipation in men, and relatively low energy intake is associated with increased constipation risk in women.","[Yang, Shuai; Wu, Xiao-Li; Wang, Shou-Qing; Guo, Fu-Zheng; Sun, Xiao-Feng] First Hosp Jilin Univ, Dept Ultrasound, Changchun, Peoples R China; [Guo, Xiang-Ling] Jilin Prov Peoples Hosp, Dept Gastroenterol, Changchun, Peoples R China",Jilin University,"Sun, XF (corresponding author), First Hosp Jilin Univ, Dept Ultrasound, Changchun, Peoples R China.",sxf@jlu.edu.cn,,,,,,,20,8,8,1,7,FRONTIERS MEDIA SA,LAUSANNE,"AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND",2296-861X,,,FRONT NUTR,Front. Nutr.,APR 12,2022,9,,,,,,,,856138,10.3389/fnut.2022.856138,http://dx.doi.org/10.3389/fnut.2022.856138,,,8,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,1A8SG,35495926,"gold, Green Published",,,2024-06-04,WOS:000792018700001,View Full Record in Web of Science
J,"Vilcanqui-Pérez, F; Vílchez-Perales, C",,,,"Vilcanqui-Perez, Fulgencio; Vilchez-Perales, Carlos",,,"Dietary fiber: New definitions, functional properties and health benefits. Review",ARCHIVOS LATINOAMERICANOS DE NUTRICION,,,Spanish,Review,,,,,,Dietary fiber; Definition; Functional properties; Physiology properties; Overweight and obesity,INTESTINAL MICROBIOTA; CHEMICAL-COMPOSITION; OBESITY; CARBOHYDRATE; CONSTIPATION; PREVALENCE; CHALLENGES; PRODUCTS; PSYLLIUM; CEREALS,"In the last ten years there have been important changes in the definition of dietary fiber under the leadership of the CODEX Alimentarius Commission. The most important was the inclusion of non-digestible carbohydrates of 3 to 9 units of degree of polymerization within the chemical definition, which was adopted in some countries and in others are in the process of evaluation such as the United States which indicates that does not exist a global consensus. Where there is a consensus is in the physiological definition of dietary fiber, considered as a group of carbohydrates resistant to the digestion by enzymes of the small intestine and fermented partially or totally in the colon, with favorable health effects. The Association of Official Analytical Chemists (AOAC), in line with the new definition of CODEX Alimentarius, established the AOAC 2009.01 and 2011.25 methods, designed to quantify soluble dietary fiber, insoluble dietary fiber and total dietary fiber. In this context, In Vitro and In Vivo research (in animals and humans) are being carried out to demonstrate the physicochemical, functional and physiological effects that are directed towards the prevention and treatment of some non-communicable diseases (NCDs). This review aims to inform the new definitions and methods of analysis, the functional and physiological properties of dietary fiber and their effects on human health.","[Vilcanqui-Perez, Fulgencio] Univ Nacl Agr Molina, Dept Nutr, Lima, Peru; Univ Nacl Micaela Bastidas Apurimac, Escuela Acad Profes Ingn Agroind, Abancay, Apurimac, Peru",University Nacional Agraria La Molina; Universidad Nacional Micaela Bastidas De Apurimac,"Vilcanqui-Pérez, F (corresponding author), Univ Nacl Agr Molina, Dept Nutr, Lima, Peru.",,"Vilcanqui Pérez, Fulgencio/ITW-2166-2023","Vilcanqui-Perez, FULGENCIO/0000-0002-9163-5655; VILCHEZ PERALES, NICEAS CARLOS/0000-0002-4757-527X",,,,,61,10,13,0,53,ARCHIVOS LATINOAMERICANOS NUTRICION,CARACAS,"APARTADO 62778 CHACAO, AVENIDA FRANCISCO MIRANDA, CARACAS 1060, VENEZUELA",0004-0622,2309-5806,,ARCH LATINOAM NUTR,Arch. Latinoam. Nutr.,JUN,2017,67,2,,,,,146,156,,,,,,11,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,FG6JU,,,,,2024-06-04,WOS:000410485100010,View Full Record in Web of Science
J,"Annells, M; Koch, T",,,,"Annells, M; Koch, T",,,"Constipation and the preached trio: diet, fluid intake, exercise",INTERNATIONAL JOURNAL OF NURSING STUDIES,,,English,Article,,,,,,constipation; diet; fluids; exercise; elderly,IDIOPATHIC CONSTIPATION; PHYSICAL-ACTIVITY; AUSTRALIAN WOMEN; PATIENT; TRANSIT,"A survey of 90 older community-dwelling people's constipation experience is reported in part. The focus is the participants' efforts to use diet, fluid intake and exercise as preventive strategies. Most feel that they have been preached to in this regard. However, constraints may prevent full adherence to the trio and although some have gained from diet adjustment, the majority is disillusioned about these strategies. Nurses should be aware that scientific and medical literature is discussing evidence that dietary fibre intake preventing constipation is not proven, that fluid intake does not necessarily determine stool bulk or speed colon transit time, and that there is no proven link between exercise levels and chronic constipation. (C) 2003 Elsevier Ltd. All rights reserved.","Royal Dist Nursing Serv S Australia Inc, RDNS Res Unit, Glenside, SA 5065, Australia; La Trobe Univ, RDNS, Helen Macpherson Smith Inst Community Hlth, Bundoora, Vic, Australia",La Trobe University,"Royal Dist Nursing Serv S Australia Inc, RDNS Res Unit, POB 247, Glenside, SA 5065, Australia.",koch.tina@rdns.sa.gov.au,,,,,,,31,33,34,1,9,PERGAMON-ELSEVIER SCIENCE LTD,OXFORD,"THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND",0020-7489,1873-491X,,INT J NURS STUD,Int. J. Nurs. Stud.,NOV,2003,40,8,,,,,843,852,,10.1016/S0020-7489(03)00075-0,http://dx.doi.org/10.1016/S0020-7489(03)00075-0,,,10,Nursing,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Nursing,739RL,14568365,,,,2024-06-04,WOS:000186360200004,View Full Record in Web of Science
J,"Champ, M; Hoebler, C",,,,"Champ, Martine; Hoebler, Christine",,,"Functional food for pregnant, lactating women and in perinatal nutrition: a role for dietary fibres?",CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE,,,English,Article,,,,,,constipation; diabetes; dietary fibre; human milk oligosaccharides; lactation; metabolic imprinting; newborn; pregnancy,CHAIN GALACTO-OLIGOSACCHARIDES; GESTATIONAL DIABETES-MELLITUS; HUMAN-MILK; GUT MICROBIOTA; WEIGHT-GAIN; DOUBLE-BLIND; IMMUNOGLOBULIN-A; FECAL MICROBIOTA; CONTROLLED-TRIAL; IMMUNE-SYSTEM,"Purpose of review If the benefits of dietary fibre in healthy adults have extensively been studied, little information is available on the specific needs of pregnant, lactating women or foetus. As far as infants are concerned, milk oligosaccharides are supposed to be the optimal 'dietary fibre'. The supplementation of infant formula with prebiotic oligosaccharides is still discussed. However, recent studies provide a large amount of information, allowing a new discussion on this topic. Recent findings Most recent findings are linked to the involvement of dietary fibre in occurrence or prevention of obesity. The multiple mechanisms appear more clearly than earlier. This finding will soon allow appropriate counselling for young mothers at risk of obesity and/or postpartum retention weight, gestational diabetes and preeclampsia. Another area which benefits from recent research is the use of prebiotics in formula. Summary Pregnancy is a critical period during which many physiologic changes occurred and is associated with several gut disorders and metabolic diseases. Dietary fibre may be helpful in the prevention and management of these diseases. Lactation and pregnancy are two phases during which food consumption of the mother can interact with the physiology of the baby. Moreover, the use of formula supplemented in oligosaccharides is able to compensate for the lack of some of the complex molecules naturally present in human milk.","[Champ, Martine; Hoebler, Christine] CHU Nantes, INRA, UMR Physiol Adaptat Nutr 1280, CRNH, F-44035 Nantes 01, France",INRAE; Nantes Universite; CHU de Nantes,"Champ, M (corresponding author), CHU Hotel Dieu, HNB1 UMR PhAN, Pl Alexis Ricordeau, F-44093 Nantes 1, France.",Martine.Champ@univ-nantes.fr,,,,,,,92,15,19,0,27,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",1363-1950,1473-6519,,CURR OPIN CLIN NUTR,Curr. Opin. Clin. Nutr. Metab. Care,NOV,2009,12,6,,,,,565,574,,10.1097/MCO.0b013e328331b4aa,http://dx.doi.org/10.1097/MCO.0b013e328331b4aa,,,10,Endocrinology & Metabolism; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Endocrinology & Metabolism; Nutrition & Dietetics,513BI,19741518,,,,2024-06-04,WOS:000271296600002,View Full Record in Web of Science
J,"Barbara, G; Barbaro, MR; Marasco, G; Cremon, C",,,,"Barbara, Giovanni; Barbaro, Maria R.; Marasco, Giovanni; Cremon, Cesare",,,Chronic constipation: from pathophysiology to management,MINERVA GASTROENTEROLOGY,,,English,Review,,,,,,Constipation; Therapeutics; Laxatives,IRRITABLE-BOWEL-SYNDROME; CHRONIC IDIOPATHIC CONSTIPATION; PLACEBO-CONTROLLED TRIAL; 3350 PLUS ELECTROLYTES; QUALITY-OF-LIFE; CLINICAL-TRIAL; DOUBLE-BLIND; PHARMACOLOGICAL THERAPIES; FUNCTIONAL CONSTIPATION; TRANSIT CONSTIPATION,"Chronic constipation (CC) is one of the most common conditions found in gastrointestinal clinical practice and defined by the presence of fewer than 3 bowel movements per week and/or more than one fourth of bowel movements with Bristol stool form types 1 or 2. CC affects people regardless of race, age, or sex, although it is most common in women and in elderly. It is associated with relevant disease burden, including significant impairment of patients' quality of life. In the absence of alarm features, patients should receive a symptom-based diagnosis. Treatment options include lifestyle and general measures, bulking agents, in particular dietary fiber supplementation. Osmotic laxatives are currently considered the first-line gold-standard pharmacological treatment of CC together with stimulant laxatives which are often used as a rescue therapy. When necessary, prokinetic agents and/or intestinal secretagogues can be used. Biofeedback may be indicated in patients with functional defecation disorders. In this review, we will briefly summarize the current understanding on epidemiology, classification, pathophysiology and clinical evaluation of CC and discuss in depth the pharmacological and not pharmacological management of patients with this disorder. (Cite this article as: Barbara G, Barbaro MR, Marasco G, Cremon C. Chronic constipation: from pathophysiology to manage","[Barbara, Giovanni; Barbaro, Maria R.; Marasco, Giovanni; Cremon, Cesare] IRCCS Azienda Osped Univ Bologna, Bologna, Italy; [Barbara, Giovanni; Marasco, Giovanni; Cremon, Cesare] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy; [Barbara, Giovanni] IRCCS Azienda Osped Univ Bologna, St Orsola Hosp, Bldg 5,Via Massarenti 9, I-40138 Bologna, Italy",IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna,"Barbara, G (corresponding author), IRCCS Azienda Osped Univ Bologna, St Orsola Hosp, Bldg 5,Via Massarenti 9, I-40138 Bologna, Italy.",giovanni.barbara@unibo.it,"Barbaro, Maria Raffaella/JDC-6398-2023; BARBARO, MARIA RAFFAELLA/J-5237-2016","Marasco, Giovanni/0000-0001-7167-8773; BARBARO, MARIA RAFFAELLA/0000-0003-4438-554X",,,,,108,3,3,11,20,EDIZIONI MINERVA MEDICA,TURIN,"CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY",2724-5985,2724-5365,,MINERVA GASTROENTERO,Minerva Gastroenterol.,JUN,2023,69,2,,,,,277,290,,10.23736/S2724-5985.22.03335-6,http://dx.doi.org/10.23736/S2724-5985.22.03335-6,,,14,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,H5QF5,36727654,,,,2024-06-04,WOS:000996499900012,View Full Record in Web of Science
J,"Tan, KY; Seow-Choen, F",,,,"Tan, Kok-Yang; Seow-Choen, Francis",,,Fiber and colorectal diseases: Separating fact from fiction,WORLD JOURNAL OF GASTROENTEROLOGY,,,English,Editorial Material,,,,,,fiber; physiology; colorectal cancer; constipation; irritable bowel syndrome; diverticulosis; hemorrhoids,DIETARY FIBER; COLON-CANCER; DIVERTICULAR-DISEASE; TRANSIT CONSTIPATION; POOLED ANALYSIS; RISK; BOWEL; VEGETABLES; TRENDS; FOOD,"Whilst fruits and vegetables are an essential part of our dietary intake, the role of fiber in the prevention of colorectal diseases remains controversial. The main feature of a high-fiber diet is its poor digestibility. Soluble fiber like pectins, guar and ispaghula produce viscous solutions in the gastrointestinal tract delaying small bowel absorption and transit. Insoluble fiber, on the other hand, pass largely unaltered through the gut. The more fiber is ingested, the more stools will have to be passed. Fermentation in the intestines results in build up of large amounts of gases in the colon. This article reviews the physiology of ingestion of fiber and defecation. It also looks into the impact of dietary fiber on various colorectal diseases. A strong case cannot be made for a protective effect of dietary fiber against colorectal polyp or cancer. Neither has fiber been found to be useful in chronic constipation and irritable bowel syndrome. It is also not useful in the treatment of perianal conditions. The fiber deficit - diverticulosis theory should also be challenged. The authors urge clinicians to keep an open mind about fiber. One must be aware of the truths and myths about fiber before recommending it. (c) 2007 WJG. All rights reserved.","Seow Choen Colorectal Ctr Pte Ltd, Mt Elizabeth Med Ctr, Singapore 228510, Singapore; Alexandra Hosp, Dept Surg, Singapore, Singapore",Mount Elizabeth Medical Centre,"Seow-Choen, F (corresponding author), Seow Choen Colorectal Ctr Pte Ltd, Mt Elizabeth Med Ctr, 3 Mt Elizabeth 09-10, Singapore 228510, Singapore.",seowchoen@colorectalcentre.com,,,,,,,58,34,37,0,14,BAISHIDENG PUBLISHING GROUP INC,PLEASANTON,"7041 Koll Center Parkway, Suite 160, PLEASANTON, CA, UNITED STATES",1007-9327,2219-2840,,WORLD J GASTROENTERO,World J. Gastroenterol.,AUG 21,2007,13,31,,,,,4161,4167,,10.3748/wjg.v13.i31.4161,http://dx.doi.org/10.3748/wjg.v13.i31.4161,,,7,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,202RC,17696243,"Green Published, hybrid",,,2024-06-04,WOS:000248919800001,View Full Record in Web of Science
J,"Zhao, XL; Wang, LZ; Quan, LF",,,,"Zhao, Xuelian; Wang, Lizhu; Quan, Longfang",,,Association between dietary phosphorus intake and chronic constipation in adults: evidence from the National Health and Nutrition Examination Survey,BMC GASTROENTEROLOGY,,,English,Article,,,,,,Phosphorus; Chronic constipation; National Health and Nutrition Examination Survey; Bowel health; Stool frequency; Stool consistency,CHRONIC IDIOPATHIC CONSTIPATION; PREVALENCE; HEMODIALYSIS; MICROBIOTA; CALCIUM; BREAD; FIBER; RISK,"BackgroundSeveral studies suggest a link between micronutrients and constipation. However, the relationship between constipation and phosphorus has rarely been examined. The main aim of this study was to investigate the association between changes in the prevalence of chronic constipation and dietary phosphorus intake among adult respondents of the National Health and Nutritional Examination Survey (NHANES).MethodsData were extracted from the NHANES database for the years 2005-2010. A total of 13,948 people were included in the analysis. Dietary information was collected using the respondents' 24-h dietary records. We conducted multiple logistic regression analyses to examine the correlation between phosphorus intake and poor bowel movement. The primary and secondary outcomes was constipation defined by stool consistency and stool frequency, respectively.ResultsFollowing multi-variate adjustment in model III, a significant association between chronic constipation and each additional 0.1-g intake of dietary phosphorus (odds ratio [OR], 0.97; 95% confidence interval [CI], 0.95, 1.00; P = 0.034 for stool consistency vs. OR, 0.94; 95% CI, 0.90, 0.99; P = 0.027 for stool frequency) was observed. Following multi-variate adjustment in model III, OR values and 95% CI from the second to fourth quartiles compared to the first quartile (reference group) were 0.92 (0.66, 1.27), 0.73 (0.47, 1.13), and 0.39 (0.20, 0.76), respectively, using the stool frequency definition.ConclusionsThis study revealed a negative correlation between phosphorus intake and chronic constipation. This may be due to the fact that dietary phosphorus intake is associated with softer stools and increased stool frequency. Further studies in different settings should be considered to verify these findings.","[Zhao, Xuelian] Shandong Univ Tradit Chinese Med, Clin Coll 1, Jinan 250013, Shandong, Peoples R China; [Wang, Lizhu] Shandong Univ Tradit Chinese Med, Affiliated Hosp, Dept Anorectal, Jinan 250014, Shandong, Peoples R China; [Quan, Longfang] China Acad Chinese Med Sci, Xiyuan Hosp, Dept Anorectal, Beijing 100091, Peoples R China","Shandong University of Traditional Chinese Medicine; Shandong University of Traditional Chinese Medicine; Xiyuan Hospital, CACMS; China Academy of Chinese Medical Sciences","Wang, LZ (corresponding author), Shandong Univ Tradit Chinese Med, Affiliated Hosp, Dept Anorectal, Jinan 250014, Shandong, Peoples R China.;Quan, LF (corresponding author), China Acad Chinese Med Sci, Xiyuan Hosp, Dept Anorectal, Beijing 100091, Peoples R China.",lizhuwang2021@163.com; bucmqlf@163.com,"Wang, Lizhu/AAG-7481-2021",,,,,,39,6,6,1,12,BMC,LONDON,"CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND",,1471-230X,,BMC GASTROENTEROL,BMC Gastroenterol.,JAN 24,2023,23,1,,,,,,,24,10.1186/s12876-022-02629-8,http://dx.doi.org/10.1186/s12876-022-02629-8,,,14,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,8C7WY,36694113,"Green Published, gold, Green Submitted",,,2024-06-04,WOS:000917816100001,View Full Record in Web of Science
J,"Leung, FW",,,,"Leung, Felix W.",,,Etiologic factors of chronic constipation - Review of the scientific evidence,DIGESTIVE DISEASES AND SCIENCES,,,English,Review,,,,,,chronic constipation; etiology,FLUID INTAKE; EXERCISE; DIETARY,"Geriatric patient educational material and a general practice review suggest insufficient dietary fiber intake, inadequate fluid intake, decrease physical activity, side effects of drugs, hypothyroidism, sex harmones and colorectal cancer obstructin may play a role in the pathogenesis of constipation. A search of recent literature, however, reveals that there is a paucity of evidence-based publications that address the etiologic factors of chronic constipation. Much of current writings on the subject may be based primarily on myths handed down from one generation to the next. In the absence of well-designed studies, there do not appear to be sufficient evidence-based information to implicate the above as major etilogic factors in the development of chronic constipation. The etiological role of each of these factors in the development of chronic constipation deserves to be assessed by modern techniques and methodologies. Funding agencies including the government and industry sponsors should support the development of evidence-based data sets. The understanding of the etiology of chronic constipation is the foundation on which cost-effective management strategies are to be built.","VA Sepulveda Ambulatory Care Ctr, Div Gastroenterol Res & Med Serv, Sepulveda, CA 91343 USA; Univ Calif Los Angeles, Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 91343 USA",University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System,"Leung, FW (corresponding author), VA Sepulveda Ambulatory Care Ctr, Div Gastroenterol Res & Med Serv, 111G,16111 Plummer St, Sepulveda, CA 91343 USA.",felix.leung@va.gov,,,,,,,16,52,53,0,10,SPRINGER,DORDRECHT,"VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS",0163-2116,,,DIGEST DIS SCI,Dig. Dis. Sci.,FEB,2007,52,2,,,,,313,316,,10.1007/s10620-006-9298-7,http://dx.doi.org/10.1007/s10620-006-9298-7,,,4,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,131XD,17219073,,,,2024-06-04,WOS:000243904600002,View Full Record in Web of Science
J,"Khatri, PK; Ali, AD; Alzadjali, N; Bhagia, G; Khaliqdina, SJ; Azizo, S",,,,"Khatri, Pooja Kumari; Ali, Anum Deedar; Alzadjali, Najla; Bhagia, Geeta; Khaliqdina, Shehryar Jehangir; Azizo, Sina",,,Frequency of functional constipation in 3 different populations and its causative factors,JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION,,,English,Article,,,,,,Functional constipation; Students; Fibre intake; Rome Ill criteria,UNITED-STATES; BOWEL HABITS; EPIDEMIOLOGY; PREVALENCE; ADULTS,"To assess the frequency of constipation and its causative factors in 3 different populations, namely, the hospitalized patients admitted at Civil Hospital Karachi, their attendants and medical students. Method: A sample size of 200 was divided into 3 groups: hospitalized patients, their attendants and medical students. Frequency of constipation was expected to be greater in patients, so 100 subjects were taken from this population; while from the other 2 populations only 50 subjects were taken. The subjects were diagnosed as constipated on the basis of Rome Ill criteria for functional constipation and their dietary habits and physical activity were also assessed. Results: The frequency of functional constipation was found to be 53% in hospitalized patients, 52% in their attendants and 345/s in medical students. Among the constipated individuals, 50.94% of hospitalized patients, 46.15% of attendants and 29.41% of medical students took laxatives for relief of their symptoms. Constipation was most prevalent among the age group of 18 to 30 years in all the 3 populations. Conclusion: Constipation was fairly common in all 3 populations. Male to female ratio is almost equal. Physical inactivity and low fiber intake were prominent risk factors for constipation.","[Khatri, Pooja Kumari; Khaliqdina, Shehryar Jehangir] Dow Univ Hlth Sci, Dept Paediat, Karachi, Pakistan",Dow University of Health Sciences,"Khatri, PK (corresponding author), Dow Univ Hlth Sci, Dept Paediat, Karachi, Pakistan.",,,,,,,,23,8,10,0,2,PAKISTAN MEDICAL ASSOC,KARACHI,"PMA HOUSE, AGA KHAN III RD, KARACHI, 00000, PAKISTAN",0030-9982,,,J PAK MED ASSOC,J. Pak. Med. Assoc.,NOV,2011,61,11,,,,,1149,1152,,,,,,4,"Medicine, General & Internal; Medicine, Research & Experimental",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine; Research & Experimental Medicine,835NU,22126005,,,,2024-06-04,WOS:000296043900031,View Full Record in Web of Science
J,"Toporovski, MS; de Morais, MB; Abuhab, A; Crippa, MA",,,,"Toporovski, Mauro Sergio; de Morais, Mauro Batista; Abuhab, Abrao; Crippa Junior, Mauro Acir",,,Effect of Polydextrose/Fructooligosaccharide Mixture on Constipation Symptoms in Children Aged 4 to 8 Years,NUTRIENTS,,,English,Article,,,,,,constipation; dietary fiber; clinical trial,FUNCTIONAL GASTROINTESTINAL DISORDERS; DOUBLE-BLIND; PEDIATRIC-PATIENTS; GASTROENTEROLOGY; POLYDEXTROSE; SYNBIOTICS; PREBIOTICS; FIBER,"Constipation is a frequent problem in children. We evaluated the effect of a mixture (polydextrose [PDX] and fructooligosaccharide [FOS]) in children with constipation. We performed a prospective interventional study with a mixture (PDX 4.17 g and FOS 0.45 g) in a daily dose of food supplement. The intervention lasted 45 days, with visits at 15, 30, and 45 days after administration. The sample comprised 105 patients, of whom 77 completed the intervention. A statistically significant reduction in the frequency of symptoms was observed at the end of the study. The frequency of children with fewer than three bowel movements per week dropped from 59.7% to 11.7%, and there was a decrease in the frequency of Bristol type 1 and 2 dry stools (68.8% to 7.8%), pain on defecation (79.2% to 10.4%), and fear of defecation (68.8% to 3.9%). The proportion of children with abdominal pain symptoms decreased from 84.2% to 2.6% at the end of the study. A relevant limitation of the present study was the lack of a control group treated with placebo. The administration of the PDX/FOS mixture was accompanied by a significant reduction in the frequency of constipation symptoms of the children evaluated. The tolerability was very good, and the rate of adverse effects was low.","[Toporovski, Mauro Sergio] Fac Ciencias Med Santa Casa Sao Paulo, Responsavel Disciplina Gastroenterol Pediat, BR-01234001 Sao Paulo, Brazil; [de Morais, Mauro Batista] Univ Fed Sao Paulo UNIFESP, Escola Paulista Med EPM, Disciplina Gastroenterol Pediat, BR-04023062 Sao Paulo, Brazil; [Abuhab, Abrao] Hypera Pharma, BR-05676120 Sao Paulo, Brazil; [Crippa Junior, Mauro Acir] Allergisa Contract Res Org, BR-13084791 Campinas, Brazil",Faculdade de Ciencias Medicas Santa Casa de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP),"Toporovski, MS (corresponding author), Fac Ciencias Med Santa Casa Sao Paulo, Responsavel Disciplina Gastroenterol Pediat, BR-01234001 Sao Paulo, Brazil.",mstoporovski@gmail.com; maurobmorais@gmail.com; abrao.abuhab@hypera.com.br; mauro.crippa@grupoinvestiga.com.br,"MORAIS, MAURO B/I-7995-2014","TOPOROVSKI, MAURO SERGIO/0000-0003-1525-7581",Hypera Pharma Brazil,Hypera Pharma Brazil,This study was funded by Hypera Pharma Brazil.,,25,6,6,2,12,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,MAY,2021,13,5,,,,,,,1634,10.3390/nu13051634,http://dx.doi.org/10.3390/nu13051634,,,10,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,ST4TI,34067961,"Green Published, gold",,,2024-06-04,WOS:000662437500001,View Full Record in Web of Science
J,"Dai, FJ; Chau, CF",,,,"Dai, Fan-Jhen; Chau, Chi-Fai",,,Classification and regulatory perspectives of dietary fiber,JOURNAL OF FOOD AND DRUG ANALYSIS,,,English,Review,,,,,,classification; definition; degree of polymerization; dietary fiber; oligosaccharide,RESISTANT STARCH; HEALTH-BENEFITS; CRUDE FIBER; DEFINITION; CONSTIPATION; MECHANISMS; PREBIOTICS; FOODS,"This review discusses the history and evolution of the state of dietary fiber (DF) with account of refinements in extraction methods and legal definitions subsequent to the launch of DF hypothesis. For a long time, defining and regulating DFs relied heavily on their chemical compositions and analytical methods. Although chemical compositions and analytical methods still play an important role in the definition of DF, physiological activity has also been taken into consideration. The precise definition of DF is still evolving, particularly whether oligosaccharides degrees of polymerization (DP) 3-9 should be considered as DF or not. Decades of scientific research have initiated the expansion of the term DF to include indigestible oligosaccharides with their DP between 3 and 9; hence responding to the positive health benefits of DF as well as fulfilling the needs in food labeling regulations. Copyright (C) 2016, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan LLC.","[Dai, Fan-Jhen; Chau, Chi-Fai] Natl Chung Hsing Univ, Dept Food Sci & Biotechnol, 250 Kuokuang Rd, Taichung 40227, Taiwan; [Chau, Chi-Fai] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung, Taiwan",National Chung Hsing University; National Chung Hsing University,"Chau, CF (corresponding author), Natl Chung Hsing Univ, Dept Food Sci & Biotechnol, 250 Kuokuang Rd, Taichung 40227, Taiwan.",chaucf@nchu.edu.tw,,"CHAU, Chi-Fai/0000-0002-6761-7932","Ministry of Science and Technology of the Republic of China [MOST 103-2313-B-005-033-MY3]; Ministry of Education, Taiwan, ROC, under the ATU plan","Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, ROC, under the ATU plan(Ministry of Education, Taiwan)","This work was supported by the Ministry of Science and Technology of the Republic of China (MOST 103-2313-B-005-033-MY3) and in part by the Ministry of Education, Taiwan, ROC, under the ATU plan.",,52,114,125,8,95,DIGITAL COMMONS BEPRESS,BERKELEY,"2100 MILVIA ST, STE 300, BERKELEY, CA 94704 USA",1021-9498,,,J FOOD DRUG ANAL,J. Food Drug Anal.,JAN,2017,25,1,,,,,37,42,,10.1016/j.jfda.2016.09.006,http://dx.doi.org/10.1016/j.jfda.2016.09.006,,,6,Food Science & Technology; Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Pharmacology & Pharmacy,EJ4IM,28911542,"hybrid, Green Published",,,2024-06-04,WOS:000393180200005,View Full Record in Web of Science
J,"Shimotoyodome, A; Meguro, S; Hase, T; Tokimitsu, I; Sakata, T",,,,"Shimotoyodome, A; Meguro, S; Hase, T; Tokimitsu, I; Sakata, T",,,"Sulfated polysaccharides, but not cellulose, increase colonic mucus in rats with loperamide-induced constipation",DIGESTIVE DISEASES AND SCIENCES,,,English,Article,,,,,,carrageenan; cellulose; chondroitin sulfate; colonic mucus; dietary fiber; loperamide,GASTROINTESTINAL MUCIN; LARGE-INTESTINE; OLIGOSACCHARIDES; GLYCOPROTEIN; LAYER,"Colonic mucus is decreased in a rat model of spastic constipation, and some types of water-insoluble dietary fiber increase colonic mucus when consumed by rats for several weeks. However, little is known about the effect of water-soluble dietary fiber on the colonic mucus. The aim of the present study was to investigate the effect of various types of water-soluble dietary fiber on colonic mucus in a rat model of spastic constipation. Oral administration of 1:5 mg/day of carrageenan and chondroitin sulfate increased the fecal excretion, epithelial mucin production, thickness of the mucous layer, and amount of luminal mucus in loperamide-administered rats. Sodium alginate, 5 mg/day, thickened the mucus layer at the fecal surface. Cellulose, 5 mg/day, increased the fecal excretion but not the colonic mucus. Carrageenan, chondroitin sulfate, and sodium alginate, but not cellulose, increased colonic mucus in the rat model of spastic constipation.","Kao Corp, Biol Sci Labs, Ichikai, Tochigi 3213497, Japan",KAO Corporation,"Tokimitsu, I (corresponding author), Kao Corp, Biol Sci Labs, 2606 Akabane, Ichikai, Tochigi 3213497, Japan.",,"; Sakata, Takashi/F-7770-2011","Meguro, Shinichi/0000-0002-3072-2632; shimotoyodome, akira/0000-0001-7567-8316; Sakata, Takashi/0000-0001-5083-2700",,,,,24,43,50,1,12,KLUWER ACADEMIC/PLENUM PUBL,NEW YORK,"233 SPRING ST, NEW YORK, NY 10013 USA",0163-2116,,,DIGEST DIS SCI,Dig. Dis. Sci.,JUL,2001,46,7,,,,,1482,1489,,10.1023/A:1010644021888,http://dx.doi.org/10.1023/A:1010644021888,,,8,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,455HZ,11478500,,,,2024-06-04,WOS:000170022600016,View Full Record in Web of Science
J,"Janssenduijghuijsen, L; van den Belt, M; Rijnaarts, I; Vos, P; Guillemet, D; Witteman, B; de Wit, N",,,,"Janssenduijghuijsen, Lonneke; van den Belt, Maartje; Rijnaarts, Iris; Vos, Paul; Guillemet, Damien; Witteman, Ben; de Wit, Nicole",,,Acacia fiber or probiotic supplements to relieve gastrointestinal complaints in patients with constipation-predominant IBS: a 4-week randomized double-blinded placebo-controlled intervention trial,EUROPEAN JOURNAL OF NUTRITION,,,English,Article; Early Access,,,,,,Irritable bowel syndrome; Constipation; Fiber; Probiotics; Stool frequency; IBS symptoms,IRRITABLE-BOWEL-SYNDROME; QUALITY-OF-LIFE; FERMENTED MILK; CLINICAL-TRIAL; SEVERITY; VALIDATION; TRANSIT; RISK; SYNBIOTICS; PREBIOTICS,"Purpose To date, no adequate treatment for irritable bowel syndrome with predominant constipation complaints (IBS-C) is available. Fibers with prebiotic properties and probiotic compounds have shown promise in relieving IBS-C-related complaints. We aimed to determine the effects of a 4-week intervention with either an Acacia fiber (AF) with prebiotic properties or a probiotic Bifidobacterium Lactis (BLa80) supplement, compared to a control supplement, on stool pattern, IBS symptoms and Quality of Life (QoL), in IBS-C individuals. Methods A parallel, double-blind, randomized controlled trial involving 180 subjects meeting the ROME IV criteria for IBS-C was conducted. Following a 4-week observation period, subjects received either AF (10 g), Probiotic BLa80 (4 g; 2 x 10(11) CFU/g) or a maltodextrin placebo (10 g) daily for 4 weeks. Subjects reported daily information on stool pattern and gastrointestinal complaints. Before and after each 4-week period, questionnaires on symptom severity, constipation symptoms, anxiety and depression and QoL were completed. Stool mass was measured for 5-days before and after the intervention. Results Stool frequency significantly improved in the AF and Probiotic BLa80 groups compared to placebo (P < 0.001, P = 0.02, respectively). Probiotic BLa80 showed a significant reduction in IBS symptom severity (P = 0.03), for AF a trend towards decreased constipation symptoms (PAC-SYM, P = 0.10) was observed. No significant changes in stool consistency, stool mass or QoL measures were observed between the AF and Probiotic BLa80 compared to placebo. Conclusion Daily dietary supplementation with Acacia fiber and probiotic supplements might help IBS-C patients by relieving IBS-related complaints compared to a placebo supplement. Registration number of clinical trial The trial is registered at ClinicalTrials.gov: NCT04798417: Study Details | Nutrition to Relieve IBS Constipation | ClinicalTrials.gov.","[Janssenduijghuijsen, Lonneke; van den Belt, Maartje; Vos, Paul; de Wit, Nicole] Wageningen Univ & Res, Wageningen Food & Biobased Res, Wageningen, Netherlands; [Rijnaarts, Iris; Witteman, Ben] Wageningen Univ & Res, Div Human Nutr & Hlth, Wageningen, Netherlands; [Witteman, Ben] Hosp Gelderse Vallei, Gastroenterol & Hepatol Dept, Ede, Netherlands; [Guillemet, Damien] Nexira, Rouen, France",Wageningen University & Research; Wageningen University & Research; Gelderse Vallei Hospital,"van den Belt, M (corresponding author), Wageningen Univ & Res, Wageningen Food & Biobased Res, Wageningen, Netherlands.",maartje.vandenbelt@wur.nl,,"Guillemet, Damien/0000-0002-6638-0531",Ministerie van Buitenlandse Zaken,Ministerie van Buitenlandse Zaken,"We thank Els Oosterink, Juliette Hooghiemstra, Niels Klaassen, Saskia Meijboom, and Odette Paling for their help in study logistics and data collection. We thank Joao Paulo and Geertje van Bergen for their support with the statistical analyses, and Nicole de Roos for her support during data interpretation and writing of the manuscript.",,49,0,0,0,0,SPRINGER HEIDELBERG,HEIDELBERG,"TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY",1436-6207,1436-6215,,EUR J NUTR,Eur. J. Nutr.,2024 APR 23,2024,,,,,,,,,,10.1007/s00394-024-03398-8,http://dx.doi.org/10.1007/s00394-024-03398-8,,APR 2024,12,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,OK4W9,38653808,hybrid,,,2024-06-04,WOS:001207161800001,View Full Record in Web of Science
J,"Castillejo, G; Bulló, M; Anguera, A; Escribano, J; Salas-Salvadó, J",,,,"Castillejo, Gemma; Bullo, Monica; Anguera, Anna; Escribano, Joaquin; Salas-Salvado, Jordi",,,"A controlled, randomized, double-blind trial to evaluate the effect of a supplement of cocoa husk that is rich in dietary fiber on colonic transit in constipated pediatric patients",PEDIATRICS,,,English,Article,,,,,,fiber; constipation; children; cocoa husk; transit time,FUNCTIONAL GASTROINTESTINAL DISORDERS; WHEAT BRAN; CHILDHOOD CONSTIPATION; CHILDREN; TIME; ROME; STOOL; RISK,"OBJECTIVE. Although a diet that is rich in fiber is widely recommended for preventing and treating constipation, the efficacy of fiber supplements have not been tested sufficiently in children. Our aim with this pilot study was to evaluate if fiber supplementation is beneficial for the treatment of children with idiopathic chronic constipation. METHODS. Using a parallel, randomized, double-blind, controlled trial, we conducted an interventional study to evaluate the efficacy of a supplement of cocoa husk rich in dietary fiber on intestinal transit time and other indices of constipation in children with constipation. After screening, the patients were randomly allocated to receive, for a period of 4 weeks, either a cocoa husk supplement or placebo plus standardized toilet training procedures. Before and after 4 weeks of treatment, we (1) performed anthropometry, a physical examination, and routine laboratory measurements, (2) determined total and segmental colonic transit time, (3) evaluated bowel movement habits and stool consistency using a diary, and (4) received a subjective evaluation from the parents regarding the efficacy of the treatment. The main variable for verifying the efficacy of the treatment was the total colonic transit time. RESULTS. Fifty-six chronically constipated children were randomly assigned into the study, but only 48 children completed it. These children, who were aged between 3 and 10 years, had a diagnosis of chronic idiopathic constipation. With respect to total, partial colon, and rectum transit time, there seemed to be a trend, although statistically nonsignificant, toward faster transit times in the cocoa husk group than in the placebo group. When we analyzed the evolution of the intestinal transit time throughout the study of children whose total basal intestinal transit time was > 50th percentile, significant differences were observed between the groups. The total transit time decreased by 45.4 +/- 38.4 hours in the cocoa husk group and by 8.7 +/- 28.9 hours in the placebo group (-38.1 hours). In the case of the right colon, changes in transit time also were significant between groups. Mean changes tended toward faster transit times in the left colon and the rectum, although the differences were not statistically significant. The children who received cocoa husk supplements tended to increase the number of bowel movements by more than that of the children of the placebo group. We also observed a reduction in the percentage of patients who reported hard stools (hard scybalous or pebble-like stools), although this reduction was significantly greater in the cocoa husk group. At the end of the intervention, 41.7% and 75.0% of the patients who received cocoa husk supplementation or placebo, respectively, reported having hard stools. Moreover, a significantly higher number of children (or their parents) reported a subjective improvement in stool consistency. No significant adverse effects were reported during the study. CONCLUSIONS. This study confirms the beneficial effect of a supplement of cocoa husk that is rich in dietary fiber on chronic idiopathic constipation in children. These benefits seem to be more evident in pediatric constipated patients with slow colonic transit time.","Univ Rovira & Virgili, Dept Bioquim & Biotecnol, Hosp Univ St Joan Reus, Human Nutr Unit, E-43201 Reus, Spain; Univ Rovira & Virgili, Dept Bioquim & Biotecnol, Hosp Univ St Joan Reus, Dept Pediat, E-43201 Reus, Spain; Madaus SA, Dept Res, Barcelona, Spain",Universitat Rovira i Virgili; Universitat Rovira i Virgili,"Salas-Salvadó, J (corresponding author), Fac Med, Unitat Nutr, C Sant Llorenc,21, Reus 43201, Spain.",jordi.salas@urv.net,"Escribano, Joaquin/ABD-6604-2020; Salas-Salvado, Jordi/C-7229-2017; Bulló, Mònica/F-2925-2016","Salas-Salvado, Jordi/0000-0003-2700-7459; Bulló, Mònica/0000-0002-0218-7046; Escribano, Joaquin/0000-0002-5041-459X",,,,,34,73,79,0,16,AMER ACAD PEDIATRICS,ELK GROVE VILLAGE,"141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA",0031-4005,1098-4275,,PEDIATRICS,Pediatrics,SEP,2006,118,3,,,,,E641,E648,,10.1542/peds.2006-0090,http://dx.doi.org/10.1542/peds.2006-0090,,,8,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,090NX,16950955,,,,2024-06-04,WOS:000240959100089,View Full Record in Web of Science
J,"Yang, XJ; Zhang, M; Zhu, HM; Tang, Z; Zhao, DD; Li, BY; Gabriel, A",,,,"Yang, Xiao-Jiao; Zhang, Mei; Zhu, Hong-Ming; Tang, Zhe; Zhao, Dan-Dan; Li, Bang-Yi; Gabriel, Amanda",,,Epidemiological study: Correlation between diet habits and constipation among elderly in Beijing region,WORLD JOURNAL OF GASTROENTEROLOGY,,,English,Article,,,,,,Constipation; Elderly; Diet; Epidemiology; Prevalence; Factors,INTESTINAL TRANSIT-TIME; LIFE-STYLE FACTORS; NONSTARCH POLYSACCHARIDES; FIBER; PSYLLIUM; STARCH,"AIM To investigate correlations between diet and prevalence of constipation among elderly people in Beijing. METHODS A total of 2776 (>= 60 years) were selected in Beijing region for investigation. Data regarding constipation and diet habits was collected via hierarchical status, segmentation and random cluster sampling. Investigation included constipation-related demographic indicators and diet habits. Door-to-door questionnaires and surveys included daily staple food intakes, frequency of fish, egg, fruits and vegetables consumption. Constipation was defined according to the China Chronic Constipation Diagnosis and Treatment Guideline (2013), with the following constipation judgment indicators: decreased defecation frequency, dry and hard stool, and difficulty in defecation. RESULTS The prevalence of constipation among elderly people in Beijing region was 13%. There was a positive correlation between prevalence of constipation and age, but negative correlations between prevalence of constipation and staple food, fish and dietary fibres (fruits and vegetables) intakes. These differences were all statistically significant. CONCLUSION The prevalence of elderly constipation in Beijing region is closely related to diet habits, and is significantly decreased by high staple foods intake, fish eating and high dietary fibres (fruits and vegetables) consumption.","[Yang, Xiao-Jiao; Gabriel, Amanda] McGill Univ, 845 Sherbrooke St West, Montreal, PQ H3A 0G4, Canada; [Zhang, Mei; Zhu, Hong-Ming; Tang, Zhe; Zhao, Dan-Dan; Li, Bang-Yi] Capital Med Univ, Xuanwu Hosp, Dept Gastroenterol, 45 Changchun St, Beijing 100053, Peoples R China",McGill University; Capital Medical University,"Zhang, M (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Gastroenterol, 45 Changchun St, Beijing 100053, Peoples R China.",zhang2955@sina.com,"Gabriel, Amanda/HGD-0853-2022","Yang, Xiaojiao/0000-0003-3667-1239",,,,,22,17,20,1,20,BAISHIDENG PUBLISHING GROUP INC,PLEASANTON,"8226 REGENCY DR, PLEASANTON, CA 94588 USA",1007-9327,2219-2840,,WORLD J GASTROENTERO,World J. Gastroenterol.,OCT 21,2016,22,39,,,,,8806,8811,,10.3748/wjg.v22.i39.8806,http://dx.doi.org/10.3748/wjg.v22.i39.8806,,,6,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,EA4QD,27818596,"Green Published, Green Submitted, hybrid",,,2024-06-04,WOS:000386597500014,View Full Record in Web of Science
J,"Zou, H; Gao, HJ; Liu, YH; Zhang, ZW; Zhao, J; Wang, WX; Ren, B; Tan, XT",,,,"Zou, Hui; Gao, Huajing; Liu, Yanhong; Zhang, Zhiwo; Zhao, Jia; Wang, Wenxuan; Ren, Bo; Tan, Xintong",,,Dietary inulin alleviated constipation induced depression and anxiety-like behaviors: Involvement of gut microbiota and microbial metabolite short-chain fatty acid,INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES,,,English,Article,,,,,,Inulin; Constipation; Depression; Gut microbiota; Short-chain fatty acids,DIPHENOXYLATE-INDUCED CONSTIPATION; FIBER,"Chronic constipation has been associated with depression-like behavior. Previous study identified the crucial role of gut microbiota in the development of constipation and depression. Dietary inulin (INU) could regulate gut microbiota. Whether INU treatment could ameliorate constipation induced depression was not clear. For this purpose, male CD-1 mice were administered diphenoxylate (20 mg/kg body weight/day) to induce constipation. We found that INU (10 % in standard diet) alleviated the diphenoxylate-induced constipation, manifested as the increase weight and moisture content of feces. Furthermore, the associated depression and anxiety-like behavior disorders were improved by inhibiting neuro-inflammation and preventing synaptic ultrastructure damage under INU treatment. Moreover, INU pretreatment improved the diphenoxylate-induced gut barrier damage by upregulating tight junction protein expression. INU also reshaped gut microbiota in constipation mice by increasing the relative abundance of Bacteroides and Proteobacteria and downregulating the abundance of Muribacalum and Melaminabacteria. The effects of INU on diphenoxylate-induced depression were abolished by gut microbiota depletion via antibiotic treatment. In addition, INU increased the concentration of short chain fatty acids (SCFAs) in feces contents. Meanwhile, supplementation of SCFAs could also partly improve diphenoxylate-induced depression. In conclusion, INU intake was a potential nutritional intervention strategy to prevent constipation induced depression via microbiota-gut-SCFAs axis.","[Zou, Hui; Gao, Huajing; Liu, Yanhong; Zhang, Zhiwo; Zhao, Jia; Wang, Wenxuan; Tan, Xintong] Shandong Agr Univ, Qual Control Shandong Higher Educ Inst, Coll Food Sci & Engn, Key Lab Food Proc Technol, Tai An 271018, Peoples R China; [Ren, Bo] Nanjing Normal Univ, Sch Food Sci & Pharmaceut Engn, Nanjing 210023, Peoples R China",Shandong Agricultural University; Nanjing Normal University,"Tan, XT (corresponding author), Shandong Agr Univ, Qual Control Shandong Higher Educ Inst, Coll Food Sci & Engn, Key Lab Food Proc Technol, Tai An 271018, Peoples R China.;Ren, B (corresponding author), Nanjing Normal Univ, Sch Food Sci & Pharmaceut Engn, Nanjing 210023, Peoples R China.",boren@nnu.edu.cn; tanxintong142536@sdau.edu.cn,"Wang, Wenxuan/AAW-9073-2020",,National Natural Science Foundation of China [32001793]; Natural Science Foundation of Shandong Province [ZR2020QC238]; Postdoctoral Research Foundation of China [2021M691972]; Key Technology Research and Development Program of Shandong [2021TZXD007]; Natural Science Foundation of Jiangsu Province of China [BK20220372],National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Postdoctoral Research Foundation of China(China Postdoctoral Science Foundation); Key Technology Research and Development Program of Shandong; Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province),"This work was supported by the National Natural Science Foundation of China (No.32001793) , Natural Science Foundation of Shandong Province (ZR2020QC238) , Postdoctoral Research Foundation of China (2021M691972) , Key Technology Research and Development Program of Shandong (2021TZXD007) and Natural Science Foundation of Jiangsu Province of China (No. BK20220372) .",,58,0,0,24,24,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",0141-8130,1879-0003,,INT J BIOL MACROMOL,Int. J. Biol. Macromol.,FEB,2024,259,,2,,,,,,129420,10.1016/j.ijbiomac.2024.129420,http://dx.doi.org/10.1016/j.ijbiomac.2024.129420,,JAN 2024,12,"Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science",Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Chemistry; Polymer Science,IF9J7,38219945,,,,2024-06-04,WOS:001165029400001,View Full Record in Web of Science
J,"Cha, RR; Park, SY; Camilleri, M",,,,"Cha, Ra Ri; Park, Seon-Young; Camilleri, Michael",,", CRGOKSONM",Constipation in Patients With Chronic Kidney Disease,JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY,,,English,Review,,,,,,Chronic kidney disease; Constipation; End-stage renal disease; Laxatives,IRRITABLE-BOWEL-SYNDROME; QUALITY-OF-LIFE; GASTROINTESTINAL SYMPTOMS; FUNCTIONAL CONSTIPATION; DIALYSIS; LACTULOSE; EFFICACY; PRUCALOPRIDE; LUBIPROSTONE; TENAPANOR,"Constipation is a frequent symptom in patients with chronic kidney disease (CKD). This review outlines the mechanisms and management of constipation in patients with CKD from a physician's perspective. Common causes of constipation in patients with CKD include concomitant medications, low dietary fiber intake, water-restricted diet, lack of physical activity, altered gut microbiota, and reduced gastrointestinal motility. Constipation has a negative impact on overall health, and, in particular, the presence of constipation has been associated with worsening kidney function and increased risk of developing advanced stages of CKD. Although lifestyle and dietary modifications may not always be practical for patients with CKD, they are recommended because they are beneficial as they lower mortality in patients with CKD. The use of laxatives containing magnesium salts, bulking agents, and osmotic laxatives may have insufficient efficacy and may be associated with adverse effects. In contrast, lactulose and lubiprostone have been shown to exhibit reno-protective effects. Linaclotide and plecanatide have very limited systemic absorption and appear safe in patients with CKD. Tenapanor reduces paracellular intestinal phosphate absorption in addition to blocking sodium uptake by enterocytes, and provides additional benefit in patients patients with CKD who have hyperphosphatemia and constipation. Prucalopride leads to improvements in bowel function and constipation-related symptoms in cases in which response to conventional laxatives are inadequate. However, the dose of prucalopride should be reduced to 1 mg once daily for patients with CKD. In conclusion, there are important advances on the impact and treatment of constipation in patients with CKD. (J Neurogastroenterol Motil 2023","[Cha, Ra Ri] Gyeongsang Natl Univ, Coll Med, Gyeongsang Natl Univ Hosp, Dept Internal Med, Jinju, South Korea; [Park, Seon-Young] Chonnam Natl Univ, Med Sch, Dept Internal Med, Div Gastroenterol, Gwangju, South Korea; [Camilleri, Michael] Mayo Clin, Clin Enter Neurosci Translat & Epidemiol Res, Rochester, MN 55905 USA; [Park, Seon-Young] Chonnam Natl Univ Hosp, Dept Internal Med, Div Gastroenterol, 42 Jaebong Ro, Gwangju 61482, South Korea",Gyeongsang National University; Gyeongsang National University Hospital; Chonnam National University; Mayo Clinic; Chonnam National University; Chonnam National University Hospital,"Park, SY (corresponding author), Chonnam Natl Univ, Med Sch, Dept Internal Med, Div Gastroenterol, Gwangju, South Korea.;Park, SY (corresponding author), Chonnam Natl Univ Hosp, Dept Internal Med, Div Gastroenterol, 42 Jaebong Ro, Gwangju 61482, South Korea.",drpsy@naver.com,,"Park, Seon-Young/0000-0002-0962-5977; cha, rari/0000-0001-6024-9201",,,,,66,2,2,1,2,KOREAN SOC NEUROGASTROENTEROLOGY & MOTILITY,GANGNAM-GU,"RM 305, LOTTE GOLD ROSE VILL II, 31 SEOLLEUNG-RO 86-GIL, GANGNAM-GU, SEOUL 135-839, SOUTH KOREA",2093-0879,2093-0887,,J NEUROGASTROENTEROL,J. Neurogastroenterol. Motil.,OCT,2023,29,4,,,,,428,435,,10.5056/jnm23133,http://dx.doi.org/10.5056/jnm23133,,,8,Gastroenterology & Hepatology; Clinical Neurology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Neurosciences & Neurology,Y9VO3,37814433,"Green Published, gold",,,2024-06-04,WOS:001108666600002,View Full Record in Web of Science
J,"JOHANSON, JF; SONNENBERG, A; KOCH, TR; MCCARTY, DJ",,,,"JOHANSON, JF; SONNENBERG, A; KOCH, TR; MCCARTY, DJ",,,ASSOCIATION OF CONSTIPATION WITH NEUROLOGIC DISEASES,DIGESTIVE DISEASES AND SCIENCES,,,English,Article,,,,,,CONSTIPATION; EPIDEMIOLOGY OF CONSTIPATION; NEURONAL DAMAGE; COLONIC MOTILITY; AGING; MEDICARE,IDIOPATHIC CONSTIPATION; DIETARY FIBER; EPIDEMIOLOGY; INNERVATION; COLON,"To investigate possible etiologic influences on the development of constipation, the present study examines the concordant occurrence of constipation with other diseases. Using 8.8 million Medicare patients hospitalized in the United States during 1987, the frequency distribution of all three-digit International Classification of Diseases (ICD) codes was compared in constipated patients and patients without constipation. Most associations and the closest associations were observed between constipation and neurologic diseases, the majority of which resulted from damage to the central nervous system. Associations between constipation and disorders of the spine also involved neuronal damage. The influence of potential confounding factors such as immobility or pain on the development of constipation was assessed and found to be minimal. The frequent association of constipation with disorders involving neuronal malfunction suggests that disruption of the neural modulation of colonic motility may play an important role in the development of constipation.","VET AFFAIRS MED CTR,DEPT BIOL BIOSTAT & EPIDEMIOL,111-C,MILWAUKEE,WI 53295; MED COLL WISCONSIN,MILWAUKEE,WI 53226",US Department of Veterans Affairs; Veterans Health Administration (VHA); Medical College of Wisconsin,,,"Koch, Timothy R/JCP-1908-2023","Koch, Timothy/0000-0002-8026-9653",,,,,29,51,56,0,4,PLENUM PUBL CORP,NEW YORK,"233 SPRING ST, NEW YORK, NY 10013",0163-2116,,,DIGEST DIS SCI,Dig. Dis. Sci.,FEB,1992,37,2,,,,,179,186,,10.1007/BF01308169,http://dx.doi.org/10.1007/BF01308169,,,8,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,HD684,1735333,,,,2024-06-04,WOS:A1992HD68400005,View Full Record in Web of Science
J,"Harada, M; Tsuboyama-Kasaoka, N; Yonekura, Y; Shimoda, H; Ogawa, A; Kobayashi, S; Sakata, K; Nishi, N",,,,"Harada, Moeka; Tsuboyama-Kasaoka, Nobuyo; Yonekura, Yuki; Shimoda, Haruki; Ogawa, Akira; Kobayashi, Seiichiro; Sakata, Kiyomi; Nishi, Nobuo",,,Associations Between Lifestyle Factors and Constipation Among Survivors After the Great East Japan Earthquake: A 9-year Follow-up Study,JOURNAL OF EPIDEMIOLOGY,,,English,Article,,,,,,Great East Japan Earthquake; constipation; lifestyle factors; dietary intake,QUALITY-OF-LIFE; DIETARY-INTAKE; WATER; FIBER,"Background: Disaster survivors experience deterioration in lifestyles and an increase in constipation. After the Great East Japan Earthquake in 2011, some survivors were evacuated for a long term, even after moving to temporary housing and public reconstruction housing. However, annual changes in constipation and the association between lifestyles and constipation among the survivors are still unknown.Methods: Overall, 9,234 survivors aged 18 years or older participated in this 9-year follow-up survey after the disaster. Information about the prevalence of constipation and lifestyle factors (diet, physical activity, and mental health) was collected using a self-reported questionnaire. Their dietary intake was categorized into the following two dietary patterns: prudent (fish and shellfish, soybean products, vegetables, fruits, and dairy products) and meat (meat and eggs). Odds ratios for constipation according to lifestyle factors were calculated using a generalized linear mixed model.Results: In women, the prevalence of constipation was the highest at baseline (8.7%) and remained around 5% afterward. In both men and women, older age, poor mental health, and poor physical activity were significantly associated with higher odds ratios of constipation. Moreover, a lower frequency of meals and a lower prudent dietary score were significantly associated with women's constipation.Conclusion: The prevalence of constipation was the highest at baseline and remained around 5% in women. Lifestyle factors, such as poor mental health, physical inactivity, and low frequency of meals were associated with constipation. Our findings suggest continuous support for the survivors with constipation for medium-to long-term after disasters.","[Harada, Moeka; Tsuboyama-Kasaoka, Nobuyo; Nishi, Nobuo] Natl Inst Biomed Innovat Hlth & Nutr, Osaka, Japan; [Yonekura, Yuki; Nishi, Nobuo] St Lukes Int Univ, Tokyo, Japan; [Shimoda, Haruki; Ogawa, Akira; Kobayashi, Seiichiro; Sakata, Kiyomi] Iwate Med Univ, Yahaba, Iwate, Japan; [Tsuboyama-Kasaoka, Nobuyo] Natl Inst Biomed Innovat Hlth & Nutr, Natl Inst Hlth & Nutr, Int Ctr Nutr & Informat, Sect Global Disaster Nutr, 3-17 Senriokashinmachi, Settsu, Osaka 5660002, Japan",St. Luke's International Hospital; Iwate Medical University; National Institute of Health & Nutrition - Japan,"Tsuboyama-Kasaoka, N (corresponding author), Natl Inst Biomed Innovat Hlth & Nutr, Natl Inst Hlth & Nutr, Int Ctr Nutr & Informat, Sect Global Disaster Nutr, 3-17 Senriokashinmachi, Settsu, Osaka 5660002, Japan.",ntsubo@nibiohn.go.jp,,"Nishi, Nobuo/0000-0002-5772-6561","Ministry of Health, Labor and Welfare, Health and Labor Sciences Research Grants, Japan [H24-Kenki-Shitei-001, H25-Kenki-Shitei-001]; [H23-Tokubetsu-Shitei-002]","Ministry of Health, Labor and Welfare, Health and Labor Sciences Research Grants, Japan(Ministry of Health, Labour and Welfare, Japan);","This study was supported by a Grant in Aid from the Ministry of Health, Labor and Welfare, Health and Labor Sciences Research Grants, Japan [H23-Tokubetsu-Shitei-002; H24-Kenki-Shitei-001, H25-Kenki-Shitei-001 (Fukkou) ] . We thank Enago ( www.enago.jp) for the English language editing.",,36,0,0,1,1,JAPAN EPIDEMIOLOGICAL ASSOC,TOKYO,"HONGO MT BLDG, 4 FL, 7-2-2, HONGO, BUNKYO-KU, TOKYO, JAPAN",0917-5040,,,J EPIDEMIOL,J. Epidemiol.,APR,2024,34,4,,,,,164,169,,10.2188/jea.JE20220284,http://dx.doi.org/10.2188/jea.JE20220284,,AUG 2023,6,"Public, Environmental & Occupational Health",Science Citation Index Expanded (SCI-EXPANDED),"Public, Environmental & Occupational Health",QU6E3,37635084,"Green Accepted, gold",,,2024-06-04,WOS:001058783900001,View Full Record in Web of Science
J,"Nakamura, T; Agata, K; Mizutani, M; Iino, H",,,,"Nakamura, T; Agata, K; Mizutani, M; Iino, H",,,Effects of Brewer's yeast cell wall on constipation and defecation in experimentally constipated rats,BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY,,,English,Article,,,,,,yeast cell wall; constipation; defecation; dietary fiber; rat,GERMINATED BARLEY FOODSTUFF; MUCOSAL PROTEIN-CONTENT; DIETARY FIBER; ULCERATIVE-COLITIS; BUTYRATE ENEMAS; BRAN,"Brewer's yeast cell wail (BYC) was tested on constipated male Sprague-Dawley rats that had been induced by loperamide (2 mg/kg of body weight). The preventive effect of BYC on constipation was examined and compared with that of a non-fiber diet (NF) as the control. The dose-response of BYC and the effect on defecation by constipated experimental rats were also compared with the chararteristics of cellulose diet (CE) group which served as a control. Defecation was observed to be greater by the rats fed with BYC than by those fed with NF or CE. The fecal water content and Eet;el of volatile fatty acids (VFA) in the cecal contents mere likewise higher in the rats fed with BYC. These results indicate that the administration of BYC was effective for improving defecation and other parameters related to defecation. These favorable effects of BYC supplemented to the diet are attributed to the fermentation ability, water holding capacity and swelling force in the large intestine.","Kirin Brewery Co Ltd, Corp Res & Dev Dept, Appl Biores Ctr, Takasaki, Gumma 3701295, Japan; Showa Womens Univ, Setagaya Ku, Tokyo 1540004, Japan",Kirin Brewery Company Limited,"Nakamura, T (corresponding author), Kirin Brewery Co Ltd, Corp Res & Dev Dept, Appl Biores Ctr, Miyahara Machi 3, Takasaki, Gumma 3701295, Japan.",to-nakamura@kirin.co.jp,,,,,,,25,22,23,0,3,TAYLOR & FRANCIS LTD,ABINGDON,"4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND",0916-8451,1347-6947,,BIOSCI BIOTECH BIOCH,Biosci. Biotechnol. Biochem.,APR,2001,65,4,,,,,774,780,,10.1271/bbb.65.774,http://dx.doi.org/10.1271/bbb.65.774,,,7,"Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology",Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology,431MG,11388452,Bronze,,,2024-06-04,WOS:000168634600005,View Full Record in Web of Science
J,"Snauwaert, E; Paglialonga, F; Vande Walle, J; Wan, M; Desloovere, A; Polderman, N; Renken-Terhaerdt, J; Shaw, V; Shroff, R",,,,"Snauwaert, Evelien; Paglialonga, Fabio; Vande Walle, Johan; Wan, Mandy; Desloovere, An; Polderman, Nonnie; Renken-Terhaerdt, Jose; Shaw, Vanessa; Shroff, Rukshana",,,The benefits of dietary fiber: the gastrointestinal tract and beyond,PEDIATRIC NEPHROLOGY,,,English,Review,,,,,,Fiber; Gut microbiome; Plant-based diets; Chronic kidney disease; Children; Pediatric Renal Nutrition Taskforce (PRNT),CHRONIC KIDNEY-DISEASE; CHRONIC-RENAL-FAILURE; P-CRESYL SULFATE; DOUBLE-BLIND; CHILDHOOD CONSTIPATION; INSULIN SENSITIVITY; OXIDATIVE STRESS; GLYCEMIC INDEX; BODY-MASS; GUAR GUM,"Dietary fiber is considered an essential constituent of a healthy child's diet. Diets of healthy children with adequate dietary fiber intake are characterized by a higher diet quality, a higher nutrient density, and a higher intake of vitamins and minerals in comparison to the diets of children with poor dietary fiber intake. Nevertheless, a substantial proportion of children do not meet the recommended dietary fiber intake. This is especially true in those children with kidney diseases, as traditional dietary recommendations in kidney diseases have predominantly focused on the quantities of energy and protein, and often restricting potassium and phosphate, while overlooking the quality and diversity of the diet. Emerging evidence suggests that dietary fiber and, by extension, a plant-based diet with its typically higher dietary fiber content are just as important for children with kidney diseases as for healthy children. Dietary fiber confers several health benefits such as prevention of constipation and fewer gastrointestinal symptoms, reduced inflammatory state, and decreased production of gut-derived uremic toxins. Recent studies have challenged the notion that a high dietary fiber intake confers an increased risk of hyperkalemia or nutritional deficits in children with kidney diseases. There is an urgent need of new studies and revised guidelines that address the dietary fiber intake in children with kidney diseases.","[Snauwaert, Evelien; Vande Walle, Johan; Desloovere, An] Univ Ghent, Ghent, Belgium; [Paglialonga, Fabio] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Policlin Milan, Milan, Italy; [Wan, Mandy] Evelina London Childrens Hosp, Paediat, London, England; [Polderman, Nonnie] BC Childrens Hosp, Vancouver, BC, Canada; [Renken-Terhaerdt, Jose] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Locatie Wilhelmina Kinderziekenhuis, Univ Med Ctr, Utrecht, Netherlands; [Shaw, Vanessa; Shroff, Rukshana] Great Ormond St Hosp NHS Trust, Great Ormond St Hosp Children NHS Fdn Trust, London, England",Ghent University; IRCCS Ca Granda Ospedale Maggiore Policlinico; BC Childrens Hospital; University of British Columbia; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust,"Snauwaert, E (corresponding author), Univ Ghent, Ghent, Belgium.",evelien.snauwaert@uzgent.be,"Polderman, Nonnie/IWE-4870-2023; Shroff, Rukshana/AAG-5383-2019; EVELIEN, SNAUWAERT/AAK-5825-2021","Shroff, Rukshana/0000-0001-8501-1072; EVELIEN, SNAUWAERT/0000-0003-2660-7460; Paglialonga, Fabio/0000-0002-9912-3371; Wan, Mandy/0000-0001-8802-0425",,,,,89,10,10,6,26,SPRINGER,NEW YORK,"ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES",0931-041X,1432-198X,,PEDIATR NEPHROL,Pediatr. Nephrol.,SEP,2023,38,9,,,,,2929,2938,,10.1007/s00467-022-05837-2,http://dx.doi.org/10.1007/s00467-022-05837-2,,DEC 2022,10,Pediatrics; Urology & Nephrology,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics; Urology & Nephrology,P1YE4,36471146,Green Published,,,2024-06-04,WOS:000893989700001,View Full Record in Web of Science
J,"Dumniem, N; Boonprakob, R; Panvichitra, C; Thongmark, S; Laohanarathip, N; Parnitvoraphoom, T; Changduangjit, S; Boonmakaew, T; Teshanukroh, N; Tummaruk, P",,,,"Dumniem, Natchanon; Boonprakob, Rafa; Panvichitra, Chayanat; Thongmark, Shutpisit; Laohanarathip, Nutthawat; Parnitvoraphoom, Thanyathep; Changduangjit, Siwapat; Boonmakaew, Tanaphum; Teshanukroh, Nakarin; Tummaruk, Padet",,,"Impacts of Fiber Supplementation in Sows during the Transition Period on Constipation, Farrowing Duration, Colostrum Production, and Pre-Weaning Piglet Mortality in the Free-Farrowing System",ANIMALS,,,English,Article,,,,,,constipation; farrowing; lactation; pig; transition feed,LATE PREGNANCY; PHYSIOLOGY; LACTATION; YIELD,"Simple Summary The current research evaluated the impact of adding dietary fiber to sows during the transitional phase, specifically examining its effects on constipation, the farrowing process, colostrum production, and the mortality of piglets before weaning within a free-farrowing system. Administering 75 g/day of dietary fiber to sows for 7 days before farrowing, especially in those with larger litters, showed a decrease in constipation rates and a reduction in the time taken for farrowing. Additionally, this fiber supplementation resulted in lower mortality rates in piglets prior to weaning. However, this addition of fiber did not improve the production of colostrum and milk, nor did it increase the consumption of colostrum by piglets. These results suggest that in a free-farrowing system, providing sows with dietary fiber during the transitional period can alleviate constipation and shorten the duration of farrowing. Nevertheless, it is advisable to manage the body condition of sows before farrowing to address issues like constipation effectively and to boost colostrum intake. This study investigated how dietary fiber supplementation during the transition period in sows affects constipation, farrowing duration, colostrum production, milk yield, and pre-weaning piglet mortality in the free-farrowing system. A total of 92 Landrace x Yorkshire sows and their 1272 offspring were included in the study. Sows were divided into two groups by parity: control (n = 41) and treatment (n = 51). The control group was fed a standard lactation diet 7 days before farrowing, whereas the treatment group received the same diet with 75 g/day of a dietary fiber supplement. The dietary fiber content analyses were 4.30% and 5.53% in the control and treatment groups, respectively. Sows were fed with 3.89 +/- 0.92 kg per day with a diet containing 17.8% crude protein, 3732 kcal/kg of metabolizable energy, and 1.1% lysine. Parameters including farrowing duration, litter characteristics, and the fecal condition of sows were measured. Piglet mortality rates were recorded at 3, 7, and 21 days of lactation. Sows had an average farrowing duration of 216 +/- 159 min, with litter sizes of 13.8 +/- 4.2 piglets per litter, and a 7.4% stillbirth rate. The treatment group showed a lower constipation rate compared to the control group (17.6% vs. 46.3%, p = 0.003). Farrowing duration did not significantly differ between groups, but the treatment group experienced a 43.6 min shorter duration. In sows with litter sizes of >= 16 piglets per litter, the farrowing duration for sows in the treatment group tended to be shorter than that of the control groups (202.0 +/- 37.9 vs. 287.5 +/- 41.3 min, p = 0.115). The mean colostrum intake of piglets in the control and treatment groups averaged 424.0 +/- 13.7 g and 421.8 +/- 12.6 g, respectively (p = 0.908). Likewise, the milk production of sows from Days 3 to 10 and from Days 10 to 17 of lactation in the treatment group (7.34 +/- 0.27 and 8.76 +/- 0.43 kg/day, respectively) did not differ from that of the control group (7.85 +/- 0.30 and 9.55 +/- 0.47 kg/day, respectively, p > 0.05). Pre-weaning piglet mortality was slightly lower in the treatment group (13.4% vs. 17.3%, p = 0.085). Across groups, piglet mortality rates within 3, 7, and 21 days were 10.3%, 11.9%, and 15.4%, respectively. Piglets with a <= 200 g colostrum intake had a higher pre-weaning mortality compared to those with a higher intake (p < 0.05), except for the 201-300 g intake (p = 0.472). In conclusion, introducing dietary fiber to sows during the transition period reduced constipation and tended to decrease farrowing duration, especially in sows with large litters. Additionally, it lowered pre-weaning piglet mortality by 3.9% in the free-farrowing system. Nonetheless, providing sows with a 75 g/day dietary fiber supplement for only 7 days before farrowing was not enough to enhance colostrum and milk production, nor did it lead to an increase in piglet colostrum consumption.","[Dumniem, Natchanon; Boonprakob, Rafa; Panvichitra, Chayanat; Thongmark, Shutpisit; Laohanarathip, Nutthawat; Parnitvoraphoom, Thanyathep; Changduangjit, Siwapat; Boonmakaew, Tanaphum; Teshanukroh, Nakarin; Tummaruk, Padet] Chulalongkorn Univ, Fac Vet Sci, Dept Obstet Gynaecol & Reprod, Bangkok 10330, Thailand; [Boonprakob, Rafa] Livestock Prod Betagro Grp, Dept Qual Assurance & Anim Hlth Off, Bangkok 10210, Thailand; [Tummaruk, Padet] Chulalongkorn Univ, Ctr Excellence Swine Reprod, Bangkok 10330, Thailand",Chulalongkorn University; Chulalongkorn University,"Tummaruk, P (corresponding author), Chulalongkorn Univ, Fac Vet Sci, Dept Obstet Gynaecol & Reprod, Bangkok 10330, Thailand.;Tummaruk, P (corresponding author), Chulalongkorn Univ, Ctr Excellence Swine Reprod, Bangkok 10330, Thailand.",natchanon.dum@gmail.com; raf.boon@gmail.com; 6135521231@student.chula.ac.th; 6135523531@student.chula.ac.th; 6135533831@student.chula.ac.th; 6135547631@student.chula.ac.th; 6135624231@student.chula.ac.th; 6135544731@student.chula.ac.th; 6135659231@student.chula.ac.th; padet.t@chula.ac.th,"Dumniem, Natchanon/HIR-1326-2022","Dumniem, Natchanon/0000-0003-3942-4866; Tummaruk, Padet/0000-0001-7000-4371",National Research Council of Thailand (NRCT),National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT)),The authors appreciate the farm staff for helping with animal handling and management.,,34,0,0,4,4,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",2076-2615,,,ANIMALS-BASEL,Animals,MAR,2024,14,6,,,,,,,854,10.3390/ani14060854,http://dx.doi.org/10.3390/ani14060854,,,17,"Agriculture, Dairy & Animal Science; Veterinary Sciences; Zoology",Science Citation Index Expanded (SCI-EXPANDED),Agriculture; Veterinary Sciences; Zoology,MF1D0,38539952,"gold, Green Published",,,2024-06-04,WOS:001192110400001,View Full Record in Web of Science
J,"Führ, JC; Lavall, JM; Trindade, ND; Gerevini, AM; Delazzeri, FCL; Adami, FS",,,,"Fuhr, Jessica Carina; Lavall, Janine Maria; Trindade, Nathascha dos Santos; Gerevini, Alessandra Mocellim; Lassen Delazzeri, Fabiani Cristina; Adami, Fernanda Scherer",,,Intestinal constipation in institutionalized elderlies,RBONE-REVISTA BRASILEIRA DE OBESIDADE NUTRICAO E EMAGRECIMENTO,,,Portuguese,Article,,,,,,Elderly; Long-Stay Institution for the Elderly; Intestianal Constipation; Sedentary behavior,,"Introduction: Due to the increase in the elderly population in the world, there is a growing demand for Long-Stay Institutions for the Elderly (LSIEs), which may be associated with constipation due to low intake of fibers, liquids and sedentary lifestyle. Objective: Verify the association of intestinal constipation with gender, age, level of physical activity, nutritional status, dietary and water intake of elderly residents of public and private LSIEs in the hinterland of Rio Grande do Sul. Materials and Methods: Cross-sectional study with a total of 245 elderlies, resident in nine LSIEs, where data were collected in 2019 and 2020. The elderly answered a structured questionnaire about gender, type of institution and water intake, additionally to the International Physical Activity Questionnaire (IPAQ) and the Rome III criteria. A 24-hour dietary recall questionnaire was applied and the amount of fiber consumed daily was calculated with the DietWin software. The results were considered significant at a maximum significance level of 5% (p<0.05). Results and discussion: Among the participant elderly, 64.5% (n=158) were women, 21.1% (n=27) were malnourished, 34.2% (n= 84) were overweight, 52.2% (n=128) were classified as having intestinal constipation and 92.7% (n=227) were sedentary. The presence of intestinal constipation was significantly associated with sedentary elderly (p=0.049) and females (p=0.046). As evidenced in other studies, constipation influences the quality of life of institutionalized elderly. Conclusion: Most of the elderly living in these institutions were sedentary women, presenting malnutrition or overweight and intestinal constipation. Intestinal constipation was significantly associated with females and sedentary women.","[Fuhr, Jessica Carina; Lavall, Janine Maria; Trindade, Nathascha dos Santos; Adami, Fernanda Scherer] Univ Vale do Taquari Univates, Curso Nutr, Lajeado, RS, Brazil; [Gerevini, Alessandra Mocellim; Lassen Delazzeri, Fabiani Cristina] Univ Vale do Taquari Univates, Lajeado, RS, Brazil",,"Adami, FS (corresponding author), Ave Avelino Talini 171, BR-95914014 Lajeado, RS, Brazil.",jefuhr@universo.univates.br; janinemlavall@gmail.com; nathascha.trindade@universo.univates.br; alegerevini@hotmail.com; vendas@atacadodelazzeri.com.br; fernandascherer@univates.br,,,,,,,38,0,0,0,0,INST BRASILEIRO PESQUISA & ENSINO FISIOLOGIA EXERCICIO-IBPEFEX,SAO PAULO,"INST BRASILEIRO PESQUISA & ENSINO FISIOLOGIA EXERCICIO-IBPEFEX, SAO PAULO, 00000, BRAZIL",1981-9919,,,RBONE-REV BRAS OBES,RBONE-Rev. Bras. Obes. Nutr. Emagrecimento,JAN-FEB,2021,15,92,,,,,72,80,,,,,,9,Nutrition & Dietetics,Emerging Sources Citation Index (ESCI),Nutrition & Dietetics,VM2PF,,,,,2024-06-04,WOS:000984491400018,View Full Record in Web of Science
J,"HEATON, KW",,,,"HEATON, KW",,,DIETARY FIBER AND CONSTIPATION,TGO-TIJDSCHRIFT VOOR GENEESMIDDELENONDERZOEK-JOURNAL OF DRUG RESEARCH-JDR,,,English,Article,,,,,,,,,,,"HEATON, KW (corresponding author), UNIV BRISTOL,BRISTOL ROYAL INFIRM,DEPT MED,BRISTOL BS2 8HW,AVON,ENGLAND.",,,,,,,,0,0,0,0,0,UITGEVERIJ EISMA BV,LEEUWARDEN,"POSTBUS 340, 8901 LEEUWARDEN, NETHERLANDS",0166-2384,,,TGO-TIJDSCHR THER GE,,,1983,8,5,,,,,1836,1839,,,,,,4,Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy,QS760,,,,,2024-06-04,WOS:A1983QS76000006,View Full Record in Web of Science
J,"Huet, F; Fargeas, MJ; Fioramonti, J; de Lahitte, JD",,,,"Huet, F; Fargeas, MJ; Fioramonti, J; de Lahitte, JD",,,"Fecal excretion and digestive transit in the chinchilla: physiological values, effect of dietary fiber intake and changes in diet",REVUE DE MEDECINE VETERINAIRE,,,French,Article,,,,,,digestive transit; dietary fiber; chinchilla,RETENTION TIME; RABBIT; FEED; PIGS,"Constipation associated with reduced dietary fiber intake is considered to be involved in most of digestive pathologies of the chinchilla. However, this assertion is not based on experimental data. The aim of our study was to describe the characteristics of fecal excretion and digestive transit in this species and to determine the role of dietary fiber on these parameters. Fourteen adult chinchillas placed during the experiments in metabolic cages allowing the collect of feces each hour, were used. Digestive transit time was define from the appearance in the feces of a marker (Cr-51 sodium chromate) given orally. Four different foods containing crude cellulose varying from 13.6 to 21.6 % were tested. We have shown that fecal excretion appeared exclusively during the night with a maximal excretion at 22:50 (+/- 125 min). The mean time of digestive transit was 12-15 hours. This time is similar to that observed in other rodents. Transit time was not modified by reducing the level of dietary fiber. However, each change of food lead to a dramatic decrease (about 50 %) of food intake, and consequently of fecal excretion. For example, on a diet containing 20.6 % of crude cellulose, digestive transit time was 13.9 +/- 1.0 h, food intake was 23.9 +/- 5.2 g/day and fecal excretion 15.2 +/- 2.6 g/day. On the third day of a new diet containing 16.6 % of crude cellulose, these values were 13.9 +/- 0.8 h, 13.3 +/- 5.0 g/day and 6.6 +/- 2.1 g/day, respectively. In conclusion, this study has shown that, unlike the current opinion, the digestive transit of the chinchilla is insensitive to the level of dietary fiber but anorexia that followed each change in diet, even minor, may play an important role in digestive pathologies of the chinchilla.","INRA, Lab Pharmacol Toxicol, F-31931 Toulouse 9, France; Ecole Natl Vet, Parasitol Lab, F-31076 Toulouse, France",INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse,"Huet, F (corresponding author), INRA, Lab Pharmacol Toxicol, 180 Chemin Tournefeuille,BP 3, F-31931 Toulouse 9, France.",,,,,,,,30,0,0,0,6,ECOLE NATIONAL VET TOULOUSE,TOULOUSE,"23 CHEMIN DES CAPELLES, 31076 TOULOUSE, FRANCE",0035-1555,,,REV MED VET-TOULOUSE,Rev. Med. Vet.,JUL,1998,149,7,,,,,739,744,,,,,,6,Veterinary Sciences,Science Citation Index Expanded (SCI-EXPANDED),Veterinary Sciences,110AD,,,,,2024-06-04,WOS:000075356400002,View Full Record in Web of Science
J,"Cirillo, C; Capasso, R",,,,"Cirillo, Carla; Capasso, Raffaele",,,Constipation and Botanical Medicines: An Overview,PHYTOTHERAPY RESEARCH,,,English,Review,,,,,,constipation; botanical medicine; anthraquinone; nutraceutical,FUNCTIONAL GASTROINTESTINAL DISORDERS; IRRITABLE-BOWEL-SYNDROME; FECAL INCONTINENCE; DIETARY FIBER; PREGNANCY; SENNA; ALOE; PAIN,"Constipation affects 14% of the adult population globally, mainly women, and significantly impacts on health-related quality of life. The causes of constipation are mainly three: lifestyle related (functional constipation), disease related, and drug induced. Constipation can generate considerable suffering, including abdominal pain and distension, anorexia, and nausea. The value of some therapeutic measures such as increased fluid intake, physical activity, diet rich in fiber, and nutritional supplements recommended for the relief of constipation is still questionable. The treatment of constipation can be carried out not only with traditional drugs but also with herbal medicines or with nutraceuticals, which are used to prevent or treat the disorder. We have reviewed the most common botanical laxatives such as senna, cascara, frangula, aloe, and rhubarb and their use in the treatment of constipation. Copyright (C) 2015 John Wiley & Sons, Ltd.","[Cirillo, Carla] Univ Leuven, Lab Enter Neurosci LENS, Translat Res Ctr Gastrointestinal Disorders, Leuven, Belgium; [Capasso, Raffaele] Univ Naples Federico II, Dept Pharm, I-80131 Naples, Italy",KU Leuven; University of Naples Federico II,"Capasso, R (corresponding author), Univ Naples Federico II, Dept Pharm, Via D Montesano 49, I-80131 Naples, Italy.",rafcapas@unina.it,"Capasso, Raffaele/AFK-6983-2022","Capasso, Raffaele/0000-0002-3335-1822; Cirillo, Carla/0000-0002-8445-5955",,,,,43,76,82,1,56,WILEY-BLACKWELL,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0951-418X,1099-1573,,PHYTOTHER RES,Phytother. Res.,OCT,2015,29,10,,,,,1488,1493,,10.1002/ptr.5410,http://dx.doi.org/10.1002/ptr.5410,,,6,"Chemistry, Medicinal; Pharmacology & Pharmacy",Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy,CT4QX,26171992,,,,2024-06-04,WOS:000362792900004,View Full Record in Web of Science
J,"Rao, SSC; Yu, S; Fedewa, A",,,,"Rao, S. S. C.; Yu, S.; Fedewa, A.",,,Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome,ALIMENTARY PHARMACOLOGY & THERAPEUTICS,,,English,Review,,,,,,,QUALITY-OF-LIFE; RANDOMIZED CLINICAL-TRIAL; GASTROINTESTINAL SYMPTOMS; UNITED-STATES; NORTH-AMERICA; PREVALENCE; EPIDEMIOLOGY; COMMUNITY; IBS; BURDEN,"BackgroundDietary fibre supplements have been advocated for the management of chronic constipation (CC) and irritable bowel syndrome (IBS). Recently, a fermentable oligosaccharide, disaccharide, monosaccharide and polyol (FODMAP) restricted diet has been recommended for IBS. AimTo systematically examine recent evidence for dietary interventions with fibre in CC and IBS and FODMAP-restricted diet in IBS, and provide recommendations. MethodsWe searched PUBMED, MEDLINE, OVID and COCHRANE databases from 2004 to 2014. Published studies in adults with CC and IBS and constipation-predominant IBS (IBS-C) that compared fibre with placebo/alternative and FODMAP-restricted diet with alternative were included. ResultsOf 550 potentially eligible clinical trials on fibre, 11 studies were found and of 23 potentially eligible studies on FODMAPs, six were found. A meta-analysis was not performed due to heterogeneity and methodological quality. Fibre was beneficial in 5/7 studies in CC and 3/3 studies in IBS-C. FODMAP-restricted diet improved overall IBS symptoms in 4/4 and IBS-C symptoms in 1/3 studies and three studies did not meet inclusion criteria. There were significant disparities in subject selection, interventions and outcome assessments in both fibre and FODMAPs studies. ConclusionsFibre supplementation is beneficial in mild to moderate CC and IBS-C, although larger, more rigorous and long-term RCTs are needed (Fair evidence-Level II, Grade B). Although the FODMAP-restricted diet may be effective in short-term management of selected patients with IBS (Fair evidence-Level II, Grade C) and IBS-C (Poor evidence-Level III, Grade C), more rigorous trials are needed to establish long-term efficacy and safety, particularly on colonic health and microbiome.","[Rao, S. S. C.; Yu, S.] Georgia Regents Univ, Sect Gastroenterol Hepatol, Dept Internal Med, Augusta, GA USA; [Fedewa, A.] Georgia Regents Univ, Dept Food & Nutr, Augusta, GA USA",University System of Georgia; Augusta University; University System of Georgia; Augusta University,"Rao, SSC (corresponding author), Georgia Regents Univ, Sect Gastroenterol & Hepatol, Digest Hlth Ctr, AD 2238,1481 Laney Walker Blvd, Augusta, GA 30912 USA.",srao@gru.edu,,,Sun Sweets corporation,Sun Sweets corporation,"Declaration of personal interests: Dr Rao reports no conflict of interest in the context of this report but has served as a consultant for Forest Laboratories, Ironwood Pharmaceuticals, Takeda Pharmaceuticals, Salix Pharmaceuticals and Given Imaging and received unrestricted research grant from Sun Sweets corporation. Dr S. Yu and Ms. A. Fedewa report no conflicts of interest.",,81,186,198,2,137,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0269-2813,1365-2036,,ALIMENT PHARM THER,Aliment. Pharmacol. Ther.,JUN,2015,41,12,,,,,1256,1270,,10.1111/apt.13167,http://dx.doi.org/10.1111/apt.13167,,,15,Gastroenterology & Hepatology; Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Pharmacology & Pharmacy,CI0UW,25903636,Bronze,,,2024-06-04,WOS:000354455200004,View Full Record in Web of Science
J,"Gavin, J; Ellis, J; Dewar, AL; Rolles, CJ; Connett, GJ",,,,"Gavin, J; Ellis, J; Dewar, AL; Rolles, CJ; Connett, GJ",,,Dietary fibre and the occurrence of gut symptoms in cystic fibrosis,ARCHIVES OF DISEASE IN CHILDHOOD,,,English,Article,,,,,,cystic fibrosis; fibre; constipation,FIBER,Objective-To evaluate the effect of currently recommended energy rich cystic fibrosis diets on fibre intake and to investigate the relationship between fibre intake and the occurrence of gut symptoms. Method-Prospective completion of nonweighed five day food diaries by 28 children with cystic fibrosis and comparison of mean daily fibre intake with age matched controls who did not have cystic fibrosis. Prospective completion of similar diaries to a total of 68 children with cystic fibrosis and comparison of fibre and lipase intake with the occurrence of gut symptoms. Results-Mean daily fibre intake in children with cystic fibrosis was 7.00 g compared with 14.65 g in controls (p<0.001). Mean daily fibre intake in eight patients troubled with moderate or severe abdominal pain was 0.144 g/kg. This was significantly lower (p<0.01) than mean values for 22 patients with occasional but mild symptoms (0.249 g/kg) and 38 with no gut symptoms (0.312 g/kg). There was a trend towards higher pancreatic enzyme doses (lipase/kg/day) in children with abdominal pain. Conclusions-Currently recommended cystic fibrosis diets have a low fibre content. A low residue diet might be an important factor in the pathogenesis of gastrointestinal symptoms.,"SOUTHAMPTON UNIV HOSP,REG CYST FIBROSIS CTR,SOUTHAMPTON SO16 6YD,HANTS,ENGLAND",University of Southampton,,,"Connett, Gary/AAU-3686-2020","Connett, Gary/0000-0003-1310-3239",,,,,12,20,21,1,6,BRITISH MED JOURNAL PUBL GROUP,LONDON,"BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR",0003-9888,,,ARCH DIS CHILD,Arch. Dis. Child.,JAN,1997,76,1,,,,,35,37,,10.1136/adc.76.1.35,http://dx.doi.org/10.1136/adc.76.1.35,,,3,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,WF393,9059158,"Bronze, Green Published",,,2024-06-04,WOS:A1997WF39300010,View Full Record in Web of Science
J,"FRANKENFIELD, DC; BEYER, PL",,,,"FRANKENFIELD, DC; BEYER, PL",,,DIETARY FIBER AND BOWEL FUNCTION IN TUBE-FED PATIENTS,JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION,,,English,Article,,,,,,,CHAIN FATTY-ACIDS; SOY-POLYSACCHARIDE FIBER; LIQUID FORMULA DIETS; HUMAN-COLON; PLANT POLYSACCHARIDES; CELL-PROLIFERATION; INTESTINAL-TRACT; WHEAT BRAN; BACTEROIDES; ABSORPTION,"In tube-fed patients, dietary fiber is often used to manage constipation/diarrhea. Dietary fiber consists of water-soluble and insoluble plant compounds that are resistant to digestion by small-bowel enzymes but are fermented to varying degrees by colonic bacteria. Many physiologic effects of fiber may be related to the degree of fermentation. Few controlled studies of fiber-containing tube feedings have been performed. These studies have limitations and are nondefinitive as to whether fiber prevents or controls constipation/diarrhea. Constipation in tube-fed patients has not been shown to respond to mixed soluble/insoluble fiber in the few studies performed to date. Likewise, fiber may be of only limited benefit in controlling diarrhea in acute illness because of such factors as stress or medication. Fiber does play a role in maintaining gut integrity in all patients, whether they have diarrhea or not. Fiber may be recommended as part of a standard tube-feeding regimen to help assure gut mucosal integrity but not specifically to treat constipation/diarrhea. Further studies are necessary before the role of fiber in the management of constipation/diarrhea in tube-fed patients is determined.","UNIV KANSAS,MED CTR,DEPT DIETET & NUTR,KANSAS CITY,KS 66103",University of Kansas; University of Kansas Medical Center,"FRANKENFIELD, DC (corresponding author), UNIV MARYLAND,MED CTR,MARYLAND INST EMERGENCY MED SERV SYST,DEPT FOOD & NUTR SERV,BALTIMORE,MD 21201, USA.",,,,,,,,86,17,18,0,2,AMER DIETETIC ASSN,CHICAGO,"216 W JACKSON BLVD #800, CHICAGO, IL 60606-6995",0002-8223,,,J AM DIET ASSOC,J. Am. Diet. Assoc.,MAY,1991,91,5,,,,,590,596,,,,,,7,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,FL248,1850436,,,,2024-06-04,WOS:A1991FL24800010,View Full Record in Web of Science
J,"Vakili, STT; Nezami, BG; Shetty, A; Chetty, VK; Srinivasan, S",,,,"Vakili, S. Taba Taba; Nezami, B. G.; Shetty, A.; Chetty, V. K.; Srinivasan, S.",,,Association of high dietary saturated fat intake and uncontrolled diabetes with constipation: evidence from the National Health and Nutrition Examination Survey,NEUROGASTROENTEROLOGY AND MOTILITY,,,English,Article,,,,,,constipation; diabetes; high-fat diet; NHANES; stool frequency,PHYSICAL-ACTIVITY; YOUNG-CHILDREN; BOWEL HABIT; BODY-WEIGHT; NHANES-III; FIBER; INHIBITION; PALMITATE; COMMUNITY; SYMPTOMS,"Background Constipation is highly prevalent in the United States. The association of dietary fat intake with constipation has not been well studied. We recently reported that mice fed a high-fat diet had higher incidence of constipation than regular diet fed mice. The aim of this study was to assess if increased intake of dietary saturated fat in humans is also associated with higher risk of constipation and reduced stool frequency. Methods Analyses were based on data from 6207 adults (>= 20 years) from the 2005-2006 and 2007-2008 cycles of the National Health and Nutrition Examination Surveys who had completed the bowel health questionnaire. Constipation was defined as a stool frequency of less than three times per week. Multivariable logistic regression analysis was used to calculate adjusted prevalence odds ratio (OR) estimates. Statistical analyses were performed using R and RStudio softwares. Key Results The prevalence of constipation in this sample was 3.1%. After multivariable adjustment high saturated fat remained associated with constipation. The OR for high saturated fat intake associated with constipation was much higher in diabetics above 65 years, especially in non-Hispanic blacks, females, and those with poor glycemic control, compared to the control group. Conclusions (sic) Inferences To the best of our knowledge, this is the first report to investigate the association of high saturated fat diet, bowel frequency, and diabetes. This study demonstrates that a high dietary saturated fat intake is associated with significant increase in the prevalence of constipation, especially in the uncontrolled diabetic, non-Hispanic black, female patients.","[Vakili, S. Taba Taba; Nezami, B. G.; Shetty, A.; Srinivasan, S.] Emory Univ, Div Digest Dis, Atlanta, GA 30322 USA; [Vakili, S. Taba Taba; Nezami, B. G.; Srinivasan, S.] Atlanta VA Med Ctr, Decatur, GA USA; [Chetty, V. K.] Boston Univ, Dept Family Med, Boston, MA 02215 USA",Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; Boston University,"Srinivasan, S (corresponding author), Emory Univ, Div Digest Dis, Whitehead Biomed Res Bldg,Suite 201A, Atlanta, GA 30322 USA.",ssrini2@emory.edu,"Srinivasan, Shanthi/A-6133-2013",,"National Institutes of Health, USA [DK080684]; National Institutes of Health, USA (VA-MERIT award)","National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, USA (VA-MERIT award)","This work was supported by a grant from the National Institutes of Health, USA (DK080684 and VA-MERIT award to SS).",,32,21,21,1,15,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1350-1925,1365-2982,,NEUROGASTROENT MOTIL,Neurogastroenterol. Motil.,OCT,2015,27,10,,,,,1389,1397,,10.1111/nmo.12630,http://dx.doi.org/10.1111/nmo.12630,,,9,Gastroenterology & Hepatology; Clinical Neurology; Neurosciences,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Neurosciences & Neurology,CW1KL,26176421,Green Accepted,,,2024-06-04,WOS:000364748700005,View Full Record in Web of Science
J,"GRAY, DS",,,,"GRAY, DS",,,THE CLINICAL USES OF DIETARY FIBER,AMERICAN FAMILY PHYSICIAN,,,English,Article,,,,,,,,"Dietary fiber has received considerable attention in both the popular press and the scientific literature. Fiber is a complex mixture of substances, and research on its effects is difficult to interpret. Dietary fiber has significant gastrointestinal effects, and it is a mainstay of treatment for constipation and hemorrhoids. Insoluble fiber, such as wheat bran, is most effective for treatment of these conditions. Increased intake of soluble dietary fiber appears to benefit patients with diabetes mellitus and hyperlipidemia. High-fiber, low-fat diets have been recommended by a variety of authorities to decrease the incidence of heart disease and certain types of cancer. Any increase in dietary fiber intake should be accompanied by an increase in water intake.",,,"GRAY, DS (corresponding author), COMMUNITY HOSP FAMILY PRACTICE RESIDENCY,SANTA ROSA,CA, USA.",,,,,,,,0,24,28,0,3,AMER ACAD FAMILY PHYSICIANS,KANSAS CITY,"8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797",0002-838X,,,AM FAM PHYSICIAN,Am. Fam. Physician,FEB 1,1995,51,2,,,,,419,425,,,,,,7,"Primary Health Care; Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,QE795,7840038,,,,2024-06-04,WOS:A1995QE79500016,View Full Record in Web of Science
J,"Buss, C; Nunes, MA; Camey, S; Manzolli, P; Soares, RM; Drehmer, M; Giacomello, A; Duncan, BB; Schmidt, MI",,,,"Buss, Caroline; Nunes, Maria Angelica; Camey, Suzi; Manzolli, Patricia; Soares, Rafael Marques; Drehmer, Michele; Giacomello, Andressa; Duncan, Bruce Bartholow; Schmidt, Maria Ines",,,Dietary fibre intake of pregnant women attending general practices in southern Brazil - The ECCAGE Study,PUBLIC HEALTH NUTRITION,,,English,Article,,,,,,Dietary fibre; Pregnancy; Dietary Reference Intake; Prenatal care; Chronic disease,LOW-INCOME WOMEN; ENERGY-INTAKE; FOOD CHOICES; WHOLE GRAINS; WEIGHT-GAIN; RISK; HEALTH; PREECLAMPSIA; ASSOCIATION; CHOLESTEROL,"Background: Increase in fibre intake during pregnancy may reduce weight gain, glucose intolerance, dyslipidaemia, pre-eclampsia and constipation. Few Studies have evaluated adequacy of fibre intake during pregnancy. Objective: To assess, through an FFQ, the dietary fibre intake of pregnant women receiving prenatal care from general public practices and compare it with Current guidelines. Design and setting: Cross-sectional analyses of a pregnancy cohort study (ECCAGE - Study of Food Intake and Eating Behaviour in Pregnancy) conducted in eighteen general practices in Southern Brazil, from June 2006 to April 2007. Subjects: Five hundred and seventy-eight pregnant women With mean (SD) age of 24.9 (6.5) years and mean gestational age of 24.5 (5.8) weeks. Results: The mean energy intake was 11615 kJ/d (2776 kcal/d). The mean total fibre intake (30.2g/d) was slightly above the recommended value of 28g/d (P<0.001), yet 50% (95% CI 46, 54) of the women failed to meet the recommendation. Whole-grain fibre constituted only 1% of total fibre intake in the cereal group. in adjusted Poisson regression analyses, not meeting the recommendation for fibre intake was associated with alcohol intake (prevalence ratio 1.29; 95% CI 1.11, 1.50) and absence of nutritional guidance (prevalence ratio 1.22; 95% CI 1.05, 1.42) during pregnancy. Conclusions: About half of the pregnant women failed to meet the recommended fibre intake, especially those not reporting nutritional guidance during pregnancy. For most women, whole-grain cereal intake was absent or trivial. Taken together, our data indicate the need, at least in this setting, for greater nutritional education in prenatal care.","[Buss, Caroline; Nunes, Maria Angelica; Manzolli, Patricia; Soares, Rafael Marques; Drehmer, Michele; Giacomello, Andressa; Duncan, Bruce Bartholow; Schmidt, Maria Ines] Univ Fed Rio Grande do Sul, Grad Studies Program Epidemiol, UFRGS Dept Med Social PPG Epidemiol, BR-90035003 Porto Alegre, RS, Brazil; [Camey, Suzi] Univ Fed Rio Grande do Sul, Dept Stat, BR-90035003 Porto Alegre, RS, Brazil",Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul,"Buss, C (corresponding author), Univ Fed Rio Grande do Sul, Grad Studies Program Epidemiol, UFRGS Dept Med Social PPG Epidemiol, Rua Ramiro Barcelos 2600 4 Andar Sala 419, BR-90035003 Porto Alegre, RS, Brazil.",caroline.buss@ufrgs.br,"Buss, Caroline/J-6571-2014; Drehmer, Michele/I-1105-2012; Manzolli, Patricia/B-2007-2013; Schmidt, Maria Inês/AGP-6441-2022; Schmidt, Maria Inês/AGT-5691-2022; Iats, Inct/K-2300-2013; Camey, Suzi Alves/Y-2756-2019; Schmidt, Maria/V-3196-2019; Duncan, Bruce/L-4140-2016","Buss, Caroline/0000-0002-0916-3127; Schmidt, Maria Inês/0000-0002-3837-0731; Camey, Suzi Alves/0000-0002-5564-081X; Duncan, Bruce/0000-0002-7491-2630",CNPq (the Brazilian National Council of Technological and Scientific Development); CAPES/MEC (the Brazilian Ministry of Education),CNPq (the Brazilian National Council of Technological and Scientific Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES/MEC (the Brazilian Ministry of Education)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)),Centers of Excellence Grant of CNPq (the Brazilian National Council of Technological and Scientific Development); CAPES/MEC (the Brazilian Ministry of Education).,,45,20,22,0,12,CAMBRIDGE UNIV PRESS,CAMBRIDGE,"EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND",1368-9800,1475-2727,,PUBLIC HEALTH NUTR,Public Health Nutr.,SEP,2009,12,9,,,,,1392,1398,,10.1017/S1368980008004096,http://dx.doi.org/10.1017/S1368980008004096,,,7,"Public, Environmental & Occupational Health; Nutrition & Dietetics",Science Citation Index Expanded (SCI-EXPANDED),"Public, Environmental & Occupational Health; Nutrition & Dietetics",488HL,19063767,Bronze,,,2024-06-04,WOS:000269339900011,View Full Record in Web of Science
J,"Reijonen, JK; Tihtonen, KMH; Uotila, JT; Vihtamäki, T; Luukkaala, TH",,,,"Reijonen, Johanna Kristiina; Tihtonen, Kati Maaria Hannele; Uotila, Jukka Tapio; Vihtamaki, Tarja; Luukkaala, Tiina Hannele",,,Dietary fibre intake and lifestyle characteristics in relation to nausea or vomiting during pregnancy-a questionnaire-based cohort study,JOURNAL OF OBSTETRICS AND GYNAECOLOGY,,,English,Article,,,,,,Hyperemesis gravidarum; nausea or vomiting in pregnancy (NVP); dietary fibre; soluble fibre; insoluble fibre,HYPEREMESIS GRAVIDARUM; TOBACCO CONSUMPTION; ADVERSE PREGNANCY; ASSOCIATION; ALCOHOL; OUTCOMES; WOMEN; RISK,"Nausea or vomiting in pregnancy (NVP) are among the commonest symptoms experienced in early pregnancy. We wanted to evaluate the association of dietary fibre intake, lifestyle characteristics and bowel function with NVP. One hundred and eighty-eight participants completed a self-administered questionnaire concerning bowel function, dietary fibre intake and lifestyle characteristics. Women suffering from NVP (n = 91) consumed significantly more fibre derived from cereal products (p=.026) and total fibre (p=.043) during pre-pregnancy period was compared to women without NVP (n = 97). In both groups, intake of total fibre and fibre derived from fruit and vegetables increased significantly during the first trimester. Dietary fibre intake did not protect from NVP. However, women suffering from NVP were able to maintain their fibre intake. Dietary fibre is tolerated well during NVP, and this finding can be used when giving diet counselling to women suffering from NVP.Impact statement What is already known on this subject? Nausea or vomiting in pregnancy (NVP) are among the commonest symptoms experienced in early pregnancy. The pathophysiology of NVP remains unknown, but it has been suggested to be multifactorial. Diet during pregnancy may have an impact on NVP. It is generally advised to avoid meat, poultry, fish, eggs and spicy and fatty foods during periods of NVP, but there is limited data on the effects of diet of NVP. What do the results of this study add? Women suffering from NVP have been shown to eat less meat (and thus protein) compared to women without NVP. Dietary fibre reduces constipation and heartburn and it also keeps blood glucose levels stable. Because of various beneficial effects of fibre on the digestive system, we hypothesised that a high fibre intake may alleviate the symptoms of NVP. What are the implications of these findings for clinical practice and/or further research? The aim of the present study was to investigate whether the amount or source of dietary fibre are associated with NVP. We wanted to investigate intake of fibre derived from cereal products (mostly representing insoluble fibre) and fibre derived from fruit and vegetables (containing mostly soluble fibre) separately in relationship to NVP, as the mechanisms of action of these fibre groups are different. There are no observational studies including also pre-pregnancy consumption of fibre when focussing on the association between fibre and NVP. The results of this study can be used when giving diet counselling to women suffering from NVP.","[Reijonen, Johanna Kristiina; Tihtonen, Kati Maaria Hannele; Vihtamaki, Tarja] Tampere Univ Hosp, Dept Obstet & Gynecol, Tampere, Finland; [Uotila, Jukka Tapio] Tampere Univ, Tampere Univ Hosp, Med Sch, Dept Obstet & Gynecol, Tampere, Finland; [Luukkaala, Tiina Hannele] Tampere Univ Hosp, Tampere Res & Innovat Ctr, Sch Hlth Sci, Tampere, Finland; [Luukkaala, Tiina Hannele] Univ Tampere, Tampere Univ Hosp, Tampere, Finland",Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital,"Reijonen, JK (corresponding author), Univ Hosp Tampere, Dept Obstet & Gynecol, PL 2000, Tampere 33521, Finland.",johanna.reijonen80@gmail.com,,"Tihtonen, Kati/0000-0003-3217-979X; Reijonen, Johanna/0000-0002-3457-9503; Luukkaala, Tiina/0000-0003-4636-9586",,,,,31,1,1,3,9,TAYLOR & FRANCIS INC,PHILADELPHIA,"530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA",0144-3615,1364-6893,,J OBSTET GYNAECOL,J. Obstet. Gynaecol.,JAN 2,2022,42,1,,,,,35,42,,10.1080/01443615.2021.1871886,http://dx.doi.org/10.1080/01443615.2021.1871886,,APR 2021,8,Obstetrics & Gynecology,Science Citation Index Expanded (SCI-EXPANDED),Obstetrics & Gynecology,YD0CX,33942705,hybrid,,,2024-06-04,WOS:000646958800001,View Full Record in Web of Science
J,"Rijnaarts, I; de Roos, NM; Wang, TJ; Zoetendal, EG; Top, J; Timmer, M; Bouwman, EP; Hogenelst, K; Witteman, B; de Wit, N",,,,"Rijnaarts, Iris; de Roos, Nicole M.; Wang, Taojun; Zoetendal, Erwin G.; Top, Jan; Timmer, Marielle; Bouwman, Emily P.; Hogenelst, Koen; Witteman, Ben; de Wit, Nicole",,,Increasing dietary fibre intake in healthy adults using personalised dietary advice compared with general advice: a single-blind randomised controlled trial,PUBLIC HEALTH NUTRITION,,,English,Article,,,,,,Dietary fibre; Tailored; Personalised; Evaluation; Advice,FOOD-FREQUENCY QUESTIONNAIRE; PROMOTING FRUIT; CANCER; WATER; CONSTIPATION; CONSUMPTION; IMPROVE; MEAL,"Objective: A high-fibre diet is associated with a lower risk for diseases. However, few adults meet the dietary fibre recommendation. Therefore, the effects and acceptance of an algorithm-generated personalised dietary advice (PDA) compared with general advice (GA) on fibre intake were investigated. Design: A 6-week, single-blind randomised controlled trial with a 3-month follow-up. Setting: PDA was based on habitual intake and provided fibre-rich alternatives using a website; GA contained brochures. Dietary intake was assessed at baseline, week 1, week 6 and 3-month follow-up. Both groups evaluated their advice at week 6. All participants had access to PDA from week 7 until 3-month follow-up. Participants: Two groups of healthy adults: PDA (n 34) and GA (n 47). For 3-month follow-up analysis, participants were re-divided into visitors (n 52) and non-visitors (n 26) of the PDA. Results: At week 6, energy intake remained stable in both groups, but fibre intake per 1000 kcal increased non-significantly in both groups (PDA = Delta 0 center dot 5 +/- 2 center dot 8; GA = Delta 0 center dot 8 +/- 3 center dot 1, P = 0 center dot 128). Importantly, a significantly higher percentage of PDA participants adhered to the recommendation compared with week 1 (PDA = 21 % increase; GA = 4 % increase, P <= 0 center dot 001). PDA participants evaluated the advice significantly better compared with GA participants. At 3-month follow-up, fibre intake increased compared with baseline (visitors = Delta 2 center dot 2 +/- 2 center dot 6, P < 0 center dot 001; non-visitors = Delta 1 center dot 5 +/- 1 center dot 9, P = 0 center dot 001), but was insignificantly different between groups. Visitors had a decrease and non-visitors had an increase in energy intake (visitors =Delta - 132 +/- 525; non-visitors = Delta 109 +/- 507, P = 0 center dot 055). Conclusions: The algorithm-generated PDA was well accepted and stimulated adherence to the recommendations more than GA, indicating to be a suitable and cost-efficient method for improving dietary fibre intake in healthy adults.","[Rijnaarts, Iris; de Roos, Nicole M.; Witteman, Ben] Wageningen Univ & Res, Div Human Nutr & Hlth, Stippeneng 4, NL-6708 WE Wageningen, Netherlands; [Rijnaarts, Iris; Wang, Taojun; Zoetendal, Erwin G.] Wageningen Univ & Res, Lab Microbiol, Wageningen, Netherlands; [Rijnaarts, Iris; Top, Jan; Timmer, Marielle; de Wit, Nicole] Wageningen Univ & Res, Wageningen Food & Biobased Res, Wageningen, Netherlands; [Bouwman, Emily P.] Wageningen Univ & Res, Wageningen Econ Res, Wageningen, Netherlands; [Hogenelst, Koen] Netherlands Org Appl Sci Res TNO, Dept Training & Performance Innovat, Soesterberg, Netherlands; [Witteman, Ben] Gelderse Vallei Hosp, Dept Gastroenterol & Hepatol, Ede, Netherlands",Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Netherlands Organization Applied Science Research; Gelderse Vallei Hospital,"Rijnaarts, I (corresponding author), Wageningen Univ & Res, Div Human Nutr & Hlth, Stippeneng 4, NL-6708 WE Wageningen, Netherlands.;Rijnaarts, I (corresponding author), Wageningen Univ & Res, Lab Microbiol, Wageningen, Netherlands.;Rijnaarts, I (corresponding author), Wageningen Univ & Res, Wageningen Food & Biobased Res, Wageningen, Netherlands.",iris.rijnaarts@wur.nl,,"Bouwman, Emily/0000-0002-5633-7425; Rijnaarts, Iris/0000-0001-7811-6669",Public Private Partnership Personalized Nutrition and Health programme from the Top consortium for Knowledge and Innovation (TKI) Agri Food [TKI-AF-15262]; Dutch Digestive Disease Foundation,Public Private Partnership Personalized Nutrition and Health programme from the Top consortium for Knowledge and Innovation (TKI) Agri Food; Dutch Digestive Disease Foundation,"This research was supported by the Public Private Partnership Personalized Nutrition and Health programme from the Top consortium for Knowledge and Innovation (TKI) Agri & Food (TKI-AF-15262), in collaboration with the Dutch Digestive Disease Foundation and companies. The funding agencies had no role in the collection, analysis and interpretation of data, or in the preparation, review or approval of the manuscript.",,49,10,10,2,15,CAMBRIDGE UNIV PRESS,CAMBRIDGE,"EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND",1368-9800,1475-2727,,PUBLIC HEALTH NUTR,Public Health Nutr.,APR,2021,24,5,,,,,1117,1128,PII S1368980020002980,10.1017/S1368980020002980,http://dx.doi.org/10.1017/S1368980020002980,,,12,"Public, Environmental & Occupational Health; Nutrition & Dietetics",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),"Public, Environmental & Occupational Health; Nutrition & Dietetics",RI7RN,32943128,"Green Published, hybrid",,,2024-06-04,WOS:000637104900037,View Full Record in Web of Science
J,"Jones, JM",,,,"Jones, Julie Miller",,,CODEX-aligned dietary fiber definitions help to bridge the 'fiber gap',NUTRITION JOURNAL,,,English,Article,,,,,,Dietary fiber; Added fiber; CODEX fiber definitions; Fiber definitions and methods; Non-starch polysaccharide (NSP); Fiber benefits; Resistant oligomers and resistant starch; DP 3-9,METABOLIC SYNDROME; RISK; CONSTIPATION; NUTRITION; HEALTH; METAANALYSIS; SUPPLEMENTS; MORTALITY; AMERICANS; GLUCOSE,"A comprehensive dietary fiber (DF) definition was adopted by the CODEX Alimentarius Commission (CAC) (1) to reflect the current state of knowledge about DF, (2) to recognize that all substances that behave like fiber regardless of how they are produced can be named as DF if they show physiological benefits, and (3) to promote international harmonization for food labeling and food composition tables. This review gives the history and evolution of the state of DF knowledge as looked at by refinements in DF methods and definitions subsequent to the launch of the DF hypothesis. The refinements parallel both interventional and epidemiological research leading to better understanding of the role of DF in contributing to the numerous physiological benefits imparted by all the various digestion resistant carbohydrates. A comparison of the CODEX definition (including its footnote that authorizes the inclusion of polymers with DP 3-9) and approved CODEX Type 1 methods with other existing definitions and methods will point out differences and emphasize the importance of adoption of CODEX-aligned definitions by all jurisdictions. Such harmonization enables comparison of nutrition research, recommendations, food composition tables and nutrition labels the world over. A case will be made that fibers are analogous to vitamins, in that they vary in structure, function and amount needed, but each when present in the right amount contributes to optimal health. Since the intake of DF is significantly below recommended levels throughout the world, the recognition that 'all fibers fit' is an important strategy in bridging the 'fiber gap' by enfranchising and encouraging greater intake of foods with inherent and added DF. Fortifying foods with added DF makes it easier to increase intakes while maintaining calories at recommended levels.","St Catherine Univ, Hills, MN 55112 USA",,"Jones, JM (corresponding author), St Catherine Univ, 4030 Valentine Ct Arden, Hills, MN 55112 USA.",jmjones@stkate.edu,,,Calorie Control Council,Calorie Control Council,The work was sponsored by the Calorie Control Council.,,77,245,278,5,91,BMC,LONDON,"CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND",,1475-2891,,NUTR J,Nutr. J.,APR 12,2014,13,,,,,,,,34,10.1186/1475-2891-13-34,http://dx.doi.org/10.1186/1475-2891-13-34,,,10,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,AG1LU,24725724,"gold, Green Published",Y,N,2024-06-04,WOS:000335177600001,View Full Record in Web of Science
J,"Leung, L; Riutta, T; Kotecha, J; Rosser, W",,,,"Leung, Lawrence; Riutta, Taylor; Kotecha, Jyoti; Rosser, Walter",,,Chronic Constipation: An Evidence-Based Review,JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE,,,English,Article,,,,,,Chronic Constipation; Clinical Review; Evidence-Based Medicine; Family Medicine; Gastrointestinal Problems; Systematic Review,ABERRANT CRYPT FOCI; PLACEBO-CONTROLLED TRIAL; QUALITY-OF-LIFE; SLOW-TRANSIT CONSTIPATION; CHLORIDE CHANNEL ACTIVATOR; LONG-TERM EFFICACY; DOUBLE-BLIND; LAXATIVE USE; FUNCTIONAL CONSTIPATION; MELANOSIS-COLI,"Background: Chronic constipation is a common condition seen in family practice among the elderly and women. There is no consensus regarding its exact definition, and it may be interpreted differently by physicians and patients. Physicians prescribe various treatments, and patients often adopt different over-the-counter remedies. Chronic constipation is either caused by slow colonic transit or pelvic floor dysfunction, and treatment differs accordingly. Methods: To update our knowledge of chronic constipation and its etiology and best-evidence treatment, information was synthesized from articles published in PubMed, EMBASE, and Cochrane Database of Systematic Reviews. Levels of evidence and recommendations were made according to the Strength of Recommendation taxonomy. Results: The standard advice of increasing dietary fibers, fluids, and exercise for relieving chronic constipation will only benefit patients with true deficiency. Biofeedback works best for constipation caused by pelvic floor dysfunction. Pharmacological agents increase bulk or water content in the bowel lumen or aim to stimulate bowel movements. Novel classes of compounds have emerged for treating chronic constipation, with promising clinical trial data. Finally, the link between senna abuse and colon cancer remains unsupported. Conclusions: Chronic constipation should be managed according to its etiology and guided by the best evidence-based treatment.(J Am Board Fam Med 2011;24:436-451.)","[Leung, Lawrence; Riutta, Taylor; Rosser, Walter] Queens Univ, Dept Family Med, Kingston, ON K7L 5E9, Canada; [Leung, Lawrence; Kotecha, Jyoti; Rosser, Walter] Queens Univ, Ctr Studies Primary Care, Kingston, ON K7L 5E9, Canada",Queens University - Canada; Queens University - Canada,"Leung, L (corresponding author), Queens Univ, Dept Family Med, 220 Bagot St, Kingston, ON K7L 5E9, Canada.",leungl@queensu.ca,,,,,,,190,140,158,4,55,AMER BOARD FAMILY MEDICINE,LEXINGTON,"2228 YOUNG DR, LEXINGTON, KY 40505 USA",1557-2625,1558-7118,,J AM BOARD FAM MED,J. Am. Board Fam. Med.,JUL-AUG,2011,24,4,,,,,436,451,,10.3122/jabfm.2011.04.100272,http://dx.doi.org/10.3122/jabfm.2011.04.100272,,,16,"Primary Health Care; Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,789FL,21737769,Bronze,,,2024-06-04,WOS:000292499800015,View Full Record in Web of Science
J,"Liu, T; Feng, P; Wang, C; Ojo, O; Wang, YY; Wang, XH",,,,"Liu, Ting; Feng, Ping; Wang, Can; Ojo, Omorogieva; Wang, Yu-yu; Wang, Xiao-hua",,,Effects of dietary fibre on enteral feeding intolerance and clinical outcomes in critically ill patients: A meta-analysis,INTENSIVE AND CRITICAL CARE NURSING,,,English,Review,,,,,,Enteral feeding intolerance; Critically ill patients; Nursing; Dietary fibre,GUT MICROBIOTA; INTENSIVE-CARE; NUTRITION; DIARRHEA; FORMULA; PREVALENCE,"Background: Although some studies have explored the relationships between dietary fibre and enteral feeding intolerance in critically ill patients, the results are equivocal.Objective: This study aimed to explore the effects of dietary fibre on enteral feeding intolerance and clinical outcomes in critically ill patients. Methods: We searched five databases from inception to July 12, 2021. Data were expressed as mean difference or odds ratio with 95% confidence interval.Results: Thirteen studies enrolled 709 critically ill patients included in the study. The results showed the dietary fibre group had a significantly decreased risk of diarrhea (OR: 0.46, 95% CI: 0.30,0.69, P < 0.001), regurgitation (OR: 0.28, 95%CI: 0.13, 0.60, P < 0.05), vomiting (OR: 0.40, 95%CI: 0.17, 0.92, P < 0.05), constipation (OR: 0.21, 95%CI: 0.09, 0.47, P < 0.001) and mortality (OR:0.34; 95%CI:- 0.13, 0.91; P < 0.05) compared with the fibre free group. Besides, there was a significant decrease on time to reach full enteral nutrition (MD: -2.08; 95%CI:- 4.05,-0.12; P < 0.05), the duration of the intensive care unit stay (MD: -4.62; 95%CI:- 6.60,-2.64; P < 0.001) and hospital stay (MD:-6.42; 95%CI:- 9.49,-3.36; P < 0.001) in the dietary fibre group.Conclusions: Dietary fibre supplementation may significantly reduce the risk of enteral feeding intolerance and improve the clinical outcomes.","[Liu, Ting; Wang, Can; Wang, Yu-yu] Soochow Univ, Dept Intens Care Med, Affiliated Hosp 1, Suzhou 215006, Peoples R China; [Feng, Ping] Soochow Univ, Dept Digest, Affiliated Hosp 1, Suzhou 215006, Peoples R China; [Ojo, Omorogieva] Univ Greenwich, Dept Adult Nursing & Paramed Sci, London, England; [Wang, Xiao-hua] Soochow Univ, Dept Cardiol, Affiliated Hosp 1, Suzhou 215006, Peoples R China",Soochow University - China; Soochow University - China; University of Greenwich; Soochow University - China,"Wang, YY (corresponding author), Soochow Univ, Dept Intens Care Med, Affiliated Hosp 1, Suzhou 215006, Peoples R China.;Wang, XH (corresponding author), Soochow Univ, Dept Cardiol, Affiliated Hosp 1, Suzhou 215006, Peoples R China.",289662520@qq.com; sxwang2001@163.com,"wang, can/A-5453-2015; Feng, Ping/AFN-9949-2022",,"Suzhou Science and Technology Project, China [SKJY2021062]","Suzhou Science and Technology Project, China","Funding Suzhou Science and Technology Project, China (Grant No SKJY2021062) .",,40,3,3,4,16,ELSEVIER SCI LTD,OXFORD,"THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND",0964-3397,1532-4036,,INTENS CRIT CARE NUR,Intensive Crit. Care Nurs.,FEB,2023,74,,,,,,,,103326,10.1016/j.iccn.2022.103326,http://dx.doi.org/10.1016/j.iccn.2022.103326,,DEC 2022,9,Nursing,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Nursing,7O5DW,36182625,,,,2024-06-04,WOS:000908045300018,View Full Record in Web of Science
J,"Arnaud, MJ",,,,"Arnaud, MJ",,,Mild dehydration: a risk factor of constipation?,EUROPEAN JOURNAL OF CLINICAL NUTRITION,,,English,Article; Proceedings Paper,2nd International Conference on Hydration throughout Life,"OCT 08-09, 2001","DORTMUND, GERMANY",,,constipation; water intake; dehydration; hypohydration; treatment,TRANSIT-TIME; SIGMOID COLON; STOOL OUTPUT; FLUID INTAKE; WATER; HEALTHY; SULFATE; DEFECATION; MANAGEMENT; DISORDERS,"Constipation defined as changes in the frequency, volume, weight, consistency and ease of passage of the stool occurs in any age group. The most important factors known to promote constipation are reduced physical activity and inadequate dietary intake of fibres, carbohydrates and fluids. Fluid losses induced by diarrhoea and febrile illness alter water balance and promote constipation. When children increase their water consumption above their usual intake, no change in stool frequency and consistency was observed. The improvement of constipation by increasing water intake, therefore, may be effective in children only when voluntary fluid consumption is lower-than-normal for the child's age and activity level. In the elderly, low fluid intake, which may be indicative of hypohydration, was a cause of constipation and a significant relationship between liquid deprivation from 2500 to 500 ml per day and constipation was reported. Dehydration is also observed when saline laxatives are used for the treatment of constipation if fluid replacement is not maintained and may affect the efficacy of the treatment. While sulphate in drinking water does not appear to have a significant laxative effect, fluid intake and magnesium sulphate-rich mineral waters were shown to improve constipation in healthy infants. In conclusion, fluid loss and fluid restriction and thus de-or hypohydration increase constipation. It is thus important to maintain euhydration as a prevention of constipation.","Nestle Water Inst, F-88804 Vittel, France",,"Nestle Water Inst, BP 101, F-88804 Vittel, France.",Maurice.Arnaud@nestle.com,,,,,,,84,72,81,1,16,NATURE PUBLISHING GROUP,LONDON,"MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND",0954-3007,1476-5640,,EUR J CLIN NUTR,Eur. J. Clin. Nutr.,DEC,2003,57,,,2,,,S88,S95,,10.1038/sj.ejcn.1601907,http://dx.doi.org/10.1038/sj.ejcn.1601907,,,8,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Nutrition & Dietetics,754VD,14681719,,,,2024-06-04,WOS:000187351600015,View Full Record in Web of Science
J,"Wu, TC; Chen, LK; Pan, WH; Tang, RB; Hwang, SJ; Wu, L; James, FE; Chen, PH",,,,"Wu, Tzee-Chung; Chen, Liang-Kung; Pan, Wen-Han; Tang, Ren-Bin; Hwang, Shinn-Jang; Wu, Lite; James, Frank Eugene; Chen, Po-Hon",,,Constipation in Taiwan elementary school students: A nationwide survey,JOURNAL OF THE CHINESE MEDICAL ASSOCIATION,,,English,Article,,,,,,Children; Constipation; Nutritional survey; Prevalence,DIETARY FIBER INTAKE; CHILDHOOD CONSTIPATION; ANORECTAL MANOMETRY; DEFECATION DISORDERS; UNITED-STATES; CHILDREN; HEALTHY; POPULATION; ENCOPRESIS; FREQUENCY,"Background: To evaluate the prevalence and associated factors of childhood constipation in Taiwan. Methods: Healthy children between 7 and 12 years of age were interviewed to determine the prevalence of constipation and associated demographic and dietary factors. A nationwide sample of 2,375 children was selected with complex multistaged sampling throughout Taiwan. Results: in total, 2,375 individuals (1,282 boys and 1,093 girls, mean age = 9.3 +/- 2.2 years) were interviewed, with a response rate of 95.1%. The prevalence of constipation was 32.2%, and girls were more likely to have constipation than boys (36.1% vs. 29.2%, p = 0.0012) in this study. The prevalence of constipation was inversely related to age (24.4% for children aged 11 and 12, 34.0% for children aged 9 and 10, and 39.6% for children aged 7 and 8, p < 0.001). Constipated children were more likely to report irregular bowl movements (37.2% vs. 29.3%, p = 0.003), and constipated children had a significantly lower body mass index (17.5 kg/m(2) vs. 18.3 kg/m(2), p < 0.001). The dietary intake for children with constipation was associated with lower intake of vegetables (4.2 servings/week vs. 5.8 servings/week, p < 0.05), fruits (5.6 servings/week vs. 7.0 servings/week, p < 0.05), soybean products (2.2 servings/week vs. 2.9 serving/week, p < 0.05), and eggs (3.9 servings/week vs. 4.6 servings/week, p < 0.05). Conclusion: Constipation is common in Taiwanese school-aged children, especially in girls. Less frequent consumption of vegetables, fruits, soybean products, and eggs is associated with childhood constipation. Establishing a regular bowel habit is encouraged to decrease the risk of constipation, and allowing the children a relaxed and sufficient time to defecate after school is essential. Copyright (C) 2011 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.","[Wu, Tzee-Chung] Taipei Vet Gen Hosp, Childrens Med Ctr, Div Gastroenterol, Taipei 112, Taiwan; [Chen, Liang-Kung; Hwang, Shinn-Jang] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Wu, Tzee-Chung; Chen, Liang-Kung; Tang, Ren-Bin; Hwang, Shinn-Jang] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Pan, Wen-Han] Acad Sinica, Inst Biomed Sci, Div Epidemiol & Genet, Taipei, Taiwan; [Wu, Lite; James, Frank Eugene] Washington Univ, Sch Publ Hlth & Commun Med, St Louis, MO 63130 USA",Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Washington University (WUSTL),"Wu, TC (corresponding author), Taipei Vet Gen Hosp, Childrens Med Ctr, Div Gastroenterol, 201,Sect 2,Shih Pai Rd, Taipei 112, Taiwan.",tcwu@vghtpe.gov.tw,"James, Frank/JXY-7841-2024; Chen, Liang-Kung/JBI-8802-2023","Chen, Liang-Kung/0000-0002-2387-8508",,,,,27,24,25,0,8,ELSEVIER TAIWAN,TAIPEI,"RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2, TAIPEI, 10449, TAIWAN",1726-4901,,,J CHIN MED ASSOC,J. Chin. Med. Assoc.,FEB,2011,74,2,,,,,57,61,,10.1016/j.jcma.2011.01.012,http://dx.doi.org/10.1016/j.jcma.2011.01.012,,,5,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,738MG,21354081,hybrid,,,2024-06-04,WOS:000288643300002,View Full Record in Web of Science
J,"Wald, A",,,,"Wald, A",,,Constipation,MEDICAL CLINICS OF NORTH AMERICA,,,English,Article,,,,,,,CHRONIC NONORGANIC CONSTIPATION; CHRONIC IDIOPATHIC CONSTIPATION; SEGMENTAL COLONIC TRANSIT; INTRACTABLE CONSTIPATION; ELDERLY PATIENTS; UNITED-STATES; BOWEL HABITS; MANAGEMENT; ADULTS; TRIAL,"Most patients with chronic constipation respond to dietary measures, fiber supplements, or laxatives. For those who do not, diagnostic tests of colonic and anorectal function help to select appropriate treatments. Therapeutic options, pharmacologic agents, and surgery, the last resort, are discussed in this article.","Univ Pittsburgh, Med Ctr, PUH, Dept Med,Div Gastroenterol Hepatol & Nutr Support, Pittsburgh, PA 15213 USA",Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh,"Univ Pittsburgh, Med Ctr, PUH, Dept Med,Div Gastroenterol Hepatol & Nutr Support, Mezzanine Level,C Wing,200 Lothrop St, Pittsburgh, PA 15213 USA.",,,,,,,,32,26,29,0,6,W B SAUNDERS CO-ELSEVIER INC,PHILADELPHIA,"1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA",0025-7125,1557-9859,,MED CLIN N AM,Med. Clin. N. Am.,SEP,2000,84,5,,,,,1231,+,,10.1016/S0025-7125(05)70284-4,http://dx.doi.org/10.1016/S0025-7125(05)70284-4,,,17,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,355JK,11026926,,,,2024-06-04,WOS:000089382400010,View Full Record in Web of Science
J,"Chouliaras, GL; Krepis, P; Bouzios, I; Zellos, A; Chrousos, G; Roma-Giannikou, E",,,,"Chouliaras, Giorgos L.; Krepis, Panagiotis; Bouzios, Ilias; Zellos, Aglaia; Chrousos, George; Roma-Giannikou, Eleftheria",,,"Dietary habits in Greek children with functional constipation based on Rome III criteria: a school-based, cross-sectional multivariate analysis",ANNALS OF GASTROENTEROLOGY,,,English,Article,,,,,,Constipation; diet; population study; children; ROME-III,GASTROINTESTINAL DISORDERS; FIBER INTAKE; HEALTH; MANAGEMENT,"Background Functional constipation (FC) is the most common gastrointestinal disorder of childhood and has a multifactorial etiology. We aimed to assess dietary habits in Greek children with FC compared to the general population (control group, CG). Methods This was a subgroup analysis of a school-based, cross-sectional study carried out in children 6-18 years of age, between January and June 2014, using the Rome III criteria for the diagnosis of FC. Dietary parameters, as well as socioeconomic and demographic data and their association with the likelihood of FC, were analyzed through multivariate logistic regression analysis and expressed as odds ratios (OR). Results A total of 1439 children (1218 CG, 221 FC) were included in the analysis. The final model showed that consumption of was the only dietary parameter significantly related to FC; higher frequency of consumption was inversely related to the likelihood of FC (OR: 0.98, 95% CI: 0.96, 0.99, P=0.048). Significant socioeconomic confounders with a positive association with FC were: parental educational level, victimization, physical activity and number of adults at home. Conclusions Increased frequency of fiber consumption is significantly associated with higher odds of FC irrespective of socioeconomic background and lifestyle parameters. Interventional studies are required to validate these cross-sectional observations.","[Chouliaras, Giorgos L.; Krepis, Panagiotis] Univ Athens P & Ag Kyriakou, Childrens Hosp, Dept Pediat 2, Thivon & Levadias St, Athens 11527, Greece; [Bouzios, Ilias; Zellos, Aglaia; Chrousos, George; Roma-Giannikou, Eleftheria] Univ Athens, Aghia Sophia Childrens Hosp, Dept Pediat 1, Athens, Greece",The Aghia Sophia Children's Hospital; National & Kapodistrian University of Athens,"Chouliaras, GL (corresponding author), Univ Athens P & Ag Kyriakou, Childrens Hosp, Dept Pediat 2, Thivon & Levadias St, Athens 11527, Greece.",georgehouliaras@msn.com,"Chrousos, George Panagiotis/G-8702-2011; Zellos, Aglaia/GNH-4286-2022",,,,,,38,1,1,0,2,HELLENIC SOC GASTROENTEROLOGY,ATHENS,"DEMOKRATIAS AVE 67, ATHENS, 15451, GREECE",1108-7471,1792-7463,,ANN GASTROENTEROL,Ann. Gastroenterol.,,2021,34,4,,,,,528,534,,10.20524/aog.2021.0626,http://dx.doi.org/10.20524/aog.2021.0626,,,7,Gastroenterology & Hepatology,Emerging Sources Citation Index (ESCI),Gastroenterology & Hepatology,TL1HQ,34276192,"gold, Green Published",,,2024-06-04,WOS:000674606100010,View Full Record in Web of Science
J,"Zhai, XC; Lin, DH; Zhao, Y; Yang, XB",,,,"Zhai, Xichuan; Lin, Dehui; Zhao, Yan; Yang, Xingbin",,,Bacterial Cellulose Relieves Diphenoxylate-Induced Constipation in Rats,JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY,,,English,Article,,,,,,aquaporins; ATPase activities; bacterial cellulose; diphenoxylate-induced constipation; intestinal neurotransmitters,SLOW-TRANSIT CONSTIPATION; LOPERAMIDE-INDUCED CONSTIPATION; ENTERIC NERVOUS-SYSTEM; INTERSTITIAL-CELLS; SIGNALING PATHWAY; GUT MICROBIOTA; COLONIC MUCUS; FATTY-ACIDS; EXPRESSION; FIBER,"This study was to probe the effects of bacterial cellulose (BC) on diphenoxylate-induced constipation in rats. Administration with BC at 500 mg/kg of body weight in diphenoxylate-induced constipation rats distinctly improved the carmine propulsion rate (83.5 +/- 5.2%), shortened the defecating time of the first red feces (249.0 +/- 23.3 min), and increased the weight of carmine red feces within 5 h (2.7 +/- 1.3 g). The levels of aquaporins (AQP-2, AQP-3, and AQP-4) and inhibitory neurotransmitters (nitric oxide, nitric oxide synthetase, vasoactive intestinal peptide, and arginine vasopressin) in the BC-treated groups reduced by 31.9-40.0% (p < 0.01) and 21.1-67.7% (p < 0.01) compared to those in the constipation group, respectively. However, the secretion of excitability neurotransmitters (substance P and motilin) in the BC-treated groups was increased by 20.0-39.9% (p < 0.01). The activities of ATPases in the colon of constipation rats were significantly weakened by BC administration (p < 0.01). Histological morphology of the colon showed that BC supplementation could effectively increase the length of villus cells and the thickness of colonic mucosa and muscle (p < 0.01). Moreover, BC supplementation could protect colonic smooth muscle cells against apoptosis. All of the findings suggest that BC supplementation effectively relieves constipation in rats and BC would be used as a great promising dietary fiber for alleviating constipation.","[Zhai, Xichuan; Lin, Dehui; Yang, Xingbin] Shaanxi Normal Univ, Coll Food Engn & Nutr Sci, Shaanxi Engn Lab Food Green Proc & Safety Control, Xian 710062, Shaanxi, Peoples R China; [Zhao, Yan] Shaanxi Normal Univ, Coll Life Sci, Natl Engn Lab Resource Developing Endangered Chin, Xian 710062, Shaanxi, Peoples R China",Shaanxi Normal University; Shaanxi Normal University,"Lin, DH; Yang, XB (corresponding author), Shaanxi Normal Univ, Coll Food Engn & Nutr Sci, Shaanxi Engn Lab Food Green Proc & Safety Control, Xian 710062, Shaanxi, Peoples R China.",lindehui504@snnu.edu.cn; xbyang@snnu.edu.cn,"Zhai, Xichuan/K-3865-2019","Zhai, Xichuan/0000-0002-7498-1230; zhao, yan/0000-0002-7829-5975; Yang, xingbin/0000-0002-8039-0525","International Scientific and Technological Cooperation and Exchange Program [2016KW068]; Postdoctoral Program of China [1202040108]; National Natural Science Foundation of China [C31671823, C31701662]",International Scientific and Technological Cooperation and Exchange Program; Postdoctoral Program of China(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)),"This study was supported by the International Scientific and Technological Cooperation and Exchange Program (Grant 2016KW068), the Postdoctoral Program of China (1202040108), and the National Natural Science Foundation of China (Grants C31671823 and C31701662).",,58,51,56,20,146,AMER CHEMICAL SOC,WASHINGTON,"1155 16TH ST, NW, WASHINGTON, DC 20036 USA",0021-8561,1520-5118,,J AGR FOOD CHEM,J. Agric. Food Chem.,APR 25,2018,66,16,,,,,4106,4117,,10.1021/acs.jafc.8b00385,http://dx.doi.org/10.1021/acs.jafc.8b00385,,,12,"Agriculture, Multidisciplinary; Chemistry, Applied; Food Science & Technology",Science Citation Index Expanded (SCI-EXPANDED),Agriculture; Chemistry; Food Science & Technology,GE3DW,29627986,,,,2024-06-04,WOS:000431095000015,View Full Record in Web of Science
J,"Huang, CF; Lyu, J; Chu, CN; Ge, L; Peng, YP; Yang, ZY; Xiong, SH; Wu, B; Chen, X; Zhang, XW",,,,"Huang, Congfu; Lyu, Jinli; Chu, Chunuo; Ge, Lan; Peng, Yuanping; Yang, Zhenyu; Xiong, Shenghua; Wu, Bin; Chen, Xiao; Zhang, Xiaowei",,,"Dietary fiber and probiotics based on gut microbiota targeting for functional constipation in children with cerebral palsy (vol 10, 1001789, 2022)",FRONTIERS IN PEDIATRICS,,,English,Correction,,,,,,gut microbiota; dietary fiber; probiotics; cerebral palsy; functional constipation,,,"[Huang, Congfu; Xiong, Shenghua; Wu, Bin; Chen, Xiao] Longgang Dist Matern & Child Healthcare Hosp, Dept Pediat, Shenzhen, Peoples R China; [Lyu, Jinli; Zhang, Xiaowei] Peking Univ, Shenzhen Hosp, Dept Obstet & Gynecol, Shenzhen, Peoples R China; [Chu, Chunuo] Shenzhen Middle Sch, Shenzhen, Peoples R China; [Ge, Lan] BGI Nutr Precis Co Ltd, Dept Nutr, Shenzhen, Peoples R China; [Peng, Yuanping] Longgang Dist Social Welf Ctr, Outpatient Dept, Shenzhen, Peoples R China; [Yang, Zhenyu] Shenzhen WeHealthGene Co, WeHealthGene Inst, Dept Microbial Res, Joint Lab Microecol & Childrens Hlth,Shenzhen Chi, Shenzhen, Peoples R China",Peking University,"Zhang, XW (corresponding author), Peking Univ, Shenzhen Hosp, Dept Obstet & Gynecol, Shenzhen, Peoples R China.",zhangivy726@163.com,"Huang, Congfu/IRY-9548-2023",,,,,,1,0,0,8,19,FRONTIERS MEDIA SA,LAUSANNE,"AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND",2296-2360,,,FRONT PEDIATR,Front. Pediatr.,NOV 21,2022,10,,,,,,,,1074856,10.3389/fped.2022.1074856,http://dx.doi.org/10.3389/fped.2022.1074856,,,1,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,6V9MP,36479280,"Green Published, gold",,,2024-06-04,WOS:000895362500001,View Full Record in Web of Science
J,"Qi, X; Tester, RF",,,,"Qi, Xin; Tester, Richard F.",,,Utilisation of dietary fibre (non-starch polysaccharide and resistant starch) molecules for diarrhoea therapy: A mini-review,INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES,,,English,Review,,,,,,Diarrhoea therapy; Dietary fibre; Polysaccharide,HYDROLYZED GUAR GUM; CHAIN FATTY-ACIDS; ORAL REHYDRATION SOLUTION; ENTERAL NUTRITION; PERSISTENT DIARRHEA; SUSCEPTIBILITY; MICROBIOTA; CONSTIPATION; MANAGEMENT; GRANULES,"Within the last ten years the utilisation of dietary fibre formats (non-starch polysaccharide and resistant starch) for diarrhoea therapy, have been evaluated. These polysaccharides ferment within the colon and generate short chain fatty acids which facilitate sodium absorption. Comparisons between polysaccharide structure/physico-chemical properties and fermentation capacity in the large intestine are presented. The potential dichotomy associated with recommending dietary fibre ingestion to avoid and treat diarrhoea is also considered. Overall, this mini-review presents an overview of the current knowledge with respect to role of dietary fibre in the management (prevention and treatment) of diarrhoea (osmotic and secretory). It aims to inform the medical and non-medical communities with respect to this relatively poorly researched and understood health related area. Different forms of dietary fibre are considered in this context along with their mechanisms of action. (C) 2018 Elsevier B.V. All rights reserved.","[Qi, Xin; Tester, Richard F.] Glycologic Ltd, Glasgow G4 0BA, Lanark, Scotland",,"Qi, X (corresponding author), Glycologic Ltd, Glasgow G4 0BA, Lanark, Scotland.",e.qi@glycologic.co.uk,,,,,,,68,22,22,3,98,ELSEVIER SCIENCE BV,AMSTERDAM,"PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",0141-8130,1879-0003,,INT J BIOL MACROMOL,Int. J. Biol. Macromol.,FEB 1,2019,122,,,,,,572,577,,10.1016/j.ijbiomac.2018.10.195,http://dx.doi.org/10.1016/j.ijbiomac.2018.10.195,,,6,"Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science",Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Chemistry; Polymer Science,HI1TA,30391429,,,,2024-06-04,WOS:000456226700064,View Full Record in Web of Science
J,"Dukas, L; Willett, WC; Giovannucci, EL",,,,"Dukas, L; Willett, WC; Giovannucci, EL",,,"Association between physical activity, fiber intake, and other lifestyle variables and constipation in a study of women",AMERICAN JOURNAL OF GASTROENTEROLOGY,,,English,Article,,,,,,,BOWEL TRANSIT-TIME; UNITED-STATES; GASTROINTESTINAL TRANSIT; ALCOHOL-CONSUMPTION; COLONIC TRANSIT; DIETARY FIBER; POPULATION; EXERCISE; ASPIRIN; HEALTH,"OBJECTIVE Because the risk factors for constipation in the general population are poorly defined, we examined the association between age, body mass index, and selected lifestyle and dietary factors with the prevalence of constipation in the Nurses' Health Study. METHODS: A total of 62,036 women, aged 36-61 yr and free of cancer, responded to mailed questionnaires in 1980 and 1982, which assessed bowel movement frequency, dietary. and lifestyle factors. Constipation was defined as two or fewer bowel movements weekly. RESULTS. A total of 3327 women (5.4%) were classified as having constipation. Age and body mass index were inversely associated with constipation (p for trend < 0.0001). In multivariate analysis, women who reported daily physical activity had a lower prevalence of constipation (prevalence ratio [PR] = 0.56, 95% Cl = 0.44-0.70). Women in the highest quintile of dietary fiber intake (median intake 20 g/day) were less likely to experience constipation (PR = 0.64 95% CI = 0.57-0.73) than women in the Lowest quintile (median intake 7 g/day). The PR for constipation for women who both reported daily physical activity and were in the highest quintile of fiber intake was 0.32 (95% CI = 0.20-0.54) compared with those with physical activity less than once weekly and those who were in the lowest quintile of fiber intake. Higher frequency of aspirin intake was associated with an increasing prevalence of constipation (PR = 1,38, 95% Cl = 1.17-1.62). Current smoking and alcohol use were inversely associated with constipation. CONCLUSIONS: Our data suggest that moderate physical activity and increasing fiber intake are associated with substantial reduction in the prevalence of constipation in women.","Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA; Univ Basel Hosp, Dept Geriatr, CH-4031 Basel, Switzerland",Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Basel,"Giovannucci, EL (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.",,,,NCI NIH HHS [CA40356] Funding Source: Medline,NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)),,,52,207,230,0,32,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",0002-9270,,,AM J GASTROENTEROL,Am. J. Gastroenterol.,AUG,2003,98,8,,,,,1790,1796,,10.1016/S0002-9270(03)00442-8,http://dx.doi.org/10.1016/S0002-9270(03)00442-8,,,7,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Gastroenterology & Hepatology,708TF,12907334,,,,2024-06-04,WOS:000184584900018,View Full Record in Web of Science
J,"Peery, AF; Sandler, RS; Ahnen, DJ; Galanko, JA; Holm, AN; Shaukat, A; Mott, LA; Barry, EL; Fried, DA; Baron, JA",,,,"Peery, Anne F.; Sandler, Robert S.; Ahnen, Dennis J.; Galanko, Joseph A.; Holm, Adrian N.; Shaukat, Aasma; Mott, Leila A.; Barry, Elizabeth L.; Fried, David A.; Baron, John A.",,,Constipation and a Low-Fiber Diet Are Not Associated With Diverticulosis,CLINICAL GASTROENTEROLOGY AND HEPATOLOGY,,,English,Article,,,,,,Diverticular Disease; Risk Factors; Database Analysis,PHYSICAL-ACTIVITY; DISEASE; COLON; RISK; INCREASES; MOTILITY; PRESSURE; SMOKING,"BACKGROUND & AIMS: Asymptomatic diverticulosis is commonly attributed to constipation caused by a low-fiber diet, although evidence for this mechanism is limited. We examined the associations between constipation and low dietary fiber intake with risk of asymptomatic diverticulosis. METHODS: We performed a cross-sectional study that analyzed data from 539 individuals with diverticulosis and 1569 without (controls). Participants underwent colonoscopy and assessment of diet, physical activity, and bowel habits. Our analysis was limited to participants with no knowledge of their diverticular disease to reduce the risk of biased responses. RESULTS: Constipation was not associated with an increased risk of diverticulosis. Participants with less frequent bowel movements (<7/wk) had reduced odds of diverticulosis compared with those with regular bowel movements (7/wk) (odds ratio [OR], 0.56; 95% confidence interval [CI], 0.40-0.80). Those reporting hard stools also had reduced odds (OR, 0.75; 95% CI, 0.55-1.02). There was no association between diverticulosis and straining (OR, 0.85; 95% CI, 0.59-1.22) or incomplete bowel movement (OR, 0.85; 95% CI, 0.61-1.20). We found no association between dietary fiber intake and diverticulosis (OR, 0.96; 95% CI, 0.71-1.30) in comparing the highest quartile with the lowest (mean intake, 25 vs 8 g/day). CONCLUSIONS: In our cross-sectional, colonoscopy-based study, neither constipation nor a low-fiber diet was associated with an increased risk of diverticulosis.","[Peery, Anne F.; Sandler, Robert S.; Galanko, Joseph A.; Baron, John A.] Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA; [Ahnen, Dennis J.] Denver Vet Affairs Med Ctr, Denver, CO USA; [Ahnen, Dennis J.] Univ Colorado Anschutz Med Campus, Denver, CO USA; [Holm, Adrian N.] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA; [Shaukat, Aasma] Minneapolis Veteran Affairs Med Ctr, Minneapolis, MN USA; [Mott, Leila A.; Barry, Elizabeth L.; Fried, David A.; Baron, John A.] Geisel Sch Med Dartmouth, Hanover, NH USA",University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Iowa; Dartmouth College,"Peery, AF (corresponding author), Univ N Carolina, Sch Med, Div Gastroenterol & Hepatol, Bioinformat Bldg,CB 7080,130 Mason Farm Rd, Chapel Hill, NC 27599 USA.",anne_peery@med.unc.edu,"Barry, Elizabeth/AAB-7916-2019","Holm, Adrian/0000-0002-7290-0185; Fried, David/0009-0005-9631-4315","National Institutes of Health [T32 DK07634, P30 DK034987, R01 DK094738, R01 CA098286]",National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA),"Supported in part by grants from the National Institutes of Health T32 DK07634, P30 DK034987, R01 DK094738, and R01 CA098286.",,37,95,99,1,13,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",1542-3565,1542-7714,,CLIN GASTROENTEROL H,Clin. Gastroenterol. Hepatol.,DEC,2013,11,12,,,,,1622,1627,,10.1016/j.cgh.2013.06.033,http://dx.doi.org/10.1016/j.cgh.2013.06.033,,,6,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,258US,23891924,"Green Published, Green Accepted",,,2024-06-04,WOS:000327484800022,View Full Record in Web of Science
J,"Hong, YP; Chen, XX; Liu, JP",,,,"Hong, Yongping; Chen, Xingxing; Liu, Junping",,,Analysis of Factors Associated with Constipation in the Population with Obesity: Evidence from the National Health and Nutrition Examination Survey,OBESITY FACTS,,,English,Article,,,,,,Constipation; Hypertension; Polypharmacy; Functional bowel disorders; Obesity,FUNCTIONAL CONSTIPATION; PHYSICAL-ACTIVITY; DIETARY FIBER; LIFE; PREVALENCE; OVERWEIGHT; SYMPTOMS; CHILDREN; ADULTS; RISK,"Introduction: Obesity and constipation are both global problems, but the factors associated with constipation in individuals with obesity are currently understudied. The aim of our study was to explore the factors associated with constipation in people with obesity. Methods: From three cycles of the National Health and Nutrition Examination Survey (NHANES) 2005-2010, data from 14,048 persons aged >= 20 years were collected. Variables included demographics, lifestyle, comorbidities, and dietary data. Multiple logistic regression analysis was used to calculate adjusted prevalence odds ratio (OR) and assess the relationship between different variables and constipation in population with obesity. Results: Using stool consistency definition, multivariate analysis revealed that education >= 12th grade (OR: 0.456; 95% CI: 0.300, 0.694; p = 0.00024), hypertension (OR: 0.505; 95% CI: 0.334, 0.763; p = 0.00119), polypharmacy (OR: 1.669; 95% CI: 1.104, 2.521; p = 0.01507), high cholesterol (OR: 0.400; 95% CI: 0.213, 0.750; p = 0.00430), and high dietary fiber (OR: 0.454; 95% CI: 0.245, 0.841; p = 0.01206) were substantially linked with constipation in the population with obesity. For constipation defined using stool frequency, multivariate regression analysis show constipation in people with obesity had a significant association with the female sex (OR: 2.684; 95% CI: 1.379, 5.223; p = 0.00366 multivariate), Mexican American (OR: 0.142; 95% CI, 0.033, 0.616; p = 0.00914 multivariate), hypertension (OR: 0.569; 95% CI: 0.324, 0.998; p = 0.04916), depression (OR: 2.280; 95% CI: 1.240, 4.195; p = 0.00803), occasional/often milk consumption (OR: 0.473; 95% CI: 0.286, 0.782; p = 0.00356), medium energy (OR: 0.318; 95% CI: 0.118, 0.856; p = 0.02338), polypharmacy (OR: 1.939; 95% CI: 1.115, 3.373; p = 0.01907), and medium moisture (OR: 0.534; 95% CI: 0.285, 0.999; p = 0.04959). In nonobese people, constipation was significantly associated with the female sex and high moisture but not with hypertension and polypharmacy. Conclusion: This study suggests that the population with obesity has many factors that affect constipation such as hypertension, polypharmacy, cholesterol, dietary fiber, depression, and so on, of which hypertension and polypharmacy were significant associated with constipation, regardless of definitions of constipation. Notably, hypertension might be associated with a reduced risk of constipation in people with obesity.","[Hong, Yongping; Liu, Junping] Wenzhou Med Univ, Peoples Hosp Xiaoshan Dist 1, Dept Anorectal Surg, Xiaoshan Affiliated Hosp, Hangzhou, Peoples R China; [Chen, Xingxing] Wenzhou Med Univ, Peoples Hosp Xiaoshan Dist 1, Dept Ultrasound, Xiaoshan Affiliated Hosp, Hangzhou, Peoples R China",Wenzhou Medical University; Wenzhou Medical University,"Liu, JP (corresponding author), Wenzhou Med Univ, Peoples Hosp Xiaoshan Dist 1, Dept Anorectal Surg, Xiaoshan Affiliated Hosp, Hangzhou, Peoples R China.",junpingliu0630@126.com,,,,,,,42,0,0,1,1,KARGER,BASEL,"ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND",1662-4025,1662-4033,,OBESITY FACTS,Obes. Facts,APR,2024,17,2,,,,,169,182,,10.1159/000536318,http://dx.doi.org/10.1159/000536318,,,14,Endocrinology & Metabolism; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Endocrinology & Metabolism; Nutrition & Dietetics,NA0J7,38266495,gold,,,2024-06-04,WOS:001197597600006,View Full Record in Web of Science
J,"Andreoli, CS; Ribeiro-Vieira, SA; Fonsêca, PCD; Moreirm, AVB; Ribeiro, SMR; Franceschini, SDC",,,,"Andreoli, Cristiana Santos; Ribeiro-Vieira, Sarah Aparecida; de Almeida Fonseca, Poliana Cristina; Bandeira Moreirm, Ana Vladia; Rocha Ribeiro, Sonia Machado; Castro Franceschini, Sylvia do Carmo",,,"Markers of healthy eating habits, water intake, and constipation in children between 4 and 7 years of age",REVISTA DE NUTRICAO-BRAZILIAN JOURNAL OF NUTRITION,,,English,Article,,,,,,Child; Constipation; Feeding behaviour; Food Consumption,FUNCTIONAL CONSTIPATION; PRESCHOOL-CHILDREN; PHYSICAL-ACTIVITY; DIETARY-INTAKE; FOOD-INTAKE; CONSUMPTION; ADOLESCENTS; PREVALENCE; FIBER,"Objective To evaluate the association between diet and constipation in children between four and seven years of age. Methods A cross-sectional study with 152 children between 4 and 7 years of age residing in Vicosa, Brazil. Constipation was defined in accordance with the Rome IV diagnostic criteria. Dietary habits were evaluated based on the frequency of food intake using a food diary for three days. Dietary analysis considered foods deemed healthy and unhealthy which could be associated with constipation, as well as the children's consumption of fruits and vegetables. The amounts of fiber and water consumed were also rated as adequate or inadequate. As part of the analyses, Student's t-test and the chi-square test were performed with a significance level of p<0.05. Results The prevalence of constipation was 32.2%. Constipation was more common among children who did not consume fruits (p=0.020) or greens (p=0.002), as well as among children who consumed instant chocolate drinks (p=0.033). An association was found between the frequent consumption of fried food (p=0.020), a daily water intake lower than 600mL, and constipation (p=0.028). Conclusion Unhealthy eating habits among children, such as the lack of fruit and greens intake and the consumption of instant chocolate drinks and fried foods, were found to be positively correlated with constipation. The low fruit and vegetable consumption observed herein reflects the need for changes in children's eating habits and the implementation of measures to promote the intake of healthy foods.","[Andreoli, Cristiana Santos] Inst Fed Minas Gerais, Curso Super Tecnol Gastron, Campus Ouro Preto,R Pandia Calogeras 898, BR-35400000 Ouro Preto, MG, Brazil; [Ribeiro-Vieira, Sarah Aparecida] Univ Fed Espirito Santo, Curso Nutr, Dept Educ Integrada Saude, Vitoria, ES, Brazil; [de Almeida Fonseca, Poliana Cristina] Univ Fed Univ Fed Maranhao, Curso Nutr, Dept Ciencias Fisiol, Sao Luis, MA, Brazil; [Bandeira Moreirm, Ana Vladia] Univ Fed Juiz de Fora, Curso Nutr, Dept Nutr, Juiz De Fora, MG, Brazil; [Rocha Ribeiro, Sonia Machado; Castro Franceschini, Sylvia do Carmo] Univ Fed Vicosa, Dept Nutr & Saude, Programa Posgrad Ciencia Nutr, Vicosa, MG, Brazil","Instituto Federal de Educacao, Ciencia e Tecnologia de Minas Gerais (IFMG); Universidade Federal do Espirito Santo; Universidade Federal de Juiz de Fora; Universidade Federal de Vicosa","Andreoli, CS (corresponding author), Inst Fed Minas Gerais, Curso Super Tecnol Gastron, Campus Ouro Preto,R Pandia Calogeras 898, BR-35400000 Ouro Preto, MG, Brazil.",cristiana.andreoli@ifmg.edu.br,"ANDREOLI, CRISTIANA/T-9386-2019","ANDREOLI, CRISTIANA/0000-0001-8765-3896; Fonseca Viola, Poliana Cristina de Almeida/0000-0002-8875-5154; Vieira Ribeiro, Sarah Aparecida/0000-0002-0304-2711",Fundacao de Amparo a Pesquisa do estado de Minas Gerais,Fundacao de Amparo a Pesquisa do estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)),Fundacao de Amparo a Pesquisa do estado de Minas Gerais for granting research funding.,,33,0,0,0,3,PONTIFICIA UNIVERSIDADE CATOLICA CAMPINAS,CAMPINAS,"NUCLEO EDITORACAO SBI-CCV, CAMPUS II AV JOHN BOYD DUNLOP S-N PREDIO ONTOLOGIA JD IPAUSSURAMA, CAMPINAS, SP 13060-904, BRAZIL",1415-5273,,,REV NUTR,Rev. Nutr.,JUL-AUG,2018,31,4,,,,,363,372,,10.1590/1678-98652018000400002,http://dx.doi.org/10.1590/1678-98652018000400002,,,10,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,HG5UA,,"Green Published, Green Submitted, gold",,,2024-06-04,WOS:000455043300002,View Full Record in Web of Science
J,"Buddington, RK; Kapadia, C; Neumer, F; Theis, S",,,,"Buddington, Randal K.; Kapadia, Cavita; Neumer, Franka; Theis, Stephan",,,Oligofructose Provides Laxation for Irregularity Associated with Low Fiber Intake,NUTRIENTS,,,English,Article,,,,,,constipation; fermentable; fiber; fructan; clinical trial; inulin; irregularity; laxation; supplement,CHAIN FATTY-ACIDS; IRRITABLE-BOWEL-SYNDROME; DIETARY FIBER; CHRONIC CONSTIPATION; GASTROINTESTINAL-TRACT; DOUBLE-BLIND; INULIN; PLACEBO; HEALTH; OLIGOSACCHARIDES,"Inadequate dietary fiber intake contributes to the prevalent irregularity and constipation in Western countries. Although eating adequate amounts of fibers from fiber-rich foods, foods with added fibers and dietary fiber supplements is considered the first option for improving laxation, the efficacy can vary among types of fibers. The present study is a randomized control trial that included healthy adult participants with 3 bowel movements/week and a habitual low dietary fiber intake in a parallel design to evaluate the benefits for laxation by supplementing the daily diet with oligofructose (Orafti((R)) P95; OF), a fermentable source of fiber and established prebiotic (n = 49); maltodextrin was the placebo (n = 48). After a run-in phase, OF was initially provided at 5 g/day, then increased to 10 and 15 g/day with four weeks for each phase. Stool frequency (bowel movements per week) for the OF and maltodextrin (MD) groups were initially similar (3.98 +/- 1.49 vs. 4.06 +/- 1.48), did not change for the placebo group, but increased for the OF group with the difference significant at 15 g/day (p = 0.023). Stool consistency was similar and remained unchanged at all doses for both groups. Gastrointestinal sensations were low for both groups. Laxation benefits were especially pronounced for participants with >13 g/day habitual dietary fiber intake, with significant laxation at 10 g and 15 g OF/day (p = 0.04 and p = 0.004, respectively) A daily supplement with a short-chain inulin-type fructan derived from chicory roots, i.e., oligofructose (Orafti((R)) P95) provided a laxation effect without causing gastrointestinal (GI) distress for healthy participants with irregularity associated with low dietary fiber intake.","[Buddington, Randal K.; Kapadia, Cavita] Univ Memphis, Sch Hlth Studies, Memphis, TN 38152 USA; [Neumer, Franka; Theis, Stephan] BENEO GmbH, BENEO Inst, Wormser Str 11, D-67283 Obrigheim, Germany",University of Memphis,"Buddington, RK (corresponding author), Univ Memphis, Sch Hlth Studies, Memphis, TN 38152 USA.",rbddngtn@memphis.edu; vita583@yahoo.com; Franka.Neumer@beneo.com; Stephan.Theis@beneo.com,"Buddington, Randal/ABH-2011-2021","Buddington, Randal/0000-0001-5790-0593","BENEO GmbH, Mannheim, Germany","BENEO GmbH, Mannheim, Germany","Funding for the research and publication costs was provided by BENEO GmbH, Mannheim, Germany, a member of the Suedzucker Group. The study results and data contained in the publication have been developed by and/or for BENEO. BENEO reserves the exclusive right to use the results and data for possible Health Claim requests.",,35,25,26,1,15,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",2072-6643,,,NUTRIENTS,Nutrients,DEC,2017,9,12,,,,,,,1372,10.3390/nu9121372,http://dx.doi.org/10.3390/nu9121372,,,11,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,FR6PQ,29258261,"gold, Green Submitted, Green Published",,,2024-06-04,WOS:000419188600097,View Full Record in Web of Science
J,"Gong, LX; Liu, FY; Liu, J; Wang, J",,,,"Gong, Lingxiao; Liu, Feiyue; Liu, Jie; Wang, Jing",,,Dietary fiber (oligosaccharide and non-starch polysaccharide) in preventing and treating functional gastrointestinal disorders - Challenges and controversies: A review,INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES,,,English,Review,,,,,,Dietary fiber; Gut microbiota; Gastrointestinal movement; Adverse effect; Modification technologies,IRRITABLE-BOWEL-SYNDROME; RANDOMIZED CLINICAL-TRIAL; CHAIN FATTY-ACIDS; GUT MICROBIOTA; ESCHERICHIA-COLI; DOUBLE-BLIND; CROHNS-DISEASE; TIGHT JUNCTION; HEALTH; CELLS,"Functional gastrointestinal disorders (FGIDs) are a group of chronic or recurrent gastrointestinal functional diseases, including functional dyspepsia, irritable bowel syndrome, and functional constipation. A lack of safe and reliable treatments for abdominal pain-related FGIDs has prompted interest in new therapies. Evidence has shown that supplementation with dietary fiber may help treat FGIDs. Dietary fibers (DFs) have been demonstrated to have regulatory effects on the gut microbiota, microbiota metabolites, and gastrointestinal movement and have important implications for preventing and treating FGIDs. However, the adverse effects of some DFs, such as fermentable oligosaccharides, on FGIDs are unclear. This review provides an overview of the DFs physiological properties and functional characteristics that influence their use in management of FGIDs, with emphasis on structural modification technology to improve their therapeutic activities. The review highlights that the use of appropriate or novel fibers is a potential therapeutic approach for FGIDs.","[Gong, Lingxiao; Liu, Feiyue; Liu, Jie; Wang, Jing] Beijing Technol & Business Univ BTBU, Key Lab Special Food Supervis Technol State Market, Sch Food & Hlth, Key Lab Geriatr Nutr & Hlth,Minist Educ, Beijing 100048, Peoples R China",Beijing Technology & Business University,"Wang, J (corresponding author), Beijing Technol & Business Univ BTBU, Key Lab Special Food Supervis Technol State Market, Sch Food & Hlth, Key Lab Geriatr Nutr & Hlth,Minist Educ, Beijing 100048, Peoples R China.",wangjing@th.btbu.edu.cn,,,"National Key Research and Development Program [2021YFD2100403]; Beijing Natural Science Foundation [6222002]; National Natural Science Foundation of China [32372321, 31972111]; Cultivation Project of Double First-Class Disciplines of Food Science and Engineering, Beijing Tech-nology & Business University [BTBUYXTD202201]","National Key Research and Development Program; Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Cultivation Project of Double First-Class Disciplines of Food Science and Engineering, Beijing Tech-nology & Business University","This research was supported by the National Key Research and Development Program (2021YFD2100403) , the Beijing Natural Science Foundation (6222002) , the National Natural Science Foundation of China (32372321, 31972111) , and the Cultivation Project of Double First-Class Disciplines of Food Science and Engineering, Beijing Tech-nology & Business University BTBUYXTD202201) .",,139,1,1,26,26,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",0141-8130,1879-0003,,INT J BIOL MACROMOL,Int. J. Biol. Macromol.,FEB,2024,258,,1,,,,,,128835,10.1016/j.ijbiomac.2023.128835,http://dx.doi.org/10.1016/j.ijbiomac.2023.128835,,DEC 2023,12,"Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science",Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Chemistry; Polymer Science,FC1O2,38128805,,,,2024-06-04,WOS:001143460700001,View Full Record in Web of Science
J,"Kondo, T; Nakae, Y",,,,"Kondo, T; Nakae, Y",,,Breath hydrogen and methane excretion produced by commercial beverages containing dietary fiber,JOURNAL OF GASTROENTEROLOGY,,,English,Article,,,,,,dietary fiber; orocecal transit time; breath hydrogen and methane; oligosaccharide; polydextrose,HEALTHY-SUBJECTS; SUPPLEMENTS; METABOLISM; PECTIN; COLON,"Soft drinks containing dietary fiber are popular in Japan. There seem to be two types, one containing polydextrose and the other, oligosaccharide. These beverages are claimed to be useful for constipation or obesity, but data are scanty. We examined four such fiber-containing beverages [Fibe-mini Otsuka Pharmaceuticals (Tokyo, Japan), Seni and Oligo Takeda Food Engineering (Osaka, Japan), Oligo CC (Calpis Food Engineering, Tokyo, Japan), and Sapitus 5289 Nakakita Pharmaceuticals (Nagoga, Japan)] for large intestine fermentability by measuring breath hy drogen (H-2) and methane (CH4). Five healthy subjects (two men, three women, 22-48 years old) participated in the study. Breath H, and CH, were measured with a MicroLyzer (Quintron Instruments, Milwaukee, Wis.). Breath H-2 increased within 2 h of beverage consumption, but CH4 excretion was observed in only two subjects. Orocecal transit time was constant for all beverages. Total H-2 plus CH4 excretion (AUC; area under the curve) after lactulose was 1294 +/- 250 ppm x min/g fiber. AUC for Oligo CC was significantly greater than that for Fibe-mini or Sapitus 5289 (P < 0.05). The AUCs of Fibe-mini, Seni and Oligo, Oligo CC, and Sapitus 5289 were 41%, 129%, 174%, and 40%, respectively, that of lactulose. It is concluded that commercial fiber-containing drinks produce H-2, and CH4 in some people. Oligosaccharide produces more H-2 and CH4 than polydextrose.",,,"Kondo, T (corresponding author), NAGOYA UNIV,RES CTR HLTH PHYS FITNESS & SPORTS,CHIKUSA KU,FURO CHO,NAGOYA,AICHI 46401,JAPAN.",,,,,,,,12,7,8,0,9,SPRINGER VERLAG,NEW YORK,"175 FIFTH AVE, NEW YORK, NY 10010",0944-1174,,,J GASTROENTEROL,J. Gastroenterol.,OCT,1996,31,5,,,,,654,658,,10.1007/BF02347612,http://dx.doi.org/10.1007/BF02347612,,,5,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,VJ728,8887030,,,,2024-06-04,WOS:A1996VJ72800004,View Full Record in Web of Science
J,"Rao, TP; Quartarone, G",,,,"Rao, Theertham Pradyumna; Quartarone, Giuseppina",,,Role of guar fiber in improving digestive health and function,NUTRITION,,,English,Review,,,,,,Constipation; Diarrhea; Guar fiber; IBD; IBS; PHGG; Prebiotics; Probiotics,IRRITABLE-BOWEL-SYNDROME; CHAIN FATTY-ACID; ORAL REHYDRATION SOLUTION; COLONIC TRANSIT-TIME; ENTERAL NUTRITION; DIETARY FIBER; SOLUBLE FIBER; DOUBLE-BLIND; GASTROINTESTINAL SYMPTOMS; BLOOD-PRESSURE,"Digestive health plays key role in our active daily life; but maintaining proper bowel movements, i.e., being free from constipation, diarrhea, irritable bowel syndrome, inflammatory bowel disease, flatulence, bloating, and abdominal pain, is complex. Dietary fibers often are recommended to maintain proper digestive health, but none seems to provide a single comprehensive solution for overall maintanance of proper digestive health. Guar fiber, however, has emerged as a credible candidate for just such a solution. This review focused on summarizing the clinically observed effects of guar fiber on digestive health. Several clinical studies suggest the guar fiber normalizes both constipation and diarrheal conditions. Also, it was effective in alleviating the symptoms associated with irritable bowel syndrome. The studies suggest that a regular intake of 5 to 10 gid guar fiber is effective to treat most of the morbidities associated with digestive health. Guar fiber is all natural. It may offer potential protection and promotion of digestive health both alone and when combined with probiotics as a synbiotic formula. (C) 2018 Elsevier Inc. All rights reserved.","[Rao, Theertham Pradyumna] Taiyo Kagaku Co Ltd, Yokaichi, Japan; [Quartarone, Giuseppina] GSK Italy, Origgio, Varese, Italy","TAIYO KAGAKU CO., LTD.","Rao, TP (corresponding author), Taiyo Kagaku Co Ltd, Yokaichi, Japan.",tprao@taiyokagaku.co.jp,,,,,,,119,16,16,1,29,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",0899-9007,1873-1244,,NUTRITION,Nutrition,MAR,2019,59,,,,,,158,169,,10.1016/j.nut.2018.07.109,http://dx.doi.org/10.1016/j.nut.2018.07.109,,,12,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,HK6MU,30496956,,,,2024-06-04,WOS:000458095600023,View Full Record in Web of Science
C,"Marteau, P; Jacobs, H; Baril, B; Signoret, C; Prevel, JM",,"VanDerKamp, JW; Jones, J; McCleary, B; Topping, D",,"Marteau, P.; Jacobs, H.; Baril, B.; Signoret, C.; Prevel, J. -M.",,,Effects of native chicory inulin on constipation in elderly people,DIETARY FIBRE: NEW FRONTIERS FOR FOOD AND HEALTH,,,English,Proceedings Paper,4th International Dietary Fibre Conference,"JUL 01-03, 2009","Vienna, AUSTRIA",Int Assoc Cereal Sci & Technol,,soluble fibre; laxation; bifidobacteria,BIFIDOBACTERIA; DISORDERS; FORMULA; HUMANS; LIPIDS,"Constipation is a common problem in the population and a major health problem in elderly people. Dietary fibre promotes laxation in healthy and constipated persons. This is a well established property of insoluble fibre; however the effect of soluble fibres is less well-known. Chicory inulin is a soluble prebiotic fibre. The aim of the present study is to evaluate the effect of native chicory inulin on bifidobacteria counts, bowel function parameters and quality of life of elderly constipated subjects. Two groups of 25 volunteers were asked to consume daily 15 g of chicory native inulin (Fibruline (R) Instant) or 15 g of placebo (maltodextrins) for four weeks. Stools were collected and stool frequency was evaluated at the beginning (V1) and after two (V2) and four weeks (V3) of treatment. Bifidobacteria counts were measured by PCR. Constipation improvement was assessed through a questionnaire and quality of life through visual analogue scale (VAS) at V1, V2 and V3. Bifidobacteria were significantly increased in the group consuming 15 g per day of chicory inulin between the beginning and the end of the study (P=0.0021) and compared to placebo at V3 (P=0.0003). A decrease in the occurrence of constipation was reported by the volunteers after four weeks of the inulin intake (with 47% less volunteers reporting no daily stools between the beginning and the end of the study, P=0.007). A trend for softer stools was reported in the inulin group between the beginning and the end of the study (with a score going from 1.32 to 1.64 after four weeks of intake, P=0.0555). A significant decrease in defecation difficulties after the four weeks of inulin intake was observed (P=0.0003). An increase in flatulence was also recorded but, more importantly, a rapid increase in digestive satisfaction (already after two weeks of the inulin intake) was observed. According to the results of this study, the daily intake of 15 g per day of chicory native inulin by elderly constipated persons, leads to an improvement of the bowel function and a modulation of the flora associated with a better quality of life.","[Marteau, P.] Univ Paris 07, Hop Lariboisiere, AP HP, 2 Rue Ambroise Pare, F-75010 Paris, France; [Jacobs, H.; Signoret, C.] Cosucra Grp Warcoing, B-7740 Warcoing, Belgium; [Baril, B.; Prevel, J. -M.] Biofortis, F-44200 Nantes, France",Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Lariboisiere-Fernand-Widal - APHP,"Marteau, P (corresponding author), Univ Paris 07, Hop Lariboisiere, AP HP, 2 Rue Ambroise Pare, F-75010 Paris, France.",csignoret@cosucra.com,"Jacobs, Heidi/E-9550-2011","Jacobs, Heidi/0000-0001-7620-3822",,,,,16,0,0,0,7,WAGENINGEN ACAD PUBL,WAGENINGEN,"POSTBUS 220, 6700 AE WAGENINGEN, NETHERLANDS",,,978-90-8686-692-2; 978-90-8686-128-6,,,,2010,,,,,,,283,293,,,,,,11,Nutrition & Dietetics,Conference Proceedings Citation Index - Science (CPCI-S),Nutrition & Dietetics,BHW25,,,,,2024-06-04,WOS:000326835300019,View Full Record in Web of Science
J,"Guedon, C; Ducrotte, P; Antoine, JM; Denis, P; Colin, R; Lerebours, E",,,,"Guedon, C; Ducrotte, P; Antoine, JM; Denis, P; Colin, R; Lerebours, E",,,Does chronic supplementation of the diet with dietary fibre extracted from pea or carrot affect colonic motility in man?,BRITISH JOURNAL OF NUTRITION,,,English,Article,,,,,,dietary fibre; colonic motility,IRRITABLE BOWEL SYNDROME; MOTOR-ACTIVITY; CHRONIC CONSTIPATION; TRANSIT; FIBER; CROSSOVER; WEIGHT; HEALTH; HUMANS; BRAN,"The aim of the present study was to assess, in healthy volunteers and under physiological conditions, the acceptability, clinical tolerance and effects on colonic motility of chronic supplementation of the usual diet with new dietary fibre sources. Three studies were carried out, one after a period of habitual diet, and two after randomized 3-week periods of supplementation with fibre extracted either from pea hulls or carrots, added to the meals as a fine powder. The 24 h motility was recorded on an unprepared colon at five levels to determine the initiation site and the number of high amplitude propagated contractions (HAPC) and to quantify motor activity every 30 min, particularly in the two periods following lunch and breakfast. With the habitual diet the motility pattern was an irregular alternation of quiescence and sporadic non-propagated contractions. HAPC always started from the ascending colon and occurred mainly after breakfast. With either type of fibre the 24 h motor profiles, the 24 h variations and the number of HAPC were not significantly modified but a more distal initiation of HAPC was found. The colonic postprandial motor response was more diffuse after dietary enrichment with carrot fibre than after enrichment with pea-hull fibre. In healthy volunteers the long-term addition of fibre extracted from pea hulls and carrots to the usual diet was easy and well-tolerated without clinical side-effects, but with limited colonic motor effects. However, the more distal initiation of HAPC observed could be deleterious.","BSN,F-75006 PARIS,FRANCE",,"Guedon, C (corresponding author), HOP CHARLES NICOLLE,GRP PHYSIOPATHOL DIGEST & NUTR,1 RUE GERMONT,F-76031 ROUEN,FRANCE.",,,,,,,,39,11,12,0,6,CAMBRIDGE UNIV PRESS,NEW YORK,"40 WEST 20TH STREET, NEW YORK, NY 10011-4211",0007-1145,,,BRIT J NUTR,Br. J. Nutr.,JUL,1996,76,1,,,,,51,61,,10.1079/BJN19960008,http://dx.doi.org/10.1079/BJN19960008,,,11,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,VB345,8774216,Bronze,,,2024-06-04,WOS:A1996VB34500006,View Full Record in Web of Science
J,"Cameron, KJ; Nyulasi, IB; Collier, GR; Brown, DJ",,,,"Cameron, KJ; Nyulasi, IB; Collier, GR; Brown, DJ",,,"Assessment of the effect of increased dietary, fibre intake on bowel function in patients with spinal cord injury",SPINAL CORD,,,English,Article,,,,,,dietary fibre; colonic transit time; stool weight; spinal cord injury,COLONIC TRANSIT-TIME; WHEAT BRAN; INTESTINAL TRANSIT; PARTICLE-SIZE; FIBER; STOOL; WEIGHT,"It is common for constipation to occur following severe spinal cord injury (SCI). Although bowel management program including a high fibre diet is an integral part of rehabilitation, the effect of a high fibre diet on large bowel function in SCI has not been examined. The aims of this study were to assess the nutrient intake of SCI patients, to determine baseline transit time, stool weight and evacuation time and to assess the effect of addition of bran on large bowel function. Eleven subjects, aged 32+/-10.5 years participated in the study. The level of injury ranged from C-4 to T-12; only one patient had an incomplete injury. Baseline mean energy intake was 7823+/-1443 kJ/d, protein intake 93+/-21g/d, carbohydrate intake 209+/-39 g/d and mean dietary fibre intake 25+/-8 g/d. Mean baseline stool. weight was 128+/-55 g/d and bowel evacuation time was 13+/-7.4 min/d. Three subjects who consumed <18 g dietary fibre/d had low stool weights of 60-70 g/d and two had very delayed transit times that were too slow to enable quantitation. Mean mouth to anus transit time was 51.3+/-31.2 h, mean colonic transit time 28.2+/-3.5 h, right colonic transit time 5.9+/-4.5 h, left colonic transit time 14.5+/-5.2 h and rectosigmoid colonic transit time 7.9+/-5.6 h. Following the addition of bran, dietary fibre intake significantly increased from 25 g/d to 31 g/d (P<0.001). However, the mean colonic transit time increased from 28.2 h to 42.2 h (P<0.05) and rectosigmoid colon transit time increased from 7.9 to 23.3 h (P<0.02). Stool weight, mouth to anus, left and right colon transit time and evacuation time did not change significantly. Results of this study suggest that increasing dietary fibre in SCI patients does not have the same effect on bowel function as has been previously demonstrated in individuals with 'normally functioning' bowels. Indeed the effect may be the opposite to that desired. This preliminary study highlights the need for further research to examine the optimal level of dietary fibre intake in SCI patients.",,,"Cameron, KJ (corresponding author), AUSTIN HOSP,SPINAL INJURIES UNIT,HEIDELBERG,VIC 3084,AUSTRALIA.",,"Desneves, Kate/IXD-7054-2023","Desneves, Kate/0000-0001-9224-3728",,,,,23,56,62,0,2,STOCKTON PRESS,BASINGSTOKE,"HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS",1362-4393,,,SPINAL CORD,Spinal Cord,MAY,1996,34,5,,,,,277,283,,10.1038/sc.1996.50,http://dx.doi.org/10.1038/sc.1996.50,,,7,Clinical Neurology; Rehabilitation,Science Citation Index Expanded (SCI-EXPANDED),Neurosciences & Neurology; Rehabilitation,UR612,8963975,Bronze,,,2024-06-04,WOS:A1996UR61200006,View Full Record in Web of Science
J,"Krogh, K; Chiarioni, G; Whitehead, W",,,,"Krogh, K.; Chiarioni, G.; Whitehead, W.",,,Management of chronic constipation in adults,UNITED EUROPEAN GASTROENTEROLOGY JOURNAL,,,English,Review,,,,,,Chronic constipation; laxatives; biofeedback; transanal irrigation; surgery,PELVIC FLOOR DYSSYNERGIA; CHRONIC IDIOPATHIC CONSTIPATION; OPIOID-INDUCED CONSTIPATION; CHLORIDE CHANNEL ACTIVATOR; SLOW TRANSIT CONSTIPATION; PLACEBO-CONTROLLED TRIAL; LONG-TERM EFFICACY; DOUBLE-BLIND; SPINAL-CORD; PARKINSONS-DISEASE,"Chronic constipation (CC) is an extremely common condition with an estimated prevalence of up to 24%. Most patients with CC should be treated in primary care. Changes in lifestyle, including increased intake of dietary fibre, fluid, and exercise, should be attempted in most patients. Osmotic or stimulant laxatives are indicated if there are insufficient effects of lifestyle changes. Prokinetics and secretagogues should be restricted to those not responding to basic treatment. Anorectal physiology tests and assessment of colorectal transit time are indicated if medical treatment fails or if symptoms indicate severely obstructed defecation. If symptoms indicate an underlying structural disorder, barium or magnetic resonance evacuation proctography is indicated. Biofeedback therapy is effective in patients with dyssynergic defecation. In patients with other evacuation disorders, rectally administered laxatives or transanal irrigation should be attempted. Surgery is restricted to the minority of CC patients with very severe symptoms not responding to conservative treatment.","[Krogh, K.] Aarhus Univ Hosp, Dept Hepatol & Gastroenterol, DK-8000 Aarhus C, Denmark; [Chiarioni, G.] Univ Verona, Gastroenterol Div, Verona, Italy; [Whitehead, W.] Univ N Carolina, Div Gastroenterol & Hepatol, Chapel Hill, NC USA; [Whitehead, W.] Univ N Carolina, Ctr Funct Gastrointestinal & Motil Disorders, Chapel Hill, NC USA",Aarhus University; University of Verona; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill,"Krogh, K (corresponding author), Aarhus Univ Hosp, Dept Hepatol & Gastroenterol, DK-8000 Aarhus C, Denmark.",klaukrog@rm.dk,"Chiarioni, Giuseppe/C-1876-2016","Chiarioni, Giuseppe/0000-0002-9183-4750; Krogh, Klaus/0000-0001-9168-2403",,,,,60,44,54,2,14,SAGE PUBLICATIONS INC,THOUSAND OAKS,"2455 TELLER RD, THOUSAND OAKS, CA 91320 USA",2050-6406,2050-6414,,UNITED EUR GASTROENT,United European Gastroenterol. J.,JUN,2017,5,4,,,,,465,472,,10.1177/2050640616663439,http://dx.doi.org/10.1177/2050640616663439,,,8,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,EV7ZU,28588875,"Green Submitted, Green Published, Bronze",,,2024-06-04,WOS:000402000900001,View Full Record in Web of Science
J,"Hongisto, SM; Paajanen, L; Saxelin, M; Korpela, R",,,,"Hongisto, SM; Paajanen, L; Saxelin, M; Korpela, R",,,A combination of fibre-rich rye bread and yoghurt containing Lactobacillus GG improves bowel function in women with self-reported constipation,EUROPEAN JOURNAL OF CLINICAL NUTRITION,,,English,Article,,,,,,rye bread; Lactobacillus GG; constipation; bowel function,LACTIC-ACID BACTERIA; POPULATION; PREVALENCE; SYMPTOMS,"Objective: The aim of the study was to investigate the effects of fibre-rich rye bread and yoghurt containing Lactobacillus GG (LGG) on intestinal transit time and bowel function, and to test whether they have an interaction in cases of self-reported constipation. Design: The study was carried out as a two-by-two factorial design. Setting: Free-living subjects. Subjects: A total of 59 healthy women with self-reported constipation, recruited by advertisement. Interventions: After a baseline period, the subjects were randomized into four diet groups: ( 1) rye bread+LGG yoghurt, ( 2) rye bread, ( 3) LGG yoghurt, and ( 4) control. The 3-week dietary intervention was followed by a 3-week follow-up period. During each period, total intestinal transit time was measured and the subjects recorded faecal frequency and consistency, difficulty in defecation and gastrointestinal symptoms. Results: The rye bread shortened total intestinal transit time ( mean difference, - 0.7; CI(95), - 1.1 to - 0.2; P = 0.007), increased faecal frequency (0.3; CI(95), 0.1 to 0.5; P = 0.001), softened faeces ( - 0.3; CI(95), - 0.4 to - 0.2; P<0.001) and made defecation easier ( - 0.4; CI(95), - 0.5 to - 0.2; P<0.001), but also increased gastrointestinal symptoms (1.6; CI(95), 0.7 to 2.4; P<0.001) compared to the low-fibre toast consumed in the LGG and control groups. There were fewer symptoms in the rye bread+LGG group compared to the rye bread group ( - 1.3; CI(95), - 2.4 to - 0.2; P = 0.027). Conclusions: Fibre-rich rye bread can be recommended in the treatment of constipation, and the simultaneous consumption of LGG yoghurt relieves the adverse gastrointestinal effects associated with increased intake of fibre.","Fdn Nutr Res, FIN-00039 Helsinki, Finland; Valio Ltd, Res & Dev, Helsinki, Finland; Univ Helsinki, Cent Hosp, Dept Allergy, Helsinki, Finland; Univ Helsinki, Inst Biomed, Dept Pharmacol, Helsinki, Finland",Valio; University of Helsinki; Helsinki University Central Hospital; University of Helsinki,"Korpela, R (corresponding author), Fdn Nutr Res, POB 30, FIN-00039 Helsinki, Finland.",Riitta.Korpela@Valio.fi,,"Korpela, Riitta/0000-0003-0337-9186",,,,,26,51,56,1,20,NATURE PUBLISHING GROUP,LONDON,"MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND",0954-3007,,,EUR J CLIN NUTR,Eur. J. Clin. Nutr.,MAR,2006,60,3,,,,,319,324,,10.1038/sj.ejcn.1602317,http://dx.doi.org/10.1038/sj.ejcn.1602317,,,6,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,017BI,16251881,,,,2024-06-04,WOS:000235668700004,View Full Record in Web of Science
J,"Gwee, KA; Ghoshal, UC; Gonlachanvit, S; Chua, ASB; Myung, SJ; Rajindrajith, S; Patcharatrakul, T; Choi, MG; Wu, JCY; Chen, MH; Gong, XR; Lu, CL; Chen, CL; Pratap, N; Abraham, P; Hou, XH; Ke, M; Ricaforte-Campos, JD; Syam, AF; Abdullah, M",,,,"Gwee, Kok-Ann; Ghoshal, Uday C.; Gonlachanvit, Sutep; Chua, Andrew Seng Boon; Myung, Seung-Jae; Rajindrajith, Shaman; Patcharatrakul, Tanisa; Choi, Myung-Gyu; Wu, Justin C. Y.; Chen, Min-Hu; Gong, Xiao-Rong; Lu, Ching-Liang; Chen, Chien-Lin; Pratap, Nitesh; Abraham, Philip; Hou, Xiao-Hua; Ke, Meiyun; Ricaforte-Campos, Jane D.; Syam, Ari Fahrial; Abdullah, Murdani",,,Primary Care Management of Chronic Constipation in Asia: The ANMA Chronic Constipation Tool,JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY,,,English,Article,,,,,,"Asia; Constipation; Management; Physicians, primary care",SLOW-TRANSIT CONSTIPATION; IRRITABLE-BOWEL-SYNDROME; PLACEBO-CONTROLLED TRIAL; QUALITY-OF-LIFE; FUNCTIONAL GASTROINTESTINAL DISORDERS; GLYCOL PLUS ELECTROLYTES; DOUBLE-BLIND; DIETARY FIBER; CHILDHOOD CONSTIPATION; COLORECTAL-CANCER,"Chronic constipation (CC) may impact on quality of life. There is substantial patient dissatisfaction; possible reasons are failure to recognize underlying constipation, inappropriate dietary advice and inadequate treatment. The aim of these practical guidelines intended for primary care physicians, and which are based on Asian perspectives, is to provide an approach to CC that is relevant to the existing health-care infrastructure. Physicians should not rely on infrequent bowel movements to diagnose CC as many patients have one or more bowel movement a day. More commonly, patients present with hard stool, straining, incomplete feeling, bloating and other dyspeptic symptoms. Physicians should consider CC in these situations and when patients are found to use laxative containing supplements. In the absence of alarm features physicians may start with a 2-4 week therapeutic trial of available pharmacological agents including osmotic, stimulant and enterokinetic agents. Where safe to do so, physicians should consider regular (as opposed to on demand dosing), combination treatment and continuous treatment for at least 4 weeks. If patients do not achieve satisfactory response, they should be referred to tertiary centers for physiological evaluation of colonic transit and pelvic floor function. Surgical referral is a last resort, which should be considered only after a thorough physiological and psychological evaluation.","[Gwee, Kok-Ann; Gong, Xiao-Rong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117548, Singapore; [Ghoshal, Uday C.] Sanjay Gandhi Postgrad Inst Med Sci, Dept Gastroenterol, Lucknow, Uttar Pradesh, India; [Gonlachanvit, Sutep; Patcharatrakul, Tanisa] Chulalongkorn Univ, Fac Med, Dept Med, GI Motil Res Unit,Div Gastroenterol, Bangkok 10330, Thailand; [Chua, Andrew Seng Boon] Gastro Ctr Ipoh, Dept Primary Care & Gastroenterol, Ipoh, Perak, Malaysia; [Myung, Seung-Jae] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol, Seoul, South Korea; [Rajindrajith, Shaman] Univ Kelaniya, Fac Med, Ragama, Sri Lanka; [Choi, Myung-Gyu] Catholic Univ Korea, Seoul St Marys Hosp, Dept Internal Med, Div Gastroenterol, Seoul, South Korea; [Wu, Justin C. Y.] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Chen, Min-Hu; Gong, Xiao-Rong] Sun Yat Sen Univ, Dept Gastroenterol & Hepatol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Lu, Ching-Liang] Natl Yang Ming Univ Taipei, Taipei Vet Gen Hosp, Div Gastroenterol, Taipei, Taiwan; [Lu, Ching-Liang] Natl Yang Ming Univ Taipei, Inst Brain Sci, Taipei, Taiwan; [Chen, Chien-Lin] Buddhist Tzu Chi Gen Hosp, Dept Med, Hualien, Taiwan; [Chen, Chien-Lin] Tzu Chi Univ, Hualien, Taiwan; [Pratap, Nitesh] Asian Inst Gastroenterol, Hyderabad, Andhra Pradesh, India; [Abraham, Philip] PD Hinduja Natl Hosp, Bombay, Maharashtra, India; [Abraham, Philip] MRC, Bombay, Maharashtra, India; [Hou, Xiao-Hua] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gastroenterol & Hepatol, Wuhan 430074, Hubei, Peoples R China; [Ke, Meiyun] Chinese Acad Med Sci, Peking Union Med Coll, Dept Gastroenterol, Beijing 100730, Peoples R China; [Ricaforte-Campos, Jane D.] Med Ctr Manila, Dept Internal Med, Gastroenterol Sect, Manila, Philippines; [Syam, Ari Fahrial; Abdullah, Murdani] Univ Indonesia, Fac Med, Cipto Mangunkusumo Gen Hosp, Div Gastroenterol,Dept Internal Med, Jakarta, Indonesia",National University of Singapore; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Chulalongkorn University; University of Ulsan; Asan Medical Center; University Kelaniya; Seoul St. Mary's Hospital; Catholic University of Korea; Chinese University of Hong Kong; Sun Yat Sen University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Huazhong University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Indonesia,"Gwee, KA (corresponding author), Gleneagles Hosp, Stomach Liver & Bowel Ctr, Annexe Block 05-37,6A Napier Rd, Singapore 258500, Singapore.",slbclinic@gmail.com,"Rajindrajith, Shaman/AAN-8675-2020; Myung, Sun-Jung/J-5464-2012; Syam, Ari Fahrial/ABI-4994-2020; Hou, Xiaohua/J-3044-2016; Choi, Myung-Gyu/D-6079-2014","Rajindrajith, Shaman/0000-0003-1379-5052; Choi, Myung-Gyu/0000-0003-4083-5187; Myung, Seung-Jae/0000-0003-0585-4016; Syam, Ari Fahrial/0000-0003-0041-3553; Abdullah, Murdani/0000-0002-8801-0283",Janssen Pharmaceuticals; Boehringer Ingelheim,Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Boehringer Ingelheim(Boehringer Ingelheim),An unrestricted educational grant was received from Janssen Pharmaceuticals and Boehringer Ingelheim to support the organization of the meetings.,,124,43,53,1,11,KOREAN SOC NEUROGASTROENTEROLOGY & MOTILITY,GANGNAM-GU,"RM 305, LOTTE GOLD ROSE VILL II, 31 SEOLLEUNG-RO 86-GIL, GANGNAM-GU, SEOUL 135-839, SOUTH KOREA",2093-0879,2093-0887,,J NEUROGASTROENTEROL,J. Neurogastroenterol. Motil.,APR,2013,19,2,,,,,149,160,,10.5056/jnm.2013.19.2.149,http://dx.doi.org/10.5056/jnm.2013.19.2.149,,,12,Gastroenterology & Hepatology; Clinical Neurology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Neurosciences & Neurology,225ZV,23667746,"Green Published, hybrid, Green Submitted",,,2024-06-04,WOS:000325004700005,View Full Record in Web of Science
J,"Baig, MK; Boyer, ML; Marquez, H; Wexner, SD",,,,"Baig, MK; Boyer, ML; Marquez, H; Wexner, SD",,,"Alleviating debilitating, chronic constipation with colostomy after appendicostomy: A case study",OSTOMY WOUND MANAGEMENT,,,English,Article,,,,,,constipation; sigmoidocele; appendicostomy; colostomy,ANTEGRADE CONTINENCE ENEMA; FECAL INCONTINENCE; IRRIGATION; CECOSTOMY,"Severe chronic constipation is a debilitating condition. Patients not only experience infrequent bowel movements, but also are often frustrated by the sensation of incomplete evacuation; pain; straining; daily use of enemas; and continual concerns regarding diet, fluids, and medications. Diagnostic tests are performed to rule out organic causes of the condition. Common treatment options consist of dietary fiber supplementation, dietary instruction, adequate fluid intake, enemas, and laxatives; additional noninvasive management includes biofeedback training and botulinum toxin type A injections. Surgery is rarely recommended, although a select group of patients may benefit from antegrade continence enema procedure. A female patient presented with a history of long-standing constipation. When antegrade continence enema offered no improvement and other treatment measures failed, she underwent successful laparoscopic-assisted sigmoid resection and end colostomy. This approach may provide options for patients in similar circumstances.","Cleveland Clin Florida, Dept Colorectal Surg, Weston, FL 33331 USA",Cleveland Clinic Foundation,"Cleveland Clin Florida, Dept Colorectal Surg, 2950 Cleveland Clin Blvd, Weston, FL 33331 USA.",mcderme@ccf.org,,,,,,,13,1,1,0,2,H M P COMMUNICATIONS,MALVERN,"83 GENERAL WARREN BLVD, STE 100, MALVERN, PA 19355 USA",0889-5899,1943-2720,,OSTOMY WOUND MANAG,Ostomy Wound Manag.,DEC,2005,51,12,,,,,60,63,,,,,,4,Surgery,Science Citation Index Expanded (SCI-EXPANDED),Surgery,025DV,16439812,,,,2024-06-04,WOS:000236246400012,View Full Record in Web of Science
J,"Axelrod, CH; Saps, M",,,,"Axelrod, Cara Hannah; Saps, Miguel",,,The Role of Fiber in the Treatment of Functional Gastrointestinal Disorders in Children,NUTRIENTS,,,English,Review,,,,,,functional constipation; irritable bowel syndrome; abdominal pain; fiber; children,IRRITABLE-BOWEL-SYNDROME; HYDROLYZED GUAR GUM; DIETARY FIBER; DOUBLE-BLIND; CHILDHOOD CONSTIPATION; PEDIATRIC-PATIENTS; COLONIC TRANSIT; ABDOMINAL-PAIN; PSYLLIUM FIBER; CORN FIBER,"We reviewed the available evidence on the role of fiber in the treatment of Functional Constipation (FC) and Irritable Bowel Syndrome (IBS) in children. The vast majority of toddlers and preschoolers do not consume enough fiber. Two of the most common reasons for consultation to a pediatric gastroenterology practice include FC and IBS. The North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society of Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) guidelines state that the evidence does not support the use of fiber supplements in the treatment of FC in children, and the Rome IV criteria do not recommend an increase in fiber consumption, in children with IBS. Despite this, in general practice, it is commonly recommended that children who experience constipation and IBS to increase their fiber intake. We conducted a systematic review of the available evidence on the role of fiber in the treatment of FC and IBS in children. Thirteen full-text articles with a total of seven hundred and twenty-three pediatric participants were included in this review. Three clinical trials found positive effects of dietary fiber for the management of IBS. Nine out of ten trials found fiber to be either more effective than placebo, or just as effective as laxative treatment. Most studies on the use of fiber for the treatment of FC and IBS have shown its benefit. However, due to the heterogeneity in study design, length of treatment, outcome measures, and amount and type of fiber, we were unable to make a definitive recommendation supporting the use of fiber for the treatment of FC and IBS in children.","[Axelrod, Cara Hannah; Saps, Miguel] Univ Miami, Miller Sch Med, Div Pediat Gastroenterol Hepatol & Nutr, Miami, FL 33136 USA",University of Miami,"Axelrod, CH (corresponding author), Univ Miami, Miller Sch Med, Div Pediat Gastroenterol Hepatol & Nutr, Miami, FL 33136 USA.",cxa630@med.miami.edu; msaps@med.miami.edu,,"axelrod, cara/0000-0002-0812-1355",,,,,57,29,30,0,19,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,NOV,2018,10,11,,,,,,,1650,10.3390/nu10111650,http://dx.doi.org/10.3390/nu10111650,,,16,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,HC1GH,30400292,"gold, Green Published, Green Submitted",,,2024-06-04,WOS:000451547700088,View Full Record in Web of Science
J,"McGrath, ML; Mellon, MW; Murphy, L",,,,"McGrath, ML; Mellon, MW; Murphy, L",,,Empirically supported treatments in pediatric psychology: Constipation and encopresis,JOURNAL OF PEDIATRIC PSYCHOLOGY,,,English,Article,,,,,,constipation; encopresis; fecal incontinence; intervention; biofeedback; efficacy,ABNORMAL DEFECATION DYNAMICS; BIOFEEDBACK TREATMENT; CHILDHOOD CONSTIPATION; RETENTIVE ENCOPRESIS; ANORECTAL MANOMETRY; FECAL INCONTINENCE; RANDOMIZED TRIAL; CHILDREN; MANAGEMENT; THERAPY,"Objective: To review the empirical research examining behavioral and medical treatments for constipation and fecal incontinence. Method: Sixty-five articles investigating intervention efficacy were identified and reviewed. Twenty-three of the studies were excluded because they were case studies or were less well-controlled single-case designs. The intervention protocol for each study was identified and coded, with studies employing the same interventions matched and evaluated according to the Chambless criteria. Results: From the literature base to date, no well-established interventions have emerged. However, four probably efficacious treatments and three promising interventions were identified. Two different medical interventions plus positive reinforcement fit the criteria for the probably efficacious category (one with fiber recommendation and one without). Three biofeedback plus medical interventions fit efficacy category criteria: one probably efficacious for constipation with abnormal defecation dynamics (full medical intervention plus biofeedback for paradoxical contraction), and two fit the promising intervention criteria for constipation and abnormal defecation dynamics (full medical intervention plus biofeedback for EAS strengthening, correction of paradoxical contraction and home practice; and biofeedback focused on correction of paradoxical contraction, medical intervention without fiber recommendation, and positive reinforcement). Two extensive behavioral interventions plus medical intervention also met efficacy criteria for constipation plus incontinence (medical intervention without laxative maintenance plus positive reinforcement, dietary education, goal setting, and skills building presented in a small-group format fits criteria for a promising intervention; and positive reinforcement and skills building focused on relaxation of the EAS during defecation, but without biofeedback, plus medical intervention meets the probably efficacious criteria). Conclusions: A discussion of the current weaknesses in this research area follows. Specific recommendations for future research are made including greater clarity in treatment protocol and sample descriptions, reporting cure rates rather than success rates, utilization of adherence checks, and investigation of potential differential outcomes for subgroups of children with constipation and incontinence.","Tulane Univ, New Orleans, LA 70118 USA; Mayo Clin, Rochester, MN 55905 USA",Tulane University; Mayo Clinic,"Tulane Univ, New Orleans, LA 70118 USA.",,,,,,,,73,55,57,0,6,OXFORD UNIV PRESS INC,CARY,"JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA",0146-8693,1465-735X,,J PEDIATR PSYCHOL,J. Pediatr. Psychol.,JUN,2000,25,4,,,,,225,254,,10.1093/jpepsy/25.4.225,http://dx.doi.org/10.1093/jpepsy/25.4.225,,,30,"Psychology, Developmental",Social Science Citation Index (SSCI),Psychology,318YG,10814690,Bronze,,,2024-06-04,WOS:000087311800004,View Full Record in Web of Science
J,"Zhuang, M; Shang, WT; Ma, QC; Strappe, P; Zhou, ZK",,,,"Zhuang, Min; Shang, Wenting; Ma, Qiuchen; Strappe, Padraig; Zhou, Zhongkai",,,Abundance of Probiotics and Butyrate-Production Microbiome Manages Constipation via Short-Chain Fatty Acids Production and Hormones Secretion,MOLECULAR NUTRITION & FOOD RESEARCH,,,English,Article,,,,,,butyrate; constipation; diversity; gut microbiota; metabolites,GUT MICROBIOTA; DIETARY FIBER; INTESTINAL MICROBIOTA; TRANSIT; METABOLITES; PATTERNS; MOTILITY; BARRIER; PYY,"ScopeThe characteristics of gut microbiota and host metabolism are hypothesized to be associated with constipation status, but the regulation mechanism is not fully understood. Thus, the current study investigates the effect of constipation symptoms on gut functionality following the modulation of gut microbiota and metabolites via dietary fiber intervention. Methods and resultsConstipation causes a significantly reduced short-chain fatty acids (SCFAs) production and a higher level of iso-butyrate. The feces of constipated people are characterized with inhibited Faecalibacterium, Ruminococcaceae and Roseburia abundance. Desulfovibrionaceae is identified to be an important endotoxin producer in constipated patients, and a butyrate-enriched SCFAs profile achieved by dietary fiber supplement accelerates gastrointestinal transit and increases the thickness of the mucosal layer, possibly through triggering the secretion of colonic hormones and enhancing the expression of tight junction proteins for maintaining intestinal barrier integrity. More importantly, an interacting regulatory mechanism among SCFAs, in particular butyrate and propionate, may be involved in signaling between the microbiome and host cells in the colon. ConclusionGut microbiota, characterized with enriched butyrate-producing and depressed Desulfovibrionaceae bacteria, attenuates constipation symptoms through promoting intestinal hormones secretion and maintaining gut barrier integrity.","[Zhuang, Min; Shang, Wenting; Ma, Qiuchen; Zhou, Zhongkai] Tianjin Univ Sci & Technol, Key Lab Food Nutr & Safety, Minist Educ, Tianjin 300457, Peoples R China; [Strappe, Padraig] Cent Queensland Univ, Sch Med & Appl Sci, Rockhampton, Qld 4700, Australia; [Zhou, Zhongkai] Charles Sturt Univ, ARC Ind Transformat Training Ctr Funct Grains, Wagga Wagga, NSW 2678, Australia",Tianjin University Science & Technology; Central Queensland University; Charles Sturt University,"Zhou, ZK (corresponding author), Tianjin Univ Sci & Technol, Key Lab Food Nutr & Safety, Minist Educ, Tianjin 300457, Peoples R China.;Zhou, ZK (corresponding author), Charles Sturt Univ, ARC Ind Transformat Training Ctr Funct Grains, Wagga Wagga, NSW 2678, Australia.",zzhou@csu.edu.au,"Zhou, Zhongkai/AAC-1412-2019; Shang, Wenting/E-8475-2018; Strappe, Padraig/AAH-5008-2019","Zhou, Zhongkai/0000-0003-1918-413X","National Nature Science Foundation of China [U1501214]; Tianjin One Belt and One Road Technological Innovation Project [18PTZWHZ00080]; National Key Research and Development Program [2016YFD0400401-2, 2016YFD0400104-4]; Australian Research Council Industrial Transformation Training Centre for Functional Grains, Charles Sturt University, Australia","National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin One Belt and One Road Technological Innovation Project; National Key Research and Development Program; Australian Research Council Industrial Transformation Training Centre for Functional Grains, Charles Sturt University, Australia(Australian Research Council)","M.Z., Z.Z., W.S., and Q.M. performed the experiments and analyzed the data. Z.Z., M.Z., and P.S. wrote the paper. Z.Z. supervised the project. This work was financially supported by National Nature Science Foundation of China (no. U1501214), Tianjin One Belt and One Road Technological Innovation Project (18PTZWHZ00080), the National Key Research and Development Program (2016YFD0400401-2, 2016YFD0400104-4), and Australian Research Council Industrial Transformation Training Centre for Functional Grains, Charles Sturt University, Australia.",,37,78,88,11,124,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1613-4125,1613-4133,,MOL NUTR FOOD RES,Mol. Nutr. Food Res.,DEC,2019,63,23,,,,,,,1801187,10.1002/mnfr.201801187,http://dx.doi.org/10.1002/mnfr.201801187,,OCT 2019,13,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,JT8JB,31556210,,,,2024-06-04,WOS:000494116500001,View Full Record in Web of Science
J,"Kapoor, MP; Sugita, M; Fukuzawa, Y; Okubo, T",,,,"Kapoor, Mahendra P.; Sugita, Masaaki; Fukuzawa, Yoshitaka; Okubo, Tsutomu",,,Impact of partially hydrolyzed guar gum (PHGG) on constipation prevention: A systematic review and meta-analysis,JOURNAL OF FUNCTIONAL FOODS,,,English,Review,,,,,,Partially hydrolyzed guar gum; Dietary fiber; Constipation; Meta-analysis; Random and fixed effect models,FUNCTIONAL GASTROINTESTINAL DISORDERS; QUALITY-OF-LIFE; CLINICAL-TRIALS; ELDERLY-PATIENTS; UNITED-STATES; PREVALENCE; LACTULOSE; POPULATION; ADULTS; SENNA,"Dietary fiber is part of the diet of many people worldwide and is commonly recognized as a health food. The aim of this study was to quantitatively evaluate the impact of partially hydrolyzed guar gum (PHGG) supplementation on constipation prevention related outcomes in apparently healthy individuals. An extensive electronic and manual bibliographic search of controlled trials was undertaken in PubMed, Embase, the Cochrane Library, and JST database as part of a wider scoping review from inception to September 2016, and a systematic review and meta-analysis was performed. The pooled effect of PHGG supplementation on constipation was assessed using fixed-effects or random-effects model. The outcomes of interest were fecal defecation frequency (FDF), fecal weight (FW), fecal moisture (FM), fecal volume (FV) and fecal excretory feeling (FEF). Fifteen trials of seven enrolled studies (4 RCTs & 3 non-RCTs) administrated PHGG involving only healthy volunteers comprising a total of 325 participants, indicated that PHGG has a favorable efficacy success rate of constipation reduction, while no adverse events were observed in context of the studies included. Trials revealed a highly significant statistically pooling difference (P < 0.00001) in pre- and post-intervention changes in FDF (SMD: 0.58 times/day; 95%CI, 0.43-0.74; I-2 = 0, p = 0.54) in the fixed-effects model. A dose-response curve revealed a tendency toward a significant relationship (p = 0.011) between FDF and dosage of PHGG, wherein the coefficient of relation (r) was 0.31. The finding revealed that daily dosage of 5-7 g PHGG is sufficient to ameliorate the FDF among the healthy participants with constipation conditions. Five studies involved in elderly and children were also evaluated separately for the reference. Results suggested that PHGG consumption led to a favorable impact on constipation prevention of the similar magnitude that was achieved with laxatives. (C) 2017 Elsevier Ltd. All rights reserved.","[Kapoor, Mahendra P.; Okubo, Tsutomu] Taiyo Kagaku Co Ltd, Nutr Div, Res & Dev, 1-3 Takaramachi, Yokaichi, Mie 5100844, Japan; [Sugita, Masaaki] Univ Mie, Fac Educ, 1577 Kurimamachiya Cho, Tsu, Mie 5148507, Japan; [Fukuzawa, Yoshitaka] Aichi Med Univ, Dept Internal Med, 21 Karimata,Nagakute Cho, Yakazo, Aichi 4801195, Japan","TAIYO KAGAKU CO., LTD.; Mie University; Aichi Medical University","Kapoor, MP (corresponding author), Taiyo Kagaku Co Ltd, Nutr Div, Res & Dev, 1-3 Takaramachi, Yokaichi, Mie 5100844, Japan.",mkapoor@taiyokagaku.co.jp,"SUGITA, Masaaki/AAO-4322-2020","SUGITA, Masaaki/0009-0009-5332-0378",,,,,59,20,21,0,40,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",1756-4646,2214-9414,,J FUNCT FOODS,J. Funct. Food.,JUN,2017,33,,,,,,52,66,,10.1016/j.jff.2017.03.028,http://dx.doi.org/10.1016/j.jff.2017.03.028,,,15,Food Science & Technology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Nutrition & Dietetics,EV6LT,,,,,2024-06-04,WOS:000401881600006,View Full Record in Web of Science
B,"Bortolotti, M; Lugli, A",,"Klein, F; Moller, G",,"Bortolotti, Mauro; Lugli, Andrea",,,DIETARY FIBERS AND GUT MOTILITY,"DIETARY FIBER, FRUIT AND VEGETABLE CONSUMPTION AND HEALTH",Nutrition and Diet Research Progress,,English,Article; Book Chapter,,,,,,,SMALL-BOWEL TRANSIT; INTESTINAL TRANSIT; WHEAT BRAN; GUAR GUM; GLUCOSE-TOLERANCE; COLONIC FUNCTION; PROPAGATED CONTRACTIONS; GASTROINTESTINAL-TRACT; RESISTANT STARCH; SOLUBLE FIBER,"The relationship between dietary fibers and motility of the digestive tract is essential for the accomplishment of their functions, but is somewhat complex, as there may be reciprocal influences. In fact, it is well known that fibers can modify gastrointestinal motility, but it is not as much known that gastrointestinal motility may modify the functions of fibers and reverse their beneficial effects. The effects of motility on fiber functions obviously is not irrelevant with respect to the fiber characteristics (e.g. viscosity, water holding capacity, fermentability etc.) and vice-versa. Consequently the kind of fibers and the kind of gut motility should be taken into account when considering their functional interactions. Fibers may influence both the motor activity of the stomach, by delaying in most cases gastric emptying, and that of the small intestine, where the most frequent fiber effect is an acceleration of transit, whereas in the colon the transit may be variously modified. However, when the motor activity is impaired, the presence of fibers in the gut lumen may became deleterious. In fact, if there is an inefficient gastric motility with gastric stasis, the accumulation of fibers in the gastric cavity induces a further worsening of gastric motility and in some cases may lead to an abnormal fermentation of fibers and formation of bezoars. A delayed intestinal transit may favour the small intestinal bacterial overgrowth, which is responsible of an out of place fiber fermentation in the small intestine with many patho-physiological problems, and, in addition, if there is a chronic pseudo-obstruction, may provoke an episode of functional obstruction. The altered transit in the colon due to constipation or diarrhoea may produce differences in fiber fermentation, that in its turn may modify the colonic transit with an abnormal production of gases. In addition, when there is a condition of severely altered colonic transit the addition of a large quantity of fibers to diet May further worsen the motor activity leading to an impaction. For these reasons the addition of fibers to a diet, that usually is beneficial for the gut transit, should be done with caution in patients with the above mentioned alterations of gut motility.","[Bortolotti, Mauro] Univ Bologna, Dept Internal Med & Gastroenterol, I-40126 Bologna, Italy",University of Bologna,"Bortolotti, M (corresponding author), Via Massarenti 48, I-40138 Bologna, Italy.",bormau@tin.it,,,,,,,113,0,0,0,2,"NOVA SCIENCE PUBLISHERS, INC",HAUPPAUGE,"400 OSER AVE, STE 1600, HAUPPAUGE, NY 11788-3635 USA",,,978-1-60876-025-1,NUTR DIET RES PROG,,,2010,,,,,,,51,81,,,,,,31,Nutrition & Dietetics,Book Citation Index – Science (BKCI-S),Nutrition & Dietetics,BPY51,,,,,2024-06-04,WOS:000280356400002,View Full Record in Web of Science
J,"Schäfer, R",,,,"Schäfer, R",,,Dietary fiber in constipation treatment,ZEITSCHRIFT FUR GASTROENTEROLOGIE,,,German,Article,,,,,,,IRRITABLE-BOWEL-SYNDROME; WHEAT BRAN; GASTROINTESTINAL TRANSIT; STOOL; TIME; WEIGHT; TRIAL; ACIDS; BILE,,"Krankenhaus Florence Nightingale, Innere Med & Gastroenterol Klin, D-40489 Dusseldorf, Germany",,"Schäfer, R (corresponding author), Krankenhaus Florence Nightingale, Innere Med & Gastroenterol Klin, Kreuzbergstr, D-40489 Dusseldorf, Germany.",,,,,,,,24,2,2,0,0,DEMETER VERLAG GEORG THIEME VERLAG,STUTTGART,"PETRA SCHLAGENHAUF, RUDIGERSTR 14, D-70469 STUTTGART, GERMANY",0044-2771,,,Z GASTROENTEROL,Z. Gastroent.,JUN,2000,,,,1,,,28,32,,,,,,5,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,345FD,,,,,2024-06-04,WOS:000088804000008,View Full Record in Web of Science
J,"MESHKINPOUR, H",,,,"MESHKINPOUR, H",,,CHRONIC CONSTIPATION AND DIETARY FIBER,JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,,,English,Letter,,,,,,,,,,,"UNIV CALIF IRVINE, SCH MED, IRVINE, CA 92717 USA.",,,,,,,,7,0,0,0,1,AMER MEDICAL ASSOC,CHICAGO,"330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA",0098-7484,1538-3598,,JAMA-J AM MED ASSOC,JAMA-J. Am. Med. Assoc.,,1983,250,23,,,,,3227,3228,,,,,,2,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,RT976,,,,,2024-06-04,WOS:A1983RT97600033,View Full Record in Web of Science
J,"Xu, J; Zhou, XQ; Chen, C; Deng, QC; Huang, QD; Yang, JE; Yang, NH; Huang, FH",,,,"Xu, Jiqu; Zhou, Xiaoqi; Chen, Chang; Deng, Qianchun; Huang, Qingde; Yang, Jin'e; Yang, Nianhong; Huang, Fenghong",,,Laxative effects of partially defatted flaxseed meal on normal and experimental constipated mice,BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE,,,English,Article,,,,,,Flaxseed; Constipation; Diphenoxylate; Dietary fibers; Laxative,CHAIN FATTY-ACIDS; DIETARY FIBER; HEALTH; FERMENTATION; LOPERAMIDE; BENEFITS; RELEASE; TRANSIT; ROLES; 5-HT,"Background: Constipation is a very common health problem in the world. Intake of sufficient amount of dietary fibers is a cornerstone in the prevention and treatment of constipation. As a traditional medicine, flaxseed has been used to treat constipation for centuries, but the controlled trials are rare. The purpose of the present study was to assess that whether partially defatted flaxseed meal (PDFM) has the potential role to facilitate fecal output in normal and experimental constipated mice. Methods: After supplemented with 2.5%, 5% and 10% (w/w) PDFM (L-, M- and H -PDFM) for 14 days, the constipation models of mice were induced by atropine-diphenoxylate. The small intestinal transit rates, start time of defecation, amount of defecation and wet weight of feces were researched in normal and constipation model mice. Results: M- and H-PDFM significantly increase small intestinal transit rates in constipation model mice. All dose of PDFM markedly shortened the start time of defecation and M- and H-PDFM significantly increase stool frequency and weight in both normal and constipation model mice. Conclusions: PDFM may be a useful laxative to facilitate fecal output in normal and constipation conditions.","[Xu, Jiqu; Deng, Qianchun; Huang, Qingde; Yang, Jin'e; Huang, Fenghong] Chinese Acad Agr Sci, Oil Crops Res Inst, Dept Prod Proc & Nutriol, Wuhan 430062, Peoples R China; [Xu, Jiqu; Deng, Qianchun; Huang, Qingde; Yang, Jin'e; Huang, Fenghong] Chinese Acad Agr Sci, Oil Crops Res Inst, Hubei Key Lab Lipid Chem & Nutr, Wuhan 430062, Peoples R China; [Zhou, Xiaoqi; Yang, Nianhong] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Food Hyg & Nutr, Wuhan 430030, Peoples R China; [Chen, Chang] 1 Hosp Yichang, Dept Gastroenterol, Yichang 443000, Peoples R China",Chinese Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Huazhong University of Science & Technology,"Huang, FH (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Dept Prod Proc & Nutriol, 2 Xudong 2nd Rd, Wuhan 430062, Peoples R China.",fhhuang@foxmail.com,"Yang, Nianhong/IQS-4379-2023",,"National Natural Science Foundation of China [NSFC-31171681]; Modern Agro-industry Technology Research System, china [CARS-17]","National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Modern Agro-industry Technology Research System, china","This work was supported by National Natural Science Foundation of China (NSFC-31171681) and the earmarked fund for Modern Agro-industry Technology Research System (CARS-17), china.",,28,36,41,5,48,BIOMED CENTRAL LTD,LONDON,"236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND",1472-6882,,,BMC COMPLEM ALTERN M,BMC Complement. Altern. Med.,MAR 9,2012,12,,,,,,,,14,10.1186/1472-6882-12-14,http://dx.doi.org/10.1186/1472-6882-12-14,,,5,Integrative & Complementary Medicine,Science Citation Index Expanded (SCI-EXPANDED),Integrative & Complementary Medicine,943TV,22400899,"Green Published, gold",,,2024-06-04,WOS:000304149000001,View Full Record in Web of Science
J,"Bortolotti, M; Levorato, M; Lugli, A; Mazzero, G",,,,"Bortolotti, Mauro; Levorato, Maurizio; Lugli, Andrea; Mazzero, Giosue",,,"Effect of a balanced mixture of dietary fibers on gastric emptying, intestinal transit and body weight",ANNALS OF NUTRITION AND METABOLISM,,,English,Article,,,,,,body weight; dietary fiber; dietary habit; gastric emptying; intestinal transit; overweight; palatability; satiety,SOLID MEAL; GLUCOSE; PECTIN; INSULIN; SATIETY; HUNGER; OLIGOFRUCTOSE; CONSTIPATION; ABSORPTION; RESPONSES,"Background/Aims: Dietary fibers are frequently included in diets to decrease body weight, but their scarce palatability and the occurrence of meteorism prevent a long-term intake. The aim of this study was to test a mixture of dietary fibers expressly chosen to decrease their negative properties and strengthen their positive effects. Methods: In a series of 10 patients with a slight overweight, the effectiveness of a palatable dietary fibers mixture on gastric emptying and intestinal transit was tested with scintigraphic methods. Then, the effects on body weight and digestive sensations and characteristics of defecations, were evaluated for 4 weeks. Results: The intestinal transit was significantly shortened by the fiber intake, while the gastric emptying was delayed, but not significantly. The body mass index significantly and progressively decreased, whereas the sense of satiation significantly increased. No effect on abdominal bloating was referred, whereas a significant increase in number of defecations with stools of normal consistency was observed. The acceptability of the fiber mixture was good. Conclusions: The present research demonstrated that it is possible to prepare a palatable mixture of dietary fibers that maintains the property of decreasing body weight, favors the sense of satiation and accelerates the intestinal transit, with normalization of the stool consistency without the occurrence of meteorism. Copyright (C) 2008 S. Karger AG, Basel.","[Bortolotti, Mauro; Lugli, Andrea; Mazzero, Giosue] Univ Bologna, Dept Internal Med & Gastroenterol, Bologna, Italy; [Levorato, Maurizio] Univ Bologna, Dept Nucl Med, Bologna, Italy",University of Bologna; University of Bologna,"Bortolotti, M (corresponding author), Via Massarenti 48, IT-40138 Bologna, Italy.",bormau@tin.it,,"Lugli, Andrea/0000-0003-4514-8247",,,,,51,13,14,1,13,KARGER,BASEL,"ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND",0250-6807,1421-9697,,ANN NUTR METAB,Ann. Nutr. Metab.,,2008,52,3,,,,,221,226,,10.1159/000138127,http://dx.doi.org/10.1159/000138127,,,6,Endocrinology & Metabolism; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Endocrinology & Metabolism; Nutrition & Dietetics,323VV,18544977,,,,2024-06-04,WOS:000257477400008,View Full Record in Web of Science
J,"Baan-Slootweg, OHV; Liem, O; Bekkali, N; van Aalderen, WMC; Rijcken, THP; Di Lorenzo, C; Benninga, MA",,,,"Baan-Slootweg, Olga H. Vd; Liem, Olivia; Bekkali, Noor; van Aalderen, Wim M. C.; Rijcken, Tammo H. Pels; Di Lorenzo, Carlo; Benninga, Marc A.",,,Constipation and Colonic Transit Times in Children With Morbid Obesity,JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION,,,English,Article,,,,,,child; colonic transit; constipation; fecal incontinence; frequency; obesity,DIETARY FIBER INTAKE; INCREASED PREVALENCE; CHILDHOOD CONSTIPATION; DEFECATION DISORDERS; OVERWEIGHT; RISK; CONSUMPTION; ADOLESCENTS; POPULATION,"Objectives: The aim of the study was to determine the frequency of functional constipation according to the Rome III criteria in children with morbid obesity and to evaluate by measuring colonic transit times (CTTs) whether decreased colonic motility is present in these children. Patients and Methods: Ninety-one children with morbid obesity ages 8 to 18 years, entering a prospective, randomized controlled study evaluating the effect of an outpatient versus inpatient treatment program of obesity, participated. All of the children filled out a standardized questionnaire regarding their bowel habits, and CTTs were measured using radioopaque markers. Food diaries were also recorded to evaluate their diet. Results: A total of 19 children (21%) had functional constipation according to the Rome III criteria, whereas 1 child had functional nonretentive fecal incontinence. Total CTT exceeded 62 hours in only 10.5% of the children with constipation, and among them, 2 had a total CTT of >100 hours. In the nonconstipated group 8.3% had a delayed CTT. Furthermore, no difference was found between the diet of children with or without constipation, specifically not with respect to fiber and fat intake. Conclusions: Our study confirms a high frequency of functional constipation in children with obesity, using the Rome III criteria. However, abnormal colonic motility, as measured by CTT, was delayed in only a minority of patients. No relation was found between constipation in these children and fiber or fat intake.","[Baan-Slootweg, Olga H. Vd; Liem, Olivia; Bekkali, Noor; Benninga, Marc A.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat Gastroenterol & Nutr, NL-1105 AZ Amsterdam, Netherlands; [Rijcken, Tammo H. Pels] Tergooiziekenhuizen, Dept Radiol, Hilversum, Netherlands; [van Aalderen, Wim M. C.] Emmas Childrens Hosp AMC, Dept Pediat Pulmonol, Amsterdam, Netherlands; [Di Lorenzo, Carlo] Nationwide Childrens Hosp, Dept Gastroenterol & Hepatol, Columbus, OH USA",University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital,"Liem, O (corresponding author), Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat Gastroenterol & Nutr, Meibergdreef 9,C2-312, NL-1105 AZ Amsterdam, Netherlands.",o.liem@amc.nl,,,,,,,30,37,42,0,3,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0277-2116,1536-4801,,J PEDIATR GASTR NUTR,J. Pediatr. Gastroenterol. Nutr.,APR,2011,52,4,,,,,442,445,,10.1097/MPG.0b013e3181ef8e3c,http://dx.doi.org/10.1097/MPG.0b013e3181ef8e3c,,,4,Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,737AZ,21240026,Bronze,,,2024-06-04,WOS:000288541100015,View Full Record in Web of Science
J,"Lee, CH; Oh, SH; Yang, EJ; Kim, YS",,,,"Lee, Chang-Hyun; Oh, Sang-Hun; Yang, Eun-Jin; Kim, Young-Soo",,,"Effects of raw, cooked, and germinated small black soybean powders on dietary fiber content and gastrointestinal functions",FOOD SCIENCE AND BIOTECHNOLOGY,,,English,Article,,,,,,small black soybean powder; dietary fiber; gastrointestinal function; loperamide-induced rats,BEANS PHASEOLUS-VULGARIS; ANTINUTRITIONAL FACTORS; CHEMICAL-COMPOSITION; GLYCINE-MAX; LOPERAMIDE; PRODUCTS,"The effects of raw and processed small black soybean powders on dietary fiber content and gastrointestinal function in rats were investigated. The crude oil, protein, and ash contents of raw small black soybean powder were not significantly different from those of processed small black soybean powders. The germination process increased soluble and insoluble dietary fiber contents significantly, as compared to raw small black soybean powder. The germinated small black soybean powder diet led to a significantly different food intake than the basal diet in both normal and loperamide-induced constipated rats. The body weight gains of the experimental groups, however, were not significantly different from that of the basal diet groups for both the normal and loperamide-induced rats. The gastrointestinal transit times and fecal weights for normal and loperamide-induced rats consuming the processed small black soybean powder diet were significantly different from those on a basal diet. These results suggest that the processes of cooking and germinating the small black soybean might contribute to acceleration of fecal excretion in both experimental normal and constipation model rats.","Woosuk Univ, Coll Oriental Med, Dept Anat, Samrye 565701, Jeonbuk, South Korea; Chonbuk Natl Univ, Fac Biotechnol Food Sci & Technol Major, Jeonju 561756, Jeonbuk, South Korea",Woosuk University; Jeonbuk National University,"Kim, YS (corresponding author), Woosuk Univ, Coll Oriental Med, Dept Anat, Samrye 565701, Jeonbuk, South Korea.",ykim@chonbuk.ac.kr,,,,,,,27,9,10,0,14,KOREAN SOCIETY FOOD SCIENCE & TECHNOLOGY-KOSFOST,SEOUL,"#605, KOREA SCI TECHNOL CENT, 635-4 YEOKSAM-DONG, KANGNAM-GU, SEOUL, 135-703, SOUTH KOREA",1226-7708,2092-6456,,FOOD SCI BIOTECHNOL,Food Sci. Biotechnol.,AUG,2006,15,4,,,,,635,638,,,,,,4,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,081MF,,,,,2024-06-04,WOS:000240321000027,View Full Record in Web of Science
J,"Baert, F; Matthys, C; Mellaerts, R; Lemaître, D; Vlaemynck, G; Foulon, V",,,,"Baert, Florence; Matthys, Christophe; Mellaerts, Randy; Lemaitre, Dirk; Vlaemynck, Geertrui; Foulon, Veerle",,,Dietary Intake of Parkinson's Disease Patients,FRONTIERS IN NUTRITION,,,English,Article,,,,,,Parkinson disease; dietary intake; fiber; meal pattern; levodopa,FATTY-ACIDS; FIBER; CONSTIPATION; THIAMIN; PROTEIN,"Background and Aims:Dietary management, as an adjuvant therapy in Parkinson's disease (PD), provides clear benefits to patients. However, baseline information about the usual dietary intake of Parkinson's patients is lacking. Methods:We conducted an observational cross-sectional study, investigating the dietary intake in Belgian PD patients, as well as their medication use and knowledge of possible food-drug interactions. A dietary record of 2 non-consecutive days, allowing the calculation of usual intake, was used. Medication use and knowledge of food-drug interactions were investigated using a self-administered questionnaire. Results:The nutrient (both macro and micro) intake in this study was similar to the dietary pattern of the general Belgian population. However, results showed that the PD population had a high dietary fiber intake of 26.2 +/- 7.7 g/day, which is in line with the recommended intake. The majority of the PD patients had an inadequate intake of vitamin D and iron (respectively, 55.9 and 76.5% of all participants). When looking into the knowledge about food-drug interactions, the majority of the PD patients claimed to be aware of the food-drug interaction between dietary proteins and levodopa. However, only 18.2% of the patients took all doses of levodopa out of meals. Conclusion:Our results show that monitoring of dietary intake in PD patients is of importance to detect possible micronutrient insufficiencies. Patients should receive professional guidance in optimizing their diet to accommodate for different complaints inherent to PD, including constipation. Furthermore, the knowledge of patients regarding the importance of correct medication intake should be improved.","[Baert, Florence; Vlaemynck, Geertrui] Flanders Res Inst Agr Fisheries & Food, Dept Technol & Food, Melle, Belgium; [Baert, Florence; Matthys, Christophe] Univ Leuven, Dept Chron Dis Metab & Ageing, Clin & Expt Endocrinol, Leuven, Belgium; [Matthys, Christophe] Univ Hosp Leuven, Dept Endocrinol, Leuven, Belgium; [Mellaerts, Randy; Foulon, Veerle] Katholieke Univ Leuven, Clin Pharmacol & Pharmacotherapy, Leuven, Belgium; [Mellaerts, Randy; Lemaitre, Dirk] Parkis KookAtelier, Leuven, Belgium; [Lemaitre, Dirk] UC Leuven Limburg, Nutr & Dietet, Leuven, Belgium",Institute For Agricultural & Fisheries Research; KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven,"Matthys, C (corresponding author), Univ Leuven, Dept Chron Dis Metab & Ageing, Clin & Expt Endocrinol, Leuven, Belgium.;Matthys, C (corresponding author), Univ Hosp Leuven, Dept Endocrinol, Leuven, Belgium.",christophe.matthys@uzleuven.be,"Matthys, Christophe/I-4203-2016; Mellaerts, Randy/I-7554-2014","Matthys, Christophe/0000-0003-1770-6862; Baert, Florence/0000-0001-8557-0528; Foulon, Veerle/0000-0002-4053-3915",,,,,35,12,14,0,12,FRONTIERS MEDIA SA,LAUSANNE,"AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND",2296-861X,,,FRONT NUTR,Front. Nutr.,JUL 21,2020,7,,,,,,,,105,10.3389/fnut.2020.00105,http://dx.doi.org/10.3389/fnut.2020.00105,,,8,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,MZ1KW,32793623,"gold, Green Published, Green Accepted",,,2024-06-04,WOS:000558882200001,View Full Record in Web of Science
J,"Mearin, F; Ciriza, C; Mínguez, M; Rey, E; Mascort, JJ; Peña, E; Cañones, P; Júdez, J",,,,"Mearin, F.; Ciriza, C.; Minguez, M.; Rey, E.; Mascort, J. J.; Pena, E.; Canones, P.; Judez, J.",,"SEPD, semFYC, SEMERGEN SEMG",Irritable bowel syndrome with constipation and functional constipation in adults: Treatment (Part 2 of 2),ATENCION PRIMARIA,,,Spanish,Article,,,,,,Irritable bowel syndrome; Functional constipation; Abdominal discomfort; Adults; Primary care; Digestive diseases; Clinical practice guide; Rome IV,PLACEBO-CONTROLLED TRIAL; RANDOMIZED CLINICAL-TRIAL; DOUBLE-BLIND; PHYSICAL-ACTIVITY; DIETARY FIBER; TRANSANAL IRRIGATION; PEPPERMINT-OIL; GASTROINTESTINAL SYMPTOMS; MANAGEMENT; LACTOBACILLUS,"In this Clinical practice guide we examine the diagnostic and therapeutic management of adult patients with constipation and abdominal discomfort, at the confluence of the spectrum of irritable bowel syndrome and functional constipation. Both fall within the framework of functional intestinal disorders and have major personal, health and social impact, altering the quality of life of the patients affected. The former is a subtype of irritable bowel syndrome in which constipation and altered bowel habit predominate, often along with recurring abdominal pain, bloating and abdominal distension. Constipation is characterised by infrequent or hard-to-pass bowel movements, often accompanied by straining during defecation or the sensation of incomplete evacuation. There is no underlying organic cause in the majority of cases; it being considered a functional bowel disorder. There are many clinical and pathophysiological similarities between the two conditions, the constipation responds in a similar way to commonly used drugs, the fundamental difference being the presence or absence of pain, but not in an all or nothing way. The severity of these disorders depends not only on the intensity of the intestinal symptoms but also on other biopsychosocial factors: association of gastrointestinal and extraintestinal symptoms, degree of involvement, forms of perception and behaviour. Functional bowel disorders are diagnosed using the Rome criteria. This Clinical practice guide adapts to the Rome iv criteria published at the end of May 2016. The first part (96, 97, 98) examined the conceptual and pathophysiological aspects, alarm criteria, diagnostic test and referral criteria between Primary Care and Gastroenterology. This second part reviews all the available treatment alternatives (exercise, fluid ingestion, diet with soluble fibre-rich foods, fibre supplements, other dietary components, osmotic or stimulating laxatives, probiotics, antibiotics, spasmolytics, peppermint essence, prucalopride, linaclotide, lubiprostone, biofeedback, ant depressants, psychological treatment, acupuncture, enemas, sacral root neurostimulation and surgery), and practical recommendations are made for each. 2017 Elsevier Espana, S.L.U.","[Mearin, F.] Ctr Med Teknon, AEG, Coordinac GPC, Comite Roma Trastornos Func Intestinales, Barcelona, Spain; [Ciriza, C.] Hosp Univ Doce Octubre, Grp Trastornos Func, SEPD, Madrid, Spain; [Minguez, M.] Univ Valencia, Hosp Clin Univ, AEG, Valencia, Spain; [Minguez, M.] Univ Valencia, Hosp Clin Univ, SEPD, Valencia, Spain; [Rey, E.] Hosp Clin Univ San Carlos, SEPD, Madrid, Spain; [Mascort, J. J.] Soc Espanola Med Familia & Comunitaria semFYC, Secretaria Cient, Barcelona, Spain; [Pena, E.] Soc Espanola Med Atenc Primaria SEMERGEN, Coordinac Digest, Madrid, Spain; [Canones, P.] Soc Espanola Med Gen & Familia SEMG, Coordinac Digest, Madrid, Spain; [Judez, J.] SEPD, Dept Gest Conocimiento, Madrid, Spain",Hospital Universitario 12 de Octubre; University of Valencia; University of Valencia,"Mascort, JJ (corresponding author), Soc Espanola Med Familia & Comunitaria semFYC, Secretaria Cient, Barcelona, Spain.",jmascort@semfyc.es,"Júdez, Javier/ABG-5828-2020; perez, miguel/GXF-5077-2022; Rey, Enrique/B-9492-2008","Judez, Javier/0000-0001-9724-5191; Minguez, Miguel/0000-0003-0148-5938; Rey, Enrique/0000-0002-5060-7105",,,,,98,5,6,0,28,EDICIONES DOYMA S A,BARCELONA,"TRAV DE GRACIA 17-21, 08021 BARCELONA, SPAIN",0212-6567,1578-1275,,ATEN PRIM,Aten. Prim.,MAR,2017,49,3,,,,,177,194,,10.1016/j.aprim.2017.01.003,http://dx.doi.org/10.1016/j.aprim.2017.01.003,,,18,"Primary Health Care; Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,EQ8KS,28238460,"gold, Green Published",,,2024-06-04,WOS:000398334900008,View Full Record in Web of Science
J,"Green, CJ",,,,"Green, CJ",,,Fibre in enteral nutrition,CLINICAL NUTRITION,,,English,Article; Proceedings Paper,11th Nutricia Symposium on Recent Developments in Clinical Nutrition,"MAY 04-06, 2000","SELSDON PARK, ENGLAND",,,dietary fibre; enteral nutrition; bowel function; constipation; diarrhoea; gut barrier function,CHAIN FATTY-ACIDS; TUBE-FED PATIENTS; EPITHELIAL-CELL PROLIFERATION; IN-VITRO FERMENTATION; HUMAN FECAL BACTERIA; WATER-HOLDING CAPACITY; HUMAN LARGE-INTESTINE; DEFINED-FORMULA DIET; HUMAN BOWEL FUNCTION; RESISTANT STARCH,"Understanding of the different types of fibre in the normal diet is growing. In parallel, there is increasing awareness that these various types of fibre serve differing and complementary physiological functions. Application of this knowledge in enteral formulas is now occurring. These liquid products have traditionally been free of fibre, or supplemented with a single fibre source, The latter approach has not proved to be as effective as might have been anticipated, and impaired bowel function, in the form of constipation and diarrhoea, continues to be cited as the most common complaint associated with enteral feeding. Inclusion of a mixture of fibres represents a more physiological approach than supplementing products with a single fibre source. Studies in healthy volunteers and in the clinical setting indicate that such products are well tolerated and help to maintain normal bowel function. Animal studies demonstrate that fibre is vital in maintaining gut structure and integrity. These results suggest that fibre should perhaps be considered as an essential ingredient in the majority of enteral formulas, Future developments may allow further refinement of fibre mixes for specific diseases and conditions. (C) 2001 Harcourt Publishers Ltd.","Nutr Hlthcare, NL-2700 MA Zoetermeer, Netherlands",,"Green, CJ (corresponding author), Nutr Hlthcare, POB 1, NL-2700 MA Zoetermeer, Netherlands.",,,,,,,,256,24,34,0,15,CHURCHILL LIVINGSTONE,EDINBURGH,"JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND",0261-5614,1532-1983,,CLIN NUTR,Clin. Nutr.,JUN,2001,20,,,1,,,23,39,,10.1054/clnu.2001.0425,http://dx.doi.org/10.1054/clnu.2001.0425,,,17,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Nutrition & Dietetics,456LA,,,,,2024-06-04,WOS:000170082900004,View Full Record in Web of Science
J,"Sairanen, U; Piirainen, L; Nevala, R; Korpela, R",,,,"Sairanen, U.; Piirainen, L.; Nevala, R.; Korpela, R.",,,"Yoghurt containing galacto-oligosaccharides, prunes and linseed reduces the severity of mild constipation in elderly subjects",EUROPEAN JOURNAL OF CLINICAL NUTRITION,,,English,Article,,,,,,constipation; elderly subjects; galacto-oligosaccharides; linseed; prunes,DIETARY FIBER; FORMULA; CONSUMPTION; MICROFLORA,"Objective: Constipation is a common problem in the elderly. Dietary fibre is recommended for its treatment. The aim was to examine whether yoghurt containing galacto-oligosaccharides (GOS), prunes and linseed relieve constipation in elderly subjects. Design: A randomized, double-blinded, cross-over study. Setting: Free-living subjects. Subjects: A group of 43 elderly subjects with self-reported constipation (mean age 76 years, range 61-92 years, 32 females, 11 males). Interventions: The study consisted of a 2-week baseline period and 2, 3-week dietary interventions, with a 2-week wash-out period between the interventions. During the interventions, the subjects ingested, in random order, 260 g/day of either control yoghurt or test yoghurt containing GOS (12 g/day), prunes (12 g/day) and linseed (6 g/day). The use of laxatives was controlled and only allowed after 2 days without defecation. Results: Defecation frequency was 5.7 times/week during the baseline period. During the test yoghurt period, defecation frequency was higher (8.0 vs 7.1 times/week, P=0.011), defecation was easier (on the scale 0-3, 1.3 vs 1.5, P=0.010), and there was a tendency towards softer stools (on the scale 0-3, 2.1 vs 2.2, P=0.059) compared with the control yoghurt period. The subjects felt that the test yoghurt relieved constipation more effectively than the control yoghurt (P=0.005). The sum of gastrointestinal symptoms did not differ between the interventions. The use of laxatives remained constant throughout the study. Conclusions: Daily intake of yoghurt containing GOS, prunes and linseed reduced the severity of constipation in elderly subjects with mild constipation. Sponsorship: Valio Ltd, R& D.","Univ Helsinki, Inst Biomed, FIN-00014 Helsinki, Finland; Valio Ltd R&D, Helsinki, Finland; Univ Helsinki, Cent Hosp, Dept Allergy, Helsinki, Finland; Fdn Nutr Res, Helsinki, Finland",University of Helsinki; Valio; University of Helsinki; Helsinki University Central Hospital,"Korpela, R (corresponding author), Univ Helsinki, Inst Biomed, POB 63, FIN-00014 Helsinki, Finland.",riitta.korpela@valio.fi,,"Korpela, Riitta/0000-0003-0337-9186",,,,,33,41,50,1,22,SPRINGERNATURE,LONDON,"CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND",0954-3007,1476-5640,,EUR J CLIN NUTR,Eur. J. Clin. Nutr.,DEC,2007,61,12,,,,,1423,1428,,10.1038/sj.ejcn.1602670,http://dx.doi.org/10.1038/sj.ejcn.1602670,,,6,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,237RD,17299467,,,,2024-06-04,WOS:000251393100012,View Full Record in Web of Science
J,"Chen, HL; Huang, YC",,,,"Chen, HL; Huang, YC",,,Fiber intake and food selection of the elderly in Taiwan,NUTRITION,,,English,Article,,,,,,dietary fiber; crude fiber; health status; food groups; elderly,NUTRITIONAL-STATUS; DIETARY FIBER; CONSTIPATION; HOME; HEALTH,"OBJECTIVES: We assessed fiber intakes and determined the major food categories that contribute. to. dietary fiber intakes in the Taiwanese elderly. We also examined the association-between fiber. intake and health status. METHODS: Macronutrients dietary, and crude fiber intakes of 173 elderly-men (76.4 +/- 0.4 y) and 140. women (76.6 +/- 0.4 y) were assessed with 24-h recall. Health status was assessed by the checklist questionnaire. Food was categorized as grain, vegetable; fruit, soy, other legumes, snack, seaweed; nuts; and mushroom groups. RESULTS: The mean dietary and crude fiber intakes by our older population were 8.79 +/- 0.24 g/d and 3.30 +/- 0.08 g/d, respectively. Significant associations were found between low fiber intakes and ' swallowing ability in the. elderly population. Vegetables, fruits, and grains contributed most (>85%) to dietary fiber intakes for men-and women. However, women consumed a greater. proportion of fiber from ' vegetables and a lesser proportion from grain and snacks than did men., CONCLUSIONS: Elderly subjects had remarkably low dietary fiber intakes (g and g/Mcal). Swallowing and, chewing ability determined the amount of fiber consumed. Vegetable contributed more than-half of dietary fiber intake. The selection of food groups exerted sex-dependent pattern in grains; vegetables and snacks.","Chung Shan Med Univ, Sch Nutr, Inst Nutr Sci, Taichung 402, Taiwan",Chung Shan Medical University,"Chen, HL (corresponding author), Chung Shan Med Univ, Sch Nutr, Inst Nutr Sci, 110 Sec 1 Chien Kuo N Rd, Taichung 402, Taiwan.",,,"Huang, Yi-Chia/0000-0003-2234-4464",,,,,21,11,13,0,8,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",0899-9007,,,NUTRITION,Nutrition,APR,2003,19,4,,,,,332,336,PII S0899-9007(02)00859-6,10.1016/S0899-9007(02)00859-6,http://dx.doi.org/10.1016/S0899-9007(02)00859-6,,,5,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,664MC,12679167,,,,2024-06-04,WOS:000182064000007,View Full Record in Web of Science
J,"Zhang, YH; Lin, Q; An, X; Tan, XY; Yang, LN",,,,"Zhang, Yuhan; Lin, Qian; An, Xin; Tan, Xiuying; Yang, Lina",,,Factors Associated with Functional Constipation among Students of a Chinese University: A Cross-Sectional Study,NUTRIENTS,,,English,Article,,,,,,functional constipation; university students; dietary patterns; associated factors,DIETARY FIBER; SLEEP QUALITY; PREVALENCE; MANAGEMENT; DISORDERS; SYMPTOMS,"Functional constipation (FC) is prevalent worldwide and is an increasingly prominent problem among university students. However, there is a paucity of research on FC in university students. This study aimed to assess the prevalence of FC among Chinese university students by the Rome III criteria and investigate its associated factors. This cross-sectional study was conducted by online questionnaires among 929 university students at a Chinese university. Food consumption was assessed with the Semi-Quantitative Food Frequency Questionnaire (SQFFQ) and dietary patterns were analyzed using factor analysis. A binary logistic regression model was applied to clarify FC-associated factors. The prevalence of FC among university students was 5.1%. Interestingly, among university students, the prevalence of FC with complex dietary pattern was significantly higher than those with vegetable, fruit, egg and milk-based and livestock and aquatic product-based dietary pattern (9.9% vs. 3.1% vs. 2.8%, p < 0.001). The prevalence of FC was significantly higher among university students with moderate to severe sleep disorders than those with the other sleep status (chi(2) = 18.100, p < 0.001). Furthermore, after adjusting the covariates, complex dietary pattern (OR = 4.023, p < 0.001), moderate to severe sleep disorders (OR = 3.003, p = 0.006), overeating (OR = 2.502, p = 0.032), long mealtime (>30 min) (OR = 6.001, p = 0.007), and poor defecation habits (OR = 3.069, p = 0.042) were positively associated with FC among university students. Based on the above-associated factors for FC, improving dietary patterns and sleep status and developing good bowel and dietary habits are essential to prevent and alleviate university students' FC.","[Zhang, Yuhan; Lin, Qian; An, Xin; Tan, Xiuying; Yang, Lina] Cent South Univ, Xiangya Sch Publ Hlth, 110 Xiangya Rd, Changsha 410078, Peoples R China",Central South University,"Yang, LN (corresponding author), Cent South Univ, Xiangya Sch Publ Hlth, 110 Xiangya Rd, Changsha 410078, Peoples R China.",ylnly1997@csu.edu.cn,"zhang, yuhan/HLH-1222-2023","zhang, yuhan/0009-0001-3739-7238; YANG, LINA/0000-0002-9503-3344",Graduate Research and Innovation Project of Central South University [2022ZZTS0297],Graduate Research and Innovation Project of Central South University,This research was funded by the Graduate Research and Innovation Project of Central South University (No. 2022ZZTS0297).,,54,1,1,2,12,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,NOV,2022,14,21,,,,,,,4590,10.3390/nu14214590,http://dx.doi.org/10.3390/nu14214590,,,13,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,6C0BD,36364851,"Green Published, gold",,,2024-06-04,WOS:000881688700001,View Full Record in Web of Science
J,"CAMILLERI, M; THOMPSON, WG; FLESHMAN, JW; PEMBERTON, JH",,,,"CAMILLERI, M; THOMPSON, WG; FLESHMAN, JW; PEMBERTON, JH",,,CLINICAL MANAGEMENT OF INTRACTABLE CONSTIPATION,ANNALS OF INTERNAL MEDICINE,,,English,Article,,,,,,,SEVERE IDIOPATHIC CONSTIPATION; PELVIC FLOOR DISORDERS; PUBORECTALIS MUSCLE; OUTLET OBSTRUCTION; DIETARY FIBER; ANAL ENDOSONOGRAPHY; COLONIC MOTILITY; SMALL-BOWEL; TRANSIT; DEFECATION,"Purpose: To review current management of intractable constipation. Data Sources: Original articles and reviews published in the English-language literature between 1965 and 1993 identified by MEDLINE search. Verbal feedback from attendees after presentation of the document as a clinical symposium at the 14th International Symposium on Gastrointestinal Motility in September 1993. Study Selection: Key words included constipation, epidemiology, colonic inertia, pseudo-obstruction, pelvic floor dysfunction, and results of therapeutic interventions, particularly the effects of biofeedback training and subtotal colectomy. Results: In most patients, constipation is usually due to lack of dietary fiber and responds to simple measures to correct these factors, often without consulting a physician. In some, probably fewer than 10% of patients who consult their physicians, structural diseases of the colon and rectum, systemic disease, or medications that slow gut transit should be excluded, and regular exercise, dietary fiber, and an osmotic laxative prescribed. In a series of 277 highly selected patients from a tertiary referral center who had intractable constipation, only 29% had a definable abnormality; identification of abnormal transit facilitates selection of patients for further investigations identifying colonic inertia or pelvic floor dysfunction. Conclusion: An algorithmic approach can carefully select patients with intractable constipation for behavioral modification and biofeedback; the long-term outcome is excellent, with at least 75% success in several series. In a minority of patients with slow transit constipation unresponsive to medical treatment, subtotal colectomy with ileorectostomy is indicated and effective.","OTTAWA CIVIC HOSP, OTTAWA K1Y 4E9, ON, CANADA; MAYO CLIN & MAYO FDN, COLON & RECTAL SURG SECT, ROCHESTER, MN 55905 USA; WASHINGTON UNIV, ST LOUIS, MO USA; UNIV OTTAWA, OTTAWA, ON, CANADA",University of Ottawa; Ottawa Hospital Research Institute; Mayo Clinic; Washington University (WUSTL); University of Ottawa,"CAMILLERI, M (corresponding author), MAYO CLIN & MAYO FDN, MAYO MED SCH, GASTROENTEROL RES UNIT, 200 1ST ST SW, ROCHESTER, MN 55905 USA.",,,,,,,,73,95,98,0,2,AMER COLL PHYSICIANS,PHILADELPHIA,"INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA",0003-4819,1539-3704,,ANN INTERN MED,Ann. Intern. Med.,OCT 1,1994,121,7,,,,,520,528,,10.7326/0003-4819-121-7-199410010-00008,http://dx.doi.org/10.7326/0003-4819-121-7-199410010-00008,,,9,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,PJ102,8067650,,,,2024-06-04,WOS:A1994PJ10200008,View Full Record in Web of Science
J,"Suares, NC; Ford, AC",,,,"Suares, N. C.; Ford, A. C.",,,Systematic review: the effects of fibre in the management of chronic idiopathic constipation,ALIMENTARY PHARMACOLOGY & THERAPEUTICS,,,English,Review,,,,,,,FUNCTIONAL GASTROINTESTINAL DISORDERS; UNITED-STATES; MULTINATIONAL SURVEY; CONTROLLED TRIAL; BOWEL DISORDERS; DOUBLE-BLIND; WHEAT BRAN; EFFICACY; TRANSIT; EPIDEMIOLOGY,"P>Background Patients with chronic idiopathic constipation are often told to increase dietary fibre intake. Whether this is of any benefit remains unclear. Aim To conduct a systematic review of the efficacy of soluble and insoluble fibre supplementation in the management of chronic idiopathic constipation. Methods MEDLINE, EMBASE, and the Cochrane central register of controlled trials were searched to identify randomised controlled trials (RCTs) comparing fibre with placebo or no therapy in adult chronic idiopathic constipation patients. Studies had to report dichotomous data assessing response to therapy, or continuous data examining either effect of therapy on mean number of stools per week, or mean symptom scores. Adverse events data were extracted where reported. Results Six RCTs were eligible. Four used soluble fibre and two used insoluble fibre. Formal meta-analysis was not undertaken due to concern about methodological quality of identified studies. Compared with placebo, soluble fibre led to improvements in global symptoms (86.5% vs. 47.4%), straining (55.6% vs. 28.6%), pain on defaecation, and stool consistency, an increase in the mean number of stools per week (3.8 stools per week after therapy compared with 2.9 stools per week at baseline), and a reduction in the number of days between stools. Evidence for any benefit of insoluble fibre was conflicting. Adverse events data were limited, with no RCT reporting total numbers. Conclusions Soluble fibre may be of benefit in chronic idiopathic constipation, but data for insoluble fibre are conflicting. More data from high quality RCTs are required before the true efficacy of either fibre type in the treatment of chronic idiopathic constipation is known.","[Suares, N. C.; Ford, A. C.] Leeds Gen Infirm, Leeds Gastroenterol Inst, Leeds LS1 3FX, W Yorkshire, England; [Ford, A. C.] Univ Leeds, Leeds Inst Mol Med, Leeds, W Yorkshire, England",University of Leeds; Leeds General Infirmary; University of Leeds,"Ford, AC (corresponding author), Leeds Gen Infirm, Leeds Gastroenterol Inst, Great George St,Clarendon Wing,D Floor,Room 230, Leeds LS1 3FX, W Yorkshire, England.",alexf12399@yahoo.com,"Ford, Alexander/K-5491-2012","Ford, Alexander/0000-0001-6371-4359",,,,,35,171,192,2,48,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0269-2813,1365-2036,,ALIMENT PHARM THER,Aliment. Pharmacol. Ther.,APR 15,2011,33,8,,,,,895,901,,10.1111/j.1365-2036.2011.04602.x,http://dx.doi.org/10.1111/j.1365-2036.2011.04602.x,,,7,Gastroenterology & Hepatology; Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Pharmacology & Pharmacy,736TA,21332763,Green Submitted,,,2024-06-04,WOS:000288515800004,View Full Record in Web of Science
B,"Rakha, A; Åman, P; Andersson, R",,"Delcour, JA; Poutanen, K",,"Rakha, A.; Aman, P.; Andersson, R.",,,Fibre-enriched and wholegrain breads,FIBRE-RICH AND WHOLEGRAIN FOODS: IMPROVING QUALITY,Woodhead Publishing India in Food Science Technology and Nutrition,,English,Article; Book Chapter,,,,,,bread; dietary fibre enrichment; processing; sensory properties,MOLECULAR-WEIGHT DISTRIBUTION; WHEAT-FLOUR DOUGH; DIETARY FIBER; BETA-GLUCAN; RESISTANT STARCH; PHYSICOCHEMICAL PROPERTIES; BARLEY FLOUR; OAT BRAN; FUNCTIONAL-PROPERTIES; ENZYME PREPARATION,"Bread is a staple food worldwide. It is a good source of energy, protein, dietary fibre (DF), minerals, vitamins and many other bioactive compounds. Increased intake of DF has been associated with a decreased risk of overweight and obesity, hypertension, cardiovascular diseases, diabetes, certain cancers and constipation. The use of refined flour in bread decreases its content of DF and associated bioactive compounds. Therefore wholemeal flour, composite flour, bran, resistant starch, fructan/fructo-oligosaccharides or fibre concentrates have been added to bread to enrich it with DF. However, these ingredients can modify many properties of the dough and the bread, so the bread-making process has to be adjusted to achieve desirable products. Many processes can result in the loss of functionality and positive health effects of the DF components, an important aspect to consider when creating innovative products.","[Rakha, A.] Univ Agr Faisalabad, Natl Inst Food Sci & Technol, Faisalabad, Pakistan; [Aman, P.; Andersson, R.] Swedish Univ Agr Sci, Dept Food Sci, SE-75007 Uppsala, Sweden",University of Agriculture Faisalabad; Swedish University of Agricultural Sciences,"Åman, P (corresponding author), Swedish Univ Agr Sci, Dept Food Sci, SE-75007 Uppsala, Sweden.",per.aman@slu.se,"DELCOUR, Jan A/P-4182-2017; Andersson, Roger/L-7914-2015; Rakha, Allah/AAQ-6764-2020","DELCOUR, Jan A/0000-0003-2954-1022; Andersson, Roger/0000-0001-8763-832X;",,,,,113,4,6,0,11,WOODHEAD PUBL LTD,CAMBRIDGE,"OFFICERS MESS BUSINESS CENTRE, ROYSTON RD, CAMBRIDGE, DUXFORD, ENGLAND",,,978-0-85709-578-7; 978-0-85709-038-6,WOODH PUB INDIA FOOD,,,2013,237,,,,,,211,235,,10.1533/9780857095787.3.211,http://dx.doi.org/10.1533/9780857095787.3.211,,,25,Food Science & Technology,Book Citation Index – Science (BKCI-S),Food Science & Technology,BA3AK,,,,,2024-06-04,WOS:000334075100010,View Full Record in Web of Science
J,"Shimada, M; Nagano, N; Goto, S; Ito, K; Tsutsui, T; Ando, T; Kamioka, H; Ogawa, T",,,,"Shimada, Mikiko; Nagano, Nobuo; Goto, Saori; Ito, Kyoko; Tsutsui, Takaaki; Ando, Tetsuo; Kamioka, Hiroharu; Ogawa, Tetsuya",,,"Effect of Polydextrose Intake on Constipation in Japanese Dialysis Patients: A Triple-Blind, Randomized, Controlled Trial",JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY,,,English,Article,,,,,,polydextrose; dietary fiber; stool frequency; hemodialysis; constipation,BOWEL FUNCTION; FIBER; FERMENTATION; TRANSIT; PREVALENCE; SYMPTOMS; BACTERIA; HEALTH; WOMEN; GUIDE,"The objective of the present study was to evaluate bowel habits induced by ingestion of 10 g polydextrose (PDX) fed to Japanese hemodialysis (HD) patients. This was a randomized, placebo-controlled, triple-blind, parallel-group controlled, 8-wk study. A total of 50 HD outpatients capable of self-management (51-79 y of age) were recruited at H Clinic. Japan. Inclusion criteria for participation in the study were ingestion of one or more laxative tablets for more than 3 mo and having received HD for more than 6 mo. The participants were randomly assigned to 2 groups: A (0 g polydextrose/d: control), B (10 g polydextrose/d: PDX). The primary outcome measure was stool frequency. Secondary outcomes were stool consistency, abdominal pain, intestinal bloating and clinical biochemistry indexes. PDX had no significant effect on blood biochemistry indexes. The PDX group showed significant improvements in bowel function (stool frequency increased from 3.0 times per week to 7.5 times per week) and reported no laxation problems (abdominal distention, cramps, and diarrhea) (p<0.01). Regular consumption of the PDX products increased dietary fiber intake to recommended levels and improved bowel habits.","[Shimada, Mikiko] Med Corp Hidaka Rehabil Hosp, Takasaki, Gunma 3702104, Japan; [Shimada, Mikiko; Kamioka, Hiroharu] Tokyo Univ Agr, Grad Sch Agr, Setagaya Ku, Tokyo 1568502, Japan; [Nagano, Nobuo; Tsutsui, Takaaki; Ando, Tetsuo] Med Corp Hidaka Hosp, Takasaki, Gunma 3700001, Japan; [Goto, Saori; Ito, Kyoko] Med Corp Heisei Hidaka Clin, Takasaki, Gunma 3700001, Japan; [Ogawa, Tetsuya] Tokyo Womens Med Univ, Dept Med, Med Ctr East, Arakawa, Tokyo 1168567, Japan",Tokyo University of Agriculture; Tokyo Women's Medical University,"Shimada, M (corresponding author), Med Corp Hidaka Rehabil Hosp, 2204 Yoshii, Takasaki, Gunma 3702104, Japan.",m2r2.smd@flower.email.ne.jp,,,,,,,28,12,14,0,8,CENTER ACADEMIC PUBL JAPAN,TOKYO,"2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN",0301-4800,1881-7742,,J NUTR SCI VITAMINOL,J. Nutr. Sci. Vitaminol.,AUG,2015,61,4,,,,,345,353,,10.3177/jnsv.61.345,http://dx.doi.org/10.3177/jnsv.61.345,,,9,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,CQ3QU,26440643,gold,,,2024-06-04,WOS:000360518400010,View Full Record in Web of Science
J,"TAKAHASHI, H; WAKO, N; OKUBO, T; ISHIHARA, N; YAMANAKA, J; YAMAMOTO, T",,,,"TAKAHASHI, H; WAKO, N; OKUBO, T; ISHIHARA, N; YAMANAKA, J; YAMAMOTO, T",,,INFLUENCE OF PARTIALLY HYDROLYZED GUAR GUM ON CONSTIPATION IN WOMEN,JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY,,,English,Article,,,,,,PARTIALLY HYDROLYZED GUAR GUM (PHGG); WATER-SOLUBLE DIETARY FIBER; CONSTIPATION; DEFECATING FREQUENCY; WOMEN; FECAL PH; FECAL MOISTURE; LACTOBACILLUS SPP,DIETARY FIBER; FECAL OUTPUT; SERUM-CHOLESTEROL; INTESTINAL-TRACT; BLOOD-LIPIDS; COLON; BRAN,"A partially hydrolyzed guar gum preparation (PHGG, average molecular weight: 20,000), obtained as a water-soluble dietary fiber by digestion of guar gum with beta-D-endomannanase, was administered as a beverage (11g a day, bid) to 15 constipated women for 3 weeks. Defecating frequency, pH, weight, moisture, and bacterial flora of the feces were investigated and compared with the control periods. Average total dietary fiber taken from food was 9.7 +/- 0.1 g/day during the experiment. PHGG caused an increase in the defecating frequency from 0.46 +/- 0.05 (frequency/day, M +/- SE) to 0.63 +/- 0.05. Fecal moisture significantly increased from 69.1% in the control period to 73.8% by ingestion of PHGG. Fecal moisture content also increased consistent with lowering the pH of feces (r=-0.478). The frequency of Lactobacillus spp. occurrence in feces significantly increased (p< 0.05) compared with the control period. These results clearly indicate that PHGG softens and improves the output of feces.","YAMANAKA HOSP GASTROENTEROL,YOKKAICHI 510,JAPAN; FUKUYAMA UNIV,DEPT BIOTECHNOL,FUKUYAMA 72909,HIROSHIMA,JAPAN",Fukuyama University,"TAKAHASHI, H (corresponding author), TAIYO KAGAKU CO LTD,CENT RES LABS,YOKKAICHI 510,JAPAN.",,,,,,,,25,51,60,1,5,CENTER ACADEMIC PUBL JAPAN,TOKYO,"4-16 YAYOI 2-CHOME, BUNKYO-KU, TOKYO 113, JAPAN",0301-4800,,,J NUTR SCI VITAMINOL,J. Nutr. Sci. Vitaminol.,JUN,1994,40,3,,,,,251,259,,,,,,9,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,NV003,7965214,gold,,,2024-06-04,WOS:A1994NV00300004,View Full Record in Web of Science
J,"Galvin, MA; Kiely, M; Harrington, KE; Robson, PJ; Moore, R; Flynn, A",,,,"Galvin, MA; Kiely, M; Harrington, KE; Robson, PJ; Moore, R; Flynn, A",,,The North/South Ireland Food Consumption Survey: the dietary fibre intake of Irish adults,PUBLIC HEALTH NUTRITION,,,English,Article,,,,,,dietary fibre; non-starch polysaccharide; intake; adults; recommendations; compliance; food groups; Ireland,CORONARY-HEART-DISEASE; RISK,"Objective: Mean daily intakes of dietary fibre (DF, Southgate) and non-starch polysaccharide (NSP, Englyst) are estimated in a representative sample of adults aged 18-64 years in Ireland. The contribution of food groups to DF and NSP intake is reported and fibre intakes are compared with dietary recommendations and with intakes in some European countries. Design: Food consumption was estimated using 7-day food diaries for a representative sample (n = 1379; 662 men, 717 women) of 18-64 year old adults in the Republic of Ireland and Northern Ireland selected from the electoral register. DF and NSP intakes were estimated from tables of food composition. Results: The mean daily intake of DF in the total sample was 20.2 g (standard deviation (SD) 7.8) [23.2 g (SD 8.5) in men, 17.4 g (SD 5.9) in women] or 2.24 g MJ(-1) (SD 0-7) [2.16 g MJ(-1) (SD 0.7) in men, 2.33 g MJ(-1) (SD 0.7) in women]. Mean daily intake of NSP was 14.8 g (SD 6.2) [16.7 g (SD 6.8) in men, 13.0 g (SD 5.0) in women] or 1.65 g MJ(-1) (SD 0.6) [1.56 g MJ(-1) (SD 0.6) in men, 1.74 g MJ(-1) (SD 0.6) in women]. The main food groups that contributed to mean daily intake of DF (NSP) in the sample were breads 31% (23%), potatoes 19% (23%), and vegetables 17% (19%). Absolute intakes of DF and NSP were higher (P < 0.001) in men than women; However, women overall consumed more (P < 0.001) fibre-dense diets than men. Women aged 18-35 years consumed less (P < 0.01) DF and NSP (g) than women aged 36-64 years. Both men and women aged 18-35 years consumed less (P < 0.01) fibre-dense diets than men and women aged 36-64 years. The NSP intake was below the nutritional goal of 18 g day(-1) in 77% of adults and below the minimum of the recommended range (12 g day(-1)) in 37% of the total sample. Compliance (i.e. the maximum number of individuals whose collective mean daily intake corresponded to the population goal) with the (UK) population goal for an average intake of 18 g day(-1) NSP was achieved by a greater proportion of the population (63%) than compliance with the (German) dietary fibre recommendation of 30 g day(-1) (27%) or the (Nordic) recommendation of 3 g MJ(-1) day(-1) (33%). Conclusion: DF (NSP) intakes were lower than dietary recommendations in a substantial proportion of the population. This is likely to contribute to impaired bowel function and constipation, which in turn, may contribute to increased risk of chronic gastrointestinal disease.","Natl Univ Ireland Univ Coll Cork, Dept Food Sci Food Technol & Nutr, Cork, Ireland; St James Hosp, Dept Clin Med, Trinity Ctr Hlth Sci, Dublin 8, Ireland; Univ Ulster, No Ireland Ctr Diet & Hlth, NICHE, Coleraine BT52 1SA, Londonderry, North Ireland",University College Cork; Trinity College Dublin; Ulster University,"Natl Univ Ireland Univ Coll Cork, Dept Food Sci Food Technol & Nutr, Cork, Ireland.",marie.galvin@ucc.ie,"Kiely, Mairead E/ABA-3235-2020; Kiely, Mairead/I-8269-2019; Robson, Paula/Q-3351-2017","Kiely, Mairead/0000-0003-0973-808X; Robson, Paula/0000-0003-4640-1371; Flynn, Albert/0000-0002-7072-4202",,,,,40,19,22,0,6,CAMBRIDGE UNIV PRESS,CAMBRIDGE,"EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND",1368-9800,1475-2727,,PUBLIC HEALTH NUTR,Public Health Nutr.,OCT,2001,4,5A,,,SI,,1061,1068,,10.1079/PHN2001187,http://dx.doi.org/10.1079/PHN2001187,,,8,"Public, Environmental & Occupational Health; Nutrition & Dietetics",Science Citation Index Expanded (SCI-EXPANDED),"Public, Environmental & Occupational Health; Nutrition & Dietetics",520TZ,11820919,Bronze,,,2024-06-04,WOS:000173798600006,View Full Record in Web of Science
J,"Lang-Illievich, K; Bornemann-Cimenti, H",,,,"Lang-Illievich, Kordula; Bornemann-Cimenti, Helmar",,,Opioid-induced constipation: a narrative review of therapeutic options in clinical management,KOREAN JOURNAL OF PAIN,,,English,Review,,,,,,Constipation; Dietary fiber; Enema; Exercise; Habits; Incidence; Laxatives; Narcotic antagonists; Opioid analgesics; Pain management; Pharmaceutical preparations; Quality of life,PROLONGED-RELEASE OXYCODONE/NALOXONE; INDUCED BOWEL DYSFUNCTION; CHRONIC NONCANCER PAIN; CONTROLLED PHASE-3 TRIAL; DOUBLE-BLIND; CANCER PAIN; EFFICACY; PLACEBO; TAPENTADOL; MORPHINE,"Pain therapy often entails gastrointestinal adverse events. While opioids are effective drugs for pain relief, the incidence of opioid-induced constipation (OIC) varies greatly from 15% to as high as 81%. This can lead to a significant impairment in quality of life, often resulting in discontinuation of opioid therapy. In this regard, a good doctor-patient relationship is especially pivotal when initiating opioid therapy. In addition to a detailed history of bowel habits, patient education regarding the possible gastrointestinal side effects of the drugs is crucial. In addition, the bowel function must be regularly evaluated for the entire duration of treatment with opioids. Furthermore, if the patient has preexisting constipation that is well under control, continuation of that treatment is important. In the absence of such history, general recommendations should include sufficient fluid intake, physical activity, and regular intake of dietary fiber. In patients of OIC with ongoing opioid therapy, the necessity of opioid use should be critically reevaluated in terms of an with acceptable quality of life, particularly in cases of non-cancer pain. If opioids must be continued, lowering the dose may help, as well as changing the type of opioid. If these measures do not suffice, the next step for persistent OIC is the administration of laxatives. If these are ineffective as well, treatment with peripherally active mu-opioid receptor antagonists should be considered. Enemas and irrigation are emergency measures, often used as a last resort.","[Lang-Illievich, Kordula; Bornemann-Cimenti, Helmar] Med Univ Graz, Dept Anesthesiol & Intens Care Med, Auenbruggerpl 29, A-8036 Graz, Austria",Medical University of Graz,"Bornemann-Cimenti, H (corresponding author), Med Univ Graz, Dept Anesthesiol & Intens Care Med, Auenbruggerpl 29, A-8036 Graz, Austria.",helmar.bornemann@medunigraz.at,"Bornemann-Cimenti, Helmar/C-1252-2009","Bornemann-Cimenti, Helmar/0000-0002-1201-3752",,,,,82,17,20,0,5,KOREAN PAIN SOC,SEOUL,"1705, YANGJAE SK HUB PRIMO, 953-1 DOGOK-DONG, GANGNAM-GU, SEOUL, 135-270, SOUTH KOREA",2005-9159,2093-0569,,KOREAN J PAIN,Korean J. Pain,APR,2019,32,2,,,,,69,78,,10.3344/kjp.2019.32.2.69,http://dx.doi.org/10.3344/kjp.2019.32.2.69,,,10,Clinical Neurology,Science Citation Index Expanded (SCI-EXPANDED),Neurosciences & Neurology,HR7HF,31091505,"Green Published, Green Submitted, gold",,,2024-06-04,WOS:000463323200002,View Full Record in Web of Science
J,"CHESKIN, LJ; KAMAL, N; CROWELL, MD; SCHUSTER, MM; WHITEHEAD, WE",,,,"CHESKIN, LJ; KAMAL, N; CROWELL, MD; SCHUSTER, MM; WHITEHEAD, WE",,,MECHANISMS OF CONSTIPATION IN OLDER PERSONS AND EFFECTS OF FIBER COMPARED WITH PLACEBO,JOURNAL OF THE AMERICAN GERIATRICS SOCIETY,,,English,Note,,,,,,,DIETARY FIBER; PREVALENCE; POPULATION; HOME; DEFINITION; DISEASE; TRANSIT; TIME,"OBJECTIVE: To investigate the mechanisms of constipation and the effect of fiber supplementation on physiology, mechanisms, stool parameters, and colonic transit times in a group of constipated older patients. DESIGN: Single-blind, randomized, placebo-controlled fiber intervention with crossover. SETTING: A university-based outpatient center. PATIENTS: Ten community-living older men and women, healthy except for chronic constipation. INTERVENTIONS: Patients were given either 24 g psyllium fiber or placebo fiber daily for 1 month, then crossed over to the other arm for an additional month. Structured testing, including total gut transit time and rectal and colonic manometry, was performed at the end of each intervention month. Patients recorded stool frequency, consistency, and weights daily. RESULTS: The predominant mechanism for constipation in these patients was outlet delay caused by pelvic dyssynergia. Fiber decreased total gut transit time from 53.9 hours (placebo condition) to 30.0 hours (P < .05). Stool weights and consistency were not significantly improved by fiber, though there was a trend toward an increase in stool frequency (1.3 vs 0.8 bowel movements per day.) Pelvic floor dyssynergia was not remedied by fiber, even when constipation was clinically improved. CONCLUSIONS: Fiber supplementation appeared to benefit constipated older patients clinically, and it improved colonic transit time, but it did not rectify the most frequent underlying abnormality, pelvic floor dyssynergia.","JOHNS HOPKINS UNIV, SCH MED, BALTIMORE, MD USA",Johns Hopkins University,"JOHNS HOPKINS BAYVIEW MED CTR, DIV DIGEST DIS, 4940 E AVE, BALTIMORE, MD 21224 USA.",,"Cheskin, Lawrence/AAM-1094-2021","Cheskin, Lawrence/0000-0003-0262-1030; Crowell, Michael/0000-0002-1162-3831",,,,,21,59,62,1,8,WILEY-BLACKWELL,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0002-8614,1532-5415,,J AM GERIATR SOC,J. Am. Geriatr. Soc.,JUN,1995,43,6,,,,,666,669,,10.1111/j.1532-5415.1995.tb07203.x,http://dx.doi.org/10.1111/j.1532-5415.1995.tb07203.x,,,4,Geriatrics & Gerontology; Gerontology,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Geriatrics & Gerontology,RB444,7775727,,,,2024-06-04,WOS:A1995RB44400012,View Full Record in Web of Science
J,"Khayyat, AJ; Abumansour, RT; Khayat, MA; Almalayo, NO; Saleh, RE; Baashar, DS; Almhmadi, MM; Almalki, RO; Ageel, M",,,,"Khayyat, Albraa J.; Abumansour, Refal T.; Khayat, Moath A.; Almalayo, Nada O.; Saleh, Raghad E.; Baashar, Doaa S.; Almhmadi, Musaad M.; Almalki, Rayan O.; Ageel, Mohammed",,,"Parents' Knowledge, Attitude, and Practice Related to Childhood Constipation in Makkah, Saudi Arabia",CUREUS JOURNAL OF MEDICAL SCIENCE,,,English,Article,,,,,,saudi arabia; practice; parents; knowledge; constipation; childhood; attitude,FUNCTIONAL CONSTIPATION; EPIDEMIOLOGY; PEDIATRICIANS; ADULTS,"Introduction Functional constipation in children is described as irregular or difficult bowel motions without underlying systemic or anatomical causes. Although constipation can have a serious negative impact on a child's health and the lives of their parents. This study aimed to assess the knowledge of parents about childhood constipation, intending to reduce morbidity and mortality through increased public health education in Makkah, Saudi Arabia. Methods The current study was a web -based, descriptive cross-sectional study. The data were obtained from May 2023 to November 2023 through an online questionnaire directed to parents in Makkah, Saudi Arabia, and analyzed using SPSS version 27.0.1 (Armonk, NY: IBM Corp.). Results A total of 796 participants were included in the present study, of which 205 (25.8%) were males and 591 (74.2%) were females. The knowledge levels among them varied, with 11.1% correctly defining constipation and 63.6% recognizing it as a symptom. Common causes like organic and functional constipation were acknowledged by 88.4% and 81.3% of participants, respectively. Regarding practices, 27.9% recommended high -fiber foods for initial home treatment, and 42.8% acknowledged that an enema is effective for fecal impaction. In the dietary recommendations, 71.7% suggested fruits and 68.8% mentioned vegetables. Concerning attitudes, 65.1% expressed fear of childhood constipation continuing into adulthood, while 30.9% feared severe medical conditions. The internet (25.5%) and friends/relatives (23.6%) were the primary sources of information. Knowledge was significantly higher among females and those with postgraduate education. Conclusion This study highlights the variability in knowledge levels among parents, with an overall moderate understanding of childhood constipation. It emphasizes a moderate level of adherence to recommended practices related to childhood constipation, with some room for improvement in Makkah, Saudi Arabia.","[Khayyat, Albraa J.; Abumansour, Refal T.; Khayat, Moath A.; Saleh, Raghad E.; Baashar, Doaa S.; Almhmadi, Musaad M.; Almalki, Rayan O.; Ageel, Mohammed] Umm Al Qura Univ, Coll Med, Dept Med & Surg, Mecca, Saudi Arabia; [Almalayo, Nada O.] Umm Al Qura Univ, Coll Med, Dept Med & Surg, Mecca, Saudi Arabia; [Ageel, Mohammed] Umm Al Qura Univ, Fac Med, Dept Surg, Mecca, Saudi Arabia",Umm Al Qura University; Umm Al Qura University; Umm Al Qura University,"Khayyat, AJ (corresponding author), Umm Al Qura Univ, Coll Med, Dept Med & Surg, Mecca, Saudi Arabia.",albraa.khayyat@gmail.com,,,,,,,23,0,0,1,1,SPRINGERNATURE,LONDON,"CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND",,2168-8184,,CUREUS J MED SCIENCE,Cureus J Med Sci,JAN 13,2024,16,1,,,,,,,e52236,10.7759/cureus.52236,http://dx.doi.org/10.7759/cureus.52236,,,12,"Medicine, General & Internal",Emerging Sources Citation Index (ESCI),General & Internal Medicine,GR2Z9,38222998,gold,,,2024-06-04,WOS:001154346000001,View Full Record in Web of Science
J,"Pawasarat, A; Biank, VF",,,,"Pawasarat, Amy; Biank, Vincent F.",,,Constipation in Pediatrics: A Clinical Review,PEDIATRIC ANNALS,,,English,Review,,,,,,,CHILDHOOD CONSTIPATION; CHILDREN,"Constipation is a common problem encountered in the pediatric setting. For many children, constipation is functional in nature-potentially stemming from a pattern of stool output that is infrequent or not fully productive (ie, incomplete stool evacuation)-and includes behavioral concerns like stool withholding. In many cases of functional constipation (FC), the pattern may have started in the toddler years during or before toilet training and may now be well established. Additional factors often include inadequate fluids and fiber, or excess dietary dairy or carbohydrates. In a small percentage of cases, constipation is a symptom of an underlying organic disease process. Laboratory tests and imaging may be helpful in determining most organic concerns. In the absence of an organic process, FC can be treated by properly educating families about the nature of FC as well as careful attention to dietary fiber and fluid intake, use of stool softeners, laxatives, and behavioral modifications.","[Pawasarat, Amy] NorthShore Univ HealthSyst, Dept Pediat Gastroenterol, Evanston, IL 60201 USA; [Biank, Vincent F.] NorthShore Univ HealthSyst, Pritzker Sch Med, Pediat, Evanston, IL 60201 USA; [Biank, Vincent F.] NorthShore Univ HealthSyst, Dept Pediat, Pediat Gastroenterol Hepatol & Nutr, Evanston, IL 60201 USA",NorthShore University Health System; NorthShore University Health System; NorthShore University Health System,"Biank, VF (corresponding author), NorthShore Univ HealthSyst, 2650 Ridge Ave,Walgreens Bldg,Suite 1524, Evanston, IL 60201 USA.",vbiank@northshore.org,,,,,,,14,4,4,1,8,SLACK INC,THOROFARE,"6900 GROVE RD, THOROFARE, NJ 08086 USA",0090-4481,1938-2359,,PEDIATR ANN,Pediatr. Ann.,AUG,2021,50,8,,,,,E320,E324,,10.3928/19382359-20210714-01,http://dx.doi.org/10.3928/19382359-20210714-01,,,5,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,UC0YS,34398719,,,,2024-06-04,WOS:000686261600005,View Full Record in Web of Science
J,"Zou, JY; Xu, Y; Wang, XH; Jiang, Q; Zhu, XM",,,,"Zou, Jing-Ying; Xu, Yi; Wang, Xiao-Hua; Jiang, Qing; Zhu, Xia-Ming",,,Improvement of Constipation in Leukemia Patients Undergoing Chemotherapy Using Sweet Potato,CANCER NURSING,,,English,Article,,,,,,Chemotherapy; Constipation; Leukemia; Sweet potato,CANCER-PATIENTS; DIETARY FIBER; PREVALENCE; STRATEGIES,"Background: Leukemia patients undergoing chemotherapy commonly develop constipation, which is difficult to treat using routine methods. Objective: The aim of this study was to determine whether sweet potato can alleviate constipation in leukemia patients undergoing chemotherapy. Methods: Leukemia patients receiving their first chemotherapy were randomized to an intervention group (n = 57) or a control group (n = 63). The control and intervention groups were managed by using routine nursing methods and routine methods plus dietary sweet potato consumption (eating sweet potato 200 g/d, from admission to discharge), respectively. Related data regarding patients' defecation were collected on the second and fifth days after chemotherapy initiation, which included rates of constipation, frequency and duration of purgative usage, constipation status assessed by Rome III criteria, and scores on defecation satisfaction. Results: On the second day, the rate of constipation and the rate of having first defecation within 24 hours after chemotherapy initiation were significantly improved in the intervention group, but the difference of the defecation satisfaction and almost no loose stools without purgative use in Rome III criteria were not significantly changed. On the fifth day, except for the sensation of anorectal obstruction and requirement of manual assistance in Rome III criteria, other items regarding defecation were significantly improved. Conclusion: This study demonstrates that sweet potato had a positive impact on the prevention of constipation and the defecation satisfaction in leukemia patients receiving their first chemotherapy. Implications for Practice: As sweet potato is inexpensive, abundant, tasty, and easy to prepare, it can be widely used in leukemia patients undergoing chemotherapy.","[Zou, Jing-Ying] Soochow Univ, Suzhou Hlth Coll, Suzhou 215006, Peoples R China; [Xu, Yi; Wang, Xiao-Hua] Soochow Univ, Sch Nursing, Suzhou 215006, Peoples R China; [Wang, Xiao-Hua; Jiang, Qing] Soochow Univ, Affiliated Hosp 1, Dept Cardiol, 188 Shizi St, Suzhou 215006, Peoples R China; [Zhu, Xia-Ming] Soochow Univ, Affiliated Hosp 1, Dept Hematol, Suzhou 215006, Peoples R China",Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China,"Wang, XH (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Cardiol, 188 Shizi St, Suzhou 215006, Peoples R China.",sxwang2001@163.com,"zhu, yujie/KBC-4009-2024; he, he/JPL-3505-2023; Jiang, Qing/JXM-6827-2024","Jiang, Qing/0000-0002-2552-9686",,,,,24,6,7,1,17,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0162-220X,1538-9804,,CANCER NURS,Cancer Nurs.,MAY-JUN,2016,39,3,,,,,181,186,,10.1097/NCC.0000000000000257,http://dx.doi.org/10.1097/NCC.0000000000000257,,,6,Oncology; Nursing,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Oncology; Nursing,DK4NP,25881813,,,,2024-06-04,WOS:000374895500010,View Full Record in Web of Science
J,"Dong, T; Xia, RX; Wang, MY; Xiao, ZY; Liu, P",,,,"Dong, Tao; Xia, Renxue; Wang, Mingyuan; Xiao, Zhiyan; Liu, Ping",,,"Changes in dietary fibre, polygalacturonase, cellulase of navel orange (Citrus sinensis (L.) Osbeck 'Cara Cara') fruits under different storage conditions",SCIENTIA HORTICULTURAE,,,English,Article,,,,,,dietary fibre; polygalacturonase (PG) and cellulase (Cx); real time PCR; storage on tree (ST); storage in room (SR),CELL-WALL POLYSACCHARIDES; PECTIC SUBSTANCES; DEGRADATION; HYDROLASES; ENZYMES; BANANA; GENE,"The consumption of dietary fibre plays an important role in the prevention of diseases, such as constipation, haemorrhoids. Recently, chemical and physical properties of citrus fibres have been widely studied. In this paper, the polygalacturonase (PG) and cellulase (Cx) gene expression of Cara Cara (Citrus sinensis (L.) Osbeck) navel orange fruit stored on tree (ST) was compared with fruit stored in room (SR). The results showed that the mRNA expression levels of PG increased significantly in the fruits of ST, in contrast, the expression levels of Cx increased slightly only in peel of ST. Total pectin (TP) and protopectin of ST fruits pulp were higher than those of SR at every time point. The contents of insoluble dietary fibre (IDF), hemicellulose (HC), cellulose (CEL) and lignin of ST fruits were less than that in SR. However, in fruits from ST, a significant increase of soluble dietary fibre (SDF) and water soluble pectin (WSP) occurred, compared with fruits of SR. Our studies indicated that fruit stored on tree is quite useful for regulating the gene expression and controlling contents of dietary fibre on Cara Cara navel orange. (c) 2008 Elsevier B.V. All rights reserved.","[Dong, Tao; Xia, Renxue; Wang, Mingyuan; Xiao, Zhiyan] Huazhong Agr Univ, Minist Educ, Key Lab Hort Plant Biol, Wuhan 430070, Peoples R China; [Liu, Ping] Huazhong Agr Univ, Natl Ctr Crop Mol Breeding, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Peoples R China",Huazhong Agricultural University; Huazhong Agricultural University,"Xia, RX (corresponding author), Huazhong Agr Univ, Minist Educ, Key Lab Hort Plant Biol, Wuhan 430070, Peoples R China.",taod2004@webmail.hzau.edu.cn; renxuexia@mail.hazu.edu.cn,"li, fangyu/KCY-0521-2024","li, fangyu/0009-0009-8303-9157",,,,,34,14,19,1,39,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",0304-4238,1879-1018,,SCI HORTIC-AMSTERDAM,Sci. Hortic.,MAY 20,2008,116,4,,,,,414,420,,10.1016/j.scienta.2008.03.006,http://dx.doi.org/10.1016/j.scienta.2008.03.006,,,7,Horticulture,Science Citation Index Expanded (SCI-EXPANDED),Agriculture,310CS,,,,,2024-06-04,WOS:000256507100013,View Full Record in Web of Science
J,"Des Varannes, SB; Lehur, PA",,,,"Des Varannes, SB; Lehur, PA",,,Treatment of chronic idiopathic constipation,GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE,,,French,Article; Proceedings Paper,Solvay Pharma Symposium,"DEC 15-16, 2000","PARIS, FRANCE",Solvay Pharma,,constipation; biofeedback; diet; laxatives; colonic irrigation,BIOFEEDBACK THERAPY; POLYETHYLENE-GLYCOL; PHYSICAL-EXERCISE; DIETARY FIBER; LACTULOSE; SLOW; INGESTION; COLECTOMY; STOOL; ENEMA,GENERAL APPROACH TO PATIENTS WITH CONSTIPATION DIET AND LIFE-STYLE MODIFICATIONS USE OF LAXATIVES IN PATIENTS WITH CONSTIPATION TREATMENT OF CONSTIPATION BY FUNCTIONAL OUTLET OBSTRUCTION SURGICAL APPROACH TO SEVERE CONSTIPATION CONCLUSIONS AND PERSPECTIVES,"CHU Nantes, F-44035 Nantes, France",Nantes Universite; CHU de Nantes,"Des Varannes, SB (corresponding author), CHU Hotel Dieu, Serv Gatroenterol & Hepatol, F-44035 Nantes, France.",bruley@easynet.fr,,,,,,,54,0,0,0,1,MASSON EDITEUR,MOULINEAUX CEDEX 9,"21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE",0399-8320,,,GASTROEN CLIN BIOL,Gastroenterol. Clin. Biol.,SEP,2001,25,,,,2,,C63,C68,,,,,,6,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Gastroenterology & Hepatology,488MF,,,,,2024-06-04,WOS:000171938400010,View Full Record in Web of Science
J,"Borum, ML",,,,"Borum, ML",,,Constipation - Evaluation and management,PRIMARY CARE,,,English,Article,,,,,,,SEEKING HEALTH-CARE; ANORECTAL MANOMETRY; COLONIC DYSFUNCTION; MULTIPLE-SCLEROSIS; UNITED-STATES; POPULATION; TRANSIT; DEFECATION; DISORDERS; DEFECOGRAPHY,"Constipation is a common symptom that can result from several disorders. Most patients with chronic constipation do not have a medical disorder contributing to the constipation and, therefore, require limited evaluation. Initial intervention should include dietary measures and fiber supplements; however, if fiber supplementation is ineffective, other agents can be used. Surgery should be reserved for patients who meet specific clinical criteria.","George Washington Univ, Med Ctr, Dept Med, Div Gastroenterol, Washington, DC 20037 USA",George Washington University,"George Washington Univ, Med Ctr, Dept Med, Div Gastroenterol, 2150 Penn Ave NW,MFA Bldg,Suite 3-410, Washington, DC 20037 USA.",,,,,,,,47,18,22,0,0,W B SAUNDERS CO-ELSEVIER INC,PHILADELPHIA,"1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA",0095-4543,1558-299X,,PRIMARY CARE,Primary Care,SEP,2001,28,3,,,,,577,+,,10.1016/S0095-4543(05)70054-3,http://dx.doi.org/10.1016/S0095-4543(05)70054-3,,,15,"Primary Health Care; Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,474AE,11483445,,,,2024-06-04,WOS:000171081500008,View Full Record in Web of Science
J,"WALKER, ARP; SEGAL, I",,,,"WALKER, ARP; SEGAL, I",,,"DIETARY FIBER, BOWEL BEHAVIOR, AND CONSTIPATION",JOURNAL OF CLINICAL GASTROENTEROLOGY,,,English,Letter,,,,,,,,,"UNIV WITWATERSRAND,BARAGWANATH HOSP,DEPT GASTROENTEROL,JOHANNESBURG 2001,SOUTH AFRICA",University of Witwatersrand,"WALKER, ARP (corresponding author), UNIV WITWATERSRAND,SCH PATHOL,DEPT TROP PATHOL,HUMAN BIOCHEM RES UNIT,JOHANNESBURG 2001,SOUTH AFRICA.",,,,,,,,14,0,0,0,2,LIPPINCOTT-RAVEN PUBL,PHILADELPHIA,"227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106",0192-0790,,,J CLIN GASTROENTEROL,J. Clin. Gastroenterol.,AUG,1990,12,4,,,,,478,479,,10.1097/00004836-199008000-00028,http://dx.doi.org/10.1097/00004836-199008000-00028,,,2,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,DQ885,2168914,,,,2024-06-04,WOS:A1990DQ88500027,View Full Record in Web of Science
J,"MEYER, F; LEQUINTREC, Y",,,,"MEYER, F; LEQUINTREC, Y",,,RELATIONSHIP BETWEEN DIETARY-FIBERS AND CONSTIPATION,NOUVELLE PRESSE MEDICALE,,,French,Article,,,,,,,,,,,"MEYER, F (corresponding author), HOP ROTHSCHILD,SERV GASTROENTEROL & PATHOL DIGEST POST OPERAT,F-75571 PARIS 12,FRANCE.",,,,,,,,9,3,3,0,0,MASSON EDITEUR,PARIS 06,"120 BLVD SAINT-GERMAIN, 75280 PARIS 06, FRANCE",0301-1518,,,NOUV PRESSE MED,,,1981,10,30,,,,,2479,2481,,,,,,3,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,LY170,6267552,,,,2024-06-04,WOS:A1981LY17000003,View Full Record in Web of Science
J,"de Penna, EW; Serrano, L; Bunger, A; Soto, D; López, L; Hernández, N; Ruales, J",,,,"de Penna, EW; Serrano, L; Bunger, A; Soto, D; López, L; Hernández, N; Ruales, J",,,Optimization of a spaghetti formula enriched wich dietary fibre and micronutrients for elderly people.,ARCHIVOS LATINOAMERICANOS DE NUTRICION,,,Spanish,Article,,,,,,enriched spaguetti; fibre-enriched food; formula optimization; elderly,,"Optimization of a spaghetti formula enriched wich dietary fibre and micronutrients for elderly people. Several studies have demonstrated low dietary fiber intake in elderly people, which increases the risk of diseases such as constipation, colon cancer and diverticulosis. A spaghetti formula enriched with lupin fibre was developed to increase the dietary fibre intake in elderly people, as spaghetti are frequently consumed in this age group. Sweet lupin bran (Vitafiber(R)) was used as fibre source and gluten was used as improving additive. Response surface methodology with a two variable composite rotatable design was applied to optimize the formulations. The independent variables were lupin bran (7.14-14.29%) and gluten Vital (0.1-2.0%). The dependent variables were the responses of a trained 10-member sensory panel who evaluated the sensory quality parameters color, shape, aroma, flavor and texture by the Karlsruhe 9-point test. The optimized formula was prepared with 66.7% semoline, 7.14% lupin bran, 1.05% gluten and 24.7% water, enriched with 0.019% of a vitamin premix (A. E, D, B-2, B-12 and folic acid) and with 0.41% of a mineral premix (Ca, Fe, Zn), in order to meet 30% of the RDA for the elderly per 100g dry spaghetti. The dietary fibre content of the optimized product was 11.05g/100g. The study showed that fibre-enriched spaghetti formula is a good way to increase dietary fibre intake in elderly people, as it is a common food, simple to prepare and easy to eat.","Univ Chile, Inst Invest Ind Alimentos, Havana, Cuba",,"de Penna, EW (corresponding author), Univ Chile, Inst Invest Ind Alimentos, Havana, Cuba.",,,,,,,,46,4,4,0,4,ARCHIVOS LATINOAMERICANOS NUTRICION,CARACAS,"APARTADO 62778 CHACAO, AVENIDA FRANCISCO MIRANDA, CARACAS 1060, VENEZUELA",0004-0622,,,ARCH LATINOAM NUTR,Arch. Latinoam. Nutr.,MAR,2002,52,1,,,,,91,100,,,,,,10,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,567ZN,,,,,2024-06-04,WOS:000176518100014,View Full Record in Web of Science
J,"Chan, MF; Chan, YL",,,,"Chan, Moon Fai; Chan, Yuk Ling",,,Investigating factors associated with functional constipation of primary school children in Hong Kong,JOURNAL OF CLINICAL NURSING,,,English,Article,,,,,,children; constipation; Hong Kong; nurses; nursing; primary school,DIETARY FIBER INTAKE; CHILDHOOD CONSTIPATION; MANAGEMENT; EXPERIENCES; ENCOPRESIS; TOILETS; HABITS; RISK,"Aim. To examine what factors were associated with functional constipation amongst primary school students. Background. Constipation in school-age children has also been brought to the attention of health care researchers because this requires long-term therapy. The prognosis of functional constipation is vague because it has many causative factors. In fact, the focus on constipation in the health care system is always placed on medical management, rather than prevention. Design. A descriptive survey. Method. The survey was conducted on March 2008 at one primary school in Hong Kong; 383 children who are studying in primary 3-5 aged from 8-10 completed a questionnaire. Three main outcome variables were employed in the study: demographic, constipation assessment scale and dietary and environmental factors. Results. There were 7.3% students with functional constipation. Students who were age similar to 10 (p < 0.001), with a total daily fluid intake (200 ml/cup) of 3-4 cups (p < 0.001) or + 5 cups (p < 0.001) and preference for eating fruit and vegetables (p < 0.001) were less likely to have functional constipation. Conclusion. The findings should aid paediatric health care professionals and parents to gain a more profound understanding of the nature and prevention of functional constipation. To help primary school students and their parents to cope with functional constipation, greater familiarity with its prevalence and the characteristics of its contributory factors is needed. It is hoped that this could providing a better understanding and awareness of this issue and that it will encourage setting up strategies to decrease the morbidity and diminish the negative consequences of functional constipation for primary school students. Relevance to clinical practice. Nurses can act as advocators for primary school students, parents and school teachers in understanding and preventing functional constipation.","[Chan, Moon Fai] Natl Univ Singapore, Alice Lee Ctr Nursing Studies, Singapore 117574, Singapore; [Chan, Yuk Ling] Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Hong Kong, Peoples R China",National University of Singapore; Hong Kong Polytechnic University,"Chan, MF (corresponding author), Natl Univ Singapore, Alice Lee Ctr Nursing Studies, Block E3A,Level 3,7 Engn Dr 1, Singapore 117574, Singapore.",nurcmf@nus.edu.sg,"Chan, Moon Fai/AFK-1967-2022; Chan, Tony/IQW-1869-2023","Chan, Moon Fai/0000-0002-2899-3118;",,,,,43,12,12,0,8,"WILEY-BLACKWELL PUBLISHING, INC",MALDEN,"COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA",0962-1067,,,J CLIN NURS,J. Clin. Nurs.,DEC,2010,19,23-24,,,,,3390,3400,,10.1111/j.1365-2702.2010.03362.x,http://dx.doi.org/10.1111/j.1365-2702.2010.03362.x,,,11,Nursing,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Nursing,682AV,20946542,,,,2024-06-04,WOS:000284369800015,View Full Record in Web of Science
J,"Chen, T; Ma, YY; Xu, L; Sun, C; Xu, HX; Zhu, JC",,,,"Chen, Ting; Ma, Yuanyuan; Xu, Lei; Sun, Cheng; Xu, Hongxia; Zhu, Jingci",,,Soluble Dietary Fiber Reduces Feeding Intolerance in Severe Acute Pancreatitis: A Randomized Study,JOURNAL OF PARENTERAL AND ENTERAL NUTRITION,,,English,Article,,,,,,enteral nutrition; feeding intolerance; intestinal motility; severe acute pancreatitis; soluble dietary fiber,ENTERAL NUTRITION; CRITICALLY-ILL; INTESTINAL PERMEABILITY; PREBIOTICS; SUPPLEMENTATION; COMPLICATIONS; CONSTIPATION; GUIDELINES; MANAGEMENT; BLIND,"Background Feeding intolerance of enteral nutrition (EN) frequently occurs in patients with severe acute pancreatitis (SAP) because of intestinal motility disorders. Soluble dietary fiber (SDF) modulates the intestinal motility. The present study examined whether SDF can improve intestinal motility and permeability, and thereby reduce feeding intolerance, in patients with SAP. Methods This study was a single-blind, randomized, controlled, single-center trial. Forty-nine patients with SAP were included. The control and SDF groups received the same EN solution via a nasojejunal tube. The SDF group additionally received 20-g/d polydextrose. The primary outcome was the time to reach the energy goal. Follow-up was continued for 28 days after admission or until discharge from the hospital. Results Among 49 randomized patients, 46 patients (n = 22, control group; n = 24, SDF group) were included in the intent-to-treat analysis. The time to reach the energy goal was 7.00 (6.00, 8.25) days and 5.00 (4.25, 6.00) days in the control and SDF groups, respectively (P < 0.001). The rates of feeding intolerance were significantly reduced in the SDF group (59.09% vs 25.00%,P < .05). SDF was associated with decreases in the incidence of abdominal distension (72.73% vs 29.17%,P < .01), diarrhea (40.91% vs 8.33%,P < .05), and constipation (72.73% vs 12.50%,P < .001). The time to first flatus and first defecation were significantly shorter in the SDF group (P < .001). The intestinal mucosal barrier function and levels of gastrointestinal hormone were improved by SDF, as evidenced by significantly reduced blood levels of diamine oxidase, D-lactic acid, endotoxin, and vasoactive intestinal peptide (P < .05). Conclusions SDF shortens the time to reach the energy goal during EN and improves intestinal permeability and motility disorders, thus reducing the incidence of feeding intolerance in SAP patients.","[Chen, Ting] Gen Hosp Western Theater Command, Gen Surg Ctr, Chengdu, Sichuan, Peoples R China; [Chen, Ting; Ma, Yuanyuan; Zhu, Jingci] Third Mil Med Univ, Sch Nursing, Dept Basic Nursing, Army Med Univ, Chongqing, Peoples R China; [Ma, Yuanyuan] 75th Army Grp Hosp, Nursing Dept, Kunming, Yunnan, Peoples R China; [Xu, Lei] 940th Hosp Joint Logist Support Force Chinese Peo, Operating Room, Lanzhou, Peoples R China; [Sun, Cheng] Guangzhou First Peoples Hosp, Dept Cardiol, Guangzhou, Peoples R China; [Xu, Hongxia] Third Mil Med Univ, Daping Hosp, Dept Clin Nutr, Army Med Univ, Chongqing, Peoples R China",Army Medical University; South China University of Technology; Army Medical University,"Zhu, JC (corresponding author), Third Mil Med Univ, Sch Nursing, Dept Basic Nursing, Army Med Univ, Chongqing, Peoples R China.;Xu, HX (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Clin Nutr, Army Med Univ, Chongqing, Peoples R China.",hx_xu1975@126.com; zhujingci2009@163.com,"Xu, Hongxia/AAN-8608-2021; chen, bin/KBQ-8114-2024","chen, bin/0000-0002-3398-1314; xu, hongxia/0000-0001-5215-734X; chen, ting/0000-0001-8414-6346; Zhu, Jingci/0000-0002-7992-8420",,,,,50,21,26,2,16,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0148-6071,1941-2444,,JPEN-PARENTER ENTER,J. Parenter. Enter. Nutr.,JAN,2021,45,1,,,,,125,135,,10.1002/jpen.1816,http://dx.doi.org/10.1002/jpen.1816,,MAR 2020,11,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,PZ4CF,32141126,,,,2024-06-04,WOS:000561147300001,View Full Record in Web of Science
J,"Silveira, EA; Santos, ASEAD; Ribeiro, JN; Noll, M; Rodrigues, APD; de Oliveira, C",,,,"Silveira, Erika Aparecida; de Carvalho Santos, Annelisa Silva e Alves; Ribeiro, Jessivane Nascimento; Noll, Matias; dos Santos Rodrigues, Ana Paula; de Oliveira, Cesar",,,Prevalence of constipation in adults with obesity class II and III and associated factors,BMC GASTROENTEROLOGY,,,English,Article,,,,,,Constipation; Dietary habits; Polypharmacy; Functional gastrointestinal disorders; Morbid obesity,FUNCTIONAL GASTROINTESTINAL DISORDERS; SYMPTOMS; EPIDEMIOLOGY; CRITERIA; CANCER; BRAZIL; STATE; DIET; RISK,"BackgroundConstipation and obesity have common risk factors. However, little is known about the occurrence of constipation in individuals with severe obesity and the associated factors.ObjectiveTo evaluate the prevalence of intestinal constipation and its associated factors in adults with obesity class II and III.MethodThis study analyzed baseline data from a randomized clinical trial with adults aged 18-64 with a Body Mass Index (BMI)>= 35 kg/m(2), living in the metropolitan region of Goiania, Brazil. Data were collected using a questionnaire containing sociodemographic, lifestyle, level of obesity, presence of comorbidities, water intake and food consumption variables. The outcome variable was constipation assessed by the Rome III criteria and the Bristol Stool Form Scale. Multiple Poisson regression analysis was used to assess the association between explanatory variables and the outcome.ResultsAmong the 150 participants, the prevalence of constipation was 24.67% (95% CI: 17.69-31.64). After multiple regression analyses constipation was associated with polypharmacy (adjusted PR: 2.99, 95% CI: 1.18-7.57, p=0.021), younger age group i.e. 18-29 years (adjusted PR: 3.12, 95% CI: 1.21-8.06, p=0.019) and former smoking (adjusted PR: 3.24, 95% CI: 1.28-9.14, p=0.014). There was no statistically significant association between constipation and daily consumption of fiber-rich foods, however, the non-consumption of whole grains was borderline significant (adjusted PR: 2.92, 95% CI: 1.00 to 8.49, p=0.050).ConclusionA high prevalence of constipation was found in adults with obesity class II and III. Constipation was significantly associated with the simultaneous use of five or more medications, younger age group and being a former smoker.","[Silveira, Erika Aparecida; de Carvalho Santos, Annelisa Silva e Alves; Ribeiro, Jessivane Nascimento; Noll, Matias; dos Santos Rodrigues, Ana Paula] Univ Fed Goias, Postgrad Program Hlth Sci, Fac Med, Goiania, Go, Brazil; [Silveira, Erika Aparecida] UCL, Affiliate Acad, Dept Epidemiol & Publ Hlth, London, England; [Noll, Matias] Fed Inst Goiano, Ceres, Brazil; [de Oliveira, Cesar] UCL, Dept Epidemiol & Publ Hlth, London, England",Universidade Federal de Goias; University of London; University College London; Instituto Federal Goiano; University of London; University College London,"Silveira, EA (corresponding author), Univ Fed Goias, Postgrad Program Hlth Sci, Fac Med, Goiania, Go, Brazil.",erikasil@terra.com.br,"de Oliveira, Cesar/B-5251-2019; Silveira, Erika Aparecida/O-7585-2018; noll, matias/AAT-6582-2020; noll, matias/E-6993-2013","Silveira, Erika Aparecida/0000-0002-8839-4520; noll, matias/0000-0002-1482-0718; noll, matias/0000-0002-1482-0718; De Oliveira, Cesar/0000-0002-4099-4762; Santos, Annelisa/0000-0003-0045-6991",Research Support Foundation of the State of Goias (FAPEG) [201310267000003]; Coordination for the Improvement of Higher Education Personnel (CAPES); Economic and Social Research Council (ESRC) [ES/T008822/11],Research Support Foundation of the State of Goias (FAPEG); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)),"Research Support Foundation of the State of Goias (FAPEG), for granting partial funding for the DieTBra Trial study (Grant No. 201310267000003), and the Coordination for the Improvement of Higher Education Personnel (CAPES) for granting a doctoral scholarship to Santos ASAC. Dr Cesar de Oliveira is supported by the Economic and Social Research Council (ESRC) (Grant ES/T008822/11).",,67,14,15,1,6,BMC,LONDON,"CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND",,1471-230X,,BMC GASTROENTEROL,BMC Gastroenterol.,MAY 12,2021,21,1,,,,,,,217,10.1186/s12876-021-01806-5,http://dx.doi.org/10.1186/s12876-021-01806-5,,,10,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,WJ8DA,33980157,"Green Published, gold",,,2024-06-04,WOS:000709268000002,View Full Record in Web of Science
J,"Imanieh, MH; Banani, SA; Dehghani, SM; Khajeh, R; Gakurya, I; Mehrabani, D",,,,"Imanieh, M. H.; Banani, S. A.; Dehghani, S. M.; Khajeh, R.; Gakurya, I.; Mehrabani, D.",,,Bowel movement patterns in children with acute appendicitis,IRANIAN RED CRESCENT MEDICAL JOURNAL,,,English,Article,,,,,,acute appendicitis; children; dietary fiber; constipation,DIETARY FIBER; APPENDECTOMY,"Background: Acute appendicitis is currently one of the most important causes of acute abdominal peritonitis and emergency laparatomy. Despite its low mortality, it remains a cause of concern for surgeons due to the postoperative complications of wound infection, sepsis, intrabdominal abscess and even bowel obstruction resulting from adhesions. High incidence of acute appendicitis provides a strong impetus for further studies. This study was conducted to determine the bowel movement patterns and dietary fiber consumption in pediatric patients with appendicitis in Shiraz, southern Iran. Methods: The study included 202 pediatric patients under the age of 18 years at Nemazee Hospital affiliated to Shiraz University of Medical Sciences, who had undergone appendectomy with the preoperative diagnosis of acute appendicitis from March 2003 to March 2004. Using a written semi-standard questionnaire, the variables recorded were age, gender, stool consistency, number of bowel movements, type of bread consumed, habit of fruit and vegetable consumption, clinical presentation (signs and symptoms) and the time taken from the onset of symptoms to arrival in hospital, the date of patients admission to the emergency room to the time of surgery, and the duration of postoperative hospitalization. The pathology of appendicitis was clarified and recorded. Results: The patients aged from 3-18 years (mean: 11.2 +/- 3.6 years), with a male to female ratio of 2:4. Anorexia was the most common symptom, affecting 78.7% of patients. Of 31 patients with constipation, 58% did not report daily regular intake of fruits while the others had regular fruit intake. Only 3 patients (9.7%) had regular daily consumption of vegetables, and 27 patients (87.1%) had pathology reports of fecalith, while in the non-constipated patients, only 1.2% had such reports. The abdominal pain was periumbilical in many patients (42.6%), which shifted to McBurny point in most (96%) patients. 134 patients (66.3%) visited a health center within 24 hours after the first symptoms. Surgeries were performed on 132 patients (65.3%) within 6 hours, on 67 patients (33%) within 6-12 hours, and on 3 patients (2%) in more than 12 hours. Conclusion: Our findings suggest a high rate of constipation in patients with lower fiber intake, which is consistent with the hypothesis indicating the role of dietary fibers in lowering the incidence of appendicitis.","[Imanieh, M. H.; Dehghani, S. M.; Khajeh, R.] Shiraz Univ Med Sci, Nemazee Hosp, Dept Pediat Gastroenterol, Shiraz, Iran; [Imanieh, M. H.; Dehghani, S. M.; Gakurya, I.; Mehrabani, D.] Shiraz Univ Med Sci, Nemazee Hosp, Gastroenterohepatol Res Ctr, Shiraz, Iran; [Banani, S. A.] Shiraz Univ Med Sci, Nemazee Hosp, Dept Pediat Surg, Shiraz, Iran",Shiraz University of Medical Science; Shiraz University of Medical Science; Shiraz University of Medical Science,"Dehghani, SM (corresponding author), Shiraz Univ Med Sci, Nemazee Hosp, Gastroenterohepatol Res Ctr, Shiraz, Iran.",dehghanism@sums.ac.ir,"Imanieh, Mohammad Hadi/AAF-7426-2019; Imanieh, Mohammad Hadi/M-7068-2016; Mehrabani, Davood/K-7509-2013","Imanieh, Mohammad Hadi/0000-0003-4610-0413; Mehrabani, Davood/0000-0002-5738-1719",,,,,17,1,1,0,0,KOWSAR PUBL,HOENSBROEK,"PATERSWEG 22,, HOENSBROEK, LIMBURG 6431 GC, NETHERLANDS",2074-1804,2074-1812,,IRAN RED CRESCENT ME,Iran. Red Crescent Med. J.,APR,2007,9,2,,,,,86,92,,,,,,7,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,319UU,,,,,2024-06-04,WOS:000257190600007,View Full Record in Web of Science
J,"Sadler, K; Arnold, F; Dean, S",,,,"Sadler, Kerry; Arnold, Frank; Dean, Spencer",,,Chronic Constipation in Adults,AMERICAN FAMILY PHYSICIAN,,,English,Article,,,,,,,CHRONIC IDIOPATHIC CONSTIPATION; STOOL FREQUENCY; DIETARY FIBER; DOUBLE-BLIND; MANAGEMENT; ASSOCIATION; EFFICACY; EPIDEMIOLOGY; LUBIPROSTONE; LINACLOTIDE,"Chronic constipation has significant quality-of-life implications. Modifiable risk factors include insufficient physical activity, depression, decreased caloric intake, and aggravating medication use. Chronic constipation is classified as primary (normal transit, slow transit, defecatory disorders, or a combination) or secondary (due to medications, chronic diseases, or anatomic abnormalities). Evaluation begins with a detailed history, medication reconciliation, and physical examination. Routine use of laboratory studies or imaging, including colonoscopy, is not recommended in the absence of alarm symptoms. Patients with alarm symptoms or who are overdue for colorectal cancer screening should be referred for colonoscopy. First-line treatment for primary constipation includes ensuring adequate fluid intake, dietary fiber supplementation, and osmotic laxatives. Second -line therapy includes a brief trial of stimulant laxatives followed by intestinal secretagogues. If the initial treatment approach is ineffective, patients should be referred to gastroenterology for more specialized testing, such as anorectal manometry and a balloon expulsion test. Patients with refractory constipation may be considered for surgery. Those in whom pelvic floor dysfunction is identified early should be referred for pelvic floor therapy with biofeedback while first-line medications, such as bulk or osmotic laxatives, are initiated. (C) Copyright 2022 American Academy of Family Physicians.","[Sadler, Kerry; Arnold, Frank; Dean, Spencer] Naval Hosp, Jacksonville Family Med Residency Program, Jacksonville, FL USA; [Sadler, Kerry; Arnold, Frank] Uniformed Serv Univ Hlth Sci, Family Med, Bethesda, MD 20814 USA",United States Department of Defense; United States Navy; Uniformed Services University of the Health Sciences - USA,"Sadler, K (corresponding author), 2080 Child St, Jacksonville, FL 32214 USA.",kerry.p.sadler.mil@mail.mil,,,,,,,46,1,1,0,3,AMER ACAD FAMILY PHYSICIANS,KANSAS CITY,"8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797 USA",0002-838X,1532-0650,,AM FAM PHYSICIAN,Am. Fam. Physician,SEP,2022,106,3,,,,,299,306,,,,,,8,"Primary Health Care; Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,4P5FJ,36126011,,,,2024-06-04,WOS:000855419400012,View Full Record in Web of Science
J,"Rollet, M; Bohn, T; Vahid, F",,,,"Rollet, Maurane; Bohn, Torsten; Vahid, Farhad",,ORISCAV Working Grp,Association between Dietary Factors and Constipation in Adults Living in Luxembourg and Taking Part in the ORISCAV-LUX 2 Survey,NUTRIENTS,,,English,Article,,,,,,macronutrients; micronutrients; diarrhea; digestive diseases; food groups; colon,BOWEL MOVEMENT FREQUENCY; BILE-ACID METABOLISM; KETOGENIC DIET; GUT MICROBIOTA; FATTY-ACID; FIBER; CONSISTENCY; POPULATION; MANAGEMENT; DISORDERS,"Constipation, a disorder of bowel movements, is among the most frequent gastrointestinal complaints in Western countries. Dietary constituents such as inadequate fiber intake have been related to constipation, but discrepancies exist in the findings regarding dietary factors. This study investigated the association between dietary patterns and bowel movements in adults living in Luxembourg. Data from 1431 participants from ORISCAV-LUX 2 (a cross-sectional survey) who completed a 174-item food frequency questionnaire (FFQ) were analyzed. A questionnaire-based constipation score was assessed by a validated scoring system. Confounders such as physical activity and serum/urine indicators were assessed. Women had higher constipation scores than men (p < 0.001). In food group-based regression models, a negative association was found between higher constipation score and intake of grains (Beta = -0.62, 95%CI: -1.18, -0.05) and lipid-rich foods (Beta = -0.84, 95%CI: -1.55, -0.13), while a positive association was found for sugary products (Beta = 0.54, 95%CI: 0.11, 0.97) (p < 0.05). In a nutrient-based regression model, a positive association was found between constipation score and total energy (Beta = 5.24, 95%CI: 0.37, 10.11) as well as sodium intake (Beta = 2.04, 95%CI: 0.21, 3.87), and a negative one was found for total fats (Beta = -4.17, 95%CI: -7.46, -0.89) and starch (Beta = -2.91, 95%CI: -4.47, -1.36) (p < 0.05). Interestingly, neither fruits and vegetables or dietary fiber were significantly associated with constipation. Thus, grains, lipid-rich foods, total fats and starch were associated with a lower constipation score, while sugary products, sodium, and higher energy intake were correlated with higher constipation.","[Rollet, Maurane; Bohn, Torsten; Vahid, Farhad] Luxembourg Inst Hlth, Nutr & Hlth Res Grp, Dept Populat Hlth, L-1445 Strassen, Luxembourg",Luxembourg Institute of Health,"Bohn, T (corresponding author), Luxembourg Inst Hlth, Nutr & Hlth Res Grp, Dept Populat Hlth, L-1445 Strassen, Luxembourg.",maurane.rollet@orange.fr; Torsten.Bohn@lih.lu; farhadvahid@outlook.com,"Bohn, Torsten/AAE-8393-2019; Vahid, Farhad/L-7547-2018","Bohn, Torsten/0000-0002-7825-0697; Vahid, Farhad/0000-0002-7380-3790; Aguayo, Gloria A/0000-0002-5625-1664",LIH,LIH,The ORISCAV-LUX 2 data collection was funded by the LIH (MESR funding).,,75,9,9,1,10,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,JAN,2022,14,1,,,,,,,122,10.3390/nu14010122,http://dx.doi.org/10.3390/nu14010122,,,18,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,YF4GH,35010999,"Green Published, gold",,,2024-06-04,WOS:000741766600001,View Full Record in Web of Science
J,"Mounsey, A; Raleigh, M; Wilson, A",,,,"Mounsey, Anne; Raleigh, Meghan; Wilson, Anthony",,,Management of Constipation in Older Adults,AMERICAN FAMILY PHYSICIAN,,,English,Article,,,,,,,OPIOID-INDUCED CONSTIPATION; DOUBLE-BLIND; THERAPIES; EFFICACY; LUBIPROSTONE; TRIALS; SAFETY; FIBER,"Chronic constipation is common in adults older than 60 years, and symptoms occur in up to 50% of nursing home residents. Primary constipation is also referred to as functional constipation. Secondary constipation is associated with chronic disease processes, medication use, and psychosocial issues. Fecal impaction should be treated with mineral oil or warm water enemas. Most patients are initially treated with lifestyle modifications, such as scheduled toileting after meals, increased fluid intake, and increased dietary fiber intake. Additional fiber intake in the form of polycarbophil, methylcellulose, or psyllium may improve symptoms. Fiber intake should be slowly increased over several weeks to decrease adverse effects. The next step in the treatment of constipation is the use of an osmotic laxative, such as polyethylene glycol, followed by a stool softener, such as docusate sodium, and then stimulant laxatives. Long-term use of magnesium-based laxatives should be avoided because of potential toxicity. If symptoms do not improve, a trial of linaclotide or lubiprostone may be appropriate, or the patient may be referred for further diagnostic evaluation. Peripherally acting mu-opioid antagonists are effective for opioid-induced constipation but are expensive. (Am Fam Physician. 2015;92 (6): 500-504. Copyright (C) 2015 American Academy of Family Physicians.)","[Mounsey, Anne] Univ N Carolina, Med Clin, Chapel Hill, NC USA; [Raleigh, Meghan; Wilson, Anthony] Univ N Carolina, Chapel Hill, NC USA",University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill,"Mounsey, A (corresponding author), Univ N Carolina, 590 Manning Dr, Chapel Hill, NC 27514 USA.",anne_mounsey@med.unc.edu,,,,,,,34,52,59,0,20,AMER ACAD FAMILY PHYSICIANS,KANSAS CITY,"8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797 USA",0002-838X,1532-0650,,AM FAM PHYSICIAN,Am. Fam. Physician,SEP 15,2015,92,6,,,,,500,504,,,,,,5,"Primary Health Care; Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,CR6AA,26371734,,,,2024-06-04,WOS:000361424300013,View Full Record in Web of Science
J,"Sarriá, B; Martínez-López, S; Fernández-Espinosa, A; Gómez-Juaristi, M; Goya, L; Mateos, R; Bravo, L",,,,"Sarria, Beatriz; Martinez-Lopez, Sara; Fernandez-Espinosa, Aranzazu; Gomez-Juaristi, Miren; Goya, Luis; Mateos, Raquel; Bravo, Laura",,,"Effects of regularly consuming dietary fibre rich soluble cocoa products on bowel habits in healthy subjects: a free-living, two-stage, randomized, crossover, single-blind intervention",NUTRITION & METABOLISM,,,English,Article,,,,,,Dietary fibre; Cocoa; Bowel function; Gastrointestinal transit time,GASTROINTESTINAL TRANSIT; INDIGESTIBLE FRACTION; PHYSICAL-ACTIVITY; HIGH-FAT; MALONDIALDEHYDE; DEFECATION; WEIGHT; FOODS; ACIDS; BRAN,"Background: Dietary fibre is both preventive and therapeutic for bowel functional diseases. Soluble cocoa products are good sources of dietary fibre that may be supplemented with this dietary component. This study assessed the effects of regularly consuming two soluble cocoa products (A and B) with different non-starch polysaccharides levels (NSP, 15.1 and 22.0% w/w, respectively) on bowel habits using subjective intestinal function and symptom questionnaires, a daily diary and a faecal marker in healthy individuals. Methods: A free-living, two-stage, randomized, crossover, single-blind intervention was carried out in 44 healthy men and women, between 18-55 y old, who had not taken dietary supplements, laxatives, or antibiotics six months before the start of the study. In the four-week-long intervention stages, separated by a three-week-wash-out stage, two servings of A and B, that provided 2.26 vs. 6.60 g/day of NSP respectively, were taken. In each stage, volunteers' diet was recorded using a 72-h food intake report. Results: Regularly consuming cocoa A and B increased fibre intake, although only cocoa B significantly increased fibre intake (p < 0.001) with respect to the non-cocoa stage. No changes in body weight were observed in either of the 4 week interventions. With cocoa product B, the number of daily bowel movements increased (p = 0.002), the frequency of having a bowel movement once a day increased (p = 0.009), the time to have a bowel movement was lower (p = 0.016) as well as the feeling of constipation (p = 0.046) without inducing adverse gastrointestinal symptoms, only flatulence increased (p = 0.019). Conclusions: Regular consumption of the cocoa products increases dietary fibre intake to recommended levels and product B improves bowel habits. The use of both objective and subjective assessments to evaluate the effects of food on bowel habits is recommended.","[Sarria, Beatriz; Martinez-Lopez, Sara; Fernandez-Espinosa, Aranzazu; Gomez-Juaristi, Miren; Goya, Luis; Mateos, Raquel; Bravo, Laura] CSIC, Inst Food Sci Technol & Nutr ICTAN, Dept Metab & Nutr, Madrid 28040, Spain",Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia y Tecnologia de Alimentos y Nutricion (ICTAN),"Sarriá, B (corresponding author), CSIC, Inst Food Sci Technol & Nutr ICTAN, Dept Metab & Nutr, Jose Antonio Novais 10, Madrid 28040, Spain.",beasarria@ictan.csic.es,"Bravo, Laura/JMC-4928-2023; Sarria, Beatriz/K-7929-2014; BRIZ, Raquel MATEOS/H-9125-2012; Bravo, Laura/F-4992-2012; Goya, Luis/H-5735-2012","Sarria, Beatriz/0000-0003-0614-4606; BRIZ, Raquel MATEOS/0000-0002-9722-1939; Bravo, Laura/0000-0002-7312-8641; Martinez Lopez, Sara/0000-0002-4587-7100; Goya, Luis/0000-0001-9449-6200","Spanish Ministry of Science and Innovation [AGL2007-64042, CSD2007-00063]; European Social Fund (ESF); CSIC; ESF; Nutrexpa S. L.",Spanish Ministry of Science and Innovation(Spanish Government); European Social Fund (ESF)(European Social Fund (ESF)); CSIC; ESF; Nutrexpa S. L.,"We thank the volunteers who participated in this study as well as Laura Barrios for her statistical assistance. Projects AGL2007-64042 and Consolider-Ingenio (CSD2007-00063) from the Spanish Ministry of Science and Innovation also acknowledged. S.M.-L. is a JAE-Predoc fellow of CSIC Programme Junta para la Ampliacion de Estudios co-funded by the European Social Fund (ESF). M.G.-J. is a predoctoral fellow of the Spanish Ministry of Science and Innovation. A.F.-E. was a FINNOVA fellow also cofinanced by CSIC and the ESF. We also thank Jose Luis Sierra-Cisnos por preparing the Brilliant Blue capsules. There are no conflicts of interest.; This study was funded by Nutrexpa S. L. It may be possible that in the future this company may gain financially from the publication of this manuscript. However, nowadays there are non-competing interests, as the interpretation of data or presentation of information has not been influenced by any personal or financial relationship with the organization, which has not financed the publication of this manuscript.",,42,7,9,0,24,BMC,LONDON,"CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND",,1743-7075,,NUTR METAB,Nutr. Metab.,APR 18,2012,9,,,,,,,,33,10.1186/1743-7075-9-33,http://dx.doi.org/10.1186/1743-7075-9-33,,,10,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,956IZ,22512838,"gold, Green Published",,,2024-06-04,WOS:000305084600001,View Full Record in Web of Science
J,"Champ, MMJ",,,,"Champ, Martine M. J.",,,More dietary fibres for mothers and their baby?,AGRO FOOD INDUSTRY HI-TECH,,,English,Article,,,,,,,HUMAN-MILK; PREGNANCY; CONSTIPATION; RISK; OLIGOSACCHARIDES; CHILDBIRTH; PREVALENCE; MICROBIOTA; GLUCOSE; INSULIN,"Both pregnancy and lactation require additional energy and nutrients for foetal growth and milk production. It is assumed that adequate intake of fibre of the pregnant and lactating women should be respectively 28 and 29g fibre per day compared to 25g for other women. As a matter of fact, there are very few data which provide precise and relevant quantitative and qualitative recommendations to the mother. However, the prevention of constipation, gestational diabetes mellitus or hypertension (preeclampsia) seems to benefit from a high intake of dietary fibre provided by foods such as whole meal cereals and fruits but more evidence have to be obtained. Breast fed infants are also exposed to non digestible carbohydrates which are sialylated and fucosylated oligosaccharides. These oligosaccharides are not yet present in infant formula however some formulae contain simpler oligosaccharides with prebiotic properties.","CHU Hotel Dieu, CRNH, INRA, UMR PhAN, F-44093 Nantes 1, France",INRAE; Nantes Universite; CHU de Nantes,"Champ, MMJ (corresponding author), CHU Hotel Dieu, CRNH, INRA, UMR PhAN, HNB1 Pl Alexis Ricordeau, F-44093 Nantes 1, France.",,,,,,,,31,0,0,1,14,TEKNOSCIENZE PUBL,MILANO,"VIALE BRIANZA 22, 20127 MILANO, ITALY",1722-6996,2035-4606,,AGRO FOOD IND HI TEC,Agro Food Ind. Hi-Tech,JAN-FEB,2011,22,1,,,,,7,9,,,,,,3,Biotechnology & Applied Microbiology; Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Biotechnology & Applied Microbiology; Food Science & Technology,732JG,,,,,2024-06-04,WOS:000288180200003,View Full Record in Web of Science
J,"Turawa, EB; Musekiwa, A; Rohwer, AC",,,,"Turawa, Eunice B.; Musekiwa, Alfred; Rohwer, Anke C.",,,Interventions for preventing postpartum constipation,COCHRANE DATABASE OF SYSTEMATIC REVIEWS,,,English,Review,,,,,,Constipation [*prevention & control]; Dietary Fiber [*therapeutic use]; Laxatives [*therapeutic use]; Perineum [injuries]; *Postpartum Period; Randomized Controlled Trials as Topic; Adult; Female; Humans,MATERNAL HEALTH; CLINICAL-TRIAL; PRIMARY REPAIR; EPIDEMIOLOGY; PREVALENCE; SYMPTOMS; WOMEN,"Background Postpartum constipation, with symptoms, such as pain or discomfort, straining, and hard stool, is a common condition affecting mothers. Haemorrhoids, pain at the episiotomy site, effects of pregnancy hormones, and haematinics used in pregnancy can increase the risk of postpartum constipation. Eating a high-fibre diet and increasing fluid intake are usually encouraged. Although laxatives are commonly used in relieving constipation, the effectiveness and safety of available interventions for preventing postpartum constipation should be ascertained. This is an update of a review first published in 2015. Objectives To evaluate the effectiveness and safety of interventions for preventing postpartum constipation. Search methods We searched Cochrane Pregnancy and Childbirth's Trials Register, and two trials registers ClinicalTrials.gov, the WHO International Clinical Trials Registry Platform (ICTRP) (7 October 2019), and screened reference lists of retrieved trials. Selection criteria We considered all randomised controlled trials (RCTs) comparing any intervention for preventing postpartum constipation versus another intervention, placebo, or no intervention in postpartum women. Interventions could include pharmacological (e.g. laxatives) and non-pharmacological interventions (e.g. acupuncture, educational and behavioural interventions). Quasi-randomised trials and cluster-RCTs were eligible for inclusion; none were identified. Trials using a cross-over design were not eligible. Data collection and analysis Two review authors independently screened the results of the search to select potentially relevant trials, extracted data, assessed risk of bias, and the certainty of the evidence, using the GRADE approach. We did not pool results in a meta-analysis, but reported them per study. Main results We included five trials (1208 postpartum mothers); three RCTs and two quasi-RCTs. Four trials compared a laxative with placebo; one compared a laxative plus a bulking agent versus the same laxative alone, in women who underwent surgical repair of third degree perineal tears. Trials were poorly reported, and four of the five trials were published over 40 years ago. We judged the risk of bias to be unclear for most domains. Overall, we found a high risk of selection and attrition bias. Laxative versus placebo We included four triaLs in this comparison. Two of the trials examined the effects of Laxatives that are no Longer used; one has been found to have carcinogenic properties (Danthron), and the other is not recommended for lactating women (Bisoxatin acetate); therefore, we did not include their results in our main findings. None of the trials included in this comparison assessed our primary outcomes: pain or straining on defecation, incidence of postpartum constipation, or quality of life; or many of our secondary outcomes. A laxative (senna) may increase the number of women having their first bowel movement within 24 hours after delivery (risk ratio (RR) 2.90, 95% confidence interval (CI) 2.24 to 3.75; 1 trial, 471 women; low-certainty evidence); may have little or no effect on the number of women having their first bowel movement on day one after delivery (RR 0.94, 95% CI 0.72 to 1.22; 1 trial, 471 women; very low-certainty evidence); may reduce the number of women having their first bowel movement on day two (RR 0.23, 95% CI 0.11 to 0.45; 1 trial, 471 women; low-certainty evidence); and day three (RR 0.05, 95% CI 0.00 to 0.89; 1 trial, 471 women; low-certainty evidence); and may have litte or no effect on the number of women having their first bowel movement on day four after delivery (RR 0.22, 95% CI 0.03 to 1.87; 1 trial, 471 women; very low-certainty evidence), but some of the evidence is very uncertain. Adverse effects were poorly reported. Low-certainty evidence suggests that the laxative (senna) may increase the number of women experiencing abdominal cramps (RR 4.23, 95% CI 1.75 to 10.19; 1 trial, 471 women). Very low-certainty evidence suggests that laxatives taken by the mother may have little or no effect on Loose stooLs in the baby (RR 0.62, 95% CI 0.16 to 2.41; 1 triaL, 281 babies); or diarrhoea (RR 2.46, 95% CI 0.23 to 26.82; 1 trial, 281 babies). Laxative plus bulking agent versus laxative only Very Low-certainty evidence from one trial (147 women) suggests no evidence of a difference between these two groups of women who underwent surgical repair of third degree perineal tears; only median and range data were reported. The trial also reported no evidence of a difference in the incidence of postpartum constipation (data not reported), but did not report on quality of life. Time to first bowel movement was reported as a median (range); very low-certainty evidence suggests little or no difference between the two groups. A laxative plus bulking agent may increase the number of women having any episode of faecal incontinence during the first 10 days postpartum (RR 1.81, 95% CI 1.01 to 3.23; 1 trial, 147 women; very low-certainty evidence). The trial did not report on adverse effects of the intervention on babies, or many of our secondary outcomes. Authors' conclusions There is insufficient evidence to make general conclusions about the effectiveness and safety of laxatives for preventing postpartum constipation. The evidence in this review was assessed as low to very low-certainty evidence, with downgrading decisions based on limitations in study design, indirectness and imprecision. We did not identify any trials assessing educational or behavioural interventions. We identified four trials that examined laxatives versus placebo, and one that examined laxatives versus laxatives plus stool bulking agents. Further, rigorous trials are needed to assess the effectiveness and safety of laxatives during the postpartum period for preventing constipation. Trials shouLd assess educationaL and behavioural interventions, and positions that enhance defecation. They should report on the primary outcomes from this review: pain or straining on defecation, incidence of postpartum constipation, quality of life, time to first bowel movement after delivery, and adverse effects caused by the intervention, such as: nausea or vomiting, pain, and flatus.","[Turawa, Eunice B.] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Global Hlth, Div Hlth Syst & Publ Hlth, Cape Town, South Africa; [Turawa, Eunice B.] South African Med Res Council, Burden Dis Res Unit, Cape Town, South Africa; [Musekiwa, Alfred] Stellenbosch Univ, Fac Med & Hlth Sci, Ctr Evidence Based Hlth Care, Div Epidemiol & Biostat, Cape Town, South Africa; [Rohwer, Anke C.] Stellenbosch Univ, Fac Med & Hlth Sci, Ctr Evidence Based Hlth Care, Cape Town, South Africa",Stellenbosch University; South African Medical Research Council; Stellenbosch University; Stellenbosch University,"Turawa, EB (corresponding author), Stellenbosch Univ, Fac Med & Hlth Sci, Dept Global Hlth, Div Hlth Syst & Publ Hlth, Cape Town, South Africa.;Turawa, EB (corresponding author), South African Med Res Council, Burden Dis Res Unit, Cape Town, South Africa.",kbolanle@gmail.com,"Musekiwa, Alfred/IUP-3659-2023","Musekiwa, Alfred/0000-0001-5880-3680","National Institute for Health Research (NIHR) Cochrane Review Incentive Scheme award, UK [14/175/47]; Research, Evidence and Development Initiative (READ-It) project, UK","National Institute for Health Research (NIHR) Cochrane Review Incentive Scheme award, UK; Research, Evidence and Development Initiative (READ-It) project, UK","National Institute for Health Research (NIHR) Cochrane Review Incentive Scheme award, UK; Award number 14/175/47; Research, Evidence and Development Initiative (READ-It) project, UK",,57,7,8,4,29,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1469-493X,1361-6137,,COCHRANE DB SYST REV,Cochrane Database Syst Rev.,,2020,,8,,,,,,,CD011625,10.1002/14651858.CD011625.pub3,http://dx.doi.org/10.1002/14651858.CD011625.pub3,,,46,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,NN3IF,32761813,Green Published,,,2024-06-04,WOS:000568684200041,View Full Record in Web of Science
J,"Boilesen, SN; Dias, FC; Tahan, S; Melli, LCFL; de Morais, MB",,,,"Boilesen, Sabine Nunes; Dias, Francine C.; Tahan, Soraia; Melli, Ligia C. F. L.; de Morais, Mauro Batista",,,Fluid intake and urinary osmolality in pediatric patients with functional constipation,EUROPEAN JOURNAL OF NUTRITION,,,English,Article,,,,,,Constipation; Drinking; Urine; Child,CHILDHOOD CONSTIPATION; HYDRATION STATUS; DIETARY FIBER; CHILDREN; WATER; PREVENTION,"Purpose This study aimed to evaluate fluid intake and urinary osmolality in pediatric patients with functional constipation. Methods This was a cross-sectional, case-control study that prospectively included two groups: 36 pediatric patients older than 4 years with functional constipation (Rome III criteria) who were consecutively admitted in a public tertiary pediatric gastroenterology outpatient clinic and 93 controls with normal bowel habits. The control group was recruited from a public school and did not have any of the characteristics of the Rome III criteria. Fluid and food intakes were assessed using a daily diet inquiry and 24 h recording method. Hypohydration was defined as osmolality greater than 800 mOsm/kg H2O in a spot urine sample. Results The age of the functional constipation group (median, 8.9 years; range 7.3-10.0 years) and the control group (8.8 years) was similar (p = 0.51). The proportion of boys in the functional constipation group (76.6%; 25/36) was higher (p = 0.01) than that in the control group (45.2%; 41/93). The total water intake of the functional constipation group (median 1566 mL) was lower (p < 0.001) than that of the control group (median 2177 mL). Urinary osmolality was higher (p = 0.039) in the functional constipation group (median 859 mOsm/kg H2O) than in the control group (median 775 mOsm/kg H2O). The association between hypohydration and functional constipation did not reach statistical significance (Odds ratio 2.06; 95% confidence interval 0.93-4.55; p = 0.073). Conclusion Compared to the control group, patients with functional constipation have lower fluid intake and higher urinary osmolality.","[Boilesen, Sabine Nunes; Dias, Francine C.; Tahan, Soraia; Melli, Ligia C. F. L.; de Morais, Mauro Batista] Univ Fed Sao Paulo, Div Pediat Gastroenterol, Escola Paulista Med, Rua Pedro de Toledo 781-12 Andar, BR-04039032 Sao Paulo, SP, Brazil",Universidade Federal de Sao Paulo (UNIFESP),"de Morais, MB (corresponding author), Univ Fed Sao Paulo, Div Pediat Gastroenterol, Escola Paulista Med, Rua Pedro de Toledo 781-12 Andar, BR-04039032 Sao Paulo, SP, Brazil.",sabine.boilesen@gmail.com; francine.canovas@gmail.com; s.tahan@uol.com.br; ligiamelli@gmail.com; maurobmorais@gmail.com,"MORAIS, MAURO B/I-7995-2014","Melli, Ligia/0000-0003-1999-5581; C. Dias, Francine/0000-0002-3820-0230; Batista de Morais, Mauro/0000-0003-4014-5549","CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (The National Council for Scientific and Technological Development, Brazil)","CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (The National Council for Scientific and Technological Development, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))","CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (The National Council for Scientific and Technological Development, Brazil).",,37,5,5,0,7,SPRINGER HEIDELBERG,HEIDELBERG,"TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY",1436-6207,1436-6215,,EUR J NUTR,Eur. J. Nutr.,DEC,2021,60,8,,,,,4647,4655,,10.1007/s00394-021-02657-2,http://dx.doi.org/10.1007/s00394-021-02657-2,,AUG 2021,9,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,WS2TS,34409509,,,,2024-06-04,WOS:000686076400001,View Full Record in Web of Science
J,"Liang, YX; Wen, P; Wang, Y; OuYang, DM; Wang, D; Chen, YZ; Song, Y; Deng, J; Sun, YM; Wang, H",,,,"Liang, Yu-Xuan; Wen, Peng; Wang, Yu; OuYang, Dong-Mei; Wang, Da; Chen, Yu-Zhong; Song, Ya; Deng, Jie; Sun, Yuan-Ming; Wang, Hong",,,The Constipation-Relieving Property of d-Tagatose by Modulating the Composition of Gut Microbiota,INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,,,English,Article,,,,,,d-tagatose; prebiotic; constipation; gut microbiota; 16S rRNA; neurotransmitter,LOPERAMIDE-INDUCED CONSTIPATION; BUTYRATE-PRODUCING BACTERIA; CHAIN FATTY-ACIDS; DIETARY FIBER; IDENTIFICATION; BACTEROIDES; PREBIOTICS; DIVERSITY; TRANSIT; MICE,"d-tagatose, a monosaccharide as well as a dietary supplement, has been reported as having a wide range of applicability in the food industry, however, the prebiotic activity, anticonstipation effects, and related mechanisms are still unclear. In this study, using the loperamide-induced constipation Kunming mice as the animal model, the effects of d-tagatose for the prevention of constipation were evaluated by gastrointestinal transit experiment and defecation experiment. Furthermore, the underlying mechanism was clarified by evaluating the change of the biochemical indicators and analyzing 16S rRNA amplicon of gut microbiota among the different mice groups. The results showed that the gastrointestinal transit rate, fecal number, and weight in six hours were significantly enhanced after the administration of d-tagatose. In addition, d-tagatose significantly increased the serum levels of acetylcholine (Ach) and substance P (SP), whereas the serum levels of nitric oxide (NO) were significantly decreased. Moreover, the 16S rRNA sequencing analysis revealed that the changes in the gut microbiota caused by constipation were restored by d-tagatose treatment. In conclusion, this study indicated that the administration of d-tagatose as a dietary supplement can effectively prevent and relieve constipation in Kunming mice, and it is a promising prebiotic candidate with constipation-relieving properties.","[Liang, Yu-Xuan; Wen, Peng; OuYang, Dong-Mei; Wang, Da; Song, Ya; Deng, Jie; Sun, Yuan-Ming; Wang, Hong] South China Agr Univ, Coll Food Sci, Guangdong Prov Key Lab Food Qual & Safety, Guangzhou 510642, Guangdong, Peoples R China; [Wang, Yu; Chen, Yu-Zhong] Guangzhou Inst Food Inspect, Guangzhou 511400, Guangdong, Peoples R China",South China Agricultural University,"Sun, YM; Wang, H (corresponding author), South China Agr Univ, Coll Food Sci, Guangdong Prov Key Lab Food Qual & Safety, Guangzhou 510642, Guangdong, Peoples R China.",l402972616@163.com; wenpeng100@163.com; xxwangyu@163.com; ouydm2019@163.com; wangda134@foxmail.com; Kittychenyuzhong@gmail.com; songya_1990@163.com; scaudengjie@163.com; ymsun@scau.edu.cn; gzwhongd@163.com,"LI, Xiang-Yang/JZE-0275-2024; Liu, Chenyu/KBQ-8899-2024; li, jing/KHY-5337-2024",,Key Realm R&D Program of GuangDong Province [2019B020211002]; National Natural Science Foundation of China [31972157]; Science and Technology Planning Project of Guangzhou City [201804020077]; International Cooperation Program of SCAU [2019SCAUGH03]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme,Key Realm R&D Program of GuangDong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangzhou City; International Cooperation Program of SCAU; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme,"This research was funded by Key Realm R&D Program of GuangDong Province (No. 2019B020211002), National Natural Science Foundation of China (No. 31972157), Science and Technology Planning Project of Guangzhou City (201804020077), International Cooperation Program of SCAU (2019SCAUGH03) and Project Supported by Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2017).",,59,20,21,4,29,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,1422-0067,,INT J MOL SCI,Int. J. Mol. Sci.,NOV,2019,20,22,,,,,,,5721,10.3390/ijms20225721,http://dx.doi.org/10.3390/ijms20225721,,,17,"Biochemistry & Molecular Biology; Chemistry, Multidisciplinary",Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Chemistry,JW0YW,31739640,"Green Published, gold",,,2024-06-04,WOS:000502786800203,View Full Record in Web of Science
J,"Sloan, KJ; McRorie, JW",,,,"Sloan, Kyle J.; McRorie, Johnson W., Jr.",,,Structure and Function of Dietary Fiber: The Physics of Fiber in the Gastrointestinal Tract,CEREAL FOODS WORLD,,,English,Article,,,,,,,RISK-FACTORS; PSYLLIUM; CONSTIPATION; HEALTH; NUTRIOSE(R)FB; TOLERANCE; SUPPLEMENTATION; METAANALYSIS; ASSOCIATION; GLUCOSE,"There are many misconceptions about the health benefits of fiber based on the misapplication of data generated on dietary fiber and isolated fiber sources to all fibers. The epidemiologic data on the benefits of dietary fiber lack the control necessary to determine whether it is the fiber or another aspect of a high-fiber diet that delivers a benefit. In contrast to dietary fiber, which is intrinsic and intact in foods, isolated fiber (e.g., fiber supplements) can be assessed for a direct effect on specific physiologic markers in well-controlled clinical trials. When isolated fibers have been studied, the metabolic benefits of lowering LDL cholesterol and improving glycemic control have been proven only for soluble gel-forming fibers like psyllium and beta-glucan. Gel-forming psyllium fiber has also been shown to provide a combination of satiety, energy intake reduction, and weight loss benefits. Some soluble nonviscous fermentable fructooligosaccharide (FOS) fibers have been shown to provide satiety benefits, but they have not been shown to provide all three benefits. In the large intestine, the delivery of a regularity benefit by fiber has also been challenged when the data from well-controlled trials is reviewed. There are only two mechanisms by which a fiber can provide a reduced constipation benefit, and both require that the fiber resist fermentation to arrive intact in stool: 1) a coarse insoluble fiber (e.g., coarse wheat bran) mechanically irritates the digestive mucosa; and 2) a viscous gel-forming fiber (e.g., psyllium) traps water in the gel, which resists dehydration throughout the large intestine. Psyllium is 3.4 times more effective than wheat bran for increasing stool output, making it the gold standard fiber for laxation. Only by recognizing that not all fibers are alike, can we identify the relevant properties to consider when choosing an isolated fiber for its specific proven health benefits.","[Sloan, Kyle J.; McRorie, Johnson W., Jr.] Procter & Gamble, Mason, OH 45040 USA",Procter & Gamble,"Sloan, KJ (corresponding author), Procter & Gamble, Mason, OH 45040 USA.",,,,,,,,41,1,1,11,39,AACC INTERNATIONAL,ST PAUL,"3340 PILOT KNOB RD, ST PAUL, MN 55121-2097 USA",0146-6283,,,CEREAL FOOD WORLD,Cereal Foods World,MAY-JUN,2020,65,3,,,,,,,28,10.1094/CFW-65-3-0028,http://dx.doi.org/10.1094/CFW-65-3-0028,,,6,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,LZ9ES,,,,,2024-06-04,WOS:000541522400004,View Full Record in Web of Science
J,"Rajindrajith, S; Devanarayana, NM",,,,"Rajindrajith, Shaman; Devanarayana, Niranga Manjuri",,,"Constipation in Children: Novel Insight Into Epidemiology, Pathophysiology and Management",JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY,,,English,Review,,,,,,Children; Constipation; Epidemiology; Management; Pathophysiology,COLONIC TRANSIT-TIME; CHRONIC FUNCTIONAL CONSTIPATION; CHILDHOOD CONSTIPATION; DOUBLE-BLIND; INTRACTABLE CONSTIPATION; IDIOPATHIC CONSTIPATION; ANORECTAL MANOMETRY; DIETARY FIBER; GASTROINTESTINAL SYMPTOMS; BIOFEEDBACK TREATMENT,"Constipation in children is a common health problem affecting 0.7% to 29.6% children across the world. Exact etiology for developing symptoms is not clear in children and the majority is considered to have functional constipation. Alteration of rectal and pelvic floor function through the brain-gut axis seems to play a crucial role in the etiology. The diagnosis is often a symptom-based clinical process. Recently developed Rome III diagnostic criteria looks promising, both in clinical and research fields. Laboratory investigations such as barium enema, colonoscopy, anorectal manometry and colonic transit studies are rarely indicated except in those who do not respond to standard management. Treatment of childhood constipation involves several facets including education and demystification, toilet training, rational use of laxatives for disimpaction and maintenance and regular follow-up. Surgical options should be considered only when medical therapy fails in long standing constipation. Since most of the management strategies of childhood constipation are not evidence-based, high-quality randomized controlled trials are required to assess the efficacy of currently available or newly emerging therapeutic options. Contrary to the common belief that children outgrow constipation as they grow up, a sizable percentage continue to have symptoms beyond puberty.","[Rajindrajith, Shaman] Univ Kelaniya, Fac Med, Dept Pediat, Ragama 11010, Sri Lanka; [Devanarayana, Niranga Manjuri] Univ Kelaniya, Fac Med, Dept Physiol, Ragama 11010, Sri Lanka",University Kelaniya; University Kelaniya,"Rajindrajith, S (corresponding author), Univ Kelaniya, Fac Med, Dept Pediat, Talagolla Rd, Ragama 11010, Sri Lanka.",shamanr0@lycos.com,"Rajindrajith, Shaman/AAN-8675-2020","Rajindrajith, Shaman/0000-0003-1379-5052; Devanarayana, Niranga Manjuri/0000-0002-2988-110X",,,,,115,75,90,1,15,KOREAN SOC NEUROGASTROENTEROLOGY & MOTILITY,GANGNAM-GU,"RM 305, LOTTE GOLD ROSE VILL II, 31 SEOLLEUNG-RO 86-GIL, GANGNAM-GU, SEOUL 135-839, SOUTH KOREA",2093-0879,2093-0887,,J NEUROGASTROENTEROL,J. Neurogastroenterol. Motil.,JAN,2011,17,1,,,,,35,47,,10.5056/jnm.2011.17.1.35,http://dx.doi.org/10.5056/jnm.2011.17.1.35,,,13,Gastroenterology & Hepatology; Clinical Neurology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Neurosciences & Neurology,V29WS,21369490,"hybrid, Green Submitted, Green Published",,,2024-06-04,WOS:000208779100007,View Full Record in Web of Science
J,"Seidenfaden, S; Ormarsson, OT; Lund, SH; Bjornsson, ES",,,,"Seidenfaden, Sandra; Ormarsson, Orri Thor; Lund, Sigrun H.; Bjornsson, Einar S.",,,Physical activity may decrease the likelihood of children developing constipation,ACTA PAEDIATRICA,,,English,Article,,,,,,Constipation; Diet; Lifestyle; Outcome; Physical activity,CHILDHOOD CONSTIPATION; FUNCTIONAL CONSTIPATION; ABDOMINAL-PAIN; DIETARY FIBER; COWS-MILK; EMERGENCY; EPIDEMIOLOGY; MANAGEMENT; TRIAL,"AimChildhood constipation is common. We evaluated children diagnosed with constipation, who were referred to an Icelandic paediatric emergency department, and determined the effect of lifestyle factors on its aetiology. MethodsThe parents of children who were diagnosed with constipation and participated in a phase IIB clinical trial on laxative suppositories answered an online questionnaire about their children's lifestyle and constipation in March-April 2013. The parents of nonconstipated children that visited the paediatric department of Landspitali University Hospital or an Icelandic outpatient clinic answered the same questionnaire. ResultsWe analysed responses regarding 190 children aged one year to 18 years: 60 with constipation and 130 without. We found that 40% of the constipated children had recurrent symptoms, 27% had to seek medical attention more than once and 33% received medication per rectum. The 47 of 130 control group subjects aged 10-18 were much more likely to exercise more than three times a week (72%) and for more than a hour (62%) than the 26 of 60 constipated children of the same age (42% and 35%, respectively). ConclusionConstipation risk factors varied with age and many children diagnosed with constipation had recurrent symptoms. Physical activity may affect the likelihood of developing constipation in older children.","[Seidenfaden, Sandra] Univ Iceland, Dept Med, Reykjavik, Iceland; [Ormarsson, Orri Thor] Landspitali Univ Hosp, Dept Paediat Surg, Reykjavik, Iceland; [Lund, Sigrun H.] Univ Iceland, Ctr Publ Hlth Sci, Reykjavik, Iceland; [Bjornsson, Einar S.] Landspitali Univ Hosp, Dept Gastroenterol, Reykjavik, Iceland",University of Iceland; Landspitali National University Hospital; University of Iceland; Landspitali National University Hospital,"Seidenfaden, S (corresponding author), Landspitali Univ Hosp, IS-101 Reykjavik, Iceland.",sandras@landspitali.is,"Lund, Sigrun Helga/K-9144-2015; Lund, Sigrún Helga/AAG-6042-2019","Lund, Sigrún Helga/0000-0002-3806-2296",,,,,26,11,13,0,22,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0803-5253,1651-2227,,ACTA PAEDIATR,Acta Paediatr.,JAN,2018,107,1,,,,,151,155,,10.1111/apa.14067,http://dx.doi.org/10.1111/apa.14067,,,5,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,FP8BQ,28898506,,,,2024-06-04,WOS:000417865400025,View Full Record in Web of Science
J,"Pretorius, RA; Palmer, DJ",,,,"Pretorius, Rachelle A.; Palmer, Debra J.",,,High-Fiber Diet during Pregnancy Characterized by More Fruit and Vegetable Consumption,NUTRIENTS,,,English,Article,,,,,,pregnancy; nutrition; dietary fiber; fruit; vegetables,WOMEN; BIRTH; MOTHERS; FOOD,"Higher dietary fiber intakes during pregnancy may have the potential health benefits of increasing gut microbiome diversity, lowering the risk of glucose intolerance and pre-eclampsia, achieving appropriate gestational weight gain, and preventing constipation. In this observational cohort study, we have assessed the dietary fiber intakes of 804 women in late pregnancy, using a semi-quantitative food frequency questionnaire (SQ-FFQ). Overall, the median (interquartile range) dietary fiber intake was 24.1 (19.0-29.7) grams per day (g/day). Only 237/804 (29.5%) women met the recommended Adequate Intake (AI) of dietary fiber during pregnancy of 28 g/day. Women consuming the highest quartile of fiber intakes (34.8 (IQR 32.1-39.5) g/day) consumed more fruit, especially apples and bananas, than women consuming the lowest quartile of fiber intakes (15.9 (IQR 14.4-17.5) g/day). These women in the highest fiber-intake quartile were older (p < 0.01), more had completed further education after secondary school (p = 0.04), and they also consumed more vegetables (67 g/day) compared to the women in the lowest fiber consumption quartile (17 g vegetables/day). Bread intakes of 39-42 g/day were consistent in quantities consumed across all four fiber-intake quartiles. Our findings suggest that antenatal education advice targeting increased fruit and vegetable consumption before and during pregnancy may be a simple strategy to achieve increased total dietary fiber intakes to reach recommended quantities.","[Pretorius, Rachelle A.; Palmer, Debra J.] Univ Western Australia, Sch Med, 35 Stirling Highway, Crawley, WA 6009, Australia; [Palmer, Debra J.] Univ Western Australia, Telethon Kids Inst, 15 Hosp Ave, Nedlands, WA 6009, Australia",University of Western Australia; University of Western Australia; Telethon Kids Institute,"Palmer, DJ (corresponding author), Univ Western Australia, Sch Med, 35 Stirling Highway, Crawley, WA 6009, Australia.;Palmer, DJ (corresponding author), Univ Western Australia, Telethon Kids Inst, 15 Hosp Ave, Nedlands, WA 6009, Australia.",rachelle.pretorius@research.uwa.edu.au; debbie.palmer@telethonkids.org.au,"Pretorius, Rachelle/AAU-7188-2021","Pretorius, Rachelle/0000-0002-8701-7918; Palmer, Debra/0000-0003-2498-8343","National Health and Medical Research Council (NHMRC) of Australia [APP1002381, APP1046036]; NHMRC Fellowship [APP1144544]; Australian Postgraduate Award; University of Western Australia; Telethon Kids Institute Fellowship Support Allowance",National Health and Medical Research Council (NHMRC) of Australia(National Health & Medical Research Council (NHMRC) of Australia); NHMRC Fellowship(National Health & Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); University of Western Australia; Telethon Kids Institute Fellowship Support Allowance,This research was funded by the National Health and Medical Research Council (NHMRC) of Australia: Project Grants (APP1002381 and APP1046036) and NHMRC Fellowship for D.J.P. APP1144544. R.P. is funded by an Australian Postgraduate Award and Safety Net Top-up scholarship from the University of Western Australia. The publication fee for this manuscript was funded by the Telethon Kids Institute Fellowship Support Allowance for D.J.P.,,49,17,18,1,14,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,JAN,2021,13,1,,,,,,,35,10.3390/nu13010035,http://dx.doi.org/10.3390/nu13010035,,,11,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,PX0RC,33374192,"Green Published, gold",,,2024-06-04,WOS:000611071600001,View Full Record in Web of Science
J,"De Schryver, AM; Keulemans, YC; Peters, HP; Akkermans, LM; Smout, AJ; De Vries, WR; Van Berge-Henegouwen, GP",,,,"De Schryver, AM; Keulemans, YC; Peters, HP; Akkermans, LM; Smout, AJ; De Vries, WR; Van Berge-Henegouwen, GP",,,Effects of regular physical activity on defecation pattern in middle-aged patients complaining of chronic constipation,SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY,,,English,Article,,,,,,constipation; elderly; exercise; physical activity; transit,CHRONIC IDIOPATHIC CONSTIPATION; COLONIC TRANSIT-TIME; GASTROINTESTINAL-TRACT; RADIOPAQUE MARKERS; BRISK WALKING; EXERCISE; WOMEN; MEN; MOTILITY; DISEASE,"Objective. It is not well known whether physical activity (PA) is useful in the management of patients complaining of constipation. The aim of this study was to test the influence of regular PA on colonic transit time and defecation in middle-aged inactive patients suffering from chronic idiopathic constipation. Material and methods. Forty-three subjects (>45 years) were randomly divided into group A (n=18, 16 F, 2 M) and group B (n=25, 20 F, 5 M). Group A subjects maintained their normal lifestyle during 12 weeks, followed by a 12-week PA programme. Group B performed a 12-week PA programme after randomization. PA comprised 30 min of brisk walking and a daily 11-min home-based programme. Both groups received dietary advice. Colonic transit time was measured using a radiographic multiple marker single film technique. Results. Despite dietary advice, mean fibre and fluid intake did not change. In group B a significant reduction in 3 out of 4 of the Rome I criteria for constipation was observed, i.e. percentage of incomplete defecations, percentage of defecations requiring straining and percentage of hard stools (p <0.05). As a consequence, the number of fulfilled Rome criteria for constipation decreased (2.7 to 1.7; p <0.05). Furthermore, the rectosigmoid and total colonic transit time decreased (17.5 to 9.6 h and 79.2 to 58.4 h, respectively; p <0.05). After PA the number of fulfilled Rome criteria also decreased in group A (2.6 to 1.7; p <0.05). Conclusions. In middle-aged inactive subjects with symptoms of chronic constipation, it is advisable to promote regular physical activity since it improves both the defecation pattern and rectosigmoid or total colonic transit time.","Univ Med Ctr, Dept Gastroenterol, Gastrointestinal Res Unit, NL-3508 GA Utrecht, Netherlands; Univ Med Ctr, Dept Surg, NL-3508 GA Utrecht, Netherlands; Univ Med Ctr, Dept Med Physiol & Sports, NL-3508 GA Utrecht, Netherlands",Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center,"Univ Med Ctr, Dept Gastroenterol, Gastrointestinal Res Unit, F02-618,POB 85500, NL-3508 GA Utrecht, Netherlands.",gbergehe@azu.nl,,,,,,,37,102,114,1,20,TAYLOR & FRANCIS LTD,ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND",0036-5521,1502-7708,,SCAND J GASTROENTERO,Scand. J. Gastroenterol.,APR,2005,40,4,,,,,422,429,,10.1080/00365520510011641,http://dx.doi.org/10.1080/00365520510011641,,,8,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,913VG,16028436,,,,2024-06-04,WOS:000228183100007,View Full Record in Web of Science
J,"Polymeros, D; Beintaris, I; Gaglia, A; Karamanolis, G; Papanikolaou, IS; Dimitriadis, G; Triantafyllou, K",,,,"Polymeros, Dimitrios; Beintaris, Iosif; Gaglia, Asimina; Karamanolis, George; Papanikolaou, Ioannis S.; Dimitriadis, George; Triantafyllou, Konstantinos",,,Partially Hydrolyzed Guar Gum Accelerates Colonic Transit Time and Improves Symptoms in Adults with Chronic Constipation,DIGESTIVE DISEASES AND SCIENCES,,,English,Article,,,,,,Chronic constipation; Partially hydrolyzed guar gum; Colonic transit time; Supplementary fiber,INTESTINAL TRANSIT; FECAL OUTPUT; DOUBLE-BLIND; FIBER; BRAN,"Partially hydrolyzed guar gum (PHGG) is a water-soluble, non-gelling dietary fiber with a wide range of uses in clinical nutrition. The aim of this prospective study was to investigate the effect of guar gum on colonic transit time (CTT) and symptoms of chronic constipation. We enrolled patients fulfilling Rome III criteria for chronic constipation. CTT was measured before and at the end of treatment. After a 2-week run-in period, patients received 5 mg PHGG daily for 4 weeks. During study period, patients kept daily symptoms, stool and laxative usage diaries. They also recorded their symptom-related satisfaction weekly and treatment adverse events. Forty-nine patients received treatment; 39 (80 %) completed the study. Treatment significantly reduced colon transit time, from 57.28 +/- A 39.25 to 45.63 +/- A 37.27 h (p = 0.026), a reduction more prominent in slow transit patients (from 85.50 +/- A 27.75 to 63.65 +/- A 38.11 h, p = 0.016). Overall, the weekly number of complete spontaneous and spontaneous bowel movements increased significantly (p < 0.001); the latter correlated significantly with the acceleration of CTT in the overall population and in slow transit patients (B = 0.382; p = 0.016 and B = 0.483; p = 0.023, respectively). In addition, the number of bowel movements with straining decreased (p < 0.001) and stool form improved (p < 0.001), while days with laxative intake and days with abdominal pain decreased (p = 0.001 and p = 0.027, respectively). Four-week PHGG use accelerates colon transit time in patients with chronic constipation, especially in those with slow transit, and improves many of their symptoms including frequency of bowel movements.","[Polymeros, Dimitrios; Beintaris, Iosif; Gaglia, Asimina; Karamanolis, George; Papanikolaou, Ioannis S.; Dimitriadis, George; Triantafyllou, Konstantinos] Univ Athens, Sch Med, Attikon Univ Gen Hosp, Hepatogastroenterol Unit,Dept Internal Med 2, Athens 12462, Greece; [Polymeros, Dimitrios; Beintaris, Iosif; Gaglia, Asimina; Karamanolis, George; Papanikolaou, Ioannis S.; Dimitriadis, George; Triantafyllou, Konstantinos] Univ Athens, Sch Med, Attikon Univ Gen Hosp, Res Inst, Athens 12462, Greece",University Hospital Attikon; National & Kapodistrian University of Athens; Athens Medical School; University Hospital Attikon; Athens Medical School; National & Kapodistrian University of Athens,"Polymeros, D (corresponding author), Univ Athens, Sch Med, Attikon Univ Gen Hosp, Hepatogastroenterol Unit,Dept Internal Med 2, Rimini 1, Athens 12462, Greece.",dimpolymeros@yahoo.com; ibeintaris@gmail.com; gagliam2000@hotmail.com; georgekaramanolis@yahoo.co.uk; ispapn@hotmail.com; gdimi@ath.forthnet.gr; ktriant@med.uoa.gr,"Papanikolaou, Ioannis S/AAA-8261-2022; Triantafyllou, Konstantinos/E-8248-2011","Triantafyllou, Konstantinos/0000-0002-5183-9426",,,,,25,29,33,0,20,SPRINGER,DORDRECHT,"VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS",0163-2116,1573-2568,,DIGEST DIS SCI,Dig. Dis. Sci.,SEP,2014,59,9,,,,,2207,2214,,10.1007/s10620-014-3135-1,http://dx.doi.org/10.1007/s10620-014-3135-1,,,8,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,AP4ZA,24711073,,,,2024-06-04,WOS:000342088300046,View Full Record in Web of Science
J,"Tabbers, MM; Boluyt, N; Berger, MY; Benninga, MA",,,,"Tabbers, Merit M.; Boluyt, Nicole; Berger, Marjolein Y.; Benninga, Marc A.",,,Nonpharmacologic Treatments for Childhood Constipation: Systematic Review,PEDIATRICS,,,English,Review,,,,,,childhood constipation; systematic review; nonpharmacologic treatments; complementary treatment; alternative treatment,DOUBLE-BLIND; ALTERNATIVE MEDICINE; DIETARY FIBER; CHILDREN; MANAGEMENT; COMPLEMENTARY; DISORDERS; LACTULOSE; PROGNOSIS; TRIAL,"OBJECTIVE: To summarize the evidence and assess the reported quality of studies concerning nonpharmacologic treatments for childhood constipation, including fiber, fluid, physical movement, prebiotics, probiotics, behavioral therapy, multidisciplinary treatment, and forms of alternative medicine. METHODS: We systematically searched 3 major electronic databases and reference lists of existing reviews. We included systematic reviews and randomized controlled trials (RCTs) that reported on nonpharmacologic treatments. Two reviewers rated the methodologic quality independently. RESULTS: We included 9 studies with 640 children. Considerable heterogeneity across studies precluded meta-analysis. We found no RCTs for physical movement, multidisciplinary treatment, or alternative medicine. Some evidence shows that fiber may be more effective than placebo in improving both the frequency and consistency of stools and in reducing abdominal pain. Compared with normal fluid intake, we found no evidence that water intake increases or that hyperosmolar fluid treatment is more effective in increasing stool frequency or decreasing difficulty in passing stools. We found no evidence to recommend the use of prebiotics or probiotics. Behavioral therapy with laxatives is not more effective than laxatives alone. CONCLUSIONS: There is some evidence that fiber supplements are more effective than placebo. No evidence for any effect was found for fluid supplements, prebiotics, probiotics, or behavioral intervention. There is a lack of well-designed RCTs of high quality concerning nonpharmacologic treatments for children with functional constipation. Pediatrics 2011;128:753-761","[Tabbers, Merit M.; Benninga, Marc A.] Emma Childrens Hospital, Acad Med Ctr, Dept Pediat Gastroenterol & Nutr, NL-1100 DD Amsterdam, Netherlands; [Boluyt, Nicole] Emma Childrens Hospital, Acad Med Ctr, Dept Pediat, NL-1100 DD Amsterdam, Netherlands; [Berger, Marjolein Y.] Univ Groningen Hosp, Dept Gen Practice, Groningen, Netherlands",University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; University of Groningen,"Tabbers, MM (corresponding author), Emma Childrens Hospital, Acad Med Ctr, Dept Pediat Gastroenterol & Nutr, H7-250,POB 22700, NL-1100 DD Amsterdam, Netherlands.",m.m.tabbers@amc.nl,,"Tabbers, Merit/0000-0001-9744-7308",,,,,25,59,72,0,21,AMER ACAD PEDIATRICS,ELK GROVE VILLAGE,"141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA",0031-4005,1098-4275,,PEDIATRICS,Pediatrics,OCT,2011,128,4,,,,,753,761,,10.1542/peds.2011-0179,http://dx.doi.org/10.1542/peds.2011-0179,,,9,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,827DH,21949142,"Green Published, Bronze",,,2024-06-04,WOS:000295406800052,View Full Record in Web of Science
J,"Arce, DA; Ermocilla, CA; Costa, H",,,,"Arce, DA; Ermocilla, CA; Costa, H",,,Evaluation of constipation,AMERICAN FAMILY PHYSICIAN,,,English,Article,,,,,,,CHILDREN; DISORDERS,"Constipation is the reason for 2.5 million physician visits per year in the United States, with more than one half of these visits to primary care physicians. Patients and physicians frequently define constipation differently. To determine the underlying cause of constipation, it is important to evaluate the patient's general health, psychosocial status, medical illnesses, dietary fiber intake, and use of constipating medications. The differential diagnosis of constipation and the approach to its evaluation differ in adults and children. Tests of physiologic function are usually reserved for constipation that does not respond to conventional therapy. Family physicians can effectively manage most patients who have constipation. Copyright(C) 2002 American Academy of Family Physicians.","SUNY Hlth Sci Ctr, Brooklyn Coll Med, Brooklyn, NY 11203 USA",City University of New York (CUNY) System; Brooklyn College (CUNY); State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center,"SUNY Hlth Sci Ctr, Brooklyn Coll Med, Brooklyn, NY 11203 USA.",,,,,,,,25,38,43,0,1,AMER ACAD FAMILY PHYSICIANS,KANSAS CITY,"8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797 USA",0002-838X,1532-0650,,AM FAM PHYSICIAN,Am. Fam. Physician,JUN 1,2002,65,11,,,,,2283,2290,,,,,,8,"Primary Health Care; Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,561ZW,12074527,,,,2024-06-04,WOS:000176173800010,View Full Record in Web of Science
J,"Liu, BY; Zhang, ZG; Liu, XQ; Hu, WW; Wu, WC",,,,"Liu, Buyu; Zhang, Zhiguo; Liu, Xingquan; Hu, Weiwei; Wu, Weicheng",,,Gastrointestinal Fermentable Polysaccharide Is Beneficial in Alleviating Loperamide-Induced Constipation in Mice,NUTRIENTS,,,English,Article,,,,,,sweet potato; polysaccharide; constipation; short-chain fatty acids (SCFAs); gut microbiota; fermentation,DIPHENOXYLATE-INDUCED CONSTIPATION; GUT MICROBIOTA; FUNCTIONAL CONSTIPATION; DIETARY FIBER; MOTILITY,"To investigate the role of gastrointestinal (GI) polysaccharide fermentation in alleviating constipation, two polysaccharide fractions were isolated from a soluble fiber extract with determined anti-constipation activity: a 2.04 kDa neutral fraction (SSP-1) contained 99.29% glucose, and a 41.66 kDa acidic fraction (SSP-2) contained 63.85% uronic acid. After mice were given loperamide for 14 d to induce constipation, the GI transit rate increased significantly in the SSP-1 group (p < 0.05) but not in the SSP-2 group. The stool weight in the SSP-2 group was significantly higher than that in SSP-1 (383.60 mg vs. 226.23 mg) (p < 0.05). Both SSP-1 and SSP-2 groups had significantly increased serum gastrin and motilin levels (p < 0.05) and changes in their fecal short-chain fatty acid (SCFA) profiles, while SSP-1 showed better fermentation properties than SSP-2 in terms of statistically higher fecal contents of acetic acid and total SCFAs (p < 0.05). Bioinformatic analysis indicated that SSP-1 upregulated bacteria such as Oscillibacter to improve SCFA metabolism and stimulate GI hormone secretion, while SSP-2 had less influence on the gut microbiota. These results suggest that the neutral polysaccharide with superior GI fermentation properties exerted beneficial effects on constipation, while the less fermentable pectic fraction might act as a stool-bulking agent.","[Liu, Buyu; Zhang, Zhiguo; Hu, Weiwei; Wu, Weicheng] Zhejiang Acad Agr Sci, Food Sci Inst, Hangzhou 310021, Peoples R China; [Liu, Buyu; Liu, Xingquan] Zhejiang Agr & Forestry Univ, Coll Food & Hlth, Hangzhou 311300, Peoples R China",Zhejiang Academy of Agricultural Sciences; Zhejiang A&F University,"Zhang, ZG; Wu, WC (corresponding author), Zhejiang Acad Agr Sci, Food Sci Inst, Hangzhou 310021, Peoples R China.",lbyuri@outlook.com; zhangkii@126.com; liuxq@zafu.edu.cn; huww@zaas.ac.cn; wuwc@zaas.ac.cn,"yang, zhou/KBB-6972-2024; wang, jiaqi/KHC-5900-2024; zhang, yan/KHC-3163-2024; LI, yue/KHC-6771-2024; liu, xinyi/KFB-4466-2024; zhou, yuwei/KHD-4127-2024; wang, shuo/KCL-3379-2024; li, jing/KHC-8303-2024; Wang, Peilin/JWP-6008-2024; wang, jin/KHD-7243-2024","Liu, Buyu/0000-0003-3704-0359",Zhejiang National Key Research and Development Program of China [2021C04010]; Nine-part Cooperation Project of Agriculture and Rural Development of Zhejiang Province [2022SNJF008],Zhejiang National Key Research and Development Program of China; Nine-part Cooperation Project of Agriculture and Rural Development of Zhejiang Province,This research was funded by the Zhejiang National Key Research and Development Program of China (2021C04010) and the Nine-part Cooperation Project of Agriculture and Rural Development of Zhejiang Province (2022SNJF008).,,53,0,0,14,17,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,OCT,2023,15,20,,,,,,,4364,10.3390/nu15204364,http://dx.doi.org/10.3390/nu15204364,,,22,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,W8VK1,37892439,"gold, Green Published",,,2024-06-04,WOS:001094348900001,View Full Record in Web of Science
J,"Forootan, M; Bagheri, N; Darvishi, M",,,,"Forootan, Mojgan; Bagheri, Nazila; Darvishi, Mohammad",,,Chronic constipation: A review of literature,MEDICINE,,,English,Review,,,,,,clinical presentation; constipation; controversial issues; diagnostic and therapeutic strategies,QUALITY-OF-LIFE; RECTAL SENSORIMOTOR DYSFUNCTION; GASTROINTESTINAL SYMPTOMS; IDIOPATHIC CONSTIPATION; FECAL INCONTINENCE; DIETARY FIBER; PELVIC FLOOR; MANAGEMENT; DIAGNOSIS; EPIDEMIOLOGY,"Background:Chronic constipation is described as a common complication determined by difficult and/or rare passage of stool or both. The difference in definition of constipation has led to a wide range of reported prevalence (i.e., between 1% and 80%). Various factors are involved in the pathogenesis of the disease, including type of diet, genetic predisposition, colonic motility, absorption, social economic status, daily behaviors, and biological and pharmaceutical factors. Diagnostic and therapeutic options play a key role in the treatment of chronic constipation. There are still debates about the timing of these diagnostic and therapeutic algorithms.Methods:A systematic and comprehensive search will be performed using MEDLINE, PubMed, EMBASE, AMED, the Cochrane Library and Google Scholar. Better understanding of the pathophysiology of chronic constipation and efficacy of pharmacological agent can help physicians for treating and managing symptoms.In this study, some of the old and new therapies in the treatment of chronic constipation have been studied based on the controlled studies and strong evidence. We are trying to address some of the controversial issues to manage the disease and to provide appropriate diagnostic options in an efficient and cost-effective way.Results:The results of this systematic review will be published in a peer-reviewed journal.Conclusion:To our knowledge, our study will provide an overall estimate of chronic constipation to assess controversial issues, available diagnostic and therapeutic strategies of chronic constipation.Ethics and dissemination:Ethical approval and informed consent are not required, as the study will be a literature review and will not involve direct contact with patients or alterations to patient care.","[Forootan, Mojgan] Shahid Beheshti Univ Med Sci, Gastrointestinal & Liver Dis Res Ctr RCGLD, Dept Gastroenterol, Tehran, Iran; [Bagheri, Nazila] Shahid Beheshti Univ Med Sci, Taleghani Educ Hosp, Dept Nephrol, Tehran, Iran; [Darvishi, Mohammad] AJA Univ Med Sci, IDTMRC, Dept Aerosp & Subaquat Med, Tehran 00982113166, Iran",Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences,"Darvishi, M (corresponding author), AJA Univ Med Sci, IDTMRC, Dept Aerosp & Subaquat Med, Tehran 00982113166, Iran.",darvishi1349@gmail.com,"bagheri, nazila/AAV-9138-2020","Darvishi, Mohammad/0000-0003-0332-2489",,,,,80,151,171,6,42,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0025-7974,1536-5964,,MEDICINE,Medicine (Baltimore),MAY,2018,97,20,,,,,,,e10631,10.1097/MD.0000000000010631,http://dx.doi.org/10.1097/MD.0000000000010631,,,9,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),General & Internal Medicine,GI3XR,29768326,"gold, Green Published",,,2024-06-04,WOS:000434305900006,View Full Record in Web of Science
J,"Wanichsetakul, W; Wongteerasut, A",,,,"Wanichsetakul, Wannaporn; Wongteerasut, Anundorn",,,RISK FACTORS OF FUNCTIONAL CONSTIPATION AMONG THAI CHILDREN,SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH,,,English,Article,,,,,,functional constipation; children; risk factor; Thailand,DIETARY FIBER INTAKE; PHYSICAL-ACTIVITY; CHILDHOOD CONSTIPATION; MANAGEMENT; GUIDELINES; DISORDERS; FAMILIES; THERAPY; HEALTH,"Functional constipation is a common problem in pre-school children precipitated by intrinsic and extrinsic conditions. Risk factors associated with functional constipation among pre-school Thai children were identified in a case-control study employing a questionnaire based on Rome IV criteria among children 1-4 years of age (constipated, n = 45, non-constipated, n = 45) attending an outpatient department between September 2017 and January 2018. A significant common risk factor was a family history of constipation (p-value = 0.012). Univariate logistic regression analysis revealed significant differences between constipated and non-constipated group in exclusive formula feeding during the first year of life (odds ratio (OR) = 9.51, 95% confidence interval (CI): 1.14-79.6), daily vegetable or fruit ingestion of less than 1 ladle (OR = 9.63; 95% CI: 3.67-25.25), less than 250 ml daily water intake (OR = 4.42, 95% CI: 1.69-11.58), daily fruit juice intake of <250 ml (OR = 2.58; 95% CI: 0.62-10.69), weekly energetic (sweating) movement/activity of >= 4 days (OR = 8.11; 95% CI: 0.95-68.87), and major stressful event (OR = 9.51, 95% CI: 1.14-79.6). A multivariate logistic regression analysis indicated limited fruit or vegetable ingestion (adjusted OR = 11.07, 95% CI: 3.82-32.08) and water intake (adjusted OR = 5.47, 95% CI: 1.73-17.34) are significant independent risks for constipation in children. The study highlights recognition of these risk factors by parents or caregivers as well as physicians in order to modify feeding behavior and avoid pharmacological intervention of constipation in children in the country.","[Wongteerasut, Anundorn] Pharmongkutklao Hosp, Dept Pediat, Bangkok 10400, Thailand; [Wongteerasut, Anundorn] Phramongkutklao Coll Med, Bangkok 10400, Thailand",Phramongkutklao Hospital; Phramongkutklao College of Medicine,"Wongteerasut, A (corresponding author), Pharmongkutklao Hosp, Dept Pediat, Bangkok 10400, Thailand.;Wongteerasut, A (corresponding author), Phramongkutklao Coll Med, Bangkok 10400, Thailand.",anundorn@gmail.com,,"Wongteerasut, Anundorn/0000-0002-7025-2567","Department of Pediatrics, Phramongkutklao Hospital and Phramongkutklao College of Medicine","Department of Pediatrics, Phramongkutklao Hospital and Phramongkutklao College of Medicine","The authors thank the Department of Pediatrics, Phramongkutklao Hospital and Phramongkutklao College of Medicine for support of the study and Ms Pawinee Saybungkla, statistician, for preliminary analysis of the statistical data.",,37,0,0,0,2,SOUTHEAST ASIAN MINISTERS EDUC ORGANIZATION,BANGKOK,"SEAMEO-TROPMED, 420-6 RAJVITHI RD,, BANGKOK 10400, THAILAND",0125-1562,,,SE ASIAN J TROP MED,Southeast Asian J. Trop. Med. Public Health,MAR,2021,52,2,,,,,191,202,,,,,,12,"Public, Environmental & Occupational Health; Infectious Diseases; Tropical Medicine",Science Citation Index Expanded (SCI-EXPANDED),"Public, Environmental & Occupational Health; Infectious Diseases; Tropical Medicine",YL7XP,,,,,2024-06-04,WOS:000746102400001,View Full Record in Web of Science
J,"Daniali, M; Nikfar, S; Abdollahi, M",,,,"Daniali, Marzieh; Nikfar, Shekoufeh; Abdollahi, Mohammad",,,An overview of interventions for constipation in adults,EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY,,,English,Review,,,,,,Constipation; management; pharmacological; nonpharmacological; expert commentary; cost,IRRITABLE-BOWEL-SYNDROME; OPIOID-INDUCED CONSTIPATION; GUANYLATE-CYCLASE C; DOUBLE-BLIND; IDIOPATHIC CONSTIPATION; COLONIC TRANSIT; DIETARY FIBER; MANAGEMENT; DIAGNOSIS; EFFICACY,"Introduction The increasing global prevalence of the symptoms of constipation adversely affects the quality of life (QOL) of symptomatic patients. An acceptable universal definition of constipation does not exist and a detailed history taking form each patient with various complaints including stool consistency, sensing of incomplete evacuation or a manual need to assist evacuation is required. Complexity of obtaining etiologic diagnosis and the wide range of therapeutic options can mislead physicians in choosing correct treatment. Areas covered This review, considers the pathophysiology of constipation and the diagnostic approach to identify the etiology of constipation. Available interventions including non-pharmacological, pharmacological, and invasive methods such as acupuncture and surgical management are discussed. This review utilized on PubMed, Google Scholar, Scopus, and clinicaltrials.gov to search for studies and reviews published between 2000 and 2020. Expert commentary Constipation necessitates careful considerations to detect the exact pathophysiology. Medical history, focused physical assessments, and selected diagnostic tests help choosing the right management. Non-pharmacological methods are beneficial in most of the cases. If a satisfactory response is not achieved, over the counter or prescribed medications are available. Options for patients who failed to respond to available medications are addressed in this review.","[Daniali, Marzieh; Abdollahi, Mohammad] Univ Tehran Med Sci, Inst Pharmaceut Sci TIPS, Pharmaceut Sci Res Ctr PSRC, Toxicol & Dis Grp TDG, Tehran, Iran; [Daniali, Marzieh; Abdollahi, Mohammad] Univ Tehran Med Sci, Sch Pharm, Dept Toxicol & Pharmacol, Tehran, Iran; [Nikfar, Shekoufeh; Abdollahi, Mohammad] Univ Tehran Med Sci, Endocrinol & Metab Res Inst, Personalized Med Res Ctr, Tehran, Iran; [Nikfar, Shekoufeh] Univ Tehran Med Sci, Pharmaceut Sci Res Ctr PSRC, Evidence Based Evaluat Cost Effectiveness & Clin, Tehran, Iran; [Nikfar, Shekoufeh] Univ Tehran Med Sci, Inst Pharmaceut Sci TIPS, Pharmaceut Management & Econ Res Ctr PMERC, Tehran, Iran; [Nikfar, Shekoufeh] Univ Tehran Med Sci, Sch Pharm, Dept Pharmacoecon & Pharmaceut Adm, Tehran, Iran",Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences,"Abdollahi, M (corresponding author), Univ Tehran Med Sci, Inst Pharmaceut Sci TIPS, Pharmaceut Sci Res Ctr PSRC, Toxicol & Dis Grp TDG, Tehran, Iran.",Mohammad@TUMS.Ac.Ir,"Daniali, Marzieh/AEG-9472-2022; Abdollahi, Mohammad/B-9232-2008; Daniali, Marzieh/HDN-5516-2022","Daniali, Marzieh/0000-0001-7703-8777; Abdollahi, Mohammad/0000-0003-0123-1209; Daniali, Marzieh/0000-0001-7703-8777; Nikfar, Shekoufeh/0000-0002-5206-6197",,,,,102,11,12,0,19,TAYLOR & FRANCIS LTD,ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND",1747-4124,1747-4132,,EXPERT REV GASTROENT,Expert Rev. Gastroenterol. Hepatol.,AUG 2,2020,14,8,,,,,721,732,,10.1080/17474124.2020.1781617,http://dx.doi.org/10.1080/17474124.2020.1781617,,,12,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,MX8RI,32772745,,,,2024-06-04,WOS:000557986400009,View Full Record in Web of Science
J,"MATZKIES, F; BERG, G",,,,"MATZKIES, F; BERG, G",,,DIETARY FIBER SYNDROME AS CAUSE OF DISEASE IN CIVILIZED SOCIETIES,ACTA HEPATO-GASTROENTEROLOGICA,,,English,Review,,,,,,,,"Burkitt (1976) hypothesized that a number of [human] diseases of the colon and certain vascular disorders might be due to a deficiency in dietary fiber. The effects of dietery fiber are discussed with respect to the definition and classification of fiber; the historical decrease in fiber consumption; feces weight and transit time; mineral balance; cholesterol metabolism; colon cancer; diverticulosis of the colon, hemorrhoids, hiatus hernia and varicosis; diabetes mellitus; high-fiber diets for the treatment of constipation and irritable colon; and side effects of high fiber diet.","UNIV ERLANGEN NURNBERG, DEPT MED, METAB & NUTR SECT, D-8520 ERLANGEN, FED REP GER",,,,,,,,,,20,3,3,0,0,GEORG THIEME VERLAG KG,STUTTGART,"RUDIGERSTR 14, D-70469 STUTTGART, GERMANY",0300-970X,,,ACTA HEPATO-GASTRO,,,1978,25,5,,,,,402,407,,,,,,6,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,FU895,364912,,,,2024-06-04,WOS:A1978FU89500016,View Full Record in Web of Science
J,"Raphael, KG; Marbach, JJ; Touger-Decker, R",,,,"Raphael, KG; Marbach, JJ; Touger-Decker, R",,,Dietary fiber intake in patients with myofascial face pain,JOURNAL OF OROFACIAL PAIN,,,English,Article,,,,,,myofascial face pain; temporomandibular disorders; quality of life; pain; nutrition,TEMPOROMANDIBULAR DISORDERS; DYSFUNCTION SYNDROME; NUTRITIONAL EPIDEMIOLOGY; MUSCLE FATIGUE; NUTRIENT; DISEASE,"Aims: To determine the impact of myofascial face pain (MFP) on dietary intake of selected nutrients. Methods: Sixty-one MFP women meeting the criteria for the myofascial subtype of temporomandibular disorders completed a 4-day daily food intake diary, as well as self-report of pain severity, pain interference with eating, and depressive symptomatology. Nutrient intake for the MFP women was compared with a demographically-equivalent sample of community women participating in the federally-sponsored Continuing Survey of Food Intakes by Individuals (CFSII). Within the MFP sample, multiple linear regression analysis was used to test whether dietary fiber intake reduction was most likely due to pain adaptation, or to depressive symptomatology or associated appetite reduction. Results: Only the subgroup of MFP patients with above-average pairs severity showed reduced dietary fiber intake compared with the community sample. MFP patients did not differ from the community sample on other nutrient intake measures (ie, total calories, protein, fat, carbohydrates and dietary fiber, calcium, and iron). Within the MFP sample, pain severity was significantly associated with reds-Iced dietary fiber intake. This relationship persisted, after controlling for depressive symptomatology, appetite, and total calories. Conclusion: Myofascial face pain patients with more severe pain intensity are likely to reduce their intake of dietary fiber. This is likely due to an effort to decrease masticatory activity to avoid exacerbating facial pain. Since low dietary fiber, especially in combination with commonly prescribed medications for MFP, increases the risk of constipation and may exacerbate comorbid medical conditions, clinicians should recommend alternative dietary fiber sources for MFP patients.","Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Psychiat, Newark, NJ 07103 USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Psychiat, Newark, NJ 07107 USA; Univ Med & Dent New Jersey, New Jersey Dent Sch, Dept Oral Pathol Biol & Diagnost Sci, Newark, NJ 07107 USA; Univ Med & Dent New Jersey, New Jersey Dent Sch, Dept Oral Pathol Biol & Diagnost Sci, Newark, NJ 07103 USA; Univ Med & Dent New Jersey, Sch Hlth Related Profess, Newark, NJ 07107 USA",Rutgers University System; Rutgers University New Brunswick; Rutgers University Biomedical & Health Sciences; Rutgers University System; Rutgers University New Brunswick; Rutgers University Biomedical & Health Sciences; Rutgers University System; Rutgers University New Brunswick; Rutgers University Biomedical & Health Sciences; Rutgers University System; Rutgers University New Brunswick; Rutgers University Biomedical & Health Sciences; Rutgers University System; Rutgers University New Brunswick; Rutgers University Biomedical & Health Sciences,"Raphael, KG (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Psychiat, 183 S Orange Ave,UBSB Room F1512, Newark, NJ 07103 USA.",,"Raphael, Karen/V-7455-2019","Raphael, Karen/0000-0002-2804-8124; Touger-Decker, Riva/0000-0003-2056-9846",NIDCR NIH HHS [DE11714] Funding Source: Medline,NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)),,,49,21,24,0,3,QUINTESSENCE PUBL CO INC,CAROL STREAM,"551 NORTH KIMBERLY DR, CAROL STREAM, IL 60188-1881 USA",1064-6655,,,J OROFAC PAIN,J. Orofac. Pain,WIN,2002,16,1,,,,,39,47,,,,,,9,"Dentistry, Oral Surgery & Medicine",Science Citation Index Expanded (SCI-EXPANDED),"Dentistry, Oral Surgery & Medicine",518WK,11889658,,,,2024-06-04,WOS:000173690700005,View Full Record in Web of Science
J,"Baker, SS; Liptak, GS; Colletti, RB; Croffie, JM; Di Lorenzo, C; Ector, W; Nurko, S",,,,"Baker, Susan S.; Liptak, Gregory S.; Colletti, Richard B.; Croffie, Joseph M.; Di Lorenzo, Carlo; Ector, Walton; Nurko, Samuel",,NASPGHAN Constipation Guideline Co,"Evaluation and treatment of constipation in children: Summary of updated recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition",JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION,,,English,Article,,,,,,constipation,POLYETHYLENE-GLYCOL; COWS MILK; DIETARY FIBER; CISAPRIDE; EFFICACY; THERAPY; INFANTS,"Constipation is a common pediatric problem. To assist health care professionals who care for children with constipation, the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) previously published a clinical guideline based on an integration of medical evidence with expert opinion. To evaluate studies published since then, the NASPGHAN Constipation Guideline Committee performed a comprehensive and systematic review of the medical literature since 1997, to identify, review and rate the quality of new evidence. Based on this review, the recommendations of the original clinical guideline were reaffirmed with several modified according to the new evidence. Below is a summary of the evidence reviewed for this update. The complete revised guideline is available online in its entirety.","NASPGHAN, Flourtown, PA 19031 USA",,"Baker, SS (corresponding author), NASPGHAN, 1501 Bethlehem Pike,POB 6, Flourtown, PA 19031 USA.",,,,,,,,32,68,75,0,5,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0277-2116,1536-4801,,J PEDIATR GASTR NUTR,J. Pediatr. Gastroenterol. Nutr.,SEP,2006,43,3,,,,,405,407,,10.1097/01.mpg.0000232574.41149.0a,http://dx.doi.org/10.1097/01.mpg.0000232574.41149.0a,,,3,Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,079VS,16954970,,,,2024-06-04,WOS:000240206600026,View Full Record in Web of Science
J,"Weber, TK; Freitas, KD; Amancio, OMS; de Morais, MB",,,,"Weber, Thabata Koester; Freitas, Karine de Cassia; Silverio Amancio, Olga Maria; de Morais, Mauro Batista",,,Effect of dietary fibre mixture on growth and intestinal iron absorption in rats recovering from iron-deficiency anaemia,BRITISH JOURNAL OF NUTRITION,,,English,Article,,,,,,Dietary fibre; Growth; Iron absorption; Iron-deficiency anaemia; Rats,ESPGHAN COMMITTEE; GROWING RATS; CONSTIPATION; INFANTS; BIOAVAILABILITY; REGENERATION; CHILDREN; CALCIUM; ZINC,"There is concern regarding the possible negative effects of ingestion of dietary fibre on growth and intestinal Fe absorption in infants. The aim of the present study was to compare the effect of a fibre mixture on the growth and the intestinal absorption of Fe in rats with Fe-deficiency anaemia with that of a diet without fibres. Faecal weight and caecal pH were also evaluated. According to the Hb depletion-repletion model, twenty-two male weaned Wistar rats were fed the AIN93-G diet without Fe until Fe-deficiency anaemia was induced with Hb <70 g/l. The anaemic rats were divided into two groups: (1) fibre mixture group - fed 100 g of fibre mixture/kg of diet (soya polysaccharide, inulin, resistant starch, Arabic gum, fructo-oligossaccharide and cellulose) (n 11); (2) control group - fed without fibres (n 11). All diets had 157 mg of ferric citrate (30 mg of elemental Fe) added to lead to recovery from anaemia. Fe intestinal absorption was measured by Hb repletion efficiency (HRE) and apparent Fe intestinal absorption. The HRE was 44.8 (SD 9.5) % in the fibre mixture group and 43.0 (SD 9.5) % in the control group (P=0.664). The apparent Fe absorption was 46.2 (SD 16.5) and 47.2 (SD 10.2) % (P=0.861) in the fibre mixture and control groups, respectively. The faecal weight median was 6.17 g in the fibre mixture group and 2.11 g in the control group (P<0.001). The caecal pH was in the same order: 6.11 (SD 0.59) and 7.07 (SD 0.34) (P<0.001). Both the groups consumed similar quantities of diet, and growth was similar in both the groups. The fibre mixture had no influence either on growth or on Fe intestinal absorption in rats recovering from anaemia. This mixture favoured an increase in faecal weight and a decrease in caecal pH.","[Weber, Thabata Koester; Freitas, Karine de Cassia; Silverio Amancio, Olga Maria; de Morais, Mauro Batista] Univ Fed Sao Paulo, Dept Pediat Gastroenterol, BR-04039031 Sao Paulo, Brazil",Universidade Federal de Sao Paulo (UNIFESP),"de Morais, MB (corresponding author), Univ Fed Sao Paulo, Dept Pediat Gastroenterol, Rua Pedro de Toledo 441, BR-04039031 Sao Paulo, Brazil.",mbmorais@osite.com.br,"MORAIS, MAURO B/I-7995-2014","WEBER/0000-0001-5588-4235; Batista de Morais, Mauro/0000-0003-4014-5549","Coordination of Improvement of Higher Education' - CAPES; National Council of Technological and Scientific Development' - CNPq, Brazil","Coordination of Improvement of Higher Education' - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council of Technological and Scientific Development' - CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))","This research was supported by 'Coordination of Improvement of Higher Education' - CAPES and the 'National Council of Technological and Scientific Development' - CNPq, Brazil. The authors thank Ms Roberta Faria Camilo Araujo and Mr Felipe Faria Pierotti for their excellent technical assistance and Support Advanced Medical Nutrition, Brazil, for providing the dietary fibre mixture, Stimulance (R). T. K. W., K. d. C. F., O. M. S. A. and M. B. M. worked on preparing the project design, data analysis, statistical study, final revision and submission of manuscript. T. K. W. and K. d. C. F. conducted the experiment with the animals and T. K. W. and O. M. S. A. performed the laboratorial analysis. The authors state that there are potential personal conflicts of interest since M. B. M. is a speaker for Support Advanced Medical Nutrition in Brazil.",,38,9,12,0,13,CAMBRIDGE UNIV PRESS,CAMBRIDGE,"EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND",0007-1145,1475-2662,,BRIT J NUTR,Br. J. Nutr.,NOV,2010,104,10,,,,,1471,1476,,10.1017/S0007114510002497,http://dx.doi.org/10.1017/S0007114510002497,,,6,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,677YV,20687971,Bronze,,,2024-06-04,WOS:000284034900008,View Full Record in Web of Science
J,"Wang, PF; Shen, X; Wang, Y; Jia, XQ",,,,"Wang, Pengfei; Shen, Xia; Wang, Yan; Jia, Xiaoqiang",,,Association between constipation and major depression in adult Americans: evidence from NHANES 2005-2010,FRONTIERS IN PSYCHIATRY,,,English,Article,,,,,,constipation; major depression; female; cross-sectional study; NHANES,CORTICOTROPIN-RELEASING-FACTOR; GASTROINTESTINAL-TRACT; REPRESENTATIVE SAMPLE; FECAL INCONTINENCE; STRESS; PREVALENCE; DISORDERS; COMMUNITY; ANXIETY; HEALTH,"Objective: Current studies on the association between constipation and depression is still insufficient. In this study, we investigated the detailed association between constipation and major depression among American adults.Methods: In this cross-sectional study, 12,352 adults aged 20 and older were selected from the National Health and Nutrition Examination Survey 2005-2010 for the sample. Constipation was defined as fewer than three defecation frequencies per week. For the assessment of major depression, the validated Patient Health Questionnaire-9 was used. Adjusted odds ratios (ORs) were calculated using multivariate logistic regression models. A subgroup analysis was carried out to ensure that the results were stable.Results: Of the 12,352 participants, 430 reported constipation, with a prevalence of 3.5%. Depression was reported in 1030 cases, indicating a prevalence rate of 8.3%. Patients with constipation were significantly more likely to have major depression (20.9%) than those without it (7.9%, p < 0.001). After adjusting for age, sex, race/ethnicity, marital status, education level, body mass index, vigorous physical activity, alcohol consumption, smoking status, poverty income ratio, diabetes, selective serotonin reuptake inhibitor use, liver disease, heart disease, pulmonary disease, hypertension, arthritis, cancer, dietary fiber intake, moisture intake, total fat intake, carbohydrates intake, and protein intake, constipation is significantly associated with major depression (OR: 2.20, 95%CI: 1.68-2.87, p < 0.001). Subgroup analyses by age, sex, dietary intake, risk behaviors, and common complications showed no statistically significant interactions (p > 0.05).Conclusion: In conclusion, this study showed that constipation were significantly associated with depression. When treating patients with constipation, it is necessary for clinicians to screen and evaluate depression, and provide timely and effective intervention for patients with depression to avoid further deterioration of the condition.","[Wang, Pengfei; Jia, Xiaoqiang] China Acad Chinese Med Sci, Dept Anorectal Surg, Xiyuan Hosp, Beijing, Peoples R China; [Shen, Xia] Jiangnan Univ, Wuxi Med Coll, Dept Nursing, Wuxi, Peoples R China; [Wang, Yan] China Acad Chinese Med Sci, Guanganmen Hosp, Dept Oncol, Beijing, Peoples R China","Xiyuan Hospital, CACMS; China Academy of Chinese Medical Sciences; Jiangnan University; Guang'anmen Hospital, CACMS; China Academy of Chinese Medical Sciences","Jia, XQ (corresponding author), China Acad Chinese Med Sci, Dept Anorectal Surg, Xiyuan Hosp, Beijing, Peoples R China.;Wang, Y (corresponding author), China Acad Chinese Med Sci, Guanganmen Hosp, Dept Oncol, Beijing, Peoples R China.",941348104@qq.com; jxq2429@163.com,"Wang, P.F/GWZ-8568-2022; 魏, 子翔/IWM-1315-2023","Wang, P.F/0000-0003-2380-5541; Wang, Pengfei/0000-0002-4084-2267","The authors thank Liu Jie (People's Liberation Army of China General Hospital, Beijing, China) and Yang Qilin (The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China) for helping in this revision.","The authors thank Liu Jie (People's Liberation Army of China General Hospital, Beijing, China) and Yang Qilin (The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China) for helping in this revision.","The authors thank Liu Jie (People's Liberation Army of China General Hospital, Beijing, China) and Yang Qilin (The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China) for helping in this revision.",,34,2,2,1,3,FRONTIERS MEDIA SA,LAUSANNE,"AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND",1664-0640,,,FRONT PSYCHIATRY,Front. Psychiatry,AUG 15,2023,14,,,,,,,,1152435,10.3389/fpsyt.2023.1152435,http://dx.doi.org/10.3389/fpsyt.2023.1152435,,,13,Psychiatry,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Psychiatry,Q4PI1,37654986,"Green Published, gold",,,2024-06-04,WOS:001057352300001,View Full Record in Web of Science
J,"Chutkan, R; Fahey, G; Wright, WL; McRorie, J",,,,"Chutkan, Robynne; Fahey, George; Wright, Wendy L.; McRorie, Johnson",,,Viscous versus nonviscous soluble fiber supplements: Mechanisms and evidence for fiber-specific health benefits,JOURNAL OF THE AMERICAN ACADEMY OF NURSE PRACTITIONERS,,,English,Review,,,,,,Soluble fiber; insoluble fiber; digestive system; metabolic syndrome; hyperlipidemia; type 2 diabetes; weight control; dietary practices,IRRITABLE-BOWEL-SYNDROME; GLUCAGON-LIKE PEPTIDE-1; DIETARY FIBER; PRUDENT DIET; GUAR GUM; OBJECTIVE MEASURES; LOWERING EFFICACY; LDL-CHOLESTEROL; ISPAGHULA HUSK; GAS-PRODUCTION,"Purpose: This review focuses on the health benefits of viscous versus nonviscous soluble fibers, why symptoms can occur with increased fiber consumption, and how to avoid symptoms to improve adherence with a high-fiber diet. Data sources: Review of scientific literature as well as evidence-based guidelines and resources. Conclusions: While it is generally known that fiber is good for you, it is less well known that specific health benefits are associated with specific fiber characteristics. Many of the health benefits of fiber can be directly correlated with the viscosity of soluble fibers when hydrated (i.e., gel-forming). A reduction in viscosity of a given fiber will attenuate these health benefits, and a nonviscous fiber does not exhibit these health benefits. Implications for practice: Increasing the viscosity of chyme with a viscous soluble fiber has been shown clinically to lower cholesterol for cardiovascular health, improve glycemic control in type 2 diabetes, normalize stool form in both constipation (softens hard stool) and diarrhea (firms loose/liquid stool), and improve the objective clinical measures of metabolic syndrome (glycemic control, lipoprotein profile, body mass index/weight loss, and blood pressure).","[McRorie, Johnson] Procter & Gamble, Personal Hlth Care, Mason, OH 45040 USA; [Chutkan, Robynne] Digest Ctr Women, Chevy Chase, MD USA; [Chutkan, Robynne] Georgetown Univ, Med Ctr, Digest Ctr Women LLC, Washington, DC 20007 USA; [Fahey, George] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Wright, Wendy L.] Wright & Associates Family Healthcare PLLC, Amherst, NH USA; [Wright, Wendy L.] Anderson Family Healthcare PLLC, Concord Ctr, Concord, NH USA; [Wright, Wendy L.] Partners Healthcare Educ, Bedford, NH USA; [McRorie, Johnson] Mississippi State Univ, Coll Vet Med, Starkville, MS USA",Procter & Gamble; Georgetown University; University of Illinois System; University of Illinois Urbana-Champaign; Mississippi State University,"McRorie, J (corresponding author), Procter & Gamble, Personal Hlth Care, 8700 Mason Montgomery Rd, Mason, OH 45040 USA.",mcrorie.jw@pg.com,,,Procter Gamble,Procter Gamble(Procter & Gamble),"Johnson McRorie is a Clinical Scientist with Procter & Gamble, which markets two fiber products. George Fahey is a paid consultant for Procter & Gamble involved with several activities related to fiber. Funding was provided by Procter & Gamble for assistance of a medical writer in preparing this manuscript.",,91,91,110,2,62,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1041-2972,1745-7599,,J AM ACAD NURSE PRAC,J. Am. Acad. Nurse Pract.,AUG,2012,24,8,,,,,476,487,,10.1111/j.1745-7599.2012.00758.x,http://dx.doi.org/10.1111/j.1745-7599.2012.00758.x,,,12,Health Care Sciences & Services; Nursing,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Health Care Sciences & Services; Nursing,980OK,22845031,,,,2024-06-04,WOS:000306902500004,View Full Record in Web of Science
J,"Marlett, JA; McBurney, MI; Slavin, JL",,,,"Marlett, JA; McBurney, MI; Slavin, JL",,,Position of the American Dietetic Association: Health implications of dietary fiber,JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION,,,English,Article,,,,,,,GLUCAGON-LIKE PEPTIDE-1; BOWEL FUNCTION; BREAST-CANCER; CALCIUM BALANCE; GLYCEMIC LOAD; RISK; IMPROVES; CHOLESTEROL; SUPPLEMENTATION; PSYLLIUM,"Dietary fiber consists of the structural and storage polysaccharides and lignin in plants that are not digested in the human stomach and small intestine. A wealth of information supports the American Dietetic Association position that the public should consume adequate amounts of dietary fiber from a variety of plant foods. Recommended intakes, 20-35 g/day for healthy adults and age plus 5 g/day for children, are not being met, because intakes of good sources of dietary fiber, fruits, vegetables, whole and high-fiber grain products, and legumes are low. Consumption of dietary fibers that are viscous lowers blood cholesterol levels and helps to normalize blood glucose and insulin levels, making these kinds of fibers part of the dietary plans to treat cardiovascular disease and type 2 diabetes, Fibers that, are incompletely or slowly fermented by microflora in the large intestine promote normal laxation and are integral components of diet plans to treat constipation and prevent the development of diverticulosis and diverticulitis, A diet adequate in fiber-containing foods is also usually rich in micronutrients and nonnutritive ingredients that have additional health benefits. It is unclear why several recently published clinical trials with dietary fiber intervention failed to show a reduction in colon polyps. Nonetheless, a fiber-rich diet is associated with a lower risk of colon cancer. A fiber-rich meal is processed more slowly, which promotes earlier satiety, and is frequently less calorically dense and lower in fat and added sugars. All of these characteristics are features of a dietary pattern to treat and prevent obesity. Appropriate kinds and amounts of dietary fiber for the critically ill and the very old have not been clearly delineated; both may need nonfood sources of fiber. Many factors confound observations of gastrointestinal function in the critically ill, and the kinds of fiber that would promote normal small and large intestinal function are usually not in a form suitable for the critically ill. Maintenance of body weight in the inactive older adult is accomplished in part by decreasing food intake. Even with a fiber-rich diet, a supplement may be needed to bring fiber intakes into a range adequate to prevent constipation. By increasing variety in the daily food pattern, the dietetics professional can help most healthy children and adults achieve adequate dietary fiber intakes.","Univ Wisconsin, Madison, WI 53706 USA; Kellogg Co, Battle Creek, MI USA; Univ Minnesota, St Paul, MN 55108 USA",University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities,"Univ Wisconsin, Madison, WI 53706 USA.",,"McBurney, Michael I./AAB-6850-2019; Slavin, Joanne/GOJ-9874-2022","McBurney, Michael I./0000-0003-4511-6034; Slavin, Joanne/0000-0003-0720-5300",,,,,77,418,508,1,90,AMER DIETETIC ASSOC,CHICAGO,"120 S RIVERSIDE PLZ, STE 2000, CHICAGO, IL 60606-6995 USA",0002-8223,,,J AM DIET ASSOC,J. Am. Diet. Assoc.,JUL,2002,102,7,,,,,993,1000,,10.1016/S0002-8223(02)90228-2,http://dx.doi.org/10.1016/S0002-8223(02)90228-2,,,8,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,571HD,12146567,,,,2024-06-04,WOS:000176711200025,View Full Record in Web of Science
J,"BUSBY, J; NELSON, R",,,,"BUSBY, J; NELSON, R",,,DIETARY FIBER SUPPLEMENTS TO TREAT CHRONIC CONSTIPATION,GERONTOLOGIST,,,English,Meeting Abstract,,,,,,,,,"VET ADM MED CTR,GRECC,GAINESVILLE,FL 32602",Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA),,,,,,,,,0,0,0,0,0,GERONTOLOGICAL SOCIETY AMER,WASHINGTON,"1275 K STREET NW SUITE 350, WASHINGTON, DC 20005-4006",0016-9013,,,GERONTOLOGIST,Gerontologist,,1985,25,,,,SI,,244,244,,,,,,1,Gerontology,Social Science Citation Index (SSCI),Geriatrics & Gerontology,ASJ88,,,,,2024-06-04,WOS:A1985ASJ8800839,View Full Record in Web of Science
J,"Müller-Lissner, SA; Kamm, MA; Scarpignato, C; Wald, A",,,,"Müller-Lissner, SA; Kamm, MA; Scarpignato, C; Wald, A",,,Myths and misconceptions about chronic constipation,AMERICAN JOURNAL OF GASTROENTEROLOGY,,,English,Review,,,,,,,SEVERE IDIOPATHIC CONSTIPATION; SLOW-TRANSIT CONSTIPATION; IRRITABLE-BOWEL-SYNDROME; LAXATIVE USE; COLORECTAL-CANCER; MELANOSIS COLI; GASTROINTESTINAL TRANSIT; HORMONE ABNORMALITIES; ANTHRANOID LAXATIVES; SODIUM PICOSULFATE,"There are many strongly held beliefs about constipation that are not evidence based. The purpose of this review is to address these beliefs concerning various aspects of constipation. There is no evidence to support the theory that diseases may arise via autointoxication, whereby poisonous substances from stools within the colon are absorbed. Dolichocolon, defined as an elongated colon, should not be seen as a cause of constipation. The role of sex hormones altering gut function during the menstrual cycle appears to be minimal. During pregnancy they may play a role in slowing gut transit. Hypothyroidism can cause constipation, but among patients presenting with constipation, hypothyroidism is rare. A diet poor in fiber should not be assumed to be the cause of chronic constipation. Some patients may be helped by a fiber-rich diet but many patients with more severe constipation get worse symptoms when increasing dietary fiber intake. There is no evidence that constipation can successfully be treated by increasing fluid intake unless there is evidence of dehydration. In the elderly constipation may correlate with decreased physical activity, but many cofactors are likely to play a role. Intervention programs to increase physical activity as part of a broad rehabilitation program may help. It is unlikely that stimulant laxatives at recommended doses are harmful to the colon. A proportion of patients with chronic constipation is dependent of laxatives to achieve satisfactory bowel function, but this is not the result of prior laxative intake. Tolerance to stimulant laxatives is uncommon. There is no indication for the occurrence of rebound constipation after stopping laxative intake. While laxatives may be misused, there is no potential for addiction.","Pk Klin Weissensee, Innere Med Abt, D-13086 Berlin, Germany; St Marks Hosp, London EC1V 2PS, England; Univ Parma, Lab Clin Pharmacol, Dept Human Anat Pharmacol & Forens Sci, I-43100 Parma, Italy; Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA",Imperial College London; University of Parma; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh,"Pk Klin Weissensee, Innere Med Abt, Schonstr 80, D-13086 Berlin, Germany.",,"Scarpignato, Carmelo/ABC-1745-2021","Scarpignato, Carmelo/0000-0001-5645-857X",,,,,105,280,315,2,44,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0002-9270,1572-0241,,AM J GASTROENTEROL,Am. J. Gastroenterol.,JAN,2005,100,1,,,,,232,242,,10.1111/j.1572-0241.2005.40885.x,http://dx.doi.org/10.1111/j.1572-0241.2005.40885.x,,,11,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,883RJ,15654804,,,,2024-06-04,WOS:000226033100034,View Full Record in Web of Science
J,"Ikee, R; Yano, K; Tsuru, T",,,,"Ikee, Ryota; Yano, Kazuhiro; Tsuru, Tomomi",,,Constipation in chronic kidney disease: it is time to reconsider,RENAL REPLACEMENT THERAPY,,,English,Review,,,,,,Constipation; Chronic kidney disease; Dialysis; Uremic toxins; Intestinal motility; Gut microbiota; Gut dysbiosis; Chronic inflammation,IRRITABLE-BOWEL-SYNDROME; PERITONEAL-DIALYSIS PATIENTS; STAGE RENAL-DISEASE; GASTROINTESTINAL SYMPTOMS; FUNCTIONAL CONSTIPATION; CARDIOVASCULAR-DISEASE; SEVELAMER HYDROCHLORIDE; HEMODIALYSIS-PATIENTS; DIABETES-MELLITUS; COLORECTAL-CANCER,"Constipation is highly prevalent in patients with chronic kidney disease (CKD) and is primarily characterized by decreased intestinal motility. This chronic disorder affects the quality of life of patients. However, nephrologist and dialysis clinicians have long had a disproportionately limited understanding of constipation. Accumulating evidence has revealed a relationship between constipation and cardiovascular disease and CKD. The pathogenesis of constipation in CKD patients is multifactorial: decreased physical activity, comorbidities affecting bowel movement, such as diabetes mellitus, cerebrovascular disease, and hyperparathyroidism, a restricted dietary intake of plant-based fiber-rich foods, and multiple medications, including phosphate binders and potassium-binding resins, have all been implicated. CKD is associated with alterations in the composition and function of the gut microbiota, so-called gut dysbiosis. Recent studies showed that CKD-related gut dysbiosis decreased intestinal motility via intestinal inflammation or the increased generation of gut-derived uremic toxins, such as indoxyl sulfate and p-cresyl sulfate. Furthermore, the gastrointestinal secretion of mucin was found to be decreased in CKD animal models, which may delay colonic transit by diminished lubrication in the alimentary tract. Thus, CKD-related gut dysbiosis may play a role in constipation, but limited information is currently available. Since constipation is often intractable, particularly in CKD patients, every available means needs to be employed in its treatment. The effects of probiotics, prebiotics, and synbiotics on the composition of the gut microbiota and gut-derived uremic toxins have been increasingly reported. However, their effects on stool consistency or frequency in CKD patients remain unclear. Some laxatives may be beneficial for improving not only bowel habits but also gut dysbiosis. Further studies are required to elucidate the CKD-specific pathogenesis of constipation and develop novel effective treatment options.","[Ikee, Ryota; Yano, Kazuhiro] Med Co LTA PS Clin, Dialysis Vasc Access Ctr, Hakata Ku, 6-18 Tenyamachi, Fukuoka, Fukuoka 8120025, Japan; [Tsuru, Tomomi] Med Co LTA PS Clin, Dept Rheumatol, Hakata Ku, 6-18 Tenyamachi, Fukuoka, Fukuoka 8120025, Japan",,"Ikee, R (corresponding author), Med Co LTA PS Clin, Dialysis Vasc Access Ctr, Hakata Ku, 6-18 Tenyamachi, Fukuoka, Fukuoka 8120025, Japan.",ryota.ikee@gmail.com,,"Ikee, Ryota/0000-0002-3683-5363",,,,,99,14,14,0,5,BMC,LONDON,"CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND",,2059-1381,,RENAL REPLACE THER,Renal Replace. Ther.,DEC 12,2019,5,1,,,,,,,51,10.1186/s41100-019-0246-3,http://dx.doi.org/10.1186/s41100-019-0246-3,,,10,Urology & Nephrology,Emerging Sources Citation Index (ESCI),Urology & Nephrology,WE0TG,,gold,,,2024-06-04,WOS:000705341700001,View Full Record in Web of Science
J,"Liu, BS; Zhu, XY; Cui, YL; Wang, WJ; Liu, H; Li, ZD; Guo, ZG; Ma, S; Li, DF; Wang, CZ; Shi, YH",,,,"Liu, Boshuai; Zhu, Xiaoyan; Cui, Yalei; Wang, Wenjing; Liu, Hua; Li, Zidan; Guo, Zhiguo; Ma, Sen; Li, Defeng; Wang, Chengzhang; Shi, Yinghua",,,Consumption of Dietary Fiber from Different Sources during Pregnancy Alters Sow Gut Microbiota and Improves Performance and Reduces Inflammation in Sows and Piglets,MSYSTEMS,,,English,Article,,,,,,dietary fiber; inflammation; gut microbiota; sows; piglets; animal nutrition,INTESTINAL PERMEABILITY; OXIDATIVE STRESS; METABOLITES; BUTYRATE; BACTERIA; HEALTH; MODULATION; GESTATION; CHILDREN; BARRIER,"In pregnant and lactating sows, metabolism and immunity undergo drastic changes, which can lead to constipation, abortion, and intrauterine growth restriction (IUGR) and reduce production performance. Dietary fiber can regulate animal gut microbiota, alleviate inflammatory responses, and improve performance. Here, 48 sows (Large x Landrace) were randomly allocated to groups including, control, and with alfalfa meal (AM), beet pulp, and soybean skin dietary supplementation for 60days of gestation. The AM diet decreased IUGR, increased food intake during lactation, and promoted the reproductive performance and physical condition of sows. Further, the AM diet significantly reduced markers of intestinal permeability (reactive oxygen species and endotoxin) in sow serum, and of systemic inflammation (interleukin-6 [IL-6] and tumor necrosis factor alpha) in sow feces and serum, as well as piglet serum, while it increased the anti-inflammatory marker, IL-10, in sow serum and feces. The AM diet also significantly affected gut microbiota by increasing the relative abundance of proinflammatory bacteria, while decreasing anti-inflammatory bacteria. Moreover, the total short-chain fatty acid (SCFA) content was higher in feces from sows fed an AM diet, with butyric acid content significantly higher during lactation, than in controls. Sow performance was correlated with intestinal permeability, inflammation, and gut microbiota, which were also vertically transmitted to piglets. Our results are significant for guiding feed management in the pig breeding industry. Further, the sows to piglets model provides a reference for the effect of dietary fiber on the gastrointestinal function of human mothers and infants. IMPORTANCE Although the direct effects of dietary fiber on gut microbiota composition have been studied extensively, systematic evaluation of different fiber sources on gut health and inflammatory responses of sows and their offspring has rarely been conducted. Excessive reactive oxygen species produced by overactive metabolic processes during late pregnancy and lactation of sows leads to increased endotoxin levels, disordered gut microbiota, decreased SCFA production, and secretion of proinflammatory factors, which in turn causes local inflammation of the gut, potential damage of the gut microbial barrier, increased gut permeability, increased blood endotoxin levels (resulting in systemic inflammation), and ultimately decreased sow and piglet performance. Our results showed that supplementation of the diet with alfalfa meal in mid and late pregnancy can reverse this process. Our findings lay a foundation for improving the gut health of sows and piglets and provide insights into the study of the gastrointestinal tract function in human mothers and infants.","[Liu, Boshuai; Zhu, Xiaoyan; Cui, Yalei; Wang, Wenjing; Liu, Hua; Li, Zidan; Guo, Zhiguo; Ma, Sen; Li, Defeng; Wang, Chengzhang; Shi, Yinghua] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Peoples R China; [Zhu, Xiaoyan; Cui, Yalei; Ma, Sen; Li, Defeng; Wang, Chengzhang; Shi, Yinghua] Henan Key Lab Innovat & Utilizat Grassland Resour, Zhengzhou, Peoples R China",Henan Agricultural University,"Shi, YH (corresponding author), Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Peoples R China.;Shi, YH (corresponding author), Henan Key Lab Innovat & Utilizat Grassland Resour, Zhengzhou, Peoples R China.",annysyh@henau.edu.cn,,,Earmarked Fund for Modern Agro-industry Technology Research System of China [CARS-34]; Science and Technology Research Key Project of Education Department of Henan Province [19B230012],Earmarked Fund for Modern Agro-industry Technology Research System of China; Science and Technology Research Key Project of Education Department of Henan Province,Financial support for this research was provided by the Earmarked Fund for Modern Agro-industry Technology Research System of China (CARS-34) and the Science and Technology Research Key Project of Education Department of Henan Province (19B230012).,,57,40,51,26,106,AMER SOC MICROBIOLOGY,WASHINGTON,"1752 N ST NW, WASHINGTON, DC 20036-2904 USA",2379-5077,,,MSYSTEMS,mSystems,JAN-FEB,2021,6,1,,,,,,,e00591-20,10.1128/mSystems.00591-20,http://dx.doi.org/10.1128/mSystems.00591-20,,,17,Microbiology,Science Citation Index Expanded (SCI-EXPANDED),Microbiology,RY1QE,33500330,"Green Published, gold",,,2024-06-04,WOS:000647691000021,View Full Record in Web of Science
J,"Potty, VH",,,,"Potty, VH",,,"Physio-chemical aspects, physiological functions, nutritional importance and technological significance of dietary fibres - A critical appraisal",JOURNAL OF FOOD SCIENCE AND TECHNOLOGY-MYSORE,,,English,Review,,,,,,dietary fibres; minerals; nutrition; diseases; bile salts; gastro-intestinal tract; processing; colon bacteria,HIGH-FIBER DIET; HIGH-CARBOHYDRATE; CELL-WALL; BLOOD-PRESSURE; WHEAT BRAN; CHOLESTEROL; POLYSACCHARIDES; BINDING; STARCH; FOODS,"Dietary fibres (DF), composed of celluloses, hemicelluloses, pectins, lignins and other non-digestible materials in the food not amenable to the action of alimentary enzymes of human beings, play a multifaceted role in preventing a number of health disorders through their influence in the gastrointestinal tract. Their effectiveness is governed by physical properties such as particle size when ingested, water holding capacity, solubility and viscosity in aqueous phase, affinity to bile acid salts, catlonic binding/exchange effect, fermentability in the bowel and chemical identity and proportion of the various constituents. DF undergo very little changes during processing of foods except size reduction. Estimation of DF is carried out by detergent treatments and/or enzyme digestions followed by gravi-metric and/or colorimetric and/or GLC techniques. Inadequate level of DF in the diet has been implicated in many human diseases like coronary heart disease, blood pressure, obesity, hypercholesterolemia, hyperlipidemia, gall stones, varicose veins, diabetes, constipation and diverticulitis. A per capita daily intake of 30g of DF or 12g of DF/1000 kCal per day is considered desirable, to be obtained from as varied sources as possible with about one-third being soluble fibre. While cereal sources provide a major part of insoluble DF, fruits, vegetables, oats, plant gums and mucilages, seaweed and microbial polysaccharides are important sources of soluble DF. Fibre concentrates containing up to 100% DF are commercially available for enrichment of food preparations and development of high fibre processed food products. Non-starch polysaccharides extracted from plant, seaweed and microbial sources, their modified derivatives and synthetic oligosaccharides are increasingly being used by the food processing industry as food adjuncts for specific functional effects such as fat replacement, textural management and lowering of caloric content of foods. While use of various DF preparations are Generally considered safe for human consumption, further studies may be necessary, at least in some cases, to confirm their absolute safety for long term use and at high concentrations. Many aspects of functions of DF in human body are still not clearly understood and this is considered to be an emerging area deserving increased attention from polysaccharide chemists, food scientists, nutritionists, clinicians and technologists in the coming years.",,,"UNIV SAINS MALAYSIA, SCH IND TECHNOL, GEORGE TOWN 11800, MALAYSIA.",,,,,,,,123,52,63,0,44,SPRINGER INDIA,NEW DELHI,"7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA",0022-1155,0975-8402,,J FOOD SCI TECH MYS,J. Food Sci. Technol.-Mysore,JAN-FEB,1996,33,1,,,,,1,18,,,,,,18,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,UV938,,,,,2024-06-04,WOS:A1996UV93800001,View Full Record in Web of Science
J,"KASPER, H; SEEMANN, R; WILD, M",,,,"KASPER, H; SEEMANN, R; WILD, M",,,TREATMENT OF CONSTIPATION BY DIETARY FIBER SUBSTITUTION,AKTUELLE ERNAHRUNGSMEDIZIN,,,German,Article,,,,,,,,,,,"KASPER, H (corresponding author), UNIV WURZBURG,MED KLIN,D-8700 WURZBURG,FED REP GER.",,,,,,,,17,7,7,0,0,GEORG THIEME VERLAG,STUTTGART,"P O BOX 30 11 20, D-70451 STUTTGART, GERMANY",0341-0501,,,AKTUEL ERNAHRUNGSMED,,,1981,6,1,,,,,22,25,,,,,,4,"Medicine, General & Internal; Nutrition & Dietetics",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine; Nutrition & Dietetics,LG407,,,,,2024-06-04,WOS:A1981LG40700006,View Full Record in Web of Science
J,"Kim, MC; Lee, S; Park, JK; Park, J; Lee, D; Park, J; Kim, BY; Cho, MS; Kim, TY; Park, H; Park, JH; Bok, MK; Lim, H",,,,"Kim, Min Cheol; Lee, Sunghee; Park, Jin Kyung; Park, Jongmi; Lee, Donghun; Park, Jaewan; Kim, Byung-Yong; Cho, Min Seok; Kim, Tae-Yoon; Park, Ha Young; Park, Ju Hyun; Bok, Min Kyung; Lim, Hyunjung",,,"Effects of ID-HWS1000 on the Perception of Bowel Activity and Microbiome in Subjects with Functional Constipation: A Randomized, Double-Blind Placebo-Controlled Study",JOURNAL OF MEDICINAL FOOD,,,English,Article,,,,,,bowel movements; functional constipation; gut microbiome; prebiotics; probiotics,CHRONIC IDIOPATHIC CONSTIPATION; GUT MICROBIOME; PROBIOTICS; PREBIOTICS; SYMPTOMS; SEARCH,"During constipation, indigestible foods, such as probiotics, prebiotics, and dietary fiber, may improve the bowel environment and activity. In this randomized, double-blind, and placebo-controlled study, the effects of ID-HWS1000, composed of Lactobacillus and Bifidobacterium species, xylooligosaccharide, and dietary fiber, were evaluated to determine whether it improves the perception of bowel activity or cause changes in the gut microbiome. Thirty Korean adults with functional constipation according to the Rome III criteria were randomly assigned to the following groups: 20 in the ID-HWS1000 group and 10 in the placebo group. ID-HWS1000 or the placebo was consumed by the participants for 4 weeks. To assess the changes in the perception of bowel activity, clinical data and gut microbiome analyses were conducted before and after the experiment. There were significant differences between the groups in the response to 9 of the 12 survey questions (the number and duration of bowel movements, amount of feces, number of irritant bowel movements, number of times bowel movements felt incomplete, shape of the feces, amount of gas in the gut, discomfort after defecation, and discomfort owing to constipation) (P < .05). There was a decrease in the proportion of Firmicutes (Ruminococcaceae and Lachnospiraceae) and an increase in Bacteroidetes (Bacteroidaceae) (P < .05). Moreover, ID-HWS1000 directly improved the discomfort associated with bowel movements, decreased the proportion of Lachnospiraceae, and increased the proportion of Bacteroidaceae. These results confirmed that ID-HWS1000 improves the perception of bowel activity and exerts positive changes in individuals with functional constipation.","[Kim, Min Cheol; Park, Jin Kyung; Park, Jongmi; Park, Ha Young] ILDONG Pharmaceut Co Ltd, Hwaseong, South Korea; [Lee, Sunghee; Lee, Donghun; Park, Jaewan; Kim, Tae-Yoon] ILDONG Pharmaceut Co Ltd, Res Lab, Hwaseong, South Korea; [Kim, Byung-Yong; Cho, Min Seok] ChunLab Inc, Microbiome Res Ctr, Seoul, South Korea; [Park, Ju Hyun; Bok, Min Kyung; Lim, Hyunjung] Kyung Hee Univ, Grad Sch East West Med Sci, Dept Med Nutr, Yongin 17104, South Korea; [Park, Ju Hyun; Bok, Min Kyung; Lim, Hyunjung] Kyung Hee Univ, Res Inst Med Nutr, Yongin, South Korea",Kyung Hee University; Kyung Hee University,"Lim, H (corresponding author), Kyung Hee Univ, Grad Sch East West Med Sci, Dept Med Nutr, Yongin 17104, South Korea.",hjlim@khu.ac.kr,", BYUNGYONG KIM/JLL-7806-2023; LEE, Sunghee/HCH-4510-2022; PARK, JIN-KYUNG/I-8716-2017","Park, Ju Hyun/0000-0002-4700-4960; Kim, Byung-Yong/0000-0002-4229-8859; Lee, Dong-Hoon/0000-0001-7976-1862; Tak, jihye/0000-0001-9914-0086",,,,,42,10,10,5,13,"MARY ANN LIEBERT, INC",NEW ROCHELLE,"140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA",1096-620X,1557-7600,,J MED FOOD,J. Med. Food,AUG 1,2021,24,8,,,,,883,893,,10.1089/jmf.2020.4746,http://dx.doi.org/10.1089/jmf.2020.4746,,,11,"Chemistry, Medicinal; Food Science & Technology; Nutrition & Dietetics",Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy; Food Science & Technology; Nutrition & Dietetics,UB5GK,34406877,,,,2024-06-04,WOS:000685874100012,View Full Record in Web of Science
J,"HELLSTROM, M; BROLIN, I",,,,"HELLSTROM, M; BROLIN, I",,,DIETARY-FIBERS IN THE PREPARATION OF THE BOWEL FOR DIAGNOSTIC BARIUM ENEMA,GASTROINTESTINAL RADIOLOGY,,,English,Article,,,,,,,,"The effect on colon cleanness of adding dietary fiber or placebo to a standard bowel preparation scheme before diagnostic barium enemas was tested in a randomized, double-blind study including 120 consecutive outpatients admitted for diagnostic barium enemas. Colon cleanness was scored as satisfactory, intermediate, or unsatisfactory. No case of unsatisfactory cleansing appeared in the group given fiber. Mean score was slightly better in the fiber group but the difference was not statistically significant. Dietary fiber does not have a negative significant. Dietary fiber does not have a negative effect on colon cleansing but may instead have a beneficial effect, which is possibly more pronounced in patients with constipation.","GOTHENBURG UNIV, E HOSP, S-41345 GOTHENBURG, SWEDEN",University of Gothenburg,"GOTHENBURG UNIV, SAHLGRENS HOSP, DEPT RADIOL, S-41345 GOTHENBURG, SWEDEN.",,"Hellström, Mikael/U-2211-2019","Hellstrom, Mikael/0000-0003-4031-332X",,,,,8,11,11,0,1,SPRINGER,NEW YORK,"ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES",0364-2356,,,GASTROINTEST RADIOL,,JAN,1987,12,1,,,,,76,78,,10.1007/BF01885108,http://dx.doi.org/10.1007/BF01885108,,,3,"Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging",Science Citation Index Expanded (SCI-EXPANDED),"Gastroenterology & Hepatology; Radiology, Nuclear Medicine & Medical Imaging",F2270,3025051,,,,2024-06-04,WOS:A1987F227000019,View Full Record in Web of Science
J,"Ashrafi, A; Arab, AM; Abdi, S; Nourbakhsh, MR",,,,"Ashrafi, Atefe; Arab, Amir Massoud; Abdi, Saeed; Nourbakhsh, Mohammad Reza",,,The association between myofascial trigger points and the incidence of chronic functional constipation,JOURNAL OF BODYWORK AND MOVEMENT THERAPIES,,,English,Article,,,,,,Functional constipation; Chronic constipation; Myofascial pain syndrome; Myofascial trigger point; Diet patterns; Physical activity levels,PHYSICAL-ACTIVITY; PELVIC PAIN; DEFECATION; MANAGEMENT; DIETARY; TRANSIT; LIFE,"Introduction: Chronic functional constipation (CFC) is the most prevalent type of constipation. Considering the proven effect of pelvic floor muscles dysfunction in these patients' symptom and the fascial connection between pelvic floor and abdominal and lumbopelvic muscles, this study aimed to examine the possible relationship between this muscles and CFC. Method: We conveniently selected 100 patients with CFC and 100 healthy participants based on the Rome IV criteria. Two groups were asked to complete the international physical activity questionnaire and food frequency questionnaire. Then both groups were assessed for the presence of trigger points in more prevalent pain sites for each muscle by pressure algometer with 50% of their caught pressure pain threshold. Results: There were no statistical differences between two groups in the intake of calories, carbohydrates, proteins, sugar, fiber, vegetables, and wheat products. Patients had a higher consumption of fat and dairy products. for the physical activity level, a statistical difference showed that patients were less physically active. The comparison of the presence and the number of trigger points for each muscle in patients and control groups indicated more than 50% impairment, and there was a significant difference between two groups. Conclusions: This study revealed that the relationship between myofascial trigger points of abdominal and lumbopelvic muscles and constipation. In addition to that, it seems that a sedentary life may influence CFC patients' condition. Moreover, it seems that the results of the dietary condition in patients could be because of conscious consumption of some certain foods. (C) 2020 Elsevier Ltd. All rights reserved.","[Ashrafi, Atefe; Arab, Amir Massoud] Univ Social Welf & Rehabil Sci, Dept Physiotherapy, Tehran, Iran; [Abdi, Saeed] Shahid Beheshti Univ Med Sci, Gastroenterol & Liver Dis Res Ctr, Tehran, Iran; [Nourbakhsh, Mohammad Reza] Univ North Georgia, Dept Phys Therapy, Dahlonega, GA USA",Shahid Beheshti University Medical Sciences; University of North Georgia,"Arab, AM (corresponding author), Univ Social Welf & Rehabil Sci, Dept Physiotherapy, Tehran, Iran.",At.ashrafi@uswr.ac.ir; am.arabloo@uswr.ac.ir; Saeedabdi@yahoo.com; Reza.Nourbakhsh@ung.edu,"arab, amir massoud/G-1141-2017; abdi, saeid/ERD-9552-2022","Arab, Amir Massoud/0000-0003-2371-6100",,,,,37,1,1,0,4,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",1360-8592,1532-9283,,J BODYW MOV THER,J. Bodyw. Mov. Ther.,APR,2021,26,,,,,,201,206,,10.1016/j.jbmt.2020.12.004,http://dx.doi.org/10.1016/j.jbmt.2020.12.004,,FEB 2021,6,Rehabilitation,Emerging Sources Citation Index (ESCI),Rehabilitation,SF8WG,33992245,,,,2024-06-04,WOS:000653028300031,View Full Record in Web of Science
J,"Yu, XR; Fu, CS; Cui, ZC; Chen, GY; Xu, YL; Yang, CM",,,,"Yu, Xiaorong; Fu, Chunsheng; Cui, Zhenchuan; Chen, Guangyong; Xu, Yinglei; Yang, Caimei",,,"Inulin and isomalto-oligosaccharide alleviate constipation and improve reproductive performance by modulating motility-related hormones, short-chain fatty acids, and feces microflora in pregnant sows",JOURNAL OF ANIMAL SCIENCE,,,English,Article,,,,,,constipation alleviation; inulin; isomalto-oligosaccharide; reproductive performance; sows,DIPHENOXYLATE-INDUCED CONSTIPATION; CARBON-INDUCED CONSTIPATION; GUT MICROBIOTA; PREBIOTICS; FUNGI; FLORA; DIET; PIGS,"Constipation in gestating and lactating sows is common and the inclusion of dietary fiber may help to alleviate this problem. We investigated the effects of inulin (INU) and isomalto-oligosaccharide (IMO), two sources of soluble dietary fiber, on gastrointestinal motility-related hormones, short-chain fatty acids (SCFA), fecal microflora, and reproductive performance in pregnant sows. On day 64 of gestation, 30 sows were randomly divided into three groups and fed as follows: a basal diet, a basal diet with 0.5% INU, and a basal diet with 0.5% IMO. We found that INU and IMO significantly modulated the levels of gastrointestinal motility-related hormones, as evidenced by an increase in substance P (P < 0.05), and a decrease in the vasoactive intestinal peptide concentrations (P < 0.05), indicating the capacity of INU and IMO to alleviate constipation. Furthermore, IMO enhanced the concentrations of acetic, propionic, isobutyric, butyric, isovaleric, and valeric acids in the feces (P < 0.05). High-throughput sequencing showed that IMO and INU increased the fecal microflora alpha- and beta-diversity (P < 0.05). Methanobrevibacter was more abundant (P < 0.05), whereas the richness of Turicibacter was lower in the INU and IMO groups than in the control group (P < 0.05). In addition, IMO significantly increased litter size (P < 0.05). Overall, our findings indicate that INU and IMO can relieve constipation, optimize intestinal flora, and promote reproductive performance in pregnant sows.","[Yu, Xiaorong; Fu, Chunsheng; Cui, Zhenchuan; Chen, Guangyong; Xu, Yinglei; Yang, Caimei] Zhejiang A&F Univ, Coll Anim Sci & Technol,Coll Vet Med, Key Lab Appl Technol Green Ecohlth Anim Husb Zhej, Zhejiang Prov Engn Lab Anim Hlth & Internet Techn, Hangzhou 311300, Peoples R China",Zhejiang A&F University,"Yang, CM (corresponding author), Zhejiang A&F Univ, Coll Anim Sci & Technol,Coll Vet Med, Key Lab Appl Technol Green Ecohlth Anim Husb Zhej, Zhejiang Prov Engn Lab Anim Hlth & Internet Techn, Hangzhou 311300, Peoples R China.",yangcaimei2012@163.com,,,"Zhejiang Provincial Key Research and Development Program [2019C02051, 2020C02032]; Zhejiang Provincial Leading Innovation Team Project [2020R01015]; National key research and development program of China [2018YFE0112700]",Zhejiang Provincial Key Research and Development Program; Zhejiang Provincial Leading Innovation Team Project; National key research and development program of China,"The present research was supported by the Zhejiang Provincial Key Research and Development Program (No. 2019C02051 and No.2020C02032), Zhejiang Provincial Leading Innovation Team Project (No.2020R01015), and the National key research and development program of China (2018YFE0112700).",,60,11,11,3,43,OXFORD UNIV PRESS INC,CARY,"JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA",0021-8812,1525-3163,,J ANIM SCI,J. Anim. Sci.,OCT,2021,99,10,,,,,,,,10.1093/jas/skab257,http://dx.doi.org/10.1093/jas/skab257,,SEP 2021,9,"Agriculture, Dairy & Animal Science",Science Citation Index Expanded (SCI-EXPANDED),Agriculture,YJ8HB,34487146,Green Published,,,2024-06-04,WOS:000744768100005,View Full Record in Web of Science
J,"Takaoka, M; Igarashi, A; Futami, A; Yamamoto-Mitani, N",,,,"Takaoka, Manami; Igarashi, Ayumi; Futami, Asako; Yamamoto-Mitani, Noriko",,,Management of constipation in long-term care hospitals and its ward manager and organization factors,BMC NURSING,,,English,Article,,,,,,Constipation; Assessment; Nursing care; Long-term care; Ward manager,CONTROLLED-TRIAL; NURSING-HOME; INTERVENTION; EXPERIENCE; BURDEN,"Background Studies examining organizational factors that may influence constipation management in long-term care (LTC) hospitals are lacking. This study aimed to clarify the practice of constipation management in LTC hospitals and to explore its factors, including ward manager's perception, organizational climate, and constipation assessment. Methods In this cross-sectional questionnaire survey of ward managers and staff nurses working in LTC wards, we determined daily assessment and practices regarding constipation management. We also conducted multivariate analyses to examine factors related to constipation management. Results There was a 20% response rate to the questionnaire. Nearly all LTC wards routinely assessed bowel movement frequency; other assessments were infrequent. Laxatives were used, but the use of dietary fiber and probiotic products was implemented in only 20-30% of wards. The implementation of non-pharmacological management and adequate use of stimulant laxatives were positively associated with the ward manager's belief and knowledge, organizational climate, the existence of nursing records for constipation assessment, planned nursing care for constipation, and organized conferences and in-hospital study sessions on constipation management. Conclusion Areas to improve constipation management in LTC hospitals include altering the ward manager's perception, improving hospital's organizational climate, and introducing standardized assessment/care planning systems.","[Takaoka, Manami; Igarashi, Ayumi; Futami, Asako; Yamamoto-Mitani, Noriko] Univ Tokyo, Grad Sch Med, Dept Gerontol Homecare & Long Term Care Nursing, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan",University of Tokyo,"Takaoka, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Gerontol Homecare & Long Term Care Nursing, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.",takaoka-manami@umin.ac.jp,"Igarashi, Ayumi/T-9981-2019; 朝子, 二見/IUQ-1047-2023","Igarashi, Ayumi/0000-0002-5292-8893; Takaoka, Manami/0000-0001-9136-0164","Department of Gerontological Home Care and Long-term Care Nursing, the University of Tokyo","Department of Gerontological Home Care and Long-term Care Nursing, the University of Tokyo","This research was partially funded by the Department of Gerontological Home Care and Long-term Care Nursing, the University of Tokyo.",,35,8,8,3,21,BMC,LONDON,"CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND",1472-6955,,,BMC NURS,BMC Nurs.,JAN 16,2020,19,1,,,,,,,5,10.1186/s12912-020-0398-z,http://dx.doi.org/10.1186/s12912-020-0398-z,,,10,Nursing,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Nursing,KL7UV,31988637,"Green Submitted, gold, Green Published",,,2024-06-04,WOS:000513624800001,View Full Record in Web of Science
J,"Spinzi, G; Amato, A; Imperiali, G; Lenoci, N; Mandelli, G; Paggi, S; Radaelli, F; Terreni, N; Terruzzi, V",,,,"Spinzi, Giancarlo; Amato, Arnaldo; Imperiali, Gianni; Lenoci, Nicoletta; Mandelli, Giovanna; Paggi, Silvia; Radaelli, Franco; Terreni, Natalia; Terruzzi, Vittorio",,,Constipation in the Elderly Management Strategies,DRUGS & AGING,,,English,Review,,,,,,,IDIOPATHIC CONSTIPATION; UNITED-STATES; EPIDEMIOLOGY; LACTULOSE; ADULTS; PREVALENCE; LAXATIVES; LONG,"Constipation is a highly prevalent and bothersome disorder that negatively affects patients' social and professional lives and places a great economic burden on both patients and national health services. An accurate determination of the prevalence of constipation is difficult because of the various definitions used, but many epidemiological studies have shown that it affects up to 20% of the population at any one time. Although constipation is not a physiological consequence of normal aging, decreased mobility and other co-morbid medical conditions may contribute to its prevalence in older adults. Functional constipation is diagnosed when no secondary causes can be identified. Patients have some unusual beliefs about their bowel habits. Systematic attention to history, examination and investigation, especially in older people, can be highly effective in resolving problems and in enhancing quality of life. There is a considerable range of treatment modalities available for patients with constipation, but the clinical evidence supporting their use varies widely. However, if constipation is not managed proactively, patients can experience negative consequences, such as anorexia, nausea, bowel impaction or bowel perforation. The clinical benefits of various traditional pharmacological and non-pharmacological agents remain unclear. The first steps in the treatment of simple constipation include increasing intake of dietary fibre and the use of a fibre supplement. Patients with severe constipation or those unable to comply with the recommended intake of fibre may benefit from the addition of laxatives. More recently, newer agents (e.g. tegaserod and lubiprostone), have been approved for the treatment of patients with chronic constipation. Additional work is needed to determine what role, if any, these agents may play in the treatment of patients with chronic constipation. The purpose of this review is to identify evidence-based interventions for the prevention and management of constipation in the elderly.","[Spinzi, Giancarlo; Amato, Arnaldo; Imperiali, Gianni; Lenoci, Nicoletta; Mandelli, Giovanna; Paggi, Silvia; Radaelli, Franco; Terreni, Natalia; Terruzzi, Vittorio] Osped Valduce, Div Gastroenterol, I-22100 Como, Italy",,"Spinzi, G (corresponding author), Osped Valduce, Div Gastroenterol, Via Dante 11, I-22100 Como, Italy.",gispinz@tin.it,"Amato, Arnaldo/ABC-5688-2020; Radaelli, F/N-8815-2019","Amato, Arnaldo/0000-0002-4397-4142; Radaelli, Franco/0000-0003-3705-841X; Terruzzi, Vittorio/0000-0002-3893-8382",,,,,42,38,46,1,32,ADIS INT LTD,NORTHCOTE,"5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND",1170-229X,1179-1969,,DRUG AGING,Drugs Aging,,2009,26,6,,,,,469,474,,10.2165/00002512-200926060-00003,http://dx.doi.org/10.2165/00002512-200926060-00003,,,6,Geriatrics & Gerontology; Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Geriatrics & Gerontology; Pharmacology & Pharmacy,478AP,19591521,,,,2024-06-04,WOS:000268560400003,View Full Record in Web of Science
J,"Tran, DL; Sintusek, P",,,,"Tran, Duc Long; Sintusek, Palittiya",,,Functional constipation in children: What physicians should know,WORLD JOURNAL OF GASTROENTEROLOGY,,,English,Review,,,,,,Constipation; Children; Laxative; Treatment; Toilet training; Herbal,POLYETHYLENE-GLYCOL 3350; GASTROINTESTINAL DISORDERS; FECAL INCONTINENCE; IDIOPATHIC CONSTIPATION; CHILDHOOD CONSTIPATION; TRANSANAL IRRIGATION; LIQUID PARAFFIN; COLONIC TRANSIT; NORMAL POSITION; DIETARY FIBER,"Functional constipation (FC) is considered the most common functional gastrointestinal disorder in children with a pooled global prevalence of 14.4% (95% confidence interval: 11.2-17.6) when diagnosed based on the Rome IV criteria. Its pathophysiological mechanisms are thought be multifactorial and complicated, resulting in difficult management. Currently, the most effective medication, when used in parallel with toilet training, is osmotic laxatives. Children's adherence to medication and parental concern regarding long-term laxative use are the main contributors to treatment failure. Recently, novel therapies with a high safety profile have been developed, such as probiotics, synbiotics, serotonin 5-hydroxytryptamine 4 receptor agonists, chloride channel activators, and herbal and transitional medicines; nonetheless, well-designed research to support the use of these therapies is needed. This review aims to focus on multiple aspects of FC in children, including global prevalence, pathogenesis, diagnostic criteria, tools, as well as conventional and novel treatment options, such as non-pharmacological management, including adequate fiber and fluid intake, physiotherapy, or neuromodulators. We also report that in very difficult cases, surgical intervention may be required.","[Tran, Duc Long] Chulalongkorn Univ, Fac Med, Thailand & Dept Pediat, Bangkok 10330, Thailand; [Tran, Duc Long] Can Tho Univ Med & Pharm, Fac Med, Can Tho City 9000, Vietnam; [Sintusek, Palittiya] Chulalongkorn Univ, King Chulalongkorn Mem Hosp & Thai Red Cross, Fac Med, Dept Pediat,Div Gastroenterol,Thai Pediat Gastroen, 1873 Rama IV Road, Bangkok 10330, Thailand",Chulalongkorn University; Chulalongkorn University,"Sintusek, P (corresponding author), Chulalongkorn Univ, King Chulalongkorn Mem Hosp & Thai Red Cross, Fac Med, Dept Pediat,Div Gastroenterol,Thai Pediat Gastroen, 1873 Rama IV Road, Bangkok 10330, Thailand.",palittiya.s@chula.ac.th,"sintusek, palittiya/IAO-6554-2023","Tran, Duc Long/0000-0002-2576-9209",Thailand and Thailand Science Research and Innovation Fund Chulalongkorn University [HEA663000047],Thailand and Thailand Science Research and Innovation Fund Chulalongkorn University,"Supported by Thailand and Thailand Science Research and Innovation Fund Chulalongkorn University, No. HEA663000047.",,164,5,5,3,17,BAISHIDENG PUBLISHING GROUP INC,PLEASANTON,"7041 Koll Center Parkway, Suite 160, PLEASANTON, CA, UNITED STATES",1007-9327,2219-2840,,WORLD J GASTROENTERO,World J. Gastroenterol.,FEB 28,2023,29,8,,,,,1261,1288,,10.3748/wjg.v29.i8.1261,http://dx.doi.org/10.3748/wjg.v29.i8.1261,,,28,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,A1BY1,36925458,"Green Published, hybrid",,,2024-06-04,WOS:000952564200002,View Full Record in Web of Science
B,"Almerigi, PF; Menarini, M; Bazzocch, G",,"Santoro, GA; Wieczorek, AP; Bartram, CI",,"Almerigi, Pier Francesco; Menarini, Mauro; Bazzocch, Gabriele",,,"Medical Treatment of Irritable Bowel Syndrome, Constipation, and Obstructed Defecation",PELVIC FLOOR DISORDERS: IMAGING AND MULTIDISCIPLINARY APPROACH TO MANAGEMENT,,,English,Article; Book Chapter,,,,,,Bulking agents; Chloride channel activators; Irritable bowel syndrome; Laxatives; Lubiprostone; Medical treatment; Obstructed defecation; Probiotics; Serotonin receptors; Slow transit constipation,CHANNEL-2 CIC-2 ACTIVATOR; CONTROLLED-TRIAL; 5-HT4 AGONIST; PHASE-III; TRANSIT; ANTAGONIST; EFFICACY; SAFETY; LUBIPROSTONE; MANAGEMENT,"The treatment of bowel dysfunction is a common medical challenge, due to the high prevalence and complexity of constipation among the populations of western countries. The aim of this chapter is to point out the main elements of the medical treatment of the bowel functional disorders that may afflict the pelvic floor. Irritable bowel syndrome (IBS) may feature constipation (IBS-C) or diarrhea (IBS-D) as predominant dysfunction, or even alternating symptoms (LBS-A). IBS can be treated with traditional therapies (antidiarrheals, dietary modifications, fiber supplementation, bulking agents, osmotic laxatives, tricyclic antidepressants, and antispasmodics). Currently, evaluation of new agents (agonists and antagonists of serotonin receptors, adrenergic modulators, chloride channel activators, probiotics, and others) is in progress. The treatment of slow transit constipation (STC) may feature therapy of the comorbidities that may result in constipation - dietary suggestions, lifestyle changes, correction of bowel habits, and laxatives, but new agents are also taken in consideration. Obstructed defecation (OD) can be treated by aiming to decrease the consistency of the stool and facilitate rectal evacuation. Many patients affected by OD and correctly treated with conservative therapies can obtain relief from their symptoms and avoid surgical treatment.","[Almerigi, Pier Francesco] Univ Bologna, S Orsola Malpighi Hosp, Dept Gen Surg & Organ Transplantat, Unit Gen Surg, Bologna, Italy; [Menarini, Mauro; Bazzocch, Gabriele] Univ Bologna, Montecatone Rehabil Inst, Unit Visceral Disorders & Auton Dysfunct, Imola, Italy",IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Bologna,"Almerigi, PF (corresponding author), Univ Bologna, S Orsola Malpighi Hosp, Dept Gen Surg & Organ Transplantat, Unit Gen Surg, Bologna, Italy.",,,,,,,,30,0,0,0,2,SPRINGER,NEW YORK,"233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES",,,978-88-470-1541-8,,,,2010,,,,,,,539,543,,10.1007/978-88-470-1542-5_74,http://dx.doi.org/10.1007/978-88-470-1542-5_74,10.1007/978-88-470-1542-5,,5,Obstetrics & Gynecology; Surgery,Book Citation Index – Science (BKCI-S),Obstetrics & Gynecology; Surgery,BRO60,,Green Submitted,,,2024-06-04,WOS:000283271600074,View Full Record in Web of Science
J,"Lionetti, P; Wine, E; Ressler, RR; Minor, GJ; Major, G; Zemrani, B; Gottrand, F; Romano, C",,,,"Lionetti, Paolo; Wine, Eytan; Ressler, Rinat Ran; Minor, Gerard J.; Major, Giles; Zemrani, Boutaina; Gottrand, Frederic; Romano, Claudio",,,Use of fiber-containing enteral formula in pediatric clinical practice: an expert opinion review,EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY,,,English,Review,,,,,,Dietary fiber; enteral nutrition; fiber; formula; pediatrics,CHAIN FATTY-ACIDS; DIETARY FIBER; RESISTANT STARCH; SOLUBLE FIBER; CHILDREN; NUTRITION; HEALTH; MICROBIOTA; CARBOHYDRATE; CONSTIPATION,"IntroductionChildren who require enteral nutrition often report gastrointestinal symptoms. There is a growing interest in nutrition formulas that meet nutritional requirements and also maintain gut ecology and function. Fiber-containing enteral formulas can improve bowel function, promote the growth of healthy gut microbiota, and improve immune homeostasis. Nonetheless, guidance in clinical practice is lacking.Areas coveredThis expert opinion article summarizes the available literature and collects the opinion of eight experts on the importance and use of fiber-containing enteral formulas in pediatrics. The present review was supported by a bibliographical literature search on Medline via PubMed to collect the most relevant articles.Expert opinionThe current evidence supports using fibers in enteral formulas as first-line nutrition therapy. Dietary fibers should be considered for all patients receiving enteral nutrition and can be slowly introduced from six months of age. Fiber properties that define the functional/physiological properties of the fiber must be considered. Clinicians should balance the dose of fiber with tolerability and feasibility. Introducing fiber-containing enteral formulas should be considered when initiating tube feeding. Dietary fiber should be introduced gradually, especially in fiber-naive children, with an individualized symptom-based approach. Patients should continue with the fiber-containing enteral formulas they tolerate best.","[Lionetti, Paolo] Univ Florence, Meyer Childrens Hosp, Dept Neurofarba, Gastroenterol & Nutr Unit, Florence, Italy; [Wine, Eytan] Univ Alberta, Dept Pediat, Div Pediat Gastroenterol & Nutr, Edmonton, AB, Canada; [Ressler, Rinat Ran] Nestle Hlth Sci, Nestle Prod Technol Ctr, Bridgewater, NJ USA; [Minor, Gerard J.] Kidz Med Serv, Pediat Gastroenterol Hepatol & Nutr, Coral Gables, FL USA; [Major, Giles] Nestle Inst Hlth Sci, Dept Gastrointestinal Hlth, Lausanne, Switzerland; [Zemrani, Boutaina] Nestle Hlth Sci, Clin Res & Dev, Pediat Med Nutr, Lausanne, Switzerland; [Gottrand, Frederic] Univ Lille, Inst Translat Res Inflammat, Div Pediat Gastroenterol Hepatol & Nutr, Lille, France; [Romano, Claudio] Univ Messina, Pediat Gastroenterol & Cyst Fibrosis Unit, Messina, Italy",University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; University of Alberta; Nestle SA; Universite de Lille; University of Messina,"Lionetti, P (corresponding author), Univ Florence, Meyer Childrens Hosp, Dept Neurofarba, Gastroenterol & Nutr Unit, Florence, Italy.",paolo.lionetti@unifi.it,"Romano, Claudio/L-1950-2016; gottrand, frederic F/G-7370-2015; Major, Giles/AAF-4207-2019","Romano, Claudio/0000-0001-8827-2091; gottrand, frederic F/0000-0002-5290-0436; Minor, Gerard/0000-0001-8182-0104; Wine, Eytan/0000-0002-3458-4142; Major, Giles/0000-0001-7944-3709; Ran-Ressler, Rinat/0000-0002-7071-0775; Zemrani, Boutaina/0000-0003-1963-388X",Nestle Health Science,Nestle Health Science(Nestle SA),"Medical writing and editorial support in preparing this paper were provided by Content Ed Net, Switzerland, and funded by Nestle Health Science. All authors take complete responsibility for the integrity and accuracy of the data presented in the review. All authors meet the International Committee of Medical Journal Editors (ICMJE) authorship criteria and approve the final version of the manuscript. Nestle Health Science is funding the open access fees of the journal.",,88,1,1,3,8,TAYLOR & FRANCIS LTD,ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND",1747-4124,1747-4132,,EXPERT REV GASTROENT,Expert Rev. Gastroenterol. Hepatol.,JUL 3,2023,17,7,,,,,665,675,,10.1080/17474124.2023.2217355,http://dx.doi.org/10.1080/17474124.2023.2217355,,JUN 2023,11,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,M1MR5,37278084,hybrid,,,2024-06-04,WOS:001002606900001,View Full Record in Web of Science
J,"Minamida, K; Nishimura, M; Miwa, K; Nishihira, J",,,,"Minamida, Kimiko; Nishimura, Mie; Miwa, Kazunori; Nishihira, Jun",,,Effects of dietary fiber with Bacillus coagulans lilac-01 on bowel movement and fecal properties of healthy volunteers with a tendency for constipation,BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY,,,English,Article,,,,,,constipation; Bacillus coagulans; human trial; synbiotics; okara,,"To elucidate the effects of Lilac LAB(Bacillus coagulans lilac-01 and okara [soy pulp] powder) on bowel movements/fecal properties, we conducted a double-blind placebo-controlled randomized trial with healthy Japanese volunteers with a tendency for constipation (n=297). The subjects ingested 2g/d placebo (okara powder) or test food (Lilac LAB, 1x10(8)CFU) once a day for 2weeks. In the test group of functionally constipated subjects, the changes in the average scores of self-reported fecal size, sensation of incomplete evacuation, and defecation frequency were significantly improved compared to the placebo group (p<0.05), and fecal color and odor tended to improve (p=0.07). In the test food group of all subjects and among the non-functionally constipated subjects, the fecal size tended to improve compared to the placebo group (p=0.06, p=0.07, respectively). Lilac LAB was effective in improving bowel movements and fecal properties in functionally constipated persons.","[Minamida, Kimiko; Miwa, Kazunori] Arterio Bio Co Ltd, Sect Res & Dev, Otaru, Hokkaido, Japan; [Nishimura, Mie] Hokkaido Food Ind Promot Org, Sect Res & Dev, Sapporo, Hokkaido, Japan; [Nishimura, Mie; Nishihira, Jun] Hokkaido Informat Univ, Hlth Informat Sci Ctr, Ebetsu, Hokkaido, Japan",,"Minamida, K (corresponding author), Arterio Bio Co Ltd, Sect Res & Dev, Otaru, Hokkaido, Japan.",lilacLAB@live.jp,,,"Japan's Ministry of Economy, Trade and Industry","Japan's Ministry of Economy, Trade and Industry","We are grateful to Ms Akiko Tanaka, Ms Rina Kawamura, Ms Tomoko Mino, and Ms Megumi Shibata for their technical assistance with the data management, and we thank Mr Jungo Hayashi for his management of the clinical trial. This study was supported by Japan's Ministry of Economy, Trade and Industry.",,20,35,40,3,39,TAYLOR & FRANCIS LTD,ABINGDON,"4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND",0916-8451,1347-6947,,BIOSCI BIOTECH BIOCH,Biosci. Biotechnol. Biochem.,FEB 1,2015,79,2,,,,,300,306,,10.1080/09168451.2014.972331,http://dx.doi.org/10.1080/09168451.2014.972331,,,7,"Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology",Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology,CB3HX,25338680,Bronze,,,2024-06-04,WOS:000349519900020,View Full Record in Web of Science
J,"Selby, W; Corte, C",,,,"Selby, Warwick; Corte, Crispin",,,Managing constipation in adults,AUSTRALIAN PRESCRIBER,,,English,Article,,,,,,colon; laxatives,,"Patients complaining of constipation require a history and examination and possibly simple investigations to find out if their problem is secondary to other conditions or drugs. If there is no underlying cause, non-drug treatments such as increasing dietary fibre should be recommended. Drug treatment can be considered if the constipation persists. Bulking agents can be tried and then osmotic laxatives. Stimulant laxatives are available, but their long-term use is not recommended. Specialist assessment should be considered if the constipation remains refractory to treatment.","[Selby, Warwick] Univ Sydney, Dept Med, Sydney, NSW 2006, Australia; [Selby, Warwick] Royal Prince Alfred Hosp, Endoscop Serv, Sydney, NSW, Australia",University of Sydney; University of Sydney; NSW Health; Royal Prince Alfred Hospital,"Selby, W (corresponding author), Univ Sydney, Dept Med, Sydney, NSW 2006, Australia.",,,,,,,,14,8,8,0,2,NATL PRESCRIBING SERVICE LTD,DEAKIN,"STE 8, 8 PHIPPS CLOSE, DEAKIN, ACT 2600, AUSTRALIA",0312-8008,1839-3942,,AUST PRESCR,Aust. Prescr.,AUG,2010,33,4,,,,,116,119,,10.18773/austprescr.2010.058,http://dx.doi.org/10.18773/austprescr.2010.058,,,4,Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy,637NR,,"Green Submitted, gold",,,2024-06-04,WOS:000280825500010,View Full Record in Web of Science
J,"Tolia, V; Ventimiglia, J; Kuhns, L",,,,"Tolia, V; Ventimiglia, J; Kuhns, L",,,Gastrointestinal tolerance of a pediatric fiber formula in developmentally disabled children,JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION,,,English,Article; Proceedings Paper,Annual Meeting of the American-Gastroenterology-Association,"MAY 15-18, 1994","NEW ORLEANS, LA",Amer Gastroenter Assoc,,constipation; fiber supplementation; neurologically disabled children,DIETARY FIBER; BOWEL FUNCTION; CONSTIPATION; TRANSIT; DISORDERS,"Objective: We performed a masked, randomized, 2-month crossover study with developmentally disabled children to study the tolerance of a pediatric adapted enteral formula with added soy fiber. Methods: Twenty children and adolescents aged 1 to 17 years, requiring liquid nutrition, were fed Pediasure(R) (PS) and Pediasure(R) with approximately 10 g total dietary fiber/l, (PSF10) as their major source of energy and nutrient intake for 1 month each. During the two 4-week periods of the crossover study, intake, tolerance of the formula, and stool characteristics were monitored daily with diaries. Criteria for gastrointestinal tolerance were symptoms of emesis, gas, irritability or fussiness. Stool characteristics included frequency, consistency, and the need to use elimination aids to induce defecation. Following completion of the crossover study, the patients were fed PSF10 for an additional 2 months. Anthropometrics were obtained at study initiation and at each biweekly visit during the crossover phase and monthly during the follow-up phase. Bowel scintigraphy studies were conducted in patients with oral or nasogastric intake during the crossover periods. Biochemical assessments were conducted at entry, at the end of each crossover period, and at exit. Results: There were no differences in any of the tolerance, stooling, growth, or biochemical measurements between the feeding regimens, in 11 children completing this phase of the study. However, there was a trend towards using less elimination aids to induce a bowel movement during the fiber supplemented formula phase. Conclusions: Pediasure(R) with fiber is well tolerated in children with developmental disabilities.","WAYNE STATE UNIV,CHILDRENS HOSP MICHIGAN,DIV GASTROENTEROL & NUTR,DETROIT,MI; WAYNE STATE UNIV,CHILDRENS HOSP MICHIGAN,DEPT DIETET,DETROIT,MI; WAYNE STATE UNIV,CHILDRENS HOSP MICHIGAN,DEPT PEDIAT IMAGING,DETROIT,MI",Children's Hospital of Michigan; Wayne State University; Wayne State University; Children's Hospital of Michigan; Wayne State University; Children's Hospital of Michigan,,,,,,,,,23,10,11,0,2,AMER COLL NUTRITION,NEW YORK,"C/O HOSP. JOINT DIS. 301 E. 17TH ST., NEW YORK, NY 10003",0731-5724,,,J AM COLL NUTR,J. Am. Coll. Nutr.,JUN,1997,16,3,,,,,224,228,,10.1080/07315724.1997.10718678,http://dx.doi.org/10.1080/07315724.1997.10718678,,,5,Nutrition & Dietetics,Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,XB707,9176828,,,,2024-06-04,WOS:A1997XB70700007,View Full Record in Web of Science
J,"Aslam, H; Mohebbi, M; Ruusunen, A; Dawson, SL; Williams, LJ; Berk, M; Holloway-Kew, KL; Collier, F; Loughman, A; Pasco, JA; Jacka, FN",,,,"Aslam, Hajara; Mohebbi, Mohammadreza; Ruusunen, Anu; Dawson, Samantha L.; Williams, Lana J.; Berk, Michael; Holloway-Kew, Kara L.; Collier, Fiona; Loughman, Amy; Pasco, Julie A.; Jacka, Felice N.",,,Associations between dairy consumption and constipation in adults: A cross-sectional study,NUTRITION AND HEALTH,,,English,Article,,,,,,Constipation; dairy; milk; bowel symptoms; milk proteins,QUALITY-OF-LIFE; GASTROINTESTINAL TRANSIT; AUSTRALIAN WOMEN; GUT MICROBIOTA; DIETARY FIBER; BETA-CASEIN; MILK; PREVALENCE; SYMPTOMS; FLUID,"Objective: The current study aimed to assess the association between dairy consumption and constipation in the general adult population. Design: Data from the Geelong Osteoporosis Study were used to assess the association between dairy consumption and constipation in women (n=632) and men (n=609). Information on milk, yogurt and cheese, and constipation were self-reported. Total dairy was calculated by summing the intake of milk, yogurt and cheese and expressed as servings per day. Multivariable logistic regression models adjusted for irritable bowel syndrome, major depressive disorders, mobility, body mass index, age and fibre intake were used to examine the odds ratio (OR) and 95% confidence interval (CI) between the consumption of categories of total dairy, milk, yogurt, cheese, and constipation. Results: In women, consumption of 1-2 servings/d of total dairy was associated with reduced odds for constipation (OR: 0.49; 95% CI: 0.26-0.90; P=0.021) compared to consuming <1 serving/d of total dairy after adjusting for covariates. Also, consumption of 1-4 servings/d of milk was associated with marginally reduced odds for constipation (OR: 0.63; 95% CI: 0.39-1.02; P=0.058) compared to women who consumed <1 serving/d of milk after adjusting for covariates. There were no significant associations detected between other types of dairy consumption and constipation in women, and none in men. Conclusion: In women, consumption of moderate amounts of dairy is associated with reduced odds for constipation whereas in men no associations were detected between dairy consumption and constipation. Further studies are warranted to confirm results.","[Aslam, Hajara; Ruusunen, Anu; Dawson, Samantha L.; Williams, Lana J.; Berk, Michael; Holloway-Kew, Kara L.; Collier, Fiona; Loughman, Amy; Pasco, Julie A.; Jacka, Felice N.] Deakin Univ, IMPACT Inst Mental & Phys Hlth & Clin Translat, Sch Med, Barwon Hlth, Geelong, Vic, Australia; [Mohebbi, Mohammadreza] Deakin Univ, Fac Hlth, Biostat Unit, Geelong, Vic, Australia; [Ruusunen, Anu] Kuopio Univ Hosp, Dept Psychiat, Kuopio, Finland; [Ruusunen, Anu] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Dawson, Samantha L.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Environm & Genet Epidemiol Res, Parkville, Vic, Australia; [Berk, Michael] Univ Melbourne, Dept Psychiat, Orygen, Ctr Excellence Youth Mental Hlth, Melbourne, Vic, Australia; [Berk, Michael] Univ Melbourne, Florey Inst Neurosci, Ctr Excellence Youth Mental Hlth, Orygen, Melbourne, Vic, Australia; [Berk, Michael] Univ Melbourne, Orygen, Mental Hlth Dept, Melbourne, Vic, Australia; [Collier, Fiona; Pasco, Julie A.] Barwon Hlth, Geelong, Vic, Australia; [Collier, Fiona] Geelong Ctr Emerging Infect Dis, Geelong, Vic, Australia; [Pasco, Julie A.] Univ Melbourne, Dept Med, Western Hlth, Melbourne, Vic, Australia; [Jacka, Felice N.] Murdoch Childrens Res Inst, Ctr Adolescent Hlth, Parkville, Vic, Australia; [Jacka, Felice N.] Black Dog Inst, Sydney, NSW, Australia","Deakin University; Barwon Health; Deakin University; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne; University of Melbourne; Orygen, The National Centre of Excellence in Youth Mental Health; Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne; Barwon Health; University of Melbourne; Western Health; Murdoch Children's Research Institute; Black Dog Institute","Aslam, H (corresponding author), Deakin Univ, Inst Mental & Phys Hlth & Clin Translat, Sch Med, Food & Mood Ctr,IMPACT, POB 281, Geelong, Vic 3220, Australia.",habdussa@deakin.edu.au,"Holloway-Kew, Kara/AAE-9800-2020; Loughman, Amy/J-9295-2018; Ackland, Julie/C-8607-2012","Holloway-Kew, Kara/0000-0001-5064-2990; Loughman, Amy/0000-0002-0257-1443; Aslam, Dr Hajara/0000-0002-6023-1658; Dawson, Samantha L/0000-0002-4701-1220","Deakin University Postgraduate Industry Research Scholarship; Alfred Deakin Postdoctoral Research Fellowship; Deakin University Deans Postdoctoral Fellowship; NHMRC Senior Principal Research Fellowship [APP1059660, 1156072]; Victorian Health Promotion Foundation; National Health and Medical Research Council (NHMRC) Australia [251638, 628582]",Deakin University Postgraduate Industry Research Scholarship; Alfred Deakin Postdoctoral Research Fellowship; Deakin University Deans Postdoctoral Fellowship; NHMRC Senior Principal Research Fellowship(National Health & Medical Research Council (NHMRC) of Australia); Victorian Health Promotion Foundation; National Health and Medical Research Council (NHMRC) Australia(National Health & Medical Research Council (NHMRC) of Australia),"The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: HA is supported by Deakin University Postgraduate Industry Research Scholarship, KLH-K is supported by an Alfred Deakin Postdoctoral Research Fellowship, AL is supported by a Deakin University Deans Postdoctoral Fellowship, MB is supported by a NHMRC Senior Principal Research Fellowship (APP1059660 and 1156072). The Geelong Osteoporosis Study (GOS) was funded by the Victorian Health Promotion Foundation, and the National Health and Medical Research Council (NHMRC) Australia (projects 251638, 628582). The funding organisations played no role in the design or conduct of the study, in the collection, management, analysis and interpretation of the data, nor in the preparation, review and approval of the manuscript.",,52,1,1,0,3,SAGE PUBLICATIONS INC,THOUSAND OAKS,"2455 TELLER RD, THOUSAND OAKS, CA 91320 USA",0260-1060,2047-945X,,NUTR HEALTH-UK,NUTR. HEALTH,MAR,2022,28,1,,,,,31,39,,10.1177/02601060211004784,http://dx.doi.org/10.1177/02601060211004784,,,9,Nutrition & Dietetics,Emerging Sources Citation Index (ESCI),Nutrition & Dietetics,CL5I0,33827333,,,,2024-06-04,WOS:001125415400006,View Full Record in Web of Science
J,"Browning, SM",,,,"Browning, SM",,,"Constipation, diarrhea, and irritable bowel syndrome",PRIMARY CARE,,,English,Article,,,,,,,SLOW TRANSIT CONSTIPATION; BALLOON EXPULSION TEST; UNITED-STATES; OUTLET OBSTRUCTION; GASTROINTESTINAL DISORDERS; IDIOPATHIC CONSTIPATION; PUBORECTALIS SYNDROME; COLONIC MOTILITY; PEPTIC-ULCER; DOUBLE-BLIND,"Constipation, diarrhea, and irritable bowel, syndrome are commonly encountered in the primary care practice. Most episodes of constipation and diarrhea are benign and self-limited. Patients with chronic constipation should undergo a screening evaluation to exclude organic disease, after which most can be managed successfully with dietary modification and fiber supplementation. The cause of chronic diarrhea usually can be discerned clinically, with irritable bowel syndrome, inflammatory bowel disease, and lactose intolerance being diagnosed most frequently. Irritable bowel syndrome is a functional gastrointestinal disorder characterized by abdominal pain and disordered defecation, which is successfully managed with a strong physician-patient relationship and periodic pharmacologic intervention.","Wilford Hall USAF Med Ctr, Dept Surg, San Antonio, TX 78236 USA",United States Department of Defense; United States Air Force,"Wilford Hall USAF Med Ctr, Dept Gen Surg, Lackland AFB, TX 78236 USA.",,,,,,,,95,13,13,0,3,W B SAUNDERS CO-ELSEVIER INC,PHILADELPHIA,"1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA",0095-4543,1558-299X,,PRIMARY CARE,Primary Care,MAR,1999,26,1,,,,,113,+,,10.1016/S0095-4543(05)70105-6,http://dx.doi.org/10.1016/S0095-4543(05)70105-6,,,28,"Primary Health Care; Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,168XL,9922298,,,,2024-06-04,WOS:000078718400009,View Full Record in Web of Science
J,"Wegh, CAM; Schoterman, MHC; Vaughan, EE; Belzer, C; Benninga, MA",,,,"Wegh, Carrie A. M.; Schoterman, Margriet H. C.; Vaughan, Elaine E.; Belzer, Clara; Benninga, Marc A.",,,The effect of fiber and prebiotics on children's gastrointestinal disorders and microbiome,EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY,,,English,Review,,,,,,Gut microbiota; children; dietary fiber; functional gastrointestinal disorders; prebiotics; oligosaccharides,IRRITABLE-BOWEL-SYNDROME; FUNCTIONAL ABDOMINAL-PAIN; HYDROLYZED GUAR GUM; QUALITY-OF-LIFE; DIETARY FIBER; DOUBLE-BLIND; PEDIATRIC-PATIENTS; CHILDHOOD CONSTIPATION; GALACTO-OLIGOSACCHARIDES; FRUCTO-OLIGOSACCHARIDES,"Introduction: The bacteria received upon birth are the start of colonization of the approximately 10(14) bacteria that are present in the mature human gastrointestinal tract, better known as the microbiota. The gut microbiota is implicated in gastrointestinal health, nutrient metabolism and benefits such as prevention of infection. Dietary fiber, including prebiotics, escape digestion in the small intestine and reach the colon intact, where they are partially or completely fermented by the gut microbiota.Areas covered: The possible interactions between dietary fiber, prebiotics and microbiota are discussed as well as how this relates to functional gastrointestinal disorders. During the first years of life the microbiota have not yet reached a stable state and is sensitive to disturbance by environmental factors. An imbalance in the microbiota early in life is found to be associated with several functional gastrointestinal disorders such as colic, functional abdominal pain, irritable bowel syndrome and constipation.Expert commentary: A better understanding of how gut microbial changes in early-life can impact gastrointestinal health might lead to new treatments or disease prevention. Nutritional strategies with fiber or prebiotics may support health due to modification of colonic microbiota composition and metabolic activity, for example by growth stimulation of Bifidobacterium and Lactobacillus.","[Wegh, Carrie A. M.; Belzer, Clara] Wageningen Univ & Res, Microbiol Lab, Wageningen, Netherlands; [Wegh, Carrie A. M.; Benninga, Marc A.] Emmas Childrens Hosp, Dept Pediat Gastroenterol & Nutr, Acad Med Ctr, Amsterdam, Netherlands; [Schoterman, Margriet H. C.] FrieslandCampina, Amersfoort, Netherlands; [Vaughan, Elaine E.] Sensus BV Royal Consun, Roosendaal, Netherlands",Wageningen University & Research; University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital,"Wegh, CAM (corresponding author), Wageningen Univ & Res Ctr, Microbiol, NL-6700 HB Wageningen, Netherlands.",carrie.wegh@wur.nl,"; Belzer, Clara/P-6500-2018","Wegh, Carrie A.M./0000-0001-7963-7634; Belzer, Clara/0000-0001-6922-836X",,,,,108,41,49,5,36,TAYLOR & FRANCIS LTD,ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND",1747-4124,1747-4132,,EXPERT REV GASTROENT,Expert Rev. Gastroenterol. Hepatol.,,2017,11,11,,,,,1031,1045,,10.1080/17474124.2017.1359539,http://dx.doi.org/10.1080/17474124.2017.1359539,,,15,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Gastroenterology & Hepatology,FM3VR,28737484,hybrid,,,2024-06-04,WOS:000414938300005,View Full Record in Web of Science
J,"Okawa, Y; Fukudo, S; Sanada, H",,,,"Okawa, Yohei; Fukudo, Shin; Sanada, Hiromi",,,Specific foods can reduce symptoms of irritable bowel syndrome and functional constipation: a review,BIOPSYCHOSOCIAL MEDICINE,,,English,Review,,,,,,Irritable bowel syndrome IBS; Functional constipation FC; Functional gastrointestinal disorders FGIDs; Fermentable oligosaccharides Disaccharides Monosaccharaides And polyols FODMAP; Functional dyspepsia FD,COLONIC TRANSIT-TIME; LOW-FODMAP DIET; GASTROINTESTINAL SYMPTOMS; GENERAL-POPULATION; IBS; OLIGOSACCHARIDES; PREDOMINANT; DISORDERS; DISEASE; FIBER,"BackgroundFunctional gastrointestinal disorders (FGIDs) are groups of disorders involving digestive symptoms that chronically persist despite the absence of organic abnormalities in the gastrointestinal tract. Representative FGIDs include functional dyspepsia (FD), irritable bowel syndrome (IBS), and functional constipation (FC). In particular, IBS is a disease representative of FGIDs in which abdominal pain and discomfort associated with abnormal bowel movements chronically persist and recur. These symptoms are known to be related to lifestyle habits, such as meals and stress. In recent years, according to advances in dietary therapy for IBS and FC, specific foods have been shown to alter these symptoms. In IBS, bowel movement abnormalities and abdominal discomfort have been reported to be reduced when patients eat these specific foods.Main topicSeveral studies suggest that individuals with certain attitudes toward eating or with preferences for fatty food, fast food, junk snack food, fried food, and hot/spicy food showed a higher prevalence of gastrointestinal (GI) symptoms. Those who are cognizant of nutritional balance or healthy food intake have a lower prevalence of GI symptoms. Thus, eating specific foods with higher dietary fiber and low FODMAP (fermentable oligosaccharides, disaccharides, monosaccharaides, and polyols) is effective for relief from some GI symptoms.First, two kinds of dietary fibers are found in foods: water-soluble dietary fiber and insoluble dietary fiber. Enduring misconceptions about the physical effects of fiber in the gut have led to misunderstandings about the health benefits attributable to insoluble and soluble fiber. Previous reviews suggest that health benefits have been shown in regard to fiber, and reproducible evidence of clinical efficacy has been published.Second, the ingestion of certain carbohydrates causes gastrointestinal symptoms. Foods rich in fermentable oligosaccharides, disaccharides, monosaccharaides, and polyols (collectively known as FODMAP) have been shown to cause abdominal pain and abdominal discomfort in westerners with IBS.ConclusionDietary therapy for FGIDs should include specific foods that have been scientifically proven to be effective for managing symptoms of irritable bowel syndrome and functional constipation.","[Okawa, Yohei; Sanada, Hiromi] Univ Tokyo, Global Nursing Res Ctr, Grad Sch Med Director, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Fukudo, Shin] Tohoku Univ, Grad Sch Med, Dept Behav Med, Sendai, Miyagi, Japan",University of Tokyo; Tohoku University,"Okawa, Y (corresponding author), Univ Tokyo, Global Nursing Res Ctr, Grad Sch Med Director, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.",pesopesogin1325@yahoo.co.jp,"Fukudo, Shin/J-4813-2014","Okawa, Yohei/0000-0002-3836-1093",,,,,34,16,17,4,27,BMC,LONDON,"CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND",1751-0759,,,BIOPSYCHOSOC MED,BioPsychoSoc. Med.,MAY 8,2019,13,,,,,,,,10,10.1186/s13030-019-0152-5,http://dx.doi.org/10.1186/s13030-019-0152-5,,,6,"Psychiatry; Psychology, Multidisciplinary",Social Science Citation Index (SSCI),Psychiatry; Psychology,HX6XL,31080496,"gold, Green Published",,,2024-06-04,WOS:000467547100001,View Full Record in Web of Science
J,"El-Salhy, M; Ystad, SO; Mazzawi, T; Gundersen, D",,,,"El-Salhy, Magdy; Ystad, Synne Otterasen; Mazzawi, Tarek; Gundersen, Doris",,,Dietary fiber in irritable bowel syndrome,INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE,,,English,Review,,,,,,microbiota; enteric nervous system; fermentation; immune system; intestinal endocrine cells; laxation; meteorism; psyllium,FUNCTIONAL GASTROINTESTINAL DISORDERS; QUALITY-OF-LIFE; HUMAN COLONIC MICROBIOTA; GUT ENDOCRINE-CELLS; INDUCED ILEAL BRAKE; PSYLLIUM SEED HUSK; PEPTIDE-YY; CHRONIC CONSTIPATION; ULCERATIVE-COLITIS; GENERAL-POPULATION,"Irritable bowel syndrome (IBS) is a common chronic gastrointestinal disorder. It is widely believed that IBS is caused by a deficient intake of dietary fiber, and most physicians recommend that patients with IBS increase their intake of dietary fiber in order to relieve their symptoms. However, different types of dietary fiber exhibit marked differences in physical and chemical properties, and the associated health benefits are specific for each fiber type. Short-chain soluble and highly fermentable dietary fiber, such as oligosaccharides results in rapid gas production that can cause abdominal pain/discomfort, abdominal bloating/distension and flatulence in patients with IBS. By contrast, long-chain, intermediate viscous, soluble and moderately fermentable dietary fiber, such as psyllium results in a low gas production and the absence of the symptoms related to excessive gas production. The effects of type of fiber have been documented in the management of IBS, and it is known to improve the overall symptoms in patients with IBS. Dietary fiber acts on the gastrointestinal tract through several mechanisms, including increased fecal mass with mechanical stimulation/irritation of the colonic mucosa with increasing secretion and peristalsis, and the actions of fermentation byproducts, particularly short-chain fatty acids, on the intestinal microbiota, immune system and the neuroendocrine system of the gastrointestinal tract. Fiber supplementation, particularly psyllium, is both safe and effective in improving IBS symptoms globally. Dietary fiber also has other health benefits, such as lowering blood cholesterol levels, improving glycemic control and body weight management.","[El-Salhy, Magdy] Stord Hosp, Div Gastroenterol, Dept Med, Box 4000, N-5416 Stord, Norway; [El-Salhy, Magdy; Mazzawi, Tarek] Univ Bergen, Dept Clin Med, N-5020 Bergen, Norway; [El-Salhy, Magdy; Ystad, Synne Otterasen; Mazzawi, Tarek] Haukeland Hosp, Dept Med, Natl Ctr Funct Gastrointestinal Disorders, N-5020 Bergen, Norway; [Gundersen, Doris] Helse Fonna, Dept Res & Innovat, N-5528 Haugesund, Norway",University of Bergen; University of Bergen; Haukeland University Hospital,"El-Salhy, M (corresponding author), Stord Hosp, Div Gastroenterol, Dept Med, Box 4000, N-5416 Stord, Norway.",magdy.el-salhy@helse-fonna.no,"Mazzawi, Tarek/D-4776-2016","Mazzawi, Tarek/0000-0001-7983-3707","Helse-Vest, Norway [911978]; Helse-Fonna Norway [40415]","Helse-Vest, Norway; Helse-Fonna Norway","The studies conducted by the authors and cited in this review were supported by grants from Helse-Vest, Norway (grant no. 911978), and Helse-Fonna Norway (grant no. 40415).",,149,84,95,4,53,SPANDIDOS PUBL LTD,ATHENS,"POB 18179, ATHENS, 116 10, GREECE",1107-3756,1791-244X,,INT J MOL MED,Int. J. Mol. Med.,SEP,2017,40,3,,,,,607,613,,10.3892/ijmm.2017.3072,http://dx.doi.org/10.3892/ijmm.2017.3072,,,7,"Medicine, Research & Experimental",Science Citation Index Expanded (SCI-EXPANDED),Research & Experimental Medicine,FE0JS,28731144,"Green Published, hybrid, Green Submitted",,,2024-06-04,WOS:000407907200002,View Full Record in Web of Science
J,"Vargas-García, EJ; Vargas-Salado, E",,,,"Joan Vargas-Garcia, Elisa; Vargas-Salado, Enrique",,,"Food intake, nutritional status and physical activity between elderly with and without chronic constipation. A comparative study",CIRUGIA Y CIRUJANOS,,,Spanish,Article,,,,,,Constipation; elderly; diet; nutritional status; and physical activity,PROLONGED EXERCISE; DEHYDRATION; PARAMETERS; QUALITY; TRANSIT; LIFE,"Background: Constipation is one of the most frequently found gastrointestinal problems in the elderly as aging modifies their food intake, nutritional status and physical activity, which are associated factors in the development of constipation. Objective: To compare food intake, nutritional status and physical activity between elderly subjects with or without chronic constipation. Methods: The study included a total of 140 subjects who were divided in two groups according to the presence or absence of constipation using the Rome III criteria. Diet intake was obtained through a 3-day dietary record (2 days during the week and one of Saturday or Sunday). Height, weight, arm circumference, and triceps skinfold thickness were measured and the International Physical Activity Questionnaire (IPAQ) was applied to all participants. Results: Fiber and water intake were not statistically different between both groups. Constipated participants showed significantly less variety and less inclusion of all food groups in their diets compared to their non-constipated counterparts (p < 0.02; p < 0.03). Mean nutritional status was overweight and it didn't differ from each studied group (p= 0.49). Higher levels of physical activity were found in non-constipated subjects (1664 vs 1049 MET, p= 0.004). Conclusion: This study indicates that lower physical activity levels as well as an incomplete and less varied diet are associated to constipation in the elderly. Water and fibre intake do not seem to be contributing to constipation.","[Joan Vargas-Garcia, Elisa] Inst Salud Publ Estado Guanajuato, Dept Invest, Guanajuato, Mexico; [Vargas-Salado, Enrique] Univ Guanajuato, Dept Med & Nutr, Div Ciencias Salud, Guanajuato, Mexico",Universidad de Guanajuato,"Vargas-Salado, E (corresponding author), Torre Med Campestre, Manantial 114-301, Monterrey, NL, Mexico.",esalado2002@yahoo.com,,,,,,,41,7,9,0,17,MEXICAN ACAD SURGERY,MEXICO D G,"CENTRO MED NAC SIGLO XXI, EDIFICIO BLOQUE B, SOTANO, AVE CUAUHTEMOC NO 330, MEXICO D G, 06700, MEXICO",0009-7411,,,CIR CIR,Cir. Cir.,MAY-JUN,2013,81,3,,,,,214,220,,,,,,7,Surgery,Science Citation Index Expanded (SCI-EXPANDED),Surgery,210IT,23769250,,,,2024-06-04,WOS:000323825600007,View Full Record in Web of Science
J,"Staller, K",,,,"Staller, Kyle",,,Refractory Constipation: What is the Clinician to Do?,JOURNAL OF CLINICAL GASTROENTEROLOGY,,,English,Review,,,,,,severe constipation; visceral hypersensitivity; biopsychosocial; laxatives; surgery,PERCUTANEOUS ENDOSCOPIC CECOSTOMY; CHRONIC IDIOPATHIC CONSTIPATION; PROLONGED BALLOON EXPULSION; TOTAL ABDOMINAL COLECTOMY; FUNCTIONAL GI DISORDERS; BIOFEEDBACK THERAPY; RADIOPAQUE MARKERS; SURGICAL-TREATMENT; TRANSIT TIMES; DIETARY FIBER,"Most clinicians will agree that chronic constipation is characterized by abnormal bowel movement consistency and/or frequency plus or minus evacuation symptoms, but patient perception of constipation varies widely and includes symptoms that may or may not meet official defining criteria. Although intermittent constipation is extremely common, only a small minority of patients seek care for their symptoms. Among these patients, dissatisfaction with the currently available laxative options is not uncommon, and many patients will require specialized care for severe or refractory symptomsespecially those with abdominal pain, irritable bowel syndrome overlap, bloating or distention, and psychological comorbidities. This review outlines a physiological assessment of the patient with refractory constipation, exploring treatment options among patients with slow transit, rectal evacuation disorders, and normal transit. In addition, we explore nonlaxative approaches to normal-transit patients bothered by ongoing symptoms, with an emphasis on the biopsychosocial model of functional gastrointestinal disease and treatment of visceral hypersensitivity using neuromodulators. Finally, we propose a comprehensive evaluation algorithm for the management of patients with refractory slow-transit constipation considering surgery and examine surgical options including colectomy and cecostomy using an antegrade continent enema.","[Staller, Kyle] Massachusetts Gen Hosp, Ctr Neurointestinal Hlth, Div Gastroenterol, Boston, MA 02114 USA; [Staller, Kyle] Harvard Med Sch, Boston, MA USA",Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School,"Staller, K (corresponding author), Massachusetts Gen Hosp, Div Gastroenterol, 55 Fruit St, Boston, MA 02114 USA.",kstaller@mgh.harvard.edu,"Staller, Kyle/W-5582-2019","Staller, Kyle/0000-0003-4925-4290",American Gastroenterological Association Research Scholar Award; Astra-Zeneca; Gelesis; Pathway Genomics; Takeda,American Gastroenterological Association Research Scholar Award; Astra-Zeneca(AstraZeneca); Gelesis; Pathway Genomics; Takeda(Takeda Pharmaceutical Company Ltd),"Supported by an American Gastroenterological Association Research Scholar Award (K.S.).; K.S. has received research support from Astra-Zeneca, Gelesis, Pathway Genomics, and Takeda and has served as a consultant to Bayer Ag.",,85,12,12,0,7,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0192-0790,1539-2031,,J CLIN GASTROENTEROL,J. Clin. Gastroenterol.,JUL,2018,52,6,,,,,490,501,,10.1097/MCG.0000000000001049,http://dx.doi.org/10.1097/MCG.0000000000001049,,,12,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,GJ4BB,29794543,,,,2024-06-04,WOS:000435290800006,View Full Record in Web of Science
J,"Koppen, IJN; Benninga, MA; Tabbers, MM",,,,"Koppen, Ilan J. N.; Benninga, Marc A.; Tabbers, Merit M.",,,"Is There A Role for Pre-, Pro- and Synbiotics in the Treatment of Functional Constipation in Children? A Systematic Review",JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION,,,English,Article; Proceedings Paper,"8th Meeting on Probiotics, Prebiotics and New Foods","SEP 13-15, 2015","Rome, ITALY",,,children; constipation; fiber; microbiota; prebiotics; probiotics; synbiotics,DIETARY FIBER MIXTURE; CHILDHOOD CONSTIPATION; DOUBLE-BLIND; LACTULOSE; MICROBIOME; PROBIOTICS,"Purpose of review: To investigate the efficacy and safety of pre-, pro- and synbiotics in the treatment of pediatric functional constipation (FC). Recent findings: A recent study reported that the gut microbiota in obese children with FC differs from that of obese children without FC. The gut microbiota may be involved in the pathophysiology of FC. Pre- and probiotics have been suggested as potential treatment modalities for FC in children. Summary: PubMed and Cochrane databases were searched from inception to February 2016. We found 6 RCTs on prebiotics, 6 RCTs on probiotics and 1 RCT concerning synbiotics. Overall, most studies were at high risk of bias. The majority of studies were unable to demonstrate a significant effect of pre-, pro- or synbiotics on predefined outcome measures such as defecation frequency, fecal incontinence and painful or difficult defecation. Pre-, pro and synbiotics were not associated with significant adverse effects. In conclusion, there is insufficient evidence to recommend pre-, pro- or synbiotics in the treatment of children with functional constipation. High-quality randomized controlled trials are warranted to further explore these treatment modalities.","[Koppen, Ilan J. N.; Benninga, Marc A.; Tabbers, Merit M.] Emma Childrens Hosp, Acad Med Ctr, Dept Pediat Gastroenterol & Nutr, NL-1100 DD Amsterdam, Netherlands",University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital,"Koppen, IJN (corresponding author), Emma Childrens Hosp, Acad Med Ctr, POB 22700, NL-1100 DD Amsterdam, Netherlands.",i.j.koppen@amc.nl,"Koppen, Ilan J.N./AAA-6800-2020","Koppen, Ilan J.N./0000-0002-1856-0968",,,,,32,26,31,4,30,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0277-2116,1536-4801,,J PEDIATR GASTR NUTR,J. Pediatr. Gastroenterol. Nutr.,JUL,2016,63,,,1,,,S27,S35,,,,,,9,Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,DP8OZ,27380596,,,,2024-06-04,WOS:000378758800010,View Full Record in Web of Science
J,"Hsieh, C",,,,"Hsieh, C",,,Treatment of constipation in older adults,AMERICAN FAMILY PHYSICIAN,,,English,Article,,,,,,,UNITED-STATES; EPIDEMIOLOGY; DEFECATION; LACTULOSE; DOCUSATE; SYMPTOMS,"Constipation is a common complaint in older adults. Although constipation is not a physiologic consequence of normal aging, decreased mobility and other comorbid medical conditions may contribute to its increased prevalence in older adults. Functional constipation is diagnosed when no secondary causes can be identified, such as a medical condition or a medicine with a side effect profile that includes constipation. Empiric treatment may be tried initially for patients with functional constipation. Management of chronic constipation includes keeping a stool diary to record the nature of the bowel movements, counseling on bowel training, increasing fluid and dietary fiber intake, and increasing physical activity. There are a variety of over-the-counter and prescription laxatives available for the treatment of constipation. Fiber and laxatives increase stool frequency and improve symptoms of constipation. If constipation is refractory to medical treatment, further diagnostic evaluation may be warranted to assess for colonic transit time and anorectal dysfunction. Alternative treatment methods such as biofeedback and surgery may be considered for these patients.","Thomas Jefferson Univ, Dept Family Med, Philadelphia, PA 19107 USA",Jefferson University,"Thomas Jefferson Univ, Dept Family Med, 1015 Walnut St,Suite 401, Philadelphia, PA 19107 USA.",,,,PHS HHS [1 K01 HP 00073-01] Funding Source: Medline,PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service),,,45,75,87,0,8,AMER ACAD FAMILY PHYSICIANS,KANSAS CITY,"8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797 USA",0002-838X,1532-0650,,AM FAM PHYSICIAN,Am. Fam. Physician,DEC 1,2005,72,11,,,,,2277,2284,,,,,,8,"Primary Health Care; Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,990ZC,16342852,,,,2024-06-04,WOS:000233780900014,View Full Record in Web of Science
J,"Bellini, M; Usai-Satta, P; Bove, A; Bocchini, R; Galeazzi, F; Battaglia, E; Alduini, P; Buscarini, E; Bassotti, G; Balzano, A; Portincasa, P; Bonfrate, L; D'Alba, L; Badiali, D; Marchi, S; Gambaccini, D; Neri, MC; Muscatiello, N; Di Stefano, M; Giannelli, C; Goffredo, F; Turco, L; Camilleri, S; Ceccarelli, G; Iovino, P; Montalbano, LM; Morreale, GC; Rentini, S; Savarino, V; Segato, S; Manfredi, G; Cannizzaro, R; Passaretti, S; Alessandri, M; Corti, F; Cuomo, R; Zito, FP; Mellone, C; Barbera, R; Milazzo, G; Pucciani, F; Soncini, M; Lai, MA; Ruggeri, M; Savarese, MF; De Bona, M; Surrenti, E; Arini, A; Dinelli, M; Leandro, G; Peralta, S; Manta, R; Quartini, M; Torresan, F; Vilardo, L; Pulvirenti, DA; Tarantino, O; Noris, RA; Monica, F; Carrara, M; Losco, A; Lauri, A; Neri, M; Grassini, M",,,,"Bellini, Massimo; Usai-Satta, Paolo; Bove, Antonio; Bocchini, Renato; Galeazzi, Francesca; Battaglia, Edda; Alduini, Pietro; Buscarini, Elisabetta; Bassotti, Gabrio; Balzano, Antonio; Portincasa, Piero; Bonfrate, Leonilde; D'Alba, Lucia; Badiali, Danilo; Marchi, Santino; Gambaccini, Dario; Neri, Maria Cristina; Muscatiello, Nicola; Di Stefano, Michele; Giannelli, Claudio; Goffredo, Fabio; Turco, Luigi; Camilleri, Salvatore; Ceccarelli, Giovanni; Iovino, Paola; Montalbano, Luigi Maria; Morreale, Gaetano Cristian; Rentini, Silvia; Savarino, Vincenzo; Segato, Sergio; Manfredi, Guido; Cannizzaro, Renato; Passaretti, Sandro; Alessandri, Matteo; Corti, Federico; Cuomo, Rosario; Zito, Francesco Paolo; Mellone, Carmine; Barbera, Roberta; Milazzo, Giuseppe; Pucciani, Filippo; Soncini, Marco; Lai, Maria Antonia; Ruggeri, Maurizio; Savarese, Maria Flavia; De Bona, Manuela; Surrenti, Elisabetta; Arini, Andrea; Dinelli, Marco; Leandro, Gioacchino; Peralta, Sergio; Manta, Raffaele; Quartini, Mariano; Torresan, Francesco; Vilardo, Luigi; Pulvirenti, D'Urso Antonino; Tarantino, Ottaviano; Noris, Roberto Antonio; Monica, Fabio; Carrara, Maurizio; Losco, Alessandra; Lauri, Adriano; Neri, Matteo; Grassini, Mario",,ChroCoDiTE Study Grp; AIGO,Chronic constipation diagnosis and treatment evaluation: the CHRO.CO.DITE study,BMC GASTROENTEROLOGY,,,English,Article,,,,,,Functional constipation; Irritable bowel syndrome; Diagnosis; Treatment,IRRITABLE-BOWEL-SYNDROME; RECTAL EXAMINATION; NORTH-AMERICA; HEALTH-CARE; PREVALENCE; GASTROENTEROLOGY; QUESTIONNAIRE; EPIDEMIOLOGY; PERSPECTIVE; VALIDATION,"Background: According to Rome criteria, chronic constipation (CC) includes functional constipation (FC) and irritable bowel syndrome with constipation (IBS-C). Some patients do not meet these criteria (No Rome Constipation, NRC). The aim of the study was is to evaluate the various clinical presentation and management of FC, IBS-C and NRC in Italy. Methods: During a 2-month period, 52 Italian gastroenterologists recorded clinical data of FC, IBS-C and NRC patients, using Bristol scale, PAC-SYM and PAC-QoL questionnaires. In addition, gastroenterologists were also asked to record whether the patients were clinically assessed for CC for the first time or were in follow up. Diagnostic tests and prescribed therapies were also recorded. Results: Eight hundred seventy-eight consecutive CC patients (706 F) were enrolled (FC 62.5%, IBS-C 31.3%, NRC 6. 2%). PAC-SYM and PAC-QoL scores were higher in IBS-C than in FC and NRC. 49.5% were at their first gastroenterological evaluation for CC. In 48.5% CC duration was longer than 10 years. A specialist consultation was requested in 31.6%, more frequently in IBS-C than in NRC. Digital rectal examination was performed in only 56.4%. Diagnostic tests were prescribed to 80.0%. Faecal calprotectin, thyroid tests, celiac serology, breath tests were more frequently suggested in IBS-C and anorectal manometry in FC. More than 90% had at least one treatment suggested on chronic constipation, most frequently dietary changes, macrogol and fibers. Antispasmodics and psychotherapy were more frequently prescribed in IBS-C, prucalopride and pelvic floor rehabilitation in FC. Conclusions: Patients with IBS-C reported more severe symptoms and worse quality of life than FC and NRC. Digital rectal examination was often not performed but at least one diagnostic test was prescribed to most patients. Colonoscopy and blood tests were the first line diagnostic tools. Macrogol was the most prescribed laxative, and prucalopride and pelvic floor rehabilitation represented a second line approach. Diagnostic tests and prescribed therapies increased by increasing CC severity.","[Bellini, Massimo] Univ Pisa, Dept Gastroenterol, Gastrointestinal Unit, Via Paradisa 2, I-56127 Pisa, Italy; [Usai-Satta, Paolo] Brotzu Hosp, Gastroenterol Unit, Cagliari, Italy; [Bove, Antonio] AORN A Cardarelli, Naples, Italy; [Bocchini, Renato] Malatesta Novello Private Hosp, Cesena, Italy; [Galeazzi, Francesca] Univ Padua, Dept Surg Oncol & Gastroenterol, Div Gastroenterol, Padua, Italy; [Battaglia, Edda] Cardinal Massaia Hosp, Gastroenterol Unit, Asti, Italy; [Alduini, Pietro] San Luca Hosp, Digest Endoscopy Unit, Lucca, Italy; [Buscarini, Elisabetta] Maggiore Hosp, Gastroenterol & Digest Endoscopy Unit, Crema, Italy; [Bassotti, Gabrio] Gastrointestinal & Hepatol Sect, Clin & Expt Med, Perugia, Italy; [Bellini, Massimo; Marchi, Santino; Gambaccini, Dario] UO Gastroenterol Univ AOU Pisana, Pisa, Italy; [Usai-Satta, Paolo] Azienda Ospedaliera G. Brotzu, SC Gastroenterol, Cagliari, Italy; [Bove, Antonio] AORN A Cardarelli, UO Gastroenterol Endoscopia Digest, Naples, Italy; [Bocchini, Renato] Casa Cura Malatesta Novello, Gastroenterol Endoscopia Digest, Fisiopatol Endoscopia Digest, Cesena, Italy; [Battaglia, Edda; Grassini, Mario] Ospedale Cardinal Massaja, SOC Gastroenterol, Asti, Italy; [Alduini, Pietro] Osped Lucca, UO Gastroenterol, Lucca, Italy; [Galeazzi, Francesca] Azienda Osped Univ Padova, UO Gastroenterol Univ, Padua, Italy; [Bassotti, Gabrio] Univ Perugia, Dipartimento Med Interna, Sez Gastroenterol Epatol, I-06100 Perugia, Italy; [Balzano, Antonio] Azienda Osped Rilevanza Nazl A Cardarelli, Naples, Italy; [Portincasa, Piero; Bonfrate, Leonilde] Univ Bari, Dipartimento Sci Biomed & Oncol Umana, Clin Med A Murri, I-70121 Bari, Italy; [D'Alba, Lucia] Az Osped San Giovanni Addolorata, UOC Gastroenterol Endoscopia Digest, Rome, Italy; [Badiali, Danilo] Dip Med Interna Special Med, Rome, Italy; [Neri, Maria Cristina] Pio Albergo Trivulzio, Ambulatorio Gastroenterol Endoscopia Digest, Milan, Italy; [Muscatiello, Nicola] UO Gastroenterol Univ, Foggia, Italy; [Di Stefano, Michele] Fondazione IRCCS Policlinico S Matteo, UO Med Interna I, Pavia, Italy; [Giannelli, Claudio; Goffredo, Fabio] Az Osped San Camillo Forlanini, UOC Gastroenterol Riabilitat, Rome, Italy; [Turco, Luigi] PO Copertino, UOC Chirurg Gen, SS Endoscopia Digest, Lecce, Italy; [Camilleri, Salvatore] Osped M Raimondi San Cataldo, UOC Gastroenterol, Caltanissetta, Italy; [Ceccarelli, Giovanni; Corti, Federico] Ospedale Versilia, UOC Gastroenterol Endoscopia Digest, Viareggio, Italy; [Iovino, Paola] Univ Salerno, Dipartimento Med Chirurg, Salerno, Italy; [Montalbano, Luigi Maria] Ospedali Riuniti Villa Sofia Cervello Palermo, UOC Gastroenterologia, Palermo, Italy; [Morreale, Gaetano Cristian] Policlin Palermo, Gastroenterol Epatol, Palermo, Italy; [Rentini, Silvia] Azienda Osped Univ Senese, UOC Gastroenterol Endoscopia Operat, Dipartimento Oncol, Siena, Italy; [Savarino, Vincenzo] IRCCS AO Univ San Martino IST, UO Clin Gastroenterol Endoscopia, Genoa, Italy; [Segato, Sergio] AOU Macchi, UO Gastroenterol Endoscopia Digest, Varese, Italy; [Buscarini, Elisabetta; Manfredi, Guido] Osped Maggiore Crema, UO Gastroenterolo Endoscopia Digest, Crema, Italy; [Cannizzaro, Renato] Ist Nazl Tumori IRCCS, Ctr Riferimento Oncol, SOC Gastroenterol Oncol, Aviano, Italy; [Passaretti, Sandro; Alessandri, Matteo] UO Gastroenterol Osped Univ San Raffaele, Milan, Italy; [Cuomo, Rosario; Zito, Francesco Paolo] Univ Naples Federico II, Dipartimento Med Clin & Sperimentale, Naples, Italy; [Mellone, Carmine] Osped Valdichiana, UOS Endoscopia Digest, Montepulciano, Italy; [Barbera, Roberta] Ospedale San Giuseppe Multimed, Milan, Italy; [Milazzo, Giuseppe] Osped Vittorio Emanuele III, UOC Med & Lungodegenza, Salemi, Italy; [Pucciani, Filippo] Univ Florence, Dipartimento Chirurg & Med Traslaz, I-50121 Florence, Italy; [Soncini, Marco] Osped San Carlo Borromeo Milano, UOC Gastroenterol, Milan, Italy; [Lai, Maria Antonia] Univ Cagliari, AOU Policlin Monserrato, Dipartimento Med Interna, I-09124 Cagliari, Italy; [Ruggeri, Maurizio] Osped Sant Andrea, UO Gastroenterol, Rome, Italy; [Savarese, Maria Flavia] AO Ist Ospitalieri Cremona, UOC Endoscopia Digest & Gastroenterol, Cremona, Italy; [De Bona, Manuela] Osped S Maria Del Prato, UOC Gastroenterol, Feltre, Italy; [Surrenti, Elisabetta] AOU Careggi, SOS Fisiopatol Apparato Digerente & Motil, Florence, Italy; [Arini, Andrea] Policlin Paolo Giaccone, UO Gastroenterol Epatol, Palermo, Italy; [Dinelli, Marco] Azienda Osped San Gerardo, UO Endoscopia Digest, Monza, Italy; [Leandro, Gioacchino] IRCCS De Bellis, Dipartimento Gastroenterol, Castellana Grotte, Italy; [Peralta, Sergio] AOU Policlin Paolo Giaccone, UOC Gastroenterol Epatol, Palermo, Italy; [Manta, Raffaele] Osped Niguarda Ca Granda, UOC Endoscopia Digest Interventist, Milan, Italy; [Quartini, Mariano] AOS Maria, SC Epatol & Gastroenterol, Terni, Italy; [Torresan, Francesco] Univ Bologna, Policlin S Orsola Malpighi, Dipartimento Med Interna & Gastroenterol, I-40126 Bologna, Italy; [Vilardo, Luigi] Osped Gen Ferrari, UOS Gastroenterologia, Castrovillari, Italy; [Pulvirenti, D'Urso Antonino] Osped Nuovo Garibaldi, UO Chirurg, Catania, Italy; [Tarantino, Ottaviano] Osped S Giuseppe, UO Gastroenterol, Empoli, Italy; [Noris, Roberto Antonio] AO Bolognini, UOC Gastroenterol Endoscopia Digest, Seriate, Italy; [Monica, Fabio] AOU Osped Cattinara, SC Gastroenterol Endoscopia Digest, Trieste, Italy; [Carrara, Maurizio] Osped Orlandi, UOSD Gastroenterol, Bussolengo, Italy; [Losco, Alessandra] Gastroenterol Osped San Paolo, Milan, Italy; [Lauri, Adriano] Osped Civile Spirito Santo, UOC Gastroenterol Endoscopia Digest, Pescara, Italy; [Neri, Matteo] Univ G DAnnunzio, Dipartimento Med & Sci Invecchiamento & CeSI, Chieti, Italy",University of Pisa; University of Padua; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Perugia; Antonio Cardarelli Hospital; Universita degli Studi di Bari Aldo Moro; Azienda Ospedaliera San Camillo-Forlanini; Ospedale Versilia; University of Salerno; University of Siena; University Hospital of Siena; Ospedale Circolo & Fondazione Macchi; IRCCS Aviano (CRO); University of Naples Federico II; Azienda Ospedaliera Universitaria Policlinico Vittorio Emanuele Presidio Ferraotto; University of Florence; San Carlo Borromeo Hospital; University of Cagliari; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Palermo; Policlinico Paolo Giaccone; IRCCS Saverio de Bellis; University of Palermo; Policlinico Paolo Giaccone; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; ULSS 9 Scaligera; Ospedale Orlandi di Bussolengo; G d'Annunzio University of Chieti-Pescara,"Bellini, M (corresponding author), Univ Pisa, Dept Gastroenterol, Gastrointestinal Unit, Via Paradisa 2, I-56127 Pisa, Italy.",mbellini@med.unipi.it,"portincasa, piero/J-7245-2018; Satta, Paolo Usai/N-2506-2019; Cuomo, Rosario/C-3446-2011; Cannizzaro, Renato/V-3804-2018; Gambaccini, Dario/AAC-6716-2022; zito, francesco/AAS-3197-2021; Bonfrate, Leonilde/ABH-1835-2021; di stefano, michele/AAC-2205-2019; IOVINO, PAOLA/G-6195-2011; Monica, Fabio/L-5943-2016","portincasa, piero/0000-0001-5359-1471; Cuomo, Rosario/0000-0003-0768-8381; Cannizzaro, Renato/0000-0002-2020-222X; Gambaccini, Dario/0000-0002-6506-0253; di stefano, michele/0000-0002-6971-6854; IOVINO, PAOLA/0000-0002-9568-0680; camilleri, salvatore/0000-0002-2492-7615; Manfredi, Guido/0000-0003-0468-2945; Monica, Fabio/0000-0002-3064-1269; bellini, massimo/0000-0002-6387-6443; morreale, gaetano cristian/0000-0001-8954-7819; Usai-Satta, Paolo/0000-0003-3344-927X; Zito, Francesco Paolo/0000-0002-1084-3373",,,,,28,48,51,1,17,BIOMED CENTRAL LTD,LONDON,"236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND",1471-230X,,,BMC GASTROENTEROL,BMC Gastroenterol.,JAN 14,2017,17,,,,,,,,11,10.1186/s12876-016-0556-7,http://dx.doi.org/10.1186/s12876-016-0556-7,,,11,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,EK1TU,28088179,"gold, Green Published",,,2024-06-04,WOS:000393709500001,View Full Record in Web of Science
J,"Moreno, AA; Parker, VJ; Winston, JA; Rudinsky, AJ",,,,"Moreno, Adam A.; Parker, Valerie J.; Winston, Jenessa A.; Rudinsky, Adam J.",,,Dietary fiber aids in the management of canine and feline gastrointestinal disease,JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION,,,English,Article,,,,,,,CHAIN FATTY-ACIDS; FECAL PROTEIN CATABOLITES; MICROBIAL-POPULATIONS; BEET PULP; NUTRIENT DIGESTIBILITY; INTESTINAL TRANSIT; METABOLIZABLE ENERGY; DOG DIETS; RADIOPAQUE MARKERS; GLYCEMIC CONTROL,"Dietary fiber describes a diverse assortment of nondigestible carbohydrates that play a vital role in the health of animals and maintenance of gastrointestinal tract homeostasis. The main roles dietary fiber play in the gastrointestinal tract include physically altering the digesta, modulating appetite and satiety, regulating digestion, and acting as a microbial energy source through fermentation. These functions can have widespread systemic effects. Fiber is a vital component of nearly all commercial canine and feline diets. Key features of fiber types, such as fermentability, solubility, and viscosity, have been shown to have clinical implications as well as health benefits in dogs and cats. Practitioners should know how to evaluate a diet for fiber content and the current knowledge on fiber supplementation as it relates to common enteropathies including acute diarrhea, chronic diarrhea, constipation, and hairball management. Understanding the fundamentals of dietary fiber allows the practicing clinician to use fiber optimally as a management modality.","[Moreno, Adam A.; Parker, Valerie J.; Winston, Jenessa A.; Rudinsky, Adam J.] Ohio State Univ, Coll Vet Med, Dept Vet Clin Sci, Columbus, OH 43210 USA; [Moreno, Adam A.; Parker, Valerie J.; Winston, Jenessa A.; Rudinsky, Adam J.] Ohio State Univ, Coll Vet Med, Comparat Hepatobiliary & Intestinal Res Program, Columbus, OH 43210 USA",University System of Ohio; Ohio State University; University System of Ohio; Ohio State University,"Rudinsky, AJ (corresponding author), Ohio State Univ, Coll Vet Med, Dept Vet Clin Sci, Columbus, OH 43210 USA.;Rudinsky, AJ (corresponding author), Ohio State Univ, Coll Vet Med, Comparat Hepatobiliary & Intestinal Res Program, Columbus, OH 43210 USA.",rudinsky.3@osu.edu,"Parker, Valerie J./G-8238-2012",,,,,,127,4,4,11,40,AMER VETERINARY MEDICAL ASSOC,SCHAUMBURG,"1931 N MEACHAM RD SUITE 100, SCHAUMBURG, IL 60173-4360 USA",0003-1488,1943-569X,,JAVMA-J AM VET MED A,JAVMA-J. Am. Vet. Med. Assoc.,DEC,2022,260,,,3,,,S33,S45,,10.2460/javma.22.08.0351,http://dx.doi.org/10.2460/javma.22.08.0351,,,13,Veterinary Sciences,Science Citation Index Expanded (SCI-EXPANDED),Veterinary Sciences,6V1PV,36288203,Bronze,,,2024-06-04,WOS:000894829800005,View Full Record in Web of Science
J,"Cabré, E",,,,"Cabré, E",,,Fibre supplementation of enteral formula-diets:: a look to the evidence,CLINICAL NUTRITION,,,English,Article; Proceedings Paper,Symposium on New Lipid Emulsions in Parenteral Nutrition,"SEP 12, 2004","Lisbon, PORTUGAL",ESPEN,,enteral nutrition; dietary fibre; diarrhea; constipation; glycaemic control; diabetes; bacterial fermentation; partially hydrolyzed guar gum; soy polysaccharide; pectin,CHAIN FATTY-ACIDS; BOWEL FUNCTION; SOLUBLE FIBER; BACTERIAL TRANSLOCATION; SOY-POLYSACCHARIDE; CONTROLLED-TRIAL; CRITICALLY-ILL; DIARRHEA; NUTRITION; TOLERANCE,"The use of fibre-supplemented enteral nutrition has been clinically assessed only for a few purposes, such as improving G-I tolerance to short-term enteral feeding (particularly in critically ill. patients), preventing constipation in long-term enteral nutrition, and improving the glycaemic control in diabetic or carbohydrate-in tolerant patients. Randomized trials have yielded divergent results regarding the ability of fibre to prevent enteral nutrition-associated diarrhea, suggesting that fermentability is a sine qua non for this purpose. Partially hydrolyzed guar gum seems to be effective, but more trials with this and other fermentable fibres are required. In contrast, non-fermentable fibre should be preferred to prevent constipation in long-term enterally fed patients. Soy polysaccharide has been the most extensively investigated fibre source for this purpose in healthy subjects on a short-term basis, but its usefulness in the clinical setting needs to be confirmed. The ability of fibre to decrease postprandial glycaemic response mostly depends of its viscosity, a property which is lost in the manufacturing process (hydrolysis) for its incorporation into enteral solutions for tube feeding. Although disease-specific enteral diets for diabetics appear to be better than standard formulas for metabolic control, it is difficult to ascertain to what extent fibre supplementation contributed to their beneficial effects. (c) 2004 Elsevier Ltd. Alrights reserved.","Hosp Badalona Germans Trias & Pujol, Dept Gastroenterol, Badalona 08916, Spain",Hospital Germans Trias i Pujol,"Hosp Badalona Germans Trias & Pujol, Dept Gastroenterol, Carretera Canyet S-N, Badalona 08916, Spain.",ecabre@ns.hugtip.scs.es,,,,,,,45,6,7,0,7,CHURCHILL LIVINGSTONE,EDINBURGH,"JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND",0261-5614,1532-1983,,CLIN NUTR,Clin. Nutr.,,2004,,,,2,,,63,71,,10.1016/j.clnu.2004.09.010,http://dx.doi.org/10.1016/j.clnu.2004.09.010,,,9,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Nutrition & Dietetics,973RI,,,,,2024-06-04,WOS:000232539900009,View Full Record in Web of Science
J,"Rao, SSC; Go, JT",,,,"Rao, Satish S. C.; Go, Jorge T.",,,Update on the management of constipation in the elderly: new treatment options,CLINICAL INTERVENTIONS IN AGING,,,English,Review,,,,,,constipation; elderly; treatment,PLACEBO-CONTROLLED TRIAL; CHLORIDE CHANNEL ACTIVATOR; SLOW TRANSIT CONSTIPATION; IRRITABLE-BOWEL-SYNDROME; QUALITY-OF-LIFE; DOUBLE-BLIND; HEALTH-CARE; DIETARY FIBER; BIOFEEDBACK; LUBIPROSTONE,"Constipation disproportionately affects older adults, with a prevalences of 50% in community-dwelling elderly and 74% in nursing-home residents. Loss of mobility, medications, underlying diseases, impaired anorectal sensation, and ignoring calls to defecate are as important as dyssynergic defecation or irritable bowel syndrome in causing constipation. Detailed medical history on medications and co-morbid problems, and meticulous digital rectal examination may help identify causes of constipation. Likewise, blood tests and colonoscopy may identify organic causes such as colon cancer. Physiological tests such as colonic transit study with radio-opaque markers or wireless motility capsule, anorectal manometry, and balloon expulsion tests can identify disorders of colonic and anorectal function. However, in the elderly, there is usually more than one mechanism, requiring an individualized but multifactorial treatment approach. The management of constipation continues to evolve. Although osmotic laxatives such as polyethylene glycol remain mainstay, several new agents that target different mechanisms appear promising such as chloride-channel activator (lubiprostone), guanylate cyclase agonist (linaclotide), 5HT(4) agonist (prucalopride), and peripherally acting mu-opioid receptor antagonists (alvimopan and methylnaltrexone) for opioid-induced constipation. Biofeedback therapy is efficacious for treating dyssynergic defecation and fecal impaction with soiling. However, data on efficacy and safety of drugs in elderly are limited and urgently needed.","[Rao, Satish S. C.; Go, Jorge T.] Univ Iowa, Dept Internal Med, Iowa Carver Coll Med, Sect Neurogastroenterol,Div Gastroenterol Hepatol, Iowa City, IA 52242 USA",University of Iowa,"Rao, SSC (corresponding author), Univ Iowa Hosp & Clin, GI Div, 200 Hawkins Dr,4612 JCP, Iowa City, IA 52242 USA.",satish-rao@uiowa.edu,,,SmartPill Corporation; Ironwood Pharmaceuticals; Takeda Pharmaceuticals; NIH [RO1 DK 57100-05],SmartPill Corporation; Ironwood Pharmaceuticals; Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA),"Dr Rao has served as an Advisory Board member, and has received research support from, SmartPill Corporation, Ironwood Pharmaceuticals, and Takeda Pharmaceuticals.; Dr Satish Rao is supported by NIH grant RO1 DK 57100-05.",,57,105,114,4,41,DOVE MEDICAL PRESS LTD,ALBANY,"PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND",,1178-1998,,CLIN INTERV AGING,Clin. Interv. Aging,,2010,5,,,,,,163,171,,,,,,9,Geriatrics & Gerontology,Science Citation Index Expanded (SCI-EXPANDED),Geriatrics & Gerontology,V21XA,20711435,,,,2024-06-04,WOS:000208239100018,View Full Record in Web of Science
J,"Bosscher, D; Van Caillie-Bertrand, M; Deelstra, H",,,,"Bosscher, D; Van Caillie-Bertrand, M; Deelstra, H",,,"Effect of thickening agents, based an soluble dietary fiber, on the availability of calcium, iron, and zinc from infant formulas",NUTRITION,,,English,Article,,,,,,availability of micronutrients; bioavailability; soluble dietary fiber; calcium; iron; zinc,WHEAT BRAN; GUAR GUM; ABSORPTION; BINDING; CHILDREN; CONSTIPATION; FOOD; PH,"Although it is accepted that dietary fiber probably is not needed in the diets of infants younger than 1 y, babies suffering from regurgitation are often fed with infant formulas thickened with considerable amounts of fiber. The effect of increasing amounts of alginic acid, locust-bean gum, and guar gum was studied from casein and whey-based infant formulas. A dialysis in vitro method with preliminary intraluminal digestion, adapted to the conditions of infants younger than 6 mo, was used. Human milk was used as the reference standard. Elemental contents of samples and dialysates were determined by atomic absorption spectrometry. Soluble dietary fiber inhibited mineral availability mon in casein than in whey-based formulas. Mineral availabilities from casein- and whey-based formulas supplemented with 0.42 g of locust-bean gum/100 mL, were 9.4%.(0.7) and 10.4% (0.6) for calcium (P < 0.05), 0.32% (0.08) and 1.45% (0.17) for iron (P < 0.05), and 3.2% (0.2) and 5.6% (0.5) for zinc (P < 0.05), respectively. Calcium availability from the whey formula decreased in the presence of each fiber source, especially guar gum and alginic acid. Supplementing 2 g of alginic acid-based agents per 100 mt depressed calcium availability from 13.3% (1.2) to 5.3% (0.3; P < 0.05). With respect to iron and zinc, availabilities increased from 1.28% (0.28) to 6.05% (0.96; P < 0.05) and from 6.7% (0.6) to 10.2% (1.0), respectively, with the addition of 2 g of alginic acid (P < 0.05). Both gums lowered iron and zinc availabilities, and guar gum affected iron availability more severely than locust-bean gum did. iron availabilities were 1.45% (0.17) from formula thickened with locust-bean gum (0.42 g/100 mt) and 0.92% (0.15) from formula thickened with guar gum (P < 0.05). Adding thickening agents based on soluble dietary fiber to traditional infant formulas probably affects calcium, iron, and zinc availability in various ways. (C) Elsevier Science Inc. 2001.","Univ Instelling Antwerp, Lab Food Sci, Dept Pharmaceut Sci, B-2610 Antwerp, Wilrijk, Belgium; Algemeen Ziekehuis, Koningin Paola Kinderziekenhuis, Dept Pediat Gastroenterol & Nutr, Antwerp, Belgium",University of Antwerp,"Univ Instelling Antwerp, Lab Food Sci, Dept Pharmaceut Sci, Univ Pl 1, B-2610 Antwerp, Wilrijk, Belgium.",bosscher@uia.ua.ac.be,,,,,,,30,66,69,0,24,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",0899-9007,1873-1244,,NUTRITION,Nutrition,JUL-AUG,2001,17,7-8,,,,,614,618,,10.1016/S0899-9007(01)00541-X,http://dx.doi.org/10.1016/S0899-9007(01)00541-X,,,5,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,450XY,11448582,,,,2024-06-04,WOS:000169771200014,View Full Record in Web of Science
J,"Schaefer, DC; Cheskin, LJ",,,,"Schaefer, DC; Cheskin, LJ",,,Constipation in the elderly,AMERICAN FAMILY PHYSICIAN,,,English,Article,,,,,,,PREVALENCE; TRANSIT,"Constipation affects as many as 26 percent of elderly men and 34 percent of elderly women and is a problem that has been related to diminished perception of quality of life. Constipation may be the sign of a serious problem such as a mass lesion, the manifestation of a systemic disorder such as hypothyroidism or a side effect of medications such as narcotic analgesics. The patient with constipation should be questioned about fluid and food intake, medications, supplements and homeopathic remedies. The physical examination may reveal local masses or thrombosed hemorrhoids, which may be contributing to the constipation. Visual inspection of the colon is useful when no obvious cause of constipation can be determined. Treatment should address the underlying abnormality. The chronic use of certain treatments, such as laxatives, should be avoided. First-line therapy should include bowel retraining, increased dietary fiber and fluid intake, and exercise when possible. Laxatives, stool softeners and nonabsorbable solutions may be needed in some patients with chronic constipation.","Johns Hopkins Univ, Sch Med, Baltimore, MD USA",Johns Hopkins University,"Schaefer, DC (corresponding author), Apple Hill Med Ctr, Ctr Digest Dis, 25 Monument Rd,Suite 250, York, PA 17403 USA.",,"Cheskin, Lawrence/AAM-1094-2021","Cheskin, Lawrence/0000-0003-0262-1030",,,,,17,50,55,0,4,AMER ACAD FAMILY PHYSICIANS,KANSAS CITY,"8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797 USA",0002-838X,1532-0650,,AM FAM PHYSICIAN,Am. Fam. Physician,SEP 15,1998,58,4,,,,,907,914,,,,,,8,"Primary Health Care; Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),General & Internal Medicine,123VA,9767726,,,,2024-06-04,WOS:000076145000019,View Full Record in Web of Science
J,"Hao, SP; Zhang, YC; Ma, WW; Li, M; Tan, SS; Li, J; Li, JY; Liu, L",,,,"Hao, Shuping; Zhang, Yongchao; Ma, Weiwei; Li, Mei; Tan, Sisi; Li, Jing; Li, Jingyun; Liu, Lan",,,Clinical study on the improvement in functional constipation for Panax notoginseng stem and leaf tea combine with panaxnotoginseng fruit and vegetable enzyme and probiotic powder,FOOD SCIENCE AND TECHNOLOGY,,,English,Article,,,,,,Panax notoginseng stem; leaf tea; probiotic powder; vegetable enzyme; functional constipation,MANAGEMENT; FIBER,"The ingredients in fruit and vegetable enzymes are not only medicine and food for relieving constipation but also rich in dietary fiber. We aimed to investigate the efficacy of panax notoginseng stem, leaf tea combined with panaxnotoginseng fruit, vegetable enzyme, and probiotic powder for functional constipation. Patients with functional constipation had been recruited and been randomly divided into the lactulose intervention group and probiotic intervention group. In the probiotic intervention group, patients received panaxnotoginseng stem and leaf tea + Panaxnotoginseng fruit and vegetable enzyme+probiotic powder, once a day. In the lactulose intervention group, patients received normal drug treatment for 2 weeks. Both probiotics intervention and lactulose intervention can improve the fecal quality of patients with constipation. Probiotics group can lead to an increase in the proportion of diarrhea in patients with constipation. Both probiotics and lactulose can significantly increase the levels of blood SP and GAS and decrease the level of MTL in patients with constipation. Both probiotics intervention and lactulose intervention can improve the quality of life of patients with constipation and the fecal quality of patients with constipation. Probiotics group can lead to an increase in the proportion of diarrhea in patients with constipation.","[Hao, Shuping; Li, Mei; Tan, Sisi; Li, Jing; Li, Jingyun] Capital Med Univ, Pinggu Hosp, Beijing Friendship Hosp, Dept Clin Nutr, Beijing, Peoples R China; [Zhang, Yongchao] Capital Med Univ, Pinggu Hosp, Beijing Friendship Hosp, Dept Gastroenterol Related Internal Med, Beijing, Peoples R China; [Ma, Weiwei] Capital Med Univ, Sch Publ Hlth, Beijing, Peoples R China; [Liu, Lan] Beijing Dietitian Assoc, Beijing, Peoples R China",Capital Medical University; Capital Medical University; Capital Medical University,"Liu, L (corresponding author), Beijing Dietitian Assoc, R&F Morgan Ctr, 6 Taiping St, Beijing, Peoples R China.",dietetic@163.com,"LI, Jing/HNB-5575-2023; li, yao/IYJ-1364-2023; wang, qi/ITT-9652-2023; Yang, Ying/ABD-2481-2022; li, bai/JNE-1502-2023; li, jy/HTT-1535-2023; li, jian/IAQ-2794-2023; wang, tao/HLG-5649-2023; cao, yutong/JJF-4531-2023; Liu, Gui/JHU-8707-2023; long, chen/JVM-8568-2024; Zhang, Yanyan/JFA-9161-2023; Wang, Jing/IQW-3496-2023; liu, xq/JDW-2596-2023; Li, Ly/JCD-4746-2023; Xi, Yang/KEH-5204-2024","Wang, Jing/0000-0002-8296-2961;",,,,,34,0,0,9,33,SOC BRASILEIRA CIENCIA TECNOLOGIA ALIMENTOS,CAMPINAS,"AV BRASIL 2880, CAXIA POSTAL 271 CEP 13001-970, CAMPINAS, SAO PAULO 00000, BRAZIL",0101-2061,1678-457X,,FOOD SCI TECH-BRAZIL,Food Sci. Technol.,,2022,42,,,,,,,,e19022,10.1590/fst.19022,http://dx.doi.org/10.1590/fst.19022,,,11,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,2L4KL,,gold,,,2024-06-04,WOS:000816986300006,View Full Record in Web of Science
J,"Camacho-Díaz, BH; Arenas-Ocampo, ML; Osorio-Díaz, P; Jiménez-Aparicio, AR; Alvarado-Jasso, GM; Saavedra-Briones, EV; Valdovinos-Díaz, MA; Gómez-Reyes, E",,,,"Camacho-Diaz, Brenda Hildeliza; Arenas-Ocampo, Martha Lucia; Osorio-Diaz, Perla; Jimenez-Aparicio, Antonio Ruperto; Alvarado-Jasso, Guadalupe Monserrat; Saavedra-Briones, Eden Valfre; Valdovinos-Diaz, Miguel angel; Gomez-Reyes, Elisa",,,"The Effects of Agave Fructans in a Functional Food Consumed by Patients with Irritable Bowel Syndrome with Constipation: A Randomized, Double-Blind, Placebo-Controlled Trial",NUTRIENTS,,,English,Article,,,,,,IBS; constipation; prebiotic jelly; agave fructans; functional foods; prebiotics; fiber intake; intestinal movements,QUALITY-OF-LIFE; MEXICAN CONSENSUS; GUT MICROBIOTA; DIETARY FIBER; DEPRESSION; IBS; VALIDATION; ANXIETY; ALTERS,"Irritable bowel syndrome displays three different subtypes: constipation (IBS-C), diarrhea (IBS-D), and mixed (IBS-M). Treatment with dietary fiber is used, with consideration given both to the chemical composition of the fiber and to the different subtypes of IBS. The IBS-D subtype is usually treated with a low-FODMAPs diet, whereas the IBS-C subtype suggests prebiotics and probiotics to promote microbiota restoration. The aim of this study was to assess the effects of employing agave fructans as the soluble fiber of a jelly (Gelyfun (R) gastro) containing 8 g per serving in the IBS-C group (n = 50), using a randomized, double-blind, time-limited trial for four weeks. We evaluated changes in the frequency and types of bowel movements through the Bristol scale, and the improvement of the condition was evaluated using quality of life (IBS-QOL) and anxiety-depression (HADS) scales. The main results were that the number of bowel movements increased by more than 80%, with at least one stool per day from fifteen days onwards, without a laxative effect for the group treated. Finally, the quality of life with the prebiotic jelly was significantly improved compared to the placebo in all specific domains, in addition to significantly reducing anxiety and depression.","[Camacho-Diaz, Brenda Hildeliza; Arenas-Ocampo, Martha Lucia; Osorio-Diaz, Perla; Jimenez-Aparicio, Antonio Ruperto] Inst Politecn Nacl, Ctr Desarrollo Prod Biot, Yautepec 62731, Morelos, Mexico; [Alvarado-Jasso, Guadalupe Monserrat] Ctr Nacl Tecnol & Seguridad Alimentaria CNTA, Ctra NA-134 Km 53, San Adrian 31570, Navarra, Spain; [Saavedra-Briones, Eden Valfre] Univ Autonoma Estado Morelos, Fac Nutr, Cuernavaca 62290, Morelos, Mexico; [Valdovinos-Diaz, Miguel angel] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Gastrointestinal Motilidad Lab, Dept Gastroenterol, Ciudad De Mexico 14080, Mexico; [Gomez-Reyes, Elisa] Tecnol Monterrey, Escuela Med & Ciencias Salud, Campus Ciudad Mexico,Calle Puente 222, Ciudad De Mexico 14380, Mexico",Instituto Politecnico Nacional - Mexico; Universidad Autonoma del Estado de Morelos; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Tecnologico de Monterrey,"Camacho-Díaz, BH (corresponding author), Inst Politecn Nacl, Ctr Desarrollo Prod Biot, Yautepec 62731, Morelos, Mexico.;Gómez-Reyes, E (corresponding author), Tecnol Monterrey, Escuela Med & Ciencias Salud, Campus Ciudad Mexico,Calle Puente 222, Ciudad De Mexico 14380, Mexico.",bcamacho@ipn.mx; mlarenas@ipn.mx; posorio@ipn.mx; aaparici@ipn.mx; gpemonserratjasso@gmail.com; eden.saavedra@uaem.edu.mx; miguelvaldovinosd@gmail.com; elisa.gomez@tec.mx,,,Fundacion MAPFRE; Ignacio H. Larramendi; Secretaria de Investigacion y Posgrado del Instituto Politecnico Nacional [SIP 20131913]; Instituto Morelense para el Financiamiento del Sector Productivo,Fundacion MAPFRE; Ignacio H. Larramendi; Secretaria de Investigacion y Posgrado del Instituto Politecnico Nacional; Instituto Morelense para el Financiamiento del Sector Productivo,"This research was funded by Fundacion MAPFRE with the Ignacio H. Larramendi grant; by a research project from Secretaria de Investigacion y Posgrado del Instituto Politecnico Nacional with grant number SIP 20131913; and by Instituto Morelense para el Financiamiento del Sector Productivo, FM/fortalece12/052/2023.",,50,0,0,2,2,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,AUG,2023,15,16,,,,,,,3526,10.3390/nu15163526,http://dx.doi.org/10.3390/nu15163526,,,15,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,Q4QQ6,37630717,"gold, Green Published",,,2024-06-04,WOS:001057387100001,View Full Record in Web of Science
J,"Koebnick, C; Wagner, I; Leitzmann, P; Stern, U; Zunft, HJF",,,,"Koebnick, C; Wagner, I; Leitzmann, P; Stern, U; Zunft, HJF",,,Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation,CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,,,English,Article,,,,,,constipation; gastrointestinal disorders; probiotics,CHRONIC FUNCTIONAL CONSTIPATION; DIETARY FIBER INTAKE; QUALITY-OF-LIFE; GENERAL-POPULATION; STRAIN SHIROTA; DIARRHEA; RISK; PREBIOTICS; FREQUENCY; DISEASES,"BACKGROUND: The aim of the present study was to investigate the effect of a probiotic beverage on gastrointestinal symptoms in patients with chronic constipation. METHODS: A double-blind, placebo-controlled, randomized study was conducted over a four-week period in patients with symptoms of chronic constipation (n=70). To all patients, 65 mL/day of a probiotic beverage containing Lactobacillus casei Shirota (LcS) or a sensorially identical placebo was administered. Patients completed a questionnaire on gastrointestinal symptoms, well-being and stool habits and underwent a medical examination weekly. Severity of constipation, flatulence and bloating was summarized into four categories (severe, moderately severe, mild and no symptoms). RESULTS: The consumption of LcS resulted in a significant improvement in self-reported severity of constipation and stool consistency, starting in the second week of the intervention phase (P<0.0001). Severe and moderately severe constipation was observed less in the LcS group. The occurrence and degree of flatulence or bloating sensation did not change. In the final examination, 89% of the LcS group and 56% of the placebo group showed a positive effect of their beverage on constipation (P=0.003). No adverse reactions were reported. CONCLUSIONS: The results indicate a beneficial effect on gastrointestinal symptoms of patients with chronic constipation. The administration of probiotic foodstuffs may be recommended as an adjunctive therapy of chronic constipation.","German Inst Human Nutr, Dept Intervent Studies, D-14558 Bergholz Rehbrucke, Germany; Yakult Deutschland GmbH, Neuss, Germany; Univ Giessen, Inst Nutrit Sci, D-35390 Giessen, Germany",Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Justus Liebig University Giessen,"German Inst Human Nutr, Dept Intervent Studies, Arthur Scheunert Allee 114-116, D-14558 Bergholz Rehbrucke, Germany.",Koebnick@mail.dife.de,,,,,,,46,199,220,2,45,HINDAWI LTD,LONDON,"ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND",2291-2797,,,CAN J GASTROENTEROL,Can. J. Gastroenterol. Hepatol.,NOV,2003,17,11,,,,,655,659,,10.1155/2003/654907,http://dx.doi.org/10.1155/2003/654907,,,5,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,744JZ,14631461,"Green Submitted, gold",,,2024-06-04,WOS:000186626900004,View Full Record in Web of Science
J,"SONNENBERG, A; MULLER, AD",,,,"SONNENBERG, A; MULLER, AD",,,CONSTIPATION AND CATHARTICS AS RISK-FACTORS OF COLORECTAL-CANCER - A METAANALYSIS,PHARMACOLOGY,,,English,Article,,,,,,BOWEL HABITS; CATHARTICS; COLORECTAL NEOPLASM; CONSTIPATION; ENVIRONMENTAL RISK FACTORS; EPIDEMIOLOGY; LAXATIVES; METAANALYSIS,LARGE-BOWEL-CANCER; UNITED-STATES; RANDOMIZED TRIALS; COLON CANCER; FIBER INTAKE; EPIDEMIOLOGY; ALCOHOL; DIET; JAPANESE; QUALITY,"Since individual case-control studies have failed to resolve the question whether constipation and use of cathartics represent significant risk factors of colorectal cancer, a meta-analysis was performed. The method by Peto was used to calculate pooled odds ratios of the cancer risk among exposed and unexposed subjects. The analysis of 14 previously published case-control studies revealed statistically significant risks for colorectal cancer associated with both constipation and use of cathartics, the pooled odds ratios and their 95 percent confidence intervals being 1.48 (1.32-1.66) and 1.46 (1.33-1.61), respectively. The increased risk applied similarly to both sexes, it was higher in cancer of the colon than rectum. Since constipation and cathartics are associated with much lower odds ratios than various dietary components, such as fat, meat, alcohol, and low-vegetable or low-residue diets, it appears that their risk reflects the confounding influence of underlying dietary habits.","VET ADM MED CTR, DIV GASTROENTEROL, DIV BIOSTAT & EPIDEMIOL, MILWAUKEE, WI USA; MED COLL WISCONSIN, MILWAUKEE, WI 53226 USA",US Department of Veterans Affairs; Veterans Health Administration (VHA); Medical College of Wisconsin,,,,,,,,,49,76,85,0,9,KARGER,BASEL,"ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND",0031-7012,1423-0313,,PHARMACOLOGY,Pharmacology,OCT,1993,47,,,1,,,224,233,,10.1159/000139862,http://dx.doi.org/10.1159/000139862,,,10,Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy,MC565,8234434,,,,2024-06-04,WOS:A1993MC56500030,View Full Record in Web of Science
J,"Gill, SK; Rossi, M; Bajka, B; Whelan, K",,,,"Gill, Samantha K.; Rossi, Megan; Bajka, Balazs; Whelan, Kevin",,,Dietary fibre in gastrointestinal health and disease,NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY,,,English,Review,,,,,,,CHAIN FATTY-ACIDS; IRRITABLE-BOWEL-SYNDROME; CHRONIC IDIOPATHIC CONSTIPATION; INERT PLASTIC PARTICLES; GUT MICROBIOTA; WHEAT BRAN; DIVERTICULAR-DISEASE; TRANSIT-TIME; GALACTO-OLIGOSACCHARIDES; RESISTANT STARCH,"Dietary fibre has been shown to be beneficial for gastrointestinal health. This Review discusses the physicochemical and functional characteristics of dietary fibres and provides insight into their role in gastrointestinal health and the management of gastrointestinal disorders. Epidemiological studies have consistently demonstrated the benefits of dietary fibre on gastrointestinal health through consumption of unrefined whole foods, such as wholegrains, legumes, vegetables and fruits. Mechanistic studies and clinical trials on isolated and extracted fibres have demonstrated promising regulatory effects on the gut (for example, digestion and absorption, transit time, stool formation) and microbial effects (changes in gut microbiota composition and fermentation metabolites) that have important implications for gastrointestinal disorders. In this Review, we detail the major physicochemical properties and functional characteristics of dietary fibres, the importance of dietary fibres and current evidence for their use in the management of gastrointestinal disorders. It is now well-established that the physicochemical properties of different dietary fibres (such as solubility, viscosity and fermentability) vary greatly depending on their origin and processing and are important determinants of their functional characteristics and clinical utility. Although progress in understanding these relationships has uncovered potential therapeutic opportunities for dietary fibres, many clinical questions remain unanswered such as clarity on the optimal dose, type and source of fibre required in both the management of clinical symptoms and the prevention of gastrointestinal disorders. The use of novel fibres and/or the co-administration of fibres is an additional therapeutic approach yet to be extensively investigated.","[Gill, Samantha K.; Rossi, Megan; Bajka, Balazs; Whelan, Kevin] Kings Coll London, Dept Nutr Sci, London, England",University of London; King's College London,"Whelan, K (corresponding author), Kings Coll London, Dept Nutr Sci, London, England.",kevin.whelan@kcl.ac.uk,"Whelan, Kevin/ABD-5350-2021; Whelan, Kevin/ABD-5154-2021","Whelan, Kevin/0000-0001-5414-2950;",Medical Research Council [MR/N029097/1]; Newton Fund [MR/N029097/1] Funding Source: UKRI,Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Newton Fund(UK Research & Innovation (UKRI)),The authors acknowledge research funding from the Medical Research Council investigating the effect of fibre on the gut (MR/N029097/1).,,206,347,364,78,481,NATURE PORTFOLIO,BERLIN,"HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY",1759-5045,1759-5053,,NAT REV GASTRO HEPAT,Nat. Rev. Gastroenterol. Hepatol.,FEB,2021,18,2,,,,,101,116,,10.1038/s41575-020-00375-4,http://dx.doi.org/10.1038/s41575-020-00375-4,,NOV 2020,16,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,QA8VV,33208922,,Y,N,2024-06-04,WOS:000590931300001,View Full Record in Web of Science
J,"MATSUO, M",,,,"MATSUO, M",,,"UTILIZATION OF DIETARY FIBER IN A NEW FOODSTUFF, OKARA-TEMPE, BY MICROFLORA IN RATS",NIPPON NOGEIKAGAKU KAISHI-JOURNAL OF THE JAPAN SOCIETY FOR BIOSCIENCE BIOTECHNOLOGY AND AGROCHEMISTRY,,,Japanese,Article,,,,,,,,"Infant rats were fed okara-tempe as their only source of dietary fiber, and the percent utilization of the dietary fiber was measured. About 50% of the total dietary fiber of this food was used, compared with use of about 4% cellulose. Use of okara was about 60%. The oligosaccharides of okara-tempe, especially raffinose, were excreted in great part in the feces, so this foodstuff would cause little meteorism. In rats fed okara-tempe, the pH in the cecum was lower and transit time through the digestive tract was shorter than in rats fed cellulose. These results suggested that dietary fiber in okara-tempe would prevent constipation without causing meteorism. Observation of the digestive residue by scanning electron microscopy suggested that this dietary fiber would be utilized by intestinal microflora in a different way from the digestion of dietary fiber in okara itself. The absorption of fat or calcium was not decreased by okara-tempe.",,,"MATSUO, M (corresponding author), GIFU WOMENS UNIV,FAC GEN EDUC,80 TAROMARU,GIFU 50125,JAPAN.",,,,,,,,2,2,2,0,2,JAPAN SOC BIOSCI BIOTECHN AGROCHEM,TOKYO,"JAPAN ACAD SOC CTR BLDG, 2-4-6 YAYOI BUNKYO-KU, TOKYO 113, JAPAN",0002-1407,,,NIPPON NOGEIK KAISHI,Nippon Nogeikagaku Kaishi-J. Jpn. Soc. Biosci. Biotechol. Agrochem.,FEB,1995,69,2,,,,,163,167,,,,,,5,"Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics",Science Citation Index Expanded (SCI-EXPANDED),Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology; Nutrition & Dietetics,QY153,,,,,2024-06-04,WOS:A1995QY15300003,View Full Record in Web of Science
J,"Cassettari, VMG; Machado, NC; Lourençao, PLTD; Carvalho, MA; Ortolan, EVP",,,,"Granado Cassettari, Vanessa Mello; Machado, Nilton Carlos; Toledo de Arruda Lourencao, Pedro Luiz; Carvalho, Marry Assis; Paiva Ortolan, Erika Veruska",,,Combinations of laxatives and green banana biomass on the treatment of functional constipation in children and adolescents: a randomized study,JORNAL DE PEDIATRIA,,,English,Article,,,,,,Constipation; Dietary fiber; Green banana; Green banana biomass; Resistant starch,STOOL FORM SCALE; RESISTANT-STARCH; SMALL-INTESTINE; FOODS,"Objectives: Evaluate the effect of combinations of green banana biomass and laxatives in children and adolescents with chronic constipation. Methods: This was a randomized study of 80 children and adolescents with functional constipation according to the Rome IV Criteria, who were divided into five groups: (1) green banana biomass alone; (2) green banana biomass plus PEG 3350 with electrolytes; (3) green banana biomass plus sodium picosulfate; (4) PEG 3350 with electrolytes alone; and (5) sodium picasulfate alone. Primary outcome measure was the reduction of the proportion of patients with Bristol Stool Form Scale ratings 1 or 2. Secondary outcome measures were: increase of the proportion of >3 bowel movements/week and reduction of the proportion of fecal incontinence, straining on defecation, painful defecation, blood in stool, abdominal pain, and decreased laxative doses. Results: On consumption of green banana biomass alone, a statistically significant reduction was observed in the proportion of children with Bristol Stool Form Scale rating 1 or 2, straining on defecation, painful defecation, and abdominal pain. Conversely, no reduction was observed in fecal incontinence episodes/week, blood in stool, and no increase was observed in the proportion of children with >3 bowel movements/week. The percentage of children who required decreased laxative dose was high when green banana biomass was associated with sodium picasulfate (87%), and PEG 3350 with electrolytes (63%). Green banana biomass alone and associated with laxatives was well tolerated, and no adverse effects were reported. Conclusion: Green banana biomass is advantageous as an adjunct therapy on functional constipation, mainly for reducing doses of laxatives. (C) 2017 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda.","[Granado Cassettari, Vanessa Mello] Univ Estadual Paulista UNESP, Fac Med Botucatu, Dept Cirurgia, Botucatu, SP, Brazil; [Machado, Nilton Carlos; Carvalho, Marry Assis] Univ Estadual Paulista UNESP, Fac Med Botucatu, Unidade Gastroenterol Pediat, Botucatu, SP, Brazil; [Toledo de Arruda Lourencao, Pedro Luiz; Paiva Ortolan, Erika Veruska] Univ Estadual Paulista UNESP, Fac Med Botucatu, Dept Cirurgia, Unidade Cirurgia Pediat, Botucatu, SP, Brazil",Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista,"Cassettari, VMG (corresponding author), Univ Estadual Paulista UNESP, Fac Med Botucatu, Dept Cirurgia, Botucatu, SP, Brazil.",vmgranado@gmail.com,"de Arruda Lourenção, Pedro Luiz Toledo/AAH-1896-2021; Ortolan, Erika V P/M-7258-2013","de Arruda Lourenção, Pedro Luiz Toledo/0000-0002-8753-646X; Ortolan, Erika/0000-0002-9697-3450",Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES),Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)),This study was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES).,,23,16,18,2,10,SOC BRASIL PEDIATRIA,"RIO DE JANEIRO, RJ","RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL",0021-7557,1678-4782,,J PEDIAT-BRAZIL,J. Pediatr.,JAN-FEB,2019,95,1,,,,,27,33,,10.1016/j.jped.2017.10.011,http://dx.doi.org/10.1016/j.jped.2017.10.011,,,7,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,HK5SF,29309737,"Green Published, gold",,,2024-06-04,WOS:000458026900005,View Full Record in Web of Science
J,"Sturtzel, B; Mikulits, C; Gisinger, C; Elmadfa, I",,,,"Sturtzel, B.; Mikulits, C.; Gisinger, C.; Elmadfa, I.",,,Use of fiber instead of laxative treatment in a geriatric hospital to improve the wellbeing of seniors,JOURNAL OF NUTRITION HEALTH & AGING,,,English,Article,,,,,,Seniors; laxatives; dietary fiber; weight; eating-habits,CHRONIC CONSTIPATION; OLDER-PEOPLE; MALNUTRITION; MANAGEMENT; NUTRITION; UPDATE; ADULTS; HEALTH; LIFE,"Constipation is a common problem in the elderly population, especially in geriatric wards. Laxatives are the most preferred solution but current studies link constipation and laxative use to weight-loss and malnutrition in nursing homes. Dietary fibers also affect stool weight and transit time. So, oat-bran effectiveness in reducing the need for bowel medication and weight-loss for geriatric care patients was examined in a geriatric hospital. To determine whether the addition of oat-bran to common oral diet can reduce the use of laxatives and improve the wellbeing and bodyweight of the inhabitants of a long-term-care facility. The study was designed as a controlled blind intervention trial among 30 frail inhabitants of a geriatric hospital aged 57-100 years with laxative use. Including criteria were: oral food intake and laxatives as therapy and excluding criteria were: parenteral and enteral feeding, surgeries in the gastro- intestinal tract, drugs that shorten or lengthen the passage through the gut, risk of aspiration, swallowing troubles. An intervention and a control group were formed. 15 of them received 7-8g oat-bran/d for 12 weeks (fiber group) mixed up in the daily common diet of the ward and 15 served as control (control group). Data collection: Bodyweight was taken at baseline, after 6 weeks and at the end of the supplementation. Data on laxative use, stool frequency and the eating habits of the elderly were recorded. Laxatives were successfully discontinued by 59% (p < 0.001) in the fiber-group; in the control-group there was an increase of 8% (p=0,218). Bodyweight remained constant in the fiber-group and decreased in the control-group (p=0,002). The oat-fiber supplementation in the introduced form was well tolerated. Use of oat-fiber allowed discontinuation of laxatives by 59% while improving body-weight and wellbeing of the seniors. Fiber supplementation is a safe and convenient alternative to laxatives in a geriatric hospital.","[Sturtzel, B.; Elmadfa, I.] Univ Vienna, Dept Nutr Sci, A-1090 Vienna, Austria; [Mikulits, C.; Gisinger, C.] Geriatr Hosp, Vienna, Austria",University of Vienna,"Elmadfa, I (corresponding author), Univ Vienna, Dept Nutr Sci, Althanstr 14, A-1090 Vienna, Austria.",ibrahim.elmadfa@univie.ac.at,,,,,,,30,20,24,3,27,SPRINGER FRANCE,PARIS,"22 RUE DE PALESTRO, PARIS, 75002, FRANCE",1279-7707,1760-4788,,J NUTR HEALTH AGING,J. Nutr. Health Aging,FEB,2009,13,2,,,,,136,139,,10.1007/s12603-009-0020-2,http://dx.doi.org/10.1007/s12603-009-0020-2,,,4,Geriatrics & Gerontology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Geriatrics & Gerontology; Nutrition & Dietetics,440NX,19214342,hybrid,,,2024-06-04,WOS:000265708100009,View Full Record in Web of Science
J,"Rijnaarts, I; de Roos, N; Zoetendal, EG; de Wit, N; Witteman, BJM",,,,"Rijnaarts, Iris; de Roos, Nicole; Zoetendal, Erwin G.; de Wit, Nicole; Witteman, Ben J. M.",,,Development and validation of the FiberScreen: A short questionnaire to screen fibre intake in adults,JOURNAL OF HUMAN NUTRITION AND DIETETICS,,,English,Article,,,,,,comparability; dietary fibre; food frequency questionnaire; functional bowel disorders; questionnaire; screening,PORTION SIZE ESTIMATION; WHOLE-GRAIN WHEAT; DIETARY ASSESSMENT; PROMOTING FRUIT; STOOL FREQUENCY; CONSTIPATION; CONSUMPTION; REPRODUCIBILITY; INDIVIDUALS; QUALITY,"Background Health effects of dietary fibres are the topic of many studies. Eligibility criteria often include a certain fibre intake, which requires dietary screening during recruitment. However, dietary assessment methods are extensive and burdensome for both the researcher and participant. Therefore, we developed and validated a short questionnaire (FiberScreen) to screen fibre intake. Methods The initial five-item questionnaire assessed fruit, vegetable, whole grain, pasta/rice/potato and legume intake. The optimised FiberScreen included 18 items, which further specified intake of the above-mentioned categories, and included nuts and seeds. The FiberScreen was completed during two fibre promoting interventions. In Study A, participants without constipation completed the five-item FiberScreen and a food frequency questionnaire (FFQ) during screening (n = 131), and the 18-item FiberScreen and a FFQ at 3-month follow-up (n = 87). In Study B, 29 constipated participants completed the 18-item FiberScreen at screening and a FFQ during the first study visit. Results The fibre estimate from the five-item FiberScreen and the FFQ was moderately correlated (r = 0.356, p < 0.001). Importantly, the 18-item FiberScreen and FFQ, when data of both studies were combined, had a strong correlation (r = 0.563, p < 0.001). The 18-item FiberScreen had a lower fibre estimate compared to the FFQ (Delta = 1.2 +/- 5.9 g, p = 0.030) but the difference was relatively small. Bland-Altman plots showed a good agreement between the questionnaires. Completion time of the 18-item FiberScreen was 4.2 +/- 2 min. Conclusions The 18-item FiberScreen is a suitable short screening questionnaire for ranking the fibre intake of adults. The 18-item FiberScreen can help to reduce screening burden for both the participant and researcher.","[Rijnaarts, Iris; de Roos, Nicole; Witteman, Ben J. M.] Wageningen Univ & Res, Div Human Nutr & Hlth, Wageningen, Netherlands; [Rijnaarts, Iris; Zoetendal, Erwin G.] Wageningen Univ & Res, Lab Microbiol, Wageningen, Netherlands; [Rijnaarts, Iris; de Wit, Nicole] Wageningen Univ & Res, Wageningen Food & Biobased Res, Wageningen, Netherlands; [Witteman, Ben J. M.] Hosp Gelderse Vallei, Dept Gastroenterol & Hepatol, Ede, Netherlands",Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Gelderse Vallei Hospital,"de Wit, N (corresponding author), Wageningen Univ & Res, Food & Biobased Res, Bornse Weilanden 9, NL-6708 WG Wageningen, Netherlands.",nicole.dewit@wur.nl,,"Rijnaarts, Iris/0000-0001-7811-6669; de Roos, Nicole/0000-0002-3655-1678; Witteman, Ben/0000-0002-1341-8540",Public Private Partnership Personalized Nutrition and Health program from the Top consortium for Knowledge and Innovation (TKI) Agri Food [TKI-AF-15262]; Dutch Digestive Disease Foundation,Public Private Partnership Personalized Nutrition and Health program from the Top consortium for Knowledge and Innovation (TKI) Agri Food; Dutch Digestive Disease Foundation,Public Private Partnership Personalized Nutrition and Health program from the Top consortium for Knowledge and Innovation (TKI) Agri & Food (TKI-AF-15262); Dutch Digestive Disease Foundation and associated companies,,56,4,4,0,5,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0952-3871,1365-277X,,J HUM NUTR DIET,J. Hum. Nutr. Diet.,DEC,2021,34,6,,,,,969,980,,10.1111/jhn.12941,http://dx.doi.org/10.1111/jhn.12941,,AUG 2021,12,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,WX8YQ,34378249,"Green Published, hybrid",,,2024-06-04,WOS:000690746500001,View Full Record in Web of Science
J,"Shafiee, NH; Razalli, NH; Mokhtar, NM; Tan, E; Ali, RAR",,,,"Shafiee, Nor Hamizah; Razalli, Nurul Huda; Mokhtar, Norfilza M.; Tan, Eunice; Ali, Raja Affendi Raja",,,An evaluation of dietary adequacy among patients with constipation-predominant irritable bowel syndrome in Malaysia,INTESTINAL RESEARCH,,,English,Article,,,,,,Irritable bowel syndrome; Nutrients; Food; Nutritional requirement,LOW FODMAP DIET; GASTROINTESTINAL SYMPTOMS; GAS-PRODUCTION; MANAGEMENT; FIBER; EPIDEMIOLOGY; PREVALENCE; HABIT; SEX; IBS,"Background/Aims: Substantial proportions of patients with constipation-predominant irritable bowel syndrome (IBS-C) linked their symptoms with particular intake of foods. However, there is lack of current data regarding the intake among IBS-C patients before any dietary interventions. Thus, this study aimed to evaluate the dietary adequacy among IBS-C against the standard recommended nutrient intake (RNI) and healthy controls. Methods: A retrospective case-control study was conducted involving IBS-C patients and healthy control subjects. A validated 126-food items frequency questionnaire was administered to all the subjects to assess their dietary intake, guided by dietitians. The calculated nutrients intake for IBS-C patients was then compared against the standard RNI and healthy controls. Results: A total of 306 subjects were recruited, among which 218 were diagnosed with IBS-C and 88 were included as healthy controls. IBS-C patients had significantly lower intake of wholegrain products, fried foods, dairy products, fruits, and vegetables compared to healthy controls. The daily intake of energy, certain macronutrients, and micronutrients among IBS-C patients was significantly lower than the healthy subjects. Less than 5% of IBS-C patients and healthy subjects achieved the standard recommendation for dietary fiber. Also, various vitamin intake (B-1, B-2, B-6, folate, B-12, E, K, and potassium) among IBS-C patients did not meet the standard RNI. Conclusions: Dietary intakes of IBS-C patients did not meet the recommended intake for Malaysian and showed the nutritional inadequacies compared to the control subjects. Our study highlighted the importance of dietary evaluation prior to planning strategies for dietary intervention targeting IBS-C patients. (Intest Res, Published online)","[Shafiee, Nor Hamizah] Univ Kebangsaan Malaysia, Fac Med, Dept Med, Kuala Lumpur, Malaysia; [Razalli, Nurul Huda] Univ Kebangsaan Malaysia, Fac Hlth Sci, Dietet Programme, Kuala Lumpur, Malaysia; [Razalli, Nurul Huda; Mokhtar, Norfilza M.; Ali, Raja Affendi Raja] Univ Kebangsaan Malaysia, Fac Med, GUT Res Grp, Kuala Lumpur, Malaysia; [Mokhtar, Norfilza M.] Univ Kebangsaan Malaysia, Fac Med, Dept Physiol, Kuala Lumpur, Malaysia; [Tan, Eunice; Ali, Raja Affendi Raja] UKM Med Ctr, Dept Med, Gastroenterol Unit, Kuala Lumpur, Malaysia",Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia,"Ali, RAR (corresponding author), Univ Kebangsaan Malaysia, UKM Med Ctr, Dept Med, Gastroenterol Unit, Jalan Yaacob Latif, Kuala Lumpur 56000, Malaysia.",draffendi@ppukm.ukm.edu.my,"Mokhtar, Norfilza Mohd/AAK-8196-2020; Raja Ali, Raja Affendi/AAK-1564-2020","Mokhtar, Norfilza Mohd/0000-0002-4863-100X; Raja Ali, Raja Affendi/0000-0003-4995-3868; Tan, Eunice/0000-0001-6194-7933; Razalli, Nurul Huda/0000-0002-1569-8718; Shafiee, Nor Hamizah/0000-0002-5233-1384",,,,,48,7,7,0,2,KOREAN ASSOC STUDY INTESTINAL DISEASES,SEOUL,"LOTTEGOLDROSE 2-F, RM 305, 890-59, DAECHI-DONG, GANGNAM-GU, SEOUL, 135-280, SOUTH KOREA",1598-9100,,,INTEST RES,Intest. Res.,JAN,2022,20,1,,,,,124,133,,10.5217/ir.2020.00050,http://dx.doi.org/10.5217/ir.2020.00050,,JAN 2021,10,Gastroenterology & Hepatology,Emerging Sources Citation Index (ESCI),Gastroenterology & Hepatology,YU0OQ,33472341,"gold, Green Published",,,2024-06-04,WOS:000702852600001,View Full Record in Web of Science
J,"Steels, E; Erhardt, R; Harnett, JE; Vigar, V; Steadman, KJ",,,,"Steels, Elizabeth; Erhardt, Rene; Harnett, Joanna E.; Vigar, Vanessa; Steadman, Kathryn J.",,,Efficacy of a prebiotic formulation for treatment of functional constipation and associated gastrointestinal symptoms in adults: A randomised controlled trial,ADVANCES IN INTEGRATIVE MEDICINE,,,English,Article,,,,,,Prebiotic; Polyphenols; Constipation; PAC-SYM; PAC-QoL,HYDROLYZED GUAR GUM; OF-LIFE QUESTIONNAIRE; PATIENT ASSESSMENT; CLINICAL-TRIAL; TRANSIT; INULIN; FIBER; SUPPLEMENTATION; METAANALYSIS; ANTIOXIDANT,"Objectives: Functional constipation is the result of a complex interplay between the gastrointestinal tract, the gut microbiome, the nervous system, along with diet and lifestyle factors. This study aimed to evaluate the efficacy of a prebiotic formulation containing plant-based extracts rich in dietary fibre and polyphenols in the management of functional constipation and associated gastrointestinal symptoms.Design: This 3-week randomised controlled study assessed the effect of a prebiotic formulation (6 g powder taken in water twice daily), by comparison with a capsule designed to have minimal effect on gastrointestinal function, on indicators of bowel health in healthy adults with low fibre intake and meeting the Rome IV criteria for functional constipation.Methods: Participants were informed that they may receive one of two products, either a powder or a capsule, both of which contained prebiotics. The primary outcome was change in frequency of complete spontaneous bowel movements. Secondary outcomes assessed were gastrointestinal symptoms, quality of life and mood using the PAC-SYM, PAC-QoL, and DASS-21. Safety and tolerability were also assessed.Results: There was a significant improvement in bowel movements (p < 0.001) and improved stool consistency (p < 0.01) in participants taking the prebiotic powder formulation compared to those taking the capsule. Accompanying this was a significant reduction in overall gastrointestinal symptoms (p < 0.001) including abdominal (p < 0.001), rectal (p = 0.004) and stool (p = 0.002) symptoms, and a significant improvement in quality of life (p 0.001). There was a significant reduction in mean score for depression, anxiety, and stress for participants in both groups, which indicated a significant improvement in mood during the study that was un-related to bowel function.Conclusions: The results showed that the prebiotic powder formulation taken twice per day for 21 days was effective in reducing clinical symptoms of functional constipation in individuals reporting a low fibre intake.","[Steels, Elizabeth; Erhardt, Rene; Steadman, Kathryn J.] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia; [Steels, Elizabeth] Evidence Sci, New Farm, Qld, Australia; [Harnett, Joanna E.] Univ Sydney, Fac Med & Hlth, Sch Pharm, Sydney, NSW, Australia; [Vigar, Vanessa] Integria Healthcare, Eight Mile Plains, Qld, Australia",University of Queensland; University of Sydney,"Steels, E (corresponding author), Univ Queensland, Sch Pharm, Brisbane, Qld, Australia.;Steels, E (corresponding author), Evidence Sci, New Farm, Qld, Australia.",e.steels@uq.edu.au,"Steels, Elizabeth L/B-9366-2012; Harnett, Joanna E/L-1214-2018; Steadman, Kathryn/C-3401-2008","Harnett, Joanna E/0000-0001-9904-2144; Steadman, Kathryn/0000-0001-7357-330X; Erhardt, Rene/0000-0002-1961-135X",,,,,57,1,1,4,9,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",2212-9588,2212-9596,,ADV INTEGR MED,Adv. Integr. Med.,MAY,2023,10,2,,,,,43,50,,10.1016/j.aimed.2023.05.001,http://dx.doi.org/10.1016/j.aimed.2023.05.001,,JUN 2023,8,Integrative & Complementary Medicine,Emerging Sources Citation Index (ESCI),Integrative & Complementary Medicine,K7KR2,,hybrid,,,2024-06-04,WOS:001018196200001,View Full Record in Web of Science
J,"Min, YW; Park, SU; Jang, YS; Kim, YH; Rhee, PL; Ko, SH; Joo, N; Kim, SI; Kim, CH; Chang, DK",,,,"Min, Yang Won; Park, Sang Un; Jang, Yeon Sil; Kim, Young-Ho; Rhee, Poong-Lyul; Ko, Seo Hyun; Joo, Nami; Kim, Sun Im; Kim, Cheol-Hyun; Chang, Dong Kyung",,,Effect of composite yogurt enriched with acacia fiber and Bifidobacterium lactic,WORLD JOURNAL OF GASTROENTEROLOGY,,,English,Article,,,,,,Acacia dietary fiber; Bifidobacterium lactis; Irritable bowel syndrome; Probiotics; Yogurt,IRRITABLE-BOWEL-SYNDROME; FUNCTIONAL GASTROINTESTINAL DISORDERS; QUALITY-OF-LIFE; FERMENTED MILK; DOUBLE-BLIND; CONTROLLED-TRIAL; COLONIC TRANSIT; DIETARY FIBER; DN-173 010; PROBIOTICS,"AIM: To investigate whether composite yogurt with acacia dietary fiber and Bifidobacterium lactis (B. lactis) has additive effects in irritable bowel syndrome (IBS). METHODS: A total of 130 patients were randomly allocated to consume, twice daily for 8 wk, either the composite yogurt or the control product. The composite yogurt contained acacia dietary fiber and high-dose B. lactis together with two classic yogurt starter cultures. Patients were evaluated using the visual analog scale via a structured questionnaire administered at baseline and after treatment. RESULTS: Improvements in bowel habit satisfaction and overall IBS symptoms from baseline were significantly higher in the test group than in the control group (27.16 vs 15.51, P = 0.010, 64.2 +/- 17.0 vs 50.4 +/- 20.5, P < 0.001; respectively). In constipation-predominant IBS, improvement in overall IBS symptoms was significantly higher in the test group than in the control group (72.4 +/- 18.4 vs 50.0 +/- 21.8, P < 0.001). In patients with diarrhea-predominant IBS, improvement in bowel habit satisfaction from baseline was significantly higher in the test group than in the control group (32.90 vs 7.81, P = 0.006). CONCLUSION: Our data suggest that composite yogurt enriched with acacia fiber and B. lactis has greater therapeutic effects in patients with IBS than standard yogurt. (C) 2012 Baishideng. All rights reserved.","[Min, Yang Won; Park, Sang Un; Jang, Yeon Sil; Kim, Young-Ho; Rhee, Poong-Lyul; Chang, Dong Kyung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Gastroenterol, Seoul 135710, South Korea; [Ko, Seo Hyun; Joo, Nami; Kim, Sun Im] Sookmyung Womens Univ, Dept Food & Nutr, Seoul 140742, South Korea; [Kim, Cheol-Hyun] Dankook Univ, Dept Anim Resource & Sci, Cheonan 330714, South Korea",Sungkyunkwan University (SKKU); Samsung Medical Center; Sookmyung Women's University; Dankook University,"Chang, DK (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Gastroenterol, 50 Irwon Dong, Seoul 135710, South Korea.",dkchang@skku.edu,"Rhee, Poong Lyul/C-9655-2011; min, yang/KEJ-2761-2024","Rhee, Poong-Lyul/0000-0003-0495-5296",Seoul Research and Business Development Program [10582]; Namyang Dairy Product Co. Ltd,Seoul Research and Business Development Program(Seoul RBD program); Namyang Dairy Product Co. Ltd,"Supported by The Seoul Research and Business Development Program, No. 10582; Namyang Dairy Product Co. Ltd, which produced and provided the test and control yogurts for this study",,36,44,46,4,34,BAISHIDENG PUBL GRP CO LTD,BEIJING,"RM 903, BLDG D, OCEAN INTERNATIONAL CTR, NO 62 DONGSIHUAN ZHONGLU, BEIJING, CHAOYANG DISTRICT 100025, PEOPLES R CHINA",1007-9327,,,WORLD J GASTROENTERO,World J. Gastroenterol.,SEP 7,2012,18,33,,,,,4563,4569,,10.3748/wjg.v18.i33.4563,http://dx.doi.org/10.3748/wjg.v18.i33.4563,,,7,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,005WA,22969230,"Green Published, hybrid",,,2024-06-04,WOS:000308779600016,View Full Record in Web of Science
J,"White, N",,,,"White, Nicole",,,A Guide to Recommending Fiber Supplements for Self-Care,AMERICAN JOURNAL OF LIFESTYLE MEDICINE,,,English,Review,,,,,,fiber; cardiovascular disease; diabetes; weight loss; constipation,LDL-CHOLESTEROL; PSYLLIUM; HEALTH,"The health benefits of dietary fiber are extensive and wide-ranging, yet most Americans do not consume the recommended amount of fiber from their diet. Fiber supplements may be used as a means to augment a low-fiber diet. But which, if any, of the benefits of dietary fiber are achieved through supplementation? And are all fiber supplements equally effective? An evidence-based approach to recommending fiber supplements for self-care will be discussed.","[White, Nicole] Creighton Univ, Sch Pharm & Hlth Profess, 2500 Calif Plaza, Omaha, NE 68178 USA",Creighton University,"White, N (corresponding author), Creighton Univ, Sch Pharm & Hlth Profess, 2500 Calif Plaza, Omaha, NE 68178 USA.",nicolewhite@creighton.edu,,,,,,,16,1,2,0,7,SAGE PUBLICATIONS INC,THOUSAND OAKS,"2455 TELLER RD, THOUSAND OAKS, CA 91320 USA",1559-8276,1559-8284,,AM J LIFESTYLE MED,Am. J. Lifestyle Med.,NOV,2020,14,6,,,,,589,591,1.55983E+15,10.1177/1559827620947375,http://dx.doi.org/10.1177/1559827620947375,,AUG 2020,3,"Public, Environmental & Occupational Health",Emerging Sources Citation Index (ESCI),"Public, Environmental & Occupational Health",OA1NB,33117099,Green Published,,,2024-06-04,WOS:000561804300001,View Full Record in Web of Science
J,"Paknejad, MS; Motaharifard, MS; Barimani, S; Kabiri, P; Karimi, M",,,,"Paknejad, Maryam Sadat; Motaharifard, Monireh Sadat; Barimani, Shandis; Kabiri, Payam; Karimi, Mehrdad",,,"Traditional, complementary and alternative medicine in children constipation: a systematic review",DARU-JOURNAL OF PHARMACEUTICAL SCIENCES,,,English,Review,,,,,,Complementary therapies; Alternative medicine; Traditional medicine; CAM; Constipation; Pediatrics,DAI-KENCHU-TO; FUNCTIONAL CONSTIPATION; CHILDHOOD CONSTIPATION; DIETARY FIBER; CEREBRAL-PALSY; HEALTH; EPIDEMIOLOGY; GLUCOMANNAN; SUPPLEMENT; LACTULOSE,"Objectives This review aims to evaluate the efficacy and safety of complementary and alternative medicine methods for constipation in the pediatric population. Evidence acquisition Medical literature search was performed in several databases for a variety of Traditional, Complementary and Alternative Medicine in childhood constipation. Databases included Web of Science, Scopus, Embase, Cochrane Library, PubMed, ScienceDirect, Google scholar and a number of Persian databases including IranDoc, Magiran and SID. No time limitation was determined. Clinical trials or case series that had evaluated the effectiveness of CAM therapies in functional constipation of 1-18 year old children were included. Papers not in English or Persian language were excluded. Related articles were screened independently by two reviewers according to their titles and abstracts. A data extraction form was filled in for each eligible paper. Quality assessment of eligible documents was also performed. Results 30 studies were included, comprising 27 clinical trials and 3 case series. Ten documents were on herbal medicine, nine on traditional medicine, ten on manual therapies and one on homeopathy. Except for two herbal and one reflexology interventions, all studies reported positive effects on childhood constipation, with the majority being statistically significant. As the number of studies in each method was limited, we could not perform a meta-analysis. Conclusion The scarcity of research on the efficacy and safety of different types of complementary and alternative medicine methods in children with constipation necessitates conducting more studies in each field.","[Paknejad, Maryam Sadat; Motaharifard, Monireh Sadat; Karimi, Mehrdad] Univ Tehran Med Sci, Sch Tradit Med, Bldg Ahmadiyeh 27,Sarparast Shomali Str, Tehran 1416663361, Iran; [Barimani, Shandis] Shiraz Univ Med Sci, Dept Persian Med, Shiraz, Iran; [Kabiri, Payam] Univ Tehran Med Sci, Dept Biostat & Epidemiol, Sch Publ Hlth, Tehran, Iran",Tehran University of Medical Sciences; Shiraz University of Medical Science; Tehran University of Medical Sciences,"Karimi, M (corresponding author), Univ Tehran Med Sci, Sch Tradit Med, Bldg Ahmadiyeh 27,Sarparast Shomali Str, Tehran 1416663361, Iran.",neurointmed@gmail.com; monirehmotahari@yahoo.com; sbarimani@yahoo.com; kabiri@sina.tums.ac.ir; mehrdadkarimi@yahoo.com,"Kabiri, Payam/A-6195-2011; karimi, mehrdad/R-7149-2019","Kabiri, Payam/0000-0002-7634-370X; Paknejad, Maryam Sadat/0000-0002-6588-3444; karimi, mehrdad/0000-0001-5395-819X",,,,,72,15,17,2,18,SPRINGER INTERNATIONAL PUBLISHING AG,CHAM,"GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND",,2008-2231,,DARU,DARU,DEC,2019,27,2,,,,,811,826,,10.1007/s40199-019-00297-w,http://dx.doi.org/10.1007/s40199-019-00297-w,,,16,Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy,KI5PD,31734825,Green Published,,,2024-06-04,WOS:000511401100024,View Full Record in Web of Science
J,"Simons, CCJM; Schouten, LJ; Weijenberg, MP; Goldbohm, RA; van den Brandt, PA",,,,"Simons, Colinda C. J. M.; Schouten, Leo J.; Weijenberg, Matty P.; Goldbohm, R. Alexandra; van den Brandt, Piet A.",,,Bowel Movement and Constipation Frequencies and the Risk of Colorectal Cancer Among Men in the Netherlands Cohort Study on Diet and Cancer,AMERICAN JOURNAL OF EPIDEMIOLOGY,,,English,Article,,,,,,cohort studies; colonic neoplasms; constipation; defecation; rectal neoplasms,ABERRANT CRYPT FOCI; POLYUNSATURATED FATTY-ACIDS; SCALE PROSPECTIVE COHORT; COLON-CANCER; LAXATIVE USE; GASTROINTESTINAL-TRACT; ANTHRANOID LAXATIVES; MALIGNANT-TUMORS; SENNA EXTRACT; STORAGE ORGAN,"The authors investigated the associations between bowel movement and constipation frequencies and colorectal cancer (CRC) endpoints among men in the Netherlands Cohort Study on Diet and Cancer (n = 58,279) and explored whether dietary fiber intake may modify associations. After 13.3 years (1986-1999), 1,207 CRC cases and 1,753 subcohort members were available for case-cohort analyses. Multivariate analyses showed a significantly increased hazard ratio for CRC overall and rectal cancer in men who reported having a bowel movement 1-2 times per day (second-highest category) as compared with once a day (CRC: hazard ratio (HR) = 1.29, 95% confidence interval (CI): 1.09, 1.53 (P(trend) < 0.001); rectal cancer: HR = 1.50, 95% CI: 1.15, 1.95 (P(trend) = 0.001)). Hazard ratios for CRC overall and rectal cancer were significantly decreased and lowest in men who reported suffering from constipation sometimes or more often versus never (CRC: HR = 0.76, 95% CI: 0.58, 0.98 (P(trend) = 0.02); rectal cancer: HR = 0.57, 95% CI: 0.35, 0.90 (P(trend) = 0.01)). No trends in the associations with proximal or distal colon cancer risk were observed. Interactions with dietary fiber intake were not significant. In this study, frequent bowel movements were associated with an increased risk of rectal cancer in men, and constipation was associated with a decreased risk.","[Simons, Colinda C. J. M.] Maastricht Univ, Dept Epidemiol, Fac Hlth Med & Life Sci, GROW Sch Oncol & Dev Biol, NL-6200 MD Maastricht, Netherlands; [Goldbohm, R. Alexandra] Netherlands Org Appl Sci Res, Dept Prevent & Hlth, TNO Qual Life, Leiden, Netherlands",Maastricht University; Netherlands Organization Applied Science Research,"Simons, CCJM (corresponding author), Maastricht Univ, Dept Epidemiol, Fac Hlth Med & Life Sci, GROW Sch Oncol & Dev Biol, POB 616, NL-6200 MD Maastricht, Netherlands.",colinda.simons@epid.unimaas.nl,"Schouten, Leo J/G-3713-2012","Schouten, Leo/0000-0003-3361-7560; van den Brandt, Piet/0000-0001-8781-8099",Dutch Cancer Society,Dutch Cancer Society(KWF Kankerbestrijding),The Netherlands Cohort Study on Diet and Cancer was funded by the Dutch Cancer Society.,,47,27,30,0,13,OXFORD UNIV PRESS INC,CARY,"JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA",0002-9262,,,AM J EPIDEMIOL,Am. J. Epidemiol.,DEC 15,2010,172,12,,,,,1404,1414,,10.1093/aje/kwq307,http://dx.doi.org/10.1093/aje/kwq307,,,11,"Public, Environmental & Occupational Health",Science Citation Index Expanded (SCI-EXPANDED),"Public, Environmental & Occupational Health",692ZA,20980354,"Green Published, Bronze",,,2024-06-04,WOS:000285193200011,View Full Record in Web of Science
J,"Thorsteinsdottir, F; Campbell, KJ; Heitmann, BL; Zheng, MB",,,,"Thorsteinsdottir, Fanney; Campbell, Karen J.; Heitmann, Berit L.; Zheng, Miaobing",,,Longitudinal Trajectories of Dietary Fibre Intake and Its Determinants in Early Childhood: Results from the Melbourne InFANT Program,NUTRIENTS,,,English,Article,,,,,,fibre intake; trajectory; determinants; obesity,PRESCHOOL-CHILDREN; CONSTIPATION; NUTRITION; HEALTH; OBESITY,"Background: Optimal nutrition during early childhood, including dietary fibre intake, is important for children's health and development. Knowledge of fibre intake and its determinants in early childhood is limited. We aimed to describe fibre intake and sources and to identify trajectories of fibre intake at age 9, 18, 42, and 60 months and its child and maternal determinants. Associations between fibre trajectory groups and BMI z-scores and child overweight status were also assessed. Methods: This is a secondary analysis of longitudinal data from the Melbourne InFANT Program, trial registration: Current Controlled Trials (ISRCTN81847050). Group-based trajectory modelling was used to identify trajectories of fibre intake from ages 9 to 60 months (n = 503). Multivariable logistic or linear regression was used to assess the determinants of fibre intake trajectories and the association between fibre intake trajectories and obesity outcomes. Results: Four fibre intake trajectory groups were identified, with three groups following stable, rising trajectories of Low (52.3%), Moderate (32.2%), and High (13.3%), respectively. The remaining followed an unstable trajectory (2.2%). Girls versus boys were more likely to follow the Low fibre intake trajectory, whereas children who were breastfed for >= 6 months and whose mother had a university education were less likely to follow the Low fibre trajectory. No association was found between fibre trajectory groups and obesity outcomes. Conclusion: Most children followed a stable, rising trajectory of low fibre intake in early childhood. Child sex, breastfeeding duration and maternal education were significant determinants of low fibre intake trajectory.","[Thorsteinsdottir, Fanney; Heitmann, Berit L.] Bispebjerg & Frederiksberg Hosp, Parker Inst, Res Unit Dietary Studies, DK-2000 Frederiksberg, Denmark; [Campbell, Karen J.; Zheng, Miaobing] Deakin Univ, Inst Phys Act & Nutr IPAN, Sch Exercise & Nutr Sci, Geelong, Vic 3220, Australia; [Heitmann, Berit L.] Univ Sydney, Fac Med & Hlth, Boden Grp, Sydney, NSW 2006, Australia; [Heitmann, Berit L.] Univ Copenhagen, Dept Publ Hlth, Sect Gen Med, DK-1353 Copenhagen, Denmark",University of Copenhagen; Bispebjerg Hospital; Deakin University; University of Sydney; University of Copenhagen,"Thorsteinsdottir, F (corresponding author), Bispebjerg & Frederiksberg Hosp, Parker Inst, Res Unit Dietary Studies, DK-2000 Frederiksberg, Denmark.",fanney.thorsteinsdottir@regionh.dk; aren.campbell@deakin.edu.au; berit.lilienthal.heitmann@regionh.dk; j.zheng@deakin.edu.au,"Heitmann, Berit Lilienthal/JBJ-6043-2023; Thorsteinsdottir, Fanney/AAR-6112-2021","Heitmann, Berit Lilienthal/0000-0002-6809-4504; Thorsteinsdottir, Fanney/0000-0002-3070-782X",,,,,36,1,1,2,2,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,APR,2023,15,8,,,,,,,1932,10.3390/nu15081932,http://dx.doi.org/10.3390/nu15081932,,,13,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,E7OU9,37111151,"gold, Green Published",,,2024-06-04,WOS:000977402600001,View Full Record in Web of Science
J,"Mulhem, E; Khondoker, F; Kandiah, S",,,,"Mulhem, Elie; Khondoker, Faiza; Kandiah, Sanjiv",,,Constipation in Children and Adolescents: Evaluation and Treatment,AMERICAN FAMILY PHYSICIAN,,,English,Article,,,,,,,FUNCTIONAL GASTROINTESTINAL DISORDERS; CHILDHOOD CONSTIPATION; MANAGEMENT; INFANTS,"Constipation in children is usually functional constipation without an organic cause. Organic causes of constipation in children, which include Hirschsprung disease, cystic fibrosis, and spinal cord abnormalities, commonly present with red flag signs and symptoms. A history and physical examination can diagnose functional constipation using the Rome IV diagnostic criteria. The first goal of managing constipation is to treat fecal impaction, and then maintenance therapy is used to prevent a recurrence. Polyethylene glycol is the first-line treatment for constipation. Second-line options include lactulose and enemas. Increasing dietary fiber and fluid intake above usual daily recommendations and adding probiotics provide no additional benefits for treating constipation. Frequent follow-up visits and referrals to a psychologist can assist in reaching some treatment goals. Clinicians should educate caregivers about the chronic course of functional constipation, frequent relapses, and the potential for prolonged therapy. Clinicians should acknowledge caregivers' specific challenges and the negative effects of constipation on the child's quality of life. Referral to a pediatric gastroenterologist is recommended when there is a concern for organic causes or constipation persists despite adequate therapy. Copyright (C) 2022 American Academy of Family Physicians.","[Mulhem, Elie] Oakland Univ, William Beaumont Sch Med, Dept Family Med & Community Hlth, Rochester, MI 48063 USA; [Khondoker, Faiza; Kandiah, Sanjiv] Beaumont Hosp, Troy, MI USA",Oakland University; Beaumont Health,"Mulhem, E (corresponding author), Oakland Univ, William Beaumont Sch Med, 44250 Dequindre Rd, Sterling Hts, MI 48314 USA.",,,,,,,,39,3,3,1,4,AMER ACAD FAMILY PHYSICIANS,KANSAS CITY,"8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797 USA",0002-838X,1532-0650,,AM FAM PHYSICIAN,Am. Fam. Physician,MAY,2022,105,5,,,,,469,478,,,,,,10,"Primary Health Care; Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,1H6SM,35559625,,,,2024-06-04,WOS:000796671200005,View Full Record in Web of Science
J,"Sharma, V; Chawla, P",,,,"Sharma, Vidisha; Chawla, Paramjit",,,Development and Nutrient Evaluation of Oat Supplemented Products for Old Aged People with Constipation,STUDIES ON ETHNO-MEDICINE,,,English,Article,,,,,,Oat Supplemented Products; Proximate Composition; Fibre Fractions,,"Constipation refers to bowel movements that are infrequent. Severe constipation includes obstipation and faecal impaction found very commonly in old aged. The First step to treat constipation is by increasing the intake of dietary fibre. Oats can be supplemented in a normal carbohydrate meal without the loss of taste, palatability Supplementary product samples of sweet dalia, salty dalia and khichdi were prepared using broken wheat and rice as control while for test samples broken wheat for both sweet and salty dalia and rice were supplemented with oats at 20 percent, 25 percent and 30 percent levels. The control and the most acceptable level of oat supplementation in the products were analysed for proximate composition (moisture, crude protein, crude fat, crude fibre, total ash) carbohydrates and energy were calculated. Fibre fractions namely NDF,ADF and lignin were also estimated. Taste of salty dalia, supplemented with 25 percent scored the best score of 8.0 while all the sensory parameters of sweet dalia supplemented with oats at same percentage had the highest scores. Addition of oats at 25 percent level in sweet/salty dalia and khichdi increased the moisture, crude protein and crude fibre value. While the fibre fractions of NDF, ADF and lignin also increased in the supplemented products.","[Sharma, Vidisha; Chawla, Paramjit] PAU, Dept Food & Nutr, Ludhiana, Punjab, India",Punjab Agricultural University,"Sharma, V (corresponding author), PAU, Dept Food & Nutr, Ludhiana, Punjab, India.",,,,,,,,12,2,3,3,12,KAMLA-RAJ ENTERPRISES,DELHI,"2273, GALI BARI PAHARWALI, CHAWRI BAZAR, DELHI, 00000, INDIA",0973-5070,,,STUD ETHNO-MED,Stud. Ethno-Med.,DEC,2011,5,3,,,,,161,164,,10.1080/09735070.2011.11886404,http://dx.doi.org/10.1080/09735070.2011.11886404,,,4,Anthropology,Social Science Citation Index (SSCI),Anthropology,875JU,,,,,2024-06-04,WOS:000299027000003,View Full Record in Web of Science
J,"Oh, SM; Hosseindoust, A; Ha, SH; Mun, JY; Moturi, J; Tajudeen, H; Choi, YH; Lee, SH; Kim, JS",,,,"Oh, Seung Min; Hosseindoust, Abdolreza; Ha, Sang Hun; Mun, Jun Young; Moturi, Joseph; Tajudeen, Habeeb; Choi, Yo Han; Lee, Su Hyup; Kim, Jin Soo",,,Importance of dietary supplementation of soluble and insoluble fibers to sows subjected to high ambient temperatures during late gestation and effects on lactation performance,ANIMAL NUTRITION,,,English,Article,,,,,,Soluble fiber; Insoluble fiber; Beet pulp; Wheat bran; Palm kernel; Metabolites,HIGH NUTRIENT DIETS; REPRODUCTIVE-PERFORMANCE; HEAT-STRESS; LITTER PERFORMANCE; CORTISOL; DURATION; BEHAVIOR,"Heat stress adversely affects sows' performance, which can be improved by applying proper nutritional strategies. This study was conducted to investigate the interactive effects of dietary fiber levels and sources on sows' reproductive performance, metabolic response during gestation, and the carry-over influence on litter performance in the lactation period during heat stress (average room temperature of 27.1 degrees C). Fifty-four multiparous sows (Landrace x Yorkshire; initial body weight of 236.3 +/- 16 kg; 2, 3 and 4 parities) at d 90 of gestation were assigned to a 2 x 3 factorial arrangement (9 sows/treatment), involving 2 dietary fiber levels (4.5% and 6% crude fiber) and 3 dietary fiber sources (wheat bran [WB], palm kernel meal [PK], and beet pulp [BP]). Sows fed the BP diet had highest (P < 0.01) feed intake and constipation index and lowest (P < 0.01) farrowing duration. Piglet weight (P = 0.041) and litter weight (P < 0.01) at weaning were higher in sows in the BP treatment compared to PK treatment. Sows in the BP treatment showed the greatest (P < 0.01) digestibility of crude protein and neutral detergent fiber. The fecal concentration of acetate was the lowest (P < 0.01) in the PK treatment. Total short -chain fatty acid production was increased in the WB and BP treatments compared with the PK. Sows in the BP treatment showed the lowest (P = 0.036) hair cortisol. The blood insulin concentration of sows was higher (P = 0.026) in the high fiber (6%) treatment compared with the low fiber (4.5%) treatment at 90 min and 120 min after the meal. The concentration of phthalic acid, succinic acid, phenylethylamine, hydrocinnamic acid, iron, linoleic acid, glycerol, ketone, and formamide were increased (P < 0.05) in the BP treatment compared with the WB. The BP treatment with high soluble fiber content improved the constipation index, farrowing duration, and litter performance, while high insoluble fibers increased sows comfort and reduced stress factors including respiratory rate and rectal temperature. Therefore, both soluble and insoluble sources of fiber are necessary to be added to the diet of gestating sows. (c) 2024 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).","[Oh, Seung Min] Gyeongbuk Livestock Res Inst, Yeongju 63052, South Korea; [Hosseindoust, Abdolreza; Ha, Sang Hun; Mun, Jun Young; Moturi, Joseph; Tajudeen, Habeeb; Kim, Jin Soo] Kangwon Natl Univ, Dept Anim Ind Convergence, Chunchon 24341, South Korea; [Choi, Yo Han] Natl Inst Anim Sci, Swine Div, Rural Dev Adm, Cheonan 31000, South Korea; [Lee, Su Hyup] Korea Natl Coll Agr & Fisheries, Dept Swine Sci, Jeonju 54874, South Korea","Kangwon National University; Rural Development Administration (RDA), Republic of Korea; National Institute of Animal Science, Republic of Korea","Kim, JS (corresponding author), Kangwon Natl Univ, Dept Anim Ind Convergence, Chunchon 24341, South Korea.",kjs896@kangwon.ac.kr,,"Kim, Jinsoo/0000-0002-9518-7917","Rural Development Administra- tion, Republic of Korea [PJ01479601]","Rural Development Administra- tion, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)","The project was supported by Rural Development Administra- tion, Republic of Korea (Grant No. PJ01479601) .",,49,0,0,25,25,KEAI PUBLISHING LTD,BEIJING,"16 DONGHUANGCHENGGEN NORTH ST, Building 5, Room 411, BEIJING, DONGCHENG DISTRICT 100009, PEOPLES R CHINA",2405-6383,2405-6545,,ANIM NUTR,Anim. Nutr.,MAR,2024,16,,,,,,73,83,,10.1016/j.aninu.2023.10.004,http://dx.doi.org/10.1016/j.aninu.2023.10.004,,,11,"Agriculture, Dairy & Animal Science; Veterinary Sciences",Science Citation Index Expanded (SCI-EXPANDED),Agriculture; Veterinary Sciences,JU3O9,38333572,gold,,,2024-06-04,WOS:001175639300001,View Full Record in Web of Science
J,"Taha, F",,,,"Taha, Faiza",,,"Effectiveness of Health Awareness Module on Pregnant Women's Perception on and Experience of Constipation at Saad Abu Alela - University Hospital, 2017",SUDAN JOURNAL OF MEDICAL SCIENCES,,,English,Article,,,,,,constipation; health awareness; pregnancy,PREVALENCE; SYMPTOMS,"Background: Pregnancy predisposes women to developing constipation, and hormonal and mechanical factors, sedentary lifestyle, and alteration of diet augments the condition, leading to discomforts experienced by pregnant women. However, this can be controlled through proper education and lifestyle modification. The present study aims to check the effect of health awareness education module on the reduction of constipation among pregnant women.Methods: A quasi-experimental study design was used. One hundred and twenty-five pregnant women were randomly selected from Saad Abu Alela Hospital between January and March 2017), and based on the ROME II criteria, 59 of them were found to have constipation. After obtaining consent from the women, health awareness module (information about constipation, dietary measures, increased fluid intake, and exercise) was offered to them. Data were collected by structured close-ended questionnaire for the knowledge, pre-and post-intervention, and checklists for the practice and follow-up of the weekly outcome over two months. Data were analyzed, and suitable statistical methods was used. P < 0.05 was considered as statistically significant.Results: The overall prevalence of constipation was 47.2% with a prevalence of 4%, 6.4%, and 36.8% in the first, second, and third trimesters of pregnancy, respectively. Pregnant women's knowledge about constipation increased significantly from 16.9% pre-to 92.9 post-intervention with P = 0.000. The fiber diet intake, fluid intake, and exercise by pregnant women increased from 37.3%, 39%, and 13.6% pre-to 72.9%, 88.1%, and 49.1% post-intervention, respectively) with P = 0.001. Moreover, 46 (78%) women were relieved of constipation post-intervention.Conclusion: The health awareness module was very effective and significantly increased the level of knowledge, practice, and outcomes with respect to constipation in pregnant women.","[Taha, Faiza] Univ Khartoum, Nursing Fac Nursing Sci, Dept Obstet & Gynecol, Khartoum, Sudan",University of Khartoum,"Taha, F (corresponding author), Univ Khartoum, Nursing Fac Nursing Sci, Dept Obstet & Gynecol, Khartoum, Sudan.",fanasr@uofk.edu,"tacchella, giulia/JMC-4431-2023",,,,,,22,0,0,1,3,KNOWLEDGE E,DUBAI,"OFF 4401, JUMEIRAH BAY X2 TOWER, JUMEIRAH LAKES TOWERS JLT, PO BOX 488239, DUBAI, 00000, U ARAB EMIRATES",,1858-5051,,SUDAN J MED SCI,Sudan J. Med. Sci.,,2022,17,3,,,,,292,302,,10.18502/sjms.v17i3.12079,http://dx.doi.org/10.18502/sjms.v17i3.12079,,,11,"Medicine, General & Internal",Emerging Sources Citation Index (ESCI),General & Internal Medicine,5E0PF,,gold,,,2024-06-04,WOS:000865332600002,View Full Record in Web of Science
J,"Proesmans, M; De Boeck, K",,,,"Proesmans, M; De Boeck, K",,,Evaluation of dietary fiber intake in Belgian children with cystic fibrosis: Is there a link with gastrointestinal complaints?,JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION,,,English,Article,,,,,,cystic fibrosis; distal intestinal obstruction syndrome; fiber intake,,"Background: Pancreatic enzyme replacement is the cornerstone of treating pancreatic insufficiency in patients with cystic fibrosis. Additionally, a high-calorie/high-fat diet is required to compensate for the increased energy requirement and the incomplete fat digestion. Even with adequate enzyme treatment, gastrointestinal problems, varying from simple constipation to inspissated stools, and distal intestinal obstruction syndrome (DIOS) may occur. Apart from residual fat malabsorption, a low fiber intake is suspected to be an underlying factor in gastrointestinal complaints. Methods: We evaluated fiber intake in 40 patients with cystic fibrosis based on the dietary history method. Patients were classified according to gastrointestinal problems: group 1, no gastrointestinal complaints; group 2, nonspecific and mild gastrointestinal complaints; and group 3, documented DIOS. Results: Overall fiber intake was adequate when compared with current recommendations. We could not show a relation between fiber intake and gastrointestinal complaints or DIOS. On the contrary, in patients with DIOS, fiber intake was higher, possibly as a therapeutic response to their gastrointestinal complaints. Conclusion: Overall fiber intake is adequate in our cystic fibrosis population. We could show no relation between low fiber intake and gastrointestinal problems in our patients with cystic fibrosis. (C) 2002 Lippincott Williams Wilkins, Inc.","Katholieke Univ Leuven Hosp, Dept Pediat Pulmonol, B-3000 Louvain, Belgium",Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven,"Katholieke Univ Leuven Hosp, Dept Pediat Pulmonol, Herestr 49, B-3000 Louvain, Belgium.",marijke.proesmans@uz.kuleuven.ac.de,,,,,,,19,19,20,0,2,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0277-2116,1536-4801,,J PEDIATR GASTR NUTR,J. Pediatr. Gastroenterol. Nutr.,NOV,2002,35,5,,,,,610,614,,10.1097/00005176-200211000-00004,http://dx.doi.org/10.1097/00005176-200211000-00004,,,5,Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,621XM,12454573,Bronze,,,2024-06-04,WOS:000179616300004,View Full Record in Web of Science
S,"Horvath, A; Szajewska, H",,"Szajewska, H; Shamir, R",,"Horvath, Andrea; Szajewska, Hania",,,"Probiotics, Prebiotics, and Dietary Fiber in the Management of Functional Gastrointestinal Disorders",EVIDENCE-BASED RESEARCH IN PEDIATRIC NUTRITION,World Review of Nutrition and Dietetics,,English,Article; Book Chapter,,,,,,,REUTERI DSM 17938; DOUBLE-BLIND; CHILDHOOD CONSTIPATION; CHILDREN; GLUCOMANNAN; LACTULOSE; MOTILITY; GG,"At best, currently available therapies provide symptomatic relief from functional gastrointestinal disorders (FGD). No existing therapy, however, can influence the natural course of any of these disorders, prompting interest in new and safe treatment options. This paper summarizes the clinical evidence from randomized controlled trials (RCTs) and their meta-analyses of the effectiveness of probiotics, prebiotics, and dietary fiber in the treatment of FGD in the pediatric population. While it is too soon to recommend the routine use of any probiotics for treating FGD, some of these therapeutic options can provide a health benefit to patients, and therefore can be discussed with patients and/or caregivers. Lactobacillus reuteri DSM 17938 has consistently improved symptoms of infantile colic. The use of Lactobacillus GG moderately increased treatment success in children with abdominal pain-related FGD, particularly among children with irritable bowel syndrome. Also, data from one trial suggest that VSL# 3 seems to be effective in ameliorating symptoms and improving the quality of life of children affected by irritable bowel syndrome. L. reuteri DSM 17938 may help infants with constipation. Limited evidence suggests that administration of a fiber supplement is more effective than placebo for the treatment of childhood constipation. Copyright (C) 2013 S. Karger AG, Basel","[Horvath, Andrea; Szajewska, Hania] Med Univ Warsaw, Dept Paediat, Dzialdowska 1, PL-01184 Warsaw, Poland",Medical University of Warsaw,"Horvath, A (corresponding author), Med Univ Warsaw, Dept Paediat, Dzialdowska 1, PL-01184 Warsaw, Poland.",andrea.hania@gmail.com,"Szajewska, Hania/M-4141-2018; Horvath, Andrea/S-5069-2018","Szajewska, Hania/0000-0002-4596-2874; Horvath, Andrea/0000-0001-9940-0001",,,,,27,10,15,2,20,KARGER,BASEL,"POSTFACH, CH-4009 BASEL, SWITZERLAND",0084-2230,1662-3975,978-3-318-02457-9; 978-3-318-02456-2,WORLD REV NUTR DIET,World Rev.Nutr.Diet.,,2013,108,,,,,,40,48,,10.1159/000351483,http://dx.doi.org/10.1159/000351483,10.1159/isbn.978-3-318-02457-9,,9,Nutrition & Dietetics; Pediatrics,Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics; Pediatrics,BE8RK,24029785,,,,2024-06-04,WOS:000376929700006,View Full Record in Web of Science
J,"Duan, RX; Zheng, Y; Kong, WR; Wang, YP; Zhou, YN",,,,"Duan, Ruixiao; Zheng, Ya; Kong, Wanru; Wang, Yuping; Zhou, Yongning",,,Association of environmental tobacco smoke exposure with chronic constipation: a nationwide survey (NHANES 2005-2010),ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH,,,English,Article,,,,,,Environmental tobacco smoke; Air pollution; Cotinine as a biomarker; Chronic constipation; NHANES; Cross-sectional study,OXIDATIVE STRESS; SECONDHAND SMOKE; STOOL FREQUENCY; DIETARY FIBER; SYMPTOMS; HEALTH; INFLAMMATION; PREVALENCE; MICROBIOTA,"Environmental tobacco smoke (ETS) exposure has been proven to induce digestive diseases such as hepatic steatosis, cirrhosis, and gastrointestinal cancer, yet little is known about the link between ETS exposure and constipation. This study aimed to investigate the impact of ETS exposure on the risk of chronic constipation in adults aged 20 years or older. This is a cross-sectional study based on population. A total number of 7705 participants from the National Health and Nutrition Examination Survey (NHANES) 2005-2010 were included. Cotinine, an alkaloid found in tobacco, serves as a reliable and precise biomarker for measuring exposure to ETS. Hence, the categorization of exposure to ETS was conducted based on serum cotinine levels, resulting in four distinct categories. The association between ETS exposure and the risk of constipation was assessed using multivariable restricted cubic spline and logistic regression with odds ratio (OR) and 95% confidence interval (CI). The weighted prevalence of constipation in this study was estimated to be 7.51% based on stool consistency, or 3.11% based on stool frequency. The fully adjusted models indicated a positive correlation between exposure to ETS and constipation as measured by stool frequency, among adults with poor dietary quality (OR (95% CI): moderate exposure: 2.49 (1.05, 5.94); high exposure: 2.36(1.13, 4.95), P for trend = 0.03), while no significant difference was observed in the subgroup with a higher healthy eating index. Furthermore, the log10-transformed serum cotinine level exhibited a non-linear inverted U-shaped association with constipation in individuals with poor dietary quality (P overall = 0.0207, P non-linear = 0.0427). Conversely, a J-shaped non-linear relationship was observed in the subgroup with a higher healthy eating index (P overall = 0.0028, P non-linear = 0.0036). Our results show that ETS exposure appears to be positively associated with stool frequency-related chronic constipation in adults with poor dietary quality.","[Duan, Ruixiao] Lanzhou Univ, Clin Med Coll 1, Lanzhou, Peoples R China; [Duan, Ruixiao; Zheng, Ya; Wang, Yuping; Zhou, Yongning] Lanzhou Univ, Hosp 1, Dept Gastroenterol, Lanzhou, Peoples R China; [Duan, Ruixiao; Zheng, Ya; Wang, Yuping; Zhou, Yongning] Lanzhou Univ, Hosp 1, Gansu Clin Med Res Ctr Cardiovasc Dis, Lanzhou, Gansu, Peoples R China; [Kong, Wanru] Gansu Prov Hosp, Dept Infect Management, Lanzhou 730000, Peoples R China",Lanzhou University; Lanzhou University; Lanzhou University,"Zhou, YN (corresponding author), Lanzhou Univ, Hosp 1, Dept Gastroenterol, Lanzhou, Peoples R China.;Zhou, YN (corresponding author), Lanzhou Univ, Hosp 1, Gansu Clin Med Res Ctr Cardiovasc Dis, Lanzhou, Gansu, Peoples R China.",zhouyn@lzu.edu.cn,,,We would like to express our heartfelt thanks to all the participants in this study.,We would like to express our heartfelt thanks to all the participants in this study.,We would like to express our heartfelt thanks to all the participants in this study.,,52,0,0,4,8,SPRINGER HEIDELBERG,HEIDELBERG,"TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY",0944-1344,1614-7499,,ENVIRON SCI POLLUT R,Environ. Sci. Pollut. Res.,NOV,2023,30,54,,,,,115776,115787,,10.1007/s11356-023-30542-4,http://dx.doi.org/10.1007/s11356-023-30542-4,,OCT 2023,12,Environmental Sciences,Science Citation Index Expanded (SCI-EXPANDED),Environmental Sciences & Ecology,GP5R3,37889412,,,,2024-06-04,WOS:001092083000007,View Full Record in Web of Science
J,"Grant, E",,,,"Grant, E",,,An audit of laxative use and fibre/fluid intakes in a care of the elderly rehabilitation ward,JOURNAL OF HUMAN NUTRITION AND DIETETICS,,,English,Article,,,,,,audit; dietary fibre; elderly people; fluids; laxatives,,"Background: Constipation is a common problem in elderly patients, resulting in considerable discomfort and expenditure on prescribed laxatives. Aims and objectives: This study aimed to audit the use of laxatives on a ward for the rehabilitation of elderly people; to assess the fibre and fluid provided to patients on the basis of hospital menus and to assess the individual, daily intakes of fluid and fibre of three patients. Methods: Pharmacy records were used to audit laxative use on the ward over a 3-month period. Provision of fluid and fibre were assessed by analysis of the regular and soft menus for 3 days, using food composition tables. A weighed intake assessment of three patients for one day was undertaken. Results: Ispaghula husk (Fybogel, Regulan) were the mast commonly used laxatives. Although the regular menu appeared to provide adequate amounts of fluid and fibre, results for the soft menu were less satisfactory. All three patients had intakes well below the recommended level of dietary fibre. Conclusion: Despite the limitations of this small study, the findings suggest that improvements in catering and food service could be implemented to increase the intake of dietary fibre by patients in this ward. These should be implemented and the use of laxatives re-audited.","Law Hosp, Carluke ML8 5ER, Lanark, Scotland",,"Grant, E (corresponding author), Law Hosp, Carluke ML8 5ER, Lanark, Scotland.",,,,,,,,5,1,1,0,0,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0952-3871,1365-277X,,J HUM NUTR DIET,J. Hum. Nutr. Diet.,OCT,1999,12,5,,,,,409,413,,10.1046/j.1365-277x.1999.00182.x,http://dx.doi.org/10.1046/j.1365-277x.1999.00182.x,,,5,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,252RC,,,,,2024-06-04,WOS:000083515200008,View Full Record in Web of Science
J,"Teuri, U; Korpel, R",,,,"Teuri, U; Korpel, R",,,Galacto-oligosaccharides relieve constipation in elderly people,ANNALS OF NUTRITION AND METABOLISM,,,English,Article,,,,,,galacto-oligo saccharides; constipation; gastrointestinal symptoms; feces,LARGE-BOWEL FUNCTION; INTESTINAL MICROFLORA; FECAL MICROFLORA; DIETARY FIBER; METABOLISM; LACTULOSE; MANAGEMENT; INGESTION; DIARRHEA; WHEAT,"The aim of the study was to investigate whether galacto-oligosaccharides (GOS) relieve constipation in elderly people. The final study population consisted of 14 female subjects, mean age 79.6 (69-87) years, who suffered from constipation. The study was a double-blind two-period cross-over study. Both study periods lasted 2 weeks. The subjects ingested either 2 control yoghurts or 2 GOS-containing yoghurts daily. The yoghurts were otherwise similar, but the daily dose of GOS (Elix'or, BWP, Holland) from the COS yoghurt was 9 g. The regular use of laxatives was stopped during the study periods and laxatives were used only when necessary. All the subjects reported the function of their intestines daily in a questionnaire. The defecation frequency per week (mean, range) was higher during the GOS period (7.1, 3-15) than during the control period (5.9, 1-14). GOS had no statistically significant effect on the use of laxatives, the consistency of feces or the ease of defecation, although GOS seemed to make defecation easier (p = 0.07). The adverse gastrointestinal symptoms were similar during both the control and the GOS periods. GOS seem to relieve constipation in most elderly people but the responses differ individually.","Valio Ltd, Ctr Res & Dev, FIN-00039 Helsinki, Finland; Univ Helsinki, Dept Pharmacol & Toxicol, Inst Biomed, FIN-00170 Helsinki, Finland; Fdn Nutr Res, Helsinki, Finland",Valio; University of Helsinki,"Teuri, U (corresponding author), Valio Ltd, Ctr Res & Dev, POB 30, FIN-00039 Helsinki, Finland.",,,,,,,,27,43,52,0,12,KARGER,BASEL,"ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND",0250-6807,,,ANN NUTR METAB,Ann. Nutr. Metab.,NOV-DEC,1998,42,6,,,,,319,327,,10.1159/000012751,http://dx.doi.org/10.1159/000012751,,,9,Endocrinology & Metabolism; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Endocrinology & Metabolism; Nutrition & Dietetics,161TP,9895419,,,,2024-06-04,WOS:000078305900002,View Full Record in Web of Science
J,"Christodoulides, S; Dimidi, E; Fragkos, KC; Farmer, AD; Whelan, K; Scott, SM",,,,"Christodoulides, S.; Dimidi, E.; Fragkos, K. C.; Farmer, A. D.; Whelan, K.; Scott, S. M.",,,Systematic review with meta-analysis: effect of fibre supplementation on chronic idiopathic constipation in adults,ALIMENTARY PHARMACOLOGY & THERAPEUTICS,,,English,Review,,,,,,,RANDOMIZED CLINICAL-TRIAL; DIETARY FIBER; COLORECTAL-CANCER; LAXATIVE USE; BOWEL; QUALITY; PSYLLIUM; MANAGEMENT; PREVALENCE; TRANSIT,"BackgroundChronic idiopathic constipation is a common symptom-based gastrointestinal disorder responsible for a substantial economic health service burden. Current guidelines recommend the use of fibre as a first-line treatment. AimTo investigate the effect of fibre (including prebiotic) supplementation on global symptom response, stool output, gut microbiota composition and adverse events in adults with chronic idiopathic constipation. MethodsMedline, EmBase, Web of Science, Scopus and the Cochrane central register of controlled trials were searched through to February 2016. Conference proceedings from 2003 to 2015 were hand-searched. There were no language restrictions. Forest plots with 95% CIs were generated using a random-effects model. ResultsThe search strategy generated 1072 citations, of which seven individual randomised controlled trials were eligible. Overall, 113 of 147 (77%) patients assigned to fibre responded to therapy, compared with 61 of 140 (44%) allocated to placebo (RR of success to respond 1.71, 95% CI 1.20-2.42, P = 0.003). Fibre significantly increased stool frequency (SMD, standardised mean difference = 0.39; 95% CI 0.03-0.76; P = 0.03) and softened stool consistency (SMD = 0.35; 95% CI 0.04-0.65; P = 0.02) compared with placebo. Flatulence was significantly higher with fibre compared to placebo (SMD 0.56, 0.12-1.00, P = 0.01). Overall quality of evidence was low. ConclusionsThis meta-analysis demonstrates that fibre is moderately effective, but also causes moderate gastrointestinal side effects. However, these findings need to be treated with caution due to a high risk of bias. Accordingly, further large, methodologically rigorous trials are required, before any definitive recommendation regarding its risk-benefit profile can be made. PROSPERO registration number CRD42014007005.","[Christodoulides, S.; Dimidi, E.; Farmer, A. D.; Scott, S. M.] Queen Mary Univ London, Wingate Inst Neurogastroenterol, London, England; [Christodoulides, S.; Dimidi, E.; Farmer, A. D.; Scott, S. M.] Queen Mary Univ London, GI Physiol Unit, Ctr Neurosci & Trauma, Blizard Inst,Barts & London Sch Med & Dent, London, England; [Christodoulides, S.; Dimidi, E.; Whelan, K.] Kings Coll London, Diabet & Nutr Sci Div, Fac Life Sci & Med, London, England; [Fragkos, K. C.] UCL, Ctr Gastroenterol & Clin Nutr, London, England; [Farmer, A. D.] Univ Hosp North Midlands, Stoke On Trent, Staffs, England",University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; King's College London; University of London; University College London,"Scott, SM (corresponding author), Wingate Inst Phys Educ & Sports, 26 Ashfield St, London E1 2AJ, England.",m.scott@qmul.ac.uk,"Whelan, Kevin/ABD-5154-2021; Whelan, Kevin/ABD-5350-2021; Fragkos, Konstantinos/B-8861-2009; Christodoulides, Stephanos/JQW-8572-2023","Whelan, Kevin/0000-0001-5414-2950; Fragkos, Konstantinos/0000-0002-7677-7989; Dimidi, Eirini/0000-0003-0140-0199",,,,,64,81,95,3,36,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0269-2813,1365-2036,,ALIMENT PHARM THER,Aliment. Pharmacol. Ther.,JUL,2016,44,2,,,,,103,116,,10.1111/apt.13662,http://dx.doi.org/10.1111/apt.13662,,,14,Gastroenterology & Hepatology; Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Pharmacology & Pharmacy,DQ0VO,27170558,"Bronze, Green Submitted",,,2024-06-04,WOS:000378920100001,View Full Record in Web of Science
J,"Katsirma, Z; Dimidi, E; Rodriguez-Mateos, A; Whelan, K",,,,"Katsirma, Zoi; Dimidi, Eirini; Rodriguez-Mateos, Ana; Whelan, Kevin",,,"Fruits and their impact on the gut microbiota, gut motility and constipation",FOOD & FUNCTION,,,English,Review,,,,,,,CHRONIC IDIOPATHIC CONSTIPATION; RED WINE POLYPHENOLS; SUN-DRIED RAISINS; PERFORMANCE LIQUID-CHROMATOGRAPHY; BOWEL MOVEMENT FREQUENCY; FICUS-CARICA PASTE; GRAPE SEED TANNINS; CHAIN FATTY-ACIDS; INDICA L. JUICE; DIETARY FIBER,"Fruits are the seed-bearing product of plants and have considerable nutritional importance in the human diet. The consumption of fruits is among the dietary strategies recommended for constipation due to its potential effects on the gut microbiota and gut motility. Dietary fiber from fruits has been the subject of research on the impact on gut microbiota, gut motility and constipation, however, fruits also contain other components that impact the intestinal luminal environment that may impact these outcomes including sorbitol and (poly)phenols. This review aims to explore the mechanisms of action and effectiveness of fruits and fruit products on the gut microbiota, gut motility and constipation, with a focus on fiber, sorbitol and (poly)phenols. In vitro, animal and human studies investigating the effects of fruits on gut motility and gut microbiota were sought through electronic database searches, hand searching and consulting with experts. Various fruits have been shown to modify the microbiota in human studies including blueberry powder (lactobacilli, bifidobacteria), prunes (bifidobacteria), kiwi fruit (Bacteroides, Faecalibacterium prausnitzii) and raisins (Ruminococcus, F. prausnitzii). Prunes, raisins and apple fiber isolate have been shown to increase fecal weight in humans, whilst kiwifruit to increase small bowel and fecal water content. Apple fiber isolate, kiwifruit, fig paste, and orange extract have been shown to reduce gut transit time, while prunes have not. There is limited evidence on which fruit components play a predominant role in regulating gut motility and constipation, or whether a synergy of multiple components is responsible for such effects.","[Katsirma, Zoi; Dimidi, Eirini; Rodriguez-Mateos, Ana; Whelan, Kevin] Kings Coll London, Dept Nutr Sci, 150 Stamford St, London SE1 9NH, England",University of London; King's College London,"Whelan, K (corresponding author), Kings Coll London, Dept Nutr Sci, 150 Stamford St, London SE1 9NH, England.",kevin.whelan@kcl.ac.uk,"Whelan, Kevin/ABD-5154-2021; Whelan, Kevin/ABD-5350-2021; Rodriguez-Mateos, Ana/ABE-1560-2020","Whelan, Kevin/0000-0001-5414-2950; Dimidi, Eirini/0000-0003-0140-0199; Rodriguez-Mateos, Ana/0000-0003-3242-402X",International Nut and Dried Fruit Council,International Nut and Dried Fruit Council,"This review was part of a Ph.D. studentship funded by the International Nut and Dried Fruit Council. The funders played no role in the design, interpretation of data, writing of the review, or the decision to submit the paper for publication.",,132,30,31,10,94,ROYAL SOC CHEMISTRY,CAMBRIDGE,"THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND",2042-6496,2042-650X,,FOOD FUNCT,Food Funct.,OCT 4,2021,12,19,,,,,8850,8866,,10.1039/d1fo01125a,http://dx.doi.org/10.1039/d1fo01125a,,AUG 2021,17,Biochemistry & Molecular Biology; Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Food Science & Technology,WA9OU,34505614,hybrid,,,2024-06-04,WOS:000694657400001,View Full Record in Web of Science
J,"Hag-Ali, RH; Rodríguez, BJG; Olivares, FJM; Montes, JMG; Venegas, SSG; Gutiérrez, JMH",,,,"Hag-Ali, RH; Rodríguez, BJG; Olivares, FJM; Montes, JMG; Venegas, SSG; Gutiérrez, JMH",,,Measuring colonic transit time in chronic idiopathic constipation,REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS,,,English,Article,,,,,,colonic transit; chronic idiopathic constipation; radio-opaque markers; anorectal manometry,,"Introduction and objectives: colonic transit time can define three types of delay: right colon (colonic inertia), left colon and recto sigmoid. The aim of this study is to compare clinic characteristics and manometric results among the different groups with segmental colonic transit disorder. Patients and methods: 61 subjects were included in our study (5 men and 56 women) with an average age of 47.5 years (range: 17-84 years). We carried out a study of segmental and total colonic transit time, with the use of radio-opaque markers and sequential abdominal X-rays. We considered that transit time was prolonged when it was longer than 72 hours, and segmental transit time, when right colon was longer than 22 hours, left colon 37.2 hours and recto-sigmoid 37.2 hours. We included different clinic data: age, sex, place of residence, stool frequency, abdominal pain, painful evacuation, incomplete evacuation, evacuation desire, dietary fibre intake, use of laxatives. We practised anorectal manometry in 20 patients. Results: the average total colonic transit time was 38.2 hours in normal transit and 103 hours with disorder. The frequency in the three colonic segments, when there was a long total colonic transit time, was: 40% in the left colon, 33% in the recto-sigmoid and 27% in the right colon. We analysed the clinical characteristics of these three groups, finding more frequency of painful evacuation and defecation desire and lower dietary fibre intake in recto sigmoid. The most important abnormality in anorectal manometry was the hiposensitivity in the anorectal area, that only appeared in subjects with long segmental transit time in the right colon (colonic inertia), statistically significant. Conclusions: the measurement of colonic transit time with radio-opaque markers is a simple technique that allows for the objective detection of the different groups of patients with chronic idiopathic constipation. The exact typification of the abnormality is important for the individualization of each treatment.","Hosp Univ Virgen Macarena, Digest Syst Serv, Seville 41017, Spain",Hospital Universitario Virgen Macarena,"Hosp Univ Virgen Macarena, Digest Syst Serv, Avda Dr Fedriani 3, Seville 41017, Spain.",jmhg@us.es,"Garcia-Montes, Josefa-Maria/AAP-7802-2021","Garcia-Montes, Josefa-Maria/0000-0003-2450-9672",,,,,8,7,7,0,3,"ARAN EDICIONES, S A",MADRID,"CASTELLO, 128, 28006 MADRID, SPAIN",1130-0108,2340-4167,,REV ESP ENFERM DIG,Rev. Esp. Enferm. Dig.,MAR,2003,95,3,,,,,186,190,,,,,,5,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,678DJ,,,,,2024-06-04,WOS:000182849500002,View Full Record in Web of Science
J,"Ho, YH; Tan, M; Goh, HS",,,,"Ho, YH; Tan, M; Goh, HS",,,Clinical and physiologic effects of biofeedback in outlet obstruction constipation,DISEASES OF THE COLON & RECTUM,,,English,Article,,,,,,biofeedback; constipation; manometry; puborectalis paradoxus,PUBORECTALIS MUSCLE; ANISMUS; DEFECATION; CONTRACTION; MANAGEMENT; DIAGNOSIS; DIVISION,"PURPOSE: We report the results of biofeedback (BF) on patients with outlet obstruction defecation (OOC), including those with and without measurable paradoxical puborectalis contractions (PP). Clinical and anorectal physiologic parameters (ARP) were assessed one week before and after a standardized course of BF. METHODS: Sixty-two consecutive patients (24 men, 38 women; mean age, 48 (standard error of the mean, 2.3) years) were recruited. All had persistent constipation despite six weeks of dietary fiber supplements. Colonic inertia was excluded by transit marker studies. Defecating proctography excluded anatomic abnormalities causing outlet obstruction. Patients underwent four outpatient sessions of biofeedback, each session lasting one hour. RESULTS: After BF, 56 patients (90.3 percent) were subjectively improved. Frequency of spontaneous bowel movements were significantly increased (P = 0.003). Frequency of laxative-induced (P = 0.004) and enema-induced (P = 0.005) stools were reduced. Anal resting (P = 0.04) and squeeze (P = 0.002) pressures were increased. Number of patients with PP was reduced from 40 to 31 (P = 0.004). Presence of PP did not affect response to BF. There were no differences in ARP between the 56 patients who improved and the 6 who did not. There mere no side effects or clinical regressions after a mean follow-up of 14.9 (standard error of the means, 0.9) months. CONCLUSIONS: BF effectively treated OOC in 90.3 percent, regardless of PP. Anal pressures were increased, and PP was decreased.",,,"Ho, YH (corresponding author), SINGAPORE GEN HOSP,DEPT COLORECTAL SURG,OUTRAM RD,SINGAPORE 169608,SINGAPORE.",,,,,,,,27,37,38,0,1,WILLIAMS & WILKINS,BALTIMORE,"351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436",0012-3706,,,DIS COLON RECTUM,Dis. Colon Rectum,MAY,1996,39,5,,,,,520,524,,10.1007/BF02058704,http://dx.doi.org/10.1007/BF02058704,,,5,Gastroenterology & Hepatology; Surgery,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Surgery,UK295,8620801,,,,2024-06-04,WOS:A1996UK29500006,View Full Record in Web of Science
J,"Chan, TC; Yu, VMW; Luk, JKH; Chu, LW; Yuen, JKY; Chan, FHW",,,,"Chan, T. C.; Yu, V. M. W.; Luk, J. K. H.; Chu, L. W.; Yuen, J. K. Y.; Chan, F. H. W.",,,Effectiveness of Partially Hydrolyzed Guar Gum in Reducing Constipation in Long Term Care Facility Residents: A Randomized Single-Blinded Placebo-Controlled Trial,JOURNAL OF NUTRITION HEALTH & AGING,,,English,Article,,,,,,Constipation; laxatives; long term carefacility; partially hydrolyzed guar gum,FIBER; PROTEIN; ENERGY,"Objectives To assess the effectiveness of partially hydrolyzed guar gum (PHGG) in improving constipation and reducing the use of laxatives among long term care facility (LTCF) residents. Design A single-center, prospective, randomized, placebo-controlled, single-blinded parallel-group trial from September 2021 to November 2021. Setting Four LTCF in Hong Kong. Participants Fifty-two LTCF residents with chronic constipation (mean age: 83.9 +/- 7.6 years, male 38%). Intervention 5g PHGG mixed with 200ml water per day for 4 weeks was given to intervention group participants. Control group received 200ml water for 4 weeks. Participants continued their usual as-needed laxative (lactulose, senna or dulcolax) on their own initiative. Measurements Baseline measurements included age, gender, Charlson comorbidity index, Roackwood's Clinical Frailty Scale, body mass index and daily dietary fiber intake. Outcome measures were fecal characteristics assessed by Bristol Stool Form Scale, bowel opening frequency and laxative use frequency at baseline, first, second, third and fourth week of trial. Adverse events were measured. The study was registered on ClinicalTrial.gov; identifier: NCT 05037565. Results There was no significant difference in bowel frequency and stool characteristics between the treatment group and control group. However, there was a significantly lower frequency of lactulose, senna, and total laxative use in the treatment group compared with controls in the third and fourth week. There was no significant difference in adverse effects between the two groups. Conclusion This study showed that daily dietary fibre supplementation by using PHGG for 4 weeks in LTCF residents results in significantly less laxative use than placebo. It may be an effective way to reduce laxative dependence among older people living in LTCFs.","[Chan, T. C.; Luk, J. K. H.] Fung Yiu King Hosp, Pokfulam, Dept Med & Geriatr, 9 Sandy Bay Rd, Hong Kong, Peoples R China; [Yu, V. M. W.] Queen Mary Hosp, Dept Manager Dietet, Hong Kong, Peoples R China; [Chu, L. W.; Chan, F. H. W.] Univ Hong Kong, Dept Med, Queen Mary Hosp, Hong Kong, Peoples R China; [Yuen, J. K. Y.] Univ Hong Kong, Li Ka Shing Fac Med, Hong Kong, Peoples R China",University of Hong Kong; University of Hong Kong; University of Hong Kong,"Chan, TC (corresponding author), Fung Yiu King Hosp, Pokfulam, Dept Med & Geriatr, 9 Sandy Bay Rd, Hong Kong, Peoples R China.",ctc029@ha.org.hk,,,Research Matching Grant Scheme of the University Grants Committee from the government of Hong Kong Special Administrative Region [207300993],Research Matching Grant Scheme of the University Grants Committee from the government of Hong Kong Special Administrative Region,"The authors gratefully acknowledge the Research Matching Grant Scheme of the University Grants Committee from the government of Hong Kong Special Administrative Region [Grant ID: 207300993], which partially supported the study financially.",,30,5,5,2,9,SPRINGER FRANCE,PARIS,"22 RUE DE PALESTRO, PARIS, 75002, FRANCE",1279-7707,1760-4788,,J NUTR HEALTH AGING,J. Nutr. Health Aging,MAR,2022,26,3,,,,,247,251,,10.1007/s12603-022-1747-2,http://dx.doi.org/10.1007/s12603-022-1747-2,,FEB 2022,5,Geriatrics & Gerontology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Geriatrics & Gerontology; Nutrition & Dietetics,ZV1TS,35297467,hybrid,,,2024-06-04,WOS:000754994800001,View Full Record in Web of Science
J,"Lee, HY; Kim, JH; Jeung, HW; Lee, CU; Kim, DS; Li, B; Lee, GH; Sung, MS; Ha, KC; Back, HI; Kim, SY; Park, SH; Oh, MR; Kim, MG; Jeon, JY; Im, YJ; Hwang, MH; So, BO; Shin, SJ; Yoo, WH; Kim, HR; Chae, HJ; Chae, SW",,,,"Lee, Hak-Yong; Kim, Jung-Hoon; Jeung, Han-Wool; Lee, Cha-Uk; Kim, Do-Sung; Li, Bo; Lee, Geum-Hwa; Sung, Myung-Soon; Ha, Ki-Chan; Back, Hyang-Im; Kim, Sun-Young; Park, Soo-Hyun; Oh, Mi-Ra; Kim, Min-Gul; Jeon, Ji-Young; Im, Yong-Jin; Hwang, Min-Ho; So, Byung-Ok; Shin, Sook-Jeong; Yoo, Wan-Hee; Kim, Hyung-Ryong; Chae, Han-Jung; Chae, Soo-Wan",,,Effects of Ficus carica paste on loperamide-induced constipation in rats,FOOD AND CHEMICAL TOXICOLOGY,,,English,Article,,,,,,Loperamide; Constipation; Fig; Intestinal transit length,DIETARY FIBER INTAKE; FATTY-ACIDS; TRANSIT-TIME; FIG; FRUIT; MUCIN; L.; METAANALYSIS; ANTIOXIDANT; CELLULOSE,"Objective: Constipation is one of the most common gastrointestinal complaints worldwide. This study examined the effects of fig (Ficus carica L) paste for the treatment of loperamide-induced constipation in a rat model. Methods: Animals were divided into one normal control group and four experimental groups (0, 1, 6, and 30 g/kg). Loperamide (2 mg/kg, twice per day) was injected intraperitoneally to induce constipation in the four experimental groups. Fig paste was administered for 4 weeks to assess its anti-constipation effects. Results: Fecal pellet number, weight and water content were increased in the fig-treated groups as compared to the control group. Reductions in body weight and increased intestinal transit length were observed in the fig-treated groups. Fecal pellet number was reduced in the distal colons of the fig-treated rats. Exercise and ileum tension increased in the experimental groups as compared to the control group. According to histological analyses, the thickness of the distal colon and areas of crypt epithelial cells that produce mucin were increased in the fig-treated groups in a dose-dependent manner. Conclusion: Constipation was decreased when fig fruit was fed to rats. Specifically, fecal number, weight, and water content, as well as histological parameters such as thickness and mucin areas in the distal colon were improved. Fig treatment may be a useful therapeutic and preventive strategy for chronic constipation. (C) 2011 Elsevier Ltd. All rights reserved.","[Lee, Hak-Yong; Chae, Han-Jung] BIOSOLOMON Inc, Jeonju, South Korea; [Kim, Jung-Hoon; Jeung, Han-Wool; Lee, Cha-Uk; Kim, Do-Sung; Li, Bo; Lee, Geum-Hwa; Chae, Han-Jung; Chae, Soo-Wan] Chonbuk Natl Univ, Dept Pharmacol, Sch Med, Jeonju, South Korea; [Sung, Myung-Soon; Yoo, Wan-Hee] Chonbuk Natl Univ, Div Rheumatol, Dept Internal Med, Sch Med, Jeonju, South Korea; [Ha, Ki-Chan] HC & MANAGEMENT Inc, Jeonju, South Korea; [Back, Hyang-Im; Kim, Sun-Young; Park, Soo-Hyun; Oh, Mi-Ra; Kim, Min-Gul; Jeon, Ji-Young; Im, Yong-Jin; Hwang, Min-Ho; So, Byung-Ok; Shin, Sook-Jeong; Chae, Soo-Wan] Chonbuk Natl Univ Hosp, Clin Trial Ctr Funct Foods, Jeonju, South Korea; [Back, Hyang-Im; Kim, Sun-Young; Park, Soo-Hyun; Oh, Mi-Ra; Kim, Min-Gul; Jeon, Ji-Young; Im, Yong-Jin; Hwang, Min-Ho; Shin, Sook-Jeong; Chae, Soo-Wan] Chonbuk Natl Univ Hosp, Clin Trial Ctr, Jeonju, South Korea; [Kim, Hyung-Ryong] Wonkwang Univ, Sch Dent, Dept Dent Pharmacol, Iksan, South Korea",Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Jeonbuk National University Hospital; Jeonbuk National University; Jeonbuk National University Hospital; Wonkwang University,"Chae, HJ (corresponding author), BIOSOLOMON Inc, Jeonju, South Korea.",hjchae@jbnu.ac.kr; soowan@jbnu.ac.kr,"Kim, Sun/GSN-4867-2022","Im, Yong-Jin/0000-0003-4304-9747; Chae, Han-Jung/0000-0003-4190-9889; Kim, Min-Gul/0000-0001-7269-9533; Kim, Hyung-Ryong/0000-0002-6710-6964; Jeon, Ji-Young/0000-0002-0338-3591",,,,,48,80,87,3,42,PERGAMON-ELSEVIER SCIENCE LTD,OXFORD,"THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND",0278-6915,1873-6351,,FOOD CHEM TOXICOL,Food Chem. Toxicol.,MAR-APR,2012,50,3-4,,,,,895,902,,10.1016/j.fct.2011.12.001,http://dx.doi.org/10.1016/j.fct.2011.12.001,,,8,Food Science & Technology; Toxicology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Toxicology,932IR,22178225,,,,2024-06-04,WOS:000303284600067,View Full Record in Web of Science
J,"Gafencu, M; Barattini, DF; Rosu, S; Clemente, AM; Ardelean, M; Murina, F",,,,"Gafencu, Mihai; Barattini, Dionisio Franco; Rosu, Serban; Clemente, Andrea Martina; Ardelean, Marius; Murina, Filippo",,,"An open label, non-comparative pilot study to assess the efficacy and safety of a food supplement containing manna in pediatric functional constipation",PROGRESS IN NUTRITION,,,English,Article,,,,,,children; functional constipation; manna; food supplement; fiber,CHILDHOOD CONSTIPATION; FOLLOW-UP; CHILDREN; HEALTH; DIETARY,"Objective. The primary objective of this study was to evaluate the efficacy and safety of the food supplement Physiomanna Baby (R) in pediatric patients with a history of functional constipation defined by Rome III criteria; secondary objective was to evaluate the adherence to the tested product in the enrolled children. Methods. The trial was designed as an open label, non-comparative pilot trial. In 3 Romanian sites (one community hospital and two private medical practice offices) 49 children (20 males, 29 females) aged 0 - 8 years were enrolled. The study was conducted between February 2016 and April 2016. The investigational product was administered as 1 g/kg in single daily oral administration from the first day and continued for a maximum of 3 days in the first week. If the constipation symptoms persisted, the children were treated in an additional cycle of treatment for a maximum of 3 days. Results. The number of Spontaneous Bowel Movements (SBM) per week has increased to normal after Physiomanna Baby (R) administration (from 1.80 +/- 0.41 at baseline to 6.04 +/- 1.54 at day 8) evidencing a statistically significant difference (P-value <0.0001). The efficacy was also demonstrated in the subpopulation of children <4 years where the mean values per week increased from 1.69 +/- 0.47 at baseline to 6.15 +/- 1.59 SBM at day 8 (P-value <0.0001). According to Investigator Global Assessment of Efficacy (IGAE), Physiomanna Baby (R) shows immediate and excellent efficacy after one or two doses for 79.60% of the children, a very good efficacy after three doses for 12.24% and good efficacy after the second cycle of administration for 6.12% of children. Both Investigator Global Assessment for Safety (IGAS) and Patient Global Assessment for Safety (PGAS) were rated as 100% excellent for all patients. Conclusions. The food supplement Physiomanna Baby (R) provided immediate efficacy, offering to pediatricians a safe solution in the care of mild to moderate functional constipation, even if the study design characteristics were limited (pilot trial with a small sample size and without control group).","[Gafencu, Mihai; Rosu, Serban] Univ Med & Pharm V Babes Timisoara, Timisoara, Romania; [Barattini, Dionisio Franco; Ardelean, Marius] Opera Contract Res Org Srl, Timisoara, Romania; [Clemente, Andrea Martina] Univ Genoa, Ist Giannina Gaslini, Genoa, Italy; [Murina, Filippo] Univ Milan, Osped Vittore Buzzi, Milan, Italy","Victor Babes University of Medicine & Pharmacy, Timisoara; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Milan","Rosu, S (corresponding author), Univ Med & Pharm V Babes Timisoara, Timisoara, Romania.",serbanrosu@gmail.com,"Murina, Filippo/AAE-5729-2019; Gafencu, Mihai/G-1251-2017; Murina, Filippo/AAL-3728-2020; Marius, Ardelean/D-3413-2018","Gafencu, Mihai/0000-0002-9029-5919; Murina, Filippo/0000-0002-9966-6448; ROSU, SERBAN/0000-0001-7502-6908; Barattini, Dionisio Franco/0000-0001-9931-6432",,,,,23,0,0,0,5,MATTIOLI 1885,FIDENZA,"VIA DELLA LODESANA 649-SX, FIDENZA, 43046 PR, ITALY",1129-8723,,,PROG NUTR,Prog. Nutr.,MAR,2018,20,1,,,,,52,58,,10.23751/pn.v20i1.6997,http://dx.doi.org/10.23751/pn.v20i1.6997,,,7,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,GB2IE,,,,,2024-06-04,WOS:000428874500007,View Full Record in Web of Science
J,"TURNBULL, GK; LENNARDJONES, JE; BARTRAM, CI",,,,"TURNBULL, GK; LENNARDJONES, JE; BARTRAM, CI",,,FAILURE OF RECTAL EXPULSION AS A CAUSE OF CONSTIPATION - WHY FIBER AND LAXATIVES SOMETIMES FAIL,LANCET,,,English,Article,,,,,,,,"High-fibre diet and laxatives are not always successful in the treatment of severe constipation. In a group of thirteen women with intractable constipation three experimental models of rectal evacuation showed that all had a disorder of defaecation. None could expel 120 ml barium paste as fast or as completely as could ten normal women; six could expel hardly any barium. Only three of the thirteen could expel a balloon containing 50 ml water from the rectum, whereas all of six normal subjects could do so easily. Four of the patients with repeated straining efforts could expel no more than 10% of a 500 ml saline enema, whereas six normal subjects rapidly passed 40-80%. It is postulated that dietary and drug treatment designed to soften and increase the bulk of the stools fails to help some patients because they find it difficult to expel even semi-solid or liquid stool. Electromyography showed that these patients tend to contract rather than relax the striated muscle of the pelvic floor on attempted defaecation. Their failure to defaecate is due to incoordination of the pelvic floor rather than an abnormality of the stool or a disorder of the colon.","ST MARKS HOSP, CITY RD, LONDON EC1V 2PS, ENGLAND",Imperial College London,,,,,,,,,14,87,87,0,0,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",0140-6736,1474-547X,,LANCET,Lancet,APR 5,1986,1,8484,,,,,767,769,,,,,,3,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,A6884,2870270,,,,2024-06-04,WOS:A1986A688400005,View Full Record in Web of Science
J,"EASTWOOD, M; EDWARDS, C; JENKINS, D; BURKITT, D; TOMLIN, J; TROWELL, H; READ, N; HEATON, K; KRAG, E; VERNIA, P; STEPHEN, A; KATAN, MB; SELVENDRAN, R",,,,"EASTWOOD, M; EDWARDS, C; JENKINS, D; BURKITT, D; TOMLIN, J; TROWELL, H; READ, N; HEATON, K; KRAG, E; VERNIA, P; STEPHEN, A; KATAN, MB; SELVENDRAN, R",,,DIETARY FIBER AND COLON PHYSIOLOGY AND CONSTIPATION DISEASES - DISCUSSION,SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY,,,English,Discussion,,,,,,,,,"ROYAL HALLAMSHIRE HOSP, SUBDEPT HUMAN GASTROINTESTINAL PHYSIOL & NUTR, SHEFFIELD S10 2JF, S YORKSHIRE, ENGLAND; UNIV TORONTO, ST MICHAELS HOSP, FAC MED, DEPT NUTR SCI, TORONTO M5B 1W8, ONTARIO, CANADA; UNIV TORONTO, ST MICHAELS HOSP, DIV ENDOCRINOL & METAB, TORONTO M5B 1W8, ONTARIO, CANADA; UNIV SHEFFIELD, SUBDEPT HUMAN GASTROINTESTINAL PHYSIOL & NUTR, SHEFFIELD S10 2TN, S YORKSHIRE, ENGLAND; UNIV BRISTOL, BRISTOL ROYAL INFIRM, DEPT MED, BRISTOL BS2 8HW, AVON, ENGLAND; HVIDOVRE HOSP, DK-2650 HVIDOVRE, DENMARK; ST BARTHOLOMEWS MED COLL, LONDON EC1A 7BE, ENGLAND; AGR UNIV WAGENINGEN, DEPT HUMAN NUTR, 6703 BC WAGENINGEN, NETHERLANDS; INST FOOD RES, NORWICH NR4 7UA, NORFOLK, ENGLAND",University of Sheffield; University of Toronto; Saint Michaels Hospital Toronto; University of Toronto; Saint Michaels Hospital Toronto; University of Sheffield; Bristol Royal Infirmary; University of Bristol; University of Copenhagen; University of London; Queen Mary University London; Wageningen University & Research; University of East Anglia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute,"EASTWOOD, M (corresponding author), UNIV EDINBURGH, WESTERN GEN HOSP, DEPT MED, WOLFSON GASTROINTESTINAL LABS, EDINBURGH EH8 9YL, MIDLOTHIAN, SCOTLAND.",,"Vernia, Piero/AAM-4267-2020",,,,,,0,0,0,0,2,INFORMA HEALTHCARE,LONDON,"TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND",0036-5521,,,SCAND J GASTROENTERO,Scand. J. Gastroenterol.,,1987,22,,,129,,,116,119,,,,,,4,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,H9947,,,,,2024-06-04,WOS:A1987H994700021,View Full Record in Web of Science
J,"Üstündag, G; Kuloglu, Z; Kirbas, N; Kansu, A",,,,"Ustundag, Gonca; Kuloglu, Zarife; Kirbas, Nihan; Kansu, Aydan",,,Can partially hydrolyzed guar gum be an alternative to lactulose in treatment of childhood constipation?,TURKISH JOURNAL OF GASTROENTEROLOGY,,,English,Article,,,,,,Partially hydrolyzed guar gum; lactulose; childhood; constipation,DIETARY FIBER; DOUBLE-BLIND; GLUCOMANNAN,"Background/aims: In the present study, we aimed to investigate if partially hydrolyzed guar gum (PHGG) can be used safely as a fiber source for treatment of constipation in children and to compare its success with the most commonly used osmotic laxative, lactulose. Methods: A randomized prospective controlled study on 61 patients (partially hydrolyzed guar gum group, n: 31; lactulose group, n: 30) was performed. Patients were given lactulose or partially hydrolyzed guar gum for four weeks. Using a standardized bowel diary, defecation frequency, stool consistency, and presence of flatulence and abdominal pain were recorded. Family questionnaires about the success, safety and side effect profile of both treatment arms were also obtained. Results: No significant differences were found in the baseline daily fiber (fruits and vegetables) intake between the two groups. Bowel movement frequency per week and stool consistency improved significantly in both treatment groups (p<0.05). The percent of children with abdominal pain and stool withholding also decreased eminently in both groups (p<0.05). Weekly defecation frequency increased from 4 +/- 0.7 to 6 +/- 1.06 and from 4 +/- 0.7 to 5 +/- 1.7 in the lactulose and partially hydrolyzed guar gum treated groups, respectively (p<0.05). According to the family questionnaire, the parents complained of bad taste, flatulence and necessity to ingest a high amount of drug in the lactulose treatment group. In the partially hydrolyzed guar gum treatment group, parents were satisfied with the defecation frequency of their children. Conclusions: Treatment with partially hydrolyzed guar gum is as effective as lactulose treatment in relieving stool withholding and constipation-associated abdominal pain, and its use improves stool consistency. Lactulose seemed to have more side effects, including flatulence and sensation of bad taste.","[Ustundag, Gonca] Zonguldak Karaelmas Univ, Sch Med, Dept Pediat Gastroenterol, Zonguldak, Turkey; [Kuloglu, Zarife] Ankara Univ, Sch Med, Dept Pediat Gastroenterol, TR-06100 Ankara, Turkey",Zonguldak Bulent Ecevit University; Ankara University,"Üstündag, G (corresponding author), Zonguldak Karaelmas Univ, Sch Med Pediat Gastroenterol, Zonguldak, Turkey.",gonnazyuc@yahoo.com,"Kuloglu, Zarife/AAG-8210-2020","Kuloglu, Zarife/0000-0001-9442-7790; KANSU, AYDAN/0000-0002-3133-9846",,,,,19,29,32,1,12,AVES,SISLI,"BUYUKDERE CAD 105-9, MECIDIYEKOY, SISLI, ISTANBUL 34394, TURKEY",,2148-5607,,TURK J GASTROENTEROL,Turk. J. Gastroenterol.,DEC,2010,21,4,,,,,360,364,,10.4318/tjg.2010.0121,http://dx.doi.org/10.4318/tjg.2010.0121,,,5,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,720MZ,21331988,,,,2024-06-04,WOS:000287286100005,View Full Record in Web of Science
J,"Pijpers, MAM; Tabbers, MM; Benninga, MA; Berger, MY",,,,"Pijpers, M. A. M.; Tabbers, M. M.; Benninga, M. A.; Berger, M. Y.",,,Currently recommended treatments of childhood constipation are not evidence based: a systematic literature review on the effect of laxative treatment and dietary measures,ARCHIVES OF DISEASE IN CHILDHOOD,,,English,Article,,,,,,,DOUBLE-BLIND; POLYETHYLENE-GLYCOL; PLUS ELECTROLYTES; RANDOMIZED-TRIAL; FECAL IMPACTION; CHILDREN; LACTULOSE; ENCOPRESIS; MANAGEMENT; BIOFEEDBACK,"Introduction: Constipation is a common complaint in children and early intervention with oral laxatives may improve complete resolution of functional constipation. However, most treatment guidelines are based on reviews of the literature that do not incorporate a quality assessment of the studies. Objective: To investigate and summarise the quantity and quality of the current evidence for the effect of laxatives and dietary measures on functional childhood constipation. Methods: The Medline and Embase databases were searched to identify studies evaluating the effect of a medicamentous treatment or dietary intervention on functional constipation. Methodological quality was assessed using a validated list of criteria. Data were statistically pooled, and in case of clinical heterogeneity results were summarised according to a best evidence synthesis. Results: Of the 736 studies found, 28 met the inclusion criteria. In total 10 studies were of high quality. The included studies were clinically and statistically heterogeneous in design. Most laxatives were not compared to placebo. Compared to all other laxatives, polyethylene glycol ( PEG) achieved more treatment success ( pooled relative risk (RR): 1.47; 95% CI 1.23 to 1.76). Lactulose was less than or equally effective in increasing the defecation frequency compared to all other laxatives investigated. There was no difference in effect on defecation frequency between fibre and placebo ( weighted standardised mean difference 0.35 bowel movements per week in favour of fibre, 95% CI -0.04 to 0.74). Conclusion: Insufficient evidence exists supporting that laxative treatment is better than placebo in children with constipation. Compared to all other laxatives, PEG achieved more treatment success, but results on defecation frequency were conflicting. Based on the results of this review, we can give no recommendations to support one laxative over the other for childhood constipation.","[Pijpers, M. A. M.; Berger, M. Y.] Erasmus MC, Dept Gen Practice, NL-3000 CA Rotterdam, Netherlands; [Tabbers, M. M.; Benninga, M. A.] Acad Med Ctr Amsterdam, Emma Childrens Hosp, Dept Pediat Gastroenterol & Nutr, Amsterdam, Netherlands",Erasmus University Rotterdam; Erasmus MC; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam,"Pijpers, MAM (corresponding author), Erasmus MC, Dept Gen Practice, Room Ff323,POB 2040, NL-3000 CA Rotterdam, Netherlands.",m.pijpers@erasmusmc.nl,,"Tabbers, Merit/0000-0001-9744-7308",,,,,54,76,82,1,10,BMJ PUBLISHING GROUP,LONDON,"BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND",0003-9888,1468-2044,,ARCH DIS CHILD,Arch. Dis. Child.,FEB,2009,94,2,,,,,117,131,,10.1136/adc.2007.127233,http://dx.doi.org/10.1136/adc.2007.127233,,,15,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,403JO,18713795,Green Published,,,2024-06-04,WOS:000263079100008,View Full Record in Web of Science
J,"Ikee, R; Sasaki, N; Yasuda, T; Fukazawa, S",,,,"Ikee, Ryota; Sasaki, Naomi; Yasuda, Takuji; Fukazawa, Sawako",,,"Chronic Kidney Disease, Gut Dysbiosis, and Constipation: A Burdensome Triplet",MICROORGANISMS,,,English,Review,,,,,,gut microbiota; dysbiosis; chronic kidney disease; constipation; intestinal motility; gut-derived uremic toxins; inflammation; short-chain fatty acids; butyrate; gut epithelial integrity,STAGE RENAL-DISEASE; EPITHELIAL TIGHT JUNCTION; HEMODIALYSIS-PATIENTS; P-CRESOL; CARDIOVASCULAR-DISEASE; GASTROINTESTINAL-TRACT; MEDITERRANEAN DIET; UREMIC TOXINS; TNF-ALPHA; DIALYSIS,"Gut dysbiosis has been implicated in the progression of chronic kidney disease (CKD). Alterations in the gut environment induced by uremic toxins, the dietary restriction of fiber-rich foods, and multiple drugs may be involved in CKD-related gut dysbiosis. CKD-related gut dysbiosis is considered to be characterized by the expansion of bacterial species producing precursors of harmful uremic toxins, such as indoxyl sulfate and p-cresyl sulfate, and the contraction of species generating beneficial short-chain fatty acids, such as butyrate. Gut-derived uremic toxins cause oxidative stress and pro-inflammatory responses, whereas butyrate exerts anti-inflammatory effects and contributes to gut epithelial integrity. Gut dysbiosis is associated with the disruption of the gut epithelial barrier, which leads to the translocation of endotoxins. Research on CKD-related gut dysbiosis has mainly focused on chronic inflammation and consequent cardiovascular and renal damage. The pathogenic relationship between CKD-related gut dysbiosis and constipation has not yet been investigated in detail. Constipation is highly prevalent in CKD and affects the quality of life of these patients. Under the pathophysiological state of gut dysbiosis, altered bacterial fermentation products may play a prominent role in intestinal dysmotility. In this review, we outline the factors contributing to constipation, such as the gut microbiota and bacterial fermentation; introduce recent findings on the pathogenic link between CKD-related gut dysbiosis and constipation; and discuss potential interventions. This pathogenic link needs to be elucidated in more detail and may contribute to the development of novel treatment options not only for constipation, but also cardiovascular disease in CKD.","[Ikee, Ryota; Yasuda, Takuji] Sapporo Nephrol Satellite Clin, Nishi Ku, 9-2-15,Hassamu 6 Jo, Sapporo, Hokkaido 0630826, Japan; [Sasaki, Naomi; Fukazawa, Sawako] Sapporo Nephrol Clin, Nishi Ku, 20-2-12 Nishimachikita, Sapporo, Hokkaido 0630061, Japan",,"Ikee, R (corresponding author), Sapporo Nephrol Satellite Clin, Nishi Ku, 9-2-15,Hassamu 6 Jo, Sapporo, Hokkaido 0630826, Japan.",ryota.ikee@gmail.com; naomi.s@email.plala.or.jp; takuji.snc@email.plala.or.jp; sawako.snc@email.plala.or.jp,,"Ikee, Ryota/0000-0002-3683-5363",,,,,147,26,26,0,19,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2076-2607,,MICROORGANISMS,Microorganisms,DEC,2020,8,12,,,,,,,1862,10.3390/microorganisms8121862,http://dx.doi.org/10.3390/microorganisms8121862,,,18,Microbiology,Science Citation Index Expanded (SCI-EXPANDED),Microbiology,PK4AE,33255763,"gold, Green Published",,,2024-06-04,WOS:000602389200001,View Full Record in Web of Science
J,"Boonprakob, R; Vimolmangkang, S; Tummaruk, P",,,,"Boonprakob, Rafa; Vimolmangkang, Sornkanok; Tummaruk, Padet",,,"Impacts of supplementing Cannabis sativa byproducts during the transition period on behaviour, feed consumption, constipation levels, colostrum production and piglet performance in hyperprolific sows",THERIOGENOLOGY,,,English,Article,,,,,,Constipation; Farrowing; Hemp; Lactation; Pig,POSTPARTURIENT DISORDERS; FARROWING DURATION; TROPICAL SOWS; BACKFAT LOSS; SURVIVAL; PHYSIOLOGY; EXPULSION; TRAITS; PARITY; YIELD,"In the modern swine industry, inflammation and pain in sows after farrowing represent a crucial animal welfare concern. Cannabis sativa, a medicinal plant, has analgesic, anti-inflammatory and antipyretic properties and is rich in fibre. The objective of this study is to examine the impacts of supplementing sows with Cannabis sativa byproducts during transition periods (7 days before and after farrowing) on various aspects including postpartum behaviour, feed intake, constipation, farrowing duration, colostrum yield and piglet performance. The experiment involved a total of 100 Landrace x Yorkshire sows. The sows were distributed according to parity numbers into two groups, i.e., control (n = 54) and treatment (n = 46). The control group was provided with a lactation diet at 3.0-3.5 kg per day for a period of 7 days before and after farrowing. The treatment groups received the same quantity of the diet but with an additional supplementation of 150 g/d of Cannabis sativa byproduct. The byproduct was analysed and contained 0.24 % (w/w) cannabidiol (CBD), resulting in a daily intake of 360 mg of CBD per sow. The conventional lactational diet had a dietary fibre content of 4.3 %, whereas the diet supple-mented with Cannabis sativa byproduct had a higher dietary fibre content of 16.9 %. Video cameras were used to observe and document the behaviour of sows within the initial 24 h after farrowing. The duration in which sows engaged in activities such as sleeping, sitting, standing, feeding and nursing their piglets was quantified. Additionally, the rectal temperature of the sows was measured, and a temperature equal to or exceeding 39.5 C-degrees was considered indicative of fever. The faecal score of the sows was assessed, and a faecal score of <= 2 was classified as constipation. On the third day postpartum, the proportion of sows with fever in the treatment group was lower than that in the control group (20.0 % and 38.9 % respectively, P = 0.051). Sows receiving supple-mentation with Cannabis sativa byproducts exhibited increased durations of standing and feeding compared to those in the control group (P < 0.05). Notably, overall, sows without constipation issues spent more time consuming feed than those experiencing constipation (P = 0.006). The prevalence of constipation was signifi-cantly lower in the treatment group compared to the control group (17.4 % and 81.5 %, respectively, P < 0.001). Furthermore, the postpartum sows demonstrated increased feed intake following supplementation with Cannabis sativa byproducts (P < 0.05). Sow colostrum yield, piglet colostrum intake, piglet mortality and other piglet traits did not differ between the control and treatment groups (P > 0.05). In conclusion, supplementing Cannabis sativa byproducts during the transition periods in peri-parturient sows under tropical conditions resulted in a reduction in constipation issues and improved sow activities, such as increased time spent standing and consuming feed within the first 24 h postpartum.","[Boonprakob, Rafa; Tummaruk, Padet] Chulalongkorn Univ, Fac Vet Sci, Dept Obstet Gynaecol & Reprod, Bangkok 10330, Thailand; [Boonprakob, Rafa] Anim Hlth Off, Dept Qual Assurance, Livestock Prod Betagro Grp, Bangkok 10210, Thailand; [Vimolmangkang, Sornkanok] Chulalongkorn Univ, Fac Pharmaceut Sci, Dept Pharmacognosy, Bangkok 10330, Thailand; [Vimolmangkang, Sornkanok] Chulalongkorn Univ, Res Cluster Cannabis & Its Nat Subst, Bangkok 10330, Thailand; [Tummaruk, Padet] Chulalongkorn Univ, Ctr Excellence Swine Reprod, Bangkok 10330, Thailand",Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University,"Tummaruk, P (corresponding author), Chulalongkorn Univ, Fac Vet Sci, Dept Obstet Gynaecol & Reprod, Bangkok 10330, Thailand.",Padet.t@chula.ac.th,,"Tummaruk, Padet/0000-0001-7000-4371","National Research Council of Thailand (NRCT), Thailand [N42A660892]; Thailand Science Research and Innovation Fund, Chulalongkorn University , Thailand [FOODF67310019]","National Research Council of Thailand (NRCT), Thailand(National Research Council of Thailand (NRCT)); Thailand Science Research and Innovation Fund, Chulalongkorn University , Thailand","This research was funded by the National Research Council of Thailand (NRCT) (N42A660892) , Thailand and the Thailand Science Research and Innovation Fund, Chulalongkorn University (FOODF67310019) , Thailand.",,55,1,1,1,1,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",0093-691X,1879-3231,,THERIOGENOLOGY,Theriogenology,FEB,2024,215,,,,,,272,280,,10.1016/j.theriogenology.2023.12.010,http://dx.doi.org/10.1016/j.theriogenology.2023.12.010,,DEC 2023,9,Reproductive Biology; Veterinary Sciences,Science Citation Index Expanded (SCI-EXPANDED),Reproductive Biology; Veterinary Sciences,EK6E7,38103404,,,,2024-06-04,WOS:001138851600001,View Full Record in Web of Science
J,"MCBURNEY, MI",,,,"MCBURNEY, MI",,,POTENTIAL WATER-HOLDING CAPACITY AND SHORT-CHAIN FATTY-ACID PRODUCTION FROM PURIFIED FIBER SOURCES IN A FECAL INCUBATION SYSTEM,NUTRITION,,,English,Article,,,,,,FERMENTATION; DIETARY FIBER; SHORT CHAIN FATTY ACIDS; CONSTIPATION; WATER HOLDING CAPACITY; FECES; ENTERAL NUTRITION,INVITRO FERMENTATION VARIABLES; DIETARY FIBER; ABSORPTION; COLON; NUTRITION; INOCULUM; COLITIS,"Liquid enteral diets supplemented with dietary fiber, typically soy fiber, are in widespread use to increase stool bulking and maintain gastrointestinal function. Yeast cells, containing beta-glucans, represent another commercially available fiber source that could be added to enteral diets. The objective of this study was to compare commercially available purified fiber sources, i.e., mixed fiber (Fibrad), psyllium hydrocolloid (Metamucil), and yeast cell walls (Fibercel), for potential use in Liquid diets in terms of potential water-holding capacity (PWHC) and SCFA production (mmol SCFA/g organic matter [OM]). Fiber samples were fermented in vitro with human fecal microbiota from three donors for 24 h, and SCFA production was greatest from beta-glucan (8.24 mmol/g OM), followed by psyllium (5.57 mmol/g OM) and mixed fiber (4.50 mmol/g OM) (p < 0.0001). WHCs of the original materials (g H2O/g OM) differed (p < 0.02) at 4.59, 5.79, and 8.63 for beta-glucan, mixed fiber, and psyllium, respectively. PWHC (g H2O/g OM), an in vitro measure of stool bulking, differed (p < 0.0001) with psyllium (4.48) > mixed fiber (3.52) > beta-glucan (2.22). These three fiber systems appear to have distinctly different physiological effects in vivo. Of the three products, mixed fiber was the most inert. Psyllium seems to enhance both SCFA production and stool bulk relative to mixed fiber, whereas beta-glucan most significantly increases SCFA production with a minimal effect on stool bulk.",,,"MCBURNEY, MI (corresponding author), UNIV ALBERTA,DEPT FOODS & NUTR,EDMONTON T6G 2M8,ALBERTA,CANADA.",,"McBurney, Michael I./AAB-6850-2019","McBurney, Michael I./0000-0003-4511-6034",,,,,25,21,24,0,4,ELSEVIER SCIENCE INC,NEW YORK,"655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010",0899-9007,,,NUTRITION,Nutrition,NOV-DEC,1991,7,6,,,,,421,424,,,,,,4,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,HC113,1666322,,,,2024-06-04,WOS:A1991HC11300006,View Full Record in Web of Science
J,"Chin, TP; Yusop, NBM",,,,"Chin, Tan Phooi; Yusop, Nor Baizura Mad.",,,Undergraduate Students' Lifestyle: Are They at Risk of Constipation?,ANNALS OF NUTRITION AND METABOLISM,,,English,Meeting Abstract,,,,,,Constipation; Energy; Dietary fiber; Total fluid intake,,,"[Chin, Tan Phooi; Yusop, Nor Baizura Mad.] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Nutr & Dietet, Serdang, Selangor, Malaysia",Universiti Putra Malaysia,,,,,,,,,0,0,0,0,0,KARGER,BASEL,"ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND",0250-6807,1421-9697,,ANN NUTR METAB,Ann. Nutr. Metab.,,2019,75,,,3,,403,145,145,,,,,,1,Endocrinology & Metabolism; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Endocrinology & Metabolism; Nutrition & Dietetics,IP7XY,,,,,2024-06-04,WOS:000480262701125,View Full Record in Web of Science
J,"ANDERSON, AS; WHICHELOW, MJ",,,,"ANDERSON, AS; WHICHELOW, MJ",,,CONSTIPATION DURING PREGNANCY - DIETARY FIBER INTAKE AND THE EFFECT OF FIBER SUPPLEMENTATION,HUMAN NUTRITION-APPLIED NUTRITION,,,English,Article,,,,,,,,,,,"ANDERSON, AS (corresponding author), ABERDEEN ROYAL INFIRM,DEPT DIETET,ABERDEEN AB9 2ZB,SCOTLAND.",,,"anderson, annie/0000-0002-0047-4500",,,,,17,29,32,1,10,JOHN LIBBEY & CO LTD,LONDON,"13 SMITHS YARD SUMMERLEY ST, LONDON, ENGLAND SW18 4HR",0308-4329,,,HUM NUTR-APPL NUTR,,,1985,39A,3,,,,,202,207,,,,,,6,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,ANS59,2995279,,,,2024-06-04,WOS:A1985ANS5900005,View Full Record in Web of Science
J,"Huaman, JW; Mego, M; Bendezú, A; Monrroy, H; Samino, S; Accarino, A; Saperas, E; Azpiroz, F",,,,"Huaman, Jose-Walter; Mego, Marianela; Bendezu, Alvaro; Monrroy, Hugo; Samino, Sara; Accarino, Anna; Saperas, Esteban; Azpiroz, Fernando",,,"Correction of Dyssynergic Defecation, but Not Fiber Supplementation, Reduces Symptoms of Functional Dyspepsia in Patients With Constipation in a Randomized Trial",CLINICAL GASTROENTEROLOGY AND HEPATOLOGY,,,English,Article,,,,,,Abdominal Pain; Abdominal Distension; Anorectal Biofeedback; Intestinal Gas,BIOFEEDBACK; PERCEPTION; RESPONSES; THERAPY; HUMANS,"BACKGROUND & AIMS: Patients with functional dyspepsia are believed to have increased sensitivity of the gastrointestinal tract, and some also have functional constipation. We investigated whether in patients with functional dyspepsia, correction of dyssynergic defecation can reduce postprandial fullness. METHODS: We performed a parallel trial at 2 referral centers in Spain, from June 2016 through January 2018 of 50 patients who fulfilled the Rome IV criteria for functional dyspepsia with postprandial distress syndrome and functional constipation and dyssynergic defecation. After a 2-week pretreatment phase, the patients were randomly assigned to groups that learned to correct dyssynergic defecation (2-3 sessions of biofeedback combined with instructions for daily exercise; n = 25) or received dietary fiber supplementation (3.5 g plantago ovata per day; n = 25) for 4 weeks. The primary outcome was change in postprandial abdominal fullness, measured daily on a scale of 0-10, during the last 7 days treatment phase vs the last 7 days of the pretreatment phase. Anal gas evacuations were measured (by an event marker) during the last 2 days of the pretreatment vs treatment phases. RESULTS: Biofeedback treatment corrected dyssynergic defecation in 19/25 patients; corrected dyssynergic defection reduced postprandial fullness by 22%+/- 1% in these patients (P < .001), and reduced the number of anal evacuations by 21%+/- 8% (P = .009). Fiber supplementation did not reduce postprandial fullness or anal evacuations (P <= .023 between groups for both parameters in the intent to treat analysis). CONCLUSIONS: Diagnosis and correction of dyssynergic defecation reduces dyspeptic symptoms by more than 20% in patients with functional dyspepsia and associated constipation. Dietary fiber supplementation does not reduce symptoms in these patients.","[Huaman, Jose-Walter; Mego, Marianela; Bendezu, Alvaro; Monrroy, Hugo; Accarino, Anna; Azpiroz, Fernando] Univ Autonoma Barcelona, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Dept Med, Digest Syst Res Unit,Univ Hosp Vall dHebron, Bellaterra, Spain; [Huaman, Jose-Walter; Mego, Marianela; Bendezu, Alvaro; Saperas, Esteban] Univ Hosp Gen Catalonia, Dept Gastroenterol, San Cugat Del Valles, Spain; [Samino, Sara] Univ Rovira & Virgili, Metabol Platform, Campus Sescelades, Tarragona, Spain; [Samino, Sara] Inst Carlos III, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain",Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Universitat Rovira i Virgili; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM,"Azpiroz, F (corresponding author), Hosp Gen Valle Hebron, Digest Syst Res Unit, Barcelona 08035, Spain.",azpiroz.fernando@gmail.com,"Huaman, Jose Walter/AAU-1967-2020; Silva, Marianela Mego/ABH-6421-2020; Azpiroz, Maite Fuentes/Y-6916-2018; Monrroy, Hugo/GLT-8152-2022","Azpiroz, Maite Fuentes/0000-0003-1304-1285; Monrroy, Hugo/0000-0002-4740-3945; Samino, Sara/0000-0001-8371-679X; Azpiroz, Fernando/0000-0002-7327-960X",Spanish Ministry of Economy and Competitiveness (Direccion General de Investigacion Cientifica y Tecnica) [SAF 2016-76648-R]; Instituto de Salud Carlos III,Spanish Ministry of Economy and Competitiveness (Direccion General de Investigacion Cientifica y Tecnica)(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIISpanish Government),"The present study was supported by the Spanish Ministry of Economy and Competitiveness (Direccion General de Investigacion Cientifica y Tecnica, SAF 2016-76648-R). The Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas funded by the Instituto de Salud Carlos III.",,19,5,5,0,3,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",1542-3565,1542-7714,,CLIN GASTROENTEROL H,Clin. Gastroenterol. Hepatol.,OCT,2020,18,11,,,,,2463,+,,10.1016/j.cgh.2019.11.048,http://dx.doi.org/10.1016/j.cgh.2019.11.048,,,9,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,NT2ZY,31811952,hybrid,,,2024-06-04,WOS:000572816500023,View Full Record in Web of Science
J,"Han, SH; Park, K; Kim, EY; Ahn, SH; Lee, HS; Suh, HJ",,,,"Han, Sung Hee; Park, Kyungmi; Kim, Eun Young; Ahn, So Hyun; Lee, Hyun-Sun; Suh, Hyung Joo",,,Cactus (Opuntia humifusa) water extract ameliorates loperamide-induced constipation in rats,BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE,,,English,Article,,,,,,Cheonnyuncho; Opuntia humifusa; Constipation; Loperamide; Gastrointestinal transit,DIETARY FIBER; FICUS-INDICA; CLADODES; MUCIN; PRESSURE; HEALTH; FRUIT; SEEDS; FOOD,"Background: Korean cactus Cheonnyuncho (Opuntia humifusa) is rich in pectin, phenols, flavonoids, and minerals such as calcium and phosphorus. Some Koreans drink Cheonnyuncho juice prepared by grinding Cheonnyuncho with water. Cheonnyuncho is well known for its functional properties and antioxidant effects, but its effect on constipation has not been sufficiently studied. Methods: Loperamide (2 mg/kg) was injected subcutaneously to induce constipation in rats. The animals were divided into four groups: a normal group (NOR), constipation control group (CON), and two constipation groups receiving the Cheonnyuncho extract (CE) at two different concentrations in drinking water, 3% (L-CE group) and 6% (H-CE group), for 25 days. Results: The fecal pellet numbers of NOR and L-CE were significantly increased from 35.67 +/- 2.09 (CON) to 50.60 +/- 1.38 and 46.50 +/- 2.91 after loperamide treatment, respectively (p < 0.05). The water content of fecal excretions was significantly enhanced in only the L-CE group (33.05 +/- 0.49%) compared to control (23.38 +/- 1.26%) (p < 0.05) after loperamide treatment. The oral intake of CE (L-CE and H-CE groups) significantly increased levels of the intestinal transit ratio (45.25 +/- 1.86% and 41.05 +/- 2.47%, respectively) compared to the CON group (32.15 +/- 2.05%) (p < 0.05). Treatment with the low concentration of CE significantly increased fecal levels of acetic, propionic, butyric, and valeric acids, as well as the total short-chain fatty acid (SCFA) concentration. Histological analyses revealed that the thickness of the distal colon also increased in the CE-treated groups in a dose-dependent manner. Conclusions: Constipation decreased when CE was fed to the rats. In particular, the fecal pellet number and water content, as well as histological parameters such as distal colon thickness, improved. The CE treatment also increased the fecal SCFA content. These results show that the extract of Cheonnyuncho (O. humifusa) alleviated the symptoms of loperamide-induced constipation.","[Han, Sung Hee] Korea Univ, Coll Hlth Sci, BK21Plus, Seoul 02841, South Korea; [Park, Kyungmi] Herbalife Korea, Regulatory Affairs & Prod Compliance Korea & Phil, Seoul 06052, South Korea; [Kim, Eun Young; Ahn, So Hyun] Korea Univ, Dept Food & Nutr, Seoul 02841, South Korea; [Lee, Hyun-Sun] Agcy Korea Natl Food Cluster, Iksan 54622, South Korea; [Suh, Hyung Joo] Korea Univ, Grad Sch, Dept Publ Hlth Sci, Seoul 02841, South Korea",Korea University; Korea University; Korea University,"Suh, HJ (corresponding author), Korea Univ, Grad Sch, Dept Publ Hlth Sci, Seoul 02841, South Korea.",suh1960@korea.ac.kr,,"Han, Sung Hee/0000-0003-0825-6687","Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) through the High Value-Added Food Technology Development Program - Ministry of Agriculture, Food and Rural Affairs (MAFRA) [114037-03-2-HD030]","Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) through the High Value-Added Food Technology Development Program - Ministry of Agriculture, Food and Rural Affairs (MAFRA)","This work was supported by the Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) through the High Value-Added Food Technology Development Program funded by the Ministry of Agriculture, Food and Rural Affairs (MAFRA) (114037-03-2-HD030).",,43,29,35,2,21,BMC,LONDON,"CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND",1472-6882,,,BMC COMPLEM ALTERN M,BMC Complement. Altern. Med.,JAN 17,2017,17,,,,,,,,49,10.1186/s12906-016-1552-8,http://dx.doi.org/10.1186/s12906-016-1552-8,,,8,Integrative & Complementary Medicine,Science Citation Index Expanded (SCI-EXPANDED),Integrative & Complementary Medicine,EI2WX,28095842,"gold, Green Published",,,2024-06-04,WOS:000392350200001,View Full Record in Web of Science
J,"Soares, ACF; Lederman, HM; Fagundes-Neto, U; de Morais, MB",,,,"Soares, ACF; Lederman, HM; Fagundes-Neto, U; de Morais, MB",,,Breath methane associated with slow colonic transit time in children with chronic constipation,JOURNAL OF CLINICAL GASTROENTEROLOGY,,,English,Article,,,,,,methane; constipation; children; colonic transit time,COLORECTAL-CANCER; DIETARY FIBER; LARGE-BOWEL; EXCRETION; ENCOPRESIS; BACTERIA,"Objective: This study analyzed the relationship between methane production and colonic transit time in children with chronic constipation. Methodology: Forty children, from 3 to 13 years of age, suffering from chronic constipation were included. Methane production was defined when the breath methane concentration was greater than 3 ppm. The total and segmental colonic transit times were measured with radio-opaque markers. Results: Soiling was present in 34 (85.0 %) of 40 patients with constipation. Methane production was present in 25 of 34 (73.5 %) patients with constipation and soiling and only in 1 (16.7 %) of 6 with constipation but without soiling (P = 0.014). The medians of total colonic transit time were 80.5 and 61.0 hours, respectively (P = 0.04), in methane and nonmethane producers. Segmental colonic transit times were 17.5 and 10.5 hours, respectively (P = 0.580), in right colon, 29.5 and 10.5 hours (P = 0.001), respectively, in left colon, and 31.5 and 27.0 hours (P = 0.202), respectively, in the rectosigmoid. By the sixth week of treatment, the reduction in the total colonic transit time was greater in patients who had become nonmethane producers. Conclusion: The presence of breath methane in children with chronic constipation may suggest the possibility of prolonged colonic transit time.","Univ Fed Sao Paulo, Paulista Sch Med, Pediat Gastroenterol Div, Sao Paulo, SP, Brazil; Univ Fed Sao Paulo, Paulista Sch Med, Dept Radiol, Sao Paulo, SP, Brazil",Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP),"Rua Araioses 75, BR-05442010 Sao Paulo, SP, Brazil.",mbmorais@osite.com.br,"MORAIS, MAURO B/I-7995-2014","Fontenele Soares, Ana Cristina/0000-0002-2246-9913; Batista de Morais, Mauro/0000-0003-4014-5549",,,,,27,52,64,1,6,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0192-0790,1539-2031,,J CLIN GASTROENTEROL,J. Clin. Gastroenterol.,JUL,2005,39,6,,,,,512,515,,10.1097/01.mcg.0000165665.94777.bd,http://dx.doi.org/10.1097/01.mcg.0000165665.94777.bd,,,4,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,936UY,15942438,,,,2024-06-04,WOS:000229882100009,View Full Record in Web of Science
J,"Fenton, C; Kang, C",,,,"Fenton, Caroline; Kang, Connie",,,Managing functional constipation: the course doesn't always run smooth,DRUGS & THERAPY PERSPECTIVES,,,English,Article,,,,,,,PLACEBO-CONTROLLED TRIAL; CHRONIC IDIOPATHIC CONSTIPATION; BALANCED SOLUTION PMF-100; DOUBLE-BLIND; CLINICAL-TRIAL; EFFICACY; SAFETY; PRUCALOPRIDE; MULTICENTER; BISACODYL,"Chronic functional constipation is symptomatically defined and includes dyssynergic defaecation and normal and slow transit constipation, not secondary to drugs or other conditions. Dietary soluble fibre and laxatives are key treatments, with biofeedback helpful especially in dyssynergic defaecation. Newer pro-secretory and motility-stimulating agents may help those non-responsive to over-the-counter treatments. Although head-to-head and combination therapy trials are lacking, combination therapy in people not responsive to monotherapy is a reasonable approach.","[Fenton, Caroline; Kang, Connie] Springer Nat, Private Bag 65901, Auckland 0754, New Zealand",,"Kang, C (corresponding author), Springer Nat, Private Bag 65901, Auckland 0754, New Zealand.",dtp@adis.com,,,,,,,34,0,0,0,1,SPRINGERNATURE,LONDON,"CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND",1172-0360,1179-1977,,DRUGS THER PERSPECT,Drugs. Ther. Perspect.,MAR,2021,37,3,,,,,108,114,,10.1007/s40267-020-00803-0,http://dx.doi.org/10.1007/s40267-020-00803-0,,,7,Pharmacology & Pharmacy,Emerging Sources Citation Index (ESCI),Pharmacology & Pharmacy,YW5RF,,,,,2024-06-04,WOS:000753469700002,View Full Record in Web of Science
J,"de Oliveira, MBB; Jardim-Botelho, A; de Morais, MB; Melo, IRD; Maciel, JF; Gurgel, RQ",,,,"de Oliveira, Marcela Barros Barbosa; Jardim-Botelho, Anne; de Morais, Mauro Batista; da Cruz Melo, Ingrid Ribeiro; Maciel, Julia Franco; Gurgel, Ricardo Queiroz",,,Impact of Infant Milk-Type and Childhood Eating Behaviors on Functional Constipation in Preschool Children,JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION,,,English,Article,,,,,,breastfeeding; child; constipation; eating behavior; preschool,PHYSICAL-ACTIVITY; DIETARY FIBER; EPIDEMIOLOGY; ASSOCIATIONS; SYMPTOMS; RISK,"Objective: To investigate the association between functional constipation, infant feeding in early infancy and eating behavior in preschool children. Methodology: A cross-sectional study was undertaken in public and private schools in the state of Sergipe (Northeast of Brazil). The sample calculation was based on a 25% estimate of constipation prevalence in Brazilian children, resulting in a sample size of 1051 children. Functional constipation was assessed using Rome IV criteria. Eating behavior was assessed using the Children's Eating Behavior Questionnaire. Adjusted odds ratios were estimated using a multivariate model. Results: The prevalence of functional constipation was 23%. After adjusting for water intake, children with food fussiness were >6 times likely to have constipation (odds ratio [OR] = 6.65; 95% confidence interval [CI] 5.19-8.52). Children who were fed with cow's milk in the first 6 months of age were up to 15.2 times more likely to have functional constipation. Bottle feeding at 0-6 months of age increased the risk of functional constipation at preschool age (whole cow's milk: OR = 17.02; 95% CI 7.33-39.51, infant formula: OR = 6.35; 95% CI 3.42-11.79, mixed breastfeeding: OR = 10.83; 95% CI 4.57-25.69). Conclusion: Food fussiness and the use of cow's milk-based feeding bottles at 0-6 months of age were associated with functional constipation in preschool children.","[de Oliveira, Marcela Barros Barbosa; Jardim-Botelho, Anne; da Cruz Melo, Ingrid Ribeiro; Gurgel, Ricardo Queiroz] Univ Fed Sergipe, Grad Program Hlth Sci, Univ Hosp, Aracaju, Sergipe, Brazil; [de Morais, Mauro Batista] Fed Univ Sao Paulo UNIFESP, Discipline Pediat Gastroenterol, Sao Paulo, SP, Brazil; [Maciel, Julia Franco] Univ Fed Sergipe, Univ Hosp, Rua Claudio Batista S-N, BR-49060100 Aracaju, Sergipe, Brazil",Universidade Federal de Sergipe; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sergipe,"de Oliveira, MBB (corresponding author), Univ Fed Sergipe, Univ Hosp, Rua Claudio Batista S-N, BR-49060100 Aracaju, Sergipe, Brazil.",marcela.nutriufs@yahoo.com.br,"MORAIS, MAURO B/I-7995-2014","Maciel, Julia/0000-0002-8603-6367",FAPITEC,FAPITEC(Fundacao de Amparo a Pesquisa do Estado do Sergipe (FAPITEC)),"We thank the parents/guardians and children for their participation in this study. The study was funded by FAPITEC and the text was professionally revised by Scientific Editing Company, Scotland.",,41,5,5,0,0,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0277-2116,1536-4801,,J PEDIATR GASTR NUTR,J. Pediatr. Gastroenterol. Nutr.,SEP,2021,73,3,,,,,E50,E56,,10.1097/MPG.0000000000003163,http://dx.doi.org/10.1097/MPG.0000000000003163,,,7,Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,TX4LP,33938529,,,,2024-06-04,WOS:000683060000005,View Full Record in Web of Science
J,"Jeon, JR; Choi, JH",,,,"Jeon, Jeong Ryae; Choi, Joon Hyuk",,,Lactic Acid Fermentation of Germinated Barley Fiber and Proliferative Function of Colonic Epithelial Cells in Loperamide-Induced Rats,JOURNAL OF MEDICINAL FOOD,,,English,Article,,,,,,constipation; epithelial cell; germinated barley fiber; lactic acid fermentation; loperamide,SODIUM-INDUCED COLITIS; DIETARY FIBER; FOODSTUFF; BIFIDOBACTERIUM; COMBINATION; BACTERIA; DAMAGE; MUCUS,"To develop a functional food from the dietary fiber fraction of germinated barley (Hordeum vulgare L.) (GBF), lactic acid fermentation was attempted using Lactobacillus acidophilus, Streptococcus thermophilus, and Bifidobacterium bifidus. The quality characteristics of the lactic acid-fermented product and its effect on gastrointestinal function in an animal model were examined. The anaerobic fermentation of 1% and 2% GBF yielded lactic acid bacteria at 8.9 +/- 1.0 x 10(8) and 1.6 +/- 0.2 x 10(9) colony-forming units/mL, and it was considered acceptable for consumption by sensory assessment. To determine the effect on gastrointestinal function, Sprague-Dawley rats were fed with three types of diets: a normal chow diet and chow diets supplemented with 10% lactic acid bacteria or a yogurt fermented with 2% GBF (GBFY). The rats fed GBFY for 6 weeks gained less body weight, excreted more fecal mass, and had improved gastrointestinal transit as examined with barium sulfate. The effect of GBFY on colonic epithelial proliferation was investigated through loperamide (LPM)-induced constipation in rats. The rats fed with GBFY for 6 weeks were intraperitoneally administered LPM twice daily for 7 days. GBFY supplementation decreased fecal excretion and moisture content in feces and depleted goblet cells as observed by hematoxylin and eosin stain. However, the rats supplemented with GBFY prior to the LPM administration had enhanced bowel movement, mucin secretion, and production of short-chain fatty acids compared with values for the LPM-alone group. Immunohistochemistry revealed that the GBFY supplement increased the numbers of nuclei stained positively for Ki-67 and extended from the base to the middle zone of crypts. These results indicate that GBFY alleviates constipation via the proliferation of the colonic crypts in LPM-administered rats.","[Choi, Joon Hyuk] Yeungnam Univ, Coll Med, Dept Pathol, Taegu 705717, South Korea; [Jeon, Jeong Ryae] Yeungnam Univ, Dept Food & Nutr, Gyongsan, South Korea",Yeungnam University; Yeungnam University,"Choi, JH (corresponding author), Yeungnam Univ, Coll Med, Dept Pathol, 317-1 Daemyung Dong, Taegu 705717, South Korea.",joonhyukchoi@ynu.ac.kr,"Choi, Joon Hyuk/AFK-3005-2022; Choi, Joon Hyuk/AAG-1437-2022",,Yeungnam University,Yeungnam University,This research was supported by a Yeungnam University research grant in 2008.,,35,15,17,2,29,"MARY ANN LIEBERT, INC",NEW ROCHELLE,"140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA",1096-620X,1557-7600,,J MED FOOD,J. Med. Food,AUG,2010,13,4,,,,,950,960,,10.1089/jmf.2009.1307,http://dx.doi.org/10.1089/jmf.2009.1307,,,11,"Chemistry, Medicinal; Food Science & Technology; Nutrition & Dietetics",Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy; Food Science & Technology; Nutrition & Dietetics,633FL,20673062,,,,2024-06-04,WOS:000280485000026,View Full Record in Web of Science
J,"Meksawan, K; Chaotrakul, C; Leeaphorn, N; Gonlchanvit, S; Eiam-Ong, S; Kanjanabuch, T",,,,"Meksawan, Kulwara; Chaotrakul, Chorsakon; Leeaphorn, Napat; Gonlchanvit, Suthep; Eiam-Ong, Somchai; Kanjanabuch, Talerngsak",,,EFFECTS OF FRUCTO-OLIGOSACCHARIDE SUPPLEMENTATION ON CONSTIPATION IN ELDERLY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS PATIENTS,PERITONEAL DIALYSIS INTERNATIONAL,,,English,Article,,,,,,Fructo-oligosaccharides; constipation; CAPD; colonic transit; elderly; nutritional status,SHORT-CHAIN FRUCTOOLIGOSACCHARIDES; HEPATIC GLUCOSE-PRODUCTION; FERMENTABLE CARBOHYDRATE; FECAL BIFIDOBACTERIA; POLYETHYLENE-GLYCOL; CHRONIC CONSUMPTION; CALCIUM-ABSORPTION; DIETARY FIBER; CAPD PATIENTS; OLIGOFRUCTOSE,"Background: Fructo-oligosaccharides (FOS) exhibit soluble-fiber properties that beneficially affect bowel function and relieve constipation. The effects of FOS supplementation on constipation and biochemical parameters were examined in elderly continuous ambulatory peritoneal dialysis (CAPD) patients. Methods: This randomized, double-blind, placebo-controlled, cross-over study was performed in elderly CAPD patients (5 males and 4 females) with chronic constipation. All subjects were randomly assigned to receive either 20 g FOS or placebo daily for 30 days. After a 14-day washout period, the patients were switched to the other substance for 1 more month. Before and after each treatment period, frequency of defecation, characteristics of feces, and colonic transit were evaluated. Biochemical parameters were also assessed. Results: Fructo-oligosaccharides significantly increased the frequency of defecation (10.5 +/- 2.0 vs 6.2 +/- 1.4 times per week, p < 0.005) and changed the feces' appearance from type 1 (nut-like) to type 4 (sausage-like). The colonic transit determined by geometric center (GC) was augmented after FOS supplementation (3.9 +/- 0.3 vs 3.2 +/- 0.4, p < 0.05). Fructo-oligosaccharides had no effects on biochemical parameters. Fructo-oligosaccharides caused mild discomforts which were well tolerated after dose adjustment. Conclusions: Fructo-oligosaccharide supplementation is effective, well tolerated, and can be an alternative to other laxatives in CAPD patients with constipation. Further-studies are needed to better assess the biochemical effects of FOS in the chronic kidney disease population.","[Meksawan, Kulwara; Chaotrakul, Chorsakon] Chulalongkorn Univ, Fac Pharmaceut Sci, Dept Food & Pharmaceut Chem, Bangkok 10330, Thailand; [Meksawan, Kulwara] Chulalongkorn Univ, Cell Based Drug & Hlth Prod Dev Res Unit, Bangkok 10330, Thailand; [Leeaphorn, Napat] Bassett Med Ctr, Dept Internal Med, Cooperstown, NY USA; [Leeaphorn, Napat] Columbia Univ Coll Phys & Surg, Cooperstown, NY USA; [Gonlchanvit, Suthep] Chulalongkorn Univ, Fac Med, Gastrointestinal Motil Res Unit, Div Gastroenterol, Bangkok 10330, Thailand; [Eiam-Ong, Somchai; Kanjanabuch, Talerngsak] Chulalongkorn Univ, Fac Med, Dept Med, Div Nephrol, Bangkok 10330, Thailand; [Kanjanabuch, Talerngsak] Chulalongkorn Univ, Fac Med, Kidney & Metab Disorders Res Unit, Bangkok 10330, Thailand",Chulalongkorn University; Chulalongkorn University; Columbia University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University,"Kanjanabuch, T (corresponding author), Chulalongkorn Univ, Fac Med, Dept Med, Div Nephrol, Bangkok 10330, Thailand.",golfnephro@hotmail.com,,"Kanjanabuch, Talerngsak/0000-0002-2996-8934","CU, Graduate School Thesis Grant, Chulalongkorn University","CU, Graduate School Thesis Grant, Chulalongkorn University","We would like to express our gratitude to Associate Professor Dr. Oranong Kangsadalampai for valuable suggestions and to Dr. Kathy Savage for reviewing the manuscript. We thank the staff of the CAPD clinic at King Chulalongkorn Memorial Hospital for their helpful cooperation and support in providing many facilities. This study was supported by CU, Graduate School Thesis Grant, Chulalongkorn University.",,35,32,34,0,14,MULTIMED INC,TORONTO,"66 MARTIN ST, TORONTO, ON L9T 2R2, CANADA",0896-8608,,,PERITON DIALYSIS INT,Perit. Dial. Int.,JAN-FEB,2016,36,1,,,,,60,66,,10.3747/pdi.2014.00015,http://dx.doi.org/10.3747/pdi.2014.00015,,,7,Urology & Nephrology,Science Citation Index Expanded (SCI-EXPANDED),Urology & Nephrology,DC3DQ,25292404,Green Published,,,2024-06-04,WOS:000369100000009,View Full Record in Web of Science
J,"Li, YL; Yu, Y; Wu, XL; Liu, B; Ma, HM; Zhao, XJ; Cao, S; Ding, SY; Li, TT; Wang, XL; Wang, P; Xu, XZ; Zhao, JY; Liu, YP; Lan, CH; Wang, J; Chen, LJ; Zeng, Q",,,,"Li, Yongli; Yu, Ying; Wu, Xiaoling; Liu, Bin; Ma, Huimin; Zhao, Xiaojuan; Cao, Shan; Ding, Suying; Li, Tiantian; Wang, Xiaolu; Wang, Pin; Xu, Xizhan; Zhao, Junying; Liu, Yanpin; Lan, Canhui; Wang, Jun; Chen, Lijun; Zeng, Qiang",,,Applied nutritional investigation Specially designed yogurt supplemented with combination of pro- and prebiotics relieved constipation in mice and humans,NUTRITION,,,English,Article,,,,,,Functional constipation; Gut microbiota; Clinical treatment; Yogurt; Metagenomics; Patient assessment scores,QUALITY-OF-LIFE; INULIN-TYPE FRUCTANS; COLONIC TRANSIT; LACTOBACILLUS; PROBIOTICS; MICROBIOTA; SYMPTOMS; PERMEABILITY; VALIDATION; ACTIVATION,"Objective: Functional constipation is a gastrointestinal disorder that affects millions of people and is correlated with gut microbiome dysbiosis. The currently available treatments are ineffective; therefore, novel treatment schemes targeting the gut microbiome are desired. The aim of this study was to assess the effects of yogurt supplemented with seven probiotic strains and six types of dietary fibers on functional constipation.Methods: In the mouse study, mice with induced constipation were administered the yogurt once a day for 1 wk, with fecal parameters and intestinal transit rate measured. In the clinical study, participants with constipation (N = 86) were given the yogurt once daily (200 g) for 4 wk. Fecal and blood samples along with Patient Assessment of Constipation-symptoms and Patient Assessment of Constipation-Quality of Life Scale questionnaires were collected to evaluate the safety and efficacy of the yogurt. Shotgun metagenomic sequencing was performed to analyze fecal samples of both mice and humans.Results: We found that constipated mice had different gut microbiomes compared with those in healthy controls; yogurt treatment significantly relieved constipation-related symptoms and resulted in shifts in the microbiome. Yogurt also relieved symptoms of antibiotic-induced constipation in mice and restored the gut microbiome to a certain extent. In the clinical trial with 86 patients, yogurt administration significantly improved constipation symptoms and showed no serious adverse effects (was generally considered safe). However, subsequent metagenomic profiling of the gut microbiome did not reveal significant changes in the microbial composition, in contrast to the results in mice. We hypothesize that the differences in dosage between mice and humans may attribute to such discrepancies, and microbiome changes may not be necessary for improvements of constipation symptoms in humans.","[Li, Yongli; Ma, Huimin; Zhao, Xiaojuan; Cao, Shan] Henan Prov Peoples Hosp, Dept Hlth Management Ctr, Zhengzhou, Peoples R China; [Li, Yongli; Wu, Xiaoling; Ma, Huimin; Zhao, Xiaojuan; Cao, Shan] Zhengzhou Univ, Peoples Hosp, Zhengzhou, Peoples R China; [Yu, Ying; Xu, Xizhan; Wang, Jun] Chinese Acad Sci, Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing, Peoples R China; [Wu, Xiaoling] Henan Prov Peoples Hosp, Dept Nucl Med, Zhengzhou, Peoples R China; [Liu, Bin; Zhao, Junying; Liu, Yanpin; Chen, Lijun] Beijing Sanyuan Foods Co Ltd, Natl Engn Ctr Dairy Maternal & Child Hlth, Beijing, Peoples R China; [Ding, Suying; Li, Tiantian] Zhengzhou Univ, Hlth Management Ctr, Affiliated Hosp 1, Zhengzhou, Peoples R China; [Wang, Xiaolu; Wang, Pin] Hosp Zhengzhou YiHe, Hlth Management Ctr, Zhengzhou, Peoples R China; [Lan, Canhui] Beijing Rexinchang Biotechnol Res Inst Co Ltd, Beijing, Peoples R China; [Zeng, Qiang] Chinese Peoples Liberat Army Gen Hosp, Hlth Management Inst, Med Ctr 2, Beijing, Peoples R China; [Zeng, Qiang] Chinese Peoples Liberat Army Gen Hosp, Natl Clin Res Ctr Geriatr Dis, Beijing, Peoples R China","Zhengzhou University; Zhengzhou University; Chinese Academy of Sciences; Institute of Microbiology, CAS; Zhengzhou University; Zhengzhou University; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital","Chen, LJ (corresponding author), Beijing Sanyuan Foods Co Ltd, Natl Engn Ctr Dairy Maternal & Child Hlth, Beijing, Peoples R China.;Zeng, Q (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Hlth Management Inst, Med Ctr 2, Beijing, Peoples R China.;Zeng, Q (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Natl Clin Res Ctr Geriatr Dis, Beijing, Peoples R China.",chenlijun@sanyuan.com.cn; zq301@126.com,"Lan, Canhui/JTU-3162-2023; Xu, Xizhan/C-4259-2018; qin, cheng/KHC-3344-2024; Cao, Shan/JOZ-2892-2023; 马, 会民/AAM-8054-2021; CAO, ying/KFA-2972-2024","Lan, Canhui/0000-0001-6052-1041; 马, 会民/0000-0001-6155-9076; Yu, Ying/0000-0002-7009-5901",National Natural Science Foundation of China [81872920]; Beijing Science and Technology Plan [Z201100008020005],National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Science and Technology Plan,"This work was supported by the National Natural Science Foundation of China (grant no. 32072191) ; Beijing Science and Technology Plan (grant no. Z201100008020005) ; and National Natural Science Foundation of China (grant no. 81872920) . YL, YY, XW, and BL contributed to the work equally and should be regarded as co-first authors.",,42,1,1,9,35,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",0899-9007,1873-1244,,NUTRITION,Nutrition,NOV-DEC,2022,103-104,,,,,,,,111802,10.1016/j.nut.2022.111802,http://dx.doi.org/10.1016/j.nut.2022.111802,,SEP 2022,8,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,4W9IQ,36063723,hybrid,,,2024-06-04,WOS:000860468800006,View Full Record in Web of Science
J,"Zhou, X; Chen, YF; Ma, X; Yu, Y; Yu, XP; Chen, XY; Suo, HY",,,,"Zhou, Xu; Chen, Yafang; Ma, Xin; Yu, Yang; Yu, Xueping; Chen, Xiaoyong; Suo, Huayi",,,Efficacy of Bacillus coagulans BC01 on loperamide hydrochloride-induced constipation model in Kunming mice,FRONTIERS IN NUTRITION,,,English,Article,,,,,,Bacillus coagulans; constipation; loperamide hydrochloride; intestinal function; fecal microbial diversity,FUNCTIONAL CONSTIPATION; INTERSTITIAL-CELLS; DIETARY FIBER; MICROBIOTA; PROBIOTICS; MOTILITY; CAJAL,"In this study, the laxative effect of Bacillus coagulans BC01 (BC01) in mice was investigated using a functional constipation mouse model. Six-week-old male specific pathogen-free (SPF) Kunming mice were randomly divided into five groups: normal control group (saline), model group (loperamide hydrochloride), drug control group (bisacodyl), BC01 low-dose group (4.0 x 10(8) CFU/mL) and BC01 high-dose group (4.0 x 10(9) CFU/mL). Except for the normal group, the functional constipation model was established by administering 0.25 mL of a loperamide hydrochloride suspension (1 mg/mL) twice daily for four consecutive days by oral gavage. After modeling, the BC01 groups were administered 0.25 mL of BC01. The bisacodyl served as a control and was administered orally at a dose of 100 mg/kg, while the other groups were administered 0.25 mL of sterile saline. After 7 days of continuous administration, the experimental mice were again induced by loperamide hydrochloride. During this period, the mechanism of BC01 to improve constipation symptoms in mice was analyzed by measuring the changes in body weight, fecal water content, small intestine propulsion rate, histology of small intestinal tissue sections, fecal microbial diversity, serum indices, as well as mRNA and protein expression levels in the small intestinal tissue. BC01 was found to significantly promote the intestinal propulsion rate and increase the fecal water content in the mice. BC01 could also alleviates constipation by regulating gastrointestinal motility (substance P, motilin, endothelin-1, somatostatin, and vasoactive intestinal peptide), gene expression (c-Kit, SCF, COX-2, NF-kappa B, iNOS, and eNOS), intestinal inflammation (eNOS, iNOS, NF-kappa B), and the intestinal microbiota composition in the constipated mice. In addition, the high-dose BC01 treatment had the best preventive effect on constipation. BC01 is a probiotic strain to effectively relieve the adverse effects of constipation.","[Zhou, Xu; Chen, Xiaoyong; Suo, Huayi] Southwest Univ, Coll Food Sci, Chongqing, Peoples R China; [Chen, Yafang] First Peoples Hosp Kunshan, Suzhou, Peoples R China; [Ma, Xin; Yu, Yang; Yu, Xueping] Thankcome Biol Sci & Technol Suzhou Co Ltd, Suzhou, Peoples R China",Southwest University - China,"Suo, HY (corresponding author), Southwest Univ, Coll Food Sci, Chongqing, Peoples R China.",birget@swu.edu.cn,"yu, xueping/M-9687-2013; Yang, Jing/JFK-4046-2023; Ma, Xin/KBQ-4275-2024","Yang, Jing/0009-0004-8274-9863; Ma, Xin/0000-0002-1605-9061",Innovation Center of Food Safety and Quality Control in Jiangsu Province; University Innovation Research Group in Chongqing; Key Construction Disciplines of Traditional Chinese Medicine in Chongqing; [CXQT21007]; [2021-4322190044],Innovation Center of Food Safety and Quality Control in Jiangsu Province; University Innovation Research Group in Chongqing; Key Construction Disciplines of Traditional Chinese Medicine in Chongqing; ;,Funding This study was supported by Innovation Center of Food Safety and Quality Control in Jiangsu Province; University Innovation Research Group in Chongqing (CXQT21007) and Key Construction Disciplines of Traditional Chinese Medicine in Chongqing (2021-4322190044).,,45,8,8,5,34,FRONTIERS MEDIA SA,LAUSANNE,"AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND",2296-861X,,,FRONT NUTR,Front. Nutr.,SEP 21,2022,9,,,,,,,,964257,10.3389/fnut.2022.964257,http://dx.doi.org/10.3389/fnut.2022.964257,,,13,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,6Q1WX,36211526,"gold, Green Published",,,2024-06-04,WOS:000891410500001,View Full Record in Web of Science
J,"Böhmer, CJM; Taminiau, JAJM; Klinkenberg-Knol, EC; Meuwissen, SGM",,,,"Böhmer, CJM; Taminiau, JAJM; Klinkenberg-Knol, EC; Meuwissen, SGM",,,The prevalence of constipation in institutionalized people with intellectual disability,JOURNAL OF INTELLECTUAL DISABILITY RESEARCH,,,English,Article,,,,,,colon motility; constipation; intellectual disability; laxatives; predisposing factors; slow transit time,CORD-INJURED PATIENTS; SPINAL-CORD; GASTROESOPHAGEAL REFLUX; COLONIC TRANSIT; BOWEL FUNCTION; FG SYNDROME; DIETARY FIBER; CHILDREN; INDIVIDUALS; MANAGEMENT,"Constipation is a common problem in people with intellectual disability (ID). Laxatives are frequently prescribed with disappointing results. The prevalence of constipation was investigated in a random population of 215 people with ID (IQ < 50) and constipation was correlatead with clinical symptoms. All subjects were scored for bowel habits. Constipation was defined as having a bowel movement less than three times a week or the necessity of using laxatives more than three times a week. Further possible accompanying factors were evaluated. The control subjects were defined as individuals who did not use laxatives. Subjects with constipation were defined as patients and were compared to subjects without constipation (controls). One hundred and forty-nine out of 215 cases (69.3%) showed constipation. Constipation was significantly correlated with non-ambulancy, cerebral palsy, the use of anticonvulsive medication or benzodiazepines, H-2-receptor antagonists or proton pump inhibitors, food refusal, and an IQ < 35. Fifty-eight per cent of the patients used bisacodyl or magnesium oxide, 39% lactulose, 13% sodium-laurylsulphoacetate/sodium citrate/sorbitol and only 10% were given sodium phosphate enemas. Faecal soiling was found in 15% of subjects, while manual evacuation of faeces was performed in nearly 7% of cases. Constipation was randomly demonstrated in almost 70% of the population with ID. Subjects with the above-mentioned accompanying factors are especially at risk for constipation. Contrary to the general population, constipation in people with ID is associated with little use of phosphate enemas, microlax, a low incidence of faecal soiling and manual evacuation of faeces, suggesting an aetiology without distal faecal impaction. The regimen and effect of therapy has to be studied to define adequate treatment schedules.","Vrije Univ Amsterdam, Acad Hosp, Dept Gastroenterol, NL-1007 MB Amsterdam, Netherlands; Emma Childrens Hosp, Acad Med Ctr, Dept Paediat Gastroenterol, Amsterdam, Netherlands",Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital,,CJM.Bohmer@AZVU.NL,,,,,,,50,78,88,0,14,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0964-2633,1365-2788,,J INTELL DISABIL RES,J. Intell. Disabil. Res.,JUN,2001,45,,3,,,,212,218,,10.1046/j.1365-2788.2001.00300.x,http://dx.doi.org/10.1046/j.1365-2788.2001.00300.x,,,7,"Education, Special; Genetics & Heredity; Clinical Neurology; Psychiatry; Rehabilitation",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Education & Educational Research; Genetics & Heredity; Neurosciences & Neurology; Psychiatry; Rehabilitation,446DC,11422645,,,,2024-06-04,WOS:000169496800004,View Full Record in Web of Science
J,"Abd El Azeem, AM; Alsharnoubi, J; Mohamed, MA",,,,"Abd El Azeem, Amany M.; Alsharnoubi, Jehan; Abd El-Rahman Mohamed, Marwa",,,Laser acupuncture improving functional chronic constipation in children: a randomized controlled trial,LASERS IN MEDICAL SCIENCE,,,English,Article,,,,,,Functional chronic constipation; Laser acupuncture; Lactulose; Bristol stool scale,CHRONIC IDIOPATHIC CONSTIPATION; MANAGEMENT; EFFICACY,"Functional chronic constipation (FCC) is a disorder caused by low fiber consumption, lack of fluid intake, lack of mobility, or side effects of medications. The objective of this study was to compare the effects of laser acupuncture and the commonly used osmotic laxative, lactulose (as the control), both combined with behavioral therapy and dietary modification, on children with FCC in a randomized controlled trial (RCT). Forty children were randomly chosen, aged 5-15 years with FCC, and randomized into two equal groups (gender ratio (50% male; 50% female), mean +/- SD weight (24.2 +/- 6.27 kg and 25.7 +/- 7.47 kg for groups A and B, respectively)). Study group (group A): used laser acupuncture (650 nm), 30 mW, 0.15 cm(2) spot size, 90 s per acupuncture point (ST25, ST36, ST37, BL25, and LI11). Control group (group B): lactulose syrup (1 to 3 mL/kg/day) orally, in divided doses 3 times weekly for 4 weeks, and behavioral training for both groups. Evaluations were conducted before and after the study to assess the efficacy of the therapy. Median value frequency significantly increased in groups A and B post-treatment (4 (6.75-3) and 3 (3.75-2), respectively) compared to pre-treatment (2 (2-1) and 2 (2-0.25), respectively) (p = 0.0001), in favor of group A (p = 0.01). Significant improvement of stool consistency according to Bristol stool scale (BSS) in groups A and B (p = 0.0001), (p = 0.002) respectively in favor of group A (p = 0.03). T-test, Fisher, and Wilcoxon signed rank tests were conducted to compare groups. Non-invasive, painless laser acupuncture therapy can be considered as an alternative therapy for patients with FCC.","[Alsharnoubi, Jehan] Cairo Univ, Natl Inst Laser Enhanced Sci NILES, Cairo, Egypt; [Abd El-Rahman Mohamed, Marwa] Cairo Univ, Fac Phys Therapy, Dept Phys Therapy Women Hlth, Cairo, Egypt",Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University,"Alsharnoubi, J (corresponding author), Cairo Univ, Natl Inst Laser Enhanced Sci NILES, Cairo, Egypt.",jehanalsharnoubi@niles.cu.edu.eg,,,"The Science, Technology & Innovation Funding Authority (STDF); The Egyptian Knowledge Bank (EKB)","The Science, Technology & Innovation Funding Authority (STDF)(Science and Technology Development Fund (STDF)); The Egyptian Knowledge Bank (EKB)","Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).",,28,1,1,3,6,SPRINGER LONDON LTD,LONDON,"236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND",0268-8921,1435-604X,,LASER MED SCI,Lasers Med. Sci.,FEB 15,2023,38,1,,,,,,,72,10.1007/s10103-023-03727-z,http://dx.doi.org/10.1007/s10103-023-03727-z,,,7,"Engineering, Biomedical; Surgery",Science Citation Index Expanded (SCI-EXPANDED),Engineering; Surgery,9F0MM,36790507,"Green Published, hybrid",,,2024-06-04,WOS:000937170800001,View Full Record in Web of Science
J,"Jin, H; Park, J; Li, R; Ji, GE; Johnston, TV; Choe, D; Park, SH; Park, MS; Ku, SC",,,,"Jin, Hui; Park, Jiwon; Li, Rui; Ji, Geun Eog; V. Johnston, Tony; Choe, Deokyeong; Park, Se -Ho; Park, Myeong Soo; Ku, Seockmo",,,"A randomized, double-blind, controlled human study: The efficacy of exopolysaccharides in milk fermented by Weissella confusa VP30 (VP30-EPS) to ameliorate functional constipation",JOURNAL OF FUNCTIONAL FOODS,,,English,Article,,,,,,Constipation; Exopolysaccharide; EPS; Weissella confusa VP30; Probiotics,DIETARY FIBER INTAKE; LEUCONOSTOC-PSEUDOMESENTEROIDES; LAXATIVE USE; FLUID INTAKE; HUMAN FECES; DEXTRAN; ADULTS; CHILDREN; YOGURT; PURIFICATION,"A randomized, double-blind, controlled human study was conducted to examine the effect of consuming exopolysaccharide (EPS) in milk fermented by Weissella confusa VP30 (VP30) on functional constipation. A total of 64 constipated adults, diagnosed by Rome III criteria for functional constipation, were randomized to receive either EPS-enriched VP30 fermented milk (VP30-EPS, n = 32) or an original VP30 fermented milk as a control fermented milk (CFM, n = 32) for 4 weeks. Questionnaires, which addressed defecation symptoms, dietary frequency and a dietary diary, were required to be completed every two weeks. Compared to the original VP30 fermented milk, EPS-enriched VP30 fermented milk was more effective in increasing defecation frequency, defecation volume, and fecal type during the 4-week treatment. The findings suggest that enrichment with EPS could improve indicators of bowel movement in individuals suffering from functional constipation. Constipation symptoms such as flatulence, pain, and bloating did not change to any statistically significant degree. The VP30EPS group exhibited a greater decrease in the sum of symptoms scores from baseline to 4th week than the CFM group, which was marginally significant (p = 0.059). Changes in ammonia production and short chain fatty acid content were not statistically significant. Gut microbiome analysis showed the proportion of Bacteroidetes in the VP30-EPS group increased slightly while Firmicutes in the VP30-EPS group decreased slightly and Prevotella increased. To the best of our knowledge, this is the first study that shows the functional effect of reducing functional constipation through human clinical studies by applying EPS produced by a Weissella strain to a fermented dairy food.","[Jin, Hui; Park, Jiwon; Li, Rui; Ji, Geun Eog] Seoul Natl Univ, Res Inst Human Ecol, Dept Food & Nutr, Seoul 08826, South Korea; [V. Johnston, Tony; Choe, Deokyeong; Ku, Seockmo] Middle Tennessee State Univ, Coll Basic & Appl Sci, Sch Agr, Fermentat Sci Program, Murfreesboro, TN 37132 USA; [Choe, Deokyeong] Kyungpook Natl Univ, Coll Agr & Life Sci, Sch Food Sci & Biotechnol, Daegu 41566, South Korea; [Park, Se -Ho; Park, Myeong Soo] BIFIDO Co Ltd, Res Ctr, Hanam Si 12930, Gyeonggi Do, South Korea",Seoul National University (SNU); Middle Tennessee State University; Kyungpook National University,"Ku, SC (corresponding author), Middle Tennessee State Univ, Coll Basic & Appl Sci, Sch Agr, Fermentat Sci Program, Murfreesboro, TN 37132 USA.",jh1030@snu.ac.kr; chocobjw@naver.com; 1766028931@qq.com; geji@snu.ac.kr; Tony.Johnston@mtsu.edu; cd02da@knu.ac.kr; p86ks1@bifido.com; bifidopark@bifido.com; Seockmo.ku@mtsu.edu,,"Choe, Deokyeong/0000-0001-7432-7688; Jin, Hui/0000-0002-3803-0745",,,,,52,4,4,8,18,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",1756-4646,2214-9414,,J FUNCT FOODS,J. Funct. Food.,MAY,2023,104,,,,,,,,105491,10.1016/j.jff.2023.105491,http://dx.doi.org/10.1016/j.jff.2023.105491,,MAR 2023,12,Food Science & Technology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Nutrition & Dietetics,C9VX6,,gold,,,2024-06-04,WOS:000965322100001,View Full Record in Web of Science
J,"Brauchla, M; McCabe, GP; Miller, KB; Kranz, S",,,,"Brauchla, Mary; McCabe, George P.; Miller, Kevin B.; Kranz, Sibylle",,,The effect of high fiber snacks on digestive function and diet quality in a sample of school-age children,NUTRITION JOURNAL,,,English,Article,,,,,,Fiber; Whole grains; Diet quality; Constipation; Children,CHRONIC CHILDHOOD CONSTIPATION; FOOD RECORDS; VALIDATION; RECALLS; HEALTH,"Background: Dietary fiber (DF) intake in American children is suboptimal, increasing the risk of GI distress and contributing to poor diet quality. The objective of this study was to determine the effect of introducing two high-fiber snacks per day on gastrointestinal function as well as nutrient and food group intake in healthy children ages 7-11 years old. Methods: This study was a randomized controlled prospective intervention study of children 7-11 years of age (n = 81) attending a rural Midwestern elementary school. Children were randomized by classroom to consume two high-fiber snacks per day (total of 10-12 g DF) or their usual snacks for 8 weeks. Participants completed two 24-hour dietary recalls and a questionnaire about their GI health at baseline, mid-intervention (week 4), and post-intervention. Dietary data was entered into NDSR 2011 and t-tests utilized to assess changes. Analyses were completed in SAS 9.2. Results: Children consumed at least half their snack 94% of the time when a snack was chosen (89% of time). Participants in both the intervention and control group had healthy scores on the GI health questionnaire at all time points. The intervention group increased DF (P = 0.0138) and whole grain (WG) intake (P = 0.0010) at mid-intervention but after the intervention returned to their baseline DF intake (P = 0.2205) and decreased their WG intake (P = 0.0420) compared to baseline. Eating high-fiber snacks increased DF intake by 2.5 g per day (21% increase), suggesting displacement of other fiber-rich foods. Conclusions: Study results indicate that children accept high-fiber foods, thus making these high-fiber foods and snacks consistently available will increase DF intake.","[Brauchla, Mary; Kranz, Sibylle] Purdue Univ, Dept Nutr Sci, W Lafayette, IN 47907 USA; [McCabe, George P.] Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA; [Miller, Kevin B.] WK Kellogg Inst Food & Nutr, Battle Creek, MI 49017 USA",Purdue University System; Purdue University; Purdue University System; Purdue University,"Kranz, S (corresponding author), Purdue Univ, Dept Nutr Sci, W Lafayette, IN 47907 USA.",kranz@purdue.edu,"Kranz, Sibylle/G-1728-2017","Kranz, Sibylle/0000-0001-5637-1706",,,,,20,14,15,0,15,BMC,LONDON,"CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND",,1475-2891,,NUTR J,Nutr. J.,NOV 25,2013,12,,,,,,,,153,10.1186/1475-2891-12-153,http://dx.doi.org/10.1186/1475-2891-12-153,,,7,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,285LI,24274323,"gold, Green Published",,,2024-06-04,WOS:000329395100001,View Full Record in Web of Science
J,"Fathallah, N; Bouchard, D; de Parades, V",,,,"Fathallah, Nadia; Bouchard, Dominique; de Parades, Vincent",,,Diet and lifestyle rules in chronic constipation in adults: From fantasy to reality...,PRESSE MEDICALE,,,French,Article,,,,,,,CHRONIC IDIOPATHIC CONSTIPATION; FUNCTIONAL CONSTIPATION; PHYSICAL-ACTIVITY; UNITED-STATES; STOOL OUTPUT; FLUID INTAKE; FIBER; MANAGEMENT; POPULATION; DEFECATION,"Chronic constipation is one of the most common chronic gastrointestinal complaints and a frequent reason for consultation. Lifestyle modification and dietary advice attract a lot of patients, often dissatisfied with a longterm drug intake. These behavioral modifications are recommended as a first-line approach in the treatment of chronic mild constipation in the majority of current guidelines despite a low level of evidence. Fiber supplementation is probably the most relevant measure because of a satisfactory level of proof. It improves stool frequency and consistency. It has a positive effect on excessive straining and colonic transit time. The recommended daily fiber intake is at least 20 to 25 g. To avoid side effects like bloating and abdominal pain, it must be gradually adjusted after a several days period. The benefice of increasing water intake or daily physical exercise in the treatment of chronic constipation have a lack of evidence, except specific situations such as elderly, hospitalized, institutionalized, dehydrated people or people consuming fluids less than 500 mL/day. Change in environmental defecation conditions or bowel habits are probably anecdotal recommendations.","[Fathallah, Nadia; de Parades, Vincent] Grp Hosp Paris St Joseph, Serv Proctol Medico Chirurgicale, 185,rue Raymond Losserand, F-75014 Paris, France; [Fathallah, Nadia] Grp Hosp Paris St Joseph, Serv Gastroenterol, 185,rue Raymond Losserand, F-75014 Paris, France; [Fathallah, Nadia] Hop Europeen Georges Pompidou, Serv Gastroenterol, 20,rue Lebianc, F-75015 Paris, France; [Bouchard, Dominique] Hop Bagatelle, Serv Proctol Medico Chirurgicale, 201,rue Robespierre, F-33400 Talence, France",Universite Paris Cite; Hopital Paris Saint-Joseph; Universite Paris Cite; Hopital Paris Saint-Joseph; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Europeen Georges-Pompidou - APHP,"Fathallah, N (corresponding author), Grp Hosp Paris St Joseph, 185,rue Raymond Losserand, F-75014 Paris, France.",nfathallah@hpsj.fr,,,,,,,41,7,11,2,17,MASSON EDITEUR,MOULINEAUX CEDEX 9,"21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE",0755-4982,2213-0276,,PRESSE MED,Presse Med.,JAN,2017,46,1,,,,,23,30,,10.1016/j.lpm.2016.03.019,http://dx.doi.org/10.1016/j.lpm.2016.03.019,,,8,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),General & Internal Medicine,EO1CL,28065611,,,,2024-06-04,WOS:000396435100004,View Full Record in Web of Science
J,"Papatsiros, VG; Katsarou, MS; Drakoulis, N; Maragkakis, G; Tzika, E; Maes, D; Tassis, PD; Lagiou, M; Christodoulopoulos, G",,,,"Papatsiros, V. G.; Katsarou, M-S; Drakoulis, N.; Maragkakis, G.; Tzika, E.; Maes, D.; Tassis, P. D.; Lagiou, M.; Christodoulopoulos, G.",,,Effects of dietary fibre on metabolism and performance in sows,POLISH JOURNAL OF VETERINARY SCIENCES,,,English,Article,,,,,,insulin; ghrelin; leptin; fibre; dysgalactia; pig,POSTPARTURIENT DISORDERS; PREGNANT SOWS; BEHAVIOR; LACTATION; LEPTIN; PARTURITION; GESTATION; DURATION; INSULIN; BALANCE,"The etiology of Postpartum dysgalactia syndrome (PDS) includes stress on preparturition and constipation associated with low water intake or low fiber intake. The aim of this study was to investigate the effects of a raw crude fibre concentrate (Arbocel (R)) on sow's metabolism and performance. 100 sows from a farm suffering from PDS, were divided into two groups, with equal distribution of their parity (1 to 5 parity): a) T1 group (control group): 50 sows were fed with regular gestation feed (GF), pre-farrowing feed (PFF), and lactation feed (LF), b) T2 group: 50 sows were fed with regular GF, PFF and LF supplemented with topdress Arbocel (R) from 104th day of gestation until 7th day of lactation). Health parameters [faeces score (FS), PDS score (PDSS), body condition score (BCS)], performance parameters and liter characteristics were recorded. Blood samples were collected from 25 sows / group (5 sows per parity) 24 h after birth of last piglet and on 14th day of lactation for the evaluation of insulin, leptin and ghrelin levels in the serum, using commercial ELISA kits. In T2 group, BCS at farrowing (p<0.001), FS (p=001) and PDSS (p=0.003) were improved significantly. The number of piglets stillborn and dead due to crushing decreased (p=0.001), while the number of liveborn (p=0.016) and weaned piglets (p=0.001) increased in T2 group. Moreover, in T2 group, the BW of piglets at weaning was higher (p<0.001). A significant increase of insulin (p=0.032) and leptin (p=0.032) levels in serum was noticed in T2 group 24 h after farrowing. In conclusion, the supplementation of extra crude fibre in breeding stock with PDS problems due to nutritional imbalance has beneficial effects on their health and performance.","[Papatsiros, V. G.; Maragkakis, G.; Christodoulopoulos, G.] Univ Thessaly, Fac Vet Med, Sch Hlth Sci, Clin Med, Trikalon 224, Kardhitsa 43100, Greece; [Katsarou, M-S; Drakoulis, N.; Lagiou, M.] Natl & Kapodistrian Univ Athens, Fac Pharm, Sch Hlth Sci, Res Grp Clin Pharmacol & Pharmacogen, Athens 15771, Greece; [Tzika, E.; Tassis, P. D.] Aristotle Univ Thessaloniki, Fac Hlth Sci, Sch Vet Med, Farm Anim Clin, 11 St Voutyra Str, Thessaloniki 54627, Greece; [Maes, D.] Univ Ghent, Fac Vet Med, Dept Reprod Obstet & Herd Hlth, 133 Entrance 4, B-9820 Merelbeke, Belgium",University of Thessaly; National & Kapodistrian University of Athens; Aristotle University of Thessaloniki; Ghent University,"Papatsiros, VG (corresponding author), Univ Thessaly, Fac Vet Med, Sch Hlth Sci, Clin Med, Trikalon 224, Kardhitsa 43100, Greece.",vpapatsiros@vet.uth.gr,"Papatsiros, Vassilis/ABC-7916-2021; Tassis, Panagiotis D/E-1830-2014; katsarou, martha/HGD-4268-2022; PAPATSIROS, VASILEIOS G/AAG-2327-2019; Katsarou, Martha-Spyridoula/HDN-8144-2022","Tassis, Panagiotis D/0000-0002-8879-4620; PAPATSIROS, VASILEIOS G/0000-0003-4955-0460;",Astron Chemicals S.A. through the Research Committee of the University of Thessaly,Astron Chemicals S.A. through the Research Committee of the University of Thessaly,This work was supported by Astron Chemicals S.A. through the Research Committee of the University of Thessaly (Scientific Responsible: Associate Professor V.G. Papatsiros).,,43,4,5,2,13,"POLSKA AKAD NAUK, POLISH ACAD SCIENCES, UNIV WARMIA & MAZURY OLSZTYN",WARSZAWA,"PL DEFILAD 1, WARSZAWA, 00-901, POLAND",1505-1773,2300-2557,,POL J VET SCI,Pol. J. Vet. Sci.,,2021,24,2,,,,,271,279,,10.24425/pjvs.2021.137662,http://dx.doi.org/10.24425/pjvs.2021.137662,,,9,Veterinary Sciences,Science Citation Index Expanded (SCI-EXPANDED),Veterinary Sciences,TD0CD,34250787,"hybrid, Green Published",,,2024-06-04,WOS:000669003300013,View Full Record in Web of Science
J,"BALSON, R; GIBSON, PR",,,,"BALSON, R; GIBSON, PR",,,LOWER GASTROINTESTINAL-TRACT .1. CONSTIPATION,MEDICAL JOURNAL OF AUSTRALIA,,,English,Article,,,,,,,,"An accurate diagnosis is of primary importance in lower gastrointestinal problems in the elderly. Reversible causes should be treated specifically whenever possible, but symptomatic treatment can be a useful adjunct or a mainstay if no cause can be found. For constipation symptomatic treatment should proceed stepwise, commencing with increase in dietary fibre content Only if this approach fails should laxatives (osmotic) be used. Stimulant laxatives and paraffin are best used intermittently if at all, because of their side effects.","ROYAL MELBOURNE HOSP,DEPT MED,MELBOURNE,VIC 3050,AUSTRALIA",Royal Melbourne Hospital,,,,,,,,,8,1,1,0,0,AUSTRALASIAN MED PUBL CO LTD,SYDNEY,"LEVEL 1, 76 BERRY ST, SYDNEY NSW 2060, AUSTRALIA",0025-729X,,,MED J AUSTRALIA,Med. J. Aust.,FEB 6,1995,162,3,,,,,155,157,,10.5694/j.1326-5377.1995.tb138482.x,http://dx.doi.org/10.5694/j.1326-5377.1995.tb138482.x,,,3,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,QF886,7854230,,,,2024-06-04,WOS:A1995QF88600014,View Full Record in Web of Science
J,"Romano, C; Pallio, S; Cucinotta, U; Accorsi, P; Dipasquale, V",,,,"Romano, Claudio; Pallio, Socrate; Cucinotta, Ugo; Accorsi, Paola; Dipasquale, Valeria",,,Fibers in pediatric functional gastrointestinal disorders. Practical considerations from clinical cases,EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY,,,English,Article,,,,,,Constipation; diarrhea; enteral nutrition; fibers; food intolerance; functional gastrointestinal disorders; irritable bowel syndrome; neurological impairment; partially hydrolyzed guar gum; short bowel syndrome,,"Introduction: Functional gastrointestinal disorders (FGIDs) are common in children and incur high direct and indirect social costs. Partially hydrolyzed guar gum (PHGG) is a natural and water-soluble dietary fiber that is derived from guar gum. It has been proposed as complementary therapy in pediatric FGIDs, especially in chronic functional constipation and irritable bowel syndrome. Areas covered: By focusing on four clinical cases, this article illustrates the use of PHGG fiber as sole supplement ingredient or as a formula component in orally- and tube-fed children suffering from malnutrition due to FGIDs, with or without special medical conditions such as neurological disability. The formula used was a whey peptide-based nutritionally complete formula containing PHGG as a source of soluble dietary fiber. It was offered under medical supervision and after full consideration of all feeding options. Expert opinion: Implementing appropriate feeding behaviors, adapted to age and potential comorbidities, is an essential requisite for therapeutic management of FGIDs. The use of a PHGG supplement or a nutritionally complete formula containing PHGG as a source of soluble dietary fiber can be helpful to manage pediatric FGIDs.","[Romano, Claudio; Cucinotta, Ugo; Dipasquale, Valeria] Univ Messina, Dept Human Pathol Adulthood & Childhood G Barresi, Pediat Gastroenterol & Cyst Fibrosis Unit, Messina, Italy; [Pallio, Socrate] Univ Messina, Div Digest Endoscopy, Messina, Italy; [Accorsi, Paola] Azienda Unit Sanit Locale Reggio Emilia IRCCS AUS, Santa Maria Nuova Hosp, Pediat Nutr Team, Pediat Unit, Reggio Emilia, Italy",University of Messina; University of Messina; IRCCS Arcispedale S. Maria Nuova,"Romano, C (corresponding author), Univ Messina, Dept Human Pathol Adulthood & Childhood G Barresi, Pediat Gastroenterol & Cyst Fibrosis Unit, Messina, Italy.",romanoc@unime.it,"Romano, Claudio/L-1950-2016; DIPASQUALE, VALERIA/ABE-4607-2021; Cucinotta, Ugo/IRZ-3474-2023","Romano, Claudio/0000-0001-8827-2091; DIPASQUALE, VALERIA/0000-0003-3328-0734; Cucinotta, Ugo/0000-0002-0178-9694",,,,,24,5,7,1,16,TAYLOR & FRANCIS LTD,ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND",1747-4124,1747-4132,,EXPERT REV GASTROENT,Expert Rev. Gastroenterol. Hepatol.,JUN 3,2021,15,6,,,,,583,587,,10.1080/17474124.2021.1884543,http://dx.doi.org/10.1080/17474124.2021.1884543,,FEB 2021,5,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,SM9LN,33522316,"hybrid, Green Published",,,2024-06-04,WOS:000619058700001,View Full Record in Web of Science
J,"Kang, YL; Yan, J",,,,"Kang, Yulong; Yan, Jin",,,Exploring the connection between caffeine intake and constipation: a cross-sectional study using national health and nutrition examination survey data,BMC PUBLIC HEALTH,,,English,Article,,,,,,Caffeine consumption; Constipation management; Middle-age people; Decaffeinated coffee,COFFEE; ASSOCIATION; FIBER,"Background Caffeine has been reported to increase gastrointestinal motility and change intestinal microbiota. Constipation may be caused by colonic motor dysfunction and colonic microbiomeis disturbances. In this study, we aimed to explore the association between caffeine intake and constipation.Methods This was a cross-sectional study based on the National Health and Nutrition Examination Survey (NHANES). Caffeine intake was assessed using 24-h dietary recall method, and constipation was defined based on stool consistency or stool frequency. Logistic regression analysis was used to assess the association between caffeine intake and constipation, and results were expressed as odds ratio (OR) with 95% confidence intervals (95%CI). Subgroup analysis was performed based on age.Results A total of 13,816 participants were finally included for analysis. After adjusting potential confounders, high intake of caffeine was found to be associated with the low odds of constipation (Q3: OR = 0.60, 95%CI: 0.49-0.74; Q4: OR = 0.77, 95%CI: 0.59-0.99; Q5: OR = 0.72, 95%CI: 0.56-0.92). The similar association was found in young people and middle-age people (P < 0.05).Conclusion High caffeine intake was associated with the low odds of constipation. Our finding indicated that individuals should develop consciousness and habit of consuming caffeinated foods and drinks to prevent and relief the constipation.","[Kang, Yulong; Yan, Jin] Northern Jiangsu Peoples Hosp, Dept Proctol, 98 Nantong Western Rd, Yangzhou 225001, Peoples R China",,"Yan, J (corresponding author), Northern Jiangsu Peoples Hosp, Dept Proctol, 98 Nantong Western Rd, Yangzhou 225001, Peoples R China.",yanjinyz@hotmail.com,,,,,,,35,0,0,2,2,BMC,LONDON,"CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND",,1471-2458,,BMC PUBLIC HEALTH,BMC Public Health,JAN 2,2024,24,1,,,,,,,3,10.1186/s12889-023-17502-w,http://dx.doi.org/10.1186/s12889-023-17502-w,,,9,"Public, Environmental & Occupational Health",Science Citation Index Expanded (SCI-EXPANDED),"Public, Environmental & Occupational Health",DX5J7,38167025,"Green Published, gold",,,2024-06-04,WOS:001135394000038,View Full Record in Web of Science
J,"Bharucha, AE; Lacy, BE",,,,"Bharucha, Adil E.; Lacy, Brian E.",,,"Mechanisms, Evaluation, and Management of Chronic Constipation",GASTROENTEROLOGY,,,English,Review,,,,,,,IRRITABLE-BOWEL-SYNDROME; CHRONIC IDIOPATHIC CONSTIPATION; SACRAL NERVE-STIMULATION; RANDOMIZED CLINICAL-TRIAL; PLACEBO-CONTROLLED TRIAL; DISTINGUISH FUNCTIONAL CONSTIPATION; RESOLUTION ANORECTAL MANOMETRY; DIGITAL RECTAL EXAMINATION; PELVIC FLOOR DYSSYNERGIA; COLONIC MOTOR-ACTIVITY,"With a worldwide prevalence of 15%, chronic constipation is one of the most frequent gastrointestinal diagnoses made in ambulatory medicine clinics, and is a common source cause for referrals to gastroenterologists and colorectal surgeons in the United States. Symptoms vary among patients; straining, incomplete evacuation, and a sense of anorectal blockage are just as important as decreased stool frequency. Chronic constipation is either a primary disorder (such as normal transit, slow transit, or defecatory disorders) or a secondary one (due to medications or, in rare cases, anatomic alterations). Colonic sensorimotor disturbances and pelvic floor dysfunction (such as defecatory disorders) are the most widely recognized pathogenic mechanisms. Guided by efficacy and cost, management of constipation should begin with dietary fiber supplementation and stimulant and/or osmotic laxatives, as appropriate, followed, if necessary, by intestinal secretagogues and/or prokinetic agents. Peripherally acting mu-opiate antagonists are another option for opioid-induced constipation. Anorectal tests to evaluate for defecatory disorders should be performed in patients who do not respond to over-the-counter agents. Colonic transit, followed if necessary with assessment of colonic motility with manometry and/or a barostat, can identify colonic dysmotility. Defecatory disorders often respond to biofeedback therapy. For specific patients, slow-transit constipation may necessitate a colectomy. No studies have compared inexpensive laxatives with newer drugs with different mechanisms. We review the mechanisms, evaluation, and management of chronic constipation. We discuss the importance of meticulous analyses of patient history and physical examination, advantages and disadvantages of diagnostic testing, guidance for individualized treatment, and management of medically refractory patients.","[Bharucha, Adil E.] Mayo Clin, Div Gastroenterol & Hepatol, 200 First St SW, Rochester, MN 55905 USA; [Lacy, Brian E.] Mayo Clin, Div Gastroenterol & Hepatol, Jacksonville, FL 32224 USA",Mayo Clinic; Mayo Clinic,"Bharucha, AE (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, 200 First St SW, Rochester, MN 55905 USA.",bharucha.adil@mayo.edu,"Bharucha, Adil/KCL-4921-2024",,US Public Health Service [R01 DK78924],US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service),This work was supported in part by US Public Health Service grant R01 DK78924.,,168,228,257,56,218,W B SAUNDERS CO-ELSEVIER INC,PHILADELPHIA,"1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA",0016-5085,1528-0012,,GASTROENTEROLOGY,Gastroenterology,APR,2020,158,5,,,,,1232,+,,10.1053/j.gastro.2019.12.034,http://dx.doi.org/10.1053/j.gastro.2019.12.034,,,21,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,KW4IK,31945360,"Bronze, Green Accepted",Y,N,2024-06-04,WOS:000521129300020,View Full Record in Web of Science
J,"Hojsak, I; Benninga, MA; Hauser, B; Kansu, A; Kelly, VB; Stephen, AM; Lopez, AM; Slavin, J; Tuohy, K",,,,"Hojsak, Iva; Benninga, Marc A.; Hauser, Bruno; Kansu, Aydan; Kelly, Veronica B.; Stephen, Alison M.; Lopez, Ana Morais; Slavin, Joanne; Tuohy, Kieran",,,Benefits of dietary fibre for children in health and disease,ARCHIVES OF DISEASE IN CHILDHOOD,,,English,Review,,,,,,child health; gastroenterology; paediatrics,CHAIN FATTY-ACIDS; FUNCTIONAL GASTROINTESTINAL DISORDERS; ESPGHAN COMMITTEE; GUT MICROBIOTA; NUTRITION; MECHANISM; NUTRIENTS; FORMULA,"Fibre is an essential nutrient in the human diet that is crucial for human health. It provides a range of functional benefits, including stool bulking, and physiological benefits through fermentation of diverse fibre types by the gut microbiome including cholesterol lowering, glycaemic control and weight control. The by-products of the fermentation of fibre in the gut confer health benefits that extend beyond the gut to the immune system and organs such as the liver, kidneys and the brain. A lack of fibre in the diet has been associated with several disorders in children including constipation, irritable bowel syndrome, allergies and immune-related disorders. In paediatric practice, concerns exist over tolerance of dietary fibre which may lead to unnecessary restrictions, especially for children receiving nutritional support. One reason for this may be the terminology which has historically been used. Fibre is often described in terms of its physico-chemical properties (solubility, viscosity), rather than its physiological effects/functionality (fermentability, bulking effects). To describe fibre in these latter terms represents more clearly the important role it plays. Most international guidelines recommend a daily quantity of fibre, failing to mention the quality aspect of the fibre required for health. Here we consider the evidence base for the current recommendations for daily fibre intakes for healthy children, those requiring nutritional support and those with functional gastrointestinal disorders. We also consider the importance of the gut microbiome and the role of fibre in maintaining gut microbial health and its role in health beyond the gut.","[Hojsak, Iva] Univ Zagreb, Childrens Hosp Zagreb, Referral Ctr Paediat Gastroenterol & Nutr, Med Sch, Zagreb, Croatia; [Benninga, Marc A.] Univ Amsterdam, Emma Childrens Hosp, Dept Paediat Gastroenterol & Nutr, Med Ctr, Amsterdam, Netherlands; [Hauser, Bruno] KidZ Hlth Castle UZ Brussel, Dept Paediat Gastroenterol & Nutr, Brussels, Belgium; [Kansu, Aydan] Ankara Univ, Sch Med, Dept Pediat Gastroenterol, Ankara, Turkey; [Kelly, Veronica B.] Childrens Hlth Ireland, Pediat Dept, Dublin, Ireland; [Kelly, Veronica B.] Evelina Childrens Hosp, Paediat Neurosci, London, England; [Stephen, Alison M.] Univ Surrey, Dept Nutr Sci, Retired Prof Publ Hlth Nutr, Surrey, England; [Lopez, Ana Morais] Hosp Univ La Paz, Pediat Nutr, Madrid, Spain; [Slavin, Joanne] Univ Minnesota, Dept Food Sci & Nutr, St Paul, MN USA; [Tuohy, Kieran] Fdn Edmund Mach Ist Agrario San Michele AllAdige, Dept Food Qual & Nutr, San Michele All Adige, Italy; [Tuohy, Kieran] Univ Leeds, Sch Food Sci & Nutr, Leeds, W Yorkshire, England",University of Zagreb; University of Amsterdam; Emma Children's Hospital; Ankara University; University of Surrey; Hospital Universitario La Paz; University of Minnesota System; University of Minnesota Twin Cities; University of Leeds,"Hojsak, I (corresponding author), Childrens Hosp Zagreb, Referral Ctr Paediat Gastroenterol & Nutr, Zagreb, Croatia.",ivahojsak@gmail.com,"Slavin, Joanne/GOJ-9874-2022; Tuohy, Kieran M/G-9142-2011; Lopez-Periago, Ana M./I-5567-2012","Slavin, Joanne/0000-0003-0720-5300; Tuohy, Kieran M/0000-0001-6882-7192; Lopez-Periago, Ana M./0000-0002-3777-3205; Hauser, Bruno/0000-0002-8431-1556; Kelly, Veronica/0000-0001-6090-4026",Abbott,Abbott(Abbott Laboratories),This work was funded by an unrestricted educational grant from Abbott. Editorial support was provided by Dr Tracey Lonergan (Ashfield Health) with financial support provided by Abbott.,,59,23,24,1,22,BMJ PUBLISHING GROUP,LONDON,"BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND",0003-9888,1468-2044,,ARCH DIS CHILD,Arch. Dis. Child.,NOV,2022,107,11,,,,,973,979,,10.1136/archdischild-2021-323571,http://dx.doi.org/10.1136/archdischild-2021-323571,,MAR 2022,7,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,5R9NG,35277379,"Green Published, hybrid",,,2024-06-04,WOS:000768947100001,View Full Record in Web of Science
J,"Williams, CL",,,,"Williams, Christine L.",,,Dietary fiber in childhood,JOURNAL OF PEDIATRICS,,,English,Article; Proceedings Paper,25th Anniversary of the Bristol-Myers-Squibb Freedom to Discover Nutrition Grants Program,"JUN 07-08, 2005","Univ Cincinnati, Cincinnati, OH",,Univ Cincinnati,,CORONARY-HEART-DISEASE; PRESCHOOL-CHILDREN; LIMITING FACTOR; NUTRIENT INTAKE; UNITED-STATES; ISABGOL HUSK; SERUM LEVELS; ENERGY; RISK; CONSTIPATION,"Dietary fiber (DF) has important health benefits in childhood, especially in promoting normal laxation. Studies also suggest that DF in childhood may be useful in preventing and treating obesity and also in lowering blood cholesterol levels, both of which may help reduce the risk of future cardiovascular disease. In adults, a high-fiber, low-fat diet has been linked to reduced rates of colon and other human cancers, and although it seems highly likely that this benefit would be even greater if this regimen had been started in childhood, epidemiologic and experimental confirmation is currently lacking. Children's typical DF consumption may not be adequate to maintain good health and prevent disease. Therefore, it would be prudent to recommend that children and adolescents increase DF intake by increasing consumption of fruits, vegetables, legumes, cereals, and other grain products. Several guidelines recommend quantitative ranges of DF intake for children. These include recommendations by the National Academy of Sciences, the Food and Drug Administration's (FDA) food label guide, and the Age+5 guideline. The goal is to achieve a DF intake that is safe even for children and adolescents with marginal intake of vitamins and minerals, provides sufficient DF for normal laxation, and reduces the risk of future chronic diseases, such as coronary artery disease. Current estimates of DF intake are much lower than recommended levels for a large proportion of the US pediatric population. This article reviews these data.","Columbia Univ, New York Presbyterian, Morgan Stanley Childrens Hosp, Dept Pediat, New York, NY 10032 USA; Columbia Univ, New York Presbyterian, Morgan Stanley Childrens Hosp, Coll Phys & Surg, New York, NY 10032 USA",Columbia University; NewYork-Presbyterian Hospital; Morgan Stanley Children's Hospital; Columbia University; NewYork-Presbyterian Hospital; Morgan Stanley Children's Hospital,"Williams, CL (corresponding author), Columbia Univ, New York Presbyterian, Morgan Stanley Childrens Hosp, Dept Pediat, 3959 Broadway BHN 7-702, New York, NY 10032 USA.",chrisw320@aol.com,,,,,,,99,15,18,0,11,MOSBY-ELSEVIER,NEW YORK,"360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA",0022-3476,1097-6833,,J PEDIATR-US,J. Pediatr.,NOV,2006,149,5,,S,,,S121,S130,,10.1016/j.jpeds.2006.06.066,http://dx.doi.org/10.1016/j.jpeds.2006.06.066,,,10,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Pediatrics,110BM,,,,,2024-06-04,WOS:000242353300013,View Full Record in Web of Science
J,"Isakov, VA; Pilipenko, V; Vlasova, AV; Kochetkova, AA",,,,"Isakov, Vasily A.; Pilipenko, Vladimir, I; Vlasova, Alina V.; Kochetkova, Alla A.",,,Evaluation of the Efficacy of Kombucha-Based Drink Enriched with Inulin and Vitamins for the Management of Constipation-Predominant Irritable Bowel Syndrome in Females: A Randomized Pilot Study,CURRENT DEVELOPMENTS IN NUTRITION,,,English,Article,,,,,,females's health; fermented beverages; dietary fibers; irritable bowel syndrome; constipation; kombucha; inulin; Bristol stool scale score; stool frequency,METAANALYSIS; IBS,"Background: Constipation-predominant irritable bowel syndrome (IBS-C) mainly affects females, and dietary interventions for symptom relief often yield poor results because of low patient adherence. The development of functional food products enriched with dietary fibers may increase patients' adherence to a healthy diet and relieve IBS-C symptoms. Objective: This proof-of-concept, open-label, randomized controlled pilot study is aimed to evaluate the efficacy of kombucha enriched with inulin and vitamins in females with IBS-C. Methods: Forty females with IBS-C were randomly assigned to receive either 220 mL of kombucha enriched with inulin (2.53 g/220 mL) and vitamins (B1 - 0.59 mg, B2 - 0.55 mg, B3 - 5.9 mg, B6 - 0.7 mg, and folic acid - 81.4 mu g/220 mL) or water for 10 d. Stool frequency, Bristol stool scale score (BSSS), and abdominal symptoms were evaluated using a 5-point Likert scale on days 5, 9 and 14 of the study. The palatability of the drink was assessed using a visual analog scale. Results: After 10 d, the kombucha group showed a significant increase in stool frequency (0.60 +/- 0.31-0.85 +/- 0.19 times/d; P = 0.004) compared with the control (0.63 +/- 0.33 compared with 0.72 +/- 0.28; P = 0.6). The mean values of the BSSS increased in the kombucha group (3.0 +/- 1.2-4.4 +/- 1.0; P = 0.001), whereas they remained unchanged in the control (2.9 +/- 1.2 compared with 3.4 +/- 1.2; P = 0.6). The kombucha group also experienced a significant decrease in the feeling of incomplete bowel emptying (1.88 +/- 0.78 compared with 1.41 +/- 0.56 points; P = 0.015), which was not observed in the control group. Conclusions: Short-term consumption of kombucha enriched with inulin and vitamins was associated with an increase in stool frequency, an improvement in the BSSS, and a reduction in the feeling of incomplete bowel emptying in females with IBS-C. Further large-scale clinical trials investigating the efficacy of kombucha enriched with inulin and vitamins in patients with IBS-C are warranted to prove the observed effects. Trial registration number: This trial was registered at clinicaltrials.gov as NCT05164861 (==https://clinicaltrials.gov/study/ NCT05164861?term=NCT05164861 & rank=1; registered on 18 December, 2021).","[Isakov, Vasily A.; Pilipenko, Vladimir, I; Vlasova, Alina V.] Fed Res Ctr Nutr Biotechnol & Food Safety, Dept Gastroenterol & Hepatol, Moscow, Russia; [Kochetkova, Alla A.] Fed Res Ctr Nutr Biotechnol & Food Safety, Lab Food Biotechnol & Foods Special Dietary Uses, Moscow, Russia","Federal Research Center of Nutrition, Biotechnology & Food Safety; Federal Research Center of Nutrition, Biotechnology & Food Safety","Isakov, VA (corresponding author), Fed Res Ctr Nutr Biotechnol & Food Safety, Dept Gastroenterol & Hepatol, Moscow, Russia.",vasily.isakov@gmail.com,"Isakov, Vasily/A-4876-2011","Isakov, Vasily/0000-0002-4417-8076",Russian Science Foundation [19-76-30014],Russian Science Foundation(Russian Science Foundation (RSF)),The research was funded by the Russian Science Foundation (Project No. 19-76-30014).,,35,0,0,2,2,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",2475-2991,,,CURR DEV NUTR,Curr. Dev. Nutr.,DEC,2023,7,12,,,,,,,102037,10.1016/j.cdnut.2023.102037,http://dx.doi.org/10.1016/j.cdnut.2023.102037,,DEC 2023,9,Nutrition & Dietetics,Emerging Sources Citation Index (ESCI),Nutrition & Dietetics,EP4W5,38149073,"gold, Green Accepted",,,2024-06-04,WOS:001140125800001,View Full Record in Web of Science
J,"Diez, M; Hornick, JL; Baldwin, P; Van Eenaeme, C; Istasse, L",,,,"Diez, M; Hornick, JL; Baldwin, P; Van Eenaeme, C; Istasse, L",,,Study of dietary Fibre in dog's diet: results of 7 experimental trials,ANNALES DE MEDECINE VETERINAIRE,,,French,Article,,,,,,,POSTPRANDIAL BLOOD-GLUCOSE; SUGAR-BEET FIBER; GUAR GUM; INSULIN CONCENTRATIONS; LIPID-METABOLISM; CHOLESTEROL; RATS; SUPPLEMENTATION; OLIGOFRUCTOSE; HYPERLIPEMIA,"The present paper presents the results and conclusions of 7 trials made in healthy (6 studies) and obese (1 study) dogs to experiment the effects of dietary fibre on faeces characteristics, nutrients digestibility, water consumption and plasma metabolites. Several incorporation rates of different fibre sources (cellulose, guar gum, inulin, fructooligosaccharides (FOS), pectins, beet fibre, beet pulp and chicory pulp) were studied. Furthermore, a blend of cellulose and guar gum was formulated to imitate the ratio of soluble-to-insoluble fibre of beet fibre to study the influence of the fibre solubility. Drinking water consumption was increased by beet fibre and inulin in the diet. With the exception of cellulose for dry matter (DM) concentration, the different fibres induced similar effects on faeces: increased daily excretion, decreased DM concentration and increased excretion of DM. Nutrient digestibility coefficients were diversely affected by fibre consumption and, excepted for the ether extract, decreased in nutrients digestibility were in relation with added total or insoluble fibre in the diet. Important metabolic effects were observed but were not in relation with the solubility of the fibre. Decreased pre- and/or postprandial plasmatic concentrations of glucose (with FOS), insulin (with guar gum), urea, cholesterol (with guar gum) and triglycerides (with FOS) suggest that most of the studied fibres should be used as an aid for dogs suffering from obesity, diabetes mellitus, hyperlipaemia, chronic renal insufficiency or constipation.","Univ Liege, Fac Med Vet, Serv Nutr, B-4000 Liege, Belgium",University of Liege,"Diez, M (corresponding author), Univ Liege, Fac Med Vet, Serv Nutr, B43, B-4000 Liege, Belgium.",,", Hornick/AAV-1394-2020",", Hornick/0000-0003-1831-1440",,,,,57,14,14,1,12,ANNALES MEDECINE VETERINAIRE,LIEGE,"UNIVERSITE LIEGE, SART TILMAN BAT 43, B-4000 LIEGE, BELGIUM",0003-4118,,,ANN MED VET,Ann. Med. Vet.,MAY-JUN,1998,142,3,,,,,185,+,,,,,,16,Veterinary Sciences,Science Citation Index Expanded (SCI-EXPANDED),Veterinary Sciences,100DU,,,,,2024-06-04,WOS:000074800500003,View Full Record in Web of Science
J,"SHANKARDASS, K; CHUCHMACH, S; CHELSWICK, K; STEFANOVICH, C; SPURR, S; BROOKS, J; TSAI, M; SAIBIL, FG; COHEN, LB; EDINGTON, JD",,,,"SHANKARDASS, K; CHUCHMACH, S; CHELSWICK, K; STEFANOVICH, C; SPURR, S; BROOKS, J; TSAI, M; SAIBIL, FG; COHEN, LB; EDINGTON, JD",,,BOWEL FUNCTION OF LONG-TERM TUBE-FED PATIENTS CONSUMING FORMULAS WITH AND WITHOUT DIETARY FIBER,JOURNAL OF PARENTERAL AND ENTERAL NUTRITION,,,English,Article,,,,,,,,"Diarrhea, constipation and subsequent laxative use are chronic problems in long-term enterally fed patients. We have conducted a double-blind randomized crossover study to evaluate the effects of two enteral formulae (Enrich, 12.8 g of dietary fiber per 1000 kcal and Ensure, fiber-free) on stool frequency, fecal weight, laxative use, gastrointestinal tolerance and bowel function in chronic care tube-fed patients. Twenty-eight subjects (24 male, 4 female) completed the study. Mean daily number of stools and mean daily fecal wet weight in Enrich-fed patients were not significantly different from those of patients receiving Ensure. Ensure-fed patients required significantly more laxatives (p = 0.02) than those receiving Enrich. There were 26 reports of diarrhea in the Ensure-fed group as compared to 6 in the Enrich-fed group, and this difference was significant (p = 0.006). Reporting rates for constipation were not significantly different in the two groups. At the end of the study, the bowel function of 57.1% of patients receiving Enrich was improved when compared with that of 14.3% of Ensure-fed patients, and this difference was significant (p = 0.005). These results suggest that the addition of dietary fiber to enteral formulae improves gastrointestinal tolerance and bowel function, and reduces laxative use in long-term enterally fed patients.","CHEDOKE MCMASTER HOSP, HAMILTON L8N 3Z5, ONTARIO, CANADA; QUEEN ELIZABETH HOSP, TORONTO, ONTARIO, CANADA; RIVERDALE HOSP, TORONTO, ONTARIO, CANADA; UNIV TORONTO, SUNNYBROOK MED CTR, TORONTO M4N 3M5, ONTARIO, CANADA; ROSS ABBOTT LABS LTD, MONTREAL, QUEBEC, CANADA",McMaster University; McGill University; University of Toronto; Sunnybrook Health Science Center; Sunnybrook Research Institute,,,,,,,,,25,68,76,0,1,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0148-6071,1941-2444,,JPEN-PARENTER ENTER,J. Parenter. Enter. Nutr.,SEP-OCT,1990,14,5,,,,,508,512,,10.1177/0148607190014005508,http://dx.doi.org/10.1177/0148607190014005508,,,5,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,DZ331,2172578,,,,2024-06-04,WOS:A1990DZ33100015,View Full Record in Web of Science
J,"Toglia, MR",,,,"Toglia, Marc R.",,,"Pathophysiology of Anal Incontinence, Constipation, and Defecatory Dysfunction",OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA,,,English,Article,,,,,,Anal incontinence; Anorectal disorders; Constipation; Defecatory dysfunction; Fecal incontinence,COLONIC TRANSIT-TIME; FECAL INCONTINENCE; RECTAL PROLAPSE; DIETARY FIBER; RISK-FACTORS; YOUNG-WOMEN; PREVALENCE; DAMAGE; SYMPTOMS; DELIVERY,"Anorectal disorders cause significant discomfort and embarrassment in women. The onset typically follows childbirth and symptoms increase with age. This article discusses anal incontinence, defecatory dysfunction, rectal prolapse, and constipation.","[Toglia, Marc R.] Thomas Jefferson Univ, Sch Med, Dept Obstet & Gynecol, Philadelphia, PA 19063 USA; [Toglia, Marc R.] Mainline Hlth Syst, Div Urogynecol & Reconstruct Pelv Surg, Wynnewood, PA USA; [Toglia, Marc R.] Urogynecol Associates Philadelphia, Media, PA 19063 USA",Jefferson University,"Toglia, MR (corresponding author), Thomas Jefferson Univ, Sch Med, Dept Obstet & Gynecol, Philadelphia, PA 19063 USA.",m.toglia@att.net,,,,,,,57,4,5,0,6,W B SAUNDERS CO-ELSEVIER INC,PHILADELPHIA,"1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA",0889-8545,1558-0474,,OBSTET GYN CLIN N AM,Obstet. Gynecol. Clin. N. Am.,SEP,2009,36,3,,,,,659,+,,10.1016/j.ogc.2009.08.004,http://dx.doi.org/10.1016/j.ogc.2009.08.004,,,14,Obstetrics & Gynecology,Science Citation Index Expanded (SCI-EXPANDED),Obstetrics & Gynecology,575BC,19932420,,,,2024-06-04,WOS:000276037000016,View Full Record in Web of Science
J,"CUMMINGS, JH",,,,"CUMMINGS, JH",,,"CONSTIPATION, DIETARY FIBER AND THE CONTROL OF LARGE BOWEL FUNCTION",POSTGRADUATE MEDICAL JOURNAL,,,English,Article,,,,,,,,,,,"ADDENBROOKS HOSP, MRC, DUNN CLIN NUTR CTR, CAMBRIDGE CB2 1QE, ENGLAND.",,,,,,,,60,99,103,0,7,BMJ PUBLISHING GROUP,LONDON,"BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND",0032-5473,1469-0756,,POSTGRAD MED J,Postgrad. Med. J.,,1984,60,709,,,,,811,819,,10.1136/pgmj.60.709.811,http://dx.doi.org/10.1136/pgmj.60.709.811,,,9,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,TR582,6095241,Green Published,,,2024-06-04,WOS:A1984TR58200015,View Full Record in Web of Science
J,"Salmoirago-Blotcher, E; Crawford, S; Jackson, E; Ockene, J; Ockene, I",,,,"Salmoirago-Blotcher, Elena; Crawford, Sybil; Jackson, Elizabeth; Ockene, Judith; Ockene, Ira",,,Constipation and Risk of Cardiovascular Disease among Postmenopausal Women,AMERICAN JOURNAL OF MEDICINE,,,English,Article,,,,,,Cardiovascular disease; Prevention; Risk factors; Women's health,CORONARY-HEART-DISEASE; DIETARY FIBER INTAKE; UNITED-STATES; LIFE-STYLE; AGED 65; HEALTH; FREQUENCY; OLDER; EPIDEMIOLOGY; DISORDERS,"BACKGROUND: Constipation is common in Western societies, accounting for 2.5 million physician visits/year in the US. Because many factors predisposing to constipation also are risk factors for cardiovascular disease, we hypothesized that constipation may be associated with increased risk of cardiovascular events. METHODS: We conducted a secondary analysis in 93,676 women enrolled in the observational arm of the Women's Health Initiative. Constipation was evaluated at baseline by a self-administered questionnaire. Estimates of the risk of cardiovascular events (cumulative end point including mortality from coronary heart disease, myocardial infarction, angina, coronary revascularization, stroke, and transient ischemic attack) were derived from Cox proportional hazards models adjusted for demographics, risk factors, and other clinical variables (median follow-up 6.9 years). RESULTS: The analysis included 73,047 women. Constipation was associated with increased age, African American and Hispanic descent, smoking, diabetes, high cholesterol, family history of myocardial infarction, hypertension, obesity, lower physical activity levels, lower fiber intake, and depression. Women with moderate and severe constipation experienced more cardiovascular events (14.2 and 19.1 events/1000 person-years, respectively) compared with women with no constipation (9.6/1000 person-years). After adjustment for demographics, risk factors, dietary factors, medications, frailty, and other psychological variables, constipation was no longer associated with an increased risk of cardiovascular events except for the severe constipation group, which had a 23% higher risk of cardiovascular events. CONCLUSION: In postmenopausal women, constipation is a marker for cardiovascular risk factors and increased cardiovascular risk. Because constipation is easily assessed, it may be a helpful tool to identify women with increased cardiovascular risk. (C) 2011 Elsevier Inc. All rights reserved. The American Journal of Medicine (2011) 124, 714-723","[Salmoirago-Blotcher, Elena; Ockene, Ira] Univ Massachusetts, Sch Med, Div Cardiovasc Med, Worcester, MA 01655 USA; [Crawford, Sybil; Ockene, Judith] Univ Massachusetts, Sch Med, Div Prevent & Behav Med, Worcester, MA 01655 USA; [Jackson, Elizabeth] Univ Michigan, Div Cardiovasc Med, Ann Arbor, MI 48109 USA",University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Michigan System; University of Michigan,"Salmoirago-Blotcher, E (corresponding author), Univ Massachusetts, Sch Med, Div Cardiovasc Med, 55 Lake Ave N,Room S3-855, Worcester, MA 01655 USA.",elena.salmoirago-blotcher@umassmed.edu,"Salmoirago-Blotcher, Elena/AFP-3700-2022","Salmoirago-Blotcher, Elena/0000-0003-4636-8698; Jackson, Elizabeth/0000-0002-5086-0418","National Heart, Lung, and Blood Institute, National Institutes of Health, US Department of Health and Human Services [N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221]","National Heart, Lung, and Blood Institute, National Institutes of Health, US Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))","The Women's Health Initiative program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, US Department of Health and Human Services through contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, and 44221.",,38,79,86,1,31,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",0002-9343,1555-7162,,AM J MED,Am. J. Med.,AUG,2011,124,8,,,,,714,723,,10.1016/j.amjmed.2011.03.026,http://dx.doi.org/10.1016/j.amjmed.2011.03.026,,,10,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,795WV,21663887,"Green Accepted, Bronze",,,2024-06-04,WOS:000293010100023,View Full Record in Web of Science
J,"Anderson, JC; Lacy, BE",,,,"Anderson, Joseph C.; Lacy, Brian E.",,,Constipation and Colorectal Cancer Risk: A Continuing Conundrum,AMERICAN JOURNAL OF GASTROENTEROLOGY,,,English,Editorial Material,,,,,,,BOWEL MOVEMENT FREQUENCY; LAXATIVE USE; COLON-CANCER; PHYSICAL-ACTIVITY; COHORT; WOMEN; MEN,"There are conflicting data regarding the association between bowel movement frequency, constipation, and colorectal cancer (CRC). In this issue, Citronberg et al. present data from a large prospective study that was designed to examine this issue. In addition to examining bowel habits, these authors included information about the participants' laxative use, distinguishing between fiber and non-fiber-based laxatives. The investigators also collected data with respect to CRC risk factors including demographics, family history, lower endoscopy exposure, smoking, medication use, and detailed dietary information. The results demonstrated no relationship between bowel movement frequency or constipation and CRC. The authors also observed an increased CRC risk in patients who were in either the low or high non-fiber laxative use groups as compared with individuals who never used these agents (low risk: hazard ratio (HR)=1.49; and high risk: HR=1.43; P-trend=0.05). Conversely, there was a statistically significant lower risk for those patients who reported a high use of fiber laxatives (HR=0.44, 95% confidence interval: 0.21-0.95) as compared with the nonuse group. These data have implications for physicians who treat patients with constipation.","[Anderson, Joseph C.] Dept VA Med Ctr, White River Jct, VT 05009 USA; [Anderson, Joseph C.; Lacy, Brian E.] Dartmouth Coll, Geisel Sch Med, Hanover, NH 03755 USA; [Lacy, Brian E.] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA",Dartmouth College; Dartmouth College,"Anderson, JC (corresponding author), Dept VA Med Ctr, 215 North Main St, White River Jct, VT 05009 USA.",joseph.anderson@dartmouth.edu,,,,,,,28,5,5,0,14,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0002-9270,1572-0241,,AM J GASTROENTEROL,Am. J. Gastroenterol.,OCT,2014,109,10,,,,,1650,1652,,10.1038/ajg.2014.292,http://dx.doi.org/10.1038/ajg.2014.292,,,3,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,AS7UM,25287089,,,,2024-06-04,WOS:000344460100021,View Full Record in Web of Science
B,"Maffei, HVL",,"Watson, RR; Preedy, VR; Zibadi, S",,"Leoni Maffei, Helga Verena",,,Dietary Fiber and Wheat Bran in Childhood Constipation and Health,"WHEAT AND RICE IN DISEASE PREVENTION AND HEALTH: BENEFITS, RISKS AND MECHANISMS OF WHOLE GRAINS IN HEALTH PROMOTION",,,English,Article; Book Chapter,,,,,,,FUNCTIONAL GASTROINTESTINAL DISORDERS; PHYSICAL-ACTIVITY; AMERICAN PRESCHOOLERS; STOOL FREQUENCY; COLONIC TRANSIT; FULL-TERM; CHILDREN; FOOD; NUTRIENT; QUALITY,,"Sao Paulo State Univ UNESP, Dept Pediat, Botucatu Med Sch, Sao Paulo, Brazil",Universidade Federal de Sao Paulo (UNIFESP); Universidade Estadual Paulista,"Maffei, HVL (corresponding author), Sao Paulo State Univ UNESP, Dept Pediat, Botucatu Med Sch, Sao Paulo, Brazil.",,,,,,,,131,1,2,0,4,ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD,LONDON,"125 LONDON WALL, LONDON EC2Y 5AS, ENGLAND",,,978-0-12-404604-7; 978-0-12-401716-0,,,,2014,,,,,,,227,239,,10.1016/B978-0-12-401716-0.00018-0,http://dx.doi.org/10.1016/B978-0-12-401716-0.00018-0,,,13,"Public, Environmental & Occupational Health; Nutrition & Dietetics",Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S),"Public, Environmental & Occupational Health; Nutrition & Dietetics",BB1MZ,,,,,2024-06-04,WOS:000341214700019,View Full Record in Web of Science
J,"Hu, JY; Zou, HD; Qiao, XY; Wang, YX; Lv, M; Zhang, KL; Wang, FY",,,,"Hu, Jiayan; Zou, Hede; Qiao, Xiyun; Wang, Yuxi; Lv, Mi; Zhang, Kunli; Wang, Fengyun",,,The relationship between oxidative balance scores and chronic diarrhea and constipation: a population-based study,BMC PUBLIC HEALTH,,,English,Article,,,,,,National health and nutrition examination survey; Oxidative balance scores; Constipation; Diarrhea; Mediation effect,BODY-MASS INDEX; GUT MICROBIOTA; PHYSICAL-ACTIVITY; NATIONAL-HEALTH; DIETARY FIBER; STRESS; INFLAMMATION; MECHANISM; CHILDREN; TRANSIT,"Background Oxidative stress is closely related to gut health. Exposures to oxidative stress in one's diet and lifestyle can be evaluated by the oxidative balance score (OBS). However, the relationship between OBS and intestinal habits is unknown. This study aimed to investigate the relationships between OBS and intestinal habits (chronic diarrhea and chronic constipation) and the underlying mechanisms involved. Methods Using data from the National Health and Nutrition Examination Survey (NHANES) database from 2005 to 2010, we included a total of 8065 participants. Twenty dietary and lifestyle factors were selected for the OBS calculates. Chronic constipation and chronic diarrhea were defined using the Bristol stool form scale (BSFS) types 1 and 2 and the BSFS 6 and 7, respectively. Multivariate logistic regression, subgroup analysis, and restricted cubic splines (RCS) analysis were used to evaluate the relationship between OBS and defecation habits. Finally, we used mediation analysis to explore the indirect effects of oxidative stress and inflammatory markers on these associations. Results After adjusting for all the covariates, multivariate logistic regression analysis revealed that OBS was negatively correlated with diarrhea (OR = 0.57; 95%CI = 0.39-0.83; P = 0.008)and positively correlated with constipation (OR = 1.75; 95%CI = 1.19-2.25; P = 0.008). The RCS showed a nonlinear relationship between OBS and diarrhea (P for nonlinearity = 0.02) and a linear relationship between OBS and constipation (P for nonlinearity = 0.19). Mediation analysis showed that the C-reactive protein (CRP) concentration and white blood cell (WBC) count mediated the correlation between OBS and diarrhea by 6.28% and 6.53%, respectively (P < 0.05). Conclusions OBS is closely related to changes in patients' defecation habits. Oxidative stress and inflammation may play a role in the relationship between the two. This result emphasizes the importance of the public adjusting their lifestyle and dietary habits according to their own situation. However, further prospective studies are needed to analyze the relationship between oxidative stress and changes in defecation habits.","[Hu, Jiayan; Zou, Hede; Qiao, Xiyun; Wang, Yuxi; Lv, Mi; Zhang, Kunli; Wang, Fengyun] China Acad Chinese Med Sci, Xiyuan Hosp, Beijing 100091, Peoples R China; [Hu, Jiayan; Qiao, Xiyun; Wang, Yuxi; Lv, Mi; Zhang, Kunli; Wang, Fengyun] China Acad Chinese Med Sci, Xiyuan Hosp, Inst Digest Dis, Beijing, Peoples R China; [Wang, Yuxi] Beijing Univ Chinese Med, Beijing, Peoples R China","China Academy of Chinese Medical Sciences; Xiyuan Hospital, CACMS; China Academy of Chinese Medical Sciences; Xiyuan Hospital, CACMS; Beijing University of Chinese Medicine","Wang, FY (corresponding author), China Acad Chinese Med Sci, Xiyuan Hosp, Beijing 100091, Peoples R China.;Wang, FY (corresponding author), China Acad Chinese Med Sci, Xiyuan Hosp, Inst Digest Dis, Beijing, Peoples R China.",wfy811@163.com,,,National Natural Science Foundation of China,National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)),We acknowledge NHANES database for providing their platforms and contributors for uploading their meaningful datasets. And we thank all participants included in our present study.,,75,0,0,1,1,BMC,LONDON,"CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND",,1471-2458,,BMC PUBLIC HEALTH,BMC Public Health,MAY 21,2024,24,1,,,,,,,1366,10.1186/s12889-024-18683-8,http://dx.doi.org/10.1186/s12889-024-18683-8,,,15,"Public, Environmental & Occupational Health",Science Citation Index Expanded (SCI-EXPANDED),"Public, Environmental & Occupational Health",RP6G8,38773415,gold,,,2024-06-04,WOS:001228898500002,View Full Record in Web of Science
J,"Harris, K; Overcash, F; Belobrajdic, D; Slavin, J",,,,"Harris, Kathryn; Overcash, Francine; Belobrajdic, Damien; Slavin, Joanne",,,Perspective: Utilizing High Amylose Wheat Flour to Increase Dietary Fiber Intake of Children and Adolescents: A Health by Stealth Approach,FRONTIERS IN PUBLIC HEALTH,,,English,Article,,,,,,fiber; resistant starch; high amylose wheat; adolescents; children,QUALITY-OF-LIFE; NATIONAL-HEALTH; CHILDHOOD CONSTIPATION; RESISTANT STARCH; WHOLE GRAINS; NUTRITION; PREFERENCES; CONSUMPTION; POPULATION; MICROBIOTA,"Children and adolescents have consistently failed to meet recommended levels of dietary fiber consumption, thus making fiber a nutrient of concern. The importance of adequate dietary fiber intake to attain a healthy diet necessitates the identification of fiber-rich and readily consumed food sources by youth. Grain-based foods derived from whole grains represent a strategic initiative to increase dietary fiber consumption and is consistent with the American diet pattern. Increased intake of foods made from whole grains have been positively associated with improved health outcomes but are also less preferred among youth compared to refined grain products, which make up the majority of their carbohydrate intake. Advances in the commercialization and availability of high amylose wheat flour, a source of resistant starch fiber, provides an opportunity to remedy the suggested acceptability issues of whole grain products indicative of sensory factors, without compromising the amount of fiber ingested. Resistant starch fiber consumption has been associated with health benefits including improved blood sugar management, improved markers of digestive and gut health, increased satiety, and a reduced inflammatory response among adults. The limited studies that indicate fiber's direct benefit among youth are largely observational, thereby necessitating the need for more controlled trials for these age groups. Replacing traditional refined wheat flour with refined high amylose wheat flour has the unique ability to increase dietary fiber consumption without compromising desired sensory and finished product characteristics and thus can help increase dietary fiber consumption in children and adolescents who struggle to meet adequate intakes of fiber.","[Harris, Kathryn] Bay State Milling, Quincy, MA USA; [Overcash, Francine; Slavin, Joanne] Univ Minnesota, Dept Food Sci & Nutr, 1334 Eckles Ave, St Paul, MN 55455 USA; [Belobrajdic, Damien] CSIRO, Canberra, ACT, Australia",University of Minnesota System; University of Minnesota Twin Cities; Commonwealth Scientific & Industrial Research Organisation (CSIRO),"Overcash, F (corresponding author), Univ Minnesota, Dept Food Sci & Nutr, 1334 Eckles Ave, St Paul, MN 55455 USA.",overc006@umn.edu,"Slavin, Joanne/GOJ-9874-2022","Slavin, Joanne/0000-0003-0720-5300","Bay State Milling, Inc.","Bay State Milling, Inc.","Bay State Milling, Inc. financially supports FO.",,52,6,7,2,16,FRONTIERS MEDIA SA,LAUSANNE,"AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND",,2296-2565,,FRONT PUBLIC HEALTH,Front. Public Health,MAR 31,2022,10,,,,,,,,817967,10.3389/fpubh.2022.817967,http://dx.doi.org/10.3389/fpubh.2022.817967,,,6,"Public, Environmental & Occupational Health",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),"Public, Environmental & Occupational Health",0V4KC,35433621,"Green Published, gold",,,2024-06-04,WOS:000788312600001,View Full Record in Web of Science
J,"Maeta, A; Katsukawa, M; Inomoto, Y; Hayase, Y; Takahashi, K",,,,"Maeta, Akihiro; Katsukawa, Masahiro; Inomoto, Yasushi; Hayase, Yaeko; Takahashi, Kyoko",,,"Intake of okara soup for 2 weeks for breakfast improved defecation habits in young Japanese women with self-reported constipation: A randomized, double-blind, placebo-controlled, intervention study",JOURNAL OF FOOD SCIENCE,,,English,Article,,,,,,defecation; fiber; gastrointestinal; nutrients; okara,IRRITABLE-BOWEL-SYNDROME; QUALITY-OF-LIFE; NATIONAL-HEALTH; DIETARY FIBER; BIFIDOBACTERIUM; MICROBIOTA; SYMPTOM; ADULTS; IMPACT; BRAN,"Okara is a byproduct of soymilk manufacturing and a rich source of protein and dietary fiber. We investigated whether okara intake improves the habit of defecation in young Japanese women (n= 52) with self-reported constipation. Subjects were categorized into placebo and test groups, who ingested soymilk (0.1 g fiber/meal) and okara (4.1 g fiber/meal) soups, respectively, every day for breakfast, for 2 weeks. Subjects' body composition, bowel movement frequency per week, and constipation assessment scale (CAS) and brief-type self-administered diet history questionnaire scores were assessed at baseline and after the intervention (Analysis 1). Further, subjects' bowel movement frequency per week and CAS scores were assessed during the 2-week follow-up (Analysis 2). There were no significant differences in age, anthropometric characteristics, nutrients intake, frequency of bowel movements per week, and total CAS scores between the placebo and test groups at baseline. After intervention, the total CAS score was significantly lower in the test group than in the placebo group. Moreover, the difference in the total CAS scores between baseline and after intervention was lower in the test group than in the placebo group, although not significant. The weekly frequency of bowel movement significantly increased for both placebo and test groups. The test group reported reduced abdominal bloating 2 weeks after the intervention, but the placebo group did not. The findings suggest that okara is effective in increasing the frequency of bowel movements and improving defecation habit in young women with self-reported constipation. Practical Application Okara is an effective food to increase the frequency of bowel movements and to improve defecation habits in young women with self-reported constipation.","[Maeta, Akihiro; Takahashi, Kyoko] Mukogawa Womens Univ, Sch Food Sci & Nutr, Dept Food Sci & Nutr, 6-46 Ikebiraki Cho, Nishinomiya, Hyogo 6638558, Japan; [Katsukawa, Masahiro; Inomoto, Yasushi; Hayase, Yaeko] Kikkoman Food Prod Co, Prod Dev Div, 250 Noda, Noda, Chiba 2780037, Japan",Mukogawa Women's University; Kikkoman Corporation,"Takahashi, K (corresponding author), Mukogawa Womens Univ, Sch Food Sci & Nutr, Dept Food Sci & Nutr, 6-46 Ikebiraki Cho, Nishinomiya, Hyogo 6638558, Japan.",taka@mukogawa-u.ac.jp,,"Maeta, Akihiro/0000-0001-9410-2670",Kikkoman Food Products Company,Kikkoman Food Products Company,This work was supported by Kikkoman Food Products Company.,,38,4,4,0,7,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0022-1147,1750-3841,,J FOOD SCI,J. Food Sci.,OCT,2020,85,10,,,,,3570,3576,,10.1111/1750-3841.15392,http://dx.doi.org/10.1111/1750-3841.15392,,SEP 2020,7,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,OC4JV,32885419,,,,2024-06-04,WOS:000565638300001,View Full Record in Web of Science
J,"Gordon, M; MacDonald, JK; Parker, CE; Akobeng, AK; Thomas, AG",,,,"Gordon, Morris; MacDonald, John K.; Parker, Claire E.; Akobeng, Anthony K.; Thomas, Adrian G.",,,Osmotic and stimulant laxatives for the management of childhood constipation,COCHRANE DATABASE OF SYSTEMATIC REVIEWS,,,English,Review,,,,,,"Constipation [drug therapy]; Defecation [drug effects; physiology]; Dietary Fiber [adverse effects; therapeutic use]; Lactulose [adverse effects; therapeutic use]; Laxatives [adverse effects; therapeutic use]; Magnesium Hydroxide [adverse effects; therapeutic use]; Mineral Oil [adverse effects; therapeutic use]; Osmosis; Polyethylene Glycols [adverse effects; therapeutic use]; Randomized Controlled Trials as Topic; Sugar Alcohols [adverse effects; therapeutic use]; Adolescent; Child; Child, Preschool; Humans; Infant",CHRONIC FUNCTIONAL CONSTIPATION; POLYETHYLENE-GLYCOL 3350; RECTAL FECAL IMPACTION; HYDROLYZED GUAR GUM; DOUBLE-BLIND; PLUS ELECTROLYTES; MAGNESIUM-HYDROXIDE; CONTROLLED-TRIAL; LIQUID PARAFFIN; PSYLLIUM FIBER,"Background Constipation within childhood is an extremely common problem. Despite the widespread use of osmotic and stimulant laxatives by health professionals to manage constipation in children, there has been a long standing paucity of high quality evidence to support this practice. Objectives We set out to evaluate the efficacy and safety of osmotic and stimulant laxatives used to treat functional childhood constipation. Search methods We searched MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, and the Cochrane IBD Group Specialized Trials Register from inception to 10 March 2016. There were no language restrictions. We also searched the references of all included studies, personal contacts and drug companies to identify studies. Selection criteria Randomised controlled trials (RCTs) which compared osmotic or stimulant laxatives to placebo or another intervention, with participants aged 0 to 18 years old were considered for inclusion. The primary outcome was frequency of defecation. Secondary endpoints included faecal incontinence, disimpaction, need for additional therapies and adverse events. Data collection and analysis Relevant papers were identified and two authors independently assessed the eligibility of trials, extracted data and assessed methodological quality using the Cochrane risk of bias tool. The primary outcome was frequency of defecation. Secondary endpoints included faecal incontinence, disimpaction, need for additional therapies and adverse events. For continuous outcomes we calculated the mean difference (MD) and 95% confidence interval (CI) using a fixed-effect model. For dichotomous outcomes we calculated the risk ratio (RR) and 95% CI using a fixed-effect model. The Chi(2) and I-2 statistics were used to assess statistical heterogeneity. A random-effects model was used in situations of unexplained heterogeneity. We assessed the overall quality of the evidence supporting the primary and secondary outcomes using the GRADE criteria. Main results Twenty-five RCTs (2310 participants) were included in the review. Fourteen studies were judged to be at high risk of bias due to lack of blinding, incomplete outcome data and selective reporting. Meta-analysis of two studies (101 patients) comparing polyethylene glycol (PEG) with placebo showed a significantly increased number of stools per week with PEG (MD 2.61 stools per week, 95% CI 1.15 to 4.08). Common adverse events in the placebo-controlled studies included flatulence, abdominal pain, nausea, diarrhoea and headache. Participants receiving high dose PEG (0.7 g/kg) had significantly more stools per week than low dose PEG (0.3 g/kg) participants (1 study, 90 participants, MD 1.30, 95% 0.76 to 1.84). Meta-analysis of 6 studies with 465 participants comparing PEG with lactulose showed a significantly greater number of stools per week with PEG (MD 0.70, 95% CI 0.10 to 1.31), although follow-up was short. Patients who received PEG were significantly less likely to require additional laxative therapies. Eighteen per cent (27/154) of PEG patients required additional therapies compared to 31% (47/150) of lactulose patients (RR 0.55, 95% CI 0.36 to 0.83). No serious adverse events were reported with either agent. Common adverse events in these studies included diarrhoea, abdominal pain, nausea, vomiting and pruritis ani. Meta-analysis of 3 studies with 211 participants comparing PEG with milk of magnesia showed that the stools per week were significantly greater with PEG (MD 0.69, 95% CI 0.48 to 0.89). However, the magnitude of this difference was quite small and may not be clinically significant. One child was noted to be allergic to PEG, but there were no other serious adverse events reported. One study found a significant difference in stools per week favouring milk of magnesia over lactulose (MD -1.51, 95% CI -2.63 to -0.39, 50 patients), Meta-analysis of 2 studies with 287 patients comparing liquid paraffin (mineral oil) with lactulose revealed a relatively large statistically significant difference in the number of stools per week favouring liquid paraffin (MD 4.94, 95% CI 4.28 to 5.61). No serious adverse events were reported. Adverse events included abdominal pain, distention and watery stools. No statistically significant differences in the number of stools per week were found between PEG and enemas (1 study, 90 patients, MD 1.00, 95% CI -1.58 to 3.58), dietary fibre mix and lactulose (1 study, 125 patients, P = 0.481), senna and lactulose (1 study, 21 patients, P > 0.05), lactitol and lactulose (1 study, 51 patients, MD -0.80, 95% CI -2.63 to 1.03), hydrolyzed guar gum and lactulose (1 study, 61 patients, MD 1.00, 95% CI -1.80 to 3.80), PEG and flixweed (1 study, 109 patients, MD 0.00, 95% CI -0.33 to 0.33), PEG and dietary fibre (1 study, 83 patients, MD 0.20, 95% CI -0.64 to 1.04), and PEG and liquid paraffin (2 studies, 261 patients, MD 0.35, 95% CI -0.24 to 0.95). Authors' conclusions The pooled analyses suggest that PEG preparations may be superior to placebo, lactulose and milk of magnesia for childhood constipation. GRADE analyses indicated that the overall quality of the evidence for the primary outcome (number of stools per week) was low or very low due to sparse data, inconsistency (heterogeneity), and high risk of bias in the studies in the pooled analyses. Thus, the results of the pooled analyses should be interpreted with caution because of quality and methodological concerns, as well as clinical heterogeneity, and short follow-up. There is also evidence suggesting the efficacy of liquid paraffin (mineral oil). There is no evidence to demonstrate the superiority of lactulose when compared to the other agents studied, although there is a lack of placebo controlled studies. Further research is needed to investigate the long term use of PEG for childhood constipation, as well as the role of liquid paraffin. The optimal dose of PEG also warrants further investigation.","[Gordon, Morris] Univ Cent Lancashire, Sch Med & Dent, Preston, Lancs, England; [Gordon, Morris] Blackpool Victoria Hosp, Families Div, Blackpool, England; [MacDonald, John K.; Parker, Claire E.] Robarts Clin Trials, Cochrane IBD Grp, London, ON, Canada; [MacDonald, John K.] Univ Western Ontario, Dept Med, London, ON, Canada; [Akobeng, Anthony K.] Sidra Med & Res Ctr, Doha, Qatar; [Thomas, Adrian G.] Royal Manchester Childrens Hosp, Manchester, Lancs, England",University of Central Lancashire; Western University (University of Western Ontario); Western University (University of Western Ontario); Sidra Medical & Research Center; Royal Manchester Children's Hospital,"Gordon, M (corresponding author), Univ Cent Lancashire, Sch Med & Dent, Preston, Lancs, England.",morris@betterprescribing.com,"Parker, Claire/JPX-5337-2023","Gordon, Morris/0000-0002-1216-5158",Crohn's and Colitis Canada (CCC),Crohn's and Colitis Canada (CCC),"Partial funding for the Cochrane IBD Group (April 1, 2016 - March 31, 2018) has been provided by Crohn's and Colitis Canada (CCC).",,70,30,34,2,26,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1469-493X,1361-6137,,COCHRANE DB SYST REV,Cochrane Database Syst Rev.,,2016,,8,,,,,,,CD009118,10.1002/14651858.CD009118.pub3,http://dx.doi.org/10.1002/14651858.CD009118.pub3,,,93,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,EE4TK,27531591,"Green Published, Green Accepted",,,2024-06-04,WOS:000389598000040,View Full Record in Web of Science
J,"Han, Y; Zhang, L; Liu, XQ; Zhao, ZJ; Lv, LX",,,,"Han, Yong; Zhang, Lei; Liu, Xiang-Qun; Zhao, Zhi-Jun; Lv, Lu-Xian",,,Effect of glucomannan on functional constipation in children: a systematic review and meta-analysis of randomised controlled trials,ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION,,,English,Review,,,,,,constipation; glucomannan; children; meta-analysis; RCTs,CHILDHOOD CONSTIPATION; FIBER GLUCOMANNAN; DIETARY FIBER; EFFICACY; QUALITY; ADULTS; HEALTH; CARE,"Background and Objectives: Constipation, a common complaint in children, considerably affects the quality of life. This systematic review assessed the treatment effects of glucomannan on children with constipation by summarising evidence from previous randomised controlled trials (RCTs). Methods and Study Design: A comprehensive electronic literature search was conducted for identifying eligible RCTs that evaluated the effectiveness of glucomannan. The results were reported as mean differences (MDs), standardised mean differences (SMDs), and risk ratios (RRs) with 95% confidence intervals (CIs). The primary outcome was the defecation frequency per week; the secondary outcomes were stool consistency and the rate of successful treatment. A meta analysis was conducted using the random effects model. Results: Three RCTs evaluating 122 participants were identified. Glucomannan use was associated with an increased frequency of defecation (3 trials; MD=1.40; 95% CI: 0.36-2.44, p=0.008); however, there were no significant differences in the outcomes of stool consistency (3 trials; SMD=0.48; 95% CI: 0.44 to 1.40, p=0.300) or the rate of successful treatment (2 trials; RR=1.36; 95% CI: 0.48-3.81, p=0.110). Conclusions: Glucomannan moderately increases the defecation frequency of children with constipation but is not associated with a reduction in stool consistency or overall improvement in the rate of successful treatment. However, these results should be cautiously interpreted because of the small sample size and the risk of products containing glucomannan need to be considered. Additional large-scale and well-designed RCTs are necessary to evaluate the efficacy and long-term safety of glucomannan.","[Han, Yong; Zhang, Lei; Liu, Xiang-Qun; Zhao, Zhi-Jun] Xinxiang Med Univ, Affiliated Hosp 2, Dept Nutr, Xinxiang, Henan, Peoples R China; [Lv, Lu-Xian] Xinxiang Med Univ, Affiliated Hosp 2, Dept Psychiat, 388 Jianshe Rd, Xinxiang 453002, Henan, Peoples R China",Xinxiang Medical University; Xinxiang Medical University,"Lv, LX (corresponding author), Xinxiang Med Univ, Affiliated Hosp 2, Dept Psychiat, 388 Jianshe Rd, Xinxiang 453002, Henan, Peoples R China.",1269015119@qq.com,"LI, Wenhui/JCD-9947-2023; Li, Juan/JEO-6872-2023",,,,,,29,9,10,2,14,"H E C PRESS, HEALTHY EATING CLUB PTY LTD",MCKINNON,"PO BOX 4121, MCKINNON, VIC 3204, AUSTRALIA",0964-7058,1440-6047,,ASIA PAC J CLIN NUTR,Asia Pac. J. Clin. Nutr.,,2017,26,3,,,,,471,477,,10.6133/apjcn.032016.03,http://dx.doi.org/10.6133/apjcn.032016.03,,,7,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,ET2SR,28429913,,,,2024-06-04,WOS:000400124900014,View Full Record in Web of Science
J,"Svistunov, AA; Osadchuk, MA; Butorova, LI; Tokmulina, GM",,,,"Svistunov, A. A.; Osadchuk, M. A.; Butorova, L. I.; Tokmulina, G. M.",,,Chronic constipation in the practice of a therapist: Features of therapy for comorbidity,TERAPEVTICHESKII ARKHIV,,,Russian,Article,,,,,,chronic constipation; comorbidity; metabolic syndrome; obesity; cardiovascular diseases; type 2 diabetes; psyllium; Mucofalk,PREVALENCE; DISEASE; LIVER; RISK,"Aim. To evaluate the clinical efficacy of laxatives with different pharmacological effects in the combination therapy in patients with chronic constipation (CC) concurrent with obesity, hypertensive disease, and type 2 diabetes mellitus (DM). Subjects and methods. A total of 110 people (45 men, 65 women) aged 45 to 72 years with CC in the presence of concomitant diseases: grade 1 or 2 hypertensive disease + obesity + type 2 DM. The investigators determined the severity of abdominal pain syndrome and flatulence, by indicating the mean frequency of defecations per week and fecal consistency according to the Bristol stool scale; anthropometric parameters; serum biochemistry tests; and serum lipoprotein phenotyping. Quality of life was assessed by the SF-36 questionnaire. The patients were divided into 3 groups according their use of agents: 1) dietary fiber (psyllium); 2) osmotic laxatives (disaccharides); 3) osmotic laxatives (polyethylene glycol). Results. The patients taking psyllium to treat constipation showed an increasing frequency of defecations and normalization of stool consistency. Incorporating psyllium into combination therapy was accompanied by a significant decrease in the levels of total cholesterol and low-density lipoprotein cholesterol. A similar trend was observed for serum triglycerides. The patients receiving combination therapy including other laxatives displayed no significant differences between lipid metabolic parameters at the beginning and after the end of treatment. Conclusion. The whole complex of properties of psyllium (Mucofalk) can be fully realized in patients with comorbidity and chronic constipation, which is accompanied not only by the normalization of bowel emptying, but also by marked positive changes in the main lipid metabolic parameters and by a reduction in overweight.","[Svistunov, A. A.; Osadchuk, M. A.; Butorova, L. I.; Tokmulina, G. M.] IM Sechenov First Moscow State Med Univ, Minist Hlth Russia, Moscow, Russia",Ministry of Health of the Russian Federation; Sechenov First Moscow State Medical University,"Osadchuk, MA (corresponding author), IM Sechenov First Moscow State Med Univ, Minist Hlth Russia, Moscow, Russia.",osadchuk.mikhail@yandex.ru,,"Osadcuk, Mihail/0000-0003-0485-6802",,,,,11,0,0,0,2,CJSC CONSILIUM MEDICUM,MOSCOW,"NOVIY ZIKOVSKIY PROEZD, D 3, 40, MOSCOW, 125167, RUSSIA",0040-3660,2309-5342,,TERAPEVT ARKH,Ter. Arkhiv,,2017,89,4,,,,,69,74,,10.17116/terarkh201789469-74,http://dx.doi.org/10.17116/terarkh201789469-74,,,6,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,EZ6MH,28514403,gold,,,2024-06-04,WOS:000404831500012,View Full Record in Web of Science
J,"Takahashi, T; Nakade, Y; Fukuda, H; Tsukamoto, K; Mantyh, C; Pappas, TN",,,,"Takahashi, Toku; Nakade, Yukiomi; Fukuda, Hiroyuki; Tsukamoto, Kiyoshi; Mantyh, Christopher; Pappas, Theodore. N.",,,Daily intake of high dietary fiber slows accelerated colonic transit induced by restrain stress in rats,DIGESTIVE DISEASES AND SCIENCES,,,English,Article,,,,,,constipation; corticotropin releasing factor; diarrhea; irritable bowel syndrome; short-chain fatty acids,IRRITABLE-BOWEL-SYNDROME; CORTICOTROPIN-RELEASING-FACTOR; CHAIN FATTY-ACIDS; INDUCED DEFECATION; WHEAT BRAN; IN-VITRO; FERMENTATION; RECEPTORS; RESPONSES,"Background Stress and central corticotropin releasing factor (CRF) are contributing factors to the pathogenesis of irritable bowel syndrome (IBS). It has been shown that restraint stress and central CRF stimulate colonic motility in rats. Short-chain fatty acids (SCFAs) are produced by bacterial fermentation from dietary fibers. It is controversial whether daily intake of dietary fiber is beneficial for patients with diarrhea-predominant IBS. We studied whether dietary fiber intake affects colonic transit and motility stimulated by restraint stress and central CRF in rats. Methods Corn starch is digested almost completely in the small intestine, while potato starch shows substantial resistance to alpha-amylase and its consumption leads to stimulation of large-bowel fermentation. Four weeks after a corn starch, potato starch, or usual diet (rat chow), colonic transit and motility stimulated by restraint stress and intracisternal (ic) injection of CRF were studied. Fecal concentration of SCFAs in the cecum was measured by high-performance liquid chromatography (HPLC). Results Four-week treatment with potato starch diet significantly increased cecal concentrations of SCFAs, compared to treatment with corn starch diet. Accelerated colonic transit induced by stress and ic injection of CRF (1 mu g) were significantly attenuated in rats receiving potato starch diet compared to rats receiving corn starch diet. The incidence of unformed stool (diarrhea) induced by stress and CRF was also reduced in rats receiving potato starch diet compared to rats receiving corn starch diet and usual diet. Conclusion It is suggested that daily intake of a high-fiber diet may prevent stress- and CRF-induced acceleration of colonic transit and diarrhea. This study may contribute to treatment for the patients of diarrhea-predominant IBS.","[Takahashi, Toku] Zablocki Vet Adm Med Ctr, Milwaukee, WI 53295 USA; [Takahashi, Toku; Nakade, Yukiomi; Fukuda, Hiroyuki; Tsukamoto, Kiyoshi; Mantyh, Christopher; Pappas, Theodore. N.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Takahashi, Toku; Nakade, Yukiomi; Fukuda, Hiroyuki; Tsukamoto, Kiyoshi; Mantyh, Christopher; Pappas, Theodore. N.] Durham Vet Affairs Med Ctr, Dept Surg, Durham, NC USA",Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center,"Takahashi, T (corresponding author), Zablocki Vet Adm Med Ctr, 5000 W Natl Ave, Milwaukee, WI 53295 USA.",ttakahashi@mcw.edu,"mantyh, christopher/AAJ-9140-2021","Pappas, Theodore/0000-0001-9110-4849","NIDDK NIH HHS [R01 DK 55808, R01 DK 62768] Funding Source: Medline",NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)),,,23,6,8,0,10,SPRINGER,DORDRECHT,"VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS",0163-2116,1573-2568,,DIGEST DIS SCI,Dig. Dis. Sci.,MAY,2008,53,5,,,,,1271,1277,,10.1007/s10620-008-0228-8,http://dx.doi.org/10.1007/s10620-008-0228-8,,,7,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,286LU,18335315,,,,2024-06-04,WOS:000254848200016,View Full Record in Web of Science
J,"Mugie, SM; Di Lorenzo, C; Benninga, MA",,,,"Mugie, Suzanne M.; Di Lorenzo, Carlo; Benninga, Marc A.",,,Constipation in childhood,NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY,,,English,Review,,,,,,,SLOW-TRANSIT CONSTIPATION; DIRECT MEDICAL COSTS; DIETARY FIBER INTAKE; DOUBLE-BLIND; COLONIC TRANSIT; INTRACTABLE CONSTIPATION; PLUS ELECTROLYTES; FECAL IMPACTION; FUNCTIONAL CONSTIPATION; INTERSTITIAL-CELLS,"Constipation in children is an often long-lasting pediatric functional gastrointestinal disorder with a worldwide prevalence varying between 0.7% and 29.6%, and estimated health-care costs of US$3.9 billion per year in the USA alone. The pathophysiology of childhood constipation is multifactorial and remains incompletely understood; however, withholding of stools, starting after an experience of a hard, painful, or frightening bowel movement is the most common cause found in children. A thorough medical history and physical examination, including a rectal examination in combination with a bowel diary, is sufficient in the majority of cases to diagnose constipation. The current standard treatment consists of education, toilet training, disimpaction, maintenance therapy and long-term follow-up. In the past decade, well-designed treatment trials in the pediatric population have emerged and long-term outcome studies have been completed. This Review summarizes the current knowledge of the clinical aspects of childhood constipation, including pathogenesis, diagnosis and treatment, with particular emphasis on the latest available data.","[Mugie, Suzanne M.; Benninga, Marc A.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, NL-1105 AZ Amsterdam, Netherlands; [Di Lorenzo, Carlo] Nationwide Childrens Hosp, Dept Pediat Gastroenterol Hepatol & Nutr, Columbus, OH 43205 USA",University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Emma Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital,"Benninga, MA (corresponding author), Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.",m.a.benninga@amc.uva.nl,,,,,,,109,98,111,1,20,NATURE PUBLISHING GROUP,NEW YORK,"75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA",1759-5045,1759-5053,,NAT REV GASTRO HEPAT,Nat. Rev. Gastroenterol. Hepatol.,SEP,2011,8,9,,,,,502,511,,10.1038/nrgastro.2011.130,http://dx.doi.org/10.1038/nrgastro.2011.130,,,10,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,814ZY,21808283,,,,2024-06-04,WOS:000294497100005,View Full Record in Web of Science
J,"Jones, MP; Talley, NJ; Nuyts, G; Dubois, D",,,,"Jones, MP; Talley, NJ; Nuyts, G; Dubois, D",,,Lack of objective evidence of efficacy of laxatives in chronic constipation,DIGESTIVE DISEASES AND SCIENCES,,,English,Article,,,,,,meta-analysis; constipation; laxatives; placebo,DOUBLE-BLIND TRIAL; ELDERLY-PATIENTS; LACTULOSE SYRUP; DIETARY FIBER; WHEAT BRAN; PSYLLIUM; SENNA; CHILDHOOD; COLON; RISK,"Laxatives are commonly used to treat constipation and can be bought over-the-counter in many countries, although some preparations need to be prescribed by physicians. A meta-analysis was conducted to quantitatively evaluate the published evidence on the efficacy of laxatives in constipation. We found that large, well-controlled, published studies whose data were comparable were lacking. Of 250 articles, 35 met the inclusion criteria but only 11 yielded usable data (N = 375 patients on laxatives, 174 on placebo). There was an effect of laxatives on stool frequency (mean increase 1.9 stools per week) and stool weight (mean increase 476 g) but this was not clearly distinguishable from that of placebo therapies (1 stool and 434 g, respectively) in studies up to 4 weeks in duration. Similarly, studies of 5-12 weeks yielded no differences overall. These results cannot definitively rule out laxatives as an effective treatment, due to the poor published evidence. Better evidence is required to justify the continued expenditure of funds on laxatives by both patients and formularies.","Univ Sydney, Dept Med, Sydney, NSW 2006, Australia; Janssen Res Fdn, B-2340 Beerse, Belgium",University of Sydney; Johnson & Johnson,"Univ Sydney, Dept Med, Nepean Hosp, POB 63, Penrith, NSW 2751, Australia.",,"Talley, Nicholas J/D-5399-2013; Jones, Michael/A-9013-2013","Jones, Michael/0000-0003-0565-4938",,,,,53,86,92,0,5,SPRINGER,DORDRECHT,"VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS",0163-2116,1573-2568,,DIGEST DIS SCI,Dig. Dis. Sci.,OCT,2002,47,10,,,,,2222,2230,UNSP 0163-2116/02/1000-2222/0,10.1023/A:1020131126397,http://dx.doi.org/10.1023/A:1020131126397,,,9,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,591YR,12395895,,,,2024-06-04,WOS:000177908700012,View Full Record in Web of Science
J,"Johanson, JF",,,,"Johanson, JF",,,Geographic distribution of constipation in the United States,AMERICAN JOURNAL OF GASTROENTEROLOGY,,,English,Article,,,,,,,EPIDEMIOLOGY,"Objective: Despite its frequent occurrence, the etiology of constipation has remained pearl-understood, The influence of widely accepted risk Factors such as inadequate dietary fiber intake, immobility, insufficient fluid intake, and poor muscle tone is unclear, This study examined the geographic distribution of constipation among Medicare beneficiaries to identify potential environmental risk Factors. Methods: All Medicare beneficiaries with a diagnosis of constipation were extracted from the total Health Care Financing Administration data file of 1987 said stratified by sex, race, and state of residence, The population of each state by sex race, and age >65 yr served as the denominator to calculate sex-and race-specific morbidity rates, Results: A distinct geographic distribution was observed. When stratified by individual states, hospital discharges for constipation were more common in rural as compared with urban states, Constipation also appeared tea be more common in northern and in poorer states, Conclusion: The distinct geographic pattern of constipation suggests thr influence of three global environmental Factors: rural living, colder temperature, and lowcr socioeconomic status, (C) 1998 by Am, Coil, of Gastroenterology).","Univ Illinois, Coll Med, Rockford, IL 61107 USA",University of Illinois System; University of Illinois Rockford; University of Illinois Chicago,"Johanson, JF (corresponding author), Univ Illinois, Coll Med, 401 Roxbury Rd, Rockford, IL 61107 USA.",,,,,,,,18,33,36,0,2,ELSEVIER SCIENCE INC,NEW YORK,"655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA",0002-9270,,,AM J GASTROENTEROL,Am. J. Gastroenterol.,FEB,1998,93,2,,,,,188,191,,10.1111/j.1572-0241.1998.00188.x,http://dx.doi.org/10.1111/j.1572-0241.1998.00188.x,,,4,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,ZB489,9468239,,,,2024-06-04,WOS:000072477100013,View Full Record in Web of Science
J,"Cicero, AFG",,,,"Cicero, A. F. G.",,,Metamucil as an additional source of dietary fiber: impact of the quality of healthcare professionals' recommendations on users' experience,EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES,,,English,Article,,,,,,Counselling; Dietary fibers; Metamucil; Nutritional supplementation,INTAKE REDUCES RISK; CHRONIC CONSTIPATION; FOOD-CONSUMPTION; METAANALYSIS; PREVENTION; CANCER; SUPPLEMENTS; DOCUSATE; PSYLLIUM; THERAPY,"OBJECTIVE: Metamucil (R) is a fiber supplementation formed by 100% natural psyllium. This study, conducted in Italy, assessed the impact of quality of pharmacists' instruction to use this product on subjects' adherence to and overall satisfaction with this test product. SUBJECTS AND METHODS: Open-label post-marketing study involving adult subjects who had purchased Metamucil (R) (follow-up: 14 +/- 7 days). Information was collected using questionnaires dedicated to the participating subject and pharmacy. RESULTS: In total, 1480 subjects and 182 pharmacies returned their questionnaires. The mean age of the subjects was 49 years, two-thirds were female and 87% went to the pharmacy with problems related to bowel movements. The median daily dose taken over the 21-day period was 1. Adherence to the test product was associated with the quality of pharmacist's counseling (p = 0.005). Similarly, satisfaction with the tested product was associated with the quality of counseling (p < 0.001). Consumers' satisfaction was also associated with the quality of pharmacist's explanation of the benefits of the test product (p < 0.001) and with adherence (p < 0.001). 93% and 83% of subjects, respectively, stated the ease of use and their overall satisfaction with the test product, with 73% of subjects agreeing that they would continue using it. Similar findings were observed in subjects who had previously taken the most commonly used branded fiber supplements containing either partially hydrated guar gum or psyllium in the previous 6 months. 92% of pharmacists stated they would recommend Metamucilr (R) for bowel regularity and 90% as it provides multiple benefits. CONCLUSIONS: Pharmacists' counseling is associated with consumers' adherence and satisfaction to Metamucil (R). A large proportion of subjects were satisfied and would continue taking the tested product as a fiber supplement.","Univ Bologna, Med & Surg Sci Dept, Bologna, Italy",University of Bologna,"Cicero, AFG (corresponding author), Univ Bologna, Med & Surg Sci Dept, Bologna, Italy.",arrigo.cicero@unibo.it,"Cicero, Arrigo F.G./H-8244-2019","Cicero, Arrigo F.G./0000-0002-4367-3884",PGT Healthcare,PGT Healthcare,"We thank the participating pharmacies and subjects who contributed to the content. This study was funded by PGT Healthcare. TFS CRO undertook project management, data management, and statistical analysis. Editorial assistance for the preparation of this manuscript was provided by Luca Giacomelli, Ph.D, on behalf of Content Ed Net; this assistance was funded by PGT Healthcare.",,28,3,3,0,7,VERDUCI PUBLISHER,ROME,"VIA GREGORIO VII, ROME, 186-00165, ITALY",1128-3602,,,EUR REV MED PHARMACO,Eur. Rev. Med. Pharmacol. Sci.,APR,2015,19,7,,,,,1297,1304,,,,,,8,Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy,CG8TX,25912593,,,,2024-06-04,WOS:000353587000028,View Full Record in Web of Science
J,"Citronberg, J; Kantor, ED; Potter, JD; White, E",,,,"Citronberg, Jessica; Kantor, Elizabeth D.; Potter, John D.; White, Emily",,,"A Prospective Study of the Effect of Bowel Movement Frequency, Constipation, and Laxative Use on Colorectal Cancer Risk",AMERICAN JOURNAL OF GASTROENTEROLOGY,,,English,Article,,,,,,,COLON-CANCER; ANTHRANOID LAXATIVES; MELANOSIS-COLI; DIETARY FIBER; LIFE-STYLE; COHORT; FOOD; INTERVENTION; EPIDEMIOLOGY; RECURRENCE,"OBJECTIVES: Constipation and laxative use have been hypothesized to increase colorectal cancer (CRC) risk, but existing epidemiologic studies have been inconclusive. To address this issue, the authors prospectively examined the association between CRC incidence and constipation, non-fiber laxative use, and fiber laxative use among 75,214 participants of the VITamins And Lifestyle study. METHODS: Information on bowel movement frequency as well as average 10-year non-fiber laxative use, fiber laxative use, and constipation was ascertained by means of a questionnaire. Patients were followed from the time of receipt of the baseline questionnaire (2000-2002) until 2008 for CRC incidence, over which time 558 incident CRC cases occurred. Cox proportional hazard models were used to estimate the multivariate-adjusted hazard ratios (HRs) and 95% confidence intervals (95% CI). RESULTS: Compared with individuals who used non-fiber laxatives less than once per year, the HRs associated with low (1-4 times per year) and high (>= 5 times per year) use were 1.49 (95 % CI: 1.04-2.14) and 1.43 (95% CI: 0.82-2.28), respectively (P-trend=0.05). HRs for CRC were statistically significantly decreased and lowest in individuals who reported using fiber laxatives often (4 + days per week for 4 + years) vs. those who reported no use (HR=0.44; 95% CI: 0.21-0.95), although the trend was not significant (P-trend=0.19). No statistically significant associations between bowel movement frequency or constipation and CRC risk were observed. CONCLUSIONS: Findings from this study suggest that risk for CRC increases with non-fiber laxative use and decreases with fiber laxative use. However, further observational and experimental studies are needed to clarify these relationships before drawing conclusions about the preferred treatment of constipation.","[Citronberg, Jessica; Kantor, Elizabeth D.; Potter, John D.; White, Emily] Fred Hutchinson Canc Res Ctr, Seattle, WA 98102 USA; [Citronberg, Jessica; Potter, John D.; White, Emily] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Potter, John D.] Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand",Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Massey University,"Citronberg, J (corresponding author), Fred Hutchinson Canc Res Ctr, POB 19024,M4-B402, Seattle, WA 98102 USA.",jcitronb@fhcrc.org,,"Kantor, Elizabeth/0000-0002-9124-5323; Potter, John/0000-0001-5439-1500",National Institutes of Health (National Cancer Institute and Office of Dietary Supplements) [K05-CA154337]; National Institutes of Health (National Cancer Institute) [R25CA094880],National Institutes of Health (National Cancer Institute and Office of Dietary Supplements); National Institutes of Health (National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)),This work was supported by the National Institutes of Health grants K05-CA154337 (National Cancer Institute and Office of Dietary Supplements) and R25CA094880 (National Cancer Institute).,,33,38,40,0,16,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0002-9270,1572-0241,,AM J GASTROENTEROL,Am. J. Gastroenterol.,OCT,2014,109,10,,,,,1640,1649,,10.1038/ajg.2014.233,http://dx.doi.org/10.1038/ajg.2014.233,,,10,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,AS7UM,25223576,Green Accepted,,,2024-06-04,WOS:000344460100020,View Full Record in Web of Science
J,"Afzal, NA; Tighe, MP; Thomson, MA",,,,"Afzal, Nadeem A.; Tighe, Mark P.; Thomson, Mike A.",,,Constipation in children,ITALIAN JOURNAL OF PEDIATRICS,,,English,Review,,,,,,,CHRONIC FUNCTIONAL CONSTIPATION; DIETARY FIBER INTAKE; DOUBLE-BLIND; CHILDHOOD CONSTIPATION; POLYETHYLENE-GLYCOL; COWS-MILK; PLUS ELECTROLYTES; FECAL IMPACTION; LACTULOSE; ENCOPRESIS,"Constipation remains a frequent presentation to paediatricians, with significant health resource implications. We present a practical guide to the management of paediatric constipation and evaluate the current evidence for treatment regimens, to help the clinician in treating a condition that can be distressing and has a significant impact on affected families.","[Afzal, Nadeem A.] Southampton Univ Hosp NHS Trust, Southampton Gen Hosp, Dept Paediat, Southampton SO16 6YD, Hants, England; [Tighe, Mark P.] Poole Hosp NHS Trust, Dept Paediat, Poole BH15 2JB, Dorset, England; [Thomson, Mike A.] Sheffield Childrens NHS Trust, Dept Paediat Gastroenterol, Sheffield S10 2TH, S Yorkshire, England",University of Southampton; University Hospital Southampton NHS Foundation Trust; Sheffield Children's NHS Foundation Trust,"Afzal, NA (corresponding author), Southampton Univ Hosp NHS Trust, Southampton Gen Hosp, Dept Paediat, Tremona Rd, Southampton SO16 6YD, Hants, England.",N.afzal@soton.ac.uk,"Tighe, Mark/JFT-0490-2023","Tighe, Mark/0000-0003-0755-8296",,,,,77,32,34,0,8,BMC,LONDON,"CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND",1720-8424,1824-7288,,ITAL J PEDIATR,Ital. J. Pediatr.,JUN 13,2011,37,,,,,,,,28,10.1186/1824-7288-37-28,http://dx.doi.org/10.1186/1824-7288-37-28,,,10,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,798WX,21668945,"gold, Green Published",,,2024-06-04,WOS:000293244000001,View Full Record in Web of Science
S,"Ciudad-Mulero, M; Fernández-Ruiz, V; Matallana-González, MC; Morales, P",,"Ferreira, ICFR; Barros, L",,"Ciudad-Mulero, Maria; Fernandez-Ruiz, Virginia; Cruz Matallana-Gonzalez, Ma; Morales, Patricia",,,Dietary fiber sources and human benefits: The case study of cereal and pseudocereals,FUNCTIONAL FOOD INGREDIENTS FROM PLANTS,Advances in Food and Nutrition Research,,English,Article; Book Chapter,,,,,,,CHIA SALVIA-HISPANICA; WHOLE-GRAIN WHEAT; RESISTANT STARCH; PHYSICOCHEMICAL PROPERTIES; FUNCTIONAL FOODS; BETA-GLUCANS; FATTY-ACIDS; NONDIGESTIBLE OLIGOSACCHARIDES; ARABINOXYLAN-OLIGOSACCHARIDES; CARDIOVASCULAR-DISEASE,"Dietary fiber (DF) includes the remnants of the edible part of plants and analogous carbohydrates that are resistant to digestion and absorption in the human small intestine with complete or partial fermentation in the human large intestine. DF can be classified into two main groups according to its solubility, namely insoluble dietary fiber (IDF) that mainly consists on cell wall components, including cellulose, some hemicelluloses, lignin and resistant starch, and soluble dietary fiber (SDF) that consists of non-cellulosic polysaccharides as non-digestible oligosaccharides, arabinoxylans (AX), beta-glucans, some hemicelluloses, pectins, gums, mucilages and inulin. The intake of DF is associated with health benefits. IDF can contribute to the normal function of the intestinal tract and it has an important role in the prevention of colonic diverticulosis and constipation. SDF is extensively fermented by gut microbiota and it is associated with carbohydrate and lipid metabolism, with important health benefits due to its hypocholesterolemic properties. Due to these nutritional and health properties, DF is widely used as functional ingredients in food industry, being whole grain cereals, pulses, fruits and vegetables the main sources of DF. Also some synthetic sources are employed, namely polydextrose, hydroxypropyl methylcellulose or cyclodextrins. The DF content of cereals varies depending on cultivars, their botanical components (pericarp, emdosperm and germ) and the processing conditions they have undergone (baking, extrusion, etc.). In cereal grains, AX are the predominant non-cellulose DF polysaccharides followed by cellulose and beta-glucans, while in pseudocereals, pectins are quantitatively predominant.","[Ciudad-Mulero, Maria; Fernandez-Ruiz, Virginia; Cruz Matallana-Gonzalez, Ma; Morales, Patricia] Univ Complutense Madrid, Fac Pharm, Dept Nutr & Food Sci, Madrid, Spain",Complutense University of Madrid,"Morales, P (corresponding author), Univ Complutense Madrid, Fac Pharm, Dept Nutr & Food Sci, Madrid, Spain.",patricia.morales@farm.ucm.es,"Morales, Patricia/L-9267-2013; FERNANDEZ-RUIZ, VIRGINIA/H-5471-2015; Ciudad-Mulero, María/ABB-9667-2021","Morales, Patricia/0000-0002-4963-2696; FERNANDEZ-RUIZ, VIRGINIA/0000-0003-4214-5120; Ciudad-Mulero, María/0000-0002-8567-0462; MATALLANA GONZALEZ, MARIA CRUZ/0000-0001-7719-1122",,,,,190,73,82,5,35,ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD,LONDON,"125 LONDON WALL, LONDON EC2Y 5AS, ENGLAND",1043-4526,,978-0-12-816568-3; 978-0-12-816567-6,ADV FOOD NUTR RES,Adv. Food Nutr. Res.,,2019,90,,,,,,83,134,,10.1016/bs.afnr.2019.02.002,http://dx.doi.org/10.1016/bs.afnr.2019.02.002,,,52,Plant Sciences; Food Science & Technology; Nutrition & Dietetics,Book Citation Index – Science (BKCI-S),Plant Sciences; Food Science & Technology; Nutrition & Dietetics,BN9CG,31445601,,,,2024-06-04,WOS:000488784600003,View Full Record in Web of Science
J,"Nurko, S; Zimmerman, LA",,,,"Nurko, Samuel; Zimmerman, Lori A.",,,Evaluation and Treatment of Constipation in Children and Adolescents,AMERICAN FAMILY PHYSICIAN,,,English,Article,,,,,,,CHILDHOOD CONSTIPATION; FUNCTIONAL CONSTIPATION; BOWEL FREQUENCY; FECAL IMPACTION; DOUBLE-BLIND; FOLLOW-UP; INFANTS; PREVALENCE; PATTERNS,"Childhood constipation is common and almost always functional without an organic etiology. Stool retention can lead to fecal incontinence in some patients. Often, a medical history and physical examination are sufficient to diagnose functional constipation. Further evaluation for Hirschsprung disease, a spinal cord abnormality, or a metabolic disorder may be warranted in a child with red flags, such as onset before one month of age, delayed passage of meconium after birth, failure to thrive, explosive stools, and severe abdominal distension. Successful therapy requires prevention and treatment of fecal impaction, with oral laxatives or rectal therapies. Polyethylene glycol based solutions have become the mainstay of therapy, although other options, such as other osmotic or stimulant laxatives, are available. An increase in dietary fiber may improve the likelihood that laxatives can be discontinued in the future. Education is equally important as medical therapy and should include counseling families to recognize withholding behaviors; to use behavior interventions, such as regular toileting and reward systems; and to expect a chronic course with prolonged therapy, frequent relapses, and a need for close follow-up. Referral to a subspecialist is recommended only when there is concern for organic disease or when the constipation persists despite adequate therapy. (Copyright (C) 2014 American Academy of Family Physicians.)","[Nurko, Samuel] Boston Childrens Hosp, Boston, MA 02115 USA; [Zimmerman, Lori A.] Boston Childrens Hosp, Dept Med, Boston, MA 02115 USA",Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital,"Nurko, S (corresponding author), Boston Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.",samuel.nurko@childrens.harvard.edu,,"Nurko, Samuel/0000-0003-0936-4807",,,,,38,54,60,0,7,AMER ACAD FAMILY PHYSICIANS,KANSAS CITY,"8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797 USA",0002-838X,1532-0650,,AM FAM PHYSICIAN,Am. Fam. Physician,JUL 15,2014,90,2,,,,,82,90,,,,,,9,"Primary Health Care; Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,AL7IE,25077577,,,,2024-06-04,WOS:000339306600002,View Full Record in Web of Science
J,"dos Santos, RG; Scatone, NK; Malinovski, J; Sczip, AC; de Oliveira, JC; Morais, JG; Ramos, CI; Nerbass, FB",,,,"dos Santos, Rafaela G.; Scatone, Natalia K.; Malinovski, Juliana; Sczip, Andrea C.; de Oliveira, Jorgiane C.; Morais, Jyana G.; Ramos, Christiane I.; Nerbass, Fabiana B.",,,Higher Frequency of Fruit Intake Is Associated With a Lower Risk of Constipation in Hemodialysis Patients: A Multicenter Study,JOURNAL OF RENAL NUTRITION,,,English,Article,,,,,,,GASTROINTESTINAL SYMPTOMS; DIALYSIS PATIENTS; DIETARY-INTAKE; HEALTH; DETERMINANTS; DISEASE; FIBER,"Objectives: Constipation is a multifactorial gastrointestinal disorder commonly found in hemodialysis (HD) patients. In this multicenter cross-sectional study, we aimed to evaluate the prevalence and factors associated with constipation, including the frequency of dietary fiber intake. Methods: HD patients from 4 dialysis clinics were invited. Participants answered a questionnaire which included Roma IV criteria to assess constipation status, use of medications, and lifestyle habits. A food frequency questionnaire with 7 response options on the main dietary fiber sources (fruits, vegetables, legumes, whole grains, and seeds) was also applied. Answers were transformed into a score to estimate the weekly intake frequency, and every score point corresponded to one time per week. Demographical and laboratory data were obtained from medical records. Univariate analysis was used to compare participants according to constipation status, and variables with P < .20 were included in the regression analysis model. Results: Three hundred five HD patients were included (male: 51%; age: 52.2 +/- 14.7 years old; HD vintage: 46 (19-82) months). Ninety-three participants had constipation (30.5%). Median (interquartile) food frequency questionnaire scores were as follows: fruits: 6 (2-14); vegetables: 6 (3-10); legumes: 3 (1-7); whole grain: 0 (0-1); and seeds: 0 (0-0). In univariate analysis, participants with constipation were significantly older, had lower literacy, higher prevalence of diabetes, and lower total beverage intake. The logistic regression analysis model also included body mass index, wheelchair need, sedentarism, fruits score, and seeds score (all with P < .20 in the univariate analysis). The independent predictors of constipation were diabetes (odds ratio = 1.96, 95% confidence interval 1.07-3.6, P = .03) and fruits intake score (odds ratio = 0.95, 95% confidence interval 0.91-0.99, P = .04). Conclusions: Almost one-third of the participants had constipation. The independent determinants of constipation were diabetes and lower frequency of fruit intake. Nutritional counseling to increase fiber intake can potentially decrease the prevalence of constipation in this population. (C) 2020 by the National Kidney Foundation, Inc. All rights reserved.","[dos Santos, Rafaela G.] Ctr Tratamento Doencas Renais, Nutr Dept, Jaragua Do Sul, Brazil; [Scatone, Natalia K.] Ctr Tratamento Doencas Renais, Nutr Dept, Joinville, Brazil; [Malinovski, Juliana; Sczip, Andrea C.] Ctr Tratamento Doencas Renais, Nutr Dept, Mafra, Brazil; [de Oliveira, Jorgiane C.; Morais, Jyana G.; Nerbass, Fabiana B.] Fundacao Pro Rim, Nutr Dept, Rua Alexandre Dumas 50, BR-89227630 Joinville, SC, Brazil; [Ramos, Christiane I.] Univ Fed Sao Paulo, Nutr Program, Sao Paulo, Brazil",Universidade Federal de Sao Paulo (UNIFESP),"Nerbass, FB (corresponding author), Fundacao Pro Rim, Nutr Dept, Rua Alexandre Dumas 50, BR-89227630 Joinville, SC, Brazil.",fabiana.nerbass@gmail.com,"Morais, José/E-6322-2014; NERBASS, FABIANA/W-8962-2019","Morais, José/0000-0002-0007-3299; NERBASS, FABIANA/0000-0001-9936-0185",,,,,28,9,9,0,12,W B SAUNDERS CO-ELSEVIER INC,PHILADELPHIA,"1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA",1051-2276,1532-8503,,J RENAL NUTR,J. Renal Nutr.,JAN,2021,31,1,,,,,85,89,,10.1053/j.jrn.2020.07.004,http://dx.doi.org/10.1053/j.jrn.2020.07.004,,,5,Nutrition & Dietetics; Urology & Nephrology,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Nutrition & Dietetics; Urology & Nephrology,PL3UI,32863164,,,,2024-06-04,WOS:000603050800012,View Full Record in Web of Science
C,"Ismail, NH; Hanafi, MS; Putriana, D",,,,"Ismail, Nazrul Hadi; Hanafi, Mohamad Shahdan; Putriana, Dittasari",,,Dietary and Physical Activity Factors Concerning Bowel Movement Frequency among Undergraduate Students during Covid-19 Pandemic,ENVIRONMENT-BEHAVIOUR PROCEEDINGS JOURNAL,,,English,Proceedings Paper,10th Asia-Pacific International Conference on E-B Studies (AicE-Bs),"SEP 07-08, 2022","Kota Kinabalu, MALAYSIA",,,bowel movement; dietary intake; physical activity; COVID-19,CONSTIPATION; ADULTS,"This study explored the association between lifestyle and bowel movement frequency among students. A cross-sectional study was employed using a structured questionnaire that was administrated via an online platform. A total of 363 participants were involved in this study, where 77.4% (n=281) were female while 72.2% (n=262) of them did not experience constipation. Further investigation found that calories, dietary fibre, drink consumption, and physical activity level were associated with bowel movement frequency. This study showed that a good nutrient intake and adequate physical activity would improve bowel movement frequency even though restricted movement due to the COVID-19 pandemic.","[Ismail, Nazrul Hadi; Hanafi, Mohamad Shahdan] Univ Teknol MARA, Fac Hlth Sci, Ctr Dietet Studies, Shah Alam, Malaysia; [Ismail, Nazrul Hadi] Univ Teknol MARA, Fac Hlth Sci, Integrated Nutr Sci & Therapy Res Grp INSPiRE, Shah Alam, Malaysia; [Putriana, Dittasari] Univ Aisyiyah Yogyakarta, Fac Hlth Sci, Nutr Study Program, Yogyakarta, Indonesia",Universiti Teknologi MARA; Universiti Teknologi MARA,"Ismail, NH (corresponding author), Univ Teknol MARA, Fac Hlth Sci, Ctr Dietet Studies, Shah Alam, Malaysia.;Ismail, NH (corresponding author), Univ Teknol MARA, Fac Hlth Sci, Integrated Nutr Sci & Therapy Res Grp INSPiRE, Shah Alam, Malaysia.",nazrul2923@uitm.edu.my; 2018288676@student.uitm.edu.my; dittasariputriana@unisayogya.ac.id,"Ismail, Nazrul Hadi/GLR-7753-2022",,,,,,28,0,0,0,4,E-IPH LTD UK,SHEFFIELD,"THE LEADMILL, 6 LEADMILL RD, PO BOX STUDIO 7, SHEFFIELD, S1 4SE, ENGLAND",2398-4287,,,ENVIRON-BEHAV PROC J,Environ.-Behav. Proc. J.,SEP,2022,7,21,,,,,173,179,,10.21834/ebpj.v7i21.3696,http://dx.doi.org/10.21834/ebpj.v7i21.3696,,,7,Environmental Studies,Conference Proceedings Citation Index - Science (CPCI-S),Environmental Sciences & Ecology,5E0HZ,,hybrid,,,2024-06-04,WOS:000865313500021,View Full Record in Web of Science
J,"Duncan, PI; Enters-Weijnen, CF; Emami, N; McLean, P; Nunes, T; Beaumont, M; Crabbe, R; Whelan, K; Scott, SM; deWit, NJ; Weits, T; Bergonzelli, G; Grobbee, DE",,,,"Duncan, Peter I.; Enters-Weijnen, Catherine F.; Emami, Nashmil; McLean, Peter; Nunes, Tiago; Beaumont, Maurice; Crabbe, Rafael; Whelan, Kevin; Scott, S. Mark; deWit, Niek J.; Weits, Teunis; Bergonzelli, Gabriela; Grobbee, Diederick E.",,,Short-Term Daily Intake of Polydextrose Fiber Does Not Shorten Intestinal Transit Time in Constipated Adults: A Randomized Controlled Trial,NUTRIENTS,,,English,Article,,,,,,constipation; fiber; polydextrose; adult; randomized controlled trial; intestinal transit; intestinal function; patient-reported outcome,QUALITY-OF-LIFE; CHRONIC IDIOPATHIC CONSTIPATION; IRRITABLE-BOWEL-SYNDROME; FUNCTIONAL CONSTIPATION; COLONIC TRANSIT; CALORIC UTILIZATION; DIETARY FIBER; SYMPTOMS; MANAGEMENT; EPIDEMIOLOGY,"Chronic constipation (CC) remains a common gastrointestinal (GI) disorder that conveys a substantial healthcare burden. Expert guidelines recommend increasing fiber intake, yet the clinical evidence to support this needs strengthening for specific fibers. The aim was to evaluate changes in intestinal transit time and GI symptoms in CC patients who consumed polydextrose. In a randomized, double-blind, placebo-controlled trial, 128 adults with CC received 8 g or 12 g polydextrose, or placebo, daily for 4 weeks. Transit time, as primary outcome, was assessed by radiopaque marker distribution after 2-weeks intervention. Bowel habits, GI symptoms and quality of life (QOL) were assessed by questionnaire, including the Patient-Assessment of Constipation (PAC) Symptoms (SYM), and PAC-QOL. Following 2-weeks intervention, no reduction was seen in transit time in any group and following 2- or 4-weeks intervention, no improvements were seen in stool frequency or consistency in any group. After 2-weeks intervention with 8 g/day polydextrose an improvement was seen in the PAC-SYM rectal score (p = 0.041). After 4-weeks intervention both rectal (p = 0.049) and stool (p = 0.029) scores improved while improvement in the QOL satisfaction score did not reach significance (p = 0.071). Overall, the results suggest that 2-weeks consumption of 8 or 12 g/day polydextrose does not significantly improve physiological measures of gut function in CC adults. Longer term consumption may improve clinical measures, but further studies will be required to substantiate this.","[Duncan, Peter I.; McLean, Peter; Nunes, Tiago; Bergonzelli, Gabriela] Nestle Res Ctr, CH-1000 Lausanne, Switzerland; [Enters-Weijnen, Catherine F.; Grobbee, Diederick E.] UMC Utrecht, Dept Epidemiol, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [Enters-Weijnen, Catherine F.; Grobbee, Diederick E.] Julius Clin, Dept Sci, NL-3703 CD Zeist, Netherlands; [Emami, Nashmil; Beaumont, Maurice; Crabbe, Rafael] Nestle Res Ctr, Clin Dev Unit, CH-1000 Lausanne, Switzerland; [Whelan, Kevin] Kings Coll London, Dept Nutr Sci, London SE1 9NH, England; [Scott, S. Mark] Queen Mary Univ London, Ctr Trauma & Surg, Barts & London Sch Med & Dent, London E1 1BB, England; [Scott, S. Mark] Queen Mary Univ London, GI Physiol Unit, Blizard Inst, Barts & London Sch Med & Dent, London E1 1BB, England; [deWit, Niek J.] UMC Utrecht, Dept Primary Care, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [Weits, Teunis] Diakonessenhuis Utrecht, Dept Radiol, NL-3582 KE Utrecht, Netherlands",Nestle SA; Utrecht University; Utrecht University Medical Center; Nestle SA; University of London; King's College London; University of London; Queen Mary University London; University of London; Queen Mary University London; Utrecht University; Utrecht University Medical Center; Diakonessenhuis,"Duncan, PI (corresponding author), Nestle Res Ctr, CH-1000 Lausanne, Switzerland.",peter.duncan@rdls.nestle.com; c.f.weijnen@umcutrecht.nl; nashmil.emami@rdls.nestle.com; peter.mclean@takeda.com; tiago.alvesnunes@nestle.com; maurice.beaumont@rdls.nestle.com; raf.crabbe57@gmail.com; kevin.whelan@kcl.ac.uk; m.scott@qmul.ac.uk; n.j.dewit@umcutrecht.nl; teunisweits@gmail.com; gabriela.bergonzelli@rdls.nestle.com; d.e.grobbee@umcutrecht.nl,"Whelan, Kevin/ABD-5154-2021; Whelan, Kevin/ABD-5350-2021","Whelan, Kevin/0000-0001-5414-2950; Scott, Mark/0000-0002-7997-1533; Beaumont, Maurice/0000-0003-0763-3444",Nestec SA,Nestec SA,This research was funded by Nestec SA.,,72,8,8,1,3,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,JUL,2018,10,7,,,,,,,920,10.3390/nu10070920,http://dx.doi.org/10.3390/nu10070920,,,16,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,GX2JK,30029461,"Green Published, Green Submitted, gold",,,2024-06-04,WOS:000447544900123,View Full Record in Web of Science
J,"Mitsui, R; Karaki, SI; Kubo, Y; Sugiura, Y; Kuwahara, A",,,,"Mitsui, R.; Karaki, S. -I.; Kubo, Y.; Sugiura, Y.; Kuwahara, A.",,,Fibre-free diet leads to impairment of neuronally mediated muscle contractile response in rat distal colon,NEUROGASTROENTEROLOGY AND MOTILITY,,,English,Article,,,,,,dietary fibre; enteric nervous system; intestine; contraction,CHAIN FATTY-ACIDS; ENTEROCHROMAFFIN CELLS; ENTEROENDOCRINE CELLS; PERISTALTIC REFLEX; SEROTONIN; 5-HT; 5-HYDROXYTRYPTAMINE; CONSTIPATION; TRANSPORTER; RELEASE,"Dietary fibre consumption is known to be beneficial to increase stool bulk and frequency. In contrast, it is unclear whether chronic dietary fibre deficiency affects colonic motor functions, especially neuronally mediated muscle contractions. In this study, rats were fed a fibre-free diet or diet containing dietary fibre (cellulose or guar gum) for 27 days. Furthermore, neurogenic and myogenic contractions were evaluated in circular and longitudinal muscle strips of the distal colon. Additionally, the number of enterochromaffin (EC) cells, which play important roles in the initiation of the peristaltic reflex, was also examined by immunohistochemistry for serotonin. Myogenic contractions induced by carbachol or substance P were examined in the presence of tetrodotoxin. Circular muscle was hyposensitive to carbachol, but longitudinal muscle was hypersensitive to substance P in the fibre-free group. Nerve-mediated circular (5-20 Hz) and longitudinal (1-2 Hz) muscle contractions evoked by electrical field stimulation were attenuated in the fibre-free group and the latter response was almost abolished by atropine, suggesting functional changes of cholinergic neurons. EC cell number was decreased in the fibre-free group. In conclusion, changes in neurogenic and myogenic contractions and a decrease in EC cell number observed may affect colonic motility of the fibre-free group.","Univ Shizuoka, Inst Environm Sci, Grad Sch Nutr & Environ Sci,Physiol Lab, Suruga Ku, Shizuoka 4228526, Japan",University of Shizuoka,"Kuwahara, A (corresponding author), Univ Shizuoka, Inst Environm Sci, Grad Sch Nutr & Environ Sci,Physiol Lab, Suruga Ku, 25-1 Yada, Shizuoka 4228526, Japan.",kuwahara@sea.u-shizuoka-ken.ac.jp,"Kuwahara, Atsukazu/B-3287-2011; Karaki, Shin-Ichiro/AGH-8018-2022","Mitsui, Retsu/0000-0003-2932-4693",,,,,37,15,17,0,5,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1350-1925,1365-2982,,NEUROGASTROENT MOTIL,Neurogastroenterol. Motil.,DEC,2006,18,12,,,,,1093,1101,,10.1111/j.1365-2982.2006.00847.x,http://dx.doi.org/10.1111/j.1365-2982.2006.00847.x,,,9,Gastroenterology & Hepatology; Clinical Neurology; Neurosciences,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Neurosciences & Neurology,105FS,17109693,,,,2024-06-04,WOS:000242016400008,View Full Record in Web of Science
J,"Corazziari, E; Badiali, D; Habib, FI; Reboa, G; Pitto, G; Mazzacca, G; Sabbatini, F; Galeazzi, R; Cilluffo, T; Vantini, I; Bardelli, E; Baldi, F",,,,"Corazziari, E; Badiali, D; Habib, FI; Reboa, G; Pitto, G; Mazzacca, G; Sabbatini, F; Galeazzi, R; Cilluffo, T; Vantini, I; Bardelli, E; Baldi, F",,,Small volume isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in treatment of chronic nonorganic constipation,DIGESTIVE DISEASES AND SCIENCES,,,English,Article,,,,,,constipation; polyethylene glycol; transit times,LAVAGE SOLUTION; DOUBLE-BLIND; COLONOSCOPY; ABSORPTION; TRIAL,"The present multicenter double-blind placebo-controlled trial evaluates the therapeutic effectiveness of small-volume daily doses of an isosmotic polyethylene glycol (PEG) electrolyte solution in the treatment of chronic nonorganic constipation. After a complete diagnostic investigation, patients still constipated at the end of a four-week placebo-treatment run-in period were enrolled and randomized to receive either placebo or PEG solution 250 ml twice a day for the following eight weeks. Patients were assessed at four and eight weeks of treatment, and they reported frequency and modality of evacuation, use of laxatives, and relative symptoms daily on a diary card. Oroanal and segmental large-bowel transit times were assessed with radiopaque markers during the fourth week of the run-in period and the last week of the treatment period. During the study period, dietary fiber and liquids were standardized and laxatives were allowed only after consecutive days without a bowel movement. Of the 55 patients enrolled, fie dropped out, three because of adverse events and two for reasons unrelated to therapy; another two were excluded from the efficacy analysis because of protocol violations. Of the remaining 48 patients (37 women, age 42 +/- 15 years, mean +/- SD) 23 were assigned to placebo and 25 to PEG treatment. In comparison to placebo, PEG solution induced a statistically significant increase in weekly bowel frequency at four weeks and at the end of the study (PEG: 4.8 +/- 2.3 vs placebo: 2.8 +/- 1.6; P <0.02), and a significant decrease in straining at defecation (P <0.01), stool consistency (p <0.02), and use of laxative (P <0.03). Oroanal, left colon, and rectal transit times were significantly shortened as far as abdominal symptoms and side effects were concerned. In conclusion, PEG solution at 250 ml twice a day is effective in increasing bowel frequency. accelerating colorectal times, and improving difficult evacuation in patients with chronic nonorganic constipation and is devoid of significant side effects.","UNIV GENOA,CLIN CHIRURG,GENOA,ITALY; UNIV ROMA LA SAPIENZA,CATTEDRA GASTROENTEROL 1,ROME,ITALY; POLICLIN 2,FAC MED 2,CATTEDRA GASTROENTEROL,NAPLES,ITALY; OSPED UMBERTO 1,DIV GASTROENTEROL,ANCONA,ITALY; UNIV VERONA,FAC MED,DIV RIABILITAZ GASTROENTEROL,OSPED VALEGGIO SM,I-37100 VERONA,ITALY; POLICLIN S ORSOLA,DIV GASTROENTEROL,BOLOGNA,ITALY",University of Genoa; Sapienza University Rome; University of Verona; IRCCS Azienda Ospedaliero-Universitaria di Bologna,,,,,,,,,20,99,104,0,6,PLENUM PUBL CORP,NEW YORK,"233 SPRING ST, NEW YORK, NY 10013",0163-2116,,,DIGEST DIS SCI,Dig. Dis. Sci.,AUG,1996,41,8,,,,,1636,1642,,10.1007/BF02087913,http://dx.doi.org/10.1007/BF02087913,,,7,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,VD696,8769292,,,,2024-06-04,WOS:A1996VD69600018,View Full Record in Web of Science
J,"Kim, MG; Jo, K; Cho, K; Park, SS; Suh, HJ; Hong, KB",,,,"Kim, Min Guk; Jo, Kyungae; Cho, Kyoungwon; Park, Sung Sun; Suh, Hyung Joo; Hong, Ki-Bae",,,Prebiotics/Probiotics Mixture Induced Changes in Cecal Microbiome and Intestinal Morphology Alleviated the Loperamide-Induced Constipation in Rat,FOOD SCIENCE OF ANIMAL RESOURCES,,,English,Article,,,,,,constipation; multi-strain probiotics; loperamide; microbiota,IRRITABLE-BOWEL-SYNDROME; CHILDHOOD CONSTIPATION; DOUBLE-BLIND; FUNCTIONAL CONSTIPATION; INTERSTITIAL-CELLS; DIETARY FIBER; COLONIC MUCUS; FATTY-ACIDS; LACTOBACILLUS; CAJAL,"The aim of this study was to investigate the effect of a mixture of multi-strain probiotics and prebiotics on loperamide-induced constipation in Sprague-Dawley rats. A multi-strain probiotics alone (loperamide-induced group with multi-strain probiotics mixture group; Lop-Pro) and a mixture of multi-strain probiotics and prebiotics (loperamide-induced group with multi-strain probiotics and prebiotics mixture group; Lop-Pro/Pre) were administered orally after inducing constipation. The fecal water content was significantly higher (by 42%) in the Lop-Pro/Pre group (33.5%) than in the loperamide-induced group (Lop) (23.7%) (p<0.05). The intestinal mucosal thickness, crypt cell area, and interstitial cells of Cajal area were significantly higher in the Lop-Pro/Pre group compared to the Lop group by 16.4%, 20.6%, and 42.3%, respectively. Additionally, the total short-chain fatty acid content was significantly increased in the Lop-Pro and Lop-Pro/Pre groups by 56.4% and 54.2%, respectively, compared with the Lop group. The Lop-Pro and Lop-Pro/Pre groups recovered loperamide-induced alteration in Bacteroidetes and Verrucomicrobia abundance among intestinal microbiota, whereas the Lop-Pro/Pre group recovered Akkermansia, Lactobacillus, Clostridium, Bacteroides, and Oscillibacter abundance. Moreover, the relative abundance of Oscillibacter and Clostridium was significantly different in the Lop-Pro/Pre group compared to the Lop group. Collectively, administration of synbiotics rather than multi-strain probiotics alone is effective in alleviating constipation.","[Kim, Min Guk; Jo, Kyungae; Suh, Hyung Joo] Korea Univ, Grad Sch, Dept Integrated Biomed & Life Sci, Seoul 02841, South Korea; [Cho, Kyoungwon; Park, Sung Sun] Chong Kun Dang Healthcare Co, Seoul 04300, South Korea; [Suh, Hyung Joo] Korea Univ, Grad Sch, Dept Healthcare Sci, Transdisciplinary Major Learning Hlth Syst, Seoul 02841, South Korea; [Hong, Ki-Bae] Jeju Natl Univ, Dept Food Sci & Nutr, Jeju 63243, South Korea",Korea University; Korea University; Jeju National University,"Suh, HJ (corresponding author), Korea Univ, Grad Sch, Dept Integrated Biomed & Life Sci, Seoul 02841, South Korea.;Hong, KB (corresponding author), Jeju Natl Univ, Dept Food Sci & Nutr, Jeju 63243, South Korea.",suh1960@korea.ac.kr; kbhong@jejunu.ac.kr,,"Jo, Kyungae/0000-0003-4056-6706; gim, mingug/0000-0001-8625-4957; Hong, Ki-Bae/0000-0001-5199-2685; Cho, Kyoungwon/0000-0002-3693-2817; Suh, Hyung Joo/0000-0001-8869-3929",,,,,51,10,10,9,33,KOREAN SOC FOOD SCIENCE ANIMAL RESOURCES,SEOUL,"806, HANGANG HYUNDAI HYEL, 213-12, SAECHANG-RO, YONGSAN-GU, SEOUL, 04376, SOUTH KOREA",2636-0772,2636-0780,,FOOD SCI ANIM RESOUR,Food Sci. Anim. Resour.,,2021,41,3,,,,,527,541,,10.5851/kosfa.2021.e17,http://dx.doi.org/10.5851/kosfa.2021.e17,,,15,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,SE9BA,34017959,"Green Published, gold",,,2024-06-04,WOS:000652361400013,View Full Record in Web of Science
J,"Boilesen, SN; Tahan, S; Dias, FC; Melli, LCFL; de Morais, MB",,,,"Boilesen, Sabine Nunes; Tahan, Soraia; Dias, Francine Canova; Fonseca Lahoz Melli, Ligia Cristina; de Morais, Mauro Batista",,,Water and fluid intake in the prevention and treatment of functional constipation in children and adolescents: is there evidence?,JORNAL DE PEDIATRIA,,,Portuguese,Article,,,,,,Constipation; Child; Fluid intake; Adolescent,PHYSICAL-ACTIVITY; DIETARY FIBER; STOOL OUTPUT; RISK-FACTORS; ASSOCIATION; PREVALENCE; GASTROENTEROLOGY; CONSUMPTION; DISORDERS; FREQUENCY,"Objective: To study the evidence on the role of water and fluid intake in the prevention and treatment of functional intestinal constipation in children and adolescents. Source of data: A search was carried out in the Medline database (between 1966 and 2016) for all published articles containing the following words: constipation, water, and fluids, published in Portuguese, English, and Spanish. All original articles that assessed children and adolescents were selected by title and abstract. The references of these articles were also evaluated. Synthesis of data: A total of 1040 articles were retrieved. Of these, 24 were selected for reading. The study included 11 articles that assessed children and adolescents. The articles were divided into two categories, those that evaluated water and fluid intake as a risk factor for intestinal constipation and those that evaluated their role in the treatment of intestinal constipation. Five articles were included in the first category. The criteria for assessing fluid intake and bowel rhythm were different in each study. Three studies demonstrated an association between low fluid intake and intestinal constipation. Regarding treatment, five articles with heterogeneous methodologies were found. None of them clearly identified the favorable role of fluid intake in the treatment of intestinal constipation. Conclusion: There are few articles on the association between fluid intake and intestinal constipation. Epidemiological evidence indicates an association between lower fluid intake and intestinal constipation. Further clinical trials and epidemiological studies that consider the international recommendations for fluid intake by children and adolescents are required. (C) 2017 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda.","[Boilesen, Sabine Nunes] Univ Fed Sao Paulo Unifesp, EPM, Programa Posgrad Pediat & Ciencias Aplicadas Pedi, Sao Paulo, SP, Brazil; [Tahan, Soraia; de Morais, Mauro Batista] Univ Fed Sao Paulo Unifesp, EPM, Disciplina Gastroenterol Pediat, Sao Paulo, SP, Brazil; [Dias, Francine Canova] Univ Fed Sao Paulo Unifesp, EPM, Programa Posgrad Nutr, Sao Paulo, SP, Brazil; [Fonseca Lahoz Melli, Ligia Cristina] Ctr Univ Unifieo, Dept Ciencias Biol & Saude, Osasco, SP, Brazil",Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Centro Universitario Fieo,"de Morais, MB (corresponding author), Univ Fed Sao Paulo Unifesp, EPM, Disciplina Gastroenterol Pediat, Sao Paulo, SP, Brazil.",maurobmorais@gmail.com,"MORAIS, MAURO B/I-7995-2014",,,,,,41,24,30,1,22,SOC BRASIL PEDIATRIA,"RIO DE JANEIRO, RJ","RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL",0021-7557,1678-4782,,J PEDIAT-BRAZIL,J. Pediatr.,JUL-AUG,2017,93,4,,,,,320,327,,10.1016/j.jped.2017.01.005,http://dx.doi.org/10.1016/j.jped.2017.01.005,,,8,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,FE5TQ,28450053,"gold, Green Published",,,2024-06-04,WOS:000408274600003,View Full Record in Web of Science
B,"Gyura, J; Seres, Z; Sakac, M; Pajin, B; Simovic, DS; Jokic, A",,"Hertsburg, CT",,"Gyura, Julianna; Seres, Zita; Sakac, Marijana; Pajin, Biljana; Simovic, Dragana Soronja; Jokic, Aleksandar",,,PRODUCTION OF DIETARY FIBER FROM SUGAR BEET CROPS FOR APPLICATION IN FOOD INDUSTRY,"SUGAR BEET CROPS: GROWTH, FERTILIZATION & YIELD",Agriculture Issues and Policies,,English,Article; Book Chapter,,,,,,,PEROXIDE-TREATED LIGNOCELLULOSE; FERULIC ACID; LIPID OXIDATION; BREAD QUALITY; ANTIOXIDANT; PULP; WHEAT; CONSTITUENTS; DECOLORIZATION; FLAVONOIDS,"Chemical and nutritional composition of sugar beet crop and high content of dietary fiber, suggests the possibility of use its as raw material for dietary fiber production. Sugar beet fiber has improved nutritive value according to dietary fiber from other sources. The structure and composition of sugar beet fiber, a unique combination of naturally occuring soluble and insoluble fiber and calcium, result in many beneficial physiological and functional properties. Insoluble and soluble fiber prevents constipation, decrease the risk of cancer and coronary heart disease, prolong the feeling of being satiated by food, and limit the necessity for calories as noted by many authors. On the other hand, sugar beet fiber significantly lowers some quality characteristics of the final products, first of all colour, when it is included in white wheat flour composition for bread production. Sugar beet fibre addition to cookies results in dark crumb colour and in lower sensory acceptability and firmness. The present study estimated physicochemical (dry matter content, cellulose, lignin, hemicellulose and heavy metal content, fiber color, water-holding capacity and the solubility in water) and technological characteristics of sugar beet fiber obtained from sugar beet by extraction with sulphurous acid (nontreated sugar beet fiber), fiber treated with peroxide or sulfite ions (treated sugar beet fiber) and commercially available sugar beet fiber - Fibrex. The aims of these investigations were the confirmation of significance of dietary fiber production from sugar beet crop. The goal of the study was as well as to obtain additives with proper characteristics for bread and cookies production by applying treatment with peroxide and sulfite ions to sugar beet fiber. After the alkaline treatment with peroxide ions, sugar beet fiber has better characteristics for application in bread or cookies, because it becomes softer and more flexible, thus the degradation of gluten-starch matrix is not expected, nor the negative effect on the product softness. The fiber obtained after the treatment with peroxide ions (0.30 mol/dm(3)) of 15 min at pH 11.0 could be recommended for bread production, because of appropiate lightness and double higher water holding capacity (WHC), that guarantees technological and economical benefits, such as increased volume and better yield of product, as well as prolonged freshness. The fiber obtained after the treatment with peroxide ions (0.30 mol/dm(3)) at pH 8.5 which is longer than 15 mm is recommended for the use as an additive in cookies production. This fiber has all the advantages of the fiber obtained at pH 11.0, except WHC, which is not changed in comparison to nontreated fiber, so that the water content of the cookies would not be increased. Bread enriched with sugar beet fibers of the highest volume and significantly improved crumb quality, even for 50% in comparison to conventional product, is attained if gluten, shortening and milk are included in dough formula at the level of 5, 5 and 2%, respectively. The optimal sensory quality, the colour ana hardness of the biscuit cake are obtained by adding 7% of dietary fiber whose particle size ranges from 95 pm to 120 mu m. The results presented in this chapter are the base for new methods for sugar beet characterization focused on chemical treatments and methods of dehydratation of dietary fiber. In addition, antioxidant properties of ethanolic extracts from above mentioned fibers were tested using: Folin-Ciocalteu, DPPH radical scavenging assay, antioxidant activity/beta-carotene bleaching test, and chelating activity. The results are compared with commercially available product - Fibrex.","[Gyura, Julianna; Seres, Zita; Pajin, Biljana; Simovic, Dragana Soronja; Jokic, Aleksandar] Univ Novi Sad, Fac Technol, Novi Sad 21000, Serbia; [Sakac, Marijana] Univ Novi Sad, Inst Food Technol, Novi Sad 21000, Serbia",University of Novi Sad; University of Novi Sad,"Seres, Z (corresponding author), Univ Novi Sad, Fac Technol, 1 Bulevar Cara Lazara, Novi Sad 21000, Serbia.",zitas@tehnol.ns.ac.yu,,,,,,,107,2,2,0,9,"NOVA SCIENCE PUBLISHERS, INC",HAUPPAUGE,"400 OSER AVE, STE 1600, HAUPPAUGE, NY 11788-3635 USA",,,978-1-60741-491-9,AGR ISSUES POLICIES,,,2010,,,,,,,43,83,,,,,,41,"Agriculture, Multidisciplinary",Book Citation Index – Science (BKCI-S),Agriculture,BPA15,,,,,2024-06-04,WOS:000278266900002,View Full Record in Web of Science
J,"Emmanuel, A; Mattace-Raso, F; Neri, MC; Petersen, KU; Rey, E; Rogers, J",,,,"Emmanuel, Anton; Mattace-Raso, Francesco; Neri, Maria Cristina; Petersen, Karl-Uwe; Rey, Enrique; Rogers, June",,,Constipation in older people: A consensus statement,INTERNATIONAL JOURNAL OF CLINICAL PRACTICE,,,English,Article,,,,,,,FECAL INCONTINENCE; LACTULOSE SYRUP; MANAGEMENT; PREVALENCE; IMPACTION; MACROGOL; ADULTS,"Background and Aims: Chronic constipation is a serious medical condition that affects 30%-40% of people over 60 years old. Although not normally life threatening, constipation reduces quality of life by the same extent as diabetes and osteoarthritis. There are currently no Europe-wide guidelines for treating constipation in older people, although there is some country-level guidance for the general population. We have evaluated the existing guidance and best clinical practice to improve the care of older people with constipation. Method: European healthcare professionals working in gastroenterology, geriatrics, nursing and pharmacology discussed the treatment of constipation in older people and reviewed existing guidance on the treatment of constipation in the general population. This manuscript represents the consensus of all authors. Discussion: Most general guidance for constipation treatment recommends increased dietary fibre, fluid intake and exercise; however, this is not always possible in older patients. Although a common first-line treatment, bulk-forming laxatives are unsuitable for older people because of an associated need to increase fluid intake, osmotic laxatives are likely to be the most suitable laxative type for older patients. Treatment is often hampered by reluctance to talk about bowel problems so healthcare providers should proactively identify older constipated patients who are self-medicating or not receiving treatment. Conclusions: With certain modifications, general treatment guidelines can be applied to older people with constipation, although specific guidelines are still required for this age group. Awareness of constipation, its complications and treatment options need to be increased among healthcare providers, patients and carers.","[Emmanuel, Anton] UCL, GI Physiol Unit, London, England; [Mattace-Raso, Francesco] Erasmus MC, Dept Geriatr Med, Rotterdam, Netherlands; [Neri, Maria Cristina] Ist Geriatr Pio Albergo Trivulzio, Milan, Italy; [Petersen, Karl-Uwe] Rhein Westfal TH Aachen, Fac Med, Aachen, Germany; [Rey, Enrique] Univ Complutense Madrid, Hosp Clin San Carlos, Inst Invest Sanitaria San Carlos, Div Digest Dis,Dept Med, Madrid, Spain; [Rogers, June] Promocon, Disabled Living, Burrows House,Wardley Ind Estate, Manchester, Lancs, England",University of London; University College London; Erasmus University Rotterdam; Erasmus MC; RWTH Aachen University; Hospital Clinico San Carlos; Complutense University of Madrid,"Rogers, J (corresponding author), Promocon, Disabled Living, Burrows House,Wardley Ind Estate, Manchester, Lancs, England.",junerogersmbe@hotmail.com,"Rey, Enrique/B-9492-2008","Rey, Enrique/0000-0002-5060-7105; Mattace-Raso, Francesco/0000-0002-1688-6497",Norgine Pharmaceuticals Limited,Norgine Pharmaceuticals Limited,Funding for this project was provided by an unrestricted educational grant from Norgine Pharmaceuticals Limited. Medical writing assistance was provided by Dr James Serginson of Niche Science & Technology Limited and was paid for by Norgine Pharmaceuticals Limited.,,51,35,37,2,37,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1368-5031,1742-1241,,INT J CLIN PRACT,Int. J. Clin. Pract.,JAN,2017,71,1,,,,,,,e12920,10.1111/ijcp.12920,http://dx.doi.org/10.1111/ijcp.12920,,,9,"Medicine, General & Internal; Pharmacology & Pharmacy",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine; Pharmacology & Pharmacy,EH7PD,27933718,"Green Submitted, gold",,,2024-06-04,WOS:000391964000011,View Full Record in Web of Science
J,"Vega, AB; Perelló, A; Martos, L; Bayo, IG; García, M; Andreu, V; Abad, A; Barenys, M",,,,"Vega, A. B.; Perello, A.; Martos, L.; Bayo, I. Garcia; Garcia, M.; Andreu, V.; Abad, A.; Barenys, M.",,,Breath methane in functional constipation: response to treatment with Ispaghula husk,NEUROGASTROENTEROLOGY AND MOTILITY,,,English,Article,,,,,,colonic transit time; functional constipation; Ispaghula husk; lactulose breath test; methane producer,IRRITABLE-BOWEL-SYNDROME; TRANSIT-TIME; INTESTINAL MICROBIOTA; STOOL CHARACTERISTICS; METHANOGENIC FLORA; COLONIC TRANSIT; WHEAT BRAN; PSYLLIUM; FIBER; FERMENTATION,"Background Colonic fermentation produces hydrogen (H-2), and also produces methane (CH4) in subjects with methanogenic flora (M+). Methane production has been associated with chronic constipation (CC) and with changes in gut motility. To determine CH4 production in CC compared to controls, and to assess whether the therapeutic response to Ispaghula husk in CC differs between CH4-producers and non-producers. Methods Forty-eight patients with functional constipation or irritable bowel syndrome-constipation and 19 healthy age-and-sex-matched volunteers (HV) filled in a 1-week symptom diary and a dietary questionnaire. They then underwent a lactulose breath test (LBT) to measure H-2 and CH4 production (peak and area under the time-concentration curve, AUC-) and a colonic transit time (CTT) assessment. In patients, measurements were repeated after a 4-week treatment with Ispaghula husk. Key Results Prevalence of M+ in patients was 60.5% vs 52.6% in HV (p = 0.37). Patients had significantly longer CTT and greater production of both H-2 and CH4 during LBT. There was a significant correlation between CH4 production and CTT (r = 0.51; p = 0.07). Treatment response rate was similar for M+ and M- patients (58.3% vs 52.9%; p = 0.76) as were the increases in bowel movements and Bristol score, changes in abdominal discomfort and bloating. In M+, treatment reduced CTT (-10 +/- 35 h; p = 0.029 vs baseline) and CH4 levels: peak CH4 (-13 +/- 24 ppm; p = 0.014) and CH4-AUC (-817 +/- 3100 ppm/min; p = 0.04). Conclusions & Inferences Although CH4 production has been associated with CC pathophysiology, we found that CH4 status did not negatively affect the response to Ispaghula husk treatment. The measurement of CH4 levels as a biomarker tool for CC requires further appraisal.","[Perello, A.; Martos, L.; Garcia, M.; Andreu, V.; Abad, A.; Barenys, M.] Hosp Viladecans, Dept Gastroenterol, Barcelona 08840, Spain; [Vega, A. B.; Perello, A.; Andreu, V.; Abad, A.; Barenys, M.] Univ Barcelona, Hosp Duran & Reynals, Inst Invest Biomed Bellvitge IDIBELL, Barcelona, Spain; [Bayo, I. Garcia] Primary Care Ctr Gava II, Barcelona, Spain",Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Valdecans; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; University of Barcelona,"Vega, AB (corresponding author), Hosp Viladecans, Dept Gastroenterol, Avda Gava 38, Barcelona 08840, Spain.",anabelen.hv@gencat.cat,,,Societat Catalana de Digestologia and Fundacion del Hospital de Viladecans per a la Recerca i la Docencia [HV 06 2009 EC],Societat Catalana de Digestologia and Fundacion del Hospital de Viladecans per a la Recerca i la Docencia,This study was supported by grant from the Societat Catalana de Digestologia and Fundacion del Hospital de Viladecans per a la Recerca i la Docencia under Grant Number HV 06 2009 EC.,,46,24,24,0,12,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1350-1925,1365-2982,,NEUROGASTROENT MOTIL,Neurogastroenterol. Motil.,JUL,2015,27,7,,,,,945,953,,10.1111/nmo.12568,http://dx.doi.org/10.1111/nmo.12568,,,9,Gastroenterology & Hepatology; Clinical Neurology; Neurosciences,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Neurosciences & Neurology,CW1JD,25952409,,,,2024-06-04,WOS:000364744700006,View Full Record in Web of Science
J,"VODERHOLZER, WA; SCHATKE, WA; MUHLDORFER, BE; KLAUSER, AG; BIRKNER, B; HEITLAND, W; MULLERLISSNER, SA",,,,"VODERHOLZER, WA; SCHATKE, WA; MUHLDORFER, BE; KLAUSER, AG; BIRKNER, B; HEITLAND, W; MULLERLISSNER, SA",,,DETERMINANTS OF THE SUCCESS OF DIETARY FIBER TREATMENT IN CHRONIC CONSTIPATION,GASTROENTEROLOGY,,,English,Meeting Abstract,,,,,,,,,"UNIV MUNICH,KLINIKUM INNENSTADT,MED KLIN,W-8000 MUNICH 2,GERMANY; KLINIKUM BOGENHAUSEN,MED KLIN 2,MUNICH,GERMANY",University of Munich; University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; Munchen Klinik,,,,,,,,,0,0,0,0,1,W B SAUNDERS CO,PHILADELPHIA,"INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399",0016-5085,,,GASTROENTEROLOGY,Gastroenterology,APR,1994,106,4,,S,,,A584,A584,,,,,,1,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,NH909,,,,,2024-06-04,WOS:A1994NH90902322,View Full Record in Web of Science
J,"Moturi, J; Hosseindoust, A; Tajudeen, H; Mun, JY; Ha, SH; Kim, JS",,,,"Moturi, Joseph; Hosseindoust, Abdolreza; Tajudeen, Habeeb; Mun, Jun Young; Ha, Sang Hun; Kim, Jin Soo",,,Influence of dietary fiber intake and soluble to insoluble fiber ratio on reproductive performance of sows during late gestation under hot climatic conditions,SCIENTIFIC REPORTS,,,English,Article,,,,,,,HEAT-STRESS; GLUCOSE-TOLERANCE; ENERGY-LEVEL; BEHAVIOR; LITTER; TEMPERATURE; MICROBIOTA; GROWTH; PERIOD; FAT,"This study evaluated dietary fiber (DF) level and the ratio of soluble fiber (SF): insoluble fiber (ISF) impact on sows' reproductive performance under heat stress. Forty sows at day 90 of gestation were assigned to four treatments. HH diet had, 20% DF, 1:4, SF:ISF ratio; HL, 20% DF, 1:6, SF:ISF ratio; LH, 14% DF, 1:4, SF:ISF, LL, 14% DF, 1:6, SF:ISF. Results showed that; lactation back-fat loss was lower (P < 0.05) in HH . Feed intake was higher (P < 0.05) in HH and HL. Farrowing duration shorter (P < 0.05) in HH. Constipation index was higher (P < 0.05) in HH and LH. Weaning piglets' body weight was greater (P < 0.05) in HH than LH and LL. Hair cortisol was lower (P < 0.05) in HH than HL, and LL. Acetate, propionate, isovalerate, and butyrate was higher (P < 0.05) in HH and LH. Plasma zonulin, fecal lipocalin-2 were lower (P < 0.05) in HH, and HL. Superoxide dismutase tended to be higher (P = 0.056) and malondialdehyde tended to be lower (P = 0.069) in HH and HL. We opined that higher levels of dietary fiber and soluble fiber could ameliorate heat stress in gestating sows.","[Moturi, Joseph; Hosseindoust, Abdolreza; Tajudeen, Habeeb; Mun, Jun Young; Ha, Sang Hun; Kim, Jin Soo] Kangwon Natl Univ, Dept Anim Ind Convergence, Chunchon 24341, South Korea",Kangwon National University,"Kim, JS (corresponding author), Kangwon Natl Univ, Dept Anim Ind Convergence, Chunchon 24341, South Korea.",kjs896@kangwon.ac.kr,"Moturi, Joseph/JPK-4491-2023","Tajudeen, Habeeb/0000-0002-5623-3175","Rural Development Administration, Republic of Korea [PJ01479601]","Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)","This work was carried out with the support of Cooperative Research Program for Agriculture Science and Technology Development (Project No. PJ01479601) Rural Development Administration, Republic of Korea.",,48,2,2,0,11,NATURE PORTFOLIO,BERLIN,"HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY",2045-2322,,,SCI REP-UK,Sci Rep,NOV 17,2022,12,1,,,,,,,19749,10.1038/s41598-022-23811-8,http://dx.doi.org/10.1038/s41598-022-23811-8,,,13,Multidisciplinary Sciences,Science Citation Index Expanded (SCI-EXPANDED),Science & Technology - Other Topics,6H0WS,36396815,"Green Published, gold",,,2024-06-04,WOS:000885172100016,View Full Record in Web of Science
J,"Rao, SSC",,,,"Rao, SSC",,,Constipation: evaluation and treatment,GASTROENTEROLOGY CLINICS OF NORTH AMERICA,,,English,Review,,,,,,,ANORECTAL FUNCTION; DOUBLE-BLIND; IDIOPATHIC CONSTIPATION; BIOFEEDBACK THERAPY; COLONIC MOTILITY; MANOMETRIC TESTS; DIETARY FIBER; UNITED-STATES; BOWEL HABITS; TRANSIT,"Constipation is a common clinical problem that comprises symptoms including excessive straining, hard stools, feeling of incomplete evacuation, use of digital maneuvers or infrequent defecation. After organic disorders are excluded, functional constipation consists of two subtypes; slow transit constipation and dyssynergic defecation. The Rome criteria for functional constipation together with modifications proposed here for dyssynergic defecation may serve as useful guidelines for making a diagnosis. However, management options are limited and evidence to support these treatments is only modest. Although laxatives remain the mainstay of therapy, prokinetics that are colon-selective are optimal for treating patients with slow transit constipation and are likely to be available soon. Biofeedback therapy is the preferred treatment for patients with dyssynergia. Surgical options should be reserved for refractory disease and after careful diagnostic work-up.","Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA",University of Iowa,"Univ Iowa, Carver Coll Med, Dept Internal Med, 200 Hawkins Dr, Iowa City, IA 52242 USA.",satish-rao@uiowa.edu,,,,,,,102,72,78,0,9,W B SAUNDERS CO-ELSEVIER INC,PHILADELPHIA,"1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA",0889-8553,1558-1942,,GASTROENTEROL CLIN N,Gastroenterol. Clin. North Am.,JUN,2003,32,2,,,,,659,+,,10.1016/S0889-8553(03)00026-8,http://dx.doi.org/10.1016/S0889-8553(03)00026-8,,,26,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,696VT,12858610,,,,2024-06-04,WOS:000183908800010,View Full Record in Web of Science
J,"Fleming, V; Wade, WE",,,,"Fleming, Virginia; Wade, William E.",,,A Review of Laxative Therapies for Treatment of Chronic Constipation in Older Adults,AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY,,,English,Review,,,,,,constipation; older adults; stool softeners; laxatives,PLACEBO-CONTROLLED TRIAL; GASTROINTESTINAL TRANSIT-TIME; CHLORIDE CHANNEL ACTIVATOR; BALANCED SOLUTION PMF-100; STAY ELDERLY PATIENTS; QUALITY-OF-LIFE; DOUBLE-BLIND; UNITED-STATES; CALCIUM POLYCARBOPHIL; DIETARY FIBER,"Background: Multiple studies have addressed the treatment of chronic constipation in adults in general; however, less guidance is available for treating this condition in older patients. Objective: The aim of this paper was to review the effectiveness of laxatives for chronic constipation in the elderly Methods: MEDLINE, Web of Science, International Pharmaceutical Abstracts, and the Cochrane Database of Systematic Reviews were searched for English-language articles evaluating the treatment of chronic constipation in older individuals from the inception of the databases until October 2010. Search terms included constipation, treatment, laxative, elderly, and geriatric. Articles were excluded if the mean age was <65 years. Results: Thirty-one trials were identified. These studies varied widely in terms of methodology, quality, sample size, efficacy end points, and duration. Mean stool frequency was 9.08 bowel movements per week with psyllium and 8.29 per week with calcium polycarbophil (P = 0.04). Docusate sodium daily, docusate sodium q12h, and docusate calcium daily for 3 weeks produced a mean stool frequency of 1.95 bowel movements per week versus 1.50 for placebo (P = NS), 2.29 versus 1.76 (P = NS), and 2.83 versus 1.75 (P < 0.02), respectively. Mean stool frequency with lactulose versus placebo was 0.7 and 0.5 bowel movements per day (P < 0.02). In patients receiving polyethylene glycol or lactulose, mean stool frequency was 1.3 and 0.9 bowel movements per day (P = 0.005). In a study comparing senna plus a bulking agent with lactulose, mean stool frequency was 4.5 per week for the combination product versus 2.2 per week for lactulose (P < 0.001). A study comparing sodium picosulfate with senna reported a mean stool frequency of 0.71 and 0.63 per day (P value not reported). Lubiprostone was associated with 5.69 spontaneous bowel movements per week versus 3.46 per week for placebo (P = 0.001). Conclusions: Higher-quality trials evaluating the treatment of constipation in older patients are needed to create a basis for more definitive recommendations in this population. The approach to older adults with constipation should be individualized. (Am J Geriatr Pharmacother. 2010;8:514-550) (C) 2010 Elsevier HS Journals, Inc.","[Fleming, Virginia; Wade, William E.] Univ Georgia, Coll Pharm, Athens, GA 30602 USA",University System of Georgia; University of Georgia,"Fleming, V (corresponding author), Univ Georgia, Coll Pharm, Athens, GA 30602 USA.",vfleming@mail.rx.uga.edu,,,,,,,122,37,50,1,49,EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC,BRIDGEWATER,"685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA",1543-5946,,,AM J GERIATR PHARMAC,Am. J. Geriatr. Pharmacother.,DEC,2010,8,6,,,,,514,550,,10.1016/S1543-5946(10)80003-0,http://dx.doi.org/10.1016/S1543-5946(10)80003-0,,,37,Geriatrics & Gerontology; Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Geriatrics & Gerontology; Pharmacology & Pharmacy,705YG,21356503,,,,2024-06-04,WOS:000286176000003,View Full Record in Web of Science
J,"WALD, A",,,,"WALD, A",,,CONSTIPATION IN ELDERLY PATIENTS - PATHOGENESIS AND MANAGEMENT,DRUGS & AGING,,,English,Review,,,,,,,DIETARY FIBER; FECAL INCONTINENCE; ANORECTAL FUNCTION; LAVAGE SOLUTION; DOUBLE-BLIND; IMPACTION; TRANSIT; HOME; DEFECOGRAPHY; POPULATION,"The incidence of constipation appears to increase with increasing age, particularly after the age of 65. There are few data on the age-related physiological changes of colonic and anorectal function; however, anal sphincter pressures are decreased in elderly patients, while colonic transit time does not appear to be altered. The successful management of constipation in elderly patients requires an understanding of colorectal function, careful characterisation of the patient's complaint, and in selected patients, specialised studies of colonic and anorectal function. The cause of constipation in elderly patients is often multifactorial and may include inactivity, inappropriate diet, depression and confusion, certain medications, and neuromuscular disorders. The treatment of chronic constipation should be based on the nature of the complaint and the presumed pathophysiological mechanisms at work in each patient. Treatment will be based on one or more strategies including dietary changes, laxatives, and in carefully defined cases, surgery.","UNIV PITTSBURGH,SCH MED,DIV GASTROENTEROL & HEPATOL,PITTSBURGH,PA 15261",Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh,,,,,,,,,50,22,23,1,6,ADIS INTERNATIONAL LTD,AUCKLAND,"41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND 10, NEW ZEALAND",1170-229X,,,DRUG AGING,Drugs Aging,MAY-JUN,1993,3,3,,,,,220,231,,10.2165/00002512-199303030-00003,http://dx.doi.org/10.2165/00002512-199303030-00003,,,12,Geriatrics & Gerontology; Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Geriatrics & Gerontology; Pharmacology & Pharmacy,LF574,8324297,,,,2024-06-04,WOS:A1993LF57400003,View Full Record in Web of Science
J,"McRorie, JW; Chey, WD",,,,"McRorie, Johnson W.; Chey, William D.",,,Fermented Fiber Supplements Are No Better Than Placebo for a Laxative Effect,DIGESTIVE DISEASES AND SCIENCES,,,English,Review,,,,,,Fiber; Supplement; Laxative; Placebo; Ferment; Stool,FECAL MICROBIOTA; DOUBLE-BLIND; GASTROINTESTINAL TOLERANCE; JERUSALEM-ARTICHOKE; OBJECTIVE MEASURES; PLASTIC PARTICLES; ISPAGHULA HUSK; ENERGY VALUE; WHEAT BRAN; HEALTHY,"Misconceptions about the effects of dietary fiber and 'functional' fiber on stool parameters and constipation persist in the literature. A comprehensive literature review was conducted with the use of the Scopus and PubMed scientific databases to identify and objectively assess well-controlled clinical studies that evaluated the effects of fiber on stool parameters and constipation. The totality of well-controlled randomized clinical studies show that, to exert a laxative effect, fiber must: (1) resist fermentation to remain intact throughout the large bowel and present in stool, and (2) significantly increase stool water content and stool output, resulting in soft/bulky/easy-to-pass stools. Poorly fermented insoluble fiber (e.g., wheat bran) remains as discreet particles which can mechanically irritate the gut mucosa, stimulating water & mucous secretion if the particles are sufficiently large/coarse. For soluble fibers, some have no effect on viscosity (e.g., inulin, wheat dextrin) while others form high viscosity gels (e.g., beta-glucan, psyllium). If the soluble fiber is readily fermented, whether non-viscous or gel-forming, it has no effect on stool output or stool water content, and has no laxative effect. In contrast, a non-fermented, gel-forming soluble fiber (e.g., psyllium) retains its gelled nature and high water-holding capacity throughout the large bowel, resulting in soft/bulky/easy-to-pass stools. When considering a recommendation for a fiber supplement regimen to treat and/or prevent constipation, it is important to consider which fibers have the physical characteristics to exert a laxative effect, and which fiber supplements have rigorous clinical evidence of a significant benefit in patients with constipation.","[McRorie, Johnson W.] Procter & Gamble, Global Clin Sci, Mason Business Ctr, 8700 Mason Montgomery Rd, Mason, OH 45040 USA; [Chey, William D.] Univ Michigan Hlth Syst, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA",Procter & Gamble; University of Michigan System; University of Michigan,"McRorie, JW (corresponding author), Procter & Gamble, Global Clin Sci, Mason Business Ctr, 8700 Mason Montgomery Rd, Mason, OH 45040 USA.",mcrorie.jw@pg.com; wchey@med.umich.edu,"Chey, William/AAY-7766-2021",,,,,,56,18,19,1,30,SPRINGER,DORDRECHT,"VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS",0163-2116,1573-2568,,DIGEST DIS SCI,Dig. Dis. Sci.,NOV,2016,61,11,,,,,3140,3146,,10.1007/s10620-016-4304-1,http://dx.doi.org/10.1007/s10620-016-4304-1,,,7,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,EA3TW,27680987,,,,2024-06-04,WOS:000386529000008,View Full Record in Web of Science
J,"Suresh, H; Mikhael, M; Ho, V; Zhou, J",,,,"Suresh, Harsha; Mikhael, Meena; Ho, Vincent; Zhou, Jerry",,,"A HPLC-ESI-Q-ToF-MS Method for the Analysis of Monomer Constituents in PHGG, Gum Arabic And Psyllium Husk Prebiotic Dietary Fibre Supplements",INTERNATIONAL JOURNAL OF FOOD PROPERTIES,,,English,Article,,,,,,HPLC-ESI-Q-ToF-MS; Soluble Fibre; Monomer Sugars,IRRITABLE-BOWEL-SYNDROME; CHAIN FATTY-ACIDS; MONOSACCHARIDE COMPOSITION; LIQUID-CHROMATOGRAPHY; GUAR GUM; POLYSACCHARIDES; ELECTROPHORESIS; SEPARATION; SUGARS; PLATES,"Soluble type dietary fibre contains polysaccharides with monomer constituents that play a major role in lowering the glycemic index of food (low-GI) and improving colonic health through gut microbiome fermentation. Soluble fibres such as partially hydrolysed guar gum (PHGG), gum Arabic and psyllium husk are of particular interest in gastrointestinal research, exploring their effects in motility disorders such as gastroparesis, constipation, diarrhea and irritable bowel syndrome (IBS) is important. The primary aim of this research was to develop a rapid pre-column derivatized HPLC-ESI-Q-ToF-MS method for the identification and quantification of monomer sugar constituents in commercial dietary fibre supplements of PHGG, gum Arabic and psyllium husk. Polysaccharides in the samples were hydrolysed and derivatized using 1-phenyl-3-methyl-5-pyrazolone (PMP). A rapid 21 min HPLC-ESI-Q-ToF-MS method separated nine different PMP-labelled monomer sugars. Five different sugars (i.e., Galactose, Arabinose, Rhamnose, Mannose and Xylose) were identified and quantified. Standard curve linearity was excellent (R-2 > 0.999), with good intra-laboratory precision (< +/- 5% SD for concentrations, <= +/- 0.02 min peak shifting for retention times). The average three-level (50%, 75% and 100%) spiking recoveries for the analytes was acceptable (96.22-109.49%). Positive scanning mode ESI-MS/MS was used to generate [M + H](+) precursor ions and three (m/z) product ion fragments to provide identity confirmation. The concentrations of monomer sugars in gum Arabic and psyllium husk dietary fibres were consistent with literature reports. In PHGG, the concentration of galactose was unexpectedly higher than mannose, indicating that the commercial hydrolysis process of guar gum during PHGG manufacturing affected monomer composition. The method presented here provides the basis for the standardisation and labelling of commercial PHGG, gum Arabic and psyllium husk supplements. Future research will need to explore the monomer variability in other prebiotic soluble fibres and their efficacy in the production of beneficial short-chain fatty acids (SCFA) in the colonic environment.","[Suresh, Harsha; Mikhael, Meena; Ho, Vincent; Zhou, Jerry] Western Sydney Univ, Sch Med, Campbelltown, NSW 2560, Australia; [Suresh, Harsha; Ho, Vincent; Zhou, Jerry] Western Sydney Univ, Gastrointestinal Motil Disorders Unit, Campbelltown, NSW, Australia; [Mikhael, Meena] Western Sydney Univ, Mass Spectrometry Unit Res Serv, Campbelltown, NSW, Australia; [Ho, Vincent] Univ Med Clin Camden & Campbelltown UMCCC, Campbelltown, NSW, Australia",University of Sydney; Western Sydney University; Western Sydney University; University of Sydney; University of Sydney; Western Sydney University,"Zhou, J (corresponding author), Western Sydney Univ, Sch Med, Campbelltown, NSW 2560, Australia.",J.Zhou@westernsydney.edu.au,,"Suresh, Harsha/0000-0003-1076-8470; Ho, Vincent/0000-0003-3127-2933; Mikhael, Meena/0000-0003-4355-4954",Western Sydney University (WSU); Australian Rotary Health (ARH); Devonport Rotary Club,Western Sydney University (WSU); Australian Rotary Health (ARH); Devonport Rotary Club,"This work was supported with a PhD scholarship jointly funded by Western Sydney University (WSU), Australian Rotary Health (ARH) and Devonport Rotary Club.",,68,2,2,2,14,TAYLOR & FRANCIS INC,PHILADELPHIA,"530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA",1094-2912,1532-2386,,INT J FOOD PROP,Int. J. Food Prop.,DEC 31,2022,25,1,,,,,1650,1667,,10.1080/10942912.2022.2096064,http://dx.doi.org/10.1080/10942912.2022.2096064,,,18,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,2U5XU,,gold,,,2024-06-04,WOS:000823234100001,View Full Record in Web of Science
J,"Saeed, A; Abuelazm, MT; Abdelnabi, M; Elewidi, M; Khaled, A; Elzahaby, A; Mousa, A; Abdelazeem, B",,,,"Saeed, Abdallah; Abuelazm, Mohamed T.; Abdelnabi, Mohamed; Elewidi, Mariam; Khaled, Asmaa; Elzahaby, Amr; Mousa, Amr; Abdelazeem, Basel",,,The efficacy and safety of vibrating capsules for functional constipation: a systematic review and meta-analysis of randomized controlled trials,CURRENT MEDICAL RESEARCH AND OPINION,,,English,Review,,,,,,Vibrating capsules; functional constipation; responder rate; meta-analysis; systematic review; >,DIAGNOSIS,"ObjectiveChronic constipation is a challenging functional gastrointestinal disorder that remains a global burden. Pharmacologic therapy, including laxatives and dietary fibers, are suggested as lines of treatment. Recent trials introduced an orally ingested vibrating capsule (VC) as an eligible option for chronic constipation management.MethodsWe conducted a literature search in English on electronic databases CENTRAL, PubMed, EMBASE, Scopus, and WOS until February 27th, 2023. RevMan was used to perform the meta-analysis. The results were reported as risk ratios (RRs), mean differences (MDs), and 95% confidence intervals (CIs). The study protocol was registered in PROSPERO with ID: (CRD42023409422).ResultsThree RCTs with a total of 601 patients were included in our analysis. There was no difference between the VC and placebo in responder rate (RR: 1.37 with 95% CI [0.82, 2.28], p = .22), CSBM change from baseline (MD: 0.21 with 95% CI [-0.26, 0.69], p = .38), SBM change from baseline (MD: 0.14 with 95% CI [-0.22, 0.49], p = .46), and the incidence of any adverse event (RR: 1.45 with a 95% CI of [0.79, 2.63], p = .23). However, VC was associated with increased vibration sensation (RR: 17.23, 95% CI [3.29, 90.20], p = .0008).ConclusionsVC was not effective to improve bowel movement in patients with functional constipation with no difference in response rate. However, evidence is still uncertain, with only three small RCTs that yielded heterogenous findings, mainly due to the different vibration protocols. Also, our findings suggest that VC is safe and well-tolerated, with no significant harmful effects observed. Therefore, more large-scale RCTs are needed to confirm the efficacy and safety of VC in patients with functional constipation, determining the most effective dose, frequency, and duration of treatment.","[Saeed, Abdallah; Abuelazm, Mohamed T.; Elewidi, Mariam; Khaled, Asmaa; Elzahaby, Amr; Mousa, Amr] Tanta Univ, Tanta, Egypt; [Abdelnabi, Mohamed] Univ Michigan, Dept Clin Pharm, Ann Arbor, MI USA; [Abdelazeem, Basel] McLaren Hlth Care, Dept Internal Med, Flint, MI USA; [Abdelazeem, Basel] Michigan State Univ, Dept Internal Med, E Lansing, MI USA; [Saeed, Abdallah] Tanta Univ, Fac Med, Tanta, Egypt",Egyptian Knowledge Bank (EKB); Tanta University; University of Michigan System; University of Michigan; Michigan State University; Egyptian Knowledge Bank (EKB); Tanta University,"Saeed, A (corresponding author), Tanta Univ, Fac Med, Tanta, Egypt.",abdallah98.saeed@gmail.com,"Saeed, Abdallah/IAQ-7855-2023; Abdelazeem, Basel/HEK-6470-2022","Abdelazeem, Basel/0000-0002-2919-6196; Saeed, Abdallah/0000-0003-4033-1106; Khaled, Asmaa/0000-0002-8250-7889; Abdelnabi, Mohamed/0000-0003-0414-8507; Abuelazm, Mohamed/0000-0002-2514-0689; Elewidi, Mariam Mahmoud/0009-0005-8144-9962",,,,,16,1,1,3,5,TAYLOR & FRANCIS LTD,ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND",0300-7995,1473-4877,,CURR MED RES OPIN,Curr. Med. Res. Opin.,SEP 2,2023,39,9,,,,,1195,1204,,10.1080/03007995.2023.2243219,http://dx.doi.org/10.1080/03007995.2023.2243219,,AUG 2023,10,"Medicine, General & Internal; Medicine, Research & Experimental",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine; Research & Experimental Medicine,Q6NH3,37526021,Green Submitted,,,2024-06-04,WOS:001046979900001,View Full Record in Web of Science
J,"Kranz, S; Mitchell, DC; Siega-Riz, AM; Smiciklas-Wright, H",,,,"Kranz, S; Mitchell, DC; Siega-Riz, AM; Smiciklas-Wright, H",,,Dietary fiber intake by American preschoolers is associated with more nutrient-dense diets,JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION,,,English,Article,,,,,,,CHILDREN; CHILDHOOD; CONSTIPATION,"Objective To illustrate and discuss implications of the new Diet Reference Intakes for fiber, relative to a nationally representative sample of American preschoolers. Design Cross-sectional study using the Continuing Survey of Food Intake by Individuals 1994-1996, 1998. Subjects Children 2 through 5 years of age who provided 2 days of dietary intake data (N=5,437) were grouped and 2- and 3-year-olds (n=2,805) were compared with 4- and 5-year-olds. Statistical Analysis Descriptive analysis (mean+/-standard error) was used to describe the sample and to rank children into quartiles of dietary fiber intake. Nonparametric test for trend was employed to examine significance level of observed changes in nutrient and food group consumption by increasing fiber intake quartiles. Results Main contributors to dietary fiber intakes were low-fiber fruits and legumes. Children in the high-fiber quartile consumed diets with higher nutrient and fiber density and increased number of servings of Food Guide Pyramid food groups. Many children in this population did not meet intake recommendations of age plus five, and most lacked the 14 g/1,000 kcal of energy consumed, even after considering a hypothetical estimated average of 5 g/day functional fiber. Conclusions Children would benefit from diets higher in fiber. Newly recommended intake levels are only met by a few and further studies need to be conducted to provide evidence for a recommended intake level of fiber in children. Average consumption of functional fiber in children has to be examined.","Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA; Univ N Carolina, Dept Nutr, Chapel Hill, NC USA; Univ N Carolina, Dept Maternal & Child Hlth, Chapel Hill, NC USA",Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill,"Penn State Univ, Dept Nutr Sci, 5G Henderson Bldg,Univ Pk, University Pk, PA 16802 USA.",sxk72@psu.edu,"Kranz, Sibylle/G-1728-2017","Kranz, Sibylle/0000-0001-5637-1706",,,,,23,43,53,0,9,AMER DIETETIC ASSOC,CHICAGO,"120 S RIVERSIDE PLZ, STE 2000, CHICAGO, IL 60606-6995 USA",0002-8223,,,J AM DIET ASSOC,J. Am. Diet. Assoc.,FEB,2005,105,2,,,,,221,225,,10.1016/j.jada.2004.11.005,http://dx.doi.org/10.1016/j.jada.2004.11.005,,,5,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,893QA,15668678,,,,2024-06-04,WOS:000226733100011,View Full Record in Web of Science
J,"Souza, DD; Tahan, S; Weber, TK; de Araujo, HB; de Morais, MB",,,,"Souza, Daniela da Silva; Tahan, Soraia; Weber, Thabata Koester; de Araujo-Filho, Humberto Bezerra; de Morais, Mauro Batista",,,"Randomized, Double-Blind, Placebo-Controlled Parallel Clinical Trial Assessing the Effect of Fructooligosaccharides in Infants with Constipation",NUTRIENTS,,,English,Article,,,,,,constipation; prebiotic; intestinal transit time; infant; Bifidobacterium,DIETARY FIBER; OLIGOSACCHARIDES; CHILDREN; FORMULA; CHILDHOOD; TIME,"Constipation often begins in the first year of life. The aim of this study was to assess the effect of fructooligosaccharides (FOS) in the treatment of infants with constipation. This randomized, double-blind, placebo-controlled clinical trial included infants with constipation who were randomly assigned to one of two parallel groups: FOS or placebo. Either the FOS supplement or the placebo was added to the infant formula. Thirty-six infants completed the 4-week intervention. Therapeutic success occurred in 83.3% of the FOS group infants and in 55.6% of the control group infants (p = 0.073; one-tailed test). Compared with the control group, the FOS group exhibited a higher frequency of softer stools (p = 0.035) and fewer episodes of straining and/or difficulty passing stools (p = 0.041). At the end of the intervention, the mouth-to-anus transit time was shorter (22.4 and 24.5 h, p = 0.035), and the Bifidobacterium sp. count was higher (p = 0.006) in the FOS group. In conclusion, the use of FOS in infants with constipation was associated with significant improvement in symptoms, but the results showed no statistical significance regarding the success of the therapy compared with the control group. FOS was associated with reduced bowel transit time and higher counts of the genus Bifidobacterium in the stool.","[Souza, Daniela da Silva; Tahan, Soraia; de Araujo-Filho, Humberto Bezerra; de Morais, Mauro Batista] Univ Fed Sao Paulo, Div Pediat Gastroenterol, Escola Paulista Med, BR-04023062 Sao Paulo, Brazil; [Weber, Thabata Koester] Univ Estadual Paulista, Inst Biociencias, BR-18618689 Botucatu, SP, Brazil",Universidade Federal de Sao Paulo (UNIFESP); Universidade Estadual Paulista,"de Morais, MB (corresponding author), Univ Fed Sao Paulo, Div Pediat Gastroenterol, Escola Paulista Med, BR-04023062 Sao Paulo, Brazil.",danielassouza@gmail.com; s.tahan@uol.com.br; thabataweber@yahoo.com.br; biogene@gmail.com; maurobmorais@gmail.com,"MORAIS, MAURO B/I-7995-2014","WEBER/0000-0001-5588-4235; Bezerra de Araujo Filho, Humberto/0000-0001-6438-0995",CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; CAPES-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior,CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)),This study and D.d.S.S. were supported by CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico and CAPES-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior.,,37,23,25,0,14,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,NOV,2018,10,11,,,,,,,1602,10.3390/nu10111602,http://dx.doi.org/10.3390/nu10111602,,,11,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,HC1GH,30388751,"Green Published, Green Submitted, gold",,,2024-06-04,WOS:000451547700040,View Full Record in Web of Science
J,"Stachowska, E; Maciejewska, D; Palma, J; Jamiol-Milc, D; Szczuko, M; Marlicz, W; Wunsch, E; Skonieczna-Zydecka, K",,,,"Stachowska, Ewa; Maciejewska, Dominika; Palma, Joanna; Jamiol-Milc, Dominika; Szczuko, Malgorzata; Marlicz, Wojciech; Wunsch, Ewa; Skonieczna-Zydecka, Karolina",,,Improvement of bowel movements among people with a sedentary lifestyle after prebiotic snack supply - preliminary study,GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY,,,English,Article,,,,,,prebiotics; dietary fibre; microbiota; constipation; clinical trial,GUT MICROBIAL COMPOSITION; CHAIN FATTY-ACIDS; CONSTIPATION; HEALTH; FIBER,"Introduction: Dietary fiber is one of the most important components of food. Fulfilling regulatory and nutritional functions for the intestinal microbiota, it appears to be an essential ingredient for people with a sedentary lifestyle. Aim: We hypothesized that regular intake of a snack containing high amounts of soluble fibre in parallel to a regular diet may rapidly improve bowel habits with simultaneous elevation of synthesis of short-chain fatty acids (SCFA). Material and methods: A total of 20 healthy volunteers, with a stool frequency of less than 3 spontaneous bowel movements per week, completed a 14-day double-blind, parallel-arm, randomized clinical trial with the intervention comprising daily intake of 2 doses (9.99% per 100 g or 13.91% per 100 g) of fibre. Food consumption was evaluated via 72-hour recall diaries at baseline and after 14 days of intervention. Gastrointestinal symptoms (abdominal comfort, distension, bloating, flatulence, stomach rumbling, number of bowel movements) were monitored via the IBS/VAS scale every day. Results: We found that the elevated fibre intake improved bowel habits significantly (defecation frequency increased from 0.28 to 0.87 times/day; p = 0.0002) in both study arms. After 14 days of the trial, an increase in SCFA concentration (for whole study group: acetic p < 0.036, propionic p < 0.019, and butyric acid p < 0.0012 compared to baseline parameters) with no adverse gastrointestinal symptoms was reported. Conclusions: Short-term, regular intake of a snack containing soluble fibre improves the SCFA synthesis and bowel habits in healthy people living a sedentary lifestyle. The exact mechanism behind this observation requires further investigation.","[Stachowska, Ewa; Maciejewska, Dominika; Palma, Joanna; Jamiol-Milc, Dominika; Szczuko, Malgorzata; Skonieczna-Zydecka, Karolina] Pomeranian Med Univ, Dept Human Nutr & Metabol, Szczecin, Poland; [Marlicz, Wojciech] Pomeranian Med Univ, Dept Gastroenterol, Szczecin, Poland; [Wunsch, Ewa] Pomeranian Med Univ, Translat Med Grp, Szczecin, Poland",Pomeranian Medical University; Pomeranian Medical University; Pomeranian Medical University,"Stachowska, E (corresponding author), Pomeranian Med Univ, Dept Human Nutr & Metabol, Szczecin, Poland.",ewast@pum.edu.pl,"stachowska, Ewa/G-9521-2017; Marlicz, Wojciech/G-5007-2013; Skonieczna-Żydecka, Karolina/K-7252-2014; Szczuko, Malgorzata MS/A-9501-2015; Palma, Joanna/AAE-7293-2020; Wunsch, Ewa/A-8487-2015; Jamioł-Milc, Dominika/ABA-4267-2020","Marlicz, Wojciech/0000-0002-2649-5967; Skonieczna-Żydecka, Karolina/0000-0002-3430-9079; Szczuko, Malgorzata MS/0000-0001-9808-0624; Palma, Joanna/0000-0003-0620-3776; Jamioł-Milc, Dominika/0000-0003-0203-1823",Ministry of Science and Higher Education; EU funds (ERDF),"Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); EU funds (ERDF)(European Union (EU))",Inkubator Innowacyjnoci + project of the Maremed consortium (Pomeranian Medical Universi-ty Technology Transfer Centre and Innovation Centre of the Maritime University Ltd.) with financial support from the Ministry of Science and Higher Education and EU funds (ERDF) .,,29,3,3,0,3,TERMEDIA PUBLISHING HOUSE LTD,POZNAN,"KLEEBERGA ST 2, POZNAN, 61-615, POLAND",1895-5770,1897-4317,,GASTROENTEROL REV,Gastroenterol. Rev.,,2022,17,1,,,,,73,80,,10.5114/pg.2021.108985,http://dx.doi.org/10.5114/pg.2021.108985,,,8,Gastroenterology & Hepatology,Emerging Sources Citation Index (ESCI),Gastroenterology & Hepatology,ZZ6HE,35371359,"gold, Green Published",,,2024-06-04,WOS:000773366600012,View Full Record in Web of Science
J,"Storz, MA; Rizzo, G; Müller, A; Lombardo, M",,,,"Storz, Maximilian Andreas; Rizzo, Gianluca; Mueller, Alexander; Lombardo, Mauro",,,Bowel Health in US Vegetarians: A 4-Year Data Report from the National Health and Nutrition Examination Survey (NHANES),NUTRIENTS,,,English,Article,,,,,,vegetarian; plant-based; fiber; bowel health; constipation; NHANES; bristol stool scale; stool,BRISTOL STOOL FORM; DIETARY FIBER; FECAL INCONTINENCE; FOOD-INTAKE; LIFE-STYLE; FREQUENCY; CONSTIPATION; ADULTS; SCALE; ASSOCIATION,"Dietary fiber is of paramount importance in the prevention of large-bowel diseases, yet fiber intake in many high income countries is well below daily recommendations. Vegetarian diets high in fiber-rich plant-foods have been associated with a higher frequency of bowel movements and softer stools. Thus, vegetarians appear to suffer less frequently from constipation and other bowel disorders. The number of studies investigating these associations, however, is limited. The present study sought to investigate bowel health and constipation prevalence in a self-identified vegetarian population from the U.S. National Health and Nutrition Examination Survey (2007-2010). Bowel health assessment included Bristol Stool Scale (BSS), Bowel Movement (BM) frequency and Fecal Incontinence Severity Index (FISI). The present study included 9531 non-vegetarians and 212 vegetarians. We found no associations between vegetarian status and all examined bowel health items (BM frequency, BSS and FISI). Vegetarians consumed significantly more fiber than omnivores (21.33 vs. 16.43 g/d, p < 0.001) but had a lower moisture intake (2811.15 vs. 3042.78 g/d, p = 0.045). The lack of an association of vegetarian status and bowel health is surprising, and may be a result of the relatively low fiber intake in this particular vegetarian cohort, which did not meet the daily fiber recommendations.","[Storz, Maximilian Andreas; Mueller, Alexander] Univ Freiburg, Freiburg Univ Hosp, Fac Med, Ctr Complementary Med,Dept Internal Med 2, D-79106 Freiburg, Germany; [Rizzo, Gianluca] Via Venezuela 66, I-98121 Messina, Italy; [Lombardo, Mauro] San Raffaele Roma Open Univ, Dept Human Sci & Promot Qual Life, I-00166 Rome, Italy",University of Freiburg,"Storz, MA (corresponding author), Univ Freiburg, Freiburg Univ Hosp, Fac Med, Ctr Complementary Med,Dept Internal Med 2, D-79106 Freiburg, Germany.",maximilian.storz@uniklinik-freiburg.de; gianlucarizzo@email.it; alexander.mueller@uniklinik-freiburg.de; mauro.lombardo@uniroma5.it,"Lombardo, Mauro/F-6133-2019; Rizzo, Gianluca/J-6540-2019; Storz, Maximilian Andreas/GLR-8109-2022","Lombardo, Mauro/0000-0001-7509-5487; Rizzo, Gianluca/0000-0002-5540-0621; Storz, Maximilian Andreas/0000-0003-3277-0301","Baden-Wuerttemberg Ministry of Science, Research and Art; University of Freiburg","Baden-Wuerttemberg Ministry of Science, Research and Art; University of Freiburg","This research received no external funding. The article processing charge was funded by the Baden-Wuerttemberg Ministry of Science, Research and Art and the University of Freiburg in the funding programme Open Access Publishing.",,69,8,8,2,6,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,FEB,2022,14,3,,,,,,,681,10.3390/nu14030681,http://dx.doi.org/10.3390/nu14030681,,,13,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,2T8JG,35277040,"Green Published, gold",,,2024-06-04,WOS:000822713700001,View Full Record in Web of Science
J,"Vitolo, MR; Campagnolo, PDB; Gama, CM",,,,"Vitolo, Marcia R.; Campagnolo, Paula D. B.; Gama, Cintia M.",,,Factors associated with risk of low dietary fiber intake in adolescents,JORNAL DE PEDIATRIA,,,English,Article,,,,,,,CARDIOVASCULAR-DISEASE; NUTRIENT INTAKE; CONSTIPATION; CHILDHOOD; CHILDREN; CONSUMPTION; COUNTRIES; PATTERNS; OBESITY; WEIGHT,"Objective. To evaluate dietary fiber intake among adolescents and to analyze factors associated with the risk of insufficient consumption of this nutrient. Methods: Cross-sectional study of 722 adolescents from the town of Sao Leopoldo, RS, Brazil. Sampling was by clusters, with a systematic randomization of 40 census sectors and residences, including all individuals aged 10 to 19 years. The adolescents' weight and height were measured and sociodemographic data on their families recorded. A 24-hour dietary recall and a frequency survey were used to assess dietary intakes. The quantity of dietary fiber in diets was calculated using Nutwin nutrition support software (Programa de Apoio a Nutricao), developed by the IT Department at Universidade Federal de Sao Paulo (UNIFESP). Statistical analysis was by means of logistic regression, employing a hierarchical model. Results: The prevalence of insufficient dietary fiber intake was 69% among girls and 49.7% for boys (p < 0.001). The determinant factors of this condition among boys were non-habitual consumption of beans (OR 2.65; 95%CI 1.05-6.68) and excessive fat intake (OR 2.67; 95%CI 11.23-5.83). For girls factors were increased age (OR 5.33; 95%CI 2.33-12.2), non-habitual consumption of beans (OR 3.01; 95%CI 1.44-6.53), excessive fat intake (OR 1.85; 95%CI 1.01-3-37), dieting for weight loss (OR 2.50; 95%CI 1.10-5.70) and presence of overweight (OR 2.06; 95%CI 1.04-4.07). Conclusions: These results admit of the conclusion that excessive fat consumption and non-habitual consumption of beans are strongly linked with the risk of insufficient dietary fiber intake in both sexes and that females exhibit a greater number of risk factors for this outcome.","[Vitolo, Marcia R.; Campagnolo, Paula D. B.; Gama, Cintia M.] Fdn Fac Fed Ciencias MEd Porto Alegre, Programa Pos Grad Ciencias Med, Porto Alegre, RS, Brazil",,"Vitolo, MR (corresponding author), Fdn Fac Fed Ciencias MEd Porto Alegre, Programa Pos Grad Ciencias Med, Porto Alegre, RS, Brazil.",,"Campagnolo, Paula/G-3806-2012","Vitolo, Marcia Regina/0000-0001-9137-3854",,,,,28,16,21,0,10,SOC BRASIL PEDIATRIA,"RIO DE JANEIRO, RJ","RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL",0021-7557,1678-4782,,J PEDIAT-BRAZIL,J. Pediatr.,JAN-FEB,2007,83,1,,,,,47,52,,10.2223/JPED.1582,http://dx.doi.org/10.2223/JPED.1582,,,6,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,275SR,17279285,"Green Submitted, Green Published",,,2024-06-04,WOS:000254092400009,View Full Record in Web of Science
J,"Kim, BK; Choi, IS; Kim, J; Han, SH; Suh, HJ; Hwang, JK",,,,"Kim, Byoung-Kook; Choi, In Suk; Kim, Jihee; Han, Sung Hee; Suh, Hyung Joo; Hwang, Jae-Kwan",,,Effects of Fermented Milk with Mixed Strains as a Probiotic on the Inhibition of Loperamide-Induced Constipation,KOREAN JOURNAL FOR FOOD SCIENCE OF ANIMAL RESOURCES,,,English,Article,,,,,,constipation; probiotic; bacteria; CKDBP; loperamide,DIETARY FIBER INTAKE; RATS; MICROFLORA; CHILDREN; DISEASE; CELLS; LIFE,"To investigate the effects of a single bacterium and a mixture of bacteria as probiotics in loperamide-treated animal models, loperamide (3 mg/kg) was administered to SD rats to induce constipation. The individual lactic acid bacterial doses, Enterococcus faecium (EF), Lactobacillus acidophilus (LA), Streptococcus thermophilus (ST), Bifidobacterium bifidum (BB), Bifidobacterium lactis (BL), Pediococcus pentosaceus (PP), and a mixture of the bacteria were orally administered to loperamide-induced constipated rats at a concentration of 108 CFU/kg for 14 days. The weights and water contents of their stools were found to be significantly higher in PP, CKDB (mixture of 5 strains except PP), and CKDBP (CKDB+PP) groups than in the normal (constipation not induced) and the control (constipation-induced) groups (p<0.05). The intestinal transit ratio was significantly higher in all probiotic-treated groups than in the control group, and was the highest in the CKDBP group (p<0.05). The mucosal length and mucus secretion were significantly improved in all probiotic-treated-groups, as compared to that in the control group, and the CKDBP group was found to be the most effective according to immunohistochemistry (IHC) staining and total short chain fatty acid content analysis (p<0.05). Lastly, PP, CKDB, and CKDBP showed relatively higher Lactobacillus sp. ratios of 61.94%, 60.31% and 51.94%, respectively, compared to the other groups, based on metagenomic analysis.","[Hwang, Jae-Kwan] Yonsei Univ, Dept Biotechnol, Seoul 03722, South Korea; [Hwang, Jae-Kwan] Yonsei Univ, Dept Biomat Sci & Engn, Seoul 03722, South Korea; [Kim, Byoung-Kook; Choi, In Suk; Kim, Jihee] Chong Kun Dang Bio Res Inst, Gyeonggi Do 15064, South Korea; [Han, Sung Hee] Korea Univ, Coll Hlth Sci, BK21Plus, Seoul 02841, South Korea; [Suh, Hyung Joo] Korea Univ, Grad Sch, Dept Publ Hlth Sci, Seoul 02841, South Korea",Yonsei University; Yonsei University; Korea University; Korea University,"Hwang, JK (corresponding author), Yonsei Univ, Dept Biotechnol, Seoul 03722, South Korea.;Hwang, JK (corresponding author), Yonsei Univ, Dept Biomat Sci & Engn, Seoul 03722, South Korea.;Han, SH (corresponding author), Korea Univ, Coll Hlth Sci, BK21Plus, Seoul 02841, South Korea.",sunghee3@gmail.com; jkhwang@yonsei.ac.kr,,"Han, Sung Hee/0000-0003-0825-6687","Cooperative Research Program for Agriculture Science & Technology Development, Rural Development Administration, Republic of Korea [PJ011287012016]","Cooperative Research Program for Agriculture Science & Technology Development, Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)","This work was carried out with the support of Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ011287012016), Rural Development Administration, Republic of Korea.",,35,7,8,1,20,KOREAN SOC FOOD SCIENCE ANIMAL RESOURCES,SEOUL,"615, COLL ANIMAL BIOSCIENCE & TECHNOLOGY, KONKUK UNIV, SEOUL, 143-701, SOUTH KOREA",1225-8563,,,KOREAN J FOOD SCI AN,Korean J. Food Sci. Anim. Resour.,DEC,2017,37,6,,,,,906,916,,10.5851/kosfa.2017.37.6.906,http://dx.doi.org/10.5851/kosfa.2017.37.6.906,,,11,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,FS4HT,29725213,,,,2024-06-04,WOS:000419750400015,View Full Record in Web of Science
J,"Zerfu, TA; Mekuria, A",,,,"Zerfu, Taddese Alemu; Mekuria, Aleme",,,Pregnant women have inadequate fiber intake while consuming fiber-rich diets in low-income rural setting: Evidences from Analysis of common ready-to-eat stable foods,FOOD SCIENCE & NUTRITION,,,English,Article,,,,,,adequacy; fiber; pregnancy; pregnant women; trimester,REQUIREMENTS; METAANALYSIS; GESTATION; WEIGHT; ENERGY; HEALTH,"The intake of fiber-rich foods during pregnancy has several health benefits to the pregnant woman including lowering the risks of diabetes, preeclampsia, and constipation. However, little is known about the content, daily intake levels, and adequacy of fiber among pregnant women in many low-income settings. We aimed to identify common food items and determine adequacy of dietary fiber intake levels among pregnant women in rural Ethiopia. Dietary data were collected from a subsample (n = 55) of pregnant women enrolled to a larger prospective cohort study (n = 414). Dietary intake level was measured using repeated 24-hr dietary recall method and weighing the total amount of daily food. Fiber content was determined using the Weende method supplemented by other sources.The mean [+/- SD] dietary fiber intake level was 25.89 [+/- 5.09 mg/g] per day, which declined across pregnancy trimester from 26.01 [+/- 9.18 mg/g] to 22.67 [+/- 9.01 mg/g] and 24.56 [+/- 9.98 mg/g] during the first, to second and third pregnancy trimesters, respectively. Boiled cereals and coffee contributed to nearly two-thirds (63.2%) of the daily fiber intake, while the major bulk of daily food, enjera, contributed to less than a quarter (24.3%) of the fiber intake. Though dietary patterns favor diversified intake for fiber, the mean intake levels below the recommended levels and proportion of women getting adequate to the physiologic stages of pregnancy were inadequate compared to the standard. Mothers, in such community, could benefit from increasing overall intake of existing food to satisfy their fiber needs during pregnancy.","[Zerfu, Taddese Alemu] Dilla Univ, Coll Hlth Sci, Dilla, Ethiopia; [Zerfu, Taddese Alemu] African Populat & Hlth Res Ctr, Maternal & Child WellBeing MCW Unit, Nairobi, Kenya; [Mekuria, Aleme] Arbaminch Coll Hlth Sci, Dept Publ Hlth, Arba Minch, Ethiopia",Dilla University; African Population & Health Research Centre,"Zerfu, TA (corresponding author), Dilla Univ, Coll Hlth Sci, Dilla, Ethiopia.",tadalzerfu@gmail.com,,,Dilla University; APHRC,Dilla University; APHRC,"The authors acknowledge Oromia Regional Health Bureau, Arsi zone health office, and district health managers. We would also like to thank Dilla University and APHRC for providing some funds for the conduction of the study. Lastly, we are highly indebted to appreciate the contribution of study participants as well as data collectors.",,30,7,7,0,4,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",2048-7177,,,FOOD SCI NUTR,Food Sci. Nutr.,OCT,2019,7,10,,,,,3286,3292,,10.1002/fsn3.1188,http://dx.doi.org/10.1002/fsn3.1188,,SEP 2019,7,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,JJ4OL,31660142,"Green Published, gold",,,2024-06-04,WOS:000485145000001,View Full Record in Web of Science
J,"Abe, A; Morishima, S; Kapoor, MP; Inoue, R; Tsukahara, T; Naito, Y; Ozeki, M",,,,"Abe, Aya; Morishima, So; Kapoor, Mahendra P.; Inoue, Ryo; Tsukahara, Takamitsu; Naito, Yuji; Ozeki, Makoto",,,"Partially hydrolyzed guar gum is associated with improvement in gut health, sleep, and motivation among healthy subjects",JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION,,,English,Article,,,,,,partially hydrolyzed guar gum; constipation; mucolytic bacteria; sleep; motivation,DIETARY FIBER; SP-NOV.; SOLUBLE FIBER; GEN. NOV.; MICROBIOME; BACTERIA; CONSTIPATION; PREVALENCE; PREBIOTICS; NUTRITION,"Partially hydrolyzed guar gum dietary fiber is well recognized for a number of health benefits. In the present study, we aim to investigate the effects of partially hydrolyzed guar gum on constipation, intestinal microbiota as well as mental health in healthy subjects. In the randomized, parallel, double-blind, and placebo-controlled study the enrolled healthy men and women volunteers took either 3 g/day (T3) or 5 g/day (T5) of dietary fiber intakes for eight consecutive weeks compared to placebo (T0). The fecal characteristics, fecal microbiota, defecation characteristics, and quality of life (QOL) questionnaire were investigated. The results revealed a significant suppression in fecal potent harmful mucolytic bacteria in the T3 and T5 groups compared to the T0 group. The defecation frequency, excretory feeling, and scores of sleep and motivation questionnaire were also improved in the dietary fiber intake groups, showing a significant difference in the T5 group compared to the T0 group. In summary, the consumption of partially hydrolyzed guar gum dietary fiber is found effective in suppressing the potent harmful mucolytic bacteria that could be associated with the improvement of constipation-related symptoms including mental health in terms of sleep and motivation among the healthy subjects.","[Abe, Aya; Morishima, So; Kapoor, Mahendra P.; Ozeki, Makoto] Taiyo Kagaku Co Ltd, Nutr Div, 1-3 Takaramachi, Yokaichi, Mie 5100844, Japan; [Inoue, Ryo] Setsunan Univ, Dept Appl Biol Sci, Lab Anim Sci, Fac Agr, Nagatoge Cho 45-1, Hirakata, Osaka 5730101, Japan; [Tsukahara, Takamitsu] Kyoto Inst Nutr & Pathol, Ujitawara, Kyoto 6100231, Japan; [Naito, Yuji] Kyoto Prefectural Univ Med, Dept Human Immunol & Nutr Sci, 465 Kajii Cho,Kamigyo Ku, Kyoto 6028566, Japan","TAIYO KAGAKU CO., LTD.; Setsunan University; Kyoto Prefectural University of Medicine","Abe, A (corresponding author), Taiyo Kagaku Co Ltd, Nutr Div, 1-3 Takaramachi, Yokaichi, Mie 5100844, Japan.",aabe@taiyokagaku.co.jp,,,,,,,82,2,2,0,3,JOURNAL CLINICAL BIOCHEMISTRY & NUTRITION,KYOTO,"KYOTO PREFECTURAL UNIV MED, GRAD SCH MEDICAL SCIENCE, DEPT MOLECULAR GASTROENTEROLOGY & HEPATOLOGY, KYOTO, 602-8566, JAPAN",0912-0009,1880-5086,,J CLIN BIOCHEM NUTR,J. Clin. Biochem. Nutr.,,2023,72,2,,,,,189,197,,10.3164/jcbn.22-75,http://dx.doi.org/10.3164/jcbn.22-75,,,9,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,Q7AK2,36936875,"Green Published, gold",,,2024-06-04,WOS:001059010300013,View Full Record in Web of Science
J,"Wegh, CAM; Baaleman, DF; Tabbers, MM; Smidt, H; Benninga, MA",,,,"Wegh, Carrie A. M.; Baaleman, Desiree F.; Tabbers, Merit M.; Smidt, Hauke; Benninga, Marc A.",,,Nonpharmacologic Treatment for Children with Functional Constipation: A Systematic Review and Meta-analysis,JOURNAL OF PEDIATRICS,,,English,Review,,,,,,,INTERFERENTIAL ELECTRICAL-STIMULATION; COWS MILK ALLERGY; INTERNATIONAL SCIENTIFIC ASSOCIATION; CASEI-RHAMNOSUS LCR35; DIETARY FIBER MIXTURE; CHILDHOOD CONSTIPATION; DOUBLE-BLIND; GASTROINTESTINAL DISORDERS; CONSENSUS STATEMENT; BIOFEEDBACK THERAPY,"Objective To evaluate the effectiveness and safety of nonpharmacologic interventions for the treatment of childhood functional constipation. Study design Randomized controlled trials (RCTs) evaluating nonpharmacologic treatments in children with functional constipation which reported at least 1 outcome of the core outcome set for children with functional constipation. Results We included 52 RCTs with 4668 children, aged between 2 weeks and 18 years, of whom 47% were females. Studied interventions included gut microbiome-directed interventions, other dietary interventions, oral supplements, pelvic floor-directed interventions, electrical stimulation, dry cupping, and massage therapy. An overall high risk of bias was found across the majority of studies. Meta-analyses for treatment success and/or defecation frequency, including 20 RCTs, showed abdominal electrical stimulation (n = 3), Cassia Fistula emulsion (n = 2), and a cow's milk exclusion diet (n = 2 in a subpopulation with constipation as a possible manifestation of cow's milk allergy) may be effective. Evidence from RCTs not included in the meta-analyses, indicated that some prebiotic and fiber mixtures, Chinese herbal medicine (Xiao'er Biantong granules), and abdominal massage are promising therapies. In contrast, studies showed no benefit for the use of probiotics, synbiotics, an increase in water intake, dry cupping, or additional biofeedback or behavioral therapy. We found no RCTs on physical movement or acupuncture. Conclusions More well-designed high quality RCTs concerning nonpharmacologic treatments for children with functional constipation are needed before changes in current guidelines are indicated.","[Wegh, Carrie A. M.; Baaleman, Desiree F.; Tabbers, Merit M.; Benninga, Marc A.] Univ Amsterdam, Emma Childrens Hosp, Dept Pediat Gastroenterol & Nutr, Amsterdam UMC, Amsterdam, Netherlands; [Wegh, Carrie A. M.; Smidt, Hauke] Wageningen Univ & Res, Lab Microbiol, Wageningen, Netherlands",University of Amsterdam; Emma Children's Hospital; Wageningen University & Research,"Wegh, CAM (corresponding author), Stippeneng 4, NL-6708 WE Wageningen, Netherlands.",c.a.wegh@amsterdamumc.nl,,"Smidt, Hauke/0000-0002-6138-5026",China Scholarship Council [201600090211],China Scholarship Council(China Scholarship Council),"We thank Faridi S. van Etten-Jamaludin for her help with building the search strategy. We thank Tatiana Degtyareva, Taojun Wang, and Siavash Atashgahi for their help with translating articles in foreign languages. We thank Ploon Defourny and Zoe Borst for their valuable insights in the evaluation of the included studies for their thesis. T.W. is financially supported by the China Scholarship Council (File No. 201600090211), has no industry relation, and no conflicts of interest. The other individuals listed in the acknowledgments declare no conflicts of interest.",,121,31,33,0,34,MOSBY-ELSEVIER,NEW YORK,"360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA",0022-3476,1097-6833,,J PEDIATR-US,J. Pediatr.,JAN,2022,240,,,,,,136,+,,10.1016/j.jpeds.2021.09.010,http://dx.doi.org/10.1016/j.jpeds.2021.09.010,,DEC 2021,19,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,YL6HX,34536492,hybrid,,,2024-06-04,WOS:000745991300025,View Full Record in Web of Science
J,"Romero, Y; Evans, JM; Fleming, KC; Phillips, SF",,,,"Romero, Y; Evans, JM; Fleming, KC; Phillips, SF",,,Constipation and fecal incontinence in the elderly population,MAYO CLINIC PROCEEDINGS,,,English,Article,,,,,,,UNITED-STATES; BIOFEEDBACK THERAPY; INTESTINAL TRANSIT; ANORECTAL FUNCTION; DIABETES-MELLITUS; DIETARY FIBER; BOWEL HABIT; PREVALENCE; IMPACTION; LAXATIVES,"Objective: To describe the assessment and management of constipation and fecal Design: We reviewed pertinent publications in the recent medical literature and outlined effective management strategies for constipation and fecal incontinence in the geriatric population, Results: Constipation can be classified into two syndromes-functional constipation and rectosigmoid outlet delay, Evaluation consists of elicitation of a detailed history, directed physical examination, and selected laboratory tests, Management involves nonpharmacologic (such as exercise and fiber) and pharmacologic measures, Fecal incontinence in elderly patients can be due to stool impaction, medications, dementia, or neuromuscular dysfunction. Management options include modification of contributing disorders, pharmacologic therapy, and behavioral techniques. Conclusion: Constipation and fecal incontinence are common and often debilitating conditions in elderly patients, Management should be highly individualized and dependent on cause, coexisting morbidities, and cognitive status.","MAYO CLIN, SECT GERIATR, ROCHESTER, MN 55905 USA",Mayo Clinic,"Romero, Y (corresponding author), MAYO CLIN, DIV GASTROENTEROL & INTERNAL MED, ROCHESTER, MN 55905 USA.",,,,,,,,73,37,37,0,6,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",0025-6196,1942-5546,,MAYO CLIN PROC,Mayo Clin. Proc.,JAN,1996,71,1,,,,,81,92,,10.4065/71.1.81,http://dx.doi.org/10.4065/71.1.81,,,12,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),General & Internal Medicine,TP459,8538239,,,,2024-06-04,WOS:A1996TP45900014,View Full Record in Web of Science
J,"Jeong, JJ; Ganesan, R; Jin, YJ; Park, HJ; Min, BH; Jeong, MK; Yoon, SJ; Choi, MR; Choi, J; Moon, JH; Min, U; Lim, JH; Lee, DY; Han, SH; Ham, YL; Kim, BY; Suk, KT",,,,"Jeong, Jin-Ju; Ganesan, Raja; Jin, Yoo-Jeong; Park, Hee Jin; Min, Byeong Hyun; Jeong, Min Kyo; Yoon, Sang Jun; Choi, Mi Ran; Choi, Jieun; Moon, Ji Hyun; Min, Uigi; Lim, Jong-Hyun; Lee, Do Yup; Han, Sang Hak; Ham, Young Lim; Kim, Byung-Yong; Suk, Ki Tae",,,"Multi-strain probiotics alleviate loperamide-induced constipation by adjusting the microbiome, serotonin, and short-chain fatty acids in rats",FRONTIERS IN MICROBIOLOGY,,,English,Article,,,,,,constipation; probiotics; microbiome; serotonin; SCFAs,ULCERATIVE-COLITIS; LACTOBACILLUS-PLANTARUM; DIETARY FIBER; BUTYRATE; MUCIN; SUPPLEMENTATION; AKKERMANSIA; SECRETION; TRANSIT; BIFIDOBACTERIA,"Constipation is one of the most common gastrointestinal (GI) disorders worldwide. The use of probiotics to improve constipation is well known. In this study, the effect on loperamide-induced constipation by intragastric administration of probiotics Consti-Biome mixed with SynBalance (R) SmilinGut (Lactobacillus plantarum PBS067, Lactobacillus rhamnosus LRH020, Bifidobacterium animalis subsp. lactis BL050; Roelmi HPC), L. plantarum UALp-05 (Chr. Hansen), Lactobacillus acidophilus DDS-1 (Chr. Hansen), and Streptococcus thermophilus CKDB027 (Chong Kun Dang Bio) to rats was evaluated. To induce constipation, 5 mg/kg loperamide was intraperitoneally administered twice a day for 7 days to all groups except the normal control group. After inducing constipation, Dulcolax-S tablets and multi-strain probiotics Consti-Biome were orally administered once a day for 14 days. The probiotics were administered 0.5 mL at concentrations of 2 x 10(8) CFU/mL (G1), 2 x 10(9) CFU/mL (G2), and 2 x 10(10) CFU/mL (G3). Compared to the loperamide administration group (LOP), the multi-strain probiotics not only significantly increased the number of fecal pellets but also improved the GI transit rate. The mRNA expression levels of serotonin- and mucin-related genes in the colons that were treated with the probiotics were also significantly increased compared to levels in the LOP group. In addition, an increase in serotonin was observed in the colon. The cecum metabolites showed a different pattern between the probiotics-treated groups and the LOP group, and an increase in short-chain fatty acids was observed in the probiotic-treated groups. The abundances of the phylum Verrucomicrobia, the family Erysipelotrichaceae and the genus Akkermansia were increased in fecal samples of the probiotic-treated groups. Therefore, the multi-strain probiotics used in this experiment were thought to help alleviate LOP-induced constipation by altering the levels of short-chain fatty acids, serotonin, and mucin through improvement in the intestinal microflora.","[Jeong, Jin-Ju; Ganesan, Raja; Park, Hee Jin; Min, Byeong Hyun; Jeong, Min Kyo; Yoon, Sang Jun; Choi, Mi Ran; Suk, Ki Tae] Hallym Univ, Inst Liver & Digest Dis, Chunchon, South Korea; [Jin, Yoo-Jeong; Min, Uigi; Lim, Jong-Hyun; Kim, Byung-Yong] Chong Kun Dang Healthcare, R&D Ctr, Seoul, South Korea; [Choi, Jieun; Moon, Ji Hyun; Lee, Do Yup] Seoul Natl Univ, Res Inst Agr & Life Sci, Ctr Food & Bioconvergence, Dept Agr Biotechnol, Seoul, South Korea; [Han, Sang Hak] Hallym Univ, Dept Pathol, Coll Med, Chunchon, South Korea; [Ham, Young Lim] Daewon Univ Coll, Dept Nursing, Jecheon, South Korea",Hallym University; Seoul National University (SNU); Hallym University,"Suk, KT (corresponding author), Hallym Univ, Inst Liver & Digest Dis, Chunchon, South Korea.;Kim, BY (corresponding author), Chong Kun Dang Healthcare, R&D Ctr, Seoul, South Korea.",bykim@ckdhc.com; ktsuk@hallym.ac.kr,"Ganesan, Raja/AAW-3703-2021; , BYUNGYONG KIM/JLL-7806-2023","Ganesan, Raja/0000-0003-3060-6217; Kim, Byung-Yong/0000-0002-4229-8859; Min, Uigi/0000-0002-7374-6829","Hallym University Research Fund; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2020R1A6A1A03043026, 2020R1I1A3073530]; Korea Institute for Advancement of Technology [P0020622]; Bio Industrial Technology Development Program - Ministry of Trade, Industry and Energy (MOTIE, Korea) [20018494]","Hallym University Research Fund; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(National Research Foundation of Korea); Korea Institute for Advancement of Technology; Bio Industrial Technology Development Program - Ministry of Trade, Industry and Energy (MOTIE, Korea)","This research was supported by Hallym University Research Fund, the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2020R1A6A1A03043026 and 2020R1I1A3073530), Korea Institute for Advancement of Technology (P0020622), and Bio Industrial Technology Development Program (20018494) funded by the Ministry of Trade, Industry and Energy (MOTIE, Korea).",,97,10,10,17,26,FRONTIERS MEDIA SA,LAUSANNE,"AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND",,1664-302X,,FRONT MICROBIOL,Front. Microbiol.,JUN 2,2023,14,,,,,,,,1174968,10.3389/fmicb.2023.1174968,http://dx.doi.org/10.3389/fmicb.2023.1174968,,,14,Microbiology,Science Citation Index Expanded (SCI-EXPANDED),Microbiology,J3FN9,37333632,"Green Published, gold",,,2024-06-04,WOS:001008503100001,View Full Record in Web of Science
J,"Almaraz, RS; Fuentes, MM; Milla, SP; Plaza, BL; López, LMB; Candela, CG",,,,"Sanchez Almaraz, Rosalia; Martin Fuentes, Maria; Palma Milla, Samara; Lopez Plaza, Bricia; Bermejo Lopez, Laura M.; Gomez Candela, Carmen",,,FIBER-TYPE INDICATION AMONG DIFFERENT PATHOLOGIES,NUTRICION HOSPITALARIA,,,Spanish,Review,,,,,,Dietetic fiber; Gastrointestinal diseases; Metabolic diseases; Colorrectal cancer,CORONARY-HEART-DISEASE; MINIMAL HEPATIC-ENCEPHALOPATHY; RANDOMIZED CLINICAL-TRIAL; IRRITABLE-BOWEL-SYNDROME; WHOLE-GRAIN CONSUMPTION; BODY-WEIGHT REDUCTION; LOW GLYCEMIC INDEX; LONG-TERM INTAKE; DIETARY FIBER; COLORECTAL-CANCER,"Introduction: fiber definition includes all those carbohydrates which are not digested nor absorbed in the upper gastrointestinal tract allowing them to reach the colon with no previous processing. Traditionally fiber has been classified according to their solubility into soluble and insoluble and different physiological properties have been defined for each type. The physiologic role of the fiber intake has been studied in diabetes, dyslipidemia or obesity. Fiber intake has also demonstrated to be beneficial in the prevention of many neoplastic diseases like colorectal cancer. It's also known that fiber plays an important role in the faecal excretion of nitrogen. Aim: to evaluate the current evidence that fiber intake plays in the management and prevention of several different diseases, being able to determine, if possible, the most recommended fiber type for each clinical condition. Methods: a non-systematic review by searching the Medline and Pubmed was made and studies which met the inclusion criteria were identified and selected for analysis. Results: different fiber types can be useful for the treatment of several gastrointestinal diseases like constipation, diarrhea, irritable bowel syndrome, ulcerative colitis remission or short bowel syndrome. Patients diagnosed with diabetes, obesity, hyperlipidemia, hypertension and other cardiometabolic diseases can get a clinical improvement with soluble fiber intake. Dietary fiber has demonstrated to play a role in the prevention of colorrectal cancer and other neoplastic diseases. Patients with hepatic encephalopathy or chronic kidney disease will also benefit from fermentable fiber intake. Discussion: fiber plays an important role in the prevention and treatment of many clinical conditions. However further investigations are needed to establish specific fiber intake recommendations.","[Sanchez Almaraz, Rosalia; Martin Fuentes, Maria; Palma Milla, Samara; Lopez Plaza, Bricia; Bermejo Lopez, Laura M.; Gomez Candela, Carmen] Univ Autonoma Madrid, Hosp Univ La Paz IdiPAZ, Inst Invest Biomed, Hosp Univ La Paz,Unidad Nutr Clin & Dietet, E-28049 Madrid, Spain",Hospital Universitario La Paz; Autonomous University of Madrid,"Candela, CG (corresponding author), Univ Autonoma Madrid, Inst Invest Biomed IdiPAZ, Hosp Univ La Paz, Unidad Nutr Clin & Dietet, Paseo Castellana 261, Madrid 28046, Spain.",cgcandela@salud.madrid.org,"Bermejo López, Laura M/HKF-3325-2023; Bermejo, Laura M/N-7810-2019; Bermejo, Laura M/G-8050-2011","Bermejo López, Laura M/0000-0001-6826-0181; Bermejo, Laura M/0000-0001-6826-0181; Bermejo, Laura M/0000-0001-6826-0181",,,,,103,18,20,0,44,"ARAN EDICIONES, S L",MADRID,"C/ CASTELLO, 128, 1O, MADRID, 28006, SPAIN",0212-1611,1699-5198,,NUTR HOSP,Nutr. Hosp.,JUN,2015,31,6,,,,,2372,2383,,10.3305/nh.2015.31.6.9023,http://dx.doi.org/10.3305/nh.2015.31.6.9023,,,12,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,CK0KV,26040341,,,,2024-06-04,WOS:000355895000005,View Full Record in Web of Science
J,"LEDERLE, FA",,,,"LEDERLE, FA",,,EPIDEMIOLOGY OF CONSTIPATION IN ELDERLY PATIENTS - DRUG UTILIZATION AND COST-CONTAINMENT STRATEGIES,DRUGS & AGING,,,English,Review,,,,,,,DIOCTYL SODIUM SULFOSUCCINATE; DIETARY FIBER; DOUBLE-BLIND; LACTULOSE; STOOL; PLACEBO; SENNA,"Constipation is a common complaint among elderly people, resulting in large amounts of money being spent on laxatives. Strategies for improving patient care while reducing this expenditure include: (a) counselling patients that daily bowel movements and purging are not essential to good health, (b) greater use of nonpharmacological measures such as hydration, exercise and dietary fibre, and (c) considering safety, effectiveness and cost in the selection of a laxative, Generic preparations of psyllium and sorbitol can be recommended in this regard, The widespread use of stool softeners, magnesium hydroxide ('milk of magnesia') and stimulant laxatives is difficult to justify from the available data.",,,"LEDERLE, FA (corresponding author), UNIV MINNESOTA,VET AFFAIRS MED CTR,DEPT MED III0,1 VET DR,MINNEAPOLIS,MN 55417, USA.",,,,,,,,27,25,25,1,4,ADIS INTERNATIONAL LTD,AUCKLAND,"41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND 10, NEW ZEALAND",1170-229X,,,DRUG AGING,Drugs Aging,JUN,1995,6,6,,,,,465,469,,10.2165/00002512-199506060-00006,http://dx.doi.org/10.2165/00002512-199506060-00006,,,5,Geriatrics & Gerontology; Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Geriatrics & Gerontology; Pharmacology & Pharmacy,RA635,7663066,,,,2024-06-04,WOS:A1995RA63500006,View Full Record in Web of Science
J,"Eswaran, S; Muir, J; Chey, WD",,,,"Eswaran, Shanti; Muir, Jane; Chey, William D.",,,Fiber and Functional Gastrointestinal Disorders,AMERICAN JOURNAL OF GASTROENTEROLOGY,,,English,Article,,,,,,,IRRITABLE-BOWEL-SYNDROME; RANDOMIZED CLINICAL-TRIAL; CHRONIC IDIOPATHIC CONSTIPATION; HYDROLYZED GUAR GUM; DIETARY FIBER; COLONIC FERMENTATION; WHEAT BRAN; PRIMARY-CARE; CALCIUM POLYCARBOPHIL; ABDOMINAL SYMPTOMS,"Despite years of advising patients to alter their dietary and supplementary fiber intake, the evidence surrounding the use of fiber for functional bowel disease is limited. This paper outlines the organization of fiber types and highlights the importance of assessing the fermentation characteristics of each fiber type when choosing a suitable strategy for patients. Fiber undergoes partial or total fermentation in the distal small bowel and colon leading to the production of short-chain fatty acids and gas, thereby affecting gastrointestinal function and sensation. When fiber is recommended for functional bowel disease, use of a soluble supplement such as ispaghula/psyllium is best supported by the available evidence. Even when used judiciously, fiber can exacerbate abdominal distension, flatulence, constipation, and diarrhea.","[Eswaran, Shanti; Chey, William D.] Univ Michigan Hlth Syst, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Muir, Jane] Monash Univ, Melbourne, Vic 3004, Australia",University of Michigan System; University of Michigan; Monash University,"Chey, WD (corresponding author), Univ Michigan Hlth Syst, Div Gastroenterol, Taubman Ctr 3912, SPC 5362, Ann Arbor, MI 48109 USA.",wchey@umich.edu,"Chey, William/AAY-7766-2021","Eswaran, Shanti/0000-0002-7142-7496",,,,,129,277,307,5,131,NATURE PUBLISHING GROUP,NEW YORK,"75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA",0002-9270,1572-0241,,AM J GASTROENTEROL,Am. J. Gastroenterol.,MAY,2013,108,5,,,,,718,727,,10.1038/ajg.2013.63,http://dx.doi.org/10.1038/ajg.2013.63,,,10,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,141FE,23545709,,,,2024-06-04,WOS:000318710200009,View Full Record in Web of Science
J,"Black, CJ; Ford, AC",,,,"Black, Christopher J.; Ford, Alexander C.",,,"Chronic idiopathic constipation in adults: epidemiology, pathophysiology, diagnosis and clinical management",MEDICAL JOURNAL OF AUSTRALIA,,,English,Review,,,,,,,IRRITABLE-BOWEL-SYNDROME; SLOW TRANSIT CONSTIPATION; DISTINGUISH FUNCTIONAL CONSTIPATION; RANDOMIZED CONTROLLED-TRIALS; DIGITAL RECTAL EXAMINATION; ROME III CRITERIA; QUALITY-OF-LIFE; COLONIC-TRANSIT; HIGH-RESOLUTION; DYSSYNERGIC DEFECATION,"Chronic idiopathic constipation (CIC) is one of the most common gastrointestinal disorders, with a global prevalence of 14%. It is commoner in women and its prevalence increases with age. There are three subtypes of CIC: dyssynergic defaecation, slow transit constipation and normal transit constipation, which is the most common subtype. Clinical assessment of the patient with constipation requires careful history taking, in order to identify any red flag symptoms that would necessitate further investigation with colonoscopy to exclude colorectal malignancy. Screening for hypercalcaemia, hypothyroidism and coeliac disease with appropriate blood tests should be considered. A digital rectal examination should be performed to assess for evidence of dyssynergic defaecation. If this is suspected, further investigation with high resolution anorectal manometry should be undertaken. Anorectal biofeedback can be offered to patients with dyssynergic defaecation as a means of correcting the associated impairment of pelvic floor, abdominal wall and rectal functioning. Lifestyle modifications, such as increasing dietary fibre, are the first step in managing other causes of CIC. If patients do not respond to these simple changes, then treatment with osmotic and stimulant laxatives should be trialled. Patients not responding to traditional laxatives should be offered treatment with prosecretory agents such as lubiprostone, linaclotide and plecanatide, or the 5-HT4 receptor agonist prucalopride, where available. If there is no response to pharmacological treatment, surgical intervention can be considered, but it is only suitable for a carefully selected subset of patients with proven slow transit constipation.","[Black, Christopher J.; Ford, Alexander C.] Univ Leeds, Leeds Inst Biomed & Clin Sci, Leeds, W Yorkshire, England",University of Leeds,"Ford, AC (corresponding author), Univ Leeds, Leeds Inst Biomed & Clin Sci, Leeds, W Yorkshire, England.",,"Black, Christopher J/ABK-1078-2022; Ford, Alexander/K-5491-2012","Black, Christopher J/0000-0001-5449-3603; Ford, Alexander/0000-0001-6371-4359",,,,,89,95,114,8,34,AUSTRALASIAN MED PUBL CO LTD,PYRMONT,"LEVEL 2, 26-32 PYRMONT BRIDGE RD, PYRMONT, NSW 2009, AUSTRALIA",0025-729X,1326-5377,,MED J AUSTRALIA,Med. J. Aust.,JUL 16,2018,209,2,,,,,86,91,,10.5694/mja18.00241,http://dx.doi.org/10.5694/mja18.00241,,,6,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,GN1DD,29996755,Green Accepted,,,2024-06-04,WOS:000438724200016,View Full Record in Web of Science
J,"GATTUSO, JM; KAMM, MA",,,,"GATTUSO, JM; KAMM, MA",,,THE MANAGEMENT OF CONSTIPATION IN ADULTS,ALIMENTARY PHARMACOLOGY & THERAPEUTICS,,,English,Review,,,,,,,SEVERE IDIOPATHIC CONSTIPATION; SLOW TRANSIT CONSTIPATION; IRRITABLE BOWEL SYNDROME; PHOSPHATE ENEMA; DIETARY FIBER; HIRSCHSPRUNGS-DISEASE; SURGICAL-TREATMENT; MEGACOLON; COLECTOMY; MEGARECTUM,"The successful management of constipation depends on defining the patient's symptoms, excluding secondary causes, and characterizing the abnormality of defecation. Constipation without gut dilatation is found commonly in pregnancy, the elderly, and those with the irritable bowel syndrome. In addition, there is a group of patients that has intractable, severe idiopathic constipation. Some have 'slow transit' and open their bowels every 1-4 weeks. Others have a defecatory disorder with normal colonic transit. Constipation with gut dilatation is seen in Hirschsprung's disease, idiopathic megarectum and megacolon, chronic intestinal pseudo-obstruction and Chagas' disease. Constipation can also result from disturbance to the autonomic outflow of the gastrointestinal tract, and colonic function may be also affected by psychological factors. This review article discusses the presentation, investigation and management of patients with constipation.",,,"GATTUSO, JM (corresponding author), ST MARKS HOSP, MED PHYSIOL UNIT, CITY RD, LONDON EC1V 2PS, ENGLAND.",,,,,,,,101,29,32,0,1,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0269-2813,1365-2036,,ALIMENT PHARM THER,Aliment. Pharmacol. Ther.,OCT,1993,7,5,,,,,487,500,,,,,,14,Gastroenterology & Hepatology; Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Pharmacology & Pharmacy,MD036,8280817,,,,2024-06-04,WOS:A1993MD03600003,View Full Record in Web of Science
J,"Benninga, MA; Vandenplas, Y; Bassil, Z; Sokhn, M; Sayad, A; Semaan, F; Eid, B; Cheriathu, J; Abdallah, A; Ghauhar, S; El Sabea, H; Al Mahmoud, AA; Sathyanarayanan, V; Shalabi, ZA; Rizk, TMG; Fawzi, E; Ammar, TG; Farid, W; Emara, I; Kamalo, M; El Daif, S",,,,"Benninga, Marc A.; Vandenplas, Yvan; Bassil, Ziad; Sokhn, Maroun; Sayad, Alain; Semaan, Firas; Eid, Bassam; Cheriathu, Jenny; Abdallah, Ayman; Ghauhar, Shahid; El Sabea, Hassan; Al Mahmoud, Ahmed Abdulattif; Sathyanarayanan, Varadarajulu; Shalabi, Zuhair Abbas; Rizk, Tamer Mohamed Gaber; Fawzi, Eman; Ammar, Tarek Galal; Farid, Waleed; Emara, Ihab; Kamalo, Mohamad; El Daif, Saleh",,MENA Infant Constipation Study Grp,The Magnesium-Rich Formula for Functional Constipation in Infants: a Randomized Comparator-Controlled Study,PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION,,,English,Article,,,,,,Constipation; Infants; Infant formula; Nutrition therapy; Defecation; Magnesium,GASTROINTESTINAL DISORDERS; CHILDHOOD CONSTIPATION; STOOL CHARACTERISTICS; DEFECATION PATTERNS; DIETARY FIBER; DOUBLE-BLIND; CHILDREN; PREVALENCE; EFFICACY; MILK,"Purpose: To compare the effectiveness of the magnesium (Mg)-enriched formula vs. control formula in constipated infants. Methods: An open-label, interventional, and the comparator-controlled study was conducted to evaluate the effectiveness of the Mg-enriched formula in formula-fed infants <= 6 months old presenting with functional constipation according to modified Rome IV criteria. Infants were randomized 1: 1 to intervention or control formula for 30 days. Parents recorded stool consistency (hard, normal, or watery) and frequency on days 1-7 and 23-29. Physicians recorded patient baseline characteristics and performed the clinical examination at the time of three patient visits (baseline, day 8, and 30). Results: Of the 286 recruited infants, 143 received the Mg-rich formula and 142 received the control formula. After 7 days, significantly more infants had stools with normal consistency with the Mg-rich formula compared to the infants fed with the control formula (81.8% vs. 41.1%; p< 0.001). The number of infants passing one or more stools per day was increased at day 7 in the Mg-rich formula group (86.7% vs. 68.2%; p< 0.001). At days 7 and 29, > 25% of infants responded completely to the Mg-rich formula compared to < 5% of infants fed with the control formula (p< 0.001). Parents of infants in the Mg-rich formula group were very satisfied with the treatment (80.8% vs. 10.2%), with the majority willing to continue treatment after 30 days (97.9% vs. 52.6%; p< 0.001). Conclusion: The Mg-rich formula significantly improved stool consistency and frequency compared to the control formula in constipated infants.","[Benninga, Marc A.] Emma Childrens Hosp, Dept Pediat Gastroenterol, Acad Med Ctr, Amsterdam, Netherlands; [Vandenplas, Yvan; Bassil, Ziad; Sokhn, Maroun; Sayad, Alain; Semaan, Firas; Eid, Bassam; Cheriathu, Jenny; Abdallah, Ayman; Ghauhar, Shahid; El Sabea, Hassan; Al Mahmoud, Ahmed Abdulattif; Sathyanarayanan, Varadarajulu; Shalabi, Zuhair Abbas; Rizk, Tamer Mohamed Gaber; Fawzi, Eman; Ammar, Tarek Galal; Farid, Waleed; Emara, Ihab; Kamalo, Mohamad; El Daif, Saleh; MENA Infant Constipation Study Grp] Vrije Univ Brussel, KidZ Hlth Castle, UZ Brussel, Laarbeeklaan 101, B-1090 Brussels, Belgium",Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Brussel; University Hospital Brussels,"Vandenplas, Y (corresponding author), Vrije Univ Brussel, KidZ Hlth Castle, UZ Brussel, Laarbeeklaan 101, B-1090 Brussels, Belgium.",yvan.vandenplas@uzbrussel.be,,,MENA Nutrition,MENA Nutrition,This work was supported by MENA Nutrition (provided support to all members who attended the preparation meeting for questionnaire development). MENA Nutrition also funded the medical writing and data analysis support.,,37,7,7,0,5,KOREAN SOC PEDIATRIC GASTROENTEROLOGY & NUTRITION,SEOUL,"301 DONGSUNG-DONG 25-I, JONGNO-GU, SEOUL, 301 DONGSUNG, SOUTH KOREA",2234-8646,2234-8840,,PEDIATR GASTROENTERO,Pediatr. Gastroenterol. Hepatol. Nutr.,MAY,2019,22,3,,,,,270,281,,10.5223/pghn.2019.22.3.270,http://dx.doi.org/10.5223/pghn.2019.22.3.270,,,12,Pediatrics,Emerging Sources Citation Index (ESCI),Pediatrics,HX3PK,31110960,"Green Published, hybrid",,,2024-06-04,WOS:000467303900008,View Full Record in Web of Science
J,"Alrefaai, L; Cade, JE; Burley, VJ",,,,"Alrefaai, L.; Cade, J. E.; Burley, V. J.",,,Dietary fibre intake and constipation in the UK Women's Cohort Study,PROCEEDINGS OF THE NUTRITION SOCIETY,,,English,Meeting Abstract,,,,,,,,,"[Alrefaai, L.; Cade, J. E.; Burley, V. J.] Univ Leeds, Sch Food Sci & Nutr, Leeds LS2 9JT, W Yorkshire, England",University of Leeds,,,"Cade, Janet/G-4250-2016","Cade, Janet/0000-0003-3421-0121",,,,,3,3,3,0,6,CAMBRIDGE UNIV PRESS,CAMBRIDGE,"EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND",0029-6651,1475-2719,,P NUTR SOC,Proc. Nutr. Soc.,,2013,72,OCE4,,,,,E287,E287,,10.1017/S0029665113003145,http://dx.doi.org/10.1017/S0029665113003145,,,1,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,298VW,,Bronze,,,2024-06-04,WOS:000330353600109,View Full Record in Web of Science
J,"Im, JH; Choi, JK; Lee, MH; Ahn, YT; Lee, JH; Huh, CS; Kim, GB",,,,"Im, Joong Hyun; Choi, Jae-Kyoung; Lee, Myoung Hee; Ahn, Young-Tae; Lee, Jung-Hee; Huh, Chul-Sung; Kim, Geun-Bae",,,Effect of Functional Yogurt (R&B Rhythm®) on the Improvement of Constipation in Animal Models,KOREAN JOURNAL FOR FOOD SCIENCE OF ANIMAL RESOURCES,,,Korean,Article,,,,,,animal trial; yogurt; R&B Rhythm (R); constipation; improvements in defecation,DIETARY FIBER; GASTROINTESTINAL TRANSIT; LACTULOSE SYRUP; FERMENTED MILK; DOUBLE-BLIND; ADULTS; PROBIOTICS; CHILDHOOD; SYMPTOMS; CHILDREN,"We investigated the improvement in intestinal function and the constipation preventive and remedial effects of the fermented. milk product R&B Rhythm (R) in mice and rats. The results showed that the effects varied significantly among different doses. The digestive tract transfer rate increased dramatically in a dose-dependent manner in both animals. Compared with treating constipation with loperamide alone, treatment with loperamide and the fermented milk R&B Rhythm improved the number of fecal pellets from the animals, suggesting that it is effective for preventing and relieving constipation. Both the quantity of feces and water content of the feces increased significantly at high levels of yogurt feeding. These results suggest that repetitively ingesting fermented milk products could be effective for preventing and treating constipation symptoms.","[Im, Joong Hyun; Choi, Jae-Kyoung; Kim, Geun-Bae] Chung Ang Univ, Dept Anim Sci & Technol, Anseong 456756, South Korea; [Lee, Myoung Hee; Ahn, Young-Tae; Lee, Jung-Hee; Huh, Chul-Sung] Korea Yakult Co Ltd, Res & Business Dev Ctr, Yongin 446901, South Korea",Chung Ang University,"Kim, GB (corresponding author), Chung Ang Univ, Dept Anim Sci & Technol, Anseong 456756, South Korea.",kimgeun@cau.ac.kr,,,,,,,28,2,2,1,19,KOREAN SOC FOOD SCIENCE ANIMAL RESOURCES,SEOUL,"615, COLL ANIMAL BIOSCIENCE & TECHNOLOGY, KONKUK UNIV, SEOUL, 143-701, SOUTH KOREA",1225-8563,,,KOREAN J FOOD SCI AN,Korean J. Food Sci. Anim. Resour.,JUN,2011,31,3,,,,,442,450,,10.5851/kosfa.2011.31.3.442,http://dx.doi.org/10.5851/kosfa.2011.31.3.442,,,9,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,789QO,,Bronze,,,2024-06-04,WOS:000292531600015,View Full Record in Web of Science
J,"Young, GP",,,,"Young, GP",,,Colorectal disorders: A dietary management perspective,ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION,,,English,Article; Proceedings Paper,"Conference on Nouveau Nutrition, Traditional, Contemporary Science","MAR 16-17, 2000","SYDNEY, AUSTRALIA",,,colon; rectum; nutrition; cancer,IRRITABLE-BOWEL-SYNDROME; DIVERTICULAR-DISEASE; CROHNS-DISEASE; COLON CANCER; FIBER; RISK; FERMENTATION; HEMORRHOIDS; BUTYRATE; WEIGHT,"Dietary lifestyle is relevant for prevention and treatment of various colorectal conditions. Colorectal disorders have significant morbidity and mortality in a western-style community, particularly irritable bowel syndrome (IBS), colorectal cancer, haemorrhoids, constipation and diverticular disease. This review addresses how bowel health can be maintained, what foods and dietary lifestyles are associated with risk for disease and what foods are of real value in management. Bowel health is that state where the individual is satisfied with defaecation, the diet does not create undue risk for disease and lumenal contents maintain an intact and functional mucosa. Bowel health depends on a healthy dietary lifestyle, but in particular on an adequate intake of non-digestable dietary polysaccharide. Diet influences biology in part by altering the lumenal environment. Effects such as high butyrate levels, lowered pH, a predominance of 'healthy'over 'unhealthy' bacteria, rapid intestinal transit, high faecal bulk, a non-leaky epithelial barrier, adsorption of dietary carcinogens by fibre, low bile salt concentrations, reduced generation of toxic bile salts or protein derivatives and provision of certain bioactive substances are seen as beneficial. Diet influences future risk for colorectal cancer (vegetables, animal fats, polysaccharides amongst others) and for diverticular disease (fibre). Adequate fibre and resistant starch can improve constipation and anorectal conditions such as fissure and haemorrhoids. The role of diet in managing patients with IBS is complex. Fibre may worsen symptoms in severe cases of IBS, diverticular disease and inflammatory bowel disease. Certain carbohydrates of limited digestibility/absorbability, such as lactose, fructose and sorbitol, can precipitate IBS symptoms. Low fat, high fibre diets may reduce recurrence of colorectal adenomas. Diet has a significant role to play in colorectal disorders.","Flinders Med Ctr, Flinders Ctr Digest Hlth, Bedford Pk, SA 5042, Australia; Flinders Univ S Australia, Bedford Pk, SA 5042, Australia",Flinders Medical Centre; Flinders University South Australia,"Flinders Med Ctr, Flinders Ctr Digest Hlth, Bedford Pk, SA 5042, Australia.",graeme.young@flinders.edu.au,,"Young, Graeme/0000-0001-9458-8383",,,,,48,10,15,2,15,"H E C PRESS, HEALTHY EATING CLUB PTY LTD",MCKINNON,"PO BOX 4121, MCKINNON, VIC 3204, AUSTRALIA",0964-7058,1440-6047,,ASIA PAC J CLIN NUTR,Asia Pac. J. Clin. Nutr.,,2000,9,,,S,,,S76,S82,,10.1046/j.1440-6047.2000.00178.x,http://dx.doi.org/10.1046/j.1440-6047.2000.00178.x,,,7,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Nutrition & Dietetics,384NB,24398283,,,,2024-06-04,WOS:000165950400013,View Full Record in Web of Science
J,"Gonçalves, GVR; Canova, R; Callegari-Jacques, SM; Frandoloso, R; Kreutz, LC; Fornari, F",,,,"Goncalves, Gissele V. R.; Canova, Raissa; Callegari-Jacques, Sidia M.; Frandoloso, Rafael; Kreutz, Luiz C.; Fornari, Fernando",,,"Short-term intestinal effects of water intake in fibre supplementation in healthy, low-habitual fibre consumers: a phase 2 clinical trial",INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION,,,English,Article,,,,,,Bowel habit; dietary fibre; faecal microbiota; healthy subjects; water intake,DIETARY FIBER; DOUBLE-BLIND; WHEAT BRAN; MICROBIOTA; DIVERSITY; CONSTIPATION; CONSUMPTION; BENEFITS,"A randomised clinical trial was conducted on 20 healthy, low-habitual fibre consumers to assess the short-term effects of water intake (2 l/day) on fibre supplementation with wheat bran, pectin, and green banana flour. During the 14-days trial, fibre intake doubled in both fibre (n = 10) and fibre/water (n = 10) interventions (p < 0.001), whereas daily water intake increased from 538 to 1990 ml in the fibre/water group (p < 0.001). Weekly bowel movements increased similarly in both interventions (fibre: 6.8-8.8; fibre/water: 8.6-10; p < 0.01), while faecal weight (71-126 g; p = 0.009) increased in the fibre/water group. This group showed higher counts of faecal Bacteroides and Prevotella, Faecalibacterium prausnitzii, and Bifidobacterium, whereas both interventions decreased the count of Desulfovibrio. Transient abdominal symptoms occurred less frequently in the fibre/water than in the fibre group (3 vs. 9 participants; p = 0.020). In healthy, low-habitual fibre consumers, short-term water intake helps the intestinal adaptation to fibre supplementation.","[Goncalves, Gissele V. R.; Fornari, Fernando] Univ Fed Rio Grande do Sul, Fac Med, Programa Posgrad Ciencias Gastroenterol & Hepatol, Porto Alegre, RS, Brazil; [Canova, Raissa; Frandoloso, Rafael; Kreutz, Luiz C.] Univ Passo Fundo UPF, Fac Agron & Med Vet, Lab Microbiol & Imunol Avancada, Programa Posgrad Bioexperimentacao, Passo Fundo, RS, Brazil; [Callegari-Jacques, Sidia M.] Univ Fed Rio Grande do Sul, Inst Matemat & Estat, Dept Estat, Porto Alegre, RS, Brazil; [Fornari, Fernando] Univ Passo Fundo UPF, Fac Med, Passo Fundo, RS, Brazil",Universidade Federal do Rio Grande do Sul; Universidade de Passo Fundo; Universidade Federal do Rio Grande do Sul; Universidade de Passo Fundo,"Fornari, F (corresponding author), Univ Passo Fundo UPF, Fac Med, Passo Fundo, RS, Brazil.",FernandoFornari@gmail.com,"Canova, Raissa/JDC-1689-2023; Frandoloso, Rafael/D-3774-2013; Kreutz, Luiz C/A-3729-2015","Fornari, Fernando/0000-0003-0899-329X",,,,,41,0,0,1,11,TAYLOR & FRANCIS LTD,ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND",0963-7486,1465-3478,,INT J FOOD SCI NUTR,Int. J. Food Sci. Nutr.,AUG 18,2022,73,6,,,,,841,849,,10.1080/09637486.2022.2079117,http://dx.doi.org/10.1080/09637486.2022.2079117,,MAY 2022,9,Food Science & Technology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Nutrition & Dietetics,4H0SC,35603590,,,,2024-06-04,WOS:000799155400001,View Full Record in Web of Science
J,"ENCK, P; OLAND, K; KALDE, S; LUBKE, HJ",,,,"ENCK, P; OLAND, K; KALDE, S; LUBKE, HJ",,,BUT IT DOES MOVE (EPPUR SI MUOVE) - DIETARY-FIBERS IN CHRONIC CONSTIPATION,GASTROENTEROLOGY,,,English,Meeting Abstract,,,,,,,,,"UNIV HOSP DUSSELDORF,DEPT GASTROENTEROL,DUSSELDORF,GERMANY",Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital,,,"Walega, Piotr/KHZ-0217-2024",,,,,,0,0,0,0,0,W B SAUNDERS CO,PHILADELPHIA,"INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399",0016-5085,,,GASTROENTEROLOGY,Gastroenterology,APR,1994,106,4,,S,,,A493,A493,,,,,,1,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,NH909,,,,,2024-06-04,WOS:A1994NH90901960,View Full Record in Web of Science
J,"Bradley, CS; Kennedy, CM; Turcea, AM; Rao, SSC; Nygaard, IE",,,,"Bradley, Catherine S.; Kennedy, Colleen M.; Turcea, Anne M.; Rao, Satish S. C.; Nygaard, Ingrid E.",,,"Constipation in pregnancy - Prevalence, symptoms, and risk factors",OBSTETRICS AND GYNECOLOGY,,,English,Article; Proceedings Paper,55th Annual Clinical Meeting of the American-College-of-Obstetricians-and-Gynecologists,"MAY 05-09, 2007","San Diego, CA",Amer Coll Obstet & Gynecol,,,IRRITABLE-BOWEL-SYNDROME; QUALITY-OF-LIFE; NORTH-AMERICA; INCONTINENCE; EPIDEMIOLOGY,"OBJECTIVE: To prospectively estimate constipation prevalence and risk factors in pregnancy. METHODS: We enrolled healthy pregnant women in this longitudinal study during the first trimester. At each trimester and 3 months postpartum, participants completed a self-administered bowel symptom questionnaire, physical activity and dietary fiber intake measures, and a prospective 7-day stool diary. Constipation was defined using the Rome II criteria (presence of at least two of the following symptoms for at least one quarter of defecations: straining, lumpy or hard stools, sensation of incomplete evacuation, sensation of anorectal obstruction, manual maneuvers to facilitate defecation, and fewer than three defecations per week). Generalized linear logistic models explored factors associated with constipation during pregnancy. RESULTS: One hundred three women were enrolled with mean ( standard deviation) age of 28 ( 5) years; 54% were nulliparous and 92% white. Constipation prevalence rates were 24% (95% confidence interval [Cl] 16-33%),26% (95% Cl 17-38%), 16% (95% Cl 8-26%), and 24% (95% Cl 13-36%) in the first, second, and third trimesters and 3 months postpartum, respectively. Additionally, irritable bowel syndrome (by Rome 11 criteria) prevalence rates were 19% (95% Cl 12-28%),13% (95% Cl 6-23%),13% (95% Cl 6-23%) and 5% (95% Cl 1-13%) in the first, second, and third trimesters and 3 months postpartum, respectively. In multivariable longitudinal analysis, iron supplements (OR 3.5, 95% Cl 1.04-12.10) and past constipation treatment (OR 3.58, 95% Cl 1.50-8.57) were associated with constipation during pregnancy. CONCLUSION: Constipation measured using the Rome 11 criteria affects up to one fourth of women throughout pregnancy and at 3 months postpartum.","Univ Iowa, Carver Coll Med, Dept Obstet & Gynecol, Iowa City, IA USA; Univ Iowa, Carver Coll Med, Dept Med, Iowa City, IA USA; Univ Utah, Dept Obstet & Gynecol, Salt Lake City, UT USA",University of Iowa; University of Iowa; Utah System of Higher Education; University of Utah,"Bradley, CS (corresponding author), Univ Iowa Hosp & Clin, Dept Obstet & Gynecol, 200 Hawkins Dr, Iowa City, IA 52242 USA.",catherine-bradley@uiowa.edu,,"Bradley, Catherine/0000-0002-7402-5476; Stockdale, Colleen/0000-0003-0074-3261","NICHD NIH HHS [K24 HD42469, K23 HD047654] Funding Source: Medline",NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)),,,26,90,100,1,25,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0029-7844,,,OBSTET GYNECOL,Obstet. Gynecol.,DEC,2007,110,6,,,,,1351,1357,,10.1097/01.AOG.0000295723.94624.b1,http://dx.doi.org/10.1097/01.AOG.0000295723.94624.b1,,,7,Obstetrics & Gynecology,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Obstetrics & Gynecology,236LH,18055731,,,,2024-06-04,WOS:000251304000021,View Full Record in Web of Science
J,"CORAZZIARI, E",,,,"CORAZZIARI, E",,,THE CHERNOBYL SYNDROME - ACUTE TRANSIENT CONSTIPATION DUE TO LOW DIETARY FIBER INTAKE,ITALIAN JOURNAL OF GASTROENTEROLOGY,,,English,Letter,,,,,,,,,,,"CORAZZIARI, E (corresponding author), UNIV ROME LA SAPIENZA,MED CLIN 2,CATTEDRA GASTROENTEROL 1,I-00185 ROME,ITALY.",,,,,,,,0,2,2,0,1,PACINI EDITORE,OSPEDALETTO PISA,"VIA DELLA GHERARDESCA-ZONA INDUSTRIALE, 56014 OSPEDALETTO PISA, ITALY",0392-0623,,,ITAL J GASTROENTEROL,Ital. J. Gastroenterol.,OCT,1986,18,5,,,,,285,285,,,,,,1,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,E5179,,,,,2024-06-04,WOS:A1986E517900017,View Full Record in Web of Science
J,"Rushdi, TA; Pichard, C; Khater, YH",,,,"Rushdi, TA; Pichard, C; Khater, YH",,,Control of diarrhea by fiber-enriched diet in ICU patients on enteral nutrition: a prospective randomized controlled trial,CLINICAL NUTRITION,,,English,Article,,,,,,dietary fibers; soluble; nutrition; enteral; diarrhea,GUAR-GUM HYDROLYSATE; CALCIUM-ABSORPTION; SOLUBLE FIBER; ILL PATIENTS; INGESTION; INULIN; RATS,"Background & aims: Enteral fiber-free diets alter intestinal transit and produce diarrhea or constipation. This prospective double blind, controlled study evaluates the use of guar gum, a soluble fiber and a candidate prebiotic in enteral feeds, to prevent diarrhea and potential health benefits in intensive care unit patients. Twenty patients on enteral nutrition with persistent diarrhea were randomized to receive a new enteral feed either enriched with 2% soluble guar gum (study group, n = 10) or fiber-free (control group, n = 10) for 4 successive days. Results: The number of liquid stools in response to a soluble fiber-enriched diet was 2.0+0.9 (first day) vs. 1.0+/-0.7 (fourth day) (P<0.01), and in the control group 1.2+/-0.7 (first day) vs. 2.1+/-0.8 (fourth day) (P<0.05). In the fiber-enriched feed group, plasma glucose and cholesterol levels at termination of the study, respectively, reached 126+/-81 and 164+/-71 mg dl(-1), as compared to 333+/-108 and 378+/-26 mg dl(-1) on Day first (P<0.01). In the control group, these values on the fourth day were, respectively, 267+/-94 and 263+/-79 vs. 247+/-115 and 315+/-78 on Day first (P>0.05). Conclusions: Guar gum-enriched enteral nutrition was related to a decrease of diarrheal. episodes in ICU patients with preexisting diarrhea; and to a trend for Lower plasma glucose and cholesterol Levels. (C) 2004 Published by Elsevier Ltd.","Cairo Univ, New Kasr El Aini Teaching Hosp, Fac Med, Cairo, Egypt; Univ Hosp Geneva, Geneva, Switzerland",Egyptian Knowledge Bank (EKB); Cairo University; University of Geneva,"19 Tehran St, Dokki Guiza 12311, Egypt.",yhkhater@mednet2.camed.eun.eg,,,,,,,25,76,93,0,8,CHURCHILL LIVINGSTONE,EDINBURGH,"JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND",0261-5614,1532-1983,,CLIN NUTR,Clin. Nutr.,DEC,2004,23,6,,,,,1344,1352,,10.1016/j.clnu.2004.04.008,http://dx.doi.org/10.1016/j.clnu.2004.04.008,,,9,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,879NJ,15556256,,,,2024-06-04,WOS:000225724200010,View Full Record in Web of Science
J,"Brenner, DM; Harris, LA; Chang, CH; Waldman, SA; Poppers, DM; Kassebaum-Ladewski, A; Sayuk, GS",,,,"Brenner, Darren M.; Harris, Lucinda A.; Chang, Christopher H.; Waldman, Scott A.; Poppers, David M.; Kassebaum-Ladewski, Amy; Sayuk, Gregory S.",,,Real-World Treatment Strategies to Improve Outcomes in Patients With Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation,AMERICAN JOURNAL OF GASTROENTEROLOGY,,,English,Article,,,,,,,CLINICAL-PRACTICE GUIDELINE; PLACEBO-CONTROLLED TRIAL; OVER-THE-COUNTER; DIETARY FIBER; CARE SEEKING; DOUBLE-BLIND; MANAGEMENT; GASTROENTEROLOGISTS; EFFICACY; PSYLLIUM,"Chronic idiopathic constipation and irritable bowel syndrome with constipation are complex, overlapping conditions. Although multiple guidelines have informed healthcare providers on appropriate treatment options for patients with chronic idiopathic constipation and irritable bowel syndrome with constipation, little direction is offered on treatment selection. First-line treatment options usually include fiber and over-the-counter osmotic laxatives; however, these are insufficient for many individuals. When these options fail, prescription secretagogues (plecanatide, linaclotide, lubiprostone, and tenapanor [pending commercial availability]), or serotonergic agents (prucalopride and tegaserod) are generally preferred. Individuals experiencing concurrent abdominal pain and/or bloating may experience greater overall improvements from prescription therapies because these agents have been proven to reduce concurrent abdominal and bowel symptoms. Should initial prescription treatments fail, retrying past treatment options (if not adequately trialed initially), combining agents from alternative classes, or use of adjunctive therapies may be considered. Given the broad spectrum of available agents, therapy should be tailored by mutual decision-making between the patient and practitioner. Overall, patients need to be actively monitored and managed to maximize clinical outcomes.","[Brenner, Darren M.] Northwestern Univ, Div Gastroenterol & Hepatol, Feinberg Sch Med, Chicago, IL 60611 USA; [Harris, Lucinda A.] Mayo Clin, Scottsdale, AZ USA; [Chang, Christopher H.] Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA; [Waldman, Scott A.] Thomas Jefferson Univ, Dept Pharmacol & Expt Therapeut, Philadelphia, PA 19107 USA; [Waldman, Scott A.] Thomas Jefferson Univ, Dept Med, Philadelphia, PA 19107 USA; [Poppers, David M.] NYU Langone Hlth, Dept Med, Div Gastroenterol, New York, NY USA; [Poppers, David M.] NYU Langone Hlth, Ctr Adv Therapeut & Innovat, New York, NY USA; [Kassebaum-Ladewski, Amy] Northwestern Mem Hosp, Digest Hlth Ctr, Chicago, IL 60611 USA; [Sayuk, Gregory S.] Washington Univ, Sch Med, Div Gastroenterol, St Louis, MO 63110 USA; [Sayuk, Gregory S.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Sayuk, Gregory S.] John Cochran Vet Affairs Med Ctr, Gastroenterol Sect, St Louis, MO USA",Northwestern University; Feinberg School of Medicine; Mayo Clinic; Mayo Clinic Phoenix; University of New Mexico; Jefferson University; Jefferson University; NYU Langone Medical Center; NYU Langone Medical Center; Northwestern Memorial Hospital; Washington University (WUSTL); Washington University (WUSTL),"Brenner, DM (corresponding author), Northwestern Univ, Div Gastroenterol & Hepatol, Feinberg Sch Med, Chicago, IL 60611 USA.",darren-brenner@northwestern.edu,,,"Salix Pharmaceuticals, Inc.","Salix Pharmaceuticals, Inc.(Takeda Pharmaceutical Company Ltd)","`This supplement was funded by Salix Pharmaceuticals, Inc.",,53,7,7,0,8,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0002-9270,1572-0241,,AM J GASTROENTEROL,Am. J. Gastroenterol.,APR,2022,117,4S,,4,,,S21,S26,,10.14309/ajg.0000000000001709,http://dx.doi.org/10.14309/ajg.0000000000001709,,,6,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,0D5GY,35354772,Bronze,,,2024-06-04,WOS:000776024800005,View Full Record in Web of Science
J,"ODES, HS; MADAR, Z",,,,"ODES, HS; MADAR, Z",,,"A DOUBLE-BLIND TRIAL OF A CELANDIN, ALOE-VERA AND PSYLLIUM LAXATIVE PREPARATION IN ADULT PATIENTS WITH CONSTIPATION",DIGESTION,,,English,Article,,,,,,CELANDIN; ALOE-VERA; PSYLLIUM; LAXATIVE; CONSTIPATION,IRRITABLE BOWEL SYNDROME; DIETARY FIBER; WHEAT BRAN; FIBROLAX; TRANSIT; STOOL,"The aim of this study was to evaluate the effect of a novel laxative preparation, composed of celandin, aloevera and psyllium in patients with chronic constipation. Thirty-five men and women were randomized to receive capsules containing celandin-aloevera-psyllium, or placebo, in a double-blind trial lasting 28 days. Symptoms in the last 2 weeks of the treatment period were compared to those in the 14-day pre-trial basal period. In the celandin, aloevera and psyllium group, bowel movements became more frequent, the stools were softer and laxative dependence was reduced. In the placebo group, all these parameters were unchanged. Abdominal pain was not reduced in either group. The results of this study show that the preparation is an effective laxative in the treatment of constipation.","BEN GURION UNIV NEGEV,IL-84105 BEER SHEVA,ISRAEL; HEBREW UNIV JERUSALEM,FAC AGR,SCH NUTR,JERUSALEM,ISRAEL",Ben Gurion University; Hebrew University of Jerusalem,"ODES, HS (corresponding author), SOROKA MED CTR,INST GASTROENTEROL,INTESTINAL DIS UNIT,POB 151,IL-84101 BEER SHEVA,ISRAEL.",,,,,,,,21,50,55,1,11,KARGER,BASEL,"ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND",0012-2823,,,DIGESTION,Digestion,JUN,1991,49,2,,,,,65,71,,10.1159/000200705,http://dx.doi.org/10.1159/000200705,,,7,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,GM298,1800188,,,,2024-06-04,WOS:A1991GM29800001,View Full Record in Web of Science
J,"CELIK, AF; TOMLIN, J; READ, NW",,,,"CELIK, AF; TOMLIN, J; READ, NW",,,THE EFFECT OF ORAL VANCOMYCIN ON CHRONIC IDIOPATHIC CONSTIPATION,ALIMENTARY PHARMACOLOGY & THERAPEUTICS,,,English,Article,,,,,,,CHAIN FATTY-ACIDS; COLONIC TRANSIT; PEPTIDE-YY; CARBOHYDRATE; MOTILITY; FLORA,"Background: A case study reporting the efficacy of oral vancomycin in a patient with chronic idiopathic constipation prompted this prospective trial of oral. vancomycin in eight female patients (aged 21-61 years) with severe constipation resistant to the action of dietary fibre. Methods: The trial was divided into two consecutive 14-day periods. During the first period, each patient was given ispaghula, 3.5 g twice a day, and during the subsequent period they took 250 mg vancomycin t.d.s. per os, as well as the fibre supplement, During both periods they collected stools and recorded daily bowel symptoms (stool frequency, straining, stool consistency, subjective stool volume) in a diary. At the end of each period whole gut transit time and the breath hydrogen response to a standard meal, giving oro-caecal transit time, were measured along with gastrointestinal symptoms which were assessed on visual analogue scales. Results: Vancomycin caused a significant improvement in stool frequency, consistency, ease of defecation and the amount of stool patients felt they produced (all P < 0.05), but objective measures of daily stool weight and whole gut or oro-caecal transit time were not significantly different, Basal breath hydrogen levels were higher after vancomycin treatment in seven out of eight patients, One patient experienced a complete remission of symptoms when she took vancomycin and remains in remission after 14 months. This patient showed no elevation in basal breath hydrogen level. Conclusion: Although this study does not support the use of vancomycin for most patients with constipation, the results suggest that modification of the intraluminal nora may be of value in the treatment of the occasional case of idiopathic constipation.","NO GEN HOSP, GASTROINTESTINAL MOTIL UNIT, SHEFFIELD S5 7AU, S YORKSHIRE, ENGLAND",Northern General Hospital,,,"celik, Ahmet/IAP-5710-2023",,,,,,27,19,21,0,1,WILEY-BLACKWELL,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0269-2813,1365-2036,,ALIMENT PHARM THER,Aliment. Pharmacol. Ther.,FEB,1995,9,1,,,,,63,68,,,,,,6,Gastroenterology & Hepatology; Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Pharmacology & Pharmacy,QH645,7766746,,,,2024-06-04,WOS:A1995QH64500010,View Full Record in Web of Science
J,"Soltanian, N; Janghorbani, M",,,,"Soltanian, Noureddin; Janghorbani, Mohsen",,,"A randomized trial of the effects of flaxseed to manage constipation, weight, glycemia, and lipids in constipated patients with type 2 diabetes",NUTRITION & METABOLISM,,,English,Article,,,,,,Flaxseed; Efficacy; Constipation; Diabetes; Lipid; Glucose,DIETARY-FIBERS; CHOLESTEROL; SUPPLEMENTATION; METAANALYSIS; REDUCTION; SYMPTOMS; MELLITUS; FAT,"Background: To compare the effects of baked flaxseed versus those who received a placebo on constipation symptom scores, weight, glycemic and lipid control in constipated patients with type 2 diabetes (T2D). Methods: In a single-blinded, randomized controlled trial, 53 constipated patients with T2D with body mass index (BMI) 20.5-48.9 kg/m(2) received either 10 g of flaxseed pre-mixed in cookies twice per day or placebo cookies for 12 weeks. The constipation symptom scores, BMI, fasting plasma glucose (FPG), glycosylated hemoglobin (HbA1c), and lipid profile were determined at the beginning and end of 4, 8, and 12-week period. Constipation was evaluated with a stool diary (ROME III). Results: After the 12-week intervention, constipation symptom scores (2.46), weight (-3.8 kg), BMI (-1.5 kg/m(2)), FPG (-26.7 mg/dl), cholesterol (-37.3 mg/dl), triglycerides (-10.4 mg/dl), LDLC (-21.0 mg/dl), HDLC (4.7 mg/dl), cholesterol/HDLC ratio (-1.4 mg/dl) significantly decreased from baseline in the flaxseed group (all P-values < 0.05). The differences of absolute change of constipation symptom scores (2.46 vs. 0.41), weight (-3.8 vs. 0.0 kg), BMI (-1.5 vs .-0.1 kg/m(2) ), FPG (-26.7 vs.-1.9 mg/dl), > HbA1c (-0.8 vs. 1.0%), cholesterol (-37.3 vs. -10.4 mg/dl), LDLC (-21.0 vs. -4.3 mg/dl), and HDLC (4.7 vs. -4.4 mg/dl) between the flaxseed and placebo groups were statistically significant (all P-values < 0.05). The compliance was good and no adverse effects were observed. Conclusion: In constipated patients with T2D, flaxseed cookies used as a snack may be a useful tool for decreasing constipation symptoms, weight, glycemic and lipid levels.","[Soltanian, Noureddin; Janghorbani, Mohsen] Isfahan Univ Med Sci, Isfahan Endocrine & Metab Res Ctr, Esfahan, Iran",Isfahan University Medical Science,"Janghorbani, M (corresponding author), Isfahan Univ Med Sci, Isfahan Endocrine & Metab Res Ctr, Esfahan, Iran.",janghorbani@hlth.mui.ac.ir,"Janghorbani, Mohsen/A-2330-2010",,Isfahan University of Medical Sciences ethics committee [IR.MUI.REC.1396.3.464],Isfahan University of Medical Sciences ethics committee,"Kamvar Co., Isfahan, Iran provided flaxseed and placebo cookies and the study was supported by the Isfahan University of Medical Sciences ethics committee (approval no. IR.MUI.REC.1396.3.464).",,31,30,34,0,24,BMC,LONDON,"CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND",,1743-7075,,NUTR METAB,Nutr. Metab.,MAY 9,2018,15,,,,,,,,36,10.1186/s12986-018-0273-z,http://dx.doi.org/10.1186/s12986-018-0273-z,,,9,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,GH0MQ,29760761,"gold, Green Published",,,2024-06-04,WOS:000433097100001,View Full Record in Web of Science
C,"Sugitha, IM; Suparthana, IP; Samanta, PN","Gunam, IBW","Mahat, NA; AbWahab, R; Huyop, FZ; Keyon, ASA; Attan, NB; Chandren, S",,"Sugitha, I. Made; Suparthana, I. Putu; Samanta, Pinky Natalia","Gunam, IBW",,Fish and Seaweed (Eucheuma cotonii) Meatball for Reducing Constipation Effect,PROCEEDINGS OF THE 2ND INTERNATIONAL CONFERENCE ON BIOSCIENCES AND MEDICAL ENGINEERING (ICBME2019): TOWARDS INNOVATIVE RESEARCH AND CROSS-DISCIPLINARY COLLABORATIONS,AIP Conference Proceedings,,English,Proceedings Paper,2nd International Conference on Biosciences and Medical Engineering (ICBME) - Towards Innovative Research and Cross-Disciplinary Collaborations,"APR 11-12, 2019","Bali, INDONESIA","Pulau Pinang,Selangor,Melaka & Kedah of Malaysia,Yayasan FELDA,ADABI,ACS, Malaysia Chapter,Univ Teknologi Malaysia,Udayana Univ",,,,"Functions of dietary fiber include increasing stool mass and reducing intestinal transit time which can be used to prevent constipation. This study aims to determine the ability of mixed catfish meatballs and sea grass flour to reduce constipation through two stages. The first stage was to get the best meatball quality (ratio of tapioca composition and seaweed flour manipulated at 100%: 0%; 90%: 10%; 80%: 20%; 70%: 30%) followed by the second stage which was in vivo testing for rat with doses of meatballs manipulated at 2 g, 4 g, 6 g and 8 g. Research data were analyzed with one-way variance analysis with a confidence level of 95%. Composition of tapioca and seaweed flour at 70%: 30% was the best fish meatball formula resulting in these data: 64.90% moisture content, 2.00% ash, 5.76% fat, 13.91% protein, 13.43% carbohydrate, total food fiber 5.94%) with sensory value: appearance 8.67 (smooth, not hollow, and bright surface), flavor 7.00 (less fish flavor), taste 6.67 (less meat fish taste), texture 9 (solid, compact, springy). The in vivo test showed that administration of 2 g / 200 g weigh body of rat was able to produce rat feces back to normal condition (47.93% moisture content) with a frequency of defecation 21 times per day (no constipation any more).","[Sugitha, I. Made; Suparthana, I. Putu] Udayana Univ, Fac Agr Technol, Food Sci & Technol Study Program, Badung, Bali, Indonesia; [Samanta, Pinky Natalia] Udayana Univ, Postgrad Program, Badung, Bali, Indonesia",Universitas Udayana; Universitas Udayana,"Sugitha, IM (corresponding author), Udayana Univ, Fac Agr Technol, Food Sci & Technol Study Program, Badung, Bali, Indonesia.",madesgt@yahoo.com; ipsuparthana@gmail.com; pinkynataliasamanta@yahoo.co.id,"Samanta, Pinky Natalia/JQV-5374-2023; Suparthana, I Putu/AAF-9940-2021","Suparthana, I Putu/0000-0001-9383-1441",,,,,11,0,0,0,7,AMER INST PHYSICS,MELVILLE,"2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA",0094-243X,,978-0-7354-1900-1,AIP CONF PROC,,,2019,2155,,,,,,,,20057,10.1063/1.5125561,http://dx.doi.org/10.1063/1.5125561,,,7,"Biology; Engineering, Biomedical",Conference Proceedings Citation Index - Science (CPCI-S),Life Sciences & Biomedicine - Other Topics; Engineering,BO6PR,,Bronze,,,2024-06-04,WOS:000521596900057,View Full Record in Web of Science
J,"Blackmer, AB; Farrington, EA",,,,"Blackmer, Allison Beck; Farrington, Elizabeth Anne",,,Constipation in the Pediatric Patient: An Overview and Pharmacologic Considerations,JOURNAL OF PEDIATRIC HEALTH CARE,,,English,Editorial Material,,,,,,Constipation; pediatrics; pharmacology,CHILDHOOD CONSTIPATION; DIETARY FIBER; MANAGEMENT,,"[Blackmer, Allison Beck] Univ Michigan, Coll Pharm, Ann Arbor, MI 48109 USA; [Farrington, Elizabeth Anne] New Hanover Reg Med Ctr, Wilmington, NC USA",University of Michigan System; University of Michigan,"Blackmer, AB (corresponding author), Univ Michigan, Coll Pharm, 428 Church St, Ann Arbor, MI 48109 USA.",ablackm@umich.edu,,,,,,,17,3,5,0,2,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",0891-5245,1532-656X,,J PEDIATR HEALTH CAR,J. Pediatr. Health Care,NOV-DEC,2010,24,6,,,,,385,399,,10.1016/j.pedhc.2010.09.003,http://dx.doi.org/10.1016/j.pedhc.2010.09.003,,,15,Health Policy & Services; Nursing; Pediatrics,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Health Care Sciences & Services; Nursing; Pediatrics,797QA,20971414,,,,2024-06-04,WOS:000293141200008,View Full Record in Web of Science
J,"Russo, L; Andreozzi, P; Zito, FP; Vozzella, L; Savino, IG; Sarnelli, G; Cuomo, R",,,,"Russo, Luigi; Andreozzi, Paolo; Zito, Francesco P.; Vozzella, Letizia; Savino, Ivana G.; Sarnelli, Giovanni; Cuomo, Rosario",,,"Partially Hydrolyzed Guar Gum in the Treatment of Irritable Bowel Syndrome with Constipation: Effects of Gender, Age, and Body Mass Index",SAUDI JOURNAL OF GASTROENTEROLOGY,,,English,Article,,,,,,Constipation; guar gum; irritable bowel syndrome,QUALITY-OF-LIFE; INTESTINAL MICROFLORA; COLONIC TRANSIT; DIETARY FIBER; OPEN TRIAL; SYMPTOMS; METAANALYSIS; MULTICENTER; ADULTS; YOUNG,"Background/Aims: Partially hydrolyzed guar gum (PHGG) relieves symptoms in constipation-predominant irritable bowel syndrome (IBS) and may have prebiotic properties. However, the correlation between the effectiveness of PHGG and patient characteristics has not been examined. We aimed to investigate the effect of PHGG in symptom relief on constipation-predominant IBS according to gender, age, and body mass index (BMI). Patients and Methods: Sixty-eight patients with IBS entered a 2-week run-in period, followed by a 4-week study period with PHGG. Patients completed a daily questionnaire to assess the presence of abdominal pain/discomfort, swelling, and the sensation of incomplete evacuation. The number of evacuations/day, the daily need for laxatives/enemas and stool consistency-form were also evaluated. All patients also underwent a colonic transit time (CTT) evaluation. Results: PHGG administration was associated with a significant improvement in symptom scores, use of laxatives/enemas, stool form/consistency and CTT. At the end of the study period and compared with baseline, the number of evacuations improved in women, patients aged >= 45 years and those with BMI >= 25 (P < 0.05 for all comparisons); abdominal bloating improved in males (P < 0.05), patients < 45 years (P < 0.01) and those with BMI < 25 (P < 0.05). A decrease in the number of perceived incomplete evacuations/day was reported in patients with a BMI >= 25 (P < 0.05). Reductions in laxative/enema use were recorded in females (P < 0.05), patients < 45 years (P < 0.01), and patients with BMI < 25 (P < 0.05). Conclusions: Gender, age, and BMI seem to influence the effect of PHGG supplementation in constipated IBS patients. Further studies are needed to clarify the interaction of such parameters with a fiber-enriched diet.","[Russo, Luigi; Andreozzi, Paolo; Zito, Francesco P.; Vozzella, Letizia; Savino, Ivana G.; Sarnelli, Giovanni; Cuomo, Rosario] Univ Naples Federico II, Gastroenterol Unit, Dept Clin Med & Surg, I-80131 Naples, Italy",University of Naples Federico II,"Cuomo, R (corresponding author), Univ Naples Federico II, Dept Clin Med & Surg, Via Sergio Pansini 5, I-80131 Naples, Italy.",rcuomo@unina.it,"Cuomo, Rosario/C-3446-2011; Sarnelli, Giovanni/AAB-4050-2019; zito, francesco/AAS-3197-2021; Andreozzi, Paolo/M-4404-2015","Cuomo, Rosario/0000-0003-0768-8381; Sarnelli, Giovanni/0000-0002-1467-1134; Andreozzi, Paolo/0000-0002-4604-0126; Zito, Francesco Paolo/0000-0002-1084-3373",,,,,30,20,20,0,11,MEDKNOW PUBLICATIONS & MEDIA PVT LTD,MUMBAI,"B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA",1319-3767,1998-4049,,SAUDI J GASTROENTERO,Saudi J. Gastroenterol.,MAR-APR,2015,21,2,,,,,104,110,,10.4103/1319-3767.153835,http://dx.doi.org/10.4103/1319-3767.153835,,,7,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,CE7IX,25843197,"Green Published, gold",,,2024-06-04,WOS:000352013700009,View Full Record in Web of Science
J,"Di Rosa, C; Altomare, A; Terrigno, V; Carbone, F; Tack, J; Cicala, M; Guarino, MPL",,,,"Di Rosa, Claudia; Altomare, Annamaria; Terrigno, Vittoria; Carbone, Florencia; Tack, Jan; Cicala, Michele; Guarino, Michele Pier Luca",,,Constipation-Predominant Irritable Bowel Syndrome (IBS-C): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms,NUTRIENTS,,,English,Review,,,,,,irritable bowel syndrome and diet; irritable bowel syndrome with constipation; IBS and diet; IBS and microbiota,MUCOSA-ASSOCIATED MICROBIOTA; CHAIN FATTY-ACIDS; GUT MICROBIOTA; DIETARY FIBER; COLONIC MICROBIOTA; CONTROLLED TRIAL; FERMENTED MILK; CLINICAL-TRIAL; DOUBLE-BLIND; BIFIDOBACTERIUM,"Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal disorder characterized by abdominal pain associated with defecation or a change in bowel habits. The pathogenesis of IBS is not completely clear, but it is known to be multifactorial and complex. Endogenous and exogenous factors such as abnormal GI motility, low-grade inflammation, increased epithelial permeability and visceral hypersensitivity, but diet and psychosocial aspects are also recognized as important actors. Furthermore, the interaction between diet and gut microbiota has gained interest as a potential contributor to the pathophysiology of IBS. To date, there is no specific diet for IBS with constipation (IBS-C); however, many studies show that fiber intake, especially soluble fiber such as inulin, could have a positive effect on symptoms. This review aims to evaluate the effects of some nutritional components such as fibers but also functional foods, prebiotics, probiotics and symbiotics on symptoms and microbiota in IBS-C subjects.","[Di Rosa, Claudia; Terrigno, Vittoria] Univ Campus Biomed Roma, Dept Sci & Technol Humans & Environm, Res Unit Food Sci & Human Nutr, Via Alvaro del Portillo 21, I-00128 Rome, Italy; [Altomare, Annamaria; Cicala, Michele; Guarino, Michele Pier Luca] Univ Campus Biomed Roma, Res Unit Gastroenterol, Via Alvaro del Portillo 21, I-00128 Rome, Italy; [Altomare, Annamaria; Cicala, Michele; Guarino, Michele Pier Luca] Fdn Policlin Univ Campus Biomed, Operat Res Unit Gastroenterol, Via Alvaro del Portillo 200, I-00128 Rome, Italy; [Carbone, Florencia; Tack, Jan] Univ Hosp Leuven, Dept Gastroenterol & Hepatol, B-3000 Leuven, Belgium",University Campus Bio-Medico - Rome Italy; University Campus Bio-Medico - Rome Italy; Fondazione Policlinico Universitario Campus Bio-Medico; KU Leuven; University Hospital Leuven,"Altomare, A (corresponding author), Univ Campus Biomed Roma, Res Unit Gastroenterol, Via Alvaro del Portillo 21, I-00128 Rome, Italy.;Altomare, A (corresponding author), Fdn Policlin Univ Campus Biomed, Operat Res Unit Gastroenterol, Via Alvaro del Portillo 200, I-00128 Rome, Italy.",c.dirosa@unicampus.it; a.altomare@unicampus.it,"Guarino, Michele Pier Luca/IQT-3994-2023","Guarino, Michele Pier Luca/0000-0003-3325-9425; Di Rosa, Claudia/0000-0002-5465-5657; Terrigno, Vittoria/0009-0006-1093-1628; Altomare, Annamaria/0000-0001-8630-7836; Tack, Jan/0000-0002-3206-6704; Carbone, Florencia/0000-0003-1790-7904",,,,,105,9,9,5,23,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,APR,2023,15,7,,,,,,,1647,10.3390/nu15071647,http://dx.doi.org/10.3390/nu15071647,,,17,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,D6OY1,37049488,"gold, Green Published",,,2024-06-04,WOS:000969915600001,View Full Record in Web of Science
J,"Zuckerman, MJ",,,,"Zuckerman, MJ",,,The role of fiber in the treatment of irritable bowel syndrome - Therapeutic recommendations,JOURNAL OF CLINICAL GASTROENTEROLOGY,,,English,Review,,,,,,irritable bowel syndrome; fiber; bulking agents; bran; diet,HYDROLYZED GUAR GUM; COARSE WHEAT BRAN; INTESTINAL GAS; DIETARY FIBER; UNITED-STATES; ISPAGHULA; PREVALENCE; SYMPTOMS; PATTERNS; PLACEBO,"Irritable bowel syndrome is a common clinical condition that often presents a therapeutic challenge. There is no standard therapy and a multilevel approach is recommended. A high-fiber diet is often one of these components. Many investigators have studied the effectiveness of either fiber supplementation or bulking agents in patients with irritable bowel syndrome. The purpose of this review is to summarize the current literature on the use of fiber in irritable bowel syndrome and to provide some specific recommendations. Systematic reviews of these trials have generally not found fiber to be significantly more effective than placebo at relieving global irritable bowel syndrome symptoms. There may be differences between results obtained with soluble and insoluble fiber. Adverse effects of fiber use may include abdominal discomfort and bloating. Although dietary fiber or bulking agents do not appear to be useful as sole treatment of irritable bowel syndrome, they may have a limited role in empiric therapy depending upon the patient's symptom complex, especially if constipation is the most significant symptom. The basic principles for using fiber therapy are to start with a low dose and increase slowly, to give an adequate trial and to evaluate the results early and periodically.","Texas Tech Univ, Hlth Sci Ctr, Div Gastroenterol, El Paso, TX 79905 USA",Texas Tech University System; Texas Tech University,"Texas Tech Univ, Hlth Sci Ctr, Div Gastroenterol, 4800 Alberta Ave, El Paso, TX 79905 USA.",Marc.Zuckerman@ttuhsc.edu,,,,,,,65,33,37,1,18,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0192-0790,1539-2031,,J CLIN GASTROENTEROL,J. Clin. Gastroenterol.,FEB,2006,40,2,,,,,104,108,,10.1097/01.mcg.0000196405.15110.bb,http://dx.doi.org/10.1097/01.mcg.0000196405.15110.bb,,,5,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,007JX,16394869,,,,2024-06-04,WOS:000234966200004,View Full Record in Web of Science
J,"Kindleysides, S; Kuhn-Sherlock, B; Yip, W; Poppitt, SD",,,,"Kindleysides, Sophie; Kuhn-Sherlock, Barbara; Yip, Wilson; Poppitt, Sally D.",,,Encapsulated green kiwifruit extract: a randomised controlled trial investigating alleviation of constipation in otherwise healthy adults,ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION,,,English,Article,,,,,,actinidin; bowel function; constipation; defecation frequency; kiwifruit extract,IRRITABLE-BOWEL-SYNDROME; PROMOTES LAXATION; DIETARY FIBER; ACTINIDIN; DIGESTION; PROTEINS; DISEASES; SCALE,"Objectives: Previous clinical trials have shown bowel function is improved through consumption of whole kiwifruit (Actinidia deliciosa). This study investigated whether encapsulated kiwifruit extract (1 g/day) could alleviate constipation in otherwise healthy adults. Methods: Forty adults with confirmed constipation entered this trial, of which 32 completed with >80% compliance. Two capsules were self-administered morning and evening for 2 periods, each of 3 weeks duration, separated by a 3+ week washout in a double blind, randomised, placebo controlled crossover. Inclusion criteria included constipation with <= 3 bowel movements (BM) per week. Daily records of defecation frequency and stool characteristics were obtained throughout treatment, as well as a measurement of gastrointestinal symptoms rating scale (GSRS) and quality of life (QoL) before and after each intervention arm. Results: There was no difference in total BM over 3 weeks (p>0.05) or mean BM during each of weeks 1, 2 and 3 (p>0.05) between the kiwifruit extract and placebo when assessed from a faecal diary. There was also no detectable difference in defecation related scores of BM ease of defecation, volume, consistency or BM type assessed using Bristol stool chart scores. Nor was there a significant change in GSRS or QoL between pre and post treatment measures, when compared to placebo (p>0.05). Conclusions: This trial showed that improvement in bowel function or comfort was not achieved through supplementation with 1 g/day freeze dried kiwifruit extract. Efficacy from prior kiwifruit powder and whole fruit trials indicate that investigating higher doses of encapsulated kiwifruit extract may be worthwhile.","[Kindleysides, Sophie; Yip, Wilson; Poppitt, Sally D.] Univ Auckland, Human Nutr Unit, Auckland 1, New Zealand; [Poppitt, Sally D.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Poppitt, Sally D.] Univ Auckland, Dept Med, Auckland 1, New Zealand",University of Auckland; University of Auckland; University of Auckland,"Poppitt, SD (corresponding author), Univ Auckland, Human Nutr Unit, 18 Carrick Pl, Auckland 1, New Zealand.",s.poppitt@auckland.ac.nz,,,"NZ Extracts Ltd, New Zealand","NZ Extracts Ltd, New Zealand","NZ Extracts Ltd, New Zealand provided the funding and the extracts for this trial. We would like to thank the participants in this trial. We also thank Dr Robin McGregor for his assistance during the study.",,25,7,8,0,19,"H E C PRESS, HEALTHY EATING CLUB PTY LTD",MCKINNON,"PO BOX 4121, MCKINNON, VIC 3204, AUSTRALIA",0964-7058,,,ASIA PAC J CLIN NUTR,Asia Pac. J. Clin. Nutr.,SEP,2015,24,3,,,,,421,429,,10.6133/apjcn.2015.24.3.15,http://dx.doi.org/10.6133/apjcn.2015.24.3.15,,,9,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,CT6JP,26420182,,,,2024-06-04,WOS:000362919600008,View Full Record in Web of Science
J,"You, JS; Park, JY; Chang, KJ",,,,"You, Jeong-Soon; Park, Ji-Yeon; Chang, Kyung-Ja",,,"A case-control study on the dietary taurine intake, nutrient status and life stress of functional constipation patients in Korean male college students",JOURNAL OF BIOMEDICAL SCIENCE,,,English,Article,,,,,,,FIBER INTAKE; FOOD; WOMEN; EPIDEMIOLOGY,"Background: Constipation is a common gastrointestinal symptom in Korea as well as in Western countries. This study was performed to investigate the dietary taurine intake, nutrient status, and life stress of functional constipation (FC) patients in Korean male college students. Methods: Research data were collected in 2008 and a total of 104 male students (52 with FC patients and 52 healthy controls without FC) were included. FC patients were defined by the codes for the Rome. Modular Questionnaire and healthy controls without FC were matched for age, height, weight and BMI. A self-administered life stress score and 3-day recall method were used to assess life stress level and dietary intake, respectively. Results: The averages of age, height, weight, body fat percentage and body mass index (BMI) of male students were 23.4 years, 174.1 cm, 71.9 kg, 19.0 % and 23.7 kg/m(2), respectively. Average intake of dietary taurine was 126.8 mg/day in FC patients and 105.1 mg/day in control group. The average intake of total calorie (p<0.05), plant protein (p<0.01), plant fat (p<0.001), carbohydrate (p<0.05), plant calcium (p< 0.05) of FC patients were significantly higher compared to control group. The average total life stress score (p<0.01), economy problem score (p< 0.05), future problem score (p<0.05) and value problem score (p<0.05) of FC patients were significantly higher compared to control group. Conclusions: These results may suggest that FC patients show a higher life stress score and intake of some nutrient such as total calorie, plant protein, plant fat, carbohydrate and plant calcium in Korean male college students. Therefore, a further large-scale study is needed about correlation between life stress and nutrients intake including dietary taurine.","[You, Jeong-Soon; Park, Ji-Yeon; Chang, Kyung-Ja] Inha Univ, Dept Food & Nutr, Inchon 402753, South Korea",Inha University,"Chang, KJ (corresponding author), Inha Univ, Dept Food & Nutr, Inchon 402753, South Korea.",kjchang@inha.ac.kr,,,INHA UNIVERSITY,INHA UNIVERSITY,This work was supported by INHA UNIVERSITY Research Grant.,,30,7,7,0,12,BMC,LONDON,"CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND",1021-7770,1423-0127,,J BIOMED SCI,J. Biomed. Sci.,AUG 24,2010,17,,,1,,,,,S41,10.1186/1423-0127-17-S1-S41,http://dx.doi.org/10.1186/1423-0127-17-S1-S41,,,5,"Cell Biology; Medicine, Research & Experimental",Science Citation Index Expanded (SCI-EXPANDED),Cell Biology; Research & Experimental Medicine,736OY,20804618,"Green Published, gold",,,2024-06-04,WOS:000288505200041,View Full Record in Web of Science
J,"Schiller, LR",,,,"Schiller, LR",,,Review Article: The therapy of constipation,ALIMENTARY PHARMACOLOGY & THERAPEUTICS,,,English,Review,,,,,,,DIOCTYL SODIUM SULFOSUCCINATE; OUTLET OBSTRUCTION CONSTIPATION; CHRONIC IDIOPATHIC CONSTIPATION; ACUTE COLONIC PSEUDOOBSTRUCTION; SLOW-TRANSIT CONSTIPATION; IRRITABLE-BOWEL-SYNDROME; OPEN-LABEL TRIAL; POLYETHYLENE-GLYCOL; MELANOSIS-COLI; DIETARY FIBER,"Constipation is a common symptom that may be idiopathic or due to various identifiable disease processes. Laxatives are agents that add bulk to intestinal contents, that retain water within the bowel lumen by virtue of osmotic effects, or that stimulate intestinal secretion or motility, thereby increasing the frequency and ease of defecation. Drugs which improve constipation by stimulating gastrointestinal motility by direct actions on the enteric nervous system are under development. Other modalities used to treat constipation include biofeedback and surgery. Laxatives and lavage solutions are also used for colon preparation and evacuation of the bowels after toxic ingestions.","Baylor Univ, Med Ctr, Dallas, TX 75246 USA",Baylor University Medical Center; Baylor University,"Baylor Univ, Med Ctr, 3500 Gaston Ave, Dallas, TX 75246 USA.",LRSMD@aol.com,,,,,,,133,87,199,0,16,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0269-2813,1365-2036,,ALIMENT PHARM THER,Aliment. Pharmacol. Ther.,JUN,2001,15,6,,,,,749,763,,10.1046/j.1365-2036.2001.00982.x,http://dx.doi.org/10.1046/j.1365-2036.2001.00982.x,,,15,Gastroenterology & Hepatology; Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Pharmacology & Pharmacy,433FB,11380313,,,,2024-06-04,WOS:000168747600002,View Full Record in Web of Science
J,"Steele, SR; Mullenix, PS; Martin, MJ; Place, RJ",,,,"Steele, SR; Mullenix, PS; Martin, MJ; Place, RJ",,,The effect of combat rations on bowel habits in a combat environment,AMERICAN JOURNAL OF SURGERY,,,English,Article; Proceedings Paper,91st Annual Meeting of the North-Pacific-Surgical-Association,"NOV 12-13, 2004","Tacoma, WA",N Pacific Surg Assoc,,fiber; combat rations; constipation; Operation Enduring Freedom,CHRONIC GASTROINTESTINAL SYMPTOMS; GULF-WAR; DIETARY FIBER; VETERANS; DISEASE,"Background: Combat rations have long been suspected to affect the bowel habits of deployed soldiers by causing significant constipation. This may create morbidity and result in decreased troop readiness. In a uniform population of deployed combat soldiers, we sought to determine the effect of combat rations on changes in bowel habits. Methods: Over a 4-month period from December 2001 through March 2002, 118 soldiers were followed prospectively using a bowel habit diary. Soldiers were evaluated by age, race, gender, past medical history, ration intake, and medications including fiber use. Subjects were then screened for changes in diarrhea and constipation. We performed an analysis to determine predictors for changing habits. Results: There were 108 males and 10 females. Mean follow-up was 42.6 +/- 23.1 days. Groups were comparable in demographics, time in the combat zone, and fluid/fiber intake (P = not significant [NS]). No change in habits were found in 58%, 19% had an increase in constipation, 13% had an increase in diarrhea, and 10% had increase in both diarrhea and constipation, while 8% had improvements. Conclusion: Combat rations and environment have variable effects on bowel habits, with no loss in workdays. Although 64% of subjects experienced either no change or improvement, and 36% had worsened symptoms, this appears unrelated to ration or fiber intake. (c) 2005 Excerpta Medica Inc. All rights reserved.","Madigan Army Med Ctr, Dept Surg, Gen Surg Serv, Tacoma, WA 98431 USA; Landstuhl Reg Med Ctr, Landstuhl, Germany",Madigan Army Medical Center; Landstuhl Regional Medical Center,"Steele, SR (corresponding author), 3434 Garfield Ave, Minneapolis, MN 55408 USA.",docsteele@hotmail.com,"Martin, Matthew/B-2676-2014","Martin, Matthew/0000-0002-9169-9069; Billingham, Richard/0000-0002-8680-5103",,,,,13,2,3,1,2,EXCERPTA MEDICA INC,NEW YORK,"650 AVENUE OF THE AMERICAS, NEW YORK, NY 10011 USA",0002-9610,,,AM J SURG,Am. J. Surg.,MAY,2005,189,5,,,,,518,521,,10.1016/j.amjsurg.2005.01.026,http://dx.doi.org/10.1016/j.amjsurg.2005.01.026,,,4,Surgery,Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED),Surgery,922MV,15862488,,,,2024-06-04,WOS:000228842900005,View Full Record in Web of Science
J,"Curtin, F; Morabia, A; Bernstein, M; Dederding, JP",,,,"Curtin, F; Morabia, A; Bernstein, M; Dederding, JP",,,A population survey of bowel habits in urban Swiss men,EUROPEAN JOURNAL OF PUBLIC HEALTH,,,English,Article,,,,,,bowel habits; constipation; prevalence; urban population; sociodemographic factors,UNITED-STATES; COLORECTAL-CANCER; DIETARY FIBER; CONSTIPATION; PREVALENCE; EPIDEMIOLOGY; DISORDERS; QUESTIONNAIRE; INCONTINENCE; FREQUENCY,"The aim of this study was to determine the prevalence of symptoms related to constipation in urban Swiss men and to identify associated sociodemographic factors and health habits. A sample of 773 men aged between 35 and 74 years randomly selected from the Geneva population answered a questionnaire on bowel habits during a personal interview in a mobile epidemiological unit. 'Constipation' was reported by more than 6% of subjects, difficulties in stool evacuation by approximately 5% and less than three stools per week by approximately 2%. These symptoms appeared less prevalent in subjects with post-baccalaureate education (the excess prevalence of self-reported constipation, difficulty in stool evacuation and frequent daily defecation was greater than 5%). Smokers were more likely to have a frequency of 3-7 stools per week and were less affected by frequent daily defecation. Self-reported constipation was more prevalent in subjects with a higher dietary fibre intake. No statistically significant effects of age, nationality, dietary fat or physical activity were observed. These results are consistent with national surveys in US populations. Factors related to socioeconomic status or education may be a cause of constipation in men, but they still need to be elucidated.","Univ Hosp Geneva, Div Clin Epidemiol, CH-1211 Geneva 14, Switzerland",University of Geneva,"Curtin, F (corresponding author), Univ Hosp Geneva, Div Clin Epidemiol, 24 Rue Micheli Crest, CH-1211 Geneva 14, Switzerland.",,,,,,,,43,8,9,0,1,OXFORD UNIV PRESS,OXFORD,"GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND",1101-1262,,,EUR J PUBLIC HEALTH,Eur. J. Public Health,JUN,1998,8,2,,,,,170,175,,10.1093/eurpub/8.2.170,http://dx.doi.org/10.1093/eurpub/8.2.170,,,6,"Public, Environmental & Occupational Health",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),"Public, Environmental & Occupational Health",ZZ792,,Bronze,,,2024-06-04,WOS:000074767600015,View Full Record in Web of Science
J,"Bouhnik, Y; Coffin, B; Rambaud, JC",,,,"Bouhnik, Y; Coffin, B; Rambaud, JC",,,Adult's chronic idiopathic constipation. Pathogenesis and therapies,ANNALES DE GASTROENTEROLOGIE ET D HEPATOLOGIE,,,French,Article,,,,,,biofeedback; alimentary fibers; bacterial flora; laxatives; pathogenesis,IRRITABLE-BOWEL-SYNDROME; SEGMENTAL COLONIC TRANSIT; DIETARY FIBER; DEFECATION; LACTULOSE; EXPULSION; MOTILITY,"The purpose of this review article is to outline the main factors underlying adult chronic idiopathic constipation (colic substrates, bacterial fermentation, colic peristalsis., perineal anomalies and psychological factors) as well as readily available exploratory methods (colic transit time, anorectal manometry). A review is made of the various therapeutic possibilities, taking into account hygienico-dietetic and pharmacological treatments (mono- or multifactorial laxatives), biofeedback and psychological approaches. The main cases seen in clinical practice are described.",,,"HOP ST LAZARE, 107 BIS, RUE FAUBOURG ST DENIS, F-75475 PARIS 10, FRANCE.",,,,,,,,40,1,1,0,0,EXPANSION SCI FRANCAISE,PARIS,"31 BLVD LATOUR MAUBOURG, 75007 PARIS, FRANCE",0066-2070,,,ANN GASTROENT HEPATO,Ann. Gastroenterol. Hepatol.,MAR-APR,1996,32,2,,,,,89,96,,,,,,8,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,UQ652,8737504,,,,2024-06-04,WOS:A1996UQ65200010,View Full Record in Web of Science
J,"Mall, JPG; Löfvendahl, L; Lindqvist, CM; Brummer, RJ; Keita, ÅV; Schoultz, I",,,,"Mall, J. P. Ganda; Lofvendahl, L.; Lindqvist, C. M.; Brummer, R. J.; Keita, A. V.; Schoultz, I.",,,Differential effects of dietary fibres on colonic barrier function in elderly individuals with gastrointestinal symptoms,SCIENTIFIC REPORTS,,,English,Article,,,,,,,INTESTINAL BARRIER; OLDER-ADULTS; BETA-GLUCAN; MACROMOLECULAR PERMEABILITY; HOSPITAL ANXIETY; MAST-CELLS; PREVALENCE; DEPRESSION; HEALTH; TRANSLOCATION,"Gastrointestinal problems are common in elderly and often associated with psychological distress and increased levels of corticotrophin-releasing hormone, a hormone known to cause mast cell (MC) degranulation and perturbed intestinal barrier function. We investigated if dietary fibres (non-digestible polysaccharides [NPS]) could attenuate MC-induced colonic hyperpermeability in elderly with gastrointestinal (GI) symptoms. Colonic biopsies from elderly with diarrhoea and/or constipation (n = 18) and healthy controls (n = 19) were mounted in Ussing chambers and pre-stimulated with a yeast-derived beta (beta)-glucan (0.5 mg/ml) or wheat-derived arabinoxylan (0.1 mg/ml) before the addition of the MC-degranulator Compound (C) 48/80 (10 ng/ml). Permeability markers were compared pre and post exposure to C48/80 in both groups and revealed higher baseline permeability in elderly with GI symptoms. beta-glucan significantly attenuated C48/80-induced hyperpermeability in elderly with GI symptoms but not in healthy controls. Arabinoxylan reduced MC-induced paracellular and transcellular hyperpermeability across the colonic mucosa of healthy controls, but did only attenuate transcellular permeability in elderly with GI symptoms. Our novel findings indicate that NPS affect the intestinal barrier differently depending on the presence of GI symptoms and could be important in the treatment of moderate constipation and/or diarrhoea in elderly.","[Mall, J. P. Ganda; Lofvendahl, L.; Lindqvist, C. M.; Brummer, R. J.; Schoultz, I.] Orebro Univ, Sch Med Sci, Fac Med & Hlth, Nutr Gut Brain Interact Res Ctr, Orebro, Sweden; [Mall, J. P. Ganda; Schoultz, I.] Orebro Univ, Sch Med Sci, Fac Med & Hlth, Nutr & Phys Act Res Ctr, Orebro, Sweden; [Keita, A. V.] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden",Orebro University; Orebro University; Linkoping University,"Schoultz, I (corresponding author), Orebro Univ, Sch Med Sci, Fac Med & Hlth, Nutr Gut Brain Interact Res Ctr, Orebro, Sweden.;Schoultz, I (corresponding author), Orebro Univ, Sch Med Sci, Fac Med & Hlth, Nutr & Phys Act Res Ctr, Orebro, Sweden.",ida.schoultz@oru.se,"Lindqvist, Carl Mårten/B-9963-2018; Brummer, Robert JM/A-3137-2009","Lindqvist, Carl Mårten/0000-0003-3887-9519; Keita, Asa/0000-0002-6820-0215; Schoultz, Ida/0000-0002-8391-1576",,,,,58,24,24,3,25,NATURE PORTFOLIO,BERLIN,"HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY",2045-2322,,,SCI REP-UK,Sci Rep,SEP 7,2018,8,,,,,,,,13404,10.1038/s41598-018-31492-5,http://dx.doi.org/10.1038/s41598-018-31492-5,,,11,Multidisciplinary Sciences,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Science & Technology - Other Topics,GS9FR,30194322,"Green Published, gold",,,2024-06-04,WOS:000444022800008,View Full Record in Web of Science
J,"Soares, ACF; Lederman, TM; Fagundes-Neto, U; de Morais, MB",,,,"Soares, ACF; Lederman, TM; Fagundes-Neto, U; de Morais, MB",,,Breath hydrogen test after a bean meal demonstrates delayed oro-cecal transit time in children with chronic constipation,JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION,,,English,Article,,,,,,oro-cecal transit time; hydrogen breath test; constipation; colonic transit time; children,SEGMENTAL COLONIC TRANSIT; GASTROINTESTINAL TRANSIT; DIETARY FIBER; DISORDERS; DEFECATION; MOTILITY; HEALTHY,"Objective: To evaluate oro-cecal transit time in children with chronic constipation. Methods: 34 patients with chronic functional constipation age 3 to 13 years and 15 controls without constipation. Oro-cecal transit time was evaluated using the hydrogen breath test after ingestion of lactulose and after a standard meal of cooked beans. Total and segmental colonic transit times were measured with radiopaque markers. Results: Of 34 patients with chronic constipation 61.8% had increased total colonic transit time (> 62 hours). Oro-cecal transit time measured with lactulose as substrate was similar (p = 0.727) in constipated patients with increased colonic transit time (63.8 +/- 16.3 minutes), in constipated patients with normal colonic transit time (66.9 +/- 22.9 minutes), and in controls (65.3 +/- 15.5 minutes). Using a test meal of beans, the hydrogen breath test showed that oro-cecal transit time of constipated patients with increased total colon transit time was higher (252.4 +/- 23.2 minutes) than oro-cecal transit time of constipated patients with normal colonic transit time (227.7 +/- 39.6 minutes) or controls (205.3 +/- 23.3 minutes) (p <.05). Conclusion: Hydrogen excretion in breath after a bean test meal showed delayed oro-cecal transit time in children with chronic constipation with abnormal total colonic transit time.","Univ Fed Sao Paulo, Pediat Gastroenterol Div, Sao Paulo, Brazil; Univ Fed Sao Paulo, Dept Med Imaging, Sao Paulo, Brazil",Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP),"Rua Araiosis,75, BR-05442010 Sao Paulo, Brazil.",mbmorais@osite.com.br,"MORAIS, MAURO B/I-7995-2014","Fontenele Soares, Ana Cristina/0000-0002-2246-9913; Batista de Morais, Mauro/0000-0003-4014-5549",,,,,26,18,21,0,6,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0277-2116,1536-4801,,J PEDIATR GASTR NUTR,J. Pediatr. Gastroenterol. Nutr.,AUG,2005,41,2,,,,,221,224,,10.1097/01.mpg.0000167499.40074.d7,http://dx.doi.org/10.1097/01.mpg.0000167499.40074.d7,,,4,Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,950VA,16056103,,,,2024-06-04,WOS:000230885000012,View Full Record in Web of Science
J,"Mafra, D; Baptista, BA; Sahiun, E; Abuznada, S; Leal, VO; Borges, NA",,,,"Mafra, D.; Baptista, B. A.; Sahiun, E.; Abuznada, S.; Leal, V. O.; Borges, N. A.",,,May polydextrose potentially improve gut health in patients with chronic kidney disease?,CLINICAL NUTRITION ESPEN,,,English,Review,,,,,,Polydextrose; Dietary fibre; Constipation; Chronic kidney disease,GLUCAGON-LIKE PEPTIDE-1; SOLUBLE MAIZE FIBER; CHAIN FATTY-ACIDS; DIETARY FIBER; ENERGY-INTAKE; CONSTIPATION; SUPPLEMENTATION; FERMENTATION; PREBIOTICS; MICROBIOTA,"Polydextrose (PDX) is a non-digestible oligosaccharide with a complex structure widely used in the food industry. Studies have shown many health benefits of polydextrose, including modulating the gut microbiota, improving the immune system, altering the lipid profile, and stimulating bowel function. Patients with chronic kidney disease (CKD) report gut dysbiosis, inflammation, dyslipidemia and con-stipation. These are major concerns that affect the quality of life. In this context, PDX can promote beneficial effects. However, little is known about PDX in CKD. This review discusses the possible bene-ficial effects of PDX on gut health for patients with CKD, particularly its impact on constipation.(c) 2022 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.","[Mafra, D.] Fed Univ Rio De Janeiro UFRJ, Grad Program Biol Sci Physiol, Rio De Janeiro, RJ, Brazil; [Mafra, D.; Baptista, B. A.] Fed Fluminense Univ UFF, Grad Program Med Sci, Niteroi, RJ, Brazil; [Mafra, D.] Fed Fluminense Univ UFF, Grad Program Nutr Sci, Niteroi, RJ, Brazil; [Sahiun, E.; Borges, N. A.] State Univ Rio De Janeiro UERJ, Inst Nutr, Rio De Janeiro, RJ, Brazil; [Abuznada, S.] Univ Glasgow, Glasgow, Scotland; [Abuznada, S.] Saudi Elect Univ, Coll Hlth Sci, Publ Hlth Dept, Jeddah, Saudi Arabia; [Leal, V. O.] Rio De Janeiro State Univ UERJ, Pedro Ernesto Univ Hosp, Nutr Div, Rio De Janeiro, Brazil; [Mafra, D.] Clin Res Unit, Rua Marques Parana,303, Niteroi, RJ, Brazil",Universidade Federal Fluminense; Universidade Federal Fluminense; Universidade do Estado do Rio de Janeiro; University of Glasgow; Saudi Electronic University; Universidade do Estado do Rio de Janeiro,"Mafra, D (corresponding author), Clin Res Unit, Rua Marques Parana,303, Niteroi, RJ, Brazil.",dm@id.uff.br,"Mafra, Denise/D-4923-2015","Mafra, Denise/0000-0001-6752-6056; Baptista, Beatriz/0000-0002-5029-8584",Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ),Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)),"Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) support Denise Mafra's research.",,102,1,2,1,5,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",2405-4577,,,CLIN NUTR ESPEN,Clin. Nutr. ESPEN,OCT,2022,51,,,,,,7,16,,10.1016/j.clnesp.2022.08.025,http://dx.doi.org/10.1016/j.clnesp.2022.08.025,,SEP 2022,10,Nutrition & Dietetics,Emerging Sources Citation Index (ESCI),Nutrition & Dietetics,7V9XA,36184250,,,,2024-06-04,WOS:000913165600002,View Full Record in Web of Science
J,"Staudacher, HM; Kurien, M; Whelan, K",,,,"Staudacher, Heidi M.; Kurien, Matthew; Whelan, Kevin",,,Nutritional implications of dietary interventions for managing gastrointestinal disorders,CURRENT OPINION IN GASTROENTEROLOGY,,,English,Review,,,,,,fiber; FODMAPs; gastrointestinal; gluten; specific carbohydrate diet,LOW-FODMAP DIET; IRRITABLE-BOWEL-SYNDROME; GLUTEN-FREE DIET; CARBOHYDRATE-DIET; CLINICAL-PRACTICE; REDUCES SYMPTOMS; CELIAC-DISEASE; REINTRODUCTION; METAANALYSIS; RESTRICTION,"Purpose of review The aim of this review is to summarize some of the key dietary interventions recommended for common gastrointestinal disorders and to discuss recent evidence regarding their nutritional implications. Recent findings The gluten-free diet has been shown to negatively influence overall diet quality. The gluten-free diet is essential in celiac disease, although it is increasingly used for other perceived health benefits for which an analysis of perceived benefit should be weighed against any nutritional risks. Evidence from short-term controlled trials of a diet low in fermentable oligosaccharides, disaccharides, monosaccharide and polyols in irritable bowel syndrome suggests compromised intake of nutrients such as fiber, iron, and calcium, although findings vary across studies. Meanwhile long-term uncontrolled trials suggest dietary adequacy improves with reintroduction and personalization. Although high-fiber diets may be beneficial in diverticular disease and constipation, it may lead to reductions in energy intake and nutrient absorption in at-risk populations. Summary The role of therapeutic diets in the management of gastrointestinal disorders is increasingly recognized, but there are limited studies investigating their nutritional implications. The judicious use of dietetic expertise should minimize potential nutritional deficits, however further prospective trials are needed to identify the individuals and nutrients most at risk.","[Staudacher, Heidi M.] Univ Queensland, Fac Med, Brisbane, Qld, Australia; [Kurien, Matthew] Univ Sheffield, Dept Infect Immun & Cardiovasc Dis, Acad Unit Gastroenterol, Sheffield, S Yorkshire, England; [Whelan, Kevin] Kings Coll London, Fac Life Sci & Med, Dept Nutr Sci, London, England",University of Queensland; University of Sheffield; University of London; King's College London,"Whelan, K (corresponding author), Kings Coll London, Dept Nutr Sci, 150 Stamford St, London SE1 9NH, England.",kevin.whelan@kcl.ac.uk,"Whelan, Kevin/ABD-5154-2021; Staudacher, Heidi/AAC-8193-2022; Whelan, Kevin/ABD-5350-2021","Staudacher, Heidi/0000-0001-6704-2131; Whelan, Kevin/0000-0001-5414-2950",Medical Research Council; National Institute of Health Research; Kenneth Rainin Foundation; Crohn's and Colitis UK; Danone; Nestle; Clasado Biosciences; Almond Board of California,Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Research(National Institutes of Health Research (NIHR)); Kenneth Rainin Foundation; Crohn's and Colitis UK; Danone(Danone Nutricia); Nestle(Nestle SA); Clasado Biosciences; Almond Board of California,"Research funding has been received from government agencies including Medical Research Council (K.W.), National Institute of Health Research (K.W., H.M.S.), charities including Kenneth Rainin Foundation (K.W.), Crohn's and Colitis UK (K.W.) as well as from industrial sources including Danone (K.W.), Nestle (K.W.), Clasado Biosciences (K.W.), Almond Board of California (K. W.).",,39,13,14,0,22,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0267-1379,1531-7056,,CURR OPIN GASTROEN,Curr. Opin. Gastroenterol.,MAR,2018,34,2,,,,,105,111,,10.1097/MOG.0000000000000421,http://dx.doi.org/10.1097/MOG.0000000000000421,,,7,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,GC3AV,29278531,"Green Submitted, Green Accepted",,,2024-06-04,WOS:000429657000008,View Full Record in Web of Science
J,"Nagahara, H; Nagahara, M; Ohmi, N; Takahashi, Y; Takara, T",,,,"Nagahara, Hodai; Nagahara, Meisen; Ohmi, Nobuo; Takahashi, Yuta; Takara, Tsuyoshi",,,"Bowel movement improvement by Mulukhiyah (Corchorus olitorius)-containing food (AOTSUBU®) consumption: A randomized, double-blind, placebo-controlled, parallel- group comparison trial",FUNCTIONAL FOODS IN HEALTH AND DISEASE,,,English,Article,,,,,,Mulukhiya; enterobacterial flora; dietary fiber; stool frequency; organic acid levels,DIETARY FIBER INTAKE; RISK; CONSTIPATION; STROKE,"Background: Mulukhiya (Corchorus olitorius) richly contains dietary fiber and is suggested to improve bowel movement. Objective: This study aimed to investigate the effects of mulukhiya-derived dietary fiber (MDF) on the intestinal environment in healthy Japanese adult subjects. Methods: This randomized, double-blinded, placebo-controlled study enrolled 22 healthy Japanese adult subjects who typically defecate three to five times per week and do not consume enough dietary fiber. All subjects were randomly allocated into the MDF group (4 men and 7 women; 45.1 +/- 11.4 years) or the placebo group (3 men and 8 women; 41.6 +/- 9.5 years) by using a computerized random number generator. Each subject was administered with assigned 30 tablets (active [77-mg dietary fiber] or placebo) daily for two weeks. We asked the subjects to record their defecation condition in a bowel movement diary from 1 week before the start of test food consumption to the day before two weeks after the start of the test-food consumption (three weeks in total). Then, we evaluated the items in the bowel movement diary such as the occupancy rate of enteric, organic acids in feces, and subjective symptoms related to constipation. Results: At one and two weeks after the start of the test-food consumption, the MDF group exhibited a significant increase in stool days, stool frequency, and stool volume compared with the placebo group (P <0.05). Regarding the occupancy rate of enteric bacteria, Prevotella (P = 0.025) and Clostridium cluster IV (P = 0.045) were significantly increased in the MDF group compared with those in the placebo group at 2 weeks after the start of the test-food consumption. As for organic acids in feces, n-butyric acid was significantly higher in the MDF group than in the placebo group at 2 weeks after the start of the test-food consumption (P = 0.037). Furthermore, no safety concerns were noted. Conclusions: The consumption of MDF-containing food for 2 weeks resulted in the increase of stool frequency, stool volume, useful enteric bacteria, and organic acids in feces in healthy Japanese adult subjects.","[Nagahara, Hodai; Nagahara, Meisen; Ohmi, Nobuo] AOTSUBU CO LTD, Kita Ku, 3406-1 Arinochoarino, Kobe, Hyogo 6511312, Japan; [Takahashi, Yuta] ORTHOMEDICO Inc, Bunkyo Ku, 2F Sumitomo Fudosan Korakuen Bldg, Tokyo 1120002, Japan; [Takara, Tsuyoshi] Med Corp Seishinkai, Shinagawa Ku, 9F Taisei Bldg,2-3-2 Higashi Gotanda, Tokyo 1410022, Japan",,"Nagahara, H (corresponding author), AOTSUBU CO LTD, Kita Ku, 3406-1 Arinochoarino, Kobe, Hyogo 6511312, Japan.",,,,"AOTSUBU CO., LTD","AOTSUBU CO., LTD","AOTSUBU CO., LTD",,33,0,0,0,3,FUNCTIONAL FOOD CENTER INC,DALLAS,"5050 QUORUM DR, STE 700, NO 338, DALLAS, TX 75254 USA",2160-3855,,,FUNCT FOODS HEALTH D,Funct. Foods Health Dis.,MAY,2020,10,5,,,,,210,227,,10.31989/ffhd.v10i5.686,http://dx.doi.org/10.31989/ffhd.v10i5.686,,,18,Food Science & Technology,Emerging Sources Citation Index (ESCI),Food Science & Technology,MA0LM,,gold,,,2024-06-04,WOS:000541608400002,View Full Record in Web of Science
J,"Griffenberg, L; Morris, M; Atkinson, N; Levenback, C",,,,"Griffenberg, L; Morris, M; Atkinson, N; Levenback, C",,,The effect of dietary fiber on bowel function following radical hysterectomy: A randomized trial,GYNECOLOGIC ONCOLOGY,,,English,Article,,,,,,,WOMEN; COLON,"Objective. To assess the effect of high-fiber dietary instruction in relieving chronic constipation, a known and accepted complication of radical hysterectomy (RH). Methods. Thirty-five women with a diagnosis of cervical cancer who were scheduled for RH were randomized into groups that followed either a high-fiber diet plan or their usual diet. Data were gathered using a validated subjective bowel function questionnaire (SBFQ); a typical day's intake form and food frequency tool; and a diary used to record food, medication, bowel, and exercise information. Patients were evaluated at 1, 4, and 7 months after surgery. Results. Postoperatively, the dietary fiber intake was significantly higher for the treatment (T) group (22.9 g) than the control (C) group (12.4 g) (P = 0.007). With regard to intergroup comparisons, there were few differences at the first follow-up. By the second visit, the T group reported taking medications to achieve regularity less often (P = 0.0269), straining less often (P = 0.0210), having pain with bowel movement (BM) less often (P = 0.0116), and having crampy abdominal pain less often (P = 0.123) than the C group. Four significant positive changes occurred in the T group, whereas only one occurred in the C group. With regard to intragroup comparison, the significant changes in bowel function in the T group were generally positive, whereas all of the C group's significant changes were negative. According to summary questions on the SBFQ, the T group reported a significant change in the frequency of BM (P = 0.0096); however, the C group reported no significant changes. Analysis of bowel function records showed clearer differences. The T group took less time to defecate (P < 0.001) but had more BMs accompanied by gas (P < 0.001). The C group had significantly more BMs with cramps (P < 0.001), straining (P < 0.001), and retention (P < 0.001) and significantly more BMs, which were hard (P < 0.001). Two C patients dropped out of the study because of severe bowel dysfunction despite maximum medication. Conclusion. Dietary management seems to be an inexpensive effective therapeutic intervention for addressing bowel dysfunction associated with RH. (C) 1997 Academic Press.","UNIV TEXAS,MD ANDERSON CANCER CTR,DEPT GYNECOL ONCOL,HOUSTON,TX 77030; UNIV TEXAS,MD ANDERSON CANCER CTR,DEPT CLIN NUTR,HOUSTON,TX 77030; UNIV TEXAS,MD ANDERSON CANCER CTR,DEPT BIOMATH,HOUSTON,TX 77030",University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center,,,,,,,,,24,32,37,0,2,ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS,SAN DIEGO,"525 B ST, STE 1900, SAN DIEGO, CA 92101-4495",0090-8258,,,GYNECOL ONCOL,Gynecol. Oncol.,SEP,1997,66,3,,,,,417,424,,10.1006/gyno.1997.4797,http://dx.doi.org/10.1006/gyno.1997.4797,,,8,Oncology; Obstetrics & Gynecology,Science Citation Index Expanded (SCI-EXPANDED),Oncology; Obstetrics & Gynecology,XY096,9299255,,,,2024-06-04,WOS:A1997XY09600011,View Full Record in Web of Science
J,"ASTRUP, A; VRIST, E; QUAADE, F",,,,"ASTRUP, A; VRIST, E; QUAADE, F",,,DIETARY FIBER ADDED TO VERY LOW CALORIE DIET REDUCES HUNGER AND ALLEVIATES CONSTIPATION,INTERNATIONAL JOURNAL OF OBESITY,,,English,Article,,,,,,,,,"UNIV COPENHAGEN,HVIDOVRE HOSP,DEPT INTERNAL MED & ENDOCRINOL,DK-2650 HVIDOVRE,DENMARK",University of Copenhagen,"ASTRUP, A (corresponding author), ROYAL VET & AGR UNIV,RES DEPT HUMAN NUTR,ROLIGHEDSVEJ 25,DK-1958 FREDERIKSBERG C,DENMARK.",,,,,,,,16,34,36,0,4,STOCKTON PRESS,BASINGSTOKE,"HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS",0307-0565,,,INT J OBESITY,Int. J. Obes.,FEB,1990,14,2,,,,,105,112,,,,,,8,Endocrinology & Metabolism; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Endocrinology & Metabolism; Nutrition & Dietetics,CW913,2160441,,,,2024-06-04,WOS:A1990CW91300002,View Full Record in Web of Science
J,"Bulloch, B; Tenenbein, M",,,,"Bulloch, B; Tenenbein, M",,,Constipation: Diagnosis and management in the pediatric emergency department,PEDIATRIC EMERGENCY CARE,,,English,Article,,,,,,constipation; encopresis; laxatives,IDIOPATHIC CONSTIPATION; LAVAGE SOLUTION; DIETARY FIBER; MINERAL-OIL; CHILDREN,,"Childrens Hosp, Dept Pediat & Child Hlth, Winnipeg, MB R3A 1S1, Canada",University of Manitoba; Children's Hospital Research Institute of Manitoba,"Childrens Hosp, Dept Pediat & Child Hlth, 840 Sherbrook St,Room CE208, Winnipeg, MB R3A 1S1, Canada.",bulloch@mb.sympatico.ca,,,,,,,18,14,14,0,1,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0749-5161,1535-1815,,PEDIATR EMERG CARE,Pediatr. Emerg. Care,AUG,2002,18,4,,,,,254,258,,10.1097/00006565-200208000-00006,http://dx.doi.org/10.1097/00006565-200208000-00006,,,5,Emergency Medicine; Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Emergency Medicine; Pediatrics,584ET,12187129,,,,2024-06-04,WOS:000177454800002,View Full Record in Web of Science
J,"Borre, M; Fassov, J; Poulsen, JL; Christensen, P; Laurberg, S; Drewes, AM; Krogh, K",,,,"Borre, Mette; Fassov, Janne; Poulsen, Jakob Lykke; Christensen, Peter; Laurberg, Soren; Drewes, Asbjorn Mohr; Krogh, Klaus",,,Dietary Intervention Improves Gastrointestinal Symptoms after Treatment of Cancer in the Pelvic Organs,JOURNAL OF CLINICAL MEDICINE,,,English,Article,,,,,,cancer; sequelae; colorectal; pelvic; complications; diet; dietary intervention,BILE-ACID MALABSORPTION; ANTERIOR RESECTION SYNDROME; QUALITY-OF-LIFE; VALIDATION; EFFICACY; DIARRHEA; OUTCOMES; MANAGE; SCALE,"Gastrointestinal (GI) symptoms are common in patients receiving radiotherapy, chemotherapy, and/or surgery for cancer in the pelvic organs. The aim of the present prospective cohort study was to report the efficacy of dietary intervention in patients with chronic GI sequelae to treatment of cancer in pelvic organs and insufficient symptomatic effect of medical treatment. Eighty-eight patients were offered specialist dietitian guidance. Gastrointestinal symptoms and quality of life were assessed before and after intervention by validated questionnaires. The main dietary interventions were low-fat diet (n = 44; 50%), modification of dietary fiber content (n = 19; 33%), dietary restrictions with a low-FODMAP (fermentable oligosaccharides, disaccharides, monosaccharides, and polyols) diet (n = 18; 20%), gluten-free diet (n = 1; 1%), and other dietary advice (n = 6; 7%). Compared to baseline, dietary intervention improved quality of life (EQ5D scale) (p < 0.01), bowel function for the last four weeks (p < 0.02), stool frequency (p < 0.03), constipation (p < 0.05), incomplete rectal emptying at defecation (p < 0.02), and performing usual activities (p < 0.0). In conclusion, this observational study using tailored dietary intervention showed that symptoms can be reduced and quality of life can be improved in patients with chronic GI sequelae following treatment of cancer in the pelvic organs not responding sufficiently to medical treatment.","[Borre, Mette; Fassov, Janne; Krogh, Klaus] Aarhus Univ Hosp, Dept Hepatol & Gastroenterol, Palle Juul Jensens Blvd 99, DK-8200 Aarhus, Denmark; [Borre, Mette; Fassov, Janne; Poulsen, Jakob Lykke; Christensen, Peter; Laurberg, Soren; Drewes, Asbjorn Mohr; Krogh, Klaus] Aarhus Univ Hosp, Danish Canc Soc Ctr Res Survivorship & Late Advers, DK-8200 Aarhus, Denmark; [Poulsen, Jakob Lykke; Drewes, Asbjorn Mohr] Aalborg Univ Hosp, Dept Gastroenterol & Hepatol, Mech Sense, DK-9000 Aalborg, Denmark; [Christensen, Peter; Laurberg, Soren] Aarhus Univ Hosp, Dept Surg, Palle Juul Jensens Blvd 99, DK-8200 Aarhus, Denmark",Aarhus University; Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University,"Borre, M (corresponding author), Aarhus Univ Hosp, Dept Hepatol & Gastroenterol, Palle Juul Jensens Blvd 99, DK-8200 Aarhus, Denmark.;Borre, M (corresponding author), Aarhus Univ Hosp, Danish Canc Soc Ctr Res Survivorship & Late Advers, DK-8200 Aarhus, Denmark.",mette.borre@aarhus.rm.dk; jannfass@rm.dk; japo@rn.dk; petchris@rm.dk; soeren.laurberg@aarhus.rm.dk; amd@rn.dk; klaukrog@rm.dk,"Drewes, Asbjørn/AAR-7479-2021","Drewes, Asbjørn/0000-0001-7465-964X; Poulsen, Jakob Lykke/0000-0002-0251-6049; Krogh, Klaus/0000-0001-9168-2403",Danish Cancer Society [R192-A11536],Danish Cancer Society(Danish Cancer Society),"The study was supported by the Danish Cancer Society (grant nr R192-A11536). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.",,42,1,1,0,0,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2077-0383,,J CLIN MED,J. Clin. Med.,JUL,2023,12,14,,,,,,,4766,10.3390/jcm12144766,http://dx.doi.org/10.3390/jcm12144766,,,11,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,N3HA2,37510881,"Green Published, gold",,,2024-06-04,WOS:001035952000001,View Full Record in Web of Science
J,"Ge, XL; Ding, C; Gong, JF; Li, N; Li, JS",,,,"Ge, Xiaolong; Ding, Chao; Gong, Jianfeng; Li, Ning; Li, Jieshou",,,Fecal Microbiota Transplantation in Combination with Soluble Dietary Fiber for the Chronic Constipation,AMERICAN JOURNAL OF GASTROENTEROLOGY,,,English,Meeting Abstract,81st Annual Scientific Meeting of the American-College-of-Gastroenterology,"OCT 21-26, 2016","Las Vegas, NV",Amer Coll Gastroenterol,,,,,"[Ge, Xiaolong; Ding, Chao; Gong, Jianfeng; Li, Ning; Li, Jieshou] Nanjing Univ, Jinling Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China",Nanjing University,,,"Li, jie/GXG-4583-2022",,,,,,0,1,1,0,5,NATURE PUBLISHING GROUP,NEW YORK,"75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA",0002-9270,1572-0241,,AM J GASTROENTEROL,Am. J. Gastroenterol.,OCT,2016,111,,,1,,2450,S1251,S1251,,10.14309/00000434-201610001-02450,http://dx.doi.org/10.14309/00000434-201610001-02450,,,1,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Gastroenterology & Hepatology,EN1IV,,,,,2024-06-04,WOS:000395764604211,View Full Record in Web of Science
J,"Kon, R; Ikarashi, N; Onuma, K; Yasukawa, Z; Ozeki, M; Sakai, H; Kamei, J",,,,"Kon, Risako; Ikarashi, Nobutomo; Onuma, Kazuhiro; Yasukawa, Zenta; Ozeki, Makoto; Sakai, Hiroyasu; Kamei, Junzo",,,Effect of partially hydrolyzed guar gum on the expression of aquaporin-3 in the colon,FOOD SCIENCE & NUTRITION,,,English,Article,,,,,,aquaporin; colon; constipation; fiber; partially hydrolyzed guar gum,QUALITY-OF-LIFE; FLUID TRANSPORT; WATER CHANNEL; CONSTIPATION; IMPACT; LOCALIZATION; CHOLESTEROL; SECRETION; BRAIN; RATS,"In recent years, the development of functional foods targeting gastrointestinal disorders has been in progress. Partially hydrolyzed guar gum (PHGG), which is a water-soluble dietary fiber, is known to have a constipation-improving effect. However, many aspects of the mechanism remain unclear. In this study, we investigated the role of aquaporin-3 (AQP3), which regulates the water content of feces in ameliorative effect of PHGG on constipation. Rats were allowed to freely consume a normal diet or a diet containing 5% PHGG for 14 days, and defecation parameters were measured. We also analyzed the expression levels of genes involved in water transport in the colon. The defecation frequency and volume of rats treated with PHGG were not different from those from the control group, but the fecal water content was significantly increased, and soft stools were observed. The expressions of claudin-1, tight junction protein-1, and cadherin-1, which are involved in tight junctions or adherens junctions, were almost the same in the PHGG-treated group and the control group. The expression level of AQP3 in the colon was significantly decreased in the PHGG-treated group. In this study, PHGG decreased the colonic AQP3 expression, thereby suppressing water transport from the luminal side to the vascular side and improving constipation.","[Kon, Risako; Ikarashi, Nobutomo; Onuma, Kazuhiro; Sakai, Hiroyasu] Hoshi Univ, Dept Biomol Pharmacol, Tokyo, Japan; [Yasukawa, Zenta] Kanazawa Gakuin Univ, Fac Nutr, Dept Nutr, Kanazawa, Ishikawa, Japan; [Ozeki, Makoto] Taiyo Kagaku Co Ltd, Yokaichi, Mie, Japan; [Kamei, Junzo] Juntendo Univ, Adv Res Inst Hlth Sci, Tokyo, Japan; [Ikarashi, Nobutomo] Hoshi Univ, Dept Biomol Pharmacol, 2-4-41 Ebara,Shinagawa Ku, Tokyo 1428501, Japan","Hoshi University; TAIYO KAGAKU CO., LTD.; Juntendo University; Hoshi University","Ikarashi, N (corresponding author), Hoshi Univ, Dept Biomol Pharmacol, 2-4-41 Ebara,Shinagawa Ku, Tokyo 1428501, Japan.",ikarashi@hoshi.ac.jp,,,"Lotte Foundation; Taiyo Kagaku Co., Ltd.","Lotte Foundation; Taiyo Kagaku Co., Ltd.","Lotte Foundation; Taiyo Kagaku Co., Ltd.",,42,1,1,6,11,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",2048-7177,,,FOOD SCI NUTR,Food Sci. Nutr.,FEB,2023,11,2,,,,,1127,1133,,10.1002/fsn3.3150,http://dx.doi.org/10.1002/fsn3.3150,,NOV 2022,7,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,8Y4YY,36789055,"gold, Green Published",,,2024-06-04,WOS:000888884900001,View Full Record in Web of Science
J,"Quitadamo, P; Coccorullo, P; Giannetti, E; Romano, C; Chiaro, A; Campanozzi, A; Poli, E; Cucchiara, S; Di Nardo, G; Staiano, A",,,,"Quitadamo, Paolo; Coccorullo, Paola; Giannetti, Eleonora; Romano, Claudio; Chiaro, Andrea; Campanozzi, Angelo; Poli, Emanuela; Cucchiara, Salvatore; Di Nardo, Giovanni; Staiano, Annamaria",,,"A Randomized, Prospective, Comparison Study of a Mixture of Acacia Fiber, Psyllium Fiber, and Fructose vs Polyethylene Glycol 3350 with Electrolytes for the Treatment of Chronic Functional Constipation in Childhood",JOURNAL OF PEDIATRICS,,,English,Article,,,,,,,DIETARY FIBER; DOUBLE-BLIND; PLUS ELECTROLYTES; CONTROLLED-TRIAL; WHEAT BRAN; CHILDREN; LACTULOSE; ENCOPRESIS; MULTICENTER; EFFICACY,"Objectives To compare the effectiveness of a mixture of acacia fiber, psyllium fiber, and fructose (AFPFF) with polyethylene glycol 3350 combined with electrolytes (PEG+E) in the treatment of children with chronic functional constipation (CFC); and to evaluate the safety and effectiveness of AFPFF in the treatment of children with CFC. Study design This was a randomized, open label, prospective, controlled, parallel-group study involving 100 children (M/F: 38/62; mean age +/- SD: 6.5 +/- 2.7 years) who were diagnosed with CFC according to the Rome III Criteria. Children were randomly divided into 2 groups: 50 children received AFPFF (16.8 g daily) and 50 children received PEG+E (0.5 g/kg daily) for 8 weeks. Primary outcome measures were frequency of bowel movements, stool consistency, fecal incontinence, and improvement of other associated gastrointestinal symptoms. Safety was assessed with evaluation of clinical adverse effects and growth measurements. Results Compliance rates were 72% for AFPFF and 96% for PEG+E. A significant improvement of constipation was seen in both groups. After 8 weeks, 77.8% of children treated with AFPFF and 83% of children treated with PEG+E had improved (P = .788). Neither PEG+E nor AFPFF caused any clinically significant side effects during the entire course of the study period. Conclusions In this randomized study, we did not find any significant difference between the efficacy of AFPFF and PEG+E in the treatment of children with CFC. Both medications were proved to be safe for CFC treatment, but PEG+E was better accepted by children. (J Pediatr 2012;161:710-15).","[Quitadamo, Paolo; Coccorullo, Paola; Giannetti, Eleonora; Staiano, Annamaria] Univ Federico II, Dept Pediat, I-80131 Naples, Italy; [Romano, Claudio; Chiaro, Andrea] Univ Messina, Dept Pediat, I-98100 Messina, Italy; [Campanozzi, Angelo; Poli, Emanuela] Univ Foggia, Dept Med Sci Pediat, Foggia, Italy; [Cucchiara, Salvatore; Di Nardo, Giovanni] Univ Roma La Sapienza, Dept Pediat, Rome, Italy",University of Naples Federico II; University of Messina; University of Foggia; Sapienza University Rome,"Staiano, A (corresponding author), Univ Federico II, Dept Pediat, Via S Pansini 5, I-80131 Naples, Italy.",staiano@unina.it,"Chiaro, Andrea/ABC-1751-2020; Romano, Claudio/L-1950-2016; Campanozzi, Angelo/AAR-6227-2020; Staiano, Annamaria/H-3026-2011; Cucchiara, Salvatore/K-1628-2016","Romano, Claudio/0000-0001-8827-2091; Campanozzi, Angelo/0000-0002-3489-2524; Staiano, Annamaria/0000-0003-0586-1339; Cucchiara, Salvatore/0000-0002-2939-9698; Di Nardo, Giovanni/0000-0002-9026-7758",Milte (Italy),Milte (Italy),Research fellowship for data analysis provided by Milte (Italy). The authors declare no conflicts of interest.,,40,35,36,0,12,MOSBY-ELSEVIER,NEW YORK,"360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA",0022-3476,,,J PEDIATR-US,J. Pediatr.,OCT,2012,161,4,,,,,710,+,,10.1016/j.jpeds.2012.04.043,http://dx.doi.org/10.1016/j.jpeds.2012.04.043,,,7,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,016KH,22677568,,,,2024-06-04,WOS:000309516400030,View Full Record in Web of Science
J,"Nakaji, S; Tokunaga, S; Sakamoto, J; Todate, M; Shimoyama, T; Umeda, T; Sugawara, K",,,,"Nakaji, S; Tokunaga, S; Sakamoto, J; Todate, M; Shimoyama, T; Umeda, T; Sugawara, K",,,Relationship between lifestyle factors and defecation in a Japanese population,EUROPEAN JOURNAL OF NUTRITION,,,English,Article,,,,,,defecation; walking; dietary factors; rice,COLON CANCER RISK; PHYSICAL-ACTIVITY; COLORECTAL-CANCER; GASTROINTESTINAL TRANSIT; DIETARY-INTAKE; BOWEL HABITS; CONSTIPATION; FIBER; OVERWEIGHT; EXERCISE,"Background There is a paucity of accurate data regarding any association in the general population between defecation and lifestyle factors such as diet, exercise, physique, and childbirth. Aims of the study To evaluate the effects of such lifestyle factors on defecation among regional residents of Japan. Methods Residents (n = 1,699) of northern Japan, aged over 40 years, were surveyed in 1995 using a questionnaire to assess their lifestyle factors (diet, beverage consumption, exercise, physique, and childbirth), and examining their defecation status. We evaluated the relationship between these lifestyle factors and defecation using logistic regression analysis. The authors used four measures (defecation frequency, subjective defecation state, subjective fecal properties, and fecal consistency) and assigned the subjects to a group defined by their defecatory status: constipation, diarrhea, or normal, depending on the responses of the subjects to all four criteria. Results The tendency for constipation correlated positively with age in males (p = 0.130), although this trend was not observed in females (p = 0.641). Of the dietary factors examined, only rice, which accounts for the largest proportion of daily dietary fiber intake in Japan, demonstrated a preventive effect on constipation in both sexes (p = 0.050 in males and 0.003 in females). Walking was a preventive factor for constipation among males (P = 0.049), and alcohol also inhibited constipation among males (p = 0.007). Conclusions These results suggest that exercise, such as walking, and a high intake of dietary fiber, such as rice, were useful in the maintenance of defecation.","Hirosaki Univ, Sch Med, Dept Hyg, Hirosaki, Aomori 0368562, Japan; Kyushu Univ, Grad Sch Med Sci, Dept Prevent Med, Fukuoka 812, Japan; Hirosaki Univ, Sch Med, Dept Internal Med 1, Hirosaki, Aomori 0368562, Japan",Hirosaki University; Kyushu University; Hirosaki University,"Nakaji, S (corresponding author), Hirosaki Univ, Sch Med, Dept Hyg, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.",,"Shimoyama, Tadashi/G-5519-2014",,,,,,44,42,48,0,7,DR DIETRICH STEINKOPFF VERLAG,DARMSTADT,"PO BOX 10 04 62, D-64204 DARMSTADT, GERMANY",1436-6207,,,EUR J NUTR,Eur. J. Nutr.,DEC,2002,41,6,,,,,244,248,,10.1007/s00394-002-0380-4,http://dx.doi.org/10.1007/s00394-002-0380-4,,,5,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,635FG,12474067,,,,2024-06-04,WOS:000180387700002,View Full Record in Web of Science
J,"Cupisti, A; Kovesdy, CP; D'Alessandro, C; Kalantar-Zadeh, K",,,,"Cupisti, Adamasco; Kovesdy, Csaba P.; D'Alessandro, Claudia; Kalantar-Zadeh, Kamyar",,,Dietary Approach to Recurrent or Chronic Hyperkalaemia in Patients with Decreased Kidney Function,NUTRIENTS,,,English,Article,,,,,,chronic kidney disease; dialysis; end-stage renal disease; hyperkalaemia; potassium; diet; nutrition; fibre,CHRONIC-RENAL-FAILURE; POTASSIUM HOMEOSTASIS; HEMODIALYSIS-PATIENTS; METABOLIC-ACIDOSIS; DISEASE; FOODS; SERUM; PATHOPHYSIOLOGY; BICARBONATE; PHOSPHORUS,"Whereas the adequate intake of potassium is relatively high in healthy adults, i.e., 4.7 g per day, a dietary potassium restriction of usually less than 3 g per day is recommended in the management of patients with reduced kidney function, especially those who tend to develop hyperkalaemia including patients who are treated with angiotensin pathway modulators. Most potassium-rich foods are considered heart-healthy nutrients with high fibre, high anti-oxidant vitamins and high alkali content such as fresh fruits and vegetables; hence, the main challenge of dietary potassium management is to maintain high fibre intake and a low net fixed-acid load, because constipation and metabolic acidosis are per se major risk factors for hyperkalaemia. To achieve a careful reduction of dietary potassium load without a decrease in alkali or fibre intake, we recommend the implementation of certain pragmatic dietary interventions as follows: Improving knowledge and education about the type of foods with excess potassium (per serving or per unit of weight); identifying foods that are needed for healthy nutrition in renal patients; classification of foods based on their potassium content normalized per unit of dietary fibre; education about the use of cooking procedures (such as boiling) in order to achieve effective potassium reduction before eating; and attention to hidden sources of potassium, in particular additives in preserved foods and low-sodium salt substitutes. The present paper aims to review dietary potassium handling and gives information about practical approaches to limit potassium load in chronic kidney disease patients at risk of hyperkalaemia.","[Cupisti, Adamasco; D'Alessandro, Claudia] Univ Pisa, Dept Clin & Expt Med, I-56126 Pisa, Italy; [Kovesdy, Csaba P.] Univ Tennessee, Hlth Sci Ctr, Dept Med, Div Nephrol, Memphis, TN 38163 USA; [Kalantar-Zadeh, Kamyar] Univ Calif Irvine, Sch Med, Div Nephrol & Hypertens, Orange, CA 92697 USA",University of Pisa; University of Tennessee System; University of Tennessee Health Science Center; University of California System; University of California Irvine,"Cupisti, A (corresponding author), Univ Pisa, Dept Clin & Expt Med, I-56126 Pisa, Italy.",adamasco.cupisti@med.unipi.it; ckovesdy@uthsc.edu; dalessandroclaudia@gmail.com; kkz@uci.edu,"D'Alessandro, Claudia/ABF-4839-2021; CUPISTI, ADAMASCO/HPG-1446-2023; Kalantar-Zadeh, Kamyar/Q-4734-2018; D Alessandro, Claudia/IXX-2842-2023","D'Alessandro, Claudia/0000-0003-2313-5461; CUPISTI, ADAMASCO/0000-0002-8995-936X; Kalantar-Zadeh, Kamyar/0000-0002-8666-0725;",Vifor Fresenius; Shire; Abbott; Amgen; Bayer; Keryx; Sanofi-aventis; Alexion; Astra-Zeneca; Aveo; Chugai; DaVita; Fresenius; Genentech; Haymarket Media; Hospira; Kabi; Novartis; Pfizer; Relypsa; Resverlogix; Sandoz; Sanofi; Vifor; UpToDate; ZS-Pharma,Vifor Fresenius; Shire; Abbott(Abbott Laboratories); Amgen(Amgen); Bayer(Bayer AG); Keryx; Sanofi-aventis(Sanofi-Aventis); Alexion(AstraZeneca); Astra-Zeneca(AstraZeneca); Aveo; Chugai; DaVita; Fresenius; Genentech(Roche HoldingGenentech); Haymarket Media; Hospira; Kabi; Novartis(Novartis); Pfizer(Pfizer); Relypsa; Resverlogix; Sandoz(Novartis); Sanofi; Vifor; UpToDate; ZS-Pharma,"A.C. received consulting fees from Vifor Fresenius, Shire, Abbott. C.P.K. received consulting fees from Abbott, Abbvie, Amgen, Bayer, Keryx and Sanofi-aventis and research support from Shire. K.K.-Z. received commercial honoraria and/or support from Abbott, Abbvie, Alexion, Amgen, Astra-Zeneca, Aveo, Chugai, DaVita, Fresenius, Genentech, Haymarket Media, Hospira, Kabi, Keryx, Novartis, Pfizer, Relypsa, Resverlogix, Sandoz, Sanofi, Shire, Vifor, UpToDate and ZS-Pharma. (US government agencies (such as NIH) and non-for profit foundations or societies (such as NKF) are not listed, while K.K.-Z. have also received additional honoraria from such entities).",,45,115,125,0,13,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",2072-6643,,,NUTRIENTS,Nutrients,MAR,2018,10,3,,,,,,,261,10.3390/nu10030261,http://dx.doi.org/10.3390/nu10030261,,,15,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,GA5WT,29495340,"Green Published, gold",,,2024-06-04,WOS:000428405300002,View Full Record in Web of Science
J,"Olaru, C; Diaconescu, S; Trandafir, L; Gimiga, N; Stefanescu, G; Ciubotariu, G; Burlea, M",,,,"Olaru, Claudia; Diaconescu, Smaranda; Trandafir, Laura; Gimiga, Nicoleta; Stefanescu, Gabriela; Ciubotariu, Gabriela; Burlea, Marin",,,Some Risk Factors of Chronic Functional Constipation Identified in a Pediatric Population Sample from Romania,GASTROENTEROLOGY RESEARCH AND PRACTICE,,,English,Article,,,,,,,CHILDHOOD CONSTIPATION; COWS-MILK; PHYSICAL-ACTIVITY; DIETARY FIBER; CHILDREN; QUESTIONNAIRE; EPIDEMIOLOGY; PREVALENCE; DEFECATION; OBESITY,"We conducted an observational study over a 1-year period, including 234 children aged 4-18 years and their caregivers and a matching control group. 60.73% of the children from the study group were males. Average age for the onset of constipation was 26.39 months. The frequency of defecation was 1/4.59 days (1/1.13 days in the control group). 38.49% of the patients in the sample group had a positive family history of functional constipation. The majority of children with functional constipation come from single-parent families, are raised by relatives, or come from orphanages. Constipated subjects had their last meal of the day at later hours and consumed fast foods more frequently than the children in the control sample. We found a statistically significant difference between groups regarding obesity/overweight and constipation (chi(2) = 104.94, df = 2, p < 0.001) and regarding physical activity and constipation (chi(2) = 18.419; df = 3; p < 0.001). There was a positive correlation between the number of hours spent watching television/using the computer and the occurrence of the disease (F = 92.162, p < 0.001, and 95% Cl). Children from broken families, with positive family history, defective dietary habits, obesity and sedentary behavior, are at higher risk to develop chronic functional constipation.","[Olaru, Claudia; Diaconescu, Smaranda; Trandafir, Laura; Gimiga, Nicoleta; Stefanescu, Gabriela; Ciubotariu, Gabriela; Burlea, Marin] Gr T Popa Univ Med & Pharm, Iasi, Romania; [Olaru, Claudia; Diaconescu, Smaranda; Trandafir, Laura; Gimiga, Nicoleta; Ciubotariu, Gabriela; Burlea, Marin] Sf Maria Emergency Hosp Children, Iasi, Romania; [Stefanescu, Gabriela] Sf Spiridon Emergency Hosp, Iasi, Romania",Grigore T Popa University of Medicine & Pharmacy; Grigore T Popa University of Medicine & Pharmacy,"Diaconescu, S (corresponding author), Gr T Popa Univ Med & Pharm, Iasi, Romania.;Diaconescu, S (corresponding author), Sf Maria Emergency Hosp Children, Iasi, Romania.",turti23@yahoo.com,"Ghiga, Gabriela/AAM-9457-2020; Diaconescu, Smaranda/J-8753-2015; Trandafir, Laura/N-7338-2014; GIMIGA, NICOLETA G/U-6335-2017","Diaconescu, Smaranda/0000-0001-8018-7191;",,,,,42,11,12,1,4,HINDAWI LTD,LONDON,"ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND",1687-6121,1687-630X,,GASTROENT RES PRACT,Gastroenterol. Res. Pract.,,2016,2016,,,,,,,,3989721,10.1155/2016/3989721,http://dx.doi.org/10.1155/2016/3989721,,,8,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,EE2QM,,"Green Published, gold, Green Submitted",,,2024-06-04,WOS:000389429300001,View Full Record in Web of Science
J,"Jisha, S; Padmaja, G; Sajeev, MS",,,,"Jisha, S.; Padmaja, G.; Sajeev, M. S.",,,NUTRITIONAL AND TEXTURAL STUDIES ON DIETARY FIBER-ENRICHED MUFFINS AND BISCUITS FROM CASSAVA-BASED COMPOSITE FLOURS,JOURNAL OF FOOD QUALITY,,,English,Article,,,,,,,CORONARY-HEART-DISEASE; WHEAT-FLOUR; BAKING PROPERTIES; CHICKPEA FLOUR; QUALITY; BRAN; MECHANISM; PEANUT; RICE; RISK,"The demand for designer food products having specific nutritional/functional attributes is on the increase worldwide. Composite flours prepared from malted and pregelatinized cassava through appropriate blending with cereal and/or legume and bran sources were used for making muffins and biscuits with high fiber content. Muffins made from Termamyl-malted and pregelatinized cassava flour had lower starch content (38.84-41.82%) than those from germinated gram amylase malted flour. The products had protein contents of 4.50-5.60% (< 1.0% in cassava flour). High dietary fiber content of 2.77-3.44% and 3.20-3.40%, respectively, was obtained in muffins and biscuits made from cassava-bran blends. The spread ratio of the test biscuits was fewer by five to eight units than the control biscuits made from refined wheat flour. The low in vitro starch digestibility of muffins/biscuits from cassava-bran blends (24-29 units and 31-34 units, respectively) was a specific advantage, suggesting their therapeutic use for obese and diabetic people. Muffins made from Termamyl-malted mixes had lower hardness and toughness than those from gram amylase malted flour. The high dietary fiber content of the two baked goods indicates their use for cardiovascular patients and also for conditions such as constipation and its related problems. PRACTICAL APPLICATIONS The study focuses on the use of cassava flour for making two baked goods viz., muffins and biscuits. The nutritional and functional properties of cassava flour were modified through malting and pregelatinization and further by blending with cereal and/or legume flours and bran sources. The composite flours that have high protein content and dietary fiber (DF) content were further enriched through the addition of wheat bran at levels of 10.0 g per formula. The products developed had high DF content of 2.77-3.44% and protein content of 4.50-5.60% (dwb). The low in vitro starch digestibility of muffins and biscuits from cassava-bran blends was an additional advantage, suggesting their use in medical nutrition therapy for treating obese and diabetic people as well as for management of cardiovascular and intestinal problems.","[Jisha, S.; Padmaja, G.; Sajeev, M. S.] Cent Tuber Crops Res Inst, Div Crop Utilizat, Thiruvananthapuram 695017, Kerala, India",Indian Council of Agricultural Research (ICAR); ICAR - Central Tuber Crops Research Institute,"Padmaja, G (corresponding author), Cent Tuber Crops Res Inst, Div Crop Utilizat, Thiruvananthapuram 695017, Kerala, India.",padmajabn@yahoo.com,"Moothandassery, Sajeev/ABA-9544-2020",,,,,,49,12,13,0,33,WILEY-HINDAWI,LONDON,"ADAM HOUSE, 3RD FL, 1 FITZROY SQ, LONDON, WIT 5HE, ENGLAND",0146-9428,1745-4557,,J FOOD QUALITY,J. Food Qual.,SEP,2010,33,,,1,,,79,99,,10.1111/j.1745-4557.2010.00313.x,http://dx.doi.org/10.1111/j.1745-4557.2010.00313.x,,,21,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,647WL,,,,,2024-06-04,WOS:000281651100006,View Full Record in Web of Science
J,"GEAR, JSS; BRODRIBB, AJM; WARE, A; MANN, JI",,,,"GEAR, JSS; BRODRIBB, AJM; WARE, A; MANN, JI",,,FIBER AND BOWEL TRANSIT TIMES,BRITISH JOURNAL OF NUTRITION,,,English,Article,,,,,,,,Bowel transit time was investigated in vegetarians and non-vegetarians and related to dietary fiber intake and the presence of diverticular disease. Vegetarians who have less diverticular disease than non-vegetarians have more rapid transit times. Subjects with total dietary fiber intake > 30 g/day had transit times < 75 h; 38% of those eating less had transit times exceeding 75 h and varying up to 124 h. Individuals with diverticular disease had faster transit times than those without the disease. The colon may respond to a fiber-depleted diet by becoming hyperactive and prone to diverticular disease or by becoming hypoactive leading to constipation.,"UNIV OXFORD, DEPT COMMUNITY MED & GEN PRACT, OXFORD OX1 3QN, ENGLAND",University of Oxford,,,,,,,,,9,58,61,0,3,CAMBRIDGE UNIV PRESS,CAMBRIDGE,"EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND",0007-1145,1475-2662,,BRIT J NUTR,Br. J. Nutr.,,1981,45,1,,,,,77,82,,10.1079/BJN19810078,http://dx.doi.org/10.1079/BJN19810078,,,6,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,LF525,6258626,Bronze,,,2024-06-04,WOS:A1981LF52500008,View Full Record in Web of Science
J,"Soares, ACF; Tahan, S; de Morais, MB",,,,"Fontenele Soares, Ana Cristina; Tahan, Soraia; de Morais, Mauro Batista",,,Effects of conventional treatment of chronic functional constipation on total and segmental colonic and orocecal transit times,JORNAL DE PEDIATRIA,,,Portuguese,Article,,,,,,,GASTROINTESTINAL DISORDERS; DIETARY FIBER; CHILDREN; CISAPRIDE; MANAGEMENT; TRIAL,"Objective: To evaluate the effects of conventional treatment of chronic functional constipation on total and segmental colonic transit times and on orocecal transit time. Methods: A total of 34 consecutive patients with functional constipation attending a specialized outpatient clinic were included in the study. Total and segmental colonic transit times were assessed using radiopaque markers. Hydrogen breath test was used to evaluate lactulose and bean orocecal transit times. Treatment consisted of disimpaction, general and dietary fiber intake instruction, and mineral oil administration. Results: At admission, colonic dysmotility was found in 71.9% (23/32) of patients. All patients who complied with the treatment showed improvement of clinical symptoms after 6 weeks of treatment, when 82.6% (19/23) of those with dysmotility at admission returned to normal or reduced the severity of colonic transit patterns. Transit time decreased (medians) between admission and eighth week of treatment: lactulose orocecal transit (from 70 to 50 minutes, p = 0.002), bean orocecal transit (from 240 to 220 minutes, p = 0.002), and total colonic transit (from 69.5 to 37.0 hours, p = 0.001). The need for mineral oil therapy for constipation after a 12-month treatment was associated with persistence of total colonic transit higher than 62 hours at the eighth week of treatment (p = 0.014). Conclusion: The conventional therapeutic approach yielded good results regardless of the presence or not of colonic dysmotility at inclusion in the study. Digestive tract motility abnormalities in functionally constipated children may be reversed, and may be secondary to constipation.","[Fontenele Soares, Ana Cristina; Tahan, Soraia; de Morais, Mauro Batista] Univ Fed Sao Paulo, Disciplina Gastroenterol Pediat, Escola Paulista Med, Sao Paulo, Brazil; [de Morais, Mauro Batista] Univ Fed Sao Paulo, Dept Pediat, Escola Paulista Med, Sao Paulo, Brazil",Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP),"de Morais, MB (corresponding author), Rua Pedro Toledo 441, BR-04039031 Sao Paulo, Brazil.",mbmorais@osite.com.br,"MORAIS, MAURO B/I-7995-2014","Batista de Morais, Mauro/0000-0003-4014-5549; Fontenele Soares, Ana Cristina/0000-0002-2246-9913",,,,,28,11,11,0,0,SOC BRASIL PEDIATRIA,"RIO DE JANEIRO, RJ","RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL",0021-7557,1678-4782,,J PEDIAT-BRAZIL,J. Pediatr.,JUL-AUG,2009,85,4,,,,,322,328,,10.2223/JPED.1912,http://dx.doi.org/10.2223/JPED.1912,,,7,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,493GY,19668908,,,,2024-06-04,WOS:000269725200009,View Full Record in Web of Science
J,"Taniguchi, K; Komae, K; Takahashi, A; Yoshioka, T; Sone, Y",,,,"Taniguchi, Keiko; Komae, Kozo; Takahashi, Asuka; Yoshioka, Toji; Sone, Yoshiaki",,,"Effect of waxy barley, Kirarimochi, consumption on bowel movements of late-stage elderly residents at Roken nursing home",JOURNAL OF PHYSIOLOGICAL ANTHROPOLOGY,,,English,Article,,,,,,Waxy barley; Dietary fiber; Defecation; Laxative administration; Bowel movement; Constipation; Nursing; home; Late-stage elderly,,"Background: It is very important for the late-stage elderly to have the least stressful bowel movements for maintaining a good quality of life. It is generally accepted that consuming adequate dietary fiber is a promising method for the prevention and management of stressful bowel movements such as those during constipation. Therefore, we examined the effect of long-term consumption of waxy barley, which is high in dietary fiber, on the bowel movements of the late-stage elderly living at Roken nursing home (a geriatric health services facility), Japan. Methods: We compared the defecation and laxative administration frequencies of the subjects before and after waxy barley consumption, for which we served 28 residents a boiled mixture of rice and waxy barley (variety name,Kirarimochi) as the main meals for 5 months, from November to March. In October, all residents were served boiled rice as the main meals. Results: The residents were categorized into constipated subjects and non-constipatedsubjects according to their weekly defecation frequency during October. Among the 14 residents categorized as constipated subjects, monthly number of days with defecation in November, January, and March significantly increased in comparison to monthly number of days with defecation in October. In addition, monthly number of days with laxative administration significantly decreased in December and February in comparison to monthly number of days with laxative administration in October. In contrast, the defecation and laxative administration frequencies did not change after waxy barley consumption among the 14 residents categorized as non-constipated subjects. Conclusions: Consumption of waxy barley, Kirarimochi, for 5 months improved the bowel movements of the constipated subjects; however, the consumption had no effect on the bowel movements of the non-constipated subjects at Roken nursing home. These results indicate that consuming waxy barley, Kirarimochi, is beneficial for the management of constipation in the late-stage elderly residents at Roken nursing home.","[Taniguchi, Keiko] Mimasaka Sakutou Nursing Home, 280 Emi, Okayama 7094234, Japan; [Taniguchi, Keiko] Hlth Promot Sect, 390-2 Kitayama, Okayama 7070014, Japan; [Komae, Kozo] Konan Womens Univ, Higashinada Ku, 6-2-23 Morikita, Kobe, Hyogo 6580001, Japan; [Takahashi, Asuka; Yoshioka, Toji] NARO Western Reg Agr Res Ctr, Crop Breeding & Food Funct Components Res Div, 1-3-1 Senyu Cho, Zentsuji, Kagawa 7658508, Japan; [Sone, Yoshiaki] Mimasaka Univ, Grad Sch Human Life Sci, 50 Kitasono Cho, Okayama 7088511, Japan",National Agriculture & Food Research Organization - Japan,"Sone, Y (corresponding author), Mimasaka Univ, Grad Sch Human Life Sci, 50 Kitasono Cho, Okayama 7088511, Japan.",soneyoshi@mimasaka.ac.jp,,,Regional Research Center of Mimasaka University,Regional Research Center of Mimasaka University,This study was supported by a research fund from the Regional Research Center of Mimasaka University.,,19,6,6,0,11,BIOMED CENTRAL LTD,LONDON,"236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND",1880-6805,,,J PHYSIOL ANTHROPOL,J. Physiol. Anthropol.,FEB 20,2017,36,,,,,,,,17,10.1186/s40101-017-0131-0,http://dx.doi.org/10.1186/s40101-017-0131-0,,,11,Physiology,Science Citation Index Expanded (SCI-EXPANDED),Physiology,EO8EF,28219413,"Green Published, gold",,,2024-06-04,WOS:000396921100001,View Full Record in Web of Science
J,"Lawton, CL; Walton, J; Hoyland, A; Howarth, E; Allan, P; Chesters, D; Dye, L",,,,"Lawton, Clare L.; Walton, Jenny; Hoyland, Alexa; Howarth, Elaine; Allan, Peter; Chesters, David; Dye, Louise",,,"Short Term (14 Days) Consumption of Insoluble Wheat Bran Fibre-Containing Breakfast Cereals Improves Subjective Digestive Feelings, General Wellbeing and Bowel Function in a Dose Dependent Manner",NUTRIENTS,,,English,Article,,,,,,dietary fibre; wheat bran; breakfast cereal; digestive health; bloating; bowel function; wellbeing,DIETARY FIBER; CANCER; RISK; SYMPTOMS; DISEASE; WEIGHT,"This study investigated whether increasing insoluble (predominantly wheat bran) fibre over 14 days improves subjective digestive feelings, general wellbeing and bowel function. A single centre, multi-site, open, within subjects design with a 14 day non-intervention (baseline) monitoring period followed by a 14 day fibre consumption (intervention) period was performed. 153 low fibre consumers (<15 g/day AOAC 985.29) completed a daily symptom diary for 14 days after which they consumed one bowl of ready-to-eat breakfast cereal containing at least 5.4 g fibre (3.5 g from wheat bran) for 14 days and completed a daily symptom diary. Significant improvements were demonstrated in subjective perception of bowel function (e. g., ease of defecation) and digestive feelings (bloating, constipation, feeling sluggish and digestive discomfort). Significant improvements were also found in subjective perception of general wellbeing (feeling less fat, more mentally alert, slim, happy and energetic whilst experiencing less stress, mental and physical tiredness, difficulty concentrating and fewer headaches). In general, improvements in study outcomes increased with increasing cereal/fibre consumption. However, consuming an additional minimum 5.4 g of fibre (3.5 g wheat bran) per day was shown to deliver measurable and significant benefits for digestive health, comfort and wellbeing. Encouraging consumption of relatively small amounts of wheat bran could also provide an effective method of increasing overall fibre consumption.","[Lawton, Clare L.; Dye, Louise] Univ Leeds, Inst Psychol Sci, Human Appetite Res Unit, Leeds LS2 9JT, W Yorkshire, England; [Walton, Jenny; Hoyland, Alexa] Kellogg Co, Manchester M16 0PU, Lancs, England; [Howarth, Elaine; Allan, Peter; Chesters, David] Intertek CRS, Unit 6, Capenhurst CH1 6EH, Cheshire, England",University of Leeds,"Lawton, CL (corresponding author), Univ Leeds, Inst Psychol Sci, Human Appetite Res Unit, Leeds LS2 9JT, W Yorkshire, England.",c.l.lawton@leeds.ac.uk; jenny.walton@kellogg.com; alexa.hoyland@kellogg.com; elaine.howarth@intertek.com; peter.allan@intertek.com; david.chesters@intertek.com; l.dye@leeds.ac.uk,,,Kellogg Company; University of Leeds,Kellogg Company; University of Leeds,"This work was supported by funding from The Kellogg Company. The authors wish to thank the staff at Intertek CRS (Cheshire, UK) who conducted the study. Thanks are also due to Catriona Campbell for her contribution to this project. Clare Lawton and Louise Dye's participation in this publication was funded under a Strategic Partnership between The Kellogg Company and The University of Leeds.",,35,18,20,1,47,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,APR,2013,5,4,,,,,1436,1455,,10.3390/nu5041436,http://dx.doi.org/10.3390/nu5041436,,,20,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,131TP,23609776,"gold, Green Submitted, Green Published",,,2024-06-04,WOS:000318019300024,View Full Record in Web of Science
J,"Fu, XD; Li, R; Zhang, T; Li, M; Mou, HJ",,,,"Fu, Xiaodan; Li, Rong; Zhang, Tan; Li, Meng; Mou, Haijin",,,Study on the ability of partially hydrolyzed guar gum to modulate the gut microbiota and relieve constipation,JOURNAL OF FOOD BIOCHEMISTRY,,,English,Article,,,,,,16S rRNA analysis; constipation relief; gut microbiota; partially hydrolyzed guar gum (PHGG); short-chain fatty acids,DIETARY FIBER; GASTROINTESTINAL TRANSIT; OLIGOSACCHARIDES; NUTRITION; BACTERIA; ACTIVATION; MANNANASE; SEQUENCES; INSIGHTS; DIARRHEA,"The aim of this study was to evaluate the effects of high- (HHGG, Mw 10,000-30,000 Da) and medium-molecular-weight (MHGG, Mw 2,000-10,000 Da) partially hydrolyzed guar gum (PHGG) on modulation of gut microbiota and relief of constipation in mice. Mice were treated with galacto-oligosaccharide (GOS) and xylo-oligosaccharide (XOS) at a dose of 1 g/kg bw as positive controls. Low- and high-dose HHGG and MHGG groups received 250 mg or 1 g/kg bw, respectively. Treatment was administered intragastrically for 15 days, and constipation model was induced by loperamide lavage at d 16. PHGG could increase fecal moisture and small intestinal transit and shortened the time to first black stool defecation after constipation. The highest short-chain fatty acid production was observed in the high-dose MHGG group. Additionally, PHGG, GOS, and XOS predominantly promoted the accumulation of Bacteroidetes and inhibited the growth of Desulfovibrio. This study suggested that MHGG treatment could elicit constipation relief in mice.","[Fu, Xiaodan; Zhang, Tan; Li, Meng; Mou, Haijin] Ocean Univ China, Coll Food Sci & Engn, 5 Yushan Rd, Qingdao 266003, Shandong, Peoples R China; [Li, Rong] Qingdao Women & Children Hosp, Qingdao, Peoples R China",Ocean University of China,"Mou, HJ (corresponding author), Ocean Univ China, Coll Food Sci & Engn, 5 Yushan Rd, Qingdao 266003, Shandong, Peoples R China.",mousun@ouc.edu.cn,"Mou, Haijin/I-8567-2018","Mou, Haijin/0000-0003-3667-1562; Fu, Xiaodan/0000-0001-6969-7369",Key Research and Development Project Foundation of Shandong Province [2017YYSP003]; Shandong Natural Science Fund [ZR2017MD006]; Shandong Province,Key Research and Development Project Foundation of Shandong Province; Shandong Natural Science Fund; Shandong Province,"Key Research and Development Project Foundation of Shandong Province, Grant/Award Number: 2017YYSP003; Shandong Natural Science Fund, Grant/Award Number: ZR2017MD006; Research and Development, Grant/Award Number: 2017YYSP003 and ZR2017MD006; Shandong Province",,62,19,20,4,50,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0145-8884,1745-4514,,J FOOD BIOCHEM,J. Food Biochem.,FEB,2019,43,2,,,,,,,e12715,10.1111/jfbc.12715,http://dx.doi.org/10.1111/jfbc.12715,,,14,Biochemistry & Molecular Biology; Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Food Science & Technology,HK9MY,31353659,gold,,,2024-06-04,WOS:000458316900022,View Full Record in Web of Science
J,"Malinowski, B; Wicinski, M; Sokolowska, MM; Hill, NA; Szambelan, M",,,,"Malinowski, Bartosz; Wicinski, Michal; Sokolowska, Maya M.; Hill, Nicholas A.; Szambelan, Monika",,,The Rundown of Dietary Supplements and Their Effects on Inflammatory Bowel Disease-A Review,NUTRIENTS,,,English,Review,,,,,,inflammatory bowel disease; Crohn's disease; ulcerative colitis; diarrhea; constipation; abdominal cramping; pain; fibers; probiotics; polyphenols; fatty acids; low FODMAP,FUNCTIONAL GASTROINTESTINAL SYMPTOMS; MODERATE ULCERATIVE-COLITIS; GERMINATED BARLEY FOODSTUFF; LOW-FODMAP DIET; DOUBLE-BLIND; PROBIOTIC VSLNUMBER-3; CROHNS-DISEASE; MILD; POLYPHENOLS; REMISSION,"Inflammatory bowel diseases, including Crohn's disease and ulcerative colitis, are a life-long, chronic, and relapsing problem affecting 11.2 million people worldwide. To date, there is pharmacological therapy to treat symptoms such as diarrhea, constipation, and abdominal cramping/pain. These medications also help to alleviate everyday discomfort; however, there are no curative therapies. Recent studies have investigated the combination of pharmacological treatment along with nutritional interventions to improve quality of life and risk of disease relapse. Dietary supplements, specifically probiotics, polyphenols, fibers, fatty acids and low fermentable oligosaccharide, disaccharide, monosaccharide, and polyol diets (FODMAP diets), have been closely looked at to determine their effect, if any, on the development of inflammatory bowel disease and its course of progression. Approximately 30 studies were carefully reviewed and analyzed to appreciate the value of these above-mentioned supplements and their influence on this gastrointestinal disease. After analysis, it has been demonstrated that by implementing fibers, polyphenols, and fatty acids, as well as keeping a low-saccharide diet for those patients with Crohn's disease and ulcerative colitis can improve quality of life and invoke clinical remission. Some polyphenols, specifically curcumin and resveratrol, have proved to decrease disease activity in studies reviewed. Although these studies have become a topic of recent interest, it would be of great value to doctors and patients alike, to continue in this direction of research and to improve the findings for best treatment substances and dosages. This would lead to increased quality of life and disease control leading to fewer complications in the future.","[Malinowski, Bartosz; Wicinski, Michal; Sokolowska, Maya M.; Hill, Nicholas A.; Szambelan, Monika] Nicolaus Copernicus Univ, Coll Med Bydgoszcz, Fac Med, Dept Pharmacol & Therapeut, M Curie 9, PL-85090 Bydgoszcz, Poland",Nicolaus Copernicus University,"Malinowski, B (corresponding author), Nicolaus Copernicus Univ, Coll Med Bydgoszcz, Fac Med, Dept Pharmacol & Therapeut, M Curie 9, PL-85090 Bydgoszcz, Poland.",bartosz.malin@gmail.com; wicinski4@wp.pl; msokolowska@trentu.ca; originnikko91@gmail.com; moniassz410@gmail.com,,"Malinowski, Bartosz/0000-0001-9612-7417",,,,,58,18,18,5,34,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,MAY,2020,12,5,,,,,,,1423,10.3390/nu12051423,http://dx.doi.org/10.3390/nu12051423,,,14,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,MB0AV,32423084,"gold, Green Published",,,2024-06-04,WOS:000542272700215,View Full Record in Web of Science
J,"de Vries, J; Le Bourgot, C; Calame, W; Respondek, F",,,,"de Vries, Jan; Le Bourgot, Cindy; Calame, Wim; Respondek, Frederique",,,Effects of β-Fructans Fiber on Bowel Function: A Systematic Review and Meta-Analysis,NUTRIENTS,,,English,Review,,,,,,bowel function; constipation; dietary fibers; fructooligosaccharides; prebiotic,DOUBLE-BLIND; CHICORY INULIN; FECAL BIFIDOBACTERIA; CROSS-OVER; GASTROINTESTINAL TOLERANCE; JERUSALEM-ARTICHOKE; OLIGOSACCHARIDES; CONSUMPTION; CONSTIPATION; FRUCTOOLIGOSACCHARIDES,"The aim of this systematic review and meta-analysis was to assess the effects of beta-fructan supplementation on bowel function in healthy volunteers and patients. The search process was based on the selection of publications listed in the Pubmed and EUPMC database until December 2017, plus two unpublished studies, to identify studies evaluating the impact of beta-fructans on bowel movement and stool parameters. Forty-seven publications were selected for inclusion. Primary parameter was frequency of bowel movements, evaluated by the number of defecations per day during the study period. Secondary outcomes were stool consistency, stool dry and wet weights, and transit time. Short-chain (DP < 10) beta-fructans contributed to increased stool frequency (0.36 defecation +/- 0.06 per day; p < 0.001), while no significant effect was reported with long-chain (DP >= 10) beta-fructans (-0.03 +/- 0.11, p = 0.82). A minimal increase in stool wet weight was also statistically demonstrated with short-chain beta-fructans. Moreover, the meta-analysis highlighted significant differences in stool consistency in contrast to fecal dry weight after beta-fructan supplementation. This systematic review and meta-analysis indicates that short-chain beta-fructan supplementation has a positive effect on bowel function by significantly increasing the frequency of bowel movements.","[de Vries, Jan] De Vries Nutr Solut Inc, NL-7213 CE Gorssel, Netherlands; [Le Bourgot, Cindy; Respondek, Frederique] Tereos, R&D Dept, Rue Senlis, F-77230 Moussy Le Vieux, France; [Calame, Wim] StatistiCal BV, NL-2241 MN Wassenaar, Netherlands",,"Le Bourgot, C (corresponding author), Tereos, R&D Dept, Rue Senlis, F-77230 Moussy Le Vieux, France.",nutritionsolutions@me.com; cindy.lebourgot@tereos.com; w.calame@kpnplanet.nl; frederique.respondek@wanadoo.fr,"de Vries, Jan/AAW-4359-2021",,Tereos,Tereos,"J.d.V. and W.C. were financially supported by Tereos with respect to the work on the present manuscript, C.L.B. and F.R. are employees of Tereos at the time of writing the present manuscript.",,84,25,28,3,14,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,JAN,2019,11,1,,,,,,,91,10.3390/nu11010091,http://dx.doi.org/10.3390/nu11010091,,,17,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,HJ8VI,30621208,"Green Published, Green Submitted, gold",,,2024-06-04,WOS:000457477800040,View Full Record in Web of Science
J,"Veugelers, R; Benninga, MA; Calis, EAC; Willemsen, SP; Evenhuis, H; Tibboel, D; Penning, C",,,,"Veugelers, Rebekka; Benninga, Marc A.; Calis, Elsbeth A. C.; Willemsen, Sten P.; Evenhuis, Heleen; Tibboel, Dick; Penning, Corine",,,Prevalence and clinical presentation of constipation in children with severe generalized cerebral palsy,DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY,,,English,Article,,,,,,,DIETARY FIBER; COLONIC TRANSIT,"AIM Our aim was to study the prevalence and characteristics of constipation in children with profound multiple disabilities, as data in this area are scarce. METHOD A cross-sectional observational study was performed in specialized day-care centres and schools in the Netherlands. The study included 152 children (81 males, 71 females; mean age 9y 6mo, SD 4y 6mo). Intellectual disability ranged from moderate (7%) to profound (52%) in all participants who also had severe motor disabilities (83% classified at Gross Motor Function Classification System level V). We collected data on defaecation characteristics, food and fluid intake, and laxative consumption using standardized bowel diaries and interviews. Constipation was defined as (1) scybalous, pebble-like, hard stools in over a quarter of defaecations in combination with a defaecation frequency of less than three times per week during a 2-week study period; (2) large stools palpable on abdominal examination; or (3) laxative use or manual disimpaction of faeces. RESULTS Of the studied population, 57% were constipated and 55% used laxatives, 27% of whom showed symptoms of constipation. Daily intakes of water and fibre were below the required standards in 87% and 53% of participants respectively, without a proven relation to constipation. INTERPRETATION Constipation is a common problem in children with severe disabilities. Laxative use is high but dosing is frequently inadequate to prevent symptoms.","[Veugelers, Rebekka; Calis, Elsbeth A. C.; Evenhuis, Heleen; Penning, Corine] Erasmus MC, Dept Gen Practice, Rotterdam, Netherlands; [Veugelers, Rebekka; Calis, Elsbeth A. C.; Tibboel, Dick; Penning, Corine] Sophia Childrens Univ Hosp, Erasmus MC, Dept Pediat Surg, Rotterdam, Netherlands; [Benninga, Marc A.] Emma Childrens Hosp AMC, Dept Paediat Gastroenterol & Nutr, Amsterdam, Netherlands; [Willemsen, Sten P.] Erasmus MC, Dept Biostat, Rotterdam, Netherlands",Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC - Sophia Children's Hospital; Erasmus MC; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC,"Veugelers, R (corresponding author), Jonker Fransstr 96D, NL-3031 AW Rotterdam, Netherlands.",r.veugelers@asz.nl,,,,,,,25,72,82,0,5,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0012-1622,1469-8749,,DEV MED CHILD NEUROL,Dev. Med. Child Neurol.,SEP,2010,52,9,,,,,E216,E221,,10.1111/j.1469-8749.2010.03701.x,http://dx.doi.org/10.1111/j.1469-8749.2010.03701.x,,,6,Clinical Neurology; Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Neurosciences & Neurology; Pediatrics,639RU,20497454,Bronze,,,2024-06-04,WOS:000280993000004,View Full Record in Web of Science
J,"Reynolds, JC",,,,"Reynolds, JC",,,Challenges in the treatment of colonic motility disorders,AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY,,,English,Article,,,,,,cisapride; colonic diseases; constipation; dietary fiber; gastrointestinal drugs; gastrointestinal motility,IRRITABLE-BOWEL-SYNDROME; FAMILIAL VISCERAL MYOPATHY; CHRONIC CONSTIPATION; IDIOPATHIC CONSTIPATION; PSEUDO-OBSTRUCTION; MOTOR-ACTIVITY; DOUBLE-BLIND; INTESTINAL PSEUDOOBSTRUCTION; GASTROINTESTINAL-TRACT; HIRSCHSPRUNGS-DISEASE,"The pathophysiology and treatment of colonic motility disorders are reviewed. Colonic dysfunction is a common reason for patients to seek medical care, although patients' perceptions may not reflect abnormal function. Abnormalities in colonic function can result from a primary disorder of the large intestine or from metabolic, neurologic, collagen vascular, neoplastic, or infectious diseases. Irritable bowel syndrome, a common disorder of colonic motility, can be caused by alterations in colonic neuromuscular functions, afferent neural function, or psychosocial factors. Colonic dysmotility can also result from malabsorption of carbohydrates. The most severe form of altered colonic motility is acute colonic pseudo-obstruction. Diagnostic studies should be limited to tests appropriate for the patient's symptoms and apparent severity of disease. Most mo; tility disorders are functional disorders and do not result in abnormal studies. Pharmacotherapy should be directed by objective measures, the most useful of which are measurement of whole gut transit time and quantification of the water content of stools. Treatment should be determined by the nature of the disorder and the symptoms involved. For constipation, treatment should begin with changes in diet, fluid and fiber intake, and concurrent medications. Irritant laxatives can have damaging effects and should not be used habitually; however, polyethylene glycol-based purgatives can be helpful. Newer prokinetic agents, such as cisapride, have been shown to promote colonic motility. For selected patients with intractable constipation, surgery has a good success rate. For patients with functional diarrhea, opioid analogues can increase fluid absorption and delay transit.",,,"ALLEGHENY UNIV HLTH SCI, DIV GASTROENTEROL & HEPATOL, BROAD & VINE ST, PHILADELPHIA, PA 19102 USA.",,,,,,,,77,3,8,0,0,AMER SOC HEALTH-SYSTEM PHARMACISTS,BETHESDA,"7272 WISCONSIN AVE, BETHESDA, MD 20814 USA",1079-2082,1535-2900,,AM J HEALTH-SYST PH,Am. J. Health-Syst. Pharm.,NOV 15,1996,53,,,3,,,S17,S26,,10.1093/ajhp/53.22_Suppl_3.S17,http://dx.doi.org/10.1093/ajhp/53.22_Suppl_3.S17,,,10,Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy,VT998,8931827,Bronze,,,2024-06-04,WOS:A1996VT99800004,View Full Record in Web of Science
J,"Rao, SSC; Lacy, BE; Emmanuel, A; Müller-Lissner, S; Pohl, D; Quigley, EMM; Whorwell, P",,,,"Rao, Satish S. C.; Lacy, Brian E.; Emmanuel, Anton; Muller-Lissner, Stefan; Pohl, Daniel; Quigley, Eamonn M. M.; Whorwell, Peter",,,Recognizing and Defining Occasional Constipation: Expert Consensus Recommendations,AMERICAN JOURNAL OF GASTROENTEROLOGY,,,English,Review,,,,,,,QUALITY-OF-LIFE; STATEMENT AIGO/SICCR DIAGNOSIS; SELF-REPORTED CONSTIPATION; POPULATION-BASED SURVEY; LAXATIVE USE; PREVALENCE; ADULTS; CRITERIA; SEEKING; FIBER,"Constipation is a common problem, affects 15% of the population, and is often self-diagnosed and self-managed. Over the past 3 decades, there have been significant advances in our understanding and management of chronic constipation, with the emerging recognition that occasional constipation (OC) is another subtype that falls outside current classifications. The purpose of this review was to describe the process of developing and proposing a new definition for OC based on expert consensus and taking into consideration the multifactorial nature of the problem such as alterations in bowel habit that include stool frequency and difficulty with stool passage, perception of the sufferer, duration of symptoms, and potential responsiveness to treatment. Leading gastroenterologists from 5 countries met virtually on multiple occasions through an online digital platform to discuss the problem of OC and recommended a practical, user-friendly definition: OC can be defined as intermittent or occasional symptomatic alteration(s) in bowel habit. This includes a bothersome reduction in the frequency of bowel movements and/or difficulty with passage of stools but without alarming features. Bowel symptoms may last for a few days or a few weeks, and episodes may require modification of lifestyle, dietary habits and/or use of over-the-counter laxatives or bulking agents to restore a satisfactory bowel habit. Prospective studies are required to validate this definition and determine OC prevalence in the community. This review highlights current knowledge gaps and could provide impetus for future research to facilitate an improved understanding of OC and development of evidence-based management guidelines.","[Rao, Satish S. C.] Augusta Univ, Med Coll Georgia, Digest Hlth Ctr, Div Gastroenterol Hepatol, Augusta, GA USA; [Lacy, Brian E.] Mayo Clin, Div Gastroenterol, Jacksonville, FL USA; [Emmanuel, Anton] Univ Coll London Hosp, GI Physiol Unit, London, England; [Pohl, Daniel] Univ Hosp Zurich, Dept Gastroenteroloy & Hepatol, Zurich, Switzerland; [Quigley, Eamonn M. M.] Houston Methodist Hosp, Weill Cornell Med Coll, Lynda K & David M Underwood Ctr Digest Disorders, Div Gastroenterol & Hepatol, Houston, TX USA; [Whorwell, Peter] Wythenshawe Hosp, Neurogastroenterol Unit, Manchester, Lancs, England",University System of Georgia; Augusta University; Mayo Clinic; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Zurich; University Zurich Hospital; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital,"Rao, SSC (corresponding author), Augusta Univ, Med Coll Georgia, Digest Hlth Ctr, Div Gastroenterol Hepatol, Augusta, GA USA.",srao@augusta.edu; Lacy.Brian@mayo.edu; anton.emmanuel@nhs.net; stefan@mueller-lissner.de; Daniel.Pohl@usz.ch; equigley@houstonmethodist.org; peter.whorwell@mft.nhs.uk,,"Rao, Satish/0000-0002-4446-8452",Sanofi,Sanofi,"This manuscript was developed based on inputs from advisors (the authors) who initiated and participated in an expert consensus meeting supported by Sanofi. The authors received an honorarium to participate in this meeting. Medical writing support for the development of this manuscript, under the direction of the authors, was provided by Ian C Grieve, PhD, of Ashfield MedComms, an Inizio company, and was funded by Sanofi.",,44,5,5,2,8,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0002-9270,1572-0241,,AM J GASTROENTEROL,Am. J. Gastroenterol.,NOV,2022,117,11,,,,,1753,1758,,10.14309/ajg.0000000000001945,http://dx.doi.org/10.14309/ajg.0000000000001945,,,6,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,5X0MP,35971230,"Green Published, hybrid",,,2024-06-04,WOS:000878303000014,View Full Record in Web of Science
J,"Illippangama, AU; Jayasena, DD; Jo, C; Mudannayake, DC",,,,"Illippangama, Ashinshana U.; Jayasena, Dinesh D.; Jo, Cheorun; Mudannayake, Deshani C.",,,Inulin as a functional ingredient and their applications in meat products,CARBOHYDRATE POLYMERS,,,English,Article,,,,,,Inulin; Dietary fiber; Functional ingredient; Meat products; Prebiotic,DIETARY FIBER; LOW-FAT; SENSORY PROPERTIES; PHYSICOCHEMICAL CHARACTERISTICS; QUALITY CHARACTERISTICS; CICHORIUM-INTYBUS; HEALTH-BENEFITS; BEEF BURGER; REPLACER; TEXTURE,"ABSTR A C T Inulin, a fructan-type non-digestible carbohydrate, is a natural functional dietary fiber found in selected plants including chicory, garlic, onion, leeks and asparagus. Due to increasing popularity of inulin and rising awareness toward its low calorie value and prebiotic related health implications, consumers are becoming more conscious on consuming inulin incorporated foods. In this review, the scientific studies published in recent years regarding potential applications of inulin in meat products; and their effects on physicochemical and sensory properties, and health implications are discussed. Meat based functional foods with inulin can lead to enhance digestive health by reducing the risk of diseases like constipation, irritable bowel syndrome, inflammatory bowel disease and colorectal cancer. Inulin can be an interesting prebiotic ingredient in healthier meat formulations, apart from being a fat replacer and dietary fiber enhancer.","[Illippangama, Ashinshana U.; Jayasena, Dinesh D.; Mudannayake, Deshani C.] Uva Wellassa Univ, Dept Anim Sci, Badulla 90000, Sri Lanka; [Jo, Cheorun] Seoul Natl Univ, Ctr Food & Bioconvergence, Dept Agr Biotechnol, Seoul 08826, South Korea; [Jo, Cheorun] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 08826, South Korea",Uva Wellassa University; Seoul National University (SNU); Seoul National University (SNU),"Mudannayake, DC (corresponding author), Uva Wellassa Univ, Dept Anim Sci, Badulla 90000, Sri Lanka.",deshani@uwu.ac.lk,"Mudannayake, Deshani Chirajeevi/ISB-8206-2023; Jo, Cheorun/D-5724-2014","Mudannayake, Deshani C./0000-0001-8572-0696",Uva Wellassa University of Sri Lanka [UWU/RG/18/38],Uva Wellassa University of Sri Lanka,Authors would like to acknowledge the financial support of Uva Wellassa University of Sri Lanka (Capital Grant No. UWU/RG/18/38) .,,115,41,44,9,95,ELSEVIER SCI LTD,OXFORD,"THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND",0144-8617,1879-1344,,CARBOHYD POLYM,Carbohydr. Polym.,JAN 1,2022,275,,,,,,,,118706,10.1016/j.carbpol.2021.118706,http://dx.doi.org/10.1016/j.carbpol.2021.118706,,OCT 2021,11,"Chemistry, Applied; Chemistry, Organic; Polymer Science",Science Citation Index Expanded (SCI-EXPANDED),Chemistry; Polymer Science,WI9ZT,34742431,,,,2024-06-04,WOS:000708711800008,View Full Record in Web of Science
J,"TURNBULL, GK; LENNARDJONES, JE; BARTRAM, CI",,,,"TURNBULL, GK; LENNARDJONES, JE; BARTRAM, CI",,,WHY INCREASED DIETARY FIBER OR LAXATIVES MAY FAIL IN THE TREATMENT OF SEVERE CONSTIPATION,GUT,,,English,Meeting Abstract,,,,,,,,,"ST MARYS HOSP,LONDON,ENGLAND",Imperial College London,,,,,,,,,0,0,0,0,0,BRITISH MED JOURNAL PUBL GROUP,LONDON,"BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR",0017-5749,,,GUT,Gut,MAY,1986,27,5,,,,,A617,A617,,,,,,1,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,C1846,,,,,2024-06-04,WOS:A1986C184600130,View Full Record in Web of Science
J,"HOPE, AK; DOWN, EC",,,,"HOPE, AK; DOWN, EC",,,DIETARY FIBER AND FLUID IN THE CONTROL OF CONSTIPATION IN A NURSING-HOME POPULATION,MEDICAL JOURNAL OF AUSTRALIA,,,English,Article,,,,,,,,,,,"HOPE, AK (corresponding author), PHILIP KENNEDY CTR,EVERARD ST,LARGS BAY,SA 5016,AUSTRALIA.",,,,,,,,7,21,21,1,2,AUSTRALASIAN MED PUBL CO LTD,SYDNEY,"LEVEL 1, 76 BERRY ST, SYDNEY NSW 2060, AUSTRALIA",0025-729X,,,MED J AUSTRALIA,Med. J. Aust.,MAR 17,1986,144,6,,,,,306,307,,10.5694/j.1326-5377.1986.tb128380.x,http://dx.doi.org/10.5694/j.1326-5377.1986.tb128380.x,,,2,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,A4519,3012298,,,,2024-06-04,WOS:A1986A451900010,View Full Record in Web of Science
J,"Khalid, W; Arshad, MS; Jabeen, A; Anjum, FM; Qaisrani, TB; Suleria, HAR",,,,"Khalid, Waseem; Arshad, Muhammad Sajid; Jabeen, Ayesha; Anjum, Faqir Muhammad; Qaisrani, Tahira Batool; Suleria, Hafiz Ansar Rasul",,,Fiber-enriched botanicals: A therapeutic too metabolic ailments,FOOD SCIENCE & NUTRITION,,,English,Article,,,,,,COVID-19; diseases; fiber; immune system; plant-based foods,CHOLESTEROL-LOWERING PROPERTIES; SOLUBLE DIETARY-FIBERS; HEALTH-BENEFITS; COLORECTAL-CANCER; BODY-WEIGHT; RICE BRAN; GUAR GUM; PHYSICOCHEMICAL PROPERTIES; FUNCTIONAL CONSTIPATION; CHEMICAL-COMPOSITION,"Plant-based foods are natural sources including vegetables, fruits, cereals and legumes. These foods consist of various types of nutrients in which carbohydrate is the basic component. However, some plant-based diets contain carbohydrates in the form of fiber. The fiber is usually a nondigestible polysaccharide that is not digested in the human body. It is present in the form of soluble or insoluble in different part of foods like peel, bran, pulp and grain. Pectin, beta-glucan, mucilage, psyllium, resistant starch and inulin are soluble fiber, and cellulose, hemicellulose and lignin are insoluble fiber attained from plant foods. The major function enhances immunity by creating gastrointestinal barrier, mucus production, immune cell activity and IgA level. Previous evidences showed that peoples with strong immunity have fewer chances of viral disease. A recent viral disease named COVID-19 spread in the world and millions of peoples died due to this viral disease. Coronavirus mostly attacks humans that suffer with weak immune system. It is due chronic diseases like diabetes and CVD (cardiovascular disease). The current review shows that fiber-containing plant-based foods boost immunity and aid human against COVID-19. The therapeutic role of fiber in the human body is to control the risk of hypertension and diabetes because a high-fiber diet has the ability to lower cholesterol, blood pressure and blood sugar. Fibers aid in GIT (gastrointestinal tract) and prevent constipation because it absorbs water and adds bulk to stool.","[Khalid, Waseem; Arshad, Muhammad Sajid; Jabeen, Ayesha] Govt Coll Univ, Fac Life Sci, Dept Food Sci, Faisalabad, Pakistan; [Anjum, Faqir Muhammad] Univ Gambia, Banjul, Gambia; [Anjum, Faqir Muhammad] IFANCA Halal Apex Pvt Ltd, Faisalabad, Pakistan; [Qaisrani, Tahira Batool] Ghazi Univ, Dept Agr Engn & Technol, Dera Ghazi Khan, Pakistan; [Suleria, Hafiz Ansar Rasul] Univ Melbourne, Dept Agr & Food Syst, Melbourne, Vic, Australia",Government College University Faisalabad; University of the Gambia; University of Melbourne,"Arshad, MS (corresponding author), Govt Coll Univ, Fac Life Sci, Dept Food Sci, Faisalabad, Pakistan.",sajid_ft@yahoo.com,"ANJUM, FAQIR/AAW-9311-2020; Arshad, Muhammad Sajid/AAR-4975-2020; Khalid, Waseem/IXN-2782-2023; Suleria, Hafiz Ansar Rasul/D-3385-2013","Suleria, Hafiz Ansar Rasul/0000-0002-2450-0830",,,,,164,8,9,4,21,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",2048-7177,,,FOOD SCI NUTR,Food Sci. Nutr.,OCT,2022,10,10,,,,,3203,3218,,10.1002/fsn3.2920,http://dx.doi.org/10.1002/fsn3.2920,,AUG 2022,16,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,5D9VY,36249968,Green Published,,,2024-06-04,WOS:000844532000001,View Full Record in Web of Science
J,"Alexandre, V; Bertin, C; Boubaya, M; Airinei, G; Bouchoucha, M; Benamouzig, R",,,,"Alexandre, Virginie; Bertin, Claire; Boubaya, Marouane; Airinei, Gheorghe; Bouchoucha, Michel; Benamouzig, Robert",,,"Randomized clinical trial: efficacy of a food supplement, TRANSITECH, on healthy individuals with mild intermittent constipation",EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY,,,English,Article,,,,,,colonic transit time; constipation; food supplement; healthy individuals; stool frequency,FUNCTIONAL GASTROINTESTINAL DISORDERS; CHRONIC IDIOPATHIC CONSTIPATION; SENNOSIDE-INDUCED SECRETION; IRRITABLE-BOWEL-SYNDROME; DIETARY FIBER; GENERAL-POPULATION; COLONIC TRANSIT; OBESITY; EPIDEMIOLOGY; PREVALENCE,"Background Constipation is a common disorder in the general population and can be observed in healthy individuals. A natural product leading to an increase in bowel movements and decrease in colonic transit time (CTT), without bloating, could be useful for the patient's care. Objectives To investigate the effects of TRANSITECH, a food supplement composed of plants and lactic ferments, on bowel movements, CTT and bloating. Methods A total of 100 healthy participants, presenting two to five stools per week, were selected and followed over a 6-day baseline period. They were randomly assigned to receive daily two tablets of TRANSITECH or placebo during 10 days. They were then followed up over 28 days after intervention. Participants daily recorded in a home questionnaire the characteristics of stools (frequency and consistency), and the importance of bloating during the preintervention period (from D-6 to D0), the intervention period (from D0 to D10) and the postintervention period (from D10 to D38). Their CTTs were also evaluated by following the propagation of radiopaque markers at D0 and D10. Results At D10, the food supplement group showed, compared with the placebo group, higher daily stool emission (0.95 +/- 0.50, 0.70 +/- 0.20, P<0.001), softer stool consistency (2.5 +/- 0.6 vs. 3.0 +/- 0.8, P<0.001) and lower CTT (33.8 +/- 28.2 vs. 56.4 +/- 36.2 h, P = 0.01). The active group also showed a sustained increase in daily stool emissions observed at D38 compared with D0 (P=0.03). Conclusion TRANSITECH is an efficient natural solution for the treatment of constipation. It increases the number of bowel movements, decreases the oroanal and segmental CTT, is well tolerated, and presents sustained effects after treatment completion. Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.","[Alexandre, Virginie; Airinei, Gheorghe; Bouchoucha, Michel; Benamouzig, Robert] Avicenne Hosp, AP HP, Dept Gastroenterol, 125 Route Stalingrad, F-93009 Bobigny, France; [Boubaya, Marouane] Avicenne Hosp, Clin Res Unit, Bobigny, France; [Alexandre, Virginie] Grp Urgo, Vivatech, Paris, France; [Bertin, Claire] Grp Urgo, Urgotech, Paris, France",Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP,"Benamouzig, R (corresponding author), Avicenne Hosp, AP HP, Dept Gastroenterol, 125 Route Stalingrad, F-93009 Bobigny, France.",robert.benamouzig@avc.aphp.fr,"BENAMOUZIG, Robert/W-8067-2019","BENAMOUZIG, ROBERT/0000-0003-1952-6830","Vivatech, Paris, France","Vivatech, Paris, France","This study was fully supported by Vivatech, Paris, France.",,42,2,2,0,6,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0954-691X,1473-5687,,EUR J GASTROEN HEPAT,Eur. J. Gastroenterol. Hepatol.,SEP,2016,28,9,,,,,1087,1093,,10.1097/MEG.0000000000000672,http://dx.doi.org/10.1097/MEG.0000000000000672,,,7,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,DS5EY,27347788,,,,2024-06-04,WOS:000380805300017,View Full Record in Web of Science
J,"Furnari, M; de Bortoli, N; Martinucci, I; Bodini, G; Revelli, M; Marabotto, E; Moscatelli, A; Del Nero, L; Savarino, E; Giannini, EG; Savarino, V",,,,"Furnari, Manuele; de Bortoli, Nicola; Martinucci, Irene; Bodini, Giorgia; Revelli, Matteo; Marabotto, Elisa; Moscatelli, Alessandro; Del Nero, Lorenzo; Savarino, Edoardo; Giannini, Edoardo G.; Savarino, Vincenzo",,,Optimal management of constipation associated with irritable bowel syndrome,THERAPEUTICS AND CLINICAL RISK MANAGEMENT,,,English,Review,,,,,,IBS; functional gastrointestinal disorders; laxatives,HYDROLYZED GUAR GUM; GUANYLATE-CYCLASE-C; FUNCTIONAL GASTROINTESTINAL DISORDERS; PLACEBO-CONTROLLED TRIAL; COLONIC TRANSIT-TIME; ROME III CRITERIA; QUALITY-OF-LIFE; INTERNATIONAL SURVEY; CLINICAL-TRIALS; ALARM FEATURES,"Irritable bowel syndrome (IBS) is a common chronic functional disorder of the gastrointestinal tract, meanly characterized by recurrent abdominal pain or discomfort and altered bowel habit. It is a complex disorder involving biological, environmental, and psychosocial factors. The diagnosis is achieved according to the Rome III criteria provided that organic causes have been excluded. Although IBS does not constitute a life-threatening condition, it has a remarkable prevalence and profoundly reduces the quality of life with burdening socioeconomic costs. One of the principal concerns about IBS is the lack of effective therapeutic options. Up to 40% of patients are not satisfied with any available medications, especially those suffering from chronic constipation. A correct management of IBS with constipation should evolve through a global approach focused on the patient, starting with careful history taking in order to assess the presence of organic diseases that might trigger the disorder. Therefore, the second step is to examine lifestyle, dietary habits, and psychological status. On these bases, a step-up management of disease is recommended: from fiber and bulking agents, to osmotic laxative drugs, to new molecules like lubiprostone and linaclotide. Although new promising tools for relief of bowel-movement-related symptoms are being discovered, a dedicated doctor-patient relationship still seems to be the key for success.","[Furnari, Manuele; Bodini, Giorgia; Marabotto, Elisa; Moscatelli, Alessandro; Del Nero, Lorenzo; Giannini, Edoardo G.; Savarino, Vincenzo] Univ Genoa, Dept Internal Med, Div Gastroenterol, I-16132 Genoa, Italy; [de Bortoli, Nicola; Martinucci, Irene] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Div Gastroenterol, Pisa, Italy; [Revelli, Matteo] San Bartolomeo Hosp, Dept Radiol, Sarzana, Italy; [Savarino, Edoardo] Univ Padua, Dept Surg Oncol & Gastroenterol, Div Gastroenterol, Padua, Italy",University of Genoa; University of Pisa; University of Padua,"Furnari, M (corresponding author), Univ Genoa, Dept Internal Med, Div Gastroenterol, Viale Benedetto XV 6, I-16132 Genoa, Italy.",manuele.furnari@unige.it,"Marabotto, Elisa/AAB-2874-2021; Savarino, Edoardo/AAC-7510-2022; Giannini, Edoardo Giovanni/E-1120-2012; Bodini, Giorgia/AAC-2888-2019; Furnari, Manuele/N-5545-2015","Marabotto, Elisa/0000-0003-4507-8605; Savarino, Edoardo/0000-0002-3187-2894; Giannini, Edoardo Giovanni/0000-0001-8526-837X; Bodini, Giorgia/0000-0002-8367-0338; Revelli, Matteo/0000-0001-6264-2381; Furnari, Manuele/0000-0001-6424-079X; DE BORTOLI, NICOLA/0000-0003-1995-1060",,,,,113,7,8,0,8,DOVE MEDICAL PRESS LTD,ALBANY,"PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND",,1178-203X,,THER CLIN RISK MANAG,Therap. Clin. Risk Manag.,,2015,11,,,,,,691,703,,10.2147/TCRM.S54298,http://dx.doi.org/10.2147/TCRM.S54298,,,13,Health Care Sciences & Services,Science Citation Index Expanded (SCI-EXPANDED),Health Care Sciences & Services,CH0KS,26028974,"Green Published, Green Submitted, gold",,,2024-06-04,WOS:000353709200001,View Full Record in Web of Science
J,"Remes-Troche, JM; Coss-Adame, E; Amieva-Balmori, M; Velasco, JAVR; Gomez-Castaños, PC; Flores-Rendón, R; Gómez-Escudero, O; Rodríguez-Leal, MC; Durán-Rosas, C; Pinto-Gálvez, SM; Priego-Parra, BA; Triana-Romero, A",,,,"Maria Remes-Troche, Jose; Coss-Adame, Enrique; Amieva-Balmori, Mercedes; Velarde-Ruiz Velasco, Jose Antonio; Cesar Gomez-Castanos, Paulo; Flores-Rendon, Ricardo; Gomez-Escudero, Octavio; Celina Rodriguez-Leal, Maria; Duran-Rosas, Cristina; Mayanin Pinto-Galvez, Samanta; Adrian Priego-Parra, Bryan; Triana-Romero, Arturo",,,Incidence of 'new-onset' constipation and associated factors during lockdown due to the COVID-19 pandemic,BMJ OPEN GASTROENTEROLOGY,,,English,Article,,,,,,,QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; EXERCISE; HEALTH; FIBER; QUESTIONNAIRE; NUTRITION; TRIALS; WATER,"Objective A minimum of physical activity and low liquid intake are factors that have been associated with constipation. The health emergency brought on by the COVID-19 pandemic has resulted in adopting behaviour, such as sheltering-in-place (less mobility) and dietary changes, creating a scenario we believe to be an adequate model for examining the appearance of symptoms of constipation and its associated factors. Design A cross-sectional and descriptive study was conducted on an open population, applying an electronic survey (4 weeks after lockdown due to COVID-19 in Mexico) to evaluate demographic characteristics, physical activity, water and fibre intake, appearance of constipation symptoms (including stool consistency), and quality of life. Results Out of 678 subjects evaluated, 170 (25%, 95% CI: 21.7 to 28.4) developed symptoms of 'new-onset' constipation, with a significant decrease in the number of daily bowel movements (p<0.05) and stool consistency (p<0.05) during lockdown. Furthermore, in the 'new-onset' constipation population there was a higher proportion of subjects (79 (47%) of 170) who stopped exercising during the pandemic compared with the subjects who did not develop constipation symptoms (187 (37%) of 508, p=0.03, OR: 1.49, 95% CI: 1.0 to 2.1). The multivariate analysis (logistic regression) showed that female sex (p=0.001), water intake (p=0.039), and physical activity (p=0.012) were associated with 'new-onset' constipation. Conclusions In our study on an open population in Mexico, we found that one-fourth of the population developed 'new-onset' constipation symptoms during the lockdown imposed due to the COVID-19 pandemic. A reduction of physical activity and less water consumption were associated factors.","[Maria Remes-Troche, Jose; Amieva-Balmori, Mercedes; Duran-Rosas, Cristina; Mayanin Pinto-Galvez, Samanta; Adrian Priego-Parra, Bryan; Triana-Romero, Arturo] Univ Veracruzana, Inst Invest Med Biol, Xalapa, Veracruz, Mexico; [Coss-Adame, Enrique] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Gastroenterol, Mexico City, DF, Mexico; [Velarde-Ruiz Velasco, Jose Antonio] Hosp Civil Guadalajara, Unidad Hosp Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico; [Cesar Gomez-Castanos, Paulo] UAS CIDOCS, Culiacan, Sinaloa, Mexico; [Flores-Rendon, Ricardo] ISSSTECALI, Tijuana, Mexico; [Gomez-Escudero, Octavio] Hosp Angeles Puebla, Puebla, Mexico; [Celina Rodriguez-Leal, Maria] IMSS UMAE 25, Monterrey, Mexico",Universidad Veracruzana; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Mexicano del Seguro Social,"Remes-Troche, JM (corresponding author), Univ Veracruzana, Inst Invest Med Biol, Xalapa, Veracruz, Mexico.",jose.remes.troche@gmail.com,"Priego-Parra, Bryan Adrian/AHH-1274-2022; Remes-Troche, Jose Maria/K-2739-2012; Velarde-Ruiz Velasco, Jose Antonio/ITV-3580-2023","Priego-Parra, Bryan Adrian/0000-0003-1506-806X; Remes-Troche, Jose Maria/0000-0001-8478-9659; Velarde-Ruiz Velasco, Jose Antonio/0000-0002-6568-7048; Triana Romero, Arturo/0000-0002-9088-0421",,,,,33,4,4,1,6,BMJ PUBLISHING GROUP,LONDON,"BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND",2054-4774,,,BMJ OPEN GASTROENTER,BMJ Open Gastroenterol.,SEP,2021,8,1,,,,,,,e000729,10.1136/bmjgast-2021-000729,http://dx.doi.org/10.1136/bmjgast-2021-000729,,,9,Gastroenterology & Hepatology,Emerging Sources Citation Index (ESCI),Gastroenterology & Hepatology,YU3CG,34531245,"Green Submitted, Green Published, gold",,,2024-06-04,WOS:000751923300001,View Full Record in Web of Science
J,"Swier, RM; Siebrasse, A; Coscia, E; Peery, AF",,,,"Swier, Rachel M.; Siebrasse, Alisa; Coscia, Emily; Peery, Anne F.",,,Diet in Benign Colonic Disorders: A Narrative Review,CLINICAL THERAPEUTICS,,,English,Review,,,,,,chronic constipation; colonic diverticulitis; diet; fecal incontinence; fiber; inflammatory bowel disease; irritable bowel syndrome,IRRITABLE-BOWEL-SYNDROME; ASSOCIATION INSTITUTE GUIDELINE; CLINICAL-PRACTICE GUIDELINES; LONG-TERM INTAKE; ULCERATIVE-COLITIS; CARBOHYDRATE-DIET; CROHNS-DISEASE; MEDICAL-MANAGEMENT; FECAL INCONTINENCE; PHYSICAL-ACTIVITY,"Purpose: Diet plays an important role in common benign colorectal diseases. This article reviews the evidence for diet and supplemental fiber in patients with chronic constipation, irritable bowel syndrome, inflammatory bowel disease, colonic diverticulitis, and fecal incontinence. Methods: We performed a narrative review of the evidence for diet and supplemental fiber in patients with 5 common benign colonic diseases and summarized guideline recommendations for each condition. We generated tables of practical dietary advice by disease. Findings: Diet advice must be individualized and depends on underlying conditions, disease severity, symptom burden, and nutrition status. Guidance from a registered dietitian is highly recommended when making any dietary changes. Data from trials suggest that soluble fiber is effective for patients with chronic constipation, irritable bowel syndrome, and fecal incontinence. A diet low in select fermentable, oligo, di-, and monosaccharides, and polyols may benefit patients with irritable bowel syndrome. Patients with inflammatory bowel disease, especially those with active disease, are at risk for malnutrition. Dietary restrictions may further increase that risk. There is limited evidence to recommend increasing or avoiding select food groups in patients with inflammatory bowel disease. Patients who have recovered from diverticulitis should adopt a prudent dietary pattern high in fruits, vegetables, whole grains, legumes, poultry, and fish. (C) 2022 Elsevier Inc.","[Swier, Rachel M.; Siebrasse, Alisa; Coscia, Emily; Peery, Anne F.] Univ N Carolina, Chapel Hill, NC 27599 USA",University of North Carolina; University of North Carolina Chapel Hill,"Peery, AF (corresponding author), Univ N Carolina, Sch Med, Bioinformat Bldg,CB 7080,130 Mason Farm Rd, Chapel Hill, NC 27599 USA.",anne_peery@med.unc.edu,,,,,,,76,3,3,3,11,ELSEVIER,BRIDGEWATER,"685 ROUTE 202-206, BRIDGEWATER, NJ 08807 USA",0149-2918,1879-114X,,CLIN THER,Clin. Ther.,MAY,2022,44,5,,,,,657,670,,10.1016/j.clinthera.2022.03.010,http://dx.doi.org/10.1016/j.clinthera.2022.03.010,,,14,Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy,3I7AS,35400534,Bronze,,,2024-06-04,WOS:000832865300005,View Full Record in Web of Science
J,"Marlett, JA; Kajs, TM; Fischer, MH",,,,"Marlett, JA; Kajs, TM; Fischer, MH",,,An unfermented gel component of psyllium seed husk promotes laxation as a lubricant in humans,AMERICAN JOURNAL OF CLINICAL NUTRITION,,,English,Article,,,,,,psyllium seed husk; Plantago ovata; dietary fiber; laxation; colon function; constipation; fermentation,IRRITABLE BOWEL SYNDROME; DIETARY FIBER CONTENT; WHEAT BRAN; STOOL CHARACTERISTICS; DIVERTICULAR-DISEASE; CALCIUM BALANCE; ISPAGHULA HUSK; TRANSIT-TIME; COLON; CONSTIPATION,"Background: In addition to increasing stool weight, supplements of psyllium seed husk produce stools that are slick and gelatinous. Objective: Our purpose was to test the hypothesis that a gel-forming fraction of psyllium escapes microbial fermentation and is responsible for the characteristics that enhance laxation. Design: Fifteen healthy adults consumed controlled diets for two 7-d periods, one of which included 8.8 g dietary fiber provided by 15 g/d of a psyllium seed husk preparation. All stools were collected and evaluated and diet was monitored throughout. Results: Psyllium significantly increased the apparent viscosity of an aqueous stool extract, stool moisture, and wet and dry stool weights. A very viscous fraction, not present in low-fiber stool and containing predominantly 2 sugars that are also found in abundance in psyllium husk, was isolated from psyllium stool. Conclusions: In contrast with other viscous fibers that are fermented completely in the colon, a component of psyllium is not fermented. This gel provided lubrication that facilitated propulsion of colon contents and produced a stool that was bulkier and more moist than were stools resulting with use of comparable amounts of other bowel-regulating fiber sources.","Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA; Procter & Gamble Co, Mason, OH USA",University of Wisconsin System; University of Wisconsin Madison; Procter & Gamble,"Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.",jmarlett@nutrisci.wisc.edu,"Bowlus, Christopher/N-9276-2016","Bowlus, Christopher/0000-0002-3906-6811",,,,,40,64,73,0,20,OXFORD UNIV PRESS,OXFORD,"GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND",0002-9165,1938-3207,,AM J CLIN NUTR,Am. J. Clin. Nutr.,SEP,2000,72,3,,,,,784,789,,,,,,6,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,349AH,10966900,,,,2024-06-04,WOS:000089021300020,View Full Record in Web of Science
J,"Culbert, TP; Banez, GA",,,,"Culbert, Timothy P.; Banez, Gerard A.",,,Integrative approaches to childhood constipation and encopresis,PEDIATRIC CLINICS OF NORTH AMERICA,,,English,Review,,,,,,,DIETARY FIBER; BIOFEEDBACK TREATMENT; ALTERNATIVE MEDICINE; ABDOMINAL MASSAGE; CHILDREN; COMPLEMENTARY; THERAPY; ACUPUNCTURE; GASTROENTEROLOGY; DEFECATION,"Constipation and encopresis (fecal soiling) are common childhood disorders that may lead to significant functional impairment. The etiology and course of constipation and encopresis are increasingly conceptualized from a broad biopsychosocial perspective, and therefore a holistic approach to assessment and treatment is indicated. Many children experience symptoms of chronic constipation and/or encopresis that are only partially responsive to conventional medical therapy. Complementary/alternative therapies can often help in the treatment of constipation/encopresis and are well accepted by patients and families.","[Culbert, Timothy P.] Childrens Hosp & Clin Minnesota, Integrat Med Program, Minneapolis, MN 55404 USA; [Banez, Gerard A.] Cleveland Clin Childrens Hosp, Behav Pediat Treatment Serv, Cleveland, OH 44195 USA",Children's Hospitals & Clinics of Minnesota; Cleveland Clinic Foundation,"Culbert, TP (corresponding author), Childrens Hosp & Clin Minnesota, Integrat Med Program, 2525 Chicago Ave S, Minneapolis, MN 55404 USA.",timothy.culbert@childrensmn.org,,,,,,,101,24,27,0,15,W B SAUNDERS CO-ELSEVIER INC,PHILADELPHIA,"1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA",0031-3955,1557-8240,,PEDIATR CLIN N AM,Pediatr. Clin. N. Am.,DEC,2007,54,6,,,,,927,+,,10.1016/j.pcl.2007.09.001,http://dx.doi.org/10.1016/j.pcl.2007.09.001,,,22,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,252AD,18061784,,,,2024-06-04,WOS:000252416300007,View Full Record in Web of Science
J,"Kim, JE; Yun, WB; Lee, ML; Choi, JY; Park, JJ; Kim, HR; Song, BR; Hong, JT; Song, HK; Hwang, DY",,,,"Kim, Ji Eun; Yun, Woo Bin; Lee, Mi Lim; Choi, Jun Young; Park, Jin Ju; Kim, Hye Ryeong; Song, Bo Ram; Hong, Jin Tae; Song, Hyun Keun; Hwang, Dae Youn",,,"Synergic Laxative Effects of an Herbal Mixture of Liriope platyphylla, Glycyrrhiza uralensis, and Cinnamomum cassia in Loperamide-Induced Constipation of Sprague Dawley Rats",JOURNAL OF MEDICINAL FOOD,,,English,Article,,,,,,Cinnamomum cassia; constipation; Glycyrrhiza uralensis; laxative effects; Liriope platyphylla,MUSCARINIC RECEPTORS; SMOOTH-MUSCLE; DIETARY FIBER; MEDICINE; INFLAMMATION; POPULATION,"Constipation is an acute or chronic illness attributed to various causes, ranging from lifestyle habits to side effects of a disease. To improve the laxative effects of some traditional medicines, herbal mixtures of Liriope platyphylla, Glycyrrhiza uralensis, and Cinnamomum cassia (LGC) were evaluated for their mechanism of action and therapeutic effects in loperamide (Lop)-induced constipated Sprague Dawley rats by examining alterations in excretion parameters, histological structure, mucin secretion, and related protein levels. Food intake and water consumption were constant for all animals. We observed that the Lop+LGC-treated group had significantly greater excretion of stool and urine than was observed in the Lop+Vehicle-treated group. Administration of LGC in the constipation model restored the intestinal transit ratio to normal levels, and increased the number of goblet cells, mucosal layer, and muscle thickness. Mucin secretion was greater in the Lop+LGC-treated group than in the Lop+Vehicle-treated group, and the expression of MUC2 and AQP8 genes were also increased. In addition, reverse transcription polymerase chain reaction and Western blot revealed an increase in the muscarinic acetylcholine receptors (mAChRs) in the Lop+LGC-treated group compared to the Lop+Vehicle-treated group. Furthermore, compared with the Lop+Vehicle-treated group, treatment with LGC reduced the phosphorylation of PKC and PI3K, and expression of G alpha protein, but increased levels of IP3. Our results suggest that the traditional herbal mixture of LGC induces a potent laxative effect in Lop-induced constipation through mucosal tissue changes and mucin production. We also demonstrated that the laxative effect of LGC is closely related to the expression of mAChR and its downstream signals, suggesting the possibility of developing a constipation-laxative agent using LGC.","[Kim, Ji Eun; Yun, Woo Bin; Lee, Mi Lim; Choi, Jun Young; Park, Jin Ju; Kim, Hye Ryeong; Song, Bo Ram; Hwang, Dae Youn] Pusan Natl Univ, Life & Ind Convergence Res Inst, Coll Nat Resources & Life Sci, Dept Biomat Sci, 50 Cheonghak Ri, Miryang 50463, Gyeongsangnam D, South Korea; [Hong, Jin Tae] Chungbuk Natl Univ, Coll Pharm, Chungju, South Korea; [Song, Hyun Keun] Changwon Natl Univ, Biomed Sci Inst, 20 Changwondae Ro, Changwon Si 51140, Gyeongsangnam D, South Korea",Pusan National University; Chungbuk National University; Changwon National University,"Hwang, DY (corresponding author), Pusan Natl Univ, Life & Ind Convergence Res Inst, Coll Nat Resources & Life Sci, Dept Biomat Sci, 50 Cheonghak Ri, Miryang 50463, Gyeongsangnam D, South Korea.;Song, HK (corresponding author), Changwon Natl Univ, Biomed Sci Inst, 20 Changwondae Ro, Changwon Si 51140, Gyeongsangnam D, South Korea.",kali71@hanmail.net; dyhwang@pusan.ac.kr,"choi, junyoung/T-4389-2019",,,,,,43,17,18,1,17,"MARY ANN LIEBERT, INC",NEW ROCHELLE,"140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA",1096-620X,1557-7600,,J MED FOOD,J. Med. Food,MAR 1,2019,22,3,,,,,294,304,,10.1089/jmf.2018.4234,http://dx.doi.org/10.1089/jmf.2018.4234,,,11,"Chemistry, Medicinal; Food Science & Technology; Nutrition & Dietetics",Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy; Food Science & Technology; Nutrition & Dietetics,HP4TN,30724689,,,,2024-06-04,WOS:000461669100010,View Full Record in Web of Science
J,"Udani, JK; Bloom, DW",,,,"Udani, Jay K.; Bloom, David W.",,,"Effects of kivia powder on Gut health in patients with occasional constipation: a randomized, double-blind, placebo-controlled study",NUTRITION JOURNAL,,,English,Article,,,,,,Constipation; Kiwi Fruit; Actinidin; Zyactinase (TM),IN-VITRO; PROTEIN DIGESTION; DIETARY FIBER; NORTH-AMERICA; ACTINIDIN; PSYLLIUM; FRUIT; MODEL,"Objective: To evaluate the efficacy of Kivia powder on supporting overall gut health through the relief of the discomfort of occasional constipation. Design: Randomized, double-blind, placebo-controlled, parallel-group trial. Interventions: The investigational product for this study was Kivia powder (Vital Food Processors Ltd., Auckland, New Zealand), containing the active ingredient Zyactinase (TM), 5.5 g taken daily for four weeks. Results: One hundred thirty-eight subjects reporting occasional constipation were screened and 87 were randomized to placebo (n = 44) and product (n = 43). Bowel movement frequency, as measured by both average daily spontaneous bowel movements (SBM) and complete spontaneous bowel movements (CSBM), were the same in both groups at baseline. There were significant increases in spontaneous bowel movements at week 1 (p = 0.001), week 2 (p = 0.001), week 3 (p = 0.000), and week 4 (p = 0.000) compared to baseline. SBM demonstrated significant differences between the treatment group and the placebo group at week 3 (p = 0.000), and week 4 (p = 0.020). The treatment group demonstrated a significantly higher rate of SBM at week 3 (p = 000) and from baseline to week 4 (p = 0.019). Significant increases in complete spontaneous bowel movements were observed at week 1 (p = 0.000), week 2 (p = 0.000), week 3 (p = 0.000), and week 4 (p = 0.000) compared to baseline. Moreover, CSBM was significantly higher for the treatment group compared to placebo at week 2 (p = 0.001). The change in average daily CSBM from baseline to week 2 was significantly higher in the treatment group than in the placebo group (p = 0.004). Abdominal discomfort or pain demonstrated significant differences between groups at week 1 (p = 0.044) and week 3 (p = 0.026). Flatulence was significantly lower for active group compared to placebo at week 2 (p = 0.047) and week 3 (p = 0.023). The number of bowel movements associated with urgency was significantly lower in the treatment group compared to the placebo group at week 3 (p = 0.048). In addition, it was decreased from baseline to week 1 (p = 0.040) and from baseline to week 3 (p = 0.024) in the treatment group, while the placebo group did not report any reductions in bowel urgency. Bowel movements in the treatment arm were significantly smoother and softer by week 2 (p = 0.020) and week 3 (p = 0.041). Conclusions: Treatment with Kivia powder, an extract of kiwifruit containing Zyactinase (TM), for four weeks was well tolerated and more effective than placebo in gently enhancing bowel movement frequency and reducing abdominal pain and flatulence in subjects with occasional constipation.","[Udani, Jay K.; Bloom, David W.] Medicus Res LLC, Agoura Hills, CA 91301 USA; [Udani, Jay K.] Northridge Hosp, Integrat Med Program, Northridge, CA 91325 USA",,"Udani, JK (corresponding author), Medicus Res LLC, Agoura Hills, CA 91301 USA.",jay.udani@medicusresearch.com,"Bloom, David/R-3176-2018","Bloom, David/0000-0001-6054-5828","Vital Food Processors Ltd., Auckland New Zealand; Vital Foods Processors, Ltd.","Vital Food Processors Ltd., Auckland New Zealand; Vital Foods Processors, Ltd.","Medicus Research has ongoing research support grants from Vital Food Processors Ltd. Auckland New Zealand. Dr. Udani has provided consulting services to Vital Food Processors Ltd. The authors and Medicus Research do not endorse any brand or product.; Medicus Research would like to thank Vital Foods Processors Ltd., Auckland, New Zealand, for supporting this clinical trial and providing the treatment and placebo products. We would also like to thank Parul Desai N.P. and the entire Stay-Well clinical staff for their tireless efforts and dedication to the health and welfare of the subjects. This study was conducted under the sponsorship of Vital Foods Processors, Ltd. The study design and protocol writing were a collaborative effort between Vital Foods Processors, Ltd., New Zealand and Medicus Research LLC, the Contract Research Organization (CRO) chosen to run the clinical operations of this study.; Vital Foods Processors Ltd., Auckland, New Zealand.",,18,23,25,2,27,BIOMED CENTRAL LTD,LONDON,"236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND",1475-2891,,,NUTR J,Nutr. J.,JUN 8,2013,12,,,,,,,,78,10.1186/1475-2891-12-78,http://dx.doi.org/10.1186/1475-2891-12-78,,,10,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,179EM,23758673,"Green Published, gold",,,2024-06-04,WOS:000321502400001,View Full Record in Web of Science
J,"Sessenwein, JL; Lomax, AE",,,,"Sessenwein, J. L.; Lomax, A. E.",,,Ghrelin receptors as targets for novel motility drugs,NEUROGASTROENTEROLOGY AND MOTILITY,,,English,Review,,,,,,constipation; defecation; ghrelin,HORMONE SECRETAGOGUE RECEPTOR; DES-ACYL GHRELIN; AGONIST; DEFECATION; FIBER; IDENTIFICATION; CONSTIPATION; STIMULATION; PATHWAYS; NEURONS,"Constipation arises from a multitude of causes, including aging, spinal cord injury (SCI), and dietary issues. The heterogeneity of inciting factors has made the treatment of constipation particularly challenging. Agonists of ghrelin receptors have beneficial effects on delayed gastric emptying, but less is known about their ability to improve colorectal motility. Recent publications indicate that the activation of the ghrelin receptors in the spinal cord can alleviate constipation due to dietary causes, Parkinsonism, and SCI in rodents. Ghrelin-responsive neurons in the intermediolateral cell column of the lumbosacral spinal cord can activate enteric microcircuits that coordinate propulsive colorectal contractions, leading to defecation. Learning more about the properties of neurons in the spinal defecation center and the roles of ghrelin receptors in the defecation reflex will accelerate the development of improved treatments of constipation.","[Sessenwein, J. L.; Lomax, A. E.] Queens Univ, Gastrointestinal Dis Res Unit, Kingston, ON, Canada",Queens University - Canada,"Lomax, AE (corresponding author), Kingston Gen Hosp, Kingston, ON K7L 2V7, Canada.",lomaxa@queensu.ca,,"Lomax, Alan/0000-0003-4743-9929",,,,,35,4,4,0,7,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1350-1925,1365-2982,,NEUROGASTROENT MOTIL,Neurogastroenterol. Motil.,MAY,2015,27,5,,,,,589,593,,10.1111/nmo.12562,http://dx.doi.org/10.1111/nmo.12562,,,5,Gastroenterology & Hepatology; Clinical Neurology; Neurosciences,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Neurosciences & Neurology,CW1IC,25903396,,,,2024-06-04,WOS:000364742000001,View Full Record in Web of Science
J,"Hamaguchi, N; Hirai, H; Bito, H; Ogawa, K",,,,"Hamaguchi, Norihisa; Hirai, Hirokazu; Bito, Hiroyuki; Ogawa, Koichi",,,Effects of Resistant Glucan Mixture on Bowel Movement in Female Volunteers,JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY,,,English,Article,,,,,,dietary fiber; bowel movement; defecation; resistant glucan mixture,FIBER; POLYDEXTROSE; CONSUMPTION; INULIN,"Resistant glucan (RG) is a water-soluble polysaccharide resistant to hydrolysis by digestive enzymes in the human gastrointestinal system. RG mixture (RGM) contains more than 75% RG as dietary fiber and other saccharides. The effects of ingestion of 3.3, 6.6, and 13.2 g/d of RGM (containing of 2.5, 5.0, and 10.0 g/d RG as dietary fiber) on the fecal properties and the frequency of defecation were investigated in 60 female volunteers with constipation. The study was designed as a randomized, single-blinded, and placebo-controlled parallel-group trial. Each subject consumed RGM or a placebo (digestible maltodextrin) for 2 wk. Questionnaire data on the effects on bowel movement were analyzed according to defecation days, defecation frequency, fecal volume, fecal shapes, fecal color, fecal odor, and fecal excretory feeling. The results showed significant increases in defecation frequency (p<0.05), defecation days (p<0.05), and fecal volume (p<0.05) during the 13.2 g/d RGM ingestion period. The effects of RGM on defecation days and frequency showed a dose-dependent increase (p<0.05). These results suggested that the intake of RGM increased defecation days, defecation frequency, and fecal volume. In the gastrointestinal tract, RGM is useful as a water-soluble dietary fiber for the improvement of bowel movements.","[Hamaguchi, Norihisa; Hirai, Hirokazu; Bito, Hiroyuki; Ogawa, Koichi] Nihon Shokuhin Kako Co Ltd, 30 Tajima, Fuji, Shizuoka 4178530, Japan",,"Hamaguchi, N (corresponding author), Nihon Shokuhin Kako Co Ltd, 30 Tajima, Fuji, Shizuoka 4178530, Japan.",norihisa.hamaguchi@nisshoku.co.jp,"Hirai, Hirokazu/ABP-1143-2022",,,,,,19,3,3,1,11,CENTER ACADEMIC PUBL JAPAN,TOKYO,"2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN",0301-4800,1881-7742,,J NUTR SCI VITAMINOL,J. Nutr. Sci. Vitaminol.,FEB,2016,62,1,,,,,62,66,,10.3177/jnsv.62.62,http://dx.doi.org/10.3177/jnsv.62.62,,,5,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,DF6DK,27117853,gold,,,2024-06-04,WOS:000371445900010,View Full Record in Web of Science
C,"Pereira, AC; Maffei, HVL",,,MEDIMOND,"Pereira, AC; Maffei, HVL",,,Food and dietary fiber intake by children with or without constipation. Assessment according to the food guide pyramid and the American Health Foundation (AHF),PEDIATRIC GASTROENTEROLOGY 2004,,,English,Proceedings Paper,"2nd World Congress of Pediatric Gastroenterology, Hepatology and Nutrition","JUL 03-07, 2004","Paris, FRANCE",,,,,"We studied the ingestion of 54 children with functional constipation (CC) and 41 without (Control), according to the Food Pyramid. A food frequency questionnaire was used, analyzing fruits with or without peel/bagasse, grains whole or refined, and beans separately. Total subjects and 2-6y CC ingested less DF (g/day) than Control (p < 0.05). The majority had high n degrees of dairy and of the meat group servings, but most groups/subgroups did not meet recommendation for fruit and vegetable. A greater proportion of fruit with peel/bagasse in Control than in CC was almost the only difference for 6-12y. There was a discrepancy between the high percentage of children with DF above AHF recommendation and the high percentage of children who did not meet Pyramid recommendations.","State Univ Sao Paulo, Dept Pediat, Botucatu, SP, Brazil",Universidade Estadual Paulista,"Pereira, AC (corresponding author), State Univ Sao Paulo, Dept Pediat, Botucatu, SP, Brazil.",,"Pereira, Alexandre/HHN-1038-2022",,,,,,6,0,0,0,2,MEDIMOND PUBLISHING CO,BOLOGNA,"VIA RUBBIANI 6/2, 40124 BOLOGNA, ITALY",,,88-7587-106-X,,,,2004,,,,,,,609,613,,,,,,5,Gastroenterology & Hepatology; Nutrition & Dietetics,Conference Proceedings Citation Index - Science (CPCI-S),Gastroenterology & Hepatology; Nutrition & Dietetics,BBR35,,,,,2024-06-04,WOS:000227354700108,View Full Record in Web of Science
J,"Kanauchi, O; Mitsuyama, K; Saiki, T; Nakamura, T; Hitomi, Y; Bamba, T; Araki, Y; Fujiyama, Y",,,,"Kanauchi, O; Mitsuyama, K; Saiki, T; Nakamura, T; Hitomi, Y; Bamba, T; Araki, Y; Fujiyama, Y",,,Germinated barley foodstuff increases fecal volume and butyrate production at relatively low doses and relieves constipation in humans,INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE,,,English,Article,,,,,,germinated barley foodstuff; butyrate; intestine; defecation; constipation,MUCOSAL PROTEIN-CONTENT; CHAIN FATTY-ACIDS; DIETARY FIBER; BRAN FLOUR; RATS; COLITIS,"Germinated barley foodstuff (GBF), derived from the aleurone layer, scutellum and germ of germinated barley, contains a large quantity of fermentable dietary fibers, especially hemicellulose. GBF was given to 9 healthy volunteers in a dose of 9 g of GBF per day for 10 consecutive days, and subsequently 18 g of GBF for another 10 days. As a control, no GBF was given for 3 days before administration of GBF (control period). Fecal weight, water content and short chain fatty acid content were measured before and during the last 3 days of each experimental period. Feeding of GBF significantly increased the fecal butyrate content as well as fecal weight at both dose-levels (9 and 18 g/day), compared with those during the control period. Daily administration of 9 g GBF induced the maximum level of defecation in humans. Relatively mild but chronic constipated volunteers (n=16) were administered 9 g of GBF daily for 14 days. In this experiment, the condition of defecation (frequency, volume) was estimated by a questionnaire survey. GBF significantly improved defecation within a short period without severe adverse effects. No major abnormalities in laboratory findings were found in hematologic and urinary analyses. In conclusion, daily administration of 9 g GBF was effective for improving defecation in healthy but constipated humans. GBF is a highly safe and effective foodstuff for improving defecation.","Kirin Brewery Co Ltd, Corp Res & Dev Div, Appl Biores Ctr, Takasaki, Gumma 3701295, Japan; Kurume Univ, Sch Med, Dept Med 2, Kurume, Fukuoka 8300011, Japan; Shiga Univ Med Sci, Dept Internal Med, Otsu, Shiga 5202100, Japan",Kirin Brewery Company Limited; Kurume University; Shiga University of Medical Science,"Kanauchi, O (corresponding author), Kirin Brewery Co Ltd, Corp Res & Dev Div, Appl Biores Ctr, Miyaharacho 3, Takasaki, Gumma 3701295, Japan.",,,,,,,,25,14,15,0,4,PROFESSOR D A SPANDIDOS,ATHENS,"1, S MERKOURI ST, EDITORIAL OFFICE,, ATHENS 116 35, GREECE",1107-3756,,,INT J MOL MED,Int. J. Mol. Med.,OCT,1998,2,4,,,,,445,450,,,,,,6,"Medicine, Research & Experimental",Science Citation Index Expanded (SCI-EXPANDED),Research & Experimental Medicine,126XX,9857232,,,,2024-06-04,WOS:000076321300013,View Full Record in Web of Science
J,"Tursi, A",,,,"Tursi, Antonio",,,Dietary pattern and colonic diverticulosis,CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE,,,English,Review,,,,,,acute diverticulitis; alcohol consumption; diverticulosis; fiber intake; meat consumption; symptomatic uncomplicated diverticular disease,FIBER DIET; DISEASE; MANAGEMENT; CONSTIPATION; RISK,"Purpose of review To assess the role of dietary pattern on the occurrence of colonic diverticulosis, diverticular disease and acute diverticulitis. Recent findings High-fiber diet does not prevent diverticulosis occurrence, and results about prevention/treatment of diverticular disease and acute diverticulitis are still conflicting. No association was seen between nut, corn or popcorn consumption and occurrence of diverticulosis, diverticular disease and acute diverticulitis. It seems to be a mild association between high alcohol intake and diverticulosis occurrence, whereas alcohol dependence seems to show lower risk of in-hospital mortality due to acute diverticulitis. Higher red-meat consumption shows mild increased risk of acute diverticulitis, especially when consumed as unprocessed red meat (defined as consumption of 'beef or lamb as main dish', 'pork as main dish', 'hamburger' and 'beef, pork or lamb as a sandwich or mixed dish'); higher consumption of poultry (viz. white meat) was not associated with risk of acute diverticulitis. Finally, higher fish intake was associated with reduced risk of diverticulitis in age-adjusted model, but not after further adjustment for other potential confounders. Summary Current literature data about the role of dietary pattern on the occurrence of colonic diverticulosis, diverticular disease and acute diverticulitis are still too conflicting.","[Tursi, Antonio] ASL BAT, Gastroenterol Serv, Via Torino 49, I-76123 Andria, BT, Italy",,"Tursi, A (corresponding author), ASL BAT, Gastroenterol Serv, Via Torino 49, I-76123 Andria, BT, Italy.",antotursi@tiscali.it,,,,,,,21,13,13,2,11,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",1363-1950,1473-6519,,CURR OPIN CLIN NUTR,Curr. Opin. Clin. Nutr. Metab. Care,SEP,2017,20,5,,,,,409,413,,10.1097/MCO.0000000000000403,http://dx.doi.org/10.1097/MCO.0000000000000403,,,5,Endocrinology & Metabolism; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Endocrinology & Metabolism; Nutrition & Dietetics,FC7DM,28768296,,,,2024-06-04,WOS:000407001300016,View Full Record in Web of Science
J,"Kahlon, TS; Chow, FI; Hoefer, JL; Betschart, AA",,,,"Kahlon, TS; Chow, FI; Hoefer, JL; Betschart, AA",,,Effect of wheat bran fiber and bran particle size on fat and fiber digestibility and gastrointestinal tract measurements in the rat,CEREAL CHEMISTRY,,,English,Article,,,,,,,DIETARY FIBER; COLONIC FUNCTION; CANCER; BIOAVAILABILITY; METABOLISM; TRANSIT,"The effect of wheat bran (AACC hard red) and bran particle size on fat and fiber digestibility and gastrointestinal tract measurements were investigated with diets containing 5.7-10.7% dietary fiber. Fifty-six male weanling Sprague-Dawley rats were randomly assigned to four diets containing 5% cellulose (C5); 10.5% cellulose (C10); 21.5% coarse (2 mm) wheat bran (CB); or 22.2% fine (0.5 mm) wheat bran (FB) in a six-week study. Dietary fiber digestibilities were significantly different (P < 0.05) among treatment diets (CB > FB > C5 > C10) but there was no effect in fat digestibility among treatments. High-fiber diets fed to rats resulted in significantly greater wet and dry fecal weights than low-fiber diets. Bran diets resulted in significantly higher fecal moisture than cellulose diets. Cecum lengths increased significantly with bran diets compared with cellulose diets. The CB diet resulted in significantly higher stomach weights than with cellulose diets. Stomachs were heavier and cecal lengths were greater with bran diets than with cellulose diets; however, a high-cellulose diet resulted in increased colon weight. Except for higher fiber digestibility of coarse bran, bran particle size had no significant effects. Healthful effects of wheat bran may be associated with gastrointestinal morphology and function. Fecal bulking and decreased intestinal transit time can prevent constipation and may dilute or reduce absorption of toxic or carcinogenic metabolites, thus improving gastrointestinal health and lowering the risk of tumor development and cancer.","USDA ARS, Western Reg Res Ctr, Albany, CA 94710 USA",United States Department of Agriculture (USDA),"USDA ARS, Western Reg Res Ctr, 800 Buchanan St, Albany, CA 94710 USA.",tsk@pw.usda.gov,,,,,,,31,7,8,0,8,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0009-0352,1943-3638,,CEREAL CHEM,Cereal Chem.,JUL-AUG,2001,78,4,,,,,481,484,,10.1094/CCHEM.2001.78.4.481,http://dx.doi.org/10.1094/CCHEM.2001.78.4.481,,,4,"Chemistry, Applied; Food Science & Technology",Science Citation Index Expanded (SCI-EXPANDED),Chemistry; Food Science & Technology,452QK,,,,,2024-06-04,WOS:000169870100020,View Full Record in Web of Science
J,"Adamidis, D; Roma-Giannikou, E; Karamolegou, K; Tselalidou, E; Constantopoulos, A",,,,"Adamidis, D; Roma-Giannikou, E; Karamolegou, K; Tselalidou, E; Constantopoulos, A",,,Fiber intake and childhood appendicitis,INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION,,,English,Article,,,,,,,DIETARY FIBER; SOUTH-AFRICA; CHILDREN; CONSTIPATION; INFECTION; DIAGNOSIS; ETIOLOGY,"In order to investigate the possible role of fiber in the etiology of acute appendicitis, 203 consecutive appendectomized children with histologically proved appendicitis and 1922 controls were studied by the diet history method. Statistics were performed by multivariate analysis of variance, discriminant analysis and chi(2). Appendectomized children had statistically significant lower mean daily intake of fiber (17.4 g versus 20.4 g, P < 0.001) including all fiber fractions: cellulose, uronic acid, pentose, exose and lignin. No statistical difference was found for energy, protein, carbohydrate and fat intake. Discriminant analysis proved that only cellulose and exose are independently correlated to appendicitis and lower fiber intake is thought to be the cause in 70% of the cases. Recurrent abdominal pain, chronic constipation and positive family history of appendectomy were more frequent in appendectomized children (P < 0.001). This study gives evidence that low fiber intake could play an important role in the pathogenesis of appendicitis.","Univ Athens, Dept Paediat 1, Athens, Greece",National & Kapodistrian University of Athens,"Adamidis, D (corresponding author), Univ Athens, Dept Paediat 1, Athens, Greece.",,,,,,,,47,28,30,0,5,CARFAX PUBLISHING,BASINGSTOKE,"RANKINE RD, BASINGSTOKE RG24 8PR, HANTS, ENGLAND",0963-7486,,,INT J FOOD SCI NUTR,Int. J. Food Sci. Nutr.,MAY,2000,51,3,,,,,153,157,,,,,,5,Food Science & Technology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Nutrition & Dietetics,331MX,10945110,,,,2024-06-04,WOS:000088023800002,View Full Record in Web of Science
J,"Park, ES; Park, CI; Cho, SR; Na, SI; Cho, YS",,,,"Park, ES; Park, CI; Cho, SR; Na, SI; Cho, YS",,,Colonic transit time and constipation in children with spastic cerebral palsy,ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION,,,English,Article,,,,,,cerebral palsy; colon; gastrointestinal motility; rehabilitation,DIETARY FIBER INTAKE; DEVELOPMENTAL-DISABILITIES; FUNCTIONAL CONSTIPATION; GASTROESOPHAGEAL REFLUX; STOOL FREQUENCY; MOTILITY; HEALTHY; SYSTEM,"Objectives: To evaluate colonic motility and to investigate contributing factors to colonic dysmotility in children with spastic cerebral palsy (CP). Design: Cross-sectional study. Setting: A university-based rehabilitation hospital. Participants: Thirty-eight children with spastic CP. Interventions: Not applicable. Main Outcome Measures: Colonic transit time was measured by using a Sitzmarks. The nutrient intake during 3 consecutive days was analyzed by using the ESHA Food Processor program. Results: A significant relationship between colon transit time and stool frequency was observed (P<.05). All children with constipation and 17 (60.8%) of 28 without constipation showed an abnormal segmental colon transit time in at least 1 segment of the colon. A transit time delay at the proximal segment of colon was remarkable in CP children with constipation. In children without constipation, a transit time delay was marked at the rectosigmoid colon only. Constipation and transit time delay were significantly related to ambulatory function (P<.05). Conclusions: A transit time delay at total or segmental colon was frequently observed in children with CP. Constipation and colonic motility were related to ambulatory function.","Yonsei Univ, Coll Med, Dept Rehabil, Severance Hosp, Seoul 120752, South Korea; Yonsei Univ, Res Inst Rehabil Med, Cerebral Palsy & Pediat Sect, Seoul 120752, South Korea; Yonsei Univ, Brain Korea 21 Project Med Sci, Seoul 120749, South Korea; Yonsei Univ, Coll Med, Severance Hosp, Rehabil Dept, Seoul 120749, South Korea; Yonsei Univ, Coll Med, Severance Hosp, Dietet Dept, Seoul 120749, South Korea",Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System,"Yonsei Univ, Coll Med, Dept Rehabil, Severance Hosp, Shinchon Dong 134, Seoul 120752, South Korea.",loup@mdhouse.com,,"Park, Eun Sook/0000-0002-9144-3063; Cho, Sung-Rae/0000-0003-1429-2684",,,,,27,47,54,0,2,W B SAUNDERS CO-ELSEVIER INC,PHILADELPHIA,"1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA",0003-9993,1532-821X,,ARCH PHYS MED REHAB,Arch. Phys. Med. Rehabil.,MAR,2004,85,3,,,,,453,456,,10.1016/S0003-9993(03)00479-9,http://dx.doi.org/10.1016/S0003-9993(03)00479-9,,,4,Rehabilitation; Sport Sciences,Science Citation Index Expanded (SCI-EXPANDED),Rehabilitation; Sport Sciences,801AC,15031832,,,,2024-06-04,WOS:000220067800016,View Full Record in Web of Science
J,"Omori, K; Miyakawa, H; Watanabe, A; Nakayama, Y; Lyu, Y; Ichikawa, N; Sasaki, H; Shibata, S",,,,"Omori, Kanako; Miyakawa, Hiroki; Watanabe, Aya; Nakayama, Yuki; Lyu, Yijin; Ichikawa, Natsumi; Sasaki, Hiroyuki; Shibata, Shigenobu",,,The Combined Effects of Magnesium Oxide and Inulin on Intestinal Microbiota and Cecal Short-Chain Fatty Acids,NUTRIENTS,,,English,Article,,,,,,MgO; water-soluble dietary fiber; SCFA; intestinal flora; laxative; administration timing,,"Constipation is a common condition that occurs in many people worldwide. While magnesium oxide (MgO) is often used as the first-line drug for chronic constipation in Japan, dietary fiber intake is also recommended. Dietary fiber is fermented by microbiota to produce short-chain fatty acids (SCFAs). SCFAs are involved in regulating systemic physiological functions and circadian rhythm. We examined the effect of combining MgO and the water-soluble dietary fiber, inulin, on cecal SCFA concentration and microbiota in mice. We also examined the MgO administration timing effect on cecal SCFAs. The cecal SCFA concentrations were measured by gas chromatography, and the microbiota was determined using next-generation sequencing. Inulin intake decreased cecal pH and increased cecal SCFA concentrations while combining MgO increased the cecal pH lowered by inulin and decreased the cecal SCFA concentrations elevated by inulin. When inulin and MgO were combined, significant changes in the microbiota composition were observed compared with inulin alone. The MgO effect on the cecal acetic acid concentration was less when administered at ZT12 than at ZT0. In conclusion, this study suggests that MgO affects cecal SCFA and microbiota during inulin feeding, and the effect on acetic acid concentration is time-dependent.","[Omori, Kanako; Miyakawa, Hiroki; Watanabe, Aya; Nakayama, Yuki; Lyu, Yijin; Ichikawa, Natsumi; Sasaki, Hiroyuki; Shibata, Shigenobu] Waseda Univ, Sch Adv Sci & Engn, Lab Physiol & Pharmacol, Shinjuku Ku, 2-2 Wakamatsu Cho, Tokyo 1628480, Japan",Waseda University,"Shibata, S (corresponding author), Waseda Univ, Sch Adv Sci & Engn, Lab Physiol & Pharmacol, Shinjuku Ku, 2-2 Wakamatsu Cho, Tokyo 1628480, Japan.",k.omori@ruri.waseda.jp; hgbbst-hiroki@toki.waseda.jp; aya_watanabe7115@suou.waseda.jp; yukibecky-6991@akane.waseda.jp; ikin@fuji.waseda.jp; natsu3@ruri.waseda.jp; hiroyuki-sasaki@asagi.waseda.jp; shibatas@waseda.jp,,"shibata, shigenobu/0000-0002-6177-1963",Japan Society for the Promotion of Science (JSPS) KAKENHI,"Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))","This work was partially supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI (A and Houga) (Shibata, S).",,54,6,6,7,24,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,JAN,2021,13,1,,,,,,,152,10.3390/nu13010152,http://dx.doi.org/10.3390/nu13010152,,,20,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,PW4RD,33466274,"gold, Green Published",,,2024-06-04,WOS:000610657300001,View Full Record in Web of Science
J,"Oliviero, C; Kokkonen, T; Heinonen, M; Sankari, S; Peltoniemi, OAT",,,,"Oliviero, C.; Kokkonen, T.; Heinonen, M.; Sankari, S.; Peltoniemi, O. A. T.",,,"Effect of Dietary Fibre on Constipation, Litter Growth and Energy Related Parameters in Periparturient Sows",REPRODUCTION IN DOMESTIC ANIMALS,,,English,Meeting Abstract,12th Annual Conference of the European-Society-of-Domestic-Animal-Reproduction,"NOV 20-23, 2008","Utrecht, NETHERLANDS","European Soc Domest Anim Reprod,Fac Vet Med,Anim Hlth Serv",,,,,"[Oliviero, C.; Kokkonen, T.; Heinonen, M.; Sankari, S.; Peltoniemi, O. A. T.] Fac Vet, Helsinki, Finland",,,,,,,,,,0,0,0,0,11,BLACKWELL PUBLISHING,OXFORD,"9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND",0936-6768,,,REPROD DOMEST ANIM,Reprod. Domest. Anim.,NOV,2008,43,,,5,,,49,49,,,,,,1,"Agriculture, Dairy & Animal Science; Reproductive Biology; Veterinary Sciences",Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED),Agriculture; Reproductive Biology; Veterinary Sciences,364AI,,,,,2024-06-04,WOS:000260308200021,View Full Record in Web of Science
J,"Kawashima, N; Tabata, A; Kumon, A; Miyashita, K; Sato, A; Onuma, H; Nakamura, S; Horiuchi, E; Hasegawa, K",,,,"Kawashima, N.; Tabata, A.; Kumon, A.; Miyashita, K.; Sato, A.; Onuma, H.; Nakamura, S.; Horiuchi, E.; Hasegawa, K.",,,"The correlation between dietary fiber, fluid intake and constipation in patients with Parkinson's disease",MOVEMENT DISORDERS,,,English,Meeting Abstract,20th International Congress of Parkinson's Disease and Movement Disorders,"JUN 19-23, 2016","Berlin, GERMANY",,,,,,,,,,,,,,,,0,0,0,0,5,WILEY-BLACKWELL,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0885-3185,1531-8257,,MOVEMENT DISORD,Mov. Disord.,JUN,2016,31,,,2,,1860,S612,S612,,,,,,1,Clinical Neurology,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Neurosciences & Neurology,DU9TD,,,,,2024-06-04,WOS:000382559803017,View Full Record in Web of Science
J,"Jang, HJ; Chung, JY; Seo, JH; Moon, JS; Choe, BH; Shim, JO",,,,"Jang, Hyo-Jeong; Chung, Ju-Young; Seo, Ji-Hyun; Moon, Jin Soo; Choe, Byung-Ho; Shim, Jung Ok",,,Nationwide Survey for Application of ROME IV Criteria and Clinical Practice for Functional Constipation in Children,JOURNAL OF KOREAN MEDICAL SCIENCE,,,English,Article,,,,,,Child; Constipation; Colonic Diseases; Functional; Questionnaire; Management,POLYETHYLENE-GLYCOL 3350; DIETARY FIBER MIXTURE; GASTROINTESTINAL DISORDERS; CHILDHOOD CONSTIPATION; PRIMARY-CARE; DOUBLE-BLIND; MANAGEMENT; ELECTROLYTES; PEDIATRICIANS; EPIDEMIOLOGY,"Background: This study aimed to investigate the awareness and application of ROME IV criteria for functional constipation (FC) in real-world practices and assessed differences between pediatric gastroenterologists (PGs) and general pediatricians. Methods: A total of 239 (47.8%) out of 500 nationwide pediatricians answered a questionnaire for diagnosis and management of pediatric FC; 60 were PGs (75% of total PGs in Korea). Results: A total of 16.6% of pediatricians were aware of the exact ROME IV criteria. Perianal examination and digital rectal examination were practiced less, with a higher tendency among PGs (P < 0.001). Treatment duration was longer among PGs for > 6 months (63.8%) than < 3 months among general pediatricians (59.2%, P< 0.001). Fecal disimpaction and rectal enema were practiced among 78.8% and 58.5% of pediatricians, respectively. High dose medication for initial treatment phase was prescribed by 70.7% of pediatricians, primarily within the first 2 weeks (48.3%). The most commonly prescribed medications in children aged > 1-year were lactulose (59.1%), followed by polyethylene glycol (PEG) 4000 (17.7%), and probiotics (11.8%). Prescription priority significantly differed between PGs and general pediatricians; lactulose or PEG 4000 were most commonly prescribed by PGs (89.7%), and lactulose or probiotics (75.7%) were prescribed by general pediatricians (P< 0.001). For patients aged < 1-year, lactulose (41.6%) and changing formula (31.7%) were commonly prescribed. Most participants recommended diet modification, and PGs more frequently used defecation diary (P = 0.002). Conclusion: Discrepancies between actual practice and Rome IV criteria and between PGs and general pediatricians were observed. This survey may help construct practice guidelines and educational programs for pediatric FC.","[Jang, Hyo-Jeong] Keimyung Univ, Sch Med, Dept Pediat, Dongsan Med Ctr, Daegu, South Korea; [Chung, Ju-Young] Inje Univ, Coll Med, Sanggye Paik Hosp, Dept Pediat, Seoul, South Korea; [Seo, Ji-Hyun] Gyeonsang Natl Univ, Sch Med, Gyeongsang Natl Inst Hlth Sci, Dept Pediat,Gyeongsang Natl Univ Hosp, Jinju, South Korea; [Moon, Jin Soo] Seoul Natl Univ, Coll Med, Dept Pediat, Childrens Hosp, Seoul, South Korea; [Choe, Byung-Ho] Kyungpook Natl Univ, Sch Med, Dept Pediat, Daegu, South Korea; [Shim, Jung Ok] Korea Univ, Coll Med, Guro Hosp, Dept Pediat, 148 Gurodong Ro, Seoul 08308, South Korea",Keimyung University; Inje University; Gyeongsang National University; Gyeongsang National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Kyungpook National University; Korea University; Korea University Medicine (KU Medicine),"Shim, JO (corresponding author), Korea Univ, Coll Med, Guro Hosp, Dept Pediat, 148 Gurodong Ro, Seoul 08308, South Korea.",shimjo@korea.ac.kr,"Choe, Byung-Ho/L-5557-2019","Choe, Byung-Ho/0000-0001-9899-9120; Jang, Hyo-Jeong/0000-0003-1496-5754; MOON, JIN SOO/0000-0001-9760-297X; Shim, Jung Ok/0000-0001-6449-7819; SEO, JI-HYUN/0000-0002-0691-3957",,,,,34,8,8,0,6,KOREAN ACAD MEDICAL SCIENCES,SEOUL,"302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA",1011-8934,1598-6357,,J KOREAN MED SCI,J. Korean Med. Sci.,JUL 8,2019,34,26,,,,,,,e183,10.3346/jkms.2019.34.e183,http://dx.doi.org/10.3346/jkms.2019.34.e183,,,11,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,II9EM,31269544,"gold, Green Published, Green Submitted",,,2024-06-04,WOS:000475498700003,View Full Record in Web of Science
J,"LOENINGBAUCKE, V",,,,"LOENINGBAUCKE, V",,,"CONSTIPATION IN EARLY-CHILDHOOD - PATIENT CHARACTERISTICS, TREATMENT, AND LONG-TERM FOLLOW-UP",GUT,,,English,Article,,,,,,,CHILDREN; FREQUENCY,"Little is known about chronic constipation in infants, toddlers, and preschool children and longterm outcome after treatment. The symptoms of 174 children less-than-or-equal-to 4 years of age, who were evaluated for chronic constipation, are reported in this study together with the longterm outcome in 90 of them. Initial symptoms were infrequent bowel movements in 58%, painful bowel movements in 77% often with screaming, and severe stool withholding manoeuvres in 97%. The treatment of chronic idiopathic constipation consisted of education, faecal disimpaction, prevention of future impaction, and promotion of regular bowel habits with dietary fibre and milk of magnesia, and finally toilet training of the preschool child. Longterm outcome could be evaluated in 90 patients (52%) (mean (SD) 6.9 (2.7)) years after initial evaluation. Fifty seven children (63%) had recovered, defined as no soiling with greater-than-or-equal-to 3 bowel movements per week, while not receiving treatment. The recovery rate of children less-than-or-equal-to 2 years of age was significantly higher than in children >2 to 4 years of age. Thirty three children (37%) had not recovered. Constipation recurred as soon as laxatives were discontinued in 31 (94%) of them. Laxatives were still used by 33% of the children who had not recovered, 39% had <3 bowel movements per week, 48% had faecal soiling, 45% had stool withholding, 27% complained of abdominal pain, 73% passed large stools, and 45% still on occasions clogged the toilet with their large stools. Symptoms of chronic constipation persisted in one third of our patients, 3-12 years after initial evaluation and treatment. Children who had not recovered deserve continued follow up, to reinforce and adjust treatment and to prevent faecal soiling.",,,"LOENINGBAUCKE, V (corresponding author), UNIV IOWA,DEPT PEDIAT,200 HAWKINS DR,JCP 2555,IOWA CITY,IA 52242, USA.",,,,,,,,20,186,203,0,8,BRITISH MED JOURNAL PUBL GROUP,LONDON,"BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR",0017-5749,,,GUT,Gut,OCT,1993,34,10,,,,,1400,1404,,10.1136/gut.34.10.1400,http://dx.doi.org/10.1136/gut.34.10.1400,,,5,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,LZ968,8244110,"Green Published, Bronze",,,2024-06-04,WOS:A1993LZ96800022,View Full Record in Web of Science
J,"Shimotoyodome, A; Yajima, N; Suzuki, J; Tokimitsu, I",,,,"Shimotoyodome, A; Yajima, N; Suzuki, J; Tokimitsu, I",,,Effects of coingestion of different fibers on fecal excretion and cecal fermentation in rats,NUTRITION RESEARCH,,,English,Article,,,,,,rat; cecal fermentation; fecal excretion; guar gum hydrolysate; low-molecular-weight sodium alginate; water content,CHAIN FATTY-ACIDS; DIETARY FIBER; ABSORPTION; COLON,"The effects of the concurrent ingestion of 2 dietary fibers of different fermentabilities on fecal excretion and cecal fermentation were examined in rats. Poorly fermentable, low-molecular-weight sodium alginate supplementation of a fiber-free diet increased fecal excretion and the water content dose-dependently but did not affect cecal pH. Highly fermentable guar gum hydrolysate supplementation decreased cecal pH dose-dependently, whereas there was only a slight increase in fecal excretion. The concurrent ingestion of both fibers increased fecal excretion, lowered cecal pH, and increased the fecal water content and cecal short-chain fatty acids, especially butyrate. The increases in both fecal excretion and cecal fermentation were not achieved by excessive ingestion of the respective fibers alone and were also observed in loperamide-induced constipation. In conclusion, the concurrent ingestion of low-molecular-weight sodium alginate and guar gum hydrolysate increases both fecal excretion and cecal fermentation as a consequence of each fiber compensating for their respective dietary disadvantages in a complementary manner. (c) 2005 Elsevier Inc. All rights reserved.","Kao Corp, Biol Sci Lab, Haga, Tochigi 3213497, Japan",KAO Corporation,"Kao Corp, Biol Sci Lab, Haga, Tochigi 3213497, Japan.",shimotoyodome.akira@kao.co.jp,,"shimotoyodome, akira/0000-0001-7567-8316",,,,,23,4,12,1,16,PERGAMON-ELSEVIER SCIENCE LTD,OXFORD,"THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND",0271-5317,,,NUTR RES,Nutr. Res.,DEC,2005,25,12,,,,,1085,1096,,10.1016/j.nutres.2005.09.018,http://dx.doi.org/10.1016/j.nutres.2005.09.018,,,12,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,997XC,,,,,2024-06-04,WOS:000234281200006,View Full Record in Web of Science
J,"Koppen, IJN; Lammers, LA; Benninga, MA; Tabbers, MM",,,,"Koppen, Ilan J. N.; Lammers, Laureen A.; Benninga, Marc A.; Tabbers, Merit M.",,,Management of Functional Constipation in Children: Therapy in Practice,PEDIATRIC DRUGS,,,English,Article,,,,,,,QUALITY-OF-LIFE; POLYETHYLENE-GLYCOL 3350; CHRONIC IDIOPATHIC CONSTIPATION; DIETARY FIBER MIXTURE; CHILDHOOD CONSTIPATION; COLONIC TRANSIT; TRANSANAL IRRIGATION; FECAL INCONTINENCE; LIQUID PARAFFIN; PHYSICAL-ACTIVITY,"Functional constipation is a common healthcare problem among children worldwide and accounts for high healthcare usage and costs. Functional constipation is a clinical diagnosis; the evaluation primarily consists of a thorough medical history and a complete physical examination. Additional investigations are not necessary in most cases. Treatment consists of non-pharmacological and pharmacological interventions. Non-pharmacological interventions involve education and demystification, toilet training (with a reward system), and a defecation diary. Pharmacological treatment comprises three steps: disimpaction, maintenance treatment, and weaning. The treatment of first choice is oral laxatives, preferably polyethylene glycol. When this is insufficient, other therapeutic agents are available. This review discusses the evaluation and management of functional constipation in the pediatric population and provides a summary of drug treatment options.","[Koppen, Ilan J. N.; Benninga, Marc A.; Tabbers, Merit M.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat Gastroenterol & Nutr, NL-1105 AZ Amsterdam, Netherlands; [Lammers, Laureen A.] Univ Amsterdam, Acad Med Ctr, Dept Hosp Pharm, NL-1105 AZ Amsterdam, Netherlands",Vrije Universiteit Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam,"Koppen, IJN (corresponding author), Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat Gastroenterol & Nutr, Meibergdreef 9,Room C2-312, NL-1105 AZ Amsterdam, Netherlands.",i.j.koppen@amc.nl; m.m.tabbers@amc.uva.nl,"Koppen, Ilan J.N./AAA-6800-2020","Koppen, Ilan J.N./0000-0002-1856-0968; Tabbers, Merit/0000-0001-9744-7308",,,,,99,81,86,0,17,ADIS INT LTD,NORTHCOTE,"5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND",1174-5878,1179-2019,,PEDIATR DRUGS,Pediatr. Drugs,OCT,2015,17,5,,,,,349,360,,10.1007/s40272-015-0142-4,http://dx.doi.org/10.1007/s40272-015-0142-4,,,12,Pediatrics; Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics; Pharmacology & Pharmacy,CR6TZ,26259965,"Green Published, hybrid",,,2024-06-04,WOS:000361481900002,View Full Record in Web of Science
J,"Vanhauwaert, E; Matthys, C; Verdonck, L; De Preter, V",,,,"Vanhauwaert, Erika; Matthys, Christophe; Verdonck, Lies; De Preter, Vicky",,,Low-Residue and Low-Fiber Diets in Gastrointestinal Disease Management,ADVANCES IN NUTRITION,,,English,Review,,,,,,dietary intake; fiber; gastrointestinal disorders; low-fiber diet; low-residue diet; bowel preparation,IRRITABLE-BOWEL-SYNDROME; CLEAR LIQUID DIET; SODIUM-PHOSPHATE; COLONOSCOPY; QUALITY; CONSTIPATION; DEFINITION; TRIAL,"Recently, low-residue diets were removed from the American Academy of Nutrition and Dietetics' Nutrition Care Manual due to the lack of a scientifically accepted quantitative definition and the unavailability of a method to estimate the amount of food residue produced. This narrative review focuses on defining the similarities and/or discrepancies between low-residue and low-fiber diets and on the diagnostic and therapeutic values of these diets in gastrointestinal disease management. Diagnostically, a low-fiber/low-residue diet is used in bowel preparation. A bowel preparation is a cleansing of the intestines of fecal matter and secretions conducted before a diagnostic procedure. Therapeutically, a low-fiber/low-residue diet is part of the treatment of acute relapses in different bowel diseases. The available evidence on low-residue and low-fiber diets is summarized. The main findings showed that within human disease research, the terms low residue and low fiber are used interchangeably, and information related to the quantity of residue in the diet usually refers to the amount of fiber. Low-fiber/low-residue diets are further explored in both diagnostic and therapeutic situations. On the basis of this literature review, the authors suggest redefining a low-residue diet as a low-fiber diet and to quantitatively define a low-fiber diet as a diet with a maximum of 10 g fiber/d. A low-fiber diet instead of a low-residue diet is recommended as a diagnostic value or as specific therapy for gastrointestinal conditions.","[Vanhauwaert, Erika; Verdonck, Lies; De Preter, Vicky] Univ Coll Leuven Limburg, Knowledge & Innovat Ctr Food & Nutr, Leuven, Belgium; [Vanhauwaert, Erika; Matthys, Christophe] Katholieke Univ Leuven, Dept Clin & Expt Med, Leuven, Belgium; [De Preter, Vicky] Katholieke Univ Leuven, Translat Res Ctr Gastrointestinal Disorders TARGI, Leuven, Belgium; [Matthys, Christophe] Univ Hosp Leuven, Dept Endocrinol, Clin Nutr Unit, Leuven, Belgium",KU Leuven; KU Leuven; KU Leuven; University Hospital Leuven,"Vanhauwaert, E (corresponding author), Univ Coll Leuven Limburg, Knowledge & Innovat Ctr Food & Nutr, Leuven, Belgium.",erika.vanhauwaert@ucll.be,"De Preter, Vicky/P-6131-2019; Matthys, Christophe/I-4203-2016","Matthys, Christophe/0000-0003-1770-6862","University College Leuven-Limburg; Leuven University (KU Leuven); University Hospital Leuven (UZ Leuven, Belgium)","University College Leuven-Limburg; Leuven University (KU Leuven)(KU Leuven); University Hospital Leuven (UZ Leuven, Belgium)(KU Leuven)","Supported by a grant from the University College Leuven-Limburg in cooperation with the Leuven University (KU Leuven) and the University Hospital Leuven (UZ Leuven, Belgium).",,50,43,46,4,19,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",2161-8313,2156-5376,,ADV NUTR,Adv. Nutr.,NOV,2015,6,6,,,,,820,827,,10.3945/an.115.009688,http://dx.doi.org/10.3945/an.115.009688,,,8,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,CV8ZQ,26567203,"hybrid, Green Published",,,2024-06-04,WOS:000364577400016,View Full Record in Web of Science
J,"Ma, JX; Huangfu, WK; Yang, X; Xu, JY; Zhang, Y; Wang, ZC; Zhu, XY; Wang, CZ; Shi, YH; Cui, YL",,,,"Ma, Jixiang; Huangfu, Weikang; Yang, Xu; Xu, Junying; Zhang, Yan; Wang, Zhichang; Zhu, Xiaoyan; Wang, Chengzhang; Shi, Yinghua; Cui, Yalei",,,"King of the forage-Alfalfa supplementation improves growth, reproductive performance, health condition and meat quality of pigs",FRONTIERS IN VETERINARY SCIENCE,,,English,Review,,,,,,alfalfa; pig; dietary fiber; production performance; intestinal health,CHAIN FATTY-ACIDS; NEUTRAL DETERGENT FIBER; MEDICAGO-SATIVA FIBER; DIETARY FIBER; PROTEIN-CONCENTRATE; LARGE-INTESTINE; IN-VITRO; CELLULOLYTIC BACTERIA; COLOSTRUM PRODUCTION; GRADED-LEVELS,"As one kind of high-quality feed with rich nutrients, including high quality protein and amino acids, dietary fiber, enriched vitamins and mineral elements and bioactive molecules, alfalfa has been widely used in the production of ruminant livestock. As the understanding of alfalfa becomes more and more comprehensive, it is found that the high-quality nutrients in alfalfa could have positive effects on pigs. An increasing number of researches have shown that supplementing dietary alfalfa to the diet of gestating sows reduced constipation, alleviated abnormal behavior, improved satiety and reproductive performance; supplementing dietary alfalfa to the diet of piglets improved growth performance and intestinal barrier function, reduced intestinal inflammatory response and diarrhea; supplementing dietary alfalfa to the diet of growing-fattening pigs improved production performance and pork quality. Moreover, the mechanisms by which various nutrients of alfalfa exert their beneficial effects on pigs mainly including dietary fiber stimulating intestinal peristalsis, enhancing the activity of digestive enzymes, and promoting the colonization of beneficial bacteria in the intestinal tract through fermentation in the intestine, producing short-chain fatty acids and thus improving intestinal health; high quality protein and amino acids are beneficial to improve animal health condition; rich vitamins and mineral elements play an important role in various physiological functions and growth and development of the body; and bioactive molecules can improve the antioxidant and anti-inflammatory level. Therefore, alfalfa could be used as pig feed ingredient to alleviate various problems in the pig industry and to improve pig production performance. In this review, we detail the current application of alfalfa in pigs and discuss the potential mechanisms involved in how alfalfa improves growth and reproductive performance, pork quality, and intestinal health of the animals, thus laying the foundation for the increased application of high-quality forage in pig production.","[Ma, Jixiang; Huangfu, Weikang; Yang, Xu; Xu, Junying; Zhang, Yan; Wang, Zhichang; Zhu, Xiaoyan; Wang, Chengzhang; Shi, Yinghua; Cui, Yalei] Henan Agr Univ, Coll Anim Sci & Technol, Zhengzhou, Peoples R China; [Wang, Zhichang; Zhu, Xiaoyan; Wang, Chengzhang; Shi, Yinghua; Cui, Yalei] Henan Key Lab Innovat & Utilizat Grassland Resourc, Zhengzhou, Peoples R China; [Wang, Zhichang; Zhu, Xiaoyan; Wang, Chengzhang; Shi, Yinghua; Cui, Yalei] Henan Forage Engn Technol Res Ctr, Zhengzhou, Peoples R China",Henan Agricultural University,"Shi, YH; Cui, YL (corresponding author), Henan Agr Univ, Coll Anim Sci & Technol, Zhengzhou, Peoples R China.;Shi, YH; Cui, YL (corresponding author), Henan Key Lab Innovat & Utilizat Grassland Resourc, Zhengzhou, Peoples R China.;Shi, YH; Cui, YL (corresponding author), Henan Forage Engn Technol Res Ctr, Zhengzhou, Peoples R China.",annysyh@henau.edu.cn; yaleicui423@henau.edu.cn,"chen, yan/JRY-4645-2023; Gu, b/JNS-4761-2023; chen, jiayi/KHV-5520-2024; wang, hongyuan/JWP-2279-2024",,Modern Agro-industry Technology Research System of China; Science and Technology Innovation Team of Henan Province High Quality Forage and Animal Health; Outstanding Talents of Henan Agricultural University; Henan Provincial Science and Technology Research Project; China Postdoctoral Science Foundation; Henan Postdoctoral Science Foundation; [CARS-34]; [22IRTSTHN022]; [30500636]; [222102110007]; [2022M710046],Modern Agro-industry Technology Research System of China; Science and Technology Innovation Team of Henan Province High Quality Forage and Animal Health; Outstanding Talents of Henan Agricultural University; Henan Provincial Science and Technology Research Project; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Henan Postdoctoral Science Foundation; ; ; ; ;,"Funding Financial support for this research was provided by Modern Agro-industry Technology Research System of China (CARS-34), Science and Technology Innovation Team of Henan Province High Quality Forage and Animal Health (No. 22IRTSTHN022), the Outstanding Talents of Henan Agricultural University (No. 30500636), Henan Provincial Science and Technology Research Project (No. 222102110007), China Postdoctoral Science Foundation (No. 2022M710046), and Henan Postdoctoral Science Foundation.",,125,4,4,14,40,FRONTIERS MEDIA SA,LAUSANNE,"AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND",,2297-1769,,FRONT VET SCI,Front. Vet. Sci.,NOV 2,2022,9,,,,,,,,1025942,10.3389/fvets.2022.1025942,http://dx.doi.org/10.3389/fvets.2022.1025942,,,13,Veterinary Sciences,Science Citation Index Expanded (SCI-EXPANDED),Veterinary Sciences,6H7OV,36406067,"gold, Green Published",,,2024-06-04,WOS:000885624800001,View Full Record in Web of Science
J,"Akbulut, G",,,,"Akbulut, Gamze",,,Nutrition in Stoma Patients: A Practical View of Dietary Therapy,UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI,,,English,Review,,,,,,Surgical stoma; Colostomy; Ileostomy; Urostomy; Diet therapy,,"This article reviews the various issues that surround the dietary planning for a patient with stoma (colostomy, ileostomy, and urostomy). The ostomy diet is necessary to keep stools normal following surgery, since the amount, frequency and consistency of stool is influenced by the diet. The goals of dietary management in stoma patients is to prevent stoma blockages after surgery, to promote healing of stoma wound and to minimise unpleasant gastrointestinal upset such as flatulence, diarrhoea, constipation and odors. On the other hand, early oral feeding in patients with colostomy is important. Since it is planned to progress from a liquid to low fiber (residue) diet. Some foods may not be as well tolerated and may cause flatulence, odors, diarrhea and/or constipation. Preoperatively, fiber and lactose intolerances are common in ileostomy patients. Postoperatively, it is important to provide a high-energy, high-protein diet for wound healing that is low in excess insoluble fiber. Certain foods and drugs can discolor the urine or produce a strong odor. In order to recognize the signs of food blockage, it is suggested to take plenty of fluids and consume a balanced diet in stoma patients.","[Akbulut, Gamze] Gazi Univ, Fac Hlth Sci, Dept Nutr Dietet, TR-06100 Ankara, Turkey",Gazi University,"Akbulut, G (corresponding author), Gazi Univ, Saglik Bilimleri Fak, Beslenme & Diyetet Bolumu, TR-06100 Ankara, Turkey.",dytgamzea@gmail.com,,,,,,,24,11,14,6,36,AKAD DOKTORLAR YAYINEVI,HILAL CANKAYA,"4 CADDE 56, SOKAK, NO 49-E, HILAL CANKAYA, ANKARA 06550, TURKEY",1306-133X,,,UHOD-ULUSLAR HEMATOL,UHOD-Uluslar. Hematol.-Onkol. De.,,2011,21,1,,,,,61,66,,10.4999/uhod.10082,http://dx.doi.org/10.4999/uhod.10082,,,6,Oncology,Science Citation Index Expanded (SCI-EXPANDED),Oncology,745BX,,Bronze,,,2024-06-04,WOS:000289140000011,View Full Record in Web of Science
J,"Singh, B; Kanwar, JS; Kumari, P",,,,"Singh, Baljit; Kanwar, J. S.; Kumari, Pooja",,,Modification of Dietary Fiber Psyllium with Poly(vinyl pyrrolidone) through Network Formation for Use in Slow Drug Delivery Application1,POLYMER SCIENCE SERIES B,,,English,Article,,,,,,,IN-VITRO; SUPERABSORBENT HYDROGELS; RADIATION SYNTHESIS; SWELLING PROPERTIES; MUCOADHESIVE BEADS; METFORMIN HCL; RELEASE; POLYSACCHARIDES; PH; CHITOSAN,"In view of the pharmacological importance of dietary fibre, psyllium, to cure the constipation and diverticulitis, in the present study, an attempt has been made to modify psyllium polysaccharide with PVP to develop the hydrogel meant for slow and controlled drug delivery systems. The polymer was characterized by SEMs, FTIR, XRD, TGA and swelling studies. Swelling of hydrogels and drug (ciprofloxacin) release profile from the drug loaded hydrogels were determined for the evaluation of the swelling/release mechanism. Bio-medical properties; biocompatibility and mucoadhesion of the hydrogels, were also studied. Swelling of the hydrogels and release of drugs from drug loaded hydrogels occurred through non-Fickian diffusion mechanism. Here it is pertinent to mention that both psyllium husk polysaccharide and antibiotic drug ciprofloxacin are used for gastrointestinal tract (GIT) problem, especially in case of diverticulitis. Hence, degradation of the polymer matrix and release of drug may exert the synergic effect and the present drug delivery system may act with enhanced potential.","[Singh, Baljit; Kumari, Pooja] Himachal Pradesh Univ Shimla, Dept Chem, Shimla 171005, Himachal Prades, India; [Kanwar, J. S.] IET Bhaddal, R&D, Tech Campus, Bhaddal Ropar 40108, Punjab, India",Himachal Pradesh University,"Singh, B (corresponding author), Himachal Pradesh Univ Shimla, Dept Chem, Shimla 171005, Himachal Prades, India.",baljitsinghhpu@yahoo.com,"singh, jasvir/ACH-8992-2022; SINGH, Baljit/B-5878-2012","singh, jasvir/0000-0001-9751-7361; SINGH, Baljit/0000-0002-0871-883X",,,,,63,2,2,3,27,MAIK NAUKA/INTERPERIODICA/SPRINGER,NEW YORK,"233 SPRING ST, NEW YORK, NY 10013-1578 USA",1560-0904,1555-6123,,POLYM SCI SER B+,Polym. Sci. Ser. B,MAY,2018,60,3,,,,,331,348,,10.1134/S156009041803017X,http://dx.doi.org/10.1134/S156009041803017X,,,18,Polymer Science,Science Citation Index Expanded (SCI-EXPANDED),Polymer Science,GL4SL,,,,,2024-06-04,WOS:000437147200010,View Full Record in Web of Science
J,"Vu, V; Muthuramalingam, K; Singh, V; Choi, C; Kim, YM; Unno, T; Cho, M",,,,"Vuong Vu; Muthuramalingam, Karthika; Singh, Vineet; Choi, Changmin; Kim, Young Mee; Unno, Tatsuya; Cho, Moonjae",,,Schizophyllum commune-derived β-glucan improves intestinal health demonstrating protective effects against constipation and common metabolic disorders,APPLIED BIOLOGICAL CHEMISTRY,,,English,Article,,,,,,beta-glucan; Constipation; Gut microbiota; Intestinal epithelium; Obesity; Prebiotic,HYDROLYZED GUAR GUM; DIETARY FIBER; COLONIC TRANSIT; GLUCOMANNAN; SYMPTOMS; FECES; MUCUS; RATS,"It has been proven that beta-glucan produced by Schizophyllum commune has beneficial effects on obesity, obesity-associated constipation, and colitis conditions; however, the protective effect of the compound on host at basal state is yet to be investigated. C57BL/6 J mice were fed with a normal diet (ND), normal diet supplemented with 3 g/kg (BG_low), and 5 g/kg (BG_high) of beta-glucan (BG) for 12 weeks. Body weight, food and water intake and fecal status were monitored weekly. Intestine was stained by Periodic acid-Schiff (PAS) and Alcian Blue to evaluate the mucin layer thickness and goblet cell population. Morphological changes in internal organs and intestinal motility were also assessed, while serum biomarkers for liver injury and glucose level were analyzed. On the other hand, fecal microbiota and associated metabolic activities were also investigated. beta-glucan bulked feces, decreased fecal moisture, and proliferated goblet cells resulted in a thickened lubricating mucin layer; however, the intestinal transit rate did not increase. The abundance of beneficial bacteria was increased while the harmful strains was decreased in a dose-dependent manner by the effect of beta-glucan. Specific short chain fatty acid (SCFA)-producing strains, such as Roseburia, Ruminococcus, and Bifidobacteria, were selectively increased by beta-glucan. In addition, consumption of beta-glucan lowered level of obesity-associated biomarkers. Schizophyllum commune beta-glucan showed an insignificant change in transit rate in healthy conditions when compared with obesity, despite similar effects on increasing mucus production and bulked feces. Nonetheless, the outcomes proposed protective effects against obesity, diabetes, inflammatory bowel diseases (IBD), and constipation, in which the modification of the gut microbiota by beta-glucan is the largest contributor.","[Vuong Vu; Cho, Moonjae] Jeju Natl Univ, Interdisciplinary Grad Program Adv Convergence Te, Jeju 63241, South Korea; [Muthuramalingam, Karthika; Choi, Changmin; Kim, Young Mee; Cho, Moonjae] Jeju Natl Univ, Sch Med, Dept Biochem, Jeju 63243, South Korea; [Singh, Vineet; Unno, Tatsuya] Jeju Natl Univ, Fac Biotechnol, Sch Life Sci, SARI, Jeju 63243, South Korea; [Unno, Tatsuya] Jeju Natl Univ, Subtrop Trop Organism Gene Bank, Jeju 63243, South Korea; [Cho, Moonjae] Jeju Natl Univ, Inst Med Sci, Jeju 63241, South Korea",Jeju National University; Jeju National University; Jeju National University; Jeju National University; Jeju National University,"Cho, M (corresponding author), Jeju Natl Univ, Interdisciplinary Grad Program Adv Convergence Te, Jeju 63241, South Korea.;Cho, M (corresponding author), Jeju Natl Univ, Sch Med, Dept Biochem, Jeju 63243, South Korea.;Unno, T (corresponding author), Jeju Natl Univ, Fac Biotechnol, Sch Life Sci, SARI, Jeju 63243, South Korea.;Unno, T (corresponding author), Jeju Natl Univ, Subtrop Trop Organism Gene Bank, Jeju 63243, South Korea.;Cho, M (corresponding author), Jeju Natl Univ, Inst Med Sci, Jeju 63241, South Korea.",tatsu@jejunu.ac.kr; moonjcho@jejunu.ac.kr,"Singh, Vineet/ABC-7000-2021; Unno, Tatsuya/C-1522-2012","Singh, Vineet/0000-0003-2458-3282;","Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [NRF-2020R1I1A3072840]","Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology","This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (NRF-2020R1I1A3072840).",,46,9,9,1,57,SPRINGER SINGAPORE PTE LTD,SINGAPORE,"#04-01 CENCON I, 1 TANNERY RD, SINGAPORE 347719, SINGAPORE",2468-0834,2468-0842,,APPL BIOL CHEM,Appl. Biol. Chem.,DEC,2022,65,1,,,,,,,9,10.1186/s13765-022-00680-3,http://dx.doi.org/10.1186/s13765-022-00680-3,,,11,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,YR8UH,,gold,,,2024-06-04,WOS:000750265100001,View Full Record in Web of Science
J,"LAMBERT, JP; BRUNT, PW; MOWAT, NAG; KHIN, CC; LAI, CKW; MORRISON, V; DICKERSON, JWT; EASTWOOD, MA",,,,"LAMBERT, JP; BRUNT, PW; MOWAT, NAG; KHIN, CC; LAI, CKW; MORRISON, V; DICKERSON, JWT; EASTWOOD, MA",,,THE VALUE OF PRESCRIBED HIGH-FIBER DIETS FOR THE TREATMENT OF THE IRRITABLE-BOWEL-SYNDROME,EUROPEAN JOURNAL OF CLINICAL NUTRITION,,,English,Article,,,,,,,WHEAT BRAN; FIBER; TRIAL,"The symptoms of 72 patients with irritable bowel syndrome were assessed by questionnaire before and 6 months after a high-fibre diet had been prescribed, to find whether those who achieved the highest fibre intake did any better than those with smaller intakes. Dietary fibre intakes were measured after 6 months by a 7-day weighed food inventory. There was a significant inverse association between the presence of symptoms and fibre intake for: incomplete defaecation, urgency and hard stools with total fibre intake; urgency and hard stools with cereal fibre intake; and borborygmi with fibre intake at breakfast. All patients with constipation, mucus, urgency or watery stools at the beginning of the study, and who were consuming more than 30 g fibre by the end, reported an improvement in these symptoms. Increasing intakes of fibre were not related in any way to abdominal distension, diarrhoea, flatulence or patient's feelings about the working of their bowels. Therefore, this study suggests that the symptoms which benefit most from the prescription of a high-fibre diet are hard stools, constipation and urgency.","ROBERT GORDONS INST TECHNOL,SCH NUTR SCI,ABERDEEN AB9 2PG,SCOTLAND; WOODEND GEN HOSP,GASTROENTEROL UNIT,ABERDEEN AB9 2YS,SCOTLAND; UNIV SURREY,DEPT BIOCHEM,DIV NUTR & FOOD SCI,GUILDFORD GU2 5XH,SURREY,ENGLAND; WESTERN GEN HOSP,WOLFSON GASTROINTESTINAL LABS,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND",Robert Gordon University; University of Surrey; University of Edinburgh,,,,,,,,,20,23,25,0,1,STOCKTON PRESS,BASINGSTOKE,"HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS",0954-3007,,,EUR J CLIN NUTR,Eur. J. Clin. Nutr.,DEC,1991,45,12,,,,,601,609,,,,,,9,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,HH291,1667298,,,,2024-06-04,WOS:A1991HH29100003,View Full Record in Web of Science
J,"Rondanelli, M; Faliva, MA; Miccono, A; Naso, M; Nichetti, M; Riva, A; Guerriero, F; De Gregori, M; Peroni, G; Perna, S",,,,"Rondanelli, Mariangela; Faliva, Milena Anna; Miccono, Alessandra; Naso, Maurizio; Nichetti, Mara; Riva, Antonella; Guerriero, Fabio; De Gregori, Manuela; Peroni, Gabriella; Perna, Simone",,,Food pyramid for subjects with chronic pain: foods and dietary constituents as anti-inflammatory and antioxidant agents,NUTRITION RESEARCH REVIEWS,,,English,Review,,,,,,Chronic pain; Nutrients; Inflammation; Food pyramid; Constipation; Opioids; Antioxidants,OPIOID-INDUCED CONSTIPATION; C-REACTIVE PROTEIN; VIRGIN OLIVE OIL; IMPROVES ENDOTHELIAL FUNCTION; CARDIOVASCULAR RISK-FACTORS; KAPPA-B ACTIVATION; OXIDATIVE STRESS; VITAMIN-D; SYSTEMIC INFLAMMATION; PHENOLIC-COMPOUNDS,"Emerging literature suggests that diet constituents may play a modulatory role in chronic pain (CP) through management of inflammation/oxidative stress, resulting in attenuation of pain. We performed a narrative review to evaluate the existing evidence regarding the optimum diet for the management of CP, and we built a food pyramid on this topic. The present review also describes the activities of various natural compounds contained in foods (i.e. phenolic compounds in extra-virgin olive oil (EVO)) listed on our pyramid, which have comparable effects to drug management therapy. This review included 172 eligible studies. The pyramid shows that carbohydrates with low glycaemic index should be consumed every day (three portions), together with fruits and vegetables (five portions), yogurt (125 ml), red wine (125 ml) and EVO; weekly: legumes and fish (four portions); white meat, eggs and fresh cheese (two portions); red or processed meats (once per week); sweets can be consumed occasionally. The food amounts are estimates based on nutritional and practical considerations. At the top of the pyramid there is a pennant: it means that CP subjects may need a specific customised supplementation (vitamin B-12, vitamin D, n-3 fatty acids, fibre). The food pyramid proposal will serve to guide dietary intake with to the intent of alleviating pain in CP patients. Moreover, a targeted diet can also help to solve problems related to the drugs used to combat CP, i.e. constipation. However, this paper would be an early hypothetical proposal due to the limitations of the studies.","[Rondanelli, Mariangela; Faliva, Milena Anna; Naso, Maurizio; Nichetti, Mara; Peroni, Gabriella; Perna, Simone] Univ Pavia, Sect Human Nutr, Dept Publ Hlth Expt & Forens Med, Endocrinol & Nutr Unit,Azienda Serv Persona, Pavia, Italy; [Miccono, Alessandra] Univ Milan, Fac Med & Surg, Dept Clin Sci, Milan, Italy; [Riva, Antonella] R&D Indena SpA, Viale Ortles 12, I-20139 Milan, Italy; [Guerriero, Fabio] Univ Pavia, Sect Geriatr & Gerontol, Dept Internal Med, Azienda Serv Persona,Ist Santa Margherita, Pavia, Italy; [De Gregori, Manuela] Fdn IRCCS Policlin San Matteo, Pain Therapy Serv, Pavia, Italy; [De Gregori, Manuela] SIMPAR Grp Study Multidisciplinary PAin Res, Parma, Italy",University of Pavia; University of Milan; University of Pavia; IRCCS Fondazione San Matteo,"Perna, S (corresponding author), Univ Pavia, Sect Human Nutr, Dept Publ Hlth Expt & Forens Med, Endocrinol & Nutr Unit,Azienda Serv Persona, Pavia, Italy.",simoneperna@hotmail.it,"Faliva, Milena Anna/AAC-3653-2022; Rondanelli, Mariangela/AGD-6274-2022; Perna, Simone/Y-8892-2018; Guerriero, Fabio/L-6393-2016","Perna, Simone/0000-0002-2720-1473; Guerriero, Fabio/0000-0002-9926-2494; Riva, Antonella/0000-0003-2819-943X",,,,,221,60,62,1,32,CAMBRIDGE UNIV PRESS,CAMBRIDGE,"EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND",0954-4224,1475-2700,,NUTR RES REV,Nutr. Res. Rev.,JUN,2018,31,1,,,,,131,151,,10.1017/S0954422417000270,http://dx.doi.org/10.1017/S0954422417000270,,,21,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,GI4YP,29679994,Bronze,,,2024-06-04,WOS:000434377600009,View Full Record in Web of Science
J,"Zhu, LX; Liu, WS; Alkhouri, R; Baker, RD; Bard, JE; Quigley, EM; Baker, SS",,,,"Zhu, Lixin; Liu, Wensheng; Alkhouri, Razan; Baker, Robert D.; Bard, Jonathan E.; Quigley, Eamonn M.; Baker, Susan S.",,,Structural changes in the gut microbiome of constipated patients,PHYSIOLOGICAL GENOMICS,,,English,Article,,,,,,constipation; microbiota; Prevotella; butyrate,CHAIN FATTY-ACIDS; FUNCTIONAL CONSTIPATION; DOUBLE-BLIND; INCREASED PREVALENCE; DISTAL ESOPHAGUS; GENUS PREVOTELLA; FIBER INTAKE; DAIRY-COWS; RAT COLON; SP-NOV,"Previous studies using culture-based methods suggested an association between constipation and altered abundance of certain taxa of the colonic microbiome. We aim to examine the global changes in gut microbial composition of constipated patients. A cross-sectional pilot study using 16S rRNA gene pyrosequencing was performed to compare stool microbial composition of eight constipated patients and 14 nonconstipated controls. Only obese children were enrolled so that the microbiome features associated with constipation would not be obscured by those associated with obesity. The sequencing reads were processed by QIIME for quantitative analysis of the microbial composition at genus and above levels. Dietary intake for all the individuals was assessed by dietary recalls and a food frequency questionnaire. The ecological diversities of fecal microbiome of the constipated patients differed from those of the controls. Significantly decreased abundance in Prevotella and increased representation in several genera of Firmicutes were observed in constipated patients compared with controls. The conventional probiotic genera Lactobacillus and Bifidobacteria were not decreased in the microbiomes of the constipated patients. These alterations in the fecal microbiome of constipated patients suggested that a novel probiotic treatment including certain Prevotella strains may be more effective than conventional probiotic products incorporating Lactobacillus or Bifidobacterium species. While it is possible that the observed changes in the microbiome in constipated subjects are a consequence of a low-fiber diet, these changes also predict a different pattern of bacterial fermentation end-products, such as increased butyrate production, which may contribute to pathogenesis of constipation.","[Zhu, Lixin; Liu, Wensheng; Alkhouri, Razan; Baker, Robert D.; Baker, Susan S.] SUNY Buffalo, Dept Pediat, Digest Dis & Nutr Ctr, Buffalo, NY 14214 USA; [Bard, Jonathan E.] SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA; [Quigley, Eamonn M.] Houston Methodist Hosp, Div Gastroenterol & Hepatol, Houston, TX USA; [Quigley, Eamonn M.] Univ Coll, Alimentary Pharmabiot Ctr, Cork, Ireland",State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; The Methodist Hospital System; The Methodist Hospital - Houston; University College Cork,"Zhu, LX (corresponding author), SUNY Buffalo, Dept Pediat, Digest Dis & Nutr Ctr, 3435 Main St,422BRB, Buffalo, NY 14214 USA.",lixinzhu@buffalo.edu,"liu, wen/HGE-3071-2022; Zhu, Lixin/ACE-1496-2022","Zhu, Lixin/0000-0001-7904-1769; Bard, Jonathan/0000-0001-7433-0086","Peter and Tommy Fund, Inc., Buffalo, NY","Peter and Tommy Fund, Inc., Buffalo, NY","This work was supported by a grant from the Peter and Tommy Fund, Inc., Buffalo, NY (to S. S. Baker) and a departmental start-up fund (to L. Zhu). The funders had no role in study design, data collection, analysis or interpretation.",,51,243,281,10,86,AMER PHYSIOLOGICAL SOC,BETHESDA,"9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA",1094-8341,1531-2267,,PHYSIOL GENOMICS,Physiol. Genomics,SEP 15,2014,46,18,,,,,679,686,,10.1152/physiolgenomics.00082.2014,http://dx.doi.org/10.1152/physiolgenomics.00082.2014,,,8,Cell Biology; Genetics & Heredity; Physiology,Science Citation Index Expanded (SCI-EXPANDED),Cell Biology; Genetics & Heredity; Physiology,AO9VE,25073603,,,,2024-06-04,WOS:000341705900002,View Full Record in Web of Science
J,"Park, EJ; Jhon, DY",,,,"Park, Eun-Jin; Jhon, Deok-Young",,,Effects of bamboo shoot consumption on lipid profiles and bowel function in healthy young women,NUTRITION,,,English,Review,,,,,,Bamboo shoots; Dietary fiber; Lipid profile; Lipid-lowering effect; Healthy women,DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; HIGH-FIBER DIET; CARDIOVASCULAR-DISEASE; SERUM CREATININE; RISK; METABOLISM; PREVENTION; REDUCTION; MORTALITY,"Objective: This study evaluated the short-term effect of bamboo shoot consumption as a dietary fiber source on blood glucose, lipid profiles, hepatic function, and constipation symptoms in healthy women. Methods: Eight subjects, 21- to 23-y-old women, with normal health status received a dietary fiber-free diet (control), a diet containing 25 g of cellulose, and a diet containing 360 g of bamboo shoots, with each diet segment lasting 6 d. At the end of each diet, blood biochemical parameters, such as glucose, triacylglycerols, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, glutamic pyruvic transaminase, glutamic oxaloacetic transaminase, and atherogenic index were measured and a questionnaire test for the evaluation of fecal excretion was taken. For statistical analysis, analysis of variance was performed. Results: Serum total cholesterol, low-density lipoprotein cholesterol, and the atherogenic index were decreased with the bamboo shoot diet feeding compared with the dietary fiber-free diet. There were no differences in serum glucose levels among the tested diets. Fecal volume and bowel movement frequency in subjects fed the bamboo shoot diet were significantly increased. Conclusion: Bamboo shoots as a dietary fiber source has beneficial effects on lipid profile and bowel function. (C) 2009 Published by Elsevier Inc.","[Jhon, Deok-Young] Chonnam Natl Univ, Dept Food Sci & Human Nutr, Kwangju, South Korea; [Park, Eun-Jin] Washington State Univ, Dept Food Sci & Human Nutr, Pullman, WA 99164 USA",Chonnam National University; Washington State University,"Jhon, DY (corresponding author), Chonnam Natl Univ, Dept Food Sci & Human Nutr, Kwangju, South Korea.",dyjhon@chonnam.ac.kr,,,,,,,45,61,74,1,38,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",0899-9007,1873-1244,,NUTRITION,Nutrition,JUL-AUG,2009,25,7-8,,,,,723,728,,10.1016/j.nut.2009.01.007,http://dx.doi.org/10.1016/j.nut.2009.01.007,,,6,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,465II,19285833,,,,2024-06-04,WOS:000267576100002,View Full Record in Web of Science
J,"Wernimont, SM; Fritsch, DA; Schiefelbein, HM; Brejda, JJ; Gross, KL",,,,"Wernimont, Susan; Fritsch, Dale; Schiefelbein, Heidi; Brejda, John; Gross, Kathy",,,Food with Specialized Dietary Fiber Sources Improves Clinical Outcomes in Adult Cats with Constipation or Diarrhea,FASEB JOURNAL,,,English,Meeting Abstract,Annual Meeting on Experimental Biology,"APR 04-07, 2020","San Diego, CA","Amer Assoc Anatomists,Amer Physiol Soc,Amer Soc Biochem & Mol Biol,Amer Soc Investigat Pathol,Amer Soc Nutr,Amer Soc Pharmacol & Expt Therapeut",,,,,"[Wernimont, Susan; Fritsch, Dale; Schiefelbein, Heidi; Gross, Kathy] Hills Pet Nutr Inc, Topeka, KS USA; [Brejda, John] Alpha Stat Consultant Inc, Lincoln, NE USA","Colgate-Palmolive Company; Hill's Pet Nutrition, Inc.",,,"Wernimont, Susan M/KFS-1562-2024","Wernimont, Susan M/0000-0001-7203-1349","Hill's Pet Nutrition, Inc.","Hill's Pet Nutrition, Inc.","This study was funded by Hill's Pet Nutrition, Inc.",,0,0,0,4,16,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0892-6638,1530-6860,,FASEB J,Faseb J.,APR,2020,34,,,1,,,,,,10.1096/fasebj.2020.34.s1.09918,http://dx.doi.org/10.1096/fasebj.2020.34.s1.09918,,,2,Biochemistry & Molecular Biology; Biology; Cell Biology,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology,MG5YS,,,,,2024-06-04,WOS:000546107905174,View Full Record in Web of Science
J,"Fernández-Bañares, F; Hinojosa, J; Sánchez-Lombraña, JL; Navarro, E; Martínez-Salmerón, JF; García-Pugés, A; González-Huix, F; Riera, J; González-Lara, V; Domínguez-Abascal, F; Giné, JJ; Moles, J; Gomollón, F; Gassull, MA",,,,"Fernández-Bañares, F; Hinojosa, J; Sánchez-Lombraña, JL; Navarro, E; Martínez-Salmerón, JF; García-Pugés, A; González-Huix, F; Riera, J; González-Lara, V; Domínguez-Abascal, F; Giné, JJ; Moles, J; Gomollón, F; Gassull, MA",,,Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis,AMERICAN JOURNAL OF GASTROENTEROLOGY,,,English,Article; Proceedings Paper,"97th Annual Meeting of the American-Gastroenterological-Association, Digestive Disease Week","MAY 10-16, 1997","WASHINGTON, D.C.",Amer Gastroenterol Assoc,,,CHAIN FATTY-ACIDS; PLACEBO-CONTROLLED TRIAL; LARGE-BOWEL CANCER; BUTYRATE ENEMAS; RECTAL IRRIGATION; COLONIC MUCOSA; RAT MODEL; PROTECTION; COLONOCYTE; NUTRITION,"Objective: Butyrate enemas may be effective in the treatment of active distal ulcerative colitis. Because colonic fermentation of Plantago ovata seeds (dietary fiber) yields butyrate, the aim of this study was to assess the efficacy and safety of Plantago ovata seeds as compared with mesalamine in maintaining remission in ulcerative colitis. Methods: An open label, parallel-group, multicenter, randomized clinical trial was conducted. A total of 105 patients with ulcerative colitis who were in remission were randomized into groups to receive oral treatment with Plantago ovata seeds (10 g b.i.d.), mesalamine (500 mg tid.), and Plantago ovata seeds plus mesalamine at the same doses. The primary efficacy outcome was maintenance of remission for 12 months. Results: Of the 105 patients, 102 were included in the final analysis. After 12 months, treatment failure rate was 40% (14 of 35 patients) in the Planta,oo ovata seed group, 35% (13 of 37) in the mesalamine group, and 30% (nine of 30) in the Plantago ovata plus mesalamine group. Probability of continued remission was similar (Mantel-Cox test, p = 0.67; intent-to-treat analysis). Therapy effects remained unchanged after adjusting for potential confounding variables with a Cox's proportional hazards survival analysis. Three patients were withdrawn because of the development of adverse events consisting of constipation and/or flatulence (Plantago ovata seed group = 1 and Plantago ovata seed plus mesalamine group = 2). A significant increase in fecal butyrate levels (p = 0.018) was observed after Plantago ovata seed administration. Conclusions: Plantago ovata seeds (dietary fiber) might be as effective as mesalamine to maintain remission in ulcerative colitis. (Am J Gastroenterol 1999;94:427-433. (C) 1999 by Am. Cell. of Gastroenterology).","Hosp Univ Germans Trias & Pujol, Dept Gastroenterol, Badalona 08916, Spain; Hosp Sagunto, Valencia, Spain; Hosp Asturias, Oviedo, Spain; Hosp Motril, Granada, Spain; Hosp Clin Barcelona, Barcelona, Spain; Hosp Josep Trueta, Girona, Spain; Hosp Son Dureta, Palma de Mallorca, Spain; Hosp Gen Gregorio Maranon, Madrid, Spain; Hosp Virgen Rocio, Seville, Spain; Hosp Verge Cinta, Tortosa, Spain; Hosp Miguel Servet, Zaragoza, Spain",Hospital Germans Trias i Pujol; University of Barcelona; Hospital Clinic de Barcelona; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Hospital Universitari Son Espases; Hospital Universitari Son Dureta; General University Gregorio Maranon Hospital; Virgen del Rocio University Hospital; Miguel Servet University Hospital,"Gassull, MA (corresponding author), Hosp Univ Germans Trias & Pujol, Dept Gastroenterol, Carretera Canyet S-N, Badalona 08916, Spain.",,"Muñoz Tenería, Fernando Alberto/HTP-8480-2023","Muñoz Tenería, Fernando Alberto/0000-0002-2338-3804",,,,,36,261,278,0,15,ELSEVIER SCIENCE INC,NEW YORK,"655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA",0002-9270,,,AM J GASTROENTEROL,Am. J. Gastroenterol.,FEB,1999,94,2,,,,,427,433,,10.1111/j.1572-0241.1999.872_a.x,http://dx.doi.org/10.1111/j.1572-0241.1999.872_a.x,,,7,Gastroenterology & Hepatology,Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,164ZB,10022641,,,,2024-06-04,WOS:000078492500024,View Full Record in Web of Science
J,"Roberts, MC; Millikan, RC; Galanko, JA; Martin, C; Sandler, RS",,,,"Roberts, MC; Millikan, RC; Galanko, JA; Martin, C; Sandler, RS",,,"Constipation, laxative use, and colon cancer in a North Carolina population",AMERICAN JOURNAL OF GASTROENTEROLOGY,,,English,Article,,,,,,,SEEKING HEALTH-CARE; COLORECTAL-CANCER; UNITED-STATES; DIETARY FIBER; RISK-FACTORS; BOWEL MOVEMENT; LIFE-STYLE; EPIDEMIOLOGY; ADULTS; ALCOHOL,"OBJECTIVE: The aim of this study was to determine whether bowel movement frequency and laxative use and type were associated with risk of colon cancer in white and black men and women. METHODS: We conducted a population-based, case-control study with equal representation by blacks. Eligible subjects between ages 40 and 80 yr residing in urban and rural communities in North Carolina were asked about bowel habits and laxatives during face-to-face interviews. There were 643 cases (349 white, 294 black) and 1048 controls (611 white, 437 black). RESULTS: Constipation, defined as fewer than three reported bowel movements per wk, was associated with a greater than two-fold risk of colon cancer (OR 2.36; 95% CI = 1.41-3.93) adjusted for age, race, sex, and relevant confounders. The association was greater for women (OR 2.69; 95% CI = 1.46-4.94) than for men (OR 1.73; 95% CI = 0.61-4.88) and stronger in blacks than whites. Black women had the highest risk (OR 3.42; 95% CI = 1.60-7.34), which remained significant (OR 3.21; 95% CI = 1.46-7.04) even after excluding subjects with late stage (distant) disease. The OR for constipation was slightly higher for distal than for proximal colon cancers. There was no association with laxative use (OR 0.88; 95% CI 0.69-1.11). Fiber commercial laxatives appeared to exert a protective effect in a small subgroup. CONCLUSIONS: This study provides support for a positive association between constipation and increased risk for colon cancer. Women, especially black women with constipation, seem to be at the highest risk.","Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC USA; Univ N Carolina, Sch Med, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC USA; N Carolina State Univ, Coll Vet Med, Dept Farm Anim Hlth & Resource Management, Raleigh, NC USA",University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; North Carolina State University,"Sandler, RS (corresponding author), Univ N Carolina, Div Digest Dis & Nutr, CB 7080-719 Burnett Womack Bldg, Chapel Hill, NC 27599 USA.",,,,NCI NIH HHS [R01 CA66635] Funding Source: Medline; NIDDK NIH HHS [P30 DK 34987] Funding Source: Medline,NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)),,,32,74,84,0,6,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",0002-9270,,,AM J GASTROENTEROL,Am. J. Gastroenterol.,APR,2003,98,4,,,,,857,864,,10.1016/S0002-9270(03)00050-9,http://dx.doi.org/10.1016/S0002-9270(03)00050-9,,,8,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,676LW,12738468,,,,2024-06-04,WOS:000182754400025,View Full Record in Web of Science
J,"Müller-Lissner, SA; Kaatz, V; Brandt, W; Keller, J; Layer, P",,,,"Müller-Lissner, SA; Kaatz, V; Brandt, W; Keller, J; Layer, P",,,The perceived effect of various foods and beverages on stool consistency,EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY,,,English,Article,,,,,,chronic constipation; irritable bowel syndrome; cocoa; chocolate; dietary fibre; tea; coffee; bananas; smoking; cigarettes,MENSTRUAL-CYCLE; BOWEL; CONSTIPATION; CONSUMPTION; CHOCOLATE; NICOTINE; TRANSIT; WEIGHT,"Aim Some people believe that chocolate and other foods or beverages may cause constipation. This study was undertaken to quantify the effect of potentially constipating foods and beverages on apparently healthy and constipated populations of German individuals. Methods A questionnaire asking for the effect of certain foods and beverages on stool form (perceived consistency) was answered by 200 healthy controls, 122 patients with chronic constipation, and 766 patients with irritable bowel syndrome with constipation (IBS-C). Results Patients with constipation or IBS-C reported altered stool form after food and beverage consumption more often than controls (controls 42.5% vs constipation 52.0% vs IBS-C 57.0%, P < 0.001). Controls experienced hardening of stools less often and experienced softening more often than either constipation or IBS-C patients. When patients were asked which foods or beverages caused constipation (open ended question), chocolate was most frequently mentioned, followed by white bread and bananas. The results of systematic questioning yielded chocolate (48-64% of respondents), bananas (29-48%), and black tea (14-24%) as constipating, while prunes (41-52%), coffee (14-24%), wine (8-30%), beer (14-24%), and smoking (42-70% in those who smoked) were considered stool softeners. Conclusion Several foodstuffs may exert an effect on stool consistency. Chocolate, bananas and black tea are perceived to cause constipation, while prunes are perceived to soften stools in many people. Coffee, wine and beer were perceived to soften stools in a minority of people. Cigarettes are perceived to soften stools by about half of the smokers. (c) 2005 Lippincott Williams & Wilkins.","Innere Med Abt, D-13086 Berlin, Germany; Int Fachpraxis, Potsdam, Germany; Israelt Krankenhaus, Hamburg, Germany",,"Innere Med Abt, Pk Klin Weissensee,Schonstr 80, D-13086 Berlin, Germany.",mueli@park-klinik.com,,,,,,,33,38,42,0,13,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0954-691X,1473-5687,,EUR J GASTROEN HEPAT,Eur. J. Gastroenterol. Hepatol.,JAN,2005,17,1,,,,,109,112,,,,,,4,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,893LF,15647650,,,,2024-06-04,WOS:000226719800021,View Full Record in Web of Science
J,"Jakobsen, LH; Wirth, R; Smoliner, C; Klebach, M; Hofman, Z; Kondrup, J",,,,"Jakobsen, L. H.; Wirth, R.; Smoliner, C.; Klebach, M.; Hofman, Z.; Kondrup, J.",,,"Gastrointestinal tolerance and plasma status of carotenoids, EPA and DHA with a fiber-enriched tube feed in hospitalized patients initiated on tube nutrition: Randomized controlled trial",CLINICAL NUTRITION,,,English,Article; Proceedings Paper,35th Congress of the European-Society-for-Clinical-Nutrition-and-Metabolism (ESPEN),2013,"Leipzig, GERMANY",European Soc Clin Nutr & Metab,,Tube feeding; Gastrointestinal tolerance; Fish oil; Carotenoids; Fiber; Diarrhea,ENTERAL NUTRITION; HUMAN HEALTH; DIARRHEA; ANTIOXIDANTS; MORTALITY; BENEFITS,"Background & aims: During the first days of tube feeding (TF) gastrointestinal (GI) complications are common and administration of sufficient nutrition is a challenge. Not all standard nutritionally complete formulas contain dietary fiber, fish oil or carotenoids, key dietary nutrients for health and wellbeing. The aim of this study was to investigate the effects of a fiber, fish oil and carotenoid enriched TF formula on diarrhea, constipation and nutrient bioavailability. Methods: A multi-center randcimized, double-blind, controlled, parallel trial compared the effects of a dietary fiber, fish oil and carotenoid-enriched TF formula (test) with an isocaloric non-enriched formula (control) in 51 patients requiring initiation of TF. Incidence of diarrhea and constipation (based on stool frequency and consistency) was recorded daily. Plasma status of EPA, DHA and carotenoids was measured after 7 days. Results: The incidence of diarrhea was lower in patients receiving the test formula compared with the control group (19% vs. 48%, p = 0.034). EPA and DHA status (% of total plasma phospholipids) was higher after 7 days in test compared with control group (EPA: p = 0.002, DHA: p = 0.082). Plasma carotenoid levels were higher after 7 days in the test group compared with control group (lutein: p = 0.024, alpha-carotene: p = 0.005, lycopene: p = 0.020, (3-carotene: p = 0.054). Conclusions: This study suggests that the nutrient-enriched TF formula tested might have a positive effect on GI tolerance with less diarrhea incidence and significantly improved EPA, DHA and carotenoid plasma levels during the initiation of TF in hospitalized patients who are at risk of diarrhea and low nutrient status. (C) 2016 Published by Elsevier Ltd.","[Jakobsen, L. H.; Kondrup, J.] Univ Copenhagen, Fac Life Sci, Dept Human Nutr, Copenhagen, Denmark; [Wirth, R.; Smoliner, C.] St Marten Hosp Borken, Dept Internal Med & Geriatr, Borken, Germany; [Klebach, M.; Hofman, Z.] Nutricia Adv Med Nutr, Nutricia Res, Schiphol, Netherlands; [Wirth, R.] Univ Erlangen Nurnberg, Inst Biomed Aging, Erlangen, Germany",University of Copenhagen; St. Marien Hospital; Danone Nutricia; University of Erlangen Nuremberg,"Klebach, M (corresponding author), Nutricia Adv Med Nutr, Nutricia Res, Schiphol, Netherlands.",Marianne.klebach@Nutricia.com,"Wirth, Rainer/F-3919-2014; Wirth, Rainer/AAF-8421-2020","Wirth, Rainer/0000-0002-7265-0163","Nutricia Research B.V., Utrecht, The Netherlands","Nutricia Research B.V., Utrecht, The Netherlands","The study was funded by Nutricia Research B.V., Utrecht, The Netherlands. L.H. Jakobsen received part of her compensation from Nutricia Research.",,29,11,12,1,9,CHURCHILL LIVINGSTONE,EDINBURGH,"JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND",0261-5614,1532-1983,,CLIN NUTR,Clin. Nutr.,APR,2017,36,2,,,,,380,388,,10.1016/j.clnu.2016.02.001,http://dx.doi.org/10.1016/j.clnu.2016.02.001,,,9,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Nutrition & Dietetics,ES5ZG,27126710,,,,2024-06-04,WOS:000399624700006,View Full Record in Web of Science
J,"Eoff, JC; Lembo, AJ",,,,"Eoff, James C., III; Lembo, Anthony J.",,,Optimal Treatment of Chronic Constipation in Managed Care: Review and Roundtable Discussion,JOURNAL OF MANAGED CARE PHARMACY,,,English,Article,,,,,,,IRRITABLE-BOWEL-SYNDROME; PLACEBO-CONTROLLED TRIAL; FUNCTIONAL ABDOMINAL-PAIN; QUALITY-OF-LIFE; HEALTH-CARE; TRANSIT CONSTIPATION; FECAL IMPACTION; DIETARY FIBER; UNITED-STATES; PELVIC FLOOR,"BACKGROUND: Prevalence studies estimate that chronic constipation affects 12%-19% of Americans. This prevalence rate exceeds that of many highly publicized chronic conditions, including diabetes and asthma. Identifying the etiology of each patient's constipation is essential for determining treatment and management plans. The etiology of chronic constipation falls into 2 broad categories: primary or idiopathic constipation caused by physical and functional problems, and secondary constipation resulting from a variety of organic conditions as well as the use of certain medications. Patients may have more than one cause of their constipation. Treatment options may be based not only on the cause but may be dictated by a patient's health care coverage and the inclusion criteria of different health care plans. OBJECTIVES: To (a) present key information on the causes, diagnosis, and treatment recommendations for patients with chronic constipation; describe how chronic constipation impacts quality of life; and (c) describe how all providers can work to improve the quality of care and health outcomes for patients with chronic constipation. SUMMARY: Chronic constipation is a prevalent condition that disproportionately affects women and the elderly. Most agents are available over-the-counter, although their efficacy has not been extensively tested. Few prescription agents are currently available, and they are more costly; therefore, managed care plans may restrict these products for patients who fail traditional treatments. A lack of evidence-based algorithms leaves many providers to treat patients empirically. Practitioners can assist patients seeking recommendations and provide information on treatment options.","[Eoff, James C., III] Univ Tennessee, Coll Pharm, Memphis, TN 38163 USA; [Lembo, Anthony J.] Harvard Univ, Sch Med, Boston, MA USA; [Lembo, Anthony J.] Beth Israel Deaconess Med Ctr, Gastrointestinal Motil Ctr, Boston, MA 02215 USA",University of Tennessee System; University of Tennessee Health Science Center; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center,"Eoff, JC (corresponding author), Univ Tennessee, Coll Pharm, 847 Monroe Ave,Ste 226, Memphis, TN 38163 USA.",jeoff@utmem.edu; alembo@bidmc.harvard.edu,,,,,,,70,40,48,0,3,ACAD MANAGED CARE PHARMACY,ALEXANDRIA,"100 N PITT ST, 400, ALEXANDRIA, VA 22314-3134 USA",1083-4087,,,J MANAGE CARE PHARM,J. Manag. Care Pharm.,NOV,2008,14,9,,A,,,S3,S15,,,,,,13,Health Care Sciences & Services; Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Health Care Sciences & Services; Pharmacology & Pharmacy,380WC,18950252,,,,2024-06-04,WOS:000261495800001,View Full Record in Web of Science
J,"Speed, C; Heaven, B; Adamson, A; Bond, J; Corbett, S; Lake, AA; May, C; Vanoli, A; McMeekin, P; Moynihan, P; Rubin, G; Steen, IN; McColl, E",,,,"Speed, C.; Heaven, B.; Adamson, A.; Bond, J.; Corbett, S.; Lake, A. A.; May, C.; Vanoli, A.; McMeekin, P.; Moynihan, P.; Rubin, G.; Steen, I. N.; McColl, E.",,,LIFELAX - diet and LIFEstyle versus LAXatives in the management of chronic constipation in older people: randomised controlled trial,HEALTH TECHNOLOGY ASSESSMENT,,,English,Article,,,,,,,QUALITY-OF-LIFE; BRIEF MOTIVATIONAL INTERVENTION; HEALTH TECHNOLOGY-ASSESSMENT; FUNCTIONAL BOWEL DISORDERS; PRIMARY-CARE; PHYSICAL-ACTIVITY; GENERAL-PRACTICE; MULTIFACTORIAL INTERVENTION; MYOCARDIAL-INFARCTION; COMPLEX INTERVENTIONS,"Objectives: To investigate the clinical effectiveness and cost-effectiveness of laxatives versus dietary and lifestyle advice, and standardised versus personalised dietary and lifestyle advice. Design: A prospective, pragmatic, three-armed cluster randomised trial with an economic evaluation. Setting: General practices in England and Scotland, UK. Participants: People aged >= 55 years with chronic constipation, living in private households. Participants were identified as those who had been prescribed laxatives three or more times in the previous 12 months, or with a recorded diagnosis of chronic functional constipation. Interventions: Prescription of laxatives, with class of laxative and dose at the discretion of the GP and patient (standard care control arm); standardised, non-personalised dietary and lifestyle advice; and, personalised dietary and lifestyle advice, with reinforcement. Outcome measures: The primary outcome was the constipation-specific Patient Assessment of Constipation-Symptoms (PAC-SYM)/Patient Assessment of Constipation-Quality of Life (PAC-QOL). Results: The trial planned to recruit and retain 1425 patients from 57 practices (19 per arm); however, only 154 patients were recruited from 19 practices. Due to these low recruitment rates it was not possible to report the conventional trial findings. Baseline characteristics of the sample from data gathered from both postal self-completion questionnaires and face-to-face interviews suggest that our sample experienced very few symptoms of constipation (PAC-SYM) and that the condition itself did not have a major impact upon their quality of life (PAC-QOL). The low level of symptoms of constipation is most likely explained by 90% of the sample using a laxative in the previous week. Most participants in our sample were satisfied with the performance of their laxatives, and levels of anxiety and depression were low. Their fibre consumption was classified as 'moderate' but their average water consumption fell below the recommended guidelines. Daily diaries, completed each day for a period of 6 months, were analysed primarily in terms of overall response rate and item response rates, and the participants accepted this method of data collection. For the economic evaluation, all of the trial arms experienced a reduction in utility, as measured by EQ-5D. There was no statistical evidence to suggest that either the personalised intervention arm or the standardised intervention arm was associated with significant changes in utility at 3 months compared with the control arm. Data on related health-care costs show a cost saving of 13.34 pound for those in the personalised arm, compared with the control arm, and a smaller cost saving for the standardised arm. These savings primarily occurred because of reduced hospital costs. There was no significant change measured in utility, so the personalised arm appeared to be the preferred course, producing the greatest cost savings. Conclusions: Due to the low number of participants in the trial, no firm conclusions could be drawn about the effectiveness of the interventions. However, a number of factors that contributed to the conduct and progress of the trial are highlighted, which may be relevant to others conducting research on a similar topic or population.","[Speed, C.; Bond, J.; McColl, E.] Univ Newcastle, Inst Hlth & Soc, Newcastle Clin Trials Unit, Newcastle Upon Tyne, Tyne & Wear, England; [Adamson, A.; Lake, A. A.; Moynihan, P.] Newcastle Univ, Human Nutr Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Moynihan, P.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne, Tyne & Wear, England; [Moynihan, P.] Newcastle Univ, Sch Dent, Newcastle Upon Tyne, Tyne & Wear, England; [Rubin, G.] Univ Sunderland, Dept Primary Care, Sunderland SR2 7EE, Durham, England; [Rubin, G.] No & Yorkshire Primary Care Res Network, Stockton On Tees, England",Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; University of Sunderland,"McColl, E (corresponding author), Univ Newcastle, Inst Hlth & Soc, Newcastle Clin Trials Unit, Newcastle Upon Tyne, Tyne & Wear, England.",e.mccoll@ncl.ac.uk,"May, Carl/A-8502-2011; McColl, Elaine/V-9906-2019; Moynihan, Paula/AAT-9649-2021","McColl, Elaine/0000-0001-8300-3204; Moynihan, Paula/0000-0002-5015-5620; Adamson, Ashley/0000-0003-3735-2846; Lake, Amelia/0000-0002-4657-8938; McMeekin, Peter/0000-0003-0946-7224; May, Carl/0000-0002-0451-2690","National Institute for Health Research [01/10/04, NF-SI-0509-10017] Funding Source: researchfish; Department of Health [01/10/04] Funding Source: Medline",National Institute for Health Research(National Institutes of Health Research (NIHR)); Department of Health,,,240,19,20,2,20,NIHR JOURNALS LIBRARY,SOUTHAMPTON,"UNIV SOUTHAMPTON, EVALUATION, TRIALS & STUDIES COORDINATING CENTRE, ALPHA HOUSE, ENTERPRISE RD, SOUTHAMPTON, SO16 7NS, ENGLAND",1366-5278,2046-4924,,HEALTH TECHNOL ASSES,Health Technol. Assess.,NOV,2010,14,52,,,,,1,+,,,,,,208,Health Care Sciences & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Health Care Sciences & Services,696MD,21059322,"Green Accepted, Green Published, gold",,,2024-06-04,WOS:000285444600001,View Full Record in Web of Science
J,"Jacobs, EJ; White, E",,,,"Jacobs, EJ; White, E",,,"Constipation, laxative use, and colon cancer among middle-aged adults",EPIDEMIOLOGY,,,English,Article,,,,,,colon cancer; bowel habits; laxatives; diet; gender,COLORECTAL-CANCER; DIETARY FIBER; RISK-FACTORS; TRANSIT-TIME; STOOL WEIGHT; POPULATIONS; WHEAT; BRAN; SEX,"We examined the associations of colon cancer with constipation and use of commercial laxatives in a case control study among men and women ages 30-62 years. We based this analysis on 424 incident cases of colon cancer, diagnosed in the Seattle metropolitan area between 1985 and 1989, and 414 random-digit-dial controls. Frequent constipation during the 10 years before the reference date (2 years before diagnosis), as defined by feeling constipated to the point of having to take something, was associated with substantially increased risk of colon cancer. The adjusted relative risk (RR) was 2.0 [95% confidence interval (Cf) = 1.2-3.6] for constipation 12-51 times per year, and 4.4 (95% CI = 2.1-8.9) for constipation 52 or more times a year. Cumulative lifetime use of commercial laxatives was also associated with increased risk of colon cancer. When constipation and commercial laxative use were adjusted for each other, the association with commercial laxative use disappeared, whereas the association with constipation remained strong. Although constipation has not consistently been associated in past studies with a large increase in risk of colon and rectal cancer combined, these results suggest that frequent constipation may be an important risk factor for colon cancer among middle-aged adults.","Fred Hutchinson Canc Res Ctr, Canc Prevent Res Program, Seattle, WA 98104 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA",Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle,"White, E (corresponding author), Fred Hutchinson Canc Res Ctr, Canc Prevent Res Program, 1124 Columbia St MP-702, Seattle, WA 98104 USA.",,,,"NCI NIH HHS [CA44790, T32 CA09661] Funding Source: Medline",NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)),,,36,66,71,1,7,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA",1044-3983,,,EPIDEMIOLOGY,Epidemiology,JUL,1998,9,4,,,,,385,391,,10.1097/00001648-199807000-00007,http://dx.doi.org/10.1097/00001648-199807000-00007,,,7,"Public, Environmental & Occupational Health",Science Citation Index Expanded (SCI-EXPANDED),"Public, Environmental & Occupational Health",ZV261,9647901,Bronze,,,2024-06-04,WOS:000074286900007,View Full Record in Web of Science
J,"CAMPBELL, AJ; BUSBY, WJ; HORWATH, CC",,,,"CAMPBELL, AJ; BUSBY, WJ; HORWATH, CC",,,FACTORS ASSOCIATED WITH CONSTIPATION IN A COMMUNITY BASED SAMPLE OF PEOPLE AGED 70 YEARS AND OVER,JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH,,,English,Article,,,,,,,HOME,"Study objective-The aim was to determine the prevalence and factors associated Design-The study was a survey involving administration of a structured questionnaire, an interview, and a dietary assessment. Setting-The survey was community based and the population studied was drawn from the practice records of all five general practitioners serving a rural township of 13 500 people. Participants-778 (91.8%) of the 856 people aged 70 years and over registered with the five practitioners took part. Main results-174 subjects had symptoms of infrequent bowel motions or frequent straining at stool or used laxatives regularly. Of this group, 34 had a bowel motion only every 3 d or less frequently and were considered to have constipation. Analysis of this subgroup showed that constipation was more common in women than men, increased with age, and was associated with the use of constipating drugs. Those whose bowels moved infrequently were a more frail group who were less physically active. Low intakes of dietary fibre, fruit, vegetables, bread and cereals, or fluid were not associated with an increased occurrence of constipation. There were 151 subjects who felt they were moderately constipated, but who had a bowel motion at least every 2 d. These people were more likely than the rest of the sample to use laxatives (55-6%), were more likely to take food for their bowels, to take hynoptics, and to regard their health as poor. Conclusions-About one third of people aged 70 years and over have some bowel problem such as infrequency, straining at stool, or frequent laxative use. Most modify their diet accordingly but laxative use remains high.","UNIV OTAGO, SCH MED, DEPT HUMAN NUTR, DUNEDIN, NEW ZEALAND",University of Otago,"UNIV OTAGO, SCH MED, DEPT MED, POB 913, DUNEDIN, NEW ZEALAND.",,,"Horwath, Caroline/0000-0002-7045-832X",,,,,13,83,88,1,7,BMJ PUBLISHING GROUP,LONDON,"BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND",0143-005X,1470-2738,,J EPIDEMIOL COMMUN H,J. Epidemiol. Community Health,FEB,1993,47,1,,,,,23,26,,10.1136/jech.47.1.23,http://dx.doi.org/10.1136/jech.47.1.23,,,4,"Public, Environmental & Occupational Health",Science Citation Index Expanded (SCI-EXPANDED),"Public, Environmental & Occupational Health",KL087,8382251,"Green Published, Bronze",,,2024-06-04,WOS:A1993KL08700007,View Full Record in Web of Science
J,"Chien, LY; Liou, YM; Chang, PL",,,,"Chien, Li-Yin; Liou, Yiing Mei; Chang, Polun",,,"Low defaecation frequency in Taiwanese adolescents: Association with dietary intake, physical activity and sedentary behaviour",JOURNAL OF PAEDIATRICS AND CHILD HEALTH,,,English,Article,,,,,,adolescent; constipation; diet; physical activity; sedentary behaviour,QUALITY-OF-LIFE; CHILDHOOD CONSTIPATION; FUNCTIONAL CONSTIPATION; INTERNATIONAL SURVEY; INCREASED PREVALENCE; FIBER INTAKE; CHILDREN; EPIDEMIOLOGY; OVERWEIGHT; OBESITY,"Aim: The objectives of this study were to estimate the prevalence of constipation, defined as less than three defaecations per week, in Taiwanese adolescents and to examine its association with the intake of vegetables, fruits and fluids; time spent on sedentary behaviour; and time spent on moderate and vigorous physical activity. Methods: This study used a questionnaire survey. The study participants were 14 626 adolescents in grades 7-12. Physical activity was measured using the International Physical Activity Questionnaire-Youth Show Card Version. Time spent on sedentary activity included studying, reading, sitting in vehicles and screen time. Consumption of fluid, fruits and vegetables was measured by asking participants to describe the average consumption of each type of food in the past 7 days. Results: The prevalence of defaecation frequency of <3 times a week was 9.3%. Multivariate logistic regression analysis showed that female sex (odds ratio (OR) = 2.2), worse health status (OR = 1.3), not being overweight/obese (OR = 0.7 and 0.3 for overweight and obesity), more time spent on sedentary activity (OR = 1.0) and low intake of fluids (<1.8 L/day; OR = 1.2), fruits (< 1 portion; OR = 1.6), vegetables (< 1 portion or 100 g; OR = 1.4) and whole-grain products (OR = 1.2) were independently associated with increased risk of low defaecation frequency. Conclusions: The prevalence of low defaecation frequency was high in Taiwanese adolescents. Decreasing sedentary behaviour and increasing the intake of fluids, vegetables, fruits and whole-grain products among those adolescents with very low intake levels could be helpful in preventing and managing constipation, irrespective of body size and health status.","[Chien, Li-Yin; Liou, Yiing Mei] Natl Yang Ming Univ, Inst Clin & Community Hlth Nursing, Taipei 11221, Taiwan; [Chang, Polun] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 11221, Taiwan",National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University,"Liou, YM (corresponding author), Natl Yang Ming Univ, Inst Clin & Community Hlth Nursing, 155 Sect 2,Li Nong St, Taipei 11221, Taiwan.",ymliou@ym.edu.tw,"Chien, Li-Yin/AAV-2982-2021","Chien, Li-Yin/0000-0002-4210-2975","Department of Physical Education, Ministry of Education, Taiwan, Republic of China","Department of Physical Education, Ministry of Education, Taiwan, Republic of China","This study was funded by the Department of Physical Education, Ministry of Education, Taiwan, Republic of China.",,26,42,43,1,12,WILEY-BLACKWELL,MALDEN,"COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA",1034-4810,,,J PAEDIATR CHILD H,J. Paediatr. Child Health,JUN,2011,47,6,,,,,381,386,,10.1111/j.1440-1754.2010.01990.x,http://dx.doi.org/10.1111/j.1440-1754.2010.01990.x,,,6,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,774QO,21309885,,,,2024-06-04,WOS:000291401400014,View Full Record in Web of Science
J,"Rao, SSC",,,,"Rao, Satish S. C.",,,Constipation: Evaluation and treatment of colonic and anorectal motility disorders,GASTROENTEROLOGY CLINICS OF NORTH AMERICA,,,English,Review,,,,,,,BALANCED SOLUTION PMF-100; IRRITABLE-BOWEL-SYNDROME; DOUBLE-BLIND; GASTROINTESTINAL TRANSIT; INTESTINAL TRANSIT; OROCECAL TRANSIT; MANOMETRIC TESTS; MOTOR-ACTIVITY; DIETARY FIBER; UNITED-STATES,"This article focuses on the colonic and anorectal motility disturbances that are associated with chronic constipation and their management. Functional chronic constipation consists of three overlapping subtypes: slow transit constipation, dyssynergic defecation, and irritable bowel syndrome with constipation. The Rome criteria may serve as a useful guide for making a clinical diagnosis of functional constipation. Today, an evidence-based approach can be used to treat patients with chronic constipation. The availability of specific drugs for the treatment of chronic constipation, such as tegaserod and lubiprostone, has enhanced the therapeutic armamentarium for managing these patients. Randomized controlled trials have also established the efficacy of biofeedback therapy in the treatment of dyssynergic defecation.","Univ Iowa Hosp & Clin, Div Gastroenterol, Iowa City, IA 52242 USA; Univ Iowa, Dept Internal Med, Carver Coll Med, Div Gastroenterol & Hepatol, Iowa City, IA USA",University of Iowa; University of Iowa,"Rao, SSC (corresponding author), Univ Iowa Hosp & Clin, Div Gastroenterol, 200 Hawkins Dr,4612 JCP, Iowa City, IA 52242 USA.",satish-rao@uiowa.edu,,,NIDDK NIH HHS [DK57100-0441] Funding Source: Medline,NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)),,,116,86,97,2,16,W B SAUNDERS CO-ELSEVIER INC,PHILADELPHIA,"1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA",0889-8553,1558-1942,,GASTROENTEROL CLIN N,Gastroenterol. Clin. North Am.,SEP,2007,36,3,,,,,687,+,,10.1016/j.gtc.2007.07.013,http://dx.doi.org/10.1016/j.gtc.2007.07.013,,,26,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,233BU,17950444,,,,2024-06-04,WOS:000251066200012,View Full Record in Web of Science
J,"Schnelle, JF; Leung, FW; Rao, SSC; Beuscher, L; Keeler, E; Clift, JW; Simmons, S",,,,"Schnelle, John F.; Leung, Felix W.; Rao, Satish S. C.; Beuscher, Linda; Keeler, Emmett; Clift, Jack W.; Simmons, Sandra",,,A Controlled Trial of an Intervention to Improve Urinary and Fecal Incontinence and Constipation,JOURNAL OF THE AMERICAN GERIATRICS SOCIETY,,,English,Article,,,,,,urinary incontinence; fecal incontinence; constipation,NURSING-HOME RESIDENTS; BIOFEEDBACK THERAPY; DYSSYNERGIC DEFECATION; ANORECTAL FUNCTION; DIETARY FIBER; DOUBLE-BLIND; PREVENTION; ADULTS; CARE; PATHOPHYSIOLOGY,"OBJECTIVES To evaluate effects of a multicomponent intervention on fecal incontinence (FI) and urinary incontinence (UI) outcomes. DESIGN Randomized controlled trial. SETTING Six nursing homes (NHs). PARTICIPANTS One hundred twelve NH residents. INTERVENTION Intervention subjects were offered toileting assistance, exercise, and choice of food and fluid snacks every 2 hours for 8 hours per day over 3 months. MEASUREMENTS Frequency of UI and FI and rate of appropriate toileting as determined by direct checks from research staff. Anorectal assessments were completed on a subset of 29 residents. RESULTS The intervention significantly increased physical activity, frequency of toileting, and food and fluid intake. UI improved (P=.049), as did frequency of bowel movements (P <.001) and percentage of bowel movements (P <.001) in the toilet. The frequency of FI did not change. Eighty-nine percent of subjects who underwent anorectal testing showed a dyssynergic voiding pattern, which could explain the lack of efficacy of this intervention program alone on FI. CONCLUSION This multicomponent intervention significantly changed multiple risk factors associated with FI and increased bowel movements without decreasing FI. The dyssynergic voiding pattern and rectal hyposensitivity suggest that future interventions may have to be supplemented with bulking agents (fiber), biofeedback therapy, or both to improve bowel function.","[Schnelle, John F.; Simmons, Sandra] Vanderbilt Univ, Sch Med, Ctr Qual Aging, Div Gen Internal Med & Publ Hlth, Nashville, TN 37232 USA; [Beuscher, Linda] Vanderbilt Univ, Sch Nursing, Nashville, TN 37232 USA; [Schnelle, John F.; Simmons, Sandra] Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Nashville, TN 37212 USA; [Leung, Felix W.] Vet Affairs Greater Angeles Healthcare Syst, Sepulveda Ambulatory Care Ctr, North Hills, CA USA; [Keeler, Emmett; Clift, Jack W.] RAND Corp, Pardee Grad Sch, Santa Monica, CA USA; [Leung, Felix W.; Keeler, Emmett] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Rao, Satish S. C.] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA",Vanderbilt University; Vanderbilt University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; RAND Corporation; Pardee RAND Graduate School; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Iowa,"Schnelle, JF (corresponding author), Vanderbilt Univ, Med Ctr, 1161 21st Ave S,S-1121 Med Ctr N, Nashville, TN 37232 USA.",Schnelle@Vanderbilt.edu,,,"National Institute of Aging [R01 AG23555-01A1, AGO28748]; Veterans Affairs Medical Research",National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs Medical Research(US Department of Veterans Affairs),"This research was supported by Grant R01 AG23555-01A1 from the National Institute of Aging, John F. Schnelle, Principal Investigator; the University of California at Los Angeles Claude Pepper Older Americans Independence Center funded by the National Institute of Aging (AGO28748); and Veterans Affairs Medical Research funds.",,35,71,76,0,19,"WILEY-BLACKWELL PUBLISHING, INC",MALDEN,"COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA",0002-8614,,,J AM GERIATR SOC,J. Am. Geriatr. Soc.,AUG,2010,58,8,,,,,1504,1511,,10.1111/j.1532-5415.2010.02978.x,http://dx.doi.org/10.1111/j.1532-5415.2010.02978.x,,,8,Geriatrics & Gerontology; Gerontology,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Geriatrics & Gerontology,635GN,20653804,Green Accepted,,,2024-06-04,WOS:000280643700012,View Full Record in Web of Science
J,"Bijkerk, CJ; Muris, JWM; Knottnerus, JA; Hoes, AW; De Wit, NJ",,,,"Bijkerk, CJ; Muris, JWM; Knottnerus, JA; Hoes, AW; De Wit, NJ",,,Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome,ALIMENTARY PHARMACOLOGY & THERAPEUTICS,,,English,Review,,,,,,,DIETARY FIBER; WHEAT BRAN; TREATMENT TRIALS; ISPAGHULA; PLACEBO; MANAGEMENT; SYMPTOMS; TIME,"Background: Both high-fibre dietary advice and the prescription of fibre as a bulking agent arc very common in primary and secondary care management of irritable bowel syndrome. Irritable bowel syndrome patients with constipation may have delayed intestinal transit. Therefore, fibres that accelerate intestinal transit may be beneficial in these patients. The uncertain benefits reported in several clinical studies, however, have led us to reappraise the value of fibre in irritable bowel syndrome management. Aim: To quantify the effect of different types of fibre on global and symptom relief from irritable bowel syndrome. Methods: Using a structured literature search in MEDLINE (1966-2002), we selected randomized controlled trials involving irritable bowel syndrome patients treated with fibre. Analyses were performed for the total group and for trials using soluble and insoluble fibre separately. Results: Seventeen studies were included in the analysis. None investigated primary care irritable bowel syndrome patients. Fibre, in general, was effective in the relief of global irritable bowel syndrome symptoms [relative risk, 1.33; 95% confidence interval (CI), 1.19-1.50]. Irritable bowel syndrome patients with constipation may receive benefit from fibre treatment (relative risk, 1.56; 95% CI 1.21-2.02), but there was no evidence that fibre was effective in the relief of abdominal pain in irritable bowel syndrome. Soluble and insoluble fibre, separately, had different effects on global irritable bowel syndrome symptoms. Soluble fibre (psyllium, ispaghula, calcium polycarbophil) showed significant improvement (relative risk, 1.55; 95% CI, 1.35-1.78), whereas insoluble fibre (corn, wheat bran), in some cases, worsened the clinical outcome, but there was no significant difference compared with placebo (relative risk, 0.89; 95% CI, 0.72-1.11). Conclusions: The benefits of fibre in the treatment of irritable bowel syndrome are marginal for global irritable bowel syndrome symptom improvement and irritable bowel syndrome-related constipation. Soluble and insoluble fibres have different effects on global irritable bowel syndrome symptoms. Indeed, in some cases, insoluble fibres may worsen the clinical outcome. Future clinical studies evaluating the effect and tolerability of fibre therapy are needed in primary care.","Maastricht Univ, Dept Gen Practice, Res Inst CAPHRI, NL-6200 MD Maastricht, Netherlands; Univ Utrecht, Med Ctr, Julius Ctr Primary Care & Hlth Sci, Utrecht, Netherlands",Maastricht University; Utrecht University,"Maastricht Univ, Dept Gen Practice, Res Inst CAPHRI, POB 616, NL-6200 MD Maastricht, Netherlands.",jean.muris@hag.unimaas.nl,"Knottnerus, Andre/F-4866-2013; Knottnerus, Johannes A/A-3829-2009","Muris, Jean/0000-0002-8780-476X",,,,,43,194,224,1,32,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0269-2813,1365-2036,,ALIMENT PHARM THER,Aliment. Pharmacol. Ther.,FEB 1,2004,19,3,,,,,245,251,,10.1111/j.0269-2813.2004.01862.x,http://dx.doi.org/10.1111/j.0269-2813.2004.01862.x,,,7,Gastroenterology & Hepatology; Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Pharmacology & Pharmacy,801IU,14984370,,,,2024-06-04,WOS:000220090400001,View Full Record in Web of Science
J,"Dahl, WJ; Whiting, SJ; Healey, A; Zello, GA; Hildebrandt, SL",,,,"Dahl, WJ; Whiting, SJ; Healey, A; Zello, GA; Hildebrandt, SL",,,Increased stool frequency occurs when finely processed pea hull fiber is added to usual foods consumed by elderly residents in long-term care,JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION,,,English,Article,,,,,,,DIETARY FIBER; CONSTIPATION; CONSUMPTION; PREVALENCE; WATER; BRAN; HOME,"Dietary fiber fortification of food offers a preventative strategy that is a less invasive alternative to laxatives and enemas in the management of constipation in elderly individuals. To determine if a moderate increase in fiber provided in foods would increase bowel movement frequency among elderly institutionalized residents, data were collected on the same elderly residents (n = 114) before and during a 6-week intervention. The intervention consisted of adding finely processed pea hull fiber (1-3 g/serving) to 3 to 4 foods each day. Laxative and enema use was monitored. Mean number of bowel movements/month increased from 18.7+/-9.4 to 20.1+/-9.6 (n= 114, P=.034), and in 17 residents with low baseline frequency, the increase was highly significant (8.8+/-1.0 to 12.6+/-3.8 bowel movements/month, P=.001). With treatment, prune-based laxative administration decreased (P<.001). Thus, addition of a moderate amount of finely processed fiber to foods results in increased bowel frequency in institutionalized elderly individuals.","Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK S7N 5C9, Canada; Luthercare Communities, Nutr & Food Serv, Saskatoon, SK, Canada",University of Saskatchewan,"Univ Saskatchewan, Coll Pharm & Nutr, 110 Sci Pl, Saskatoon, SK S7N 5C9, Canada.",Susan.whiting@usask.ca,,"Dahl, Wendy/0000-0003-2061-4731",,,,,27,32,41,0,11,AMER DIETETIC ASSOC,CHICAGO,"120 S RIVERSIDE PLZ, STE 2000, CHICAGO, IL 60606-6995 USA",0002-8223,,,J AM DIET ASSOC,J. Am. Diet. Assoc.,SEP,2003,103,9,,,,,1199,1202,,10.1016/S0002-8223(03)00977-5,http://dx.doi.org/10.1016/S0002-8223(03)00977-5,,,4,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,719XT,12963953,,,,2024-06-04,WOS:000185230900022,View Full Record in Web of Science
J,"Alyousif, Z; Ford, AL; Dahl, WJ",,,,"Alyousif, Zainab; Ford, Amanda L.; Dahl, Wendy J.",,,Calcium Supplementation Does Not Contribute to Constipation in Healthy Women,CANADIAN JOURNAL OF DIETETIC PRACTICE AND RESEARCH,,,English,Article,,,,,,,DIETARY FIBER; ASSOCIATION,"Purpose: It is commonly suggested that calcium supplementation contributes to constipation; however, little research has explored the effects of calcium supplementation on gut motility. Methods: In an 8-week, randomized, double-blind, crossover pilot study, healthy females (n = 27, aged 43.0 +/- 10.6 years) received a split dose of 500 mg/d of elemental calcium from calcium carbonate or calcium phosphate each for 2 weeks, after a 2-week baseline and separated by a 2-week washout. Participants completed daily questionnaires of stool frequency, Bristol Stool Form Scale (BSFS), and supplement intake compliance. Results: There were no differences among periods. Mean +/- SE stool frequency averaged 1.3 +/- 0.1 stools/d in each period. Participants reported 34%, 34%, 37%, and 29% of stools were indicative of slow transit or constipation (BSFS of 1 or 2) during baseline, calcium carbonate, calcium phosphate, and washout periods, respectively. Participants also reported from 6% to 10% of stools as fast transit or diarrhea (BSFS of 6 or 7) during the periods. Conclusion: This study suggests that neither calcium carbonate nor calcium phosphate, providing 500 mg/d of calcium, affects stool frequency or form. Although stool frequency was normal, the healthy females participating in the study experienced stools indicating slow (constipation) and fast (diarrhea) transit.","[Alyousif, Zainab; Ford, Amanda L.; Dahl, Wendy J.] Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA",State University System of Florida; University of Florida,"Alyousif, Z (corresponding author), Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA.",,,"Dahl, Wendy/0000-0003-2061-4731",Innophos Inc.,Innophos Inc.,Innophos Inc.,,15,3,3,0,8,DIETITIANS CANADA,TORONTO,"480 UNIV AVE, SUITE 604, TORONTO, ONTARIO M5G 1V2, CANADA",1486-3847,2292-9592,,CAN J DIET PRACT RES,Can. J. Diet. Pract. Res.,JUN,2016,77,2,,,,,103,105,,10.3148/cjdpr-2015-043,http://dx.doi.org/10.3148/cjdpr-2015-043,,,3,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,DN0QK,26771423,,,,2024-06-04,WOS:000376768400011,View Full Record in Web of Science
J,"Benninga, MA; Voskuijl, WP; Taminiau, JAJM",,,,"Benninga, MA; Voskuijl, WP; Taminiau, JAJM",,,Childhood constipation: Is there new light in the tunnel?,JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION,,,English,Review,,,,,,children; constipation; encopresis; treatment; review,COLONIC TRANSIT-TIME; TERM FOLLOW-UP; CHRONIC IDIOPATHIC CONSTIPATION; GLYCOL ELECTROLYTE-SOLUTION; TOTAL ABDOMINAL COLECTOMY; RADIO-OPAQUE MARKERS; SCHOOL-AGED CHILDREN; DIETARY FIBER INTAKE; POLYETHYLENE-GLYCOL; ANORECTAL MANOMETRY,,"Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Paediat Gastroenterol & Nutr, NL-1105 AZ Amsterdam, Netherlands",University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Emma Children's Hospital,"Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Paediat Gastroenterol & Nutr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.",m.a.benninga@amc.uva.nl,,"Voskuijl, Wieger/0000-0001-5825-2831",,,,,210,140,159,1,11,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0277-2116,1536-4801,,J PEDIATR GASTR NUTR,J. Pediatr. Gastroenterol. Nutr.,NOV,2004,39,5,,,,,448,464,,10.1097/00005176-200411000-00002,http://dx.doi.org/10.1097/00005176-200411000-00002,,,17,Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,876OT,15572881,Bronze,,,2024-06-04,WOS:000225507400002,View Full Record in Web of Science
J,"Han, D; Iragorri, N; Clement, F; Lorenzetti, D; Spackman, E",,,,"Han, Dolly; Iragorri, Nicolas; Clement, Fiona; Lorenzetti, Diane; Spackman, Eldon",,,Cost Effectiveness of Treatments for Chronic Constipation: A Systematic Review,PHARMACOECONOMICS,,,English,Review,,,,,,,ECONOMIC EVALUATIONS; PLUS ELECTROLYTES; MANAGEMENT; LACTULOSE; HEALTH; EFFICACY; QUALITY; PEOPLE; LIFE,"Background Chronic constipation (CC) has a significant impact on patients' quality of life and imposes an economic burden on individuals and the healthcare system. Treatment options include dietary changes, lifestyle modifications, fibre supplements, stool softeners, and laxatives. Objective We undertook this systematic review to comprehensively evaluate the cost effectiveness of treatments for CC. Methods We searched ten common databases to identify economic evaluations published to 13 June 2017. Abstract and full-text review were completed in duplicate. The quality of the included studies was assessed using the Consensus on Health Economic Criteria. Data extracted included costs and outcomes of treatments for CC and cost-effectiveness methods. A narrative synthesis was completed. Results From the 4338 unique citations identified, 79 proceeded to full-text review, with 10 studies forming the final dataset. Eight different definitions of CC were used to define the study populations. Study designs used were decision-tree models (4), Markov model (1), and retrospective (1) and prospective (4) studies. Quality-adjusted life-years (QALY) were reported in five studies; other outcomes included, discontinuation of laxative treatment and frequency of bowel movements. The majority of studies stated that their results were from a payer perspective; however, some of these studies only considered treatment costs, a subset of costs included in the payer perspective. Lifestyle advice, dietary treatments and abdominal massage were each compared with current care with laxatives, while polyethylene glycol (PEG) and senna-fibre combination were each compared with lactulose. Two studies compared newer treatments in patients who had not responded to laxatives: prucalopride was compared with continuing laxatives, and linaclotide was compared with lubiprostone. All of the interventions were reported by the study authors to be cost effective, with the exception of abdominal massage. Conclusions A consistent definition of CC is needed and the QALY should be used to capture the diverse symptoms of CC. Further analysis is needed comparing all available treatments for patients who have not responded to laxatives. Overall, results from economic evaluations appear to align with stepwise practice guidelines.","[Han, Dolly; Iragorri, Nicolas; Clement, Fiona; Lorenzetti, Diane; Spackman, Eldon] Univ Calgary, Dept Community Hlth Sci, Teaching Res & Wellness Bldg,3280 Hosp Dr NW, Calgary, AB, Canada; [Han, Dolly; Iragorri, Nicolas; Clement, Fiona; Lorenzetti, Diane; Spackman, Eldon] Univ Calgary, OBrien Inst Publ Hlth, Teaching Res & Wellness Bldg,3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada; [Han, Dolly; Iragorri, Nicolas; Clement, Fiona; Lorenzetti, Diane; Spackman, Eldon] Univ Calgary, Hlth Technol Assessment Unit, Community Hlth Sci, Teaching Res & Wellness Bldg,3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada",University of Calgary; University of Calgary; University of Calgary,"Spackman, E (corresponding author), Univ Calgary, Dept Community Hlth Sci, Teaching Res & Wellness Bldg,3280 Hosp Dr NW, Calgary, AB, Canada.;Spackman, E (corresponding author), Univ Calgary, OBrien Inst Publ Hlth, Teaching Res & Wellness Bldg,3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.;Spackman, E (corresponding author), Univ Calgary, Hlth Technol Assessment Unit, Community Hlth Sci, Teaching Res & Wellness Bldg,3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.",eldon.spackman@ucalgary.ca,,"Spackman, David Eldon/0000-0001-8558-5973",,,,,27,14,17,0,27,ADIS INT LTD,NORTHCOTE,"5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND",1170-7690,1179-2027,,PHARMACOECONOMICS,Pharmacoeconomics,APR,2018,36,4,,,,,435,449,,10.1007/s40273-018-0609-6,http://dx.doi.org/10.1007/s40273-018-0609-6,,,15,Economics; Health Care Sciences & Services; Health Policy & Services; Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Business & Economics; Health Care Sciences & Services; Pharmacology & Pharmacy,FY5UL,29352437,,,,2024-06-04,WOS:000426901000006,View Full Record in Web of Science
J,"Hayeeawaema, F; Wichienchot, S; Khuituan, P",,,,"Hayeeawaema, Fittree; Wichienchot, Santad; Khuituan, Pissared",,,Amelioration of gut dysbiosis and gastrointestinal motility by konjac oligo-glucomannan on loperamide-induced constipation in mice,NUTRITION,,,English,Article,,,,,,Colonic motility; Colonic smooth muscle; Gut microbiota; Gut transit time; Prebiotics; Laxative,,"Objective: Konjac oligo-glucomannan (KOG) is a non-digestible dietary fiber that is resistant to digestion and absorption in gastrointestinal (GI) tract. Thus, it might be used as an alternative management for constipation. The aim of this study was to evaluate the effects of KOG on gut motility and microbiota to relieve constipation in mice. Methods: Mice received Bifidobacterium animalis, lactulose, konjac glucomannan (KGM), or KOG for 14 d. Constipation was induced by 5 mg/kg loperamide days 12 through 14 in all groups except the control. Defecation frequency, small intestinal transit, and total gut transit time were indicated by counting the number of feces, and using charcoal meal and Evans blue as markers, respectively. Smooth muscle (SM) contraction and gut motility were evaluated by organ bath and GI motility monitor system. Gut microbiota were measured by fluorescence in situ hybridization technique. Results: KOG significantly (P < 0.01) increased defecation frequency and small intestinal transit but decreased total gut transit time when compared with the constipation-without-treatment group. These results were similar to the effects of Bifidobacterium animalis, lactulose, and KGM. KOG ameliorated the effect of loperamide on contraction frequency of distal colonic circular SM. The motility patterns were changed in the KOG group from non-propagation to propagation contraction. KOG significantly inhibited the effects of loperamide on gut microbiota by increasing the numbers of Bifidobacterium spp. and decreasing the numbers of Clostridium spp. and Bacteroides spp. Conclusion: These results suggest that KOG acts as a prebiotic and stimulant laxative for relief and prevention of constipation. (C) 2019 Elsevier Inc. All rights reserved.","[Hayeeawaema, Fittree; Khuituan, Pissared] Prince Songkla Univ, Gut Biol & Microbiota Res Unit, Hat Yai, Thailand; [Hayeeawaema, Fittree; Khuituan, Pissared] Prince Songkla Univ, Fac Sci, Dept Physiol, Hat Yai, Thailand; [Wichienchot, Santad] Prince Songkla Univ, Interdisciplinary Grad Sch Nutraceut & Funct Food, Hat Yai, Thailand",Prince of Songkla University; Prince of Songkla University; Prince of Songkla University,"Khuituan, P (corresponding author), Prince Songkla Univ, Gut Biol & Microbiota Res Unit, Hat Yai, Thailand.;Khuituan, P (corresponding author), Prince Songkla Univ, Fac Sci, Dept Physiol, Hat Yai, Thailand.",pissared.k@psu.ac.th,"Wichienchot, Santad/AAR-6845-2021; Khuituan, Pissared/GNW-5846-2022","Khuituan, Pissared/0000-0003-1376-3253",Prince of Songkla University [SCI610513S],Prince of Songkla University,This work was supported by a grant from Prince of Songkla University (grant no. SCI610513S). The authors have no conflicts of interest to declare.,,24,28,29,4,67,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",0899-9007,1873-1244,,NUTRITION,Nutrition,MAY,2020,73,,,,,,,,110715,10.1016/j.nut.2019.110715,http://dx.doi.org/10.1016/j.nut.2019.110715,,,11,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,LN2UI,32135415,,,,2024-06-04,WOS:000532798500011,View Full Record in Web of Science
J,"Wegh, CAM; Schoterman, MHC; Vaughan, EE; van der Zalm, SCC; Smidt, H; Belzer, C; Benninga, MA",,,,"Wegh, Carrie A. M.; Schoterman, Margriet H. C.; Vaughan, Elaine E.; van der Zalm, Sofie C. C.; Smidt, Hauke; Belzer, Clara; Benninga, Marc A.",,,"Effect of prebiotic oligosaccharides on bowel habit and the gut microbiota in children with functional constipation (Inside study): study protocol for a randomised, placebo-controlled, multi-centre trial",TRIALS,,,English,Article,,,,,,Gastroenterology; Nutrition; Gut microbiota; Paediatrics; Oligosaccharides; Prebiotic; Functional constipation; Stool consistency; Stool frequency; Bowel habit,QUALITY-OF-LIFE; GASTROINTESTINAL DISORDERS; STOOL CONSISTENCY; DIETARY FIBER; ADULTS,"Background Functional constipation (FC) in children is a common gastrointestinal disorder with a worldwide-pooled prevalence of 9.5%. Complaints include infrequent bowel movements, painful defecation due to hard and/or large stools, faecal incontinence, and abdominal pain. Prebiotic oligosaccharides have been shown to relieve constipation symptoms in young adults and elderly. However, sufficient evidence is lacking linking additional prebiotic intake to improve symptoms in children with FC. We hypothesise that prebiotic oligosaccharides are able to relieve symptoms of constipation in young children as well.Methods In the present randomised, double-blind, placebo-controlled, multi-centre study, we will study the effects of two prebiotic oligosaccharides in comparison to placebo on constipation symptoms in children of 1-5 years (12 to 72 months) of age diagnosed with FC according to the Rome IV criteria for functional gastrointestinal disorders. The primary outcome measure will be change in stool consistency. Secondary outcomes include stool frequency and stool consistency in a number of cases (%). Tertiary outcomes include among others painful defecation, use of rescue medication, and quality of life. In addition, the impact on gut microbiome outcomes such as faecal microbiota composition and metabolites will be investigated. Participants start with a run-in period, after which they will receive supplements delivered in tins with scoops for 8 weeks, containing one of the two prebiotic oligosaccharides or placebo, followed by a 4-week wash-out period.Discussion This randomised double-blind, placebo-controlled multi-centre study will investigate the effectiveness of prebiotic oligosaccharides in children aged 1-5 years with FC.Trial registration ClinicalTrials.gov NCT04282551. Registered on 24 February 2020.","[Wegh, Carrie A. M.; Benninga, Marc A.] Univ Amsterdam, Emma Childrens Hosp, Dept Paediat Gastroenterol & Nutr, Amsterdam UMC, Amsterdam, Netherlands; [Wegh, Carrie A. M.; van der Zalm, Sofie C. C.; Smidt, Hauke; Belzer, Clara] Wageningen Univ & Res, Lab Microbiol, Wageningen, Netherlands; [Schoterman, Margriet H. C.] FrieslandCampina, Amersfoort, Netherlands; [Vaughan, Elaine E.] Sensus Royal Cosun, Roosendaal, Netherlands",Emma Children's Hospital; University of Amsterdam; Wageningen University & Research,"Wegh, CAM (corresponding author), Univ Amsterdam, Emma Childrens Hosp, Dept Paediat Gastroenterol & Nutr, Amsterdam UMC, Amsterdam, Netherlands.;Wegh, CAM; Smidt, H (corresponding author), Wageningen Univ & Res, Lab Microbiol, Wageningen, Netherlands.",carriewegh@gmail.com; hauke.smidt@wur.nl,"Belzer, Clara/P-6500-2018","Smidt, Hauke/0000-0002-6138-5026",Topconsortium voor Kennis en Innovatie,Topconsortium voor Kennis en Innovatie,"The authors would like to thank Flore Vroegop for her support in the execution of the trial, and Carlos Agudelo and Marjan Nouwens-Roest for their excellent assistance in preparing the study products. We would also like to thank Arjen Nauta and Angela Pettinato for their contributions to the study design. Moreover, we are very grateful to all paediatricians involved in this trial: Desiree F. Baaleman, Michelle Bloem, Clara M.A. de Bruijn, dr. Joery Goede, Charlotte Jonker, Yenny Kho, Margreet M.S. Wessels, dr. Maartje M. van den Berg and dr. Michael Groeneweg.",,41,0,0,3,3,BMC,LONDON,"CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND",,1745-6215,,TRIALS,Trials,APR 5,2024,25,1,,,,,,,238,10.1186/s13063-024-08050-8,http://dx.doi.org/10.1186/s13063-024-08050-8,,,9,"Medicine, Research & Experimental",Science Citation Index Expanded (SCI-EXPANDED),Research & Experimental Medicine,MY3Y0,38576033,"Green Published, Green Submitted, gold",,,2024-06-04,WOS:001197168800001,View Full Record in Web of Science
J,"Watanabe, S; Adachi, K; Wakino, S; Hisada, T; Mochizuki, J",,,,"Watanabe, Shaw; Adachi, Kyoka; Wakino, Shu; Hisada, Takahisa; Mochizuki, Jun",,,Dietary therapy with low protein genmai (brown rice) to improve the gut-kidney axis and reduce CKD progression,ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION,,,English,Review,,,,,,chronic kidney disease (CKD); dietary therapy; fermented low protein genmai (LPFG); dysbiosis; leaky gut,CHRONIC-RENAL-FAILURE; DISEASE; RESTRICTION; METAANALYSIS; FRAILTY,"Low protein rice can be part of a nutritionally adequate dietary pattern in the prevention of chronic kidney disease. We developed a low protein fermented genmai (brown rice) LPFG) to improve chronic kidney disease (CKD) management. The principal functional features of brown rice are retained in LPFG, lessening the negative spiral of gut-kidney associative spiral attributable to uremic dysbiosis and a leaky gut. LPFG is characterized by (1) an energy value the same as white rice, (2) a protein content less than 0.2 g/ 100 g, (3) a potassium content almost zero, (4) phosphorus less than a quarter that of conventional rice, (5) the presence of dietary fiber, (6) having gamma-oryzanol, and (7) antioxidant activity. Dietary therapy for CKD patients is challenged by the joint needs to pro-vide enough energy and to restrict protein. Patients replaced staple foods with LPFG without side dish restriction. Preliminary study of intervention with 3 months of LPFG reduced constipation probably by increased Blautia wexlerae, Bifidobacteria, acetic acid, and a decrease in potentially harmful bacteria. Protein intake decreased from 60 to 50 g per day. Urinary protein excretion decreased from 510 to 300 mg per day, and beta 2-microglobulin from 926 to 250 mu g/L. Adherence to the LPFG diet enabled improvement in glomerular and tubular function.","[Watanabe, Shaw] Tokyo Univ Agr, Lifesci Res Inst, Tokyo, Japan; [Adachi, Kyoka] Keio Univ, Dept Internal Med, Sch Med, Tokyo, Japan; [Wakino, Shu] Tokushima Univ, Med Sch, Tokushima, Japan; [Hisada, Takahisa; Mochizuki, Jun] Technosuruga Lab, Shizuoka, Japan; [Watanabe, Shaw] Tokyo Univ Agr, Lifesci Res Inst, 1-1-1, Sakuragaoke, Tokyo, Tokyo 1568502, Japan",Tokyo University of Agriculture; Keio University; Tokushima University; Tokyo University of Agriculture,"Watanabe, S (corresponding author), Tokyo Univ Agr, Lifesci Res Inst, Tokyo, Japan.;Watanabe, S (corresponding author), Tokyo Univ Agr, Lifesci Res Inst, 1-1-1, Sakuragaoke, Tokyo, Tokyo 1568502, Japan.",gwatashaw@gmail.com,,,,,,,47,1,1,2,9,"H E C PRESS, HEALTHY EATING CLUB PTY LTD",MCKINNON,"PO BOX 4121, MCKINNON, VIC 3204, AUSTRALIA",0964-7058,1440-6047,,ASIA PAC J CLIN NUTR,Asia Pac. J. Clin. Nutr.,SEP,2022,31,3,,,,,341,347,,10.6133/apjcn.202209_31(3).0001,http://dx.doi.org/10.6133/apjcn.202209_31(3).0001,,,7,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,5T0JC,36173205,,,,2024-06-04,WOS:000875563500001,View Full Record in Web of Science
J,"Jung, SJ; Oh, MR; Park, SH; Chae, SW",,,,"Jung, Su-Jin; Oh, Mi-Ra; Park, Soo-Hyun; Chae, Soo-Wan",,,Effects of rice-based and wheat-based diets on bowel movements in young Korean women with functional constipation,EUROPEAN JOURNAL OF CLINICAL NUTRITION,,,English,Article,,,,,,,FIBER SUPPLEMENTS; DOUBLE-BLIND; RYE BREAD; PLACEBO; ADULTS; CONSUMPTION; MICROFLORA; MARKERS; HEALTH; CANCER,"Background Although several studies have reported the effects that dietary fiber intake from different types of grains and fiber components have on bowel movements, insufficient attention has been paid to comparing and evaluating the effects of rice-based and wheat-based diets. This study compared and evaluated the effects of ingesting rice-based (brown rice-based diet: BRD; white rice-based diet: WRD) and wheat-based diet (WD) on the bowel movements of young women with functional constipation. Method Based on an open, randomized, controlled, and parallel design, 39 subjects were assigned to BRD, WRD, and WD groups (13 in each group). Each participant had received three types of experimental diets over the course of 4 weeks and we recommended that the subjects eat only the test diet provided during the study. Primary outcomes (total colon transit time TCTT) and secondary outcomes (bowel movements, short-chain fatty acid content, and fecal enzyme activity) were compared before and after the 4-week intervention period. Results After the 4-week study, the rice-based diet (BRD and WRD) groups and the WD group had a statistically significant difference in TCTT (p = 0.028). The TCTT of the BRD group was significantly reduced (p = 0.028) compared with the WRD group (-16.5 +/- 8.1 vs +6.8 +/- 2.1), and the TCTT of the WD group was also significantly reduced (p = 0.022) compared with that of the WRD group (-17.1 +/- 11.9 vs +6.8 +/- 2.1). Conclusion Among women with functional constipation, the BRD and WD both improved bowel function by reducing TCTT and increasing the number of bowel movements compared with the WRD group.","[Jung, Su-Jin; Oh, Mi-Ra; Park, Soo-Hyun; Chae, Soo-Wan] Chonbuk Natl Univ Hosp, Clin Trial Ctr Funct Foods, Jeonju 54907, Jeonbuk, South Korea; [Jung, Su-Jin; Chae, Soo-Wan] Chonbuk Natl Univ Hosp, Biomed Res Inst, Jeonju 54907, Jeonbuk, South Korea; [Chae, Soo-Wan] Jeonbuk Natl Univ, Dept Pharmacol, Med Sch, Jeonju 54896, Jeonbuk, South Korea",Jeonbuk National University; Jeonbuk National University Hospital; Jeonbuk National University; Jeonbuk National University Hospital; Jeonbuk National University,"Chae, SW (corresponding author), Chonbuk Natl Univ Hosp, Clin Trial Ctr Funct Foods, Jeonju 54907, Jeonbuk, South Korea.;Chae, SW (corresponding author), Chonbuk Natl Univ Hosp, Biomed Res Inst, Jeonju 54907, Jeonbuk, South Korea.;Chae, SW (corresponding author), Jeonbuk Natl Univ, Dept Pharmacol, Med Sch, Jeonju 54896, Jeonbuk, South Korea.",soowan@jbnu.ac.kr,,,"Korean Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries (IPET), Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea","Korean Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries (IPET), Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea(Institute of Planning & Evaluation for Technology in Food, Agriculture, Forestry, & Fisheries (iPET), Republic of Korea)","This research was supported by the Korean Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries (IPET), Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea.",,37,7,8,0,10,SPRINGERNATURE,LONDON,"CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND",0954-3007,1476-5640,,EUR J CLIN NUTR,Eur. J. Clin. Nutr.,NOV,2020,74,11,,,,,1565,1575,,10.1038/s41430-020-0636-1,http://dx.doi.org/10.1038/s41430-020-0636-1,,APR 2020,11,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,OK2SR,32322048,"hybrid, Green Published",,,2024-06-04,WOS:000528118800003,View Full Record in Web of Science
J,"Liu, QH; Ke, X; Xiao, CX",,,,"Liu, Qi-Hong; Ke, Xiao; Xiao, Cenxin",,,Current Applications of Fecal Microbiota Transplantation in Functional Constipation,EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE,,,English,Review,,,,,,,GUT MICROBIOME; DIETARY FIBER; SYMPTOMS; EFFICACY; TRANSIT; FLORA,"Functional constipation (FC) is a common condition that would be hard to treat in clinical practice with a prevalence incidence in the population. Pharmacotherapy is a common treatment modality. However, clinical effects are limited and patients continue to suffer from it. In recent years, with the gradual increase in research on gut microbiota, it is understood that dysbiosis of the gut microbiota is importantly associated with the development of constipation. Recent studies have shown that fecal microbiota transplantation (FMT) is an effective method for restoring gut microbiota, as well as being efficacious in the treatment of FC. This mini review explains the characteristics of gut microbiota in FC patients, the mechanism of action of PMT, treatment modalities, current efficacy, and related problems. The purpose is to provide research directions and references for the future applications of FMT in PC.","[Liu, Qi-Hong; Ke, Xiao; Xiao, Cenxin] Fujian Univ Chinese Med, Peoples Hosp 2, Fuzhou 350003, Peoples R China; [Liu, Qi-Hong; Ke, Xiao] Fujian Clin Med Res Ctr Chinese Med Spleen & Stom, Fuzhou 350003, Peoples R China",Fujian University of Traditional Chinese Medicine,"Ke, X (corresponding author), Fujian Univ Chinese Med, Peoples Hosp 2, Fuzhou 350003, Peoples R China.;Ke, X (corresponding author), Fujian Clin Med Res Ctr Chinese Med Spleen & Stom, Fuzhou 350003, Peoples R China.",drkxkx@163.com,,,Project of building evidence-based practice capacity for TCM [2019XZZXXH001]; National Construction Project of Regional Diagnostic and Treatment Chinese Medicine Specialist Center [2100202],Project of building evidence-based practice capacity for TCM; National Construction Project of Regional Diagnostic and Treatment Chinese Medicine Specialist Center,This work was supported by the 2019 Project of building evidence-based practice capacity for TCM (no. 2019XZZXXH001) and National Construction Project of Regional Diagnostic and Treatment Chinese Medicine Specialist Center (no. 2100202).,,30,2,2,5,27,HINDAWI LTD,LONDON,"ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND",1741-427X,1741-4288,,EVID-BASED COMPL ALT,Evid.-based Complement Altern. Med.,JUL 13,2022,2022,,,,,,,,7931730,10.1155/2022/7931730,http://dx.doi.org/10.1155/2022/7931730,,,6,Integrative & Complementary Medicine,Science Citation Index Expanded (SCI-EXPANDED),Integrative & Complementary Medicine,6E6DE,35873640,"gold, Green Published",,,2024-06-04,WOS:000883467400008,View Full Record in Web of Science
J,"Oh, S; Hosseindoust, A; Ha, S; Moturi, J; Mun, J; Tajudeen, H; Kim, J",,,,"Oh, SeungMin; Hosseindoust, Abdolreza; Ha, SangHun; Moturi, Joseph; Mun, JunYoung; Tajudeen, Habeeb; Kim, JinSoo",,,Metabolic Responses of Dietary Fiber during Heat Stress: Effects on Reproductive Performance and Stress Level of Gestating Sows,METABOLITES,,,English,Article,,,,,,metabolites; metabolomics; short-chain fatty acid; digestibility; fermentation; intestine,HIGH NUTRIENT DIETS; CHAIN FATTY-ACIDS; LITTER PERFORMANCE; MILK-COMPOSITION; LACTATING SOWS; ENERGY; BEHAVIOR; SYSTEM; DIGESTIBILITY; FERMENTATION,"Heat stress is an important issue, and the addition of fiber to the diet is an option in modifying intestinal health. This study evaluated the effect of acid detergent fiber (ADF) levels on reproductive performance, intestinal integrity, and metabolism of gestating sows, and its carry-over effect on the lactation period during heat stress. The diets included 4.3% (Low fiber; LF), 5.4% (Medium fiber; MF), and 6.5% (High fiber; HF) ADF. Sows fed the HF diet showed a lower respiratory rate, hair cortisol concentration, and farrowing duration compared with the LF treatment. The HF diet increased the pyruvate, citrate cycle, glyoxylate, dicarboxylate, and thiamine metabolism compared with the MF. The concentration of acetate and total short-chain fatty acids were increased in the sows fed the HF diet. The gene expression of glucose transporter 3 and glucose transporter 4 was increased in the HF treatment. The gene expression of heat shock protein 70 was decreased in the HF treatment. The HF diet during gestation increased feed intake, constipation index, piglet weight, and litter weight compared with the LF. Sows in the LF treatment showed the greatest digestibility of crude protein and the lowest digestibility of ADF. In conclusion, a 6.5% ADF level is recommended for gestating sows during heat stress.","[Oh, SeungMin] Gyeongbuk Livestock Res Inst, Yeongju 63052, South Korea; [Hosseindoust, Abdolreza; Ha, SangHun; Moturi, Joseph; Mun, JunYoung; Tajudeen, Habeeb; Kim, JinSoo] Kangwon Natl Univ, Dept Anim Ind Convergence, Chunchon 24341, South Korea",Kangwon National University,"Kim, J (corresponding author), Kangwon Natl Univ, Dept Anim Ind Convergence, Chunchon 24341, South Korea.",ssamgoon@korea.kr; hosseindoust@kangwon.ac.kr; kayne7602@kangwon.ac.kr; motkondo@gmail.com; 202016455@kangwon.ac.kr; habeebtop@gmail.com; kjs896@kangwon.ac.kr,"Moturi, Joseph/JPK-4491-2023",,"Rural Development Administration, Republic of Korea [PJ014796]","Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)","This work was supported by Grant No. PJ014796 from Rural Development Administration, Republic of Korea.",,55,8,9,1,11,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2218-1989,,METABOLITES,Metabolites,APR,2022,12,4,,,,,,,280,10.3390/metabo12040280,http://dx.doi.org/10.3390/metabo12040280,,,16,Biochemistry & Molecular Biology,Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology,0Q9FC,35448467,"Green Published, gold",,,2024-06-04,WOS:000785214000001,View Full Record in Web of Science
J,"Slavin, JL; Greenberg, NA",,,,"Slavin, JL; Greenberg, NA",,,Partially hydrolyzed guar gum: Clinical nutrition uses,NUTRITION,,,English,Review,,,,,,dietary fiber; partially hydrolyzed guar gum; laxation; short chain fatty acids,DIETARY FIBER; SOLUBLE FIBER; CALCIUM-ABSORPTION; DIARRHEA; SUPPLEMENTATION; CONSTIPATION; INCREASES; INGESTION; BACTERIA,OBJECTIVE: This paper provides A review of research on partially hydrolyzed guar gum that is relevant to clinical nutrition practice. METHODS: All relevant papers published on partially hydrolyzed guar gum were reviewed and the results summarized. RESULTS: Partially hydrolyzed guar gum (PHGG) is a water-soluble dietary fiber with a wide range of uses in clinical nutrition. Its low viscosity allows its use in enteral products and beverages. PHGG can be added to enteral formulas and food products as a dietary fiber source. PHGG provides the benefits associated with dietary fiber ingestion. Addition of PHGG to the diet reduced laxative dependence in a nursing home population. PHGG also reduced the incidence of diarrhea in septic patients receiving total enteral nutrition and reduced symptoms of irritable bowel syndrome. PHGG also increased production of Bifidobacterium in the gut. CONCLUSION: The ease of use of PHGG and its clinical effectiveness make ita good choice in clinical nutrition practice.,"Univ Minnesota, Dept Food Sci & Nutr, St Paul, MN 55108 USA; Novartis Nutr Corp, St Louis Pk, MN USA",University of Minnesota System; University of Minnesota Twin Cities; Novartis,"Univ Minnesota, Dept Food Sci & Nutr, 1334 Eckles Ave, St Paul, MN 55108 USA.",jslavin@umn.edu,"Slavin, Joanne/GOJ-9874-2022","Slavin, Joanne/0000-0003-0720-5300",,,,,33,115,133,0,40,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",0899-9007,1873-1244,,NUTRITION,Nutrition,JUN,2003,19,6,,,,,549,552,PII S0899-9007(02)01032-8,10.1016/S0899-9007(02)01032-8,http://dx.doi.org/10.1016/S0899-9007(02)01032-8,,,4,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,684YP,12781858,,,,2024-06-04,WOS:000183234300014,View Full Record in Web of Science
J,"Nowicki, MJ; Bishop, PR",,,,"Nowicki, MJ; Bishop, PR",,,Organic causes of constipation in infants and children,PEDIATRIC ANNALS,,,English,Article,,,,,,,FAMILIAL VISCERAL MYOPATHY; GASTROINTESTINAL TRANSIT-TIME; HIRSCHSPRUNGS-DISEASE; DIETARY FIBER; BOWEL HABIT; COW MILK; FORMULA; STOOL; DIAGNOSIS; TRACT,"Constipation may represent a major symptom of a disease state, or may merely be an incidental, insignificant symptom. The authors discuss some of the more common organic causes of this problem.","Univ Mississippi, Med Ctr, Blair E Batson Childrens Hosp, Div Pediat Gastroenterol & Nutr, Jackson, MS 39216 USA",University of Mississippi Medical Center; University of Mississippi,"Nowicki, MJ (corresponding author), Univ Mississippi, Med Ctr, Div Pediat Gastroenterol, 2500 N State St, Jackson, MS 39216 USA.",,,"Bishop, Phyllis/0000-0002-4630-606X",,,,,50,7,10,0,2,SLACK INC,THOROFARE,"6900 GROVE RD, THOROFARE, NJ 08086 USA",0090-4481,1938-2359,,PEDIATR ANN,Pediatr. Ann.,MAY,1999,28,5,,,,,293,+,,10.3928/0090-4481-19990501-08,http://dx.doi.org/10.3928/0090-4481-19990501-08,,,9,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,196RP,10341349,,,,2024-06-04,WOS:000080321600006,View Full Record in Web of Science
J,"Sahin, M; Dogan, I; Cengiz, M; Ünal, S",,,,"Sahin, Memduh; Dogan, Ibrahim; Cengiz, Mustafa; Unal, Selahattin",,,The impact of anorectal biofeedback therapy on the quality of life of patients with dyssynergic defecation,TURKISH JOURNAL OF GASTROENTEROLOGY,,,English,Article,,,,,,Constipation; anorectal; biofeedback; quality of life,RANDOMIZED CONTROLLED-TRIAL; PELVIC FLOOR DYSSYNERGIA; FUNCTIONAL CONSTIPATION; TRANSIT CONSTIPATION; DISORDERS; SUPERIOR,"Background/Aims: Dyssynergic defecation is a common health problem affecting the quality of life of patients adversely. We aimed to evaluate the impact of biofeedback therapy on the quality of life of constipated patients due to dyssynergic defecation. Materials and Methods: Constipated patients due to dyssynergic defecation were enrolled to the study. Patients having secondary causes of constipation and who didn't fulfill the eligible criteria were excluded. All the patients underwent three to ten sessions each of which was thirty minutes biofeedback therapy under the supervision of a trained nurse. After one month the patients were assessed for the control. The impact of biofeedback therapy on the quality of life of patients having dyssynergic defecation was assessed using the validated Medical Outcomes Study Short Form-36 (SF-36) questionnaire before and one month after therapy. Results: Thirty-two patients (20 female 62.5%, 12 male 37.5% and mean age 48 (18-72) underwent three to ten sessions biofeedback therapy. Post-therapy improvements of subscores of SF-36 consists of eight domains were all statistically significant when we compared with the pre-therapy values. Conclusion: This study showed not only the effectiveness of biofeedback as a therapy modality for constipation but also its impact on the improvement of QOL of constipated patients due to dyssynergic defecation. Patients with chronic constipation not improved by dietary fiber and laxatives should be referred to specialized centers that have facilities for further anorectal physiological assessments.","[Sahin, Memduh; Dogan, Ibrahim; Cengiz, Mustafa; Unal, Selahattin] Gazi Univ, Fac Med, Dept Gastroenterol, Ankara, Turkey",Gazi University,"Dogan, I (corresponding author), Gazi Univ, Fac Med, Dept Gastroenterol, Ankara, Turkey.",idogan@gmail.com,"Cengiz, Mustafa/ACL-5305-2022; Dogan, Ibrahim/A-9274-2016","Cengiz, Mustafa/0000-0002-3306-8058;",,,,,20,7,9,0,11,AVES,SISLI,"BUYUKDERE CAD 105-9, MECIDIYEKOY, SISLI, ISTANBUL 34096, TURKEY",1300-4948,,,TURK J GASTROENTEROL,Turk. J. Gastroenterol.,MAR,2015,26,2,,,,,140,144,,10.5152/tjg.2015.4689,http://dx.doi.org/10.5152/tjg.2015.4689,,,5,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,CE2JX,25835112,,,,2024-06-04,WOS:000351643000010,View Full Record in Web of Science
J,"Singh, P; Tuck, C; Gibson, PR; Chey, WD",,,,"Singh, Prashant; Tuck, Caroline; Gibson, Peter R.; Chey, William D.",,,The Role of Food in the Treatment of Bowel Disorders: Focus on Irritable Bowel Syndrome and Functional Constipation,AMERICAN JOURNAL OF GASTROENTEROLOGY,,,English,Article,,,,,,,LOW-FODMAP DIET; RANDOMIZED CONTROLLED-TRIAL; FERMENTABLE OLIGO; GASTROINTESTINAL SYMPTOMS; CLINICAL-RESPONSE; REDUCES SYMPTOMS; GREEN KIWIFRUIT; POLYOLS DIET; MONOSACCHARIDES; REINTRODUCTION,"Irritable bowel syndrome (IBS) and functional constipation (FC) are among the most common disorders of gut-brain interaction, affecting millions of individuals worldwide. Most patients with disorders of gut-brain interaction perceive food as a trigger for their gastrointestinal symptoms, and specific dietary manipulations/advice have now been recognized as a cornerstone therapeutic option for IBS and FC. We discuss in detail the 2 most common dietary interventions used for the management of IBS-general dietary advice based on the National Institute for Health and Care Excellence guidelines and a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs). We summarize the literature around the possible mechanisms of FODMAP-mediated IBS pathophysiology, the current 3-step, top-down approach of administering a low FODMAP diet (LFD) (restriction phase, followed by reintroduction and personalization), the efficacy data of its restriction and personalization phases, and possible biomarkers for response to an LFD. We also summarize the limitations and challenges of an LFD along with the alternative approach to administering an LFD (e.g., bottom-up). Finally, we discuss the available efficacy data for fiber, other dietary interventions (e.g., Mediterranean diet, gluten-free diet, and holistic dietary interventions), and functional foods (e.g., kiwifruit, rhubarb, aloe, and prunes) in the management of IBS and FC.","[Singh, Prashant; Chey, William D.] Univ Michigan, Dept Internal Med, Div Gastroenterol & Hepatol, Ann Arbor, MI 48109 USA; [Tuck, Caroline] La Trobe Univ, Dept Dietet Nutr & Sport, Bundoora, Vic, Australia; [Gibson, Peter R.] Monash Univ, Cent Clin Sch, Dept Gastroenterol, Melbourne, Vic, Australia",University of Michigan System; University of Michigan; La Trobe University; Monash University,"Chey, WD (corresponding author), Univ Michigan, Dept Internal Med, Div Gastroenterol & Hepatol, Ann Arbor, MI 48109 USA.",wchey@med.umich.edu,"singh, prashant/AAQ-4412-2020; Chey, William/AAY-7766-2021; Tuck, Caroline/JDN-3399-2023",,,,,,94,28,29,3,29,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0002-9270,1572-0241,,AM J GASTROENTEROL,Am. J. Gastroenterol.,JUN,2022,117,6,,,,,947,957,,10.14309/ajg.0000000000001767,http://dx.doi.org/10.14309/ajg.0000000000001767,,,11,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,1U7PO,35435179,"Green Published, hybrid",,,2024-06-04,WOS:000805600000026,View Full Record in Web of Science
C,"Giacosa, A",,"Hill, M",,"Giacosa, A",,,The effects of fibre on constipation and functional bowel disease,RIGHT FIBRE FOR THE RIGHT DISEASE,ROYAL SOCIETY OF MEDICINE INTERNATIONAL CONGRESS AND SYMPOSIUM SERIES,,English,Proceedings Paper,Symposium on the Right Fibre for the Right Disease,"JUN 05, 1998","LONDON, ENGLAND",Reckitt & Colman Prod Ltd,,,DIETARY FIBER; DIVERTICULAR-DISEASE; WHEAT BRAN; POPULATION; SYMPTOMS; TRIAL; COLON; TIME,,"Natl Inst Canc Res, Genoa, Italy",University of Genoa; IRCCS AOU San Martino IST,"Giacosa, A (corresponding author), Natl Inst Canc Res, Largo Rosanna Banzi 10, Genoa, Italy.",,,,,,,,25,0,0,0,1,ROYAL SOC MEDICINE PRESS LTD,LONDON,"1 WIMPOLE STREET, LONDON W1M 8AE, ENGLAND",0142-2367,,1-85315-384-2,ROY SOC MED INT CONG,,,1999,,236,,,,,51,57,,,,,,7,"Gastroenterology & Hepatology; Medicine, General & Internal; Nutrition & Dietetics",Conference Proceedings Citation Index - Science (CPCI-S),Gastroenterology & Hepatology; General & Internal Medicine; Nutrition & Dietetics,BM73V,,,,,2024-06-04,WOS:000079661400007,View Full Record in Web of Science
J,"Garcia, JJ; Fernandez, N; Carriedo, D; Diez, MJ; Sahagun, A; Gonzalez, A; Calle, A; Sierra, M",,,,"Garcia, JJ; Fernandez, N; Carriedo, D; Diez, MJ; Sahagun, A; Gonzalez, A; Calle, A; Sierra, M",,,Hydrosoluble fiber (Plantago ovata husk) and levodopa I:: Experimental study of the pharmacokinetic interaction,EUROPEAN NEUROPSYCHOPHARMACOLOGY,,,English,Article,,,,,,levodopa; Plantago ovata husk; interaction; pharmacokinetics; rabbits; fiber,ADVANCED PARKINSONS-DISEASE; L-DOPA; DIETARY FIBER; GASTROINTESTINAL DYSFUNCTION; ENZYMES INVITRO; FOOD-INTAKE; BIOAVAILABILITY; ABSORPTION; ETHINYLESTRADIOL; LEVOTHYROXINE,"Fiber therapy could be used in patients with Parkinson disease to reduce the symptoms of gastrointestinal disorders; however, it could interact with levodopa reducing its effectiveness. In this experimental study we have investigated whether the presence of Plantago ovata husk (water-soluble fiber) modifies in rabbits the bioavailability and other pharmacokinetic parameters of levodopa (20 mg/kg) when administered by the oral route at the same time. We have also studied whether pharmacokinetic modifications are fiber-dose dependent (100 and 400 mg/kg). The extent of levodopa absorbed when administering 100 mg/kg of fiber (AUC=43.4 mu g min ml(-1)) is approximately the same as when levodopa is administered alone (AUC=47.1 mu g min ml(-1)); however, C-max is lower (1.04 versus 1.43 mu g ml(-1)). Results obtained indicate that fiber at the higher dose increases the extent of levodopa absorbed (AUC=62.2 mu g min ml(-1)), being the value of C-max similar (1.46 mu g ml(-1)). The value of t(max) increases from 10 min when levodopa is administered alone to 20 min when the animals receive fiber. On the other hand, since certain time on, levodopa concentrations are always higher in the groups that receive fiber: 60 min with 100 mg/kg fiber and 20 min with 400 mg/kg fiber. Fiber also increases the mean residence time (MRT). P. ovata husk administration with levodopa could be beneficial, not only in patients with constipation, due to: lower adverse reactions (lower values Of C-max) and longer and more stable effects (higher final concentrations and more time in the body). (c) 2005 Elsevier B.V. and ECNP. All rights reserved.","Univ Leon, Area Farmacol, E-24071 Leon, Spain",Universidad de Leon,"Univ Leon, Area Farmacol, E-24071 Leon, Spain.",dftnfm@unileon.es,"Sierra, Matilde/F-8990-2016; Garcia, Juan Jose/F-8979-2016; Sahagun Prieto, Ana M/F-8928-2016; Fernandez, Nelida/F-9573-2016; Diez, Maria Jose/F-8956-2016","Sierra, Matilde/0000-0002-0208-9542; Garcia, Juan Jose/0000-0001-7821-9502; Sahagun Prieto, Ana M/0000-0003-3311-4226; Fernandez, Nelida/0000-0002-1225-4097; Diez, Maria Jose/0000-0002-2101-3906; Calle Pardo, Angela Pilar/0000-0002-6261-8266; Carriedo Ule, Demetrio/0000-0001-8823-268X",,,,,39,15,16,0,4,ELSEVIER SCIENCE BV,AMSTERDAM,"PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",0924-977X,1873-7862,,EUR NEUROPSYCHOPHARM,Eur. Neuropsychopharmacol.,OCT,2005,15,5,,,,,497,503,,10.1016/j.euroneuro.2005.01.005,http://dx.doi.org/10.1016/j.euroneuro.2005.01.005,,,7,Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry,Science Citation Index Expanded (SCI-EXPANDED),Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry,969VQ,16139166,Green Published,,,2024-06-04,WOS:000232263900002,View Full Record in Web of Science
J,"Danjo, K; Sakamoto, J; Iwane, S; Tamura, K; Nakaji, S; Fukuda, S; Murakami, H; Shimoyama, T; Takahashi, I; Umeda, T",,,,"Danjo, Kazuma; Sakamoto, Juichi; Iwane, Satoru; Tamura, Ken; Nakaji, Shigeyuki; Fukuda, Shinsaku; Murakami, Hideki; Shimoyama, Tadashi; Takahashi, Ippei; Umeda, Takashi",,,Effects of cellulose supplementation on fecal consistency and fecal weight,DIGESTIVE DISEASES AND SCIENCES,,,English,Article,,,,,,fecal consistency; fecal weight; cellulose; dietary fiber,BOWEL TRANSIT-TIME; DIETARY FIBER; COLORECTAL-CANCER; COLON-CANCER; STOOL WEIGHT; WHEAT BRAN; RISK; CALCIUM; CONSTIPATION; CONSUMPTION,"We investigated the effects of cellulose supplementation on fecal consistency and fecal weight. About 26 women were classified into two groups-normal defecation and constipation groups. All subjects ate the following meals during the experiment: ordinary meals (first week), experimental meals (second week), and experimental meals mixed with 4 g (third week) and 8 g (fourth week) cellulose. The experimental meal contained 16.7 g fiber. Fecal weights, fecal water content, fecal consistency, and defecation frequency were measured during the experimental period. As a result, in the normal defecation group, the mean fecal weight was 222.9 g day(-1) in the first week, and thereafter decreased. Although 20/24 g of fiber intake in the third/fourth week increased the fecal weight to over 150 g, the fecal consistency was still lower than the optimal consistency of around 300 g cm(-2). However, these changes were not observed in the constipated group.","[Danjo, Kazuma; Nakaji, Shigeyuki; Takahashi, Ippei; Umeda, Takashi] Hirosaki Univ, Sch Med, Dept Social Med, Hirosaki, Aomori 0368562, Japan; [Sakamoto, Juichi; Iwane, Satoru; Tamura, Ken; Fukuda, Shinsaku; Murakami, Hideki; Shimoyama, Tadashi] Hirosaki Univ, Sch Med, Dept Internal Med 1, Hirosaki, Aomori 0368562, Japan",Hirosaki University; Hirosaki University,"Nakaji, S (corresponding author), Hirosaki Univ, Sch Med, Dept Social Med, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.",nakaji@cc.hirosaki-u.ac.jp,"Shimoyama, Tadashi/G-5519-2014",,,,,,46,6,6,0,14,SPRINGER,DORDRECHT,"VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS",0163-2116,1573-2568,,DIGEST DIS SCI,Dig. Dis. Sci.,MAR,2008,53,3,,,,,712,718,,10.1007/s10620-007-9938-6,http://dx.doi.org/10.1007/s10620-007-9938-6,,,7,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,268HK,17763952,,,,2024-06-04,WOS:000253570700016,View Full Record in Web of Science
J,"Mori, N; Asano, C; Nagata, T; Ito, T",,,,"Mori, Naoko; Asano, Chiemi; Nagata, Tadahiro; Ito, Teruko",,,Effect of Dietary Steamed and Cured Sweet Potato Slices on Bowel Movement in Female Students,JOURNAL OF THE JAPANESE SOCIETY FOR FOOD SCIENCE AND TECHNOLOGY-NIPPON SHOKUHIN KAGAKU KOGAKU KAISHI,,,Japanese,Article,,,,,,steamed and cured sweet potato slices; defecation; intervention study,JAPANESE WOMEN; FIBER INTAKE; CONSTIPATION; ASSOCIATION,"The impact of dietary steamed and cured sweet potato slices (100 g/day for 2 weeks) on bowel movement was examined in 84 Japanese female students, comprising a constipation group (n=15) and a non-constipation group (n=69). During the test period, the subjects recorded their bowel movement themselves status daily. Subjects completed a food-frequency questionnaire and were given a physical examination once a week. In all subjects, it was observed that the intake of the test food significantly increased the number of days of stool frequency, amount of stool, flatus, and the proportion of subjects who had soft stools.","[Mori, Naoko; Asano, Chiemi; Nagata, Tadahiro; Ito, Teruko] Seitoku Univ, Dept Human Nutr, Fac Humanities, Matsudo, Chiba 2718555, Japan",,"Mori, N (corresponding author), Seitoku Univ, Dept Human Nutr, Fac Humanities, 550 Iwase, Matsudo, Chiba 2718555, Japan.",nkawano@seitoku.ac.jp,,,,,,,9,1,1,0,5,JAPAN SOC FOOD SCIENCE TECHNOLOGY,IBARAKI-KEN,"2-1-12 KANNONDAI TSUKUBA-SHI, IBARAKI-KEN, 305-8642, JAPAN",1341-027X,,,J JPN SOC FOOD SCI,J. Jpn. Soc. Food Sci. Technol.-Nippon Shokuhin Kagaku Kogaku Kaishi,,2014,61,3,,,,,144,149,,10.3136/nskkk.61.144,http://dx.doi.org/10.3136/nskkk.61.144,,,6,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,AE0MZ,,Bronze,,,2024-06-04,WOS:000333661700007,View Full Record in Web of Science
J,"Erdinç, AS; Aksoy, EK; Sapmaz, FP; Dikmen, D",,,,"Erdinc, A. Seyma; Aksoy, Evrim Kahramanoglu; Sapmaz, Ferdane Pirincci; Dikmen, Derya",,,The dietary fibre intake of patients with constipation-predominant irritable bowel syndrome who applied different medical nutrition therapies,PROCEEDINGS OF THE NUTRITION SOCIETY,,,English,Meeting Abstract,,,,,,,,,"[Erdinc, A. Seyma; Dikmen, Derya] Hacettepe Univ, Dept Nutr & Dietet, Fac Hlth Sci, Ankara, Turkey; [Aksoy, Evrim Kahramanoglu; Sapmaz, Ferdane Pirincci] Ankara Kecioren Educ Res Hosp, Ankara, Turkey",Hacettepe University; Ankara Kecioren Training & Research Hospital,,,"DIKMEN, DERYA/I-9979-2013",,,,,,2,0,0,2,12,CAMBRIDGE UNIV PRESS,CAMBRIDGE,"EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND",0029-6651,1475-2719,,P NUTR SOC,Proc. Nutr. Soc.,,2021,80,OCE2,,,SI,,,,E75,10.1017/S0029665121000872,http://dx.doi.org/10.1017/S0029665121000872,,,1,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,RY0BW,,Bronze,,,2024-06-04,WOS:000647581000026,View Full Record in Web of Science
J,"JENKINS, DJA; PETERSON, RD; THORNE, MJ; FERGUSON, PW",,,,"JENKINS, DJA; PETERSON, RD; THORNE, MJ; FERGUSON, PW",,,WHEAT FIBER AND LAXATION - DOSE-RESPONSE AND EQUILIBRATION TIME,AMERICAN JOURNAL OF GASTROENTEROLOGY,,,English,Article,,,,,,,,"We studied the dose response to soft white winter wheat fiber on fecal output in a group of healthy volunteers whose breakfast consisted of wheat fiber cereals in amounts that provide 0.3 g, 5.6 g, 9.5 g, 11.2 g, 19.0 g, and 28.4 g dietary fiber per day for 14 days; no other aspects of their diet were altered. A linear dose response was observed between the six levels of fiber intake (r = 0.983, p < 0.01) with a 1-g increase in wheat fiber, producing a mean 2.7-g increase in fecal weight. This increase was independent of the initial daily fecal weight of the volunteer (mean 117 .+-. 64 g/day, range 5-297 g/day, n = 73). The maximum increase in fecal output due to cereal fiber was reached after the first week on the supplement. These data support the use of graded amounts of cereal fiber in the management of constipation.","UNIV TORONTO, FAC MED, DEPT NUTR SCI, TORONTO M5S 1A8, ONTARIO, CANADA; ST MICHAELS HOSP, DIV ENDOCRINOL & METAB, TORONTO M5B 1W8, ONTARIO, CANADA; TORONTO GEN HOSP, DIV GASTROENTEROL, TORONTO M5G 1L7, ONTARIO, CANADA; KELLOGG SALADA CANADA INC, REXDALE, ONTARIO, CANADA; KELLOGG CO, BATTLE CREEK, MI USA",,,,"Jenkins, David JA/A-1992-2009",,,,,,49,34,35,0,2,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0002-9270,1572-0241,,AM J GASTROENTEROL,Am. J. Gastroenterol.,DEC,1987,82,12,,,,,1259,1263,,,,,,5,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,L2994,2825514,,,,2024-06-04,WOS:A1987L299400005,View Full Record in Web of Science
J,"Gras, B; Magge, S; Ballom, A; Lembo, A",,,,"Gras, Beatriz; Magge, Suma; Ballom, Andrea; Lembo, Anthony",,,Motility disorders of the colon and rectum,CURRENT OPINION IN GASTROENTEROLOGY,,,English,Review,,,,,,colonic motility; constipation; diarrhea; diverticular disease; scintigraphy; wireless motility capsule,ACID TRANSPORTER INHIBITOR; BOWEL; CONSTIPATION; TRANSIT; A3309; DIET,"Purpose of review Symptoms associated with disorders of the motility of colon and rectum are common problems in clinical practice. Advances in this field continue to expand our understanding of these disorders and provide new and different treatments with promising results. Recent findings This article reviews new advances in the past year on the measurement and diagnosis of colonic transit. Recently published data question the importance of dietary fiber in the prevention of colonic diverticulosis and diverticulitis, and support the efficacy of a number of different therapies aimed at improving colonic motility and visceral sensation in constipation and reversing the effects of opioid induced constipation with peripherally acting opioid antagonists. Summary The articles referenced in this review help inform the reader on new developments in the diagnosis and management of patients with colonic and rectal motility disorders.","[Gras, Beatriz; Magge, Suma; Ballom, Andrea; Lembo, Anthony] Beth Israel Deaconess Med Ctr, Dept Med, Div Gastroenterol, Boston, MA 02215 USA",Harvard University; Beth Israel Deaconess Medical Center,"Lembo, A (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Gastroenterol, 330 Brookline Ave,Rabb Rose 1, Boston, MA 02215 USA.",alembo@bidmc.harvard.edu,,"Gras-Miralles, Beatriz/0000-0002-5943-7755",,,,,23,3,4,0,14,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0267-1379,1531-7056,,CURR OPIN GASTROEN,Curr. Opin. Gastroenterol.,JAN,2013,29,1,,,,,66,71,,10.1097/MOG.0b013e32835a80e7,http://dx.doi.org/10.1097/MOG.0b013e32835a80e7,,,6,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,050RN,23207598,Bronze,,,2024-06-04,WOS:000312071800011,View Full Record in Web of Science
J,"FIORAMONTI, J; BUENO, L",,,,"FIORAMONTI, J; BUENO, L",,,MOTOR-ACTIVITY IN THE LARGE-INTESTINE OF THE PIG RELATED TO DIETARY FIBER AND RETENTION TIME,BRITISH JOURNAL OF NUTRITION,,,English,Article,,,,,,,,"Large intestine electromyograms were recorded from 4 pigs receiving successively 3 diets containing different amounts of fiber (standard cereal diet, milk substitute and milk plus 170 g bran/kg). For each diet the mean retention time of a marker added to 1 meal was determined. Three occurrences of spontaneous constipation were studied. Slow waves were observed in the colon during 10% of the recording time at a frequency of 10.3 .+-. 1.1/min. Two kinds of spiking activity were recorded on the colon: short spike bursts of 0.5-2 s duration and long spike bursts of .apprxeq. 7 s duration. Long spike bursts alone were recorded on the cecum. The mean retention time of the marker was 40 h on the standard diet, 120 h on the milk-substitute diet and 66 h on the milk plus bran diet. On the standard diet .apprxeq. 1500 colonic long spike bursts were recorded daily and short spike bursts occupied 15% of the recording time. On the milk diet the number of long spike bursts decreased significantly (P < 0.01) to 500/d [day] and the short spike bursts increased significantly (P < 0.05) to take up to 21% of the time. Intermediate values (1100/d and 19%) were observed when bran was added to the milk diet. The lowest values for long spike bursts (300/d) and highest values for short spike bursts (44% of the time) were observed in constipation. Long spike bursts apparently are associated with propulsion of intestinal contents and short spike bursts are non-propulsive.","ECOLE NATL VET, INRA, PHYSIO PATHOL DIGEST LAB, F-31076 TOULOUSE, FRANCE",,,,,,,,,,16,81,83,0,0,CAMBRIDGE UNIV PRESS,CAMBRIDGE,"EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND",0007-1145,1475-2662,,BRIT J NUTR,Br. J. Nutr.,,1980,43,1,,,,,155,162,,10.1079/BJN19800074,http://dx.doi.org/10.1079/BJN19800074,,,8,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,JE308,6245676,Bronze,,,2024-06-04,WOS:A1980JE30800015,View Full Record in Web of Science
J,"Zhu, QN; Iwai, R; Okaguchi, T; Shirasaka, Y; Tamai, I",,,,"Zhu, Qiunan; Iwai, Ryusuke; Okaguchi, Takehiro; Shirasaka, Yoshiyuki; Tamai, Ikumi",,,Apple juice relieves loperamide-induced constipation in rats by downregulating the intestinal apical sodium-dependent bile acid transporter ASBT,FOOD & FUNCTION,,,English,Article,,,,,,,DRUG ABSORPTION; GENE-EXPRESSION; DIETARY FIBER; PERMEABILITY; COMPONENTS; SECRETION; MECHANISM; INSULIN; MOUSE; CELLS,"Apples are known to exhibit various beneficial effects on human health. In the present study, we investigated the effect of continuous intake of apple juice (AJ) on constipation status. A single dose of loperamide in rats as the constipation model markedly decreased the weight and number of fecal pellets compared to saline-administered rats as a control. After the administration of AJ twice a day for seven days, recovery of defecation close to that of the control was observed in loperamide-treated rats. In addition, the total bile acid content in the feces increased from day 4 after the administration of AJ. Among hepatic and intestinal transporters and enzymes that regulate bile acids, the mRNA expression of the apical sodium-dependent bile acid transporter (Asbt, slc10a2) was decreased by AJ in rats. Furthermore, the Asbt-mediated bile acid transport activity in the rat ileum decreased after AJ administration. Moreover, in human colonic cancer-derived Caco-2 cells, AJ exposure for 24 and 48 h decreased the expressions of ASBT mRNA and protein, and the uptake activity of taurocholic acid in both 7- and 21-d cultures. Several components of AJ, such as procyanidins, decreased the expression of ASBT in Caco-2 cells. In conclusion, ASBT downregulation is a possible mechanism responsible for the constipation-relieving effect of apples, and procyanidins may play a role in downregulating ASBT, which leads to the beneficial effects of apples against constipation. Although it is generally agreed that the common dietary compositions play a role in constipation relief, the novel specific mechanism of apples found in this study would facilitate understanding food functions.","[Zhu, Qiunan; Iwai, Ryusuke; Okaguchi, Takehiro; Shirasaka, Yoshiyuki; Tamai, Ikumi] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Pharmaceut Sci, Dept Membrane Transport & Biopharmaceut, Kanazawa, Japan",Kanazawa University,"Tamai, I (corresponding author), Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Pharmaceut Sci, Dept Membrane Transport & Biopharmaceut, Kanazawa, Japan.",tamai@p.kanazawa-u.ac.jp,"ZHU, Qiunan/HLX-0259-2023","ZHU, Qiunan/0000-0002-2624-1908; Tamai, Ikumi/0000-0003-4388-083X","Japan Society for the Promotion of Science (JSPS) [16H05111, 20K21474]; JST SPRING [JPMJSP2135]; Japan Science and Technology Agency (JST)","Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST SPRING; Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))","This study was supported by a Grant-in-Aid for Scientific Research (B) [16H05111] (IT), a Grant-in-Aid for Challenging Research (Exploratory) [20K21474] (IT) from the Japan Society for the Promotion of Science (JSPS), and JST SPRING [JPMJSP2135] (QZ) from the Japan Science and Technology Agency (JST).",,44,2,2,6,13,ROYAL SOC CHEMISTRY,CAMBRIDGE,"THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND",2042-6496,2042-650X,,FOOD FUNCT,Food Funct.,MAY 22,2023,14,10,,,,,4836,4846,,10.1039/d3fo00510k,http://dx.doi.org/10.1039/d3fo00510k,,APR 2023,11,Biochemistry & Molecular Biology; Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Food Science & Technology,G5WK5,37129213,,,,2024-06-04,WOS:000979110000001,View Full Record in Web of Science
J,"Felt, B; Wise, CG; Olson, A; Kochhar, P; Marcus, S; Coran, A",,,,"Felt, B; Wise, CG; Olson, A; Kochhar, P; Marcus, S; Coran, A",,,Guideline for the management of pediatric idiopathic constipation and soiling,ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE,,,English,Article,,,,,,,TERM FOLLOW-UP; DIETARY FIBER; ENCOPRESIS; CHILDREN; DEFECATION; CHILDHOOD; THERAPY; INFANTS,"Objective: To develop an evidence-based guideline for the primary pediatric care of children (birth to 18 years old) with idiopathic constipation and soiling. Data Sources: References were identified through a MEDLINE search from January 1975 through January 1998 to address 3 focus questions: (1) the best path to early, accurate diagnosis; (2) best methods for adequate clean-out; and (3) best approaches to promote patient and family compliance with management. Data Selection: Twenty-five references were identified. Data Extraction: References were reviewed by a multidisciplinary team and graded according to the following criteria: randomized controlled trial; controlled trial, no randomization; observational study; and expert opinion. Evidence tables were developed for each focus question. Data Synthesis: An algorithm and clinical care guideline were developed by consultation and consensus among team members. Emphasis was placed on methods to promote early identification of pediatric idiopathic constipation and soiling, to recognize points of referral, and to increase patient and family compliance-with treatment through use of education, developmentally based interventions, and variables for tracking success of management. Conclusion: An algorithm and guideline for pediatric idiopathic constipation and soiling are presented for use by primary care physicians.","Univ Michigan, Sch Med, Div Gen Acad Pediat, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Div Gastroenterol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA",University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan,"Felt, B (corresponding author), Univ Michigan, Sch Med, Div Gen Acad Pediat, 300 N Ingalls St, Ann Arbor, MI 48109 USA.",,,,,,,,26,50,57,0,0,AMER MEDICAL ASSOC,CHICAGO,"515 N STATE ST, CHICAGO, IL 60610 USA",1072-4710,,,ARCH PEDIAT ADOL MED,Arch. Pediatr. Adolesc. Med.,APR,1999,153,4,,,,,380,385,,,,,,6,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,184TN,10201721,,,,2024-06-04,WOS:000079629700009,View Full Record in Web of Science
J,"ISSENMAN, RM; HEWSON, S; PIRHONEN, D; TAYLOR, W; TIROSH, A",,,,"ISSENMAN, RM; HEWSON, S; PIRHONEN, D; TAYLOR, W; TIROSH, A",,,ARE CHRONIC DIGESTIVE COMPLAINTS THE RESULT OF ABNORMAL DIETARY PATTERNS - DIET AND DIGESTIVE COMPLAINTS IN CHILDREN AT 22 AND 40 MONTHS OF AGE,AMERICAN JOURNAL OF DISEASES OF CHILDREN,,,English,Article,,,,,,,,"We studied 149 healthy children at 22 months of age and 74 at 40 months of age, employing a 24-hour dietary record based on premailed food measurement guide and telephone questionnaire. Parents cooperated in 94% of contacts. Chronic digestive complaints decreased from 27% to 5% of the sample over the study period: constipation from 16% of 3%, chronic diarrhea from 8% to 1%, and abbdominal pain from 5% of 1%. Excessive fluid intake (1470 .+-. 600 vs 840 .+-. 300 mL/d) correlated most strongly for seven children at 22 months experiencing alternating symptoms of chronic diarrhea and constipation or abdominal pain. Many other children tolerated dietary extremes without complaint. All macronutrient categories except dietary fiber intake increase over the study period. Thus, excessive fluid intake may provoke symptoms suggesting the irritable bowel syndrome in a susceptible group of younger children. Failure to increase fiber intake from 22 to 40 months of age leaves children on an immature diet whose effects require further study.","MCMASTER UNIV, DEPT BIOSTAT & EPIDEMIOL, HAMILTON L8N 3Z5, ONTARIO, CANADA; MCMASTER UNIV, DEPT PEDIAT, HAMILTON L8N 3Z5, ONTARIO, CANADA",McMaster University; McMaster University,,,,"Issenman, Robert/0000-0002-1411-3925",,,,,17,47,53,0,0,AMER MEDICAL ASSOC,CHICAGO,"330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA",0096-8994,,,AM J DIS CHILD,Am. J. Dis. Child.,JUN,1987,141,6,,,,,679,682,,10.1001/archpedi.1987.04460060095043,http://dx.doi.org/10.1001/archpedi.1987.04460060095043,,,4,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,H5019,3578195,,,,2024-06-04,WOS:A1987H501900040,View Full Record in Web of Science
J,"ORNSTEIN, MH; LITTLEWOOD, ER; BAIRD, IM; FOWLER, J; NORTH, WRS; COX, AG",,,,"ORNSTEIN, MH; LITTLEWOOD, ER; BAIRD, IM; FOWLER, J; NORTH, WRS; COX, AG",,,ARE FIBER SUPPLEMENTS REALLY NECESSARY IN DIVERTICULAR-DISEASE OF THE COLON - A CONTROLLED CLINICAL-TRIAL,BMJ-BRITISH MEDICAL JOURNAL,,,English,Article,,,,,,,,"Fifty-eight patients with uncomplicated diverticular disease of the colon took bran crispbread, ispaghula drink and placebo for 4 mo. each in a randomized, cross-over, double-blind controlled trial. Assessments were made subjectively, using a monthly self-administered questionnaire and objectively, by examining a 7-day stool collection at the end of each treatment period. In terms of a pain score, lower bowel symptom score (the pain score and sensation of incomplete emptying, straining, stool consistency, flatus and aperients taken) and total symptom score (belching, nausea, vomiting, dyspepsia and abdominal distension) fiber supplementation conferred no benefit. Symptoms of constipation when assessed alone, were significantly relieved. Both fiber regimens produced the expected changes in stool weight, consistency and frequency. Dietary fiber supplements in the commonly used doses do no more than relieve constipation. Perhaps the impression that fiber helps diverticular disease is simply a manifestation of Western civilization''s obsession with the need for regular frequent defecation.","W MIDDLESEX UNIV HOSP, DEPT MED, ISLEWORTH TW7 6AF, MIDDLESEX, ENGLAND; NORTHWICK PK HOSP, MRC, EPIDEMIOL & MED CARE UNIT, HARROW HA1 3UJ, MIDDLESEX, ENGLAND; NORTHWICK PK HOSP, DEPT SURG, HARROW HA1 3UJ, MIDDLESEX, ENGLAND",Imperial College London; Imperial College London; Imperial College London,,,,,,,,,22,118,120,1,1,BMJ PUBLISHING GROUP,LONDON,"BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND",0959-535X,1756-1833,,BMJ-BRIT MED J,BMJ-British Medical Journal,,1981,282,6273,,,,,1353,1356,,10.1136/bmj.282.6273.1353,http://dx.doi.org/10.1136/bmj.282.6273.1353,,,4,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,LL825,6263396,"Green Submitted, Green Published, Bronze",,,2024-06-04,WOS:A1981LL82500009,View Full Record in Web of Science
J,"Tavakoli-Dastjerdi, S; Tavakkoli-Kakhki, M; Derakhshan, AR; Teimouri, A; Motavasselian, M",,,,"Tavakoli-Dastjerdi, Sedigheh; Tavakkoli-Kakhki, Mandana; Derakhshan, Ali R.; Teimouri, Azam; Motavasselian, Malihe",,,Dietary Modifications in Fissure-in-ano: A Qualitative Study Based on Persian Medicine,CURRENT NUTRITION & FOOD SCIENCE,,,English,Review,,,,,,Constipation; diet; fissure-in-ano; Persian medicine; temperament; food; traditional medicine,FODMAPS REDUCES SYMPTOMS; IRRITABLE-BOWEL-SYNDROME; CHRONIC ANAL-FISSURE; FUNCTIONAL CONSTIPATION; FOOD HYPERSENSITIVITY; MANAGEMENT; CONSUMPTION,"Background: Anal fissure (AF) is a common disease associated with severe pain and reduced quality of life. Factors related to lifestyle, including diet and bowel habits, play a pivotal role in its pathogenesis. Most of the chronic fissures are not responsive to drugs and more likely to recur. Given the significance of diet in Persian medicine (PM), investigation on physiopathology and appropriate foods can be useful for decreases in AF symptoms and consequences. Objective: This study was intended to evaluate the role of diet in the formation and progression of AF from the perspective of PM. Methods: In this study, the most important resources of PM dating back to thousands of years were reviewed. All these textbooks contained a section on AF, its causes, and treatment. Further analysis was performed on these resources in comparison with databank and resources of modern medicine to develop a food-based strategy for AF management. Results: From the view of PM, the warmth and dryness of anus temperament accounted for AF. Both Persian and modem medicine identified constipation as another cause for AF. Therefore, avoidance from some foods and commercial baked goods was recommended. Both Persian and modem medicine forbad the following foods: potato, cabbage, cauliflower, pasta, beef, fish, and so forth. High fiber and oligo-antigen diets with some limitations have garnered more attention. Conclusion: An integrative approach is recommended employing both Persian and modem medicine for AF. There have been some evidence in this regard, however standardized clinical trials are required for future research.","[Tavakoli-Dastjerdi, Sedigheh; Tavakkoli-Kakhki, Mandana; Derakhshan, Ali R.; Motavasselian, Malihe] Mashhad Univ Med Sci, Sch Persian & Complementary Med, Dept Persian Med, Mashhad, Razavi Khorasan, Iran; [Teimouri, Azam] Isfahan Univ Med Sci, Gastroentrol Dept, Esfahan, Iran",Mashhad University Medical Science; Isfahan University Medical Science,"Motavasselian, M (corresponding author), Mashhad Univ Med Sci, Sch Persian & Complementary Med, Dept Persian Med, Mashhad, Razavi Khorasan, Iran.",m_motevasselian@yahoo.com,", AzamTeimouri/AAF-7146-2019; Derakhshan, Ali Reza/AFC-8272-2022",", AzamTeimouri/0000-0001-9703-6779; Derakhshan, Ali Reza/0000-0002-3597-1312","Research Council at the Mashhad University of Medical Sciences, Mashhad, Iran [950357]","Research Council at the Mashhad University of Medical Sciences, Mashhad, Iran","This study was supported by the Research Council at the Mashhad University of Medical Sciences, Mashhad, Iran (Grant No. 950357).",,47,1,1,0,4,BENTHAM SCIENCE PUBL LTD,SHARJAH,"EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES",1573-4013,2212-3881,,CURR NUTR FOOD SCI,Curr. Nutr. Food Sci.,,2020,16,6,,,,,860,865,,10.2174/1573401314666180924123007,http://dx.doi.org/10.2174/1573401314666180924123007,,,6,Nutrition & Dietetics,Emerging Sources Citation Index (ESCI),Nutrition & Dietetics,MO2SC,,,,,2024-06-04,WOS:000551381400003,View Full Record in Web of Science
J,"Shimada, Y; Terasawa, M; Okazaki, F; Nakayama, H; Zang, LQ; Nishiura, K; Matsuda, K; Nishimura, N",,,,"Shimada, Yasuhito; Terasawa, Masahiro; Okazaki, Fumiyoshi; Nakayama, Hiroko; Zang, Liqing; Nishiura, Kaoru; Matsuda, Koichi; Nishimura, Norihiro",,,Rhamnan sulphate from green algae Monostroma nitidum improves constipation with gut microbiome alteration in double-blind placebo-controlled trial,SCIENTIFIC REPORTS,,,English,Article,,,,,,,POLYSACCHARIDES; ASSOCIATION; RESISTANCE,"Rhamnan sulphate (RS), a sulphated polysaccharide from Monostroma nitidum, possesses several biological properties that help in treating diseases such as viral infection, thrombosis, and obesity. In the present study, we first administered RS (0.25 mg/g food volume) orally to high-fat diet-treated mice for 4 weeks. RS increased the faecal volume and calorie excretion with decreased plasma lipids, which was in accordance with the results of our previous zebrafish study. Notably, as the excretion amount by RS increased in the mice, we hypothesised that RS could decrease the chance of constipation in mice and also in human subjects because RS is considered as a dietary fibre. We administrated RS (100 mg/day) to subjects with low defaecation frequencies (3-5 times/week) for 2 weeks in double-blind placebo-controlled manner. As a result, RS administration significantly increased the frequency of dejection without any side effects, although no effect was observed on the body weight and blood lipids. Moreover, we performed 16s rRNA-seq analysis of the gut microbiota in these subjects. Metagenomics profiling using PICRUSt revealed functional alternation of the KEGG pathways, which could be involved in the therapeutic effect of RS for constipation.","[Shimada, Yasuhito] Mie Univ, Grad Sch Med, Dept Integrat Pharmacol, 2-174 Edobashi, Tsu, Mie 5148507, Japan; [Shimada, Yasuhito; Terasawa, Masahiro; Okazaki, Fumiyoshi; Nakayama, Hiroko; Zang, Liqing; Nishimura, Norihiro] Mie Univ, Zebrafish Drug Screening Ctr, Tsu, Mie 5148507, Japan; [Shimada, Yasuhito; Okazaki, Fumiyoshi] Mie Univ, Adv Sci Res Promot Ctr, Dept Bioinformat, Tsu, Mie 5148507, Japan; [Okazaki, Fumiyoshi] Mie Univ, Grad Sch Bioresources, Tsu, Mie 5148507, Japan; [Nakayama, Hiroko; Zang, Liqing; Nishimura, Norihiro] Mie Univ, Grad Sch Reg Innovat Studies, Tsu, Mie 5148507, Japan; [Terasawa, Masahiro; Nishiura, Kaoru; Matsuda, Koichi] Konan Chem Mfg Co Ltd, Yokaichi, Mie 5100103, Japan",Mie University; Mie University; Mie University; Mie University; Mie University,"Shimada, Y (corresponding author), Mie Univ, Grad Sch Med, Dept Integrat Pharmacol, 2-174 Edobashi, Tsu, Mie 5148507, Japan.;Shimada, Y (corresponding author), Mie Univ, Zebrafish Drug Screening Ctr, Tsu, Mie 5148507, Japan.;Shimada, Y (corresponding author), Mie Univ, Adv Sci Res Promot Ctr, Dept Bioinformat, Tsu, Mie 5148507, Japan.",shimada.yasuhito@mie-u.ac.jp,"Shimada, Yasuhito/H-2916-2019; Zang, Liqing/AEM-5969-2022","Shimada, Yasuhito/0000-0002-4111-8262; Zang, Liqing/0000-0001-6936-795X","Konan Chemical Manufacturing Co., Ltd.","Konan Chemical Manufacturing Co., Ltd.","We thank Ms. Takako Taguchi and Ms. Azusa Kato for their secretarial assistance. We would like to thank Editage (www.editage.jp) for English language editing. Financial support for this study was provided by Konan Chemical Manufacturing Co., Ltd.",,49,14,14,3,28,NATURE PORTFOLIO,BERLIN,"HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY",2045-2322,,,SCI REP-UK,Sci Rep,JUL 5,2021,11,1,,,,,,,13384,10.1038/s41598-021-92459-7,http://dx.doi.org/10.1038/s41598-021-92459-7,,,14,Multidisciplinary Sciences,Science Citation Index Expanded (SCI-EXPANDED),Science & Technology - Other Topics,TI2HY,34226572,"Green Submitted, Green Published, gold",,,2024-06-04,WOS:000672611500001,View Full Record in Web of Science
J,"Kumar, V; Sinha, AK; Makkar, HPS; de Boeck, G; Becker, K",,,,"Kumar, Vikas; Sinha, Amit K.; Makkar, Harinder P. S.; de Boeck, Gudrun; Becker, Klaus",,,Dietary Roles of Non-Starch Polysachharides in Human Nutrition: A Review,CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION,,,English,Review,,,,,,gut viscocity; colo-rectal cancer; prebiotic; constipation; diabetes mellitus; cardiovascular disease,CHAIN FATTY-ACIDS; PLANT-CELL WALLS; CARDIOVASCULAR-DISEASE RISK; GLUCAGON-LIKE PEPTIDE-1; BREAST-CANCER RISK; PLEUROTUS-TUBER-REGIUM; NECROSIS-FACTOR-ALPHA; LINKED BETA-GLUCANS; BLOOD-GLUCOSE; STRUCTURAL FEATURES,"Nonstarch polysaccharides (NSPs) occur naturally in many foods. The physiochemical and biological properties of these compounds correspond to dietary fiber. Nonstarch polysaccharides show various physiological effects in the small and large intestine and therefore have important health implications for humans. The remarkable properties of dietary NSPs are water dispersibility, viscosity effect, bulk, and fermentibility into short chain fatty acids (SCFAs). These features may lead to diminished risk of serious diet related diseases which are major problems in Western countries and are emerging in developing countries with greater affluence. These conditions include coronary heart disease, colo-rectal cancer, inflammatory bowel disease, breast cancer, tumor formation, mineral related abnormalities, and disordered laxation. Insoluble NSPs (cellulose and hemicellulose) are effective laxatives whereas soluble NSPs (especially mixed-link beta-glucans) lower plasma cholesterol levels and help to normalize blood glucose and insulin levels, making these kinds of polysaccharides a part of dietary plans to treat cardiovascular diseases and Type 2 diabetes. Moreover, a major proportion of dietary NSPs escapes the small intestine nearly intact, and is fermented into SCFAs by commensal microflora present in the colon and cecum and promotes normal laxation. Short chain fatty acids have a number of health promoting effects and are particularly effective in promoting large bowel function. Certain NSPs through their fermented products may promote the growth of specific beneficial colonic bacteria which offer a prebiotic effect. Various modes of action of NSPs as therapeutic agent have been proposed in the present review. In addition, NSPs based films and coatings for packaging and wrapping are of commercial interest because they are compatible with several types of food products. However, much of the physiological and nutritional impact of NSPs and the mechanism involved is not fully understood and even the recommendation on the dose of different dietary NSPs intake among different age groups needs to be studied.","[Kumar, Vikas; Makkar, Harinder P. S.; Becker, Klaus] Univ Hohenheim, Inst Anim Prod Trop & Subtrop, D-70599 Stuttgart, Germany; [Kumar, Vikas; Sinha, Amit K.; de Boeck, Gudrun] Univ Antwerp, Dept Biol, Lab Ecophysiol Biochem & Toxicol, B-2020 Antwerp, Belgium",University Hohenheim; University of Antwerp,"Makkar, HPS (corresponding author), Univ Hohenheim, Inst Anim Prod Trop & Subtrop, D-70599 Stuttgart, Germany.",makkar@uni-hohenheim.de,"Kumar, Vikas/N-8955-2018; De Boeck, Gudrun/A-1938-2015","De Boeck, Gudrun/0000-0003-0941-3488; Sinha, Amit Kumar/0000-0003-0419-7640",,,,,385,199,227,4,332,TAYLOR & FRANCIS INC,PHILADELPHIA,"530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA",1040-8398,1549-7852,,CRIT REV FOOD SCI,Crit. Rev. Food Sci. Nutr.,,2012,52,10,,,,,899,935,,10.1080/10408398.2010.512671,http://dx.doi.org/10.1080/10408398.2010.512671,,,37,Food Science & Technology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Nutrition & Dietetics,968IW,22747080,,,,2024-06-04,WOS:000305973300003,View Full Record in Web of Science
J,"Gordon, M; Naidoo, K; Akobeng, AK; Thomas, AG",,,,"Gordon, Morris; Naidoo, Khimara; Akobeng, Anthony K.; Thomas, Adrian G.",,,Osmotic and stimulant laxatives for the management of childhood constipation,COCHRANE DATABASE OF SYSTEMATIC REVIEWS,,,English,Review,,,,,,,POLYETHYLENE-GLYCOL 3350; CHRONIC FUNCTIONAL CONSTIPATION; DOUBLE-BLIND; PLUS ELECTROLYTES; FECAL IMPACTION; LIQUID PARAFFIN; LAVAGE SOLUTION; MINERAL-OIL; CHILDREN; LACTULOSE,"Background Constipation within childhood is an extremely common problem. Despite the widespread use of osmotic and stimulant laxatives by health professionals to manage constipation in children, there has been a long standing paucity of high quality evidence to support this practice. Objectives We set out to evaluate the efficacy and safety of osmotic and stimulant laxatives used to treat functional childhood constipation. Search methods The search (inception to May 7, 2012) was standardised and not limited by language and included electronic searching (MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Group Specialized Trials Register), reference searching of all included studies, personal contacts and drug companies. Selection criteria Randomised controlled trials (RCTs) which compared osmotic or stimulant laxatives with either placebo or another intervention, with patients aged 0 to 18 years old were considered for inclusion. The primary outcome was frequency of defecation. Secondary endpoints included faecal incontinence, disimpaction, need for additional therapies and adverse events. Data collection and analysis Relevant papers were identified and the authors independently assessed the eligibility of trials. Methodological quality was assessed using the Cochrane risk of bias tool. The Cochrane RevMan software was used for analyses. Patients with final missing outcomes were assumed to have relapsed. For continuous outcomes we calculated a mean difference (MD) and 95% confidence interval (CI) using a fixed-effect model. For dichotomous outcomes we calculated an odds ratio (OR) and 95% confidence intervals (95% CI) using a fixed-effect model. The chi square and I-2 statistics were used to assess statistical heterogeneity. A random-effects model was used in situations of unexplained heterogeneity Main results Eighteen RCTs (1643 patients) were included in the review. Nine studies were judged to be at high risk of bias due to lack of blinding, incomplete outcome data and selective reporting. Meta-analysis of two studies (101 patients) comparing polyethylene glycol (PEG) with placebo showed a significantly increased number of stools per week with PEG (MD 2.61 stools per week, 95% CI 1.15 to 4.08). Common adverse events in the placebo-controlled studies included flatulence, abdominal pain, nausea, diarrhoea and headache. Meta-analysis of 4 studies with 338 participants comparing PEG with lactulose showed significantly greater stools per week with PEG (MD 0.95 stools per week, 95% CI 0.46 to 1.44), although follow up was short. Patients who received PEG were significantly less likely to require additional laxative therapies. Eighteen per cent of PEG patients required additional therapies compared to 30% of lactulose patients (OR 0.49, 95% CI 0.27 to 0.89). No serious adverse events were reported with either agent. Common adverse events in these studies included diarrhoea, abdominal pain, nausea, vomiting and pruritis ani. Meta-analysis of 3 studies with 211 participants comparing PEG with milk of magnesia showed that the stools/wk was significantly greater with PEG (MD 0.69 stools per week, 95% CI 0.48 to 0.89). However, the magnitude of this difference is quite small and may not be clinically significant. One child was noted to be allergic to PEG, but there were no other serious adverse events reported. Meta-analysis of 2 studies with 287 patients comparing liquid paraffin (mineral oil) with lactulose revealed a relatively large statistically significant difference in the number of stools per week favouring paraffin (MD 4.94 stools per week, 95% CI 4.28 to 5.61). No serious adverse events were reported. Adverse events included abdominal pain, distention and watery stools. No statistically significant differences in the number of stools per week were found between PEG and enemas (1 study, 90 patients, MD 1.00, 95% CI -1.58 to 3.58), dietary fibre mix and lactulose (1 study, 125 patients, P = 0.481), senna and lactulose (1 study, 21 patients, P > 0.05), lactitol and lactulose (1 study, 51 patients, MD -0.80, 95% CI -2.63 to 1.03), and PEG and liquid paraffin (1 study, 158 patients, MD 0.70, 95% CI -0.38 to 1.78). Authors' conclusions The pooled analyses suggest that PEG preparations may be superior to placebo, lactulose and milk of magnesia for childhood constipation. GRADE analyses indicated that the overall quality of the evidence for the primary outcome (number of stools per week) was low or very low due to sparse data, inconsistency (heterogeneity), and high risk of bias in the studies in the pooled analyses. Thus, the results of the pooled analyses should be interpreted with caution because of quality and methodological concerns, as well as clinical heterogeneity, and short follow up. However, PEG appears safe and well tolerated. There is also evidence suggesting the efficacy of liquid paraffin (mineral oil), which was also well tolerated. There is no evidence to demonstrate the superiority of lactulose when compared to the other agents studied, although there is a lack of placebo controlled studies. Further research is needed to investigate the long term use of PEG for childhood constipation, as well as the role of liquid paraffin.","[Gordon, Morris; Akobeng, Anthony K.; Thomas, Adrian G.] Royal Manchester Childrens Hosp, Manchester M13 9WL, Lancs, England; [Gordon, Morris] Univ Salford, Fac Hlth & Social Care, Salford M5 4WT, Lancs, England; [Naidoo, Khimara] Guys & St Thomas NHS Fdn Trust, London, England",Royal Manchester Children's Hospital; University of Salford; Guy's & St Thomas' NHS Foundation Trust,"Thomas, AG (corresponding author), Royal Manchester Childrens Hosp, Oxford Rd, Manchester M13 9WL, Lancs, England.",adrian.thomas@cmft.nhs.uk,,"Gordon, Morris/0000-0002-1216-5158","Norgine Pharmaceuticals; Cassen Fleet Pharmaceuticals; Ferring Pharmaceuticals; Canadian Institutes of Health Research (CIHR) Knowledge Translation Branch [CON - 105145]; CIHR Institutes of Nutrition, Metabolism and Diabetes (INMD); Infection and Immunity (III); Ontario Ministry of Health and Long Term Care [HLTC3968FL-2010-2235]; Olive Stewart Fund","Norgine Pharmaceuticals; Cassen Fleet Pharmaceuticals; Ferring Pharmaceuticals(Ferring Pharmaceuticals); Canadian Institutes of Health Research (CIHR) Knowledge Translation Branch(Canadian Institutes of Health Research (CIHR)); CIHR Institutes of Nutrition, Metabolism and Diabetes (INMD)(Canadian Institutes of Health Research (CIHR)); Infection and Immunity (III); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Olive Stewart Fund","Morris Gordon received a travel grant from Norgine Pharmaceuticals to present the results of this review at Digestive Disease Week in Chicago, May 2011. Norgine had no input in the design, execution or write up of the study. Additionally, Morris Gordon has received travel grants since completing this review from Cassen Fleet Pharmaceuticals and Ferring Pharmaceuticals to attend Digestive Disease Week 2012, but again they have had no involvement in this or any other research works completed.; Funding for the IBD/FBD Review Group (September 1, 2010 August 31, 2015) has been provided by the Canadian Institutes of Health Research (CIHR) Knowledge Translation Branch (CON - 105145) and the CIHR Institutes of Nutrition, Metabolism and Diabetes (INMD); and Infection and Immunity (III) and the Ontario Ministry of Health and Long Term Care (HLTC3968FL-2010-2235).; Miss Ila Stewart has provided support for the IBD/FBD Review Group through the Olive Stewart Fund.",,54,64,64,2,2,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1469-493X,1361-6137,,COCHRANE DB SYST REV,Cochrane Database Syst Rev.,,2012,,7,,,,,,,CD009118,10.1002/14651858.CD009118.pub2,http://dx.doi.org/10.1002/14651858.CD009118.pub2,,,50,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,972MC,22786523,Green Accepted,,,2024-06-04,WOS:000306280200023,View Full Record in Web of Science
J,"Cheng, C; Chan, AOO; Hui, WM; Lam, SK",,,,"Cheng, C; Chan, AOO; Hui, WM; Lam, SK",,,"Coping strategies, illness perception, anxiety and depression of patients with idiopathic constipation: a population-based study",ALIMENTARY PHARMACOLOGY & THERAPEUTICS,,,English,Article,,,,,,,HOSPITAL ANXIETY; DIETARY FIBER; EXERCISE; DISORDERS; SCALE,"Background: Functional constipation has important psychological elements. Aim: To investigate the prevalence of functional constipation in an Asian population, and the interplay among functional constipation, anxiety/depression, perception and coping strategies. Methods: An interview of 3282 patients was made by telephone survey. Constipation was diagnosed by Rome II criteria. Coping ability and anxiety/depression were assessed by validated questionnaires. Results: Fourteen percent of the interviewees had constipation. Anxiety and depression scores were higher in constipated than in healthy subjects (P<0.0001 and <0.0001), and in female than male patients (P=0.02 and <0.0001). Patients who were aware of their symptoms perceived greater impact on their lives (P<0.001). Frequent use of coping strategies associated with lower anxiety scores (P<0.0001). Female were more frequently aware of the symptoms (P=0.004), less frequently used coping strategies (P=0.008). Regression analysis showed that female and high anxiety level were the independent factors for predicting the perception of constipation, whereas anxiety was the only independent factor for predicting the use of coping strategies. Conclusion: Constipation associated with anxiety and depression is prevalent in the general Asian population. Female sex and anxiety are important aetiological factors in constipation, affecting perception and the use of coping strategies.","Hong Kong Univ Sci & Technol, Div Social Sci, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China",Hong Kong University of Science & Technology; University of Hong Kong,"Chan, AOO (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China.",,,"Cheng, Cecilia/0000-0002-7250-2224",,,,,29,139,161,2,8,BLACKWELL PUBLISHING LTD,OXFORD,"9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND",0269-2813,,,ALIMENT PHARM THERAP,Aliment. Pharmacol. Ther.,AUG 1,2003,18,3,,,,,319,326,,10.1046/j.1365-2036.2003.01663.x,http://dx.doi.org/10.1046/j.1365-2036.2003.01663.x,,,8,Gastroenterology & Hepatology; Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Gastroenterology & Hepatology; Pharmacology & Pharmacy,707PX,12895216,,,,2024-06-04,WOS:000184520000007,View Full Record in Web of Science
J,"Freitas, KD; Amancio, OMS; Novo, NF; Fagundes-Neto, U; de Morais, MB",,,,"de Cassia Freitas, Karine; Silverio Amancio, Olga Maria; Novo, Neil Ferreira; Fagundes-Neto, Ulysses; de Morais, Mauro Batista",,,Partially hydrolyzed guar gum increases intestinal absorption of iron in growing rats with iron deficiency anemia,CLINICAL NUTRITION,,,English,Article,,,,,,dietary fiber; intestinal absorption; iron deficiency anaemia; rats,DIETARY FIBER; SOLUBLE FIBER; ESPGHAN COMMITTEE; ENTERAL NUTRITION; INFANT FORMULAS; DOUBLE-BLIND; FATTY-ACIDS; WHEAT BRAN; CONSTIPATION; CHILDREN,"Objective: The objective of this study was to evaluate the effect of partially hydrolyzed guar gum (PHGG) dietary fiber towards intestinal iron absorption, for dietary intake and on the growth of rats with iron deficiency anemia in comparison to those fed on a diet with cellulose and without dietary fiber. Materials and methods: Mate Wistar rats (n = 24) weaned at 21 days were fed with AIN93-G diet without iron for 2 weeks in order to induce iron deficiency anemia. At 36 days old, the anemic rats were divided into three groups: (1) PHGG group-100 g of PHGG per kg of diet; (2) Cellulose group-100g of cellulose per kg of diet; (3) Control group-diet without dietary fiber. All the diets had 25 mg of elemental iron/kg of diet added to lead to recovery from iron deficiency anemia. Results: The final hemoglobin values in g/dl, for the PHGG group, the cellulose group and the control group were, respectively: 11.3 +/- 1.2, 8.6 +/- 0.7 and 8.1 +/- 0.9 (P < 0.001). The Levels of hepatic iron, in Vg/g of dry tissue, in the same order, were: 322.2 +/- 66.6, 217.2 +/- 59.1 and 203.7 +/- 42.4 (P < 0.001). Apparent iron intestinal absorption was, respectively: 67.5 +/- 8.9%, 35.4 +/- 15.3% and 31.3 +/- 24.9% (P < 0.001). The three groups consumed similar quantities of diet. The changes in weight and in body length were similar in the three groups studied. Conclusion: PHGG led to greater intestinal absorption of iron, regeneration of hemoglobin and hepatic levels of iron than diet with cellulose and diet control. (c) 2006 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","Univ Fed Sao Paulo, Paulista Sch Med, EPM, Dept Pediat Gastroenterol, BR-04039031 Sao Paulo, Brazil",Universidade Federal de Sao Paulo (UNIFESP),"de Morais, MB (corresponding author), Univ Fed Sao Paulo, Paulista Sch Med, EPM, Dept Pediat Gastroenterol, Rua Pedro Toledo 441, BR-04039031 Sao Paulo, Brazil.",mbmorais@osite.com.br,"Novo, Neil/AAP-8238-2020; MORAIS, MAURO B/I-7995-2014","Batista de Morais, Mauro/0000-0003-4014-5549",,,,,55,16,19,0,8,CHURCHILL LIVINGSTONE,EDINBURGH,"JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND",0261-5614,1532-1983,,CLIN NUTR,Clin. Nutr.,OCT,2006,25,5,,,,,851,858,,10.1016/j.clnu.2006.02.010,http://dx.doi.org/10.1016/j.clnu.2006.02.010,,,8,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,099SL,16678310,,,,2024-06-04,WOS:000241615800018,View Full Record in Web of Science
J,"Smith, AP",,,,"Smith, Andrew P.",,,"BREAKFAST CEREAL, FIBRE, DIGESTIVE PROBLEMS AND WELL-BEING",CURRENT TOPICS IN NUTRACEUTICAL RESEARCH,,,English,Article,,,,,,Breakfast cereal; fibre; digestive problems; well-being,DIETARY FIBER; CARDIOVASCULAR-DISEASE; VEGETABLE CONSUMPTION; SUBJECTIVE REPORTS; EPIC-NORFOLK; HEALTH; FRUIT; CONSTIPATION; POPULATION; WEIGHT,"Research has shown that regular breakfast cereal consumption is associated with better well-being (subjective reports of health and functioning). There is also evidence that a high fibre diet is associated with increased well-being. The present study involved a secondary analysis of baseline data from Smith et al. (2001). Initial analyses examined associations between high fibre intake and well-being (emotional distress, fatigue, cognitive difficulties and somatic symptoms). The results showed that high fibre intake was associated with increased well-being. Subsequent analyses examined whether the effects of total fibre intake could be accounted for by ingestion of specific sources of fibre, namely breakfast cereal and fruit/vegetables. The results showed that it was the breakfast cereal that was largely responsible for the increased well-being. Digestive problems are also associated with reduced well-being and a second set of analyses examined whether the benefits of fibre were due to a reduction in digestive problems. The results showed that digestive problems reduced well-being but these effects were independent of the effects of fibre.","Cardiff Univ, Ctr Occupat & Hlth Psychol, Sch Psychol, Cardiff CF11 3YG, S Glam, Wales",Cardiff University,"Smith, AP (corresponding author), Cardiff Univ, Ctr Occupat & Hlth Psychol, Sch Psychol, POB 901, Cardiff CF11 3YG, S Glam, Wales.",SmithAP@Cardiff.ac.uk,"Smith, Andrew P/B-2192-2010","Smith, Andrew/0000-0001-8805-8028",Kellogg's,Kellogg's,The present study was supported by Kellogg's.,,30,4,4,0,16,"NEW CENTURY HEALTH PUBLISHERS, LLC",COPPELL,"PO BOX 175, COPPELL, TX 75019 USA",1540-7535,,,CURR TOP NUTRACEUT R,Curr. Top. Nutraceutical Res.,AUG,2010,8,2-3,,,,,117,125,,,,,,9,Nutrition & Dietetics; Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Nutrition & Dietetics; Pharmacology & Pharmacy,645VJ,,,,,2024-06-04,WOS:000281494000009,View Full Record in Web of Science
J,"Rees, G; Davies, J; Thompson, R; Parker, M; Liepins, P",,,,"Rees, G; Davies, J; Thompson, R; Parker, M; Liepins, P",,,Randomised-controlled trial of a fibre supplement on the symptoms of irritable bowel syndrome,JOURNAL OF THE ROYAL SOCIETY FOR THE PROMOTION OF HEALTH,,,English,Article,,,,,,dietary fibre; irritable bowel syndrome (IBS); non-starch polysaccharide (NSP); wheat bran,COARSE WHEAT BRAN; TRANSIT-TIME; STOOL FORM; FREQUENCY; GUT,"The aim of this study was to assess the effect of coarse wheat bran on specific bowel function parameters and symptoms in patients with irritable bowel syndrome (IBS). A longitudinal, prospective, randomised, placebo-controlted trial was undertaken. The duration of treatment was eight to 12 weeks and this consisted of 10-20g/day of coarse wheat bran or a tow fibre placebo taken in addition to the normal diet. Twenty-eight outpatients fulfilling the Rome criteria for constipation-predominant IBS were recruited to the trial (14 in the treatment group; 14 in the placebo group). Twelve people completed the trial in the treatment group and ten in the placebo group. The main outcome measures included changes in symptoms recorded in a diary, changes in objective measurements of bowel function and subjective overall feelings of improvement. The bran group significantly increased their non-starch polysaccharide (NSP) intake over that of the placebo group (p < 0.05). Mean stool wet weight increased significantly more in the bran group than in the placebo group (p < 0.05), but other bowel function measurements and all recorded symptoms were not different. Many patients reported changes in bowel habit that were not reflected in the objective measurements. The addition of coarse wheat bran to the diet increased NSP ingestion and stool wet weight in this group of IBS patients, but no evidence was obtained that such treatment was of benefit to these patients, other than a placebo effect on symptoms.","London Metropolitan Univ, London N7 8DB, England; London S Bank Univ, Nutr Res Ctr, London SE1 0AA, England; St Thomas Hosp, Rayne Inst, Gastrointestinal Lab, London SE1 7EH, England; London S Bank Univ, Dept Math Stat & Fdn Studies, London SE1 0AA, England; Guys Kings & St Thomas Sch Med, Div Radiol Sci & Med Engn, London, England",London Metropolitan University; London South Bank University; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; London South Bank University; University of London; King's College London,"Rees, G (corresponding author), London Metropolitan Univ, 166-220 Holloway Rd, London N7 8DB, England.",g.rees@tondonmet.ac.uk,"Parker, Mike/M-1085-2013","Parker, Mike/0000-0002-1597-4858",,,,,24,41,44,1,8,ROYAL SOC OF HEALTH,LONDON,"38A ST, GEORGES DR, LONDON SW1V 4BH, ENGLAND",1466-4240,,,J R SOC PROMO HEALTH,J. R. Soc. Promot. Health,JAN,2005,125,1,,,,,30,34,,10.1177/146642400512500112,http://dx.doi.org/10.1177/146642400512500112,,,5,"Public, Environmental & Occupational Health",Social Science Citation Index (SSCI),"Public, Environmental & Occupational Health",901XJ,15712850,,,,2024-06-04,WOS:000227315300008,View Full Record in Web of Science
J,"Dahl, WJ; Mendoza, DR",,,,"Dahl, Wendy J.; Mendoza, Daniela Rivero",,,Is Fibre an Effective Strategy to Improve Laxation in Long-Term Care Residents?,CANADIAN JOURNAL OF DIETETIC PRACTICE AND RESEARCH,,,English,Article,,,,,,,NURSING-HOME RESIDENTS; COLONIC TRANSIT-TIME; HYDROLYZED GUAR GUM; DIETARY-INTAKE; CLOSTRIDIUM-DIFFICILE; NUTRITIONAL-STATUS; BOWEL FUNCTION; GASTROINTESTINAL TOLERANCE; SUPPLEMENTATION PROGRAM; CHRONIC CONSTIPATION,"The high prevalence of constipation in long-term care (LTC) residents has been a long-standing issue for caregivers, attending health professionals, and the residents themselves. The traditional medical response has been to utilize pharmaceutical laxatives, enemas, and suppositories for treatment. The purpose of this review was to determine if fibre supplementation (including fibre added to foods) is effective in increasing stool frequency, improving stool consistency, and decreasing laxative use in LTC residents. A systematic search was conducted using PubMed and CINAHL databases, inclusive to March 2017. Search terms included: long-term care or nursing home AND fiber (fibre), bran, psyllium, inulin, or prebiotic. Intervention trials of fibre supplementation with >= 5 LTC residents were included. The search generated 456 articles following removal of duplicates; 8 studies met the inclusion criteria. Three additional trials were identified through a hand search of references of pertinent articles. Current evidence suggests that added fibre may be effective in increasing stool frequency and/or decreasing laxative use in LTC residents and, thus, may lessen the burden of constipation. However, randomized controlled trials are needed to clearly demonstrate the effects of adding fibre to foods, particularly insoluble and less fermentable sources, on constipation in LTC residents.","[Dahl, Wendy J.; Mendoza, Daniela Rivero] Univ Florida, Food Sci & Human Nutr Dept, Gainesville, FL 32611 USA",State University System of Florida; University of Florida,"Dahl, WJ (corresponding author), Univ Florida, Food Sci & Human Nutr Dept, Gainesville, FL 32611 USA.",,,"Rivero-Mendoza, Daniela/0000-0002-7649-8728; Dahl, Wendy/0000-0003-2061-4731","SENESCYT (Secretaria Nacional de Educacion Superior, Ciencia y Tecnologia) Ecuador","SENESCYT (Secretaria Nacional de Educacion Superior, Ciencia y Tecnologia) Ecuador","Graduate student funding provided by SENESCYT (Secretaria Nacional de Educacion Superior, Ciencia y Tecnologia) Ecuador.",,101,3,3,0,19,DIETITIANS CANADA,TORONTO,"480 UNIV AVE, SUITE 604, TORONTO, ONTARIO M5G 1V2, CANADA",1486-3847,2292-9592,,CAN J DIET PRACT RES,Can. J. Diet. Pract. Res.,MAR,2018,79,1,,,,,35,41,,10.3148/cjdpr-2017-028,http://dx.doi.org/10.3148/cjdpr-2017-028,,,7,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Nutrition & Dietetics,FV9KL,28971691,,,,2024-06-04,WOS:000424906500008,View Full Record in Web of Science
J,"Sun, CS; Song, R; Zhou, JY; Jia, YB; Lu, JJ",,,,"Sun, Chuansong; Song, Rui; Zhou, Jianyong; Jia, Yubiao; Lu, Jianjun",,,Fermented Bamboo Fiber Improves Productive Performance by Regulating Gut Microbiota and Inhibiting Chronic Inflammation of Sows and Piglets during Late Gestation and Lactation,MICROBIOLOGY SPECTRUM,,,English,Article,,,,,,fermented bamboo fiber; sows; piglets; gut microbiota; inflammation; immunity,CHAIN FATTY-ACIDS; DIETARY FIBER; FEED-INTAKE; HEALTH; METABOLITES; NUTRITION; CYTOKINES; LIFE,"Sows exhibit metabolic syndrome and significant changes in intestinal microbiota during late gestation and lactation, affecting sow performance and piglet health. Dietary fiber (DF) is widely applied to improve sow performance by modulating gut microbiota and their by-products. Here, 60 sows were randomly allocated to groups, including CON (8% wheat bran), FBF-1 (1% fermented bamboo fiber), FBF-2 (2.5% fermented bamboo fiber), and FBF-3 (4% fermented bamboo fiber) from day 80 of gestation (G80d) to the end of lactation (L21d). Compared with CON, the FBF-3 diet decreased lactation backfat loss, increased average daily feed intake (ADFI) during lactation, and the weight gain of piglets, while supplementation of FBF increased fecal water content and reduced the rate of constipation in sows. Further, the yield and quality of milk of sows in FBF groups were improved. The FBF-3 diet significantly reduced markers of intestinal permeability (diamine oxidase and endotoxin) and systemic inflammation (interleukin-6 [IL-6] and tumor necrosis factor alpha) in sow serum during lactation, while it increased the anti-inflammatory marker (IL-10). Similarly, the piglets in the FBF-2 and FBF-3 groups had lower levels of IL-6 and higher levels of IgG, IgM, and insulin-like growth factor in serum. In addition, sows fed the 4% FBF diet had higher levels of acetate, propionate, butyrate, and total short-chain fatty acids (SCFAs) in feces than CON, and total SCFAs were promoted in piglets from the FBF-3 group. Spearman correlation analysis showed that immunity, inflammation, and intestinal microbiota are closely related to sow performance, which can affect piglet growth. The potential mechanism could be that FBF promoted the enrichment of beneficial genera such as Lachnospira, Lachnospiracea_XPB1014_Group, and Roseburia and the production of SCFAs in the sow's intestine, and reduced the relative abundance of harmful bacteria such as Fusobacterium, Sutterellaceae, and Sutterella. Meanwhile, the intake of FBF by sows affected the gut microbial composition of their offspring piglets, significantly increasing the relative abundance of beneficial bacteria Alistipes and Lachnoclostridium and decreasing the relative abundance of pathogenic bacteria Trueperella among colonic microorganisms.","[Sun, Chuansong; Song, Rui; Zhou, Jianyong; Jia, Yubiao; Lu, Jianjun] Zhejiang Univ, Inst Feed Sci, Coll Anim Sci, Hangzhou, Peoples R China; [Sun, Chuansong; Song, Rui; Zhou, Jianyong; Jia, Yubiao; Lu, Jianjun] Zhejiang Univ, Natl Dev & Reform Commiss, Natl Engn Lab Feed Safety & Pollut Prevent & Contr, Hangzhou, Peoples R China; [Sun, Chuansong; Song, Rui; Zhou, Jianyong; Jia, Yubiao; Lu, Jianjun] Zhejiang Univ, Key Lab Mol Anim Nutr, Minist Educ, Hangzhou, Peoples R China; [Sun, Chuansong; Song, Rui; Zhou, Jianyong; Jia, Yubiao; Lu, Jianjun] Zhejiang Univ, Key Lab Anim Nutr & Feed Sci, Minist Agr & Rural Affairs, Hangzhou, Peoples R China; [Sun, Chuansong; Song, Rui; Zhou, Jianyong; Jia, Yubiao; Lu, Jianjun] Zhejiang Univ, Key Lab Anim Feed & Nutr Zhejiang Prov, Hangzhou, Peoples R China",Zhejiang University; Zhejiang University; Zhejiang University; Ministry of Agriculture & Rural Affairs; Zhejiang University; Zhejiang University,"Lu, JJ (corresponding author), Zhejiang Univ, Inst Feed Sci, Coll Anim Sci, Hangzhou, Peoples R China.;Lu, JJ (corresponding author), Zhejiang Univ, Natl Dev & Reform Commiss, Natl Engn Lab Feed Safety & Pollut Prevent & Contr, Hangzhou, Peoples R China.;Lu, JJ (corresponding author), Zhejiang Univ, Key Lab Mol Anim Nutr, Minist Educ, Hangzhou, Peoples R China.;Lu, JJ (corresponding author), Zhejiang Univ, Key Lab Anim Nutr & Feed Sci, Minist Agr & Rural Affairs, Hangzhou, Peoples R China.;Lu, JJ (corresponding author), Zhejiang Univ, Key Lab Anim Feed & Nutr Zhejiang Prov, Hangzhou, Peoples R China.",jjlu@zju.edu.cn,"Song, Ruiqi/HKN-0776-2023","Song, Ruiqi/0000-0001-8617-5474",[2021N008],,"ACKNOWLEDGMENTS We have no conflicts of interest to declare. This study was supported by the selected best candidate project of Jinhua City (2021N008). All authors made substantial contributions to the study. C.S. contributed conceptualization, methodology, data curation, and preparation of the experiments and original draft. R.S. contributed resources, software, and formal analysis. J.Z. and Y.J. contributed to the visualization and investigation. J.L. contributed to project administration and funding acquisition.",,72,8,8,14,48,AMER SOC MICROBIOLOGY,WASHINGTON,"1752 N ST NW, WASHINGTON, DC 20036-2904 USA",2165-0497,,,MICROBIOL SPECTR,Microbiol. Spectr.,JUN,2023,11,3,,,,,,,,10.1128/spectrum.04084-22,http://dx.doi.org/10.1128/spectrum.04084-22,,APR 2023,20,Microbiology,Science Citation Index Expanded (SCI-EXPANDED),Microbiology,L4IY3,37042787,"gold, Green Published",,,2024-06-04,WOS:000968946800001,View Full Record in Web of Science
J,"ODES, HS; MADAR, Z; TROP, M; NAMIR, S; GROSS, J; COHEN, T",,,,"ODES, HS; MADAR, Z; TROP, M; NAMIR, S; GROSS, J; COHEN, T",,,SPENT GRAIN AS A SOURCE OF DIETARY FIBER IN THE TREATMENT OF PATIENTS WITH IRRITABLE BOWEL SYNDROME AND CONSTIPATION,GASTROENTEROLOGY,,,English,Meeting Abstract,,,,,,,,,"BEN GURION UNIV NEGEV,GASTROENTEROL UNIT,IL-84105 BEERSHEBA,ISRAEL; BEN GURION UNIV NEGEV,APPL BIOL UNIT,IL-84105 BEERSHEBA,ISRAEL; BEN GURION UNIV NEGEV,EPIDEMIOL UNIT,IL-84105 BEERSHEBA,ISRAEL; BEN GURION UNIV NEGEV,HLTH SCI EVALUAT UNIT,IL-84105 BEERSHEBA,ISRAEL; HEBREW UNIV JERUSALEM,IL-76100 REHOVOT,ISRAEL",Ben Gurion University; Ben Gurion University; Ben Gurion University; Ben Gurion University; Hebrew University of Jerusalem,,,,,,,,,0,3,3,0,1,W B SAUNDERS CO,PHILADELPHIA,"INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399",0016-5085,,,GASTROENTEROLOGY,Gastroenterology,,1985,88,5,,,,,1521,1521,,,,,,1,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,AFW22,,,,,2024-06-04,WOS:A1985AFW2200888,View Full Record in Web of Science
J,"Sabater-Molina, M; Larqué, E; Torrella, F; Zamora, S",,,,"Sabater-Molina, M.; Larque, E.; Torrella, F.; Zamora, S.",,,Dietary fructooligosaccharides and potential benefits on health,JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY,,,English,Review,,,,,,Fructooligosaccharides; Prebiotic; Infant formulas; Human milk,HUMAN-MILK OLIGOSACCHARIDES; BREAST-FED INFANTS; EPITHELIAL-CELL PROLIFERATION; HUMAN COLONIC MICROBIOTA; FRUCTO-OLIGOSACCHARIDES; MINERAL METABOLISM; RATS; OLIGOFRUCTOSE; PREBIOTICS; INULIN,"M. SABATER-MOLINA, E. LARQU, F. TORRELLA and S. ZAMORA. Dietary fructooligosaccharides and potential benefits on health, (minireview). J Physiol Biochem, 65 (3), 315-328, 2009. Fructooligosaccharides (FOS) are oligosaccharides that occur naturally in plants such as onion, chicory, garlic, asparagus, banana, artichoke, among many others. They are composed of linear chains of fructose units, linked by beta (2-1) bonds. The number of fructose units ranges from 2 to 60 and often terminate in a glucose unit. Dietary FOS are not hydrolyzed by small intestinal glycosidases and reach the cecum structurally unchanged. There, they are metabolized by the intestinal microflora to form short-chain carboxylic acids, L -lactate, CO2, hydrogen and other metabolites. FOS have a number of interesting properties, including a low sweetness intensity; they are also caloric free, non-cariogenic and are considered as soluble dietary fibre. Furthermore, FOS have important beneficial physiological effects such as low carcinogenicity, a prebiotic effect, improved mineral absorption and decreased levels of serum cholesterol, triacylglycerols and phospholipids. Currently FOS are increasingly included in food products and infant formulas due to their prebiotic effect stimulate the growth of nonpathogenic intestinal microflora. Their consumption increases fecal bolus and the frequency of depositions, while a dose of 4-15 g/day given to healthy subjects will reduce constipation, considered one of the growing problems of modern society, and newborns during the first months of life.","[Sabater-Molina, M.; Larque, E.; Zamora, S.] Univ Murcia, Dept Physiol, Fac Biol, E-30001 Murcia, Spain; [Torrella, F.] Univ Murcia, Dept Microbiol, Fac Biol, E-30001 Murcia, Spain",University of Murcia; University of Murcia,"Sabater-Molina, M (corresponding author), Univ Murcia, Dept Physiol, Fac Biol, E-30001 Murcia, Spain.",mariasm@um.es,"Larqué Daza, Elvira/HNC-4859-2023; Sabater-Molina, Maria/I-2722-2015; TORRELLA, FRANCISCO/H-9789-2015","Larqué Daza, Elvira/0000-0001-6805-3449; Sabater-Molina, Maria/0000-0003-1352-1748; TORRELLA, FRANCISCO/0000-0001-8157-0440",,,,,69,228,251,3,112,SPRINGER,DORDRECHT,"VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS",1138-7548,1877-8755,,J PHYSIOL BIOCHEM,J. Physiol. Biochem.,SEP,2009,65,3,,,,,315,328,,10.1007/BF03180584,http://dx.doi.org/10.1007/BF03180584,,,14,Biochemistry & Molecular Biology; Physiology,Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Physiology,547AS,20119826,,,,2024-06-04,WOS:000273857700011,View Full Record in Web of Science
J,"Granito, M; Guinand, J; Pérez, S; Pérez, D; Morros, M",,,,"Granito, M.; Guinand, J.; Perez, S.; Perez, D.; Morros, M.",,,Carbohydrate content in autochthonous varieties of Phaseolus vulgaris grown in Venezuela,REVISTA DE LA FACULTAD DE AGRONOMIA DE LA UNIVERSIDAD DEL ZULIA,,,Spanish,Article,,,,,,Phaseolus vulgaris; carbohydrates; starches; fiber,DIETARY FIBER; RESISTANT STARCH; CHEMICAL-COMPOSITION; DIGESTIBILITY; DIGESTION; PEA,"P. vulgaris, commonly known in Venezuela as black bean, is the legume of highest consumption among all social strata, because takes part of the dietary habits of the population. Its high nutritional potential, as well as easy access makes it a potentially strategic foodstuff for the achievement of the food self-sufficiency of the Venezuelan people. The objective of this work was to evaluate the carbohydrates content present in autochthonous varieties of P. vulgaris cultivated by growers in different geographical areas of the country, aiming to contribute to the identification and characterization of P. vulgaris varieties grown in Venezuela. Nine raw varieties were analyzed respect to their contents of total, available and resistant starch, total dietary fiber, soluble and insoluble, stachyose and raffinose. Mean contents of 43.9% for total starch, 39% for available starch, 25.5% for resistant starch, 26.9% for total dietary fiber, being 24.4% insoluble fiber and 2.4% soluble fiber, 2.3% for raffinose and 8% for stachyose were found. Based on the results found, it can be concluded that Phaseolus vulgaris represents an important source of energy and of bioactive compounds. The Poncha variety (F) grown in Lara state had the highest total starch content and insoluble fiber and the lowest concentration of soluble fiber and alpha-galactosides and could therefore represent an excellent option for providing energy to the population, preventing constipation without cause flatulence.","[Granito, M.; Guinand, J.] Univ Simon Bolivar, Caracas 108A, Venezuela; [Perez, D.; Morros, M.] Inst Nacl Invest Agr, Maracay 2101A, Aragua, Venezuela",Simon Bolivar University,"Granito, M (corresponding author), Univ Simon Bolivar, Apartado Postal 89-000, Caracas 108A, Venezuela.",mgranito@usb.ve,,,Fondo Nacional para la Investigacion y la Teenologia (FONACIT) [S1-2001856]; Banco Interamericano de Desarrollo (BID) [BID-FONACIT 26110],Fondo Nacional para la Investigacion y la Teenologia (FONACIT); Banco Interamericano de Desarrollo (BID),"This research has been possible by the financing of the Fondo Nacional para la Investigacion y la Teenologia (FONACIT) project S1-2001856 and the Banco Interamericano de Desarrollo (BID), Sub Project BID-FONACIT 26110.",,32,0,1,0,7,"UNIV ZULIA, FACULTAD AGRONOMIA",MARACAIBO,"APARTADO 15205, MARACAIBO, ZU 4005, VENEZUELA",0378-7818,2477-9407,,REV FAC AGRON LUZ,Rev. Fac. Agron.,OCT-DEC,2008,25,4,,,,,649,664,,,,,,16,Agronomy,Science Citation Index Expanded (SCI-EXPANDED),Agriculture,382AZ,,,,,2024-06-04,WOS:000261578400004,View Full Record in Web of Science
J,"Glabska, D; Guzek, D; Zakrzewska, P; Lech, G",,,,"Glabska, Dominika; Guzek, Dominika; Zakrzewska, Paulina; Lech, Gustaw",,,Intake of Lutein and Zeaxanthin as a Possible Factor Influencing Gastrointestinal Symptoms in Caucasian Individuals with Ulcerative Colitis in Remission Phase,JOURNAL OF CLINICAL MEDICINE,,,English,Article,,,,,,colitis ulcerosa; gastrointestinal symptoms; constipation; lutein; zeaxanthin,INFLAMMATORY-BOWEL-DISEASE; IBS-LIKE SYMPTOMS; QUALITY-OF-LIFE; OXIDATIVE STRESS; SERUM CAROTENOIDS; DIETARY FIBER; CONSTIPATION; SUPPLEMENTATION; DIFFERENTIATION; METAANALYSIS,"The vitamin A deficiencies are commonly observed in the case of ulcerative colitis individuals. The decreased antioxidant defence may influence the intestine, inducing higher susceptibility to oxidative damage of tissues and altering the symptoms and course of disease. Intestinal symptoms, ranging from diarrhea to constipation, occur more commonly in remission ulcerative colitis individuals than in general population. The aim of the study was to analyze the association between retinoid intake and gastrointestinal symptoms in Caucasian individuals in the remission phase of ulcerative colitis. Reitnoid (total vitamin A, retinol, -carotene, -carotene, -cryptoxanthin, lycopene, as well as lutein and zeaxanthin) intakes were analyzed on the basis of three-day dietary records. Gastrointestinal symptoms (daily number of bowel movements, and the presence of painful tenesmus, flatulence, and constipation) were self-reported. The study was conducted in a group of 56 ulcerative colitis remission individuals, stratified by the gastrointestinal symptoms. One in every seven individuals reported recurring constipation. Higher intake of lutein and zeaxanthin (median 1386.2 mu g, 289.0-13221.3 mu g vs. median 639.0 mu g, 432.7-1309.0 mu g) may lower the incidence of constipation (p = 0.013). The intake of retinoids other than lutein and zeaxanthin was not associated with the incidence of constipation or other gastrointestinal symptoms.","[Glabska, Dominika; Zakrzewska, Paulina] UWarsaw niv Life Sci SGGW WULS, Dept Dietet, Fac Human Nutr & Consumer Sci, 159c Nowoursynowska St, PL-02776 Warsaw, Poland; [Guzek, Dominika] Warsaw Univ Life Sci SGGW WULS, Dept Org & Consumpt Econ, Fac Human Nutr & Consumer Sci, 159c Nowoursynowska St, PL-02776 Warsaw, Poland; [Lech, Gustaw] Med Univ Warsaw, Dept Gen Gastroenterol & Oncol Surg, 1a Banacha St, PL-02097 Warsaw, Poland",Warsaw University of Life Sciences; Warsaw University of Life Sciences; Medical University of Warsaw,"Glabska, D (corresponding author), UWarsaw niv Life Sci SGGW WULS, Dept Dietet, Fac Human Nutr & Consumer Sci, 159c Nowoursynowska St, PL-02776 Warsaw, Poland.",dominika_glabska@sggw.pl; dominika_guzek@sggw.pl; paulina_zakrzewska@sggw.pl; gustaw.lech@wum.edu.pl,"Głąbska, Dominika/H-8442-2019; Guzek, Dominika/B-8475-2013; Lech, Gustaw/B-9494-2012","Głąbska, Dominika/0000-0001-8588-7357; Guzek, Dominika/0000-0002-0784-3604; Lech, Gustaw/0000-0002-3814-8874","Polish Ministry of Science and Higher Education within Faculty of Human Nutrition and Consumer Sciences, Warsaw University of Life Sciences (WULS)","Polish Ministry of Science and Higher Education within Faculty of Human Nutrition and Consumer Sciences, Warsaw University of Life Sciences (WULS)","This research was funded by Polish Ministry of Science and Higher Education within funds of Faculty of Human Nutrition and Consumer Sciences, Warsaw University of Life Sciences (WULS), for scientific research.",,65,15,15,0,17,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2077-0383,,J CLIN MED,J. Clin. Med.,JAN,2019,8,1,,,,,,,77,10.3390/jcm8010077,http://dx.doi.org/10.3390/jcm8010077,,,16,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,HJ4JU,30641888,"Green Published, gold, Green Submitted",,,2024-06-04,WOS:000457141100076,View Full Record in Web of Science
J,"Nelson, RL; Persky, V; Turyk, M",,,,"Nelson, RL; Persky, V; Turyk, M",,,Determination of factors responsible for the declining incidence of colorectal cancer,DISEASES OF THE COLON & RECTUM,,,English,Article; Proceedings Paper,11th World Congress of Gastroenterology,"SEP 05-13, 1998","VIENNA, AUSTRIA",,,colorectal cancer; time trend; polypectomy; dietary fat; fiber,COLON-CANCER; UNITED-STATES; RISK-FACTORS; PHYSICAL-ACTIVITY; DIETARY-FAT; TIME TRENDS; FOLLOW-UP; NATIONAL-HEALTH; BOWEL-CANCER; FIBER INTAKE,"INTODUCTION: After rising for IS pears in the United States, the incidence of colorectal cancer began to fall in 1986 and has continued to drop since then. This report contains an analysis of the pattern of declining colorectal cancer risk by colorectal subsite, race, and gender and a time trend investigation of suspected risk modifiers of colorectal cancer. METHOD: Colorectal cancer incidence data were obtained from the Surveillance, Epidemiology, and End Results Public Use Files from 1973 to 1994. The following exposure variables were assessed, focussing principally on the period 1970 to 1980. dietary fat, fiber, ethanolic beverages, vitamin A, vitamin C, iron, calcium, estrogen, aspirin, energy intake, body mass index, serum cholesterol, body iron stores, cholecystectomy, constipation, cigarette use, physical activity and colonoscopic polypectomy. Data sources used in these analyses were principally National Health and Nutrition Examination Surveys I, II, and III. RESULTS: After 1985 colorectal cancer incidence declined predominantly in the distal colorectum almost equally in both white males and white females. Some exposures remained unchanged or trended in the wrong direction (dietary fat, calcium, ethanol, energy intake, physical activity, overweight prevalence, and cholecystectomy). Others did not apply equally to both genders (estrogen, aspirin, ethanol, calcium, and cholecystectomy). Others may become significant in the future, such as aspirin, estrogen, or calcium, because their supplementation is now prevalent, but were not in 1970 to 1975. Of all the risk factors or interventions assessed, the one most consistent with the observed pattern of change is increased use of colonoscopic polypectomy. CONCLUSION: The best method to diminish the incidence of colorectal cancer today may be to increase the use of screening colonoscopy and polypectomy.","Univ Illinois, Coll Med, Dept Surg, Chicago, IL USA; Univ Illinois, Sch Publ Hlth, Epidemiol Biometry Div, Chicago, IL USA",University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital,"Univ Illinois, Coll Med, Dept Surg, Chicago, IL USA.",,,,,,,,79,44,55,0,2,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0012-3706,1530-0358,,DIS COLON RECTUM,Dis. Colon Rectum,JUN,1999,42,6,,,,,741,752,,10.1007/BF02236929,http://dx.doi.org/10.1007/BF02236929,,,12,Gastroenterology & Hepatology; Surgery,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Gastroenterology & Hepatology; Surgery,205GX,10378598,,,,2024-06-04,WOS:000080813900009,View Full Record in Web of Science
J,"MCCLUNG, HJ; BOYNE, LJ; LINSHEID, T; HEITLINGER, LA; MURRAY, RD; FYDA, J; LI, BUK",,,,"MCCLUNG, HJ; BOYNE, LJ; LINSHEID, T; HEITLINGER, LA; MURRAY, RD; FYDA, J; LI, BUK",,,IS COMBINATION THERAPY FOR ENCOPRESIS NUTRITIONALLY SAFE,PEDIATRICS,,,English,Article,,,,,,ENCOPRESIS; FIBER; MINERAL OIL; LAXATIVES,CHRONIC CONSTIPATION; CHILDREN; FIBER; DIETS,"Chronic constipation accounts for 3% to 5% of pediatric primary care outpatient visits. The most severely affected of this group develop a flaccid colon insensitive to distention, and encopresis. Laxatives and lubricants have been the standard therapeutic agents during the bowel decompression phase of encopretic therapy. Fiber has been the cornerstone of maintenance programs. Each of these agents is accompanied by considerable anxiety in the lay literature. This study evaluates the safety of combined high-fiber, laxative, and lubricant therapy on bowel movement frequency, fecal soiling, and nutritional status over a 6-month period. Blood chemistry values, dietary fiber intake, defecation pattern, and a psychological profile were evaluated before and after the 6-month study. Biochemical and anthropometric indicators of nutritional status were not adversely affected by the therapy. Seventy-five percent of the children were able to remain free of soiling and the remaining 4 of 16 had soiling episodes reduced to a frequency of less than once a week. This study confirms that children with encopresis can respond to a combined program of increased fiber intake, laxatives, and mineral oil following a complete bowel cleanout, without experiencing deleterious effects.","OHIO STATE UNIV,DIV PEDIAT GASTROENTEROL,COLUMBUS,OH 43210; OHIO STATE UNIV,DIV MED DIETET,COLUMBUS,OH 43210; OHIO STATE UNIV,DIV PEDIAT PSYCHOL,COLUMBUS,OH 43210",University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University,"MCCLUNG, HJ (corresponding author), COLUMBUS CHILDRENS HOSP,700 CHILDRENS DR,COLUMBUS,OH 43205, USA.",,,,,,,,16,29,29,0,0,AMER ACAD PEDIATRICS,ELK GROVE VILLAGE,"141 NORTH-WEST POINT BLVD, ELK GROVE VILLAGE, IL 60007-1098",0031-4005,,,PEDIATRICS,Pediatrics,MAR,1993,91,3,,,,,591,594,,,,,,4,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,KP638,8382783,,,,2024-06-04,WOS:A1993KP63800014,View Full Record in Web of Science
J,"Dreher, ML",,,,"Dreher, Mark L.",,,Whole Fruits and Fruit Fiber Emerging Health Effects,NUTRIENTS,,,English,Review,,,,,,prebiotic effects; gastrointestinal health; weight management; cardiovascular disease; diabetes; metabolic syndrome; successful aging; cancer; psychological well-being; depression; asthma; bone mineral density,INFLAMMATORY-BOWEL-DISEASE; DOSE-RESPONSE METAANALYSIS; INTAKE REDUCES RISK; CHAIN FATTY-ACID; TYPE-2 DIABETES-MELLITUS; DIETARY ENERGY DENSITY; IN-VITRO FERMENTATION; BONE-MINERAL DENSITY; VEGETABLE CONSUMPTION; BLOOD-PRESSURE,"Less than 10% of most Western populations consume adequate levels of whole fruits and dietary fiber with typical intake being about half of the recommended levels. Evidence of the beneficial health effects of consuming adequate levels of whole fruits has been steadily growing, especially regarding their bioactive fiber prebiotic effects and role in improved weight control, wellness and healthy aging. The primary aim of this narrative review article is to examine the increasing number of health benefits which are associated with the adequate intake of whole fruits, especially fruit fiber, throughout the human lifecycle. These potential health benefits include: protecting colonic gastrointestinal health (e.g., constipation, irritable bowel syndrome, inflammatory bowel diseases, and diverticular disease); promoting long-term weight management; reducing risk of cardiovascular disease, type 2 diabetes and metabolic syndrome; defending against colorectal and lung cancers; improving odds of successful aging; reducing the severity of asthma and chronic obstructive pulmonary disease; enhancing psychological well-being and lowering the risk of depression; contributing to higher bone mineral density in children and adults; reducing risk of seborrheic dermatitis; and helping to attenuate autism spectrum disorder severity. Low whole fruit intake represents a potentially more serious global population health threat than previously recognized, especially in light of the emerging research on whole fruit and fruit fiber health benefits.","[Dreher, Mark L.] Nutr Sci Solut LLC, Wimberley, TX 78676 USA",,"Dreher, ML (corresponding author), Nutr Sci Solut LLC, Wimberley, TX 78676 USA.",mdreher@nutriscisolutions.com,,,Hass Avocado Board,Hass Avocado Board,"Funding was provided by the Hass Avocado Board, which had no input as to the content of this manuscript.",,356,146,162,4,49,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,DEC,2018,10,12,,,,,,,1833,10.3390/nu10121833,http://dx.doi.org/10.3390/nu10121833,,,54,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Nutrition & Dietetics,HG6EG,30487459,"gold, Green Published, Green Submitted",,,2024-06-04,WOS:000455073200014,View Full Record in Web of Science
J,"Tavhare, SD",,,,"Tavhare, Swagata Dilip",,,Millets as a dietary supplement for managing chemotherapy induced side effects,JOURNAL OF AYURVEDA AND INTEGRATIVE MEDICINE,,,English,Review,,,,,,Ayurveda; Adjuvant; Cancer; Chemotherapy induced side effects; Diet; Millets; NCDs; SDG 3.4,ELEUSINE-CORACANA L.; FINGER MILLET; FOXTAIL MILLET; CANCER; FIBER; INHIBITION; PROTEIN; PREVENTION; PHENOLICS; STOMACH,"Millets, the nutria -cereals, are one of the oldest utilized grain. Millets are reported to possess nutraceuticals health benefits which include improvement in functioning of digestive system, reduction in cholesterol, prevention of heart disease, protection against diabetes, lowering risks of cancer etc. With the widespread commemoration of the International Year of Millets in 2023, the Indian government is moving towards the global recognition of millets in light of its medicinal value in correction of lifestyles diseases. One of the common noncommunicable diseases is cancer. Chemotherapy is used as adjuvant, neo-adjuvant or as a combination, in metastatic settings. It is linked to outcomes, but it also has unfavorable side effects that lower a patient's quality of life. The reported chemotherapy side effects includes loss of appetite, nausea, vomiting, weakness, hair loss, osteoporosis, immunological suppression and gastric disturbances such as dry mouth, altered taste, ulcers, constipation etc. The effectiveness of tumor therapy and the extension of treatment are both influenced by side effect management. One way to help cancer patients with their polypharmacy load is through dietary management. Rich in phytochemicals, fiber, vitamins, and minerals, millets can be suggested as a dietary therapeutic intervention in addition to chemotherapy. Being widely accessible, cost effective, nutrient -dense, high in fiber, gluten -free, anti-inflammatory, antioxidant, lipid lowering, gastro-protective, immunomodulator in action, millets can serve as a good diet choice to minimize side effects of chemotherapy.","[Tavhare, Swagata Dilip] DY Patil Vidyapeeth Deemed be Univ, Dr D Y Patil Coll Ayurved & Res Ctr, Dept Dravyaguna, Pimpri 411018, Pune, India",,"Tavhare, SD (corresponding author), DY Patil Vidyapeeth Deemed be Univ, Dr D Y Patil Coll Ayurved & Res Ctr, Dept Dravyaguna, Pimpri 411018, Pune, India.",drswagata32@gmail.com,,,,,,,68,0,0,1,1,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",0975-9476,0976-2809,,J AYURVEDA INTEGR ME,J. Ayurveda Integr. Med.,JAN-FEB,2024,15,1,,,,,,,100901,10.1016/j.jaim.2024.100901,http://dx.doi.org/10.1016/j.jaim.2024.100901,,FEB 2024,6,Integrative & Complementary Medicine,Emerging Sources Citation Index (ESCI),Integrative & Complementary Medicine,ON5B0,38422821,"gold, Green Published",,,2024-06-04,WOS:001207956100001,View Full Record in Web of Science
J,"Hu, TG; Wen, P; Fu, HZ; Lin, GY; Liao, ST; Zou, YX",,,,"Hu, Teng-Gen; Wen, Peng; Fu, Hui-Zhan; Lin, Guang-Yue; Liao, Sen-Tai; Zou, Yu-Xiao",,,Protective effect of mulberry (Morus atropurpurea) fruit against diphenoxylate-induced constipation in mice through the modulation of gut microbiota,FOOD & FUNCTION,,,English,Article,,,,,,,LOPERAMIDE-INDUCED CONSTIPATION; CHAIN FATTY-ACIDS; QUALITY-OF-LIFE; DIETARY FIBER; EXTRACT; POLYSACCHARIDES; ANTIDIARRHEAL; BACTERIA; AMERICA; TRANSIT,"Mulberry (Morus atropurpurea) has long been used to treat gastro-intestinal ailments; however, the functional basis of its therapeutic effects remains unclear. The aim of this study was to measure the effects of mulberry (administered by gavage) on diphenoxylate-induced constipation in mice and elucidate the mechanisms underlying these effects using constipation and physicochemical indexes, histological morphology and 16S rDNA amplicon analysis of fecal microbiota. Sixty Kunming mice were randomly divided into the following six groups (n = 10 per group): normal control, constipation model, positive control, and low-, mid- and high-dose mulberry groups. After 14 days of treatment, constipation was induced over 5 days and measurements were conducted. The results show that mulberry treatment prevented constipation by increasing the fecal water content, shortening the first red fecal defecation time, promoting gastric evacuation, and increasing the gastric-intestinal transit rate (P < 0.05). Compared with the constipation model group, the mulberry-treated groups showed decreased aquaporin gene expression (Aqp3, Aqp4, Aqp8 and Aqp9), decreased serum levels of inhibitory neurotransmitters (nitric oxide and vasoactive intestinal peptide) (P < 0.05), and increased serum levels of excitability neurotransmitters (acetyl choline, substance P, and motilin). The histological morphology of the colon showed that mulberry treatment increased the number of mucus cells (P < 0.05). Mulberry treatment also increased the concentrations of acetic, propionic, butyric, valeric and isovaleric acids (P < 0.05), increased the abundance of Lactobacillus and Bifidobacterium in feces, and decreased the abundance of Helicobacter and Prevotellaceae in feces. Our findings indicate that mulberry consumption effectively prevents constipation in mice and is a promising therapeutic candidate for constipation.","[Hu, Teng-Gen; Wen, Peng; Fu, Hui-Zhan; Lin, Guang-Yue; Liao, Sen-Tai; Zou, Yu-Xiao] Guangdong Acad Agr Sci, Guangdong Key Lab Agr Prod Proc, Sericultural & Agrifood Res Inst, Key Lab Funct Foods,Minist Agr, Guangzhou, Guangdong, Peoples R China; [Hu, Teng-Gen; Wen, Peng] South China Univ Technol, Sch Food Sci & Engn, Guangzhou, Guangdong, Peoples R China",Guangdong Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; South China University of Technology,"Liao, ST; Zou, YX (corresponding author), Guangdong Acad Agr Sci, Guangdong Key Lab Agr Prod Proc, Sericultural & Agrifood Res Inst, Key Lab Funct Foods,Minist Agr, Guangzhou, Guangdong, Peoples R China.",liaost@163.com; yuxiaozou@126.com,,,"Applied Research & Development Special Foundation of Guangdong Province [2015B020234006]; Science and Technology Plan Project of Guangdong Province [2017A050501022]; Special Fund for Agro-Scientific Research in the Public Interest, China [201403064]; Innovation Teams of Modern Agricultural Industry Technology System in Guangdong Province [2016LM1087, 2016LM2151]","Applied Research & Development Special Foundation of Guangdong Province; Science and Technology Plan Project of Guangdong Province; Special Fund for Agro-Scientific Research in the Public Interest, China; Innovation Teams of Modern Agricultural Industry Technology System in Guangdong Province","We acknowledge the Applied Research & Development Special Foundation of Guangdong Province (No. 2015B020234006), the Science and Technology Plan Project of Guangdong Province (No. 2017A050501022), the Special Fund for Agro-Scientific Research in the Public Interest, China (No. 201403064), and the Innovation Teams of Modern Agricultural Industry Technology System in Guangdong Province (No. 2016LM1087, 2016LM2151) for their financial support. In addition, we thank Alice Tait, PhD, from Liwen Bianji, Edanz Editing China (http://www.liwenbianji.cn/ac), for editing the English text of a draft of this manuscript.",,74,67,72,13,158,ROYAL SOC CHEMISTRY,CAMBRIDGE,"THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND",2042-6496,2042-650X,,FOOD FUNCT,Food Funct.,MAR,2019,10,3,,,,,1513,1528,,10.1039/c9fo00132h,http://dx.doi.org/10.1039/c9fo00132h,,,16,Biochemistry & Molecular Biology; Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Food Science & Technology,HS4AY,30785176,,,,2024-06-04,WOS:000463805200020,View Full Record in Web of Science
J,"Uchiyama-Tanaka, Y; Shimabukuro, F; Okumura, E; Fujishima, M",,,,"Uchiyama-Tanaka, Yoko; Shimabukuro, Fumi; Okumura, Eri; Fujishima, Masaki",,,The effect of Chlorella supplementation in pregnant women with low-grade inflammation,FOOD SCIENCE & NUTRITION,,,English,Article,,,,,,Chlorella; constipation; low-grade inflammation; pregnant women,,"Pregnancy dramatically changes maternal metabolism and the microbiome. Low-grade inflammation can cause maternal complications and fetal abnormalities. The objective of this open-label, randomized, controlled study was to evaluate the efficacy and safety of orally administered Chlorella, a green alga that is commercially available as a dietary supplement with rich nutrients and dietary fiber for pregnant women with low-grade inflammation. Patients with C-reactive protein levels >0.05 mg/dL (16 weeks gestation, n = 22) were enrolled and randomly allocated to the Chlorella group (n = 10) or control group (n = 12). We conducted blood biochemical tests at 25, 30, and 35 weeks gestation and evaluated the evacuation status (symptoms depending on the Rome IV C2 criteria and laxative usage), side effects, and complications throughout the investigation. We also monitored the status of the offspring. The Chlorella group (n = 0) showed a significantly lower rate of constipation than the control group (n = 8). This study demonstrated the beneficial effects and safety of Chlorella supplementation in pregnant women, which prevented constipation and unnecessary laxative administration.","[Uchiyama-Tanaka, Yoko] Yoko Clin, Kitakyushu, Fukuoka, Japan; [Shimabukuro, Fumi] Yui Clin, Noborikawa, Okinawa, Japan; [Okumura, Eri; Fujishima, Masaki] Sun Chlorella Corp, Kyoko, Japan; [Uchiyama-Tanaka, Yoko] Yoko Clin, 3-3-13 Takami,Yahatahigashi Ku, Kitakyushu 8050016, Japan",,"Uchiyama-Tanaka, Y (corresponding author), Yoko Clin, 3-3-13 Takami,Yahatahigashi Ku, Kitakyushu 8050016, Japan.",yoko-uchiyama-tanaka@yoko-clinic.net,"Masaki, Fujishima/AAT-6049-2021","Masaki, Fujishima/0000-0002-0396-6199","The Sun Chlorella A tablets used in this study were provided without charge by Sun Chlorella Corp. (Kyoto, Japan).","The Sun Chlorella A tablets used in this study were provided without charge by Sun Chlorella Corp. (Kyoto, Japan).","The Sun Chlorella A tablets used in this study were provided without charge by Sun Chlorella Corp. (Kyoto, Japan).",,24,0,0,8,9,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",2048-7177,,,FOOD SCI NUTR,Food Sci. Nutr.,JAN,2024,12,1,,,,,292,297,,10.1002/fsn3.3759,http://dx.doi.org/10.1002/fsn3.3759,,OCT 2023,6,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,GQ2S2,38268875,gold,,,2024-06-04,WOS:001084865500001,View Full Record in Web of Science
J,"CHAPMAN, ND; GRILLAGE, MG; MAZUMDER, R; ATKINSON, SN",,,,"CHAPMAN, ND; GRILLAGE, MG; MAZUMDER, R; ATKINSON, SN",,,"A COMPARISON OF MEBEVERINE WITH HIGH-FIBER DIETARY ADVICE AND MEBEVERINE PLUS ISPAGHULA IN THE TREATMENT OF IRRITABLE-BOWEL-SYNDROME - AN OPEN, PROSPECTIVELY RANDOMIZED, PARALLEL GROUP-STUDY",BRITISH JOURNAL OF CLINICAL PRACTICE,,,English,Article,,,,,,,DOUBLE-BLIND; INTRALUMINAL PRESSURE; COLON SYNDROME; FIBER; CONSTIPATION; TRANSIT; DISEASE; TRIAL; BRAN,"Objective To compare the efficacy and acceptability of mebeverine and high-fibre dietary advice versus mebeverine and ispaghula in fixed combination in the treatment of irritable bowel syndrome in adults. Design Open, prospectively randomised, parallel group comparison of mebeverine/dietary advice and mebeverine/ispaghula during an eight-week study period. Setting General practices in the UK. Patients One hundred and eleven patients with irritable bowel syndrome diagnosed by symptom profile or negative investigations between the ages of 18 and 75 years were entered. All patients had a history of abdominal pain occurring at least once a week for a period of three months or more. Intervention Dosage was 135 mg of mebeverine hydrochloride, three times daily before meals, together with advice on high-fibre dietary intake, or 135 mg of mebeverine hydrochloride plus 3.5 g of ispaghla husk twice or three times daily before meals. Measurements and results Details of abdominal pain severity and frequency, bowel frequency and stool consistency were recorded by means of clinicians' assessments and patient diaries. Pre-treatment assessments revealed no significant differences between the two groups with respect to any of the parameters. Both treatment groups demonstrated highly significant improvements in the numbers of pain attacks and their severity; no statistically significant differences between the two groups were demonstrated. Five patients in the mebeverine/dietary advice group reported five concurrent effects and nine patients in the mebeverine/ispaghula group reported 13 concurrent effects. All of the mebeverine/dietary advice group found their treatment acceptable but up to 28% of the mebeverine/ispaghula group found their treatment unpalatable. Conclusion Both treatments are effective in the treatment of irritable bowel syndrome in adults. The fixed combination of mebeverine/ispaghula, however, was found to be unpalatable by up to 28% of the patients in that group. There does not, therefore, appear to be any advantage in using fixed combination therapy in this condition.","DUPHAR RES LABS LTD,DEPT MED,GATERS HILL,W END,SOUTHAMPTON SO3 3JD,ENGLAND; NORTHBROOK RD HLTH CTR,SHIRLEY,ENGLAND; MOORFIELD RD HLTH CTR,ENFIELD,ENGLAND",,,,,,,,,,31,14,14,0,1,MEDICOM INTERNATIONAL,KINGSTON-UPON-THAMES,"QUADRANT, 118 LONDON RD, KINGSTON-UPON-THAMES, ENGLAND KT2 6QJ",0007-0947,,,BRIT J CLIN PRACT,Br. J. Clin. Pract.,NOV,1990,44,11,,,,,461,466,,,,,,6,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,FM699,2177997,,,,2024-06-04,WOS:A1990FM69900009,View Full Record in Web of Science
J,"Smithgall, S",,,,"Smithgall, Sean",,,Medications for the Gut,PHYSICIAN ASSISTANT CLINICS,,,English,Article,,,,,,Gastroesophageal reflux disease; Constipation; Diarrhea; Proton-pump inhibitors; Antacids; Probiotics,PROTON PUMP INHIBITORS; MANAGEMENT; PROBIOTICS; ADULTS; CONSTIPATION; METAANALYSIS; PREVENTION; GUIDELINE,"Medications for the gut have different mechanisms of action and efficacy for each GI indication. GERD treatment should be individualized to the patient with PPI reserved for patients with esophagitis, or severe symptoms. Constipation is best prevented with dietary fiber; however, there are more potent agents for immediate evacuation. Diar-rhea has not been shown to be prevented with probiotics and opioid-like drugs are the most effective treatment despite their abuse potential. PUD regimens can be complex and require careful consideration of local resistance rates. Probiotics in general may or may not have benefits in certain conditions; however, they are overall safe, and pa-tients should be fine taking them.","[Smithgall, Sean] Auburn Univ, Harrison Coll Pharm, 650 Clin Dr,Suite 2100, Mobile, AL 36688 USA",Auburn University System; Auburn University,"Smithgall, S (corresponding author), Auburn Univ, Harrison Coll Pharm, 650 Clin Dr,Suite 2100, Mobile, AL 36688 USA.",Ses0131@auburn.edu,,,,,,,41,0,0,0,0,ELSEVIER INC,SAN DIEGO,"525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA",2405-7991,,,PHYS ASSIST CLIN,Phys. Assist. Clin.,APR,2023,8,2,,,,,339,351,,10.1016/j.cpha.2022.10.011,http://dx.doi.org/10.1016/j.cpha.2022.10.011,,FEB 2023,13,"Medicine, General & Internal",Emerging Sources Citation Index (ESCI),General & Internal Medicine,9V0RS,,,,,2024-06-04,WOS:000948109300001,View Full Record in Web of Science
J,"Freeman, KA; Riley, A; Duke, DC; Fu, RW",,,,"Freeman, Kurt A.; Riley, Andrew; Duke, Danny C.; Fu, Rongwei",,,Systematic Review and Meta-Analysis of Behavioral Interventions for Fecal Incontinence With Constipation,JOURNAL OF PEDIATRIC PSYCHOLOGY,,,English,Review,,,,,,encopresis; evidence-based practice; fecal incontinence; meta-analysis; systematic review,ABNORMAL DEFECATION DYNAMICS; RANDOMIZED CONTROLLED-TRIALS; CHILDHOOD CONSTIPATION; ENCOPRETIC CHILDREN; RETENTIVE ENCOPRESIS; PEDIATRIC PSYCHOLOGY; DIETARY FIBER; BIOFEEDBACK; PREVALENCE; MANAGEMENT,"Background Multiple treatments exist for fecal incontinence. However, the relative and additive influence of commonly used behavioral approaches remains unclear. Objective We conducted a systematic review of randomized controlled trials to synthesize the effects of behavioral treatment of fecal incontinence with constipation in children aged 4-18 years. Mixed treatment comparisons (MTCs) and random effects models were used to analyze outcomes. Risk of bias and quality of evidence were rated. Results Although 10 studies were identified for MTCs, results did not yield reliable or valid estimates. Four studies were retained for random effects pooled outcome analysis. Results indicated that behavioral intervention was more effective than control conditions for author-defined success and soiling frequency. Conclusion Although evidence supports behavioral treatments for fecal incontinence with constipation in children, available evidence is limited. More and higher-quality trials are needed to better understand the relative effects of different treatments, including behavioral strategies.","[Freeman, Kurt A.; Riley, Andrew; Duke, Danny C.] Oregon Hlth & Sci Univ, Div Psychol, Inst Dev & Disabil, Portland, OR 97239 USA; [Fu, Rongwei] Oregon Hlth & Sci Univ, Dept Publ Hlth & Preventat Med, Portland, OR 97239 USA",Oregon Health & Science University; Oregon Health & Science University,"Freeman, KA (corresponding author), Oregon Hlth & Sci Univ, 707 SW Gaines, Portland, OR 97239 USA.",freemaku@ohsu.edu,"Riley, Andrew R/AAP-2843-2021","Riley, Andrew R/0000-0001-7484-4263; Duke, Danny/0000-0002-1726-1149",,,,,64,25,26,0,15,OXFORD UNIV PRESS INC,CARY,"JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA",0146-8693,1465-735X,,J PEDIATR PSYCHOL,J. Pediatr. Psychol.,SEP,2014,39,8,,,SI,,887,902,,10.1093/jpepsy/jsu039,http://dx.doi.org/10.1093/jpepsy/jsu039,,,16,"Psychology, Developmental",Social Science Citation Index (SSCI),Psychology,AR2FD,24925894,Bronze,,,2024-06-04,WOS:000343398100008,View Full Record in Web of Science
J,"Lu, D; Pi, Y; Ye, H; Han, D; Kemp, B; Soede, N; Wang, J",,,,"Lu, D.; Pi, Y.; Ye, H.; Han, D.; Kemp, B.; Soede, N.; Wang, J.",,,"EFFECTS OF DIETARY FIBERS WITH DIFFERENT PHYSICOCHEMICAL PROPERTIES ON CONSTIPATION, PARTURITION DURATION, AND THE NUMBER OF STILLBORN PIGLETS IN SOWS",MOLECULAR REPRODUCTION AND DEVELOPMENT,,,English,Meeting Abstract,11th International Conference on Pig Reproduction (ICPR),"JUN 05-07, 2023","Ghent, BELGIUM",,,,,,"[Lu, D.; Pi, Y.; Han, D.; Wang, J.] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing, Peoples R China; [Lu, D.; Ye, H.; Kemp, B.; Soede, N.] Wageningen Univ, Dept Anim Sci, Adaptat Physiol Grp, Wageningen, Netherlands",China Agricultural University; Wageningen University & Research,,,,,,,,,0,0,0,0,0,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1040-452X,1098-2795,,MOL REPROD DEV,Mol. Reprod. Dev.,JUL,2023,90,7,,,SI,10,712,713,,,,,,2,Biochemistry & Molecular Biology; Cell Biology; Developmental Biology; Reproductive Biology,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Biochemistry & Molecular Biology; Cell Biology; Developmental Biology; Reproductive Biology,R3KW3,,,,,2024-06-04,WOS:001063384300029,View Full Record in Web of Science
J,"Nishihira, J; Hara, H; Tanaka, A; Kagami-Katsuyama, H",,,,"Nishihira, Jun; Hara, Hideo; Tanaka, Aiko; Kagami-Katsuyama, Hiroyo",,,"Amelioration of bowel movement by daily ingestion of Kumaizasa (Sasa. senanensis) powder: A placebo-controlled, randomized, double-blind, parallel-group comparison study",FUNCTIONAL FOODS IN HEALTH AND DISEASE,,,English,Article,,,,,,clinical trial; Kumaizasa; constipation,DIETARY FIBER; TRANSIT-TIME; CONSTIPATION; CELLULOSE,"Background: Kumaizasa (Sasa. senanensis (Franchet et Savatier) Rehder) is a bush-type bamboo grown in Hokkaido, Japan and has traditionally been used as a material for herbal medicine and health food. The purpose of this study was to investigate the effect of daily ingestion of Kumaizasa powder (4.2g/day) for 2 weeks for improvement of constipation. Methods: We conducted a placebo-controlled, randomized, double-blind, parallel-group comparison study on 80 healthy Japanese men and women between the ages of 20 and 65 who complained of chronic constipation. Results: The stool frequency per week as the primary outcome showed a significant increase after 2-week ingestion of the active food (Kumaizasa powder) compared with the placebo (starch). The stool odor was also significantly improved after 2-week ingestion of Kumaizasa powder compared with the placebo. Abdominal condition was also significantly improved by visual analogue scale (VAS) evaluation. Conclusions: We concluded that daily ingestion of Kumaizasa powder is useful for improvement of constipation.","[Nishihira, Jun; Tanaka, Aiko; Kagami-Katsuyama, Hiroyo] Hokkaido Informat Univ, Hlth Informat Sci Res Ctr, Nishi Nopporo 59-2, Ebetsu, Hokkaido 0698585, Japan; [Hara, Hideo] UNIAL Co Ltd, Hokkaido Bioresources Innovat Ctr, Itabashi Ku, Tokyo, Japan",,"Nishihira, J (corresponding author), Hokkaido Informat Univ, Hlth Informat Sci Res Ctr, Nishi Nopporo 59-2, Ebetsu, Hokkaido 0698585, Japan.",,,,Northern Advancement Center for Science & Technology of Hokkaido Japan,Northern Advancement Center for Science & Technology of Hokkaido Japan,"This study was conducted with research funds under contract with UNIAL Co., LTD. and supported in part by Grants-in-Aid for Regional R&D Proposal-Based Program from Northern Advancement Center for Science & Technology of Hokkaido Japan.",,10,1,1,2,6,FUNCTIONAL FOOD CENTER INC,RICHARDSON,"1212 HAMPSHIRE LN, STE 213, RICHARDSON, TX 75080 USA",2160-3855,,,FUNCT FOODS HEALTH D,Funct. Foods Health Dis.,MAY,2019,9,5,,,,,341,356,,10.31989/ffhd.v9i5.603,http://dx.doi.org/10.31989/ffhd.v9i5.603,,,16,Food Science & Technology,Emerging Sources Citation Index (ESCI),Food Science & Technology,IA8DQ,,gold,,,2024-06-04,WOS:000469788500004,View Full Record in Web of Science
J,"Li, PH; Chan, YJ; Hou, YW; Lu, WC; Chen, WH; Tseng, JY; Mulio, AT",,,,"Li, Po-Hsien; Chan, Yung-Jia; Hou, Ya-Wen; Lu, Wen-Chien; Chen, Wen-Hui; Tseng, Jie-Yun; Mulio, Amanda Tresiliana",,,Functionality of Djulis (Chenopodium formosanum) By-Products and In Vivo Anti-Diabetes Effect in Type 2 Diabetes Mellitus Patients,BIOLOGY-BASEL,,,English,Article,,,,,,djulis (Chenopodium formosanum Koidz; ); diabetes mellitus; dietary fibre; physicochemical properties; postprandial glucose,,"Simple Summary According to a report from International Diabetes Federation, in 2020 approximately 463 million adults (20-79 years) were living with diabetes, the principles of medical nutrition therapy are to decrease the risk of diabetes by encouraging healthy food choices and physical activity. Djulis is a unique traditional pseudo-cereal crop native to Taiwan. The hull of djulis, which is usually considered to be agricultural waste, is disposed of in landfills and causes some environmental problems. In recent years, many studies have investigated the functional properties of djulis hull. The focus has been on the byproducts of djulis, a waste utilization approach, to further develop enriched functional foods. Djulis hull contained dietary fibre 75.21 +/- 0.17% dry weight, and insoluble dietary fibre (IDF) reached 71.54 +/- 0.27% dry weight. The IDF postponed the adsorption of glucose and reduced the activity of alpha-amylase. We found that it is a good source of valuable ingredients that contain a high amount of dietary fibre. Furthermore, for patients with T2DM, consuming djulis hull 30 and 60 min before a meal significantly reduced blood glucose content as compared with patients at the same postprandial times who did not consume it. Djulis (Chenopodium formosanum Koidz.) is a species of cereal grain native to Taiwan. It is rich in dietary fibre and antioxidants and therefore reputed to relieve constipation, suppress inflammation, and lower blood glucose. The aim of this study was to investigate the composition and physicochemical properties of dietary fibre from djulis hull. Meanwhile, determination of the in vivo antidiabetic effect on patients with type 2 diabetes mellitus (T2DM) after consuming the djulis hull powder. Djulis hull contained dietary fibre 75.21 +/- 0.17% dry weight, and insoluble dietary fibre (IDF) reached 71.54 +/- 0.27% dry weight. The IDF postponed the adsorption of glucose and reduced the activity of alpha-amylase. Postprandial blood glucose levels in patients with T2DM showed three different tendencies. First, the area under the glucose curve was significantly lower after ingesting 10 or 5 g djulis hull powder, which then postponed the adsorption of glucose, but the area under the glucose curve was similar with the two doses. After consuming 10 g djulis hull before 75 g glucose 30 and 60 min after the meal, patients with T2DM had blood glucose values that were significantly lower at the same postprandial times than those of patients who did not consume djulis hull. In short, patients who consumed djulis hull prior to glucose administration had decreased blood glucose level compared with those who did not. Djulis hull may have benefits for patients with T2DM.","[Li, Po-Hsien; Chen, Wen-Hui; Tseng, Jie-Yun; Mulio, Amanda Tresiliana] Da Yeh Univ, Dept Med Bot & Hlth Applicat, 168 Univ Rd, Dacun 51591, Changhua, Taiwan; [Chan, Yung-Jia] Da Yeh Univ, Coll Biotechnol & Bioresources, 168 Univ Rd, Dacun 51591, Changhua, Taiwan; [Hou, Ya-Wen] Council Agr, Fisheries Res Inst, 199 Hou lh Rd, Keelung 202008, Taiwan; [Lu, Wen-Chien] Chung Jen Jr Coll Nursing Hlth Sci & Management, Dept Food & Beverage Management, 217 Hung Mao Pi, Chiayi 60077, Taiwan; [Chen, Wen-Hui] Changhua Lukang Christian Hosp, Div Nutr, 480 Zhongzheng Rd, Changhua 50544, Taiwan",Da Yeh University; Da Yeh University; Taiwan Fish Research Institute,"Li, PH (corresponding author), Da Yeh Univ, Dept Med Bot & Hlth Applicat, 168 Univ Rd, Dacun 51591, Changhua, Taiwan.;Lu, WC (corresponding author), Chung Jen Jr Coll Nursing Hlth Sci & Management, Dept Food & Beverage Management, 217 Hung Mao Pi, Chiayi 60077, Taiwan.",pohsien@mail.dyu.edu.tw; d0867601@cloud.dyu.edu.tw; ywhou@mail.tfrin.gov.tw; m104046@cjc.edu.tw; 704874@cch.org.tw; f338879@ncku.edu.tw; f0665601@cloud.dyu.edu.tw,"Li, Po-Hsien/AAR-4618-2020; chen, wenhui/HGB-6912-2022",/0000-0001-9686-8434,Ministry of Science and Technology [104-2221-E-212-007]; Changhua Lukang Christian Hospital Taiwan [102-GCH-IRP-101],Ministry of Science and Technology(Spanish Government); Changhua Lukang Christian Hospital Taiwan,This study was supported by grants provided by the Ministry of Science and Technology (grants no. 104-2221-E-212-007) in Taiwan. This study was also supported by a grant from Changhua Lukang Christian Hospital Taiwan (grant no. 102-GCH-IRP-101).,,38,10,10,4,28,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2079-7737,,BIOLOGY-BASEL,Biology-Basel,FEB,2021,10,2,,,,,,,160,10.3390/biology10020160,http://dx.doi.org/10.3390/biology10020160,,,14,Biology,Science Citation Index Expanded (SCI-EXPANDED),Life Sciences & Biomedicine - Other Topics,QM9VW,33671283,"Green Published, gold",,,2024-06-04,WOS:000622121900001,View Full Record in Web of Science
J,"Markland, AD; Goode, PS; Palsson, OS; Goode, PS; Burgin, KL; Busby-Whitehead, J; Whitehead, WE",,,,"Markland, Alayne D.; Goode, Patricia S.; Palsson, Olafur S.; Goode, Patricia S.; Burgin, Kathy L.; Busby-Whitehead, Jan; Whitehead, William E.",,,Association of Low Dietary Intake of Fiber and Liquids With Constipation: Evidence From the National Health and Examination Survey (NHANES),GASTROENTEROLOGY,,,English,Meeting Abstract,Conference on Digestive Disease Week 2011,"MAY 07-10, 2011","Chicago, IL",,,,,,,,,,,,,,,,0,0,0,0,3,W B SAUNDERS CO-ELSEVIER INC,PHILADELPHIA,"1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA",0016-5085,,,GASTROENTEROLOGY,Gastroenterology,MAY,2011,140,5,,1,,,S152,S152,,,,,,1,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Gastroenterology & Hepatology,758LW,,,,,2024-06-04,WOS:000290167300617,View Full Record in Web of Science
J,"Chmielewska, A; Horvath, A; Dziechciarz, P; Szajewska, H",,,,"Chmielewska, Anna; Horvath, Andrea; Dziechciarz, Piotr; Szajewska, Hania",,,"Glucomannan is not effective for the treatment of functional constipation in children: A double-blind, placebo-controlled, randomized trial",CLINICAL NUTRITION,,,English,Article,,,,,,Pediatrics; Treatment; RCT,CHILDHOOD CONSTIPATION; FIBER GLUCOMANNAN; DIETARY FIBER; LACTULOSE; EPIDEMIOLOGY; MULTICENTER; INFANTS,"Background & aims: Treatment measures for constipation in children are often not satisfactory. The aim was to assess the efficacy of glucomannan (GNN) as a sole treatment for functional constipation. Methods: Children aged 3-16 years with functional constipation according to Rome III criteria were randomly assigned to receive GNN (2.52 g/d) or placebo for 4 weeks. Results: Of the 80 children, 72 (90%) completed the study. The primary outcome, treatment success (>= 3 stools per week with no soiling), was similar in the GNN (n = 36) and placebo (n = 36) groups (relative risk 0.95, 95% CI 0.6 to 1.4). In the GNN group, the stool consistency score was higher at week 1 (P < 0.0001), lower at week 3 (P = 0.008), and similar at weeks 2 and 4. Stool frequency was higher only at week 3 (P = 0.007). Abdominal pain episodes were more frequent in the GNN group at week 1 (P = 0.04) and week 4 (P < 0.0001) but were similar between groups at weeks 2 and 3. No difference was observed in the frequency of any other secondary outcome or adverse event. Conclusions: In our setting, GNN, as dosed in this study, was not more effective than placebo in achieving therapeutic success in constipated children. The trial was registered at ClinicalTrials.gov (http://clinicaltrials.gov), number NCT01151878. (C) 2011 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","[Chmielewska, Anna; Horvath, Andrea; Dziechciarz, Piotr; Szajewska, Hania] Med Univ Warsaw, Dept Paediat, PL-01183 Warsaw, Poland",Medical University of Warsaw,"Chmielewska, A (corresponding author), Med Univ Warsaw, Dept Paediat, Dzialdowska 1, PL-01183 Warsaw, Poland.",aachmielewska@gmail.com; andrea.hania@gmail.com; piotrdz@hotmail.com; hania@ipgate.pl,"Szajewska, Hania/M-4141-2018; Horvath, Andrea/S-5069-2018; Dziechciarz, Piotr/X-3659-2018","Szajewska, Hania/0000-0002-4596-2874; Horvath, Andrea/0000-0001-9940-0001; Dziechciarz, Piotr/0000-0003-4227-3130",Medical University of Warsaw,Medical University of Warsaw,This work was funded by the Medical University of Warsaw.,,26,31,35,0,6,CHURCHILL LIVINGSTONE,EDINBURGH,"JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND",0261-5614,1532-1983,,CLIN NUTR,Clin. Nutr.,AUG,2011,30,4,,,,,462,468,,10.1016/j.clnu.2011.01.012,http://dx.doi.org/10.1016/j.clnu.2011.01.012,,,7,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,809DT,21320737,,,,2024-06-04,WOS:000294032700010,View Full Record in Web of Science
J,"Lembo, T",,,,"Lembo, T",,,Fiber and its effect on colonic function in health and disease,CURRENT OPINION IN GASTROENTEROLOGY,,,English,Article,,,,,,,IRRITABLE-BOWEL-SYNDROME; CHAIN FATTY-ACIDS; CONSTIPATION; DIETARY; CANCER; TRIAL; BRAN; RISK,"Dietary fiber is an extremely complex mixture of substances that include cellulose, hemicellulose, pectic substances, gums, mucilages, ligins, and algal polysaccharides, Recent data support at least some of the purported beneficial effects of dietary fiber on the gastrointestinal tract and health. The following review discusses some of the recent advances in our understanding of the effects of fiber on colonic function in health and disease.","Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA 02215 USA",Harvard University; Beth Israel Deaconess Medical Center,"Beth Israel Deaconess Med Ctr, Div Gastroenterol, Dana 501,30 Brookline Ave, Boston, MA 02215 USA.",,,,,,,,37,5,5,1,4,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0267-1379,1531-7056,,CURR OPIN GASTROEN,Curr. Opin. Gastroenterol.,JAN,1998,14,1,,,,,1,5,,10.1097/00001574-199801000-00001,http://dx.doi.org/10.1097/00001574-199801000-00001,,,5,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,YT673,,,,,2024-06-04,WOS:000071630600001,View Full Record in Web of Science
J,"Fernandez, N; Carriedo, D; Sierra, M; Diez, MJ; Sahagun, A; Calle, A; Gonzalez, A; Garcia, JJ",,,,"Fernandez, N; Carriedo, D; Sierra, M; Diez, MJ; Sahagun, A; Calle, A; Gonzalez, A; Garcia, JJ",,,Hydrosoluble fiber (Plantago ovata husk) and levodopa II:: Experimental study of the pharmacokinetic interaction in the presence of carbidopa,EUROPEAN NEUROPSYCHOPHARMACOLOGY,,,English,Article,,,,,,levodopa; carbidopa; Plantago ovata husk; pharmacokinetics; rabbits; fiber,"ADVANCED PARKINSONS-DISEASE; L-DOPA; DIETARY FIBER; 3,4-DIHYDROXYPHENYLPYRUVIC ACID; ORAL LEVODOPA; RATS; FLUCTUATIONS; BENEFITS; INVITRO; TIME","Levodopa combined with carbidopa constitutes one of the most frequent medication in the treatment of Parkinson's disease. Plantago ovata husk (water-soluble fiber) improves levodopa absorption conditions, but when this drug is administered with carbidopa, fiber could reduce its effectiveness. The purpose of this study is to investigate whether the presence of R ovata husk modifies in rabbits the bioavailability and other pharmacokinetic parameters of levodopa (20 mg/kg) when administered by the oral route with carbidopa (5 mg/ kg). We have also studied whether pharmacokinetic modifications are fiber-dose dependent (100 and 400 mg/kg). When levodopa and carbidopa were administered with 100 mg/kg R ovata husk, the value of AUC for levodopa diminishes 29.7% (sign, n = 6, P < 0.05) and C-max 28.1% (sign, n = 6, P < 0.05) in relation to the values obtained when these drugs were administered without fiber. If the dose of fiber was 400 mg/kg, the decrease was smaller: 20.4% for AUC (no significant difference) and 24.6% for C-max (sign, n = 6, P < 0.05), that may indicate an inhibitory action of AADC by the fiber or any of its partial hydrolysis products. On the other hand, since certain time on, levodopa concentrations are always higher in the groups that receive fiber: 210 min with 100 mg/kg and 150 min with 400 mg/kg. The administration of P ovata husk with levodopa/carbidopa to patients with Parkinson disease could be beneficial and in particular in those patients who also suffer constipation due to an improvement of levodopa kinetic profile with higher final concentrations, a longer plasma half-life and lower C-max. (c) 2005 Elsevier B.V. and ECNP. All rights reserved.","Univ Leon, Area Farmacol, E-24071 Leon, Spain",Universidad de Leon,"Univ Leon, Area Farmacol, E-24071 Leon, Spain.",dftnfm@unileon.es,"Sierra, Matilde/F-8990-2016; Garcia, Juan Jose/F-8979-2016; Sahagun Prieto, Ana M/F-8928-2016; Diez, Maria Jose/F-8956-2016; Fernandez, Nelida/F-9573-2016","Sierra, Matilde/0000-0002-0208-9542; Garcia, Juan Jose/0000-0001-7821-9502; Sahagun Prieto, Ana M/0000-0003-3311-4226; Carriedo Ule, Demetrio/0000-0001-8823-268X; Calle Pardo, Angela Pilar/0000-0002-6261-8266; Diez, Maria Jose/0000-0002-2101-3906; Fernandez, Nelida/0000-0002-1225-4097",,,,,31,19,20,0,8,ELSEVIER SCIENCE BV,AMSTERDAM,"PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",0924-977X,1873-7862,,EUR NEUROPSYCHOPHARM,Eur. Neuropsychopharmacol.,OCT,2005,15,5,,,,,505,509,,10.1016/j.euroneuro.2005.01.006,http://dx.doi.org/10.1016/j.euroneuro.2005.01.006,,,5,Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry,Science Citation Index Expanded (SCI-EXPANDED),Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry,969VQ,16139167,Green Published,,,2024-06-04,WOS:000232263900003,View Full Record in Web of Science
J,"Woolery, M; Bisanz, A; Lyons, HF; Gaido, L; Yenulevich, M; Fulton, S; McMillan, SC",,,,"Woolery, Myra; Bisanz, Annette; Lyons, Hannah F.; Gaido, Lindsay; Yenulevich, Mary; Fulton, Stephanie; McMillan, Susan C.",,,Putting evidence into Practice®:: Evidence-based interventions for the prevention and management of constipation in patients with cancer,CLINICAL JOURNAL OF ONCOLOGY NURSING,,,English,Review,,,,,,,OPIOID-INDUCED CONSTIPATION; CHRONIC NONCANCER PAIN; RELEASE ORAL MORPHINE; TRANSDERMAL FENTANYL; DIETARY FIBER; DOUBLE-BLIND; LACTULOSE; EFFICACY; METHYLNALTREXONE; ANTAGONISTS,"Constipation is a major source of distress for patients with cancer, significantly affecting quality of life. It can be secondary to disease sequelae, side effects of treatment, or preexisting conditions. It often is unrecognized, underassessed, and ineffectively managed. Nurses play a key role in the prevention and management of constipation and need evidence-based interventions. This article summarizes the existing research evidence for constipation interventions and identifies gaps, Many of the strategies have been evaluated in nononcology populations; researchers should evaluate their effectiveness in oncology populations.","[Woolery, Myra] Natl Inst Hlth, Bethesda, MD 20892 USA; [Woolery, Myra] Univ Maryland, Sch Nursing, Baltimore, MD 21201 USA; [Bisanz, Annette] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Lyons, Hannah F.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Gaido, Lindsay; Fulton, Stephanie] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Yenulevich, Mary] Dana Farber Canc Inst, Boston, MA 02115 USA; [McMillan, Susan C.] Univ S Florida, Coll Nursing, Tampa, FL USA",National Institutes of Health (NIH) - USA; University System of Maryland; University of Maryland Baltimore; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Massachusetts General Hospital; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute; State University System of Florida; University of South Florida,"Woolery, M (corresponding author), Natl Inst Hlth, Bethesda, MD 20892 USA.",mwoolery@cc.nih.gov,,"Fulton, Stephanie/0000-0001-7543-3546",,,,,82,36,44,1,10,ONCOLOGY NURSING SOC,PITTSBURGH,"125 ENTERPRISE DR, PITTSBURGH, PA 15275 USA",1092-1095,1538-067X,,CLIN J ONCOL NURS,Clin. J. Oncol. Nurs.,APR,2008,12,2,,,,,317,337,,10.1188/08.CJON.317-337,http://dx.doi.org/10.1188/08.CJON.317-337,,,21,Oncology; Nursing,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Oncology; Nursing,299DN,18390467,Bronze,,,2024-06-04,WOS:000255736100018,View Full Record in Web of Science
J,"Araki, Y; Andoh, A; Fujiyama, Y; Kanauchi, O; Takenaka, K; Higuchi, A; Bamba, T",,,,"Araki, Y; Andoh, A; Fujiyama, Y; Kanauchi, O; Takenaka, K; Higuchi, A; Bamba, T",,,Germinated barley foodstuff exhibits different adsorption properties for hydrophilic versus hydrophobic bile acids,DIGESTION,,,English,Article,,,,,,germinated barley foodstuff; dietary fiber; bile salts; adsorption,INCREASES FECAL VOLUME; SODIUM-INDUCED COLITIS; BUTYRATE PRODUCTION; ULCERATIVE-COLITIS; DIETARY FIBER; RATS; CONSTIPATION; HUMANS,"Background/Aims: Germinated barley foodstuff (GBF), a type of dietary fiber, exhibits therapeutic effects in ulcerative colitis (UC) patients. However, the precise mechanisms responsible for these effects are still under investigation. On the other hand, it has been suggested that bile salts in the gut lumen play an important role in the integrity of the intestinal mucosa. The aim of the present study was to investigate the ability of GBF to adsorb bile salts in vitro. Methods: The binding capacities of GBF, enzymatically digested GBF (GBF-fiber), and alpha-cellulose for unconjugated and conjugated bile salts were measured using Langmuir's method. The morphology of these fibers was observed by light and fluorescence microscopy. Results: GBF adsorbed bile salts very strongly, especially hydrophobic bile salts. Even after enzymatic digestion, the GBF fiber still exhibited strong binding capacity, whereas a-cellulose exhibited very low binding capacity. Microscopically, GBF consists mainly of aleurone, a lattice-like cell wall with cytoplasm enclosed. After enzymatic digestion, the cytoplasm was also digested. Conclusion: GBF possesses a great capacity to adsorb bile salts. This may be part of the mechanism for the therapeutic effects of GBF in UC patients.","Nagahama Red Cross Hosp, Dept Internal Med, Nagahama, Japan; Shiga Univ Med Sci, Dept Internal Med, Shiga, Japan; Kirin Brewery Co Ltd, Appl Biores Ctr, Corp Res & Dev Div, Gunma, Japan",Shiga University of Medical Science; Kirin Brewery Company Limited,"Araki, Y (corresponding author), 6-13-20 Aoyama, Shiga 5202101, Japan.",,"Andoh, Akira/AAB-9303-2022",,,,,,32,19,19,1,8,KARGER,BASEL,"ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND",0012-2823,,,DIGESTION,Digestion,,2001,64,4,,,,,248,254,,10.1159/000048869,http://dx.doi.org/10.1159/000048869,,,7,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,523WC,11842282,,,,2024-06-04,WOS:000173979700007,View Full Record in Web of Science
J,"Caballero, N; Benslaiman, B; Ansell, J; Serra, J",,,,"Caballero, Noemi; Benslaiman, Bouchra; Ansell, Juliet; Serra, Jordi",,,The effect of green kiwifruit on gas transit and tolerance in healthy humans,NEUROGASTROENTEROLOGY AND MOTILITY,,,English,Article,,,,,,bloating; constipation; intestinal gas; kiwifruit,IRRITABLE-BOWEL-SYNDROME; INTESTINAL GAS; DIETARY FIBER; CONSTIPATION; DISTENSION; MANAGEMENT; HYPERSENSITIVITY; RETENTION; COLON,"Background Green kiwifruit is a fiber-rich fruit that has been shown effective for treatment of constipation. However, fermentation of fibers by colonic bacteria may worsen commonly associated gas-related abdominal symptoms. Aim: To determine the effect of green kiwifruit on transit and tolerance to intestinal gas in humans. Methods In 11 healthy individuals, two gas challenge tests were performed (a) after 2 weeks on a low-flatulogenic diet and daily intake of 2 green kiwifruits and (b) after 2 weeks on a similar diet without intake of kiwifruits. The gas challenge test consisted in continuous infusion of a mixture of gases into the jejunum at 12 mL/min for 2 hours while measuring rectal gas evacuation, abdominal symptoms, and abdominal distension. During the 2 weeks prior to each gas challenge test (on-kiwifruit and off-kiwifruit), the number and consistency of stools, and abdominal symptoms were registered. Key Results Intake of kiwifruits was associated with more bowel movements per day (1.8 +/- 0.1 vs 1.5 +/- 0.1 off-kiwifruit; P = .001) and somewhat looser stools (Bristol score 3.3 +/- 0.2 vs 2.8 +/- 0.1 off-kiwifruit; P = .072) without relevant abdominal symptoms. Gas infusion produced similar gas evacuation (1238 +/- 254 mL and 1172 +/- 290 mL; P = .4355), perception of symptoms (score 1.2 +/- 0.2 and 1.3 +/- 0.3; P = .2367), and abdominal distension (17 +/- 7 mm and 17 +/- 6 mm; P = .4704) while on-kiwifruit or off-kiwifruit. Conclusions and Inferences In healthy subjects, green kiwifruit increases stool frequency without relevant effects on intestinal gas transit and tolerance. If confirmed in patients, these fruits may provide a natural and well-tolerated treatment alternative for constipation.","[Caballero, Noemi; Benslaiman, Bouchra; Serra, Jordi] Univ Hosp Germans Trias & Pujol, Motil & Funct Gut Disorders Unit, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Badalona, Spain; [Caballero, Noemi; Benslaiman, Bouchra; Serra, Jordi] Autonomous Univ Barcelona, Dept Med, Badalona, Spain; [Ansell, Juliet] Zespri Int Ltd, Mt Maunganui, New Zealand",CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Autonomous University of Barcelona,"Serra, J (corresponding author), Univ Hosp Germans Trias & Pujol, Gastroenterol Dept, Badalona 08916, Spain.",jserrap.germanstrias@gencat.cat,"Serra, Jordi/AAD-8330-2022; Serra, Jordi/ABH-6319-2020","Serra, Jordi/0000-0003-2120-6270",Zespri International Limited; Paraguayan Government,Zespri International Limited; Paraguayan Government,Zespri International Limited; Paraguayan Government,,39,6,6,0,2,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1350-1925,1365-2982,,NEUROGASTROENT MOTIL,Neurogastroenterol. Motil.,SEP,2020,32,9,,,,,,,e13874,10.1111/nmo.13874,http://dx.doi.org/10.1111/nmo.13874,,MAY 2020,8,Gastroenterology & Hepatology; Clinical Neurology; Neurosciences,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Neurosciences & Neurology,NL3LH,32431019,"Green Published, hybrid",,,2024-06-04,WOS:000533988300001,View Full Record in Web of Science
J,"Solzi, GF; Di Lorenzo, C",,,,"Solzi, GF; Di Lorenzo, C",,,Are constipated children different from constipated adults?,DIGESTIVE DISEASES,,,English,Review,,,,,,constipation; children; adults; functional fecal retention,CHRONIC IDIOPATHIC CONSTIPATION; SLOW-TRANSIT CONSTIPATION; TERM FOLLOW-UP; FUNCTIONAL CONSTIPATION; INTRACTABLE CONSTIPATION; BIOFEEDBACK; MOTILITY; DIETARY; FIBER; MANAGEMENT,"Constipation represents a diagnostic category of high prevalence both in children and adults, but with low disability and hospitalization rates. This review is written to be a relatively practical guide to physicians providing information for the evaluation and management of one of the most common chronic digestive disorders. In this article we emphasize the differences between constipation in children and adults. The approach to childhood constipation needs to focus on the behavioral nature of this disorder. Diagnostic techniques often used in constipated adults may not provide useful data when applied to children. Treatment of childhood constipation requires a team effort involving the physician, parents and child. Copyright (C) 2000 S. Karger AG. Basel.","Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Pediat Gastroenterol, Pittsburgh, PA 15213 USA",Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh,"Di Lorenzo, C (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Pediat Gastroenterol, 3705 5th Ave, Pittsburgh, PA 15213 USA.",,,,,,,,55,13,14,0,1,KARGER,BASEL,"ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND",0257-2753,,,DIGEST DIS,Dig. Dis.,,1999,17,5-6,,,,,308,315,,10.1159/000016956,http://dx.doi.org/10.1159/000016956,,,8,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,324JM,10838488,,,,2024-06-04,WOS:000087618600009,View Full Record in Web of Science
J,"Holma, R; Hongisto, SM; Saxelin, M; Korpela, R",,,,"Holma, Reetta; Hongisto, Sanna-Maria; Saxelin, Maija; Korpela, Riitta",,,Constipation Is Relieved More by Rye Bread Than Wheat Bread or Laxatives without Increased Adverse Gastrointestinal Effects,JOURNAL OF NUTRITION,,,English,Article,,,,,,,IMPROVES BOWEL FUNCTION; WHOLE-GRAIN RYE; LACTOBACILLUS-GG; DIETARY FIBER; INTESTINAL MICROBIOTA; ENZYME-ACTIVITIES; COLONIC TRANSIT; DOUBLE-BLIND; WOMEN; CHILDREN,"Rye bread and lactobacilli modify the colonic environment and have the potential to relieve constipation and could be a safe and convenient alternative to laxatives. The effects of rye bread and cultured buttermilk with Lactobacillus rhamnosus GG (LGG) on bowel function and colon metabolism were investigated and compared with laxatives in 51 constipated adults. They were randomized to receive whole-grain rye bread (minimum 240 g/d), LGG (2 x 10(10) colony-forming units/d), whole-grain rye bread (minimum 240 g/d) + LGG (2 x 10(10) colony-forming units/d), white wheat bread (maximum 192 g/d), or laxatives (as usual for a participant) for 3 wk. Participants recorded their dietary habits, bowel function, and gastrointestinal symptoms. Fecal weight, pH, SCFA and bacterial enzyme activities, total intestinal transit time (TITT), and breath hydrogen were determined. Rye bread, compared with white wheat bread, shortened TITT by 23% (P = 0.040), increased weekly defecations by 1.4 (P = 0.014), softened feces [odds ratio (OR) 3.98; P = 0.037], eased defecation (OR 5.08; P = 0.018), increased fecal acetic acid and butyric acid contents by 24% (P = 0.044) and 63% (P < 0.001), respectively, and reduced fecal beta-glucuronidase activity by 23% (P = 0.014). Compared with laxatives, rye bread reduced TITT by 41% (P = 0.006), fecal beta-glucuronidase activity by 38% (P = 0.033), and fecal pH by 0.31 units (P = 0.006). LGG did not relieve constipation or significantly affect colonic metabolism. Gastrointestinal adverse effects did not significantly differ among the study groups. In conclusion, rye bread relieves mild constipation and improves colonic metabolism compared with white wheat bread and commonly used laxatives without increasing gastrointestinal adverse effects. J. Nutr. 140: 534-541, 2010.","[Holma, Reetta; Korpela, Riitta] Univ Helsinki, Inst Biomed, FIN-00014 Helsinki, Finland; [Holma, Reetta] Navidia Ltd, FIN-00140 Helsinki, Finland; [Hongisto, Sanna-Maria] Fazer Bakeries Ltd, FIN-15101 Lahti, Finland; [Saxelin, Maija; Korpela, Riitta] Valio Res Ctr, FIN-00039 Helsinki, Finland",University of Helsinki; Valio,"Holma, R (corresponding author), Univ Helsinki, Inst Biomed, FIN-00014 Helsinki, Finland.",reetta.holma@helsinki.fi,,"Korpela, Riitta/0000-0003-0337-9186",Finnish National Technology Agency; Valio Ltd; Fazer Bakeries Ltd.,Finnish National Technology Agency; Valio Ltd; Fazer Bakeries Ltd.,"Supported by the Finnish National Technology Agency TEKES program Innovation in Foods, Valio Ltd, and Fazer Bakeries Ltd.",,44,31,32,0,11,AMER SOC NUTRITIONAL SCIENCE,BETHESDA,"9650 ROCKVILLE PIKE, RM L-2407A, BETHESDA, MD 20814 USA",0022-3166,,,J NUTR,J. Nutr.,MAR,2010,140,3,,,,,534,541,,10.3945/jn.109.118570,http://dx.doi.org/10.3945/jn.109.118570,,,8,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,559FJ,20089780,hybrid,,,2024-06-04,WOS:000274807800015,View Full Record in Web of Science
J,"Eady, SL; Wallace, AJ; Butts, CA; Hedderley, D; Drummond, L; Ansell, J; Gearry, RB",,,,"Eady, Sarah L.; Wallace, Alison J.; Butts, Christine A.; Hedderley, Duncan; Drummond, Lynley; Ansell, Juliet; Gearry, Richard B.",,,The effect of 'Zesy002' kiwifruit (Actinidia chinensis var. chinensis) on gut health function: a randomised cross-over clinical trial,JOURNAL OF NUTRITIONAL SCIENCE,,,English,Article,,,,,,Kiwifruit; Metamucil; Constipation; Gastrointestinal comfort; Complete spontaneous bowel movements,IRRITABLE-BOWEL-SYNDROME; CHRONIC CONSTIPATION; PREVALENCE; PSYLLIUM; THERAPY; ADULTS; FRUIT; RISK,"Functional gastrointestinal disorders including constipation affect up to 14 % of the world's population. Treatment is difficult and challenging resulting in a need for alternative safe and effective therapies. The present study investigated whether daily consumption of three gold-fleshed kiwifruit could alleviate constipation and improve gastrointestinal discomfort in mildly constipated individuals with and without pain. A total of thirty-two participants were enrolled in a 16-week randomised, single-blind, crossover study. Participants received either three 'Zesy002' kiwifruit or 14.75 g MetamucilA (R) (5 g dietary fibre/d (a positive control)) for 4 weeks each with a 4-week washout between treatments. A 2-week washout period was included at the beginning and end of the study. Daily bowel habit diaries were kept throughout the study. The primary outcome measure was differences in the number of complete spontaneous bowel movements (CSBM). Secondary outcome measures were bowel movement frequency and stool form as well as digestive symptoms and comfort. The number of CSBM per week was significantly greater during daily consumption of three kiwifruit compared with the baseline (6.3 v. 3.3; P < 0.05) and the MetamucilA (R) treatment (6.3 v. 4.5; P < 0.05). Stool consistency was also improved, with kiwifruit producing softer stools and less straining (P < 0.05). Gastrointestinal discomfort was also improved compared with baseline for abdominal pain, constipation and indigestion (P < 0.05) during the kiwifruit intervention and constipation during the MetamucilA (R) intervention (P < 0.05). This randomised controlled trial demonstrates that daily consumption of three gold-fleshed kiwifruit is associated with a significant increase of two CSBM per week and reduction in gastrointestinal discomfort in mildly constipated adults.","[Eady, Sarah L.; Wallace, Alison J.] New Zealand Inst Plant & Food Res Ltd, Lincoln, New Zealand; [Butts, Christine A.; Hedderley, Duncan] New Zealand Inst Plant & Food Res Ltd, Palmerston North, New Zealand; [Drummond, Lynley] Drummond Food Sci Advisory Ltd, Christchurch, New Zealand; [Ansell, Juliet] Zespri Int Ltd, Mt Maunganui, New Zealand; [Gearry, Richard B.] Univ Otago, Dept Med, Christchurch, New Zealand",New Zealand Institute for Plant & Food Research Ltd; New Zealand Institute for Plant & Food Research Ltd; University of Otago,"Eady, SL (corresponding author), New Zealand Inst Plant & Food Res Ltd, Lincoln, New Zealand.",sarah.eady@plantandfood.co.nz,"Butts, Christine A/I-4875-2015; Gearry, Richard B/H-3959-2019","Butts, Christine A/0000-0002-5565-1455; Gearry, Richard B/0000-0002-2298-5141; Eady, Sarah/0000-0001-8016-0992","'Foods for Health at Different Life Stages' - Ministry of Business, Innovation and Employment, New Zealand [C11X1312]; Zespri International Ltd.; New Zealand Ministry of Business, Innovation & Employment (MBIE) [C11X1312] Funding Source: New Zealand Ministry of Business, Innovation & Employment (MBIE)","'Foods for Health at Different Life Stages' - Ministry of Business, Innovation and Employment, New Zealand; Zespri International Ltd.; New Zealand Ministry of Business, Innovation & Employment (MBIE)(New Zealand Ministry of Business, Innovation and Employment (MBIE))","This work was supported by 'Foods for Health at Different Life Stages' funded by Ministry of Business, Innovation and Employment, New Zealand (contract C11X1312) and Zespri International Ltd.; R. B. G. has received research grants, travel awards and honoraria from Zespri International Ltd. L. D. was involved in the design of the study and interpretation of the results. She has also served on advisory boards and was paid to undertake the present work on behalf of Zespri International Ltd. J. A. is an employee of Zespri International Ltd.",,44,19,19,1,7,CAMBRIDGE UNIV PRESS,NEW YORK,"32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA",2048-6790,,,J NUTR SCI,J. Nutr. Sci.,MAY 3,2019,8,,,,,,,,e18,10.1017/jns.2019.14,http://dx.doi.org/10.1017/jns.2019.14,,,11,Nutrition & Dietetics,Emerging Sources Citation Index (ESCI),Nutrition & Dietetics,HW5SB,31080591,"Green Published, gold",,,2024-06-04,WOS:000466748300001,View Full Record in Web of Science
J,"RYDNING, A; BERSTAD, A",,,,"RYDNING, A; BERSTAD, A",,,FIBER DIET AND ANTACIDS IN THE SHORT-TERM TREATMENT OF DUODENAL-ULCER,SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY,,,English,Article,,,,,,,,"Eighty patients with active duodenal ulcer were randomized to a diet poor or rich in fiber for a treatment period of 4 weeks. In addition, all patients received one antacid tablet (Link, 1.1 g) four times a day (total neutralizing capacity, 120 mmol HCl/day). The ulcer healed in 27 (67.5%) of the 40 patients in the high-fiber group, compared with in 24 (60%) of the 40 patients in the low-fiber group (p < 0.5). Ulcer symptoms did not differ significantly between groups during the 4-week treatment period. No serious side effects were recorded. Constipation, the most frequently registered side effect, was seen in 11 (27.5%) of the patients in the low-fiber group, compared within 4 (10%) in the high-fiber group (chi-square = 4.0; p < 0.05). Patients with unhealed ulcer after 4 weeks'' treatment received ranitidine instead of antacids. While they were receiving ranitidine treatment, no significant differences in healing rates were seen between the two dietary groups.","LOVISENBERG HOSP, DEPT MED, N-0456 OSLO 4, NORWAY",,,,,,,,,,13,14,14,0,0,TAYLOR & FRANCIS LTD,ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND",0036-5521,1502-7708,,SCAND J GASTROENTERO,Scand. J. Gastroenterol.,,1985,20,9,,,,,1078,1082,,10.3109/00365528509088875,http://dx.doi.org/10.3109/00365528509088875,,,5,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,AVW57,3003883,,,,2024-06-04,WOS:A1985AVW5700009,View Full Record in Web of Science
J,"Yamauchi, Y; Masutomi, H; Ishihara, K; Hartanto, T; Lee, CG; Fukuda, S",,,,"Yamauchi, Yohsuke; Masutomi, Hirofumi; Ishihara, Katsuyuki; Hartanto, Tenagy; Lee, Chol Gyu; Fukuda, Shinji",,,"The differential effect of two cereal foods on gut environment: a randomized, controlled, double-blind, parallel-group study",FRONTIERS IN NUTRITION,,,English,Article,,,,,,fruit granola; corn flakes; gut microbiota; defecation; dietary fiber; short-chain fatty acids,DIETARY FIBER; MICROBIOTA; HEALTH; CONSTIPATION; BREAKFAST; BENEFITS; ADULTS,"Background and aims Cereal-based foods such as fruit granola (FG) and corn flakes (CF) form part of a fiber-rich diet. Dietary fiber has a good effect on human health. However, changes in gut microbiota and intestinal immunity have not been investigated. We conducted a randomized, double-blind, placebo-controlled trial to investigate the effects of FG and CF intake on gut microbiota, metabolome, and the immune system.Methods Subjects continuously consume CF or FG for 4 weeks. Stool samples, and questionnaires on defecation were collected before, 2 weeks after, and 4 weeks after intake. Gut microbiota was analyzed using 16S rRNA gene amplicon sequencing. Fecal metabolomes were analyzed using GC/MS and CE-TOF/MS. Fecal IgA was analyzed using ELISA.Results The defecation frequency after cereal based food intake was improved. The different cereal-based foods had different effects on gut microbiome. The increase in intestinal IgA levels was positively correlated with the relative abundance of Dialister and the Lachnospiraceae ND3007 group in CF and FG group, respectively. SCFAs showed a positive correlation with Prevotella 9 in the FG group.Conclusion This study showed that the supplement in dietary fiber contained in CF and FG improves bowel movements. CF and FG each had different effects on gut microbes, metabolites and different relationships between fecal IgA or SCFAs and gut microbiota.","[Yamauchi, Yohsuke; Hartanto, Tenagy; Lee, Chol Gyu; Fukuda, Shinji] Metagen Inc, Tsuruoka, Japan; [Masutomi, Hirofumi; Ishihara, Katsuyuki] Calbee Inc, Res & Dev Div, Utsunomiya, Japan; [Fukuda, Shinji] Keio Univ, Inst Adv Biosci, Tsuruoka, Japan; [Fukuda, Shinji] Kanagawa Inst Ind Sci & Technol, Gut Environm Design Grp, Kawasaki, Kanagawa, Japan; [Fukuda, Shinji] Univ Tsukuba, Transborder Med Res Ctr, Tsukuba, Japan; [Fukuda, Shinji] Juntendo Univ, Lab Regenerat Microbiol, Grad Sch Med, Tokyo, Japan",Keio University; Kanagawa Academy Science & Technology; University of Tsukuba; Juntendo University,"Fukuda, S (corresponding author), Metagen Inc, Tsuruoka, Japan.;Fukuda, S (corresponding author), Keio Univ, Inst Adv Biosci, Tsuruoka, Japan.;Fukuda, S (corresponding author), Kanagawa Inst Ind Sci & Technol, Gut Environm Design Grp, Kawasaki, Kanagawa, Japan.;Fukuda, S (corresponding author), Univ Tsukuba, Transborder Med Res Ctr, Tsukuba, Japan.;Fukuda, S (corresponding author), Juntendo Univ, Lab Regenerat Microbiol, Grad Sch Med, Tokyo, Japan.",sfukuda@metagen.co.jp,,"Fukuda, Shinji/0000-0001-5161-9880","Calbee, Inc.","Calbee, Inc.",The authors would like to express their appreciation to the subjects who participated in the study.,,39,0,0,2,2,FRONTIERS MEDIA SA,LAUSANNE,"AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND",2296-861X,,,FRONT NUTR,Front. Nutr.,FEB 22,2024,10,,,,,,,,1254712,10.3389/fnut.2023.1254712,http://dx.doi.org/10.3389/fnut.2023.1254712,,,11,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,JW4K8,38455871,"Green Published, gold",,,2024-06-04,WOS:001176183900001,View Full Record in Web of Science
J,"Xing, LC; Santhi, D; Shar, AG; Saeed, M; Arain, MA; Shar, AH; Bhutto, ZA; Kakar, MU; Manzoor, R; El-Hack, MEA; Alagawany, M; Dhama, K; Ling, MC",,,,"Xing, Li Chang; Santhi, Dhanasikar; Shar, Abdul Ghaffar; Saeed, Muhammad; Arain, Muhammad Asif; Shar, Akhtar Hussain; Bhutto, Zohaib Ahmed; Kakar, Mohib Ullah; Manzoor, Robina; El-Hack, Mohamed E. Abd; Alagawany, Mahmoud; Dhama, Kuldeep; Ling, Mo Chen",,,"Psyllium Husk (Plantago ovata) as a Potent Hypocholesterolemic Agent in Animal, Human and Poultry",INTERNATIONAL JOURNAL OF PHARMACOLOGY,,,English,Review,,,,,,Psyllium; ispaghula; dietary fiber; hypocholesterolemic; poultry,DIETARY FIBER; SERUM-LIPIDS; SEED HUSK; CHOLESTEROL; HYPERCHOLESTEROLEMIA; THERAPY; POLYSACCHARIDE; ARABINOXYLAN; METAANALYSIS; PLASMA,"Medicinal plants have gained great popularity and their importance is realized world over. Psyllium (Plantago ovata) is a native plant of India. The hydrophilic mucilloid, water-soluble fiber derived from psyllium husk and seed had been used since ancient times as vital curative agent for constipation, mainly as a part of the traditional Indian Ayurvedic medicine. Psyllium is a rich source of fiber and has numerous other therapeutic impacts such as cholesterol lowering, antidiarrhoeal, laxative, antidiabetic, energy increasing, hemorrhoid remedy, soothing inflammation and weight loss agent. Psyllium husk plays a key role in lowering serum cholesterol, so psyllium is being considered as a potential supportive agent in the therapy of hyperlipidemia. The cholesterol level is lowered in different animal models by the binding of psyllium husk with bile acids in the small intestine and thus reducing its absorption. The husk of psyllium could be used as an additive in milk replacer of the neonatal dairy calves to improve the physiological functions and enhance the performance and health status. Psyllium may also has positive impacts in growth and productive performance of different poultry species. The main aim of this review was to discuss the role of psyllium in managing the hypercholesterolemia in humans and the application of psyllium husk as a safe feed additive in poultry farming for the production of organic and low cholesterol designer egg and meat.","[Xing, Li Chang] Qinghai Univ, Med Coll, Dept Human Anat, Xining 810000, Qinghai, Peoples R China; [Santhi, Dhanasikar] Tamil Nadu Vet & Anim Sci Univ, Vet Coll & Res Inst, Dept Livestock Prod Technol Meat Sci, Madras, Tamil Nadu, India; [Shar, Abdul Ghaffar] Northwest A&F Univ, Coll Nat Resources & Environm, Yangling 712100, Peoples R China; [Saeed, Muhammad; Arain, Muhammad Asif] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Peoples R China; [Arain, Muhammad Asif; Bhutto, Zohaib Ahmed] Lasbela Univ Agr Water & Marine Sci, Fac Vet & Anim Sci, Uthal 3800, Balochistan, Pakistan; [Shar, Akhtar Hussain] Northwest A&F Univ, Coll Life Sci, Yangling 712100, Peoples R China; [Kakar, Mohib Ullah; Manzoor, Robina] Lasbela Univ Agr Water & Marine Sci, Fac Marine Sci, Uthal 3800, Balochistan, Pakistan; [El-Hack, Mohamed E. Abd; Alagawany, Mahmoud] Zagazig Univ, Poultry Dept, Fac Agr, Zagazig 44511, Egypt; [Dhama, Kuldeep] Indian Vet Res Inst, ICAR, Div Pathol, Izatnagar 243122, Uttar Pradesh, India; [Ling, Mo Chen] Fourth Peoples Hosp Qinghai Prov, Dept Resp, Xining 810000, Qinghai, Peoples R China",Qinghai University; Tamil Nadu Veterinary & Animal Sciences University; Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China; Egyptian Knowledge Bank (EKB); Zagazig University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute,"Ling, MC (corresponding author), Fourth Peoples Hosp Qinghai Prov, Dept Resp, Xining 810000, Qinghai, Peoples R China.",,"Arain, Muhammad Asif/JFA-4122-2023; Abd El-Hack, Mohamed E./H-9342-2019; Dhama, Kuldeep/B-7852-2015; Alagawany, Mahmoud/P-3051-2014; Saeed, Muhammad/D-1844-2017; SAEED, MUHAMMAD/J-4100-2019","Abd El-Hack, Mohamed E./0000-0002-2831-8534; Dhama, Kuldeep/0000-0001-7469-4752; Saeed, Muhammad/0000-0001-5048-5753; SAEED, MUHAMMAD/0000-0001-5048-5753",,,,,53,11,11,4,46,ASIAN NETWORK SCIENTIFIC INFORMATION-ANSINET,FAISALABAD,"308-LASANI TOWN, SARGODHA RD, FAISALABAD, 38090, PAKISTAN",1811-7775,1812-5700,,INT J PHARMACOL,Int. J. Pharmacol.,,2017,13,7,,,,,690,697,,10.3923/ijp.2017.690.697,http://dx.doi.org/10.3923/ijp.2017.690.697,,,8,Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy,FB9YO,,Bronze,,,2024-06-04,WOS:000406495500003,View Full Record in Web of Science
B,"Or, SLY; Chan, ZCY",,"Chan, ZCY",,"Or, Serin L. Y.; Chan, Zenobia C. Y.",,,HEALTHY BOWEL HABITS OF SCHOOLCHILDREN IN EASTERN DISTRICT,"HEALTH ISSUES IN CHINESE CONTEXTS, VOL 4",Health Issues in Chinese Contexts,,English,Article; Book Chapter,,,,,,,CONSTIPATION,"The habit of preferring animal foods is always developed in school age children. Dietary fibre intake has been shown to be markedly deficient in a number of Hong Kong children. Our three-year Healthy bowel habits program aims to reduce the extension of common functional constipation in school age children to adolescents. The program objective has three main goals a) targeting children's and families' understanding of what constipation is, its risk factors and preventive methods; (b) increasing schoolchildren's consumption of dietary fibre such as fruits and vegetables; and (c) ensuring that schoolchildren have daily regular sporting activity and toilet training. The program has three parts: Part I - Literature review of the bowel health problem regarding bowel habit issues of children in Hong Kong and worldwide; Part 11 - Assessment of the Hong Kong community, planning strategies, presenting program implementation methods and evaluation methods in the community. Part Ill - Discussion and conclusion of the program. This program emphasizes the intake of dietary fibre by school age children to prevent childhood constipation. Hong Kong lacks health education programs for the child population but our proposal is limited by data shortage to explain teenagers' fibre intake condition. Above all, dietary fibre intake should be an important issue in promotion of children's health.","[Or, Serin L. Y.] Kwong Wah Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Chan, Zenobia C. Y.] Hong Kong Polytech Univ, Hong Kong, Hong Kong, Peoples R China",Kwong Wah Hospital; Hong Kong Polytechnic University,"Or, SLY (corresponding author), Kwong Wah Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China.",serinor@hotmail.com,"Chan, Zenobia C. Y./B-2086-2014","Chan, Zenobia C. Y./0000-0003-1060-1259",,,,,33,0,0,0,0,"NOVA SCIENCE PUBLISHERS, INC",HAUPPAUGE,"400 OSER AVE, STE 1600, HAUPPAUGE, NY 11788-3635 USA",,,978-1-60876-178-4,HEALTH ISS CHIN CONT,,,2010,4,,,,,,127,137,,,,,,11,"Public, Environmental & Occupational Health",Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S),"Public, Environmental & Occupational Health",BPE19,,,,,2024-06-04,WOS:000278669300011,View Full Record in Web of Science
J,"ROUSE, M; CHAPMAN, N; MAHAPATRA, M; GRILLAGE, M; ATKINSON, SN; PRESCOTT, P",,,,"ROUSE, M; CHAPMAN, N; MAHAPATRA, M; GRILLAGE, M; ATKINSON, SN; PRESCOTT, P",,,"AN OPEN, RANDOMIZED, PARALLEL GROUP-STUDY OF LACTULOSE VERSUS ISPAGHULA IN THE TREATMENT OF CHRONIC CONSTIPATION IN ADULTS",BRITISH JOURNAL OF CLINICAL PRACTICE,,,English,Article,,,,,,,DIETARY FIBER; HEALTHY,"The efficacy, tolerance and acceptability of lactulose (Duphalac) and ispaghula (Fybogel Orange) were assessed in the treatment of chronic constipation in adults. In an open, prospectively randomised, parallel group study, 124 patients with a history of constipation for more than three weeks were treated with either 15 ml bd of lactulose (increasing to 60 ml daily if necessary) or one sachet bd of ispaghula. Over the four-week treatment period both treatments were shown to be effective, and numbers of concurrent effects were similar between the two groups. Differences were demonstrated with regard to acceptability in favour of lactulose.","DUPHAR RES LABS LTD,DEPT MED,GATERS HILL,W END,SOUTHAMPTON SO3 3JD,ENGLAND; NORTHBROOK HLTH CTR,SOLIHULL,ENGLAND; UNIV SOUTHAMPTON,FAC MATH STUDIES,SOUTHAMPTON SO9 5NH,HANTS,ENGLAND",University of Southampton,,,,,,,,,17,34,34,0,3,MEDICOM INTERNATIONAL,KINGSTON-UPON-THAMES,"QUADRANT, 118 LONDON RD, KINGSTON-UPON-THAMES, ENGLAND KT2 6QJ",0007-0947,,,BRIT J CLIN PRACT,Br. J. Clin. Pract.,SPR,1991,45,1,,,,,28,30,,,,,,3,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,FJ041,1931536,,,,2024-06-04,WOS:A1991FJ04100008,View Full Record in Web of Science
J,"RYDNING, A; WEBERG, R; LANGE, O; BERSTAD, A",,,,"RYDNING, A; WEBERG, R; LANGE, O; BERSTAD, A",,,HEALING OF BENIGN GASTRIC-ULCER WITH LOW-DOSE ANTACIDS AND FIBER DIET,GASTROENTEROLOGY,,,English,Article,,,,,,,,"A randomized, double-blind, placebo-controlled trial was conducted to determine the efficacy of a low-dose aluminum-magnesium antacid regimen (Link one tablet q.i.d.) (total neutralizing capacity 120 mmol HCl/day) in combination with a high- or a low fiber diet in ulcer healing and relief of symptoms in patients with benign gastric ulcer. After 6 wk, the ulcer healed in 28 (67%) of the 42 patients treated with antacids compared with 11 (25%) of the 44 patients treated with placebo (p < 0.001). Antacids were also significantly more effective than placebo in the relief of symptoms. The dietary treatment did not significantly influence ulcer healing or ulcer symptoms. Constipation was more frequently seen with the low- than with the high-fiber diet (p < 0.01). No significant side effects from antacids were recorded.","LOVISENBERG HOSP, DEPT MED, LOVISENBERGGT 17, N-0456 OSLO 4, NORWAY; MOLDE CITY HOSP, DEPT MED, MOLDE, NORWAY",,,,,,,,,,16,49,49,0,0,W B SAUNDERS CO-ELSEVIER INC,PHILADELPHIA,"1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA",0016-5085,1528-0012,,GASTROENTEROLOGY,Gastroenterology,JUL,1986,91,1,,,,,56,61,,10.1016/0016-5085(86)90438-5,http://dx.doi.org/10.1016/0016-5085(86)90438-5,,,6,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,C7688,3011583,,,,2024-06-04,WOS:A1986C768800008,View Full Record in Web of Science
J,"RYTTIG, KR",,,,"RYTTIG, KR",,,MANAGEMENT OF OVERWEIGHT AND OBESITY,EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY,,,English,Article,,,,,,HIGH-FIBER DIET; NONSTARCH POLYSACCHARIDES; OVERWEIGHT; DIETARY FIBER SUPPLEMENTS; WEIGHT REDUCTION,,"A diet naturally rich in fibre is likely to be low in fat and sugar, and also to be less palatable and more chewy and hence, perhaps, more satiating than a typical Western diet. All of this should aid weight control. The experimental evidence that the fibre in food has an effect per se on energy balance is slight and hard to obtain. Studies with supplements of concentrated fibre suggest that fibre, especially soluble fibre, does have satiating and hunger-suppressing properties. Double-blind, placebo-controlled trials confirm that in subjects trying to lose weight, the addition of a fibre supplement can increase weight loss. This may be because of improved compliance with the diet which in turn could be because constipation is prevented. Another mode of action is increased excretion of energy in the stools. Weight-reducing diets should, if possible, be rich in natural food fibre but supplements of concentrated fibre are a reasonable alternative.",,,"RYTTIG, KR (corresponding author), KAROLINSKA HOSP,OBES UNIT,S-10401 STOCKHOLM 60,SWEDEN.",,,,,,,,0,0,0,0,1,RAPID SCIENCE PUBLISHERS,LONDON,"2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8NH",0954-691X,,,EUR J GASTROEN HEPAT,Eur. J. Gastroenterol. Hepatol.,AUG,1993,5,8,,,,,578,582,,10.1097/00042737-199308000-00004,http://dx.doi.org/10.1097/00042737-199308000-00004,,,5,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,LV086,,,,,2024-06-04,WOS:A1993LV08600004,View Full Record in Web of Science
B,"Sen, ASY; Tien-Ho, KS; Gwee, KA",,"Rao, SSC; Lee, YY; Ghoshal, UC",,"Sen, Alex Soh Yu; Tien-Ho, Kewin Siah; Gwee, Kok-Ann",,,Chronic constipation,CLINICAL AND BASIC NEUROGASTROENTEROLOGY AND MOTILITY,,,English,Article; Book Chapter,,,,,,,CHRONIC IDIOPATHIC CONSTIPATION; IRRITABLE-BOWEL-SYNDROME; QUALITY-OF-LIFE; DIETARY FIBER; MANAGEMENT; EFFICACY; QUESTIONNAIRE; PRUCALOPRIDE; LUBIPROSTONE; ASSOCIATION,,"[Sen, Alex Soh Yu; Tien-Ho, Kewin Siah] Natl Univ Singapore Hosp, Dept Med, Div Gastroenterol & Hepatol, Singapore, Singapore; [Sen, Alex Soh Yu; Tien-Ho, Kewin Siah; Gwee, Kok-Ann] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore",National University of Singapore; National University of Singapore,"Sen, ASY (corresponding author), Natl Univ Singapore Hosp, Dept Med, Div Gastroenterol & Hepatol, Singapore, Singapore.;Sen, ASY (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore.",,,,,,,,44,0,0,0,0,ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD,LONDON,"125 LONDON WALL, LONDON EC2Y 5AS, ENGLAND",,,978-0-12-813038-4; 978-0-12-813037-7,,,,2020,,,,,,,435,443,,10.1016/B978-0-12-813037-7.00031-5,http://dx.doi.org/10.1016/B978-0-12-813037-7.00031-5,10.1016/C2015-0-06629-1,,9,Gastroenterology & Hepatology; Neurosciences,Book Citation Index – Science (BKCI-S),Gastroenterology & Hepatology; Neurosciences & Neurology,BR7AP,,,,,2024-06-04,WOS:000664941700033,View Full Record in Web of Science
J,"Todhunter-Brown, A; Booth, L; Campbell, P; Cheer, B; Cowie, J; Elders, A; Hagen, S; Jankulak, K; Mason, H; Millington, C; Ogden, M; Paterson, C; Richardson, D; Smith, D; Sutcliffe, J; Thomson, K; Torrens, C; McClurg, D",,,,"Todhunter-Brown, Alex; Booth, Lorna; Campbell, Pauline; Cheer, Brenda; Cowie, Julie; Elders, Andrew; Hagen, Suzanne; Jankulak, Karen; Mason, Helen; Millington, Clare; Ogden, Margaret; Paterson, Charlotte; Richardson, Davina; Smith, Debs; Sutcliffe, Jonathan; Thomson, Katie; Torrens, Claire; McClurg, Doreen",,,Strategies used for childhood chronic functional constipation: the SUCCESS evidence synthesis,HEALTH TECHNOLOGY ASSESSMENT,,,English,Article,,,,,,,ANTEGRADE CONTINENCE ENEMAS; POLYETHYLENE-GLYCOL 3350; SACRAL NERVE-STIMULATION; QUALITY-OF-LIFE; MACROGOL-3350 PLUS ELECTROLYTES; RANDOMIZED CONTROLLED-TRIAL; PEDIATRIC FECAL IMPACTION; DIETARY FIBER MIXTURE; HYDROLYZED GUAR GUM; DOUBLE-BLIND,"Background: Up to 30% of children have constipation at some stage in their life. Although often shortlived, in one-third of children it progresses to chronic functional constipation, potentially with overflow incontinence. Optimal management strategies remain unclear. Objective: To determine the most effective interventions, and combinations and sequences of interventions, for childhood chronic functional constipation, and understand how they can best be implemented. Methods: Key stakeholders, comprising two parents of children with chronic functional constipation, two adults who experienced childhood chronic functional constipation and four health professional/ continence experts, contributed throughout the research. We conducted pragmatic mixed -method reviews. For all reviews, included studies focused on any interventions/strategies, delivered in any setting, to improve any outcomes in children (0-18 years) with a clinical diagnosis of chronic functional constipation (excluding studies of diagnosis/assessment) included. Dual reviewers applied inclusion criteria and assessed risk of bias. One reviewer extracted data, checked by a second reviewer. Scoping review: We systematically searched electronic databases (including Medical Literature Analysis and Retrieval System Online, Excerpta Medica Database, Cumulative Index to Nursing and Allied Health Literature) (January 2011 to March 2020) and grey literature, including studies (any design) reporting any intervention/strategy. Data were coded, tabulated and mapped. Research quality was not evaluated. Systematic reviews of the evidence of effectiveness: For each different intervention, we included existing systematic reviews judged to be low risk of bias (using the Risk of Bias Assessment Tool for Systematic Reviews), updating any meta -analyses with new randomised controlled trials. Where there was no existing low risk of bias systematic reviews, we included randomised controlled trials and other primary studies. The risk of bias was judged using design -specific tools. Evidence was synthesised narratively, and a process of considered judgement was used to judge certainty in the evidence as high, moderate, low, very low or insufficient evidence. Economic synthesis: Included studies (any design, English -language) detailed intervention -related costs. Studies were categorised as cost -consequence, cost-effectiveness, cost -utility or cost -benefit, and reporting quality evaluated using the consensus health economic criteria checklist. Systematic review of implementation factors: Included studies reported data relating to implementation barriers or facilitators. Using a best -fit framework synthesis approach, factors were synthesised around the consolidated framework for implementation research domains. Results: Stakeholders prioritised outcomes, developed a model which informed evidence synthesis and identified evidence gaps. Scoping review: 651 studies, including 190 randomised controlled trials and 236 primary studies, conservatively reported 48 interventions/intervention combinations. Effectiveness systematic reviews: studies explored service delivery models (n = 15); interventions delivered by families/carers (n = 32), wider children's workforce (n = 21), continence teams (n = 31) and specialist consultant -led teams (n = 42); complementary therapies (n = 15); and psychosocial interventions (n = 4). One intervention (probiotics) had moderate -quality evidence; all others had low to very -low -quality evidence. Thirty-one studies reported evidence relating to cost or resource use; data were insufficient to support generalisable conclusions. One hundred and six studies described implementation barriers and facilitators. Conclusions: Management of childhood chronic functional constipation is complex. The available evidence remains limited, with small, poorly conducted and reported studies. Many evidence gaps were identified. Treatment recommendations within current clinical guidelines remain largely unchanged, but there is a need for research to move away from considering effectiveness of single interventions. Clinical care and future studies must consider the individual characteristics of children.","[Todhunter-Brown, Alex; Booth, Lorna; Campbell, Pauline; Cowie, Julie; Elders, Andrew; Hagen, Suzanne; Thomson, Katie; McClurg, Doreen] Glasgow Caledonian Univ, Nursing Midwifery & Allied Hlth Profess NMAHP Res, Glasgow, Scotland; [Cheer, Brenda] Childrens Bowel & Bladder Char, ERIC, Bristol, England; [Jankulak, Karen; Mason, Helen; Millington, Clare; Ogden, Margaret; Smith, Debs] Glasgow Caledonian Univ, Yunus Ctr Social Business & Hlth, Glasgow, Scotland; [Paterson, Charlotte; Torrens, Claire] Univ Stirling, Nursing Midwifery & Allied Hlth Profess NMAHP Res, Stirling, England; [Richardson, Davina] Bladder & Bowel UK, Manchester, England; [Sutcliffe, Jonathan] Leeds Teaching Hosp NHS Trust, Leeds, England; [Thomson, Katie] Glasgow Caledonian Univ, Dept Occupat Therapy Human Nutr & Dietet, Glasgow, Scotland",Glasgow Caledonian University; Glasgow Caledonian University; University of Stirling; University of Leeds; Glasgow Caledonian University,"Todhunter-Brown, A (corresponding author), Glasgow Caledonian Univ, Nursing Midwifery & Allied Hlth Profess NMAHP Res, Glasgow, Scotland.",Alex.TodhunterBrown@gcu.ac.uk,"Todhunter-Brown, Alex/KHU-9170-2024; Thomson, Katie/AAR-1083-2021; Elders, Andrew/N-4195-2015","Todhunter-Brown, Alex/0000-0003-4941-7985; Booth, Lorna/0000-0001-5776-3541; Cowie, Julie/0000-0002-4653-1283; Jankulak, Karen/0000-0001-5105-228X; Cheer, Brenda/0000-0001-5090-6562; Thomson, Katie/0000-0002-2558-2559; Elders, Andrew/0000-0003-4172-4702",National Institute for Health and Care Research (NIHR) Health Technology Assessment programme [128470]; NIHR,National Institute for Health and Care Research (NIHR) Health Technology Assessment programme; NIHR(National Institutes of Health Research (NIHR)),"This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: 128470) and is published in full in Health Technology Assessment; Vol. 28, No. 5. See the NIHR Funding and Awards website for further award information.",,393,0,0,2,2,NIHR JOURNALS LIBRARY,SOUTHAMPTON,"UNIV SOUTHAMPTON, EVALUATION, TRIALS & STUDIES COORDINATING CENTRE, ALPHA HOUSE, ENTERPRISE RD, SOUTHAMPTON, SO16 7NS, ENGLAND",1366-5278,2046-4924,,HEALTH TECHNOL ASSES,Health Technol. Assess.,JAN,2024,28,5,,,,,1,304,,10.3310/PLTR9622,http://dx.doi.org/10.3310/PLTR9622,,,304,Health Care Sciences & Services,Science Citation Index Expanded (SCI-EXPANDED),Health Care Sciences & Services,HX8R7,38343084,"gold, Green Published",,,2024-06-04,WOS:001162906300001,View Full Record in Web of Science
J,"Shah, BJ; Rughwani, N; Rose, S",,,,"Shah, Brijen J.; Rughwani, Nisha; Rose, Suzanne",,,Constipation,ANNALS OF INTERNAL MEDICINE,,,English,Editorial Material,,,,,,,DIETARY FIBER; THERAPIES; ASSOCIATION; DYSFUNCTION; DEFECATION; MANAGEMENT; PATTERNS; PSYLLIUM; SODIUM; ADULTS,,,,,,,,,,,,53,8,10,3,19,AMER COLL PHYSICIANS,PHILADELPHIA,"INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA",0003-4819,1539-3704,,ANN INTERN MED,Ann. Intern. Med.,APR 7,2015,162,7,,,,,,,,10.7326/AITC201504070,http://dx.doi.org/10.7326/AITC201504070,,,15,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,CW0CW,25845017,,,,2024-06-04,WOS:000364658000002,View Full Record in Web of Science
J,"Hu, MM; Fang, CQ; Liu, YQ; Gao, M; Zhang, DJ; Shi, GF; Yin, ZQ; Zheng, RD; Zhang, J",,,,"Hu, Mengmeng; Fang, Changqian; Liu, Youqian; Gao, Meng; Zhang, Dongjian; Shi, Gaofeng; Yin, Zhiqi; Zheng, Rendong; Zhang, Jian",,,Comparative study of the laxative effects of konjac oligosaccharides and konjac glucomannan on loperamide-induced constipation in rats,FOOD & FUNCTION,,,English,Article,,,,,,,MISCONCEPTIONS,"Dietary fiber is the basic therapeutic method to relieve the symptoms of chronic constipation. The aim of this study was to compare the laxative effect of konjac glucomannan (KGM) and konjac oligosaccharides (KOS) on constipated rats. KGM and KOS were administered to loperamide-induced constipated rats at dosages of 100 mg per kg bw and 400 mg per kg bw for 15 days. Feces were collected to evaluate the defecation function. X-ray imaging and an electrophysiological system were used to determine gastrointestinal (GI) motility. Immunohistochemistry and western blotting were used to measure the protein levels. Magnetic resonance imaging (MRI) was performed to assess flatulence. Our results demonstrated that low-dose KOS (L-KOS) exerted the best laxative effect. Compared to the normal control (NC) group, the fecal number in the L-KOS group increased by 39.4%, and the fecal weight significantly increased by 31.9% which was higher than those in the low-dose KGM (L-KGM) and high-dose KGM (H-KGM) groups. The fecal moisture content and transit scores were significantly increased only in the L-KOS group. Meanwhile, less GI gas was produced by KOS. Additionally, further investigations suggested that KOS could upregulate the protein expression of stem cell factors (SCF)/c-kit, and significantly promoted the secretion of mucus. In conclusion, compared to KGM, KOS had a conspicuous laxative effect especially at a low dosage. The potential laxative mechanisms of KOS probably are regulating the SCF/c-kit signalling pathway and increasing mucus secretion. These findings indicated that as a kind of functional oligosaccharide, KOS is more conducive to alleviating constipation compared to polysaccharides.","[Hu, Mengmeng; Gao, Meng; Zhang, Dongjian; Shi, Gaofeng; Zhang, Jian] Jiangsu Prov Acad Tradit Chinese Med, Labs Translat Med, Nanjing 210028, Peoples R China; [Hu, Mengmeng; Yin, Zhiqi] China Pharmaceut Univ, Sch Tradit Chinese Pharm, Nanjing 210009, Peoples R China; [Fang, Changqian; Zheng, Rendong] Nanjing Lishui Dist Hosp Tradit Chinese Med, Dept Endocrinol, Nanjing 211200, Peoples R China; [Liu, Youqian] Nanjing Lishui Dist Hosp Tradit Chinese Med, Dept Gastroenterol, Nanjing 211200, Peoples R China; [Zheng, Rendong] Nanjing Univ Chinese Med, Affiliated Hosp Integrated Tradit Chinese & Weste, Dept Endocrinol & Metab, Nanjing 210028, Peoples R China",Nanjing University of Chinese Medicine; China Pharmaceutical University; Nanjing University of Chinese Medicine,"Zhang, J (corresponding author), Jiangsu Prov Acad Tradit Chinese Med, Labs Translat Med, Nanjing 210028, Peoples R China.",zhangjian@jsatcm.com,"li, yuwen/HGU-6435-2022; Hu, Mengmeng/AAJ-3751-2020",,Qing Lan Project of Jiangsu Higher Education Institutions; Jiangsu Province Traditional Chinese Medicine Bureau [FY201804]; Funding of Double First-rate Discipline Innovation Team [CPU2018GF05],Qing Lan Project of Jiangsu Higher Education Institutions; Jiangsu Province Traditional Chinese Medicine Bureau; Funding of Double First-rate Discipline Innovation Team,"This work was partially sponsored by the Qing Lan Project of Jiangsu Higher Education Institutions, Jiangsu Province Traditional Chinese Medicine Bureau (FY201804) and the Funding of Double First-rate Discipline Innovation Team (CPU2018GF05).",,38,9,9,5,43,ROYAL SOC CHEMISTRY,CAMBRIDGE,"THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND",2042-6496,2042-650X,,FOOD FUNCT,Food Funct.,SEP 7,2021,12,17,,,,,7709,7717,,10.1039/d1fo01237a,http://dx.doi.org/10.1039/d1fo01237a,,JUN 2021,9,Biochemistry & Molecular Biology; Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Food Science & Technology,UM2HJ,34286775,,,,2024-06-04,WOS:000674762500001,View Full Record in Web of Science
J,"Storz, MA; Lombardo, M; Rizzo, G; Müller, A; Lederer, AK",,,,"Storz, Maximilian Andreas; Lombardo, Mauro; Rizzo, Gianluca; Mueller, Alexander; Lederer, Ann-Kathrin",,,Bowel Health in US Shift Workers: Insights from a Cross-Sectional Study (NHANES),INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH,,,English,Article,,,,,,diet; nutrition; shiftwork; work schedule; NHANES; bowel health; gastrointestinal symptoms; constipation; diarrhea,BRISTOL STOOL FORM; PHYSICAL-ACTIVITY; NATIONAL-HEALTH; GASTROINTESTINAL DISORDERS; FECAL INCONTINENCE; LOW-CARBOHYDRATE; FLUID INTAKE; FIBER; CONSTIPATION; PREVALENCE,"Working outside of regular daytime hours is increasingly common in current societies and poses a substantial challenge to an individual's biological rhythm. Disruptions of the gastrointestinal tract's circadian rhythm and poor dietary choices subsequent to shiftwork may predispose the shift workforce to an increased risk of gastrointestinal disorders, including constipation, peptic ulcer disease, and erosive gastritis. We investigated bowel health in a US population of shift workers, using data from the National Health and Nutrition Examination Survey, and compared bowel movement (BM) frequency and defecation patterns between 2007 day workers and 458 shift workers (representing 55,305,037 US workers). Using bivariate and multivariate logistic regression techniques, our results suggested no association between shiftwork status and BM frequency, bowel leakage of gas, and stool consistency. Constipation prevalence was high but comparable in both groups (6.90% vs. 7.09%). The low fiber intake observed in both groups (15.07 vs. 16.75 g/day) could play a potential role here. The two groups did not differ with regard to other nutrients that may influence BM frequency and stool consistency (e.g., carbohydrate or caffeine intake). Additional studies including food group analyses and fecal biomarkers are warranted for a better understanding of GI health in shift workers.","[Storz, Maximilian Andreas; Mueller, Alexander; Lederer, Ann-Kathrin] Univ Freiburg, Freiburg Univ Hosp, Fac Med, Dept Internal Med 2,Ctr Complementary Med, D-79106 Freiburg, Germany; [Lombardo, Mauro] San Raffaele Roma Open Univ, Dept Human Sci & Promot Qual Life, I-00166 Rome, Italy; [Rizzo, Gianluca] Via Venezuela 66, I-98121 Messina, Italy; [Lederer, Ann-Kathrin] Johannes Gutenberg Univ Mainz, Dept Gen Visceral & Transplantat Surg, Univ Med Ctr, D-55116 Mainz, Germany",University of Freiburg; Johannes Gutenberg University of Mainz,"Storz, MA (corresponding author), Univ Freiburg, Freiburg Univ Hosp, Fac Med, Dept Internal Med 2,Ctr Complementary Med, D-79106 Freiburg, Germany.",maximilian.storz@uniklinik-freiburg.de; mauro.lombardo@uniroma5.it; gianlucarizzo@email.it; alexander.mueller@uniklinik-freiburg.de; ann-kathrin.lederer@uniklinik-freiburg.de,"Storz, Maximilian Andreas/GLR-8109-2022; Lombardo, Mauro/F-6133-2019; Rizzo, Gianluca/J-6540-2019","Storz, Maximilian Andreas/0000-0003-3277-0301; Lombardo, Mauro/0000-0001-7509-5487; Rizzo, Gianluca/0000-0002-5540-0621",,,,,80,4,4,0,3,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,1660-4601,,INT J ENV RES PUB HE,Int. J. Environ. Res. Public Health,MAR,2022,19,6,,,,,,,3334,10.3390/ijerph19063334,http://dx.doi.org/10.3390/ijerph19063334,,,17,"Environmental Sciences; Public, Environmental & Occupational Health",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),"Environmental Sciences & Ecology; Public, Environmental & Occupational Health",0C5BI,35329018,"gold, Green Published",,,2024-06-04,WOS:000775328000001,View Full Record in Web of Science
J,"Rush, EC; Patel, M; Plank, LD; Ferguson, LR",,,,"Rush, EC; Patel, M; Plank, LD; Ferguson, LR",,,Kiwifruit promotes laxation in the elderly,ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION,,,English,Article,,,,,,constipation; controlled trial; elderly; human; kiwifruit; laxation,CELL-WALLS; CONSTIPATION; FRUIT; IDENTIFICATION,"Numerous anecdotal reports have suggested that kiwifruit (Actinidia deliciosa) has laxative effects. This could be an acceptable dietary supplement, especially for elderly people who often present with constipation. We wished to obtain objective evidence as to whether or not kiwifruit eaten regularly could promote laxation in elderly people. Thirty-eight healthy adults of age > 60 years consumed their normal diet, with or without one kiwifruit per 30 kg bodyweight for three weeks, followed by a 3-week crossover period. Daily records were taken on frequency of defecation and characteristics of the stools. Kiwifruit significantly enhanced all tested measures of laxation in these adults. The regular use of kiwifruit appeared to lead to a bulkier and softer stool, as well as more frequent stool production. Kiwifruit as a natural remedy appears palatable to most of the population and provides improved laxation for elderly individuals who are otherwise healthy. It is likely that a number of factors in the whole fruit are involved, but the nature of the stools suggest fibre is important. This study provides evidence of the potential for improvement in bowel function, health and well-being through changes in diet.","Auckland Univ Technol, Dept Appl Sci, Auckland 1020, New Zealand; Univ Auckland, Fac Med & Hlth Sci, Div Surg, Auckland, New Zealand; Univ Auckland, Fac Med & Hlth Sci, Discipline Nutr, Auckland, New Zealand",Auckland University of Technology; University of Auckland; University of Auckland,"Auckland Univ Technol, Dept Appl Sci, Private Bag 92006, Auckland 1020, New Zealand.",elaine.rush@aut.ac.nz,"Rush, Elaine/AAQ-9992-2021; Ferguson, Lynnette Robin/F-5989-2011","Rush, Elaine/0000-0001-7713-6203; Plank, Lindsay/0000-0003-2737-0151",,,,,19,102,108,1,31,"H E C PRESS, HEALTHY EATING CLUB PTY LTD",MCKINNON,"PO BOX 4121, MCKINNON, VIC 3204, AUSTRALIA",0964-7058,1440-6047,,ASIA PAC J CLIN NUTR,Asia Pac. J. Clin. Nutr.,,2002,11,2,,,,,164,168,,10.1046/j.1440-6047.2002.00287.x,http://dx.doi.org/10.1046/j.1440-6047.2002.00287.x,,,5,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,562GE,12074185,,,,2024-06-04,WOS:000176188400015,View Full Record in Web of Science
J,"Kwon, D; Folle, AD; Del Rosario, I; Zhang, KR; Paul, KC; Keener, AM; Bronstein, JM; Ritz, B",,,,"Kwon, Dayoon; Folle, Aline D.; Del Rosario, Irish; Zhang, Keren; Paul, Kimberly C.; Keener, Adrienne M.; Bronstein, Jeff M.; Ritz, Beate",,,Diet quality and Parkinson's disease: Potential strategies for non-motor symptom management,PARKINSONISM & RELATED DISORDERS,,,English,Article,,,,,,Diet quality; Nutrients; Phenotype; Constipation,PATTERN,"Introduction: Parkinson's disease (PD) is now considered a systemic disease, and some phenotypes may be modifiable by diet. We will compare the diet quality and intake of specific nutrients and food groups of PD patients with household and community controls to examine how diet may influence PD clinical features.Methods: We conducted a case-control study of 98 PD patients and 83 controls (household = 53; community = 30) in central California, assessing dietary habits over the past month and calculating the Healthy Eating Index (HEI)-2015. We employed multivariate logistic and linear regression analyses to assess associations between diet and PD status, PD symptom profiles, and medication, adjusting for relevant confounders.Results: PD patients had a lower HEI score than controls, with an OR of 0.65 (95% CI: 0.45, 0.94) per 10-points increase in HEI. Lower-quality diet was characterized by higher intakes of carbohydrates, total and added sugars, and trans fats and lower intakes of fiber, folate, unsaturated fatty acids, protein, and fat. PD patients with chronic constipation had a 4.84 point lower HEI score than those without (& beta; per 10-point in HEI: -0.48; 95% CI: -0.97, -0.00). Furthermore, patients on high dopamine agonist doses consumed more sugar than those on lower doses.Conclusion: PD patients consume a lower-quality diet compared to household and community controls. Dietary modifications may alleviate non-motor symptoms like constipation, and promoting a healthy diet should become a part of routine care and disease management for PD patients, with special attention on agonist-treated and hyposmic patients.","[Kwon, Dayoon; Folle, Aline D.; Del Rosario, Irish; Zhang, Keren; Ritz, Beate] UCLA, Dept Epidemiol, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Paul, Kimberly C.; Keener, Adrienne M.; Bronstein, Jeff M.; Ritz, Beate] UCLA, David Geffen Sch Med, Dept Neurol, Los Angeles, CA USA; [Ritz, Beate] UCLA, Dept Epidemiol, Fielding Sch Publ Hlth, 650 Charles E Young Dr South, Los Angeles, CA 90095 USA",University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles,"Ritz, B (corresponding author), UCLA, Dept Epidemiol, Fielding Sch Publ Hlth, 650 Charles E Young Dr South, Los Angeles, CA 90095 USA.",britz@ucla.edu,,"Duarte Folle, Aline/0000-0002-8051-0064; Paul, Kimberly/0000-0002-4476-2352; Kwon, Dayoon/0000-0001-7967-8508","National Institute of Environmental Health Sciences of the National Institutes of Health [R01 ES031106, R01 ES010544, U54-ES012078, P01-ES016732, P50- NS038367, P30-ES07048]; American Parkinson's Disease Association [20161386]; Parkinson Alliance",National Institute of Environmental Health Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); American Parkinson's Disease Association; Parkinson Alliance,"This work was supported by the National Institute of Environmental Health Sciences of the National Institutes of Health (grant numbers: R01 ES031106, R01 ES010544, U54-ES012078, P01-ES016732, P50- NS038367, and initial pilot funding P30-ES07048), the American Parkinson's Disease Association (grant number 20161386) and the Parkinson Alliance.",,12,3,3,1,2,ELSEVIER SCI LTD,OXFORD,"THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND",1353-8020,1873-5126,,PARKINSONISM RELAT D,Parkinsonism Relat. Disord.,OCT,2023,115,,,,,,,,105816,10.1016/j.parkreldis.2023.105816,http://dx.doi.org/10.1016/j.parkreldis.2023.105816,,AUG 2023,4,Clinical Neurology,Science Citation Index Expanded (SCI-EXPANDED),Neurosciences & Neurology,S4XM4,37611510,hybrid,,,2024-06-04,WOS:001071213000001,View Full Record in Web of Science
J,"NABORS, L; MORGAN, SB",,,,"NABORS, L; MORGAN, SB",,,TREATING RETENTIVE ENCOPRESIS - DIETARY MODIFICATION AND BEHAVIORAL-TECHNIQUES,CHILD & FAMILY BEHAVIOR THERAPY,,,English,Article,,,,,,,MANAGEMENT; CONSTIPATION; SECONDARY,"This clinical case study used a home-based contingency management program consisting of diet modification, laxatives, correction for soiling accidents, stimulus control training, and positive reinforcement of appropriate toileting to treat a 4 1/2-year-old encopretic male. Diet modification consisted of increasing liquids and dietary fiber using a point system. Diet modification combined with increased practice of appropriate toileting were associated with eliminating use of laxatives, decreasing soiling accidents, and increasing appropriate bowel movements. Gains were maintained after one year. The findings provide evidence supporting the effectiveness of dietary modification combined with behavior management techniques for treating retentive encopresis. Limitations of the program are reviewed and recommendations made for future studies.","MEMPHIS STATE UNIV,DEPT PSYCHOL,MEMPHIS,TN 38152",University of Memphis,"NABORS, L (corresponding author), UNIV N CAROLINA,FRANK PORTER GRAHAM CHILD DEV CTR,CB 8180,105 SMITH LEVEL RD,CHAPEL HILL,NC 27514, USA.",,,,,,,,15,3,3,0,0,HAWORTH PRESS INC,BINGHAMTON,"10 ALICE ST, BINGHAMTON, NY 13904-1580",0731-7107,,,CHILD FAM BEHAV THER,Child Fam. Behav. Ther.,,1995,17,1,,,,,47,58,,10.1300/J019v17n01_04,http://dx.doi.org/10.1300/J019v17n01_04,,,12,"Psychology, Clinical; Family Studies",Social Science Citation Index (SSCI),Psychology; Family Studies,RL176,,,,,2024-06-04,WOS:A1995RL17600004,View Full Record in Web of Science
J,"Bayer, SB; Gearry, RB; Drummond, LN",,,,"Bayer, Simone Birgit; Gearry, Richard Blair; Drummond, Lynley Ngaio",,,Putative mechanisms of kiwifruit on maintenance of normal gastrointestinal function,CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION,,,English,Review,,,,,,Kiwifruit; kissper; motility; actinidin; constipation; IBS,IRRITABLE-BOWEL-SYNDROME; CHAIN FATTY-ACIDS; SLOW TRANSIT CONSTIPATION; NECROSIS-FACTOR-ALPHA; DELICIOSA CV HAYWARD; L-ASCORBIC-ACID; PROTEINASE-ACTIVATED RECEPTOR-2; SEROTONIN REUPTAKE TRANSPORTER; RECOMMENDED DIETARY ALLOWANCE; ARTICHOKE LEAF EXTRACT,"Kiwifruits are recognized as providing relief from constipation and symptoms of constipation-predominant irritable bowel syndrome (IBS-C). However, the underlying mechanisms, specifically in regards to gastrointestinal transit time and motility, are still not completely understood. This review provides an overview on the physiological and pathophysiological processes underlying constipation and IBS-C, the composition of kiwifruit, and recent advances in the research of kiwifruit and abdominal comfort. In addition, gaps in the research are highlighted and scientific studies of other foods with known effects on the gastrointestinal tract are consulted to find likely mechanisms of action. While the effects of kiwifruit fiber are well documented, observed increases in gastrointestinal motility caused by kiwifruit are not fully characterized. There are a number of identified mechanisms that may be activated by kiwifruit compounds, such as the induction of motility via protease-activated signaling, modulation of microflora, changes in colonic methane status, bile flux, or mediation of inflammatory processes.","[Bayer, Simone Birgit] Univ Otago, Ctr Free Radical Res, Dept Pathol, 2 Riccarton Ave,POB 4345, Christchurch 8140, New Zealand; [Gearry, Richard Blair] Univ Otago, Dept Med, 2 Riccarton Ave,POB 4345, Christchurch, New Zealand; [Drummond, Lynley Ngaio] Drummond Food Sci Advisory Ltd, 1137 Drain Rd,Killinchy RD 2, Leeston, New Zealand",University of Otago; University of Otago,"Bayer, SB (corresponding author), Univ Otago, Ctr Free Radical Res, Dept Pathol, 2 Riccarton Ave,POB 4345, Christchurch 8140, New Zealand.",Simone.bayer@otago.ac.nz,"Gearry, Richard B/H-3959-2019","Gearry, Richard B/0000-0002-2298-5141; Drummond, Lynley/0000-0002-1350-8132; Bayer, Simone/0000-0002-5880-2095",Zespri International Limited,Zespri International Limited,This review was funded by Zespri International Limited.,,348,20,21,3,34,TAYLOR & FRANCIS INC,PHILADELPHIA,"530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA",1040-8398,1549-7852,,CRIT REV FOOD SCI,Crit. Rev. Food Sci. Nutr.,,2018,58,14,,,,,2432,2452,,10.1080/10408398.2017.1327841,http://dx.doi.org/10.1080/10408398.2017.1327841,,,21,Food Science & Technology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Nutrition & Dietetics,HF6FA,28557573,hybrid,,,2024-06-04,WOS:000454329200010,View Full Record in Web of Science
J,"Ashraf, W; Park, F; Lof, J; Quigley, EMM",,,,"Ashraf, W; Park, F; Lof, J; Quigley, EMM",,,"Effects of psyllium therapy on stool characteristics, colon transit and anorectal function in chronic idiopathic constipation",ALIMENTARY PHARMACOLOGY & THERAPEUTICS,,,English,Article,,,,,,,IRRITABLE BOWEL SYNDROME; UNITED-STATES; DIETARY FIBER; WHEAT BRAN; DIVERTICULAR-DISEASE; POPULATION; TIME; DISORDERS; ISPAGHULA,"Background: Psyllium is widely used in the symptomatic therapy of constipation, Its effects on colonic function and their correlation with symptomatic response have not been defined. Methods: After a 4-week baseline, placebo, run-in phase, 22 subjects with idiopathic constipation confirmed by prospectively administered stool diaries were randomly assigned to receive either psyllium (5 g b.d., 11 patients) or placebo (11 patients) for 8 weeks, followed by another 4-week wash-out, placebo phase, A colon transit study and anorectal manometry were performed at the beginning and at the end of each study phase, Subjects recorded, in diaries, their daily stool frequency, difficulty with defecation and weekly stool weight. Results: Stool frequency increased significantly after 8 weeks of psyllium treatment (3.8 +/- 0.4 vs. 2.9 +/- 0.1 stools/week, P < 0.05) as did stool weight (665.3 +/- 95.8 g vs. 405.2 +/- 75.9 g, P < 0.05). Subjects also reported an improvement in stool consistency (stool consistency score: 3.2 +/- 0.2 vs. 3.8 +/- 0.2, P < 0.05) and pain on defecation (pain score: 2.0 +/- 0.4 vs. 2.6. +/- 0.5, P < 0.05) on psyllium. Colon transit and anorectal manometry parameters were unchanged on psyllium. Subjects treated with placebo did not show any change in either subjective or objective measures of constipation. Conclusions: Psyllium increases stool frequency and weight and improves stool consistency in idiopathic constipation. These effects are not associated with significant changes in either colonic or rectal motor function. We suggest that the beneficial effects of psyllium in constipation are primarily related to a facilitation of the defecatory process.","UNIV NEBRASKA, MED CTR, SECT GASTROENTEROL & HEPATOL, OMAHA, NE 68198 USA",University of Nebraska System; University of Nebraska Medical Center,,,,,,,,,39,114,119,1,12,WILEY-BLACKWELL,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0269-2813,1365-2036,,ALIMENT PHARM THER,Aliment. Pharmacol. Ther.,DEC,1995,9,6,,,,,639,647,,,,,,9,Gastroenterology & Hepatology; Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Pharmacology & Pharmacy,TR116,8824651,,,,2024-06-04,WOS:A1995TR11600008,View Full Record in Web of Science
J,"Peng, Y; Zeng, YT; Zheng, TT; Xie, XN; Wu, JF; Fu, LZ; Lu, FH; Zhang, L; Chen, Y; Liu, XS; Wang, L",,,,"Peng, Yu; Zeng, Yuting; Zheng, Tingting; Xie, Xiaoning; Wu, Jianfeng; Fu, Lizhe; Lu, Fuhua; Zhang, La; Chen, Yang; Liu, Xusheng; Wang, Lei",,,Effects of Tiaopi Xiezhuo decoction on constipation and gut dysbiosis in patients with peritoneal dialysis,PHARMACEUTICAL BIOLOGY,,,English,Article,,,,,,Clinical study; end-stage kidney disease; peritonitis; gut microbiota; probiotic bacteria,CHAIN FATTY-ACIDS; ESCHERICHIA-COLI PERITONITIS; GASTROINTESTINAL SYMPTOMS; DIETARY FIBER; ACTIVATION; PREVOTELLA; PATTERNS; DISEASE,"Context A Chinese herbal formula, Tiaopi Xiezhuo decoction (TXD), is developed from a classical Chinese prescription Sanhuang Xiexin decoction. Objective To investigate the regulatory effect of TXD on gut dysbiosis, as a treatment of constipation in patients with peritoneal dialysis (PD). Materials and methods The chemical content of TXD was assessed by high-performance liquid chromatography. A total of 29 PD patients were enrolled and treated with TXD orally (3 g crude drug/each/twice/day) for 3 months. Blood and faecal samples were collected at the beginning and end, to determine the changes in biochemical characteristics and gut microbial composition. The stool conditions were asked to be scored. Additional 30 healthy individuals were recruited as a control for the analysis of gut microbiota. Results Although having no significant effects on serum biochemical characteristics, 3-month TXD intervention improved constipation in PD patients: decreased 80% abdominal distention (p < 0.01), increased 2.6-fold sloppy stools (p < 0.05) and eliminated hard stool completely (p < 0.01). The analysis of gut microbiota showed that, compared to the healthy group, the microbial richness was reduced in PD patients. After a 3-month TXD treatment, this reduced richness was raised, and Paraprevotella clara, Lachnospiraceae bacterium 2-146FA, Phascolarctobaterium succinatutens, Lachnospiraceae bacterium 2-1-58FAA, Fusobacterium mortiferum, and Prevotella copri were accumulated in the intestinal flora. Furthermore, the bacterial species enriched by TXD correlated with the improvement of constipation. Discussion and conclusions TXD treatment may improve constipation by modulating gut dysbiosis in PD patients. These findings provide data to support the further application of TXD in the adjuvant treatment of PD.","[Peng, Yu; Zheng, Tingting; Xie, Xiaoning; Wu, Jianfeng; Fu, Lizhe; Lu, Fuhua; Zhang, La; Liu, Xusheng] Guangzhou Univ Chinese Med, Guangzhou Univ Tradit Chinese Med, Dept Nephrol, Affiliated Hosp 2, Guangzhou, Peoples R China; [Zeng, Yuting; Wang, Lei] Guangzhou Univ Chinese Med, Sch Pharmaceut Sci, Guangzhou, Peoples R China; [Chen, Yang] Guangzhou Univ Chinese Med, Guangzhou Univ Tradit Chinese Med, Guangdong Prov Key Lab Clin Res Tradit Chinese Med, Affiliated Hosp 2, Guangzhou, Peoples R China; [Wang, Lei] Guangzhou Univ Chinese Med, Sch Pharmaceut Sci, 232 East Waihuan Rd, Guangzhou 510006, Peoples R China",Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine,"Liu, XS (corresponding author), Guangzhou Univ Chinese Med, Guangzhou Univ Tradit Chinese Med, Dept Nephrol, Affiliated Hosp 2, Guangzhou, Peoples R China.;Wang, L (corresponding author), Guangzhou Univ Chinese Med, Sch Pharmaceut Sci, 232 East Waihuan Rd, Guangzhou 510006, Peoples R China.",liuxu801@126.com; wanglei202023@outlook.com,"Xie, Xiaoning/I-8947-2014",,National Natural Science Foundation of China [82174308],National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)),This study was supported by the National Natural Science Foundation of China [No. 82174308].,,45,5,6,5,12,TAYLOR & FRANCIS LTD,ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND",1388-0209,1744-5116,,PHARM BIOL,Pharm. Biol.,DEC 31,2023,61,1,,,,,531,540,,10.1080/13880209.2023.2193595,http://dx.doi.org/10.1080/13880209.2023.2193595,,,10,Plant Sciences; Medical Laboratory Technology; Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Plant Sciences; Medical Laboratory Technology; Pharmacology & Pharmacy,C2PZ1,36994999,"Green Published, gold",,,2024-06-04,WOS:000960411700001,View Full Record in Web of Science
J,"Rao, SSC",,,,"Rao, S. S. C.",,,"Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome (vol 41, pg 1256, 2015)",ALIMENTARY PHARMACOLOGY & THERAPEUTICS,,,English,Correction,,,,,,,,,"Georgia Regents Univ, Sect Gastroenterol & Hepatol, Digest Hlth Ctr, Augusta, GA 30912 USA",University System of Georgia; Augusta University,"Rao, SSC (corresponding author), Georgia Regents Univ, Sect Gastroenterol & Hepatol, Digest Hlth Ctr, AD 2238,1481 Laney Walker Blvd, Augusta, GA 30912 USA.",srao@gru.edu,,,,,,,1,2,2,1,21,WILEY-BLACKWELL,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0269-2813,1365-2036,,ALIMENT PHARM THER,Aliment. Pharmacol. Ther.,AUG,2015,42,4,,,,,490,490,,10.1111/apt.13293,http://dx.doi.org/10.1111/apt.13293,,,1,Gastroenterology & Hepatology; Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Pharmacology & Pharmacy,CM7TU,,Bronze,,,2024-06-04,WOS:000357900200015,View Full Record in Web of Science
J,"Liu, M; Wang, YH; Guan, GQ; Lu, X; Zhu, YZ; Duan, XQ",,,,"Liu, Meng; Wang, Yuhui; Guan, Guoqiang; Lu, Xi; Zhu, Yizhun; Duan, Xiaoqun",,,Dietary Supplementation of Ancientino Ameliorates Dextran Sodium Sulfate-Induced Colitis by Improving Intestinal Barrier Function and Reducing Inflammation and Oxidative Stress,NUTRIENTS,,,English,Article,,,,,,ulcerative colitis; Ancientino; inflammatory response; intestinal barrier function; oxidation stress,INDUCED ULCERATIVE-COLITIS; FIBER; DISEASE,"Ancientino, a complex dietary fiber supplement mimicking the ancient diet, has improved chronic heart failure, kidney function, and constipation. However, its effect on ulcerative colitis is unknown. This study explores the impact of Ancientino on colitis caused by dextran sulfate sodium (DSS) and its mechanisms. Data analyses showed that Ancientino alleviated bodyweight loss, colon shortening and injury, and disease activity index (DAI) score, regulated levels of inflammatory factors (tumor necrosis factor-alpha (TNF-& alpha;), interleukin-10 (IL-10), interleukin-1 beta (IL-1 & beta;), and interleukin 6 (IL-6)), reduced intestinal permeability (d-lactate and endotoxin), fluorescein isothiocyanate-dextran (FITC-dextran), and diamine oxidase (DAO), repaired colonic function (ZO-1 and occludin), and suppressed oxidative stress (superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), and malondialdehyde (MDA)) in vivo and in vitro. In short, this study demonstrated that Ancientino alleviates colitis and exerts an anticolitis effect by reducing inflammatory response, suppressing oxidative stress, and repairing intestinal barrier function. Thus, Ancientino may be an effective therapeutic dietary resource for ulcerative colitis.","[Liu, Meng; Zhu, Yizhun; Duan, Xiaoqun] Macau Univ Sci & Technol, Fac Med, Sch Pharm, Macau 999078, Peoples R China; [Wang, Yuhui; Guan, Guoqiang; Duan, Xiaoqun] Guilin Med Univ, Sch Biomed Ind, Guilin 541199, Peoples R China; [Wang, Yuhui; Guan, Guoqiang; Duan, Xiaoqun] Guilin Med Univ, Ind Technol Res Inst, Guilin 541199, Peoples R China; [Guan, Guoqiang; Lu, Xi] Guilin Med Univ, Sch Pharm, Guilin 541199, Peoples R China; [Zhu, Yizhun] Macau Univ Sci & Technol, Sch Pharm, State Key Lab Qual Res Chinese Med, Macau 999078, Peoples R China",Macau University of Science & Technology; Guilin Medical University; Guilin Medical University; Guilin Medical University; Macau University of Science & Technology,"Zhu, YZ; Duan, XQ (corresponding author), Macau Univ Sci & Technol, Fac Med, Sch Pharm, Macau 999078, Peoples R China.;Duan, XQ (corresponding author), Guilin Med Univ, Sch Biomed Ind, Guilin 541199, Peoples R China.;Duan, XQ (corresponding author), Guilin Med Univ, Ind Technol Res Inst, Guilin 541199, Peoples R China.;Zhu, YZ (corresponding author), Macau Univ Sci & Technol, Sch Pharm, State Key Lab Qual Res Chinese Med, Macau 999078, Peoples R China.",21098533pp30001@student.must.edu.mo; 112016010@glmc.edu.cn; 21207041261@stu.glmc.edu.cn; 22006033@glmc.edu.cn; yzzhu@must.edu.mo; 112006012@glmc.edu.cn,"Zhu, Yi Zhun/ABG-8449-2021","Zhu, Yi Zhun/0000-0001-7700-8041; Liu, Meng/0000-0002-4554-4154; Guan, Guoqiang/0000-0002-0263-810X",,,,,61,1,2,10,30,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,JUN,2023,15,12,,,,,,,2798,10.3390/nu15122798,http://dx.doi.org/10.3390/nu15122798,,,20,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,K2QF9,37375702,"Green Published, gold",,,2024-06-04,WOS:001014929900001,View Full Record in Web of Science
J,"STARK, LJ; OWENSSTIVELY, J; SPIRITO, A; LEWIS, A; GUEVREMONT, D",,,,"STARK, LJ; OWENSSTIVELY, J; SPIRITO, A; LEWIS, A; GUEVREMONT, D",,,GROUP BEHAVIORAL TREATMENT OF RETENTIVE ENCOPRESIS,JOURNAL OF PEDIATRIC PSYCHOLOGY,,,English,Article,,,,,,RETENTIVE ENCOPRESIS; DIETARY FIBER; CHILDREN; GROUP TREATMENT,CONSTIPATION; MANAGEMENT; CHILDREN,"Investigated the efficacy of behaviour group treatment for children with retentive encopresis who had previously failed medical management. Eighteen children between the ages of 4 and 11 years and their parents were seen in small treatment groups of 3 to 5 families over 6 sessions. The sessions focused on education about retentive encopresis, and the integration of behavioral parenting procedures with medical management. Parents and children were taught to deliver an enema clean-out, increase the chldren''s dietary fiber, and appropriate toileting techniques. The results indicated that children significantly increased their fiber consumption by 40%, increased appropriate toileting by 116%, and decreased their soiling accidents by 83% pre- to posttreatment. Further, these treatment gains maintained or improved at the 6-month follow-up. The results are discussed in terms of cost-effective interventions and the interface between psychology and medicine in pediatric psychology.","BROWN UNIV, PROGRAM MED, PROVIDENCE, RI 02912 USA; BROWN UNIV, SCH MED, PROVIDENCE, RI 02912 USA; UNIV MICHIGAN, MED CTR, ANN ARBOR, MI 48109 USA; UNIV MASSACHUSETTS, MED CTR, AMHERST, MA 01003 USA",Brown University; Brown University; University of Michigan System; University of Michigan; University of Massachusetts System; University of Massachusetts Amherst,,,,,,,,,21,37,39,0,2,OXFORD UNIV PRESS INC,CARY,"JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA",0146-8693,1465-735X,,J PEDIATR PSYCHOL,J. Pediatr. Psychol.,OCT,1990,15,5,,,,,659,671,,10.1093/jpepsy/15.5.659,http://dx.doi.org/10.1093/jpepsy/15.5.659,,,13,"Psychology, Developmental",Social Science Citation Index (SSCI),Psychology,EU461,2283574,,,,2024-06-04,WOS:A1990EU46100007,View Full Record in Web of Science
J,"Alajmi, AM; Garcia, AL; Edwards, CA",,,,"Alajmi, A. M.; Garcia, A. L.; Edwards, C. A.",,,"Online survey of knowledge, beliefs and practices of health professionals in Kuwait regarding dietary fibre and constipation in people over 60 years",PROCEEDINGS OF THE NUTRITION SOCIETY,,,English,Meeting Abstract,,,,,,,,,"[Alajmi, A. M.; Garcia, A. L.; Edwards, C. A.] Univ Glasgow, Sch Med Dent & Nursing, Human Nutr Dept, Glasgow, Scotland",University of Glasgow,"Alajmi, AM (corresponding author), Univ Glasgow, Sch Med Dent & Nursing, Human Nutr Dept, Glasgow, Scotland.",,"Garcia, Ada L/ACW-5470-2022",,,,,,1,0,0,2,2,CAMBRIDGE UNIV PRESS,CAMBRIDGE,"EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND",0029-6651,1475-2719,,P NUTR SOC,Proc. Nutr. Soc.,,2023,82,OCE1,,,SI,,,,,10.1017/S0029665123000472,http://dx.doi.org/10.1017/S0029665123000472,,,1,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,9R1FW,,Bronze,,,2024-06-04,WOS:000945401800019,View Full Record in Web of Science
J,"Risso, D; Laurie, I; Sarkkinen, E; Karnik, K",,,,"Risso, Davide; Laurie, Ieva; Sarkkinen, Essi; Karnik, Kavita",,,"The effect of polydextrose on fecal bulk and bowel function in mildly constipated healthy adults: a double-blind, placebo controlled study",FUNCTIONAL FOODS IN HEALTH AND DISEASE,,,English,Article,,,,,,polydextrose; PDX; constipation; bowel function; clinical trial gut health; fibre,PATIENT-REPORTED OUTCOMES; SOLUBLE MAIZE FIBER; DIETARY FIBER; GUT HEALTH; SUPPLEMENTATION; MANAGEMENT; WEIGHT; IMPACT; INULIN; INDEX,"Background: Polydextrose (PDX) (8-30g/day) increases fecal bulk and consistency, helping to ease stool passage. However, the results of its effect on defecation frequency and colonic transit have been discordant, and most focused on either healthy or highly constipated adults, leaving the question on if and how PDX could also aid mildly constipated individuals partially unanswered. Material and Methods: We investigated the effects of PDX consumption by healthy subjects experiencing one or more symptoms of mild constipation on fecal bulk, defecation frequency, stool consistency, ease of stool passage, and total colonic transit time to further characterize and generate additional evidence regarding the potential beneficial effects of this fibre. 51 subjects participated in a 4-week, two-center, randomized, double-blind, placebo-controlled, parallel study testing a control (CON) and a PDX treatment (18 g/d included in biscuits and drink mixtures) (registered on clinicaltrials.gov with the identifier NCT05309837). Results: Consumption of PDX resulted in 120.7 g and 25.7 g higher fecal wet and dry weight, respectively (p < 0.05). Colonic transit time was similar to 4 h shorter in the PDX group: although this difference did not reach significance (p > 0.05) as it was underpowered to detect a significant difference for this secondary outcome, this result still carries a physiological importance. Consumption of PDX was well-tolerated, with some PDX volunteers reporting more mild flatulence (p < 0.05). Conclusion: All in all, our study adds new evidence on how a moderate (18g) daily intake of PDX could increase fecal bulking and potentially shorten colonic transit time, making this ingredient a good candidate to be used to reformulate packaged goods by replacing caloric carbohydrates with lower caloric content, enriching food items easily consumed to enhance fibre intake and support bowel function.","[Risso, Davide; Laurie, Ieva; Karnik, Kavita] Tate & Lyle PLC, 5 Marble Arch, London W1H 7EJ, England; [Sarkkinen, Essi] Medfiles Ltd CRO, Rajatorpantie 41 C, FI-01640 Vantaa, Finland",,"Risso, D (corresponding author), Tate & Lyle PLC, 5 Marble Arch, London W1H 7EJ, England.",,"Dutka, Peyton/IWE-5033-2023; Risso, Davide/J-6841-2015","Risso, Davide/0000-0001-9848-8996",,,,,64,1,1,1,3,FUNCTIONAL FOOD CENTER INC,DALLAS,"5050 QUORUM DR, STE 700, NO 338, DALLAS, TX 75254 USA",2160-3855,,,FUNCT FOODS HEALTH D,Funct. Foods Health Dis.,MAY,2023,13,5,,,,,240,257,,10.31989/ffhd.v13i5.1099,http://dx.doi.org/10.31989/ffhd.v13i5.1099,,,18,Food Science & Technology,Emerging Sources Citation Index (ESCI),Food Science & Technology,G0QN1,,gold,,,2024-06-04,WOS:000986305900001,View Full Record in Web of Science
J,"Lewis, S; Bolton, C; Heaton, K",,,,"Lewis, S; Bolton, C; Heaton, K",,,Lack of influence of intestinal transit on oxidative status in premenopausal women,EUROPEAN JOURNAL OF CLINICAL NUTRITION,,,English,Article,,,,,,oxidative status; fibre,SERUM ESTROGEN CONCENTRATIONS; DEOXYCHOLIC-ACID; DIETARY FIBER; METABOLISM; SUPPLEMENTATION; CANCER; BILE; TIME,"Objective: There are reasons for believing that diet can alter the risk of malignancy by alteration of the body's oxidative status. Intestinal contents and enterohepatically recirculated substances are influenced by intestinal transit rate. A low fibre diet has been linked to the increase in constipation seen in countries consuming a westernized diet, as well as to the aetiology of many diseases. We studied the effects of altering intestinal transit rates and of wheat bran on oxidative status. Design: 40 premenopausal women were randomized to receive dietary supplements of wheat bran, senna or loperamide for the length of two menstrual cycles. Dietary records, whole gut transit time (WGTT) and plasma lipid peroxides, measured as TEARS (specifically malondialdehyde) were determined at the beginning and end of each intervention. Setting: University department of Medicine, Bristol Royal Infirmary. Results: 36 volunteers completed the study. WGTT increased in those receiving loperamide and decreased in those receiving senna. The decrease in WGTT was not significant in those receiving wheat bran. Diets did not change. There were no changes in TEARS, cholesterol, triglyceride or TEARS adjusted for cholesterol and triglyceride, during any intervention. Conclusions: Dietary supplementation with wheat bran and pharmacological alteration of intestinal transit had no influence on oxidative status or on plasma cholesterol or triglycerides.","UNIV BRISTOL,SOUTHMEAD HOSP,DEPT MED,BRISTOL,AVON,ENGLAND",Southmead Hospital; University of Bristol,"Lewis, S (corresponding author), UNIV BRISTOL,BRISTOL ROYAL INFIRM,DEPT MED,BRISTOL BS2 8HW,AVON,ENGLAND.",,,,,,,,25,11,13,0,0,STOCKTON PRESS,BASINGSTOKE,"HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS",0954-3007,,,EUR J CLIN NUTR,Eur. J. Clin. Nutr.,AUG,1996,50,8,,,,,565,568,,,,,,4,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,VD083,8863019,,,,2024-06-04,WOS:A1996VD08300012,View Full Record in Web of Science
J,"Mälkki, Y; Virtanen, E",,,,"Mälkki, Y; Virtanen, E",,,Gastrointestinal effects of oat bran and oat gum -: A review,LEBENSMITTEL-WISSENSCHAFT UND-TECHNOLOGIE-FOOD SCIENCE AND TECHNOLOGY,,,English,Review,,,,,,oat bran; fibre; beta-glucan; gastrointestinal effects,CHAIN FATTY-ACIDS; DIETARY FIBER; ENZYME-ACTIVITY; GUAR GUM; POSTPRANDIAL LIPEMIA; COLONIC FERMENTATION; DIABETES-MELLITUS; MILLING FRACTIONS; EPITHELIAL-CELLS; SODIUM-BUTYRATE,"In addition to the well-known effects of reducing blood cholesterol and affecting glycaemic response, dietary fibre of oat bran has been shown to hare numerous other physiological effects. It delays gastric emptying, diminishes absorption of nutrients, affects the motility in the small bowel, and prolongs satiety after the meal. In the large bowel, soluble dietary fibre increases the fermentation activity, especially production of butyric acid, enhances growth and colonisation of some probiotic bacterial strains, increases production of microbial mass and thereby aids the removal of nitrogen via faeces. It also increases wet weight of stools, thereby alleviating constipation. Short-chain fatty acids formed enhance cell proliferation of the colonic mucosa. According to the present view, this reduces the risk of colon cancer, In addition to the effects of the viscosity of the intestinal contents and colon fermentation, the physiological effects are in part mediated ilia insulin and gastrointestinal hormone secretion. Papers documenting these effects are reviewed.","Cerefi Ltd, FIN-02160 Espoo, Finland; Avena Oy, FIN-00100 Helsinki, Finland",,,,,,,,,,113,133,154,1,62,ACADEMIC PRESS INC ELSEVIER SCIENCE,SAN DIEGO,"525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA",0023-6438,,,LEBENSM-WISS TECHNOL,Lebensm.-Wiss. Technol.-Food Sci. Technol.,,2001,34,6,,,,,337,347,,10.1006/fstl.2001.0795,http://dx.doi.org/10.1006/fstl.2001.0795,,,11,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,475KJ,,,,,2024-06-04,WOS:000171162900001,View Full Record in Web of Science
J,"Nowak, W; Jeziorek, M",,,,"Nowak, Wioletta; Jeziorek, Malgorzata",,,The Role of Flaxseed in Improving Human Health,HEALTHCARE,,,English,Review,,,,,,flaxseed; lignans; alpha-linolenic acid; dietary fiber; bioavailability,BLOOD-PRESSURE; DOUBLE-BLIND; OIL; SUPPLEMENTATION; CONSUMPTION; WOMEN,"Flaxseed contains high amounts of biologically active components such as alpha-linolenic acid, lignans, and dietary fiber. Due to its numerous nutritional properties, flaxseed has been classified as a superfood , that is, a food of natural origin with various bioactive components and many health-promoting benefits. Flaxseed consumption can be an important factor in the prevention of diseases, particularly related to nutrition. The regular consumption of flaxseed may help to improve lipid profile and lower blood pressure, fasting glucose, and insulin resistance index (HOMA-IR). Moreover, flaxseed is characterized by anticancer and antioxidant properties and can significantly reduce the intensity of symptoms associated with menopause, constipation, and mental fatigue, improve skin condition, and accelerate wound healing. In addition to its bioactive compounds, flaxseed also contains antinutrients such as cyanogenic glycosides (CGs), cadmium, trypsin inhibitors, and phytic acid that can reduce the bioavailability of essential nutrients and/or limit its health-promoting effects. Three common forms of flaxseed available for human consumption include whole flaxseed, ground flaxseed, and flaxseed oil. The bioavailability of ALA and lignans is also dependent on the form of flaxseed consumed. To ensure high bioavailability of its bioactive components, flaxseed should be consumed in the ground form.","[Nowak, Wioletta; Jeziorek, Malgorzata] Wroclaw Med Univ, Fac Pharm, Dept Dietet & Bromatol, Borowska 211, PL-50556 Wroclaw, Poland",Wroclaw Medical University,"Jeziorek, M (corresponding author), Wroclaw Med Univ, Fac Pharm, Dept Dietet & Bromatol, Borowska 211, PL-50556 Wroclaw, Poland.",malgorzata.jeziorek@umw.edu.pl,"Jeziorek, Małgorzata/ABC-3595-2021","Jeziorek, Małgorzata/0000-0001-6704-1788",,,,,47,6,6,12,44,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2227-9032,,HEALTHCARE-BASEL,Healthcare,FEB,2023,11,3,,,,,,,395,10.3390/healthcare11030395,http://dx.doi.org/10.3390/healthcare11030395,,,20,Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Health Care Sciences & Services,8Y2WV,36766971,"gold, Green Published",,,2024-06-04,WOS:000932561500001,View Full Record in Web of Science
J,"Kamran, M; Saleem, N; Umer, ZN",,,,"Kamran, Muhammad; Saleem, Nida; Umer, Zahida N.",,,Ready-to-eat (RTE) wheat bran breakfast cereal as a high-fiber diet,JOURNAL OF FOOD PROCESSING AND PRESERVATION,,,English,Article,,,,,,,CANCER; DISEASE,"Bran is an excellent source of dietary fiber; for addition to food, it offers all the nutritional and nutraceutical benefits of whole grain. Ready-to-eat breakfast cereal is in line with dietary fiber recommendations; therefore, a process on wheat bran-based breakfast with fruits has been formulated with a unique formulation, following the toasting of raw wheat bran at 170-175C for 40-45 min to inhibit rancidity, then the mixing and wetting of wheat bran preserve with other nutritional ingredients, i.e., fruit banana preserve and binding syrup, according to formulation in order to enhance the nutritional importance of the product from the health point of view. The products were the most acceptable in terms of color, texture and having a concentrated flavor of wheat bran and fruit with a natural color, and no off-taste was observed in these products. Sensory evaluation, shelf-life studies and microbiological examination show that wheat bran products (products A and B) are fit for human consumption, can be utilized throughout the year in the form of preserve especially with fruit (banana), is a possible breakfast diet for obesity and diseases, such as diabetes, and is useful in the prevention and treatment of constipation, cardiovascular diseases and hypertension.","[Kamran, Muhammad; Saleem, Nida; Umer, Zahida N.] PCSIR Labs Complex, Karachi, Pakistan",PCSIR Laboratories Complex,"Kamran, M (corresponding author), PCSIR Labs Complex, Karachi, Pakistan.",kamikorish09@yahoo.com,,,,,,,27,7,8,2,18,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0145-8892,1745-4549,,J FOOD PROCESS PRES,J. Food Process Preserv.,OCT,2008,32,5,,,,,853,867,,10.1111/j.1745-4549.2008.00218.x,http://dx.doi.org/10.1111/j.1745-4549.2008.00218.x,,,15,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,354BB,,gold,,,2024-06-04,WOS:000259612800011,View Full Record in Web of Science
J,"Müller-Lissner, S",,,,"Mueller-Lissner, Stefan",,,Conservative treatment of disordered defecation,CHIRURGISCHE GASTROENTEROLOGIE,,,German,Article,,,,,,pelvic floor dyssynergia; dietary fiber; laxative; biofeedback,SLOW-TRANSIT CONSTIPATION; PARADOXICAL PUBORECTALIS CONTRACTION; OUTLET OBSTRUCTION CONSTIPATION; PELVIC FLOOR DYSSYNERGIA; RECTAL ULCER SYNDROME; BIOFEEDBACK TREATMENT; FUNCTIONAL CONSTIPATION; VISUAL BIOFEEDBACK; DOUBLE-BLIND; ANISMUS,"If straining upon defecation can be avoided, previously disordered defecation is often no longer a problem. This may sometimes be accomplished by a fiber-rich diet, but dietary fiber is often neither successful nor well tolerated, and treatment with laxatives is indicated. The currently available laxatives are efficacious and safe, treatment is usually lifelong. One approach is to increase stool volume by macrogol, the other is to stimulate colonic motility ( and to decrease water absorption) by the stimulant laxatives bisacodyl, picosulphate, or anthraquinones. Bisacodyl may also be given as a suppository which may be a good choice in disordered defecation. Much attention has been paid to biofeedback training which seems to improve pelvic floor dyssynergia in a high proportion of patients. However, establishing the diagnosis of pelvic floor dyssynergia is difficult in itself. Muscle relaxation training seems to be similarly effective as biofeedback training.","Pk Klin Weissensee, Innere Med Abt, D-13086 Berlin, Germany",,"Müller-Lissner, S (corresponding author), Pk Klin Weissensee, Innere Med Abt, Schonstr 80, D-13086 Berlin, Germany.",mueli@park-klinik.com,,,,,,,45,0,0,1,1,KARGER,BASEL,"ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND",0177-9990,,,CHIR GASTROENTEROL,Chir. Gastroenterol.,,2007,23,3,,,,,245,250,,10.1159/000105461,http://dx.doi.org/10.1159/000105461,,,6,Gastroenterology & Hepatology; Surgery,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Surgery,216VL,,,,,2024-06-04,WOS:000249907000005,View Full Record in Web of Science
J,"Ito, M; Yoshimoto, J; Maeda, T; Ishii, S; Wada, Y; Kishi, M; Koikeda, T",,,,"Ito, Mamoru; Yoshimoto, Joto; Maeda, Tetsuya; Ishii, Sho; Wada, Yu; Kishi, Mikiya; Koikeda, Takashi",,,Effects of high-fiber food product consumption and personal health record use on body mass index and bowel movement,JOURNAL OF FUNCTIONAL FOODS,,,English,Article,,,,,,Health program; Yellow pea-based high-fiber food; Personal health record; Body mass index; Bowel movement,TYPE-2 DIABETES-MELLITUS; QUALITY-OF-LIFE; DIETARY FIBER; BLOOD-PRESSURE; WEIGHT-LOSS; URIC-ACID; METAANALYSIS; CONSTIPATION; SUPPLEMENTATION; GLUCOMANNAN,"A health program including consumption of high-fiber ZENB Noodles (ZN) and ZENB Sticks (ZS), combined with the use of a personal health record (PHR) was employed; effects on body mass index (BMI) and bowel movement were evaluated. Fifty-nine healthy adults with overweight (mean baseline BMI, 27.0 kg/m2) participated and consumed ZN and ZS once daily, five days/week for 12 weeks and tracked their dietary intake, body weight, and blood pressure using a mobile PHR application (Welby My Carte). Mean BMI decreased significantly to 26.8 kg/ m2 at 8 weeks (p = 0.031). The mean number of weekly bowel movements per participant increased significantly from 6.95 at baseline to 8.78, 8.34, and 8.58 at 4, 8, and 12 weeks, respectively (allp < 0.001). Thus, high-fiber food product consumption and PHR use decreased BMI and improved bowel movement among healthy adults with overweight. This study was registered in the UMIN Clinical Trials Registry (UMIN trial ID: UMIN000040105).","[Ito, Mamoru; Yoshimoto, Joto; Ishii, Sho; Kishi, Mikiya] Mizkan Holdings Co Ltd, Cent Res Inst, Handa, Aichi, Japan; [Maeda, Tetsuya; Wada, Yu] Mizkan Holdings Co Ltd, New Business Dev, Chuo Ku, Tokyo, Japan; [Koikeda, Takashi] Shiba Palace Clin, Minato Ku, Tokyo, Japan",,"Ito, M (corresponding author), Mizkan Holdings Co Ltd, Cent Res Inst, Handa, Aichi, Japan.",mamoru_ito@mizkan.co.jp,,,,,,,52,5,5,2,5,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",1756-4646,2214-9414,,J FUNCT FOODS,J. Funct. Food.,MAR,2023,102,,,,,,,,105443,10.1016/j.jff.2023.105443,http://dx.doi.org/10.1016/j.jff.2023.105443,,FEB 2023,8,Food Science & Technology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Nutrition & Dietetics,9P9JM,,gold,,,2024-06-04,WOS:000944592500001,View Full Record in Web of Science
J,"Markland, AD; Palsson, O; Goode, PS; Burgio, KL; Busby-Whitehead, J; Whitehead, WE",,,,"Markland, A. D.; Palsson, O.; Goode, P. S.; Burgio, K. L.; Busby-Whitehead, J.; Whitehead, W. E.",,,Association of Low Dietary Intake of Fiber and Liquids with Constipation in Older Adults: Evidence from the National Health and Examination Survey (NHANES),JOURNAL OF THE AMERICAN GERIATRICS SOCIETY,,,English,Meeting Abstract,Annual Scientific Meeting on the American-Geriatrics-Society,"MAY 11-14, 2011","National Harbor, MD",Amer Geriatr Soc,,,,,"[Markland, A. D.; Goode, P. S.; Burgio, K. L.] Univ Alabama, Birmingham, AL USA; [Palsson, O.; Busby-Whitehead, J.; Whitehead, W. E.] Univ N Carolina, Chapel Hill, NC USA; [Markland, A. D.; Goode, P. S.; Burgio, K. L.] VAMC, Birmingham Atlanta GRECC, Birmingham, AL USA",University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Chapel Hill; Geriatric Research Education & Clinical Center,,,,,,,,,0,0,0,0,4,WILEY-BLACKWELL,MALDEN,"COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA",0002-8614,,,J AM GERIATR SOC,J. Am. Geriatr. Soc.,APR,2011,59,,,1,,,S71,S71,,,,,,1,Geriatrics & Gerontology; Gerontology,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S),Geriatrics & Gerontology,750DJ,,,,,2024-06-04,WOS:000289524600207,View Full Record in Web of Science
J,"Samara, VC; Jerant, P; Gibson, S; Bromberg, M",,,,"Samara, Verena C.; Jerant, Patricia; Gibson, Summer; Bromberg, Mark",,,"Bowel, bladder, and sudomotor symptoms in ALS patients",JOURNAL OF THE NEUROLOGICAL SCIENCES,,,English,Article,,,,,,ALS; Constipation; Bowel symptoms; Urinary symptoms; Sudomotor symptoms,AMYOTROPHIC-LATERAL-SCLEROSIS; URINARY-TRACT SYMPTOMS; EXTERNAL ANAL-SPHINCTER; CHRONIC CONSTIPATION; OVERACTIVE BLADDER; ONUFS NUCLEUS; INVOLVEMENT; INCONTINENCE; DYSFUNCTION; PREVALENCE,"Objectives: To describe prevalence rates of bowel, bladder, and sudomotor symptoms in patients with amyotrophic lateral sclerosis (ALS) in relation to disease onset and progression. Treatment strategies and efficacies were also assessed. Methods: A pilot patient cohort revealed increased incidences of bowel/bladder and sudomotor symptoms. Questionnaires derived from formal bowel and bladder survey instruments were administered to a second cohort of patients during multidisciplinary ALS clinic visits. Results: The pilot cohort of 30 patients reported an increase in bowel symptoms from 17% prior to 70% after the diagnosis of ALS, and an increase in urinary symptoms from 24% to 76%. In the second cohort of 66 patients an increase in constipation from 33% prior to 64.7% after the diagnosis of ALS was reported. 25.4% of patients reported bowel urgency initially, which increased to 33.3% over time. Constipation was most commonly treated with docusate, dietary fiber supplementation, fluid/exercise, and polyethylene glycol. In the second cohort the prevalence of overactive bladder symptoms increased from 3.1% prior to 25.0% after the diagnosis of ALS. Urinary symptoms are most commonly treated with catheters and oxybutynin. A sudomotor survey found stinging eyes in 17.2% of patients, oily/greasy skin in 14.1% of patients, and flaking of the skin in 29.7% of patients. Conclusions: Bowel and bladder symptoms are common in the ALS population and respond to treatment. Sudomotor symptoms are also common. Inquiring about these symptoms at clinic visits and initiating treatment can significantly improve the patients' quality of life.","[Samara, Verena C.] PeaceHlth Neurol, Springfield, OR 97477 USA; [Samara, Verena C.; Jerant, Patricia; Gibson, Summer; Bromberg, Mark] Univ Utah, Dept Neurol, Salt Lake City, UT USA",Utah System of Higher Education; University of Utah,"Samara, VC (corresponding author), PeaceHlth Neurol, Springfield, OR 97477 USA.",Verena.Samara@gmail.com,,,,,,,19,10,10,1,3,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",0022-510X,1878-5883,,J NEUROL SCI,J. Neurol. Sci.,AUG 15,2021,427,,,,,,,,117543,10.1016/j.jns.2021.117543,http://dx.doi.org/10.1016/j.jns.2021.117543,,JUN 2021,5,Clinical Neurology; Neurosciences,Science Citation Index Expanded (SCI-EXPANDED),Neurosciences & Neurology,TS1UO,34182195,,,,2024-06-04,WOS:000679443200022,View Full Record in Web of Science
C,"Yamanaka, T; Li, D; Nakajima, S",,,IEEE,"Yamanaka, Takuya; Li, Da; Nakajima, Shinsuke",,,Preliminary Analysis of Dietary Management Support Method for Improving the Symptoms in Irritable Bowel Syndrome,"2023 INTERNATIONAL CONFERENCE ON COMPUTING, NETWORKING AND COMMUNICATIONS, ICNC",International Conference on Computer Networking and Communications,,English,Proceedings Paper,"International Conference on Computing, Networking and Communications (ICNC)","FEB 20-22, 2023","Honolulu, HI",,,Irritable Bowel Syndrome; IBS; machine learning; data mining; health care,LIFE-STYLE; DISORDERS; RISK,"Irritable bowel syndrome (IBS) is a syndrome of chronic abdominal discomfort and abnormal bowel movements such as diarrhea and constipation, despite the absence of inflammation or ulcers in the intestines on normal examination. Dietary therapy is one of the treatment options for IBS, and is recommended to reduce symptoms by avoiding stimulants, high-fat foods, high-fiber foods, and fermented foods. However, because the intestinal environment varies from person to person, some foods are suitable for some people and others are not. We thought that if patients could find foods that suit their bodies, their symptoms could be improved. In this study, we propose machine learning based methods to predict whether IBS symptoms appear or not based on the data of patients daily meals and their stomach condition. In addition, we describe our experimental results and evaluation of the proposed method.","[Yamanaka, Takuya; Nakajima, Shinsuke] Kyoto Sangyo Univ, Kyoto, Japan; [Li, Da] Fukuoka Univ, Fukuoka, Japan",Kyoto Sangyo University; Fukuoka University,"Yamanaka, T (corresponding author), Kyoto Sangyo Univ, Kyoto, Japan.",i2186221@cc.kyoto-su.ac.jp; lida@fukuoka-u.ac.jp; nakajima@cc.kyoto-su.ac.jp,,,JSPS KAKENHI research grant [20H04293]; Kyoto Sangyo University [M2001],JSPS KAKENHI research grant; Kyoto Sangyo University,"This work was supported by a JSPS KAKENHI research grant (20H04293). It is also a product of research activity of the Institute of Advanced Technology and the Center for Sciences towards Symbiosis among Human, Machine and Data which was financially supported by a Kyoto Sangyo University Research Grant (M2001).",,27,0,0,0,0,IEEE,NEW YORK,"345 E 47TH ST, NEW YORK, NY 10017 USA",2325-2626,,978-1-6654-5719-4,INT CONF COMPUT NETW,,,2023,,,,,,,536,540,,10.1109/ICNC57223.2023.10073984,http://dx.doi.org/10.1109/ICNC57223.2023.10073984,,,5,"Computer Science, Hardware & Architecture; Computer Science, Information Systems; Computer Science, Theory & Methods; Telecommunications",Conference Proceedings Citation Index - Science (CPCI-S),Computer Science; Telecommunications,BV4AE,,,,,2024-06-04,WOS:001026593400093,View Full Record in Web of Science
J,"De Lillo, AR; Rose, S",,,,"De Lillo, AR; Rose, S",,,"Functional bowel disorders in the geriatric patient: Constipation, fecal impaction, and fecal incontinence",AMERICAN JOURNAL OF GASTROENTEROLOGY,,,English,Article,,,,,,,ELDERLY PATIENTS; INTESTINAL TRANSIT; DIABETES-MELLITUS; DIETARY FIBER; UNITED-STATES; MANAGEMENT; POPULATION; BRAN; PREVALENCE; CISAPRIDE,"Functional bowel disorders, including constipation, fecal impaction, and fecal incontinence, are common gastrointestinal diseases in the elderly and a major source of morbidity. Often the etiology is multifactorial. Evaluation should investigate presenting symptoms and important historical clues. An appropriate workup, including radiological studies, endoscopy, and physiological testing should be individualized. Therapy should be directed against relieving the major complaint and treating the underlying pathophysiological mechanism. (C) 2000 by Am. Cell. of Gastroenterology.","Mt Sinai Sch Med, Div Gastroenterol, New York, NY 10029 USA",Icahn School of Medicine at Mount Sinai,"Rose, S (corresponding author), Mt Sinai Sch Med, Div Gastroenterol, Box 1257,1 Gustave L Levy Pl, New York, NY 10029 USA.",,,,,,,,52,53,58,1,10,ELSEVIER SCIENCE INC,NEW YORK,"655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA",0002-9270,,,AM J GASTROENTEROL,Am. J. Gastroenterol.,APR,2000,95,4,,,,,901,905,,10.1016/S0002-9270(00)00718-8,http://dx.doi.org/10.1016/S0002-9270(00)00718-8,,,5,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Gastroenterology & Hepatology,301HU,10763934,,,,2024-06-04,WOS:000086305400008,View Full Record in Web of Science
J,"Razagui, IB; Barlow, PJ; Taylor, KDA; Izmeth, MGA",,,,"Razagui, IB; Barlow, PJ; Taylor, KDA; Izmeth, MGA",,,Dietary zinc intake of a group of long-stay mentally handicapped women - Some bioavailability considerations,BIOLOGICAL TRACE ELEMENT RESEARCH,,,English,Article,,,,,,zinc; diet; bioavailability; women; mentally handicapped,WHEAT BRAN; NUTRITIONAL-STATUS; ZN AVAILABILITY; PHYTATE CONTENT; IRON; FIBER; ABSORPTION; CALCIUM; BREAD; VEGETABLES,"Dietary factors affecting zinc bioavailability were evaluated according to their relative distribution in the individual daily meals making up the basic diet of 17 institutionalized, mentally handicapped adult women. Mean intake values of zinc, phytate, nonstarch polysaccharides (NSP), calcium, protein, and energy were calculated from a dietary survey of 7 consecutive days, which also served to obtain values for the two zinc bioavailability predictor formulas, phytate/Zn millimolar ratio and [Ca][phytate]/[Zn][energy] ratio. Mean daily zinc intake was 8.5 +/- 1.8 mg, with noon and evening meals accounting for the highest contribution to this value (45% and 35%, respectively), whereas breakfast meals' contribution was 16%. The mean protein intake was 55 +/- 13 g, with noon and evening meals being the major contributors to total daily intake (42% and 38%, respectively). Breakfast meals accounted for 77% of daily phytate intake, giving a respective phytate/Zn millimolar ratio of 20.4 +/- 7.6 and a [Ca][phytate]/[Zn][energy] ratio of 336 +/- 127 mmol/Mcal. Values for both ratios based on noon and evening meals were negligible in comparison. The mean daily NSP intake was 9.8 +/- 4.2 g, with 53% of total daily intake supplied from breakfast meals, whereas noon and evening meals accounted for 30% and 14%, respectively. The results, while suggesting that zinc bioavailability is unlikely to be adversely affected, indicated that dietary fiber intake levels are probably inadequate, particularly in view of the nonambulant condition and low physical activity prevalent in such individuals, who may, as a consequence, be susceptible to health disorders associated with impaired bowel function and constipation.","Univ Lincolnshire & Humberside, Sch Appl Sci & Technol, Grimsby DN34 5AA, NE Lincs, England; Greaves Hall Hosp, Mental Handicap Serv Sect, Southport PR9 8BL, Merseyside, England",University of Lincoln,"Taylor, KDA (corresponding author), Univ Lincolnshire & Humberside, Sch Appl Sci & Technol, Humber Lodge,61 Bargate, Grimsby DN34 5AA, NE Lincs, England.",,,,,,,,52,0,0,0,1,HUMANA PRESS INC,TOTOWA,"999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA",0163-4984,1559-0720,,BIOL TRACE ELEM RES,Biol. Trace Elem. Res.,APR,1999,68,1,,,,,25,39,,10.1007/BF02784394,http://dx.doi.org/10.1007/BF02784394,,,15,Biochemistry & Molecular Biology; Endocrinology & Metabolism,Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Endocrinology & Metabolism,181HX,10208654,,,,2024-06-04,WOS:000079436900003,View Full Record in Web of Science
J,"CUMMINGS, JH; BINGHAM, SA; HEATON, KW; EASTWOOD, MA",,,,"CUMMINGS, JH; BINGHAM, SA; HEATON, KW; EASTWOOD, MA",,,"FECAL WEIGHT, COLON CANCER RISK, AND DIETARY-INTAKE OF NONSTARCH POLYSACCHARIDES (DIETARY FIBER)",GASTROENTEROLOGY,,,English,Article,,,,,,,LARGE-BOWEL FUNCTION; TRANSIT-TIME; HEALTHY-SUBJECTS; STOOL WEIGHT; CONSTIPATION; BALANCE; CALCIUM; BRAN; EPIDEMIOLOGY; INDIVIDUALS,,"UNIV CAMBRIDGE,CAMBRIDGE,ENGLAND; BRISTOL ROYAL INFIRM & GEN HOSP,DEPT MED,BRISTOL BS2 8HW,AVON,ENGLAND; WESTERN GEN HOSP,GASTROINTESTINAL UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND",University of Cambridge; Bristol Royal Infirmary; University of Edinburgh,"CUMMINGS, JH (corresponding author), MRC,DUNN CLIN NUTR CTR,100 TENNIS COURT RD,CAMBRIDGE CB2 1QL,ENGLAND.",,"Cummings, John/AAC-2007-2019; Cummings, John H/H-3538-2011",,,,,,57,352,381,0,39,W B SAUNDERS CO,PHILADELPHIA,"INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399",0016-5085,,,GASTROENTEROLOGY,Gastroenterology,DEC,1992,103,6,,,,,1783,1789,,10.1016/0016-5085(92)91435-7,http://dx.doi.org/10.1016/0016-5085(92)91435-7,,,7,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,KA026,1333426,Bronze,,,2024-06-04,WOS:A1992KA02600011,View Full Record in Web of Science
J,"Choi, HI; Cha, JM; Jeong, IK; Cho, IJ; Yoon, JY; Kwak, MS; Jeon, JW; Kim, SJ",,,,"Choi, Hyoung Il; Cha, Jae Myung; Jeong, In-Kyung; Cho, In-Jin; Yoon, Jin Young; Kwak, Min Seob; Jeon, Jung Won; Kim, Soo Jin",,,Efficacy and safety of Gelidium elegans intake on bowel symptoms in obese adults A 12-week randomized double-blind placebo-controlled trial,MEDICINE,,,English,Article,,,,,,Defecation; dietary fiber; Gelidium elegans; obesity; seaweed,DIETARY FIBER; FUNCTIONAL CONSTIPATION; GASTROINTESTINAL SYMPTOMS; INCREASED PREVALENCE; LIFE-STYLE; ASSOCIATION; SEAWEED; POPULATION; OVERWEIGHT; MANAGEMENT,"Background/aims: Gelidium elegans (GE) is known to have antiobesity effects and beneficial effects on functional bowel symptoms in preclinical studies. The aim of this study was to determine the efficacy and safety of GE intake on bowel symptoms in obese human adults. Methods: This 12-week single-center randomized double-blind placebo-controlled study was performed from September 2016 to May 2017. Consecutive obese subjects were randomly assigned (1: 1) to either GE (1 g) or placebo (1 g) once daily group for 12 weeks. Patients' bowel symptoms were evaluated using the Bristol Stool Form Scale, Constipation Scoring System (CSS), and Patient Assessment of Constipation-Symptoms (PAC-SYM) questionnaire. Results: The stool symptom score of PAC-SYM significantly improved in the GE group compared with the placebo group after the 12-week treatment (P=.041). Abdominal discomfort score of CSS significantly decreased at 12 weeks compared to that at baseline in the GE group (P=.003), but not in the placebo group (P=.398). In addition, abdominal discomfort score of CSS slightly decreased in the GE group compared with the placebo group after the 12-week treatment (P=.060). However, stool consistency, total CSS score, and PAC-SYM score did not change significantly in both GE group and the placebo group over the 12-week treatment period. Conclusions: GE treatment for 12 weeks improved the stool symptom score on the PAC-SYM and abdominal discomfort score on the CSS in obese adults. However, further research is needed in large-scale human studies.","[Choi, Hyoung Il; Yoon, Jin Young] Kyung Hee Univ, Grad Sch, Dept Med, Seoul, South Korea; [Cha, Jae Myung; Jeong, In-Kyung; Cho, In-Jin; Yoon, Jin Young; Kwak, Min Seob; Jeon, Jung Won] Kyung Hee Univ Hosp Gangdong, Dept Internal Med, Seoul, South Korea; [Kim, Soo Jin] Kyung Hee Univ Hosp Gangdong, Inst Med Sci, Seoul, South Korea",Kyung Hee University; Kyung Hee University; Kyung Hee University Hospital; Kyung Hee University; Kyung Hee University Hospital,"Cha, JM (corresponding author), Kyung Hee Univ, Sch Med, Kyung Hee Univ Hosp Gangdong, Dept Internal Med, 892 Dongnam Ro, Seoul 05278, South Korea.;Jeong, IK (corresponding author), Kyung Hee Univ, Sch Med, Kyung Hee Univ Hosp Gangdong, Dept Endocrinol, 892 Dongnam Ro, Seoul 05278, South Korea.",drcha@khu.ac.kr; jik1016@naver.com,"Cheon, Jae Hee/B-4523-2015; Jeong, In-Kyung/AAI-6488-2020","Jeong, In-Kyung/0000-0001-7857-546X","Ministry of Oceans and Fisheries, Republic of Korea [20150349]","Ministry of Oceans and Fisheries, Republic of Korea","This work was supported by the Industry Technology Development Program of Fisheries Food, 20150349, Development of functional ingredient approved by MFDS and global finished product for improving metabolic syndrome using Gelidium elegans by the Ministry of Oceans and Fisheries, Republic of Korea.",,47,2,2,0,3,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0025-7974,1536-5964,,MEDICINE,Medicine (Baltimore),APR,2019,98,17,,,,,,,e14981,10.1097/MD.0000000000014981,http://dx.doi.org/10.1097/MD.0000000000014981,,,8,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,HX4AS,31027051,"Green Published, gold",,,2024-06-04,WOS:000467337400002,View Full Record in Web of Science
J,"Vandenplas, Y; Hegar, B; Munasir, Z; Astawan, M; Juffrie, M; Bardosono, S; Sekartini, R; Basrowi, RW; Wasito, E",,,,"Vandenplas, Yvan; Hegar, Badriul; Munasir, Zakiudin; Astawan, Made; Juffrie, Mohammad; Bardosono, Saptawati; Sekartini, Rini; Basrowi, Ray Wagiu; Wasito, Erika",,,The role of soy plant-based formula supplemented with dietary fiber to support children's growth and development: An expert opinion,NUTRITION,,,English,Review,,,,,,Soy-based infant formula; Child growth and development; Expert opinion,INFANT FORMULAS; FEEDING INFANTS; PROTEIN; IRON; MILK; CONSTIPATION; POSITION; ALLERGY; SAFETY; ANEMIA,"Objectives: Soy-based formula has evolved in usage and processing technology since its introduction in 1909, and has been used as substitute formula for infants or children with cow milk allergy since 1929. At present, personal opinions, religious background, availability, palatability, and cost are part of the reasons soy-based formula is chosen. Technology in processing soy-based formula has evolved from using soy flour to soy protein isolate, which provides advantages. However, concerns remain regarding the impact of its use on the growth and development of children. Methods: An expert meeting, attended by 12 experts, was initiated in Jakarta, Indonesia, to obtain an evidence-based consensus on the role of soy protein isolate formula, as well as its nutritional value to support growth and development. Results: Ensuring that plant-based formula (i.e., soy protein isolate formula) is fortified with key nutrients, such as calcium, iron, and dietary fiber is important. Conclusions: Consensus was achieved, concluding that soy protein isolate formula is safe, affordable, and an alternative option for cow's milk-based formula for term infants. (c) 2021 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)","[Vandenplas, Yvan] Vrije Univ Brussel, UZ Brussel, KidZ Hlth Castle, Brussels, Belgium; [Hegar, Badriul; Munasir, Zakiudin; Sekartini, Rini] Univ Indonesia, Cipto Mangunkusumo Gen Hosp, Fac Med, Dept Pediat, Jakarta, Indonesia; [Astawan, Made] IPB Univ, Dept Food Sci & Technol, Bogor, Indonesia; [Juffrie, Mohammad] Univ Gajah Mada, Dept Child Hlth, Fac Med, Yogyakarta, Indonesia; [Bardosono, Saptawati] Univ Indonesia, Cipto Mangunkusumo Gen Hosp, Fac Med, Dept Nutr, Jakarta, Indonesia; [Basrowi, Ray Wagiu; Wasito, Erika] Danone Specialized Nutr Indonesia, Jakarta, Indonesia",University Hospital Brussels; Vrije Universiteit Brussel; University of Indonesia; Bogor Agricultural University; Gadjah Mada University; University of Indonesia,"Vandenplas, Y (corresponding author), Vrije Univ Brussel, UZ Brussel, KidZ Hlth Castle, Brussels, Belgium.",yvan.vandenplas@uzbrussel.be,"Astawan, Made/GPC-8927-2022; basrowi, ray wagiu/S-1689-2018","Astawan, Made/0000-0002-1274-2859; basrowi, ray wagiu/0000-0002-9507-527X",PT Nutricia Indonesia Sejahtera,PT Nutricia Indonesia Sejahtera(Danone Nutricia),"The authors thank Drs. Susianto, Nia Kurniati, Lanny Christine Gultom, I Gusti Lanang Sidiartha, and Dadi Hidayat Maskar for their valuable contribution and inputs during the discussion in the expert meeting. Ray Wagiu Basrowi and Erika Wasito are employ-ees of Nutricia-Danone Specialized Nutrition Indonesia. The other authors declare that they have no competing interests. The expert meeting was funded by PT Nutricia Indonesia Sejahtera.",,51,7,7,2,28,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",0899-9007,1873-1244,,NUTRITION,Nutrition,OCT,2021,90,,,,,,,,111278,10.1016/j.nut.2021.111278,http://dx.doi.org/10.1016/j.nut.2021.111278,,MAY 2021,5,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,US8PV,34004412,hybrid,,,2024-06-04,WOS:000697689200019,View Full Record in Web of Science
J,"Bouchoucha, M; Faye, A; Savarieau, B; Arsac, M",,,,"Bouchoucha, M; Faye, A; Savarieau, B; Arsac, M",,,Effect of an oral bulking agent and a rectal laxative administered alone or in a combination for the treatment of constipation,GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE,,,English,Article,,,,,,,TRANSIT-TIME; DIETARY FIBER; STOOL FORM; PSYLLIUM; MANAGEMENT; DOCUSATE; SYMPTOMS; THERAPY; COLON; SLOW,"Objectives - The aim of the present study was to search for a synergetic action between psyllium and a defecation-inducing drug, Eductyl(R), for symptom relief in patients suffering from chronic constipation. Methods - Twenty healthy volunteers and 20 patients complaining of chronic constipation were included in a randomized crossover study. The study was divided into four 2-weeks periods: pre-inclusion and three periods of treatment with psyllium, Eductyl(R), and Eductyl(R) + psyllium respectively. Colonic transit time was determined at the end of each period of treatment. During each of the four periods, a self-administered questionnaire was used to assess symptoms of constipation. Results - For constipated patients, treatment with Eductyl(R) and Eductyl(R)-psyllium improved clinical symptoms of constipation: increased stool frequency, resulted in fewer hard stools and less sensation of incomplete evacuation and less straining to defecate. The improvement was associated with a decrease in total and segmental colonic transit time. The Eductyl(R)-psyllium combination did not exhibit any synergetic effect. Conclusion - Treatment with Eductyl(R) alone is more efficient than with psyllium alone in providing symptom relief. Combination with psyllium is not synergetic.","Univ Paris 05, Hop Broussais, Lab Physiol Digest, F-75014 Paris, France; Ctr Hosp Intercommunal Creteil, F-94010 Creteil, France",Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Europeen Georges-Pompidou - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil,"Bouchoucha, M (corresponding author), Univ Paris 05, Hop Broussais, Lab Physiol Digest, 96,Rue Didot, F-75014 Paris, France.",michel.bouchoucha@brs.op-hop-paris.fr,,"Bouchoucha, Michel/0000-0002-5376-9265",,,,,34,18,20,0,5,MASSON EDITEUR,MOULINEAUX CEDEX 9,"21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE",0399-8320,,,GASTROEN CLIN BIOL,Gastroenterol. Clin. Biol.,MAY,2004,28,5,,,,,438,443,,10.1016/S0399-8320(04)94953-6,http://dx.doi.org/10.1016/S0399-8320(04)94953-6,,,6,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,839EW,15243316,,,,2024-06-04,WOS:000222767200003,View Full Record in Web of Science
J,"Murray, CDR; Emmanuel, AV",,,,"Murray, CDR; Emmanuel, AV",,,Medical management of diverticular disease,BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY,,,English,Article,,,,,,diverticular disease; dietary fibre; irritable bowel syndrome; functional gastrointestinal disease,IRRITABLE-BOWEL-SYNDROME; HIGH-FIBER DIET; INTRALUMINAL PRESSURE; COLON FUNCTION; ANIMAL-MODEL; BRAN; LACTULOSE; RIFAXIMIN; PATHOPHYSIOLOGY; CONSTIPATION,"Diverticular disease is a common disorder affecting 30-55% of the population in the developed world. It has been described as 'a deficiency disease of Western civilization', a theory that has been proposed since it was observed that diverticular disease was uncommon in African and other developing countries where dietary fibre consumption was high. At the turn of the century the medical treatment of colonic diverticulosis involved the avoidance of 'roughage', which was felt to exacerbate the problem. However, the use of high fibre diets in the prevention and treatment of the symptoms of diverticular disease has now become commonplace, and the development of this practice is discussed in this chapter.","St Marks Hosp, Harrow HA1 3UJ, Middx, England",Imperial College London,"St Marks Hosp, Northwick Pk,Watford Rd, Harrow HA1 3UJ, Middx, England.",a.emmanuel@ic.ac.uk,"Murray, Charles D R/T-7847-2019","Murray, Charles D R/0000-0001-6736-1546",,,,,61,4,5,1,5,ELSEVIER SCI LTD,OXFORD,"THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND",1521-6918,1532-1916,,BEST PRACT RES CL GA,Best Pract. Res. Clin. Gastroenterol.,AUG,2002,16,4,,,,,611,620,,10.1053/bega.2002.0301,http://dx.doi.org/10.1053/bega.2002.0301,,,10,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,612XA,12406454,,,,2024-06-04,WOS:000179099700007,View Full Record in Web of Science
J,"Stevenson, C; Blaauw, R; Fredericks, E; Visser, J; Roux, S",,,,"Stevenson, Cheryl; Blaauw, Renee; Fredericks, Ernst; Visser, Janicke; Roux, Saartjie",,,Probiotic effect and dietary correlations on faecal microbiota profiles in irritable bowel syndrome,SOUTH AFRICAN JOURNAL OF CLINICAL NUTRITION,,,English,Article,,,,,,diet; gut microbiota; irritable bowel syndrome; probiotic,INTESTINAL MICROBIOTA; TEMPORAL STABILITY; CLINICAL-TRIAL; SYMPTOMS; DIVERSITY; UPDATE; IMPACT; IBS,"Objective: Probiotics and nutrient intakes modulate gastrointestinal (GIT) microbiota and symptoms of irritable bowel syndrome (IBS). The extent to which these factors influence the microbiota is relatively unknown. The primary objective of this paper was to investigate the effect of a probiotic on gut microbiota and IBS symptoms. The secondary objective was exploring correlations between dietary intake and gut microbiota. Design: This study was an extension of a randomised clinical trial (Clinical Trials Registry NCT018867810). Dietary intake was recorded by three-day estimated food records. Faecal samples were collected at three time points: (1) baseline (A), (2) after eight weeks' probiotic supplementation (Lactobacillus plantarum 299v) (B) and (3) following a two-week washout period (C). Total Bacteroides spp., Bifidobacteria bifidum and Lactobacillus plantarum were quantified by quantitative real-time polymerase chain reaction (qPCR). Results: Twenty-eight diarrhoea-predominant IBS (D-IBS) and 24 constipation-predominant IBS (C-IBS) patients participated. Lactobacillus plantarum profiles at baseline (A) were significantly different between C-IBS and D-IBS (-0.956 +/- 1.239 vs. -1.700 +/- 1.239; p = 0.024). There was no significant change in bacterial counts after completion of the trial (B) and following the washout period (C) between groups. In both groups there were significant direct correlations between fibre and Lactobacillus plantarum and inverse correlations between fibre and Bacteroides spp. There was no difference in symptom severity scores between treatment and placebo groups during the study. Conclusion: The probiotic had no effect on symptoms and GIT microbiota. Certain nutrients strongly correlate to certain bacterial profiles, suggesting that nutrients can significantly influence gastrointestinal microbiota composition.","[Stevenson, Cheryl; Blaauw, Renee; Visser, Janicke] Stellenbosch Univ, Div Human Nutr, Fac Med & Hlth Sci, Cape Town, South Africa; [Fredericks, Ernst; Roux, Saartjie] Nelson Mandela Univ, Dept Biochem & Microbiol, Port Elizabeth, South Africa",Stellenbosch University; Nelson Mandela University,"Stevenson, C (corresponding author), Stellenbosch Univ, Div Human Nutr, Fac Med & Hlth Sci, Cape Town, South Africa.",cheryl@retaildc.co.za,"Visser, Janicke/ABF-7925-2020","Roux, Saartjie/0000-0002-6823-8934",Nestle Nutrition Institute Africa; South African National Research Foundation [2075266],Nestle Nutrition Institute Africa(Nestle SA); South African National Research Foundation(National Research Foundation - South Africa),This study was funded in part by Nestle Nutrition Institute Africa (www.nnia.org) and the South African National Research Foundation [gun number 2075266].,,36,2,2,1,8,TAYLOR & FRANCIS LTD,ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND",1607-0658,2221-1268,,S AFR J CLIN NUTR,S. Afr. J. Clin. Nutr.,JUL 3,2021,34,3,,,,,84,89,,10.1080/16070658.2019.1697038,http://dx.doi.org/10.1080/16070658.2019.1697038,,DEC 2019,6,Nutrition & Dietetics,Emerging Sources Citation Index (ESCI),Nutrition & Dietetics,UM4FE,,gold,,,2024-06-04,WOS:000502184200001,View Full Record in Web of Science
J,"Sanjoaquin, MA; Appleby, PN; Spencer, EA; Key, TJ",,,,"Sanjoaquin, MA; Appleby, PN; Spencer, EA; Key, TJ",,,"Nutrition and lifestyle in relation to bowel movement frequency: a cross-sectional study of 20,630 men and women in EPIC-Oxford",PUBLIC HEALTH NUTRITION,,,English,Article,,,,,,constipation; bowel movennts; risk factors; lifestyle; nutrition,DIETARY FIBER; CANCER; CONSTIPATION; INDIVIDUALS; EXERCISE; HABITS,"Objective: To investigate the relationships between nutritional and lifestyle factors and bowel movement frequency. Design: Cross-sectional analysis using data from a prospective study. Mean numbers of bowel movements were calculated in relation to a range of factors. in addition, individuals were categorised according to frequency of bowel movements: fewer than 7 per week ('less than daily') versus 7 or more per week ('daily'), and odds ratios were calculated from logistic regression models. Results for each factor were adjusted for the other factors under consideration. Setting: The European Prospective Investigation into Cancer and Nutrition, Oxford cohort (EPIC-Oxford), UK. Participants: In total, 20 630 men and women aged 22-97 years at recruitment. Thirty per cent of the subjects were vegetarians or vegans. Results: Women had fewer bowel movements on average than men, and were less likely to have daily bowel movements. Mean bowel movement frequency was higher in vegetarians (10.5 in men, 9.1 in women) and especially in vegans (11.6 in men, 10.5 in women) compared with participants who ate meat (9.5 in men, 8.2 in women). There were also significant positive associations between bowel movement frequency and body mass index (BMI), intakes of dietary fibre and non-alcoholic fluids, for both men and women. Vigorous exercise was positively associated with bowel movement frequency in women although results for men were less clear. Alcohol intake was positively associated with bowel movement frequency in men but not in women. Conclusion: Being vegetarian and especially vegan is strongly associated with a higher frequency of bowel movements. Moreover, having a high intake of dietary fibre and fluids and a high BMI are associated with an increase in frequency of bowel movements.","Univ Oxford, Radcliffe Infirm, Canc Res UK, Epidemiol Unit, Oxford OX2 6HE, England",Radcliffe Infirmary; Cancer Research UK; University of Oxford,"Univ Oxford, Radcliffe Infirm, Canc Res UK, Epidemiol Unit, Gibson Bldg, Oxford OX2 6HE, England.",Miguel.SanJoaquin@cancer.org.uk,"Spencer, Elizabeth/AAE-7409-2022","Spencer, Elizabeth/0000-0002-9079-8006",,,,,25,67,68,2,18,CAMBRIDGE UNIV PRESS,CAMBRIDGE,"EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND",1368-9800,1475-2727,,PUBLIC HEALTH NUTR,Public Health Nutr.,FEB,2004,7,1,,,,,77,83,,10.1079/PHN2003522,http://dx.doi.org/10.1079/PHN2003522,,,7,"Public, Environmental & Occupational Health; Nutrition & Dietetics",Science Citation Index Expanded (SCI-EXPANDED),"Public, Environmental & Occupational Health; Nutrition & Dietetics",777XV,14972075,Bronze,,,2024-06-04,WOS:000189209900010,View Full Record in Web of Science
J,"Wagstaff, AJ; Frampton, JE; Croom, KF",,,,"Wagstaff, AJ; Frampton, JE; Croom, KF",,,Tegaserod - A review of its use in the management of irritable bowel syndrome with constipation in women,DRUGS,,,English,Article,,,,,,,RECEPTOR PARTIAL AGONIST; SDZ HTF 919; SEROTONIN 5-HT4 RECEPTOR; GASTROINTESTINAL MOTILITY; CLINICAL PHARMACOKINETICS; SIGNIFICANTLY AFFECT; PERISTALTIC REFLEX; PROMOTILE DRUG; DOUBLE-BLIND; IBS-C,"The treatment of irritable bowel syndrome with constipation (IBS-C) has historically been based on the severity of symptoms, with education, reassurance, dietary advice, bulking agents and laxative therapy offered as appropriate. Tegaserod (Zelnorm(R), Zelmac(R)) is the first selective serotonin 5-HT4 receptor partial agonist to be approved for the treatment of this syndrome. Tegaserod is active against multiple irritable bowel syndrome (IBS) symptoms; it stimulates gut motility and reduces visceral sensitivity and pain. The drug does not cure IBS and was not designed to treat the diarrhoea-predominant version. Its efficacy in men has not been established. Three large well designed clinical trials of tegaserod 6mg twice daily for 12 weeks in patients (mainly women) with IBS-C have demonstrated superiority versus placebo in global relief from symptoms. Global relief response rates were 38.4-46.8% with tegaserod 6mg twice daily and 28.3-38.8% with placebo (p < 0.05-0.0001 vs placebo). The relative increases in response rates with tegaserod 6mg twice daily over the already high responses in the placebo groups ranged from 12-65% after 4-12 weeks of treatment. A response was seen within the first week. The proportion of patients with satisfactory relief from symptoms fell over the 4-week period following withdrawal of tegaserod and placebo, but did not reach baseline levels during this time. Diarrhoea has been associated with tegaserod in clinical trials (an incidence of about 10% versus 5% with placebo, usually occurring in the first week of treatment), but the drug is otherwise well tolerated. There were no apparent changes in the tolerability profile with extended tegaserod treatment (less than or equal to12 months). In conclusion, oral tegaserod 6mg twice daily for 12 weeks is effective and well tolerated in the treatment of IBS-C in women. Data on long term and comparative efficacy, cost-effectiveness and quality-of-life effects would be beneficial; however, in light of the fact that very few alternatives for the treatment of IBS-C have proven efficacy, tegaserod appears to be a promising option in women not responding to increased dietary fibre or osmotic laxative therapy.","Adis Int Ltd, Auckland 10, New Zealand",Adis International,"Wagstaff, AJ (corresponding author), Adis Int Ltd, 41 Centorian Dr,Private Bag 65901,Mairangi Bay, Auckland 10, New Zealand.",demail@adis.co.nz,,,,,,,82,31,33,0,0,ADIS INT LTD,NORTHCOTE,"5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND",0012-6667,1179-1950,,DRUGS,Drugs,,2003,63,11,,,,,1101,1120,,10.2165/00003495-200363110-00013,http://dx.doi.org/10.2165/00003495-200363110-00013,,,20,Pharmacology & Pharmacy; Toxicology,Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy; Toxicology,687ZF,12749744,,,,2024-06-04,WOS:000183406600013,View Full Record in Web of Science
J,"Akram, M; Thiruvengadam, M; Zainab, R; Daniyal, M; Bankole, MM; Rebezov, M; Shariati, MA; Okuskhanova, E",,,,"Akram, Muhammad; Thiruvengadam, Muthu; Zainab, Rida; Daniyal, Muhammad; Bankole, Marc Moboladji; Rebezov, Maksim; Shariati, Mohammad Ali; Okuskhanova, Eleonora",,,Herbal Medicine for the Management of Laxative Activity,CURRENT PHARMACEUTICAL BIOTECHNOLOGY,,,English,Review,,,,,,Laxative; constipation; medicinal effects; herbal medicines; pharmacological; non-pharmacological,IRRITABLE-BOWEL-SYNDROME; STAY ELDERLY PATIENTS; CHRONIC CONSTIPATION; DOUBLE-BLIND; DIETARY FIBER; FUNCTIONAL CONSTIPATION; ANORECTAL MANOMETRY; ISCHEMIC COLITIS; GENERAL-PRACTICE; LACTULOSE,"Constipation is one of the most common and prevalent chronic gastrointestinal conditions across the globe that is treated or managed through various methods. Laxatives are used for the treatment or management of chronic/acute constipation. But due to the adverse effects associated with these laxatives, herbal foods should be considered as alternative therapies for constipation. In this review, the laxative potential of plant-based medicines used for constipation is discussed. Constipation may be caused by various factors such as lifestyle, particular food habits, pregnancy and even due to some medication. Chronic constipation is responsible for different health issues. Pharmacological and non-pharmacological paradigms are applied for the treatment or management of constipation. In the pharmacological way of treatment, medicinal plants have a key role because of their fibrous nature. Numerous plants such as Prunus persica (Rosaceae), Cyamopsis tetragonolobus (Leguminosae), Citrus sinensis (Rutaceae), Planta goovata (Plantaginaceae), Rheum emodi (Polygonaceae), Cassia auriculata (Caesalpinacea), Ricinus communis (Euphorbiaceae), Croton tiglium (Euphorbiaceae), Aloe barbadensis (Liliaceae), Mareya micrantha (Euphorbiaceae), Euphorbia thymifolia (Euphorbiaceae), Cascara sagrada (Rhamnaceae), Cassia angustifolia (Fabaceae) have laxative activity. Medicinal plants possess a significant laxative potential and support their folklore; therefore, further, well-designed clinical-based studies are required to prove and improve the efficacy of herbal medicine for constipation. The present review showed that herbs laxative effect in various in vivo/ in vitro models.","[Akram, Muhammad; Zainab, Rida] Govt Coll Univ Faisalabad, Dept Eastern Med, Faisalabad, Punjab, Pakistan; [Thiruvengadam, Muthu] Konkuk Univ, Coll Sanghuh Life Sci, Dept Crop Sci, Seoul 05029, South Korea; [Daniyal, Muhammad] Hamdard Univ, Fac Eastern Med, Karachi, Pakistan; [Bankole, Marc Moboladji] Univ Port Harcourt, African Ctr Excellence World Bank Publ Hlth & Tox, Port Harcourt, Rivers State, Nigeria; [Rebezov, Maksim] Russian Acad Sci, VM Gorbatov Fed Res Ctr Food Syst, Moscow, Russia; [Rebezov, Maksim] Russian Acad Sci, Prokhorov Gen Phys Inst, Moscow, Russia; [Shariati, Mohammad Ali] KG Razumovsky Moscow State Univ Technol & Managem, Cossack Univ 1, Moscow 109004, Russia; [Okuskhanova, Eleonora] Shakarim State Univ Semey, Semey, Kazakhstan",Government College University Faisalabad; Konkuk University; Hamdard University; University of Port Harcourt; Russian Academy of Sciences; Russian Academy of Sciences; Prokhorov General Physics Institute of the Russian Academy of Sciences; K.G. Razumovsky Moscow State University of Technologies & Management the First Cossack University; Semey State University Shakarim,"Thiruvengadam, M (corresponding author), Konkuk Univ, Coll Sanghuh Life Sci, Dept Crop Sci, Seoul 05029, South Korea.",muthu@konkuk.ac.kr,"Shariati, Mohammad Ali/HCI-4375-2022; Akram, Muhammad/A-5679-2018; Okuskhanova, Eleonora/O-1627-2015; Rebezov, Maksim/E-5487-2016; Daniyal, Muhammad/A-1617-2015","Shariati, Mohammad Ali/0000-0001-9376-5771; Rebezov, Maksim/0000-0003-0857-5143; Daniyal, Muhammad/0000-0002-5663-5211; Bankole, Marc Moboladji/0000-0001-5324-7443","KU Research Professor Program of Konkuk University, Seoul, South Korea","KU Research Professor Program of Konkuk University, Seoul, South Korea","This paper was supported by the KU Research Professor Program of Konkuk University, Seoul, South Korea.",,141,5,5,2,12,BENTHAM SCIENCE PUBL LTD,SHARJAH,"EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES",1389-2010,1873-4316,,CURR PHARM BIOTECHNO,Curr. Pharm. Biotechnol.,,2022,23,10,,,,,1269,1283,,10.2174/1389201022666210812121328,http://dx.doi.org/10.2174/1389201022666210812121328,,,15,Biochemistry & Molecular Biology; Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Pharmacology & Pharmacy,2U8SX,34387161,,,,2024-06-04,WOS:000823425700005,View Full Record in Web of Science
J,"ZIEGENHAGEN, DJ; TEWINKEL, G; KRUIS, W; HERRMANN, F",,,,"ZIEGENHAGEN, DJ; TEWINKEL, G; KRUIS, W; HERRMANN, F",,,ADDING MORE FLUID TO WHEAT BRAN HAS NO SIGNIFICANT EFFECTS ON INTESTINAL FUNCTIONS OF HEALTHY-SUBJECTS,JOURNAL OF CLINICAL GASTROENTEROLOGY,,,English,Article,,,,,,BRAN; CONSTIPATION; GASTRIC EMPTYING; OROCECAL TRANSIT; WHOLE GUT TRANSIT; FIBER THERAPY,DIETARY FIBER; BOWEL FUNCTION; CONSTIPATION; TRANSIT,"To regulate intestinal transit, increased fluid intake, along with fiber is recommended. Considering the usually large volumes of intestinal secretion, this advice is questionable. To demonstrate the effects of adding fluid to fiber, 11 volunteers ingested 15 g of wheat bran twice a day, randomly given without or with 600 mL of additional fluid. Stool weight and frequency were similarly increased in the two settings. Gastric emptying was delayed by bran only when bran was given without additional fluid. Orocecal transit showed no significant changes. Whole gut transit was slightly more accelerated with added fluid (20.6 vs. 13.5%). No test showed significant differences in direct comparison of bran and bran with additional fluid. We conclude that in healthy persons, such effects of wheat bran as acceleration of transit and increase in stool weight and frequency do not depend on and additional intake of fluid.","UNIV COLOGNE,DEPT MED STAT,W-5000 COLOGNE 41,GERMANY",University of Cologne,"ZIEGENHAGEN, DJ (corresponding author), UNIV COLOGNE,INTERNAL MED CLIN 1,GASTROENTEROL UNIT,BH E 4-8,JOSEF STELZMANN STR 9,W-5000 COLOGNE 41,GERMANY.",,,,,,,,21,27,28,0,0,LIPPINCOTT-RAVEN PUBL,PHILADELPHIA,"227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106",0192-0790,,,J CLIN GASTROENTEROL,J. Clin. Gastroenterol.,OCT,1991,13,5,,,,,525,530,,10.1097/00004836-199110000-00010,http://dx.doi.org/10.1097/00004836-199110000-00010,,,6,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,GJ253,1660502,,,,2024-06-04,WOS:A1991GJ25300009,View Full Record in Web of Science
J,"Bedigian, D",,,,"Bedigian, Dorothea",,,Feeding the Forgotten: Wild and Cultivated Ceratotheca and Sesamum (Pedaliaceae) That Nourish and Provide Remedies in Africa,ECONOMIC BOTANY,,,English,Review,,,,,,Dietary fiber; disturbance vegetation; edible weeds; gendered knowledge; herbarium vouchers; mucilage; nutrition; sesame relatives; vernacular names; women's health,TRADITIONAL LEAFY VEGETABLES; MEDICINAL-PLANTS; CRUDE EXTRACTS; HERBAL DRUGS; OKRA FRUITS; LEAVES; DOMESTICATION; DIVERSITY; RADIATUM; INDICUM,"The usage and cultural importance of wild and weedy edible leaves of wild relatives of sesame, Ceratotheca and Sesamum in Africa, is reported from herbarium records, published sources, and firsthand observations. They contribute not only nutritionallyprotein, lipid, and micronutrients, especially calcium and ironbut release a little scrutinized valuable product, water-soluble polysaccharide mucilage, that serves as a source of fiber and provides beneficial dietary bulk, enhances gastrointestinal function, alleviates constipation, protects against diabetes, and lowers cholesterol. Dissimilar genera and species are used in similar ways. Their utility was discovered by women gathering edible leaves to accompany dry cereal staples. African vernacular names from several disparate cultures refer to their slimy consistency. Corresponding nutritional and mucilage constituents of several other popular African vegetables are evaluated for comparison.","[Bedigian, Dorothea] Missouri Bot Garden, St Louis, MO 63110 USA",Missouri Botanical Gardens,"Bedigian, D (corresponding author), Missouri Bot Garden, St Louis, MO 63110 USA.",dbedigian@yahoo.com,,"Bedigian, Dorothea/0000-0001-6652-2758","Antioch College Faculty Development Award (1994); National Geographic Society Research and Exploration Grant NGS [6218-98, 7732-04, 9813-15]",Antioch College Faculty Development Award (1994); National Geographic Society Research and Exploration Grant NGS(National Geographic Society),"The African Studies Program, University of Illinois initiated this study with a Regional Africanist Fellowship for library research (1992). The Knight Foundation covered travel expenses to Kenya (1993); the Institute for Advanced Study, and the Botany Department at Maseno University, hosted me for 9 weeks, supported by Antioch College Faculty Development Award (1994). National Geographic Society Research and Exploration Grants NGS #6218-98, NGS #7732-04, and NGS #9813-15 financed recent fieldwork.",,209,5,5,2,14,SPRINGER,NEW YORK,"ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES",0013-0001,1874-9364,,ECON BOT,Econ. Bot.,DEC,2018,72,4,,,,,496,542,,10.1007/s12231-018-9437-z,http://dx.doi.org/10.1007/s12231-018-9437-z,,,47,Plant Sciences,Science Citation Index Expanded (SCI-EXPANDED),Plant Sciences,IC5NJ,,,,,2024-06-04,WOS:000471014600009,View Full Record in Web of Science
J,"HOTZ, J; PLEIN, K",,,,"HOTZ, J; PLEIN, K",,,EFFECT OF PSYLLIUM SEEDS COMPARED TO WHEAT BRAN ON STOOL FREQUENCY AND COMPLAINTS IN PATIENTS WITH IRRITABLE-BOWEL-SYNDROME AND CONSTIPATION,MEDIZINISCHE KLINIK,,,German,Article,,,,,,,,"Background and aim: The importance of dietary fibres in treatment of irritable bowel syndrome increased during the last years. Yet the results of clinical studies on the different dietary fibres are not consistant. Therefore we decided to perform a controlled trial with a well. defined group of patients to compare the effectiveness of wheat bran to psyllium seeds. Patients and Methods: Thirty patients each with irritable bowel syndrome group II to III were treated in an open, not controlled study design either with 3 times 3.25 g psylium seeds or 3 times 7 g wheat bran daily. All patients entering the study had not been treated for at least 3 weeks before. The study comprised two treatment phases of two weeks each, separated by two weeks without any treatment, thus leading to a study duration of 6 weeks altogether. Parameters for evaluation were stool frequency and consistancy and the symptoms pain and abdominal distention, measured by a score (1 to 4). Results: In both treatments groups stool frequency and consistancy improved apparantly compared to the starting point or the two weeks treatment free time in between. The improvement of stool frequency was statistically significant (p < 0.0001) for both substances. Furthermore the effect of psyllium seeds exceeded that of wheat bran statistically significant in week 1, 2, 3, 5 and 6 (p < 0.005). Other symptoms such as abdominal pain improved too by therapy, psyllium seeds again tending to show better results. A significant difference between both substances could be observed on the symptom abdominal distension. Whereas abdominal distension decreased under treatment with psyllium seeds it increased with wheat bran. This lead to discontinuation of the study in 5 cases, 3 of which could be changed successfully to psyllium seeds. The difference between psyllium seeds and wheat bran concerning the occurence of abdominal distension was statistically significant (p < 0.01). Conclusion: The results of this study demonstrate the effectiveness of psyllium seeds and wheat bran on stool frequency and consistency of patients with irritable bowel syndrome. Psyllium seeds showed to be superior to wheat bran with respect to stool frequency and abdominal distension so that it should be preferred in treatment of irritable bowel syndrome and constipation.",,,"HOTZ, J (corresponding author), ALLGEMEINES KRANKENHAUS,KLIN INNERE MED & GASTROENTEROL,SIEMENSPLATZ 4,D-29223 CELLE,GERMANY.",,,,,,,,0,15,15,0,3,URBAN & VOGEL,MUNICH,"LINDWURMSTRASSE 95, D-80337 MUNICH, GERMANY",0723-5003,,,MED KLIN,Med. Klin.,DEC 15,1994,89,12,,,,,645,651,,,,,,7,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,QA635,7869999,,,,2024-06-04,WOS:A1994QA63500004,View Full Record in Web of Science
J,"Waitzberg, DL; Pereira, CCA; Logullo, L; Jacintho, TM; Almeida, D; da Silva, MDT; Torrinhas, RSMD",,,,"Linetzky Waitzberg, D.; Alves Pereira, C. C.; Logullo, L.; Manzoni Jacintho, T.; Almeida, D.; Teixeira da Silva, Ma. de L.; de Miranda Torrinhas, R. S. Matos",,,Microbiota benefits after inulin and partially hydrolized guar gum supplementation - a randomized clinical trial in constipated women,NUTRICION HOSPITALARIA,,,English,Article,,,,,,Guar gum; Inulin; Gut microbiota; Short-chain fatty acids; Constipation,CLOSTRIDIUM-PERFRINGENS; DIETARY FIBER; UNITED-STATES; FATTY-ACIDS; BIFIDOBACTERIA; EPIDEMIOLOGY; TRANSIT,"Introduction: Prebiotics positively affect gut microbiota composition, thus improving gut function. These properties may be useful for the treatment of constipation. Objectives: This study assessed the tolerance and effectiveness of a prebiotic inulin/partially hydrolyzed guar gum mixture (I-PHGG) for the treatment of constipation in females, as well as its influence on the composition of intestinal microbiota and production of short chain fatty acids. Methods: Our study enrolled 60 constipated female health worker volunteers. Participants reported less than 3 bowel movements per week. Volunteers were randomized to treatment with prebiotic or placebo. Treatment consisted of 3 weeks supplementation with 15 g/d I-PHGG (fiber group) or maltodextrin (placebo group). Abdominal discomfort, flatulence, stool consistency, and bowel movements were evaluated by a recorded daily questionnaire and a weekly interview. Changes in fecal bacterial population and short chain fatty acids were assessed by real-time PCR and gas chromatography, respectively. Results: There was an increased frequency of weekly bowel movements and patient satisfaction in both the fiber and placebo groups with no significant differences. Total Clostridium sp significantly decreased in the fiber group (p = 0.046) and increased in the placebo group (p = 0.047). There were no changes in fecal short chain fatty acid profile. Conclusions: Consumption of I-PHGG produced clinical results comparable to placebo in constipated females, but had additional protective effects on gut rnicrobiota by decreasing the amount of pathological bacteria of the Clostridium genera.","[Linetzky Waitzberg, D.] Univ Sao Paulo, Fac Med, Sch Med, Dept Gastroenterol,Surg Gastroenterol Discipline, BR-01246903 Sao Paulo, Brazil; [Alves Pereira, C. C.] Univ Fed Sao Paulo, Dept Biociences, Santos, Brazil; [Linetzky Waitzberg, D.; Logullo, L.; Teixeira da Silva, Ma. de L.] GANEP Nutr Humana, Sao Paulo, Brazil",Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP),"Waitzberg, DL (corresponding author), Univ Sao Paulo, Fac Med, Sch Med, Dept Gastroenterol,Surg Gastroenterol Discipline, Avda Dr Arnaldo 455,2 Andar,Sala 2108, BR-01246903 Sao Paulo, Brazil.",dan.waitzberg@gmail.com,"Torrinhas, Raquel Susana/AAH-4722-2019","Torrinhas, Raquel Susana/0000-0003-0874-3995",Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (Fapesp) [07/58600-2],Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (Fapesp)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)),This study was funded by a grant from the Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (Fapesp project 07/58600-2).,,33,55,60,0,39,"ARAN EDICIONES, S L",MADRID,"C/ CASTELLO, 128, 1O, MADRID, 28006, SPAIN",0212-1611,1699-5198,,NUTR HOSP,Nutr. Hosp.,JAN-FEB,2012,27,1,,,,,123,129,,10.3305/nh.2012.27.1.5445,http://dx.doi.org/10.3305/nh.2012.27.1.5445,,,7,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,888WW,22566311,,,,2024-06-04,WOS:000300036300014,View Full Record in Web of Science
J,"Patcharatrakul, T; Valestin, J; Schmeltz, A; Schulze, K; Rao, SSC",,,,"Patcharatrakul, Tanisa; Valestin, Jessica; Schmeltz, Amanda; Schulze, Konrad; Rao, Satish S. C.",,,Factors Associated With Response to Biofeedback Therapy for Dyssynergic Defecation,CLINICAL GASTROENTEROLOGY AND HEPATOLOGY,,,English,Article,,,,,,Pelvic Floor Disorder; Behavioral Therapy; Clinic Trial; Constipation,RANDOMIZED CONTROLLED-TRIAL; PELVIC FLOOR DYSSYNERGIA; IRRITABLE-BOWEL-SYNDROME; LONG-TERM EFFICACY; TRANSIT CONSTIPATION; ANORECTAL DISORDERS; SUPERIOR,"BACKGROUND & AIMS: Biofeedback therapy is effective for dyssynergic defecation (DD), but it is not widely available or reimbursed, and is labor intensive. It is therefore important to select the appropriate patients for this treatment. We investigated symptoms and demographic, manometric, and other factors associated with outcomes of biofeedback therapy in patients with DD. METHODS: We performed a post hoc analysis of 2 prospective studies of biofeedback therapy in 127 adult outpatients (18-75 years old, 120 female) with chronic constipation who failed to respond to treatment with dietary fiber or laxatives (>1 year) and were diagnosed with DD based on standard criteria. In each study, patients received 1-hour, biweekly office biofeedback therapy (6 sessions) or home biofeedback therapy with a device. A therapist used visual feedback, postural, and diaphragmatic breathing techniques to teach subjects to improve defecation. Treatment success was defined by a composite of normalization of dyssynergia pattern and increase of 20 mm in baseline bowel satisfaction score. Factors were compared between the treatment success and failure groups. Intention-to-treat analysis was performed. RESULTS: Of the 127 patients enrolled, 77 (61%) had treatment success. Dyssynergia was corrected in 78% of patients and bowel satisfaction improved in 64% of patients. Baseline demographic features, constipation symptoms, manometric and sensory parameters, balloon expulsion time, and colonic transit results were similar between treatment failure and success groups. Patients with lower baseline bowel satisfaction score (P = .008) and patients who used digital maneuvers (P = .04) were more likely to have successful biofeedback therapy. CONCLUSIONS: Biofeedback therapy is successful in more than 60% of patients with DD. Patients who used digital maneuvers and patients with lower baseline levels of bowel satisfaction were more likely to have treatment success, whereas other factors were not associated with success. Biofeedback therapy should be offered to all patients with DD, irrespective of baseline symptoms or anorectal physiology findings.","[Patcharatrakul, Tanisa; Schmeltz, Amanda; Rao, Satish S. C.] Augusta Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Augusta, GA USA; [Patcharatrakul, Tanisa] Thai Red Cross Soc, King Chulalongkorn Mem Hosp, Dept Med, Div Gastroenterol, Bangkok, Thailand; [Valestin, Jessica; Schulze, Konrad] Univ Iowa Hosp & Clin, Dept Internal Med, Div Gastroenterol, Iowa City, IA 52242 USA",University System of Georgia; Augusta University; Thai Red Cross Society; Chulalongkorn University; University of Iowa,"Rao, SSC (corresponding author), Augusta Univ, Div Gastroenterol & Hepatol, Digest Hlth Ctr, AD 2238,1481 Laney Walker Blvd, Augusta, GA 30912 USA.",srao@augusta.edu,,,"National Institutes of Health grant [RO1 DK 57100-05]; General Clinical Research Centers program, National Center for Research Resources grant [RR00059]","National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); General Clinical Research Centers program, National Center for Research Resources grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))","This study was supported by National Institutes of Health grant RO1 DK 57100-05 and the General Clinical Research Centers program, National Center for Research Resources grant RR00059 awarded to Satish Rao, Jessica Valestin, and Konrad Schulze.",,17,37,39,0,17,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",1542-3565,1542-7714,,CLIN GASTROENTEROL H,Clin. Gastroenterol. Hepatol.,MAY,2018,16,5,,,,,715,721,,10.1016/j.cgh.2017.10.027,http://dx.doi.org/10.1016/j.cgh.2017.10.027,,,7,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,GD7CY,29111136,,,,2024-06-04,WOS:000430668200026,View Full Record in Web of Science
J,"Dalile, B; La Torre, D; Kalc, P; Zoppas, F; Roye, C; Loret, C; Lamothe, L; Bergonzelli, G; Courtin, CM; Vervliet, B; Oudenhove, LV; Verbeke, K",,,,"Dalile, Boushra; La Torre, Danique; Kalc, Polona; Zoppas, Francesca; Roye, Chiara; Loret, Chrystel; Lamothe, Lisa; Bergonzelli, Gabriela; Courtin, Christophe M.; Vervliet, Bram; Oudenhove, Lukas Van; Verbeke, Kristin",,,"Extruded Wheat Bran Consumption Increases Serum Short-Chain Fatty Acids but Does Not Modulate Psychobiological Functions in Healthy Men: A Randomized, Placebo-Controlled Trial",FRONTIERS IN NUTRITION,,,English,Article,,,,,,short-chain fatty acids; psychosocial stress; fear conditioning; wheat bran; dietary fiber; gut-brain axis,IRRITABLE-BOWEL-SYNDROME; INTESTINAL PERMEABILITY; STRESS; FIBER; FERMENTATION; BENEFITS; EXTINCTION; VALIDATION; MARKER,"BackgroundIncorporation of wheat bran (WB) into food products increases intake of dietary fiber, which has been associated with improved mood and cognition and a lower risk for psychiatric disorders such as depression, with short-chain fatty acids (SCFAs) as candidate mediators of these effects. Modifying WB using extrusion cooking increases SCFA production in vitro relative to unmodified WB. ObjectiveThe aim of this study was to evaluate the effects of extruded WB on psychobiological functioning and the mediating role of SCFAs. MethodsIn a randomized, triple-blind, placebo-controlled trial, 69 healthy male participants consumed 55 g of breakfast cereal containing either extruded WB or placebo daily for 28 days. At pre- and post-intervention visits, the cortisol response to experimentally induced stress was measured as a primary outcome. In addition, serum SCFAs and brain-derived neurotrophic factors were quantified as potential mediators. Secondary psychobiological outcomes included subjective stress responses, responses to experimentally induced fear, cortisol awakening response, heart rate variability, and retrospective subjective mood ratings. Intestinal permeability, fecal SCFAs, and stool consistency were measured as secondary biological outcomes. ResultsExtruded WB increased serum acetate and butyrate (p < 0.05). None of the primary or secondary outcomes were affected by the intervention. Participants who consumed a placebo exhibited an increase in the percentage of fecal dry weight but did not report increased constipation. Despite these statistically significant effects, these changes were small in magnitude. ConclusionsExtruded WB consumption increased serum short-chain fatty acids but did not modulate psychobiological functions in healthy men. Effective modulation of psychobiological functions may require greater increases in SCFAs than those achieved following extruded WB consumption. Rather than attempting to induce health benefits with a single fiber-rich food, combinations of different fibers, particularly highly fermentable ones, might be needed to further increase SCFA production and uptake in the systemic circulation to observe an effect on psychobiological processes.","[Dalile, Boushra; La Torre, Danique; Kalc, Polona; Zoppas, Francesca; Oudenhove, Lukas Van; Verbeke, Kristin] Katholieke Univ Leuven, Fac Med, Translat Res Ctr Gastrointestinal Disorders TARGID, Dept Chron Dis & Metab, Leuven, Belgium; [Dalile, Boushra; La Torre, Danique; Vervliet, Bram; Oudenhove, Lukas Van] Katholieke Univ Leuven, Leuven Brain Inst, Leuven, Belgium; [Roye, Chiara; Courtin, Christophe M.] Katholieke Univ Leuven, Nutr Res Ctr LFoRCe, Lab Food Chem & Biochem & Leuven Food Sci, Leuven, Belgium; [Loret, Chrystel] Coffee Soc Prod Nestle SA, Nestle Prod Technol Ctr, Lausanne, Switzerland; [Lamothe, Lisa] Soc Prod Nestle SA, Nestle Inst Mat Sci, Nestle Res, Lausanne, Switzerland; [Bergonzelli, Gabriela] Soc Prod Nestle SA, Nestle Inst Hlth Sci, Nestle Res, Lausanne, Switzerland; [Vervliet, Bram] Katholieke Univ Leuven, Fac Psychol & Educ Sci, Lab Biol Psychol Brain & Cognit, Leuven, Belgium; [Oudenhove, Lukas Van] Dartmouth Coll, Dept Psychol & Brain Sci, Cognit & Affect Neurosci Lab, Hanover, NH USA",KU Leuven; KU Leuven; KU Leuven; Nestle SA; Nestle SA; Nestle SA; KU Leuven; Dartmouth College,"Verbeke, K (corresponding author), Katholieke Univ Leuven, Fac Med, Translat Res Ctr Gastrointestinal Disorders TARGID, Dept Chron Dis & Metab, Leuven, Belgium.",kristin.verbeke@kuleuven.be,"Dalile, Boushra/AAM-4680-2020; La Torre, Danique/JHU-2730-2023; Kalc, Polona/HOC-7681-2023; Courtin, Christophe M/Q-1916-2016","Kalc, Polona/0000-0001-5672-7442; Courtin, Christophe M/0000-0002-1203-9063; Dalile, Boushra/0000-0003-1064-7214; La Torre, Danique/0000-0002-2423-3568; Verbeke, Kristin/0000-0002-5352-7565",,,,,78,10,10,0,6,FRONTIERS MEDIA SA,LAUSANNE,"AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND",2296-861X,,,FRONT NUTR,Front. Nutr.,MAY 26,2022,9,,,,,,,,896154,10.3389/fnut.2022.896154,http://dx.doi.org/10.3389/fnut.2022.896154,,,15,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,1Y6KA,35694161,"gold, Green Published",,,2024-06-04,WOS:000808250100001,View Full Record in Web of Science
J,"Chandler, ML; Guilford, G; Lawoko, CRO; Whittem, T",,,,"Chandler, ML; Guilford, G; Lawoko, CRO; Whittem, T",,,Gastric emptying and intestinal transit times of radiopaque markers in cats fed a high-fiber diet with and without low-dose intravenous diazepam,VETERINARY RADIOLOGY & ULTRASOUND,,,English,Article,,,,,,gastric emptying; colonic transit; radiopaque markers; intestinal transit; cats; feline; diazepam; dietary fiber,COLONIC TRANSIT; NONDIGESTIBLE SOLIDS; STOOL WEIGHT; BOWEL; CONSTIPATION; DOGS; CELLULOSE; MOTILITY; DIARRHEA; PECTIN,"Reference ranges for gastric emptying time (GET), small intestinal transit time (SITT), and colonic transit time of 1.5-mm and 5-mm radiopaque markers in healthy cats fed a high-fiber meal were determined, and the influence of low-dose diazepam intravenous injection on the gastrointestinal transit of the markers was examined. The mean GETs and SITTs, and the mean residence times (MRTs) and geometric centers (GCs) of markers in the colon were determined. The effect of intravenous diazepam injection and marker size on these parameters was examined. Diazepam injection had no significant influence on gastrointestinal transit. The GETs of the 1.5-mm markers were significantly more rapid than those of the 5.0-mm markers. There were no significant differences between the SITTs or GCs of the 1.5-mm and 5.0-mm markers, Reference values were developed for GET, SITT, and colonic transit of radiopaque markers for cats fed a high-fiber meal, Diazepam injection had no effect on these parameters.","Massey Univ, Dept Vet Clin Sci, Palmerston North, New Zealand; Massey Univ, Dept Stat, Palmerston North, New Zealand",Massey University; Massey University,"Chandler, ML (corresponding author), Univ Liverpool, Small Anim Hosp, Dept Vet Clin Sci, Liverpool L7 7EX, Merseyside, England.",,"Guilford, Grant/C-9954-2009; Whittem, Ted/H-7203-2013","Whittem, Ted/0000-0002-4182-903X",,,,,44,20,20,1,9,AMER COLL VETERINARY RADIOLOGY,RALEIGH,"2520 BEECHRIDGE RD, RALEIGH, NC 27608 USA",1058-8183,,,VET RADIOL ULTRASOUN,Vet. Radiol. Ultrasound,JAN-FEB,1999,40,1,,,,,3,8,,10.1111/j.1740-8261.1999.tb01831.x,http://dx.doi.org/10.1111/j.1740-8261.1999.tb01831.x,,,6,Veterinary Sciences,Science Citation Index Expanded (SCI-EXPANDED),Veterinary Sciences,163GT,10023988,,,,2024-06-04,WOS:000078396800001,View Full Record in Web of Science
J,"Stark, LJ; Opipari, LC; Donaldson, DL; Danovsky, MB; Rasile, DA; DelSanto, AF",,,,"Stark, LJ; Opipari, LC; Donaldson, DL; Danovsky, MB; Rasile, DA; DelSanto, AF",,,Evaluation of a standard protocol for retentive encopresis: A replication,JOURNAL OF PEDIATRIC PSYCHOLOGY,,,English,Article,,,,,,encopresis; constipation; group behavior therapy; children,CHILDREN; MANAGEMENT; CONSTIPATION,"Replicated the efficacy of a short-term, combined medical and behavioral intervention protocol for retentive encopresis. Fifty-nine children who had failed standard medical management for retentive encopresis and their parents participated in six 1-hour group treatment sessions. Treatment protocol combined the medical management strategies of enema clean out, increasing dietary fiber, and daily toilet sitting with the child behavior management strategies of differential attention, contingency management, and contracting. For the overall sample, the number of soiling incidents decreased 85%, the weekly frequency of independent bowel movements increased 15%, the weekly, frequency of parent-prompted bowel movements increased 9%, and daily dietary fiber intake increased 121% pre-to posttreatment. The majority of the sample (86%) stopped soiling by the end of treatment and did not require further treatment. Results are discussed in terms of the comparability with previous findings and the utility of combined medical and psychological treatments for children with encopresis who have failed standard medical approaches.",,,"BROWN UNIV, DIV CHILD & FAMILY PSYCHIAT, RHODE ISL HOSP, SCH MED, 593 EDDY ST, PROVIDENCE, RI 02903 USA.",,,,,,,,19,29,31,0,4,OXFORD UNIV PRESS INC,CARY,"JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA",0146-8693,1465-735X,,J PEDIATR PSYCHOL,J. Pediatr. Psychol.,OCT,1997,22,5,,,,,619,633,,10.1093/jpepsy/22.5.619,http://dx.doi.org/10.1093/jpepsy/22.5.619,,,15,"Psychology, Developmental",Social Science Citation Index (SSCI),Psychology,YF223,9383926,Bronze,,,2024-06-04,WOS:A1997YF22300003,View Full Record in Web of Science
J,"Floch, MH; Narayan, R",,,,"Floch, MH; Narayan, R",,,Diet in the irritable bowel syndrome,JOURNAL OF CLINICAL GASTROENTEROLOGY,,,English,Article; Proceedings Paper,Workshop on Irritable Bowel Syndrome,"SEP 26, 2001","YALE UNIV, NEW HAVEN, CT",,YALE UNIV,,FOOD INTOLERANCE; CELIAC-DISEASE; WHEAT BRAN; MAST-CELLS; FIBER; HYPERSENSITIVITY; REDUCTION; DIARRHEA; ALLERGY,"Patients with irritable bowel syndrome (IBS) often request dietary recommendations. They must eat, and they want to know what to eat. Present national guidelines recommend dietary treatment with fiber for IBS patients with constipation. Diet recommendations are made based on symptoms. There may be different dietary recommendations for constipation, diarrhea, and pain or bloating. This article reviews the relationship of foods to IBS and issues of food intolerances and hypersensitivities, and recommendations for diet therapy. The role of dietary fiber, both soluble and insoluble, is reviewed. Although there are few studies to substantiate exact diets, broad dietary plans are recommended for the different symptoms of IBS. In addition, the recent literature on probiotics and prebiotics pertinent to IBS is reviewed.","Yale Univ, Sch Med, Norwalk, CT 06856 USA; Norwalk Hosp, Gastroenterol & Nutr Sect, Norwalk, CT 06856 USA",Yale University,"Yale Univ, Sch Med, 30 Stevens St,Suite E, Norwalk, CT 06856 USA.",martinfloch@snet.net,,,,,,,55,32,36,0,11,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0192-0790,1539-2031,,J CLIN GASTROENTEROL,J. Clin. Gastroenterol.,JUL,2002,35,1,,S,,,S45,S52,,10.1097/00004836-200207001-00009,http://dx.doi.org/10.1097/00004836-200207001-00009,,,8,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Gastroenterology & Hepatology,566QH,12184139,,,,2024-06-04,WOS:000176439400009,View Full Record in Web of Science
J,"Patel, M; Schimpf, MO; O'Sullivan, DM; LaSala, CA",,,,"Patel, Minita; Schimpf, Megan O.; O'Sullivan, David M.; LaSala, Christine A.",,,"The use of senna with docusate for postoperative constipation after pelvic reconstructive surgery: a randomized, double-blind, placebo-controlled trial",AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY,,,English,Article; Proceedings Paper,30th Annual Meeting of the American-Urogynecologic-Society,"SEP 24-26, 2009","Hollywood, FL",Amer Urogynecol Soc,,constipation; pelvic organ prolapse; senna with docusate,DIETARY FIBER; FUNCTIONAL BOWEL; ORGAN PROLAPSE; DISORDERS; WOMEN; BRAN,"OBJECTIVE: The objective of the study was to compare time to first bowel movement (BM) after surgery in subjects randomized to placebo or senna with docusate. STUDY DESIGN: Ninety-six subjects completed a baseline 7-day bowel diary before and after surgery. After pelvic reconstructive surgery, the subjects were randomized to either placebo (n = 45) or senna (8.6 mg) with docusate (50 mg) (n = 48). Time to first BM and postoperative use of magnesium citrate were compared. RESULTS: There was a significant difference in the time to first BM in those receiving senna with docusate vs placebo (3.00 +/- 1.50 vs 4.05 +/- 1.50 days; P < .002). More subjects in the placebo group needed to use magnesium citrate to initiate a bowel movement (43.6% vs 7.0%; P < .001). CONCLUSION: The use of senna with docusate decreases time to first BM in those undergoing pelvic reconstructive surgery compared with placebo. Subjects using senna with docusate are also significantly less likely to use magnesium citrate.","[Patel, Minita; LaSala, Christine A.] Univ Connecticut, Sch Med, Div Urogynecol, Dept Obstet & Gynecol, Hartford, CT 06112 USA; [O'Sullivan, David M.] Hartford Hosp, Dept Res Adm, Hartford, CT 06115 USA; [Schimpf, Megan O.] Univ Penn, Sch Med, Div Urogynecol & Pelv Reconstruct Surg, Philadelphia, PA 19104 USA; [Schimpf, Megan O.] Penn Hosp, Philadelphia, PA 19107 USA",University of Connecticut; Hartford Hospital; University of Pennsylvania; University of Pennsylvania,"Patel, M (corresponding author), 85 Seymour St,Suite 525, Hartford, CT 06106 USA.",mpatel@harthosp.org,,,,,,,14,17,17,0,0,MOSBY-ELSEVIER,NEW YORK,"360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA",0002-9378,,,AM J OBSTET GYNECOL,Am. J. Obstet. Gynecol.,MAY,2010,202,5,,,,,,,479.e1,10.1016/j.ajog.2010.01.003,http://dx.doi.org/10.1016/j.ajog.2010.01.003,,,5,Obstetrics & Gynecology,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Obstetrics & Gynecology,592TM,20207340,,,,2024-06-04,WOS:000277403200026,View Full Record in Web of Science
J,"Nishimoto, Y; Nomaguchi, T; Mori, Y; Ito, M; Nakamura, Y; Fujishima, M; Murakami, S; Yamada, T; Fukuda, S",,,,"Nishimoto, Yuichiro; Nomaguchi, Tatsuhiro; Mori, Yuka; Ito, Masaki; Nakamura, Yuya; Fujishima, Masaki; Murakami, Shinnosuke; Yamada, Takuji; Fukuda, Shinji",,,The Nutritional Efficacy of Chlorella Supplementation Depends on the Individual Gut Environment: A Randomised Control Study,FRONTIERS IN NUTRITION,,,English,Article,,,,,,prebiotics (sources; MeSH); gut microbiome; gut metabolome; dietary fibre; Chlorella,PROBIOTIC INTERVENTION; GLUCOSE-METABOLISM; OMEGA-OXIDATION; MICROBIOTA; VULGARIS; ACID; MODULATION; PRODUCTS,"Recent studies have accumulated evidence that the intestinal environment is strongly correlated with host diet, which influences host health. A number of dietary products whose mechanisms of influence operate via the gut microbiota have been revealed, but they are still limited. Here, we investigated the dietary influence of Chlorella, a green alga commercially available as a dietary supplement. A randomised, double-blind, placebo-controlled crossover trial including 40 Japanese participants with constipation was performed. In this study, the primary outcome and secondary outcome were set as defecation frequency and blood folate level, respectively. In both outcomes, no significant differences were detected compared to the control intake. Therefore, we analysed the gut microbiome, gut metabolome, and blood parameters in an integrated manner as an exploratory analysis. We revealed that the consumption of Chlorella increased the level of several dicarboxylic acids in faeces. Furthermore, the analysis showed that individuals with low concentrations of faecal propionate showed an increase in propionate concentration upon Chlorella intake. In addition, increasing blood folate levels were negatively correlated with defecation frequency at baseline. Our study suggested that the effect of Chlorella consumption varies among individuals depending on their intestinal environment, which illustrates the importance of stratified dietary management based on the intestinal environment in individuals.","[Nishimoto, Yuichiro; Nomaguchi, Tatsuhiro; Mori, Yuka; Ito, Masaki; Nakamura, Yuya; Murakami, Shinnosuke; Yamada, Takuji; Fukuda, Shinji] Metabologenomics Inc, Tsuruoka, Yamagata, Japan; [Fujishima, Masaki] Sun Chlorella Corp, Kyoko, Japan; [Murakami, Shinnosuke; Fukuda, Shinji] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Yamada, Takuji] Tokyo Inst Technol, Dept Life Sci & Technol, Tokyo, Japan; [Fukuda, Shinji] Kanagawa Inst Ind Sci & Technol, Intestinal Microbiota Project, Kawasaki, Kanagawa, Japan; [Fukuda, Shinji] Univ Tsukuba, Transborder Med Res Ctr, Tsukuba, Ibaraki, Japan",Keio University; Tokyo Institute of Technology; Kanagawa Academy Science & Technology; University of Tsukuba,"Yamada, T; Fukuda, S (corresponding author), Metabologenomics Inc, Tsuruoka, Yamagata, Japan.;Fukuda, S (corresponding author), Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan.;Yamada, T (corresponding author), Tokyo Inst Technol, Dept Life Sci & Technol, Tokyo, Japan.;Fukuda, S (corresponding author), Kanagawa Inst Ind Sci & Technol, Intestinal Microbiota Project, Kawasaki, Kanagawa, Japan.;Fukuda, S (corresponding author), Univ Tsukuba, Transborder Med Res Ctr, Tsukuba, Ibaraki, Japan.",yamada@metagen.co.jp; sfukuda@metagen.co.jp,"Masaki, Fujishima/AAT-6049-2021; Yamada, Takuji/GVS-1079-2022","Masaki, Fujishima/0000-0002-0396-6199; Yamada, Takuji/0000-0002-9622-1849; Murakami, Shinnosuke/0000-0002-1101-9255; Fukuda, Shinji/0000-0001-5161-9880; Nakamura, Yuya/0000-0003-4018-1718","Sun Chlorella Corp.; Metabologenomics, Inc.","Sun Chlorella Corp.; Metabologenomics, Inc.","This study was funded by Sun Chlorella Corp., and Metabologenomics, Inc.",,32,5,5,3,22,FRONTIERS MEDIA SA,LAUSANNE,"AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND",2296-861X,,,FRONT NUTR,Front. Nutr.,MAY 31,2021,8,,,,,,,,648073,10.3389/fnut.2021.648073,http://dx.doi.org/10.3389/fnut.2021.648073,,,10,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,SR5IG,34136514,"Green Published, Green Submitted, gold",,,2024-06-04,WOS:000661074400001,View Full Record in Web of Science
J,"Choi, JS; Kim, JW; Kim, KY; Lee, JK; Sohn, JH; Ku, SK",,,,"Choi, Jae-Suk; Kim, Joo Wan; Kim, Ki-Young; Lee, Jong-Kwang; Sohn, Jae Hak; Ku, Sae-Kwang",,,Synergistic Effect of Fermented Rice Extracts on the Probiotic and Laxative Properties of Yoghurt in Rats with Loperamide-Induced Constipation,EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE,,,English,Article,,,,,,,ANTI-DIARRHEAL AGENT; CONTROLLED-TRIAL; DIETARY FIBER; DOUBLE-BLIND; BRAN; BIFIDOBACTERIUM; CHILDHOOD; INTESTINE; BACTERIA; CELLS,"Aim. The objective was to evaluate the synergistic effects of fermented rice extracts (FRe) on the laxative and probiotic properties of yoghurt in rats with loperamide-induced constipation. Methods. After constipation induction, yoghurt containing FRe (BFRe; 0.05%, 0.1%, or 1%) was administered orally once per day for 6 days. Results. Loperamide treatment caused marked decreases in fecal pellet numbers and water content discharged, as well as in the surface mucosal thickness of the colonic lumen, intestinal charcoal transit ratio, thickness, and number of mucous-producing goblet cells in the colonic mucosa, whereas it increased the remnant fecal pellet number and the mean diameter of the colonic lumen. However, this loperamide-induced constipation was ameliorated by treatment with FRe, yoghurt single formula, or 0.05%, 0.1%, or 1% BFRe (10 mL/kg). Additionally, the viable numbers of Lactobacillus in the cecal contents and feces were markedly higher than those in constipated rats. Moreover, greater probiotic and laxative effects were detected in BFRe-treated rats than in rats treated with equivalent doses of yoghurt or FRe single formula. Conclusion. The results suggest that addition of FRe to liquid yoghurt will enhance the probiotic and beneficial laxative effects of yoghurt in the digestive tract, without causing side effects.","[Choi, Jae-Suk; Sohn, Jae Hak] Silla Univ, RIS Ctr, IACF, Pusan 617736, South Korea; [Choi, Jae-Suk; Sohn, Jae Hak] Silla Univ, Dept Biofood Mat, Pusan 617736, South Korea; [Kim, Joo Wan; Kim, Ki-Young] Glucan Corp Marine Bioind Dev Ctr, Pusan 619912, South Korea; [Lee, Jong-Kwang] JKnutra, Seoul 138160, South Korea; [Ku, Sae-Kwang] Daegu Haany Univ, Coll Oriental Med, Dept Anat & Histol, Gyongsan 712715, Gyeongsanbuk Do, South Korea",Silla University; Silla University; Daegu Haany University,"Sohn, JH (corresponding author), Silla Univ, RIS Ctr, IACF, Pusan 617736, South Korea.",jhsohn@silla.ac.kr; gucci200@hanmail.net,,"Choi, Jae-Suk/0000-0002-8151-6054","Busan Tradition Liquor Industry RIS [B0012284]; Ministry of Trade, Industry and Energy, Republic of Korea [R0002840]","Busan Tradition Liquor Industry RIS; Ministry of Trade, Industry and Energy, Republic of Korea","This study was supported by a Grant (B0012284) from the Busan Tradition Liquor Industry RIS and was also supported by a Grant (R0002840) from the Ministry of Trade, Industry and Energy, Republic of Korea.",,44,12,14,4,12,HINDAWI LTD,LONDON,"ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND",1741-427X,1741-4288,,EVID-BASED COMPL ALT,Evid.-based Complement Altern. Med.,,2014,2014,,,,,,,,878503,10.1155/2014/878503,http://dx.doi.org/10.1155/2014/878503,,,12,Integrative & Complementary Medicine,Science Citation Index Expanded (SCI-EXPANDED),Integrative & Complementary Medicine,AQ6QS,25214876,"Green Published, Green Submitted, gold",,,2024-06-04,WOS:000342939500001,View Full Record in Web of Science
J,"Ansell, J; Butts, CA; Paturi, G; Eady, SL; Wallace, AJ; Hedderley, D; Gearry, RB",,,,"Ansell, Juliet; Butts, Christine A.; Paturi, Gunaranjan; Eady, Sarah L.; Wallace, Alison J.; Hedderley, Duncan; Gearry, Richard B.",,,"Kiwifruit-derived supplements increase stool frequency in healthy adults: a randomized, double-blind, placebo-controlled study",NUTRITION RESEARCH,,,English,Article,,,,,,Bowel movements; Constipation; Kiwifruit; Laxation; Stool frequency; Actazin (TM),IRRITABLE-BOWEL-SYNDROME; DIETARY FIBER; CONSTIPATION,"The worldwide growth in the incidence of gastrointestinal disorders has created an immediate need to identify safe and effective interventions. In this randomized, double-blind, placebo-controlled study, we examined the effects of Actazin and Gold, kiwifruit-derived nutritional ingredients, on stool frequency, stool form, and gastrointestinal comfort in healthy and functionally constipated (Rome III criteria for C3 functional constipation) individuals. Using a crossover design, all participants consumed all 4 dietary interventions (Placebo, Actazin low dose [Actazin-L] [600 mg/day], Actazin high dose [Actazin-H] [2400 mg/day], and Gold [2400 mg/day]). Each intervention was taken for 28 days followed by a 14-day washout period between interventions. Participants recorded their daily bowel movements and well-being parameters in daily questionnaires. In the healthy cohort (n = 19), the Actazin-H (P = .014) and Gold (P = .009) interventions significantly increased the mean daily bowel movements compared with the washout. No significant differences were observed in stool form as determined by use of the Bristol stool scale. In a subgroup analysis of responders in the healthy cohort, Actazin-L (P = .005), Actazin-H (P < .001), and Gold (P = .001) consumption significantly increased the number of daily bowel movements by greater than 1 bowel movement per week. In the functionally constipated cohort (n = 9), there were no significant differences between interventions for bowel movements and the Bristol stool scale values or in the subsequent subgroup analysis of responders. This study demonstrated that Actazin and Gold produced clinically meaningful increases in bowel movements in healthy individuals. (C) 2015 The Authors. Published by Elsevier Inc.","[Ansell, Juliet; Butts, Christine A.; Hedderley, Duncan] New Zealand Inst Plant & Food Res Ltd, Palmerston North 4442, New Zealand; [Paturi, Gunaranjan] New Zealand Inst Plant & Food Res Ltd, Auckland 1142, New Zealand; [Eady, Sarah L.; Wallace, Alison J.] New Zealand Inst Plant & Food Res Ltd, Christchurch 8140, New Zealand; [Gearry, Richard B.] Univ Otago, Dept Med, Christchurch 8140, New Zealand",New Zealand Institute for Plant & Food Research Ltd; New Zealand Institute for Plant & Food Research Ltd; New Zealand Institute for Plant & Food Research Ltd; University of Otago,"Butts, CA (corresponding author), New Zealand Inst Plant & Food Res Ltd, Private Bag 11600, Palmerston North 4442, New Zealand.",chrissie.butts@plantandfood.co.nz,"Butts, Christine A/I-4875-2015; Gearry, Richard B/H-3959-2019; Paturi, Gunaranjan/H-2262-2019; Gea, Luis/A-2542-2012","Butts, Christine A/0000-0002-5565-1455; Gearry, Richard B/0000-0002-2298-5141; Paturi, Gunaranjan/0000-0002-0998-9607; Eady, Sarah/0000-0001-8016-0992; Wallace, Alison/0000-0002-9315-8530; Hedderley, Duncan/0000-0001-7522-2212; Gea, Luis/0000-0003-4949-5027","Anagenix Ltd (Wellington, New Zealand); Stratum Nutrition (St Charles, MO, USA); Callaghan Innovation (Wellington, New Zealand)","Anagenix Ltd (Wellington, New Zealand); Stratum Nutrition (St Charles, MO, USA); Callaghan Innovation (Wellington, New Zealand)","This study was funded by Anagenix Ltd (Wellington, New Zealand), Stratum Nutrition (St Charles, MO, USA), and Callaghan Innovation (Wellington, New Zealand).",,19,21,27,0,16,PERGAMON-ELSEVIER SCIENCE LTD,OXFORD,"THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND",0271-5317,,,NUTR RES,Nutr. Res.,MAY,2015,35,5,,,,,401,408,,10.1016/j.nutres.2015.04.005,http://dx.doi.org/10.1016/j.nutres.2015.04.005,,,8,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,CJ3MB,25931419,hybrid,,,2024-06-04,WOS:000355387000006,View Full Record in Web of Science
J,"Zhou, MY; Jia, P; Chen, JP; Xiu, AH; Zhao, Y; Zhan, YB; Chen, P; Zhang, JF",,,,"Zhou, Mengyi; Jia, Ping; Chen, Jinping; Xiu, Aihui; Zhao, Yue; Zhan, Yibei; Chen, Peng; Zhang, Jianfa",,,Laxative effects of Salecan on normal and two models of experimental constipated mice,BMC GASTROENTEROLOGY,,,English,Article,,,,,,Salecan; Constipation; Intestinal motility; Loperamide; Clonidine,BETA-GLUCAN; NORTH-AMERICA; DIETARY FIBER; EPIDEMIOLOGY; THERAPIES; VISCOSITY; HEALTH; SAFETY,"Background: Constipation is one of the most common gastrointestinal complaints with a highly prevalent and often chronic functional gastrointestinal disorder affecting health-related quality of life. The aim of the present study was to evaluate the effects of Salecan on fecal output and small intestinal transit in normal and two models of drug-induced constipation mice. Methods: ICR mice were administrated intragastrically (i.g.) by gavage with 100, 200 and 300 mg/kg body weight (BW) of Salecan while the control mice were received saline. The constipated mice were induced by two types of drugs, loperamide (5 mg/kg BW, i.g.) and clonidine (200 mu g/kg BW, i.g.), after Salecan treatment while the control mice were received saline. Number, weight and water content of feces were subsequently measured. Small intestinal transit was monitored by phenol red marker meal. Results: Salecan (300 mg/kg BW) significantly increased the number and weight of feces in normal mice. In two models of drug-induced constipation, Salecan dose-dependently restored the fecal number and fecal weight. The water content of feces was markedly affected by loperamide, but not by clonidine. Treatment with Salecan significantly raised the fecal water content in loperamide-induced constipation mice. Moreover, Salecan markedly stimulated the small intestinal transit in both loperamide- and clonidine-induced constipation model mice. Conclusions: These results suggest that Salecan has a potential to be used as a hydrophilic laxative for constipation.","[Zhou, Mengyi; Jia, Ping; Chen, Jinping; Xiu, Aihui; Zhao, Yue; Zhan, Yibei; Chen, Peng; Zhang, Jianfa] Nanjing Univ Sci & Technol, Ctr Mol Metab, Nanjing 210094, Jiangsu, Peoples R China",Nanjing University of Science & Technology,"Zhang, JF (corresponding author), Nanjing Univ Sci & Technol, Ctr Mol Metab, 200 Xiaolingwei St, Nanjing 210094, Jiangsu, Peoples R China.",jfzhang@mail.njust.edu.cn,"Zhao, Yue/AAJ-4026-2021","Zhao, Yue/0000-0003-2869-5257",973 Program [2012CB517505]; JSSTP [BE2011836]; FRFCU [2011XQTR07],973 Program(National Basic Research Program of China); JSSTP; FRFCU,"This work was supported by grant from 973 Program 2012CB517505, JSSTP BE2011836 and FRFCU 2011XQTR07.",,34,43,50,3,37,BIOMED CENTRAL LTD,LONDON,"236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND",1471-230X,,,BMC GASTROENTEROL,BMC Gastroenterol.,MAR 20,2013,13,,,,,,,,52,10.1186/1471-230X-13-52,http://dx.doi.org/10.1186/1471-230X-13-52,,,6,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,113OM,23514598,"Green Published, gold",,,2024-06-04,WOS:000316677400001,View Full Record in Web of Science
J,"Evans, JM; Fleming, KC; Talley, NJ; Schleck, CD; Zinsmeister, AR; Melton, LJ",,,,"Evans, JM; Fleming, KC; Talley, NJ; Schleck, CD; Zinsmeister, AR; Melton, LJ",,,Relation of colonic transit to functional bowel disease in older people: A population-based study,JOURNAL OF THE AMERICAN GERIATRICS SOCIETY,,,English,Article,,,,,,,PHYSICAL-ACTIVITY; IRRITABLE BOWEL; COLLEGE ALUMNI; CONSTIPATION; QUESTIONNAIRE; PREVALENCE; COMMUNITY; FIBER; RISK; HOME,"OBJECTIVE: The pathophysiology underlying chronic constipation in older people is poorly understood. Our objective was to determine if functional bowel disease (particularly constipation) in this population is associated with risk factors (age, immobility, low dietary fiber intake, and medication use) or directly with slow colonic transit. METHODS: A previously validated questionnaire was administered to a random sample of older residents (age range 65-104 years, n = 1609) of Olmsted County, MN. A random subset who met standard diagnostic criteria for functional constipation (n = 52) or irritable bowel syndrome (IBS) (n = 55) and a group without gastrointestinal symptoms (n = 93) were selected for further study. Each subject underwent structured interview and physical examination. Total caloric and fiber intake were assessed by dietitian interview, a food frequency questionnaire, and a food diary. Physical activity was assessed using a previously validated instrument. Medication use was determined by self-report, physician interview, and review of medical records. Total and segmental colonic transit was assessed radiographically using radioopaque markers. RESULTS: Total colonic transit times were prolonged in subjects with functional constipation (median 50.4 hours) but not in subjects with IBS (median 34.2 hours) or in healthy controls (median 28.8 hours); however, only rectosigmoid transit was delayed significantly. Age, gender, physical activity, and dietary fiber intake were not associated with total transit times, nor could they discriminate among the three patient groups. Laxative use was associated with prolonged total transit times independent of patient group. CONCLUSIONS: Older subjects can be classified by abdominal pain and bowel symptoms, which reflect colonic transit times. Older subjects with constipation symptoms generally have prolonged rectosigmoid transit. Other potential risk factors do not distinguish symptom subgroups, nor are they associated with altered colonic transit although older people who use laxatives regularly have prolonged colonic transit.","Mayo Clin & Mayo Fdn, Div Community Internal Med, Sect Geriatr, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Div Gastroenterol & Internal Med, Rochester, MN 55905 USA",Mayo Clinic; Mayo Clinic; Mayo Clinic,"Mayo Clin, 200 1st St SW, Rochester, MN 55905 USA.",,"Talley, Nicholas J/D-5399-2013",,NIAMS NIH HHS [AR30582] Funding Source: Medline; NIA NIH HHS [AG09440] Funding Source: Medline,NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)),,,20,48,52,0,5,WILEY-BLACKWELL,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0002-8614,1532-5415,,J AM GERIATR SOC,J. Am. Geriatr. Soc.,JAN,1998,46,1,,,,,83,87,,10.1111/j.1532-5415.1998.tb01018.x,http://dx.doi.org/10.1111/j.1532-5415.1998.tb01018.x,,,5,Geriatrics & Gerontology; Gerontology,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Geriatrics & Gerontology,YQ047,9434670,,,,2024-06-04,WOS:000071342100014,View Full Record in Web of Science
J,"Fart, F; Tingö, L; Engelheart, S; Lindqvist, CM; Brummer, RJ; Kihlgren, A; Schoultz, I",,,,"Fart, Frida; Tingo, Lina; Engelheart, Stina; Lindqvist, Carl Marten; Brummer, Robert J.; Kihlgren, Annica; Schoultz, Ida",,,Gut Health and Its Association with Wellbeing and Nutrient Intake in Community-Dwelling Older Adults,GASTROENTEROLOGY INSIGHTS,,,English,Article,,,,,,gastrointestinal symptoms; elderly; dietary intake; general health,QUALITY-OF-LIFE; GASTROESOPHAGEAL-REFLUX DISEASE; IRRITABLE-BOWEL-SYNDROME; GASTROINTESTINAL SYMPTOMS; FUNCTIONAL DYSPEPSIA; PROTEIN-INTAKE; DIETARY FIBER; PREVALENCE; POPULATION; SCALE,"Many of the increasing number of community-dwelling older adults will need increased healthcare in the future. By characterising gut health and its association with wellbeing and nutrient intake in this population, we aim to recognise areas along the gut-brain axis through which the health of community-dwelling older adults might be promoted. In this cross-sectional observational study, validated questionnaires were used to assess gut health, nutrient intake, and wellbeing in 241 community-dwelling older adults (>= 65 years old). In total, 65% of the participants experienced at least one gastrointestinal symptom, of which females had more abdominal pain and constipation, while the oldest old (i.e., >= 80 years old) had more diarrhoea. Increased gastrointestinal symptoms correlated with more stress, anxiety, depression, and a decreased quality of life, in addition to dyspepsia which correlated with a lower E% of protein. Most of the participants did not reach the recommended intake for protein, fibre and polyunsaturated fats. Males had a lower intake of protein (E%) and fibre (g/MJ) than females, and the oldest old had a lower E% of protein than younger older adults. In conclusion, our results demonstrate that gastrointestinal symptoms are common, and most of the study participants had an imbalanced macronutrient intake, which could be a target for future possible dietary interventions to improve overall health.","[Fart, Frida; Tingo, Lina; Engelheart, Stina; Lindqvist, Carl Marten; Brummer, Robert J.; Schoultz, Ida] Orebro Univ, Fac Med & Hlth, Sch Med Sci, S-70281 Orebro, Sweden; [Tingo, Lina] Linkoping Univ, Dept Biomed & Clin Sci, Div Inflammat & Infect, S-58183 Linkoping, Sweden; [Kihlgren, Annica] Orebro Univ, Fac Med & Hlth, Sch Hlth Sci, S-70281 Orebro, Sweden",Orebro University; Linkoping University; Orebro University,"Schoultz, I (corresponding author), Orebro Univ, Fac Med & Hlth, Sch Med Sci, S-70281 Orebro, Sweden.",ida.schoultz@oru.se,"Lindqvist, Carl Mårten/B-9963-2018; Brummer, Robert/A-3137-2009","Lindqvist, Carl Mårten/0000-0003-3887-9519; Tingo, Lina/0000-0002-2482-9281; Engelheart, Stina/0000-0002-2921-7508; Brummer, Robert/0000-0002-0362-0008",Bo Rydins stiftelse [F0514]; Knowledge Foundation [20110225]; Faculty of Medicine and Health at Orebro University,Bo Rydins stiftelse; Knowledge Foundation; Faculty of Medicine and Health at Orebro University,"This research was funded by Bo Rydins stiftelse (grant ref.: F0514, principal investigator IS), and the Knowledge Foundation (grant ref: 20110225, principal investigator RJB) as well as The Faculty of Medicine and Health at OErebro University.",,65,1,1,1,2,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",2036-7414,2036-7422,,GASTROENTEROL INSIGH,Gastroenterol. Insights,DEC,2022,13,4,,,,,349,364,,10.3390/gastroent13040035,http://dx.doi.org/10.3390/gastroent13040035,,,16,Gastroenterology & Hepatology,Emerging Sources Citation Index (ESCI),Gastroenterology & Hepatology,7G4TQ,,"Green Published, gold",,,2024-06-04,WOS:000902519200001,View Full Record in Web of Science
J,"PharmD, CE; StatD, AN; Nobili, A; Ianes, A; Pasina, L",,,,"PharmD, Chiara Elli; StatD, Alessio Novella; Nobili, Alessandro; Ianes, Aladar; Pasina, Luca",,,Laxative Agents in Nursing Homes: An Example of Prescribing Cascade,JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION,,,English,Article,,,,,,Laxatives; nursing homes; constipation; prescribing cascade,CHRONIC CONSTIPATION; MEDICATION USE; DIETARY FIBER; RESIDENTS; POLYPHARMACY; PEOPLE,"Objectives: Laxatives are among the most prescribed medications to nursing home (NH) patients, and we evaluated the hypothesis that laxative agents could be prescribed as a result of a prescribing cascade. The aims of the study are (1) to investigate the use of laxative drugs in a large sample of Italian NHs and (2) to assess the relationship between medications that can induce constipation and laxative use. Design: Retrospective cross-sectional multicenter study. Setting and Participants: Individuals living in long-term care NHs. Methods: Study conducted in a sample of Italian long-term care NHs distributed throughout the country. Information on drug prescriptions, diseases and sociodemographic characteristics collected 4 times during 2018 and 2019. Results: Among the 2602 patients recruited from 27 NHs (mean age +/- standard deviation: 88.4 +/- 8.5; women: 1994, 76.6%), 1248 were receiving laxatives (48%). Parkinson disease, cerebrovascular disease, and hemiplegia were associated with laxative prescription, and diabetes was associated with a decrease. Benzodiazepines, anti-Parkinson dopaminergic agents, and antidepressants (tricyclic antidepressants and mirtazapine) were associated with laxative treatment in univariate and adjusted models. Tricyclic antidepressants users were 3 times more likely to be taking laxatives than nonusers (odds ratio 2.98, 95% confidence interval 1.31-6.77, P =.0093). A larger number of drugs that can induce constipation was associated with laxative use (P =.0003). In all, 2002 individuals had at least 2 different prescription times: from the first to the last visit laxative use rose from 46.1% to 49.9%. Time of stay was also associated with laxative use (P = .016). Conclusions and Implications: Laxatives are among the most prescribed medications in Italian NHs. Medications that can induce constipation, such as antidepressants, anti-Parkinson dopaminergic agents, and benzodiazepines, are often used together with laxatives, and combinations of these drugs further increase the use of laxatives. Optimizing the prescription of psychotropic drugs could help reduce the prescribing cascade with laxatives. The length of stay in NHs is often proportional to laxative use and chronic treatment is very common. (c) 2021 AMDA -The Society for Post-Acute and Long-Term Care Medicine.","[PharmD, Chiara Elli; StatD, Alessio Novella; Nobili, Alessandro; Pasina, Luca] Ist Ric Farmacol Mario Negri IRCCS, Milan, Italy; [Ianes, Aladar] Med Direct, Milan, Italy",Istituto di Ricerche Farmacologiche Mario Negri IRCCS,"PharmD, CE (corresponding author), Ist Ric Farmacol Mario Negri IRCCS, Pharmacotherapy & Appropriateness Drug Prescript, Via Mario Negri 2, I-20156 Milan, Italy.",chiara.elli@marionegri.it,"Nobili, Alessandro/ABG-4516-2020; Elli, Chiara/ABF-8988-2021; Novella, Alessio/ABF-9696-2021","Nobili, Alessandro/0000-0002-7813-0572; Elli, Chiara/0000-0001-6035-4474; Novella, Alessio/0000-0001-5927-811X",,,,,33,5,5,0,6,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",1525-8610,1538-9375,,J AM MED DIR ASSOC,J. Am. Med. Dir. Assoc.,DEC,2021,22,12,,,,,2559,2564,,10.1016/j.jamda.2021.04.021,http://dx.doi.org/10.1016/j.jamda.2021.04.021,,NOV 2021,6,Geriatrics & Gerontology,Science Citation Index Expanded (SCI-EXPANDED),Geriatrics & Gerontology,XC6OI,34023302,,,,2024-06-04,WOS:000722129900025,View Full Record in Web of Science
J,"Raber, MM; Bowling, SM; Dorn, M",,,,"Raber, McKenzie M.; Bowling, Sean M.; Dorn, Matthew",,,Complicated Diverticulitis in a 35-Year-Old Patient With Williams Syndrome: A Case Report,CUREUS JOURNAL OF MEDICAL SCIENCE,,,English,Article,,,,,,preventative care; constipation; sigmoid diverticulitis; hartmann procedure; williams-beuren syndrome,MANAGEMENT,"Williams syndrome is caused by a deletion of the elastin gene on chromosome 7. One of the main roles of this gene is to maintain the strength and elasticity of the intestinal wall, and the absence of the elastin gene may predispose these patients to gastrointestinal pathology such as diverticulitis. Our patient was a 35-year -old Caucasian female with Williams syndrome who presented to the emergency department with diffuse abdominal pain for two days. A computed tomography (CT) scan of her abdomen and pelvis initially showed locally perforated sigmoid diverticulitis with pelvic abscess and acute peritonitis. Surgical management was indicated after the patient failed to respond to conservative treatment. She was treated with Hartmann's procedure which showed purulent peritoneal fluid intraoperatively. Her hospital course was complicated by postoperative ileus and a peri-incisional abscess. After a 15-day hospital stay, she was discharged home with plans for ostomy reversal in six months. Patients with Williams syndrome have an increased risk of developing diverticulitis at a younger age than the general population due to their propensity for chronic constipation stemming from their child-like eating habits and low dietary fiber. Thus, we emphasize the importance of treating constipation in patients with Williams syndrome to prevent diverticulitis. If these patients present to the emergency department with acute diverticulitis, aggressive surgical management may be beneficial because rapid progression could ensue.","[Raber, McKenzie M.; Bowling, Sean M.] Edward Via Coll Osteopath Med, Dept Surg, Blacksburg, VA 24060 USA; [Dorn, Matthew] Johnston Mem Hosp, Gen Surg, Abingdon, VA 24211 USA",,"Raber, MM (corresponding author), Edward Via Coll Osteopath Med, Dept Surg, Blacksburg, VA 24060 USA.",mraber@vt.vcom.edu,,,,,,,9,1,1,0,3,SPRINGERNATURE,LONDON,"CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND",,2168-8184,,CUREUS J MED SCIENCE,Cureus J Med Sci,JUL 6,2022,14,7,,,,,,,26604,10.7759/cureus.26604,http://dx.doi.org/10.7759/cureus.26604,,,4,"Medicine, General & Internal",Emerging Sources Citation Index (ESCI),General & Internal Medicine,3C1LA,35936144,"Green Published, gold",,,2024-06-04,WOS:000828390900003,View Full Record in Web of Science
J,"KLOPFENSTEIN, CF",,,,"KLOPFENSTEIN, CF",,,NUTRITIONAL PROPERTIES OF COARSE AND FINE SUGAR-BEET FIBER AND HARD RED WHEAT BRAN .1. EFFECTS ON RAT SERUM AND LIVER CHOLESTEROL AND TRIGLYCERIDES AND ON FECAL CHARACTERISTICS,CEREAL CHEMISTRY,,,English,Article,,,,,,,,"The object of the experiment was to determine the effects of coarse and fine sugar beet fiber and coarse wheat bran compared with cellulose on rat weight gains, serum and liver lipids, and fecal weight and water-holding capacity. No significant differences were found in overall weight gains or feed efficiencies with diets containing the various fibers at the 5% level of supplementation. By the end of the sixth week, total serum cholesterol levels were lower in animals fed beet fiber diets than in those fed the cellulose diet, and the lowering effect was not at the expense of high-density lipoprotein cholesterol. No dose-response effect of beet fiber was noted, however. Animals fed the 5% wheat brain diet had cholesterol levels intermediate between those of animals fed cellulose and beet fiber. In general, our results corroborate those of other investigators, who have found little or no hypocholesterolemic effect of dietary wheat fiber. Increasing levels of beet fiber also resulted in reduced liver cholesterol pools. At the end of week 6, serum triglyceride concentrations did not differ significantly among groups, but rats fed sugar beet fiber had lower liver triglyceride concentrations (which appeared to be concentration related) than those fed cellulose or wheat bran. Coarse beet fiber appeared to have a greater effect than fine beet fiber. No differences were found in fecal water-holding capacity among rats fed wheat bran and coarse and fine beet fiber at the 5% level of supplementation, but feces of rats fed 5% cellulose had a significantly lower water-holding capacity. Beet fiber particle size appeared to have no effect on wet or dry feces weight or water-holding capacity. In general, these results show that sugar beet fiber has potential as a dietary aid in the treatment of hypercholesterolemia and constipation.","KANSAS STATE UNIV AGR & APPL SCI, DEPT GRAIN SCI & IND, MANHATTAN, KS 66506 USA",Kansas State University,,,,,,,,,30,16,16,0,0,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0009-0352,1943-3638,,CEREAL CHEM,Cereal Chem.,NOV-DEC,1990,67,6,,,,,538,541,,,,,,4,"Chemistry, Applied; Food Science & Technology",Science Citation Index Expanded (SCI-EXPANDED),Chemistry; Food Science & Technology,EK091,,,,,2024-06-04,WOS:A1990EK09100006,View Full Record in Web of Science
J,"Chaichanavichkij, P; Hartmann, M; Scott, SM; Fenton, N; Knowles, CH; Disorders Defaecation Delphi Grp",,,,"Chaichanavichkij, P.; Hartmann, M.; Scott, S. M.; Fenton, N.; Knowles, C. H.; Disorders Defaecation Delphi Grp",,,Evaluating the risk factors for the development of benign disorders of defaecation: a surgical perspective,TECHNIQUES IN COLOPROCTOLOGY,,,English,Article,,,,,,Risk factors; Faecal incontinence; Constipation; Delphi,PELVIC FLOOR DISORDERS; FECAL INCONTINENCE; GASTROINTESTINAL SYMPTOMS; FUNCTIONAL CONSTIPATION; DIETARY FIBER; SEXUAL-ABUSE; PREVALENCE; POPULATION; HEALTH; DELPHI,"PurposeThere remains uncertainty as to which risk factors are important for the development of defaecatory problems as a result of heterogeneity of published evidence. Understanding the impact of risk factors may be important in selecting targets for disease prevention or reversal. The aim of this study was to identify and evaluate risk factors for faecal incontinence and chronic constipation.MethodsRisk factors for chronic constipation and faecal incontinence were long-listed from scientific literature, then anonymously evaluated (by 50 predominantly colorectal surgical experts from the UK Pelvic Floor Society) using a Delphi technique. Each risk factor was rated as independent, a co-factor, or not a risk factor. Independent risk factors were rated between 1 (not important) and 10 (critically important) with mean (& PLUSMN; standard deviation) calculated.ResultsThirty-eight risk factors for chronic constipation were evaluated. Eighteen were classed as independent and 16 as co-factors. Opioid analgesia (7.87 & PLUSMN; 2.05), eating disorders (7.80 & PLUSMN; 1.72), and history of abuse (7.70 & PLUSMN; 1.89) were scored as most important independent risk factors. Female sex (6.60 & PLUSMN; 2.02) was considered an independent risk factor but increasing age was rated a co-factor. Thirty-three risk factors for faecal incontinence were evaluated. Twenty were classed as independent and eight as co-factors. Third- or fourth-degree tear (8.88 & PLUSMN; 1.57), instrumental delivery (8.47 & PLUSMN; 1.58), and grand multiparity (8.00 & PLUSMN; 1.63) were rated most important. Increasing age (7.41 & PLUSMN; 2.14) and female sex (7.58 & PLUSMN; 2.05) were both considered independent risk factors.ConclusionsSeveral risk factors for chronic constipation and faecal incontinence were selected by Delphi approach. These factors will feed forward into Bayesian models of disease prediction that combine data and expert knowledge.","[Chaichanavichkij, P.; Scott, S. M.; Knowles, C. H.] Queen Mary Univ London, Natl Bowel Res Ctr, 1st Floor, Abernethy Bldg, 2 Newark St, London E1 2AT, England; [Chaichanavichkij, P.; Scott, S. M.; Knowles, C. H.] Queen Mary Univ London, Blizard Inst, Ctr Neurosci Surgery & Trauma, GI Physiol Unit, 1st Floor, Abernethy Bldg, 2 Newark St, London E1 2AT, England; [Hartmann, M.; Fenton, N.] Queen Mary Univ London, Sch Elect Engn & Comp Sci, Risk & Informat Management Res Grp, London, England",University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London,"Chaichanavichkij, P (corresponding author), Queen Mary Univ London, Natl Bowel Res Ctr, 1st Floor, Abernethy Bldg, 2 Newark St, London E1 2AT, England.;Chaichanavichkij, P (corresponding author), Queen Mary Univ London, Blizard Inst, Ctr Neurosci Surgery & Trauma, GI Physiol Unit, 1st Floor, Abernethy Bldg, 2 Newark St, London E1 2AT, England.",p.chaichanavichkij@qmul.ac.uk,,"Hartmann, Morghan/0000-0003-4386-9040; Chaichanavichkij, Pam/0000-0003-2244-5775; Knowles, Charles/0000-0001-9854-6754",,,,,45,1,1,0,1,SPRINGER-VERLAG ITALIA SRL,MILAN,"VIA DECEMBRIO, 28, MILAN, 20137, ITALY",1123-6337,1128-045X,,TECH COLOPROCTOL,Tech. Coloproctology,OCT,2023,27,10,,,,,847,857,,10.1007/s10151-023-02843-w,http://dx.doi.org/10.1007/s10151-023-02843-w,,JUL 2023,11,Gastroenterology & Hepatology; Surgery,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Surgery,R7LK6,37498418,"Green Published, hybrid",,,2024-06-04,WOS:001038559500001,View Full Record in Web of Science
J,"Meng, QR; Chen, F; Gao, WJ",,,,"Meng, Qingran; Chen, Feng; Gao, Wenjie",,,Effects of superfine grinding on asparagus pomace. Part II: Changes on intestinal function and health,LWT-FOOD SCIENCE AND TECHNOLOGY,,,English,Article,,,,,,Asparagus pomace; Superfine grinding; Constipation; Intestinal function,DIETARY FIBER,"This study aims to evaluate the effects of asparagus pomace with different particle size (similar to 10 mu m, similar to 30 mu m, and similar to 80 mu m) on intestinal function and health. One hundred and forty male Kunming mice were divided into fourteen groups and were used for small intestine movement experiment, defecation experiment, and intestinal function and health experiment, respectively. Results showed that, asparagus pomace samples treatment could markedly alleviate the constipation caused by loperamide with improved intestinal propulsion rate, reduced initial time of the first black stool, and increased the total mass of faeces within 6 h (P < 0.05), and finer samples worked better. All asparagus pomace-treated groups could significantly reduce the cecum ammonia concentration, increase the faeces dry weight and moisture content, and lower the beta-D-glucosidase and beta-D-glucuronidase activities. However, the difference in aforementioned properties between similar to 10 mu m and similar to 30 mu m groups were not significant (P > 0.05), and the respective maximal efficiency were observed when the sample was ranged within the size in similar to 30 mu m, which indicated that a rational granularity can meet its objectives. This paper is expected to provide new insights of pulverization on functional properties of fiber-rich food materials.","[Meng, Qingran] Shanghai Inst Technol, Sch Perfume & Aroma Technol, Engn Res Ctr Perfume & Aroma & Cosmet, Minist Educ, Shanghai 201418, Peoples R China; [Chen, Feng] Clemson Univ, Dept Food Nutr & Packaging Sci, Clemson, SC 29634 USA; [Gao, Wenjie] Shanghai Inst Technol, Sch Ecol Technol & Engn, Shanghai 201418, Peoples R China",Shanghai Institute of Technology; Clemson University; Shanghai Institute of Technology,"Gao, WJ (corresponding author), Shanghai Inst Technol, Sch Ecol Technol & Engn, Shanghai 201418, Peoples R China.",gaowenjie0724@sit.edu.cn,"Meng, Qingran/HII-9489-2022","Meng, Qingran/0000-0002-5731-0857","Science and Technology Talent Development Fund for Young Teachers of Shanghai Institute of Technology [10120K209026-A06-ZQ2020-2, 10120K209028-A06-ZQ2020-4, 10120K206062-A06-YJ2020-25]",Science and Technology Talent Development Fund for Young Teachers of Shanghai Institute of Technology,This study is financially supported by the Science and Technology Talent Development Fund for Young Teachers of Shanghai Institute of Technology (10120K209026-A06-ZQ2020-2 and 10120K209028-A06-ZQ2020-4) and the Start-up Funding of Shanghai Institute of Technology (10120K206062-A06-YJ2020-25).,,28,2,2,6,30,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",0023-6438,1096-1127,,LWT-FOOD SCI TECHNOL,LWT-Food Sci. Technol.,APR,2021,140,,,,,,,,110799,10.1016/j.lwt.2020.110799,http://dx.doi.org/10.1016/j.lwt.2020.110799,,,7,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,RH3GW,,,,,2024-06-04,WOS:000636112600061,View Full Record in Web of Science
J,"Gigic, B; Boeing, H; Toth, R; Böhm, J; Habermann, N; Scherer, D; Schrotz-King, P; Abbenhardt-Martin, C; Skender, S; Brenner, H; Chang-Claude, J; Hoffmeister, M; Syrjala, K; Jacobsen, PB; Schneider, M; Ulrich, A; Ulrich, CM",,,,"Gigic, Biljana; Boeing, Heiner; Toth, Reka; Bohm, Jurgen; Habermann, Nina; Scherer, Dominique; Schrotz-King, Petra; Abbenhardt-Martin, Clare; Skender, Stephanie; Brenner, Hermann; Chang-Claude, Jenny; Hoffmeister, Michael; Syrjala, Karen; Jacobsen, Paul B.; Schneider, Martin; Ulrich, Alexis; Ulrich, Cornelia M.",,,Associations Between Dietary Patterns and Longitudinal Quality of Life Changes in Colorectal Cancer Patients: The ColoCare Study,NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL,,,English,Article,,,,,,,EUROPEAN-ORGANIZATION; MEDITERRANEAN DIET; FECAL INCONTINENCE; STYLE FACTORS; POPULATION; NUTRITION; DIAGNOSIS; SURVIVAL; FIBER; IMPACT,"Quality of life (QoL) is an important clinical outcome in cancer patients. We investigated associations between dietary patterns and QoL changes in colorectal cancer (CRC) patients. The study included 192 CRC patients with available EORTC QLQ-C30 data before and 12 months post-surgery and food frequency questionnaire data at 12 months post-surgery. Principal component analysis was used to identify dietary patterns. Multivariate regression models assessed associations between dietary patterns and QoL changes over time. We identified four major dietary patterns: Western dietary pattern characterized by high consumption of potatoes, red and processed meat, poultry, and cakes, fruit& vegetable pattern: high intake of vegetables, fruits, vegetable oils, and soy products, bread& butter pattern: high intake of bread, butter and margarine, and high-carb pattern: high consumption of pasta, grains, nonalcoholic beverages, sauces and condiments. Patients following a Western diet had lower chances to improve in physical functioning (OR = 0.45 [0.21-0.99]), constipation (OR = 0.30 [0.13-0.72]) and diarrhea (OR: 0.44 [0.20-0.98]) over time. Patients following a fruit& vegetable diet showed improving diarrhea scores (OR: 2.52 [1.21-5.34]. A Western dietary pattern after surgery is inversely associated with QoL in CRC patients, whereas a diet rich in fruits and vegetables may be beneficial for patients' QoL over time.","[Gigic, Biljana; Schneider, Martin; Ulrich, Alexis] Univ Clin Heidelberg, Dept Surg, Heidelberg, Germany; [Gigic, Biljana; Schrotz-King, Petra; Abbenhardt-Martin, Clare; Skender, Stephanie; Brenner, Hermann; Ulrich, Cornelia M.] Natl Ctr Tumor Dis, Div Prevent Oncol, Heidelberg, Germany; [Gigic, Biljana; Schrotz-King, Petra; Abbenhardt-Martin, Clare; Skender, Stephanie; Brenner, Hermann; Ulrich, Cornelia M.] German Canc Res Ctr, Heidelberg, Germany; [Gigic, Biljana; Brenner, Hermann] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany; [Boeing, Heiner] German Inst Human Nutr, Dept Epidemiol, Potsdam, Germany; [Toth, Reka] German Canc Res Ctr, Div Epigen & Canc Risk Factors, Heidelberg, Germany; [Bohm, Jurgen; Ulrich, Cornelia M.] Huntsman Canc Inst, Populat Sci, Salt Lake City, UT 84112 USA; [Habermann, Nina] European Mol Biol Lab, Genome Biol Unit, Heidelberg, Germany; [Scherer, Dominique] Heidelberg Univ, Inst Med Biometry & Informat, Heidelberg, Germany; [Brenner, Hermann; Hoffmeister, Michael] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Chang-Claude, Jenny] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Syrjala, Karen] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Jacobsen, Paul B.] H Lee Moffitt Canc Ctr & Res Inst, Dept Hlth Outcomes & Behav, Tampa, FL USA; [Ulrich, Cornelia M.] Fred Hutchinson Canc Res Ctr, Canc Prevent Program, 1124 Columbia St, Seattle, WA 98104 USA",Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Helmholtz Association; German Cancer Research Center (DKFZ); Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Fred Hutchinson Cancer Center; H Lee Moffitt Cancer Center & Research Institute; Fred Hutchinson Cancer Center,"Ulrich, CM (corresponding author), Huntsman Canc Inst, 2000 Circle Hope,Rm 4725, Salt Lake City, UT 84112 USA.",neli.ulrich@hci.utah.edu,"Brenner, Hermann/ABE-6383-2020; Toth, Reka/AAB-1695-2020; Hoffmeister, Michael/AAB-2321-2022; Hoffmeister, Michael/T-7187-2019; Brenner, Hermann/B-4627-2017; Schneider, Martin/KCZ-2988-2024","Brenner, Hermann/0000-0002-6129-1572; Toth, Reka/0000-0002-6096-1052; Hoffmeister, Michael/0000-0002-8307-3197; Hoffmeister, Michael/0000-0002-8307-3197; Brenner, Hermann/0000-0002-6129-1572; Jacobsen, Paul/0000-0002-4427-8800","Matthias Lackas Foundation; ERA-NET on Translational Cancer Research (TRANSCAN) project [01KT1503]; National Cancer Institute [NIH R01 CA 189184, NIH U01 CA 206110, R01CA189184]; Huntsman Cancer Foundation; NIH [R01 CA207371]; German Consortium of Translational Cancer Research (DKTK); Transcan-ERANET grant [01KT1503]; German Cancer Research Center (DKFZ), Heidelberg, Germany","Matthias Lackas Foundation; ERA-NET on Translational Cancer Research (TRANSCAN) project; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Huntsman Cancer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Consortium of Translational Cancer Research (DKTK); Transcan-ERANET grant; German Cancer Research Center (DKFZ), Heidelberg, Germany","Biljana Gigic was funded by the Matthias Lackas Foundation, the ERA-NET on Translational Cancer Research (TRANSCAN) project 01KT1503, and the National Cancer Institute project R01CA189184. Dr. Cornelia M Ulrich and Dr. Jurgen Bohm were funded by the National Cancer Institute projects NIH R01 CA 189184 and NIH U01 CA 206110 and the Huntsman Cancer Foundation. Dr. Ulrich was further funded by NIH R01 CA207371. The Heidelberg ColoCare study was supported by the Matthias Lackas Foundation, the German Consortium of Translational Cancer Research (DKTK) and the Transcan-ERANET grant 01KT1503 (FOCUS consortium) and institutional funding from the German Cancer Research Center (DKFZ), Heidelberg, Germany to the Division of Preventive Oncology (Dr. Cornelia M. Ulrich, Dr. Hermann Brenner) at the National Center for Tumor Diseases (NCT), Heidelberg, Germany.",,46,37,39,1,17,"ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD",ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND",0163-5581,1532-7914,,NUTR CANCER,Nutr. Cancer,,2018,70,1,,,,,51,60,,10.1080/01635581.2018.1397707,http://dx.doi.org/10.1080/01635581.2018.1397707,,,10,Oncology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Oncology; Nutrition & Dietetics,GB7MK,29244538,Green Accepted,,,2024-06-04,WOS:000429258500007,View Full Record in Web of Science
J,"Sasaki, H; Hayashi, K; Imamura, M; Hirota, Y; Hosoki, H; Nitta, L; Furutani, A; Shibata, S",,,,"Sasaki, Hiroyuki; Hayashi, Katsuki; Imamura, Momoko; Hirota, Yuro; Hosoki, Haruka; Nitta, Lyie; Furutani, Akiko; Shibata, Shigenobu",,,Combined resistant dextrin and low-dose Mg oxide administration increases short-chain fatty acid and lactic acid production by gut microbiota,JOURNAL OF NUTRITIONAL BIOCHEMISTRY,,,English,Article,,,,,,resistant dextrin; short -chain fatty acid; Mg; microbiota; glucose-6-phosphate.,DIETARY MAGNESIUM; CONSTIPATION; PHYSIOLOGY; FIBER; COLON,"The consumption of resistant dextrin improves constipation, while its fermentation and degradation by the intestinal microbiota produce short-chain fatty acids (SCFA) and lactic acid, which have beneficial effects on host metabolism and immunity. Mg oxide (MgO) is an important mineral that is used to treat constipation. Therefore, resistant dextrin and MgO are often administered together to improve constipation. However, limited information is available regarding the effect of this combination on SCFA and lactic acid production. Crl:CD1(ICR) mice were fed a Mg-free diet with 5% resistant dextrin, followed by oral administration of MgO. We collected the cecum contents and measured SCFA and lactic acid levels. Additionally, the human subjects received resistant dextrin and Mg supplements as part of their habitual diet. The results of this study demonstrate that intestinal microbiota cannot promote SCFA and lactic acid production in the absence of Mg. In a mouse model, low doses of MgO promoted the production of SCFA and lactic acid, whereas high doses decreased their production. In humans, the combined consumption of resistant dextrin and Mg supplements increased the production of SCFA and lactic acid. The production of SCFA and lactic acid from dietary fiber may be augmented by the presence of MgO. & COPY; 2023 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ )","[Sasaki, Hiroyuki; Hayashi, Katsuki; Imamura, Momoko; Hirota, Yuro; Hosoki, Haruka; Nitta, Lyie; Furutani, Akiko; Shibata, Shigenobu] Waseda Univ, Sch Adv Sci & Engn, Lab Physiol & Pharmacol, Shinjuku Ku, Tokyo 1620056, Japan; [Furutani, Akiko] Aikoku Gakuen Jr Coll, Fac Home Econ, Edogawa ku, Tokyo 1338585, Japan",Waseda University,"Shibata, S (corresponding author), Waseda Univ, Sch Adv Sci & Engn, Lab Physiol & Pharmacol, Shinjuku Ku, Tokyo 1620056, Japan.",shibatas@waseda.jp,,,Japan Society for the Promotion of Science (JSPS) KAKENHI; JST-Mirai Program; [JMPJM120D5],"Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST-Mirai Program;","This work was partially supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI (Houga) [Shibata. S] , and JST-Mirai Program (Grant Number JMPJM120D5) (Japan; S. Shibata) .",,61,2,2,10,23,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",0955-2863,1873-4847,,J NUTR BIOCHEM,J. Nutr. Biochem.,OCT,2023,120,,,,,,,,109420,10.1016/j.jnutbio.2023.109420,http://dx.doi.org/10.1016/j.jnutbio.2023.109420,,AUG 2023,15,Biochemistry & Molecular Biology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Nutrition & Dietetics,P8NK3,37516314,hybrid,,,2024-06-04,WOS:001053180800001,View Full Record in Web of Science
J,"Calderon, G; Patel, C; Camilleri, M; James-Stevenson, T; Bohm, M; Siwiec, R; Rogers, N; Wo, J; Lockett, C; Gupta, A; Xu, HP; Shin, A",,,,"Calderon, Gerardo; Patel, Chirag; Camilleri, Michael; James-Stevenson, Toyia; Bohm, Matthew; Siwiec, Robert; Rogers, Nicholas; Wo, John; Lockett, Carolyn; Gupta, Anita; Xu, Huiping; Shin, Andrea",,,Associations of Habitual Dietary Intake With Fecal Short-Chain Fatty Acids and Bowel Functions in Irritable Bowel Syndrome,JOURNAL OF CLINICAL GASTROENTEROLOGY,,,English,Article,,,,,,nutrition; acetate; butyrate; propionate; functional gastrointestinal disorder,STOOL FORM; SYMPTOMS; FERMENTATION; MICROBIOTA; CARBOHYDRATE; RESTRICTION; POPULATION; DEFECATION; FREQUENCY; DIARRHEA,"Background & Goals: Diet may contribute to symptoms of irritable bowel syndrome (IBS) and luminal production of putative IBS biomarkers including short-chain fatty acids (SCFAs). Study aims were to to assess relationships of habitual fiber or starch intake with fecal SCFAs in patients with IBS and healthy volunteers (HVs). Study: In 18 HVs and 30 patients with IBS (13 constipation-predominant [IBS-C] and 17 diarrhea-predominant [IBS-D]), habitual diet using a food frequency questionnaire; bowel functions using a validated bowel diary; and fecal SCFAs by HPLC-mass spectrometry were assessed. Associations of fiber and starch with SCFAs were analyzed using Spearman (r ( s )) and Pearson (R) correlations. Relationships between other dietary endpoints, SCFAs, and bowel functions were explored. Results: Habitual fiber or starch intakes were not significantly correlated with SCFAs or bowel functions in all participants or HVs nor with SCFAs in IBS. Starch was negatively correlated (R=-0.53; P=0.04) with complete evacuation in IBS-D. Fiber (r ( s )=0.65; P=0.02) and starch (r ( s )=0.56; P=0.05) were correlated with ease of passage in IBS-C. Stool form, frequency, and ease of passage were positively correlated with total SCFAs (all P<0.05), acetate (all P<0.01), propionate (all P<0.05), and butyrate (form P=0.01; ease of passage P=0.05) among all participants, but not in IBS. Complete evacuation was negatively correlated with propionate (R=-0.34; P=0.04) in all participants. Total (P=0.04) and individual SCFAs (all P<0.05) were positively correlated with stool form in HVs. Conclusions: Habitual fiber and starch intake does not influence fecal SCFAs but may influence bowel functions in IBS. Fecal SCFAs correlate with bowel functions among all participants including HVs.","[Calderon, Gerardo; Patel, Chirag; James-Stevenson, Toyia; Bohm, Matthew; Siwiec, Robert; Rogers, Nicholas; Wo, John; Lockett, Carolyn; Gupta, Anita; Shin, Andrea] Indiana Univ Sch Med, Dept Med, Div Gastroenterol & Hepatol, Indianapolis, IN 46202 USA; [Xu, Huiping] Indiana Univ Sch Med, Dept Biostat, Indianapolis, IN 46202 USA; [Camilleri, Michael] Mayo Clin, Clin Enter Neurosci Translat & Epidemiol Res CENT, Div Gastroenterol & Hepatol, Rochester, MN USA",Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Mayo Clinic,"Shin, A (corresponding author), Indiana Univ Sch Med, 702 Rotary Circle,Suite 225, Indianapolis, IN 46202 USA.",ashin@iu.edu,,,"NIH [K23DK122015]; Indiana University Health Research Award; Indiana CTSI (National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award) [UL1TR002529]","NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana University Health Research Award; Indiana CTSI (National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award)","A.S. is supported by NIH K23DK122015 and the Indiana University Health Research Award and Indiana CTSI (funded in part by UL1TR002529 from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award).",,59,4,4,0,7,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0192-0790,1539-2031,,J CLIN GASTROENTEROL,J. Clin. Gastroenterol.,MAR,2022,56,3,,,,,234,242,,10.1097/MCG.0000000000001521,http://dx.doi.org/10.1097/MCG.0000000000001521,,,9,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,ZC5BE,33780215,Green Accepted,,,2024-06-04,WOS:000757534700020,View Full Record in Web of Science
J,"Patel, NV",,,,"Patel, Neha, V",,,Let Food Be Thy Medicine: Diet and Supplements in Irritable Bowel Syndrome,CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY,,,English,Review,,,,,,IBS; FODMAP; probiotics; microbiome; diarrhea; constipation; abdominal pain; bloating; gluten; sensitivity; dietary; disease; treatment,RANDOMIZED CONTROLLED-TRIAL; FERMENTABLE OLIGO; POLYOLS DIET; DOUBLE-BLIND; MANAGEMENT; SYMPTOMS; ADVICE; MONOSACCHARIDES; PLACEBO; ADULTS,"Overview: The purpose of this review is to introduce options for dietary therapies and supplements for the treatment of irritable bowel syndrome (IBS). IBS is a common condition with heterogeneity in pathogenesis and clinical presentation. Current treatment options are targeted at symptom relief with medications. Patients naturally pursue dietary modifications when dealing with symptoms. Dietary therapy for IBS has been poorly studied in the past; however, newer evidence suggests the use of certain diets, such as the low FODMAP (fermentable oligosaccharides, disaccharides, monosaccharides and polyols) diet, as an intervention in patients with IBS for symptom improvement. Exclusion strategies are frequently tried, such as gluten restriction or lactose avoidance, but lack quality evidence behind their use. Additionally, supplements, such as fiber, probiotics, and peppermint oil, have also been used for IBS with more recent data suggesting the use of these supplements with specific caveats.","[Patel, Neha, V] Univ Texas Southwestern Med Ctr Dallas, Digest & Liver Dis Internal Med, Dallas, TX 75390 USA",University of Texas System; University of Texas Southwestern Medical Center Dallas,"Patel, NV (corresponding author), UT Southwestern Med Ctr, 5959 Harry Hines Blvd HP5-520, Dallas, TX 75235 USA.",neha.patel@utsouthwestern.edu,,"Patel, Neha/0000-0001-9102-7572",,,,,31,4,4,2,13,DOVE MEDICAL PRESS LTD,ALBANY,"PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND",1178-7023,,,CLIN EXP GASTROENTER,Clin. Exp. Gastroenterol.,,2021,14,,,,,,377,384,,10.2147/CEG.S321054,http://dx.doi.org/10.2147/CEG.S321054,,,8,Gastroenterology & Hepatology,Emerging Sources Citation Index (ESCI),Gastroenterology & Hepatology,UW6JG,34588791,"Green Published, gold",,,2024-06-04,WOS:000700259000001,View Full Record in Web of Science
J,"Scarpellini, E; Balsiger, LM; Broeders, B; Houte, KV; Routhiaux, K; Raymenants, K; Carbone, F; Tack, J",,,,"Scarpellini, Emidio; Balsiger, Lukas Michaja; Broeders, Bert; Houte, Karen Van Den; Routhiaux, Karen; Raymenants, Karlien; Carbone, Florencia; Tack, Jan",,,Nutrition and Disorders of Gut-Brain Interaction,NUTRIENTS,,,English,Review,,,,,,nutrients; disturbances of gut-brain axis; functional dyspepsia; malabsorption; irritable bowel syndrome; diarrhea; constipation,IRRITABLE-BOWEL-SYNDROME; FUNCTIONAL DYSPEPSIA; DIETARY FIBER; LACTOSE-INTOLERANCE; HEALTHY-SUBJECTS; CONTROLLED-TRIAL; FOOD-INTAKE; GLUTEN-FREE; SYMPTOMS; CONSTIPATION,"Background: Disorders of gut-brain interaction (DGBIs) have a complex pathophysiology that is often characterized by a relationship between food ingestion and triggering of symptoms. Understanding of the underlying mechanisms and the role of nutrients as a therapeutic target are rapidly evolving. Aims and methods: We performed a narrative review of the literature using the following keywords, their acronyms, and their associations: nutrients, disorders of gut-brain interaction; functional dyspepsia; malabsorption; irritable bowel syndrome; diarrhea; constipation. Results: Functional dyspepsia displayed a significant correlation between volume, fat and/or wheat abundance, chemical composition of ingested food and symptoms of early satiety, fullness and weight loss. Carbohydrate malabsorption is related to enzyme deficiency throughout the GI tract. Food composition and richness in soluble vs. non-soluble fibers is related to constipation and diarrhea. The elimination of fermentable oligo-, di-, monosaccharides and polyols (FODMAPs) has a significant and non-unidirectional impact on irritable bowel syndrome (IBS) symptoms. Conclusions: Food volume, nutritive and chemical composition, and its malabsorption are associated with symptom generation in DGBIs. Further multicenter, randomized-controlled clinical trials are needed to clarify the underlying pathophysiology.","[Scarpellini, Emidio; Balsiger, Lukas Michaja; Broeders, Bert; Houte, Karen Van Den; Routhiaux, Karen; Raymenants, Karlien; Carbone, Florencia; Tack, Jan] Katholieke Univ Leuven, Gasthuisberg Univ Hosp, Translat Res Gastrointestinal Disoerders TARGID, Herestraat 49, B-3000 Lueven, Belgium; [Scarpellini, Emidio] Madonna Soccorso Gen Hosp, Internal Med Unit, Via Luciano Manara 7, I-63074 San Benedetto Tronto, Italy",KU Leuven,"Tack, J (corresponding author), Katholieke Univ Leuven, Gasthuisberg Univ Hosp, Translat Res Gastrointestinal Disoerders TARGID, Herestraat 49, B-3000 Lueven, Belgium.",emidio.scarpellini@med.kuleuven.be; lukasmichaja.balsiger@kuleuven.be; bert.broeders@med.kuleuven.be; karen.vandenhoute@med.kuleuven.be; karen.routhiaux@med.kuleuven.be; karlien.raymenants@med.kuleuven.be; florencia.carbone@uzleuven.be; jan.tack@med.kuleuven.be,"Scarpellini, Emidio/AAT-2052-2020","Scarpellini, Emidio/0000-0002-2101-1118; Balsiger, Lukas/0000-0001-7399-8500; Tack, Jan/0000-0002-3206-6704; Carbone, Florencia/0000-0003-1790-7904",,,,,94,0,0,9,9,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,JAN,2024,16,1,,,,,,,176,10.3390/nu16010176,http://dx.doi.org/10.3390/nu16010176,,,14,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,ER0I7,38202005,"Green Published, gold",,,2024-06-04,WOS:001140529200001,View Full Record in Web of Science
B,"Kaur, L; Singh, J",,"Govil, JN; Singh, VK",,"Kaur, Lovedeep; Singh, Jaspreet",,,The Role of Galactomannan Seed Gums in Diet and Health - A Review,STANDARDIZATION OF HERBAL/AYURVEDIC FORMATIONS,Recent Progress in Medicinal Plants,,English,Article; Book Chapter,,,,,,Galactomannan; Guar gum; Locust bean gum; Fenugreek; Dietary fiber; Blood glucose; Serum cholesterol,HYDROLYZED GUAR GUM; SOLUBLE FIBER; ENTERAL NUTRITION; ENERGY-INTAKE; DOUBLE-BLIND; IN-VITRO; GLUCOSE; INSULIN; FENUGREEK; SATIETY,"This review emphasizes on the potential of galactomannan seed gums such as, guar, locust bean gum and fenugreek seed extract, as a health ingredient, for lowering of blood cholesterol levels (both total and LDL); and for lowering of postprandial blood glucose and insulin. The dietary significance of the gums is associated to their effects at various sites in the gastrointestinal tract. The activities of these gums in the upper gut are linked to their ability to produce high viscosity (at low concentration) in the gut lumen, thereby, considerably affecting the nutrient absorption and postprandial plasma nutrient levels. The fermentation of these gums by the microflora in the large intestine may be beneficial in enteral nutrition, for the treatment of constipation, diabetes and in preventing Colon cancer.","[Kaur, Lovedeep; Singh, Jaspreet] Massey Univ, Riddet Inst, Palmerston North, New Zealand",Massey University,"Kaur, L (corresponding author), Massey Univ, Riddet Inst, Private Bag 11222, Palmerston North, New Zealand.",l.kaur@massey.ac.nz,"Singh, Jaspreet/G-9084-2011; kaur, Lovedeep/A-8820-2009",,,,,,65,11,11,0,2,STUDIUM PRESS LLC,HOUSTON,"PO BOX 722200, HOUSTON, TX 77072 USA",,,978-1-933699-14-1,RECENT PROG MED PLAN,,,2009,24,,,,,,329,343,,,,,,15,Plant Sciences; Pharmacology & Pharmacy,Book Citation Index – Science (BKCI-S),Plant Sciences; Pharmacology & Pharmacy,BKM20,,,,,2024-06-04,WOS:000268472900018,View Full Record in Web of Science
J,"Cong, L; Ma, JT; Jin, ZJ; Duan, LW; Su, WP; Zheng, J; Zhang, LJ; Xu, J; Li, DF",,,,"Cong, Liang; Ma, Jing-Ting; Jin, Zhen-Jing; Duan, Li-Wei; Su, Wei-Ping; Zheng, Jing; Zhang, Ling-Juan; Xu, Jia; Li, Dong-Fu",,,"Efficacy and Safety of High Specific Volume Polysaccharide-A New Type of Dietary Fiber for Treatment of Functional Constipation and IBS-C (vol 61, pg 326, 2015)",JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY,,,English,Correction,,,,,,,,,,,,,"su, wei/GZM-3986-2022",,,,,,1,0,0,1,15,CENTER ACADEMIC PUBL JAPAN,TOKYO,"2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN",0301-4800,1881-7742,,J NUTR SCI VITAMINOL,J. Nutr. Sci. Vitaminol.,FEB,2016,62,1,,,,,71,71,,,,,,1,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,DF6DK,,,,,2024-06-04,WOS:000371445900012,View Full Record in Web of Science
J,"Minor, G; Sentongo, T; Heine, RG; Zemrani, B",,,,"Minor, Gerard; Sentongo, Timothy; Heine, Ralf G.; Zemrani, Boutaina",,,"Tolerability and safety of a semi-elemental enteral formula with partially hydrolyzed guar gum (PHGG) in tube-fed children aged 1-4 years: An open-label, single-arm study",CLINICAL NUTRITION ESPEN,,,English,Article,,,,,,Fiber; Enteral nutrition; Children,CHAIN FATTY-ACIDS; IRRITABLE-BOWEL-SYNDROME; SOLUBLE FIBER; DIETARY FIBER; DIARRHEA; CONSTIPATION; NUTRITION; HEALTH; SUPPLEMENTATION; MICROBIOTA,"Background and aims: Partially hydrolyzed guar gum (PHGG) is a water-soluble fiber supporting digestive health with well-established safety and efficacy. This open-label, single-arm, multicenter trial aimed to assess the tolerability and safety of a semi-elemental enteral formula containing PHGG at 12 g/L in tube-fed young children.Methods: Children aged 1-4 years with stable conditions requiring tube feeding to provide >= 80% of their nutritional needs received the study formula for seven days. Tolerability, safety, adequacy of energy/ protein intake, and weight change were assessed.Results: Of 24 children (mean age 33.5 months; 10 [41.7%] female), 23 (95.8%) commenced treatment and 18 (75%) completed the study. All children had underlying neuro-developmental disabilities, often in association with gastrointestinal comorbidities requiring treatment for constipation (70.8%) or gastro-esophageal reflux (66.7%). The formula was well-tolerated by 19 (82.6%) subjects, while 4 (17.4%; 95% CI: 5%, 39%) subjects withdrew early from the study due to gastrointestinal intolerance. The mean (SD) percentage energy and protein intake across the 7-day period were 103.5% (24.7) and 139.5% [50], respectively. Weight remained stable over the 7-day period (p = 0.43). The study formula was associated with a shift towards softer and more frequent stools. Pre-existing constipation was generally well controlled, and 3/16 (18.7%) subjects ceased laxatives during the study. Adverse events were reported in 12 (52%) subjects and were deemed 'probably related' or 'related' to the formula in 3 (13%) subjects. Gastrointestinal adverse events appeared more common in fiber-naive patients (p = 0.09).Conclusion: The present study indicates that the study formula was safe and generally well tolerated in young tube-fed children.Clinicaltrials.gov identifier: NCT04516213. (c) 2023 The Author(s). Published by Elsevier Ltd on behalf of European Society for Clinical Nutrition and Metabolism. This is an open access article under the CC BY license (http://creativecommons.org/licenses/ by/4.0/).","[Minor, Gerard] KIDZ Med Serv, Pediat Gastroenterol, Hepatol & Nutr, Hollywood, FL 33021 USA; [Sentongo, Timothy] Univ Chicago, Comer Childrens Hosp, Dept Pediat, Sect Pediat Gastroenterol Hepatol & Nutr, Chicago, IL USA; [Heine, Ralf G.; Zemrani, Boutaina] Nestle Hlth Sci, Clin Res & Dev, Pediat Med Nutr, Vevey, Switzerland",University of Chicago; Nestle SA,"Minor, G (corresponding author), KIDZ Med Serv, Pediat Gastroenterol, Hepatol & Nutr, Hollywood, FL 33021 USA.",gerardminor@gmail.com; tsentong@peds.bsd.uchicago.edu; Ralf.Heine@au.nestle.com; Boutaina.Zemrani@nestle.com,,"Minor, Gerard/0000-0001-8182-0104; Zemrani, Boutaina/0000-0003-1963-388X; Heine, Ralf Gunter/0000-0002-3343-0379",,,,,53,0,0,2,3,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",2405-4577,,,CLIN NUTR ESPEN,Clin. Nutr. ESPEN,JUN,2023,55,,,,,,392,399,,10.1016/j.clnesp.2023.04.004,http://dx.doi.org/10.1016/j.clnesp.2023.04.004,,APR 2023,8,Nutrition & Dietetics,Emerging Sources Citation Index (ESCI),Nutrition & Dietetics,G4XN9,37202073,hybrid,,,2024-06-04,WOS:000989204000001,View Full Record in Web of Science
J,"Marteau, P; Jacobs, H; Cazaubiel, M; Signoret, C; Prevel, JM; Housez, B",,,,"Marteau, Philippe; Jacobs, Heidi; Cazaubiel, Murielle; Signoret, Cathy; Prevel, Jean-Michel; Housez, Beatrice",,,Effects of chicory inulin in constipated elderly people: a double-blind controlled trial,INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION,,,English,Article,,,,,,Inulin; prebiotic; bifidobacteria; constipation; elderly,BIFIDOBACTERIUM-LACTIS; FECAL BIFIDOBACTERIA; INFANT FORMULA; HEALTHY HUMANS; DIETARY FIBER; PREBIOTICS; OLIGOFRUCTOSE; MICROBIOTA; OLIGOSACCHARIDES; PROBIOTICS,"The impact of the daily consumption of 15 g chicory native inulin on fecal levels of bifidobacteria, stool parameters and quality of life of elderly constipated volunteers was investigated in a randomized, double-blind, controlled versus placebo clinical trial. The impact of supplementation on constipation was assessed with questionnaires on bowel motor function parameters, visual analogue scales on bowel symptoms and quality of life. Fecal bacteria counts were determined at the beginning and at the end of the supplementation. Inulin supplementation led to a significant increase in total fecal bacteria (P < 0.01) and bifidobacteria (P < 0.001) concentrations after 28 days of consumption. Volunteers (n = 25) in the inulin group reported increased satisfaction about digestion (P < 0.01) and reduced defecation difficulties (P < 0.001) during the supplementation. Slight gastrointestinal symptoms (flatulence) were reported but did not lead to discontinuation. Daily supplementation with 15 g inulin improves constipation and quality of life in an elderly population with constipation.","[Jacobs, Heidi; Signoret, Cathy] Cosucra Grp Warcoing, B-7740 Warcoing, Belgium; [Marteau, Philippe] Lariboisiere Hosp, AP HP, Medicosurg Dept Digest Dis, Paris, France; [Marteau, Philippe] Univ Paris 07, Paris, France; [Cazaubiel, Murielle; Prevel, Jean-Michel; Housez, Beatrice] Biofortis, Nantes, France",Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Universite Paris Cite,"Signoret, C (corresponding author), Cosucra Grp Warcoing, Rue Sucrerie 1, B-7740 Warcoing, Belgium.",csignoret@cosucra.com,,"philippe, marteau/0000-0002-7621-6719",,,,,45,59,68,8,33,TAYLOR & FRANCIS LTD,ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND",0963-7486,1465-3478,,INT J FOOD SCI NUTR,Int. J. Food Sci. Nutr.,MAR,2011,62,2,,,,,164,170,,10.3109/09637486.2010.527323,http://dx.doi.org/10.3109/09637486.2010.527323,,,7,Food Science & Technology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Nutrition & Dietetics,733BJ,21091293,,,,2024-06-04,WOS:000288235100011,View Full Record in Web of Science
J,"Grundmann, O; Yoon, SL; Mason, S; Smith, K",,,,"Grundmann, Oliver; Yoon, Saunjoo L.; Mason, Sydney; Smith, Keore",,,"Gastrointestinal symptom improvement from fiber, STW 5, peppermint oil, and probiotics use-Results from an online survey",COMPLEMENTARY THERAPIES IN MEDICINE,,,English,Article,,,,,,Gastrointestinal disorders; Fiber; STW 5; Probiotics; Peppermint; Online survey,IRRITABLE-BOWEL-SYNDROME; QUALITY-OF-LIFE; DIETARY FIBER; MANAGEMENT; DISORDERS; DIAGNOSIS; EPIDEMIOLOGY; CONSTIPATION; SEVERITY; WOMEN,"Objectives: Several common supplements are used by a significant number of patients affected by gastrointestinal (GI) disorders to improve symptoms and quality of life. We investigated the impact of GI symptom improvement with the use of fiber, STW 5, probiotics, and peppermint oil in relation to overall GI pain and quality of life via an online survey. Design: We used a cross-sectional, descriptive, correlation design. A Qualtrics online survey was utilized to collect data from January to June 2013 through various websites. Areas evaluated included participant demographics, use of supplements, and gastrointestinal symptom severity. Results: The rate of supplement use among patients with GI disorders was high (90% in past year) and consultation with healthcare providers was reported by 80%. Participants who completed the survey (n = 68) reported a strong correlation between GI symptom severity and overall quality of life (r(2) = 0.8682, p < 0.001). The use of fiber improved GI symptom severity while both STW 5 and probiotics were linked to specific improvements. Conclusions: Persons with chronic GI disorders often choose the complementary use of common supplements to mitigate GI symptoms and consult with their healthcare providers frequently. The use of STW 5 and probiotics specifically is linked to overall reduction in GI symptoms and improvement of quality of life.","[Grundmann, Oliver] Univ Florida, Coll Pharm, Dept Med Chem, 1345 Ctr Dr,Room P6-20, Gainesville, FL 32610 USA; [Grundmann, Oliver; Yoon, Saunjoo L.; Mason, Sydney; Smith, Keore] Univ Florida, Coll Nursing, Dept Biobehav Nursing Sci, Gainesville, FL 32610 USA",State University System of Florida; University of Florida; State University System of Florida; University of Florida,"Grundmann, O (corresponding author), Univ Florida, Coll Pharm, Dept Med Chem, 1345 Ctr Dr,Room P6-20, Gainesville, FL 32610 USA.",grundman@ufl.edu,"Grundmann, Oliver/AFK-1252-2022; Grundmann, Oliver/AAF-8411-2022; YOON, SAUNJOO/IWE-4420-2023","Grundmann, Oliver/0000-0003-2302-8949; Grundmann, Oliver/0000-0003-2302-8949; YOON, SAUNJOO/0000-0001-5669-8709",,,,,31,6,7,1,4,CHURCHILL LIVINGSTONE,EDINBURGH,"JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND",0965-2299,1873-6963,,COMPLEMENT THER MED,Complement. Ther. Med.,DEC,2018,41,,,,,,225,230,,10.1016/j.ctim.2018.10.003,http://dx.doi.org/10.1016/j.ctim.2018.10.003,,,6,Integrative & Complementary Medicine,Science Citation Index Expanded (SCI-EXPANDED),Integrative & Complementary Medicine,HE6FF,30477844,,,,2024-06-04,WOS:000453498000034,View Full Record in Web of Science
J,"Taylor, CM; Northstone, K; Wernimont, S; Emmett, P",,,,"Taylor, C. M.; Northstone, K.; Wernimont, S.; Emmett, P.",,,Eat your vegetables! Dietary fibre intakes and stool hardness in picky eaters,PROCEEDINGS OF THE NUTRITION SOCIETY,,,English,Meeting Abstract,,,,,,,FOOD NEOPHOBIA; CONSTIPATION; CHILDREN; CHILDHOOD,,"[Taylor, C. M.; Emmett, P.] Univ Bristol, Sch Social & Community Med, Ctr Child & Adolescent Hlth, Bristol BS8 2BN, Avon, England; [Northstone, K.] Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England; [Wernimont, S.] Nestle Nutr, King Of Prussia, PA 19406 USA",University of Bristol; University of Bristol; Nestle SA,,,"Wernimont, Susan M/KFS-1562-2024; Emmett, Pauline/AAL-6815-2021; Northstone, Kate/A-8165-2011","Wernimont, Susan M/0000-0001-7203-1349; Taylor, Caroline/0000-0001-8347-5092; Northstone, Kate/0000-0002-0602-1983",,,,,7,0,0,0,6,CAMBRIDGE UNIV PRESS,CAMBRIDGE,"EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND",0029-6651,1475-2719,,P NUTR SOC,Proc. Nutr. Soc.,,2015,74,OCE4,,,,,E221,E221,,10.1017/S0029665115002633,http://dx.doi.org/10.1017/S0029665115002633,,,1,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,CR2WE,,Bronze,,,2024-06-04,WOS:000361190700018,View Full Record in Web of Science
J,"Hyams, JS",,,,"Hyams, JS",,,Diet and gastrointestinal disease,CURRENT OPINION IN PEDIATRICS,,,English,Review,,,,,,,CELIAC-DISEASE; ELEMENTAL DIET; CROHNS-DISEASE; CONSTIPATION; PREVALENCE; ENCOPRESIS; FAILURE; FIBER; TRIAL,"Dietary manipulation can be an important part of therapy for several common gastrointestinal disorders. In Crohn disease, the provision of adequate protein and calories may not only improve symptoms but may be associated with acceleration of growth. In celiac disease, the dietary restriction of gluten is curative of the intestinal inflammation. In chronic nonspecific diarrhea and functional constipation, the provision of appropriate amounts of fiber and fluids may ameliorate symptoms. A thorough understanding of the role of diet is essential to the management of these disorders. (C) 2002 Lippincott Williams Wilkins, Inc.","Univ Connecticut, Sch Med, Hartford, CT 06106 USA; Connecticut Childrens Med Ctr, Div Digest Dis & Nutr, Hartford, CT USA",University of Connecticut; Connecticut Children's Medical Center,"Univ Connecticut, Sch Med, 282 Washington St, Hartford, CT 06106 USA.",jhyams@ccmckids.org,,,,,,,32,4,4,1,6,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",1040-8703,1531-698X,,CURR OPIN PEDIATR,CURR. OPIN. PEDIATR.,OCT,2002,14,5,,,,,567,569,,10.1097/00008480-200210000-00001,http://dx.doi.org/10.1097/00008480-200210000-00001,,,3,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,597EQ,12352249,,,,2024-06-04,WOS:000178209600001,View Full Record in Web of Science
J,"Sumida, K; Biruete, A; Kistler, BM; Khor, BH; Ebrahim, Z; Giannini, R; Sussman-Dabach, EJ; Avesani, CM; Chan, M; Lambert, K; Wang, AM; Clegg, DJ; Burrowes, JD; Palmer, BF; Carrero, JJ; Kovesdy, CP",,,,"Sumida, Keiichi; Biruete, Annabel; Kistler, Brandon M.; Khor, Ban-Hock; Ebrahim, Zarina; Giannini, Rossella; Sussman-Dabach, Elizabeth J.; Avesani, Carla Maria; Chan, Maria; Lambert, Kelly; Wang, Angela Yee-Moon; Clegg, Deborah J.; Burrowes, Jerrilynn D.; Palmer, Biff F.; Carrero, Juan-Jesus; Kovesdy, Csaba P.",,,New Insights Into Dietary Approaches to Potassium Management in Chronic Kidney Disease,JOURNAL OF RENAL NUTRITION,,,English,Review,,,,,,Chronic kidney disease; End-stage kidney disease; Dialysis; Dyskalemia; Fiber intake; Gut; Hyperkalemia; Kidney failure; Laxative; Plant-based diet; Potassium intake,METABOLIC-ACIDOSIS; SODIUM; HYPERKALEMIA; PHOSPHORUS; RISK; CONSTIPATION; VEGETABLES; MORTALITY; PRODUCTS; PATTERNS,"Potassium disorders are one of the most common electrolyte abnormalities in patients with chronic kidney disease (CKD), contributing to poor clinical outcomes. Maintaining serum potassium levels within the physiologically normal range is critically important in these patients. Dietary potassium restriction has long been considered a core strategy for the management of chronic hyperkalemia in patients with CKD. However, this has been challenged by recent evidence suggesting a paradigm shift toward fostering more liberalized, plant-based dietary patterns. The advent of novel potassium binders and an improved understanding of gastrointestinal processes involved in potassium homeostasis (e.g., gastrointestinal potassium wasting) may facilitate a paradigm shift and incorporation of heart-healthy potassium-enriched food sources. Nevertheless, uncertainty regarding the risk-benefit of plant-based diets in the context of potassium management in CKD remains, requiring well-designed clinical trials to determine the efficacy of dietary potassium manipulation toward improvement of clinical outcomes in patients with CKD.","[Sumida, Keiichi; Kovesdy, Csaba P.] Univ Tennessee, Dept Med, Div Nephrol, Hlth Sci Ctr, 956 Court Ave,Suite A220, Memphis, TN 38163 USA; [Biruete, Annabel] Indiana Univ Purdue Univ, Dept Nutr & Dietet, Indianapolis, IN 46202 USA; [Biruete, Annabel] Indiana Univ Sch Med, Dept Med, Div Nephrol, Indianapolis, IN 46202 USA; [Biruete, Annabel; Kistler, Brandon M.] Purdue Univ, Dept Nutr Sci, W Lafayette, IN 47907 USA; [Kistler, Brandon M.] Ball State Univ, Dept Nutr & Hlth Sci, Muncie, IN 47306 USA; [Khor, Ban-Hock] Univ Malaysia Sabah, Fac Food Sci & Nutr, Kota Kinabalu, Malaysia; [Ebrahim, Zarina] Stellenbosch Univ, Dept Global Hlth, Div Human Nutr, Stellenbosch, South Africa; [Giannini, Rossella] Univ Hosp Modena, Div Metab Dis & Clin Nutr, Modena, Italy; [Sussman-Dabach, Elizabeth J.] Calif State Univ Northridge, Dept Family & Consumer Sci, Northridge, CA 91330 USA; [Avesani, Carla Maria] Karolinska Inst, Dept Clin Sci, Baxter Novum, Div Renal Med, Stockholm, Sweden; [Chan, Maria] St George Hosp, Dept Nutr & Dietet, Kogarah, NSW, Australia; [Chan, Maria] St George Hosp, Dept Renal Med, Kogarah, NSW, Australia; [Lambert, Kelly] Univ Wollongong, Fac Sci Med & Hlth, Sch Med Indigenous & Hlth Sci, Wollongong, NSW, Australia; [Wang, Angela Yee-Moon] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Peoples R China; [Clegg, Deborah J.] Texas Tech Med Ctr, Paul Foster Sch Med, Dept Internal Med, El Paso, TX USA; [Burrowes, Jerrilynn D.] Long Isl Univ Post, Dept Hlth Sci & Adm, Program Nutr & Dietet, Greenvale, NY USA; [Palmer, Biff F.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX USA; [Carrero, Juan-Jesus] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden",University of Tennessee System; University of Tennessee Health Science Center; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; Purdue University System; Purdue University; Ball State University; Universiti Malaysia Sabah; Stellenbosch University; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; California State University System; California State University Northridge; Karolinska Institutet; St George Hospital; St George Hospital; University of Wollongong; University of Hong Kong; Texas Tech University System; Texas Tech University Health Science Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; Karolinska Institutet,"Sumida, K (corresponding author), Univ Tennessee, Dept Med, Div Nephrol, Hlth Sci Ctr, 956 Court Ave,Suite A220, Memphis, TN 38163 USA.",ksumida@uthsc.edu,"Avesani, Carla Maria/AAA-4128-2019; Lambert, Kelly/A-3940-2015","Avesani, Carla Maria/0000-0002-4458-8358; Biruete, Annabel/0000-0003-2549-0539; Ebrahim, Zarina/0000-0001-8612-1839; Lambert, Kelly/0000-0001-5935-7328","National Institutes of Health, National Center for Advancing Translational Sciences [KL2TR002530, UL1TR002529]; National Institutes of Health, Clinical and Translational Sciences Award [KL2TR002530, UL1TR002529]","National Institutes of Health, National Center for Advancing Translational Sciences; National Institutes of Health, Clinical and Translational Sciences Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)","A.B. is part of the AUGmeNtworkgroup fromthe Academy ofNutrition and Dietetics. A.B. was supported by Indiana CTSI-KL2 (This publication wasmade possiblewith support from GrantNumbers KL2TR002530 [Sheri Robb, PI] andUL1TR002529 [SarahWiehe and Sharon Moe, co-PIs] from the National Institutes of Health, National Center for Advancing Translational Sciences, and Clinical and Translational Sciences Award).",,51,5,5,4,4,W B SAUNDERS CO-ELSEVIER INC,PHILADELPHIA,"1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA",1051-2276,1532-8503,,J RENAL NUTR,J. Renal Nutr.,NOV,2023,33,6,,S,,,S6,S12,,10.1053/j.jrn.2022.12.003,http://dx.doi.org/10.1053/j.jrn.2022.12.003,,NOV 2023,7,Nutrition & Dietetics; Urology & Nephrology,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics; Urology & Nephrology,AI9H0,37610407,,,,2024-06-04,WOS:001117949100002,View Full Record in Web of Science
J,"Villanueva, A; Domínguez-Muñoz, JE; Mearin, F",,,,"Villanueva, A; Domínguez-Muñoz, JE; Mearin, F",,,Update in the therapeutic management of irritable bowel syndrome,DIGESTIVE DISEASES,,,English,Review,,,,,,dietary fiber; diet; brain-gut axis; antidiarrheal agents; antispasmodic agents; psychotherapy; prokinetic agents; antidepressant agents; analgesics; serotonin receptor; serotonin receptor antagonists,QUALITY-OF-LIFE; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; WHEAT BRAN; CONSTIPATION; ANTAGONISM; ALOSETRON; DISORDERS; EFFICACY; PAIN,"Irritable bowel syndrome (IBS) is a remarkably frequent disorder that leads to relevant impairment in patients' quality of life. Four mechanisms are involved in the pathogenesis of IBS: altered intestinal motility; increased visceral sensitivity; disturbed intestinal reflexes (intrinsic and extrinsic), and psychological disorders. The close relationship between the central nervous system and the enteric nervous system (the brain-gut axis) is the basis of the actual research on IBS therapy. It is conceivable that in the near future a better understanding of IBS pathophysiology will help us to tailor treatment for different IBS patients. At the moment, the subclassification of the diverse patterns of symptomatology allows the adjustment of treatments for IBS according to the clinical predominance of each patient. Dietary modifications like fiber supplementation, antidiarrheal agents and antispasmodic drugs are the basis of the current treatment of IBS and depend on the predominant symptom (constipation, diarrhea or pain, respectively). If severe pain is present, antidepressant agents are an appropriate alternative. However, the scientific evidence supporting this current therapeutic approach is limited. Visceral analgesics and serotonin agonists and antagonists may play an important therapeutic role in the near future. However, it is not likely that one single treatment will help every IBS patient and many of them will need a more complex approach with multidisciplinary therapy (diet, psychotherapy, medications). Copyright (C) 2001 S. Karger AG, Basel.","Univ Hosp, Dept Gastroenterol, E-15706 Santiago, Spain; Vall dHebron Hosp, Barcelona, Spain",Hospital Universitari Vall d'Hebron,,jdominguezm@medynet.com,"Augusto, Villanueva/F-9378-2012; Dominguez-Munoz, J. Enrique/Q-8922-2017","Dominguez-Munoz, J. Enrique/0000-0001-8283-3185; Villanueva, Augusto/0000-0003-3585-3727",,,,,42,7,9,0,1,KARGER,BASEL,"ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND",0257-2753,1421-9875,,DIGEST DIS,Dig. Dis.,,2001,19,3,,,,,244,250,,10.1159/000050687,http://dx.doi.org/10.1159/000050687,,,7,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,509GP,11752844,,,,2024-06-04,WOS:000173138300010,View Full Record in Web of Science
C,"Fithriani, D",,"Setyobudi, RH; Burlakovs, J; Mel, M; Adinurani, PG; VincevicaGaile, Z",,"Fithriani, Diini",,,OPPORTUNITIES AND CHALLENGES FOR DEVELOPING CAULERPA RACEMOSA AS FUNCTIONAL FOODS,INTERNATIONAL SYMPOSIUM ON AQUATIC PRODUCT PROCESSING (ISAPPROSH) 2013,KnE Life Sciences,,English,Proceedings Paper,"1st International Symposium on Aquatic Product Processing, Safety and Health (ISAPPROSH)","NOV 13-14, 2013","Bogor, INDONESIA",,,antioxidant; Caulerpa racemosa; fiber; functional food; health,VAR. CYLINDRACEA; CHLOROPHYTA; TAXIFOLIA; INVASION,"The higher public awareness of the health in community would made the view of some people for food has shifted, not only as relieving hunger, but also can provide a real impact for health. This phenomenon has resulted a term what is called functional food'. Functional food is defined as food which contain active compounds that play a role in increasing endurance, minimize the risk of attack of certain diseases and to provide maximum health benefits. One of marine resource that have a potency to develop as functional foods is Caulerpa racemosa. Caulerpa racemosa is one of green seaweed that grows naturally in the waters of Indonesia. Caulerpa racemosa found growing on coral substrate or a substrate of sand-rubble. Caulerpa racemosa is edible or can be consumed by humans. Caulerpa racemosa from Indonesia contains high insoluble dietary fiber. Insoluble dietary fiber contains cellulose and hemicellulose, who plays an important role in preventing constipation, colitis and hemmoroid. In other hand Caulerpa racemosa can also produce secondary metabolites, including antioxidants. Antioxidants are substances that are capable of slowing or preventing the oxidation processes that are beneficial to health.","[Fithriani, Diini] Res Ctr & Dev Prod Proc & Biotechnol Marine & Fis, Jakarta, Indonesia",,"Fithriani, D (corresponding author), Res Ctr & Dev Prod Proc & Biotechnol Marine & Fis, Jakarta, Indonesia.",diini_fithriani@yahoo.com,,,,,,,33,1,1,0,8,KNOWLEDGE E,DUBAI,"OFFICE 4402, X2 TOWER, JLT, PO BOX 488239, DUBAI, 00000, U ARAB EMIRATES",2413-0877,,,KNE LIFE SCI,,,2015,1,,,,,,85,96,,10.18502/kls.v1i0.90,http://dx.doi.org/10.18502/kls.v1i0.90,,,12,Food Science & Technology,Conference Proceedings Citation Index - Science (CPCI-S),Food Science & Technology,BH8HX,,Bronze,,,2024-06-04,WOS:000403321300015,View Full Record in Web of Science
J,"Werts, RL; Van Calcar, SC; Wargowski, DS; Smith, SM",,,,"Werts, Rachel L.; Van Calcar, Sandra C.; Wargowski, David S.; Smith, Susan M.",,,Inappropriate Feeding Behaviors and Dietary Intakes in Children with Fetal Alcohol Spectrum Disorder or Probable Prenatal Alcohol Exposure,ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH,,,English,Article,,,,,,Fetal Alcohol Spectrum Disorders; Nutrition; Abnormal Feeding; Pediatric Obesity; Vitamin D; Choline,BODY-MASS INDEX; ETHANOL EXPOSURE; BLOOD-PRESSURE; ENERGY-INTAKE; ADOLESCENTS; PREVALENCE; ADIPOSITY; EMPHASIS,"BackgroundPrenatal alcohol exposure (PAE) is a leading cause of significant neurobehavioral and neurocognitive deficits. Its potential consequences for eating behaviors, nutritional status, and other nutritional issues in childhood have received little attention. MethodsNineteen children (11 boys, 8 girls) of mean age 9.6years, referred for fetal alcohol spectrum disorder (FASD) screening and assessment, were analyzed with physical exams and caregiver questionnaires to identify possible abnormalities in food and eating behaviors. Fourteen children contributed 24-hour diet recalls and were assessed for nutritional status. ResultsSeventy-nine percent of participants were diagnosed with FASD and 63.2% had confirmed PAE. Fifty percent of girls were overweight or obese, whereas 37% of boys had reduced stature, weight, or body mass index for their age. Recurring feeding problems included constant snacking (36.8%), lack of satiety (26.3%), and picky eating/poor appetite (31.6%). None had oral feeding problems. Constipation was common (26.3%). Macronutrient intakes were largely normal, but sugar consumption was excessive (140 to 190% of recommendations) in 57% of subjects. Vitamin A intake exceeded the upper limit for 64% of participants, whereas 50% had intakes <80% of recommended daily allowances (RDAs) for choline, vitamin E, potassium, -carotene, and essential fatty acids; 100% had vitamin D intakes <80% of the RDA. ConclusionsPAE may be associated with altered acquisition and distribution of body mass with increasing age. Disordered eating was common. The increased feeding behaviors surrounding lack of satiety suggest that self-regulation may be altered. Constipation could reflect low dietary fiber or altered gastrointestinal function. These exploratory data suggest that children with PAE may be at risk for nutritional deficiencies, which are influenced by inappropriate food preferences, disordered eating patterns, medication use, and the stressful dynamics surrounding food preparation and mealtime.","[Werts, Rachel L.; Van Calcar, Sandra C.; Wargowski, David S.; Smith, Susan M.] Univ Wisconsin, Sch Med & Publ Hlth, Waisman Ctr, Madison, WI 53706 USA; [Werts, Rachel L.; Smith, Susan M.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA; [Van Calcar, Sandra C.; Wargowski, David S.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53706 USA",University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison,"Smith, SM (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.",suesmith@nutrisci.wisc.edu,,,NIH [P30 HD03352]; Northrop Grumman Information Technology through the FASD Center for Excellence; Wisconsin Department of Health Services through the Wisconsin FASD Treatment Outreach Project,NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northrop Grumman Information Technology through the FASD Center for Excellence; Wisconsin Department of Health Services through the Wisconsin FASD Treatment Outreach Project,"The FASD clinic was supported in part by NIH Core Grant P30 HD03352, by Northrop Grumman Information Technology through the FASD Center for Excellence, and Wisconsin Department of Health Services through the Wisconsin FASD Treatment Outreach Project.",,35,41,51,0,64,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0145-6008,1530-0277,,ALCOHOL CLIN EXP RES,Alcoholism (NY),MAR,2014,38,3,,,,,871,878,,10.1111/acer.12284,http://dx.doi.org/10.1111/acer.12284,,,8,Substance Abuse,Science Citation Index Expanded (SCI-EXPANDED),Substance Abuse,AC8BO,24164456,Green Accepted,,,2024-06-04,WOS:000332758200032,View Full Record in Web of Science
J,"Liu, M; Zheng, FJ; Ni, L; Sun, Y; Wu, RH; Zhang, TY; Zhang, JC; Zhong, XG; Li, YH",,,,Liu Miao; Zheng Fengjie; Ni Lei; Sun Yan; Wu Ruohan; Zhang Tianyu; Zhang Jinchao; Zhong Xianggen; Li Yuhang,,,"Sugarcane bagasse dietary fiber as an adjuvant therapy for stable chronic obstructive pulmonary disease: a four-center, randomized, double-blind, placebo-controlled study",JOURNAL OF TRADITIONAL CHINESE MEDICINE,,,English,Article,,,,,,"Saccharum; Pulmonary disease, chronic obstructive; Randomized clinical trial; Medicine, Chinese Traditional",C-REACTIVE PROTEIN; QUALITY-OF-LIFE; HEALTH-STATUS; COPD; CONSTIPATION; PREVALENCE; DYSPNEA; BURDEN; WOMEN; RISK,"OBJECTIVE: To evaluate the efficacy and safety of sugarcane bagasse dietary. fiber as an adjuvant therapy for improving quality of life in patients with stable chronic obstructive pulmonary disease (COPD). METHODS: This was a multicenter, randomized, double-blind, placebo-controlled trial. A total of 196 participants were randomized into a trial group (treated with 6 g/day sugarcane bagase plus conventional treatment, n = 98) and a control group (treated with placebo plus conventional treatment, n = 98). All efficacy analyses were performed according to the intention-to-treat (ITT) principle. A per-protocol analysis set (PPS) was used to analyze the cases that completed the clinical trial with good compliance. The trial period was 30 days, with a 6-month follow-up. Pre- and post-treatment pulmonary symptom scores (cough, sputum, wheezing, and dyspnea) were recorded for both groups. The St. George's Respiratory Questionnaire (SGRQ) and the modified Medical Research Council (mMRC) dyspnea scale were assessed before treatment and at the end of the 6-month follow-up. RESULTS: The ITT population was 178 and the PPS population was 166. Post-treatment pulmonary clinical symptoms and severity of dyspnea (mMRC and SGRQ evaluation) were significantly improved in both the trial group and the control group (ITT and PPS: P < 0.05). However, there was no statistical difference between the two groups in post-treatment pulmonary symptoms and mMRC. There was a greater reduction in the SGRQ sub scales of activity, effect and total score in the trial group compared with the control group (ITT and PPS: P < 0.01). There was no statistical difference in pre- and post-treatment safety variables in either group. CONCLUSION: Sugarcane bagasse combined with conventional treatment improved quality of life in patients with stable COPD. Sugarcane bagasse appears to be a safe herbal medicine with potential for treating patients with stable COPD when taken orally as an adjuvant therapy. (C) 2016 JTCM. All rights reserved.","[Liu Miao; Zheng Fengjie; Ni Lei; Sun Yan; Wu Ruohan; Zhang Tianyu; Zhang Jinchao; Zhong Xianggen; Li Yuhang] Beijing Univ Chinese Med, Sch Preclin Med, Beijing 100029, Peoples R China",Beijing University of Chinese Medicine,"Li, YH (corresponding author), Beijing Univ Chinese Med, Sch Preclin Med, Beijing 100029, Peoples R China.",liyuhang@bucm.edu.cn,"Li, Yu Hang/H-3048-2018; Zhang, Yulin/KEI-1610-2024","Wu, Ruohan/0000-0002-0468-9920",Ministry of Science and Technology of the People's Republic of China,"Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)",The authors are grateful to the Ministry of Science and Technology of the People's Republic of China for funding this study.,,41,4,4,2,14,JOURNAL TRADITIONAL CHINESE MED,BEIJING,"16 NANXIAOJIE, DONGZHIMEN NEI, BEIJING, 100700, PEOPLES R CHINA",0255-2922,1577-7014,,J TRADIT CHIN MED,J. Tradit. Chin. Med.,AUG 15,2016,36,4,,,,,418,426,,,,,,9,Integrative & Complementary Medicine,Science Citation Index Expanded (SCI-EXPANDED),Integrative & Complementary Medicine,DS8WV,28459236,hybrid,,,2024-06-04,WOS:000381064600002,View Full Record in Web of Science
J,"de Oliveira, AL; Moreira, APB; Netto, MP; Leite, ICG",,,,"de Oliveira, Ana Livia; Boroni Moreira, Ana Paula; Netto, Michele Pereira; Goncalves Leite, Isabel Cristina",,,"A Cross-sections Study of Nutritional Status, Diet, and Dietary Restrictions Among Persons With an Ileostomy or Colostomy",OSTOMY WOUND MANAGEMENT,,,English,Article,,,,,,cross-sectional study; colostomy; ileostomy; nutritional status; food preferences,QUALITY-OF-LIFE; STOMA; PROFILE,"Little is known about the nutritional status and dietary habits of persons with an intestinal stoma, and no specific dietary guidelines have been established. A cross-sectional study was conducted among patients of a Stoma Patient Health Care Service in Juiz de Fora, Brazil, to compare the nutritional status of persons with an ileostomy or colostomy and to evaluate which foods are avoided most frequently and why. Anthropometric measurements (weight, height, arm circumference, and triceps and subscapular skinfold thickness) and body fat were assessed. Habitual dietary intake (energy, protein, carbohydrate, fiber, fat, calcium, iron, sodium, potassium, thiamin, riboflavin, vitamin B-6, vitamin B-3 [niacin], and vitamin B-12) was assessed using a validated quantitative food frequency questionnaire. Foods avoided and reasons for avoidance (increased odor, increased gas, increased output, constipation, appliance leakage, and feelings regarding leaving home) were assessed. All data were collected without personal identifiers and stored in electronic files. Data were analyzed descriptively, and the Student's t test or Mann-Whitney test was used to compare the groups. Chi-squared analysis with Yates' continuity correction or Fisher's exact test was employed to examine the differences in the frequency of avoided foods by reasons for avoidance between the 2 groups. Of the 103 participants (52 [50.5%] men, 51 [49.5%] women; mean age 60.5 +/- 12.9 years); 63 (61.2%) had a colostomy and 40 (38.8%) had an ileostomy. For both groups combined, time since surgery ranged from 1 to 360 months. Anthropometric measurements and body composition did not suggest nutritional deficiencies and did not differ significantly between groups. Persons with an ileostomy had a significantly lower fat and niacin intake than persons with a colostomy (P <.05). No other dietary intake differences were observed. Avoiding foods due to appliance leakage was more common among participants with an ileostomy (8, 20%) than a colostomy (3, 4.8%), and vegetables and fruits were reported as the most problematic foods. None of the other cited reasons was significantly different. The results of this study confirm that many persons with a stoma adjust their dietary intake and avoid certain foods which, especially in persons with an ileostomy, may increase their risk for nutritional deficiencies. Additional research to assess dietary intake and nutritional status variables as well as patient needs is needed to facilitate the development of specific nutritional status monitoring and dietary recommendations for persons with an ileostomy or colostomy.","[de Oliveira, Ana Livia; Boroni Moreira, Ana Paula; Netto, Michele Pereira] Univ Fed Juiz de Fora, Dept Nutr, Juiz De Fora, MG, Brazil; [Goncalves Leite, Isabel Cristina] Univ Fed Juiz de Fora, Sch Med, Dept Publ Hlth, Juiz De Fora, MG, Brazil",Universidade Federal de Juiz de Fora; Universidade Federal de Juiz de Fora,"de Oliveira, AL (corresponding author), Fed Univ Juiz de Fora UFJF, Dept Nutr, Jose Lourenco Kelmer S-N,Campus Univ, BR-36036330 Juiz De Fora, MG, Brazil.",analivia.oliveira@ufjf.edu.br,"Leite, Isabel/ABG-4137-2020; Leite, Isabel Cristina Gonçalves/I-9630-2016","Leite, Isabel Cristina Gonçalves/0000-0003-1258-7331; de Oliveira, Ana Livia/0000-0003-3252-9446",,,,,42,21,24,1,27,H M P COMMUNICATIONS,MALVERN,"83 GENERAL WARREN BLVD, STE 100, MALVERN, PA 19355 USA",0889-5899,1943-2720,,OSTOMY WOUND MANAG,Ostomy Wound Manag.,MAY,2018,64,5,,,,,18,29,,10.25270/owm.2018.5.1829,http://dx.doi.org/10.25270/owm.2018.5.1829,,,8,Surgery,Science Citation Index Expanded (SCI-EXPANDED),Surgery,GQ6XD,29847308,,,,2024-06-04,WOS:000441871700004,View Full Record in Web of Science
J,"Li, Y; Tong, WD; Qian, Y",,,,"Li, Yi; Tong, Wei-Dong; Qian, Yang",,,"Effect of Physical Activity on the Association Between Dietary Fiber and Constipation: Evidence From the National Health and Nutrition Examination Survey 2005-2010 (vol 27, pg 97, 2021)",JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY,,,English,Correction,,,,,,,,,,,,,"Tong, Weidong/A-2729-2011","Tong, Weidong/0000-0001-6150-9941",,,,,1,0,0,0,3,KOREAN SOC NEUROGASTROENTEROLOGY & MOTILITY,GANGNAM-GU,"RM 305, LOTTE GOLD ROSE VILL II, 31 SEOLLEUNG-RO 86-GIL, GANGNAM-GU, SEOUL 135-839, SOUTH KOREA",2093-0879,2093-0887,,J NEUROGASTROENTEROL,J. Neurogastroenterol. Motil.,JUL,2021,27,3,,,,,440,440,,10.5056/jnm20051E,http://dx.doi.org/10.5056/jnm20051E,,,1,Gastroenterology & Hepatology; Clinical Neurology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Neurosciences & Neurology,TG6ZK,,"gold, Green Published",,,2024-06-04,WOS:000671550200019,View Full Record in Web of Science
J,"Arrari, F; Jabri, MA; Hammami, I; Sebai, H",,,,"Arrari, Fatma; Jabri, Mohamed-Amine; Hammami, Imen; Sebai, Hichem",,,Extraction of Pectin from Orange Peel and Study of Its Protective Effect Against Loperamide-Induced Impaired Gastrointestinal Motor Functions and Oxidative Stress in Rats,JOURNAL OF MEDICINAL FOOD,,,English,Article,,,,,,constipation; gastrointestinal motility; LOP; oxidative stress; pectin,INDUCED CONSTIPATION; IN-VITRO; AQUEOUS EXTRACT; NERVOUS-SYSTEM; DIETARY FIBER; ANTIDIARRHEAL; PREBIOTICS; SECRETION; CELLULOSE; RISK,"Pectin is a polysaccharide attached to carbohydrates. These are substances exclusively of plant origin. The aim of the present study is to evaluate the laxative effects of orange peel pectin extract (OPPE) against constipation induced by loperamide (LOP) in rats. Rats were equally divided into six groups and treated daily 1 week as follows: Control, LOP (3 mg/kg, body weight [b.w.], Per Os [p.o.]), LOP+yohimbine (2 mg/kg, b.w., i.p.), and LOP+OPPE (6.25, 12.5, and 25 mg/kg, b.w., p.o.). At the end of the experiment, the effects of OPPE were assessed by fecal parameters (numbers, weight, and water content), gastrointestinal transit, gastric emptying, serum metabolic parameter changes, intestinal and colon mucosa oxidative stress, and the histological examination. The defecation test showed that administration of LOP (3 mg/kg, b.w., p.o.) leads to the production of remarkable constipation. Indeed, the number and water content of stools decreased (25.50 [n/24 h] and 29.86%) significantly (P < .05).Acute pretreatment with OPPE significantly and dose dependently accelerated the stool moistening and allowed an increase of stool weight (2.85, 3.61, 3.93 [g/24 h/rat]) as well as the frequency of defecation (47.36, 54.54, and 56.26 [n/24 h]). OPPE also significantly (P < .05) and dose dependently increased the intestinal motility (70.78%, 73.33%, and 75.01%) and gastric emptying. LOP-induced reduction (P < .05) of intestinal secretion was accompanied by a colonic and small bowel oxidative stress status and histological changes, which was attenuated by OPPE treatment. The findings of this study indicate that OPPE possesses an important role in the gastrointestinal motility regulation, and thus lend pharmacological credence to the suggested use of the natural pectin for the treatment, management, and/or control of constipation.","[Arrari, Fatma; Jabri, Mohamed-Amine; Sebai, Hichem] Univ Jendouba, Higher Inst Biotechnol Beja, Unit Funct Physiol & Valorizat Bioresources, BP 382, Beja 9000, Tunisia; [Hammami, Imen] Tunis El Manar Univ, Fac Med, Res Unit 17 ES 13, Tunis, Tunisia",Universite de Jendouba; Universite de Tunis-El-Manar; Faculte de Medecine de Tunis (FMT),"Jabri, MA (corresponding author), Univ Jendouba, Higher Inst Biotechnol Beja, Unit Funct Physiol & Valorizat Bioresources, BP 382, Beja 9000, Tunisia.",jabri.amino@gmail.com,"Arrari, Fatma/KIJ-4885-2024","Arrari, Fatma/0000-0002-6207-4641",,,,,66,1,1,6,25,"MARY ANN LIEBERT, INC",NEW ROCHELLE,"140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA",1096-620X,1557-7600,,J MED FOOD,J. Med. Food,SEP 1,2022,25,9,,,,,892,901,,10.1089/jmf.2021.0091,http://dx.doi.org/10.1089/jmf.2021.0091,,FEB 2022,10,"Chemistry, Medicinal; Food Science & Technology; Nutrition & Dietetics",Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy; Food Science & Technology; Nutrition & Dietetics,4O9YB,35143346,,,,2024-06-04,WOS:000753739000001,View Full Record in Web of Science
J,"McCallum, P; Walsh, D; Nelson, KA",,,,"McCallum, P; Walsh, D; Nelson, KA",,,Can a soft diet prevent bowel obstruction in advanced pancreatic cancer?,SUPPORTIVE CARE IN CANCER,,,English,Article,,,,,,diet; dietary instruction; intestinal obstruction,,"Although many patients are advised to follow a high-fiber diet to avoid constipation, it seems that a soft diet such as that recommended after bowel surgery may well be more helpful in avoidance of intestinal obstruction.","Cleveland Clin Fdn, Taussig Canc Ctr, Palliat Med Program, Cleveland, OH 44195 USA",Cleveland Clinic Foundation,"Walsh, D (corresponding author), Cleveland Clin Fdn, Taussig Canc Ctr, Palliat Med Program, R-35,9500 Euclid Ave, Cleveland, OH 44195 USA.",,,"Walsh, (Thomas) Declan/0000-0002-9310-1729",,,,,5,4,4,0,2,SPRINGER-VERLAG,NEW YORK,"175 FIFTH AVE, NEW YORK, NY 10010 USA",0941-4355,,,SUPPORT CARE CANCER,Support. Care Cancer,MAR,2002,10,2,,,,,174,175,,10.1007/s005200100307,http://dx.doi.org/10.1007/s005200100307,,,2,Oncology; Health Care Sciences & Services; Rehabilitation,Science Citation Index Expanded (SCI-EXPANDED),Oncology; Health Care Sciences & Services; Rehabilitation,534YE,11862508,,,,2024-06-04,WOS:000174616700012,View Full Record in Web of Science
J,"Giannini, EG; Mansi, C; Dulbecco, P; Savarino, V",,,,"Giannini, EG; Mansi, C; Dulbecco, P; Savarino, V",,,Role of partially hydrolyzed guar gum in the treatment of irritable bowel syndrome,NUTRITION,,,English,Review,,,,,,irritable bowel syndrome; fibers; treatment,QUALITY-OF-LIFE; DIETARY FIBER; INTESTINAL MICROFLORA; SOLUBLE FIBER; HEALTH-CARE; WHEAT BRAN; MANAGEMENT; MULTICENTER; DISORDERS; REDUCTION,"Irritable bowel syndrome (IBS) is the world's most common gastrointestinal functional disorder and is associated with several social and economic costs. Health-related quality of life is often impaired in patients with IBS. The pathophysiologic mechanisms underlying EBS remain poorly defined. The therapeutic approach to patients with IBS is based on symptoms, and fibers may play an important role in treatment. Among the various types of fiber, water-soluble, non-gelling fibers seem to be a promising option for treatment of IBS. Partially hydrolyzed guar gum (PHGG) is a water-soluble, non-gelling fiber that has provided therapeutic benefits. In clinical trials, PHGG decreased symptoms in constipation-predominant and diarrhea-predominant forms of IBS and decreased abdominal pain. Further, an improvement in quality of life was observed in patients with IBS during and after treatment with PHGG. Moreover, PHGG seems to have prebiotic properties because it increases the colonic contents of short-chain fatty acids, Lactobacilli, and Bifidobacteria. (c) 2006 Elsevier Inc. All rights reserved.","Univ Genoa, Dept Internal Med, Gastroenterol Unit, Genoa, Italy",University of Genoa,"Univ Genoa, Dept Internal Med, Gastroenterol Unit, Genoa, Italy.",egiannini@unige.it,"Giannini, Edoardo Giovanni/E-1120-2012","Giannini, Edoardo Giovanni/0000-0001-8526-837X",,,,,66,73,85,1,23,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",0899-9007,1873-1244,,NUTRITION,Nutrition,MAR,2006,22,3,,,,,334,342,,10.1016/j.nut.2005.10.003,http://dx.doi.org/10.1016/j.nut.2005.10.003,,,9,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,020GZ,16413751,,,,2024-06-04,WOS:000235898000017,View Full Record in Web of Science
J,"Lukosiene, JI; Reichert, MC; Lammert, F; Schramm, C; Goeser, T; Kiudelis, G; Jonaitis, LV; Tamelis, A; Kupcinskas, J",,,,"Lukosiene, Jaune Ieva; Reichert, Matthias Christian; Lammert, Frank; Schramm, Christoph; Goeser, Tobias; Kiudelis, Gediminas; Jonaitis, Laimas Virginijus; Tamelis, Algimantas; Kupcinskas, Juozas",,,Environmental and Dietary Risk Factors for Colonic Diverticulosis and Diverticulitis,JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES,,,English,Article,,,,,,ecolonic diverticulosis; diverticular disease; risk factors; pathophysiology,FIBER DIET; DISEASE; OBESITY; EPIDEMIOLOGY; CONSTIPATION; DECREASES; INCREASES; IMPACT,"Background & Aims: Colonic diverticulosis (CD) is among the most common conditions of the large bowel. Several factors have been associated with an increased risk of CD and its complications, including advanced age, obesity, physical inactivity, and a low-fiber diet. Available data is conflicting and a comprehensive analysis of different bowel, dietary and environmental habits linked with CD is lacking. We aimed to investigate the relationship between potential risk factors and CD prevalence using full data from a colonoscopy-based cross-sectional study in Europe. Methods: The study was conducted at three tertiary referral centers in Germany and Lithuania. It included consecutive adult patients referred for routine colonoscopy who completed a detailed questionnaire on our considered multiple risk factors for diverticulosis and diverticulitis, including dietary and environmental factors, and bowel habits. Results: The study included 1,333 patients, 696 women and 635 men. Colonic diverticulosis was diagnosed in 858 (64%) of patients. Multivariate analysis revealed that age (OR: 1.08, 95%CI: 1.06-1.10, p<0.001) and obesity (OR: 1.05, 95%CI: 1.02-1.09, p=0.004) were associated with CD. We also revealed new risk factors for CD: increased frequency of bowel movements (OR: 0.10, 95%CI: 0.03-0.33, p<0.001) and feeling of incomplete bowel emptying (OR: 2.05, 95%CI: 1.47-2.87, p<0.001). Older participants had reduced odds (OR: 0.921, 95 CI: 0.89-0.95, p<0.05) of diverticulitis compared to younger subjects. Feeling of incomplete bowel emptying after defecation was associated with increased odds (OR: 2.769, 95% CI 1.35-5.7, p<0.006) for diverticulitis. Moreover, participants with a higher educational status had increased odds (OR: 2.453, 95%CI: 1.31-4.59, p=0.005) for diverticulitis compared to the lower education group. Conclusions. Study shows that older age, obesity, frequency of bowel movements, and feeling of incomplete bowel emptying are associated with the risk of CD. Furthermore, older age, feeling of incomplete bowel emptying, and higher education were associated with the risk of diverticulitis among CD patients.","[Lukosiene, Jaune Ieva; Kiudelis, Gediminas; Jonaitis, Laimas Virginijus; Kupcinskas, Juozas] Lithuanian Univ Hlth Sci, Dept Gastroenterol, Eiveniu G 2, LT-50009 Kaunas, Lithuania; [Lukosiene, Jaune Ieva; Kiudelis, Gediminas; Jonaitis, Laimas Virginijus; Kupcinskas, Juozas] Lithuanian Univ Hlth Sci, Inst Digest Res, Eiveniu G 2, LT-50009 Kaunas, Lithuania; [Reichert, Matthias Christian; Lammert, Frank] Saarland Univ, Dept Med 2, Med Ctr, Homburg, Germany; [Schramm, Christoph; Goeser, Tobias] Univ Hosp Cologne, Dept Gastroenterol & Hepatol, Cologne, Germany; [Tamelis, Algimantas] Lithuanian Univ Hlth Sci, Dept Surg, Kaunas, Lithuania",Lithuanian University of Health Sciences; Lithuanian University of Health Sciences; Universitatsklinikum des Saarlandes; University of Cologne; Lithuanian University of Health Sciences,"Kupcinskas, J (corresponding author), Lithuanian Univ Hlth Sci, Dept Gastroenterol, Eiveniu G 2, LT-50009 Kaunas, Lithuania.;Kupcinskas, J (corresponding author), Lithuanian Univ Hlth Sci, Inst Digest Res, Eiveniu G 2, LT-50009 Kaunas, Lithuania.",juozas.kupcinskas@lsmuni.lt,"Jonaitis, Laimas Virginijus/HJP-0617-2023; Kupcinskas, Juozas/AAU-6968-2021",,,,,,37,4,4,0,3,MEDICAL UNIV PRESS,CLUJ-NAPOCA,"3RD MEDICAL CLINIC, STR CROITORILOR NO 19-21, CLUJ-NAPOCA, 400162, ROMANIA",1841-8724,1842-1121,,J GASTROINTEST LIVER,J. Gastrointest. Liver Dis.,MAR,2021,30,1,,,,,66,72,,10.15403/jgld-3208,http://dx.doi.org/10.15403/jgld-3208,,,7,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,QW9ZF,33723560,gold,,,2024-06-04,WOS:000629007900014,View Full Record in Web of Science
J,"Mizuno, H; Bamba, S; Abe, N; Sasaki, M",,,,"Mizuno, Hideaki; Bamba, Shigeki; Abe, Nobutsugu; Sasaki, Masaya",,,"Effects of an alginate-containing variable-viscosity enteral nutrition formula on defecation, intestinal microbiota, and short-chain fatty acid production",JOURNAL OF FUNCTIONAL FOODS,,,English,Article,,,,,,Diarrhea; Constipation; Fermentation,ESPEN GUIDELINES; OLIGOSACCHARIDES; POLYSACCHARIDE; CONSTIPATION; ABSORPTION; STOOL,"This study aimed to elucidate the effects of a liquid polymeric formula containing alginate, a source of watersoluble dietary fiber, on stool form, intestinal microbiota, and the production of short-chain fatty acid production. Participants were 11 elderly patients with malnutrition and poor oral intake, who required enteral feeding. The alginate-containing liquid formula, which characteristically changes state from liquid to semi-solidified depending on pH, was administered for 4 weeks. This variable-viscosity liquid formula significantly improved the values of nutritional indices and stool form. Analysis of fecal specimens revealed significant decreases in pH. The concentrations of short-chain fatty acids did not change significantly in stool samples, but acetic acid and propionic acid were significantly increased in blood samples. The proportion of Clostridium cluster XI in fecal microbiota was also significantly increased. The alginate-containing variable-viscosity liquid formula significantly improved stool form, lowered fecal pH, and short-chain fatty acid concentrations in blood.","[Mizuno, Hideaki] Etsudenkai Mejiro Second Hosp, Dept Gen Surg, Tokyo, Japan; [Bamba, Shigeki; Sasaki, Masaya] Shiga Univ Med Sci, Dept Clin Nutr, Otsu, Shiga 5202192, Japan; [Abe, Nobutsugu] Kyorin Univ Hosp, Dept Digest & Gen Surg, Tokyo, Japan",Shiga University of Medical Science; Kyorin University,"Bamba, S (corresponding author), Shiga Univ Med Sci, Dept Clin Nutr, Otsu, Shiga 5202192, Japan.",sb@belle.shiga-med.ac.jp,,"Bamba, Shigeki/0000-0002-4108-5894",,,,,40,15,15,1,14,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",1756-4646,2214-9414,,J FUNCT FOODS,J. Funct. Food.,APR,2020,67,,,,,,,,103852,10.1016/j.jff.2020.103852,http://dx.doi.org/10.1016/j.jff.2020.103852,,,6,Food Science & Technology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Nutrition & Dietetics,LD0RC,,gold,,,2024-06-04,WOS:000525739700021,View Full Record in Web of Science
J,"Rusch, C; Beke, M; Tucciarone, L; Dixon, K; Nieves, C; Mai, V; Stiep, T; Tholanikunnel, T; Ramirez-Zamora, A; Hess, CW; Langkamp-Henken, B",,,,"Rusch, Carley; Beke, Matthew; Tucciarone, Lily; Dixon, Katherine; Nieves, Carmelo, Jr.; Mai, Volker; Stiep, Tamara; Tholanikunnel, Tracy; Ramirez-Zamora, Adolfo; Hess, Christopher W.; Langkamp-Henken, Bobbi",,,Effect of a Mediterranean diet intervention on gastrointestinal function in Parkinson's disease (the MEDI-PD study): study protocol for a randomised controlled trial,BMJ OPEN,,,English,Article,,,,,,Parkinson's disease; nutrition & dietetics; functional bowel disorders; immunology,RATING-SCALE; INFLAMMATION; MICROBIOTA; QUESTIONNAIRE; CONSTIPATION; ADHERENCE; SCREENER; INDEX,"Introduction Constipation is a common and sometimes debilitating non-motor symptom of Parkinson's disease (PD) that can result in intestinal inflammation and microbial dysbiosis. The Mediterranean diet, rich in fermentable fibres and anti-inflammatory phenolic compounds, is associated with reduced risk of developing PD and slower progression of parkinsonism. The Mediterranean diet is often recommended for people with PD; however, no studies to date examine this diet as a therapeutic intervention to modulate gastrointestinal (GI) dysfunction. Methods and analysis This is a randomised, controlled, parallel study. During a 2-week run-in, participants with PD and constipation symptoms (n=52) will undergo baseline nutritional and neurological assessments and provide a stool sample. Participants will be stratified by sex and Hoehn and Yahr stage and randomised to follow standard of care for constipation (control) or standard of care plus a Mediterranean diet (intervention) for 8 weeks. A study dietitian will provide dietary instruction and weekly follow-up via telephone to both groups to support adherence and monitor adverse events. Questionnaires will assess dietary intake and GI function including stool frequency, form, symptoms and laxative usage. Measurements completed at baseline will be repeated at 4 and 8 weeks of the intervention. The primary outcome is to evaluate the difference between mean change (final-baseline) in Gastrointestinal Symptom Rating Scale (GSRS) constipation syndrome scores for the control versus intervention groups. Secondary outcomes will assess stool frequency and form, weekly GSRS syndrome scores, digestive quality of life, laxative usage, faecal microbial communities and inflammatory markers, anxiety, depression, quality life, body weight and composition, dietary fibre intake and Mediterranean diet adherence. Ethics and dissemination The study has received University of Florida Institutional Review Board-01 approval (IRB202001333). Findings will be disseminated via conference presentations, lectures and peer-reviewed publications.","[Rusch, Carley; Beke, Matthew; Tucciarone, Lily; Dixon, Katherine; Nieves, Carmelo, Jr.; Langkamp-Henken, Bobbi] Univ Florida, Food Sci & Human Nutr Dept, Gainesville, FL 32611 USA; [Rusch, Carley; Beke, Matthew; Stiep, Tamara; Tholanikunnel, Tracy; Ramirez-Zamora, Adolfo; Hess, Christopher W.] Univ Florida, Norman Fixel Inst Neurol Dis, Dept Neurol, Gainesville, FL USA; [Mai, Volker] Univ Florida, Emerging Pathogens Inst, Dept Epidemiol, Gainesville, FL USA",State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida,"Rusch, C (corresponding author), Univ Florida, Food Sci & Human Nutr Dept, Gainesville, FL 32611 USA.",crusch792@ufl.edu,,"Rusch, Carley/0000-0002-6185-9535; Beke, Matthew/0000-0001-6807-9892; Ramirez-Zamora, Adolfo/0000-0001-9253-3899; Mai, Volker/0000-0002-6997-9750; Langkamp-Henken, Bobbi/0000-0002-8429-0011","University of Florida; USDA National Institute of Food and Agriculture, Hatch Project [FLA-FOS-005636]","University of Florida(University of Florida); USDA National Institute of Food and Agriculture, Hatch Project","This work was supported by the University of Florida and the USDA National Institute of Food and Agriculture, Hatch Project (FLA-FOS-005636).",,51,6,6,2,10,BMJ PUBLISHING GROUP,LONDON,"BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND",2044-6055,,,BMJ OPEN,BMJ Open,SEP,2021,11,9,,,,,,,e053336,10.1136/bmjopen-2021-053336,http://dx.doi.org/10.1136/bmjopen-2021-053336,,,8,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,UW8SR,34551955,"gold, Green Published",,,2024-06-04,WOS:000700423700017,View Full Record in Web of Science
J,"Mohamed, RS; Abozed, SS; El-Damhougy, S; Salama, MF; Hussein, MM",,,,"Mohamed, Rasha S.; Abozed, Safaa S.; El-Damhougy, S.; Salama, Manal F.; Hussein, Mona M.",,,Efficiency of newly formulated functional instant soup mixtures as dietary supplements for elderly,HELIYON,,,English,Article,,,,,,Food science; Nutrition; Qualitative research in nutrition; Consumer sensory research; Food acceptance; Chickpea; Vegetables; By-products; Olive oil; Elderly,BONE-MINERAL DENSITY; COLORIMETRIC METHOD; NUTRITIONAL-VALUE; HEALTH-BENEFITS; SERUM; PRECIPITATION; ANTIOXIDANTS; POPULATION; CROPS; ASSAY,"Healthy diet for elderly not only provides them with their needs from macro and micronutrients but also help preventing and treating age-related disorders including non-communicable diseases. So, the present study established to evaluate physical, sensory, chemical and biological characteristics of newly formulated functional instant soup mixtures as dietary supplements for elderly. Lyophilized chickpea, some vegetables and some by-products (at 5% and 10%) were incorporated in the preparation of two instant soup mixtures. The biological effects of the mixtures were studied using a geriatric animal model. The results revealed a reasonable acceptance of the two mixtures even after storage period (4 months) in addition to their contents from protein, fat, crude fiber and carbohydrates (16.62, 6.20, 6.60 and 65.89%, respectively in mixture I; 16.89, 6.30, 6.30 and 54.16%, respectively in mixture II). Mixture II was more promised in flavonoids content and scavenging radical activity than mixture I. Feeding the geriatric rats on the two mixtures did not produce any change in either liver or kidney functions and suggested the ability of these mixtures to prevent the hyperglycemia and hyperlipidemia and improve bone health. A slight decrease in brain lipid peroxidation, although not statistically significant, of rats has been observed upon feeding on these mixtures. Also, the two mixtures increased feces weight of rats which indicates to the beneficial effects of these mixtures in prevention of constipation. In conclusion the formulated instant soup mixtures with high acceptability and antioxidant activity can provide elderly people with high percent of their requirements from macro and micronutrients.","[Mohamed, Rasha S.; El-Damhougy, S.; Hussein, Mona M.] Natl Res Ctr, Nutr & Food Sci Dept, Cairo, Egypt; [Abozed, Safaa S.; Salama, Manal F.] Natl Res Ctr, Food Technol Dept, Cairo, Egypt",Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); National Research Centre (NRC),"Mohamed, RS (corresponding author), Natl Res Ctr, Nutr & Food Sci Dept, Cairo, Egypt.",smarasha2005@yahoo.com,"Salama, Manal/JYQ-4277-2024; Mohamed, Rasha Salah/AAW-1896-2020","Mohamed, Rasha Salah/0000-0003-4223-000X; Hussein, Mona/0000-0002-4823-7627",,,,,79,14,14,1,17,ELSEVIER SCI LTD,OXFORD,"THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND",,2405-8440,,HELIYON,Heliyon,JAN,2020,6,1,,,,,,,e03197,10.1016/j.heliyon.2020.e03197,http://dx.doi.org/10.1016/j.heliyon.2020.e03197,,,8,Multidisciplinary Sciences,Science Citation Index Expanded (SCI-EXPANDED),Science & Technology - Other Topics,KH1BC,31956718,"gold, Green Published",,,2024-06-04,WOS:000510380200157,View Full Record in Web of Science
J,"Piirainen, L; Peuhkuri, K; Bäckström, K; Korpela, R; Salminen, S",,,,"Piirainen, Laura; Peuhkuri, Katri; Backstrom, Karin; Korpela, Riitta; Salminen, Seppo",,,Prune juice has a mild laxative effect in adults with certain gastrointestinal symptoms,NUTRITION RESEARCH,,,English,Article,,,,,,constipation; gastrointestinal symptoms; human; prune,DIETARY FIBER; UNITED-STATES; CONSTIPATION; XYLITOL; FOOD,"Prunes are believed to have a laxative effect. Our aim was to study whether prune juice affects gastrointestinal function in adults with certain gastrointestinal symptoms. The study comprised 54 volunteers (13 men, 41 women) whose mean age was 44 years (range, 24-82 years). The study began with a 1-week baseline period, followed by a 2-week prune juice period, and finally a 1-week follow-up period. During the prune juice period, the subjects drank, twice a day, 125 mL of the test prune juice, which consisted of plum juice concentrate, prune puree, water, and fructose. During the 4 study weeks the subjects kept a daily record of fecal frequency, difficulty of defecation, stool consistency, and gastrointestinal symptoms. The subjects reported fewer days with difficulty in defecation during the prune juice period (combined first and second weeks) than during the baseline week (1.3 vs 1.7 days, P =.02). This effect appeared to continue into the follow-up week. The mean frequency of days with flatulence was higher during the prune juice period than during the baseline week (2.1 vs 1.4 days, P =.02). Regularly ingested prune juice had a mild laxative effect in adults with certain gastrointestinal symptoms. However, it also increased flatulence. Prune juice may offer an alternative to laxatives, at least, in cases of mild constipation. (c) 2007 Elsevier Inc. All rights reserved.","Fdn Nutr Res, FIN-0039 Helsinki, Finland; Helsinki Univ Cent Hosp, Dept Allergy, FIN-00029 Helsinki, Finland; Valio Ltd R&D, FIN-00039 Helsinki, Finland; Univ Helsinki, Inst Biomed Pharmacol, FIN-00014 Helsinki, Finland; Turku Univ, FIN-20014 Turku, Finland",University of Helsinki; Helsinki University Central Hospital; Valio; University of Helsinki; University of Turku,"Korpela, R (corresponding author), Fdn Nutr Res, POB 30, FIN-0039 Helsinki, Finland.",riitta.korpela@valio.fi,,"Korpela, Riitta/0000-0003-0337-9186",,,,,18,16,18,3,31,PERGAMON-ELSEVIER SCIENCE LTD,OXFORD,"THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND",0271-5317,,,NUTR RES,Nutr. Res.,AUG,2007,27,8,,,,,511,513,,10.1016/j.nutres.2007.06.008,http://dx.doi.org/10.1016/j.nutres.2007.06.008,,,3,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,200QM,,,,,2024-06-04,WOS:000248777900010,View Full Record in Web of Science
J,"Müller-Lissner, S",,,,"Müller-Lissner, S",,,"Classification, pharmacology, and side-effects of common laxatives",ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,,,English,Article,,,,,,abuse; definition; fibre; laxatives; melanosis coli; prokinetics; side-effects,DIETARY FIBER; CONSTIPATION; DIARRHEA; ORIGIN; BRAN,"No definition of the term laxative is satisfactory since their mode of actions affects multiple mechanisms, absorption/secretion and motor activity: Laxatives are very heterogeneous chemically. They act by either holding water inside the bowel lumen (dietary fibre, osmotic laxatives), by inhibition of water absorption or stimulation of secretion (stimulation laxatives), ol by stimulation of colonic motility (stimulant laxatives, 5HT(4) agonists). Most laxatives have side-effects but these ape usually mild.","Pk Klin Weissensee, D-13086 Berlin, Germany",,"Müller-Lissner, S (corresponding author), Pk Klin Weissensee, D-13086 Berlin, Germany.",,,,,,,,22,4,4,0,6,PACINI EDITORE,OSPEDALETTO PISA,"VIA DELLA GHERARDESCA-ZONA INDUSTRIALE, 56014 OSPEDALETTO PISA, ITALY",1125-8055,,,ITAL J GASTROENTEROL,Ital. J. Gastroenterol. Hepatol.,NOV,1999,31,,,3,,,S234,S237,,,,,,4,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,260QZ,10726225,,,,2024-06-04,WOS:000083962500003,View Full Record in Web of Science
J,"Sayre, CL; Yellepeddi, VK; Job, KM; Krepkova, LV; Sherwin, CMT; Enioutina, EY",,,,"Sayre, Casey L.; Yellepeddi, Venkata Kashyap; Job, Kathleen M.; Krepkova, Lubov V.; Sherwin, Catherine M. T.; Enioutina, Elena Y.",,,Current use of complementary and conventional medicine for treatment of pediatric patients with gastrointestinal disorders,FRONTIERS IN PHARMACOLOGY,,,English,Review,,,,,,gastrointestinal disease; pediatric patients; conventional treatment; complementary treatment; dietary supplements; probiotics,IRRITABLE-BOWEL-SYNDROME; FUNCTIONAL ABDOMINAL-PAIN; REUTERI DSM 17938; POLYETHYLENE-GLYCOL 3350; PERSISTENT DIARRHEA; DOUBLE-BLIND; ACUTE GASTROENTERITIS; YOUNG-CHILDREN; PEPPERMINT OIL; DIETARY FIBER,"Infants, children, and adolescents are at risk of experiencing a multitude of gastrointestinal disorders (GID). These disorders can adversely affect the quality of life or be life-threatening. Various interventions that span the conventional and complementary therapeutic categories have been developed. Nowadays, parents increasingly seek complementary options for their children to use concurrently with conventional therapies. Due to the high prevalence and morbidity of diarrhea, constipation, and irritable bowel syndrome (IBS) in children, in this review, we decided to focus on the current state of the evidence for conventional and complementary therapies used for the treatment of these diseases in children. Diarrhea treatment focuses on the identification of the cause and fluid management. Oral rehydration with supplementation of deficient micronutrients, especially zinc, is well established and recommended. Some probiotic strains have shown promise in reducing the duration of diarrhea. For the management of constipation, available clinical trials are insufficient for conclusive recommendations of dietary modifications, including increased use of fruit juice, fiber, and fluid. However, the role of laxatives as conventional treatment is becoming more established. Polyethylene glycol is the most studied, with lactulose, milk of magnesia, mineral oil, bisacodyl, and senna presenting as viable alternatives. Conventional treatments of the abdominal pain associated with IBS are poorly studied in children. Available studies investigating the effectiveness of antidepressants on abdominal pain in children with IBS were inconclusive. At the same time, probiotics and peppermint oil have a fair record of benefits and safety. The overall body of evidence indicates that a careful balance of conventional and complementary treatment strategies may be required to manage gastrointestinal conditions in children.","[Sayre, Casey L.; Yellepeddi, Venkata Kashyap; Job, Kathleen M.; Enioutina, Elena Y.] Roseman Univ Hlth Sci, Sch Med, Div Clin Pharmacol Pediat, Salt Lake City, UT 89014 USA; [Sayre, Casey L.] Roseman Univ Hlth Sci, Coll Pharm, South Jordan, UT USA; [Krepkova, Lubov V.] All Russian Res Inst Med & Aromat Plants VILAR, Ctr Med, Moscow, Russia; [Sherwin, Catherine M. T.] Wright State Univ, Boonshoft Sch Med, Dept Pediat, Dayton, OH USA",All-Russian Research Institute of Medicinal & Aromatic Plants; University System of Ohio; Wright State University Dayton,"Enioutina, EY (corresponding author), Roseman Univ Hlth Sci, Sch Med, Div Clin Pharmacol Pediat, Salt Lake City, UT 89014 USA.",elena.enioutina@hsc.utah.edu,"Sherwin, Catherine M/B-2888-2012; Job, Kathleen M/G-3200-2018","Sherwin, Catherine M/0000-0002-0844-3207; Krepkova, Lubov/0000-0002-3580-336X",,,,,105,2,2,3,5,FRONTIERS MEDIA SA,LAUSANNE,"AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND",,1663-9812,,FRONT PHARMACOL,Front. Pharmacol.,JAN 27,2023,14,,,,,,,,1051442,10.3389/fphar.2023.1051442,http://dx.doi.org/10.3389/fphar.2023.1051442,,,14,Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy,8X5CX,36778015,"gold, Green Published",,,2024-06-04,WOS:000932031500001,View Full Record in Web of Science
J,"Lacy, BE",,,,"Lacy, Brian E.",,,"The Science, Evidence, and Practice of Dietary Interventions in Irritable Bowel Syndrome",CLINICAL GASTROENTEROLOGY AND HEPATOLOGY,,,English,Review,,,,,,Bloating; Celiac Disease; Diet; Fiber; FODMAP; Fructans; Fructose; Gluten; Irritable Bowel Syndrome; Lactose; Microbiome,GLUTEN-FREE DIET; QUALITY-OF-LIFE; GASTROINTESTINAL SYMPTOMS; UNITED-STATES; INTESTINAL PERMEABILITY; LACTOSE-MALABSORPTION; FOOD INTOLERANCE; PERCEIVED FOOD; CELIAC-DISEASE; GAS-PRODUCTION,"Irritable bowel syndrome (IBS) is a highly prevalent disorder that is characterized by symptoms of abdominal pain, bloating, constipation, and/or diarrhea. The diagnosis can be made using Rome III criteria or published guidelines after taking a thoughtful history, excluding warning signs, and performing a careful physical examination. Limited testing (ie, complete blood count and C-reactive protein level) may be useful in appropriate patients. A number of pharmacologic options are available, although many patients fail to respond to pharmacologic therapy. Although several IBS diets frequently are recommended, data supporting their use are limited. This article provides a rationale as to why specific diets might improve IBS symptoms and evaluates published trials.","Dartmouth Hitchcock Med Ctr, Div Gastroenterol & Hepatol, Lebanon, NH 03756 USA",Dartmouth College,"Lacy, BE (corresponding author), Dartmouth Hitchcock Med Ctr, Div Gastroenterol & Hepatol, 1 Med Ctr Dr, Lebanon, NH 03756 USA.",brian.e.lacy@hitchcock.org,,,,,,,85,27,29,1,46,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",1542-3565,1542-7714,,CLIN GASTROENTEROL H,Clin. Gastroenterol. Hepatol.,NOV,2015,13,11,,,,,1899,1906,,10.1016/j.cgh.2015.02.043,http://dx.doi.org/10.1016/j.cgh.2015.02.043,,,8,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,CT9VW,25769411,Bronze,,,2024-06-04,WOS:000363165700012,View Full Record in Web of Science
J,"Alyousif, Z; Miller, JL; Auger, J; Sandoval, M; Piano, A; Tompkins, TA; Dahl, WJ",,,,"Alyousif, Zainab; Miller, Jennifer L.; Auger, Jeremie; Sandoval, Mariana; Piano, Amanda; Tompkins, Thomas A.; Dahl, Wendy J.",,,"Microbiota profile and efficacy of probiotic supplementation on laxation in adults affected by Prader-Willi Syndrome: A randomized, double-blind, crossover trial",MOLECULAR GENETICS & GENOMIC MEDICINE,,,English,Article,,,,,,Bristol Stool Form; constipation; HEI-2015; Prader-Willi syndrome; probiotic; stool frequency,IRRITABLE-BOWEL-SYNDROME; FUNCTIONAL CONSTIPATION; NATIONAL-HEALTH; DIETARY FIBER; METAANALYSIS; FERMENTATION; CONSUMPTION; UNIFRAC; LIFE,"Background Probiotics may provide a benefit for adults with Prader-Willi syndrome (PWS) experiencing constipation. The primary aim was to determine if Bifidobacterium animalis ssp. lactis B94 (B.lactis B94) improves stool frequency, with secondary aims of stool form and gastrointestinal symptoms. Exploratory aims included diet quality and fecal microbiota composition. Methods Following a 4-week baseline, 25 adults with PWS were randomized to consume B.lactis B94 by capsule (15 billion) or placebo for 4 weeks, followed by 4-week washout in a double-blind, crossover design. Stool frequency and Bristol Stool Form (BSF) were assessed daily, and Gastrointestinal Symptom Rating Scale (GSRS) and dietary intake (7-days food records), per period. Fecal microbiota per period was analyzed using 16S rRNA gene amplicon sequencing and taxa of interest by qPCR (n = 24). Results No adverse events were reported. Stool frequency at baseline (n = 25; 2.0 +/- 0.1 stools/day), GSRS syndromes, and microbiota composition did not differ with the probiotic intervention overall; however, a delayed, carry-over effect on BSF types 6 and 7 was seen. Diet quality by HEI-2015 was 65.4 +/- 8.5. Conclusion In adults with PWS, B.lactis B94 exhibited little effect on laxation over 4 weeks; however, further research is needed.","[Alyousif, Zainab; Dahl, Wendy J.] Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA; [Miller, Jennifer L.] Univ Florida, Coll Med, Dept Pediat, Div Endocrinol, Gainesville, FL USA; [Auger, Jeremie; Sandoval, Mariana; Piano, Amanda; Tompkins, Thomas A.] Rosell Inst Microbiome & Probiot, Montreal, PQ, Canada",State University System of Florida; University of Florida; State University System of Florida; University of Florida,"Dahl, WJ (corresponding author), Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA.",wdahl@ufl.edu,,"Tompkins, Thomas A./0000-0002-2990-2265; Dahl, Wendy/0000-0003-2061-4731","Lallemand Health Solutions Inc. (University of Florida) [AWD03033]; King Abdullah Scholarship Program, Saudi Arabian Cultural Mission (SACM)","Lallemand Health Solutions Inc. (University of Florida); King Abdullah Scholarship Program, Saudi Arabian Cultural Mission (SACM)","This study was funded by Lallemand Health Solutions Inc. (University of Florida grant AWD03033) and inkind support from the Department of Food Science and Human Nutrition, University of Florida/Institute of Food and Agricultural Sciences. ZA received a doctoral scholarship through the King Abdullah Scholarship Program, Saudi Arabian Cultural Mission (SACM).",,61,8,9,0,10,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",2324-9269,,,MOL GENET GENOM MED,Mol. Genet. Genom. Med.,DEC,2020,8,12,,,,,,,e1535,10.1002/mgg3.1535,http://dx.doi.org/10.1002/mgg3.1535,,OCT 2020,11,Genetics & Heredity,Science Citation Index Expanded (SCI-EXPANDED),Genetics & Heredity,PL4ED,33103385,"Green Published, gold",,,2024-06-04,WOS:000583207900001,View Full Record in Web of Science
J,"Tan, CQ; Wei, HK; Sun, HQ; Long, G; Ao, JT; Jiang, SW; Peng, J",,,,"Tan, C. Q.; Wei, H. K.; Sun, H. Q.; Long, G.; Ao, J. T.; Jiang, S. W.; Peng, J.",,,"Effects of supplementing sow diets during two gestations with konjac flour and Saccharomyces boulardii on constipation in peripartal period, lactation feed intake and piglet performance",ANIMAL FEED SCIENCE AND TECHNOLOGY,,,English,Article,,,,,,Konjac flour; Saccharomyces boulardii; Faecal scores; Lactation feed intake; Sow,HIGH-FIBER DIET; REPRODUCTIVE-PERFORMANCE; GLUCOMANNAN; MICROFLORA; NUTRITION; COLOSTRUM; YEAST,"This study investigated the effects of supplementation of konjac flour (KF) and Saccharomyces boulardii (SB) either alone or in combination to sow gestation diets over two successive reproductive cycles on constipation in peripartal period, quality of colostrum and milk, lactation feed intake of sows and piglet performance in the second reproductive cycle. Multiparous large white sows (n=144) were assigned randomly to one of four experimental treatments: the control diet; 2.2% KF diet; 0.01% SB diet; or 1.2% KF plus 0.01% SB diet. Sows from all four groups were restrict-fed with their respective diets during gestation and offered feed ad libitum during lactation. The sows remained on the dietary treatments for two reproductive cycles. However, at the end of the first reproductive cycle, some piglets in the experiment were affected by acute diarrhea and analysis of partial results of those which were not infected showed no treatment effects. The results for the second reproductive cycle showed that dietary treatments had no effect on body weight, backfat thickness, weaning-to-estrus interval, fecal moisture content or the composition of colostrum or milk. However, sows fed the three supplemented diets had higher fecal scores on day 113 of gestation (P<0.05), days 4 (P<0.01) and 5 (P<0.05) of lactation than their control counterparts. Supplementation of the diets with SB and KF plus SB also reduced fecal counts for Clostridium and Escherichia coil (P<0.01) while supplementation of the diet with KF increased fecal Lactobacillus counts and reduced Clostridium counts (P<0.01). Sows fed the three supplemented diets also ate more feed during lactation (P<0.05) and weaned significantly heavier pigs (P<0.01) than those fed the control diet. (C) 2015 Elsevier B.V. All rights reserved.","[Tan, C. Q.; Wei, H. K.; Long, G.; Ao, J. T.; Peng, J.] Huazhong Agr Univ, Coll Anim Sci & Technol, Dept Anim Nutr & Feed Sci, Wuhan 430070, Peoples R China; [Sun, H. Q.] YangXiang Joint Stock Co, Guigang 53700, Peoples R China; [Jiang, S. W.] Huazhong Agr Univ, Minist Agr, Coll Anim Sci & Technol, Key Lab Swine Breeding & Genet, Wuhan 430070, Peoples R China",Huazhong Agricultural University; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs,"Jiang, SW (corresponding author), Huazhong Agr Univ, Minist Agr, Coll Anim Sci & Technol, Key Lab Swine Breeding & Genet, Wuhan 430070, Peoples R China.",jiangsiwen@mail.hzaueducn; pengjian@mail.hzau.edu.cn,"Wei, Hong-kui/E-8971-2015","Wei, Hong-kui/0000-0001-7386-9936","Fundamental Research Funds for the Central Universities [2013 PY047, 2012MBDX010, 2011PY019]",Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities),"This research was supported by Fundamental Research Funds for the Central Universities (2013 PY047, nos. 2012MBDX010 and 2011PY019). We would like to thank PhD Sun and Mr Bang Lu at FengHuang Pig Farm for their support during the feeding trail. We also thank YangXiang Joint Stock Company for providing sow feeding facilities.",,25,37,44,4,85,ELSEVIER SCIENCE BV,AMSTERDAM,"PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",0377-8401,1873-2216,,ANIM FEED SCI TECH,Anim. Feed Sci. Technol.,DEC,2015,210,,,,,,254,262,,10.1016/j.anifeedsci.2015.10.013,http://dx.doi.org/10.1016/j.anifeedsci.2015.10.013,,,9,"Agriculture, Dairy & Animal Science",Science Citation Index Expanded (SCI-EXPANDED),Agriculture,CY2JS,,,,,2024-06-04,WOS:000366235400027,View Full Record in Web of Science
C,"Kokke, FTM; Taminiau, JAJM; Benninga, MA",,"Hernell, O; Schmitz, J",,"Kokke, FTM; Taminiau, JAJM; Benninga, MA",,,The role of dietary fiber in childhood and its applications in pediatric gastroenterology,FEEDING DURING LATE INFANCY AND EARLY CHILDHOOD: IMPACT ON HEALTH,Nestle Nutrition Institute Workshop Series,,English,Proceedings Paper,56th Nestle Pediatric Nutrition Workshop,"NOV 14-18, 2004","Noordwijk, NETHERLANDS",,,,CHRONIC CONSTIPATION; TRANSIT-TIME; CHILDREN; GLUCOMANNAN; PREBIOTICS; FREQUENCY; BUTYRATE,,"Rijnstate Hosp, Dept Pediat, Arnhem, Netherlands",Rijnstate Hospital,"Rijnstate Hosp, Dept Pediat, Arnhem, Netherlands.",j.a.taminiau@amc.uva.nl; m.a.benninga@amc.uva.nl,,,,,,,40,0,0,0,0,KARGER,BASEL,"POSTFACH, CH-4009 BASEL, SWITZERLAND",1664-2147,1664-2155,3-8055-7906-3,NESTLE NUTR WORKS SE,,,2005,56,,,,,,111,126,,10.1159/000086279,http://dx.doi.org/10.1159/000086279,,,16,Nutrition & Dietetics; Pediatrics,Conference Proceedings Citation Index - Science (CPCI-S),Nutrition & Dietetics; Pediatrics,BDD04,16632948,,,,2024-06-04,WOS:000232792000009,View Full Record in Web of Science
J,"Bouchoucha, M; Fysekidis, M; Rompteaux, P; Airinei, G; Sabate, JM; Benamouzig, R",,,,"Bouchoucha, Michel; Fysekidis, Marinos; Rompteaux, Pierre; Airinei, Gheorge; Sabate, Jean-Marc; Benamouzig, Robert",,,Influence of Age and Body Mass Index on Total and Segmental Colonic Transit Times in Constipated Subjects,JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY,,,English,Article,,,,,,Abdominal pain; Constipation; Functional gastrointestinal disorders; Irritable bowel syndrome,FUNCTIONAL GASTROINTESTINAL DISORDERS; IRRITABLE-BOWEL-SYNDROME; SLOW TRANSIT; DIETARY FIBER; SYMPTOMS; OBESITY; ASSOCIATION; DEFECATION; MOTILITY; PAINFUL,"Background/Aims Discordant data are found in the literature for the relationships between total and segmental colonic transit time (CTT) and demographic parameters. The aim of this study is to examine the influence of age, and body mass index (BMI) on total and segmental CTT in constipated subjects. Methods We included 354 constipated patients on this cross-sectional study. According to the Rome III criteria, patients were classified as having irritable bowel syndrome with constipation, or functional constipation. All patients filled the Bristol stool form, and reported the severity of constipation, bloating, and abdominal pain on a 10-point Likert scale. Total and segmental CTT were measured using radiopaque markers. Results Females were 84% of patients, with a mean age of 46.0 +/- 15.9 years. The association between total and segmental CTT with age and BMI was significant after adjustment for gender, clinical phenotype, the presence of defecation disorders, and abdominal pain or bloating intensity despite the severity of symptoms, and the frequency of defecation disorders were higher in irritable bowel syndrome with constipation than in functional constipation patients. By comparison with subjects less than 30 years, rectosigmoid transit time (RSTT) was lower in patients between 30 and 60 years. Age was negatively associated with RSTT (P = 0.004). By comparison with patients with normal BMI, RSTT and total CTT were lower in patients of the overweight group. BMI was negatively associated with RSTT (P < 0.001). The severity of constipation was correlated with total (P < 0.001), right (P = 0.002), and left CTT (P = 0.049). Conclusion Age and BMI are both associated with RSTT in constipated patients.","[Bouchoucha, Michel] Univ Paris V Rene Descartes, Paris, France; [Bouchoucha, Michel; Rompteaux, Pierre; Airinei, Gheorge; Sabate, Jean-Marc; Benamouzig, Robert] Hop Avicenne, Serv Gastroenterol, Bobigny, France; [Fysekidis, Marinos] Hop Avicenne, Serv Endocrinol & Diabetol, Bobigny, France",Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13,"Bouchoucha, M (corresponding author), Hop Avicenne, Serv Gastroenterol, CEFRED, 125 Rue Stalingrad, F-93009 Bobigny, France.",michel.bouchoucha@avc.aphp.fr,"BENAMOUZIG, Robert/W-8067-2019",,,,,,45,13,15,0,2,KOREAN SOC NEUROGASTROENTEROLOGY & MOTILITY,GANGNAM-GU,"RM 305, LOTTE GOLD ROSE VILL II, 31 SEOLLEUNG-RO 86-GIL, GANGNAM-GU, SEOUL 135-839, SOUTH KOREA",2093-0879,2093-0887,,J NEUROGASTROENTEROL,J. Neurogastroenterol. Motil.,APR,2019,25,2,,,,,258,+,,10.5056/jnm18167,http://dx.doi.org/10.5056/jnm18167,,,12,Gastroenterology & Hepatology; Clinical Neurology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Neurosciences & Neurology,HT4HX,30982242,"Green Published, gold",,,2024-06-04,WOS:000464525700011,View Full Record in Web of Science
J,"Singh, B",,,,"Singh, Baljit",,,Psyllium as therapeutic and drug delivery agent,INTERNATIONAL JOURNAL OF PHARMACEUTICS,,,English,Review,,,,,,psyllium; hydrogels; controlled drug delivery devices; therapeutic agent,IRRITABLE-BOWEL-SYNDROME; CHAIN FATTY-ACIDS; DIETARY SOLUBLE FIBER; POLYACRYLAMIDE BASED HYDROGELS; DEPENDENT DIABETES-MELLITUS; CHOLESTEROL-LOWERING ACTION; FECAL STEROL EXCRETION; PLANTAGO-OVATA SEEDS; WHOLE-GUT TRANSIT; ISPAGHULA HUSK,"There is no doubt that fibers, in particular viscous dietary fibers, have positive effects on human health, both in the prevention and in treatment of chronic diseases. Dietary fibers from psyllium have been used extensively both as pharmacological supplements, food ingredients, in processed food to aid weight control, to regulation of glucose control for diabetic patients and reducing serum lipid levels in hyperlipidemics. Keeping in view, the pharmacological importance of psyllium polysaccharide and its gel-forming nature, this article discusses the therapeutic value of psyllium for the treatment of constipation, diarrhea, irritable bowel syndrome, inflammatory bowel disease-ulcerative colitis, colon cancer, diabetes and hypercholesterolemia and exploitation of psyllium for developing drug delivery systems. (c) 2007 Elsevier B.V. All rights reserved.","Himachal Pradesh Univ, Dept Chem, Shimla 171005, Himachal Prades, India",Himachal Pradesh University,"Singh, B (corresponding author), Himachal Pradesh Univ, Dept Chem, Summer Hill, Shimla 171005, Himachal Prades, India.",baljitsinghhpu@yahoo.com,"SINGH, Baljit/B-5878-2012","SINGH, Baljit/0000-0002-0871-883X",,,,,190,241,256,5,64,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",0378-5173,1873-3476,,INT J PHARMACEUT,Int. J. Pharm.,APR 4,2007,334,1-2,,,,,1,14,,10.1016/j.ijpharm.2007.01.028,http://dx.doi.org/10.1016/j.ijpharm.2007.01.028,,,14,Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy,158EP,17329047,,,,2024-06-04,WOS:000245774400001,View Full Record in Web of Science
J,"Mearin, F; Ciriza, C; Mínguez, M; Rey, E; Mascort, JJ; Peña, E; Cañones, P; Júdez, J",,,,"Mearin, Fermin; Ciriza, Constanza; Minguez, Miguel; Rey, Enrique; Jose Mascort, Juan; Pena, Enrique; Canones, Pedro; Judez, Javier",,SEPD; SemFYC; Soc Espanola Med Atencion Primaria; Soc Espanola Med Gen Familia SEMG,Clinical Practice Guideline: Irritable bowel syndrome with constipation and functional constipation in the adult,REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS,,,Spanish,Article,,,,,,,PLACEBO-CONTROLLED TRIAL; QUALITY-OF-LIFE; PELVIC FLOOR DYSSYNERGIA; DOUBLE-BLIND; PHYSICAL-ACTIVITY; DIETARY FIBER; TRANSANAL IRRIGATION; PEPPERMINT-OIL; GASTROINTESTINAL SYMPTOMS; TRANSIT SCINTIGRAPHY,,"[Mearin, Fermin] Com Roma Trastornos Func Intestinales, GPC, Barcelona, Spain; [Ciriza, Constanza] Hosp Univ 12 Octubre, SEPD, Grp Trastornos Func, Madrid, Spain; [Minguez, Miguel] Univ Valencia, Hosp Clin Univ, Valencia, Spain; [Rey, Enrique] Hosp Clin Univ San Carlos, SEPD, Madrid, Spain; [Jose Mascort, Juan] semFYC, Madrid, Spain; [Pena, Enrique] SEMERGEN, Madrid, Spain; [Canones, Pedro] SEMG, Madrid, Spain",Hospital Universitario 12 de Octubre; University of Valencia; Hospital Clinic Universitari de Valencia,"Júdez, J (corresponding author), Sociedad Espanola Patol Digest, Dept Gest Conocimiento, C Sancho Davila 6, Madrid 28028, Spain.",jjudez@sepd.es,"perez, miguel/GXF-5077-2022; Júdez, Javier/ABG-5828-2020; Rey, Enrique/B-9492-2008","Judez, Javier/0000-0001-9724-5191; Minguez, Miguel/0000-0003-0148-5938; Rey, Enrique/0000-0002-5060-7105",,,,,154,92,113,0,25,"ARAN EDICIONES, S A",MADRID,"CASTELLO, 128, 28006 MADRID, SPAIN",1130-0108,2340-4167,,REV ESP ENFERM DIG,Rev. Esp. Enferm. Dig.,JUN,2016,108,6,,,,,332,363,,,,,,32,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,DQ7EZ,27230827,"gold, Green Published",,,2024-06-04,WOS:000379371000007,View Full Record in Web of Science
J,"Kleessen, B; Sykura, B; Zunft, HJ; Blaut, M",,,,"Kleessen, B; Sykura, B; Zunft, HJ; Blaut, M",,,"Effects of inulin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons",AMERICAN JOURNAL OF CLINICAL NUTRITION,,,English,Article,,,,,,bifidobacteria; constipation; elderly subjects; fecal microflora; inulin; lactose; stool analysis; short-chain fatty acids,HUMAN LARGE-INTESTINE; HUMAN-COLON; DIETARY FIBER; OLIGOFRUCTOSE; FERMENTATION; METABOLISM; BIFIDOBACTERIA; OLIGOSACCHARIDES; BACTERIA,"Constipation is an ailment encountered often in elderly people. A study was initiated to test the effects of lactose or inulin on the bowel habits of constipated elderly patients and to correlate these effects with several variables measured in feces such as microflora composition, concentration of lactate and short-chain fatty acids (SCFAs), pH, and the activities of beta-glucosidase and beta-glucuronidase. Groups of 15 and 10 patients received lactose and inulin, respectively, for a period of 19 d. The dose, 20 g/d from days 1 to 8, was gradually increased to 40 g/d from days 9 to 11 and was kept at this dose from days 12 to 19. There was considerable interindividual variations with this kind of dietary intervention. Inulin increased bifidobacteria significantly from 7.9 to 9.2 log(10)/g dry feces, but decreased enterococci in number and enterobacteria in frequency. In individuals consuming lactose, a noticeable increase in fecal counts of enterococci and a decrease in lactobacilli and clostridia was detected. Total bacterial counts remained unchanged. No changes in the concentrations of fecal SCFAs and lactate were observed. SCFAs showed a slight trend toward higher molar ratios of acetate to butyrate in response to the intake of lactose or inulin. The fecal pH and the beta-glucosidase and beta-glucuronidase activities were not influenced by sugar intake. Inulin showed a better laxative effect than lactose and reduced functional constipation with only mild discomfort.","INTERNAL MED MED CTR,ORANIENBURG,GERMANY; GERMAN INST HUMAN NUTR,POTSDAM,GERMANY",Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE),,,,"Blaut, Michael/0000-0002-6628-2907",,,,,40,395,446,3,69,AMER SOC CLINICAL NUTRITION,BETHESDA,"9650 ROCKVILLE PIKE, SUBSCRIPTIONS, RM L-2310, BETHESDA, MD 20814-3998",0002-9165,,,AM J CLIN NUTR,Am. J. Clin. Nutr.,MAY,1997,65,5,,,,,1397,1402,,10.1093/ajcn/65.5.1397,http://dx.doi.org/10.1093/ajcn/65.5.1397,,,6,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,WW078,9129468,hybrid,,,2024-06-04,WOS:A1997WW07800005,View Full Record in Web of Science
J,"Aziz, S; Fakih, HAM; Di Lorenzo, C",,,,"Aziz, Sina; Fakih, Hafiz Abdul Moiz; Di Lorenzo, Carlo",,,Bowel Habits and Toilet Training in Rural and Urban Dwelling Children in a Developing Country,JOURNAL OF PEDIATRICS,,,English,Article,,,,,,,CONSTIPATION; CHILDHOOD; ENCOPRESIS; DEFECATION; DURATION; GROWTH,"Objectives To determine the bowel habits and toilet training of developmentally normal children ages 5 to 8 years in rural and urban areas of the province of Sindh, Pakistan. Study design We conducted a descriptive cross-sectional study, conducted at households of rural (District Khairpur) and urban (Karachi) areas of Sindh, Pakistan, which enrolled 1000 children between 5 and 8 years of age, (half from rural and half from urban areas). A questionnaire regarding age, ethnicity, and sex was completed by two separate investigators from each setting. Recall information was elicited about bowel habits for the previous 2 weeks and the frequency and quality of stools, size of stools, and dietary habit for the previous 24 hours. A constipation score that was based on modified Rome III criteria was developed for each child. Results Functional constipation was reported 1.6 times more in the rural than the urban population (P < .001). Toilet training was initiated and completed earlier in the urban (18.6 +/- 6.8 and 46 +/- 12.5 months) than the rural children (28.6 +/- 6.1 and 56.5 +/- 6.7 months) (P < .001). The daily calorie, macronutrient, fiber, and water intake was higher in the urban population (P < .001). Functional constipation was significantly (P = .016) negatively correlated (r = -0.076) with the fiber intake. Conclusions Functional constipation was found more frequently in the rural area. Toilet training was initiated and completed significantly earlier in the urban population. (J Pediatr 2011; 158: 784-8).","[Aziz, Sina; Fakih, Hafiz Abdul Moiz] Dow Univ Hlth Sci, Dept Pediat, Karachi, Pakistan; [Di Lorenzo, Carlo] Ohio State Univ, Sch Med, Nationwide Childrens Hosp, Dept Pediat, Columbus, OH 43210 USA",Dow University of Health Sciences; University System of Ohio; Ohio State University; Nationwide Childrens Hospital,"Aziz, S (corresponding author), DHA, Ahmed House 7-1,6th Gizri Lane,Phase 4, Karachi 75500, Pakistan.",sigma_98@hotmail.com,,,,,,,28,7,8,0,10,MOSBY-ELSEVIER,NEW YORK,"360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA",0022-3476,1097-6833,,J PEDIATR-US,J. Pediatr.,MAY,2011,158,5,,,,,784,788,,10.1016/j.jpeds.2010.11.024,http://dx.doi.org/10.1016/j.jpeds.2010.11.024,,,5,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,746YH,21183187,,,,2024-06-04,WOS:000289286100020,View Full Record in Web of Science
J,"Blanco, AC; López, MTF; Rodríguez, GL; Olmos, MAM; Carballeira, RP; Gutiérrez, FP; Pérez, CT",,,,"Canton Blanco, Ana; Fernandez Lopez, Ma Teresa; Lugo Rodriguez, Gloria; Martinez Olmos, Miguel A.; Palmeiro Carballeira, Regina; Pita Gutierrez, Francisco; Tejera Perez, Cristina",,,Clinical utility of partially hydrolyzed guar gum: review of evidence and experience,NUTRICION HOSPITALARIA,,,English,Review,,,,,,Partially hydrolyzed guar gum; Diarrhoea; Enteral nutrition; Fiber; Inflammatory bowel disease,IRRITABLE-BOWEL-SYNDROME; DIETARY FIBER; ENTERAL NUTRITION; SOLUBLE FIBER; INTESTINAL FAILURE; ESPEN GUIDELINES; CONSTIPATION; DIARRHEA; BENEFITS; DEFINITIONS,"Introduction: Dietary fiber is an important component of human diet. Since each fiber type has specific metabolic and gastrointestinal function effects, in each specific pathology we will have to choose the optimum type of fiber, considering its chemical, physical and physiological properties. Objective: to put partially hydrolyzed guar gum in its place in the complex framework of dietary fiber, to review its physicochemical properties and possible mechanisms of action; as well as its potential usefulness in different clinical situations in adult patients. Methods: non-systematic review in Medline. Results: Partially hydrolyzed guar gum (PHGG) is obtained from a partial enzymatic hydrolysis of guar gum by the enzyme p-endo-mannanase. It is a soluble, highly fermentable fiber with low viscosity. The fermentation of GGPH in colon produces short chain fatty acids, implicated in the main pathophysiological mechanisms responsible for their clinical effects. Its use in enteral nutrition associated diarrhea is supported by several studies and by the recommendations of scientific societies such as the European Society for Clinical Nutrition and Metabolism and the American Society for Parenteral and Enteral Nutrition. The usefulness of GGPH has been studied in many other clinical situations, such as diabetes, hypercholesterolemia, bacterial overgrowth, etc. with promising results. Conclusions: GGPH is useful in The management of enteral nutrition associated diarrhea. In other clinical situations, more quality studies would be necessary in order to make concrete recommendations.","[Canton Blanco, Ana; Martinez Olmos, Miguel A.] Complejo Hosp Univ Santiago de Compostela, Santiago De Compostela, A Coruna, Spain; [Fernandez Lopez, Ma Teresa] Complejo Hosp Univ Ourense, Orense, Spain; [Lugo Rodriguez, Gloria; Pita Gutierrez, Francisco] Complejo Hosp Univ A Coruna, La Coruna, Spain; [Palmeiro Carballeira, Regina] Complejo Hosp Univ Vigo, Vigo, Spain; [Tejera Perez, Cristina] Complejo Hosp Univ Ferrol El Ferrol, La Coruna, Spain","Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Ourense, Verin e O Barco de Valdeorras; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Complexo Hospitalario Universitario de Vigo; Complejo Hospitalario Universitario de Ferrol","Olmos, MAM (corresponding author), Complejo Hosp Univ Santiago de Compostela, Serv Endocrinol & Nutr, Santiago De Compostela 15706, A Coruna, Spain.",miguel.angel.martinez.olmos@sergas.es,"Tejera Pérez, Cristina/AAA-4356-2022; Tejera Pérez, Cristina/IXN-3878-2023","Tejera Pérez, Cristina/0000-0002-2987-5922; Tejera Pérez, Cristina/0000-0002-2987-5922; Martinez Olmos, Miguel Angel/0000-0002-3279-8091; Pita-Gutierrez, Francisco/0000-0003-2317-9376",,,,,56,1,1,1,35,"ARAN EDICIONES, S L",MADRID,"C/ CASTELLO, 128, 1O, MADRID, 28006, SPAIN",0212-1611,1699-5198,,NUTR HOSP,Nutr. Hosp.,JAN-FEB,2017,34,1,,,,,216,223,,10.20960/nh.998,http://dx.doi.org/10.20960/nh.998,,,8,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,EL6KH,28244794,"Green Submitted, gold",,,2024-06-04,WOS:000394730700031,View Full Record in Web of Science
J,"Rao, SSC; Patcharatrakul, T",,,,"Rao, Satish S. C.; Patcharatrakul, Tanisa",,,Diagnosis and Treatment of Dyssynergic Defecation,JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY,,,English,Review,,,,,,Constipation; Defecation; Laxatives,IRRITABLE-BOWEL-SYNDROME; CHRONIC IDIOPATHIC CONSTIPATION; RANDOMIZED CONTROLLED-TRIAL; PELVIC FLOOR DYSSYNERGIA; LONG-TERM EFFICACY; QUALITY-OF-LIFE; BIOFEEDBACK THERAPY; DIETARY FIBER; ANORECTAL MANOMETRY; RADIOPAQUE MARKERS,"Dyssynergic defecation is common and affects up to one half of patients with chronic constipation. This acquired behavioral problem is due to the inability to coordinate the abdominal and pelvic floor muscles to evacuate stools. A detailed history, prospective stool diaries, and a careful digital rectal examination will not only identify the nature of bowel dysfunction, but also raise the index of suspicion for this evacuation disorder. Anorectal physiology tests and balloon expulsion test are essential for a diagnosis. Newer techniques such as high-resolution manometry and magnetic resonance defecography can provide mechanistic insights. Recently, randomized controlled trials have shown that biofeedback therapy is more effective than laxatives and other modalities, both in the short term and long term, without side effects. Also, symptom improvements correlated with changes in underlying pathophysiology. Biofeedback therapy has been recommended as the first-line of treatment for dyssynergic defecation. Here, we provide an overview of the burden of illness and pathophysiology of dyssynergic defecation, and how to diagnose and treat this condition with biofeedback therapy.","[Rao, Satish S. C.; Patcharatrakul, Tanisa] Augusta Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Augusta, GA USA; [Patcharatrakul, Tanisa] King Chulalongkorn Mem Hosp, Thai Red Cross Soc, Dept Med, Div Gastroenterol, Bangkok, Thailand",University System of Georgia; Augusta University; Chulalongkorn University; Thai Red Cross Society,"Rao, SSC (corresponding author), Augusta Univ, Div Gastroenterol & Hepatol, Digest Hlth Ctr, AD 2238,1481 Laney Walker Blvd, Augusta, GA 30912 USA.",srao@augusta.edu,,,,,,,83,130,148,4,25,KOREAN SOC NEUROGASTROENTEROLOGY & MOTILITY,GANGNAM-GU,"RM 305, LOTTE GOLD ROSE VILL II, 31 SEOLLEUNG-RO 86-GIL, GANGNAM-GU, SEOUL 135-839, SOUTH KOREA",2093-0879,2093-0887,,J NEUROGASTROENTEROL,J. Neurogastroenterol. Motil.,JUL,2016,22,3,,,,,423,435,,10.5056/jnm16060,http://dx.doi.org/10.5056/jnm16060,,,13,Gastroenterology & Hepatology; Clinical Neurology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Neurosciences & Neurology,DQ4PW,27270989,"Green Submitted, Green Published, gold",,,2024-06-04,WOS:000379186800007,View Full Record in Web of Science
J,"Scarlett, Y",,,,"Scarlett, Y",,,Medical management of fecal incontinence,GASTROENTEROLOGY,,,English,Article; Proceedings Paper,Conference on Advancing the Treatment of Fecal and Urinary Incontinence Through Research: Trial Design Outcome Measures and Research Priorities,"NOV 03-05, 2002","MILWAUKEE, WI",,,,IRRITABLE-BOWEL-SYNDROME; ANAL-SPHINCTER FUNCTION; QUALITY-OF-LIFE; DOUBLE-BLIND; BISMUTH SUBSALICYLATE; CHRONIC DIARRHEA; LOPERAMIDE; CONSTIPATION; PREVALENCE; DIPHENOXYLATE,"Diarrhea and constipation are known risk factors for fecal incontinence. This report reviews how to diagnose and medically treat patients with chronic diarrhea, chronic constipation with overflow incontinence, and incontinence resulting from rectal mucosal prolapse secondary to hemorrhoids. Antidiarrheal agents (including loperamide, diphenoxylate, and difenoxin) and the tricyclic antidepressant amitriptyline improve continence in patients with diarrhea-associated incontinence. Other antidiarrheal agents are under investigation. The mechanism is believed to be decreased intestinal motility and stool frequency resulting in more formed stools. Increases in anal canal resting pressure may also contribute to improvement in continence. Adverse effects are constipation from excessive use. In,addition to antidiarrheal drugs, fiber supplements may improve incontinence associated with diarrhea. Transient, benign cases of constipation usually respond to increasing fluid intake and dietary fiber, improving mobility, or eliminating the concurrent use of constipating drugs. For mild to moderate constipation, bulking agents, laxatives, and stool softeners are used cautiously so as not to excessively loosen stools and exacerbate anal incontinence. Laxatives have been shown to improve continence, possibly through the mechanism of eliminating fecal impaction. Prolapsing hemorrhoids may partially obstruct defecation and cause soilage from the passage of fecal material, mucus, or blood. With endoscopic banding, a ligator is attached to an endoscope and a tight band is placed around the enlarged vein, causing the hemorrhoid to thrombose.","Univ N Carolina, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC 27599 USA",University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine,"Scarlett, Y (corresponding author), Univ N Carolina, Sch Med, Dept Med, Div Gastroenterol & Hepatol, 1140-B Bioinformat Bldg,CB 7080, Chapel Hill, NC 27599 USA.",yolanda_scarlett@med.unc.edu,,,,,,,47,49,52,1,11,W B SAUNDERS CO-ELSEVIER INC,PHILADELPHIA,"1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA",0016-5085,1528-0012,,GASTROENTEROLOGY,Gastroenterology,JAN,2004,126,1,,1,,,S55,S63,,10.1053/j.gastro.2003.10.007,http://dx.doi.org/10.1053/j.gastro.2003.10.007,,,9,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Gastroenterology & Hepatology,761CJ,14978639,Green Published,,,2024-06-04,WOS:000187881900009,View Full Record in Web of Science
J,"Topping, DL; Morell, MK; King, RA; Li, ZY; Bird, AR; Noakes, M",,,,"Topping, DL; Morell, MK; King, RA; Li, ZY; Bird, AR; Noakes, M",,,"Resistant starch and health -: Himalaya 292, a novel barley cultivar to deliver benefits to consumers",STARCH-STARKE,,,English,Review,,,,,,cereals; fibre; health; resistant starch; barley,VOLATILE FATTY-ACIDS; LARGE-BOWEL; COLORECTAL-CANCER; BROWN RICE; FIBER; FERMENTATION; CONSUMPTION; CORNSTARCH; ABSORPTION; CALCIUM,"Dietary and lifestyle change is a recognised strategy for the management and prevention of socio-economically important non-infectious diseases. Dietary fibre is composed largely of non-starch polysaccharides (NSP), and greater consumption of NSP-rich foods relieves simple constipation very effectively. Starch (as resistant starch, RS) is also receiving attention for its potential role in promoting colonic function. Resistant starch is that fraction of starch which escapes human small intestinal digestion and enters the large bowel where (together with a variable fraction of NSP) it is fermented by the resident microflora. The resulting short chain fatty acids (SCFA) are taken up by the large bowel and metabolised. SCFA mediate many of the health benefits ascribed to NSP and RS. Starch consumption is low in affluent westernised countries, despite recommendations by health agencies. In Australia, foods enriched in RS as a high amylose maize starch have gained consumer acceptance. However, scope remains for additional products and ingredients and a company, Ascentia Pty Ltd, has been established to develop a novel barley cultivar (Hordeum vulgare var. himalaya 292) for this purpose. This cultivar has a specific gene alteration leading to a loss of starch synthetase IIa activity resulting in a grain which is low in starch but disproportionately higher in amylose and also NSP. Animal and human studies have shown that Himalaya 292 is high in RS relative to existing products and has a low glycaemic index and the cultivar offers promise as a vehicle to deliver health benefits to consumers.","CSIRO, HLth Sci & Nutr, Adelaide, SA 5000, Australia; CSIRO, Plant Ind, Canberra, ACT 2600, Australia",Commonwealth Scientific & Industrial Research Organisation (CSIRO); Health Sciences & Nutrition; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Plant Industry,"CSIRO, HLth Sci & Nutr, POB 10041,Kintore Ave, Adelaide, SA 5000, Australia.",david.topping@csiro.au,"topping, david l/H-7969-2013; Morell, Matthew/AAQ-5368-2021; Li, Zhongyi/A-2932-2010","Morell, Matthew/0000-0003-4467-1626; Li, Zhongyi/0000-0002-7334-8935",,,,,34,49,62,2,40,WILEY-V C H VERLAG GMBH,WEINHEIM,"POSTFACH 101161, 69451 WEINHEIM, GERMANY",0038-9056,1521-379X,,STARCH-STARKE,Starch-Starke,DEC,2003,55,12,,,,,539,545,,10.1002/star.200300221,http://dx.doi.org/10.1002/star.200300221,,,7,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,756TD,,,,,2024-06-04,WOS:000187497100001,View Full Record in Web of Science
J,"Camilleri, M; Boeckxstaens, G",,,,"Camilleri, Michael; Boeckxstaens, Guy",,,Dietary and pharmacological treatment of abdominal pain in IBS,GUT,,,English,Article,,,,,,,IRRITABLE-BOWEL-SYNDROME; RANDOMIZED CONTROLLED-TRIAL; CHRONIC IDIOPATHIC CONSTIPATION; LOW-FODMAP DIET; FUNCTIONAL GASTROINTESTINAL DISORDERS; QUALITY-OF-LIFE; ALTERED RECTAL PERCEPTION; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; OTILONIUM BROMIDE,"This review introduces the principles of visceral sensation and appraises the current approaches to management of visceral pain in functional GI diseases, principally IBS. These approaches include dietary measures including fibre supplementation, low fermentable oligosaccharides, disaccharides, monosaccharides and polyols diet, and pharmacological approaches such as antispasmodics, peppermint oil, antidepressants (tricyclic agents, selective serotonin reuptake inhibitors), 5-HT3 receptor antagonists (alosetron, ondansetron, ramosetron), non-absorbed antibiotic (rifaximin), secretagogues (lubiprostone, linaclotide), mu-opioid receptor (OR) and kappa-OR agonist, delta-OR antagonist (eluxadoline), histamine H1 receptor antagonist (ebastine), neurokinin-2 receptor antagonist (ibodutant) and GABAergic agents (gabapentin and pregabalin). Efficacy and safety are discussed based on pivotal trials or published systematic reviews and metaanalysis, expressing ORs or relative risks and their 95% CIs. Potential new approaches may be based on recent insights on mucosal expression of genes, and microRNA and epigenetic markers in human biopsies and in animal models of visceral hypersensitivity. The objectives of this review are to appraise the physiology and anatomy of gut sensation and the efficacy in the relief of visceral pain (typically in IBS) of several classes of therapies. These include fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) and different classes of medications (box 1).","[Camilleri, Michael] Mayo Clin, CENTER, Charlton Bldg,Rm 8-110,200 First St SW, Rochester, MN 55905 USA; [Boeckxstaens, Guy] Katholieke Univ Leuven, Translat Res Ctr Gastrointestinal Disorders TARGI, Dept Clin & Expt Med, Leuven, Belgium",Mayo Clinic; KU Leuven,"Camilleri, M (corresponding author), Mayo Clin, CENTER, Charlton Bldg,Rm 8-110,200 First St SW, Rochester, MN 55905 USA.",camilleri.michael@mayo.edu,"Boeckxstaens, Guy/AAP-2502-2020",,National Institutes of Health [R01-DK92179]; Takeda; KU Leuven University Grant (Global Opportunities for Associations) [GOA 14.011],National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Takeda(Takeda Pharmaceutical Company Ltd); KU Leuven University Grant (Global Opportunities for Associations),MC is supported by National Institutes of Health grant R01-DK92179. GB received a research grant from Takeda and is supported by a KU Leuven University Grant (Global Opportunities for Associations GOA 14.011).,,111,101,107,0,66,BMJ PUBLISHING GROUP,LONDON,"BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND",0017-5749,1468-3288,,GUT,Gut,MAY,2017,66,5,,,,,966,974,,10.1136/gutjnl-2016-313425,http://dx.doi.org/10.1136/gutjnl-2016-313425,,,9,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,ER1QH,28232472,Green Accepted,,,2024-06-04,WOS:000398566800022,View Full Record in Web of Science
J,"Hearing, SD; Thomas, LA; Heaton, KW; Hunt, L",,,,"Hearing, SD; Thomas, LA; Heaton, KW; Hunt, L",,,"Effect of cholecystectomy on bowel function: a prospective, controlled study",GUT,,,English,Article,,,,,,cholecystectomy; bowel habit; stools; diarrhoea; constipation; irritable bowel syndrome,BILE-ACID MALABSORPTION; IRRITABLE-BOWEL; INTESTINAL TRANSIT; STOOL FORM; GASTROINTESTINAL DISORDERS; SYMPTOMS; POPULATION; COMMUNITY; DIARRHEA; STONES,"Background-Published estimates of the prevalence of postcholecystectomy diarrhoea derive from retrospective or uncontrolled data. They ignore functional bowel syndromes and possible changes in diet and drug use. Aims-To determine prospectively whether and how often cholecystectomy leads to changes in bowel function and bowel symptoms, especially to liquid stools, over and above any non-specific effect of laparoscopic surgery. Subjects-Patients: 106 adults undergoing laparoscopic cholecystectomy (85 women, 21 men). Controls: 37 women undergoing laparoscopic sterilisation. Methods-Before and 2-6 months after surgery patients were administered questionnaires about bowel frequency, bowel symptoms, diet, and drugs, and kept records of five consecutive defecations with assessment of stool form or appearance on a seven point scale. Results-In cholecystectomised women, stated bowel frequency increased, on average by one movement a week, and fewer subjects felt that they became constipated. However, records showed no consistent change in bowel frequency, stool form, or defecatory symptoms. Six women reported diarrhoea after the operation but in only one was it clearly new and in her it was mild. Change in dietary fibre intake did not associate with change in bowel function but stopping constipating drugs did in a minority. In women being sterilised there was no consistent change in bowel function. In men having cholecystectomy no consistent changes were observed. Conclusions-In women, cholecystectomy leads to the perception of less constipation and slightly more frequent defecations but short term recordings show no consistent change in bowel function. Clinical diarrhoea develops rarely and is not severe.","Univ Bristol, Bristol Royal Infirm, Dept Med, Bristol BS2 8HW, Avon, England; Univ Bristol, Royal Hosp Sick Children, Div Child Hlth, Bristol BS2 8HW, Avon, England",University of Bristol; Bristol Royal Infirmary; Bristol Royal Hospital For Children; University of Bristol,"Heaton, KW (corresponding author), Claverham House, N Somerset BS49 4QD, England.",,,,,,,,30,32,34,0,5,BRITISH MED JOURNAL PUBL GROUP,LONDON,"BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND",0017-5749,,,GUT,Gut,DEC,1999,45,6,,,,,889,894,,10.1136/gut.45.6.889,http://dx.doi.org/10.1136/gut.45.6.889,,,6,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,260KB,10562588,"Green Published, Green Submitted, Bronze",,,2024-06-04,WOS:000083947700019,View Full Record in Web of Science
S,"Drummond, L; Gearry, RB",,"Boland, M; Moughan, PJ",,"Drummond, Lynley; Gearry, Richard B.",,,Kiwifruit Modulation of Gastrointestinal Motility,NUTRITIONAL BENEFITS OF KIWIFRUIT,Advances in Food and Nutrition Research,,English,Article; Book Chapter,,,,,,,DIETARY FIBER; CHILDHOOD CONSTIPATION; HEALTH; PREVALENCE; EXTRACTS; ALLERGEN; TRANSIT; IMPACT; GENE,"Disorders of gastrointestinal motility are common, resulting in a decreased quality of life of individuals, and an economic burden. Gastrointestinal motility is categorized according to location within the gastrointestinal tract: stomach, small intestine, and colon, with the colon being the dominant compartment in determining overall gastrointestinal transit. Constipation results from gastrointestinal dysmotility and is a significant chronic health issue globally. Clinical studies in a range of adult populations consistently indicate that kiwifruit are a highly effective dietary option to promote laxation. This, together with emerging evidence for the putative effects of kiwifruit in beneficially promoting gastric emptying and digesta mixing, suggests that kiwifruit are physiologically active throughout the gastrointestinal tract. Although the mechanisms of this action remain unknown, the unique behavior of kiwifruit fiber during digestion and the potential action of bioactive components in kiwifruit may contribute to the effectiveness of kiwifruit in modulating gastrointestinal motility.","[Drummond, Lynley] Drummond Food Sci Advisory Ltd, Waihi, New Zealand; [Gearry, Richard B.] Univ Otago, Dept Med, Christchurch, New Zealand",University of Otago,"Drummond, L (corresponding author), Drummond Food Sci Advisory Ltd, POB 265, Waihi, New Zealand.",lynley_dfsa@me.com,"Gearry, Richard B/H-3959-2019","Gearry, Richard B/0000-0002-2298-5141; Drummond, Lynley/0000-0002-1350-8132",,,,,39,14,15,1,14,ELSEVIER ACADEMIC PRESS INC,SAN DIEGO,"525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA",1043-4526,,978-0-12-394631-7; 978-0-12-394294-4,ADV FOOD NUTR RES,Adv. Food Nutr. Res.,,2013,68,,,,,,219,232,,10.1016/B978-0-12-394294-4.00012-2,http://dx.doi.org/10.1016/B978-0-12-394294-4.00012-2,,,14,Food Science & Technology; Nutrition & Dietetics,Book Citation Index – Science (BKCI-S),Food Science & Technology; Nutrition & Dietetics,BID20,23394990,,,,2024-06-04,WOS:000327634800013,View Full Record in Web of Science
J,"Lambert, K; Bird, L; Borst, AC; Fuller, A; Wang, YN; Rogers, GB; Stanford, J; Sanderson-Smith, ML; Williams, JG; McWhinney, BC; Neale, EP; Probst, Y; Lonergan, M",,,,"Lambert, Kelly; Bird, Luke; Borst, Addison C.; Fuller, Andrew; Wang, Yanan; Rogers, Geraint B.; Stanford, Jordan; Sanderson-Smith, Martina L.; Williams, Jonathan G.; McWhinney, Brett C.; Neale, Elizabeth P.; Probst, Yasmine; Lonergan, Maureen",,,Safety and Efficacy of Using Nuts to Improve Bowel Health in Hemodialysis Patients,JOURNAL OF RENAL NUTRITION,,,English,Article,,,,,,,CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; GASTROINTESTINAL SYMPTOMS; RECEIVING DIALYSIS; DIETARY PATTERNS; CONSTIPATION; BIOACCESSIBILITY; CONSUMPTION; PREVALENCE; PRURITUS,"Objective: Constipation is common in patients with end-stage kidney disease. Nondrug strategies to manage constipation are challenging because of dietary potassium, phosphate, and fluid restrictions. Nuts are a high-fiber food but are excluded from the diet because of the high potassium and phosphate content. The aim of this study was to examine the safety and efficacy of using nuts to improve constipation in adults undertaking hemodialysis (HD). Design and Methods: Adult patients undertaking HD were recruited to this nonrandomized, 10-week repeated measures, within-subject, pragmatic clinical trial, conducted in two HD units. The intervention consisted of consumption of 40g of raw almonds daily for four weeks, followed by a two-week washout and four-week control period. The primary safety outcome measures were change in predialysis serum potassium and phosphate levels. The primary efficacy outcome was reduction in constipation, measured using the Bristol Stool Form Scale and Palliative Care Outcome Scale (POS-S) renal symptom score. Secondary outcomes included quality of life, selected uremic toxins, cognition, gut microbiota profile, and symptom burden. Results: Twenty patients completed the trial (median age: 67 [interquartile range: 57.5-77.8] years, 51% male). After controlling for dialysis adequacy, anuria, dietary intake, bicarbonate, and parathyroid hormone, there were no statistically significant changes in serum potassium (P = 0.21) or phosphate (P = 0.16) associated with daily consumption of almonds. However, statistically significant improvements in constipation were seen at weeks 2, 3, 4, and 10. There were statistically significant improvements in quality of life (P = 0.030), overall symptom burden (P = 0.002), vomiting (P = 0.020), itching (P = 0.006), and skin changes (P = 0.002). Conclusion: Daily consumption of almonds for four weeks was safe, effective, and well tolerated. Improvements in quality of life and symptom burden warrant further research to elucidate potential mechanisms. The findings support the potential reinclusion of foods such as nuts into the diet of patients who underwent HD. (C) 2019 by the National Kidney Foundation, Inc. All rights reserved.","[Lambert, Kelly; Borst, Addison C.; Fuller, Andrew; Stanford, Jordan; Neale, Elizabeth P.; Probst, Yasmine; Lonergan, Maureen] Univ Wollongong, Fac Sci Med & Hlth, Sch Med, Northfields Ave, Wollongong, NSW 2522, Australia; [Lambert, Kelly; Sanderson-Smith, Martina L.; Williams, Jonathan G.; Neale, Elizabeth P.; Probst, Yasmine; Lonergan, Maureen] Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Lambert, Kelly; Bird, Luke; Lonergan, Maureen] Illawarra Shoalhaven Local Hlth Dist, Wollongong, NSW, Australia; [Wang, Yanan; Rogers, Geraint B.] South Australian Hlth & Med Res Inst, Microbiome & Host Hlth Programme, Adelaide, SA, Australia; [Sanderson-Smith, Martina L.; Williams, Jonathan G.] Univ Wollongong, Fac Sci Med & Hlth, Sch Chem & Mol Biosci, Wollongong, NSW, Australia; [McWhinney, Brett C.] Pathol Queensland, Dept Chem Pathol, Brisbane, Qld, Australia",University of Wollongong; University of Wollongong; Illawarra Health & Medical Research Institute; Illawarra Shoalhaven Local Health District; South Australian Health & Medical Research Institute (SAHMRI); University of Wollongong,"Lambert, K (corresponding author), Univ Wollongong, Fac Sci Med & Hlth, Sch Med, Northfields Ave, Wollongong, NSW 2522, Australia.",klambert@uow.edu.au,"Wang, Yahui/JCO-6233-2023; Sanderson-Smith, Martina/O-9387-2019; Probst, Yasmine/A-1342-2008; wang, ya/HQZ-7558-2023; Lambert, Kelly/A-3940-2015","Probst, Yasmine/0000-0002-1971-173X; Stanford, Jordan/0000-0003-3541-8960; Lambert, Kelly/0000-0001-5935-7328; Williams, Jonathan/0000-0002-2878-0999",Collaborative Grant from the Illawarra Health and Medical Research Institute,Collaborative Grant from the Illawarra Health and Medical Research Institute,This study was funded by a Collaborative Grant from the Illawarra Health and Medical Research Institute. The Almond Board of Australia provided almonds for the study with no restrictions on the reporting of results or the conduct of the study.,,45,8,8,1,14,W B SAUNDERS CO-ELSEVIER INC,PHILADELPHIA,"1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA",1051-2276,1532-8503,,J RENAL NUTR,J. Renal Nutr.,SEP,2020,30,5,,,,,462,469,,10.1053/j.jrn.2019.10.002,http://dx.doi.org/10.1053/j.jrn.2019.10.002,,,8,Nutrition & Dietetics; Urology & Nephrology,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Nutrition & Dietetics; Urology & Nephrology,NW6LD,32001127,Green Submitted,,,2024-06-04,WOS:000575125800013,View Full Record in Web of Science
J,"Wang, YQ; Ma, WJ; Mehta, R; Nguyen, LH; Song, MY; Drew, DA; Asnicar, F; Huttenhower, C; Segata, N; Wolf, J; Spector, T; Berry, S; Staller, K; Chan, AT",,,,"Wang, Yiqing; Ma, Wenjie; Mehta, Raaj; Nguyen, Long H.; Song, Mingyang; Drew, David A.; Asnicar, Francesco; Huttenhower, Curtis; Segata, Nicola; Wolf, Jonathan; Spector, Tim; Berry, Sarah; Staller, Kyle; Chan, Andrew T.",,,Diet and gut microbial associations in irritable bowel syndrome according to disease subtype,GUT MICROBES,,,English,Article,,,,,,Fiber; functional bowel disorder; diarrhea; microbial enzymes; glycan metabolism,ROME III; PREVALENCE; METABOLISM; MECHANISMS; BUTYRATE; CRITERIA; IMPACT,"The role of diet and the gut microbiome in the etiopathogenesis of irritable bowel syndrome (IBS) is not fully understood. Therefore, we investigated the interplay between dietary risk factors and gut microbiota in IBS subtypes using a food frequency questionnaire and stool metagenome data from 969 participants aged 18-65 years in the ZOE PREDICT 1 study, an intervention study designed to predict postprandial metabolic responses. We identified individuals with IBS subtype according to the Rome III criteria based on predominant bowel habits during symptom onset: diarrhea (i.e. looser), constipation (i.e. harder), and mixed. Participants with IBS-D (n = 59) consumed more healthy plant-based foods (e.g. whole grains, leafy vegetables) and fiber, while those with IBS-C (n = 49) tended to consume more unhealthy plant-based foods (e.g. refined grains, fruit juice) than participants without IBS (n = 797). Microbial diversity was nominally lower in patients with IBS-D than in participants without IBS or with IBS-C. Using multivariable-adjusted linear regression, we identified specific microbiota variations in IBS subtypes, including slight increases in pro-inflammatory taxa in IBS-C (e.g. Escherichia coli) and loss of strict anaerobes in IBS-D (e.g. Faecalibacterium prausnitzii). Our analysis also revealed intriguing evidence of interactions between diet and Faecalibacterium prausnitzii. The positive associations between fiber and iron intake and IBS-diarrhea were stronger among individuals with a higher relative abundance of Faecalibacterium prausnitzii, potentially driven by carbohydrate metabolic pathways, including the superpathway of & beta;-D-glucuronide and D-glucuronate degradation. In conclusion, our findings suggest subtype-specific variations in dietary habits, gut microbial composition and function, and diet-microbiota interactions in IBS, providing insights into potential microbiome-informed dietary interventions.","[Wang, Yiqing; Ma, Wenjie; Mehta, Raaj; Nguyen, Long H.; Song, Mingyang; Drew, David A.; Staller, Kyle; Chan, Andrew T.] Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit, Boston, MA USA; [Wang, Yiqing; Ma, Wenjie; Mehta, Raaj; Nguyen, Long H.; Song, Mingyang; Drew, David A.; Staller, Kyle; Chan, Andrew T.] Harvard Med Sch, Boston, MA USA; [Wang, Yiqing; Ma, Wenjie; Mehta, Raaj; Nguyen, Long H.; Song, Mingyang; Drew, David A.; Staller, Kyle; Chan, Andrew T.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA USA; [Nguyen, Long H.; Huttenhower, Curtis] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Song, Mingyang] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Song, Mingyang; Chan, Andrew T.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, 677 Huntington Ave, Boston, MA USA; [Asnicar, Francesco; Segata, Nicola] Univ Trento, Dept Cellular Computat & Integrat Biol, Trento, Italy; [Huttenhower, Curtis] Broad Inst MIT & Harvard, Cambridge, MA USA; [Segata, Nicola] Sci Inst Res Hospitalizat & Healthcare, European Inst Oncol, Milan, Italy; [Wolf, Jonathan] Zoe Ltd, London, England; [Spector, Tim] Kings Coll London, Dept Twin Res, London, England; [Berry, Sarah] Kings Coll London, Dept Nutr Sci, London, England; [Chan, Andrew T.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA USA; [Chan, Andrew T.] Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit, 55 Fruit St,GRJ-825C, Boston, MA 02114 USA; [Chan, Andrew T.] Harvard Med Sch, 55 Fruit St,GRJ-825C, Boston, MA 02114 USA",Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Trento; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; IRCCS European Institute of Oncology (IEO); University of London; King's College London; University of London; King's College London; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School,"Chan, AT (corresponding author), Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA USA.;Chan, AT (corresponding author), Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit, 55 Fruit St,GRJ-825C, Boston, MA 02114 USA.;Chan, AT (corresponding author), Harvard Med Sch, 55 Fruit St,GRJ-825C, Boston, MA 02114 USA.",achan@mgh.harvard.edu,"Segata, Nicola/K-7240-2016; Asnicar, Francesco/AAB-9255-2020; wang, yi/HOF-6668-2023","Segata, Nicola/0000-0002-1583-5794; Asnicar, Francesco/0000-0003-3732-1468; Wang, Yiqing/0000-0003-1984-1777","We thank the participants of the Zoe PREDICT 1 study, staff of Zoe Global, and all members of the Segata, Berry, and Spector laboratories for running the study, data collection, and data processing.; Spector laboratories","We thank the participants of the Zoe PREDICT 1 study, staff of Zoe Global, and all members of the Segata, Berry, and Spector laboratories for running the study, data collection, and data processing.; Spector laboratories(Randox Laboratories)","We thank the participants of the Zoe PREDICT 1 study, staff of Zoe Global, and all members of the Segata, Berry, and Spector laboratories for running the study, data collection, and data processing.",,48,2,2,6,7,TAYLOR & FRANCIS INC,PHILADELPHIA,"530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA",1949-0976,1949-0984,,GUT MICROBES,Gut Microbes,DEC 18,2023,15,2,,,,,,,2262130,10.1080/19490976.2023.2262130,http://dx.doi.org/10.1080/19490976.2023.2262130,,,13,Gastroenterology & Hepatology; Microbiology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Microbiology,S9LN5,37786251,"gold, Green Published",,,2024-06-04,WOS:001074308800001,View Full Record in Web of Science
J,"Yoon, SJ; Chu, DC; Juneja, LR",,,,"Yoon, Seon-Joo; Chu, Djong-Chi; Juneja, Lekh Raj",,,Physiological functions of partially hydrolyzed guar gum,JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION,,,English,Review,,,,,,partially hydrolyzed guar gum (PGHH); intestinal microflora; mineral absorption; hyperlipidemia; glucose tolerance,CHAIN FATTY-ACIDS; TUBE-FED PATIENTS; DIETARY FIBER; HUMAN-COLON; SERUM-CHOLESTEROL; SOLUBLE FIBER; GROWING-RATS; INTESTINAL TRANSIT; ENTERAL NUTRITION; GLUCOSE-TOLERANCE,"Partially hydrolyzed guar gum (PHGG) has a number of properties associated with dietary fiber. PHGG ingestion results in not only an increase in defecting frequency and softer stools in persons with constipation but also significantly improvement of diarrhea in patient with gastrointestinal intolerance. The lowering of fecal pH by intake of PHGG resulted in the growth of Lactobacillus spp. and Bifidobacterium spp., intestinal flora good for human health. Improvement of balance of intestinal microflora resulted in prevention from infection and colonization of Salmonella enteritidis. Further the ingestion of PHGG promoted absorption of mineral and lowered serum cholesterol and triglycerides in the rat and serum cholesterol in human by improving lipid metabolism without reduction of protein utilization. In addition, PHGG significantly reduced the level of plasma glucose, and thereby improved acute postprandial plasma glucose and insulin response. All these observations suggest that the PHGG is prospective one of dietary fiber with various biological functions.","Univ Washington, Dept Pathobiol, Seattle, WA 98195 USA; Taiyo Kagaku Co Ltd, Cent Res Labs, Yokaichi, Mie 5100844, Japan","University of Washington; University of Washington Seattle; TAIYO KAGAKU CO., LTD.","Yoon, SJ (corresponding author), Univ Washington, Dept Pathobiol, Box 357238,HS Bldg, F-143, Seattle, WA 98195 USA.",yoonsj@u.washington.edu,,,,,,,83,27,27,0,18,JOURNAL CLINICAL BIOCHEMISTRY & NUTRITION,KYOTO,"KYOTO PREFECTURAL UNIV MED, GRAD SCH MEDICAL SCIENCE, DEPT MOLECULAR GASTROENTEROLOGY & HEPATOLOGY, KYOTO, 602-8566, JAPAN",0912-0009,1880-5086,,J CLIN BIOCHEM NUTR,J. Clin. Biochem. Nutr.,NOV,2006,39,3,,,,,132,142,,,,,,11,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,107XX,,,,,2024-06-04,WOS:000242205400004,View Full Record in Web of Science
B,"Tester, RF; Al-Ghazzewi, FH",,"Hollingworth, CS",,"Tester, R. F.; Al-Ghazzewi, F. H.",,,UTILISATION OF GLUCOMANNANS FOR HEALTH,"FOOD HYDROCOLLOIDS: CHARACTERISTICS, PROPERTIES AND STRUCTURES",Food Science and Technology Series,,English,Article; Book Chapter,,,,,,,CHAIN FATTY-ACIDS; UNCOMPLICATED DIVERTICULAR-DISEASE; CONTROLLED METABOLIC TRIAL; KONJAC GLUCOMANNAN; DIETARY-FIBER; CHRONIC CONSTIPATION; ESCHERICHIA-COLI; IMMUNE FUNCTION; AFLATOXIN B-1; IN-VITRO,"Glucomannans are a source of soluble dietary fibre. In nature they are distributed in both softwood tissues such as roots or corms and the hemicellulose of hardwood plants where they serve as energy reserves and in some cases structural roles. As glucomannans contain components which may have a positive effect on health, for instance by selectively stimulating the gut-friendly bacteria and inhibiting pathogens, they can be utilised to serve as valuable 'functional foods'. Outside the gut, the impact of ingested glucomannans for broader health benefits include cholesterol lowering, reducing the risk of chronic constipation, diabetes management, cancer prevention, treating diverticular disease, stimulating the immune system and contributing towards weight reduction.","[Tester, R. F.; Al-Ghazzewi, F. H.] Glasgow Caledonian Univ, Glycol Ltd, Glasgow G4 0BA, Lanark, Scotland",Glasgow Caledonian University,"Al-Ghazzewi, FH (corresponding author), Glasgow Caledonian Univ, Glycol Ltd, Cowcaddens Rd, Glasgow G4 0BA, Lanark, Scotland.",f.h.alghazzewi@glycologic.co.uk,,,,,,,64,6,6,0,4,"NOVA SCIENCE PUBLISHERS, INC",HAUPPAUGE,"400 OSER AVE, STE 1600, HAUPPAUGE, NY 11788-3635 USA",,,978-1-60876-222-4,FOOD SCI TECHN-HAUPP,,,2010,,,,,,,243,251,,,,,,9,Food Science & Technology,Book Citation Index – Science (BKCI-S),Food Science & Technology,BSF80,,,,,2024-06-04,WOS:000284345000009,View Full Record in Web of Science
J,"BURKITT, DP",,,,"BURKITT, DP",,,DIET AND DISEASES OF AFFLUENCE,QUALITAS PLANTARUM-PLANT FOODS FOR HUMAN NUTRITION,,,English,Article,,,,,,,,"A number of the most common diseases in Western society are rare and in some instances almost unknown in communities minimally influenced by modern Western culture. The dietary change most consistently associated with increased prevalence of these diseases is a reduction in the amount of dietary [plant] fiber consumed. Hypotheses were postulated to explain the relationship between these diseases and fiber-depleted diets. In some, for example constipation and diverticular disease, the evidence is generally accepted as almost conclusive. Others require further testing, but for some no alternative hypotheses consistent with epidemiological evidence were formulated.","ST THOMAS HOSP & MED SCH, GEOG PATHOL UNIT, LONDON SE1 7EH, ENGLAND",University of London; King's College London,,,,,,,,,33,0,0,0,3,SPRINGER,DORDRECHT,"VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS",0377-3205,,,QUAL PLANT,,,1977,27,3-4,,,,,227,238,,10.1007/BF01092315,http://dx.doi.org/10.1007/BF01092315,,,12,Plant Sciences; Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Plant Sciences; Food Science & Technology,EE146,,,,,2024-06-04,WOS:A1977EE14600001,View Full Record in Web of Science
J,"Alaradi, O; Barkin, JS",,,,"Alaradi, O; Barkin, JS",,,Irritable bowel syndrome: Update on pathogenesis and management,MEDICAL PRINCIPLES AND PRACTICE,,,English,Article; Proceedings Paper,Conference on Minimal Intervention Approach for Dental Treatment,"DEC 06-08, 1999","KIWAIT UNIV, FAC DENT HLTH SCI CTR, KIWAIT CITY, KUWAIT",,"KIWAIT UNIV, FAC DENT HLTH SCI CTR",irritable bowel syndrome; visceral hyperalgesia; serotonin; enteric nervous system; Rome criteria; brain-gut interaction; motor function; sensory function; diarrhea; constipation,FUNCTIONAL GASTROINTESTINAL DISORDERS; MANNING CRITERIA; PSYCHOSOCIAL-ASPECTS; BIOLOGICAL MARKER; COLONIC TRANSIT; DISTINCT UPPER; HEALTH-CARE; SYMPTOMS; CONSTIPATION; PAIN,"Irritable bowel syndrome (IBS) comprises a major proportion of gastrointestinal and primary care practice worldwide. The past several years have seen the rapid evolution of a new and comprehensive model of IBS based on alterations in brain-gut interactions. Alterations in the bidirectional communication between the enteric nervous system and the central nervous system are implicated in the pathogenesis of IBS. 5-Hydroxytryptamine (5-HT; serotonin), a major neurotransmitter in the gastrointestinal tract, and its receptors 5-HT3 and 5-HT4 are involved in the control of gastrointestinal function. A number of abnormal motor and sensory patterns have been reported in patients with IBS. However, it is not known whether these abnormalities are related to symptoms or have a role in establishing a diagnosis of functional gastrointestinal disorders. Visceral hyperalgesia in IBS patients can be secondary to altered receptor sensitivity at the viscus itself and altered central modulation of sensation involving psychological influences in the interpretation of these sensations. The development of diagnostic criteria for IBS helps to avoid unnecessary and costly investigations. A detailed history allows us to diagnose IBS and search for another cause if warning symptoms are present. The Rome criteria are presently used to define IBS and are currently the most widely applied criteria used in clinical diagnosis and research purposes. Abdominal pain or discomfort associated with chronic altered bowel habits are the mainstay in diagnosis, while the supportive criteria may be used to further classify IBS patients into diarrhea-predominant or constipation-predominant subgroups. Minimal diagnostic tests have been advocated in the initial diagnostic approach to patients with suspected IBS, depending on the predominant symptom. The therapeutic goals in IBS must focus on the overall well-being of the patient, including abdominal symptoms and the accompanying nonbowel symptoms and affective disorders. It is important to establish an effective physician-patient relationship and to reassure the patient once the diagnosis of IBS is made. Dietary modification may be of value in some patients with IBS. Dietary fiber is frequently recommended for patients with constipation-predominant IBS. Two novel serotonin agonists are currently under development for constipated IBS patients, tegaserod and prucalopride. Antidiarrheal agents, including loperamide and diphenoxylate, may help patients with diarrhea-predominant IBS. 5-HT3 receptor antagonists may play a role in the management of such patients in the future. Psychological treatment and antidepressants should be considered when IBS symptoms are severe or refractory or associated with psychological distress and impaired quality of life. Copyright (C) 2002 S. Karger AG, Basel.","Univ Miami, Div Gastroenterol, Mt Sinai Med Ctr, Sch Med, Miami Beach, FL 33140 USA",University of Miami; Mount Sinai Medical Center,"Univ Miami, Div Gastroenterol, Mt Sinai Med Ctr, Sch Med, 4300 Alton Rd, Miami Beach, FL 33140 USA.",s-vance@msmc.com,,,,,,,124,14,18,0,11,KARGER,BASEL,"ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND",1011-7571,1423-0151,,MED PRIN PRACT,Med. Princ. Pract.,JAN-MAR,2002,11,1,,,,,2,17,,10.1159/000048654,http://dx.doi.org/10.1159/000048654,,,16,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),General & Internal Medicine,533TD,12116690,Bronze,,,2024-06-04,WOS:000174545600002,View Full Record in Web of Science
J,"Agakidis, C; Kotzakioulafi, E; Petridis, D; Apostolidou, K; Karagiozoglou-Lampoudi, T",,,,"Agakidis, Charalampos; Kotzakioulafi, Evangelia; Petridis, Dimitrios; Apostolidou, Konstantina; Karagiozoglou-Lampoudi, Thomai",,,Mediterranean Diet Adherence is Associated with Lower Prevalence of Functional Gastrointestinal Disorders in Children and Adolescents,NUTRIENTS,,,English,Article,,,,,,functional constipation; functional gastrointestinal symptoms; KIDMED score; MedDiet; QPGS-III; survey,ROME-II CRITERIA; GUT MICROBIOTA; CHILDHOOD CONSTIPATION; PEDIATRIC-PATIENTS; ABDOMINAL-PAIN; FIBER MIXTURE; FOOD; YOUTH; QUESTIONNAIRE; VALIDATION,"Dietary patterns may have a role in the prevention of functional gastrointestinal disorders (FGIDs). The current study aimed at examining the association between FGIDs and adherence to the Mediterranean diet (MD) among elementary school children (ESC), as well as high school students (HSS). In a prospective cohort study, data from 1116 subjects (387 ESC and 448 HSS) aged 6-18 years were collected. FGID identification was based on the Questionnaire on Pediatric Gastrointestinal Symptoms-Rome III (QPGS-RIII). Adherence to the MD was assessed using the KIDMED Index. Full data were available on 835/1116 questionnaires. Based on Rome III criteria, 184/835 participants (22%) were identified with FGID (122 (66%) with functional constipation (FC)). The prevalence of FGIDs (p = 0.001) was significantly higher in HSS (13-18 years). The KIDMED score in the cohort was 5.7 +/- 2.5. Subjects with FGIDs demonstrated a lower KIDMED score compared to the non-FGID group, both in the cohort, as well as in the ESC and HSS subgroups (FGID vs. non-FGID: p = 0.001, p = 0.007, and p = 0.032, respectively). Multivariate analysis highlighted the KIDMED score as a significant predictor of FGIDs and FC after controlling for the age subgroups. We conclude that good adherence to the MD is associated to lower prevalence of FGIDs, while adolescents display a significantly higher prevalence of FGIDs compared to children.","[Agakidis, Charalampos] Aristotle Univ Thessaloniki, Ippokrat Gen Hosp, Pediat Dept 1, Konstantinoupoleos 49, Thessaloniki 54246, Greece; [Kotzakioulafi, Evangelia; Apostolidou, Konstantina; Karagiozoglou-Lampoudi, Thomai] Alexander Technol Educ Inst Thessaloniki, Dept Nutr & Dietet, Thessaloniki 57400, Greece; [Petridis, Dimitrios] Alexander Technol Educ Inst Thessaloniki, Dept Food Technol, Thessaloniki 57400, Greece",Aristotle University of Thessaloniki,"Agakidis, C (corresponding author), Aristotle Univ Thessaloniki, Ippokrat Gen Hosp, Pediat Dept 1, Konstantinoupoleos 49, Thessaloniki 54246, Greece.",cagakidis@gmail.com; evelinakotzak@hotmail.com; petridis@food.teithe.gr; nantia@otenet.gr; thomaiskl@gmail.com,"AGAKIDIS, CHARALAMPOS/GXZ-7865-2022; Kotzakioulafi, Evangelia/ABD-6959-2020; Kotzakioulafi, Evangelia/AAY-1890-2020","AGAKIDIS, CHARALAMPOS/0000-0002-2800-6530; Kotzakioulafi, Evangelia/0000-0003-4841-1928; Kotzakioulafi, Evangelia/0000-0003-4841-1928; Karagiozoglou- Lampoudi, Thomai/0000-0003-0285-1370",,,,,49,25,26,0,7,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,JUN,2019,11,6,,,,,,,1283,10.3390/nu11061283,http://dx.doi.org/10.3390/nu11061283,,,11,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,II1AJ,31174310,"gold, Green Published, Green Submitted",,,2024-06-04,WOS:000474936700089,View Full Record in Web of Science
J,"Maruti, SS; Lampe, JW; Potter, JD; Ready, A; White, E",,,,"Maruti, Sonia S.; Lampe, Johanna W.; Potter, John D.; Ready, Ann; White, Emily",,,A prospective study of bowel motility and related factors on breast cancer risk,CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION,,,English,Article,,,,,,,GASTROINTESTINAL TRANSIT-TIME; SERUM ESTROGEN CONCENTRATIONS; FOOD FREQUENCY QUESTIONNAIRE; COLONIC TRANSIT; STOOL FREQUENCY; LIFE-STYLE; WOMEN; DIET; PREMENOPAUSAL; CONSTIPATION,"Background: Estrogen is an established risk factor for breast cancer. Greater bowel motility has been associated with increased estrogen excretion and lower serum estrogen levels, suggesting that it may influence breast cancer risk. However, only one other epidemiologic study thus far, to our knowledge, has examined the relation between bowel motility and breast cancer risk. Methods: We prospectively examined whether bowel motility, measured by self-reported frequency of bowel movements, and related factors (constipation, laxative use, water consumption, and dietary fiber intake) were associated with incidence of breast cancer among 28,586 postmenopausal women, ages 50 to 76 years, in the Vitamins and Lifestyle study. Cox proportional hazards models were used to estimate multivariate-adjusted relative risks (RR) and 95% confidence intervals (95% CI). From 2000 to 2005, 507 incident invasive breast cancers among the cohort were identified. Results: Women with very frequent (>= 3/d) bowel movements had a 46% decreased risk compared with 1/d women (RR, 0.54; 95% CI, 0.31-0.92), but the test for linear trend was not significant (P-trend = 0.41). Constipation was nonsignificantly associated with increased risk (RR, 1.30 for >= 1/wk versus <1/y; 95% Cl, 0.87-1.95). No statistically significant associations were observed for the other study exposures: 10-year chemical laxative use, 10-year use of fiber laxatives, water consumption, and dietary fiber intake. Conclusion: This study adds limited support to the hypothesis that increased bowel motility lowers breast cancer risk.","[Maruti, Sonia S.; Lampe, Johanna W.; Potter, John D.; White, Emily] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Maruti, Sonia S.; Lampe, Johanna W.; Potter, John D.; Ready, Ann; White, Emily] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Ready, Ann] Bastyr Univ, Seattle, WA USA",Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle,"White, E (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1100 Fairview Ave N,POB 19024,M3-B232, Seattle, WA 98109 USA.",ewhite@fhcrc.org,,"Potter, John/0000-0001-5439-1500","NCI NIH HHS [R01 CA074846-05, R25 CA 94880, R01 CA 74846, R01 CA074846, R25 CA094880-08, R25 CA094880] Funding Source: Medline",NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)),,,27,14,16,0,2,AMER ASSOC CANCER RESEARCH,PHILADELPHIA,"615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA",1055-9965,,,CANCER EPIDEM BIOMAR,Cancer Epidemiol. Biomarkers Prev.,JUL,2008,17,7,,,,,1746,1750,,10.1158/1055-9965.EPI-07-2850,http://dx.doi.org/10.1158/1055-9965.EPI-07-2850,,,5,"Oncology; Public, Environmental & Occupational Health",Science Citation Index Expanded (SCI-EXPANDED),"Oncology; Public, Environmental & Occupational Health",327NJ,18628427,"Bronze, Green Accepted",,,2024-06-04,WOS:000257735500025,View Full Record in Web of Science
J,"GAMBLE, CL",,,,"GAMBLE, CL",,,LIPID DISORDERS - TAILORING DIET AND DRUG-THERAPY FOR INDIVIDUAL NEEDS,GERIATRICS-US,,,English,Article,,,,,,,HYPERCHOLESTEROLEMIA,"Treatment of hypercholesterolemia begins with a low-fat, low-cholesterol diet. In older patients, it is important that dietary measures do not compromise adequate intake of calories, calcium, sodium, and carbohydrates and do not exacerbate constipation. Drug therapy may be indicated if diet fails to achieve desired lipid levels. Bile acid binding resins, nicotinic acid, and HMG-CoA reductase inhibitors are effective for lowering LDL. Fibric acid derivatives are the most potent triglyceride-lowering agents. Depending on the drug prescribed, you may need to monitor liver function and watch for signs of myalgia. Constipation is also a common side effect of many of these drugs and may be minimized by increasing water intake or dietary fiber.",,,"GAMBLE, CL (corresponding author), COOPER CLIN, DEPT ENDOCRINE & METAB DIS, FT SMITH, AR USA.",,,,,,,,8,0,0,0,0,ADVANSTAR COMMUNICATIONS INC,DULUTH,"131 W 1ST STREET, DULUTH, MN 55802 USA",0016-867X,1936-5764,,GERIATRICS-US,Geriatrics,NOV,1994,49,11,,,,,52,+,,,,,,1,Geriatrics & Gerontology,Science Citation Index Expanded (SCI-EXPANDED),Geriatrics & Gerontology,PT016,7959076,,,,2024-06-04,WOS:A1994PT01600009,View Full Record in Web of Science
J,"Suárez-González, M; Bousoño-García, C; Jiménez-Treviño, S; Díaz-Martín, JJ",,,,"Suarez-Gonzalez, Marta; Bousono-Garcia, Carlos; Jimenez-Trevino, Santiago; Jose Diaz-Martin, Juan",,,"Gluten-Free Diet: Nutritional Strategies to Improve Eating Habits in Children with Celiac Disease: A Prospective, Single-arm Intervention Study",NUTRIENTS,,,English,Article,,,,,,dietitian; nutritional management; healthy eating; gluten-free diet; dietary therapy,ULTRA-PROCESSED FOODS; BONE-MINERAL DENSITY; NUTRIENT INTAKE; LONG-TERM; CONSUMPTION; GUIDELINES; ADOLESCENTS; PRODUCTS; FIBER; MANAGEMENT,"Background: Elimination of gluten-containing cereals and consumption of ultra-processed gluten-free foods might cause an unbalanced diet, deficient in fiber and rich in sugar and fat, circumstances that may predispose celiac children to chronic constipation. Aim: to evaluate if counseling with a registered dietitian (RD) was capable of improving eating and bowel habits in a celiac pediatric population. Methods: Dietetic, lipid profile and stool modifications were analyzed, comparing baseline assessments with those twelve months after receiving heathy eating and nutrition education sessions. At both time points, 3-day food records, a bowel habit record and a lipid panel were conducted. Calculated relative intake of macro- and micro-nutrients were compared with current recommendations by the European Food Safety Authority (EFSA). Student's paired t-test, McNemar test, Mandasky test and Pearson correlation tests were used. Results: Seventy-two subjects (58.3% girls) with a mean (standard deviation (SD)) age of 10.2 (3.4) years were included. Baseline diets were imbalanced in macronutrient composition. Significant improvements were observed in their compliance with dietary reference values (DRVs), where 50% of the subjects met fat requirements after the education and 67% and 49% with those of carbohydrates and fiber, respectively (p < 0.001). Celiac children decreased red meat and ultra-processed foods consumption (p < 0.001) and increased fruits and vegetables intake (p < 0.001), leading to a reduction in saturated fat (p < 0.001) and sugar intake (p < 0.001). Furthermore, 92% of the patients achieved a normal bowel habit, including absence of hard stools in 80% of children constipated at baseline (p < 0.001). Conclusions: RD-led nutrition education is able to improve eating patterns in children with celiac disease (CD).","[Suarez-Gonzalez, Marta; Bousono-Garcia, Carlos; Jimenez-Trevino, Santiago; Jose Diaz-Martin, Juan] Cent Univ Hosp Asturias, Pediat Gastroenterol & Nutr Unit, Asturias Av Roma S-N, Oviedo 33011, Spain",Central University Hospital Asturias,"Suárez-González, M (corresponding author), Cent Univ Hosp Asturias, Pediat Gastroenterol & Nutr Unit, Asturias Av Roma S-N, Oviedo 33011, Spain.",marta.suarezglez@gmail.com; ringerbou@yahoo.es; principevegeta@hotmail.com; juanjo.diazmartin@gmail.com,"DIAZ MARTIN, JUAN JOSE/KOC-6445-2024","DIAZ MARTIN, JUAN JOSE/0000-0003-0962-8403; Jimenez, Santiago/0000-0002-1968-5826; Suarez-Gonzalez, Marta/0000-0001-7552-4894",Fundacion Nutricion y Crecimiento,Fundacion Nutricion y Crecimiento,This research was funded by Fundacion Nutricion y Crecimiento.,,68,4,4,1,10,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,APR,2021,13,4,,,,,,,1108,10.3390/nu13041108,http://dx.doi.org/10.3390/nu13041108,,,15,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,RR8RC,33800620,"Green Published, gold",,,2024-06-04,WOS:000643357500001,View Full Record in Web of Science
J,"Closa-Monasterolo, R; Ferré, N; Castillejo-DeVillasante, G; Luque, V; Gispert-Llaurado, M; Zaragoza-Jordana, M; Theis, S; Escribano, J",,,,"Closa-Monasterolo, Ricardo; Ferre, Natalia; Castillejo-DeVillasante, Gemma; Luque, Veronica; Gispert-Llaurado, Mariona; Zaragoza-Jordana, Marta; Theis, Stephan; Escribano, Joaquin",,,The use of inulin-type fructans improves stool consistency in constipated children. A randomised clinical trial: pilot study,INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION,,,English,Article,,,,,,Constipation; prebiotics; inulin; stool consistency; non-pharmacological treatment; children,DIETARY FIBER INTAKE; CHILDHOOD CONSTIPATION; OLIGOFRUCTOSE; HEALTH; EPIDEMIOLOGY; PROGNOSIS; VALIDITY; ADULTS,"Background: Constipation is a common disorder in children.Objective: The objective of this study is to assess the beneficial effects of a daily supplementation with Orafti((R)) inulin-type fructans in 2-5 year old constipated children.Methods: Double-blind, randomised, placebo-controlled parallel group trial where constipated children received two doses of 2g Orafti((R)) inulin-type fructans (OF:IN) or placebo (maltodextrin) for 6 weeks. Primary outcome was stool consistency. Secondary outcomes were stool frequency and gastrointestinal symptoms.Results: Twenty-two children were included, 17 completed the study protocol (nine and eight for the control and the OF:IN group, respectively). Results showed that Orafti((R)) inulin-type fructans supplemented children had softer stools (p=.003). The longitudinal analysis showed no significant changes in controls, whereas supplemented children increased their stool consistency from 2.2 to 2.6 on the modified Bristol scale for children (five items instead of seven) (p=.040).Conclusions: Prebiotic inulin-type fructans supplementation improves stool consistency in constipated 2-5-year old children.Clinicaltrials.gov, with number NCT02863848.","[Closa-Monasterolo, Ricardo; Luque, Veronica] Hosp Univ Joan XXIII Tarragona, Neonatal Unit, Tarragona, Spain; [Closa-Monasterolo, Ricardo; Ferre, Natalia; Castillejo-DeVillasante, Gemma; Luque, Veronica; Gispert-Llaurado, Mariona; Zaragoza-Jordana, Marta; Escribano, Joaquin] Univ Rovira & Virgili, Paediat Res Unit, IISPV, St Llorenc 21, Reus 43201, Spain; [Theis, Stephan; Escribano, Joaquin] Beneo GmbH Obrigheim, Nutr Sci, Mannheim, Germany; [Castillejo-DeVillasante, Gemma] Hosp Univ St Joan Reus, Paediat Unit, Reus, Spain",Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV),"Escribano, J (corresponding author), Univ Rovira & Virgili, Paediat Res Unit, IISPV, St Llorenc 21, Reus 43201, Spain.",jescribano@grupsagessa.com,"Gispert-Llaurado, Mariona/AAL-1143-2020; Zaragoza-Jordana, Marta/AAL-1342-2020; Ferré, Natalia/ABE-5700-2020; Escribano, Joaquin/ABD-6604-2020; Luque, Veronica/AAC-9002-2019; Ferre, Natalia/AGA-5684-2022","Gispert-Llaurado, Mariona/0000-0002-4586-8079; Zaragoza-Jordana, Marta/0000-0001-9704-6950; Luque, Veronica/0000-0003-2615-8175; Ferre, Natalia/0000-0002-2838-1525; Escribano, Joaquin/0000-0002-5041-459X",BeneoGmbH,BeneoGmbH,BeneoGmbH.,,30,43,51,1,30,TAYLOR & FRANCIS LTD,ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND",0963-7486,1465-3478,,INT J FOOD SCI NUTR,Int. J. Food Sci. Nutr.,,2017,68,5,,,,,587,594,,10.1080/09637486.2016.1263605,http://dx.doi.org/10.1080/09637486.2016.1263605,,,8,Food Science & Technology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Nutrition & Dietetics,EV9CH,27931142,"hybrid, Green Submitted",,,2024-06-04,WOS:000402081600009,View Full Record in Web of Science
J,"Ma, KD; Su, B; Li, FY; Li, JF; Nie, JW; Xiong, WY; Luo, JX; Huang, SB; Zhou, T; Liang, XD; Li, FC; Deng, JP; Tan, CQ",,,,"Ma, Kaidi; Su, Bin; Li, Fuyong; Li, Jinfeng; Nie, Jiawei; Xiong, Wenyu; Luo, Jinxi; Huang, Shuangbo; Zhou, Tong; Liang, Xide; Li, Facai; Deng, Jinping; Tan, Chengquan",,,Maternal or post-weaning dietary fructo-oligosaccharide supplementation reduces stillbirth rate of sows and diarrhea of weaned piglets,ANIMAL NUTRITION,,,English,Article,,,,,,Stillbirth; Diarrhea; Fructo-oligosaccharide; Sow; Weaned piglet,CHAIN FATTY-ACIDS; CHITOSAN OLIGOSACCHARIDE; COLONIC MICROBIOTA; INSULIN-RESISTANCE; PERFORMANCE; FIBER; FRUCTOOLIGOSACCHARIDE; GESTATION; PREGNANCY; BACTERIA,"Fructo-oligosaccharides (FOS) are well-known prebiotics that have the potential to improve sow reproductive performance and increase piglet growth. However, previous studies were observed in sole FOS-supplemented diets of sows or weaned piglets and did not consider the sow-to-piglet transfer effect on the performance and diarrhea rate of weaned piglets. This study explores the effects of dietary FOS supplementation on the reproductive performance of sows, and the effects of FOS supplementation at different stages on the growth performance and diarrhea rate of weaned piglets. A split-plot experimental design was used with sow diet effect in the whole plot and differing piglet diet effect in the subplot. Fifty-two multiparous sows (223.24 +/- 14.77 kg) were randomly divided into 2 groups (0 or 0.2% FOS). The experiment lasted from day 85 of gestation to day 21 of lactation. Reproductive performance, glucose tolerance, placental angiogenesis, and intestinal flora of sows were assessed. At weaning, 192 weaned piglets were grouped in 2 x 2 factorial designs, with the main effects of FOS supplemental level of sow diet (0 and 0.2%), and FOS supplemental level of weaned piglet diet (0 and 0.2%), respectively. The growth performance and diarrhea rate of the weaned piglets were analyzed during a 28-d experiment. Maternal dietary supplementation of FOS was shown to reduce the stillbirth and invalid piglet rates ( P < 0.05), improve the insulin sensitivity ( P < 0.05) and fecal scores ( P < 0.05) of sows, increase the abundance of Akkermansia muciniphila ( P = 0.016), decrease the abundance of Escherichia coli ( P = 0.035), and increase the isovalerate content in feces ( P = 0.086). Meanwhile, the placental angiogenesis marker CD31 expression was increased in sows fed FOS diet ( P < 0.05). Moreover, maternal and post-weaning dietary FOS supplementation reduced the diarrhea rate of weaned piglets ( P < 0.05) and increased the content of short-chain fatty acids in feces ( P < 0.05). Furthermore, only post-weaning dietary FOS supplementation could improve nutrient digestibility of weaned piglets ( P < 0.05). Collectively, FOS supplementation in sows can reduce stillbirth rate, perinatal constipation, and insulin resistance, as well as improve placental vascularization barrier. Additionally, maternal and post-weaning dietary FOS supplementation reduced the diarrhea rate of weaned piglets, but only FOS supplementation in piglets alone at weaning stage could improve their nutrient digestibility. (c) 2024 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","[Ma, Kaidi; Su, Bin; Li, Fuyong; Li, Jinfeng; Nie, Jiawei; Xiong, Wenyu; Luo, Jinxi; Huang, Shuangbo; Deng, Jinping; Tan, Chengquan] South China Agr Univ, Inst Subtrop Anim Nutr & Feed, Natl Engn Res Ctr Breeding Swine Ind, Coll Anim Sci,Guangdong Prov Key Lab Anim Nutr Con, Guangzhou 510642, Peoples R China; [Zhou, Tong] Guangzhou Pucheng Biol Technol Co, Guangzhou 511300, Peoples R China; [Liang, Xide; Li, Facai] Baolingbao Biol Co Ltd, Dezhou 251200, Peoples R China",South China Agricultural University,"Deng, JP; Tan, CQ (corresponding author), South China Agr Univ, Inst Subtrop Anim Nutr & Feed, Natl Engn Res Ctr Breeding Swine Ind, Coll Anim Sci,Guangdong Prov Key Lab Anim Nutr Con, Guangzhou 510642, Peoples R China.",dengjinping@scau.edu.cn; tanchengquan@scau.edu,,,"National Natural Science Foundation China [32172744, 32272895]",National Natural Science Foundation China(National Natural Science Foundation of China (NSFC)),The authors would like to thank the Guangzhou Pucheng Biological Technology Co. for animal management. This project was funded by National Natural Science Foundation China (32172744 or 32272895) .,,63,0,0,0,0,KEAI PUBLISHING LTD,BEIJING,"16 DONGHUANGCHENGGEN NORTH ST, Building 5, Room 411, BEIJING, DONGCHENG DISTRICT 100009, PEOPLES R CHINA",2405-6383,2405-6545,,ANIM NUTR,Anim. Nutr.,JUN,2024,17,,,,,,155,164,,10.1016/j.aninu.2024.04.002,http://dx.doi.org/10.1016/j.aninu.2024.04.002,,,10,"Agriculture, Dairy & Animal Science; Veterinary Sciences",Science Citation Index Expanded (SCI-EXPANDED),Agriculture; Veterinary Sciences,RV3O3,38774024,gold,,,2024-06-04,WOS:001230398300001,View Full Record in Web of Science
J,"SMITH, LJ; FRANCHETTI, B; MCCOULL, K; PATTISON, D; PICKSTOCK, J",,,,"SMITH, LJ; FRANCHETTI, B; MCCOULL, K; PATTISON, D; PICKSTOCK, J",,,A BEHAVIORAL-APPROACH TO RETRAINING BOWEL FUNCTION AFTER LONG-STANDING CONSTIPATION AND FECAL IMPACTION IN PEOPLE WITH LEARNING-DISABILITIES,DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY,,,English,Article,,,,,,,FECAL INCONTINENCE; DIETARY FIBER; ENCOPRESIS; CHILDREN; DEFECATION; ASSOCIATION; DISORDERS,"The authors describe a behavioural programme-involving prompted toilet-sitting after meals, rewards for appropriate evacuation and increased fibre-for four people with severe learning disabilities. Although treatment times were long, such training resulted in near-normal bowel function. While this behavioural approach does not ignore the biological aspects of the problem, soiling in intellectually disabled people should not be attributed to the handicapping condition alone. Training at an earlier age should be considered.","PRUDHOE HOSP,PRUDHOE,NORTHD,ENGLAND; NO COUNTIES SCH DEAF,NEWCASTLE TYNE,TYNE & WEAR,ENGLAND",,"SMITH, LJ (corresponding author), SANDERSON CTR,DEPT PSYCHOL,BRACKENFIELD RD,NEWCASTLE TYNE NE3 4OX,TYNE & WEAR,ENGLAND.",,,,,,,,51,12,12,0,3,CAMBRIDGE UNIV PRESS,NEW YORK,"40 WEST 20TH STREET, NEW YORK, NY 10011-4211",0012-1622,,,DEV MED CHILD NEUROL,Dev. Med. Child Neurol.,JAN,1994,36,1,,,,,41,49,,,,,,9,Clinical Neurology; Pediatrics,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Neurosciences & Neurology; Pediatrics,MR164,8132113,,,,2024-06-04,WOS:A1994MR16400006,View Full Record in Web of Science
J,"TREEM, WR; HYAMS, JS; BLANKSCHEN, E; ETIENNE, N; PAULE, CL; BORSCHEL, MW",,,,"TREEM, WR; HYAMS, JS; BLANKSCHEN, E; ETIENNE, N; PAULE, CL; BORSCHEL, MW",,,EVALUATION OF THE EFFECT OF A FIBER-ENRICHED FORMULA ON INFANT COLIC,JOURNAL OF PEDIATRICS,,,English,Article,,,,,,,IRRITABLE-BOWEL SYNDROME; DOUBLE-BLIND CROSSOVER; CHAIN FATTY-ACIDS; DIETARY FIBER; CONTROLLED TRIAL; COLON SYNDROME; TRANSIT-TIME; WHEAT FIBER; CONSTIPATION; HYDROGEN,"Because infants with colic appear to have abdominal pain similar to that of adults with irritable bowel syndrome, who may benefit from the addition of fiber to their diet, we tested whether fiber added to infant formula would alleviate colic. Twenty-seven normal, term infants (aged 2 to 8 weeks; 14 girls) with colic, defined as crying plus fussing for more than 3 hours a day for at least 3 days of a 6-day baseline period, were enrolled. Infants were randomly assigned in 9-day periods to a sequence of placebo (Isomil formula) followed by fiber-supplemented formula (Isomil plus soy polysaccharide) (n = 12) or the reverse (n = 15). Daily diaries of crying, fussing, sleeping, formula, intake, and stooling were kept. Twenty-two infants completed three lactulose breath hydrogen tests at the end of the baseline period and after each study period. The crossover trial was followed by 30 to 35 days of use of the study formula chosen by the parents as most beneficial but unknown to the investigators. Growth was monitored throughout. Serum cholesterol, calcium, phosphate, albumin, iron, and zinc concentrations were measured at the conclusion. There were no significant differences in average daily time spent by the infants in fussing and crying during ingestion of the fiber-supplemented formula. However, parents of 18 of 27 infants chose fiber-supplemented formula as most beneficial in ameliorating symptoms of colic. While the infants were consuming fiber-supplemented formula, stool frequency increased, and breath hydrogen excretion increased significantly, in response to lactulose. Growth and serum biochemical measurements were normal in all infants. Supplementation of infant formula with the level of soy polysaccharide used in this study may have reduced crying and fussing in some infants but did not affect colicky behavior in the majority of infants, who continued to cry and fuss excessively.","UNIV CONNECTICUT, SCH MED, DEPT PEDIAT, FARMINGTON, CT 06032 USA; ROSS LABS, PEDIAT NUTR RES, COLUMBUS, OH USA",University of Connecticut,"HARTFORD HOSP, DIV PEDIAT GASTROENTEROL & NUTR, 80 SEYMOUR ST, HARTFORD, CT 06115 USA.",,,,,,,,33,31,37,0,4,MOSBY-ELSEVIER,NEW YORK,"360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA",0022-3476,1097-6833,,J PEDIATR-US,J. Pediatr.,NOV,1991,119,5,,,,,695,701,,10.1016/S0022-3476(05)80282-3,http://dx.doi.org/10.1016/S0022-3476(05)80282-3,,,7,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,GN296,1658281,,,,2024-06-04,WOS:A1991GN29600002,View Full Record in Web of Science
J,"Di Nardo, G; Barbara, G; Borrelli, O; Cremon, C; Giorgio, V; Greco, L; La Pietra, M; Marasco, G; Pensabene, L; Piccirillo, M; Romano, C; Salvatore, S; Saviano, M; Stanghellini, V; Strisciuglio, C; Tambucci, R; Turco, R; Zenzeri, L; Staiano, A",,,,"Di Nardo, Giovanni; Barbara, Giovanni; Borrelli, Osvaldo; Cremon, Cesare; Giorgio, Valentina; Greco, Luigi; La Pietra, Michele; Marasco, Giovanni; Pensabene, Licia; Piccirillo, Marisa; Romano, Claudio; Salvatore, Silvia; Saviano, Michele; Stanghellini, Vincenzo; Strisciuglio, Caterina; Tambucci, Renato; Turco, Rossella; Zenzeri, Letizia; Staiano, Annamaria",,,Italian guidelines for the management of irritable bowel syndrome in children and adolescents,ITALIAN JOURNAL OF PEDIATRICS,,,English,Review,,,,,,Irritable bowel syndrome; Children; Functional gastrointestinal disorders; Constipation; Diarrhea; Chronic abdominal pain,FUNCTIONAL GASTROINTESTINAL DISORDERS; RECURRENT ABDOMINAL-PAIN; ROME III CRITERIA; PEDIATRIC GASTROENTEROLOGY HEPATOLOGY; INTESTINAL BACTERIAL OVERGROWTH; ENDOSCOPY EUROPEAN-SOCIETY; PLACEBO-CONTROLLED TRIAL; LOW FODMAP DIET; DOUBLE-BLIND; CELIAC-DISEASE,"The irritable bowel syndrome (IBS) is a functional gastrointestinal disorder (FGID), whose prevalence has widely increased in pediatric population during the past two decades. The exact pathophysiological mechanism underlying IBS is still uncertain, thus resulting in challenging diagnosis and management. Experts from 4 Italian Societies participated in a Delphi consensus, searching medical literature and voting process on 22 statements on both diagnosis and management of IBS in children. Recommendations and levels of evidence were evaluated according to the grading of recommendations, assessment, development, and evaluation (GRADE) criteria. Consensus was reached for all statements. These guidelines suggest a positive diagnostic strategy within a symptom-based approach, comprehensive of psychological comorbidities assessment, alarm signs and symptoms' exclusion, testing for celiac disease and, under specific circumstances, fecal calprotectin and C-reactive protein. Consensus also suggests to rule out constipation in case of therapeutic failure. Conversely, routine stool testing for enteric pathogens, testing for food allergy/intolerance or small intestinal bacterial overgrowth are not recommended. Colonoscopy is recommended only in patients with alarm features. Regarding treatment, the consensus strongly suggests a dietary approach, psychologically directed therapies and, in specific conditions, gut-brain neuromodulators, under specialist supervision. Conditional recommendation was provided for both probiotics and specific fibers supplementation. Polyethylene glycol achieved consensus recommendation for specific subtypes of IBS. Secretagogues and 5-HT4 agonists are not recommended in children with IBS-C. Certain complementary alternative therapies, antispasmodics and, in specific IBS subtypes, loperamide and rifaximin could be considered.","[Di Nardo, Giovanni; Piccirillo, Marisa; Zenzeri, Letizia] Sapienza Univ Rome, St Andrea Univ Hosp, Fac Med & Psychol, Pediat Unit,Dept Neurosci Mental Hlth & Sensory Or, Rome, Italy; [Barbara, Giovanni; Cremon, Cesare; Marasco, Giovanni; Stanghellini, Vincenzo] IRCCS Azienda Osped Univ Bologna, I-40126 Bologna, Italy; [Barbara, Giovanni; Cremon, Cesare; Marasco, Giovanni; Stanghellini, Vincenzo] Univ Bologna, Dept Med & Surg Sci, I-40126 Bologna, Italy; [Borrelli, Osvaldo] Great Ormond St Hosp Sick Children, Gastroenterol Dept, Neurogastroenterol & Motil Unit, London, England; [Giorgio, Valentina] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Dept Woman & Child Hlth & Publ Hlth, Rome, Italy; [Greco, Luigi] Heath Care Agcy Bergamo, Bergamo, Italy; [La Pietra, Michele; Saviano, Michele] Heath Care Agcy Naples, Naples, Italy; [Pensabene, Licia] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Pediat Unit, Catanzaro, Italy; [Romano, Claudio] Univ Messina, Dept Human Pathol Adulthood & Childhood G Barresi, Pediat Gastroenterol & Cyst Fibrosis Unit, Messina, Italy; [Salvatore, Silvia] Univ Insubria, F Del Ponte Hosp, Pediat Dept, Varese, Italy; [Strisciuglio, Caterina] Univ Campania Luigi Vanvitelli, Dept Woman Child Gen & Specialized Surg, Naples, Italy; [Tambucci, Renato] Bambino Gesu Pediat Hosp, Digest Endoscopy & Surg Unit, IRCCS, Rome, Italy; [Turco, Rossella] Santobono Pausilipon Childrens Hosp, Dept Pediat, Naples, Italy; [Staiano, Annamaria] Univ Federico II, Dept Translat Med Sci, Sect Pediat, Via S Pansini 5, I-80131 Naples, Italy",Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Magna Graecia University of Catanzaro; University of Messina; University of Insubria; Universita della Campania Vanvitelli; IRCCS Bambino Gesu; University of Naples Federico II,"Staiano, A (corresponding author), Univ Federico II, Dept Translat Med Sci, Sect Pediat, Via S Pansini 5, I-80131 Naples, Italy.",Annamaria.staiano@unina.it,"zenzeri, letizia/AAA-8190-2019","zenzeri, letizia/0000-0001-5220-680X; Piccirillo, Marisa/0009-0001-4903-8718",,,,,190,0,0,1,1,BMC,LONDON,"CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND",1720-8424,1824-7288,,ITAL J PEDIATR,Ital. J. Pediatr.,MAR 14,2024,50,1,,,,,,,51,10.1186/s13052-024-01607-y,http://dx.doi.org/10.1186/s13052-024-01607-y,,,23,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,LG3G1,38486305,gold,,,2024-06-04,WOS:001185584200001,View Full Record in Web of Science
J,"McEligot, AJ; Gilpin, EA; Rock, CL; Newman, V; Hollenbach, KA; Thomson, CA; Pierce, JP",,,,"McEligot, AJ; Gilpin, EA; Rock, CL; Newman, V; Hollenbach, KA; Thomson, CA; Pierce, JP",,,High dietary fiber consumption is not associated with gastrointestinal discomfort in a diet intervention trial,JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION,,,English,Article,,,,,,,BREAST-CANCER RECURRENCE; HIGH-VEGETABLE DIET; INTESTINAL TRANSIT; WHEAT BRAN; CONSTIPATION; CAROTENOIDS; WOMEN; STOOL,,"Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 93093 USA; Univ Calif Irvine, Dept Med, Div Epidemiol, Irvine, CA 92717 USA; Univ Calif San Diego, Ctr Canc, La Jolla, CA 93093 USA; Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA",University of California System; University of California San Diego; University of California System; University of California Irvine; University of California System; University of California San Diego; Arizona Center Cancer Care; University of Arizona,"Pierce, JP (corresponding author), Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 93093 USA.",,,"Pierce, John/0000-0002-0075-7471","NCI NIH HHS [R01-CA69375, P01-CA72092] Funding Source: Medline",NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)),,,17,11,12,0,3,AMER DIETETIC ASSOC,CHICAGO,"216 W JACKSON BLVD #800, CHICAGO, IL 60606-6995 USA",0002-8223,,,J AM DIET ASSOC,J. Am. Diet. Assoc.,APR,2002,102,4,,,,,549,551,,10.1016/S0002-8223(02)90127-6,http://dx.doi.org/10.1016/S0002-8223(02)90127-6,,,3,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,538YU,11985415,,,,2024-06-04,WOS:000174843300026,View Full Record in Web of Science
J,"Ternent, CA; Amir, LB; Morin, NA; Ellis, CN; Hyman, NH; Buie, WD",,,,"Ternent, Charles A.; Amir, L. Bastawrous; Morin, Nancy A.; Ellis, C. Neal; Hyman, Neil H.; Buie, W. Donald",,Stand Practice Task Force Amer,Practice parameters for the evaluation and management of constipation,DISEASES OF THE COLON & RECTUM,,,English,Article,,,,,,,TRANSANAL RECTAL RESECTION; SLOW-TRANSIT CONSTIPATION; PELVIC FLOOR DYSSYNERGIA; BALLOON EXPULSION TEST; RECTOCELE REPAIR; SURGICAL-TREATMENT; LONG-TERM; OUTLET OBSTRUCTION; COLONIC TRANSIT; DIETARY FIBER,,"[Ternent, Charles A.; Amir, L. Bastawrous; Morin, Nancy A.; Ellis, C. Neal; Hyman, Neil H.; Buie, W. Donald] Fletcher Allen Hlth Care, Burlington, VT 05401 USA",University of Vermont Medical Center,"Hyman, NH (corresponding author), Fletcher Allen Hlth Care, 111 Colchester Ave,Fletcher 301, Burlington, VT 05401 USA.",,,,,,,,99,52,62,0,10,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0012-3706,1530-0358,,DIS COLON RECTUM,Dis. Colon Rectum,DEC,2007,50,12,,,,,2013,2022,,10.1007/s10350-007-9000-y,http://dx.doi.org/10.1007/s10350-007-9000-y,,,10,Gastroenterology & Hepatology; Surgery,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Surgery,241FG,17665250,,,,2024-06-04,WOS:000251641700001,View Full Record in Web of Science
J,"Nagasawa, H; Ueda, S; Otsuka, T; Kaifu, K; Ono, S; Okuma, T; Kobayashi, T; Matsushita, S; Kasai, T; Dohi, T; Fukushima, Y; Amano, A; Suzuki, Y",,,,"Nagasawa, Hajime; Ueda, Seiji; Otsuka, Tomoyuki; Kaifu, Kumiko; Ono, Shigeo; Okuma, Teruyuki; Kobayashi, Takashi; Matsushita, Satoshi; Kasai, Takatoshi; Dohi, Tomotaka; Fukushima, Yoshifumi; Amano, Atsushi; Suzuki, Yusuke",,,Safety and efficacy of using cereal food (Frugra®) to improve blood pressure and bowel health in patients undergoing chronic hemodialysis: A pilot study,JOURNAL OF PHARMACOLOGICAL SCIENCES,,,English,Article,,,,,,Bowel health; Cereal food; Hemodialysis; Hypertension; Indoxyl sulfate,CLINICAL-PRACTICE GUIDELINES; INDOXYL SULFATE; DIETARY FIBER; DIALYSIS; DISEASE; ACCUMULATION; PROGRESSION; GLUCAN,"Hypertension and constipation are major hemodialysis complications. Salt restriction is one of the most important nonpharmacological interventions in managing hypertension. In patients undergoing hemodialysis, nonpharmacological strategies to manage constipation are extremely difficult to develop owing to the presence of excess dietary potassium and fluids. Frugra (R), which is a cereal food that has a low salt content of 0.5 g per serving, may help reduce salt intake. Additionally, Frugra is rich in dietary fiber, thereby beneficial for such patients. In this study, we evaluated the safety and efficacy of Frugra in patients undergoing hemodialysis, focusing mainly on blood pressure and bowel health by changing the usual breakfast meal to Frugra for 8 weeks. We enrolled 11 patients undergoing hemodialysis. Despite the absence of changes in the patients' dry weight levels, their systolic blood pressure levels decreased from 155.5 +/- 20.9 mmHg to 137.9 +/- 10.3 mmHg after 2 months (P < 0.05). All participants reported improvements in bowel movement, and the levels of indoxyl sulfate, a representative gut-derived uremic toxin, were decreased from 49.3 mu g/ml to 33.4 mu g/ml. Furthermore, adverse events including electrolyte abnormalities were not observed. Therefore, Frugra may be useful to manage the health of patients undergoing hemodialysis. (C) 2021 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.","[Nagasawa, Hajime; Ueda, Seiji; Otsuka, Tomoyuki; Okuma, Teruyuki; Kobayashi, Takashi; Suzuki, Yusuke] Juntendo Univ, Dept Nephrol, Fac Med, Tokyo, Japan; [Nagasawa, Hajime; Ueda, Seiji; Otsuka, Tomoyuki; Okuma, Teruyuki; Kobayashi, Takashi; Matsushita, Satoshi; Kasai, Takatoshi; Dohi, Tomotaka; Fukushima, Yoshifumi; Amano, Atsushi] Juntendo Univ, Dept Granola Hlth Care & Prevent Med, Fac Med, Tokyo, Japan; [Kaifu, Kumiko; Ono, Shigeo] Kaifu Clin, Takamatsu, Kagawa, Japan; [Matsushita, Satoshi; Amano, Atsushi] Juntendo Univ, Dept Cardiovasc Surg, Fac Med, Tokyo, Japan; [Kasai, Takatoshi; Dohi, Tomotaka; Fukushima, Yoshifumi] Juntendo Univ, Fac Med, Dept Cardiovasc Biol & Med, Tokyo, Japan",Juntendo University; Juntendo University; Juntendo University; Juntendo University,"Ueda, S (corresponding author), Juntendo Univ, Fac Med, Dept Nephrol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.",se-ueda@juntendo.ac.jp,"Dohi, Tomotaka/ABH-3047-2021; 葛西, 隆敏/HJY-9104-2023","Dohi, Tomotaka/0000-0002-6646-468X;","Calbee Inc., Ltd. Tokyo, Japan; Juntendo University","Calbee Inc., Ltd. Tokyo, Japan; Juntendo University","The study was financially supported by Calbee Inc., Ltd. Tokyo, Japan and Juntendo University.",,24,1,1,0,3,JAPANESE PHARMACOLOGICAL SOC,KYOTO,"EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN",1347-8613,1347-8648,,J PHARMACOL SCI,J. Pharmacol. Sci.,SEP,2021,147,1,,,,,132,137,,10.1016/j.jphs.2021.06.007,http://dx.doi.org/10.1016/j.jphs.2021.06.007,,JUN 2021,6,Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy,TL2EP,34294364,gold,,,2024-06-04,WOS:000674666800018,View Full Record in Web of Science
J,"Leung, JSM",,,,"Leung, John S. M.",,,Streptococcus gallolyticus endocarditis-an uncommon but serious complication of constipation management,HONG KONG MEDICAL JOURNAL,,,English,Letter,,,,,,,DIETARY FIBER,,"[Leung, John S. M.] St Pauls Hosp, Dept Cardiothorac Surg, Causeway Bay, Hong Kong, Peoples R China",Hong Kong St. Paul's Hospital,"Leung, JSM (corresponding author), St Pauls Hosp, Dept Cardiothorac Surg, Causeway Bay, Hong Kong, Peoples R China.",leungsiumanjohn@yahoo.com.hk,"Leung, John Siu Man/HLH-0577-2023","Leung, John Siu Man/0000-0001-9283-2733",,,,,5,2,2,0,0,HONG KONG ACAD MEDICINE PRESS,HONG KONG,"9/F/, ROOM 901, 99 WONG CHUK HANG RD, ABERDEEN, HONG KONG, 00000, PEOPLES R CHINA",1024-2708,,,HONG KONG MED J,Hong Kong Med. J.,JUN,2019,25,3,,,,,257,257,,10.12809/hkmj197978,http://dx.doi.org/10.12809/hkmj197978,,,1,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,IE6UR,31182677,"gold, Green Submitted",,,2024-06-04,WOS:000472511700017,View Full Record in Web of Science
J,"Shaikh, OA; Shaikh, G; Aftab, RM; Baktashi, H; Ullah, I; Asghar, MS",,,,"Shaikh, Omer Ahmed; Shaikh, Gulrukh; Aftab, Rameel Muhammad; Baktashi, Haisum; Ullah, Irfan; Asghar, Muhammad Sohaib",,,Unconventional but effective: breaking through IBS-D clinical practice guidelines - correspondence,ANNALS OF MEDICINE AND SURGERY,,,English,Letter,,,,,,constipation; diarrhea; dyspepsia; gastroenterology; IBS,IRRITABLE-BOWEL-SYNDROME; PHARMACOLOGICAL MANAGEMENT; DIAGNOSIS,"Irritable Bowel Syndrome (IBS) is a chronic, one of the commonest and persistent gastrointestinal (GI) disorder. Previously, the management plan for IBS-D included enhancing awareness; first line treatment included an increased dietary fiber intake, opioids for diarrhea and antispasmodics for pain management. A recent treatment guideline by the American Gastroenterology Association (AGA) suggests a modified approach to treating patients with IBS-D. Eight drug recommendations were made, and a set of instructions on when to employ which medication was devised. With the incorporation of these structured guidelines, a more tailored and focused approach to IBS management may become plausible.","[Shaikh, Omer Ahmed; Aftab, Rameel Muhammad] Ziauddin Univ, Dept Med, Karachi, Pakistan; [Shaikh, Gulrukh; Baktashi, Haisum] Liaquat Natl Hosp, Med Coll, Dept Med, Karachi, Pakistan; [Ullah, Irfan] Gandhara Univ, Kabir Med Coll, Peshawar, Pakistan; [Asghar, Muhammad Sohaib] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA; [Asghar, Muhammad Sohaib] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55905 USA",Ziauddin University; Mayo Clinic; Mayo Clinic,"Asghar, MS (corresponding author), Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55905 USA.",omerahmedshaikh@gmail.com; gulrukhshaikh@gmail.com; rameel.aftab@gmail.com; haisumbaktashi@yahoo.com; irfanullahecp2@gmail.com; sohaib_asghar123@yahoo.com,"Ullah, Irfan/X-2858-2019; Asghar, Muhammad Sohaib/ABB-7824-2020","Ullah, Irfan/0000-0003-1100-101X; Asghar, Muhammad Sohaib/0000-0001-6705-2030; Shaikh, Omer Ahmed/0000-0002-2504-390X",,,,,7,0,0,0,2,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",2049-0801,,,ANN MED SURG,Ann. Med. Surg.,APR,2023,85,4,,,,,1312,1313,,10.1097/MS9.0000000000000338,http://dx.doi.org/10.1097/MS9.0000000000000338,,,2,"Medicine, General & Internal",Emerging Sources Citation Index (ESCI),General & Internal Medicine,J5PN2,37113818,"gold, Green Published",,,2024-06-04,WOS:001010136900145,View Full Record in Web of Science
J,"Swennen, K; Courtin, CM; Delcour, JA",,,,"Swennen, Katrien; Courtin, Christophe M.; Delcour, Jan A.",,,Non-digestible oligosaccharides with prebiotic properties,CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION,,,English,Review,,,,,,non-digestible oligosaccharides; prebiotics; dietary fiber; production; characterization; health,ANION-EXCHANGE CHROMATOGRAPHY; FUNCTIONAL FOOD CONCEPT; XYLO-OLIGOSACCHARIDES; MASS-SPECTROMETRY; STRUCTURAL-CHARACTERIZATION; DIETARY OLIGOSACCHARIDES; INTESTINAL MICROFLORA; H-1-NMR SPECTROSCOPY; ENZYMATIC PRODUCTION; MOLECULAR-WEIGHT,"The search for functional foods or functional food ingredients, i.e. foods or food ingredients that can enhance health, is beyond any doubt one of the leading trends in today's food industry. In this context, probiotics, i.e. living microbial food supplements, and prebiotics, i.e. non-digestible food ingredients, receive much attention. Both popular concepts target the gastrointestinal microbiota. While in the Western world, intake of probiotics has been recommended for long, prebiotics in general, and non-digestible oligosaccharides in particular, have only recently received attention. This review deals with production and characterization of non-digestible oligosaccharides and focuses on their role in promoting health and treating diseases. Attention is paid to the effects of non- digestible oligosaccharides on constipation, mineral absorption, lipid metabolism, cancer prevention, hepatic encephalopathy, glycemia/insulinemia, and immunomodulation.","Katholieke Univ Leuven, Food Chem Lab, B-3001 Louvain, Belgium",KU Leuven,"Swennen, K (corresponding author), Kasteelpk Arenberg 20, B-3001 Louvain, Belgium.",katrien.swennen@agr.kuleuven.ac.be,"DELCOUR, Jan A/P-4182-2017; Courtin, Christophe M/Q-1916-2016","DELCOUR, Jan A/0000-0003-2954-1022; Courtin, Christophe M/0000-0002-1203-9063",,,,,196,246,282,4,145,TAYLOR & FRANCIS INC,PHILADELPHIA,"530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA",1040-8398,1549-7852,,CRIT REV FOOD SCI,Crit. Rev. Food Sci. Nutr.,SEP,2006,46,6,,,,,459,471,,10.1080/10408390500215746,http://dx.doi.org/10.1080/10408390500215746,,,13,Food Science & Technology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Nutrition & Dietetics,073XS,16864139,,,,2024-06-04,WOS:000239776600002,View Full Record in Web of Science
J,"Kalantar-Zadeh, K; Joshi, S; Schlueter, R; Cooke, J; Brown-Tortorici, A; Donnelly, M; Schulman, S; Lau, WL; Rhee, CM; Streja, E; Tantisattamo, E; Ferrey, AJ; Hanna, R; Chen, JLT; Malik, S; Nguyen, DV; Crowley, ST; Kovesdy, CP",,,,"Kalantar-Zadeh, Kamyar; Joshi, Shivam; Schlueter, Rebecca; Cooke, Joanne; Brown-Tortorici, Amanda; Donnelly, Meghan; Schulman, Sherry; Lau, Wei-Ling; Rhee, Connie M.; Streja, Elani; Tantisattamo, Ekamol; Ferrey, Antoney J.; Hanna, Ramy; Chen, Joline L. T.; Malik, Shaista; Nguyen, Danh, V; Crowley, Susan T.; Kovesdy, Csaba P.",,,Plant-Dominant Low-Protein Diet for Conservative Management of Chronic Kidney Disease,NUTRIENTS,,,English,Review,,,,,,plant-dominant; low-protein; dietary protein intake; glomerular hyperfiltration,CHRONIC-RENAL-FAILURE; MALNUTRITION-INFLAMMATION SCORE; GUT BACTERIAL TRANSLOCATION; NEAR-INFRARED INTERACTANCE; SIZED POLYETHYLENE-GLYCOLS; ALL-CAUSE MORTALITY; QUALITY-OF-LIFE; LEAN BODY-MASS; HEMODIALYSIS-PATIENTS; SYSTEMIC INFLAMMATION,"Chronic kidney disease (CKD) affects >10% of the adult population. Each year, approximately 120,000 Americans develop end-stage kidney disease and initiate dialysis, which is costly and associated with functional impairments, worse health-related quality of life, and high early-mortality rates, exceeding 20% in the first year. Recent declarations by the World Kidney Day and the U.S. Government Executive Order seek to implement strategies that reduce the burden of kidney failure by slowing CKD progression and controlling uremia without dialysis. Pragmatic dietary interventions may have a role in improving CKD outcomes and preventing or delaying dialysis initiation. Evidence suggests that a patient-centered plant-dominant low-protein diet (PLADO) of 0.6-0.8 g/kg/day composed of >50% plant-based sources, administered by dietitians trained in non-dialysis CKD care, is promising and consistent with the precision nutrition. The scientific premise of the PLADO stems from the observations that high protein diets with high meat intake not only result in higher cardiovascular disease risk but also higher CKD incidence and faster CKD progression due to increased intraglomerular pressure and glomerular hyperfiltration. Meat intake increases production of nitrogenous end-products, worsens uremia, and may increase the risk of constipation with resulting hyperkalemia from the typical low fiber intake. A plant-dominant, fiber-rich, low-protein diet may lead to favorable alterations in the gut microbiome, which can modulate uremic toxin generation and slow CKD progression, along with reducing cardiovascular risk. PLADO is a heart-healthy, safe, flexible, and feasible diet that could be the centerpiece of a conservative and preservative CKD-management strategy that challenges the prevailing dialysis-centered paradigm.","[Kalantar-Zadeh, Kamyar; Brown-Tortorici, Amanda; Lau, Wei-Ling; Rhee, Connie M.; Streja, Elani; Tantisattamo, Ekamol; Ferrey, Antoney J.; Hanna, Ramy; Nguyen, Danh, V] Univ Calif Irvine UCI, Dept Med, Div Nephrol Hypertens & Kidney Transplantat, Orange, CA 90286 USA; [Kalantar-Zadeh, Kamyar; Streja, Elani; Chen, Joline L. T.] Tibor Rubin VA Long Beach Healthcare Syst, Long Beach, CA 90822 USA; [Joshi, Shivam] NYU, Dept Med, Grossman Sch Med, New York, NY 10016 USA; [Schlueter, Rebecca] Lexington VA Healthcare Syst, Lexington, KY 40502 USA; [Cooke, Joanne] Kansas City VA Med Ctr, Kansas City, MO 64128 USA; [Donnelly, Meghan] Flavis Dr Schar USA Inc, Lyndhurst, NJ 07071 USA; [Schulman, Sherry; Malik, Shaista] UCI Hlth Susan Samueli Ctr, Integrat Hlth Inst, Irvine, CA 92626 USA; [Crowley, Susan T.] VA Connecticut Healthcare Syst, West Haven, CT 06516 USA; [Crowley, Susan T.] Yale Univ, Div Nephrol, Sch Med, New Haven, CT 06516 USA; [Kovesdy, Csaba P.] Univ Tennessee, Div Nephrol, Hlth Sci Ctr, Memphis, TN 38163 USA",University of California System; University of California Irvine; New York University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; University of Tennessee System; University of Tennessee Health Science Center,"Kalantar-Zadeh, K (corresponding author), Univ Calif Irvine UCI, Dept Med, Div Nephrol Hypertens & Kidney Transplantat, Orange, CA 90286 USA.;Kalantar-Zadeh, K (corresponding author), Tibor Rubin VA Long Beach Healthcare Syst, Long Beach, CA 90822 USA.",kkz@uci.edu; shivam.joshi@nyulangone.org; rebecca.schlueter@va.gov; Joanne.Cooke@va.gov; amandab@uci.edu; meghan.donnelly@drschar.com; sschulm1@hs.uci.edu; wllau@uci.edu; crhee1@uci.edu; estreja@uci.edu; etantisa@hs.uci.edu; ferreya@uci.edu; ramyh1@uci.edu; jolinec@uci.edu; smalik@hs.uci.edu; danhvn1@uci.edu; Susan.Crowley@va.gov; ckovesdy@uthsc.edu,"Kalantar-Zadeh, Kamyar/Q-4734-2018","Kalantar-Zadeh, Kamyar/0000-0002-8666-0725; Tantisattamo, Ekamol/0000-0003-0883-6892; Malik, Shaista/0000-0001-7580-8491","National Institutes of Health, National Institute of Diabetes, Digestive and Kidney Disease [K24-DK091419]","National Institutes of Health, National Institute of Diabetes, Digestive and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))","This work was partially supported by KKZ's research grants from the National Institutes of Health, National Institute of Diabetes, Digestive and Kidney Disease grant K24-DK091419.",,150,123,127,7,90,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,JUL,2020,12,7,,,,,,,1931,10.3390/nu12071931,http://dx.doi.org/10.3390/nu12071931,,,25,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,MV4VD,32610641,"Green Published, gold",Y,N,2024-06-04,WOS:000556356800001,View Full Record in Web of Science
J,"Sielezneff, I; Antoine, K; Lécuyer, J; Saisse, J; Thirion, X; Sarles, JC; Sastre, B",,,,"Sielezneff, I; Antoine, K; Lécuyer, J; Saisse, J; Thirion, X; Sarles, JC; Sastre, B",,,There a relationship between eating habits and hemorrhoids?,PRESSE MEDICALE,,,French,Article,,,,,,,PORTAL-HYPERTENSION; ANORECTAL VARICES; PATHOGENESIS; CONSTIPATION; CHILDREN,"OBJECTIVES: it is empirically accepted that certain foods play a role in the pathogenesis of hemorrhoids or their acute exacerbation. The aim of this work was to determine whether there is a relationship between hemorrhoids and certain food-related or common toxin-related factors. PATIENTS AND METHODS: Two groups of 50 subjects were compared, Group I was composed of 50 patients with hemorrhoid symptoms. Fifty volunteers with no proctologic abnormality were included in group II. We used a diet survey to compare total calorie, protein, carbohydrate, fat, food fiber, water, alcohol, salt, pepper, pimento, tea, and coffee intake was well as smoking habits. Episodes of constipation were also noted. RESULTS: Overall calorie intake, as well as protein, carbohydrate and fiber intake were similar in the two groups as were use of salt coffee and tea. Dietary intake in group I was higher for fat (p = 0.02), alcohol (p = 0.01), pepper (p = 0.04, and pimento (p = 0.001). Subjects in group I drank less water (p = 0.008), smoked more (p = 0.01) and were more often constipated (p < 0.001) than those in group II. CONCLUSION: Our findings provide further arguments suggesting that dietary imbalance or smoking could be involved in the development of hemorrhoids. These factors should be evaluated in appropriate dietary inquires. Epidemiological surveys would be required to confirm their possible causal effect.","Hop St Marguerite, Serv Chirurg Digest, F-13274 Marseille 9, France; Hop St Marguerite, Dept Med Informat, Marseille, France",Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille,"Sielezneff, I (corresponding author), Hop St Marguerite, Serv Chirurg Digest, 270 Blvd St Marguerite,BP 29, F-13274 Marseille 9, France.",bsastre@aphm1.ap-hm.fr,,,,,,,36,18,20,0,3,MASSON EDITEUR,PARIS 06,"120 BLVD SAINT-GERMAIN, 75280 PARIS 06, FRANCE",0755-4982,,,PRESSE MED,Presse Med.,MAR 21,1998,27,11,,,,,513,517,,,,,,5,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,ZD809,9767961,,,,2024-06-04,WOS:000072726600002,View Full Record in Web of Science
J,"Schiller, LR",,,,"Schiller, LR",,,Clinical pharmacology and use of laxatives and lavage solutions,JOURNAL OF CLINICAL GASTROENTEROLOGY,,,English,Review,,,,,,laxatives; cathartics; lavage solutions; constipation; toxic ingestions,DIOCTYL SODIUM SULFOSUCCINATE; MELANOSIS-COLI; BOWEL PREPARATION; POLYETHYLENE-GLYCOL; CLEANSING METHODS; RICINOLEIC ACID; HUMAN INTESTINE; MOTOR-ACTIVITY; DIETARY FIBER; BARIUM ENEMA,"Laxatives and lavage solutions are used in the treatment of constipation and toxic ingestion and also for preparation of the colon before endoscopic or surgical procedures. Several differ ent categories of agents are available for use. These include bulking agents, osmotic agents, secretagogues and agents with direct effects on epithelial nerve or smooth muscle cells, and lubricating agents. Each category has different pharmacologic effects, side effects, and clinical indications. This review summarizes current information about these agents.","Baylor Univ, Med Ctr, Dallas, TX 75246 USA",Baylor University Medical Center; Baylor University,"Schiller, LR (corresponding author), Baylor Univ, Med Ctr, 3500 Gaston Ave, Dallas, TX 75246 USA.",,,,,,,,82,28,29,0,2,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0192-0790,1539-2031,,J CLIN GASTROENTEROL,J. Clin. Gastroenterol.,JAN,1999,28,1,,,,,11,18,,10.1097/00004836-199901000-00003,http://dx.doi.org/10.1097/00004836-199901000-00003,,,8,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,153AD,9916658,,,,2024-06-04,WOS:000077809800003,View Full Record in Web of Science
J,"Aichbichler, BW; Wenzl, HH; Santa Ana, CA; Porter, JL; Schiller, LR; Fordtran, JS",,,,"Aichbichler, BW; Wenzl, HH; Santa Ana, CA; Porter, JL; Schiller, LR; Fordtran, JS",,,A comparison of stool characteristics from normal and constipated people,DIGESTIVE DISEASES AND SCIENCES,,,English,Article,,,,,,constipation; stool weight; stool solids; stool consistency; stool hardness; stool form; straining with bowel movement,CHRONIC IDIOPATHIC CONSTIPATION; FECAL BILE-ACIDS; BOWEL FUNCTION; DIETARY FIBER; HEALTHY-SUBJECTS; WHEAT BRAN; GASTROINTESTINAL TRANSIT; NEUTRAL STEROLS; SERUM-LIPIDS; PSYLLIUM,"In people with constipation, it is not known if decreased frequency of defecation is associated with abnormalities in the weight or in the consistency of stools or if the weight or the consistency of stools correlates with the severity of various discomforts associated with bowel movements. In neither normal nor constipated subjects has the consistency of stools been carefully correlated with their relative contents of water and solids. Our aim was to gain insight into these questions. Twenty subjects with idiopathic chronic constipation and 20 age-and sex-matched control subjects were recruited by advertisement. Stools were collected for one week. After each bowel movement, the subject's perception of various discomforts associated with the bowel movement were recorded. The stools were then analyzed. The results and conclusions were as follows: (1) Stool weight per bowel movement was similar in the two groups but stool weight per week was markedly reduced in constipated subjects. (2) Reduced stool weight per week in constipated subjects was due to a nearly proportional reduction in stool water and stool solids output. (3) Using data from both groups, there was a curvilinear correlation between percent insoluble stool solids and stool hardness, as measured by a texture analyzer; hardness increased only slightly as percent insoluble solids increased between 7 and 20%, but hardness increased dramatically when percent insoluble solids exceeded 25%. (4) Only 6% of stools from constipated subjects (2 of 34) had abnormally high values for percent stool solids and physical hardness. (5) In subjects with constipation, the severity of various discomforts associated with bowel movements (such as straining) correlated poorly with the weight or the hardness of stool that was produced by the bowel movement.","Baylor Univ, Med Ctr, Dept Internal Med, Dallas, TX 75246 USA",Baylor University; Baylor University Medical Center,"Baylor Univ, Med Ctr, Dept Internal Med, 2nd Floor Hobilitzelle,3500 Gaston Ave, Dallas, TX 75246 USA.",,,,NIDDK NIH HHS [5-R01-DK37172-05] Funding Source: Medline,NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)),,,42,32,34,2,11,SPRINGER,DORDRECHT,"VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS",0163-2116,1573-2568,,DIGEST DIS SCI,Dig. Dis. Sci.,NOV,1998,43,11,,,,,2353,2362,,10.1023/A:1026699525487,http://dx.doi.org/10.1023/A:1026699525487,,,10,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,140WD,9824119,,,,2024-06-04,WOS:000077111500001,View Full Record in Web of Science
J,"Klauser, AG; Voderholzer, WA; Schindlbeck, NE; MullerLissner, SA",,,,"Klauser, AG; Voderholzer, WA; Schindlbeck, NE; MullerLissner, SA",,,Functional diagnostic work-up in patients with irritable bowel syndrome,ZEITSCHRIFT FUR GASTROENTEROLOGIE,,,English,Article,,,,,,functional bowel disorder; Manning criteria; symptom score; discriminant analysis,CHRONIC CONSTIPATION; POSITIVE DIAGNOSIS; MOTILITY; DISEASE; SYMPTOMS,"The first aim of the study was to find a cause of symptoms in patients suffering from ''irritable bowel syndrome'' using diagnostic tests aimed a functional disorders of lower gut. A second aim was to test, whether the presence of irritable bowel syn drome (or, synonymously, absence of classic organic disease) can be predicted by specific symptoms. 134 consecutive patients (50 +/- 16 SD years, range 17 to 88, 94 women) presenting in our gastroenterological outpatient department with abdominal pain and altered bowel habits were included. A conventional diagnostic work-up aimed at classic organic diseases and, ii negative, a functional diagnostic work-up aimed at gastrointestinal malfunction such as dietary fibre trial, functional proctoscopy, defecography, colonic transit of radiopaque markers, anorectal manometry, and lactose tolerance test were done. A classic organic disease was found in only 15 of 134 patients by conventional diagnostic tests. Functional diagnostic work-up yielded a diagnosis in 70 of the remaining 119 patients that else would have been labeled to suffer from IBS (25 slow transit constipation, 20 disordered defecation, nine low fibre intake, and nine lactose intolerance among them). When symptoms were evaluated with a standardized questionnaire, ''constipation'' and the ''necessity of straining to open bowels'' were very specific for functional bowel disorder (92% and 100%), but sensitivity of both symptoms was only about 60%. The so-called ''Manning criteria'' had a very low prevalence in our sample and so were not discriminatory. Since in more than half of the patients with ''irritable bowel syndrome'' a specific diagnosis can be reached, functional tests should be considered in such patients. The symptom ''constipation'' in patients with-lower gut complaints predicted a functional disorder rather than a classic organic disease with a high specificity.",,,"Klauser, AG (corresponding author), UNIV MUNICH,KLINIKUM INNENSTADT,MED KLIN,DEPT GASTROENTEROL,ZIEMSSENSTR 1,D-80336 MUNICH,GERMANY.",,,,,,,,28,9,10,0,0,DEMETER VERLAG,BALINGEN,"AMMONITENSTRASSE 1, D-72336 BALINGEN, GERMANY",0044-2771,,,Z GASTROENTEROL,Z. Gastroent.,MAY,1996,34,5,,,,,273,278,,,,,,6,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,UN789,8686358,,,,2024-06-04,WOS:A1996UN78900002,View Full Record in Web of Science
J,"HAYAMA, S; AKAMATSU, R; KISHIMOTO, M; SUZUKI, M; NIGI, H",,,,"HAYAMA, S; AKAMATSU, R; KISHIMOTO, M; SUZUKI, M; NIGI, H",,,A CASE OF DIVERTICULAR-DISEASE OF THE COLON IN A JAPANESE MONKEY (MACACA-FUSCATA),PRIMATES,,,English,Note,,,,,,,,"Diverticular disease of the colon was detected in a female Japanese monkey by X-ray examination. The monkey was 15 years old and had been kept under captive conditions for nine years. Lack of appetite and activity, and constipation were observed. The monkey was given fiber-rich vegetables and wild plants, and its appetite and activity then improved. Based on a consideration of various factors, it is suggested that one possible cause of the diverticulosis in this case was a low dietary fiber intake.",,,"NIPPON VET & ZOOTECH COLL, DEPT WILD ANIM MED, MUSASHINO, TOKYO 180, JAPAN.",,,"HAYAMA, Shin-ichi/0000-0002-4882-7969",,,,,3,4,4,0,1,SPRINGER JAPAN KK,TOKYO,"SHIROYAMA TRUST TOWER 5F, 4-3-1 TORANOMON, MINATO-KU, TOKYO, 105-6005, JAPAN",0032-8332,1610-7365,,PRIMATES,Primates,JUL,1988,29,3,,,,,423,426,,10.1007/BF02380966,http://dx.doi.org/10.1007/BF02380966,,,4,Zoology,Science Citation Index Expanded (SCI-EXPANDED),Zoology,Q1282,,,,,2024-06-04,WOS:A1988Q128200014,View Full Record in Web of Science
J,"Andrade, DRM; Mendonça, MH; Helm, CV; Magalhaes, WLE; de Muniz, GIB; Kestur, SG",,,,"Mendes Andrade, Dayanne Regina; Mendonca, Marcia Helena; Helm, Cristiane Vieira; Magalhaes, Washington L. E.; Bonzon de Muniz, Graciela Ines; Kestur, Satyanarayana G.",,,Assessment of Nano Cellulose from Peach Palm Residue as Potential Food Additive: Part II: Preliminary Studies,JOURNAL OF FOOD SCIENCE AND TECHNOLOGY-MYSORE,,,English,Article,,,,,,Nano fibrils; Food-additive; Diet; Mice; Biochemical; Histology; Bactris gasipaes,FIBER; DIGESTIBILITY; DIETS; RATS,"High consumption of dietary fibers in the diet is related to the reduction of the risk of non-transmitting of chronic diseases, prevention of the constipation etc. Rich diets in dietary fibers promote beneficial effects for the metabolism. Considering the above and recognizing the multifaceted advantages of nano materials, there have been many attempts in recent times to use the nano materials in the food sector including as food additive. However, whenever new product for human and animal consumption is developed, it has to be tested for their effectiveness regarding improvement in the health of consumers, safety aspects and side effects. However, before it is tried with human beings, normally such materials would be assessed through biological tests on a living organism to understand its effect on health condition of the consumer. Accordingly, based on the authors' finding reported in a previous paper, this paper presents body weight, biochemical (glucose, cholesterol and lipid profile in blood, analysis of feces) and histological tests carried out with biomass based cellulose nano fibrils prepared by the authors for its possible use as food additive. Preliminary results of the study with mice have clearly brought out potential of these fibers for the said purpose.","[Mendes Andrade, Dayanne Regina; Mendonca, Marcia Helena] Univ Fed Parana, UFPR, BR-80060000 Curitiba, PR, Brazil; [Mendes Andrade, Dayanne Regina; Helm, Cristiane Vieira; Magalhaes, Washington L. E.; Kestur, Satyanarayana G.] Embrapa Forestry, BR-83411000 Colombo, PR, Brazil; [Bonzon de Muniz, Graciela Ines] Univ Fed Parana, DETF, UFPR, BR-80060000 Curitiba, PR, Brazil; [Kestur, Satyanarayana G.] Poornaprajna Inst Sci Res, PPISR, Bidalur Post, Devanahalli, Bangalore 562110, Karnataka, India",Universidade Federal do Parana; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal do Parana,"Kestur, SG (corresponding author), Poornaprajna Inst Sci Res, PPISR, Bangalore 562110, Karnataka, India.",dayannerm@yahoo.com.br; marmend@ufpr.br; cristiane.helm@embrapa.br; washington.magalhaes@embrapa.br; gbmunize@ufpr.br; gundsat42@hotmail.com,"magalhaes, washington luiz esteves/K-6012-2014; Katakam, Satayanarayana/AAA-6997-2019; Katakam, Satayanarayana/CAI-1973-2022; Kestur, Satyanarayana/I-9362-2014; Bolzon de Muniz, Graciela Ines/N-9440-2018","magalhaes, washington luiz esteves/0000-0003-4405-293X; Katakam, Satayanarayana/0000-0003-3114-2071; Katakam, Satayanarayana/0000-0003-3114-2071; Kestur, Satyanarayana/0000-0003-0240-882X; Bolzon de Muniz, Graciela Ines/0000-0003-4417-0178",CNPq,CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)),"The authors acknowledge EMBRAPA for their encouragement, interest in this work and the permission to publish this paper. The authors would like to express their sincere thanks to Prof. Lorena Benathar Ballod Tavares, who extended support during this study at the Bioterism Center at the Federal University of Blumenau, Blumenau (SC) Brazil. They would also thank Histotechnology Department of the Federal University of Parana, Curitiba, particularly, the technicians Eliane Regina Mendes, who helped in the preparation of samples and Herculano Nino Reis, who helped in the interpretation of data. Two of the authors (KGS and WLEM) would also like to thank CNPq for the award of a Fellowship during the course of this work.",,37,40,45,0,50,SPRINGER INDIA,NEW DELHI,"7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA",0022-1155,0975-8402,,J FOOD SCI TECH MYS,J. Food Sci. Technol.-Mysore,SEP,2015,52,9,,,,,5641,5650,,10.1007/s13197-014-1684-0,http://dx.doi.org/10.1007/s13197-014-1684-0,,,10,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,CP7OK,26344977,Green Published,,,2024-06-04,WOS:000360077300023,View Full Record in Web of Science
J,"Cockerell, KM; Watkins, ASM; Reeves, LB; Goddard, L; Lomer, MCE",,,,"Cockerell, K. M.; Watkins, A. S. M.; Reeves, L. B.; Goddard, L.; Lomer, M. C. E.",,,Effects of linseeds on the symptoms of irritable bowel syndrome: a pilot randomised controlled trial,JOURNAL OF HUMAN NUTRITION AND DIETETICS,,,English,Article,,,,,,diet; irritable bowel syndrome; linseeds; nutrition,DIETARY FIBER; TRANSIT,"Background: Manipulation of dietary fibre intake represents a longstanding treatment for patients with irritable bowel syndrome (IBS), particularly for those with constipation. Linseeds are often recommended by both clinicians and dietitians as a source of dietary fibre to alleviate symptoms. Recent guidance on the management of irritable bowel syndrome (IBS) advises that linseeds may reduce wind and bloating, although there is limited clinical evidence to support this recommendation. The present pilot study aimed to compare the clinical effectiveness of: (i) whole linseeds versus ground linseeds; (ii) whole linseeds versus no linseeds; and (iii) ground linseeds versus no linseeds in the management of IBS symptoms. Methods: In an open randomised controlled trial, subjects with IBS (n = 40) were allocated to one of three intervention groups: two tablespoons of whole linseeds per day (n = 14), two tablespoons of ground linseeds per day (n = 13) and no linseeds as controls (n = 13). Symptom severity (primary outcome) and bowel habit were assessed before and after a 4-week intervention and statistical differences between the groups were compared. Results: Thirty-one subjects completed the present study. Between-group analysis comparing the improvement in symptom severity did not reach statistical significance for whole linseeds (n = 11) versus ground linseeds (n = 11; P = 0.62), whole linseeds versus controls (n = 9; P = 0.12) and ground linseeds versus controls (P = 0.10). There were no significant changes in stool frequency or stool consistency for any of the groups. Conclusions: Linseeds may be useful in relief of IBS symptoms. Further research is needed to detect clear differences between the effects of whole and ground linseeds.","[Cockerell, K. M.; Watkins, A. S. M.; Lomer, M. C. E.] Kings Coll London, Diabet & Nutr Sci Div, Sch Med, London SE1 9NH, England; [Reeves, L. B.] E Oxford Hlth Ctr, Dept Community Nutr & Dietet, Oxford, England; [Goddard, L.] Imperial Coll Healthcare NHS Trust, Dept Nutr & Dietet, London, England; [Lomer, M. C. E.] Guys & St Thomas NHS Fdn Trust, Dept Gastroenterol, London, England; [Lomer, M. C. E.] Guys & St Thomas NHS Fdn Trust, Dept Nutr & Dietet, London, England",University of London; King's College London; Imperial College London; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust,"Lomer, MCE (corresponding author), Kings Coll London, Diabet & Nutr Sci Div, Sch Med, London SE1 9NH, England.",miranda.lomer@kcl.ac.uk,,"Lomer, Miranda/0000-0002-9369-8115",,,,,25,23,25,1,20,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0952-3871,1365-277X,,J HUM NUTR DIET,J. Hum. Nutr. Diet.,OCT,2012,25,5,,,,,435,443,,10.1111/j.1365-277X.2012.01263.x,http://dx.doi.org/10.1111/j.1365-277X.2012.01263.x,,,9,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,007GH,22690855,,,,2024-06-04,WOS:000308876300004,View Full Record in Web of Science
J,"Bueno, LR; Soley, BD; Abboud, KY; França, IW; da Silva, KS; de Oliveira, NMT; Barros, JS; Gois, MB; Cordeiro, LMC; Maria-Ferreira, D",,,,"Bueno, Laryssa Regis; Soley, Bruna da Silva; Abboud, Kahlile Youssef; Franca, Isabella Wzorek; da Silva, Karien Sauruk; Turin de Oliveira, Natalia Mulinari; Barros, Juliana Santos; Gois, Marcelo Biondaro; Cortes Cordeiro, Lucimara Mach; Maria-Ferreira, Daniele",,,Protective Effect of Dietary Polysaccharides from Yellow Passion Fruit Peel on DSS-Induced Colitis in Mice,OXIDATIVE MEDICINE AND CELLULAR LONGEVITY,,,English,Article,,,,,,,INFLAMMATORY-BOWEL-DISEASE; INDUCED ULCERATIVE-COLITIS; GUT MICROBIOTA; STRUCTURAL-CHARACTERIZATION; OXIDATIVE STRESS; CONSTIPATION; FIBER; ACTIVATION; BARRIER; HEALTH,"Inflammatory bowel disease (IBD) is a complex inflammatory disorder characterized by chronic and spontaneously relapsing inflammation of the gastrointestinal tract. IBD includes two idiopathic disorders: Crohn's disease (CD) and ulcerative colitis (UC). In particular, UC causes inflammation and ulceration of the colon and rectum. There is no cure for UC. The pharmacological treatment is aimed at controlling and/or reducing the inflammatory process and promoting disease remission. The present study investigated the possible protective effects of soluble dietary fiber (SDF) isolated from yellow passion fruit peel in the dextran sulfate sodium- (DSS-) induced colitis model in mice, induced by 5% of DSS. The animals were treated with SDF (10, 30, or 100 mg/kg (po)), and the disease activity index was monitored. Colon tissues were collected, measured, and prepared for oxidative stress, inflammation, and histology analysis. SDF improved body weight loss, colon length, and disease activity index and prevented colonic oxidative stress by regulating GSH levels and SOD activity. Furthermore, SDF reduced colonic MPO activity, TNF-alpha, and IL-1 beta levels and increased IL-10 and IL-6 levels. As observed by histological analysis, SDF treatment preserved the colonic tissue, the mucus barrier, and reduced inflammatory cell infiltration. Although this is a preliminary study, taken together, our data indicate that SDF may improve the course of DSS-UC. More studies are needed to explore and understand how SDF promotes this protection.","[Bueno, Laryssa Regis; Soley, Bruna da Silva; Franca, Isabella Wzorek; da Silva, Karien Sauruk; Turin de Oliveira, Natalia Mulinari; Maria-Ferreira, Daniele] Inst Pesquisa Pele Pequeno Principe, BR-80250060 Curitiba, Parana, Brazil; [Bueno, Laryssa Regis; Soley, Bruna da Silva; Franca, Isabella Wzorek; da Silva, Karien Sauruk; Turin de Oliveira, Natalia Mulinari; Maria-Ferreira, Daniele] Fac Pequeno Principe, Programa Posgrad Biotecnol Aplicada Saade Crianca, BR-80230020 Curitiba, Parana, Brazil; [Abboud, Kahlile Youssef; Cortes Cordeiro, Lucimara Mach] Univ Fed Parana, Dept Biochem & Mol Biol, Curitiba, Parana, Brazil; [Barros, Juliana Santos; Gois, Marcelo Biondaro] Univ Fed Bahia, Inst Ciencias Saude, Santo Antonio De Jesus, BA, Brazil; [Barros, Juliana Santos; Gois, Marcelo Biondaro] Univ Fed Reconcavo Bahia, Ctr Ciencias Saude, Santo Antonio De Jesus, BA, Brazil; [Gois, Marcelo Biondaro] Univ Fed Rondonopolis, Fac Ciencias Saude, Rondonopolis, MT, Brazil",Hospital Pequeno Principe; Hospital Pequeno Principe; Universidade Federal do Parana; Universidade Federal da Bahia; Universidade Federal do Reconcavo da Bahia,"Maria-Ferreira, D (corresponding author), Inst Pesquisa Pele Pequeno Principe, BR-80250060 Curitiba, Parana, Brazil.",daniele.ferreira@pelepequenoprincipe.org.br,"Gois, Marcelo Biondaro/F-9028-2016; Maria-Ferreira, Daniele/AAE-9373-2020; Cordeiro, Lucimara Mach C./Q-1808-2015; Maria-Ferreira, Daniele/L-6905-2013","Gois, Marcelo Biondaro/0000-0003-0822-8440; Cordeiro, Lucimara Mach C./0000-0001-6680-8967; Mulinari Turin de Oliveira, Natalia/0000-0003-2174-5282; Maria-Ferreira, Daniele/0000-0001-7992-510X; Wzorek Franca dos Santos, Isabella/0000-0001-8380-9427; abboud, kahlile/0000-0002-9132-7409","Instituto de Pesquisa Pele Pequeno Principe (Brazil); Instituto de Pesquisa Pele Pequeno Principe; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES; Brazil) [001]; CNPq [404717/2016-0, 307314/2018-9]",Instituto de Pesquisa Pele Pequeno Principe (Brazil); Instituto de Pesquisa Pele Pequeno Principe; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES; Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)),"This work was supported by the Instituto de Pesquisa Pele Pequeno Principe (Brazil). L.R.B. is a master student and B.S. is a postdoctoral student, both receiving a grant from the Instituto de Pesquisa Pele Pequeno Principe. I.F.W. is a master student receiving a grant from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES; finance code 001; Brazil). N.M.T.d.O. and K.S.S. are PhD students, receiving a grant from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil), or Instituto de Pesquisa Pele Pequeno Principe. L.M.C.C. received grant from CNPq (process numbers 404717/2016-0 and 307314/2018-9).",,87,7,7,14,26,HINDAWI LTD,LONDON,"ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND",1942-0900,1942-0994,,OXID MED CELL LONGEV,Oxidative Med. Cell. Longev.,OCT 15,2022,2022,,,,,,,,6298662,10.1155/2022/6298662,http://dx.doi.org/10.1155/2022/6298662,,,15,Cell Biology,Science Citation Index Expanded (SCI-EXPANDED),Cell Biology,5U4FX,36285298,"gold, Green Published",,,2024-06-04,WOS:000876505900002,View Full Record in Web of Science
J,"Wu, KL; Rayner, CK; Chuah, SK; Chiu, KW; Lu, CC; Chiu, YC",,,,"Wu, Keng-Liang; Rayner, Christopher K.; Chuah, Seng-Kee; Chiu, King-Wah; Lu, Chien-Chang; Chiu, Yi-Chun",,,Impact of Low-Residue Diet on Bowel Preparation for Colonoscopy,DISEASES OF THE COLON & RECTUM,,,English,Article,,,,,,Dietary residue; Colonoscopy; Bowel preparation,CLEAR LIQUID DIET; LOW-FIBER DIET; POLYETHYLENE-GLYCOL; PREPARATION QUALITY; MAGNESIUM CITRATE; SODIUM-PHOSPHATE; EFFICACY; TRIAL; COLON,"BACKGROUND: Few studies have focused on the effect of dietary residue on preparation for colonoscopy. OBJECTIVE: To determine the impact of a low-residue diet on the quality of bowel preparation. SETTING: Chang Gung Memorial Hospital, Kaohsiung Medical Center, Taiwan. PATIENTS: Eight hundred four consecutive patients (50.4 +/- 11.6 y (range, 18-88 y), 43.6% female) undergoing colonoscopy between May 2008 and June 2009. INTERVENTION: Subjects were advised to consume a low-residue diet for 2 days before the procedure, and they recorded food intake by use of diet diaries. MAIN OUTCOME MEASURES: The quality of bowel cleansing was evaluated using the Ottawa bowel preparation scale. Patient variables and details of each procedure were recorded, and factors that determined the quality of colon cleansing were determined. LIMITATIONS: Categories of foods consumed were recorded, but not the amount eaten, and diet diaries were completed retrospectively. RESULTS: Data from 789 patients were analyzed. Only 44.2% of patients adhered to a low-residue diet, and 39.3% of patients were inadequately prepared. On multivariate logistic regression analysis, age (P = .007), body mass index (P = .01), abdominal girth (P = .041), bowel habit tending to constipation (P = .015), and high-residue diet (P < .0001) were independent predictors of inadequate bowel preparation. There was a linear relationship between dietary residue score and bowel cleanliness score (r = -0.475; P < .001). CONCLUSIONS: A low-residue diet for 2 days of before colonoscopy improves bowel cleansing, but compliance with this advice is poor. The importance of a low-residue diet should be emphasized to patients undergoing preparation for colonoscopy.","[Wu, Keng-Liang; Chuah, Seng-Kee; Chiu, King-Wah; Chiu, Yi-Chun] Chang Gung Univ, Chang Gung Mem Hosp, Kaohsiung Med Ctr, Coll Med,Div Hepatogastroenterol,Dept Internal Me, Kaohsiung, Taiwan; [Lu, Chien-Chang] Chang Gung Univ, Chang Gung Mem Hosp, Kaohsiung Med Ctr, Coll Med,Div Colon & Rectal Surg,Dept Surg, Kaohsiung, Taiwan; [Rayner, Christopher K.] Univ Adelaide, Royal Adelaide Hosp, Discipline Med, Adelaide, SA, Australia",Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; University of Adelaide; Royal Adelaide Hospital,"Chiu, YC (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Kaohsiung Med Ctr, Coll Med,Div Hepatogastroenterol,Dept Internal Me, Kaohsiung, Taiwan.",chiuku@ms14.hinet.net,,"Chiu, King-Wah/0000-0003-2108-6539",,,,,20,75,83,1,20,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0012-3706,1530-0358,,DIS COLON RECTUM,Dis. Colon Rectum,JAN,2011,54,1,,,,,107,112,,10.1007/DCR.0b013e3181fb1e52,http://dx.doi.org/10.1007/DCR.0b013e3181fb1e52,,,6,Gastroenterology & Hepatology; Surgery,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Surgery,695NK,21160321,,,,2024-06-04,WOS:000285377500017,View Full Record in Web of Science
J,"Bush, JR; Baisley, J; Harding, SV; Alfa, MJ",,,,"Bush, Jason R.; Baisley, Joshua; Harding, Scott V.; Alfa, Michelle J.",,,"Consumption of Solnul™ Resistant Potato Starch Produces a Prebiotic Effect in a Randomized, Placebo-Controlled Clinical Trial",NUTRIENTS,,,English,Article,,,,,,prebiotic; constipation; diarrhea; potato; resistant starch; Bifidobacterium; Akkermansia; microbiome,GUT MICROBIOTA COMPOSITION; INSULIN SENSITIVITY; DIETARY FIBER; IN-VITRO; SUPPLEMENTATION; FERMENTATION; HEMODIALYSIS; MODULATION; OVERWEIGHT; WEIGHT,"The effects of resistant starch at high doses have been well-characterized, but the potential prebiotic effects of resistant starch at doses comparable to oligosaccharide prebiotics have not been evaluated. A three-arm randomized, double-blind, placebo-controlled clinical trial was conducted to evaluate the effect of 3.5 g and 7 g daily doses of Solnul((TM)) resistant potato starch (RPS) on beneficial populations of gut bacteria and stool consistency after a 4-week period. The relative abundance of Bifidobacterium and Akkermansia was determined by employing 16Sv4 sequencing of stool samples. To assess the effect of RPS on laxation and bowel movements, stools were recorded and scored using the Bristol Stool Form Scale. Participants consuming 3.5 g/day of RPS experienced significantly greater changes in Bifidobacterium and Akkermansia compared to the placebo after 4 weeks. The number of diarrhea- and constipation-associated bowel movements were both significantly lower in the 3.5 g RPS arm compared to the placebo group. Participants consuming 7 g of RPS responded similarly to those in the 3.5 g arm. Our analyses demonstrate that Solnul((TM)) RPS has a prebiotic effect when consumed for 4 weeks at the 3.5 g per day dose, stimulating increases in beneficial health-associated bacteria and reducing diarrhea- and constipation-associated bowel movements when compared to the placebo group.","[Bush, Jason R.] MSP Starch Prod Inc, Carberry, MB R0K 0H0, Canada; [Baisley, Joshua] Nutrasource Pharmaceut & Nutraceut Serv, Guelph, ON N1G 0B4, Canada; [Harding, Scott V.] Mem Univ Newfoundland, Fac Sci, Dept Biochem, St John, NF A1C 5S7, Canada; [Alfa, Michelle J.] AlfaMed Consulting, Winnipeg, MB R2M 5M3, Canada",Memorial University Newfoundland,"Bush, JR (corresponding author), MSP Starch Prod Inc, Carberry, MB R0K 0H0, Canada.",jbush@solnul.com,,,MSP Starch Products Inc.,MSP Starch Products Inc.,This research and the APC were funded by MSP Starch Products Inc.,,59,1,1,6,12,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,APR,2023,15,7,,,,,,,1582,10.3390/nu15071582,http://dx.doi.org/10.3390/nu15071582,,,16,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,D6XP9,37049425,"gold, Green Published",,,2024-06-04,WOS:000970141900001,View Full Record in Web of Science
J,"Ibarra, A; Pelipyagina, T; Rueffer, M; Evans, M; Ouwehand, AC",,,,"Ibarra, Alvin; Pelipyagina, Tetyana; Rueffer, Matthew; Evans, Malkanthi; Ouwehand, Arthur C.",,,"Efficacy of Polydextrose Supplementation on Colonic Transit Time, Bowel Movements, and Gastrointestinal Symptoms in Adults: A Double-Blind, Randomized, Placebo-Controlled Trial",NUTRIENTS,,,English,Article,,,,,,polydextrose; transit time; bowel movements,QUALITY-OF-LIFE; CHRONIC CONSTIPATION; FUNCTIONAL CONSTIPATION; LACTIS HN019; VALIDATION; EPIDEMIOLOGY; IMPACT; FOOD,"The addition of fiber is one of the most important dietary means to relieve constipation through lifestyle modification. Polydextrose (PDX) has been reported in several studies to increase fecal bulk, soften stools, and increase the number of defecations. However, there are few studies on the effect of PDX on colonic transit time (CTT). Therefore, the aim of this study was to demonstrate the effect of PDX on CTT and other aspects of gastrointestinal function during two weeks (Day 1 to Day 14), preceded by a 2-week run-in period (Day -14 to Day -1). A total of 192 adults who were diagnosed with functional constipation per Rome III criteria were recruited for the study. Participants were randomized equally into 4 groups (12 g, 8 g, or 4 g of PDX or placebo per day). The primary endpoint was CTT, assessed using radio-opaque markers and abdominal X-rays on Day 0, the baseline; and Day 15, the end of the intervention. Secondary outcomes that were measured using inventories were the patient assessment of constipation symptoms and quality of life, bowel function index, relief of constipation, bowel movement frequency (BMF), stool consistency, degree of straining, and proportion of bowel movements. Ancillary parameters and harms were also evaluated. The recruited population was not sufficiently constipated (e.g., baseline values for CTT and BMF of 42 h and 8.7 BMF/week, respectively). Despite this limitation, our results demonstrated an increased number of bowel movements when supplemented with PDX at a dosage of 12 g per day for 2 weeks. This dosage also consistently improved the secondary outcomes that were measured using inventories at Day 15, compared with the baseline. No serious or significant adverse events were reported during the study.","[Ibarra, Alvin; Ouwehand, Arthur C.] DuPont Nutr & Hlth, Danisco Sweeteners Oy Sokeritehtaantie, Kantvik 02460, Finland; [Pelipyagina, Tetyana; Rueffer, Matthew; Evans, Malkanthi] KGK Synergize Inc, Suite 1440,One London Pl,255 Queens Ave, London, ON N6A 5R8, Canada",,"Ibarra, A (corresponding author), DuPont Nutr & Hlth, Danisco Sweeteners Oy Sokeritehtaantie, Kantvik 02460, Finland.",alvin.ibarra@dupont.com; tetyana@kgksynergize.com; matthew@kgksynergize.com; mevans@kgkscience.com; Arthur.Ouwehand@dupont.com,,,DuPont Nutrition and Health,DuPont Nutrition and Health,This study was fully sponsored by DuPont Nutrition and Health,,43,10,11,2,8,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,FEB,2019,11,2,,,,,,,439,10.3390/nu11020439,http://dx.doi.org/10.3390/nu11020439,,,17,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,HO3NH,30791557,"Green Published, gold, Green Submitted",,,2024-06-04,WOS:000460829700230,View Full Record in Web of Science
J,"Jalanka, J; Major, G; Murray, K; Singh, G; Nowak, A; Kurtz, C; Silos-Santiago, I; Johnston, JM; de Vos, WM; Spiller, R",,,,"Jalanka, Jonna; Major, Giles; Murray, Kathryn; Singh, Gulzar; Nowak, Adam; Kurtz, Caroline; Silos-Santiago, Inmaculada; Johnston, Jeffrey M.; de Vos, Willem M.; Spiller, Robin",,,The Effect of Psyllium Husk on Intestinal Microbiota in Constipated Patients and Healthy Controls,INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES,,,English,Article,,,,,,prebiotics; microbiome; ispaghula; constipation; transit,HYDROGEN-SULFIDE; DIETARY FIBER; FERMENTATION; TIME; DIVERSITY; BACTERIAL; TRANSIT; GENE; BRAN,"Psyllium is a widely used treatment for constipation. It traps water in the intestine increasing stool water, easing defaecation and altering the colonic environment. We aimed to assess the impact of psyllium on faecal microbiota, whose key role in gut physiology is being increasingly recognised. We performed two randomised, placebo-controlled, double-blinded trials comparing 7 days of psyllium with a placebo (maltodextrin) in 8 healthy volunteers and 16 constipated patients respectively. We measured the patients' gastrointestnal (GI) transit, faecal water content, short-chain fatty acid (SCFA) and the stool microbiota composition. While psyllium supplement had a small but significant effect on the microbial composition of healthy adults (increasing Veillonella and decreasing Subdoligranulum), in constipated subjects there were greater effects on the microbial composition (increased Lachnospira, Faecalibacterium, Phascolarctobacterium, Veillonella and Sutterella and decreased uncultured Coriobacteria and Christensenella) and alterations in the levels of acetate and propionate. We found several taxa to be associated with altered GI transit, SCFAs and faecal water content in these patients. Significant increases in three genera known to produce butyrate, Lachnospira, Roseburia and Faecalibacterium, correlated with increased faecal water. In summary, psyllium supplementation increased stool water and this was associated with significant changes in microbiota, most marked in constipated patients.","[Jalanka, Jonna] Univ Helsinki, Fac Med, Immunobiol Res Program, Hy Helsinki 00014, Finland; [Jalanka, Jonna] Univ Helsinki, Fac Med, Dept Bacteriol & Immunol, Hy Helsinki 00014, Finland; [Jalanka, Jonna; Major, Giles; Murray, Kathryn; Singh, Gulzar; Spiller, Robin] Univ Nottingham, Nottingham Univ Hosp NHS Trust, Nottingham Digest Dis Ctr, Notts NG7 2UH, England; [Jalanka, Jonna; Major, Giles; Murray, Kathryn; Singh, Gulzar; Spiller, Robin] Univ Nottingham, Nottingham Univ Hosp NHS Trust, NIHR Nottingham Biomed Res Ctr, Notts NG7 2UH, England; [Nowak, Adam] Univ Nottingham, Nottingham Univ Hosp NHS Trust, Nottingham NG5 1PB, Notts, England; [Kurtz, Caroline] Synl Therapeut, Cambridge, MA 02142 USA; [Silos-Santiago, Inmaculada] Decibel Therapeut Inc, Boston, MA 02215 USA; [Johnston, Jeffrey M.] Neurogastrx Inc, Woburn, MA 01801 USA; [de Vos, Willem M.] Wageningen Univ, Lab Microbiol, NL-6708WE Wageningen, Netherlands",University of Helsinki; University of Helsinki; Nottingham University Hospital NHS Trust; University of Nottingham; University of Nottingham; Nottingham University Hospital NHS Trust; University of Nottingham; Nottingham University Hospital NHS Trust; Wageningen University & Research,"Spiller, R (corresponding author), Univ Nottingham, Nottingham Univ Hosp NHS Trust, Nottingham Digest Dis Ctr, Notts NG7 2UH, England.;Spiller, R (corresponding author), Univ Nottingham, Nottingham Univ Hosp NHS Trust, NIHR Nottingham Biomed Res Ctr, Notts NG7 2UH, England.",Jonna.Jalanka@helsinki.fi; giles.major1@nottingham.ac.uk; Kathryn.Murray@nottingham.ac.uk; Gulzar.Singh@nottingham.ac.uk; adam.nowak@nhs.net; carolinebkurtz@gmail.com; asilos@decibeltx.com; jjohnston@neurogastrx.com; willem.devos@wur.nl; Robin.Spiller@Nottingham.ac.uk,"spiller, robin/ABE-6690-2021; Major, Giles/AAF-4207-2019","spiller, robin/0000-0001-6371-4500; Major, Giles/0000-0001-7944-3709; De Vos, Willem M/0000-0002-0273-3166; jalanka, jonna/0000-0002-3847-8136","Finnish Academy [0313471-7]; Ironwood Pharmaceuticals Inc., Cambridge, MA, USA","Finnish Academy(Research Council of Finland); Ironwood Pharmaceuticals Inc., Cambridge, MA, USA","This research was funded by the Finnish Academy (grant no. 0313471-7 for J.J.). The clinical trials were collaborative studies undertaken by the Nottingham Digestive Diseases Centre and NIHR Nottingham Biomedical Research Centre at Nottingham University Hospitals NHS Trust, the University of Nottingham, funded by Ironwood Pharmaceuticals Inc., Cambridge, MA, USA.",,40,96,106,6,52,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",1422-0067,,,INT J MOL SCI,Int. J. Mol. Sci.,JAN 2,2019,20,2,,,,,,,433,10.3390/ijms20020433,http://dx.doi.org/10.3390/ijms20020433,,,12,"Biochemistry & Molecular Biology; Chemistry, Multidisciplinary",Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Chemistry,HM8QS,30669509,"Green Published, gold, Green Submitted",,,2024-06-04,WOS:000459746500201,View Full Record in Web of Science
J,"Yanaka, A",,,,"Yanaka, Akinori",,,Daily intake of broccoli sprouts normalizes bowel habits in human healthy subjects,JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION,,,English,Article,,,,,,broccoli sprouts; sulforaphane; defecation; oxidative stress; constipation score system,OXIDATIVE STRESS; GASTROINTESTINAL-TRACT; PROTECTIVE AGENTS; BRUSSELS-SPROUTS; DIETARY FIBER; CONSTIPATION; METAANALYSIS; ANTIOXIDANT; ENZYMES; DISEASE,"Chronic oxidative stress impairs regular defecation. Sulforaphane (SFN) enhances anti-oxidant systems, ameliorating oxidative injury. SFN inhibits overgrowth of anaerobic microflora and protects small intestine from oxidative injury. We assessed whether daily intake of SFN-rich broccoli sprouts (BS) improves defecation in humans. Forty-eight subjects, with a constipation scoring system (CSS) >2 points, were assigned to either the BS group (n = 24) or the alfalfa sprouts (AS) group (n = 24), and were requested to eat 20 g daily of raw BS or AS, respectively, for 4 weeks. BS contains 4.4 mg/g sulforaphane glucosinolates (SGS), while AS contains no SGS. CSS-based questionnaires were performed to evaluate bowel habit. Stool samples were collected to evaluate intestinal micro flora using a terminal restriction fragment length polymorphism flora analysis. Intervention with BS, but not AS, caused a significant decrease in the duration of attempted defecation and the total CSS score. Intervention with BS decreased the percentage of Bifidobacterium in the stool. These results suggest that daily intake of BS improves bowel habit in human subjects. Since BS treatment enhance antioxidant enzyme activities, these effects of BS appear to relate with the SFN-mediated modulation of the intestinal motility during exposure to oxidative stress.","[Yanaka, Akinori] Univ Tsukuba, Univ Tsukuba Hosp, Hitachi Med Educ & Res Ctr, Div Gastroenterol,Fac Med, Tsukuba, Ibaraki 3058575, Japan",University of Tsukuba,"Yanaka, A (corresponding author), Univ Tsukuba, Univ Tsukuba Hosp, Hitachi Med Educ & Res Ctr, Div Gastroenterol,Fac Med, Tsukuba, Ibaraki 3058575, Japan.",ynk-aki@md.tsukuba.ac.jp,,,,,,,28,19,20,0,22,JOURNAL CLINICAL BIOCHEMISTRY & NUTRITION,KYOTO,"KYOTO PREFECTURAL UNIV MED, GRAD SCH MEDICAL SCIENCE, DEPT MOLECULAR GASTROENTEROLOGY & HEPATOLOGY, KYOTO, 602-8566, JAPAN",0912-0009,1880-5086,,J CLIN BIOCHEM NUTR,J. Clin. Biochem. Nutr.,JAN 1,2018,62,1,,,,,75,82,,10.3164/jcbn.17-42,http://dx.doi.org/10.3164/jcbn.17-42,,,8,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,FZ1NX,29371757,"gold, Green Published, Green Submitted",,,2024-06-04,WOS:000427344500010,View Full Record in Web of Science
J,"Ahmed, A; Khalid, N; Ahmad, A; Abbasi, NA; Latif, MSZ; Randhawa, MA",,,,"Ahmed, A.; Khalid, N.; Ahmad, A.; Abbasi, N. A.; Latif, M. S. Z.; Randhawa, M. A.",,,Phytochemicals and biofunctional properties of buckwheat: a review,JOURNAL OF AGRICULTURAL SCIENCE,,,English,Review,,,,,,,FAGOPYRUM-ESCULENTUM MOENCH; D-CHIRO-INOSITOL; FATTY-ACID-COMPOSITION; SOY PROTEIN ISOLATE; IN-VITRO; TARTARY BUCKWHEAT; COMMON BUCKWHEAT; DIETARY FIBER; ANTIOXIDANT ACTIVITY; NUTRITIONAL-EVALUATION,"A growing trend for nutraceutical and gluten-free cereal-based products highlights the need for development of new products. Buckwheat is one of the potential candidates for such products and the present paper reviews the functional and nutraceutical compounds present in common buckwheat (Fagopyrum esculentum) and tartary buckwheat (Fagopyrum tataricum). The vital functional substances in buckwheat are flavonoids, phytosterols, fagopyrins, fagopyritols, phenolic compounds, resistant starch, dietary fibre, lignans, vitamins, minerals and antioxidants, which make it a highly active biological pseudocereal. Cholesterol-lowering effects that lessen the problems of constipation and obesity are important health benefits that can be achieved through the functional substances of buckwheat.","[Ahmed, A.; Ahmad, A.] Arid Agr Univ, Dept Food Technol, Rawalpindi 46300, Pakistan; [Khalid, N.] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Global Agr Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Abbasi, N. A.] Arid Agr Univ, Dept Hort, Rawalpindi 46300, Pakistan; [Latif, M. S. Z.] Khawaja Muhammad Safdar Med Coll, Dept Biochem, Sialkot, Pakistan; [Randhawa, M. A.] Univ Agr Faisalabad, Natl Inst Food Sci & Technol, Faisalabad 38040, Pakistan",Arid Agriculture University; University of Tokyo; Arid Agriculture University; University of Agriculture Faisalabad,"Khalid, N (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Global Agr Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.",nauman_khalid120@yahoo.com,"abbasi, nadeem akhtar/AAF-3860-2021; Ahmad, Asif/F-6117-2010; Ahmad, Asif/GWB-9399-2022; Khalid, Nauman/G-8134-2015; Randhawa, Muhammad Atif/Y-9543-2019; Ahmed, Anwaar/X-8823-2019","abbasi, nadeem akhtar/0000-0002-8043-1892; Ahmad, Asif/0000-0003-4657-7561; Ahmad, Asif/0000-0003-4657-7561; Khalid, Nauman/0000-0002-8045-199X; Randhawa, Muhammad Atif/0000-0002-7816-3411; Ahmed, Anwaar/0000-0002-2244-1187",,,,,178,152,168,9,277,CAMBRIDGE UNIV PRESS,NEW YORK,"32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA",0021-8596,1469-5146,,J AGR SCI-CAMBRIDGE,J. Agric. Sci.,JUN,2014,152,3,,,,,349,369,,10.1017/S0021859613000166,http://dx.doi.org/10.1017/S0021859613000166,,,21,"Agriculture, Multidisciplinary",Science Citation Index Expanded (SCI-EXPANDED),Agriculture,AG1IY,,,,,2024-06-04,WOS:000335169900001,View Full Record in Web of Science
J,"Nishiumi, S; Izumi, Y; Kobayashi, T; Yoshida, M",,,,"Nishiumi, Shin; Izumi, Yoshihiro; Kobayashi, Takashi; Yoshida, Masaru",,,A Pilot Study: Effects of Kombu Intake on Lifestyle-related Diseases -Possibility that Kombu Intake is Effective in Individuals with Abnormally High Serum Triglyceride Levels,FOOD SCIENCE AND TECHNOLOGY RESEARCH,,,English,Article,,,,,,kombu; triglyceride; pilot study; human study,DIETARY FIBER; SODIUM ALGINATE; FUCOIDAN; HEALTH; SUPPLEMENTATION; CHOLESTEROL; SYMPTOMS,"In Japan, kombu (Laminaria japonica), a type of seaweed, has been consumed for centuries. It contains a variety of active compounds such as minerals, vitamins, and dietary fiber. The aim of this human pilot study is to investigate the effects of kombu on lifestyle-related diseases. The study had a randomized crossover design, and the subjects (N=48) freely took 6 g of roasted kombu a day for 4 weeks. The subjects' responses to the Gastrointestinal Symptom Rating Scale questionnaire suggested that the frequent intake of kombu may lead to the relief of constipation, diarrhea, and hard stools. In addition, blood tests indicated the possibility that the frequent intake of kombu can decrease the serum triglyceride levels of subjects with abnormally high serum triglyceride levels. Kombu intake might lead to relief from intestinal ailments and improvements in hypertriglyceridemia.","[Nishiumi, Shin; Izumi, Yoshihiro; Kobayashi, Takashi; Yoshida, Masaru] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Gastroenterol, Kobe, Hyogo 6500017, Japan; [Yoshida, Masaru] Kobe Univ, Grad Sch Med, Dept Internal Med Related, Div Metab Res, Kobe, Hyogo 6500017, Japan; [Yoshida, Masaru] AMED, AMED CREST, Kobe, Hyogo 6500017, Japan",Kobe University; Kobe University,"Nishiumi, S; Yoshida, M (corresponding author), Kobe Univ, Grad Sch Med, Dept Internal Med, Div Gastroenterol, Kobe, Hyogo 6500017, Japan.;Yoshida, M (corresponding author), Kobe Univ, Grad Sch Med, Dept Internal Med Related, Div Metab Res, Kobe, Hyogo 6500017, Japan.;Yoshida, M (corresponding author), AMED, AMED CREST, Kobe, Hyogo 6500017, Japan.",nishiums@med.kobe-u.ac.jp; myoshida@med.kobe-u.ac.jp,"KOBAYASHI, Takashi/AAM-7549-2021; Nishiumi, Shin/ABD-5775-2020","KOBAYASHI, Takashi/0000-0002-9202-7643; Nishiumi, Shin/0000-0003-2126-3013; Izumi, Yoshihiro/0000-0003-4608-4652","Ministry of Agriculture, Forestry, and Fisheries (MAFF) of Japan; Japan Agency for Medical Research and Development","Ministry of Agriculture, Forestry, and Fisheries (MAFF) of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))","This study was supported by grants for project research (for the development of fundamental technology for the analysis and evaluation of functional agricultural products and functional foods) from the Ministry of Agriculture, Forestry, and Fisheries (MAFF) of Japan [M.Y.] and for AMED-CREST by the Japan Agency for Medical Research and Development [M,Y.]. We greatly appreciate the assistance of Minami Kayabe, Fisheries Cooperative Associations (Hokkaido, Japan), Akira Inoue, PhD, of Hokkaido University (Hokkaido, Japan), Takao Ojima, PhD, of Hokkaido University (Hokkaido, Japan), and Kazuki Kanazawa, PhD, of Kobe University (Hyogo, Japan).",,22,5,5,0,14,JAPANESE SOC FOOD SCI & TECHNOLOGY,Tsukuba,"2-1-12 Kannondai, Tsukuba, Ibaraki 305 8642, JAPAN",1344-6606,1881-3984,,FOOD SCI TECHNOL RES,Food Sci. Technol. Res.,NOV,2019,25,6,,,,,827,834,,10.3136/fstr.25.827,http://dx.doi.org/10.3136/fstr.25.827,,,8,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,JR6WI,,,,,2024-06-04,WOS:000499762800009,View Full Record in Web of Science
J,"Wolf, RL; Cauley, JA; Baker, CE; Ferrell, RE; Charron, M; Caggiula, AW; Salamone, LM; Heaney, RP; Kuller, LH",,,,"Wolf, RL; Cauley, JA; Baker, CE; Ferrell, RE; Charron, M; Caggiula, AW; Salamone, LM; Heaney, RP; Kuller, LH",,,Factors associated with calcium absorption efficiency in pre- and perimenopausal women,AMERICAN JOURNAL OF CLINICAL NUTRITION,,,English,Article,,,,,,calcium absorption efficiency; variation; premenopausal women; perimenopausal women; vitamin D; receptor polymorphisms; parathyroid hormone,"D-RECEPTOR GENOTYPES; PREMENOPAUSAL WOMEN; BONE-DENSITY; VITAMIN; 1,25-DIHYDROXYVITAMIN-D; GENE; RISK","Background: The amount of calcium ingested by an individual may affect several chronic conditions, including osteoporosis, hypertension, and colon cancer. However, individuals vary in their ability to absorb the calcium they consume. Objective: The purpose of this study was to examine sources of interindividual variation in the efficiency of calcium absorption in women. Design: Fractional calcium absorption was estimated in 142 healthy pre- and perimenopausal women. Dietary habits, lifestyle factors, calciotropic hormones, and vitamin D receptor gene polymorphisms were also assessed. Results: Calcium absorption values averaged 35% and ranged from 17% to 58%. Fractional calcium absorption was positively associated with body mass index (r = 0.22, P = 0.007), dietary fat intake (r = 0.29, P = 0.001), serum 1,25 dihydroxyvitamin D [1,25(OH)(2)D] concentrations (r = 0.23, P = 0.006), and parathyroid hormone concentrations (r = 0.21, P = 0.015). Fractional calcium absorption was inversely associated with total calcium intake (r = -0.18, P = 0.030), dietary fiber intake (r = -0.19, P = 0.028), alcohol consumption (r = -0.14, P = 0.094), physical activity (r = -0.22, P = 0.007), and symptoms of constipation (r = -0.16, P = 0.059). In stepwise regression analysis, dietary fat, dietary fiber, serum 1,25(OH)(2)D, and alcohol consumption emerged as independent predictors of calcium absorption, explaining 21.02% of the observed variation. Women in the lowest tertile of the ratio of dietary fat to fiber had 19% lower fractional calcium absorption values than did women in the highest tertile of ratio of dietary fat to fiber (test of trend, P < 0.001). Conclusions: There is a wide range of calcium absorption values in healthy women. The amount of dietary fat consumed relative to dietary fiber appears to have an important role in determining differences in calcium absorption performance among individuals.","Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Educ, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Genet, Pittsburgh, PA 15260 USA; Childrens Hosp Pittsburgh, Dept Radiol, Pittsburgh, PA USA; Creighton Univ, Omaha, NE 68178 USA",Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Creighton University,"Wolf, RL (corresponding author), Columbia Univ, Teachers Coll, Dept Hlth & Behav Studies, 525 W 120th St,Box 114, New York, NY 10027 USA.",,"Cauley, Jane A/N-4836-2015","Cauley, Jane A/0000-0003-0752-4408",NHLBI NIH HHS [HL 45167-03] Funding Source: Medline; NIA NIH HHS [T32 AG00181] Funding Source: Medline,NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)),,,32,73,87,0,4,AMER SOC CLINICAL NUTRITION,BETHESDA,"9650 ROCKVILLE PIKE, SUBSCRIPTIONS, RM L-3300, BETHESDA, MD 20814-3998 USA",0002-9165,,,AM J CLIN NUTR,Am. J. Clin. Nutr.,AUG,2000,72,2,,,,,466,471,,,,,,6,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,340YW,10919942,,,,2024-06-04,WOS:000088565100023,View Full Record in Web of Science
J,"Moshiree, B",,,,"Moshiree, Baha",,,ASSESSMENT AND TREATMENT OF CONSTIPATION IN CF: WHAT'S ON THE HORIZON?,PEDIATRIC PULMONOLOGY,,,English,Meeting Abstract,,,,,,,CYSTIC-FIBROSIS; DIETARY FIBER; ADULTS,,"[Moshiree, Baha] Univ N Carolina, Med, Charlotte, NC USA",University of North Carolina; University of North Carolina Charlotte,,,,,,,,,13,0,0,0,0,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",8755-6863,1099-0496,,PEDIATR PULM,Pediatr. Pulmonol.,SEP,2018,53,,,2,,S20.4,126,126,,,,,,1,Pediatrics; Respiratory System,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics; Respiratory System,GS8GR,,,,,2024-06-04,WOS:000443947300076,View Full Record in Web of Science
C,"Kudo, S",,"VanderKamp, JW; Asp, NG; Jones, JM; Schaafsma, G",,"Kudo, S",,,Intestinal flora and health,DIETARY FIBRE: BIO-ACTIVE CARBOHYDRATES FOR FOOD AND FEED,,,English,Proceedings Paper,Dietary Fibre 2003 Conference,"MAY 18-21, 2003","Noordwijkerhout, NETHERLANDS",,,intestinal flora; Lactobacillus; Bifidobacterium; sub-optimal health; probiotics,BLADDER-CANCER,"A general idea of probiotics is given with some links to the dietary fibre. Human beings must be associated with microorganisms. The skin has hundreds grams of bacteria although, more surprisingly, the gastric tract is calculated to have I kg of microorganisms, the so-called intestinal flora. In other words, it is up to 10(11-12)/g of faeces. The most dominant genera (10(9-11)/g faeces) belonging to class I are anaerobic bacteria including Bifidobacteria. Group II includes facultative bacteria and their numbers are relatively low (10(5-8)/g faeces). The fewest bacteria such as pathogenic Clostridium perfringens and E. coli belong to class III (Mitsuoka., 1975). The small intestine possesses relatively low numbers of bacteria. However, this organ is very important because of a particular immune trap for bacteria, Peyer's patch scattering over the area. The large intestine is the largest house for the microbes. Aging is known to invite a significant reduction in Bifidobacteria, the most beneficial bacteria. Diet influences the intestinal flora balance as well. Probiotic bacteria should belong to group W. They are usually transient bacteria and proven to give beneficial effects on both digestive and immune systems. For example, Bifidobacterium breve strain Yakult improved the growth of preterm infants (Kitajima et al., 1997). Lactobacillus casei Shirota was reported to improve the constipation (Koebnick et al., 2001), and to increase natural killer cell activity. In this streamline, a habitual intake of this probiotic strain was reported to reduce the risk of bladder cancer (Aso et al., 1995, Ohashi et al., 2002). In addition there are many reports of other probiotic strains improving digestive health (Duggan et al., 2002).","Yakult Europe BV, Dept Sci, NL-1332 EN Almere, Netherlands",,"Kudo, S (corresponding author), Yakult Europe BV, Dept Sci, Schutsluisweg 1, NL-1332 EN Almere, Netherlands.",,,,,,,,11,2,2,1,8,WAGENINGEN ACADEMIC PUBLISHERS,WAGENINGEN,"POSTBUS 220, 6700 AE WAGENINGEN, NETHERLANDS",,,90-76998-32-9,,,,2004,,,,,,,197,202,,,,,,6,Food Science & Technology; Nutrition & Dietetics,Conference Proceedings Citation Index - Science (CPCI-S),Food Science & Technology; Nutrition & Dietetics,BBP25,,,,,2024-06-04,WOS:000226861600015,View Full Record in Web of Science
J,"Nurko, S; Benninga, MA; Solari, T; Chumpitazi, BP",,,,"Nurko, Samuel; Benninga, Marc A.; Solari, Toni; Chumpitazi, Bruno P.",,,Pediatric Aspects of Nutrition Interventions for Disorders of Gut-Brain Interaction,AMERICAN JOURNAL OF GASTROENTEROLOGY,,,English,Article,,,,,,,FUNCTIONAL GASTROINTESTINAL DISORDERS; RECURRENT ABDOMINAL-PAIN; IRRITABLE-BOWEL-SYNDROME; COWS-MILK ALLERGY; LOW FODMAP DIET; HYDROLYZED GUAR GUM; BREAST-FED INFANTS; DOUBLE-BLIND; GASTROESOPHAGEAL-REFLUX; DISACCHARIDASE DEFICIENCIES,"Dietary factors may play an important role in the generation of symptoms in children with disorders of gut-brain interaction (DGBIs). Although dietary modification may provide successful treatment, there is a relative paucity of controlled trials that have shown the effectiveness of dietary interventions. This study is a narrative review that explores the existing literature on food and pediatric DGBIs. The following have been shown to be beneficial: (i) in infants with colic, removing cow's milk from the infant's diet or from the maternal diet in those who are breastfed; (ii) in infants with regurgitation, adding thickeners to the formula or removing cow's milk protein from the infant's diet or the maternal diet in those who are breastfed; and (iii) in children with pain-predominant DGBIs, using soluble fiber supplementation or a low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet. In children with functional constipation, there is no evidence that adding fiber is beneficial. Given that most dietary interventions include restriction of different foods in children, a thoughtful approach and close follow-up are needed.","[Nurko, Samuel; Solari, Toni] Boston Childrens Hosp, Ctr Motilityand Funct Gastrointestinal Disorders, Boston, MA 02115 USA; [Benninga, Marc A.] Amsterdam UMC, Departmentof Pediat Gastroenterol, Emma Childrens Hosp, Amsterdam, Netherlands; [Chumpitazi, Bruno P.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Chumpitazi, Bruno P.] USDA, Childrens Nutr Res Ctr, Houston, TX USA",Harvard University; Boston Children's Hospital; University of Amsterdam; Emma Children's Hospital; Baylor College of Medicine; United States Department of Agriculture (USDA),"Nurko, S (corresponding author), Boston Childrens Hosp, Ctr Motilityand Funct Gastrointestinal Disorders, Boston, MA 02115 USA.",samuel.nurko@childrens.harvard.edu,,,,,,,127,7,7,1,12,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0002-9270,1572-0241,,AM J GASTROENTEROL,Am. J. Gastroenterol.,JUN,2022,117,6,,,,,995,1009,,10.14309/ajg.0000000000001779,http://dx.doi.org/10.14309/ajg.0000000000001779,,,15,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,1U7PO,35416794,"Green Published, hybrid",,,2024-06-04,WOS:000805600000031,View Full Record in Web of Science
J,"Kubota, Y; Iso, H; Tamakoshi, A",,,,"Kubota, Yasuhiko; Iso, Hiroyasu; Tamakoshi, Akiko",,Jacc Study Grp,"Bowel Movement Frequency, Laxative Use, and Mortality From Coronary Heart Disease and Stroke Among Japanese Men and Women: The Japan Collaborative Cohort (JACC) Study",JOURNAL OF EPIDEMIOLOGY,,,English,Article,,,,,,bowel movement frequency; laxatives; constipation; mortality; atherosclerosis,CHRONIC MESENTERIC ISCHEMIA; AUTONOMIC NERVOUS-SYSTEM; CARDIOVASCULAR-DISEASE; SLEEP DURATION; DIETARY FIBER; RISK; DYSFUNCTION; PHOSPHATIDYLCHOLINE; HYPERTENSION; CONSTIPATION,"Background: The associations of bowel movement frequency and laxative use with cardiovascular disease (CVD) are unclear. Methods: A total of 72 014 subjects (29 668 men and 42 346 women) aged 40 to 79 years, without a history of CVD or cancer, completed a lifestyle questionnaire at baseline between 1988 and 1990 that included information on bowel movement frequency (daily, every 2-3 days, or once every 4 or more days) and laxative use (yes or no), and were followed-up until 2009. Results: During the subjects' 1 165 569 person-years of follow-up, we documented 977 deaths from coronary heart disease (561 men and 416 women), 2024 from total stroke (1028 men and 996 women), 1127 from ischemic stroke (606 men and 521 women), and 828 from hemorrhagic stroke (388 men and 440 women). The prevalence of CVD risk factors, such as diabetes, stress, depression, and physical inactivity, was higher in laxative users and in those with a lower frequency of bowel movements. The multivariable HRs (95% confidence intervals [CIs]) of laxative users were as follows: 1.56 (95% CI, 1.21-2.03) for coronary heart disease and 1.37 (95% CI, 1.07-1.76) for ischemic stroke in men, and 1.27 (95% CI, 1.08-1.49) for total stroke, and 1.45 (95% CI, 1.17-1.79) for ischemic stroke in women. Similar results were observed even after the exclusion of deaths that occurred early in the follow-up period. A significant association between bowel movement frequency and mortality from CVD was not observed. Conclusions: Constipation could be a marker of exposure to CVD risk factors, and laxative use could be a risk factor for mortality from coronary heart disease and ischemic stroke.","[Kubota, Yasuhiko; Iso, Hiroyasu] Osaka Univ, Dept Social Med, Grad Sch Med, Publ Hlth, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Tamakoshi, Akiko] Hokkaido Univ, Grad Sch Med, Dept Publ Hlth, Sapporo, Japan",Osaka University; Hokkaido University,"Iso, H (corresponding author), Osaka Univ, Dept Social Med, Grad Sch Med, Publ Hlth, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.",iso@pbhel.med.osaka-u.ac.jp,,,"Ministry of Education, Science, Sports, and Culture of Japan (Monbusho); Japanese Ministry of Education, Culture, Sports, Science and Technology (Monbukagakusho) [1010068, 2151065, 3151064, 4151063, 5151069, 61010076, 62010074, 63010074, 6279102, 11181101, 17015022, 18014011, 20014026, 20390156]; Grants-in-Aid for Scientific Research [16H06277, 26293138] Funding Source: KAKEN","Ministry of Education, Science, Sports, and Culture of Japan (Monbusho)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Education, Culture, Sports, Science and Technology (Monbukagakusho)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))","This study was supported by the Ministry of Education, Science, Sports, and Culture of Japan (Monbusho) and the Japanese Ministry of Education, Culture, Sports, Science and Technology (Monbukagakusho): grant numbers 1010068, 2151065, 3151064, 4151063, 5151069, 61010076, 62010074, 63010074, 6279102, 11181101, 17015022, 18014011, 20014026, and 20390156.",,33,31,35,2,29,JAPAN EPIDEMIOLOGICAL ASSOC,TOKYO,"C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN",0917-5040,1349-9092,,J EPIDEMIOL,J. Epidemiol.,MAY,2016,26,5,,,,,242,248,,10.2188/jea.JE20150123,http://dx.doi.org/10.2188/jea.JE20150123,,,7,"Public, Environmental & Occupational Health",Science Citation Index Expanded (SCI-EXPANDED),"Public, Environmental & Occupational Health",DL8VF,26725286,"Green Published, Green Submitted, gold",,,2024-06-04,WOS:000375919300002,View Full Record in Web of Science
J,"STARE, FJ",,,,"STARE, FJ",,,3 SCORE AND 10 PLUS MORE,JOURNAL OF THE AMERICAN GERIATRICS SOCIETY,,,English,Editorial Material,,,,,,,,"The elderly in society are required to make many social and psychologic adjustments. In addition, they have to cope with the inevitable physiologic changes associated with the aging process. These alterations in lifestyle and in body functioning call for modified dietary patterns during this phase of life. In particular, older persons should reduce caloric intake while maintaining a highly nourishing diet. Other recommended dietary modifications include a shift toward smaller meals eaten more frequently, and the use of generous amounts of fiber and liquid to avoid constipation. As a result of growing community awareness, some programs have been started to assist the elderly in overcoming problems that may cause poor nourishment.","HARVARD UNIV, SCH PUBL HLTH, DEPT NUTR, BOSTON, MA 02115 USA",,,,,,,,,,0,3,3,0,0,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0002-8614,1532-5415,,J AM GERIATR SOC,J. Am. Geriatr. Soc.,,1977,25,12,,,,,529,533,,10.1111/j.1532-5415.1977.tb00836.x,http://dx.doi.org/10.1111/j.1532-5415.1977.tb00836.x,,,5,Geriatrics & Gerontology; Gerontology,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Geriatrics & Gerontology,ED541,925281,,,,2024-06-04,WOS:A1977ED54100001,View Full Record in Web of Science
J,"Singh, B; Kumari, A; Sharma, P; Mohan, M",,,,"Singh, Baljit; Kumari, Ankita; Sharma, Prerna; Mohan, Man",,,Fabrication of arabinoxylan psyllium-phosphated polymers for biomedical applications,BIOACTIVE CARBOHYDRATES AND DIETARY FIBRE,,,English,Article,,,,,,Hydrogel; Phosphated polymers; drug Delivery,IN-VITRO; NETWORK PROPERTIES; CONTROLLED-RELEASE; SWELLING DYNAMICS; PLANTAGO-OVATA; DRUG-DELIVERY; HYDROGEL; SUPERABSORBENT; ACID; NANOPARTICLES,"Dietary fibers are known for their therapeutic role in colon ailments and enhancement of gut microbial growth. Dietary fiber psyllium has been explored as dietary supplement for the treatment of gastrointestinal problems like constipation, colon inflammation and diverticulitis. Hence, in the present work, psyllium has been used to design the hydrogel based drug delivery (DD) system. The antibiotic drug cefuroxime encapsulated arabinoxylan psyllium-phosphated network hydrogels were prepared for drug delivery to colon problems to synergize the effect of antibiotic drug. These grafted and crosslinked copolymers were characterized by solid state 13C NMR, FTIR, TGA-DTG, DSC, SEM, AFM and XRD. The presence of FTIR peak at 1153.30 cm-1 (due to -P--O of poly (BMEP) and at 977.53 cm-1 (due to P-O-C of poly (BMEP) and absence of peak at around 130 ppm in solid state 13C NMR confirmed the incorporation of the phosphate polymers [poly (bis [2-methacryloyloxy] ethyl phosphate [(poly (BMEP)] in to copolymer hydrogels. XRD results indicated the amorphous nature of the polymers. The mesh size (xi) and crosslink density (rho) of network hydrogel was found 74.763 nm and 0.74 x 10-5 mol/cm3 respectively which indicated the porous nature of the hydrogels. Polymers showed 0.50 N mucoadhesion with mucosal membrane. The haemolysis was found less than 5% during blood-polymer interaction indicated blood compatible nature of polymers. The sustained diffusion of cefuroxime was observed with non-Fickian mechanism with Korsmeyer-Peppas best fit kinetic model. Overall, results indicated the suitability of arabinoxylan psylliumphosphated polymers for drug delivery applications.","[Singh, Baljit; Kumari, Ankita; Sharma, Prerna; Mohan, Man] Himachal Pradesh Univ, Dept Chem, Shimla 171005, India",Himachal Pradesh University,"Singh, B (corresponding author), Himachal Pradesh Univ, Dept Chem, Shimla 171005, India.",baljitsinghhpu@yahoo.com,,,,,,,68,0,0,0,0,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",2212-6198,,,BIOACT CARB DIET FIB,Bioact. Carbohydr. Diet. Fibre,MAY,2023,29,,,,,,,,100351,10.1016/j.bcdf.2023.100351,http://dx.doi.org/10.1016/j.bcdf.2023.100351,,,10,Food Science & Technology,Emerging Sources Citation Index (ESCI),Food Science & Technology,QO4K3,,,,,2024-06-04,WOS:001221798400002,View Full Record in Web of Science
J,"Qin, YQ; Wang, LY; Yang, XY; Xu, YJ; Fan, G; Fan, YG; Ren, JN; An, Q; Li, X",,,,"Qin, Yu-Qing; Wang, Liu-Yan; Yang, Xin-Yu; Xu, Yi-Jie; Fan, Gang; Fan, Yan-Ge; Ren, Jing-Nan; An, Qi; Li, Xiao",,,Inulin: properties and health benefits,FOOD & FUNCTION,,,English,Review,,,,,,,CHAIN FATTY-ACIDS; GUT MICROBIOTA; DOUBLE-BLIND; DIETARY FIBER; LIPID-METABOLISM; CHICORY INULIN; COLON-CANCER; EXTRACTION; FRUCTANS; SUPPLEMENTATION,"Inulin, a soluble dietary fiber, is widely found in more than 36 000 plant species as a reserve polysaccharide. The primary sources of inulin, include Jerusalem artichoke, chicory, onion, garlic, barley, and dahlia, among which Jerusalem artichoke tubers and chicory roots are often used as raw materials for inulin production in the food industry. It is universally acknowledged that inulin as a prebiotic has an outstanding effect on the regulation of intestinal microbiota via stimulating the growth of beneficial bacteria. In addition, inulin also exhibits excellent health benefits in regulating lipid metabolism, weight loss, lowering blood sugar, inhibiting the expression of inflammatory factors, reducing the risk of colon cancer, enhancing mineral absorption, improving constipation, and relieving depression. In this review paper, we attempt to present an exhaustive overview of the function and health benefits of inulin.","[Qin, Yu-Qing; Wang, Liu-Yan; Yang, Xin-Yu; Xu, Yi-Jie; Fan, Gang; Ren, Jing-Nan; An, Qi; Li, Xiao] Huazhong Agr Univ, Coll Food Sci & Technol, Key Lab Environm Correlat Dietol, Minist Educ, Wuhan 430070, Peoples R China; [Fan, Yan-Ge] Henan Acad Sci, Inst Chem Co Ltd, Zhengzhou 450002, Peoples R China",Huazhong Agricultural University; Henan Academy of Sciences,"Fan, G (corresponding author), Huazhong Agr Univ, Coll Food Sci & Technol, Key Lab Environm Correlat Dietol, Minist Educ, Wuhan 430070, Peoples R China.;Fan, YG (corresponding author), Henan Acad Sci, Inst Chem Co Ltd, Zhengzhou 450002, Peoples R China.",fangang@mail.hzau.edu.cn,"Qin, Yuqing/GWR-2523-2022; zhou, wei/JQJ-0490-2023; li, wl/JJC-0768-2023; yang, xinyu/AFD-8194-2022; Chen, Feng/JQW-8742-2023","Fan, Yange/0009-0004-5674-4145",Fundamental Research Funds for the Central Universities [2662020SPPY002]; Science and Technology Department of Henan Province [HNGD2021036]; Henan Academy of Sciences [200503004],Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Science and Technology Department of Henan Province; Henan Academy of Sciences,"This study was supported by the Fundamental Research Funds for the Central Universities (Program No. 2662020SPPY002), the project from Science and Technology Department of Henan Province (No. HNGD2021036) and Henan Academy of Sciences (No. 200503004).",,141,23,24,65,142,ROYAL SOC CHEMISTRY,CAMBRIDGE,"THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND",2042-6496,2042-650X,,FOOD FUNCT,Food Funct.,APR 3,2023,14,7,,,,,2948,2968,,10.1039/d2fo01096h,http://dx.doi.org/10.1039/d2fo01096h,,FEB 2023,21,Biochemistry & Molecular Biology; Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Food Science & Technology,C0AO3,36876591,,Y,N,2024-06-04,WOS:000943428200001,View Full Record in Web of Science
J,"CASSIGNEUL, J; CROS, RC; SARLES, H",,,,"CASSIGNEUL, J; CROS, RC; SARLES, H",,,"PROSPECTIVE-STUDY OF CLINICAL SYMPTOMS, DIET, AND RADIOLOGICAL MODIFICATIONS OF SMALL BOWEL AND COLON IN 106 PATIENTS PRESENTING WITH FUNCTIONAL INTESTINAL DISORDERS",GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE,,,French,Article,,,,,,,,"A prospective statistical study of clinical symptoms, radiological modifications of the colon and small bowel, as judged by a morphometric method and dietary habits, was performed in 106 patients who presented with functional intestinal disorders. Four different associations of symptoms and signs were found: pain, sometimes severe in the left upper quadrant and the umbilical region, was associated with morphometric modifications of the small bowel (increased diameter of the upper part, decreased diameter and increased number of folds in the lower part of ileum); slight pain in the 3 upper quadrants and the 2 flanks was associated with flatulence, and was not correlated with modifications of the radiological aspect of the small bowel and colon; constipation and diarrhea were not correlated with any type of morphometric modifications of the colon and constipation was significantly correlated with low fiber diet.","INSERM, U-31, UNITE RECH PATHOL DIGEST, 46 BLVD GAYE, F-13009 MARSEILLE, FRANCE; HOP ST MARGUERITE, MALAD APPAREIL DIGEST & NUTR CLIN, F-13227 MARSEILLE 9, FRANCE",Institut National de la Sante et de la Recherche Medicale (Inserm); Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille,,,,,,,,,7,4,4,0,0,MASSON EDITEUR,MOULINEAUX CEDEX 9,"21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE",0399-8320,,,GASTROEN CLIN BIOL,Gastroenterol. Clin. Biol.,,1983,7,12,,,,,992,996,,,,,,5,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,RY138,6662334,,,,2024-06-04,WOS:A1983RY13800008,View Full Record in Web of Science
J,"Griffin, GC; Roberts, SD; Graham, G",,,,"Griffin, GC; Roberts, SD; Graham, G",,,How to resolve stool retention in a child - Underwear soiling is not a behavior problem,POSTGRADUATE MEDICINE,,,English,Article,,,,,,,CHRONIC CONSTIPATION; ENCOPRESIS; THERAPY; SAFE,"Many parents do not realize their child has stool retention when they bring him or her for an office visit. Some complaints that may be a tip-off and should prompt questioning about stool frequency and underwear soiling are vague abdominal pain, urinary incontinence, and stools so large they plug the toilet. A rectal examination is usually adequate to confirm the diagnosis. Management begins with educating parents that leaking of liquid stool around impaction and onto underwear is completely involuntary, so the child should never be scolded or embarrassed. Stool retention may begin because of unpleasant or unavailable toilet facilities, constipation, or painful elimination and often becomes self-perpetuating. Impaction must be removed immediately; magnesium citrate solution is usually effective. To allow the rectum to return to its normal size, which can take an extended time, stool must be kept soft and movable with administration of mineral oil and appropriate dietary choices (eg, fruit, juice, fiber). Recurrence is common, so ongoing measures and follow-up are important.","Utah Valley Reg Med Ctr, Utah Valley Family Practice Residency, Provo, UT 84604 USA",,"Griffin, GC (corresponding author), 1700 N 2000 E, Mapleton, UT 84664 USA.",,,,,,,,16,4,4,1,2,MCGRAW HILL HEALTHCARE PUBLICATIONS,MINNEAPOLIS,"4530 WEST 77TH ST, MINNEAPOLIS, MN 55435-5000 USA",0032-5481,,,POSTGRAD MED,Postgrad. Med.,JAN,1999,105,1,,,,,159,+,,10.3810/pgm.1999.01.506,http://dx.doi.org/10.3810/pgm.1999.01.506,,,7,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,158BA,9924501,,,,2024-06-04,WOS:000078095100018,View Full Record in Web of Science
J,"Quigley, EMM",,,,"Quigley, Eamonn M. M.",,,Can diet change the natural history of gastrointestinal diseases?,JGH OPEN,,,English,Review,,,,,,celiac disease; constipation; diet; diverticular disease; eosinophilic esophagitis; food allergy; food intolerance; natural history; non-celiac wheat intolerance; post-infection irritable bowel syndrome,IRRITABLE-BOWEL-SYNDROME; DIVERTICULAR-DISEASE; CELIAC-DISEASE; FOOD ALLERGY; FIBER; GLUTEN; COLON; PREVALENCE; DEFICIENCY; ANTIBODIES,"Belatedly, gastroenterologists have begun to pay attention to the role of diet in the exacerbation of gastrointestinal symptoms in many digestive disorders-a recognition that has spurred both high-quality clinical trials and translational research into this area. It has become clear that multiple mechanisms acting either in isolation or together can induce gut symptoms and that appropriate interventions can lead to significant relief. What this review will explore is not the role of diet in the production of certain symptoms or symptom clusters, but rather whether a dietary intervention can beneficially alter the natural history of a gastrointestinal disease-a much more demanding expectation. Yet there are examples of where a diet, if sustained, can have a long-term impact on at least some of those affected by conditions such as eosinophilic esophagitis, celiac disease, food allergy, and constipation.","[Quigley, Eamonn M. M.] Houston Methodist Hosp, Lynda K & David M Underwood Ctr Digest Disorders, Houston, TX USA; [Quigley, Eamonn M. M.] Weill Cornell Med Coll, Houston, TX USA; [Quigley, Eamonn M. M.] Houston Methodist Hosp, Houston Methodist Gastroenterol Associates, 6550 Fannin St, SM 1201, Houston, TX 77030 USA",The Methodist Hospital System; The Methodist Hospital - Houston; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston,"Quigley, EMM (corresponding author), Houston Methodist Hosp, Houston Methodist Gastroenterol Associates, 6550 Fannin St, SM 1201, Houston, TX 77030 USA.",equigley@houstonmethodist.org,,"Quigley, Eamonn/0000-0003-4151-7180",,,,,71,0,0,0,0,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",2397-9070,,,JGH OPEN,JGH Open,MAY,2024,8,5,,,,,,,e13063,10.1002/jgh3.13063,http://dx.doi.org/10.1002/jgh3.13063,,,6,Gastroenterology & Hepatology,Emerging Sources Citation Index (ESCI),Gastroenterology & Hepatology,RI2T5,38770354,gold,,,2024-06-04,WOS:001226976800001,View Full Record in Web of Science
J,"Washabau, RJ; Holt, D",,,,"Washabau, RJ; Holt, D",,,"Pathogenesis, diagnosis, and therapy of feline idiopathic megacolon",VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE,,,English,Article,,,,,,,GASTROINTESTINAL PROKINETIC THERAPY; SMOOTH-MUSCLE FUNCTION; SUBTOTAL COLECTOMY; CATS; CISAPRIDE; DYSAUTONOMIA; DRUGS; CONSTIPATION; OBSTIPATION; DOGS,"Scientific advances in the past decade have brought new understandings to the pathogenesis and therapy of feline colonic motility disorders. Epizootiologic studies have shown, for example, that 96% of the documented cases of obstipation are accounted for by idiopathic megacolon (62%), pelvic canal stenosis (23%), nerve injury (6%), or Manx sacral spinal cord deformity (5%). Recent physiologic studies suggest that most of the idiopathic cases result from colonic smooth muscle dysfunction. The latter studies have also provided evidence that colonic prokinetic agents are useful adjunctive therapy in the treatment of constipation. Many cats are now successfully treated with multicomponent therapy (i.e., dietary fiber supplementation, emollient or hyperosmotic laxatives, and colonic prokinetic agents). Those cats who fail to respond to conservative medical management will generally manifest marked clinical improvement with subtotal colectomy.","Univ Penn, Sch Vet Med, Dept Clin Studies, Philadelphia, PA 19104 USA",University of Pennsylvania,"Washabau, RJ (corresponding author), Univ Penn, Sch Vet Med, Dept Clin Studies, 3900 Delancey St, Philadelphia, PA 19104 USA.",,,,,,,,47,39,39,1,77,W B SAUNDERS CO,PHILADELPHIA,"INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA",0195-5616,,,VET CLIN N AM-SMALL,Vet. Clin. N. Am.-Small Anim. Pract.,MAR,1999,29,2,,,,,589,+,,,,,,16,Veterinary Sciences,Science Citation Index Expanded (SCI-EXPANDED),Veterinary Sciences,187BZ,10202804,hybrid,,,2024-06-04,WOS:000079767400013,View Full Record in Web of Science
J,"Ibrahim, IN; Kamaruding, NA; Ismail, N; Shaharuddin, S",,,,"Ibrahim, Ilya Nasuha; Kamaruding, Noor Azlina; Ismail, Noraznawati; Shaharuddin, Shahrulzaman",,,Value addition to ice cream by fortification with okara and probiotic,JOURNAL OF FOOD PROCESSING AND PRESERVATION,,,English,Article,,,,,,,RHEOLOGICAL PROPERTIES; SENSORY PROPERTIES; DIETARY FIBER; FAT-CONTENT; PRODUCTS; HEALTH; IMPACT; COLOR; MIX,"Synbiotic ice cream offers sufficient viable probiotics and value-added nutrients to satisfy health needs. This study aimed to formulate the optimum synbiotic ice cream incorporated with okara (1-3%) and the probiotic, Lactobacillus plantarum (ATCC 8014). Results showed a viscous texture was produced when more than 2% okara was added to ice cream. This formulation also minimally caused ice cream to melt for around 90 min at a melting rate of 19-76%. Furthermore, ice cream incorporated with okara had an increase in protein content (>5%) and a decrease in fat content (>13%) compared with the control (no okara), indicating that it is a low-fat item. The addition of more than 2% okara increased the viability of L. plantarum on day 60. Overall, 1% okara addition showed significant acceptability for potential symbiotic ice cream formulation. Novelty impact statement One of the greatest challenges in the ice cream manufacturing industry is the short shelf-life and fast melting rate of milk-based ice cream, as it lowers a storage period and affects the textural characteristic. To overcome the said problems, the use of soybean by-product (okara), a potential prebiotic for dietary fiber source, was found to minimally caused ice cream to melt and was able to increase the viability of Lactobacillus plantarum. The function of dietary fiber is not only able to support the growth of probiotics, but also scientifically proven to strengthen the digestive system and reduce the possibility of developing diseases including cardiovascular diseases, diabetes, constipation, and bowel cancer.","[Ibrahim, Ilya Nasuha] Univ Kuala Lumpur, Malaysian Inst Chem & Bioengn Technol, Sect Food Engn Technol, Taboh Naning, Melaka, Malaysia; [Kamaruding, Noor Azlina; Ismail, Noraznawati] Univ Malaysia Terengganu, Inst Marine Biotechnol, Terengganu, Malaysia; [Shaharuddin, Shahrulzaman] Univ Kuala Lumpur, Plant Engn Technol Sect, Malaysian Inst Ind Technol, Branch Campus, Bandar Seri Alam, Johor, Malaysia",University of Kuala Lumpur; Universiti Malaysia Terengganu; University of Kuala Lumpur,"Shaharuddin, S (corresponding author), Univ Kuala Lumpur, Malaysian Inst Ind Technol, Branch Campus, Johor Baharu 81750, Johor, Malaysia.",shahrulzaman@unikl.edu.my,"Shaharuddin, Shahrulzaman/AAC-6239-2022","Shaharuddin, Shahrulzaman/0000-0002-9929-3207","Universiti Kuala Lumpur, Malaysian Institute of Chemical and Bioengineering Technology (UniKL MICET), Section of Food Engineering Technology","Universiti Kuala Lumpur, Malaysian Institute of Chemical and Bioengineering Technology (UniKL MICET), Section of Food Engineering Technology","This research was supported by Universiti Kuala Lumpur, Malaysian Institute of Chemical and Bioengineering Technology (UniKL MICET) especially Section of Food Engineering Technology.",,56,11,11,2,25,WILEY-HINDAWI,LONDON,"ADAM HOUSE, 3RD FL, 1 FITZROY SQ, LONDON, WIT 5HE, ENGLAND",0145-8892,1745-4549,,J FOOD PROCESS PRES,J. Food Process Preserv.,FEB,2022,46,2,,,,,,,e16253,10.1111/jfpp.16253,http://dx.doi.org/10.1111/jfpp.16253,,DEC 2021,12,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,YV7CN,,gold,,,2024-06-04,WOS:000730934500001,View Full Record in Web of Science
J,"Barbara, G; Cremon, C; Bellini, M; Corsetti, M; Di Nardo, G; Falangone, F; Fuccio, L; Galeazzi, F; Iovino, P; Sarnelli, G; Savarino, EV; Stanghellini, V; Staiano, A; Stasi, C; Tosetti, C; Turco, R; Ubaldi, E; Zagari, RM; Zenzeri, L; Marasco, G",,,,"Barbara, Giovanni; Cremon, Cesare; Bellini, Massimo; Corsetti, Maura; Di Nardo, Giovanni; Falangone, Francesca; Fuccio, Lorenzo; Galeazzi, Francesca; Iovino, Paola; Sarnelli, Giovanni; Savarino, Edoardo Vincenzo; Stanghellini, Vincenzo; Staiano, Annamaria; Stasi, Cristina; Tosetti, Cesare; Turco, Rossella; Ubaldi, Enzo; Zagari, Rocco Maurizio; Zenzeri, Letizia; Marasco, Giovanni",,,"Italian guidelines for the management of irritable bowel syndrome Joint Consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM) Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), General Medicine (SIMG), Gastroenterology, Hepatology and Pediatric Nutrition (SIGENP) and Pediatrics (SIP)",DIGESTIVE AND LIVER DISEASE,,,English,Article,,,,,,Irritable bowel syndrome; Diarrhea; Constipation; Disorders of gut-brain interaction,FUNCTIONAL GASTROINTESTINAL DISORDERS; RANDOMIZED CLINICAL-TRIAL; BILE-ACID MALABSORPTION; CHRONIC IDIOPATHIC CONSTIPATION; TRADITIONAL DIETARY ADVICE; DIGITAL RECTAL EXAMINATION; FODMAPS REDUCES SYMPTOMS; PLACEBO-CONTROLLED TRIAL; CELIAC-DISEASE; DOUBLE-BLIND,"The irritable bowel syndrome (IBS) is a chronic disorder of gut-brain interaction. IBS is still associated with areas of uncertainties, especially regarding the optimal diagnostic work-up and the more appropriate management. Experts from 7 Italian Societies conducted a Delphi consensus with literature summary and voting process on 27 statements. Recommendations and quality of evidence were evaluated using the grading of recommendations, assessment, development, and evaluation (GRADE) criteria. Consensus was defined as > 80% agreement and reached for all statements. In terms of diagnosis, the consensus supports a positive diagnostic strategy with a symptom-based approach, including the psychological comorbidities assessment and the exclusion of alarm symptoms, together with the digital rectal examination, full blood count, C-reactive protein, serology for coeliac disease, and fecal calprotectin assessment. Colonoscopy should be recommended in patients with alarm features. Regarding treatment, the consensus strongly supports a dietary approach for patients with IBS, the use of soluble fiber, secretagogues, tricyclic antidepressants, psychologically directed therapies and, only in specific IBS subtypes, rifaximin. A conditional recommendation was achieved for probiotics, polyethylene glycol, antispasmodics, selective serotonin reuptake inhibitors and, only in specific IBS subtypes, 5-HT3 antagonists, 5-HT4 agonists, bile acid sequestrants. (c) 2022 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","[Barbara, Giovanni; Cremon, Cesare; Stanghellini, Vincenzo; Marasco, Giovanni] IRCCS Azienda Ospedaliero Univ Bologna, I-40126 Bologna, Italy; [Barbara, Giovanni; Cremon, Cesare; Fuccio, Lorenzo; Stanghellini, Vincenzo; Zagari, Rocco Maurizio; Marasco, Giovanni] Univ Bologna, Dept Med & Surg Sci, Via Massarenti 9, I-40126 Bologna, Italy; [Bellini, Massimo] Univ Pisa, Dept Translat Sci & New Technol Med & Surg, Gastrointestinal Unit, I-56010 Pisa, Italy; [Corsetti, Maura] Nottingham Univ Hosp NHS Trust, NIHR Nottingham Biomed Res Ctr BRC, Nottingham, England; [Corsetti, Maura] Univ Nottingham, Nottingham Digest Dis Ctr, Nottingham Digest Dis Biomed Res Ctr, Sch Med, Nottingham, England; [Di Nardo, Giovanni; Zenzeri, Letizia] Sapienza Univ Rome, St Andrea Univ Hosp, Fac Med & Psychol, NESMOS Dept, Rome, Italy; [Falangone, Francesca] Univ Sapienza, Med Surg Dept Clin Sci & Translat Med, Rome, Italy; [Fuccio, Lorenzo; Zagari, Rocco Maurizio] IRCCS Azienda Ospedaliero Univ Bologna, Gastroenterol Unit, I-40126 Bologna, Italy; [Galeazzi, Francesca; Savarino, Edoardo Vincenzo] Azienda Osped Univ Padova, Gastroenterol Unit, I-35128 Padua, Italy; [Iovino, Paola] Univ Salerno, Gastrointestinal Unit, Dept Med Surg & Dent Scuola Med Salernitana, I-84081 Baronissi, Italy; [Sarnelli, Giovanni] Univ Naples Federico II, Dept Clin Med & Surg, I-80131 Naples, Italy; [Staiano, Annamaria; Turco, Rossella] Univ Federico II, Dept Translat Med Sci, Sect Pediat, I-80100 Naples, Italy; [Stasi, Cristina] Careggi Univ Hosp, Dept Expt & Clin Med, Internal Med & Liver Unit, Florence, Italy; [Tosetti, Cesare] Heath Care Agcy Bologna, Primary Care, Bologna, Italy; [Ubaldi, Enzo] Hlth Care Agcy Ascoli Piceno, Primary Care, Ascoli Piceno, Italy",IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Pisa; Nottingham University Hospital NHS Trust; University of Nottingham; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Sapienza University Rome; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Salerno; University of Naples Federico II; University of Naples Federico II; University of Florence; Azienda Ospedaliero Universitaria Careggi,"Barbara, G (corresponding author), Univ Bologna, Dept Med & Surg Sci, Via Massarenti 9, I-40126 Bologna, Italy.",giovanni.barbara@unibo.it,"Savarino, Edoardo/AAC-7510-2022; zenzeri, letizia/AAA-8190-2019; Stasi, Cristina/K-3473-2016; Marasco, Giovanni/ADF-5293-2022; Sarnelli, Giovanni/AAB-4050-2019; IOVINO, PAOLA/G-6195-2011","Savarino, Edoardo/0000-0002-3187-2894; zenzeri, letizia/0000-0001-5220-680X; Stasi, Cristina/0000-0002-9146-9968; Marasco, Giovanni/0000-0001-7167-8773; Sarnelli, Giovanni/0000-0002-1467-1134; IOVINO, PAOLA/0000-0002-9568-0680",,,,,220,22,22,7,13,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",1590-8658,1878-3562,,DIGEST LIVER DIS,Dig. Liver Dis.,FEB,2023,55,2,,,,,187,207,,10.1016/j.dld.2022.11.015,http://dx.doi.org/10.1016/j.dld.2022.11.015,,JAN 2023,21,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,8O6XJ,36517261,Green Accepted,Y,N,2024-06-04,WOS:000925978100001,View Full Record in Web of Science
J,"Pomenti, S; Devinsky, J; Jodorkovsky, D",,,,"Pomenti, Sydney; Devinsky, Julie; Jodorkovsky, Daniela",,,Diet for Functional Gastrointestinal Disorders/Disorders of Gut-Brain Interaction,MEDICAL CLINICS OF NORTH AMERICA,,,English,Article,,,,,,Gastroesophageal reflux disease; Functional dyspepsia; Irritable bowel syndrome; Constipation; Fiber; Dietary intervention,IRRITABLE-BOWEL-SYNDROME; GASTROESOPHAGEAL-REFLUX DISEASE; DOUBLE-BLIND TRIAL; CLINICAL GUIDELINE MANAGEMENT; GLUTEN-FREE DIET; LOW-FODMAP DIET; PEPPERMINT-OIL; PSYLLIUM THERAPY; RISK-FACTORS; WHEAT BRAN,,"[Pomenti, Sydney; Devinsky, Julie; Jodorkovsky, Daniela] Columbia Univ, Div Digest & Liver Dis, Irving Med Ctr, 630 West 168th St Suite 3-401, New York, NY 10032 USA",Columbia University; NewYork-Presbyterian Hospital,"Jodorkovsky, D (corresponding author), Columbia Univ, Div Digest & Liver Dis, Irving Med Ctr, 630 West 168th St Suite 3-401, New York, NY 10032 USA.",Dj2470@cumc.columbia.edu,"Ayubi, Tazeen/HLH-8767-2023",,,,,,85,1,1,2,12,W B SAUNDERS CO-ELSEVIER INC,PHILADELPHIA,"1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA",0025-7125,1557-9859,,MED CLIN N AM,Med. Clin. N. Am.,SEP,2022,106,5,,,,,899,912,,10.1016/j.mcna.2022.03.005,http://dx.doi.org/10.1016/j.mcna.2022.03.005,,SEP 2022,14,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,6S6CS,36154707,,,,2024-06-04,WOS:000893073200012,View Full Record in Web of Science
J,"Lever, E; Cole, J; Scott, SM; Emery, PW; Whelan, K",,,,"Lever, E.; Cole, J.; Scott, S. M.; Emery, P. W.; Whelan, K.",,,Systematic review: the effect of prunes on gastrointestinal function,ALIMENTARY PHARMACOLOGY & THERAPEUTICS,,,English,Review,,,,,,,DRIED PLUMS PRUNES; CHRONIC CONSTIPATION; DIETARY FIBER; BOWEL HABITS; HEALTH; PREVALENCE; FOOD; POPULATION; DISORDERS; FREQUENCY,"Background Prunes (dried plums) are high in fibre and are perceived to promote healthy gastrointestinal (GI) function. Aim To assess the effect of prunes on GI function through a systematic review of randomised controlled trials (RCTs). Methods Sixteen electronic databases were searched, a hand search was performed and key opinion leaders were contacted. RCTs investigating the effect of prunes on GI function were included. Two reviewers independently screened relevant articles, extracted data and assessed risk of bias. Results Four trials met the inclusion criteria, one in constipation and three in non-constipated subjects. In constipation, 3 weeks of prune consumption (100 g/day) improved stool frequency (3.5 vs. 2.8 CSBM per week, P = 0.006) and stool consistency (3.2 vs. 2.8 on Bristol stool form scale, P = 0.02) compared with psyllium (22 g/day). In non-constipated subjects, prunes softened stool consistency in one trial and increased stool weight (628 g vs. 514 g/72 h wet weight, P = 0.001) in another trial, compared with control. No trials found differences in GI symptoms between prunes and comparator. Meta-analysis was not appropriate due to heterogeneity in populations and methods. Two of the trials were limited by unclear risk of bias. Conclusions In constipation, prunes appear superior to psyllium for improving stool frequency and consistency, however, the evidence for other outcomes and the effects in non-constipated subjects is weak. Although prunes may be a promising intervention for the management of constipation and increasing stool weight, this needs to be confirmed by further rigorous research.","[Lever, E.; Cole, J.; Emery, P. W.; Whelan, K.] Kings Coll London, Diabet & Nutr Sci Div, Sch Med, London SE1 9NH, England; [Scott, S. M.] Queen Mary Univ London, Wingate Inst Neurogastroenterol, Barts & London Sch Med & Dent, London, England",University of London; King's College London; University of London; Queen Mary University London,"Whelan, K (corresponding author), Kings Coll London, Diabet & Nutr Sci Div, 150 Stamford St, London SE1 9NH, England.",kevin.whelan@kcl.ac.uk,"Whelan, Kevin/ABD-5154-2021; Whelan, Kevin/ABD-5350-2021","Whelan, Kevin/0000-0001-5414-2950; Cole, Jayne/0000-0002-0976-4774",California Dried Plum Board,California Dried Plum Board,"Declaration of funding interests: This systematic review was part of a PhD studentship funded by the California Dried Plum Board. The funders played no role in design, analysis, interpretation of data, writing of the report or the decision to submit the paper for publication.",,41,36,42,0,32,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0269-2813,1365-2036,,ALIMENT PHARM THER,Aliment. Pharmacol. Ther.,OCT,2014,40,7,,,,,750,758,,10.1111/apt.12913,http://dx.doi.org/10.1111/apt.12913,,,9,Gastroenterology & Hepatology; Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Pharmacology & Pharmacy,AQ3JG,25109788,Bronze,,,2024-06-04,WOS:000342687900002,View Full Record in Web of Science
J,"Papadopoulos, M; Mutalib, M; Nikaki, K; Volonaki, E; Rybak, A; Thapar, N; Lindley, K; Borelli, O; Das, A; Crespi, D; Cleeve, S; Athanasakos, E",,,,"Papadopoulos, M.; Mutalib, M.; Nikaki, K.; Volonaki, E.; Rybak, A.; Thapar, N.; Lindley, K.; Borelli, O.; Das, A.; Crespi, D.; Cleeve, S.; Athanasakos, E.",,,Radiopaque marker colonic transit study in the pediatric population BSPGHAN Motility Working Group consensus statement,NEUROGASTROENTEROLOGY AND MOTILITY,,,English,Article,,,,,,colonic manometry; colonic transit time (CTT); constipation; pediatrics; radiopaque marker study (ROMS); scintigraphy,QUALITY-OF-LIFE; FUNCTIONAL GASTROINTESTINAL DISORDERS; NONRETENTIVE FECAL INCONTINENCE; CHILDHOOD CONSTIPATION; SLOW-TRANSIT; ANORECTAL MANOMETRY; DEFECATION DISORDERS; DIETARY FIBER; CHILDREN; TIME,"Functional constipation (FC) is a common condition in childhood in the United Kingdom and worldwide. Various radiological approaches have been established for diagnostic purposes. The radiopaque marker study (ROMS) is universally accepted and used to assess colonic transit time (CTT) in children with FC. Despite being widely used, there is a lack of standardization with various technical protocols, reproducibility of different populations, the purpose for using investigation, variance in the number of markers used, the amount of study days and calculations, the need to empty the colon before performing the test, and whether to perform on medication or off, or the use of specific diets. As part of the British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) motility working group (MWG), we decided to explore further into the evidence, in order to provide guidance regarding the use of ROMS in dealing with FC in the pediatric population.","[Papadopoulos, M.; Mutalib, M.] Evelina London Childrens Hosp, St Thomas Hosp, Dept Paediat Gastroenterol, London, England; [Nikaki, K.; Rybak, A.; Lindley, K.; Borelli, O.] Great Ormond St Hosp Sick Children, Gastroenterol Dept, London, England; [Volonaki, E.] Univ Hosp Bristol NHS Fdn Trust, Dept Paediat Gastroenterol, Bristol, England; [Thapar, N.] Queensland Childrens Hosp, Gastroenterol Hepatol & Liver Transplant, Brisbane, Qld, Australia; [Thapar, N.] Univ Queensland, Fac Med, Brisbane, Qld, Australia; [Thapar, N.] Queensland Univ Technol, Ctr Child Nutr Res, Brisbane, Qld, Australia; [Thapar, N.] UCL Inst Child Hlth, Stem Cells & Regenerat Med, London, England; [Das, A.] Broomfield Hosp, Paediat Dept, Broomfield, England; [Crespi, D.; Cleeve, S.; Athanasakos, E.] Royal London Hosp, Dept Paediat Surg, Barts Hlth NHS, London, England; [Papadopoulos, M.] Evelina London Childrens Hosp, St Thomas Hosp, Dept Paediat Gastroenterol, Westminster Bridge Rd, London SE1 7EH, England",Guy's & St Thomas' NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Bristol; Childrens Health Queensland Hospital & Health Service; Queensland Childrens Hospital; University of Queensland; Queensland University of Technology (QUT); University of London; University College London; Mid Essex Hospital Services NHS Trust; Broomfield Hospital; Barts Health NHS Trust; Royal London Hospital; Guy's & St Thomas' NHS Foundation Trust,"Papadopoulos, M (corresponding author), Evelina London Childrens Hosp, St Thomas Hosp, Dept Paediat Gastroenterol, Westminster Bridge Rd, London SE1 7EH, England.",michalis.papadopoulos@gstt.nhs.uk,,/0000-0003-0241-0508,,,,,89,0,0,0,0,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1350-1925,1365-2982,,NEUROGASTROENT MOTIL,Neurogastroenterol. Motil.,MAY,2024,36,5,,,,,,,,10.1111/nmo.14776,http://dx.doi.org/10.1111/nmo.14776,,MAR 2024,11,Gastroenterology & Hepatology; Clinical Neurology; Neurosciences,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Neurosciences & Neurology,OJ5D0,38454312,,,,2024-06-04,WOS:001180262400001,View Full Record in Web of Science
J,"Rangan, V; Mitsuhashi, S; Singh, P; Ballou, S; Hirsch, W; Sommers, T; Nee, J; Iturrino, J; Lembo, A",,,,"Rangan, Vikram; Mitsuhashi, Shuji; Singh, Prashant; Ballou, Sarah; Hirsch, William; Sommers, Thomas; Nee, Judy; Iturrino, Johanna; Lembo, Anthony",,,"Risk Factors for Fecal Urgency Among Individuals With and Without Diarrhea, Based on Data From the National Health and Nutrition Examination Survey",CLINICAL GASTROENTEROLOGY AND HEPATOLOGY,,,English,Article,,,,,,Irritable Bowel Syndrome; Stool Form; Dietary Factors; United States Population,IRRITABLE-BOWEL-SYNDROME; INCONTINENCE; SYMPTOMS; DYSFUNCTION; EPIDEMIOLOGY; PREVALENCE; PERCEPTION; ALOSETRON; EFFICACY; SAFETY,"BACKGROUND & AIMS: Fecal urgency is a common symptom among patients with gastrointestinal disorders, but can also occur in healthy individuals with normal bowel habits. There have been few studies of fecal urgency in the general population. We performed a cross-sectional analysis of data from the National Health and Nutrition Examination Survey (NHANES) to analyze the prevalence of and risk factors for this symptom. METHODS: We analyzed data from 4676 persons who completed the Bowel Health Questionnaire from the NHANES, from 2009 through 2010. The NHANES sampled a nationally representative group of adults in the United States and provides information on demographics, medical comorbidities, and dietary habits of survey participants. The Bowel Health Questionnaire provided additional information about bowel symptoms such as urgency, incontinence, constipation, and diarrhea. We identified individuals with fecal urgency and calculated differences in fecal urgency among subgroups using chi-squared analysis. We used logistic regression to identify factors associated with urgency. RESULTS: In our study population, the prevalence of fecal urgency was 3.3%; 29.5% of individuals with fecal urgency had diarrhea. The prevalence of fecal urgency was significantly higher in individuals who had diarrhea (14.8%) than in individuals without diarrhea (3.1%). Older age, female sex, poverty, urinary urge incontinence, diarrhea, and increased stool frequency were all associated with fecal urgency on multivariable analysis. Decreased fiber intake and increased carbohydrate intake were associated with urgency among individuals with diarrhea. CONCLUSIONS: In an analysis of data from 4676 individuals who completed a Bowel Health Questionnaire from the NHANES, we found a significantly higher proportion of individuals with diarrhea to have fecal urgency. However, most individuals with fecal urgency do not have diarrhea. Factors associated with fecal urgency vary among individuals with and without diarrhea.","[Rangan, Vikram; Mitsuhashi, Shuji; Singh, Prashant; Ballou, Sarah; Hirsch, William; Sommers, Thomas; Nee, Judy; Iturrino, Johanna; Lembo, Anthony] Harvard Med Sch, Div Gastroenterol, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA",Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School,"Lembo, A (corresponding author), Harvard Med Sch, Div Gastroenterol, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.",alembo@bidmc.harvard.edu,"singh, prashant/AAQ-4412-2020; Ballou, Sarah/AAM-1049-2020","Sommers, Thomas/0000-0002-1300-8234; Hirsch, William/0000-0003-2849-659X; Rangan, Vikram/0000-0001-9804-958X","National Institutes of Health [R01AT00857303, T32DK007760]",National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA),Research reported in this publication was supported by the National Institutes of Health awards R01AT00857303 (A.L.) and T32DK007760 (S.B.).,,28,17,17,0,2,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",1542-3565,1542-7714,,CLIN GASTROENTEROL H,Clin. Gastroenterol. Hepatol.,SEP,2018,16,9,,,,,1450,+,,10.1016/j.cgh.2018.02.020,http://dx.doi.org/10.1016/j.cgh.2018.02.020,,,11,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,GQ3NE,29474972,Green Accepted,,,2024-06-04,WOS:000441570500022,View Full Record in Web of Science
J,"Müller-Lissner, S",,,,"Mueller-Lissner, S.",,,Motility disorders of the colon,INTERNIST,,,German,Article,,,,,,Enteric nervous system; Peristalsis; Transit time; Megacolon; Pelvic floor dyssynergia,IDIOPATHIC MEGARECTUM,"The motility of the colon is modulated by the enteric nervous system. It is very complex, governing backward and forward movements of the feces. Primary megacolon and megarectum are clinically diverse. Megacolon refractory to laxative treatment may be subject to colectomy, while megarectum should be treated by consistent laxation. Acute colonic pseudo-obstruction may occur with severe systemic diseases and electrolyte disturbances or it may be postoperatively and/or medically induced. A small proportion of chronically constipated patients suffer from slow transit constipation, others from disordered defecation. In the remaining patients no objective cause of the complaints may be found. In slow transit constipation, propulsive colonic motility is disturbed, dietary fiber is ineffective, and the response to bisacodyl is blunted. Pelvic floor dyssynergia is characterized by a voluntary (although unconscious) contraction of the anal sphincter simultaneously with the abdominal muscles. It can be treated by avoiding straining and by sphincter training.","Charite, Lehrkrankenhaus, Pk Klin Weissensee, Innere Med Abt, D-13086 Berlin, Germany",Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin,"Müller-Lissner, S (corresponding author), Charite, Lehrkrankenhaus, Pk Klin Weissensee, Innere Med Abt, Schonstr 80, D-13086 Berlin, Germany.",mueli@park-klinik.com,,,,,,,23,1,1,0,11,SPRINGER HEIDELBERG,HEIDELBERG,"TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY",0020-9554,1432-1289,,INTERNIST,Internist,JUN,2015,56,6,,,,,648,652,,10.1007/s00108-014-3607-6,http://dx.doi.org/10.1007/s00108-014-3607-6,,,5,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,CK0BM,25940144,,,,2024-06-04,WOS:000355868900006,View Full Record in Web of Science
J,"Scheperjans, F; Pekkonen, E; Kaakkola, S; Auvinen, P",,,,"Scheperjans, Filip; Pekkonen, Eero; Kaakkola, Seppo; Auvinen, Petri",,,"Linking Smoking, Coffee, Urate, and Parkinson's Disease - A Role for Gut Microbiota?",JOURNAL OF PARKINSONS DISEASE,,,English,Article,,,,,,Gut-brain axis; risk factors; non-motor symptoms; gut motility; constipation; nicotine; caffeine; inflammation; gut permeability; dietary fiber,INTESTINAL MICROBIOTA; ALPHA-SYNUCLEIN; GASTROINTESTINAL MICROBIOTA; NONMOTOR SYMPTOMS; DIETARY-INTAKE; RISK-FACTORS; NICOTINE; BRAIN; CONSTIPATION; BEHAVIOR,"While the etiology and pathogenesis of Parkinson's disease (PD) is still obscure, there is evidence for lifestyle factors influencing disease risk. Best established are the inverse associations with smoking and coffee consumption. In other contexts there is evidence that health effects of lifestyle factors may depend on gut microbiome composition. Considering the gastrointestinal involvement in PD, it was recently speculated, that the associations between smoking, coffee, and PD risk could be mediated by gut microbiota. Here we review such a possible mediatory role of gut microbiota taking into account recent findings on microbiome composition in PD and extending the scope also to urate.","[Scheperjans, Filip; Pekkonen, Eero; Kaakkola, Seppo] Helsinki Univ Hosp, Dept Neurol, Helsinki 00290, Finland; [Scheperjans, Filip; Pekkonen, Eero; Kaakkola, Seppo] Univ Helsinki, Dept Clin Neurosci Neurol, Helsinki, Finland; [Auvinen, Petri] Univ Helsinki, Inst Biotechnol, DNA Sequencing & Genom Lab, Helsinki, Finland",University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki,"Scheperjans, F (corresponding author), Helsinki Univ Hosp, Dept Neurol, Haartmaninkatu 4, Helsinki 00290, Finland.",filip.scheperjans@hus.fi,"Auvinen, Petri/AAP-8117-2021; Auvinen, Petri/D-5044-2009; Scheperjans, Filip/F-7628-2015","Auvinen, Petri/0000-0002-3947-4778; Scheperjans, Filip/0000-0001-9502-7131",,,,,78,55,61,2,45,IOS PRESS,AMSTERDAM,"NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS",1877-7171,1877-718X,,J PARKINSON DIS,J. Parkinsons Dis.,,2015,5,2,,,,,255,262,,10.3233/JPD-150557,http://dx.doi.org/10.3233/JPD-150557,,,8,Neurosciences,Science Citation Index Expanded (SCI-EXPANDED),Neurosciences & Neurology,CJ8GL,25882059,hybrid,,,2024-06-04,WOS:000355738100005,View Full Record in Web of Science
J,"Afshar, S; Kelly, SB; Seymour, K; Woodcock, S; Werner, AD; Mathers, JC",,,,"Afshar, Sorena; Kelly, Seamus B.; Seymour, Keith; Woodcock, Sean; Werner, Anke-Dorothee; Mathers, John C.",,,The Effects of Bariatric Procedures on Bowel Habit,OBESITY SURGERY,,,English,Article,,,,,,Bariatric surgery; Bowel habit; Gut transit; Bristol stool form,GLUCAGON-LIKE PEPTIDE-1; GASTRIC BYPASS-SURGERY; STOOL FORM; POPULATION; FREQUENCY; ENERGY; YY,"Bariatric procedures are increasingly being used to combat the rising obesity epidemic. The aim of this study was to assess the effect of these interventions on bowel habit. We recruited obese adults listed for a bariatric procedure. Demographic data, medical history, medications and anthropometric measurements were recorded. Bowel habit was characterized using a 7-day Bristol Stool Form Scale (BSFS) diary. A validated food frequency questionnaire (FFQ) was used to assess diet. Twenty-six patients were assessed pre-operatively and at a median of 6.4 months post-operatively. Nineteen had a Roux-en-Y gastric bypass (RYGB), five had a sleeve gastrectomy (SG) and two had an intra-gastric balloon (IGB) with median percentage excess weight loss (% EWL) of 67.9, 52.4 and 31.3 %, respectively. Dietary fibre intake decreased from 24.4 (+/- 12.1) g/day pre-operatively to 17.5 (+/- 7.3) g/day post-operatively (P = 0.008). Frequency of bowel motions decreased from 8.6 (+/- 3.5) to 5.7 (+/- 3.5) motions/week (P = 0.001). Mean usual BSFS score decreased (towards firmer stool) from 4.1 (+/- 1.3) pre-operatively to 3.1 (+/- 1.9) post-operatively (P = 0.016). Constipation increased from 8 to 27 %, but this did not reach statistical significance (P = 0.125). Constipation is a common problem after bariatric surgery. The decrease in bowel motion frequency and change towards firmer stools suggest prolonged intestinal transit time after bariatric procedures. Reduction in dietary fibre intake is likely to be a contributory factor.","[Afshar, Sorena; Kelly, Seamus B.; Seymour, Keith; Woodcock, Sean] Northumbria Healthcare NHS Fdn Trust, North Shields, Tyne & Wear, England; [Afshar, Sorena; Werner, Anke-Dorothee; Mathers, John C.] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England",Newcastle University - UK,"Afshar, S (corresponding author), Northumbria Healthcare NHS Fdn Trust, North Shields, Tyne & Wear, England.;Afshar, S (corresponding author), Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England.",s.afshar@doctors.org.uk,,"Mathers, John/0000-0003-3406-3002; Afshar, Sorena/0000-0002-4676-8117",,,,,31,20,23,0,5,SPRINGER,NEW YORK,"233 SPRING ST, NEW YORK, NY 10013 USA",0960-8923,1708-0428,,OBES SURG,Obes. Surg.,OCT,2016,26,10,,,,,2348,2354,,10.1007/s11695-016-2100-9,http://dx.doi.org/10.1007/s11695-016-2100-9,,,7,Surgery,Science Citation Index Expanded (SCI-EXPANDED),Surgery,DW0MY,26894909,"Green Published, hybrid",,,2024-06-04,WOS:000383335700011,View Full Record in Web of Science
J,"D'Alfonso, A; De Carolis, F; Serva, A; Valiyeva, S; Guido, M; Pietroletti, R",,,,"D'Alfonso, Angela; De Carolis, Francesca; Serva, Alessandro; Valiyeva, Sayali; Guido, Maurizio; Pietroletti, Renato",,,Haemorrhoidal disease in pregnancy: results from a self-assessment questionnaire administered by means of a social network,BMC GASTROENTEROLOGY,,,English,Article,,,,,,Haemorrhoids; Pregnancy; Social media; Maternal health; Anal symptoms,THROMBOSED EXTERNAL HEMORRHOIDS; ITALIAN SOCIETY; MANAGEMENT; CHILDBIRTH; PREVALENCE; GUIDELINES; SYMPTOMS; RISK,"Background The anal symptoms occurring during pregnancy and post-partum, mainly related to Haemorrhoidal Disease (HD), have been reported with in a wide range of incidence in the literature. Although in many cases the course of the disease is mild and self-limiting, sometimes it is severe enough to affect quality of life. Methods Our study has been conducted through a questionnaire administered via social media with the aim of obtaining epidemiologic data on the incidence of the symptoms of HD in an unselected population of pregnant women. In addition, we looked for the presence of those factors notoriously predisposing or associated to HD (constipation, straining on the toilet, low dietary fibres and fluid intake). Results Out of 133 patients 51% reported symptoms of HD during pregnancy, mainly in the second and third trimester. Constipation, straining on the toilet, low dietary fibres and fluid intake were not significantly related to incidence of HD. Only a previous history of HD was correlated to onset of symptoms of HD in pregnancy and reached a statistical significance (odds ratio = 5.2, p < 0.001). Conclusion Although with the limitations posed by the nature of our retrospective study via a self-assessment interview, our results suggest that the occurrence of HD in pregnancy seems not sustained by the classical risk factors observed in the general population. At the moment, specific therapeutic measures are lacking and treatment relies on empiric suggestions concerning diet, fluid intake, bowel care, local ointment. Further studies are needed in order to identify a targeted etiologic treatment.","[D'Alfonso, Angela; Serva, Alessandro; Guido, Maurizio] Univ Aquila, Dept Life Hlth & Environm Sci, Unit Obstet & Gynaecol, Laquila, Italy; [De Carolis, Francesca; Valiyeva, Sayali; Pietroletti, Renato] Univ Aquila, Hosp Val Vibrata, Surg Coloproctol, St Omero, TE, Italy; [Pietroletti, Renato] Univ Aquila, Surg Coloproctolgy Hosp Val Vibrata St Omero, Dept Clin Sci & Biotechnol, I-64027 St Omero, TE, Italy",University of L'Aquila; University of L'Aquila; University of L'Aquila,"Pietroletti, R (corresponding author), Univ Aquila, Hosp Val Vibrata, Surg Coloproctol, St Omero, TE, Italy.;Pietroletti, R (corresponding author), Univ Aquila, Surg Coloproctolgy Hosp Val Vibrata St Omero, Dept Clin Sci & Biotechnol, I-64027 St Omero, TE, Italy.",renato.pietroletti@univaq.it,,,,,,,38,0,0,0,0,BMC,LONDON,"CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND",,1471-230X,,BMC GASTROENTEROL,BMC Gastroenterol.,MAY 2,2024,24,1,,,,,,,150,10.1186/s12876-024-03228-5,http://dx.doi.org/10.1186/s12876-024-03228-5,,,7,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,RE2M1,38698334,,,,2024-06-04,WOS:001225927300003,View Full Record in Web of Science
J,"Ramos, CI; Armani, RG; Canziani, ME; Dolenga, CJR; Nakao, LS; Campbell, KL; Cuppari, L",,,,"Ramos, Christiane Ishikawa; Armani, Rachel Gatti; Canziani, Maria Eugenia; Dolenga, Carla Juliana Ribeiro; Nakao, Lia Sumie; Campbell, Katrina Louise; Cuppari, Lilian",,,Bowel Habits and the Association With Uremic Toxins in Non-Dialysis-Dependent Chronic Kidney Disease Patients,JOURNAL OF RENAL NUTRITION,,,English,Article,,,,,,,GASTROINTESTINAL SYMPTOMS; RETENTION TIME; GUT MICROBIOTA; RENAL-FAILURE; P-CRESOL; HEMODIALYSIS; CONSTIPATION; BACTERIA; SYSTEM; SCALE,"Objective: The aim of this study is to evaluate the association between bowel habits and microbial-derived uremic toxins p-cresyl sulfate (PCS) and indoxyl sulfate (IS) in patients with non-dialysis-dependent chronic kidney disease (NDD-CKD). Design and Methods: This is a cross-sectional analysis including 43 nondiabetic NDD-CKD patients (58% men; 59.0 +/- 13.5 years; estimated glomerular filtration rate, 21.3 +/- 7.9 mL/min/1.73 m(2)). Bowel habit was assessed by the Bristol Stool Scale (BSS <3, characterized by hard consistency of stools and/or low frequency of evacuation and BSS >= 3, representing a more regular bowel habit) and by the Rome III criteria. PCS and IS (serum, free and total; urinary, total) were determined by high-performance liquid chromatography. Dietary intake was assessed by the 3-day food records. Results: The frequency of constipation assessed by BSS and Rome III criteria was 33% (n = 14/43) and 35% (n = 15/43), respectively. The BSS <3 exhibited higher PCS, independent of renal function and dietary protein-fiber ratio (beta [95% confidence interval {CI}]: serum, total PCS = 1.54 [1.06-2.23], P = .02; serum free PCS = 1.40 [1.00-1.97], P = .05; urinary PCS = 1.78 [1.10-2.90], P < .02). According to the Rome III criteria, a tendency for a higher serum total PCS (beta [95% CI]: 1.39 [0.95-2.03 mu mol/L], P = .09) and a significantly higher urinary PCS (beta [95% CI]: 1.80 [1.11-2.94 mu mol/24 h], P = .02) was found in constipated participants. No effect of a compromised bowel habit (Rome III criteria or BSS) was found on IS. Conclusion: Constipation may lead to production of PCS in nondiabetic NDD-CKD patients. (C) 2019 by the National Kidney Foundation, Inc. All rights reserved.","[Ramos, Christiane Ishikawa; Cuppari, Lilian] Univ Fed Sao Paulo, Nutr Program, UNIFESP, Sao Paulo, SP, Brazil; [Ramos, Christiane Ishikawa; Armani, Rachel Gatti; Canziani, Maria Eugenia; Cuppari, Lilian] Fundacao Oswaldo Ramos, Hosp Rim, Rua Pedro de Toledo 282, BR-04039000 Sao Paulo, SP, Brazil; [Armani, Rachel Gatti; Canziani, Maria Eugenia; Cuppari, Lilian] Univ Fed Sao Paulo, Div Nephrol, UNIFESP, Sao Paulo, SP, Brazil; [Dolenga, Carla Juliana Ribeiro; Nakao, Lia Sumie] Univ Fed Parana, Dept Basic Pathol, UFPR, Curitiba, Parana, Brazil; [Campbell, Katrina Louise] Bond Univ, Fac Hlth Sci & Med, Gold Coast, Australia",Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Parana; Bond University,"Cuppari, L (corresponding author), Fundacao Oswaldo Ramos, Hosp Rim, Rua Pedro de Toledo 282, BR-04039000 Sao Paulo, SP, Brazil.;Cuppari, L (corresponding author), Univ Fed Sao Paulo, Div Nephrol, Rua Pedro de Toledo 282, BR-04039000 Sao Paulo, SP, Brazil.;Cuppari, L (corresponding author), Univ Fed Sao Paulo, Nutr Program, Rua Pedro de Toledo 282, BR-04039000 Sao Paulo, SP, Brazil.",lcuppari@uol.com.br,"Nakao, Lia S/M-1507-2018; Armani, Rachel/AAP-9698-2021; Cuppari, Lilian/C-3394-2012; Canziani, Maria E F/AGI-3240-2022","Nakao, Lia S/0000-0001-9647-6350; Cuppari, Lilian/0000-0002-5927-9179; Dolenga, Carla Juliana Ribeiro/0000-0001-7781-2259","Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil; MCTI/CNPq) [14/2014]; Fundacao de Amparoa Pesquisa do Estado de Sao Paulo (FAPESP, Brazil) [2014/20725-2, 2016/19724-7]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil); Hospital do Rim-Fundacao Oswaldo Ramos (Sao Paulo, Brazil); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [16/19724-7, 14/20725-2] Funding Source: FAPESP","Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil; MCTI/CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Fundacao de Amparoa Pesquisa do Estado de Sao Paulo (FAPESP, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Hospital do Rim-Fundacao Oswaldo Ramos (Sao Paulo, Brazil); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))","Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil; MCTI/CNPq no.: 14/2014), Fundacao de Amparoa Pesquisa do Estado de Sao Paulo (FAPESP, Brazil; number: 2014/20725-2 and 2016/19724-7), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil), and Hospital do Rim-Fundacao Oswaldo Ramos (Sao Paulo, Brazil) for the financial or material support.",,27,33,33,0,5,W B SAUNDERS CO-ELSEVIER INC,PHILADELPHIA,"1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA",1051-2276,1532-8503,,J RENAL NUTR,J. Renal Nutr.,JAN,2020,30,1,,,,,31,35,,10.1053/j.jrn.2019.02.004,http://dx.doi.org/10.1053/j.jrn.2019.02.004,,,5,Nutrition & Dietetics; Urology & Nephrology,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics; Urology & Nephrology,JY4SR,30956092,,,,2024-06-04,WOS:000504407000006,View Full Record in Web of Science
J,"DUPONT, C; BARAU, E",,,,"DUPONT, C; BARAU, E",,,IRRITABLE-COLON-SYNDROME IN THE CHILD AND FOOD ALLERGY,REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE,,,French,Article,,,,,,,,"Irritable colon syndrome is characterised either by abdominal pain, often accompanied by constipation, or by soft stools and sometimes alteration between the two types of symptoms. Dietary management is often effective: fecal overload, frequently responsible for abdominal pain, is treated by a high fibre diet. Lactose intolerance, which is common, responds to the replacement of milk by yoghourt, which contains a lactase. Certain studies suggest the responsibility of a food allergy, with the ingestion of certain foods being capable in sensitised individuals of inducing intestinal hyperpermeability, the detection of which can serve as an effective guide for an avoidance diet.",,,"HOP ST VINCENT DE PAUL, 82 AVE DENFERT ROCHEREAU, F-75674 PARIS 14, FRANCE.",,,,,,,,0,0,0,0,3,ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER,PARIS,"23 RUE LINOIS, 75724 PARIS, FRANCE",0335-7457,,,REV FR ALLERGOL,Rev. Fr. Allergol. Immunol. Clin.,JAN-MAR,1992,32,1,,,,,36,40,,10.1016/S0335-7457(05)80176-5,http://dx.doi.org/10.1016/S0335-7457(05)80176-5,,,5,Allergy,Science Citation Index Expanded (SCI-EXPANDED),Allergy,HJ588,,,,,2024-06-04,WOS:A1992HJ58800008,View Full Record in Web of Science
J,"Ito, D; Yamamoto, Y; Maekita, T; Yamagishi, N; Kawashima, S; Yoshikawa, T; Tanioka, K; Yoshida, T; Iguchi, M; Kunitatsu, K; Kanai, Y; Kato, S; Kitano, M",,,,"Ito, Daisaku; Yamamoto, Yuta; Maekita, Takao; Yamagishi, Naoko; Kawashima, Shuji; Yoshikawa, Takanori; Tanioka, Kensuke; Yoshida, Takeichi; Iguchi, Mikitaka; Kunitatsu, Kosei; Kanai, Yoshimitsu; Kato, Seiya; Kitano, Masayuki",,,"Do synbiotics really enhance beneficial synbiotics effect on defecation symptoms in healthy adults? Randomized, double-blind, placebo-controlled trial",MEDICINE,,,English,Article,,,,,,BDHQ; Bifidobacterium longum NT strain; PAC-SYM; probiotics; synbiotics,ANIMALIS SUBSP LACTIS; GALACTO-OLIGOSACCHARIDES; FUNCTIONAL CONSTIPATION; INTESTINAL TRANSIT; BOWEL MOVEMENT; PARALLEL-GROUP; DIETARY FIBER; FREQUENCY; SUPPLEMENTATION; BIFIDOBACTERIA,"Goals: We examined whether synbiotics enhance improvement by probiotics. Background: Probiotics, which are beneficial microbacteria, are a nutritional intervention for treatment of functional constipation or its tendency. Prebiotics, meanwhile, can promote the proliferation of probiotics in the gastrointestinal tract and enhance their beneficial effects. Synbiotics, a combination of probiotics and prebiotics, may be superior to probiotics in the treatment of defecation-related symptoms, but this requires elucidation. Study: This randomized, double-blind, placebo-controlled study enrolled 69 healthy adults with constipation tendency. Participants were allocated to either control, probiotics, or synbiotics groups and they recorded details of their defecations and their condition. The first 2 weeks were the observation period and the latter 2 weeks were the intervention period, in which participants took test foods. Probiotic foods included Bifidobacterium longum NT strain (10(10) CFU/day), synbiotic foods included the NT strain (10(10) CFU/day) and galactooligosaccharide (1 g/day). Placebo foods contained the vehicle only. Participants answered questionnaires (Patient Assessment on Constipation Symptoms [PAC-SYM], and one on dietary history) on the last day of each period. Results: Nine participants withdrew consent, and 2 of the remaining 60 had missing data. Age, body mass index, and sex were not significantly different between the 3 groups. Frequency of bowel movements in the fourth week, the primary endpoint, was not increased in the probiotics or synbiotics groups compared with the control group, and the frequency of bowel movements and days with defecation were not changed by probiotics or synbiotics during the intervention period. Probiotics and synbiotics did not improve stool conditions, although incomplete defecation was improved by probiotics but not by synbiotics compared with placebo. PAC-SYM indicated that stool condition and total scores were improved by probiotics but not by synbiotics during the intervention compared with placebo. Conclusion: The probiotic strain Bifidobacterium longum NT can improve constipation symptoms, especially stool condition, but it does not increase bowel movement frequency in healthy adults with constipation tendency. Synbiotics treatment seemed to diminish this improvement of constipation induced by probiotics. This study indicates the possibility of attenuation of beneficial effects from probiotics by the use of synbiotics, contrary to synbiotics theory.","[Ito, Daisaku; Maekita, Takao; Yoshida, Takeichi; Iguchi, Mikitaka; Kitano, Masayuki] Wakayama Med Univ, Dept Internal Med 2, Kimiidera 811-1, Wakayama, Japan; [Yamamoto, Yuta; Yamagishi, Naoko; Kanai, Yoshimitsu] Wakayama Med Univ, Dept Anat & Cell Biol, Kimiidera 811-1, Wakayama 6418509, Japan; [Kawashima, Shuji; Kunitatsu, Kosei; Kato, Seiya] Wakayama Med Univ, Dept Emergency & Crit Care Med, Kimiidera 811-1, Wakayama, Japan; [Yoshikawa, Takanori; Tanioka, Kensuke] Wakayama Med Univ, Clin Study Support Ctr, Kimiidera 811-1, Wakayama, Japan",Wakayama Medical University; Wakayama Medical University; Wakayama Medical University; Wakayama Medical University,"Yamamoto, Y (corresponding author), Wakayama Med Univ, Dept Anat & Cell Biol, Kimiidera 811-1, Wakayama 6418509, Japan.",yuta-y@wakayama-med.ac.jp,"Yamamoto, Yuta/R-1143-2019; Kanai, Yoshimitsu/W-3486-2019","Yamamoto, Yuta/0000-0001-5225-6989; Kanai, Yoshimitsu/0000-0002-0375-6853",Noster Inc.,Noster Inc.,This study was supported by funding from Noster Inc. The funder had no role in data collection or data analysis.,,32,4,4,5,18,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0025-7974,1536-5964,,MEDICINE,Medicine (Baltimore),FEB 25,2022,101,8,,,,,,,e28858,10.1097/MD.0000000000028858,http://dx.doi.org/10.1097/MD.0000000000028858,,,9,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,ZH4YB,35212286,"gold, Green Published",,,2024-06-04,WOS:000760945400028,View Full Record in Web of Science
J,"Shin, D",,,,"Shin, Dongsoon",,,The effect of seamustard on blood lipid profiles and glucose level of rats fed diet with different energy composition,NUTRITION RESEARCH AND PRACTICE,,,English,Article,,,,,,Seamustard; dietary energy composition; blood lipid profile; weight loss; Sprague-Dawley rats,PLASMA; CHOLESTEROL,"Recently, Korean people are consuming seaweeds almost 3.5 times more now than three decades ago. It is well known that seaweeds contain lots of Soluble dietary fiber in addition to micronutrients such as beta-carotene, iodine and some bioactive components. Seaweeds are considered to be effective for preventing chronic diseases including obesity, diabetes mellitus, atherosclerosis, cancer or constipation. This study was conducted to investigate the effect of seamustard intake on body weight gain, blood glucose level and lipid profiles in rats fed diets with different energy nutrient composition. Male Sprague-Dawley rats (average initial weight 103.7 g) were divided into groups for two experiments as follows Control, M2.5 & M5 groups (Exp. 1) and M5, M10, HCM5, HCM10, HFM5 & HFM10 groups (Exp. 11). The rats were fed diet and water ad libitum for 4 weeks. In general, there was no significant difference in blood glucose and triglyceride concentration among groups. In Exp. 1, serum LDL-cholesterol level of rats fed diet with 5%, seamustard powder (M5) was significantly lower than that of control group, while HDL-cholesterol level. TC/LDL ratio and weight of adrenal gland were higher. In Exp. II, food intake, body weight gain and EER of high tat diet with 10% seamustard group (HFM10) were the lowest among groups. Except gastroenemius Muscle, all organ weights of HFM10 group were the lowest. Fecal cholesterol excretion and serum LDL-cholesterol concentration of HFM10 group were the highest, while serum HDL-cholesterol level was the lowest among groups. Interestingly, HDL-cholesterol concentration was the highest in HCM5 group among groups. From these results, it was suggested that seamustard intake might be more effective for body weight control, but not for improving blood lipid profiles in high fat diet than in high carbohydrate diet.","Kyungnam Univ, Dept Food & Nutr Sci, Masan 631701, Kyungnam, South Korea",Kyungnam University,"Shin, D (corresponding author), Kyungnam Univ, Dept Food & Nutr Sci, 449 Wolyong Dong, Masan 631701, Kyungnam, South Korea.",shinds@kyungnam.ac.kr,,,Kyungnam University in 2007,Kyungnam University in 2007,This study was supported by grant of Kyungnam University in 2007.,,21,6,7,0,7,KOREAN NUTRITION SOC,SEOUL,"804 KST CTR, 635-4 YEOGSAM-SONG KANGNAM-KU, SEOUL, 135-703, SOUTH KOREA",1976-1457,2005-6168,,NUTR RES PRACT,Nutr. Res. Pract.,SPR,2009,3,1,,,,,31,37,,10.4162/nrp.2009.3.1.31,http://dx.doi.org/10.4162/nrp.2009.3.1.31,,,7,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,460YE,20016699,"Green Published, Green Submitted",,,2024-06-04,WOS:000267228500005,View Full Record in Web of Science
C,"Jennings, A; Davies, GJ; Dettmar, PW",,"Williams, PA; Phillips, GO",,"Jennings, A; Davies, GJ; Dettmar, PW",,,"Dietary hydrocolloids, special consideration with children",GUMS AND STABILIZERS FOR THE FOOD INDUSTRY 12,ROYAL SOCIETY OF CHEMISTRY SPECIAL PUBLICATIONS,,English,Proceedings Paper,12th Conference on Gums and Stabilisers for the Food Industry,"JUN 23-27, 2003","N E Wales Inst, Wrexham, WALES",,N E Wales Inst,,SCHOOL-AGED CHILDREN; CHRONIC CONSTIPATION; FIBER; SCHOOLCHILDREN; CHILDHOOD,,"S Bank Univ, Nutr Res Ctr, London SE1 0AA, England",London South Bank University,"Jennings, A (corresponding author), S Bank Univ, Nutr Res Ctr, London SE1 0AA, England.",,,,,,,,23,0,0,0,0,ROYAL SOC CHEMISTRY,CAMBRIDGE,"THOMAS GRAHAM HOUSE, SCIENCE PARK, CAMBRIDGE CB4 4WF, CAMBS, ENGLAND",0260-6291,,0-85404-891-X,ROY SOC CH,,,2004,,294,,,,,581,588,,10.1039/9781847551214-00581,http://dx.doi.org/10.1039/9781847551214-00581,,,8,"Chemistry, Applied; Food Science & Technology",Conference Proceedings Citation Index - Science (CPCI-S),Chemistry; Food Science & Technology,BAR97,,,,,2024-06-04,WOS:000223333300061,View Full Record in Web of Science
J,"Kongdang, P; Dukaew, N; Pruksakorn, D; Koonrungsesomboon, N",,,,"Kongdang, Patiwat; Dukaew, Nahathai; Pruksakorn, Dumnoensun; Koonrungsesomboon, Nut",,,Biochemistry of Amaranthus polyphenols and their potential benefits on gut ecosystem: A comprehensive review of the literature,JOURNAL OF ETHNOPHARMACOLOGY,,,English,Review,,,,,,Amaranthus polyphenols; Gut biological activities; Gut microbiota; Amaranthus spp; Biotransformation,"DIETARY PHENOLIC-COMPOUNDS; ELLAGIC ACID; ANTIOXIDANT PROPERTIES; MICROBIAL-METABOLISM; OXIDATIVE STRESS; CAFFEIC ACID; 3,4-DIHYDROXYPHENYLACETIC ACID; PHYTOCHEMICAL COMPOSITION; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY","Ethnopharmacological relevance: The genus Amaranthus is phytonutrients-rich plant distributed worldwide and has been recognized as having medicinal value in traditional use against several diseases and conditions. There are a large amount of research data on the polyphenol profiles of Amaranthus plants and their links with potential benefits against gastrointestinal disorders. Aim of the review: This review article aims to provide a comprehensive review of Amaranthus phenolic compounds and their microbial metabolites, as well as the biological and/or pharmacological effects of those compounds/ metabolites. Methodology: The relevant information about the genus Amaranthus was collected from various sources and databases, including Google Scholar, Google Books, PubMed, Web of Science, Scopus, Science Direct, and other internet sources. The World Flora Online (2021) database was used to verify the scientific names of the plants. Results: Comprehensive review of identified compounds in Amaranthus plants revealed the presence of phenolic acids, flavonoids, and coumarins in each part of the plants. The biotransformation by gut microbiota enzymes prominently produces diverse bioactive metabolites that are potentially active than their precursors. Lines of the evidence support the beneficial roles of Amaranthus extracts in several gastrointestinal diseases, particularly with the polar extracts of several plant parts. Dietary fibers in Amaranthus plants also coordinate the alteration of gut microbiota-related metabolisms and may be beneficial to certain gastrointestinal disorders in particular, such as constipation. Conclusions: Amaranthus plants are rich in polyphenols and dietary fibers. Several microbial metabolites are biologically active, so alteration of gut microbiota is largely linked to the metabolic feature of the plants. Based on the evidence available to date, several Amaranthus plants containing a combination of phytonutrients, particularly polyphenols and dietary fibers, may be a promising candidate that is of interest to be further developed for use in the treatment of certain gastrointestinal conditions/disorders.","[Kongdang, Patiwat; Pruksakorn, Dumnoensun; Koonrungsesomboon, Nut] Chiang Mai Univ, Musculoskeletal Sci & Translat Res MSTR Ctr, Fac Med, Chiang Mai, Thailand; [Dukaew, Nahathai; Koonrungsesomboon, Nut] Chiang Mai Univ, Dept Pharmacol, Fac Med, Chiang Mai 50200, Thailand; [Pruksakorn, Dumnoensun] Chiang Mai Univ, Ctr Multidisciplinary Technol Adv Med CMUTEAM, Fac Med, Chiang Mai, Thailand; [Pruksakorn, Dumnoensun] Chiang Mai Univ, Biomed Engn Inst, Chiang Mai, Thailand",Chiang Mai University; Chiang Mai University; Chiang Mai University; Chiang Mai University,"Koonrungsesomboon, N (corresponding author), Chiang Mai Univ, Dept Pharmacol, Fac Med, Chiang Mai 50200, Thailand.",patiwat.kongdang@gmail.com; nahathai.d@cmu.ac.th; dumnoensun.p@cmu.ac.th; nut.koonrung@cmu.ac.th,"Koonrungsesomboon, Nut/L-2805-2013; Kongdang, Patiwat/AGC-0520-2022","Koonrungsesomboon, Nut/0000-0003-4649-597X; Kongdang, Patiwat/0000-0002-4075-0362",,,,,225,5,7,1,29,ELSEVIER IRELAND LTD,CLARE,"ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND",0378-8741,1872-7573,,J ETHNOPHARMACOL,J. Ethnopharmacol.,DEC 5,2021,281,,,,,,,,114547,10.1016/j.jep.2021.114547,http://dx.doi.org/10.1016/j.jep.2021.114547,,AUG 2021,23,"Plant Sciences; Chemistry, Medicinal; Integrative & Complementary Medicine; Pharmacology & Pharmacy",Science Citation Index Expanded (SCI-EXPANDED),Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary Medicine,WD4CL,34425138,,,,2024-06-04,WOS:000704890700008,View Full Record in Web of Science
J,"Hwang, N; Eom, T; Gupta, SK; Jeong, SY; Jeong, DY; Kim, YS; Lee, JH; Sadowsky, MJ; Unno, T",,,,"Hwang, Nakwon; Eom, Taekil; Gupta, Sachin K.; Jeong, Seong-Yeop; Jeong, Do-Youn; Kim, Yong Sung; Lee, Ji-Hoon; Sadowsky, Michael J.; Unno, Tatsuya",,,Genes and Gut Bacteria Involved in Luminal Butyrate Reduction Caused by Diet and Loperamide,GENES,,,English,Article,,,,,,butyrate synthesis; gut microbiota; gut dysbiosis; metagenomics; mucin,CHAIN FATTY-ACIDS; INDUCED CONSTIPATION; LACTOCOCCUS-LACTIS; METABOLISM; MICROBIOTA; OBESITY; CELL; OSCILLOSPIRA; ASSOCIATIONS; CONTRIBUTES,"Unbalanced dietary habits and gut dysmotility are causative factors in metabolic and functional gut disorders, including obesity, diabetes, and constipation. Reduction in luminal butyrate synthesis is known to be associated with gut dysbioses, and studies have suggested that restoring butyrate formation in the colon may improve gut health. In contrast, shifts in different types of gut microbiota may inhibit luminal butyrate synthesis, requiring different treatments to restore colonic bacterial butyrate synthesis. We investigated the influence of high-fat diets (HFD) and low-fiber diets (LFD), and loperamide (LPM) administration, on key bacteria and genes involved in reduction of butyrate synthesis in mice. MiSeq-based microbiota analysis and HiSeq-based differential gene analysis indicated that different types of bacteria and genes were involved in butyrate metabolism in each treatment. Dietary modulation depleted butyrate kinase and phosphate butyryl transferase by decreasing members of the Bacteroidales and Parabacteroides. The HFD also depleted genes involved in succinate synthesis by decreasing Lactobacillus. The LFD and LPM treatments depleted genes involved in crotonoyl-CoA synthesis by decreasing Roseburia and Oscilllibacter. Taken together, our results suggest that different types of bacteria and genes were involved in gut dysbiosis, and that selected treatments may be needed depending on the cause of gut dysfunction.","[Hwang, Nakwon; Gupta, Sachin K.; Unno, Tatsuya] Jeju Natl Univ, Sch Life Sci, Fac Biotechnol, SARI, Jeju 63243, South Korea; [Eom, Taekil; Unno, Tatsuya] Jeju Natl Univ, Subtrop Trop Organism Gene Bank, Jeju 63243, South Korea; [Jeong, Seong-Yeop; Jeong, Do-Youn] MIFI, Sunchang 595804, Jeonbuk, South Korea; [Kim, Yong Sung] Wonkwang Univ, Sanbon Hosp, Dept Gastroenterol, Gunpo 435040, South Korea; [Lee, Ji-Hoon] Chonbuk Natl Univ, Dept Bioenvironm Chem, Jeonju 54896, South Korea; [Sadowsky, Michael J.] Univ Minnesota, BioTechnol Insittute, St Paul, MN 55108 USA; [Sadowsky, Michael J.] Univ Minnesota, Dept Soil Water & Climate, St Paul, MN 55108 USA; [Sadowsky, Michael J.] Univ Minnesota, Dept Plant & Microbial Biol, St Paul, MN 55108 USA",Jeju National University; Jeju National University; Wonkwang University; Jeonbuk National University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities,"Unno, T (corresponding author), Jeju Natl Univ, Sch Life Sci, Fac Biotechnol, SARI, Jeju 63243, South Korea.;Unno, T (corresponding author), Jeju Natl Univ, Subtrop Trop Organism Gene Bank, Jeju 63243, South Korea.",nakwon3070@gmail.com; taekil7@hanmail.net; sachinkumargupta1721@gmail.com; khs8706@naver.com; jdy2534@korea.kr; wms89@hanmail.net; jhlee2@jbnu.ac.kr; sadowsky@umn.edu; tatsu@jejunu.ac.kr,"Kim, Yong Sung/GMW-8652-2022; Unno, Tatsuya/C-1522-2012; Sadowsky, Michael/J-2507-2016","Kim, Yong Sung/0000-0001-8836-4818; Sadowsky, Michael/0000-0001-8779-2781; Unno, Tatsuya/0000-0003-2373-2100","Traditional Culture Convergence Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2016M3C1B5907205]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2016R1A6A1A03012862]","Traditional Culture Convergence Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education","This research was supported by Traditional Culture Convergence Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2016M3C1B5907205), and the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2016R1A6A1A03012862). We are grateful to Sustainable Agriculture Research Institute (SARI) in Jeju National University for providing the experimental facilities.",,54,30,36,1,25,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2073-4425,,GENES-BASEL,Genes,DEC,2017,8,12,,,,,,,350,10.3390/genes8120350,http://dx.doi.org/10.3390/genes8120350,,,12,Genetics & Heredity,Science Citation Index Expanded (SCI-EXPANDED),Genetics & Heredity,FR6YC,29182580,"Green Published, Green Submitted, gold",,,2024-06-04,WOS:000419212400011,View Full Record in Web of Science
J,"Scheppach, W; Luehrs, H; Menzel, T",,,,"Scheppach, W; Luehrs, H; Menzel, T",,,Beneficial health effects of low-digestible carbohydrate consumption,BRITISH JOURNAL OF NUTRITION,,,English,Article; Proceedings Paper,International Symposium on Low-Digestible Carbohydrates,"JUN 24-25, 1999","UNIV SALFORD, SALFORD, ENGLAND","Roquette Freres,Palatinit GmbH,Purac Biochem BV,Cerestar,Danisco Sweeteners",UNIV SALFORD,low-digestible carbohydrates; dietary fibre; non-starch polysaccharides; short-chain fatty acids; total parenteral nutrition; colorectal cancer,CHAIN FATTY-ACIDS; PORTAL-SYSTEMIC ENCEPHALOPATHY; COLONIC EPITHELIAL-CELLS; CORONARY-HEART-DISEASE; DIETARY FIBER; DIVERTICULAR-DISEASE; BACTERIAL TRANSLOCATION; ULCERATIVE-COLITIS; FRUCTO-OLIGOSACCHARIDES; NUTRITIONAL FACTORS,"Low-digestible carbohydrates represent a class of enzyme-resistant saccharides that have specific effects on the human gastrointestinal tract. In the small bowel, they affect nutrient digestion and absorption, glucose and lipid metabolism and protect against known risk factors of cardiovascular disease. In the colon they are mainly degraded by anaerobic bacteria in a process called fermentation. As a consequence, faecal nitrogen excretion is enhanced, which is used clinically to prevent or treat hepatic encephalopathy. Low-digestible carbohydrates are trophic to the epithelia of the ileum and colon, which helps to avoid bacterial translocation. Short-chain fatty acids are important fermentation products and are evaluated as new therapeutics in acute colitis. They are considered in the primary prevention of colorectal cancer. The bifidogenic effect of fructo-oligosaccharides merits further attention. Unfermented carbohydrates increase faecal bulk and play a role in the treatment of chronic functional constipation, symptomatic diverticulosis and, possibly, the irritable bowel syndrome. In conclusion, low-digestible carbohydrates may play a role in the maintenance of human digestive health. However, the strength of evidence differs between disease entities.","Univ Wurzburg, Dept Med, D-97080 Wurzburg, Germany",University of Wurzburg,"Univ Wurzburg, Dept Med, D-97080 Wurzburg, Germany.",w.scheppach@medizin.uni-wuerzburg.de,,,,,,,84,111,136,0,28,CAMBRIDGE UNIV PRESS,CAMBRIDGE,"EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND",0007-1145,1475-2662,,BRIT J NUTR,Br. J. Nutr.,MAR,2001,85,,,1,,,S23,S30,,10.1079/BJN2000259,http://dx.doi.org/10.1079/BJN2000259,,,8,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S),Nutrition & Dietetics,425EJ,11321025,Bronze,,,2024-06-04,WOS:000168275100004,View Full Record in Web of Science
J,"Camilleri, M; Heading, RC; Thompson, WG",,,,"Camilleri, M; Heading, RC; Thompson, WG",,,"Consensus report: clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome",ALIMENTARY PHARMACOLOGY & THERAPEUTICS,,,English,Review,,,,,,,FUNCTIONAL GASTROINTESTINAL DISORDERS; QUALITY-OF-LIFE; BILE-ACID MALABSORPTION; DOUBLE-BLIND; INTESTINAL GAS; CHRONIC CONSTIPATION; COLONIC MOTILITY; CONTROLLED TRIAL; 5-HT4 RECEPTOR; DIETARY FIBER,"This consensus document reviews the current status of the epidemiology, social impact, patient quality of life, pathophysiology, diagnosis and treatment of irritable bowel syndrome. Current evidence suggests that two major mechanisms may interact in irritable bowel syndrome: altered gastrointestinal motility and increased sensitivity of the intestine. However, other factors, such as psychosocial factors, intake of food and prior infection, may contribute to its development. Management of patients is based on a positive diagnosis of the symptom complex, careful history and physical examination to exclude 'red flags' as risk factors for organic disease, and, if indicated, investigations to exclude other disorders. Therapeutic choices include dietary fibre for constipation, opioid agents for diarrhoea and low-dose antidepressants or infrequent use of antispasmodics for pain, although the evidence basis for efficacy is limited or in some cases absent. Psychotherapy and hypnotherapy are the subject of ongoing study. Treatment should be tailored to patient needs and fears. Novel therapies are emerging, and drugs acting on serotonin receptors have proven efficacy and a scientific rationale and, if approved, should be useful in the overall management of patients with irritable bowel syndrome. Patient and physician education, early identification of psychosocial issues and better therapies are important strategies to reduce the suffering and societal cost of irritable bowel syndrome.","Mayo Clin, ENTER Program, Rochester, MN 55905 USA; Royal Infirm, Edinburgh, Midlothian, Scotland; Univ Ottawa, Ottawa, ON K1N 6N5, Canada",Mayo Clinic; Royal Infirmary of Edinburgh; University of Ottawa,"Mayo Clin, ENTER Program, Charlton 7-154,200 1st St SW, Rochester, MN 55905 USA.",camilleri.michael@mayo.edu,,,"NIDDK NIH HHS [R01 DK54681, K24 DK02638] Funding Source: Medline",NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)),,,230,104,113,0,12,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0269-2813,1365-2036,,ALIMENT PHARM THER,Aliment. Pharmacol. Ther.,AUG,2002,16,8,,,,,1407,1430,,10.1046/j.1365-2036.2002.01305.x,http://dx.doi.org/10.1046/j.1365-2036.2002.01305.x,,,24,Gastroenterology & Hepatology; Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Pharmacology & Pharmacy,585CP,12182741,Bronze,,,2024-06-04,WOS:000177505700003,View Full Record in Web of Science
J,"Khan, MMURH; Hashmi, JZ; Lateef, N; Mumtaz, M; Saleem, F",,,,"Khan, Mohammad Masood Ur Rauf Hiraj; Hashmi, Junaid Zia; Lateef, Naeem; Mumtaz, Moazam; Saleem, Farah",,,Impaction of Phytobezoar at Meckel's Diveticulum,JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN,,,English,Article,,,,,,Phytobezoar; Obstruction; Psychiatric evaluation,,"Small bowel obstruction secondary to phytobezoars is a rare presentation in surgery. These are masses of undigested food and vegetables, which obstruct the narrowest part of gut. We discuss a case of a young patient presenting in emergency department with history of acute abdominal pain, distension and constipation. Diagnosis of acute intestinal obstruction was made on the basis of history, examination, and initial investigations. Exploratory laparotomy revealed a phytobezoar at the origin of Meckel's diverticulum, which was an incidental finding. He underwent wedge resection with primary closure and removal of phytobezoar. The change in dietary habits, decreased fiber intake, and psychiatric evaluation can prevent recurrence.","[Khan, Mohammad Masood Ur Rauf Hiraj; Hashmi, Junaid Zia; Lateef, Naeem; Mumtaz, Moazam; Saleem, Farah] Nishtar Hosp, Dept Gen Surg, Multan, Pakistan",,"Hashmi, JZ (corresponding author), Nishtar Hosp, Dept Gen Surg, Multan, Pakistan.",juneehashmi@yahoo.com,,,,,,,7,1,1,0,0,COLL PHYSICIANS & SURGEONS PAKISTAN,KARACHI,"SEVENTH CENTRAL ST, DEFENCE HOUSING AUTHORITY, KARACHI, 75500, PAKISTAN",1022-386X,1681-7168,,JCPSP-J COLL PHYSICI,JCPSP-J. Coll. Physicians Surg.,MAR,2019,29,3,,,,,276,277,,10.29271/jcpsp.2019.03.276,http://dx.doi.org/10.29271/jcpsp.2019.03.276,,,2,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,HN0RB,30823958,gold,,,2024-06-04,WOS:000459895000019,View Full Record in Web of Science
J,"Smid, A; Strnisa, L; Bajc, K; Vujic-Podlipec, D; Matijasic, BB; Rogelj, I",,,,"Smid, Alenka; Strnisa, Luka; Bajc, Katarina; Vujic-Podlipec, Dunja; Matijasic, Bojana Bogavic; Rogelj, Irena",,,Randomized clinical trial: The effect of fermented milk with the probiotic cultures Lactobacillus acidophilus La-5® and Bifidobacteriurn BB-12® and Beneo dietary fibres on health-related quality of life and the symptoms of irritable bowel syndrome in adults,JOURNAL OF FUNCTIONAL FOODS,,,English,Article,,,,,,Synbiotic; Irritable bowel syndrome; Quality of life; Randomized clinical trial,GASTROINTESTINAL MICROBIOTA; SYMBIOTIC FORMULATION; FECAL MICROBIOTA; DOUBLE-BLIND; EFFICACY; MANAGEMENT; MULTICENTER; PREBIOTICS; IBS; METAANALYSIS,"Clinical trials evaluating the effects of synbiotics on irritable bowel syndrome (IBS) are lacking. The aim of this study was to assess the effect of a synbiotic fermented milk on health related quality of life (QoL) and IBS symptoms in patients with constipation-predominant IBS. Altogether, 76 patients (test = 33, control = 43) were randomized in this multicentre, double-blind, randomized and placebo-controlled trial. On average, an 18% improvement in total IBS-QoL score was reported and significant improvements in bloating severity, satisfaction with bowel movements and the severity of IBS symptoms' interference with patients' everyday life were observed; however, there were no statistically significant differences between the synbiotic group and the placebo group. Sustained improvements in several IBS symptoms and total IBS-QoL score observed in both groups could suggest there may be derivable benefits from the regular consumption of fermented milk; however, this would need to be confirmed in a separate clinical trial. (c) 2016 Elsevier Ltd. All rights reserved.","[Smid, Alenka] Univ Ljubljana, Fac Pharm, Ljubljana 1000, Slovenia; [Strnisa, Luka] Univ Med Ctr Ljubljana, Dept Gastroenterol, Ljubljana 1000, Slovenia; [Bajc, Katarina; Vujic-Podlipec, Dunja] Clinres Farm Doo, Ljubljana 1000, Slovenia; [Matijasic, Bojana Bogavic; Rogelj, Irena] Univ Ljubljana, Biotech Fac, Inst Dairy Sci & Probiot, Domzale 1230, Slovenia",University of Ljubljana; University Medical Centre Ljubljana; University of Ljubljana,"Smid, A (corresponding author), Univ Ljubljana, Fac Pharm, Ljubljana 1000, Slovenia.",alenka.smid@ffa.uni-li.si,"Matijašić, Bojana Bogovič/ABI-8319-2020; Matijasic, Bojana Bogovic/J-2885-2012","Matijašić, Bojana Bogovič/0000-0003-0666-6981;","European Union (EU) - European Regional Development Fund (ERDF); Ministry of Education, Science and Sport of the Republic of Slovenia","European Union (EU) - European Regional Development Fund (ERDF)(European Union (EU)); Ministry of Education, Science and Sport of the Republic of Slovenia","The European Union (EU) - European Regional Development Fund (ERDF) and the Ministry of Education, Science and Sport of the Republic of Slovenia co-financed the Competence Center for Biotechnological Development and Innovation project (from 2010 to 2013). Within the framework of this project, the study was conducted. We would like to express our gratitude to all the patients, investigators, and other personnel who participated in this clinical trial for their invaluable contribution.",,53,14,19,1,47,ELSEVIER SCIENCE BV,AMSTERDAM,"PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",1756-4646,,,J FUNCT FOODS,J. Funct. Food.,JUN,2016,24,,,,,,549,557,,10.1016/j.jff.2016.04.031,http://dx.doi.org/10.1016/j.jff.2016.04.031,,,9,Food Science & Technology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Nutrition & Dietetics,DP3BJ,,,,,2024-06-04,WOS:000378367100053,View Full Record in Web of Science
J,"Ehrenpreis, ED; Chang, D; Eichenwald, E",,,,"Ehrenpreis, Eli D.; Chang, David; Eichenwald, Elad",,,Pharmacotherapy for fecal incontinence: A review,DISEASES OF THE COLON & RECTUM,,,English,Article; Proceedings Paper,International Symposium on Colorectal Disease,"FEB 17-19, 2005","Ft Lauderdale, FL",,,incontinence; feces; bulking agents; anal sphincter; fiber; biomaterials; constipation; fecal impaction; fecal incontinence; fecal disimpaction,IRRITABLE-BOWEL-SYNDROME; INJECTABLE SILICONE BIOMATERIAL; ANAL-SPHINCTER DYSFUNCTION; AUTOLOGOUS FAT INJECTION; CHRONIC DIARRHEA; CONTROLLED-TRIAL; TOPICAL PHENYLEPHRINE; BIOFEEDBACK TREATMENT; DIETARY FIBER; LOPERAMIDE,"Fecal incontinence is a common clinical problem that often is frustrating to the patient and treating physician. Nonsurgical management for fecal incontinence includes dietary manipulation, Kegel exercises, perianal skin care, and biofeedback therapy. Pharmacotherapies often are used to assist in management of fecal incontinence. A variety of pharmacotherapies have been utilized for the management of fecal incontinence; limited data from randomized, placebo-controlled trials are available. This is a review of the existing literature on clinical trials of several classes of drugs and other medical therapies that may be beneficial for patients with fecal incontinence. The information in this article was obtained by a MEDLINE search for all clinical trials of drug therapy for fecal incontinence. These treatments and the existing data on their use are summarized. Treatments reviewed include stool bulking agents, with an emphasis on the most promising effect obtained with calcium polycarbophil, constipating agents, including loperamide, codeine, amitriptyline, atropine, and diphenoxylate agents injected into the anal sphincter, drugs to enhance anal sphincter function, including topical phenylepherine and oral sodium valproate, and trials of fecal disimpaction. A new classification to easily remember the treatment categories for this condition, based on the ABCs of treatment for fecal incontinence, has been introduced into the structure of this review.","Rush Presbyterian St Lukes Med Ctr, Div Gastroenterol, Chicago, IL USA; Univ Penn, Philadelphia, PA 19104 USA; Semmelweis Univ, Budapest, Hungary",Rush University; University of Pennsylvania; Semmelweis University,"Ehrenpreis, ED (corresponding author), 1538 N Arlington Heights Rd, Arlington Hts, IL 60004 USA.",ehrenpreis@gipharm.net,"Ehrenpreis, Eli D/F-4586-2017","Ehrenpreis, Eli D/0000-0002-7209-729X",,,,,49,37,43,0,26,SPRINGER,NEW YORK,"233 SPRING STREET, NEW YORK, NY 10013 USA",0012-3706,,,DIS COLON RECTUM,Dis. Colon Rectum,MAY,2007,50,5,,,,,641,649,,10.1007/s10350-006-0778-9,http://dx.doi.org/10.1007/s10350-006-0778-9,,,9,Gastroenterology & Hepatology; Surgery,Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Surgery,168KG,17205204,,,,2024-06-04,WOS:000246522900009,View Full Record in Web of Science
J,"Schäfer, C",,,,"Schaefer, C.",,,"Gluten-free diet - consequences, which should be considered",ALLERGOLOGIE,,,German,Review,,,,,,gluten; glutenfree diet; NCGS; celiac disease; content of gluten; risks of a glutenfree diet; dietary fiber; constipation,METABOLIC DISEASES DGVS; CELIAC-DISEASE; NONCELIAC GLUTEN; CHRONIC CONSTIPATION; GERMAN SOCIETY; DIAGNOSIS; PATHOPHYSIOLOGY; DEFINITION; PREVALENCE; SENSITIVITY,"The gluten-free diet is the only treatment of choice for patients with celiac disease. This precisely is why this food selection and the practice transfer make high demands on the implementation of this diet. It is important to avoid possible internal and gastroenterological sequelae, which are demonstrably to be expected due to the eating pattern. With regard to that, it is incomprehensible that many people with unclear gastrointestinal symptoms choose a gluten-free diet on their own or based on someone's recommendation, especially if they are not informed about risks and possible negative effects of the diet. The presentation of the target groups, the problems that are to be expected and above all the risks if the persons concerned carry out a gluten-free diet, enables preventive derivations and, if necessary, changes to the estimated unjustified diet recommendations.","[Schaefer, C.] Allergol Schwerpunktpraxis Hamburg, Hamburg, Germany",,"Schäfer, C (corresponding author), Allergol Schwerpunktpraxis, Colonnaden 72, D-20354 Hamburg, Germany.",info@christianeschaefer.de,,,,,,,46,1,1,0,16,DUSTRI-VERLAG DR KARL FEISTLE,DEISENHOFEN-MUENCHEN,"BAHNHOFSTRASSE 9 POSTFACH 49, D-82032 DEISENHOFEN-MUENCHEN, GERMANY",0344-5062,,,ALLERGOLOGIE,Allergologie,JUN,2018,41,6,,,,,244,251,,10.5414/ALX02027,http://dx.doi.org/10.5414/ALX02027,,,8,Allergy,Science Citation Index Expanded (SCI-EXPANDED),Allergy,GJ6VS,,,,,2024-06-04,WOS:000435523100003,View Full Record in Web of Science
J,"Kim, B; Lee, J; Jung, ES; Lee, S; Suh, DH; Park, YJ; Kim, J; Kwak, JM; Lee, S",,,,"Kim, Boyeon; Lee, Jiwon; Jung, Eun Sung; Lee, Sunyoung; Suh, Dong Ho; Park, Yu Jin; Kim, Jin; Kwak, Jung-Myun; Lee, Soohyeon",,,The impact of a modified microbiota-accessible carbohydrate diet on gut microbiome and clinical symptoms in colorectal cancer patients following surgical resection,FRONTIERS IN MICROBIOLOGY,,,English,Article,,,,,,modified MAC diet; colorectal cancer; microbiota; metabolites; bowel habit,FIBER; HEALTH,"A high-fiber diet is widely recognized for its positive effects on the gut microbiome. However, the specific impact of a high-fiber diet on the gut microbiome and bowel habits of patients with colon cancer remains poorly understood. In this study, we aimed to assess the effects of a modified microbiota-accessible carbohydrate (mMAC) diet on gut microbiota composition and clinical symptoms in colon cancer patients who underwent surgical resection. To achieve this, we enrolled 40 patients in two groups: those who received adjuvant chemotherapy and those who did not. Fecal samples were collected before and after dietary interventions for microbial and metabolite analyses. Each group was randomized in a 1: 1 ratio to follow either a 3-week conventional diet followed by a 3-week mMAC diet, or the reverse sequence. Although there were no significant differences in the microbial diversity data before and after the mMAC diet in both the non-chemotherapy and chemotherapy groups, distinct differences in gut microbial composition were revealed after the mMAC diet. Specifically, the abundance of Prevotella, which is associated with high-fiber diets, was further elevated with increased concentrations of acetate and propionate after the mMAC diet. Additionally, patients who experienced improved diarrhea and constipation after the mMAC diet exhibited an enrichment of beneficial bacteria and notable changes in metabolites. In conclusion, this study provides valuable insights into the potential benefits of the mMAC diet, specifically its impact on the gut microbiome and clinical symptoms in postoperative colorectal cancer (CRC) patients. These findings emphasize the potential role of a high-fiber diet in influencing the gut microbiome, and the clinical symptoms warrant further investigation.","[Kim, Boyeon; Lee, Jiwon; Lee, Soohyeon] Korea Univ, Canc Res Inst, Coll Med, Seoul, South Korea; [Kim, Boyeon; Lee, Jiwon; Lee, Soohyeon] Korea Univ, Dept Internal Med, Div Med Oncol & Hematol, Coll Med, Seoul, South Korea; [Jung, Eun Sung; Lee, Sunyoung; Suh, Dong Ho; Park, Yu Jin] HEM Pharm Inc, Suwon, Gyeonggi, South Korea; [Kim, Jin; Kwak, Jung-Myun] Korea Univ, Coll Med, Dept Surg, Seoul, South Korea",Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine),"Lee, S (corresponding author), Korea Univ, Canc Res Inst, Coll Med, Seoul, South Korea.;Lee, S (corresponding author), Korea Univ, Dept Internal Med, Div Med Oncol & Hematol, Coll Med, Seoul, South Korea.",soohyeon_lee@korea.ac.kr,"Lee, Jiwon/KIB-9488-2024","Lee, Jiwon/0000-0002-4274-3633; Lee, Soohyeon/0000-0001-9665-062X",Korea University; Dr. Kitchen company,Korea University; Dr. Kitchen company,"This research was made possible by the generous research funding provided by Dr. Kitchen Company, and Dr. Kitchen and Hyejin Cho for technical support and sharing their expertise in developing mMAC diet plans for the study. Special thanks go to [HEM Pharma Inc. colleagues] for their technical assistance and support with raw data production and data analysis. Their expertise played a crucial role in the successful completion of this study.r The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This research was supported by a Korea University grant and Dr. Kitchen company.",,44,0,0,0,0,FRONTIERS MEDIA SA,LAUSANNE,"AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND",,1664-302X,,FRONT MICROBIOL,Front. Microbiol.,FEB 6,2024,15,,,,,,,,1282932,10.3389/fmicb.2024.1282932,http://dx.doi.org/10.3389/fmicb.2024.1282932,,,11,Microbiology,Science Citation Index Expanded (SCI-EXPANDED),Microbiology,IE4X7,38380099,"gold, Green Published",,,2024-06-04,WOS:001164649200001,View Full Record in Web of Science
J,"Talley, NJ",,,,"Talley, NJ",,,Evaluation of drug treatment in irritable bowel syndrome,BRITISH JOURNAL OF CLINICAL PHARMACOLOGY,,,English,Review,,,,,,alosetron; antidepressants; antispasmodics; irritable bowel syndrome; pharmacological methods; serotonin; tegaserod,FUNCTIONAL GASTROINTESTINAL DISORDERS; CONTROLLED CLINICAL-TRIAL; DOUBLE-BLIND TRIAL; PLACEBO-CONTROLLED TRIAL; SMOOTH-MUSCLE RELAXANTS; LONG-TERM TREATMENT; COARSE WHEAT BRAN; CIMETROPIUM BROMIDE; PEPPERMINT OIL; SYMPTOM IMPROVEMENT,"The irritable bowel syndrome (IBS) remains a therapeutic challenge in part because of the limited understanding of the pathophysiology. The placebo response rate varies in randomized controlled trials from 20 to 70%, and can persist for up to at least 1 year. It is contentious whether dietary fibre and bulking agents relieve the symptoms of IBS; constipation probably improves. Anticholinergic and antispasmodic agents are of questionable benefit in IBS despite positive meta-analyses of poor quality trials. A meta-analysis concluded that the tricyclic antidepressants were superior to placebo in IBS, although the individual trial results were variable. Selective serotonin reuptake inhibitors are of uncertain benefit. Laxatives are used for constipation but probably poorly control the IBS symptom complex. Loperamide is superior to placebo in improvement of diarrhoea but not abdominal pain in IBS. Tegaserod is a well-tolerated aminoguanidine indole derivative of serotonin that is a partial 5HT(4)-receptor agonist with prokinetic properties; a therapeutic gain over placebo of 5% to 15% has been observed in constipation-predominant IBS in females. Alosetron is a 5HT(3)-receptor antagonist that is efficacious in females with diarrhoea-predominant IBS, with a 12% to 17% therapeutic gain; the risk of ischaemic colitis is 1 in 350, with very severe constipation occurring in about 1 in 1000. Optimizing study design remains a challenge in IBS. New visceral analgesic and motility modifying agents, as well as anti-inflammatory agents are in trials, and hopefully additional efficacious therapeutic options for patients with IBS will soon emerge.","Mayo Clin, Rochester, MN 55905 USA",Mayo Clinic,"Mayo Clin, Charlton 8-138,200 1st St SW, Rochester, MN 55905 USA.",talley.nicholas@mayo.edu,"Talley, Nicholas J/D-5399-2013",,,,,,94,44,59,1,10,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0306-5251,1365-2125,,BRIT J CLIN PHARMACO,Br. J. Clin. Pharmacol.,OCT,2003,56,4,,,,,362,369,,10.1046/j.1365-2125.2003.01966.x,http://dx.doi.org/10.1046/j.1365-2125.2003.01966.x,,,8,Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy,721LJ,12968980,"Bronze, Green Published",,,2024-06-04,WOS:000185317600004,View Full Record in Web of Science
J,"Grundmann, O; Yoon, SL",,,,"Grundmann, Oliver; Yoon, Saunjoo L.",,,"Irritable bowel syndrome: Epidemiology, diagnosis and treatment: An update for health-care practitioners",JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,,,English,Review,,,,,,functional bowel disorders; inflammatory bowel disease; irritable bowel syndrome,FUNCTIONAL GASTROINTESTINAL DISORDERS; REUPTAKE INHIBITOR CITALOPRAM; QUALITY-OF-LIFE; TRICYCLIC ANTIDEPRESSANTS; CROHNS-DISEASE; PEPPERMINT OIL; DOUBLE-BLIND; PREVALENCE; METAANALYSIS; EFFICACY,"Irritable bowel syndrome (IBS), a chronic gastrointestinal disorder, affects from 3-20% of the US population, depending on sociocultural and comorbid factors. IBS is characterized by a symptom complex of abdominal pain and abnormal bowel habits that present as diarrhea or constipation, and general physical weakness in the absence of abnormal morphological, histological or inflammatory markers. The main diagnostic Rome III criteria as established by international professional organizations are based on exclusion criteria and the occurrence and rate of symptoms. Because the pathophysiology and causes of IBS are poorly understood, treatment approaches are mainly focused on symptom management to maintain everyday functioning and improve quality of life for persons with IBS. The mainstay of intervention is pharmacological treatment with antispasmodics and antidiarrheals for diarrhea, prokinetics and high-fiber diets for constipation, and supportive therapy with low-dose antidepressants to normalize gastrointestinal motility. Other interventions include lifestyle and dietary changes, psychotherapy, herbal therapies and acupuncture. The purpose of this review is to critically assess benefits and risks of current treatment approaches as well as promising complementary and alternative therapies.","[Grundmann, Oliver] Univ Florida, Coll Pharm, Dept Med Chem, Gainesville, FL 32610 USA; [Yoon, Saunjoo L.] Univ Florida, Coll Nursing, Dept Adult & Elderly, Gainesville, FL 32610 USA",State University System of Florida; University of Florida; State University System of Florida; University of Florida,"Grundmann, O (corresponding author), Univ Florida, Coll Pharm, Dept Med Chem, POB 100485, Gainesville, FL 32610 USA.",grundman@cop.ufl.edu,"Grundmann, Oliver/AFK-1252-2022; YOON, SAUNJOO/IWE-4420-2023; Grundmann, Oliver/AAF-8411-2022","Grundmann, Oliver/0000-0003-2302-8949; Grundmann, Oliver/0000-0003-2302-8949; YOON, SAUNJOO/0000-0001-5669-8709",,,,,80,139,156,1,40,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0815-9319,1440-1746,,J GASTROEN HEPATOL,J. Gastroenterol. Hepatol.,APR,2010,25,4,,,,,691,699,,10.1111/j.1440-1746.2009.06120.x,http://dx.doi.org/10.1111/j.1440-1746.2009.06120.x,,,9,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,574UN,20074154,Bronze,,,2024-06-04,WOS:000276019600008,View Full Record in Web of Science
J,"Patel, S; Goyal, A",,,,"Patel, Seema; Goyal, Arun",,,The current trends and future perspectives of prebiotics research: a review,3 BIOTECH,,,English,Review,,,,,,Prebiotics; Oligosaccharides; Anticancer; Colitis prevention; Cholesterol reduction,HUMAN COLONIC MICROBIOTA; IN-VITRO; GALACTO-OLIGOSACCHARIDES; ENZYMATIC-HYDROLYSIS; DIETARY MODULATION; ALPHA-GLUCOSIDASE; GUT MICROBIOTA; HEALTHY-MEN; RESPONSES; FRUCTOOLIGOSACCHARIDES,"Prebiotics are non-digestible food ingredients that stimulate the growth of bifidogenic and lactic acid bacteria in the gastro-intestinal tract. Typically, the prebiotics consist of dietary fibers and oligosaccharides. Prebiotics exert a plethora of health-promoting effects, owing to which multi million food and pharma industries have been established. Prebiotics are being implicated in starter culture formulation, gut health maintenance, colitis prevention, cancer inhibition, immunopotentiaton, cholesterol removal, reduction of cardiovascular disease, prevention of obesity and constipation, bacteriocin production, use in fishery, poultry, pig, cattle feed and pet food. Looking at the ever-increasing demand of prebiotics, in this review, recent trends in prebiotic production from new novel sources, from food industrial wastes, prebiotic supplementation in food, commercially available prebiotic agents, prebiotic production by various techniques and future perspectives has been discussed. The critical insight into this hot research area aims to stimulate further ponderance.","[Patel, Seema] Lovely Profess Univ, Dept Biotechnol, Jalandhar 144402, Punjab, India; [Goyal, Arun] Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati 781039, Assam, India",Lovely Professional University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati,"Patel, S (corresponding author), Lovely Profess Univ, Dept Biotechnol, Jalandhar 144402, Punjab, India.",seemabiotech83@gmail.com; arungoyl@iitg.ernet.in,,,,,,,97,137,158,6,52,SPRINGER HEIDELBERG,HEIDELBERG,"TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY",2190-572X,2190-5738,,3 BIOTECH,3 Biotech,JUN,2012,2,2,,,,,115,125,,10.1007/s13205-012-0044-x,http://dx.doi.org/10.1007/s13205-012-0044-x,,,11,Biotechnology & Applied Microbiology,Science Citation Index Expanded (SCI-EXPANDED),Biotechnology & Applied Microbiology,V39WV,,"Green Published, hybrid",,,2024-06-04,WOS:000209442000002,View Full Record in Web of Science
J,"Schincaglia, RM; Pimentel, GD; Peixoto, MDG; Cuppari, L; Mota, JF",,,,"Schincaglia, Raquel M.; Pimentel, Gustavo D.; Peixoto, Maria do Rosario G.; Cuppari, Lilian; Mota, Joao Felipe",,,The Effect of Baru (Dypterix alata Vog.) Almond Oil on Markers of Bowel Habits in Hemodialysis Patients,EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE,,,English,Article,,,,,,,STATEMENT AIGO/SICCR DIAGNOSIS; STOOL FORM SCALE; LIQUID PARAFFIN; CHRONIC CONSTIPATION; OLIVE OIL; NUTS; EFFICACY; DISEASE; CHOLESTEROL; SEEDS,"Gastrointestinal symptoms are common in patients in hemodialysis treatment and were frequently associated with low intake of dietary fibers and liquids, oral iron supplementation, phosphate binders, and low level of physical activity. Thus, the aim of this study was to evaluate the effect of baru almond oil in comparison with mineral oil supplementation on bowel habits of hemodialysis patients. Thirty-five patients on hemodialysis (57% men, 49.9 +/- 12.4 years) were enrolled in a 12-week single-blind clinical trial. Patients were allocated (1 : 2) by sex and age into (1) the mineral group: 10 capsules per day of mineral oil (500 mg each) or (2) the baru almond oil group: 10 capsules per day of baru almond oil (500 mg each). Bowel habits were assessed by the Rome IV criteria, Bristol scale, and self-perception of constipation. Food consumption, physical activity level, and time spent sitting were also evaluated at the baseline and at the end of the study. After 12 weeks of supplementation, the baru almond oil group showed reduced Rome IV score (6.1 +/- 5.5 vs 2.8 +/- 4.3, p=0.04) and the straining on the evacuation score (1.2 +/- 1.4 vs 0.4 +/- 0.7; p=0.04), while the mineral group did not show any change in the parameters. The frequency of self-perception of constipation was lower in the baru almond oil group after intervention (45.0% vs 15.0%, p=0.04). Baru almond oil improved bowel habit and the straining on evacuation in hemodialysis patients.","[Schincaglia, Raquel M.; Pimentel, Gustavo D.; Mota, Joao Felipe] Fed Univ Goias UFG, Fac Nutr, Clin & Sports Nutr Res Lab Labince, BR-74030306 Goiania, Go, Brazil; [Peixoto, Maria do Rosario G.] Fed Univ Goias UFG, Fac Nutr, BR-74030306 Goiania, Go, Brazil; [Cuppari, Lilian] Univ Fed Sao Paulo, Div Nephrol, BR-04021001 Sao Paulo, Brazil; [Cuppari, Lilian] Oswaldo Ramos Fdn, BR-04021001 Sao Paulo, Brazil",Universidade Federal de Sao Paulo (UNIFESP),"Mota, JF (corresponding author), Fed Univ Goias UFG, Fac Nutr, Clin & Sports Nutr Res Lab Labince, BR-74030306 Goiania, Go, Brazil.",raquelms@outlook.com; gupimentel@yahoo.com.br; mrg.peixoto@uol.com.br; lcuppari@uol.com.br; jfemota@gmail.com,"Mota, João Felipe/AAU-9194-2020; Peixoto, Maria do Rosário/JMB-1935-2023","Mota, João Felipe/0000-0001-6123-7616; Peixoto, Maria do Rosário/0000-0003-1950-0817; Schincaglia, Raquel/0000-0002-8450-6775",Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES) [001],Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)),This study was partially funded by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES)-Finance Code 001.,,34,3,3,0,0,HINDAWI LTD,LONDON,"ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND",1741-427X,1741-4288,,EVID-BASED COMPL ALT,Evid.-based Complement Altern. Med.,MAY 27,2021,2021,,,,,,,,3187305,10.1155/2021/3187305,http://dx.doi.org/10.1155/2021/3187305,,,8,Integrative & Complementary Medicine,Science Citation Index Expanded (SCI-EXPANDED),Integrative & Complementary Medicine,TD0OC,34135977,"gold, Green Published",,,2024-06-04,WOS:000669034500007,View Full Record in Web of Science
J,"Palavra, NC; Lubomski, M; Flood, VM; Davis, RL; Sue, CM",,,,"Palavra, Natalie C.; Lubomski, Michal; Flood, Victoria M.; Davis, Ryan L.; Sue, Carolyn M.",,,Increased Added Sugar Consumption Is Common in Parkinson's Disease,FRONTIERS IN NUTRITION,,,English,Article,,,,,,Parkinson' s disease; diet; nutrition; carbohydrates; sugars,MOTOR FLUCTUATIONS; DIETARY HABITS; BODY-WEIGHT; QUESTIONNAIRE; FOOD; MANAGEMENT; PROTEIN; INDEX; CARBOHYDRATE; ASSOCIATION,"Objectives: There is limited information about the dietary habits of patients with Parkinson's Disease (PD), or associations of diet with clinical PD features. We report on nutritional intake in an Australian PD cohort. Methods: 103 PD patients and 81 healthy controls (HCs) completed a validated, semi-quantitative food frequency questionnaire. Food and nutrient intake was quantified, with consideration of micronutrients and macronutrients (energy, protein, carbohydrate, fat, fibre, and added sugar). Participants also completed PD-validated non-motor symptom questionnaires to determine any relationships between dietary intake and clinical disease features. Results: Mean daily energy intake did not differ considerably between PD patients and HCs (11,131 kJ/day vs. 10,188 kJ/day, p = 0.241). However, PD patients reported greater total carbohydrate intake (279 g/day vs. 232 g/day, p = 0.034). This was largely attributable to increased daily sugar intake (153 g/day vs. 119 g/day, p = 0.003) and in particular free sugars (61 g/day vs. 41 g/day, p = 0.001). PD patients who (1) experienced chronic pain, (2) were depressed, or (3) reported an impulse control disorder, consumed more total sugars than HCs (all p < 0.05). Increased sugar consumption was associated with an increase in non-motor symptoms, including poorer quality of life, increased constipation severity and greater daily levodopa dose requirement. Conclusions: We provide clinically important insights into the dietary habits of PD patients that may inform simple dietary modifications that could alleviate disease symptoms and severity. The results of this study support clinician led promotion of healthy eating and careful management of patient nutrition as part of routine care.","[Palavra, Natalie C.; Lubomski, Michal; Sue, Carolyn M.] Royal North Shore Hosp, Dept Neurol, Sydney, NSW, Australia; [Lubomski, Michal; Davis, Ryan L.; Sue, Carolyn M.] Univ Sydney, Kolling Inst, Dept Neurogenet, Sydney, NSW, Australia; [Lubomski, Michal; Davis, Ryan L.; Sue, Carolyn M.] Northern Sydney Local Hlth Dist, Sydney, NSW, Australia; [Lubomski, Michal] Univ Notre Dame Australia, Sch Med, Sydney, NSW, Australia; [Flood, Victoria M.] Univ Sydney, Fac Med & Hlth, Sch Hlth Sci, Camperdown, NSW, Australia; [Flood, Victoria M.] Westmead Hosp, Western Sydney Local Hlth Dist, Allied Hlth Res Unit, Sydney, NSW, Australia",Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; Northern Sydney Local Health District; The University of Notre Dame Australia; University of Notre Dame Australia - Sydney; University of Sydney; NSW Health; Westmead Hospital; University of Sydney; Western NSW Local Health District,"Lubomski, M; Sue, CM (corresponding author), Royal North Shore Hosp, Dept Neurol, Sydney, NSW, Australia.;Lubomski, M; Sue, CM (corresponding author), Univ Sydney, Kolling Inst, Dept Neurogenet, Sydney, NSW, Australia.;Lubomski, M; Sue, CM (corresponding author), Northern Sydney Local Hlth Dist, Sydney, NSW, Australia.;Lubomski, M (corresponding author), Univ Notre Dame Australia, Sch Med, Sydney, NSW, Australia.;Flood, VM (corresponding author), Univ Sydney, Fac Med & Hlth, Sch Hlth Sci, Camperdown, NSW, Australia.;Flood, VM (corresponding author), Westmead Hosp, Western Sydney Local Hlth Dist, Allied Hlth Res Unit, Sydney, NSW, Australia.",mlub6241@uni.sydney.edu.au; vicki.flood@sydney.edu.au; carolyn.sue@sydney.edu.au,"Davis, Ryan/A-7430-2015; Flood, Victoria/A-8732-2016","Davis, Ryan/0000-0003-0512-8989; Sue, Carolyn/0000-0003-1255-3617; Flood, Victoria/0000-0001-5310-7221",RACP Research Entry Scholarship; NHMRC Practitioner Fellowship [APP1136800],RACP Research Entry Scholarship; NHMRC Practitioner Fellowship(National Health & Medical Research Council (NHMRC) of Australia),ML was the recipient of a RACP Research Entry Scholarship. RD was a New South Wales Health Early-Mid Career Research Fellow. CS was the recipient of a NHMRC Practitioner Fellowship (APP1136800).,,60,20,22,0,2,FRONTIERS MEDIA SA,LAUSANNE,"AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND",2296-861X,,,FRONT NUTR,Front. Nutr.,MAY 7,2021,8,,,,,,,,628845,10.3389/fnut.2021.628845,http://dx.doi.org/10.3389/fnut.2021.628845,,,11,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Nutrition & Dietetics,SF0ZX,34026805,"gold, Green Published",,,2024-06-04,WOS:000652494100001,View Full Record in Web of Science
J,"Rahman, MM; Mahadeva, S; Ghoshal, UC",,,,"Rahman, M. Masudur; Mahadeva, Sanjiv; Ghoshal, Uday C.",,,"Epidemiological and clinical perspectives on irritable bowel syndrome in India, Bangladesh and Malaysia: A review",WORLD JOURNAL OF GASTROENTEROLOGY,,,English,Review,,,,,,Epidemiology; Functional gastrointestinal disorders; Irritable bowel syndrome; Asia; Symptom; Constipation; Diarrhea,FUNCTIONAL GASTROINTESTINAL DISORDERS; INTESTINAL BACTERIAL OVERGROWTH; QUALITY-OF-LIFE; ROME III QUESTIONNAIRES; ASIA-PACIFIC CONSENSUS; TROPICAL-SPRUE; MAST-CELLS; LACTOSE-MALABSORPTION; MICROSCOPIC COLITIS; GENERAL-POPULATION,"Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder, common in clinic and in the community. It has a significant impact on both society and patients' quality of life. The epidemiology, clinical presentation, and management of IBS may vary in different geographical regions due to differences in diet, gastrointestinal infection, socio-cultural and psychosocial factors, religious and illness beliefs, symptom perception and reporting. Although previous reviews and consensus reports on IBS in Asia have been published, Asia is quite diverse socio-demographically. In this context, India, Bangladesh and Malaysia share some similarities, including: (1) large proportion of the population living in rural areas; (2) rapid development and associated lifestyle changes in urban areas; and (3) dietary, cultural and religious practices. The present review explores the clinical and epidemiological data on IBS from these three major nations in South and South-East Asia. In-depth review of the literature revealed important differences between IBS in the East, as revealed by studies from these three countries, and the West; these include a predominantly rural profile, differences in bowel habit and symptom profile, raising concern with regards to diagnostic criteria and subtyping of IBS, higher dietary fiber consumption, frequent lactose malabsorption, parasitosis, and possible overlap between post-infectious IBS and tropical sprue. Moreover, the current perception on difference in prevalence of the disorder in these countries, as compared to the West, might be related to variation in survey methods.","[Rahman, M. Masudur] Dhaka Med Coll & Hosp, Dept Gastroenterol, Dhaka 1000, Bangladesh; [Mahadeva, Sanjiv] Univ Malaya, Div Gastroenterol, Dept Med, Kuala Lumpur 50603, Malaysia; [Ghoshal, Uday C.] Sanjay Gandhi Postgrad Inst Med Sci, Dept Gastroenterol, Lucknow 226014, Uttar Pradesh, India",Dhaka Medical College; Universiti Malaya; Sanjay Gandhi Postgraduate Institute of Medical Sciences,"Ghoshal, UC (corresponding author), Sanjay Gandhi Postgrad Inst Med Sci, Dept Gastroenterol, Lucknow 226014, Uttar Pradesh, India.",udayghoshal@gmail.com,"Mahadeva, Sanjiv/E-1711-2011","Mahadeva, Sanjiv/0000-0001-5824-0590",,,,,109,38,39,0,3,BAISHIDENG PUBLISHING GROUP INC,PLEASANTON,"8226 REGENCY DR, PLEASANTON, CA 94588 USA",1007-9327,2219-2840,,WORLD J GASTROENTERO,World J. Gastroenterol.,OCT 7,2017,23,37,,,,,6788,6801,,10.3748/wjg.v23.i37.6788,http://dx.doi.org/10.3748/wjg.v23.i37.6788,,,14,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,FI3VZ,29085223,"Green Published, Green Submitted, hybrid",,,2024-06-04,WOS:000411899600004,View Full Record in Web of Science
J,"Simón, MA; Bueno, AM; Durán, M",,,,"Simon, Miguel A.; Bueno, Ana M.; Duran, Montserrat",,,Biofeedback treatment in chronically constipated patients with dyssynergic defecation,REVISTA LATINOAMERICANA DE PSICOLOGIA,,,English,Article,,,,,,dyssynergic defecation; chronic constipation; functional defecation disorders; EMG-biofeedback treatment,THERAPY; CONTRACTION; MANOMETRY; SUPERIOR; PATTERNS; ANISMUS; MUSCLE; TRIAL,"The aim of this study was to evaluate the effects of electromyographic biofeedback training in chronically constipated patients with dyssynergic defecation. With this purpose, ten patients (4 males, 6 females) with dyssynergic defecation unresponsive to dietary corrections and fibre supplements were selected and enclosed in the study on the basis of fulfilled the Rome III criteria for this functional gastrointestinal disorder. The study was carried Out following a series of defined phases: clinical and psychophysiological assessment prior to the treatment (4 weeks), EMG-biofeedback treatment (8 sessions, two per week) and follow-up (4 weeks) one month later. In all phases, four clinical variables were assessed through self-monitoring (frequency of defecations per week, sensation of incomplete evacuation, difficulty evacuation level, and perianal pain at defecation); moreover, psychophysiological measures were obtained through electromyography (EMG) of the external anal sphincter. Results show significant improvements in psychophysiological measures (EMG-activity during straining to defecate and anismus index), as well as in clinical variables. Biofeedback's benefits were maintained at the follow-up period.","[Simon, Miguel A.; Bueno, Ana M.; Duran, Montserrat] Univ A Coruna, Dept Psychol, Res Grp Clin & Hlth Psychol, La Coruna 15071, Spain",Universidade da Coruna,"Simón, MA (corresponding author), Univ A Coruna, Dept Psychol, Res Grp Clin & Hlth Psychol, Campus Elvina, La Coruna 15071, Spain.",,"Simón, Miguel A./X-6884-2019; Simón, Miguel A./A-5912-2011","Simón, Miguel A./0000-0002-1256-7106; Simón, Miguel A./0000-0002-1256-7106; Bueno, Ana M./0000-0002-1255-3409",,,,,24,1,1,1,2,FOUNDATION ADVANCEMENT PSYCHOLOGY,BOGOTA D C,"APARTADO AEREO 92621, BOGOTA D C, COLOMBIA",0120-0534,,,REV LAT AM PSICOL,Rev. Latinoam. Psicol.,,2011,43,1,,,,,105,111,,,,,,7,"Psychology, Multidisciplinary",Social Science Citation Index (SSCI),Psychology,751IN,,,,,2024-06-04,WOS:000289610800010,View Full Record in Web of Science
J,"Safour, W; Hovey, R",,,,"Safour, Wafaa; Hovey, Richard",,,A Phenomenalogic Study About the Dietary Habits and Digestive Complications for People Living with Temporomandibular Joint Disorders,JOURNAL OF ORAL & FACIAL PAIN AND HEADACHE,,,English,Article,,,,,,digestion; experience; nutrition/diet/food; orofacial pain; ternporomandibular disorders,IRRITABLE-BOWEL-SYNDROME; QUALITY-OF-LIFE; OROFACIAL PAIN; EATING-DISORDERS; MYOFASCIAL PAIN; UNITED-STATES; FIBER INTAKE; PREVALENCE; SYMPTOMS; IMPACT,"Aims: To better understand the experiences of individuals who must alter the types of food they eat because of having a chronic temporomandibular joint disorders (TMD) and the digestive issues that these alterations produce. Methods: Six participants answered open-ended questions during semi-structured interviews about their experiences with TMD-related changes in diet and digestion. These interviews, held face-to-face with the participants in a nonclinical environment, were recorded and transcribed. Interpretive phenomenology was used to arrange and analyze the narrative data collected. Results: The authors identified three common themes among the participants: (1) constipation and bloating; (2) loss of chewing function; and (3) weight change. For each of these themes, participants expressed physiologic and psychologic complications, which were largely unaddressed by their health care providers. Conclusion: These findings highlight the need for health care providers to establish nutritional guidelines for TMD individuals at risk of physiologic and psychologic comorbidities. Health care intervention programs to treat people living with chronic TMD pain and that provide nutritional guidance will help decrease medical crises and the need for expensive interventions and will better assist these patients.","[Safour, Wafaa; Hovey, Richard] McGill Univ, Fac Dent, Div Oral Hlth & Soc, Montreal, PQ, Canada; [Safour, Wafaa] Sebha Univ, Fac Dent, Dept Oral Biol, Sebha, Libya",McGill University; Sebha University,"Safour, W (corresponding author), 6710 Chemin Cote St Luc, Montreal, PQ H4V 1H2, Canada.;Hovey, R (corresponding author), 2001 McGill Coll,Suite 537, Montreal, PQ H3A 1G1, Canada.",wafaa.safour@mail.mcgill.ca; richard.hovey@mcgill.ca,,,,,,,112,4,4,1,4,MRE PRESS,SINGAPORE,"14 ROBINSON RD #08-01A FAR EAST FINANCE, SINGAPORE, SINGAPORE",2333-0384,2333-0376,,J ORAL FACIAL PAIN H,J. Oral Facial Pain Headache,FAL,2019,33,4,,,,,377,388,PMID 31247062,10.11607/ofph.2302,http://dx.doi.org/10.11607/ofph.2302,,,12,"Dentistry, Oral Surgery & Medicine",Science Citation Index Expanded (SCI-EXPANDED),"Dentistry, Oral Surgery & Medicine",JI3XB,31247062,,,,2024-06-04,WOS:000493401100005,View Full Record in Web of Science
J,"Kumpitsch, C; Fischmeister, FPS; Mahnert, A; Lackner, S; Wilding, M; Sturm, C; Springer, A; Madl, T; Holasek, S; Högenauer, C; Berg, IA; Schoepf, V; Moissl-Eichinger, C",,,,"Kumpitsch, Christina; Fischmeister, Florian Ph S.; Mahnert, Alexander; Lackner, Sonja; Wilding, Marilena; Sturm, Corina; Springer, Anna; Madl, Tobias; Holasek, Sandra; Hogenauer, Christoph; Berg, Ivan A.; Schoepf, Veronika; Moissl-Eichinger, Christine",,,Reduced B12 uptake and increased gastrointestinal formate are associated with archaeome-mediated breath methane emission in humans,MICROBIOME,,,English,Article,,,,,,Archaeome; Microbiome; Methanogens; Methane; Gut; Gastrointestinal tract; Metabolome; Metagenome; Methanobrevibacter; Christensenellaceae,METHANOBREVIBACTER-SMITHII; BACTERIA; GENOME; DEFICIENCY; COMMUNITY; HYDROGEN; PROPOSAL; NOV.,"Background: Methane is an end product of microbial fermentation in the human gastrointestinal tract. This gas is solely produced by an archaeal subpopulation of the human microbiome. Increased methane production has been associated with abdominal pain, bloating, constipation, IBD, CRC or other conditions. Twenty percent of the (healthy) Western populations innately exhale substantially higher amounts (>5 ppm) of this gas. The underlying principle for differential methane emission and its effect on human health is not sufficiently understood. Results: We assessed the breath methane content, the gastrointestinal microbiome, its function and metabolome, and dietary intake of one-hundred healthy young adults (female: n = 52, male: n = 48; mean age =24.1). On the basis of the amount of methane emitted, participants were grouped into high methane emitters (CH4 breath content 5-75 ppm) and low emitters (CH4 < 5 ppm). The microbiomes of high methane emitters were characterized by a 1000-fold increase in Methanobrevibacter smithii. This archaeon co-occurred with a bacterial community specialized on dietary fibre degradation, which included members of Ruminococcaceae and Christensenellaceae. As confirmed by metagenomics and metabolomics, the biology of high methane producers was further characterized by increased formate and acetate levels in the gut. These metabolites were strongly correlated with dietary habits, such as vitamin, fat and fibre intake, and microbiome function, altogether driving archaeal methanogenesis. Conclusions: This study enlightens the complex, multi-level interplay of host diet, genetics and microbiome composition/function leading to two fundamentally different gastrointestinal phenotypes and identifies novel points of therapeutic action in methane-associated disorders.","[Kumpitsch, Christina; Mahnert, Alexander; Moissl-Eichinger, Christine] Med Univ Graz, Diagnost & Res Inst Hyg Microbiol & Environm Med, Neue Stiftingtalstr 6, A-8010 Graz, Austria; [Fischmeister, Florian Ph S.; Wilding, Marilena; Sturm, Corina] Karl Franzens Univ Graz, Dept Psychol, A-8010 Graz, Austria; [Fischmeister, Florian Ph S.; Schoepf, Veronika] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, A-1090 Vienna, Austria; [Lackner, Sonja; Holasek, Sandra] Med Univ Graz, Div Immunol & Pathophysiol, A-8010 Graz, Austria; [Springer, Anna; Madl, Tobias] Med Univ Graz, Gottfried Schatz Res Ctr Cell Signaling Metab & A, A-8010 Graz, Austria; [Madl, Tobias; Moissl-Eichinger, Christine] BioTechMed, A-8010 Graz, Austria; [Hogenauer, Christoph] Med Univ Graz, Div Gastroenterol & Hepatol, Graz, Austria; [Berg, Ivan A.] Univ Munster, Inst Mol Microbiol & Biotechnol, Munster, Germany",Medical University of Graz; University of Graz; Medical University of Vienna; Medical University of Graz; Medical University of Graz; Medical University of Graz; University of Munster,"Moissl-Eichinger, C (corresponding author), Med Univ Graz, Diagnost & Res Inst Hyg Microbiol & Environm Med, Neue Stiftingtalstr 6, A-8010 Graz, Austria.;Moissl-Eichinger, C (corresponding author), BioTechMed, A-8010 Graz, Austria.",christine.moissl-eichinger@medunigraz.at,"Fischmeister, Florian Ph.S/M-5310-2013; Berg, Ivan/AAZ-3917-2020; Madl, Tobias/B-1682-2012; Moissl-Eichinger, Christine/A-6682-2015","Fischmeister, Florian Ph.S/0000-0003-4573-7666; Madl, Tobias/0000-0002-9725-5231; Hogenauer, Christoph/0000-0003-4566-0806; Sturm, Corina Maria/0009-0007-0885-0834; Springer, Anna/0000-0003-1190-266X","Austrian Science Fund (FWF) [P 32697, KLI 639, P28854, I3792, DK-MCD W1226]; Austrian Research Promotion Agency (FFG) [864690, 870454]; Integrative Metabolism Research Center Graz; Austrian Infrastructure Program 2016/2017; Styrian Government (Zukunftsfonds); BioTechMed-Graz (Flagship project DYNIMO); Austrian Science Fund (FWF) [I3792] Funding Source: Austrian Science Fund (FWF)",Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Research Promotion Agency (FFG); Integrative Metabolism Research Center Graz; Austrian Infrastructure Program 2016/2017; Styrian Government (Zukunftsfonds); BioTechMed-Graz (Flagship project DYNIMO); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)),"We appreciate the financial support provided by the Austrian Science Fund (FWF): P 32697 given to CME and KLI 639 given to CME, VS and FF. We are thankful to all participants of the study for providing sample material and questionnaires. TM was supported by Austrian Science Fund (FWF) grants P28854, I3792 and DK-MCD W1226, the Austrian Research Promotion Agency (FFG) Grants 864690 and 870454; the Integrative Metabolism Research Center Graz; Austrian Infrastructure Program 2016/2017, the Styrian Government (Zukunftsfonds) and BioTechMed-Graz (Flagship project DYNIMO). The funding body had no influence on the study, collection, analysis and interpretation of data, and in writing the manuscript.",,74,22,23,4,27,BMC,LONDON,"CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND",2049-2618,,,MICROBIOME,Microbiome,SEP 24,2021,9,1,,,,,,,193,10.1186/s40168-021-01130-w,http://dx.doi.org/10.1186/s40168-021-01130-w,,,18,Microbiology,Science Citation Index Expanded (SCI-EXPANDED),Microbiology,UU7FJ,34560884,"gold, Green Published",,,2024-06-04,WOS:000698960900001,View Full Record in Web of Science
J,"De Bellis, P; Sisto, A; Lavermicocca, P",,,,"De Bellis, Palmira; Sisto, Angelo; Lavermicocca, Paola",,,Probiotic bacteria and plant-based matrices: An association with improved health-promoting features,JOURNAL OF FUNCTIONAL FOODS,,,English,Article,,,,,,Health-promoting plant properties; Prebiotic molecules; Food carrier for probiotics; Plant-based matrices; Fibers; Phenolic compounds,LACTIC-ACID BACTERIA; CHAIN FATTY-ACIDS; NITRIC-OXIDE SYNTHASE; TABLE OLIVES; DIETARY FIBER; IN-VITRO; FUNCTIONAL CONSTIPATION; LACTOBACILLUS-PENTOSUS; BLACK OLIVES; ARTICHOKE,"The performance of probiotic bacterial strains is influenced by the carrier food and its functional components which while buffering the probiotic through the gastro-intestinal tract, contribute to an efficient implantation of bacterial cells and regulate probiotic features. Particularly, plant-based matrices are eligible substrate for hosting and delivering microbial populations because of their richness in nutrients, fibers, vitamins, minerals and dietary bioactive phytochemicals. The available data indicate that the intrinsic health-promoting properties of diverse plant-based matrices can be successfully exploited and improved developing effective association with probiotics, whose beneficial activity could be in turn improved and modulated by components of the plant-based carrier. In this review, the health-promoting properties of solid plant-based matrices (particularly artichokes, table olives, apple and cabbage) and their association with probiotic bacteria are also described indicating the role of the food matrix in sustaining probiotic cells during product processing, digestive process, gut implantation, and finally in exerting beneficial effects.","[De Bellis, Palmira; Sisto, Angelo; Lavermicocca, Paola] Natl Res Council CNR, Inst Sci Food Prod ISPA, Via Amendola 122-O, I-70126 Bari, Italy",Consiglio Nazionale delle Ricerche (CNR); Istituto Scienze delle Produzioni Alimentari (ISPA-CNR),"Lavermicocca, P (corresponding author), Natl Res Council CNR, Inst Sci Food Prod ISPA, Via Amendola 122-O, I-70126 Bari, Italy.",mirella.debellis@ispa.cnr.it; angelo.sisto@ispa.cnr.it; paola.lavermicocca@ispa.cnr.it,,,"CNR project NUTR-AGE [FOE-2019, DSB.AD004.271]",CNR project NUTR-AGE,"CNR project NUTR-AGE (FOE-2019, DSB.AD004.271).",,112,13,13,2,18,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",1756-4646,2214-9414,,J FUNCT FOODS,J. Funct. Food.,DEC,2021,87,,,,,,,,104821,10.1016/j.jff.2021.104821,http://dx.doi.org/10.1016/j.jff.2021.104821,,OCT 2021,13,Food Science & Technology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Nutrition & Dietetics,WS3BU,,gold,,,2024-06-04,WOS:000715061300004,View Full Record in Web of Science
J,"Sharma, A; Yadav, BS; Ritika",,,,"Sharma, Alka; Yadav, Baljeet Singh; Ritika",,,Resistant starch: Physiological roles and food applications,FOOD REVIEWS INTERNATIONAL,,,English,Review,,,,,,resistant starch; glycemic index; fecal bulking; colon cancer; cholesterol; short chain fatty acids,CHAIN FATTY-ACIDS; HIGH AMYLOSE CORNSTARCH; IN-VITRO FERMENTATION; DIETARY FIBER; GLYCEMIC INDEX; COLON-CANCER; NUTRITIONAL PROPERTIES; INSULIN RESPONSES; POTATO STARCH; ENERGY VALUE,"A portion of starch and starch products that resist digestion in small intestine has been described as resistant starch. Starch may become resistant to digestion due to several reasons, as it may be physically inaccessible, retrograded or chemically modified. Resistant starch may be categorized as a functional dietary fiber, as defined by the American Association of Cereal Chemists and Food and Nutrition Board of the Institute of Medicine of the National Academics. Resistant starch appears to confer considerable health benefits like reduction in risk of colon cancer, hemorrhoids, diverticulosis, constipation, increased fecal bulking, modulation of blood glucose level, and blood cholesterol level as well as play a prebiotic role. Resistant starch has low water holding capacity, small particle size, and bland flavor. Incorporation of resistant starches in baked products, pasta products and beverages imparts improved textural properties and health benefits. Resistant starches are being examined for both their potential health benefits as well as functional properties to produce high quality foods. However, the results and findings of different studies are hampered by differences in experiment design, and differences in sources, types, and doses of resistant starch.","[Sharma, Alka; Yadav, Baljeet Singh; Ritika] Guru Jambheshwar Univ Sci & Technol, Dept Food Technol, Hisar 125001, Haryana, India",Guru Jambheshwar University of Science & Technology,"Sharma, A (corresponding author), Guru Jambheshwar Univ Sci & Technol, Dept Food Technol, Hisar 125001, Haryana, India.",alkabhardwaj@rediffmail.com,"Yadav, Ritika B/IAR-9693-2023; SUAREZ, TEODORO/D-2371-2016","Yadav, Ritika B/0000-0002-9704-6309; Yadav, Baljeet/0000-0003-1503-3473",,,,,247,161,193,9,202,TAYLOR & FRANCIS INC,PHILADELPHIA,"530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA",8755-9129,1525-6103,,FOOD REV INT,Food Rev. Int.,APR-JUN,2008,24,2,,,,,193,234,,10.1080/87559120801926237,http://dx.doi.org/10.1080/87559120801926237,,,42,Food Science & Technology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Nutrition & Dietetics,287KA,,,,,2024-06-04,WOS:000254914800001,View Full Record in Web of Science
J,"Doma, KM; Farrell, EL; Leith-Bailey, ER; Soucier, VD; Duncan, AM",,,,"Doma, Katarina M.; Farrell, Emily L.; Leith-Bailey, Erin R.; Soucier, Victoria D.; Duncan, Alison M.",,,Older Adults' Awareness and Knowledge of Beans in Relation to Their Nutrient Content and Role in Chronic Disease Risk,NUTRIENTS,,,English,Article,,,,,,nutrition awareness; beans; chronic disease risk; nutrition knowledge; older adults; mixed-methods; questionnaire; focus groups,NUTRITION KNOWLEDGE; HEALTH-BENEFITS; CONSUMPTION,"Awareness and knowledge of nutrient-dense foods are important for older adults to help them make dietary choices that support a food-first approach to healthy aging. This is especially important since age is a major risk factor for chronic disease and the proportion of older adults in North America is increasing. Beans can contribute to a food-first approach to healthy aging as they are nutrient-dense and can reduce the risk of chronic diseases. However, studies exploring awareness and knowledge of beans in older adults are lacking. Therefore, the aim of this study was to explore older adults' awareness of beans in relation to their nutrient content and role in chronic disease risk. Community-dwelling older adults (>= 65 years old) were recruited and completed a validated researcher-administered questionnaire (n = 250), which was followed by 10 focus groups (n = 49). Results showed that the majority of older adults considered beans as a healthy food and thought consuming them could improve their health (99.2% and 98.0%, respectively); however, only 51.2% were bean consumers. While the majority (83.6%) of older adults were aware that a serving of beans is high in dietary fibre, bean consumers were significantly more likely to think that consuming beans could improve health areas related to dietary fibre including body weight management and constipation. Furthermore, most (84.8%) older adults thought consuming beans could improve heart health; however, bean consumers were significantly more likely to be aware that one serving of beans is low in nutrients relevant to heart health including total fat, saturated and trans fat as well as cholesterol. This research can help to inform healthcare professionals and public health agencies to create specific dietary strategies focusing on increasing older adults' awareness and knowledge of beans in relation to their nutrient profile and role in promoting health.","[Doma, Katarina M.; Farrell, Emily L.; Leith-Bailey, Erin R.; Soucier, Victoria D.; Duncan, Alison M.] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada",University of Guelph,"Duncan, AM (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada.",kdoma@uoguelph.ca; efarre01@uoguelph.ca; eleithba@uoguelph.ca; vsoucier@uoguelph.ca; amduncan@uoguelph.ca,,,Ontario Agri-Food Innovation Alliance [030193],Ontario Agri-Food Innovation Alliance,"This work was supported by the Ontario Agri-Food Innovation Alliance (Project #030193). The funding source had no role in the study design, data collection, data analysis, results interpretation or the process of manuscript preparation and submission.",,29,12,13,1,6,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,NOV,2019,11,11,,,,,,,2680,10.3390/nu11112680,http://dx.doi.org/10.3390/nu11112680,,,11,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Nutrition & Dietetics,JV3OC,31694320,"Green Published, gold",,,2024-06-04,WOS:000502274600131,View Full Record in Web of Science
J,"Rahim, MA; Saeed, F; Khalid, W; Hussain, M; Anjum, FM",,,,"Rahim, Muhammad Abdul; Saeed, Farhan; Khalid, Waseem; Hussain, Muzzamal; Anjum, Faqir M.",,,Functional and nutraceutical properties of fructo-oligosaccharides derivatives: a review,INTERNATIONAL JOURNAL OF FOOD PROPERTIES,,,English,Review,,,,,,Prebiotic; Fructo-oligosaccharides; Extraction methods; Health benefits,DIETARY FIBER; FRUCTOOLIGOSACCHARIDES; PREBIOTICS; INULIN; PROBIOTICS; FRUCTOSYLTRANSFERASE; OPTIMIZATION; METABOLISM; EXTRACTION; PROFILE,"Prebiotics are good source of dietary fiber or a group of nutrients or non-digestible short chain carbohydrates which human body cannot digest and it stimulates the growth and activity of some friendly bacteria in your intestinal tract. Prebiotics fibers are linked to beta-(2 -> 1) fructosyl units and are universally agreed to be fructooligosaccharides (FOS) or oligofructose or oligosaccharide or inulin. FOS are oligosaccharides that occur naturally in a variety of plants such as garlic and onions, wheat, rye, chicory roots, jerusalem artichokes, nectarine, seaweed, sugar cane bagasse, cassava waste, rice bran, rice straw, apple pomace, papaya, beet root peels, flaxseed, cereals, and banana peels among many others. These are extracted from fruits, vegetables, seeds and cereals using the various novel techniques such as membrane ultra-filtration method, microwave extraction, Ultrasonic Microwave Assisted Extraction, and high-pressure solvent extraction method. FOS are non-digestible carbohydrates with low-calorie that improve the taste and texture of food products while immunity booster, nutraceutical properties, bone health, microbial properties and its prebiotic activity in digestive track are the limelight of current review article. In addition, the main beneficial physiological effects of FOS such as low carcinogenicity, improved mineral absorption in gut and a reduction in serum cholesterol levels, triacylglycerols and phospholipids are the major part of this review. Moreover, FOS is beneficial for long-term blood glucose and its sensitivity to insulin due to the higher contents of plasma-free fatty acids using low tissue glucose. Conclusively, FOS improves intestinal flora, with subsequent relief of constipation, reduce the risk of heart diseases and certain cancers, improved blood lipids in hyperlipidemia, suppressed the production of intestinal putrefactive-substances and make your digestive work better.","[Rahim, Muhammad Abdul; Saeed, Farhan; Khalid, Waseem; Hussain, Muzzamal] Govt Coll Univ, Dept Food Sci, Faisalabad, Pakistan; [Anjum, Faqir M.] Univ Gambia, Adm Dept, Banjul, Gambia",Government College University Faisalabad; University of the Gambia,"Saeed, F (corresponding author), Govt Coll Univ, Dept Food Sci, Faisalabad, Pakistan.;Anjum, FM (corresponding author), Univ Gambia, Adm Dept, Banjul, Gambia.",f.saeed@gcuf.edu.pk; dranjum@utg.edu.gm,"Khalid, Waseem/IXN-2782-2023; ANJUM, FAQIR/AAW-9311-2020; Saeed, Farhan/ABD-2112-2021; Hussain, Muzzamal/AAC-1261-2022; Rahim, Muhammad Abdul/JVD-7113-2023; rahim, muhammad Sadiq/KFT-2740-2024","Saeed, Farhan/0000-0001-5340-4015; Hussain, Muzzamal/0000-0001-6508-1962;",,,,,102,36,37,14,85,TAYLOR & FRANCIS INC,PHILADELPHIA,"530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA",1094-2912,1532-2386,,INT J FOOD PROP,Int. J. Food Prop.,JAN 1,2021,24,1,,,,,1588,1602,,10.1080/10942912.2021.1986520,http://dx.doi.org/10.1080/10942912.2021.1986520,,,15,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,WC5NV,,gold,,,2024-06-04,WOS:000704304900001,View Full Record in Web of Science
J,"VINCENT, R; ROBERTS, A; FRIER, M; PERKINS, AC; MACDONALD, IA; SPILLER, RC",,,,"VINCENT, R; ROBERTS, A; FRIER, M; PERKINS, AC; MACDONALD, IA; SPILLER, RC",,,EFFECT OF BRAN PARTICLE-SIZE ON GASTRIC-EMPTYING AND SMALL-BOWEL TRANSIT IN HUMANS - A SCINTIGRAPHIC STUDY,GUT,,,English,Article,,,,,,GASTRIC EMPTYING; BRAN; FIBER; MOTILITY; SCINTIGRAPHY,DIETARY FIBER; VISCOSITY; GLUCOSE; SATIETY; MEAL,"Bran is an effective treatment for constipation but its use is often limited by heartburn and bloating. This study examined the effect of fine and coarse bran (15 g) on the gastric emptying and small bowel transit of a 325 kcal rice test meal. Twelve healthy volunteers underwent a three way cross over study, ingesting the technetium-99m labelled rice meal with or without 15 g of indium-111m labelled fine or coarse bran, in random order. Serial scintigraphic images were obtained to define gastric emptying and colonic arrival of label. Compared with control values (99 (9) minutes) (mean (SEM)), the time to 50% gastric emptying was significantly delayed by coarse but not fine bran, being 121 (6) and 104 (9) minutes respectively, p < 0.05, n = 12. Fundal emptying was unchanged but both brans seemed to increase the proportion of isotope in the antrum at 90 minutes. Small bowel transit was slightly faster with both bran types but in this study the difference was not significant. Both the bran and rice labels moved down the gut without significant separation. Fine bran causes less disturbance of gastric physiology than coarse bran.","UNIV NOTTINGHAM HOSP,QUEENS MED CTR,DEPT MED,NOTTINGHAM NG7 2UH,ENGLAND; UNIV NOTTINGHAM HOSP,QUEENS MED CTR,DEPT PHYSIOL & PHARMACOL,NOTTINGHAM NG7 2UH,ENGLAND; UNIV NOTTINGHAM HOSP,QUEENS MED CTR,DEPT MED PHYS,NOTTINGHAM NG7 2UH,ENGLAND",University of Nottingham; University of Nottingham; University of Nottingham,,,"spiller, robin/ABE-6690-2021","spiller, robin/0000-0001-6371-4500; Macdonald, Ian/0000-0002-7540-9850",,,,,21,59,67,0,12,BRITISH MED JOURNAL PUBL GROUP,LONDON,"BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR",0017-5749,,,GUT,Gut,AUG,1995,37,2,,,,,216,219,,10.1136/gut.37.2.216,http://dx.doi.org/10.1136/gut.37.2.216,,,4,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,RN260,7557571,"Green Published, Bronze",,,2024-06-04,WOS:A1995RN26000013,View Full Record in Web of Science
J,"Carrera-Juliá, S; Catarina-Moreira, A; Adriana-Santos, C; Fonseca, J; Drehmer, E",,,,"Carrera-Julia, Sandra; Catarina-Moreira, Ana; Adriana-Santos, Carla; Fonseca, Jorge; Drehmer, Eraci",,,Nutritional intake of patients affected by amyotrophic lateral sclerosis in an ambulatory artificial nutrition clinic in Portugal,REVISTA ESPANOLA DE NUTRICION HUMANA Y DIETETICA,,,Spanish,Article,,,,,,Amyotrophic Lateral Sclerosis; Eating; Nutritional Status; Antioxidants; Portugal,DIETARY-INTAKE; RISK; MANAGEMENT; MAGNESIUM; CALCIUM; BIOTIN,"Introduction: Amyotrophic lateral sclerosis (ALS) is a chronic and progressive neurodegenerative pathology, which causes motor neuron death. It results in weight loss, loss of muscle mass and increased nutritional deficiencies. There is a link between nutritional intake and the pathogenesis of ALS. The aim of this analysis was to describe the sociodemographic, anthropometric and clinic characteristics as well as the nutritional intake in a sample of Portuguese ALS patients. Material and Methods: A brief clinical history was taken. Body weight was measured according to the protocol of the International Society for the Advancement of Kinanthropometry (ISAK) and height was taken from the patient's clinical record. A dietary-nutritional anamnesis and a dietary record were performed. Nutritional intake was analysed with the Nutrition and Health (R) software and compared with the dietary reference intakes (DRI). The nutritional adequacy index was consider below recommendations when it was <= 80%. Results: 13 patients (7 men) aged 53-83 years were analysed. 69.20% presented bulbar ALS. 54% were normal weight. All patients had dysphagia and dysarthria and 84.62% had constipation. Compared to the DRI, in both sexes, nutritional deficiency of fiber, vitamin D, E, B-8, B-9, calcium, magnesium and iodine was identified, accompanied by a nutritional excess of protein, lipids, saturated fatty acids and sodium. Conclusions: The finding of these nutritional deficiencies is relevant because the nutrients involved influence pathogenic mechanisms of ALS, because they are antioxidant, anti-inflammatory and contribute to normal motor neuron function. Identified nutritional excesses are associated with oxidative stress, inflammation and increased risk of ALS. Further research in larger sample sizes are needed to contribute to the understanding of the associations between nutritional excess and deficiencies and risk of ALS development and/or progression.","[Carrera-Julia, Sandra] Catholic Univ Valencia San Vicente Martir, Doctoral Sch, Valencia, Spain; [Carrera-Julia, Sandra; Drehmer, Eraci] Catholic Univ Valencia San Vicente Martir, Dept Human Nutr & Dietetich, Valencia, Spain; [Catarina-Moreira, Ana] Polytech Inst Lisbon, Lisbon Higher Sch Hlth Technol, Lisbon, Portugal; [Catarina-Moreira, Ana; Adriana-Santos, Carla] H&TRC Hlth & Technol Res Ctr, Lisbon, Portugal; [Adriana-Santos, Carla; Fonseca, Jorge] Garcia Orta Hosp, Nutr Serv, Almada, Portugal; [Adriana-Santos, Carla; Fonseca, Jorge] Hosp Garcia Orta, GENE Artificial Feeding Team, Almada, Portugal; [Fonseca, Jorge] Interdisciplinary Res Ctr Egas Moniz, PaMNEC Med Pathol Grp, Nutr & Clin Exercise, CiiEM, Monte De Caparica, Portugal",Universidad Catolica de Valencia San Vicente Martir; Universidad Catolica de Valencia San Vicente Martir; Polytechnic Institute of Lisbon; Hospital Garcia de Orta; Hospital Garcia de Orta,"Carrera-Juliá, S (corresponding author), Catholic Univ Valencia San Vicente Martir, Doctoral Sch, Valencia, Spain.;Carrera-Juliá, S (corresponding author), Catholic Univ Valencia San Vicente Martir, Dept Human Nutr & Dietetich, Valencia, Spain.",sandra.carrera@ucv.es,"Juliá, Sandra Carrera -/J-5951-2018","Fonseca, Jorge/0000-0001-6477-7028",,,,,48,0,0,1,4,ASOC ESPANOLA DIETISTAS NUTRICIONISTAS,BARCELONA,"C CONSELL CENT, 314 PRAL B, BARCELONA, 08007, SPAIN",2173-1292,2174-5145,,REV ESP NUTR HUM DIE,Rev. Esp. Nutr. Hum. Diet.,OCT-DEC,2021,25,4,,,,,353,364,,10.14306/renhyd.25.4.1308,http://dx.doi.org/10.14306/renhyd.25.4.1308,,,12,Nutrition & Dietetics,Emerging Sources Citation Index (ESCI),Nutrition & Dietetics,5N7RT,,"Green Submitted, Green Published, gold",,,2024-06-04,WOS:000871986500002,View Full Record in Web of Science
J,"Heizer, WD; Southern, S; McGovern, S",,,,"Heizer, William D.; Southern, Susannah; McGovern, Susan",,,The Role of Diet in Symptoms of Irritable Bowel Syndrome in Adults: A Narrative Review,JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION,,,English,Review,,,,,,,FUNCTIONAL GASTROINTESTINAL DISORDERS; FRUCTOSE-SORBITOL MALABSORPTION; PLACEBO-CONTROLLED CROSSOVER; RANDOMIZED CONTROLLED-TRIAL; FOOD ALLERGY; DOUBLE-BLIND; LACTOSE-INTOLERANCE; ADVERSE-REACTIONS; CELIAC-DISEASE; PEPPERMINT OIL,"This review summarizes what is known about the effect of diet on irritable bowel syndrome (IBS) symptoms emphasizing-data from randomized, controlled clinical trials. Studies suggest that IBS symptoms in one quarter of patients may be caused or exacerbated by one or more dietary components. Recent studies indicate that a diet restricted in fermentable, poorly absorbed carbohydrates, including fructose, fructans (present in wheat and onions), sorbitol, and other sugar alcohols is beneficial, but confirmatory studies are needed. Despite a long history of enthusiastic use, fiber is marginally beneficial. Insoluble fiber may worsen symptoms. Some patients with IBS, especially those with constipation, will improve with increased intake of soluble fiber. Prebiotic fibers have not been adequately tested. Daily use of peppermint oil is effective in relieving IBS symptoms. The usefulness of probiotics in the form of foods such as live-culture yogurt and buttermilk for IBS symptoms is not established. In clinical practice, it is very difficult to establish that a patient's symptoms result from an adverse reaction to food. A double blind placebo-controlled food challenge is the most reliable method, but it is not suitable for routine clinical use. A modified exclusion diet and stepwise reintroduction of foods or trials of eliminating classes of food may be useful. J Am Diet Assoc. 2009;109:1204-1214.","[Heizer, William D.] Univ N Carolina, Sch Med, Div Gastroenterol & Hepatol, Chapel Hill, NC USA; [Southern, Susannah; McGovern, Susan] Univ N Carolina Hosp, Nutr & Food Serv Dept, Chapel Hill, NC USA",University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University North Carolina Hospital,"Heizer, WD (corresponding author), 929 Phils Creek Rd, Chapel Hill, NC 27516 USA.",wdheizer@earthlink.net,,,,,,,176,126,139,1,57,AMER DIETETIC ASSOC,CHICAGO,"120 S RIVERSIDE PLZ, STE 2000, CHICAGO, IL 60606-6995 USA",0002-8223,,,J AM DIET ASSOC,J. Am. Diet. Assoc.,JUL,2009,109,7,,,,,1204,1214,,10.1016/j.jada.2009.04.012,http://dx.doi.org/10.1016/j.jada.2009.04.012,,,11,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,468UE,19559137,,,,2024-06-04,WOS:000267847400017,View Full Record in Web of Science
J,"Prokopowicz, D",,,,"Prokopowicz, D",,,Health promoting attributes of amarantus (Amaranthus cruentus),MEDYCYNA WETERYNARYJNA,,,Polish,Review,,,,,,amarantus; sclerosis and colon cancer prophylaxis; gluten-free diet; fodder,GRAIN,"Amarantus is a valuable plant. It contains unsaturated lipid acids and dietary fiber. In the review some of the available products of amarantus were described. The most important constituent of amarantus is skwalen, which until the present was extracted from the liver of whales and sharks. Introduction of this plant to food products tray act prophylactically, i.e. it appears to possess antisclerotic properties and combat constipation. This latter property may he used in the prophylaxis against cancer of the in. Amarantus may be prescribed for children who require a gluten-free diet. The preparation of amarantus sed not only for consumption by human beings, but also as a component for pharmaceutics and for cosmetic industry, and what is specially important nowadays, for the production of packaging. Amarantus is also recommended as a component of fodder.","Zakazna Akad Med, Klinika Obserwacyjno, PL-15540 Bialystok, Poland",,"Prokopowicz, D (corresponding author), Ul Zurawia 14, PL-15540 Bialystok, Poland.",,,,,,,,17,10,13,1,4,POLISH SOC VETERINARY SCIENCES EDITORIAL OFFICE,LUBLIN,"AKADEMICKA 12, 20-950 LUBLIN, POLAND",0025-8628,,,MED WETER,Med. Weter.,AUG,2001,57,8,,,,,559,561,,,,,,3,Veterinary Sciences,Science Citation Index Expanded (SCI-EXPANDED),Veterinary Sciences,459ET,,,,,2024-06-04,WOS:000170238600005,View Full Record in Web of Science
J,"Perret, C; Stoffel-Kurt, N",,,,"Perret, Claudio; Stoffel-Kurt, Nadine",,,Comparison of nutritional intake between individuals with acute and chronic spinal cord injury,JOURNAL OF SPINAL CORD MEDICINE,,,English,Article,,,,,,Spinal cord injuries; Acute; Chronic; Paraplegia; Tetraplegia; Resting energy expenditure; Dietary intake; Body fat content; Nutrition; Education,CHRONIC GASTROINTESTINAL PROBLEMS; BODY-COMPOSITION; ENERGY-EXPENDITURE; DIETARY; CONSTIPATION,"Objective: To compare the nutritional intake of patients with acute and chronic spinal cord injury (SCI). Design: Cross-sectional, observational study. Setting: Spinal cord unit. Methods: Twelve in-house patients of a spinal cord unit with acute SCI and paralysis duration of 5.3 +/- 2.5 months (acute group) were compared with 12 subjects with chronic SCI (chronic group) with lesion duration of 55.5 +/- 21.0 months. All subjects recorded their nutritional intake for 7 days, which was analyzed for intake of energy, proteins, fat, carbohydrates, vitamins, mineral nutrients, fluid, and dietary fiber. Resting energy expenditure (REE) and total body fat were also determined. Results: The chronic group showed a significantly higher total body fat content compared to the acute group (19.4 +/- 3.8 vs. 15.7 +/- 4.3%). All other parameters were not significantly different between groups. Both groups ingested excessive fat and insufficient amounts of carbohydrates compared with common nutritional recommendations. Low intakes of vitamins C, D, E, biotin, folic acid, as well as potassium and iron were found. Conclusions: No differences were found in the nutritional intakes of two comparable groups of subjects with acute and chronic SCI. Independent of lesion duration, subjects with SCI showed considerable deviations from the general accepted nutritional recommendations concerning macro-and micronutrients intake. Professional nutritional education for persons with SCI should start as soon as possible after injury to prevent nutrition-related secondary complications like cardiovascular diseases. Periodic determinations of body fat content and REE combined with a physical activity program might be helpful as well.","[Perret, Claudio] Swiss Parapleg Ctr, Inst Sports Med, CH-6207 Nottwil, LU, Switzerland; [Stoffel-Kurt, Nadine] Swiss Fed Inst Technol, Zurich, Switzerland",Swiss Paraplegic Research; Swiss Federal Institutes of Technology Domain; ETH Zurich,"Perret, C (corresponding author), Swiss Parapleg Ctr, Inst Sports Med, CH-6207 Nottwil, LU, Switzerland.",Claudio.perret@paranet.ch,,"Stoffel, Karl/0000-0003-4431-3626; Perret, Claudio/0000-0003-3953-589X",,,,,29,33,39,0,11,TAYLOR & FRANCIS LTD,ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND",1079-0268,2045-7723,,J SPINAL CORD MED,J. Spinal Cord. Med.,NOV,2011,34,6,,,,,569,575,,10.1179/2045772311Y.0000000026,http://dx.doi.org/10.1179/2045772311Y.0000000026,,,7,Clinical Neurology,Science Citation Index Expanded (SCI-EXPANDED),Neurosciences & Neurology,870KV,22330112,Green Published,,,2024-06-04,WOS:000298669100007,View Full Record in Web of Science
J,"Zoran, DL",,,,"Zoran, DL",,,Pathophysiology and management of canine colonic diseases,COMPENDIUM ON CONTINUING EDUCATION FOR THE PRACTICING VETERINARIAN,,,English,Article,,,,,,,INFLAMMATORY BOWEL-DISEASE; ULCERATIVE-COLITIS; DIETARY FIBER; DOGS; CATS; SUPPLEMENTATION; GIARDIASIS; DIAGNOSIS; NEOPLASIA; EFFICACY,"Diet and infectious/parasitic agents are the most common causes of large bowel diarrhea in dogs. A diagnosis of lymphocytic-plasmacytic colitis (the most common form of colonic inflammatory bowel disease) should be reserved for patients in which an etiologic agent or dietary cause cannot be found. The cause of constipation should be established and aggressively corrected or controlled to prevent progression to megacolon. This article discusses the basics of colonic physiology, reviews the diseases most commonly associated with colonic disease in dogs, and presents an approach to the management of these disorders.","Texas A&M Univ, Coll Vet Med, Dept Small Anim Med & Surg, College Stn, TX 77843 USA",Texas A&M University System; Texas A&M University College Station,"Texas A&M Univ, Coll Vet Med, Dept Small Anim Med & Surg, College Stn, TX 77843 USA.",,,,,,,,53,1,1,1,7,VETERINARY LEARNING SYSTEMS,YARDLEY,"780 TOWNSHIP LINE RD, YARDLEY, PA 19067-4200 USA",0193-1903,,,COMP CONT EDUC PRACT,Compend. Contin. Educ. Pract. Vet.,SEP,1999,21,9,,,,,824,+,,,,,,14,Veterinary Sciences,Science Citation Index Expanded (SCI-EXPANDED),Veterinary Sciences,241UE,,,,,2024-06-04,WOS:000082900300006,View Full Record in Web of Science
J,"Singh, B; Bala, R",,,,"Singh, Baljit; Bala, Ritu",,,Radiation Formation of Psyllium Cross-Linked Poly( hydroxyethylmethacrylate)-co-poly(acrylamide) Based Sterile Hydrogels for Drug Delivery Applications,POLYMER SCIENCE SERIES A,,,English,Article,,,,,,,POLYMERIZED POLY(2-HYDROXY ETHYL-METHACRYLATE); DYNAMIC SWELLING KINETICS; CO-IONIC HYDROGELS; METHACRYLATE; PH; RELEASE; TEMPERATURE; COPOLYMERS; PURPOSES; BEHAVIOR,"Both, gel forming dietary fiber psyllium and antibiotic drug ciprofloxacin, have pharmacological importance in case of gastrointestinal tract problems. Hence, in the present work, an attempt has been made to design the ciprofloxacin loaded psyllium cross-linked poly(hydroxyethylmethacrylate-co-acrylamide) based sterile hydrogels for drug delivery application in gastrointestinal tract problems diverticulitis which occur due to constipation and microbial infestation. These polymers have been characterized by SEM, cryo-SEM, EDAX, FTIR, TGA/ DTA/DTG, XRD. The swelling of the hydrogels and release dynamics of drug from the hydrogels have been studied for the evaluation of the swelling and drug release mechanism respectively. The release of the drug from the hydrogels occurred through non-Fickian diffusion mechanism in slow manner. Overall, the ciprofloxacin loaded psyllium based drug delivery system may act with enhanced potential to cure the diverticulitis.","[Singh, Baljit; Bala, Ritu] Himachal Pradesh Univ, Dept Chem, Shimla 171005, India",Himachal Pradesh University,"Singh, B (corresponding author), Himachal Pradesh Univ, Dept Chem, Shimla 171005, India.",baljitsinghhpu@yahoo.com,"SINGH, Baljit/B-5878-2012","SINGH, Baljit/0000-0002-0871-883X; Bala, Ritu/0000-0002-4450-8493",,,,,58,5,5,1,19,MAIK NAUKA/INTERPERIODICA/SPRINGER,NEW YORK,"233 SPRING ST, NEW YORK, NY 10013-1578 USA",0965-545X,1555-6107,,POLYM SCI SER A+,Polym. Sci. Ser. A,MAY,2017,59,3,,,,,363,375,,10.1134/S0965545X17030166,http://dx.doi.org/10.1134/S0965545X17030166,,,13,Polymer Science,Science Citation Index Expanded (SCI-EXPANDED),Polymer Science,EW0PR,,,,,2024-06-04,WOS:000402194200011,View Full Record in Web of Science
J,"Korkut, E; Peksoz, R; Disci, E; Atamanalp, SS",,,,"Korkut, Ercan; Peksoz, Rifat; Disci, Esra; Atamanalp, Sabri Selcuk",,,Factors affecting recurrence in sigmoid volvulus,PAKISTAN JOURNAL OF MEDICAL SCIENCES,,,English,Article,,,,,,Sigmoid volvulus; Recurrence; Volvulus attack; Predisposing factor,COLONIC VOLVULUS; ENDOSCOPIC MANAGEMENT; ANATOMY,"Objectives: Recurrence is a relatively common outcome following endoscopic decompression in sigmoid volvulus (SV). This study aims to evaluate the factors affecting recurrence in SV. Methods: In 434 patients with SV treated between June 1986 and January 2022, probable recurrence-affecting factors including age, age of SV onset, gender, dietary habit, defecation habit, altitude of living area, and SV attack count were analyzed in prospectively collected data. Results: Of 434 patients, 111 (25.6%) had recurrent SV with mean 1.6 +/- 2.3 of volvulus episodes (range: 1-21 attacks). SV recurrence demonstrated a significant linear increase with age (14.3%, 17.1%, 21.5%, and 29.9%, respectively, in young, middle aged, mature, and elderly patients, p < 0.001). Recurrent SV was also significantly higher in male gender (28.5% vs 12.7%, p = 0.004), high-fiber diet habit (32.9% vs 17.7%, p < 0.001), and living at high altitude (26.9% vs 12.5%, p = 0.047). Although SV recurrence was higher in patients with chronic constipation, the difference was not significant (36.7% vs. 20.3%, p = 0.594). When compared with that of the patients with mature onset or elderly onset patients, SV attack count was significantly higher in young-onset cases (1.3 +/- 0.9 and 1.1 +/- 0.3 vs 4.6 +/- 6.9, p < 0.001). Conclusion: Elderliness, early-onset, maleness, high-fiber diet habit, high altitude, and most likely chronic constipation may be the practical clinical parameters of recurrent SV. These parameters, as well as the presence of previous SV episode history, must be considered in the decision-making process in the elective treatment of SV.","[Korkut, Ercan; Peksoz, Rifat; Disci, Esra; Atamanalp, Sabri Selcuk] Ataturk Univ, Dept Gen Surg, Fac Med, TR-25040 Erzurum, Turkiye",Ataturk University,"Atamanalp, SS (corresponding author), Ataturk Univ, Dept Gen Surg, Fac Med, TR-25040 Erzurum, Turkiye.",ssa@atauni.edu.tr,"dişçi, esra/GRS-0553-2022; KORKUT, ERCAN/GSE-3887-2022; peksöz, Rıfat/AAG-1820-2021","dişçi, esra/0000-0003-3657-3620; KORKUT, ERCAN/0000-0001-8543-7778; peksöz, Rıfat/0000-0003-4658-5254",,,,,25,4,4,0,4,PROFESSIONAL MEDICAL PUBLICATIONS,SADDAR,"PANORAMA CENTRE, RM 522, 5TH FLOOR, BLDG 2, RAJA GHAZANFAR ALI RD, PO BOX 8766, SADDAR, KARACHI 00000, PAKISTAN",1682-024X,1681-715X,,PAK J MED SCI,Pak. J. Med. Sci.,JAN-FEB,2023,39,1,,,,,,,,10.12669/pjms.39.1.6882,http://dx.doi.org/10.12669/pjms.39.1.6882,,,4,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,6J2BF,36694777,"gold, Green Published",,,2024-06-04,WOS:000886631300004,View Full Record in Web of Science
J,"Strate, LL; Modi, R; Cohen, E; Spiegel, BMR",,,,"Strate, Lisa L.; Modi, Rusha; Cohen, Erica; Spiegel, Brennan M. R.",,,Diverticular Disease as a Chronic Illness: Evolving Epidemiologic and Clinical Insights,AMERICAN JOURNAL OF GASTROENTEROLOGY,,,English,Review,,,,,,,IRRITABLE-BOWEL-SYNDROME; PRACTICE PARAMETERS; DIGESTIVE DISEASES; DIETARY FIBER; RISK-FACTORS; COLON; BURDEN; PERCEPTION; MESALAZINE; MANAGEMENT,"Diverticular disease imposes a significant burden on Western and industrialized societies. The traditional pathogenesis model posits that low dietary fiber predisposes to diverticulosis, and fecalith obstruction prompts acute diverticulitis that is managed with broad-spectrum antibiotics or surgery. However, a growing body of knowledge is shifting the paradigm of diverticular disease from an acute surgical illness to a chronic bowel disorder composed of recurrent abdominal symptoms and considerable psychosocial impact. New research implicates a role for low-grade inflammation, sensory-motor nerve damage, and dysbiosis in a clinical picture that mimics irritable bowel syndrome (IBS) and even inflammatory bowel disease (IBD). Far from being an isolated event, acute diverticulitis may be the catalyst for chronic symptoms including abdominal pain, cramping, bloating, diarrhea, constipation, and post-diverticulitis IBS. In addition, studies reveal lower health-related quality of life in patients with chronic diverticular disease vs. controls. Health-care providers should maintain a high index of suspicion for the multifaceted presentations of diverticular disease, and remain aware that it might contribute to long-term emotional distress beyond traditional diverticulitis attacks. These developments are prompting a shift in therapeutic approaches from widespread antimicrobials and supportive care to the use of probiotics, mesalamine, and gut-directed antibiotics. This review addresses the emerging literature regarding epidemiology, pathophysiology, and management of chronic, symptomatic diverticular disease, and provides current answers to common clinical questions.","[Strate, Lisa L.] Univ Washington, Harborview Med Ctr, Sch Med, Div Gastroenterol,Dept Med, Seattle, WA 98104 USA; [Modi, Rusha; Spiegel, Brennan M. R.] Univ Calif Los Angeles, VA Ctr Outcomes Res & Educ, Los Angeles, CA USA; [Cohen, Erica; Spiegel, Brennan M. R.] VA Greater Los Angeles Healthcare Syst, Dept Med, Div Gastroenterol, Los Angeles, CA USA; [Spiegel, Brennan M. R.] Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Dept Med, Los Angeles, CA 90095 USA; [Spiegel, Brennan M. R.] Univ Calif Los Angeles, Sch Publ Hlth, Dept Hlth Serv, Los Angeles, CA 90024 USA",University of Washington; University of Washington Seattle; Harborview Medical Center; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles,"Spiegel, BMR (corresponding author), 11301 Wilshire Blvd,Bldg 115,Room 215, Los Angeles, CA 90073 USA.",bspiegel@mednet.ucla.edu,,,Amgen; Ironwood Pharmaceuticals; Shire Pharmaceuticals,Amgen(Amgen); Ironwood Pharmaceuticals; Shire Pharmaceuticals,"Brennan Spiegel has served as an advisor for Prometheus and Ironwood Pharmaceuticals, and has received research support from Amgen, Ironwood Pharmaceuticals, and Shire Pharmaceuticals. Lisa Strate has served as an advisor for Shire Pharmaceuticals.",,69,240,253,0,40,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0002-9270,1572-0241,,AM J GASTROENTEROL,Am. J. Gastroenterol.,OCT,2012,107,10,,,,,1486,1493,,10.1038/ajg.2012.194,http://dx.doi.org/10.1038/ajg.2012.194,,,8,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,018XK,22777341,,,,2024-06-04,WOS:000309701000007,View Full Record in Web of Science
J,"Shakil, A; Church, RJ; Rao, SS",,,,"Shakil, Amer; Church, Robert J.; Rao, Shobha S.",,,Gastrointestinal complications of diabetes,AMERICAN FAMILY PHYSICIAN,,,English,Article,,,,,,,FATTY LIVER-DISEASE; GLYCEMIC CONTROL; LONG-TERM; MELLITUS; GASTROPARESIS; PREVALENCE; HEPATITIS; ABNORMALITIES; SYMPTOMS; THERAPY,"Gastrointestinal complications of diabetes include gastroparesis, intestinal enteropathy (which can cause diarrhea, constipation, and fecal incontinence), and nonalcoholic fatty liver disease. Patients with gastroparesis may present with early satiety, nausea, vomiting, bloating, postprandial fullness, or upper abdominal pain. The diagnosis of diabetic gastroparesis is made when other causes are excluded and postprandial gastric stasis is confirmed by gastric emptying scintigraphy. Whenever possible, patients should discontinue medications that exacerbate gastric dysmotility; control blood glucose levels; increase the liquid content of their diet; eat smaller meals more often; discontinue the use of tobacco products; and reduce the intake of insoluble dietary fiber, foods high in fat, and alcohol. Prokinetic agents (e.g., metoclopramide, erythromycin) may be helpful in controlling symptoms of gastroparesis. Treatment of diabetes-related constipation and diarrhea is aimed at supportive measures and symptom control. Nonalcoholic fatty liver disease is common in persons who are obese and who have diabetes. In persons with diabetes who have elevated hepatic transaminase levels, it is important to search for other causes of liver disease, including hepatitis and hemochromatosis. Gradual weight loss, control of blood glucose levels, and use of medications (e.g., pioglitazone, metformin) may normalize hepatic transamirase levels, but the clinical benefit of aggressively treating nonalcoholic fatty liver disease is unknown. Controlling blood glucose levels is important for managing most gastrointestinal complications.","[Shakil, Amer; Church, Robert J.; Rao, Shobha S.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA",University of Texas System; University of Texas Southwestern Medical Center Dallas,"Shakil, A (corresponding author), Univ Texas SW Med Ctr Dallas, 6263 Harry Hines Blvd,Clin 1 Bldg, Dallas, TX 75390 USA.",,,,,,,,32,70,90,0,6,AMER ACAD FAMILY PHYSICIANS,KANSAS CITY,"8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797 USA",0002-838X,,,AM FAM PHYSICIAN,Am. Fam. Physician,JUN 15,2008,77,12,,,,,1697,1702,,,,,,6,"Primary Health Care; Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,335TF,18619079,,,,2024-06-04,WOS:000258312900007,View Full Record in Web of Science
J,"Zador, D; Wall, PML; Webster, I",,,,"Zador, D; Wall, PML; Webster, I",,,"High sugar intake in a group of women on methadone maintenance in South Western Sydney, Australia",ADDICTION,,,English,Article,,,,,,,NUTRITIONAL-STATUS; ADDICTS; USERS,"Nutritional assessment comprising dietary and anthropometric measurements was conducted in a group of 86 women attending a methadone maintenance clinic in South Western Sydney, Australia. Dietary data were obtained by two 24-hour recall interviews using a standardized interview format Nutrient intake was analysed using the NUTTAB data base of Australian foods (1992). Mean age of the sample was 29.8 (range 18-46) years and mean body mass index was 22.7 (range 16.2-43.4) kg/m(2). The diet of the study group was characterized by a low energy intake of 6.48 MJ (95% CI 6.02-6.94), a high sugars intake of 122 g (95% CI 112-132), a high percentage of total energy (31%, 95% CI 29-32) derived from sugars, and a low dietary fibre intake of 10.7 g (95% CI 9.7-12.3). This eating pattern may contribute to the high prevalence of dental caries and chronic constipation observed in the group. The results also support anecdotal evidence of a craving for sweetness described by addicts. Despite the low energy intake, body mass indices of the group were no different from the normal population. It is possible that 2 days' intake was insufficient to accurately measure accustomed diet in this group of women. Alternatively, the low intake may be a consequence of their largely sedentary life-styles.","S W SYDNEY AREA HLTH SERV,DIV PUBL HLTH,DRUG & ALCOHOL SERV,KENSINGTON,NSW,AUSTRALIA; UNIV SYDNEY,DEPT BIOCHEM,HUMAN NUTR UNIT,SYDNEY,NSW 2006,AUSTRALIA; UNIV NEW S WALES,SCH COMMUNITY MED,KENSINGTON,NSW 2033,AUSTRALIA",University of Sydney; University of New South Wales Sydney,,,,"Lyons-Wall, Philippa/0000-0002-0001-1055",,,,,28,72,77,0,13,CARFAX PUBL CO,ABINGDON,"PO BOX 25, ABINGDON, OXFORDSHIRE, ENGLAND OX14 3UE",0965-2140,,,ADDICTION,Addiction,JUL,1996,91,7,,,,,1053,1061,,10.1111/j.1360-0443.1996.tb03601.x,http://dx.doi.org/10.1111/j.1360-0443.1996.tb03601.x,,,9,Substance Abuse; Psychiatry,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Substance Abuse; Psychiatry,UW084,8688819,,,,2024-06-04,WOS:A1996UW08400017,View Full Record in Web of Science
J,"Moore, N; Chao, CW; Yang, LP; Storm, H; Oliva-Hemker, M; Saavedra, JM",,,,"Moore, N; Chao, CW; Yang, LP; Storm, H; Oliva-Hemker, M; Saavedra, JM",,,"Effects of fructo-oligosaccharide-supplemented infant cereal: a double-blind, randomized trial",BRITISH JOURNAL OF NUTRITION,,,English,Article,,,,,,fructo-oligosaccharides; stool characteristics; infant cereal; weaning foods,DIETARY FIBER; FECAL BIFIDOBACTERIA; FRUCTOOLIGOSACCHARIDE; OLIGOFRUCTOSE; ABSORPTION; FORMULA,"Fructo-oligosaccharides (FOS) may have potential benefits, since they exhibit many soluble dietary fibre-like properties. Foods currently available for weaning infants are generally low in fibre content and lack these potential benefits. Data documenting tolerance of FOS in weaning foods are greatly lacking. Our present objective was to evaluate the tolerance and gastrointestinal effects of FOS-supplemented infant cereal used as a daily addition to the diet of healthy infants. Healthy infants were randomly assigned to receive either 0.75 g FOS per serving of cereal or placebo for 28 d. The primary outcome of interest was gastrointestinal tolerance, which was assessed by daily parental reporting of functional variables for 28 d, including stool patterns and signs and symptoms of gastrointestinal tolerance. Secondary outcomes were also measured including: cereal intake (g cereal and g FOS/d), stool pH, changes in anthropometric measurements and adverse events. The study population included a total of fifty-six infants, age range 16.2-46.2 weeks with a mean age of 32.5 (SD 8.9) weeks; twenty-nine infants were randomized to the control group (age 31.8 (SD 9.0) weeks) and twenty-seven to the FOS-supplemented group (34.7 (SD 8.9) weeks). Average daily total intake per infant and average intake per serving were similar in both groups. Average FOS consumption was 0.74 (SD 0.39) g/d and as high as 3.00 g/d. Stool consistency was less likely to be described as 'hard', and more likely to be described as 'soft' or 'loose', in the FOS v. control group. The mean number of stools per infant was 1.99 (SD 0.62) per d in the FOS-supplemented group compared with 1.58 (SD 0.66) in the control group (P=0.02). There were no differences between the groups in reporting for crying, spitting-up or colic. No differences were found for stool pH. FOS-supplements added to cereal were well tolerated in doses of up to 3.00 g/d. FOS consumption led to more regular and softer stools, without diarrhoea, as well as less-reported frequency of symptoms associated with constipation such as hard stools or skipped days without stool. The present study is one of few studies documenting tolerance to increased fibre intake in the form of FOS as part of a weaning food.","Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; Nestle Nutr Inst, Glendale, CA USA",Johns Hopkins University,"Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA.",nabmoore@comcast.net,,"Saavedra, Jose M./0000-0003-4343-7176; Oliva-Hemker, Maria/0000-0002-4054-7372",,,,,24,75,86,0,7,CAMBRIDGE UNIV PRESS,CAMBRIDGE,"EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND",0007-1145,1475-2662,,BRIT J NUTR,Br. J. Nutr.,SEP,2003,90,3,,,,,581,587,,10.1079/BJN2003950,http://dx.doi.org/10.1079/BJN2003950,,,7,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,722HZ,13129464,Bronze,,,2024-06-04,WOS:000185370500013,View Full Record in Web of Science
J,"Thirumal, P; Sumathi, B; Nirmala, D",,,,"Thirumal, P.; Sumathi, B.; Nirmala, D.",,,A Clinical Entity Often Missed-Solitary Rectal Ulcer Syndrome in Children,FRONTIERS IN PEDIATRICS,,,English,Article,,,,,,bleeding per rectum; mucorrhea; constipation; solitary rectal ulcer; children,BENIGN,"Background:Solitary Rectal Ulcer Syndrome (SRUS) was a relatively uncommon and easily misdiagnosed clinical entity in children. The diagnosis of this condition was often delayed due to lack of clinical suspicion. Only case series were available and no definitive treatment was postulated. Here, we share our experience of SRUS in our institute and reviewed the literature published so far. Aim:To study the clinical profile and treatment response of Solitary Rectal ulcer Syndrome in Children (SRUS). Materials:The clinical profile and 1 year follow up response of the diagnosed cases of SRUS over a period of 5 years was retrospectively collected from medical record department. Results:The median age of presentation among 24 children was 8 years with majority (75%) above 5 years. All children presented with intermittent rectal bleeding with median duration of 5.5 months. The other presenting symptoms documented were hard stool (79%), mucorrhea (70%), and abdominal pain (58%). One child presented with rectal prolapse. On colonoscopy, 46% had single ulcer while another 46% had multiple ulcers and 8% had polypoidal lesion. All lesions were within distal rectum and had characteristic histological pattern. All children were treated with conventional treatment like dietary fibers and laxatives along with toilet training. About 75% children attained remission and 25% had relapse but responded with corticosteroid enema. None required surgery. Conclusion:Conventional treatments itself induce and maintain remission in most of SRUS patients if treatment is instituted at the earliest. Thus, early suspicion and diagnosis is needed to achieve remission.","[Thirumal, P.] Sri Manakula Vinayagar Med Coll & Hosp, Gastroenterol Clin, Pondicherry, India; [Sumathi, B.; Nirmala, D.] Inst Child Hlth & Hosp Children, Gastroenterol, Chennai, Tamil Nadu, India",,"Thirumal, P (corresponding author), Sri Manakula Vinayagar Med Coll & Hosp, Gastroenterol Clin, Pondicherry, India.",drthirugastro@gmail.com,,,,,,,28,4,6,0,3,FRONTIERS MEDIA SA,LAUSANNE,"AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND",2296-2360,,,FRONT PEDIATR,Front. Pediatr.,JUL 17,2020,8,,,,,,,,396,10.3389/fped.2020.00396,http://dx.doi.org/10.3389/fped.2020.00396,,,6,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,MU6WK,32766189,"Green Published, gold",,,2024-06-04,WOS:000555811400001,View Full Record in Web of Science
J,"Laatikainen, R; Koskenpato, J; Hongisto, SM; Loponen, J; Poussa, T; Hillilä, M; Korpela, R",,,,"Laatikainen, R.; Koskenpato, J.; Hongisto, S. -M.; Loponen, J.; Poussa, T.; Hillila, M.; Korpela, R.",,,Randomised clinical trial: low-FODMAP rye bread vs. regular rye bread to relieve the symptoms of irritable bowel syndrome,ALIMENTARY PHARMACOLOGY & THERAPEUTICS,,,English,Article,,,,,,,GASTROINTESTINAL SYMPTOMS; DIETARY FIBER; CONSTIPATION; RESTRICTION; MANAGEMENT; GRAINS; IBS,"BackgroundGrains are high in FODMAPs (Fermentable Oligo-, Di-, Monosaccharides And Polyols) and often considered as triggers of IBS symptoms. AimTo evaluate if rye bread low in FODMAPs would be better tolerated than regular rye bread in subjects with IBS. MethodsThe study was conducted as a randomised double blind controlled cross-over study (n=87). Participants were supplied with both regular rye bread and low-FODMAP rye bread for 4weeks. Symptoms were measured with a symptom severity scoring system (IBS-SSS) and visual analogue scale (VAS) assessments of individual symptoms. Quality of life was monitored. Colonic fermentation was measured by the breath hydrogen test and dietary intake by food diaries. ResultsDietary fibre intake increased during both study periods compared to baseline. Many signs of IBS i.e. flatulence, abdominal pain, cramps and stomach rumbling were milder on the low-FODMAP rye bread (P-values: 0.04; 0.049; 0.01 and 0.001). The mean of VAS measurements was favourable towards LF bread [-3 (95% CI): -6 to -1, P=0.02] but no differences were detected in IBS-SSS or quality of life. The AUC of breath hydrogen values was significantly lower during the low-FODMAP bread period (median 52.9 vs. 72.6; P=0.01). ConclusionsLow-FODMAP rye bread helps IBS patients to control their symptoms and reduces gastrointestinal gas accumulation. However, replacing regular rye bread by low-FODMAP bread without concomitant broader dietary changes does not improve quality of life or IBS-SSS. Nonetheless, inclusion of low-FODMAP rye bread in diet might be one way that IBS patients could increase their fibre intake.","[Laatikainen, R.; Korpela, R.] Univ Helsinki, Fac Med, Dept Pharmacol, Helsinki, Finland; [Laatikainen, R.; Koskenpato, J.; Hillila, M.] Aava Med Ctr, Helsinki, Finland; [Koskenpato, J.; Hillila, M.] Univ Helsinki, Gastroenterol Clin, Helsinki, Finland; [Koskenpato, J.; Hillila, M.] Helsinki Univ Hosp, Helsinki, Finland; [Hongisto, S. -M.] Fazer Bakeries Ltd, Vantaa, Finland; [Poussa, T.] STAT Consulting Ltd, Nokia, Finland",University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital,"Laatikainen, R (corresponding author), Booston Oy Ltd, Viikinkaari 6, Helsinki 00790, Finland.",reijo.laatikainen@booston.fi,,"Korpela, Riitta/0000-0003-0337-9186; , Jussi/0000-0002-6987-1627",Fazer Bakeries,Fazer Bakeries,Fazer Bakeries funded the study and provided the breads.,,28,80,88,4,50,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0269-2813,1365-2036,,ALIMENT PHARM THER,Aliment. Pharmacol. Ther.,SEP,2016,44,5,,,,,460,470,,10.1111/apt.13726,http://dx.doi.org/10.1111/apt.13726,,,11,Gastroenterology & Hepatology; Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Pharmacology & Pharmacy,DS6VO,27417338,"Green Published, hybrid",,,2024-06-04,WOS:000380921300004,View Full Record in Web of Science
J,"Song, BK; Kim, YS; Kim, HS; Oh, JW; Lee, O; Kim, JS",,,,"Song, Bong Kil; Kim, Yeon Soo; Kim, Hee Soo; Oh, Jung-Woo; Lee, On; Kim, Joon-Sik",,,Combined exercise improves gastrointestinal motility in psychiatric in patients,WORLD JOURNAL OF CLINICAL CASES,,,English,Article,,,,,,Combined exercise; Constipation; Colonic transit time; Radio-opaque marker; Psychiatry unit patient,COLON TRANSIT-TIME; COLORECTAL-CANCER; PHYSICAL-ACTIVITY; MENTAL-ILLNESS; DIETARY FIBER; CONSTIPATION; MORTALITY; PEOPLE,"AIM To examine the effect of combined exercise on colonic transit time (CTT) in admitted psychiatric patients. METHODS Over a 6-mo period, consecutive in patients with mental illness were recruited from the Somang Hospital Psychiatry Unit. A combined exercise program that included 60 min per day of exercise 3 d per week for 12 wk was performed. Physical fitness and CTT of the patients were measured twice before and twice after the exercise program. CTT was measured using a multiple marker technique with a radio-opaque marker. Changes in the exercising patients' CTT and weight-, cardiovascular- and fitness-related parameters were statistically assessed. RESULTS After the 12-wk combined exercise intervention, decreased intestinal transit time was observed in all CTTs of the exercise group, including the right CTT (exercise: 15.6 +/- 15.2 vs 9.2 +/- 11.9, control: 13.1 +/- 10.4 vs 10.9 +/- 18.7), left CTT (exercise: 19.7 +/- 23.5 vs 10.4 +/- 13.2, control: 19.2 +/- 19.0 vs 16.9 +/- 19.8), recto-sigmoid CTT (exercise: 14.3 +/- 16.7 vs 6.7 +/- 7.9, control: 15.0 +/- 14.4 vs 19.3 +/- 30.3), and total colonic transit time (TCTT) (exercise: 50.2 +/- 38.1 vs 27.1 +/- 28.0, control: 47.4 +/- 34.6 vs 47.3 +/- 47.3). After the 12-wk combined exercise period, TCTT was significantly shortened in the exercise group compared with that in the control group. In addition to eating habits, water intake, and fiber intake, the increased physical activity level as a result of the 12-wk combined exercise program reduced the CTT. CONCLUSION The CTT of the psychiatric patients was reduced due to increased physical activity via a 12-wk combined exercise program.","[Song, Bong Kil; Kim, Yeon Soo; Kim, Hee Soo; Oh, Jung-Woo; Lee, On; Kim, Joon-Sik] Seoul Natl Univ, Inst Sports Sci, Hlth & Exercise Sci Lab, 71-1 408,Kwanak Ro 1, Seoul 151742, South Korea; [Kim, Hee Soo] Namyangju Hanyang Gen Hosp, Namyangju 12048, South Korea",Seoul National University (SNU),"Kim, YS (corresponding author), Seoul Natl Univ, Inst Sports Sci, Hlth & Exercise Sci Lab, 71-1 408,Kwanak Ro 1, Seoul 151742, South Korea.",kys0101@snu.ac.kr,"SONG, BONG KIL/V-7789-2019; song, bong kil/C-6467-2019","kim, joonsik/0000-0002-5935-7851",,,,,25,6,6,0,5,BAISHIDENG PUBLISHING GROUP INC,PLEASANTON,"7041 Koll Center Parkway, Suite 160, PLEASANTON, CA, UNITED STATES",2307-8960,,,WORLD J CLIN CASES,World J. Clin. Cases,AUG 16,2018,6,8,,,,,207,213,,10.12998/wjcc.v6.i8.207,http://dx.doi.org/10.12998/wjcc.v6.i8.207,,,7,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),General & Internal Medicine,GQ6HC,30148149,"Green Submitted, Green Published, gold",,,2024-06-04,WOS:000441806500007,View Full Record in Web of Science
J,"Freitas, KD; Amancio, OMS; de Morais, MB",,,,"Freitas, Karine de Cassia; Silverio Amancio, Olga Maria; de Morais, Mauro Batista",,,High-performance inulin and oligofructose prebiotics increase the intestinal absorption of iron in rats with iron deficiency anaemia during the growth phase,BRITISH JOURNAL OF NUTRITION,,,English,Article,,,,,,Dietary fibre; Inulin; Intestinal absorption; Iron deficiency anaemia; Rats,PREVENT POSTGASTRECTOMY ANEMIA; CHAIN FATTY-ACIDS; DIETARY FIBER; NONHEME-IRON; NONDIGESTIBLE OLIGOSACCHARIDES; FRUCTO-OLIGOSACCHARIDES; CHRONIC CONSTIPATION; APPARENT ABSORPTION; CELL-PROLIFERATION; GROWING RATS,"Considering the high frequency of anaemia due to Fe deficiency, it is important to evaluate the effects of prebiotics on the absorption of Fe. The aim of the present study was to evaluate the effects of high-performance (HP) inulin, oligofructose and synergy1 during recovery from anaemia in rats through the intestinal absorption of Fe, food intake, body growth, caecal pH and weight of the intestine. Wistar rats (n 47) were fed with rations of AIN93-G with no Fe to induce Fe deficiency anaemia. At 36 d of life, anaemic rats were divided into four groups: (1) the HP inulin group; (2) the synergy1 group; and (3) the oligofructose group, all with 100 g of the respective prebiotic per kg of ration; and (4) a control group, in which the prebiotic was replaced by maize starch. Then, 25 mg of elemental Fe/kg of ration was added to all rations to allow recovery from anaemia. The final values of Hb in the HP inulin, synergy1, oligofructose and control groups were, respectively: 98 (94-99); 83 (81-92); 100 (90-114); 77 (72-81) g/l, with a statistically significant difference (P <= 0.001) between the oligofructose and control groups and the HP inulin and control groups. The four groups had an increase in weight and body length and had similar consumption of rations. The intestinal weight and caecal pH were significantly different between the groups that consumed prebiotics and the control group. HP inulin and oligofructose increased the intestinal absorption of Fe in rats.","[Silverio Amancio, Olga Maria; de Morais, Mauro Batista] Univ Fed Sao Paulo, Dept Pediat, Res Lab, Nutrol Discipline, BR-04039031 Sao Paulo, Brazil; [Freitas, Karine de Cassia] Fed Univ Grande Dourados, Dourados, MS, Brazil",Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal da Grande Dourados,"de Morais, MB (corresponding author), Univ Fed Sao Paulo, Dept Pediat, Res Lab, Nutrol Discipline, Rua Pedro de Toledo 441, BR-04039031 Sao Paulo, Brazil.",mbmorais@osite.com.br,"MORAIS, MAURO B/I-7995-2014","Batista de Morais, Mauro/0000-0003-4014-5549","'Coordination of Improvement of Higher Education' - CAPES; 'Sao Paulo Research Foundation' - FAPESP, Brazil","'Coordination of Improvement of Higher Education' - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); 'Sao Paulo Research Foundation' - FAPESP, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))","The present research was supported by 'Coordination of Improvement of Higher Education' - CAPES and the 'Sao Paulo Research Foundation' - FAPESP, Brazil. The authors' contributions were as follows: K. d. C. F., M. B. d. M. and O. M. S. A. were instrumental in the conception and design of the study. K. d. C. F. and M. B. d. M. were responsible for the generation of the study. K. d. C. F. and M. B. d. M. performed the assembly, analysis and interpretation of the data (statistical analysis). K. d. C. F., M. B. d. M. and O. M. S. A. contributed to the revision of the manuscript. None of the authors had any personal or financial interest in any organisation sponsoring this research or any conflict of interest related to their participation in this study.",,53,30,34,0,27,CAMBRIDGE UNIV PRESS,CAMBRIDGE,"EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND",0007-1145,1475-2662,,BRIT J NUTR,Br. J. Nutr.,SEP 28,2012,108,6,,,,,1008,1016,,10.1017/S0007114511006301,http://dx.doi.org/10.1017/S0007114511006301,,,9,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,003BO,22172251,Bronze,,,2024-06-04,WOS:000308583400008,View Full Record in Web of Science
J,"Taylor, CM; Emmett, PM",,,,"Taylor, Caroline M.; Emmett, Pauline M.",,,Picky eating in children: causes and consequences,PROCEEDINGS OF THE NUTRITION SOCIETY,,,English,Article; Proceedings Paper,Meeting of the Irish-Section of the Nutrition-Society / Conference on Targeted Approaches to Tackling Current Nutritional Issues / Symposium 1 on Current Nutritional Issues at the Population Level,"JUN 20-22, 2018","Univ Ulster, Coleraine, IRELAND","Nutr Soc, Irish Sect",Univ Ulster,Picky eating; Child; Diet; Fussy eating; Selective eating; Child development; Growth,FOOD NEOPHOBIA; WEIGHT STATUS; BIDIRECTIONAL ASSOCIATIONS; PRESCHOOL-CHILDREN; FEEDING PRACTICES; DIETARY PATTERNS; BEHAVIORS; CHILDHOOD; AGE; PREVALENCE,"Picky eating is a common behaviour in early childhood. There is neither a universally accepted definition of picky eating, nor is there agreement on the best tool to identify it. Causes of picky eating include early feeding difficulties, late introduction of lumpy foods at weaning, pressure to eat and early choosiness, especially if the mother is worried by this; protective factors include the provision of fresh foods and eating the same meal as the child. The consequences for the child's diet include poor dietary variety and a possible distortion of nutrient intakes, with low intakes of iron and zinc (associated with low intakes of meat, and fruit and vegetables) being of particular concern. Low intakes of dietary fibre, as a result of low intakes of fruit and vegetables, are associated with constipation in picky eaters. There may be developmental difficulties in some children with persistent picky eating. There is little evidence, however, for a consistent effect of being a picky eater on growth trajectories. There may be a small subgroup of children in whom picky eating does not resolve who might be at risk of thinness during adolescence, or of developing an eating disorder or adult picky eating: these children need to be identified at an early age to enable support, monitoring and advice to be offered to parents. Strategies for avoiding or ameliorating picky eating include repeated exposures to unfamiliar foods, parental modelling of eating fruit and vegetables and unfamiliar foods, and the creation of positive social experiences around mealtimes.","[Taylor, Caroline M.; Emmett, Pauline M.] Univ Bristol, Ctr Acad Child Hlth, Bristol Med Sch, Bristol, Avon, England",University of Bristol,"Taylor, CM (corresponding author), Univ Bristol, Ctr Acad Child Hlth, Bristol Med Sch, Bristol, Avon, England.",Caroline.m.taylor@bristol.ac.uk,"Emmett, Pauline/AAL-6815-2021","Taylor, Caroline/0000-0001-8347-5092",Wellcome Trust Career ReEntry Fellowship [104077/Z/14/Z],Wellcome Trust Career ReEntry Fellowship(Wellcome Trust),C. M. T. was supported by a Wellcome Trust Career ReEntry Fellowship (Grant ref: 104077/Z/14/Z).,,66,77,89,7,47,CAMBRIDGE UNIV PRESS,CAMBRIDGE,"EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND",0029-6651,1475-2719,,P NUTR SOC,Proc. Nutr. Soc.,MAY,2019,78,2,,,,,161,169,,10.1017/S0029665118002586,http://dx.doi.org/10.1017/S0029665118002586,,,9,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S),Nutrition & Dietetics,HY8BZ,30392488,"Green Submitted, Green Accepted, Bronze",,,2024-06-04,WOS:000468363700003,View Full Record in Web of Science
J,"Macedol, JL; Silva, DJS; da Silva, RL; Assunçao, MDSM",,,,"Macedol, Joyce Lopes; Sousa Silva, Daisy Jacqueline; da Silva, Raynara Lima; Sousa Magalhaes Assuncao, Magnolia de Jesus",,,Food consumption and practice of physical exercises by individuals with diabetes mellitus,RBONE-REVISTA BRASILEIRA DE OBESIDADE NUTRICAO E EMAGRECIMENTO,,,Portuguese,Article,,,,,,Food consumption; Physical exercise; Diabetes Mellitus; Quality of life; Glycemia,INSULIN-RESISTANCE; HIGH-INTENSITY; ADHERENCE; GLUCOSE; CARE,"Objective: To verify dietary intake and physical exercise by individuals with diabetes mellitus. Methods: This is an integrative review study where we searched for studies published between 2014 and 2019, where the Lilacs, Pubmed and Scielo databases were used. Results: According to the analysis of the studies, it was observed that a diet rich in foods with low glycemic index and soluble fibers, allows additional improvements in glycemic control, metabolic syndrome, lipid profile, Chronic Renal Disease, insulin sensitivity and micro inflammation, significantly improves constipation and diarrhea in diabetic individuals. Among the benefits of physical exercise are increased insulin action, increased glucose uptake by muscles, reduced glycemia and increased cellular sensitivity to insulin, and decreased body fat, among others. Conclusion: The present study showed that it is of primary importance to educate individuals with Diabetes Mellitus about lifestyle changes in the impact of their illness, such as adherence to healthy eating habits and physical activity.","[Macedol, Joyce Lopes; da Silva, Raynara Lima] Ctr Univ Ciencias & Tecnol Maranhao UNIFACEMA, Caxias, MA, Brazil; [Sousa Silva, Daisy Jacqueline] Univ Fed Piaui UFPI, Programa Posgrad Alimentos & Nutr, Teresina, PI, Brazil; [Sousa Magalhaes Assuncao, Magnolia de Jesus] Univ Luterana Brasil ULBRA, Biol Celular & Mol Aplicada Saude, Canoas, RS, Brazil",Universidade Federal do Piaui; Universidade Luterana do Brasil,"Macedol, JL (corresponding author), Ctr Univ Ciencias & Tecnol Maranhao UNIFACEMA, Caxias, MA, Brazil.",joycelopes385@gmail.com; d.jack204@hotmail.com; raynaralima_ps@hotmail.com; magmagalhaes2009@hotmail.com,,,,,,,30,0,0,0,1,INST BRASILEIRO PESQUISA & ENSINO FISIOLOGIA EXERCICIO-IBPEFEX,SAO PAULO,"INST BRASILEIRO PESQUISA & ENSINO FISIOLOGIA EXERCICIO-IBPEFEX, SAO PAULO, 00000, BRAZIL",1981-9919,,,RBONE-REV BRAS OBES,RBONE-Rev. Bras. Obes. Nutr. Emagrecimento,JAN-DEC,2019,13,83,,1,,,1143,1150,,,,,,8,Nutrition & Dietetics,Emerging Sources Citation Index (ESCI),Nutrition & Dietetics,OO6LY,,,,,2024-06-04,WOS:000587490200016,View Full Record in Web of Science
J,"Kato, N; Iwami, K",,,,"Kato, N; Iwami, K",,,Resistant protein; Its existence and function beneficial to health,JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY,,,English,Review,,,,,,resistant protein; soybean HMF; buckwheat protein; silk sericin; short-chain fatty acids,PLASMA-CHOLESTEROL; SILK PROTEIN; COLON CARCINOGENESIS; SOYBEAN PROTEIN; RATS; EXTRACT; CONSUMPTION; SERICIN; CARBOHYDRATE; ABSORPTION,"The remnants of proteins themselves or complexes with protein remaining no longer indigestible in the intestine are referred to as resistant proteins, which exert physiological functions similar to dietary fibers and are also better for health. In recent years, noticeable functions attributable to resistant proteins have become gradually apparent with regard to several proteinous items. Recent investigations have revealed that the relevant ingredients are either condensed in isolates or concentrates of vegetable proteins or causally brought about as a consequence of denaturation and/or entanglement in the process of preparation. Some protein components inherently insusceptible to mammalian digestive enzymes also belong to the group of resistant proteins in case of edibility irrespective of their sources. Among the medicinal benefits of several resistant proteins hitherto pointed out by animal experiments, there were preventive effects against hypercholesterolemia, constipation, corpulence, tumorigenesis (colon, liver, mammary gland), gallstone formation or poisoning, and wholesome improvements in enteric fermentation of short-chain fatty acids.","Kyoto Prefectural Univ, Dept Biol Resource Chem, Sakyo Ku, Kyoto 6068522, Japan; Hiroshima Univ, Dept Appl Biochem, Higashihiroshima 7398528, Japan",Kyoto Prefectural University; Hiroshima University,"Iwami, K (corresponding author), Kyoto Prefectural Univ, Dept Biol Resource Chem, Sakyo Ku, Kyoto 6068522, Japan.",nkato@hiroshima-u.ac.jp; k_iwami@love.kpu.ac.jp,,"Kato, Norihisa/0000-0002-5467-3126",,,,,39,31,36,0,14,CENTER ACADEMIC PUBL JAPAN,TOKYO,"2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN",0301-4800,1881-7742,,J NUTR SCI VITAMINOL,J. Nutr. Sci. Vitaminol.,FEB,2002,48,1,,,,,1,5,,,,,,5,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,534AB,12026181,gold,,,2024-06-04,WOS:000174561500001,View Full Record in Web of Science
J,"Zhang, ZL; Zhou, ML; Tang, Y; Li, FL; Tang, YX; Shao, JR; Xue, WT; Wu, YM",,,,"Zhang, Zhan-Lu; Zhou, Mei-Liang; Tang, Yu; Li, Fa-Liang; Tang, Yi-Xiong; Shao, Ji-Rong; Xue, Wen-Tong; Wu, Yan-Min",,,Bioactive compounds in functional buckwheat food,FOOD RESEARCH INTERNATIONAL,,,English,Review,,,,,,Antioxidant; Fagopyrum; Flavonoid; Metabolic engineering; Rutin,FAGOPYRUM-ESCULENTUM-MOENCH; HAIRY ROOT CULTURES; TARTARY BUCKWHEAT; ANTIOXIDANT ACTIVITY; GALLSTONE FORMATION; PHENOLIC-COMPOUNDS; TATARICUM GAERTN.; SERUM-ALBUMIN; RUTIN; COMMON,"Buckwheat is an ancient dicotyledonous crop belonging to Polygonaceae family. It is cultivated and adapted to marginal lands with harsh environments. Buckwheat has been praised as one of the most faddish green functional foods. Many functional foods including tea made from buckwheat have been put into production around the globe. The buckwheat proteins are particularly rich in lysine and contain less glumatic acid and praline, and more arginine and aspartic acid than cereal proteins. Buckwheat proteins also show a strong supplemental effect with other proteins to improve the dietary amino acid balance with special biological activities of cholesterol-lowering effects, antihypertensition effects, and improving the constipation and obesity conditions by acting in a similar way as dietary fiber and interrupting the in vivo metabolisms. Besides its high-quality proteins, buckwheat is also rich in many rare components that have healing effects on some chronic diseases. Among these components, the most attractive ones are flavones, flavonoids, phytosterols, D-chiro-Inositol, and myo-inositol. In this review we focus on buckwheat's general physical and chemical properties, rare components, functional effects, metabolic engineering of bioactive compounds and trends in the development of functional tea from buckwheat in the latest three years. (C) 2012 Elsevier Ltd. All rights reserved.","[Shao, Ji-Rong] Sichuan Agr Univ, Sch Life Sci, Yaan 625014, Sichuan, Peoples R China; [Zhang, Zhan-Lu; Zhou, Mei-Liang; Tang, Yi-Xiong; Shao, Ji-Rong] Sichuan Agr Univ, Sch Life Sci, Yaan 625014, Sichuan, Peoples R China; [Zhang, Zhan-Lu; Xue, Wen-Tong] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing 100083, Peoples R China; [Zhang, Zhan-Lu; Zhou, Mei-Liang; Wu, Yan-Min] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100081, Peoples R China; [Tang, Yu] Sichuan Higher Inst Cuisine, Dept Tourism Culture, Chengdu 610072, Sichuan, Peoples R China; [Li, Fa-Liang] Xichang Inst Agr Sci, Alpine Crop Res Stn, Xichang 616150, Sichuan, Peoples R China","Sichuan Agricultural University; Sichuan Agricultural University; China Agricultural University; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS","Shao, JR (corresponding author), Sichuan Agr Univ, Sch Life Sci, Yaan 625014, Sichuan, Peoples R China.",zhml39@hotmail.com; xwt315@hotmail.com; wuyanmin211@hotmail.com,"Lu, Wang/JVO-0416-2024",,"Key Project of Science and Technology of Sichuan, China [04NG001-015]","Key Project of Science and Technology of Sichuan, China","This research was supported by the Key Project of Science and Technology of Sichuan, China (grant no. 04NG001-015, Protection and exploitation of wild-type buckwheat germplasm resource). We are also grateful to Trillian Ross (Plant Cell Physiology, Institute of Biology, Leiden University, The Netherlands) for giving some useful comments on this manuscript.",,67,177,205,9,255,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",0963-9969,1873-7145,,FOOD RES INT,Food Res. Int.,NOV,2012,49,1,,,,,389,395,,10.1016/j.foodres.2012.07.035,http://dx.doi.org/10.1016/j.foodres.2012.07.035,,,7,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,044AT,,,,,2024-06-04,WOS:000311592500049,View Full Record in Web of Science
J,"Rtibi, K; Selmi, S; Grami, D; Amri, M; Eto, B; El-Benna, J; Sebai, H; Marzouki, L",,,,"Rtibi, Kais; Selmi, Slimen; Grami, Dhekra; Amri, Mohamed; Eto, Bruno; El-Benna, Jamel; Sebai, Hichem; Marzouki, Lamjed",,,Chemical constituents and pharmacological actions of carob pods and leaves (Ceratonia siliqua L.) on the gastrointestinal tract: A review,BIOMEDICINE & PHARMACOTHERAPY,,,English,Review,,,,,,Ceratonia siliqua l; Phytochemical constituents; Pharmacological activities; Gastrointestinal tract,IN-VITRO; ANTIOXIDANT ACTIVITY; HUMAN NEUTROPHILS; OXIDATIVE STRESS; POLYPHENOLS; EXTRACTS; HEALTH; BIOACCESSIBILITY; BIOAVAILABILITY; INDUCTION,"Carob tree, Ceratonia siliqua L., is a medicinal plant used in Tunisian traditional medicine for the treatment of the gastro-intestinal (GI) disorders. In this respect, a relatively large number of scientific publications on the carob tree have been published in recent years. Therefore, the present review was aimed to analyze the traditional uses, phytochemical constituents and pharmacological activities of Ceratonia siliqua on the GI tract. Indeed, previous investigations on the carob pods and leaves have revealed the presence of a number of compounds including high amounts of carbohydrates, dietary fibers, minerals, polyphenols, flavonoids and low amounts of protein and lipids. This plant possesses anti-inflammatory, antimicrobial, anti-diarrheique, antioxidant, anti-ulcer, anti-constipation and anti-absorptive of glucose activities in the gastrointestinal tract. Based on the chemical and pharmacological characteristics of C. siliqua, we concluded that this species has beneficial preventive and therapeutic properties, especially, in digestive tract. (C) 2017 Elsevier Masson SAS. All rights reserved.","[Rtibi, Kais; Selmi, Slimen; Grami, Dhekra; Sebai, Hichem; Marzouki, Lamjed] Inst Super Biotechnol Beja, Lab Physiol Fonct & Valorisat Bioressources, BP 382, Beja 9000, Tunisia; [Rtibi, Kais; Amri, Mohamed; Marzouki, Lamjed] Fac Sci Tunis, Dept Sci Biol, Lab Neurophysiol Fonct & Pathol, Tunis 2092, Tunisia; [El-Benna, Jamel] Univ Paris 07, Biomed Res Ctr, INSERM, U1149, F-75018 Paris, France; [Eto, Bruno] Univ Paris 07, TransCell Lab, F-75018 Paris, France",Universite de Jendouba; Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite,"Rtibi, K (corresponding author), Inst Super Biotechnol Beja, Lab Physiol Fonct & Valorisat Bioressources, BP 382, Beja 9000, Tunisia.",rtibikais@yahoo.fr,,"Selmi, Slimen/0000-0001-9861-5780; ETO, Bruno/0000-0001-9397-2690; Amri, Mohamed/0000-0001-5309-7633",,,,,68,70,74,1,32,ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER,ISSY-LES-MOULINEAUX,"65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE",0753-3322,1950-6007,,BIOMED PHARMACOTHER,Biomed. Pharmacother.,SEP,2017,93,,,,,,522,528,,10.1016/j.biopha.2017.06.088,http://dx.doi.org/10.1016/j.biopha.2017.06.088,,,7,"Medicine, Research & Experimental; Pharmacology & Pharmacy",Science Citation Index Expanded (SCI-EXPANDED),Research & Experimental Medicine; Pharmacology & Pharmacy,FE0PU,28686965,,,,2024-06-04,WOS:000407923000058,View Full Record in Web of Science
J,"Janicke, DM; Finney, JW",,,,"Janicke, DM; Finney, JW",,,Empirically supported treatments in pediatric psychology: Recurrent abdominal pain,JOURNAL OF PEDIATRIC PSYCHOLOGY,,,English,Article,,,,,,recurrent abdominal pain; empirically supported treatment; psychological intervention,IRRITABLE-BOWEL-SYNDROME; BRIEF TARGETED THERAPY; NEGATIVE LIFE EVENTS; PRIMARY HEALTH-CARE; SOMATIC COMPLAINTS; ILLNESS BEHAVIOR; DIETARY FIBER; CHILDREN; SYMPTOMS; ADOLESCENTS,"Objective: To review the status of empirically supported treatments for recurrent abdominal pain (RAP). Methods: We identified studies based on literature search and contact with experts in the field and evaluated studies based on guidelines modified from the criteria established by the Task Force on Promotion and Dissemination of Psychological Procedures. Results: Nine published intervention studies were identified that fell into three distinctive approaches: operant procedures, fiber treatments, and cognitive-behavioral treatments. Conclusions: Operant procedures did not meet even the most lenient category (promising intervention) of the guidelines. Fiber treatment for RAP associated with constipation met the criteria for a promising intervention. Cognitive-behavioral treatment met the criteria for a probably efficacious intervention. We discuss implications and offer recommendations for future intervention research.","Virginia Tech, Dept Psychol, Blacksburg, VA 24061 USA",Virginia Polytechnic Institute & State University,"Finney, JW (corresponding author), Virginia Tech, Dept Psychol, Blacksburg, VA 24061 USA.",,"Finney, Jack/B-8270-2008","Finney, Jack/0000-0001-8421-5655; Janicke, David/0000-0002-8493-610X",,,,,52,64,71,0,1,OXFORD UNIV PRESS INC,CARY,"JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA",0146-8693,,,J PEDIATR PSYCHOL,J. Pediatr. Psychol.,APR,1999,24,2,,,,,115,127,,10.1093/jpepsy/24.2.115,http://dx.doi.org/10.1093/jpepsy/24.2.115,,,13,"Psychology, Developmental",Social Science Citation Index (SSCI),Psychology,182EC,10361390,Bronze,,,2024-06-04,WOS:000079484700006,View Full Record in Web of Science
J,"Sharma, S; Chakraborty, D",,,,"Sharma, Swati; Chakraborty, Dipjyoti",,,Antimicrobial and antioxidant activity of Coriandrum sativum L.,ANNALS OF PHYTOMEDICINE-AN INTERNATIONAL JOURNAL,,,English,Article,,,,,,Coriandrum sativum L.; polyphenolic compound; antioxidant; antimicrobial agent,PHENOLIC-ACIDS; IN-VITRO; ROSMARINIC ACID; PLANT; EXTRACT; CAPACITY,"Coriander is an annual herb which belongs to the Apiaceae family, its leaves and roots have been widely used as spice. It is a good source of dietary fibre which helps in preventing constipation and ensures proper bowl movement. Roots are used to make curries and soups. Whole plants are eatable, but the fresh and green leaves are used traditionally in cooking and as medicine. This traditional plant has been also used as anti-inflammatory, analgesic and antimicrobial agent. In present study, the antimicrobial and antioxidant potential of this well known spice have been assessed using standard protocols. The obtained results showed that the leaves, roots and their juice have remarkable efficacies against selected pathogenic strains of bacteria and fungi. Further, the leaves have significant antioxidative properties. On the basis of results, it is evident that the daily use of this precious plant is beneficial for the human health in many ways.","[Sharma, Swati; Chakraborty, Dipjyoti] Banasthali Vidyapith, Dept Biosci & Biotechnol, Banasthali 304022, Rajasthan, India",Banasthali Vidyapith,"Chakraborty, D (corresponding author), Banasthali Vidyapith, Dept Biosci & Biotechnol, Banasthali 304022, Rajasthan, India.",cdipjyoti@banasthali.in,"Chakraborty, Dipjyoti/AAJ-4665-2020; Chakraborty, Dipjyoti/B-6766-2008","Chakraborty, Dipjyoti/0000-0003-4784-4799; Chakraborty, Dipjyoti/0000-0003-4784-4799",,,,,40,7,7,0,7,UKAAZ PUBLICATIONS,HYDERABAD,"16-11-511/D/408, SHALIVAHANA NAGAR, MOOSARAMBAGH, HYDERABAD, 500036, INDIA",2393-9885,2278-9839,,ANN PHYTOMEDICINE,Ann. Phytomedicine,JAN-JUN,2019,8,1,,,,,135,139,,10.21276/ap.2019.8.1.17,http://dx.doi.org/10.21276/ap.2019.8.1.17,,,5,Pharmacology & Pharmacy,Emerging Sources Citation Index (ESCI),Pharmacology & Pharmacy,JH9YE,,gold,,,2024-06-04,WOS:000493124300017,View Full Record in Web of Science
J,"Chiarelli, M; Guttadauro, A; Maternini, M; Lo Bianco, G; Tagliabue, F; Achilli, P; Terragni, S; Gabrielli, F",,,,"Chiarelli, Marco; Guttadauro, Angelo; Maternini, Matteo; Lo Bianco, Giulia; Tagliabue, Fulvio; Achilli, Pietro; Terragni, Sabrina; Gabrielli, Francesco",,,The clinical and therapeutic approach to anal stenosis,ANNALI ITALIANI DI CHIRURGIA,,,English,Article,,,,,,Anal stenosis; Anal stricture; Proctology,GIANT CONDYLOMA ACUMINATUM; Y-V ANOPLASTY; MUCOSAL ECTROPION; ADVANCEMENT ANOPLASTY; SURGICAL-TREATMENT; FLAP ANOPLASTY; PEDICLE FLAP; STRICTURE; HEMORRHOIDECTOMY; REPAIR,"Anal stenosis is a fibrous narrowing of the anal channel. It develops, in most cases, in the aftermath of proctologic surgical procedures with extensive anoderm excision or in the presence of chronic anal inflammation in patients with Crohn Disease. However rare, this condition is thoroughly debilitating for the patients. Symptoms include constipation, pain and bleeding with defecation and a reduction of the caliber of stools. Diagnosis is essentially clinical. Prevention of post-surgical stenosis is based on a scrupulous surgical technique and on an extensive and carefully- planned follow up. Treatment is based on an initially conservative approach with regularization of stool transit through hydration, dietary fibers and bulk-forming laxatives. The role of mechanical dilatation in the treatment of AS is still debated. For severe cases and cases that are not responsive to conservative treatment we must resort to surgery. Surgical approach is tailored on the severity, position and extension. The most severe cases require anoplasty procedures with mucosal or anal flaps.","[Guttadauro, Angelo; Lo Bianco, Giulia; Gabrielli, Francesco] Univ Milanobicocca, Gen Surg Dept, Ist Clin Zucchi, Monza, Italy; [Chiarelli, Marco; Tagliabue, Fulvio; Achilli, Pietro; Terragni, Sabrina] Osped Lecco, Gen Surg Dept, Lecce, Italy; [Maternini, Matteo] Ist Clin Zucchi, Gen Surg Dept, Monza, Italy",University of Milano-Bicocca,"Maternini, M (corresponding author), Ist Clin Zucchi, Gen Surg Dept, Monza, Italy.",matteo.maternini@live.it,"Chiarelli, Marco/AAG-4753-2020","Chiarelli, Marco/0000-0003-1729-4925; Achilli, Pietro/0000-0001-9021-9521",,,,,36,9,9,0,1,EDIZIONI LUIGI POZZI,ROME,"VIA PANAMA 68, 00198 ROME, ITALY",0003-469X,2239-253X,,ANN ITAL CHIR,Ann. Ital. Chir.,MAY-JUN,2018,89,3,,,,,237,241,PII S0003469X18028488,,,,,5,Surgery,Science Citation Index Expanded (SCI-EXPANDED),Surgery,GP4YM,30588920,,,,2024-06-04,WOS:000440878300008,View Full Record in Web of Science
J,"Li, SQ; Zhang, QH",,,,"Li, SQ; Zhang, QH",,,Advances in the development of functional foods from buckwheat,CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION,,,English,Review,,,,,,buckwheat seeds; proteins; flavonoids; fagopyrin; phytosterols; nutritional value; functionalities; allergenic proteins; trypsin inhibitors; thiamin-binding proteins,THIAMINE-BINDING PROTEIN; PLASMA-CHOLESTEROL LEVEL; AMINO-ACID-COMPOSITION; DIETARY PROTEINS; SOYBEAN PROTEIN; IN-VITRO; RATS; FLAVONOIDS; GLYCINE; CASEIN,"Buckwheat originated in North or East Asia and is widely adapted in North America. It has been grown since at least 1000 BC in China. It has very strong adaptability to adverse environments with a very short growing span. Many varieties are growing around the world, but mainly in the north hemisphere. Currently the most common buckwheat spice is Fagopyrum esculentum Moench (common buckwheat or sweet buckwheat), while Fagopyrum tartaricum is also available in some mountainous regions. Many nutraceutical compounds exist in buckwheat seeds and other tissues. Buckwheat has been used and will be better used as an important raw material for functional food production. In this review we focus on works related to the development of functional foods from common buckwheat, Fagopyrum esculentum Moench. A lot of research has be conducted in the functionalities and properties of buckwheat proteins, flavonoids, flavones, phytosterols, thiamin-binding proteins, and other rare compounds in buckwheat seeds. Buckwheat proteins have unique amino acid composition with special biological activities of cholesterol-lowering effects, antihypertensition effects, and improving the constipation and obisity conditions by acting similar as to dietary fiber and interrupting the in vivo metabolisms. The trypsin inhibitors isolated from buckwheat seeds are heat stable and can cause poor digestion if they are not suitably cooked before consumption. The allergenic proteins existing in the buckwheat seeds and their derivatives were reviewed with respect to their chemical and biochemical characteristics as well as the physiological reactions after digestion. Some possible mechanisms involved in these effects are discussed in this review. Experiments, both with animal models and with human beings, revealed that buckwheat flour can improve diabetes, obesity, hypertension, hypercholesterolemia and constipation. Methods to exploit buckwheat seeds and flour to produce highly effective nutraceuticals are also reviewed.","Ohio State Univ, Dept Food Sci & Technol, Columbus, OH 43210 USA",University System of Ohio; Ohio State University,"Ohio State Univ, Dept Food Sci & Technol, 122 Vivian Hall,2121 Fyffe Rd, Columbus, OH 43210 USA.",li.345@osu.edu,,,,,,,95,297,348,4,171,TAYLOR & FRANCIS INC,PHILADELPHIA,"530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA",1040-8398,1549-7852,,CRIT REV FOOD SCI,Crit. Rev. Food Sci. Nutr.,,2001,41,6,,,,,451,464,,10.1080/20014091091887,http://dx.doi.org/10.1080/20014091091887,,,14,Food Science & Technology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Nutrition & Dietetics,478WG,11592684,,,,2024-06-04,WOS:000171370600002,View Full Record in Web of Science
J,"Azpiroz, F; Dubray, C; Bernalier-Donadille, A; Cardot, JM; Accarino, A; Serra, J; Wagner, A; Respondek, F; Dapoigny, M",,,,"Azpiroz, F.; Dubray, C.; Bernalier-Donadille, A.; Cardot, J-M; Accarino, A.; Serra, J.; Wagner, A.; Respondek, F.; Dapoigny, M.",,,"Effects of scFOS on the composition of fecal microbiota and anxiety in patients with irritable bowel syndrome: a randomized, double blind, placebo controlled study",NEUROGASTROENTEROLOGY AND MOTILITY,,,English,Article,,,,,,anxiety; fibers; fructooligosaccharides; irritable bowel syndrome; microbiota,CHAIN FRUCTO-OLIGOSACCHARIDES; ALTERED RECTAL PERCEPTION; TEMPORAL STABILITY; QUANTITATIVE PCR; SYMPTOM SEVERITY; HEALTHY HUMANS; BIFIDOBACTERIA; BUTYRATE; DISTENSION; RATS,"BackgroundShort-chain fructooligosaccharides (scFOS) have beneficial effects in subjects with minor digestive complaints, but the potential mechanisms involved have not been elucidated. The aim of the study was to evaluate changes in rectal sensitivity related to the clinical effects of scFOS in a selected group of patients with irritable bowel syndrome (IBS) and rectal hypersensitivity. MethodsIn 79 IBS patients (defined by Rome III criteria) with rectal hypersensitivity (defined as discomfort threshold 44g) a parallel, placebo-controlled, randomized, and double-blind study was performed to assess the effects of dietary supplementation (5gd(-1)) with scFOS vs placebo for 4weeks on rectal sensitivity (primary outcome: tolerance to increasing wall tension applied by a tensostat), clinical outcomes (IBS, anxiety/depression and quality of life scores) and composition of fecal microbiota. Key ResultsRectal discomfort threshold, and IBS and quality of life scores, significantly improved during treatment, but in a similar manner in both scFOS and placebo groups; a post-hoc analysis showed that the effect of scFOS on rectal sensitivity was more pronounced in constipation-predominant-IBS patients (P=.051 vs placebo). Contrary with placebo, scFOS significantly reduced anxiety scores and increased fecal Bifidobacteria (P<.05 for both) without modifying other bacterial groups. Conclusions & InterfencesThe effect of scFOS on anxiety may be related to modulation of the gut microbiota; demonstration of effects of scFOS on rectal sensitivity may require higher doses and may depend on the IBS subgroup.","[Azpiroz, F.; Accarino, A.; Serra, J.] Univ Hosp Vall dHebron, Digest Syst Res Unit, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Azpiroz, F.; Accarino, A.; Serra, J.] Univ Autonoma Barcelona, Dept Med, Bellaterra, Cerdanyola Del, Spain; [Dubray, C.; Cardot, J-M] Clermont Ferrand Hosp, Inserm CIC 501, Clin Pharmacol Ctr, Clermont Ferrand, France; [Bernalier-Donadille, A.] Clermont Ferrand Res Ctr, Microbiol Unit UR454, St Genes Champanelle, France; [Wagner, A.; Respondek, F.] Tereos, ZI & Portuaire, Marckolsheim, France; [Dapoigny, M.] Univ Auvergne, CHU Clermont Ferrand, INSERM UMR 1107, Neurodol, Clermont Ferrand, France",CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); CHU Clermont Ferrand,"Respondek, F (corresponding author), Tereos, ZI & Portuaire, Marckolsheim, France.",frederique.respondek@tereos.com,"Serra, Jordi/ABH-6319-2020; Garaventa, Anna Accarino/Q-8658-2017; Azpiroz, Maite Fuentes/Y-6916-2018; Serra, Jordi/AAD-8330-2022","Serra, Jordi/0000-0003-2120-6270; Azpiroz, Maite Fuentes/0000-0003-1304-1285; Azpiroz, Fernando/0000-0002-7327-960X",Beghin-Meiji Company; Spanish Ministry of Economy and Competitiveness (Direccion General de Investigatcion Cientifica y Tecnica) [SAF 2013-43677-R]; Instituo de Salud Carlos III,Beghin-Meiji Company; Spanish Ministry of Economy and Competitiveness (Direccion General de Investigatcion Cientifica y Tecnica); Instituo de Salud Carlos III(Instituto de Salud Carlos III),"The study was financially supported by Beghin-Meiji Company and by the Spanish Ministry of Economy and Competitiveness (Direccion General de Investigatcion Cientifica y Tecnica, SAF 2013-43677-R; Ciberhed is funded by the Instituo de Salud Carlos III.",,47,81,85,1,40,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1350-1925,1365-2982,,NEUROGASTROENT MOTIL,Neurogastroenterol. Motil.,FEB,2017,29,2,,,,,,,e12911,10.1111/nmo.12911,http://dx.doi.org/10.1111/nmo.12911,,,8,Gastroenterology & Hepatology; Clinical Neurology; Neurosciences,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Neurosciences & Neurology,EK5JF,27477485,"hybrid, Green Published",,,2024-06-04,WOS:000393962000001,View Full Record in Web of Science
J,"Bhavani, M; Sonia; Deepika; Awuchi, CG",,,,"Bhavani, Maligi; Sonia; Deepika; Awuchi, Chinaza Godswill",,,"Bioactive, antioxidant, industrial, and nutraceutical applications of banana peel",INTERNATIONAL JOURNAL OF FOOD PROPERTIES,,,English,Article,,,,,,Antioxidants; food processing; beverage industry; zero hunger; good health and well-being,PHENOLIC-COMPOUNDS; EXTRACTION; REMOVAL,"People usually waste or discard the numerous benefits of banana peel due to a lack of awareness. Banana peel is a rich source of many bioactive compounds like carotenoids, biogenic amines, polyphenols, phytosterols, and antioxidants. It also contains minerals like iron, calcium, sodium, phosphorus, magnesium, and good levels of dietary fiber. The use of antioxidants present in banana peels can help reduce the risk of diseases like cancer. Antioxidants play a crucial role in the removal of toxins from the human body. One complete banana comprises about 30-40% peel, and the rest is the pulp portion. Banana peels are used in a wide range of industries like cosmetics, medicine, food processing, beverages, textiles, energy resources, paper manufacture, bio-absorbents, biofuel production, and the agricultural sector. An epic transformation in different industrial sectors can be seen because of the versatile nature of banana peel. In agricultural sectors, banana peel can be used as fertilizer to enhance the soil's physical properties, crop quality, and yield due to potassium. Even fiber-rich banana peels can be used to treat constipation problems. Banana peel carries anti-inflammatory properties that can be used in daily life as a first-aid at home to control, reduce, and cure inflammation and infections. Banana is commonly available in our homes, and thus it can be known as a zero-budget organic cosmetic product. Industrial products like paper, fiber, and textiles can be manufactured from banana peels.","Lovely Profess Univ, Sch Agr, Dept Hort, Phagwara, Punjab, India; [Sonia] Lovely Profess Univ, Sch Agr, Dept Food Technol & Nutr, Phagwara, Punjab, India; [Awuchi, Chinaza Godswill] Kampala Int Univ, Sch Nat & Appl Sci, Kampala, Uganda",Lovely Professional University; Lovely Professional University,"Sonia (corresponding author), Lovely Profess Univ, Sch Agr, Dept Food Technol & Nutr, Phagwara, Punjab, India.;Awuchi, CG (corresponding author), Kampala Int Univ, Sch Nat & Appl Sci, Kampala, Uganda.",sonia.morya8199@gmail.com; awuchi.chinaza@kiu.ac.ug,"Awuchi, Chinaza Godswill/AAO-9006-2021; Morya, Sonia/AEK-9229-2022","Awuchi, Chinaza Godswill/0000-0001-5071-8895; Morya, Sonia/0000-0002-8137-2759",,,,,71,7,7,9,26,TAYLOR & FRANCIS INC,PHILADELPHIA,"530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA",1094-2912,1532-2386,,INT J FOOD PROP,Int. J. Food Prop.,DEC 31,2023,26,1,,,,,1277,1289,,10.1080/10942912.2023.2209701,http://dx.doi.org/10.1080/10942912.2023.2209701,,,13,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,G3EN8,,gold,,,2024-06-04,WOS:000988031000001,View Full Record in Web of Science
J,"Muscaritoli, M; Kushta, I; Molfino, A; Inghilleri, M; Sabatelli, M; Rossi Fanelli, F",,,,"Muscaritoli, Maurizio; Kushta, Irma; Molfino, Alessio; Inghilleri, Maurizio; Sabatelli, Mario; Rossi Fanelli, Filippo",,,Nutritional and metabolic support in patients with amyotrophic lateral sclerosis,NUTRITION,,,English,Review,,,,,,Amyotrophic lateral sclerosis; Malnutrition; Metabolic support; Artificial nutrition,MOTOR-NEURON DISEASE; GAMMA-LINOLENIC ACID; SKELETAL-MUSCLE ATROPHY; ENTERAL NUTRITION; PERCUTANEOUS GASTROSTOMY; EICOSAPENTAENOIC ACID; INSULIN-RESISTANCE; VENTILATED PATIENTS; MITOCHONDRIAL-DNA; GLUCOSE-TOLERANCE,"Amyotrophic lateral sclerosis (ALS) is the most common form of progressive motor neuron disease and the most devastating neurodegenerative disorder. ALS is characterized by progressive paralysis and respiratory failure leading to death within 3 to 5 years after its onset. Protein-energy malnutrition is a frequent finding in ALS. The pathogenesis of protein-energy malnutrition in ALS is multifactorial. Muscle atrophy, hypophagia, dysphagia, and hypermetabolism play a role in determining the deterioration of nutritional status. A multidisciplinary approach is crucial to set an appropriate plan for metabolic and nutritional support in ALS. Nutritional management incorporates a continuous assessment and implementation of dietary modifications throughout the duration of the disease. The nutritional and metabolic approaches to ALS should start when the diagnosis of ALS is made and should become an integral part of the continuous care to the patient, including nutritional surveillance, dietary counseling, management of dysphagia, and enteral nutrition when needed. Parenteral nutrition is rarely indicated. Standard polymeric enteral formulas are routinely used, usually providing 25 to 30 kcal/kg and protein 0.8 to 1.2 g /kg per day. The use of fiber-enriched formulas may help prevent constipation. However, considering the complex metabolic abnormalities of ALS, standard and/or fiber-enriched formulas might not be sufficient to achieve optimal metabolic and nutritional support. Based on the most recent clinical and experimental evidence, it is tempting to hypothesize that personalized nutritional support including specific nutritional substrates could act on disease progression and improve the quality of life and the response to the few and yet scarcely effective, currently available pharmacologic therapies. (C) 2012 Elsevier Inc. All rights reserved.","[Muscaritoli, Maurizio; Kushta, Irma; Molfino, Alessio; Rossi Fanelli, Filippo] Univ Rome, Dept Clin Med, Rome, Italy; [Inghilleri, Maurizio] Univ Rome, Dept Neurol Sci, Rome, Italy; [Sabatelli, Mario] Univ Cattolica Sacro Cuore, Inst Neurol, I-00168 Rome, Italy",Sapienza University Rome; Sapienza University Rome; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli,"Muscaritoli, M (corresponding author), Univ Rome, Dept Clin Med, Rome, Italy.",maurizio.muscaritoli@uniroma1.it,"Molfino, Alessio/AAC-1608-2019; Inghilleri, Maurizio/AAZ-6136-2020; Rossi Fanelli, Filippo/E-9587-2011","Molfino, Alessio/0000-0002-6432-0236; Inghilleri, Maurizio/0000-0001-5365-3417; Sabatelli, Mario/0000-0001-6635-4985; Rossi Fanelli, Filippo/0000-0002-8674-1672",,,,,139,36,44,1,30,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",0899-9007,1873-1244,,NUTRITION,Nutrition,OCT,2012,28,10,,,,,959,966,,10.1016/j.nut.2012.01.011,http://dx.doi.org/10.1016/j.nut.2012.01.011,,,8,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,013QJ,22677356,,,,2024-06-04,WOS:000309319600002,View Full Record in Web of Science
J,"Spiller, RC",,,,"Spiller, R. C.",,,"Changing views on diverticular disease: impact of aging, obesity, diet, and microbiota",NEUROGASTROENTEROLOGY AND MOTILITY,,,English,Review,,,,,,diet; diverticulitis; diverticulosis; obesity; pain,GASTROINTESTINAL SYMPTOMS; SEROTONIN TRANSPORTER; SMOOTH-MUSCLE; NITRIC-OXIDE; MOUSE MODEL; FIBER DIET; RISK; PREVALENCE; COLITIS; HYPERSENSITIVITY,"The development of colonic diverticulosis is a common aging change in industrialized nations. While most patients have asymptomatic diverticulosis, around one in five develops symptomatic diverticular disease. This is characterized by recurrent abdominal pain and disturbed bowel habit. Some of the pain episodes are prolonged and are due to acute diverticulitis, which itself may be complicated by abscess, perforation, fistulation, or stricture formation. Risk factors favouring the development of symptomatic diverticular disease include obesity, smoking and diets low in fiber but high in red meat and animal fat. What determines the transition from asymptomatic diverticulosis to symptomatic diverticular disease is unclear but neuromuscular changes following acute diverticulitis may be responsible in some cases. The severity of symptoms generated depends on cerebral pain processing which is influenced by psychosocial factors. These are important considerations in deciding optimal patient management. Prior theories of the cause of diverticulosis suggested that constipation was an important cause, but new data challenge this and has provoked new ideas. Underlying mechanisms causing diverticulosis include weakening of the colonic wall and/or degenerative changes in the enteric nerves. Dietary induced changes in microbiota and the host inflammatory response may underlie the subsequent development of acute/chronic diverticulitis and its sequela.","[Spiller, R. C.] Univ Nottingham, Queens Med Ctr, Nottingham Digest Dis Ctr, Nottingham NG7 2RD, England",University of Nottingham,"Spiller, RC (corresponding author), Univ Nottingham, Queens Med Ctr, Nottingham Digest Dis Ctr, Gastroenterol, Nottingham NG7 2RD, England.",robin.spiller@nottingham.ac.uk,"spiller, robin/ABE-6690-2021","spiller, robin/0000-0001-6371-4500",NIHR for the Nottingham Digestive Diseases Biomedical Research Unit; National Institute for Health Research [NF-SI-0509-10005] Funding Source: researchfish,NIHR for the Nottingham Digestive Diseases Biomedical Research Unit; National Institute for Health Research(National Institutes of Health Research (NIHR)),The author was supported by a grant from the NIHR for the Nottingham Digestive Diseases Biomedical Research Unit.,,55,43,45,0,39,WILEY-BLACKWELL,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1350-1925,1365-2982,,NEUROGASTROENT MOTIL,Neurogastroenterol. Motil.,MAR,2015,27,3,,,,,305,312,,10.1111/nmo.12526,http://dx.doi.org/10.1111/nmo.12526,,,8,Gastroenterology & Hepatology; Clinical Neurology; Neurosciences,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Neurosciences & Neurology,CC2CV,25703217,,,,2024-06-04,WOS:000350153400001,View Full Record in Web of Science
J,"Washington, N; Harris, M; Mussellwhite, A; Spiller, RC",,,,"Washington, N; Harris, M; Mussellwhite, A; Spiller, RC",,,Moderation of lactulose-induced diarrhea by psyllium: effects on motility and fermentation,AMERICAN JOURNAL OF CLINICAL NUTRITION,,,English,Article,,,,,,gastric emptying; colon transit; lactulose; psyllium; diarrhea; constipation; irritable bowel syndrome; gamma scintigraphy; small bowel,IRRITABLE-BOWEL-SYNDROME; TRANSIT-TIME; VISCOUS POLYSACCHARIDES; JEJUNAL MOTILITY; ISPAGHULA HUSK; DIETARY FIBER; COLON TRANSIT; ILEAL BRAKE; MEAL; ABSORPTION,"Psyllium has been reported to inhibit lactulose-induced colonic mass movements and to benefit patients with irritable bowel syndrome, improving both constipation and diarrhea. Our aim was to define how psyllium modified the whole-gut transit of a radiolabeled lactulose-containing test meal by using gamma scintigraphy. Eight subjects participated in a randomized crossover study comparing gastric emptying and small bower and colonic transit after consumption of 20 mt lactulose three times daily with or without 3.5 g psyllium three times daily. Psyllium significantly delayed gastric emptying: the time to 50% emptying increased from a control value of 69 +/- 9 to 87 +/- 11 min ((x) over bar +/- SEM; P < 0.05, n = 8). Small bower transit was unaltered. However, progression through the colon was delayed with an increase in the percentage of the dose at 24 h in the ascending (control group: 2 +/- 3%, psyllium group: 11 +/- 8%; P < 0.02) and transverse colon (control group: 5 +/- 12%, psyllium group: 21 +/- 14%) with correspondingly less in the descending colon. Although the time for 50% of the isotope to reach the colon was not significantly different with psyllium, psyllium significantly delayed the rise in breath-hydrogen concentrations, which reached 50% of their peak at 217 +/- 34 min compared with control values of 155 +/- 27 min (P < 0.05). Psyllium delays gastric emptying, probably by increasing meal viscosity, and reduces the acceleration of colon transit, possibly by delaying the production of gaseous fermentation products.","Queens Med Ctr, Dept Surg, Nottingham NG7 2UH, England; Queens Med Ctr, Div Gastroenterol, Nottingham NG7 2UH, England",University of Nottingham; University of Nottingham,"Washington, N (corresponding author), Queens Med Ctr, Dept Surg, E Floor,W Block, Nottingham NG7 2UH, England.",,"spiller, robin/ABE-6690-2021","spiller, robin/0000-0001-6371-4500",,,,,35,67,73,0,8,AMER SOC CLINICAL NUTRITION,BETHESDA,"9650 ROCKVILLE PIKE, SUBSCRIPTIONS, RM L-3300, BETHESDA, MD 20814-3998 USA",0002-9165,,,AM J CLIN NUTR,Am. J. Clin. Nutr.,FEB,1998,67,2,,,,,317,321,,10.1093/ajcn/67.2.237,http://dx.doi.org/10.1093/ajcn/67.2.237,,,5,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,YU348,9459381,hybrid,,,2024-06-04,WOS:000071708100022,View Full Record in Web of Science
J,"Tester, R; Al-Ghazzewi, F",,,,"Tester, Richard; Al-Ghazzewi, Farage",,,Glucomannans and nutrition,FOOD HYDROCOLLOIDS,,,English,Article,,,,,,Glucomannan; Health benefit; Konjac; Nutrition,UNCOMPLICATED DIVERTICULAR-DISEASE; KONJAC-GLUCOMANNAN; DIETARY-FIBER; FRUCTO-OLIGOSACCHARIDE; CHRONIC CONSTIPATION; CROHNS-DISEASE; GUT MICROBIOTA; BILE-ACID; MANNAN; CHOLESTEROL,"The roles of native and depolymerised glucomannans in the diet are reviewed together with their impact in health and disease. The structure and properties of the carbohydrates are also considered together with their roles as microbiological substrates and their interactions with non-pathogens and pathogens. Native glucomannans have been consumed for centuries in Asia within food products and are permitted food thickeners through the world. However, their strong gel structures limit applications in the diet. Depolymerised and native glucomannans are considered therefore in this review with relevant dietary applications. These applications include swallowing (dysphagia), nutrient absorption control, satiety, dietary-fibre, inflammatory bowel disease, colonic benefits (such as prebiotic). (C) 2016 Elsevier Ltd. All rights reserved.","[Tester, Richard; Al-Ghazzewi, Farage] Glycologic Ltd, 70 Cowcaddens Rd, Glasgow G4 0BA, Lanark, Scotland",,"Al-Ghazzewi, F (corresponding author), Glycologic Ltd, 70 Cowcaddens Rd, Glasgow G4 0BA, Lanark, Scotland.",f.h.alghazzewi@glycologic.co.uk,,,,,,,115,39,46,7,140,ELSEVIER SCI LTD,OXFORD,"THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND",0268-005X,1873-7137,,FOOD HYDROCOLLOID,Food Hydrocolloids,JUL,2017,68,,,,SI,,246,254,,10.1016/j.foodhyd.2016.05.017,http://dx.doi.org/10.1016/j.foodhyd.2016.05.017,,,9,"Chemistry, Applied; Food Science & Technology",Science Citation Index Expanded (SCI-EXPANDED),Chemistry; Food Science & Technology,ER5UE,,,,,2024-06-04,WOS:000398868000028,View Full Record in Web of Science
J,"Kistler, BM; Biruete, A; Chapman-Novakofski, K; Wilund, KR",,,,"Kistler, Brandon M.; Biruete, Annabel; Chapman-Novakofski, Karen; Wilund, Kenneth R.",,,The Relationship Between Intradialytic Nutrition and Gastrointestinal Symptoms Using a Modified Version of the Gastrointestinal Symptom Rating Scale,JOURNAL OF RENAL NUTRITION,,,English,Article,,,,,,,CHRONIC-HEMODIALYSIS PATIENTS; MAINTENANCE HEMODIALYSIS; ENTERAL NUTRITION; OUTCOMES; SUPPLEMENTATION; DIALYSIS; DISEASE; EAT,"Objective: Intradialytic nutrition has been shown to improve nutritional status in maintenance hemodialysis (HD) patients but remains controversial due in part to concerns over hemodynamic stability and gastrointestinal (GI) distress. There are limited data on the relationship between intradialytic nutrition and GI symptoms, possibly due to the lack of a validated tool. Therefore, we intended to validate a questionnaire to measure GI symptoms associated with a single HD treatment and determine the relationship between intradialytic nutrition and GI symptoms. Design: Cross-sectional study. Forty-eight maintenance HD patients. Main Outcome Measure: GI symptoms and dietary intake during HD treatment. Results: In general, we found acceptable internal consistency (Cronbach's alpha >0.5, exception reflux domain) and repeatability in all 5 domains of a modified version of the Gastrointestinal Symptom Rating Scale. The prevalence of GI symptoms associated with a single HD treatment (generalized score greater than 1) was 54.2, 43.7, 6.2, 41.7, and 45.8% for the abdominal pain, indigestion, reflux, diarrhea, and constipation domains, respectively. More than two-thirds of patients chose to eat during treatment (168.6 +/- 165.6 kcal) with the most commonly consumed items being candy, oral supplements, and cookies. There was no difference in GI symptoms among patients who did or did not eat (P > .05). However, the amount of total dietary fat and fiber consumed during treatment was associated with greater indigestion (P < .05) prior to accounting for outliers or multiple comparisons. Conclusion: In this sample, the modified version of the Gastrointestinal Symptom Rating Scale was a generally valid tool for measuring GI symptoms associated with a single HD treatment. Patients who ate during treatment did not experience greater GI symptoms than those who did not; however, high amounts of fat and fiber may be associated with greater GI symptoms. Prospective trials should examine the relationship between GI symptoms and dietary intake during treatment in HD patients. (C) 2017 by the National Kidney Foundation, Inc. All rights reserved.","[Kistler, Brandon M.; Wilund, Kenneth R.] Univ Illinois, Kinesiol & Community Hlth, Urbana, IL USA; [Kistler, Brandon M.] Ball State Univ, Dept Nutr & Hlth Sci, Muncie, IN 47306 USA; [Biruete, Annabel; Chapman-Novakofski, Karen; Wilund, Kenneth R.] Univ Illinois, Div Nutr Sci, Urbana, IL USA",University of Illinois System; University of Illinois Urbana-Champaign; Ball State University; University of Illinois System; University of Illinois Urbana-Champaign,"Kistler, BM (corresponding author), CL326K Cooper Sci Bldg,2000 West Univ Ave, Muncie, IN 47306 USA.",bmkistler@bsu.edu,"Akdoğan, Mehtap/IAO-2608-2023","Biruete, Annabel/0000-0003-2549-0539",American Heart Association Predoctoral Fellowship; Renal Research Institute; National Institutes of Health,American Heart Association Predoctoral Fellowship(American Heart Association); Renal Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA),B.M.K. was funded by an American Heart Association Predoctoral Fellowship. A.B. is a predoctoral fellow through CONACyT (the Mexico Council of Science and Technology) and has received funding from the Renal Research Institute. K.C.-.N. has no disclosures relevant to this paper. K.W. has received funding from the National Institutes of Health and the Renal Research Institute.,,26,4,4,0,7,W B SAUNDERS CO-ELSEVIER INC,PHILADELPHIA,"1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA",1051-2276,1532-8503,,J RENAL NUTR,J. Renal Nutr.,MAR,2018,28,2,,,,,129,134,,10.1053/j.jrn.2017.08.006,http://dx.doi.org/10.1053/j.jrn.2017.08.006,,,6,Nutrition & Dietetics; Urology & Nephrology,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics; Urology & Nephrology,FX7DK,29471989,Green Accepted,,,2024-06-04,WOS:000426247300010,View Full Record in Web of Science
J,"Chen, HL; Cheng, HC; Liu, YJ; Liu, SY; Wu, WT",,,,"Chen, Hsiao-Ling; Cheng, Han-Chung; Liu, Yann-Jiu; Liu, Su-Yuan; Wu, Wen-Tze",,,Konjac acts as a natural laxative by increasing stool bulk and improving colonic ecology in healthy adults,NUTRITION,,,English,Article,,,,,,konjac; glucomannan; defecation; stool bulk; bifidobacteria; short-chain fatty acid,CHRONIC CONSTIPATION; INTESTINAL BACTERIA; DIETARY FIBER; GLUCOMANNANS; MICROFLORA; COMPONENT; NEOPLASM; BOWEL; FOODS,"Objective: Konjac glucomannan (KGM) has been shown to relieve constipation, which could be associated with increased stool bulk and improved colonic ecology. Methods: This placebo-controlled study consisted of a 21-d placebo period, a 7-d adaptation period when volunteers. consumed KGM progressively, and a 21-d KGM-supplemented period (1.5 g/meal, 4.5 g/d). Eight healthy adults consumed 7-d cycle menus of typical low-fiber Chinese food throughout the study. The gastrointestinal response W as monitored daily. Stools were fully collected on days 15 to 21 of placebo and KGM periods to determine the fecal mass, components, microflora, and short-chain fatty acid contents. Results: The KGM supplement significantly increased the mean defecation frequency (number/day), wet stool weight, and dry stool weight (g/d) by similar to 27.0% (P < 0.05), 30.2% (P < 0.05), and 21.7% (P < 0.05), respectively. The dry fecal mass increased mainly in the plant and soluble material, whereas bacterial mass tended to increase from 12.9 +/- 1.6 to 13.6 +/- 2.7 g/d (P > 0.05). However, KGM significantly promoted the fecal concentrations (log counts/g wet feces) of lactobacilli (P < 0.05) and total bacteria (P < 0.05), and promoted the daily output (log counts per day) of bifidobacteria (P < 0.05), lactobacilli (P < 0.05), and total bacteria (P < 0.05) as evaluated by the fluorescence in situ hybridization method. KGM supplement also promoted colonic fermentation as shown in the decreased fecal pH (P < 0.05) and increased fecal short-chain fatty acid concentrations (P < 0.05). Conclusion: Supplementation of KGM into a low-fiber diet promoted the defecation frequency in healthy adults, possibly by increasing the stool bulk, thus promoting the growth of lactic acid bacteria and colonic fermentation. (C) 2006 Elsevier Inc. All rights reserved.","Chung Shan Med Univ, Inst Nutr Sci, Taichung, Taiwan; Natl Cheng Kung Univ, Dept Nutr, Tainan 70101, Taiwan",Chung Shan Medical University; National Cheng Kung University,"Chen, HL (corresponding author), Chung Shan Med Univ, Inst Nutr Sci, Taichung, Taiwan.",hlchen@csmu.edu.tw,,,,,,,37,91,102,3,50,ELSEVIER SCIENCE INC,NEW YORK,"STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA",0899-9007,1873-1244,,NUTRITION,Nutrition,NOV-DEC,2006,22,11-12,,,,,1112,1119,,10.1016/j.nut.2006.08.009,http://dx.doi.org/10.1016/j.nut.2006.08.009,,,8,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,108VS,17027233,,,,2024-06-04,WOS:000242267900005,View Full Record in Web of Science
J,"Junejo, SA; Geng, HH; Li, SN; Kaka, AK; Rashid, A; Zhou, YB",,,,"Junejo, Shahid Ahmed; Geng, Huihui; Li, Songnan; Kaka, Ajeet Kumar; Rashid, Alam; Zhou, Yibin",,,Superfine wheat bran improves the hyperglycemic and hyperlipidemic properties in a high-fat rat model,FOOD SCIENCE AND BIOTECHNOLOGY,,,English,Article,,,,,,Superfine wheat bran; High-fat rat model; Postprandial glucose; Lipid profile,DIETARY FIBER CONTENT; OBESITY; PURIFICATION,"Wheat bran (WB) is an abundant source of fiber, promoting the health for constipation, irritable bowel syndrome, and gastrointestinal disorders. However, the role of superfine-WB in improving the obesity, hyperglycemia, and hyperlipidemia needs to be revealed. The superfine-WB (low and high treatments) was studied on body-weight, blood sugar, serum, and liver lipids in a high-fat rat model for 5-weeks. The high-fat diet substantially increased body-weight, sugar levels, lipids, and malondialdehyde in serum and liver. In contrast, the superfine-WB treatments reduced food and energy intake, postprandial glucose, body-weight, blood and liver cholesterol, triglycerides, malondialdehyde, low-density lipoprotein, and increased the level of high-density lipoprotein. Additionally, when the two different concentrations were compared, the maximum impact was exhibited by the superfine-WB containing high concentration. These results suggest that the superfine-WB significantly improves the hyperglycemia, hyperlipidemia, and possibly also protecting against other acute, recurrent, or chronic diseases.","[Junejo, Shahid Ahmed; Geng, Huihui; Rashid, Alam; Zhou, Yibin] Anhui Agr Univ, Key Lab Agr Prod Proc Engn, 130 Chang Jiang West Rd, Hefei 230036, Peoples R China; [Junejo, Shahid Ahmed; Li, Songnan] South China Univ Technol, Sch Food Sci & Engn, Key Lab Green Proc Nat Prod & Prod Safety, Guangzhou 510640, Peoples R China; [Kaka, Ajeet Kumar] Khairpur Coll Agr Engn & Technol, Dept Postharvest Technol & Proc Engn, Khairpur Mirs, Pakistan",Anhui Agricultural University; South China University of Technology,"Zhou, YB (corresponding author), Anhui Agr Univ, Key Lab Agr Prod Proc Engn, 130 Chang Jiang West Rd, Hefei 230036, Peoples R China.",shahidfst42@gmail.com; m18326910755_1@163.com; 837333606@qq.com; ajeetkumarkaka@gmail.com; rashidahmad00gilgit@gmail.com; zhouyibin@ahau.edu.cn,"Ahmed, Shahid/ABB-8639-2020; Li, Songnan/KLZ-3263-2024; Ahmed, Shahid/HPG-0424-2023","Ahmed, Shahid/0000-0001-6552-6626; Li, Songnan/0000-0002-8494-9197; Ahmed, Shahid/0000-0001-6552-6626",,,,,35,7,8,0,15,KOREAN SOCIETY FOOD SCIENCE & TECHNOLOGY-KOSFOST,SEOUL,"#605, KOREA SCI TECHNOL CENT, 635-4 YEOKSAM-DONG, KANGNAM-GU, SEOUL, 135-703, SOUTH KOREA",1226-7708,2092-6456,,FOOD SCI BIOTECHNOL,Food Sci. Biotechnol.,APR,2020,29,4,,,,,559,567,,10.1007/s10068-019-00684-8,http://dx.doi.org/10.1007/s10068-019-00684-8,,,9,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,LB8DQ,32296567,Green Published,,,2024-06-04,WOS:000524860200013,View Full Record in Web of Science
J,"Burlina, A; Tims, S; van Spronsen, F; Sperl, W; Burlina, AP; Kuhn, M; Knol, J; Rakhshandehroo, M; Coskun, T; Singh, RH; MacDonald, A",,,,"Burlina, Alberto; Tims, Sebastian; van Spronsen, Francjan; Sperl, Wolfgang; Burlina, Alessandro P.; Kuhn, Mirjam; Knol, Jan; Rakhshandehroo, Maryam; Coskun, Turgay; Singh, Rani H.; MacDonald, Anita",,,The potential role of gut microbiota and its modulators in the management of propionic and methylmalonic acidemia,EXPERT OPINION ON ORPHAN DRUGS,,,English,Article,,,,,,Propionic acid; methylmalonic acid; prebiotic; probiotic; microbiota,BUTYRATE-PRODUCING BACTERIA; PROTEIN TUBE FEEDS; CHAIN FATTY-ACIDS; IN-VITRO; ORGANIC ACIDEMIAS; GALACTO-OLIGOSACCHARIDES; INTESTINAL TRANSPORT; PHENOTYPIC SPECTRUM; CEREAL FRUCTANS; MOUSE MODELS,"Introduction: Propionic and methylmalonic acidemia (PA/MMA) are rare inborn errors of metabolism characterized by accumulation of propionyl CoA and/or methylmalonyl CoA, resulting in potentially serious metabolic crises arid clinical complications. The gut microbiota contributes a significant proportion of total propionate production and provides a potentially modifiable target. Empiric use of oral antibiotics to reduce propionate production is a common approach but is hampered by possible drug resistance, perturbation of normal gut microbiota, and toxicity. Moreover, constipation, associated with low fiber intake, inadequate fluid intake, low gut motility, and other factors, is a chronic problem in this patient population and may influence propionate production. Newer management techniques that reduce the burden of propionate and address these clinical challenges are needed. Areas covered: This paper summarizes the potential contribution of gut-related factors in PA/MMA and considers modifying gut microbiota as a management approach. Expert opinion: Dietary management of PA/MMA may be improved by specific prebiotics that modify gut microbiota to stabilize or possibly reduce PA production.","[Burlina, Alberto] Reference Ctr Expanded Newborn Screening, Div Inherited Metab Dis, Padua, Italy; [Tims, Sebastian; Knol, Jan; MacDonald, Anita] Nutricia Res, Adv Med Nutr, Gut & Microbiol Platform, Utrecht, Netherlands; [van Spronsen, Francjan] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Div Metab Dis, Groningen, Netherlands; [Sperl, Wolfgang] Salzburger Landeskliniken, Salzburg, Austria; [Sperl, Wolfgang] Paracelsus Med Univ Salzburg, Salzburg, Austria; [Burlina, Alessandro P.] St Bassiano Hosp, Neurol Unit, Bassano Del Grappa, Italy; [Kuhn, Mirjam; Rakhshandehroo, Maryam] Nutricia Res, Adv Med Nutr, Res Dept Paediat Care & Metab Control, Utrecht, Netherlands; [Knol, Jan] Wageningen Univ, Lab Microbiol, Wageningen, Netherlands; [Coskun, Turgay] Hacettepe Univ, Fac Med, Dept Pediat, Div Metab & Nutr, Ankara, Turkey; [Singh, Rani H.] Emory Univ, Nutr Sect, Div Med Genet, Atlanta, GA 30322 USA; [MacDonald, Anita] Birmingham Childrens Hosp, Birmingham, W Midlands, England",Danone Nutricia; University of Groningen; Paracelsus Private Medical University; ULSS 7 Pedemontana; Ospedale San Bassiano; Danone Nutricia; Wageningen University & Research; Hacettepe University; Emory University; University of Birmingham,"Burlina, A (corresponding author), Univ Hosp, Reference Ctr Expanded Newborn Screening, Div Inherited Metab Dis, Paediat Dept, Padua, Italy.",alberto.burlina@unipd.it,"burlina, alberto/AHE-6095-2022; Knol, Jan/AAL-6487-2020; Singh, Rani/AAU-8246-2020","Knol, Jan/0000-0002-2103-5961; Singh, Rani/0000-0003-2096-2592",,,,,92,6,7,5,10,TAYLOR & FRANCIS LTD,ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND",2167-8707,,,EXPERT OPIN ORPHAN D,Exp. Opin. Orphan Drugs,,2018,6,11,,,,,683,692,,10.1080/21678707.2018.1536540,http://dx.doi.org/10.1080/21678707.2018.1536540,,,10,Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy,HB9HD,,,,,2024-06-04,WOS:000451401200005,View Full Record in Web of Science
J,"Godeberge, P; Sheikh, P; Zagriadskii, E; Lohsiriwat, V; Montaño, AJ; Kosorok, P; De Schepper, H",,,,"Godeberge, Philippe; Sheikh, Parvez; Zagriadskii, Evgeny; Lohsiriwat, Varut; Montano, Abel Jalife; Kosorok, Pavle; De Schepper, Heiko",,,Hemorrhoidal disease and chronic venous insufficiency: Concomitance or coincidence; results of the CHORUS study (Chronic venous and HemORrhoidal diseases evalUation and Scientific research),JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,,,English,Article,,,,,,chronic venous disease; hemorrhoidal disease; risk factors,PREVALENCE; GUIDELINES; MANAGEMENT; DISORDERS; CONSTIPATION; POPULATION; SYMPTOMS,"Background and Aim The CHORUS study (Chronic venous and HemORrhoidal diseases evalUation and Scientific research) was conducted to provide data on patients presenting with hemorrhoidal disease (HD) in clinical practice and to explore the frequency with which it coexists with chronic venous disease (CVD) and shared risk factors. Methods This international, noninterventional study enrolled adult patients attending a consultation for hemorrhoidal complaints. The questionnaire completed by physicians established the subjects' demographic and lifestyle characteristics and collected information on HD grade and symptoms and signs of CVD. Results A total of 5617 patients were analyzed. Symptoms commonly reported were bleeding (71.8%), pain (67.4%), swelling (55.0%), itching (44.1%), and prolapse (36.2%). Multivariate analysis revealed the variables with the strongest association with HD severity were older age, higher CVD CEAP (Clinical manifestations, Etiologic factors, Anatomic distribution of disease, and underlying Pathophysiology) class, constipation, and male gender (all P < 0.0001). Elevated BMI was a risk factor for HD recurrence. Among women, number of births had a significant association with both HD grade and recurrence. The presence of CVD, reported in approximately half the patients (51.2%), was strongly associated with advanced grade of HD (P < 0.0001). Treatments most commonly prescribed were venoactive drugs (94.3%), dietary fiber (71.4%), topical treatment (70.3%), analgesics (26.3%), and surgery (23.5%). Conclusions CHORUS provides a snap shot of current profiles, risk factors, and treatments of patients with HD across the globe. The coexistence of HD and CVD in more than half the study population highlights the importance of examining for CVD among patients with a hemorrhoid diagnosis, particularly when shared risk factors are present.","[Godeberge, Philippe] Paris Descartes Univ, Mutualist Inst Montsouris, Dept Gastroenterol, Paris, France; [Sheikh, Parvez] Saifee Hosp Mumbai, Dept Gastroenterol, Mumbai, Maharashtra, India; [Zagriadskii, Evgeny] Med Ctr ON CLIN, Dept Proctol, Moscow, Russia; [Lohsiriwat, Varut] Mahidol Univ, Fac Med, Siriraj Hosp, Bangkok, Thailand; [Montano, Abel Jalife] Gen Hosp Mexico, Dept Proctol, Mexico City, DF, Mexico; [Kosorok, Pavle] Iatros Med Ctr, Dept Proctol, Ljubljana, Slovenia; [De Schepper, Heiko] Univ Hosp Antwerp, Dept Gastroenterol & Hepatol, Edegem, Belgium",Universite Paris Cite; Institute Mutualiste Montsouris; Mahidol University; University of Antwerp,"Godeberge, P (corresponding author), Univ Paris V, Inst Mutualiste Montsouris, Dept Gastroenterol, 42 Bd Jourdan, F-75014 Paris, France.",p.godeberge@orange.fr,"Lohsiriwat, Varut/AAG-5649-2020; Lohsiriwat, Varut/AAD-7143-2019; De Schepper, Heiko/E-7288-2019","Lohsiriwat, Varut/0000-0002-2252-9509; Lohsiriwat, Varut/0000-0002-2252-9509; De Schepper, Heiko/0000-0001-8201-2651",Servier Affaires Medicales; Servier,Servier Affaires Medicales; Servier(Servier),"The trial was sponsored and funded by Servier, which was responsible for the study design, study management, data collection, and data analysis and was involved in the writing of the report. Editorial assistance for this paper was provided by Jenny Grice and funded by Servier Affaires Medicales.",,26,10,12,0,5,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0815-9319,1440-1746,,J GASTROEN HEPATOL,J. Gastroenterol. Hepatol.,APR,2020,35,4,,,,,577,585,,10.1111/jgh.14857,http://dx.doi.org/10.1111/jgh.14857,,OCT 2019,9,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,LC4VW,31512275,"Green Published, hybrid",,,2024-06-04,WOS:000493338100001,View Full Record in Web of Science
J,"Sakakibara, R; Uchiyama, T; Yamanishi, T; Shirai, K; Hattori, T",,,,"Sakakibara, R.; Uchiyama, T.; Yamanishi, T.; Shirai, K.; Hattori, T.",,,Bladder and bowel dysfunction in Parkinson's disease,JOURNAL OF NEURAL TRANSMISSION,,,English,Review,,,,,,Parkinson's disease; bladder dysfunction; bowel dysfunction; autonomic nervous system; dopamine,MULTIPLE SYSTEM ATROPHY; LOWER URINARY-TRACT; ENTERIC NERVOUS-SYSTEM; QUESTIONNAIRE-BASED ASSESSMENT; IMPAIRED CONTRACTILE FUNCTION; VENTRAL TEGMENTAL AREA; COLONIC TRANSIT TIMES; MICTURITION REFLEX; OVERACTIVE BLADDER; VOIDING DYSFUNCTION,"Bladder dysfunction (urinary urgency/frequency) and bowel dysfunction (constipation) are common non-motor disorders in Parkinson's disease (PD). In contrast to motor disorder, the pelvic autonomic dysfunction is often non-responsive to levodopa treatment. Brain pathology mostly accounts for the bladder dysfunction (appearance of overactivity) via altered dopamine-basal ganglia circuit, which normally suppresses the micturition reflex. In contrast, peripheral enteric pathology mostly accounts for the bowel dysfunction (slow transit and decreased phasic contraction) via altered dopamine-enteric nervous system circuit, which normally promotes the peristaltic reflex. In addition, weak strain and paradoxical anal contraction might be the results of brain pathology. Pathophysiology of the pelvic organ dysfunction in PD differs from that in multiple system atrophy; therefore it might aid the differential diagnosis. Drugs to treat bladder dysfunction in PD include anticholinergic agents. Drugs to treat bowel dysfunction in PD include dietary fibers, peripheral dopaminergic antagonists, and selective serotonergic agonists. These treatments might be beneficial not only in maximizing patients' quality of life, but also in promoting intestinal absorption of levodopa and avoiding gastrointestinal emergency.","[Sakakibara, R.; Shirai, K.] Toho Univ, Div Neurol, Sakura Med Ctr, Dept Internal Med, 564-1 Shimoshizu, Sakura, Ibaraki 2858741, Japan; [Sakakibara, R.; Uchiyama, T.; Hattori, T.] Chiba Univ, Dept Neurol, Chiba, Japan; [Yamanishi, T.] Dokkyo Med Coll, Dept Urol, Mibu, Tochigi, Japan",Toho University; Chiba University; Dokkyo Medical University,"Sakakibara, R (corresponding author), Toho Univ, Div Neurol, Sakura Med Ctr, Dept Internal Med, 564-1 Shimoshizu, Sakura, Ibaraki 2858741, Japan.",sakakibara@sakura.med.toho-u.ac.jp,"Sakakibara, Ryuji/AAE-3829-2019","Sakakibara, Ryuji/0000-0002-5803-169X",,,,,206,116,122,1,15,SPRINGER WIEN,WIEN,"SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA",0300-9564,1435-1463,,J NEURAL TRANSM,J. Neural Transm.,MAR,2008,115,3,,,,,443,460,,10.1007/s00702-007-0855-9,http://dx.doi.org/10.1007/s00702-007-0855-9,,,18,Clinical Neurology; Neurosciences,Science Citation Index Expanded (SCI-EXPANDED),Neurosciences & Neurology,274IT,18327532,,,,2024-06-04,WOS:000253995700008,View Full Record in Web of Science
C,"Park, KY; Kil, JH; Jung, KO; Kong, CS; Lee, JM",,"Lim, YP",,"Park, Kun-Young; Kil, Jeung-Ha; Jung, Keun-Ok; Kong, Chang-Suk; Lee, JeongMin",,,Functional properties of kimchi (Korean fermented vegetables),PROCEEDINGS OF THE JOINT MEETING OF THE FOURTEENTH CRUCIFER GENETICS WORKSHOP AND FOURTH ISHS SYMPOSIUM ON BRASSICAS,Acta Horticulturae,,English,Proceedings Paper,Joint Meeting of the 14th Crucifer Genetics Workshop/4th Symposium on Brassicas,"OCT 24-28, 2004","Chungnam Natl Univ, Daejeon, SOUTH KOREA","Int Soc Hort Sci,Minist Sci & Technol,Minist Agr & Forestry,Rural Dev Adm,Chungcheon Nam Do Agr Res & Serv,Korea Sci & Engn Fdn,Biogreen 21 Program, Rural Dev Adm,Crop Funct Genom Ctr, MOST,Plant Divers Res Ctr, MOST,Gyensang, Natl Univ, Environm Biotech, Natl Core Res Ctr",Chungnam Natl Univ,kimchi; baechu cabbage; functionality; fermentation,,"Kimchi is Korean fermented vegetables with salt, spices and other condiments. Almost all vegetables cultivated in Korea have been linked to kimchi preparation. However, Chinese cabbage (baechu in Korean) kimchi is the most popular, generally known as kimchi. Kimchi contains high levels of vitamins, minerals, dietary fibers and phytochemicals from the ingredients. Kimchi that is optimally ripened (pH 4.24.5, total acidity 0.6 similar to 0.8%) contains a high number of lactic acid bacteria (10(8)/ml), organic acids (such as lactic, acetic, succinic, propionic acids, etc.), vitamin B complex, and modified functional phytochemicals formed during the fermentation process. Kimchi has lots of functionality, especially the kimchi diet has been known to cause weight loss and to prevent constipation and colon cancer. Kimchi, a good source of lactic acid bacteria as probiotics, reduces serum cholesterol levels in relation to anti-atherosclerosis. In addition, anticancer effects of kimchi have been recently reported and related to its components such as antioxidative nutrients, phytochemicals and lactic acid bacteria. http://www.actahort.org/members/showpdf?session=27401","[Park, Kun-Young; Kil, Jeung-Ha; Jung, Keun-Ok; Kong, Chang-Suk] Pusan Natl Univ, Dept Food Sci & Nutr, Busan 609735, South Korea; [Park, Kun-Young; Kil, Jeung-Ha; Jung, Keun-Ok; Kong, Chang-Suk] Pusan Natl Univ, Kimchi Res Inst, Busan 609735, South Korea; [Lee, JeongMin] Nambu Univ, Dept Food & Life Sci, Gwangju 506824, South Korea",Pusan National University; Pusan National University; Nambu University,"Park, KY (corresponding author), Pusan Natl Univ, Dept Food Sci & Nutr, Busan 609735, South Korea.;Park, KY (corresponding author), Pusan Natl Univ, Kimchi Res Inst, Busan 609735, South Korea.",kunypark@pusan.ae.kr,,,ARPC [302001-03-2-HD110],ARPC,Some of the research shown in this paper was supported by ARPC fund (Project #302001-03-2-HD110).,,21,3,3,3,22,INT SOC HORTICULTURAL SCIENCE,LEUVEN 1,"PO BOX 500, 3001 LEUVEN 1, BELGIUM",0567-7572,2406-6168,90-6605-445-X,ACTA HORTIC,,,2006,,706,,,,,167,+,,10.17660/ActaHortic.2006.706.19,http://dx.doi.org/10.17660/ActaHortic.2006.706.19,,,4,Horticulture,Conference Proceedings Citation Index - Science (CPCI-S),Agriculture,BEO04,,,,,2024-06-04,WOS:000238386200019,View Full Record in Web of Science
J,"Sakakibara, R; Kishi, M; Ogawa, E; Tateno, F; Uchiyama, T; Yamamoto, T; Yamanishi, T",,,,"Sakakibara, Ryuji; Kishi, Masahiko; Ogawa, Emina; Tateno, Fuyuki; Uchiyama, Tomoyuki; Yamamoto, Tatsuya; Yamanishi, Tomonori",,,"Bladder, Bowel, and Sexual Dysfunction in Parkinson's Disease",PARKINSONS DISEASE,,,English,Review,,,,,,,LOWER URINARY-TRACT; DEEP BRAIN-STIMULATION; MULTIPLE SYSTEM ATROPHY; POLYCARBOPHIL IMPROVES CONSTIPATION; SUBTHALAMIC NUCLEUS STIMULATION; QUESTIONNAIRE-BASED ASSESSMENT; VENTRAL TEGMENTAL AREA; COLONIC TRANSIT TIMES; MICTURITION REFLEX; OVERACTIVE BLADDER,"Bladder dysfunction (urinary urgency/frequency), bowel dysfunction (constipation), and sexual dysfunction (erectile dysfunction) (also called pelvic organ dysfunctions) are common nonmotor disorders in Parkinson's disease (PD). In contrast to motor disorders, pelvic organ autonomic dysfunctions are often nonresponsive to levodopa treatment. The brain pathology causing the bladder dysfunction (appearance of overactivity) involves an altered dopamine-basal ganglia circuit, which normally suppresses the micturition reflex. By contrast, peripheral myenteric pathology causing slowed colonic transit (loss of rectal contractions) and central pathology causing weak strain and paradoxical anal sphincter contraction on defecation (PSD, also called as anismus) are responsible for the bowel dysfunction. In addition, hypothalamic dysfunction is mostly responsible for the sexual dysfunction (decrease in libido and erection) in PD, via altered dopamine-oxytocin pathways, which normally promote libido and erection. The pathophysiology of the pelvic organ dysfunction in PD differs from that in multiple system atrophy; therefore, it might aid in differential diagnosis. Anticholinergic agents are used to treat bladder dysfunction in PD, although these drugs should be used with caution particularly in elderly patients who have cognitive decline. Dietary fibers, laxatives, and prokinetic drugs such as serotonergic agonists are used to treat bowel dysfunction in PD. Phosphodiesterase inhibitors are used to treat sexual dysfunction in PD. These treatments might be beneficial in maximizing the patients' quality of life.","[Sakakibara, Ryuji; Kishi, Masahiko; Ogawa, Emina; Tateno, Fuyuki] Toho Univ, Neurol Div, Dept Internal Med, Sakura Med Ctr, 564-1 Shimoshizu, Sakura 2858741, Japan; [Uchiyama, Tomoyuki; Yamamoto, Tatsuya] Chiba Univ, Dept Neurol, Chiba 2638522, Japan; [Yamanishi, Tomonori] Dokkyo Med Univ, Dept Urol, Mibu, Tochigi 3210293, Japan",Toho University; Chiba University; Dokkyo Medical University,"Sakakibara, R (corresponding author), Toho Univ, Neurol Div, Dept Internal Med, Sakura Med Ctr, 564-1 Shimoshizu, Sakura 2858741, Japan.",sakakibara@sakura.med.toho-u.ac.jp,"Sakakibara, Ryuji/AAE-3829-2019","Sakakibara, Ryuji/0000-0002-5803-169X",,,,,253,80,84,1,7,HINDAWI LTD,LONDON,"ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND",2090-8083,2042-0080,,PARKINSONS DIS-US,Parkinsons Dis.,,2011,2011,,,,,,,,924605,10.4061/2011/924605,http://dx.doi.org/10.4061/2011/924605,,,21,Clinical Neurology,Science Citation Index Expanded (SCI-EXPANDED),Neurosciences & Neurology,V29RN,,"gold, Green Submitted, Green Published",,,2024-06-04,WOS:000208765600081,View Full Record in Web of Science
J,"Rana, SV; Malik, A",,,,"Rana, Satya Vati; Malik, Aastha",,,Breath tests and irritable bowel syndrome,WORLD JOURNAL OF GASTROENTEROLOGY,,,English,Article,,,,,,Bacterial overgrowth; Breath test; Carbohydrate malabsorption; Irritable bowel syndrome; Lactulose breath test; Small intestine; Sorbitol breath test,INTESTINAL BACTERIAL OVERGROWTH; PREDOMINANT METHANOGENIC FLORA; REPORTED MILK INTOLERANCE; SULFATE-REDUCING BACTERIA; HYDROGEN H2 MEASUREMENTS; LACTOSE-INTOLERANCE; CARBOHYDRATE MALABSORPTION; METHANE PRODUCTION; HEALTHY-SUBJECTS; GAS-PRODUCTION,"Breath tests are non-invasive tests and can detect H-2 and CH4 gases which are produced by bacterial fermentation of unabsorbed intestinal carbohydrate and are excreted in the breath. These tests are used in the diagnosis of carbohydrate malabsorption, small intestinal bacterial overgrowth, and for measuring the orocecal transit time. Malabsorption of carbohydrates is a key trigger of irritable bowel syndrome (IBS)-type symptoms such as diarrhea and/or constipation, bloating, excess flatulence, headaches and lack of energy. Abdominal bloating is a common nonspecific symptom which can negatively impact quality of life. It may reflect dietary imbalance, such as excess fiber intake, or may be a manifestation of IBS. However, bloating may also represent small intestinal bacterial overgrowth. Patients with persistent symptoms of abdominal bloating and distension despite dietary interventions should be referred for H-2 breath testing to determine the presence or absence of bacterial overgrowth. If bacterial overgrowth is identified, patients are typically treated with antibiotics. Evaluation of IBS generally includes testing of other disorders that cause similar symptoms. Carbohydrate malabsorption (lactose, fructose, sorbitol) can cause abdominal fullness, bloating, nausea, abdominal pain, flatulence, and diarrhea, which are similar to the symptoms of IBS. However, it is unclear if these digestive disorders contribute to or cause the symptoms of IBS. Research studies show that a proper diagnosis and effective dietary intervention significantly reduces the severity and frequency of gastrointestinal symptoms in IBS. Thus, diagnosis of malabsorption of these carbohydrates in IBS using a breath test is very important to guide the clinician in the proper treatment of IBS patients. (C) 2014 Baishideng Publishing Group Inc. All rights reserved.","[Rana, Satya Vati; Malik, Aastha] Post Grad Inst Med Educ & Res, Dept Super Specialty Gastroenterol, Chandigarh 160012, India","Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh","Rana, SV (corresponding author), Post Grad Inst Med Educ & Res, Dept Super Specialty Gastroenterol, House 137,Sector 15-A, Chandigarh 160012, India.",svrana25@hotmail.com,,,,,,,124,36,41,0,27,BAISHIDENG PUBLISHING GROUP INC,PLEASANTON,"8226 REGENCY DR, PLEASANTON, CA 94588 USA",1007-9327,2219-2840,,WORLD J GASTROENTERO,World J. Gastroenterol.,JUN 28,2014,20,24,,,,,7587,7601,,10.3748/wjg.v20.i24.7587,http://dx.doi.org/10.3748/wjg.v20.i24.7587,,,15,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,AK6EE,24976698,"hybrid, Green Published",,,2024-06-04,WOS:000338520100006,View Full Record in Web of Science
J,"Barichella, M; Cereda, E; Pezzoli, G",,,,"Barichella, Michela; Cereda, Emanuele; Pezzoli, Gianni",,,Major Nutritional Issues in the Management of Parkinson's Disease,MOVEMENT DISORDERS,,,English,Review,,,,,,Parkinson's disease; nutrition; gastrointestinal dysfunction; body weight; diet; levodopa,DAILY ENERGY-EXPENDITURE; BODY-WEIGHT GAIN; ELDERLY-PATIENTS; LEWY BODIES; CRICOPHARYNGEAL DYSFUNCTION; OROPHARYNGEAL DYSPHAGIA; MASS INDEX; RISK; STIMULATION; ASSOCIATION,"As with other neurodegenerative diseases, neurologic and nutritional elements may interact affecting each other in Parkinson's disease (PD). However, the long-term effects Of Such interactions on prognosis and outcome have not been given much attention and are poorly addressed by current research. Factors contributing to the clinical conditions of patients with PD are not only the basic features of PD, progression of disease, and the therapeutic approach but also fiber and nutrient intakes (in terms of both energy and protein content), fluid and micronutrient balance, and pharmaconutrient interactions (protein and levodopa). During the Course of PD nutritional requirements frequently change. Accordingly, both body weight gain and loss may occur and, despite controversy, it seems that both changes in energy expenditure and food intake contribute. Nonmotor symptoms play a significant role and dysphagia may be responsible for the impairment of nutritional status and fluid balance. Constipation, gastroparesis, and gastro-oesophageal reflux significantly affect quality of life. Finally, any micronutrient deficiencies should be taken into account. Nutritional assessments should be performed routinely. Optimization of pharmacologic treatment for both motor and nonmotor symptoms is essential, but nutritional interventions and counseling could and should also be planned with regard to nutritional balance designed to prevent weight loss or gain; optimization of levodopa pharmacokinetics and avoidance of interaction with proteins; improvement in gastrointestinal dysfunction (e.g., dysphagia and constipation); prevention and treatment Of nutritional deficiencies (micronutrients or vitamins). A balanced Mediterranean-like dietary regimen should be recommended before the introduction of levodopa; afterward, patients with advanced disease may benefit considerably from protein redistribution and low-protein regimens. (C) 2009 Movement Disorder Society","[Cereda, Emanuele] Univ Milan, ICANS, I-20133 Milan, Italy; [Barichella, Michela; Cereda, Emanuele; Pezzoli, Gianni] Ist Clin Perfez Amento, Parkinson Inst, Milan, Italy",University of Milan,"Cereda, E (corresponding author), Univ Milan, ICANS, Via Botticelli 21, I-20133 Milan, Italy.",emanuele.cereda@virgilio.it,"Cereda, Emanuele/AAA-2247-2019","Cereda, Emanuele/0000-0002-0747-1951; Pezzoli, Gianni/0000-0003-4665-6710",Fondazione Grigioni per il Morbo di Parkinson,Fondazione Grigioni per il Morbo di Parkinson,"The authors thank Jennifer S. Hartwig, MD, for assistance in drafting the manuscript. This work was supported by the Fondazione Grigioni per il Morbo di Parkinson.",,108,158,175,0,54,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0885-3185,1531-8257,,MOVEMENT DISORD,Mov. Disord.,OCT 15,2009,24,13,,,,,1881,1892,,10.1002/mds.22705,http://dx.doi.org/10.1002/mds.22705,,,12,Clinical Neurology,Science Citation Index Expanded (SCI-EXPANDED),Neurosciences & Neurology,516PW,19691125,Green Submitted,,,2024-06-04,WOS:000271555700001,View Full Record in Web of Science
J,"Dietvorst, CAW; Bot, D; van der Holst, M; Niks, EH",,,,"Dietvorst, Carmen A. W.; Bot, Daphne; van der Holst, Menno; Niks, Erik H.",,,The Relation Between Nutritional Intake and Body Weight in 4-18 Year Old Patients with DMD: What could possibly be done to prevent weight gain?,JOURNAL OF NEUROMUSCULAR DISEASES,,,English,Article,,,,,,Duchenne muscular dystrophy; dietary intake; nutritional intake; body mass index; body weight,DUCHENNE MUSCULAR-DYSTROPHY; RESTING ENERGY-EXPENDITURE; FIBER INTAKE; BOYS; CONSTIPATION; MANAGEMENT; DIAGNOSIS; CHILDREN; OBESITY,"Background: Overweight is a common problem in Duchenne muscular dystrophy (DMD) and is associated with reduced mobility and quality of life. The influence of nutritional intake on (over)weight is unclear. Objective: To investigate weight and energy and macronutrients intake compared to age-specific requirements in DMD patients (4-18 years). Methods: We assessed weight and body mass index (BMI) and the amount of energy (kcal/day) and macronutrients based on self-reported nutrition diaries. Nutritional intake was compared to requirements for 3 age-groups according to the Dutch Healthy Diet Guideline (4-8/9-13/14-18 years) using a student's t-test, and relations with age and BMI were investigated by means of Pearson's correlations. Results: Forty-eight patients participated, 22 ambulatory, median age 10.8 years. The majority used corticosteroids (N = 41). Overweight (BMI z-score > 2.07) was present in 19 patients; 6% (4-8 years), 73% (9-13 years) and 47% (14-18 years). Overweight was more common in non-ambulatory (61.6%) than ambulatory patients (13.6%). Patients aged 4-8 received 290 kcal/day more than required (p < 0.001). Patients aged 9-13 received 349 kcal/day (p = 0.005) less than required. Overall, intake of fibre, nuts, meat/fish/eggs/legumes and dairy was lower than recommended (p < 0.05). The difference between energy intake versus requirement correlated moderately to age (r = -0.549, p < 0.001) and BMI (r = -0.562, p < 0.001). Conclusions: Overweight was found especially in patients aged 9-18 even though they received less energy than required. Younger patients (4-8) had good weight but consumed more energy than required. All patients did not consume enough fibre, nuts, meat/fish/eggs/legumes and dairy. Limiting energy and increasing fibre/protein intake at an early age may prevent overweight at a later age.","[Dietvorst, Carmen A. W.; Bot, Daphne] Leiden Univ, Med Ctr, Dept Dietet & Social Work, Leiden, Netherlands; [van der Holst, Menno] Leiden Univ, Med Ctr, Dept Orthoped Rehabil & Phys Therapy, Leiden, Netherlands; [Niks, Erik H.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands",Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC),"Bot, D (corresponding author), Leids Univ, Med Ctr, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.",d.bot@lumc.nl,"van der Holst, Menno/AAO-3512-2020; Niks, Erik H/M-3520-2016","van der Holst, Menno/0000-0002-0797-5711; Niks, Erik H/0000-0001-5892-5143; Dietvorst, Carmen/0009-0005-3936-0411",,,,,43,0,0,1,2,IOS PRESS,AMSTERDAM,"NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS",2214-3599,2214-3602,,J NEUROMUSCULAR DIS,J. Neuromusc. Dis.,,2022,9,6,,,,,701,711,,10.3233/JND-220796,http://dx.doi.org/10.3233/JND-220796,,,11,Clinical Neurology; Neurosciences,Science Citation Index Expanded (SCI-EXPANDED),Neurosciences & Neurology,6J6IJ,36214005,,,,2024-06-04,WOS:000886925100003,View Full Record in Web of Science
J,"Ducrotté, P",,,,"Ducrotte, Philippe",,,Irritable bowel syndrome:: current treatment options,PRESSE MEDICALE,,,English,Article,,,,,,,SMOOTH-MUSCLE RELAXANTS; CONTROLLED-TRIAL; DOUBLE-BLIND; PSYCHOLOGICAL TREATMENTS; THERAPEUTIC TARGETS; METAANALYSIS; EFFICACY; PLACEBO; HYPNOTHERAPY; TEGASEROD,"Relieving abdominal pain is the principal treatment objective for patients with irritable bowel syndrome. No single drug stands out in the treatment strategy for this illness. Antispasmodics, magnesium aluminum silicates, and alverine citrate drugs all remain initial options for treatment although their prescription is impeded by the fact that on increasing number ore no longer approved for reimbursement. Increased dietary fibers often have a harmful effect on symptoms. Some patients are probably intolerant to some foods but there is no satisfactory proof on which to base a restrictive diet. Improved knowledge of the pathophysiology of irritable bowel syndrome has made it possible to diversify treatments that act first on one of the key pathophysiologic elements, visceral hypersensitivity Antidepressants (especially tricyclics) can be used at low doses. Among the serotonergic drugs, serotonin S-HT4 receptors agonists (tegaserod) may be available soon, but the development of 5-HT3 antagonists (alosetron, cilansetron) has been stopped for safety reasons (ischemic colitis and severe constipation). Non-drug options such as hypnosis, psychotherapy relaxation, or yoga, may also be proposed to some patients. Probiotics ore a possible treatment in the future.","Ctr Hosp Rouen, Dept Hepatogastroenterol & Nutr, IFRMP 23, ADEN, F-76031 Rouen, France",Universite de Rouen Normandie,"Ducrotté, P (corresponding author), Ctr Hosp Rouen, Dept Hepatogastroenterol & Nutr, IFRMP 23, ADEN, F-76031 Rouen, France.",philippeducrotte@numericable.fr,,,,,,,51,7,7,1,11,MASSON EDITEUR,MOULINEAUX CEDEX 9,"21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE",0755-4982,2213-0276,,PRESSE MED,Presse Med.,NOV,2007,36,11,2,,,,1619,1626,,10.1016/j.lpm.2007.03.008,http://dx.doi.org/10.1016/j.lpm.2007.03.008,,,8,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,233FW,17490849,,,,2024-06-04,WOS:000251076800003,View Full Record in Web of Science
J,"Farouk, R; Duthie, GS",,,,"Farouk, R; Duthie, GS",,,Rectal prolapse and rectal invagination,EUROPEAN JOURNAL OF SURGERY,,,English,Review,,,,,,rectal prolapse; solitary rectal ulcer; rectal ulcer; rectal intussusception; surgery,ABDOMINAL RECTOPEXY; ULCER SYNDROME; LAPAROSCOPIC RECTOPEXY; RIPSTEIN PROCEDURE; ANORECTAL FUNCTION; SIGMOID RESECTION; INCONTINENCE; EXPERIENCE; OPERATION; INTUSSUSCEPTION,"Solitary rectal ulcer, internal rectal intussusception, and complete rectal prolapse are a range of defaecatory disorders that may have a common aetiology, namely chronic straining. If the pelvic floor is weak, external prolapse is often complicated by faecal incontinence. Few patients, a lack of randomised trials, and difficulties in the interpretation of studies of anorectal physiology (the results of which often seem conflicting) have made the understanding of these disorders difficult. The basis for treatment is clear, however-patients who have symptomatic defaecatory disorders associated with an internal intussusception, or solitary rectal ulcer, or both should have a course of training of pelvic floor muscles, dietary advice, and should use fibre supplements as primary treatment. Operation should be reserved for those patients in whom medical treatment has failed, and it may be expected to relieve symptoms in above two thirds of patients. Defaecating proctography may be useful in assessing which patients may not benefit from operation. Operation is the primary treatment for external prolapse. The choice of surgical approach should be tailored according to the expertise available, the medical condition of the patient, and the presence or absence of pre-existing constipation or incontinence.","Univ Hull, Castle Hill Hosp, Acad Surg Unit, Hull, PQ, Canada",,"Univ Hull, Castle Hill Hosp, Acad Surg Unit, Castle Rd, Hull, PQ, Canada.",,"Farouk, Ridzuan/T-5968-2017","Farouk, Ridzuan/0000-0002-7644-4682",,,,,77,20,20,0,2,TAYLOR & FRANCIS AS,OSLO,"KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY",1102-4151,,,EUR J SURG,Eur. J. Surg.,MAY,1998,164,5,,,,,323,332,,,,,,10,Surgery,Science Citation Index Expanded (SCI-EXPANDED),Surgery,ZR595,9667465,,,,2024-06-04,WOS:000073994100001,View Full Record in Web of Science
J,"Frexinos, J",,,,"Frexinos, J",,,Are food fibers useful in patients with the irritable bowel syndrome?,GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE,,,French,Article,,,,,,,DOUBLE-BLIND TRIAL; COARSE WHEAT BRAN; DIETARY FIBER; DIVERTICULAR-DISEASE; TRANSIT-TIME; INTESTINAL TRANSIT; COLON; CONSTIPATION; CROSSOVER; SUPPLEMENTATION,,"CHU Rangueil, F-31054 Toulouse, France",CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier,"Frexinos, J (corresponding author), CHU Rangueil, F-31054 Toulouse, France.",,,,,,,,52,0,0,0,0,MASSON EDITEUR,PARIS 06,"120 BLVD SAINT-GERMAIN, 75280 PARIS 06, FRANCE",0399-8320,,,GASTROEN CLIN BIOL,Gastroenterol. Clin. Biol.,JUN,1999,23,5BIS,,,,,B130,B134,,,,,,5,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,234QV,10897784,,,,2024-06-04,WOS:000082496600019,View Full Record in Web of Science
J,"Peckham, EJ; Cooper, K; Roberts, ER; Agrawal, A; Brabyn, S; Tew, G",,,,"Peckham, Emily J.; Cooper, Katy; Roberts, E. Rachel; Agrawal, Anurag; Brabyn, Sally; Tew, Garry",,,Homeopathy for treatment of irritable bowel syndrome,COCHRANE DATABASE OF SYSTEMATIC REVIEWS,,,English,Review,,,,,,*Ferula; Constipation [therapy]; Dicyclomine [therapeutic use]; Dietary Fiber [therapeutic use]; Homeopathy [*methods]; Irritable Bowel Syndrome [*therapy]; Phytotherapy [methods]; Randomized Controlled Trials as Topic; Adult; Female; Humans; Male,QUALITY-OF-LIFE; CONTROLLED TRIALS; COMPLEMENTARY; MEDICINE; DISORDERS; DISEASE; COLON; UK,"Background Irritable bowel syndrome (IBS) is a common, chronic disorder that leads to decreased health-related quality of life and work productivity. A previous version of this review was not able to draw firm conclusions about the effectiveness of homeopathic treatment for IBS and recommended that further high quality RCTs were conducted to explore the clinical and cost effectiveness of homeopathic treatment for IBS. Two types of homeopathic treatment were evaluated in this systematic review: 1. Clinical homeopathy where a specific remedy is prescribed for a specific condition; 2. individualised homeopathic treatment, where a homeopathic remedy based on a person's individual symptoms is prescribed after a detailed consultation. Objectives To assess the effectiveness and safety of homeopathic treatment for IBS. Search methods For this update we searched MEDLINE, CENTRAL, Embase, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Allied and Complementary Medicine Database (AMED), the Cochrane IBD Group Specialised Register and trials registers from inception to 31 August 2018. Selection criteria Randomised controlled trials (RCM), cohort and case-control studies that compared homeopathic treatment with placebo, other control treatments, or usual care, in adults with IBS were considered for inclusion. Data collection and analysis Two authors independently assessed the risk of bias and extracted data. The primary outcome was global improvement in IBS as measured by an IBS symptom severity score. Secondary outcomes included quality of life, abdominal pain, stool frequency, stool consistency, and adverse events. The overall certainty of the evidence supporting the primary and secondary outcomes was assessed using the GRADE criteria. We used the Cochrane risk of bias tool to assess risk of bias. We calculated the mean difference (MD) and 95% confidence interval (CI) for continuous outcomes and the risk ratio (RR) and 95% CI for dichotomous outcomes. Main results Four RCTs (307 participants) were included. Two studies compared clinical homeopathy (homeopathic remedy, asafoetida or asafoetida plus nux vomica) to placebo for IBS with constipation (IBS-C). One study compared individualised homeopathic treatment (consultation plus remedy) to usual care for the treatment of IBS in female patients. One study was a three armed RCT comparing individualised homeopathic treatment to supportive listening or usual care. The risk of bias in three studies (the two studies assessing clinical homeopathy and the study comparing individualised homeopathic treatment to usual care) was unclear on most criteria and high for selective reporting in one of the clinical homeopathy studies. The three armed study comparing individualised homeopathic treatment to usual care and supportive listening was at low risk of bias in four of the domains and high risk of bias in two (performance bias and detection bias). A meta-analysis of the studies assessing clinical homeopathy, (171 participants with IBS-C) was conducted. At short-term follow-up of two weeks, global improvement in symptoms was experienced by 73% (46/63) of asafoetida participants compared to 45% (30/66) of placebo participants (RR 1.61, 95% CI 1.18 to 2.18; 2 studies, very low certainty evidence). In the other clinical homeopathy study at two weeks, 68% (13/19) of those in the asafoetida plus nux vomica arm and 52% (12/23) of those in the placebo arm experienced a global improvement in symptoms (RR 1.31, 95% CI 0.80 to 2.15; very low certainty evidence). In the study comparing individualised homeopathic treatment to usual care (N = 20), the mean global improvement score (feeling unwell) at 12 weeks was 1.44 +/- 4.55 (n=9) in the individualised homeopathic treatment arm compared to 1.41 +/- 1.97 (n=11) in the usual care arm (MD 0.03; 95% CI -3.16 to 3.22; very low certainty evidence). In the study comparing individualised homeopathic treatment to usual care, the mean IBS symptom severity score at 6 months was 210.44 +/- 112.4 (n = 16) in the individualised homeopathic treatment arm compared to 237.3 + 110.22 (n = 60) in the usual care arm (MD -26.86, 95% CI -88.59 to 34.87; low certainty evidence). The mean quality of life score (EQ-5D) at 6 months in homeopathy participants was 69.07 (SD 17.35) compared to 63.41 (SD 23.31) in usual care participants (MD 5.66, 95% CI -4.69 to 16.01; low certainty evidence). For In the study comparing individualised homeopathic treatment to supportive listening, the mean IBS symptom severity score at 6 months was 210.44 +/- 112.4 (n = 16) in the individualised homeopathic treatment arm compared to 262 + 120.72 (n = 18) in the supportive listening arm (MD -51.56, 95% CI -129.94 to 26.82; very low certainty evidence). The mean quality of life score at 6 months in homeopathy participants was 69.07 (SD 17.35) compared to 63.09 (SD 24.38) in supportive listening participants (MD 5.98, 95% CI -8.13 to 20.09; very low certainty evidence). None of the included studies reported on abdominal pain, stool frequency, stool consistency, or adverse events. Authors' conclusions The results for the outcomes assessed in this review are uncertain. Thus no firm conclusions regarding the effectiveness and safety of homeopathy for the treatment of IBS can be drawn. Further high quality, adequately powered RCTs are required to assess the efficacy and safety of clinical and individualised homeopathy for IBS compared to placebo or usual care.","[Peckham, Emily J.; Brabyn, Sally] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Cooper, Katy] Univ Sheffield, Sch Hlth & Related Res ScHARR, Sheffield, S Yorkshire, England; [Roberts, E. Rachel] Homeopathy Res Inst, London, England; [Agrawal, Anurag] Doncaster Royal Infirm, Dept Gastroenterol & Med, Doncaster, England; [Tew, Garry] Northumbria Univ, Dept Sport Exercise & Rehabil, Newcastle Upon Tyne, Tyne & Wear, England",University of York - UK; University of Sheffield; Northumbria University,"Peckham, EJ (corresponding author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.",emily.peckham@york.ac.uk,"Agrawal, Anurag/GZL-5821-2022; Cooper, Katy L/A-3546-2010",,"University of Leeds, UK; Homeopathy Research Institute, UK; ScHARR, UK","University of Leeds, UK; Homeopathy Research Institute, UK; ScHARR, UK","Internal sourcesr University of Leeds, UK.r Homeopathy Research Institute, UK.r ScHARR, UK.",,64,10,10,3,20,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1469-493X,1361-6137,,COCHRANE DB SYST REV,Cochrane Database Syst Rev.,,2019,,9,,,,,,,CD009710,10.1002/14651858.CD009710.pub3,http://dx.doi.org/10.1002/14651858.CD009710.pub3,,,44,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,KG7RQ,31483486,"Green Accepted, Green Published",,,2024-06-04,WOS:000510145900052,View Full Record in Web of Science
J,"Wiesner, M; Naylor, SJ; Copping, A; Furlong, A; Lynch, AG; Parkes, M; Hunter, JO",,,,"Wiesner, Maureen; Naylor, Sally J.; Copping, Ann; Furlong, Anita; Lynch, Andrew G.; Parkes, Miles; Hunter, John O.",,,Symptom classification in irritable bowel syndrome as a guide to treatment,SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY,,,English,Article,,,,,,Classification; constipation; diarrhoea; irritable bowel syndrome; symptoms; treatment,ABDOMINAL-PAIN; FOOD INTOLERANCE; BACTERIAL GASTROENTERITIS; HYPERVENTILATION; FERMENTATION; DISORDERS; ORIGIN; FIBER; DIET; RISK,"Objective. The treatment of irritable bowel syndrome (IBS) remains unsatisfactory. There are no objective markers for diagnosis, and classification (currently based on symptoms) provides little insight into potential causes or optimal therapy. The aim of this study was to determine whether a Swedish classification of IBS based on cluster analysis of patients' symptoms might provide a guide to successful treatment. Material and methods. Patients in a research clinic for IBS were classified according to criteria published by Ragnarsson & Bodemar (R&B) and also assessed independently by a clinician. Patients fulfilling the R&B criteria for subgroups I and 2 received specific treatments, either bulk laxatives or dietary treatment to reduce colonic fermentation, respectively. Patients who did not fit into these categories were given best treatment targeted at their predominant symptoms, but not limited in any way. Results before and after follow-up were assessed using a validated symptom-scoring scale. Results. Seventy-one successive patients were recruited, and the numbers falling into R&B subgroups I and 2 were 15 (21%), and 28 (39%), respectively, leaving 28 (39%) unclassified. Receiver operating characteristic plots showed that the criteria for separation into subgroups I and 2 correlated well with the clinician's assessment. After treatment, symptom scores for the whole group showed a significant improvement (p < 0.0001), but results were significantly better in subgroups 1 and 2 than in those unclassified, even when allowance was made for a potential therapeutic placebo effect of 40%. Conclusion. The R&B classification provides a helpful guide to treatment in many cases of IBS.","[Wiesner, Maureen; Naylor, Sally J.; Copping, Ann; Furlong, Anita; Parkes, Miles; Hunter, John O.] Addenbrookes Hosp, Gastroenterol Res Unit, Cambridge CB2 2QQ, England; [Lynch, Andrew G.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Appl Med Stat, Cambridge CB2 1TN, England",University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge,"Hunter, JO (corresponding author), Addenbrookes Hosp, Gastroenterol Res Unit, Box 262,Hills Rd, Cambridge CB2 2QQ, England.",john.hunter@addenbrookes.nhs.uk,,"Parkes, Miles/0000-0002-6467-0631; Lynch, Andy/0000-0002-7876-7338",Cancer Research UK [10825] Funding Source: Medline,Cancer Research UK(Cancer Research UK),,,33,8,8,0,2,TAYLOR & FRANCIS LTD,ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND",0036-5521,1502-7708,,SCAND J GASTROENTERO,Scand. J. Gastroenterol.,JUL,2009,44,7,,,,,796,803,,10.1080/00365520902964705,http://dx.doi.org/10.1080/00365520902964705,,,8,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,478HW,19452358,,,,2024-06-04,WOS:000268579400005,View Full Record in Web of Science
J,"Wilkinson-Smith, V; Dellschaft, N; Ansell, J; Hoad, C; Marciani, L; Gowland, P; Spiller, R",,,,"Wilkinson-Smith, Victoria; Dellschaft, Neele; Ansell, Juliet; Hoad, Caroline; Marciani, Luca; Gowland, Penny; Spiller, Robin",,,Mechanisms underlying effects of kiwifruit on intestinal function shown by MRI in healthy volunteers,ALIMENTARY PHARMACOLOGY & THERAPEUTICS,,,English,Article,,,,,,,IRRITABLE-BOWEL-SYNDROME; CHRONIC IDIOPATHIC CONSTIPATION; WHOLE GUT TRANSIT; WATER-CONTENT; FIBER; SYMPTOMS,"Background Chronic constipation affects approximately 17% of the population worldwide and remains an important unmet need since patients are often dissatisfied with treatment. Kiwifruit may offer an alternative to traditional laxatives and have been shown to increase stool volume, frequency and improve consistency. Aims Using non-invasive MRI techniques, we assessed the effect of ingestion of kiwifruit on fluid distribution in the intestines and bowel function. Methods Two period crossover trial of kiwifruit vs control in healthy adults. Intervention: two kiwifruits twice daily vs isocaloric control (maltodextrin) twice daily, consumed for a total of 3 days. Subjects underwent MRI scanning fasted and at hourly intervals for 7 hours on the third day. Primary outcome: T1 relaxation time of ascending colon (T1AC) using MRI. Secondary outcomes: Small bowel water content (SBWC), colonic volume, gut transit time, T1 of descending colon, stool frequency and form. Results Fourteen volunteers completed the study. T1AC was higher after kiwifruit ingestion (P = 0.029) during the second half of the day (when meal residue would be expected to reach the AC, AUC T1 T240-420 minutes; mean (SD) 137 (39) s*minute with kiwifruit versus 108 (40) s*minute with control. SBWC (P < 0.001), colon volumes (P = 0.004), as well as stool frequency (1.46 +/- 0.66 with kiwifruit vs 1.14 +/- 0.46 stools per day with control; P = 0.034) and stool form score (Bristol Stool Chart score 4.1 (0.9) with kiwifruit versus 3.4 (0.7) with control; P = 0.011) were markedly increased in participants consuming kiwifruit compared to control. Conclusion Consumption of kiwifruit in healthy volunteers increases water retention in the small bowel and ascending colon and increases total colonic volume. The data may explain the observed increase in stool frequency and looser stool consistencies, suggesting that kiwifruit could be used as a dietary alternative to laxatives in mild constipation.","[Wilkinson-Smith, Victoria; Hoad, Caroline; Marciani, Luca; Gowland, Penny; Spiller, Robin] Nottingham Univ Hosp NHS Trust, Nottingham Biomed Res Ctr, NIHR, Nottingham, England; [Wilkinson-Smith, Victoria; Hoad, Caroline; Marciani, Luca; Gowland, Penny; Spiller, Robin] Univ Nottingham, Nottingham, England; [Wilkinson-Smith, Victoria; Marciani, Luca; Spiller, Robin] Univ Nottingham, Nottingham Digest Dis Ctr, Nottingham, England; [Dellschaft, Neele; Hoad, Caroline; Gowland, Penny] Univ Nottingham, Sir Peter Mansfield Imaging Ctr, Nottingham, England; [Ansell, Juliet] Zespri Int Ltd, Mt Maunganui, New Zealand",University of Nottingham; Nottingham University Hospital NHS Trust; University of Nottingham; University of Nottingham; University of Nottingham,"Spiller, R (corresponding author), Queens Med Hosp, NIHR Biomed Res Ctr, Nottingham Digest Dis Ctr, Nottingham, England.",robin.spiller@nottingham.ac.uk,"spiller, robin/ABE-6690-2021; Wilkinson-Smith, Victoria/V-3887-2019; Gowland, Penny/I-9016-2012","spiller, robin/0000-0001-6371-4500; Wilkinson-Smith, Victoria/0000-0002-0878-1687; Gowland, Penny/0000-0002-4900-4817; Dellschaft, Neele/0000-0001-5483-1684","Zespri International Limited, a consortium of kiwifruit growers; MRC [MR/N026810/1] Funding Source: UKRI","Zespri International Limited, a consortium of kiwifruit growers; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))","This study and Dr Dellschaft's post have been funded by Zespri International Limited, a consortium of kiwifruit growers.",,30,29,29,0,9,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0269-2813,1365-2036,,ALIMENT PHARM THER,Aliment. Pharmacol. Ther.,MAR,2019,49,6,,,,,759,768,,10.1111/apt.15127,http://dx.doi.org/10.1111/apt.15127,,,10,Gastroenterology & Hepatology; Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Pharmacology & Pharmacy,HM9TL,30706488,"Green Published, hybrid",,,2024-06-04,WOS:000459827800012,View Full Record in Web of Science
J,"Khalid, W; Arshad, MS; Aziz, A; Rahim, MA; Qaisrani, TB; Afzal, F; Ali, A; Ranjha, MMAN; Khalid, MZ; Anjum, FM",,,,"Khalid, Waseem; Arshad, Muhammad Sajid; Aziz, Afifa; Rahim, Muhammad Abdul; Qaisrani, Tahira Batool; Afzal, Fareed; Ali, Anwar; Ranjha, Muhammad Modassar Ali Nawaz; Khalid, Muhammad Zubair; Anjum, Faqir Muhammad",,,Chia seeds (Salvia hispanica L.): A therapeutic weapon in metabolic disorders,FOOD SCIENCE & NUTRITION,,,English,Review,,,,,,cancer; cardiovascular disease; chia seeds; functional components; GI tract,DISEASE RISK-FACTORS; FATTY-ACID-COMPOSITION; DIETARY-FIBER; CARDIOVASCULAR-DISEASE; PHENOLIC-COMPOUNDS; CHEMICAL-CHARACTERIZATION; ANTIOXIDANT ACTIVITY; PHYSICOCHEMICAL PROPERTIES; OXIDATIVE STRESS; HEALTH-BENEFITS,"The growth of functional components containing agricultural foods is enhancing because these components aid the human body against different chronic diseases. Currently, chia seeds basically belong to the mint family and are edible seeds of Salvia hispanica. These seeds are composed of different functional components including fiber, polyphenols, antioxidants, omega-3 fatty acid vitamins, minerals, and peptides. Besides, these seeds are also a good source of vegetable protein, unsaturated fat, carbohydrates, and ash. Chia seed components are helpful in cardiovascular disease (CVD) by reducing blood pressure, platelet aggregation, cholesterol, and oxidation. In GI-tract-related diseases like diabetes and constipation, chia fiber reduces the blood glucose level and provides bulk to stool. However, antioxidants and polyphenols are protected beta cells of the pancreas from inflammation. These components are protected from the cell damage of the different body parts, which can provide help in different types of cancer including breast, colorectal, liver, and pancreatic. Conclusively, some pervious studies approved that chia seed components are played important role in chronic diseases.","[Khalid, Waseem; Arshad, Muhammad Sajid; Aziz, Afifa; Rahim, Muhammad Abdul; Afzal, Fareed; Khalid, Muhammad Zubair] Govt Coll Univ Faisalabad, Dept Food Sci, Faisalabad, Pakistan; [Qaisrani, Tahira Batool] Ghazi Univ, Dept Agr Engn & Technol, Dera Ghazi Khan, Pakistan; [Ali, Anwar] Cent South Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Changsha, Hunan, Peoples R China; [Ranjha, Muhammad Modassar Ali Nawaz] Univ Sargodha, Inst Food Sci & Nutr, Sargodha, Pakistan; [Anjum, Faqir Muhammad] IFANCA Halal Apex Pvt Ltd, Islamic Food & Nutr Council Amer, Faisalabad, Pakistan",Government College University Faisalabad; Central South University; University of Sargodha,"Arshad, MS (corresponding author), Govt Coll Univ Faisalabad, Dept Food Sci, Faisalabad, Pakistan.",sajid_ft@yahoo.com,"ANJUM, FAQIR/AAW-9311-2020; ALI, ANWAR/ADP-3857-2022; Rahim, Muhammad Abdul/JVD-7113-2023; rahim, muhammad Sadiq/KFT-2740-2024; Aadil, Rana Muhammad/JXL-7960-2024; Arshad, Muhammad Sajid/AAR-4975-2020; Khalid, Waseem/IXN-2782-2023","ALI, ANWAR/0000-0003-3169-1804; Abdul Rahim, Muhammad/0000-0002-8184-5480",,,,,143,22,22,5,29,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",2048-7177,,,FOOD SCI NUTR,Food Sci. Nutr.,JAN,2023,11,1,,,,,3,16,,10.1002/fsn3.3035,http://dx.doi.org/10.1002/fsn3.3035,,DEC 2022,14,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,8J1UF,36655089,"Green Published, gold",,,2024-06-04,WOS:000898755300001,View Full Record in Web of Science
J,"Lever, E; Scott, SM; Louis, P; Emery, PW; Whelan, K",,,,"Lever, Ellen; Scott, S. Mark; Louis, Petra; Emery, Peter W.; Whelan, Kevin",,,"The effect of prunes on stool output, gut transit time and gastrointestinal microbiota: A randomised controlled trial",CLINICAL NUTRITION,,,English,Article,,,,,,Prunes; Dried plums; Fibre; Stool weight; Transit time; Microbiota,CHRONIC IDIOPATHIC CONSTIPATION; DIETARY FIBER; BOWEL FUNCTION; FECAL WEIGHT; CELLULOSE; PECTIN; INDIVIDUALS; METABOLISM; SYMPTOMS; SORBITOL,"Background & aim: Prunes (dried plums) are perceived to maintain healthy bowel function, however their effects on gastrointestinal (GI) function are poorly researched and potential mechanisms of action are not clear. We aimed to investigate the effect of prunes on stool output, whole gut transit time (WGIT), gut microbiota and short-chain fatty acids (SCFA) in healthy adults Methods: We conducted a parallel group, randomised controlled trial with three treatment arms in 120 healthy adults with low fibre intakes and stool frequency of 3-6 stools/wk. Subjects were randomised to 80 g/d prunes (plus 300 ml/d water); 120 g/d prunes (plus 300 ml/d water) or control (300 ml/d water) for 4 weeks. Stool weight was the primary outcome and determined by 7-day stool collection. Secondary outcomes included stool frequency and consistency (stool diary), WGTT (radio-opaque markers), GI symptoms (diary), microbiota (quantitative PCR) and SCFA (gas liquid chromatography). Group assignment was concealed from the outcome assessors. Results: There were significantly greater increases in stool weight in both the 80 g/d (mean + 22.2 g/d, 95% CI -1-45.3) and 120 g/d (+32.8 g/d, 95% CI 13.9-51.7) prune groups compared with control (-0.8 g/d, 95% CI 17.2 to 15.6, P = 0.026). Stool frequency was significantly greater following 80 g/d (mean 6.8 bowel movements/wk, SD 3.8) and 120 g/d (5.6, SD 1.9) prune consumption compared with control (5.4, SD 2.1) (P = 0.023), but WCIT was unchanged. The incidence of flatulence was significantly higher after prune consumption. There were no significant differences in any of the bacteria measured, except for a greater increase in Bifidobacteria across the groups (P = 0.046). Prunes had no effect on SCFA or stool pH. Conclusions: In healthy individuals with infrequent stool habits and low fibre intake, prunes significantly increased stool weight and frequency and were well tolerated. Prunes may have health benefits in populations with low stool weight. Clinical trial registry number and website: ISRCTN42793297 http://www.isrctn.corn/ISRCTN42793297. (C) 2018 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).","[Lever, Ellen; Emery, Peter W.; Whelan, Kevin] Kings Coll London, Fac Life Sci & Med, Dept Nutr Sci, London, England; [Scott, S. Mark] Queen Mary Univ London, Barts & London Sch Med & Dent, Wingate Inst Neurogastroenterol, London, England; [Louis, Petra] Univ Aberdeen, Rowett Inst, Gut Hlth Theme, Microbiol Grp, Aberdeen, Scotland",University of London; King's College London; University of London; Queen Mary University London; University of Aberdeen,"Whelan, K (corresponding author), Kings Coll London, Dept Nutr Sci, 150 Stamford St, London SE1 9NH, England.",kevin.whelan@kcl.ac.uk,"Whelan, Kevin/ABD-5350-2021; Louis, Petra/Y-3779-2019; Whelan, Kevin/ABD-5154-2021","Whelan, Kevin/0000-0001-5414-2950; Louis, Petra/0000-0003-2115-2399;",California Dried Plum Board PhD studentship; Scottish Government Rural and Environment Science and Analytical Services Division,California Dried Plum Board PhD studentship; Scottish Government Rural and Environment Science and Analytical Services Division,"This trial formed part of a California Dried Plum Board PhD studentship. The funders had no role in trial design, data collection, analysis or interpretation, report writing or submission of the paper for publication. PL received support from the Scottish Government Rural and Environment Science and Analytical Services Division.",,51,23,25,2,26,CHURCHILL LIVINGSTONE,EDINBURGH,"JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND",0261-5614,1532-1983,,CLIN NUTR,Clin. Nutr.,FEB,2019,38,1,,,,,165,173,,10.1016/j.clnu.2018.01.003,http://dx.doi.org/10.1016/j.clnu.2018.01.003,,,9,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,HR9EQ,29398337,"Green Published, hybrid, Green Submitted",,,2024-06-04,WOS:000463462400013,View Full Record in Web of Science
J,"Lee, S; You, H; Lee, Y; Baik, H; Paik, J; Lee, H; Park, S; Shim, J; Lee, J; Hyun, S",,,,"Lee, Songhee; You, Heesang; Lee, Yeongju; Baik, Haingwoon; Paik, Jeankyung; Lee, Hayera; Park, Soodong; Shim, Jaejung; Lee, Junglyoul; Hyun, Sunghee",,,Intake of MPRO3 over 4 Weeks Reduces Glucose Levels and Improves Gastrointestinal Health and Metabolism,MICROORGANISMS,,,English,Article,,,,,,gut microbiota; 16S rRNA; probiotics; prebiotics; synbiotics,STOOL FORM SCALE; BIFIDOBACTERIUM-ANIMALIS; INSULIN-RESISTANCE; GUT MICROBIOME; HIGH-FAT; PATHWAY; ADULTS; OLIGOFRUCTOSE; FERMENTATION; METAGENOME,"Human gut microbiota are involved in different metabolic processes, such as digestion and nutrient synthesis, among others. For the elderly, supplements are a major means of maintaining health and improving intestinal homeostasis. In this study, 51 elderly women were administered MPRO3 (n = 17), a placebo (n = 16), or both (MPRO3: 1 week, placebo: 3 weeks; n = 18) for 4 weeks. The fecal microbiota were analyzed by sequencing the 16S rRNA gene V3-V4 super-variable region. The dietary fiber intake increased, and glucose levels decreased with 4-week MPRO3 intake. Reflux, indigestion, and diarrhea syndromes gradually improved with MPRO3 intake, whereas constipation was maintained. The stool shape also improved. Bifidobacterium animalis, B. pseudolongum, Lactobacillus plantarum, and L. paracasei were relatively more abundant after 4 weeks of MPRO3 intake than in those subjects after a 1-week intake. Bifidobacterium and B. longum abundances increased after 1 week of MPRO3 intake but decreased when the intake was discontinued. Among different modules and pathways, all 10 modules analyzed showed a relatively high association with 4-week MPRO3 intake. The mineral absorption pathway and cortisol biosynthesis and secretion pathways correlated with the B. animalis and B. pseudolongum abundances at 4 weeks. Therefore, 4-week MPRO3 intake decreased the fasting blood glucose level and improved intestinal health and metabolism.","[Lee, Songhee; Lee, Yeongju; Hyun, Sunghee] Eulji Univ, Grad Sch, Dept Biomed Lab Sci, 712,Dongil ro, Uijongbu 11759, South Korea; [You, Heesang; Hyun, Sunghee] Eulji Univ, Grad Sch, Dept Senior Hlthcare, 712,Dongil ro, Uijongbu 11759, South Korea; [Baik, Haingwoon] Eulji Univ, Sch Med, Grad Sch, Dept Biochem & Mol Biol, Daejeon 34824, South Korea; [Paik, Jeankyung] Eulji Univ, Grad Sch, Dept Food & Nutr, Seongnam 13135, South Korea; [Lee, Hayera; Park, Soodong; Shim, Jaejung; Lee, Junglyoul] R&BD Ctr hy Co Ltd, 22,Giheungdanji ro 24beon gil, Yongin 17086, South Korea",Eulji University; Eulji University; Eulji University; Eulji University,"Hyun, S (corresponding author), Eulji Univ, Grad Sch, Dept Biomed Lab Sci, 712,Dongil ro, Uijongbu 11759, South Korea.;Hyun, S (corresponding author), Eulji Univ, Grad Sch, Dept Senior Hlthcare, 712,Dongil ro, Uijongbu 11759, South Korea.",song-1107@naver.com; yhs1532@nate.com; dlddwn1@gmail.com; baikhw@eulji.ac.kr; jkpaik@eulji.ac.kr; yera@hy.co.kr; soodpark@hy.co.kr; jjshim@hy.co.kr; jlleesk@hy.co.kr; hyunsh@eulji.ac.kr,,"LEE, yeongju/0000-0003-0820-2275; Paik, Jean Kyung/0000-0003-0393-0353; Hyun, Sung Hee/0000-0002-8980-1036; Lee, Hayera/0000-0002-0446-5441; songhee, Lee/0000-0001-5235-8686",,,,,75,4,4,0,7,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2076-2607,,MICROORGANISMS,Microorganisms,JAN,2022,10,1,,,,,,,88,10.3390/microorganisms10010088,http://dx.doi.org/10.3390/microorganisms10010088,,,20,Microbiology,Science Citation Index Expanded (SCI-EXPANDED),Microbiology,ZC0YN,35056536,"gold, Green Published",,,2024-06-04,WOS:000757256600001,View Full Record in Web of Science
J,"Mehraj, M; Das, S; Feroz, F; Wani, A; Dar, SQ; Kumar, S; Wani, AK; Farid, A",,,,"Mehraj, Mahrukh; Das, Susmita; Feroz, Fathima; Wani, Ab Waheed; Dar, S. Q.; Kumar, Sanjeev; Wani, Atif Khurshid; Farid, Arshad",,,Nutritional Composition and Therapeutic Potential of Pineapple Peel- A Comprehensive Review,CHEMISTRY & BIODIVERSITY,,,English,Review,,,,,,Pineapple peels; Nutrition; Bromelain; Antioxidants; anti-inflammatory,ANANAS-COMOSUS; BROMELAIN,"Pineapple (Ananas comosus), the succulent and vibrant tropical fruit, is a symbol of exoticism and sweetness that captures the hearts and palates of people around the world. The pineapple peel, often considered as waste, has garnered attention for its potential applications. The pineapple peel is rich in essential nutrients, including calcium, potassium, vitamin C, carbohydrates, dietary fiber, and water, making it beneficial for the digestive system, weight management, and overall balanced nutrition. It contains significant amounts of sugars such as sucrose, glucose, and fructose, along with citric acid as the predominant organic acid. The peel also contains bromelain, a proteolytic enzyme known for its digestive properties. Studies have highlighted the pharmacological properties of pineapple peel, such as its potential anti-parasitic effects, alleviation of constipation, and benefits for individuals with irritable bowel syndrome (IBS). Efforts are being made to promote the utilization of pineapple peel as a valuable resource rather than mere waste. Its applications range from the production of vinegar, alcohol, and citric acid to the development of various food products, including squash, syrup, jelly, and pickles. Further research and innovation are required to fully explore the potential of pineapple peel and establish sustainable practices for its utilization, contributing to waste reduction and the development of value-added products. image","[Mehraj, Mahrukh; Feroz, Fathima] Lovely Profess Univ, Sch Agr, Dept Food Technol & Nutr, Phagwara, Punjab, India; [Das, Susmita; Wani, Ab Waheed; Kumar, Sanjeev] Lovely Profess Univ, Sch Agr, Dept Hort, Phagwara, Punjab, India; [Dar, S. Q.] India Fdn, ISAP, Goosu Pulwama, Waheed, India; [Wani, Atif Khurshid] Lovely Profess Univ, Sch Bioengn & Biosci, Phagwara 144411, Punjab, India; [Farid, Arshad] Gomal Univ, Gomal Ctr Biochem & Biotechnol, Dera Ismail Khan 29050, Pakistan",Lovely Professional University; Lovely Professional University; Lovely Professional University; Gomal University,"Das, S; Wani, A (corresponding author), Lovely Profess Univ, Sch Agr, Dept Hort, Phagwara, Punjab, India.;Farid, A (corresponding author), Gomal Univ, Gomal Ctr Biochem & Biotechnol, Dera Ismail Khan 29050, Pakistan.",skhowai94@gmail.com; waheedwani1@gmail.com; arshadfarid@gu.edu.pk,"Farid, Arshad/AAD-5741-2022","Farid, Arshad/0000-0001-5147-5936",,,,,56,0,0,7,7,WILEY-V C H VERLAG GMBH,WEINHEIM,"POSTFACH 101161, 69451 WEINHEIM, GERMANY",1612-1872,1612-1880,,CHEM BIODIVERS,Chem. Biodivers.,MAY,2024,21,5,,,,,,,,10.1002/cbdv.202400315,http://dx.doi.org/10.1002/cbdv.202400315,,APR 2024,11,"Biochemistry & Molecular Biology; Chemistry, Multidisciplinary",Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Chemistry,QU4E2,38484117,,,,2024-06-04,WOS:001199800000001,View Full Record in Web of Science
J,"Marsh, ED; Beisang, A; Buie, T; Benke, TA; Gaucher, B; Motil, KJ",,,,"Marsh, Eric D.; Beisang, Arthur; Buie, Timothy; Benke, Timothy A.; Gaucher, Brian; Motil, Kathleen J.",,,Recommendations for the management of diarrhea with trofinetide use in Rett syndrome,EXPERT OPINION ON ORPHAN DRUGS,,,English,Article,,,,,,gastrointestinal; neurodevelopmental disorder; recommendations; stool patterns; Rett syndrome; trofinetide,DOUBLE-BLIND; SUPPLEMENTATION; REVERSAL; HEALTH; ANALOG; STOOL; MECP2,"Background Trofinetide is a recently approved treatment for Rett syndrome (RTT), a rare neurodevelopmental disorder with no previously approved therapy. The phase 3 LAVENDER trial showed improvements in efficacy measures compared with placebo, but diarrhea rates were high in trofinetide-treated participants. To manage possible diarrhea, recommendations that can be used by health care providers are needed. Research design and methods Additional analyses were conducted on LAVENDER data to elucidate predictors of trofinetide-associated diarrhea. A panel of advisors was convened to refine a set of practical recommendations for the prevention and management of diarrhea in individuals with RTT treated with trofinetide. Results No examined demographic or treatment factors appeared to influence trofinetide-associated diarrhea. Advisors recommend establishing baseline bowel activity and providing caregivers with diarrhea management information. On initiation of trofinetide, constipation medications should be stopped or reduced, concomitant liquid medications with sugar alcohols should be substituted if possible, and fiber should be initiated. Bowel movements should be tracked and loperamide started following the onset of diarrhea. Dietary and hydration measures are also recommended. Conclusions Trofinetide treatment confers improvements in RTT-related symptoms. With these recommendations, diarrhea associated with trofinetide use can be managed, enhancing the lives of individuals with RTT and caregivers.","[Marsh, Eric D.; Gaucher, Brian] Childrens Hosp Philadelphia, Div Neurol, USA, Philadelphia, PA USA; [Marsh, Eric D.] Univ Penn Perelman Sch Med, Dept Neurol, Philadelphia, PA USA; [Beisang, Arthur] Gillette Childrens Hosp, Dept Pediat, St Paul, MN USA; [Buie, Timothy] Boston Childrens Hosp, Harvard Med Sch, Div Gastroenterol Hepatol & Nutr, Boston, MA USA; [Buie, Timothy] Harvard Med Sch, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Boston, MA USA; [Benke, Timothy A.] Childrens Hosp Colorado, Dept Pediat Child Neurol, Aurora, CO USA; [Benke, Timothy A.] Univ Colorado, Sch Med, Aurora, CO USA; [Motil, Kathleen J.] Baylor Coll Med, Dept Pediat, Houston, TX USA; [Motil, Kathleen J.] Baylor Coll Med, Childrens Nutr Res Ctr, One Baylor Plaza, Houston, TX 77030 USA",University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Baylor College of Medicine; Baylor College of Medicine,"Motil, KJ (corresponding author), Baylor Coll Med, Childrens Nutr Res Ctr, One Baylor Plaza, Houston, TX 77030 USA.",kmotil@bcm.edu,,,Acadia Pharmaceutics Inc,Acadia Pharmaceutics Inc,Acadia Pharmaceutics Inc. provided funding for the development of this manuscript and received courtesy reviews for medical accuracy but did not direct the content.,,43,2,2,3,7,TAYLOR & FRANCIS LTD,ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND",2167-8707,,,EXPERT OPIN ORPHAN D,Exp. Opin. Orphan Drugs,DEC 31,2023,11,1,,,,,1,8,,10.1080/21678707.2023.2217328,http://dx.doi.org/10.1080/21678707.2023.2217328,,,8,Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy,I9DP3,,hybrid,,,2024-06-04,WOS:001005716500001,View Full Record in Web of Science
J,"McCarty, MF",,,,"McCarty, MF",,,Glucomannan minimizes the postprandial insulin surge: a potential adjuvant for hepatothermic therapy,MEDICAL HYPOTHESES,,,English,Article,,,,,,,CONTROLLED METABOLIC TRIAL; DIETARY FIBER; CHOLESTEROL 7-ALPHA-HYDROXYLASE; KONJAC-MANNAN; FATTY-ACIDS; DISEASE; CELLS; RATS,"Glucomannan (GM) is differentiated from other soluble fibers by the extraordinarily high viscosity of GM solutions. Administration of 4-5g of GM with meals, blended into fluid or mixed with food, can slow carbohydrate absorption and dampen the postprandial insulin response by up to 50%. Controlled clinical studies document that GM can promote satiety and weight loss, lower LDL cholesterol, improve diabetic control, and correct constipation, with minimal if any side-effects. Rodent studies suggest that GM may have potential for decreasing cancer risk and possibly even slowing the ageing process. Hepatothermic therapy, a technique for achieving rapid loss of body fat by optimizing the liver's capacity for fat oxidation, can only achieve its optimal efficacy if diurnal insulin levels are kept low; ingestion of GM with meals will evidently be of benefit in this regard by moderating postprandial insulin surges. (C) 2002 Published by Elsevier Science Ltd.","Pantox Labs, San Diego, CA 92109 USA",,"Pantox Labs, 4622 Santa Fe St, San Diego, CA 92109 USA.",,,,,,,,44,38,40,0,14,CHURCHILL LIVINGSTONE,EDINBURGH,"JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND",0306-9877,1532-2777,,MED HYPOTHESES,Med. Hypotheses,JUN,2002,58,6,,,,,487,490,,10.1054/mehy.2001.1457,http://dx.doi.org/10.1054/mehy.2001.1457,,,4,"Medicine, Research & Experimental",Science Citation Index Expanded (SCI-EXPANDED),Research & Experimental Medicine,596ZG,12323114,,,,2024-06-04,WOS:000178196400008,View Full Record in Web of Science
J,"Ohkuma, T; Iwase, M; Fujii, H; Kitazono, T",,,,"Ohkuma, Toshiaki; Iwase, Masanori; Fujii, Hiroki; Kitazono, Takanari",,,"Sex differences in cardiovascular risk, lifestyle, and psychological factors in patients with type 2 diabetes: the Fukuoka Diabetes Registry",BIOLOGY OF SEX DIFFERENCES,,,English,Article,,,,,,Cardiovascular risk factor; Diabetes; Lifestyle; Psychosocial factor; Sex difference,GENDER-DIFFERENCES; SLEEP DURATION; CARDIOMETABOLIC RISK; 64 COHORTS; DISEASE; INDIVIDUALS; DISPARITIES; WOMEN; MEN; COMPLICATIONS,"BackgroundThe excess risk of cardiovascular diseases associated with diabetes is greater in women than in men. The present study aimed to examine sex differences in the control of cardiovascular risk factors, as well as lifestyle and psychological factors, in patients with type 2 diabetes.MethodsA total of 4923 Japanese patients with type 2 diabetes were included in this cross-sectional study. Female/male differences in cardiovascular risk factor levels, and corresponding odds ratios for achieving recommended ranges for preventing cardiovascular diseases and having unhealthy lifestyle and psychological factors were computed by linear and logistic regression models.ResultsWomen were less likely than men to achieve recommended ranges for glycated hemoglobin, low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and obesity-related anthropometric indices such as body mass index and waist circumference, but were more likely than men to be on target for high-density lipoprotein cholesterol and triglycerides. Women were also more likely than men to have an unhealthy lifestyle and psychological factors, including less dietary fiber intake, less leisure-time physical activity, shorter sleep duration, more constipation, and more depressive symptoms. Similar findings were observed when the participants were subgrouped by age (< 65 and >= 65 years) and past history of cardiovascular disease.ConclusionsWe observed significant sex differences for a range of cardiovascular risk factors, as well as lifestyle and psychological factors, suggesting the importance of adopting a sex-specific approach for the daily clinical management of diabetes. Plain Language SummaryDiabetes increases the risk of cardiovascular diseases, and growing evidence suggests that the risk increases more in women than men. Differences between the sexes in terms of the control of risk factors have been proposed to explain this association. Although ethnic and regional differences in the management of cardiovascular risk factors have been reported, most evidence has come from Western countries, and evidence from Asia is limited. Given the differences in health care systems, as well as cultural and sociological backgrounds, it is important to clarify the sex differences in the management of cardiovascular risk factors, lifestyle, and psychological factors in order to incorporate appropriate sex-specific approaches into public health policies.The present study comprehensively assessed sex differences in a wide range of cardiovascular risk factors, as well as lifestyle and psychological factors in Japanese patients with type 2 diabetes. The results showed that women were less likely than men to achieve recommended ranges for glycemic control, low-density lipoprotein-cholesterol and non-high-density lipoprotein-cholesterol, as well as obesity-related anthropometric indices, but were more likely to be on target for high-density lipoprotein-cholesterol and triglycerides. In addition, women were more likely to have unhealthy lifestyle and psychological factors, such as less dietary fiber intake, less physical activity, shorter sleep duration, and more constipation, and depressive symptoms. These results suggest the need for a comprehensive and sex-specific approach for the management of cardiovascular risk factors, as well as lifestyle and psychological factors, to reduce the risk of cardiovascular diseases in patients with diabetes.","[Ohkuma, Toshiaki; Iwase, Masanori; Fujii, Hiroki; Kitazono, Takanari] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Maidashi 3-1-1,Higashi-Ku, Fukuoka 8128582, Japan; [Iwase, Masanori] Hakujyuji Hosp, Diabet Ctr, Fukuoka, Japan; [Fujii, Hiroki] Fukuoka Dent Coll, Div Internal Med, Fukuoka, Japan",Kyushu University; Fukuoka Dental College (FDC),"Ohkuma, T (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Maidashi 3-1-1,Higashi-Ku, Fukuoka 8128582, Japan.",okuma.toshiaki.704@m.kyushu-u.ac.jp,,,"Japan Society for the Promotion of Science (KAKENHI), from the Ministry of Education, Culture, Sports, Science~and Technology of Japan [23249037, 23659353, 16K00861, 19K24229, 21K11700]; Japan Diabetes Society; Japan Association for Diabetes Education and Care; Japan Diabetes Foundation; Smoking Research Foundation","Japan Society for the Promotion of Science (KAKENHI), from the Ministry of Education, Culture, Sports, Science~and Technology of Japan; Japan Diabetes Society; Japan Association for Diabetes Education and Care; Japan Diabetes Foundation; Smoking Research Foundation","This work was supported in part by The Japan Society for the Promotion of Science (KAKENHI), from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant Numbers 23249037, 23659353, 16K00861, 19K24229, and 21K11700), a Junior Scientist Development Grant from the Japan Diabetes Society, Grants from Japan Association for Diabetes Education and Care, Grants for young researchers from Japan Association for Diabetes Education and Care, a grant from the Japan Diabetes Foundation, and a grant from Smoking Research Foundation.",,52,1,1,4,7,BMC,LONDON,"CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND",,2042-6410,,BIOL SEX DIFFER,Biol. Sex Differ.,MAY 22,2023,14,1,,,,,,,32,10.1186/s13293-023-00517-8,http://dx.doi.org/10.1186/s13293-023-00517-8,,,10,Endocrinology & Metabolism; Genetics & Heredity,Science Citation Index Expanded (SCI-EXPANDED),Endocrinology & Metabolism; Genetics & Heredity,G8LW4,37211595,"Green Published, gold",,,2024-06-04,WOS:000991617300001,View Full Record in Web of Science
J,"Langyan, S; Yadava, P; Khan, FN; Sharma, S; Singh, R; Bana, RS; Singh, N; Kaur, V; Kalia, S; Kumar, A",,,,"Langyan, Sapna; Yadava, Pranjal; Khan, Fatima Nazish; Sharma, Sanjula; Singh, Renu; Bana, Ram Swaroop; Singh, Nisha; Kaur, Vikender; Kalia, Sanjay; Kumar, Ashok",,,Trends and advances in pre- and post-harvest processing of linseed oil for quality food and health products,CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION,,,English,Review; Early Access,,,,,,Linseed; bioactive compounds; health-promoting properties; functional food; nutraceutical,SUPERCRITICAL-FLUID EXTRACTION; N-3 FATTY-ACIDS; ANTIOXIDANT ACTIVITY; SECOISOLARICIRESINOL DIGLUCOSIDE; FLAXSEED OIL; PHENOLIC-COMPOUNDS; DIETARY FLAXSEED; LINOLENIC ACID; LIGNAN SECOISOLARICIRESINOL; LIQUID-CHROMATOGRAPHY,"Linseed is an ancient crop used for diverse purposes since the beginning of civilization. In recent times, linseed has emerged as a superfood due to its high content of health-promoting omega-3 fatty acids and other bioactive compounds. Among primary health effects, it has potential to manage hypertension, diabetes, osteoporosis, atherosclerosis, cancer, arthritis, neurological, cardiovascular diseases including blood cholesterol levels, constipation, diarrhea, and autoimmune disorders etc. due to the presence of omega-3 fatty acid, lignans, high dietary fibers, and proteins, whereas, secondary health effects comprise of relieving from various skin disorders. Due to these health-beneficial properties, interest in linseed oil necessitates the intensification of research efforts on various aspects. These include cultivation technology, varietal and genetic improvement, post-harvest processing, profiling of nutrients and bioactive compounds, pre-clinical and clinical studies, etc. The present review discussed the advances in linseed research including pre- and post-harvest processing. However, focus on the bioactive compounds present in linseed oil and their health effects are also presented. Linseed cultivation, pre- and post-harvest processing aspects are covered including climatic, edaphic, agronomic factors, type of cultivar and storage conditions etc, which impact the overall oil yield and its nutritional quality. Various emerging applications of linseed oil in functional food, nutraceutical, pharmaceutical, and cosmeceutical preparations were also presented in detail. Further, recommendations were made on linseed oil research in the field of genetics, breeding germplasm resources and genome editing for exploring its full applications as a nutrition and health product.","[Langyan, Sapna; Kaur, Vikender; Kumar, Ashok] ICAR Natl Bur Plant Genet Resources, New Delhi, India; [Yadava, Pranjal; Singh, Renu; Bana, Ram Swaroop] Indian Agr Res Inst, New Delhi, India; [Khan, Fatima Nazish] Jamia Milia Islamia, New Delhi, India; [Sharma, Sanjula] Punjab Agr Univ, Oilseed Sect, Ludhiana, India; [Singh, Nisha] Natl Inst Plant Biotechnol, New Delhi, India; [Kalia, Sanjay] Dept Biotechnol, New Delhi, India",Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Jamia Millia Islamia; Punjab Agricultural University; Indian Council of Agricultural Research (ICAR); ICAR - National Institute For Plant Biotechnology (NIPB),"Langyan, S (corresponding author), ICAR Natl Bur Plant Genet Resources, New Delhi, India.",Singh.sapna06@gmail.com,"Sharma, Sanjula/JNJ-2376-2023","Sharma, Sanjula/0000-0002-1815-9701",DBT,DBT(Department of Biotechnology (DBT) India),"The authors are thankful to ICAR and DBT for providing motivation and support. We are thankful to Dr. Rakesh Choudhary, Rani Lakshmi Bai Central Agricultural University, Jhansi, India for providing the linseed crop photographs.",,191,1,1,12,18,TAYLOR & FRANCIS INC,PHILADELPHIA,"530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA",1040-8398,1549-7852,,CRIT REV FOOD SCI,Crit. Rev. Food Sci. Nutr.,2023 NOV 8,2023,,,,,,,,,,10.1080/10408398.2023.2280768,http://dx.doi.org/10.1080/10408398.2023.2280768,,NOV 2023,24,Food Science & Technology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Nutrition & Dietetics,Z3XW7,38032160,,,,2024-06-04,WOS:001111451100001,View Full Record in Web of Science
J,"Begum, M; Rahman, G; Susmitha, G",,,,"Begum, Mariya; Rahman, Gazala; Susmitha, G.",,,A CAUSATIVE RISK OF COLORECTAL CANCER BY RED MEAT,INTERNATIONAL JOURNAL OF LIFE SCIENCE AND PHARMA RESEARCH,,,English,Article,,,,,,Red Meat; Processed Meat; Colorectal Cancer; Polyps Formation; Sedentary Lifestyle,,"Colorectal Cancer is the 2ND Most Leading cause of death.It is 2nd most common in Women & 3rd Most Common in Men. It occurs due to changes in the Genes that lies in Colon & Rectum due to which there is no control on Cell Growth that may result in escape of Growth (or)Fast Growth which becomes Tumor leading to COLORECTAL CANCER. These genetic changes builds up over the years,& by the age of 50-60 people starts with development of POLYPS, which are small growths on the lining of the intestinal tract that develops into cancer,and these few of polyps becomes causative agents for Cancer.Major Risk of Colorectal Cancer is due to RED MEAT or PROCESSED MEAT, since it contains Large amount of Iron,Creatine,Minerals such as Zinc & Phosphorus,and vit B (niacin,Vit B12,thiamin & riboflavin, Also red meat is a source of Lipoic Acid, other related risk factors are:Age above 45yrs, Inflammatory Bowel Disease(IBD), Family history,Diet-high Fat diet, low fiber, Smoking,Sedentary lifestyle, History of Polyps, Obesity.The Signs & Symptoms of Colorectal Cancer Includes : A Persistent change in bowel habbits including diarrhea or constipation or change in consistency of your Stool. Rectal bleeding or blood in your stool, persistent abdominal discomfort, such as gas,Cramps, or Pain.Weakness or fatigue, Unexplained weight loss.Mostly the Diagnosis of Colorectal Cancer is done by Colonoscopy, Tissue Biopsy during Sigmoidscopy.However Preventive measures when taken will reduce the risk of colorectal Cancer by reducing the intake of Red Meat or Processed Meat in diet,changing the sedentary lifestyle, doing physical activity, Avoiding Smoking &Alcohol consumption, Diary Foods, Fried Foods,including dietary Fiber.","[Begum, Mariya; Rahman, Gazala; Susmitha, G.] Bhaskar Pharm Coll, Dept Pharm Practice, Hyderabad 500075, India",,"Begum, M (corresponding author), Bhaskar Pharm Coll, Dept Pharm Practice, Hyderabad 500075, India.",susmi.aswi@gmail.com,,,,,,,12,0,0,3,31,INT JOURNAL LIFESCIENCE & PHARMA RESEARCH,TAMILNADU,"PLOT NO 10, 2 MAIN RD, RENGA NAGAR NEAR TO OLD ALPHA SCH, SATHANOOR MAIN RD, TIRUCHIRAPALLI, TAMILNADU, INDIA",2250-0480,,,INT J LIFE SCI PHARM,Int. J. Life Sci. Pharma Res.,JAN,2020,,,,,9,,105,108,,,,,,4,"Chemistry, Medicinal",Emerging Sources Citation Index (ESCI),Pharmacology & Pharmacy,MR4LS,,,,,2024-06-04,WOS:000553561100050,View Full Record in Web of Science
J,"von Schassen, H; Andresen, V; Layer, P",,,,"von Schassen, Henrike; Andresen, Viola; Layer, Peter",,,The new guideline on irritable bowel syndrome: what is new?,DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT,,,German,Article,,,,,,irritable bowel syndrome; heterogeneous clinical picture; multifactorial genesis; gut-brain axis; microbiome,CONSTIPATION; EFFICACY; TOLERABILITY; RIFAXIMIN; SAFETY,"Irritable bowel syndrome: what is new? The following refers only to irritable bowel syndrome (IBS) in adults. The new guideline includes a separate section on IBS for paediatric patients. Irritable bowel syndrome (IBS) presents as a heterogeneous picture with chronic abdominal complaints related to the bowel. These are usually accompanied by changes in bowel movements and lead to impaired quality of life. The genesis is multifactorial and there are complex underlying pathophysiological mechanisms associated with IBS.Thus, disturbances in various components of the gut-brain axis and the increasing importance of the microbiome can be identified. Various psychological comorbidities also play a role. Diagnostics The diagnosis is made by a thorough anamnesis and symptom-oriented exclusion of important differential diagnoses. A subdivision into different subtypes depending on the main symptoms is beneficial for the further management of IBS patients. The diagnosis of IBS should be made as early as possible after reliable exclusion of the important differential diagnoses. If diarrhoea dominates as a symptom, a detailed differential diagnosis and functional diagnosis should be carried out. Therapy There is no proven causal and no established standard therapy. Due to the variable genesis and symptom manifestation of IBS, a broad spectrum of therapy options results, whereby there is no individual prediction regarding effectiveness and therefore every therapy is initially probationary. Symptom-independent general therapies that can be used for all subtypes include dietary methods (e.g. the low-FODMAP diet), probiotics, psychotherapy methods and complementary medicine. The choice of symptom-dependent drug treatments is made according to the subtype/main symptom. In the case of diarrhoea, bile acid binders, the non-absorbable antibiotic rifaximin or, in individual cases, 5-HT (3) -antagonists can be used in addition to loperamide. In constipation, prucalopride and linaclotide have value in addition to the use of soluble fibre and macrogol/other laxatives. For abdominal pain/cramps, studies show good results for spasmolytics, especially peppermint oil, and for tricyclic-type antidepressants. For the main symptom of flatulence, probiotics, rifaximin and especially the low-FODMAP diet can show positive results in studies.","[von Schassen, Henrike] Israelit Krankenhaus Hamburg, Facharztin Med Klin 1, Hamburg, Germany; [Andresen, Viola] Israelit Krankenhaus Hamburg, Oberarztin Med Klin 1, Hamburg, Germany; [Layer, Peter] Klin Israelit Krankenhaus, Med 1, Hamburg, Germany",,"Andresen, V (corresponding author), Israelit Krankenhaus, Med Klin, Orchideenstieg 14, D-22297 Hamburg, Germany.",H.vonSchassen@ik-h.de; v.andresen@ik-h.de; P.Layer@ik-h.de,,,,,,,12,1,1,0,8,GEORG THIEME VERLAG KG,STUTTGART,"RUDIGERSTR 14, D-70469 STUTTGART, GERMANY",0012-0472,1439-4413,,DEUT MED WOCHENSCHR,Dtsch. Med. Wochenschr.,OCT,2021,146,19,,,,,1243,1248,,10.1055/a-1331-6478,http://dx.doi.org/10.1055/a-1331-6478,,,6,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,UT0NR,34553347,,,,2024-06-04,WOS:000697822700003,View Full Record in Web of Science
C,"Mitra, SK; Devi, HL; Debnath, S",,"Chomchalow, N; Chantrasmi, V; Sukhvibul, N",,"Mitra, S. K.; Devi, H. L.; Debnath, S.",,,Tropical and Subtropical Fruits and Human Health,INTERNATIONAL SYMPOSIUM ON TROPICAL AND SUBTROPICAL FRUITS,Acta Horticulturae,,English,Proceedings Paper,International Symposium on Tropical and Subtropical Fruits,"DEC 19-22, 2011","Chiang Mai, THAILAND",Int Soc Hort Sci,,riboflavin; thiamine; vitamins; antioxidants; phytochemical,CANCER; ANTIOXIDANTS; VEGETABLES; DIET,"Fruit is a rich natural source of valuable nutritional constituents and calories and thus plays a most significant role in human nutrition. Essential minerals, vitamins, fatty acids and dietary fiber are available in sufficient quantity and quality from fruits. The important vitamins in fruits are ascorbic acid (vitamin C), riboflavin, vitamin A, thiamine, niacin, pyridoxine, folic acid and vitamin E. Calcium, potassium, iron, phosphorus, magnesium are the important minerals available from fruits. However, each kind of fruit is unique in its composition. Banana yields highest calories per unit area and takes least time for digestion. Cashew nut is rich in protein (21.2%) while mango and papaya lead in vitamin A content. Bael fruit is rich in riboflavin while Barbados cherry and aonla are rich in vitamin C. Litchi is rich in calcium. Fruit is unique as a healthy food because it does not contain cholesterol, compared to many forms or sources of food. The amount of quality fiber present in many tropical and sub-tropical fruits is another important constituent. It prevents constipation, reduces cholesterol levels, improves bowel movement, rejuvenates digestive system and hence helps fight obesity, high blood pressure and heart diseases. Fruits are the rich source of natural bioactive substances called phytochemicals and antioxidants that have the property to prevent oxidative chain reaction by removal of free radicals' intermediates and even being oxidized themselves. Research suggests that phytochemicals, working together with nutrients found in fruits, may help slow the aging process, reduce cell damage, stimulate the immune system and reduce the risk of many diseases. This paper will discuss the health benefits of tropical and sub-tropical fruits.","[Mitra, S. K.; Devi, H. L.; Debnath, S.] Bidhan Chandra Krishi Viswavidyalaya, Fac Hort, Mohanpur 741252, W Bengal, India",Bidhan Chandra Agricultural University,"Mitra, SK (corresponding author), Bidhan Chandra Krishi Viswavidyalaya, Fac Hort, Mohanpur 741252, W Bengal, India.",,,,,,,,19,1,1,0,19,INT SOC HORTICULTURAL SCIENCE,LEUVEN 1,"PO BOX 500, 3001 LEUVEN 1, BELGIUM",0567-7572,2406-6168,978-94-62610-10-1,ACTA HORTIC,,,2014,1024,,,,,,39,47,,,,,,9,Agronomy; Plant Sciences; Horticulture,Conference Proceedings Citation Index - Science (CPCI-S),Agriculture; Plant Sciences,BB5GS,,,,,2024-06-04,WOS:000343863100002,View Full Record in Web of Science
J,"Moding, M; Ohlsson, B",,,,"Moding, Magnus; Ohlsson, Bodil",,,The role of fermentable carbohydrates and beverages in the symptomatology of functional gastrointestinal disease,SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY,,,English,Article,,,,,,Beverages; FODMAPs; functional gastrointestinal diseases,IRRITABLE-BOWEL-SYNDROME; DIETARY-MANAGEMENT; GAS-PRODUCTION; LIFE-STYLE; SYMPTOMS; FODMAP; RESTRICTION; ASSOCIATION; PREVALENCE; MECHANISMS,"Objectives: The pathophysiology behind functional gastrointestinal disease (FGID) has not been defined, but an intestinal accumulation of fermentable short-chain carbohydrates (FODMAPs) is thought to be involved. A restricted coffee intake is recommended. The aim was to investigate if symptoms of FGID were associated with intake of certain foods (including FODMAPs), as well as beverages (including coffee and tea). Method and materials: Data were used from participants, age range 45-75 years, who had answered the EpiHealth questionnaire about their background factors, health status and intake of food and beverages. After exclusion of organic bowel diseases, 16,840 participants remained. The impact of food and beverages on functional abdominal pain, functional bloating, functional constipation and functional diarrhea were examined by adjusted binary logistic regression. Results: Wholemeal bread (Swedish cracker) (OR: 1.361; 95% CI: 1.001-1.851) and white bread (low fiber content) (OR: 1.527; 95% CI: 1.075-2.169) were associated with constipation, whereas soft wholemeal bread (high fiber content) was associated with diarrhea (OR: 1.601; 95% CI: 1.040-2.463). Cheese was associated with bloating (OR: 1.460; 95% CI: 1.004-2.123). A high tea intake was associated with abdominal pain (p for trend = .003), bloating (p for trend = 0.39) and diarrhea (p for trend <. 001), whereas coffee intake was associated with a decreased risk of abdominal pain (p for trend = .002) and bloating (p for trend = .007). High soda intake associated with abdominal pain and bloating and juice with diarrhea. Conclusion: There are weak associations between intake of grain and dairy products and FGID symptoms. Tea is associated with increased risks, whereas coffee is associated with lower risks, of FGID symptoms.","[Moding, Magnus; Ohlsson, Bodil] Lund Univ, Skane Univ Hosp, Dept Internal Med, Malmo, Sweden",Lund University; Skane University Hospital,"Ohlsson, B (corresponding author), Skane Univ Hosp, Dept Clin Sci, Jan Waldenstrom St 15, S-20502 Malmo, Sweden.",bodil.ohlsson@med.lu.se,,,Development Foundation of Region Skane; Dir Albert Pahlsson's Foundation,Development Foundation of Region Skane; Dir Albert Pahlsson's Foundation,This work was funded by Development Foundation of Region Skane and Dir Albert Pahlsson's Foundation.,,40,5,5,1,11,TAYLOR & FRANCIS LTD,ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND",0036-5521,1502-7708,,SCAND J GASTROENTERO,Scand. J. Gastroenterol.,,2017,52,11,,,,,1224,1234,,10.1080/00365521.2017.1365931,http://dx.doi.org/10.1080/00365521.2017.1365931,,,11,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,FT6NW,28826271,,,,2024-06-04,WOS:000423271900010,View Full Record in Web of Science
J,"Chen, HL; Lu, YH; Lin, JJ; Ko, LY",,,,"Chen, HL; Lu, YH; Lin, JJ; Ko, LY",,,Effects of fructooligosaccharide on bowel function and indicators of nutritional status in constipated elderly men,NUTRITION RESEARCH,,,English,Article,,,,,,fructooligosaccharide; large bowel function; short-chain fatty acid; nutritional status; elderly,WHEAT BRAN; DIETARY FIBER; OLIGOSACCHARIDES; GLUCOSE,"Five subjects completed the study consisting of a 30-d low fiber control period and another 30-d experimental period in which 10 g of FO was supplemented to a 3-d cycle menus. Status of large bowel function was monitored daily. Feces were completely collected on last 5 d of each period to determine the fecal characteristics and fecal short-chain fatty acid (SCFA) contents. Nutrient intake, body weight, arm anthropometric parameters, serum albumin, total protein, triglyceride, cholesterol, and electrolytes were measured as indices of nutritional status. Incorporation of FO significantly increased the defecation frequency, daily stool weight, weight per stool and decreased the use of enema. Concentrations of fecal acetate, propionate, i-butyrate, n-butyrate, i-valerate and n-valerate increased by 3-18 fold in the experimental period. Nutrient intake and anthropometric indices remained constant throughout the study. Serum concentrations of Na and K were decreased and concentrations of Ca and P were increased in the experimental period. Other blood biochemical parameters were not affected by the treatment. Therefore, we conclude that supplementation of FO was able to alleviate constipation, increase stool weight and fecal SCFA concentrations without affecting plasma lipid concentrations in the normolipidemic, constipated elderly men. (C) 2000 Elsevier Science Inc.","Chung Shan Med & Dent Coll, Inst Nutrit Sci, Taichung, Taiwan; Chung Shan Med & Dent Coll, Sch Nutr, Taichung, Taiwan; Hung Kuang Inst Technol, Taichung, Taiwan; Taichung Municipal Aging Care Hosp, Taichung, Taiwan",Chung Shan Medical University; Chung Shan Medical University; Hungkuang University,"Chen, HL (corresponding author), 110 Sec 1 Chien Kuo N Rd, Taichung 402, Taiwan.",,,,,,,,23,40,46,1,8,PERGAMON-ELSEVIER SCIENCE LTD,OXFORD,"THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND",0271-5317,,,NUTR RES,Nutr. Res.,DEC,2000,20,12,,,,,1725,1733,,10.1016/S0271-5317(00)00274-8,http://dx.doi.org/10.1016/S0271-5317(00)00274-8,,,9,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,387JE,,,,,2024-06-04,WOS:000166118800005,View Full Record in Web of Science
J,"Rathmann, W; Enck, P; Ziegler, D",,,,"Rathmann, W; Enck, P; Ziegler, D",,,Gastrointestinal disorders in autonomic neuropathy: Current aspects on diagnosis and therapy,NERVENHEILKUNDE,,,German,Review,,,,,,autonomic neuropathy; gastrointestinal system; diabetic gastroparesis,DEPENDENT DIABETES-MELLITUS; TRANSPYLORIC FLUID MOVEMENT; GASTRIC-EMPTYING RATE; ACID BREATH TEST; ANTRODUODENAL MOTILITY; FECAL INCONTINENCE; DUPLEX SONOGRAPHY; GASTROPARESIS; ERYTHROMYCIN; ABNORMALITIES,"Gastrointestinal (GI) motility is regulated through interactions of the autonomic with the enteric nervous system, which can be modified by GI-hormones. This complex network makes it difficult to detect a gastrointestinal autonomic neuropathy (GAN). Therefore, the diagnosis of a GAN is mainly based on GI function tests. Scintigraphic and radiologic diagnostic techniques and ultrasonography are used to measure transit times in the upper GI-tract. A novel, non-invasive test for assessment of gastric emptying is the C-13-octanoic acid breath test. Disturbances of Gf-motility can be detected by manometry, but may also be identified by non-invasive recording of gastric myoelectrical activity (electrogastrogram). Colon transit can be measured by radiological detection of orally administered pellets (Hinton test), whereas chronic diarrhea primarily needs to be further evaluated for causes other than GAN (e.g. pancreatic insufficiency with steatorrhea). Fecal incontinence may be caused by a defect in the anorectal sensory response which can be detected by anorectal manometry. Prokinetic drugs (cisapride, metoclopramide, erythromycin) are used for symptomatic treatment of gastroesophageal motility disorders. Treatment of constipation mainly consists of the use of dietary fibers. Diarrhoea, on the other hand, can be handled by use of synthetic opioid drugs (loperamide) after an initial treatment with a broad-spectrum antibiotic was not successful (bacterial overgrowth secondary to intestinal atony). Biofeedback training can be used for patients with fecal incontinence.","UNIV DUSSELDORF,KLIN GASTROENTEROL & INFEKTIOL,DUSSELDORF,GERMANY; UNIV DUSSELDORF,DIABET FORSCHUNGSINST,KLIN ABT,D-4000 DUSSELDORF,GERMANY",Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf,"Rathmann, W (corresponding author), UNIV DUSSELDORF,DIABET FORSCHUNGSINST,ABT BIOMETRIE & EPIDEMIOL,HENNEKAMP 65,D-40225 DUSSELDORF,GERMANY.",,,,,,,,45,0,0,0,1,F K SCHATTAUER VERLAG GMBH,STUTTGART,"P O BOX 10 45 45, LENZHALDE 3, D-70040 STUTTGART, GERMANY",0722-1541,,,NERVENHEILKUNDE,Nervenheilkunde,NOV,1996,15,7,,,,,414,419,,,,,,10,Clinical Neurology; Psychiatry,Science Citation Index Expanded (SCI-EXPANDED),Neurosciences & Neurology; Psychiatry,VV434,,,,,2024-06-04,WOS:A1996VV43400006,View Full Record in Web of Science
J,"Rathnanand, M; Narkhede, R; Udupa, N; Kalra, A",,,,"Rathnanand, Mahalaxmi; Narkhede, Rajkiran; Udupa, N.; Kalra, Atin",,,Development of Novel Floating Delivery System based on Psyllium: Application on Metformin Hydrochloride,CURRENT DRUG DELIVERY,,,English,Article,,,,,,psyllium; Metformin hydrochloride; Floating drug delivery,GLUCOSE,"psyllium, a medicinally active gel forming natural polysaccharide and a dietary fiber has been used as a medicine in myriad of conditions such as constipation and inflammatory bowel syndrome. One of its more recent uses that have received attention has been its ability to reduce blood sugar levels in diabetics. Therefore present work is an attempt to formulate anti diabetic drug Metformin as a controlled release floating delivery making use of pysllium as release retardant and to assist the drug in stabilizing blood sugar level in type II diabetics. Drug and excipients compatibility studies were monitored by thermal analysis using differential scanning calorimeter (DSC) and Fourier transform infra red (FTIR). The DSC thermogram and FTIR of drug and drug-polymer mixture did not reveal any incompatibility. psyllium was tried in different concentrations along with other polymers like HPMC K15M and carbopol 940 to achieve the desired release profile. The total drug: polymer ratio was kept between 1:0.4 to 1:0.5, and different polymer combinations were tried to achieve desired drug release for 12 hours. The prepared tablets were evaluated for in vitro release studies and floating behavior. Our conclusion from the present study indicated that pysllium could potentially be used in conjunction with other polymers to formulate controlled release formulations of anti-diabetic drugs to provide better control over blood glucose levels.","[Rathnanand, Mahalaxmi; Narkhede, Rajkiran; Udupa, N.; Kalra, Atin] Manipal Univ, Manipal Coll Pharmaceut Sci, Manipal, Karnataka, India",Manipal Academy of Higher Education (MAHE),"Kalra, A (corresponding author), Manipal Univ, Manipal Coll Pharmaceut Sci, Manipal, Karnataka, India.",mahalaxmi.rathnanand@gmail.com; atinkalra11@gmail.com,,"Udupa, Nayanabhirama/0000-0003-3842-5218","Novo Nordisk India; Department of Science and Technology, New Delhi and Manipal University","Novo Nordisk India(Novo Nordisk); Department of Science and Technology, New Delhi and Manipal University(Department of Science & Technology (India))","The authors are grateful to Novo Nordisk India for financial assistance and IR & DSC facility provided by Department of Science and Technology, New Delhi and Manipal University is duly acknowledged.",,16,2,2,0,17,BENTHAM SCIENCE PUBL LTD,SHARJAH,"EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES",1567-2018,1875-5704,,CURR DRUG DELIV,Curr. Drug Deliv.,JUN,2013,10,3,,,,,336,342,,10.2174/1567201811310030010,http://dx.doi.org/10.2174/1567201811310030010,,,7,Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy,149QY,23410070,,,,2024-06-04,WOS:000319337400010,View Full Record in Web of Science
J,"WIRTH, A; MIDDELHOFF, G; BRAEUNING, C; SCHLIERF, G",,,,"WIRTH, A; MIDDELHOFF, G; BRAEUNING, C; SCHLIERF, G",,,TREATMENT OF FAMILIAL HYPERCHOLESTEROLEMIA WITH A COMBINATION OF BEZAFIBRATE AND GUAR,ATHEROSCLEROSIS,,,English,Article,,,,,,,,"The effect of guar, (15.6 g/day), a dietary fiber, and simultaneous administration of benzafibrate [a lipid-lowering drug used in the treatment of atherosclerosis] (600 mg/day) during dietetic treatment on the plasma lipoproteins and apolipoproteins was investigated in 12 patients with familial hypercholesterolemia (corresponding to the HLP [hyperlipoproteinemia] type IIa pattern). Either benzafibrate alone or bezafibrate in combination with guar was administered in a cross-over study for 3 mo. Guar led to an additional lowering of the total cholesterol in the plasma by 7% (P .ltoreq. 0.05) associated with a fall of the low densitylipoprotein cholesterol (LDL-cholesterol) by 13% (P .ltoreq. 0.01) without any changes in the very low density lipoprotein (VLDL) and high density lipoprotein (HDL) cholesterols. In parallel with the decrease in LDL-cholesterol, the apoprotein B also was diminished by 20% (P .ltoreq. 0.05). The plasma triglyceride level and the triglyceride distribution within the individual lipoprotein fractions were not altered in any consistent manner by the addition of guar. Neither the fasting plasma glucose level nor the body weight were affected. The side-effects due to guar treatment consisted of slight nausea, meteorism and constipation, but this did not in any of the cases lead to early termination of the study. Evidently, guar exerts its cholesteol-lowering effect in addition to that of bezafibrate.","UNIV HEIDELBERG, MED KLIN, KLIN INST HERZINFARKTFORSCH, D-6900 HEIDELBERG 1, FED REP GER; BOEHRINGER MANNHEIM GMBH, DEPT MED RES, D-6800 MANNHEIM 31, FED REP GER",,,,,,,,,,18,18,19,0,0,ELSEVIER IRELAND LTD,CLARE,"ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND",0021-9150,1879-1484,,ATHEROSCLEROSIS,Atherosclerosis,,1982,45,3,,,,,291,297,,10.1016/0021-9150(82)90230-1,http://dx.doi.org/10.1016/0021-9150(82)90230-1,,,7,Cardiac & Cardiovascular Systems; Peripheral Vascular Disease,Science Citation Index Expanded (SCI-EXPANDED),Cardiovascular System & Cardiology,PU354,7159500,,,,2024-06-04,WOS:A1982PU35400005,View Full Record in Web of Science
J,"Thomas, A; Quigley, EMM",,,,"Thomas, Anusha; Quigley, Eamonn M. M.",,,Diet and irritable bowel syndrome,CURRENT OPINION IN GASTROENTEROLOGY,,,English,Review,,,,,,diet; FODMAPs; gluten; irritable bowel syndrome; probiotics,CELIAC GLUTEN SENSITIVITY; ENDOCRINE-IMMUNE PATHWAYS; GASTROINTESTINAL SYMPTOMS; INTESTINAL MICROBIOTA; DOUBLE-BLIND; DISEASE; PREVALENCE; CONSTIPATION; MANAGEMENT; IBS,"Purpose of review Those who suffer from irritable bowel syndrome (IBS) have long reported the frequent precipitation of their symptoms in relation to food ingestion and have often been convinced that certain foods were especially problematic. However, until very recently, research on the responses to food or individual dietary constituents, in IBS, has been scarce. This review addresses recent literature on diet and IBS. Recent findings The complexity of food-symptom interactions in IBS is being revealed in recent and ongoing research. Such studies have revealed the variable effects of fibre in IBS and the susceptibility of IBS individuals to the ingestion of poorly digested and absorbed carbohydrates. The latter has led to the widespread adoption of the low-fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) diet. Less certain is the role of another widely adopted dietary strategy, gluten restriction. Diet-microbe interactions are critical to the homeostasis of the gut microbiome in health and may well be disturbed in disease; enthusiasm continues, therefore, for the use of probiotics in IBS. Summary Food is a common precipitant of symptoms in IBS and recent research has focused on the role(s) of individual dietary constituents in IBS and on fibre, FODMAPs, gluten and probiotics, in particular. Each may have a role in certain IBS sufferers.","[Thomas, Anusha; Quigley, Eamonn M. M.] Houston Methodist Hosp, Weill Cornell Med Coll, Dept Internal Med, Houston, TX 77030 USA; [Quigley, Eamonn M. M.] Houston Methodist Hosp, Weill Cornell Med Coll, Div Gastroenterol & Hepatol, Houston, TX 77030 USA",The Methodist Hospital System; The Methodist Hospital - Houston; Cornell University; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston,"Quigley, EMM (corresponding author), Houston Methodist Hosp, 6550 Fannin St,SM 1001, Houston, TX 77030 USA.",equigley@tmhs.org,,,,,,,53,15,17,1,52,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0267-1379,1531-7056,,CURR OPIN GASTROEN,Curr. Opin. Gastroenterol.,MAR,2015,31,2,,,,,166,171,,10.1097/MOG.0000000000000158,http://dx.doi.org/10.1097/MOG.0000000000000158,,,6,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,CB2RC,25612261,,,,2024-06-04,WOS:000349474600013,View Full Record in Web of Science
J,"Rajendra, S; Ho, JJ",,,,"Rajendra, S; Ho, JJ",,,Colonic diverticular disease in a multiracial Asian patient population has an ethnic predilection,EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY,,,English,Article,,,,,,Asians; colonoscopy; diverticulosis; ethnicity,LARGE-BOWEL; LARGE-INTESTINE; SIGMOID COLON; HONG-KONG; POLYPS; IDENTIFY; MOTILITY; PATTERNS; NECROPSY; HEALTH,"Background Traditionally, diverticular disease of the colon has been attributed to ageing, low dietary fibre and a high intraluminal pressure. Recently, genetic and racial factors have also been implicated. Methods Four-hundred and ten consecutive multiracial Asian patients undergoing colonoscopy for a variety of bowel symptoms in a private endoscopy unit were studied for differing frequencies (if any) in colonic diverticular disease and concomitant abnormalities. Results Forty-one patients (10%) had diverticular disease. Diverticula were present in 22/147 Chinese (115%), 14/153 Indians (9%) and 5/110 Malays (4.5%). The mean age of patients with diverticular disease was 55 years as compared with 51.3 years in those without (P= 0.12) and there was no gender difference. Thirty-six patients (88%) had diverticula in the right colon only, four patients (10%) exclusively in the left hemicolon, and one patient (2%) had bilateral involvement. Using regression analysis, Chinese ethnicity [odds ratio (OR)= 2.11; 95% confidence interval (CI), 1.09-4.09; P=0.027), constipation (OR= 2.65; 95% CI, 1.23-5.42; P=0.007) and colorectal adenomas (OR=2.65; 95% CI, 1.08-6.46; P=0.033) were independently associated with diverticular disease. Conclusions Colonic diverticular disease in a multiracial Asian patient population has an ethnic predilection and is predominantly right-sided.","Royal Coll Med, Dept Med, Div Gastroenterol, Perak 30450, Malaysia; Royal Coll Med, Dept Paediat, Div Epidemiol, Perak 30450, Malaysia",University of Kuala Lumpur; University of Kuala Lumpur,"Royal Coll Med, Dept Med, Div Gastroenterol, Perak 30450, Malaysia.",shanraj@pd.jaring.my,"Ho, Jacqueline J/IZD-8603-2023; Ho, Jacqueline J/AAN-4341-2020","Ho, Jacqueline J/0000-0001-9939-7551; Ho, Jacqueline J/0000-0001-9939-7551",,,,,36,37,39,0,3,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0954-691X,1473-5687,,EUR J GASTROEN HEPAT,Eur. J. Gastroenterol. Hepatol.,AUG,2005,17,8,,,,,871,875,,10.1097/00042737-200508000-00015,http://dx.doi.org/10.1097/00042737-200508000-00015,,,5,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,957RX,16003138,,,,2024-06-04,WOS:000231392100015,View Full Record in Web of Science
J,"Toglia, MR",,,,"Toglia, MR",,,Pathophysiology of anorectal dysfunction,OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA,,,English,Article,,,,,,,SLOW-TRANSIT CONSTIPATION; FECAL INCONTINENCE; RECTAL PROLAPSE; ANAL INCONTINENCE; YOUNG-WOMEN; SPHINCTER MUSCULATURE; VAGINAL DELIVERY; DIETARY FIBER; UNITED-STATES; BOWEL HABITS,"Anorectal disorders are the cause of significant discomfort and embarrassment in women. The onset typically follows childbirth and symptoms increase with age. Anal incontinence, rectovaginal fistula, rectal prolapse, anal fissure, and constipation are considered.","Hahnemann Univ, Sch Med, Dept Obstet & Gynecol, Philadelphia, PA USA",Drexel University,"Toglia, MR (corresponding author), Riddle Mem Hosp, Suite 3406,Outpatient Pavil,1098 W Baltimore Pike, Media, PA 19063 USA.",,,,,,,,63,21,22,0,2,W B SAUNDERS CO,PHILADELPHIA,"INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA",0889-8545,,,OBSTET GYN CLIN N AM,Obstet. Gynecol. Clin. N. Am.,DEC,1998,25,4,,,,,771,+,,10.1016/S0889-8545(05)70042-5,http://dx.doi.org/10.1016/S0889-8545(05)70042-5,,,12,Obstetrics & Gynecology,Science Citation Index Expanded (SCI-EXPANDED),Obstetrics & Gynecology,147VE,9921556,,,,2024-06-04,WOS:000077517300007,View Full Record in Web of Science
J,"SAUNDERS, D; SILLERY, J; CHAPMAN, R",,,,"SAUNDERS, D; SILLERY, J; CHAPMAN, R",,,EFFECT OF CALCIUM-CARBONATE AND ALUMINUM HYDROXIDE ON HUMAN INTESTINAL FUNCTION,DIGESTIVE DISEASES AND SCIENCES,,,English,Article,,,,,,,,"The effect of calcium carbonate (6 g daily carbonate) (6 g daily) and of aluminum hydroxide (Amphojel, 7.2 g daily) on human gastrointestinal function was examined because these population antacids have a documented effect on fecal fat, an undocumented association with constipation, and a putative ability to ameliorate cocarcinogenic effects of bile acids and fatty acids on colonic mucosa. Intake-output studies were conducted over periods of three weeks during which time dietary intake was controlled (20 fiber daily), and the order of treatment (control, calcium carbonate, aluminum hydroxide) was randomized. Neither calcium carbonate nor aluminum hydroxide altered the mean intestinal transit time of eight subjects. Calcium carbonate increased daily output of feces from 106 .+-. 30 (SD) to 131 .+-. 41 g, of fecal fatty acids from 7.9 .+-. 1.4 to 16.8 .+-. 5.4 mmol, and of fecal 3.alpha.-hdyroxy-bile acids from 411 .+-. 223 to 769 .+-. 505 .mu.mol. Aluminum hydroxide increased daily output of feces to 143 .+-. 43 g, of fecal fatty acids to 12.4 .+-. 5 mmol, and of fecal bile acids to 735 .+-. 592 .mu.mol. both Ca2+ and Al3+ precipitated deoxycholate when these ions were incubated in vitro. These observations help to explain how these two antacids may lower blood lipids and ameliorate the effects of fecal bile acids and fatty acids on colonic mucosa.","UNIV WASHINGTON, DEPT MED, DIV GASTROENTEROL RG-24, SEATTLE, WA 98195 USA",,,,,,,,,,11,33,33,0,5,SPRINGER,DORDRECHT,"VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS",0163-2116,1573-2568,,DIGEST DIS SCI,Dig. Dis. Sci.,APR,1988,33,4,,,,,409,413,,10.1007/BF01536023,http://dx.doi.org/10.1007/BF01536023,,,5,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,M8443,3349887,,,,2024-06-04,WOS:A1988M844300006,View Full Record in Web of Science
J,"Cherbut, C",,,,"Cherbut, C",,,Lactulose and colonic motility,ANNALES DE GASTROENTEROLOGIE ET D HEPATOLOGIE,,,French,Article,,,,,,constipation; fermentation; lactulose; motility; neuro-humoral readjustment; transit,CHAIN FATTY-ACIDS; FECAL INCUBATION SYSTEM; MOTOR-ACTIVITY; CHRONIC CONSTIPATION; MYOELECTRICAL ACTIVITY; DIETARY FIBER; HUMANS; INGESTION; TRANSIT; FERMENTATION,"Three types of contractions are adapted to the major functions of the large intestine, i.e. slow propagation of digesta in the proximal part, allowing fermentation and water absorption, stool retention in the distal part, then voluntary expulsion. Nevertheless, the exact contribution of each type of contractions to the digesta transit rate is still poorly known. Beside grouped contractions, propagated on short distances in both anal and oral directions, which account for mixing and stiring of the luminal content, giant migrating contractions are associated with mass movements and stimulate rapid propulsion of digesta toward the anus. These motor patterns, controled by myogenic, nervous and chemical mechanisms, are modified in constipated patients. Stationary activity, which brakes propulsion, is particularly increased, whereas frequency of the giant migrating contractions is reduced. Lactulose helps to re-establish motility and to boost transit rate by several combined mechanisms. While elevated doses induce an osmotic effect, the lower doses usually prescribed stimulate colonic motility and improve Stool output through fermentation of lactulose by the intestinal microbiota. Increase of water-rich biomass, production of short-chain fatty acids and decrease of intracolonic pH, evoked by lactulose fermentation, lead to normalization of the large intestinal function, increase in stool frequency and reduction in transit time.","INRA, Ctr Rech Nutr Humaine, F-44316 Nantes, France",INRAE,"Cherbut, C (corresponding author), INRA, Ctr Rech Nutr Humaine, BP 71627, F-44316 Nantes, France.",,,,,,,,55,0,0,0,2,EXPANSION SCI FRANCAISE,PARIS,"31 BLVD LATOUR MAUBOURG, 75007 PARIS, FRANCE",0066-2070,,,ANN GASTROENT HEPATO,Ann. Gastroenterol. Hepatol.,JUN,1998,34,2,,,,,85,94,,,,,,10,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,106XG,,,,,2024-06-04,WOS:000075176100008,View Full Record in Web of Science
J,"Agha, REN; Saeed, A; Nazar, H",,,,"Agha, Rukh-e-Nasreen; Saeed, Aftab; Nazar, Halima",,,Plantago ovata: Clinical study of overuse,PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES,,,English,Article,,,,,,Plantago ovata; constipation; husk; herbal drug; hepatotoxic; neurotoxic,DIETARY FIBER; SEEDS; PSYLLIUM,"The objective of the study was to undertake evidence-base study to evaluate clinical manifestation of the overestimated use of herbal drug Plantago ovata and to compare it with placebo for the efficacy and adverse effects. The patients of both genders were included. Blood urea, creatinine, ALT, Serum B12, CP, ESR and liver function. tests were performed. The data was statistically analyzed in both groups for differential symptomatology. In anorexia test verses control results showed that Plantago ovata husk and placebo showed the affected ratio as 81 percent and 50 percent, correspondingly. Whereas in clinical performance of heart burning, pain in epigastrium, low libido, body pain, dyspepsia, fever, burning sensation in palm and sole in test drug showed affected response as adverse effect 90%, 88% and as control drug, 36%, 29%, 22%, 25%, 38%, 30%, 33%, 57%, respectively. The results were highly marked in test drug i.e. in comparison with placebo. This is clearly evident from data analysis that effect observed in test arm is far more superior hence null hypothesis was rejected clearly. Similarly serological and biochemical reports study i.e. (ALT, Vit. B1 and Vit A) revealed that there is no hepatotoxic and neurotoxic effect found in both the drugs.","[Agha, Rukh-e-Nasreen] Hamdard Univ, Fac Eastern Med, Shifaul Mulk Mem Hosp, New Delhi, India; [Saeed, Aftab] Hamdard Univ, Fac Eastern Med, HIRUM, New Delhi, India; [Nazar, Halima] Hamdard Univ, Fac Eastern Med, HACEM, Dept Med & Surg, New Delhi, India",Jamia Hamdard University; Jamia Hamdard University; Jamia Hamdard University,"Nazar, H (corresponding author), Hamdard Univ, Fac Eastern Med, HACEM, Dept Med & Surg, New Delhi, India.",haddiii@yahoo.com,"Nazar, Halima/AAP-7223-2021",,,,,,18,0,0,0,9,UNIV KARACHI,KARACHI,"UNIV CAMPUS, FAC PHARMACY, KARACHI, 75270, PAKISTAN",1011-601X,,,PAK J PHARM SCI,Pak. J. Pharm. Sci.,MAR,2016,29,2,,,,,563,567,,,,,,5,Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy,DK3ET,27087080,,,,2024-06-04,WOS:000374800500028,View Full Record in Web of Science
J,"Okada, C; Kim, JI; Melamed, ML; Abraham, N; Halani, PK",,,,"Okada, Chihiro; Kim, Joseph I.; Melamed, Michal L.; Abraham, Nitya; Halani, Priyanka Kadam",,,The relationship between fecal incontinence and food insecurity in United States women: an analysis of 2005e2010 National Health and Nutrition Examination Survey,AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY,,,English,Article,,,,,,accidental bowel leakage; fecal incontinence; food insecurity; social determinants of health,QUALITY-OF-LIFE; RISK-FACTORS; DIET QUALITY; ADULTS; IMPACT; EPIDEMIOLOGY; DETERMINANTS; PREVALENCE; SYMPTOMS; COST,"BACKGROUND: Fecal incontinence is a prevalent debilitating pelvic floor disorder characterized by the involuntary loss of stool. Fecal incontinence is known to be associated with constipation and loose stool, advancing age, chronic comorbidities, and previous anorectal trauma, among other biologic risk factors. The relationship between social determinants of health, such as food insecurity, and fecal incontinence is not well elucidated. OBJECTIVE: This study aimed to investigate the association between fecal incontinence and food insecurity using a nationally representative sample of US adult women. Our secondary aim was to examine the role of diet by assessing dietary differences between participants with and without fecal incontinence and between food-insecure women with and without fecal incontinence. STUDY DESIGN: This study analyzed data from the National Health and Nutrition Examination Survey, a nationally representative series of cross-sectional health surveys. Fecal incontinence was defined as accidental leakage of stool within the last 30 days. Food insecurity was assessed using the household food security measure created by the US Department of Agriculture. Dietary data from the National Health and Nutrition Examination Survey dietary interviews titled Individual Foods, First Day and Individual Foods, Second Day, which estimate the foods and drinks consumed in the preceding 24 hours, were pooled. The association between fecal incontinence and food insecurity was analyzed using logistic regression after controlling for patient characteristics. RESULTS: Overall, 3216 women were included, representing nearly 130 million US women. Of these women, 10.9% had fecal incontinence. There was no significant difference in diet between women with and without fecal incontinence (p>0.05). Food-insecurewomen in the overall sample reported higher carbohydrate and sugar intake and lower fiber and alcohol intake (all P<.05). Among food-insecure women, those with fecal incontinence had higher calorie and total fats intake than those without fecal incontinence; there was no significant difference in other dietary components (p>0.05). There was a significant association between food insecurity and fecal incontinence, such that women with food insecurity had higher odds of fecal incontinence after adjusting for patient characteristics and diet (odds ratio, 1.76; 95% confidence interval, 1.17-2.66; P=.008). CONCLUSION: Food insecurity was associated with fecal incontinence even after accounting for diet. Understanding the role of social determinants of health in fecal incontinence symptomatology and treatment is important to potentially alleviate symptom burden and improve the quality of life in at-risk populations.","[Okada, Chihiro; Kim, Joseph I.] Albert Einstein Coll Med, Bronx, NY USA; [Melamed, Michal L.] Montefiore Med Ctr, Div Nephrol, Dept Med, Bronx, NY USA; [Melamed, Michal L.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY USA; [Abraham, Nitya] Albert Einstein Coll Med, Dept Urol, Montefiore Med Ctr, Bronx, NY USA; [Halani, Priyanka Kadam] Albert Einstein Coll Med, Div Female Pelv Med & Reconstruct Surg, Dept Obstet & Gynecol & Womens Hlth, Montefiore Med Ctr, Bronx, NY 10461 USA",Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center,"Halani, PK (corresponding author), Albert Einstein Coll Med, Div Female Pelv Med & Reconstruct Surg, Dept Obstet & Gynecol & Womens Hlth, Montefiore Med Ctr, Bronx, NY 10461 USA.",pkadamhalani@gmail.com,,"Okada, Chihiro/0000-0002-4088-3405",American Urogynecologic Society/Duke University Clinical Research Educational Scientist Training program; National Institute of Health [R25HD094667],American Urogynecologic Society/Duke University Clinical Research Educational Scientist Training program; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA),P.K.H. is a participant in the American Urogynecologic Society/Duke University Clinical Research Educational Scientist Training program; the program is supported by an R25 grant from the National Institute of Health (grant number R25HD094667; principal investigator: Dr Cindy Amundsen).,,49,2,2,3,4,MOSBY-ELSEVIER,NEW YORK,"360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA",0002-9378,1097-6868,,AM J OBSTET GYNECOL,Am. J. Obstet. Gynecol.,APR,2023,228,4,,,,,,,,10.1016/j.ajog.2022.12.007,http://dx.doi.org/10.1016/j.ajog.2022.12.007,,MAR 2023,13,Obstetrics & Gynecology,Science Citation Index Expanded (SCI-EXPANDED),Obstetrics & Gynecology,Y0DN4,36509175,hybrid,,,2024-06-04,WOS:001102062400001,View Full Record in Web of Science
J,"Sunarti; Mumpuni, H; Yasmine, N; Marsono, Y; Fibri, DLN; Murdiati, A",,,,"Sunarti; Mumpuni, Hasanah; Yasmine, Nadia; Marsono, Yustinus; Fibri, Dwi Larasatie Nur; Murdiati, Agnes",,,FiberCreme as a Functional Food Ingredient Reduces Hyperlipidemia and Risk of Cardiovascular Diseases in Subjects with Hyperlipidemia,PREVENTIVE NUTRITION AND FOOD SCIENCE,,,English,Article,,,,,,cardiac risk ratio scores; cholesterol; FiberCreme; isomalto-oligosaccharides; triglyceride,ISOMALTO-OLIGOSACCHARIDES; CONSTIPATION,"FiberCreme is a commercial nondairy creamer made with isomalto-oligosaccharides (IMO) that is a source of dietary fiber. A study showed that IMO could decrease cholesterol (CH) and triglycerides, which are factors related to the risk of cardiovascular diseases and insulin resistance. This study evaluated FiberCreme's ability as a functional food ingredient to reduce CH and the risk of cardiovascular diseases in subjects with hyperlipidemic. This controlled clinical study trial involved 53 (23 similar to 57 years old) subjects with borderline high CH (>190 mg/dL) or triglycerides (>150 mg/dL) or both, who were divided into FiberCreme and control groups. The participant received 86 g of cookies daily for 4 weeks. The FiberCreme and control groups consumed FiberCreme-containing cookies and cookies with coconut cream with 5.78% and 4.69% fibers, respectively. Lipid profile, anthropometry, body composition, and food intake were also measured. Data analysis was performed using SPSS v.25. This study suggests that FiberCreme cookies can significantly reduce CH, triglycerides, and cardiac risk ratio scores.","[Sunarti] Gadjah Mada Univ, Dept Biochem, Fac Med Publ Hlth & Nursing, Yogyakarta 55281, Indonesia; [Mumpuni, Hasanah] Gadjah Mada Univ, Dr Sardjito Gen Hosp, Dept Cardiol & Vasc Med, Fac Med Publ Hlth & Nursing, Yogyakarta 55281, Indonesia; [Yasmine, Nadia] Gadjah Mada Univ, Fac Med Publ Hlth & Nursing, Yogyakarta 55281, Indonesia; [Marsono, Yustinus; Fibri, Dwi Larasatie Nur; Murdiati, Agnes] Gadjah Mada Univ, Fac Agr Technol, Dept Food & Agr Product Technol, Yogyakarta 55281, Indonesia",Gadjah Mada University; Gadjah Mada University; Gadjah Mada University; Gadjah Mada University,"Sunarti (corresponding author), Gadjah Mada Univ, Dept Biochem, Fac Med Publ Hlth & Nursing, Yogyakarta 55281, Indonesia.",nartyr@ugm.ac.id,,"Fibri, Dwi Larasatie Nur/0000-0001-9130-1957","Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada [014.PRJ/LNK-FKKMK UGM/III/2021]","Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada","This work was funded by PT. Lautan Natural Krimerindo and supported by Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada (grant no. 014.PRJ/LNK-FKKMK UGM/III/2021).",,21,3,3,1,1,KOREAN SOC FOOD SCIENCE NUTRITION,BUSAN,"1010, 993, JUNGANG-DAERO, BUSANJIN-GU, BUSAN, 47209, SOUTH KOREA",2287-1098,2287-8602,,PREV NUTR FOOD SCI,Prev. Nutr. Food Sci.,JUN,2022,27,2,,,,,165,171,,10.3746/pnf.2022.27.2.165,http://dx.doi.org/10.3746/pnf.2022.27.2.165,,,7,Food Science & Technology; Nutrition & Dietetics,Emerging Sources Citation Index (ESCI),Food Science & Technology; Nutrition & Dietetics,F5RI9,35919567,"Green Published, hybrid",,,2024-06-04,WOS:000982913500003,View Full Record in Web of Science
J,"Haeuser, W; Layer, P; Henningsen, P; Kruis, W",,,,"Haeuser, Winfried; Layer, Peter; Henningsen, Peter; Kruis, Wolfgang",,,Functional Bowel Disorders in Adults,DEUTSCHES ARZTEBLATT INTERNATIONAL,,,English,Article,,,,,,,PRIMARY-CARE; POPULATION; DIAGNOSIS; IBS; CONSTIPATION; GUIDELINES; MANAGEMENT; THERAPIES; EFFICACY; FIBER,"Background: Chronic abdominal pain, bloating, constipation, diarrhea, and stool irregularity are common symptoms in primary care and gastroenterology. A routine diagnostic evaluation fails to reveal any underlying somatic condition in about half of the affected patients, who are therefore said to have a functional bowel disorder. Physicians are often unsure how extensive the work-up must be to exclude a somatic cause. Methods: This review is based on a selective review of the literature, including published guidelines from Germany and abroad. Results: Functional bowel disorders are diagnosed on the basis of a typical constellation of symptoms and the absence of pathological findings that would adequately explain them (exclusive criteria). The basic diagnostic assessment, consisting of a physical examination, basic laboratory tests, abdominal ultrasonography, and (in women) a gynecological examination, is supplemented by further testing that depends on the patient's symptoms. Colonoscopy is obligatory to rule out underlying pathological abnormalities. By communicating the diagnosis of irritable bowel syndrome to the patient, the physician shows that the patient's symptoms and concerns have been taken seriously. The mainstays of treatment are patient education on the benign course of the disease and the encouragement of a salubrious lifestyle. Further treatment options include dietary measures, time-limited symptomatic treatment with drugs, and psychotherapy. Conclusion: The diagnosis of a functional bowel disorder is based on a thorough history (positive criteria) and a small battery of diagnostic tests to exclude somatic disease. Both the diagnostic assessment and the treatment should be carried out in accordance with published guidelines.","[Kruis, Wolfgang] Univ Cologne, Evangel Krankenhauses Kalk, Abt Innere Med, D-51103 Cologne, Germany; [Haeuser, Winfried] Klinikum Saarbrucken, Med Klin 1, Saarbrucken, Germany; [Layer, Peter] Israelit Krankenhaus Hamburg, Med Klin, Hamburg, Germany; [Henningsen, Peter] Tech Univ Munich, Klin Psychosomat Med & Psychotherapie, D-8000 Munich, Germany",University of Cologne; Technical University of Munich,"Kruis, W (corresponding author), Univ Cologne, Evangel Krankenhauses Kalk, Abt Innere Med, Buchforststr 2, D-51103 Cologne, Germany.",wolfgang.kruis@googlemail.com,"Häuser, Winfried/KHD-2965-2024; Häuser, Winfried/AAX-6231-2021; Häuser, Winfried/AAH-6633-2021","Häuser, Winfried/0000-0002-3742-729X;",Eli Lilly; Falk Foundation; Abbott; Solvay; Shire; Norgine,Eli Lilly(Eli Lilly); Falk Foundation; Abbott(Abbott Laboratories); Solvay(Solvay SA); Shire; Norgine,"PD Dr. Hauser has received reimbursement of meeting participation fees and of travel and accomodation expenses from Eli Lilly and the Falk Foundation. He has received honoraria for the preparation of scientific continuing education events from Eli Lilly, the Falk Foundation, Mundipharma, Janssen-Cilag, and Pfizer.; Prof. Layer has received consulting fees from Abbott, Solvay, Shire, and Norgine. He has received reimbursement of travel and accommodation expenses from Shire and Norgine. He has received honoraria for the preparation of scientific continuing education events from Falk, Shire, Norgine, Abbott, Axcan, Boehringer, and Novartis. He has received payment for the performance of clinical trials on behalf of Axcan and Solvay.",,44,29,35,0,2,DEUTSCHER AERZTE-VERLAG GMBH,COLOGNE,"DIESELSTRABE 2, POSTFACH 400265, D-50859 COLOGNE, GERMANY",1866-0452,,,DTSCH ARZTEBL INT,Dtsch. Arztebl. Int.,FEB 3,2012,109,5,,,,,83,U41,,10.3238/arztebl.2012.0083,http://dx.doi.org/10.3238/arztebl.2012.0083,,,15,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,934SD,22368721,Green Published,,,2024-06-04,WOS:000303466000013,View Full Record in Web of Science
J,"Sumida, K; Dashputre, AA; Potukuchi, PK; Thomas, F; Obi, Y; Molnar, MZ; Gatwood, JD; Streja, E; Kalantar-Zadeh, K; Kovesdy, CP",,,,"Sumida, Keiichi; Dashputre, Ankur A.; Potukuchi, Praveen K.; Thomas, Fridtjof; Obi, Yoshitsugu; Molnar, Miklos Z.; Gatwood, Justin D.; Streja, Elani; Kalantar-Zadeh, Kamyar; Kovesdy, Csaba P.",,,Laxative Use and Change in Estimated Glomerular Filtration Rate in Patients With Advanced Chronic Kidney Disease,JOURNAL OF RENAL NUTRITION,,,English,Article,,,,,,,ACUTE PHOSPHATE NEPHROPATHY; IRRITABLE-BOWEL-SYNDROME; CHRONIC CONSTIPATION; DOUBLE-BLIND; BLOOD-PRESSURE; MORTALITY; DIALYSIS; BISACODYL; FAILURE; HEALTH,"Objectives: Constipation is highly prevalent in advanced chronic kidney disease (CKD), due in part to dietary (e.g., fiber) restrictions, and is often managed by laxatives; however, the effect of laxative use on kidney function in advanced CKD remains unclear. We aimed to examine the association of laxative use with longitudinal change in estimated glomerular filtration rate (eGFR) in patients with advanced CKD. Design and Methods: In a retrospective cohort of 43,622 US veterans transitioning to end-stage renal disease (ESRD) from 2007 to 2015, we estimated changes in eGFR (slope) by linear mixed-effects models using $2 available outpatient eGFR measurements during the 2-year period before transition to ESRD. The association of laxative use with change in eGFR was examined by testing the interaction of time-varying laxative use with time for eGFR slope in the mixed-effects models with adjustment for fixed and time-varying confounders. Results: Laxatives were prescribed in 49.8% of patients during the last 2-year pre-ESRD period. In the crude model, time-varying laxative use was modestly associated with more progressive eGFR decline compared with non-use of laxatives (median [interquartile interval] -7.1 [-11.9, -4.3] vs. -6.8 [-11.6, -4.0] mL/min/1.73 m2/year, P < .001). After multivariable adjustment, a faster eGFR decline associated with laxative use (vs. non-use of laxatives) remained statistically significant, although the between-group difference in eGFR slope was minimal (median [interquartile interval] -8.8 [-12.9, -5.9] vs. -8.6 [-12.6, -5.6] mL/min/1.73 m2/year, P < .001). The significant association was no longer evident across different types of laxatives (i.e., stool softeners, stimulants, or hyperosmotics). Conclusions: There was a clinically negligible association of laxative use with change in eGFR during the last 2-year pre-ESRD period, suggesting the renal safety profile of laxatives in advanced CKD patients. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","[Sumida, Keiichi; Dashputre, Ankur A.; Potukuchi, Praveen K.; Obi, Yoshitsugu; Molnar, Miklos Z.; Kovesdy, Csaba P.] Univ Tennessee, Div Nephrol, Dept Med, Hlth Sci Ctr, Memphis, TN USA; [Dashputre, Ankur A.; Potukuchi, Praveen K.] Univ Tennessee, Inst Hlth Outcomes & Policy, Coll Grad Hlth Sci, Hlth Sci Ctr, Memphis, TN USA; [Thomas, Fridtjof] Univ Tennessee, Div Biostat, Dept Prevent Med, Coll Med,Hlth Sci Ctr, Memphis, TN USA; [Molnar, Miklos Z.] Methodist Univ Hosp, James D Eason Transplant Inst, Memphis, TN USA; [Molnar, Miklos Z.] Univ Tennessee, Dept Surg, Div Transplant, Hlth Sci Ctr, Memphis, TN USA; [Molnar, Miklos Z.] Semmelweis Univ, Dept Transplantat & Surg, Budapest, Hungary; [Gatwood, Justin D.] Univ Tennessee, Hlth Sci Ctr, Dept Clin Pharm & Translat Sci, Coll Pharm, Nashville, TN USA; [Streja, Elani; Kalantar-Zadeh, Kamyar] Univ Calif Irvine, Div Nephrol & Hypertens, Harold Simmons Ctr Chron Dis Res & Epidemiol, Orange, CA USA; [Kovesdy, Csaba P.] Memphis VA Med Ctr, Nephrol Sect, 1030 Jefferson Ave, Memphis, TN 38104 USA",University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Semmelweis University; University of Tennessee System; University of Tennessee Health Science Center; University of California System; University of California Irvine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center,"Kovesdy, CP (corresponding author), Memphis VA Med Ctr, Nephrol Sect, 1030 Jefferson Ave, Memphis, TN 38104 USA.",ckovesdy@uthsc.edu,"Kalantar-Zadeh, Kamyar/Q-4734-2018; dashputre, ankur/U-9886-2017; Obi, Yoshitsugu/G-5764-2017","Kalantar-Zadeh, Kamyar/0000-0002-8666-0725; dashputre, ankur/0000-0003-0898-959X; Obi, Yoshitsugu/0000-0001-7032-4383; Thomas, Fridtjof/0000-0003-1325-4870","National Institute of Health [5U01DK102163]; Veterans Health Administration; Office of Research and Development; Health Services Research and Development; Veterans Affairs Information Resource Center [SDR 02-237, 98-004]; Department of Veterans Affairs",National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Health Administration(US Department of Veterans Affairs); Office of Research and Development; Health Services Research and Development; Veterans Affairs Information Resource Center; Department of Veterans Affairs(US Department of Veterans Affairs),"This study is supported by grant 5U01DK102163 from the National Institute of Health to K.K.Z. and C.P.K., and by resources from the U.S. Department of Veterans Affairs. The data reported here have been supplied in part by the United States Renal Data System. Support for Veterans Affairs/Centers for Medicare and Medicaid Services data are provided by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development, and Veterans Affairs Information Resource Center (Project Numbers SDR 02-237 and 98-004).",,50,8,9,0,1,W B SAUNDERS CO-ELSEVIER INC,PHILADELPHIA,"1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA",1051-2276,1532-8503,,J RENAL NUTR,J. Renal Nutr.,JUL,2021,31,4,,,,,361,369,,10.1053/j.jrn.2020.08.005,http://dx.doi.org/10.1053/j.jrn.2020.08.005,,JUN 2021,9,Nutrition & Dietetics; Urology & Nephrology,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics; Urology & Nephrology,TD0MG,32952006,"Green Accepted, Green Submitted",,,2024-06-04,WOS:000669029700005,View Full Record in Web of Science
J,"SUZUKI, M; SATO, A",,,,"SUZUKI, M; SATO, A",,,NUTRITIONAL SIGNIFICANCE OF CYCLODEXTRINS - INDIGESTIBILITY AND HYPOLIPEMIC EFFECT OF ALPHA-CYCLODEXTRIN,JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY,,,English,Article,,,,,,,,"Digestibility of .alpha.- and .beta.-cyclodextrin (cD) and nutritional consequences of .alpha.-CD and a CD mixture (n-dextrin, .alpha.-, .beta.- and .gamma.-CD = 50, 30, 15 and 5% by wt) were investigated in rats. In contrast with .beta.-CD, .alpha.-CD was indigestible. Growing rats were fed on diets supplemented with the CD mixture at 19.5, 39, 58.5 and 78% levels for 110 days, resulting in smaller wt gain and body fat deposition when they were fed on a higher CD diet. Rats of wt loss during the restricted feeding were faster in rats fed on a higher CD diet. These were due to food efficiency lowered by CD. Reduced serum and liver triacylglycerol (TG) levels were noted during a 110-day period of feeding of the CD diets; the former was revealed due to a reduced hepatic-intestinal TG secretion rate. Rats fed on a 78% CD diet, which contained .alpha.-CD at the 24% level, showed abnormal symptoms such as poor appetite and constipation with gas accumulation in the large intestine. Some of them died during the first 2-wk feeding period. The surviving animals showed adaptation to the diet in the later period of the 110-day feeding. .alpha.-CD may evidently be classified as dietary fiber which can modulate lipid metabolism in rats. The CD mixture may be available as a calorie substitute for wt control, which may owe mostly to .alpha.-CD.","UNIV TSUKUBA, INST HLTH & SPORTS SCI, BIOCHEM EXERCISE & NUTR LAB, SAKURA, IBARAKI 305, JAPAN",,,,,,,,,,15,36,47,0,1,CENTER ACADEMIC PUBL JAPAN,TOKYO,"2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN",0301-4800,1881-7742,,J NUTR SCI VITAMINOL,J. Nutr. Sci. Vitaminol.,,1985,31,2,,,,,209,223,,,,,,15,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,AJS74,4032075,gold,,,2024-06-04,WOS:A1985AJS7400009,View Full Record in Web of Science
J,"MacIntosh, A; Heenan, PE; Wright-McNaughton, M; Frampton, C; Skidmore, P; Wall, CL; Muir, J; Talley, NJ; Roy, NC; Gearry, RB",,,,"MacIntosh, Alice; Heenan, Phoebe E.; Wright-McNaughton, Morag; Frampton, Chris; Skidmore, Paula; Wall, Catherine L.; Muir, Jane; Talley, Nicholas Joseph; Roy, Nicole Clemence; Gearry, Richard B.",,,The relationship between fermentable carbohydrates and post-prandial bowel symptoms in patients with functional bowel disorders,FRONTIERS IN NUTRITION,,,English,Article,,,,,,FODMAP; functional bowel disorder; fiber; post-prandial bowel symptoms; diet; gastrointestinal symptom; irritable bowel syndrome,FOOD-FREQUENCY QUESTIONNAIRES; COMMON AUSTRALIAN VEGETABLES; LOW FODMAP DIET; GASTROINTESTINAL SYMPTOMS; FRUCTOSE; INDIVIDUALS; EFFICACY,"Background and aimsA low fermentable oligosaccharide, disaccharide, monosaccharide, and polyols (FODMAP) diet alleviates symptoms of irritable bowel syndrome (IBS). We aimed to investigate the relationship between habitual FODMAP intake and post-prandial bowel symptoms in adults with IBS, functional diarrhoea (FD), or constipation (FD) (functional bowel disorders), and in healthy adults (controls). Methods292 participants (173 with functional bowel disorders and 119 controls) completed a food and symptom times diary. Estimated meal portion sizes were entered into the Monash FODMAP Calculator to analyse FODMAP content. Wilcoxon and ANOVA tests were used to investigate the relationship between FODMAP intake and post-prandial bowel symptoms. ResultsIBS participants experienced more post-prandial bowel symptoms compared to participants with other functional bowel disorders or controls. Meals associated with abdominal pain contained on average increased excess fructose (0.31 g vs. 0.18 g, p < 0.05), sorbitol (0.27 g vs. 0.10 g, p < 0.01), and total FODMAP (3.46 g vs. 2.96 g, p < 0.05) compared to meals not associated with pain. Abdominal swelling was associated with increased sorbitol (0.33 g vs. 0.11 g, p < 0.01), and total FODMAP (3.26 g vs. 3.02 g, p < 0.05) consumption. Abdominal bloating was associated with increased galacto oligosaccharide consumption (0.18 g vs. 0.14 g, p < 0.05). ConclusionThese findings support the role of FODMAP in post-prandial bowel symptom onset, however, the amount and type of FODMAP triggering symptoms vary between individuals. Future research should investigate the relationship between the effect of individual FODMAP consumption on post-prandial bowel symptoms for each subtype, the interaction of FODMAP with differing functional bowel disorders and whether longitudinally symptoms and dietary intake are stable.","[MacIntosh, Alice; Wright-McNaughton, Morag; Skidmore, Paula; Roy, Nicole Clemence] Univ Otago, Dept Human Nutr, Dunedin, New Zealand; [Heenan, Phoebe E.; Frampton, Chris; Wall, Catherine L.; Gearry, Richard B.] Univ Otago, Dept Med, Christchurch, New Zealand; [Heenan, Phoebe E.; Wall, Catherine L.; Roy, Nicole Clemence; Gearry, Richard B.] Univ Auckland, High Value Nutr Natl Sci Challenge, Liggins Inst, Auckland, New Zealand; [Muir, Jane] Monash Univ, Dept Gastroenterol, Melbourne, Vic, Australia; [Talley, Nicholas Joseph] Univ Newcastle, Sch Med, Newcastle, NSW, Australia; [Talley, Nicholas Joseph] Univ Newcastle, NHMRC Ctr Res Excellence Digest Hlth, Newcastle, NSW, Australia; [Roy, Nicole Clemence] Riddet Inst, Palmerston North, New Zealand",University of Otago; University of Otago; University of Auckland; Monash University; University of Newcastle; University of Newcastle,"Gearry, RB (corresponding author), Univ Otago, Dept Med, Christchurch, New Zealand.;Gearry, RB (corresponding author), Univ Auckland, High Value Nutr Natl Sci Challenge, Liggins Inst, Auckland, New Zealand.",richard.gearry@cdhb.health.nz,"Gearry, Richard B/H-3959-2019","Gearry, Richard B/0000-0002-2298-5141","Ministry of Business, Innovation and Employment in New Zealand [UOAX1902]; National Health and Medical Research Foundation of Australia; Department of Gastroenterology at Monash University; New Zealand Ministry of Business, Innovation & Employment (MBIE) [UOAX1902] Funding Source: New Zealand Ministry of Business, Innovation & Employment (MBIE)","Ministry of Business, Innovation and Employment in New Zealand(New Zealand Ministry of Business, Innovation and Employment (MBIE)); National Health and Medical Research Foundation of Australia(National Health & Medical Research Council (NHMRC) of Australia); Department of Gastroenterology at Monash University; New Zealand Ministry of Business, Innovation & Employment (MBIE)(New Zealand Ministry of Business, Innovation and Employment (MBIE))","The Christchurch cohort to investigate Mechanisms For gut Relief and improved Transit (COMFORT) study is a part of the Healthy Digestion Priority Research Programme of the High-Value Nutrition National Science Challenge funded by the Ministry of Business, Innovation and Employment in New Zealand (UOAX1902). PH received financial support (stipends and tuition fee) from the same grant. The clinical study team was based out of the University of Otago, Christchurch Department of Medicine in Christchurch, New Zealand. JM was supported by a Research Fellowship from the National Health and Medical Research Foundation of Australia. Funds raised contribute to the research of the Department of Gastroenterology at Monash University.",,49,2,2,1,9,FRONTIERS MEDIA SA,LAUSANNE,"AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND",2296-861X,,,FRONT NUTR,Front. Nutr.,FEB 2,2023,10,,,,,,,,1060928,10.3389/fnut.2023.1060928,http://dx.doi.org/10.3389/fnut.2023.1060928,,,9,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,8Z5IU,36819701,"Green Published, gold",,,2024-06-04,WOS:000933412500001,View Full Record in Web of Science
J,"Tan, YM; Goh, KL; Muhidayah, R; Ooi, CL; Salem, O",,,,"Tan, YM; Goh, KL; Muhidayah, R; Ooi, CL; Salem, O",,,Prevalence of irritable bowel syndrome in young adult Malaysians: A survey among medical students,JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY,,,English,Article,,,,,,Asian; irritable bowel syndrome; prevalence; Rome criteria,HEALTH-CARE SEEKING; PSYCHOSOCIAL FACTORS; POPULATION; DISORDERS; SYMPTOMS; DYSFUNCTION; OUTPATIENTS,"Background and Aims: Irritable bowel syndrome (IBS) is a common functional bowel disease in the West. Information on the prevalence of IBS in the Asian population is relatively scanty. The aims of the present study were to determine the prevalence of IBS and to assess the symptom subgroups based on the predominant bowel habit in a young adult population of Asian origin. Methods: Basic demographic data and symptoms of IBS using the Rome I criteria were sought using a questionnaire administered to all apparently healthy students in a medical school. Other questions asked related to alcohol intake, smoking, chili consumption, dietary fiber intake, and to psychological and psychosomatic symptoms of anxiety, depression, insomnia, headache, and backache. The health-care seeking behavior of the subjects was also analyzed. Results: Of the 610 questionnaires administered, 533 complete responses were received (response rate of 87.4%). The responders comprised 229 men (43.0%) and 304 (57.0%) women with a mean age of 22 +/- 1.8 years. The ethnic distribution was Malays 278 (52.2%), Chinese 179 (33.6%), Indians 46 (8.6%), and others 30 (5.6%). Eighty-four (15.8%) reported symptoms consistent with the diagnosis of IBS, predominantly women. Sixty-five (77.4%) and six (7.1%) were of the constipation-predominant and diarrhea-predominant IBS subgroups, respectively. Thirteen (15.5%) subjects fell into the non-specific IBS subgroup. The self-reported psychological and psychosomatic symptoms of anxiety (P = 0.02), depression (P = 0.002), insomnia (P = 0.006), headache (P = 0.04), and backache (P = 0.006) were encountered more frequently in the subjects with IBS. Only 13.1% of the IBS group had consulted their health-care practitioner, and 20.2% reported self-medication. Conclusions: Symptoms supportive of the diagnosis of IBS were common among young Malaysians, with a prevalence rate of 15.8%. There were significantly more women with IBS than men. Within the IBS population, the majority (77.4%) was of the constipation-predominant IBS subgroup. A significantly higher prevalence of psychological and psychosomatic symptoms was found in individuals with IBS. Only a minority sought medical advice for their symptoms. (C) 2003 Blackwell Publishing Asia Pty Ltd.","Univ Malaya, Fac Med, Dept Med, Kuala Lumpur 59100, Malaysia",Universiti Malaya,"Tan, YM (corresponding author), Univ Malaya, Fac Med, Dept Med, Kuala Lumpur 59100, Malaysia.",,"OMAR, A/P DR.SALEM/B-9677-2010; Goh, Khean-Lee/B-6404-2009","Goh, Khean-Lee/0000-0002-9965-1561",,,,,23,79,82,0,4,BLACKWELL PUBLISHING ASIA,CARLTON,"54 UNIVERSITY ST, P O BOX 378, CARLTON, VICTORIA 3053, AUSTRALIA",0815-9319,,,J GASTROEN HEPATOL,J. Gastroenterol. Hepatol.,DEC,2003,18,12,,,,,1412,1416,,10.1046/j.1440-1746.2003.03212.x,http://dx.doi.org/10.1046/j.1440-1746.2003.03212.x,,,5,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,745QA,14675271,,,,2024-06-04,WOS:000186698300013,View Full Record in Web of Science
J,"Han, YR; Ali, MY; Woo, MH; Jung, HA; Choi, JS",,,,"Han, Yu Ran; Ali, Md Yousof; Woo, Mi-Hee; Jung, Hyun Ah; Choi, Jae Sue",,,Anti-Diabetic and Anti-Inflammatory Potential of the Edible Brown Alga Hizikia Fusiformis,JOURNAL OF FOOD BIOCHEMISTRY,,,English,Article,,,,,,,NITRIC-OXIDE SYNTHASE; EISENIA-BICYCLIS; ANTIOXIDANT PROPERTIES; TYROSINE NITRATION; ALPHA-GLUCOSIDASE; SUPEROXIDE ANION; MACULA DENSA; IN-VITRO; KAPPA-B; PEROXYNITRITE,"Hizikia fusiformis, an edible brown alga, is found abundantly in Korea, Japan and China. We investigated the methanolic (MeOH) extract of H.fusiformis and its different fractions for anti-diabetic and anti-inflammatory activity. Of these, the CH2Cl2 and EtOAc fractions exhibited remarkable inhibitory activities against ONOO- free radicals, PTP1B and -glucosidase. Repeated column chromatography based on bioactivity-guided fractionation yielded fucosterol and fucoxanthin from the CH2Cl2 fraction and these two compounds inhibited tyrosine nitration in a dose-dependent manner. Furthermore, the CH2Cl2 fraction inhibited nitric oxide production and significantly suppressed expression of inducible nitric oxide synthase (iNOS) protein, whereas the EtOAc fraction effectively inhibited t-butyl hydroperoxide (t-BHP)-induced generation of reactive oxygen species in RAW 264.7 cells. The results demonstrate the potential anti-diabetic and anti-inflammatory activities of H.fusiformis. Practical ApplicationsHizikia fusiformis has been used as a health food for hundreds of years in northwest Pacific areas. It is well known for its distinctive flavor and high content of calcium, vitamin A, inorganic salt, iodine and dietary fiber, all of which enable prevention of various diseases including diabetes, high blood pressure, colorectal cancer, constipation, thyroid cancer and beriberi. Modern research has suggested its potential for treatment of arteriosclerosis and osteoporosis. The findings of this study demonstrate the anti-diabetic and anti-inflammatory activities of the methanolic (MeOH) extracts of H.fusiformis and supports use of this seaweed as a functional food and a potential anti-diabetic.","[Han, Yu Ran; Ali, Md Yousof; Choi, Jae Sue] Pukyong Natl Univ, Dept Food & Life Sci, Busan 608737, South Korea; [Woo, Mi-Hee] Catholic Univ Daegu, Coll Pharm, Gyongsan 712702, South Korea; [Jung, Hyun Ah] Chonbuk Natl Univ, Dept Food Sci & Human Nutr, Jeonju 561756, South Korea",Pukyong National University; Catholic University of Daegu; Jeonbuk National University,"Choi, JS (corresponding author), Pukyong Natl Univ, Dept Food & Life Sci, Busan 608737, South Korea.",choijs@pknu.ac.kr,,"Ali, Md Yousof/0000-0003-1488-5711",Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education [2012R1A6A1028677]; Regional Innovation Center (RIC) Program of the Ministry of Knowledge and Economy [RIC-B-0009046],Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education; Regional Innovation Center (RIC) Program of the Ministry of Knowledge and Economy,This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) and by the Ministry of Education (2012R1A6A1028677) and supported by the Regional Innovation Center (RIC) Program of the Ministry of Knowledge and Economy (RIC-B-0009046).,,79,27,28,0,44,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0145-8884,1745-4514,,J FOOD BIOCHEM,J. Food Biochem.,AUG,2015,39,4,,,,,417,428,,10.1111/jfbc.12138,http://dx.doi.org/10.1111/jfbc.12138,,,12,Biochemistry & Molecular Biology; Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Food Science & Technology,CN3NN,,gold,,,2024-06-04,WOS:000358333700008,View Full Record in Web of Science
J,"Aranceta, JA",,,,"Aranceta, JA",,,Fruits and vegetables.,ARCHIVOS LATINOAMERICANOS DE NUTRICION,,,Spanish,Article,,,,,,fruit; vegetables; food pattern; food preferences,CANCER PREVENTION,"Fruits and vegetables. Fruits and vegetables are particularly interesting for health for their content in minerals, antioxidant vitamins, phytochemicals and dietary fiber. All these substances are related to lower risk for the development of health probems, such as certain types of cancer, cardiovascular diseases. type 2 diabetes, obesity, constipation or diverticolsys.The sound basis of scientific evidence led European and American scientific organizations and societies to recommend an intake up to 150-200 g of vegetables every day; ie. 2 or more portions daily and 3 or more portions of fruits five portions of fruit andvegetables all together. According to the consumer panel from the Spanish Ministry of Agriculture, Fisheries and Food, between the late 80s and the end of the 90s, consumption of fruit and vegetables decreased. However, in late years this trend has slow down and even reversed. Results from food consumption studies based on individual level assessment in Spain estimate an average consumption of fruit and vegetables of 154 g/per person/day in adults aged 25- 60 yr. Prevalence of inadequate intake of fruit and vegetables is high among children and young people. In this age group above 70% of the population consume less than 3 portions of fruit every day on average. Reorientation of prevailing food patterns nowadays require investment in measures aimed at increasing the consumption of plant foods and estimulate healthy food habits in families.",,,,,"Aranceta, Javier/F-1740-2013","Aranceta Bartrina, Javier/0000-0002-5666-7328",,,,,33,8,9,2,16,ARCHIVOS LATINOAMERICANOS NUTRICION,CARACAS,"APARTADO 62778 CHACAO, AVENIDA FRANCISCO MIRANDA, CARACAS 1060, VENEZUELA",0004-0622,,,ARCH LATINOAM NUTR,Arch. Latinoam. Nutr.,JUN,2004,54,2,,1,,,65,71,,,,,,7,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,869LI,15584475,,,,2024-06-04,WOS:000224984400010,View Full Record in Web of Science
J,"Weber, MP; Biourge, VC; Nguyen, PG",,,,"Weber, M. P.; Biourge, V. C.; Nguyen, P. G.",,,Digestive sensitivity varies according to size of dogs: a review,JOURNAL OF ANIMAL PHYSIOLOGY AND ANIMAL NUTRITION,,,English,Review,,,,,,canine; large breed dogs; small breed dogs; fermentation; faecal quality; nutrition,INTESTINAL TRANSIT-TIME; ACID BREATH TEST; BODY-SIZE; HEALTHY DOGS; DIETARY FIBER; FECAL QUALITY; IN-VITRO; FERMENTATIVE ACTIVITY; CARBOHYDRATE SOURCES; RADIOPAQUE MARKERS,"Field observations on food tolerance have repeatedly shown that when fed an identical diet, large breed (> 25 kg) dogs present softer and moister faeces than small breed ones (<15 kg). The purpose of this review is to highlight the findings of four PhD theses, carried out between 1998 and 2013, whose objectives were to investigate the anatomical and physiological peculiarities that would explain, at least in part, this observation, as well as their nutritional implication. This work showed that large breed dogs, in contrast with smaller breeds, present a highly developed caecum and colon, which could explain the relatively longer colonic transit time. A prolonged colonic transit time could explain higher colonic fermentative activity, as supported by higher faecal concentrations of fermentative by-products. This effect would be reinforced by increased intestinal permeability and reduced sodium net-absorption. Taken together, these elements could be a possible cause of higher digestive sensitivity in large breed dogs. When prescribing a diet to a small or large breed dog, several aspects of the formulation must be taken into account. For a large breed dog, the general goal is to limit any ingredient that could increase the level of fermentable undigested residues and, in fine, exacerbate colonic fermentation. Highly digestible sources of proteins and starches are therefore strongly recommended to maintain an optimal digestive tolerance. Fermentable fibre sources (i.e. beet pulp and FOS) must also be used in limited quantity in their diet. Conversely, the incorporation of non-fermentable fibre (i.e. cellulose) appears useful to increase their stool quality. For a small breed dog, the general objective is to minimize any ingredient that could excessively limit colonic fermentation and induce in fine constipation. Purified starches and cellulose are therefore not really suitable for them. In contrast, cereals flours as well as non-fermentable fibre provided by cereals are recommended.","[Weber, M. P.; Biourge, V. C.] Royal Canin Res Ctr, Ave Petite Camargue, F-30470 Aimargues, France; [Nguyen, P. G.] LUNAM Univ, Endocrinol & Nutr Unit, Oniris, Natl Coll Vet Med Food Sci & Engn, Nantes, France","Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique","Weber, MP (corresponding author), Royal Canin Res Ctr, Ave Petite Camargue, F-30470 Aimargues, France.",mickael.weber@royalcanin.com,,,,,,,61,19,20,1,33,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0931-2439,1439-0396,,J ANIM PHYSIOL AN N,J. Anim. Physiol. Anim. Nutr.,FEB,2017,101,1,,,,,1,9,,10.1111/jpn.12507,http://dx.doi.org/10.1111/jpn.12507,,,9,"Agriculture, Dairy & Animal Science; Veterinary Sciences",Science Citation Index Expanded (SCI-EXPANDED),Agriculture; Veterinary Sciences,EO7UT,27045769,hybrid,,,2024-06-04,WOS:000396896300001,View Full Record in Web of Science
J,"Munck, A; Alberti, C; Colombo, C; Kashirskaya, N; Ellemunter, H; Fotoulaki, M; Houwen, R; Robberecht, E; Boizeau, P; Wilschanski, M",,,,"Munck, Anne; Alberti, Corinne; Colombo, Carla; Kashirskaya, Nataliya; Ellemunter, Helmut; Fotoulaki, Maria; Houwen, Roderick; Robberecht, Eddy; Boizeau, Priscilla; Wilschanski, Michael",,CF Pancreas ESPGHAN Working Grp; DIOS Study Grp,International prospective study of distal intestinal obstruction syndrome in cystic fibrosis: Associated factors and outcome,JOURNAL OF CYSTIC FIBROSIS,,,English,Article,,,,,,Cystic fibrosis; Abdominal pain; Distal intestinal obstruction syndrome; Incidence,DIETARY FIBER; MECONIUM ILEUS; MANAGEMENT; DIAGNOSIS,"Background: Distal intestinal obstruction syndrome (DIOS) is a specific complication of cystic fibrosis. Methods: A study was performed in 10 countries to prospectively evaluate the incidence, associated factors, and treatment modalities in children and adults. Results: 102 patients presented 112 episodes. The incidence of DIOS was similar in children and adults. Medical treatment failed only in cases of complete DIOS (11%). Children with meconium ileus had a higher rate of surgery for DIOS (15% vs. 2%, p = 0.02). Complete DIOS entailed longer hospitalisation (4 [3; 7] days vs. 3 [1; 4], p = 0.002). Delayed arrival at hospital and prior weight loss had a significant impact on the time needed for DIOS resolution. Associated CF co-morbidities for DIOS included meconium ileus (40% vs. 18%, p < 0.0001), exocrine pancreatic insufficiency (92% vs. 84%, p = 0.03), liver disease (22% vs. 12%, p = 0.004), diabetes mellitus (49% vs. 25%, p = 0.0003), and Pseudomonas aeruginosa (68% vs. 52%, p = 0.01); low fibre intake and insufficient hydration were frequently observed. Female gender was associated with recurrent DIOS (75% vs. 52%, p = 0.04), constipation with incomplete episodes (39% vs. 11%, p = 0.03), and poor patient compliance in taking pancreatic enzyme therapy during complete episodes (25% vs. 3%, p = 0.02). Conclusion: DIOS is a multifactorial condition having a similar incidence in children and adults. We show that delayed arrival at hospital after the initial symptoms causes significant morbidity. Early recognition and treatment would improve the prognosis. 2016 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.","[Munck, Anne] Univ Paris 07, CF Ctr, Paediat Gastroenterol & Resp Dept, Hop Robert Debre, 48 Blvd Serurier, F-75019 Paris, France; [Alberti, Corinne; Boizeau, Priscilla] Hop Robert Debre, Clin Epidemiol Unit, F-75019 Paris, France; [Alberti, Corinne] Univ Paris Diderot, Sorbonne Paris Cite, ECEVE, UMR S1123, F-75019 Paris, France; INSERM, U1123, F-75019 Paris, France; [Alberti, Corinne] CIC EC 1426, F-75019 Paris, France; [Colombo, Carla] Univ Milan, Osped Maggiore Policlin, Fdn IRCCS CaGranda, Milan, Italy; [Kashirskaya, Nataliya] Med Genet Res Ctr, Fed State Budgetary Inst, Moscow, Russia; [Ellemunter, Helmut] Med Univ Innsbruck, Innsbruck, Austria; [Fotoulaki, Maria] Univ Thessaloniki, Thessaloniki, Greece; [Houwen, Roderick] Univ Med Ctr, Wilhelmina Childrens Hosp, Utrecht, Netherlands; [Robberecht, Eddy] Univ Hosp, Ghent, Belgium; [Wilschanski, Michael] Hadassah Hebrew Univ, Med Ctr, Jerusalem, Israel",Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Robert-Debre - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite; Hopital Universitaire Robert-Debre - APHP; Universite Paris Cite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Research Centre for Medical Genetics; Medical University of Innsbruck; Aristotle University of Thessaloniki; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Ghent University; Ghent University Hospital; Hebrew University of Jerusalem; Hadassah University Medical Center,"Munck, A (corresponding author), Univ Paris 07, CF Ctr, Paediat Gastroenterol & Resp Dept, Hop Robert Debre, 48 Blvd Serurier, F-75019 Paris, France.",anne.munck@rdb.aphp.fr,"Colombo, Carla/J-9777-2018; Houwen, Roderick/HMW-0094-2023; Kashirskaya, Nataliya Y/C-6404-2012; corinne, alberti/HZJ-4687-2023","Kashirskaya, Nataliya Y/0000-0003-0503-6371; Boizeau, Priscilla/0000-0003-4573-4617; ALBERTI, Corinne/0000-0002-9336-1395; Fotoulaki, Maria/0000-0003-1389-3912",French Cystic Fibrosis Foundation Vaincre La Mucoviscidose [10RC1017]; Swiss Cystic Fibrosis Society (CFCH),French Cystic Fibrosis Foundation Vaincre La Mucoviscidose; Swiss Cystic Fibrosis Society (CFCH),Grant support: Supported by the French Cystic Fibrosis Foundation Vaincre La Mucoviscidose (grant no 10RC1017) and the Swiss Cystic Fibrosis Society (CFCH).,,30,40,43,0,4,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",1569-1993,1873-5010,,J CYST FIBROS,J. Cyst. Fibros,JUL,2016,15,4,,,,,531,539,,10.1016/j.jcf.2016.02.002,http://dx.doi.org/10.1016/j.jcf.2016.02.002,,,9,Respiratory System,Science Citation Index Expanded (SCI-EXPANDED),Respiratory System,DU6US,26927601,hybrid,,,2024-06-04,WOS:000382350700020,View Full Record in Web of Science
J,"Chong, SKF",,,,"Chong, SKF",,,Gastrointestinal problems in the handicapped child,CURRENT OPINION IN PEDIATRICS,,,English,Review,,,,,,,PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; ESOPHAGEAL SPHINCTER RELAXATIONS; HELICOBACTER-PYLORI INFECTION; GASTROESOPHAGEAL-REFLUX; CEREBRAL-PALSY; DIETARY FIBER; NISSEN FUNDOPLICATION; CHRONIC CONSTIPATION; HIGH PREVALENCE; SPINAL-CORD,"Gastrointestinal issues are a major chronic problem in 80 to 90% of children with cerebral palsy and in children with neurodevelopmental disabilities who are at special risk of developing malnutrition because of uncoordinated swallowing, gastroesophageal reflux, and constipation. In addition to poor linear growth, there is a decrease in muscle strength and coordination, impaired cerebral function leading to decreased motivation and energy, Significant neurodevelopmental progress can be achieved with improved nutritional status. A multidisciplinary approach, with input from neurologists, gastroenterologists, nurses, occupational therapists, and dieticians, can make a major contribution to the medical wellbeing and quality of life of these children. Different neurological diseases (eg, spinal dysraphism, syringomyelia, tethered cord syndromes) can give rise to gastrointestinal dysfunction and symptoms that may need different gastrointestinal or surgical management. The introduction of new drugs, including proton pump inhibitors and innovative endoscopic and surgical techniques in the management of gastroesophageal reflux disease and constipation also may have an impact on the treatment of neurologically handicapped children in the future. Curr Opin Pediatr 2001, 13:441-446 (C) 2001 Lippincott Williams & Wilkins, Inc.","Queen Marys Hosp Children, Epson & St Helier NHS Trust, Carshalton SM5 1AA, Surrey, England",,"Queen Marys Hosp Children, Epson & St Helier NHS Trust, Wrythe Lane, Carshalton SM5 1AA, Surrey, England.",Schong@sthelier.sghms.ac.uk,,,,,,,59,40,45,0,4,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",1040-8703,1531-698X,,CURR OPIN PEDIATR,CURR. OPIN. PEDIATR.,OCT,2001,13,5,,,,,441,446,,10.1097/00008480-200110000-00010,http://dx.doi.org/10.1097/00008480-200110000-00010,,,6,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,498GY,11801890,,,,2024-06-04,WOS:000172502500010,View Full Record in Web of Science
J,"Uyar, GÖ; Yildiran, H",,,,"Uyar, Gizem Ozata; Yildiran, Hilal",,,A nutritional approach to microbiota in Parkinson's disease,BIOSCIENCE OF MICROBIOTA FOOD AND HEALTH,,,English,Review,,,,,,Parkinson's disease; alpha-synuclein; microbiota; nutrition; probiotics; gut-brain axis,GUT-BRAIN AXIS; HELICOBACTER-PYLORI; INTESTINAL PERMEABILITY; STRUCTURAL-CHANGES; DIETARY PATTERNS; DOUBLE-BLIND; POLYPHENOLS; PROBIOTICS; FIBER; PREBIOTICS,"Parkinson's disease (PD) is a neurodegenerative disease characterized by motor impairment and the accumulation of alpha-synucleinopathy (alpha-syn), which can affect different levels of the brain-gut axis. There is a two-way communication between the gastrointestinal tract, and brain that includes the gut microbiota. This bidirectional communication between the gut microbiota and the brain includes many pathways, such as immune mechanisms, the vagus nerve, and microbial neurometabolite production. The common cause of constipation in PD is thought to be the accumulation of alpha-syn proteins in the enteric nervous system. Recent studies have focused on changes in microbial metabolites and gut microbiota dysbiosis. Microbiota dysbiosis is associated with increased intestinal permeability, intestinal inflammation, and neuroinflammation. Many factors, such as unbalanced nutrition, antibiotic use, age, and infection, result in alteration of microbial metabolites, triggering alpha-syn accumulation in the intestinal mucosa cells. Increased evidence indicates that the amount, type, and balance of dietary macronutrients (carbohydrates, proteins, and fats); high consumption of vegetables, fruits, and omega-3 fatty acids; and healthy diet patterns such as the Mediterranean diet may have a great protective impact on PD. This review focuses on the potential benefits of prebiotics, probiotics, and synbiotics to regulate microbiota dysbiosis along with the effect of diet on the gut microbiota in PD.","[Uyar, Gizem Ozata; Yildiran, Hilal] Gazi Univ, Fac Hlth Sci, Dept Nutr & Dietet, Ankara, Turkey",Gazi University,"Uyar, GÖ (corresponding author), Gazi Univ, Fac Hlth Sci, Dept Nutr & Dietet, Ankara, Turkey.",gizemozata91@gmail.com,"YILDIRAN, HİLAL/AID-4577-2022; ÖZATA UYAR, Gizem/AED-0847-2022","ÖZATA UYAR, Gizem/0000-0002-9022-6956",,,,,142,25,26,2,18,BMFH PRESS,TOKYO,"ATTN-BMFH, EDITORIAL OFF IPEC INC, 1-24-12 SUGAMO,TOSHIMA-KU, TOKYO, 170-0002, JAPAN",2186-6953,2186-3342,,BIOSCI MICROB FOOD H,Biosci. Microbiota Food Health,,2019,38,4,,,,,115,127,,10.12938/bmfh.19-002,http://dx.doi.org/10.12938/bmfh.19-002,,,13,Microbiology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Microbiology; Nutrition & Dietetics,JI5YS,31763115,"Green Published, gold",,,2024-06-04,WOS:000493544100001,View Full Record in Web of Science
J,"Hitl, M; Gavaric, N; Kladar, N; Brkic, S; Samojlik, I; Dragovic, G; Bozin, B",,,,"Hitl, Maja; Gavaric, Neda; Kladar, Nebojsa; Brkic, Snezana; Samojlik, Isidora; Dragovic, Gordana; Bozin, Biljana",,,"Herbal preparations use in prevention and treatment of gastrointestinal and hepatic disorders-Data from Vojvodina, Serbia",COMPLEMENTARY THERAPIES IN MEDICINE,,,English,Article,,,,,,Herbal medicines; Efficacy; Safety; Gastrointestinal diseases,ALTERNATIVE MEDICINE USE; TRADITIONAL USE; COMPLEMENTARY; PLANTS,"Objective: Gastrointestinal (GI) disorders are estimated to be frequent among general population. Various types of traditional and complementary therapies, primarily phytotherapy, can be used for prevention and treatment of many diseases and conditions, including GI complaints. Thus, the aim of this study was to investigate the patterns of use of medicinal herbs in treatment and prevention of GI disorders, together with their efficacy and safety. Methods: A prospective, repeated cross-sectional, descriptive study was conducted in the form of a specifically created questionnaire, filled in by consumers and/or patients in pharmacies on the territory of Autonomous Province of Vojvodina, Republic of Serbia. All data were statistically analyzed in Microsoft Excel 2007. Results: In the total number of 1137 patients, 10.4% declared themselves as consumers of phytopreparations for GI disorders. The most common diseases were constipation (44%) and dyspepsia (23%). The most frequently used preparations contained laxatives (with both anthraquinones and dietary fibers), artichoke and silymarin. Iberogast (R) was also frequently used. Pharmacists were the main source of recommendation for the most adequate herbal remedies. At the same time, phytopreparations were well tolerated, with no major side effects, and were evidently or presumably effective. Conclusions: Some mild and moderate GI disorders seem to be treated frequently with phytopreparatons. Various herbal remedies are well accepted by patients, and the phytopreparations seem to have favorable ratio of safety and efficacy. Further integration into conventional medicine will improve the quality of the products used and provide a rational plan of use of medicinal plants.","[Hitl, Maja; Gavaric, Neda; Kladar, Nebojsa; Bozin, Biljana] Univ Novi Sad, Fac Med, Dept Pharm, Hajduk Veljkova 3, Novi Sad 21000, Serbia; [Brkic, Snezana] Univ Novi Sad, Fac Med, Dept Infect Dis, Hajduk Veljkova 3, Novi Sad 21000, Serbia; [Brkic, Snezana] Clin Ctr Vojvodina, Clin Infect Dis, Novi Sad 21000, Serbia; [Samojlik, Isidora] Univ Novi Sad, Fac Med, Dept Pharmacol Toxicol & Clin Pharmacol, Hajduk Veljkova 3, Novi Sad 21000, Serbia; [Dragovic, Gordana] Univ Belgrade, Sch Med, Deportment Pharmacol Clin Pharmacol & Toxicol, Dr Subotica 1-3, Belgrade 11000, Serbia",University of Novi Sad; University of Novi Sad; University of Novi Sad; University of Belgrade,"Hitl, M (corresponding author), Univ Novi Sad, Fac Med, Dept Pharm, Hajduk Veljkova 3, Novi Sad 21000, Serbia.",maja.belcut@mf.uns.ac.rs; neda.gavaric@mf.uns.ac.rs; nebojsa.kladar@mf.uns.ac.rs; snezana.brkic@mf.uns.ac.rs; isidora.samojlik@mf.uns.ac.rs; gordana.dragovic@med.bg.ac.rs; biljana.bozin@mf.uns.ac.rs,"Dragović, Gordana/AAQ-1944-2020; Kladar, Nebojša/AAY-7849-2020","Kladar, Nebojša/0000-0001-5781-6412; Bozin, Biljana/0000-0002-4018-3337; Hitl, Maja/0000-0002-7612-4785; Dragovic, Gordana/0000-0002-0438-0309; Samojlik, Isidora/0000-0002-1081-6666","Ministry of Education, Science and Technological Development, Republic of Serbia [OI 172058]","Ministry of Education, Science and Technological Development, Republic of Serbia","This work was supported by The Ministry of Education, Science and Technological Development, Republic of Serbia (grant number OI 172058).",,36,5,5,1,4,CHURCHILL LIVINGSTONE,EDINBURGH,"JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND",0965-2299,1873-6963,,COMPLEMENT THER MED,Complement. Ther. Med.,APR,2019,43,,,,,,265,270,,10.1016/j.ctim.2019.02.018,http://dx.doi.org/10.1016/j.ctim.2019.02.018,,,6,Integrative & Complementary Medicine,Science Citation Index Expanded (SCI-EXPANDED),Integrative & Complementary Medicine,HU1WL,30935541,,,,2024-06-04,WOS:000465062400039,View Full Record in Web of Science
J,"JORGE, JMN; WEXNER, SD; EHRENPREIS, ED",,,,"JORGE, JMN; WEXNER, SD; EHRENPREIS, ED",,,THE LACTULOSE HYDROGEN BREATH TEST AS A MEASURE OF OROCECAL TRANSIT-TIME,EUROPEAN JOURNAL OF SURGERY,,,English,Article,,,,,,SMALL INTESTINAL TRANSIT; BREATH HYDROGEN TEST; GASTROINTESTINAL MOTILITY,SMALL-BOWEL TRANSIT; HUMAN SMALL-INTESTINE; GASTROINTESTINAL TRANSIT; OROCECAL TRANSIT; BACTERIAL OVERGROWTH; CHRONIC CONSTIPATION; DIETARY FIBER; COLECTOMY; MOUTH; MEAL,"Objective: To establish normal values and assess the reproducibility of the lactulose hydrogen breath test in measuring orocaecal transit time in control subjects, and to report results in a group of patients with chronic constipation as a result of colonic inertia. Design: Open study. Setting: Academic clinic. Subjects: 42 Control subjects (29 women and 13 men) in 25 of whom the test was repeated within 2-4 weeks, and 19 patients. Interventions: Lactulose hydrogen breath test. Main outcome measures: Sustained increase in hydrogen production of 3 ppm or more. Results: Coefficient of variation within subjects was 8% compared with 38% between subjects; 3 of the control subjects (7%) and 3 of the patients (16%) did not ferment lactulose, the incidence was similar in men (1/13, 8%) and women (2/29, 7%). Mean (SD) orocaecal transit time was significantly shorter among the 29 women (60 (27) minutes) than among the 11 men (89 (24) minutes) (p < 0.005). There were no significant differences between men in the control group and those with constipation. Conclusions: The lactulose hydrogen breath test is valuable to assess orocaecal transit time. It is simple, non-invasive, and reproducible, and may be of value in differentiating between generalised hypomotility and colonic inertia.","CLEVELAND CLIN FLORIDA, DEPT COLORECTAL SURG, FT LAUDERDALE, FL USA; CLEVELAN CLIN FLORIDA, DEPT GASTROENTEROL, FT LAUDERDALE, FL USA",Cleveland Clinic Foundation; Cleveland Clinic Foundation,,,"Ehrenpreis, Eli D/F-4586-2017","Ehrenpreis, Eli D/0000-0002-7209-729X",,,,,48,30,33,0,1,TAYLOR & FRANCIS AS,OSLO,"KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY",1102-4151,,,EUR J SURG,Eur. J. Surg.,AUG,1994,160,8,,,,,409,416,,,,,,8,Surgery,Science Citation Index Expanded (SCI-EXPANDED),Surgery,PG327,7811826,,,,2024-06-04,WOS:A1994PG32700002,View Full Record in Web of Science
J,"GHADIRIAN, P; BOYLE, P; SIMARD, A; BAILLARGEON, J; MAISONNEUVE, P; PERRET, C",,,,"GHADIRIAN, P; BOYLE, P; SIMARD, A; BAILLARGEON, J; MAISONNEUVE, P; PERRET, C",,,"REPORTED FAMILY AGGREGATION OF PANCREATIC-CANCER WITHIN A POPULATION-BASED CASE-CONTROL STUDY IN THE FRANCOPHONE-COMMUNITY IN MONTREAL, CANADA",INTERNATIONAL JOURNAL OF PANCREATOLOGY,,,English,Article,,,,,,PANCREATIC CANCER; FAMILY; EPIDEMIOLOGY; ETIOLOGY,PAST MEDICAL HISTORY; ABO BLOOD-GROUPS; RISK-FACTORS; ALCOHOL; DIET; CONSUMPTION; CARCINOMA; TOBACCO; ADENOCARCINOMA; EPIDEMIOLOGY,"As part of the SEARCH Collaborating Study Group of the International Agency for Research on Cancer (IARC), a population-based case-control study of cancer of the pancreas was conducted in Montreal, interviewing 179 patients and 179 controls matched for age, sex, and language (French) and selected by a modified random-digit dialing method. Results showed a positive and strong association between cigaret smoking and pancreatic cancer. Total fat, particularly saturated fat, and cholesterol consumption and excess energy derived from fat were associated with positive risk; dietary fiber intake, retinol equivalent, beta-carotene, vitamin C, and calcium showed inverse association with risk. History of such medical conditions as constipation, gallbladder problems, and diabetes was also found to be associated with risk. More important, 7.8% of the pancreatic cancer patients reported a positive family history of the same disease, as compared with 0.6% among controls, a 13-fold difference between cases and controls. Within the original case-control study a further study of patients with instances of familial pancreatic cancer was conducted, based on 14 cases and 56 matched controls. The results support the finding of the main study, and there were no apparent differences in environmental-risk-factor profile in familial and nonfamilial cases. This unusual aggregation of familial pancreatic cancer among French Canadians cannot be explained by environmental factors alone. Some familial predisposition (hereditary factors) may play an important role in the etiology of this cancer, at least in this study region. The findings suggest the potential importance of conducting genetic studies of pancreatic cancer.","MONTREAL CANC INST,MONTREAL,QUEBEC,CANADA; HOP NOTRE DAME DE BON SECOURS,MONTREAL H2L 4K8,QUEBEC,CANADA; INT AGCY RES CANC,F-69372 LYONS,FRANCE",Universite de Montreal; Universite de Montreal; World Health Organization; International Agency for Research on Cancer (IARC),"GHADIRIAN, P (corresponding author), HOP HOTEL DIEU,RES CTR,EPIDEMIOL RES UNIT,3850 RUE ST URBAIN,MONTREAL H2W 1T8,QUEBEC,CANADA.",,"Maisonneuve, Patrick/U-9789-2018; Boyle, Peter/A-4380-2014","Maisonneuve, Patrick/0000-0002-5309-4704; Boyle, Peter/0000-0001-6251-0610",,,,,44,142,151,0,2,HUMANA PRESS INC,TOTOWA,"999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512",0169-4197,,,INT J PANCREATOL,Int. J. Pancreatol.,NOV-DEC,1991,10,3-4,,,,,183,196,,,,,,14,Endocrinology & Metabolism; Physiology,Science Citation Index Expanded (SCI-EXPANDED),Endocrinology & Metabolism; Physiology,GY614,1787333,,,,2024-06-04,WOS:A1991GY61400002,View Full Record in Web of Science
J,"Ferreira, VC; Barroso, TLCT; Castro, LEN; da Rosa, RG; Oliveira, LD",,,,"Ferreira, Vanessa Cosme; Barroso, Tiago Linhares Cruz Tabosa; Castro, Luiz Eduardo Nochi; da Rosa, Rafael Gabriel; Oliveira, Luciana de Siqueira",,,An overview of prebiotics and their applications in the food industry,EUROPEAN FOOD RESEARCH AND TECHNOLOGY,,,English,Review,,,,,,Functional foods; Prebiotics; Bioactive compounds; Bibliometric,FUNCTIONAL FOOD; BIOTECHNOLOGICAL PRODUCTION; PHYSICOCHEMICAL PROPERTIES; BETA-GALACTOSIDASE; IMMUNE PARAMETERS; RECENT INSIGHTS; GUT MICROBIOTA; FATTY-ACIDS; INULIN; OLIGOSACCHARIDES,"Prebiotics are bioactive compounds added to or naturally found in some foods that serve as substrates for specific host microorganisms of the gastrointestinal tract, conferring health benefits. The objective of this work was to demonstrate, through an updated bibliographic survey, the importance of prebiotics, considering their performance in food technology, as well as their benefits in the health of their consumers. The definition of functional foods and prebiotics was presented, which are classified into three main classes: polyols, oligosaccharides, and dietary fibers. Prebiotics are widely used in the production of beverages, bakery, dairy products, and meats, both for their health benefits and for their technological properties. They are also added along with probiotics in symbiotic foods, promoting increased viability, growth, and development of probiotic bacteria during processing and digestion. Benefits such as improved lipid metabolism, constipation relief, reduced risk of gastrointestinal diseases, increased absorption of vitamins and minerals, prevention of type II diabetes, help in controlling blood glucose, weight loss, and stimulation of the immune system have already been proven through in vivo and in vitro studies. These studies demonstrate that prebiotics present countless benefits to health, and these benefits vary according to the type of prebiotic consumed. For this reason, it is of the utmost importance to know the functional foods supplemented with prebiotics, as well as their functionality. Along with the studies of new prebiotics, new health benefits will emerge, making it increasingly necessary to have a functional diet through diets with the inclusion of prebiotics.","[Ferreira, Vanessa Cosme; Barroso, Tiago Linhares Cruz Tabosa; Castro, Luiz Eduardo Nochi; da Rosa, Rafael Gabriel] Univ Estadual Campinas, Sch Food Engn FEA, UNICAMP, BR-13083862 Campinas, Brazil; [Oliveira, Luciana de Siqueira] Fed Univ Ceara UFC, Dept Food Engn, BR-60455760 Fortaleza, CE, Brazil",Universidade Estadual de Campinas,"Ferreira, VC; Barroso, TLCT (corresponding author), Univ Estadual Campinas, Sch Food Engn FEA, UNICAMP, BR-13083862 Campinas, Brazil.",v183882@dac.unicamp.br; t234201@dac.unicamp.br,"Barroso, Tiago Linhares Cruz Tabosa/JXX-3834-2024; Castro, Luiz Eduardo Nochi/JAC-5049-2023; de Siqueira Oliveira, Luciana/E-1344-2019","Barroso, Tiago Linhares Cruz Tabosa/0000-0002-0133-2969; Castro, Luiz Eduardo Nochi/0000-0002-5968-8968; de Siqueira Oliveira, Luciana/0000-0003-3047-9211; da Rosa, Rafael Gabriel/0000-0001-9885-6197","Brazilian Science and Research Foundation (CNPq, Brazil) [308482/2022-0]","Brazilian Science and Research Foundation (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))","AcknowledgementsThis work was supported by the Brazilian Science and Research Foundation (CNPq, Brazil) (productivity grant 308482/2022-0).",,199,2,2,27,49,SPRINGER,NEW YORK,"ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES",1438-2377,1438-2385,,EUR FOOD RES TECHNOL,Eur. Food Res. Technol.,NOV,2023,249,11,,,,,2957,2976,,10.1007/s00217-023-04341-7,http://dx.doi.org/10.1007/s00217-023-04341-7,,AUG 2023,20,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,S1FY7,,,,,2024-06-04,WOS:001041348000001,View Full Record in Web of Science
J,"Roberfroid, MB",,,,"Roberfroid, MB",,,Functional foods: concepts and application to inulin and oligofructose,BRITISH JOURNAL OF NUTRITION,,,English,Editorial Material,,,,,,functional foods; health claims; prebiotics,FRUCTO-OLIGOSACCHARIDES; COLON; BIFIDOBACTERIA; HYDROLYSIS; EXCRETION,"A food can be regarded as functional if it is satisfactorily demonstrated to affect beneficially one or more target functions in the body, beyond adequate nutritional effects, in a way which is relevant to either the state of well-being and health or the reduction of the risk of a disease. Health claims are expected to be authorized for functional foods based either on enhanced function (type A claim) or disease risk reduction (type B claim). Their development is a unique opportunity to contribute to the improvement of the quality of the food offered to consumer's choice for the benefit of his well-being and health. But only a rigorous scientific approach producing sound data will garantee its success. The functional food components that are discussed in the proceedings of the 3rd ORAFTI Research Conference are the inulin-type fructans, natural food components found in miscellaneous edible plants. They are non-digestible oligosaccharides that are classified as dietary fiber. The targets for their functional effects are the colonic microflora that use them as selective 'fertilizers'; the gastrointestinal physiology; the immune functions; the bioavailability of minerals; and the metabolism of lipids. Potential health benefits may also concern reduction of the risk of some diseases like intestinal infections, constipation, non-insulin dependent diabetes, obesity, osteoporosis or colon cancer. The present proceedings review the scientific data available and, by reference to the concepts in functional food science, they assess the scientific evidence which will be used to substantiate health claims.","Catholic Univ Louvain, B-1200 Brussels, Belgium",Universite Catholique Louvain,"Catholic Univ Louvain, B-1200 Brussels, Belgium.",roberfroid@pmnt.ucl.ac.be,,,,,,,30,148,171,1,40,CAMBRIDGE UNIV PRESS,CAMBRIDGE,"EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND",0007-1145,1475-2662,,BRIT J NUTR,Br. J. Nutr.,MAY,2002,87,,,2,,,S139,S143,,10.1079/BJN/2002529,http://dx.doi.org/10.1079/BJN/2002529,,,5,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,567DG,12088510,Bronze,,,2024-06-04,WOS:000176469700001,View Full Record in Web of Science
J,"Zeng, YW; Pu, XY; Yang, JZ; Du, J; Yang, XM; Li, X; Li, L; Zhou, Y; Yang, T",,,,"Zeng, Yawen; Pu, Xiaoying; Yang, Jiazhen; Du, Juan; Yang, Xiaomeng; Li, Xia; Li, Ling; Zhou, Yan; Yang, Tao",,,Preventive and Therapeutic Role of Functional Ingredients of Barley Grass for Chronic Diseases in Human Beings,OXIDATIVE MEDICINE AND CELLULAR LONGEVITY,,,English,Review,,,,,,,GAMMA-AMINOBUTYRIC-ACID; HORDEUM-VULGARE-L.; ACTIVATED POTASSIUM CHANNELS; SUPEROXIDE-DISMUTASE; SECONDARY METABOLITES; ANTIOXIDANT ACTIVITY; GERMINATED BARLEY; NELUMBO-NUCIFERA; OXIDATIVE DAMAGE; GABAERGIC SYSTEM,"Barley grass powder is the best functional food that provides nutrition and eliminates toxins from cells in human beings; however, its functional ingredients have played an important role as health benefit. In order to better cognize the preventive and therapeutic role of barley grass for chronic diseases, we carried out the systematic strategies for functional ingredients of barley grass, based on the comprehensive databases, especially the PubMed, Baidu, ISI Web of Science, and CNKI, between 2008 and 2017. Barley grass is rich in functional ingredients, such as gamma-aminobutyric acid (GABA), flavonoids, saponarin, lutonarin, superoxide dismutase (SOD), K, Ca, Se, tryptophan, chlorophyll, vitamins (A, B1, C, and E), dietary fiber, polysaccharide, alkaloid, metallothioneins, and polyphenols. Barley grass promotes sleep; has antidiabetic effect; regulates blood pressure; enhances immunity; protects liver; has anti-acne/detoxifying and antidepressant effects; improves gastrointestinal function; has anticancer, anti-inflammatory, antioxidant, hypolipidemic, and antigout effects; reduces hyperuricemia; prevents hypoxia, cardiovascular diseases, fatigue, and constipation; alleviates atopic dermatitis; is a calcium supplement; improves cognition; and so on. These results support that barley grass may be one of the best functional foods for preventive chronic diseases and the best raw material of modern diet structure in promoting the development of large health industry and further reveal that GABA, flavonoids, SOD, K-Ca, vitamins, and tryptophan mechanism of barley grass have preventive and therapeutic role for chronic diseases. This paper can be used as a scientific evidence for developing functional foods and novel drugs for barley grass for preventive chronic diseases.","[Zeng, Yawen; Pu, Xiaoying; Yang, Jiazhen; Du, Juan; Yang, Xiaomeng; Li, Xia; Yang, Tao] Yunnan Acad Agr Sci, Biotechnol & Germplasm Resources Inst, Agr Biotechnol Key Lab Yunnan Prov, Kunming 650205, Yunnan, Peoples R China; [Pu, Xiaoying; Yang, Jiazhen] Kunming Tiankang Sci & Technol Ltd Co, Kunming 650231, Yunnan, Peoples R China; [Li, Ling] Kunming Med Univ, Biomed Engn Res Ctr, Kunming 650500, Yunnan, Peoples R China; [Zhou, Yan] Second Peoples Hosp Yunnan Prov, Clin Nutr Dept, Kunming 650021, Yunnan, Peoples R China",Yunnan Academy of Agricultural Sciences; Kunming Medical University,"Zeng, YW; Pu, XY; Yang, JZ (corresponding author), Yunnan Acad Agr Sci, Biotechnol & Germplasm Resources Inst, Agr Biotechnol Key Lab Yunnan Prov, Kunming 650205, Yunnan, Peoples R China.;Pu, XY; Yang, JZ (corresponding author), Kunming Tiankang Sci & Technol Ltd Co, Kunming 650231, Yunnan, Peoples R China.",zengyw1967@126.com; puxiaoying@163.com; yangjiazhen415@163.com,,"jiazhen, yang/0000-0003-2201-3059; Zeng, Yawen/0000-0001-7616-9177","China Agriculture Research System [CARS-05-01A, CARS-05-02B]; National Natural Science Foundation of China [31260326]; Science and Technology to Benefit the People [2014RA060]; Natural Science Foundation from Yunnan Provincial Scientific and Technology Department [2017FD021]",China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology to Benefit the People; Natural Science Foundation from Yunnan Provincial Scientific and Technology Department,"This research was supported by China Agriculture Research System (CARS-05-01A, CARS-05-02B), the National Natural Science Foundation of China (no. 31260326), and the Science and Technology to Benefit the People (2014RA060) and Natural Science Foundation (no. 2017FD021) from Yunnan Provincial Scientific and Technology Department. The authors thank Dr. Md. Jahid Hasan and Mainuddin from Bangladesh for revisions of the grammar mistakes for the manuscript.",,167,61,66,14,52,HINDAWI LTD,LONDON,"ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND",1942-0900,1942-0994,,OXID MED CELL LONGEV,Oxidative Med. Cell. Longev.,,2018,2018,,,,,,,,3232080,10.1155/2018/3232080,http://dx.doi.org/10.1155/2018/3232080,,,15,Cell Biology,Science Citation Index Expanded (SCI-EXPANDED),Cell Biology,GD1QC,29849880,"Green Published, gold, Green Submitted",,,2024-06-04,WOS:000430275400001,View Full Record in Web of Science
J,"Bion, FM; Chagas, MHD; Muniz, GD; de Sousa, LGO",,,,"Bion, F. Martins; de Castro Chagas, M. H.; Muniz, G. de Santana; Oliveira de Sousa, L. G.",,,"Nutritional status, anthropometrical measurements, socio-economic status, and physical activity in Brazilian university students",NUTRICION HOSPITALARIA,,,Spanish,Article,,,,,,dietary intake; physical activity; Brazilian university; students; quality of life,,"Introduction: The physical activity and adequate food plays a key role in improving health and the control of diseases. Objective: This paper aims at determining the nutritional state through antropometric measures, socioeconomic level, the most common illnesses and type of physical activity, beyond food consumption and the place where meals are taken, of under-graduate students of the Nutrition course in UFPE. Methods: The sample is constituted of 68 female students, of different periods and at ages between 18 and 27 years old. The process of selection of the sample was for convenience. The students voluntarily participated and answered three questionnaires, respectively, on their socioeconomic level (income of the family) and possible illnesses they had, measures of the cutaneous folds and type of practiced physical activity; register of consumed foods and local where the meals were carried. Statistical analysis was performed by absolute frequency, percentage, average and standard deviation. The margin of error used in the testing employees was 5%. Results: In relation to the incomes, they had predominated above three minimum wages (86%), the parents have a predominant role in the expenditure of their study (46%), followed by the father (24%), mother (9%), husband (4%), other responsible ones (10%); 7% did not give information. The most common illnesses were: allergic rinite, tonsilitis, sleeplessness and intestinal constipation. The weight, the height, the index of body mass and the relation waist hip of the students were within normal standards. The abdominal circumference varied only in 2.57 cm between the studied age range. In relation to the practice of physical activities, 67 % were sedentary, 20 % practiced light activity and 13 % moderate. In relation to where the meals are had, breakfast, in its majority (76 %), was carried at home, followed by supper (56%), while lunch (41 %) and snack 1 (34%), at University. Among the pupils who did not inform the place where they had their meals there was a high percentage for the big meals and a small one for the minor ones. The main kinds of consumed meals were breakfast, lunch and supper (98%). For the small meals, the values were: snack 1 (54%), snack 2 (61%), snack 3 (45%). The analysis of food consumption for three days disclosed ingestion of energy with deficit of 21% in relation to the recommended one (p < 0.001); the macro-nutrients showed percentages within the standards; the intake of fiber (11.8 g/day) was less than recommended (p < 0.001). Meat, eggs and cereals were ingested daily (for about 80%); vegetables (40%), legumes, fruits and candies (25% 30%), around four or six days a week. Roots and tubercles, salty, embedded and non alcoholic drinks were consumed from one to three days weekly (70%). Animal guts were not consumed by 50% of the studied population. Conclusions: Having analyzed all this, the studied students need to modify their food habits, acquiring knowledge on the importance of a balanced diet, as well as the practice of physical activity systematically, to prevent illnesses and attain a better quality of life.","[Bion, F. Martins; de Castro Chagas, M. H.] Univ Fed Pernambuco, Dept Nutr, Recife, Brazil; [Muniz, G. de Santana] Univ Fed Pernambuco, Curso Nutr, Recife, Brazil; [Oliveira de Sousa, L. G.] Univ Salgado Oliveira Univ, Curso Grad Educ Fis, Oliveira, Brazil",Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Universidade Salgado de Oliveira,"Bion, FM (corresponding author), Univ Fed Pernambuco, Dept Nutr, Recife, Brazil.",franciscabion@yahoo.com.br,"saez, lourdes basurto/AAO-6641-2020; Oliveira de Sousa, Luis Gustavo/M-6807-2017","Oliveira de Sousa, Luis Gustavo/0000-0003-1013-2595",,,,,35,21,26,0,10,"ARAN EDICIONES, S L",MADRID,"C/ CASTELLO, 128, 1O, MADRID, 28006, SPAIN",0212-1611,1699-5198,,NUTR HOSP,Nutr. Hosp.,MAY-JUN,2008,23,3,,,,,234,241,,,,,,8,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,303UI,18560700,,,,2024-06-04,WOS:000256066000010,View Full Record in Web of Science
J,"Shadman, Z; Akhoundan, M; Poorsoltan, N; Nikoo, MK; Larijani, B; Zhand, CA; Soleymanzadeh, M; Rohani, ZAS; Jamshidi, Z",,,,"Shadman, Zhaleh; Akhoundan, Mahdieh; Poorsoltan, Nooshin; Nikoo, Mohsen Khoshniat; Larijani, Bagher; Zhand, Camelia Akhgar; Soleymanzadeh, Mozhdeh; Rohani, Zahra Alsadat Seyed; Jamshidi, Zahra",,,"Nutritional Education Needs in Relation to Ramadan Fasting and Its Complications in Tehran, Iran",IRANIAN RED CRESCENT MEDICAL JOURNAL,,,English,Article,,,,,,Ramadan; Fasting; Education; Diet; Adverse Effects,DIETARY FIBER; SLEEP; MIGRAINE; ATTACKS; FOOD,"Background: Ramadan fasting is associated with some lifestyle changes. A lack of nutritional needs knowledge or the improper performance of fasting, particularly in relation to time, type and amount of food intake, can cause disorders such as indigestion, bloating, constipation, headaches and other clinical problems. Objectives: To investigate the general knowledge regarding dietary factors associated with Ramadan fasting and its related complications. Patients and Methods: This prospective, non-interventional, observational study was conducted from April to July, 2012 to coincide with the month before and the month of Ramadan. The initial participants were 600 fasting and 588 non-fasting people (aged 18 65 years, BMI 18.5-40 kg/m(2)) chosen by random cluster sampling in Tehran, Iran. A questionnaire of Ramadan fasting nutritional knowledge was developed and validated in a pilot study. The Likert scale was used two weeks before Ramadan and during the third and fourth weeks of Ramadan to estimate Ramadan-related complications. Seven-day, 24-hour food recalls were used to assess food intakes. Results: The lowest level of general knowledge was identified in the context of foods associated with hunger (22.1%) and hypoglycemia (24.8%) and the highest level of general knowledge was identified in reference to unsuitable foods for Sahar (91.4%). During Ramadan, all attributed complications increased in fasting subjects (P < 0.001). High calorie, carbohydrate, fat and protein intakes in the Ramadan diet were associated with some gastrointestinal and sleep complications (P < 0.05). Conclusions: Despite the relatively high level of knowledge in the context of the general principles of a diet to prevent Ramadan-related complications, practical training in regard to the amounts of nutrients associated with Ramadan-related complications is both necessary and recommended.","[Shadman, Zhaleh; Larijani, Bagher; Zhand, Camelia Akhgar; Soleymanzadeh, Mozhdeh; Rohani, Zahra Alsadat Seyed; Jamshidi, Zahra] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran; [Akhoundan, Mahdieh; Poorsoltan, Nooshin; Nikoo, Mohsen Khoshniat] Univ Tehran Med Sci, Diabet Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran",Tehran University of Medical Sciences; Tehran University of Medical Sciences,"Nikoo, MK (corresponding author), Univ Tehran Med Sci, Diabet Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran.",M.khoshniatnikoo@yahoo.com,"larijani, Bagher/ABE-3315-2020","larijani, Bagher/0000-0001-5386-7597","Endocrinology and Metabolism Research Center of Tehran University of Medical Sciences in Tehran, Iran","Endocrinology and Metabolism Research Center of Tehran University of Medical Sciences in Tehran, Iran","This study was supported by the Endocrinology and Metabolism Research Center of Tehran University of Medical Sciences in Tehran, Iran. No reimbursements, fees, funding or salaries were received from any organization that holds or has applied for patents concerning the contents of the manuscript.",,25,5,5,0,5,KOWSAR PUBL,HOENSBROEK,"PATERSWEG 22,, HOENSBROEK, LIMBURG 6431 GC, NETHERLANDS",2074-1804,2074-1812,,IRAN RED CRESCENT ME,Iran. Red Crescent Med. J.,AUG,2016,18,8,,,,,,,e26130,10.5812/ircmj.26130,http://dx.doi.org/10.5812/ircmj.26130,,,8,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,EK9UI,27781112,"Green Published, Green Submitted",,,2024-06-04,WOS:000394269000002,View Full Record in Web of Science
J,"Dunphy, RC; Verne, GN",,,,"Dunphy, RC; Verne, GN",,,Drug treatment options for irritable bowel syndrome - Managing for success,DRUGS & AGING,,,English,Article,,,,,,,FUNCTIONAL GASTROINTESTINAL DISORDERS; KAPPA-AGONIST FEDOTOZINE; CHINESE HERBAL MEDICINE; CLINICAL-PHARMACOLOGY; RECEPTOR ANTAGONISTS; CONTROLLED TRIAL; DIETARY FIBER; SMOOTH-MUSCLE; ARTICLE; CONSTIPATION,"Irritable bowel syndrome (IBS) is a functional gut disorder the diagnosis of which is based on clinical symptoms as set forth by the Rome criteria. As the population ages, especially with the population of patients >75 years of age expanding greatly over the next 10 years, IBS is becoming one of the most common diseases of the elderly. Thus far, developing treatment strategies for patients with IBS has been difficult because of the lack of pharmacological targets and the wide range of symptomatology. Additionally, demonstration of a therapeutic benefit is difficult in the presence of a high placebo response observed regardless of the therapy employed. Fibre, antidiarrhoeals and antispasmodics all play some role in the symptomatic treatment of IBS. With the evolution of IBS as a disorder of visceral hypersensitivity, new drugs have been developed that target the enteric nervous system. Tricyclic antidepressants (TCAs) have been found to target the enteric neurons and play a role in pain modulation. Currently, the TCAs are recommended only for severe cases of IBS pain. The newest class of drugs to be approved for use in IBS are the serotonin (5-hydroxytryptamine; 5-HT) antagonists. Specifically, the 5-HT3 receptor antagonists have been shown to decrease symptoms in female patients with IBS. A related class of drugs, the 5-HT4 receptor agonists, is being developed for the treatment of constipation-predominant IBS. Further investigation into the role of spinal afferent neurons in visceral hypersensitivity is at the forefront of IBS research. Several experimental drug therapies for IBS are also discussed in this review including N-methyl-D-aspartate receptor antagonists, neurokinin-1 receptor antagonists, octreotide, clonidine and the selective M3 receptor antagonist, zamifenacin.","Univ Florida, Dept Med, Div Gastroenterol Hepatol & Nutr, Gainesville, FL USA",State University System of Florida; University of Florida,"Malcolm Randall VAMC, 111C,1601 SW Archer Rd, Gainesville, FL 32608 USA.",,,,,,,,61,17,22,0,3,ADIS INT LTD,NORTHCOTE,"5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND",1170-229X,1179-1969,,DRUG AGING,Drugs Aging,,2001,18,3,,,,,201,211,,10.2165/00002512-200118030-00005,http://dx.doi.org/10.2165/00002512-200118030-00005,,,11,Geriatrics & Gerontology; Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Geriatrics & Gerontology; Pharmacology & Pharmacy,417YC,11302287,,,,2024-06-04,WOS:000167862200005,View Full Record in Web of Science
J,"Okazaki, Y; Tomotake, H; Tsujimoto, K; Sasaki, M; Kato, N",,,,"Okazaki, Yukako; Tomotake, Hiroyuki; Tsujimoto, Kazuhisa; Sasaki, Masahiro; Kato, Norihisa",,,"Consumption of a Resistant Protein, Sericin, Elevates Fecal Immunoglobulin A, Mucins, and Cecal Organic Acids in Rats Fed a High-Fat Diet",JOURNAL OF NUTRITION,,,English,Article,,,,,,,REDUCING OXIDATIVE STRESS; ABERRANT CRYPT FOCI; SILK PROTEIN; COLON-CANCER; CELL-PROLIFERATION; GLUCOSE-TOLERANCE; HUMAN FECES; MICE; FIBER; MOUSE,"We previously reported that consumption of a resistant protein, sericin, reduces colon tumorigenesis, constipation, and serum TG in rodents. The present study was conducted to elucidate the effects of dietary sericin on the intestinal luminal environment in rats fed a high-fat (HF) diet. Rats were fed 300 or 50 g/kg of beef tallow with or without 40 g/kg sericin, a protein purified from cocoons of Bombix mori, for 3 wk. Intestinal luminal variables, including IgA (index of intestinal immune function), mucins (index of barrier function), organic acids, microflora, and secondary bile acids, were measured. Dietary sericin markedly elevated fecal IgA in the HF diet group (3-fold, P < 0.05) but not in the low-fat (LF) diet group. Fecal mucin levels were elevated by sericin intake in the HF diet group (P < 0.05). Cecal organic acids, including acetate, propionate, n-butyrate, and succinate, were significantly lower in the HF diet group compared with the LF diet group. Dietary sericin significantly elevated cecal acetate and n-butyrate in the HF diet group but not in the LE diet group. Compared with the LF diet, the HF diet significantly increased serum TG in the untreated group but not in those fed sericin. The HF diet increased lower density lipoprotein (VLDL + IDL + LDL) cholesterol and it was reduced by sericin intake (P < 0.05). There was an inverse correlation between serum TG and cecal acetate (Spearman rank correlation coefficient = -0.63; P < 0.001). The profile of microflora in cecal digesta and fecal secondary bile acids (a risk factor for colon cancer) did not differ between the HF diet and HF diet with sericin groups. These results suggest a novel and favorable effect of sericin on colon health by modulating intestinal immune and barrier functions and fermentation in rats fed a HF diet. J. Nutr. 141: 1975-1981, 2011.","[Okazaki, Yukako] Fuji Womens Univ, Fac Human Life Sci, Ishikari, Hokkaido, Japan; [Tomotake, Hiroyuki] Iida Womens Jr Coll, Iida, Japan; [Tsujimoto, Kazuhisa; Sasaki, Masahiro] Seiren Co Ltd, Fukui, Japan; [Kato, Norihisa] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 724, Japan",Hiroshima University,"Okazaki, Y (corresponding author), Fuji Womens Univ, Fac Human Life Sci, Ishikari, Hokkaido, Japan.",yokazaki@fujijoshi.ac.jp,,"Kato, Norihisa/0000-0002-5467-3126","Ministry of Education, Culture, Sports, Science and Technology of Japan [20700597]; Grants-in-Aid for Scientific Research [23500947, 20700597] Funding Source: KAKEN","Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))","Supported in part by a Grant-in-Aid for Young Scientists (B) (no. 20700597) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.",,46,52,53,3,23,AMER SOC NUTRITION-ASN,BETHESDA,"9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA",0022-3166,,,J NUTR,J. Nutr.,NOV,2011,141,11,,,,,1975,1981,,10.3945/jn.111.144246,http://dx.doi.org/10.3945/jn.111.144246,,,7,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,837PD,21940508,hybrid,,,2024-06-04,WOS:000296214800009,View Full Record in Web of Science
J,"Jones, J; Lembo, A; Heidelbaugh, J; Kuritzky, L; Lacy, B",,,,"Jones, Jennifer; Lembo, Anthony; Heidelbaugh, Joel; Kuritzky, Louis; Lacy, Brian",,,Management of irritable bowel syndrome with diarrhea: focus on eluxadoline,CURRENT MEDICAL RESEARCH AND OPINION,,,English,Review,,,,,,Eluxadoline; health care; irritable bowel syndrome; diagnosis; disease management; gastroenterology,QUALITY-OF-LIFE; BILE-ACID MALABSORPTION; GASTROINTESTINAL SYMPTOMS; DIET LOW; GASTROENTEROLOGY MONOGRAPH; AMERICAN-COLLEGE; PEPPERMINT OIL; IBS-D; EFFICACY; PREVALENCE,"Objective We sought to summarize current recommendations for the diagnosis of diarrhea-predominant irritable bowel syndrome (IBS-D) and describe available management options, highlighting a newer US Food and Drug Administration (FDA)-approved agent, eluxadoline. Methods Literature on IBS-D was assessed up to January 2020 using PubMed, with key search terms including IBS-D diagnosis, IBS-D management, and eluxadoline. Results IBS is a common gastrointestinal disorder affecting up to 14% of US adults and is particularly prevalent in women and those aged under 50. Symptoms include abdominal pain associated with altered bowel habits (i.e. diarrhea and/or constipation subtyped based on the predominant stool pattern). As IBS-D is challenging to manage with varying symptom severity, effective treatment requires a personalized management approach. Evidence-based therapeutic options endorsed by the American Gastroenterological Association and the American College of Gastroenterology can be used to effectively guide treatment. Dietary and lifestyle modifications, including adequate hydration, reducing caffeine and alcohol intake, and increasing soluble fiber intake may lead to symptom improvement. Over-the-counter medications such as loperamide are frequently recommended and may improve stool frequency and rectal urgency; however, for the outcome of abdominal pain, mixed results have been observed. Several off-label prescription medications are useful in IBS-D management, including tricyclic antidepressants, bile acid sequestrants, and antispasmodics. Three prescription medications have been approved by the FDA for IBS-D: alosetron, eluxadoline, and rifaximin. Conclusions IBS-D can be effectively managed in the primary care setting in the absence of alarm features. Benefits and risks of pharmacologic interventions should be weighed during treatment selection.","[Jones, Jennifer] UCF Coll Med, HCA Consortium Family Med Residency, 6500 W Newberry Rd, Gainesville, FL 32605 USA; [Lembo, Anthony] Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA 02215 USA; [Heidelbaugh, Joel] Univ Michigan, Sch Med, Dept Family Med, Ann Arbor, MI USA; [Heidelbaugh, Joel] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI USA; [Kuritzky, Louis] Univ Florida, Coll Med, Dept Community Hlth & Family Med, Gainesville, FL USA; [Lacy, Brian] Mayo Clin, Div Gastroenterol & Hepatol, Jacksonville, FL 32224 USA",State University System of Florida; University of Central Florida; Harvard University; Beth Israel Deaconess Medical Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; State University System of Florida; University of Florida; Mayo Clinic,"Jones, J (corresponding author), UCF Coll Med, HCA Consortium Family Med Residency, 6500 W Newberry Rd, Gainesville, FL 32605 USA.",purdiejonesmd@gmail.com,,,"Allergan plc, Dublin, Ireland","Allergan plc, Dublin, Ireland","This review was sponsored by Allergan plc, Dublin, Ireland (prior to acquisition by AbbVie Inc.). Allergan (now AbbVie) provided suggestions for topic ideas and for authors of this manuscript to Complete HealthVizion, Inc., Chicago, IL, USA. Allergan (now AbbVie) was not involved in the development of the manuscript with the authors or the vendor. Allergan (now AbbVie) had the opportunity to review the final version of the manuscript and provide comments; however, the authors maintained complete control over the content of the paper.",,124,6,6,2,6,TAYLOR & FRANCIS LTD,ABINGDON,"2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND",0300-7995,1473-4877,,CURR MED RES OPIN,Curr. Med. Res. Opin.,APR 3,2021,37,4,,,,,567,578,,10.1080/03007995.2021.1888705,http://dx.doi.org/10.1080/03007995.2021.1888705,,FEB 2021,12,"Medicine, General & Internal; Medicine, Research & Experimental",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine; Research & Experimental Medicine,RA8OI,33566707,hybrid,,,2024-06-04,WOS:000624987500001,View Full Record in Web of Science
C,"Kontareva, VY; Belik, SN; Morgul, EV; Gorlov, IF; Slozhenkina, MI",,,IOP,"Kontareva, V. Yu; Belik, S. N.; Morgul, E., V; Gorlov, I. F.; Slozhenkina, M., I",,,Yogurt enriched to correct intestinal microflora in dysbiosis,"III INTERNATIONAL SCIENTIFIC CONFERENCE: AGRITECH-III-2020: AGRIBUSINESS, ENVIRONMENTAL ENGINEERING AND BIOTECHNOLOGIES, PTS 1-8",IOP Conference Series-Earth and Environmental Science,,English,Proceedings Paper,"3rd International Conference on Agribusiness, Environmental Engineering and Biotechnologies (AGRITECH)","JUN 18-20, 2020","Krasnoyarsk, RUSSIA","Int & Russian Union Sci & Engn Assoc,Krasnoyarsk Reg Union Sci & Engn Assoc,Krasnoyarsk State Agrarian Univ,Krasnoyarsk Sci & Technol City Hall",,,,"The high incidence of dysbiotic disorders, growing threat of new intestinal bacterial pathogens with multidrug resistance and high virulence, and high level of xenobiotic contamination of food products and the environment require the search for alternative nonmedicinal products aimed at improving and maintaining health of the intestinal tract. The authors developed a recipe and technology of two-layer yogurt enriched with a prebiotic complex, containing dietary fiber of wheat bran, indigestible food components that promote the growth of normal intestinal microflora (bifidobacteria and lactobacilli), an inactivated yeast culture of Saccharomycescerevisiae (vini), and blueberry and cornelian cherry puree-a source of polyphenolic compounds. The yoghurt culture used in the technology contains freeze-dehydrated strains of probiotic cultures, i.e., Streptococcus thrmophilus, Lactobacillus delbrueckiissp.bulgaricus, Lactobacillus acidophilus, Bifidobacterium lactis, and lactose. The authors studied the effect of the developed yogurt on the intestinal microflora and their ability to prevent and correct dysbiosis. To this end, a model of experimental antibiotic-associated dysbiosis was reproduced using a broad-spectrum antibiotic Gentamicin in white mice. The antibiotic was being injected intraperitoneally for 5 days. After withdrawal of gentamicin, a considerable increase in opportunistic enterobacteria (Enterobacteraerogenes, Enterobactercloacae, and Citrobacterfreundii), Proteussp, and Candidasp. was observed. There was also a decrease in the quantity and quality of Lactobacillussp. E.coli and a decrease in the content of Bifidobacteriumsp. Enriched yogurt in the diet of mice allowed the microbiological evidences of dysbiosis to be eliminated in a short time, prevented clinical symptoms of dysbiosis, i.e., decreased physical activity and poor appetite, stool softening, constipation, flatulence, and worsening the appearance. Thus, the developed enriched yogurt can be used to prevent and correct dysbiotic intestinal disorders.","[Kontareva, V. Yu] Don State Agr Univ, Krivoshlykova St 24, Persianovsky 346493, Rostov Region, Russia; [Belik, S. N.; Morgul, E., V] Rostov State Med Univ, 29 Nakhichevan Lane, Rostov Na Donu 344022, Russia; [Gorlov, I. F.; Slozhenkina, M., I] Volga Reg Res Inst Manufacture & Proc Meat & Milk, 6 Rokossovsky Str, Volgograd 400131, Russia",Don State Agrarian University; Rostov State Medical University; Volga Research Institute of Production & Processing of Meat & Dairy Products,"Belik, SN (corresponding author), Rostov State Med Univ, 29 Nakhichevan Lane, Rostov Na Donu 344022, Russia.",superbelik@mail.ru,"Morgul, Elena/KCY-7270-2024; Belik, Svetlana S/K-6371-2015; Slozhenkina, Marina I/Q-5752-2017; Gorlov, Ivan/L-1334-2015","Gorlov, Ivan/0000-0002-8683-8159; Slozhenkina, Marina/0000-0001-9542-5893",,,,,11,2,2,1,3,IOP PUBLISHING LTD,BRISTOL,"DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND",1755-1307,,,IOP C SER EARTH ENV,IOP Conf. Ser. Earth Envir. Sci.,,2020,548,,,,,,,,82051,10.1088/1755-1315/548/8/082051,http://dx.doi.org/10.1088/1755-1315/548/8/082051,,,6,"Agricultural Engineering; Agriculture, Multidisciplinary; Ecology; Engineering, Environmental; Food Science & Technology",Conference Proceedings Citation Index - Science (CPCI-S),Agriculture; Environmental Sciences & Ecology; Engineering; Food Science & Technology,BR6DD,,gold,,,2024-06-04,WOS:000659907503104,View Full Record in Web of Science
J,"Barba, FJ; Putnik, P; Kovacevic, DB; Poojary, MM; Roohinejad, S; Lorenzo, JM; Koubaa, M",,,,"Barba, Francisco J.; Putnik, Predrag; Kovacevic, Danijela Bursac; Poojary, Mahesha M.; Roohinejad, Shahin; Lorenzo, Jose M.; Koubaa, Mohamed",,,Impact of conventional and non-conventional processing on prickly pear (Opuntia spp.) and their derived products: From preservation of beverages to valorization of by-products,TRENDS IN FOOD SCIENCE & TECHNOLOGY,,,English,Review,,,,,,Opuntia; Food preservation; Extraction of valuable compounds; Non-conventional processing; Thermal treatment,PULSED ELECTRIC-FIELD; HIGH-PRESSURE TREATMENT; FATTY-ACID-COMPOSITION; ANTIOXIDANT PROPERTIES; BIOACTIVE COMPOUNDS; PHENOLIC-COMPOUNDS; FRUIT JUICE; CHEMICAL-CHARACTERIZATION; EMERGING TECHNOLOGIES; ASSISTED EXTRACTION,"Background: In recent years, both food researchers and food industry have shown growing interest in Opuntia fruits, as they constitute a good source of phytochemicals such as phenolics, vitamin C, vitamin E, polysaccharides and betalains. Many of these compounds have shown antioxidant, anti-cancer, anti atherosclerotic and/or hepatoprotective properties. Moreover, the fruit is also a source of dietary fibers, which promote bowel transit, thus preventing constipation. Scope and approach: Due to these properties, Opuntia fruits are considered as functional products offering numerous health benefits when are consumed as fresh or processed product. However, these compounds can lose their properties and could be transformed into antinutrients depending on processing conditions. Therefore, there is a dire need for investigating the effect of processing on bioactive compounds of Opuntia Spp. On the other hand, during Opuntia fruit processing, a large amount of waste and by-products are generated including peel, pulp and seed, which are a great source of high-added value compounds. Nowadays, extraction of valuable compounds from Opuntia by-products is drawing more and more attention, making it on the verge of commercialization. Key findings and conclusions: The processing and preservation techniques strongly influence the stability of phytochemicals present in Opuntia fruits and their derived products. The available reports suggest that, along with conventional methods, novel non-thermal technologies are efficient to recover high added value compounds from Opuntia fruit by-products/waste. Overall, high pressure processing and pulsed electric field technology have emerged as promising methods to extend Opuntia beverages shelf life, and supercritical CO2 extraction as an effective tool to extract oils. (C) 2017 Elsevier Ltd. All rights reserved.","[Barba, Francisco J.] Univ Valencia, Nutr & Food Sci Area, Prevent Med & Publ Hlth Food Sci Toxicol & Forens, Avda Vicent Andres Estelles S-N, E-46100 Valencia, Spain; [Putnik, Predrag; Kovacevic, Danijela Bursac] Univ Zagreb, Fac Food Technol & Biotechnol, Pierottijeva 6, Zagreb 10000, Croatia; [Poojary, Mahesha M.] Univ Copenhagen, Dept Food Sci, Rolighedsvej 26, DK-1958 Frederiksberg C, Denmark; [Poojary, Mahesha M.] Univ Camerino, Sch Sci & Technol, Chem Sect, Via S Agostino 1, I-62032 Camerino, Italy; [Roohinejad, Shahin] Fed Res Inst Nutr & Food, Max Rubner Inst, Dept Food Technol & Bioproc Engn, Haid & Neu Str 9, D-76131 Karlsruhe, Germany; [Roohinejad, Shahin] Shiraz Univ Med Sci, Div Food & Nutr, Burn & Wound Healing Res Ctr, Shiraz, Iran; [Lorenzo, Jose M.] Ctr Tecnol Carne Galicia, Galicia St 4,Parque Tecnol Galicia, San Cibrao Das Vinas 32900, Ourense, Spain; [Koubaa, Mohamed] Univ Technol Compiegne, Sorbonne Univ, Ctr Rech Royallieu,ESCOM,EA 4297, Lab Transformat Integrees Mat Renouvelable,TIMR, CS 60319, F-60203 Compiegne, France",University of Valencia; University of Zagreb; University of Copenhagen; University of Camerino; Shiraz University of Medical Science; Sorbonne Universite; Universite de Technologie de Compiegne,"Roohinejad, S (corresponding author), Fed Res Inst Nutr & Food, Max Rubner Inst, Dept Food Technol & Bioproc Engn, Haid & Neu Str 9, D-76131 Karlsruhe, Germany.",shahin.roohinejad@mri.bund.de,"Bursać Kovačević, Danijela/I-2099-2019; Poojary, Mahesha Manjunatha/AAQ-1212-2020; Putnik, Predrag/B-6495-2016; Poojary, Mahesha M./AFQ-8993-2022; Barba, Francisco J./L-6596-2014; Lorenzo, Jose Manuel/K-6375-2014; Roohinejad, Shahin/L-1514-2014","Bursać Kovačević, Danijela/0000-0002-6829-6472; Poojary, Mahesha Manjunatha/0000-0002-8212-364X; Putnik, Predrag/0000-0003-0342-6114; Poojary, Mahesha M./0000-0002-8212-364X; Barba, Francisco J./0000-0002-5630-3989; Lorenzo, Jose Manuel/0000-0002-7725-9294; Roohinejad, Shahin/0000-0002-1524-2534",Alexander von Humboldt Foundation,Alexander von Humboldt Foundation(Alexander von Humboldt Foundation),"Shahin Roohinejad would like to acknowledge the Alexander von Humboldt Foundation, for his postdoctoral research fellowship award.",,104,95,95,4,83,ELSEVIER SCIENCE LONDON,LONDON,"84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND",0924-2244,,,TRENDS FOOD SCI TECH,Trends Food Sci. Technol.,SEP,2017,67,,,,,,260,270,,10.1016/j.tifs.2017.07.012,http://dx.doi.org/10.1016/j.tifs.2017.07.012,,,11,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,FE2UX,,,,,2024-06-04,WOS:000408073600022,View Full Record in Web of Science
J,"Wilkins, T; Embry, K; George, R",,,,"Wilkins, Thad; Embry, Katherine; George, Ruth",,,Diagnosis and Management of Acute Diverticulitis,AMERICAN FAMILY PHYSICIAN,,,English,Article,,,,,,,COLONIC DIVERTICULITIS; DISEASE; HOSPITALIZATION; METAANALYSIS; PERITONITIS; PREDICTORS; INCREASES; OBESITY; CT,"Uncomplicated diverticulitis is localized diverticular inflammation, whereas complicated diverticulitis is diverticular inflammation associated with an abscess, phlegmon, fistula, obstruction, bleeding, or perforation. Patients with acute diverticulitis may present with left lower quadrant pain, tenderness, abdominal distention, and fever. Other symptoms may include anorexia, constipation, nausea, diarrhea, and dysuria. Initial laboratory studies include a complete blood count, basic metabolic panel, urinalysis, and measurement of C-reactive protein. Computed tomography, the most commonly performed imaging test, is useful to establish the diagnosis and the extent and severity of disease, and to exclude complications in selected patients. Colonoscopy is recommended four to six weeks after resolution of symptoms for patients with complicated disease or for another indication, such as age-appropriate screening. In mild, uncomplicated diverticulitis, antibiotics do not accelerate recovery, or prevent complications or recurrences. Hospitalization should be considered if patients have signs of peritonitis or there is suspicion of complicated diverticulitis. Inpatient management includes intravenous fluid resuscitation and intravenous antibiotics. Patients with a localized abscess may be candidates for computed tomography-guided percutaneous drainage. Fifteen to 30 percent of patients admitted with acute diverticulitis require surgical intervention during that admission. Laparoscopic surgery results in a shorter length of stay, fewer complications, and lower in-hospital mortality compared with open colectomy. The decision to proceed to surgery in patients with recurrent diverticulitis should be individualized and based on patient preference, comorbidities, and lifestyle. Interventions to prevent recurrences of diverticulitis include increased intake of dietary fiber, exercise, cessation of smoking, and, in persons with a body mass index of 30 kg per m(2) or higher, weight loss. Copyright (C) 2013 American Academy of Family Physicians.","[Wilkins, Thad; Embry, Katherine; George, Ruth] Georgia Regents Univ, Dept Family Med, Augusta, GA 30912 USA",University System of Georgia; Augusta University,"Wilkins, T (corresponding author), Georgia Regents Univ, 1120 15th St,HB-4032, Augusta, GA 30912 USA.",jwilkins@gru.edu,"Wilkins, Thad/G-2541-2010","Wilkins, Thad/0009-0005-8558-7932",,,,,43,43,49,0,10,AMER ACAD FAMILY PHYSICIANS,KANSAS CITY,"8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797 USA",0002-838X,1532-0650,,AM FAM PHYSICIAN,Am. Fam. Physician,MAY 1,2013,87,9,,,,,612,620,,,,,,9,"Primary Health Care; Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,136WM,23668524,,,,2024-06-04,WOS:000318394100003,View Full Record in Web of Science
J,"Richardson, DP; Ansell, J; Drummond, LN",,,,"Richardson, David P.; Ansell, Juliet; Drummond, Lynley N.",,,The nutritional and health attributes of kiwifruit: a review,EUROPEAN JOURNAL OF NUTRITION,,,English,Review,,,,,,Kiwifruit; Nutritional composition; Vitamin C; Digestive health; Metabolic benefits,IRRITABLE-BOWEL-SYNDROME; FUNCTIONAL GASTROINTESTINAL DISORDERS; RANDOMIZED CONTROLLED-TRIAL; KIWI FRUIT PEPTIDE; DIGESTION IN-VITRO; LOW-FODMAP DIET; VITAMIN-C; ANTIOXIDANT CAPACITY; ACTINIDIA-DELICIOSA; GREEN KIWIFRUIT,"Purpose To describe the nutritional and health attributes of kiwifruit and the benefits relating to improved nutritional status, digestive, immune and metabolic health. The review includes a brief history of green and gold varieties of kiwifruit from an ornamental curiosity from China in the 19th century to a crop of international economic importance in the 21st century; comparative data on their nutritional composition, particularly the high and distinctive amount of vitamin C; and an update on the latest available scientific evidence from well-designed and executed human studies on the multiple beneficial physiological effects. Of particular interest are the digestive benefits for healthy individuals as well as for those with constipation and other gastrointestinal disorders, including symptoms of irritable bowel syndrome. The mechanisms of action behind the gastrointestinal effects, such as changes in faecal (stool) consistency, decrease in transit time and reduction of abdominal discomfort, relate to the water retention capacity of kiwifruit fibre, favourable changes in the human colonic microbial community and primary metabolites, as well as the naturally present proteolytic enzyme actinidin, which aids protein digestion both in the stomach and the small intestine. The effects of kiwifruit on metabolic markers of cardiovascular disease and diabetes are also investigated, including studies on glucose and insulin balance, bodyweight maintenance and energy homeostasis. Conclusions The increased research data and growing consumer awareness of the health benefits of kiwifruit provide logical motivation for their regular consumption as part of a balanced diet. Kiwifruit should be considered as part of a natural and effective dietary strategy to tackle some of the major health and wellness concerns around the world.","[Richardson, David P.] DPR Nutr Ltd, 34 Grimwade Ave, Croydon CR0 5DG, Surrey, England; [Ansell, Juliet] Zespri Int Ltd, 400 Maunganui Rd, Mt Maunganui 3116, Tauranga, New Zealand; [Drummond, Lynley N.] Drummond Food Sci Advisory Ltd, 1137 Drain Rd, Killinchy 7682, New Zealand",,"Drummond, LN (corresponding author), Drummond Food Sci Advisory Ltd, 1137 Drain Rd, Killinchy 7682, New Zealand.",drummondl@mac.com,"Drummond, Lynley/AAJ-6055-2020","Drummond, Lynley/0000-0002-1350-8132","Zespri International Ltd, Mount Maunganui, New Zealand","Zespri International Ltd, Mount Maunganui, New Zealand","Funding for this review was provided by Zespri International Ltd, Mount Maunganui, New Zealand.",,163,168,179,26,139,SPRINGER HEIDELBERG,HEIDELBERG,"TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY",1436-6207,1436-6215,,EUR J NUTR,Eur. J. Nutr.,DEC,2018,57,8,,,,,2659,2676,,10.1007/s00394-018-1627-z,http://dx.doi.org/10.1007/s00394-018-1627-z,,,18,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,HB1ZF,29470689,"Green Published, hybrid",,,2024-06-04,WOS:000450829600001,View Full Record in Web of Science
J,"Bishop, PR; Nowicki, MJ",,,,"Bishop, PR; Nowicki, MJ",,,Defecation disorders in the neurologically impaired child,PEDIATRIC ANNALS,,,English,Article,,,,,,,ANTEGRADE CONTINENCE ENEMA; SPINAL-CORD INJURY; FECAL INCONTINENCE; MULTIPLE-SCLEROSIS; PERCUTANEOUS CECOSTOMY; DIETARY FIBER; BIOFEEDBACK; MANAGEMENT; MYELOMENINGOCELE; DYSFUNCTION,"The authors discuss the normal anatomy and physiology of defecation, identify the neurologic diseases complicated by constipation, and propose realistic treatment plans for the neurologically impaired child.","Univ Mississippi, Med Ctr, Blair E Batson Childrens Hosp, Div Pediat Gastroenterol & Nutr, Jackson, MS 39216 USA",University of Mississippi Medical Center; University of Mississippi,"Bishop, PR (corresponding author), Univ Mississippi, Med Ctr, Div Pediat Gastroenterol, 2500 N State St, Jackson, MS 39216 USA.",,,"Bishop, Phyllis/0000-0002-4630-606X",,,,,44,11,11,0,1,SLACK INC,THOROFARE,"6900 GROVE RD, THOROFARE, NJ 08086 USA",0090-4481,,,PEDIATR ANN,Pediatr. Annu.,MAY,1999,28,5,,,,,322,+,,10.3928/0090-4481-19990501-13,http://dx.doi.org/10.3928/0090-4481-19990501-13,,,9,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,196RP,10341354,,,,2024-06-04,WOS:000080321600011,View Full Record in Web of Science
J,"Sáenz, AT; López, ER; Valderrama, VMM; Garza, NEM",,,,"Tijerina Saenz, Alexandra; Ramirez Lopez, Erik; Meneses Valderrama, Vctor Manuel; Martinez Garza, Nancy Edith",,,Intakes of energy and macronutrients in pregnant women in the northeast of Mexico,ARCHIVOS LATINOAMERICANOS DE NUTRICION,,,Spanish,Article,,,,,,Pregnancy; energy; macronutrients; intake; diet,CONSTIPATION; PREVALENCE; DIET,"Descriptive and transversal study, first to report the dietary intake of energy and macronutrients in pregnant women in the northeast of Mexico. Convenience sample of 125 pregnant women (15-45 years of age) in the third trimester, who were prenatal patients in the Hospital Regional Materno Infantil, Nuevo Leon, Mexico. It was reported the level of studies, marital and professional status, weight, height and body mass index (BMI). Diet was evaluated by 24-hour food recalls, in 3 non-consecutive days. There were analyzed the intake of energy and the percentage contribution of calories from macronutrients according to the recommendations of intake of pregnant women. Intake of energy was 1683,8 Cal/day. The caloric contribution of saturated fat was higher than the recommendation in 53,6 % of women. 76,8 % of participants ate more than 55 % of energy from carbohydrates, while 86,4 % ate more sugars than the amount suggested. The median intake of protein was 12,0 % of total energy intake. 75% of participants consumed less than 22,5 g of total dietary fiber. The relevance of knowing the intakes of energy and macronutrients in pregnant women may be due to the possible influence of diet over the child's appetite and maternal complications. Results of this study suggest the need to provide women with adequate nutritional recommendations since the first trimester of gestation, according to their nutritional status and social environment.","[Tijerina Saenz, Alexandra] Univ Autonoma Nuevo Leon, Fac Salud Publ & Nutr, Ctr Invest Nutr & Salud Publ, Monterrey, NL, Mexico; Hosp Reg Materno Infantil Alta Especialidad, Secretaria Salud Nuevo Leon, Guadalupe, NL, Mexico",Universidad Autonoma de Nuevo Leon,"Sáenz, AT (corresponding author), Univ Autonoma Nuevo Leon, Fac Salud Publ & Nutr, Ctr Invest Nutr & Salud Publ, Monterrey, NL, Mexico.",,,,,,,,16,5,6,0,7,ARCHIVOS LATINOAMERICANOS NUTRICION,CARACAS,"APARTADO 62778 CHACAO, AVENIDA FRANCISCO MIRANDA, CARACAS 1060, VENEZUELA",0004-0622,2309-5806,,ARCH LATINOAM NUTR,Arch. Latinoam. Nutr.,,2014,64,3,,,,,174,181,,,,,,8,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,AZ5TX,26137793,,,,2024-06-04,WOS:000348284100004,View Full Record in Web of Science
S,"Hojsak, I",,"Koletzko, B; Bhatia, J; Bhutta, ZA; Cooper, P; Makrides, M; Uauy, R; Wang, W",,"Hojsak, Iva",,,Digestible and Non-Digestible Carbohydrates,"PEDIATRIC NUTRITION IN PRACTICE, 2ND EDITION",World Review of Nutrition and Dietetics,,English,Article; Book Chapter,,,,,,Carbohydrate; Fibre; Glycaemic carbohydrate; Prebiotics,ESPGHAN COMMITTEE; DIETARY FIBER; CHILDREN; CONSTIPATION; PREBIOTICS; OBESITY; HEALTH; FOOD,,"Childrens Hosp Zagreb, Referral Ctr Paediat Gastroenterol & Nutr, HR-10000 Zagreb, Croatia",University of Zagreb,"Hojsak, I (corresponding author), Childrens Hosp Zagreb, Referral Ctr Paediat Gastroenterol & Nutr, Klaiceva 16, HR-10000 Zagreb, Croatia.",ivahojsak@gmail.com,"Hojsak, Iva/AAI-8937-2020","Hojsak, Iva/0000-0003-3262-5964",,,,,18,1,1,2,17,KARGER,BASEL,"POSTFACH, CH-4009 BASEL, SWITZERLAND",0084-2230,1662-3975,978-3-318-02691-7; 978-3-318-02690-0,WORLD REV NUTR DIET,World Rev.Nutr.Diet.,,2015,113,,,,,,46,50,,10.1159/000360316,http://dx.doi.org/10.1159/000360316,10.1159/isbn.978-3-318-02691-7,,5,Nutrition & Dietetics; Pediatrics,Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics; Pediatrics,BD3CI,25906855,,,,2024-06-04,WOS:000359469200010,View Full Record in Web of Science
J,"O'Neil, CE; Nicklas, TA; Fulgoni, VL; DiRienzo, MA",,,,"O'Neil, Carol E.; Nicklas, Theresa A.; Fulgoni, Victor L., III; DiRienzo, Maureen A.",,,"Cooked oatmeal consumption is associated with better diet quality, better nutrient intakes, and reduced risk for central adiposity and obesity in children 2-18 years: NHANES 2001-2010",FOOD & NUTRITION RESEARCH,,,English,Article,,,,,,children; oatmeal; cooked cereal; NHANES; nutrient intake; diet quality; obesity,NUTRITION EXAMINATION SURVEY; EAT BREAKFAST CEREAL; SATIVA L. EXTRACTS; NATIONAL-HEALTH; ANTIOXIDANT CAPACITY; CHRONIC CONSTIPATION; WHOLE GRAINS; FIBER INTAKE; ADOLESCENTS; POPULATION,"Background: None of the studies of whole grains that have looked either at diet or weight/adiposity measures have focused exclusively on oatmeal. Objective: The objective of this study was to assess the association between oatmeal consumption and nutrient intake, diet quality, and weight/adiposity of children aged 2-18. Design: A nationally representative sample of children aged 2-18 (N = 14,690) participating in National Health and Nutrition Examination Survey 2001-2010 was used. Intake was determined from a single 24-h dietary recall. Diet quality was measured using the Healthy Eating Index-2010 (HEI-2010). Covariate-adjusted regression analyses, using appropriate sample weights, were used to determine differences between oatmeal consumers and non-consumers for demographics, nutrient intakes, diet quality, and weight/adiposity measures (p < 0.01). Logistic regression was performed to calculate odds ratios for weight measures and obesity (p < 0.05). Results: Compared to non-consumers, oatmeal consumers were more likely to be younger and less likely to be smokers. Consumers had higher intakes of dietary fiber, vitamin A, thiamin, riboflavin, calcium, phosphorus, magnesium, iron, copper, and potassium, and significantly lower intakes of total, monounsaturated and saturated fatty acids, cholesterol, and sodium. Oatmeal consumers had higher dietary quality scores attributable to higher intakes of whole grains and lower intakes of refined grains and empty calories. Children consuming oatmeal were at lower risk for having central adiposity and being obese. Conclusions: Consumption of oatmeal by children was associated with better nutrient intake, diet quality, and reduced risk for central adiposity and obesity and should be encouraged as part of an overall healthful diet.","[O'Neil, Carol E.] Louisiana State Univ, Ctr Agr, Sch Nutr & Food Sci, Baton Rouge, LA 70803 USA; [Nicklas, Theresa A.] Baylor Coll Med, Childrens Nutr Res Ctr, Dept Pediat, Houston, TX 77030 USA; [Fulgoni, Victor L., III] Nutr Impact LLC, Battle Creek, MI USA; [DiRienzo, Maureen A.] Quadrant Nutr LLC, Hendersonville, NC USA","Louisiana State University System; Louisiana State University; Baylor College of Medicine; Nutrition Impact, LLC","O'Neil, CE (corresponding author), Louisiana State Univ, Ctr Agr, Sch Nutr & Food Sci, 261 Knapp Hall,110 LSU Union Sq, Baton Rouge, LA 70803 USA.",ceoneil1@lsu.edu,,,Pepsico; USDA Agricultural Research Service [58-6250-6-003]; USDA Hatch Project [LAB 94209],Pepsico; USDA Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); USDA Hatch Project,"At the time this manuscript was written C.E. O'Neil was a member of the Kellogg's Breakfast Council, which had no input into the study design or interpretation of the data. V.L. Fulgoni III, T.A. Nicklas, and Maureen A. DiRienzo have no potential conflicts of interest to declare other than the funding declaration elsewhere. This research project was supported by Pepsico and the USDA Agricultural Research Service through specific cooperative agreement 58-6250-6-003 (T.A. Nicklas). Partial support was received from the USDA Hatch Project LAB 94209 (C.E. O'Neil). The funding agencies had no input into the study design or interpretation of the data. This work is a publication of the United States Department of Agriculture (USDA/ARS) Children's Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, and Houston, TX. The contents of this publication do not necessarily reflect the views or policies of the USDA, nor does mention of trade names, commercial products, or organizations imply endorsement from the US Government.",,54,7,10,0,19,SWEDISH NUTRITION FOUNDATION-SNF,LUND,"IDEON SCIENCE PARK, BESOK SCHEELEV 17 BETA 5, 3V, LUND, 223 70, SWEDEN",1654-6628,1654-661X,,FOOD NUTR RES,Food Nutr. Res.,,2015,59,,,,,,,,26673,10.3402/fnr.v59.26673,http://dx.doi.org/10.3402/fnr.v59.26673,,,8,Food Science & Technology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Nutrition & Dietetics,CK0EU,26022379,"Green Published, Green Submitted, gold",,,2024-06-04,WOS:000355879100001,View Full Record in Web of Science
J,"Ajdzanovic, V; Miler, M; Sosic-Jurjevic, B; Filipovic, B",,,,"Ajdzanovic, Vladimir; Miler, Marko; Sosic-Jurjevic, Branka; Filipovic, Branko",,,The close proximity between the human rectum and prostate: a functional-anatomic arrangement favoring prostate health,JOURNAL OF MENS HEALTH,,,English,Review,,,,,,Rectum; Defecation; Prostate drainage; Plant based diet; Polyphenols,SERUM TESTOSTERONE; EJACULATION FREQUENCY; DIETARY POLYPHENOLS; CANCER-MORTALITY; CONSTIPATION; PREVENTION; MODELS; RISK; ZINC,"Prostate health is related to the frequency of ejaculation and prostate drainage. Frequent, repetitive ejaculations theoretically may pose a prostate cancer risk due to ensuing high testosterone levels and loss of zinc. In line with this, the proximity of the human rectum and prostate is of diagnostic and therapeutic importance. We provide evidence to support the view that the proximity of the rectum and prostate in men enables lower bowel distention to compress the prostate's lateral side to facilitate drainage, which might lower cancer risk. This drainage mechanism is likely on-going and gradual, compared to rapid drainage following ejaculation. The physiological context suggests that these mechanisms of prostate drainage are complementary. Dietary content containing polyphenol- and fiber-rich meals, along with voluminous stool formation and increased gastrointestinal transit may all help improve prostate drainage. This may be important in voluntary abstinent men or other categories of sexually limited men. Recognizing that the anatomic relationship between the rectal area and prostate may facilitate prostate drainage, because of diet and gastro-intestinal activity, could be important to prostate health maintenance.","[Ajdzanovic, Vladimir; Miler, Marko; Sosic-Jurjevic, Branka; Filipovic, Branko] Univ Belgrade, Natl Inst Republ Serbia, Inst Biol Res Sinisa Stankovic, Dept Cytol, Belgrade 11060, Serbia",University of Belgrade,"Ajdzanovic, V (corresponding author), Univ Belgrade, Natl Inst Republ Serbia, Inst Biol Res Sinisa Stankovic, Dept Cytol, Belgrade 11060, Serbia.",avlada@ibiss.bg.ac.rs,"Miler, Marko/AAC-8346-2019; Šošić-Jurjević, Branka/AHD-4810-2022","Miler, Marko/0000-0002-8366-3138; Šošić-Jurjević, Branka/0000-0002-5496-0619","Ministry of Science, Tech-nological Development and Innovations of the Republic of Serbia [451-03-47/2023-01/200007]; Ministry","Ministry of Science, Tech-nological Development and Innovations of the Republic of Serbia; Ministry","FUNDING Our work was supported by the Ministry of Science, Tech-nological Development and Innovations of the Republic of Serbia, via direct financing of our Institute (contract number: 451-03-47/2023-01/200007) . Ministry is engaged only in the research and preparation of the article funding.",,58,0,0,1,1,MRE PRESS,SINGAPORE,"14 ROBINSON RD #08-01A FAR EAST FINANCE, SINGAPORE, SINGAPORE",1875-6867,1875-6859,,J MENS HEALTH,J. Mens Health,OCT,2023,19,10,,,,,1,6,,10.22514/jomh.2023.094,http://dx.doi.org/10.22514/jomh.2023.094,,,6,"Public, Environmental & Occupational Health",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),"Public, Environmental & Occupational Health",X5DS4,,gold,,,2024-06-04,WOS:001098660000001,View Full Record in Web of Science
J,"Yasukawa, Z; Inoue, R; Ozeki, M; Okubo, T; Takagi, T; Honda, A; Naito, Y",,,,"Yasukawa, Zenta; Inoue, Ryo; Ozeki, Makoto; Okubo, Tsutomu; Takagi, Tomohisa; Honda, Akira; Naito, Yuji",,,"Effect of Repeated Consumption of Partially Hydrolyzed Guar Gum on Fecal Characteristics and Gut Microbiota: A Randomized, Double-Blind, Placebo-Controlled, and Parallel-Group Clinical Trial",NUTRIENTS,,,English,Article,,,,,,partially hydrolyzed guar gum; Bristol stool scale; diarrhea; gut microbiota; 16S rRNA,IRRITABLE-BOWEL-SYNDROME; ANTIBIOTIC-ASSOCIATED DIARRHEA; QUALITY-OF-LIFE; COMMENSAL MICROBIOTA; DIETARY FIBER; HEALTH; BRAIN; CONSTIPATION; DYSBIOSIS; IMPACT,"Partially hydrolyzed guar gum (PHGG) is a water-soluble dietary fiber and is used in solid and liquid food to regulate gut function. The aim of this study was to investigate effects of PHGG on bowel movements (stool form and frequency), plasma bile acids, quality of life, and gut microbiota of healthy volunteers with a tendency toward diarrhea, i.e., irritable bowel syndrome diarrhea (IBS-D)-like symptoms. A randomized, double-blind, placebo-controlled, and parallel trial was performed on 44 healthy volunteers (22 males, 22 females, 41.9 +/- 6.3 years old (average +/- SD)) with minimum 7 bowel movements every week, wherein above 50% of their stool was between the Bristol stool scale (BSS) value of 5 and 6. Intake of the PHGG for 3 months significantly improved stool form, evaluated using BSS, and had no effects on stool frequency. BSS was significantly normalized in the group consuming the PHGG compared with the placebo. Comprehensive fecal microbiome analysis by the 16S rRNA-sequence method detected significant changes in the ratio of some bacteria, such as an increase of Bifidobacterium (p < 0.05) in the PHGG group. Our results suggest that intake of PHGG improves human stool form via regulating intestinal microbiota.","[Yasukawa, Zenta; Ozeki, Makoto; Okubo, Tsutomu] Taiyo Kagaku Co Ltd, Nutr Div, Yokaichi, Mie 5100844, Japan; [Yasukawa, Zenta; Ozeki, Makoto; Okubo, Tsutomu] Mie Univ, Acad Ind Grad Sch, Tsu, Mie 5148507, Japan; [Inoue, Ryo] Kyoto Prefectural Univ, Dept Agr & Life Sci, Lab Anim Sci, Kyoto 6068522, Japan; [Takagi, Tomohisa; Naito, Yuji] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Mol Gastroenterol & Hepatol, Kyoto 6028566, Japan; [Honda, Akira] Tokyo Med Univ, Ibaraki Med Ctr, Gastroenterol, Inashiki, Ibaraki 3000395, Japan","TAIYO KAGAKU CO., LTD.; Mie University; Kyoto Prefectural University; Kyoto Prefectural University of Medicine; Tokyo Medical University","Yasukawa, Z (corresponding author), Taiyo Kagaku Co Ltd, Nutr Div, Yokaichi, Mie 5100844, Japan.;Yasukawa, Z (corresponding author), Mie Univ, Acad Ind Grad Sch, Tsu, Mie 5148507, Japan.",zyasukawa@taiyokagaku.co.jp,,"Naito, Yuji/0000-0001-5443-788X; Honda, Akira/0000-0003-0902-8272; Inoue, Ryo/0000-0002-7233-366X","Taiyo Kagaku Co., Ltd.","Taiyo Kagaku Co., Ltd.","This research was funded by Taiyo Kagaku Co., Ltd.",,55,39,44,3,18,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,SEP,2019,11,9,,,,,,,2170,10.3390/nu11092170,http://dx.doi.org/10.3390/nu11092170,,,15,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,JA6PP,31509971,"Green Published, gold",,,2024-06-04,WOS:000487964600248,View Full Record in Web of Science
J,"Kim, HH; Kim, DS; Kim, SW; Lim, SH; Kim, DK; Shin, TY; Kim, SH",,,,"Kim, Hui-Hun; Kim, Duk-Sil; Kim, Sung-Wan; Lim, Se-Hyun; Kim, Dae Keun; Shin, Tae-Yong; Kim, Sang-Hyun",,,"Inhibitory effects of Diospyros kaki in a model of allergic inflammation: Role of cAMP, calcium and nuclear factor-κB",INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE,,,English,Article,,,,,,Diospyros kaki; allergic inflammation; histamine; nuclear factor-kappa B; mast cells,MAST-CELLS; HISTAMINE-RELEASE; CYTOKINE PRODUCTION; LEAVES; PERSIMMON; ANAPHYLAXIS; MECHANISM; EXTRACT; MICE,"Diospyros kaki (D. kaki) has been cultivated throughout Eastern Asia for hundreds of years. D. kaki contains various biological active compounds, such as amino acids, carotenoids, flavonoids, tannins, catechins and vitamin A. Previous studies have shown that D. kaki has beneficial effects on homeostasis, constipation, hypertension, atherosclerosis and allergic dermatitis and is a good source of antioxidants, polyphenols and dietary fiber. However, the anti-allergic and anti-inflammatory effects of D. kaki have not yet been elucidated. This study aimed to investigate the protective effects of the aqueous extract of Diospyros kaki (AEDK) on mast cell-mediated allergic inflammation and to determine its possible mechanisms of action by using in vitro and in vivo mast cell-based models. The cAMP and intracellular calcium levels were measured to clarify the mechanisms by which AEDK inhibits the release of histamine from mast cells. AEDK inhibited the release of histamine and beta-hexosaminidase from mast cells by modulating cAMP and intracellular calcium levels. We also measured the expression of pro-inflammatory cytokines, such as tumor necrosis factor (TNF)-alpha and interleukin (IL)-1 beta. AEDK decreased gene expression and the secretion of the pro-inflammatory cytokines, TNF-alpha and IL-1 beta by inhibiting nuclear factor-kappa B. In addition, AEDK inhibited systemic and cutaneous allergic reaction. The inhibitory effects of AEDK on allergic reaction and the release of histamine were found to be similar to those of disodium cromoglycate, a known anti-allergic drug. To isolate the active component of AEDK, activity-guided fractionation was performed, based on the inhibitory effects on systemic anaphylaxis. Catechin was identified as an active compound. The present findings provide evidence that AEDK inhibits allergic inflammation and suggest the therapeutic application of AEDK in allergic inflammatory disorders.","[Kim, Hui-Hun] Korea Tradit Med Agcy, Korea Promot Inst Tradit Med Ind, Gyongsan 712210, South Korea; [Kim, Hui-Hun; Kim, Sang-Hyun] Kyungpook Natl Univ, Sch Med, Dept Pharmacol, Cell & Matrix Res Inst, Taegu 700422, South Korea; [Kim, Duk-Sil; Kim, Sung-Wan] CHA Univ, CHA Gumi Med Ctr, Dept Thorac & Cardiovasc Surg, Gumi 730040, South Korea; [Lim, Se-Hyun; Kim, Dae Keun; Shin, Tae-Yong] Woosuk Univ, Coll Pharm, Jeonju 565701, South Korea",Kyungpook National University; Pochon Cha University; Woosuk University,"Kim, SH (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Pharmacol, 2-101 Dongin Dong, Taegu 700422, South Korea.",tyshin@woosuk.ac.kr; shkim72@knu.ac.kr,"Kim, Sung-Wan/KBR-1666-2024",,"NRF; Ministry of Science, ICT & Future Planning [2012M3A9B6055416]","NRF; Ministry of Science, ICT & Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)","This study was supported by NRF funded by the Ministry of Science, ICT & Future Planning (2012M3A9B6055416).",,33,25,28,1,11,SPANDIDOS PUBL LTD,ATHENS,"POB 18179, ATHENS, 116 10, GREECE",1107-3756,,,INT J MOL MED,Int. J. Mol. Med.,OCT,2013,32,4,,,,,945,951,,10.3892/ijmm.2013.1465,http://dx.doi.org/10.3892/ijmm.2013.1465,,,7,"Medicine, Research & Experimental",Science Citation Index Expanded (SCI-EXPANDED),Research & Experimental Medicine,209AL,23921373,Bronze,,,2024-06-04,WOS:000323725200026,View Full Record in Web of Science
J,"Bernier, JJ",,,,"Bernier, JJ",,,"Hard stools, soft stools. New insight on fecal water: Water in solid materials and dilution water",GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE,,,French,Article,,,,,,constipation; diarrhea; fecal water; fecal dilution water; fecal consistency; colonic transit time; fecal bacteria,DIETARY FIBER,,"HOP ST LAZARE,PARIS,FRANCE",,,,,,,,,,13,5,5,0,1,MASSON EDITEUR,PARIS 06,"120 BLVD SAINT-GERMAIN, 75280 PARIS 06, FRANCE",0399-8320,,,GASTROEN CLIN BIOL,Gastroenterol. Clin. Biol.,JAN,1997,21,1,,,,,3,6,,,,,,4,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,WJ971,9091388,,,,2024-06-04,WOS:A1997WJ97100002,View Full Record in Web of Science
B,"Almerigi, PF; Ciaroni, V; Bazzocchi, G",,"Santoro, GA; Wieczorek, AP; Bartram, CI",,"Almerigi, Pier Francesco; Ciaroni, Valentina; Bazzocchi, Gabriele",,,Medical Treatment,PELVIC FLOOR DISORDERS: IMAGING AND MULTIDISCIPLINARY APPROACH TO MANAGEMENT,,,English,Article; Book Chapter,,,,,,Alosetron; Amitryptiline; Bowel habits; Diarrhea; Fecal incontinence; Fiber implementation; Hygienic measures; Loperamide; Phenylephrine gel; Urgency,IRRITABLE-BOWEL-SYNDROME; FECAL INCONTINENCE; CHRONIC DIARRHEA; TOPICAL PHENYLEPHRINE; CHRONIC CONSTIPATION; RECEPTOR ANTAGONIST; LOPERAMIDE; ALOSETRON,"Fecal incontinence is a common dysfunction whose prevalence is underestimated and increases with age. A conservative approach with changing of bowel habits, dietary modifications, and medical treatment may be considered for minor degrees of incontinence. The best choice of medical treatment can be reached through an accurate integration of clinical features and instrumental diagnostic results. The main goal of conservative treatment should be not the complete resolution of dysfunction but the improvement of symptoms and quality of life.","[Almerigi, Pier Francesco; Ciaroni, Valentina] Univ Bologna, Unit Gen Surg, Dept Gen Surg & Organ Transplantat, S Orsola Malpighi Hosp, Bologna, Italy; [Bazzocchi, Gabriele] Univ Bologna, Unit Visceral Disorders & Auton Dysfunct, Montecatone Rehabil Inst, Bologna, Italy",University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna,"Almerigi, PF (corresponding author), Univ Bologna, Unit Gen Surg, Dept Gen Surg & Organ Transplantat, S Orsola Malpighi Hosp, Bologna, Italy.",,,,,,,,20,0,0,0,0,SPRINGER,NEW YORK,"233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES",,,978-88-470-1541-8,,,,2010,,,,,,,371,373,,10.1007/978-88-470-1542-5_50,http://dx.doi.org/10.1007/978-88-470-1542-5_50,10.1007/978-88-470-1542-5,,3,Obstetrics & Gynecology; Surgery,Book Citation Index – Science (BKCI-S),Obstetrics & Gynecology; Surgery,BRO60,,Green Submitted,,,2024-06-04,WOS:000283271600050,View Full Record in Web of Science
J,"Luo, ZF; Zhao, YY; Zeng, LM; Yin, J; Zeng, QH; Li, XL; He, JH; Wang, J; Tan, B",,,,"Luo, Zhenfu; Zhao, Yuanyuan; Zeng, Liming; Yin, Jie; Zeng, Qinghua; Li, Xilong; He, Jianhua; Wang, Jing; Tan, Bi'e",,,Effects of Fermented Radix puerariae Residue on Nutrient Digestibility and Reproductive Performance of Sows,FRONTIERS IN NUTRITION,,,English,Article,,,,,,fermented Radix puerariae residue; nutrient digestibility; reproductive performance; sows; offspring,HIGH-FIBER DIET; POSTPARTURIENT DISORDERS; IMMUNE FUNCTION; GESTATING SOWS; GUT MICROBIOTA; PREGNANT SOWS; SUPPLEMENTATION; DURATION; BEHAVIOR; ISOFLAVONES,"This study was conducted to investigate the effect of fermented Radix puerariae residue (FRPR) on reproductive performance, apparent total tract digestibility (ATTD) of nutrients, and fecal short-chain fatty acid (SCFA) contents of sows. A total of 36 landrace x large white multiparous sows were randomly arranged into three treatments, representing supplementation with 0, 2, and 4% FRPR to a corn-soybean meal and wheat bran-based diet during the whole gestation period. The results showed that dietary FRPR had no effects on litter size and the number of total alive piglets (P > 0.05), and that the number of weaned piglets and weaning weight of litter were increased in sows with 4% FRPR treatment compared with control treatment (P < 0.05). Dietary 4% FRPR significantly decreased constipation rate, improved the ATTD of dry matter and organics, and fecal contents of acetate, propionate, and total SCFAs (P < 0.05). In the offspring piglets, serum concentrations of total protein, alkaline phosphatase, IgG, IL-10, and TGF-beta were increased, but blood urea nitrogen content was decreased with 4% FRPR treatment (P < 0.05). There were no significant differences in all determined indexes except for fecal acetic acid and total SCFAs between control and 2% FRPR treatment (P > 0.05). These findings indicated that FRPR used in the diets of sows showed positive effects on fecal characteristics, utilization of nutrients, and reproductive performance. Maternal supplementation with 4% FRPR is recommended for improving immune responses, weaning litter size, and litter weight of offspring piglets, which provide useful information for the application of residues of R. puerariae.","[Luo, Zhenfu; Zhao, Yuanyuan; Yin, Jie; Zeng, Qinghua; He, Jianhua; Wang, Jing; Tan, Bi'e] Hunan Agr Univ, Coll Anim Sci & Technol, Changsha, Peoples R China; [Zeng, Liming] Jiangxi Agr Univ, Coll Anim Sci, Nanchang, Jiangxi, Peoples R China; [Li, Xilong] Minist Agr Peoples Republ China, Key Lab Feed Biotechnol, Beijing, Peoples R China",Hunan Agricultural University; Jiangxi Agricultural University; Ministry of Agriculture & Rural Affairs,"Tan, B (corresponding author), Hunan Agr Univ, Coll Anim Sci & Technol, Changsha, Peoples R China.",bietan@hunau.edu.cn,"Zeng, Qinghua/G-2000-2011; Tan, Bie/KMX-8635-2024",,"National Natural Science Foundation of China [U20A2054]; Innovation Province Project [2019RS3021]; Key R&D Program of Hunan Province [2018WK2070]; Open Project Program of Key Laboratory of Feed Biotechnology, The Ministry of Agriculture of the People's Republic of China","National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Province Project; Key R&D Program of Hunan Province; Open Project Program of Key Laboratory of Feed Biotechnology, The Ministry of Agriculture of the People's Republic of China","The authors would like to acknowledge the financial support from the National Natural Science Foundation of China (U20A2054), Innovation Province Project (2019RS3021), Key R&D Program of Hunan Province (2018WK2070), and Open Project Program of Key Laboratory of Feed Biotechnology, The Ministry of Agriculture of the People's Republic of China.",,44,2,3,1,30,FRONTIERS MEDIA SA,LAUSANNE,"AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND",2296-861X,,,FRONT NUTR,Front. Nutr.,AUG 30,2021,8,,,,,,,,715713,10.3389/fnut.2021.715713,http://dx.doi.org/10.3389/fnut.2021.715713,,,9,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,UU2GG,34527689,"Green Published, gold",,,2024-06-04,WOS:000698619200001,View Full Record in Web of Science
J,"Tripp, ML; Dahlberg, CJ; Eliason, S; Lamb, JJ; Ou, JJ; Gao, W; Bhandari, J; Graham, D; Dudleenamjil, E; Babish, JG",,,,"Tripp, Matthew L.; Dahlberg, Clinton J.; Eliason, Sarah; Lamb, Joseph J.; Ou, Joseph J.; Gao, Wei; Bhandari, Jay; Graham, David; Dudleenamjil, Enkhmart; Babish, John G.",,,"A Low-Glycemic, Mediterranean Diet and Lifestyle Modification Program with Targeted Nutraceuticals Reduces Body Weight, Improves Cardiometabolic Variables and Longevity Biomarkers in Overweight Subjects: A 13-Week Observational Trial",JOURNAL OF MEDICINAL FOOD,,,English,Article,,,,,,low-glycemic load diet; nitric oxide; obesity; polyphenols,CALORIE RESTRICTION; OXIDATIVE STRESS; OBESE ADULTS; RISK; FATNESS; CANCER; FIBER; NONOBESE; GLUCOSE,"Among the comorbidities of high body mass index, cardiovascular disease continued to be the leading cause of death and disability globally in 2015, while type 2 diabetes remained second. The primary objectives of this observational study were to confirm the safety, tolerability, and efficacy of our calorie-restricted Mediterranean diet with targeted dietary supplementation (PROG1) using globally recognized dietary supplementation. Fifty healthy overweight and obese subjects with cardiometabolic risk factors were assigned a modified Mediterranean diet, including protein shakes and targeted supplementation (PROG2), providing similar to 68-76% of subject estimated calorie requirements. Salivary nitrite was assessed weekly and key cardiometabolic metrics were recorded at baseline and weeks 9 and 13. PROG2 was well tolerated with 86% compliance. The most common adverse effects were bloating, flatulence, and constipation, which were self-limiting. Subjects exhibited decreases (P < .01) from baseline of 12% in body weight, 18% in body fat, and 8.8% in waist circumference. Total cholesterol (TC), low-density lipoprotein (LDL) cholesterol, and triglycerides (TG) were reduced (P < .01), respectively, 19%, 22%, and 40%. Lipid ratios of TC/high-density lipoprotein (HDL), TG/HDL, and oxidized LDL (oxLDL)/HDL were decreased 15% (P < .01), 35% (P < .01), and 13% (P < .05), respectively. Inflammation biomarkers, oxLDL and high-sensitivity C-reactive protein, were reduced 17% (P < .01) and 30% (P < .05), respectively. Reductions of 9.0% for systolic (P < .01) and 12% (P < .01) for diastolic blood pressure were noted. In concert, the nitrogen dioxide salivary biomarker for nitric oxide was increased relative to baseline. PROG2 produced a dramatic 50% reduction in subjects meeting cardiometabolic syndrome criteria and a 38% decrease in Framingham 10-year cardiovascular risk. These results confirmed our previous findings that the addition of targeted nutraceutical supplementation to a calorie-restricted Mediterranean diet with lifestyle modifications improves multiple longevity risk factors more effectively than diet and lifestyle modification alone.","[Tripp, Matthew L.; Dahlberg, Clinton J.; Eliason, Sarah; Ou, Joseph J.; Gao, Wei; Bhandari, Jay; Graham, David; Dudleenamjil, Enkhmart] Nat Sunshine, Hughes Ctr Res & Innovat, Lehi, UT USA; [Lamb, Joseph J.] Personalized Med Inc, 9770 44th Ave NW,Suite 102, Gig Harbor, WA USA; [Babish, John G.] Bio Nexus Ltd, 508 White Church Rd, Brooktondale, NY 14817 USA",,"Babish, JG (corresponding author), Bio Nexus Ltd, 508 White Church Rd, Brooktondale, NY 14817 USA.",jgb7@cornell.edu,,"Gao, Wei/0000-0003-0843-1449",,,,,49,10,10,0,17,"MARY ANN LIEBERT, INC",NEW ROCHELLE,"140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA",1096-620X,1557-7600,,J MED FOOD,J. Med. Food,MAY 1,2019,22,5,,,,,479,489,,10.1089/jmf.2018.0063,http://dx.doi.org/10.1089/jmf.2018.0063,,,11,"Chemistry, Medicinal; Food Science & Technology; Nutrition & Dietetics",Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy; Food Science & Technology; Nutrition & Dietetics,HY2PC,31084538,,,,2024-06-04,WOS:000467964100006,View Full Record in Web of Science
J,"Clausen, MR; Mortensen, PB",,,,"Clausen, MR; Mortensen, PB",,,"Lactulose, disaccharides and colonic flora - Clinical consequences",DRUGS,,,English,Review,,,,,,,CHAIN FATTY-ACIDS; FECAL INCUBATION SYSTEM; HUMAN LARGE-INTESTINE; HEPATIC-COMA; CIRRHOTIC-PATIENTS; OSMOTIC DIARRHEA; DIETARY FIBER; AMINO-ACIDS; METABOLISM; ABSORPTION,"Lactulose is one of the most frequently utilised agents in the treatment of constipation and hepatic encephalopathy because of its efficacy and good safety profile. The key to understanding the possible modes of action by which lactulose achieves its therapeutic effects in these disorders lies in certain pharmacological phenomena: (a) lactulose is a synthetic disaccharide that does not occur naturally; (b) there is no disaccharidase on the microvillus membrane of enterocytes in the human small intestine that hydrolyses lactulose; and (c) lactulose is not absorbed from the small intestine. Thus, the primary site of action is the colon in which lactulose is readily fermented by the colonic bacterial flora with the production of short-chain fatty acids and Various gases. The purpose of this review is to focus on some pertinent basic aspects of the clinical pharmacology of lactulose and to discuss the possible mechanisms by which lactulose benefits patients with constipation and hepatic encephalopathy.",,,"UNIV COPENHAGEN, RIGSHOSP, DEPT MED CA 2101, DIV GASTROENTEROL, BLEGDAMSVEJ 9, DK-2100 COPENHAGEN, DENMARK.",,"Mortensen, Preben B/F-6758-2015; Clausen, Morten Rahr R/J-1018-2014",,,,,,72,83,92,0,4,ADIS INT LTD,NORTHCOTE,"5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND",0012-6667,1179-1950,,DRUGS,Drugs,JUN,1997,53,6,,,,,930,942,,10.2165/00003495-199753060-00003,http://dx.doi.org/10.2165/00003495-199753060-00003,,,13,Pharmacology & Pharmacy; Toxicology,Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy; Toxicology,XB650,9179525,"Green Published, Bronze",,,2024-06-04,WOS:A1997XB65000003,View Full Record in Web of Science
J,"Okawa, Y",,,,"Okawa, Yohei",,,The Impact of Nutritional Therapy on Gastrointestinal Motility in Older Adults,HEALTHCARE,,,English,Review,,,,,,elderly; nutritional therapy; gastrointestinal motility; functional digestive disease FGID; daily lifestyle habits,PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; TOTAL PARENTERAL-NUTRITION; HYDROLYZED GUAR GUM; IRRITABLE-BOWEL-SYNDROME; COLONIC TRANSIT-TIME; FECAL INCONTINENCE; BACTERIAL TRANSLOCATION; ACUTE STROKE; FIBER SUPPLEMENTATION; HOSPITALIZED-PATIENTS,"Japan is becoming a superaged society, and nutrition therapy for the elderly population is very important. Elderly individuals often have multiple diseases and are prone to malnutrition. Furthermore, functional constipation, diarrhoea, faecal incontinence, etc., may occur despite no organic abnormality of digestive tract function. Due to these disabilities, the resulting malnutrition, and the slow recovery, it is often difficult for elderly individuals to reintegrate into society. Secondary or incorrect nutritional management increases complications, decreases physical function and worsens the prognosis. Previous statistical research suggests that in-hospital mortality is significantly higher among hospitalised patients aged >= 65 years who ingest less than half of their caloric needs. Therefore, appropriate nutritional management from an early stage is essential for elderly individuals. Moreover, functional excretion disorders, dementia, and sarcopenia (muscle-wasting disease) are attracting attention as pathological conditions unique to elderly individuals, and it is essential to undergo rehabilitation early with nutritional management. Being elderly does not preclude nutritional management, and it is necessary to reconsider appropriate nutritional therapy even in the terminal stage and in advanced physical and mental illnesses. This review explores the relationship between dietary intake and FGIDs, with a focus on elderly adults.","[Okawa, Yohei] Tohoku Univ, Grad Sch Med, Dept Psychosomat Med, 2-1 Seiryo Machi,Aoba Ku, Sendai, Miyagi 9808575, Japan",Tohoku University,"Okawa, Y (corresponding author), Tohoku Univ, Grad Sch Med, Dept Psychosomat Med, 2-1 Seiryo Machi,Aoba Ku, Sendai, Miyagi 9808575, Japan.",yohei-tky@umin.ac.jp,,"Okawa, Yohei/0000-0002-3836-1093",We want to express our sincere gratitude to the reviewers for providing valuable suggestions for developing this article.,We want to express our sincere gratitude to the reviewers for providing valuable suggestions for developing this article.,We want to express our sincere gratitude to the reviewers for providing valuable suggestions for developing this article.,,100,0,0,2,2,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2227-9032,,HEALTHCARE-BASEL,Healthcare,NOV,2023,11,21,,,,,,,2829,10.3390/healthcare11212829,http://dx.doi.org/10.3390/healthcare11212829,,,13,Health Care Sciences & Services; Health Policy & Services,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Health Care Sciences & Services,X6IR0,37957974,gold,,,2024-06-04,WOS:001099471100001,View Full Record in Web of Science
J,"Fernandez-Martinez, MN; Hernandez-Echevarria, L; Sierra-Vega, M; Diez-Liebana, MJ; Calle-Pardo, A; Carriedo-Ule, D; Sahagún-Prieto, AM; Anguera-Vila, A; Garcia-Vieitez, JJ",,,,"Nelida Fernandez-Martinez, M.; Hernandez-Echevarria, Luis; Sierra-Vega, Matilde; Jose Diez-Liebana, M.; Calle-Pardo, Angela; Carriedo-Ule, Demetrio; Sahagun-Prieto, Ana M.; Anguera-Vila, Anna; Jose Garcia-Vieitez, Juan",,,A randomised clinical trial to evaluate the effects of Plantago ovata husk in Parkinson patients: changes in levodopa pharmacokinetics and biochemical parameters,BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE,,,English,Article,,,,,,Levodopa; Parkinson patients; Pharmacokinetics; Biochemical parameters; Plantago ovata husk,L-DOPA ABSORPTION; CARBIDOPA BIOAVAILABILITY; DIETARY FIBER; DISEASE; PHARMACODYNAMICS; OPTIMIZATION; CONSTIPATION,"Background: Plantago ovata husk therapy could be used in patients with Parkinson disease to reduce the symptoms of gastrointestinal disorders, but it is important to know whether this compound modifies levodopa pharmacokinetics. The maintenance of constant plasma concentrations of levodopa abolishes the clinical fluctuations in parkinsonian patients. The aim of this randomised clinical trial was to establish the influence of the fiber Plantago ovata husk in the pharmacokinetics of levodopa when administered to Parkinson patients well controlled by their oral medication. Methods: To evaluate the effects of this fiber on several biochemical parameters. 18 volunteers participated in the study and received alternatively two treatments (Plantago ovata husk or placebo) with their usual levodopa/carbidopa oral dose. On days 0 (initial situation), 14 and 35 of the study, blood samples were taken to assess levodopa pharmacokinetics and to determine biochemical parameters. Results: Levodopa C-max was very similar in the initial situation (603.2 ng/ml) and after placebo administration (612.0 ng/ml), being slightly lower (547.8 ng/ml) when Plantago ovata husk was given. AUC was very similar in the three groups: initial situation. - 62.87 mu g.min/ml, fiber treatment.- 64.47 mu g.min/ml and placebo treatment.- 65.10 mu g.min/ml. Fiber reduced significantly the number of peaks observed in the levodopa concentrations, maintaining concentrations more stable. No significant differences were found in total cholesterol, LDL-cholesterol and triglycerides with the administration of Plantago ovata husk. Conclusions: Plantago ovata husk administration caused a smoothing and homogenization of levodopa absorption, providing more stable concentrations and final higher levels, resulting in a great benefit for patients.","[Nelida Fernandez-Martinez, M.; Sierra-Vega, Matilde; Jose Diez-Liebana, M.; Calle-Pardo, Angela; Sahagun-Prieto, Ana M.; Jose Garcia-Vieitez, Juan] Univ Leon, Inst Biomed IBIOMED, Area Farmacol, E-24071 Leon, Spain; [Hernandez-Echevarria, Luis; Carriedo-Ule, Demetrio] Complejo Hosp Univ Leon, Leon 24071, Spain; [Anguera-Vila, Anna] Labs Rottapharm, Barcelona 08033, Spain",Universidad de Leon; Universidad de Leon; Hospital de Leon,"Fernandez-Martinez, MN (corresponding author), Univ Leon, Inst Biomed IBIOMED, Area Farmacol, E-24071 Leon, Spain.",nelida.fernandez@unileon.es,"Sierra, Matilde/F-8990-2016; Sahagun Prieto, Ana M/F-8928-2016; chuang, kuang quing/J-3032-2014; Garcia, Juan Jose/F-8979-2016; Diez, Maria Jose/F-8956-2016; Fernandez, Nelida/F-9573-2016","Sierra, Matilde/0000-0002-0208-9542; Sahagun Prieto, Ana M/0000-0003-3311-4226; Garcia, Juan Jose/0000-0001-7821-9502; Hernandez Echebarria, Luis/0000-0002-3069-0511; Diez, Maria Jose/0000-0002-2101-3906; Fernandez, Nelida/0000-0002-1225-4097; Carriedo Ule, Demetrio/0000-0001-8823-268X; Calle Pardo, Angela Pilar/0000-0002-6261-8266",,,,,33,8,8,1,11,BIOMED CENTRAL LTD,LONDON,"236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND",1472-6882,,,BMC COMPLEM ALTERN M,BMC Complement. Altern. Med.,AUG 12,2014,14,,,,,,,,296,10.1186/1472-6882-14-296,http://dx.doi.org/10.1186/1472-6882-14-296,,,10,Integrative & Complementary Medicine,Science Citation Index Expanded (SCI-EXPANDED),Integrative & Complementary Medicine,AO1YA,25112783,"gold, Green Published",,,2024-06-04,WOS:000341110300001,View Full Record in Web of Science
J,"Watson, AW; Houghton, D; Avery, PJ; Stewart, C; Vaughan, EE; Meyer, PD; Kuil, MJJD; Weijs, PJM; Brandt, K",,,,"Watson, Anthony W.; Houghton, David; Avery, Peter J.; Stewart, Christopher; Vaughan, Elaine E.; Meyer, P. Diederick; Kuil, Minse J. J. de Bos; Weijs, Peter J. M.; Brandt, Kirsten",,,"Changes in stool frequency following chicory inulin consumption, and effects on stool consistency, quality of life and composition of gut microbiota",FOOD HYDROCOLLOIDS,,,English,Article,,,,,,Inulin; Digestive health; Microbiology,DIETARY FIBER; DOUBLE-BLIND; CONSTIPATION; BOWEL; BIFIDOBACTERIA; MODULATION; NUTRITION; FRUCTANS,"Inulin is a soluble dietary fibre, also classified as a prebiotic, extracted from chicory roots. The present study aimed to determine the effect of consumption of native chicory inulin on the stool frequency of middle-aged to older adults (40-75 years old) with uncomfortably but not clinically relevant low stool frequency, specified as two to four days without bowel movements per week. Two randomised, double blind, placebo-controlled crossover trials were conducted using similar protocols in differing populations. Trial A was conducted in Amsterdam, The Netherlands and subsequently Trial B was conducted in Newcastle, United Kingdom. Both trials involved supplementation for 5 weeks with 10 g per day of inulin or placebo, a washout period of 2 weeks, and then crossed over to receive the other treatment. In Trial B, faecal gut microbiota composition was assessed using 16S rRNA gene sequencing. In Trial A, which 10 volunteers completed, the stool frequency was significantly increased to an average 4.9 +/- 0.23 (SEM) times per week during inulin periods versus 3.6 +/- 0.25 in the periods with placebo (p = 0.01). In contrast, in Trial B which 20 volunteers completed, there was no significant effect of the inulin on stool frequency (7.5 +/- 2.1 times per week with inulin, 8.1 +/- 3.0 with placebo, p = 0.35). However, many subjects in Trial B had a stool frequency > 5 per week also for the placebo period, in breach of the inclusion criteria. Combining the data of 16 low stool frequency subjects from Trials A and B showed a significant effect of inulin to increase stool frequency from 4.1 to 5.0 per week (p = 0.032). Regarding secondary outcomes, stool consistency was significantly softer with inulin treatment compared to placebo periods, it increased 0.29 on the Bristol stool scale (p = 0.008) when data from all subjects of Trials A and B were combined. No other differences in bowel habit parameters due to inulin consumption were significant. None of the differences in specific bacterial abundance, alpha or beta diversity were significant, however the trends were in directions consistent with published studies on other types of inulin. We conclude that 10 g per day of native chicory inulin can increase stool frequency in subjects with low stool frequency.","[Watson, Anthony W.; Brandt, Kirsten] Newcastle Univ, Human Nutr Res Ctr, NU Food Res Facil, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Houghton, David] Newcastle Univ, Inst Cell & Mol Biosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Houghton, David] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Avery, Peter J.] Newcastle Univ, Sch Math & Stat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Watson, Anthony W.; Stewart, Christopher; Brandt, Kirsten] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Vaughan, Elaine E.; Meyer, P. Diederick] Sensus Royal Cosun, Borchwerf 3, NL-4704 RG Roosendaal, Netherlands; [Kuil, Minse J. J. de Bos; Weijs, Peter J. M.] Amsterdam Univ Appl Sci, Dept Nutr & Dietet, Postbus 2165, NL-1000 CD Amsterdam, Netherlands",Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK,"Brandt, K (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.",kirsten.brandt@ncl.ac.uk,"Stewart, Christopher/M-4615-2017; Brandt, Kirsten/B-4707-2008","Stewart, Christopher/0000-0002-6033-338X; Brandt, Kirsten/0000-0002-7001-2459; Weijs, Peter/0000-0001-8281-0426",Sensus BV; NIHR Newcastle Biomedical Research Centre; Medical Research Council [L0916354]; Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; UK National Institute for Health Research Biomedical Research Centre on Ageing and Age-related Diseases,Sensus BV; NIHR Newcastle Biomedical Research Centre; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Centre for Mitochondrial Research(Wellcome Trust); UK National Institute for Health Research Biomedical Research Centre on Ageing and Age-related Diseases,"We are grateful to Dianne Bakker and Marissa Jansen from the Nutrition and Dietetics group of Amsterdam University of Applied Sciences for excellent assistance. Senior Lecturer Dr Peter Avery (School of Mathematics & Statistics, Newcastle University) is thanked for helpful discussions and advice on statistical analysis. Sensus BV funded the trials A and B and the statistical analysis of the trial data. Frutafit (R) inulin HD is a product of Sensus BV. Microbiota analysis was funded by the NIHR Newcastle Biomedical Research Centre awarded to the Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University,. Newcastle Centre for Ageing and Vitality supported by the Medical Research Council (L0916354), the Wellcome Centre for Mitochondrial Research (203105/Z/16/Z) and the UK National Institute for Health Research Biomedical Research Centre on Ageing and Age-related Diseases.",,50,30,35,7,57,ELSEVIER SCI LTD,OXFORD,"THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND",0268-005X,1873-7137,,FOOD HYDROCOLLOID,Food Hydrocolloids,NOV,2019,96,,,,,,688,698,,10.1016/j.foodhyd.2019.06.006,http://dx.doi.org/10.1016/j.foodhyd.2019.06.006,,,11,"Chemistry, Applied; Food Science & Technology",Science Citation Index Expanded (SCI-EXPANDED),Chemistry; Food Science & Technology,IH5GA,31680713,"Green Published, hybrid",,,2024-06-04,WOS:000474521200072,View Full Record in Web of Science
J,"Lewandowski, K; Kaniewska, M; Karlowicz, K; Rosolowski, M; Rydzewska, G",,,,"Lewandowski, Konrad; Kaniewska, Magdalena; Karlowicz, Katarzyna; Rosolowski, Mariusz; Rydzewska, Grazyna",,,The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome,GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY,,,English,Article,,,,,,irritable bowel syndrome; symptoms; overweight; sodium butyrate,DIETARY FIBER,"Aim: The aim of the study was to assess the effectiveness of a patented preparation of sodium butyrate in the triglyceride matrix at reducing clinical symptoms and improving quality of life in patients with irritable bowel syndrome (IBS). Material and methods: In this prospective multicenter clinical trial, we observed a total of 3000 non-hospitalized patients with confirmed IBS who were treated with sodium butyrate in a triglyceride matrix at a dosage of 150 mg twice a day for 12 weeks. The primary outcome was to evaluate the efficacy of sodium butyrate at reducing the severity of clinical symptoms and improving quality of life in patients with IBS. Results: A total of 2990 complete surveys were collected. A statistically significant improvement in severity of abdominal pain was noticed (p < 0.001). Moreover, flatulence, diarrhea, constipation, urgent pressure for bowel movements, nausea, and vomiting decreased significantly (p < 0.001). Most of the respondents (93.90%) declared that they would continue the therapy and 88.9% would recommend using sodium butyrate to other IBS patients. Conclusions: Sodium butyrate in the triglyceride matrix, as a postbiotic substance, may be effective in relieving the symptoms of IBS by modifying the intestinal microbiota.","[Lewandowski, Konrad; Kaniewska, Magdalena; Karlowicz, Katarzyna; Rydzewska, Grazyna] Minist Inferior & Adm, Clin Dept Internal Med & Gastroenterol, Inflammatory Bowel Dis Unit, Cent Clin Hosp, 137 Woloska St, PL-02507 Warsaw, Poland; [Rosolowski, Mariusz] Med Univ Bialystok, Dept Internal Med & Hypertens, Bialystok, Poland; [Rosolowski, Mariusz] Med Univ Bialystok, Dept Hypertens Gastroenterol & Internal Med, Clin Hosp, Bialystok, Poland; [Rydzewska, Grazyna] Jan Kochanowski Univ, Coll Med, Kielce, Poland",Medical University of Bialystok; Medical University of Bialystok; Jan Kochanowski University,"Kaniewska, M (corresponding author), Minist Inferior & Adm, Clin Dept Internal Med & Gastroenterol, Inflammatory Bowel Dis Unit, Cent Clin Hosp, 137 Woloska St, PL-02507 Warsaw, Poland.",kaniewscy@o2.pl,"Lewandowski, Konrad/HJA-4639-2022","Lewandowski, Konrad/0000-0003-3866-4905",,,,,16,7,7,1,7,TERMEDIA PUBLISHING HOUSE LTD,POZNAN,"KLEEBERGA 2, POZNAN, 61-615, POLAND",1895-5770,1897-4317,,GASTROENTEROL REV,Gastroenterol. Rev.,,2022,17,1,,,,,28,34,,10.5114/pg.2021.112681,http://dx.doi.org/10.5114/pg.2021.112681,,,7,Gastroenterology & Hepatology,Emerging Sources Citation Index (ESCI),Gastroenterology & Hepatology,ZZ6HE,35371361,"Green Published, gold",,,2024-06-04,WOS:000773366600006,View Full Record in Web of Science
J,"García, JJ; Fernández, N; Calle, AP; Diez, MJ; Sahagún, A; Sierra, M",,,,"Garcia, Juan J.; Fernandez, Nelida; Calle, Angela P.; Jose Diez, M.; Sahagun, Ana; Sierra, Matilde",,,Effects of Plantago ovata Husk on Levodopa (with Carbidopa) Bioavailability in Rabbits with Autonomic Gastrointestinal Disorders,DRUG METABOLISM AND DISPOSITION,,,English,Article,,,,,,,GASTRIC-EMPTYING TIME; PARKINSONS-DISEASE; DIETARY FIBER; DYSFUNCTION; CISAPRIDE; PSYLLIUM; CONSTIPATION; SYMPTOMS; MOTILITY; AGENTS,"Gastrointestinal dysfunction is common in Parkinson's disease. Fiber therapy could be used to reduce the symptoms of gastrointestinal motility disorders. In a previous study, we showed that slowed gastrointestinal motility modified levodopa pharmacokinetics: area under the plasma concentration-time curve (AUC) and maximum plasma concentration (C-max) decreased and the elimination was delayed. In this study, we evaluated whether or not the hydrosoluble fiber Plantago ovata husk is useful in improving levodopa pharmacokinetics in rabbits with autonomic gastrointestinal disorders induced by the administration of the anticholinergic biperiden. Levodopa + carbidopa (20:5 mg/kg), biperiden (100 mu g/kg), and P. ovata husk (at two different doses: 100 and 400 mg/kg) were administered orally to rabbits for two periods of time (7 or 14 days). In all groups of animals, the AUC values were approximately 50% higher on the final day of treatment than on day 1. C-max was also higher, with the greater increase at the 400 mg/kg dose of fiber, which resulted in a boost of approximately 35%. On day 1 of treatment and with both doses of fiber, AUC values were very similar to those obtained in previous work in rabbits with normal gastrointestinal motility, but the C-max was lower. However, after 7 or 14 days, the AUC values were higher, but C-max remained lower. The greatest differences were observed in plasma concentration before drug administration (C-min), for which the highest increase was obtained with the dose of 400 mg/kg fiber on day 14 of treatment (349.8%). P. ovata husk could be beneficial in patients with Parkinson's disease because it regulates stool transit in the intestine and because it improves levodopa pharmacokinetics when gastrointestinal peristalsis is slowed. These changes could lead to a possible delay in the onset of dyskinesias and to changes in prognosis.","[Garcia, Juan J.; Fernandez, Nelida; Calle, Angela P.; Jose Diez, M.; Sahagun, Ana; Sierra, Matilde] Univ Leon, Area Farmacol, Inst Biomed, E-24071 Leon, Spain",Universidad de Leon,"Fernández, N (corresponding author), Univ Leon, Area Farmacol, Inst Biomed, E-24071 Leon, Spain.",nelida.fernandez@unileon.es,"Garcia, Juan Jose/F-8979-2016; Sahagun Prieto, Ana M/F-8928-2016; Sierra, Matilde/F-8990-2016; Diez, Maria Jose/F-8956-2016; Fernandez, Nelida/F-9573-2016","Garcia, Juan Jose/0000-0001-7821-9502; Sahagun Prieto, Ana M/0000-0003-3311-4226; Sierra, Matilde/0000-0002-0208-9542; Diez, Maria Jose/0000-0002-2101-3906; Fernandez, Nelida/0000-0002-1225-4097; Calle Pardo, Angela Pilar/0000-0002-6261-8266",,,,,30,9,9,0,2,AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS,BETHESDA,"9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA",0090-9556,1521-009X,,DRUG METAB DISPOS,Drug Metab. Dispos.,JUL,2009,37,7,,,,,1434,1442,,10.1124/dmd.108.026229,http://dx.doi.org/10.1124/dmd.108.026229,,,9,Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy,459UF,19389862,,,,2024-06-04,WOS:000267135200011,View Full Record in Web of Science
J,"Souli, A; Sebai, H; Rtibi, K; Chehimi, L; Sakly, M; Amri, M; El-Benna, J",,,,"Souli, Abdellaziz; Sebai, Hichem; Rtibi, Kais; Chehimi, Latifa; Sakly, Mohsen; Amri, Mohamed; El-Benna, Jamel",,,Effects of Dates Pulp Extract and Palm Sap (Phoenix dactylifera L.) on Gastrointestinal Transit Activity in Healthy Rats,JOURNAL OF MEDICINAL FOOD,,,English,Article,,,,,,dates pulp; GIT activity; minerals; palm sap; rat; sugars,CHEMICAL-COMPOSITION; AQUEOUS EXTRACT; DIETARY FIBER; FRUIT; CONSTIPATION; ANTIOXIDANT; VARIETIES; RISK; MICE,"The current study was performed to measure the chemical composition and the effects of dates pulp extract and palm sap on gastrointestinal transit (GIT) activity in healthy adult rats. In this respect, male Wistar rats fasted for 24 hours were used and received per orally (p.o.) sodium chloride (NaCl) (0,9%) (control group) or various doses of dates pulp extract (150 and 300 mg/kg, body weight [b.w.]) and palm sap (0.4 and 4 mL/kg, b.w.). Two other groups of rats (batch tests) received, respectively, clonidine (an alpha-2 adrenergic agonist, 1 mg/kg, b.w.) and yohimbine (an alpha-2 adrenergic antagonist, 2mg/kg, b.w.). Chemical analysis showed that the dates pulp extract is more rich in sugars and minerals, especially potassium and sucrose, as compared with palm sap composition. On the other hand, in vivo study showed that the aqueous dates pulp extract significantly, and dose dependently, increased the GIT activity while the palm sap slightly increased it. Moreover, a converse effect has been observed using clonidine (decreased 68%) and yohimbine (increased 33%) on the GIT activity. These findings suggest that dates pulp extract and palm sap have a stimulating effect on GIT activity in rats and confirm their use in traditional Tunisian medicine for the treatment of constipation.","[Souli, Abdellaziz; Sebai, Hichem; Rtibi, Kais] Inst Super Biotechnol Beja, Lab Nutr & Physiol Anim, Beja, Tunisia; [Souli, Abdellaziz; Rtibi, Kais; Amri, Mohamed] Fac Sci Tunis, Lab Neurophysiol Fonct & Pathol, Dept Sci Biol, Tunis 1060, Tunisia; [Sebai, Hichem; Chehimi, Latifa; Sakly, Mohsen] Fac Sci Bizerte, Lab Physiol Integree, Jarzouna, Tunisia; [El-Benna, Jamel] Fac Med X, INSERM Ctr Rech Biomed U773, Paris, France",Universite de Jendouba; Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); Universite de Carthage; Institut National de la Sante et de la Recherche Medicale (Inserm),"Sebai, H (corresponding author), Fac Sci Bizerte, Lab Physiol Integree, Dept Sci Vie, Zarzouna 7021, Tunisia.",sebaihichem@yahoo.fr,,"Amri, Mohamed/0000-0001-5309-7633",Tunisian Ministry of Higher Education and Scientific Research,Tunisian Ministry of Higher Education and Scientific Research,Financial support of the Tunisian Ministry of Higher Education and Scientific Research is gratefully acknowledged.,,41,22,22,0,7,"MARY ANN LIEBERT, INC",NEW ROCHELLE,"140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA",1096-620X,1557-7600,,J MED FOOD,J. Med. Food,JUL,2014,17,7,,,,,782,786,,10.1089/jmf.2013.0112,http://dx.doi.org/10.1089/jmf.2013.0112,,,5,"Chemistry, Medicinal; Food Science & Technology; Nutrition & Dietetics",Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy; Food Science & Technology; Nutrition & Dietetics,AL5KO,24611963,Green Published,,,2024-06-04,WOS:000339172700007,View Full Record in Web of Science
J,"Khosroshahi, HT; Vaziri, ND; Abedi, B; Asl, BH; Ghojazadeh, M; Jing, WH; Vatankhah, AM",,,,"Khosroshahi, Hamid Tayebi; Vaziri, Nosratola D.; Abedi, Behzad; Asl, Bahlol Habibi; Ghojazadeh, Morteza; Jing, Wanghui; Vatankhah, Amir Mansur",,,Effect of high amylose resistant starch (HAM-RS2) supplementation on biomarkers of inflammation and oxidative stress in hemodialysis patients: a randomized clinical trial,HEMODIALYSIS INTERNATIONAL,,,English,Article,,,,,,End stage renal disease; hemodialysis; high maize resistant starch2; inflammatory marker; oxidative markers,CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; C-REACTIVE PROTEIN; GUT BACTERIAL TRANSLOCATION; EPITHELIAL TIGHT JUNCTION; CHAIN FATTY-ACIDS; DIETARY FIBER; SYSTEMIC INFLAMMATION; UREMIC TOXICITY; MICROBIAL-FLORA,"Introduction: Systemic inflammation and oxidative stress play a central role in the pathogenesis of cardiovascular disease and numerous other complications of CKD. Recent studies demonstrated that consumption of a diet enriched with amylose (HAM-RS2), attenuates oxidative stress and inflammation, and improves intestinal microbiome in CKD rats. The present study was designed to explore the effect of dietary amylose supplementation in hemodialysis patients. Methods: Forty-six stable hemodialysis patients were randomized to receive biscuits containing 20 g/day during the first four weeks and 25 g/day in the next four weeks of either HAM-RS2 or wheat-flour. Fasting predialysis blood samples obtained before, during and at the end of trial were processed for biomarkers of oxidative stress and inflammation. Findings: There was no significant difference in baseline clinical or biochemical parameters between the two groups. Serum levels of TNF-, IL-6, and malondialdehyde declined significantly (P<0.05) in the HAM-RS2-treated group but remained unchanged in the placebo-treated group. No significant difference was observed in serum Interleukin-1 (IL-1) and hs-CRP concentrations and total antioxidant activity between two groups. Serum urea and creatinine concentrations significantly declined and severity of constipation improved in HAM-RS2-treated patients (P<0.05). HAM-RS2 consumption was well tolerated and did not cause discernible side effects. Discussion: Administration of HAM-RS2 for eight weeks significantly reduced levels of inflammatory and oxidative markers in hemodialysis patients confirming the results observed in CKD animals. Long term trials are needed to explore the impact of HAM-RS2 supplementation on clinical outcomes in end stage renal disease population.","[Khosroshahi, Hamid Tayebi] Tabriz Univ Med Sci, Kidney Res Ctr, Tabriz, Iran; [Vaziri, Nosratola D.; Jing, Wanghui] UC Irvine Med Ctr, Div Nephrol & Hypertens, Irvine, CA USA; [Abedi, Behzad] Tabriz Univ Med Sci, Dept Nanotechnol, Tabriz, Iran; [Asl, Bahlol Habibi] Tabriz Univ Med Sci, Sch Adv Med Sci, Fac Pharmacol, Tabriz, Iran; [Ghojazadeh, Morteza] Tabriz Univ Med Sci, Res Ctr Evidence Based Med, Tabriz, Iran; [Vatankhah, Amir Mansur] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran",Tabriz University of Medical Science; University of California System; University of California Irvine; Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science; Tabriz University of Medical Science,"Vaziri, ND (corresponding author), Univ Calif Irvine, Div Nephrol & Hypertens, Med Sci C, Sch Med, C351,101 City Dr, Irvine, CA 92868 USA.",ndvaziri@uci.edu,"khosroshahi, hamid tayebi/AAC-8783-2021; Habibi-Asl, Bohloul/M-7535-2018","Habibi-asl, Bohloul/0000-0001-8427-9149",Tabriz University of Medical Sciences,Tabriz University of Medical Sciences,The funding for this study was provided by Tabriz University of Medical Sciences.,,47,58,62,1,32,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1492-7535,1542-4758,,HEMODIAL INT,Hemodial. Int.,OCT,2018,22,4,,,,,492,500,,10.1111/hdi.12653,http://dx.doi.org/10.1111/hdi.12653,,,9,Urology & Nephrology,Science Citation Index Expanded (SCI-EXPANDED),Urology & Nephrology,GX6EG,29532981,"Green Submitted, Bronze",,,2024-06-04,WOS:000447850400012,View Full Record in Web of Science
J,"Minamida, K; Sujaya, IN; Tamura, A; Shigematsu, N; Sone, T; Yokota, A; Asano, K; Benno, Y; Tomita, F",,,,"Minamida, K; Sujaya, IN; Tamura, A; Shigematsu, N; Sone, T; Yokota, A; Asano, K; Benno, Y; Tomita, F",,,"The effects of di-D-fructofuranose-1,2′:2,3′-dianhydride (DFA III) administration on human intestinal microbiota",JOURNAL OF BIOSCIENCE AND BIOENGINEERING,,,English,Article,,,,,,"di-D-fructofuranose-1,2 ': 2,3 '-dianhydride (DFA III); human intestinal microbiota; denaturing gradient gel electrophoresis (DGGE)",16S RIBOSOMAL-RNA; GEL-ELECTROPHORESIS ANALYSIS; POLYMERASE-CHAIN-REACTION; DIFRUCTOSE ANHYDRIDE-III; IN-SITU HYBRIDIZATION; DIETARY FIBER; HUMAN FECES; CALCIUM-ABSORPTION; FECAL SAMPLES; HUMAN GUT,"Di-D-fructofuranose-1,2':2,3'-dianhydride (DFA III) was shown to enhance Ca absorption in rat and human intestine. The effects of DFA III administration (9 g per day for 4 weeks that corresponded to 3-fold the optimal dosage of DFA III) on human intestinal microbiota were studied using denaturing gradient gel electrophoresis (DGGE). The major groups of human intestinal microbiota reported previously: the Bacteroides, the Clostridium coccoides group (Clostridium cluster XIVa), the Clostridium leptum group (Clostridium cluster IV), and the Bifidobacterium group were detected. The similarity of 30 DGGE profiles based on the V3 region (before and after administration to the 15 subjects) of the 16S rDNA were calculated using Pearson's correlation based on numbers, positions and intensity of bands, and then a dendrogram of DGGE profiles was constructed by the unweighted pair group method using arithmetic average (UPGMA) clustering method. By these analyses, no difference in DGGE profiles after DFA III administration was observed in healthy subjects, while two subjects with chronic constipation showed different profiles, namely on numbers, positions and the intensity of some bands. Their stools were softer and stool frequencies increased and they obtained relief from constipation.","No Advancement Ctr Sci & Technol, Kita Ku, Sapporo, Hokkaido 0010021, Japan; Fancl Corp, Totsuka Ku, Yokohama, Kanagawa 2440806, Japan; Hokkaido Univ, Grad Sch Agr, Appl Microbiol Lab, Kita Ku, Sapporo, Hokkaido 0608589, Japan; Hokkaido Univ, Grad Sch Agr, Lab Microbial Resources & Ecol, Kita Ku, Sapporo, Hokkaido 0608589, Japan; RIKEN, Japan Collect Microorganisms, Wako, Saitama 3510198, Japan",FANCL Corporation; Hokkaido University; Hokkaido University; RIKEN,"Tomita, F (corresponding author), Univ Air, Hokkaido Study Ctr, Kita Ku, Kita 17,Nishi 8, Sapporo, Hokkaido 0600817, Japan.",ftomita@chem.agr.hokudai.ac.jp,"Sone, Teruo/A-4269-2012; Sujaya, I Nengah/GLS-7523-2022; Shigematsu, Naoyuki/B-9374-2014; ASANO, Kozo/F-6927-2012","Sone, Teruo/0000-0001-7400-8601; Sujaya, I Nengah/0000-0002-7826-2831;",,,,,25,23,24,1,13,SOC BIOSCIENCE BIOENGINEERING JAPAN,OSAKA,"OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN",1389-1723,,,J BIOSCI BIOENG,J. Biosci. Bioeng.,OCT,2004,98,4,,,,,244,250,,10.1263/jbb.98.244,http://dx.doi.org/10.1263/jbb.98.244,,,7,Biotechnology & Applied Microbiology; Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Biotechnology & Applied Microbiology; Food Science & Technology,881VT,16233700,Green Submitted,,,2024-06-04,WOS:000225898200003,View Full Record in Web of Science
J,"Maev, IV; Cheremushkin, SV; Kucheryavyi, YA; Cheremushkina, NV",,,,"Maev, I. V.; Cheremushkin, S. V.; Kucheryavyi, Yu. A.; Cheremushkina, N. V.",,,Pharmacotherapy for irritable bowel syndrome in the context of evidence-based medicine,TERAPEVTICHESKII ARKHIV,,,Russian,Editorial Material,,,,,,irritable bowel syndrome; controlled trials; meta-analysis; review; treatment,QUALITY-OF-LIFE; FUNCTIONAL GASTROINTESTINAL DISORDERS; CONTROLLED-TRIAL; THERAPY; CONSTIPATION; METAANALYSIS; MESALAZINE; PROBIOTICS; RIFAXIMIN; EFFICACY,"The paper analyzes an evidence base for the pharmacotherapy of irritable bowel syndrome (IBS) A large number of randomized placebo-controlled trials (RPCTs) systematized in a number of meta-analyses suggest that monotherapy regimens with spasmolytics, antidepressants, dietary fibers, polyethylene glycol, rifaximin, probiotics, and mesalamine are effective. Only some RPCTs evaluate the efficiency of combined pharmacotherapy versus placebo for IBS. Since the basis for the pathophysiology of the latter is motility and functional disorders, visceral hypersensitivity, and, probably, impaired microbiota, we anticipate that the need to use combined approaches to treating the majority of patients with IBS, by covering a few components of its pathogenesis, is relevant. Thus, to choose pharmacotherapy for IBS in each specific case is a challenge as this is determined by the form of IBS, the availability of an approved medicine on the domestic market, the indications for use, possible long-term use, high safety, and efficacy evidence drawn from RPCTs.","[Maev, I. V.; Cheremushkin, S. V.; Kucheryavyi, Yu. A.; Cheremushkina, N. V.] AI Evdokimov Moscow State Univ Med & Dent, Minist Hlth Russia, Moscow, Russia",Ministry of Health of the Russian Federation; Moscow State University of Medicine & Dentistry,"Maev, IV (corresponding author), AI Evdokimov Moscow State Univ Med & Dent, Minist Hlth Russia, Moscow, Russia.",svch555362@yandex.ru,"Maev, Igor V/N-9320-2014",,,,,,46,2,4,0,7,CJSC CONSILIUM MEDICUM,MOSCOW,"NOVIY ZIKOVSKIY PROEZD, D 3, 40, MOSCOW, 125167, RUSSIA",0040-3660,2309-5342,,TERAPEVT ARKH,Ter. Arkhiv,,2015,87,2,,,,,4,10,,10.17116/terarkh20158724-10,http://dx.doi.org/10.17116/terarkh20158724-10,,,7,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,CF0PL,25864340,,,,2024-06-04,WOS:000352246600001,View Full Record in Web of Science
J,"Tierney, BT; Versalovic, J; Fasano, A; Petrosino, JF; Chumpitazi, BP; Mayer, EA; Boetes, J; Smits, G; Parkar, SG; Voreades, N; Kartal, E; Al-Ghalith, GA; Pane, M; Bron, PA; Reid, G; Dhir, R; Mason, CE",,,,"Tierney, Braden T.; Versalovic, James; Fasano, Alessio; Petrosino, Joseph F.; Chumpitazi, Bruno P.; Mayer, Emeran A.; Boetes, Jared; Smits, Gerard; Parkar, Shanthi G.; Voreades, Noah; Kartal, Ece; Al-Ghalith, Gabriel A.; Pane, Marco; Bron, Peter A.; Reid, Gregor; Dhir, Raja; Mason, Christopher E.",,,Functional response to a microbial synbiotic in the gastrointestinal system of children: a randomized clinical trial,PEDIATRIC RESEARCH,,,English,Article,,,,,,,DIETARY FIBER INTAKE; GUT MICROBIOTA; CONSTIPATION; PROBIOTICS; SUPPLEMENTATION; OLIGOFRUCTOSE; METAANALYSIS; MULTICENTER; PREBIOTICS; OBESITY,"Background Oral microbial therapy has been studied as an intervention for a range of gastrointestinal disorders. Though research suggests that microbial exposure may affect the gastrointestinal system, motility, and host immunity in a pediatric population, data have been inconsistent, with most prior studies being in neither a randomized nor placebo-controlled setting. The aim of this randomized, placebo-controlled study was to evaluate the efficacy of a synbiotic on increasing weekly bowel movements (WBMs) in constipated children. Methods Sixty-four children (3-17 years of age) were randomized to receive a synbiotic (n = 33) comprising mixed-chain length oligosaccharides and nine microbial strains, or placebo (n = 31) for 84 days. Stool microbiota was analyzed on samples collected at baseline and completion. The primary outcome was a change from baseline of WBMs in the treatment group compared to placebo. Results Treatment increased (p < 0.05) the number of WBMs in children with low baseline WBMs, despite broadly distinctive baseline microbiome signatures. Sequencing revealed that low baseline microbial richness in the treatment group significantly anticipated improvements in constipation (p = 0.00074). Conclusions These findings suggest the potential for (i) multi-species-synbiotic interventions to improve digestive health in a pediatric population and (ii) bioinformatics-based methods to predict response to microbial interventions in children. Impact Synbiotic microbial treatment improved the number of spontaneous weekly bowel movements in children compared to placebo. Intervention induced an increased abundance of bifidobacteria in children, compared to placebo. All administered probiotic species were enriched in the gut microbiome of the intervention group compared to placebo. Baseline microbial richness demonstrated potential as a predictive biomarker for response to intervention.","[Tierney, Braden T.; Mason, Christopher E.] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Tierney, Braden T.; Boetes, Jared; Smits, Gerard; Parkar, Shanthi G.; Voreades, Noah; Al-Ghalith, Gabriel A.; Pane, Marco; Bron, Peter A.; Dhir, Raja] Seed Hlth, Venice, CA 90291 USA; [Versalovic, James] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Versalovic, James] Texas Childrens Hosp, Dept Pathol, Houston, TX 77030 USA; [Fasano, Alessio] Massachusetts Gen Hosp Children, Mucosal Immunol & Biol Res Ctr, Ctr Celiac Res & Treatment, Boston, MA USA; [Fasano, Alessio] Massachusetts Gen Hosp Children, Div Pediat Gastroenterol & Nutr, Boston, MA USA; [Petrosino, Joseph F.] Baylor Coll Med, Alkek Ctr Metagen & Microbiome Res, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Chumpitazi, Bruno P.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Chumpitazi, Bruno P.] Texas Childrens Hosp, Neurogastroenterol & Motil Program, Houston, TX 77030 USA; [Mayer, Emeran A.] Univ Calif Los Angeles, David Geffen Sch Med, Vatche & Tamar Manoukian Div Digest Dis, Los Angeles, CA 90095 USA; [Mayer, Emeran A.] G Oppenheimer Ctr Neurobiol Stress & Resilience, Los Angeles, CA USA; [Kartal, Ece] Heidelberg Univ Hosp, Inst Computat Biomed, Heidelberg, Germany; [Reid, Gregor] Lawson Hlth Res Inst, Ctr Human Microbiome & Probiot Res, London, ON, Canada; [Reid, Gregor] Western Univ, Dept Microbiol & Immunol, London, ON, Canada",Cornell University; Weill Cornell Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Ruprecht Karls University Heidelberg; Western University (University of Western Ontario); Western University (University of Western Ontario),"Mason, CE (corresponding author), Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA.;Dhir, R (corresponding author), Seed Hlth, Venice, CA 90291 USA.",raja@seed.com; chm2042@med.cornell.edu,"Petrosino, Joseph F./AAF-1621-2019; Fasano, Alessio/K-5486-2016; Mason, Christopher/HCH-3977-2022","Fasano, Alessio/0000-0002-2134-0261; Boetes, Jared/0000-0002-8277-4784",Seed Health (SH),Seed Health (SH),"DY This work was funded by Seed Health (SH). SH funding contributed towards study design, microbiome sequencing, bioinformatics, and manuscript preparation.",,56,2,2,1,5,SPRINGERNATURE,LONDON,"CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND",0031-3998,1530-0447,,PEDIATR RES,Pediatr. Res.,JUN,2023,93,7,,,,,2005,2013,,10.1038/s41390-022-02289-0,http://dx.doi.org/10.1038/s41390-022-02289-0,,NOV 2022,9,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,L3PZ0,36319696,"hybrid, Green Published",,,2024-06-04,WOS:000877746600001,View Full Record in Web of Science
J,"Ferguson, LR; Harris, PJ",,,,"Ferguson, LR; Harris, PJ",,,Particle size of wheat bran in relation to colonic function in rats,FOOD SCIENCE AND TECHNOLOGY-LEBENSMITTEL-WISSENSCHAFT & TECHNOLOGIE,,,English,Article,,,,,,wheat bran; particle size; colonic function; rats,DIETARY FIBER; OAT BRAN; DIVERTICULAR-DISEASE; COLORECTAL-CANCER; BOWEL FUNCTION; CHOLESTEROL; TRANSIT; BARLEY; CONSTIPATION; DIFFER,"Wheat bran is widely used in the treatment of constipation and may be beneficial in preventing a range of diseases including colorectal cancer: However, the results of different studies show variability in the effects of wheat bran. This could be a consequence of different brans having different ranges of particle sizes which may affect the transit time through the gastrointestinal tract. This possibility was tested using male Fisher 344 rats which have been widely used in carcinogenicity studies The effects on transit time of supplementing the diet (a high fat modification of the AIN-76(TM) diet) with wheat bran fractions with particle size ranges of 212-710 mu m, 710-1000 mu m, and 1000-1700 mu m was examined. Fractions were obtained by sieving wheat bran obtained from a hard bread wheat (cv. Otane). Transit times were measured using glass bends (diameter 150-170 mu m). Supplementation of the diet with each of the wheat bran fractions significantly reduced transit times (P < 0.05), but the fraction with the largest particles was the most effective. Similarly, each fraction increased the rate of excretion of faeces (on a dry weight basis), the fraction with the largest particles producing the greatest effect. These results are consistent with human studies which showed that shorter transit times resulted from supplementing the diet with large compared with small wheat bran. (C) 1997 Academic Press Limited.","UNIV AUCKLAND,SCH BIOL SCI,AUCKLAND 1000,NEW ZEALAND",University of Auckland,"Ferguson, LR (corresponding author), UNIV AUCKLAND,FAC MED & HLTH SCI,CANC RES LAB,PRIVATE BAG 92019,AUCKLAND 1000,NEW ZEALAND.",,"Ferguson, Lynnette Robin/F-5989-2011",,,,,,42,17,19,0,4,ACADEMIC PRESS LTD,LONDON,"24-28 OVAL RD, LONDON, ENGLAND NW1 7DX",0023-6438,,,FOOD SCI TECHNOL-LEB,Food Sci. Technol.-Lebensm.-Wiss. Technol.,,1997,30,7,,,,,735,742,,10.1006/fstl.1997.0260,http://dx.doi.org/10.1006/fstl.1997.0260,,,8,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,YE521,,,,,2024-06-04,WOS:A1997YE52100016,View Full Record in Web of Science
J,"Asuncion, P; Liu, CQ; Castro, R; Yon, V; Rosas, M; Hooshmand, S; Kern, M; Hong, MY",,,,"Asuncion, Pia; Liu, Changqi; Castro, Robert; Yon, Viviana; Rosas Jr, Martin; Hooshmand, Shirin; Kern, Mark; Hong, Mee Young",,,The effects of fresh mango consumption on gut health and microbiome - Randomized controlled trial,FOOD SCIENCE & NUTRITION,,,English,Article,,,,,,fruit; gut health; gut permeability proteins; mango; microbiome; obese,DIETARY FIBER,"Some individual fruits have been widely researched for their effects on overall health and correlations with chronic diseases. The beneficial effects of mango supplementation on metabolic diseases have been detected. However, research into mango consumption on gut health, including the microbiome, is limited to processed mango preparations or peels. Our goal was to examine the effects of fresh mango consumption on the gut microbiome, gut permeability proteins, and bowel movement habits in overweight/obese individuals. In a 12-week crossover design study, 27 participants consumed 100 kcal/day of either mangos or low-fat cookies with a washout period of 4 weeks. The mango intervention showed higher Shannon-Wiener and Simpson alpha diversity indices of the microbiome than the low-fat cookie intervention in week 4. Significant differences in beta diversity of the microbiome were found between diet interventions at week 12. Mango consumption increased the abundance of Prevotella maculosa, Corynebacterium pyruviciproducens, and Mogibacterium timidum while it decreased Prevotella copri. Low-fat cookie intake increased Cyanobacterium aponinum and Desulfovibrio butyratiphilus and reduced Alloscardovia omnicolens. There were no significant differences in circulating gut permeability protein (ZO-1, claudin-2, and occludin) levels. There was a slight increase in the amount of bowel movement with mango consumption, but no significant findings for frequency, consistency, strain, pain, and constipation in bowel movement between trials. Given these results, it can be concluded that consumption of mango may have positive effects on the gut health, which may yield possible health benefits for chronic disease that deserve further study.","[Asuncion, Pia; Liu, Changqi; Castro, Robert; Yon, Viviana; Rosas Jr, Martin; Hooshmand, Shirin; Kern, Mark; Hong, Mee Young] San Diego State Univ, Sch Exercise & Nutr Sci, 5500 Campanile Dr, San Diego, CA 92182 USA",California State University System; San Diego State University,"Hong, MY (corresponding author), San Diego State Univ, Sch Exercise & Nutr Sci, 5500 Campanile Dr, San Diego, CA 92182 USA.",mhong2@sdsu.edu,"Liu, Changqi/K-6862-2014","Liu, Changqi/0000-0001-6526-5024; Hong, Mee Young/0000-0003-1262-0074",National Mango Board [603024],National Mango Board,"ACKNOWLEDGMENTS This study was supported by the National Mango Board [#603024]. The authors wish to acknowledge the contributions of all participants to the study. The authors thank Celeste O'Mealy, Sherry Pinneo, and Michelle Tsang for their help with sample collection.",,41,5,5,4,15,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",2048-7177,,,FOOD SCI NUTR,Food Sci. Nutr.,APR,2023,11,4,,,,,2069,2078,,10.1002/fsn3.3243,http://dx.doi.org/10.1002/fsn3.3243,,FEB 2023,10,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,C9LB5,37051355,"Green Published, gold",,,2024-06-04,WOS:000920229500001,View Full Record in Web of Science
J,"Utz, S; Bittel, M; Langhorst, J",,,,"Utz, Sandra; Bittel, Miriam; Langhorst, Jost",,,Phytotherapeutische Empfehlungen in medizinischen Leitlinien zur Behandlung gastroenterologischer Erkrankungen - ein systematischer Überblick,ZEITSCHRIFT FUR GASTROENTEROLOGIE,,,German,Article; Early Access,,,,,,guidelines; gastroenterological disorders; phytotherapy; phytopharmaceuticals; herbal medicine; review,IRRITABLE-BOWEL-SYNDROME; RANDOMIZED CLINICAL-TRIAL; PLACEBO-CONTROLLED TRIAL; WORMWOOD ARTEMISIA-ABSINTHIUM; MODERATE ULCERATIVE-COLITIS; RESECTED COLORECTAL-CANCER; DIETARY FIBER INTAKE; DOUBLE-BLIND; CROHNS-DISEASE; PEPPERMINT OIL,"Phytotherapeutics are gaining influence in the treatment of gastroenterological diseases. Their popularity and growing evidence of efficacy contribute to their integration into medical guidelines. A systematic screening identified recommended phytotherapeutic approaches. Based on current scientific data, some recommendations for the use of phytotherapeutic agents are given. For irritable bowel syndrome the use of peppermint oil is strongly recommended, especially for pain and flatulence. Other phytotherapeutics such as STW-5 , Tibetan Padma Lax or warm caraway oil pads have proven effective in alleviating symptoms. It is recommended to integrate them into the treatment concept. For chronic constipation , 30g of fiber per day is recommended. Best data exists for plantago psyllium with moderate evidence and chicory inulin . In case of ulcerative colitis , plantago psyllium as well as the combination of myrrh , chamomile flower extract, and coffee charcoal can be used as a complementary treatment in maintaining remission. There is also an open recommendation for curcumin for both, remission induction and maintenance. Some phytotherapeutic treatments (e.g., Artemisia absintium , Boswellia serata ) show evidence of effectiveness for the treatment of Crohn's disease , but data are not yet sufficient for recommendations. Cannabis-based medicines can be considered for abdominal pain and clinically relevant appetite loss if standard therapy is ineffective or contraindicated, but they should not be used for acute inflammation in active Crohn's disease. Further recommendations for other gastroenterological diseases are discussed. The safety and tolerability of the phytotherapeutics were rated as predominantly very good to acceptable. Some clear recommendations for the use of phytotherapeutics to treat gastroenterological diseases show their great potential. Due to their wide range of effects, phytotherapeutics can be used very well as a complement to conventional medicines in case of complex regulatory disorders. However, further methodologically well-conducted impact studies would be helpful in order to be able to make further recommendations.","[Utz, Sandra; Bittel, Miriam; Langhorst, Jost] Sozialstiftung Bamberg, Dept Internal & Integrat Med, Bamberg, Germany; [Utz, Sandra; Bittel, Miriam; Langhorst, Jost] Univ Duisburg Essen, Med Fac, Dept Integrat Med, Duisburg, Germany",University of Duisburg Essen,"Langhorst, J (corresponding author), Klinikum Bamberg, Dept Internal & Integrat Med, Bamberg, Germany.",Jost.Langhorst@sozialstiftung-bamberg.de,,,,,,,100,0,0,0,0,GEORG THIEME VERLAG KG,STUTTGART,"RUDIGERSTR 14, D-70469 STUTTGART, GERMANY",0044-2771,1439-7803,,Z GASTROENTEROL,Z. Gastroent.,2024 APR 11,2024,,,,,,,,,,10.1055/a-2279-5045,http://dx.doi.org/10.1055/a-2279-5045,,APR 2024,14,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,NL0V1,38604221,,,,2024-06-04,WOS:001200501200001,View Full Record in Web of Science
J,"Jennings, A; Davies, GJ; Costarelli, V; Dettmar, PW",,,,"Jennings, A.; Davies, G. J.; Costarelli, V.; Dettmar, P. W.",,,"Bowel habit, diet and body weight in preadolescent children",JOURNAL OF HUMAN NUTRITION AND DIETETICS,,,English,Article,,,,,,body weight; bowel habit; child; diet,COLONIC TRANSIT-TIME; FIBER INTAKE; FUNCTIONAL CONSTIPATION; CHILDHOOD CONSTIPATION; INCREASED PREVALENCE; OVERWEIGHT; SYMPTOMS; ADOLESCENTS,"Background: The possible influence of diet and body weight on bowel habit in children is unknown. The present study aimed to investigate the inter-relationships between bowel function, excess body weight and dietary intake in a group of preadolescent children. Methods: Eighty-four preadolescent children aged 7-10 years were recruited [mean (SD) age 9.7 (1.0) years]. All children completed a bowel habit diary, examining specific parameters of bowel function and a weighed food inventory concurrently for seven consecutive days. Height and weight measurements were also taken. Children were grouped according to whether they met dietary recommendations and by overweight status; differences in bowel function between the groups were then analysed. Results: Children who exceeded reference values for fat were more likely to report an incidence of straining to start (P = 0.005) and pain during defaecation (P = 0.021). Subjects who met protein recommendations were less likely to report incomplete evacuation (P = 0.000) and those who met zinc recommendations were less likely to report pain during defaecation (P = 0.044). Excess body weight (according to International Obesity Task Force cut-offs) was also associated with poor bowel habit, with overweight and obese children reporting lower defaecation frequency and a higher incidence of straining and feelings of incomplete evacuation, although these findings were not statistically significant. Defaecation frequency in healthy children was 1.4 defaecations per day compared to 1.2 defaecations for overweight and obese children. Conclusion: A poor diet that fails to meet dietary recommendations as well as being overweight and obese appears to be associated with increased defaecation problems in preadolescent children.","[Jennings, A.; Davies, G. J.] London S Bank Univ, Acad Sport Phys Act & Wellbeing, London, England; [Costarelli, V.] Harokopio Univ, Dept Home Econ & Ecol, Athens, Greece; [Dettmar, P. W.] Technost Ltd, Kingston Upon Hull, Yorks, England",London South Bank University; Harokopio University Athens,"Jennings, A (corresponding author), Univ E Anglia, Sch Med, Norwich NR4 7TJ, Norfolk, England.",amy.jennings@uea.ac.uk,"Costarelli, Vassiliki/AAM-1210-2020","Costarelli, Vassiliki/0000-0002-3863-838X",Reckitt Benckiser Healthcare,Reckitt Benckiser Healthcare,"This study was funded by Reckitt Benckiser Healthcare. AJ, GJD, VC and PWD contributed to the study design, data collection, analysis and interpretation. The manuscript was written by AJ. All authors critically reviewed the manuscript and approved the final version submitted for publication.",,39,8,10,0,7,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0952-3871,1365-277X,,J HUM NUTR DIET,J. Hum. Nutr. Diet.,OCT,2010,23,5,,,,,511,519,,10.1111/j.1365-277X.2009.01039.x,http://dx.doi.org/10.1111/j.1365-277X.2009.01039.x,,,9,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,648SI,20163508,Bronze,,,2024-06-04,WOS:000281713900008,View Full Record in Web of Science
J,"Teixeira, C; Trabulo, D; Ribeiro, S; Martins, C; Alves, AL; Cremers, I; Oliveira, AP",,,,"Teixeira, Cristina; Trabulo, Daniel; Ribeiro, Suzane; Martins, Claudio; Alves, Ana Luisa; Cremers, Isabelle; Oliveira, Ana Paula",,,Colonic diverticulosis and the metabolic syndrome: an association?,REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS,,,English,Article,,,,,,Colonic diverticulosis; Metabolic syndrome; Risk factors,RISK-FACTORS; NITRIC-OXIDE; SIDED COLON; FIBER DIET; DISEASE; OBESITY; CONSTIPATION; EPIDEMIOLOGY; MULTICENTER; PREVALENCE,"Background and objectives: Colonic diverticulosis (CD) is related to advanced age and a lack of dietary fiber. Recently, several studies have shown that metabolic syndrome (MS) is also implicated in the etiopathogenesis of CD. This study aimed to assess the association between MS, obesity and CD. Methods: This was a prospective study of a one-year duration. The MS was defined according to the National Cholesterol Education Program-Adult Treatment Panel III (NCEP-ATP III). Demographic data, risk factors for MS and endoscopic findings of patients who underwent a total colonoscopy in the department were collected. Obesity was defined as a body mass index >= 30 kg/m(2). Informed consent was obtained. The local Ethics Committee and National Data Protection Committee approved the study. Statistical analysis was performed with SPSS 21 and statistical significance was defined as p < 0.05. Results: The study included 203 patients, 95 males with a mean age of 65.5 years. CD was diagnosed in 30.5% of patients. Univariate analysis showed that age, hypertension, increased waist circumference and hyperlipidemia were associated with colonic diverticulosis. There was no association with gender, obesity or type 2 diabetes mellitus. Multivariate analysis showed that age and a greater waist circumference increased the risk of diverticulosis. Age-adjusted analysis showed that MS was associated with diverticulosis. The prevalence of adenoma in patients with CD was similar to that in patients without CD. Conclusion: In this series, MS was significantly associated with CD. The identification of risk groups is important since diverticulosis can have serious and potentially fatal complications. To our knowledge, this is the first Southern European prospective study evaluating the association between MS and CD.","[Teixeira, Cristina; Trabulo, Daniel; Ribeiro, Suzane; Martins, Claudio; Alves, Ana Luisa; Cremers, Isabelle; Oliveira, Ana Paula] Ctr Hosp Setubal, Gastroenterol Dept, Rua Camilo Castelo Branco, P-2910446 Setubal, Portugal",,"Teixeira, C (corresponding author), Ctr Hosp Setubal, Gastroenterol Dept, Rua Camilo Castelo Branco, P-2910446 Setubal, Portugal.",ac.corda.teixeira@gmail.com,"Oliveira, Ana Paula/B-8366-2009",,,,,,40,12,12,0,1,"ARAN EDICIONES, S A",MADRID,"CASTELLO, 128, 28006 MADRID, SPAIN",1130-0108,2340-4167,,REV ESP ENFERM DIG,Rev. Esp. Enferm. Dig.,,2017,109,11,,,,,768,771,,10.17235/reed.2017.5009/2017,http://dx.doi.org/10.17235/reed.2017.5009/2017,,,4,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,FL5HP,28776378,gold,,,2024-06-04,WOS:000414264700005,View Full Record in Web of Science
J,"Ticinesi, A; Nouvenne, A; Corrente, V; Tana, C; Di Mario, F; Meschi, T",,,,"Ticinesi, Andrea; Nouvenne, Antonio; Corrente, Vincenzo; Tana, Claudio; Di Mario, Francesco; Meschi, Tiziana",,,Diverticular Disease: a Gut Microbiota Perspective,JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES,,,English,Review,,,,,,diverticulosis; microbiome; mucosa-associated microbiome; fecal microbiota; metagenomics; acute diverticulitis; dysbiosis; diet; constipation,DIETARY FIBER INTAKE; FECAL MICROBIOTA; HEPATIC-ENCEPHALOPATHY; COLONIC-MUCOSA; PROBIOTICS; RIFAXIMIN; METABOLOME; EXERCISE; RISK; ASSOCIATION,"Gut microbiota composition and functionality are involved in the pathophysiology of several intestinal and extraintestinal diseases, and are increasingly considered a modulator of local and systemic inflammation. However, the involvement of gut microbiota in diverticulosis and in diverticular disease is still poorly investigated. In this review, we critically analyze the existing evidence on the fecal and mucosa-associated microbiota composition and functionality across different stages of diverticular disease. We also explore the influence of risk factors for diverticulosis on gut microbiota composition, and speculate on the possible relevance of these associations for the pathogenesis of diverticula. We overview the current treatments of diverticular disease targeting the intestinal microbiome, highlighting the current areas of uncertainty and the need for future studies. Although no conclusive remarks on the relationship between microbiota and diverticular disease can be made, preliminary data suggest that abdominal symptoms are associated with reduced representation of taxa with a possible anti-inflammatory effect, such as Clostridium cluster IV, and overgrowth of Enterobacteriaceae, Bifidobacteria and Akkermansia. The role of the microbiota in the early stages of the disease is still very uncertain. Future studies should help to disentangle the role of the microbiome in the pathogenesis of diverticular disease and its progression towards more severe forms.","[Ticinesi, Andrea; Nouvenne, Antonio; Corrente, Vincenzo; Tana, Claudio; Di Mario, Francesco; Meschi, Tiziana] Univ Hosp Parma, Geriatr Rehabil Dept, Parma, Italy; [Ticinesi, Andrea; Nouvenne, Antonio; Meschi, Tiziana] Univ Parma, Microbiome Res Hub, Parma, Italy; [Di Mario, Francesco; Meschi, Tiziana] Univ Parma, Dept Med & Surg, Parma, Italy",University of Parma; University Hospital of Parma; University of Parma; University of Parma,"Ticinesi, A (corresponding author), Azienda Osped Univ Parma, Geriatr Rehabil Dept, Parma Univ Hosp, Via Antonio Gramsci 14, I-43126 Parma, Italy.",aticinesi@ao.pr.it,"Tana, Claudio/AFU-7973-2022; Ticinesi, Andrea/K-5017-2016","Tana, Claudio/0000-0002-9162-7866; Ticinesi, Andrea/0000-0001-9171-8592",,,,,111,28,29,0,6,MEDICAL UNIV PRESS,CLUJ-NAPOCA,"3RD MEDICAL CLINIC, STR CROITORILOR NO 19-21, CLUJ-NAPOCA, 400162, ROMANIA",1841-8724,1842-1121,,J GASTROINTEST LIVER,J. Gastrointest. Liver Dis.,SEP,2019,28,3,,,,,327,+,,10.15403/jgld-277,http://dx.doi.org/10.15403/jgld-277,,,11,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,IX7TT,31517330,"Green Submitted, gold",,,2024-06-04,WOS:000485888600014,View Full Record in Web of Science
J,"François, IEJA; Lescroart, O; Veraverbeke, WS; Marzorati, M; Possemiers, S; Evenepoel, P; Hamer, H; Houben, E; Windey, K; Welling, GW; Delcour, JA; Courtin, CM; Verbeke, K; Broekaert, WF",,,,"Francois, Isabelle E. J. A.; Lescroart, Olivier; Veraverbeke, Wim S.; Marzorati, Massimo; Possemiers, Sam; Evenepoel, Pieter; Hamer, Henrike; Houben, Els; Windey, Karen; Welling, Gjalt W.; Delcour, Jan A.; Courtin, Christophe M.; Verbeke, Kristin; Broekaert, Willem F.",,,"Effects of a wheat bran extract containing arabinoxylan oligosaccharides on gastrointestinal health parameters in healthy adult human volunteers: a double-blind, randomised, placebo-controlled, cross-over trial",BRITISH JOURNAL OF NUTRITION,,,English,Article,,,,,,Wheat bran extract; Prebiotics; Protein fermentation reduction; Colonic SCFA; p-Cresol,16S RIBOSOMAL-RNA; IN-SITU HYBRIDIZATION; CHAIN FATTY-ACIDS; BUTYRATE-PRODUCING BACTERIA; RESISTANT STARCH; CHICORY INULIN; FECAL BIFIDOBACTERIA; DIETARY INCLUSION; GUT BACTERIA; P-CRESOL,"Wheat bran extract (WBE) is a food-grade soluble fibre preparation that is highly enriched in arabinoxylan oligosaccharides. In this placebo-controlled cross-over human intervention trial, tolerance and effects on colonic protein and carbohydrate fermentation were studied. After a 1-week run-in period, sixty-three healthy adult volunteers consumed 3, 10 and 0 g WBE/d for 3 weeks in a random order, with 2 weeks' washout between each treatment period. Fasting blood samples were collected at the end of the run-in period and at the end of each treatment period for analysis of haematological and clinical chemistry parameters. Additionally, subjects collected a stool sample for analysis of microbiota, SCFA and pH. A urine sample, collected over 48 h, was used for analysis of p-cresol and phenol content. Finally, the subjects completed questionnaires scoring occurrence frequency and distress severity of eighteen gastrointestinal symptoms. Urinary p-cresol excretion was significantly decreased after WBE consumption at 10 g/d. Faecal bifidobacteria levels were significantly increased after daily intake of 10 g WBE. Additionally, WBE intake at 10 g/d increased faecal SCFA concentrations and lowered faecal pH, indicating increased colonic fermentation of WBE into desired metabolites. At 10 g/d, WBE caused a mild increase in flatulence occurrence frequency and distress severity and a tendency for a mild decrease in constipation occurrence frequency. In conclusion, WBE is well tolerated at doses up to 10 g/d in healthy adults volunteers. Intake of 10 g WBE/d exerts beneficial effects on gut health parameters.","[Francois, Isabelle E. J. A.; Lescroart, Olivier; Veraverbeke, Wim S.; Broekaert, Willem F.] FUGEIA NV, B-3001 Louvain, Belgium; [Marzorati, Massimo; Possemiers, Sam] Univ Ghent, Lab Microbial Ecol & Technol LabMet, B-9000 Ghent, Belgium; [Evenepoel, Pieter] Univ Hosp UZ Leuven, Div Nephrol, B-3000 Louvain, Belgium; [Hamer, Henrike; Houben, Els; Windey, Karen; Verbeke, Kristin] Univ Hosp UZ Leuven, Leuven Food Sci & Nutr Ctr LFoRCe, B-3000 Louvain, Belgium; [Welling, Gjalt W.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, NL-9713 GZ Groningen, Netherlands; [Delcour, Jan A.; Courtin, Christophe M.] Katholieke Univ Leuven, Lab Food Chem & Biochem, B-3001 Louvain, Belgium; [Delcour, Jan A.; Courtin, Christophe M.] Katholieke Univ Leuven, Leuven Food Sci & Nutr Res Ctr LFoRCe, B-3001 Louvain, Belgium",Ghent University; University of Groningen; KU Leuven; KU Leuven,"François, IEJA (corresponding author), FUGEIA NV, Arenberg Sci Pk,Gaston Geenslaan 1, B-3001 Louvain, Belgium.",isabelle.francois@fugeia.com,"P, Evenepoel/D-9597-2018; Courtin, Christophe M/Q-1916-2016; DELCOUR, Jan A/P-4182-2017; Meijers, Bjorn/D-6169-2018","Courtin, Christophe M/0000-0002-1203-9063; DELCOUR, Jan A/0000-0003-2954-1022; Verbeke, Kristin/0000-0002-5352-7565; Possemiers, Sam/0000-0002-6893-5780; Meijers, Bjorn/0000-0002-2846-2026; Hamer, Henrike/0000-0002-6544-2331",Fugeia NV,Fugeia NV,"The authors thank Jan Wijffels (BNOSAC - the Belgium Network of Open Source Analytical Consultants) for the statistical analysis. The authors are also grateful to Erwin Raangs for technical assistance in analysing the faecal microbiota. The authors' responsibilities were as follows: I. E. J. A. F., O. L., J. A. D., C. M. C., K. V. and W. F. B. conceived of and designed the study; W. S. V. coordinated the production of the study's soft drinks; M. M. and S. P. were responsible for the analysis of ammonia content in stool samples; P. E. was responsible for the analysis of p-cresylsulfate content in serum; H. H., E. H. and K. W. were responsible for the analysis of the percentage moisture in the faecal samples and for the analysis of p-cresol content in urine; G. W. W. was responsible for the analysis of microbiota levels in the faecal samples; I. E. J. A. F. and W. F. B. were responsible for interaction with Jan Wijffels for analysis of the data; I. E. J. A. F. and W. F. B. had full access to all of the data in the study and jointly take responsibility for its integrity; I. E. J. A. F., O. L. and W. F. B. wrote the paper. I. E. J. A. F., O. L., W. S. V. and W. F. B. are presently employed by Fugeia NV, which manufactures the wheat bran extract product and is the sole sponsor source of funding for the studies described in the present paper.",,83,92,100,5,94,CAMBRIDGE UNIV PRESS,CAMBRIDGE,"EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND",0007-1145,1475-2662,,BRIT J NUTR,Br. J. Nutr.,DEC 28,2012,108,12,,,,,2229,2242,,10.1017/S0007114512000372,http://dx.doi.org/10.1017/S0007114512000372,,,14,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,056AM,22370444,"Bronze, Green Submitted, Green Published",,,2024-06-04,WOS:000312459300014,View Full Record in Web of Science
J,"Machado, AM; da Silva, NBM; Chaves, JBP; Alfenas, RDG",,,,"Machado, Adriane M.; da Silva, Nayara B. M.; Chaves, Jose Benicio P.; Alfenas, Rita de Cassia G.",,,"Consumption of yacon flour improves body composition and intestinal function in overweight adults: A randomized, double-blind, placebo-controlled clinical trial",CLINICAL NUTRITION ESPEN,,,English,Article,,,,,,Yacon; Fructooligosaccharides; Adiposity; Glycemia; Gastrointestinal function,SMALLANTHUS-SONCHIFOLIUS POEPP.; FRUCTOOLIGOSACCHARIDES; OLIGOFRUCTOSE; CONSTIPATION; TRANSLATION; PORTUGUESE; TRANSIT; WEIGHT; SCALE; ENDL,"Background & aims: Yacon root is a natural source of fructooligosaccharides (FOS), and it has been studied for its potential effect as a functional food. However, FOS in the in natura root are rapidly hydrolyzed. Thus, the use of dehydrated products such as flour ensures stability of FOS. The effect of chronic consumption of yacon flour on body composition, food intake and of biochemical variables concentration has not yet been evaluated in humans. Thus, we evaluated the effects of yacon flour consumption on these variables associated with excess body weight. Methods: Twenty-six adults (31.3 +/- 8.5 years) with excess weight (30.4 +/- 2.4 kg/m(2), 40.16 +/- 6.7% body fat) participated in this randomized, double-blind, six-week study. Subjects were randomly allocated to one of the experimental groups (control (n = 13) or yacon flour (n = 13)), received the prescription of energy-restricted diets (- 500 kcal/day) and daily consumed a breakfast drink not containing or containing 25 g of yacon flour (0.1 g of FOS/kg body weight). At the beginning and at the end of the study, biochemical analyses (glycemia, insulinemia, lipid profile and liver function markers), anthropometrics (weight, waist, hip and neck circumference and sagittal abdominal diameter), body composition (lean mass, total body fat, trunk fat, android fat and gynoid fat), blood pressure, intestinal function, and food intake were assessed. Results: Daily yacon flour consumption was well tolerated, did not cause adverse gastrointestinal effects, increased dietary fiber consumption, promoted greater body weight, waist circumference, waist to height index, sagittal abdominal diameter, and body fat reduction, besides improving bowel function in comparison to the control group. Conclusions: Yacon flour served as a natural fiber supplement and proved to be an effective adjuvant to be used in nutritional strategies to control excess body weight. (C) 2018 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.","[Machado, Adriane M.; Alfenas, Rita de Cassia G.] Univ Fed Vicosa, Dept Nutr & Saude, Ave PH Rolfs S-N, BR-36570000 Vicosa, MG, Brazil; [da Silva, Nayara B. M.; Chaves, Jose Benicio P.] Univ Fed Vicosa, Dept Tecnol Alimentos, Vicosa, MG, Brazil",Universidade Federal de Vicosa; Universidade Federal de Vicosa,"Machado, AM (corresponding author), Univ Fed Vicosa, Dept Nutr & Saude, Ave PH Rolfs S-N, BR-36570000 Vicosa, MG, Brazil.",adrianemoreiramachado@gmail.com,,"Benedito Martins da Silva, Nayara/0000-0001-6501-8349; Alfenas, Rita/0000-0003-2290-1611",Fundacao de Amparoa Pesquisa do Estado de Minas Gerais (FAPEMIG); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),Fundacao de Amparoa Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)),"We thank Fundacao de Amparoa Pesquisa do Estado de Minas Gerais (FAPEMIG), the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for providing research grants to the authors. We thank Bioclin (R) for providing biochemical assays kits. We thank Piracanjuba (R) and Tial (R) for providing milk and juice for the breakfast and dinner to participants. These companies had no role in design, analysis, or writing of this manuscript.",,30,25,26,2,17,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",2405-4577,,,CLIN NUTR ESPEN,Clin. Nutr. ESPEN,FEB,2019,29,,,,,,22,29,,10.1016/j.clnesp.2018.12.082,http://dx.doi.org/10.1016/j.clnesp.2018.12.082,,,8,Nutrition & Dietetics,Emerging Sources Citation Index (ESCI),Nutrition & Dietetics,HH9ME,30661690,,,,2024-06-04,WOS:000456061800003,View Full Record in Web of Science
J,"Marsh, A; Eslick, EM; Eslick, GD",,,,"Marsh, Abigail; Eslick, Enid M.; Eslick, Guy D.",,,Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis,EUROPEAN JOURNAL OF NUTRITION,,,English,Review,,,,,,FODMAP; Diet; Functional gastrointestinal disorders; FGID; Symptoms; Meta-analysis,IRRITABLE-BOWEL-SYNDROME; QUALITY-OF-LIFE; FERMENTABLE CARBOHYDRATES FODMAPS; CELIAC GLUTEN SENSITIVITY; RESPONSE FOLLOWING ADVICE; DOUBLE-BLIND; FIBER; MONOSACCHARIDES; CONSTIPATION; GUIDANCE,"Background Functional gastrointestinal symptoms such as abdominal pain, bloating, distension, constipation, diarrhea and flatulence have been noted in patients with irritable bowel syndrome (IBS) or inflammatory bowel disease (IBD). The diversity of symptoms has meant that finding an effective treatment has been challenging with most treatments alleviating only the primary symptom. A novel treatment option for IBS and IBD currently generating much excitement is the low fermentable, oligo-, di-, mono-saccharides and polyol (FODMAP) diet. The aim of this meta-analysis was to determine the evidence of the efficacy of such a diet in the treatment of functional gastrointestinal symptoms. Methods Electronic databases were searched through to March 2015 to identify relevant studies. Pooled odds ratios (ORs) and 95 % confidence intervals were calculated for the effect of a low FODMAP diet on the reduction in IBS [Symptoms Severity Score (SSS)] score and increase in IBS quality of life (QOL) score for both randomized clinical trials (RCTs) and non-randomized interventions using a random-effects model. Results Six RCTs and 16 non-randomized interventions were included in the analysis. There was a significant decrease in IBS SSS scores for those individuals on a low FODMAP diet in both the RCTs (OR 0.44, 95 % CI 0.25-0.76; I (2) = 35.52, p = 0.00) and non-randomized interventions (OR 0.03, 95 % CI 0.01-0.2; I (2) = 69.1, p = 0.02). In addition, there was a significant improvement in the IBS-QOL score for RCTs (OR 1.84, 95 % CI 1.12-3.03; I (2) = 0.00, p = 0.39) and for non-randomized interventions (OR 3.18, 95 % CI 1.60-6.31; I (2) = 0.00, p = 0.89). Further, following a low FODMAP diet was found to significantly reduce symptom severity for abdominal pain (OR 1.81, 95 % CI 1.13-2.88; I (2) = 0.00, p = 0.56), bloating (OR 1.75, 95 % CI 1.07-2.87; I (2) = 0.00, p = 0.45) and overall symptoms (OR 1.81, 95 % CI 1.11-2.95; I (2) = 0.00, p = 0.4) in the RCTs. In the non-randomized interventions similar findings were observed. Conclusion The present meta-analysis supports the efficacy of a low FODMAP diet in the treatment of functional gastrointestinal symptoms. Further research should ensure studies include dietary adherence, and more studies looking at greater number of patients and long-term adherence to a low FODMAP diet need to be conducted.","[Marsh, Abigail; Eslick, Enid M.; Eslick, Guy D.] Univ Sydney, Nepean Hosp, Whiteley Martin Res Ctr, Discipline Surg, Level 3,Clin Bldg, Penrith, NSW 2751, Australia",University of Sydney; Nepean Hospital,"Eslick, GD (corresponding author), Univ Sydney, Nepean Hosp, Whiteley Martin Res Ctr, Discipline Surg, Level 3,Clin Bldg, Penrith, NSW 2751, Australia.",eslickg@med.usyd.edu.au,"Eslick, Guy/HMT-5739-2023","Eslick, Guy/0000-0002-0098-1705; Marsh, Abigail/0000-0002-4168-7238",,,,,53,219,234,0,122,SPRINGER HEIDELBERG,HEIDELBERG,"TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY",1436-6207,1436-6215,,EUR J NUTR,Eur. J. Nutr.,APR,2016,55,3,,,,,897,906,,10.1007/s00394-015-0922-1,http://dx.doi.org/10.1007/s00394-015-0922-1,,,10,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,DJ3NS,25982757,,,,2024-06-04,WOS:000374112900002,View Full Record in Web of Science
J,"Sarfraz, RM; Khan, H; Maheen, S; Afzal, S; Akram, MR; Mahmood, A; Afzal, K; Abrar, MA; Akram, MA; Andaleeb, M; Haider, I; Abbas, K; Yasmeen, T",,,,"Sarfraz, Rai Muhammad; Khan, Hafeezullah; Maheen, Safirah; Afzal, Samina; Akram, Muhammad Rouf; Mahmood, Asif; Afzal, Khurram; Abrar, Muhammad Asad; Akram, Muhammad Abdullah; Andaleeb, Mehwish; Haider, Ihtasham; Abbas, Khawar; Yasmeen, Tahira",,,"PLANTAGO OVATA: A COMPREHENSIVE REVIEW ON CULTIVATION, BIO-CHEMICAL, PHARMACEUTICAL AND PHARMACOLOGICAL ASPECTS",ACTA POLONIAE PHARMACEUTICA,,,English,Review,,,,,,Plantago ovata; gelling agent; disintegrant; suspending agent; anti-inflammatory; cytotoxic,ALTERNATIVE GELLING AGENT; PHYSICOCHEMICAL CHARACTERIZATION; DIETARY FIBER; PLASMA LDL; PSYLLIUM; HUSK; DISINTEGRANT; MUCILAGE; ISUBGOL; GLUCOSE,"The basic aspire of current study was to review different aspects of Plantago ovata together with its cultivation, growth, biochemistry, pharmaceutical and pharmacological attributes. Plantugo virtu belongs to family Plantaginaceae. It is an annual herb. indigenous to Mediterranean region especially Southern Europe, North Africa and West Asia. Different electronic databases (Medlin, Science Direct. Springer link. Pubmed. Google and Google Scholar) were analyzed for the literature on medicinal properties of Plantago ovum. The literature analysis has revealed that Plantago. ovata has been endowed with diverse pharmaceutical and pharmacological activities. It is widely used in numerous medicines owing to its both pharmaceutical properties such as mucilage. superdisintegrant, gelling agent, suspending agent as well as pharmacological actions like anti-diarrheal, anti-constipation, wound healer. hypocholestrolemic and hypoglycemic. Thus. Plantago ()rata can be employed in the manufacture of a number of pharmaceutical products as well as a safe and efficacious ethnobotanical remedy in several health problems.","[Sarfraz, Rai Muhammad; Khan, Hafeezullah; Maheen, Safirah; Akram, Muhammad Rouf] Univ Sargodha, Fac Pharm, Sargodha, Pakistan; [Afzal, Samina; Afzal, Khurram] Bahauddin Zakariya Univ, Fac Pharm, Multan, Pakistan; [Mahmood, Asif] Univ Agr Faisalabad, Inst Pharm Physiol & Pharmacol, Faisalabad, Pakistan; [Abrar, Muhammad Asad; Andaleeb, Mehwish] Islamia Univ Bahawalpur, Fac Pharm, Bahawalpur, Pakistan; [Akram, Muhammad Abdullah] Gomel Univ, Fac Pharm, Dera Ismail Khan, BELARUS; [Haider, Ihtasham] Islam Med & Dent Coll, Sialkot, Pakistan; [Abbas, Khawar] Islamia Univ Bahawalpur, Univ Coll Convent Med, Bahawalpur, Pakistan; [Yasmeen, Tahira] Childrens Hosp, Lahore, Pakistan; [Yasmeen, Tahira] Inst Child Hlth, Lahore, Pakistan",University of Sargodha; Bahauddin Zakariya University; University of Agriculture Faisalabad; Islamia University of Bahawalpur; Francisk Skorina Gomel State University; Islamia University of Bahawalpur,"Sarfraz, RM (corresponding author), Univ Sargodha, Fac Pharm, Sargodha, Pakistan.",sarfrazrai85@gmail.com,"Sarfraz, Rai/K-8451-2019; Mahmood, Asif/J-3656-2019; Mahmood, Dr. Asif/ITT-1347-2023; Maheen, Safirah/K-8389-2019","Sarfraz, Rai/0000-0003-3121-651X; Mahmood, Asif/0000-0002-4468-1069; Mahmood, Dr. Asif/0000-0002-4468-1069; Andleeb, Mehwish/0000-0003-2619-8513",,,,,43,13,14,2,18,POLSKIE TOWARZYSTWO FARMACEUTYCZNE,WARSAW,"DLUGA 16, 00-238 WARSAW, POLAND",0001-6837,2353-5288,,ACTA POL PHARM,ACTA POL. PHARM.,MAY-JUN,2017,74,3,,,,,739,746,,,,,,8,Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy,GD4CJ,29513942,,,,2024-06-04,WOS:000430449800001,View Full Record in Web of Science
J,"McKenzie, SJ; Brown, WY; Price, IR",,,,"McKenzie, Samantha J.; Brown, Wendy Y.; Price, Ian R.",,,"Reduction in grass eating behaviours in the domestic dog, Canis familiaris, in response to a mild gastrointestinal disturbance",APPLIED ANIMAL BEHAVIOUR SCIENCE,,,English,Article,,,,,,Canis familiaris; Diarrhoea; Domestic dog; Feeding behaviour; Fructo-oligosaccharide; Grass eating,DIETARY FIBER; FECAL QUALITY; TRANSIT-TIME; DIGESTIBILITY,"Grass eating behaviour in the domestic dog may be related to gastrointestinal distress. To explore this theory, the current study observed grass eating behaviours in dogs fed a standard diet with and without supplementation of a fructo-oligosaccharide (FOS). The FOS diet temporarily induced loose, watery stools to Simulate a mild gastrointestinal disturbance. During both FOS Diet and Standard Diet periods, dogs were presented with couch (Cynodon dactylon) and kikuyu (Pennisetum clandestinum) grasses, and the time spent eating grass and the number of grass eating and vomiting events was recorded. Our study found that dogs spent significantly more time eating grass when fed the standard diet and producing normal stools than when they were fed the FOS diet and producing loose stools, suggesting that dogs do not use grass to self-medicate a diarrhoeal gastrointestinal disturbance. However, this does not preclude that other forms of gastrointestinal disturbance may be self-medicated by grass eating behaviours. Importantly, dogs did not use grass as an emetic, as there were only two vomiting events and 374 grass eating events observed. Alternatively, the reduction in grass eating may be attributable to a feeling of satiety caused by the fermentation of FOS. For further clarity, future research should examine the effect of other gastrointestinal disturbances, such as constipation (hard, dry stools) or nausea, on grass eating behaviour in the domestic dog. (C) 2009 Elsevier B.V. All rights reserved.","[McKenzie, Samantha J.; Price, Ian R.] Univ New England, Sch Behav Cognit & Social Sci Psychol, Armidale, NSW 2351, Australia; [Brown, Wendy Y.] Univ New England, Sch Environm & Rural Sci Anim Sci, Armidale, NSW 2351, Australia",University of New England; University of New England,"McKenzie, SJ (corresponding author), Univ Queensland, Sch Populat Hlth, Herston Rd, Herston, Qld 4006, Australia.",s.mckenzie5@uq.edu.au; wbrown@une.edu.au; iprice@une.edu.au,"McKenzie, Samantha/A-2516-2010","McKenzie, Samantha/0000-0003-1328-4527; Brown, Wendy/0000-0002-5309-3381",,,,,31,8,8,1,27,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",0168-1591,1872-9045,,APPL ANIM BEHAV SCI,Appl. Anim. Behav. Sci.,FEB,2010,123,1-2,,,,,51,55,,10.1016/j.applanim.2009.12.003,http://dx.doi.org/10.1016/j.applanim.2009.12.003,,,5,"Agriculture, Dairy & Animal Science; Behavioral Sciences; Veterinary Sciences",Science Citation Index Expanded (SCI-EXPANDED),Agriculture; Behavioral Sciences; Veterinary Sciences,566BI,,,,,2024-06-04,WOS:000275344300007,View Full Record in Web of Science
J,"Whelan, K; Martin, LD; Staudacher, HM; Lomer, MCE",,,,"Whelan, K.; Martin, L. D.; Staudacher, H. M.; Lomer, M. C. E.",,,"The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation in clinical practice",JOURNAL OF HUMAN NUTRITION AND DIETETICS,,,English,Review,,,,,,Irritable bowel syndrome; FODMAP; FODMAPs; fructans; dietitian,QUALITY-OF-LIFE; FUNCTIONAL GASTROINTESTINAL SYMPTOMS; CHRONIC IDIOPATHIC CONSTIPATION; COMMON AUSTRALIAN VEGETABLES; HEALTH SURVEY SF-36; STOOL FORM SCALE; FERMENTABLE OLIGOSACCHARIDES; FIBER SUPPLEMENTATION; LACTOSE-INTOLERANCE; PRACTICE GUIDELINES,"Dietary restriction of fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) is effective in the management of functional gastrointestinal symptoms that occur in irritable bowel syndrome (IBS). Numerous reviews have been published regarding the evidence for their restriction in the low FODMAP diet; however, few reviews discuss the implementation of the low FODMAP diet in practice. The aim of this review is to provide practical guidance on patient assessment and the implementation and monitoring of the low FODMAP diet. Broadly speaking, the low FODMAP diet consists of three stages: FODMAP restriction; FODMAP reintroduction; and FODMAP personalisation. These stages can be covered in at least two dietetic appointments. The first appointment focuses on confirmation of diagnosis, comprehensive symptom and dietary assessment, detailed description of FODMAPs and their association with symptom induction, followed by counselling regarding FODMAP restriction. Dietary counselling should be tailored to individual needs and appropriate resources provided. At the second appointment, symptoms and diet are re-assessed and, if restriction has successfully reduced IBS symptoms, education is provided on FODMAP reintroduction to identify foods triggering symptoms. Following this, the patient can follow FODMAP personalisation for which a less restrictive diet is consumed that excludes their personal FODMAP triggers and enables a more diverse dietary intake. This review provides evidence and practice guidance to assist in delivering high-quality clinical service in relation to the low FODMAP diet.","[Whelan, K.; Martin, L. D.; Staudacher, H. M.; Lomer, M. C. E.] Kings Coll London, Sch Life Course Sci, Dept Nutr Sci, Fac Life Sci & Med, London, England; [Staudacher, H. M.; Lomer, M. C. E.] Guys & St Thomas NHS Fdn Trust, Dept Gastroenterol, London, England; [Staudacher, H. M.] Univ Queensland, Fac Med, Princess Alexandra Southside Clin Unit, Brisbane, Qld, Australia; [Lomer, M. C. E.] Guys & St Thomas NHS Fdn Trust, Dept Nutr & Dietet, London, England",University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of Queensland; Guy's & St Thomas' NHS Foundation Trust,"Whelan, K (corresponding author), Kings Coll London, Dept Nutr Sci, Franklin Wilkins Bldg,150 Stamford St, London SE1 9NH, England.",kevin.whelan@kcl.ac.uk,"Whelan, Kevin/ABD-5350-2021; Staudacher, Heidi/AAC-8193-2022; Whelan, Kevin/ABD-5154-2021","Whelan, Kevin/0000-0001-5414-2950; Staudacher, Heidi/0000-0001-6704-2131; Lomer, Miranda/0000-0002-9369-8115; Martin, Lee/0000-0003-0157-5271",,,,,113,170,180,5,85,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0952-3871,1365-277X,,J HUM NUTR DIET,J. Hum. Nutr. Diet.,APR,2018,31,2,,,,,239,255,,10.1111/jhn.12530,http://dx.doi.org/10.1111/jhn.12530,,,17,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,FZ4SH,29336079,"Bronze, Green Submitted",,,2024-06-04,WOS:000427581700009,View Full Record in Web of Science
J,"Belorio, M; Gómez, M",,,,"Belorio, Mayara; Gomez, Manuel",,,Psyllium: a useful functional ingredient in food systems,CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION,,,English,Review,,,,,,Psyllium; bakery products; gluten-free; low-fat; health claims,PLANTAGO-OVATA-FORSK; GLUTEN-FREE DOUGH; DIETARY FIBER; DIFFERENT HYDROCOLLOIDS; RHEOLOGICAL PROPERTIES; STALING PROPERTIES; GELLING PROPERTIES; BREAD QUALITY; STEAMED BREAD; HUSK FIBER,"Psyllium gum is a hydrocolloid found in the husk of seeds fromPlantago ovata. Psyllium husk has been used in traditional medicine in areas of India and China. Its consumption has been shown to provide nutritional benefits, such as the capacity to reduce the glycaemic index, to minimize the risk of cardiovascular diseases, to decrease cholesterol and constipation problems and others. Thus, interest in the incorporation of psyllium in food products is twofold. First, it can be a natural alternative to the use of other gums and hydrocolloids considered additives. Second, it can be used to improve the nutritional properties of products in which it is incorporated. However, for this purpose, it is necessary to add great quantities of psyllium. This review analyses the potential use of psyllium in distinct food products, considering its advantages and inconveniences as well as possible solutions for undesired effects. Among the analyzed products there are bakery products and, in particular, gluten-free breads where psyllium has been used as a gluten substitute. The incorporation of psyllium into dairy products such as yogurts and those derived from fruits, among others, is also addressed.","[Belorio, Mayara; Gomez, Manuel] Univ Valladolid, Coll Agr Engn, Food Technol Area, Palencia 34071, Spain",Universidad de Valladolid,"Belorio, M (corresponding author), Univ Valladolid, Coll Agr Engn, Food Technol Area, Palencia 34071, Spain.",beloriom@gmail.com,"Gomez, Manuel/K-2545-2013","Gomez, Manuel/0000-0003-2650-4082",FEDER-Interreg Espana-Portugal programme through the project TRANSCOLAB [0612_TRANS_CO_LAB_2_P],FEDER-Interreg Espana-Portugal programme through the project TRANSCOLAB,The authors are grateful to FEDER-Interreg Espana-Portugal programme for financial support through the project TRANSCOLAB (0612_TRANS_CO_LAB_2_P).,,130,40,42,14,104,TAYLOR & FRANCIS INC,PHILADELPHIA,"530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA",1040-8398,1549-7852,,CRIT REV FOOD SCI,Crit. Rev. Food Sci. Nutr.,,2022,62,2,,,,,527,538,,10.1080/10408398.2020.1822276,http://dx.doi.org/10.1080/10408398.2020.1822276,,SEP 2020,12,Food Science & Technology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Nutrition & Dietetics,XW7XM,32951436,,,,2024-06-04,WOS:000571296600001,View Full Record in Web of Science
J,"Shao, BW; Li, HJ; Zhang, PF; Teng, XL; Wang, HL; Verdi, T; Bhat, LT; Zhang, FQ",,,,"Shao, Baowei; Li, Haijie; Zhang, Pengfei; Teng, Xilong; Wang, Honglu; Verdi, Thais; Bhat, Latha T.; Zhang, Fengquan",,,The effect of gum consumption on blood pressure as a risk factor for coronary heart disease: A meta-analysis of controlled trials,INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH,,,English,Review,,,,,,Meta-analysis; blood pressure; SBP; DBP; gum,GUAR GUM; METABOLIC-SYNDROME; SOLUBLE FIBER; DIVERSE APPLICATIONS; DIETARY FIBER; HYPERTENSION; INSULIN; STATEMENT; PSYLLIUM; GLUCOSE,"Guar gum has been used in the management of hypercholesterolemia, constipation, weight loss, type 2 diabetes mellitus and hypertension. Our aim was to verify the hypothesis that Guar gum can be used as an alternative to pharmacological agents in the treatment of mild hypertension. Thus, we conducted a systematic review and meta-analysis to evaluate the effectiveness of Guar gum in reducing blood pressure. We searched the Cochrane Library, PubMed/Medline, Scopus and Google Scholar databases for studies published in the English language up to June 2020 which evaluated the effects of gum consumption on systolic blood pressure (SBP) and diastolic blood pressure (DBP). Nine randomized clinical trials with suitable comparison groups (placebo/control) reported SBP and DBP as outcome measures. These trials involved in total 640 participants. The overall results indicated that the consumption of gum resulted in a significant change in SBP (WMD: -1.190 mmHg, 95% CI: -2.011, -0.370) and DBP (WMD: -1.101 mmHg, 95% CI: -1.597, -0.605). Moreover, the greatest reduction in blood pressure was seen in patients with type 2 diabetes mellitus and metabolic syndrome who consumed Guar gum (WMD: -3.375 mmHg). In addition, there was a significant decrease in SBP if the gum dosage was > 15 g (WMD: -6.637 mmHg) and if the intervention duration was > 12 weeks (WMD: -1.668 mmHg). The results of the present dose-response meta-analysis support the employment of gum consumption in the reduction of SBP and DBP. Based on the sub-group analyses, we highlight that the greatest decrease in SBP was experienced if the gum dosage was > 15 g and when the intervention lasted > 12 weeks.","[Shao, Baowei; Li, Haijie; Zhang, Pengfei; Teng, Xilong; Wang, Honglu; Zhang, Fengquan] Jinan Cent Hosp, Dept Cardiac Surg, Jinan, Shandong, Peoples R China; [Verdi, Thais] Univ Estadual Campinas, Dept Iochem PhysioPlogy Training & Sports Nutr, Campinas, Brazil; [Bhat, Latha T.] Manipal Univ, Manipal Coll Nursing Manipal, Dept Med Surg Nursing, Manipal, India; [Zhang, Fengquan] Jinan Cent Hosp, Dept Cardiac Surg, 105 Jiefang Rd, Jinan 250013, Shandong, Peoples R China",Shandong First Medical University & Shandong Academy of Medical Sciences; Universidade Estadual de Campinas; Manipal Academy of Higher Education (MAHE); Shandong First Medical University & Shandong Academy of Medical Sciences,"Zhang, FQ (corresponding author), Jinan Cent Hosp, Dept Cardiac Surg, 105 Jiefang Rd, Jinan 250013, Shandong, Peoples R China.",shanquan8283@sina.com,"T, Latha/JQX-2950-2023","T, Latha/0000-0003-0856-4380",,,,,66,0,0,2,4,HOGREFE AG-HOGREFE AG SUISSE,BERN,"LANGGASS STRASSE 76, BERN, SWITZERLAND",0300-9831,1664-2821,,INT J VITAM NUTR RES,Int. J. Vitam. Nutr. Res.,FEB,2023,93,1,,,,,61,71,,10.1024/0300-9831/a000696,http://dx.doi.org/10.1024/0300-9831/a000696,,,11,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,8Z9HZ,33472439,,,,2024-06-04,WOS:000933681900008,View Full Record in Web of Science
J,"Nishiwaki, H; Ito, M; Ishida, T; Hamaguchi, T; Maeda, T; Kashihara, K; Tsuboi, Y; Ueyama, J; Shimamura, T; Mori, H; Kurokawa, K; Katsuno, M; Hirayama, M; Ohno, K",,,,"Nishiwaki, Hiroshi; Ito, Mikako; Ishida, Tomohiro; Hamaguchi, Tomonari; Maeda, Tetsuya; Kashihara, Kenichi; Tsuboi, Yoshio; Ueyama, Jun; Shimamura, Teppei; Mori, Hiroshi; Kurokawa, Ken; Katsuno, Masahisa; Hirayama, Masaaki; Ohno, Kinji",,,Meta-Analysisof Gut Dysbiosis in Parkinson's Disease,MOVEMENT DISORDERS,,,English,Article,,,,,,confounding factors; gut microbiota; meta-analysis; Parkinson's disease; pathway analysis,CHAIN FATTY-ACIDS; ALPHA-SYNUCLEIN; SODIUM-BUTYRATE; DIETARY FIBER; MICROBIOTA; PATHOLOGY; MODEL; NEUROINFLAMMATION; EXPRESSION; VAGOTOMY,"Background PD may begin with the intestinal accumulation of alpha-synuclein fibrils, which can be causally associated with gut dysbiosis. The variability of gut microbiota across countries prevented us from identifying shared gut dysbiosis in PD. Objectives To identify gut dysbiosis in PD across countries. Methods We performed 16S ribosomal RNA gene sequencing analysis of gut microbiota in 223 patients with PD and 137 controls, and meta-analyzed gut dysbiosis by combining our dataset with four previously reported data sets from the United States, Finland, Russia, and Germany. We excluded uncommon taxa from our analyses. For pathway analysis, we developed the Kyoto Encyclopedia of Genes and Genomes orthology set enrichment analysis method. Results After adjusting for confounding factors (body mass index, constipation, sex, age, and catechol-O-methyl transferase inhibitor), generaAkkermansiaandCatabacter, as well as familiesAkkermansiaceae, were increased, whereas generaRoseburia,Faecalibacterium, andLachnospiraceae ND3007 groupwere decreased in PD. Catechol-O-methyl transferase inhibitor intake markedly increased familyLactobacillaceae. Inspection of these bacteria in 12 datasets that were not included in the meta-analysis revealed that increased genusAkkermansiaand decreased generaRoseburiaandFaecalibacteriumwere frequently observed across countries. Kyoto Encyclopedia of Genes and Genomes orthology set enrichment analysis revealed changes in short-chain fatty acid metabolisms in our dataset. Conclusions We report that intestinal mucin layer-degradingAkkermansiais increased and that short-chain fatty acid-producingRoseburiaandFaecalibacteriumare decreased in PD across countries. (c) 2020 International Parkinson and Movement Disorder Society","[Nishiwaki, Hiroshi; Ito, Mikako; Hamaguchi, Tomonari; Ohno, Kinji] Nagoya Univ, Ctr Neurol Dis & Canc, Div Neurogenet, Grad Sch Med, Nagoya, Aichi, Japan; [Ishida, Tomohiro; Ueyama, Jun; Hirayama, Masaaki] Nagoya Univ, Dept Pathophysiol Lab Sci, Grad Sch Med, Nagoya, Aichi, Japan; [Maeda, Tetsuya] Iwate Med Univ, Sch Med, Dept Internal Med, Div Neurol & Gerontol, Morioka, Iwate, Japan; [Kashihara, Kenichi] Okayama Kyokuto Hosp, Dept Neurol, Okayama, Japan; [Tsuboi, Yoshio] Fukuoka Univ, Dept Neurol, Fukuoka, Japan; [Shimamura, Teppei] Nagoya Univ, Ctr Neurol Dis & Canc, Div Syst Biol, Grad Sch Med, Nagoya, Aichi, Japan; [Mori, Hiroshi; Kurokawa, Ken] Natl Inst Genet, Dept Informat, Genome Evolut Lab, Mishima, Shizuoka, Japan; [Katsuno, Masahisa] Nagoya Univ, Dept Neurol, Grad Sch Med, Nagoya, Aichi, Japan",Nagoya University; Nagoya University; Iwate Medical University; Fukuoka University; Nagoya University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Nagoya University,"Ohno, K (corresponding author), Nagoya Univ, Ctr Neurol Dis & Canc, Div Neurogenet, Grad Sch Med,Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.;Hirayama, M (corresponding author), Nagoya Univ, Dept Pathophysiol Lab Sci, Grad Sch Med, Higashi Ku, 1-1-20 Daiko Minami, Nagoya, Aichi 4618673, Japan.",hirasan@met.nagoya-u.ac.jp; ohnok@med.nagoya-u.ac.jp,"Ohno, Kinji/H-4020-2012; Hirayama, Masaaki/ABH-2669-2020; Hamaguchi, Tomonari/AAT-2423-2021; Ueyama, Jun/I-6273-2014; Ito, Mikako/I-1941-2012; Hirayama, Masaaki/I-9341-2018","Ueyama, Jun/0000-0003-0660-2726; Maeda, Tetsuya/0000-0002-6207-8343; Mori, Hiroshi/0000-0003-0806-7704; Kashihara, Kenichi/0000-0002-1815-9832; Hirayama, Masaaki/0000-0003-0092-7837; Shimamura, Teppei/0000-0003-2994-872X","Japan Society for the Promotion of Science [JP17K07094, JP19K16516]; Ministry of Health, Labour and Welfare of Japan [H29-Nanchi-Ippan-030]; Japan Agency for Medical Research and Development [JJP19gm1010002, JP19ek0109230, JP19ek0109281, JP19bm0804005]; National Center of Neurology and Psychiatry [29-4]; Smoking Research Foundation; Hori Sciences and Arts Foundation; Grants-in-Aid for Scientific Research [20K06925, 20H03561, 20H04281, 20H04841, 20K21832] Funding Source: KAKEN","Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); National Center of Neurology and Psychiatry(National Center for Neurology & Psychiatry - Japan); Smoking Research Foundation; Hori Sciences and Arts Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))","This study was supported by Grants-in-Aid from the Japan Society for the Promotion of Science (JP17K07094 and JP19K16516); the Ministry of Health, Labour and Welfare of Japan (H29-Nanchi-Ippan-030); the Japan Agency for Medical Research and Development (JJP19gm1010002, JP19ek0109230, JP19ek0109281, and JP19bm0804005), the National Center of Neurology and Psychiatry (29-4), The Smoking Research Foundation, and the Hori Sciences and Arts Foundation. Funding agencies had no role in the management, analysis, or interpretation of the data nor were they involved in preparation, review, or approval of the manuscript. The funders were also not involved in the decision to submit the manuscript for publication.",,81,183,199,4,76,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0885-3185,1531-8257,,MOVEMENT DISORD,Mov. Disord.,SEP,2020,35,9,,,,,1626,1635,,10.1002/mds.28119,http://dx.doi.org/10.1002/mds.28119,,JUN 2020,10,Clinical Neurology,Science Citation Index Expanded (SCI-EXPANDED),Neurosciences & Neurology,NO0JX,32557853,Bronze,Y,N,2024-06-04,WOS:000540868200001,View Full Record in Web of Science
J,"Moreira-Rosario, A; Marques, C; Pinheiro, H; Norberto, S; Sintra, D; Teixeira, JA; Calhau, C; Azevedo, LF",,,,"Moreira-Rosario, Andre; Marques, Claudia; Pinheiro, Helder; Norberto, Sonia; Sintra, Diana; Teixeira, Jose Antonio; Calhau, Conceicao; Azevedo, Luis Filipe",,,Daily intake of wheat germ-enriched bread may promote a healthy gut bacterial microbiota: a randomised controlled trial,EUROPEAN JOURNAL OF NUTRITION,,,English,Article,,,,,,Gastrointestinal discomfort; Gut microbiota; Bread; Wheat germ; Randomised controlled trial,QUALITY-OF-LIFE; DIETARY FIBER; CONSTIPATION; ASSOCIATION; PREBIOTICS; SYMPTOMS; IMPACT; PRUCALOPRIDE; DIVERSITY; NUTRITION,"Purpose Wheat bran fibre has a beneficial effect on gastrointestinal function, but evidence for wheat germ is scarce. Accordingly, we evaluated the effects of daily intake of wheat germ on gastrointestinal discomfort and gut microbiota by adding wheat germ to refined (white) wheat bread, the most consumed bread type. We hypothesised that an improvement in the composition of refined bread could beneficially affect intestinal health without compromising consumers' acceptance. Methods Fifty-five healthy adults were recruited for a randomised, double-blind, crossover, controlled trial comprising two 4-week intervention periods separated by a 5-week washout stage. During the first 4-week period, one group consumed wheat bread enriched with 6 g of wheat germ and the control group consumed non-enriched wheat bread. Results Wheat germ-enriched bread was well-appreciated and the number of participants that demonstrated minimal gastrointestinal improvements after wheat-germ intake was higher than in the control arm. Importantly, intake of wheat germ-enriched bread decreased the perceived gastrointestinal discomfort-related quality of life (subscale worries and concerns) over refined white bread. The improvements in the gastrointestinal function were accompanied by favourable changes in gut microbiota, increasing the number ofBacteroidesspp. andBifidobacteriumspp. Conclusions Adding wheat germ to industrially made white bread without altering sensory properties may promote a healthy gut bacterial microbiota and the gastrointestinal health.","[Moreira-Rosario, Andre; Marques, Claudia; Norberto, Sonia; Sintra, Diana; Calhau, Conceicao; Azevedo, Luis Filipe] Ctr Hlth Technol & Serv Res CINTESIS, Porto, Portugal; [Moreira-Rosario, Andre; Azevedo, Luis Filipe] Univ Porto, Fac Med, Dept Community Med Informat & Hlth Decis Sci MEDC, Porto, Portugal; [Marques, Claudia; Pinheiro, Helder; Calhau, Conceicao] NOVA Univ Lisbon, NOVA Med Sch, Nutr & Metab, Lisbon, Portugal; [Pinheiro, Helder] Hosp Curry Cabral, Infect Dis Serv, Lisbon, Portugal; [Teixeira, Jose Antonio] Univ Minho, Ctr Biol Engn, Campus Gualtar, Braga, Portugal; [Calhau, Conceicao] Univ Unit Lifestyle Med, Jose de Mello Saude NOVA Med Sch, Lisbon, Portugal",Universidade do Porto; Universidade Nova de Lisboa; Universidade do Minho,"Moreira-Rosario, A (corresponding author), Ctr Hlth Technol & Serv Res CINTESIS, Porto, Portugal.;Moreira-Rosario, A (corresponding author), Univ Porto, Fac Med, Dept Community Med Informat & Hlth Decis Sci MEDC, Porto, Portugal.",andrerosario@med.up.pt,"Azevedo, Luís/J-7819-2012; Teixeira, Diana Marina Silva/GNM-9140-2022; Teixeira, Jose/A-6268-2012; Moreira-Rosario, Andre/L-9893-2014","Azevedo, Luís/0000-0002-8421-2937; Teixeira, Diana Marina Silva/0000-0002-2162-1450; Calhau, Conceicao/0000-0001-9567-3379; Teixeira, Jose/0000-0002-4918-3704; Norberto, Sonia/0000-0002-5388-3682; Marques, Claudia/0000-0002-8365-7934; Moreira-Rosario, Andre/0000-0003-0320-1839; Pinheiro, Helder/0000-0001-6076-2670",Fundação para a Ciência e a Tecnologia [POCI-01-0145-FEDER-007746] Funding Source: Medline,Fundação para a Ciência e a Tecnologia(Fundacao para a Ciencia e a Tecnologia (FCT)),,,49,6,6,3,37,SPRINGER HEIDELBERG,HEIDELBERG,"TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY",1436-6207,1436-6215,,EUR J NUTR,Eur. J. Nutr.,AUG,2020,59,5,,,,,1951,1961,,10.1007/s00394-019-02045-x,http://dx.doi.org/10.1007/s00394-019-02045-x,,,11,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,MH8HM,31325040,Green Published,,,2024-06-04,WOS:000546963100016,View Full Record in Web of Science
S,"Carvalho, R; Di Lorenzo, C",,"Quigley, EMM; Hongo, M; Fukudo, S",,"Carvalho, Ryan; Di Lorenzo, Carlo",,,Specific Clinical Contexts - Part 3: The Child with Neurodevelopmental Delay,FUNCTIONAL AND GI MOTILITY DISORDERS,Frontiers of Gastrointestinal Research,,English,Article; Book Chapter,,,,,,,NEUROLOGICALLY IMPAIRED CHILDREN; GASTROESOPHAGEAL-REFLUX DISEASE; ENTERIC NERVOUS-SYSTEM; COLONIC TRANSIT-TIME; CEREBRAL-PALSY; ANTIREFLUX SURGERY; DIETARY FIBER; DOWN-SYNDROME; ESOPHAGOGASTRIC DISCONNECTION; GASTROINTESTINAL MOTILITY,"Varying degrees of gut dysmotility accompany the musculoskeletal disabilities of most children with neurodevelopmental delay. The majority of children with cerebral palsy, the most extensively studied among the diseases with neurodevelopmental delays, have clinically significant gastrointestinal symptoms, including swallowing difficulties, regurgitation and/or vomiting, pulmonary aspiration and chronic constipation. If inadequately diagnosed or treated, these disorders may result in malnutrition, growth delay and further impairment of the quality of life. Over the last two decades, considerable progress has been made in understanding the pathophysiologic mechanisms underlying gastrointestinal functional and motility disorders in pediatric patients. These findings have resulted in more specific diagnosis and the development of novel therapeutic approaches. Such advancement in neuroscience research has also helped gain considerable insight into the pathogenesis of symptoms in children with neurodevelopmental delay. This review focuses mostly on children with cerebral palsy and the clinical manifestations of their gastrointestinal motility dysfunctions. We describe the prevalence and clinical presentation of different disorders and discuss the diagnostic tests that have a role in their evaluation. Finally, we summarize the evidence supporting different medical and surgical treatment options. (C) 2014 S. Karger AG, Basel","[Carvalho, Ryan; Di Lorenzo, Carlo] Ohio State Univ, Div Gastroenterol Hepatol & Nutr, Dept Pediat, Nationwide Childrens Hosp,Wexner Coll Med, Columbus, OH 43210 USA",University System of Ohio; Ohio State University; Nationwide Childrens Hospital,"Carvalho, R (corresponding author), Ohio State Univ, Div Gastroenterol Hepatol & Nutr, Dept Pediat, Nationwide Childrens Hosp,Wexner Coll Med, Columbus, OH 43210 USA.",,,,,,,,82,0,0,0,0,KARGER,BASEL,"POSTFACH, CH-4009 BASEL, SWITZERLAND",0302-0665,,978-3-318-02579-8; 978-3-318-02578-1,FRONT GASTROINT RES,Front.Gastrointest.Res.,,2014,33,,,,,,150,162,,10.1159/000356993,http://dx.doi.org/10.1159/000356993,10.1159/isbn.978-3-318-02579-8,,13,Gastroenterology & Hepatology,Book Citation Index – Science (BKCI-S),Gastroenterology & Hepatology,BG3GX,,,,,2024-06-04,WOS:000387943100015,View Full Record in Web of Science
J,"Chand, M; Chopra, R; Talwar, B; Homroy, S; Singh, PK; Dhiman, A; Payyunni, AW",,,,"Chand, Monika; Chopra, Rajni; Talwar, Binanshu; Homroy, Snigdha; Singh, Priyanka Kumari; Dhiman, Aishwarya; Payyunni, Abdul Wahid",,,"Unveiling the potential of linseed mucilage, its health benefits, and applications in food packaging",FRONTIERS IN NUTRITION,,,English,Review,,,,,,linseed mucilage; extraction; edible films; coatings; health; by-product,WATER-SOLUBLE POLYSACCHARIDES; ULTRASOUND-ASSISTED EXTRACTION; FLAXSEED LINUM-USITATISSIMUM; FENUGREEK SEED MUCILAGE; IN-VITRO ASSESSMENT; RHEOLOGICAL PROPERTIES; FUNCTIONAL-PROPERTIES; DIETARY-FIBERS; PHYSICOCHEMICAL PROPERTIES; CHEMICAL-COMPOSITION,"Industrial waste products derived from the oil industry often contain valuable substances and elements with great potential. These by-products can be used for various purposes, including as nutrients, bioactive compounds, fuels, and polymers. Linseed mucilage (LM) is one such example of a beneficial by-product obtained from linseed. It possesses favorable chemical and functional properties, depending on its method of extraction. Different pretreatments, such as enzymatic extraction, microwave-assisted extraction, pulse electric field, and ultrasound-assisted extraction, have been explored by various researchers to enhance both the yield and quality of mucilage. Furthermore, LM has exhibited therapeutic effects in the treatment of obesity, diabetes, constipation, hyperlipidemia, cancer, and other lifestyle diseases. Additionally, it demonstrates favorable functional characteristics that make it suitable to be used in bioplastic production. These properties preserve food quality, prolong shelf life, and confer antimicrobial activity. It also has the potential to be used as a packaging material, especially considering the increasing demand for sustainable and biodegradable alternatives to plastics because of their detrimental impact on environmental health. This review primarily focuses on different extraction techniques used for linseed mucilage, its mechanism of action in terms of health benefits, and potential applications in food packaging.","[Chand, Monika; Chopra, Rajni; Talwar, Binanshu; Homroy, Snigdha; Dhiman, Aishwarya; Payyunni, Abdul Wahid] Natl Inst Food Technol Entrepreneurship & Manageme, Dept Food Sci & Technol, Kundli, Haryana, India; [Singh, Priyanka Kumari] Univ Delhi, Inst Home Econ, Dept Food & Nutr & Food Technol, New Delhi, India",University of Delhi,"Chopra, R (corresponding author), Natl Inst Food Technol Entrepreneurship & Manageme, Dept Food Sci & Technol, Kundli, Haryana, India.",rajnichopra.niftem@gmail.com,,,,,,,186,1,1,7,7,FRONTIERS MEDIA SA,LAUSANNE,"AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND",2296-861X,,,FRONT NUTR,Front. Nutr.,FEB 7,2024,11,,,,,,,,1334247,10.3389/fnut.2024.1334247,http://dx.doi.org/10.3389/fnut.2024.1334247,,,20,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,IW7E5,38385008,"gold, Green Published",,,2024-06-04,WOS:001169432200001,View Full Record in Web of Science
J,"Trimingham, C; McDonald, S; Dansie, K; Jesudason, S; Faull, R; Clayton, P; Liew, G; Le Leu, R; Meade, A",,,,"Trimingham, Claire; McDonald, Stephen; Dansie, Kathryn; Jesudason, Shilpa; Faull, Randall; Clayton, Phil; Liew, Grace; Le Leu, Richard; Meade, Anthony",,,BOWEL HEALTH IN CHRONIC KIDNEY DISEASE: PATIENT PERCEPTIONS DIFFER FROM CLINICAL DEFINITIONS,JOURNAL OF RENAL CARE,,,English,Article,,,,,,Chronic kidney disease; Haemodialysis; Kidney transplant; Peritoneal dialysis; Bowel health,DIETARY FIBER; GASTROINTESTINAL SYMPTOMS; HEMODIALYSIS-PATIENTS; LAXATIVE REQUIREMENT; PERITONEAL-DIALYSIS; CONSTIPATION; PREVALENCE; HYPERPHOSPHATEMIA; FOODS,"Background: The bowel health of those with chronic kidney disease (CKD) can be affected by medications, fluid/dietary allowances, reduced activity and pre-existing medical conditions. Patient perceptions of their bowel health can differ from those of health care professionals and the burden of gastrointestinal symptoms could be inaccurately reported. Methods: Adults with CKD, including those undergoing haemodialysis, peritoneal dialysis and kidney transplant from four South Australian hospitals enrolled in the study. Participants completed a five-item questionnaire, to investigate their perception of bowel health compared with clinical criteria for 'normal and abnormal' bowel health using the Bristol Stool Form Scale, bowel frequency and reported symptoms. Results: A total of 324 individuals completed the questionnaire. Of those with clinically defined 'abnormal' bowel health (n = 180), 50.6% perceived their bowels as 'normal' or 'more normal than abnormal'. Only 6% of this clinically 'abnormal' group perceived their bowel health as abnormal. Of those with clinically defined 'normal' bowel health (n = 144), 16% perceived their bowel health as 'abnormal', 'more abnormal than normal' or 'variable'. Fifty-seven percent of patients with clinically defined 'abnormal' bowel health were not taking any treatments. Peritoneal dialysis recipients were the highest users of treatments to improve bowel function, with 62% using 1 or more treatment. Conclusions: It is common for patients with CKD to experience signs and symptoms of abnormal bowel health. There is a disconnect between patient perceptions and clinical definitions of normal or abnormal bowel health. Clinical care team members must carefully obtain and clarify patient-reported symptoms related to bowel function in order to help ensure recommendations and use of appropriate treatments.","[Trimingham, Claire; McDonald, Stephen; Jesudason, Shilpa; Faull, Randall; Clayton, Phil; Le Leu, Richard; Meade, Anthony] Royal Adelaide Hosp, Cent & Northern Adelaide Renal & Transplantat Ser, North Terrace, Adelaide, SA 5000, Australia; [McDonald, Stephen; Dansie, Kathryn; Clayton, Phil] South Australian Hlth & Med Res Inst, ANZDATA, Adelaide, SA, Australia; [Liew, Grace] Flinders Univ S Australia, Adelaide, SA, Australia",Royal Adelaide Hospital; South Australian Health & Medical Research Institute (SAHMRI); Flinders University South Australia,"Trimingham, C (corresponding author), Royal Adelaide Hosp, Cent & Northern Adelaide Renal & Transplantat Ser, North Terrace, Adelaide, SA 5000, Australia.",claire.trimingham@sa.gov.au,"Trimingham, Claire/I-9225-2019; McDonald, Stephen/G-4010-2013; Jesudason, Shilpanjali/AAA-5717-2021; Clayton, Philip A/D-5613-2011; Le Leu, Richard K/H-4555-2013","McDonald, Stephen/0000-0001-6103-1386; Le Leu, Richard K/0000-0003-4704-4943; Jesudason, Shilpanjali/0000-0001-9695-0761",CNARTS Clinical Research Group,CNARTS Clinical Research Group,"The manuscript was supported by the CNARTS Clinical Research Group. We would like to thank the patients from our service for participating in this questionnaire and Alex Day, Dietitian for volunteering to assist with data collection. The authors state that the results presented in this paper have not been published previously in whole or part, except in abstract format.",,22,6,6,0,2,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",1755-6678,1755-6686,,J RENAL CARE,J. Ren. Care,JUN,2018,44,2,,,,,65,72,,10.1111/jorc.12230,http://dx.doi.org/10.1111/jorc.12230,,,8,Nursing; Urology & Nephrology,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Nursing; Urology & Nephrology,GF0ZB,29316279,,,,2024-06-04,WOS:000431659600002,View Full Record in Web of Science
J,"Moreira-Rosário, A; Pinheiro, H; Calhau, C; Azevedo, LF",,,,"Moreira-Rosario, Andre; Pinheiro, Helder; Calhau, Conceicao; Azevedo, Luis Filipe",,,Can wheat germ have a beneficial effect on human health? A study protocol for a randomised crossover controlled trial to evaluate its health effects,BMJ OPEN,,,English,Article,,,,,,,CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; GLYCEMIC INDEX; PATIENT ASSESSMENT; FOOD-CONSUMPTION; PLASMA-LIPIDS; ALL-CAUSE; CONSTIPATION,"Introduction: Cardiovascular diseases (CVD) are the leading cause of mortality worldwide and diet is an important contributor to CVD risk. Thus, several food derivatives are being investigated for their beneficial impact on reducing cardiometabolic risk factors, either in risk groups or in healthy population as a preventive measure. Wheat germ is a food by-product with high nutritional value, especially as a concentrated source of dietary fibre and essential fatty acids, but its incorporation into the diet has been rare up to now. Previous studies do not clarify the hypothesised potential causal relationship between the consumption of wheat germ and benefits for human health. Methods and analysis: We are conducting a randomised, double-blinded, crossover, placebocontrolled clinical trial designed to assess the physiological effects of daily consumption of wheat germ-enriched bread (containing 6 g of wheat germ) compared with non-enriched bread, over a 4-week period with a 15-week follow-up, in a healthy human population. A total of 55 participants (healthy volunteers, aged 18-60) have been recruited from the Porto metropolitan area in northern Portugal. Our aim is to evaluate the health effects of wheat germ on blood cholesterol and triglycerides, postprandial glycaemic response, gastrointestinal function and discomfort, and changes in intestinal microbiota and insulin resistance as secondary outcomes. The study follows the best practices for evaluating health claims in food according to the European Food Safety Authority (EFSA) scientific opinion, namely random allocation, double blinding, reporting methods to measure and maximise compliance, and validated outcomes with beneficial physiological effects as recommended by EFSA. Ethics and dissemination: The study has been approved by the Health Ethics Committee of Sao Joao Hospital Centre (156-15) and the Ethics Committee of Faculty of Medicine of the University of Porto (PCEDCSS-FMUP07/2015). Results will be disseminated through peer-reviewed publications and presentations at international scientific meetings.","[Moreira-Rosario, Andre; Calhau, Conceicao; Azevedo, Luis Filipe] Univ Porto, Ctr Hlth Technol & Serv Res CINTESIS, Fac Med, Oporto, Portugal; [Moreira-Rosario, Andre] Univ Porto, Dept Biochem, Fac Med, Oporto, Portugal; [Moreira-Rosario, Andre; Azevedo, Luis Filipe] Univ Porto, Dept Hlth Informat & Decis Sci CIDES, Fac Med, Oporto, Portugal; [Pinheiro, Helder] Hosp Curry Cabral, Ctr Hosp Lisboa Cent, Serv Doencas Infecciosas, Lisbon, Portugal; [Calhau, Conceicao] NOVA Univ Lisbon, NOVA Med Sch, Dept Nutr & Metab, Lisbon, Portugal","Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade de Lisboa; Centro Hospitalar de Lisboa Central, EPE; Universidade Nova de Lisboa","Moreira-Rosario, A (corresponding author), Univ Porto, Ctr Hlth Technol & Serv Res CINTESIS, Fac Med, Oporto, Portugal.;Moreira-Rosario, A (corresponding author), Univ Porto, Dept Biochem, Fac Med, Oporto, Portugal.;Moreira-Rosario, A (corresponding author), Univ Porto, Dept Hlth Informat & Decis Sci CIDES, Fac Med, Oporto, Portugal.",andrerosario@med.up.pt,"Calhau, Conceição/L-8041-2013; Azevedo, Luís/J-7819-2012; Moreira-Rosario, Andre/L-9893-2014","Azevedo, Luís/0000-0002-8421-2937; Pinheiro, Helder/0000-0001-6076-2670; Moreira-Rosario, Andre/0000-0003-0320-1839; Calhau, Conceicao/0000-0001-9567-3379","FEDER - Programa Operacional Competitividade e Internacionalizacao - COMPETE [FCOMP-01-0202-FEDER-038861, POCI-01-0145-FEDER-007746]; FCT - Fundacao para a Ciencia e a Tecnologia within CINTESIS, RD Unit [UID/IC/4255/2013]","FEDER - Programa Operacional Competitividade e Internacionalizacao - COMPETE; FCT - Fundacao para a Ciencia e a Tecnologia within CINTESIS, RD Unit","This work was supported by FEDER through the operations FCOMP-01-0202-FEDER-038861 and POCI-01-0145-FEDER-007746 funded by the Programa Operacional Competitividade e Internacionalizacao - COMPETE2020 and by National Funds through FCT - Fundacao para a Ciencia e a Tecnologia within CINTESIS, R&D Unit (reference UID/IC/4255/2013).",,57,9,10,0,8,BMJ PUBLISHING GROUP,LONDON,"BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND",2044-6055,,,BMJ OPEN,BMJ Open,,2016,6,11,,,,,,,e013098,10.1136/bmjopen-2016-013098,http://dx.doi.org/10.1136/bmjopen-2016-013098,,,9,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,EG8JQ,28157671,"gold, Green Published",,,2024-06-04,WOS:000391303400130,View Full Record in Web of Science
J,"Spiller, R; Marciani, L",,,,"Spiller, Robin; Marciani, Luca",,,Intraluminal Impact of Food: New Insights from MRI,NUTRIENTS,,,English,Review,,,,,,magnetic resonance imaging; stomach; small bowel; colon; food,IRRITABLE-BOWEL-SYNDROME; HEALTHY-SUBJECTS; WATER-CONTENT; KIWIFRUIT EXTRACT; DIETARY FIBER; CROSSOVER MRI; SOLID MEAL; COLON; CONSTIPATION; INGESTION,"Understanding how the gut responds to food has always been limited by the available investigatory techniques. Previous methods involving intubation and aspiration are largely limited to liquid-only meals. The aim of this review is to describe how MRI has allowed analysis of the processing of complex multiphase meals. This has demonstrated the role of physical factors such as viscosity, fat and fibre content in controlling gastric secretion and motility. It has also allowed the description of changes induced in small bowel water content and the role of osmotic effects of poorly absorbed carbohydrates such as fructose, sorbitol and mannitol. Intestinal secretions can be shown to be stimulated by a range of fruit and vegetables and the effect of this on colonic water content can also be measured. This has been used to demonstrate the mode of action of commonly used laxatives including bran and psyllium. The wealth of data which can be obtained together with its non-invasive nature and safety makes the technique ideal for the serial evaluation of the impact of different nutrients and drugs in both health and disease.","[Spiller, Robin; Marciani, Luca] Univ Nottingham, Nottingham Digest Dis Ctr, Nottingham NG7 2UH, England; [Spiller, Robin; Marciani, Luca] Univ Nottingham, NIHR Nottingham Biomed Res Ctr, Nottingham NG7 2UH, England",University of Nottingham; University of Nottingham,"Spiller, R (corresponding author), Univ Nottingham, Nottingham Digest Dis Ctr, Nottingham NG7 2UH, England.",Robin.Spiller@nottingham.ac.uk; Luca.Marciani@nottingham.ac.uk,"spiller, robin/ABE-6690-2021","spiller, robin/0000-0001-6371-4500; Marciani, Luca/0000-0001-9092-4300","Danone, Paris, France","Danone, Paris, France(Danone Nutricia)","Publication of this manuscript was made possible through an unrestricted educational grant from Danone, Paris, France to the European Society of Neurogastroenterology and Motility (ESNM), Vienna, Austria.",,45,21,23,1,11,MDPI,BASEL,"ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND",,2072-6643,,NUTRIENTS,Nutrients,MAY,2019,11,5,,,,,,,1147,10.3390/nu11051147,http://dx.doi.org/10.3390/nu11051147,,,14,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,IC5PY,31126027,"Green Published, Green Submitted, gold",,,2024-06-04,WOS:000471021600207,View Full Record in Web of Science
J,"Hirayama, M; Nishiwaki, H; Hamaguchi, T; Ohno, K",,,,"Hirayama, Masaaki; Nishiwaki, Hiroshi; Hamaguchi, Tomonari; Ohno, Kinji",,,Gastrointestinal disorders in Parkinson's disease and other Lewy body diseases,NPJ PARKINSONS DISEASE,,,English,Review,,,,,,,CHAIN FATTY-ACIDS; 4TH CONSENSUS REPORT; ALPHA-SYNUCLEIN; GUT MICROBIOTA; AKKERMANSIA-MUCINIPHILA; INTESTINAL PERMEABILITY; CROHNS-DISEASE; MOTOR DEFICITS; DIETARY FIBER; RISK,"Parkinson's disease (PD) is pathologically characterized by the abnormal accumulation of alpha-synuclein fibrils (Lewy bodies) in the substantia nigra and other brain regions, although the role of Lewy bodies remains elusive. Constipation usually precedes the motor symptoms in PD, which is in accordance with the notion that alpha-synuclein fibrils start from the intestinal neural plexus and ascend to the brain in at least half of PD patients. The gut microbiota is likely to be involved in intestinal and brain pathologies. Analyses of the gut microbiota in PD, rapid-eye-movement sleep behavior disorder, and dementia with Lewy bodies suggest three pathological pathways. First, Akkermansia, which is increased in PD, degrades the intestinal mucus layer and increases intestinal permeability, which triggers inflammation and oxidative stress in the intestinal neural plexus. Second, decreased short-chain fatty acids (SCFAs)-producing bacteria in PD reduce the number of regulatory T cells. Third, SCFAs also aggravate microglial activation with an unelucidated pathway. In addition, in dementia with Lewy bodies (DLB), which is another form of alpha-synucleinopathies, increased genera, Ruminococcus torques and Collinsella, may mitigate neuroinflammation in the substantia nigra by increasing secondary bile acids. Interventions for the gut microbiota and their metabolites may potentially delay or mitigate the development and progression of PD and other Lewy body diseases.","[Hirayama, Masaaki] Nagoya Univ, Dept Pathophysiol Lab Sci, Grad Sch Med, Nagoya, Japan; [Nishiwaki, Hiroshi; Hamaguchi, Tomonari; Ohno, Kinji] Nagoya Univ, Ctr Neurol Dis & Canc, Div Neurogenet, Grad Sch Med, Nagoya, Japan",Nagoya University; Nagoya University,"Hirayama, M (corresponding author), Nagoya Univ, Dept Pathophysiol Lab Sci, Grad Sch Med, Nagoya, Japan.;Ohno, K (corresponding author), Nagoya Univ, Ctr Neurol Dis & Canc, Div Neurogenet, Grad Sch Med, Nagoya, Japan.",hirasan@met.nagoya-u.ac.jp; ohnok@med.nagoya-u.ac.jp,"Hirayama, Masaaki/ABH-2669-2020; Ohno, Kinji/H-4020-2012; Hirayama, Masaaki/I-9341-2018","Ohno, Kinji/0000-0002-1529-2750; Hirayama, Masaaki/0000-0003-0092-7837","Japan Agency for Medical Research and Development [JP21gm1010002, JP22bm0804005, JP22ek0109488]; Japan Society for the Promotion of Science [JP20H03561, JP22K17343, JP22K15394]; Ministry of Health, Labor, and Welfare of Japan [20FC1036]; Hori Science and Arts Foundation; National Center of Neurology and Psychiatry [2-5]","Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Hori Science and Arts Foundation; National Center of Neurology and Psychiatry(National Center for Neurology & Psychiatry - Japan)","Studies performed in the authors' laboratories were supported by Grants-in-Aid from the Japan Agency for Medical Research and Development (JP21gm1010002, JP22bm0804005, and JP22ek0109488), the Japan Society for the Promotion of Science (JP20H03561, JP22K17343, and JP22K15394), the Ministry of Health, Labor, and Welfare of Japan (20FC1036), the National Center of Neurology and Psychiatry (2-5), and the Hori Science and Arts Foundation.",,129,5,5,0,6,NATURE PORTFOLIO,BERLIN,"HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY",,2373-8057,,NPJ PARKINSONS DIS,npj Parkinsons Dis.,MAY 5,2023,9,1,,,,,,,71,10.1038/s41531-023-00511-2,http://dx.doi.org/10.1038/s41531-023-00511-2,,,8,Neurosciences,Science Citation Index Expanded (SCI-EXPANDED),Neurosciences & Neurology,F6HM3,37147392,"gold, Green Published",,,2024-06-04,WOS:000983333800001,View Full Record in Web of Science
J,"O'Malley, D",,,,"O'Malley, Dervla",,,Endocrine regulation of gut function - a role for glucagon-like peptide-1 in the pathophysiology of irritable bowel syndrome,EXPERIMENTAL PHYSIOLOGY,,,English,Review,,,,,,glucagon-like peptide-1; irritable bowel syndrome; L-cells,DEPENDENT INSULINOTROPIC POLYPEPTIDE; CHAIN FATTY-ACIDS; VAGAL PATHWAYS; GASTROINTESTINAL SYMPTOMS; COLONIC TRANSIT; CLINICAL-TRIAL; DIETARY FIBER; SYNDROME IBS; CENTRAL CRF; BILE-ACIDS,"The prevalent and debilitating functional bowel disorder, irritable bowel syndrome (IBS), is characterized by symptoms that include abdominal pain, bloating, diarrhoea and/or constipation. The heterogeneity of IBS underscores a complex multifactorial pathophysiology, which is not completely understood but involves dysfunction of the bi-directional signalling axis between the brain and the gut. This axis incorporates efferent and afferent branches of the autonomic nervous system, circulating endocrine hormones and immune factors, local paracrine and neurocrine factors and microbial metabolites. L-cells, which are electrically excitable biosensors embedded in the gastrointestinal epithelium, secrete glucagon-like peptide-1 (GLP-1) in response to nutrients in the small intestine. However, they appear to function in a different manner more distally in the gastrointestinal tract, where they are activated by luminal factors including short-chain fatty acids, bile acids and microbial metabolic products, all of which are altered in IBS patients. Glucagon-like peptide-1 can also interact with the hypothalamic-pituitary-adrenal stress axis and the immune system, both of which are activated in IBS. Given that a GLP-1 mimetic has been found to alleviate acute pain symptoms in IBS patients, GLP-1 might be important in the manifestation of IBS symptoms. This review assesses the current knowledge about the role of GLP-1 in IBS pathophysiology and its potential role as a signal transducer in the microbiome-gut-brain signalling axis.","[O'Malley, Dervla] Univ Coll Cork, Dept Physiol, Cork, Ireland",University College Cork,"O'Malley, D (corresponding author), Dept Physiol, Western Gateway Bldg,Western Rd, Cork T12XF62, Ireland.",d.omalley@ucc.ie,,"O'Malley, Dervla/0000-0002-7031-4879","Wellcome Trust-Health Research Board; Ireland-Science Foundation Ireland Seed Award [WT108228MA]; APC Microbiome Ireland Science Foundation Ireland centre grant [12/RC/2273]; Translational Research Access Programme University College Cork, Ireland","Wellcome Trust-Health Research Board; Ireland-Science Foundation Ireland Seed Award(Science Foundation Ireland); APC Microbiome Ireland Science Foundation Ireland centre grant(Science Foundation Ireland); Translational Research Access Programme University College Cork, Ireland","Wellcome Trust-Health Research Board, Ireland-Science Foundation Ireland Seed Award (WT108228MA), APC Microbiome Ireland Science Foundation Ireland centre grant (12/RC/2273), Translational Research Access Programme University College Cork, Ireland (2015).",,91,12,12,0,20,WILEY,HOBOKEN,"111 RIVER ST, HOBOKEN 07030-5774, NJ USA",0958-0670,1469-445X,,EXP PHYSIOL,Exp. Physiol.,JAN,2019,104,1,,,,,3,10,,10.1113/EP087443,http://dx.doi.org/10.1113/EP087443,,,8,Physiology,Science Citation Index Expanded (SCI-EXPANDED),Physiology,HG0AE,30444291,"Bronze, Green Published",,,2024-06-04,WOS:000454603300002,View Full Record in Web of Science
J,"Batiha, GES; Tene, ST; Teibo, JO; Shaheen, HM; Oluwatoba, OS; Teibo, TKA; Al-kuraishy, HM; Al-Garbee, A; Alexiou, A; Papadakis, M",,,,"Batiha, Gaber El-Saber; Tene, Stephano Tambo; Teibo, John Oluwafemi; Shaheen, Hazem M.; Oluwatoba, Oyerinde Samson; Teibo, Titilade Kehinde Ayandeyi; Al-kuraishy, Hayder M.; Al-Garbee, Ali, I; Alexiou, Athanasios; Papadakis, Marios",,,"The phytochemical profiling, pharmacological activities, and safety of malva sylvestris: a review",NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY,,,English,Review,,,,,,Malva sylvestris; Traditional medicine; Phytochemistry profiling; Pharmacological activities; Safety,RADICAL SCAVENGING PROPERTIES; WOUND-HEALING ACTIVITY; IN-VITRO ANTIOXIDANT; CENTRAL ITALY MARCHE; MEDICINAL-PLANTS; 8-HYDROXYFLAVONOID GLUCURONIDES; LIPID-PEROXIDATION; OXIDATIVE STRESS; DIETARY FIBER; INSECT VISITS,"Malva sylvestris is a plant commonly found in Europe, Asia, and Africa. The leaves and flowers of this plant have been used for centuries in traditional medicine to treat various ailments such as cough, cold, diarrhoea, and constipation. Google Scholar, PubMed, Scopus, and Web of Science were used to search for relevant material on the phytochemical profiling and pharmacologic activities of Malva sylvestris. The techniques used in phytochemical profiling and the pharmacologic activity of each compound were extracted from the included studies, including in vitro, in vivo, and clinical studies. The phytochemical analysis of Malva sylvestris revealed that the leaves and flowers are the most commonly used parts of the plant and contain various bioactive compounds such as flavonoids, mucilages, terpenoids, phenol derivatives, coumarins, sterols, tannins, saponins, and alkaloids. These phytochemicals are responsible for the many pharmacological activities of Malva sylvestris, such as anti-inflammatory, antimicrobial, hepatoprotective, laxative, antiproliferative and antioxidant properties. This review has presented an overview of the antinociceptive and anti-inflammatory activities and the cytotoxic effects of Malva sylvestris on different types of cancer cells. It has also summarised the work on developing copper oxide nanoparticles using Malva sylvestris leaf extract and its potential use in food and medicine. This review aims to highlight the traditional uses, phytochemistry, pharmacological activities, and safety of Malva sylvestris.","[Batiha, Gaber El-Saber; Shaheen, Hazem M.] Damanhour Univ, Fac Vet Med, Dept Pharmacol & Therapeut, Damanhour 22511, Albeheira, Egypt; [Tene, Stephano Tambo] Univ Dschang, Fac Sci, Dept Biochem, Res Unit Biochem Med Plants, Dschang, Cameroon; [Teibo, John Oluwafemi] Univ Sao Paulo, Dept Biochem & Immunol, Ribeirao Preto Med Sch, Ribeirao Preto, SP, Brazil; [Oluwatoba, Oyerinde Samson] Univ Ilorin, Fac Vet Med, Dept Vet Pharmacol & Toxicol, Ilorin, Nigeria; [Teibo, Titilade Kehinde Ayandeyi] Univ Sao Paulo, Coll Nursing, Dept Maternal Infant & Publ Hlth Nursing, Ribeirao Preto, SP, Brazil; [Al-kuraishy, Hayder M.; Al-Garbee, Ali, I] Almustansiriyiah Univ, Coll Med, Dept Clin Pharmacol & Therapeut Med, Baghdad, Iraq; [Alexiou, Athanasios] Novel Global Community Educ Fdn, Dept Sci & Engn, Hebersham, NSW 2770, Australia; [Alexiou, Athanasios] AFNP Med, A-1030 Vienna, Austria; [Papadakis, Marios] Univ Witten Herdecke, Dept Surg 2, Univ Hosp Witten Herdecke, Heusnerstr 40, D-42283 Wuppertal, Germany",Egyptian Knowledge Bank (EKB); Damanhour University; Universite de Dschang; Universidade de Sao Paulo; University of Ilorin; Universidade de Sao Paulo; Witten Herdecke University,"Batiha, GES (corresponding author), Damanhour Univ, Fac Vet Med, Dept Pharmacol & Therapeut, Damanhour 22511, Albeheira, Egypt.;Teibo, JO (corresponding author), Univ Sao Paulo, Dept Biochem & Immunol, Ribeirao Preto Med Sch, Ribeirao Preto, SP, Brazil.;Papadakis, M (corresponding author), Univ Witten Herdecke, Dept Surg 2, Univ Hosp Witten Herdecke, Heusnerstr 40, D-42283 Wuppertal, Germany.",gaberbatiha@gmail.com; johnteibo@usp.br; drhazemshaheen3010@yahoo.com; oyerindeoluwasamson@gmail.com; tayandeyi@usp.br; hayderm36@yahoo.com; alextha@yahoo.gr; marios_papadakis@yahoo.gr,"Alexiou, Athanasios/AAT-8491-2021; Al-Gareeb, A./I-8330-2019; TAMBO TENE, Stephano/IYS-3877-2023; al-kuraishy, hayder/AAE-6673-2019; Teibo, John Oluwafemi/AAD-6734-2021; Papadakis, Marios/AAI-6622-2020","Alexiou, Athanasios/0000-0002-2206-7236; Al-Gareeb, A./0000-0001-8284-8897; al-kuraishy, hayder/0000-0003-3097-2962; Teibo, John Oluwafemi/0000-0002-0833-4828; Papadakis, Marios/0000-0002-9020-874X","Projekt DEAL; University of Witten-Herdecke, Wuppertal, Germany","Projekt DEAL; University of Witten-Herdecke, Wuppertal, Germany","Open Access funding enabled and organized by Projekt DEAL. This study is supported by the University of Witten-Herdecke, 42283, Wuppertal, Germany.",,175,8,8,4,17,SPRINGER,NEW YORK,"ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES",0028-1298,1432-1912,,N-S ARCH PHARMACOL,Naunyn-Schmiedebergs Arch. Pharmacol.,MAR,2023,396,3,,,,,421,440,,10.1007/s00210-022-02329-w,http://dx.doi.org/10.1007/s00210-022-02329-w,,NOV 2022,20,Pharmacology & Pharmacy,Science Citation Index Expanded (SCI-EXPANDED),Pharmacology & Pharmacy,8P0AS,36418467,"hybrid, Green Published",,,2024-06-04,WOS:000886811400001,View Full Record in Web of Science
J,"Haapalahti, M; Mykkänen, H; Tikkanen, S; Kokkonen, J",,,,"Haapalahti, M; Mykkänen, H; Tikkanen, S; Kokkonen, J",,,Food habits in 10-11-year-old children with functional gastrointestinal disorders,EUROPEAN JOURNAL OF CLINICAL NUTRITION,,,English,Article,,,,,,children; gastrointestinal; symptoms; abdominal pain; food habits; nutrient intake; psychosocial,RECURRENT ABDOMINAL-PAIN; CARBOHYDRATE MALABSORPTION; PSYCHOSOMATIC SYMPTOMS; CHRONIC CONSTIPATION; SOMATIC COMPLAINTS; DIETARY FIBER; LIFE EVENTS; CHILDHOOD; DIARRHEA,"Objective: To evaluate the role of food habits and nutrient intake in children with functional gastrointestinal disorders (FGIDs) considering their association with psychosocial factors. Design: Cross-sectional. Setting: A rural town in Mid-Western Finland. Subjects: After excluding organic gastrointestinal (GI) disorders, a total of 49 children with FGID and 78 control children without GI symptoms from a cohort of 422 children were studied. Methods: Food frequency questionnaire, GI-symptoms questionnaire and the Child Behaviour Check List (CBCL) filled in by parents together with their child, and 24-h dietary recall and anthropometric and haematological measurements. Results: Compared to control children, fewer children with FGID had daily family dinner (77 vs 91%, P = 0.030) and they used less often vegetables (P = 0.023), fruits (P = 0.027) and berries (P = 0.011), but more often ice cream (P = 0.018) and soft drinks (P = 0.027) and had a higher sucrose intake (9 vs 7E%, P = 0.032) and lower lactose intake (27 vs 36 g, P = 0.001). Reported food-related symptoms were more common among FGID group (69 vs 11%), as well as restricted milk use (31 vs 0%). Children with FGID had higher total problem scores in CBCL (P = 0.002), and the behavioural/emotional problems associated with occurrence of FGID (OR 1.04, 95% CI 1.07-1.076) as did the sugar intake (OR 1.1, 95% CI 1.004-1.215). Conclusions: This population-based study suggests that school-aged children with FGIDs have less-organized food habits and higher milk avoidance, and they display internalizing psychological characteristics.","Univ Oulu, Dept Pediat, FIN-90014 Oulu, Finland; Univ Kuopio, Dept Clin Nutr, FIN-70211 Kuopio, Finland",University of Oulu; University of Eastern Finland,"Univ Oulu, Dept Pediat, POB 5000, FIN-90014 Oulu, Finland.",mila.haapalahti@uku.fi,,"Hyytinen, Mila Maarit/0000-0001-5361-6421",,,,,31,7,7,0,3,NATURE PUBLISHING GROUP,LONDON,"MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND",0954-3007,1476-5640,,EUR J CLIN NUTR,Eur. J. Clin. Nutr.,JUL,2004,58,7,,,,,1016,1021,,10.1038/sj.ejcn.1601925,http://dx.doi.org/10.1038/sj.ejcn.1601925,,,6,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,832NS,15220943,,,,2024-06-04,WOS:000222274800006,View Full Record in Web of Science
S,"Wald, A",,"Guandalini, S; Vaziri, H",,"Wald, Arnold",,,Irritable Bowel Syndrome,DIARRHEA: DIAGNOSTIC AND THERAPEUTIC ADVANCES,Clinical Gastroenterology,,English,Article; Book Chapter,,,,,,Irritable bowel syndrome (IBS); Diarrhea; Manning criteria; Rome criteria for IBS; Celiac disease; Placebo response; Physician-patient relationship; Antispasmodic agents; Tricyclic agents; Antidepressants; Loperamide; Serotonin 3 receptor antagonists; Cognitive behavioral therapy; Hypnosis,FUNCTIONAL GASTROINTESTINAL DISORDERS; COGNITIVE-BEHAVIOR THERAPY; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; DIAGNOSTIC-TESTS; PRIMARY-CARE; SYMPTOMS; CRITERIA; FIBER; CONSTIPATION,"Irritable bowel syndrome (IBS) is a gastrointestinal syndrome characterized by chronic abdominal pain and altered bowel habits in the absence of an organic cause. One of the four subtypes is IBS with diarrhea, defined as loose or watery stools >= 25% of bowel movements and hard or lumpy stools <= 25% of bowel movements. The diagnostic approach to patients with IBS symptoms and no alarm signs includes a complete history and physical examination and a limited number of diagnostic studies to rule out organic illness. The focus of treatment should be on symptom relief and addressing the patient's concerns. The most important component is the establishment of a strong, therapeutic physician patient relationship. Other elements include pateient education, dietary modifications, pharmacologic agents and, in selected patients, behavioral treatments such as cognitive behavioral therapy, hypnotherapy, and dynamic psychotherapy.","Univ Wisconsin, Sch Med & Publ Hlth, Sect Gastroenterol & Hepatol, Madison, WI 53705 USA",University of Wisconsin System; University of Wisconsin Madison,"Wald, A (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Sect Gastroenterol & Hepatol, UWHC H6-516,750 Highland Ave, Madison, WI 53705 USA.",,,,,,,,37,1,1,0,0,HUMANA PRESS INC,TOTOWA,"999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA",2197-7399,2197-7704,978-1-60761-182-0,CLIN GASTROENT-SER,,,2011,,,,,,,325,339,,10.1007/978-1-60761-183-7_19,http://dx.doi.org/10.1007/978-1-60761-183-7_19,10.1007/978-1-60761-183-7,,15,Gastroenterology & Hepatology,Book Citation Index – Science (BKCI-S),Gastroenterology & Hepatology,BSK47,,,,,2024-06-04,WOS:000284745600019,View Full Record in Web of Science
J,"Turck, D; Castenmiller, J; De Henauw, S; Hirsch-Ernst, KI; Kearney, J; Knutsen, HK; Maciuk, A; Mangelsdorf, I; McArdle, HJ; Naska, A; Pelaez, C; Pentieva, K; Thies, F; Tsabouri, S; Vinceti, M; Bresson, JL; Siani, A",,,,"Turck, Dominique; Castenmiller, Jacqueline; De Henauw, Stefaan; Hirsch-Ernst, Karen Ildico; Kearney, John; Knutsen, Helle Katrine; Maciuk, Alexandre; Mangelsdorf, Inge; McArdle, Harry J.; Naska, Androniki; Pelaez, Carmen; Pentieva, Kristina; Thies, Frank; Tsabouri, Sophia; Vinceti, Marco; Bresson, Jean-Louis; Siani, Alfonso",,EFSA Panel Nutr Novel Foods,Green kiwifruit (lat. Actinidia deliciosa var. Hayward) and maintenance of normal defecation: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006,EFSA JOURNAL,,,English,Article,,,,,,kiwifruit; Actinidia deliciosa; defecation; health claim,DIETARY FIBER; CONSTIPATION; EXTRACT,"Following an application from Zespri International Limited, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Belgium, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to green kiwifruit (lat. Actinidia deliciosa var. Hayward) and maintenance of normal defecation. The scope of the application was proposed to fall under a health claim based on newly developed scientific evidence. The food proposed by the applicant as the subject of the health claim is green kiwifruit. The Panel considers that green kiwifruit (Actinidia deliciosa var. Hayward) is sufficiently characterised. The claimed effect proposed by the applicant is 'maintenance of normal defecation'. Maintenance of normal defecation is a beneficial physiological effect provided that it does not result in diarrhoea. All human intervention studies submitted had different limitations and could not be used on their own for the scientific substantiation of the claim. However, the results of six pertinent human intervention studies are consistent with respect to an effect of consuming daily between two and four green kiwifruits var. Hayward on an increase in stool frequency. Two out of four studies in which a validated instrument was used to assess stool consistency showed an effect also on stool consistency. There is evidence for a plausible mechanism by which kiwifruit could exert an effect on normal defecation. The consumption of kiwifruit in the studies did not result in diarrhoea. A cause and effect relationship has been established between the consumption of green kiwifruit (Actinidia deliciosa var. Hayward) and maintenance of normal defecation. The following wordings reflect the scientific evidence: 'consumption of kiwifruit contributes to the maintenance of normal defecation'. In order to obtain the claimed effect, two large green kiwifruits (i.e. around 200 g of kiwi flesh) should be consumed. (C) 2021 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority.",,,,,"Tsabouri, Sophia/HSF-8262-2023; Vinceti, Marco/O-2509-2015; Pentieva, Kristina/AAC-5016-2019","Vinceti, Marco/0000-0002-0551-2473; Pentieva, Kristina/0000-0003-2059-534X",,,,,30,5,5,0,2,EUROPEAN FOOD SAFETY AUTHORITY-EFSA,PARMA,"EUROPEAN FOOD SAFETY AUTHORITY-EFSA, PARMA, 00000, ITALY",,1831-4732,,EFSA J,EFSA J.,JUN,2021,19,6,,,,,,,e06641,10.2903/j.efsa.2021.6641,http://dx.doi.org/10.2903/j.efsa.2021.6641,,,12,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,TC2TA,34136006,"Green Published, gold",,,2024-06-04,WOS:000668493000045,View Full Record in Web of Science
J,"Campos-Acuña, J; Elgueta, D; Pacheco, R",,,,"Campos-Acuna, Javier; Elgueta, Daniela; Pacheco, Rodrigo",,,T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease,FRONTIERS IN IMMUNOLOGY,,,English,Review,,,,,,CD4(+) T-cell mediated immunity; neo-antigens; gut microbiota; gut-brain axis; Parkinson's disease; neuroinflammation,CHAIN FATTY-ACIDS; NITRATED ALPHA-SYNUCLEIN; ENTERIC NERVOUS-SYSTEM; MOUSE MODEL; BOWEL-DISEASE; COLONIC INFLAMMATION; DENDRITIC CELLS; DIETARY FIBER; TH17 CELLS; DOPAMINE,"Parkinson's disease (PD) is a neurodegenerative disorder affecting mainly the dopaminergic neurons of the nigrostriatal pathway, a neuronal circuit involved in the control of movements, thereby the main manifestations correspond to motor impairments. The major molecular hallmark of this disease corresponds to the presence of pathological protein inclusions called Lewy bodies in the midbrain of patients, which have been extensively associated with neurotoxic effects. Importantly, different research groups have demonstrated that CD4(+) T-cells infiltrate into the substantia nigra of PD patients and animal models. Moreover, several studies have consistently demonstrated that T-cell deficiency results in a strong attenuation of dopaminergic neurodegeneration in animal models of PD, thus indicating a key role of adaptive immunity in the neurodegenerative process. Recent evidence has shown that CD4(+) T-cell response involved in PD patients is directed to oxidised forms of alpha-synuclein, one of the main constituents of Lewy bodies. On the other hand, most PD patients present a number of non-motor manifestations. Among non-motor manifestations, gastrointestinal dysfunctions result especially important as potential early biomarkers of PD, since they are ubiquitously found among confirmed patients and occur much earlier than motor symptoms. These gastrointestinal dysfunctions include constipation and inflammation of the gut mucosa and the most distinctive pathologic features associated are the loss of neurons of the enteric nervous system and the generation of Lewy bodies in the gut. Moreover, emerging evidence has recently shown a pivotal role of gut microbiota in triggering the development of PD in genetically predisposed individuals. Of note, PD has been positively correlated with inflammatory bowel diseases, a group of disorders involving a T-cell driven inflammation of gut mucosa, which is strongly dependent in the composition of gut microbiota. Here we raised the hypothesis that T-cell driven inflammation, which mediates dopaminergic neurodegeneration in PD, is triggered in the gut mucosa. Accordingly, we discuss how structural components of commensal bacteria or how different mediators produced by gut-microbiota, including short-chain fatty acids and dopamine, may affect the behaviour of T-cells, triggering the development of T-cell responses against Lewy bodies, initially confined to the gut mucosa but later extended to the brain.","[Campos-Acuna, Javier; Elgueta, Daniela; Pacheco, Rodrigo] Fdn Ciencia & Vida, Lab Neuroinmunol, Santiago, Chile; [Pacheco, Rodrigo] Univ Andres Bello, Fac Ciencias Vida, Dept Ciencias Biol, Santiago, Chile",Universidad Andres Bello,"Pacheco, R (corresponding author), Fdn Ciencia & Vida, Lab Neuroinmunol, Santiago, Chile.;Pacheco, R (corresponding author), Univ Andres Bello, Fac Ciencias Vida, Dept Ciencias Biol, Santiago, Chile.",rpacheco@cienciavida.org,,"Pacheco, Rodrigo/0000-0001-8057-9806","Fondo Nacional de Desarrollo Cientifico y Tecnologico de Chile [FONDECYT-1170093]; Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT) [AFB-170004]; Michael J. Fox Foundation for Parkinson's Research [MJFF-15076, MJFF-10332.01]; Programa de Formacion de Capital Humano Avanzado-Doctorado Nacional from CONICYT [folio 21180205]",Fondo Nacional de Desarrollo Cientifico y Tecnologico de Chile; Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Michael J. Fox Foundation for Parkinson's Research; Programa de Formacion de Capital Humano Avanzado-Doctorado Nacional from CONICYT,"This work was supported by grants FONDECYT-1170093 (to RP), from Fondo Nacional de Desarrollo Cientifico y Tecnologico de Chile, AFB-170004 (to RP) from Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT) and MJFF-15076 and MJFF-10332.01 (to RP) from Michael J. Fox Foundation for Parkinson's Research. JC-A holds a fellowship (folio 21180205) from the Programa de Formacion de Capital Humano Avanzado-Doctorado Nacional from CONICYT.",,131,78,89,3,22,FRONTIERS MEDIA SA,LAUSANNE,"AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND",1664-3224,,,FRONT IMMUNOL,Front. Immunol.,FEB 15,2019,10,,,,,,,,239,10.3389/fimmu.2019.00239,http://dx.doi.org/10.3389/fimmu.2019.00239,,,14,Immunology,Science Citation Index Expanded (SCI-EXPANDED),Immunology,HL5TD,30828335,"Green Published, gold",,,2024-06-04,WOS:000458792400001,View Full Record in Web of Science
J,"Reichert, MC; Kupcinskas, J; Krawczyk, M; Jüngst, C; Casper, M; Grünhage, F; Appenrodt, B; Zimmer, V; Weber, SN; Tamelis, A; Lukosiene, JI; Pauziene, N; Kiudelis, G; Jonaitis, L; Schramm, C; Goeser, T; Schulz, A; Malinowski, M; Glanemann, M; Kupcinskas, L; Lammert, F",,,,"Reichert, Matthias Christian; Kupcinskas, Juozas; Krawczyk, Marcin; Juengst, Christoph; Casper, Markus; Gruenhage, Frank; Appenrodt, Beate; Zimmer, Vincent; Weber, Susanne Nicole; Tamelis, Algimantas; Lukosiene, Jaune Ieva; Pauziene, Neringa; Kiudelis, Gediminas; Jonaitis, Laimas; Schramm, Christoph; Goeser, Tobias; Schulz, Antje; Malinowski, Maciej; Glanemann, Matthias; Kupcinskas, Limas; Lammert, Frank",,,A Variant of COL3A1 (rs3134646) Is Associated With Risk of Developing Diverticulosis in White Men,DISEASES OF THE COLON & RECTUM,,,English,Article,,,,,,Colon; Diverticular disease; Diverticulosis; Gene polymorphism; Single-nucleotide polymorphism,PELVIC ORGAN PROLAPSE; ALPHA-1 POLYMORPHISM; III ALPHA-1; FIBER DIET; DISEASE; COLON; GENE; CONSTIPATION; POPULATION; HERNIA,"BACKGROUND: Colonic diverticulosis is one of the most common gastroenterological disorders. Although diverticulosis is typically benign, many individuals develop diverticulitis or other aspects of diverticular disease. Diverticulosis is thought to stem from a complex interaction of environmental, dietary, and genetic factors; however, the contributing genetic factors remain unknown. OBJECTIVE: The aim of our present study was to determine the role of genetic variants within genes encoding for collagens of the connective tissue in diverticulosis. DESIGN: This was a transsectional genetic association study. SETTINGS: This study was conducted at three tertiary referral centers in Germany and Lithuania. PATIENTS: Single-nucleotide polymorphisms in COL3A1 (rs3134646, rs1800255) and COL1A1 (rs1800012) were genotyped in 422 patients with diverticulosis and 285 controls of white descent by using TaqMan assays. MAIN OUTCOME MEASURES: The association of colonoscopy-proven diverticulosis with genetic polymorphisms with herniations was assessed in multivariate models. RESULTS: The rs3134646, rs1800255, and rs1800012 variants were significantly associated with the risk of developing diverticulosis in the univariate model; however, these associations were not significant in the multivariate logistic regression analysis including additional nongenetic variables. When selectively analyzing sexes, the genotype AA (AA) in rs3134646 remained significantly associated with diverticulosis in men (OR, 1.82; 95% CI, 1.04-3.20; p = 0.04). LIMITATIONS: Because a candidate approach was used, additional relevant variants could be missed. Within our cohort of patients with diverticulosis, only a small proportion had diverticular disease and thus, we could not examine the variants in these subgroups. Functional studies, including the analysis of the involved collagens, are also warranted. CONCLUSIONS: Our study shows that a variant of COL3A1 (rs3134646) is associated with the risk of developing colonic diverticulosis in white men, whereas rs1800255 (COL3A1) and rs1800012 (COL1A1) were not associated with this condition after adjusting for confounding factors. Our data provide novel valuable insights in the genetic susceptibility to diverticulosis. See Video Abstract at http://links.lww.com/DCR/A504.","[Reichert, Matthias Christian; Krawczyk, Marcin; Juengst, Christoph; Casper, Markus; Gruenhage, Frank; Appenrodt, Beate; Zimmer, Vincent; Weber, Susanne Nicole; Lammert, Frank] Saarland Univ, Med Ctr, Dept Med 2, D-66421 Homburg, Germany; [Kupcinskas, Juozas; Lukosiene, Jaune Ieva; Kiudelis, Gediminas; Jonaitis, Laimas; Kupcinskas, Limas] Lithuanian Univ Hlth Sci, Dept Gastroenterol, Kaunas, Lithuania; [Krawczyk, Marcin] Med Univ Warsaw, Dept Gen Transplant & Liver Surg, Lab Metab Liver Dis, Warsaw, Poland; [Gruenhage, Frank] RKN Hosp Grevenbroich, Dept Gastroenterol Hepatol & Oncol, Grevenbroich, Germany; [Tamelis, Algimantas] Lithuanian Univ Hlth Sci, Dept Surg, Kaunas, Lithuania; [Pauziene, Neringa] Lithuanian Univ Hlth Sci, Inst Anat, Kaunas, Lithuania; [Schramm, Christoph; Goeser, Tobias] Univ Hosp Cologne, Dept Gastroenterol & Hepatol, Cologne, Germany; [Schulz, Antje; Malinowski, Maciej; Glanemann, Matthias] Saarland Univ, Med Ctr, Dept Gen Visceral Vasc & Pediat Surg, Homburg, Germany",Universitatsklinikum des Saarlandes; Lithuanian University of Health Sciences; Medical University of Warsaw; Lithuanian University of Health Sciences; Lithuanian University of Health Sciences; University of Cologne; Universitatsklinikum des Saarlandes,"Reichert, MC (corresponding author), Saarland Univ, Med Ctr, Dept Med 2, D-66421 Homburg, Germany.",matthias.reichert@uks.eu,"Zimmer, Vincent/A-9601-2008; Kupcinskas, Juozas/AAU-6968-2021; Krawczyk, Marcin/AAG-4356-2020","Krawczyk, Marcin/0000-0002-0113-0777; Jungst, Christoph/0000-0001-5048-390X","Faculty of Medicine, Saarland University (HOMFOR grant) [T201000747]; Research Council of Lithuania [SEN-06/2015/PRM15-135]","Faculty of Medicine, Saarland University (HOMFOR grant); Research Council of Lithuania(Research Council of Lithuania (LMTLT))","This study was supported by a grant from the Faculty of Medicine, Saarland University (HOMFOR grant T201000747) to Dr Reichert and a grant of the Research Council of Lithuania No. SEN-06/2015/PRM15-135.",,32,25,28,0,1,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0012-3706,1530-0358,,DIS COLON RECTUM,Dis. Colon Rectum,MAY,2018,61,5,,,,,604,611,,10.1097/DCR.0000000000001001,http://dx.doi.org/10.1097/DCR.0000000000001001,,,8,Gastroenterology & Hepatology; Surgery,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Surgery,GL9QQ,29533249,,,,2024-06-04,WOS:000437671500704,View Full Record in Web of Science
J,"Ribeiro, TCM; Costa-Ribeiro, H; Almeida, PS; Pontes, MV; Leite, MEQ; Filadelfo, LR; Khoury, JC; Bean, JA; Mitmesser, SH; Vanderhoof, JA; Scalabrin, DMF",,,,"Ribeiro, Tereza C. M.; Costa-Ribeiro, Hugo, Jr.; Almeida, Patricia S.; Pontes, Mariana V.; Leite, Maria E. Q.; Filadelfo, Lais R.; Khoury, Jane C.; Bean, Judy A.; Mitmesser, Susan H.; Vanderhoof, Jon A.; Scalabrin, Deolinda M. F.",,,Stool Pattern Changes in Toddlers Consuming a Follow-on Formula Supplemented With Polydextrose and Galactooligosaccharides,JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION,,,English,Article,,,,,,children; follow-on formula; galactooligosaccharides; polydextrose; prebiotics; stool pattern,DIETARY FIBER; FED INFANTS; CHILDREN; OLIGOSACCHARIDES; CONSTIPATION; PREBIOTICS; CHILDHOOD,"Healthy 9- to 48-month-old children (n = 133) were randomized to receive a cow's-milk-based follow-on formula (control) or the same formula with polydextrose and galactooligosaccharides (PDX/GOS) for 108 days. Pediatricians assessed diarrheal disease, stool pattern, acute respiratory infection, systemic antibiotic use, and growth. The 2 groups had similar weight-for-length/height z score and similar odds of having diarrheal disease, acute respiratory infection, and systemic antibiotic use; however, PDX/GOS had greater odds of increased defecation than control (P <= 0.01). Addition of PDX and GOS to a follow-on formula was well tolerated and induced a pattern of more frequent and softer stools in toddlers.","[Ribeiro, Tereza C. M.; Costa-Ribeiro, Hugo, Jr.; Almeida, Patricia S.; Pontes, Mariana V.; Leite, Maria E. Q.; Filadelfo, Lais R.] Univ Fed Bahia, Dept Pediat, Fima Lifshitz Res Ctr, Univ Hosp Complex Prof Edgard Santos, Salvador, BA, Brazil; [Khoury, Jane C.; Bean, Judy A.] Cincinnati Childrens Hosp, Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH USA; [Mitmesser, Susan H.; Vanderhoof, Jon A.; Scalabrin, Deolinda M. F.] Mead Johnson Nutr, Dept Clin Res, Med Affairs, Evansville, IN 47721 USA",Universidade Federal da Bahia; Cincinnati Children's Hospital Medical Center,"Mitmesser, SH (corresponding author), Mead Johnson Nutr, Dept Clin Res, Med Affairs, 2400 W Lloyd Expressway, Evansville, IN 47721 USA.",susan.mitmesser@mjn.com,"Khoury, Jane/O-2068-2015",,Mead Johnson Nutrition,Mead Johnson Nutrition,The present study was supported by Mead Johnson Nutrition.,,17,27,34,1,16,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0277-2116,1536-4801,,J PEDIATR GASTR NUTR,J. Pediatr. Gastroenterol. Nutr.,FEB,2012,54,2,,,,,288,290,,10.1097/MPG.0b013e31823a8a4c,http://dx.doi.org/10.1097/MPG.0b013e31823a8a4c,,,3,Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology; Nutrition & Dietetics; Pediatrics,882SN,22002482,"Bronze, Green Published",,,2024-06-04,WOS:000299584300024,View Full Record in Web of Science
J,"Yazici, C; Arslan, DC; Abraham, R; Cushing, K; Keshavarzian, A; Mutlu, EA",,,,"Yazici, Cemal; Arslan, Deniz Cagil; Abraham, Rana; Cushing, Kelly; Keshavarzian, Ali; Mutlu, Ece A.",,,Breath Methane Levels Are Increased Among Patients with Diverticulosis,DIGESTIVE DISEASES AND SCIENCES,,,English,Article,,,,,,Breath methane level; Diverticulosis; Methanogenesis; Methanogenic archaea,METHANOGENIC FLORA; DIETARY FIBER; CONSTIPATION; POPULATION; RIFAXIMIN; TRANSIT; DISEASE,"Diverticulosis and its complications are important healthcare problems in the USA and throughout the Western world. While mechanisms as to how diverticulosis occurs have partially been explored, few studies examined the relationship between colonic gases such as methane and diverticulosis in humans. This study aimed to demonstrate a significant relationship between methanogenic Archaea and development of diverticulosis. Subjects who consecutively underwent hydrogen breath test at Rush University Medical Center between 2003 and 2010 were identified retrospectively through a database. Medical records were reviewed for presence of a colonoscopy report. Two hundred and sixty-four subjects were identified who had both a breath methane level measurement and a colonoscopy result. Additional demographic and clinical data were obtained with chart review. Mean breath methane levels were higher in subjects with diverticulosis compared to those without diverticulosis (7.89 vs. 4.94 ppm, p = 0.04). Methane producers (defined as those with baseline fasting breath methane level > 5 ppm) were more frequent among subjects with diverticulosis compared to those without diverticulosis (50.9 vs. 34 %, p = 0.0025). When adjusted for confounders, breath methane levels and age were the two independent predictors of diverticulosis on colonoscopy with logistic regression modeling. Methanogenesis is associated with the presence of diverticulosis. Further studies are needed to confirm our findings and prospectively evaluate a possible etiological role of methanogenesis and methanogenic archaea in diverticulosis.","[Yazici, Cemal] Univ Illinois, Dept Med, Div Gastroenterol & Hepatol, 840 S Wood St,Suite 718E, Chicago, IL 60612 USA; [Arslan, Deniz Cagil; Abraham, Rana; Keshavarzian, Ali; Mutlu, Ece A.] Rush Univ, Med Ctr, Div Digest Dis & Nutr, Rush Presbyterian St Lukes Med Ctr, 1725 W Harrison,Suite 206, Chicago, IL 60612 USA; [Cushing, Kelly] Washington Univ, Sch Med, Dept Med, Div Gastroenterol, 660 S Euclid Ave, St Louis, MO 63110 USA",University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rush University; Washington University (WUSTL),"Mutlu, EA (corresponding author), Rush Univ, Med Ctr, Div Digest Dis & Nutr, Rush Presbyterian St Lukes Med Ctr, 1725 W Harrison,Suite 206, Chicago, IL 60612 USA.",Ece_Mutlu@rush.edu,,,NCCIH NIH HHS [R21 AT001628] Funding Source: Medline; NIDDK NIH HHS [R21 DK071838] Funding Source: Medline,NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)),,,18,14,17,0,10,SPRINGER,DORDRECHT,"VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS",0163-2116,1573-2568,,DIGEST DIS SCI,Dig. Dis. Sci.,SEP,2016,61,9,,,,,2648,2654,,10.1007/s10620-016-4174-6,http://dx.doi.org/10.1007/s10620-016-4174-6,,,7,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,DU1TP,27129485,Green Accepted,,,2024-06-04,WOS:000381992700025,View Full Record in Web of Science
J,"Choi, YK; Lee, CH; Lee, MW; Kwon, J; Song, GS; Kim, YS",,,,"Choi, Yun-Kyung; Lee, Chang-Hyun; Lee, Moon-Won; Kwon, Jin; Song, Geun-Seoup; Kim, Young-Soo",,,Effect of alcohol insoluble residues from stem and root barks of elm (Ulmus davidiana) on intestinal characteristics in rats,FOOD SCIENCE AND BIOTECHNOLOGY,,,English,Article,,,,,,alcohol insoluble residue; elm; gastrointestinal transit time; fecal weight; mucosal villi,DIETARY FIBER; WHEAT BRAN; POLYSACCHARIDES; CONSTIPATION; MORPHOLOGY; TRANSIT; COLON; PEEL,"Sprague-Dawley rats (n=32) were fed a diet containing basal (control), cellulose (5%), or alcohol insoluble residue (AIR) (5%) extracted from the stem and root barks of elm (Ulmus davidiana var. japonica Nakai) for 4 weeks. The effects of the diets, on gastrointestinal functions and morphology were evaluated. The weight gains, food intake, and food efficiencies for the cellulose and AIR diet-fed groups were not significantly different from those of the AIR-free (basal) diet. The gastrointestinal transit times of the stem and root bark AIR diets were significantly reduced (p < 0.01) compared to the basal diet, and were slower than those of the cellulose diet. The fecal weights of the stem and root bark AIR diets were significantly increased (p < 0.01) up to 4-fold compared to those of the basal diet. The height of the mucosal villi, and mucosal and muscle layer thicknesses of the colon were greater and more developed in the stem and root bark AIR diets (p < 0.01) than in the basal diet. The villus heights in the jejunum and the colon mucosal goblet cells were more developed in the order of cellulose > stem bark AIR > root bark AIR diets.","Chonbuk Natl Univ, Fac Biotechnol, Jeonju 561756, Jeonbuk, South Korea; Woosuk Univ, Coll Oriental Med, Dept Anat, Samrye 565701, Jeonbuk, South Korea; Korea Natl Coll Rehabil & Welf, Dept Prosthet & Orthot, Pyongtaek 459070, Gyeonggi, South Korea; Iksan Natl Coll, Dept Food Engn, Iksan 570752, Jeonbuk, South Korea",Jeonbuk National University; Woosuk University,"Kim, YS (corresponding author), Chonbuk Natl Univ, Fac Biotechnol, Jeonju 561756, Jeonbuk, South Korea.",ykim@chonbuk.ac.kr,,,,,,,21,4,4,0,2,KOREAN SOC FOOD SCIENCE TECHNOLOGY,SEOUL,"KOREA SCIENCE TECHNOLOGY CENTER #605, 635-4 YEOGSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA",1226-7708,,,FOOD SCI BIOTECHNOL,Food Sci. Biotechnol.,JUN,2006,15,3,,,,,380,384,,,,,,5,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,060RO,,,,,2024-06-04,WOS:000238819500010,View Full Record in Web of Science
J,"Hale, EM; Smith, E; James, JS; Wojner-Alexandrov, AW",,,,"Hale, Earlie McClain; Smith, Eva; St. James, James; Wojner-Alexandrov, Anne W.",,,Pilot study of the feasibility and effectiveness of a natural laxative mixture,GERIATRIC NURSING,,,English,Article,,,,,,,LONG-TERM-CARE; CHRONIC CONSTIPATION; DIETARY FIBER; BOWEL FUNCTION; RESIDENTS,"We sought to determine the effect of a natural laxative mixture compared with daily prescribed laxatives on bowel movement frequency in elderly long-term care residents. Secondary endpoints included ease of administration and costs of the natural laxative. A randomized controlled trial comparing the effect of the Beverley-Travis natural laxative mixture to prescribed laxatives was conducted over an 8-week period. Subjects were randomized to treatment and control groups; control subjects continued on regularly prescribed laxatives, and treatment group subjects discontinued prescribed laxatives and received 2 tablespoons of the natural laxative mixture twice a day for the remaining 4-week period. Bowel movement frequency and consistency were collected, and ease of natural laxative administration as well as costs associated with use of the natural or prescribed laxatives were calculated. The study included 45 residents, with 34 completing the 8-week study period (16 treatment group subjects and 18 control subjects). Treatment group subjects had a significant increase in average number of bowel movements from 15.5 to 22.2 (P =.007) following initiation of the natural laxative, and no difference in bowel movement frequency was observed among control subjects (P = NS). The natural laxative mixture was rated as easy or very easy to administer by 90%-92% of nurses, and cost savings of $103.04 was estimated. The Beverley-Travis natural laxative mixture, given at a dosage of 2 tablespoons twice daily, is easy to use, cost-effective, and more effective than daily prescribed laxatives at producing normal bowel movements.","Methodist Hosp, Clarian Hlth Partners, Indianapolis, IN USA; Univ Illinois, Coll Nursing, Dept Med Surg Nursing, Chicago, IL USA; Millikin Univ, Dept Behav Sci, Decatur, IL USA; Arizona State Univ, Ctr Evidence Based Practice, Tempe, AZ USA",Indiana University Health; IU Health Methodist Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Arizona State University; Arizona State University-Tempe,"Hale, EM (corresponding author), Methodist Hosp, Clarian Hlth Partners, Indianapolis, IN USA.",,,,,,,,29,4,5,0,3,MOSBY-ELSEVIER,NEW YORK,"360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA",0197-4572,,,GERIATR NURS,Geriatr. Nurs.,MAR-APR,2007,28,2,,,,,104,111,,10.1016/j.gerinurse.2006.10.002,http://dx.doi.org/10.1016/j.gerinurse.2006.10.002,,,8,Geriatrics & Gerontology; Gerontology; Nursing,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Geriatrics & Gerontology; Nursing,162GM,17430744,,,,2024-06-04,WOS:000246074900012,View Full Record in Web of Science
J,"Roager, HM; Hansen, LBS; Bahl, MI; Frandsen, HL; Carvalho, V; Gobel, RJ; Dalgaard, MD; Plichta, DR; Sparholt, MH; Vestergaard, H; Hansen, T; Sicheritz-Pontén, T; Nielsen, HB; Pedersen, O; Lauritzen, L; Kristensen, M; Gupta, R; Licht, TR",,,,"Roager, Henrik M.; Hansen, Lea B. S.; Bahl, Martin I.; Frandsen, Henrik L.; Carvalho, Vera; Gobel, Rikke J.; Dalgaard, Marlene D.; Plichta, Damian R.; Sparholt, Morten H.; Vestergaard, Henrik; Hansen, Torben; Sicheritz-Ponten, Thomas; Nielsen, H. Bjorn; Pedersen, Oluf; Lauritzen, Lotte; Kristensen, Mette; Gupta, Ramneek; Licht, Tine R.",,,Colonic transit time is related to bacterial metabolism and mucosal turnover in the gut,NATURE MICROBIOLOGY,,,English,Article,,,,,,,DIETARY FIBER; P-CRESOL; MICROBIOTA; POLYPHENOLS; 7-METHYLGUANINE; CONSTIPATION; DEGRADATION; ASSOCIATION; ENTEROTYPES; DIVERSITY,"Little is known about how colonic transit time relates to human colonic metabolism and its importance for host health, although a firm stool consistency, a proxy for a long colonic transit time, has recently been positively associated with gut microbial richness. Here, we show that colonic transit time in humans, assessed using radio-opaque markers, is associated with overall gut microbial composition, diversity and metabolism. We find that a long colonic transit time associates with high microbial richness and is accompanied by a shift in colonic metabolism from carbohydrate fermentation to protein catabolism as reflected by higher urinary levels of potentially deleterious protein-derived metabolites. Additionally, shorter colonic transit time correlates with metabolites possibly reflecting increased renewal of the colonic mucosa. Together, this suggests that a high gut microbial richness does not per se imply a healthy gut microbial ecosystem and points at colonic transit time as a highly important factor to consider in microbiome and metabolomics studies.","[Roager, Henrik M.; Bahl, Martin I.; Frandsen, Henrik L.; Carvalho, Vera; Licht, Tine R.] Tech Univ Denmark, Natl Food Inst, DK-2860 Soborg, Denmark; [Hansen, Lea B. S.; Dalgaard, Marlene D.; Plichta, Damian R.; Sicheritz-Ponten, Thomas; Nielsen, H. Bjorn; Gupta, Ramneek] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Gobel, Rikke J.; Vestergaard, Henrik; Hansen, Torben; Pedersen, Oluf] Univ Copenhagen, Novo Nordisk Fdn, Sect Metab Genet, Ctr Basic Metab Res, DK-2200 Copenhagen N, Denmark; [Sparholt, Morten H.] Bispebjerg Hosp, Dept Radiol, DK-2400 Copenhagen NV, Denmark; [Lauritzen, Lotte; Kristensen, Mette] Univ Copenhagen, Dept Nutr Exercise & Sport, DK-1958 Frederiksberg C, Denmark",Technical University of Denmark; Technical University of Denmark; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen,"Licht, TR (corresponding author), Tech Univ Denmark, Natl Food Inst, DK-2860 Soborg, Denmark.",trli@food.dtu.dk,"Hansen, Torben F/J-8065-2012; Roager, Henrik/T-2779-2019; Pedersen, Oluf/AAG-8015-2020; Lauritzen, Lotte/F-2921-2013; Kristensen, Mette/A-4219-2011; Gupta, Ramneek/G-7278-2012; Pedersen, Oluf/Z-1731-2019; Nielsen, Henrik Bjorn/B-8961-2019; Sicheritz-Ponten, Thomas/A-4325-2017","Roager, Henrik/0000-0002-2504-8313; Lauritzen, Lotte/0000-0001-7184-5949; Pedersen, Oluf/0000-0002-3321-3972; Bahl, Martin Iain/0000-0003-1579-8038; Hansen, Torben/0000-0001-8748-3831; Nielsen, Henrik Bjorn/0000-0003-2281-5713; Licht, Tine Rask/0000-0002-6399-9574; Plichta, Damian/0000-0002-6555-2557; Sicheritz-Ponten, Thomas/0000-0001-6615-1141; Vestergaard, Henrik/0000-0003-3090-269X","Danish Council for Strategic Research (Center for Gut, Grain and Greens) [11-116163]; Technical University of Denmark; personal Danisco Award; Novo Nordisk Foundation","Danish Council for Strategic Research (Center for Gut, Grain and Greens); Technical University of Denmark; personal Danisco Award; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)","The authors thank K.V. Vibefelt for helping out with DNA extraction and N. Bicen for performing the PCR and sequencing. The sequencing was carried out by the DTU in-house facility (DTU Multi-Assay Core, DMAC), Technical University of Denmark. This work was funded by the Danish Council for Strategic Research (grant no. 11-116163; Center for Gut, Grain and Greens), by the Technical University of Denmark and by the personal Danisco Award (to T.R.L.). The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent research centre at the University of Copenhagen and is partly funded by an unrestricted donation from the Novo Nordisk Foundation.",,71,260,276,3,99,NATURE PORTFOLIO,BERLIN,"HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY",2058-5276,,,NAT MICROBIOL,NAT. MICROBIOL,SEP,2016,1,9,,,,,,,16093,10.1038/NMICROBIOL.2016.93,http://dx.doi.org/10.1038/NMICROBIOL.2016.93,,,9,Microbiology,Science Citation Index Expanded (SCI-EXPANDED),Microbiology,DW4KB,27562254,,Y,N,2024-06-04,WOS:000383610500015,View Full Record in Web of Science
J,"Yadav, N; Sharma, V; Kapila, S; Malik, RK; Arora, S",,,,"Yadav, Nidhi; Sharma, Vivek; Kapila, Suman; Malik, Ravinder Kumar; Arora, Sumit",,,Hypocholesterolaemic and prebiotic effect of partially hydrolysed psyllium husk supplemented yoghurt,JOURNAL OF FUNCTIONAL FOODS,,,English,Article,,,,,,Psyllium husk; Partially hydrolysed psyllium husk; Yoghurt; Hypocholesterolaemic effect; Prebiotic effect,CHAIN FATTY-ACIDS; MODERATE HYPERCHOLESTEROLEMIA; MICROBIAL-FLORA; DIETARY FIBER; SOLUBLE-FIBER; PRUDENT DIET; CHOLESTEROL; GLUCOSE; FERMENTATION; CONSTIPATION,"Wistar rats fed with partially hydrolysed psyllium husk (PHPH) supplemented yoghurt for 60 days showed a significant (P < 0.05) decrease of 10.6% in triacylglycerol level (TGs), 16.2% in total cholesterol (TC), 53.01% in low density lipoprotein (LDL)-cholesterol and an increase of 25.49% in high density lipoprotein (HDL)-cholesterol in their blood. In addition, short chain fatty acid (SCFA) concentration and lactobacilli count in the faecal matter of PHPH supplemented yoghurt fed rat group were high compared to the faecal matter of the native psyllium husk supplemented yoghurt fed rat group and other control groups (positive, negative and test control). Results showed that psyllium husk retained its hypocholesterolaemic property on partial hydrolysis besides the increase in its prebiotic effect. Therefore, the biofunctional effect of PHPH on cardiovascular and gut health (by qualitatively changing the gut microbiota) can be accounted for hypocholesterolaemic and prebiotic effects, respectively. (c) 2016 Elsevier Ltd. All rights reserved.","[Yadav, Nidhi; Sharma, Vivek; Arora, Sumit] Natl Dairy Res Inst, Div Dairy Chem, Karnal 132001, Haryana, India; [Kapila, Suman] Natl Dairy Res Inst, Anim Biochem Div, Karnal 132001, Haryana, India; [Malik, Ravinder Kumar] Natl Dairy Res Inst, Dairy Microbiol Div, Karnal 132001, Haryana, India",Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute,"Yadav, N (corresponding author), Natl Dairy Res Inst, Div Dairy Chem, Karnal 132001, Haryana, India.",nidhi.ndri@gmail.com,"Kapila, Suman/O-5288-2019","Kapila, Suman/0000-0003-2627-773X; Sharma, Vivek/0000-0002-6287-3419",,,,,40,19,19,2,40,ELSEVIER SCIENCE BV,AMSTERDAM,"PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",1756-4646,,,J FUNCT FOODS,J. Funct. Food.,JUN,2016,24,,,,,,351,358,,10.1016/j.jff.2016.04.028,http://dx.doi.org/10.1016/j.jff.2016.04.028,,,8,Food Science & Technology; Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology; Nutrition & Dietetics,DP3BJ,,,,,2024-06-04,WOS:000378367100034,View Full Record in Web of Science
J,"Ahmad, A; Anjum, FM; Zahoor, T; Nawaz, H; Ahmed, Z",,,,"Ahmad, Asif; Anjum, Faqir Muhammad; Zahoor, Tahir; Nawaz, Haq; Ahmed, Zaheer",,,Extraction and characterization of β-D-glucan from oat for industrial utilization,INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES,,,English,Article,,,,,,beta-D-Glucan; Oat; Extraction; Characterization; Industrial utilization,DIETARY FIBER; STRUCTURAL-CHARACTERIZATION; RHEOLOGICAL PROPERTIES; PHYSICAL-PROPERTIES; BARLEY; VISCOSITY; POLYSACCHARIDES; CONSTIPATION; FRACTIONS; RESPONSES,"Oat beta-D-glucan is a valuable functional ingredient having numerous industrial, nutritional and health benefits Its extraction needs careful attention as extraction process may affect the physiochemical and functional properties of extracted beta-D-glucan The present study aimed at analyzing the effect of extraction of beta-D-glucan gum pellets from oat cultivar followed by detailed chemical and functional analysis Enzymatic extraction process resulted in highest yield and recovery Chemical analysis revealed protein as a dominating impurity The water binding capacity of the beta-D-glucan ranged between 3 14 and 4 52 g g(-1) of sample beta-D-G lucan exhibited ideal foaming stability when appropriate extraction technique was used The viscosity of beta-D-glucan gum ranged between 35 6 and 56 16 cp The color analysis showed L* value of beta-D-glucan gum pellet ranged between 72 18 and 83 54 Phosphorus, potassium and calcium appeared as major minerals in beta-D-glucan gum whereas iron, manganese and copper appeared as minor minerals. FTIR spectroscopy also confirms the presence of beta-D-glucan, protein and other components in extracted beta-D-glucan gum pellets. Overall, extracted beta-D-glucan showed a good potential for industrial usage (C) 2010 Elsevier B V All rights reserved","[Ahmed, Zaheer] Allama Iqbal Open Univ, Dept Home & Hlth Sci, Islamabad, Pakistan; [Ahmad, Asif] PMAS Arid Agr Univ Rawalpindi, Dept Food Technol, Rawalpindi, Pakistan; [Anjum, Faqir Muhammad; Zahoor, Tahir] Univ Agr Faisalabad, Natl Inst Food Sci & Technol, Faisalabad, Pakistan; [Nawaz, Haq] Univ Agr Faisalabad, Inst Anim Nutr & Feed Technol, Faisalabad, Pakistan",Arid Agriculture University; University of Agriculture Faisalabad; University of Agriculture Faisalabad,"Ahmed, Z (corresponding author), Allama Iqbal Open Univ, Dept Home & Hlth Sci, Islamabad, Pakistan.",,"Ahmad, Asif/F-6117-2010; Ahmed, Zaheer/AAE-6036-2019; Ahmad, Asif/G-2373-2011; ANJUM, FAQIR/AAW-9311-2020; AHMED, ZAHEER/KFS-4463-2024; Ahmad, Asif/GWB-9399-2022","Ahmad, Asif/0000-0003-4657-7561; Ahmad, Asif/0000-0003-4657-7561; Ahmad, Asif/0000-0003-4657-7561",,,,,53,125,137,5,90,ELSEVIER,AMSTERDAM,"RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS",0141-8130,1879-0003,,INT J BIOL MACROMOL,Int. J. Biol. Macromol.,APR 1,2010,46,3,,,,,304,309,,10.1016/j.ijbiomac.2010.01.002,http://dx.doi.org/10.1016/j.ijbiomac.2010.01.002,,,6,"Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science",Science Citation Index Expanded (SCI-EXPANDED),Biochemistry & Molecular Biology; Chemistry; Polymer Science,579OM,20083136,,,,2024-06-04,WOS:000276381300005,View Full Record in Web of Science
J,"MORAN, BJ; JACKSON, AA",,,,"MORAN, BJ; JACKSON, AA",,,FUNCTION OF THE HUMAN COLON,BRITISH JOURNAL OF SURGERY,,,English,Review,,,,,,,DIETARY FIBER; ILEAL-RESECTION; SMALL-INTESTINE; FATTY-ACIDS; CONSTIPATION; TRANSIT; ABSORPTION; METABOLISM; DIGESTION; FERMENTATION,"Despite the volume of research on human colonic dysfunction, little is known about colonic function in health. This has stemmed partly from the difficulty in obtaining access to the organ. Two approaches have been use& studies on patients with stomas, and intestinal intubation techniques. The colonoscope has also recently been used to gain access. All these methods have limitations and results must be interpreted with caution. The accepted roles of the colon include the conservation of water and electrolytes and the controlled evacuation of faeces. Recent research has demonstrated its importance as a metabolic organ with an influence on overall metabolism, an effect that may in large part be attributed to the activity of colonic microflora. Evidence demonstrating that the defunctioned colon behaves differently from the functioning colon in the same individual has implications for a proper understanding of the organ, as practically all previous in vivo studies have been conducted in cleansed or defunctioned human colon.","UNIV SOUTHAMPTON,DEPT SURG,SOUTHAMPTON SO9 5NH,HANTS,ENGLAND; UNIV SOUTHAMPTON,DEPT HUMAN NUTR,SOUTHAMPTON SO9 5NH,HANTS,ENGLAND",University of Southampton; University of Southampton,,,,,,,,,65,21,25,1,10,BLACKWELL SCIENCE LTD,OXFORD,"OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL",0007-1323,,,BRIT J SURG,Br. J. Surg.,NOV,1992,79,11,,,,,1132,1137,,10.1002/bjs.1800791106,http://dx.doi.org/10.1002/bjs.1800791106,,,6,Surgery,Science Citation Index Expanded (SCI-EXPANDED),Surgery,JY105,1467882,,,,2024-06-04,WOS:A1992JY10500004,View Full Record in Web of Science
J,"Hong, WD; Geng, WJ; Wang, C; Dong, LM; Pan, S; Yang, XJ; Zippi, M; Xu, CF; Zhou, MT; Pan, JY",,,,"Hong, Wandong; Geng, Wujun; Wang, Chao; Dong, Lemei; Pan, Shuang; Yang, Xinjing; Zippi, Maddalena; Xu, Chunfang; Zhou, Mengtao; Pan, Jingye",,,Prevalence of colonic diverticulosis in mainland China from 2004 to 2014,SCIENTIFIC REPORTS,,,English,Article,,,,,,,INFLAMMATORY-BOWEL-DISEASE; DIETARY FIBER INTAKE; SEX-DIFFERENCES; PATTERNS; TRENDS; RISK; CONSTIPATION; ASSOCIATION; MULTICENTER; CONSUMPTION,"The aim of this study was to determine the prevalence of colonic diverticulosis in mainland China. Sixty two thousand and thirty-four colonoscopies performed between Jan 2004 and Dec 2014 were reviewed retrospectively. The overall diverticulosis prevalence was 1.97% and out of this, 85.3% was right-sided. Prevalence does not change, significantly, on trends between the period 2004-2014. The peak of prevalence of diverticulosis was compared between the female group aged >70 years to the male one of 41-50 years. The other peak, otherwise, was compared between the group of 51-60 years with the right-sided diverticulosis to the one of >70 years with left-sided disease. Multivariate analysis suggested that the male gender could be a risk factor for diverticulosis in the group aged <= 70 years, but not for the older patients. In addition, among men was registered an increased risk factor for right-sided diverticulosis and, at the same time, a protective one for left-sided localization. In conclusion, the prevalence of colonic diverticulosis is very low in mainland China and it does not change significantly on trends over the time. Both the prevalence of this condition and its distribution changes according to the age and the genders. These findings may lead the researchers to investigate the mechanisms causing this kind of disease and its distribution in regard of the age and the gender.","[Hong, Wandong; Dong, Lemei; Pan, Shuang] Wenzhou Med Univ, Affiliated Hosp 1, Dept Gastroenterol & Hepatol, Wenzhou, Zhejiang, Peoples R China; [Geng, Wujun] Wenzhou Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Wenzhou, Zhejiang, Peoples R China; [Hong, Wandong; Wang, Chao; Yang, Xinjing; Xu, Chunfang] Soochow Univ, Affiliated Hosp 1, Dept Gastroenterol, Suzhou, Jiangsu, Peoples R China; [Zippi, Maddalena] Sandro Pertini Hosp, Unit Gastroenterol & Digest Endoscopy, Rome, Italy; [Zhou, Mengtao] Wenzhou Med Univ, Affiliated Hosp 1, Dept Surg, Wenzhou, Zhejiang, Peoples R China; [Pan, Jingye] Wenzhou Med Coll, Affiliated Hosp 1, Intens Care Unit, Wenzhou, Zhejiang, Peoples R China",Wenzhou Medical University; Wenzhou Medical University; Soochow University - China; Ospedale Sandro Pertini; Wenzhou Medical University; Wenzhou Medical University,"Xu, CF (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Gastroenterol, Suzhou, Jiangsu, Peoples R China.;Zhou, MT (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Surg, Wenzhou, Zhejiang, Peoples R China.",xcfstudy@sina.com; studyzhoumengtao@sina.com,"Zippi, Maddalena/R-4837-2019; Zippi, Maddalena/P-5144-2018; Wang, Chao/GRF-4590-2022","Zippi, Maddalena/0000-0001-5876-3199; Zippi, Maddalena/0000-0001-5876-3199; Wang, Chao/0000-0001-6979-8506; Hong, Wandong/0000-0001-6857-4252",,,,,46,15,17,0,5,NATURE PORTFOLIO,BERLIN,"HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY",2045-2322,,,SCI REP-UK,Sci Rep,MAY 17,2016,6,,,,,,,,26237,10.1038/srep26237,http://dx.doi.org/10.1038/srep26237,,,8,Multidisciplinary Sciences,Science Citation Index Expanded (SCI-EXPANDED),Science & Technology - Other Topics,DL9QD,27184602,"Green Published, gold",,,2024-06-04,WOS:000375976900001,View Full Record in Web of Science
J,"Tunc, VT; Camurdan, AD; Iihan, MN; Sahhin, F; Beyazova, U",,,,"Tunc, Vildan Taylan; Camurdan, Aysu Duyan; Iihan, Mustafa N.; Sahhin, Figen; Beyazova, Ufuk",,,Factors associated with defecation patterns in 0-24-month-old children,EUROPEAN JOURNAL OF PEDIATRICS,,,English,Article,,,,,,Defecation pattern; Infant; Meconium; Stool consistency; Stool frequency,BIRTH-WEIGHT INFANTS; MECONIUM PASSAGE; BOWEL FREQUENCY; DIETARY FIBER; STOOL; CONSTIPATION; FORMULA; TIME; BREAST; HABIT,"To identify the normal defecation patterns and the factors affecting these patterns in the first two years of life, a questionnaire was given to the parents of 1,021 children who were followed in a well-child clinic. The time of first meconium passage, presence of colic symptoms, frequency, color, and consistency of stools were recorded.Mann Whitney U, Wilcoxon, chi-square, and correlation tests were used in the statistical analyses. The median number of defecations per day was six in the first month of life. This decreased to once in the second month and almost all cases remained so until the end of the 24th month. At the second month of age, 39.3% of infants passed stools less than once a day. This pattern of rare defecation was seen until the end of 6 months, when supplemental foods were started. Stool frequency was higher in exclusively breast-fed infants (p = 0.0001). Infants who had colic symptoms in the first 2 months had less frequent defecation during the first 2 years of life (p = 0.0001). In addition to confirming the previously observed defecation patterns of 0-2-year-old infants, this study provides the relationship between colic symptoms and stool frequency, and showed that the second month of life was unique in the sense that the frequency of stooling decreased to half of the previous month and 39.3% of these infants defecated less than once a day.","[Tunc, Vildan Taylan] Ankara Numune Training & Res Hosp, Dept Family Practice, Ankara, Turkey; [Iihan, Mustafa N.] Gazi Univ, Sch Med, Dept Publ Hlth, Ankara, Turkey; [Camurdan, Aysu Duyan; Sahhin, Figen; Beyazova, Ufuk] Gazi Univ, Sch Med, Dept Social Pediat, Ankara, Turkey",Ankara Numune Training & Research Hospital; Gazi University; Gazi University,"Camurdan, AD (corresponding author), Eryaman Mahallesi 354 Sokak,Yesiloz Sitesi 8-5, TR-06374 Ankara, Turkey.",aysucamurdan@yahoo.com,,,,,,,23,63,70,0,8,SPRINGER,NEW YORK,"233 SPRING ST, NEW YORK, NY 10013 USA",0340-6199,,,EUR J PEDIATR,Eur. J. Pediatr.,DEC,2008,167,12,,,,,1357,1362,,10.1007/s00431-008-0669-2,http://dx.doi.org/10.1007/s00431-008-0669-2,,,6,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,362FD,18264719,,,,2024-06-04,WOS:000260182700002,View Full Record in Web of Science
J,"Caldwell, PHY; Lim, M; Nankivell, G",,,,"Caldwell, Patrina H. Y.; Lim, Melissa; Nankivell, Gail",,,An interprofessional approach to managing children with treatment-resistant enuresis: an educational review,PEDIATRIC NEPHROLOGY,,,English,Review,,,,,,Enuresis; Treatment resistance; Multidisciplinary approach; Interdisciplinary approach; Nocturnal enuresis; Urinary incontinence,MONOSYMPTOMATIC NOCTURNAL ENURESIS; DIETARY FIBER MIXTURE; OVERACTIVE BLADDER; URINE OUTPUT; SLEEP; ADOLESCENTS; ELECTROENCEPHALOGRAPHY; STANDARDIZATION; INCONTINENCE; CONSTIPATION,"Enuresis (intermittent urinary incontinence during sleep in a child aged 5 years) is commonly seen in paediatric practice. Despite the availability of effective interventions, treatment resistance is encountered in up to 50% of children. In this educational review we attempt to provide insight into the causes of treatment resistance, and offer practical suggestions for addressing this condition using an interprofessional approach. We explore the pathophysiology of and standard treatments for enuresis and discuss why standard treatments may fail. An interprofessional approach to treatment resistance is proposed which utilises the expertise of professionals from different disciplines to address the problems and barriers to treatment. The two interprofessional approaches include a multidisciplinary approach that involves the patient being sent to experts in different disciplines at different times to address their treatment resistance utilising the skills of the respective experts, and an interdisciplinary approach that involves a patient being managed by members of interdisciplinary team who integrate their separate discipline perspectives into a single treatment plan. Although an interdisciplinary approach is ideal, interdisciplinary teams may not be available in all circumstances. Understanding the roles of other disciplines and engaging clinicians from other disciplines when appropriate can still be helpful when treatment resistance is encountered.","[Caldwell, Patrina H. Y.; Lim, Melissa; Nankivell, Gail] Childrens Hosp Westmead, Locked Bag 4001, Westmead, NSW 2145, Australia; [Caldwell, Patrina H. Y.] Univ Sydney, Discipline Child & Adolescent Hlth, Sydney, NSW, Australia",University of Sydney; NSW Health; The Children's Hospital at Westmead; Sydney Childrens Hospitals Network; University of Sydney,"Caldwell, PHY (corresponding author), Childrens Hosp Westmead, Locked Bag 4001, Westmead, NSW 2145, Australia.;Caldwell, PHY (corresponding author), Univ Sydney, Discipline Child & Adolescent Hlth, Sydney, NSW, Australia.",patrina.caldwell@health.nsw.gov.au,"Caldwell, Patrina/C-4211-2013","Caldwell, Patrina/0000-0003-1124-6578",,,,,54,10,10,0,3,SPRINGER,NEW YORK,"ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES",0931-041X,1432-198X,,PEDIATR NEPHROL,Pediatr. Nephrol.,OCT,2018,33,10,,,,,1663,1670,,10.1007/s00467-017-3830-1,http://dx.doi.org/10.1007/s00467-017-3830-1,,,8,Pediatrics; Urology & Nephrology,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Pediatrics; Urology & Nephrology,GS8XM,29110081,,,,2024-06-04,WOS:000443998400005,View Full Record in Web of Science
J,"Lee, PC; Hu, YW; Hung, MH; Chen, CC; Lin, HC; Lee, FY; Hung, YP; Su, VYF; Yen, SH; Tzeng, CH; Chiou, TJ; Liu, CJ",,,,"Lee, Pei-Chang; Hu, Yu-Wen; Hung, Man-Hsin; Chen, Chun-Chia; Lin, Han-Chieh; Lee, Fa-Yauh; Hung, Yi-Ping; Su, Vincent Yi-Fong; Yen, Sang-Hue; Tzeng, Cheng-Hwai; Chiou, Tzeon-Jye; Liu, Chia-Jen",,,The Risk of Cancer in Patients with Benign Anal Lesions: A Nationwide Population-based Study,AMERICAN JOURNAL OF MEDICINE,,,English,Article,,,,,,benign anal lesions; hemorrhoids; cancer risk,COLORECTAL-CANCER; LAXATIVE USE; EPIDEMIOLOGIC EVIDENCE; HUMAN-PAPILLOMAVIRUS; PROSTATE-CANCER; DIETARY FIBER; COLON-CANCER; HEMORRHOIDS; CONSTIPATION; CARCINOMA,"OBJECTIVE: To evaluate the risk of cancer among patients diagnosed with hemorrhoids and benign anal inflammatory lesions. METHODS: A population-based, retrospective cohort study was conducted that included patients diagnosed with hemorrhoids or benign inflammatory anal lesions (eg, anal fissure, fistula, and perianal abscesses) that were registered in the National Health Insurance Research Database in Taiwan between January 1, 2000 and December 31, 2010. Standardized incidence ratios (SIRs) were calculated to compare the cancer incidence of these patients to the general population. RESULTS: During a median observation period of 6.23 years, 3080 cancers developed among 70,513 hemorrhoid patients, with a follow-up period of 438,425.6 person-years, entailing the SIR of 1.52 (95% confidence interval [CI], 1.47-1.58). Increased cancer risk (SIR 1.16; 95% CI, 1.11-1.21) was still noted even after excluding the first year of observation. Significant long-term risk for colorectal cancer (SIR 1.50; 95% CI, 1.35-1.66) and prostate cancer (SIR 1.40; 95% CI, 1.17-1.66) was observed after corrections were made for multiple comparisons. In contrast, there was no remarkable increase in cancer risk for patients with inflammatory anal lesions when cancers detected within the first year of diagnosis were excluded. CONCLUSION: The presence of hemorrhoids is associated significantly with a long-term risk of developing colorectal cancer or prostate cancer. In contrast, benign inflammatory anal lesions do not appear to increase the risk of malignancy. (C) 2013 Elsevier Inc. All rights reserved.","[Lee, Pei-Chang; Chen, Chun-Chia; Lin, Han-Chieh; Lee, Fa-Yauh] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei 11217, Taiwan; [Hu, Yu-Wen; Chen, Chun-Chia; Lin, Han-Chieh; Lee, Fa-Yauh; Yen, Sang-Hue; Tzeng, Cheng-Hwai; Chiou, Tzeon-Jye; Liu, Chia-Jen] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Hu, Yu-Wen; Yen, Sang-Hue] Taipei Vet Gen Hosp, Ctr Canc, Taipei 11217, Taiwan; [Hu, Yu-Wen; Liu, Chia-Jen] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Hung, Man-Hsin; Hung, Yi-Ping; Tzeng, Cheng-Hwai; Chiou, Tzeon-Jye; Liu, Chia-Jen] Taipei Vet Gen Hosp, Dept Med, Div Hematol & Oncol, Taipei 11217, Taiwan; [Su, Vincent Yi-Fong] Taipei Vet Gen Hosp, Dept Chest Med, Taipei 11217, Taiwan; [Yen, Sang-Hue] Natl Yang Ming Univ Hosp, Dept Biomed Imaging & Radiol Sci, Yilan, Taiwan; [Liu, Chia-Jen] Natl Yang Ming Univ Hosp, Dept Internal Med, Yilan, Taiwan",Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital,"Liu, CJ (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Hematol & Oncol, 201,Sec 2,Shipai Rd, Taipei 11217, Taiwan.",chiajenliu@gmail.com,"lee, pei/HNS-9797-2023; Lin, Han/GRF-1081-2022","Hung, Man Hsin/0000-0002-7449-5857; Hu, Yu-Wen/0000-0002-7983-415X",Taipei Veterans General Hospital [V102D-001-1],Taipei Veterans General Hospital(Taipei Veterans General Hospital),This study is partly supported by a grant from Taipei Veterans General Hospital (V102D-001-1).,,35,12,12,0,4,ELSEVIER SCIENCE INC,NEW YORK,"360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA",0002-9343,1555-7162,,AM J MED,Am. J. Med.,DEC,2013,126,12,,,,,,,1143.e9,10.1016/j.amjmed.2013.05.016,http://dx.doi.org/10.1016/j.amjmed.2013.05.016,,,10,"Medicine, General & Internal",Science Citation Index Expanded (SCI-EXPANDED),General & Internal Medicine,257OC,24135515,,,,2024-06-04,WOS:000327393300051,View Full Record in Web of Science
J,"Petticrew, M; Rodgers, M; Booth, A",,,,"Petticrew, M; Rodgers, M; Booth, A",,,Effectiveness of laxatives in adults,QUALITY IN HEALTH CARE,,,English,Article,,,,,,,BALANCED SOLUTION PMF-100; CHRONIC CONSTIPATION; ELDERLY-PATIENTS; TRANSIT-TIME; DOUBLE-BLIND; MANAGEMENT; LACTULOSE; DIETARY; FIBER; STOOL,,"Univ York, NHS Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England; Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland",University of York - UK; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow,"Univ York, NHS Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England.",mr14@york.ac.uk,"Petticrew, Mark/AAY-6274-2021; Booth, Alison/I-8044-2015","Booth, Alison/0000-0001-7138-6295",,,,,65,38,41,0,5,BMJ PUBLISHING GROUP,LONDON,"BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND",0963-8172,,,QUAL HEALTH CARE,Qual. Health Care,DEC,2001,10,4,,,,,268,273,,10.1136/qhc.0100268,http://dx.doi.org/10.1136/qhc.0100268,,,6,"Health Care Sciences & Services; Public, Environmental & Occupational Health",Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),"Health Care Sciences & Services; Public, Environmental & Occupational Health",504WY,11743157,Green Published,,,2024-06-04,WOS:000172880100014,View Full Record in Web of Science
J,"Corsello, A; Scatigno, L; Fiore, G; Baresi, S; Eletti, F; Zuccotti, G; Strisciuglio, C; Dilillo, D; Verduci, E",,,,"Corsello, Antonio; Scatigno, Lorenzo; Fiore, Giulia; Baresi, Stefano; Eletti, Francesca; Zuccotti, Gianvincenzo; Strisciuglio, Caterina; Dilillo, Dario; Verduci, Elvira",,,Nutraceuticals and biotics in pediatric gastrointestinal disorders,EUROPEAN JOURNAL OF CLINICAL NUTRITION,,,English,Review,,,,,,,IRRITABLE-BOWEL-SYNDROME; INTERNATIONAL SCIENTIFIC ASSOCIATION; PROBIOTIC LACTOBACILLUS STRAINS; RANDOMIZED CLINICAL-TRIAL; CASEI-RHAMNOSUS LCR35; DIETARY FIBER MIXTURE; FUNCTIONAL CONSTIPATION; CHILDHOOD CONSTIPATION; ACUTE GASTROENTERITIS; CONSENSUS STATEMENT,"In recent years there has been growing interest in the use of nutraceuticals and biotics in both pediatric and adult clinical practice. The overlapping and often ambiguous symptoms of both functional and organic gastrointestinal disorders have led to a search for alternative therapeutic approaches that avoid the use of synthetic or chemical treatments. However, while nutraceuticals and natural supplements are widely used, their health benefits are often not supported by adequate scientific evidence, and an unregulated use of nutraceuticals can be potentially harmful. The correct use of nutraceuticals, prebiotics, and probiotics can optimize the results of drug therapy in some cases and reduce the risk of side effects. This review aims to provide clinicians with guidance on the use of complementary therapies for pediatric gastrointestinal symptoms and disorders, highlighting the scarcity of studies on the kinetics and dynamics of nutraceuticals and biotics. While it is generally difficult to associate their intakes with adverse events due to the often-coexisting pharmacological treatments, it is essential to avoid the abandonment of traditional drugs with proven efficacy in the treatment of single diseases. Overall, the use of nutraceuticals, prebiotics, and probiotics in pediatric gastroenterological practice requires caution and medical supervision. Further research is needed to determine the effects of alternative therapies on pediatric gastrointestinal symptoms and disorders, and to ensure their safe and effective use in the clinical practice.","[Corsello, Antonio; Scatigno, Lorenzo; Fiore, Giulia; Baresi, Stefano; Eletti, Francesca; Zuccotti, Gianvincenzo; Dilillo, Dario; Verduci, Elvira] Univ Milan, Vittore Buzzi Childrens Hosp, Dept Pediat, Milan, Italy; [Fiore, Giulia; Verduci, Elvira] Univ Milan, Dept Hlth Sci, Milan, Italy; [Zuccotti, Gianvincenzo] Univ Milan, Dept Biomed & Clin Sci, Milan, Italy; [Strisciuglio, Caterina] Univ Campania Luigi Vanvitelli, Dept Woman Child & Gen & Specialized Surg, Naples, Italy",University of Milan; University of Milan; University of Milan; Universita della Campania Vanvitelli,"Strisciuglio, C (corresponding author), Univ Campania Luigi Vanvitelli, Dept Woman Child & Gen & Specialized Surg, Naples, Italy.",caterina.strisciuglio@unicampania.it,"Verduci, Elvira/D-7338-2014; Corsello, Antonio/AAH-7881-2021; Strisciuglio, Caterina/ABD-2466-2020; Zuccotti, Gianvincenzo/H-8572-2017","Corsello, Antonio/0000-0003-4578-0066; Strisciuglio, Caterina/0000-0002-9005-6571; Zuccotti, Gianvincenzo/0000-0002-2795-9874; Baresi, Stefano/0009-0005-2460-2756",,,,,146,1,1,3,3,SPRINGERNATURE,LONDON,"CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND",0954-3007,1476-5640,,EUR J CLIN NUTR,Eur. J. Clin. Nutr.,FEB,2024,78,2,,,,,87,98,,10.1038/s41430-023-01362-z,http://dx.doi.org/10.1038/s41430-023-01362-z,,OCT 2023,12,Nutrition & Dietetics,Science Citation Index Expanded (SCI-EXPANDED),Nutrition & Dietetics,HK0I0,37875612,,,,2024-06-04,WOS:001088156900002,View Full Record in Web of Science
J,"Maekita, T; Kato, J; Enomoto, S; Yoshida, T; Utsunomiya, H; Hayashi, H; Hanamitsu, T; Inoue, I; Maeda, Y; Moribata, K; Muraki, Y; Shingaki, N; Deguchi, H; Ueda, K; Iguchi, M; Tamai, H; Ichinose, M",,,,"Maekita, Takao; Kato, Jun; Enomoto, Shotaro; Yoshida, Takeichi; Utsunomiya, Hirotoshi; Hayashi, Hideyuki; Hanamitsu, Toshiko; Inoue, Izumi; Maeda, Yoshimasa; Moribata, Kosaku; Muraki, Yosuke; Shingaki, Naoki; Deguchi, Hisanobu; Ueda, Kazuki; Iguchi, Mikitaka; Tamai, Hideyuki; Ichinose, Masao",,,Japanese apricot improves symptoms of gastrointestinal dysmotility associated with gastroesophageal reflux disease,WORLD JOURNAL OF GASTROENTEROLOGY,,,English,Article,,,,,,Japanese apricot; Umeboshi; Gastroesophageal reflux disease; Frequency Scale for Symptoms of gastroesophageal reflux disease; Dysmotility,PRUNUS-MUME SIEBOLD; HELICOBACTER-PYLORI ERADICATION; FRUIT-JUICE CONCENTRATE; DIETARY FIBER; CITRIC-ACID; IN-VITRO; ZUCC.; GERD; GASTROPARESIS; CONSTIPATION,"AIM: To investigate the effects of Japanese apricot (JA) consumption on gastroesophageal reflux disease (GERD)-related symptoms. METHODS: Participants included individuals living in Minabe-cho, a well-known JA-growing region, who received specific medical check-ups by the local community health service in 2010. GERD-related symptoms were examined in 1303 Japanese individuals using a validated questionnaire, the Frequency Scale for Symptoms of GERD (FSSG), which consists of 7 questions associated with acid reflux symptoms and 5 questions asking about gastrointestinal dysmotility symptoms. Each question was answered using a 4-point scale, with higher scores indicating more severe GERD-related symptoms. Subjects were divided into two groups according to their intake of dried and pickled JA: daily intake (>= 1 JA daily) (392 subjects) and none or occasional intake (< 1 JA daily) (911 subjects). FSSG scores were compared between subjects who consumed JA daily and those who did not. Next, subjects were stratified by age, gender and Helicobacter pylori (H. pylori) status for subanalyses. RESULTS: Those who ate JA daily were significantly older than those who did not (60.6 +/- 10.5 years vs 56.0 +/- 11.0 years, P < 0.001). Total FSSG scores were significantly lower in subjects with daily JA intake than in those with none or only occasional intake (2.13 +/- 3.14 vs 2.70 +/- 3.82, P = 0.005). In particular, subjects who consumed JA daily showed significantly improved FSSG dysmotility scores compared with subjects who did not (1.05 +/- 1.58 vs 1.46 +/- 2.11, P < 0.001). In contrast, the FSSG reflux score did not differ between subjects with and without daily intake of JA (1.08 +/- 1.90 vs 1.24 +/- 2.11, P = 0.177). Subanalysis indicated that improvement in dysmotility by JA intake was specifically observed in non-elderly (1.24 +/- 1.68 vs 1.62 +/- 2.22, P = 0.005) and H. pylori-negative subjects (0.99 +/- 1.58 vs 1.57 +/- 2.06, P < 0.001). GERD patients (total FSSG score >= 8) were less frequently observed among subjects with daily intake of JA as compared to those without daily intake of JA (6.1% vs 9.7%, P = 0.040). CONCLUSION: Daily JA intake may improve digestive dysmotility symptoms, resulting in relief of GERD symptoms. The effect is more obvious in non-elderly and H. pylori -negative subjects.","[Maekita, Takao; Kato, Jun; Enomoto, Shotaro; Yoshida, Takeichi; Utsunomiya, Hirotoshi; Inoue, Izumi; Maeda, Yoshimasa; Moribata, Kosaku; Muraki, Yosuke; Shingaki, Naoki; Deguchi, Hisanobu; Ueda, Kazuki; Iguchi, Mikitaka; Tamai, Hideyuki; Ichinose, Masao] Wakayama Med Univ, Dept Gastroenterol, Sch Med, Wakayama, Wakayama 6410012, Japan; [Hayashi, Hideyuki] Minabe Town Off, Dept Japanese Apricot, Wakayama 6450002, Japan; [Hanamitsu, Toshiko] Minabe Town Off, Dept Hlth Welf, Wakayama 6450002, Japan",Wakayama Medical University,"Maekita, T (corresponding author), Wakayama Med Univ, Dept Gastroenterol, Sch Med, 811-1 Kimiidera, Wakayama, Wakayama 6410012, Japan.",maekita@wakayama-med.ac.jp,"Ichinose, Masao/HAB-1645-2022; Tamai, Hideyuki/HIZ-8949-2022","Tamai, Hideyuki/0000-0003-4511-4573",Grants-in-Aid for Scientific Research [25460933] Funding Source: KAKEN,"Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))",,,30,6,6,0,17,BAISHIDENG PUBLISHING GROUP INC,PLEASANTON,"8226 REGENCY DR, PLEASANTON, CA 94588 USA",1007-9327,2219-2840,,WORLD J GASTROENTERO,World J. Gastroenterol.,JUL 14,2015,21,26,,,,,8170,8177,,10.3748/wjg.v21.i26.8170,http://dx.doi.org/10.3748/wjg.v21.i26.8170,,,8,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,CM5SR,26185391,"Green Published, hybrid",,,2024-06-04,WOS:000357749400026,View Full Record in Web of Science
J,"Lerebours, E; Michel, P; Dechelotte, P",,,,"Lerebours, E; Michel, P; Dechelotte, P",,,What is effective nutritional therapy in digestive disease?,GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE,,,French,Article,,,,,,,IRRITABLE-BOWEL-SYNDROME; GASTROESOPHAGEAL REFLUX; DIETARY FIBER; FOOD INTOLERANCE; DIVERTICULAR-DISEASE; ANTIOXIDANT VITAMINS; LACTOSE-INTOLERANCE; CROHNS-DISEASE; SYMPTOMS; CONSTIPATION,,"Hop Charles Nicolle, GBPDN, F-76031 Rouen, France",Universite de Rouen Normandie,"Lerebours, E (corresponding author), Hop Charles Nicolle, GBPDN, F-76031 Rouen, France.",,"Ayubi, Tazeen/HLH-8767-2023",,,,,,55,0,0,0,0,MASSON EDITEUR,PARIS 06,"120 BLVD SAINT-GERMAIN, 75280 PARIS 06, FRANCE",0399-8320,,,GASTROEN CLIN BIOL,Gastroenterol. Clin. Biol.,JUN,1999,23,5BIS,,,,,B95,B100,,,,,,6,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,234QV,10897779,,,,2024-06-04,WOS:000082496600014,View Full Record in Web of Science
J,"Nigam, GB; Limdi, JK; Vasant, DH",,,,"Nigam, Gaurav B.; Limdi, Jimmy K.; Vasant, Dipesh H.",,,Current perspectives on the diagnosis and management of functional anorectal disorders in patients with inflammatory bowel disease,THERAPEUTIC ADVANCES IN GASTROENTEROLOGY,,,English,Review,,,,,,functional anorectal disorders; inflammatory bowel disease; faecal incontinence; dyssynergic defaecation; biofeedback therapy; anorectal dysfunction,QUALITY-OF-LIFE; GASTROINTESTINAL MOTILITY DISORDERS; IBS-LIKE SYMPTOMS; VISCERAL HYPERSENSITIVITY; DYSSYNERGIC DEFECATION; FECAL INCONTINENCE; NERVE-STIMULATION; DIETARY FIBER; PREVALENCE; CONSTIPATION,"Despite advances in inflammatory bowel disease (IBD) therapies, a significant proportion of patients with quiescent disease experience persistent, debilitating symptoms of faecal incontinence (FI), urgency and defaecatory disorders due to anorectal dysfunction. Such symptoms are often underreported or misdiagnosed and can lead to potentially premature treatment 'escalation' and under-utilisation of pelvic floor investigations. In this review article, we consider putative pathophysiological post-inflammatory changes resulting in altered anorectal sensitivity, motility and neuromuscular coordination and how this may drive symptoms in quiescent IBD. Finally, we discuss a pragmatic approach to investigating and managing anorectal dysfunction and highlight areas for future research for this often-neglected group of patients.","[Vasant, Dipesh H.] Univ Manchester, Div Diabet Endocrinol & Gastroenterol, Manchester Univ NHS Fdn Trust, Neurogastroenterol Unit,Wythenshawe Hosp, Southmoor Rd, Manchester M23 9LT, Lancs, England; [Nigam, Gaurav B.; Limdi, Jimmy K.] Pennine Acute Hosp NHS Trust, Manchester, England; [Limdi, Jimmy K.] Univ Manchester, Div Diabet Endocrinol & Gastroenterol, Manchester, Lancs, England",University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester,"Vasant, DH (corresponding author), Univ Manchester, Div Diabet Endocrinol & Gastroenterol, Manchester Univ NHS Fdn Trust, Neurogastroenterol Unit,Wythenshawe Hosp, Southmoor Rd, Manchester M23 9LT, Lancs, England.",dipesh.vasant@mft.nhs.uk,"Limdi, Jimmy K/AAS-4941-2020; Vasant, Dipesh/AAX-9854-2020","Limdi, Jimmy K/0000-0002-1039-6251; Vasant, Dipesh/0000-0002-2329-0616; Nigam, Gaurav Bhaskar/0000-0003-4699-2263",Guts UK,Guts UK,This work was supported by a quality improvement project grant awarded to DHV by Dr Falk and Guts UK.,,97,13,13,1,3,SAGE PUBLICATIONS LTD,LONDON,"1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND",1756-283X,1756-2848,,THER ADV GASTROENTER,Ther. Adv. Gastroenterol.,DEC 6,2018,11,,,,,,,,1.75628E+15,10.1177/1756284818816956,http://dx.doi.org/10.1177/1756284818816956,,,13,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED),Gastroenterology & Hepatology,HJ2ZD,30574193,"Green Published, gold",,,2024-06-04,WOS:000457038300001,View Full Record in Web of Science
J,"Stiens, SA; Bergman, SB; Goetz, LL",,,,"Stiens, SA; Bergman, SB; Goetz, LL",,,Neurogenic bowel dysfunction after spinal cord injury: Clinical evaluation and rehabilitative management,ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION,,,English,Review,,,,,,,COLONIC TRANSIT-TIME; DIOCTYL SODIUM SULFOSUCCINATE; ANTEGRADE CONTINENCE ENEMA; ANORECTAL FUNCTION; GASTROINTESTINAL TRANSIT; COLORECTAL-CANCER; FECAL IMPACTION; MOTOR-ACTIVITY; DIETARY FIBER; CONSTIPATION,"Neurogenic bowel dysfunction (NBD) is one of many impairments that result from spinal cord injury (SCI), The experience of persons with SCI reveals that the risk and occurrence of fecal incontinence and difficulty with evacuation are particularly significant life-limiting problems, This review relates the anatomy and physiology of colon function to the specific pathophysiology that detracts from the quality of life of persons after SCI, There are two patterns of NBD after SCI: the upper motor neuron bowel, which results from a spinal cord lesion above the sacral level, and the lower motor neuron bowel, which results from a lesion to the sacral spinal cord, roots, or peripheral nerve innervation of the colon, Rehabilitation evaluation consists of a comprehensive history and examination to define impairments, disabilities, and handicaps pertinent to NBD. Rehabilitation goals include continence of stool, simple willful independent defecation, and prevention of gastrointestinal complications, Intervention consists of derivation and implementation of an individualized person-centered bowel program, which may include diet, oral/rectal medications, equipment, and scheduling of bowel care. Bowel care is a procedure devised to initiate defecation and accomplish fecal evacuation, Digital-rectal stimulation is a technique utilized during bowel care to open the anal sphincter and facilitate reflex peristalsis. Recent advances in rehabilitation practices, equipment, pharmacology, and surgery have offered patients new bowel program alternatives, Interdisciplinary development of solutions for problems of NBD are evolving rapidly. (C) 1997 by the American Academy of Physical Medicine and Rehabilitation.","MED CTR,NEW ENGLAND REG SPINAL CORD INJURY CTR,BOSTON,MA 02118; VA PUGET SOUND HLTH CARE SYST,SEATTLE,WA 98108",US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System,"Stiens, SA (corresponding author), UNIV WASHINGTON,SEATTLE,WA 98195, USA.",,,,,,,,129,160,173,1,13,W B SAUNDERS CO,PHILADELPHIA,"INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399",0003-9993,,,ARCH PHYS MED REHAB,Arch. Phys. Med. Rehabil.,MAR,1997,78,3,,S,,,S86,S102,,10.1016/S0003-9993(97)90416-0,http://dx.doi.org/10.1016/S0003-9993(97)90416-0,,,17,Rehabilitation; Sport Sciences,Science Citation Index Expanded (SCI-EXPANDED),Rehabilitation; Sport Sciences,WN778,9084372,,,,2024-06-04,WOS:A1997WN77800012,View Full Record in Web of Science
J,"Baaleman, DF; Wegh, CAM; de Leeuw, TJM; van Etten-Jamaludin, FS; Vaughan, EE; Schoterman, MHC; Belzer, C; Smidt, H; Tabbers, MM; Benninga, MA; Koppen, IJN",,,,"Baaleman, Desiree F.; Wegh, Carrie A. M.; de Leeuw, Tessa J. M.; van Etten-Jamaludin, Faridi S.; Vaughan, Elaine E.; Schoterman, Margriet H. C.; Belzer, Clara; Smidt, Hauke; Tabbers, Merit M.; Benninga, Marc A.; Koppen, Ilan J. N.",,,What are Normal Defecation Patterns in Healthy Children up to Four Years of Age? A Systematic Review and Meta-Analysis,JOURNAL OF PEDIATRICS,,,English,Review,,,,,,,TODDLER STOOL SCALE; INFANT MILK FORMULA; BOWEL HABITS; GASTROINTESTINAL TOLERANCE; GALACTO-OLIGOSACCHARIDE; FUNCTIONAL CONSTIPATION; NEONATAL JAUNDICE; FECAL MICROBIOTA; BRUSSELS INFANT; DIETARY FIBER,"Objective To summarize available data on defecation frequency and stool consistency of healthy children up to age 4 in order to estimate normal references values. Study design Systematic review including cross-sectional, observational, and interventional studies published in English, that reported on defecation frequency and/or stool consistency in healthy children 0-4 years old. Results Seventy-five studies were included with 16393 children and 40033 measurements of defecation fre-quency and/or stool consistency. Based on visual inspection of defecation frequency data, a differentiation was made between two age categories: young infants (0-14 weeks old) and young children (15 weeks-4 years old). Young infants had a mean defecation frequency of 21.8 per week (95 % CI, 3.9-35.2) compared with 10.9 (CI, 5.7-16.7) in young children (P < .001). Among young infants, human milk-fed (HMF) infants had the highest mean defecation frequency per week (23.2 [CI, 8.8-38.1]), followed by formula-fed (FF) infants (13.7 [CI 5.4-23.9]), and mixed-fed (MF) infants (20.7 [CI, 7.0-30.2]). Hard stools were infrequently reported in young infants (1.5%) compared with young children (10.5%), and a reduction in the frequency of soft/watery stools was observed with higher age (27.0% in young infants compared with 6.2% in young children). HMF young infants had softer stools compared with FF young infants. Conclusions Young infants (0-14 weeks old) have softer and more frequent stools compared with young children (15 weeks-4 years old). (J Pediatr 2023;261:113559).","[Baaleman, Desiree F.; Wegh, Carrie A. M.; Belzer, Clara; Tabbers, Merit M.; Benninga, Marc A.; Koppen, Ilan J. N.] Univ Amsterdam, Emma Childrens Hosp, Dept Pediat Gastroenterol & Nutr, Amsterdam UMC, Amsterdam, Netherlands; [Wegh, Carrie A. M.; de Leeuw, Tessa J. M.; Smidt, Hauke] Wageningen Univ & Res, Lab Microbiol, Wageningen, Netherlands; [van Etten-Jamaludin, Faridi S.] Amsterdam UMC Locat Univ Amsterdam, Med Lib AMC, Amsterdam, Netherlands; [Vaughan, Elaine E.] Sensus BV Royal Cosun, Roosendaal, Netherlands; [Schoterman, Margriet H. C.] FrieslandCampina, Amersfoort, Netherlands; [Baaleman, Desiree F.] Amsterdam UMC, Emma Childrens Hosp, Dept Pediat Gastroenterol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands",University of Amsterdam; Emma Children's Hospital; Wageningen University & Research; University of Amsterdam; Emma Children's Hospital,"Baaleman, DF (corresponding author), Amsterdam UMC, Emma Childrens Hosp, Dept Pediat Gastroenterol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.",d.f.baaleman@amsterdamumc.nl,"Belzer, Clara/P-6500-2018","Smidt, Hauke/0000-0002-6138-5026",,,,,112,0,0,4,5,MOSBY-ELSEVIER,NEW YORK,"360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA",0022-3476,1097-6833,,J PEDIATR-US,J. Pediatr.,OCT,2023,261,,,,,,,,,10.1016/j.jpeds.2023.113559,http://dx.doi.org/10.1016/j.jpeds.2023.113559,,JUL 2023,30,Pediatrics,Science Citation Index Expanded (SCI-EXPANDED),Pediatrics,O9YF9,37331467,hybrid,,,2024-06-04,WOS:001047293600001,View Full Record in Web of Science
J,"Tester, RF; Al-Ghazzewi, FH",,,,"Tester, Richard F.; Al-Ghazzewi, Farage H.",,,"Mannans and health, with a special focus on glucomannans",FOOD RESEARCH INTERNATIONAL,,,English,Review,,,,,,Konjac glucomannans; Health benefits; Physiological disorders; Mannans; Prebiotic,CHAIN FATTY-ACIDS; UNCOMPLICATED DIVERTICULAR-DISEASE; HYDROLYZED KONJAC GLUCOMANNAN; ESCHERICHIA-COLI; CHRONIC CONSTIPATION; DIETARY-FIBER; BETA-MANNANASES; COLONIC ECOLOGY; CROHNS-DISEASE; AFLATOXIN B-1,"This review aims to highlight some of the health benefits associated with consuming native and depolymerised glucomannans-especially konjac glucomannans. The mannans provide a number of health benefits in the body. The ability of mannans, especially konjac glucomannans, to prevent specific pathogens including Escherichia coli from adhering to the gut or bladder mucosa is highlighted. Other benefits associated with the local gut environment are discussed together with more systemic effects in and on other organs. The glucomannans could be candidates for use as possible therapeutic tools for the treatment of a range of physiological disorders such as diverticulitis, Crohn's disease or ulcerative colitis. (c) 2012 Elsevier Ltd. All rights reserved.","[Tester, Richard F.; Al-Ghazzewi, Farage H.] Glycologic Ltd, Glasgow G4 0BA, Lanark, Scotland",,"Al-Ghazzewi, FH (corresponding author), Glycologic Ltd, 70 Cowcaddens Rd, Glasgow G4 0BA, Lanark, Scotland.",r.f.tester@glycologic.co.uk; f.h.alghazzewi@glycologic.co.uk,,,,,,,97,76,87,2,119,ELSEVIER SCIENCE BV,AMSTERDAM,"PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS",0963-9969,1873-7145,,FOOD RES INT,Food Res. Int.,JAN,2013,50,1,,,,,384,391,,10.1016/j.foodres.2012.10.037,http://dx.doi.org/10.1016/j.foodres.2012.10.037,,,8,Food Science & Technology,Science Citation Index Expanded (SCI-EXPANDED),Food Science & Technology,099IE,,,,,2024-06-04,WOS:000315613900047,View Full Record in Web of Science
J,"Silk, DBA",,,,"Silk, DBA",,,Management of irritable bowel syndrome: start of a new era?,EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY,,,English,Review,,,,,,,LACTOBACILLUS-PLANTARUM 299V; RECEPTOR PARTIAL AGONIST; COLONIC MOTOR-ACTIVITY; DOUBLE-BLIND; FOOD INTOLERANCE; INTESTINAL GAS; DIETARY FIBER; GASTROINTESTINAL TRANSIT; 5-HT3 ANTAGONIST; CONSTIPATION-PREDOMINANT,,"Cent Middlesex Hosp NHS Trust, Dept Gastroenterol & Nutr, London NW10 7NS, England; Univ London Imperial Coll Sci Technol & Med, Anaesthet & Intens Care Div, London, England",Imperial College London,"Silk, DBA (corresponding author), Cent Middlesex Hosp NHS Trust, Dept Gastroenterol & Nutr, Acton Lane, London NW10 7NS, England.",,,,,,,,245,13,14,0,1,LIPPINCOTT WILLIAMS & WILKINS,PHILADELPHIA,"TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA",0954-691X,1473-5687,,EUR J GASTROEN HEPAT,Eur. J. Gastroenterol. Hepatol.,JUN,2003,15,6,,,,,679,696,,10.1097/00042737-200306000-00016,http://dx.doi.org/10.1097/00042737-200306000-00016,,,18,Gastroenterology & Hepatology,Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI),Gastroenterology & Hepatology,688HC,12840681,,,,2024-06-04,WOS:000183427300016,View Full Record in Web of Science
